cancer.type	eQTL.type	tagSNP	LD	SNP.ID	SNP.position.hg19	Gene.symbol	Gene.position.hg19	Beta	t-stat	P-value	GWAS-Traits	
THCA	cis	1	rs10000348	chr4:111379036	ENPEP	chr4:111397229-111484491:+	0.17	4.12	4.45E-5	Blood pressure	
THCA	cis	1	rs1000113	chr5:150240076	LOC134466	chr5:150310000-150326146:-	0.46	6.14	1.71E-9	Crohn's disease	
THCA	cis	1	rs1000113	chr5:150240076	ZNF300	chr5:150273964-150284391:-	0.16	3.42	0.000675	Crohn's disease	
THCA	cis	1	rs10002332	chr4:129875301	C4orf33	chr4:130014829-130033842:+	0.56	8.91	1.04E-17	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs10002541	chr4:56395011	TMEM165	chr4:56262090-56292342:+	0.15	3.71	0.000234	Personality dimensions	
THCA	cis	1	rs10003229	chr4:57809598	C4orf14	chr4:57829517-57843826:-	0.22	4.04	6.27E-5	Response to bleomycin (chromatid breaks)	
THCA	cis	1	rs10003641	chr4:71340427	AMTN	chr4:71384298-71398459:+	0.22	5.33	1.55E-7	Alcoholism (heaviness of drinking)	
THCA	cis	1	rs10003708	chr4:90643051	MMRN1	chr4:90816003-90875778:+	0.31	3.98	8.02E-5	Parkinson's disease	
THCA	cis	1	rs10005733	chr4:292001	ZNF718	chr4:53272-156488:+	0.55	11.5	3.43E-27	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs10005932	chr4:122664782	EXOSC9	chr4:122722472-122738175:+	0.15	3.98	8.04E-5	Type 2 diabetes	
THCA	cis	1	rs10005989	chr4:56405206	TMEM165	chr4:56262090-56292342:+	0.16	4.11	4.69E-5	Personality dimensions	
THCA	cis	1	rs10006789	chr4:1330333	CRIPAK	chr4:1385340-1389782:+	0.37	7.07	5.67E-12	Systolic blood pressure	
THCA	cis	1	rs10007119	chr4:3473066	LRPAP1	chr4:3514290-3534224:-	0.2	4.85	1.66E-6	Triglycerides;Cholesterol, total;LDL cholesterol	
THCA	cis	1	rs10007789	chr4:165890377	C4orf39	chr4:165878100-165880273:+	0.19	5.38	1.19E-7	Ovarian cancer in BRCA1 mutation carriers	
THCA	cis	1	rs10008757	chr4:76903036	NAAA	chr4:76831809-76862166:-	-0.35	-6.99	9.18E-12	Longevity	
THCA	cis	1	rs1000940	chr17:5283252	C1QBP	chr17:5336099-5342471:-	0.14	4	7.47E-5	Body mass index	
THCA	cis	1	rs1000940	chr17:5283252	NLRP1	chr17:5404719-5487832:-	-0.21	-4.25	2.55E-5	Body mass index	
THCA	cis	1	rs1000940	chr17:5283252	RABEP1	chr17:5185558-5289131:+	-0.12	-3.51	0.000496	Body mass index	
THCA	cis	1	rs10009741	chr4:75711506	BTC	chr4:75671448-75719882:-	0.2	3.92	0.000103	Electroencephalogram traits	
THCA	cis	1	rs1001021	chr22:26403599	HPS4	chr22:26847447-26879820:-	-0.3	-3.62	0.000331	Schizophrenia, bipolar disorder and depression (combined)	
THCA	cis	1	rs10011259	chr4:54285952	SCFD2	chr4:53739152-54232242:-	0.2	3.92	0.000101	DNA methylation (variation)	
THCA	cis	1	rs10011543	chr4:75711122	BTC	chr4:75671448-75719882:-	-0.2	-3.87	0.000124	Electroencephalogram traits	
THCA	cis	1	rs10011647	chr4:75711216	BTC	chr4:75671448-75719882:-	0.2	3.92	0.000103	Electroencephalogram traits	
THCA	cis	1	rs10011835	chr4:71340722	AMTN	chr4:71384298-71398459:+	0.22	5.33	1.55E-7	Alcoholism (heaviness of drinking)	
THCA	cis	1	rs10012335	chr4:17628630	MED28	chr4:17616273-17629791:+	0.2	4.42	1.22E-5	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs10012625	chr4:118651007	NDST3	chr4:118954773-119179786:+	-0.25	-4.76	2.55E-6	Neutrophil count	
THCA	cis	1	rs10013113	chr4:53348892	KIAA0114	chr4:53578621-53580305:+	0.19	3.65	0.000296	Biochemical measures	
THCA	cis	1	rs10014189	chr4:75710935	BTC	chr4:75671448-75719882:-	-0.2	-3.92	0.000102	Electroencephalogram traits	
THCA	cis	1	rs1001446	chr19:32900957	DPY19L3	chr19:32896677-32975236:+	0.17	4.87	1.54E-6	Bipolar disorder	
THCA	cis	1	rs1001446	chr19:32900957	ZNF507	chr19:32836514-32878571:+	0.25	6.27	7.97E-10	Bipolar disorder	
THCA	cis	1	rs1001530	chr5:176985515	DOK3	chr5:176928915-176937427:-	0.27	6.2	1.22E-9	Alzheimer disease and age of onset	
THCA	cis	1	rs10016433	chr4:122664771	EXOSC9	chr4:122722472-122738175:+	0.15	3.98	8.04E-5	Type 2 diabetes	
THCA	cis	1	rs10016506	chr4:56396674	TMEM165	chr4:56262090-56292342:+	0.15	3.7	0.000238	Personality dimensions	
THCA	cis	1	rs10017445	chr4:68423787	CENPC1	chr4:68337989-68411256:-	0.29	6.4	3.7E-10	Parkinson's disease	
THCA	cis	1	rs10017445	chr4:68423787	STAP1	chr4:68424446-68473053:+	-0.14	-3.34	0.000888	Parkinson's disease	
THCA	cis	1	rs10017903	chr4:54267009	SCFD2	chr4:53739152-54232242:-	0.2	3.92	0.000101	DNA methylation (variation)	
THCA	cis	1	rs10018049	chr4:39117401	KLHL5	chr4:39046659-39123828:+	-0.2	-5.67	2.52E-8	Uric acid levels	
THCA	cis	1	rs10019856	chr4:17615742	MED28	chr4:17616273-17629791:+	0.18	4.02	6.79E-5	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs10021364	chr4:310691	ZNF718	chr4:53272-156488:+	-0.51	-9.38	2.76E-19	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs10023335	chr4:77358987	CCDC158	chr4:77234193-77328458:-	0.17	3.69	0.000251	Creatinine levels	
THCA	cis	1	rs10023335	chr4:77358987	FAM47E	chr4:77135193-77204923:+	0.15	3.96	8.71E-5	Creatinine levels	
THCA	cis	1	rs10024243	chr4:118651065	NDST3	chr4:118954773-119179786:+	-0.25	-4.79	2.27E-6	Neutrophil count	
THCA	cis	1	rs10026531	chr4:154727070	RNF175	chr4:154631313-154681387:-	-0.2	-4.34	1.71E-5	Electrocardiographic conduction measures	
THCA	cis	1	rs10026676	chr4:56478752	KDR	chr4:55944427-55991762:-	-0.11	-3.49	0.00052	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs10026676	chr4:56478752	NMU	chr4:56461405-56502465:-	0.2	3.59	0.000361	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs10026676	chr4:56478752	PDCL2	chr4:56422693-56458379:-	0.31	4.81	2.0E-6	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs1002675	chr3:38445226	ACVR2B	chr3:38495790-38534631:+	0.14	3.49	0.000521	Electrocardiographic conduction measures	
THCA	cis	1	rs1002675	chr3:38445226	LOC100128640	chr3:38492524-38496311:-	0.23	4.87	1.52E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs1002675	chr3:38445226	XYLB	chr3:38388251-38456467:+	0.2	4.86	1.58E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs1002676	chr3:38444932	LOC100128640	chr3:38492524-38496311:-	-0.21	-4.27	2.39E-5	Electrocardiographic conduction measures	
THCA	cis	1	rs1002676	chr3:38444932	SCN5A	chr3:38589554-38691164:-	-0.17	-3.52	0.000474	Electrocardiographic conduction measures	
THCA	cis	1	rs1002676	chr3:38444932	XYLB	chr3:38388251-38456467:+	-0.21	-5.07	5.79E-7	Electrocardiographic conduction measures	
THCA	cis	1	rs10026775	chr4:39116775	KLHL5	chr4:39046659-39123828:+	-0.21	-5.73	1.77E-8	Uric acid levels	
THCA	cis	1	rs10027138	chr4:53402581	KIAA0114	chr4:53578621-53580305:+	0.18	3.66	0.000277	Biochemical measures	
THCA	cis	1	rs10027325	chr4:282608	ZNF718	chr4:53272-156488:+	0.49	9.65	3.1E-20	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs10027437	chr4:103557251	CISD2	chr4:103790135-103809913:+	-0.16	-3.52	0.000465	Primary biliary cirrhosis	
THCA	cis	1	rs10027437	chr4:103557251	NFKB1	chr4:103422486-103538458:+	0.16	4.54	7.1E-6	Primary biliary cirrhosis	
THCA	cis	1	rs10027813	chr4:39121438	KLHL5	chr4:39046659-39123828:+	-0.21	-5.77	1.47E-8	Uric acid levels	
THCA	cis	1	rs10028351	chr4:71295971	AMTN	chr4:71384298-71398459:+	0.21	5.06	5.97E-7	Alcoholism (heaviness of drinking)	
THCA	cis	1	rs10030019	chr4:106998448	TBCK	chr4:106967233-107237861:-	0.34	7.03	7.03E-12	Airflow obstruction	
THCA	cis	1	rs10030904	chr4:39115223	KLHL5	chr4:39046659-39123828:+	-0.21	-5.74	1.65E-8	Uric acid levels	
THCA	cis	1	rs10032326	chr4:17630717	MED28	chr4:17616273-17629791:+	0.2	4.32	1.89E-5	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs10033071	chr4:111375852	ENPEP	chr4:111397229-111484491:+	0.15	3.66	0.00028	Blood pressure	
THCA	cis	1	rs10033209	chr4:90653704	MMRN1	chr4:90816003-90875778:+	0.31	3.89	0.000115	Parkinson's disease	
THCA	cis	1	rs10034433	chr4:56421176	TMEM165	chr4:56262090-56292342:+	0.16	3.98	8.05E-5	Personality dimensions	
THCA	cis	1	rs10035646	chr5:115534974	COMMD10	chr5:115420727-115628978:+	0.48	5.84	9.44E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs10036292	chr5:115595871	COMMD10	chr5:115420727-115628978:+	0.49	5.93	5.67E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs10036441	chr5:101707048	SLCO4C1	chr5:101569694-101632253:-	0.25	5.81	1.13E-8	Schizophrenia	
THCA	cis	1	rs10037055	chr5:176691279	MXD3	chr5:176732501-176739292:-	0.16	4.97	9.19E-7	Migraine without aura	
THCA	cis	1	rs1003719	chr21:38491095	DSCR9	chr21:38580804-38594036:+	-0.19	-3.82	0.000149	Eye color traits	
THCA	cis	1	rs1003719	chr21:38491095	PIGP	chr21:38437664-38445458:-	-0.54	-15.23	5.39E-43	Eye color traits	
THCA	cis	1	rs1003719	chr21:38491095	TTC3	chr21:38445571-38575406:+	0.31	10.77	2.3E-24	Eye color traits	
THCA	cis	1	rs10038972	chr5:101704518	SLCO4C1	chr5:101569694-101632253:-	0.26	5.85	9.35E-9	Schizophrenia	
THCA	cis	1	rs10041072	chr5:150259642	LOC134466	chr5:150310000-150326146:-	0.37	5.27	2.03E-7	Crohn's disease	
THCA	cis	1	rs10041507	chr5:101813160	SLCO4C1	chr5:101569694-101632253:-	0.24	5.55	4.84E-8	Schizophrenia	
THCA	cis	1	rs10041525	chr5:101813238	SLCO4C1	chr5:101569694-101632253:-	0.24	5.55	4.84E-8	Schizophrenia	
THCA	cis	1	rs10042278	chr5:115532928	COMMD10	chr5:115420727-115628978:+	0.48	5.84	9.44E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs10043228	chr5:115597048	COMMD10	chr5:115420727-115628978:+	0.49	5.93	5.67E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs10044208	chr5:101797136	SLCO4C1	chr5:101569694-101632253:-	0.24	5.54	5.1E-8	Schizophrenia	
THCA	cis	1	rs1004467	chr10:104594507	AS3MT	chr10:104613967-104661653:+	-0.28	-3.92	9.99E-5	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs1004467	chr10:104594507	C10orf26	chr10:104503727-104591851:+	-0.26	-4.62	4.9E-6	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs1004467	chr10:104594507	INA	chr10:105036920-105050106:+	-0.26	-3.57	0.000388	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs1004467	chr10:104594507	SFXN2	chr10:104474298-104498946:+	-0.34	-4.22	2.87E-5	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs10048323	chr18:47204395	CXXC1	chr18:47808715-47814692:-	-0.09	-3.51	0.000483	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	
THCA	cis	1	rs10048648	chr2:26320315	GPR113	chr2:26531041-26569685:-	-0.42	-6.7	5.97E-11	Gut microbiome composition (summer)	
THCA	cis	1	rs10048648	chr2:26320315	HADHA	chr2:26413505-26467594:-	-0.16	-3.35	0.00088	Gut microbiome composition (summer)	
THCA	cis	1	rs10048683	chr2:26320519	GPR113	chr2:26531041-26569685:-	-0.44	-6.97	1.09E-11	Gut microbiome composition (summer)	
THCA	cis	1	rs1004868	chr2:231038910	SP110	chr2:231033645-231084827:-	0.24	5.02	7.46E-7	Obesity-related traits	
THCA	cis	1	rs1004869	chr2:231039271	SP110	chr2:231033645-231084827:-	0.24	4.97	9.31E-7	Obesity-related traits	
THCA	cis	1	rs10050159	chr4:106765915	INTS12	chr4:106603787-106629881:-	-0.46	-4.34	1.74E-5	Post bronchodilator FEV1	
THCA	cis	1	rs10050333	chr4:106765813	INTS12	chr4:106603787-106629881:-	-0.46	-4.34	1.74E-5	Post bronchodilator FEV1	
THCA	cis	1	rs10051240	chr5:115569931	COMMD10	chr5:115420727-115628978:+	0.48	5.89	7.35E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs10051544	chr5:101660963	SLCO4C1	chr5:101569694-101632253:-	0.25	5.65	2.77E-8	Schizophrenia	
THCA	cis	1	rs10051747	chr5:56083289	C5orf35	chr5:56205103-56213010:+	0.99	22.42	1.26E-76	Type 2 diabetes	
THCA	cis	1	rs10051804	chr5:150226424	LOC134466	chr5:150310000-150326146:-	0.39	5.45	8.07E-8	Crohn's disease	
THCA	cis	1	rs10051924	chr5:150226639	LOC134466	chr5:150310000-150326146:-	0.39	5.45	8.07E-8	Crohn's disease	
THCA	cis	1	rs10052606	chr5:150272217	LOC134466	chr5:150310000-150326146:-	0.39	5.41	9.98E-8	Crohn's disease	
THCA	cis	1	rs10053625	chr5:101661976	SLCO4C1	chr5:101569694-101632253:-	0.25	5.65	2.77E-8	Schizophrenia	
THCA	cis	1	rs10053750	chr5:150270051	LOC134466	chr5:150310000-150326146:-	0.38	5.28	2.01E-7	Crohn's disease	
THCA	cis	1	rs10054149	chr5:101707293	SLCO4C1	chr5:101569694-101632253:-	0.25	5.81	1.13E-8	Schizophrenia	
THCA	cis	1	rs10055753	chr5:101707342	SLCO4C1	chr5:101569694-101632253:-	0.25	5.81	1.13E-8	Schizophrenia	
THCA	cis	1	rs10055868	chr5:115471612	COMMD10	chr5:115420727-115628978:+	0.49	5.93	5.67E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs10056179	chr5:110442137	TSLP	chr5:110405778-110413722:+	-0.3	-4.01	6.93E-5	Eosinophil counts	
THCA	cis	1	rs10056340	chr5:110190052	TMEM232	chr5:109624934-110062381:-	0.22	4.41	1.29E-5	Asthma and hay fever	
THCA	cis	1	rs10057988	chr5:150272062	LOC134466	chr5:150310000-150326146:-	0.39	5.41	9.98E-8	Crohn's disease	
THCA	cis	1	rs10058821	chr5:150226385	LOC134466	chr5:150310000-150326146:-	0.39	5.45	8.07E-8	Crohn's disease	
THCA	cis	1	rs10058943	chr5:150226586	LOC134466	chr5:150310000-150326146:-	0.39	5.45	8.07E-8	Crohn's disease	
THCA	cis	1	rs10061105	chr5:150255185	LOC134466	chr5:150310000-150326146:-	0.37	5.2	2.97E-7	Crohn's disease	
THCA	cis	1	rs10061105	chr5:150255185	ZNF300	chr5:150273964-150284391:-	0.15	3.4	0.000719	Crohn's disease	
THCA	cis	1	rs1006176	chr11:116788133	PCSK7	chr11:117075789-117102811:-	0.43	5.27	2.08E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs10061842	chr5:110402855	TSLP	chr5:110405778-110413722:+	-0.31	-3.96	8.79E-5	Eosinophil counts	
THCA	cis	1	rs10062350	chr5:115453497	COMMD10	chr5:115420727-115628978:+	0.49	5.98	4.49E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs10062929	chr5:110408179	TSLP	chr5:110405778-110413722:+	-0.32	-4	7.37E-5	Eosinophil counts	
THCA	cis	1	rs10062929	chr5:110408179	WDR36	chr5:110427870-110466201:+	0.2	3.64	0.000301	Eosinophil counts	
THCA	cis	1	rs10063647	chr5:127371588	SLC12A2	chr5:127419483-127525379:+	0.12	3.47	0.000576	Height	
THCA	cis	1	rs10063907	chr5:101796594	SLCO4C1	chr5:101569694-101632253:-	0.24	5.54	5.1E-8	Schizophrenia	
THCA	cis	1	rs1006396	chr22:30017000	NIPSNAP1	chr22:29950800-29977144:-	0.24	3.64	0.000299	Lipid traits	
THCA	cis	1	rs10064130	chr5:138309307	SIL1	chr5:138282412-138534065:-	0.14	4.18	3.4E-5	Age-related hearing impairment (interaction)	
THCA	cis	1	rs10064201	chr5:138309405	SIL1	chr5:138282412-138534065:-	0.15	4.49	9.06E-6	Age-related hearing impairment (interaction)	
THCA	cis	1	rs1006441	chr11:77932126	NARS2	chr11:78147017-78285909:-	-0.39	-7.04	6.64E-12	Testicular germ cell tumor	
THCA	cis	1	rs10065172	chr5:150227998	LOC134466	chr5:150310000-150326146:-	0.39	5.38	1.17E-7	Crohn's disease	
THCA	cis	1	rs1006581	chr7:150511923	TMEM176A	chr7:150497854-150502208:+	-0.16	-4.55	6.94E-6	Forced expiratory volume in 1 second (environmental interaction)	
THCA	cis	1	rs10066259	chr5:115451892	COMMD10	chr5:115420727-115628978:+	0.48	5.79	1.3E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs1006722	chr4:17618713	MED28	chr4:17616273-17629791:+	-0.15	-3.38	0.000786	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs10067645	chr5:101740751	SLCO4C1	chr5:101569694-101632253:-	0.24	5.58	4.05E-8	Schizophrenia	
THCA	cis	1	rs1007123	chr20:31345840	MAPRE1	chr20:31407699-31438210:+	0.18	4.23	2.78E-5	Ulcerative colitis	
THCA	cis	1	rs1007124	chr20:31345752	MAPRE1	chr20:31407699-31438210:+	0.18	4.26	2.49E-5	Ulcerative colitis	
THCA	cis	1	rs1007133	chr10:38225293	LOC399744	chr10:38717074-38741080:+	-0.27	-3.68	0.000261	Obesity (extreme)	
THCA	cis	1	rs1007190	chr17:43038209	C17orf104	chr17:42733982-42755658:+	-0.28	-3.47	0.000568	DNA methylation (variation)	
THCA	cis	1	rs10073364	chr5:115592582	COMMD10	chr5:115420727-115628978:+	0.49	5.93	5.67E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs10073425	chr5:110163206	TMEM232	chr5:109624934-110062381:-	0.21	4.14	4.1E-5	Asthma and hay fever	
THCA	cis	1	rs10074324	chr5:101766574	SLCO4C1	chr5:101569694-101632253:-	0.25	5.62	3.21E-8	Schizophrenia	
THCA	cis	1	rs10075318	chr5:101701924	SLCO4C1	chr5:101569694-101632253:-	0.25	5.81	1.13E-8	Schizophrenia	
THCA	cis	1	rs10076701	chr5:131596419	P4HA2	chr5:131528306-131563556:-	0.48	11.33	1.66E-26	Blood metabolite levels	
THCA	cis	1	rs10078968	chr5:150244273	LOC134466	chr5:150310000-150326146:-	0.38	5.36	1.31E-7	Crohn's disease	
THCA	cis	1	rs10078	chr5:438102	C5orf55	chr5:441645-443258:-	0.39	9.95	2.63E-21	Fat distribution (HIV)	
THCA	cis	1	rs10079394	chr5:115600919	COMMD10	chr5:115420727-115628978:+	0.48	5.88	7.87E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs10080429	chr6:109738106	AKD1	chr6:109814059-110012415:-	-0.35	-7.75	5.42E-14	Height	
THCA	cis	1	rs10080429	chr6:109738106	FIG4	chr6:110012424-110146634:+	-0.19	-3.9	0.00011	Height	
THCA	cis	1	rs10080429	chr6:109738106	SMPD2	chr6:109761931-109765121:+	0.33	8.28	1.24E-15	Height	
THCA	cis	1	rs10082867	chr12:123796997	C12orf65	chr12:123717841-123742481:+	-0.24	-4.1	4.9E-5	HDL cholesterol	
THCA	cis	1	rs10083343	chr14:65853133	LOC645431	chr14:65877313-65879335:-	-0.41	-5.29	1.85E-7	Ischemic stroke	
THCA	cis	1	rs10083346	chr14:65853273	LOC645431	chr14:65877313-65879335:-	-0.41	-5.29	1.85E-7	Ischemic stroke	
THCA	cis	1	rs10083348	chr14:65853401	LOC645431	chr14:65877313-65879335:-	-0.41	-5.29	1.85E-7	Ischemic stroke	
THCA	cis	1	rs10083363	chr14:66200768	LOC645431	chr14:65877313-65879335:-	0.26	3.43	0.000654	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs10083421	chr14:65851158	LOC645431	chr14:65877313-65879335:-	-0.41	-5.29	1.85E-7	Ischemic stroke	
THCA	cis	1	rs10083485	chr14:65853114	LOC645431	chr14:65877313-65879335:-	-0.41	-5.29	1.85E-7	Ischemic stroke	
THCA	cis	1	rs10083488	chr14:65853346	LOC645431	chr14:65877313-65879335:-	-0.4	-5.25	2.35E-7	Ischemic stroke	
THCA	cis	1	rs10083525	chr14:65851556	LOC645431	chr14:65877313-65879335:-	0.4	5.16	3.62E-7	Ischemic stroke	
THCA	cis	1	rs1008374	chr4:17683219	MED28	chr4:17616273-17629791:+	0.16	3.41	0.000701	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs1008375	chr4:17682834	MED28	chr4:17616273-17629791:+	0.17	3.73	0.000217	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs10086327	chr8:89406955	MMP16	chr8:89049462-89339717:-	0.31	5.04	6.5E-7	Electrodermal activity	
THCA	cis	1	rs10086541	chr8:96033950	C8orf38	chr8:95908040-96088396:+	-0.26	-4.47	9.74E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs10086778	chr8:10814140	CTSB	chr8:11700036-11725646:-	0.22	3.45	0.000611	Asthma and hay fever	
THCA	cis	1	rs10086872	chr8:10814210	CTSB	chr8:11700036-11725646:-	0.22	3.49	0.000536	Asthma and hay fever	
THCA	cis	1	rs10087268	chr8:89414888	MMP16	chr8:89049462-89339717:-	0.31	5.04	6.5E-7	Electrodermal activity	
THCA	cis	1	rs10088380	chr8:89416018	MMP16	chr8:89049462-89339717:-	0.31	5.04	6.5E-7	Electrodermal activity	
THCA	cis	1	rs10088439	chr8:8576699	SGK223	chr8:8175259-8239257:-	-0.31	-5.64	2.89E-8	Obesity-related traits	
THCA	cis	1	rs1008953	chr20:43980726	ZNF335	chr20:44577293-44600833:-	-0.16	-3.57	0.000396	Psoriasis	
THCA	cis	1	rs10089941	chr8:89420861	MMP16	chr8:89049462-89339717:-	0.32	5.19	3.04E-7	Electrodermal activity	
THCA	cis	1	rs1009051	chr3:49521549	GMPPB	chr3:49758932-49761384:-	-0.18	-4.05	5.9E-5	Menarche (age at onset)	
THCA	cis	1	rs1009051	chr3:49521549	P4HTM	chr3:49027341-49044579:+	0.17	4.28	2.28E-5	Menarche (age at onset)	
THCA	cis	1	rs1009051	chr3:49521549	WDR6	chr3:49044637-49053386:+	-0.18	-3.84	0.000138	Menarche (age at onset)	
THCA	cis	1	rs1009168	chr12:62510495	FAM19A2	chr12:62102043-62653925:-	-0.15	-3.38	0.000794	Post bronchodilator FEV1/FVC ratio in COPD	
THCA	cis	1	rs10092003	chr8:96036422	C8orf38	chr8:95908040-96088396:+	-0.26	-4.5	8.44E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs1009242	chr9:131916832	CRAT	chr9:131857075-131873070:-	0.31	7.52	2.69E-13	Blood metabolite ratios	
THCA	cis	1	rs10093191	chr8:89411565	MMP16	chr8:89049462-89339717:-	0.31	5.01	7.65E-7	Electrodermal activity	
THCA	cis	1	rs1009358	chr2:65276452	CEP68	chr2:65283495-65314141:+	0.16	4.15	3.95E-5	Triglycerides	
THCA	cis	1	rs10093594	chr8:96033236	C8orf38	chr8:95908040-96088396:+	0.26	4.41	1.31E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs10093818	chr8:89421010	MMP16	chr8:89049462-89339717:-	0.32	5.19	3.04E-7	Electrodermal activity	
THCA	cis	1	rs10094278	chr8:89414854	MMP16	chr8:89049462-89339717:-	0.31	5.04	6.5E-7	Electrodermal activity	
THCA	cis	1	rs1009465	chr14:65970370	LOC645431	chr14:65877313-65879335:-	0.26	3.54	0.000434	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs10095262	chr8:89432538	MMP16	chr8:89049462-89339717:-	0.32	5.19	3.04E-7	Electrodermal activity	
THCA	cis	1	rs10095390	chr8:10815515	CTSB	chr8:11700036-11725646:-	0.22	3.45	0.000614	Asthma and hay fever	
THCA	cis	1	rs10095499	chr8:89432760	MMP16	chr8:89049462-89339717:-	0.32	5.19	3.04E-7	Electrodermal activity	
THCA	cis	1	rs10095630	chr8:92071264	LRRC69	chr8:92114847-92231464:+	-0.23	-3.76	0.000194	Migraine - clinic-based	
THCA	cis	1	rs10095733	chr8:8574646	SGK223	chr8:8175259-8239257:-	-0.31	-5.64	2.87E-8	Obesity-related traits	
THCA	cis	1	rs10096195	chr8:89432587	MMP16	chr8:89049462-89339717:-	-0.26	-4.42	1.23E-5	Electrodermal activity	
THCA	cis	1	rs10096350	chr8:124184470	FAM83A	chr8:124191287-124222317:+	-0.34	-4.25	2.56E-5	Urinary uromodulin levels	
THCA	cis	1	rs10096455	chr8:96041250	C8orf38	chr8:95908040-96088396:+	-0.26	-4.56	6.5E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs10097930	chr8:96025735	C8orf38	chr8:95908040-96088396:+	-0.25	-4.23	2.81E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs10098197	chr8:96042890	C8orf38	chr8:95908040-96088396:+	-0.26	-4.56	6.5E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs10098234	chr8:8576692	SGK223	chr8:8175259-8239257:-	-0.31	-5.66	2.6E-8	Obesity-related traits	
THCA	cis	1	rs10098453	chr8:96029756	C8orf38	chr8:95908040-96088396:+	0.24	4.16	3.79E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs10098834	chr8:89430837	MMP16	chr8:89049462-89339717:-	0.32	5.19	3.04E-7	Electrodermal activity	
THCA	cis	1	rs10099075	chr8:89431248	MMP16	chr8:89049462-89339717:-	0.32	5.19	3.04E-7	Electrodermal activity	
THCA	cis	1	rs10099233	chr8:89403561	MMP16	chr8:89049462-89339717:-	0.31	5.05	6.28E-7	Electrodermal activity	
THCA	cis	1	rs10099461	chr8:89403715	MMP16	chr8:89049462-89339717:-	0.31	5.04	6.5E-7	Electrodermal activity	
THCA	cis	1	rs10099697	chr8:89418325	MMP16	chr8:89049462-89339717:-	0.32	5.07	5.71E-7	Electrodermal activity	
THCA	cis	1	rs1009977	chr14:55603002	FBXO34	chr14:55738021-55893431:+	-0.15	-3.51	0.000492	Protein biomarker	
THCA	cis	1	rs1009977	chr14:55603002	KIAA0831	chr14:55833110-55878576:-	-0.13	-3.69	0.00025	Protein biomarker	
THCA	cis	1	rs10100089	chr8:96025093	C8orf38	chr8:95908040-96088396:+	-0.25	-4.21	3.09E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs10100842	chr8:96025903	C8orf38	chr8:95908040-96088396:+	-0.25	-4.21	3.11E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs1010181	chr7:118160303	ANKRD7	chr7:117864712-117882782:+	0.25	4.12	4.5E-5	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs10102505	chr8:89416415	MMP16	chr8:89049462-89339717:-	0.32	5.08	5.4E-7	Electrodermal activity	
THCA	cis	1	rs1010254	chr5:151734109	NMUR2	chr5:151771102-151784840:-	-0.52	-9.56	6.08E-20	Optic nerve measurement (cup area)	
THCA	cis	1	rs10103178	chr8:89411050	MMP16	chr8:89049462-89339717:-	0.31	5.03	7.05E-7	Electrodermal activity	
THCA	cis	1	rs10103336	chr8:89403893	MMP16	chr8:89049462-89339717:-	0.31	5.04	6.5E-7	Electrodermal activity	
THCA	cis	1	rs10103474	chr8:89411286	MMP16	chr8:89049462-89339717:-	0.31	5.04	6.5E-7	Electrodermal activity	
THCA	cis	1	rs10103769	chr8:8573036	SGK223	chr8:8175259-8239257:-	-0.3	-5.44	8.49E-8	Obesity-related traits	
THCA	cis	1	rs10103841	chr8:96025904	C8orf38	chr8:95908040-96088396:+	-0.25	-4.21	3.11E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs10103	chr4:119956685	C4orf3	chr4:120217575-120221968:-	0.25	4	7.38E-5	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs10104706	chr8:89406894	MMP16	chr8:89049462-89339717:-	0.31	5.04	6.5E-7	Electrodermal activity	
THCA	cis	1	rs10106491	chr8:96038959	C8orf38	chr8:95908040-96088396:+	-0.26	-4.56	6.5E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs10107591	chr8:10812785	CTSB	chr8:11700036-11725646:-	0.22	3.5	0.000501	Asthma and hay fever	
THCA	cis	1	rs10109475	chr8:89414848	MMP16	chr8:89049462-89339717:-	0.31	5.04	6.5E-7	Electrodermal activity	
THCA	cis	1	rs10109812	chr8:41524899	ANK1	chr8:41510745-41754280:-	-0.22	-4.59	5.79E-6	Type 2 diabetes	
THCA	cis	1	rs10110267	chr8:92073814	LRRC69	chr8:92114847-92231464:+	-0.22	-3.64	0.000302	Migraine - clinic-based	
THCA	cis	1	rs10110453	chr8:89432552	MMP16	chr8:89049462-89339717:-	0.3	5	7.88E-7	Electrodermal activity	
THCA	cis	1	rs10110591	chr8:8576608	SGK223	chr8:8175259-8239257:-	0.31	5.66	2.61E-8	Obesity-related traits	
THCA	cis	1	rs10110635	chr8:96025069	C8orf38	chr8:95908040-96088396:+	-0.24	-4.15	3.94E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs10111179	chr8:89421080	MMP16	chr8:89049462-89339717:-	0.32	5.21	2.85E-7	Electrodermal activity	
THCA	cis	1	rs10111300	chr8:96025631	C8orf38	chr8:95908040-96088396:+	-0.25	-4.21	3.09E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs10112230	chr8:96038072	C8orf38	chr8:95908040-96088396:+	-0.26	-4.56	6.5E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs10112258	chr8:89414904	MMP16	chr8:89049462-89339717:-	0.31	5.04	6.5E-7	Electrodermal activity	
THCA	cis	1	rs10112810	chr8:89431405	MMP16	chr8:89049462-89339717:-	0.32	5.19	3.04E-7	Electrodermal activity	
THCA	cis	1	rs10113214	chr8:89432421	MMP16	chr8:89049462-89339717:-	0.32	5.19	3.04E-7	Electrodermal activity	
THCA	cis	1	rs10113545	chr8:96029707	C8orf38	chr8:95908040-96088396:+	-0.24	-4.16	3.79E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs1011527	chr1:65988093	LEPR	chr1:65886318-66102820:+	-0.26	-3.82	0.000154	Obesity (early onset extreme)	
THCA	cis	1	rs10115492	chr9:99550737	FAM22G	chr9:99690592-99704572:+	0.96	8.66	7.31E-17	Height	
THCA	cis	1	rs10115492	chr9:99550737	HIATL2	chr9:99695549-99775862:-	0.71	6.39	4.04E-10	Height	
THCA	cis	1	rs10115492	chr9:99550737	LOC441454	chr9:99671357-99672736:+	0.42	4.03	6.49E-5	Height	
THCA	cis	1	rs10116439	chr9:99552105	FAM22G	chr9:99690592-99704572:+	0.96	8.65	7.61E-17	Height	
THCA	cis	1	rs10116439	chr9:99552105	HIATL2	chr9:99695549-99775862:-	0.71	6.39	3.85E-10	Height	
THCA	cis	1	rs10116439	chr9:99552105	LOC441454	chr9:99671357-99672736:+	0.41	4	7.41E-5	Height	
THCA	cis	1	rs10117059	chr9:123653477	LOC253039	chr9:123605320-123616644:+	-0.5	-9.2	1.16E-18	Rheumatoid arthritis	
THCA	cis	1	rs10117059	chr9:123653477	PSMD5	chr9:123578334-123605206:-	-0.27	-5.21	2.87E-7	Rheumatoid arthritis	
THCA	cis	1	rs10117162	chr9:99603996	FAM22G	chr9:99690592-99704572:+	0.94	8.22	1.92E-15	Height	
THCA	cis	1	rs10117162	chr9:99603996	HIATL2	chr9:99695549-99775862:-	0.71	6.13	1.89E-9	Height	
THCA	cis	1	rs10117162	chr9:99603996	LOC441454	chr9:99671357-99672736:+	0.39	3.69	0.000252	Height	
THCA	cis	1	rs10117921	chr9:99550434	FAM22G	chr9:99690592-99704572:+	0.95	8.62	9.87E-17	Height	
THCA	cis	1	rs10117921	chr9:99550434	HIATL2	chr9:99695549-99775862:-	0.7	6.29	7.01E-10	Height	
THCA	cis	1	rs10117921	chr9:99550434	LOC441454	chr9:99671357-99672736:+	0.43	4.18	3.48E-5	Height	
THCA	cis	1	rs10117923	chr9:99550447	FAM22G	chr9:99690592-99704572:+	0.95	8.62	9.87E-17	Height	
THCA	cis	1	rs10117923	chr9:99550447	HIATL2	chr9:99695549-99775862:-	0.7	6.29	7.01E-10	Height	
THCA	cis	1	rs10117923	chr9:99550447	LOC441454	chr9:99671357-99672736:+	0.43	4.18	3.48E-5	Height	
THCA	cis	1	rs10118617	chr9:99550469	FAM22G	chr9:99690592-99704572:+	0.92	8.75	3.59E-17	Height	
THCA	cis	1	rs10118617	chr9:99550469	HIATL2	chr9:99695549-99775862:-	0.59	5.49	6.54E-8	Height	
THCA	cis	1	rs10118617	chr9:99550469	LOC441454	chr9:99671357-99672736:+	0.36	3.66	0.000286	Height	
THCA	cis	1	rs10119556	chr9:99551986	FAM22G	chr9:99690592-99704572:+	0.94	8.53	1.92E-16	Height	
THCA	cis	1	rs10119556	chr9:99551986	HIATL2	chr9:99695549-99775862:-	0.69	6.27	8.03E-10	Height	
THCA	cis	1	rs10119556	chr9:99551986	LOC441454	chr9:99671357-99672736:+	0.41	4.04	6.32E-5	Height	
THCA	cis	1	rs10120103	chr9:102695468	STX17	chr9:102668915-102736817:+	-0.16	-4.12	4.55E-5	Alopecia areata	
THCA	cis	1	rs10120515	chr9:99547165	FAM22G	chr9:99690592-99704572:+	0.96	8.66	7.31E-17	Height	
THCA	cis	1	rs10120515	chr9:99547165	HIATL2	chr9:99695549-99775862:-	0.71	6.39	4.04E-10	Height	
THCA	cis	1	rs10120515	chr9:99547165	LOC441454	chr9:99671357-99672736:+	0.42	4.03	6.49E-5	Height	
THCA	cis	1	rs1012053	chr13:42653437	KIAA0564	chr13:42140962-42535221:-	0.16	3.44	0.00064	Bipolar disorder	
THCA	cis	1	rs10121601	chr9:102687445	STX17	chr9:102668915-102736817:+	-0.17	-4.33	1.86E-5	Alopecia areata	
THCA	cis	1	rs10122464	chr9:99552321	FAM22G	chr9:99690592-99704572:+	0.98	7.96	1.27E-14	Height	
THCA	cis	1	rs10122464	chr9:99552321	HIATL2	chr9:99695549-99775862:-	0.71	5.75	1.6E-8	Height	
THCA	cis	1	rs10122464	chr9:99552321	LOC441454	chr9:99671357-99672736:+	0.44	3.89	0.000113	Height	
THCA	cis	1	rs10123261	chr9:102695442	STX17	chr9:102668915-102736817:+	-0.16	-4.05	6.04E-5	Alopecia areata	
THCA	cis	1	rs1012376	chr14:65294790	CHURC1	chr14:65381140-65411309:+	0.46	6.03	3.31E-9	Daytime sleep phenotypes	
THCA	cis	1	rs10124033	chr9:99614104	FAM22G	chr9:99690592-99704572:+	-0.93	-8.51	2.34E-16	Height	
THCA	cis	1	rs10124033	chr9:99614104	HIATL2	chr9:99695549-99775862:-	-0.7	-6.32	6.07E-10	Height	
THCA	cis	1	rs10124033	chr9:99614104	LOC441454	chr9:99671357-99672736:+	-0.36	-3.5	0.000507	Height	
THCA	cis	1	rs10124911	chr9:99567384	FAM22G	chr9:99690592-99704572:+	-0.88	-7.18	2.77E-12	Height	
THCA	cis	1	rs10124911	chr9:99567384	HIATL2	chr9:99695549-99775862:-	-0.63	-5.08	5.35E-7	Height	
THCA	cis	1	rs10124911	chr9:99567384	NCBP1	chr9:100395705-100436027:+	0.27	3.44	0.000626	Height	
THCA	cis	1	rs10127539	chr1:110620117	ALX3	chr1:110602998-110613322:-	-0.32	-7.78	4.49E-14	Blood metabolite levels	
THCA	cis	1	rs10128658	chr11:71733519	FAM86C	chr11:71498557-71512276:+	0.32	3.89	0.000116	Severe influenza A (H1N1) infection	
THCA	cis	1	rs10128682	chr11:116863458	PCSK7	chr11:117075789-117102811:-	0.41	5.18	3.34E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs10128711	chr11:18632984	SPTY2D1	chr11:18627949-18656020:-	-0.14	-4.61	5.23E-6	Cholesterol, total	
THCA	cis	1	rs10131630	chr14:97286105	VRK1	chr14:97263684-97347950:+	0.16	3.81	0.000158	Neutrophil count	
THCA	cis	1	rs1013338	chr22:38974154	JOSD1	chr22:39081549-39096459:-	-0.13	-3.39	0.000765	Resting heart rate	
THCA	cis	1	rs1013338	chr22:38974154	LOC646851	chr22:38974125-39052634:-	0.13	3.52	0.000478	Resting heart rate	
THCA	cis	1	rs1013338	chr22:38974154	TOMM22	chr22:39077954-39080763:+	-0.19	-4.15	3.92E-5	Resting heart rate	
THCA	cis	1	rs10135137	chr14:80585158	DIO2	chr14:80663870-80697397:-	-0.14	-3.38	0.000775	Lung function (FEV1)	
THCA	cis	1	rs10135248	chr14:104122310	KLC1	chr14:104029299-104167887:+	-0.23	-4.72	3.05E-6	Body mass index	
THCA	cis	1	rs10135969	chr14:65982345	LOC645431	chr14:65877313-65879335:-	0.26	3.5	0.000507	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs10135	chr22:39082174	JOSD1	chr22:39081549-39096459:-	0.14	3.55	0.000417	Resting heart rate	
THCA	cis	1	rs10135	chr22:39082174	LOC646851	chr22:38974125-39052634:-	-0.14	-3.78	0.000176	Resting heart rate	
THCA	cis	1	rs10136947	chr14:65854611	LOC645431	chr14:65877313-65879335:-	-0.41	-5.29	1.85E-7	Ischemic stroke	
THCA	cis	1	rs10136948	chr14:75511075	EIF2B2	chr14:75469612-75476292:+	0.18	4.98	8.93E-7	Height	
THCA	cis	1	rs10136948	chr14:75511075	MLH3	chr14:75480467-75518235:-	0.29	8.8	2.42E-17	Height	
THCA	cis	1	rs10136948	chr14:75511075	RPS6KL1	chr14:75372347-75389958:-	0.33	7.17	2.93E-12	Height	
THCA	cis	1	rs10136953	chr14:65854676	LOC645431	chr14:65877313-65879335:-	-0.41	-5.29	1.85E-7	Ischemic stroke	
THCA	cis	1	rs10137323	chr14:76685733	ESRRB	chr14:76837690-76968178:+	-0.33	-5.05	6.33E-7	Blood pressure	
THCA	cis	1	rs10138183	chr14:75615227	EIF2B2	chr14:75469612-75476292:+	0.19	5.13	4.28E-7	Height	
THCA	cis	1	rs10138183	chr14:75615227	MLH3	chr14:75480467-75518235:-	0.3	8.9	1.14E-17	Height	
THCA	cis	1	rs10138183	chr14:75615227	RPS6KL1	chr14:75372347-75389958:-	0.32	6.79	3.32E-11	Height	
THCA	cis	1	rs10138765	chr14:65860239	LOC645431	chr14:65877313-65879335:-	-0.55	-7.19	2.46E-12	Ischemic stroke	
THCA	cis	1	rs10138868	chr14:81776770	STON2	chr14:81727000-81893748:-	0.21	4.2	3.16E-5	Obesity-related traits	
THCA	cis	1	rs10139288	chr14:52506486	C14orf166	chr14:52456228-52471419:+	-0.14	-3.96	8.78E-5	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs10140433	chr14:74659989	C14orf45	chr14:74486059-74549566:+	-0.16	-4.64	4.53E-6	Common traits (Other)	
THCA	cis	1	rs10140433	chr14:74659989	COQ6	chr14:74416643-74429811:+	-0.14	-3.79	0.000167	Common traits (Other)	
THCA	cis	1	rs10140433	chr14:74659989	LIN52	chr14:74551656-74667117:+	-0.52	-13.79	1.19E-36	Common traits (Other)	
THCA	cis	1	rs10140851	chr14:75512612	EIF2B2	chr14:75469612-75476292:+	0.18	4.93	1.12E-6	Height	
THCA	cis	1	rs10140851	chr14:75512612	MLH3	chr14:75480467-75518235:-	0.29	8.74	3.9E-17	Height	
THCA	cis	1	rs10140851	chr14:75512612	RPS6KL1	chr14:75372347-75389958:-	0.32	7.05	6.12E-12	Height	
THCA	cis	1	rs10140857	chr14:55619611	FBXO34	chr14:55738021-55893431:+	-0.14	-3.38	0.000776	Protein biomarker	
THCA	cis	1	rs1014098	chr1:119458215	WARS2	chr1:119573841-119683295:-	-0.26	-3.55	0.00042	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs10142626	chr14:75555636	EIF2B2	chr14:75469612-75476292:+	0.19	5.14	4.01E-7	Height	
THCA	cis	1	rs10142626	chr14:75555636	MLH3	chr14:75480467-75518235:-	0.3	8.99	5.61E-18	Height	
THCA	cis	1	rs10142626	chr14:75555636	RPS6KL1	chr14:75372347-75389958:-	0.32	6.88	1.87E-11	Height	
THCA	cis	1	rs1014268	chr7:118035388	ANKRD7	chr7:117864712-117882782:+	-0.28	-4.6	5.5E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs10142865	chr14:75555624	EIF2B2	chr14:75469612-75476292:+	0.19	5.14	4.01E-7	Height	
THCA	cis	1	rs10142865	chr14:75555624	MLH3	chr14:75480467-75518235:-	0.3	8.99	5.61E-18	Height	
THCA	cis	1	rs10142865	chr14:75555624	RPS6KL1	chr14:75372347-75389958:-	0.32	6.88	1.87E-11	Height	
THCA	cis	1	rs10143132	chr14:75525850	EIF2B2	chr14:75469612-75476292:+	0.18	4.81	2.06E-6	Height	
THCA	cis	1	rs10143132	chr14:75525850	MLH3	chr14:75480467-75518235:-	0.29	8.57	1.45E-16	Height	
THCA	cis	1	rs10143132	chr14:75525850	RPS6KL1	chr14:75372347-75389958:-	0.31	6.75	4.41E-11	Height	
THCA	cis	1	rs10144220	chr14:74647904	C14orf45	chr14:74486059-74549566:+	-0.16	-4.42	1.23E-5	Common traits (Other)	
THCA	cis	1	rs10144220	chr14:74647904	COQ6	chr14:74416643-74429811:+	-0.13	-3.68	0.000255	Common traits (Other)	
THCA	cis	1	rs10144220	chr14:74647904	LIN52	chr14:74551656-74667117:+	-0.5	-13.41	5.01E-35	Common traits (Other)	
THCA	cis	1	rs10144321	chr14:100882405	WDR25	chr14:100842755-100996638:+	-0.37	-8.21	2.1E-15	Menarche (age at onset)	
THCA	cis	1	rs10145383	chr14:97283495	VRK1	chr14:97263684-97347950:+	0.17	3.83	0.000144	Neutrophil count	
THCA	cis	1	rs10146374	chr14:65857412	LOC645431	chr14:65877313-65879335:-	-0.44	-5.62	3.25E-8	Ischemic stroke	
THCA	cis	1	rs10146482	chr14:75574087	EIF2B2	chr14:75469612-75476292:+	0.19	5.09	5.13E-7	Height	
THCA	cis	1	rs10146482	chr14:75574087	MLH3	chr14:75480467-75518235:-	0.29	8.81	2.36E-17	Height	
THCA	cis	1	rs10146482	chr14:75574087	RPS6KL1	chr14:75372347-75389958:-	0.3	6.48	2.31E-10	Height	
THCA	cis	1	rs10146571	chr14:97338777	VRK1	chr14:97263684-97347950:+	0.16	3.74	0.000207	Neutrophil count	
THCA	cis	1	rs10149107	chr14:97305926	VRK1	chr14:97263684-97347950:+	0.17	3.89	0.000114	Neutrophil count	
THCA	cis	1	rs10149489	chr14:81776403	STON2	chr14:81727000-81893748:-	0.21	4.2	3.16E-5	Obesity-related traits	
THCA	cis	1	rs10149880	chr14:75633008	EIF2B2	chr14:75469612-75476292:+	-0.19	-5.06	6.04E-7	Height	
THCA	cis	1	rs10149880	chr14:75633008	MLH3	chr14:75480467-75518235:-	-0.29	-8.52	2.14E-16	Height	
THCA	cis	1	rs10149880	chr14:75633008	RPS6KL1	chr14:75372347-75389958:-	-0.31	-6.6	1.1E-10	Height	
THCA	cis	1	rs10150201	chr14:74649157	C14orf45	chr14:74486059-74549566:+	-0.16	-4.58	5.84E-6	Common traits (Other)	
THCA	cis	1	rs10150201	chr14:74649157	COQ6	chr14:74416643-74429811:+	-0.14	-3.99	7.55E-5	Common traits (Other)	
THCA	cis	1	rs10150201	chr14:74649157	LIN52	chr14:74551656-74667117:+	-0.51	-13.52	1.65E-35	Common traits (Other)	
THCA	cis	1	rs10152119	chr15:84570381	LOC388152	chr15:84867600-84898920:-	-0.21	-4	7.19E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs10152139	chr15:84570262	LOC388152	chr15:84867600-84898920:-	-0.21	-4.03	6.36E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs10152544	chr15:67444747	SMAD3	chr15:67358195-67487532:+	0.16	4	7.43E-5	Asthma	
THCA	cis	1	rs10153800	chr2:242179134	FARP2	chr2:242295711-242434255:+	0.27	5.79	1.28E-8	Chronic lymphocytic leukemia	
THCA	cis	1	rs10153800	chr2:242179134	SEPT2	chr2:242254723-242293439:+	-0.24	-4.76	2.53E-6	Chronic lymphocytic leukemia	
THCA	cis	1	rs1015415	chr7:87330101	DBF4	chr7:87505544-87538856:+	-0.27	-3.77	0.000181	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs1015424	chr7:118172840	ANKRD7	chr7:117864712-117882782:+	0.25	4.09	5.09E-5	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs10155014	chr3:49432321	GMPPB	chr3:49758932-49761384:-	-0.18	-4.2	3.15E-5	Menarche (age at onset)	
THCA	cis	1	rs10155014	chr3:49432321	P4HTM	chr3:49027341-49044579:+	0.17	4.35	1.63E-5	Menarche (age at onset)	
THCA	cis	1	rs10155014	chr3:49432321	WDR6	chr3:49044637-49053386:+	-0.17	-3.69	0.000254	Menarche (age at onset)	
THCA	cis	1	rs10155600	chr5:115620107	COMMD10	chr5:115420727-115628978:+	0.37	4.84	1.79E-6	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs10157597	chr1:45990278	AKR1A1	chr1:46016498-46035720:+	-0.14	-3.91	0.000108	Homocysteine levels	
THCA	cis	1	rs10157597	chr1:45990278	CCDC163P	chr1:45960581-45965646:-	-1.1	-31.76	7.21E-120	Homocysteine levels	
THCA	cis	1	rs10157597	chr1:45990278	MUTYH	chr1:45794915-45806142:-	0.21	5.1	4.79E-7	Homocysteine levels	
THCA	cis	1	rs10157597	chr1:45990278	PRDX1	chr1:45976708-45987609:-	-0.4	-10.2	3.08E-22	Homocysteine levels	
THCA	cis	1	rs10164319	chr19:18569833	ELL	chr19:18553475-18632937:-	-0.25	-6.53	1.65E-10	Breast cancer	
THCA	cis	1	rs10164319	chr19:18569833	ISYNA1	chr19:18545625-18548943:-	0.12	4.61	5.14E-6	Breast cancer	
THCA	cis	1	rs10164319	chr19:18569833	LRRC25	chr19:18501955-18508421:-	-0.14	-4.86	1.59E-6	Breast cancer	
THCA	cis	1	rs10164323	chr19:18569492	ELL	chr19:18553475-18632937:-	-0.25	-6.48	2.22E-10	Breast cancer	
THCA	cis	1	rs10164323	chr19:18569492	ISYNA1	chr19:18545625-18548943:-	0.12	4.63	4.62E-6	Breast cancer	
THCA	cis	1	rs10164323	chr19:18569492	LRRC25	chr19:18501955-18508421:-	-0.14	-4.79	2.18E-6	Breast cancer	
THCA	cis	1	rs10165098	chr2:27796526	FNDC4	chr2:27714751-27718126:-	-0.15	-3.54	0.000436	Oral cavity cancer	
THCA	cis	1	rs10165485	chr2:54481636	C2orf73	chr2:54558071-54588714:+	0.32	4.68	3.82E-6	Telomere length	
THCA	cis	1	rs1016669	chr3:41894440	ULK4	chr3:41288091-42003660:-	1.09	20.95	1.23E-69	Diastolic blood pressure	
THCA	cis	1	rs10167422	chr2:227777554	COL4A4	chr2:227867435-228029275:-	0.15	3.79	0.00017	Pulmonary function	
THCA	cis	1	rs10169714	chr2:73808773	ALMS1P	chr2:73872046-73912692:+	0.73	11.3	2.13E-26	Metabolite levels	
THCA	cis	1	rs10169714	chr2:73808773	NAT8	chr2:73867850-73869537:-	0.41	6.38	4.24E-10	Metabolite levels	
THCA	cis	1	rs10170359	chr2:26272219	GPR113	chr2:26531041-26569685:-	-0.47	-7.29	1.28E-12	Gut microbiome composition (summer)	
THCA	cis	1	rs10170359	chr2:26272219	HADHA	chr2:26413505-26467594:-	-0.17	-3.46	0.000582	Gut microbiome composition (summer)	
THCA	cis	1	rs10170846	chr2:223517705	FARSB	chr2:223436162-223520827:-	-0.22	-4.51	8.31E-6	Schizophrenia (inflammation and infection response interaction)	
THCA	cis	1	rs1017302	chr12:9367402	DDX12	chr12:9570288-9600768:-	0.15	3.34	0.000893	Non-alcoholic fatty liver disease histology (AST)	
THCA	cis	1	rs1017302	chr12:9367402	LOC144571	chr12:9217773-9220651:+	0.13	3.38	0.000785	Non-alcoholic fatty liver disease histology (AST)	
THCA	cis	1	rs1017302	chr12:9367402	LOC642846	chr12:9436253-9466684:+	0.41	7.96	1.26E-14	Non-alcoholic fatty liver disease histology (AST)	
THCA	cis	1	rs10173081	chr2:102957348	IL1RL1	chr2:102927962-102968497:+	0.23	4.47	9.6E-6	Asthma	
THCA	cis	1	rs10173181	chr2:17780733	GEN1	chr2:17935162-17966632:+	0.57	6.82	2.81E-11	Psychosis and Alzheimer's disease	
THCA	cis	1	rs10175180	chr2:73673123	ALMS1P	chr2:73872046-73912692:+	0.71	11.32	1.83E-26	Metabolite levels	
THCA	cis	1	rs10175180	chr2:73673123	NAT8	chr2:73867850-73869537:-	0.38	6.01	3.75E-9	Metabolite levels	
THCA	cis	1	rs10175180	chr2:73673123	TPRKB	chr2:73956957-73964517:-	-0.17	-4.39	1.4E-5	Metabolite levels	
THCA	cis	1	rs1017698	chr2:219170525	TMBIM1	chr2:219138917-219157280:-	-0.14	-3.38	0.000798	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs10177970	chr2:37512968	CEBPZ	chr2:37428778-37458740:-	0.18	4.09	5.04E-5	Chronic lymphocytic leukemia	
THCA	cis	1	rs10178409	chr2:73855507	ALMS1P	chr2:73872046-73912692:+	0.79	11.62	1.2E-27	Urinary metabolites	
THCA	cis	1	rs10178409	chr2:73855507	NAT8	chr2:73867850-73869537:-	0.39	5.63	3.13E-8	Urinary metabolites	
THCA	cis	1	rs10178975	chr2:37514564	CEBPZ	chr2:37428778-37458740:-	-0.18	-4.11	4.65E-5	Chronic lymphocytic leukemia	
THCA	cis	1	rs10178982	chr2:202227640	ALS2CR12	chr2:202153148-202222101:-	-0.37	-7.36	8.31E-13	Basal cell carcinoma	
THCA	cis	1	rs10178982	chr2:202227640	PPIL3	chr2:201735680-201753999:-	-0.24	-4.98	9.01E-7	Basal cell carcinoma	
THCA	cis	1	rs1017908	chr11:77948095	NARS2	chr11:78147017-78285909:-	-0.37	-6.33	5.5E-10	Testicular germ cell tumor	
THCA	cis	1	rs10179134	chr2:73637519	ALMS1P	chr2:73872046-73912692:+	0.74	11.4	8.25E-27	Metabolite levels	
THCA	cis	1	rs10179134	chr2:73637519	NAT8	chr2:73867850-73869537:-	0.38	5.87	8.2E-9	Metabolite levels	
THCA	cis	1	rs10179458	chr2:102934974	IL1RL1	chr2:102927962-102968497:+	0.22	4.42	1.2E-5	Asthma	
THCA	cis	1	rs1018184	chr6:86648475	SNHG5	chr6:86386726-86388451:-	0.48	10.53	1.8E-23	Response to antipsychotic treatment	
THCA	cis	1	rs10182857	chr2:26344411	GPR113	chr2:26531041-26569685:-	-0.42	-6.71	5.42E-11	Gut microbiome composition (summer)	
THCA	cis	1	rs10183486	chr2:171990971	TLK1	chr2:171847333-172087824:-	0.11	3.36	0.000853	Menopause (age at onset)	
THCA	cis	1	rs10184268	chr2:73627044	ALMS1P	chr2:73872046-73912692:+	0.68	10.6	1.03E-23	Metabolite levels	
THCA	cis	1	rs10184268	chr2:73627044	NAT8	chr2:73867850-73869537:-	0.35	5.49	6.68E-8	Metabolite levels	
THCA	cis	1	rs10184268	chr2:73627044	TPRKB	chr2:73956957-73964517:-	-0.17	-4.39	1.42E-5	Metabolite levels	
THCA	cis	1	rs10186458	chr2:20598510	TTC32	chr2:20096518-20101744:-	0.16	3.43	0.000658	Kidney disease (early stage) in type 1 diabetes	
THCA	cis	1	rs10186501	chr2:73697844	ALMS1P	chr2:73872046-73912692:+	0.7	11.19	5.71E-26	Metabolite levels	
THCA	cis	1	rs10186501	chr2:73697844	NAT8	chr2:73867850-73869537:-	0.38	5.98	4.48E-9	Metabolite levels	
THCA	cis	1	rs10186501	chr2:73697844	TPRKB	chr2:73956957-73964517:-	-0.18	-4.59	5.75E-6	Metabolite levels	
THCA	cis	1	rs10187192	chr2:73713500	ALMS1P	chr2:73872046-73912692:+	0.76	11.56	2.01E-27	Metabolite levels	
THCA	cis	1	rs10187192	chr2:73713500	NAT8	chr2:73867850-73869537:-	0.41	6.11	2.05E-9	Metabolite levels	
THCA	cis	1	rs10187416	chr2:73713741	ALMS1P	chr2:73872046-73912692:+	0.69	10.83	1.35E-24	Metabolite levels	
THCA	cis	1	rs10187416	chr2:73713741	NAT8	chr2:73867850-73869537:-	0.35	5.48	6.74E-8	Metabolite levels	
THCA	cis	1	rs10187416	chr2:73713741	TPRKB	chr2:73956957-73964517:-	-0.18	-4.66	4.04E-6	Metabolite levels	
THCA	cis	1	rs1018741	chr21:34686345	IFNAR1	chr21:34696734-34732126:+	0.22	5.28	1.93E-7	Narcolepsy	
THCA	cis	1	rs1018742	chr21:34686381	IFNAR1	chr21:34696734-34732126:+	0.22	5.28	1.93E-7	Narcolepsy	
THCA	cis	1	rs10189154	chr2:102937544	IL1RL1	chr2:102927962-102968497:+	0.23	4.51	8.31E-6	Asthma	
THCA	cis	1	rs10189526	chr2:102937883	IL1RL1	chr2:102927962-102968497:+	0.23	4.51	8.31E-6	Asthma	
THCA	cis	1	rs10189574	chr2:73698518	ALMS1P	chr2:73872046-73912692:+	0.69	10.9	7.26E-25	Metabolite levels	
THCA	cis	1	rs10189574	chr2:73698518	NAT8	chr2:73867850-73869537:-	0.37	5.81	1.12E-8	Metabolite levels	
THCA	cis	1	rs10189574	chr2:73698518	TPRKB	chr2:73956957-73964517:-	-0.17	-4.43	1.16E-5	Metabolite levels	
THCA	cis	1	rs10189996	chr2:240908800	NDUFA10	chr2:240900158-240964798:-	0.31	8.57	1.47E-16	Odorant perception (isobutyraldehyde)	
THCA	cis	1	rs10190105	chr2:47481641	CRIPT	chr2:46844325-46852880:+	-0.23	-3.65	0.000293	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs10190219	chr2:73658331	ALMS1P	chr2:73872046-73912692:+	0.74	11.42	7.11E-27	Metabolite levels	
THCA	cis	1	rs10190219	chr2:73658331	NAT8	chr2:73867850-73869537:-	0.39	5.97	4.59E-9	Metabolite levels	
THCA	cis	1	rs10191791	chr2:218279247	DIRC3	chr2:218148748-218621316:-	0.21	5.07	5.84E-7	Height	
THCA	cis	1	rs1019180	chr7:38219012	STARD3NL	chr7:38217933-38270269:+	-0.53	-12.48	3.9E-31	Treatment response for severe sepsis	
THCA	cis	1	rs1019217	chr11:22842622	SVIP	chr11:22843600-22851382:-	0.28	6.96	1.16E-11	Dialysis-related mortality	
THCA	cis	1	rs10193316	chr2:227777650	COL4A4	chr2:227867435-228029275:-	0.15	3.84	0.000139	Pulmonary function	
THCA	cis	1	rs10193373	chr2:281886	SH3YL1	chr2:218138-264810:-	-0.94	-25.99	1.72E-93	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs10193404	chr2:227777757	COL4A4	chr2:227867435-228029275:-	0.15	3.78	0.000175	Pulmonary function	
THCA	cis	1	rs10193610	chr2:240940618	NDUFA10	chr2:240900158-240964798:-	0.31	8.87	1.52E-17	Odorant perception (isobutyraldehyde)	
THCA	cis	1	rs10193972	chr2:73717656	ALMS1P	chr2:73872046-73912692:+	0.7	11.19	5.71E-26	Metabolite levels	
THCA	cis	1	rs10193972	chr2:73717656	NAT8	chr2:73867850-73869537:-	0.37	5.82	1.1E-8	Metabolite levels	
THCA	cis	1	rs10193972	chr2:73717656	TPRKB	chr2:73956957-73964517:-	-0.18	-4.58	6.04E-6	Metabolite levels	
THCA	cis	1	rs10197757	chr2:227763244	COL4A4	chr2:227867435-228029275:-	0.15	3.83	0.000144	Pulmonary function	
THCA	cis	1	rs1020004	chr7:12255778	VWDE	chr7:12370509-12443852:-	-0.24	-4.14	4.07E-5	Response to amphetamines	
THCA	cis	1	rs10202478	chr2:26276049	GPR113	chr2:26531041-26569685:-	-0.47	-7.26	1.58E-12	Gut microbiome composition (summer)	
THCA	cis	1	rs10202478	chr2:26276049	HADHA	chr2:26413505-26467594:-	-0.17	-3.46	0.000589	Gut microbiome composition (summer)	
THCA	cis	1	rs1020410	chr2:176784138	KIAA1715	chr2:176790410-176867514:-	-0.16	-4.93	1.14E-6	Obesity-related traits	
THCA	cis	1	rs10204368	chr2:227774244	COL4A4	chr2:227867435-228029275:-	0.16	3.88	0.000117	Pulmonary function	
THCA	cis	1	rs10205364	chr2:27794233	FNDC4	chr2:27714751-27718126:-	-0.16	-3.67	0.000271	Oral cavity cancer	
THCA	cis	1	rs10205487	chr2:70151471	ASPRV1	chr2:70187226-70314147:-	0.12	3.34	0.000898	Carotid plaque burden (smoking interaction)	
THCA	cis	1	rs10206231	chr2:202229225	ALS2CR12	chr2:202153148-202222101:-	-0.36	-7.04	6.87E-12	Basal cell carcinoma	
THCA	cis	1	rs10206231	chr2:202229225	PPIL3	chr2:201735680-201753999:-	-0.23	-4.81	2.02E-6	Basal cell carcinoma	
THCA	cis	1	rs10206993	chr2:240900919	NDUFA10	chr2:240900158-240964798:-	0.31	8.58	1.3E-16	Odorant perception (isobutyraldehyde)	
THCA	cis	1	rs10207220	chr2:73785046	ALMS1P	chr2:73872046-73912692:+	0.75	11.49	3.84E-27	Metabolite levels	
THCA	cis	1	rs10207220	chr2:73785046	NAT8	chr2:73867850-73869537:-	0.42	6.39	3.87E-10	Metabolite levels	
THCA	cis	1	rs10208155	chr2:61115039	C2orf74	chr2:61372243-61391964:+	0.42	6.51	1.85E-10	Inflammatory skin disease	
THCA	cis	1	rs10209620	chr2:61173941	AHSA2	chr2:61404553-61414058:+	-0.11	-3.42	0.00067	Inflammatory skin disease	
THCA	cis	1	rs10209620	chr2:61173941	C2orf74	chr2:61372243-61391964:+	0.39	6.15	1.59E-9	Inflammatory skin disease	
THCA	cis	1	rs10210763	chr2:227776029	COL4A4	chr2:227867435-228029275:-	0.16	3.88	0.000117	Pulmonary function	
THCA	cis	1	rs10212536	chr3:41827026	ULK4	chr3:41288091-42003660:-	1.07	19.91	1.15E-64	Diastolic blood pressure	
THCA	cis	1	rs10213867	chr5:76533530	PDE8B	chr5:76506706-76723226:+	0.11	3.41	0.000706	Thyroid hormone levels	
THCA	cis	1	rs10214634	chr6:26564582	BTN2A3	chr6:26422317-26431927:+	0.18	4.29	2.18E-5	Educational attainment	
THCA	cis	1	rs10214634	chr6:26564582	HCG11	chr6:26521934-26527610:+	-0.22	-4.31	2.0E-5	Educational attainment	
THCA	cis	1	rs10214634	chr6:26564582	HMGN4	chr6:26538572-26547162:+	-0.16	-4.19	3.3E-5	Educational attainment	
THCA	cis	1	rs10214634	chr6:26564582	LOC100270746	chr6:26987146-26988085:-	-0.14	-3.46	0.000587	Educational attainment	
THCA	cis	1	rs10214634	chr6:26564582	ZNF322A	chr6:26634612-26659963:-	-0.16	-4.63	4.61E-6	Educational attainment	
THCA	cis	1	rs1021464	chr1:76375415	ACADM	chr1:76190043-76229353:+	-0.25	-5.08	5.52E-7	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs1021464	chr1:76375415	ST6GALNAC3	chr1:76540389-77096669:+	-0.25	-3.35	0.000878	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs10215453	chr7:77488678	PTPN12	chr7:77166773-77269388:+	-0.16	-3.65	0.000288	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs10215453	chr7:77488678	RSBN1L	chr7:77325743-77409120:+	0.15	3.71	0.000234	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs10215700	chr7:87492050	DBF4	chr7:87505544-87538856:+	-0.27	-3.75	0.000202	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs10215948	chr7:65747786	ASL	chr7:65540776-65558321:+	0.16	4.32	1.9E-5	Aortic root size	
THCA	cis	1	rs10215948	chr7:65747786	GUSB	chr7:65425675-65447246:-	-0.28	-5.46	7.66E-8	Aortic root size	
THCA	cis	1	rs10215948	chr7:65747786	RABGEF1	chr7:66093890-66276446:+	-0.66	-14.31	6.66E-39	Aortic root size	
THCA	cis	1	rs10215973	chr7:87491724	DBF4	chr7:87505544-87538856:+	-0.28	-3.95	9.17E-5	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs10216533	chr8:143763690	C8orf55	chr8:143808621-143818350:+	0.36	8.51	2.25E-16	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs10216533	chr8:143763690	LY6K	chr8:143781529-143785582:+	0.28	5.2	2.95E-7	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs10216533	chr8:143763690	LYNX1	chr8:143845758-143859640:-	-0.2	-4.24	2.72E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs10216533	chr8:143763690	PSCA	chr8:143761875-143764142:+	0.36	6.44	2.96E-10	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs10217337	chr9:102710396	STX17	chr9:102668915-102736817:+	-0.17	-4.33	1.86E-5	Alopecia areata	
THCA	cis	1	rs10217366	chr9:102710555	STX17	chr9:102668915-102736817:+	-0.17	-4.33	1.86E-5	Alopecia areata	
THCA	cis	1	rs10217692	chr9:102710431	STX17	chr9:102668915-102736817:+	-0.17	-4.26	2.44E-5	Alopecia areata	
THCA	cis	1	rs10218458	chr1:107571327	NTNG1	chr1:107682629-108024471:+	0.2	3.39	0.000746	AIDS	
THCA	cis	1	rs10218795	chr1:145416056	NOTCH2NL	chr1:145209111-145295525:+	1.03	15.11	1.83E-42	Coronary heart disease	
THCA	cis	1	rs10225368	chr7:87395206	DBF4	chr7:87505544-87538856:+	-0.27	-4.08	5.34E-5	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs10226849	chr7:87413080	DBF4	chr7:87505544-87538856:+	-0.3	-4.51	8.03E-6	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs1022687	chr20:47648854	ARFGEF2	chr20:47538275-47653229:+	0.12	3.97	8.3E-5	Anger	
THCA	cis	1	rs1022687	chr20:47648854	CSE1L	chr20:47662838-47713484:+	-0.41	-10.14	5.2E-22	Anger	
THCA	cis	1	rs10228845	chr7:21583617	DNAH11	chr7:21582833-21941455:+	-0.26	-5.64	2.92E-8	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
THCA	cis	1	rs10229224	chr7:21583921	DNAH11	chr7:21582833-21941455:+	-0.26	-5.66	2.64E-8	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
THCA	cis	1	rs10229552	chr7:99234899	ATP5J2	chr7:99055785-99063808:-	-0.18	-3.86	0.00013	Blood metabolite levels	
THCA	cis	1	rs10229552	chr7:99234899	ZNF655	chr7:99156045-99174074:+	-0.16	-3.44	0.000624	Blood metabolite levels	
THCA	cis	1	rs10230718	chr7:87443972	DBF4	chr7:87505544-87538856:+	-0.28	-3.82	0.000149	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs10231294	chr7:32465357	AVL9	chr7:32535176-33079034:+	-0.16	-4.68	3.82E-6	Metabolite levels (HVA/MHPG ratio)	
THCA	cis	1	rs10232457	chr7:87462515	DBF4	chr7:87505544-87538856:+	0.3	4.34	1.72E-5	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs10234018	chr7:66146284	GUSB	chr7:65425675-65447246:-	-0.32	-6.39	3.88E-10	Aortic root size	
THCA	cis	1	rs10234018	chr7:66146284	LOC493754	chr7:65993446-66057363:-	0.19	3.47	0.000567	Aortic root size	
THCA	cis	1	rs10234018	chr7:66146284	RABGEF1	chr7:66093890-66276446:+	-0.5	-10.25	1.99E-22	Aortic root size	
THCA	cis	1	rs10234018	chr7:66146284	TYW1	chr7:66461817-66704496:+	-0.18	-3.83	0.000147	Aortic root size	
THCA	cis	1	rs10234309	chr7:135311167	PL-5283	chr7:135347221-135378160:+	0.71	16.4	2.78E-48	Paget's disease	
THCA	cis	1	rs10234309	chr7:135311167	SLC13A4	chr7:135365993-135412933:-	-0.73	-12	3.43E-29	Paget's disease	
THCA	cis	1	rs10235395	chr7:12286050	VWDE	chr7:12370509-12443852:-	-0.27	-4.54	7.16E-6	Response to amphetamines	
THCA	cis	1	rs10236369	chr7:12280838	VWDE	chr7:12370509-12443852:-	-0.26	-4.37	1.52E-5	Response to amphetamines	
THCA	cis	1	rs10237097	chr7:87491388	DBF4	chr7:87505544-87538856:+	-0.27	-4.03	6.4E-5	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs10237201	chr7:87491352	DBF4	chr7:87505544-87538856:+	-0.3	-4.47	9.7E-6	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs10237619	chr7:54774106	SEC61G	chr7:54819941-54826939:-	0.16	4.69	3.5E-6	Systemic lupus erythematosus	
THCA	cis	1	rs10238070	chr7:23909791	C7orf46	chr7:23719749-23742268:+	0.13	3.89	0.000114	Schizophrenia	
THCA	cis	1	rs10238564	chr7:87412489	DBF4	chr7:87505544-87538856:+	-0.27	-4.08	5.33E-5	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs10239908	chr7:87497323	DBF4	chr7:87505544-87538856:+	0.3	4.37	1.55E-5	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs1024037	chr3:47318449	C3orf75	chr3:47537131-47555199:-	0.1	4.35	1.7E-5	Colorectal cancer	
THCA	cis	1	rs1024037	chr3:47318449	NBEAL2	chr3:47021173-47051193:+	0.12	3.84	0.000141	Colorectal cancer	
THCA	cis	1	rs10240479	chr7:38221256	STARD3NL	chr7:38217933-38270269:+	-0.52	-12.33	1.63E-30	Treatment response for severe sepsis	
THCA	cis	1	rs10240648	chr7:118083471	ANKRD7	chr7:117864712-117882782:+	-0.27	-4.29	2.16E-5	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs10242018	chr7:110929652	IMMP2L	chr7:110303110-111202538:-	0.18	4.07	5.42E-5	Schizophrenia	
THCA	cis	1	rs10244498	chr7:66116056	ASL	chr7:65540776-65558321:+	-0.14	-3.78	0.000178	Aortic root size	
THCA	cis	1	rs10244498	chr7:66116056	GUSB	chr7:65425675-65447246:-	0.25	4.92	1.17E-6	Aortic root size	
THCA	cis	1	rs10244498	chr7:66116056	LOC729156	chr7:66274980-66309813:-	0.17	3.61	0.000339	Aortic root size	
THCA	cis	1	rs10244498	chr7:66116056	RABGEF1	chr7:66093890-66276446:+	0.69	15.39	1.09E-43	Aortic root size	
THCA	cis	1	rs1024460	chr7:118000843	ANKRD7	chr7:117864712-117882782:+	0.27	4.5	8.46E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs10245161	chr7:23907692	C7orf46	chr7:23719749-23742268:+	0.13	3.96	8.79E-5	Schizophrenia	
THCA	cis	1	rs10246687	chr7:32465183	AVL9	chr7:32535176-33079034:+	-0.16	-4.68	3.82E-6	Metabolite levels (HVA/MHPG ratio)	
THCA	cis	1	rs10246786	chr7:87511396	DBF4	chr7:87505544-87538856:+	-0.25	-3.86	0.000131	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs10247258	chr7:87386604	DBF4	chr7:87505544-87538856:+	-0.27	-3.89	0.000114	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs10247443	chr7:50620586	FIGNL1	chr7:50511834-50518088:-	-0.18	-4.58	5.84E-6	Malaria	
THCA	cis	1	rs10247526	chr7:65780696	CCT6P1	chr7:65216092-65228661:+	-0.43	-6.76	4.02E-11	Diabetic kidney disease	
THCA	cis	1	rs10247526	chr7:65780696	CRCP	chr7:65579805-65619551:+	0.28	4.24	2.73E-5	Diabetic kidney disease	
THCA	cis	1	rs10247526	chr7:65780696	LOC493754	chr7:65993446-66057363:-	-0.3	-3.44	0.000623	Diabetic kidney disease	
THCA	cis	1	rs10247526	chr7:65780696	RABGEF1	chr7:66093890-66276446:+	-0.6	-7.41	5.92E-13	Diabetic kidney disease	
THCA	cis	1	rs10250513	chr7:50621488	FIGNL1	chr7:50511834-50518088:-	-0.16	-4.33	1.85E-5	Malaria	
THCA	cis	1	rs10250808	chr7:32466153	AVL9	chr7:32535176-33079034:+	-0.16	-4.78	2.34E-6	Metabolite levels (HVA/MHPG ratio)	
THCA	cis	1	rs10252662	chr7:44811223	H2AFV	chr7:44866488-44887725:-	-0.17	-4.14	4.11E-5	Educational attainment (years of education)	
THCA	cis	1	rs10252662	chr7:44811223	ZMIZ2	chr7:44788180-44810733:+	-0.14	-3.56	0.000402	Educational attainment (years of education)	
THCA	cis	1	rs10252765	chr7:66228732	GUSB	chr7:65425675-65447246:-	0.31	6.22	1.07E-9	Aortic root size	
THCA	cis	1	rs10252765	chr7:66228732	RABGEF1	chr7:66093890-66276446:+	0.5	10.11	6.47E-22	Aortic root size	
THCA	cis	1	rs10252765	chr7:66228732	TYW1	chr7:66461817-66704496:+	0.17	3.62	0.000323	Aortic root size	
THCA	cis	1	rs10252990	chr7:87459951	DBF4	chr7:87505544-87538856:+	-0.26	-3.93	9.74E-5	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs10253106	chr7:87460030	DBF4	chr7:87505544-87538856:+	-0.3	-4.37	1.55E-5	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs1025646	chr3:41754422	ULK4	chr3:41288091-42003660:-	1.05	18.72	4.62E-59	Diastolic blood pressure	
THCA	cis	1	rs10256972	chr7:1039003	GPER	chr7:1121844-1133451:+	0.14	4.17	3.57E-5	Longevity;Endometriosis	
THCA	cis	1	rs10256972	chr7:1039003	ZFAND2A	chr7:1192544-1199855:-	0.44	11.9	9.24E-29	Longevity;Endometriosis	
THCA	cis	1	rs10257427	chr7:65743208	ASL	chr7:65540776-65558321:+	0.16	4.32	1.9E-5	Aortic root size	
THCA	cis	1	rs10257427	chr7:65743208	GUSB	chr7:65425675-65447246:-	-0.28	-5.46	7.66E-8	Aortic root size	
THCA	cis	1	rs10257427	chr7:65743208	RABGEF1	chr7:66093890-66276446:+	-0.66	-14.31	6.66E-39	Aortic root size	
THCA	cis	1	rs10257777	chr7:23910981	C7orf46	chr7:23719749-23742268:+	0.13	3.98	7.83E-5	Schizophrenia	
THCA	cis	1	rs1025935	chr12:62520165	FAM19A2	chr12:62102043-62653925:-	-0.15	-3.43	0.000663	Post bronchodilator FEV1/FVC ratio in COPD	
THCA	cis	1	rs10261707	chr7:54173177	SEC61G	chr7:54819941-54826939:-	-0.23	-3.82	0.000151	Periodontal disease-related phenotypes	
THCA	cis	1	rs10262624	chr7:23915676	C7orf46	chr7:23719749-23742268:+	0.13	3.94	9.2E-5	Schizophrenia	
THCA	cis	1	rs10264856	chr7:87262581	DBF4	chr7:87505544-87538856:+	-0.24	-3.55	0.000422	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs10267268	chr7:54175501	SEC61G	chr7:54819941-54826939:-	-0.22	-3.38	0.000785	Periodontal disease-related phenotypes	
THCA	cis	1	rs10269158	chr7:87467125	DBF4	chr7:87505544-87538856:+	-0.27	-3.71	0.000231	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs10269692	chr7:54787067	SEC61G	chr7:54819941-54826939:-	0.16	4.47	9.96E-6	Systemic lupus erythematosus	
THCA	cis	1	rs10274773	chr7:66133578	GUSB	chr7:65425675-65447246:-	-0.33	-6.8	3.22E-11	Aortic root size	
THCA	cis	1	rs10274773	chr7:66133578	RABGEF1	chr7:66093890-66276446:+	-0.51	-10.49	2.65E-23	Aortic root size	
THCA	cis	1	rs10274773	chr7:66133578	TYW1	chr7:66461817-66704496:+	-0.18	-3.93	9.79E-5	Aortic root size	
THCA	cis	1	rs10275978	chr7:32466719	AVL9	chr7:32535176-33079034:+	-0.16	-4.8	2.12E-6	Metabolite levels (HVA/MHPG ratio)	
THCA	cis	1	rs10276499	chr7:87261736	DBF4	chr7:87505544-87538856:+	-0.24	-3.66	0.000283	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs10276819	chr7:87481505	DBF4	chr7:87505544-87538856:+	-0.26	-3.93	9.73E-5	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs1027730	chr8:94085539	C8orf83	chr8:93895865-94029901:-	-0.28	-4.54	7.15E-6	Attention deficit hyperactivity disorder	
THCA	cis	1	rs1027731	chr8:94085378	C8orf83	chr8:93895865-94029901:-	0.27	4.25	2.56E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs1027732	chr8:94085322	C8orf83	chr8:93895865-94029901:-	0.27	4.25	2.56E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs10278291	chr7:87493807	DBF4	chr7:87505544-87538856:+	-0.26	-3.93	9.74E-5	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs10278546	chr7:100516003	ACHE	chr7:100487616-100494539:-	-0.24	-3.84	0.000142	Resting heart rate	
THCA	cis	1	rs10279537	chr7:77474961	PTPN12	chr7:77166773-77269388:+	-0.17	-3.89	0.000113	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs10279537	chr7:77474961	RSBN1L	chr7:77325743-77409120:+	0.15	3.56	0.000409	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs10282407	chr7:38233393	STARD3NL	chr7:38217933-38270269:+	-0.52	-12.38	9.54E-31	Treatment response for severe sepsis	
THCA	cis	1	rs10282532	chr7:54773399	SEC61G	chr7:54819941-54826939:-	0.16	4.7	3.45E-6	Systemic lupus erythematosus	
THCA	cis	1	rs1028390	chr6:55935791	COL21A1	chr6:55921389-56258892:-	-0.64	-7.91	1.86E-14	Psychosis (atypical)	
THCA	cis	1	rs1028449	chr14:35512995	FAM177A1	chr14:35514113-35552587:+	-0.23	-4.32	1.91E-5	Atopic dermatitis	
THCA	cis	1	rs1028449	chr14:35512995	KIAA0391	chr14:35591776-35786673:+	0.28	5.34	1.42E-7	Atopic dermatitis	
THCA	cis	1	rs1028449	chr14:35512995	PPP2R3C	chr14:35554679-35591679:-	0.53	9.99	1.74E-21	Atopic dermatitis	
THCA	cis	1	rs1028488	chr6:170590475	DLL1	chr6:170591296-170599697:-	0.16	4.31	1.96E-5	Interferon alpha levels in systemic lupus erythematosus	
THCA	cis	1	rs1029740	chr7:22873586	TOMM7	chr7:22852254-22862421:-	-0.3	-8.31	1.03E-15	Fibrinogen	
THCA	cis	1	rs1030094	chr19:32910431	DPY19L3	chr19:32896677-32975236:+	0.18	5.01	7.56E-7	Bipolar disorder	
THCA	cis	1	rs1030094	chr19:32910431	ZNF507	chr19:32836514-32878571:+	0.25	6.29	7.09E-10	Bipolar disorder	
THCA	cis	1	rs1030136	chr2:190735660	ASNSD1	chr2:190526125-190535556:+	-0.53	-5.48	6.79E-8	Subcutaneous adipose tissue	
THCA	cis	1	rs1030420	chr8:67360725	ADHFE1	chr8:67344718-67381042:+	-0.27	-5.57	4.26E-8	Blood metabolite levels	
THCA	cis	1	rs1030420	chr8:67360725	C8orf46	chr8:67405491-67430757:+	0.3	4.95	1.02E-6	Blood metabolite levels	
THCA	cis	1	rs1030730	chr2:26284143	GPR113	chr2:26531041-26569685:-	-0.47	-7.31	1.15E-12	Gut microbiome composition (summer)	
THCA	cis	1	rs1030730	chr2:26284143	HADHA	chr2:26413505-26467594:-	-0.17	-3.48	0.000549	Gut microbiome composition (summer)	
THCA	cis	1	rs1030831	chr4:130025037	C4orf33	chr4:130014829-130033842:+	-0.6	-9.87	4.77E-21	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs1031755	chr15:53951435	WDR72	chr15:53805938-54051859:-	0.15	3.6	0.000346	Chronic kidney disease;Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs1031756	chr15:53951548	WDR72	chr15:53805938-54051859:-	0.15	3.53	0.000448	Chronic kidney disease;Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs1031925	chr3:51379274	HEMK1	chr3:50606583-50622419:+	-0.2	-4.15	3.89E-5	Melanoma	
THCA	cis	1	rs1031925	chr3:51379274	TEX264	chr3:51705222-51738338:+	0.23	6.1	2.14E-9	Melanoma	
THCA	cis	1	rs1032157	chr2:67601816	ETAA1	chr2:67624442-67637533:+	-0.16	-3.93	9.56E-5	Pancreatic cancer	
THCA	cis	1	rs1032524	chr1:201790826	SHISA4	chr1:201858032-201861426:+	0.3	6.57	1.35E-10	Body mass index	
THCA	cis	1	rs1032935	chr11:93644645	HEPHL1	chr11:93754378-93847374:+	-0.44	-3.99	7.61E-5	Obesity-related traits	
THCA	cis	1	rs1033299	chr2:17774153	GEN1	chr2:17935162-17966632:+	0.5	6.67	7.04E-11	Psychosis and Alzheimer's disease	
THCA	cis	1	rs1033301	chr2:17773998	GEN1	chr2:17935162-17966632:+	0.49	6.55	1.45E-10	Psychosis and Alzheimer's disease	
THCA	cis	1	rs1033667	chr22:29130300	CHEK2	chr22:29083731-29137822:-	0.15	3.46	0.00058	Esophageal cancer and gastric cancer	
THCA	cis	1	rs1035142	chr2:202153078	ALS2CR12	chr2:202153148-202222101:-	-0.44	-9.03	4.25E-18	Melanoma;Esophageal squamous cell carcinoma	
THCA	cis	1	rs1035411	chr5:179729519	MAPK9	chr5:179660597-179719071:-	0.15	3.57	0.000395	Height	
THCA	cis	1	rs1036036	chr4:39112724	KLHL5	chr4:39046659-39123828:+	-0.21	-5.93	5.75E-9	Uric acid levels	
THCA	cis	1	rs1036037	chr4:39112892	KLHL5	chr4:39046659-39123828:+	-0.21	-5.71	2.0E-8	Uric acid levels	
THCA	cis	1	rs1036038	chr4:39113003	KLHL5	chr4:39046659-39123828:+	-0.21	-5.73	1.77E-8	Uric acid levels	
THCA	cis	1	rs1036554	chr2:86236099	LOC90784	chr2:86247339-86250991:-	-0.57	-6.67	6.95E-11	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs1037036	chr17:18764077	FAM18B	chr17:18684582-18710026:+	-0.43	-10.65	6.45E-24	Educational attainment (years of education)	
THCA	cis	1	rs1037036	chr17:18764077	FBXW10	chr17:18647326-18682661:+	-0.24	-5.27	2.03E-7	Educational attainment (years of education)	
THCA	cis	1	rs1037036	chr17:18764077	LOC220594	chr17:18414577-18445234:-	-0.22	-3.52	0.000468	Educational attainment (years of education)	
THCA	cis	1	rs1037147	chr4:130025873	C4orf33	chr4:130014829-130033842:+	-0.61	-9.87	4.98E-21	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs1038108	chr17:20921548	USP22	chr17:20902908-20947073:-	-0.18	-3.8	0.000162	Blood trace element (Se levels)	
THCA	cis	1	rs1039664	chr7:65449716	CCT6P1	chr7:65216092-65228661:+	0.39	6.24	9.65E-10	Diabetic kidney disease	
THCA	cis	1	rs1039664	chr7:65449716	CRCP	chr7:65579805-65619551:+	-0.27	-4.22	2.96E-5	Diabetic kidney disease	
THCA	cis	1	rs1039664	chr7:65449716	RABGEF1	chr7:66093890-66276446:+	0.5	6.26	8.41E-10	Diabetic kidney disease	
THCA	cis	1	rs10400248	chr11:247029	PSMD13	chr11:236808-252984:+	-0.22	-6.65	7.8E-11	Menarche (age at onset)	
THCA	cis	1	rs10400248	chr11:247029	SIRT3	chr11:214625-236931:-	0.12	3.45	0.000613	Menarche (age at onset)	
THCA	cis	1	rs10401485	chr19:7222234	ZNF557	chr19:7069471-7087976:+	-0.17	-3.61	0.00034	Triglycerides	
THCA	cis	1	rs10402468	chr19:17384003	ABHD8	chr19:17402941-17414282:-	0.27	4.3	2.06E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs10402468	chr19:17384003	ANKLE1	chr19:17392454-17398454:+	0.29	4.82	1.92E-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs10402468	chr19:17384003	OCEL1	chr19:17337055-17340027:+	0.22	4.18	3.43E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs10402727	chr19:52370379	ZNF577	chr19:52359056-52394145:-	-0.24	-5.82	1.08E-8	Breast cancer	
THCA	cis	1	rs10402727	chr19:52370379	ZNF649	chr19:52392489-52408247:-	-0.19	-4.02	6.65E-5	Breast cancer	
THCA	cis	1	rs10402988	chr19:52363104	ZNF577	chr19:52359056-52394145:-	-0.24	-5.66	2.56E-8	Breast cancer	
THCA	cis	1	rs10402988	chr19:52363104	ZNF649	chr19:52392489-52408247:-	-0.18	-3.76	0.000194	Breast cancer	
THCA	cis	1	rs10403249	chr19:18604942	ELL	chr19:18553475-18632937:-	-0.25	-6.53	1.64E-10	Breast cancer	
THCA	cis	1	rs10403249	chr19:18604942	ISYNA1	chr19:18545625-18548943:-	0.12	4.54	7.15E-6	Breast cancer	
THCA	cis	1	rs10403249	chr19:18604942	LRRC25	chr19:18501955-18508421:-	-0.13	-4.61	5.21E-6	Breast cancer	
THCA	cis	1	rs10403370	chr19:32992855	DPY19L3	chr19:32896677-32975236:+	0.19	4.84	1.73E-6	Bipolar disorder	
THCA	cis	1	rs10403370	chr19:32992855	ZNF507	chr19:32836514-32878571:+	0.3	6.99	9.59E-12	Bipolar disorder	
THCA	cis	1	rs10403540	chr19:39204846	LGALS7	chr19:39261608-39264157:-	-0.23	-4.75	2.76E-6	Heart rate	
THCA	cis	1	rs1040393	chr1:166861596	MAEL	chr1:166958519-166991447:+	0.44	5.93	5.92E-9	Schizophrenia	
THCA	cis	1	rs10403962	chr19:46160638	SNRPD2	chr19:46190713-46195443:-	-0.09	-3.39	0.000746	Type 2 diabetes	
THCA	cis	1	rs10404142	chr19:46160698	SNRPD2	chr19:46190713-46195443:-	-0.09	-3.39	0.000755	Type 2 diabetes	
THCA	cis	1	rs10404211	chr19:33093565	LRP3	chr19:33685599-33699767:+	0.24	3.47	0.000574	Eosinophilic esophagitis	
THCA	cis	1	rs10404486	chr19:53284135	ZNF600	chr19:53268750-53290034:-	0.59	10.03	1.29E-21	Phospholipid levels (plasma)	
THCA	cis	1	rs10405348	chr19:12062853	ZNF763	chr19:12035900-12091196:+	-0.4	-4.85	1.71E-6	Multiple sclerosis	
THCA	cis	1	rs10405382	chr19:32896716	DPY19L3	chr19:32896677-32975236:+	0.19	5.14	4.06E-7	Bipolar disorder	
THCA	cis	1	rs10405382	chr19:32896716	ZNF507	chr19:32836514-32878571:+	0.3	7.55	2.15E-13	Bipolar disorder	
THCA	cis	1	rs10405457	chr19:44296582	LYPD5	chr19:44300080-44324808:-	-0.25	-5.26	2.16E-7	Breast cancer	
THCA	cis	1	rs10405457	chr19:44296582	ZNF155	chr19:44488355-44502477:+	-0.25	-5.5	6.25E-8	Breast cancer	
THCA	cis	1	rs10405457	chr19:44296582	ZNF404	chr19:44376516-44384288:-	-0.24	-6.41	3.52E-10	Breast cancer	
THCA	cis	1	rs1040558	chr6:20713706	SOX4	chr6:21593972-21598847:+	0.12	3.48	0.000556	Type 2 diabetes	
THCA	cis	1	rs10405636	chr19:18538742	ELL	chr19:18553475-18632937:-	-0.25	-6.4	3.74E-10	Breast cancer	
THCA	cis	1	rs10405636	chr19:18538742	ISYNA1	chr19:18545625-18548943:-	0.13	4.71	3.25E-6	Breast cancer	
THCA	cis	1	rs10405636	chr19:18538742	LRRC25	chr19:18501955-18508421:-	-0.14	-4.74	2.87E-6	Breast cancer	
THCA	cis	1	rs10406778	chr19:39170473	LGALS7	chr19:39261608-39264157:-	-0.21	-4.38	1.49E-5	Heart rate	
THCA	cis	1	rs10406920	chr19:17389648	ABHD8	chr19:17402941-17414282:-	0.25	4.13	4.35E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs10406920	chr19:17389648	ANKLE1	chr19:17392454-17398454:+	0.29	4.94	1.08E-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs10406920	chr19:17389648	OCEL1	chr19:17337055-17340027:+	0.21	4.22	2.91E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs1040726	chr20:3264267	ITPA	chr20:3190056-3204504:+	-0.24	-5.87	8.02E-9	IFN-related cytopenia	
THCA	cis	1	rs1040727	chr20:3264292	ITPA	chr20:3190056-3204504:+	-0.25	-6.07	2.65E-9	IFN-related cytopenia	
THCA	cis	1	rs10408585	chr19:22613247	ZNF98	chr19:22573899-22605148:-	-0.28	-4.12	4.39E-5	Dental caries;Response to statins (LDL cholesterol change)	
THCA	cis	1	rs10409331	chr19:52370962	ZNF577	chr19:52359056-52394145:-	-0.24	-5.82	1.08E-8	Breast cancer	
THCA	cis	1	rs10409331	chr19:52370962	ZNF649	chr19:52392489-52408247:-	-0.19	-4.02	6.65E-5	Breast cancer	
THCA	cis	1	rs10409483	chr19:18590223	ELL	chr19:18553475-18632937:-	-0.26	-6.54	1.6E-10	Breast cancer	
THCA	cis	1	rs10409483	chr19:18590223	ISYNA1	chr19:18545625-18548943:-	0.12	4.65	4.27E-6	Breast cancer	
THCA	cis	1	rs10409483	chr19:18590223	LRRC25	chr19:18501955-18508421:-	-0.14	-4.82	1.9E-6	Breast cancer	
THCA	cis	1	rs10409485	chr19:41920765	B3GNT8	chr19:41931265-41934635:-	0.36	8.31	9.74E-16	Height	
THCA	cis	1	rs10409505	chr19:18590251	ELL	chr19:18553475-18632937:-	-0.26	-6.62	9.77E-11	Breast cancer	
THCA	cis	1	rs10409505	chr19:18590251	ISYNA1	chr19:18545625-18548943:-	0.13	4.71	3.19E-6	Breast cancer	
THCA	cis	1	rs10409505	chr19:18590251	LRRC25	chr19:18501955-18508421:-	-0.14	-4.81	2.01E-6	Breast cancer	
THCA	cis	1	rs10409835	chr19:32888660	DPY19L3	chr19:32896677-32975236:+	0.19	5.24	2.47E-7	Bipolar disorder	
THCA	cis	1	rs10409835	chr19:32888660	ZNF507	chr19:32836514-32878571:+	0.27	6.99	9.15E-12	Bipolar disorder	
THCA	cis	1	rs10409882	chr19:46160935	SNRPD2	chr19:46190713-46195443:-	-0.09	-3.39	0.000755	Type 2 diabetes	
THCA	cis	1	rs10410204	chr19:7224350	ZNF557	chr19:7069471-7087976:+	-0.18	-3.76	0.000192	Triglycerides	
THCA	cis	1	rs10410651	chr19:45160896	PVR	chr19:45147098-45169426:+	0.25	5.05	6.21E-7	Multiple sclerosis	
THCA	cis	1	rs10410770	chr19:32902404	DPY19L3	chr19:32896677-32975236:+	0.19	5.08	5.36E-7	Bipolar disorder	
THCA	cis	1	rs10410770	chr19:32902404	ZNF507	chr19:32836514-32878571:+	0.3	7.3	1.25E-12	Bipolar disorder	
THCA	cis	1	rs10411009	chr19:18606266	ELL	chr19:18553475-18632937:-	-0.26	-6.75	4.26E-11	Breast cancer	
THCA	cis	1	rs10411009	chr19:18606266	ISYNA1	chr19:18545625-18548943:-	0.12	4.71	3.32E-6	Breast cancer	
THCA	cis	1	rs10411009	chr19:18606266	LRRC25	chr19:18501955-18508421:-	-0.13	-4.61	5.18E-6	Breast cancer	
THCA	cis	1	rs10411161	chr19:52372976	ZNF577	chr19:52359056-52394145:-	-0.23	-5.53	5.34E-8	Breast cancer	
THCA	cis	1	rs10411161	chr19:52372976	ZNF649	chr19:52392489-52408247:-	-0.18	-3.76	0.000188	Breast cancer	
THCA	cis	1	rs10412080	chr19:52373508	ZNF577	chr19:52359056-52394145:-	-0.23	-5.36	1.28E-7	Breast cancer	
THCA	cis	1	rs10412080	chr19:52373508	ZNF649	chr19:52392489-52408247:-	-0.2	-4.06	5.64E-5	Breast cancer	
THCA	cis	1	rs10412219	chr19:33413246	C19orf40	chr19:33463148-33467955:+	-0.17	-3.4	0.000725	Blood metabolite levels;Urinary metabolites (H-NMR features);Urinary metabolites	
THCA	cis	1	rs10412219	chr19:33413246	SLC7A9	chr19:33321421-33360683:-	-0.27	-6.32	6.04E-10	Blood metabolite levels;Urinary metabolites (H-NMR features);Urinary metabolites	
THCA	cis	1	rs10413237	chr19:18548249	ELL	chr19:18553475-18632937:-	-0.25	-6.36	4.59E-10	Breast cancer	
THCA	cis	1	rs10413237	chr19:18548249	ISYNA1	chr19:18545625-18548943:-	0.13	4.91	1.25E-6	Breast cancer	
THCA	cis	1	rs10413237	chr19:18548249	LRRC25	chr19:18501955-18508421:-	-0.14	-4.65	4.4E-6	Breast cancer	
THCA	cis	1	rs10413735	chr19:41921071	B3GNT8	chr19:41931265-41934635:-	-0.36	-8.33	8.76E-16	Height	
THCA	cis	1	rs10414104	chr19:52368132	ZNF577	chr19:52359056-52394145:-	-0.24	-5.77	1.46E-8	Breast cancer	
THCA	cis	1	rs10414104	chr19:52368132	ZNF649	chr19:52392489-52408247:-	-0.19	-3.85	0.000133	Breast cancer	
THCA	cis	1	rs10415145	chr19:32841053	DPY19L3	chr19:32896677-32975236:+	-0.2	-5.61	3.45E-8	Bipolar disorder	
THCA	cis	1	rs10415145	chr19:32841053	ZNF507	chr19:32836514-32878571:+	-0.31	-7.97	1.21E-14	Bipolar disorder	
THCA	cis	1	rs10415219	chr19:39150235	LGALS7	chr19:39261608-39264157:-	-0.22	-4.38	1.43E-5	Heart rate	
THCA	cis	1	rs10415744	chr19:32880580	DPY19L3	chr19:32896677-32975236:+	0.21	5.69	2.21E-8	Bipolar disorder	
THCA	cis	1	rs10415744	chr19:32880580	ZNF507	chr19:32836514-32878571:+	0.31	7.94	1.48E-14	Bipolar disorder	
THCA	cis	1	rs10416218	chr19:33599127	GPATCH1	chr19:33571786-33621318:+	0.35	8.53	1.9E-16	Bone properties (heel)	
THCA	cis	1	rs10416265	chr19:33605300	GPATCH1	chr19:33571786-33621318:+	0.29	6.75	4.34E-11	Bone properties (heel)	
THCA	cis	1	rs10416600	chr19:18386063	KIAA1683	chr19:18367906-18385319:-	-0.26	-7.52	2.74E-13	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs10416654	chr19:17385176	ABHD8	chr19:17402941-17414282:-	0.25	4.18	3.49E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs10416654	chr19:17385176	ANKLE1	chr19:17392454-17398454:+	0.29	4.96	1.0E-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs10416654	chr19:17385176	OCEL1	chr19:17337055-17340027:+	0.22	4.28	2.3E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs10417006	chr19:12157253	ZNF763	chr19:12035900-12091196:+	-0.37	-4.48	9.33E-6	Multiple sclerosis	
THCA	cis	1	rs10417152	chr19:32888900	DPY19L3	chr19:32896677-32975236:+	0.19	5.29	1.89E-7	Bipolar disorder	
THCA	cis	1	rs10417152	chr19:32888900	ZNF507	chr19:32836514-32878571:+	0.3	7.51	2.9E-13	Bipolar disorder	
THCA	cis	1	rs10417311	chr19:41902038	B3GNT8	chr19:41931265-41934635:-	-0.34	-8	9.28E-15	Height	
THCA	cis	1	rs10417311	chr19:41902038	EXOSC5	chr19:41892278-41903256:-	-0.1	-3.44	0.000639	Height	
THCA	cis	1	rs1041748	chr22:24700854	CYTSA	chr22:24666786-24813707:+	-0.15	-3.74	0.000209	Gut microbiome composition (summer)	
THCA	cis	1	rs1041748	chr22:24700854	GGT5	chr22:24615623-24641110:-	-0.21	-4.32	1.87E-5	Gut microbiome composition (summer)	
THCA	cis	1	rs1041748	chr22:24700854	POM121L9P	chr22:24647589-24661490:+	-0.41	-9.31	4.71E-19	Gut microbiome composition (summer)	
THCA	cis	1	rs10417997	chr19:41902361	B3GNT8	chr19:41931265-41934635:-	-0.35	-8.17	2.84E-15	Height	
THCA	cis	1	rs10417997	chr19:41902361	EXOSC5	chr19:41892278-41903256:-	-0.1	-3.37	0.000805	Height	
THCA	cis	1	rs10418154	chr19:17386006	ABHD8	chr19:17402941-17414282:-	0.25	4.1	4.84E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs10418154	chr19:17386006	ANKLE1	chr19:17392454-17398454:+	0.29	4.91	1.28E-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs10418154	chr19:17386006	OCEL1	chr19:17337055-17340027:+	0.21	4.21	3.04E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs10418362	chr19:17386107	ABHD8	chr19:17402941-17414282:-	0.25	4.1	4.84E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs10418362	chr19:17386107	ANKLE1	chr19:17392454-17398454:+	0.29	4.91	1.28E-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs10418362	chr19:17386107	OCEL1	chr19:17337055-17340027:+	0.21	4.21	3.04E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs10421560	chr19:39186613	LGALS7	chr19:39261608-39264157:-	-0.22	-4.45	1.05E-5	Heart rate	
THCA	cis	1	rs10421887	chr19:44294849	LYPD5	chr19:44300080-44324808:-	0.24	5.14	4.08E-7	Breast cancer	
THCA	cis	1	rs10421887	chr19:44294849	ZNF155	chr19:44488355-44502477:+	0.26	5.71	1.96E-8	Breast cancer	
THCA	cis	1	rs10421887	chr19:44294849	ZNF404	chr19:44376516-44384288:-	0.26	6.83	2.66E-11	Breast cancer	
THCA	cis	1	rs10422783	chr19:41906436	B3GNT8	chr19:41931265-41934635:-	-0.34	-8	9.28E-15	Height	
THCA	cis	1	rs10422783	chr19:41906436	EXOSC5	chr19:41892278-41903256:-	-0.1	-3.44	0.000639	Height	
THCA	cis	1	rs10422956	chr19:41901261	B3GNT8	chr19:41931265-41934635:-	-0.34	-8.01	8.72E-15	Height	
THCA	cis	1	rs10422956	chr19:41901261	EXOSC5	chr19:41892278-41903256:-	-0.1	-3.43	0.000653	Height	
THCA	cis	1	rs10423531	chr19:33600140	GPATCH1	chr19:33571786-33621318:+	0.36	8.74	3.94E-17	Bone properties (heel)	
THCA	cis	1	rs10424665	chr19:32895631	DPY19L3	chr19:32896677-32975236:+	0.19	5.18	3.25E-7	Bipolar disorder	
THCA	cis	1	rs10424665	chr19:32895631	ZNF507	chr19:32836514-32878571:+	0.27	6.93	1.35E-11	Bipolar disorder	
THCA	cis	1	rs10425939	chr19:17397244	ABHD8	chr19:17402941-17414282:-	0.29	4.69	3.56E-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs10425939	chr19:17397244	ANKLE1	chr19:17392454-17398454:+	0.31	5.17	3.43E-7	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs10425939	chr19:17397244	OCEL1	chr19:17337055-17340027:+	0.21	4.01	6.92E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs10425982	chr19:18586519	ELL	chr19:18553475-18632937:-	-0.25	-6.48	2.22E-10	Breast cancer	
THCA	cis	1	rs10425982	chr19:18586519	ISYNA1	chr19:18545625-18548943:-	0.12	4.63	4.62E-6	Breast cancer	
THCA	cis	1	rs10425982	chr19:18586519	LRRC25	chr19:18501955-18508421:-	-0.14	-4.79	2.18E-6	Breast cancer	
THCA	cis	1	rs10426297	chr19:37798373	ZNF607	chr19:38187276-38210691:-	-0.21	-3.77	0.000185	Coronary artery calcification	
THCA	cis	1	rs1042658	chr17:38173902	GSDMA	chr17:38119226-38134019:+	-0.32	-7.23	1.87E-12	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THCA	cis	1	rs1042658	chr17:38173902	ORMDL3	chr17:38077296-38083854:-	0.14	3.36	0.00083	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THCA	cis	1	rs10427083	chr19:18550276	ELL	chr19:18553475-18632937:-	-0.25	-6.44	2.94E-10	Breast cancer	
THCA	cis	1	rs10427083	chr19:18550276	ISYNA1	chr19:18545625-18548943:-	0.13	4.75	2.73E-6	Breast cancer	
THCA	cis	1	rs10427083	chr19:18550276	LRRC25	chr19:18501955-18508421:-	-0.14	-4.83	1.86E-6	Breast cancer	
THCA	cis	1	rs1042992	chr8:26269191	PPP2R2A	chr8:25230075-26228645:+	-0.21	-4.04	6.19E-5	Schizophrenia	
THCA	cis	1	rs1043096	chr1:111682307	DRAM2	chr1:111659955-111682838:-	0.26	4.13	4.32E-5	Liver enzyme levels (gamma-glutamyl transferase)	
THCA	cis	1	rs10431060	chr11:108288228	ATM	chr11:108093559-108239826:+	-0.1	-3.37	0.000816	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
THCA	cis	1	rs10431505	chr12:58178589	FAM119B	chr12:58166383-58176323:+	0.4	11.12	1.06E-25	Multiple sclerosis	
THCA	cis	1	rs10431505	chr12:58178589	METTL1	chr12:58162352-58165914:-	-0.18	-4.52	7.74E-6	Multiple sclerosis	
THCA	cis	1	rs10431505	chr12:58178589	TSFM	chr12:58176536-58191367:+	-0.57	-19.7	1.05E-63	Multiple sclerosis	
THCA	cis	1	rs10431505	chr12:58178589	XRCC6BP1	chr12:58335445-58351051:+	-0.22	-4.57	6.16E-6	Multiple sclerosis	
THCA	cis	1	rs10431765	chr15:66044551	DPP8	chr15:65737999-65810035:-	-0.1	-4.2	3.17E-5	Mean corpuscular hemoglobin	
THCA	cis	1	rs10431765	chr15:66044551	SLC24A1	chr15:65903704-65953256:+	-0.16	-3.72	0.000225	Mean corpuscular hemoglobin	
THCA	cis	1	rs1043413	chr19:41939297	B3GNT8	chr19:41931265-41934635:-	0.34	7.87	2.4E-14	Height	
THCA	cis	1	rs1043413	chr19:41939297	EXOSC5	chr19:41892278-41903256:-	0.11	3.6	0.000347	Height	
THCA	cis	1	rs1043441	chr22:39130964	LOC646851	chr22:38974125-39052634:-	0.15	3.86	0.000127	Resting heart rate	
THCA	cis	1	rs1043515	chr17:36922196	PSMB3	chr17:36909002-36920477:+	0.13	5.32	1.59E-7	Height	
THCA	cis	1	rs1043674	chr14:75549370	EIF2B2	chr14:75469612-75476292:+	0.19	5.14	4.01E-7	Height	
THCA	cis	1	rs1043674	chr14:75549370	MLH3	chr14:75480467-75518235:-	0.3	8.99	5.61E-18	Height	
THCA	cis	1	rs1043674	chr14:75549370	RPS6KL1	chr14:75372347-75389958:-	0.32	6.88	1.87E-11	Height	
THCA	cis	1	rs10437345	chr10:65202946	LOC84989	chr10:65224989-65226320:+	-0.27	-4.4	1.31E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs10437345	chr10:65202946	NRBF2	chr10:64893007-64914785:+	-0.27	-4.64	4.48E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs10439608	chr20:30258814	COX4I2	chr20:30225691-30232800:+	0.12	3.81	0.000159	Subcortical brain region volumes	
THCA	cis	1	rs10442696	chr1:207438128	CD55	chr1:207494817-207534309:+	0.19	7.52	2.67E-13	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs10442	chr19:18545341	ELL	chr19:18553475-18632937:-	-0.25	-6.49	2.2E-10	Breast cancer	
THCA	cis	1	rs10442	chr19:18545341	ISYNA1	chr19:18545625-18548943:-	0.13	4.8	2.12E-6	Breast cancer	
THCA	cis	1	rs10442	chr19:18545341	LRRC25	chr19:18501955-18508421:-	-0.14	-4.81	2.03E-6	Breast cancer	
THCA	cis	1	rs10443172	chr1:85485768	MCOLN2	chr1:85391267-85462796:-	0.26	6.14	1.73E-9	Serum sulfate level	
THCA	cis	1	rs1044414	chr17:20904451	USP22	chr17:20902908-20947073:-	-0.18	-3.8	0.000162	Blood trace element (Se levels)	
THCA	cis	1	rs10444439	chr12:123766437	C12orf65	chr12:123717841-123742481:+	-0.26	-4.32	1.87E-5	HDL cholesterol	
THCA	cis	1	rs10445300	chr17:2114587	SRR	chr17:2207248-2228553:+	-0.82	-17.07	2.42E-51	Esophageal cancer (squamous cell)	
THCA	cis	1	rs1044595	chr1:180943529	STX6	chr1:180913175-180992046:-	-0.19	-3.85	0.000132	Progressive supranuclear palsy	
THCA	cis	1	rs10446630	chr4:17958690	DCAF16	chr4:17802280-17812381:-	-0.19	-4.37	1.54E-5	Height	
THCA	cis	1	rs1044717	chr1:45976587	AKR1A1	chr1:46016498-46035720:+	-0.14	-3.8	0.000167	Homocysteine levels	
THCA	cis	1	rs1044717	chr1:45976587	CCDC163P	chr1:45960581-45965646:-	-1.11	-31.33	6.04E-118	Homocysteine levels	
THCA	cis	1	rs1044717	chr1:45976587	MUTYH	chr1:45794915-45806142:-	0.22	5.1	4.94E-7	Homocysteine levels	
THCA	cis	1	rs1044717	chr1:45976587	PRDX1	chr1:45976708-45987609:-	-0.4	-10.19	3.3E-22	Homocysteine levels	
THCA	cis	1	rs10454108	chr19:53670550	ZNF665	chr19:53666552-53696619:-	-0.15	-4.14	4.03E-5	Yu-Zhi constitution type in type 2 diabetes	
THCA	cis	1	rs10454142	chr2:48646399	FOXN2	chr2:48541795-48606434:+	-0.16	-3.84	0.00014	Sex hormone-binding globulin levels	
THCA	cis	1	rs10454142	chr2:48646399	GTF2A1L	chr2:48844948-48960284:+	-0.24	-3.63	0.000315	Sex hormone-binding globulin levels	
THCA	cis	1	rs10454142	chr2:48646399	KLRAQ1	chr2:48667908-48742524:+	0.49	9.98	1.94E-21	Sex hormone-binding globulin levels	
THCA	cis	1	rs10454142	chr2:48646399	STON1	chr2:48757308-48826025:+	0.16	3.71	0.000228	Sex hormone-binding globulin levels	
THCA	cis	1	rs10455158	chr6:86672825	SNHG5	chr6:86386726-86388451:-	-0.48	-10.65	6.29E-24	Response to antipsychotic treatment	
THCA	cis	1	rs1045531	chr8:143763547	C8orf55	chr8:143808621-143818350:+	0.36	8.46	3.29E-16	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs1045531	chr8:143763547	LY6K	chr8:143781529-143785582:+	0.29	5.25	2.28E-7	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs1045531	chr8:143763547	LYNX1	chr8:143845758-143859640:-	-0.19	-4.18	3.44E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs1045531	chr8:143763547	PSCA	chr8:143761875-143764142:+	0.36	6.41	3.48E-10	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs10455449	chr6:86592226	SNHG5	chr6:86386726-86388451:-	-0.51	-10.99	3.27E-25	Response to antipsychotic treatment	
THCA	cis	1	rs10455455	chr6:86670214	SNHG5	chr6:86386726-86388451:-	-0.51	-11.16	7.09E-26	Response to antipsychotic treatment	
THCA	cis	1	rs10455456	chr6:86670322	SNHG5	chr6:86386726-86388451:-	-0.48	-10.64	6.96E-24	Response to antipsychotic treatment	
THCA	cis	1	rs1045547	chr8:143763757	C8orf55	chr8:143808621-143818350:+	0.36	8.51	2.31E-16	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs1045547	chr8:143763757	LY6K	chr8:143781529-143785582:+	0.28	5.21	2.85E-7	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs1045547	chr8:143763757	LYNX1	chr8:143845758-143859640:-	-0.2	-4.23	2.78E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs1045547	chr8:143763757	PSCA	chr8:143761875-143764142:+	0.36	6.44	2.98E-10	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs1045574	chr8:143763958	C8orf55	chr8:143808621-143818350:+	0.36	8.49	2.58E-16	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs1045574	chr8:143763958	LY6K	chr8:143781529-143785582:+	0.28	5.22	2.71E-7	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs1045574	chr8:143763958	LYNX1	chr8:143845758-143859640:-	-0.19	-4.21	3.07E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs1045574	chr8:143763958	PSCA	chr8:143761875-143764142:+	0.34	6.17	1.45E-9	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs10455768	chr6:159364322	RSPH3	chr6:159398268-159421198:-	0.28	5.97	4.73E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs10455769	chr6:159374007	RSPH3	chr6:159398268-159421198:-	0.28	6	3.97E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs10455770	chr6:159374304	RSPH3	chr6:159398268-159421198:-	0.28	6	3.97E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs10455772	chr6:159396403	RSPH3	chr6:159398268-159421198:-	0.29	6.05	2.96E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs10455830	chr6:159361236	RSPH3	chr6:159398268-159421198:-	0.28	5.97	4.73E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs10455832	chr6:159364354	RSPH3	chr6:159398268-159421198:-	0.28	5.97	4.73E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs10455835	chr6:159392353	RSPH3	chr6:159398268-159421198:-	0.29	6.05	2.96E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs10455836	chr6:159394754	RSPH3	chr6:159398268-159421198:-	0.29	6.1	2.23E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs1045605	chr8:143764101	C8orf55	chr8:143808621-143818350:+	0.36	8.54	1.77E-16	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs1045605	chr8:143764101	LY6K	chr8:143781529-143785582:+	0.29	5.25	2.31E-7	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs1045605	chr8:143764101	LYNX1	chr8:143845758-143859640:-	-0.19	-4.17	3.64E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs1045605	chr8:143764101	PSCA	chr8:143761875-143764142:+	0.36	6.47	2.47E-10	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs10456078	chr6:35118075	UHRF1BP1	chr6:34759794-34853117:+	-0.11	-3.76	0.00019	Airway responsiveness in chronic obstructive pulmonary disease	
THCA	cis	1	rs10456303	chr6:24317399	MRS2	chr6:24403153-24425809:+	0.15	3.43	0.000645	Uric acid levels	
THCA	cis	1	rs10456362	chr6:28221816	ZKSCAN3	chr6:28317691-28334523:+	0.24	4.93	1.14E-6	Depression	
THCA	cis	1	rs10456362	chr6:28221816	ZNF187	chr6:28234788-28245978:+	0.28	5.93	5.67E-9	Depression	
THCA	cis	1	rs10456362	chr6:28221816	ZNF193	chr6:28193067-28201260:+	-0.21	-4.06	5.67E-5	Depression	
THCA	cis	1	rs10456362	chr6:28221816	ZNF323	chr6:28292517-28324048:-	-0.39	-5.75	1.58E-8	Depression	
THCA	cis	1	rs10456362	chr6:28221816	ZNF389	chr6:28129551-28137375:+	0.43	6.46	2.65E-10	Depression	
THCA	cis	1	rs10456362	chr6:28221816	ZSCAN23	chr6:28393287-28411279:-	-0.22	-5.21	2.83E-7	Depression	
THCA	cis	1	rs10456420	chr6:33754301	IP6K3	chr6:33689443-33714762:-	0.42	6.73	4.93E-11	Obesity (extreme)	
THCA	cis	1	rs10456622	chr6:49396453	CENPQ	chr6:49431096-49460820:+	-0.26	-5.46	7.61E-8	Folate pathway vitamin levels	
THCA	cis	1	rs10456622	chr6:49396453	MUT	chr6:49398994-49431031:-	0.28	9.39	2.44E-19	Folate pathway vitamin levels	
THCA	cis	1	rs1045722	chr4:90645671	MMRN1	chr4:90816003-90875778:+	0.3	3.82	0.000151	Parkinson's disease	
THCA	cis	1	rs10457315	chr6:117871548	DCBLD1	chr6:117803820-117891018:+	0.24	4.7	3.4E-6	Height	
THCA	cis	1	rs10457315	chr6:117871548	GOPC	chr6:117639351-117923681:-	0.18	5.05	6.19E-7	Height	
THCA	cis	1	rs10457678	chr6:139122240	CCDC28A	chr6:139094657-139114454:+	0.19	3.62	0.000322	Colorectal or endometrial cancer	
THCA	cis	1	rs10459917	chr17:2009752	SRR	chr17:2207248-2228553:+	-0.23	-3.39	0.000753	Body mass index	
THCA	cis	1	rs10460081	chr18:47196328	CXXC1	chr18:47808715-47814692:-	-0.1	-3.75	0.000202	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	
THCA	cis	1	rs1046073	chr20:25281333	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs1046073	chr20:25281333	FAM182A	chr20:26035250-26067552:+	-0.18	-3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs1046073	chr20:25281333	FAM182B	chr20:25744102-25848786:-	0.27	5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs1046073	chr20:25281333	NINL	chr20:25433338-25566153:-	-0.35	-7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs1046073	chr20:25281333	PYGB	chr20:25228706-25278647:+	-0.16	-4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs10461617	chr5:56104308	C5orf35	chr5:56205103-56213010:+	1.01	23.43	2.13E-81	Type 2 diabetes	
THCA	cis	1	rs10463240	chr5:150256853	LOC134466	chr5:150310000-150326146:-	0.37	5.2	2.97E-7	Crohn's disease	
THCA	cis	1	rs10463240	chr5:150256853	ZNF300	chr5:150273964-150284391:-	0.15	3.4	0.000719	Crohn's disease	
THCA	cis	1	rs10463307	chr5:150254620	LOC134466	chr5:150310000-150326146:-	0.4	5.55	4.86E-8	Crohn's disease	
THCA	cis	1	rs10463310	chr5:150260905	LOC134466	chr5:150310000-150326146:-	0.38	5.28	2.01E-7	Crohn's disease	
THCA	cis	1	rs10463979	chr5:101778491	SLCO4C1	chr5:101569694-101632253:-	0.25	5.62	3.21E-8	Schizophrenia	
THCA	cis	1	rs1046701	chr14:59939804	C14orf149	chr14:59939406-59951126:-	0.35	4.06	5.74E-5	Schizophrenia	
THCA	cis	1	rs1046701	chr14:59939804	JKAMP	chr14:59951161-59972080:+	-0.43	-5.1	4.92E-7	Schizophrenia	
THCA	cis	1	rs10468036	chr15:66710276	TIPIN	chr15:66629008-66649054:-	-0.39	-3.93	9.8E-5	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs10468513	chr17:53062903	STXBP4	chr17:53046126-53241449:+	-0.15	-4.18	3.4E-5	Breast cancer	
THCA	cis	1	rs10468513	chr17:53062903	TOM1L1	chr17:52978052-53039328:+	-0.13	-3.37	0.000824	Breast cancer	
THCA	cis	1	rs1046875	chr17:80685426	FN3KRP	chr17:80674582-80685889:+	0.55	10.79	1.9E-24	Glycated hemoglobin levels	
THCA	cis	1	rs1046896	chr17:80685533	FN3KRP	chr17:80674582-80685889:+	0.55	10.78	2.12E-24	Glycated hemoglobin levels	
THCA	cis	1	rs1046917	chr17:80685655	FN3KRP	chr17:80674582-80685889:+	0.55	10.81	1.65E-24	Glycated hemoglobin levels	
THCA	cis	1	rs10470527	chr3:184751266	C3orf70	chr3:184795840-184870802:-	-0.23	-4.68	3.82E-6	Heschl's gyrus morphology	
THCA	cis	1	rs10470686	chr3:48449956	ATRIP	chr3:48488141-48507708:+	0.18	3.87	0.000123	Longevity	
THCA	cis	1	rs10470686	chr3:48449956	TREX1	chr3:48501186-48509043:+	-0.26	-5.94	5.41E-9	Longevity	
THCA	cis	1	rs1047171	chr20:25428786	ENTPD6	chr20:25176339-25207360:+	-0.32	-7.43	5.05E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs1047171	chr20:25428786	FAM182A	chr20:26035250-26067552:+	-0.18	-3.44	0.000635	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs1047171	chr20:25428786	FAM182B	chr20:25744102-25848786:-	0.25	5.25	2.3E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs1047171	chr20:25428786	NINL	chr20:25433338-25566153:-	-0.34	-7.11	4.29E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs1047171	chr20:25428786	PYGB	chr20:25228706-25278647:+	-0.15	-3.78	0.000174	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs1047206	chr11:64089216	PRDX5	chr11:64085569-64089282:+	-0.16	-3.99	7.5E-5	Mean platelet volume	
THCA	cis	1	rs1047418	chr14:75605792	EIF2B2	chr14:75469612-75476292:+	0.19	5.1	4.83E-7	Height	
THCA	cis	1	rs1047418	chr14:75605792	MLH3	chr14:75480467-75518235:-	0.3	9.03	4.27E-18	Height	
THCA	cis	1	rs1047418	chr14:75605792	RPS6KL1	chr14:75372347-75389958:-	0.32	6.91	1.57E-11	Height	
THCA	cis	1	rs10478026	chr5:110196467	TMEM232	chr5:109624934-110062381:-	0.21	4.19	3.34E-5	Asthma and hay fever	
THCA	cis	1	rs10478278	chr5:115452758	COMMD10	chr5:115420727-115628978:+	0.48	6.05	2.86E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs10478288	chr5:115505621	COMMD10	chr5:115420727-115628978:+	0.48	5.84	9.44E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs10479179	chr5:137564115	KLHL3	chr5:136953190-137071779:-	-0.13	-3.44	0.000639	Resting heart rate	
THCA	cis	1	rs10483863	chr14:75322327	MLH3	chr14:75480467-75518235:-	-0.13	-3.7	0.000242	Caffeine consumption	
THCA	cis	1	rs10483863	chr14:75322327	RPS6KL1	chr14:75372347-75389958:-	-0.31	-6.65	7.9E-11	Caffeine consumption	
THCA	cis	1	rs10484442	chr6:26555879	BTN2A3	chr6:26422317-26431927:+	0.18	4.17	3.56E-5	Educational attainment	
THCA	cis	1	rs10484442	chr6:26555879	HCG11	chr6:26521934-26527610:+	-0.22	-4.25	2.57E-5	Educational attainment	
THCA	cis	1	rs10484442	chr6:26555879	HMGN4	chr6:26538572-26547162:+	-0.17	-4.3	2.11E-5	Educational attainment	
THCA	cis	1	rs10484442	chr6:26555879	LOC100270746	chr6:26987146-26988085:-	-0.16	-3.72	0.000226	Educational attainment	
THCA	cis	1	rs10484442	chr6:26555879	ZNF322A	chr6:26634612-26659963:-	-0.16	-4.38	1.44E-5	Educational attainment	
THCA	cis	1	rs10484629	chr6:133117870	C6orf192	chr6:133090507-133119747:-	-0.26	-4.06	5.73E-5	Type 2 diabetes nephropathy	
THCA	cis	1	rs10485508	chr20:33605098	PROCR	chr20:33758727-33765164:+	-0.36	-5.75	1.55E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs10485508	chr20:33605098	TRPC4AP	chr20:33590215-33680618:-	0.32	3.88	0.000118	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs10486607	chr7:29184489	CPVL	chr7:29035249-29234892:-	0.29	3.6	0.000354	Diabetes related insulin traits	
THCA	cis	1	rs10487397	chr7:118007961	ANKRD7	chr7:117864712-117882782:+	0.27	4.41	1.28E-5	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs10487488	chr7:127149291	GRM8	chr7:126078652-126893147:-	-0.34	-3.5	0.000506	Medication adherence in chronic diseases	
THCA	cis	1	rs10490541	chr2:207587173	MDH1B	chr2:207598943-207630050:-	0.36	4.89	1.39E-6	Episodic memory	
THCA	cis	1	rs10490762	chr2:218284397	DIRC3	chr2:218148748-218621316:-	-0.21	-4.94	1.07E-6	Height	
THCA	cis	1	rs10490958	chr10:17233450	TRDMT1	chr10:17184983-17243681:-	0.45	10.41	5.34E-23	Homocysteine levels	
THCA	cis	1	rs10492096	chr12:6580582	TAPBPL	chr12:6561177-6575601:+	-0.45	-6.47	2.39E-10	Hip geometry	
THCA	cis	1	rs10494057	chr1:107576399	NTNG1	chr1:107682629-108024471:+	0.2	3.45	0.000607	AIDS	
THCA	cis	1	rs10494075	chr1:108330356	VAV3	chr1:108113782-108507545:-	0.49	6.69	6.3E-11	Hypothyroidism	
THCA	cis	1	rs10494079	chr1:108374875	VAV3	chr1:108113782-108507545:-	0.57	8.13	3.63E-15	Hypothyroidism	
THCA	cis	1	rs10494217	chr1:119469188	WARS2	chr1:119573841-119683295:-	0.26	3.49	0.000532	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs10494304	chr1:156285764	BGLAP	chr1:156182784-156213112:+	-0.23	-5.57	4.15E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs10494304	chr1:156285764	C1orf85	chr1:156259882-156265449:-	0.18	4.22	2.9E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs10494304	chr1:156285764	CCT3	chr1:156278752-156308195:-	0.31	6.72	5.04E-11	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs10494818	chr1:200749160	DDX59	chr1:200610119-200639126:-	-0.25	-3.83	0.000148	Epilepsy	
THCA	cis	1	rs10494874	chr1:205754688	PM20D1	chr1:205797154-205819245:-	-0.43	-7.09	4.69E-12	Prostate-specific antigen levels	
THCA	cis	1	rs10494889	chr1:207460308	CD55	chr1:207494817-207534309:+	0.19	7.72	6.89E-14	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs10494890	chr1:207424386	CD55	chr1:207494817-207534309:+	-0.18	-7.14	3.57E-12	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs10495571	chr2:9736066	IAH1	chr2:9614670-9636671:+	0.16	3.44	0.00063	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	
THCA	cis	1	rs1049564	chr14:20940606	CHD8	chr14:21853358-21905404:-	-0.14	-4.16	3.76E-5	Interferon alpha levels in systemic lupus erythematosus	
THCA	cis	1	rs10496191	chr2:73673798	ALMS1P	chr2:73872046-73912692:+	0.71	11.32	1.83E-26	Metabolite levels	
THCA	cis	1	rs10496191	chr2:73673798	NAT8	chr2:73867850-73869537:-	0.38	6.01	3.75E-9	Metabolite levels	
THCA	cis	1	rs10496191	chr2:73673798	TPRKB	chr2:73956957-73964517:-	-0.17	-4.39	1.4E-5	Metabolite levels	
THCA	cis	1	rs10496193	chr2:73773503	ALMS1P	chr2:73872046-73912692:+	0.7	11.06	1.86E-25	Metabolite levels	
THCA	cis	1	rs10496193	chr2:73773503	NAT8	chr2:73867850-73869537:-	0.39	6.19	1.32E-9	Metabolite levels	
THCA	cis	1	rs10496193	chr2:73773503	TPRKB	chr2:73956957-73964517:-	-0.17	-4.25	2.52E-5	Metabolite levels	
THCA	cis	1	rs10498471	chr14:55353717	GCH1	chr14:55308724-55369542:-	-0.2	-4.18	3.48E-5	Rheumatoid arthritis;Obesity-related traits	
THCA	cis	1	rs1049887	chr1:10460485	KIF1B	chr1:10270764-10441659:+	0.21	6.26	8.66E-10	Hepatocellular carcinoma	
THCA	cis	1	rs10498958	chr6:86649705	SNHG5	chr6:86386726-86388451:-	0.51	11	3.15E-25	Response to antipsychotic treatment	
THCA	cis	1	rs10500303	chr19:50512033	SIGLEC16	chr19:50472912-50479075:+	0.64	5.96	5.01E-9	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
THCA	cis	1	rs10501426	chr11:78057122	NARS2	chr11:78147017-78285909:-	-0.39	-7.55	2.16E-13	Testicular germ cell tumor	
THCA	cis	1	rs10504554	chr8:74919713	TMEM70	chr8:74888430-74895011:+	-0.17	-3.65	0.000293	Postoperative atrial fibrillation in coronary artery bypass grafting surgery	
THCA	cis	1	rs10504839	chr8:89439731	MMP16	chr8:89049462-89339717:-	0.32	5.23	2.6E-7	Electrodermal activity	
THCA	cis	1	rs10504841	chr8:89415821	MMP16	chr8:89049462-89339717:-	-0.32	-5.13	4.33E-7	Electrodermal activity	
THCA	cis	1	rs10504857	chr8:89582625	MMP16	chr8:89049462-89339717:-	-0.16	-3.56	0.000405	Body mass index and cholesterol (psychopharmacological treatment)	
THCA	cis	1	rs10504923	chr8:94088197	C8orf83	chr8:93895865-94029901:-	0.27	4.25	2.56E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs10504924	chr8:94088261	C8orf83	chr8:93895865-94029901:-	0.27	4.28	2.27E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs10505430	chr8:124191933	FAM83A	chr8:124191287-124222317:+	0.28	3.73	0.000217	Urinary uromodulin levels	
THCA	cis	1	rs1050631	chr18:33694120	SLC39A6	chr18:33688495-33709357:-	-0.13	-3.89	0.000114	Esophageal squamous cell cancer (length of survival)	
THCA	cis	1	rs10506839	chr12:81445603	ACSS3	chr12:81471809-81649582:+	0.22	4.67	4.01E-6	Neuroticism	
THCA	cis	1	rs1050779	chr16:58080215	C16orf57	chr16:58035305-58055521:+	-0.33	-4.98	8.84E-7	Pulmonary function;Pulmonary function (interaction)	
THCA	cis	1	rs1050779	chr16:58080215	MMP15	chr16:58059282-58080802:+	0.16	3.74	0.000204	Pulmonary function;Pulmonary function (interaction)	
THCA	cis	1	rs1050779	chr16:58080215	TEPP	chr16:58010339-58022015:+	-0.32	-4.66	4.14E-6	Pulmonary function;Pulmonary function (interaction)	
THCA	cis	1	rs1050779	chr16:58080215	ZNF319	chr16:58028573-58033762:-	-0.36	-5.28	1.99E-7	Pulmonary function;Pulmonary function (interaction)	
THCA	cis	1	rs10507948	chr13:85667675	SLITRK6	chr13:86366922-86373483:-	-0.2	-3.66	0.000279	Bipolar disorder (mania)	
THCA	cis	1	rs10509671	chr10:96069054	TBC1D12	chr10:96162186-96296089:+	-0.18	-4.08	5.21E-5	Esophageal cancer and gastric cancer	
THCA	cis	1	rs10509741	chr10:101917366	BLOC1S2	chr10:102033713-102046439:-	-0.43	-6.36	4.78E-10	Schizophrenia	
THCA	cis	1	rs10509741	chr10:101917366	CWF19L1	chr10:101992055-102027437:-	-0.43	-5.22	2.65E-7	Schizophrenia	
THCA	cis	1	rs10509744	chr10:102271579	SEC31B	chr10:102246403-102289636:-	-0.27	-8.66	7.28E-17	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs10509767	chr10:74045917	DNAJB12	chr10:74092588-74114907:-	-0.21	-4.84	1.73E-6	Heschl's gyrus morphology	
THCA	cis	1	rs10510110	chr10:124192430	PLEKHA1	chr10:124134220-124191866:+	-0.18	-4.93	1.13E-6	Height	
THCA	cis	1	rs10510761	chr3:52965255	RFT1	chr3:53122503-53164470:-	-0.57	-6.52	1.8E-10	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs10510761	chr3:52965255	TMEM110	chr3:52867139-52931547:-	-0.37	-4.33	1.85E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs10511779	chr9:26725702	LRRC19	chr9:26993143-27005691:-	-0.36	-3.91	0.000108	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs10515505	chr5:138313146	SIL1	chr5:138282412-138534065:-	0.13	3.92	0.000101	Age-related hearing impairment (interaction)	
THCA	cis	1	rs10516315	chr4:18016877	DCAF16	chr4:17802280-17812381:-	-0.2	-4.54	6.97E-6	Height	
THCA	cis	1	rs10516525	chr4:106668025	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs10516526	chr4:106688904	INTS12	chr4:106603787-106629881:-	-0.62	-5.3	1.78E-7	Post bronchodilator FEV1	
THCA	cis	1	rs10516527	chr4:106734346	INTS12	chr4:106603787-106629881:-	-0.61	-5.18	3.25E-7	Post bronchodilator FEV1	
THCA	cis	1	rs10516844	chr4:90639847	MMRN1	chr4:90816003-90875778:+	0.32	4.07	5.5E-5	Parkinson's disease	
THCA	cis	1	rs10517073	chr4:25417371	ZCCHC4	chr4:25314396-25372003:+	-0.18	-3.93	9.66E-5	Rheumatoid arthritis	
THCA	cis	1	rs10517825	chr4:165893486	C4orf39	chr4:165878100-165880273:+	-0.19	-5.19	3.1E-7	Ovarian cancer in BRCA1 mutation carriers	
THCA	cis	1	rs10518128	chr4:75713368	BTC	chr4:75671448-75719882:-	0.2	3.89	0.000113	Electroencephalogram traits	
THCA	cis	1	rs10518693	chr15:40700022	C15orf23	chr15:40674922-40686488:+	-0.26	-5.17	3.42E-7	Blood metabolite levels;Blood metabolite ratios	
THCA	cis	1	rs10518693	chr15:40700022	DISP2	chr15:40650434-40663256:+	0.27	5.05	6.39E-7	Blood metabolite levels;Blood metabolite ratios	
THCA	cis	1	rs10518839	chr15:56484363	MNS1	chr15:56720929-56757335:-	-0.23	-3.42	0.000684	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs10518839	chr15:56484363	TEX9	chr15:56657644-56738071:+	-0.34	-5.88	7.89E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs10518842	chr15:56495136	MNS1	chr15:56720929-56757335:-	-0.23	-3.39	0.000759	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs10518842	chr15:56495136	TEX9	chr15:56657644-56738071:+	-0.34	-6.07	2.68E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs10518843	chr15:56496525	TEX9	chr15:56657644-56738071:+	-0.34	-5.88	7.84E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs10519203	chr15:78814046	CHRNA5	chr15:78857906-78886458:+	0.4	8.1	4.48E-15	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs1051921	chr7:73007943	MLXIPL	chr7:73007524-73038870:-	0.23	4.23	2.82E-5	Triglycerides	
THCA	cis	1	rs10519226	chr15:49738233	DTWD1	chr15:49913226-49937332:+	-0.23	-5.14	4.06E-7	Thyroid volume	
THCA	cis	1	rs10519226	chr15:49738233	GALK2	chr15:49447976-49622002:+	0.16	3.45	0.000609	Thyroid volume	
THCA	cis	1	rs10519226	chr15:49738233	SECISBP2L	chr15:49280967-49338630:-	0.14	3.61	0.000343	Thyroid volume	
THCA	cis	1	rs1051931	chr6:46672943	CYP39A1	chr6:46517445-46620523:-	-0.27	-4.28	2.27E-5	Lipoprotein-associated phospholipase A2 activity and mass	
THCA	cis	1	rs10520543	chr4:183822229	DCTD	chr4:183811245-183838630:-	0.24	5.1	4.93E-7	Obesity-related traits	
THCA	cis	1	rs10521241	chr16:51357286	SALL1	chr16:51169886-51185183:-	-0.18	-3.64	0.000301	Left superior temporal gyrus thickness (schizophrenia interaction)	
THCA	cis	1	rs1052501	chr3:41925398	ULK4	chr3:41288091-42003660:-	-1.09	-20.92	1.8E-69	Diastolic blood pressure	
THCA	cis	1	rs1053639	chr10:74035041	ASCC1	chr10:73856278-73976892:-	0.19	3.47	0.00056	Heschl's gyrus morphology	
THCA	cis	1	rs1053639	chr10:74035041	DNAJB12	chr10:74092588-74114907:-	0.21	4.95	1.03E-6	Heschl's gyrus morphology	
THCA	cis	1	rs1054029	chr4:103553053	CISD2	chr4:103790135-103809913:+	-0.15	-3.5	0.000517	Primary biliary cirrhosis	
THCA	cis	1	rs1054029	chr4:103553053	NFKB1	chr4:103422486-103538458:+	0.14	4.04	6.22E-5	Primary biliary cirrhosis	
THCA	cis	1	rs1054037	chr4:103552709	CISD2	chr4:103790135-103809913:+	-0.15	-3.4	0.000729	Primary biliary cirrhosis	
THCA	cis	1	rs1054037	chr4:103552709	NFKB1	chr4:103422486-103538458:+	0.14	3.96	8.67E-5	Primary biliary cirrhosis	
THCA	cis	1	rs1054399	chr10:102312565	SEC31B	chr10:102246403-102289636:-	-0.28	-9.13	1.99E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs1055429	chr3:51570508	HEMK1	chr3:50606583-50622419:+	0.19	3.98	8.01E-5	Melanoma	
THCA	cis	1	rs1055429	chr3:51570508	TEX264	chr3:51705222-51738338:+	-0.2	-5.48	6.82E-8	Melanoma	
THCA	cis	1	rs1056610	chr22:39080078	LOC646851	chr22:38974125-39052634:-	-0.14	-3.69	0.000253	Resting heart rate	
THCA	cis	1	rs1056667	chr6:26510564	BTN2A3	chr6:26422317-26431927:+	0.2	4.64	4.57E-6	Educational attainment	
THCA	cis	1	rs1056667	chr6:26510564	HCG11	chr6:26521934-26527610:+	-0.23	-4.47	9.87E-6	Educational attainment	
THCA	cis	1	rs1056667	chr6:26510564	HMGN4	chr6:26538572-26547162:+	-0.16	-4.08	5.38E-5	Educational attainment	
THCA	cis	1	rs1056667	chr6:26510564	ZNF322A	chr6:26634612-26659963:-	-0.14	-3.78	0.000176	Educational attainment	
THCA	cis	1	rs1056801	chr2:242292307	ANO7	chr2:242127924-242164791:+	0.35	4.06	5.82E-5	Prostate cancer	
THCA	cis	1	rs1056801	chr2:242292307	SEPT2	chr2:242254723-242293439:+	-0.29	-4.24	2.71E-5	Prostate cancer	
THCA	cis	1	rs1056964	chr22:51017476	CHKB	chr22:51017378-51021428:-	0.51	6.1	2.22E-9	Narcolepsy	
THCA	cis	1	rs1056964	chr22:51017476	CPT1B	chr22:51007291-51017096:-	-0.43	-8.59	1.29E-16	Narcolepsy	
THCA	cis	1	rs1057208	chr20:44563007	WFDC3	chr20:44402847-44420547:-	-0.27	-3.91	0.000106	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
THCA	cis	1	rs1057395	chr19:32974738	DPY19L3	chr19:32896677-32975236:+	0.18	4.96	9.87E-7	Bipolar disorder	
THCA	cis	1	rs1057395	chr19:32974738	ZNF507	chr19:32836514-32878571:+	0.3	7.54	2.42E-13	Bipolar disorder	
THCA	cis	1	rs1057397	chr19:32974913	DPY19L3	chr19:32896677-32975236:+	0.19	5.07	5.81E-7	Bipolar disorder	
THCA	cis	1	rs1057397	chr19:32974913	ZNF507	chr19:32836514-32878571:+	0.3	7.48	3.56E-13	Bipolar disorder	
THCA	cis	1	rs1057510	chr12:6683287	C1R	chr12:7187517-7245043:-	-0.13	-3.67	0.00027	Myopia (pathological)	
THCA	cis	1	rs1057510	chr12:6683287	TAPBPL	chr12:6561177-6575601:+	-0.32	-4.78	2.36E-6	Myopia (pathological)	
THCA	cis	1	rs1058600	chr5:115166713	ATG12	chr5:115165818-115177520:-	0.27	5.69	2.22E-8	IgG glycosylation	
THCA	cis	1	rs1058600	chr5:115166713	CCDC112	chr5:114602885-114632458:-	0.18	3.54	0.000444	IgG glycosylation	
THCA	cis	1	rs1058600	chr5:115166713	CDO1	chr5:115140432-115152405:-	0.37	7.13	3.79E-12	IgG glycosylation	
THCA	cis	1	rs1059312	chr12:129278864	GLT1D1	chr12:129338081-129469509:+	0.21	5.42	9.46E-8	Systemic lupus erythematosus	
THCA	cis	1	rs1059312	chr12:129278864	SLC15A4	chr12:129277739-129308541:-	0.17	4.21	3.05E-5	Systemic lupus erythematosus	
THCA	cis	1	rs1060330	chr3:52288945	NEK4	chr3:52744803-52804951:-	-0.12	-3.94	9.33E-5	Electroencephalogram traits	
THCA	cis	1	rs1060330	chr3:52288945	NT5DC2	chr3:52558386-52569093:-	-0.24	-5.75	1.58E-8	Electroencephalogram traits	
THCA	cis	1	rs1060330	chr3:52288945	PBRM1	chr3:52579368-52719866:-	0.13	5.02	7.42E-7	Electroencephalogram traits	
THCA	cis	1	rs1061270	chr19:19821367	ZNF14	chr19:19821281-19843921:-	0.24	4.74	2.84E-6	Toenail selenium levels	
THCA	cis	1	rs1061377	chr4:39124750	KLHL5	chr4:39046659-39123828:+	-0.21	-5.93	5.86E-9	Uric acid levels	
THCA	cis	1	rs1062687	chr22:39134715	LOC646851	chr22:38974125-39052634:-	0.15	4.02	6.89E-5	Resting heart rate	
THCA	cis	1	rs1062794	chr20:30381758	COX4I2	chr20:30225691-30232800:+	0.12	3.86	0.000129	Subcortical brain region volumes	
THCA	cis	1	rs10634	chr7:23240596	NUPL2	chr7:23221446-23240629:+	0.36	5.31	1.67E-7	Chronic obstructive pulmonary disease	
THCA	cis	1	rs1063538	chr3:186574183	RTP4	chr3:187086168-187089367:+	-0.15	-3.53	0.000456	Adiponectin levels	
THCA	cis	1	rs1065201	chr22:39069510	JOSD1	chr22:39081549-39096459:-	-0.15	-3.86	0.000127	Resting heart rate	
THCA	cis	1	rs1065201	chr22:39069510	LOC646851	chr22:38974125-39052634:-	0.13	3.43	0.000646	Resting heart rate	
THCA	cis	1	rs1065201	chr22:39069510	TOMM22	chr22:39077954-39080763:+	-0.16	-3.49	0.000525	Resting heart rate	
THCA	cis	1	rs10732856	chr11:116907113	PCSK7	chr11:117075789-117102811:-	-0.28	-4.89	1.41E-6	Protein quantitative trait loci	
THCA	cis	1	rs10733790	chr10:65100334	LOC84989	chr10:65224989-65226320:+	-0.27	-4.39	1.38E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs10733790	chr10:65100334	NRBF2	chr10:64893007-64914785:+	-0.28	-4.79	2.21E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs10733886	chr10:74039074	DNAJB12	chr10:74092588-74114907:-	0.2	4.75	2.74E-6	Heschl's gyrus morphology	
THCA	cis	1	rs10734259	chr11:18314865	GTF2H1	chr11:18343816-18388590:+	0.37	9.78	1.04E-20	Pancreatic cancer	
THCA	cis	1	rs10734765	chr12:9369385	DDX12	chr12:9570288-9600768:-	0.15	3.34	0.000893	Non-alcoholic fatty liver disease histology (AST)	
THCA	cis	1	rs10734765	chr12:9369385	LOC144571	chr12:9217773-9220651:+	0.13	3.38	0.000785	Non-alcoholic fatty liver disease histology (AST)	
THCA	cis	1	rs10734765	chr12:9369385	LOC642846	chr12:9436253-9466684:+	0.41	7.96	1.26E-14	Non-alcoholic fatty liver disease histology (AST)	
THCA	cis	1	rs10736426	chr1:45984353	AKR1A1	chr1:46016498-46035720:+	0.13	3.56	0.000404	Homocysteine levels	
THCA	cis	1	rs10736426	chr1:45984353	CCDC163P	chr1:45960581-45965646:-	1.02	27.93	1.64E-102	Homocysteine levels	
THCA	cis	1	rs10736426	chr1:45984353	MUTYH	chr1:45794915-45806142:-	-0.2	-4.98	8.79E-7	Homocysteine levels	
THCA	cis	1	rs10736426	chr1:45984353	PRDX1	chr1:45976708-45987609:-	0.38	10.06	9.77E-22	Homocysteine levels	
THCA	cis	1	rs10736781	chr11:71650368	FAM86C	chr11:71498557-71512276:+	0.32	4.08	5.31E-5	Severe influenza A (H1N1) infection	
THCA	cis	1	rs10736786	chr11:71763274	FAM86C	chr11:71498557-71512276:+	0.32	3.91	0.000107	Severe influenza A (H1N1) infection	
THCA	cis	1	rs10739388	chr9:115977175	ALAD	chr9:116148593-116163618:-	0.15	3.59	0.00037	Hematology traits	
THCA	cis	1	rs10739388	chr9:115977175	BSPRY	chr9:116111812-116133512:+	0.12	3.75	0.000195	Hematology traits	
THCA	cis	1	rs10739388	chr9:115977175	CDC26	chr9:116029290-116037869:-	-0.47	-10.41	5.41E-23	Hematology traits	
THCA	cis	1	rs10739388	chr9:115977175	HDHD3	chr9:116135698-116139237:-	0.11	3.49	0.000519	Hematology traits	
THCA	cis	1	rs10739388	chr9:115977175	PRPF4	chr9:116037974-116055054:+	0.19	4.44	1.14E-5	Hematology traits	
THCA	cis	1	rs10739496	chr9:100552559	C9orf156	chr9:100666772-100684852:-	0.14	3.86	0.000128	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	cis	1	rs10739496	chr9:100552559	FOXE1	chr9:100615537-100618986:+	0.12	3.37	0.00081	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	cis	1	rs10740093	chr10:52770562	PRKG1	chr10:52750945-54055274:+	-0.23	-5.1	5.02E-7	Migraine	
THCA	cis	1	rs10740117	chr10:65098277	LOC84989	chr10:65224989-65226320:+	-0.27	-4.35	1.64E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs10740117	chr10:65098277	NRBF2	chr10:64893007-64914785:+	-0.28	-4.77	2.41E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs10740397	chr10:74039762	DNAJB12	chr10:74092588-74114907:-	0.2	4.75	2.64E-6	Heschl's gyrus morphology	
THCA	cis	1	rs10740398	chr10:74046191	ASCC1	chr10:73856278-73976892:-	0.18	3.39	0.000748	Heschl's gyrus morphology	
THCA	cis	1	rs10740398	chr10:74046191	DNAJB12	chr10:74092588-74114907:-	0.2	4.69	3.57E-6	Heschl's gyrus morphology	
THCA	cis	1	rs10741243	chr10:132947962	TCERG1L	chr10:132890656-133109984:-	0.4	6.04	3.08E-9	Type 2 diabetes	
THCA	cis	1	rs10741741	chr11:18342081	GTF2H1	chr11:18343816-18388590:+	-0.32	-8.77	3.16E-17	Pancreatic cancer	
THCA	cis	1	rs10741742	chr11:18342160	GTF2H1	chr11:18343816-18388590:+	0.36	9.77	1.14E-20	Pancreatic cancer	
THCA	cis	1	rs1074407	chr22:38156183	LGALS2	chr22:37966254-37976024:-	-0.16	-4.57	6.31E-6	Optic cup area;Vertical cup-disc ratio	
THCA	cis	1	rs1074407	chr22:38156183	TRIOBP	chr22:38082344-38172562:+	0.36	9.78	1.07E-20	Optic cup area;Vertical cup-disc ratio	
THCA	cis	1	rs10746496	chr1:11964147	PLOD1	chr1:11994746-12035593:+	0.14	3.4	0.00073	Folate pathway vitamin levels	
THCA	cis	1	rs10747783	chr12:58176614	FAM119B	chr12:58166383-58176323:+	0.41	11.2	5.12E-26	Multiple sclerosis	
THCA	cis	1	rs10747783	chr12:58176614	METTL1	chr12:58162352-58165914:-	-0.2	-4.88	1.44E-6	Multiple sclerosis	
THCA	cis	1	rs10747783	chr12:58176614	TSFM	chr12:58176536-58191367:+	-0.59	-20.09	1.64E-65	Multiple sclerosis	
THCA	cis	1	rs10747783	chr12:58176614	XRCC6BP1	chr12:58335445-58351051:+	-0.22	-4.46	1.01E-5	Multiple sclerosis	
THCA	cis	1	rs10749860	chr1:46328210	CCDC163P	chr1:45960581-45965646:-	-0.51	-10.1	7.22E-22	Body mass index	
THCA	cis	1	rs10749860	chr1:46328210	GPBP1L1	chr1:46092978-46152302:-	0.16	4.05	5.93E-5	Body mass index	
THCA	cis	1	rs10749860	chr1:46328210	MMACHC	chr1:45965856-45976737:+	-0.2	-4.4	1.34E-5	Body mass index	
THCA	cis	1	rs10749860	chr1:46328210	MUTYH	chr1:45794915-45806142:-	0.31	8.53	1.99E-16	Body mass index	
THCA	cis	1	rs10749863	chr1:47174328	CYP4B1	chr1:47264670-47285020:+	0.21	3.41	0.000708	Response to hepatitis C treatment	
THCA	cis	1	rs10749863	chr1:47174328	CYP4Z1	chr1:47533160-47583992:+	0.27	4.08	5.19E-5	Response to hepatitis C treatment	
THCA	cis	1	rs10749863	chr1:47174328	DMBX1	chr1:46972668-46979884:+	0.23	4.07	5.5E-5	Response to hepatitis C treatment	
THCA	cis	1	rs10750100	chr11:116917244	PCSK7	chr11:117075789-117102811:-	-0.31	-5.53	5.24E-8	Protein quantitative trait loci	
THCA	cis	1	rs10750101	chr11:116979689	PCSK7	chr11:117075789-117102811:-	-0.3	-5.34	1.47E-7	Protein quantitative trait loci	
THCA	cis	1	rs10750421	chr11:129692511	C11orf45	chr11:128769468-128776100:-	0.3	3.35	0.000866	Obesity-related traits	
THCA	cis	1	rs10750421	chr11:129692511	NFRKB	chr11:129733671-129765490:-	0.22	3.88	0.000121	Obesity-related traits	
THCA	cis	1	rs10751189	chr11:71670578	FAM86C	chr11:71498557-71512276:+	-0.3	-3.81	0.000157	Severe influenza A (H1N1) infection	
THCA	cis	1	rs10751190	chr11:71680757	FAM86C	chr11:71498557-71512276:+	0.32	3.89	0.000116	Severe influenza A (H1N1) infection	
THCA	cis	1	rs10751193	chr11:71785356	FAM86C	chr11:71498557-71512276:+	0.31	3.84	0.000142	Severe influenza A (H1N1) infection	
THCA	cis	1	rs1075232	chr15:31741216	FAM7A2	chr15:30864758-30892900:+	-0.44	-3.99	7.75E-5	Survival in colorectal cancer (non-distant metastatic)	
THCA	cis	1	rs10752615	chr1:156248609	BGLAP	chr1:156182784-156213112:+	0.23	5.47	7.3E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs10752615	chr1:156248609	C1orf85	chr1:156259882-156265449:-	-0.17	-3.96	8.8E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs10752615	chr1:156248609	CCT3	chr1:156278752-156308195:-	-0.32	-7.02	7.8E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs10753232	chr1:180950126	MR1	chr1:181003139-181024633:+	0.12	3.34	0.000898	Progressive supranuclear palsy	
THCA	cis	1	rs10753232	chr1:180950126	STX6	chr1:180913175-180992046:-	0.18	3.53	0.000453	Progressive supranuclear palsy	
THCA	cis	1	rs10753249	chr1:31859558	ZCCHC17	chr1:31769842-31837780:+	-0.31	-6.01	3.64E-9	Schizophrenia	
THCA	cis	1	rs10753558	chr1:19697915	CAPZB	chr1:19665274-19811992:-	0.14	3.82	0.000153	Crohn's disease and psoriasis	
THCA	cis	1	rs10753559	chr1:19698026	CAPZB	chr1:19665274-19811992:-	-0.14	-3.83	0.000147	Crohn's disease and psoriasis	
THCA	cis	1	rs1075374	chr10:91376975	FLJ37201	chr10:91451057-91457685:-	-0.18	-3.74	0.000209	Metabolic traits	
THCA	cis	1	rs1075403	chr19:18384950	KIAA1683	chr19:18367906-18385319:-	-0.26	-7.48	3.51E-13	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs10754323	chr1:89119492	CCBL2	chr1:89401456-89458643:-	0.62	13.88	4.64E-37	Height	
THCA	cis	1	rs10754797	chr1:236032494	LYST	chr1:235824345-236046940:-	-0.31	-9.89	4.2E-21	Systemic lupus erythematosus	
THCA	cis	1	rs10758308	chr9:35509782	CREB3	chr9:35732317-35737004:+	0.13	3.41	0.000709	Psoriasis	
THCA	cis	1	rs10759636	chr9:116018777	CDC26	chr9:116029290-116037869:-	-0.47	-10.6	1.04E-23	Hematology traits	
THCA	cis	1	rs10759636	chr9:116018777	PRPF4	chr9:116037974-116055054:+	0.18	4.3	2.1E-5	Hematology traits	
THCA	cis	1	rs10759927	chr9:100542176	C9orf156	chr9:100666772-100684852:-	0.13	3.39	0.00077	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	cis	1	rs10760021	chr9:100697648	C9orf156	chr9:100666772-100684852:-	-0.14	-3.82	0.000152	Quantitative traits	
THCA	cis	1	rs10760118	chr9:123641616	LOC253039	chr9:123605320-123616644:+	-0.5	-9.19	1.21E-18	Rheumatoid arthritis	
THCA	cis	1	rs10760118	chr9:123641616	PSMD5	chr9:123578334-123605206:-	-0.27	-5.26	2.2E-7	Rheumatoid arthritis	
THCA	cis	1	rs10760121	chr9:123647915	LOC253039	chr9:123605320-123616644:+	-0.51	-9.23	8.54E-19	Rheumatoid arthritis	
THCA	cis	1	rs10760121	chr9:123647915	PSMD5	chr9:123578334-123605206:-	-0.27	-5.18	3.34E-7	Rheumatoid arthritis	
THCA	cis	1	rs10760206	chr9:100984855	TBC1D2	chr9:100961281-101018003:-	0.29	7.48	3.51E-13	Post-traumatic stress disorder	
THCA	cis	1	rs10760206	chr9:100984855	TSTD2	chr9:100362364-100395962:-	0.17	3.74	0.000206	Post-traumatic stress disorder	
THCA	cis	1	rs10760589	chr9:131906293	CRAT	chr9:131857075-131873070:-	0.29	6.87	2.0E-11	Blood metabolite ratios	
THCA	cis	1	rs10760700	chr9:102681811	STX17	chr9:102668915-102736817:+	-0.16	-4.13	4.28E-5	Alopecia areata	
THCA	cis	1	rs10760704	chr9:102708564	STX17	chr9:102668915-102736817:+	-0.16	-4.17	3.68E-5	Alopecia areata	
THCA	cis	1	rs10760706	chr9:102723692	STX17	chr9:102668915-102736817:+	-0.17	-4.31	1.96E-5	Alopecia areata	
THCA	cis	1	rs1076160	chr9:135776034	C9orf98	chr9:135600965-135754198:-	-0.22	-5.36	1.29E-7	Psoriasis	
THCA	cis	1	rs10761662	chr10:52758221	PRKG1	chr10:52750945-54055274:+	-0.2	-4.65	4.3E-6	Migraine	
THCA	cis	1	rs10761723	chr10:64955581	NRBF2	chr10:64893007-64914785:+	-0.29	-6.95	1.22E-11	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs10761727	chr10:64995493	NRBF2	chr10:64893007-64914785:+	-0.28	-6.64	8.57E-11	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs10761730	chr10:65017053	LOC84989	chr10:65224989-65226320:+	-0.26	-4.27	2.33E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs10761730	chr10:65017053	NRBF2	chr10:64893007-64914785:+	-0.28	-4.64	4.43E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs10761742	chr10:65085048	NRBF2	chr10:64893007-64914785:+	-0.29	-6.8	3.18E-11	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs10761745	chr10:65101071	LOC84989	chr10:65224989-65226320:+	-0.27	-4.39	1.38E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs10761745	chr10:65101071	NRBF2	chr10:64893007-64914785:+	-0.28	-4.79	2.21E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs10762504	chr10:74039335	DNAJB12	chr10:74092588-74114907:-	0.2	4.71	3.33E-6	Heschl's gyrus morphology	
THCA	cis	1	rs10762505	chr10:74046212	DNAJB12	chr10:74092588-74114907:-	-0.21	-4.86	1.56E-6	Heschl's gyrus morphology	
THCA	cis	1	rs10762582	chr10:75968316	VCL	chr10:75754951-75879912:+	-0.19	-3.47	0.000558	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs10762794	chr10:54343080	DKK1	chr10:54074041-54077416:+	-0.26	-4.88	1.44E-6	Metabolite levels  (X-11787)	
THCA	cis	1	rs10762800	chr10:54356980	DKK1	chr10:54074041-54077416:+	-0.28	-5.12	4.43E-7	Metabolite levels  (X-11787)	
THCA	cis	1	rs1076394	chr3:47322781	C3orf75	chr3:47537131-47555199:-	0.1	4.38	1.44E-5	Colorectal cancer	
THCA	cis	1	rs1076394	chr3:47322781	NBEAL2	chr3:47021173-47051193:+	0.12	3.83	0.000145	Colorectal cancer	
THCA	cis	1	rs1076539	chr22:18439598	MICAL3	chr22:18270418-18507325:-	-0.2	-4.26	2.48E-5	Presence of antiphospholipid antibodies	
THCA	cis	1	rs1076540	chr22:18439958	MICAL3	chr22:18270418-18507325:-	-0.2	-4.26	2.48E-5	Presence of antiphospholipid antibodies	
THCA	cis	1	rs1076541	chr22:18440026	MICAL3	chr22:18270418-18507325:-	-0.21	-4.28	2.25E-5	Presence of antiphospholipid antibodies	
THCA	cis	1	rs1076542	chr22:18446452	MICAL3	chr22:18270418-18507325:-	0.23	4.79	2.28E-6	Presence of antiphospholipid antibodies	
THCA	cis	1	rs1076543	chr22:18446490	MICAL3	chr22:18270418-18507325:-	-0.2	-4.11	4.6E-5	Presence of antiphospholipid antibodies	
THCA	cis	1	rs1076544	chr22:18446565	MICAL3	chr22:18270418-18507325:-	-0.2	-4.11	4.6E-5	Presence of antiphospholipid antibodies	
THCA	cis	1	rs10766814	chr11:3260222	MRGPRE	chr11:3249042-3253616:-	-0.19	-3.69	0.000253	Multiple sclerosis	
THCA	cis	1	rs10766969	chr11:22849952	SVIP	chr11:22843600-22851382:-	-0.3	-7.61	1.52E-13	Dialysis-related mortality	
THCA	cis	1	rs10767693	chr11:28093926	METT5D1	chr11:28129798-28355054:+	-0.19	-3.67	0.000274	Bipolar disorder	
THCA	cis	1	rs10767971	chr11:32895664	CCDC73	chr11:32623627-32816187:-	0.31	6.58	1.27E-10	Parkinson's disease (age of onset)	
THCA	cis	1	rs10767971	chr11:32895664	QSER1	chr11:32914792-33014862:+	0.1	3.57	0.000391	Parkinson's disease (age of onset)	
THCA	cis	1	rs10767972	chr11:32896419	CCDC73	chr11:32623627-32816187:-	0.3	6.28	7.62E-10	Parkinson's disease (age of onset)	
THCA	cis	1	rs10767972	chr11:32896419	QSER1	chr11:32914792-33014862:+	0.1	3.49	0.00053	Parkinson's disease (age of onset)	
THCA	cis	1	rs10768026	chr11:4490110	TRIM68	chr11:4619902-4629437:-	0.16	3.54	0.000441	Amyotrophic lateral sclerosis	
THCA	cis	1	rs10768083	chr11:34611806	ABTB2	chr11:34172535-34378802:-	-0.15	-3.65	0.000286	Volumetric brain MRI	
THCA	cis	1	rs10769054	chr11:5566489	UBQLNL	chr11:5535624-5537956:-	-0.28	-6.54	1.56E-10	QRS duration in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs10771431	chr12:9380859	LOC642846	chr12:9436253-9466684:+	0.28	6.87	2.01E-11	Breast size	
THCA	cis	1	rs10773003	chr12:123775127	C12orf65	chr12:123717841-123742481:+	0.2	3.5	0.000517	HDL cholesterol	
THCA	cis	1	rs10773004	chr12:123788758	C12orf65	chr12:123717841-123742481:+	-0.25	-4.25	2.6E-5	HDL cholesterol	
THCA	cis	1	rs10773005	chr12:123790007	C12orf65	chr12:123717841-123742481:+	-0.25	-4.21	3.03E-5	HDL cholesterol	
THCA	cis	1	rs10773006	chr12:123790051	C12orf65	chr12:123717841-123742481:+	-0.25	-4.22	2.9E-5	HDL cholesterol	
THCA	cis	1	rs1077358	chr4:103553926	CISD2	chr4:103790135-103809913:+	-0.15	-3.5	0.000517	Primary biliary cirrhosis	
THCA	cis	1	rs1077358	chr4:103553926	NFKB1	chr4:103422486-103538458:+	0.14	4.04	6.22E-5	Primary biliary cirrhosis	
THCA	cis	1	rs1077514	chr1:23766233	ASAP3	chr1:23755056-23811057:-	-0.28	-4.68	3.75E-6	Cholesterol, total	
THCA	cis	1	rs1077514	chr1:23766233	TCEA3	chr1:23707555-23751261:-	-0.23	-4.38	1.47E-5	Cholesterol, total	
THCA	cis	1	rs1077889	chr20:25267893	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs1077889	chr20:25267893	FAM182A	chr20:26035250-26067552:+	-0.18	-3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs1077889	chr20:25267893	FAM182B	chr20:25744102-25848786:-	0.27	5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs1077889	chr20:25267893	NINL	chr20:25433338-25566153:-	-0.35	-7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs1077889	chr20:25267893	PYGB	chr20:25228706-25278647:+	-0.16	-4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs10783342	chr12:50628466	C12orf62	chr12:50505900-50514234:+	-0.1	-4.12	4.51E-5	Schizophrenia	
THCA	cis	1	rs10783342	chr12:50628466	SMARCD1	chr12:50478983-50494493:+	-0.13	-3.34	0.000897	Schizophrenia	
THCA	cis	1	rs1078338	chr5:101678793	SLCO4C1	chr5:101569694-101632253:-	0.25	5.62	3.21E-8	Schizophrenia	
THCA	cis	1	rs10783594	chr12:54067135	SOAT2	chr12:53497274-53518322:+	-0.19	-4.3	2.1E-5	Height	
THCA	cis	1	rs10783832	chr12:57961494	FAM119B	chr12:58166383-58176323:+	0.17	4.5	8.63E-6	Rheumatoid arthritis	
THCA	cis	1	rs10783832	chr12:57961494	TSFM	chr12:58176536-58191367:+	-0.25	-7.02	7.67E-12	Rheumatoid arthritis	
THCA	cis	1	rs10783847	chr12:58196447	FAM119B	chr12:58166383-58176323:+	0.4	11.1	1.3E-25	Multiple sclerosis	
THCA	cis	1	rs10783847	chr12:58196447	METTL1	chr12:58162352-58165914:-	-0.19	-4.6	5.43E-6	Multiple sclerosis	
THCA	cis	1	rs10783847	chr12:58196447	TSFM	chr12:58176536-58191367:+	-0.57	-19.46	1.57E-62	Multiple sclerosis	
THCA	cis	1	rs10783847	chr12:58196447	XRCC6BP1	chr12:58335445-58351051:+	-0.22	-4.39	1.38E-5	Multiple sclerosis	
THCA	cis	1	rs10783848	chr12:58196528	FAM119B	chr12:58166383-58176323:+	0.4	11.15	8.13E-26	Multiple sclerosis	
THCA	cis	1	rs10783848	chr12:58196528	METTL1	chr12:58162352-58165914:-	-0.19	-4.63	4.81E-6	Multiple sclerosis	
THCA	cis	1	rs10783848	chr12:58196528	TSFM	chr12:58176536-58191367:+	-0.57	-19.58	4.11E-63	Multiple sclerosis	
THCA	cis	1	rs10783848	chr12:58196528	XRCC6BP1	chr12:58335445-58351051:+	-0.22	-4.39	1.41E-5	Multiple sclerosis	
THCA	cis	1	rs10784281	chr12:62502979	FAM19A2	chr12:62102043-62653925:-	-0.15	-3.34	0.000892	Post bronchodilator FEV1/FVC ratio in COPD	
THCA	cis	1	rs10785581	chr12:45930973	LOC400027	chr12:46119810-46121530:-	-0.12	-3.38	0.000788	Hypertension	
THCA	cis	1	rs10785814	chr1:107610540	NTNG1	chr1:107682629-108024471:+	0.22	3.78	0.000175	AIDS	
THCA	cis	1	rs10786596	chr10:102282126	SEC31B	chr10:102246403-102289636:-	-0.28	-8.99	5.63E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs10786597	chr10:102291287	SEC31B	chr10:102246403-102289636:-	-0.28	-9.14	1.74E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs10786598	chr10:102291579	SEC31B	chr10:102246403-102289636:-	-0.28	-9.14	1.74E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs1078679	chr6:26568741	BTN2A3	chr6:26422317-26431927:+	0.18	4.22	2.98E-5	Educational attainment	
THCA	cis	1	rs1078679	chr6:26568741	HCG11	chr6:26521934-26527610:+	-0.21	-4.11	4.7E-5	Educational attainment	
THCA	cis	1	rs1078679	chr6:26568741	HMGN4	chr6:26538572-26547162:+	-0.16	-4.16	3.71E-5	Educational attainment	
THCA	cis	1	rs1078679	chr6:26568741	LOC100270746	chr6:26987146-26988085:-	-0.14	-3.36	0.000857	Educational attainment	
THCA	cis	1	rs1078679	chr6:26568741	ZNF322A	chr6:26634612-26659963:-	-0.16	-4.59	5.75E-6	Educational attainment	
THCA	cis	1	rs1078895	chr1:19331408	TMCO4	chr1:20008707-20126758:-	-0.16	-3.6	0.000345	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
THCA	cis	1	rs10789475	chr1:46304177	CCDC163P	chr1:45960581-45965646:-	-0.49	-9.57	5.98E-20	Body mass index	
THCA	cis	1	rs10789475	chr1:46304177	GPBP1L1	chr1:46092978-46152302:-	0.16	4.12	4.45E-5	Body mass index	
THCA	cis	1	rs10789475	chr1:46304177	MMACHC	chr1:45965856-45976737:+	-0.19	-4.22	2.97E-5	Body mass index	
THCA	cis	1	rs10789475	chr1:46304177	MUTYH	chr1:45794915-45806142:-	0.3	8.17	2.69E-15	Body mass index	
THCA	cis	1	rs10789481	chr1:46383583	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.22	2.71E-22	Body mass index	
THCA	cis	1	rs10789481	chr1:46383583	GPBP1L1	chr1:46092978-46152302:-	0.15	3.76	0.000189	Body mass index	
THCA	cis	1	rs10789481	chr1:46383583	MMACHC	chr1:45965856-45976737:+	-0.21	-4.6	5.37E-6	Body mass index	
THCA	cis	1	rs10789481	chr1:46383583	MUTYH	chr1:45794915-45806142:-	0.32	8.69	5.75E-17	Body mass index	
THCA	cis	1	rs10789487	chr1:46420221	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.14	5.21E-22	Body mass index	
THCA	cis	1	rs10789487	chr1:46420221	GPBP1L1	chr1:46092978-46152302:-	0.15	3.83	0.000146	Body mass index	
THCA	cis	1	rs10789487	chr1:46420221	MMACHC	chr1:45965856-45976737:+	-0.21	-4.57	6.3E-6	Body mass index	
THCA	cis	1	rs10789487	chr1:46420221	MUTYH	chr1:45794915-45806142:-	0.3	8.13	3.66E-15	Body mass index	
THCA	cis	1	rs10789491	chr1:47179310	CYP4B1	chr1:47264670-47285020:+	0.22	3.42	0.000687	Response to hepatitis C treatment	
THCA	cis	1	rs10789491	chr1:47179310	CYP4Z1	chr1:47533160-47583992:+	0.27	4.04	6.34E-5	Response to hepatitis C treatment	
THCA	cis	1	rs10789491	chr1:47179310	DMBX1	chr1:46972668-46979884:+	0.23	4	7.19E-5	Response to hepatitis C treatment	
THCA	cis	1	rs1078968	chr3:53123486	ITIH4	chr3:52847007-52866554:-	0.16	4.58	6.06E-6	Height	
THCA	cis	1	rs1078968	chr3:53123486	RFT1	chr3:53122503-53164470:-	-0.75	-18.21	1.15E-56	Height	
THCA	cis	1	rs10789823	chr11:111172403	C11orf92	chr11:111164171-111175770:-	-0.18	-3.84	0.000138	Colorectal cancer	
THCA	cis	1	rs10790172	chr11:116927740	PCSK7	chr11:117075789-117102811:-	-0.29	-5.2	2.99E-7	Protein quantitative trait loci	
THCA	cis	1	rs10790268	chr11:118729391	TREH	chr11:118528942-118550381:-	0.26	4.21	3.09E-5	Rheumatoid arthritis	
THCA	cis	1	rs10791054	chr11:129697006	NFRKB	chr11:129733671-129765490:-	0.23	4.11	4.59E-5	Obesity-related traits	
THCA	cis	1	rs10791055	chr11:129697106	NFRKB	chr11:129733671-129765490:-	0.22	4.02	6.76E-5	Obesity-related traits	
THCA	cis	1	rs10792320	chr11:61746291	BEST1	chr11:61717356-61731939:+	0.27	5.51	5.8E-8	Phospholipid levels (plasma)	
THCA	cis	1	rs10793016	chr11:71755063	FAM86C	chr11:71498557-71512276:+	-0.34	-4.11	4.56E-5	Severe influenza A (H1N1) infection	
THCA	cis	1	rs10793273	chr11:77742595	ALG8	chr11:77811988-77850699:-	0.3	6.22	1.1E-9	Pelvic organ prolapse	
THCA	cis	1	rs10793295	chr11:77996521	NARS2	chr11:78147017-78285909:-	0.38	7.19	2.43E-12	Testicular germ cell tumor	
THCA	cis	1	rs10793297	chr11:78009660	NARS2	chr11:78147017-78285909:-	-0.36	-6.41	3.42E-10	Testicular germ cell tumor	
THCA	cis	1	rs10793300	chr11:78019582	NARS2	chr11:78147017-78285909:-	-0.36	-6.47	2.45E-10	Testicular germ cell tumor	
THCA	cis	1	rs10793302	chr11:78040961	NARS2	chr11:78147017-78285909:-	-0.37	-6.84	2.49E-11	Testicular germ cell tumor	
THCA	cis	1	rs10793303	chr11:78060750	NARS2	chr11:78147017-78285909:-	-0.39	-7	8.63E-12	Testicular germ cell tumor	
THCA	cis	1	rs10793304	chr11:78064907	NARS2	chr11:78147017-78285909:-	-0.41	-7.75	5.42E-14	Testicular germ cell tumor	
THCA	cis	1	rs10793308	chr11:78086005	NARS2	chr11:78147017-78285909:-	-0.39	-7.46	4.19E-13	Testicular germ cell tumor	
THCA	cis	1	rs10793309	chr11:78093799	NARS2	chr11:78147017-78285909:-	-0.38	-7.11	4.13E-12	Testicular germ cell tumor	
THCA	cis	1	rs10793311	chr11:78104399	NARS2	chr11:78147017-78285909:-	-0.4	-7.06	5.95E-12	Testicular germ cell tumor	
THCA	cis	1	rs1079389	chr10:1161980	IDI2	chr10:1064847-1071799:-	0.4	4.01	7.03E-5	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs1079390	chr10:1161653	IDI2	chr10:1064847-1071799:-	0.4	4.02	6.67E-5	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs1079418	chr6:166047034	PDE10A	chr6:165740779-166075584:-	-0.24	-4.82	1.93E-6	Thyroid hormone levels	
THCA	cis	1	rs10794302	chr11:234102	PSMD13	chr11:236808-252984:+	-0.22	-6.78	3.51E-11	Menarche (age at onset)	
THCA	cis	1	rs10794302	chr11:234102	SIRT3	chr11:214625-236931:-	0.12	3.36	0.000854	Menarche (age at onset)	
THCA	cis	1	rs10794349	chr11:945678	TSPAN4	chr11:842824-867116:+	0.16	3.78	0.000174	Alzheimer's disease (late onset)	
THCA	cis	1	rs10794357	chr11:973374	TSPAN4	chr11:842824-867116:+	0.17	3.99	7.56E-5	Alzheimer's disease (late onset)	
THCA	cis	1	rs10794639	chr16:377367	DECR2	chr16:451858-462486:+	0.21	4.43	1.15E-5	Bone mineral density (spine);Bone mineral density	
THCA	cis	1	rs10794671	chr1:121168242	HIST2H2BA	chr1:120906034-120914842:+	0.23	5.22	2.65E-7	Hip geometry	
THCA	cis	1	rs1079467	chr11:7969711	EIF3F	chr11:8008445-8017716:+	0.19	3.97	8.38E-5	Response to anti-TNF therapy in rheumatoid arthritis	
THCA	cis	1	rs10794720	chr10:1156165	IDI2	chr10:1064847-1071799:-	-0.31	-3.52	0.000477	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs10794720	chr10:1156165	WDR37	chr10:1102344-1178237:+	-0.24	-3.54	0.000435	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs10795443	chr10:17137500	CUBN	chr10:16865966-17171816:-	0.21	4.88	1.44E-6	Whole-brain volume	
THCA	cis	1	rs10795452	chr10:17192712	TRDMT1	chr10:17184983-17243681:-	0.29	6.6	1.11E-10	Homocysteine levels	
THCA	cis	1	rs10795452	chr10:17192712	VIM	chr10:17270258-17279592:+	0.18	3.5	0.000509	Homocysteine levels	
THCA	cis	1	rs10795465	chr10:17260525	TRDMT1	chr10:17184983-17243681:-	0.24	5.35	1.39E-7	Cholesterol, total	
THCA	cis	1	rs1079576	chr22:18446318	MICAL3	chr22:18270418-18507325:-	-0.2	-4.11	4.6E-5	Presence of antiphospholipid antibodies	
THCA	cis	1	rs1079596	chr11:113296619	TTC12	chr11:113185251-113244016:+	0.39	6.33	5.59E-10	Select biomarker traits	
THCA	cis	1	rs1079597	chr11:113296286	TTC12	chr11:113185251-113244016:+	0.38	6.2	1.22E-9	Select biomarker traits	
THCA	cis	1	rs10797432	chr1:2501338	MMEL1	chr1:2522081-2564481:-	-0.15	-3.96	8.79E-5	Ulcerative colitis	
THCA	cis	1	rs10798686	chr1:179470357	C1orf125	chr1:179335107-179523868:+	0.32	3.67	0.000268	Multiple sclerosis (age of onset)	
THCA	cis	1	rs10798847	chr1:31858984	ZCCHC17	chr1:31769842-31837780:+	-0.3	-5.66	2.61E-8	Schizophrenia	
THCA	cis	1	rs10798848	chr1:31874162	ZCCHC17	chr1:31769842-31837780:+	-0.32	-5.78	1.33E-8	Schizophrenia	
THCA	cis	1	rs1080060	chr2:27768808	FNDC4	chr2:27714751-27718126:-	-0.15	-3.51	0.000486	Oral cavity cancer	
THCA	cis	1	rs10803116	chr1:236031654	LYST	chr1:235824345-236046940:-	-0.31	-9.89	4.2E-21	Systemic lupus erythematosus	
THCA	cis	1	rs10804111	chr2:202145612	ALS2CR12	chr2:202153148-202222101:-	-0.43	-8.67	6.83E-17	Melanoma;Esophageal squamous cell carcinoma	
THCA	cis	1	rs10804260	chr2:218290048	DIRC3	chr2:218148748-218621316:-	0.2	4.65	4.27E-6	Height	
THCA	cis	1	rs10804632	chr3:134294501	ANAPC13	chr3:134196547-134204865:-	0.36	11.5	3.34E-27	Height	
THCA	cis	1	rs10804632	chr3:134294501	CEP63	chr3:134204575-134293852:+	0.3	6.58	1.24E-10	Height	
THCA	cis	1	rs10805359	chr4:17684886	MED28	chr4:17616273-17629791:+	0.16	3.43	0.000658	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs10806701	chr6:159385223	RSPH3	chr6:159398268-159421198:-	0.29	5.99	4.08E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs1080698	chr10:102295114	SEC31B	chr10:102246403-102289636:-	-0.28	-9.08	2.93E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs10807508	chr6:55950812	COL21A1	chr6:55921389-56258892:-	-0.65	-8.16	3.02E-15	Psychosis (atypical)	
THCA	cis	1	rs10807510	chr6:56006672	COL21A1	chr6:55921389-56258892:-	-0.71	-8.8	2.42E-17	Psychosis (atypical)	
THCA	cis	1	rs10807701	chr7:65724686	CCT6P1	chr7:65216092-65228661:+	-0.44	-6.91	1.6E-11	Diabetic kidney disease	
THCA	cis	1	rs10807701	chr7:65724686	CRCP	chr7:65579805-65619551:+	0.29	4.44	1.12E-5	Diabetic kidney disease	
THCA	cis	1	rs10807701	chr7:65724686	LOC493754	chr7:65993446-66057363:-	-0.29	-3.37	0.000808	Diabetic kidney disease	
THCA	cis	1	rs10807701	chr7:65724686	RABGEF1	chr7:66093890-66276446:+	-0.6	-7.42	5.51E-13	Diabetic kidney disease	
THCA	cis	1	rs10807702	chr7:65767843	CCT6P1	chr7:65216092-65228661:+	0.4	6.41	3.6E-10	Diabetic kidney disease	
THCA	cis	1	rs10807702	chr7:65767843	CRCP	chr7:65579805-65619551:+	-0.31	-4.75	2.75E-6	Diabetic kidney disease	
THCA	cis	1	rs10807702	chr7:65767843	RABGEF1	chr7:66093890-66276446:+	0.53	6.6	1.09E-10	Diabetic kidney disease	
THCA	cis	1	rs10813951	chr9:33128021	B4GALT1	chr9:33110639-33167356:-	-0.26	-6.13	1.81E-9	IgG glycosylation	
THCA	cis	1	rs10813957	chr9:33153527	B4GALT1	chr9:33110639-33167356:-	0.28	6.27	8.19E-10	IgG glycosylation	
THCA	cis	1	rs10815094	chr9:4845520	RCL1	chr9:4792834-4885917:+	-0.19	-3.41	0.000715	Red blood cell traits;Mean corpuscular hemoglobin;Mean corpuscular volume	
THCA	cis	1	rs10816446	chr9:109597347	ZNF462	chr9:109625378-109773789:+	-0.11	-3.8	0.000165	Height	
THCA	cis	1	rs10816448	chr9:109612511	ZNF462	chr9:109625378-109773789:+	-0.11	-3.79	0.000171	Height	
THCA	cis	1	rs10816533	chr9:99539138	FAM22G	chr9:99690592-99704572:+	-0.94	-8.59	1.25E-16	Height	
THCA	cis	1	rs10816533	chr9:99539138	HIATL2	chr9:99695549-99775862:-	-0.7	-6.32	5.96E-10	Height	
THCA	cis	1	rs10816533	chr9:99539138	LOC441454	chr9:99671357-99672736:+	-0.41	-3.99	7.65E-5	Height	
THCA	cis	1	rs10816600	chr9:99576424	FAM22G	chr9:99690592-99704572:+	0.91	8.48	2.74E-16	Height	
THCA	cis	1	rs10816600	chr9:99576424	HIATL2	chr9:99695549-99775862:-	0.68	6.24	9.88E-10	Height	
THCA	cis	1	rs10816600	chr9:99576424	LOC441454	chr9:99671357-99672736:+	0.36	3.63	0.000319	Height	
THCA	cis	1	rs10818480	chr9:123643170	LOC253039	chr9:123605320-123616644:+	-0.5	-9.18	1.29E-18	Rheumatoid arthritis	
THCA	cis	1	rs10818480	chr9:123643170	PSMD5	chr9:123578334-123605206:-	-0.27	-5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs10819464	chr9:131876277	CRAT	chr9:131857075-131873070:-	0.28	6.71	5.45E-11	Blood metabolite ratios	
THCA	cis	1	rs10819466	chr9:131881492	CRAT	chr9:131857075-131873070:-	0.29	6.95	1.19E-11	Blood metabolite ratios	
THCA	cis	1	rs10819469	chr9:131882067	CRAT	chr9:131857075-131873070:-	0.28	6.82	2.77E-11	Blood metabolite ratios	
THCA	cis	1	rs10819471	chr9:131896325	CRAT	chr9:131857075-131873070:-	0.28	6.78	3.65E-11	Blood metabolite ratios	
THCA	cis	1	rs10820614	chr9:99196094	CDC14B	chr9:99262397-99382112:-	-0.12	-3.6	0.000353	Resting heart rate	
THCA	cis	1	rs10820633	chr9:99214796	CDC14B	chr9:99262397-99382112:-	-0.17	-5.15	3.84E-7	Height	
THCA	cis	1	rs10822145	chr10:64934548	NRBF2	chr10:64893007-64914785:+	-0.28	-6.6	1.11E-10	Triglycerides	
THCA	cis	1	rs10822149	chr10:64987412	NRBF2	chr10:64893007-64914785:+	-0.29	-6.87	2.04E-11	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs10822161	chr10:65118203	NRBF2	chr10:64893007-64914785:+	-0.29	-6.88	1.92E-11	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs10822163	chr10:65124098	NRBF2	chr10:64893007-64914785:+	-0.29	-6.88	1.92E-11	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs10823911	chr10:74040034	DNAJB12	chr10:74092588-74114907:-	0.2	4.75	2.64E-6	Heschl's gyrus morphology	
THCA	cis	1	rs10824026	chr10:75421208	BMS1P4	chr10:75458909-75490272:-	-0.3	-6.12	1.96E-9	Atrial fibrillation	
THCA	cis	1	rs10824026	chr10:75421208	NUDT13	chr10:74870210-74891580:+	-0.21	-3.81	0.000154	Atrial fibrillation	
THCA	cis	1	rs10824075	chr10:75880254	VCL	chr10:75754951-75879912:+	-0.21	-3.81	0.000156	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs10824078	chr10:75892120	VCL	chr10:75754951-75879912:+	-0.24	-4.28	2.25E-5	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs10824085	chr10:75911984	VCL	chr10:75754951-75879912:+	-0.2	-3.59	0.000366	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs10824088	chr10:75921490	VCL	chr10:75754951-75879912:+	-0.23	-4	7.38E-5	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs10824090	chr10:75923446	VCL	chr10:75754951-75879912:+	-0.19	-3.6	0.000348	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs10824096	chr10:75937554	VCL	chr10:75754951-75879912:+	-0.24	-4.28	2.25E-5	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs10824098	chr10:75943579	VCL	chr10:75754951-75879912:+	-0.19	-3.58	0.000374	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs10824099	chr10:75943625	VCL	chr10:75754951-75879912:+	-0.23	-4.03	6.62E-5	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs10824101	chr10:75947438	VCL	chr10:75754951-75879912:+	-0.23	-4.05	5.91E-5	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs10824102	chr10:75948915	VCL	chr10:75754951-75879912:+	-0.21	-3.89	0.000116	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs10824103	chr10:75949415	VCL	chr10:75754951-75879912:+	-0.21	-3.87	0.000125	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs10824105	chr10:75952881	VCL	chr10:75754951-75879912:+	-0.21	-3.87	0.000125	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs10824106	chr10:75958408	VCL	chr10:75754951-75879912:+	0.21	3.51	0.000487	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs10824110	chr10:75968098	VCL	chr10:75754951-75879912:+	-0.19	-3.47	0.000558	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs10824113	chr10:75969018	VCL	chr10:75754951-75879912:+	-0.19	-3.47	0.000558	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs10824125	chr10:75997498	VCL	chr10:75754951-75879912:+	-0.18	-3.38	0.000795	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs10824128	chr10:76007903	VCL	chr10:75754951-75879912:+	-0.18	-3.38	0.000795	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs10827823	chr10:38039381	LOC399744	chr10:38717074-38741080:+	0.29	3.79	0.000172	Obesity (extreme)	
THCA	cis	1	rs10827824	chr10:38047039	LOC399744	chr10:38717074-38741080:+	0.28	3.69	0.000251	Obesity (extreme)	
THCA	cis	1	rs10827829	chr10:38104282	LOC399744	chr10:38717074-38741080:+	0.29	4.05	5.92E-5	Obesity (extreme)	
THCA	cis	1	rs10827829	chr10:38104282	ZNF25	chr10:38238795-38265453:-	0.16	3.36	0.000843	Obesity (extreme)	
THCA	cis	1	rs10827831	chr10:38110813	LOC399744	chr10:38717074-38741080:+	0.31	4.3	2.09E-5	Obesity (extreme)	
THCA	cis	1	rs10827831	chr10:38110813	ZNF25	chr10:38238795-38265453:-	0.16	3.48	0.000541	Obesity (extreme)	
THCA	cis	1	rs10827832	chr10:38119941	LOC399744	chr10:38717074-38741080:+	0.31	4.27	2.34E-5	Obesity (extreme)	
THCA	cis	1	rs10827832	chr10:38119941	ZNF25	chr10:38238795-38265453:-	0.16	3.47	0.000575	Obesity (extreme)	
THCA	cis	1	rs10829156	chr10:18950555	NSUN6	chr10:18802051-18940550:-	0.17	3.94	9.48E-5	Sudden cardiac arrest	
THCA	cis	1	rs10829157	chr10:18951463	NSUN6	chr10:18802051-18940550:-	0.16	3.8	0.000164	Sudden cardiac arrest	
THCA	cis	1	rs10832921	chr11:18380835	GTF2H1	chr11:18343816-18388590:+	0.33	8.79	2.64E-17	Pancreatic cancer	
THCA	cis	1	rs10832956	chr11:18645668	SPTY2D1	chr11:18627949-18656020:-	-0.15	-4.98	8.87E-7	Cholesterol, total	
THCA	cis	1	rs10832962	chr11:18656271	SPTY2D1	chr11:18627949-18656020:-	-0.14	-4.61	5.13E-6	Cholesterol, total	
THCA	cis	1	rs10832963	chr11:18664241	SPTY2D1	chr11:18627949-18656020:-	-0.13	-4.15	3.93E-5	Cholesterol, total	
THCA	cis	1	rs10833824	chr11:22847485	SVIP	chr11:22843600-22851382:-	-0.28	-7.08	5.18E-12	Dialysis-related mortality	
THCA	cis	1	rs10833825	chr11:22850753	SVIP	chr11:22843600-22851382:-	-0.3	-7.46	4.17E-13	Dialysis-related mortality	
THCA	cis	1	rs10835661	chr11:30381076	C11orf46	chr11:30344649-30359978:+	0.21	3.99	7.8E-5	Sex hormone levels;Menopause (age at onset)	
THCA	cis	1	rs10837697	chr11:5281018	HBG1	chr11:5269502-5271087:-	0.25	3.93	9.86E-5	Hemoglobin levels	
THCA	cis	1	rs10837697	chr11:5281018	HBG2	chr11:5269502-5667011:-	0.28	4.34	1.76E-5	Hemoglobin levels	
THCA	cis	1	rs10838276	chr11:5555503	UBQLNL	chr11:5535624-5537956:-	0.28	6.43	3.12E-10	QRS duration in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs10838277	chr11:5555551	UBQLNL	chr11:5535624-5537956:-	-0.28	-6.44	2.9E-10	QRS duration in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs10838290	chr11:5560150	UBQLNL	chr11:5535624-5537956:-	-0.27	-6.34	5.46E-10	QRS duration in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs10838291	chr11:5560226	UBQLNL	chr11:5535624-5537956:-	-0.28	-6.46	2.63E-10	QRS duration in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs10838299	chr11:5566830	UBQLNL	chr11:5535624-5537956:-	-0.27	-6.1	2.14E-9	QRS duration in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs10838738	chr11:47663049	C1QTNF4	chr11:47611216-47615961:-	-0.31	-5.43	9.05E-8	Subjective well-being	
THCA	cis	1	rs10838747	chr11:47716324	C1QTNF4	chr11:47611216-47615961:-	-0.31	-5.43	9.05E-8	Subjective well-being	
THCA	cis	1	rs10838748	chr11:47716381	C1QTNF4	chr11:47611216-47615961:-	-0.32	-5.55	4.74E-8	Subjective well-being	
THCA	cis	1	rs10838757	chr11:47763016	C1QTNF4	chr11:47611216-47615961:-	-0.31	-5.35	1.34E-7	Subjective well-being	
THCA	cis	1	rs10840085	chr11:8613949	STK33	chr11:8413418-8615775:-	0.24	5.65	2.81E-8	Body mass index	
THCA	cis	1	rs10840085	chr11:8613949	TRIM66	chr11:8633586-8693413:-	0.18	4.61	5.16E-6	Body mass index	
THCA	cis	1	rs10841992	chr12:22507319	KIAA0528	chr12:22601526-22697452:-	-0.23	-4.29	2.18E-5	Coronary artery calcification	
THCA	cis	1	rs10842017	chr12:22547175	KIAA0528	chr12:22601526-22697452:-	0.2	3.47	0.000577	Coronary artery calcification	
THCA	cis	1	rs10842026	chr12:22570161	KIAA0528	chr12:22601526-22697452:-	0.23	3.85	0.000136	Coronary artery calcification	
THCA	cis	1	rs10846506	chr12:123777815	C12orf65	chr12:123717841-123742481:+	-0.25	-4.25	2.6E-5	HDL cholesterol	
THCA	cis	1	rs10846579	chr12:124407403	DNAH10	chr12:124247042-124420265:+	0.19	3.82	0.000149	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs10846579	chr12:124407403	ZNF664	chr12:124457670-124499967:+	-0.15	-4.3	2.11E-5	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs10846580	chr12:124415453	DNAH10	chr12:124247042-124420265:+	0.17	3.41	0.000714	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs10846580	chr12:124415453	ZNF664	chr12:124457670-124499967:+	-0.15	-4.16	3.78E-5	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs10848943	chr12:3944022	PARP11	chr12:3918027-3982608:-	-0.16	-3.52	0.000482	Cognitive performance	
THCA	cis	1	rs10849462	chr12:6575992	TAPBPL	chr12:6561177-6575601:+	-0.46	-6.74	4.65E-11	Hip geometry	
THCA	cis	1	rs10849605	chr12:1064438	ERC1	chr12:1100404-1605099:+	-0.1	-4	7.36E-5	Lung cancer	
THCA	cis	1	rs10849605	chr12:1064438	RAD52	chr12:1021255-1099219:-	-0.32	-7.24	1.81E-12	Lung cancer	
THCA	cis	1	rs10849691	chr12:120154254	TMEM233	chr12:120031264-120079363:+	-0.22	-5.41	9.73E-8	Urgency urinary incontinence	
THCA	cis	1	rs10851478	chr15:49829019	SECISBP2L	chr15:49280967-49338630:-	-0.13	-3.91	0.000107	Oral cavity cancer	
THCA	cis	1	rs10851604	chr15:56510059	MNS1	chr15:56720929-56757335:-	-0.23	-3.41	0.000699	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs10851604	chr15:56510059	TEX9	chr15:56657644-56738071:+	-0.34	-5.84	9.5E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs1085243	chr1:46544768	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.17	4.03E-22	Body mass index	
THCA	cis	1	rs1085243	chr1:46544768	GPBP1L1	chr1:46092978-46152302:-	0.13	3.41	0.000705	Body mass index	
THCA	cis	1	rs1085243	chr1:46544768	MMACHC	chr1:45965856-45976737:+	-0.21	-4.48	9.32E-6	Body mass index	
THCA	cis	1	rs1085243	chr1:46544768	MUTYH	chr1:45794915-45806142:-	0.28	7.49	3.29E-13	Body mass index	
THCA	cis	1	rs1085244	chr1:46563680	CCDC163P	chr1:45960581-45965646:-	-0.51	-9.9	3.88E-21	Body mass index	
THCA	cis	1	rs1085244	chr1:46563680	GPBP1L1	chr1:46092978-46152302:-	0.15	3.73	0.000214	Body mass index	
THCA	cis	1	rs1085244	chr1:46563680	MMACHC	chr1:45965856-45976737:+	-0.21	-4.53	7.42E-6	Body mass index	
THCA	cis	1	rs1085244	chr1:46563680	MUTYH	chr1:45794915-45806142:-	0.29	7.65	1.12E-13	Body mass index	
THCA	cis	1	rs10853057	chr17:62998023	AMZ2P1	chr17:62962668-62971703:-	0.7	9.95	2.47E-21	White matter microstructure (global fractional anisotropy)	
THCA	cis	1	rs10853057	chr17:62998023	GNA13	chr17:63005409-63052920:-	-0.3	-5.37	1.24E-7	White matter microstructure (global fractional anisotropy)	
THCA	cis	1	rs10853751	chr19:41903220	B3GNT8	chr19:41931265-41934635:-	-0.34	-8	9.28E-15	Height	
THCA	cis	1	rs10853751	chr19:41903220	EXOSC5	chr19:41892278-41903256:-	-0.1	-3.44	0.000639	Height	
THCA	cis	1	rs10857712	chr10:135225666	LOC619207	chr10:135267432-135337062:+	-0.14	-3.61	0.000341	Systemic lupus erythematosus	
THCA	cis	1	rs10857712	chr10:135225666	MTG1	chr10:135207621-135234173:+	0.58	14.06	7.74E-38	Systemic lupus erythematosus	
THCA	cis	1	rs10857712	chr10:135225666	SPRN	chr10:135234171-135238121:-	0.19	3.82	0.000154	Systemic lupus erythematosus	
THCA	cis	1	rs10857811	chr1:110617688	ALX3	chr1:110602998-110613322:-	0.31	7.65	1.12E-13	Blood metabolite levels	
THCA	cis	1	rs10859179	chr12:92072728	CLLU1	chr12:92815307-92877456:+	-0.26	-3.5	0.000506	Biochemical measures	
THCA	cis	1	rs10862219	chr12:81430043	ACSS3	chr12:81471809-81649582:+	0.22	4.67	3.84E-6	Neuroticism	
THCA	cis	1	rs10862222	chr12:81436607	ACSS3	chr12:81471809-81649582:+	0.22	4.67	4.01E-6	Neuroticism	
THCA	cis	1	rs10862368	chr12:82244514	PPFIA2	chr12:81652880-82153109:-	0.21	4.03	6.51E-5	Resting heart rate	
THCA	cis	1	rs10862371	chr12:82249298	PPFIA2	chr12:81652880-82153109:-	0.22	4.13	4.25E-5	Resting heart rate	
THCA	cis	1	rs10862372	chr12:82249804	PPFIA2	chr12:81652880-82153109:-	0.21	4.01	6.97E-5	Resting heart rate	
THCA	cis	1	rs10862373	chr12:82250657	PPFIA2	chr12:81652880-82153109:-	0.21	4.03	6.45E-5	Resting heart rate	
THCA	cis	1	rs10862374	chr12:82250809	PPFIA2	chr12:81652880-82153109:-	0.21	4	7.35E-5	Resting heart rate	
THCA	cis	1	rs10864167	chr1:207421572	CD55	chr1:207494817-207534309:+	0.15	6.66	7.44E-11	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs10864175	chr1:207433349	CD55	chr1:207494817-207534309:+	0.15	6.72	5.14E-11	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs10864178	chr1:207445678	CD55	chr1:207494817-207534309:+	0.15	6.63	8.92E-11	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs10864180	chr1:207445761	CD55	chr1:207494817-207534309:+	0.14	6.57	1.28E-10	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs10864181	chr1:207448051	CD55	chr1:207494817-207534309:+	0.17	7.11	4.27E-12	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs10864231	chr1:207506329	CD55	chr1:207494817-207534309:+	0.15	6.52	1.82E-10	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs10864459	chr1:10563609	APITD1	chr1:10490159-10512208:+	0.13	3.67	0.000269	Prostate cancer	
THCA	cis	1	rs10864655	chr1:231172810	EXOC8	chr1:231468483-231473578:-	0.15	3.48	0.00054	Carotid plaque burden (smoking interaction)	
THCA	cis	1	rs10865914	chr3:41919499	ULK4	chr3:41288091-42003660:-	-1.08	-20.62	4.85E-68	Diastolic blood pressure	
THCA	cis	1	rs10865956	chr3:49581559	GMPPB	chr3:49758932-49761384:-	-0.16	-3.58	0.000383	Menarche (age at onset)	
THCA	cis	1	rs10865956	chr3:49581559	P4HTM	chr3:49027341-49044579:+	0.17	4.26	2.43E-5	Menarche (age at onset)	
THCA	cis	1	rs10865956	chr3:49581559	WDR6	chr3:49044637-49053386:+	-0.17	-3.61	0.000334	Menarche (age at onset)	
THCA	cis	1	rs10865970	chr3:51357501	HEMK1	chr3:50606583-50622419:+	0.2	4.18	3.4E-5	Melanoma	
THCA	cis	1	rs10865970	chr3:51357501	TEX264	chr3:51705222-51738338:+	-0.22	-6.05	2.93E-9	Melanoma	
THCA	cis	1	rs10867159	chr9:91800566	CKS2	chr9:91926113-91931617:+	-0.24	-4.69	3.56E-6	Pelvic organ prolapse (moderate/severe)	
THCA	cis	1	rs10867161	chr9:91806749	CKS2	chr9:91926113-91931617:+	-0.25	-4.48	9.16E-6	Pelvic organ prolapse (moderate/severe)	
THCA	cis	1	rs10869767	chr9:79019811	GCNT1	chr9:79034752-79122330:+	-0.15	-3.53	0.000455	Dialysis-related mortality	
THCA	cis	1	rs10869767	chr9:79019811	PCSK5	chr9:78505560-78808338:+	-0.15	-3.39	0.000766	Dialysis-related mortality	
THCA	cis	1	rs10869767	chr9:79019811	RFK	chr9:79000433-79009444:-	-0.19	-4.02	6.84E-5	Dialysis-related mortality	
THCA	cis	1	rs10869773	chr9:79035347	GCNT1	chr9:79034752-79122330:+	-0.16	-3.68	0.00026	Dialysis-related mortality	
THCA	cis	1	rs10869773	chr9:79035347	RFK	chr9:79000433-79009444:-	-0.18	-3.69	0.000253	Dialysis-related mortality	
THCA	cis	1	rs10869777	chr9:79049157	RPSAP9	chr9:79013515-79014954:+	-0.25	-4.82	1.93E-6	Acute graft versus host disease in bone marrow transplantation (recipient effect)	
THCA	cis	1	rs10869778	chr9:79050338	RPSAP9	chr9:79013515-79014954:+	-0.24	-4.8	2.16E-6	Acute graft versus host disease in bone marrow transplantation (recipient effect)	
THCA	cis	1	rs10871290	chr16:74472696	RFWD3	chr16:74655298-74700779:-	0.17	4.09	5.01E-5	Breast cancer	
THCA	cis	1	rs10872032	chr6:109676776	AKD1	chr6:109814059-110012415:-	-0.33	-7.44	4.71E-13	Height	
THCA	cis	1	rs10872032	chr6:109676776	FIG4	chr6:110012424-110146634:+	-0.17	-3.53	0.000459	Height	
THCA	cis	1	rs10872032	chr6:109676776	SMPD2	chr6:109761931-109765121:+	0.33	8.49	2.71E-16	Height	
THCA	cis	1	rs10872623	chr6:101165047	ASCC3	chr6:100956609-101329224:-	-0.09	-3.51	0.000482	Menarche (age at onset)	
THCA	cis	1	rs10872623	chr6:101165047	GRIK2	chr6:101846905-102517957:+	-0.14	-3.42	0.000668	Menarche (age at onset)	
THCA	cis	1	rs10873086	chr14:55349258	GCH1	chr14:55308724-55369542:-	-0.22	-4.55	6.68E-6	Rheumatoid arthritis;Obesity-related traits	
THCA	cis	1	rs10873192	chr14:66110653	LOC645431	chr14:65877313-65879335:-	0.26	3.42	0.000675	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs10873275	chr14:75531460	EIF2B2	chr14:75469612-75476292:+	0.19	5.09	5.12E-7	Height	
THCA	cis	1	rs10873275	chr14:75531460	MLH3	chr14:75480467-75518235:-	0.3	9.02	4.62E-18	Height	
THCA	cis	1	rs10873275	chr14:75531460	RPS6KL1	chr14:75372347-75389958:-	0.32	6.93	1.36E-11	Height	
THCA	cis	1	rs10873336	chr14:81779134	STON2	chr14:81727000-81893748:-	0.21	4.2	3.16E-5	Obesity-related traits	
THCA	cis	1	rs10874122	chr1:75235866	CRYZ	chr1:75171175-75199092:-	-0.44	-7.51	2.98E-13	Resistin levels	
THCA	cis	1	rs10874910	chr1:95707567	TMEM56	chr1:95582894-95663159:+	0.2	4.3	2.04E-5	Non-alcoholic fatty liver disease histology (AST)	
THCA	cis	1	rs10875746	chr12:48518264	ASB8	chr12:48541575-48551377:-	0.16	4.21	3.07E-5	Longevity (90 years and older)	
THCA	cis	1	rs10875746	chr12:48518264	C12orf68	chr12:48577366-48579709:+	0.18	3.56	0.000401	Longevity (90 years and older)	
THCA	cis	1	rs10875746	chr12:48518264	OR10AD1	chr12:48596122-48597075:-	0.18	3.36	0.000852	Longevity (90 years and older)	
THCA	cis	1	rs10875746	chr12:48518264	ZNF641	chr12:48735912-48745021:-	0.13	4.54	7.11E-6	Longevity (90 years and older)	
THCA	cis	1	rs10876080	chr12:51155194	DIP2B	chr12:50898768-51142448:+	-0.24	-8.74	4.04E-17	Colorectal cancer	
THCA	cis	1	rs10876480	chr12:54066271	SOAT2	chr12:53497274-53518322:+	-0.19	-4.22	2.91E-5	Height	
THCA	cis	1	rs10876481	chr12:54066743	SOAT2	chr12:53497274-53518322:+	-0.19	-4.22	2.91E-5	Height	
THCA	cis	1	rs10877012	chr12:58162085	FAM119B	chr12:58166383-58176323:+	0.38	10.36	8.05E-23	Multiple sclerosis	
THCA	cis	1	rs10877012	chr12:58162085	METTL1	chr12:58162352-58165914:-	-0.18	-4.49	8.88E-6	Multiple sclerosis	
THCA	cis	1	rs10877012	chr12:58162085	TSFM	chr12:58176536-58191367:+	-0.57	-19.22	2.0E-61	Multiple sclerosis	
THCA	cis	1	rs10877012	chr12:58162085	XRCC6BP1	chr12:58335445-58351051:+	-0.22	-4.48	9.34E-6	Multiple sclerosis	
THCA	cis	1	rs10877013	chr12:58165085	FAM119B	chr12:58166383-58176323:+	0.38	10.63	7.86E-24	Multiple sclerosis	
THCA	cis	1	rs10877013	chr12:58165085	METTL1	chr12:58162352-58165914:-	-0.18	-4.37	1.53E-5	Multiple sclerosis	
THCA	cis	1	rs10877013	chr12:58165085	TSFM	chr12:58176536-58191367:+	-0.55	-18.44	9.3E-58	Multiple sclerosis	
THCA	cis	1	rs10877013	chr12:58165085	XRCC6BP1	chr12:58335445-58351051:+	-0.21	-4.41	1.3E-5	Multiple sclerosis	
THCA	cis	1	rs10877014	chr12:58167661	FAM119B	chr12:58166383-58176323:+	0.39	10.83	1.31E-24	Multiple sclerosis	
THCA	cis	1	rs10877014	chr12:58167661	METTL1	chr12:58162352-58165914:-	-0.18	-4.41	1.29E-5	Multiple sclerosis	
THCA	cis	1	rs10877014	chr12:58167661	TSFM	chr12:58176536-58191367:+	-0.55	-18.66	9.35E-59	Multiple sclerosis	
THCA	cis	1	rs10877014	chr12:58167661	XRCC6BP1	chr12:58335445-58351051:+	-0.22	-4.59	5.61E-6	Multiple sclerosis	
THCA	cis	1	rs10877015	chr12:58167788	FAM119B	chr12:58166383-58176323:+	0.38	10.55	1.52E-23	Multiple sclerosis	
THCA	cis	1	rs10877015	chr12:58167788	METTL1	chr12:58162352-58165914:-	-0.18	-4.38	1.46E-5	Multiple sclerosis	
THCA	cis	1	rs10877015	chr12:58167788	TSFM	chr12:58176536-58191367:+	-0.57	-19.46	1.45E-62	Multiple sclerosis	
THCA	cis	1	rs10877015	chr12:58167788	XRCC6BP1	chr12:58335445-58351051:+	-0.21	-4.31	1.98E-5	Multiple sclerosis	
THCA	cis	1	rs10877019	chr12:58172929	FAM119B	chr12:58166383-58176323:+	-0.37	-9.87	4.81E-21	Multiple sclerosis	
THCA	cis	1	rs10877019	chr12:58172929	METTL1	chr12:58162352-58165914:-	0.16	3.83	0.000144	Multiple sclerosis	
THCA	cis	1	rs10877019	chr12:58172929	TSFM	chr12:58176536-58191367:+	0.55	17.7	2.66E-54	Multiple sclerosis	
THCA	cis	1	rs10877019	chr12:58172929	XRCC6BP1	chr12:58335445-58351051:+	0.2	3.94	9.4E-5	Multiple sclerosis	
THCA	cis	1	rs10877792	chr12:62503621	FAM19A2	chr12:62102043-62653925:-	-0.15	-3.34	0.000892	Post bronchodilator FEV1/FVC ratio in COPD	
THCA	cis	1	rs10880230	chr12:42450253	GXYLT1	chr12:42475650-42538673:-	-0.14	-3.85	0.000132	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	
THCA	cis	1	rs10880230	chr12:42450253	PPHLN1	chr12:42632249-42853517:+	-0.13	-3.53	0.00045	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	
THCA	cis	1	rs10880812	chr12:45931200	LOC400027	chr12:46119810-46121530:-	0.12	3.41	0.000697	Hypertension	
THCA	cis	1	rs10880813	chr12:45931201	LOC400027	chr12:46119810-46121530:-	0.12	3.41	0.000697	Hypertension	
THCA	cis	1	rs10881608	chr10:91374649	FLJ37201	chr10:91451057-91457685:-	-0.18	-3.74	0.000208	Metabolic traits	
THCA	cis	1	rs10881610	chr10:91374833	FLJ37201	chr10:91451057-91457685:-	-0.18	-3.74	0.000208	Metabolic traits	
THCA	cis	1	rs10882643	chr10:97375171	SORBS1	chr10:97071531-97321171:-	0.13	3.35	0.00087	Blood metabolite levels	
THCA	cis	1	rs10883492	chr10:102206089	SEC31B	chr10:102246403-102289636:-	-0.3	-10.17	3.96E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs10883493	chr10:102208188	SEC31B	chr10:102246403-102289636:-	-0.3	-10.17	3.96E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs10883496	chr10:102221931	SEC31B	chr10:102246403-102289636:-	-0.3	-10.24	2.25E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs10883497	chr10:102228519	SEC31B	chr10:102246403-102289636:-	-0.31	-10.38	6.47E-23	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs10883499	chr10:102232188	SEC31B	chr10:102246403-102289636:-	-0.3	-10.24	2.25E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs10883500	chr10:102238324	SEC31B	chr10:102246403-102289636:-	-0.3	-10.04	1.22E-21	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs10883501	chr10:102238326	SEC31B	chr10:102246403-102289636:-	-0.3	-10.04	1.22E-21	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs10883502	chr10:102238343	SEC31B	chr10:102246403-102289636:-	-0.3	-10.04	1.22E-21	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs10883503	chr10:102275504	SEC31B	chr10:102246403-102289636:-	-0.27	-8.54	1.76E-16	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs10883504	chr10:102280687	SEC31B	chr10:102246403-102289636:-	-0.28	-8.92	9.62E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs10883505	chr10:102280772	SEC31B	chr10:102246403-102289636:-	-0.28	-8.91	1.04E-17	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs10883506	chr10:102289743	SEC31B	chr10:102246403-102289636:-	-0.28	-9.14	1.74E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs10883507	chr10:102291275	SEC31B	chr10:102246403-102289636:-	-0.28	-9.14	1.74E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs10883508	chr10:102294413	SEC31B	chr10:102246403-102289636:-	-0.28	-8.98	6.39E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs10883509	chr10:102296461	SEC31B	chr10:102246403-102289636:-	-0.28	-8.98	6.14E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs10883510	chr10:102297018	SEC31B	chr10:102246403-102289636:-	-0.28	-9.08	2.85E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs10883511	chr10:102299407	SEC31B	chr10:102246403-102289636:-	-0.28	-8.88	1.32E-17	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs10883512	chr10:102308516	SEC31B	chr10:102246403-102289636:-	-0.28	-8.81	2.36E-17	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs10883513	chr10:102316964	SEC31B	chr10:102246403-102289636:-	-0.3	-8.99	5.99E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs10887150	chr10:124180578	PLEKHA1	chr10:124134220-124191866:+	-0.21	-5.76	1.52E-8	Height	
THCA	cis	1	rs10888527	chr1:153001363	SPRR3	chr1:152974223-152976332:+	0.15	3.56	0.000408	Inflammatory skin disease	
THCA	cis	1	rs10888576	chr1:150200792	ADAMTSL4	chr1:150521898-150533410:+	-0.13	-3.39	0.000754	Morning vs. evening chronotype	
THCA	cis	1	rs1088984	chr11:2377581	CD81	chr11:2398547-2418649:+	0.17	3.43	0.000667	Bacteremia	
THCA	cis	1	rs1088985	chr11:2377852	CD81	chr11:2398547-2418649:+	0.18	3.58	0.00038	Bacteremia	
THCA	cis	1	rs10890352	chr1:46283628	CCDC163P	chr1:45960581-45965646:-	-0.51	-10.03	1.24E-21	Body mass index	
THCA	cis	1	rs10890352	chr1:46283628	GPBP1L1	chr1:46092978-46152302:-	0.16	4.07	5.54E-5	Body mass index	
THCA	cis	1	rs10890352	chr1:46283628	MMACHC	chr1:45965856-45976737:+	-0.19	-4.28	2.28E-5	Body mass index	
THCA	cis	1	rs10890352	chr1:46283628	MUTYH	chr1:45794915-45806142:-	0.31	8.34	7.97E-16	Body mass index	
THCA	cis	1	rs10890354	chr1:46305347	CCDC163P	chr1:45960581-45965646:-	-0.51	-10.03	1.26E-21	Body mass index	
THCA	cis	1	rs10890354	chr1:46305347	GPBP1L1	chr1:46092978-46152302:-	0.16	4.07	5.44E-5	Body mass index	
THCA	cis	1	rs10890354	chr1:46305347	MMACHC	chr1:45965856-45976737:+	-0.19	-4.28	2.24E-5	Body mass index	
THCA	cis	1	rs10890354	chr1:46305347	MUTYH	chr1:45794915-45806142:-	0.31	8.34	7.9E-16	Body mass index	
THCA	cis	1	rs10890361	chr1:46346234	CCDC163P	chr1:45960581-45965646:-	-0.42	-7.73	6.61E-14	Body mass index	
THCA	cis	1	rs10890361	chr1:46346234	GPBP1L1	chr1:46092978-46152302:-	0.15	3.95	9.07E-5	Body mass index	
THCA	cis	1	rs10890361	chr1:46346234	MMACHC	chr1:45965856-45976737:+	-0.17	-3.67	0.000268	Body mass index	
THCA	cis	1	rs10890361	chr1:46346234	MUTYH	chr1:45794915-45806142:-	0.26	6.69	6.25E-11	Body mass index	
THCA	cis	1	rs10890363	chr1:46356148	CCDC163P	chr1:45960581-45965646:-	0.51	9.78	1.07E-20	Body mass index	
THCA	cis	1	rs10890363	chr1:46356148	GPBP1L1	chr1:46092978-46152302:-	-0.16	-4.13	4.28E-5	Body mass index	
THCA	cis	1	rs10890363	chr1:46356148	MMACHC	chr1:45965856-45976737:+	0.22	4.69	3.53E-6	Body mass index	
THCA	cis	1	rs10890363	chr1:46356148	MUTYH	chr1:45794915-45806142:-	-0.33	-8.78	2.82E-17	Body mass index	
THCA	cis	1	rs10890383	chr1:46588503	CCDC163P	chr1:45960581-45965646:-	-0.52	-9.78	9.97E-21	Body mass index	
THCA	cis	1	rs10890383	chr1:46588503	GPBP1L1	chr1:46092978-46152302:-	0.15	3.6	0.000351	Body mass index	
THCA	cis	1	rs10890383	chr1:46588503	MMACHC	chr1:45965856-45976737:+	-0.21	-4.49	8.9E-6	Body mass index	
THCA	cis	1	rs10890383	chr1:46588503	MUTYH	chr1:45794915-45806142:-	0.31	7.98	1.07E-14	Body mass index	
THCA	cis	1	rs10890844	chr11:108334127	ACAT1	chr11:107992258-108018889:+	-0.26	-6.36	4.7E-10	Melanoma	
THCA	cis	1	rs10892040	chr11:116756986	PCSK7	chr11:117075789-117102811:-	0.44	5.3	1.74E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs10892050	chr11:116816394	PCSK7	chr11:117075789-117102811:-	0.46	5.6	3.67E-8	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs10892051	chr11:116832718	PCSK7	chr11:117075789-117102811:-	0.43	5.18	3.28E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs10892056	chr11:116870411	PCSK7	chr11:117075789-117102811:-	0.41	5.18	3.34E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs10894147	chr11:129698856	NFRKB	chr11:129733671-129765490:-	0.19	3.4	0.000738	Obesity-related traits	
THCA	cis	1	rs10894149	chr11:129702471	NFRKB	chr11:129733671-129765490:-	0.23	4.14	4.17E-5	Obesity-related traits	
THCA	cis	1	rs10896043	chr11:65543827	CTSW	chr11:65647284-65651212:+	0.23	4.73	2.94E-6	Systemic lupus erythematosus	
THCA	cis	1	rs10896043	chr11:65543827	RNASEH2C	chr11:65485146-65488409:-	0.18	4.46	1.04E-5	Systemic lupus erythematosus	
THCA	cis	1	rs10896043	chr11:65543827	SNX32	chr11:65601410-65621170:+	-0.39	-5.25	2.27E-7	Systemic lupus erythematosus	
THCA	cis	1	rs10896598	chr11:57052007	TIMM10	chr11:57295936-57298232:-	-0.2	-3.58	0.000378	Low high density lipoprotein cholesterol levels	
THCA	cis	1	rs10896608	chr11:57108911	TIMM10	chr11:57295936-57298232:-	-0.2	-3.81	0.000155	Low high density lipoprotein cholesterol levels	
THCA	cis	1	rs10897009	chr11:59923194	MS4A14	chr11:60145958-60185226:+	0.17	4.4	1.31E-5	Alzheimer's disease (late onset)	
THCA	cis	1	rs10898191	chr11:71194601	NADSYN1	chr11:71164217-71212579:+	0.19	4.41	1.3E-5	Vitamin D levels	
THCA	cis	1	rs10898193	chr11:71197083	NADSYN1	chr11:71164217-71212579:+	-0.19	-4.43	1.15E-5	Vitamin D levels	
THCA	cis	1	rs10898211	chr11:71210677	NADSYN1	chr11:71164217-71212579:+	0.18	4.23	2.75E-5	Vitamin D levels	
THCA	cis	1	rs10898223	chr11:71219264	NADSYN1	chr11:71164217-71212579:+	0.18	4.08	5.34E-5	Vitamin D levels	
THCA	cis	1	rs10898234	chr11:71236684	NADSYN1	chr11:71164217-71212579:+	0.17	3.91	0.000104	Vitamin D levels	
THCA	cis	1	rs10898814	chr11:71736505	FAM86C	chr11:71498557-71512276:+	0.31	3.77	0.000186	Severe influenza A (H1N1) infection	
THCA	cis	1	rs10899021	chr11:74338054	POLD3	chr11:74303629-74353765:+	0.26	4.51	7.99E-6	Response to metformin (IC50)	
THCA	cis	1	rs10899025	chr11:74367040	POLD3	chr11:74303629-74353765:+	-0.21	-3.38	0.000782	Response to metformin (IC50)	
THCA	cis	1	rs10899451	chr11:77991222	NARS2	chr11:78147017-78285909:-	-0.36	-6.49	2.15E-10	Testicular germ cell tumor	
THCA	cis	1	rs10899452	chr11:77995143	NARS2	chr11:78147017-78285909:-	-0.34	-5.91	6.62E-9	Testicular germ cell tumor	
THCA	cis	1	rs10899453	chr11:77997482	NARS2	chr11:78147017-78285909:-	-0.38	-6.91	1.52E-11	Testicular germ cell tumor	
THCA	cis	1	rs10899454	chr11:77997513	NARS2	chr11:78147017-78285909:-	-0.38	-6.91	1.52E-11	Testicular germ cell tumor	
THCA	cis	1	rs10899455	chr11:77999163	NARS2	chr11:78147017-78285909:-	-0.35	-6.51	1.92E-10	Testicular germ cell tumor	
THCA	cis	1	rs10899456	chr11:78000155	NARS2	chr11:78147017-78285909:-	-0.37	-6.88	1.83E-11	Testicular germ cell tumor	
THCA	cis	1	rs10899457	chr11:78001163	NARS2	chr11:78147017-78285909:-	-0.35	-6.33	5.53E-10	Testicular germ cell tumor	
THCA	cis	1	rs10899458	chr11:78007451	NARS2	chr11:78147017-78285909:-	-0.36	-6.41	3.42E-10	Testicular germ cell tumor	
THCA	cis	1	rs10899460	chr11:78010080	NARS2	chr11:78147017-78285909:-	-0.36	-6.45	2.69E-10	Testicular germ cell tumor	
THCA	cis	1	rs10899465	chr11:78013588	NARS2	chr11:78147017-78285909:-	-0.37	-6.49	2.11E-10	Testicular germ cell tumor	
THCA	cis	1	rs10899467	chr11:78014057	NARS2	chr11:78147017-78285909:-	-0.35	-6.09	2.33E-9	Testicular germ cell tumor	
THCA	cis	1	rs10899468	chr11:78016650	NARS2	chr11:78147017-78285909:-	-0.36	-6.47	2.45E-10	Testicular germ cell tumor	
THCA	cis	1	rs10899469	chr11:78018313	NARS2	chr11:78147017-78285909:-	-0.36	-6.47	2.45E-10	Testicular germ cell tumor	
THCA	cis	1	rs10899470	chr11:78020052	NARS2	chr11:78147017-78285909:-	-0.36	-6.47	2.45E-10	Testicular germ cell tumor	
THCA	cis	1	rs10899474	chr11:78043636	NARS2	chr11:78147017-78285909:-	-0.38	-6.79	3.29E-11	Testicular germ cell tumor	
THCA	cis	1	rs10899475	chr11:78051610	NARS2	chr11:78147017-78285909:-	-0.4	-7.65	1.08E-13	Testicular germ cell tumor	
THCA	cis	1	rs10899476	chr11:78051794	NARS2	chr11:78147017-78285909:-	-0.39	-6.89	1.73E-11	Testicular germ cell tumor	
THCA	cis	1	rs10899477	chr11:78052104	NARS2	chr11:78147017-78285909:-	-0.39	-6.98	1.01E-11	Testicular germ cell tumor	
THCA	cis	1	rs10899478	chr11:78052238	NARS2	chr11:78147017-78285909:-	-0.41	-7.75	5.42E-14	Testicular germ cell tumor	
THCA	cis	1	rs10899479	chr11:78052539	NARS2	chr11:78147017-78285909:-	-0.39	-7	8.63E-12	Testicular germ cell tumor	
THCA	cis	1	rs10899481	chr11:78058721	NARS2	chr11:78147017-78285909:-	0.37	7.15	3.27E-12	Testicular germ cell tumor	
THCA	cis	1	rs10899483	chr11:78061057	NARS2	chr11:78147017-78285909:-	-0.41	-7.75	5.42E-14	Testicular germ cell tumor	
THCA	cis	1	rs10899485	chr11:78072383	NARS2	chr11:78147017-78285909:-	0.41	7.92	1.64E-14	Testicular germ cell tumor	
THCA	cis	1	rs10899486	chr11:78072398	NARS2	chr11:78147017-78285909:-	-0.39	-7	8.63E-12	Testicular germ cell tumor	
THCA	cis	1	rs10899489	chr11:78095373	NARS2	chr11:78147017-78285909:-	-0.39	-7.2	2.33E-12	Testicular germ cell tumor	
THCA	cis	1	rs10899491	chr11:78106305	NARS2	chr11:78147017-78285909:-	-0.39	-7	8.63E-12	Testicular germ cell tumor	
THCA	cis	1	rs10899492	chr11:78109810	NARS2	chr11:78147017-78285909:-	-0.4	-7.6	1.59E-13	Testicular germ cell tumor	
THCA	cis	1	rs10899495	chr11:78123293	NARS2	chr11:78147017-78285909:-	-0.43	-7.74	5.82E-14	Testicular germ cell tumor	
THCA	cis	1	rs10901212	chr9:135647021	C9orf98	chr9:135600965-135754198:-	0.21	3.6	0.000353	Obesity-related traits	
THCA	cis	1	rs10901513	chr10:127699936	DHX32	chr10:127524909-127585027:-	-0.26	-5.7	2.08E-8	Visceral fat	
THCA	cis	1	rs10901513	chr10:127699936	UROS	chr10:127477148-127511837:-	-0.31	-7.66	1.04E-13	Visceral fat	
THCA	cis	1	rs10901514	chr10:127700066	DHX32	chr10:127524909-127585027:-	-0.26	-5.7	2.08E-8	Visceral fat	
THCA	cis	1	rs10901514	chr10:127700066	UROS	chr10:127477148-127511837:-	-0.31	-7.66	1.04E-13	Visceral fat	
THCA	cis	1	rs10901520	chr10:127718837	DHX32	chr10:127524909-127585027:-	-0.26	-5.82	1.1E-8	Visceral fat	
THCA	cis	1	rs10901520	chr10:127718837	UROS	chr10:127477148-127511837:-	-0.31	-7.58	1.78E-13	Visceral fat	
THCA	cis	1	rs10902110	chr11:237648	PSMD13	chr11:236808-252984:+	-0.22	-6.75	4.25E-11	Menarche (age at onset)	
THCA	cis	1	rs10902110	chr11:237648	SIRT3	chr11:214625-236931:-	0.12	3.38	0.000785	Menarche (age at onset)	
THCA	cis	1	rs10902112	chr11:244106	PSMD13	chr11:236808-252984:+	-0.22	-6.73	4.91E-11	Menarche (age at onset)	
THCA	cis	1	rs10902112	chr11:244106	SIRT3	chr11:214625-236931:-	0.12	3.37	0.000812	Menarche (age at onset)	
THCA	cis	1	rs10902113	chr11:245523	PSMD13	chr11:236808-252984:+	-0.22	-6.73	4.91E-11	Menarche (age at onset)	
THCA	cis	1	rs10902113	chr11:245523	SIRT3	chr11:214625-236931:-	0.12	3.37	0.000812	Menarche (age at onset)	
THCA	cis	1	rs10902114	chr11:246234	PSMD13	chr11:236808-252984:+	-0.22	-6.73	4.91E-11	Menarche (age at onset)	
THCA	cis	1	rs10902114	chr11:246234	SIRT3	chr11:214625-236931:-	0.12	3.37	0.000812	Menarche (age at onset)	
THCA	cis	1	rs10902233	chr11:925510	TSPAN4	chr11:842824-867116:+	0.15	3.63	0.000318	Alzheimer's disease (late onset)	
THCA	cis	1	rs10902246	chr11:953674	TSPAN4	chr11:842824-867116:+	0.15	3.68	0.000259	Alzheimer's disease (late onset)	
THCA	cis	1	rs10902728	chr1:26598281	CNKSR1	chr1:26503981-26516373:+	-0.16	-4.36	1.57E-5	Obesity-related traits	
THCA	cis	1	rs10902728	chr1:26598281	ZNF593	chr1:26496388-26497362:+	0.14	4.25	2.58E-5	Obesity-related traits	
THCA	cis	1	rs10902853	chr10:124740621	C10orf88	chr10:124690419-124713919:-	-0.22	-4.08	5.37E-5	Migraine without aura	
THCA	cis	1	rs10903159	chr1:121181997	HIST2H2BA	chr1:120906034-120914842:+	0.22	5.06	5.94E-7	Hip geometry	
THCA	cis	1	rs10903161	chr1:121178741	HIST2H2BA	chr1:120906034-120914842:+	0.22	5.13	4.21E-7	Hip geometry	
THCA	cis	1	rs10903252	chr5:179733934	MAPK9	chr5:179660597-179719071:-	0.15	3.71	0.000229	Height	
THCA	cis	1	rs10904908	chr10:17260290	TRDMT1	chr10:17184983-17243681:-	0.23	5.2	2.94E-7	Cholesterol, total	
THCA	cis	1	rs10904909	chr10:17264521	TRDMT1	chr10:17184983-17243681:-	0.25	5.53	5.3E-8	Cholesterol, total	
THCA	cis	1	rs10905218	chr10:7733898	ITIH5	chr10:7601636-7708934:-	-0.2	-3.98	7.89E-5	Ovarian reserve	
THCA	cis	1	rs10905219	chr10:7738411	ITIH5	chr10:7601636-7708934:-	-0.18	-3.54	0.000435	Ovarian reserve	
THCA	cis	1	rs10906982	chr15:84568158	LOC388152	chr15:84867600-84898920:-	-0.2	-3.85	0.000133	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs10906983	chr15:84569183	LOC388152	chr15:84867600-84898920:-	-0.21	-3.95	8.82E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs10908494	chr1:156263097	BGLAP	chr1:156182784-156213112:+	0.22	5.27	2.04E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs10908494	chr1:156263097	C1orf85	chr1:156259882-156265449:-	-0.17	-4.02	6.86E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs10908494	chr1:156263097	CCT3	chr1:156278752-156308195:-	-0.32	-6.86	2.08E-11	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs10908495	chr1:156263940	BGLAP	chr1:156182784-156213112:+	0.23	5.39	1.09E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs10908495	chr1:156263940	C1orf85	chr1:156259882-156265449:-	-0.17	-4.18	3.53E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs10908495	chr1:156263940	CCT3	chr1:156278752-156308195:-	-0.33	-7.13	3.62E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs10908496	chr1:156264000	BGLAP	chr1:156182784-156213112:+	0.23	5.55	4.68E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs10908496	chr1:156264000	C1orf85	chr1:156259882-156265449:-	-0.17	-4.16	3.82E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs10908496	chr1:156264000	CCT3	chr1:156278752-156308195:-	-0.33	-7.21	2.16E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs10908498	chr1:156278175	BGLAP	chr1:156182784-156213112:+	0.23	5.39	1.09E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs10908498	chr1:156278175	C1orf85	chr1:156259882-156265449:-	-0.17	-4.18	3.53E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs10908498	chr1:156278175	CCT3	chr1:156278752-156308195:-	-0.33	-7.13	3.62E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs10908499	chr1:156279176	BGLAP	chr1:156182784-156213112:+	0.23	5.39	1.09E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs10908499	chr1:156279176	C1orf85	chr1:156259882-156265449:-	-0.17	-4.18	3.53E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs10908499	chr1:156279176	CCT3	chr1:156278752-156308195:-	-0.33	-7.13	3.62E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs10908500	chr1:156280671	BGLAP	chr1:156182784-156213112:+	0.23	5.39	1.09E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs10908500	chr1:156280671	C1orf85	chr1:156259882-156265449:-	-0.17	-4.18	3.53E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs10908500	chr1:156280671	CCT3	chr1:156278752-156308195:-	-0.33	-7.13	3.62E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs10908502	chr1:156300082	BGLAP	chr1:156182784-156213112:+	0.23	5.51	5.77E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs10908502	chr1:156300082	C1orf85	chr1:156259882-156265449:-	-0.17	-4.09	5.11E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs10908502	chr1:156300082	CCT3	chr1:156278752-156308195:-	-0.33	-7.07	5.4E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs10910092	chr1:2501516	MMEL1	chr1:2522081-2564481:-	-0.15	-3.96	8.72E-5	Ulcerative colitis	
THCA	cis	1	rs10910845	chr1:145723120	NUDT17	chr1:145586494-145590461:-	-0.16	-3.79	0.000171	Urate levels;Urate levels in overweight individuals	
THCA	cis	1	rs10910845	chr1:145723120	PDZK1	chr1:145727726-145764073:+	0.21	3.7	0.000241	Urate levels;Urate levels in overweight individuals	
THCA	cis	1	rs10911902	chr1:186632317	C1orf27	chr1:186344890-186390502:+	0.21	3.58	0.000378	Schizophrenia	
THCA	cis	1	rs10914347	chr1:31773496	ZCCHC17	chr1:31769842-31837780:+	-0.29	-5.54	4.96E-8	Schizophrenia	
THCA	cis	1	rs10914371	chr1:31857590	ZCCHC17	chr1:31769842-31837780:+	-0.3	-5.79	1.3E-8	Schizophrenia	
THCA	cis	1	rs10914374	chr1:31872581	ZCCHC17	chr1:31769842-31837780:+	-0.3	-5.45	8.16E-8	Schizophrenia	
THCA	cis	1	rs10916248	chr1:224256348	DEGS1	chr1:224363458-224381140:+	0.21	4.53	7.4E-6	QT interval (interaction)	
THCA	cis	1	rs10916433	chr1:229281986	SPHAR	chr1:229440129-229441248:+	-0.27	-3.42	0.000692	Dental caries	
THCA	cis	1	rs10916814	chr1:20892931	CDA	chr1:20915444-20945398:+	0.23	4.71	3.24E-6	Age-related hearing impairment (interaction)	
THCA	cis	1	rs10916814	chr1:20892931	FAM43B	chr1:20878932-20881512:+	-0.2	-4.03	6.44E-5	Age-related hearing impairment (interaction)	
THCA	cis	1	rs10916820	chr1:20903792	CDA	chr1:20915444-20945398:+	-0.24	-4.77	2.46E-6	Age-related hearing impairment (interaction)	
THCA	cis	1	rs10916820	chr1:20903792	FAM43B	chr1:20878932-20881512:+	0.19	3.69	0.000248	Age-related hearing impairment (interaction)	
THCA	cis	1	rs10917151	chr1:22422721	WNT4	chr1:22443800-22470385:-	-0.19	-3.89	0.000116	Endometriosis	
THCA	cis	1	rs10917434	chr1:19707302	CAPZB	chr1:19665274-19811992:-	0.15	3.91	0.000108	Crohn's disease and psoriasis	
THCA	cis	1	rs10927875	chr1:16299312	CLCNKA	chr1:16345370-16360544:+	-0.14	-4.02	6.63E-5	Dilated cardiomyopathy	
THCA	cis	1	rs10927875	chr1:16299312	HSPB7	chr1:16340523-16346089:-	-0.55	-11.29	2.29E-26	Dilated cardiomyopathy	
THCA	cis	1	rs10929965	chr2:160906931	LY75	chr2:160625141-160761262:-	-0.21	-4.99	8.29E-7	Idiopathic membranous nephropathy	
THCA	cis	1	rs10929966	chr2:160908341	LY75	chr2:160625141-160761262:-	0.21	4.95	1.02E-6	Idiopathic membranous nephropathy	
THCA	cis	1	rs10932772	chr2:219177148	TMBIM1	chr2:219138917-219157280:-	0.15	3.4	0.000734	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs10933518	chr2:241838091	C2orf54	chr2:241825466-241835573:-	0.28	6.4	3.69E-10	Urinary metabolites	
THCA	cis	1	rs10934850	chr3:127886957	EEFSEC	chr3:127872313-128127488:+	-0.24	-4.16	3.77E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs10935120	chr3:134233092	ANAPC13	chr3:134196547-134204865:-	-0.37	-11.72	4.84E-28	Height	
THCA	cis	1	rs10935120	chr3:134233092	CEP63	chr3:134204575-134293852:+	-0.3	-6.49	2.09E-10	Height	
THCA	cis	1	rs10935186	chr3:136346206	PCCB	chr3:135969167-136056737:+	0.2	5.82	1.06E-8	Schizophrenia	
THCA	cis	1	rs10935253	chr3:137253992	NCK1	chr3:136581073-136667967:+	0.12	3.46	0.000593	Glucocorticoid-induced osteonecrosis	
THCA	cis	1	rs10935835	chr3:150998157	GPR87	chr3:151011876-151034636:-	0.21	4.69	3.49E-6	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs10935835	chr3:150998157	P2RY14	chr3:150929905-150996230:-	-0.2	-4.18	3.46E-5	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs10936601	chr3:169528449	LRRC34	chr3:169511266-169530720:-	0.25	4.8	2.15E-6	Multiple myeloma and monoclonal gammopathy;Interstitial lung disease	
THCA	cis	1	rs10937470	chr3:191000808	UTS2D	chr3:190984945-191048325:-	-0.18	-3.51	0.000491	Total ventricular volume (Alzheimer's disease interaction)	
THCA	cis	1	rs10938353	chr4:44582487	GUF1	chr4:44680433-44702696:+	-0.27	-5.87	8.0E-9	Body mass index	
THCA	cis	1	rs10939738	chr4:17604295	MED28	chr4:17616273-17629791:+	0.18	4.02	6.82E-5	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs10939740	chr4:17617490	MED28	chr4:17616273-17629791:+	0.19	4.11	4.69E-5	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs10939746	chr4:17684951	MED28	chr4:17616273-17629791:+	-0.15	-3.36	0.000851	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs10939749	chr4:17692319	MED28	chr4:17616273-17629791:+	0.15	3.36	0.000847	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs10939756	chr4:17693867	MED28	chr4:17616273-17629791:+	0.15	3.38	0.000775	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs10944161	chr6:86630376	SNHG5	chr6:86386726-86388451:-	-0.48	-10.64	6.96E-24	Response to antipsychotic treatment	
THCA	cis	1	rs10944163	chr6:86658693	SNHG5	chr6:86386726-86388451:-	-0.51	-11.15	8.37E-26	Response to antipsychotic treatment	
THCA	cis	1	rs10944169	chr6:86683036	SNHG5	chr6:86386726-86388451:-	-0.48	-10.61	9.03E-24	Response to antipsychotic treatment	
THCA	cis	1	rs10944170	chr6:86685469	SNHG5	chr6:86386726-86388451:-	-0.48	-10.64	6.96E-24	Response to antipsychotic treatment	
THCA	cis	1	rs10945188	chr6:70488475	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.45	0.000602	Sleep duration	
THCA	cis	1	rs10945581	chr6:159376252	RSPH3	chr6:159398268-159421198:-	0.28	6	3.97E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs10945582	chr6:159381088	RSPH3	chr6:159398268-159421198:-	-0.26	-5.34	1.41E-7	Bladder cancer (smoking interaction)	
THCA	cis	1	rs10946403	chr6:20717404	SOX4	chr6:21593972-21598847:+	-0.13	-3.94	9.18E-5	Type 2 diabetes	
THCA	cis	1	rs10946700	chr6:24442158	MRS2	chr6:24403153-24425809:+	-0.15	-4.37	1.51E-5	Liver enzyme levels	
THCA	cis	1	rs1094677	chr3:195129744	C3orf21	chr3:194789015-194991895:-	-0.26	-6.18	1.4E-9	Body mass index	
THCA	cis	1	rs10946834	chr6:26533664	BTN2A3	chr6:26422317-26431927:+	0.19	4.52	7.72E-6	Educational attainment	
THCA	cis	1	rs10946834	chr6:26533664	HCG11	chr6:26521934-26527610:+	-0.23	-4.43	1.18E-5	Educational attainment	
THCA	cis	1	rs10946834	chr6:26533664	HMGN4	chr6:26538572-26547162:+	-0.16	-4.05	5.86E-5	Educational attainment	
THCA	cis	1	rs10946834	chr6:26533664	ZNF322A	chr6:26634612-26659963:-	-0.14	-3.77	0.000183	Educational attainment	
THCA	cis	1	rs10946835	chr6:26533757	BTN2A3	chr6:26422317-26431927:+	0.19	4.52	7.72E-6	Educational attainment	
THCA	cis	1	rs10946835	chr6:26533757	HCG11	chr6:26521934-26527610:+	-0.23	-4.43	1.18E-5	Educational attainment	
THCA	cis	1	rs10946835	chr6:26533757	HMGN4	chr6:26538572-26547162:+	-0.16	-4.05	5.86E-5	Educational attainment	
THCA	cis	1	rs10946835	chr6:26533757	ZNF322A	chr6:26634612-26659963:-	-0.14	-3.77	0.000183	Educational attainment	
THCA	cis	1	rs10947673	chr6:37445079	C6orf129	chr6:37450699-37467700:-	0.2	6.16	1.53E-9	Cognitive performance	
THCA	cis	1	rs10948974	chr6:55992520	COL21A1	chr6:55921389-56258892:-	-0.65	-8.05	6.7E-15	Psychosis (atypical)	
THCA	cis	1	rs10948975	chr6:55992744	COL21A1	chr6:55921389-56258892:-	-0.65	-8.05	6.7E-15	Psychosis (atypical)	
THCA	cis	1	rs10950032	chr7:65738591	CCT6P1	chr7:65216092-65228661:+	-0.44	-6.92	1.49E-11	Diabetic kidney disease	
THCA	cis	1	rs10950032	chr7:65738591	CRCP	chr7:65579805-65619551:+	0.29	4.43	1.19E-5	Diabetic kidney disease	
THCA	cis	1	rs10950032	chr7:65738591	LOC493754	chr7:65993446-66057363:-	-0.3	-3.38	0.000785	Diabetic kidney disease	
THCA	cis	1	rs10950032	chr7:65738591	RABGEF1	chr7:66093890-66276446:+	-0.6	-7.44	4.68E-13	Diabetic kidney disease	
THCA	cis	1	rs10950973	chr7:23917277	C7orf46	chr7:23719749-23742268:+	0.13	3.96	8.57E-5	Schizophrenia	
THCA	cis	1	rs10950974	chr7:23917280	C7orf46	chr7:23719749-23742268:+	0.13	3.96	8.57E-5	Schizophrenia	
THCA	cis	1	rs10950975	chr7:23917480	C7orf46	chr7:23719749-23742268:+	0.13	3.95	9.03E-5	Schizophrenia	
THCA	cis	1	rs10951552	chr7:38229782	STARD3NL	chr7:38217933-38270269:+	-0.52	-12.39	8.84E-31	Treatment response for severe sepsis	
THCA	cis	1	rs10952899	chr7:87393137	DBF4	chr7:87505544-87538856:+	-0.27	-4.08	5.34E-5	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs10953870	chr7:118205866	ANKRD7	chr7:117864712-117882782:+	0.23	3.76	0.00019	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs10954872	chr8:29978612	LEPROTL1	chr8:29952922-29995222:+	-0.18	-3.94	9.28E-5	Migraine	
THCA	cis	1	rs10954872	chr8:29978612	MBOAT4	chr8:29989188-30002200:-	-0.34	-4.6	5.36E-6	Migraine	
THCA	cis	1	rs10954872	chr8:29978612	TMEM66	chr8:29920632-29940649:-	0.19	3.74	0.000209	Migraine	
THCA	cis	1	rs10955943	chr8:120944143	DSCC1	chr8:120846182-120868170:-	-0.23	-4.62	4.96E-6	Interstitial lung disease	
THCA	cis	1	rs10957375	chr8:67355484	ADHFE1	chr8:67344718-67381042:+	0.26	5.48	6.93E-8	Blood metabolite levels	
THCA	cis	1	rs10957375	chr8:67355484	C8orf46	chr8:67405491-67430757:+	-0.3	-4.95	1.05E-6	Blood metabolite levels	
THCA	cis	1	rs10957388	chr8:68427777	PREX2	chr8:68864348-69143897:+	-0.12	-3.51	0.000498	Educational attainment	
THCA	cis	1	rs10966	chr20:25282944	ENTPD6	chr20:25176339-25207360:+	-0.32	-7.48	3.62E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs10966	chr20:25282944	FAM182A	chr20:26035250-26067552:+	-0.18	-3.42	0.000686	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs10966	chr20:25282944	FAM182B	chr20:25744102-25848786:-	0.26	5.47	7.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs10966	chr20:25282944	NINL	chr20:25433338-25566153:-	-0.34	-7.1	4.5E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs10966	chr20:25282944	PYGB	chr20:25228706-25278647:+	-0.16	-4.17	3.65E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs10971721	chr9:33827694	UBE2R2	chr9:33817182-33920399:+	-0.35	-3.61	0.000335	Body mass index	
THCA	cis	1	rs10972790	chr9:36212592	SIT1	chr9:35649297-35650947:-	-0.12	-3.4	0.000727	Bipolar disorder (inflammation and infection response interaction)	
THCA	cis	1	rs10978963	chr9:99546081	FAM22G	chr9:99690592-99704572:+	0.96	8.66	7.31E-17	Height	
THCA	cis	1	rs10978963	chr9:99546081	HIATL2	chr9:99695549-99775862:-	0.71	6.39	4.04E-10	Height	
THCA	cis	1	rs10978963	chr9:99546081	LOC441454	chr9:99671357-99672736:+	0.42	4.03	6.49E-5	Height	
THCA	cis	1	rs10978968	chr9:99546449	FAM22G	chr9:99690592-99704572:+	0.96	8.66	7.31E-17	Height	
THCA	cis	1	rs10978968	chr9:99546449	HIATL2	chr9:99695549-99775862:-	0.71	6.39	4.04E-10	Height	
THCA	cis	1	rs10978968	chr9:99546449	LOC441454	chr9:99671357-99672736:+	0.42	4.03	6.49E-5	Height	
THCA	cis	1	rs10978970	chr9:99546458	FAM22G	chr9:99690592-99704572:+	0.96	8.66	7.31E-17	Height	
THCA	cis	1	rs10978970	chr9:99546458	HIATL2	chr9:99695549-99775862:-	0.71	6.39	4.04E-10	Height	
THCA	cis	1	rs10978970	chr9:99546458	LOC441454	chr9:99671357-99672736:+	0.42	4.03	6.49E-5	Height	
THCA	cis	1	rs10978971	chr9:99546485	FAM22G	chr9:99690592-99704572:+	0.96	8.66	7.31E-17	Height	
THCA	cis	1	rs10978971	chr9:99546485	HIATL2	chr9:99695549-99775862:-	0.71	6.39	4.04E-10	Height	
THCA	cis	1	rs10978971	chr9:99546485	LOC441454	chr9:99671357-99672736:+	0.42	4.03	6.49E-5	Height	
THCA	cis	1	rs10978973	chr9:99546586	FAM22G	chr9:99690592-99704572:+	0.96	8.66	7.31E-17	Height	
THCA	cis	1	rs10978973	chr9:99546586	HIATL2	chr9:99695549-99775862:-	0.71	6.39	4.04E-10	Height	
THCA	cis	1	rs10978973	chr9:99546586	LOC441454	chr9:99671357-99672736:+	0.42	4.03	6.49E-5	Height	
THCA	cis	1	rs10979212	chr9:99591728	FAM22G	chr9:99690592-99704572:+	0.91	8.48	2.74E-16	Height	
THCA	cis	1	rs10979212	chr9:99591728	HIATL2	chr9:99695549-99775862:-	0.68	6.24	9.88E-10	Height	
THCA	cis	1	rs10979212	chr9:99591728	LOC441454	chr9:99671357-99672736:+	0.36	3.63	0.000319	Height	
THCA	cis	1	rs10979329	chr9:99616824	FAM22G	chr9:99690592-99704572:+	0.91	8.48	2.74E-16	Height	
THCA	cis	1	rs10979329	chr9:99616824	HIATL2	chr9:99695549-99775862:-	0.68	6.24	9.88E-10	Height	
THCA	cis	1	rs10979329	chr9:99616824	LOC441454	chr9:99671357-99672736:+	0.36	3.63	0.000319	Height	
THCA	cis	1	rs10981012	chr9:114453006	GNG10	chr9:114423861-114432524:+	-0.26	-3.44	0.000638	Coronary artery disease	
THCA	cis	1	rs10983700	chr9:100537455	C9orf156	chr9:100666772-100684852:-	0.13	3.39	0.00077	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	cis	1	rs10983701	chr9:100537577	C9orf156	chr9:100666772-100684852:-	0.13	3.44	0.000637	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	cis	1	rs10983761	chr9:100553957	C9orf156	chr9:100666772-100684852:-	0.13	3.65	0.000295	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	cis	1	rs10984361	chr9:100681490	C9orf156	chr9:100666772-100684852:-	-0.13	-3.48	0.000538	Quantitative traits	
THCA	cis	1	rs10984506	chr9:100716140	C9orf156	chr9:100666772-100684852:-	-0.14	-3.58	0.000378	Quantitative traits	
THCA	cis	1	rs10985500	chr9:100984191	TBC1D2	chr9:100961281-101018003:-	0.28	7.38	6.91E-13	Post-traumatic stress disorder	
THCA	cis	1	rs10985500	chr9:100984191	TSTD2	chr9:100362364-100395962:-	0.17	3.7	0.000238	Post-traumatic stress disorder	
THCA	cis	1	rs10985808	chr9:101069762	TBC1D2	chr9:100961281-101018003:-	0.21	5.23	2.5E-7	Schizophrenia	
THCA	cis	1	rs10985811	chr9:101070487	TBC1D2	chr9:100961281-101018003:-	-0.16	-4.33	1.83E-5	Schizophrenia	
THCA	cis	1	rs10985817	chr9:101071090	TBC1D2	chr9:100961281-101018003:-	0.19	5.02	7.43E-7	Schizophrenia	
THCA	cis	1	rs10985819	chr9:101071192	TBC1D2	chr9:100961281-101018003:-	0.19	4.99	8.56E-7	Schizophrenia	
THCA	cis	1	rs10985825	chr9:101072843	TBC1D2	chr9:100961281-101018003:-	0.17	4.53	7.56E-6	Schizophrenia	
THCA	cis	1	rs10985826	chr9:101072951	TBC1D2	chr9:100961281-101018003:-	0.18	4.58	5.85E-6	Schizophrenia	
THCA	cis	1	rs10985839	chr9:101075752	TBC1D2	chr9:100961281-101018003:-	0.19	4.87	1.54E-6	Schizophrenia	
THCA	cis	1	rs10988125	chr9:131572903	C9orf114	chr9:131584346-131592085:-	0.3	6.82	2.72E-11	Blood metabolite levels	
THCA	cis	1	rs10988125	chr9:131572903	ENDOG	chr9:131580779-131584954:+	0.42	14.15	3.36E-38	Blood metabolite levels	
THCA	cis	1	rs10988214	chr9:131883752	CRAT	chr9:131857075-131873070:-	0.28	6.75	4.3E-11	Blood metabolite ratios	
THCA	cis	1	rs10988223	chr9:131903021	CRAT	chr9:131857075-131873070:-	0.28	6.67	7.02E-11	Blood metabolite ratios	
THCA	cis	1	rs10988224	chr9:131903334	CRAT	chr9:131857075-131873070:-	0.29	6.88	1.85E-11	Blood metabolite ratios	
THCA	cis	1	rs10988232	chr9:131915348	CRAT	chr9:131857075-131873070:-	0.31	7.63	1.32E-13	Blood metabolite ratios	
THCA	cis	1	rs10988920	chr9:102673982	STX17	chr9:102668915-102736817:+	-0.17	-4.26	2.42E-5	Alopecia areata	
THCA	cis	1	rs10995506	chr10:65094466	LOC84989	chr10:65224989-65226320:+	-0.27	-4.35	1.64E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs10995506	chr10:65094466	NRBF2	chr10:64893007-64914785:+	-0.28	-4.77	2.41E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs10995543	chr10:65239547	LOC84989	chr10:65224989-65226320:+	0.27	4.29	2.17E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs10995543	chr10:65239547	NRBF2	chr10:64893007-64914785:+	0.26	4.37	1.5E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs10999525	chr10:72525764	TYSND1	chr10:71897735-71906496:-	0.23	3.61	0.000344	Prion diseases	
THCA	cis	1	rs11000887	chr10:75897542	VCL	chr10:75754951-75879912:+	-0.2	-3.67	0.000266	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs11000888	chr10:75901929	VCL	chr10:75754951-75879912:+	-0.21	-3.84	0.00014	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs11000890	chr10:75904073	VCL	chr10:75754951-75879912:+	-0.21	-3.84	0.00014	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs11000894	chr10:75906598	VCL	chr10:75754951-75879912:+	-0.24	-4.28	2.25E-5	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs11000897	chr10:75911276	VCL	chr10:75754951-75879912:+	-0.2	-3.67	0.000266	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs11000900	chr10:75918440	VCL	chr10:75754951-75879912:+	-0.22	-3.98	8.0E-5	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs11000901	chr10:75919971	VCL	chr10:75754951-75879912:+	-0.21	-3.75	0.000198	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs11000902	chr10:75920483	VCL	chr10:75754951-75879912:+	-0.23	-3.91	0.000107	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs11000905	chr10:75925532	VCL	chr10:75754951-75879912:+	-0.24	-4.28	2.25E-5	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs11000909	chr10:75944828	VCL	chr10:75754951-75879912:+	-0.23	-4.03	6.45E-5	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs11000912	chr10:75948477	VCL	chr10:75754951-75879912:+	-0.21	-3.89	0.000116	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs11000916	chr10:75953909	VCL	chr10:75754951-75879912:+	-0.19	-3.47	0.000558	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs11000922	chr10:75969305	VCL	chr10:75754951-75879912:+	-0.2	-3.61	0.000336	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs11000930	chr10:75982982	VCL	chr10:75754951-75879912:+	0.22	3.67	0.000275	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs11000941	chr10:76018301	VCL	chr10:75754951-75879912:+	-0.22	-3.86	0.000128	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs11011314	chr10:37949915	LOC399744	chr10:38717074-38741080:+	0.24	3.35	0.000876	Obesity (extreme)	
THCA	cis	1	rs11011315	chr10:37950093	LOC399744	chr10:38717074-38741080:+	0.24	3.35	0.000876	Obesity (extreme)	
THCA	cis	1	rs11011339	chr10:37996346	LOC399744	chr10:38717074-38741080:+	0.26	3.72	0.000226	Obesity (extreme)	
THCA	cis	1	rs11011344	chr10:38004846	LOC399744	chr10:38717074-38741080:+	0.28	3.93	9.78E-5	Obesity (extreme)	
THCA	cis	1	rs11011344	chr10:38004846	ZNF37A	chr10:38383275-38412276:+	-0.16	-3.36	0.00083	Obesity (extreme)	
THCA	cis	1	rs11011366	chr10:38074158	LOC399744	chr10:38717074-38741080:+	0.28	3.69	0.000251	Obesity (extreme)	
THCA	cis	1	rs11011370	chr10:38083018	LOC399744	chr10:38717074-38741080:+	0.28	3.69	0.000251	Obesity (extreme)	
THCA	cis	1	rs11011372	chr10:38087283	LOC399744	chr10:38717074-38741080:+	0.28	3.69	0.000251	Obesity (extreme)	
THCA	cis	1	rs11013424	chr10:23664336	C10orf67	chr10:23605521-23633772:-	-0.24	-4.3	2.04E-5	Crohn's disease and sarcoidosis (combined)	
THCA	cis	1	rs11014306	chr10:25224462	PRTFDC1	chr10:25137554-25241533:-	0.27	3.93	9.91E-5	Metabolite levels (Pyroglutamine)	
THCA	cis	1	rs11014307	chr10:25224718	PRTFDC1	chr10:25137554-25241533:-	0.27	3.93	9.91E-5	Metabolite levels (Pyroglutamine)	
THCA	cis	1	rs11014308	chr10:25224739	PRTFDC1	chr10:25137554-25241533:-	-0.27	-3.93	9.91E-5	Metabolite levels (Pyroglutamine)	
THCA	cis	1	rs11017743	chr10:132939259	TCERG1L	chr10:132890656-133109984:-	0.37	5.29	1.88E-7	Type 2 diabetes	
THCA	cis	1	rs11020587	chr11:93643089	HEPHL1	chr11:93754378-93847374:+	-0.44	-3.97	8.43E-5	Obesity-related traits	
THCA	cis	1	rs11022131	chr11:12072213	DKK3	chr11:11984545-12031316:-	0.18	3.53	0.000455	Warfarin maintenance dose	
THCA	cis	1	rs11024739	chr11:18645843	SPTY2D1	chr11:18627949-18656020:-	0.14	4.57	6.21E-6	Cholesterol, total	
THCA	cis	1	rs11026412	chr11:22114093	ANO5	chr11:22214722-22304913:+	0.32	5.96	4.98E-9	Parkinson's disease	
THCA	cis	1	rs11026416	chr11:22125058	ANO5	chr11:22214722-22304913:+	0.34	6.37	4.51E-10	Parkinson's disease	
THCA	cis	1	rs11026797	chr11:22822270	SVIP	chr11:22843600-22851382:-	0.2	3.51	0.00049	Dialysis-related mortality	
THCA	cis	1	rs11026798	chr11:22822579	SVIP	chr11:22843600-22851382:-	0.2	3.6	0.000353	Dialysis-related mortality	
THCA	cis	1	rs11026804	chr11:22841582	SVIP	chr11:22843600-22851382:-	0.26	6.46	2.66E-10	Dialysis-related mortality	
THCA	cis	1	rs11031058	chr11:30375889	C11orf46	chr11:30344649-30359978:+	0.23	4.28	2.22E-5	Sex hormone levels;Menopause (age at onset)	
THCA	cis	1	rs11032345	chr11:4483678	TRIM68	chr11:4619902-4629437:-	0.17	3.59	0.000361	Amyotrophic lateral sclerosis	
THCA	cis	1	rs11032378	chr11:4492466	TRIM68	chr11:4619902-4629437:-	0.17	3.88	0.000119	Amyotrophic lateral sclerosis	
THCA	cis	1	rs11036474	chr11:5275178	HBG1	chr11:5269502-5271087:-	0.26	4.07	5.42E-5	Hemoglobin levels	
THCA	cis	1	rs11036474	chr11:5275178	HBG2	chr11:5269502-5667011:-	0.3	4.66	4.02E-6	Hemoglobin levels	
THCA	cis	1	rs11037984	chr11:5556662	UBQLNL	chr11:5535624-5537956:-	-0.28	-6.5	2.07E-10	QRS duration in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs11037993	chr11:5557197	UBQLNL	chr11:5535624-5537956:-	-0.28	-6.55	1.47E-10	QRS duration in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs11038000	chr11:5557704	UBQLNL	chr11:5535624-5537956:-	-0.28	-6.37	4.39E-10	QRS duration in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs11038004	chr11:5557918	UBQLNL	chr11:5535624-5537956:-	-0.28	-6.37	4.39E-10	QRS duration in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs11038357	chr11:45237858	PRDM11	chr11:45115564-45246902:+	-0.15	-3.69	0.000249	Thyroid hormone levels	
THCA	cis	1	rs11038357	chr11:45237858	SYT13	chr11:45261853-45307884:-	-0.32	-5.29	1.88E-7	Thyroid hormone levels	
THCA	cis	1	rs11038897	chr11:46470827	PACSIN3	chr11:47199085-47207958:-	0.17	3.88	0.000118	Schizophrenia	
THCA	cis	1	rs11038914	chr11:46561301	PACSIN3	chr11:47199085-47207958:-	-0.17	-4.05	5.88E-5	Schizophrenia	
THCA	cis	1	rs11038919	chr11:46585781	PACSIN3	chr11:47199085-47207958:-	0.18	3.89	0.000115	Schizophrenia	
THCA	cis	1	rs11039255	chr11:47495746	C1QTNF4	chr11:47611216-47615961:-	-0.31	-5.56	4.38E-8	Subjective well-being	
THCA	cis	1	rs11039255	chr11:47495746	MYBPC3	chr11:47352958-47374253:-	-0.17	-3.36	0.000848	Subjective well-being	
THCA	cis	1	rs11039390	chr11:47796295	C1QTNF4	chr11:47611216-47615961:-	-0.3	-5.23	2.59E-7	Subjective well-being	
THCA	cis	1	rs11039412	chr11:47841581	C1QTNF4	chr11:47611216-47615961:-	-0.32	-5.4	1.03E-7	Subjective well-being	
THCA	cis	1	rs11039426	chr11:47863119	C1QTNF4	chr11:47611216-47615961:-	-0.31	-5.3	1.74E-7	Subjective well-being	
THCA	cis	1	rs11040899	chr11:6520015	FXC1	chr11:6502677-6505910:+	0.16	4.33	1.79E-5	DNA methylation (variation)	
THCA	cis	1	rs11040899	chr11:6520015	TRIM3	chr11:6469844-6495689:-	-0.17	-4.12	4.47E-5	DNA methylation (variation)	
THCA	cis	1	rs11042108	chr11:8906021	TMEM9B	chr11:8968840-8986481:-	-0.24	-4.49	8.84E-6	Schizophrenia	
THCA	cis	1	rs11042114	chr11:8919889	TMEM9B	chr11:8968840-8986481:-	-0.22	-4.44	1.12E-5	Schizophrenia	
THCA	cis	1	rs11043222	chr12:122301275	WDR66	chr12:122356480-122441830:+	0.24	3.88	0.000119	Urinary metabolites	
THCA	cis	1	rs11045885	chr12:21386018	ABCC9	chr12:21950326-22094336:-	-0.16	-3.36	0.000849	Blood metabolite levels;Bilirubin levels	
THCA	cis	1	rs11045982	chr12:8665760	CLEC4D	chr12:8666136-8674958:+	0.22	3.87	0.000125	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	
THCA	cis	1	rs11045983	chr12:8666118	CLEC4D	chr12:8666136-8674958:+	0.21	3.78	0.000175	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	
THCA	cis	1	rs11046429	chr12:22565648	KIAA0528	chr12:22601526-22697452:-	-0.2	-3.49	0.000521	Coronary artery calcification	
THCA	cis	1	rs11046430	chr12:22566429	KIAA0528	chr12:22601526-22697452:-	0.2	3.47	0.000566	Coronary artery calcification	
THCA	cis	1	rs11049516	chr12:28452582	CCDC91	chr12:28332210-28703098:+	0.3	6.15	1.6E-9	Height	
THCA	cis	1	rs11049532	chr12:28476912	CCDC91	chr12:28332210-28703098:+	0.3	6.18	1.4E-9	Height	
THCA	cis	1	rs11051970	chr12:32537488	FGD4	chr12:32638906-32798982:+	-0.29	-7.56	2.05E-13	Response to tocilizumab in rheumatoid arthritis	
THCA	cis	1	rs11057223	chr12:123755055	C12orf65	chr12:123717841-123742481:+	-0.25	-4.26	2.44E-5	HDL cholesterol	
THCA	cis	1	rs11057224	chr12:123755179	C12orf65	chr12:123717841-123742481:+	-0.25	-4.19	3.39E-5	HDL cholesterol	
THCA	cis	1	rs11057393	chr12:124403769	ZNF664	chr12:124457670-124499967:+	-0.17	-4.69	3.6E-6	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11057394	chr12:124407676	DNAH10	chr12:124247042-124420265:+	0.19	3.82	0.000149	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11057394	chr12:124407676	ZNF664	chr12:124457670-124499967:+	-0.15	-4.3	2.11E-5	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11057396	chr12:124419062	ZNF664	chr12:124457670-124499967:+	-0.17	-4.87	1.55E-6	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11057397	chr12:124419728	ZNF664	chr12:124457670-124499967:+	-0.18	-4.89	1.38E-6	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11057399	chr12:124425078	ZNF664	chr12:124457670-124499967:+	-0.18	-5	8.1E-7	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs1105881	chr15:42072530	MGA	chr15:41913764-42062139:+	0.09	3.41	0.000715	Educational attainment	
THCA	cis	1	rs11059919	chr12:129289190	GLT1D1	chr12:129338081-129469509:+	-0.23	-5.68	2.4E-8	Systemic lupus erythematosus	
THCA	cis	1	rs11059919	chr12:129289190	SLC15A4	chr12:129277739-129308541:-	-0.17	-4.13	4.28E-5	Systemic lupus erythematosus	
THCA	cis	1	rs1106287	chr1:113242122	MOV10	chr1:113217048-113243367:+	0.2	4.78	2.39E-6	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs1106287	chr1:113242122	ST7L	chr1:113066142-113162405:-	0.66	10.75	2.63E-24	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs11064210	chr12:6576721	TAPBPL	chr12:6561177-6575601:+	-0.47	-6.94	1.32E-11	Hip geometry	
THCA	cis	1	rs11064218	chr12:6586261	TAPBPL	chr12:6561177-6575601:+	-0.44	-6.36	4.68E-10	Hip geometry	
THCA	cis	1	rs11064881	chr12:120146925	PRKAB1	chr12:120105757-120119428:+	-0.52	-4.64	4.49E-6	Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs1106547	chr5:2788832	IRX2	chr5:2746281-2751769:-	-0.25	-3.89	0.000116	Toenail selenium levels	
THCA	cis	1	rs1106565	chr10:102211613	SEC31B	chr10:102246403-102289636:-	-0.3	-10.21	2.82E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs11067231	chr12:109993603	KCTD10	chr12:109886460-109915155:-	-0.23	-6.05	2.99E-9	HDL cholesterol	
THCA	cis	1	rs11070798	chr15:50883263	SPPL2A	chr15:50999739-51057910:-	0.28	7.49	3.31E-13	QT interval	
THCA	cis	1	rs11070800	chr15:50907347	SPPL2A	chr15:50999739-51057910:-	0.26	7.03	7.33E-12	QT interval	
THCA	cis	1	rs11070805	chr15:50964192	ATP8B4	chr15:50150436-50411419:-	-0.11	-3.42	0.000682	QT interval	
THCA	cis	1	rs11070805	chr15:50964192	SPPL2A	chr15:50999739-51057910:-	0.29	7.45	4.3E-13	QT interval	
THCA	cis	1	rs11070807	chr15:50974505	ATP8B4	chr15:50150436-50411419:-	-0.11	-3.44	0.000634	QT interval	
THCA	cis	1	rs11070807	chr15:50974505	SPPL2A	chr15:50999739-51057910:-	0.29	7.44	4.59E-13	QT interval	
THCA	cis	1	rs11071246	chr15:56377778	MNS1	chr15:56720929-56757335:-	-0.27	-3.99	7.67E-5	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11071246	chr15:56377778	TEX9	chr15:56657644-56738071:+	-0.36	-6.17	1.46E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11071253	chr15:56471123	MNS1	chr15:56720929-56757335:-	-0.25	-3.58	0.000385	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11071253	chr15:56471123	TEX9	chr15:56657644-56738071:+	-0.35	-5.99	4.06E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11071649	chr15:62312297	VPS13C	chr15:62144592-62352647:-	-0.11	-4.15	3.93E-5	Height	
THCA	cis	1	rs11071846	chr15:65792839	DPP8	chr15:65737999-65810035:-	0.09	3.72	0.000225	Mean corpuscular hemoglobin	
THCA	cis	1	rs11071885	chr15:66625161	TIPIN	chr15:66629008-66649054:-	-0.38	-3.85	0.000137	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs11071894	chr15:66773733	TIPIN	chr15:66629008-66649054:-	0.43	4.45	1.07E-5	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs11072603	chr15:76881138	SCAPER	chr15:76640529-77197744:-	-0.17	-5.62	3.28E-8	Blood metabolite levels	
THCA	cis	1	rs1107328	chr9:131917534	CRAT	chr9:131857075-131873070:-	-0.31	-7.35	8.94E-13	Blood metabolite ratios	
THCA	cis	1	rs11073619	chr15:85188839	WDR73	chr15:85186012-85197524:-	0.29	4.24	2.67E-5	Positive affect	
THCA	cis	1	rs11075733	chr16:69773435	COG4	chr16:70514473-70557457:-	-0.19	-3.78	0.000178	IgE levels	
THCA	cis	1	rs11075734	chr16:69801397	COG4	chr16:70514473-70557457:-	-0.18	-3.57	0.000393	IgE levels	
THCA	cis	1	rs1107840	chr18:33707164	SLC39A6	chr18:33688495-33709357:-	0.13	3.82	0.00015	Esophageal squamous cell cancer (length of survival)	
THCA	cis	1	rs11079034	chr17:40288890	HSPB9	chr17:40274756-40275371:+	0.33	4.93	1.15E-6	Fibrinogen levels	
THCA	cis	1	rs11079319	chr17:55747082	BZRAP1	chr17:56378596-56406152:-	0.18	4.06	5.83E-5	Coronary artery calcification	
THCA	cis	1	rs11079321	chr17:55747416	BZRAP1	chr17:56378596-56406152:-	-0.15	-3.6	0.000357	Coronary artery calcification	
THCA	cis	1	rs11079508	chr17:61750066	FTSJ3	chr17:61896795-61905031:-	0.31	6.04	3.13E-9	Body mass index	
THCA	cis	1	rs11079508	chr17:61750066	MAP3K3	chr17:61699775-61773669:+	0.26	5.46	7.79E-8	Body mass index	
THCA	cis	1	rs11079509	chr17:61762148	FTSJ3	chr17:61896795-61905031:-	0.32	5.69	2.28E-8	Body mass index	
THCA	cis	1	rs11079509	chr17:61762148	MAP3K3	chr17:61699775-61773669:+	0.26	4.89	1.4E-6	Body mass index	
THCA	cis	1	rs11079511	chr17:61858537	FTSJ3	chr17:61896795-61905031:-	0.31	5.81	1.15E-8	Body mass index	
THCA	cis	1	rs11079511	chr17:61858537	MAP3K3	chr17:61699775-61773669:+	0.27	5.4	1.06E-7	Body mass index	
THCA	cis	1	rs11079691	chr17:65362552	PSMD12	chr17:65336620-65362721:-	-0.17	-3.37	0.000802	Diisocyanate-induced asthma	
THCA	cis	1	rs11079706	chr17:65835470	C17orf58	chr17:65987218-65989765:-	0.2	3.91	0.000106	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs11079707	chr17:65835617	C17orf58	chr17:65987218-65989765:-	-0.2	-3.84	0.000138	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs11080114	chr17:28407287	ANKRD13B	chr17:27916801-27941778:+	-0.36	-8.76	3.43E-17	Coffee consumption (cups per day)	
THCA	cis	1	rs11080114	chr17:28407287	CORO6	chr17:27941774-27948441:-	-0.5	-11.45	5.5E-27	Coffee consumption (cups per day)	
THCA	cis	1	rs11080114	chr17:28407287	EFCAB5	chr17:28256874-28435469:+	-0.59	-11.27	2.8E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs11080114	chr17:28407287	GIT1	chr17:27900487-27916610:-	-0.28	-6.6	1.08E-10	Coffee consumption (cups per day)	
THCA	cis	1	rs11080114	chr17:28407287	LRRC37B2	chr17:28903483-28992715:+	-0.18	-3.96	8.69E-5	Coffee consumption (cups per day)	
THCA	cis	1	rs11080114	chr17:28407287	SSH2	chr17:27952965-28257018:-	-0.34	-7.76	5.26E-14	Coffee consumption (cups per day)	
THCA	cis	1	rs11080114	chr17:28407287	TP53I13	chr17:27895739-27900174:+	-0.2	-5.43	9.17E-8	Coffee consumption (cups per day)	
THCA	cis	1	rs11081934	chr18:33705304	SLC39A6	chr18:33688495-33709357:-	0.13	3.76	0.000193	Esophageal squamous cell cancer (length of survival)	
THCA	cis	1	rs11082563	chr18:44659001	HDHD2	chr18:44633782-44676871:-	0.21	4.01	7.01E-5	Sitting height ratio	
THCA	cis	1	rs11082563	chr18:44659001	PIAS2	chr18:44392061-44500123:-	-0.15	-3.45	0.000607	Sitting height ratio	
THCA	cis	1	rs11083274	chr18:19257123	ABHD3	chr18:19230858-19284766:-	-0.19	-3.98	8.08E-5	Phospholipid levels (plasma)	
THCA	cis	1	rs11083475	chr19:39188112	LGALS7	chr19:39261608-39264157:-	-0.23	-4.76	2.58E-6	Heart rate	
THCA	cis	1	rs11084084	chr19:52030156	SIGLEC6	chr19:52022784-52035064:-	-0.28	-3.58	0.000381	Carotid intima media thickness	
THCA	cis	1	rs11084084	chr19:52030156	ZNF175	chr19:52074531-52092990:+	-0.34	-4.23	2.77E-5	Carotid intima media thickness	
THCA	cis	1	rs11084085	chr19:52030384	ZNF175	chr19:52074531-52092990:+	-0.31	-3.79	0.000167	Carotid intima media thickness	
THCA	cis	1	rs11084222	chr19:53677644	ZNF665	chr19:53666552-53696619:-	-0.17	-4.64	4.53E-6	Yu-Zhi constitution type in type 2 diabetes	
THCA	cis	1	rs1108431	chr16:31054607	C16orf93	chr16:30768753-30773542:-	-0.15	-4.2	3.12E-5	Response to metformin (IC50)	
THCA	cis	1	rs1108431	chr16:31054607	HSD3B7	chr16:30996519-31000473:+	0.43	11.04	2.22E-25	Response to metformin (IC50)	
THCA	cis	1	rs1108431	chr16:31054607	MYST1	chr16:31128985-31142713:+	0.14	4.78	2.36E-6	Response to metformin (IC50)	
THCA	cis	1	rs1108431	chr16:31054607	PRSS53	chr16:31094747-31106276:-	-0.15	-4.04	6.32E-5	Response to metformin (IC50)	
THCA	cis	1	rs11084785	chr19:35282054	ZNF181	chr19:35225151-35233774:+	-0.25	-6.15	1.64E-9	Urate levels (BMI interaction)	
THCA	cis	1	rs11084785	chr19:35282054	ZNF302	chr19:35168567-35177302:+	0.16	4.37	1.5E-5	Urate levels (BMI interaction)	
THCA	cis	1	rs11084786	chr19:35282181	ZNF181	chr19:35225151-35233774:+	-0.26	-6.15	1.68E-9	Urate levels (BMI interaction)	
THCA	cis	1	rs11084786	chr19:35282181	ZNF302	chr19:35168567-35177302:+	0.16	4.37	1.53E-5	Urate levels (BMI interaction)	
THCA	cis	1	rs11085534	chr19:22613229	ZNF98	chr19:22573899-22605148:-	-0.24	-3.77	0.000184	Dental caries;Response to statins (LDL cholesterol change)	
THCA	cis	1	rs11086102	chr19:18398628	KIAA1683	chr19:18367906-18385319:-	-0.27	-8	9.71E-15	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11087520	chr20:25436827	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.86	2.15E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs11087520	chr20:25436827	FAM182A	chr20:26035250-26067552:+	-0.19	-3.45	0.000604	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs11087520	chr20:25436827	FAM182B	chr20:25744102-25848786:-	0.25	5.23	2.6E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs11087520	chr20:25436827	NINL	chr20:25433338-25566153:-	-0.36	-7.27	1.45E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs11087520	chr20:25436827	PYGB	chr20:25228706-25278647:+	-0.13	-3.35	0.000876	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs11087521	chr20:25440648	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.88	1.84E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs11087521	chr20:25440648	FAM182A	chr20:26035250-26067552:+	-0.19	-3.46	0.000596	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs11087521	chr20:25440648	FAM182B	chr20:25744102-25848786:-	0.25	5.08	5.38E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs11087521	chr20:25440648	NINL	chr20:25433338-25566153:-	-0.37	-7.57	1.93E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs11088226	chr21:33925531	TCP10L	chr21:33947152-33957845:-	-0.51	-9.3	4.89E-19	Gastritis	
THCA	cis	1	rs1109227	chr3:48479207	ATRIP	chr3:48488141-48507708:+	0.2	4.36	1.61E-5	Longevity	
THCA	cis	1	rs1109227	chr3:48479207	TREX1	chr3:48501186-48509043:+	-0.25	-5.83	1.05E-8	Longevity	
THCA	cis	1	rs1109227	chr3:48479207	ZNF589	chr3:48282596-48329113:+	0.16	3.38	0.000794	Longevity	
THCA	cis	1	rs1109501	chr4:71329490	AMTN	chr4:71384298-71398459:+	0.22	5.24	2.41E-7	Alcoholism (heaviness of drinking)	
THCA	cis	1	rs1109560	chr12:123757905	C12orf65	chr12:123717841-123742481:+	-0.25	-4.19	3.39E-5	HDL cholesterol	
THCA	cis	1	rs1109619	chr8:8571616	SGK223	chr8:8175259-8239257:-	-0.3	-5.48	6.72E-8	Obesity-related traits	
THCA	cis	1	rs11096982	chr4:39134867	KLHL5	chr4:39046659-39123828:+	-0.21	-5.77	1.46E-8	Uric acid levels	
THCA	cis	1	rs11097901	chr4:106729933	INTS12	chr4:106603787-106629881:-	-0.62	-5.19	3.05E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11097912	chr4:107000462	TBCK	chr4:106967233-107237861:-	0.34	7.04	6.57E-12	Airflow obstruction	
THCA	cis	1	rs1110042	chr1:113236534	MOV10	chr1:113217048-113243367:+	0.2	4.8	2.1E-6	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs1110042	chr1:113236534	ST7L	chr1:113066142-113162405:-	0.66	10.75	2.66E-24	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs11100712	chr4:142160229	ZNF330	chr4:142142049-142155848:+	-0.12	-3.34	0.0009	Conduct disorder	
THCA	cis	1	rs11100852	chr4:139137476	SLC7A11	chr4:139085248-139163503:-	0.23	4.56	6.37E-6	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	
THCA	cis	1	rs11100	chr20:25281184	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs11100	chr20:25281184	FAM182A	chr20:26035250-26067552:+	-0.18	-3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs11100	chr20:25281184	FAM182B	chr20:25744102-25848786:-	0.27	5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs11100	chr20:25281184	NINL	chr20:25433338-25566153:-	-0.35	-7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs11100	chr20:25281184	PYGB	chr20:25228706-25278647:+	-0.16	-4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs11101721	chr10:135190358	ECHS1	chr10:135175988-135186908:-	0.46	6.98	9.62E-12	Lifespan	
THCA	cis	1	rs11101723	chr10:135192139	ECHS1	chr10:135175988-135186908:-	0.52	7.01	8.15E-12	Lifespan	
THCA	cis	1	rs11101724	chr10:135192153	ECHS1	chr10:135175988-135186908:-	0.42	6.38	4.15E-10	Lifespan	
THCA	cis	1	rs1110659	chr22:18444675	MICAL3	chr22:18270418-18507325:-	-0.21	-4.27	2.33E-5	Presence of antiphospholipid antibodies	
THCA	cis	1	rs1110660	chr22:18444693	MICAL3	chr22:18270418-18507325:-	-0.21	-4.27	2.33E-5	Presence of antiphospholipid antibodies	
THCA	cis	1	rs1110662	chr22:18444908	MICAL3	chr22:18270418-18507325:-	-0.21	-4.27	2.33E-5	Presence of antiphospholipid antibodies	
THCA	cis	1	rs11109086	chr12:97909601	RMST	chr12:97858799-97958793:+	-0.17	-3.45	0.000601	Obesity (early onset extreme)	
THCA	cis	1	rs11114703	chr12:81434989	ACSS3	chr12:81471809-81649582:+	0.22	4.67	4.01E-6	Neuroticism	
THCA	cis	1	rs11114704	chr12:81436269	ACSS3	chr12:81471809-81649582:+	0.22	4.67	4.01E-6	Neuroticism	
THCA	cis	1	rs11114710	chr12:81440183	ACSS3	chr12:81471809-81649582:+	0.22	4.67	4.01E-6	Neuroticism	
THCA	cis	1	rs11114711	chr12:81440265	ACSS3	chr12:81471809-81649582:+	0.22	4.67	4.01E-6	Neuroticism	
THCA	cis	1	rs11114720	chr12:81443764	ACSS3	chr12:81471809-81649582:+	0.22	4.67	4.01E-6	Neuroticism	
THCA	cis	1	rs11114722	chr12:81447755	ACSS3	chr12:81471809-81649582:+	0.22	4.67	4.01E-6	Neuroticism	
THCA	cis	1	rs11114723	chr12:81449343	ACSS3	chr12:81471809-81649582:+	0.22	4.67	4.01E-6	Neuroticism	
THCA	cis	1	rs11114724	chr12:81449717	ACSS3	chr12:81471809-81649582:+	0.22	4.67	4.01E-6	Neuroticism	
THCA	cis	1	rs11114735	chr12:81457413	ACSS3	chr12:81471809-81649582:+	0.22	4.67	4.01E-6	Neuroticism	
THCA	cis	1	rs11114736	chr12:81457508	ACSS3	chr12:81471809-81649582:+	0.22	4.67	4.01E-6	Neuroticism	
THCA	cis	1	rs11114737	chr12:81457732	ACSS3	chr12:81471809-81649582:+	0.22	4.67	4.01E-6	Neuroticism	
THCA	cis	1	rs11114739	chr12:81459675	ACSS3	chr12:81471809-81649582:+	0.22	4.66	4.02E-6	Neuroticism	
THCA	cis	1	rs11114740	chr12:81459887	ACSS3	chr12:81471809-81649582:+	0.22	4.67	4.01E-6	Neuroticism	
THCA	cis	1	rs11114743	chr12:81464705	ACSS3	chr12:81471809-81649582:+	0.24	5.07	5.74E-7	Neuroticism	
THCA	cis	1	rs11115015	chr12:82174543	PPFIA2	chr12:81652880-82153109:-	0.21	3.89	0.000114	Resting heart rate	
THCA	cis	1	rs11115017	chr12:82176914	PPFIA2	chr12:81652880-82153109:-	0.21	3.89	0.000114	Resting heart rate	
THCA	cis	1	rs11115030	chr12:82203021	PPFIA2	chr12:81652880-82153109:-	0.2	3.82	0.00015	Resting heart rate	
THCA	cis	1	rs11115047	chr12:82232773	PPFIA2	chr12:81652880-82153109:-	0.22	4.1	4.91E-5	Resting heart rate	
THCA	cis	1	rs1111863	chr6:109611206	CD164	chr6:109687718-109703762:-	-0.13	-3.45	0.000614	Red blood cell traits	
THCA	cis	1	rs11120733	chr1:207506649	CD55	chr1:207494817-207534309:+	0.15	6.55	1.47E-10	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs11121022	chr1:7836659	VAMP3	chr1:7831329-7841491:+	0.38	8.25	1.53E-15	Morning vs. evening chronotype	
THCA	cis	1	rs1112137	chr1:247215375	OR2T8	chr1:248084320-248085256:+	-0.19	-3.64	0.000299	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs1112137	chr1:247215375	OR2W3	chr1:248031265-248060142:+	-0.17	-3.34	0.000889	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs11121532	chr1:10277898	KIF1B	chr1:10270764-10441659:+	0.21	6.58	1.22E-10	Hepatocellular carcinoma	
THCA	cis	1	rs11121533	chr1:10292888	KIF1B	chr1:10270764-10441659:+	0.21	6.6	1.09E-10	Hepatocellular carcinoma	
THCA	cis	1	rs11121552	chr1:10435324	KIF1B	chr1:10270764-10441659:+	0.2	6.08	2.4E-9	Hepatocellular carcinoma	
THCA	cis	1	rs1112163	chr8:89425263	MMP16	chr8:89049462-89339717:-	0.32	5.19	3.04E-7	Electrodermal activity	
THCA	cis	1	rs11122199	chr1:231172686	EXOC8	chr1:231468483-231473578:-	0.15	3.49	0.000527	Carotid plaque burden (smoking interaction)	
THCA	cis	1	rs11123170	chr2:113978940	LOC654433	chr2:113993107-114024579:+	-0.85	-19.78	4.47E-64	Renal function-related traits (BUN)	
THCA	cis	1	rs11124575	chr2:37500435	CEBPZ	chr2:37428778-37458740:-	-0.18	-3.94	9.49E-5	Chronic lymphocytic leukemia	
THCA	cis	1	rs111248783	chr4:106770998	INTS12	chr4:106603787-106629881:-	-0.61	-5.18	3.23E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11125529	chr2:54475866	C2orf73	chr2:54558071-54588714:+	-0.31	-4.33	1.83E-5	Telomere length	
THCA	cis	1	rs111259072	chr19:12156569	ZNF763	chr19:12035900-12091196:+	-0.37	-4.48	9.33E-6	Multiple sclerosis	
THCA	cis	1	rs11125949	chr2:63357876	C2orf86	chr2:63348537-63815851:-	-0.22	-4.76	2.53E-6	Subjective well-being	
THCA	cis	1	rs11126252	chr2:70181154	ASPRV1	chr2:70187226-70314147:-	-0.18	-3.95	9.12E-5	Obesity-related traits	
THCA	cis	1	rs11126253	chr2:70181318	ASPRV1	chr2:70187226-70314147:-	-0.18	-3.68	0.000259	Obesity-related traits	
THCA	cis	1	rs11126254	chr2:70182491	ASPRV1	chr2:70187226-70314147:-	-0.18	-4.05	6.08E-5	Obesity-related traits	
THCA	cis	1	rs11126340	chr2:26253255	GPR113	chr2:26531041-26569685:-	-0.44	-6.82	2.77E-11	Gut microbiome composition (summer)	
THCA	cis	1	rs11126364	chr2:26314515	GPR113	chr2:26531041-26569685:-	-0.45	-7.05	6.34E-12	Gut microbiome composition (summer)	
THCA	cis	1	rs11126375	chr2:26344787	GPR113	chr2:26531041-26569685:-	-0.42	-6.71	5.42E-11	Gut microbiome composition (summer)	
THCA	cis	1	rs11127071	chr2:27838058	FNDC4	chr2:27714751-27718126:-	-0.14	-3.41	0.000717	Oral cavity cancer	
THCA	cis	1	rs11127188	chr2:28972852	PPP1CB	chr2:28974612-29025805:+	0.17	4.16	3.85E-5	Body mass index	
THCA	cis	1	rs11127188	chr2:28972852	TRMT61B	chr2:29072690-29093175:-	-0.5	-10.08	8.71E-22	Body mass index	
THCA	cis	1	rs111295372	chr2:86283357	LOC90784	chr2:86247339-86250991:-	-0.62	-6.58	1.27E-10	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs11130127	chr3:47398793	C3orf75	chr3:47537131-47555199:-	0.09	4.37	1.56E-5	Colorectal cancer	
THCA	cis	1	rs11130127	chr3:47398793	NBEAL2	chr3:47021173-47051193:+	0.12	3.79	0.000168	Colorectal cancer	
THCA	cis	1	rs11130170	chr3:48449897	ATRIP	chr3:48488141-48507708:+	0.18	3.93	9.64E-5	Longevity	
THCA	cis	1	rs11130170	chr3:48449897	TREX1	chr3:48501186-48509043:+	-0.25	-5.86	8.85E-9	Longevity	
THCA	cis	1	rs11130171	chr3:48462461	ATRIP	chr3:48488141-48507708:+	0.19	4.23	2.8E-5	Longevity	
THCA	cis	1	rs11130171	chr3:48462461	TREX1	chr3:48501186-48509043:+	-0.25	-5.76	1.47E-8	Longevity	
THCA	cis	1	rs11130189	chr3:49347357	GMPPB	chr3:49758932-49761384:-	-0.17	-3.65	0.000296	Menarche (age at onset)	
THCA	cis	1	rs11130189	chr3:49347357	P4HTM	chr3:49027341-49044579:+	0.17	4.1	4.88E-5	Menarche (age at onset)	
THCA	cis	1	rs11130189	chr3:49347357	WDR6	chr3:49044637-49053386:+	-0.17	-3.55	0.000431	Menarche (age at onset)	
THCA	cis	1	rs11130190	chr3:49402137	GMPPB	chr3:49758932-49761384:-	-0.17	-3.74	0.000208	Menarche (age at onset)	
THCA	cis	1	rs11130190	chr3:49402137	P4HTM	chr3:49027341-49044579:+	0.17	4.25	2.57E-5	Menarche (age at onset)	
THCA	cis	1	rs11130190	chr3:49402137	WDR6	chr3:49044637-49053386:+	-0.18	-3.68	0.000257	Menarche (age at onset)	
THCA	cis	1	rs11130213	chr3:49712297	MST1	chr3:49721381-49726196:-	0.14	4.17	3.64E-5	Crohn's disease;Ulcerative colitis	
THCA	cis	1	rs11130213	chr3:49712297	UBA7	chr3:49842639-49851391:-	0.15	3.36	0.000843	Crohn's disease;Ulcerative colitis	
THCA	cis	1	rs11130214	chr3:49735746	CCDC36	chr3:49235861-49295537:+	-0.18	-3.8	0.000161	Resting heart rate	
THCA	cis	1	rs11130214	chr3:49735746	DAG1	chr3:49507565-49573046:+	0.09	3.39	0.000758	Resting heart rate	
THCA	cis	1	rs11130214	chr3:49735746	RBM6	chr3:49977592-50137484:+	0.14	4.25	2.58E-5	Resting heart rate	
THCA	cis	1	rs11130216	chr3:49736172	CCDC36	chr3:49235861-49295537:+	0.18	3.78	0.000179	Resting heart rate	
THCA	cis	1	rs11130216	chr3:49736172	RBM6	chr3:49977592-50137484:+	-0.14	-4.19	3.28E-5	Resting heart rate	
THCA	cis	1	rs11130338	chr3:53120924	ITIH4	chr3:52847007-52866554:-	0.16	4.58	6.06E-6	Height	
THCA	cis	1	rs11130338	chr3:53120924	RFT1	chr3:53122503-53164470:-	-0.75	-18.21	1.15E-56	Height	
THCA	cis	1	rs11130607	chr3:57990804	PDHB	chr3:58413355-58419565:-	-0.15	-3.51	0.000498	Optic cup area	
THCA	cis	1	rs111315781	chr2:201738724	CFLAR	chr2:201980816-202029001:+	-0.25	-4.6	5.3E-6	Triptolide cytotoxicity	
THCA	cis	1	rs111315781	chr2:201738724	PPIL3	chr2:201735680-201753999:-	-1.02	-17.89	3.73E-55	Triptolide cytotoxicity	
THCA	cis	1	rs11131605	chr4:66482312	EPHA5	chr4:66185282-66535653:-	0.19	3.36	0.000847	HIV-1 viral setpoint	
THCA	cis	1	rs11132254	chr4:185611592	CCDC111	chr4:185570767-185616112:+	0.3	6.98	1.0E-11	Kawasaki disease	
THCA	cis	1	rs11132254	chr4:185611592	MLF1IP	chr4:185615220-185655286:-	-0.43	-9.67	2.46E-20	Kawasaki disease	
THCA	cis	1	rs11133399	chr4:56413831	TMEM165	chr4:56262090-56292342:+	0.14	3.55	0.000423	Personality dimensions	
THCA	cis	1	rs11137528	chr9:91790626	CKS2	chr9:91926113-91931617:+	-0.25	-4.42	1.22E-5	Pelvic organ prolapse (moderate/severe)	
THCA	cis	1	rs111392237	chr11:96122783	CCDC82	chr11:96085930-96123083:-	-0.26	-3.72	0.000223	Parkinson's disease	
THCA	cis	1	rs111392584	chr3:10075991	C3orf10	chr3:10157333-10168873:+	-0.2	-4.3	2.08E-5	Alzheimer's disease	
THCA	cis	1	rs111392584	chr3:10075991	VHL	chr3:10183319-10193744:+	-0.19	-4.42	1.24E-5	Alzheimer's disease	
THCA	cis	1	rs1114380	chr2:73804708	ALMS1P	chr2:73872046-73912692:+	0.75	11.45	5.59E-27	Metabolite levels	
THCA	cis	1	rs1114380	chr2:73804708	NAT8	chr2:73867850-73869537:-	0.42	6.41	3.46E-10	Metabolite levels	
THCA	cis	1	rs11144880	chr9:79025675	GCNT1	chr9:79034752-79122330:+	-0.15	-3.57	0.0004	Dialysis-related mortality	
THCA	cis	1	rs11144880	chr9:79025675	PCSK5	chr9:78505560-78808338:+	-0.15	-3.36	0.000854	Dialysis-related mortality	
THCA	cis	1	rs11144880	chr9:79025675	RFK	chr9:79000433-79009444:-	-0.19	-3.98	7.89E-5	Dialysis-related mortality	
THCA	cis	1	rs11148252	chr13:53009048	CKAP2	chr13:53029495-53050763:+	-0.65	-17.68	3.4E-54	Lewy body disease	
THCA	cis	1	rs11148252	chr13:53009048	NEK3	chr13:52706780-52733996:-	0.2	4.93	1.13E-6	Lewy body disease	
THCA	cis	1	rs11148252	chr13:53009048	VPS36	chr13:52986739-53024763:-	0.19	4.86	1.62E-6	Lewy body disease	
THCA	cis	1	rs11149710	chr16:74472546	RFWD3	chr16:74655298-74700779:-	0.16	4.01	7.17E-5	Breast cancer	
THCA	cis	1	rs11150189	chr16:79734227	MAF	chr16:79627746-79634622:-	-0.25	-4.27	2.35E-5	Urate levels	
THCA	cis	1	rs11150190	chr16:79734249	MAF	chr16:79627746-79634622:-	-0.23	-3.94	9.37E-5	Urate levels	
THCA	cis	1	rs11150589	chr16:30482494	LOC595101	chr16:30278914-30346695:-	0.24	4.08	5.23E-5	Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs11150589	chr16:30482494	TBX6	chr16:30097117-30103208:-	-0.17	-3.67	0.000274	Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs11153170	chr6:109652528	AKD1	chr6:109814059-110012415:-	0.45	6.46	2.61E-10	Hematological parameters	
THCA	cis	1	rs111547017	chr6:43341689	ZNF318	chr6:43278872-43337181:-	0.19	3.39	0.000768	Schizophrenia	
THCA	cis	1	rs11156875	chr14:35619816	FAM177A1	chr14:35514113-35552587:+	-0.2	-3.83	0.000147	Atopic dermatitis	
THCA	cis	1	rs11156875	chr14:35619816	KIAA0391	chr14:35591776-35786673:+	0.3	5.62	3.32E-8	Atopic dermatitis	
THCA	cis	1	rs11156875	chr14:35619816	PPP2R3C	chr14:35554679-35591679:-	0.52	9.97	2.12E-21	Atopic dermatitis	
THCA	cis	1	rs11157696	chr14:50105746	MGAT2	chr14:50087489-50090198:+	-0.22	-4.35	1.63E-5	Carotid intima media thickness	
THCA	cis	1	rs11157696	chr14:50105746	RPL36AL	chr14:50085407-50087349:-	-0.54	-15.66	6.38E-45	Carotid intima media thickness	
THCA	cis	1	rs11158027	chr14:55349103	GCH1	chr14:55308724-55369542:-	-0.22	-4.55	6.68E-6	Rheumatoid arthritis;Obesity-related traits	
THCA	cis	1	rs11158559	chr14:65240949	CHURC1	chr14:65381140-65411309:+	0.36	6.66	7.59E-11	Obesity-related traits	
THCA	cis	1	rs11159067	chr14:74637444	C14orf45	chr14:74486059-74549566:+	0.16	4.4	1.32E-5	Common traits (Other)	
THCA	cis	1	rs11159067	chr14:74637444	COQ6	chr14:74416643-74429811:+	0.14	3.87	0.000126	Common traits (Other)	
THCA	cis	1	rs11159067	chr14:74637444	LIN52	chr14:74551656-74667117:+	0.5	13.06	1.56E-33	Common traits (Other)	
THCA	cis	1	rs11159117	chr14:75584867	EIF2B2	chr14:75469612-75476292:+	0.19	5.12	4.49E-7	Height	
THCA	cis	1	rs11159117	chr14:75584867	MLH3	chr14:75480467-75518235:-	0.3	8.98	6.21E-18	Height	
THCA	cis	1	rs11159117	chr14:75584867	RPS6KL1	chr14:75372347-75389958:-	0.32	6.87	1.95E-11	Height	
THCA	cis	1	rs11159183	chr14:76662902	ESRRB	chr14:76837690-76968178:+	0.32	5.22	2.74E-7	Blood pressure	
THCA	cis	1	rs111596617	chr6:26191678	HIST1H2AE	chr6:26217148-26217711:+	-0.23	-3.69	0.000249	Renal underexcretion gout;Gout	
THCA	cis	1	rs111596617	chr6:26191678	HIST1H3E	chr6:26224427-26226589:+	0.43	7.04	6.71E-12	Renal underexcretion gout;Gout	
THCA	cis	1	rs11159856	chr14:88883929	SPATA7	chr14:88852012-88904802:+	-0.2	-4.12	4.46E-5	Coronary artery calcification	
THCA	cis	1	rs111602331	chr20:44557474	WFDC3	chr20:44402847-44420547:-	-0.28	-4.13	4.25E-5	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
THCA	cis	1	rs11161510	chr1:76210289	ACADM	chr1:76190043-76229353:+	-0.13	-3.6	0.000346	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs11161510	chr1:76210289	MSH4	chr1:76262630-76378923:+	-0.25	-4.23	2.85E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs11161511	chr1:76210477	ACADM	chr1:76190043-76229353:+	-0.13	-3.52	0.000466	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs11161511	chr1:76210477	MSH4	chr1:76262630-76378923:+	-0.22	-3.69	0.000252	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs11161515	chr1:76212559	ACADM	chr1:76190043-76229353:+	0.13	3.62	0.000324	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs11161515	chr1:76212559	MSH4	chr1:76262630-76378923:+	0.25	4.24	2.72E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs11161521	chr1:76216330	ACADM	chr1:76190043-76229353:+	0.13	3.62	0.000324	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs11161521	chr1:76216330	MSH4	chr1:76262630-76378923:+	0.25	4.24	2.72E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs11161820	chr1:86900760	CLCA2	chr1:86889769-86922238:+	-0.25	-3.86	0.000128	Crohn's disease-related phenotypes	
THCA	cis	1	rs11161820	chr1:86900760	ODF2L	chr1:86814412-86862003:-	-0.17	-3.8	0.000161	Crohn's disease-related phenotypes	
THCA	cis	1	rs11163924	chr1:76132070	MSH4	chr1:76262630-76378923:+	-0.27	-4.48	9.48E-6	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs111641740	chr20:33707177	PROCR	chr20:33758727-33765164:+	-0.37	-6.54	1.55E-10	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs111641740	chr20:33707177	TRPC4AP	chr20:33590215-33680618:-	0.32	4.16	3.74E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs111649495	chr5:118356415	DTWD2	chr5:118172571-118324240:-	-0.17	-3.71	0.000235	Response to amphetamines	
THCA	cis	1	rs11167254	chr20:33654584	PROCR	chr20:33758727-33765164:+	-0.32	-5.36	1.32E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs11167254	chr20:33654584	TRPC4AP	chr20:33590215-33680618:-	0.28	3.53	0.000461	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs11167260	chr20:33775200	PROCR	chr20:33758727-33765164:+	-0.33	-5.09	5.11E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs11167260	chr20:33775200	TRPC4AP	chr20:33590215-33680618:-	0.31	3.66	0.000281	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs11167515	chr5:150239471	LOC134466	chr5:150310000-150326146:-	0.46	6.17	1.47E-9	Crohn's disease	
THCA	cis	1	rs11167515	chr5:150239471	ZNF300	chr5:150273964-150284391:-	0.16	3.42	0.000674	Crohn's disease	
THCA	cis	1	rs11167518	chr5:150258920	LOC134466	chr5:150310000-150326146:-	0.38	5.28	2.01E-7	Crohn's disease	
THCA	cis	1	rs11167519	chr5:150265407	LOC134466	chr5:150310000-150326146:-	0.38	5.28	2.01E-7	Crohn's disease	
THCA	cis	1	rs11167520	chr5:150265639	LOC134466	chr5:150310000-150326146:-	0.38	5.28	2.01E-7	Crohn's disease	
THCA	cis	1	rs11167521	chr5:150271785	LOC134466	chr5:150310000-150326146:-	0.39	5.41	9.98E-8	Crohn's disease	
THCA	cis	1	rs11167526	chr5:150332481	LOC134466	chr5:150310000-150326146:-	0.43	5.44	8.35E-8	Crohn's disease	
THCA	cis	1	rs11168036	chr5:139707439	HBEGF	chr5:139712429-139726188:-	-0.15	-3.42	0.00068	Alzheimer's disease in APOE e4- carriers	
THCA	cis	1	rs11168036	chr5:139707439	PCDHA9	chr5:140227357-140391929:+	-0.21	-3.54	0.000433	Alzheimer's disease in APOE e4- carriers	
THCA	cis	1	rs11168036	chr5:139707439	ZMAT2	chr5:140080032-140086239:+	-0.15	-3.55	0.000427	Alzheimer's disease in APOE e4- carriers	
THCA	cis	1	rs11168351	chr12:48403765	C12orf54	chr12:48877023-48890165:+	0.22	4.03	6.51E-5	Bipolar disorder and schizophrenia	
THCA	cis	1	rs11169544	chr12:51144749	DIP2B	chr12:50898768-51142448:+	0.24	8.68	6.05E-17	Colorectal cancer	
THCA	cis	1	rs11169552	chr12:51155663	DIP2B	chr12:50898768-51142448:+	-0.24	-8.66	7.53E-17	Colorectal cancer	
THCA	cis	1	rs11169554	chr12:51160207	DIP2B	chr12:50898768-51142448:+	-0.24	-8.59	1.23E-16	Colorectal cancer	
THCA	cis	1	rs111696803	chr9:100696636	C9orf156	chr9:100666772-100684852:-	-0.14	-3.63	0.000317	Quantitative traits	
THCA	cis	1	rs1117010	chr4:48410949	OCIAD1	chr4:48833015-48863831:+	-0.14	-4.21	3.0E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs11172086	chr12:57449206	FAM119B	chr12:58166383-58176323:+	-0.28	-4.09	4.97E-5	Asthma	
THCA	cis	1	rs11172254	chr12:57968738	FAM119B	chr12:58166383-58176323:+	-0.17	-4.31	1.97E-5	Rheumatoid arthritis	
THCA	cis	1	rs11172254	chr12:57968738	TSFM	chr12:58176536-58191367:+	0.23	6.08	2.47E-9	Rheumatoid arthritis	
THCA	cis	1	rs11172333	chr12:58170335	FAM119B	chr12:58166383-58176323:+	0.4	11.05	1.89E-25	Multiple sclerosis	
THCA	cis	1	rs11172333	chr12:58170335	METTL1	chr12:58162352-58165914:-	-0.19	-4.51	8.17E-6	Multiple sclerosis	
THCA	cis	1	rs11172333	chr12:58170335	TSFM	chr12:58176536-58191367:+	-0.59	-20.81	5.67E-69	Multiple sclerosis	
THCA	cis	1	rs11172333	chr12:58170335	XRCC6BP1	chr12:58335445-58351051:+	-0.23	-4.66	4.08E-6	Multiple sclerosis	
THCA	cis	1	rs11172335	chr12:58175201	FAM119B	chr12:58166383-58176323:+	0.4	10.89	8.3E-25	Multiple sclerosis	
THCA	cis	1	rs11172335	chr12:58175201	METTL1	chr12:58162352-58165914:-	-0.19	-4.67	3.99E-6	Multiple sclerosis	
THCA	cis	1	rs11172335	chr12:58175201	TSFM	chr12:58176536-58191367:+	-0.59	-20.24	2.97E-66	Multiple sclerosis	
THCA	cis	1	rs11172335	chr12:58175201	XRCC6BP1	chr12:58335445-58351051:+	-0.22	-4.4	1.36E-5	Multiple sclerosis	
THCA	cis	1	rs11172342	chr12:58187758	FAM119B	chr12:58166383-58176323:+	0.4	10.89	8.3E-25	Multiple sclerosis	
THCA	cis	1	rs11172342	chr12:58187758	METTL1	chr12:58162352-58165914:-	-0.19	-4.67	3.99E-6	Multiple sclerosis	
THCA	cis	1	rs11172342	chr12:58187758	TSFM	chr12:58176536-58191367:+	-0.59	-20.24	2.97E-66	Multiple sclerosis	
THCA	cis	1	rs11172342	chr12:58187758	XRCC6BP1	chr12:58335445-58351051:+	-0.22	-4.4	1.36E-5	Multiple sclerosis	
THCA	cis	1	rs11172343	chr12:58188157	FAM119B	chr12:58166383-58176323:+	0.4	10.89	8.3E-25	Multiple sclerosis	
THCA	cis	1	rs11172343	chr12:58188157	METTL1	chr12:58162352-58165914:-	-0.19	-4.67	3.99E-6	Multiple sclerosis	
THCA	cis	1	rs11172343	chr12:58188157	TSFM	chr12:58176536-58191367:+	-0.59	-20.24	2.97E-66	Multiple sclerosis	
THCA	cis	1	rs11172343	chr12:58188157	XRCC6BP1	chr12:58335445-58351051:+	-0.22	-4.4	1.36E-5	Multiple sclerosis	
THCA	cis	1	rs11172344	chr12:58193448	FAM119B	chr12:58166383-58176323:+	0.4	11.17	6.53E-26	Multiple sclerosis	
THCA	cis	1	rs11172344	chr12:58193448	METTL1	chr12:58162352-58165914:-	-0.19	-4.64	4.46E-6	Multiple sclerosis	
THCA	cis	1	rs11172344	chr12:58193448	TSFM	chr12:58176536-58191367:+	-0.57	-19.55	5.54E-63	Multiple sclerosis	
THCA	cis	1	rs11172344	chr12:58193448	XRCC6BP1	chr12:58335445-58351051:+	-0.22	-4.37	1.54E-5	Multiple sclerosis	
THCA	cis	1	rs11172349	chr12:58212528	FAM119B	chr12:58166383-58176323:+	0.39	10.76	2.46E-24	Multiple sclerosis	
THCA	cis	1	rs11172349	chr12:58212528	METTL1	chr12:58162352-58165914:-	-0.19	-4.58	6.0E-6	Multiple sclerosis	
THCA	cis	1	rs11172349	chr12:58212528	TSFM	chr12:58176536-58191367:+	-0.59	-20.14	9.02E-66	Multiple sclerosis	
THCA	cis	1	rs11172349	chr12:58212528	XRCC6BP1	chr12:58335445-58351051:+	-0.24	-4.81	2.07E-6	Multiple sclerosis	
THCA	cis	1	rs11172351	chr12:58213485	FAM119B	chr12:58166383-58176323:+	0.39	10.66	5.97E-24	Multiple sclerosis	
THCA	cis	1	rs11172351	chr12:58213485	METTL1	chr12:58162352-58165914:-	-0.19	-4.57	6.14E-6	Multiple sclerosis	
THCA	cis	1	rs11172351	chr12:58213485	TSFM	chr12:58176536-58191367:+	-0.59	-19.89	1.38E-64	Multiple sclerosis	
THCA	cis	1	rs11172351	chr12:58213485	XRCC6BP1	chr12:58335445-58351051:+	-0.23	-4.59	5.69E-6	Multiple sclerosis	
THCA	cis	1	rs1117367	chr15:76872330	SCAPER	chr15:76640529-77197744:-	-0.16	-5.23	2.55E-7	Blood metabolite levels	
THCA	cis	1	rs11174324	chr12:62502250	FAM19A2	chr12:62102043-62653925:-	-0.15	-3.34	0.000892	Post bronchodilator FEV1/FVC ratio in COPD	
THCA	cis	1	rs11174325	chr12:62503773	FAM19A2	chr12:62102043-62653925:-	-0.15	-3.34	0.000892	Post bronchodilator FEV1/FVC ratio in COPD	
THCA	cis	1	rs11174334	chr12:62519039	FAM19A2	chr12:62102043-62653925:-	-0.15	-3.43	0.000663	Post bronchodilator FEV1/FVC ratio in COPD	
THCA	cis	1	rs11178195	chr12:70739495	YEATS4	chr12:69753532-69784575:+	-0.24	-3.58	0.00038	Amyotrophic lateral sclerosis (age of onset)	
THCA	cis	1	rs11180559	chr12:75920285	GLIPR1L2	chr12:75784889-75825591:+	0.44	5.84	9.67E-9	Daytime sleep phenotypes	
THCA	cis	1	rs11181308	chr12:42445259	GXYLT1	chr12:42475650-42538673:-	-0.14	-3.85	0.000132	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	
THCA	cis	1	rs11181308	chr12:42445259	PPHLN1	chr12:42632249-42853517:+	-0.13	-3.53	0.00045	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	
THCA	cis	1	rs11181328	chr12:42504679	GXYLT1	chr12:42475650-42538673:-	-0.15	-3.92	0.000101	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	
THCA	cis	1	rs11181328	chr12:42504679	PPHLN1	chr12:42632249-42853517:+	-0.13	-3.52	0.000465	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	
THCA	cis	1	rs11183094	chr12:45924015	LOC400027	chr12:46119810-46121530:-	0.12	3.46	0.000593	Hypertension	
THCA	cis	1	rs11183098	chr12:45926120	LOC400027	chr12:46119810-46121530:-	-0.13	-3.57	0.000387	Hypertension	
THCA	cis	1	rs11183099	chr12:45930141	LOC400027	chr12:46119810-46121530:-	0.12	3.43	0.000649	Hypertension	
THCA	cis	1	rs11183103	chr12:45937181	LOC400027	chr12:46119810-46121530:-	0.13	3.65	0.000288	Hypertension	
THCA	cis	1	rs11185056	chr1:107578610	NTNG1	chr1:107682629-108024471:+	0.21	3.37	0.000806	AIDS	
THCA	cis	1	rs11185057	chr1:107596964	NTNG1	chr1:107682629-108024471:+	0.2	3.48	0.000541	AIDS	
THCA	cis	1	rs11185058	chr1:107603269	NTNG1	chr1:107682629-108024471:+	0.2	3.55	0.00043	AIDS	
THCA	cis	1	rs11185760	chr10:91331304	FLJ37201	chr10:91451057-91457685:-	-0.17	-3.57	0.000394	Metabolic traits	
THCA	cis	1	rs11185773	chr10:91349331	FLJ37201	chr10:91451057-91457685:-	-0.19	-3.94	9.5E-5	Metabolic traits	
THCA	cis	1	rs11185780	chr10:91363624	FLJ37201	chr10:91451057-91457685:-	0.2	4.18	3.43E-5	Metabolic traits	
THCA	cis	1	rs11185790	chr10:91372533	FLJ37201	chr10:91451057-91457685:-	0.18	3.76	0.000193	Metabolic traits	
THCA	cis	1	rs11185792	chr10:91374967	FLJ37201	chr10:91451057-91457685:-	-0.18	-3.74	0.000208	Metabolic traits	
THCA	cis	1	rs11185793	chr10:91375224	FLJ37201	chr10:91451057-91457685:-	-0.18	-3.74	0.000208	Metabolic traits	
THCA	cis	1	rs11185794	chr10:91375419	FLJ37201	chr10:91451057-91457685:-	-0.18	-3.74	0.000208	Metabolic traits	
THCA	cis	1	rs11185795	chr10:91375429	FLJ37201	chr10:91451057-91457685:-	-0.18	-3.74	0.000208	Metabolic traits	
THCA	cis	1	rs11185796	chr10:91375482	FLJ37201	chr10:91451057-91457685:-	-0.18	-3.74	0.000208	Metabolic traits	
THCA	cis	1	rs11185797	chr10:91375798	FLJ37201	chr10:91451057-91457685:-	-0.18	-3.74	0.000208	Metabolic traits	
THCA	cis	1	rs11185798	chr10:91375968	FLJ37201	chr10:91451057-91457685:-	-0.18	-3.74	0.000208	Metabolic traits	
THCA	cis	1	rs11185799	chr10:91377466	FLJ37201	chr10:91451057-91457685:-	-0.18	-3.74	0.000209	Metabolic traits	
THCA	cis	1	rs11185800	chr10:91378080	FLJ37201	chr10:91451057-91457685:-	-0.18	-3.82	0.000149	Metabolic traits	
THCA	cis	1	rs11185801	chr10:91378716	FLJ37201	chr10:91451057-91457685:-	-0.18	-3.74	0.000209	Metabolic traits	
THCA	cis	1	rs11185802	chr10:91378754	FLJ37201	chr10:91451057-91457685:-	-0.18	-3.74	0.000209	Metabolic traits	
THCA	cis	1	rs11185804	chr10:91379093	FLJ37201	chr10:91451057-91457685:-	0.17	3.62	0.000323	Metabolic traits	
THCA	cis	1	rs11185806	chr10:91380215	FLJ37201	chr10:91451057-91457685:-	-0.19	-3.95	8.91E-5	Metabolic traits	
THCA	cis	1	rs11185808	chr10:91381110	FLJ37201	chr10:91451057-91457685:-	-0.19	-3.88	0.000119	Metabolic traits	
THCA	cis	1	rs11185809	chr10:91381231	FLJ37201	chr10:91451057-91457685:-	-0.19	-3.88	0.000119	Metabolic traits	
THCA	cis	1	rs11185810	chr10:91381481	FLJ37201	chr10:91451057-91457685:-	-0.19	-3.88	0.000119	Metabolic traits	
THCA	cis	1	rs1118651	chr5:2786321	IRX2	chr5:2746281-2751769:-	-0.26	-4	7.42E-5	Toenail selenium levels	
THCA	cis	1	rs111873045	chr4:106639712	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11187840	chr10:96050351	TMEM20	chr10:95653730-95713998:+	-0.17	-3.36	0.00085	Sudden cardiac arrest	
THCA	cis	1	rs11187842	chr10:96052511	TMEM20	chr10:95653730-95713998:+	-0.17	-3.4	0.000736	Sudden cardiac arrest	
THCA	cis	1	rs11187851	chr10:96069875	TBC1D12	chr10:96162186-96296089:+	-0.18	-4.09	5.13E-5	Esophageal cancer and gastric cancer	
THCA	cis	1	rs111899361	chr7:1112348	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.69	2.27E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs11190130	chr10:101275206	NKX2-3	chr10:101292690-101296278:+	-0.32	-5.71	1.95E-8	Dental caries	
THCA	cis	1	rs111902838	chr19:50496614	SIGLEC16	chr19:50472912-50479075:+	0.65	5.99	4.1E-9	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
THCA	cis	1	rs11190540	chr10:102202629	SEC31B	chr10:102246403-102289636:-	-0.3	-10.24	2.25E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs11190541	chr10:102203071	SEC31B	chr10:102246403-102289636:-	-0.3	-10.18	3.73E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs11190551	chr10:102204734	SEC31B	chr10:102246403-102289636:-	-0.3	-10.17	3.96E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs11190552	chr10:102206607	SEC31B	chr10:102246403-102289636:-	-0.3	-10.21	2.82E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs11190555	chr10:102209160	SEC31B	chr10:102246403-102289636:-	-0.3	-10.17	3.96E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs11190556	chr10:102209223	SEC31B	chr10:102246403-102289636:-	-0.3	-10.17	3.96E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs11190557	chr10:102209369	SEC31B	chr10:102246403-102289636:-	-0.3	-10.17	3.96E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs11190558	chr10:102209397	SEC31B	chr10:102246403-102289636:-	-0.3	-10.17	3.96E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs11190569	chr10:102227409	SEC31B	chr10:102246403-102289636:-	-0.3	-10.09	7.67E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs11190570	chr10:102227702	SEC31B	chr10:102246403-102289636:-	-0.3	-10.24	2.25E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs11190572	chr10:102232879	SEC31B	chr10:102246403-102289636:-	-0.3	-10.24	2.25E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs11190578	chr10:102238953	SEC31B	chr10:102246403-102289636:-	-0.3	-10.17	3.98E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs11190587	chr10:102266638	SEC31B	chr10:102246403-102289636:-	-0.28	-8.79	2.81E-17	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs11190589	chr10:102275471	SEC31B	chr10:102246403-102289636:-	-0.27	-8.69	5.8E-17	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs11190592	chr10:102291059	SEC31B	chr10:102246403-102289636:-	-0.29	-9.27	6.33E-19	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs11190595	chr10:102291761	SEC31B	chr10:102246403-102289636:-	-0.28	-9.14	1.74E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs11190596	chr10:102293238	SEC31B	chr10:102246403-102289636:-	-0.29	-9.12	2.09E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs11190597	chr10:102293676	SEC31B	chr10:102246403-102289636:-	-0.29	-9.27	6.33E-19	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs11190599	chr10:102295420	SEC31B	chr10:102246403-102289636:-	-0.28	-8.96	7.03E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs11190601	chr10:102296730	SEC31B	chr10:102246403-102289636:-	-0.28	-8.95	7.61E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs11190602	chr10:102297256	SEC31B	chr10:102246403-102289636:-	-0.28	-9.09	2.6E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs11190604	chr10:102302457	SEC31B	chr10:102246403-102289636:-	-0.28	-9.05	3.61E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs11190607	chr10:102303614	SEC31B	chr10:102246403-102289636:-	-0.28	-9.04	3.94E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs11190613	chr10:102313997	SEC31B	chr10:102246403-102289636:-	0.28	9.12	2.12E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs11191416	chr10:104604916	AS3MT	chr10:104613967-104661653:+	0.26	3.55	0.000418	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs11191416	chr10:104604916	C10orf26	chr10:104503727-104591851:+	0.25	4.3	2.08E-5	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs11191416	chr10:104604916	INA	chr10:105036920-105050106:+	0.27	3.58	0.000385	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs11191416	chr10:104604916	SFXN2	chr10:104474298-104498946:+	0.35	4.15	3.96E-5	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs11191419	chr10:104612335	AS3MT	chr10:104613967-104661653:+	-0.36	-7.27	1.44E-12	Schizophrenia	
THCA	cis	1	rs11191419	chr10:104612335	C10orf26	chr10:104503727-104591851:+	-0.15	-3.72	0.000223	Schizophrenia	
THCA	cis	1	rs11191419	chr10:104612335	C10orf32	chr10:104613967-104624718:+	-0.31	-8.06	6.04E-15	Schizophrenia	
THCA	cis	1	rs11191419	chr10:104612335	SFXN2	chr10:104474298-104498946:+	-0.23	-3.89	0.000112	Schizophrenia	
THCA	cis	1	rs11191425	chr10:104625970	AS3MT	chr10:104613967-104661653:+	-0.28	-3.8	0.000164	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs11191425	chr10:104625970	C10orf26	chr10:104503727-104591851:+	-0.22	-3.83	0.000145	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs11191425	chr10:104625970	SFXN2	chr10:104474298-104498946:+	-0.37	-4.35	1.7E-5	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs11191425	chr10:104625970	SUFU	chr10:104263764-104393209:+	0.2	3.49	0.000536	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs111957218	chr19:10839089	SLC44A2	chr19:10713121-10755234:+	0.3	3.4	0.000743	LDL cholesterol	
THCA	cis	1	rs111966557	chr8:89370198	MMP16	chr8:89049462-89339717:-	0.31	4.88	1.48E-6	Electrodermal activity	
THCA	cis	1	rs11200595	chr10:124142629	PLEKHA1	chr10:124134220-124191866:+	-0.21	-5.78	1.38E-8	Height	
THCA	cis	1	rs11200606	chr10:124148765	PLEKHA1	chr10:124134220-124191866:+	-0.2	-5.65	2.7E-8	Height	
THCA	cis	1	rs11200608	chr10:124157821	PLEKHA1	chr10:124134220-124191866:+	-0.21	-5.74	1.7E-8	Height	
THCA	cis	1	rs11200609	chr10:124157858	PLEKHA1	chr10:124134220-124191866:+	-0.21	-5.74	1.7E-8	Height	
THCA	cis	1	rs11200629	chr10:124198585	PLEKHA1	chr10:124134220-124191866:+	-0.21	-5.89	7.29E-9	Height	
THCA	cis	1	rs11200967	chr10:81731562	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs11200971	chr10:81731950	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs11200982	chr10:81732349	LOC219347	chr10:81805991-81838949:-	-0.51	-5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs11200984	chr10:81732366	LOC219347	chr10:81805991-81838949:-	-0.51	-5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs11200985	chr10:81732653	LOC219347	chr10:81805991-81838949:-	-0.51	-5.15	3.8E-7	Rheumatoid arthritis	
THCA	cis	1	rs11201297	chr10:81793749	LOC219347	chr10:81805991-81838949:-	1.02	15.16	1.14E-42	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs11201298	chr10:81793751	LOC219347	chr10:81805991-81838949:-	1.03	15.31	2.39E-43	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs11201312	chr10:81795778	LOC219347	chr10:81805991-81838949:-	1.07	15.77	2.02E-45	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs11201660	chr10:81854531	LOC219347	chr10:81805991-81838949:-	-0.84	-12.36	1.2E-30	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs11201799	chr10:81881954	LOC219347	chr10:81805991-81838949:-	-0.83	-11.92	7.27E-29	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs11203030	chr10:90964286	CH25H	chr10:90965696-90967071:-	0.48	8.12	4.13E-15	Heart failure	
THCA	cis	1	rs11203031	chr10:90964395	CH25H	chr10:90965696-90967071:-	0.46	7.85	2.68E-14	Heart failure	
THCA	cis	1	rs11203032	chr10:90964614	CH25H	chr10:90965696-90967071:-	0.47	7.97	1.19E-14	Heart failure	
THCA	cis	1	rs11203033	chr10:90964731	CH25H	chr10:90965696-90967071:-	-0.48	-8	9.52E-15	Heart failure	
THCA	cis	1	rs11204330	chr17:20925846	USP22	chr17:20902908-20947073:-	-0.18	-3.83	0.000146	Blood trace element (Se levels)	
THCA	cis	1	rs11204971	chr1:152259078	FLG	chr1:152274651-152297679:-	0.29	4.17	3.63E-5	Atopic dermatitis	
THCA	cis	1	rs11204971	chr1:152259078	HRNR	chr1:152184558-152196669:-	-0.42	-5.45	8.16E-8	Atopic dermatitis	
THCA	cis	1	rs112074927	chr4:75716421	BTC	chr4:75671448-75719882:-	0.21	3.98	8.1E-5	Electroencephalogram traits	
THCA	cis	1	rs11209718	chr1:41688938	SCMH1	chr1:41492875-41707788:-	-0.2	-4.81	2.03E-6	Height	
THCA	cis	1	rs1121089	chr4:17676476	MED28	chr4:17616273-17629791:+	0.16	3.49	0.000527	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs1121090	chr4:17676437	MED28	chr4:17616273-17629791:+	0.16	3.45	0.000603	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs1121091	chr4:17676386	MED28	chr4:17616273-17629791:+	0.16	3.47	0.000566	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs11211132	chr1:45990516	AKR1A1	chr1:46016498-46035720:+	-0.14	-3.91	0.000108	Homocysteine levels	
THCA	cis	1	rs11211132	chr1:45990516	CCDC163P	chr1:45960581-45965646:-	-1.1	-31.76	7.21E-120	Homocysteine levels	
THCA	cis	1	rs11211132	chr1:45990516	MUTYH	chr1:45794915-45806142:-	0.21	5.1	4.79E-7	Homocysteine levels	
THCA	cis	1	rs11211132	chr1:45990516	PRDX1	chr1:45976708-45987609:-	-0.4	-10.2	3.08E-22	Homocysteine levels	
THCA	cis	1	rs11211199	chr1:46287869	CCDC163P	chr1:45960581-45965646:-	-0.51	-10.03	1.24E-21	Body mass index	
THCA	cis	1	rs11211199	chr1:46287869	GPBP1L1	chr1:46092978-46152302:-	0.16	4.07	5.54E-5	Body mass index	
THCA	cis	1	rs11211199	chr1:46287869	MMACHC	chr1:45965856-45976737:+	-0.19	-4.28	2.28E-5	Body mass index	
THCA	cis	1	rs11211199	chr1:46287869	MUTYH	chr1:45794915-45806142:-	0.31	8.34	7.97E-16	Body mass index	
THCA	cis	1	rs11211208	chr1:46334256	CCDC163P	chr1:45960581-45965646:-	-0.51	-10.1	6.94E-22	Body mass index	
THCA	cis	1	rs11211208	chr1:46334256	GPBP1L1	chr1:46092978-46152302:-	0.15	3.78	0.000175	Body mass index	
THCA	cis	1	rs11211208	chr1:46334256	HPDL	chr1:45792545-45794344:+	0.19	3.35	0.000858	Body mass index	
THCA	cis	1	rs11211208	chr1:46334256	MMACHC	chr1:45965856-45976737:+	-0.2	-4.37	1.51E-5	Body mass index	
THCA	cis	1	rs11211208	chr1:46334256	MUTYH	chr1:45794915-45806142:-	0.32	8.62	1.01E-16	Body mass index	
THCA	cis	1	rs11211230	chr1:46406767	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.14	5.21E-22	Body mass index	
THCA	cis	1	rs11211230	chr1:46406767	GPBP1L1	chr1:46092978-46152302:-	0.15	3.83	0.000146	Body mass index	
THCA	cis	1	rs11211230	chr1:46406767	MMACHC	chr1:45965856-45976737:+	-0.21	-4.57	6.3E-6	Body mass index	
THCA	cis	1	rs11211230	chr1:46406767	MUTYH	chr1:45794915-45806142:-	0.3	8.13	3.66E-15	Body mass index	
THCA	cis	1	rs11211234	chr1:46438787	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.14	5.21E-22	Body mass index	
THCA	cis	1	rs11211234	chr1:46438787	GPBP1L1	chr1:46092978-46152302:-	0.15	3.83	0.000146	Body mass index	
THCA	cis	1	rs11211234	chr1:46438787	MMACHC	chr1:45965856-45976737:+	-0.21	-4.57	6.3E-6	Body mass index	
THCA	cis	1	rs11211234	chr1:46438787	MUTYH	chr1:45794915-45806142:-	0.3	8.13	3.66E-15	Body mass index	
THCA	cis	1	rs11211241	chr1:46452683	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.14	5.21E-22	Body mass index	
THCA	cis	1	rs11211241	chr1:46452683	GPBP1L1	chr1:46092978-46152302:-	0.15	3.83	0.000146	Body mass index	
THCA	cis	1	rs11211241	chr1:46452683	MMACHC	chr1:45965856-45976737:+	-0.21	-4.57	6.3E-6	Body mass index	
THCA	cis	1	rs11211241	chr1:46452683	MUTYH	chr1:45794915-45806142:-	0.3	8.13	3.66E-15	Body mass index	
THCA	cis	1	rs11211342	chr1:47163098	CYP4B1	chr1:47264670-47285020:+	0.22	3.5	0.000509	Response to hepatitis C treatment	
THCA	cis	1	rs11211342	chr1:47163098	CYP4Z1	chr1:47533160-47583992:+	0.28	4.17	3.55E-5	Response to hepatitis C treatment	
THCA	cis	1	rs11211342	chr1:47163098	DMBX1	chr1:46972668-46979884:+	0.23	3.97	8.39E-5	Response to hepatitis C treatment	
THCA	cis	1	rs11212610	chr11:108274593	ATM	chr11:108093559-108239826:+	-0.1	-3.36	0.000838	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
THCA	cis	1	rs11212619	chr11:108289167	ATM	chr11:108093559-108239826:+	-0.1	-3.37	0.000816	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
THCA	cis	1	rs112143304	chr17:61822401	FTSJ3	chr17:61896795-61905031:-	0.32	5.71	1.96E-8	Body mass index	
THCA	cis	1	rs112143304	chr17:61822401	MAP3K3	chr17:61699775-61773669:+	0.26	5.04	6.45E-7	Body mass index	
THCA	cis	1	rs11216174	chr11:116757248	PCSK7	chr11:117075789-117102811:-	0.43	5.3	1.79E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs11216175	chr11:116757398	PCSK7	chr11:117075789-117102811:-	0.43	5.3	1.79E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs11216185	chr11:116782974	PCSK7	chr11:117075789-117102811:-	0.43	5.29	1.9E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs11216186	chr11:116784692	PCSK7	chr11:117075789-117102811:-	0.43	5.33	1.53E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs11216193	chr11:116815599	PCSK7	chr11:117075789-117102811:-	0.46	5.6	3.67E-8	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs11216197	chr11:116816778	PCSK7	chr11:117075789-117102811:-	0.46	5.6	3.67E-8	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs11216199	chr11:116831016	PCSK7	chr11:117075789-117102811:-	0.43	5.18	3.28E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs11216204	chr11:116839614	PCSK7	chr11:117075789-117102811:-	0.42	5.02	7.46E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs11216209	chr11:116848186	PCSK7	chr11:117075789-117102811:-	0.43	5.18	3.29E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs11216215	chr11:116852687	PCSK7	chr11:117075789-117102811:-	0.43	5.18	3.29E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs11216217	chr11:116857652	PCSK7	chr11:117075789-117102811:-	0.45	5.37	1.24E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs11216218	chr11:116862661	PCSK7	chr11:117075789-117102811:-	0.45	5.37	1.24E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs11216219	chr11:116862755	PCSK7	chr11:117075789-117102811:-	0.45	5.37	1.24E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs11216316	chr11:117081500	PCSK7	chr11:117075789-117102811:-	0.33	5.69	2.18E-8	Protein quantitative trait loci	
THCA	cis	1	rs112181719	chr10:81728929	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs1121	chr16:15131076	NTAN1	chr16:15131717-15149833:-	0.13	3.76	0.000195	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs1121	chr16:15131076	PDXDC1	chr16:15068599-15233195:+	0.33	7.75	5.41E-14	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs11221848	chr11:129673813	C11orf45	chr11:128769468-128776100:-	0.3	3.34	0.000896	Obesity-related traits	
THCA	cis	1	rs11221848	chr11:129673813	NFRKB	chr11:129733671-129765490:-	0.22	3.84	0.000137	Obesity-related traits	
THCA	cis	1	rs112225232	chr8:94079213	C8orf83	chr8:93895865-94029901:-	0.26	4.07	5.41E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs1122326	chr17:40274873	HSPB9	chr17:40274756-40275371:+	0.35	5.12	4.34E-7	Fibrinogen levels	
THCA	cis	1	rs11224811	chr11:101385734	TRPC6	chr11:101322296-101454659:-	-0.26	-4.31	1.95E-5	Facial depth	
THCA	cis	1	rs11224815	chr11:101390471	TRPC6	chr11:101322296-101454659:-	-0.25	-4.18	3.52E-5	Facial depth	
THCA	cis	1	rs11227284	chr11:65503224	CTSW	chr11:65647284-65651212:+	-0.27	-5.38	1.14E-7	Systemic lupus erythematosus	
THCA	cis	1	rs11227284	chr11:65503224	RNASEH2C	chr11:65485146-65488409:-	-0.19	-4.63	4.81E-6	Systemic lupus erythematosus	
THCA	cis	1	rs11227284	chr11:65503224	SNX32	chr11:65601410-65621170:+	0.4	5.14	4.06E-7	Systemic lupus erythematosus	
THCA	cis	1	rs11227288	chr11:65516588	CTSW	chr11:65647284-65651212:+	-0.24	-4.95	1.04E-6	Systemic lupus erythematosus	
THCA	cis	1	rs11227288	chr11:65516588	RNASEH2C	chr11:65485146-65488409:-	-0.18	-4.56	6.53E-6	Systemic lupus erythematosus	
THCA	cis	1	rs11227288	chr11:65516588	SNX32	chr11:65601410-65621170:+	0.39	5.18	3.23E-7	Systemic lupus erythematosus	
THCA	cis	1	rs112279857	chr8:89463938	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs11228925	chr11:56923361	TIMM10	chr11:57295936-57298232:-	-0.21	-3.6	0.000345	Low high density lipoprotein cholesterol levels	
THCA	cis	1	rs11228927	chr11:56930363	TIMM10	chr11:57295936-57298232:-	-0.23	-3.82	0.000149	Low high density lipoprotein cholesterol levels	
THCA	cis	1	rs11228973	chr11:57030244	TIMM10	chr11:57295936-57298232:-	-0.2	-3.57	0.000389	Low high density lipoprotein cholesterol levels	
THCA	cis	1	rs11229003	chr11:57108291	TIMM10	chr11:57295936-57298232:-	-0.24	-4.25	2.54E-5	Low high density lipoprotein cholesterol levels	
THCA	cis	1	rs1122979	chr7:150915071	RHEB	chr7:151163098-151217010:-	-0.2	-3.51	0.000482	Bone mineral density	
THCA	cis	1	rs11230147	chr11:59877394	MS4A14	chr11:60145958-60185226:+	0.16	4.26	2.44E-5	Alzheimer's disease (late onset)	
THCA	cis	1	rs11230155	chr11:59904959	MS4A14	chr11:60145958-60185226:+	0.17	4.33	1.79E-5	Alzheimer's disease (late onset)	
THCA	cis	1	rs11230160	chr11:59919165	MS4A14	chr11:60145958-60185226:+	-0.15	-4.05	6.04E-5	Alzheimer's disease (late onset)	
THCA	cis	1	rs11230161	chr11:59920231	MS4A14	chr11:60145958-60185226:+	-0.17	-4.29	2.2E-5	Alzheimer's disease (late onset)	
THCA	cis	1	rs11230394	chr11:60346932	MS4A12	chr11:60260251-60274895:+	-0.38	-6.53	1.64E-10	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	
THCA	cis	1	rs1123072	chr16:67898797	C16orf86	chr16:67700717-67702659:+	-0.32	-3.59	0.000371	Crohn's disease	
THCA	cis	1	rs1123072	chr16:67898797	ZDHHC1	chr16:67428323-67450339:-	0.42	4.23	2.86E-5	Crohn's disease	
THCA	cis	1	rs11231018	chr11:62062509	ZBTB3	chr11:62518437-62521656:-	0.17	3.58	0.000372	HIV-1 viral setpoint	
THCA	cis	1	rs11231629	chr11:63648573	RCOR2	chr11:63678704-63684316:-	-0.14	-3.44	0.000637	Schizophrenia	
THCA	cis	1	rs11233933	chr11:71210070	NADSYN1	chr11:71164217-71212579:+	0.18	4.12	4.4E-5	Vitamin D levels	
THCA	cis	1	rs11233977	chr11:71221605	NADSYN1	chr11:71164217-71212579:+	0.18	4.17	3.6E-5	Vitamin D levels	
THCA	cis	1	rs11234027	chr11:71234107	NADSYN1	chr11:71164217-71212579:+	0.18	4.08	5.23E-5	Vitamin D levels	
THCA	cis	1	rs11235440	chr11:71826644	FAM86C	chr11:71498557-71512276:+	-0.33	-4.06	5.78E-5	Severe influenza A (H1N1) infection	
THCA	cis	1	rs11236186	chr11:74362865	POLD3	chr11:74303629-74353765:+	-0.22	-3.65	0.000289	Response to metformin (IC50)	
THCA	cis	1	rs11236187	chr11:74364566	XRRA1	chr11:74518784-74660232:-	-0.19	-3.37	0.000823	Colorectal cancer	
THCA	cis	1	rs11236193	chr11:74368307	POLD3	chr11:74303629-74353765:+	-0.23	-3.62	0.000329	Response to metformin (IC50)	
THCA	cis	1	rs11237438	chr11:77998488	NARS2	chr11:78147017-78285909:-	-0.38	-6.91	1.52E-11	Testicular germ cell tumor	
THCA	cis	1	rs11237456	chr11:78040780	NARS2	chr11:78147017-78285909:-	-0.39	-7.46	3.99E-13	Testicular germ cell tumor	
THCA	cis	1	rs11237460	chr11:78056274	NARS2	chr11:78147017-78285909:-	-0.41	-7.77	4.74E-14	Testicular germ cell tumor	
THCA	cis	1	rs11237462	chr11:78058812	NARS2	chr11:78147017-78285909:-	-0.39	-7	8.63E-12	Testicular germ cell tumor	
THCA	cis	1	rs11237468	chr11:78072833	NARS2	chr11:78147017-78285909:-	-0.4	-7.59	1.67E-13	Testicular germ cell tumor	
THCA	cis	1	rs11237469	chr11:78072875	NARS2	chr11:78147017-78285909:-	-0.4	-7.04	6.55E-12	Testicular germ cell tumor	
THCA	cis	1	rs11237471	chr11:78082604	NARS2	chr11:78147017-78285909:-	-0.38	-7.11	4.4E-12	Testicular germ cell tumor	
THCA	cis	1	rs11237480	chr11:78110385	NARS2	chr11:78147017-78285909:-	-0.4	-7.57	1.91E-13	Testicular germ cell tumor	
THCA	cis	1	rs112401426	chr1:76466103	ACADM	chr1:76190043-76229353:+	-0.22	-4.65	4.26E-6	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs112401426	chr1:76466103	ST6GALNAC3	chr1:76540389-77096669:+	-0.27	-3.75	0.000199	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs112410494	chr11:18452755	LDHC	chr11:18433853-18472792:+	-0.3	-3.58	0.000379	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs11242077	chr5:130771037	P4HA2	chr5:131528306-131563556:-	-0.26	-5	8.18E-7	Life satisfaction	
THCA	cis	1	rs11242320	chr5:101400466	SLCO4C1	chr5:101569694-101632253:-	-0.18	-4.11	4.74E-5	QRS duration	
THCA	cis	1	rs112428033	chr5:115618260	COMMD10	chr5:115420727-115628978:+	0.48	5.66	2.56E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs11242	chr3:53125922	ITIH4	chr3:52847007-52866554:-	-0.16	-4.58	6.0E-6	Height	
THCA	cis	1	rs11242	chr3:53125922	RFT1	chr3:53122503-53164470:-	0.74	17.84	5.89E-55	Height	
THCA	cis	1	rs112434347	chr3:127840447	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.61	5.13E-6	Post bronchodilator FEV1	
THCA	cis	1	rs1124376	chr3:20108546	EFHB	chr3:19920968-19988501:-	-0.23	-3.37	0.000821	Bipolar disorder and schizophrenia	
THCA	cis	1	rs11246359	chr11:967943	TSPAN4	chr11:842824-867116:+	0.16	3.74	0.000207	Alzheimer's disease (late onset)	
THCA	cis	1	rs1124769	chr15:51352249	SPPL2A	chr15:50999739-51057910:-	0.32	6.96	1.12E-11	Cognitive performance	
THCA	cis	1	rs11247915	chr1:26650550	CNKSR1	chr1:26503981-26516373:+	-0.13	-3.74	0.000207	Obesity-related traits	
THCA	cis	1	rs11247915	chr1:26650550	TRIM63	chr1:26377798-26394121:-	0.23	4.24	2.65E-5	Obesity-related traits	
THCA	cis	1	rs11247980	chr4:1274734	KIAA1530	chr4:1341104-1381836:+	-0.21	-3.45	0.000617	Type 2 diabetes	
THCA	cis	1	rs11248009	chr4:220149	ZNF718	chr4:53272-156488:+	0.5	9.35	3.5E-19	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs11248009	chr4:220149	ZNF732	chr4:259482-299263:-	-0.24	-3.39	0.000755	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs11248013	chr4:311425	ZNF718	chr4:53272-156488:+	0.51	9.41	2.07E-19	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs11248348	chr10:124730840	C10orf88	chr10:124690419-124713919:-	-0.22	-4.02	6.65E-5	Migraine without aura	
THCA	cis	1	rs11248850	chr16:163598	NPRL3	chr16:134273-188672:-	0.24	6.14	1.77E-9	Red blood cell traits	
THCA	cis	1	rs11249350	chr1:121178446	HIST2H2BA	chr1:120906034-120914842:+	0.22	4.99	8.28E-7	Hip geometry	
THCA	cis	1	rs11249351	chr1:121171942	HIST2H2BA	chr1:120906034-120914842:+	0.23	5.16	3.63E-7	Hip geometry	
THCA	cis	1	rs11249502	chr4:71341161	AMTN	chr4:71384298-71398459:+	0.22	5.31	1.71E-7	Alcoholism (heaviness of drinking)	
THCA	cis	1	rs11250096	chr8:10811574	CTSB	chr8:11700036-11725646:-	0.22	3.5	0.000501	Asthma and hay fever	
THCA	cis	1	rs11250249	chr10:1116999	IDI2	chr10:1064847-1071799:-	0.42	3.77	0.000186	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs11250252	chr10:1124939	IDI2	chr10:1064847-1071799:-	0.33	3.38	0.000797	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs11250264	chr10:1151723	IDI2	chr10:1064847-1071799:-	0.34	3.55	0.000417	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs112509186	chr3:10156533	C3orf10	chr3:10157333-10168873:+	-0.22	-4.6	5.32E-6	Alzheimer's disease	
THCA	cis	1	rs112509186	chr3:10156533	VHL	chr3:10183319-10193744:+	-0.19	-4.34	1.78E-5	Alzheimer's disease	
THCA	cis	1	rs1125203	chr3:41760895	ULK4	chr3:41288091-42003660:-	1.06	19.75	6.57E-64	Diastolic blood pressure	
THCA	cis	1	rs112528936	chr4:106633029	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs112529587	chr8:96060035	C8orf38	chr8:95908040-96088396:+	-0.27	-4.58	5.97E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs112537273	chr8:38248306	DDHD2	chr8:38089009-38120286:+	0.16	3.7	0.000243	Schizophrenia	
THCA	cis	1	rs112537273	chr8:38248306	LSM1	chr8:38020861-38034169:-	-0.15	-3.93	9.91E-5	Schizophrenia	
THCA	cis	1	rs1125394	chr11:113297185	TTC12	chr11:113185251-113244016:+	0.39	6.35	5.04E-10	Select biomarker traits	
THCA	cis	1	rs11255291	chr10:7736904	ITIH5	chr10:7601636-7708934:-	-0.19	-3.78	0.000177	Ovarian reserve	
THCA	cis	1	rs112590700	chr1:108362695	VAV3	chr1:108113782-108507545:-	0.56	8.05	6.61E-15	Hypothyroidism	
THCA	cis	1	rs112591243	chr21:47718796	C21orf56	chr21:47581063-47604373:-	0.32	3.51	0.000493	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	
THCA	cis	1	rs11259928	chr15:84568095	LOC388152	chr15:84867600-84898920:-	-0.21	-3.92	0.000103	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs11259929	chr15:84577202	LOC388152	chr15:84867600-84898920:-	-0.21	-3.98	7.86E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs11259930	chr15:84577350	LOC388152	chr15:84867600-84898920:-	-0.21	-3.98	7.86E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs11259932	chr15:84580057	LOC388152	chr15:84867600-84898920:-	-0.21	-3.98	7.86E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs11259933	chr15:84580156	LOC388152	chr15:84867600-84898920:-	-0.2	-3.81	0.000159	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs11259934	chr15:84580171	LOC388152	chr15:84867600-84898920:-	-0.21	-3.98	7.86E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs11259935	chr15:84580427	LOC388152	chr15:84867600-84898920:-	-0.21	-3.98	7.86E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs11259936	chr15:84580582	LOC388152	chr15:84867600-84898920:-	0.21	3.87	0.000122	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs11259937	chr15:84587833	LOC388152	chr15:84867600-84898920:-	-0.21	-3.98	7.86E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs11264422	chr1:155907823	FDPS	chr1:155278539-155290457:+	-0.21	-4.33	1.83E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs11264422	chr1:155907823	RIT1	chr1:155867601-155881177:-	0.19	4.15	3.92E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs11264462	chr1:156241728	BGLAP	chr1:156182784-156213112:+	0.23	5.37	1.21E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs11264462	chr1:156241728	C1orf85	chr1:156259882-156265449:-	-0.17	-4.1	4.88E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs11264462	chr1:156241728	CCT3	chr1:156278752-156308195:-	-0.33	-7.2	2.33E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs11264464	chr1:156250887	BGLAP	chr1:156182784-156213112:+	0.23	5.47	7.46E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs11264464	chr1:156250887	C1orf85	chr1:156259882-156265449:-	-0.17	-4.03	6.45E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs11264464	chr1:156250887	CCT3	chr1:156278752-156308195:-	-0.32	-6.99	9.47E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs11264467	chr1:156273061	BGLAP	chr1:156182784-156213112:+	-0.19	-4.63	4.82E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs11264467	chr1:156273061	C1orf85	chr1:156259882-156265449:-	0.16	3.92	0.000103	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs11264467	chr1:156273061	CCT3	chr1:156278752-156308195:-	0.29	6.46	2.59E-10	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs11264467	chr1:156273061	PAQR6	chr1:156213207-156217843:-	0.12	3.64	0.000299	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs11264468	chr1:156274585	BGLAP	chr1:156182784-156213112:+	0.23	5.56	4.57E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs11264468	chr1:156274585	C1orf85	chr1:156259882-156265449:-	-0.17	-4.08	5.25E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs11264468	chr1:156274585	CCT3	chr1:156278752-156308195:-	-0.33	-7.24	1.76E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs11264535	chr1:156722424	C1orf66	chr1:156698263-156706751:+	0.12	3.37	0.000804	HDL cholesterol	
THCA	cis	1	rs112654776	chr4:106765058	INTS12	chr4:106603787-106629881:-	-0.58	-5	8.08E-7	Post bronchodilator FEV1	
THCA	cis	1	rs1127489	chr6:170107702	C6orf70	chr6:170151721-170181617:+	0.25	5.11	4.72E-7	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs1127489	chr6:170107702	WDR27	chr6:169857307-170102159:-	-0.2	-5.98	4.36E-9	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs112751982	chr6:26191958	HIST1H2AE	chr6:26217148-26217711:+	-0.23	-3.69	0.000249	Renal underexcretion gout;Gout	
THCA	cis	1	rs112751982	chr6:26191958	HIST1H3E	chr6:26224427-26226589:+	0.43	7.04	6.71E-12	Renal underexcretion gout;Gout	
THCA	cis	1	rs112777695	chr20:33693177	PROCR	chr20:33758727-33765164:+	-0.33	-5.64	2.95E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs112777695	chr20:33693177	TRPC4AP	chr20:33590215-33680618:-	0.34	4.49	8.97E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs112795376	chr4:75716413	BTC	chr4:75671448-75719882:-	0.21	3.98	8.1E-5	Electroencephalogram traits	
THCA	cis	1	rs1128320	chr11:244167	PSMD13	chr11:236808-252984:+	-0.22	-6.73	4.91E-11	Menarche (age at onset)	
THCA	cis	1	rs1128320	chr11:244167	SIRT3	chr11:214625-236931:-	0.12	3.37	0.000812	Menarche (age at onset)	
THCA	cis	1	rs1128322	chr11:244197	PSMD13	chr11:236808-252984:+	0.21	6.56	1.44E-10	Menarche (age at onset)	
THCA	cis	1	rs1128322	chr11:244197	SIRT3	chr11:214625-236931:-	-0.12	-3.41	0.000705	Menarche (age at onset)	
THCA	cis	1	rs112847840	chr3:10101652	C3orf10	chr3:10157333-10168873:+	-0.21	-4.34	1.71E-5	Alzheimer's disease	
THCA	cis	1	rs112847840	chr3:10101652	VHL	chr3:10183319-10193744:+	-0.2	-4.51	8.09E-6	Alzheimer's disease	
THCA	cis	1	rs112875818	chr11:63029307	COX8A	chr11:63742079-63744014:+	-0.18	-3.5	0.000501	Sex hormone levels	
THCA	cis	1	rs112897605	chr4:75707366	BTC	chr4:75671448-75719882:-	0.21	3.95	9.05E-5	Electroencephalogram traits	
THCA	cis	1	rs11292	chr10:102313607	SEC31B	chr10:102246403-102289636:-	-0.29	-9.36	3.15E-19	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs1129448	chr22:38170026	LGALS2	chr22:37966254-37976024:-	-0.17	-4.78	2.39E-6	Optic cup area;Vertical cup-disc ratio	
THCA	cis	1	rs1129448	chr22:38170026	SH3BP1	chr22:38030661-38062939:+	-0.1	-3.36	0.000849	Optic cup area;Vertical cup-disc ratio	
THCA	cis	1	rs1129448	chr22:38170026	TRIOBP	chr22:38082344-38172562:+	0.37	10.07	8.93E-22	Optic cup area;Vertical cup-disc ratio	
THCA	cis	1	rs113033627	chr19:12166369	ZNF763	chr19:12035900-12091196:+	-0.38	-4.52	7.92E-6	Multiple sclerosis	
THCA	cis	1	rs113036885	chr11:18452732	LDHC	chr11:18433853-18472792:+	-0.3	-3.58	0.000379	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs1130650	chr14:20940626	CHD8	chr14:21853358-21905404:-	-0.14	-4.2	3.15E-5	Interferon alpha levels in systemic lupus erythematosus	
THCA	cis	1	rs113066613	chr7:1094128	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.5	6.04E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs113075795	chr14:65968955	LOC645431	chr14:65877313-65879335:-	-0.6	-7.99	1.02E-14	Ischemic stroke	
THCA	cis	1	rs113104783	chr11:60348915	MS4A12	chr11:60260251-60274895:+	-0.38	-6.26	8.73E-10	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	
THCA	cis	1	rs1131052	chr3:58411530	PXK	chr3:58318617-58410878:+	0.34	5.98	4.47E-9	Cholesterol, total	
THCA	cis	1	rs1131095	chr3:49714225	MST1	chr3:49721381-49726196:-	0.14	4.17	3.64E-5	Crohn's disease;Ulcerative colitis	
THCA	cis	1	rs1131095	chr3:49714225	UBA7	chr3:49842639-49851391:-	0.15	3.36	0.000843	Crohn's disease;Ulcerative colitis	
THCA	cis	1	rs113134232	chr17:61715461	FTSJ3	chr17:61896795-61905031:-	0.32	5.63	3.07E-8	Body mass index	
THCA	cis	1	rs113134232	chr17:61715461	MAP3K3	chr17:61699775-61773669:+	0.26	4.99	8.66E-7	Body mass index	
THCA	cis	1	rs113134644	chr3:10086286	C3orf10	chr3:10157333-10168873:+	-0.2	-4.16	3.82E-5	Alzheimer's disease	
THCA	cis	1	rs113134644	chr3:10086286	VHL	chr3:10183319-10193744:+	-0.2	-4.69	3.56E-6	Alzheimer's disease	
THCA	cis	1	rs113143821	chr5:127893353	FBN2	chr5:127593602-127873916:-	0.51	6.91	1.56E-11	Multiple system atrophy	
THCA	cis	1	rs113146460	chr7:1105164	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.8	1.19E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs113153120	chr3:10156398	C3orf10	chr3:10157333-10168873:+	-0.22	-4.6	5.48E-6	Alzheimer's disease	
THCA	cis	1	rs113153120	chr3:10156398	VHL	chr3:10183319-10193744:+	-0.19	-4.36	1.61E-5	Alzheimer's disease	
THCA	cis	1	rs113179672	chr12:117327241	FBXW8	chr12:117348761-117470180:+	-0.28	-4.73	2.91E-6	Subcortical brain region volumes	
THCA	cis	1	rs113205216	chr12:117326943	FBXW8	chr12:117348761-117470180:+	-0.28	-4.76	2.57E-6	Subcortical brain region volumes	
THCA	cis	1	rs113227361	chr5:109731861	TMEM232	chr5:109624934-110062381:-	0.38	4.19	3.3E-5	Cardiac structure and function	
THCA	cis	1	rs113269636	chr16:77780610	NUDT7	chr16:77756411-77776153:+	0.39	5.34	1.47E-7	Obesity-related traits	
THCA	cis	1	rs1133146	chr19:53666660	ZNF665	chr19:53666552-53696619:-	0.15	4.11	4.65E-5	Yu-Zhi constitution type in type 2 diabetes	
THCA	cis	1	rs113315674	chr9:100720053	C9orf156	chr9:100666772-100684852:-	-0.15	-3.87	0.000126	Quantitative traits	
THCA	cis	1	rs113333037	chr17:2200106	SRR	chr17:2207248-2228553:+	-0.82	-16.73	8.56E-50	Esophageal cancer (squamous cell)	
THCA	cis	1	rs1133353	chr2:241522267	GPR35	chr2:241544848-241570675:+	-0.26	-5.1	4.91E-7	Bipolar disorder	
THCA	cis	1	rs113427979	chr19:32855408	DPY19L3	chr19:32896677-32975236:+	0.2	5.54	5.14E-8	Bipolar disorder	
THCA	cis	1	rs113427979	chr19:32855408	ZNF507	chr19:32836514-32878571:+	0.32	8.22	1.98E-15	Bipolar disorder	
THCA	cis	1	rs113450334	chr16:77780609	NUDT7	chr16:77756411-77776153:+	0.39	5.34	1.47E-7	Obesity-related traits	
THCA	cis	1	rs113474297	chr5:60554934	ZSWIM6	chr5:60628100-60841998:+	-0.22	-3.59	0.000369	Educational attainment (years of education)	
THCA	cis	1	rs113497813	chr11:18453674	LDHC	chr11:18433853-18472792:+	-0.3	-3.57	0.000399	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs113522867	chr3:10154503	C3orf10	chr3:10157333-10168873:+	-0.21	-4.49	8.8E-6	Alzheimer's disease	
THCA	cis	1	rs113522867	chr3:10154503	VHL	chr3:10183319-10193744:+	-0.19	-4.42	1.21E-5	Alzheimer's disease	
THCA	cis	1	rs1135663	chr11:116788837	PCSK7	chr11:117075789-117102811:-	0.42	5.11	4.66E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs113575110	chr7:1084394	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.02	7.29E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs1135999	chr16:15131962	NTAN1	chr16:15131717-15149833:-	0.13	3.76	0.000193	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs1135999	chr16:15131962	PDXDC1	chr16:15068599-15233195:+	0.32	7.56	2.09E-13	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs1136001	chr16:15131974	NTAN1	chr16:15131717-15149833:-	0.13	3.76	0.000193	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs1136001	chr16:15131974	PDXDC1	chr16:15068599-15233195:+	0.32	7.56	2.09E-13	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs113638727	chr15:40706101	C15orf23	chr15:40674922-40686488:+	0.65	8.55	1.71E-16	Heschl's gyrus morphology	
THCA	cis	1	rs113638727	chr15:40706101	IVD	chr15:40697686-40713512:+	-0.56	-9.85	5.94E-21	Heschl's gyrus morphology	
THCA	cis	1	rs113725670	chr11:18443300	LDHC	chr11:18433853-18472792:+	-0.31	-3.77	0.000186	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs113738158	chr8:89445712	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs113767110	chr4:106599814	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs113770724	chr6:159370137	RSPH3	chr6:159398268-159421198:-	0.28	6	3.97E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs113771705	chr3:10075983	C3orf10	chr3:10157333-10168873:+	-0.2	-4.3	2.08E-5	Alzheimer's disease	
THCA	cis	1	rs113771705	chr3:10075983	VHL	chr3:10183319-10193744:+	-0.19	-4.42	1.24E-5	Alzheimer's disease	
THCA	cis	1	rs113792528	chr8:89439450	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs1137	chr2:74939176	MRPL53	chr2:74699110-74699923:-	0.12	3.64	0.000298	Myopia (pathological)	
THCA	cis	1	rs1137	chr2:74939176	TTC31	chr2:74710200-74721691:+	-0.19	-4.13	4.3E-5	Myopia (pathological)	
THCA	cis	1	rs113812453	chr20:3963193	MAVS	chr20:3827449-3856761:+	-0.23	-3.51	0.000484	Response to antidepressants in depression	
THCA	cis	1	rs1138273	chr3:134261437	ANAPC13	chr3:134196547-134204865:-	0.4	12.55	1.92E-31	Height	
THCA	cis	1	rs1138273	chr3:134261437	CEP63	chr3:134204575-134293852:+	0.31	6.53	1.69E-10	Height	
THCA	cis	1	rs113835537	chr11:66339639	DPP3	chr11:66247880-66277130:+	-0.23	-4.55	6.92E-6	Airway imaging phenotypes	
THCA	cis	1	rs113835537	chr11:66339639	PELI3	chr11:66234336-66244807:+	-0.2	-3.58	0.000378	Airway imaging phenotypes	
THCA	cis	1	rs113855569	chr10:81728958	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs113858334	chr7:1073476	ZFAND2A	chr7:1192544-1199855:-	-0.3	-4.4	1.33E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs1139178	chr16:69781468	COG4	chr16:70514473-70557457:-	-0.19	-3.79	0.000167	IgE levels	
THCA	cis	1	rs113919636	chr17:41877740	MPP3	chr17:41878169-41910538:-	0.29	4.85	1.65E-6	Triglycerides	
THCA	cis	1	rs113995589	chr3:53132372	RFT1	chr3:53122503-53164470:-	0.61	7.4	6.29E-13	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs1140047	chr11:18327684	GTF2H1	chr11:18343816-18388590:+	0.37	9.85	5.58E-21	Pancreatic cancer	
THCA	cis	1	rs114007205	chr20:33647503	PROCR	chr20:33758727-33765164:+	-0.32	-5.09	5.08E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs114007205	chr20:33647503	TRPC4AP	chr20:33590215-33680618:-	0.32	3.9	0.00011	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs114031213	chr2:207619463	MDH1B	chr2:207598943-207630050:-	0.48	6.07	2.64E-9	Episodic memory	
THCA	cis	1	rs114050731	chr2:45655974	SRBD1	chr2:45615820-45838433:-	-0.37	-4.16	3.73E-5	Glaucoma	
THCA	cis	1	rs114079739	chr2:203825106	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.69	2.21E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs114079739	chr2:203825106	ICA1L	chr2:203637873-203736371:-	0.27	4.48	9.33E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs114085878	chr12:62505234	FAM19A2	chr12:62102043-62653925:-	-0.15	-3.34	0.000892	Post bronchodilator FEV1/FVC ratio in COPD	
THCA	cis	1	rs114110842	chr2:203823400	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.69	2.21E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs114110842	chr2:203823400	ICA1L	chr2:203637873-203736371:-	0.27	4.48	9.33E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs114112131	chr11:129686553	NFRKB	chr11:129733671-129765490:-	0.22	3.86	0.000129	Obesity-related traits	
THCA	cis	1	rs114123510	chr2:203831212	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.69	2.21E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs114123510	chr2:203831212	ICA1L	chr2:203637873-203736371:-	0.27	4.48	9.33E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs1141313	chr2:27460968	C2orf28	chr2:27434899-27440044:+	0.18	5.34	1.44E-7	Blood metabolite levels	
THCA	cis	1	rs1141313	chr2:27460968	SLC5A6	chr2:27422459-27435071:-	-0.3	-6.37	4.57E-10	Blood metabolite levels	
THCA	cis	1	rs1141321	chr6:49412433	CENPQ	chr6:49431096-49460820:+	-0.27	-5.61	3.45E-8	Folate pathway vitamin levels	
THCA	cis	1	rs1141321	chr6:49412433	MUT	chr6:49398994-49431031:-	0.28	9.62	3.81E-20	Folate pathway vitamin levels	
THCA	cis	1	rs114142124	chr11:78047537	NARS2	chr11:78147017-78285909:-	-0.4	-7.02	7.8E-12	Testicular germ cell tumor	
THCA	cis	1	rs114155121	chr2:203718682	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.98	4.33E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs114155121	chr2:203718682	ICA1L	chr2:203637873-203736371:-	0.26	4.31	1.98E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs114166836	chr8:89359381	MMP16	chr8:89049462-89339717:-	0.31	4.88	1.48E-6	Electrodermal activity	
THCA	cis	1	rs114171212	chr4:106616191	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs114200987	chr14:35586916	FAM177A1	chr14:35514113-35552587:+	-0.2	-3.81	0.00016	Atopic dermatitis	
THCA	cis	1	rs114200987	chr14:35586916	KIAA0391	chr14:35591776-35786673:+	0.31	5.74	1.73E-8	Atopic dermatitis	
THCA	cis	1	rs114200987	chr14:35586916	PPP2R3C	chr14:35554679-35591679:-	0.54	10.31	1.18E-22	Atopic dermatitis	
THCA	cis	1	rs114244137	chr5:150264753	LOC134466	chr5:150310000-150326146:-	0.38	5.28	2.01E-7	Crohn's disease	
THCA	cis	1	rs114256679	chr4:106636598	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs114304428	chr1:152254010	FLG	chr1:152274651-152297679:-	0.29	4.18	3.53E-5	Atopic dermatitis	
THCA	cis	1	rs114304428	chr1:152254010	HRNR	chr1:152184558-152196669:-	-0.42	-5.46	7.49E-8	Atopic dermatitis	
THCA	cis	1	rs114330751	chr11:18462475	LDHC	chr11:18433853-18472792:+	-0.3	-3.57	0.000399	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs1143438	chr19:46889161	CCDC8	chr19:46913587-46916919:-	-0.2	-3.34	0.000888	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs114393235	chr2:203795987	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.95	5.24E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs114393235	chr2:203795987	ICA1L	chr2:203637873-203736371:-	0.26	4.29	2.13E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs114395475	chr2:203769112	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.94	5.6E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs114395475	chr2:203769112	ICA1L	chr2:203637873-203736371:-	0.25	4.21	3.08E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs1144333	chr1:76275100	ACADM	chr1:76190043-76229353:+	0.25	5.25	2.25E-7	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs114433731	chr8:89439454	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs1144815	chr1:247781569	OR2W3	chr1:248031265-248060142:+	-0.17	-3.68	0.000262	Response to platinum-based chemotherapy (carboplatin)	
THCA	cis	1	rs1144815	chr1:247781569	TRIM58	chr1:248020501-248043436:+	-0.17	-4.03	6.55E-5	Response to platinum-based chemotherapy (carboplatin)	
THCA	cis	1	rs1144894	chr7:65542894	ASL	chr7:65540776-65558321:+	0.19	4.83	1.86E-6	Aortic root size	
THCA	cis	1	rs1144894	chr7:65542894	GUSB	chr7:65425675-65447246:-	-0.27	-5.12	4.41E-7	Aortic root size	
THCA	cis	1	rs1144894	chr7:65542894	RABGEF1	chr7:66093890-66276446:+	-0.63	-12.63	9.14E-32	Aortic root size	
THCA	cis	1	rs1144895	chr7:65541307	ASL	chr7:65540776-65558321:+	0.2	5	8.23E-7	Aortic root size	
THCA	cis	1	rs1144895	chr7:65541307	GUSB	chr7:65425675-65447246:-	-0.28	-5.26	2.2E-7	Aortic root size	
THCA	cis	1	rs1144895	chr7:65541307	RABGEF1	chr7:66093890-66276446:+	-0.64	-12.96	3.77E-33	Aortic root size	
THCA	cis	1	rs114490726	chr4:17680898	MED28	chr4:17616273-17629791:+	0.16	3.47	0.000574	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs114520702	chr2:203697092	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.67	2.47E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs114520702	chr2:203697092	ICA1L	chr2:203637873-203736371:-	0.27	4.41	1.26E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs114527590	chr2:203787405	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.95	5.24E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs114527590	chr2:203787405	ICA1L	chr2:203637873-203736371:-	0.26	4.29	2.13E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs114548661	chr8:94066825	C8orf83	chr8:93895865-94029901:-	0.3	4.7	3.47E-6	Attention deficit hyperactivity disorder	
THCA	cis	1	rs114562844	chr3:52991584	RFT1	chr3:53122503-53164470:-	0.62	7.15	3.23E-12	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs114562844	chr3:52991584	TMEM110	chr3:52867139-52931547:-	0.36	4.1	4.84E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs114604770	chr8:89587010	MMP16	chr8:89049462-89339717:-	0.16	3.59	0.00036	Body mass index and cholesterol (psychopharmacological treatment)	
THCA	cis	1	rs11466750	chr5:110412894	TSLP	chr5:110405778-110413722:+	-0.33	-4.32	1.89E-5	Eosinophil counts	
THCA	cis	1	rs11466750	chr5:110412894	WDR36	chr5:110427870-110466201:+	0.2	3.74	0.000206	Eosinophil counts	
THCA	cis	1	rs11466754	chr5:110413731	TSLP	chr5:110405778-110413722:+	-0.35	-4.47	9.97E-6	Eosinophil counts	
THCA	cis	1	rs11466754	chr5:110413731	WDR36	chr5:110427870-110466201:+	0.21	3.76	0.000189	Eosinophil counts	
THCA	cis	1	rs114702158	chr2:203821793	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.69	2.21E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs114702158	chr2:203821793	ICA1L	chr2:203637873-203736371:-	0.27	4.48	9.33E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs114707452	chr3:119287090	ADPRH	chr3:119298523-119308791:+	-0.22	-3.69	0.000249	Vitiligo	
THCA	cis	1	rs1147610	chr10:105941167	C10orf79	chr10:105889647-105992120:-	0.25	8	9.29E-15	Attention deficit hyperactivity disorder	
THCA	cis	1	rs114799538	chr8:10815827	CTSB	chr8:11700036-11725646:-	0.22	3.57	0.000399	Asthma and hay fever	
THCA	cis	1	rs1148000	chr12:75936301	GLIPR1L2	chr12:75784889-75825591:+	-0.4	-6.28	7.53E-10	Polycystic ovary syndrome	
THCA	cis	1	rs1148003	chr12:75978996	GLIPR1L2	chr12:75784889-75825591:+	-0.37	-5.77	1.46E-8	Polycystic ovary syndrome	
THCA	cis	1	rs1148004	chr12:75978677	GLIPR1L2	chr12:75784889-75825591:+	-0.39	-6.09	2.3E-9	Polycystic ovary syndrome	
THCA	cis	1	rs1148005	chr12:75978513	GLIPR1L2	chr12:75784889-75825591:+	-0.37	-5.73	1.75E-8	Polycystic ovary syndrome	
THCA	cis	1	rs1148006	chr12:75978358	GLIPR1L2	chr12:75784889-75825591:+	-0.34	-5.31	1.72E-7	Polycystic ovary syndrome	
THCA	cis	1	rs114810099	chr4:75708771	BTC	chr4:75671448-75719882:-	0.21	3.93	9.85E-5	Electroencephalogram traits	
THCA	cis	1	rs114832687	chr18:51836446	POLI	chr18:51795849-51824602:+	0.18	5.08	5.31E-7	Psoriasis	
THCA	cis	1	rs11485224	chr1:9154306	H6PD	chr1:9294863-9331392:+	0.18	3.52	0.000478	Response to antidepressant treatment (citalopram)	
THCA	cis	1	rs11485508	chr1:152253167	FLG	chr1:152274651-152297679:-	-0.3	-4.71	3.27E-6	Atopic dermatitis	
THCA	cis	1	rs11485508	chr1:152253167	HRNR	chr1:152184558-152196669:-	0.5	7.22	2.04E-12	Atopic dermatitis	
THCA	cis	1	rs114897909	chr8:89449958	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs114899426	chr2:203771652	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.94	5.6E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs114899426	chr2:203771652	ICA1L	chr2:203637873-203736371:-	0.25	4.21	3.08E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs11492508	chr10:38098136	LOC399744	chr10:38717074-38741080:+	0.32	4.41	1.27E-5	Obesity (extreme)	
THCA	cis	1	rs11492508	chr10:38098136	ZNF25	chr10:38238795-38265453:-	0.16	3.35	0.000861	Obesity (extreme)	
THCA	cis	1	rs114948279	chr20:33733641	PROCR	chr20:33758727-33765164:+	-0.32	-5.28	1.98E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs114948279	chr20:33733641	TRPC4AP	chr20:33590215-33680618:-	0.31	3.92	0.000102	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs114960066	chr3:41882323	ULK4	chr3:41288091-42003660:-	1.09	21.14	1.55E-70	Diastolic blood pressure	
THCA	cis	1	rs114976176	chr2:264621	SH3YL1	chr2:218138-264810:-	-0.93	-24.95	1.3E-88	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs114981855	chr1:146875087	FMO5	chr1:146655885-146697230:-	0.25	3.93	9.7E-5	Protein quantitative trait loci	
THCA	cis	1	rs115067791	chr2:207033306	INO80D	chr2:206858446-206950906:-	0.25	3.42	0.000686	Childhood body mass index	
THCA	cis	1	rs11513782	chr12:81464588	ACSS3	chr12:81471809-81649582:+	0.24	5.07	5.74E-7	Neuroticism	
THCA	cis	1	rs11514430	chr12:45919179	LOC400027	chr12:46119810-46121530:-	0.13	3.44	0.000638	Hypertension	
THCA	cis	1	rs115177506	chr4:75708112	BTC	chr4:75671448-75719882:-	0.21	3.95	9.05E-5	Electroencephalogram traits	
THCA	cis	1	rs115188238	chr3:184736757	C3orf70	chr3:184795840-184870802:-	-0.23	-4.62	4.85E-6	Heschl's gyrus morphology	
THCA	cis	1	rs11519750	chr12:81464627	ACSS3	chr12:81471809-81649582:+	0.24	5.09	5.18E-7	Neuroticism	
THCA	cis	1	rs11519754	chr12:82209181	PPFIA2	chr12:81652880-82153109:-	0.22	4.12	4.52E-5	Resting heart rate	
THCA	cis	1	rs1152591	chr14:64680848	MTHFD1	chr14:64854759-64926727:+	-0.2	-5.05	6.17E-7	Atrial fibrillation	
THCA	cis	1	rs11532322	chr12:123731423	ABCB9	chr12:123413540-123459752:-	-0.18	-3.46	0.000587	Schizophrenia	
THCA	cis	1	rs11532322	chr12:123731423	C12orf65	chr12:123717841-123742481:+	0.18	4.47	9.62E-6	Schizophrenia	
THCA	cis	1	rs11532322	chr12:123731423	CDK2AP1	chr12:123745542-123756687:-	0.18	5.46	7.58E-8	Schizophrenia	
THCA	cis	1	rs11532322	chr12:123731423	MPHOSPH9	chr12:123640948-123717658:-	-0.18	-5.94	5.46E-9	Schizophrenia	
THCA	cis	1	rs11532322	chr12:123731423	OGFOD2	chr12:123459354-123464588:+	-0.12	-4.43	1.19E-5	Schizophrenia	
THCA	cis	1	rs11532322	chr12:123731423	PITPNM2	chr12:123468027-123635285:-	-0.22	-4.81	2.05E-6	Schizophrenia	
THCA	cis	1	rs11532774	chr7:107201579	DLD	chr7:107531586-107561642:+	0.14	3.53	0.000461	Osteoarthritis	
THCA	cis	1	rs11535	chr2:233743532	GIGYF2	chr2:233562015-233725285:+	-0.11	-4.06	5.68E-5	Schizophrenia	
THCA	cis	1	rs11535	chr2:233743532	KCNJ13	chr2:233630860-233641275:-	-0.13	-3.49	0.000519	Schizophrenia	
THCA	cis	1	rs11535	chr2:233743532	NGEF	chr2:233743396-233877951:-	-0.13	-3.35	0.00087	Schizophrenia	
THCA	cis	1	rs11538349	chr7:65421871	CCT6P1	chr7:65216092-65228661:+	0.38	6.08	2.41E-9	Diabetic kidney disease	
THCA	cis	1	rs11538349	chr7:65421871	CRCP	chr7:65579805-65619551:+	-0.27	-4.13	4.33E-5	Diabetic kidney disease	
THCA	cis	1	rs11538349	chr7:65421871	RABGEF1	chr7:66093890-66276446:+	0.54	6.85	2.3E-11	Diabetic kidney disease	
THCA	cis	1	rs11538549	chr1:27248283	ZDHHC18	chr1:27153201-27182207:+	0.75	7.77	4.97E-14	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs115396314	chr2:203721314	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.98	4.33E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs115396314	chr2:203721314	ICA1L	chr2:203637873-203736371:-	0.26	4.31	1.98E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs11541642	chr15:40683702	C15orf23	chr15:40674922-40686488:+	0.65	7.66	1.07E-13	Heschl's gyrus morphology	
THCA	cis	1	rs11541642	chr15:40683702	IVD	chr15:40697686-40713512:+	-0.59	-9.27	6.36E-19	Heschl's gyrus morphology	
THCA	cis	1	rs115418388	chr10:75976296	VCL	chr10:75754951-75879912:+	-0.18	-3.39	0.000751	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs11542372	chr8:145677089	KIFC2	chr8:145691738-145699498:+	-0.13	-3.97	8.36E-5	Age at first birth	
THCA	cis	1	rs11542372	chr8:145677089	LRRC14	chr8:145743391-145750557:+	0.18	5.11	4.66E-7	Age at first birth	
THCA	cis	1	rs11542372	chr8:145677089	RECQL4	chr8:145736672-145743200:-	0.16	3.57	0.000399	Age at first birth	
THCA	cis	1	rs11542372	chr8:145677089	ZNF34	chr8:145998503-146012725:-	0.15	3.81	0.000155	Age at first birth	
THCA	cis	1	rs11542436	chr17:61778689	FTSJ3	chr17:61896795-61905031:-	0.31	6.02	3.47E-9	Body mass index	
THCA	cis	1	rs11542436	chr17:61778689	MAP3K3	chr17:61699775-61773669:+	0.25	5.24	2.44E-7	Body mass index	
THCA	cis	1	rs1154435	chr4:100285148	ADH1C	chr4:100257651-100273917:-	-0.19	-3.56	0.000401	Oral cavity and pharyngeal cancer	
THCA	cis	1	rs1154510	chr12:122295335	WDR66	chr12:122356480-122441830:+	-0.23	-3.66	0.000281	Urinary metabolites	
THCA	cis	1	rs1154513	chr12:122391963	WDR66	chr12:122356480-122441830:+	-0.22	-3.6	0.00035	Urinary metabolites	
THCA	cis	1	rs11547772	chr4:99992793	ADH5	chr4:99992132-100009931:-	0.21	3.42	0.000678	Smoking initiation	
THCA	cis	1	rs115515961	chr18:51836253	POLI	chr18:51795849-51824602:+	0.18	5.24	2.41E-7	Psoriasis	
THCA	cis	1	rs11553387	chr20:47841660	CSE1L	chr20:47662838-47713484:+	-0.19	-3.34	0.000892	Height	
THCA	cis	1	rs11553387	chr20:47841660	DDX27	chr20:47835832-47860612:+	0.27	4.93	1.11E-6	Height	
THCA	cis	1	rs11553746	chr2:272203	SH3YL1	chr2:218138-264810:-	-0.95	-26.48	8.61E-96	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs11555809	chr1:27216669	ZDHHC18	chr1:27153201-27182207:+	0.77	8.03	7.82E-15	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs11557072	chr15:40713374	C15orf23	chr15:40674922-40686488:+	0.66	8.62	9.7E-17	Heschl's gyrus morphology	
THCA	cis	1	rs11557072	chr15:40713374	IVD	chr15:40697686-40713512:+	-0.57	-10.01	1.52E-21	Heschl's gyrus morphology	
THCA	cis	1	rs11562317	chr9:99568735	FAM22G	chr9:99690592-99704572:+	-0.92	-8.45	3.6E-16	Height	
THCA	cis	1	rs11562317	chr9:99568735	HIATL2	chr9:99695549-99775862:-	-0.67	-6.12	1.92E-9	Height	
THCA	cis	1	rs11562317	chr9:99568735	LOC441454	chr9:99671357-99672736:+	-0.39	-3.82	0.000152	Height	
THCA	cis	1	rs115630919	chr5:115505416	COMMD10	chr5:115420727-115628978:+	0.48	5.7	2.09E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs115634863	chr2:63328774	C2orf86	chr2:63348537-63815851:-	-0.24	-4.64	4.58E-6	Subjective well-being	
THCA	cis	1	rs115650067	chr3:184668515	C3orf70	chr3:184795840-184870802:-	-0.26	-4.96	9.92E-7	Heschl's gyrus morphology	
THCA	cis	1	rs115654617	chr2:203893999	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.72	1.86E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs115654617	chr2:203893999	ICA1L	chr2:203637873-203736371:-	0.27	4.48	9.19E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs115669892	chr2:190755706	ASNSD1	chr2:190526125-190535556:+	-0.55	-5.87	8.32E-9	Subcutaneous adipose tissue	
THCA	cis	1	rs115714635	chr1:200786230	DDX59	chr1:200610119-200639126:-	-0.26	-4	7.31E-5	Epilepsy	
THCA	cis	1	rs115743514	chr22:51011933	CHKB	chr22:51017378-51021428:-	0.52	6.31	6.2E-10	Narcolepsy	
THCA	cis	1	rs115743514	chr22:51011933	CPT1B	chr22:51007291-51017096:-	-0.41	-8.28	1.25E-15	Narcolepsy	
THCA	cis	1	rs11576866	chr1:10414432	KIF1B	chr1:10270764-10441659:+	0.2	6.03	3.38E-9	Hepatocellular carcinoma	
THCA	cis	1	rs115772301	chr1:27075684	ZDHHC18	chr1:27153201-27182207:+	0.8	8.68	6.18E-17	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs115779493	chr13:96300448	DZIP1	chr13:96229329-96296957:-	0.2	3.92	0.0001	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
THCA	cis	1	rs115779493	chr13:96300448	UGGT2	chr13:96453838-96705736:-	-0.24	-3.71	0.000229	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
THCA	cis	1	rs11578788	chr1:10422958	KIF1B	chr1:10270764-10441659:+	0.2	6.1	2.23E-9	Hepatocellular carcinoma	
THCA	cis	1	rs11579567	chr1:65957141	LEPR	chr1:65886318-66102820:+	0.28	3.99	7.59E-5	Obesity (early onset extreme)	
THCA	cis	1	rs11579634	chr1:46466391	CCDC163P	chr1:45960581-45965646:-	0.51	9.9	3.97E-21	Body mass index	
THCA	cis	1	rs11579634	chr1:46466391	GPBP1L1	chr1:46092978-46152302:-	-0.15	-3.75	0.0002	Body mass index	
THCA	cis	1	rs11579634	chr1:46466391	MMACHC	chr1:45965856-45976737:+	0.21	4.56	6.58E-6	Body mass index	
THCA	cis	1	rs11579634	chr1:46466391	MUTYH	chr1:45794915-45806142:-	-0.3	-8.01	8.6E-15	Body mass index	
THCA	cis	1	rs11579964	chr1:224538940	CNIH4	chr1:224544595-224567143:+	-0.23	-4.09	5.13E-5	Major depressive disorder	
THCA	cis	1	rs11580382	chr1:207418392	CD55	chr1:207494817-207534309:+	0.19	7.43	4.99E-13	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs11580387	chr1:207418408	CD55	chr1:207494817-207534309:+	0.19	7.47	3.96E-13	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs115808154	chr5:133464275	PHF15	chr5:133860066-133918918:+	-0.24	-3.43	0.000665	Systemic lupus erythematosus	
THCA	cis	1	rs1158097	chr13:78386375	EDNRB	chr13:78469616-78549664:-	0.14	4.06	5.67E-5	Hair color	
THCA	cis	1	rs115810193	chr2:203943168	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.68	2.35E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs115810193	chr2:203943168	ICA1L	chr2:203637873-203736371:-	0.28	4.61	5.22E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs11582249	chr1:207441608	CD55	chr1:207494817-207534309:+	0.19	7.52	2.67E-13	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs1158282	chr14:76172916	TTLL5	chr14:76127621-76421421:+	0.19	4.6	5.34E-6	Large artery stroke	
THCA	cis	1	rs11584921	chr1:207441975	CD55	chr1:207494817-207534309:+	0.19	7.31	1.17E-12	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs115852057	chr6:55983101	COL21A1	chr6:55921389-56258892:-	-0.67	-8.31	1.01E-15	Psychosis (atypical)	
THCA	cis	1	rs11588062	chr1:46779764	FAAH	chr1:46859939-46879520:+	0.16	5.47	7.1E-8	Age-related hearing impairment (interaction)	
THCA	cis	1	rs11588062	chr1:46779764	NSUN4	chr1:46806390-46830690:+	0.25	5.54	4.92E-8	Age-related hearing impairment (interaction)	
THCA	cis	1	rs11588170	chr1:152286032	FLG	chr1:152274651-152297679:-	0.28	4.04	6.24E-5	Atopic dermatitis	
THCA	cis	1	rs11588170	chr1:152286032	HRNR	chr1:152184558-152196669:-	-0.43	-5.6	3.58E-8	Atopic dermatitis	
THCA	cis	1	rs11588186	chr1:108306557	VAV3	chr1:108113782-108507545:-	0.53	7.2	2.42E-12	Hypothyroidism	
THCA	cis	1	rs115889150	chr2:207597807	MDH1B	chr2:207598943-207630050:-	0.47	5.97	4.7E-9	Episodic memory	
THCA	cis	1	rs11589562	chr1:46466721	CCDC163P	chr1:45960581-45965646:-	0.53	10.24	2.28E-22	Body mass index	
THCA	cis	1	rs11589562	chr1:46466721	GPBP1L1	chr1:46092978-46152302:-	-0.16	-4.03	6.46E-5	Body mass index	
THCA	cis	1	rs11589562	chr1:46466721	MMACHC	chr1:45965856-45976737:+	0.21	4.41	1.25E-5	Body mass index	
THCA	cis	1	rs11589562	chr1:46466721	MUTYH	chr1:45794915-45806142:-	-0.32	-8.47	3.0E-16	Body mass index	
THCA	cis	1	rs11590365	chr1:152165489	FLG	chr1:152274651-152297679:-	0.31	4.54	7.04E-6	Atopic dermatitis	
THCA	cis	1	rs11590365	chr1:152165489	HRNR	chr1:152184558-152196669:-	-0.43	-5.67	2.49E-8	Atopic dermatitis	
THCA	cis	1	rs11594111	chr10:14945406	DCLRE1C	chr10:14940229-14996094:-	-0.29	-4.03	6.53E-5	Migraine	
THCA	cis	1	rs115953525	chr2:203744445	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.93	5.93E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs115953525	chr2:203744445	ICA1L	chr2:203637873-203736371:-	0.25	4.18	3.49E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs11595684	chr10:38083804	LOC399744	chr10:38717074-38741080:+	0.28	3.69	0.000251	Obesity (extreme)	
THCA	cis	1	rs115965884	chr22:24594662	SUSD2	chr22:24577444-24585074:+	0.32	3.84	0.000141	Amyotrophic lateral sclerosis	
THCA	cis	1	rs115971514	chr11:116774499	PCSK7	chr11:117075789-117102811:-	0.44	5.3	1.74E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs115971798	chr7:87290865	DBF4	chr7:87505544-87538856:+	-0.3	-4.47	9.7E-6	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs11597286	chr10:38106455	LOC399744	chr10:38717074-38741080:+	0.31	4.27	2.34E-5	Obesity (extreme)	
THCA	cis	1	rs11597286	chr10:38106455	ZNF25	chr10:38238795-38265453:-	0.16	3.47	0.000575	Obesity (extreme)	
THCA	cis	1	rs11598044	chr10:38342693	LOC399744	chr10:38717074-38741080:+	0.28	3.74	0.000206	Obesity (extreme)	
THCA	cis	1	rs11598044	chr10:38342693	ZNF25	chr10:38238795-38265453:-	0.16	3.38	0.000772	Obesity (extreme)	
THCA	cis	1	rs11600716	chr11:59924422	MS4A14	chr11:60145958-60185226:+	0.16	4.16	3.78E-5	Alzheimer's disease (late onset)	
THCA	cis	1	rs11600990	chr11:64082807	PRDX5	chr11:64085569-64089282:+	-0.17	-4.17	3.68E-5	Mean platelet volume	
THCA	cis	1	rs11601161	chr11:78073280	NARS2	chr11:78147017-78285909:-	-0.4	-7.04	6.55E-12	Testicular germ cell tumor	
THCA	cis	1	rs11601196	chr11:78043431	NARS2	chr11:78147017-78285909:-	-0.39	-6.92	1.48E-11	Testicular germ cell tumor	
THCA	cis	1	rs11601590	chr11:78073288	NARS2	chr11:78147017-78285909:-	-0.4	-7.59	1.67E-13	Testicular germ cell tumor	
THCA	cis	1	rs11601872	chr11:64147627	GPR137	chr11:64037534-64056965:+	-0.16	-3.62	0.000323	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs11601872	chr11:64147627	VEGFB	chr11:64002266-64006258:+	-0.14	-3.4	0.000724	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs11602266	chr11:57094509	TIMM10	chr11:57295936-57298232:-	-0.23	-4.03	6.62E-5	Low high density lipoprotein cholesterol levels	
THCA	cis	1	rs11602622	chr11:78010830	NARS2	chr11:78147017-78285909:-	-0.35	-6.53	1.65E-10	Testicular germ cell tumor	
THCA	cis	1	rs11603112	chr11:78073491	NARS2	chr11:78147017-78285909:-	-0.39	-7.55	2.16E-13	Testicular germ cell tumor	
THCA	cis	1	rs11603160	chr11:72894273	ATG16L2	chr11:72525451-72554715:+	0.14	3.96	8.67E-5	Body mass index in asthmatics	
THCA	cis	1	rs116034011	chr4:106735622	INTS12	chr4:106603787-106629881:-	-0.61	-5.18	3.25E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11603691	chr11:57107617	TIMM10	chr11:57295936-57298232:-	-0.23	-4.01	7.14E-5	Low high density lipoprotein cholesterol levels	
THCA	cis	1	rs11604149	chr11:6519642	FXC1	chr11:6502677-6505910:+	-0.16	-4.39	1.38E-5	DNA methylation (variation)	
THCA	cis	1	rs11604149	chr11:6519642	TRIM3	chr11:6469844-6495689:-	0.16	3.94	9.28E-5	DNA methylation (variation)	
THCA	cis	1	rs11604876	chr11:46768041	ZNF408	chr11:46722368-46727461:+	-0.19	-3.66	0.000278	HDL cholesterol	
THCA	cis	1	rs11605774	chr11:47832793	C1QTNF4	chr11:47611216-47615961:-	-0.32	-5.4	1.03E-7	Subjective well-being	
THCA	cis	1	rs11606049	chr11:112033129	BCO2	chr11:112046208-112095421:+	0.24	4.79	2.27E-6	Interleukin-18 levels	
THCA	cis	1	rs11606049	chr11:112033129	IL18	chr11:112013976-112034840:-	-0.24	-4.63	4.75E-6	Interleukin-18 levels	
THCA	cis	1	rs11607950	chr11:57107361	TIMM10	chr11:57295936-57298232:-	-0.24	-4.25	2.54E-5	Low high density lipoprotein cholesterol levels	
THCA	cis	1	rs11608143	chr11:129693666	NFRKB	chr11:129733671-129765490:-	0.22	3.88	0.000118	Obesity-related traits	
THCA	cis	1	rs11609231	chr12:50932430	DIP2B	chr12:50898768-51142448:+	0.12	3.86	0.000131	Fibrinogen	
THCA	cis	1	rs11610324	chr12:22589577	KIAA0528	chr12:22601526-22697452:-	0.25	4.72	3.05E-6	Coronary artery calcification	
THCA	cis	1	rs11611246	chr12:939480	ERC1	chr12:1100404-1605099:+	0.11	3.37	0.000824	Body mass index	
THCA	cis	1	rs11611670	chr12:9385535	LOC642846	chr12:9436253-9466684:+	0.3	7.23	1.92E-12	Breast size	
THCA	cis	1	rs11613196	chr12:82173251	PPFIA2	chr12:81652880-82153109:-	-0.21	-3.95	9.0E-5	Resting heart rate	
THCA	cis	1	rs11613331	chr12:351467	CCDC77	chr12:498516-551804:+	-0.35	-6.25	9.1E-10	Blood metabolite ratios	
THCA	cis	1	rs116134049	chr5:115529655	COMMD10	chr5:115420727-115628978:+	0.48	5.7	2.09E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs11613879	chr12:48477577	C12orf54	chr12:48877023-48890165:+	-0.35	-3.47	0.000573	Prostate cancer	
THCA	cis	1	rs116139393	chr7:6771660	C7orf28B	chr7:6838572-6865861:-	-0.28	-3.48	0.000551	Alzheimer's disease (APOE e4 interaction)	
THCA	cis	1	rs116139393	chr7:6771660	PMS2CL	chr7:6749757-6793492:+	-0.47	-6.81	3.0E-11	Alzheimer's disease (APOE e4 interaction)	
THCA	cis	1	rs116196672	chr8:89359880	MMP16	chr8:89049462-89339717:-	0.32	4.95	1.04E-6	Electrodermal activity	
THCA	cis	1	rs11621587	chr14:93098339	RIN3	chr14:92980125-93155332:+	0.17	3.49	0.000521	Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs11622962	chr14:65299145	CHURC1	chr14:65381140-65411309:+	0.46	6.07	2.68E-9	Daytime sleep phenotypes	
THCA	cis	1	rs11623413	chr14:75588824	EIF2B2	chr14:75469612-75476292:+	-0.18	-4.84	1.77E-6	Height	
THCA	cis	1	rs11623413	chr14:75588824	MLH3	chr14:75480467-75518235:-	-0.29	-8.64	8.46E-17	Height	
THCA	cis	1	rs11623413	chr14:75588824	RPS6KL1	chr14:75372347-75389958:-	-0.32	-6.77	3.74E-11	Height	
THCA	cis	1	rs11624776	chr14:93595591	ITPK1	chr14:93403259-93582263:-	0.24	4.62	5.05E-6	Migraine;Thyroid hormone levels	
THCA	cis	1	rs11624776	chr14:93595591	MOAP1	chr14:93648543-93651249:-	-0.12	-3.41	0.000707	Migraine;Thyroid hormone levels	
THCA	cis	1	rs11627075	chr14:94972242	IFI27	chr14:94577079-94583033:+	-0.26	-3.4	0.000719	Obesity-related traits	
THCA	cis	1	rs11627441	chr14:93099234	RIN3	chr14:92980125-93155332:+	0.17	3.5	0.000501	Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs11628710	chr14:74649280	C14orf45	chr14:74486059-74549566:+	0.16	4.61	5.17E-6	Common traits (Other)	
THCA	cis	1	rs11628710	chr14:74649280	COQ6	chr14:74416643-74429811:+	0.14	3.92	0.000102	Common traits (Other)	
THCA	cis	1	rs11628710	chr14:74649280	LIN52	chr14:74551656-74667117:+	0.51	13.49	2.36E-35	Common traits (Other)	
THCA	cis	1	rs11629596	chr15:62370113	VPS13C	chr15:62144592-62352647:-	-0.11	-4.01	7.08E-5	Height	
THCA	cis	1	rs11629674	chr15:56469583	MNS1	chr15:56720929-56757335:-	-0.25	-3.58	0.000385	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11629674	chr15:56469583	TEX9	chr15:56657644-56738071:+	-0.35	-5.99	4.06E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs116300850	chr5:76852234	WDR41	chr5:76728069-76788332:-	0.33	4.95	1.03E-6	Alzheimer disease and age of onset	
THCA	cis	1	rs11630417	chr15:68012609	C15orf61	chr15:67813522-67819638:+	0.12	3.38	0.000791	Motion sickness	
THCA	cis	1	rs11630417	chr15:68012609	IQCH	chr15:67547188-67794139:+	0.17	5.24	2.46E-7	Motion sickness	
THCA	cis	1	rs11630417	chr15:68012609	MAP2K5	chr15:67835021-68099451:+	0.14	3.48	0.000539	Motion sickness	
THCA	cis	1	rs11631518	chr15:56441360	MNS1	chr15:56720929-56757335:-	-0.24	-3.5	0.000508	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11631518	chr15:56441360	TEX9	chr15:56657644-56738071:+	-0.34	-5.95	5.15E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs116318787	chr2:45641826	SRBD1	chr2:45615820-45838433:-	-0.38	-4.11	4.75E-5	Glaucoma	
THCA	cis	1	rs11631910	chr15:56524096	MNS1	chr15:56720929-56757335:-	-0.24	-3.51	0.000485	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11631910	chr15:56524096	TEX9	chr15:56657644-56738071:+	-0.34	-5.81	1.12E-8	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11631963	chr15:83318202	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.13	4.12	4.5E-5	Schizophrenia	
THCA	cis	1	rs11632023	chr15:56457442	MNS1	chr15:56720929-56757335:-	-0.24	-3.54	0.00044	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11632023	chr15:56457442	TEX9	chr15:56657644-56738071:+	-0.35	-5.99	4.11E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11632081	chr15:56524268	MNS1	chr15:56720929-56757335:-	-0.24	-3.51	0.000485	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11632081	chr15:56524268	TEX9	chr15:56657644-56738071:+	-0.34	-5.81	1.12E-8	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11632087	chr15:56524307	MNS1	chr15:56720929-56757335:-	-0.24	-3.51	0.000485	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11632087	chr15:56524307	TEX9	chr15:56657644-56738071:+	-0.34	-5.81	1.12E-8	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11632310	chr15:65882326	DPP8	chr15:65737999-65810035:-	-0.08	-3.59	0.000369	Mean corpuscular hemoglobin	
THCA	cis	1	rs11632310	chr15:65882326	SLC24A1	chr15:65903704-65953256:+	-0.15	-3.77	0.000186	Mean corpuscular hemoglobin	
THCA	cis	1	rs11632394	chr15:56511949	MNS1	chr15:56720929-56757335:-	-0.23	-3.41	0.000699	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11632394	chr15:56511949	TEX9	chr15:56657644-56738071:+	-0.34	-5.84	9.5E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11632465	chr15:85282045	GOLGA6L5	chr15:85047738-85060078:-	-0.15	-3.88	0.00012	Schizophrenia	
THCA	cis	1	rs11632465	chr15:85282045	LOC388152	chr15:84867600-84898920:-	-0.47	-8	9.7E-15	Schizophrenia	
THCA	cis	1	rs11632465	chr15:85282045	NMB	chr15:85198362-85201802:-	0.36	7.73	6.62E-14	Schizophrenia	
THCA	cis	1	rs11632619	chr15:56508995	MNS1	chr15:56720929-56757335:-	-0.23	-3.41	0.000699	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11632619	chr15:56508995	TEX9	chr15:56657644-56738071:+	-0.34	-5.84	9.5E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11633301	chr15:84585038	LOC388152	chr15:84867600-84898920:-	0.2	3.73	0.000211	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs11633500	chr15:62372475	VPS13C	chr15:62144592-62352647:-	-0.1	-3.82	0.000149	Height	
THCA	cis	1	rs11633958	chr15:78862064	CHRNA5	chr15:78857906-78886458:+	-0.43	-8.38	5.96E-16	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs11634404	chr15:56413388	MNS1	chr15:56720929-56757335:-	-0.25	-3.63	0.000317	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11634404	chr15:56413388	TEX9	chr15:56657644-56738071:+	-0.35	-6.11	2.04E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11634455	chr15:56490549	TEX9	chr15:56657644-56738071:+	-0.34	-5.88	7.84E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11634689	chr15:56516920	MNS1	chr15:56720929-56757335:-	-0.24	-3.5	0.000514	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11634689	chr15:56516920	TEX9	chr15:56657644-56738071:+	-0.34	-5.75	1.58E-8	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11634746	chr15:50941496	ATP8B4	chr15:50150436-50411419:-	-0.11	-3.36	0.000854	QT interval	
THCA	cis	1	rs11634746	chr15:50941496	SPPL2A	chr15:50999739-51057910:-	0.27	7.3	1.2E-12	QT interval	
THCA	cis	1	rs11634746	chr15:50941496	TRPM7	chr15:50852491-50978994:-	0.11	3.44	0.000641	QT interval	
THCA	cis	1	rs11634793	chr15:67447452	SMAD3	chr15:67358195-67487532:+	0.16	4	7.2E-5	Asthma	
THCA	cis	1	rs11635977	chr15:62370484	VPS13C	chr15:62144592-62352647:-	-0.11	-3.96	8.71E-5	Height	
THCA	cis	1	rs11636040	chr15:56439202	MNS1	chr15:56720929-56757335:-	-0.25	-3.61	0.000334	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11636040	chr15:56439202	TEX9	chr15:56657644-56738071:+	-0.35	-6	3.94E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11636148	chr15:65796880	DPP8	chr15:65737999-65810035:-	0.09	3.74	0.000204	Mean corpuscular hemoglobin	
THCA	cis	1	rs11636148	chr15:65796880	SLC24A1	chr15:65903704-65953256:+	0.15	3.66	0.000282	Mean corpuscular hemoglobin	
THCA	cis	1	rs11636964	chr15:50899616	SPPL2A	chr15:50999739-51057910:-	0.26	7.03	7.33E-12	QT interval	
THCA	cis	1	rs11637027	chr15:67937755	IQCH	chr15:67547188-67794139:+	0.18	5.42	9.43E-8	Motion sickness	
THCA	cis	1	rs11637027	chr15:67937755	MAP2K5	chr15:67835021-68099451:+	0.16	3.85	0.000134	Motion sickness	
THCA	cis	1	rs11637142	chr15:85295927	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-3.75	0.0002	Schizophrenia	
THCA	cis	1	rs11637142	chr15:85295927	LOC388152	chr15:84867600-84898920:-	-0.47	-7.95	1.35E-14	Schizophrenia	
THCA	cis	1	rs11637142	chr15:85295927	NMB	chr15:85198362-85201802:-	0.36	7.69	8.22E-14	Schizophrenia	
THCA	cis	1	rs11637228	chr15:50899972	SPPL2A	chr15:50999739-51057910:-	0.26	7.03	7.33E-12	QT interval	
THCA	cis	1	rs11637431	chr15:65882251	DPP8	chr15:65737999-65810035:-	-0.09	-3.67	0.000269	Mean corpuscular hemoglobin	
THCA	cis	1	rs11637431	chr15:65882251	SLC24A1	chr15:65903704-65953256:+	-0.16	-3.84	0.000139	Mean corpuscular hemoglobin	
THCA	cis	1	rs11637433	chr15:83321336	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.13	4.2	3.15E-5	Schizophrenia	
THCA	cis	1	rs11637515	chr15:56511683	MNS1	chr15:56720929-56757335:-	-0.23	-3.41	0.000699	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11637515	chr15:56511683	TEX9	chr15:56657644-56738071:+	-0.34	-5.84	9.5E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11637866	chr15:84587958	LOC388152	chr15:84867600-84898920:-	-0.21	-3.98	7.86E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs11637998	chr15:56516133	MNS1	chr15:56720929-56757335:-	-0.24	-3.45	0.00061	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11637998	chr15:56516133	TEX9	chr15:56657644-56738071:+	-0.34	-5.73	1.74E-8	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs116382857	chr2:203751932	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.93	5.93E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs116382857	chr2:203751932	ICA1L	chr2:203637873-203736371:-	0.25	4.18	3.49E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs11638290	chr15:85227636	GOLGA6L5	chr15:85047738-85060078:-	-0.15	-3.9	0.000108	Schizophrenia	
THCA	cis	1	rs11638290	chr15:85227636	LOC388152	chr15:84867600-84898920:-	-0.49	-8.22	1.95E-15	Schizophrenia	
THCA	cis	1	rs11638290	chr15:85227636	NMB	chr15:85198362-85201802:-	0.37	7.73	6.55E-14	Schizophrenia	
THCA	cis	1	rs11638297	chr15:84782417	GOLGA6L5	chr15:85047738-85060078:-	-0.2	-5.09	5.03E-7	Schizophrenia	
THCA	cis	1	rs11638297	chr15:84782417	LOC388152	chr15:84867600-84898920:-	-0.71	-12.84	1.3E-32	Schizophrenia	
THCA	cis	1	rs11638297	chr15:84782417	NMB	chr15:85198362-85201802:-	0.23	4.54	7.09E-6	Schizophrenia	
THCA	cis	1	rs11638297	chr15:84782417	SH3GL3	chr15:84116091-84287491:+	0.23	3.66	0.00028	Schizophrenia	
THCA	cis	1	rs11638394	chr15:84778928	GOLGA6L5	chr15:85047738-85060078:-	-0.21	-5.43	8.9E-8	Schizophrenia	
THCA	cis	1	rs11638394	chr15:84778928	LOC388152	chr15:84867600-84898920:-	-0.72	-13.06	1.57E-33	Schizophrenia	
THCA	cis	1	rs11638394	chr15:84778928	NMB	chr15:85198362-85201802:-	0.24	4.76	2.54E-6	Schizophrenia	
THCA	cis	1	rs11638394	chr15:84778928	SH3GL3	chr15:84116091-84287491:+	0.24	3.75	0.000201	Schizophrenia	
THCA	cis	1	rs11638709	chr15:56493724	TEX9	chr15:56657644-56738071:+	-0.34	-5.88	7.84E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11638815	chr15:83352282	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.18	4.88	1.44E-6	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy	
THCA	cis	1	rs11638818	chr15:89119711	DET1	chr15:89054788-89089912:-	-0.25	-4.4	1.33E-5	Thyroid hormone levels	
THCA	cis	1	rs116397649	chr5:115506021	COMMD10	chr5:115420727-115628978:+	0.48	5.7	2.09E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs11641521	chr16:69823081	COG4	chr16:70514473-70557457:-	-0.19	-3.93	9.85E-5	IgE levels	
THCA	cis	1	rs11641566	chr16:58835180	GOT2	chr16:58741035-58768246:-	-0.27	-7.59	1.64E-13	Blood metabolite ratios	
THCA	cis	1	rs11641566	chr16:58835180	SLC38A7	chr16:58700298-58718674:-	-0.15	-5.15	3.83E-7	Blood metabolite ratios	
THCA	cis	1	rs11641836	chr16:58832047	GOT2	chr16:58741035-58768246:-	-0.24	-6.77	3.9E-11	Blood metabolite ratios	
THCA	cis	1	rs11641836	chr16:58832047	SLC38A7	chr16:58700298-58718674:-	-0.15	-5.3	1.75E-7	Blood metabolite ratios	
THCA	cis	1	rs11642568	chr16:20405191	ACSM1	chr16:20634559-20709066:-	0.26	3.43	0.000649	Urinary uromodulin levels	
THCA	cis	1	rs11643134	chr16:27242880	JMJD5	chr16:27214807-27233089:+	-0.18	-3.77	0.000187	Night sleep phenotypes	
THCA	cis	1	rs116434420	chr5:115582971	COMMD10	chr5:115420727-115628978:+	0.48	5.7	2.09E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs11644601	chr16:15172118	NTAN1	chr16:15131717-15149833:-	-0.18	-4.8	2.1E-6	Metabolite levels (lipid measures)	
THCA	cis	1	rs11644601	chr16:15172118	PDXDC1	chr16:15068599-15233195:+	-0.28	-5.88	7.64E-9	Metabolite levels (lipid measures)	
THCA	cis	1	rs11644836	chr16:79712655	MAF	chr16:79627746-79634622:-	-0.23	-3.78	0.000177	Urate levels	
THCA	cis	1	rs11644838	chr16:69812705	COG4	chr16:70514473-70557457:-	-0.19	-3.94	9.44E-5	IgE levels	
THCA	cis	1	rs11644891	chr16:58833825	GOT2	chr16:58741035-58768246:-	-0.27	-7.59	1.64E-13	Blood metabolite ratios	
THCA	cis	1	rs11644891	chr16:58833825	SLC38A7	chr16:58700298-58718674:-	-0.15	-5.15	3.83E-7	Blood metabolite ratios	
THCA	cis	1	rs11645002	chr16:20617841	ACSM1	chr16:20634559-20709066:-	0.69	9.72	1.71E-20	Urinary metabolites	
THCA	cis	1	rs11645002	chr16:20617841	ACSM3	chr16:20775312-20808478:+	-0.28	-3.68	0.000255	Urinary metabolites	
THCA	cis	1	rs11646919	chr16:20400969	ACSM1	chr16:20634559-20709066:-	0.26	3.4	0.000735	Urinary uromodulin levels	
THCA	cis	1	rs11647946	chr16:4462836	C16orf5	chr16:4560679-4588816:-	0.23	5.63	3.11E-8	Schizophrenia	
THCA	cis	1	rs11648514	chr16:58832080	GOT2	chr16:58741035-58768246:-	-0.27	-7.59	1.64E-13	Blood metabolite ratios	
THCA	cis	1	rs11648514	chr16:58832080	SLC38A7	chr16:58700298-58718674:-	-0.15	-5.15	3.83E-7	Blood metabolite ratios	
THCA	cis	1	rs11650372	chr17:45721795	TBKBP1	chr17:45772630-45789427:+	-0.38	-10.74	3.05E-24	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
THCA	cis	1	rs116508643	chr1:66017718	LEPR	chr1:65886318-66102820:+	-0.29	-4.1	4.81E-5	Obesity (early onset extreme)	
THCA	cis	1	rs11651264	chr17:79576394	ARL16	chr17:79648234-79650954:-	0.12	3.39	0.000748	Eye color traits	
THCA	cis	1	rs11651264	chr17:79576394	TSPAN10	chr17:79609349-79615778:+	-0.8	-17.82	7.47E-55	Eye color traits	
THCA	cis	1	rs11652797	chr17:79574124	ARL16	chr17:79648234-79650954:-	-0.12	-3.4	0.000738	Eye color traits	
THCA	cis	1	rs11652797	chr17:79574124	TSPAN10	chr17:79609349-79615778:+	0.8	17.83	6.91E-55	Eye color traits	
THCA	cis	1	rs11654335	chr17:61797579	FTSJ3	chr17:61896795-61905031:-	0.3	5.78	1.32E-8	Body mass index	
THCA	cis	1	rs11654335	chr17:61797579	MAP3K3	chr17:61699775-61773669:+	0.26	5.37	1.26E-7	Body mass index	
THCA	cis	1	rs11654553	chr17:17462149	ATPAF2	chr17:17918373-17942480:-	-0.23	-3.94	9.2E-5	Obsessive-compulsive symptoms	
THCA	cis	1	rs11654777	chr17:17462630	ATPAF2	chr17:17918373-17942480:-	-0.23	-3.94	9.2E-5	Obsessive-compulsive symptoms	
THCA	cis	1	rs116551361	chr6:24483512	GPLD1	chr6:24428405-24489850:-	0.2	3.75	0.0002	Hematological and biochemical traits	
THCA	cis	1	rs116551361	chr6:24483512	MRS2	chr6:24403153-24425809:+	0.24	5.35	1.35E-7	Hematological and biochemical traits	
THCA	cis	1	rs11656769	chr17:17599850	ATPAF2	chr17:17918373-17942480:-	-0.25	-3.93	9.66E-5	Obsessive-compulsive symptoms	
THCA	cis	1	rs11657081	chr17:61792339	FTSJ3	chr17:61896795-61905031:-	0.31	5.88	7.61E-9	Body mass index	
THCA	cis	1	rs11657081	chr17:61792339	MAP3K3	chr17:61699775-61773669:+	0.26	5.39	1.12E-7	Body mass index	
THCA	cis	1	rs11657120	chr17:61857218	FTSJ3	chr17:61896795-61905031:-	0.3	5.77	1.4E-8	Body mass index	
THCA	cis	1	rs11657120	chr17:61857218	MAP3K3	chr17:61699775-61773669:+	0.26	5.4	1.03E-7	Body mass index	
THCA	cis	1	rs11657306	chr17:61704822	FTSJ3	chr17:61896795-61905031:-	0.29	5.63	3.04E-8	Body mass index	
THCA	cis	1	rs11657306	chr17:61704822	MAP3K3	chr17:61699775-61773669:+	0.25	5.14	4.08E-7	Body mass index	
THCA	cis	1	rs11657371	chr17:46843873	CALCOCO2	chr17:46908372-46942228:+	-0.13	-3.5	0.000501	Schizophrenia or bipolar disorder	
THCA	cis	1	rs11657371	chr17:46843873	SNF8	chr17:47007461-47022154:-	-0.25	-7.39	6.82E-13	Schizophrenia or bipolar disorder	
THCA	cis	1	rs11657371	chr17:46843873	UBE2Z	chr17:46985767-47006422:+	-0.19	-4.01	6.91E-5	Schizophrenia or bipolar disorder	
THCA	cis	1	rs11657636	chr17:2053920	SRR	chr17:2207248-2228553:+	-0.39	-6.63	9.09E-11	Bone mineral density	
THCA	cis	1	rs11657678	chr17:17424303	ATPAF2	chr17:17918373-17942480:-	-0.24	-3.49	0.000532	Obsessive-compulsive symptoms	
THCA	cis	1	rs11658168	chr17:7406134	CHRNB1	chr17:7348406-7360931:+	0.19	3.86	0.00013	Height	
THCA	cis	1	rs11658175	chr17:61923838	FTSJ3	chr17:61896795-61905031:-	0.29	5.5	6.18E-8	Body mass index	
THCA	cis	1	rs11658175	chr17:61923838	MAP3K3	chr17:61699775-61773669:+	0.25	5.13	4.29E-7	Body mass index	
THCA	cis	1	rs11658311	chr17:17470526	ATPAF2	chr17:17918373-17942480:-	-0.24	-4.09	5.05E-5	Obsessive-compulsive symptoms	
THCA	cis	1	rs11658329	chr17:61763031	FTSJ3	chr17:61896795-61905031:-	-0.31	-5.96	4.91E-9	Body mass index	
THCA	cis	1	rs11658329	chr17:61763031	MAP3K3	chr17:61699775-61773669:+	-0.25	-5.03	7.01E-7	Body mass index	
THCA	cis	1	rs11658555	chr17:18817486	FAM18B	chr17:18684582-18710026:+	0.31	7.06	6.01E-12	Pancreatic cancer	
THCA	cis	1	rs11658740	chr17:61751069	FTSJ3	chr17:61896795-61905031:-	0.32	6.2	1.23E-9	Body mass index	
THCA	cis	1	rs11658740	chr17:61751069	MAP3K3	chr17:61699775-61773669:+	0.28	5.82	1.05E-8	Body mass index	
THCA	cis	1	rs11658944	chr17:17425279	ATPAF2	chr17:17918373-17942480:-	-0.23	-3.39	0.000755	Obsessive-compulsive symptoms	
THCA	cis	1	rs116597701	chr11:116811487	PCSK7	chr11:117075789-117102811:-	0.46	5.6	3.67E-8	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs116616340	chr3:53132371	RFT1	chr3:53122503-53164470:-	0.61	7.4	6.29E-13	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs11662721	chr18:19261413	ABHD3	chr18:19230858-19284766:-	-0.21	-4.44	1.12E-5	Phospholipid levels (plasma)	
THCA	cis	1	rs11662840	chr18:19261864	ABHD3	chr18:19230858-19284766:-	-0.21	-4.34	1.74E-5	Phospholipid levels (plasma)	
THCA	cis	1	rs11663558	chr18:21133937	NPC1	chr18:21108363-21166581:-	0.14	4.7	3.43E-6	Body mass index	
THCA	cis	1	rs116648076	chr2:99882347	LIPT1	chr2:99771418-99779611:+	0.2	3.88	0.000117	IgG glycosylation	
THCA	cis	1	rs11665924	chr19:44286982	LYPD5	chr19:44300080-44324808:-	-0.24	-5.14	4.09E-7	Breast cancer	
THCA	cis	1	rs11665924	chr19:44286982	ZNF155	chr19:44488355-44502477:+	-0.25	-5.63	3.14E-8	Breast cancer	
THCA	cis	1	rs11665924	chr19:44286982	ZNF404	chr19:44376516-44384288:-	-0.26	-6.79	3.4E-11	Breast cancer	
THCA	cis	1	rs11666415	chr19:24228512	LOC100101266	chr19:24344995-24346249:-	0.37	6.19	1.27E-9	Response to taxane treatment (placlitaxel)	
THCA	cis	1	rs11667192	chr19:9975970	ZNF266	chr19:9523272-9546234:-	-0.17	-4.05	5.93E-5	Sleep duration	
THCA	cis	1	rs11667192	chr19:9975970	ZNF846	chr19:9862816-9879410:-	0.22	4.11	4.56E-5	Sleep duration	
THCA	cis	1	rs116678869	chr2:203819471	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.69	2.21E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs116678869	chr2:203819471	ICA1L	chr2:203637873-203736371:-	0.27	4.48	9.33E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs11668269	chr19:22513960	ZNF492	chr19:22817126-22850472:+	0.22	3.96	8.52E-5	Telomere length	
THCA	cis	1	rs11668269	chr19:22513960	ZNF98	chr19:22573899-22605148:-	0.4	9.37	2.94E-19	Telomere length	
THCA	cis	1	rs11669175	chr19:44289824	LYPD5	chr19:44300080-44324808:-	-0.24	-5.01	7.69E-7	Breast cancer	
THCA	cis	1	rs11669175	chr19:44289824	ZNF155	chr19:44488355-44502477:+	-0.25	-5.62	3.23E-8	Breast cancer	
THCA	cis	1	rs11669175	chr19:44289824	ZNF404	chr19:44376516-44384288:-	-0.26	-6.77	3.83E-11	Breast cancer	
THCA	cis	1	rs11669385	chr19:52571952	ZNF432	chr19:52536678-52552073:-	-0.18	-4.57	6.14E-6	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	
THCA	cis	1	rs11669540	chr19:52549739	ZNF432	chr19:52536678-52552073:-	-0.18	-4.57	6.14E-6	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	
THCA	cis	1	rs11670668	chr19:41920454	B3GNT8	chr19:41931265-41934635:-	-0.35	-8.18	2.68E-15	Height	
THCA	cis	1	rs11670757	chr19:41913431	B3GNT8	chr19:41931265-41934635:-	-0.36	-8.47	3.13E-16	Height	
THCA	cis	1	rs11671653	chr19:10838486	SLC44A2	chr19:10713121-10755234:+	-0.3	-3.4	0.000743	LDL cholesterol	
THCA	cis	1	rs11673286	chr19:52540318	ZNF432	chr19:52536678-52552073:-	-0.18	-4.51	8.12E-6	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	
THCA	cis	1	rs1167411	chr7:65539264	ASL	chr7:65540776-65558321:+	0.2	4.97	9.39E-7	Aortic root size	
THCA	cis	1	rs1167411	chr7:65539264	GUSB	chr7:65425675-65447246:-	-0.28	-5.22	2.74E-7	Aortic root size	
THCA	cis	1	rs1167411	chr7:65539264	RABGEF1	chr7:66093890-66276446:+	-0.64	-12.99	2.95E-33	Aortic root size	
THCA	cis	1	rs11674602	chr2:73723185	ALMS1P	chr2:73872046-73912692:+	0.73	11.26	3.08E-26	Metabolite levels	
THCA	cis	1	rs11674602	chr2:73723185	NAT8	chr2:73867850-73869537:-	0.4	6.18	1.37E-9	Metabolite levels	
THCA	cis	1	rs11674838	chr2:218274700	DIRC3	chr2:218148748-218621316:-	0.22	5.17	3.52E-7	Height	
THCA	cis	1	rs1167612	chr7:65567976	ASL	chr7:65540776-65558321:+	0.17	4.33	1.78E-5	Aortic root size	
THCA	cis	1	rs1167612	chr7:65567976	GUSB	chr7:65425675-65447246:-	-0.28	-5.27	2.03E-7	Aortic root size	
THCA	cis	1	rs1167612	chr7:65567976	LOC729156	chr7:66274980-66309813:-	-0.16	-3.41	0.000697	Aortic root size	
THCA	cis	1	rs1167612	chr7:65567976	RABGEF1	chr7:66093890-66276446:+	-0.65	-13.57	1.05E-35	Aortic root size	
THCA	cis	1	rs1167613	chr7:65487439	CCT6P1	chr7:65216092-65228661:+	0.39	6.3	6.96E-10	Diabetic kidney disease	
THCA	cis	1	rs1167613	chr7:65487439	CRCP	chr7:65579805-65619551:+	-0.29	-4.43	1.16E-5	Diabetic kidney disease	
THCA	cis	1	rs1167613	chr7:65487439	RABGEF1	chr7:66093890-66276446:+	0.55	6.85	2.32E-11	Diabetic kidney disease	
THCA	cis	1	rs11676903	chr2:9763201	IAH1	chr2:9614670-9636671:+	0.17	3.56	0.000407	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	
THCA	cis	1	rs1167725	chr12:120968559	COQ5	chr12:120941083-120966964:-	0.14	3.48	0.000551	Type 1 diabetes nephropathy	
THCA	cis	1	rs1167725	chr12:120968559	POP5	chr12:121016849-121019201:-	-0.16	-4.95	1.05E-6	Type 1 diabetes nephropathy	
THCA	cis	1	rs1167726	chr12:120967364	POP5	chr12:121016849-121019201:-	0.16	4.83	1.83E-6	Type 1 diabetes nephropathy	
THCA	cis	1	rs1167726	chr12:120967364	RNF10	chr12:120972132-121015396:+	-0.2	-3.37	0.000805	Type 1 diabetes nephropathy	
THCA	cis	1	rs1167727	chr12:120965508	COQ5	chr12:120941083-120966964:-	0.14	3.54	0.000444	Type 1 diabetes nephropathy	
THCA	cis	1	rs1167727	chr12:120965508	POP5	chr12:121016849-121019201:-	-0.16	-4.97	9.55E-7	Type 1 diabetes nephropathy	
THCA	cis	1	rs1167727	chr12:120965508	RNF10	chr12:120972132-121015396:+	0.21	3.51	0.000499	Type 1 diabetes nephropathy	
THCA	cis	1	rs11678157	chr2:26321526	GPR113	chr2:26531041-26569685:-	-0.42	-6.81	2.95E-11	Gut microbiome composition (summer)	
THCA	cis	1	rs116781589	chr11:71825006	FAM86C	chr11:71498557-71512276:+	-0.32	-3.91	0.000107	Severe influenza A (H1N1) infection	
THCA	cis	1	rs1167827	chr7:75163169	PMS2L3	chr7:75137070-75157418:-	-0.36	-8.34	8.28E-16	Body mass index	
THCA	cis	1	rs1167827	chr7:75163169	POM121C	chr7:75046066-75115568:-	-0.18	-4.29	2.12E-5	Body mass index	
THCA	cis	1	rs1167827	chr7:75163169	SPDYE5	chr7:75124299-75133627:+	0.24	4.73	2.9E-6	Body mass index	
THCA	cis	1	rs1167827	chr7:75163169	STAG3L1	chr7:74988447-75026250:+	-0.29	-5.67	2.44E-8	Body mass index	
THCA	cis	1	rs116795182	chr5:76852236	WDR41	chr5:76728069-76788332:-	0.33	4.95	1.03E-6	Alzheimer disease and age of onset	
THCA	cis	1	rs11681299	chr2:88901732	RPIA	chr2:88991176-89050451:+	0.35	6.59	1.14E-10	Height	
THCA	cis	1	rs11681497	chr2:242344333	SEPT2	chr2:242254723-242293439:+	1.04	22.02	1.08E-74	Chronic lymphocytic leukemia	
THCA	cis	1	rs116828138	chr12:62503431	FAM19A2	chr12:62102043-62653925:-	-0.15	-3.34	0.000892	Post bronchodilator FEV1/FVC ratio in COPD	
THCA	cis	1	rs11686072	chr2:227777493	COL4A4	chr2:227867435-228029275:-	0.15	3.79	0.00017	Pulmonary function	
THCA	cis	1	rs11688129	chr2:28952581	PPP1CB	chr2:28974612-29025805:+	-0.17	-4.16	3.82E-5	Body mass index	
THCA	cis	1	rs11688129	chr2:28952581	TRMT61B	chr2:29072690-29093175:-	0.51	10.21	2.93E-22	Body mass index	
THCA	cis	1	rs11689392	chr2:73622026	ALMS1P	chr2:73872046-73912692:+	0.69	10.95	4.74E-25	Metabolite levels	
THCA	cis	1	rs11689392	chr2:73622026	NAT8	chr2:73867850-73869537:-	0.37	5.77	1.42E-8	Metabolite levels	
THCA	cis	1	rs11689392	chr2:73622026	TPRKB	chr2:73956957-73964517:-	-0.16	-4.13	4.25E-5	Metabolite levels	
THCA	cis	1	rs116894096	chr7:107178477	DLD	chr7:107531586-107561642:+	0.14	3.54	0.000443	Osteoarthritis	
THCA	cis	1	rs11690423	chr2:28951537	PPP1CB	chr2:28974612-29025805:+	-0.17	-4.27	2.36E-5	Body mass index	
THCA	cis	1	rs11690423	chr2:28951537	TRMT61B	chr2:29072690-29093175:-	0.5	10.03	1.28E-21	Body mass index	
THCA	cis	1	rs11692112	chr2:9723732	IAH1	chr2:9614670-9636671:+	0.16	3.42	0.000689	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	
THCA	cis	1	rs11692572	chr2:227774503	COL4A4	chr2:227867435-228029275:-	0.16	3.97	8.27E-5	Pulmonary function	
THCA	cis	1	rs11695244	chr2:242176706	FARP2	chr2:242295711-242434255:+	0.26	5.61	3.51E-8	Chronic lymphocytic leukemia	
THCA	cis	1	rs11695244	chr2:242176706	SEPT2	chr2:242254723-242293439:+	-0.24	-4.64	4.41E-6	Chronic lymphocytic leukemia	
THCA	cis	1	rs11696396	chr20:47753019	ARFGEF2	chr20:47538275-47653229:+	-0.12	-3.83	0.000145	Anger	
THCA	cis	1	rs11696396	chr20:47753019	CSE1L	chr20:47662838-47713484:+	0.41	10.13	5.59E-22	Anger	
THCA	cis	1	rs11696501	chr20:44124523	WFDC3	chr20:44402847-44420547:-	0.37	6.01	3.74E-9	Brain structure	
THCA	cis	1	rs11696845	chr20:43371320	KCNK15	chr20:43374488-43379666:+	0.18	3.87	0.000125	Obesity-related traits	
THCA	cis	1	rs11696870	chr20:47725607	ARFGEF2	chr20:47538275-47653229:+	-0.13	-4.09	5.13E-5	Anger	
THCA	cis	1	rs11696870	chr20:47725607	CSE1L	chr20:47662838-47713484:+	0.41	10.23	2.32E-22	Anger	
THCA	cis	1	rs116988415	chr14:65292145	CHURC1	chr14:65381140-65411309:+	0.47	6.11	2.01E-9	Daytime sleep phenotypes	
THCA	cis	1	rs11699251	chr20:16456295	KIF16B	chr20:16252749-16554078:-	-0.16	-3.74	0.000204	Intelligence	
THCA	cis	1	rs11699551	chr20:55087964	C20orf43	chr20:55043647-55093942:+	0.28	7.43	5.21E-13	Refractive astigmatism	
THCA	cis	1	rs11699551	chr20:55087964	CSTF1	chr20:54967427-54979582:+	0.17	3.6	0.000349	Refractive astigmatism	
THCA	cis	1	rs116995979	chr15:56524043	MNS1	chr15:56720929-56757335:-	-0.24	-3.51	0.000485	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs116995979	chr15:56524043	TEX9	chr15:56657644-56738071:+	-0.34	-5.81	1.12E-8	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11699883	chr20:55087041	C20orf43	chr20:55043647-55093942:+	0.29	7.49	3.39E-13	Refractive astigmatism	
THCA	cis	1	rs11701091	chr21:33920244	TCP10L	chr21:33947152-33957845:-	-0.53	-9.44	1.62E-19	Gastritis	
THCA	cis	1	rs11701627	chr21:33927794	TCP10L	chr21:33947152-33957845:-	-0.5	-9.18	1.32E-18	Gastritis	
THCA	cis	1	rs11703032	chr22:34337383	LARGE	chr22:33669063-34318584:-	0.47	7.31	1.13E-12	Educational attainment (years of education)	
THCA	cis	1	rs117031571	chr15:84572654	GOLGA6L5	chr15:85047738-85060078:-	-0.11	-3.36	0.000834	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs117031571	chr15:84572654	LOC388152	chr15:84867600-84898920:-	-0.21	-4	7.46E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs11703808	chr22:32024980	SFI1	chr22:31892261-32014533:+	0.15	3.58	0.000382	Intelligence	
THCA	cis	1	rs11703914	chr22:24767602	GGT5	chr22:24615623-24641110:-	-0.2	-4.1	4.94E-5	Gut microbiome composition (summer)	
THCA	cis	1	rs11703914	chr22:24767602	POM121L9P	chr22:24647589-24661490:+	-0.39	-8.69	5.69E-17	Gut microbiome composition (summer)	
THCA	cis	1	rs11704021	chr22:39074716	JOSD1	chr22:39081549-39096459:-	-0.15	-3.87	0.000125	Resting heart rate	
THCA	cis	1	rs11704021	chr22:39074716	LOC646851	chr22:38974125-39052634:-	0.13	3.44	0.000642	Resting heart rate	
THCA	cis	1	rs11704021	chr22:39074716	TOMM22	chr22:39077954-39080763:+	-0.16	-3.59	0.000369	Resting heart rate	
THCA	cis	1	rs11704059	chr22:18449543	MICAL3	chr22:18270418-18507325:-	-0.2	-4.02	6.64E-5	Presence of antiphospholipid antibodies	
THCA	cis	1	rs11704733	chr22:18446212	MICAL3	chr22:18270418-18507325:-	-0.19	-3.96	8.62E-5	Presence of antiphospholipid antibodies	
THCA	cis	1	rs11704827	chr22:18450287	MICAL3	chr22:18270418-18507325:-	-0.2	-3.98	7.86E-5	Presence of antiphospholipid antibodies	
THCA	cis	1	rs11704899	chr22:29918482	ASCC2	chr22:30184603-30234254:-	-0.2	-3.38	0.000788	Lipid traits	
THCA	cis	1	rs11705221	chr22:18443287	MICAL3	chr22:18270418-18507325:-	-0.21	-4.27	2.33E-5	Presence of antiphospholipid antibodies	
THCA	cis	1	rs11705483	chr22:46630544	PKDREJ	chr22:46651561-46659219:-	-0.49	-5.52	5.65E-8	Cholesterol, total;LDL cholesterol	
THCA	cis	1	rs11706035	chr3:53011868	RFT1	chr3:53122503-53164470:-	0.64	7.35	8.57E-13	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs11706035	chr3:53011868	TMEM110	chr3:52867139-52931547:-	0.36	4.14	4.19E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs11706117	chr3:134212526	ANAPC13	chr3:134196547-134204865:-	0.39	12.25	3.52E-30	Height	
THCA	cis	1	rs11706117	chr3:134212526	CEP63	chr3:134204575-134293852:+	0.29	6.3	6.82E-10	Height	
THCA	cis	1	rs11706304	chr3:128050614	EEFSEC	chr3:127872313-128127488:+	-0.22	-3.76	0.000188	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs11706420	chr3:58392411	PXK	chr3:58318617-58410878:+	-0.3	-5.55	4.64E-8	Cholesterol, total	
THCA	cis	1	rs11706455	chr3:127891991	EEFSEC	chr3:127872313-128127488:+	-0.25	-4.27	2.32E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs11706826	chr3:128032991	EEFSEC	chr3:127872313-128127488:+	-0.19	-3.43	0.000665	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs11706852	chr3:128032887	EEFSEC	chr3:127872313-128127488:+	-0.19	-3.44	0.000634	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs11707462	chr3:127838630	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.62	5.04E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs11707575	chr3:53113762	RFT1	chr3:53122503-53164470:-	0.56	6.93	1.4E-11	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs11707780	chr3:53084326	RFT1	chr3:53122503-53164470:-	-0.57	-7.51	3.01E-13	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs11708531	chr3:134224902	ANAPC13	chr3:134196547-134204865:-	0.39	12.57	1.72E-31	Height	
THCA	cis	1	rs11708531	chr3:134224902	CEP63	chr3:134204575-134293852:+	0.29	6.4	3.83E-10	Height	
THCA	cis	1	rs11708590	chr3:58336635	KCTD6	chr3:58477823-58488085:+	-0.22	-3.35	0.000871	Cholesterol, total	
THCA	cis	1	rs11708590	chr3:58336635	PXK	chr3:58318617-58410878:+	-0.35	-6.37	4.58E-10	Cholesterol, total	
THCA	cis	1	rs11709066	chr3:127874912	EEFSEC	chr3:127872313-128127488:+	0.25	4.32	1.91E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs11709377	chr3:127815670	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.61	5.13E-6	Post bronchodilator FEV1	
THCA	cis	1	rs11709525	chr3:49690496	MST1	chr3:49721381-49726196:-	0.12	3.72	0.000226	Crohn's disease;Ulcerative colitis	
THCA	cis	1	rs11709525	chr3:49690496	UBA7	chr3:49842639-49851391:-	0.15	3.41	0.000702	Crohn's disease;Ulcerative colitis	
THCA	cis	1	rs11709611	chr3:128067275	EEFSEC	chr3:127872313-128127488:+	-0.23	-3.98	7.88E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs11709976	chr3:58325347	PXK	chr3:58318617-58410878:+	0.3	5.58	3.94E-8	Cholesterol, total	
THCA	cis	1	rs11710058	chr3:58383048	PXK	chr3:58318617-58410878:+	0.34	6.01	3.64E-9	Cholesterol, total	
THCA	cis	1	rs11710292	chr3:53117798	RFT1	chr3:53122503-53164470:-	0.63	7.39	6.57E-13	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs11710292	chr3:53117798	SFMBT1	chr3:52938628-53080070:-	-0.2	-3.41	0.000717	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs11710434	chr3:49346130	GMPPB	chr3:49758932-49761384:-	-0.17	-3.78	0.000179	Menarche (age at onset)	
THCA	cis	1	rs11710434	chr3:49346130	P4HTM	chr3:49027341-49044579:+	0.17	4.34	1.71E-5	Menarche (age at onset)	
THCA	cis	1	rs11710434	chr3:49346130	WDR6	chr3:49044637-49053386:+	-0.17	-3.55	0.000429	Menarche (age at onset)	
THCA	cis	1	rs11710627	chr3:128047009	EEFSEC	chr3:127872313-128127488:+	-0.21	-3.7	0.000237	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs11710675	chr3:49751900	CCDC36	chr3:49235861-49295537:+	0.18	3.81	0.000157	Resting heart rate	
THCA	cis	1	rs11710675	chr3:49751900	DAG1	chr3:49507565-49573046:+	-0.09	-3.4	0.000739	Resting heart rate	
THCA	cis	1	rs11710675	chr3:49751900	RBM6	chr3:49977592-50137484:+	-0.14	-4.23	2.75E-5	Resting heart rate	
THCA	cis	1	rs11710704	chr3:128047236	EEFSEC	chr3:127872313-128127488:+	-0.21	-3.59	0.00037	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs11710707	chr3:52975916	RFT1	chr3:53122503-53164470:-	0.63	6.99	9.58E-12	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs11710707	chr3:52975916	TMEM110	chr3:52867139-52931547:-	0.38	4.26	2.44E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs1171112	chr6:84226568	SNAP91	chr6:84262607-84419127:-	-0.18	-3.7	0.000241	Bipolar disorder with mood-incongruent psychosis	
THCA	cis	1	rs1171113	chr6:84226595	SNAP91	chr6:84262607-84419127:-	-0.18	-3.7	0.000241	Bipolar disorder with mood-incongruent psychosis	
THCA	cis	1	rs1171115	chr6:84229623	SNAP91	chr6:84262607-84419127:-	-0.18	-3.76	0.000194	Bipolar disorder with mood-incongruent psychosis	
THCA	cis	1	rs11711499	chr3:2472345	CNTN4	chr3:2140550-3099644:+	0.38	8.62	9.87E-17	Blood pressure (smoking interaction)	
THCA	cis	1	rs11711710	chr3:127872506	EEFSEC	chr3:127872313-128127488:+	-0.27	-4.74	2.82E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs11712111	chr3:156608940	LEKR1	chr3:156544076-156763918:+	0.3	8.12	4.04E-15	Multiple sclerosis (severity)	
THCA	cis	1	rs11712561	chr3:48435272	ATRIP	chr3:48488141-48507708:+	0.18	3.91	0.000106	Longevity	
THCA	cis	1	rs11712561	chr3:48435272	TREX1	chr3:48501186-48509043:+	-0.25	-5.83	1.02E-8	Longevity	
THCA	cis	1	rs11712653	chr3:53070875	RFT1	chr3:53122503-53164470:-	-0.5	-5.96	4.96E-9	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs11712653	chr3:53070875	TMEM110	chr3:52867139-52931547:-	-0.33	-3.94	9.22E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs11712798	chr3:127894294	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.57	6.09E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs117128498	chr12:62503517	FAM19A2	chr12:62102043-62653925:-	-0.15	-3.34	0.000892	Post bronchodilator FEV1/FVC ratio in COPD	
THCA	cis	1	rs11713206	chr3:52999243	RFT1	chr3:53122503-53164470:-	0.63	7.06	6.08E-12	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs11713206	chr3:52999243	TMEM110	chr3:52867139-52931547:-	0.38	4.22	2.98E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs11713214	chr3:58445991	PXK	chr3:58318617-58410878:+	0.34	5.99	4.01E-9	Cholesterol, total	
THCA	cis	1	rs11713290	chr3:52971579	RFT1	chr3:53122503-53164470:-	0.61	7.05	6.27E-12	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs11713290	chr3:52971579	TMEM110	chr3:52867139-52931547:-	0.36	4.16	3.72E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs117136824	chr11:108329001	ACAT1	chr11:107992258-108018889:+	-0.34	-7.5	3.1E-13	Melanoma	
THCA	cis	1	rs117136824	chr11:108329001	ATM	chr11:108093559-108239826:+	-0.16	-3.44	0.000642	Melanoma	
THCA	cis	1	rs11713859	chr3:53042080	RFT1	chr3:53122503-53164470:-	0.62	6.93	1.34E-11	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs11713859	chr3:53042080	TMEM110	chr3:52867139-52931547:-	0.37	4.15	3.91E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs11714052	chr3:127814457	EEFSEC	chr3:127872313-128127488:+	-0.25	-4.37	1.5E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs11714294	chr3:47339723	C3orf75	chr3:47537131-47555199:-	0.1	4.36	1.56E-5	Colorectal cancer	
THCA	cis	1	rs11714294	chr3:47339723	NBEAL2	chr3:47021173-47051193:+	0.12	3.95	8.83E-5	Colorectal cancer	
THCA	cis	1	rs11714406	chr3:121372513	HCLS1	chr3:121350247-121379791:-	-0.07	-3.57	0.00039	Cognitive performance	
THCA	cis	1	rs11714406	chr3:121372513	IQCB1	chr3:121488610-121553926:-	0.53	10.19	3.25E-22	Cognitive performance	
THCA	cis	1	rs11714574	chr3:58380465	ABHD6	chr3:58223259-58280459:+	0.2	4.1	4.86E-5	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	
THCA	cis	1	rs11714619	chr3:127850076	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.47	9.77E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs11714876	chr3:53101640	RFT1	chr3:53122503-53164470:-	-0.61	-7.74	6.0E-14	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs11715394	chr3:127893564	EEFSEC	chr3:127872313-128127488:+	-0.24	-4.18	3.44E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs11715445	chr3:58343888	PXK	chr3:58318617-58410878:+	0.38	6.54	1.63E-10	Cholesterol, total	
THCA	cis	1	rs11716221	chr3:2464738	CNTN4	chr3:2140550-3099644:+	0.37	8.76	3.54E-17	Blood pressure (smoking interaction)	
THCA	cis	1	rs11716941	chr3:127875374	EEFSEC	chr3:127872313-128127488:+	0.25	4.29	2.2E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs11717256	chr3:49868520	CCDC36	chr3:49235861-49295537:+	0.19	4.06	5.78E-5	Resting heart rate	
THCA	cis	1	rs11717256	chr3:49868520	RBM6	chr3:49977592-50137484:+	-0.14	-4.18	3.5E-5	Resting heart rate	
THCA	cis	1	rs11717423	chr3:58330177	PXK	chr3:58318617-58410878:+	0.37	6.48	2.33E-10	Cholesterol, total	
THCA	cis	1	rs11717619	chr3:53003179	RFT1	chr3:53122503-53164470:-	0.62	7.18	2.69E-12	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs11717619	chr3:53003179	TMEM110	chr3:52867139-52931547:-	0.36	4.13	4.29E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs11718165	chr3:49696797	MST1	chr3:49721381-49726196:-	0.14	4.1	4.77E-5	Crohn's disease;Ulcerative colitis	
THCA	cis	1	rs11718165	chr3:49696797	UBA7	chr3:49842639-49851391:-	0.16	3.67	0.000265	Crohn's disease;Ulcerative colitis	
THCA	cis	1	rs11718538	chr3:52975987	RFT1	chr3:53122503-53164470:-	0.61	7.05	6.27E-12	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs11718538	chr3:52975987	TMEM110	chr3:52867139-52931547:-	0.36	4.16	3.72E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs11718752	chr3:53130745	RFT1	chr3:53122503-53164470:-	0.6	7.23	1.99E-12	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs11718834	chr3:52963668	RFT1	chr3:53122503-53164470:-	0.58	6.68	6.65E-11	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs11718834	chr3:52963668	TMEM110	chr3:52867139-52931547:-	0.39	4.51	8.28E-6	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs11719079	chr3:127824049	EEFSEC	chr3:127872313-128127488:+	-0.25	-4.4	1.33E-5	Post bronchodilator FEV1	
THCA	cis	1	rs11719458	chr3:121382005	HCLS1	chr3:121350247-121379791:-	-0.07	-3.56	0.000411	Cognitive performance	
THCA	cis	1	rs11719458	chr3:121382005	IQCB1	chr3:121488610-121553926:-	0.54	10.31	1.22E-22	Cognitive performance	
THCA	cis	1	rs11719546	chr3:127872602	EEFSEC	chr3:127872313-128127488:+	-0.27	-4.74	2.82E-6	Post bronchodilator FEV1	
THCA	cis	1	rs11719762	chr3:49409002	GMPPB	chr3:49758932-49761384:-	-0.18	-4.12	4.51E-5	Menarche (age at onset)	
THCA	cis	1	rs11719762	chr3:49409002	P4HTM	chr3:49027341-49044579:+	0.17	4.32	1.9E-5	Menarche (age at onset)	
THCA	cis	1	rs11719762	chr3:49409002	WDR6	chr3:49044637-49053386:+	-0.18	-3.77	0.000181	Menarche (age at onset)	
THCA	cis	1	rs11719957	chr3:58415031	PXK	chr3:58318617-58410878:+	0.33	5.77	1.42E-8	Cholesterol, total	
THCA	cis	1	rs11720191	chr3:53013839	RFT1	chr3:53122503-53164470:-	0.64	7.35	8.57E-13	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs11720191	chr3:53013839	TMEM110	chr3:52867139-52931547:-	0.36	4.14	4.19E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs11720239	chr3:127817955	EEFSEC	chr3:127872313-128127488:+	-0.25	-4.42	1.23E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs11720542	chr3:49357427	GMPPB	chr3:49758932-49761384:-	-0.17	-3.78	0.000179	Menarche (age at onset)	
THCA	cis	1	rs11720542	chr3:49357427	P4HTM	chr3:49027341-49044579:+	0.17	4.34	1.71E-5	Menarche (age at onset)	
THCA	cis	1	rs11720542	chr3:49357427	WDR6	chr3:49044637-49053386:+	-0.17	-3.55	0.000429	Menarche (age at onset)	
THCA	cis	1	rs11721213	chr3:128067441	EEFSEC	chr3:127872313-128127488:+	0.21	3.73	0.000216	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs11721318	chr3:121429485	IQCB1	chr3:121488610-121553926:-	0.54	10.57	1.27E-23	Cognitive performance	
THCA	cis	1	rs11722037	chr4:17683811	MED28	chr4:17616273-17629791:+	0.16	3.41	0.000694	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs11722197	chr4:281707	ZNF718	chr4:53272-156488:+	0.5	9.32	4.29E-19	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs11722225	chr4:106766430	INTS12	chr4:106603787-106629881:-	-0.61	-5.16	3.7E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11722521	chr4:276765	ZNF718	chr4:53272-156488:+	0.5	9.51	9.24E-20	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs11722521	chr4:276765	ZNF876P	chr4:206389-249771:+	-0.23	-3.36	0.000855	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs11723120	chr4:103502551	NFKB1	chr4:103422486-103538458:+	0.16	4.57	6.08E-6	Ulcerative colitis	
THCA	cis	1	rs11723225	chr4:106746065	INTS12	chr4:106603787-106629881:-	-0.61	-5.18	3.25E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11723240	chr4:106736936	INTS12	chr4:106603787-106629881:-	-0.61	-5.18	3.25E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11723261	chr4:282499	ZNF718	chr4:53272-156488:+	0.5	9.32	4.29E-19	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs11723615	chr4:276983	ZNF718	chr4:53272-156488:+	0.51	9.61	4.02E-20	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs11723615	chr4:276983	ZNF876P	chr4:206389-249771:+	-0.24	-3.5	0.000506	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs11723639	chr4:106741163	INTS12	chr4:106603787-106629881:-	-0.61	-5.18	3.25E-7	Post bronchodilator FEV1	
THCA	cis	1	rs117236853	chr20:33667783	PROCR	chr20:33758727-33765164:+	-0.31	-4.74	2.76E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs117236853	chr20:33667783	TRPC4AP	chr20:33590215-33680618:-	0.3	3.5	0.000508	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs11723803	chr4:292369	ZNF718	chr4:53272-156488:+	0.51	11.17	6.7E-26	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs11724176	chr4:224901	ZNF718	chr4:53272-156488:+	0.51	9.54	7.09E-20	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs11724417	chr4:223352	ZNF718	chr4:53272-156488:+	0.51	9.56	6.09E-20	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs11724417	chr4:223352	ZNF732	chr4:259482-299263:-	-0.24	-3.36	0.000853	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs11724495	chr4:17621310	MED28	chr4:17616273-17629791:+	0.16	3.51	0.000497	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs11724614	chr4:103550248	NFKB1	chr4:103422486-103538458:+	0.14	4	7.36E-5	Primary biliary cirrhosis	
THCA	cis	1	rs11724839	chr4:106638256	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11724884	chr4:106677384	INTS12	chr4:106603787-106629881:-	-0.62	-5.3	1.78E-7	Post bronchodilator FEV1	
THCA	cis	1	rs117249133	chr20:33773630	PROCR	chr20:33758727-33765164:+	-0.32	-5.08	5.29E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs117249133	chr20:33773630	TRPC4AP	chr20:33590215-33680618:-	0.35	4.25	2.56E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs117249133	chr20:33773630	UQCC	chr20:33890383-33999833:-	-0.2	-3.64	0.000303	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs11726094	chr4:106773387	INTS12	chr4:106603787-106629881:-	-0.61	-5.18	3.23E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11726124	chr4:106766496	INTS12	chr4:106603787-106629881:-	0.57	4.97	9.25E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11726569	chr4:106606608	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11726609	chr4:56400869	TMEM165	chr4:56262090-56292342:+	-0.14	-3.51	0.000497	Personality dimensions	
THCA	cis	1	rs11726829	chr4:224948	ZNF718	chr4:53272-156488:+	0.54	11.01	2.76E-25	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs11727189	chr4:106619140	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11727348	chr4:106679848	INTS12	chr4:106603787-106629881:-	-0.62	-5.3	1.78E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11727500	chr4:106745948	INTS12	chr4:106603787-106629881:-	-0.61	-5.18	3.25E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11727546	chr4:103557664	CISD2	chr4:103790135-103809913:+	-0.16	-3.7	0.000241	Primary biliary cirrhosis	
THCA	cis	1	rs11727546	chr4:103557664	NFKB1	chr4:103422486-103538458:+	0.15	4.34	1.74E-5	Primary biliary cirrhosis	
THCA	cis	1	rs11727735	chr4:106631870	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11727745	chr4:106716527	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11727803	chr4:88213158	HSD17B11	chr4:88257691-88312455:-	0.32	6.44	2.97E-10	Platelet count	
THCA	cis	1	rs11727803	chr4:88213158	HSD17B13	chr4:88224941-88244056:-	-0.22	-3.63	0.000317	Platelet count	
THCA	cis	1	rs11727835	chr4:88213244	HSD17B11	chr4:88257691-88312455:-	0.32	6.44	2.97E-10	Platelet count	
THCA	cis	1	rs11727835	chr4:88213244	HSD17B13	chr4:88224941-88244056:-	-0.22	-3.63	0.000317	Platelet count	
THCA	cis	1	rs11727875	chr4:39135319	KLHL5	chr4:39046659-39123828:+	-0.21	-5.77	1.46E-8	Uric acid levels	
THCA	cis	1	rs11728044	chr4:106604786	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs1172822	chr19:55819845	TMEM150B	chr19:55824227-55845416:-	0.15	3.41	0.000702	Menopause (age at onset);Menarche and menopause (age at onset)	
THCA	cis	1	rs11728716	chr4:106755996	INTS12	chr4:106603787-106629881:-	0.58	5	8.08E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11729365	chr4:272524	ZNF718	chr4:53272-156488:+	0.51	9.52	8.79E-20	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs11730202	chr4:210096	ZNF718	chr4:53272-156488:+	0.49	9.09	2.68E-18	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs11730354	chr4:106773435	INTS12	chr4:106603787-106629881:-	-0.61	-5.19	3.1E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11731386	chr4:106600338	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11731417	chr4:106746012	INTS12	chr4:106603787-106629881:-	-0.61	-5.18	3.25E-7	Post bronchodilator FEV1	
THCA	cis	1	rs117316403	chr20:33693175	PROCR	chr20:33758727-33765164:+	-0.33	-5.57	4.24E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs117316403	chr20:33693175	TRPC4AP	chr20:33590215-33680618:-	0.33	4.31	2.02E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs11731714	chr4:106675946	INTS12	chr4:106603787-106629881:-	-0.62	-5.3	1.78E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11731938	chr4:106725140	INTS12	chr4:106603787-106629881:-	-0.62	-5.3	1.78E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11731957	chr4:139133635	SLC7A11	chr4:139085248-139163503:-	0.23	4.55	6.94E-6	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	
THCA	cis	1	rs11732298	chr4:106701679	INTS12	chr4:106603787-106629881:-	0.63	5.49	6.48E-8	Post bronchodilator FEV1	
THCA	cis	1	rs11732629	chr4:106754347	INTS12	chr4:106603787-106629881:-	-0.58	-5	8.08E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11732650	chr4:106754231	INTS12	chr4:106603787-106629881:-	-0.59	-5.02	7.37E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11733093	chr4:106765063	INTS12	chr4:106603787-106629881:-	-0.58	-5	8.08E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11733124	chr4:106677541	INTS12	chr4:106603787-106629881:-	-0.62	-5.31	1.66E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11733150	chr4:106765351	INTS12	chr4:106603787-106629881:-	-0.58	-5	8.08E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11733223	chr4:106765525	INTS12	chr4:106603787-106629881:-	0.53	4.58	5.85E-6	Post bronchodilator FEV1	
THCA	cis	1	rs11733225	chr4:106705363	INTS12	chr4:106603787-106629881:-	-0.62	-5.3	1.78E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11733284	chr4:48028097	CNGA1	chr4:47937996-48018610:-	0.54	9.67	2.52E-20	Renal underexcretion gout;Gout	
THCA	cis	1	rs11733284	chr4:48028097	FRYL	chr4:48499380-48782316:-	0.12	3.58	0.000378	Renal underexcretion gout;Gout	
THCA	cis	1	rs11733284	chr4:48028097	NIPAL1	chr4:48018791-48039078:+	0.29	9.89	4.22E-21	Renal underexcretion gout;Gout	
THCA	cis	1	rs11733287	chr4:106705339	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.85E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11733654	chr4:106730710	INTS12	chr4:106603787-106629881:-	-0.62	-5.19	3.05E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11733864	chr4:56321530	TMEM165	chr4:56262090-56292342:+	-0.16	-4.11	4.62E-5	Personality dimensions	
THCA	cis	1	rs11734039	chr4:54264428	SCFD2	chr4:53739152-54232242:-	0.27	5.41	9.74E-8	DNA methylation (variation)	
THCA	cis	1	rs117344347	chr8:89464275	MMP16	chr8:89049462-89339717:-	0.33	5.11	4.7E-7	Electrodermal activity	
THCA	cis	1	rs11734488	chr4:139130133	SLC7A11	chr4:139085248-139163503:-	0.23	4.55	6.95E-6	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	
THCA	cis	1	rs11734571	chr4:106703557	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.85E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11735092	chr4:88226231	HSD17B11	chr4:88257691-88312455:-	0.31	6.21	1.13E-9	Platelet count	
THCA	cis	1	rs11735092	chr4:88226231	HSD17B13	chr4:88224941-88244056:-	-0.22	-3.7	0.000243	Platelet count	
THCA	cis	1	rs11735213	chr4:106527508	INTS12	chr4:106603787-106629881:-	-0.6	-5.03	7.09E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11735527	chr4:106679692	INTS12	chr4:106603787-106629881:-	-0.62	-5.3	1.78E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11735851	chr4:106697254	INTS12	chr4:106603787-106629881:-	-0.62	-5.3	1.78E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11736834	chr4:106708764	INTS12	chr4:106603787-106629881:-	-0.62	-5.3	1.78E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11736859	chr4:106708785	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.85E-7	Post bronchodilator FEV1	
THCA	cis	1	rs11737268	chr4:224452	ZNF718	chr4:53272-156488:+	0.54	11.01	2.76E-25	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs11737481	chr4:159621250	ETFDH	chr4:159593277-159629839:+	-0.17	-4.24	2.65E-5	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
THCA	cis	1	rs11737481	chr4:159621250	PPID	chr4:159630280-159644552:-	0.2	3.76	0.00019	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
THCA	cis	1	rs11739344	chr5:56111087	C5orf35	chr5:56205103-56213010:+	1	22.93	5.15E-79	Type 2 diabetes	
THCA	cis	1	rs11739619	chr5:150264662	LOC134466	chr5:150310000-150326146:-	0.38	5.28	2.01E-7	Crohn's disease	
THCA	cis	1	rs11739677	chr5:150294883	LOC134466	chr5:150310000-150326146:-	0.45	5.97	4.64E-9	Crohn's disease	
THCA	cis	1	rs11740172	chr5:150300278	LOC134466	chr5:150310000-150326146:-	0.43	5.76	1.52E-8	Crohn's disease	
THCA	cis	1	rs11741688	chr5:178395850	ZNF354B	chr5:178286954-178311423:+	0.12	3.96	8.68E-5	Sleep duration	
THCA	cis	1	rs11741688	chr5:178395850	ZNF454	chr5:178368224-178393434:+	-0.22	-4.45	1.05E-5	Sleep duration	
THCA	cis	1	rs11741861	chr5:150277909	LOC134466	chr5:150310000-150326146:-	-0.47	-6.04	3.19E-9	Crohn's disease	
THCA	cis	1	rs11741861	chr5:150277909	ZNF300	chr5:150273964-150284391:-	-0.17	-3.41	0.0007	Crohn's disease	
THCA	cis	1	rs11743488	chr5:150279218	LOC134466	chr5:150310000-150326146:-	0.45	5.87	8.16E-9	Crohn's disease	
THCA	cis	1	rs11743488	chr5:150279218	ZNF300	chr5:150273964-150284391:-	0.17	3.43	0.000646	Crohn's disease	
THCA	cis	1	rs11743697	chr5:2784489	C5orf38	chr5:2752262-2755512:+	-0.24	-3.43	0.000665	Toenail selenium levels	
THCA	cis	1	rs11743697	chr5:2784489	IRX2	chr5:2746281-2751769:-	-0.29	-4.28	2.21E-5	Toenail selenium levels	
THCA	cis	1	rs11746108	chr5:150264622	LOC134466	chr5:150310000-150326146:-	0.38	5.28	2.01E-7	Crohn's disease	
THCA	cis	1	rs11746560	chr5:150185925	LOC134466	chr5:150310000-150326146:-	0.44	5.7	2.13E-8	Crohn's disease	
THCA	cis	1	rs11746560	chr5:150185925	ZNF300	chr5:150273964-150284391:-	0.18	3.72	0.000222	Crohn's disease	
THCA	cis	1	rs11746807	chr5:150300419	LOC134466	chr5:150310000-150326146:-	0.43	5.74	1.68E-8	Crohn's disease	
THCA	cis	1	rs11746907	chr5:598224	CEP72	chr5:612405-653664:+	0.36	7.07	5.38E-12	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs11747065	chr5:150295486	LOC134466	chr5:150310000-150326146:-	0.43	5.76	1.52E-8	Crohn's disease	
THCA	cis	1	rs11747270	chr5:150258867	LOC134466	chr5:150310000-150326146:-	-0.38	-5.3	1.74E-7	Crohn's disease	
THCA	cis	1	rs11748151	chr5:150226292	LOC134466	chr5:150310000-150326146:-	0.39	5.45	8.07E-8	Crohn's disease	
THCA	cis	1	rs11748158	chr5:150226345	LOC134466	chr5:150310000-150326146:-	0.38	5.31	1.71E-7	Crohn's disease	
THCA	cis	1	rs11748553	chr5:150184553	LOC134466	chr5:150310000-150326146:-	0.44	5.7	2.13E-8	Crohn's disease	
THCA	cis	1	rs11748553	chr5:150184553	ZNF300	chr5:150273964-150284391:-	0.18	3.72	0.000222	Crohn's disease	
THCA	cis	1	rs11749391	chr5:150229066	LOC134466	chr5:150310000-150326146:-	0.38	5.26	2.23E-7	Crohn's disease	
THCA	cis	1	rs11750992	chr6:42496457	PRPH2	chr6:42664334-42690358:-	0.28	3.74	0.000206	Obesity-related traits	
THCA	cis	1	rs11752297	chr6:33735154	LEMD2	chr6:33738991-33756906:-	-0.3	-6.79	3.31E-11	Crohn's disease	
THCA	cis	1	rs117526668	chr11:44285431	ACCS	chr11:44087475-44105569:+	-0.26	-3.67	0.000269	Response to abacavir-containing treatment in HIV-1 infection (virologic failure);Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	
THCA	cis	1	rs11753081	chr6:20705590	SOX4	chr6:21593972-21598847:+	-0.12	-3.44	0.000631	Type 2 diabetes	
THCA	cis	1	rs11753083	chr6:33761111	LEMD2	chr6:33738991-33756906:-	0.25	4.98	8.85E-7	Body mass index	
THCA	cis	1	rs11754690	chr6:33744157	LEMD2	chr6:33738991-33756906:-	0.25	5.07	5.68E-7	Body mass index	
THCA	cis	1	rs11754744	chr6:26202605	HIST1H2AE	chr6:26217148-26217711:+	-0.23	-3.69	0.000254	Renal underexcretion gout;Gout	
THCA	cis	1	rs11754744	chr6:26202605	HIST1H3E	chr6:26224427-26226589:+	0.43	7.08	5.02E-12	Renal underexcretion gout;Gout	
THCA	cis	1	rs11755068	chr6:155911026	TFB1M	chr6:155578791-155635626:-	0.26	3.73	0.000215	Schizophrenia	
THCA	cis	1	rs11755210	chr6:26202768	HIST1H2AE	chr6:26217148-26217711:+	-0.23	-3.69	0.000254	Renal underexcretion gout;Gout	
THCA	cis	1	rs11755210	chr6:26202768	HIST1H3E	chr6:26224427-26226589:+	0.43	7.08	5.02E-12	Renal underexcretion gout;Gout	
THCA	cis	1	rs11755487	chr6:42506099	PRPH2	chr6:42664334-42690358:-	-0.29	-3.91	0.000105	Obesity-related traits	
THCA	cis	1	rs11755593	chr6:33740325	LEMD2	chr6:33738991-33756906:-	0.25	4.99	8.56E-7	Body mass index	
THCA	cis	1	rs11755845	chr6:43904780	LOC100132354	chr6:43858765-43905943:+	-0.17	-4.48	9.32E-6	Thyroid hormone levels	
THCA	cis	1	rs11755845	chr6:43904780	MRPS18A	chr6:43639042-43655528:-	0.14	3.42	0.000668	Thyroid hormone levels	
THCA	cis	1	rs11756120	chr6:26529808	BTN2A3	chr6:26422317-26431927:+	0.19	4.52	7.72E-6	Educational attainment	
THCA	cis	1	rs11756120	chr6:26529808	HCG11	chr6:26521934-26527610:+	-0.23	-4.43	1.18E-5	Educational attainment	
THCA	cis	1	rs11756120	chr6:26529808	HMGN4	chr6:26538572-26547162:+	-0.16	-4.05	5.86E-5	Educational attainment	
THCA	cis	1	rs11756120	chr6:26529808	ZNF322A	chr6:26634612-26659963:-	-0.14	-3.77	0.000183	Educational attainment	
THCA	cis	1	rs11756352	chr6:42497571	PRPH2	chr6:42664334-42690358:-	-0.27	-3.65	0.000296	Obesity-related traits	
THCA	cis	1	rs11756783	chr6:101118109	ASCC3	chr6:100956609-101329224:-	0.11	4.2	3.12E-5	Menarche (age at onset)	
THCA	cis	1	rs117573845	chr20:33651621	PROCR	chr20:33758727-33765164:+	-0.34	-5.45	8.29E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs117573845	chr20:33651621	TRPC4AP	chr20:33590215-33680618:-	0.33	3.93	9.8E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs11758152	chr6:42496494	PRPH2	chr6:42664334-42690358:-	0.28	3.67	0.000266	Obesity-related traits	
THCA	cis	1	rs11758351	chr6:26203910	HIST1H2AE	chr6:26217148-26217711:+	-0.24	-3.78	0.000177	Renal underexcretion gout;Gout	
THCA	cis	1	rs11758351	chr6:26203910	HIST1H3E	chr6:26224427-26226589:+	0.44	7.2	2.42E-12	Renal underexcretion gout;Gout	
THCA	cis	1	rs11758849	chr6:86708262	SNHG5	chr6:86386726-86388451:-	-0.47	-10.33	1.05E-22	Response to antipsychotic treatment	
THCA	cis	1	rs11758943	chr6:42501162	PRPH2	chr6:42664334-42690358:-	-0.28	-3.68	0.000255	Obesity-related traits	
THCA	cis	1	rs11759804	chr6:151875122	C6orf97	chr6:151815175-151942327:+	0.29	4.18	3.46E-5	Bone mineral density (spine)	
THCA	cis	1	rs11759855	chr6:86610841	SNHG5	chr6:86386726-86388451:-	-0.49	-10.88	8.79E-25	Response to antipsychotic treatment	
THCA	cis	1	rs117616040	chr20:33565528	PROCR	chr20:33758727-33765164:+	-0.34	-5.23	2.49E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs117616040	chr20:33565528	TRPC4AP	chr20:33590215-33680618:-	0.32	3.75	0.000199	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs11761941	chr7:1097183	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.51	5.78E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs11763020	chr7:1060288	ZFAND2A	chr7:1192544-1199855:-	-0.25	-3.65	0.000288	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs11763147	chr7:65326821	GUSB	chr7:65425675-65447246:-	-0.34	-6.73	5.01E-11	Corneal structure	
THCA	cis	1	rs11763147	chr7:65326821	RABGEF1	chr7:66093890-66276446:+	-0.48	-9.62	3.72E-20	Corneal structure	
THCA	cis	1	rs11763147	chr7:65326821	ZNF117	chr7:64434830-64467121:-	-0.21	-4.86	1.62E-6	Corneal structure	
THCA	cis	1	rs11763793	chr7:1094342	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.51	5.78E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs117638181	chr19:22163014	ZNF492	chr19:22817126-22850472:+	0.26	3.56	0.000411	Body mass index (change over time)	
THCA	cis	1	rs11763835	chr7:1094513	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.51	5.78E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs11764748	chr7:1094508	ZFAND2A	chr7:1192544-1199855:-	-0.37	-5.7	2.14E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs11765693	chr7:75985373	STYXL1	chr7:75625656-75677321:-	-0.16	-3.98	8.12E-5	Multiple sclerosis	
THCA	cis	1	rs11765693	chr7:75985373	UPK3B	chr7:76139745-76157197:+	-0.27	-4.67	3.88E-6	Multiple sclerosis	
THCA	cis	1	rs11765986	chr7:77357274	PTPN12	chr7:77166773-77269388:+	-0.17	-3.97	8.18E-5	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs11766312	chr7:38227592	STARD3NL	chr7:38217933-38270269:+	-0.52	-12.39	8.84E-31	Treatment response for severe sepsis	
THCA	cis	1	rs11766341	chr7:38227749	STARD3NL	chr7:38217933-38270269:+	-0.52	-12.27	2.91E-30	Treatment response for severe sepsis	
THCA	cis	1	rs11766526	chr7:1101433	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.81	1.11E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs117669807	chr8:89464285	MMP16	chr8:89049462-89339717:-	0.33	5.11	4.7E-7	Electrodermal activity	
THCA	cis	1	rs11767124	chr7:23919080	C7orf46	chr7:23719749-23742268:+	0.13	3.79	0.000167	Schizophrenia	
THCA	cis	1	rs11767527	chr7:1097394	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.51	5.78E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs11767651	chr7:77390380	PTPN12	chr7:77166773-77269388:+	-0.17	-3.89	0.000115	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs11767651	chr7:77390380	RSBN1L	chr7:77325743-77409120:+	0.14	3.48	0.000554	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs11768309	chr7:97773812	BRI3	chr7:97910979-97922275:+	-0.11	-3.79	0.000169	Prostate cancer (gene x gene interaction);Prostate cancer	
THCA	cis	1	rs11768309	chr7:97773812	TECPR1	chr7:97846060-97881468:-	-0.14	-3.95	8.87E-5	Prostate cancer (gene x gene interaction);Prostate cancer	
THCA	cis	1	rs11768761	chr7:1069807	ZFAND2A	chr7:1192544-1199855:-	-0.3	-4.4	1.33E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs11768889	chr7:117993350	ANKRD7	chr7:117864712-117882782:+	0.27	4.5	8.46E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs11770446	chr7:77358072	PTPN12	chr7:77166773-77269388:+	-0.18	-4.02	6.75E-5	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs11770909	chr7:1086716	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.02	7.29E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs117735470	chr12:22592653	KIAA0528	chr12:22601526-22697452:-	0.23	3.82	0.000148	Coronary artery calcification	
THCA	cis	1	rs11773829	chr7:66141074	GUSB	chr7:65425675-65447246:-	-0.33	-6.8	3.22E-11	Aortic root size	
THCA	cis	1	rs11773829	chr7:66141074	RABGEF1	chr7:66093890-66276446:+	-0.51	-10.49	2.65E-23	Aortic root size	
THCA	cis	1	rs11773829	chr7:66141074	TYW1	chr7:66461817-66704496:+	-0.18	-3.93	9.79E-5	Aortic root size	
THCA	cis	1	rs11774085	chr8:96020877	C8orf38	chr8:95908040-96088396:+	-0.28	-4.66	4.06E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs11776189	chr8:96036741	C8orf38	chr8:95908040-96088396:+	-0.26	-4.5	8.44E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs117775624	chr7:107124113	DLD	chr7:107531586-107561642:+	0.15	3.64	0.000304	Osteoarthritis	
THCA	cis	1	rs117802529	chr20:33786677	PROCR	chr20:33758727-33765164:+	-0.31	-4.93	1.16E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs117802529	chr20:33786677	TRPC4AP	chr20:33590215-33680618:-	0.33	4.14	4.06E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs11780931	chr8:96043829	C8orf38	chr8:95908040-96088396:+	-0.26	-4.56	6.5E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs11781040	chr8:96041746	C8orf38	chr8:95908040-96088396:+	-0.26	-4.56	6.5E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs117813661	chr11:108126353	ACAT1	chr11:107992258-108018889:+	-0.33	-7.23	1.99E-12	Melanoma	
THCA	cis	1	rs117813661	chr11:108126353	ATM	chr11:108093559-108239826:+	-0.16	-3.42	0.000688	Melanoma	
THCA	cis	1	rs11781619	chr8:96017323	C8orf38	chr8:95908040-96088396:+	-0.28	-4.48	9.26E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs11782652	chr8:82653644	CHMP4C	chr8:82644688-82671746:+	-1.31	-18.16	2.02E-56	Epithelial ovarian cancer;Ovarian cancer	
THCA	cis	1	rs11786380	chr8:96028136	C8orf38	chr8:95908040-96088396:+	-0.25	-4.23	2.82E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs11786878	chr8:96033292	C8orf38	chr8:95908040-96088396:+	-0.27	-4.56	6.58E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs117877581	chr11:116810954	PCSK7	chr11:117075789-117102811:-	0.46	5.6	3.67E-8	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs1178977	chr7:72857049	CLDN3	chr7:73183328-73184600:-	0.22	3.69	0.000247	Triglycerides	
THCA	cis	1	rs11789898	chr9:136925663	BRD3	chr9:136895454-136933655:-	0.32	8.28	1.27E-15	Platelet count	
THCA	cis	1	rs117907570	chr6:86601283	SNHG5	chr6:86386726-86388451:-	-0.53	-12.62	1.01E-31	Response to antipsychotic treatment	
THCA	cis	1	rs11792308	chr9:78033362	C9orf41	chr9:77597875-77643310:-	0.13	3.87	0.000123	Schizophrenia	
THCA	cis	1	rs11792861	chr9:111809295	C9orf5	chr9:111777416-111882225:-	0.2	5.63	3.09E-8	Menarche (age at onset)	
THCA	cis	1	rs11792861	chr9:111809295	CTNNAL1	chr9:111704851-111775764:-	0.17	4.75	2.65E-6	Menarche (age at onset)	
THCA	cis	1	rs117981067	chr11:57064112	TIMM10	chr11:57295936-57298232:-	-0.2	-3.6	0.000357	Low high density lipoprotein cholesterol levels	
THCA	cis	1	rs11800820	chr1:246661236	CNST	chr1:246729639-246831883:+	0.13	3.58	0.000382	Obesity-related traits	
THCA	cis	1	rs11800820	chr1:246661236	SMYD3	chr1:245912645-246670614:-	0.19	3.46	0.000595	Obesity-related traits	
THCA	cis	1	rs11801695	chr1:205916175	PM20D1	chr1:205797154-205819245:-	-0.24	-4.4	1.36E-5	Cystic fibrosis-related diabetes	
THCA	cis	1	rs118059236	chr7:1073202	ZFAND2A	chr7:1192544-1199855:-	-0.3	-4.4	1.33E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs11807824	chr1:27270338	ZDHHC18	chr1:27153201-27182207:+	0.61	6.61	1.03E-10	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs11810993	chr1:46478793	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.19	3.27E-22	Body mass index	
THCA	cis	1	rs11810993	chr1:46478793	GPBP1L1	chr1:46092978-46152302:-	0.15	3.78	0.000177	Body mass index	
THCA	cis	1	rs11810993	chr1:46478793	MMACHC	chr1:45965856-45976737:+	-0.21	-4.59	5.57E-6	Body mass index	
THCA	cis	1	rs11810993	chr1:46478793	MUTYH	chr1:45794915-45806142:-	0.3	8.16	3.01E-15	Body mass index	
THCA	cis	1	rs118110670	chr10:81792242	LOC219347	chr10:81805991-81838949:-	1.04	15.15	1.27E-42	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs11813099	chr10:17183451	TRDMT1	chr10:17184983-17243681:-	-0.42	-9.48	1.22E-19	Homocysteine levels	
THCA	cis	1	rs118135259	chr15:56495784	TEX9	chr15:56657644-56738071:+	-0.34	-5.88	7.84E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11814792	chr10:64917559	LOC84989	chr10:65224989-65226320:+	0.27	4.32	1.87E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs11814792	chr10:64917559	NRBF2	chr10:64893007-64914785:+	0.27	4.47	9.73E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs11816485	chr10:1147974	IDI2	chr10:1064847-1071799:-	0.34	3.55	0.000417	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs11816840	chr10:102309220	SEC31B	chr10:102246403-102289636:-	-0.28	-8.81	2.36E-17	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs11817689	chr10:64924217	LOC84989	chr10:65224989-65226320:+	-0.25	-4.1	4.94E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs11817689	chr10:64924217	NRBF2	chr10:64893007-64914785:+	-0.29	-4.85	1.68E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs11818194	chr10:65180452	LOC84989	chr10:65224989-65226320:+	0.27	4.32	1.88E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs11818194	chr10:65180452	NRBF2	chr10:64893007-64914785:+	0.28	4.72	3.09E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs11818314	chr10:1148157	IDI2	chr10:1064847-1071799:-	0.34	3.55	0.000417	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs11819230	chr10:1128812	IDI2	chr10:1064847-1071799:-	0.33	3.4	0.00073	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs11819869	chr11:46560680	PACSIN3	chr11:47199085-47207958:-	0.16	3.71	0.000231	Schizophrenia	
THCA	cis	1	rs11822435	chr11:93627325	HEPHL1	chr11:93754378-93847374:+	-0.44	-3.75	0.0002	Obesity-related traits	
THCA	cis	1	rs1182377	chr7:157048403	UBE3C	chr7:156931655-157062065:+	-0.1	-3.45	0.000611	Body mass index	
THCA	cis	1	rs1182378	chr7:157048322	UBE3C	chr7:156931655-157062065:+	-0.11	-3.79	0.000172	Body mass index	
THCA	cis	1	rs1182381	chr7:157043473	UBE3C	chr7:156931655-157062065:+	-0.11	-3.79	0.000173	Body mass index	
THCA	cis	1	rs1182384	chr7:157040642	UBE3C	chr7:156931655-157062065:+	-0.11	-3.78	0.000178	Body mass index	
THCA	cis	1	rs1182385	chr7:157040583	UBE3C	chr7:156931655-157062065:+	-0.1	-3.76	0.000195	Body mass index	
THCA	cis	1	rs1182389	chr7:157038803	UBE3C	chr7:156931655-157062065:+	0.1	3.5	0.000517	Body mass index	
THCA	cis	1	rs1182410	chr7:157063837	UBE3C	chr7:156931655-157062065:+	-0.1	-3.62	0.000324	Body mass index	
THCA	cis	1	rs1182413	chr7:157058557	UBE3C	chr7:156931655-157062065:+	-0.1	-3.38	0.000773	Body mass index	
THCA	cis	1	rs1182414	chr7:157058363	UBE3C	chr7:156931655-157062065:+	-0.1	-3.4	0.00073	Body mass index	
THCA	cis	1	rs1182452	chr7:157053618	UBE3C	chr7:156931655-157062065:+	-0.1	-3.38	0.000785	Body mass index	
THCA	cis	1	rs11825709	chr11:93704049	HEPHL1	chr11:93754378-93847374:+	0.48	3.87	0.000126	Obesity-related traits	
THCA	cis	1	rs1182882	chr7:65562063	ASL	chr7:65540776-65558321:+	0.18	4.6	5.53E-6	Aortic root size	
THCA	cis	1	rs1182882	chr7:65562063	GUSB	chr7:65425675-65447246:-	-0.28	-5.21	2.75E-7	Aortic root size	
THCA	cis	1	rs1182882	chr7:65562063	RABGEF1	chr7:66093890-66276446:+	-0.64	-13.27	1.93E-34	Aortic root size	
THCA	cis	1	rs11832315	chr12:50943932	DIP2B	chr12:50898768-51142448:+	0.12	3.8	0.000164	Fibrinogen	
THCA	cis	1	rs1183245	chr7:65541185	ASL	chr7:65540776-65558321:+	0.19	4.83	1.86E-6	Aortic root size	
THCA	cis	1	rs1183245	chr7:65541185	GUSB	chr7:65425675-65447246:-	-0.27	-5.12	4.41E-7	Aortic root size	
THCA	cis	1	rs1183245	chr7:65541185	RABGEF1	chr7:66093890-66276446:+	-0.63	-12.63	9.14E-32	Aortic root size	
THCA	cis	1	rs11833002	chr12:124446616	DNAH10	chr12:124247042-124420265:+	0.18	3.79	0.000167	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11833002	chr12:124446616	ZNF664	chr12:124457670-124499967:+	-0.17	-4.95	1.04E-6	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11835839	chr12:124431049	DNAH10	chr12:124247042-124420265:+	0.18	3.81	0.000159	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs11835839	chr12:124431049	ZNF664	chr12:124457670-124499967:+	-0.17	-4.92	1.17E-6	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs1183609	chr17:3665600	GSG2	chr17:3627197-3629990:+	-0.13	-3.81	0.000159	Attention deficit hyperactivity disorder	
THCA	cis	1	rs1183609	chr17:3665600	MED11	chr17:4634723-4636894:+	-0.15	-4.44	1.14E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs11844348	chr14:65859480	LOC645431	chr14:65877313-65879335:-	-0.46	-5.77	1.42E-8	Ischemic stroke	
THCA	cis	1	rs11844747	chr14:65870128	LOC645431	chr14:65877313-65879335:-	0.6	7.9	1.99E-14	Ischemic stroke	
THCA	cis	1	rs11845639	chr14:75570293	EIF2B2	chr14:75469612-75476292:+	0.18	4.97	9.37E-7	Height	
THCA	cis	1	rs11845639	chr14:75570293	MLH3	chr14:75480467-75518235:-	0.29	8.7	5.25E-17	Height	
THCA	cis	1	rs11845639	chr14:75570293	RPS6KL1	chr14:75372347-75389958:-	0.32	6.81	3.0E-11	Height	
THCA	cis	1	rs11845794	chr14:65848118	LOC645431	chr14:65877313-65879335:-	-0.43	-5.54	5.08E-8	Ischemic stroke	
THCA	cis	1	rs11848209	chr14:66022832	LOC645431	chr14:65877313-65879335:-	0.25	3.41	0.000717	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs11849252	chr14:66069769	LOC645431	chr14:65877313-65879335:-	-0.49	-6.45	2.7E-10	Ischemic stroke	
THCA	cis	1	rs11850160	chr14:65848123	LOC645431	chr14:65877313-65879335:-	-0.43	-5.54	5.08E-8	Ischemic stroke	
THCA	cis	1	rs11850163	chr14:65848145	LOC645431	chr14:65877313-65879335:-	-0.36	-4.69	3.51E-6	Ischemic stroke	
THCA	cis	1	rs11850847	chr14:65933798	LOC645431	chr14:65877313-65879335:-	-0.59	-7.49	3.44E-13	Ischemic stroke	
THCA	cis	1	rs11851013	chr14:66016212	LOC645431	chr14:65877313-65879335:-	-0.59	-7.44	4.62E-13	Ischemic stroke	
THCA	cis	1	rs11851772	chr14:66022047	LOC645431	chr14:65877313-65879335:-	-0.6	-7.55	2.21E-13	Ischemic stroke	
THCA	cis	1	rs1185260	chr12:122389248	WDR66	chr12:122356480-122441830:+	-0.22	-3.6	0.00035	Urinary metabolites	
THCA	cis	1	rs11853024	chr15:91514797	HDDC3	chr15:91474157-91475774:-	-0.15	-4.15	3.91E-5	Type 2 diabetes	
THCA	cis	1	rs11853052	chr15:84576159	LOC388152	chr15:84867600-84898920:-	-0.21	-4	7.19E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs11856184	chr15:43919162	ADAL	chr15:43622872-43646094:+	-0.42	-9.24	8.3E-19	Tumor biomarkers	
THCA	cis	1	rs11856184	chr15:43919162	CATSPER2	chr15:43922774-43959900:-	-0.31	-5.52	5.51E-8	Tumor biomarkers	
THCA	cis	1	rs11856184	chr15:43919162	STRC	chr15:43891762-43924561:-	0.42	7.7	7.69E-14	Tumor biomarkers	
THCA	cis	1	rs11856184	chr15:43919162	TUBGCP4	chr15:43663313-43698238:+	0.13	3.72	0.000222	Tumor biomarkers	
THCA	cis	1	rs11858714	chr15:40717447	C15orf23	chr15:40674922-40686488:+	0.66	8.6	1.15E-16	Heschl's gyrus morphology	
THCA	cis	1	rs11858714	chr15:40717447	IVD	chr15:40697686-40713512:+	-0.56	-9.85	5.69E-21	Heschl's gyrus morphology	
THCA	cis	1	rs11859274	chr16:31361059	HSD3B7	chr16:30996519-31000473:+	-0.15	-3.64	0.000307	IgA nephropathy	
THCA	cis	1	rs11861657	chr16:67824395	LRRC36	chr16:67360747-67419108:+	0.36	3.4	0.000721	Crohn's disease	
THCA	cis	1	rs11861657	chr16:67824395	ZDHHC1	chr16:67428323-67450339:-	0.43	4.9	1.29E-6	Crohn's disease	
THCA	cis	1	rs11862744	chr16:31057800	C16orf93	chr16:30768753-30773542:-	-0.15	-4.35	1.65E-5	Response to metformin (IC50)	
THCA	cis	1	rs11862744	chr16:31057800	HSD3B7	chr16:30996519-31000473:+	0.47	12.48	3.96E-31	Response to metformin (IC50)	
THCA	cis	1	rs11862744	chr16:31057800	MYST1	chr16:31128985-31142713:+	0.16	5.51	5.8E-8	Response to metformin (IC50)	
THCA	cis	1	rs11862744	chr16:31057800	PRSS53	chr16:31094747-31106276:-	-0.14	-3.96	8.58E-5	Response to metformin (IC50)	
THCA	cis	1	rs11864901	chr16:79731805	MAF	chr16:79627746-79634622:-	-0.26	-4.35	1.68E-5	Urate levels	
THCA	cis	1	rs11865131	chr16:163667	NPRL3	chr16:134273-188672:-	0.23	6.13	1.84E-9	Red blood cell traits	
THCA	cis	1	rs11866682	chr16:69484625	CYB5B	chr16:69458498-69500167:+	-0.23	-3.94	9.38E-5	Blood pressure (smoking interaction)	
THCA	cis	1	rs11867405	chr17:40570741	NAGLU	chr17:40687951-40696464:+	-0.23	-4.87	1.53E-6	Crohn's disease	
THCA	cis	1	rs11867405	chr17:40570741	TUBG2	chr17:40811266-40819023:+	-0.23	-5.43	9.06E-8	Crohn's disease	
THCA	cis	1	rs11868085	chr17:46847575	CALCOCO2	chr17:46908372-46942228:+	-0.14	-3.69	0.000253	Schizophrenia or bipolar disorder	
THCA	cis	1	rs11868085	chr17:46847575	SNF8	chr17:47007461-47022154:-	-0.24	-6.97	1.08E-11	Schizophrenia or bipolar disorder	
THCA	cis	1	rs11868085	chr17:46847575	UBE2Z	chr17:46985767-47006422:+	-0.18	-3.88	0.00012	Schizophrenia or bipolar disorder	
THCA	cis	1	rs11869069	chr17:40287101	HSPB9	chr17:40274756-40275371:+	0.34	4.96	9.66E-7	Fibrinogen levels	
THCA	cis	1	rs11869819	chr17:65868669	C17orf58	chr17:65987218-65989765:-	0.2	3.97	8.17E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs11870068	chr17:65944515	C17orf58	chr17:65987218-65989765:-	0.2	4	7.24E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs11870797	chr17:61804622	FTSJ3	chr17:61896795-61905031:-	0.3	5.78	1.32E-8	Body mass index	
THCA	cis	1	rs11870797	chr17:61804622	MAP3K3	chr17:61699775-61773669:+	0.26	5.37	1.26E-7	Body mass index	
THCA	cis	1	rs11870935	chr17:45732605	TBKBP1	chr17:45772630-45789427:+	0.37	10.41	5.34E-23	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
THCA	cis	1	rs11871767	chr17:61698723	FTSJ3	chr17:61896795-61905031:-	0.31	5.81	1.12E-8	Body mass index	
THCA	cis	1	rs11871767	chr17:61698723	MAP3K3	chr17:61699775-61773669:+	0.27	5.57	4.2E-8	Body mass index	
THCA	cis	1	rs11871801	chr17:40570772	NAGLU	chr17:40687951-40696464:+	-0.22	-4.81	2.04E-6	Crohn's disease	
THCA	cis	1	rs11871801	chr17:40570772	TUBG2	chr17:40811266-40819023:+	-0.23	-5.49	6.69E-8	Crohn's disease	
THCA	cis	1	rs11873168	chr18:33707581	SLC39A6	chr18:33688495-33709357:-	0.14	3.88	0.000118	Esophageal squamous cell cancer (length of survival)	
THCA	cis	1	rs11875097	chr18:47214838	CXXC1	chr18:47808715-47814692:-	-0.09	-3.38	0.00079	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	
THCA	cis	1	rs11877974	chr18:23663392	SS18	chr18:23596219-23671164:-	0.26	3.34	0.000901	Rhegmatogenous retinal detachment	
THCA	cis	1	rs11879853	chr19:23029434	ZNF492	chr19:22817126-22850472:+	0.43	6.56	1.36E-10	Bronchopulmonary dysplasia	
THCA	cis	1	rs11880333	chr19:49144790	SEC1	chr19:49141296-49185501:+	-0.66	-7.33	9.9E-13	Elevated serum carcinoembryonic antigen levels	
THCA	cis	1	rs11880539	chr19:41918949	B3GNT8	chr19:41931265-41934635:-	0.34	7.94	1.5E-14	Height	
THCA	cis	1	rs11880569	chr19:32969254	DPY19L3	chr19:32896677-32975236:+	0.19	5.1	4.8E-7	Bipolar disorder	
THCA	cis	1	rs11880569	chr19:32969254	ZNF507	chr19:32836514-32878571:+	0.3	7.44	4.58E-13	Bipolar disorder	
THCA	cis	1	rs11880706	chr19:6080482	RFX2	chr19:5993176-6110664:-	-0.37	-3.91	0.000107	Bipolar disorder and schizophrenia	
THCA	cis	1	rs11880710	chr19:12156895	ZNF442	chr19:12460185-12476475:-	0.29	3.7	0.000242	Multiple sclerosis	
THCA	cis	1	rs11880710	chr19:12156895	ZNF763	chr19:12035900-12091196:+	0.24	4.51	8.21E-6	Multiple sclerosis	
THCA	cis	1	rs11882144	chr19:42072602	CEACAM21	chr19:42055886-42093196:+	0.63	16.29	9.02E-48	Schizophrenia	
THCA	cis	1	rs11882234	chr19:22145727	ZNF492	chr19:22817126-22850472:+	0.24	3.37	0.000806	Body mass index (change over time)	
THCA	cis	1	rs11882498	chr19:23060012	ZNF492	chr19:22817126-22850472:+	-0.43	-6.27	8.32E-10	Bronchopulmonary dysplasia	
THCA	cis	1	rs11883104	chr19:41923799	B3GNT8	chr19:41931265-41934635:-	-0.36	-8.32	9.47E-16	Height	
THCA	cis	1	rs11883143	chr19:32969256	DPY19L3	chr19:32896677-32975236:+	0.18	5.17	3.42E-7	Bipolar disorder	
THCA	cis	1	rs11883143	chr19:32969256	ZNF507	chr19:32836514-32878571:+	0.26	6.8	3.14E-11	Bipolar disorder	
THCA	cis	1	rs11887056	chr2:99243861	UNC50	chr2:99225042-99234975:+	-0.22	-4.45	1.07E-5	Bipolar disorder	
THCA	cis	1	rs11888062	chr2:67605358	ETAA1	chr2:67624442-67637533:+	-0.17	-4.08	5.18E-5	Pancreatic cancer	
THCA	cis	1	rs11893118	chr2:241828308	C2orf54	chr2:241825466-241835573:-	0.31	6.9	1.66E-11	Urinary metabolites	
THCA	cis	1	rs11893832	chr2:88507537	KRCC1	chr2:88326724-88355248:-	-0.23	-3.56	0.000414	Plasma clusterin levels	
THCA	cis	1	rs11893832	chr2:88507537	THNSL2	chr2:88469835-88486145:+	-0.71	-9.02	4.69E-18	Plasma clusterin levels	
THCA	cis	1	rs11893881	chr2:73824373	ALMS1P	chr2:73872046-73912692:+	0.72	11.08	1.57E-25	Metabolite levels	
THCA	cis	1	rs11893881	chr2:73824373	NAT8	chr2:73867850-73869537:-	0.42	6.55	1.47E-10	Metabolite levels	
THCA	cis	1	rs11893881	chr2:73824373	TPRKB	chr2:73956957-73964517:-	-0.14	-3.51	0.000495	Metabolite levels	
THCA	cis	1	rs11896604	chr2:54479199	C2orf73	chr2:54558071-54588714:+	-0.29	-4.33	1.83E-5	Telomere length	
THCA	cis	1	rs11896653	chr2:53227895	CHAC2	chr2:53994929-54002287:+	0.23	3.53	0.000458	Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs11898716	chr2:241828311	C2orf54	chr2:241825466-241835573:-	0.29	6.31	6.3E-10	Urinary metabolites	
THCA	cis	1	rs11899576	chr2:86256193	LOC90784	chr2:86247339-86250991:-	-0.56	-6.62	9.48E-11	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs11899740	chr2:73631212	ALMS1P	chr2:73872046-73912692:+	0.73	11	2.98E-25	Metabolite levels	
THCA	cis	1	rs11899740	chr2:73631212	NAT8	chr2:73867850-73869537:-	0.4	6.01	3.77E-9	Metabolite levels	
THCA	cis	1	rs11899902	chr2:73631564	ALMS1P	chr2:73872046-73912692:+	0.71	11.16	7.15E-26	Metabolite levels	
THCA	cis	1	rs11899902	chr2:73631564	NAT8	chr2:73867850-73869537:-	0.39	6.13	1.89E-9	Metabolite levels	
THCA	cis	1	rs11901272	chr2:73720444	ALMS1P	chr2:73872046-73912692:+	0.69	10.92	6.16E-25	Metabolite levels	
THCA	cis	1	rs11901272	chr2:73720444	NAT8	chr2:73867850-73869537:-	0.36	5.67	2.51E-8	Metabolite levels	
THCA	cis	1	rs11901272	chr2:73720444	TPRKB	chr2:73956957-73964517:-	-0.17	-4.42	1.22E-5	Metabolite levels	
THCA	cis	1	rs11902295	chr2:70084599	ASPRV1	chr2:70187226-70314147:-	-0.14	-3.48	0.000545	Colorectal or endometrial cancer	
THCA	cis	1	rs11902295	chr2:70084599	SNRNP27	chr2:70121090-70132348:+	0.17	4.06	5.77E-5	Colorectal or endometrial cancer	
THCA	cis	1	rs11903034	chr2:70060278	SNRNP27	chr2:70121090-70132348:+	0.16	3.7	0.000236	Colorectal or endometrial cancer	
THCA	cis	1	rs11903916	chr2:73815328	ALMS1P	chr2:73872046-73912692:+	0.7	11.34	1.46E-26	Metabolite levels	
THCA	cis	1	rs11903916	chr2:73815328	NAT8	chr2:73867850-73869537:-	0.39	6.26	8.44E-10	Metabolite levels	
THCA	cis	1	rs11903916	chr2:73815328	TPRKB	chr2:73956957-73964517:-	-0.16	-4.11	4.71E-5	Metabolite levels	
THCA	cis	1	rs1190447	chr2:233420052	EIF4E2	chr2:233415357-233448349:+	0.27	5.19	3.08E-7	Height	
THCA	cis	1	rs1190448	chr2:233419084	EIF4E2	chr2:233415357-233448349:+	0.23	4.53	7.42E-6	Height	
THCA	cis	1	rs1190450	chr2:233418302	EIF4E2	chr2:233415357-233448349:+	0.24	4.58	5.96E-6	Height	
THCA	cis	1	rs11905214	chr20:47888610	DDX27	chr20:47835832-47860612:+	0.27	4.94	1.06E-6	Height	
THCA	cis	1	rs11905354	chr20:33677164	PROCR	chr20:33758727-33765164:+	-0.32	-5.27	2.05E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs11905354	chr20:33677164	TRPC4AP	chr20:33590215-33680618:-	0.28	3.53	0.000455	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs1190554	chr14:102918686	ANKRD9	chr14:102973198-102976128:-	0.17	3.61	0.000344	QT interval	
THCA	cis	1	rs1190596	chr14:102595625	RAGE	chr14:102690838-102771531:-	0.26	7.55	2.24E-13	Behavioural disinhibition (generation interaction)	
THCA	cis	1	rs11906148	chr20:33784021	PROCR	chr20:33758727-33765164:+	-0.31	-4.93	1.16E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs11906148	chr20:33784021	TRPC4AP	chr20:33590215-33680618:-	0.33	4.14	4.06E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs11906274	chr20:3945536	MAVS	chr20:3827449-3856761:+	-0.23	-3.56	0.000403	Response to antidepressants in depression	
THCA	cis	1	rs11906318	chr20:33729442	MMP24	chr20:33814539-33864804:+	-0.22	-3.48	0.000541	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs11906318	chr20:33729442	PROCR	chr20:33758727-33765164:+	-0.31	-5.09	5.18E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs11906318	chr20:33729442	TRPC4AP	chr20:33590215-33680618:-	0.29	3.74	0.00021	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs11907010	chr20:33737661	PROCR	chr20:33758727-33765164:+	-0.33	-5.35	1.37E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs11907010	chr20:33737661	TRPC4AP	chr20:33590215-33680618:-	0.31	3.89	0.000114	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs11907011	chr20:33767770	PROCR	chr20:33758727-33765164:+	-0.31	-5	8.22E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs11907011	chr20:33767770	TRPC4AP	chr20:33590215-33680618:-	0.31	3.86	0.00013	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs11907438	chr20:33641220	PROCR	chr20:33758727-33765164:+	-0.34	-5.6	3.69E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs11907546	chr20:32719797	RALY	chr20:32581732-32672675:+	0.14	4.21	3.02E-5	Cancer;Cancer (pleiotropy)	
THCA	cis	1	rs11907594	chr20:33673843	PROCR	chr20:33758727-33765164:+	-0.32	-5.35	1.4E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs11907594	chr20:33673843	TRPC4AP	chr20:33590215-33680618:-	0.28	3.54	0.000437	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs11908100	chr20:33729479	MMP24	chr20:33814539-33864804:+	-0.22	-3.39	0.000746	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs11908100	chr20:33729479	PROCR	chr20:33758727-33765164:+	-0.31	-5.09	5.28E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs11908100	chr20:33729479	TRPC4AP	chr20:33590215-33680618:-	0.29	3.73	0.000213	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs11908232	chr20:33729477	MMP24	chr20:33814539-33864804:+	-0.22	-3.39	0.000746	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs11908232	chr20:33729477	PROCR	chr20:33758727-33765164:+	-0.31	-5.09	5.28E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs11908232	chr20:33729477	TRPC4AP	chr20:33590215-33680618:-	0.29	3.73	0.000213	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs11908424	chr20:61863955	BIRC7	chr20:61867276-61871853:+	0.3	3.75	0.000199	Response to cytadine analogues (cytosine arabinoside)	
THCA	cis	1	rs11908424	chr20:61863955	NKAIN4	chr20:61872137-61885892:-	0.31	3.49	0.000536	Response to cytadine analogues (cytosine arabinoside)	
THCA	cis	1	rs11908473	chr20:60957770	CABLES2	chr20:60963686-60982339:-	-0.19	-3.47	0.000559	Colorectal cancer	
THCA	cis	1	rs11908683	chr20:33720920	PROCR	chr20:33758727-33765164:+	-0.32	-5.22	2.66E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs11908683	chr20:33720920	TRPC4AP	chr20:33590215-33680618:-	0.3	3.72	0.000222	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs11918615	chr3:72942407	GXYLT2	chr3:72937385-73024520:+	0.26	5.65	2.69E-8	Motion sickness	
THCA	cis	1	rs11919350	chr3:134235970	ANAPC13	chr3:134196547-134204865:-	-0.38	-12.04	2.37E-29	Height	
THCA	cis	1	rs11919350	chr3:134235970	CEP63	chr3:134204575-134293852:+	-0.31	-6.57	1.33E-10	Height	
THCA	cis	1	rs11920570	chr3:122090102	WDR5B	chr3:122130700-122134882:-	0.27	5.31	1.72E-7	Resting heart rate	
THCA	cis	1	rs11920900	chr3:49823024	CCDC36	chr3:49235861-49295537:+	0.19	4.02	6.85E-5	Resting heart rate	
THCA	cis	1	rs11920900	chr3:49823024	RBM6	chr3:49977592-50137484:+	-0.14	-4.32	1.89E-5	Resting heart rate	
THCA	cis	1	rs11923562	chr3:41760331	ULK4	chr3:41288091-42003660:-	0.99	16.82	3.18E-50	Diastolic blood pressure	
THCA	cis	1	rs11925037	chr3:151079041	GPR87	chr3:151011876-151034636:-	0.19	4.13	4.23E-5	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs11925037	chr3:151079041	P2RY14	chr3:150929905-150996230:-	-0.19	-3.9	0.00011	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs11926145	chr3:151019928	GPR87	chr3:151011876-151034636:-	0.21	4.73	2.91E-6	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs11926145	chr3:151019928	P2RY14	chr3:150929905-150996230:-	-0.2	-4.17	3.66E-5	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs11927068	chr3:134266321	ANAPC13	chr3:134196547-134204865:-	-0.39	-12.14	9.6E-30	Height	
THCA	cis	1	rs11927068	chr3:134266321	CEP63	chr3:134204575-134293852:+	-0.31	-6.6	1.07E-10	Height	
THCA	cis	1	rs11927309	chr3:38935115	WDR48	chr3:39093507-39138149:+	0.29	3.76	0.000189	Social communication problems	
THCA	cis	1	rs11928090	chr3:49604904	AMIGO3	chr3:49754268-49757238:-	-0.15	-3.4	0.000719	Menarche (age at onset)	
THCA	cis	1	rs11928090	chr3:49604904	GMPPB	chr3:49758932-49761384:-	-0.17	-3.94	9.41E-5	Menarche (age at onset)	
THCA	cis	1	rs11928090	chr3:49604904	P4HTM	chr3:49027341-49044579:+	0.17	4.23	2.78E-5	Menarche (age at onset)	
THCA	cis	1	rs11928090	chr3:49604904	WDR6	chr3:49044637-49053386:+	-0.18	-3.74	0.000206	Menarche (age at onset)	
THCA	cis	1	rs11928499	chr3:134232350	ANAPC13	chr3:134196547-134204865:-	-0.38	-12.04	2.37E-29	Height	
THCA	cis	1	rs11928499	chr3:134232350	CEP63	chr3:134204575-134293852:+	-0.31	-6.57	1.33E-10	Height	
THCA	cis	1	rs11928580	chr3:41885722	ULK4	chr3:41288091-42003660:-	1.09	20.61	5.22E-68	Diastolic blood pressure	
THCA	cis	1	rs11930105	chr4:17972078	DCAF16	chr4:17802280-17812381:-	-0.2	-4.45	1.05E-5	Height	
THCA	cis	1	rs11930366	chr4:17960168	DCAF16	chr4:17802280-17812381:-	-0.2	-4.37	1.51E-5	Height	
THCA	cis	1	rs11931061	chr4:56338793	TMEM165	chr4:56262090-56292342:+	-0.16	-4.06	5.7E-5	Personality dimensions	
THCA	cis	1	rs11931074	chr4:90639515	MMRN1	chr4:90816003-90875778:+	0.32	4.07	5.41E-5	Parkinson's disease	
THCA	cis	1	rs11932207	chr4:71330534	AMTN	chr4:71384298-71398459:+	0.22	5.24	2.41E-7	Alcoholism (heaviness of drinking)	
THCA	cis	1	rs11933575	chr4:17971138	DCAF16	chr4:17802280-17812381:-	-0.2	-4.41	1.26E-5	Height	
THCA	cis	1	rs11933767	chr4:17967896	DCAF16	chr4:17802280-17812381:-	-0.2	-4.42	1.24E-5	Height	
THCA	cis	1	rs11936911	chr4:17948668	DCAF16	chr4:17802280-17812381:-	-0.2	-4.47	9.97E-6	Height	
THCA	cis	1	rs11936915	chr4:17948497	DCAF16	chr4:17802280-17812381:-	-0.19	-4.37	1.54E-5	Height	
THCA	cis	1	rs11938188	chr4:17973698	DCAF16	chr4:17802280-17812381:-	-0.2	-4.41	1.26E-5	Height	
THCA	cis	1	rs11942153	chr4:106960172	TBCK	chr4:106967233-107237861:-	0.32	6.73	5.01E-11	Airflow obstruction	
THCA	cis	1	rs11944331	chr4:90690329	MMRN1	chr4:90816003-90875778:+	0.3	3.81	0.000159	Parkinson's disease	
THCA	cis	1	rs11945223	chr4:90643325	MMRN1	chr4:90816003-90875778:+	0.31	3.9	0.00011	Parkinson's disease	
THCA	cis	1	rs11945359	chr4:17960008	DCAF16	chr4:17802280-17812381:-	-0.19	-4.27	2.34E-5	Height	
THCA	cis	1	rs11948089	chr5:110464393	TSLP	chr5:110405778-110413722:+	-0.39	-5.31	1.65E-7	Eosinophil counts	
THCA	cis	1	rs11950957	chr5:150253914	LOC134466	chr5:150310000-150326146:-	0.37	5.2	2.97E-7	Crohn's disease	
THCA	cis	1	rs11950957	chr5:150253914	ZNF300	chr5:150273964-150284391:-	0.15	3.4	0.000719	Crohn's disease	
THCA	cis	1	rs11951515	chr5:43382858	C5orf34	chr5:43486810-43515187:-	-0.16	-3.71	0.000233	Metabolite levels  (X-11787)	
THCA	cis	1	rs11951694	chr5:150254338	LOC134466	chr5:150310000-150326146:-	0.37	5.2	2.97E-7	Crohn's disease	
THCA	cis	1	rs11951694	chr5:150254338	ZNF300	chr5:150273964-150284391:-	0.15	3.4	0.000719	Crohn's disease	
THCA	cis	1	rs11952868	chr5:2783714	IRX2	chr5:2746281-2751769:-	-0.25	-3.84	0.000142	Toenail selenium levels	
THCA	cis	1	rs11955172	chr5:150254378	LOC134466	chr5:150310000-150326146:-	0.37	5.2	2.97E-7	Crohn's disease	
THCA	cis	1	rs11955172	chr5:150254378	ZNF300	chr5:150273964-150284391:-	0.15	3.4	0.000719	Crohn's disease	
THCA	cis	1	rs11957134	chr5:150230950	LOC134466	chr5:150310000-150326146:-	-0.46	-6.17	1.47E-9	Crohn's disease	
THCA	cis	1	rs11957134	chr5:150230950	ZNF300	chr5:150273964-150284391:-	-0.16	-3.42	0.000674	Crohn's disease	
THCA	cis	1	rs11961560	chr6:170130121	C6orf70	chr6:170151721-170181617:+	0.25	5.08	5.39E-7	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs11961560	chr6:170130121	WDR27	chr6:169857307-170102159:-	-0.18	-5.53	5.37E-8	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs11962024	chr6:25610203	SCGN	chr6:25652429-25702006:+	-0.3	-5.89	7.43E-9	Uric acid levels	
THCA	cis	1	rs11962089	chr6:105612220	BVES	chr6:105544700-105585049:-	0.23	3.79	0.00017	Multiple sclerosis	
THCA	cis	1	rs11962469	chr6:24482421	GPLD1	chr6:24428405-24489850:-	0.2	3.75	0.0002	Hematological and biochemical traits	
THCA	cis	1	rs11962469	chr6:24482421	MRS2	chr6:24403153-24425809:+	0.24	5.35	1.35E-7	Hematological and biochemical traits	
THCA	cis	1	rs11965538	chr6:28239915	ZKSCAN3	chr6:28317691-28334523:+	-0.27	-5.25	2.35E-7	Depression	
THCA	cis	1	rs11965538	chr6:28239915	ZNF187	chr6:28234788-28245978:+	-0.34	-6.81	3.0E-11	Depression	
THCA	cis	1	rs11965538	chr6:28239915	ZNF193	chr6:28193067-28201260:+	0.2	3.76	0.000193	Depression	
THCA	cis	1	rs11965538	chr6:28239915	ZNF323	chr6:28292517-28324048:-	0.45	6.09	2.31E-9	Depression	
THCA	cis	1	rs11965538	chr6:28239915	ZNF389	chr6:28129551-28137375:+	-0.48	-6.8	3.1E-11	Depression	
THCA	cis	1	rs11965538	chr6:28239915	ZSCAN23	chr6:28393287-28411279:-	0.23	5.04	6.61E-7	Depression	
THCA	cis	1	rs11970772	chr6:41925290	BYSL	chr6:41888965-41900782:+	-0.18	-3.9	0.000112	Hematological parameters	
THCA	cis	1	rs11971779	chr7:139040258	KLRG2	chr7:139138089-139168457:-	0.2	3.66	0.000277	Diisocyanate-induced asthma	
THCA	cis	1	rs11971949	chr7:65626014	ASL	chr7:65540776-65558321:+	0.17	4.35	1.66E-5	Aortic root size	
THCA	cis	1	rs11971949	chr7:65626014	GUSB	chr7:65425675-65447246:-	-0.26	-5.05	6.25E-7	Aortic root size	
THCA	cis	1	rs11971949	chr7:65626014	LOC729156	chr7:66274980-66309813:-	-0.17	-3.64	0.0003	Aortic root size	
THCA	cis	1	rs11971949	chr7:65626014	RABGEF1	chr7:66093890-66276446:+	-0.66	-14.29	7.82E-39	Aortic root size	
THCA	cis	1	rs11974219	chr7:65647410	ASL	chr7:65540776-65558321:+	0.16	4.28	2.23E-5	Aortic root size	
THCA	cis	1	rs11974219	chr7:65647410	GUSB	chr7:65425675-65447246:-	-0.27	-5.32	1.61E-7	Aortic root size	
THCA	cis	1	rs11974219	chr7:65647410	LOC729156	chr7:66274980-66309813:-	-0.16	-3.47	0.000572	Aortic root size	
THCA	cis	1	rs11974219	chr7:65647410	RABGEF1	chr7:66093890-66276446:+	-0.66	-14.15	3.08E-38	Aortic root size	
THCA	cis	1	rs11974264	chr7:65647582	ASL	chr7:65540776-65558321:+	0.17	4.34	1.75E-5	Aortic root size	
THCA	cis	1	rs11974264	chr7:65647582	GUSB	chr7:65425675-65447246:-	-0.26	-5	8.15E-7	Aortic root size	
THCA	cis	1	rs11974264	chr7:65647582	LOC729156	chr7:66274980-66309813:-	-0.17	-3.6	0.000352	Aortic root size	
THCA	cis	1	rs11974264	chr7:65647582	RABGEF1	chr7:66093890-66276446:+	-0.67	-14.41	2.25E-39	Aortic root size	
THCA	cis	1	rs11974384	chr7:12256540	VWDE	chr7:12370509-12443852:-	-0.23	-3.98	8.11E-5	Response to amphetamines	
THCA	cis	1	rs11974409	chr7:72989390	MLXIPL	chr7:73007524-73038870:-	0.23	4.34	1.76E-5	Triglycerides	
THCA	cis	1	rs11974702	chr7:99163951	ARPC1B	chr7:98972329-98992402:+	0.18	3.44	0.000633	Blood metabolite levels	
THCA	cis	1	rs11975942	chr7:143740580	ARHGEF35	chr7:143883677-143892736:-	-0.52	-10.71	3.82E-24	Obesity-related traits	
THCA	cis	1	rs11975942	chr7:143740580	OR2A1	chr7:144015236-144016148:+;chr7	-0.19	-3.89	0.000116	Obesity-related traits	
THCA	cis	1	rs11975942	chr7:143740580	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-6.48	2.25E-10	Obesity-related traits	
THCA	cis	1	rs11976020	chr7:72247800	CLDN4	chr7:73242074-73247014:+	0.13	3.58	0.000379	Educational attainment (years of education)	
THCA	cis	1	rs11976020	chr7:72247800	TYW1B	chr7:72023729-72298813:-	1.07	23.68	1.37E-82	Educational attainment (years of education)	
THCA	cis	1	rs11976031	chr7:87365282	DBF4	chr7:87505544-87538856:+	-0.27	-3.75	0.000202	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs11976037	chr7:143741024	ARHGEF35	chr7:143883677-143892736:-	-0.52	-10.69	4.63E-24	Obesity-related traits	
THCA	cis	1	rs11976037	chr7:143741024	OR2A1	chr7:144015236-144016148:+;chr7	-0.19	-3.86	0.000129	Obesity-related traits	
THCA	cis	1	rs11976037	chr7:143741024	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-6.45	2.77E-10	Obesity-related traits	
THCA	cis	1	rs11976180	chr7:143741580	ARHGEF35	chr7:143883677-143892736:-	-0.52	-10.69	4.75E-24	Obesity-related traits	
THCA	cis	1	rs11976180	chr7:143741580	OR2A1	chr7:144015236-144016148:+;chr7	-0.19	-3.86	0.000129	Obesity-related traits	
THCA	cis	1	rs11976180	chr7:143741580	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-6.42	3.29E-10	Obesity-related traits	
THCA	cis	1	rs11976447	chr7:44752100	OGDH	chr7:44646171-44748668:+	0.19	3.55	0.000421	Systolic blood pressure change trajectories	
THCA	cis	1	rs11979476	chr7:128993756	ATP6V1F	chr7:128502898-128505902:+	-0.11	-3.38	0.000797	White matter hyperintensity burden	
THCA	cis	1	rs1198433	chr1:23756695	ASAP3	chr1:23755056-23811057:-	0.28	4.67	3.93E-6	Cholesterol, total	
THCA	cis	1	rs1198433	chr1:23756695	TCEA3	chr1:23707555-23751261:-	0.22	4.05	5.86E-5	Cholesterol, total	
THCA	cis	1	rs1198440	chr1:23780861	ASAP3	chr1:23755056-23811057:-	0.31	4.99	8.48E-7	Cholesterol, total	
THCA	cis	1	rs1198440	chr1:23780861	TCEA3	chr1:23707555-23751261:-	0.24	4.41	1.29E-5	Cholesterol, total	
THCA	cis	1	rs11984566	chr8:66851472	PDE7A	chr8:66629906-66753755:-	0.17	3.81	0.000156	Myopia (pathological)	
THCA	cis	1	rs11984618	chr8:66851464	PDE7A	chr8:66629906-66753755:-	0.17	3.69	0.00025	Myopia (pathological)	
THCA	cis	1	rs11986470	chr8:66836283	PDE7A	chr8:66629906-66753755:-	0.18	3.92	0.000101	Myopia (pathological)	
THCA	cis	1	rs11986631	chr8:66820326	PDE7A	chr8:66629906-66753755:-	0.18	3.92	0.000101	Myopia (pathological)	
THCA	cis	1	rs11988157	chr8:124194740	FAM83A	chr8:124191287-124222317:+	0.3	4.14	4.07E-5	Urinary uromodulin levels	
THCA	cis	1	rs11992152	chr8:124189455	FAM83A	chr8:124191287-124222317:+	-0.29	-3.85	0.000136	Urinary uromodulin levels	
THCA	cis	1	rs11995536	chr8:120945268	DSCC1	chr8:120846182-120868170:-	-0.26	-5.11	4.56E-7	Interstitial lung disease	
THCA	cis	1	rs11995572	chr8:89592083	MMP16	chr8:89049462-89339717:-	0.15	3.39	0.000764	Schizophrenia	
THCA	cis	1	rs11995730	chr8:89471148	MMP16	chr8:89049462-89339717:-	0.31	5.19	3.04E-7	Electrodermal activity	
THCA	cis	1	rs11996961	chr8:10812204	CTSB	chr8:11700036-11725646:-	0.22	3.5	0.000508	Asthma and hay fever	
THCA	cis	1	rs1201451	chr2:233419396	EIF4E2	chr2:233415357-233448349:+	0.24	4.56	6.41E-6	Height	
THCA	cis	1	rs12021578	chr1:107597501	NTNG1	chr1:107682629-108024471:+	0.21	3.62	0.00033	AIDS	
THCA	cis	1	rs12021587	chr1:46472759	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.19	3.35E-22	Body mass index	
THCA	cis	1	rs12021587	chr1:46472759	GPBP1L1	chr1:46092978-46152302:-	0.15	3.78	0.000174	Body mass index	
THCA	cis	1	rs12021587	chr1:46472759	MMACHC	chr1:45965856-45976737:+	-0.21	-4.59	5.61E-6	Body mass index	
THCA	cis	1	rs12021587	chr1:46472759	MUTYH	chr1:45794915-45806142:-	0.3	8.16	3.05E-15	Body mass index	
THCA	cis	1	rs12022194	chr1:156312331	BGLAP	chr1:156182784-156213112:+	0.23	5.51	5.77E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12022194	chr1:156312331	C1orf85	chr1:156259882-156265449:-	-0.17	-4.09	5.11E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12022194	chr1:156312331	CCT3	chr1:156278752-156308195:-	-0.33	-7.07	5.4E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12022452	chr1:40953300	DEM1	chr1:40974433-40982212:+	0.33	4.64	4.42E-6	Age-related hearing impairment (interaction)	
THCA	cis	1	rs12022784	chr1:179469016	C1orf125	chr1:179335107-179523868:+	0.33	3.76	0.000191	Multiple sclerosis (age of onset)	
THCA	cis	1	rs12023357	chr1:179474732	C1orf125	chr1:179335107-179523868:+	0.33	3.76	0.000191	Multiple sclerosis (age of onset)	
THCA	cis	1	rs12023438	chr1:156254358	BGLAP	chr1:156182784-156213112:+	0.23	5.32	1.63E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12023438	chr1:156254358	C1orf85	chr1:156259882-156265449:-	-0.17	-3.99	7.72E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12023438	chr1:156254358	CCT3	chr1:156278752-156308195:-	-0.32	-6.95	1.24E-11	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12023704	chr1:156294149	BGLAP	chr1:156182784-156213112:+	0.23	5.56	4.57E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12023704	chr1:156294149	C1orf85	chr1:156259882-156265449:-	-0.17	-4.08	5.25E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12023704	chr1:156294149	CCT3	chr1:156278752-156308195:-	-0.33	-7.24	1.76E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12024813	chr1:156224529	BGLAP	chr1:156182784-156213112:+	0.23	5.2	2.93E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12024813	chr1:156224529	C1orf85	chr1:156259882-156265449:-	-0.17	-3.94	9.52E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12024813	chr1:156224529	CCT3	chr1:156278752-156308195:-	-0.34	-7.28	1.37E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12024813	chr1:156224529	PAQR6	chr1:156213207-156217843:-	-0.12	-3.52	0.000472	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12024880	chr1:155908910	FDPS	chr1:155278539-155290457:+	-0.21	-4.3	2.04E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs12024880	chr1:155908910	RIT1	chr1:155867601-155881177:-	0.17	3.84	0.000139	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs12027103	chr1:156244856	BGLAP	chr1:156182784-156213112:+	0.23	5.47	7.3E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12027103	chr1:156244856	C1orf85	chr1:156259882-156265449:-	-0.17	-3.96	8.8E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12027103	chr1:156244856	CCT3	chr1:156278752-156308195:-	-0.32	-7.02	7.8E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12027412	chr1:155908930	FDPS	chr1:155278539-155290457:+	-0.2	-4.1	4.8E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs12027412	chr1:155908930	RIT1	chr1:155867601-155881177:-	0.17	3.88	0.000117	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs12027741	chr1:156248148	BGLAP	chr1:156182784-156213112:+	0.23	5.47	7.3E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12027741	chr1:156248148	C1orf85	chr1:156259882-156265449:-	-0.17	-3.96	8.8E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12027741	chr1:156248148	CCT3	chr1:156278752-156308195:-	-0.32	-7.02	7.8E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12029787	chr1:179473917	C1orf125	chr1:179335107-179523868:+	0.33	3.76	0.000191	Multiple sclerosis (age of onset)	
THCA	cis	1	rs12030612	chr1:113215637	MOV10	chr1:113217048-113243367:+	0.18	4.16	3.82E-5	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs12030612	chr1:113215637	ST7L	chr1:113066142-113162405:-	0.67	10.64	7.06E-24	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs12030641	chr1:113215717	MOV10	chr1:113217048-113243367:+	0.18	4.16	3.82E-5	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs12030641	chr1:113215717	ST7L	chr1:113066142-113162405:-	0.67	10.64	7.06E-24	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs12031278	chr1:40976918	DEM1	chr1:40974433-40982212:+	0.35	4.97	9.51E-7	Age-related hearing impairment (interaction)	
THCA	cis	1	rs1203156	chr6:88079694	C6orf162	chr6:88032306-88052043:+	-0.17	-3.61	0.000334	Depressive episodes in bipolar disorder	
THCA	cis	1	rs1203156	chr6:88079694	C6orf164	chr6:88032306-88109459:+	-0.32	-5.98	4.39E-9	Depressive episodes in bipolar disorder	
THCA	cis	1	rs1203156	chr6:88079694	SLC35A1	chr6:88146444-88222051:+	0.17	3.42	0.000671	Depressive episodes in bipolar disorder	
THCA	cis	1	rs12034162	chr1:40964605	DEM1	chr1:40974433-40982212:+	0.33	4.72	3.1E-6	Age-related hearing impairment (interaction)	
THCA	cis	1	rs12037222	chr1:40064961	PABPC4	chr1:40026485-40042521:-	-0.29	-4.94	1.07E-6	C-reactive protein levels or triglyceride levels (pleiotropy)	
THCA	cis	1	rs12038203	chr1:156248265	BGLAP	chr1:156182784-156213112:+	0.23	5.47	7.3E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12038203	chr1:156248265	C1orf85	chr1:156259882-156265449:-	-0.17	-3.96	8.8E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12038203	chr1:156248265	CCT3	chr1:156278752-156308195:-	-0.32	-7.02	7.8E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12038217	chr1:156248297	BGLAP	chr1:156182784-156213112:+	0.23	5.47	7.3E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12038217	chr1:156248297	C1orf85	chr1:156259882-156265449:-	-0.17	-3.96	8.8E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12038217	chr1:156248297	CCT3	chr1:156278752-156308195:-	-0.32	-7.02	7.8E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12038481	chr1:156284815	BGLAP	chr1:156182784-156213112:+	0.23	5.55	4.68E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12038481	chr1:156284815	C1orf85	chr1:156259882-156265449:-	-0.17	-4.16	3.82E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12038481	chr1:156284815	CCT3	chr1:156278752-156308195:-	-0.33	-7.21	2.16E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12039431	chr1:38082122	SNIP1	chr1:38002145-38019903:-	0.23	5.42	9.43E-8	Epithelial ovarian cancer	
THCA	cis	1	rs12040868	chr1:156284803	BGLAP	chr1:156182784-156213112:+	0.23	5.56	4.57E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12040868	chr1:156284803	C1orf85	chr1:156259882-156265449:-	-0.17	-4.08	5.25E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12040868	chr1:156284803	CCT3	chr1:156278752-156308195:-	-0.33	-7.24	1.76E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12040988	chr1:113173804	MOV10	chr1:113217048-113243367:+	0.18	4.08	5.34E-5	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs12040988	chr1:113173804	ST7L	chr1:113066142-113162405:-	0.68	10.73	3.34E-24	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs12041164	chr1:156279811	BGLAP	chr1:156182784-156213112:+	0.23	5.39	1.09E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12041164	chr1:156279811	C1orf85	chr1:156259882-156265449:-	-0.17	-4.18	3.53E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12041164	chr1:156279811	CCT3	chr1:156278752-156308195:-	-0.33	-7.13	3.62E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12045339	chr1:156294211	BGLAP	chr1:156182784-156213112:+	0.23	5.39	1.09E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12045339	chr1:156294211	C1orf85	chr1:156259882-156265449:-	-0.17	-4.18	3.53E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12045339	chr1:156294211	CCT3	chr1:156278752-156308195:-	-0.33	-7.13	3.62E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12046650	chr1:38082123	SNIP1	chr1:38002145-38019903:-	0.23	5.42	9.43E-8	Epithelial ovarian cancer	
THCA	cis	1	rs12046961	chr1:236032287	LYST	chr1:235824345-236046940:-	-0.32	-9.69	2.2E-20	Systemic lupus erythematosus	
THCA	cis	1	rs12047116	chr1:121185770	HIST2H2BA	chr1:120906034-120914842:+	0.22	5.01	7.58E-7	Hip geometry	
THCA	cis	1	rs12047808	chr1:179469314	C1orf125	chr1:179335107-179523868:+	0.32	3.62	0.000324	Multiple sclerosis (age of onset)	
THCA	cis	1	rs1204780	chr6:116529114	TSPYL4	chr6:116571133-116575261:-	-0.15	-4.2	3.22E-5	Dental caries	
THCA	cis	1	rs1204781	chr6:116530201	TSPYL4	chr6:116571133-116575261:-	-0.15	-4.2	3.22E-5	Dental caries	
THCA	cis	1	rs1204782	chr6:116530767	TSPYL4	chr6:116571133-116575261:-	-0.15	-4.2	3.22E-5	Dental caries	
THCA	cis	1	rs1204783	chr6:116530795	TSPYL4	chr6:116571133-116575261:-	-0.15	-4.2	3.22E-5	Dental caries	
THCA	cis	1	rs1204788	chr6:116536251	TSPYL4	chr6:116571133-116575261:-	-0.14	-3.96	8.52E-5	Dental caries	
THCA	cis	1	rs1204789	chr6:116536612	TSPYL4	chr6:116571133-116575261:-	-0.15	-4.13	4.33E-5	Dental caries	
THCA	cis	1	rs1204793	chr6:116540842	DSE	chr6:116575336-116759440:+	0.13	3.45	0.0006	Dental caries	
THCA	cis	1	rs1204793	chr6:116540842	TSPYL4	chr6:116571133-116575261:-	-0.15	-4.07	5.53E-5	Dental caries	
THCA	cis	1	rs1204795	chr6:116541376	DSE	chr6:116575336-116759440:+	0.13	3.45	0.0006	Dental caries	
THCA	cis	1	rs1204795	chr6:116541376	TSPYL4	chr6:116571133-116575261:-	-0.15	-4.07	5.53E-5	Dental caries	
THCA	cis	1	rs1204798	chr6:116543847	TSPYL4	chr6:116571133-116575261:-	-0.14	-4	7.24E-5	Dental caries	
THCA	cis	1	rs1204800	chr6:116544094	DSE	chr6:116575336-116759440:+	-0.14	-3.58	0.000382	Dental caries	
THCA	cis	1	rs1204800	chr6:116544094	TSPYL4	chr6:116571133-116575261:-	0.15	4.16	3.83E-5	Dental caries	
THCA	cis	1	rs1204801	chr6:116545708	DSE	chr6:116575336-116759440:+	0.13	3.45	0.000607	Dental caries	
THCA	cis	1	rs1204801	chr6:116545708	TSPYL4	chr6:116571133-116575261:-	-0.15	-4.22	2.88E-5	Dental caries	
THCA	cis	1	rs1204807	chr6:116549281	DSE	chr6:116575336-116759440:+	0.13	3.45	0.000607	Dental caries	
THCA	cis	1	rs1204807	chr6:116549281	TSPYL4	chr6:116571133-116575261:-	-0.15	-4.22	2.88E-5	Dental caries	
THCA	cis	1	rs1204811	chr6:116552103	DSE	chr6:116575336-116759440:+	0.14	3.51	0.000491	Dental caries	
THCA	cis	1	rs1204811	chr6:116552103	TSPYL4	chr6:116571133-116575261:-	-0.15	-4.07	5.57E-5	Dental caries	
THCA	cis	1	rs1204821	chr6:116563263	DSE	chr6:116575336-116759440:+	0.14	3.54	0.000442	Dental caries	
THCA	cis	1	rs1204821	chr6:116563263	TSPYL4	chr6:116571133-116575261:-	-0.14	-4	7.42E-5	Dental caries	
THCA	cis	1	rs1204841	chr6:116519640	DSE	chr6:116575336-116759440:+	0.13	3.42	0.000683	Dental caries	
THCA	cis	1	rs1204841	chr6:116519640	TSPYL4	chr6:116571133-116575261:-	-0.15	-4.11	4.68E-5	Dental caries	
THCA	cis	1	rs1204842	chr6:116520348	DSE	chr6:116575336-116759440:+	-0.13	-3.37	0.000811	Dental caries	
THCA	cis	1	rs1204842	chr6:116520348	TSPYL4	chr6:116571133-116575261:-	0.14	3.73	0.000212	Dental caries	
THCA	cis	1	rs1204843	chr6:116520985	DSE	chr6:116575336-116759440:+	0.13	3.42	0.000683	Dental caries	
THCA	cis	1	rs1204843	chr6:116520985	TSPYL4	chr6:116571133-116575261:-	-0.15	-4.11	4.68E-5	Dental caries	
THCA	cis	1	rs1204848	chr6:116524263	DSE	chr6:116575336-116759440:+	0.13	3.37	0.000807	Dental caries	
THCA	cis	1	rs1204848	chr6:116524263	TSPYL4	chr6:116571133-116575261:-	-0.15	-4.14	4.14E-5	Dental caries	
THCA	cis	1	rs1204851	chr6:116527120	DSE	chr6:116575336-116759440:+	0.13	3.37	0.000807	Dental caries	
THCA	cis	1	rs1204851	chr6:116527120	TSPYL4	chr6:116571133-116575261:-	-0.15	-4.14	4.14E-5	Dental caries	
THCA	cis	1	rs12048678	chr1:40947768	DEM1	chr1:40974433-40982212:+	0.31	4.27	2.4E-5	Age-related hearing impairment (interaction)	
THCA	cis	1	rs12049351	chr1:229718001	ABCB10	chr1:229652330-229694442:-	-0.16	-3.51	0.000488	Circulating myeloperoxidase levels (plasma)	
THCA	cis	1	rs12049351	chr1:229718001	NUP133	chr1:229577045-229644088:-	-0.17	-3.67	0.00027	Circulating myeloperoxidase levels (plasma)	
THCA	cis	1	rs12049588	chr1:46472422	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.19	3.35E-22	Body mass index	
THCA	cis	1	rs12049588	chr1:46472422	GPBP1L1	chr1:46092978-46152302:-	0.15	3.78	0.000174	Body mass index	
THCA	cis	1	rs12049588	chr1:46472422	MMACHC	chr1:45965856-45976737:+	-0.21	-4.59	5.61E-6	Body mass index	
THCA	cis	1	rs12049588	chr1:46472422	MUTYH	chr1:45794915-45806142:-	0.3	8.16	3.05E-15	Body mass index	
THCA	cis	1	rs12050300	chr14:74386523	PTGR2	chr14:74318534-74352166:+	0.36	4.74	2.84E-6	Morning vs. evening chronotype	
THCA	cis	1	rs12050434	chr14:74341438	PTGR2	chr14:74318534-74352166:+	0.33	4.51	8.1E-6	Morning vs. evening chronotype	
THCA	cis	1	rs12051443	chr16:71691329	MARVELD3	chr16:71660070-71675866:+	-0.17	-3.67	0.000273	Prostate cancer	
THCA	cis	1	rs12051443	chr16:71691329	ZNF19	chr16:71507976-71523254:-	-0.19	-4.09	5.06E-5	Prostate cancer	
THCA	cis	1	rs12052257	chr2:202241594	ALS2CR12	chr2:202153148-202222101:-	0.3	5.88	7.73E-9	Basal cell carcinoma	
THCA	cis	1	rs12052257	chr2:202241594	PPIL3	chr2:201735680-201753999:-	0.19	3.99	7.8E-5	Basal cell carcinoma	
THCA	cis	1	rs12053254	chr2:190607153	ASNSD1	chr2:190526125-190535556:+	-0.69	-6.75	4.18E-11	Subcutaneous adipose tissue	
THCA	cis	1	rs12053519	chr2:99875018	LIPT1	chr2:99771418-99779611:+	0.21	4.07	5.54E-5	IgG glycosylation	
THCA	cis	1	rs12054923	chr5:150249059	LOC134466	chr5:150310000-150326146:-	0.4	5.53	5.29E-8	Crohn's disease	
THCA	cis	1	rs12058198	chr1:31854391	ZCCHC17	chr1:31769842-31837780:+	-0.3	-5.85	9.06E-9	Schizophrenia	
THCA	cis	1	rs12070216	chr1:9156814	H6PD	chr1:9294863-9331392:+	0.18	3.52	0.000478	Response to antidepressant treatment (citalopram)	
THCA	cis	1	rs12078461	chr1:117472049	IGSF3	chr1:117117031-117210314:-	0.26	3.41	0.000695	Erectile dysfunction and prostate cancer treatment	
THCA	cis	1	rs12078893	chr1:76370862	ACADM	chr1:76190043-76229353:+	-0.25	-5.06	5.86E-7	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs12082448	chr1:76353225	ACADM	chr1:76190043-76229353:+	-0.22	-4.54	7.24E-6	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs12087533	chr1:117470954	IGSF3	chr1:117117031-117210314:-	0.29	3.73	0.000212	Erectile dysfunction and prostate cancer treatment	
THCA	cis	1	rs12088915	chr1:19708363	CAPZB	chr1:19665274-19811992:-	0.14	3.81	0.000156	Crohn's disease and psoriasis	
THCA	cis	1	rs12091564	chr1:145395604	GNRHR2	chr1:145509753-145516076:-	0.22	3.57	0.000387	Coronary heart disease	
THCA	cis	1	rs12091564	chr1:145395604	NOTCH2NL	chr1:145209111-145295525:+	-0.96	-14.25	1.22E-38	Coronary heart disease	
THCA	cis	1	rs12091720	chr1:76186949	ACADM	chr1:76190043-76229353:+	0.13	3.49	0.000531	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs12091720	chr1:76186949	MSH4	chr1:76262630-76378923:+	0.24	4.07	5.48E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs1209221	chr6:116528979	DSE	chr6:116575336-116759440:+	0.13	3.37	0.000807	Dental caries	
THCA	cis	1	rs1209221	chr6:116528979	TSPYL4	chr6:116571133-116575261:-	-0.15	-4.14	4.14E-5	Dental caries	
THCA	cis	1	rs1209223	chr6:116547589	DSE	chr6:116575336-116759440:+	0.13	3.45	0.000607	Dental caries	
THCA	cis	1	rs1209223	chr6:116547589	TSPYL4	chr6:116571133-116575261:-	-0.15	-4.22	2.88E-5	Dental caries	
THCA	cis	1	rs12095015	chr1:207456474	CD55	chr1:207494817-207534309:+	-0.17	-7.17	2.89E-12	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs12095069	chr1:76463072	ACADM	chr1:76190043-76229353:+	-0.22	-4.68	3.72E-6	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs12095069	chr1:76463072	ST6GALNAC3	chr1:76540389-77096669:+	-0.27	-3.73	0.000216	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs12097884	chr1:31864518	ZCCHC17	chr1:31769842-31837780:+	-0.31	-5.85	9.16E-9	Schizophrenia	
THCA	cis	1	rs12101597	chr15:65935195	DPP8	chr15:65737999-65810035:-	-0.1	-4.05	6.04E-5	Mean corpuscular hemoglobin	
THCA	cis	1	rs12101597	chr15:65935195	SLC24A1	chr15:65903704-65953256:+	-0.16	-3.91	0.000105	Mean corpuscular hemoglobin	
THCA	cis	1	rs12102486	chr16:69464474	CYB5B	chr16:69458498-69500167:+	-0.24	-4.18	3.51E-5	Blood pressure (smoking interaction)	
THCA	cis	1	rs12103803	chr17:20944604	USP22	chr17:20902908-20947073:-	-0.18	-3.83	0.000146	Blood trace element (Se levels)	
THCA	cis	1	rs12105167	chr2:48175338	MSH6	chr2:48010221-48034084:+	0.15	3.65	0.000287	Asthma	
THCA	cis	1	rs12105996	chr20:33731010	MMP24	chr20:33814539-33864804:+	-0.21	-3.36	0.00084	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs12105996	chr20:33731010	PROCR	chr20:33758727-33765164:+	-0.3	-5.19	3.07E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs12105996	chr20:33731010	TRPC4AP	chr20:33590215-33680618:-	0.29	3.79	0.000168	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs12106067	chr20:55086063	C20orf43	chr20:55043647-55093942:+	0.29	7.2	2.42E-12	Refractive astigmatism	
THCA	cis	1	rs12106339	chr21:46906012	SUMO3	chr21:46225532-46238044:-	-0.41	-4.22	2.88E-5	Alzheimer disease and age of onset	
THCA	cis	1	rs12107539	chr3:151042464	GPR87	chr3:151011876-151034636:-	0.2	4.48	9.43E-6	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs12107539	chr3:151042464	P2RY14	chr3:150929905-150996230:-	-0.21	-4.48	9.52E-6	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs12113196	chr7:44743344	OGDH	chr7:44646171-44748668:+	0.19	3.56	0.000403	Systolic blood pressure change trajectories	
THCA	cis	1	rs12117765	chr1:10268170	KIF1B	chr1:10270764-10441659:+	0.2	6.23	1.01E-9	Hepatocellular carcinoma	
THCA	cis	1	rs12117903	chr1:156311165	BGLAP	chr1:156182784-156213112:+	0.23	5.36	1.28E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12117903	chr1:156311165	C1orf85	chr1:156259882-156265449:-	-0.17	-4.04	6.17E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12117903	chr1:156311165	CCT3	chr1:156278752-156308195:-	-0.33	-7.03	7.17E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12117947	chr1:156244058	BGLAP	chr1:156182784-156213112:+	0.23	5.47	7.46E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12117947	chr1:156244058	C1orf85	chr1:156259882-156265449:-	-0.17	-4.03	6.45E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12117947	chr1:156244058	CCT3	chr1:156278752-156308195:-	-0.32	-6.99	9.47E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12117951	chr1:156305286	BGLAP	chr1:156182784-156213112:+	0.23	5.51	5.77E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12117951	chr1:156305286	C1orf85	chr1:156259882-156265449:-	-0.17	-4.09	5.11E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12117951	chr1:156305286	CCT3	chr1:156278752-156308195:-	-0.33	-7.07	5.4E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12118238	chr1:156235221	BGLAP	chr1:156182784-156213112:+	0.23	5.32	1.58E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12118238	chr1:156235221	C1orf85	chr1:156259882-156265449:-	-0.17	-4.02	6.65E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12118238	chr1:156235221	CCT3	chr1:156278752-156308195:-	-0.34	-7.31	1.13E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12118238	chr1:156235221	PAQR6	chr1:156213207-156217843:-	-0.11	-3.39	0.000748	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12118323	chr1:10469641	KIF1B	chr1:10270764-10441659:+	0.23	7.33	9.79E-13	Hepatocellular carcinoma	
THCA	cis	1	rs12120231	chr1:102734781	OLFM3	chr1:102268127-102462790:-	-0.27	-3.35	0.000876	Glomerular filtration rate	
THCA	cis	1	rs12120956	chr1:113202571	MOV10	chr1:113217048-113243367:+	0.18	4.14	4.08E-5	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs12120956	chr1:113202571	ST7L	chr1:113066142-113162405:-	0.68	10.68	5.18E-24	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs12121805	chr1:156257876	BGLAP	chr1:156182784-156213112:+	0.23	5.32	1.63E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12121805	chr1:156257876	C1orf85	chr1:156259882-156265449:-	-0.17	-3.99	7.72E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12121805	chr1:156257876	CCT3	chr1:156278752-156308195:-	-0.32	-6.95	1.24E-11	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12122180	chr1:156244559	BGLAP	chr1:156182784-156213112:+	0.23	5.47	7.3E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12122180	chr1:156244559	C1orf85	chr1:156259882-156265449:-	-0.17	-3.96	8.8E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12122180	chr1:156244559	CCT3	chr1:156278752-156308195:-	-0.32	-7.02	7.8E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12122184	chr1:31858784	ZCCHC17	chr1:31769842-31837780:+	-0.3	-5.66	2.61E-8	Schizophrenia	
THCA	cis	1	rs12122236	chr1:31858901	ZCCHC17	chr1:31769842-31837780:+	-0.32	-6.27	7.97E-10	Schizophrenia	
THCA	cis	1	rs12122290	chr1:247215810	OR2T8	chr1:248084320-248085256:+	-0.2	-3.69	0.000246	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs12122290	chr1:247215810	OR2W3	chr1:248031265-248060142:+	-0.17	-3.41	0.000715	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs12123977	chr1:76209754	ACADM	chr1:76190043-76229353:+	-0.14	-3.47	0.000561	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs12123977	chr1:76209754	MSH4	chr1:76262630-76378923:+	-0.29	-4.48	9.3E-6	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs12124015	chr1:102734224	OLFM3	chr1:102268127-102462790:-	-0.28	-3.36	0.000829	Glomerular filtration rate	
THCA	cis	1	rs12125555	chr1:41707111	SCMH1	chr1:41492875-41707788:-	-0.2	-4.71	3.22E-6	Height	
THCA	cis	1	rs12126607	chr1:76217097	ACADM	chr1:76190043-76229353:+	0.13	3.68	0.000262	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs12126607	chr1:76217097	MSH4	chr1:76262630-76378923:+	0.25	4.13	4.3E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs12126971	chr1:113231286	MOV10	chr1:113217048-113243367:+	0.18	4.22	2.96E-5	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs12126971	chr1:113231286	ST7L	chr1:113066142-113162405:-	0.67	10.68	4.91E-24	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs12127402	chr1:76205643	ACADM	chr1:76190043-76229353:+	0.14	3.68	0.000259	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs12127402	chr1:76205643	MSH4	chr1:76262630-76378923:+	0.24	4.1	4.8E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs12129035	chr1:10291166	KIF1B	chr1:10270764-10441659:+	0.21	6.6	1.09E-10	Hepatocellular carcinoma	
THCA	cis	1	rs12130075	chr1:247218491	OR2T8	chr1:248084320-248085256:+	-0.19	-3.56	0.000405	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs12130075	chr1:247218491	OR2W3	chr1:248031265-248060142:+	-0.18	-3.61	0.000336	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs12130075	chr1:247218491	TRIM58	chr1:248020501-248043436:+	-0.15	-3.34	0.000894	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs12130219	chr1:152162106	FLG2	chr1:152321214-152332482:-	0.25	4.47	9.6E-6	Inflammatory skin disease	
THCA	cis	1	rs12130219	chr1:152162106	FLG	chr1:152274651-152297679:-	0.48	8.87	1.51E-17	Inflammatory skin disease	
THCA	cis	1	rs12130219	chr1:152162106	HRNR	chr1:152184558-152196669:-	-0.24	-3.7	0.000242	Inflammatory skin disease	
THCA	cis	1	rs12130220	chr1:10359944	KIF1B	chr1:10270764-10441659:+	0.21	6.41	3.55E-10	Hepatocellular carcinoma	
THCA	cis	1	rs12130243	chr1:113169667	MOV10	chr1:113217048-113243367:+	0.18	4.08	5.34E-5	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs12130243	chr1:113169667	ST7L	chr1:113066142-113162405:-	0.68	10.73	3.34E-24	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs12130361	chr1:156260301	BGLAP	chr1:156182784-156213112:+	0.23	5.47	7.3E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12130361	chr1:156260301	C1orf85	chr1:156259882-156265449:-	-0.17	-3.96	8.8E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12130361	chr1:156260301	CCT3	chr1:156278752-156308195:-	-0.32	-7.02	7.8E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12131428	chr1:162426451	HSD17B7	chr1:162760496-162782607:+	-0.29	-3.55	0.000422	Discordance in emotional problems in monozygotic twins	
THCA	cis	1	rs12132635	chr1:10430479	KIF1B	chr1:10270764-10441659:+	0.2	6.1	2.23E-9	Hepatocellular carcinoma	
THCA	cis	1	rs12132794	chr1:156281020	BGLAP	chr1:156182784-156213112:+	-0.23	-5.46	7.62E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12132794	chr1:156281020	C1orf85	chr1:156259882-156265449:-	0.18	4.4	1.33E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12132794	chr1:156281020	CCT3	chr1:156278752-156308195:-	0.35	7.72	6.79E-14	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12132919	chr1:156318141	BGLAP	chr1:156182784-156213112:+	0.24	5.54	4.94E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12132919	chr1:156318141	C1orf85	chr1:156259882-156265449:-	-0.18	-4.15	3.86E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12132919	chr1:156318141	CCT3	chr1:156278752-156308195:-	-0.32	-6.71	5.6E-11	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12133583	chr1:113240790	MOV10	chr1:113217048-113243367:+	0.2	4.82	1.92E-6	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs12133583	chr1:113240790	ST7L	chr1:113066142-113162405:-	0.66	10.76	2.44E-24	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs12133982	chr1:119464002	WARS2	chr1:119573841-119683295:-	0.25	3.4	0.000739	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12134073	chr1:41689283	SCMH1	chr1:41492875-41707788:-	-0.2	-4.77	2.48E-6	Height	
THCA	cis	1	rs12134133	chr1:207457845	CD55	chr1:207494817-207534309:+	0.19	7.43	5.16E-13	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs12134163	chr1:119466993	WARS2	chr1:119573841-119683295:-	0.25	3.4	0.000737	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12134983	chr1:156290409	BGLAP	chr1:156182784-156213112:+	0.23	5.55	4.68E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12134983	chr1:156290409	C1orf85	chr1:156259882-156265449:-	-0.17	-4.16	3.82E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12134983	chr1:156290409	CCT3	chr1:156278752-156308195:-	-0.33	-7.21	2.16E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12135657	chr1:119470813	WARS2	chr1:119573841-119683295:-	0.26	3.49	0.000532	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12135802	chr1:65992140	LEPR	chr1:65886318-66102820:+	-0.31	-4.45	1.08E-5	Obesity (early onset extreme)	
THCA	cis	1	rs12136376	chr1:10296452	KIF1B	chr1:10270764-10441659:+	0.21	6.57	1.31E-10	Hepatocellular carcinoma	
THCA	cis	1	rs12138117	chr1:16305279	CLCNKA	chr1:16345370-16360544:+	0.14	4.09	5.02E-5	Dilated cardiomyopathy	
THCA	cis	1	rs12138117	chr1:16305279	HSPB7	chr1:16340523-16346089:-	0.55	11.39	9.19E-27	Dilated cardiomyopathy	
THCA	cis	1	rs12138343	chr1:119495317	WARS2	chr1:119573841-119683295:-	0.26	3.51	0.000486	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12138493	chr1:66003765	LEPR	chr1:65886318-66102820:+	-0.29	-4.12	4.53E-5	Obesity (early onset extreme)	
THCA	cis	1	rs12139321	chr1:156230429	BGLAP	chr1:156182784-156213112:+	0.23	5.38	1.16E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12139321	chr1:156230429	C1orf85	chr1:156259882-156265449:-	-0.17	-4.07	5.49E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12139321	chr1:156230429	CCT3	chr1:156278752-156308195:-	-0.33	-7.19	2.49E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12139321	chr1:156230429	PAQR6	chr1:156213207-156217843:-	-0.11	-3.34	0.000888	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12139630	chr1:46350935	CCDC163P	chr1:45960581-45965646:-	-0.51	-10.11	6.85E-22	Body mass index	
THCA	cis	1	rs12139630	chr1:46350935	GPBP1L1	chr1:46092978-46152302:-	0.16	4.04	6.11E-5	Body mass index	
THCA	cis	1	rs12139630	chr1:46350935	MMACHC	chr1:45965856-45976737:+	-0.2	-4.41	1.3E-5	Body mass index	
THCA	cis	1	rs12139630	chr1:46350935	MUTYH	chr1:45794915-45806142:-	0.31	8.54	1.77E-16	Body mass index	
THCA	cis	1	rs12139690	chr1:119491316	WARS2	chr1:119573841-119683295:-	0.26	3.5	0.000515	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12140910	chr1:66002660	LEPR	chr1:65886318-66102820:+	-0.29	-4.18	3.46E-5	Obesity (early onset extreme)	
THCA	cis	1	rs12141236	chr1:156302575	BGLAP	chr1:156182784-156213112:+	0.23	5.51	5.77E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12141236	chr1:156302575	C1orf85	chr1:156259882-156265449:-	-0.17	-4.09	5.11E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12141236	chr1:156302575	CCT3	chr1:156278752-156308195:-	-0.33	-7.07	5.4E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12141416	chr1:10327867	KIF1B	chr1:10270764-10441659:+	0.24	7.7	8.0E-14	Hepatocellular carcinoma	
THCA	cis	1	rs12141651	chr1:119492703	WARS2	chr1:119573841-119683295:-	0.26	3.48	0.000556	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12142808	chr1:156230546	BGLAP	chr1:156182784-156213112:+	0.23	5.38	1.16E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12142808	chr1:156230546	C1orf85	chr1:156259882-156265449:-	-0.17	-4.07	5.49E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12142808	chr1:156230546	CCT3	chr1:156278752-156308195:-	-0.33	-7.19	2.49E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12142808	chr1:156230546	PAQR6	chr1:156213207-156217843:-	-0.11	-3.34	0.000888	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12143789	chr1:119497154	WARS2	chr1:119573841-119683295:-	-0.26	-3.48	0.000556	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12144263	chr1:46352446	CCDC163P	chr1:45960581-45965646:-	-0.51	-10.11	6.85E-22	Body mass index	
THCA	cis	1	rs12144263	chr1:46352446	GPBP1L1	chr1:46092978-46152302:-	0.16	4.04	6.11E-5	Body mass index	
THCA	cis	1	rs12144263	chr1:46352446	MMACHC	chr1:45965856-45976737:+	-0.2	-4.41	1.3E-5	Body mass index	
THCA	cis	1	rs12144263	chr1:46352446	MUTYH	chr1:45794915-45806142:-	0.31	8.54	1.77E-16	Body mass index	
THCA	cis	1	rs12144610	chr1:119501103	WARS2	chr1:119573841-119683295:-	0.26	3.51	0.000486	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12145080	chr1:121185531	HIST2H2BA	chr1:120906034-120914842:+	-0.22	-5.06	6.07E-7	Hip geometry	
THCA	cis	1	rs12145310	chr1:20901064	CDA	chr1:20915444-20945398:+	-0.22	-4.58	5.98E-6	Age-related hearing impairment (interaction)	
THCA	cis	1	rs12145310	chr1:20901064	FAM43B	chr1:20878932-20881512:+	0.21	4.06	5.75E-5	Age-related hearing impairment (interaction)	
THCA	cis	1	rs12145351	chr1:20901181	CDA	chr1:20915444-20945398:+	-0.22	-4.6	5.54E-6	Age-related hearing impairment (interaction)	
THCA	cis	1	rs12145351	chr1:20901181	FAM43B	chr1:20878932-20881512:+	0.2	3.97	8.22E-5	Age-related hearing impairment (interaction)	
THCA	cis	1	rs12145450	chr1:31862949	ZCCHC17	chr1:31769842-31837780:+	-0.3	-5.66	2.61E-8	Schizophrenia	
THCA	cis	1	rs12145743	chr1:156700651	C1orf66	chr1:156698263-156706751:+	0.13	3.42	0.000673	HDL cholesterol	
THCA	cis	1	rs12145953	chr1:31793766	ZCCHC17	chr1:31769842-31837780:+	-0.32	-6.25	9.34E-10	Schizophrenia	
THCA	cis	1	rs12147422	chr14:55344015	GCH1	chr14:55308724-55369542:-	-0.21	-4.51	8.24E-6	Rheumatoid arthritis;Obesity-related traits	
THCA	cis	1	rs12147450	chr14:20957433	PNP	chr14:20937542-20945246:+	-0.33	-5.16	3.62E-7	Response to antipsychotic therapy (extrapyramidal side effects)	
THCA	cis	1	rs12147450	chr14:20957433	RNASE10	chr14:20973696-20979314:+	-0.44	-6.02	3.44E-9	Response to antipsychotic therapy (extrapyramidal side effects)	
THCA	cis	1	rs12147450	chr14:20957433	RNASE11	chr14:21051054-21058417:-	-0.28	-4.21	3.09E-5	Response to antipsychotic therapy (extrapyramidal side effects)	
THCA	cis	1	rs12147952	chr14:76624884	ESRRB	chr14:76837690-76968178:+	-0.31	-4.77	2.41E-6	Blood pressure	
THCA	cis	1	rs12148477	chr15:51653119	GLDN	chr15:51633713-51700207:+	0.22	4.74	2.81E-6	Follicule stimulating hormone	
THCA	cis	1	rs12148786	chr15:76800362	SCAPER	chr15:76640529-77197744:-	-0.17	-5.4	1.04E-7	Blood metabolite levels	
THCA	cis	1	rs12149862	chr16:69497203	CYB5B	chr16:69458498-69500167:+	0.22	3.88	0.000118	Blood pressure (smoking interaction)	
THCA	cis	1	rs12152512	chr3:10143770	C3orf10	chr3:10157333-10168873:+	-0.21	-4.43	1.15E-5	Alzheimer's disease	
THCA	cis	1	rs12152512	chr3:10143770	VHL	chr3:10183319-10193744:+	-0.18	-4.21	3.01E-5	Alzheimer's disease	
THCA	cis	1	rs12152515	chr3:10143976	C3orf10	chr3:10157333-10168873:+	-0.21	-4.43	1.15E-5	Alzheimer's disease	
THCA	cis	1	rs12152515	chr3:10143976	VHL	chr3:10183319-10193744:+	-0.18	-4.21	3.01E-5	Alzheimer's disease	
THCA	cis	1	rs12152964	chr5:115609965	COMMD10	chr5:115420727-115628978:+	0.48	5.66	2.56E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs12153717	chr5:115571914	COMMD10	chr5:115420727-115628978:+	0.48	5.7	2.09E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs12153877	chr6:33765465	IP6K3	chr6:33689443-33714762:-	0.4	6.48	2.28E-10	Obesity (extreme)	
THCA	cis	1	rs12154056	chr6:86634094	SNHG5	chr6:86386726-86388451:-	-0.48	-10.64	6.96E-24	Response to antipsychotic treatment	
THCA	cis	1	rs12158264	chr22:38001504	ANKRD54	chr22:38226863-38240303:-	-0.49	-6.53	1.65E-10	Response to anti-depressant treatment in major depressive disorder	
THCA	cis	1	rs12158264	chr22:38001504	C22orf23	chr22:38339533-38349603:-	-0.4	-4.94	1.09E-6	Response to anti-depressant treatment in major depressive disorder	
THCA	cis	1	rs12158264	chr22:38001504	CDC42EP1	chr22:37956471-37965408:+	-0.25	-4.1	4.85E-5	Response to anti-depressant treatment in major depressive disorder	
THCA	cis	1	rs12158264	chr22:38001504	CSNK1E	chr22:38686698-38794527:-	-0.36	-5.02	7.41E-7	Response to anti-depressant treatment in major depressive disorder	
THCA	cis	1	rs12158264	chr22:38001504	DDX17	chr22:38879445-38903665:-	-0.27	-3.79	0.000168	Response to anti-depressant treatment in major depressive disorder	
THCA	cis	1	rs12158264	chr22:38001504	EIF3L	chr22:38245370-38284637:+	-0.55	-6.39	4.06E-10	Response to anti-depressant treatment in major depressive disorder	
THCA	cis	1	rs12158264	chr22:38001504	GCAT	chr22:38203955-38213183:+	-0.31	-4.54	7.24E-6	Response to anti-depressant treatment in major depressive disorder	
THCA	cis	1	rs12158264	chr22:38001504	GGA1	chr22:38004503-38029570:+	-0.36	-4.33	1.85E-5	Response to anti-depressant treatment in major depressive disorder	
THCA	cis	1	rs12158264	chr22:38001504	H1F0	chr22:38201114-38203442:+	-0.3	-3.37	0.000803	Response to anti-depressant treatment in major depressive disorder	
THCA	cis	1	rs12158264	chr22:38001504	IFT27	chr22:37154255-37172114:-	-0.36	-4.93	1.14E-6	Response to anti-depressant treatment in major depressive disorder	
THCA	cis	1	rs12158264	chr22:38001504	MPST	chr22:37415702-37425862:+	-0.34	-4.65	4.37E-6	Response to anti-depressant treatment in major depressive disorder	
THCA	cis	1	rs12158264	chr22:38001504	NOL12	chr22:38082344-38089484:+	-0.45	-7.12	4.02E-12	Response to anti-depressant treatment in major depressive disorder	
THCA	cis	1	rs12158264	chr22:38001504	PDXP	chr22:38054737-38062939:+	-0.37	-3.84	0.000141	Response to anti-depressant treatment in major depressive disorder	
THCA	cis	1	rs12158264	chr22:38001504	PICK1	chr22:38453262-38471707:+	-0.48	-5.92	6.29E-9	Response to anti-depressant treatment in major depressive disorder	
THCA	cis	1	rs12158264	chr22:38001504	PLA2G6	chr22:38507502-38577836:-	-0.27	-5.03	7.11E-7	Response to anti-depressant treatment in major depressive disorder	
THCA	cis	1	rs12158264	chr22:38001504	POLR2F	chr22:38349674-38384341:+	-0.41	-6.23	1.01E-9	Response to anti-depressant treatment in major depressive disorder	
THCA	cis	1	rs12158264	chr22:38001504	TMEM184B	chr22:38615298-38669016:-	-0.25	-3.6	0.00035	Response to anti-depressant treatment in major depressive disorder	
THCA	cis	1	rs12158264	chr22:38001504	TRIOBP	chr22:38082344-38172562:+	-0.41	-5.56	4.55E-8	Response to anti-depressant treatment in major depressive disorder	
THCA	cis	1	rs12158264	chr22:38001504	TST	chr22:37406907-37415491:-	-0.32	-3.95	8.85E-5	Response to anti-depressant treatment in major depressive disorder	
THCA	cis	1	rs12158906	chr22:18437382	MICAL3	chr22:18270418-18507325:-	-0.21	-4.49	9.02E-6	Presence of antiphospholipid antibodies	
THCA	cis	1	rs12161427	chr1:156705822	C1orf66	chr1:156698263-156706751:+	0.13	3.63	0.000316	HDL cholesterol	
THCA	cis	1	rs12171333	chr4:129879711	C4orf33	chr4:130014829-130033842:+	0.59	9.05	3.55E-18	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs12173563	chr6:70483192	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.48	0.000552	Sleep duration	
THCA	cis	1	rs12175229	chr6:70391992	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.53	0.000462	Sleep duration	
THCA	cis	1	rs12184878	chr13:45115319	CCDC122	chr13:44410491-44453826:-	0.32	3.52	0.00047	Antineutrophil cytoplasmic antibody-associated vasculitis	
THCA	cis	1	rs12185102	chr15:75352201	ARID3B	chr15:74833548-74890470:+	-0.14	-3.7	0.000245	Blood trace element (Zn levels)	
THCA	cis	1	rs12185102	chr15:75352201	MAN2C1	chr15:75648135-75660941:-	0.14	3.43	0.000653	Blood trace element (Zn levels)	
THCA	cis	1	rs12185102	chr15:75352201	PPCDC	chr15:75315927-75343066:+	0.14	3.93	9.57E-5	Blood trace element (Zn levels)	
THCA	cis	1	rs12185102	chr15:75352201	SCAMP5	chr15:75287901-75313836:+	0.44	7.79	4.16E-14	Blood trace element (Zn levels)	
THCA	cis	1	rs12185764	chr20:44550020	WFDC3	chr20:44402847-44420547:-	-0.31	-4.35	1.64E-5	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
THCA	cis	1	rs12186295	chr4:53376325	KIAA0114	chr4:53578621-53580305:+	0.17	3.42	0.000674	Biochemical measures	
THCA	cis	1	rs12188164	chr5:428236	C5orf55	chr5:441645-443258:-	0.34	8.33	8.6E-16	Cystic fibrosis severity	
THCA	cis	1	rs12188678	chr5:428231	C5orf55	chr5:441645-443258:-	0.34	8.33	8.6E-16	Cystic fibrosis severity	
THCA	cis	1	rs12189567	chr6:55933942	COL21A1	chr6:55921389-56258892:-	-0.64	-7.91	1.86E-14	Psychosis (atypical)	
THCA	cis	1	rs12189571	chr6:55933987	COL21A1	chr6:55921389-56258892:-	-0.64	-7.91	1.86E-14	Psychosis (atypical)	
THCA	cis	1	rs12189725	chr6:33703394	CUTA	chr6:33384319-33386065:-	-0.13	-3.43	0.000662	Obesity (extreme)	
THCA	cis	1	rs12189725	chr6:33703394	IP6K3	chr6:33689443-33714762:-	0.39	6.74	4.51E-11	Obesity (extreme)	
THCA	cis	1	rs12189725	chr6:33703394	PSMB8	chr6:32808497-32812712:-	-0.14	-3.98	8.09E-5	Obesity (extreme)	
THCA	cis	1	rs12189725	chr6:33703394	TAPBP	chr6:33267472-33281989:-	-0.17	-3.36	0.000853	Obesity (extreme)	
THCA	cis	1	rs12190146	chr6:159414155	RSPH3	chr6:159398268-159421198:-	0.28	5.96	4.98E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs12190598	chr6:86686074	SNHG5	chr6:86386726-86388451:-	-0.48	-10.33	1.06E-22	Response to antipsychotic treatment	
THCA	cis	1	rs12190604	chr6:86716215	SNHG5	chr6:86386726-86388451:-	-0.48	-10.52	2.02E-23	Response to antipsychotic treatment	
THCA	cis	1	rs12190671	chr6:55959857	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs12190695	chr6:55943429	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs12190930	chr6:55977027	COL21A1	chr6:55921389-56258892:-	-0.67	-8.31	1.01E-15	Psychosis (atypical)	
THCA	cis	1	rs12190954	chr6:33746618	IP6K3	chr6:33689443-33714762:-	0.41	6.71	5.55E-11	Obesity (extreme)	
THCA	cis	1	rs12191865	chr6:56014006	COL21A1	chr6:55921389-56258892:-	-0.71	-8.8	2.42E-17	Psychosis (atypical)	
THCA	cis	1	rs12192279	chr6:110055313	AKD1	chr6:109814059-110012415:-	0.42	6.41	3.5E-10	Hematological parameters	
THCA	cis	1	rs12192279	chr6:110055313	FIG4	chr6:110012424-110146634:+	0.26	3.58	0.000381	Hematological parameters	
THCA	cis	1	rs12192947	chr6:24318570	MRS2	chr6:24403153-24425809:+	0.15	3.43	0.000645	Uric acid levels	
THCA	cis	1	rs12192992	chr6:86609915	SNHG5	chr6:86386726-86388451:-	-0.49	-10.86	1.02E-24	Response to antipsychotic treatment	
THCA	cis	1	rs12193198	chr6:169734411	PHF10	chr6:170104004-170124106:-	-0.14	-3.71	0.000235	Obesity-related traits	
THCA	cis	1	rs12193658	chr6:33705528	IP6K3	chr6:33689443-33714762:-	0.41	6.8	3.1E-11	Obesity (extreme)	
THCA	cis	1	rs12193658	chr6:33705528	PSMB8	chr6:32808497-32812712:-	-0.14	-4.13	4.28E-5	Obesity (extreme)	
THCA	cis	1	rs12193911	chr6:55966889	COL21A1	chr6:55921389-56258892:-	-0.65	-8.13	3.79E-15	Psychosis (atypical)	
THCA	cis	1	rs12194192	chr6:55954089	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs12194997	chr6:55970434	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs12195340	chr6:55967008	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs12195409	chr6:33757482	IP6K3	chr6:33689443-33714762:-	0.42	6.73	4.93E-11	Obesity (extreme)	
THCA	cis	1	rs12196037	chr6:86694631	SNHG5	chr6:86386726-86388451:-	-0.51	-11.15	8.37E-26	Response to antipsychotic treatment	
THCA	cis	1	rs12196050	chr6:55985113	COL21A1	chr6:55921389-56258892:-	-0.67	-8.31	1.01E-15	Psychosis (atypical)	
THCA	cis	1	rs12196213	chr6:55932547	COL21A1	chr6:55921389-56258892:-	-0.64	-7.91	1.86E-14	Psychosis (atypical)	
THCA	cis	1	rs12196411	chr6:86779762	SNHG5	chr6:86386726-86388451:-	-0.51	-10.93	5.42E-25	Response to antipsychotic treatment	
THCA	cis	1	rs12196526	chr6:55955754	COL21A1	chr6:55921389-56258892:-	0.6	7.47	3.86E-13	Psychosis (atypical)	
THCA	cis	1	rs12196670	chr6:55941044	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs12196709	chr6:55941100	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs12196860	chr6:55950374	COL21A1	chr6:55921389-56258892:-	-0.65	-8.22	1.97E-15	Psychosis (atypical)	
THCA	cis	1	rs12196937	chr6:49382808	CENPQ	chr6:49431096-49460820:+	-0.26	-5.43	8.84E-8	Folate pathway vitamin levels	
THCA	cis	1	rs12196937	chr6:49382808	MUT	chr6:49398994-49431031:-	0.28	9.54	7.4E-20	Folate pathway vitamin levels	
THCA	cis	1	rs12196944	chr6:55941564	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs12197114	chr6:109735498	AKD1	chr6:109814059-110012415:-	-0.4	-9.15	1.7E-18	Height	
THCA	cis	1	rs12197114	chr6:109735498	FIG4	chr6:110012424-110146634:+	-0.24	-4.98	8.75E-7	Height	
THCA	cis	1	rs12197114	chr6:109735498	SMPD2	chr6:109761931-109765121:+	0.32	8.17	2.83E-15	Height	
THCA	cis	1	rs12197114	chr6:109735498	ZBTB24	chr6:109783719-109804440:-	-0.15	-3.37	0.000806	Height	
THCA	cis	1	rs12197951	chr6:55946916	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs12198188	chr6:24442482	MRS2	chr6:24403153-24425809:+	-0.16	-4.35	1.64E-5	Liver enzyme levels	
THCA	cis	1	rs12198225	chr6:55947475	COL21A1	chr6:55921389-56258892:-	-0.66	-8.1	4.59E-15	Psychosis (atypical)	
THCA	cis	1	rs12198637	chr6:55981400	COL21A1	chr6:55921389-56258892:-	-0.67	-8.24	1.65E-15	Psychosis (atypical)	
THCA	cis	1	rs12199132	chr6:33708250	IP6K3	chr6:33689443-33714762:-	0.4	6.84	2.38E-11	Obesity (extreme)	
THCA	cis	1	rs12199132	chr6:33708250	PSMB8	chr6:32808497-32812712:-	-0.14	-4.15	3.9E-5	Obesity (extreme)	
THCA	cis	1	rs12199516	chr6:86726221	SNHG5	chr6:86386726-86388451:-	-0.48	-10.77	2.36E-24	Response to antipsychotic treatment	
THCA	cis	1	rs12199784	chr6:86726808	SNHG5	chr6:86386726-86388451:-	-0.48	-10.83	1.34E-24	Response to antipsychotic treatment	
THCA	cis	1	rs12200330	chr6:86656653	SNHG5	chr6:86386726-86388451:-	-0.49	-10.86	1.04E-24	Response to antipsychotic treatment	
THCA	cis	1	rs12200525	chr6:55982301	COL21A1	chr6:55921389-56258892:-	-0.67	-8.31	1.01E-15	Psychosis (atypical)	
THCA	cis	1	rs12200667	chr6:55982461	COL21A1	chr6:55921389-56258892:-	-0.67	-8.31	1.01E-15	Psychosis (atypical)	
THCA	cis	1	rs12201413	chr6:55933348	COL21A1	chr6:55921389-56258892:-	-0.64	-7.91	1.86E-14	Psychosis (atypical)	
THCA	cis	1	rs12201571	chr6:86609750	SNHG5	chr6:86386726-86388451:-	-0.49	-10.88	8.79E-25	Response to antipsychotic treatment	
THCA	cis	1	rs12201735	chr6:86656939	SNHG5	chr6:86386726-86388451:-	-0.48	-10.66	6.08E-24	Response to antipsychotic treatment	
THCA	cis	1	rs12201741	chr6:86602619	SNHG5	chr6:86386726-86388451:-	-0.48	-10.71	3.96E-24	Response to antipsychotic treatment	
THCA	cis	1	rs12201880	chr6:86627007	SNHG5	chr6:86386726-86388451:-	-0.48	-10.64	6.96E-24	Response to antipsychotic treatment	
THCA	cis	1	rs12202075	chr6:49427655	CENPQ	chr6:49431096-49460820:+	-0.26	-5.52	5.72E-8	Folate pathway vitamin levels	
THCA	cis	1	rs12202075	chr6:49427655	MUT	chr6:49398994-49431031:-	0.29	9.91	3.38E-21	Folate pathway vitamin levels	
THCA	cis	1	rs12202783	chr6:159388629	RSPH3	chr6:159398268-159421198:-	0.29	6.05	2.96E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs12203179	chr6:55994237	COL21A1	chr6:55921389-56258892:-	0.59	7.38	6.95E-13	Psychosis (atypical)	
THCA	cis	1	rs12203286	chr6:55994438	COL21A1	chr6:55921389-56258892:-	-0.65	-7.95	1.4E-14	Psychosis (atypical)	
THCA	cis	1	rs12203407	chr6:55994431	COL21A1	chr6:55921389-56258892:-	-0.65	-7.99	1.04E-14	Psychosis (atypical)	
THCA	cis	1	rs12203464	chr6:55934339	COL21A1	chr6:55921389-56258892:-	-0.64	-7.91	1.79E-14	Psychosis (atypical)	
THCA	cis	1	rs12203483	chr6:159386228	RSPH3	chr6:159398268-159421198:-	0.29	6.05	2.96E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs12203493	chr6:86758642	SNHG5	chr6:86386726-86388451:-	-0.49	-10.75	2.64E-24	Response to antipsychotic treatment	
THCA	cis	1	rs12203653	chr6:55964693	COL21A1	chr6:55921389-56258892:-	-0.67	-8.17	2.71E-15	Psychosis (atypical)	
THCA	cis	1	rs12203924	chr6:86776412	SNHG5	chr6:86386726-86388451:-	-0.49	-10.86	1.07E-24	Response to antipsychotic treatment	
THCA	cis	1	rs12203977	chr6:133122760	C6orf192	chr6:133090507-133119747:-	-0.24	-4	7.46E-5	Type 2 diabetes nephropathy	
THCA	cis	1	rs12204015	chr6:86598334	SNHG5	chr6:86386726-86388451:-	-0.54	-12.78	2.18E-32	Response to antipsychotic treatment	
THCA	cis	1	rs12204027	chr6:133122831	C6orf192	chr6:133090507-133119747:-	-0.24	-4.01	6.96E-5	Type 2 diabetes nephropathy	
THCA	cis	1	rs12204365	chr6:86700532	SNHG5	chr6:86386726-86388451:-	-0.48	-10.64	6.96E-24	Response to antipsychotic treatment	
THCA	cis	1	rs12204789	chr6:55947818	COL21A1	chr6:55921389-56258892:-	-0.66	-8.1	4.59E-15	Psychosis (atypical)	
THCA	cis	1	rs12204992	chr6:33741724	IP6K3	chr6:33689443-33714762:-	0.42	6.73	4.93E-11	Obesity (extreme)	
THCA	cis	1	rs12205230	chr6:55995496	COL21A1	chr6:55921389-56258892:-	-0.66	-8.1	4.64E-15	Psychosis (atypical)	
THCA	cis	1	rs12205336	chr6:86722367	SNHG5	chr6:86386726-86388451:-	-0.49	-10.87	9.85E-25	Response to antipsychotic treatment	
THCA	cis	1	rs12205548	chr6:86759770	SNHG5	chr6:86386726-86388451:-	-0.51	-10.95	4.54E-25	Response to antipsychotic treatment	
THCA	cis	1	rs12205653	chr6:55960169	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs12205903	chr6:55960583	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs12206452	chr6:24318680	MRS2	chr6:24403153-24425809:+	0.15	3.45	0.000617	Uric acid levels	
THCA	cis	1	rs12206574	chr6:110067773	AKD1	chr6:109814059-110012415:-	-0.45	-6.85	2.24E-11	Hematological parameters	
THCA	cis	1	rs12206574	chr6:110067773	FIG4	chr6:110012424-110146634:+	-0.29	-4.13	4.23E-5	Hematological parameters	
THCA	cis	1	rs12206920	chr6:55966027	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs12207120	chr6:55936134	COL21A1	chr6:55921389-56258892:-	-0.64	-8	9.48E-15	Psychosis (atypical)	
THCA	cis	1	rs12207305	chr6:86723502	SNHG5	chr6:86386726-86388451:-	-0.48	-10.83	1.34E-24	Response to antipsychotic treatment	
THCA	cis	1	rs12207610	chr6:86688016	SNHG5	chr6:86386726-86388451:-	-0.48	-10.71	3.96E-24	Response to antipsychotic treatment	
THCA	cis	1	rs12207665	chr6:55991330	COL21A1	chr6:55921389-56258892:-	-0.65	-8.05	6.7E-15	Psychosis (atypical)	
THCA	cis	1	rs12207795	chr6:159366261	RSPH3	chr6:159398268-159421198:-	0.28	6.05	2.98E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs12207932	chr6:24318912	MRS2	chr6:24403153-24425809:+	0.15	3.41	0.000703	Uric acid levels	
THCA	cis	1	rs12208493	chr6:86662267	SNHG5	chr6:86386726-86388451:-	-0.49	-10.86	1.04E-24	Response to antipsychotic treatment	
THCA	cis	1	rs12208500	chr6:55933259	COL21A1	chr6:55921389-56258892:-	-0.64	-7.91	1.86E-14	Psychosis (atypical)	
THCA	cis	1	rs12208615	chr6:55933489	COL21A1	chr6:55921389-56258892:-	-0.64	-7.91	1.86E-14	Psychosis (atypical)	
THCA	cis	1	rs12208823	chr6:55966902	COL21A1	chr6:55921389-56258892:-	-0.65	-8.13	3.79E-15	Psychosis (atypical)	
THCA	cis	1	rs12208892	chr6:159371192	RSPH3	chr6:159398268-159421198:-	0.28	6	3.97E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs12208901	chr6:159371238	RSPH3	chr6:159398268-159421198:-	0.28	6	3.97E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs12209127	chr6:86724427	SNHG5	chr6:86386726-86388451:-	-0.49	-10.87	9.85E-25	Response to antipsychotic treatment	
THCA	cis	1	rs12209192	chr6:55967702	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs12209420	chr6:55937876	COL21A1	chr6:55921389-56258892:-	-0.65	-8.03	7.92E-15	Psychosis (atypical)	
THCA	cis	1	rs12209464	chr6:55985189	COL21A1	chr6:55921389-56258892:-	-0.67	-7.91	1.83E-14	Psychosis (atypical)	
THCA	cis	1	rs12209509	chr6:55962183	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs12209529	chr6:55932278	COL21A1	chr6:55921389-56258892:-	-0.64	-7.91	1.86E-14	Psychosis (atypical)	
THCA	cis	1	rs12210218	chr6:159377219	RSPH3	chr6:159398268-159421198:-	0.28	6	3.97E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs12210228	chr6:55973083	COL21A1	chr6:55921389-56258892:-	-0.65	-8.1	4.74E-15	Psychosis (atypical)	
THCA	cis	1	rs12210402	chr6:55943418	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs12210468	chr6:55934393	COL21A1	chr6:55921389-56258892:-	-0.64	-7.91	1.86E-14	Psychosis (atypical)	
THCA	cis	1	rs12211223	chr6:55959848	COL21A1	chr6:55921389-56258892:-	-0.65	-7.98	1.09E-14	Psychosis (atypical)	
THCA	cis	1	rs12211490	chr6:33725528	IP6K3	chr6:33689443-33714762:-	0.4	6.49	2.17E-10	Obesity (extreme)	
THCA	cis	1	rs12211554	chr6:33725788	IP6K3	chr6:33689443-33714762:-	0.4	6.48	2.36E-10	Obesity (extreme)	
THCA	cis	1	rs12211565	chr6:33725852	IP6K3	chr6:33689443-33714762:-	0.4	6.49	2.17E-10	Obesity (extreme)	
THCA	cis	1	rs12211619	chr6:56014005	COL21A1	chr6:55921389-56258892:-	-0.71	-8.8	2.42E-17	Psychosis (atypical)	
THCA	cis	1	rs12212032	chr6:56005703	COL21A1	chr6:55921389-56258892:-	-0.66	-8.06	6.22E-15	Psychosis (atypical)	
THCA	cis	1	rs12212090	chr6:37431808	C6orf129	chr6:37450699-37467700:-	0.19	6.09	2.37E-9	Cognitive performance	
THCA	cis	1	rs12212135	chr6:55965006	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs12212143	chr6:55965055	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs12212211	chr6:55995226	COL21A1	chr6:55921389-56258892:-	-0.66	-8.1	4.64E-15	Psychosis (atypical)	
THCA	cis	1	rs12212733	chr6:86726013	SNHG5	chr6:86386726-86388451:-	-0.49	-10.88	8.44E-25	Response to antipsychotic treatment	
THCA	cis	1	rs12213149	chr6:86668644	SNHG5	chr6:86386726-86388451:-	-0.49	-10.86	1.04E-24	Response to antipsychotic treatment	
THCA	cis	1	rs12213291	chr6:55957074	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs12213434	chr6:159369128	RSPH3	chr6:159398268-159421198:-	0.28	6	3.97E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs12213571	chr6:55957493	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs12213740	chr6:86656733	SNHG5	chr6:86386726-86388451:-	-0.48	-10.71	3.96E-24	Response to antipsychotic treatment	
THCA	cis	1	rs12214519	chr6:55966884	COL21A1	chr6:55921389-56258892:-	-0.65	-8.13	3.79E-15	Psychosis (atypical)	
THCA	cis	1	rs12214594	chr6:56010824	COL21A1	chr6:55921389-56258892:-	-0.71	-8.88	1.32E-17	Psychosis (atypical)	
THCA	cis	1	rs12214813	chr6:159362013	RSPH3	chr6:159398268-159421198:-	0.28	5.97	4.73E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs12214878	chr6:159362118	RSPH3	chr6:159398268-159421198:-	0.28	5.97	4.73E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs12215037	chr6:86727631	SNHG5	chr6:86386726-86388451:-	-0.51	-11.14	8.56E-26	Response to antipsychotic treatment	
THCA	cis	1	rs12215903	chr6:86675028	SNHG5	chr6:86386726-86388451:-	-0.48	-10.59	1.1E-23	Response to antipsychotic treatment	
THCA	cis	1	rs12215913	chr6:55996995	COL21A1	chr6:55921389-56258892:-	-0.66	-8.1	4.64E-15	Psychosis (atypical)	
THCA	cis	1	rs12215936	chr6:159371324	RSPH3	chr6:159398268-159421198:-	0.28	6	3.97E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs12216203	chr6:86675301	SNHG5	chr6:86386726-86388451:-	-0.49	-10.89	8.0E-25	Response to antipsychotic treatment	
THCA	cis	1	rs12216314	chr6:55997673	COL21A1	chr6:55921389-56258892:-	-0.66	-8.1	4.64E-15	Psychosis (atypical)	
THCA	cis	1	rs12216328	chr6:86703418	SNHG5	chr6:86386726-86388451:-	-0.49	-10.88	8.91E-25	Response to antipsychotic treatment	
THCA	cis	1	rs12216499	chr6:159368524	RSPH3	chr6:159398268-159421198:-	0.28	6	3.97E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs12216994	chr1:179477137	C1orf125	chr1:179335107-179523868:+	0.33	3.76	0.000191	Multiple sclerosis (age of onset)	
THCA	cis	1	rs12217477	chr10:81731756	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs12218176	chr10:81731372	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs12218952	chr10:81731392	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs12219158	chr10:102302923	SEC31B	chr10:102246403-102289636:-	-0.29	-9.16	1.47E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs12219789	chr10:102213778	SEC31B	chr10:102246403-102289636:-	-0.3	-10.21	2.82E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs12219790	chr10:91375491	FLJ37201	chr10:91451057-91457685:-	-0.18	-3.74	0.000208	Metabolic traits	
THCA	cis	1	rs12220091	chr10:96053689	TMEM20	chr10:95653730-95713998:+	-0.17	-3.4	0.000736	Sudden cardiac arrest	
THCA	cis	1	rs12220238	chr10:75952670	VCL	chr10:75754951-75879912:+	-0.2	-3.68	0.00026	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs12220311	chr10:79681507	DLG5	chr10:79550551-79686348:-	0.23	4.01	6.94E-5	Liver enzyme levels (gamma-glutamyl transferase)	
THCA	cis	1	rs12220328	chr10:79681482	DLG5	chr10:79550551-79686348:-	0.22	3.77	0.000186	Liver enzyme levels (gamma-glutamyl transferase)	
THCA	cis	1	rs12220777	chr10:81788104	LOC219347	chr10:81805991-81838949:-	-1.01	-14.93	1.22E-41	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs12220902	chr10:79682918	DLG5	chr10:79550551-79686348:-	0.22	3.79	0.000171	Liver enzyme levels (gamma-glutamyl transferase)	
THCA	cis	1	rs12223690	chr11:8901824	TMEM9B	chr11:8968840-8986481:-	-0.24	-4.43	1.18E-5	Schizophrenia	
THCA	cis	1	rs12233940	chr5:109709565	TMEM232	chr5:109624934-110062381:-	-0.26	-3.65	0.000293	Cardiac structure and function	
THCA	cis	1	rs12236125	chr9:99583468	FAM22G	chr9:99690592-99704572:+	0.71	6.1	2.2E-9	Height	
THCA	cis	1	rs12236125	chr9:99583468	HIATL2	chr9:99695549-99775862:-	0.57	4.95	1.03E-6	Height	
THCA	cis	1	rs12236179	chr9:99625730	FAM22G	chr9:99690592-99704572:+	0.93	8.57	1.42E-16	Height	
THCA	cis	1	rs12236179	chr9:99625730	HIATL2	chr9:99695549-99775862:-	0.68	6.2	1.19E-9	Height	
THCA	cis	1	rs12236179	chr9:99625730	LOC441454	chr9:99671357-99672736:+	0.36	3.6	0.000358	Height	
THCA	cis	1	rs12237653	chr9:2551654	VLDLR	chr9:2621793-2654485:+	-0.2	-3.45	0.000607	Gambling	
THCA	cis	1	rs12237908	chr9:99583394	FAM22G	chr9:99690592-99704572:+	0.96	8.65	7.61E-17	Height	
THCA	cis	1	rs12237908	chr9:99583394	HIATL2	chr9:99695549-99775862:-	0.71	6.39	3.85E-10	Height	
THCA	cis	1	rs12237908	chr9:99583394	LOC441454	chr9:99671357-99672736:+	0.41	4	7.41E-5	Height	
THCA	cis	1	rs12241958	chr10:81731274	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs12242005	chr10:81731290	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs12243096	chr10:101812302	CWF19L1	chr10:101992055-102027437:-	0.42	7.69	8.37E-14	Bone mineral density	
THCA	cis	1	rs12243433	chr10:81732777	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs12245535	chr10:81733004	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs12247653	chr10:81731061	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs12247705	chr10:81731118	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs12250141	chr10:1160106	IDI2	chr10:1064847-1071799:-	0.47	4.23	2.86E-5	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs12259284	chr10:81687408	LOC219347	chr10:81805991-81838949:-	0.46	4.23	2.8E-5	Rheumatoid arthritis	
THCA	cis	1	rs12260159	chr10:100702737	HPSE2	chr10:100218877-100995619:-	0.27	3.4	0.000719	Migraine	
THCA	cis	1	rs12264259	chr10:81732788	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs12269901	chr11:116973929	SIK3	chr11:116714120-116968993:-	-0.18	-4.61	5.25E-6	HDL cholesterol	
THCA	cis	1	rs12270434	chr11:78103300	NARS2	chr11:78147017-78285909:-	-0.38	-7.1	4.55E-12	Testicular germ cell tumor	
THCA	cis	1	rs12270837	chr11:116826643	PCSK7	chr11:117075789-117102811:-	0.45	5.41	1.01E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12272213	chr11:71816219	FAM86C	chr11:71498557-71512276:+	-0.32	-3.91	0.000107	Severe influenza A (H1N1) infection	
THCA	cis	1	rs12272491	chr11:116804370	PCSK7	chr11:117075789-117102811:-	0.45	5.41	1.02E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12272973	chr11:116863047	PCSK7	chr11:117075789-117102811:-	0.41	5.08	5.31E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12273762	chr11:116777063	PCSK7	chr11:117075789-117102811:-	0.43	5.27	2.03E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12274771	chr11:116856698	PCSK7	chr11:117075789-117102811:-	0.45	5.37	1.24E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12274773	chr11:116856709	PCSK7	chr11:117075789-117102811:-	0.45	5.37	1.24E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12275355	chr11:116824162	PCSK7	chr11:117075789-117102811:-	0.45	5.41	1.01E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12275565	chr11:116753552	PCSK7	chr11:117075789-117102811:-	0.43	5.32	1.62E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12275855	chr11:5559202	UBQLNL	chr11:5535624-5537956:-	-0.28	-6.37	4.39E-10	QRS duration in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs12276805	chr11:116878759	PCSK7	chr11:117075789-117102811:-	0.41	5.18	3.34E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12277648	chr11:78054336	NARS2	chr11:78147017-78285909:-	-0.39	-7.55	2.16E-13	Testicular germ cell tumor	
THCA	cis	1	rs12278117	chr11:116748169	PCSK7	chr11:117075789-117102811:-	0.44	5.33	1.54E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12278943	chr11:116874358	PCSK7	chr11:117075789-117102811:-	0.45	5.37	1.24E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12278954	chr11:108328952	ACAT1	chr11:107992258-108018889:+	-0.25	-6.19	1.28E-9	Melanoma	
THCA	cis	1	rs12279433	chr11:116748221	PCSK7	chr11:117075789-117102811:-	0.44	5.38	1.18E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12280030	chr11:116775196	PCSK7	chr11:117075789-117102811:-	0.43	5.27	2.03E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12281140	chr11:22823334	SVIP	chr11:22843600-22851382:-	0.2	3.43	0.000662	Dialysis-related mortality	
THCA	cis	1	rs12281729	chr11:116838130	PCSK7	chr11:117075789-117102811:-	0.42	5.02	7.46E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12283172	chr11:46442526	PACSIN3	chr11:47199085-47207958:-	-0.18	-4.1	4.93E-5	Schizophrenia	
THCA	cis	1	rs12283462	chr11:71835406	FAM86C	chr11:71498557-71512276:+	-0.32	-3.86	0.00013	Severe influenza A (H1N1) infection	
THCA	cis	1	rs12284346	chr11:116757793	PCSK7	chr11:117075789-117102811:-	0.43	5.19	3.14E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12284404	chr11:45228686	PRDM11	chr11:45115564-45246902:+	0.15	3.78	0.000174	Thyroid hormone levels	
THCA	cis	1	rs12284404	chr11:45228686	SYT13	chr11:45261853-45307884:-	0.31	5.15	3.86E-7	Thyroid hormone levels	
THCA	cis	1	rs12285715	chr11:68821648	TPCN2	chr11:68816350-68929907:+	-0.15	-3.63	0.000319	Hair color	
THCA	cis	1	rs1228632	chr11:83325114	CCDC90B	chr11:82972506-82997414:-	-0.16	-3.76	0.000195	Subcortical brain region volumes	
THCA	cis	1	rs12286581	chr11:116748744	PCSK7	chr11:117075789-117102811:-	0.44	5.33	1.54E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12286683	chr11:18348662	GTF2H1	chr11:18343816-18388590:+	0.39	10.64	6.89E-24	Pancreatic cancer	
THCA	cis	1	rs12287768	chr11:116856322	PCSK7	chr11:117075789-117102811:-	0.45	5.37	1.24E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12287832	chr11:65553492	CTSW	chr11:65647284-65651212:+	-0.29	-5.62	3.32E-8	Systemic lupus erythematosus	
THCA	cis	1	rs12287832	chr11:65553492	RNASEH2C	chr11:65485146-65488409:-	-0.2	-4.82	1.9E-6	Systemic lupus erythematosus	
THCA	cis	1	rs12287832	chr11:65553492	SNX32	chr11:65601410-65621170:+	0.46	5.86	8.68E-9	Systemic lupus erythematosus	
THCA	cis	1	rs12289032	chr11:116899580	PCSK7	chr11:117075789-117102811:-	0.45	5.37	1.24E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12289603	chr11:18471370	LDHAL6A	chr11:18477374-18501147:+	0.27	3.45	0.000617	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs12289603	chr11:18471370	LDHC	chr11:18433853-18472792:+	-0.33	-3.99	7.76E-5	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs12289974	chr11:116824286	PCSK7	chr11:117075789-117102811:-	0.45	5.41	1.01E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12291040	chr11:116826617	PCSK7	chr11:117075789-117102811:-	0.45	5.41	1.01E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12292278	chr11:116758693	PCSK7	chr11:117075789-117102811:-	-0.4	-4.81	2.05E-6	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12292371	chr11:116795948	PCSK7	chr11:117075789-117102811:-	0.45	5.41	1.02E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12292425	chr11:46644143	PACSIN3	chr11:47199085-47207958:-	0.17	3.92	0.000103	Schizophrenia	
THCA	cis	1	rs12292434	chr11:116796065	PCSK7	chr11:117075789-117102811:-	0.45	5.41	1.02E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12292614	chr11:116748515	PCSK7	chr11:117075789-117102811:-	0.44	5.33	1.54E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12293755	chr11:116819264	PCSK7	chr11:117075789-117102811:-	0.45	5.41	1.01E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12293885	chr11:71816092	FAM86C	chr11:71498557-71512276:+	-0.32	-3.91	0.000107	Severe influenza A (H1N1) infection	
THCA	cis	1	rs12294104	chr11:30382899	C11orf46	chr11:30344649-30359978:+	0.21	4.01	7.05E-5	Sex hormone levels;Menopause (age at onset)	
THCA	cis	1	rs12294191	chr11:116759824	PCSK7	chr11:117075789-117102811:-	0.45	5.64	2.92E-8	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12294369	chr11:5567068	UBQLNL	chr11:5535624-5537956:-	0.29	6.67	7.23E-11	QRS duration in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs12294657	chr11:116807368	PCSK7	chr11:117075789-117102811:-	0.46	5.6	3.67E-8	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12298484	chr12:124418674	ZNF664	chr12:124457670-124499967:+	-0.18	-4.88	1.43E-6	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12299125	chr12:123862447	CDK2AP1	chr12:123745542-123756687:-	-0.24	-6.59	1.14E-10	Educational attainment;Height;Head circumference (infant)	
THCA	cis	1	rs12299125	chr12:123862447	MPHOSPH9	chr12:123640948-123717658:-	0.18	5.41	9.99E-8	Educational attainment;Height;Head circumference (infant)	
THCA	cis	1	rs12299125	chr12:123862447	PITPNM2	chr12:123468027-123635285:-	0.27	5.32	1.63E-7	Educational attainment;Height;Head circumference (infant)	
THCA	cis	1	rs1229978	chr4:100256199	ADH1C	chr4:100257651-100273917:-	-0.18	-3.38	0.00078	Oral cavity and pharyngeal cancer	
THCA	cis	1	rs12301299	chr12:991710	RAD52	chr12:1021255-1099219:-	-0.29	-4.56	6.6E-6	Colorectal cancer	
THCA	cis	1	rs12301673	chr12:124455818	ZNF664	chr12:124457670-124499967:+	-0.18	-5.12	4.39E-7	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12304878	chr12:51353851	SLC11A2	chr12:51373319-51422058:-	-0.23	-4.64	4.6E-6	Type 2 diabetes	
THCA	cis	1	rs12304878	chr12:51353851	TFCP2	chr12:51488608-51566917:-	-0.2	-4.28	2.3E-5	Type 2 diabetes	
THCA	cis	1	rs12304921	chr12:51357542	SLC11A2	chr12:51373319-51422058:-	0.21	4.21	3.0E-5	Type 2 diabetes	
THCA	cis	1	rs12304921	chr12:51357542	TFCP2	chr12:51488608-51566917:-	0.18	3.94	9.48E-5	Type 2 diabetes	
THCA	cis	1	rs12305170	chr12:51345265	SLC11A2	chr12:51373319-51422058:-	-0.23	-4.64	4.46E-6	Type 2 diabetes	
THCA	cis	1	rs12305170	chr12:51345265	TFCP2	chr12:51488608-51566917:-	-0.19	-4.07	5.58E-5	Type 2 diabetes	
THCA	cis	1	rs12306808	chr12:51354803	SLC11A2	chr12:51373319-51422058:-	-0.24	-4.77	2.5E-6	Type 2 diabetes	
THCA	cis	1	rs12306808	chr12:51354803	TFCP2	chr12:51488608-51566917:-	-0.2	-4.29	2.14E-5	Type 2 diabetes	
THCA	cis	1	rs12309274	chr12:975948	RAD52	chr12:1021255-1099219:-	-0.28	-4.37	1.54E-5	Colorectal cancer	
THCA	cis	1	rs12310837	chr12:120880572	POP5	chr12:121016849-121019201:-	-0.13	-3.71	0.000233	Type 1 diabetes nephropathy	
THCA	cis	1	rs12310837	chr12:120880572	RNF10	chr12:120972132-121015396:+	0.21	3.45	0.000608	Type 1 diabetes nephropathy	
THCA	cis	1	rs12311303	chr12:129301592	GLT1D1	chr12:129338081-129469509:+	0.26	4.27	2.33E-5	Systemic lupus erythematosus	
THCA	cis	1	rs12312603	chr12:988269	RAD52	chr12:1021255-1099219:-	-0.3	-4.9	1.29E-6	Colorectal cancer	
THCA	cis	1	rs12315928	chr12:51355931	SLC11A2	chr12:51373319-51422058:-	-0.24	-4.74	2.88E-6	Type 2 diabetes	
THCA	cis	1	rs12315928	chr12:51355931	TFCP2	chr12:51488608-51566917:-	-0.2	-4.29	2.15E-5	Type 2 diabetes	
THCA	cis	1	rs12317103	chr12:123802814	C12orf65	chr12:123717841-123742481:+	-0.24	-4.14	4.15E-5	HDL cholesterol	
THCA	cis	1	rs12317171	chr12:51337669	SLC11A2	chr12:51373319-51422058:-	0.23	4.63	4.63E-6	Type 2 diabetes	
THCA	cis	1	rs12317171	chr12:51337669	TFCP2	chr12:51488608-51566917:-	0.19	4.19	3.29E-5	Type 2 diabetes	
THCA	cis	1	rs12317176	chr12:124404718	DNAH10	chr12:124247042-124420265:+	0.19	3.85	0.000135	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12317176	chr12:124404718	ZNF664	chr12:124457670-124499967:+	-0.15	-4.3	2.08E-5	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12317452	chr12:123788246	C12orf65	chr12:123717841-123742481:+	-0.25	-4.25	2.62E-5	HDL cholesterol	
THCA	cis	1	rs12318464	chr12:51357346	SLC11A2	chr12:51373319-51422058:-	-0.24	-4.83	1.87E-6	Type 2 diabetes	
THCA	cis	1	rs12318464	chr12:51357346	TFCP2	chr12:51488608-51566917:-	-0.2	-4.28	2.25E-5	Type 2 diabetes	
THCA	cis	1	rs12323975	chr15:66674634	TIPIN	chr15:66629008-66649054:-	-0.42	-4.34	1.71E-5	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs12324912	chr15:75361006	ARID3B	chr15:74833548-74890470:+	-0.15	-3.95	9.09E-5	Blood trace element (Zn levels)	
THCA	cis	1	rs12324912	chr15:75361006	PPCDC	chr15:75315927-75343066:+	0.15	4.28	2.27E-5	Blood trace element (Zn levels)	
THCA	cis	1	rs12324912	chr15:75361006	SCAMP5	chr15:75287901-75313836:+	0.44	7.81	3.56E-14	Blood trace element (Zn levels)	
THCA	cis	1	rs12325866	chr17:61755974	FTSJ3	chr17:61896795-61905031:-	0.31	6.04	3.13E-9	Body mass index	
THCA	cis	1	rs12325866	chr17:61755974	MAP3K3	chr17:61699775-61773669:+	0.26	5.46	7.79E-8	Body mass index	
THCA	cis	1	rs12326600	chr18:44596497	HDHD2	chr18:44633782-44676871:-	0.34	5.84	9.64E-9	Sitting height ratio	
THCA	cis	1	rs12328085	chr2:86262009	LOC90784	chr2:86247339-86250991:-	-0.56	-6.63	9.3E-11	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs12330157	chr3:58364562	PXK	chr3:58318617-58410878:+	0.36	6.19	1.28E-9	Cholesterol, total	
THCA	cis	1	rs12332489	chr5:115579386	COMMD10	chr5:115420727-115628978:+	0.48	5.89	7.35E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs12332585	chr5:115581395	COMMD10	chr5:115420727-115628978:+	0.48	5.89	7.35E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs12332658	chr5:115545606	COMMD10	chr5:115420727-115628978:+	0.46	5.63	3.14E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs12338076	chr9:139121740	QSOX2	chr9:139098182-139137687:-	0.14	3.59	0.000367	Height	
THCA	cis	1	rs12339579	chr9:99594611	FAM22G	chr9:99690592-99704572:+	0.96	7.5	3.08E-13	Height	
THCA	cis	1	rs12339579	chr9:99594611	HIATL2	chr9:99695549-99775862:-	0.7	5.46	7.65E-8	Height	
THCA	cis	1	rs12339579	chr9:99594611	LOC441454	chr9:99671357-99672736:+	0.42	3.56	0.000408	Height	
THCA	cis	1	rs12340602	chr9:99540709	FAM22G	chr9:99690592-99704572:+	0.98	7.96	1.27E-14	Height	
THCA	cis	1	rs12340602	chr9:99540709	HIATL2	chr9:99695549-99775862:-	0.71	5.75	1.6E-8	Height	
THCA	cis	1	rs12340602	chr9:99540709	LOC441454	chr9:99671357-99672736:+	0.44	3.89	0.000113	Height	
THCA	cis	1	rs12342831	chr9:33124872	B4GALT1	chr9:33110639-33167356:-	0.27	6.18	1.41E-9	IgG glycosylation	
THCA	cis	1	rs12349952	chr9:99540519	FAM22G	chr9:99690592-99704572:+	0.9	7.35	8.67E-13	Height	
THCA	cis	1	rs12349952	chr9:99540519	HIATL2	chr9:99695549-99775862:-	0.67	5.53	5.33E-8	Height	
THCA	cis	1	rs12349952	chr9:99540519	LOC441454	chr9:99671357-99672736:+	0.39	3.5	0.000517	Height	
THCA	cis	1	rs12354411	chr10:102294537	SEC31B	chr10:102246403-102289636:-	-0.28	-8.96	7.03E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs12355721	chr10:102244911	SEC31B	chr10:102246403-102289636:-	-0.3	-10.06	1.02E-21	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs12355771	chr10:75894404	VCL	chr10:75754951-75879912:+	-0.23	-4.06	5.85E-5	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs12355784	chr10:65121565	NRBF2	chr10:64893007-64914785:+	-0.29	-6.86	2.12E-11	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs12357418	chr10:37993860	LOC399744	chr10:38717074-38741080:+	0.25	3.44	0.000625	Obesity (extreme)	
THCA	cis	1	rs12357530	chr10:75928654	VCL	chr10:75754951-75879912:+	-0.24	-4.28	2.25E-5	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs12358094	chr10:38015506	LOC399744	chr10:38717074-38741080:+	0.29	3.84	0.000141	Obesity (extreme)	
THCA	cis	1	rs12358108	chr10:38015607	LOC399744	chr10:38717074-38741080:+	0.29	3.83	0.000147	Obesity (extreme)	
THCA	cis	1	rs12358187	chr10:102284449	SEC31B	chr10:102246403-102289636:-	-0.28	-8.91	1.1E-17	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs12358475	chr10:11848792	ECHDC3	chr10:11784356-11806064:+	-0.25	-3.46	0.000592	Breast cancer (survival)	
THCA	cis	1	rs1235848	chr13:28111559	MTIF3	chr13:28009783-28024711:-	-0.16	-3.56	0.000402	Weight	
THCA	cis	1	rs12358614	chr10:75906173	VCL	chr10:75754951-75879912:+	-0.23	-4.03	6.45E-5	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs12359456	chr10:75937994	VCL	chr10:75754951-75879912:+	-0.23	-4.03	6.45E-5	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs12360411	chr10:38046634	LOC399744	chr10:38717074-38741080:+	0.28	3.69	0.000251	Obesity (extreme)	
THCA	cis	1	rs12361031	chr11:47783076	C1QTNF4	chr11:47611216-47615961:-	-0.3	-5.23	2.59E-7	Subjective well-being	
THCA	cis	1	rs12363232	chr11:47623890	C1QTNF4	chr11:47611216-47615961:-	-0.3	-5.35	1.4E-7	Subjective well-being	
THCA	cis	1	rs12366580	chr12:82222784	PPFIA2	chr12:81652880-82153109:-	0.22	4.06	5.72E-5	Resting heart rate	
THCA	cis	1	rs12366872	chr12:123804721	C12orf65	chr12:123717841-123742481:+	-0.24	-4.14	4.11E-5	HDL cholesterol	
THCA	cis	1	rs12367791	chr12:82237278	PPFIA2	chr12:81652880-82153109:-	0.21	3.95	8.98E-5	Resting heart rate	
THCA	cis	1	rs12372597	chr12:42412850	GXYLT1	chr12:42475650-42538673:-	-0.14	-3.72	0.000222	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	
THCA	cis	1	rs12372597	chr12:42412850	PPHLN1	chr12:42632249-42853517:+	-0.13	-3.55	0.000426	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	
THCA	cis	1	rs12372623	chr12:42531666	GXYLT1	chr12:42475650-42538673:-	-0.15	-3.96	8.63E-5	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	
THCA	cis	1	rs12372623	chr12:42531666	PPHLN1	chr12:42632249-42853517:+	-0.13	-3.45	0.0006	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	
THCA	cis	1	rs12372990	chr15:24840137	PWRN1	chr15:24778839-24832924:+	0.39	7.94	1.48E-14	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
THCA	cis	1	rs12374115	chr3:10134766	C3orf10	chr3:10157333-10168873:+	0.21	4.33	1.82E-5	Alzheimer's disease	
THCA	cis	1	rs12374115	chr3:10134766	VHL	chr3:10183319-10193744:+	0.19	4.35	1.67E-5	Alzheimer's disease	
THCA	cis	1	rs12374256	chr4:106617361	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs12377604	chr9:100697287	C9orf156	chr9:100666772-100684852:-	-0.14	-3.63	0.000317	Quantitative traits	
THCA	cis	1	rs12402052	chr1:10318652	KIF1B	chr1:10270764-10441659:+	0.21	6.36	4.75E-10	Hepatocellular carcinoma	
THCA	cis	1	rs12405278	chr1:152282267	FLG	chr1:152274651-152297679:-	0.28	3.99	7.76E-5	Atopic dermatitis	
THCA	cis	1	rs12405278	chr1:152282267	HRNR	chr1:152184558-152196669:-	-0.43	-5.6	3.65E-8	Atopic dermatitis	
THCA	cis	1	rs12405451	chr1:46384326	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.14	4.96E-22	Body mass index	
THCA	cis	1	rs12405451	chr1:46384326	GPBP1L1	chr1:46092978-46152302:-	0.15	3.83	0.000147	Body mass index	
THCA	cis	1	rs12405451	chr1:46384326	MMACHC	chr1:45965856-45976737:+	-0.21	-4.56	6.37E-6	Body mass index	
THCA	cis	1	rs12405451	chr1:46384326	MUTYH	chr1:45794915-45806142:-	0.3	8.15	3.33E-15	Body mass index	
THCA	cis	1	rs12407992	chr1:10311983	KIF1B	chr1:10270764-10441659:+	0.21	6.42	3.29E-10	Hepatocellular carcinoma	
THCA	cis	1	rs12409773	chr1:46358831	CCDC163P	chr1:45960581-45965646:-	-0.51	-10.06	1.04E-21	Body mass index	
THCA	cis	1	rs12409773	chr1:46358831	GPBP1L1	chr1:46092978-46152302:-	0.16	4.09	5.03E-5	Body mass index	
THCA	cis	1	rs12409773	chr1:46358831	MMACHC	chr1:45965856-45976737:+	-0.2	-4.47	9.85E-6	Body mass index	
THCA	cis	1	rs12409773	chr1:46358831	MUTYH	chr1:45794915-45806142:-	0.32	8.58	1.33E-16	Body mass index	
THCA	cis	1	rs12410060	chr1:75245848	CRYZ	chr1:75171175-75199092:-	-0.44	-7.45	4.28E-13	Resistin levels	
THCA	cis	1	rs12410071	chr1:46358886	CCDC163P	chr1:45960581-45965646:-	-0.51	-10.05	1.14E-21	Body mass index	
THCA	cis	1	rs12410071	chr1:46358886	GPBP1L1	chr1:46092978-46152302:-	0.16	4.12	4.4E-5	Body mass index	
THCA	cis	1	rs12410071	chr1:46358886	MMACHC	chr1:45965856-45976737:+	-0.21	-4.55	6.76E-6	Body mass index	
THCA	cis	1	rs12410071	chr1:46358886	MUTYH	chr1:45794915-45806142:-	0.32	8.53	2.01E-16	Body mass index	
THCA	cis	1	rs12410532	chr1:19845279	CAPZB	chr1:19665274-19811992:-	-0.16	-3.37	0.0008	Thyroid volume	
THCA	cis	1	rs12410657	chr1:47278471	NSUN4	chr1:46806390-46830690:+	0.22	3.36	0.000835	Blood metabolite levels	
THCA	cis	1	rs12410724	chr1:76459134	ACADM	chr1:76190043-76229353:+	-0.21	-4.56	6.38E-6	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs12410724	chr1:76459134	ST6GALNAC3	chr1:76540389-77096669:+	-0.24	-3.39	0.000763	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs12411269	chr1:46271052	CCDC163P	chr1:45960581-45965646:-	-0.51	-10.03	1.24E-21	Body mass index	
THCA	cis	1	rs12411269	chr1:46271052	GPBP1L1	chr1:46092978-46152302:-	0.16	4.07	5.54E-5	Body mass index	
THCA	cis	1	rs12411269	chr1:46271052	MMACHC	chr1:45965856-45976737:+	-0.19	-4.28	2.28E-5	Body mass index	
THCA	cis	1	rs12411269	chr1:46271052	MUTYH	chr1:45794915-45806142:-	0.31	8.34	7.97E-16	Body mass index	
THCA	cis	1	rs12411988	chr10:65315397	LOC84989	chr10:65224989-65226320:+	-0.25	-3.91	0.000106	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs12411988	chr10:65315397	NRBF2	chr10:64893007-64914785:+	-0.23	-3.68	0.000259	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs12412012	chr10:65315763	LOC84989	chr10:65224989-65226320:+	0.25	3.84	0.000142	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs12412012	chr10:65315763	NRBF2	chr10:64893007-64914785:+	0.23	3.62	0.000322	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs12413029	chr10:65189126	LOC84989	chr10:65224989-65226320:+	0.26	4.13	4.27E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs12413029	chr10:65189126	NRBF2	chr10:64893007-64914785:+	0.27	4.45	1.09E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs12413415	chr10:64919511	LOC84989	chr10:65224989-65226320:+	0.27	4.32	1.87E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs12413415	chr10:64919511	NRBF2	chr10:64893007-64914785:+	0.27	4.47	9.73E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs12413730	chr10:64964148	LOC84989	chr10:65224989-65226320:+	0.27	4.38	1.44E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs12413730	chr10:64964148	NRBF2	chr10:64893007-64914785:+	0.28	4.68	3.68E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs12414159	chr10:65238777	LOC84989	chr10:65224989-65226320:+	0.27	4.29	2.17E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs12414159	chr10:65238777	NRBF2	chr10:64893007-64914785:+	0.26	4.37	1.5E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs12414475	chr10:23661291	C10orf67	chr10:23605521-23633772:-	0.23	4.71	3.27E-6	Crohn's disease and sarcoidosis (combined)	
THCA	cis	1	rs12414796	chr10:65303087	LOC84989	chr10:65224989-65226320:+	0.25	4.02	6.84E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs12414796	chr10:65303087	NRBF2	chr10:64893007-64914785:+	0.25	4.12	4.46E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs12414891	chr10:81690385	MBL1P	chr10:81664654-81710783:+	0.35	5.16	3.63E-7	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs12414891	chr10:81690385	PLAC9	chr10:81892258-81904784:+	-0.28	-5.82	1.07E-8	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs12414891	chr10:81690385	TSPAN14	chr10:82214038-82282390:+	0.26	3.98	7.97E-5	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs12415038	chr10:65160858	LOC84989	chr10:65224989-65226320:+	0.28	4.46	1.03E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs12415038	chr10:65160858	NRBF2	chr10:64893007-64914785:+	0.28	4.65	4.26E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs12415984	chr10:64910288	LOC84989	chr10:65224989-65226320:+	0.27	4.36	1.62E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs12415984	chr10:64910288	NRBF2	chr10:64893007-64914785:+	0.27	4.57	6.28E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs12416113	chr10:64896477	LOC84989	chr10:65224989-65226320:+	0.26	4.16	3.84E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs12416113	chr10:64896477	NRBF2	chr10:64893007-64914785:+	0.27	4.59	5.58E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs12416349	chr10:65277543	LOC84989	chr10:65224989-65226320:+	0.27	4.22	2.88E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs12416349	chr10:65277543	NRBF2	chr10:64893007-64914785:+	0.26	4.38	1.43E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs12416687	chr10:104629011	AS3MT	chr10:104613967-104661653:+	-0.3	-5.3	1.77E-7	Arsenic metabolism	
THCA	cis	1	rs12416687	chr10:104629011	C10orf32	chr10:104613967-104624718:+	-0.5	-13.09	1.14E-33	Arsenic metabolism	
THCA	cis	1	rs12416987	chr11:116754265	PCSK7	chr11:117075789-117102811:-	0.44	5.3	1.74E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12417152	chr11:116839293	PCSK7	chr11:117075789-117102811:-	0.42	5.02	7.46E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12417570	chr11:462684	IRF7	chr11:612556-615999:-	0.23	3.46	0.000596	Body mass index	
THCA	cis	1	rs12418015	chr11:60343295	MS4A12	chr11:60260251-60274895:+	-0.4	-6.72	5.08E-11	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	
THCA	cis	1	rs12418015	chr11:60343295	MS4A7	chr11:60145958-60163424:+	-0.15	-3.36	0.000834	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	
THCA	cis	1	rs12418190	chr11:8899818	TMEM9B	chr11:8968840-8986481:-	-0.23	-4.28	2.31E-5	Schizophrenia	
THCA	cis	1	rs12418208	chr11:116787633	PCSK7	chr11:117075789-117102811:-	0.43	5.27	2.08E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12418735	chr11:116804762	PCSK7	chr11:117075789-117102811:-	0.45	5.41	1.02E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12418852	chr11:47868853	C1QTNF4	chr11:47611216-47615961:-	-0.31	-5.3	1.74E-7	Subjective well-being	
THCA	cis	1	rs12419047	chr11:116819906	PCSK7	chr11:117075789-117102811:-	0.45	5.41	1.01E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12419437	chr11:116820690	PCSK7	chr11:117075789-117102811:-	0.45	5.41	1.01E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12419692	chr11:47624714	C1QTNF4	chr11:47611216-47615961:-	0.29	5.09	5.04E-7	Subjective well-being	
THCA	cis	1	rs12420857	chr11:116829442	PCSK7	chr11:117075789-117102811:-	0.42	5.02	7.46E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12421210	chr11:47779586	C1QTNF4	chr11:47611216-47615961:-	-0.3	-5.23	2.59E-7	Subjective well-being	
THCA	cis	1	rs12421834	chr11:116820023	PCSK7	chr11:117075789-117102811:-	0.45	5.41	1.01E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs12421902	chr11:116814646	PCSK7	chr11:117075789-117102811:-	0.46	5.6	3.67E-8	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs1242229	chr11:117062370	PCSK7	chr11:117075789-117102811:-	-0.37	-6.31	6.26E-10	Protein quantitative trait loci	
THCA	cis	1	rs12422771	chr12:6580273	TAPBPL	chr12:6561177-6575601:+	-0.45	-6.47	2.39E-10	Hip geometry	
THCA	cis	1	rs12423325	chr12:62507054	FAM19A2	chr12:62102043-62653925:-	-0.15	-3.34	0.000892	Post bronchodilator FEV1/FVC ratio in COPD	
THCA	cis	1	rs12424860	chr12:51159140	DIP2B	chr12:50898768-51142448:+	-0.24	-8.66	7.53E-17	Colorectal cancer	
THCA	cis	1	rs12425896	chr12:62506902	FAM19A2	chr12:62102043-62653925:-	-0.15	-3.34	0.000892	Post bronchodilator FEV1/FVC ratio in COPD	
THCA	cis	1	rs12427239	chr12:6590626	TAPBPL	chr12:6561177-6575601:+	-0.35	-5.28	1.91E-7	Hip geometry	
THCA	cis	1	rs12427878	chr13:85672306	SLITRK6	chr13:86366922-86373483:-	-0.2	-3.66	0.000279	Bipolar disorder (mania)	
THCA	cis	1	rs12428035	chr13:96300872	DZIP1	chr13:96229329-96296957:-	-0.18	-3.54	0.000442	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
THCA	cis	1	rs12428035	chr13:96300872	UGGT2	chr13:96453838-96705736:-	0.24	3.8	0.000162	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
THCA	cis	1	rs12428	chr20:25433821	ENTPD6	chr20:25176339-25207360:+	0.31	6.86	2.14E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs12428	chr20:25433821	FAM182B	chr20:25744102-25848786:-	-0.24	-4.94	1.09E-6	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs12428	chr20:25433821	NINL	chr20:25433338-25566153:-	0.37	7.5	3.22E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs12429254	chr13:96299663	DZIP1	chr13:96229329-96296957:-	0.2	3.95	9.14E-5	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
THCA	cis	1	rs12429254	chr13:96299663	UGGT2	chr13:96453838-96705736:-	-0.25	-3.74	0.000207	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
THCA	cis	1	rs12429256	chr13:42136383	C13orf15	chr13:42031542-42045013:+	-0.15	-3.58	0.000374	Multiple sclerosis	
THCA	cis	1	rs12429385	chr13:96301936	DZIP1	chr13:96229329-96296957:-	0.19	3.7	0.000238	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
THCA	cis	1	rs12429385	chr13:96301936	UGGT2	chr13:96453838-96705736:-	-0.25	-3.86	0.000131	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
THCA	cis	1	rs12431420	chr14:66001076	LOC645431	chr14:65877313-65879335:-	-0.54	-7.08	5.31E-12	Ischemic stroke	
THCA	cis	1	rs12433416	chr14:65854175	LOC645431	chr14:65877313-65879335:-	-0.41	-5.29	1.85E-7	Ischemic stroke	
THCA	cis	1	rs12433423	chr14:65854237	LOC645431	chr14:65877313-65879335:-	-0.41	-5.22	2.71E-7	Ischemic stroke	
THCA	cis	1	rs12433464	chr14:88824015	SPATA7	chr14:88852012-88904802:+	-0.17	-3.43	0.000663	Coronary artery calcification	
THCA	cis	1	rs12433827	chr14:66055610	LOC645431	chr14:65877313-65879335:-	-0.6	-7.52	2.8E-13	Ischemic stroke	
THCA	cis	1	rs12434585	chr14:65938368	LOC645431	chr14:65877313-65879335:-	-0.59	-7.8	4.04E-14	Ischemic stroke	
THCA	cis	1	rs12435391	chr14:75601737	EIF2B2	chr14:75469612-75476292:+	0.18	4.96	9.99E-7	Height	
THCA	cis	1	rs12435391	chr14:75601737	MLH3	chr14:75480467-75518235:-	0.29	8.78	2.87E-17	Height	
THCA	cis	1	rs12435391	chr14:75601737	RPS6KL1	chr14:75372347-75389958:-	0.31	6.76	4.09E-11	Height	
THCA	cis	1	rs12435835	chr14:65499909	CHURC1	chr14:65381140-65411309:+	0.22	4.47	9.71E-6	Red blood cell traits	
THCA	cis	1	rs12435835	chr14:65499909	FNTB	chr14:65381140-65529369:+	-0.21	-4.28	2.29E-5	Red blood cell traits	
THCA	cis	1	rs12435908	chr14:66121468	LOC645431	chr14:65877313-65879335:-	0.44	5.73	1.8E-8	Ischemic stroke	
THCA	cis	1	rs12437310	chr14:76642757	ESRRB	chr14:76837690-76968178:+	0.28	4.54	6.98E-6	Blood pressure	
THCA	cis	1	rs12437749	chr15:31649888	FAM7A2	chr15:30864758-30892900:+	-0.45	-4.05	5.98E-5	Survival in colorectal cancer (non-distant metastatic)	
THCA	cis	1	rs12438305	chr15:50912454	SPPL2A	chr15:50999739-51057910:-	0.26	7.08	5.05E-12	QT interval	
THCA	cis	1	rs12438318	chr15:31680445	CHRFAM7A	chr15:30653443-30685864:-	-0.35	-3.51	0.000485	Survival in colorectal cancer (non-distant metastatic)	
THCA	cis	1	rs12438318	chr15:31680445	FAM7A2	chr15:30864758-30892900:+	-0.51	-4.55	6.7E-6	Survival in colorectal cancer (non-distant metastatic)	
THCA	cis	1	rs12438690	chr15:62380390	VPS13C	chr15:62144592-62352647:-	-0.12	-4.47	9.71E-6	Height	
THCA	cis	1	rs12438803	chr15:62374942	VPS13C	chr15:62144592-62352647:-	-0.1	-3.79	0.000167	Height	
THCA	cis	1	rs12439239	chr15:31651718	FAM7A2	chr15:30864758-30892900:+	-0.5	-4.39	1.37E-5	Survival in colorectal cancer (non-distant metastatic)	
THCA	cis	1	rs12439356	chr15:62380595	VPS13C	chr15:62144592-62352647:-	-0.11	-4.26	2.42E-5	Height	
THCA	cis	1	rs12439744	chr15:50899211	SPPL2A	chr15:50999739-51057910:-	0.26	7.03	7.33E-12	QT interval	
THCA	cis	1	rs12441433	chr15:76816015	SCAPER	chr15:76640529-77197744:-	-0.17	-5.48	7.02E-8	Blood metabolite levels	
THCA	cis	1	rs12442212	chr15:62380482	VPS13C	chr15:62144592-62352647:-	-0.11	-4.11	4.73E-5	Height	
THCA	cis	1	rs12442510	chr15:66099113	DPP8	chr15:65737999-65810035:-	0.09	3.76	0.00019	Mean corpuscular hemoglobin	
THCA	cis	1	rs12442510	chr15:66099113	SLC24A1	chr15:65903704-65953256:+	0.15	3.66	0.000282	Mean corpuscular hemoglobin	
THCA	cis	1	rs12442675	chr15:62346056	VPS13C	chr15:62144592-62352647:-	0.11	4.19	3.34E-5	Height	
THCA	cis	1	rs12442787	chr15:50918107	SPPL2A	chr15:50999739-51057910:-	0.26	7.04	6.76E-12	QT interval	
THCA	cis	1	rs12443102	chr15:43932103	ADAL	chr15:43622872-43646094:+	-0.43	-9.21	1.05E-18	Tumor biomarkers	
THCA	cis	1	rs12443102	chr15:43932103	CATSPER2	chr15:43922774-43959900:-	-0.3	-5.23	2.5E-7	Tumor biomarkers	
THCA	cis	1	rs12443102	chr15:43932103	STRC	chr15:43891762-43924561:-	0.4	7.26	1.56E-12	Tumor biomarkers	
THCA	cis	1	rs12443118	chr15:56406027	MNS1	chr15:56720929-56757335:-	-0.25	-3.66	0.000279	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12443118	chr15:56406027	TEX9	chr15:56657644-56738071:+	-0.35	-6.11	2.11E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12443137	chr15:76840832	SCAPER	chr15:76640529-77197744:-	-0.16	-5.28	2.0E-7	Blood metabolite levels	
THCA	cis	1	rs12444166	chr16:79709950	MAF	chr16:79627746-79634622:-	-0.23	-3.82	0.000152	Urate levels	
THCA	cis	1	rs12444810	chr16:50080597	HEATR3	chr16:50099881-50139373:+	-0.41	-6.17	1.46E-9	Esophageal cancer (squamous cell)	
THCA	cis	1	rs12445650	chr16:31044897	C16orf93	chr16:30768753-30773542:-	-0.15	-4.32	1.87E-5	Response to metformin (IC50)	
THCA	cis	1	rs12445650	chr16:31044897	HSD3B7	chr16:30996519-31000473:+	0.47	12.45	5.27E-31	Response to metformin (IC50)	
THCA	cis	1	rs12445650	chr16:31044897	MYST1	chr16:31128985-31142713:+	0.17	5.51	5.82E-8	Response to metformin (IC50)	
THCA	cis	1	rs12445650	chr16:31044897	PRSS53	chr16:31094747-31106276:-	-0.14	-4.01	7.14E-5	Response to metformin (IC50)	
THCA	cis	1	rs12446201	chr16:69815586	COG4	chr16:70514473-70557457:-	-0.2	-4	7.34E-5	IgE levels	
THCA	cis	1	rs12446632	chr16:19935389	C16orf88	chr16:19717676-19729492:-	0.46	6.31	6.22E-10	Body mass index;Menarche (age at onset);Childhood body mass index;Obesity	
THCA	cis	1	rs12446632	chr16:19935389	GPRC5B	chr16:19870295-19896832:-	0.23	4.28	2.27E-5	Body mass index;Menarche (age at onset);Childhood body mass index;Obesity	
THCA	cis	1	rs12446947	chr16:50095385	HEATR3	chr16:50099881-50139373:+	-0.4	-6.21	1.16E-9	Esophageal cancer (squamous cell)	
THCA	cis	1	rs12447804	chr16:58075282	C16orf57	chr16:58035305-58055521:+	-0.34	-5.09	5.17E-7	Pulmonary function;Pulmonary function (interaction)	
THCA	cis	1	rs12447804	chr16:58075282	MMP15	chr16:58059282-58080802:+	0.15	3.6	0.00035	Pulmonary function;Pulmonary function (interaction)	
THCA	cis	1	rs12447804	chr16:58075282	TEPP	chr16:58010339-58022015:+	-0.32	-4.67	3.95E-6	Pulmonary function;Pulmonary function (interaction)	
THCA	cis	1	rs12447804	chr16:58075282	ZNF319	chr16:58028573-58033762:-	-0.36	-5.38	1.18E-7	Pulmonary function;Pulmonary function (interaction)	
THCA	cis	1	rs12447826	chr16:4464617	C16orf5	chr16:4560679-4588816:-	0.21	5.26	2.2E-7	Schizophrenia	
THCA	cis	1	rs12448508	chr16:50093538	HEATR3	chr16:50099881-50139373:+	-0.4	-6.21	1.16E-9	Esophageal cancer (squamous cell)	
THCA	cis	1	rs12450191	chr17:80407948	C17orf62	chr17:80400520-80408694:-	-0.27	-6.49	2.17E-10	Protein quantitative trait loci	
THCA	cis	1	rs12450191	chr17:80407948	NARF	chr17:80416060-80446141:+	-0.17	-3.37	0.000798	Protein quantitative trait loci	
THCA	cis	1	rs12450240	chr17:80423712	C17orf62	chr17:80400520-80408694:-	-0.27	-6.41	3.43E-10	Protein quantitative trait loci	
THCA	cis	1	rs12451511	chr17:65874861	C17orf58	chr17:65987218-65989765:-	0.2	3.97	8.17E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs12451707	chr17:65871598	C17orf58	chr17:65987218-65989765:-	0.21	4.03	6.37E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs12451721	chr17:65939075	C17orf58	chr17:65987218-65989765:-	0.21	4.11	4.59E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs12452511	chr17:65832576	C17orf58	chr17:65987218-65989765:-	0.2	3.85	0.000132	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs12452603	chr17:7504977	C17orf68	chr17:8128140-8151413:-	0.15	3.44	0.000625	IgA nephropathy	
THCA	cis	1	rs12452603	chr17:7504977	SHBG	chr17:7517382-7536700:+	0.18	3.42	0.00067	IgA nephropathy	
THCA	cis	1	rs12459123	chr19:12689741	RTBDN	chr19:12936293-12946230:-	0.21	3.67	0.000273	Bipolar disorder	
THCA	cis	1	rs12459222	chr19:46859301	PPP5C	chr19:46850294-46894103:+	-0.23	-3.95	8.85E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs12459469	chr19:53667913	ZNF665	chr19:53666552-53696619:-	-0.15	-4.1	4.83E-5	Yu-Zhi constitution type in type 2 diabetes	
THCA	cis	1	rs12460161	chr19:44293986	LYPD5	chr19:44300080-44324808:-	-0.24	-5.21	2.87E-7	Breast cancer	
THCA	cis	1	rs12460161	chr19:44293986	ZNF155	chr19:44488355-44502477:+	-0.25	-5.62	3.27E-8	Breast cancer	
THCA	cis	1	rs12460161	chr19:44293986	ZNF404	chr19:44376516-44384288:-	-0.25	-6.55	1.52E-10	Breast cancer	
THCA	cis	1	rs12460170	chr19:53669492	ZNF665	chr19:53666552-53696619:-	-0.15	-4.09	4.98E-5	Yu-Zhi constitution type in type 2 diabetes	
THCA	cis	1	rs12460678	chr19:52018951	SIGLEC6	chr19:52022784-52035064:-	-0.28	-3.37	0.000818	Carotid intima media thickness	
THCA	cis	1	rs12460678	chr19:52018951	ZNF175	chr19:52074531-52092990:+	-0.38	-4.5	8.73E-6	Carotid intima media thickness	
THCA	cis	1	rs12461762	chr19:52026450	ZNF175	chr19:52074531-52092990:+	-0.36	-4.26	2.49E-5	Carotid intima media thickness	
THCA	cis	1	rs12461773	chr19:52026219	ZNF175	chr19:52074531-52092990:+	-0.36	-4.26	2.49E-5	Carotid intima media thickness	
THCA	cis	1	rs12462270	chr19:39201488	LGALS7	chr19:39261608-39264157:-	-0.22	-4.7	3.34E-6	Heart rate	
THCA	cis	1	rs12465922	chr2:48389336	FOXN2	chr2:48541795-48606434:+	0.24	4.25	2.54E-5	Schizophrenia	
THCA	cis	1	rs12469163	chr2:26283587	GPR113	chr2:26531041-26569685:-	-0.44	-7.03	7.11E-12	Gut microbiome composition (summer)	
THCA	cis	1	rs12469163	chr2:26283587	HADHA	chr2:26413505-26467594:-	-0.16	-3.34	0.000904	Gut microbiome composition (summer)	
THCA	cis	1	rs12470450	chr2:232113888	ARMC9	chr2:232063342-232238606:+	0.41	9.83	6.6E-21	Food antigen IgG levels	
THCA	cis	1	rs12470837	chr2:132582511	C2orf27A	chr2:132480064-132524977:+	0.39	7.57	1.96E-13	Cerebrospinal fluid clusterin levels in APOEe4+ carriers;Cerebrospinal fluid clusterin levels	
THCA	cis	1	rs12471809	chr2:26307140	GPR113	chr2:26531041-26569685:-	-0.45	-7.05	6.4E-12	Gut microbiome composition (summer)	
THCA	cis	1	rs12472274	chr2:239095422	HES6	chr2:239146910-239148681:-	0.33	6.67	6.95E-11	Phospholipid levels (plasma)	
THCA	cis	1	rs12472274	chr2:239095422	ILKAP	chr2:239079044-239112324:-	0.16	4.93	1.11E-6	Phospholipid levels (plasma)	
THCA	cis	1	rs12472274	chr2:239095422	LOC151174	chr2:239133754-239140318:-	0.24	3.91	0.000104	Phospholipid levels (plasma)	
THCA	cis	1	rs12473740	chr2:88527647	KRCC1	chr2:88326724-88355248:-	-0.23	-3.75	0.000197	Plasma clusterin levels	
THCA	cis	1	rs12473740	chr2:88527647	THNSL2	chr2:88469835-88486145:+	-0.68	-8.69	5.61E-17	Plasma clusterin levels	
THCA	cis	1	rs12473894	chr2:63376570	C2orf86	chr2:63348537-63815851:-	-0.19	-3.93	9.82E-5	Subjective well-being	
THCA	cis	1	rs12475492	chr2:48380718	FOXN2	chr2:48541795-48606434:+	0.24	4.25	2.62E-5	Schizophrenia	
THCA	cis	1	rs12475854	chr2:26267375	GPR113	chr2:26531041-26569685:-	-0.4	-6.53	1.65E-10	Gut microbiome composition (summer)	
THCA	cis	1	rs12476268	chr2:69722616	AAK1	chr2:69685127-69870977:-	-0.22	-4.54	7.04E-6	Parkinson's disease (age of onset)	
THCA	cis	1	rs12476268	chr2:69722616	NFU1	chr2:69623255-69664753:-	-0.16	-3.54	0.000433	Parkinson's disease (age of onset)	
THCA	cis	1	rs12478744	chr2:23947589	LOC375190	chr2:24299728-24397519:+	0.33	8.27	1.37E-15	Obesity-related traits	
THCA	cis	1	rs12478819	chr2:207645078	MDH1B	chr2:207598943-207630050:-	0.48	6.08	2.42E-9	Episodic memory	
THCA	cis	1	rs12479491	chr20:30265450	COX4I2	chr20:30225691-30232800:+	0.12	3.86	0.000126	Subcortical brain region volumes	
THCA	cis	1	rs12480839	chr20:32727430	RALY	chr20:32581732-32672675:+	0.14	4.37	1.51E-5	Tanning;Skin sensitivity to sun;Red vs. non-red hair color;Freckles;Burning and freckling	
THCA	cis	1	rs12483148	chr21:37013621	CBR3	chr21:37507263-37518858:+	0.22	3.42	0.000692	Obesity-related traits	
THCA	cis	1	rs12483517	chr21:42691920	FAM3B	chr21:42676177-42729654:+	0.53	7.67	9.46E-14	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
THCA	cis	1	rs12484859	chr22:29844884	NIPSNAP1	chr22:29950800-29977144:-	0.32	4.05	5.97E-5	Carotid atherosclerosis in HIV infection	
THCA	cis	1	rs12484859	chr22:29844884	THOC5	chr22:29904157-29949736:-	0.21	3.81	0.000156	Carotid atherosclerosis in HIV infection	
THCA	cis	1	rs12487542	chr3:48426076	ATRIP	chr3:48488141-48507708:+	0.17	3.81	0.000155	Longevity	
THCA	cis	1	rs12487542	chr3:48426076	TREX1	chr3:48501186-48509043:+	-0.26	-5.97	4.57E-9	Longevity	
THCA	cis	1	rs12488359	chr3:191001294	UTS2D	chr3:190984945-191048325:-	0.17	3.38	0.000771	Total ventricular volume (Alzheimer's disease interaction)	
THCA	cis	1	rs12488768	chr3:53086234	GLYCTK	chr3:52321836-52329271:+	-0.16	-3.72	0.00022	Ulcerative colitis	
THCA	cis	1	rs12490835	chr3:134223730	ANAPC13	chr3:134196547-134204865:-	0.4	12.84	1.2E-32	Height	
THCA	cis	1	rs12490835	chr3:134223730	CEP63	chr3:134204575-134293852:+	0.29	6.27	8.12E-10	Height	
THCA	cis	1	rs12497019	chr3:151044903	GPR87	chr3:151011876-151034636:-	0.21	4.71	3.22E-6	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs12497019	chr3:151044903	P2RY14	chr3:150929905-150996230:-	-0.21	-4.5	8.38E-6	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs12498722	chr4:103554522	CISD2	chr4:103790135-103809913:+	-0.15	-3.52	0.000477	Primary biliary cirrhosis	
THCA	cis	1	rs12498722	chr4:103554522	NFKB1	chr4:103422486-103538458:+	0.15	4.13	4.24E-5	Primary biliary cirrhosis	
THCA	cis	1	rs12498808	chr4:165906905	C4orf39	chr4:165878100-165880273:+	0.18	5.04	6.53E-7	Ovarian cancer in BRCA1 mutation carriers	
THCA	cis	1	rs12499266	chr4:39119753	KLHL5	chr4:39046659-39123828:+	0.21	5.86	8.67E-9	Uric acid levels	
THCA	cis	1	rs12500118	chr4:155344634	DCHS2	chr4:155155527-155412930:-	0.15	3.42	0.000691	Alzheimer's disease (age of onset)	
THCA	cis	1	rs1250229	chr2:216304384	ATIC	chr2:216176692-216214477:+	0.16	4.02	6.84E-5	Cholesterol, total;LDL cholesterol	
THCA	cis	1	rs1250232	chr2:216306635	ATIC	chr2:216176692-216214477:+	0.15	3.72	0.000226	Cholesterol, total;LDL cholesterol	
THCA	cis	1	rs12503997	chr4:17948089	DCAF16	chr4:17802280-17812381:-	0.19	4.37	1.54E-5	Height	
THCA	cis	1	rs12504643	chr4:159634916	ETFDH	chr4:159593277-159629839:+	-0.14	-3.36	0.000845	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
THCA	cis	1	rs12504643	chr4:159634916	PPID	chr4:159630280-159644552:-	0.23	4.36	1.56E-5	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
THCA	cis	1	rs12505475	chr4:159635244	ETFDH	chr4:159593277-159629839:+	-0.14	-3.36	0.000829	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
THCA	cis	1	rs12505475	chr4:159635244	PPID	chr4:159630280-159644552:-	0.23	4.39	1.38E-5	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
THCA	cis	1	rs12505749	chr4:57334112	SRP72	chr4:57333762-57369846:+	-0.25	-4.82	1.9E-6	Airflow obstruction	
THCA	cis	1	rs12505835	chr4:297525	ZNF718	chr4:53272-156488:+	0.5	9.26	6.73E-19	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs12506752	chr4:17948352	DCAF16	chr4:17802280-17812381:-	-0.19	-4.37	1.54E-5	Height	
THCA	cis	1	rs12507142	chr4:17656103	MED28	chr4:17616273-17629791:+	0.17	3.75	0.000202	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs12508946	chr4:77127771	NUP54	chr4:77035818-77069655:-	0.17	3.61	0.000333	Body mass index	
THCA	cis	1	rs12509366	chr4:107003343	TBCK	chr4:106967233-107237861:-	0.36	7.34	9.29E-13	Airflow obstruction	
THCA	cis	1	rs12509640	chr4:106996677	TBCK	chr4:106967233-107237861:-	-0.35	-7.35	8.56E-13	Airflow obstruction	
THCA	cis	1	rs12510966	chr4:106983604	TBCK	chr4:106967233-107237861:-	0.35	7.29	1.3E-12	Airflow obstruction	
THCA	cis	1	rs12511456	chr4:17975603	DCAF16	chr4:17802280-17812381:-	-0.2	-4.41	1.26E-5	Height	
THCA	cis	1	rs12511600	chr4:17939921	DCAF16	chr4:17802280-17812381:-	-0.19	-4.37	1.54E-5	Height	
THCA	cis	1	rs12511991	chr4:48422768	OCIAD1	chr4:48833015-48863831:+	-0.14	-4.21	3.0E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs12512283	chr4:165908927	C4orf39	chr4:165878100-165880273:+	0.19	5.32	1.58E-7	Ovarian cancer in BRCA1 mutation carriers	
THCA	cis	1	rs12512683	chr4:106999471	TBCK	chr4:106967233-107237861:-	0.34	7.1	4.52E-12	Airflow obstruction	
THCA	cis	1	rs12513324	chr4:18006951	DCAF16	chr4:17802280-17812381:-	-0.2	-4.49	9.12E-6	Height	
THCA	cis	1	rs12513391	chr5:109774372	TMEM232	chr5:109624934-110062381:-	0.34	4.2	3.14E-5	Cardiac structure and function	
THCA	cis	1	rs12514600	chr5:115470655	COMMD10	chr5:115420727-115628978:+	0.48	5.75	1.63E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs12515251	chr5:115626966	COMMD10	chr5:115420727-115628978:+	0.48	5.7	2.09E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs12515308	chr5:115450441	COMMD10	chr5:115420727-115628978:+	0.5	6.16	1.54E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs12515466	chr5:115591877	COMMD10	chr5:115420727-115628978:+	0.49	5.93	5.67E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs12516100	chr5:115451750	COMMD10	chr5:115420727-115628978:+	0.48	5.75	1.63E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs12517508	chr5:115423574	COMMD10	chr5:115420727-115628978:+	0.49	5.94	5.37E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs12517604	chr5:130748500	P4HA2	chr5:131528306-131563556:-	-0.27	-5.16	3.61E-7	Life satisfaction	
THCA	cis	1	rs12519989	chr5:115562642	COMMD10	chr5:115420727-115628978:+	0.48	5.89	7.35E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs12520076	chr5:115458830	COMMD10	chr5:115420727-115628978:+	0.48	5.75	1.63E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs12520182	chr5:109769710	TMEM232	chr5:109624934-110062381:-	-0.44	-4.53	7.42E-6	Cardiac structure and function	
THCA	cis	1	rs12520568	chr5:115621505	COMMD10	chr5:115420727-115628978:+	0.5	6.16	1.51E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs12520594	chr5:115621597	COMMD10	chr5:115420727-115628978:+	0.48	4.84	1.76E-6	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs12520632	chr5:115591766	COMMD10	chr5:115420727-115628978:+	0.48	5.7	2.09E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs12521320	chr5:130755920	P4HA2	chr5:131528306-131563556:-	-0.25	-4.92	1.21E-6	Life satisfaction	
THCA	cis	1	rs12521440	chr5:115670364	COMMD10	chr5:115420727-115628978:+	0.48	5.7	2.09E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs12521612	chr5:115582605	COMMD10	chr5:115420727-115628978:+	0.48	5.7	2.09E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs12522027	chr5:115616531	COMMD10	chr5:115420727-115628978:+	0.48	5.66	2.56E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs12522034	chr5:36425593	UGT3A2	chr5:36035124-36066984:-	-0.21	-3.88	0.000119	Hypertension	
THCA	cis	1	rs12522441	chr5:115523805	COMMD10	chr5:115420727-115628978:+	0.48	5.84	9.44E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs12523022	chr5:598643	CEP72	chr5:612405-653664:+	0.38	7.37	7.52E-13	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs12523347	chr5:115572395	COMMD10	chr5:115420727-115628978:+	0.48	5.89	7.35E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs12524423	chr6:159375364	RSPH3	chr6:159398268-159421198:-	0.28	6	3.97E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs12524768	chr6:33760478	LEMD2	chr6:33738991-33756906:-	0.24	5.13	4.21E-7	Body mass index	
THCA	cis	1	rs12524835	chr6:33730843	LEMD2	chr6:33738991-33756906:-	0.25	4.93	1.12E-6	Body mass index	
THCA	cis	1	rs12525128	chr6:101174245	ASCC3	chr6:100956609-101329224:-	0.12	4.82	1.91E-6	Menarche (age at onset)	
THCA	cis	1	rs12525773	chr6:44913863	SUPT3H	chr6:44777054-45345670:-	0.17	3.4	0.000718	Height	
THCA	cis	1	rs12525951	chr6:70476729	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.49	0.000529	Sleep duration	
THCA	cis	1	rs12526680	chr6:26550954	BTN2A3	chr6:26422317-26431927:+	0.19	4.53	7.59E-6	Educational attainment	
THCA	cis	1	rs12526680	chr6:26550954	HCG11	chr6:26521934-26527610:+	-0.22	-4.36	1.57E-5	Educational attainment	
THCA	cis	1	rs12526680	chr6:26550954	HMGN4	chr6:26538572-26547162:+	-0.15	-3.88	0.000119	Educational attainment	
THCA	cis	1	rs12526680	chr6:26550954	LOC100270746	chr6:26987146-26988085:-	-0.14	-3.42	0.000689	Educational attainment	
THCA	cis	1	rs12526680	chr6:26550954	ZNF322A	chr6:26634612-26659963:-	-0.16	-4.54	7.19E-6	Educational attainment	
THCA	cis	1	rs12527396	chr6:159389017	RSPH3	chr6:159398268-159421198:-	0.28	5.91	6.35E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs12529519	chr6:105543354	BVES	chr6:105544700-105585049:-	0.25	4.14	4.12E-5	Multiple sclerosis	
THCA	cis	1	rs12530783	chr7:54175931	SEC61G	chr7:54819941-54826939:-	-0.22	-3.38	0.000785	Periodontal disease-related phenotypes	
THCA	cis	1	rs1253099	chr14:59946830	C14orf149	chr14:59939406-59951126:-	-0.32	-3.94	9.23E-5	Schizophrenia	
THCA	cis	1	rs1253099	chr14:59946830	JKAMP	chr14:59951161-59972080:+	0.41	4.95	1.03E-6	Schizophrenia	
THCA	cis	1	rs1253102	chr14:59947861	C14orf149	chr14:59939406-59951126:-	-0.32	-3.94	9.23E-5	Schizophrenia	
THCA	cis	1	rs1253102	chr14:59947861	JKAMP	chr14:59951161-59972080:+	0.41	4.95	1.03E-6	Schizophrenia	
THCA	cis	1	rs1253107	chr14:59952947	C14orf149	chr14:59939406-59951126:-	-0.34	-4.02	6.8E-5	Schizophrenia	
THCA	cis	1	rs1253107	chr14:59952947	JKAMP	chr14:59951161-59972080:+	0.4	4.7	3.42E-6	Schizophrenia	
THCA	cis	1	rs12532143	chr7:111025948	IMMP2L	chr7:110303110-111202538:-	0.17	3.87	0.000126	Schizophrenia	
THCA	cis	1	rs12532941	chr7:87396446	DBF4	chr7:87505544-87538856:+	-0.31	-4.52	7.81E-6	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs12532960	chr7:42325625	GLI3	chr7:42000550-42276618:-	0.36	3.91	0.000104	Inflammatory biomarkers	
THCA	cis	1	rs12532998	chr7:65967459	ASL	chr7:65540776-65558321:+	-0.16	-4.18	3.52E-5	Aortic root size	
THCA	cis	1	rs12532998	chr7:65967459	GUSB	chr7:65425675-65447246:-	0.27	5.29	1.89E-7	Aortic root size	
THCA	cis	1	rs12532998	chr7:65967459	RABGEF1	chr7:66093890-66276446:+	0.67	14.41	2.48E-39	Aortic root size	
THCA	cis	1	rs12533477	chr7:87426853	DBF4	chr7:87505544-87538856:+	-0.27	-3.76	0.000191	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs12533694	chr7:107102817	DLD	chr7:107531586-107561642:+	0.15	3.55	0.000417	Osteoarthritis	
THCA	cis	1	rs12533997	chr7:65965377	ASL	chr7:65540776-65558321:+	-0.16	-4.32	1.89E-5	Aortic root size	
THCA	cis	1	rs12533997	chr7:65965377	GUSB	chr7:65425675-65447246:-	0.28	5.45	8.17E-8	Aortic root size	
THCA	cis	1	rs12533997	chr7:65965377	RABGEF1	chr7:66093890-66276446:+	0.66	14.36	3.99E-39	Aortic root size	
THCA	cis	1	rs12535799	chr7:118161181	ANKRD7	chr7:117864712-117882782:+	0.23	3.79	0.000168	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs12539061	chr7:118206237	ANKRD7	chr7:117864712-117882782:+	0.23	3.81	0.000158	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs12539395	chr7:87279856	DBF4	chr7:87505544-87538856:+	-0.27	-4.04	6.35E-5	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs12540032	chr7:87402367	DBF4	chr7:87505544-87538856:+	-0.27	-4.08	5.34E-5	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs12540931	chr7:87302835	DBF4	chr7:87505544-87538856:+	-0.27	-3.71	0.00023	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs12541837	chr8:100881873	VPS13B	chr8:100025494-100889807:+	0.13	3.79	0.000172	Glucose homeostasis traits	
THCA	cis	1	rs12545771	chr8:8567977	SGK223	chr8:8175259-8239257:-	-0.31	-5.6	3.68E-8	Obesity-related traits	
THCA	cis	1	rs12546962	chr8:9198185	SGK223	chr8:8175259-8239257:-	-0.28	-4.74	2.8E-6	Body mass index	
THCA	cis	1	rs12547721	chr8:8570671	SGK223	chr8:8175259-8239257:-	-0.31	-5.58	4.04E-8	Obesity-related traits	
THCA	cis	1	rs12547941	chr8:29980332	LEPROTL1	chr8:29952922-29995222:+	0.19	4.24	2.73E-5	Migraine	
THCA	cis	1	rs12547941	chr8:29980332	MBOAT4	chr8:29989188-30002200:-	0.33	4.37	1.5E-5	Migraine	
THCA	cis	1	rs12550458	chr8:8567832	SGK223	chr8:8175259-8239257:-	-0.31	-5.6	3.68E-8	Obesity-related traits	
THCA	cis	1	rs12550762	chr8:8576535	SGK223	chr8:8175259-8239257:-	-0.31	-5.78	1.31E-8	Obesity-related traits	
THCA	cis	1	rs12561806	chr1:46396776	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.14	4.96E-22	Body mass index	
THCA	cis	1	rs12561806	chr1:46396776	GPBP1L1	chr1:46092978-46152302:-	0.15	3.83	0.000147	Body mass index	
THCA	cis	1	rs12561806	chr1:46396776	MMACHC	chr1:45965856-45976737:+	-0.21	-4.56	6.37E-6	Body mass index	
THCA	cis	1	rs12561806	chr1:46396776	MUTYH	chr1:45794915-45806142:-	0.3	8.15	3.33E-15	Body mass index	
THCA	cis	1	rs12563631	chr1:156258953	BGLAP	chr1:156182784-156213112:+	0.23	5.38	1.18E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12563631	chr1:156258953	C1orf85	chr1:156259882-156265449:-	-0.17	-4.05	6.05E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12563631	chr1:156258953	CCT3	chr1:156278752-156308195:-	-0.32	-6.92	1.42E-11	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs12563783	chr1:108312454	VAV3	chr1:108113782-108507545:-	0.5	6.87	2.03E-11	Hypothyroidism	
THCA	cis	1	rs12564541	chr1:46380237	CCDC163P	chr1:45960581-45965646:-	-0.51	-9.86	5.39E-21	Body mass index	
THCA	cis	1	rs12564541	chr1:46380237	GPBP1L1	chr1:46092978-46152302:-	0.16	4.09	5.14E-5	Body mass index	
THCA	cis	1	rs12564541	chr1:46380237	MMACHC	chr1:45965856-45976737:+	-0.2	-4.4	1.34E-5	Body mass index	
THCA	cis	1	rs12564541	chr1:46380237	MUTYH	chr1:45794915-45806142:-	0.31	8.38	5.89E-16	Body mass index	
THCA	cis	1	rs12567136	chr1:11883731	CLCN6	chr1:11866207-11907674:+	-0.16	-3.53	0.000463	QRS complex (12-leadsum)	
THCA	cis	1	rs12567463	chr1:152180128	FLG	chr1:152274651-152297679:-	0.3	4.71	3.22E-6	Atopic dermatitis	
THCA	cis	1	rs12567463	chr1:152180128	HRNR	chr1:152184558-152196669:-	-0.44	-6.24	9.57E-10	Atopic dermatitis	
THCA	cis	1	rs12570145	chr10:111712913	DUSP5	chr10:112257625-112271300:+	-0.12	-3.38	0.000779	Biliary atresia	
THCA	cis	1	rs12571820	chr10:38009354	LOC399744	chr10:38717074-38741080:+	0.28	3.67	0.000265	Obesity (extreme)	
THCA	cis	1	rs12571872	chr10:111676114	DUSP5	chr10:112257625-112271300:+	-0.14	-3.68	0.000259	Biliary atresia	
THCA	cis	1	rs12573978	chr11:46578400	PACSIN3	chr11:47199085-47207958:-	0.18	4.03	6.57E-5	Schizophrenia	
THCA	cis	1	rs12574512	chr11:46768405	ZNF408	chr11:46722368-46727461:+	-0.19	-3.72	0.000222	HDL cholesterol	
THCA	cis	1	rs12574668	chr11:46422686	PACSIN3	chr11:47199085-47207958:-	0.17	3.72	0.000223	Schizophrenia	
THCA	cis	1	rs12575519	chr11:46391602	PACSIN3	chr11:47199085-47207958:-	0.16	3.64	0.000298	Schizophrenia	
THCA	cis	1	rs12575609	chr11:46807378	DDB2	chr11:47236493-47260769:+	0.22	3.48	0.000544	HDL cholesterol	
THCA	cis	1	rs12575609	chr11:46807378	ZNF408	chr11:46722368-46727461:+	-0.19	-3.61	0.000338	HDL cholesterol	
THCA	cis	1	rs12577142	chr11:46377770	PACSIN3	chr11:47199085-47207958:-	0.16	3.58	0.000373	Schizophrenia	
THCA	cis	1	rs12577464	chr11:43662440	HSD17B12	chr11:43702143-43878160:+	-0.68	-14.26	1.07E-38	Forced vital capacity	
THCA	cis	1	rs12578042	chr11:46515004	PACSIN3	chr11:47199085-47207958:-	-0.16	-3.55	0.000421	Schizophrenia	
THCA	cis	1	rs12579753	chr12:82219376	PPFIA2	chr12:81652880-82153109:-	0.2	3.81	0.000156	Resting heart rate	
THCA	cis	1	rs12579846	chr12:62509328	FAM19A2	chr12:62102043-62653925:-	0.15	3.42	0.00068	Post bronchodilator FEV1/FVC ratio in COPD	
THCA	cis	1	rs12580330	chr12:82241280	PPFIA2	chr12:81652880-82153109:-	0.21	4.03	6.51E-5	Resting heart rate	
THCA	cis	1	rs1258061	chr1:47105000	CYP4Z1	chr1:47533160-47583992:+	-0.26	-3.84	0.000139	Response to hepatitis C treatment	
THCA	cis	1	rs1258061	chr1:47105000	DMBX1	chr1:46972668-46979884:+	-0.24	-4.13	4.21E-5	Response to hepatitis C treatment	
THCA	cis	1	rs12583	chr3:49571462	GMPPB	chr3:49758932-49761384:-	0.16	3.54	0.00044	Menarche (age at onset)	
THCA	cis	1	rs12583	chr3:49571462	P4HTM	chr3:49027341-49044579:+	-0.17	-4.18	3.53E-5	Menarche (age at onset)	
THCA	cis	1	rs12583	chr3:49571462	WDR6	chr3:49044637-49053386:+	0.17	3.44	0.00064	Menarche (age at onset)	
THCA	cis	1	rs12587386	chr14:88827764	SPATA7	chr14:88852012-88904802:+	-0.17	-3.58	0.000384	Coronary artery calcification	
THCA	cis	1	rs12588160	chr14:81776666	STON2	chr14:81727000-81893748:-	0.21	4.2	3.16E-5	Obesity-related traits	
THCA	cis	1	rs12588234	chr14:81773032	STON2	chr14:81727000-81893748:-	0.21	4.2	3.16E-5	Obesity-related traits	
THCA	cis	1	rs12588240	chr14:75612083	EIF2B2	chr14:75469612-75476292:+	0.19	5.14	3.97E-7	Height	
THCA	cis	1	rs12588240	chr14:75612083	MLH3	chr14:75480467-75518235:-	0.3	8.82	2.1E-17	Height	
THCA	cis	1	rs12588240	chr14:75612083	RPS6KL1	chr14:75372347-75389958:-	0.32	6.84	2.38E-11	Height	
THCA	cis	1	rs12589376	chr14:75561152	EIF2B2	chr14:75469612-75476292:+	0.19	5.13	4.3E-7	Height	
THCA	cis	1	rs12589376	chr14:75561152	MLH3	chr14:75480467-75518235:-	0.3	9.04	3.85E-18	Height	
THCA	cis	1	rs12589376	chr14:75561152	RPS6KL1	chr14:75372347-75389958:-	0.32	6.92	1.5E-11	Height	
THCA	cis	1	rs12589467	chr14:88823583	SPATA7	chr14:88852012-88904802:+	-0.17	-3.54	0.000447	Coronary artery calcification	
THCA	cis	1	rs12589480	chr14:88881270	SPATA7	chr14:88852012-88904802:+	-0.19	-3.83	0.000142	Coronary artery calcification	
THCA	cis	1	rs12589815	chr14:75544101	EIF2B2	chr14:75469612-75476292:+	0.19	5.13	4.3E-7	Height	
THCA	cis	1	rs12589815	chr14:75544101	MLH3	chr14:75480467-75518235:-	0.3	9.04	3.86E-18	Height	
THCA	cis	1	rs12589815	chr14:75544101	RPS6KL1	chr14:75372347-75389958:-	0.32	6.92	1.49E-11	Height	
THCA	cis	1	rs12589876	chr14:75544189	EIF2B2	chr14:75469612-75476292:+	0.18	4.99	8.37E-7	Height	
THCA	cis	1	rs12589876	chr14:75544189	MLH3	chr14:75480467-75518235:-	0.29	8.72	4.76E-17	Height	
THCA	cis	1	rs12589876	chr14:75544189	RPS6KL1	chr14:75372347-75389958:-	0.32	6.81	2.86E-11	Height	
THCA	cis	1	rs12590407	chr14:24835115	ADCY4	chr14:24787571-24804277:-	0.13	4.67	3.9E-6	Height	
THCA	cis	1	rs12590407	chr14:24835115	LTB4R	chr14:24780705-24787061:+	-0.15	-3.37	0.000818	Height	
THCA	cis	1	rs12590452	chr14:75548756	EIF2B2	chr14:75469612-75476292:+	0.19	5.14	4.01E-7	Height	
THCA	cis	1	rs12590452	chr14:75548756	MLH3	chr14:75480467-75518235:-	0.3	8.99	5.61E-18	Height	
THCA	cis	1	rs12590452	chr14:75548756	RPS6KL1	chr14:75372347-75389958:-	0.32	6.88	1.87E-11	Height	
THCA	cis	1	rs12591093	chr15:56510287	MNS1	chr15:56720929-56757335:-	-0.23	-3.41	0.000699	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12591093	chr15:56510287	TEX9	chr15:56657644-56738071:+	-0.34	-5.84	9.5E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12591150	chr15:56499482	TEX9	chr15:56657644-56738071:+	-0.34	-5.88	7.84E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12591151	chr15:56499483	TEX9	chr15:56657644-56738071:+	-0.34	-5.88	7.84E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12591751	chr15:50972497	SPPL2A	chr15:50999739-51057910:-	0.28	7.46	4.1E-13	QT interval	
THCA	cis	1	rs1259180	chr15:83244680	CPEB1	chr15:83211952-83316728:-	-0.15	-3.42	0.000691	Schizophrenia	
THCA	cis	1	rs1259180	chr15:83244680	GOLGA6L9	chr15:82711895-82731584:+;chr15	-0.15	-4.6	5.34E-6	Schizophrenia	
THCA	cis	1	rs12591980	chr15:56499326	TEX9	chr15:56657644-56738071:+	-0.34	-5.88	7.84E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12592130	chr15:56465885	MNS1	chr15:56720929-56757335:-	-0.25	-3.58	0.000385	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12592130	chr15:56465885	TEX9	chr15:56657644-56738071:+	-0.35	-5.99	4.06E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12592402	chr15:62349020	VPS13C	chr15:62144592-62352647:-	-0.12	-4.35	1.67E-5	Height	
THCA	cis	1	rs12592899	chr15:56525311	MNS1	chr15:56720929-56757335:-	-0.24	-3.51	0.000485	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12592899	chr15:56525311	TEX9	chr15:56657644-56738071:+	-0.34	-5.81	1.12E-8	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12593096	chr15:56506298	MNS1	chr15:56720929-56757335:-	-0.23	-3.41	0.000699	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12593096	chr15:56506298	TEX9	chr15:56657644-56738071:+	-0.34	-5.84	9.5E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12593261	chr15:91520319	HDDC3	chr15:91474157-91475774:-	-0.17	-4.66	4.12E-6	Type 2 diabetes	
THCA	cis	1	rs12593439	chr15:56531365	MNS1	chr15:56720929-56757335:-	-0.24	-3.55	0.000417	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12593439	chr15:56531365	TEX9	chr15:56657644-56738071:+	-0.34	-5.86	8.84E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12593713	chr15:56513500	MNS1	chr15:56720929-56757335:-	-0.23	-3.46	0.000582	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12593713	chr15:56513500	TEX9	chr15:56657644-56738071:+	-0.34	-5.86	8.41E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12593752	chr15:56485967	MNS1	chr15:56720929-56757335:-	-0.24	-3.57	0.000398	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12593752	chr15:56485967	TEX9	chr15:56657644-56738071:+	-0.35	-6.04	3.07E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12594061	chr15:66046429	DPP8	chr15:65737999-65810035:-	-0.09	-3.9	0.000109	Mean corpuscular hemoglobin	
THCA	cis	1	rs12594061	chr15:66046429	SLC24A1	chr15:65903704-65953256:+	-0.15	-3.73	0.000218	Mean corpuscular hemoglobin	
THCA	cis	1	rs12594212	chr15:76802014	SCAPER	chr15:76640529-77197744:-	-0.17	-5.47	7.25E-8	Blood metabolite levels	
THCA	cis	1	rs12594245	chr15:56499380	TEX9	chr15:56657644-56738071:+	-0.34	-5.88	7.84E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12594541	chr15:76834368	SCAPER	chr15:76640529-77197744:-	-0.16	-5.36	1.29E-7	Blood metabolite levels	
THCA	cis	1	rs12594658	chr15:62305090	VPS13C	chr15:62144592-62352647:-	-0.11	-4.16	3.85E-5	Height	
THCA	cis	1	rs12594908	chr15:56493287	TEX9	chr15:56657644-56738071:+	-0.34	-5.88	7.84E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12595072	chr15:56418771	MNS1	chr15:56720929-56757335:-	-0.25	-3.63	0.000317	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12595072	chr15:56418771	TEX9	chr15:56657644-56738071:+	-0.35	-6.11	2.04E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12595323	chr15:56506243	MNS1	chr15:56720929-56757335:-	-0.23	-3.41	0.000699	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12595323	chr15:56506243	TEX9	chr15:56657644-56738071:+	-0.34	-5.84	9.5E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12595366	chr15:56459914	MNS1	chr15:56720929-56757335:-	-0.25	-3.58	0.000385	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12595366	chr15:56459914	TEX9	chr15:56657644-56738071:+	-0.35	-5.99	4.06E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12595496	chr15:56528806	MNS1	chr15:56720929-56757335:-	-0.24	-3.46	0.000594	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12595496	chr15:56528806	TEX9	chr15:56657644-56738071:+	-0.34	-5.87	8.26E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12595649	chr15:56494368	TEX9	chr15:56657644-56738071:+	-0.34	-5.88	7.84E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12596679	chr16:69822680	COG4	chr16:70514473-70557457:-	0.2	4.15	4.0E-5	IgE levels	
THCA	cis	1	rs12598978	chr16:30482540	LOC595101	chr16:30278914-30346695:-	0.24	4.11	4.62E-5	Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs12598978	chr16:30482540	TBX6	chr16:30097117-30103208:-	-0.17	-3.64	0.0003	Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs12599931	chr16:58826531	GOT2	chr16:58741035-58768246:-	-0.24	-6.81	2.99E-11	Blood metabolite ratios	
THCA	cis	1	rs12599931	chr16:58826531	SLC38A7	chr16:58700298-58718674:-	-0.15	-5.28	1.92E-7	Blood metabolite ratios	
THCA	cis	1	rs12600578	chr17:5299950	C1QBP	chr17:5336099-5342471:-	0.13	3.73	0.000212	Body mass index	
THCA	cis	1	rs12600578	chr17:5299950	NLRP1	chr17:5404719-5487832:-	-0.2	-4.1	4.82E-5	Body mass index	
THCA	cis	1	rs12600578	chr17:5299950	RABEP1	chr17:5185558-5289131:+	-0.13	-3.78	0.000178	Body mass index	
THCA	cis	1	rs12600855	chr17:28279591	ANKRD13B	chr17:27916801-27941778:+	0.37	9.22	9.59E-19	Coffee consumption (cups per day)	
THCA	cis	1	rs12600855	chr17:28279591	CORO6	chr17:27941774-27948441:-	0.51	11.95	5.73E-29	Coffee consumption (cups per day)	
THCA	cis	1	rs12600855	chr17:28279591	EFCAB5	chr17:28256874-28435469:+	0.58	11.11	1.13E-25	Coffee consumption (cups per day)	
THCA	cis	1	rs12600855	chr17:28279591	GIT1	chr17:27900487-27916610:-	0.3	7	8.59E-12	Coffee consumption (cups per day)	
THCA	cis	1	rs12600855	chr17:28279591	LRRC37B2	chr17:28903483-28992715:+	0.17	3.72	0.00022	Coffee consumption (cups per day)	
THCA	cis	1	rs12600855	chr17:28279591	SSH2	chr17:27952965-28257018:-	0.33	7.56	2.06E-13	Coffee consumption (cups per day)	
THCA	cis	1	rs12600855	chr17:28279591	TP53I13	chr17:27895739-27900174:+	0.2	5.45	8.2E-8	Coffee consumption (cups per day)	
THCA	cis	1	rs12600941	chr17:65918807	C17orf58	chr17:65987218-65989765:-	0.21	4.1	4.89E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs12600993	chr17:28291222	ANKRD13B	chr17:27916801-27941778:+	0.37	9.1	2.41E-18	Coffee consumption (cups per day)	
THCA	cis	1	rs12600993	chr17:28291222	CORO6	chr17:27941774-27948441:-	0.51	12.08	1.68E-29	Coffee consumption (cups per day)	
THCA	cis	1	rs12600993	chr17:28291222	EFCAB5	chr17:28256874-28435469:+	0.59	11.19	5.5E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs12600993	chr17:28291222	GIT1	chr17:27900487-27916610:-	0.31	7.24	1.83E-12	Coffee consumption (cups per day)	
THCA	cis	1	rs12600993	chr17:28291222	LRRC37B2	chr17:28903483-28992715:+	0.17	3.81	0.000155	Coffee consumption (cups per day)	
THCA	cis	1	rs12600993	chr17:28291222	SSH2	chr17:27952965-28257018:-	0.34	7.68	8.8E-14	Coffee consumption (cups per day)	
THCA	cis	1	rs12600993	chr17:28291222	TP53I13	chr17:27895739-27900174:+	0.2	5.44	8.5E-8	Coffee consumption (cups per day)	
THCA	cis	1	rs12602655	chr17:65909442	C17orf58	chr17:65987218-65989765:-	0.21	4.02	6.74E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs12602901	chr17:4824625	GP1BA	chr17:4835592-4838324:+	-0.2	-3.54	0.000442	Blood metabolite levels	
THCA	cis	1	rs12602901	chr17:4824625	SLC25A11	chr17:4840605-4843325:-	-0.14	-3.8	0.000162	Blood metabolite levels	
THCA	cis	1	rs12602912	chr17:65870073	C17orf58	chr17:65987218-65989765:-	0.2	3.97	8.17E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs12603327	chr17:40290552	HSPB9	chr17:40274756-40275371:+	0.34	5.08	5.36E-7	Fibrinogen levels	
THCA	cis	1	rs12603330	chr17:40290589	HSPB9	chr17:40274756-40275371:+	0.34	5.01	7.63E-7	Fibrinogen levels	
THCA	cis	1	rs12608504	chr19:18389135	KIAA1683	chr19:18367906-18385319:-	-0.27	-7.93	1.53E-14	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12608544	chr19:49136651	SEC1	chr19:49141296-49185501:+	-0.64	-6.49	2.13E-10	Elevated serum carcinoembryonic antigen levels	
THCA	cis	1	rs12609219	chr19:52580996	ZNF432	chr19:52536678-52552073:-	-0.18	-4.57	6.14E-6	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	
THCA	cis	1	rs12609390	chr19:46891260	CCDC8	chr19:46913587-46916919:-	-0.21	-3.46	0.000596	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs12609594	chr19:9972417	ZNF266	chr19:9523272-9546234:-	0.19	4.44	1.1E-5	Sleep duration	
THCA	cis	1	rs12609594	chr19:9972417	ZNF846	chr19:9862816-9879410:-	-0.23	-4.23	2.78E-5	Sleep duration	
THCA	cis	1	rs12610373	chr19:18398284	KIAA1683	chr19:18367906-18385319:-	-0.27	-7.94	1.44E-14	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12611088	chr19:44072802	XRCC1	chr19:44047464-44079730:-	-0.19	-3.73	0.000217	Plasma amyloid beta peptide concentrations (ABx-42)	
THCA	cis	1	rs12611088	chr19:44072802	ZNF575	chr19:44029649-44040282:+	-0.23	-4.41	1.27E-5	Plasma amyloid beta peptide concentrations (ABx-42)	
THCA	cis	1	rs12612513	chr2:86301225	LOC90784	chr2:86247339-86250991:-	-0.35	-3.43	0.000649	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs12612513	chr2:86301225	POLR1A	chr2:86253453-86333278:-	-0.29	-3.75	0.0002	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs12614260	chr2:86303079	POLR1A	chr2:86253453-86333278:-	-0.34	-4.45	1.06E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs12614581	chr2:70079400	SNRNP27	chr2:70121090-70132348:+	0.17	3.99	7.57E-5	Colorectal or endometrial cancer	
THCA	cis	1	rs12615749	chr2:54475885	C2orf73	chr2:54558071-54588714:+	0.3	4.18	3.4E-5	Telomere length	
THCA	cis	1	rs12615793	chr2:54475914	C2orf73	chr2:54558071-54588714:+	-0.28	-3.99	7.68E-5	Telomere length	
THCA	cis	1	rs12615988	chr2:227769000	COL4A4	chr2:227867435-228029275:-	0.15	3.77	0.000183	Pulmonary function	
THCA	cis	1	rs12617061	chr2:70182338	ASPRV1	chr2:70187226-70314147:-	-0.18	-3.94	9.19E-5	Obesity-related traits	
THCA	cis	1	rs12617363	chr2:233440296	EIF4E2	chr2:233415357-233448349:+	-0.23	-4.27	2.35E-5	Height	
THCA	cis	1	rs12617717	chr2:86342303	LOC90784	chr2:86247339-86250991:-	-0.42	-4.2	3.12E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs12618262	chr2:190708073	ASNSD1	chr2:190526125-190535556:+	0.59	6.2	1.22E-9	Subcutaneous adipose tissue	
THCA	cis	1	rs12618769	chr2:99239931	UNC50	chr2:99225042-99234975:+	0.22	4.45	1.06E-5	Bipolar disorder	
THCA	cis	1	rs12619369	chr2:242282957	SEPT2	chr2:242254723-242293439:+	-0.29	-4.89	1.35E-6	Prostate cancer	
THCA	cis	1	rs12619985	chr2:46641627	PIGF	chr2:46808414-46844251:-	0.14	3.34	0.000895	HDL cholesterol	
THCA	cis	1	rs12620810	chr2:86391481	LOC90784	chr2:86247339-86250991:-	-0.35	-3.68	0.000258	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs12621280	chr2:232132984	ARMC9	chr2:232063342-232238606:+	0.55	13.31	1.27E-34	Food antigen IgG levels	
THCA	cis	1	rs12621567	chr2:232118813	ARMC9	chr2:232063342-232238606:+	0.44	10.53	1.84E-23	Food antigen IgG levels	
THCA	cis	1	rs12622009	chr2:86248325	LOC90784	chr2:86247339-86250991:-	-0.57	-6.68	6.54E-11	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs12623494	chr2:99245917	UNC50	chr2:99225042-99234975:+	-0.23	-4.66	4.07E-6	Bipolar disorder	
THCA	cis	1	rs12627787	chr22:51012381	CHKB	chr22:51017378-51021428:-	0.52	6.33	5.61E-10	Narcolepsy	
THCA	cis	1	rs12627787	chr22:51012381	CPT1B	chr22:51007291-51017096:-	-0.41	-8.34	8.14E-16	Narcolepsy	
THCA	cis	1	rs12630450	chr3:169480204	LRRC34	chr3:169511266-169530720:-	-0.24	-4.61	5.11E-6	Multiple myeloma and monoclonal gammopathy;Interstitial lung disease	
THCA	cis	1	rs12631684	chr3:137256080	NCK1	chr3:136581073-136667967:+	0.13	3.51	0.000488	Glucocorticoid-induced osteonecrosis	
THCA	cis	1	rs12637390	chr3:137251335	NCK1	chr3:136581073-136667967:+	0.13	3.51	0.000483	Glucocorticoid-induced osteonecrosis	
THCA	cis	1	rs12637751	chr3:134266124	ANAPC13	chr3:134196547-134204865:-	-0.39	-12.14	9.6E-30	Height	
THCA	cis	1	rs12637751	chr3:134266124	CEP63	chr3:134204575-134293852:+	-0.31	-6.6	1.07E-10	Height	
THCA	cis	1	rs12638253	chr3:156626091	LEKR1	chr3:156544076-156763918:+	-0.3	-8.27	1.36E-15	Multiple sclerosis (severity)	
THCA	cis	1	rs12639255	chr3:41861738	ULK4	chr3:41288091-42003660:-	1.04	19.85	2.05E-64	Diastolic blood pressure	
THCA	cis	1	rs12642900	chr4:107010329	TBCK	chr4:106967233-107237861:-	0.34	7.14	3.46E-12	Airflow obstruction	
THCA	cis	1	rs12643926	chr4:56310621	TMEM165	chr4:56262090-56292342:+	-0.16	-4.12	4.38E-5	Personality dimensions	
THCA	cis	1	rs12644381	chr4:103552430	CISD2	chr4:103790135-103809913:+	-0.15	-3.4	0.000729	Primary biliary cirrhosis	
THCA	cis	1	rs12644381	chr4:103552430	NFKB1	chr4:103422486-103538458:+	0.14	3.96	8.67E-5	Primary biliary cirrhosis	
THCA	cis	1	rs12645134	chr4:154713430	RNF175	chr4:154631313-154681387:-	-0.19	-4.05	6.09E-5	Electrocardiographic conduction measures	
THCA	cis	1	rs12645620	chr4:66498215	EPHA5	chr4:66185282-66535653:-	0.22	3.77	0.000182	HIV-1 viral setpoint	
THCA	cis	1	rs12646078	chr4:56368204	TMEM165	chr4:56262090-56292342:+	-0.14	-3.55	0.000426	Personality dimensions	
THCA	cis	1	rs12646124	chr4:154718084	RNF175	chr4:154631313-154681387:-	-0.19	-4.02	6.87E-5	Electrocardiographic conduction measures	
THCA	cis	1	rs12646251	chr4:39134371	KLHL5	chr4:39046659-39123828:+	-0.21	-5.76	1.49E-8	Uric acid levels	
THCA	cis	1	rs12646758	chr4:154731625	RNF175	chr4:154631313-154681387:-	-0.2	-4.29	2.17E-5	Electrocardiographic conduction measures	
THCA	cis	1	rs12648232	chr4:17612537	MED28	chr4:17616273-17629791:+	-0.16	-3.37	0.000805	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs12649527	chr4:48376802	OCIAD1	chr4:48833015-48863831:+	0.14	4.12	4.46E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs12649528	chr4:48376806	OCIAD1	chr4:48833015-48863831:+	0.12	3.44	0.000637	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs12651051	chr4:154722114	RNF175	chr4:154631313-154681387:-	-0.19	-4.03	6.46E-5	Electrocardiographic conduction measures	
THCA	cis	1	rs12652003	chr5:150231945	LOC134466	chr5:150310000-150326146:-	0.46	6.17	1.47E-9	Crohn's disease	
THCA	cis	1	rs12652003	chr5:150231945	ZNF300	chr5:150273964-150284391:-	0.16	3.42	0.000674	Crohn's disease	
THCA	cis	1	rs12654593	chr5:130756867	P4HA2	chr5:131528306-131563556:-	-0.25	-4.92	1.21E-6	Life satisfaction	
THCA	cis	1	rs12656538	chr5:150251380	LOC134466	chr5:150310000-150326146:-	0.44	5.85	9.03E-9	Crohn's disease	
THCA	cis	1	rs12656538	chr5:150251380	ZNF300	chr5:150273964-150284391:-	0.16	3.39	0.000744	Crohn's disease	
THCA	cis	1	rs12656600	chr5:150311872	LOC134466	chr5:150310000-150326146:-	0.44	5.8	1.22E-8	Crohn's disease	
THCA	cis	1	rs12658240	chr5:81173265	ATP6AP1L	chr5:81575281-81614146:+	-0.21	-3.64	0.000301	Cognitive function	
THCA	cis	1	rs12658259	chr5:81173250	ATP6AP1L	chr5:81575281-81614146:+	-0.22	-3.69	0.000248	Cognitive function	
THCA	cis	1	rs12659961	chr5:110187004	TMEM232	chr5:109624934-110062381:-	0.19	3.76	0.000188	Asthma and hay fever	
THCA	cis	1	rs12660955	chr6:33760320	IP6K3	chr6:33689443-33714762:-	0.41	6.71	5.55E-11	Obesity (extreme)	
THCA	cis	1	rs12661204	chr6:86678586	SNHG5	chr6:86386726-86388451:-	-0.51	-11.17	6.65E-26	Response to antipsychotic treatment	
THCA	cis	1	rs12661224	chr6:70448033	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.47	0.000566	Sleep duration	
THCA	cis	1	rs12662447	chr6:33714673	CUTA	chr6:33384319-33386065:-	-0.14	-3.41	0.000698	Obesity (extreme)	
THCA	cis	1	rs12662447	chr6:33714673	IP6K3	chr6:33689443-33714762:-	0.41	6.7	5.7E-11	Obesity (extreme)	
THCA	cis	1	rs12662447	chr6:33714673	PSMB8	chr6:32808497-32812712:-	-0.12	-3.48	0.000541	Obesity (extreme)	
THCA	cis	1	rs12663651	chr6:86701655	SNHG5	chr6:86386726-86388451:-	-0.48	-10.64	6.96E-24	Response to antipsychotic treatment	
THCA	cis	1	rs12663690	chr6:86640162	SNHG5	chr6:86386726-86388451:-	0.48	10.77	2.27E-24	Response to antipsychotic treatment	
THCA	cis	1	rs12664322	chr6:87803671	C6orf164	chr6:88032306-88109459:+	0.23	4.49	9.09E-6	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	
THCA	cis	1	rs12664335	chr6:86597774	SNHG5	chr6:86386726-86388451:-	0.49	10.78	2.07E-24	Response to antipsychotic treatment	
THCA	cis	1	rs12665321	chr6:86769289	SNHG5	chr6:86386726-86388451:-	-0.51	-10.95	4.54E-25	Response to antipsychotic treatment	
THCA	cis	1	rs12666249	chr7:12260546	VWDE	chr7:12370509-12443852:-	-0.23	-4.04	6.34E-5	Response to amphetamines	
THCA	cis	1	rs12667362	chr7:54178110	SEC61G	chr7:54819941-54826939:-	-0.22	-3.37	0.000825	Periodontal disease-related phenotypes	
THCA	cis	1	rs12668073	chr7:54186648	SEC61G	chr7:54819941-54826939:-	-0.24	-3.72	0.000227	Periodontal disease-related phenotypes	
THCA	cis	1	rs12669619	chr7:87514832	DBF4	chr7:87505544-87538856:+	-0.28	-4.27	2.32E-5	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs12671584	chr7:23915422	C7orf46	chr7:23719749-23742268:+	0.13	3.89	0.000114	Schizophrenia	
THCA	cis	1	rs12671624	chr7:23915413	C7orf46	chr7:23719749-23742268:+	0.13	3.9	0.000108	Schizophrenia	
THCA	cis	1	rs12672761	chr7:151118604	CRYGN	chr7:151127057-151137899:-	-0.15	-3.8	0.000165	Coronary heart disease	
THCA	cis	1	rs12675542	chr8:29986454	LEPROTL1	chr8:29952922-29995222:+	-0.17	-3.69	0.000254	Migraine	
THCA	cis	1	rs12675542	chr8:29986454	MBOAT4	chr8:29989188-30002200:-	-0.4	-5.2	2.91E-7	Migraine	
THCA	cis	1	rs12675542	chr8:29986454	TMEM66	chr8:29920632-29940649:-	0.18	3.45	0.000621	Migraine	
THCA	cis	1	rs1267657	chr15:83215251	CPEB1	chr15:83211952-83316728:-	-0.16	-3.38	0.000774	Schizophrenia	
THCA	cis	1	rs1267657	chr15:83215251	GOLGA6L9	chr15:82711895-82731584:+;chr15	-0.16	-4.95	1.03E-6	Schizophrenia	
THCA	cis	1	rs12677487	chr8:117710779	EIF3H	chr8:117657056-117778494:-	0.2	3.59	0.000365	Body mass index	
THCA	cis	1	rs1267817	chr7:66110040	CCT6P1	chr7:65216092-65228661:+	0.44	6.76	3.99E-11	Gout	
THCA	cis	1	rs1267817	chr7:66110040	CRCP	chr7:65579805-65619551:+	-0.3	-4.45	1.06E-5	Gout	
THCA	cis	1	rs1267817	chr7:66110040	GUSB	chr7:65425675-65447246:-	0.29	3.49	0.000523	Gout	
THCA	cis	1	rs1267817	chr7:66110040	RABGEF1	chr7:66093890-66276446:+	0.63	7.68	8.87E-14	Gout	
THCA	cis	1	rs1267818	chr7:66107024	CCT6P1	chr7:65216092-65228661:+	0.44	6.73	4.74E-11	Gout	
THCA	cis	1	rs1267818	chr7:66107024	CRCP	chr7:65579805-65619551:+	-0.3	-4.42	1.21E-5	Gout	
THCA	cis	1	rs1267818	chr7:66107024	GUSB	chr7:65425675-65447246:-	0.29	3.52	0.000479	Gout	
THCA	cis	1	rs1267818	chr7:66107024	RABGEF1	chr7:66093890-66276446:+	0.63	7.67	9.9E-14	Gout	
THCA	cis	1	rs1267820	chr7:66050295	CCT6P1	chr7:65216092-65228661:+	0.43	6.57	1.29E-10	Diabetic kidney disease	
THCA	cis	1	rs1267820	chr7:66050295	CRCP	chr7:65579805-65619551:+	-0.27	-3.97	8.4E-5	Diabetic kidney disease	
THCA	cis	1	rs1267820	chr7:66050295	GUSB	chr7:65425675-65447246:-	0.29	3.45	0.000607	Diabetic kidney disease	
THCA	cis	1	rs1267820	chr7:66050295	RABGEF1	chr7:66093890-66276446:+	0.64	7.69	8.58E-14	Diabetic kidney disease	
THCA	cis	1	rs12678539	chr8:94084076	C8orf83	chr8:93895865-94029901:-	0.21	3.48	0.00054	Attention deficit hyperactivity disorder	
THCA	cis	1	rs12680842	chr8:95582606	KIAA1429	chr8:95500600-95565688:-	-0.16	-5.43	9.08E-8	Body mass index	
THCA	cis	1	rs12681963	chr8:29982518	MBOAT4	chr8:29989188-30002200:-	-0.38	-4.88	1.44E-6	Migraine	
THCA	cis	1	rs12681963	chr8:29982518	TMEM66	chr8:29920632-29940649:-	0.18	3.44	0.000627	Migraine	
THCA	cis	1	rs12683072	chr9:36192912	SIT1	chr9:35649297-35650947:-	0.12	3.37	0.000825	Bipolar disorder (inflammation and infection response interaction)	
THCA	cis	1	rs12691307	chr16:29939877	FAM57B	chr16:30035749-30042186:-	-0.17	-3.39	0.000756	Schizophrenia	
THCA	cis	1	rs12691307	chr16:29939877	GIYD2	chr16:29465866-29469538:+;chr16	0.15	3.6	0.000347	Schizophrenia	
THCA	cis	1	rs12691307	chr16:29939877	LOC595101	chr16:30278914-30346695:-	-0.2	-3.81	0.000155	Schizophrenia	
THCA	cis	1	rs12691307	chr16:29939877	MYLPF	chr16:30386123-30389310:+	0.17	3.74	0.000205	Schizophrenia	
THCA	cis	1	rs12691307	chr16:29939877	RUNDC2C	chr16:29339874-29418349:+	0.17	4.24	2.65E-5	Schizophrenia	
THCA	cis	1	rs12691307	chr16:29939877	TBX6	chr16:30097117-30103208:-	0.23	5.65	2.8E-8	Schizophrenia	
THCA	cis	1	rs12696304	chr3:169481271	LRRC34	chr3:169511266-169530720:-	-0.26	-5.1	5.01E-7	Multiple myeloma and monoclonal gammopathy;Interstitial lung disease	
THCA	cis	1	rs12696543	chr3:184968818	CHRD	chr3:184097861-184107619:+	-0.14	-3.72	0.000223	Cognitive performance	
THCA	cis	1	rs12698509	chr7:65418876	CCT6P1	chr7:65216092-65228661:+	0.4	6.49	2.17E-10	Diabetic kidney disease	
THCA	cis	1	rs12698509	chr7:65418876	CRCP	chr7:65579805-65619551:+	-0.27	-4.28	2.24E-5	Diabetic kidney disease	
THCA	cis	1	rs12698509	chr7:65418876	RABGEF1	chr7:66093890-66276446:+	0.54	6.79	3.35E-11	Diabetic kidney disease	
THCA	cis	1	rs12698523	chr7:65968113	ASL	chr7:65540776-65558321:+	-0.16	-4.21	3.03E-5	Aortic root size	
THCA	cis	1	rs12698523	chr7:65968113	GUSB	chr7:65425675-65447246:-	0.27	5.32	1.57E-7	Aortic root size	
THCA	cis	1	rs12698523	chr7:65968113	RABGEF1	chr7:66093890-66276446:+	0.66	14.13	3.92E-38	Aortic root size	
THCA	cis	1	rs12699336	chr7:12283250	VWDE	chr7:12370509-12443852:-	-0.26	-4.38	1.46E-5	Response to amphetamines	
THCA	cis	1	rs12701220	chr7:1022728	C7orf50	chr7:1036623-1177893:-	-0.12	-3.66	0.000281	Bronchopulmonary dysplasia	
THCA	cis	1	rs12701220	chr7:1022728	CYP2W1	chr7:1022835-1029276:+	-0.19	-3.37	0.000821	Bronchopulmonary dysplasia	
THCA	cis	1	rs12701220	chr7:1022728	ZFAND2A	chr7:1192544-1199855:-	-0.18	-3.37	0.000815	Bronchopulmonary dysplasia	
THCA	cis	1	rs12702087	chr7:44812607	H2AFV	chr7:44866488-44887725:-	-0.17	-4.21	3.08E-5	Educational attainment (years of education)	
THCA	cis	1	rs12702087	chr7:44812607	ZMIZ2	chr7:44788180-44810733:+	-0.14	-3.63	0.000318	Educational attainment (years of education)	
THCA	cis	1	rs12705089	chr7:100465355	ACHE	chr7:100487616-100494539:-	0.27	4.25	2.57E-5	Resting heart rate	
THCA	cis	1	rs12705762	chr7:111039799	IMMP2L	chr7:110303110-111202538:-	0.16	3.57	0.000395	Schizophrenia	
THCA	cis	1	rs12706181	chr7:118002480	ANKRD7	chr7:117864712-117882782:+	0.28	4.51	8.04E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs12709013	chr16:58829790	GOT2	chr16:58741035-58768246:-	0.24	6.75	4.36E-11	Blood metabolite ratios	
THCA	cis	1	rs12709013	chr16:58829790	SLC38A7	chr16:58700298-58718674:-	0.15	5.34	1.41E-7	Blood metabolite ratios	
THCA	cis	1	rs12709812	chr19:37794850	ZNF607	chr19:38187276-38210691:-	0.19	3.35	0.000881	Coronary artery calcification	
THCA	cis	1	rs12709812	chr19:37794850	ZNF793	chr19:37997841-38034237:+	-0.15	-3.44	0.000631	Coronary artery calcification	
THCA	cis	1	rs12710454	chr21:40656919	HMGN1	chr21:40714247-40721270:-	-0.27	-6.29	7.19E-10	Cognitive function	
THCA	cis	1	rs12710454	chr21:40656919	PSMG1	chr21:40547390-40555440:-	-0.16	-3.94	9.42E-5	Cognitive function	
THCA	cis	1	rs12710454	chr21:40656919	SH3BGR	chr21:40817797-40887426:+	0.28	5.82	1.05E-8	Cognitive function	
THCA	cis	1	rs12710454	chr21:40656919	WRB	chr21:40752213-40769814:+	0.29	5.51	5.81E-8	Cognitive function	
THCA	cis	1	rs1271200	chr12:32441270	BICD1	chr12:32260185-32531140:+	0.13	4.1	4.93E-5	Pancreatic cancer	
THCA	cis	1	rs1271200	chr12:32441270	FGD4	chr12:32638906-32798982:+	0.16	4.38	1.48E-5	Pancreatic cancer	
THCA	cis	1	rs12712530	chr2:37505561	CEBPZ	chr2:37428778-37458740:-	-0.19	-4.12	4.56E-5	Chronic lymphocytic leukemia	
THCA	cis	1	rs12715519	chr3:58002106	PDHB	chr3:58413355-58419565:-	-0.16	-3.54	0.000442	Optic cup area	
THCA	cis	1	rs12723108	chr1:29408387	MECR	chr1:29519385-29557454:-	0.15	3.65	0.000294	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs12724265	chr1:31806081	ZCCHC17	chr1:31769842-31837780:+	-0.3	-5.72	1.88E-8	Schizophrenia	
THCA	cis	1	rs12725198	chr1:16080171	SLC25A34	chr1:16062809-16067885:+	0.21	4.82	1.93E-6	Cardiac Troponin-T levels	
THCA	cis	1	rs12725694	chr1:16080501	SLC25A34	chr1:16062809-16067885:+	-0.2	-4.78	2.33E-6	Cardiac Troponin-T levels	
THCA	cis	1	rs12725833	chr1:16080618	SLC25A34	chr1:16062809-16067885:+	-0.21	-4.85	1.69E-6	Cardiac Troponin-T levels	
THCA	cis	1	rs12726081	chr1:27037575	ZDHHC18	chr1:27153201-27182207:+	0.8	8.6	1.15E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs12726287	chr1:27039228	ZDHHC18	chr1:27153201-27182207:+	0.8	8.6	1.15E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs12729444	chr1:27037154	ZDHHC18	chr1:27153201-27182207:+	0.8	8.6	1.15E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs12730386	chr1:27037989	ZDHHC18	chr1:27153201-27182207:+	0.8	8.6	1.15E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs12731136	chr1:200830443	DDX59	chr1:200610119-200639126:-	-0.22	-3.47	0.000568	Epilepsy	
THCA	cis	1	rs1273153	chr14:59946459	C14orf149	chr14:59939406-59951126:-	0.32	3.89	0.000117	Schizophrenia	
THCA	cis	1	rs1273153	chr14:59946459	JKAMP	chr14:59951161-59972080:+	-0.4	-4.92	1.18E-6	Schizophrenia	
THCA	cis	1	rs12731749	chr1:27085562	PIGV	chr1:27114455-27124886:+	-0.29	-3.39	0.000755	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs12731749	chr1:27085562	ZDHHC18	chr1:27153201-27182207:+	0.8	8.61	1.03E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs12733173	chr1:152173972	FLG2	chr1:152321214-152332482:-	0.25	4.47	9.6E-6	Inflammatory skin disease	
THCA	cis	1	rs12733173	chr1:152173972	FLG	chr1:152274651-152297679:-	0.48	8.87	1.51E-17	Inflammatory skin disease	
THCA	cis	1	rs12733173	chr1:152173972	HRNR	chr1:152184558-152196669:-	-0.24	-3.7	0.000242	Inflammatory skin disease	
THCA	cis	1	rs12733378	chr1:200827806	DDX59	chr1:200610119-200639126:-	-0.26	-3.97	8.19E-5	Epilepsy	
THCA	cis	1	rs12734068	chr1:10376803	KIF1B	chr1:10270764-10441659:+	0.2	6.16	1.54E-9	Hepatocellular carcinoma	
THCA	cis	1	rs12734551	chr1:10391536	KIF1B	chr1:10270764-10441659:+	0.2	6.12	1.94E-9	Hepatocellular carcinoma	
THCA	cis	1	rs12735702	chr1:200815927	DDX59	chr1:200610119-200639126:-	-0.33	-4.39	1.4E-5	Epilepsy	
THCA	cis	1	rs12736176	chr1:200801028	DDX59	chr1:200610119-200639126:-	-0.26	-3.99	7.7E-5	Epilepsy	
THCA	cis	1	rs12736630	chr1:9153885	H6PD	chr1:9294863-9331392:+	0.17	3.36	0.000857	Response to antidepressant treatment (citalopram)	
THCA	cis	1	rs12736722	chr1:200780420	DDX59	chr1:200610119-200639126:-	-0.28	-4.16	3.79E-5	Epilepsy	
THCA	cis	1	rs12737946	chr1:27079894	ZDHHC18	chr1:27153201-27182207:+	0.8	8.63	9.37E-17	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs12738345	chr1:27019744	PIGV	chr1:27114455-27124886:+	-0.29	-3.4	0.000718	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs12738345	chr1:27019744	ZDHHC18	chr1:27153201-27182207:+	0.79	8.27	1.35E-15	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs12738912	chr1:9152080	H6PD	chr1:9294863-9331392:+	0.18	3.53	0.000456	Response to antidepressant treatment (citalopram)	
THCA	cis	1	rs12739698	chr1:27230033	ZDHHC18	chr1:27153201-27182207:+	0.75	7.75	5.42E-14	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs12740374	chr1:109817590	SYPL2	chr1:110009100-110024763:+	-0.16	-3.56	0.000414	Cholesterol, total;Myocardial infarction;Coronary artery disease;Lipoprotein-associated phospholipase A2 activity and mass	
THCA	cis	1	rs12741472	chr1:27221609	ZDHHC18	chr1:27153201-27182207:+	0.75	7.87	2.31E-14	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs12742115	chr1:27079931	ZDHHC18	chr1:27153201-27182207:+	0.8	8.63	9.29E-17	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs12742376	chr1:27285195	ZDHHC18	chr1:27153201-27182207:+	0.73	7.54	2.42E-13	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs12743862	chr1:27028221	ZDHHC18	chr1:27153201-27182207:+	0.8	8.62	1.0E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs12744212	chr1:180952516	MR1	chr1:181003139-181024633:+	-0.13	-3.54	0.000438	Progressive supranuclear palsy	
THCA	cis	1	rs12744212	chr1:180952516	STX6	chr1:180913175-180992046:-	-0.2	-4.1	4.85E-5	Progressive supranuclear palsy	
THCA	cis	1	rs12744221	chr1:145645606	NUDT17	chr1:145586494-145590461:-	0.32	6.93	1.4E-11	Epilepsy (remission after treatment)	
THCA	cis	1	rs12746810	chr1:27013133	PIGV	chr1:27114455-27124886:+	-0.29	-3.35	0.000862	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs12746810	chr1:27013133	ZDHHC18	chr1:27153201-27182207:+	0.8	8.48	2.89E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs12747799	chr1:200717686	DDX59	chr1:200610119-200639126:-	-0.24	-3.81	0.000156	Epilepsy	
THCA	cis	1	rs12748010	chr1:200773547	DDX59	chr1:200610119-200639126:-	-0.27	-4.08	5.33E-5	Epilepsy	
THCA	cis	1	rs12748136	chr1:200835590	DDX59	chr1:200610119-200639126:-	-0.24	-3.65	0.000289	Epilepsy	
THCA	cis	1	rs12748152	chr1:27138393	ZDHHC18	chr1:27153201-27182207:+	0.81	8.64	8.68E-17	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs12752711	chr1:27250258	ZDHHC18	chr1:27153201-27182207:+	0.74	7.81	3.78E-14	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs12753569	chr1:76484014	ST6GALNAC3	chr1:76540389-77096669:+	0.21	4.17	3.58E-5	Personality dimensions	
THCA	cis	1	rs12753920	chr1:92665899	KIAA1107	chr1:92632609-92650279:+	0.2	5.24	2.43E-7	Systemic lupus erythematosus	
THCA	cis	1	rs12753981	chr1:27001893	ZDHHC18	chr1:27153201-27182207:+	0.79	8.56	1.52E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs12754041	chr1:180957962	MR1	chr1:181003139-181024633:+	-0.13	-3.68	0.000255	Progressive supranuclear palsy	
THCA	cis	1	rs12754041	chr1:180957962	STX6	chr1:180913175-180992046:-	-0.2	-4.05	6.04E-5	Progressive supranuclear palsy	
THCA	cis	1	rs12754089	chr1:37965304	SNIP1	chr1:38002145-38019903:-	-0.18	-3.37	0.00082	Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs12754423	chr1:37965549	SNIP1	chr1:38002145-38019903:-	-0.18	-3.37	0.00082	Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs12754468	chr1:27014748	ZDHHC18	chr1:27153201-27182207:+	0.78	8.38	6.05E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs1275468	chr12:75935157	GLIPR1L2	chr12:75784889-75825591:+	-0.4	-6.4	3.71E-10	Polycystic ovary syndrome	
THCA	cis	1	rs1275469	chr12:75935230	GLIPR1L2	chr12:75784889-75825591:+	-0.4	-6.36	4.72E-10	Polycystic ovary syndrome	
THCA	cis	1	rs1275501	chr2:27419282	C2orf28	chr2:27434899-27440044:+	-0.16	-4.69	3.49E-6	Blood metabolite levels	
THCA	cis	1	rs1275501	chr2:27419282	SLC5A6	chr2:27422459-27435071:-	0.33	7.17	2.91E-12	Blood metabolite levels	
THCA	cis	1	rs12755094	chr1:10305711	KIF1B	chr1:10270764-10441659:+	0.21	6.64	8.67E-11	Hepatocellular carcinoma	
THCA	cis	1	rs1275522	chr2:27426878	C2orf28	chr2:27434899-27440044:+	-0.17	-5.13	4.26E-7	Blood metabolite levels	
THCA	cis	1	rs1275522	chr2:27426878	SLC5A6	chr2:27422459-27435071:-	0.31	6.65	7.97E-11	Blood metabolite levels	
THCA	cis	1	rs1275528	chr2:27430781	C2orf28	chr2:27434899-27440044:+	-0.17	-5.13	4.26E-7	Blood metabolite levels	
THCA	cis	1	rs1275528	chr2:27430781	SLC5A6	chr2:27422459-27435071:-	0.31	6.65	7.97E-11	Blood metabolite levels	
THCA	cis	1	rs1275530	chr2:27432547	C2orf28	chr2:27434899-27440044:+	-0.17	-5.05	6.17E-7	Blood metabolite levels	
THCA	cis	1	rs1275530	chr2:27432547	SLC5A6	chr2:27422459-27435071:-	0.32	6.74	4.72E-11	Blood metabolite levels	
THCA	cis	1	rs1275537	chr2:27441302	C2orf28	chr2:27434899-27440044:+	0.15	4.6	5.39E-6	Blood metabolite levels	
THCA	cis	1	rs1275537	chr2:27441302	SLC5A6	chr2:27422459-27435071:-	-0.34	-7.32	1.09E-12	Blood metabolite levels	
THCA	cis	1	rs1275538	chr2:27441397	C2orf28	chr2:27434899-27440044:+	0.15	4.55	6.86E-6	Blood metabolite levels	
THCA	cis	1	rs1275538	chr2:27441397	C2orf70	chr2:26785481-26802394:+	0.18	3.52	0.000471	Blood metabolite levels	
THCA	cis	1	rs1275538	chr2:27441397	SLC5A6	chr2:27422459-27435071:-	-0.35	-7.47	3.92E-13	Blood metabolite levels	
THCA	cis	1	rs12756074	chr1:27047893	ZDHHC18	chr1:27153201-27182207:+	0.8	8.6	1.18E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs12756886	chr1:200840467	DDX59	chr1:200610119-200639126:-	-0.22	-3.36	0.000853	Epilepsy	
THCA	cis	1	rs12756996	chr1:200780333	DDX59	chr1:200610119-200639126:-	-0.25	-3.89	0.000115	Epilepsy	
THCA	cis	1	rs12757820	chr1:10266671	KIF1B	chr1:10270764-10441659:+	0.2	6.14	1.75E-9	Hepatocellular carcinoma	
THCA	cis	1	rs12760175	chr1:46447840	CCDC163P	chr1:45960581-45965646:-	-0.52	-9.92	3.26E-21	Body mass index	
THCA	cis	1	rs12760175	chr1:46447840	GPBP1L1	chr1:46092978-46152302:-	0.15	3.73	0.00021	Body mass index	
THCA	cis	1	rs12760175	chr1:46447840	MMACHC	chr1:45965856-45976737:+	-0.22	-4.68	3.74E-6	Body mass index	
THCA	cis	1	rs12760175	chr1:46447840	MUTYH	chr1:45794915-45806142:-	0.32	8.27	1.32E-15	Body mass index	
THCA	cis	1	rs12760759	chr1:27158344	PIGV	chr1:27114455-27124886:+	0.29	3.52	0.00047	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs12760759	chr1:27158344	ZDHHC18	chr1:27153201-27182207:+	-0.82	-9.12	2.07E-18	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs12763390	chr10:38084432	LOC399744	chr10:38717074-38741080:+	0.28	3.69	0.000251	Obesity (extreme)	
THCA	cis	1	rs12763409	chr10:38092690	LOC399744	chr10:38717074-38741080:+	0.28	3.72	0.000225	Obesity (extreme)	
THCA	cis	1	rs12766567	chr10:38035222	LOC399744	chr10:38717074-38741080:+	0.29	3.76	0.00019	Obesity (extreme)	
THCA	cis	1	rs12767633	chr10:102056440	PKD2L1	chr10:102047903-102090243:-	-0.26	-3.35	0.000875	Obesity-related traits	
THCA	cis	1	rs12768613	chr10:81916566	MBL1P	chr10:81664654-81710783:+	0.25	4.36	1.57E-5	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs12768613	chr10:81916566	PLAC9	chr10:81892258-81904784:+	-0.23	-5.9	6.88E-9	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs12768834	chr10:74043874	ASCC1	chr10:73856278-73976892:-	0.18	3.38	0.000798	Heschl's gyrus morphology	
THCA	cis	1	rs12768834	chr10:74043874	DNAJB12	chr10:74092588-74114907:-	0.2	4.76	2.63E-6	Heschl's gyrus morphology	
THCA	cis	1	rs12771477	chr10:17209464	TRDMT1	chr10:17184983-17243681:-	-0.44	-10.33	1.02E-22	Homocysteine levels	
THCA	cis	1	rs12771477	chr10:17209464	VIM	chr10:17270258-17279592:+	-0.19	-3.51	0.000483	Homocysteine levels	
THCA	cis	1	rs12772239	chr10:37988944	LOC399744	chr10:38717074-38741080:+	0.25	3.41	0.000697	Obesity (extreme)	
THCA	cis	1	rs12772275	chr10:17204542	TRDMT1	chr10:17184983-17243681:-	-0.43	-9.88	4.4E-21	Homocysteine levels	
THCA	cis	1	rs12773642	chr10:17196055	TRDMT1	chr10:17184983-17243681:-	-0.44	-10.09	7.66E-22	Homocysteine levels	
THCA	cis	1	rs12773642	chr10:17196055	VIM	chr10:17270258-17279592:+	-0.19	-3.48	0.000539	Homocysteine levels	
THCA	cis	1	rs12774134	chr10:4963327	AKR1C2	chr10:4964715-5060207:-	0.3	3.97	8.28E-5	Height	
THCA	cis	1	rs12774378	chr10:91331621	FLJ37201	chr10:91451057-91457685:-	-0.18	-3.72	0.000221	Metabolic traits	
THCA	cis	1	rs12776158	chr10:71218094	TSPAN15	chr10:71211226-71267423:+	0.25	3.7	0.000238	Age-related hearing impairment (interaction)	
THCA	cis	1	rs12777243	chr10:91336117	FLJ37201	chr10:91451057-91457685:-	-0.19	-3.92	0.000101	Metabolic traits	
THCA	cis	1	rs12777800	chr10:1070361	IDI2	chr10:1064847-1071799:-	-0.25	-3.59	0.000359	Response to angiotensin II receptor blocker therapy	
THCA	cis	1	rs12780845	chr10:17223244	TRDMT1	chr10:17184983-17243681:-	-0.42	-9.82	7.66E-21	Homocysteine levels	
THCA	cis	1	rs12780845	chr10:17223244	VIM	chr10:17270258-17279592:+	-0.2	-3.71	0.000234	Homocysteine levels	
THCA	cis	1	rs12781703	chr10:38044627	LOC399744	chr10:38717074-38741080:+	0.28	3.69	0.000251	Obesity (extreme)	
THCA	cis	1	rs12782327	chr10:38092443	LOC399744	chr10:38717074-38741080:+	0.27	3.62	0.000322	Obesity (extreme)	
THCA	cis	1	rs12782687	chr10:17223368	TRDMT1	chr10:17184983-17243681:-	-0.43	-10.21	2.74E-22	Homocysteine levels	
THCA	cis	1	rs12782687	chr10:17223368	VIM	chr10:17270258-17279592:+	-0.2	-3.8	0.000165	Homocysteine levels	
THCA	cis	1	rs12783490	chr10:17223716	TRDMT1	chr10:17184983-17243681:-	-0.44	-10.24	2.22E-22	Homocysteine levels	
THCA	cis	1	rs12783490	chr10:17223716	VIM	chr10:17270258-17279592:+	-0.2	-3.63	0.00032	Homocysteine levels	
THCA	cis	1	rs12784772	chr10:65195455	LOC84989	chr10:65224989-65226320:+	0.26	4.18	3.51E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs12784772	chr10:65195455	NRBF2	chr10:64893007-64914785:+	0.27	4.44	1.12E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs1278493	chr3:135814009	PCCB	chr3:135969167-136056737:+	-0.21	-6.3	6.62E-10	Gestational age at birth (child effect)	
THCA	cis	1	rs12785488	chr11:64107521	PRDX5	chr11:64085569-64089282:+	-0.16	-3.87	0.000125	Mean platelet volume	
THCA	cis	1	rs12786942	chr11:101394765	TRPC6	chr11:101322296-101454659:-	-0.26	-4.05	6.01E-5	Facial depth	
THCA	cis	1	rs12787330	chr11:47812311	C1QTNF4	chr11:47611216-47615961:-	-0.32	-5.4	1.03E-7	Subjective well-being	
THCA	cis	1	rs12787909	chr11:117546482	ATP5L	chr11:118272104-118280561:+	0.24	4.03	6.55E-5	Lipoprotein (a) - cholesterol levels	
THCA	cis	1	rs12788189	chr11:4483631	TRIM68	chr11:4619902-4629437:-	0.17	3.59	0.000361	Amyotrophic lateral sclerosis	
THCA	cis	1	rs12792834	chr11:101396383	TRPC6	chr11:101322296-101454659:-	-0.26	-4.13	4.35E-5	Facial depth	
THCA	cis	1	rs12793746	chr11:101367985	TRPC6	chr11:101322296-101454659:-	-0.23	-3.72	0.000222	Facial depth	
THCA	cis	1	rs1279389	chr13:78375312	EDNRB	chr13:78469616-78549664:-	0.14	4.13	4.21E-5	Hair color	
THCA	cis	1	rs1279390	chr13:78376196	EDNRB	chr13:78469616-78549664:-	0.14	4.13	4.29E-5	Hair color	
THCA	cis	1	rs1279391	chr13:78376956	EDNRB	chr13:78469616-78549664:-	0.14	4.13	4.29E-5	Hair color	
THCA	cis	1	rs1279392	chr13:78377519	EDNRB	chr13:78469616-78549664:-	0.14	4.12	4.49E-5	Hair color	
THCA	cis	1	rs1279396	chr13:78378593	EDNRB	chr13:78469616-78549664:-	0.14	3.96	8.5E-5	Hair color	
THCA	cis	1	rs1279397	chr13:78378687	EDNRB	chr13:78469616-78549664:-	0.14	3.96	8.5E-5	Hair color	
THCA	cis	1	rs1279399	chr13:78379199	EDNRB	chr13:78469616-78549664:-	0.14	3.96	8.5E-5	Hair color	
THCA	cis	1	rs1279402	chr13:78382504	EDNRB	chr13:78469616-78549664:-	0.14	4.23	2.82E-5	Hair color	
THCA	cis	1	rs12794	chr1:47141718	CYP4Z1	chr1:47533160-47583992:+	0.26	3.89	0.000112	Response to hepatitis C treatment	
THCA	cis	1	rs12794	chr1:47141718	DMBX1	chr1:46972668-46979884:+	0.23	4.04	6.19E-5	Response to hepatitis C treatment	
THCA	cis	1	rs1279674	chr13:78389826	EDNRB	chr13:78469616-78549664:-	0.14	4.12	4.49E-5	Hair color	
THCA	cis	1	rs1279675	chr13:78389693	EDNRB	chr13:78469616-78549664:-	0.14	4.12	4.45E-5	Hair color	
THCA	cis	1	rs12798036	chr11:947585	TSPAN4	chr11:842824-867116:+	0.15	3.68	0.000259	Alzheimer's disease (late onset)	
THCA	cis	1	rs1279831	chr3:135933264	PCCB	chr3:135969167-136056737:+	0.21	6.03	3.27E-9	Gestational age at birth (child effect)	
THCA	cis	1	rs12799017	chr11:61738545	BEST1	chr11:61717356-61731939:+	0.29	5.82	1.06E-8	Phospholipid levels (plasma)	
THCA	cis	1	rs12799017	chr11:61738545	FADS2	chr11:61583728-61634825:+	0.18	3.89	0.000116	Phospholipid levels (plasma)	
THCA	cis	1	rs12806241	chr11:101361028	TRPC6	chr11:101322296-101454659:-	-0.25	-4.17	3.64E-5	Facial depth	
THCA	cis	1	rs12806	chr10:101911142	BLOC1S2	chr10:102033713-102046439:-	-0.44	-6.43	3.13E-10	Schizophrenia	
THCA	cis	1	rs12806	chr10:101911142	CWF19L1	chr10:101992055-102027437:-	-0.45	-5.42	9.56E-8	Schizophrenia	
THCA	cis	1	rs12809125	chr12:124407991	DNAH10	chr12:124247042-124420265:+	0.19	3.82	0.000149	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12809125	chr12:124407991	ZNF664	chr12:124457670-124499967:+	-0.15	-4.3	2.11E-5	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12811063	chr12:81440720	ACSS3	chr12:81471809-81649582:+	-0.21	-4.43	1.16E-5	Neuroticism	
THCA	cis	1	rs12811607	chr12:82233619	PPFIA2	chr12:81652880-82153109:-	0.22	4.1	4.91E-5	Resting heart rate	
THCA	cis	1	rs12814773	chr12:129280786	GLT1D1	chr12:129338081-129469509:+	-0.22	-5.55	4.7E-8	Systemic lupus erythematosus	
THCA	cis	1	rs12814773	chr12:129280786	SLC15A4	chr12:129277739-129308541:-	-0.18	-4.44	1.11E-5	Systemic lupus erythematosus	
THCA	cis	1	rs12821073	chr12:82183260	PPFIA2	chr12:81652880-82153109:-	0.17	3.35	0.000884	Resting heart rate	
THCA	cis	1	rs12827398	chr12:81445457	ACSS3	chr12:81471809-81649582:+	0.22	4.67	4.01E-6	Neuroticism	
THCA	cis	1	rs12827923	chr12:82242067	PPFIA2	chr12:81652880-82153109:-	0.21	4.03	6.51E-5	Resting heart rate	
THCA	cis	1	rs12828040	chr12:7326541	PEX5	chr12:7341759-7371167:+	0.42	10.01	1.56E-21	IgG glycosylation	
THCA	cis	1	rs12828421	chr12:7335217	PEX5	chr12:7341759-7371167:+	-0.41	-9.88	4.48E-21	IgG glycosylation	
THCA	cis	1	rs12829595	chr12:62507518	FAM19A2	chr12:62102043-62653925:-	-0.15	-3.34	0.000892	Post bronchodilator FEV1/FVC ratio in COPD	
THCA	cis	1	rs12830268	chr12:82233627	PPFIA2	chr12:81652880-82153109:-	0.22	4.1	4.91E-5	Resting heart rate	
THCA	cis	1	rs1284464	chr12:57964617	FAM119B	chr12:58166383-58176323:+	0.17	4.52	7.92E-6	Rheumatoid arthritis	
THCA	cis	1	rs1284464	chr12:57964617	TSFM	chr12:58176536-58191367:+	-0.24	-6.72	5.21E-11	Rheumatoid arthritis	
THCA	cis	1	rs12866839	chr13:42152254	MRPS31	chr13:41303433-41345347:-	0.19	3.46	0.000578	Multiple sclerosis	
THCA	cis	1	rs12867333	chr13:42138165	C13orf15	chr13:42031542-42045013:+	0.15	3.52	0.000465	Multiple sclerosis	
THCA	cis	1	rs12869969	chr13:42140340	C13orf15	chr13:42031542-42045013:+	-0.15	-3.86	0.000131	Multiple sclerosis	
THCA	cis	1	rs12871457	chr13:85685272	SLITRK6	chr13:86366922-86373483:-	-0.21	-3.79	0.000171	Bipolar disorder (mania)	
THCA	cis	1	rs12872842	chr13:85664592	SLITRK6	chr13:86366922-86373483:-	-0.21	-3.78	0.000177	Bipolar disorder (mania)	
THCA	cis	1	rs12874649	chr13:85673495	SLITRK6	chr13:86366922-86373483:-	-0.2	-3.66	0.000279	Bipolar disorder (mania)	
THCA	cis	1	rs12879542	chr14:75507525	EIF2B2	chr14:75469612-75476292:+	0.18	5	7.94E-7	Height	
THCA	cis	1	rs12879542	chr14:75507525	MLH3	chr14:75480467-75518235:-	0.3	8.98	6.04E-18	Height	
THCA	cis	1	rs12879542	chr14:75507525	RPS6KL1	chr14:75372347-75389958:-	0.33	7.21	2.26E-12	Height	
THCA	cis	1	rs12879642	chr14:76682967	ESRRB	chr14:76837690-76968178:+	0.3	4.57	6.2E-6	Blood pressure	
THCA	cis	1	rs12882853	chr14:97330150	VRK1	chr14:97263684-97347950:+	0.17	4.07	5.5E-5	Neutrophil count	
THCA	cis	1	rs12889309	chr14:75593902	EIF2B2	chr14:75469612-75476292:+	0.19	5.12	4.49E-7	Height	
THCA	cis	1	rs12889309	chr14:75593902	MLH3	chr14:75480467-75518235:-	0.3	8.98	6.21E-18	Height	
THCA	cis	1	rs12889309	chr14:75593902	RPS6KL1	chr14:75372347-75389958:-	0.32	6.87	1.95E-11	Height	
THCA	cis	1	rs12889472	chr14:75543979	EIF2B2	chr14:75469612-75476292:+	0.18	4.88	1.48E-6	Height	
THCA	cis	1	rs12889472	chr14:75543979	MLH3	chr14:75480467-75518235:-	0.29	8.8	2.42E-17	Height	
THCA	cis	1	rs12889472	chr14:75543979	RPS6KL1	chr14:75372347-75389958:-	0.32	6.89	1.75E-11	Height	
THCA	cis	1	rs12897094	chr14:75579416	EIF2B2	chr14:75469612-75476292:+	0.19	5.1	4.83E-7	Height	
THCA	cis	1	rs12897094	chr14:75579416	MLH3	chr14:75480467-75518235:-	0.3	9.03	4.26E-18	Height	
THCA	cis	1	rs12897094	chr14:75579416	RPS6KL1	chr14:75372347-75389958:-	0.32	6.91	1.57E-11	Height	
THCA	cis	1	rs12897731	chr14:97266352	VRK1	chr14:97263684-97347950:+	0.18	4.1	4.89E-5	Neutrophil count	
THCA	cis	1	rs12898259	chr15:75369780	ARID3B	chr15:74833548-74890470:+	-0.15	-4.02	6.81E-5	Blood trace element (Zn levels)	
THCA	cis	1	rs12898259	chr15:75369780	PPCDC	chr15:75315927-75343066:+	0.13	3.78	0.000175	Blood trace element (Zn levels)	
THCA	cis	1	rs12898259	chr15:75369780	SCAMP2	chr15:75136073-75165670:-	-0.15	-3.34	0.000897	Blood trace element (Zn levels)	
THCA	cis	1	rs12898259	chr15:75369780	SCAMP5	chr15:75287901-75313836:+	0.41	7.35	8.43E-13	Blood trace element (Zn levels)	
THCA	cis	1	rs12898311	chr15:91517780	HDDC3	chr15:91474157-91475774:-	-0.15	-4.18	3.49E-5	Type 2 diabetes	
THCA	cis	1	rs12898430	chr15:76874923	SCAPER	chr15:76640529-77197744:-	-0.17	-5.64	2.95E-8	Blood metabolite levels	
THCA	cis	1	rs12899981	chr15:85302373	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-3.75	0.0002	Schizophrenia	
THCA	cis	1	rs12899981	chr15:85302373	LOC388152	chr15:84867600-84898920:-	-0.47	-7.95	1.35E-14	Schizophrenia	
THCA	cis	1	rs12899981	chr15:85302373	NMB	chr15:85198362-85201802:-	0.36	7.69	8.22E-14	Schizophrenia	
THCA	cis	1	rs12900061	chr15:66009248	DPP8	chr15:65737999-65810035:-	-0.14	-4.68	3.79E-6	Educational attainment (years of education)	
THCA	cis	1	rs12900413	chr15:90321039	MESP1	chr15:90293100-90294540:-	-0.31	-6.66	7.6E-11	Coronary artery aneurysm in Kawasaki disease	
THCA	cis	1	rs12900413	chr15:90321039	MESP2	chr15:90303822-90321980:+	-0.33	-5.82	1.08E-8	Coronary artery aneurysm in Kawasaki disease	
THCA	cis	1	rs12901243	chr15:75374233	ARID3B	chr15:74833548-74890470:+	-0.15	-4.02	6.81E-5	Blood trace element (Zn levels)	
THCA	cis	1	rs12901243	chr15:75374233	PPCDC	chr15:75315927-75343066:+	0.13	3.78	0.000175	Blood trace element (Zn levels)	
THCA	cis	1	rs12901243	chr15:75374233	SCAMP2	chr15:75136073-75165670:-	-0.15	-3.34	0.000897	Blood trace element (Zn levels)	
THCA	cis	1	rs12901243	chr15:75374233	SCAMP5	chr15:75287901-75313836:+	0.41	7.35	8.43E-13	Blood trace element (Zn levels)	
THCA	cis	1	rs12902672	chr15:84716986	GOLGA6L5	chr15:85047738-85060078:-	-0.21	-5.39	1.1E-7	Schizophrenia	
THCA	cis	1	rs12902672	chr15:84716986	LOC388152	chr15:84867600-84898920:-	-0.72	-13.04	1.82E-33	Schizophrenia	
THCA	cis	1	rs12902672	chr15:84716986	NMB	chr15:85198362-85201802:-	0.23	4.54	7.12E-6	Schizophrenia	
THCA	cis	1	rs12902672	chr15:84716986	SH3GL3	chr15:84116091-84287491:+	0.24	3.77	0.000182	Schizophrenia	
THCA	cis	1	rs12903134	chr15:85337699	GOLGA6L5	chr15:85047738-85060078:-	-0.15	-4.03	6.61E-5	Schizophrenia	
THCA	cis	1	rs12903134	chr15:85337699	LOC388152	chr15:84867600-84898920:-	-0.48	-8.23	1.75E-15	Schizophrenia	
THCA	cis	1	rs12903134	chr15:85337699	NMB	chr15:85198362-85201802:-	0.35	7.53	2.63E-13	Schizophrenia	
THCA	cis	1	rs12903201	chr15:75370776	ARID3B	chr15:74833548-74890470:+	-0.15	-4.02	6.81E-5	Blood trace element (Zn levels)	
THCA	cis	1	rs12903201	chr15:75370776	PPCDC	chr15:75315927-75343066:+	0.13	3.78	0.000175	Blood trace element (Zn levels)	
THCA	cis	1	rs12903201	chr15:75370776	SCAMP2	chr15:75136073-75165670:-	-0.15	-3.34	0.000897	Blood trace element (Zn levels)	
THCA	cis	1	rs12903201	chr15:75370776	SCAMP5	chr15:75287901-75313836:+	0.41	7.35	8.43E-13	Blood trace element (Zn levels)	
THCA	cis	1	rs12903820	chr15:84723820	GOLGA6L5	chr15:85047738-85060078:-	-0.21	-5.39	1.1E-7	Schizophrenia	
THCA	cis	1	rs12903820	chr15:84723820	LOC388152	chr15:84867600-84898920:-	-0.72	-13.04	1.82E-33	Schizophrenia	
THCA	cis	1	rs12903820	chr15:84723820	NMB	chr15:85198362-85201802:-	0.23	4.54	7.12E-6	Schizophrenia	
THCA	cis	1	rs12903820	chr15:84723820	SH3GL3	chr15:84116091-84287491:+	0.24	3.77	0.000182	Schizophrenia	
THCA	cis	1	rs12904329	chr15:24839870	PWRN1	chr15:24778839-24832924:+	0.39	7.94	1.48E-14	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
THCA	cis	1	rs12904436	chr15:65720706	DPP8	chr15:65737999-65810035:-	-0.09	-3.87	0.000124	Mean corpuscular hemoglobin	
THCA	cis	1	rs12904436	chr15:65720706	SLC24A1	chr15:65903704-65953256:+	-0.16	-3.75	0.000196	Mean corpuscular hemoglobin	
THCA	cis	1	rs12905057	chr15:85210765	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.09	4.98E-5	Schizophrenia	
THCA	cis	1	rs12905057	chr15:85210765	LOC388152	chr15:84867600-84898920:-	-0.49	-8.16	2.97E-15	Schizophrenia	
THCA	cis	1	rs12905057	chr15:85210765	NMB	chr15:85198362-85201802:-	0.37	7.77	4.88E-14	Schizophrenia	
THCA	cis	1	rs12906032	chr15:24822388	PWRN1	chr15:24778839-24832924:+	0.25	5.73	1.77E-8	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
THCA	cis	1	rs12906196	chr15:65884888	DPP8	chr15:65737999-65810035:-	-0.09	-3.67	0.000269	Mean corpuscular hemoglobin	
THCA	cis	1	rs12906196	chr15:65884888	SLC24A1	chr15:65903704-65953256:+	-0.16	-3.84	0.000139	Mean corpuscular hemoglobin	
THCA	cis	1	rs12908161	chr15:85207825	GOLGA6L5	chr15:85047738-85060078:-	-0.15	-4	7.44E-5	Schizophrenia	
THCA	cis	1	rs12908161	chr15:85207825	LOC388152	chr15:84867600-84898920:-	-0.48	-8.11	4.17E-15	Schizophrenia	
THCA	cis	1	rs12908161	chr15:85207825	NMB	chr15:85198362-85201802:-	0.37	7.85	2.85E-14	Schizophrenia	
THCA	cis	1	rs12908549	chr15:85322351	GOLGA6L5	chr15:85047738-85060078:-	-0.15	-3.81	0.000156	Schizophrenia	
THCA	cis	1	rs12908549	chr15:85322351	LOC388152	chr15:84867600-84898920:-	-0.48	-8.08	5.36E-15	Schizophrenia	
THCA	cis	1	rs12908549	chr15:85322351	NMB	chr15:85198362-85201802:-	0.35	7.43	5.01E-13	Schizophrenia	
THCA	cis	1	rs12909095	chr15:43558142	STRC	chr15:43891762-43924561:-	0.27	5.79	1.28E-8	Lung cancer	
THCA	cis	1	rs12909280	chr15:85429356	LOC388152	chr15:84867600-84898920:-	-0.29	-4.75	2.74E-6	Alzheimer's disease (age of onset)	
THCA	cis	1	rs12909280	chr15:85429356	NMB	chr15:85198362-85201802:-	0.24	4.85	1.7E-6	Alzheimer's disease (age of onset)	
THCA	cis	1	rs12910012	chr15:85298662	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-3.75	0.0002	Schizophrenia	
THCA	cis	1	rs12910012	chr15:85298662	LOC388152	chr15:84867600-84898920:-	-0.47	-7.95	1.35E-14	Schizophrenia	
THCA	cis	1	rs12910012	chr15:85298662	NMB	chr15:85198362-85201802:-	0.36	7.69	8.22E-14	Schizophrenia	
THCA	cis	1	rs12910644	chr15:75358388	ARID3B	chr15:74833548-74890470:+	-0.15	-3.77	0.000181	Blood trace element (Zn levels)	
THCA	cis	1	rs12910644	chr15:75358388	MAN2C1	chr15:75648135-75660941:-	0.15	3.57	0.000387	Blood trace element (Zn levels)	
THCA	cis	1	rs12910644	chr15:75358388	PPCDC	chr15:75315927-75343066:+	0.15	4.17	3.69E-5	Blood trace element (Zn levels)	
THCA	cis	1	rs12910644	chr15:75358388	SCAMP5	chr15:75287901-75313836:+	0.43	7.64	1.24E-13	Blood trace element (Zn levels)	
THCA	cis	1	rs12910992	chr15:90372465	AP3S2	chr15:90373832-90456222:-	-0.7	-17.26	3.05E-52	Type 2 diabetes	
THCA	cis	1	rs12910992	chr15:90372465	C15orf38	chr15:90443832-90456222:-	0.35	7.74	5.88E-14	Type 2 diabetes	
THCA	cis	1	rs12911132	chr15:43560436	STRC	chr15:43891762-43924561:-	0.28	5.72	1.9E-8	Lung cancer	
THCA	cis	1	rs12911736	chr15:85240008	GOLGA6L5	chr15:85047738-85060078:-	-0.15	-3.84	0.000137	Schizophrenia	
THCA	cis	1	rs12911736	chr15:85240008	LOC388152	chr15:84867600-84898920:-	-0.49	-8.14	3.43E-15	Schizophrenia	
THCA	cis	1	rs12911736	chr15:85240008	NMB	chr15:85198362-85201802:-	0.37	7.7	8.02E-14	Schizophrenia	
THCA	cis	1	rs12912388	chr15:85344550	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.2	3.18E-5	Schizophrenia	
THCA	cis	1	rs12912388	chr15:85344550	LOC388152	chr15:84867600-84898920:-	-0.48	-8.12	3.93E-15	Schizophrenia	
THCA	cis	1	rs12912388	chr15:85344550	NMB	chr15:85198362-85201802:-	0.36	7.6	1.55E-13	Schizophrenia	
THCA	cis	1	rs12913259	chr15:51014716	SPPL2A	chr15:50999739-51057910:-	0.14	3.46	0.000578	Fibrinogen levels	
THCA	cis	1	rs12913951	chr15:62372592	VPS13C	chr15:62144592-62352647:-	-0.1	-3.79	0.000172	Height	
THCA	cis	1	rs12914773	chr15:68019958	C15orf61	chr15:67813522-67819638:+	0.12	3.38	0.000791	Motion sickness	
THCA	cis	1	rs12914773	chr15:68019958	IQCH	chr15:67547188-67794139:+	0.17	5.24	2.46E-7	Motion sickness	
THCA	cis	1	rs12914773	chr15:68019958	MAP2K5	chr15:67835021-68099451:+	0.14	3.48	0.000539	Motion sickness	
THCA	cis	1	rs12914857	chr15:84581166	LOC388152	chr15:84867600-84898920:-	-0.21	-3.98	7.86E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs12915234	chr15:84758301	GOLGA6L5	chr15:85047738-85060078:-	-0.21	-5.39	1.1E-7	Schizophrenia	
THCA	cis	1	rs12915234	chr15:84758301	LOC388152	chr15:84867600-84898920:-	-0.72	-13.03	2.08E-33	Schizophrenia	
THCA	cis	1	rs12915234	chr15:84758301	NMB	chr15:85198362-85201802:-	0.23	4.56	6.37E-6	Schizophrenia	
THCA	cis	1	rs12915234	chr15:84758301	SH3GL3	chr15:84116091-84287491:+	0.24	3.82	0.000153	Schizophrenia	
THCA	cis	1	rs12916348	chr15:84765527	GOLGA6L5	chr15:85047738-85060078:-	-0.21	-5.37	1.26E-7	Schizophrenia	
THCA	cis	1	rs12916348	chr15:84765527	LOC388152	chr15:84867600-84898920:-	-0.72	-12.99	3.1E-33	Schizophrenia	
THCA	cis	1	rs12916348	chr15:84765527	NMB	chr15:85198362-85201802:-	0.23	4.63	4.62E-6	Schizophrenia	
THCA	cis	1	rs12916348	chr15:84765527	SH3GL3	chr15:84116091-84287491:+	0.24	3.8	0.000164	Schizophrenia	
THCA	cis	1	rs12917018	chr15:43024063	GANC	chr15:42565856-42645863:+	-0.18	-3.84	0.000142	MGMT methylation in smokers	
THCA	cis	1	rs12917429	chr15:85425097	LOC388152	chr15:84867600-84898920:-	0.32	5.04	6.56E-7	Alzheimer's disease (age of onset)	
THCA	cis	1	rs12917429	chr15:85425097	NMB	chr15:85198362-85201802:-	-0.24	-4.66	4.04E-6	Alzheimer's disease (age of onset)	
THCA	cis	1	rs12917429	chr15:85425097	WDR73	chr15:85186012-85197524:-	0.19	3.61	0.000335	Alzheimer's disease (age of onset)	
THCA	cis	1	rs12919718	chr16:58350225	CCDC113	chr16:58283840-58317732:+	-0.19	-3.55	0.000416	Systemic lupus erythematosus	
THCA	cis	1	rs12923297	chr16:31360944	HSD3B7	chr16:30996519-31000473:+	-0.15	-3.82	0.000154	IgA nephropathy	
THCA	cis	1	rs12924215	chr16:58071092	C16orf57	chr16:58035305-58055521:+	-0.33	-4.84	1.79E-6	Pulmonary function;Pulmonary function (interaction)	
THCA	cis	1	rs12924215	chr16:58071092	TEPP	chr16:58010339-58022015:+	-0.33	-4.77	2.45E-6	Pulmonary function;Pulmonary function (interaction)	
THCA	cis	1	rs12924215	chr16:58071092	ZNF319	chr16:58028573-58033762:-	-0.34	-4.91	1.27E-6	Pulmonary function;Pulmonary function (interaction)	
THCA	cis	1	rs12925371	chr16:69773885	COG4	chr16:70514473-70557457:-	-0.18	-3.64	0.000301	IgE levels	
THCA	cis	1	rs1292642	chr11:4476267	TRIM68	chr11:4619902-4629437:-	0.16	3.45	0.0006	Amyotrophic lateral sclerosis	
THCA	cis	1	rs12926993	chr16:58823122	GOT2	chr16:58741035-58768246:-	-0.27	-7.64	1.21E-13	Blood metabolite ratios	
THCA	cis	1	rs12926993	chr16:58823122	SLC38A7	chr16:58700298-58718674:-	-0.15	-5.13	4.19E-7	Blood metabolite ratios	
THCA	cis	1	rs12937756	chr17:40576813	NAGLU	chr17:40687951-40696464:+	-0.22	-4.6	5.54E-6	Crohn's disease	
THCA	cis	1	rs12937756	chr17:40576813	TUBG2	chr17:40811266-40819023:+	-0.23	-5.46	7.68E-8	Crohn's disease	
THCA	cis	1	rs12938856	chr17:40570649	NAGLU	chr17:40687951-40696464:+	-0.23	-4.89	1.4E-6	Crohn's disease	
THCA	cis	1	rs12938856	chr17:40570649	TUBG2	chr17:40811266-40819023:+	-0.23	-5.38	1.18E-7	Crohn's disease	
THCA	cis	1	rs1293988	chr1:186266293	C1orf27	chr1:186344890-186390502:+	0.15	3.41	0.000703	Clozapine-induced cytotoxicity	
THCA	cis	1	rs12940106	chr17:53067683	STXBP4	chr17:53046126-53241449:+	-0.15	-3.86	0.000128	Breast cancer	
THCA	cis	1	rs12940106	chr17:53067683	TOM1L1	chr17:52978052-53039328:+	-0.17	-4.21	3.11E-5	Breast cancer	
THCA	cis	1	rs12942660	chr17:37982038	C17orf37	chr17:37885411-37886788:-	-0.28	-4.55	6.8E-6	Systemic lupus erythematosus	
THCA	cis	1	rs12943498	chr17:40593901	NAGLU	chr17:40687951-40696464:+	-0.22	-4.65	4.28E-6	Crohn's disease	
THCA	cis	1	rs12943498	chr17:40593901	TUBG2	chr17:40811266-40819023:+	-0.23	-5.45	8.03E-8	Crohn's disease	
THCA	cis	1	rs12947597	chr17:3999199	ANKFY1	chr17:4066667-4167274:-	0.14	3.34	0.000896	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	
THCA	cis	1	rs12948099	chr17:79600799	ARL16	chr17:79648234-79650954:-	-0.12	-3.35	0.000867	Eye color traits	
THCA	cis	1	rs12948099	chr17:79600799	TSPAN10	chr17:79609349-79615778:+	0.79	17.31	1.8E-52	Eye color traits	
THCA	cis	1	rs12948909	chr17:40570602	NAGLU	chr17:40687951-40696464:+	-0.23	-4.81	2.02E-6	Crohn's disease	
THCA	cis	1	rs12948909	chr17:40570602	TUBG2	chr17:40811266-40819023:+	-0.22	-5.15	3.87E-7	Crohn's disease	
THCA	cis	1	rs12950390	chr17:45830948	TBKBP1	chr17:45772630-45789427:+	0.19	3.83	0.000147	IgG glycosylation	
THCA	cis	1	rs12951549	chr17:40593502	NAGLU	chr17:40687951-40696464:+	-0.22	-4.65	4.28E-6	Crohn's disease	
THCA	cis	1	rs12951549	chr17:40593502	TUBG2	chr17:40811266-40819023:+	-0.23	-5.45	8.03E-8	Crohn's disease	
THCA	cis	1	rs12951640	chr17:40594298	NAGLU	chr17:40687951-40696464:+	-0.23	-4.96	9.72E-7	Crohn's disease	
THCA	cis	1	rs12951640	chr17:40594298	TUBG2	chr17:40811266-40819023:+	-0.23	-5.44	8.4E-8	Crohn's disease	
THCA	cis	1	rs12959333	chr18:33199916	MAPRE2	chr18:32556892-32722377:+	-0.15	-3.85	0.000136	Post bronchodilator FEV1	
THCA	cis	1	rs12959570	chr18:54333584	TXNL1	chr18:54270055-54318502:-	-0.14	-3.36	0.000838	Tourette's syndrome or obsessive-compulsive disorder	
THCA	cis	1	rs12960119	chr18:23614703	SS18	chr18:23596219-23671164:-	0.26	3.36	0.000841	Rhegmatogenous retinal detachment	
THCA	cis	1	rs1296028	chr8:11698747	CTSB	chr8:11700036-11725646:-	0.21	4.24	2.66E-5	Parkinson's disease	
THCA	cis	1	rs1296028	chr8:11698747	FAM86B2	chr8:12283126-12293864:-	-0.21	-3.67	0.000273	Parkinson's disease	
THCA	cis	1	rs12963315	chr18:23586661	SS18	chr18:23596219-23671164:-	0.27	3.43	0.000665	Rhegmatogenous retinal detachment	
THCA	cis	1	rs12965497	chr18:47213517	CXXC1	chr18:47808715-47814692:-	-0.09	-3.55	0.000423	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	
THCA	cis	1	rs12966340	chr18:23584044	SS18	chr18:23596219-23671164:-	0.27	3.43	0.000655	Rhegmatogenous retinal detachment	
THCA	cis	1	rs12971799	chr19:53667126	ZNF665	chr19:53666552-53696619:-	0.15	4.25	2.62E-5	Yu-Zhi constitution type in type 2 diabetes	
THCA	cis	1	rs12972121	chr19:53667295	ZNF665	chr19:53666552-53696619:-	-0.16	-4.33	1.79E-5	Yu-Zhi constitution type in type 2 diabetes	
THCA	cis	1	rs12973620	chr19:58249643	ZNF586	chr19:58281025-58311962:+	-0.26	-3.95	9.02E-5	Allergic rhinitis	
THCA	cis	1	rs12973901	chr19:19823270	ZNF14	chr19:19821281-19843921:-	0.24	4.81	1.98E-6	Toenail selenium levels	
THCA	cis	1	rs12980225	chr19:23026745	ZNF492	chr19:22817126-22850472:+	-0.43	-6.46	2.56E-10	Bronchopulmonary dysplasia	
THCA	cis	1	rs12980403	chr19:18398139	KIAA1683	chr19:18367906-18385319:-	-0.27	-7.94	1.44E-14	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs12982273	chr19:19830144	ZNF14	chr19:19821281-19843921:-	0.23	4.66	4.12E-6	Toenail selenium levels	
THCA	cis	1	rs12983728	chr19:58671267	ZNF460	chr19:57791419-57805436:+	0.24	3.82	0.000152	Cholesterol, total	
THCA	cis	1	rs12983770	chr19:23023614	ZNF492	chr19:22817126-22850472:+	-0.43	-6.46	2.56E-10	Bronchopulmonary dysplasia	
THCA	cis	1	rs12985467	chr19:53667357	ZNF665	chr19:53666552-53696619:-	-0.15	-4.1	4.83E-5	Yu-Zhi constitution type in type 2 diabetes	
THCA	cis	1	rs12986080	chr19:53667351	ZNF665	chr19:53666552-53696619:-	-0.15	-4.1	4.83E-5	Yu-Zhi constitution type in type 2 diabetes	
THCA	cis	1	rs12986120	chr19:19820139	ZNF14	chr19:19821281-19843921:-	0.23	4.72	3.12E-6	Toenail selenium levels	
THCA	cis	1	rs12987661	chr2:69813458	AAK1	chr2:69685127-69870977:-	0.38	7.36	8.08E-13	Metabolite levels (Dihydroxy docosatrienoic acid)	
THCA	cis	1	rs12988385	chr2:231036311	SP110	chr2:231033645-231084827:-	0.24	4.95	1.05E-6	Obesity-related traits	
THCA	cis	1	rs1298908	chr10:82013134	TSPAN14	chr10:82214038-82282390:+	-0.13	-3.43	0.000645	Diabetic kidney disease	
THCA	cis	1	rs12989701	chr2:127887985	BIN1	chr2:127805607-127864864:-	-0.36	-6.06	2.84E-9	Alzheimer's disease (late onset)	
THCA	cis	1	rs12992201	chr2:218312036	IGFBP5	chr2:217536829-217560272:-	0.23	4.92	1.21E-6	Metabolite levels (MHPG)	
THCA	cis	1	rs12995491	chr2:88527414	THNSL2	chr2:88469835-88486145:+	-0.27	-5.04	6.68E-7	Response to metformin (IC50)	
THCA	cis	1	rs12995739	chr2:231037481	SP110	chr2:231033645-231084827:-	0.24	4.97	9.26E-7	Obesity-related traits	
THCA	cis	1	rs13003464	chr2:61186829	AHSA2	chr2:61404553-61414058:+	-0.14	-5.06	5.95E-7	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs13003464	chr2:61186829	C2orf74	chr2:61372243-61391964:+	0.48	9.38	2.63E-19	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs13004848	chr2:127887560	BIN1	chr2:127805607-127864864:-	0.34	5.78	1.35E-8	Alzheimer's disease (late onset)	
THCA	cis	1	rs13008738	chr2:61078921	C2orf74	chr2:61372243-61391964:+	0.4	6.15	1.68E-9	Inflammatory skin disease	
THCA	cis	1	rs13009551	chr2:127889118	BIN1	chr2:127805607-127864864:-	-0.36	-5.98	4.42E-9	Alzheimer's disease (late onset)	
THCA	cis	1	rs13010639	chr2:231035745	SP110	chr2:231033645-231084827:-	0.26	5.16	3.6E-7	Obesity-related traits	
THCA	cis	1	rs13010998	chr2:231035729	SP110	chr2:231033645-231084827:-	0.27	5.15	3.88E-7	Obesity-related traits	
THCA	cis	1	rs13014235	chr2:202215492	ALS2CR12	chr2:202153148-202222101:-	-0.37	-7.32	1.05E-12	Basal cell carcinoma	
THCA	cis	1	rs13014235	chr2:202215492	PPIL3	chr2:201735680-201753999:-	-0.24	-4.9	1.3E-6	Basal cell carcinoma	
THCA	cis	1	rs13015447	chr2:167377978	SCN7A	chr2:167261539-167350717:-	-0.2	-3.67	0.00027	Amyotrophic lateral sclerosis	
THCA	cis	1	rs13015457	chr2:70125763	ASPRV1	chr2:70187226-70314147:-	-0.12	-3.35	0.000866	Carotid plaque burden (smoking interaction)	
THCA	cis	1	rs13016963	chr2:202162811	ALS2CR12	chr2:202153148-202222101:-	-0.41	-8.27	1.31E-15	Melanoma;Esophageal squamous cell carcinoma	
THCA	cis	1	rs13020991	chr2:70068642	SNRNP27	chr2:70121090-70132348:+	0.17	4.09	4.97E-5	Colorectal or endometrial cancer	
THCA	cis	1	rs13025209	chr2:231038169	SP110	chr2:231033645-231084827:-	0.24	4.98	8.95E-7	Obesity-related traits	
THCA	cis	1	rs13025520	chr2:231038029	SP110	chr2:231033645-231084827:-	0.24	5.01	7.78E-7	Obesity-related traits	
THCA	cis	1	rs13026323	chr2:231038403	SP110	chr2:231033645-231084827:-	-0.18	-3.71	0.000231	Obesity-related traits	
THCA	cis	1	rs13026475	chr2:239178455	LOC151174	chr2:239133754-239140318:-	0.49	5.35	1.34E-7	Irritable bowel syndrome	
THCA	cis	1	rs13026621	chr2:27807624	FNDC4	chr2:27714751-27718126:-	-0.15	-3.51	0.000491	Oral cavity cancer	
THCA	cis	1	rs13030858	chr2:26315451	GPR113	chr2:26531041-26569685:-	-0.45	-7.05	6.34E-12	Gut microbiome composition (summer)	
THCA	cis	1	rs13033143	chr2:61161095	C2orf74	chr2:61372243-61391964:+	0.41	6.25	8.98E-10	Inflammatory skin disease	
THCA	cis	1	rs13033501	chr2:239181860	LOC151174	chr2:239133754-239140318:-	0.48	5.25	2.24E-7	Irritable bowel syndrome	
THCA	cis	1	rs13037594	chr20:55040168	C20orf43	chr20:55043647-55093942:+	0.28	7.61	1.44E-13	Refractive astigmatism	
THCA	cis	1	rs13038202	chr20:47835618	CSE1L	chr20:47662838-47713484:+	-0.19	-3.34	0.000892	Height	
THCA	cis	1	rs13038202	chr20:47835618	DDX27	chr20:47835832-47860612:+	0.27	4.93	1.11E-6	Height	
THCA	cis	1	rs13038485	chr20:43767759	STK4	chr20:43595120-43708591:+	-0.17	-4.03	6.37E-5	Parental longevity (mother's age at death)	
THCA	cis	1	rs13038621	chr20:47908060	DDX27	chr20:47835832-47860612:+	0.25	4.56	6.46E-6	Height	
THCA	cis	1	rs13038834	chr20:25441433	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.81	2.87E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs13038834	chr20:25441433	FAM182A	chr20:26035250-26067552:+	-0.19	-3.54	0.000445	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs13038834	chr20:25441433	FAM182B	chr20:25744102-25848786:-	0.25	5.1	4.88E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs13038834	chr20:25441433	NINL	chr20:25433338-25566153:-	-0.37	-7.46	4.04E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs13041953	chr20:55081353	C20orf43	chr20:55043647-55093942:+	0.28	7.32	1.06E-12	Refractive astigmatism	
THCA	cis	1	rs13041953	chr20:55081353	CSTF1	chr20:54967427-54979582:+	0.18	3.63	0.000313	Refractive astigmatism	
THCA	cis	1	rs13042991	chr20:43767178	STK4	chr20:43595120-43708591:+	-0.17	-4.12	4.42E-5	Parental longevity (mother's age at death)	
THCA	cis	1	rs13043313	chr20:60958269	CABLES2	chr20:60963686-60982339:-	-0.19	-3.47	0.000559	Colorectal cancer	
THCA	cis	1	rs13043526	chr20:55088798	C20orf43	chr20:55043647-55093942:+	0.28	7.42	5.55E-13	Refractive astigmatism	
THCA	cis	1	rs1305024	chr9:91809082	CKS2	chr9:91926113-91931617:+	-0.24	-4.63	4.67E-6	Pelvic organ prolapse (moderate/severe)	
THCA	cis	1	rs13050445	chr21:34703597	IFNAR1	chr21:34696734-34732126:+	-0.23	-5.45	7.9E-8	Narcolepsy	
THCA	cis	1	rs13053667	chr22:18443404	MICAL3	chr22:18270418-18507325:-	-0.21	-4.27	2.33E-5	Presence of antiphospholipid antibodies	
THCA	cis	1	rs13053758	chr22:29855489	NIPSNAP1	chr22:29950800-29977144:-	0.33	4.22	2.88E-5	Carotid atherosclerosis in HIV infection	
THCA	cis	1	rs13053758	chr22:29855489	THOC5	chr22:29904157-29949736:-	0.21	3.96	8.58E-5	Carotid atherosclerosis in HIV infection	
THCA	cis	1	rs13054220	chr22:31704492	RNF185	chr22:31556138-31603004:+	0.25	4.67	3.86E-6	Paclitaxel-induced neuropathy	
THCA	cis	1	rs13054354	chr22:29840180	NIPSNAP1	chr22:29950800-29977144:-	0.28	3.61	0.000335	Carotid atherosclerosis in HIV infection	
THCA	cis	1	rs13054985	chr22:23458577	GNAZ	chr22:23412669-23467221:+	-0.27	-5.59	3.74E-8	Bone mineral density	
THCA	cis	1	rs13055259	chr22:29856892	NIPSNAP1	chr22:29950800-29977144:-	0.33	4.24	2.65E-5	Carotid atherosclerosis in HIV infection	
THCA	cis	1	rs13055259	chr22:29856892	THOC5	chr22:29904157-29949736:-	0.21	3.96	8.81E-5	Carotid atherosclerosis in HIV infection	
THCA	cis	1	rs13055707	chr22:29851172	NIPSNAP1	chr22:29950800-29977144:-	0.33	4.19	3.35E-5	Carotid atherosclerosis in HIV infection	
THCA	cis	1	rs13055707	chr22:29851172	THOC5	chr22:29904157-29949736:-	0.21	3.94	9.38E-5	Carotid atherosclerosis in HIV infection	
THCA	cis	1	rs13056719	chr22:24724099	GGT5	chr22:24615623-24641110:-	-0.22	-4.46	1.01E-5	Gut microbiome composition (summer)	
THCA	cis	1	rs13056719	chr22:24724099	POM121L9P	chr22:24647589-24661490:+	-0.41	-9.01	4.87E-18	Gut microbiome composition (summer)	
THCA	cis	1	rs13057203	chr22:18446024	MICAL3	chr22:18270418-18507325:-	-0.19	-3.96	8.62E-5	Presence of antiphospholipid antibodies	
THCA	cis	1	rs13057382	chr22:29850334	NIPSNAP1	chr22:29950800-29977144:-	0.31	3.99	7.55E-5	Carotid atherosclerosis in HIV infection	
THCA	cis	1	rs13057382	chr22:29850334	THOC5	chr22:29904157-29949736:-	0.21	3.95	8.92E-5	Carotid atherosclerosis in HIV infection	
THCA	cis	1	rs13057815	chr22:29853526	NIPSNAP1	chr22:29950800-29977144:-	0.33	4.22	2.89E-5	Carotid atherosclerosis in HIV infection	
THCA	cis	1	rs13057815	chr22:29853526	THOC5	chr22:29904157-29949736:-	0.22	3.99	7.71E-5	Carotid atherosclerosis in HIV infection	
THCA	cis	1	rs13058399	chr22:30694428	NF2	chr22:29999545-30094583:+	-0.23	-3.42	0.000686	Coronary artery calcification	
THCA	cis	1	rs13058817	chr3:53024139	RFT1	chr3:53122503-53164470:-	0.62	7.06	5.94E-12	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs13058817	chr3:53024139	TMEM110	chr3:52867139-52931547:-	0.36	4.16	3.76E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs13058903	chr3:38513365	EXOG	chr3:38537763-38567796:+	0.17	3.54	0.000438	Electrocardiographic conduction measures	
THCA	cis	1	rs13058903	chr3:38513365	LOC100128640	chr3:38492524-38496311:-	-0.23	-4.88	1.48E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs13058903	chr3:38513365	XYLB	chr3:38388251-38456467:+	-0.21	-5.15	3.73E-7	Electrocardiographic conduction measures	
THCA	cis	1	rs13059720	chr3:134242021	ANAPC13	chr3:134196547-134204865:-	-0.39	-12.14	9.39E-30	Height	
THCA	cis	1	rs13059720	chr3:134242021	CEP63	chr3:134204575-134293852:+	-0.31	-6.6	1.12E-10	Height	
THCA	cis	1	rs13059843	chr3:195028183	C3orf21	chr3:194789015-194991895:-	0.28	6.53	1.65E-10	Body mass index	
THCA	cis	1	rs13059975	chr3:127849684	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.47	9.62E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs13060453	chr3:127810738	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.61	5.13E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs13060489	chr3:58339287	PXK	chr3:58318617-58410878:+	0.39	6.59	1.17E-10	Cholesterol, total	
THCA	cis	1	rs13062252	chr3:127828631	EEFSEC	chr3:127872313-128127488:+	-0.25	-4.43	1.19E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs13062518	chr3:195038287	C3orf21	chr3:194789015-194991895:-	0.27	6.26	8.81E-10	Body mass index	
THCA	cis	1	rs13063504	chr3:58409854	PXK	chr3:58318617-58410878:+	0.34	5.98	4.47E-9	Cholesterol, total	
THCA	cis	1	rs13066269	chr3:58449244	PXK	chr3:58318617-58410878:+	0.34	5.99	4.01E-9	Cholesterol, total	
THCA	cis	1	rs13066848	chr3:190668204	UTS2D	chr3:190984945-191048325:-	0.18	3.34	0.000904	Alzheimer's disease biomarkers	
THCA	cis	1	rs13067650	chr3:127889542	EEFSEC	chr3:127872313-128127488:+	-0.24	-4.16	3.77E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs13068223	chr3:156470955	LEKR1	chr3:156544076-156763918:+	0.13	3.46	0.000591	Age-related hearing impairment (interaction)	
THCA	cis	1	rs13069006	chr3:52973305	RFT1	chr3:53122503-53164470:-	0.63	6.99	9.58E-12	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs13069006	chr3:52973305	TMEM110	chr3:52867139-52931547:-	0.38	4.26	2.44E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs13069054	chr3:127855982	EEFSEC	chr3:127872313-128127488:+	-0.25	-4.4	1.31E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs13069724	chr3:48478039	ATRIP	chr3:48488141-48507708:+	0.18	3.86	0.000128	Longevity	
THCA	cis	1	rs13069724	chr3:48478039	TREX1	chr3:48501186-48509043:+	-0.26	-6.07	2.58E-9	Longevity	
THCA	cis	1	rs13069724	chr3:48478039	ZNF589	chr3:48282596-48329113:+	0.16	3.54	0.000439	Longevity	
THCA	cis	1	rs13071337	chr3:48438189	ATRIP	chr3:48488141-48507708:+	0.17	3.81	0.000157	Longevity	
THCA	cis	1	rs13071337	chr3:48438189	TREX1	chr3:48501186-48509043:+	-0.26	-6.01	3.76E-9	Longevity	
THCA	cis	1	rs13071551	chr3:134310867	ANAPC13	chr3:134196547-134204865:-	-0.39	-12.22	4.44E-30	Height	
THCA	cis	1	rs13071551	chr3:134310867	CEP63	chr3:134204575-134293852:+	-0.31	-6.59	1.13E-10	Height	
THCA	cis	1	rs13071688	chr3:58398730	PXK	chr3:58318617-58410878:+	0.33	5.77	1.42E-8	Cholesterol, total	
THCA	cis	1	rs13071740	chr3:127881568	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.46	1.03E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs13072395	chr3:52980573	RFT1	chr3:53122503-53164470:-	0.63	7.06	6.08E-12	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs13072395	chr3:52980573	TMEM110	chr3:52867139-52931547:-	0.38	4.22	2.98E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs13072457	chr3:53102389	RFT1	chr3:53122503-53164470:-	0.64	7.49	3.42E-13	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs13072457	chr3:53102389	SFMBT1	chr3:52938628-53080070:-	-0.2	-3.41	0.000694	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs13072809	chr3:38468171	EXOG	chr3:38537763-38567796:+	-0.16	-3.38	0.000782	Electrocardiographic conduction measures	
THCA	cis	1	rs13072809	chr3:38468171	LOC100128640	chr3:38492524-38496311:-	0.23	4.83	1.86E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs13072809	chr3:38468171	SCN5A	chr3:38589554-38691164:-	0.16	3.38	0.000779	Electrocardiographic conduction measures	
THCA	cis	1	rs13072809	chr3:38468171	XYLB	chr3:38388251-38456467:+	0.21	5.18	3.27E-7	Electrocardiographic conduction measures	
THCA	cis	1	rs13072818	chr3:53074263	RFT1	chr3:53122503-53164470:-	0.57	6.71	5.53E-11	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs13072818	chr3:53074263	TMEM110	chr3:52867139-52931547:-	0.34	4.03	6.36E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs13072826	chr3:195064755	C3orf21	chr3:194789015-194991895:-	0.28	6.55	1.53E-10	Body mass index	
THCA	cis	1	rs13074025	chr3:38455704	EXOG	chr3:38537763-38567796:+	-0.16	-3.36	0.000854	Electrocardiographic conduction measures	
THCA	cis	1	rs13074025	chr3:38455704	LOC100128640	chr3:38492524-38496311:-	0.23	4.73	3.02E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs13074025	chr3:38455704	SCN5A	chr3:38589554-38691164:-	0.16	3.42	0.00068	Electrocardiographic conduction measures	
THCA	cis	1	rs13074025	chr3:38455704	XYLB	chr3:38388251-38456467:+	0.2	4.9	1.34E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs13074160	chr3:38455650	EXOG	chr3:38537763-38567796:+	-0.16	-3.36	0.000854	Electrocardiographic conduction measures	
THCA	cis	1	rs13074160	chr3:38455650	LOC100128640	chr3:38492524-38496311:-	0.23	4.73	3.02E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs13074160	chr3:38455650	SCN5A	chr3:38589554-38691164:-	0.16	3.42	0.00068	Electrocardiographic conduction measures	
THCA	cis	1	rs13074160	chr3:38455650	XYLB	chr3:38388251-38456467:+	0.2	4.9	1.34E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs13074392	chr3:2485795	CNTN4	chr3:2140550-3099644:+	0.35	8.21	2.09E-15	Blood pressure (smoking interaction)	
THCA	cis	1	rs13074524	chr3:52974184	RFT1	chr3:53122503-53164470:-	0.61	7.05	6.27E-12	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs13074524	chr3:52974184	TMEM110	chr3:52867139-52931547:-	0.36	4.16	3.72E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs13076033	chr3:52898427	RFT1	chr3:53122503-53164470:-	0.56	6.44	2.98E-10	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs13076033	chr3:52898427	TMEM110	chr3:52867139-52931547:-	0.41	4.84	1.72E-6	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs13076076	chr3:48479039	ATRIP	chr3:48488141-48507708:+	0.19	4.22	2.93E-5	Longevity	
THCA	cis	1	rs13076076	chr3:48479039	TREX1	chr3:48501186-48509043:+	-0.25	-5.72	1.88E-8	Longevity	
THCA	cis	1	rs1307667	chr2:233419972	EIF4E2	chr2:233415357-233448349:+	-0.2	-3.95	9.06E-5	Height	
THCA	cis	1	rs13076951	chr3:58436703	PXK	chr3:58318617-58410878:+	0.32	5.75	1.64E-8	Cholesterol, total	
THCA	cis	1	rs13077790	chr3:127882658	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.46	1.03E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs13077913	chr3:127882604	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.46	1.03E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs13078787	chr3:58430487	PXK	chr3:58318617-58410878:+	0.32	5.75	1.64E-8	Cholesterol, total	
THCA	cis	1	rs13078971	chr3:53103645	RFT1	chr3:53122503-53164470:-	0.63	7.5	3.16E-13	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs13078971	chr3:53103645	SFMBT1	chr3:52938628-53080070:-	-0.2	-3.38	0.00079	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs13079391	chr3:151007759	GPR87	chr3:151011876-151034636:-	0.21	4.73	2.98E-6	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs13079391	chr3:151007759	P2RY14	chr3:150929905-150996230:-	-0.19	-4.08	5.2E-5	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs13079757	chr3:38491444	LOC100128640	chr3:38492524-38496311:-	0.23	4.89	1.35E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs13079757	chr3:38491444	SCN5A	chr3:38589554-38691164:-	0.17	3.49	0.000531	Electrocardiographic conduction measures	
THCA	cis	1	rs13079757	chr3:38491444	XYLB	chr3:38388251-38456467:+	0.21	5.02	7.16E-7	Electrocardiographic conduction measures	
THCA	cis	1	rs13081177	chr3:134289860	ANAPC13	chr3:134196547-134204865:-	-0.39	-12.33	1.64E-30	Height	
THCA	cis	1	rs13081177	chr3:134289860	CEP63	chr3:134204575-134293852:+	-0.31	-6.56	1.43E-10	Height	
THCA	cis	1	rs13081688	chr3:134259954	ANAPC13	chr3:134196547-134204865:-	-0.39	-12.14	9.6E-30	Height	
THCA	cis	1	rs13081688	chr3:134259954	CEP63	chr3:134204575-134293852:+	-0.31	-6.6	1.07E-10	Height	
THCA	cis	1	rs13082038	chr3:127828456	EEFSEC	chr3:127872313-128127488:+	-0.25	-4.42	1.23E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs13083794	chr3:121464928	IQCB1	chr3:121488610-121553926:-	0.54	10.57	1.27E-23	Cognitive performance	
THCA	cis	1	rs13084976	chr3:2462852	CNTN4	chr3:2140550-3099644:+	0.39	8.9	1.18E-17	Blood pressure (smoking interaction)	
THCA	cis	1	rs13085791	chr3:49721798	MST1	chr3:49721381-49726196:-	0.13	3.8	0.000161	Crohn's disease;Ulcerative colitis	
THCA	cis	1	rs13086611	chr3:49385417	IP6K2	chr3:48725437-48754920:-	-0.14	-4.23	2.77E-5	Educational attainment	
THCA	cis	1	rs13087299	chr3:94229344	STX19	chr3:93733215-93747454:-	0.28	3.55	0.000422	Blood pressure measurement (high sodium intervention)	
THCA	cis	1	rs13087578	chr3:121369207	IQCB1	chr3:121488610-121553926:-	0.53	10.1	6.94E-22	Cognitive performance	
THCA	cis	1	rs13087719	chr3:41951576	ULK4	chr3:41288091-42003660:-	-1.09	-20.75	1.16E-68	Diastolic blood pressure	
THCA	cis	1	rs13087875	chr3:134261123	ANAPC13	chr3:134196547-134204865:-	-0.39	-12.14	9.6E-30	Height	
THCA	cis	1	rs13087875	chr3:134261123	CEP63	chr3:134204575-134293852:+	-0.31	-6.6	1.07E-10	Height	
THCA	cis	1	rs13088281	chr3:53147576	RFT1	chr3:53122503-53164470:-	-0.58	-7.02	7.5E-12	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs13088281	chr3:53147576	WDR82	chr3:52288438-52312659:-	-0.19	-3.4	0.000729	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs13088309	chr3:49368317	GMPPB	chr3:49758932-49761384:-	-0.17	-3.72	0.00022	Menarche (age at onset)	
THCA	cis	1	rs13088309	chr3:49368317	P4HTM	chr3:49027341-49044579:+	0.17	4.31	1.96E-5	Menarche (age at onset)	
THCA	cis	1	rs13088309	chr3:49368317	WDR6	chr3:49044637-49053386:+	-0.17	-3.55	0.000418	Menarche (age at onset)	
THCA	cis	1	rs13088455	chr3:53087482	GLYCTK	chr3:52321836-52329271:+	-0.17	-3.81	0.000154	Ulcerative colitis	
THCA	cis	1	rs13089394	chr3:38446309	EXOG	chr3:38537763-38567796:+	-0.17	-3.4	0.000732	Electrocardiographic conduction measures	
THCA	cis	1	rs13089394	chr3:38446309	LOC100128640	chr3:38492524-38496311:-	0.22	4.62	4.9E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs13089394	chr3:38446309	XYLB	chr3:38388251-38456467:+	0.21	5.03	6.89E-7	Electrocardiographic conduction measures	
THCA	cis	1	rs13089966	chr3:134279197	ANAPC13	chr3:134196547-134204865:-	-0.39	-12.29	2.24E-30	Height	
THCA	cis	1	rs13089966	chr3:134279197	CEP63	chr3:134204575-134293852:+	-0.31	-6.54	1.54E-10	Height	
THCA	cis	1	rs13090388	chr3:49391082	IP6K2	chr3:48725437-48754920:-	-0.12	-3.88	0.000118	Educational attainment (years of education)	
THCA	cis	1	rs13090969	chr3:134307257	ANAPC13	chr3:134196547-134204865:-	-0.39	-12.22	4.44E-30	Height	
THCA	cis	1	rs13090969	chr3:134307257	CEP63	chr3:134204575-134293852:+	-0.31	-6.59	1.13E-10	Height	
THCA	cis	1	rs13091785	chr3:48494098	ATRIP	chr3:48488141-48507708:+	0.19	4.14	4.15E-5	Longevity	
THCA	cis	1	rs13091785	chr3:48494098	TREX1	chr3:48501186-48509043:+	-0.26	-6	3.88E-9	Longevity	
THCA	cis	1	rs13091844	chr3:53010271	RFT1	chr3:53122503-53164470:-	0.64	7.35	8.57E-13	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs13091844	chr3:53010271	TMEM110	chr3:52867139-52931547:-	0.36	4.14	4.19E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs13091924	chr3:195051136	C3orf21	chr3:194789015-194991895:-	0.28	6.46	2.63E-10	Body mass index	
THCA	cis	1	rs13092352	chr3:52969697	RFT1	chr3:53122503-53164470:-	0.61	7.05	6.27E-12	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs13092352	chr3:52969697	TMEM110	chr3:52867139-52931547:-	0.36	4.16	3.72E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs13093350	chr3:112993063	SIDT1	chr3:113251218-113348421:+	-0.21	-3.65	0.00029	Dental caries	
THCA	cis	1	rs13094203	chr3:112993367	SIDT1	chr3:113251218-113348421:+	0.21	3.51	0.000494	Dental caries	
THCA	cis	1	rs13094241	chr3:196190893	TCTEX1D2	chr3:196018090-196045159:-	0.16	3.9	0.000111	Fat distribution (HIV)	
THCA	cis	1	rs13094414	chr3:38930568	WDR48	chr3:39093507-39138149:+	0.29	3.74	0.000205	Social communication problems	
THCA	cis	1	rs13095660	chr3:127848156	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.47	9.77E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs13095806	chr3:156456060	LEKR1	chr3:156544076-156763918:+	-0.14	-3.77	0.000187	Age-related hearing impairment (interaction)	
THCA	cis	1	rs13096020	chr3:58367771	PXK	chr3:58318617-58410878:+	0.36	6.19	1.28E-9	Cholesterol, total	
THCA	cis	1	rs13096474	chr3:49443081	AMIGO3	chr3:49754268-49757238:-	0.15	3.35	0.000883	Menarche (age at onset)	
THCA	cis	1	rs13096474	chr3:49443081	GMPPB	chr3:49758932-49761384:-	0.17	3.87	0.000125	Menarche (age at onset)	
THCA	cis	1	rs13096474	chr3:49443081	P4HTM	chr3:49027341-49044579:+	-0.17	-4.4	1.33E-5	Menarche (age at onset)	
THCA	cis	1	rs13096474	chr3:49443081	WDR6	chr3:49044637-49053386:+	0.17	3.66	0.000285	Menarche (age at onset)	
THCA	cis	1	rs13096604	chr3:134250099	ANAPC13	chr3:134196547-134204865:-	-0.39	-12.14	9.6E-30	Height	
THCA	cis	1	rs13096604	chr3:134250099	CEP63	chr3:134204575-134293852:+	-0.31	-6.6	1.07E-10	Height	
THCA	cis	1	rs13096715	chr3:195074488	C3orf21	chr3:194789015-194991895:-	0.28	6.4	3.69E-10	Body mass index	
THCA	cis	1	rs13099	chr14:75599155	EIF2B2	chr14:75469612-75476292:+	-0.18	-5	8.26E-7	Height	
THCA	cis	1	rs13099	chr14:75599155	MLH3	chr14:75480467-75518235:-	-0.3	-8.98	6.02E-18	Height	
THCA	cis	1	rs13099	chr14:75599155	RPS6KL1	chr14:75372347-75389958:-	-0.3	-6.35	4.9E-10	Height	
THCA	cis	1	rs13102385	chr4:56345255	TMEM165	chr4:56262090-56292342:+	-0.16	-4.06	5.7E-5	Personality dimensions	
THCA	cis	1	rs13104111	chr4:17935045	DCAF16	chr4:17802280-17812381:-	-0.22	-4.49	8.81E-6	Height	
THCA	cis	1	rs13105385	chr4:48404094	OCIAD1	chr4:48833015-48863831:+	-0.14	-4.17	3.62E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs13105471	chr4:17959776	DCAF16	chr4:17802280-17812381:-	-0.2	-4.37	1.51E-5	Height	
THCA	cis	1	rs13109003	chr4:129975969	C4orf33	chr4:130014829-130033842:+	-0.6	-9.39	2.44E-19	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs13109200	chr4:39126016	KLHL5	chr4:39046659-39123828:+	-0.21	-5.93	5.86E-9	Uric acid levels	
THCA	cis	1	rs13110633	chr4:48470296	OCIAD1	chr4:48833015-48863831:+	0.14	3.57	0.00039	Schizophrenia	
THCA	cis	1	rs13112545	chr4:18020822	DCAF16	chr4:17802280-17812381:-	-0.17	-3.53	0.00045	Height	
THCA	cis	1	rs13112557	chr4:103552253	CISD2	chr4:103790135-103809913:+	-0.15	-3.4	0.000729	Primary biliary cirrhosis	
THCA	cis	1	rs13112557	chr4:103552253	NFKB1	chr4:103422486-103538458:+	0.14	3.96	8.67E-5	Primary biliary cirrhosis	
THCA	cis	1	rs13114435	chr4:183821662	DCTD	chr4:183811245-183838630:-	0.24	4.93	1.12E-6	Obesity-related traits	
THCA	cis	1	rs13116230	chr4:18004014	DCAF16	chr4:17802280-17812381:-	-0.17	-3.55	0.000424	Height	
THCA	cis	1	rs13116978	chr4:87833030	C4orf36	chr4:87797359-87813575:-	0.19	4.21	3.0E-5	Amyotrophic lateral sclerosis	
THCA	cis	1	rs13118159	chr4:1365127	CRIPAK	chr4:1385340-1389782:+	0.27	5.61	3.42E-8	Longevity	
THCA	cis	1	rs13120847	chr4:48030036	CNGA1	chr4:47937996-48018610:-	0.54	9.67	2.52E-20	Renal underexcretion gout;Gout	
THCA	cis	1	rs13120847	chr4:48030036	FRYL	chr4:48499380-48782316:-	0.12	3.58	0.000378	Renal underexcretion gout;Gout	
THCA	cis	1	rs13120847	chr4:48030036	NIPAL1	chr4:48018791-48039078:+	0.29	9.89	4.22E-21	Renal underexcretion gout;Gout	
THCA	cis	1	rs13121235	chr4:56311947	TMEM165	chr4:56262090-56292342:+	-0.16	-4.1	4.95E-5	Personality dimensions	
THCA	cis	1	rs13122400	chr4:39713743	PDS5A	chr4:39824484-39979576:-	-0.11	-3.36	0.000832	Plasma amyloid beta peptide concentrations (ABx-40)	
THCA	cis	1	rs13122400	chr4:39713743	RPL9	chr4:39455747-39460568:-	-0.43	-7.86	2.52E-14	Plasma amyloid beta peptide concentrations (ABx-40)	
THCA	cis	1	rs13122400	chr4:39713743	UBE2K	chr4:39699664-39784408:+	-0.16	-3.87	0.000122	Plasma amyloid beta peptide concentrations (ABx-40)	
THCA	cis	1	rs13123358	chr4:139131346	SLC7A11	chr4:139085248-139163503:-	0.22	4.49	9.05E-6	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	
THCA	cis	1	rs13123703	chr4:18029165	DCAF16	chr4:17802280-17812381:-	-0.22	-4.39	1.4E-5	Height	
THCA	cis	1	rs13124276	chr4:1700368	FAM53A	chr4:1641609-1685854:-	0.17	3.74	0.000204	Height	
THCA	cis	1	rs13124276	chr4:1700368	TMEM129	chr4:1717680-1723084:-	0.16	5.14	4.07E-7	Height	
THCA	cis	1	rs13125804	chr4:17998043	DCAF16	chr4:17802280-17812381:-	-0.22	-4.39	1.37E-5	Height	
THCA	cis	1	rs13125949	chr4:48026560	CNGA1	chr4:47937996-48018610:-	0.55	9.81	7.96E-21	Renal underexcretion gout;Gout	
THCA	cis	1	rs13125949	chr4:48026560	FRYL	chr4:48499380-48782316:-	0.12	3.63	0.000317	Renal underexcretion gout;Gout	
THCA	cis	1	rs13125949	chr4:48026560	NIPAL1	chr4:48018791-48039078:+	0.3	9.9	3.88E-21	Renal underexcretion gout;Gout	
THCA	cis	1	rs13127416	chr4:17976779	DCAF16	chr4:17802280-17812381:-	-0.2	-4.42	1.24E-5	Height	
THCA	cis	1	rs13130762	chr4:130022875	C4orf33	chr4:130014829-130033842:+	-0.6	-9.74	1.44E-20	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs13132994	chr4:17990181	DCAF16	chr4:17802280-17812381:-	-0.2	-4.39	1.41E-5	Height	
THCA	cis	1	rs13133311	chr4:88217223	HSD17B11	chr4:88257691-88312455:-	0.32	6.41	3.52E-10	Platelet count	
THCA	cis	1	rs13133311	chr4:88217223	HSD17B13	chr4:88224941-88244056:-	-0.23	-3.93	9.76E-5	Platelet count	
THCA	cis	1	rs13134489	chr4:165889437	C4orf39	chr4:165878100-165880273:+	0.19	5.16	3.63E-7	Ovarian cancer in BRCA1 mutation carriers	
THCA	cis	1	rs13139377	chr4:183821922	DCTD	chr4:183811245-183838630:-	0.24	5.06	6.08E-7	Obesity-related traits	
THCA	cis	1	rs13140744	chr4:122950069	BBS7	chr4:122745639-122791642:-	-0.14	-3.37	0.000806	Emphysema imaging phenotypes	
THCA	cis	1	rs13140968	chr4:48025095	CNGA1	chr4:47937996-48018610:-	0.55	9.84	6.3E-21	Renal underexcretion gout;Gout	
THCA	cis	1	rs13140968	chr4:48025095	FRYL	chr4:48499380-48782316:-	0.12	3.62	0.000332	Renal underexcretion gout;Gout	
THCA	cis	1	rs13140968	chr4:48025095	NIPAL1	chr4:48018791-48039078:+	0.3	9.89	4.13E-21	Renal underexcretion gout;Gout	
THCA	cis	1	rs13141329	chr4:139125405	SLC7A11	chr4:139085248-139163503:-	0.23	4.55	6.95E-6	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	
THCA	cis	1	rs13142655	chr4:88195494	HSD17B11	chr4:88257691-88312455:-	0.3	6.06	2.81E-9	Platelet count	
THCA	cis	1	rs13142905	chr4:48025298	CNGA1	chr4:47937996-48018610:-	0.55	9.81	7.96E-21	Renal underexcretion gout;Gout	
THCA	cis	1	rs13142905	chr4:48025298	FRYL	chr4:48499380-48782316:-	0.12	3.63	0.000317	Renal underexcretion gout;Gout	
THCA	cis	1	rs13142905	chr4:48025298	NIPAL1	chr4:48018791-48039078:+	0.3	9.9	3.88E-21	Renal underexcretion gout;Gout	
THCA	cis	1	rs13144223	chr4:17872707	DCAF16	chr4:17802280-17812381:-	-0.23	-4.57	6.25E-6	Height	
THCA	cis	1	rs13144374	chr4:39130479	KLHL5	chr4:39046659-39123828:+	-0.21	-5.93	5.86E-9	Uric acid levels	
THCA	cis	1	rs13144742	chr4:17974181	DCAF16	chr4:17802280-17812381:-	-0.2	-4.45	1.06E-5	Height	
THCA	cis	1	rs13146142	chr4:17931318	DCAF16	chr4:17802280-17812381:-	-0.21	-4.59	5.71E-6	Height	
THCA	cis	1	rs13146880	chr4:48031499	CNGA1	chr4:47937996-48018610:-	0.54	9.48	1.23E-19	Renal underexcretion gout;Gout	
THCA	cis	1	rs13146880	chr4:48031499	FRYL	chr4:48499380-48782316:-	0.13	3.76	0.000188	Renal underexcretion gout;Gout	
THCA	cis	1	rs13146880	chr4:48031499	NIPAL1	chr4:48018791-48039078:+	0.3	10.05	1.1E-21	Renal underexcretion gout;Gout	
THCA	cis	1	rs13148900	chr4:71361114	AMTN	chr4:71384298-71398459:+	-0.19	-4.5	8.5E-6	Alcoholism (heaviness of drinking)	
THCA	cis	1	rs13151390	chr4:68422349	CENPC1	chr4:68337989-68411256:-	0.29	6.3	6.78E-10	Parkinson's disease	
THCA	cis	1	rs13151431	chr4:17959581	DCAF16	chr4:17802280-17812381:-	-0.2	-4.37	1.51E-5	Height	
THCA	cis	1	rs13151620	chr4:17991679	DCAF16	chr4:17802280-17812381:-	-0.22	-4.4	1.35E-5	Height	
THCA	cis	1	rs13152352	chr4:17976846	DCAF16	chr4:17802280-17812381:-	-0.2	-4.42	1.24E-5	Height	
THCA	cis	1	rs13165556	chr5:146433478	PPP2R2B	chr5:145969070-146461054:-	0.17	3.39	0.000745	Cognitive test performance	
THCA	cis	1	rs13168670	chr5:140146899	PCDHA10	chr5:140235634-140391929:+	-0.25	-4.01	7.12E-5	Schizophrenia	
THCA	cis	1	rs13168670	chr5:140146899	PCDHA13	chr5:140261854-140391929:+	0.22	4.23	2.77E-5	Schizophrenia	
THCA	cis	1	rs13168670	chr5:140146899	PCDHA4	chr5:140186672-140391929:+	-0.21	-3.74	0.000209	Schizophrenia	
THCA	cis	1	rs13168670	chr5:140146899	PCDHA7	chr5:140213969-140391929:+	-0.2	-3.49	0.000525	Schizophrenia	
THCA	cis	1	rs13168670	chr5:140146899	PCDHA9	chr5:140227357-140391929:+	-0.26	-4.47	9.61E-6	Schizophrenia	
THCA	cis	1	rs13168670	chr5:140146899	SLC4A9	chr5:139739787-139754722:+	-0.18	-3.38	0.000774	Schizophrenia	
THCA	cis	1	rs13168670	chr5:140146899	WDR55	chr5:140044384-140050551:+	-0.31	-9.11	2.32E-18	Schizophrenia	
THCA	cis	1	rs13168670	chr5:140146899	ZMAT2	chr5:140080032-140086239:+	-0.19	-4.58	6.03E-6	Schizophrenia	
THCA	cis	1	rs1316952	chr12:124399550	DNAH10	chr12:124247042-124420265:+	0.25	3.69	0.000252	Visceral adipose tissue adjusted for BMI;Visceral adipose tissue/subcutaneous adipose tissue ratio	
THCA	cis	1	rs1316952	chr12:124399550	ZNF664	chr12:124457670-124499967:+	-0.17	-3.59	0.00037	Visceral adipose tissue adjusted for BMI;Visceral adipose tissue/subcutaneous adipose tissue ratio	
THCA	cis	1	rs1317140	chr3:49878652	CCDC36	chr3:49235861-49295537:+	0.21	4.19	3.28E-5	Resting heart rate	
THCA	cis	1	rs1317140	chr3:49878652	RBM6	chr3:49977592-50137484:+	-0.15	-4.24	2.72E-5	Resting heart rate	
THCA	cis	1	rs1317149	chr11:47486885	C1QTNF4	chr11:47611216-47615961:-	-0.31	-5.43	8.75E-8	Subjective well-being	
THCA	cis	1	rs13174348	chr5:115138748	ATG12	chr5:115165818-115177520:-	0.24	5.1	4.95E-7	IgG glycosylation	
THCA	cis	1	rs13174348	chr5:115138748	CCDC112	chr5:114602885-114632458:-	0.17	3.51	0.000483	IgG glycosylation	
THCA	cis	1	rs13174348	chr5:115138748	CDO1	chr5:115140432-115152405:-	0.36	7.08	5.3E-12	IgG glycosylation	
THCA	cis	1	rs13176880	chr5:37081882	C5orf42	chr5:37106330-37249530:-	-0.09	-3.67	0.00027	Height	
THCA	cis	1	rs13177576	chr5:125917249	ALDH7A1	chr5:125878918-125931082:-	0.49	6.9	1.64E-11	Osteoporosis	
THCA	cis	1	rs13178541	chr5:135164618	LOC153328	chr5:135170365-135224324:+	-0.21	-3.46	0.000592	IgG glycosylation	
THCA	cis	1	rs13180135	chr5:2798572	IRX2	chr5:2746281-2751769:-	-0.25	-3.84	0.000141	Toenail selenium levels	
THCA	cis	1	rs131801	chr22:50966634	SCO2	chr22:50961999-50964034:-	-0.15	-5	7.95E-7	Mean corpuscular hemoglobin	
THCA	cis	1	rs131801	chr22:50966634	TYMP	chr22:50964184-50968514:-	0.14	4.6	5.5E-6	Mean corpuscular hemoglobin	
THCA	cis	1	rs13182402	chr5:125918148	ALDH7A1	chr5:125878918-125931082:-	-0.45	-6.84	2.39E-11	Osteoporosis	
THCA	cis	1	rs1318241	chr11:77930792	NARS2	chr11:78147017-78285909:-	-0.38	-6.81	3.0E-11	Testicular germ cell tumor	
THCA	cis	1	rs13182	chr4:39122913	KLHL5	chr4:39046659-39123828:+	-0.21	-5.76	1.51E-8	Uric acid levels	
THCA	cis	1	rs13190742	chr6:163008758	PACRG	chr6:163148164-163736523:+	0.45	7.03	7.07E-12	Body mass index	
THCA	cis	1	rs13191362	chr6:163033350	PACRG	chr6:163148164-163736523:+	0.51	7.33	9.94E-13	Body mass index	
THCA	cis	1	rs13192894	chr6:163052444	PACRG	chr6:163148164-163736523:+	0.51	7.18	2.74E-12	Body mass index	
THCA	cis	1	rs13193282	chr6:163015442	PACRG	chr6:163148164-163736523:+	0.45	7	8.92E-12	Body mass index	
THCA	cis	1	rs13194248	chr6:70589711	COL19A1	chr6:70576448-70922157:+	-0.27	-4.1	4.9E-5	Subjective well-being	
THCA	cis	1	rs13194429	chr6:86646705	SNHG5	chr6:86386726-86388451:-	-0.49	-10.88	8.91E-25	Response to antipsychotic treatment	
THCA	cis	1	rs13195226	chr6:163006421	PACRG	chr6:163148164-163736523:+	0.44	6.89	1.77E-11	Body mass index	
THCA	cis	1	rs13195401	chr6:26463574	BTN3A2	chr6:26365398-26378546:+	-0.9	-12.85	1.11E-32	Schizophrenia	
THCA	cis	1	rs13195402	chr6:26463575	BTN3A2	chr6:26365398-26378546:+	-0.9	-12.85	1.11E-32	Schizophrenia	
THCA	cis	1	rs13196930	chr6:86652245	SNHG5	chr6:86386726-86388451:-	-0.51	-11.16	7.09E-26	Response to antipsychotic treatment	
THCA	cis	1	rs13197107	chr6:111833234	KIAA1919	chr6:111580482-111590259:+	0.47	5.86	8.67E-9	Psoriasis	
THCA	cis	1	rs13199006	chr6:86608708	SNHG5	chr6:86386726-86388451:-	-0.53	-12.62	1.01E-31	Response to antipsychotic treatment	
THCA	cis	1	rs13199223	chr6:163001083	PACRG	chr6:163148164-163736523:+	0.46	7.08	5.13E-12	Body mass index	
THCA	cis	1	rs13200063	chr6:33730171	IP6K3	chr6:33689443-33714762:-	0.4	6.48	2.32E-10	Obesity (extreme)	
THCA	cis	1	rs13200063	chr6:33730171	PSMB8	chr6:32808497-32812712:-	-0.12	-3.34	0.000905	Obesity (extreme)	
THCA	cis	1	rs13200171	chr6:70593803	COL19A1	chr6:70576448-70922157:+	0.27	4.13	4.29E-5	Subjective well-being	
THCA	cis	1	rs13200329	chr6:163004418	PACRG	chr6:163148164-163736523:+	0.44	6.89	1.77E-11	Body mass index	
THCA	cis	1	rs13200462	chr6:28218199	ZKSCAN3	chr6:28317691-28334523:+	-0.24	-4.56	6.37E-6	Depression	
THCA	cis	1	rs13200462	chr6:28218199	ZNF187	chr6:28234788-28245978:+	-0.36	-7.18	2.67E-12	Depression	
THCA	cis	1	rs13200462	chr6:28218199	ZNF193	chr6:28193067-28201260:+	0.21	3.83	0.000145	Depression	
THCA	cis	1	rs13200462	chr6:28218199	ZNF323	chr6:28292517-28324048:-	0.42	5.57	4.3E-8	Depression	
THCA	cis	1	rs13200462	chr6:28218199	ZNF389	chr6:28129551-28137375:+	-0.49	-6.83	2.67E-11	Depression	
THCA	cis	1	rs13200462	chr6:28218199	ZSCAN23	chr6:28393287-28411279:-	0.24	5	8.2E-7	Depression	
THCA	cis	1	rs13201023	chr6:162981381	PACRG	chr6:163148164-163736523:+	0.45	6.95	1.2E-11	Body mass index	
THCA	cis	1	rs13202339	chr6:163081812	PACRG	chr6:163148164-163736523:+	0.51	6.99	9.0E-12	Body mass index	
THCA	cis	1	rs13204013	chr6:163002480	PACRG	chr6:163148164-163736523:+	0.46	7.08	5.13E-12	Body mass index	
THCA	cis	1	rs13204439	chr6:163015358	PACRG	chr6:163148164-163736523:+	-0.44	-6.88	1.85E-11	Body mass index	
THCA	cis	1	rs13206253	chr6:163166902	PACRG	chr6:163148164-163736523:+	0.49	6.93	1.37E-11	Body mass index	
THCA	cis	1	rs13207239	chr6:163008772	PACRG	chr6:163148164-163736523:+	0.45	7.04	6.9E-12	Body mass index	
THCA	cis	1	rs13207671	chr6:162979056	PACRG	chr6:163148164-163736523:+	0.44	6.92	1.44E-11	Body mass index	
THCA	cis	1	rs13208890	chr6:111821823	KIAA1919	chr6:111580482-111590259:+	0.45	5.61	3.43E-8	Psoriasis	
THCA	cis	1	rs1320893	chr7:143752112	ARHGEF35	chr7:143883677-143892736:-	-0.51	-10.7	4.24E-24	Obesity-related traits	
THCA	cis	1	rs1320893	chr7:143752112	OR2A1	chr7:144015236-144016148:+;chr7	-0.17	-3.68	0.000255	Obesity-related traits	
THCA	cis	1	rs1320893	chr7:143752112	OR2A9P	chr7:143991573-143997832:+;chr7	-0.29	-6.18	1.37E-9	Obesity-related traits	
THCA	cis	1	rs1320894	chr7:143751802	ARHGEF35	chr7:143883677-143892736:-	-0.51	-10.69	4.83E-24	Obesity-related traits	
THCA	cis	1	rs1320894	chr7:143751802	OR2A1	chr7:144015236-144016148:+;chr7	-0.19	-4.07	5.46E-5	Obesity-related traits	
THCA	cis	1	rs1320894	chr7:143751802	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-6.56	1.38E-10	Obesity-related traits	
THCA	cis	1	rs13209100	chr6:163159350	PACRG	chr6:163148164-163736523:+	0.46	6.66	7.65E-11	Body mass index	
THCA	cis	1	rs13209728	chr6:162997533	PACRG	chr6:163148164-163736523:+	0.44	6.84	2.37E-11	Body mass index	
THCA	cis	1	rs1320996	chr6:56100431	COL21A1	chr6:55921389-56258892:-	0.77	16.55	5.6E-49	Pulse pressure	
THCA	cis	1	rs13210412	chr6:163019478	PACRG	chr6:163148164-163736523:+	0.43	6.8	3.21E-11	Body mass index	
THCA	cis	1	rs13210756	chr6:163009030	PACRG	chr6:163148164-163736523:+	0.44	6.84	2.4E-11	Body mass index	
THCA	cis	1	rs13211285	chr6:47479618	CD2AP	chr6:47445525-47594994:+	0.15	3.78	0.000177	Alzheimer's disease (late onset)	
THCA	cis	1	rs1321252	chr6:25616232	SCGN	chr6:25652429-25702006:+	-0.31	-5.98	4.44E-9	Uric acid levels	
THCA	cis	1	rs13212608	chr6:163032128	PACRG	chr6:163148164-163736523:+	0.48	7.17	2.91E-12	Body mass index	
THCA	cis	1	rs13213408	chr6:162998049	PACRG	chr6:163148164-163736523:+	0.44	6.92	1.5E-11	Body mass index	
THCA	cis	1	rs13213522	chr6:111705341	KIAA1919	chr6:111580482-111590259:+	0.48	5.6	3.62E-8	Psoriasis	
THCA	cis	1	rs13213582	chr6:151873896	C6orf97	chr6:151815175-151942327:+	0.3	4.33	1.85E-5	Bone mineral density (spine)	
THCA	cis	1	rs1321426	chr20:31766204	C20orf70	chr20:31755960-31769223:+	-0.42	-3.74	0.000204	Smooth-surface caries	
THCA	cis	1	rs13214516	chr6:163121583	PACRG	chr6:163148164-163736523:+	0.52	7.19	2.57E-12	Body mass index	
THCA	cis	1	rs1321479	chr6:26501897	BTN2A3	chr6:26422317-26431927:+	-0.18	-4.26	2.42E-5	Educational attainment	
THCA	cis	1	rs1321479	chr6:26501897	HCG11	chr6:26521934-26527610:+	0.21	4.15	3.93E-5	Educational attainment	
THCA	cis	1	rs1321479	chr6:26501897	HMGN4	chr6:26538572-26547162:+	0.14	3.62	0.00033	Educational attainment	
THCA	cis	1	rs1321479	chr6:26501897	ZNF322A	chr6:26634612-26659963:-	0.13	3.67	0.000266	Educational attainment	
THCA	cis	1	rs1321480	chr6:26532742	BTN2A3	chr6:26422317-26431927:+	0.19	4.53	7.62E-6	Educational attainment	
THCA	cis	1	rs1321480	chr6:26532742	HCG11	chr6:26521934-26527610:+	-0.23	-4.42	1.21E-5	Educational attainment	
THCA	cis	1	rs1321480	chr6:26532742	HMGN4	chr6:26538572-26547162:+	-0.16	-4.06	5.81E-5	Educational attainment	
THCA	cis	1	rs1321480	chr6:26532742	ZNF322A	chr6:26634612-26659963:-	-0.14	-3.77	0.000181	Educational attainment	
THCA	cis	1	rs1321481	chr6:26538210	BTN2A3	chr6:26422317-26431927:+	0.18	4.32	1.9E-5	Educational attainment	
THCA	cis	1	rs1321481	chr6:26538210	HCG11	chr6:26521934-26527610:+	-0.22	-4.34	1.75E-5	Educational attainment	
THCA	cis	1	rs1321481	chr6:26538210	HMGN4	chr6:26538572-26547162:+	-0.16	-4.03	6.38E-5	Educational attainment	
THCA	cis	1	rs1321481	chr6:26538210	ZNF322A	chr6:26634612-26659963:-	-0.14	-3.91	0.000106	Educational attainment	
THCA	cis	1	rs13215491	chr6:163010325	PACRG	chr6:163148164-163736523:+	0.45	7.03	7.07E-12	Body mass index	
THCA	cis	1	rs13217384	chr6:86720000	SNHG5	chr6:86386726-86388451:-	-0.49	-10.81	1.59E-24	Response to antipsychotic treatment	
THCA	cis	1	rs13217925	chr6:70585650	COL19A1	chr6:70576448-70922157:+	-0.27	-4.1	4.9E-5	Subjective well-being	
THCA	cis	1	rs1321798	chr6:117731192	DCBLD1	chr6:117803820-117891018:+	0.46	10.18	3.71E-22	Lung cancer	
THCA	cis	1	rs1321798	chr6:117731192	GOPC	chr6:117639351-117923681:-	0.22	6.5	2.0E-10	Lung cancer	
THCA	cis	1	rs1321799	chr6:117731177	DCBLD1	chr6:117803820-117891018:+	-0.46	-10.04	1.23E-21	Lung cancer	
THCA	cis	1	rs1321799	chr6:117731177	GOPC	chr6:117639351-117923681:-	-0.23	-6.76	3.94E-11	Lung cancer	
THCA	cis	1	rs1321815	chr6:117742078	DCBLD1	chr6:117803820-117891018:+	0.47	9.61	4.17E-20	Lung cancer	
THCA	cis	1	rs1321815	chr6:117742078	GOPC	chr6:117639351-117923681:-	0.22	6.14	1.69E-9	Lung cancer	
THCA	cis	1	rs1321816	chr6:117734533	DCBLD1	chr6:117803820-117891018:+	0.47	10.17	4.15E-22	Lung cancer	
THCA	cis	1	rs1321816	chr6:117734533	GOPC	chr6:117639351-117923681:-	0.23	6.72	5.2E-11	Lung cancer	
THCA	cis	1	rs13218900	chr6:163081638	PACRG	chr6:163148164-163736523:+	0.52	7.27	1.47E-12	Body mass index	
THCA	cis	1	rs13219957	chr6:149270829	RAET1G	chr6:150238014-150244214:-	0.23	3.39	0.00076	Job-related exhaustion	
THCA	cis	1	rs13220048	chr6:163004325	PACRG	chr6:163148164-163736523:+	0.46	7.08	5.13E-12	Body mass index	
THCA	cis	1	rs13220181	chr6:163004401	PACRG	chr6:163148164-163736523:+	0.44	6.89	1.77E-11	Body mass index	
THCA	cis	1	rs13220495	chr6:26441640	BTN3A2	chr6:26365398-26378546:+	-0.92	-12.72	4.04E-32	Schizophrenia	
THCA	cis	1	rs13220510	chr6:56779141	BEND6	chr6:56819773-56892138:+	-0.31	-6.51	1.96E-10	Menarche (age at onset)	
THCA	cis	1	rs13220510	chr6:56779141	KIAA1586	chr6:56911384-56920021:+	-0.33	-5.14	3.93E-7	Menarche (age at onset)	
THCA	cis	1	rs13220979	chr7:65363204	CCT6P1	chr7:65216092-65228661:+	0.38	6.07	2.54E-9	Diabetic kidney disease	
THCA	cis	1	rs13220979	chr7:65363204	CRCP	chr7:65579805-65619551:+	-0.26	-4.08	5.37E-5	Diabetic kidney disease	
THCA	cis	1	rs13220979	chr7:65363204	RABGEF1	chr7:66093890-66276446:+	0.54	6.78	3.55E-11	Diabetic kidney disease	
THCA	cis	1	rs1322319	chr10:38145509	LOC399744	chr10:38717074-38741080:+	0.29	4.05	5.95E-5	Obesity (extreme)	
THCA	cis	1	rs1322319	chr10:38145509	ZNF25	chr10:38238795-38265453:-	0.16	3.37	0.000825	Obesity (extreme)	
THCA	cis	1	rs13224397	chr7:118008745	ANKRD7	chr7:117864712-117882782:+	0.27	4.38	1.46E-5	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs13226728	chr7:143746578	ARHGEF35	chr7:143883677-143892736:-	-0.52	-10.93	5.51E-25	Obesity-related traits	
THCA	cis	1	rs13226728	chr7:143746578	OR2A1	chr7:144015236-144016148:+;chr7	-0.2	-4.29	2.17E-5	Obesity-related traits	
THCA	cis	1	rs13226728	chr7:143746578	OR2A9P	chr7:143991573-143997832:+;chr7	-0.31	-6.82	2.77E-11	Obesity-related traits	
THCA	cis	1	rs13232179	chr7:151120948	CRYGN	chr7:151127057-151137899:-	0.14	3.5	0.000509	Coronary heart disease	
THCA	cis	1	rs13235972	chr7:65883605	CCT6P1	chr7:65216092-65228661:+	0.43	6.71	5.64E-11	Diabetic kidney disease	
THCA	cis	1	rs13235972	chr7:65883605	CRCP	chr7:65579805-65619551:+	-0.27	-3.97	8.2E-5	Diabetic kidney disease	
THCA	cis	1	rs13235972	chr7:65883605	RABGEF1	chr7:66093890-66276446:+	0.63	7.65	1.11E-13	Diabetic kidney disease	
THCA	cis	1	rs13237037	chr7:65997882	CCT6P1	chr7:65216092-65228661:+	0.43	6.6	1.09E-10	Diabetic kidney disease	
THCA	cis	1	rs13237037	chr7:65997882	CRCP	chr7:65579805-65619551:+	-0.27	-3.99	7.67E-5	Diabetic kidney disease	
THCA	cis	1	rs13237037	chr7:65997882	GUSB	chr7:65425675-65447246:-	0.28	3.42	0.00069	Diabetic kidney disease	
THCA	cis	1	rs13237037	chr7:65997882	RABGEF1	chr7:66093890-66276446:+	0.63	7.67	9.47E-14	Diabetic kidney disease	
THCA	cis	1	rs13237206	chr7:117999451	ANKRD7	chr7:117864712-117882782:+	0.27	4.5	8.46E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs13239254	chr7:110917686	IMMP2L	chr7:110303110-111202538:-	0.16	3.53	0.000462	Schizophrenia	
THCA	cis	1	rs13239306	chr7:66136017	GUSB	chr7:65425675-65447246:-	-0.31	-6.15	1.62E-9	Aortic root size	
THCA	cis	1	rs13239306	chr7:66136017	RABGEF1	chr7:66093890-66276446:+	-0.54	-10.74	3.12E-24	Aortic root size	
THCA	cis	1	rs13239306	chr7:66136017	TYW1	chr7:66461817-66704496:+	-0.22	-4.59	5.74E-6	Aortic root size	
THCA	cis	1	rs13240464	chr7:110898915	IMMP2L	chr7:110303110-111202538:-	0.15	3.35	0.000861	Schizophrenia	
THCA	cis	1	rs13241378	chr7:54173713	SEC61G	chr7:54819941-54826939:-	-0.22	-3.4	0.000729	Periodontal disease-related phenotypes	
THCA	cis	1	rs13241388	chr7:54173722	SEC61G	chr7:54819941-54826939:-	-0.22	-3.38	0.000785	Periodontal disease-related phenotypes	
THCA	cis	1	rs13243677	chr7:143746572	ARHGEF35	chr7:143883677-143892736:-	-0.52	-10.93	5.51E-25	Obesity-related traits	
THCA	cis	1	rs13243677	chr7:143746572	OR2A1	chr7:144015236-144016148:+;chr7	-0.2	-4.29	2.17E-5	Obesity-related traits	
THCA	cis	1	rs13243677	chr7:143746572	OR2A9P	chr7:143991573-143997832:+;chr7	-0.31	-6.82	2.77E-11	Obesity-related traits	
THCA	cis	1	rs13244265	chr7:23917903	C7orf46	chr7:23719749-23742268:+	0.13	3.88	0.000117	Schizophrenia	
THCA	cis	1	rs13245225	chr7:29181626	CPVL	chr7:29035249-29234892:-	0.3	3.7	0.000245	Diabetes related insulin traits	
THCA	cis	1	rs13247184	chr7:65358928	CCT6P1	chr7:65216092-65228661:+	0.41	6.5	2.08E-10	Diabetic kidney disease	
THCA	cis	1	rs13247184	chr7:65358928	CRCP	chr7:65579805-65619551:+	-0.26	-4.02	6.63E-5	Diabetic kidney disease	
THCA	cis	1	rs13247184	chr7:65358928	RABGEF1	chr7:66093890-66276446:+	0.52	6.35	4.89E-10	Diabetic kidney disease	
THCA	cis	1	rs1325195	chr1:179071756	ABL2	chr1:179068463-179198819:-	-0.18	-5.65	2.8E-8	IgE grass sensitization	
THCA	cis	1	rs1325195	chr1:179071756	TOR3A	chr1:179051112-179065127:+	-0.26	-6.09	2.36E-9	IgE grass sensitization	
THCA	cis	1	rs13252719	chr8:71734569	XKR9	chr8:71581600-71648176:+	1.07	28.52	3.1E-105	Bone mineral density	
THCA	cis	1	rs13253842	chr8:71625503	XKR9	chr8:71581600-71648176:+	1.06	27.63	4.18E-101	Bone mineral density	
THCA	cis	1	rs13254978	chr8:89499245	MMP16	chr8:89049462-89339717:-	0.33	5.09	5.11E-7	Electrodermal activity	
THCA	cis	1	rs13254984	chr8:89499247	MMP16	chr8:89049462-89339717:-	0.33	5.09	5.11E-7	Electrodermal activity	
THCA	cis	1	rs13255935	chr8:95965685	INTS8	chr8:95835534-95892720:+	0.15	3.59	0.000365	Type 2 diabetes	
THCA	cis	1	rs13256369	chr8:8577379	SGK223	chr8:8175259-8239257:-	-0.31	-5.7	2.11E-8	Obesity-related traits	
THCA	cis	1	rs13256903	chr8:89596159	MMP16	chr8:89049462-89339717:-	0.16	3.64	0.000305	Body mass index and cholesterol (psychopharmacological treatment)	
THCA	cis	1	rs13259806	chr8:124190103	FAM83A	chr8:124191287-124222317:+	-0.3	-3.9	0.000108	Urinary uromodulin levels	
THCA	cis	1	rs13260318	chr8:124190165	FAM83A	chr8:124191287-124222317:+	-0.3	-3.9	0.000108	Urinary uromodulin levels	
THCA	cis	1	rs13260626	chr8:124190317	FAM83A	chr8:124191287-124222317:+	-0.3	-3.9	0.000108	Urinary uromodulin levels	
THCA	cis	1	rs13260775	chr8:124190167	FAM83A	chr8:124191287-124222317:+	-0.3	-3.9	0.000108	Urinary uromodulin levels	
THCA	cis	1	rs13260798	chr8:124190192	FAM83A	chr8:124191287-124222317:+	-0.3	-3.9	0.000108	Urinary uromodulin levels	
THCA	cis	1	rs13261021	chr8:124190239	FAM83A	chr8:124191287-124222317:+	-0.3	-3.9	0.000108	Urinary uromodulin levels	
THCA	cis	1	rs13261066	chr8:124190276	FAM83A	chr8:124191287-124222317:+	-0.3	-3.9	0.000108	Urinary uromodulin levels	
THCA	cis	1	rs13261100	chr8:124190312	FAM83A	chr8:124191287-124222317:+	-0.3	-3.9	0.000108	Urinary uromodulin levels	
THCA	cis	1	rs13266699	chr8:8570313	SGK223	chr8:8175259-8239257:-	0.31	5.58	3.98E-8	Obesity-related traits	
THCA	cis	1	rs13267501	chr8:8574058	SGK223	chr8:8175259-8239257:-	-0.3	-5.55	4.75E-8	Obesity-related traits	
THCA	cis	1	rs13267565	chr8:89596182	MMP16	chr8:89049462-89339717:-	0.15	3.42	0.00069	Body mass index and cholesterol (psychopharmacological treatment)	
THCA	cis	1	rs13268482	chr8:89596484	MMP16	chr8:89049462-89339717:-	0.16	3.62	0.000324	Body mass index and cholesterol (psychopharmacological treatment)	
THCA	cis	1	rs13271434	chr8:57158821	LYN	chr8:56792386-56923936:+	-0.15	-3.83	0.000148	Height	
THCA	cis	1	rs13271966	chr8:8575472	SGK223	chr8:8175259-8239257:-	-0.3	-5.55	4.75E-8	Obesity-related traits	
THCA	cis	1	rs13282915	chr8:8570891	SGK223	chr8:8175259-8239257:-	-0.3	-5.47	7.3E-8	Obesity-related traits	
THCA	cis	1	rs133009	chr22:38569653	PLA2G6	chr22:38507502-38577836:-	0.1	3.67	0.000269	Cutaneous nevi	
THCA	cis	1	rs133012	chr22:38570721	PLA2G6	chr22:38507502-38577836:-	0.1	3.67	0.000273	Cutaneous nevi	
THCA	cis	1	rs13310597	chr7:65598540	CCT6P1	chr7:65216092-65228661:+	0.42	6.7	5.9E-11	Diabetic kidney disease	
THCA	cis	1	rs13310597	chr7:65598540	CRCP	chr7:65579805-65619551:+	-0.3	-4.63	4.66E-6	Diabetic kidney disease	
THCA	cis	1	rs13310597	chr7:65598540	LOC493754	chr7:65993446-66057363:-	0.29	3.36	0.000833	Diabetic kidney disease	
THCA	cis	1	rs13310597	chr7:65598540	RABGEF1	chr7:66093890-66276446:+	0.57	7.14	3.42E-12	Diabetic kidney disease	
THCA	cis	1	rs1331215	chr20:3376565	ITPA	chr20:3190056-3204504:+	-0.24	-5.96	4.9E-9	IFN-related cytopenia	
THCA	cis	1	rs13313561	chr17:37954451	C17orf37	chr17:37885411-37886788:-	-0.26	-4.15	3.91E-5	Systemic lupus erythematosus	
THCA	cis	1	rs13314659	chr3:48449149	ATRIP	chr3:48488141-48507708:+	-0.18	-3.89	0.000112	Longevity	
THCA	cis	1	rs13314659	chr3:48449149	TREX1	chr3:48501186-48509043:+	0.26	6.1	2.18E-9	Longevity	
THCA	cis	1	rs13314892	chr3:69795052	MITF	chr3:69788633-70017486:+	0.28	4.98	8.9E-7	QRS complex (12-leadsum)	
THCA	cis	1	rs13315871	chr3:58381287	PXK	chr3:58318617-58410878:+	0.34	6.01	3.77E-9	Cholesterol, total	
THCA	cis	1	rs13316065	chr3:49884913	CCDC36	chr3:49235861-49295537:+	0.22	4.29	2.21E-5	Resting heart rate	
THCA	cis	1	rs13316065	chr3:49884913	RBM6	chr3:49977592-50137484:+	-0.16	-4.5	8.44E-6	Resting heart rate	
THCA	cis	1	rs13316589	chr3:168673121	MECOM	chr3:168801287-169381563:-	0.49	5.38	1.17E-7	Aging (time to event)	
THCA	cis	1	rs13316695	chr3:49684917	MST1	chr3:49721381-49726196:-	0.13	3.88	0.000117	Crohn's disease;Ulcerative colitis	
THCA	cis	1	rs13317400	chr3:58408792	PXK	chr3:58318617-58410878:+	0.34	5.98	4.47E-9	Cholesterol, total	
THCA	cis	1	rs13317835	chr3:58383275	PXK	chr3:58318617-58410878:+	0.34	6.01	3.64E-9	Cholesterol, total	
THCA	cis	1	rs13318796	chr3:69795183	MITF	chr3:69788633-70017486:+	-0.29	-5.16	3.69E-7	QRS complex (12-leadsum)	
THCA	cis	1	rs13319597	chr3:10126312	C3orf10	chr3:10157333-10168873:+	0.2	4.35	1.68E-5	Alzheimer's disease	
THCA	cis	1	rs13319597	chr3:10126312	VHL	chr3:10183319-10193744:+	0.19	4.34	1.73E-5	Alzheimer's disease	
THCA	cis	1	rs13320620	chr3:58408845	PXK	chr3:58318617-58410878:+	0.34	5.98	4.47E-9	Cholesterol, total	
THCA	cis	1	rs13321783	chr3:119615375	GSK3B	chr3:119540804-119813264:-	-0.13	-4.52	7.89E-6	HDL cholesterol	
THCA	cis	1	rs13322305	chr3:134310791	ANAPC13	chr3:134196547-134204865:-	0.37	11.55	2.1E-27	Height	
THCA	cis	1	rs13322305	chr3:134310791	CEP63	chr3:134204575-134293852:+	0.29	6.27	8.23E-10	Height	
THCA	cis	1	rs13322887	chr3:49555583	GMPPB	chr3:49758932-49761384:-	0.16	3.68	0.00026	Menarche (age at onset)	
THCA	cis	1	rs13322887	chr3:49555583	P4HTM	chr3:49027341-49044579:+	-0.17	-4.29	2.16E-5	Menarche (age at onset)	
THCA	cis	1	rs13322887	chr3:49555583	WDR6	chr3:49044637-49053386:+	0.17	3.62	0.000324	Menarche (age at onset)	
THCA	cis	1	rs13323323	chr3:44333324	KIAA1143	chr3:44790239-44803173:-	-0.22	-4.74	2.77E-6	IgG glycosylation	
THCA	cis	1	rs13323323	chr3:44333324	ZNF197	chr3:44666511-44689962:+	0.22	6.04	3.12E-9	IgG glycosylation	
THCA	cis	1	rs13324487	chr3:184679915	C3orf70	chr3:184795840-184870802:-	-0.22	-4.57	6.08E-6	Heschl's gyrus morphology	
THCA	cis	1	rs13324903	chr3:195086647	C3orf21	chr3:194789015-194991895:-	-0.28	-6.63	9.37E-11	Body mass index	
THCA	cis	1	rs13325965	chr3:41914942	ULK4	chr3:41288091-42003660:-	1.03	18.54	3.42E-58	Diastolic blood pressure	
THCA	cis	1	rs13327709	chr3:58408767	PXK	chr3:58318617-58410878:+	0.34	5.98	4.47E-9	Cholesterol, total	
THCA	cis	1	rs13331733	chr16:29848417	MAPK3	chr16:30125427-30134630:-	-0.24	-3.4	0.000718	Multiple sclerosis	
THCA	cis	1	rs13332078	chr16:29850705	MAPK3	chr16:30125427-30134630:-	-0.24	-3.35	0.000871	Multiple sclerosis	
THCA	cis	1	rs13337337	chr16:69461367	CYB5B	chr16:69458498-69500167:+	-0.24	-4.18	3.51E-5	Blood pressure (smoking interaction)	
THCA	cis	1	rs13339205	chr16:69457343	CYB5B	chr16:69458498-69500167:+	-0.24	-3.94	9.23E-5	Blood pressure (smoking interaction)	
THCA	cis	1	rs13339262	chr16:50091383	HEATR3	chr16:50099881-50139373:+	-0.4	-6.49	2.13E-10	Esophageal cancer (squamous cell)	
THCA	cis	1	rs1333963	chr6:163192571	PACRG	chr6:163148164-163736523:+	0.51	7	8.83E-12	Body mass index	
THCA	cis	1	rs13340416	chr6:5071438	LYRM4	chr6:5108654-5261168:-	-0.15	-3.51	0.000496	Venous thromboembolism (SNP x SNP interaction)	
THCA	cis	1	rs13342397	chr17:17460926	ATPAF2	chr17:17918373-17942480:-	-0.2	-3.37	0.000806	Obsessive-compulsive symptoms	
THCA	cis	1	rs13344563	chr19:41945904	B3GNT8	chr19:41931265-41934635:-	0.34	7.91	1.84E-14	Height	
THCA	cis	1	rs13344563	chr19:41945904	EXOSC5	chr19:41892278-41903256:-	0.11	3.63	0.000317	Height	
THCA	cis	1	rs13356202	chr5:137564588	KLHL3	chr5:136953190-137071779:-	-0.13	-3.43	0.000652	Resting heart rate	
THCA	cis	1	rs1335645	chr1:111684276	DRAM2	chr1:111659955-111682838:-	-0.28	-4.34	1.76E-5	Liver enzyme levels (gamma-glutamyl transferase)	
THCA	cis	1	rs13357258	chr5:115444166	COMMD10	chr5:115420727-115628978:+	0.5	6.16	1.54E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs13359107	chr5:110458812	TSLP	chr5:110405778-110413722:+	-0.34	-4.2	3.18E-5	Eosinophil counts	
THCA	cis	1	rs13359107	chr5:110458812	WDR36	chr5:110427870-110466201:+	0.22	3.87	0.000124	Eosinophil counts	
THCA	cis	1	rs13361189	chr5:150223387	LOC134466	chr5:150310000-150326146:-	0.37	5.02	7.44E-7	Crohn's disease	
THCA	cis	1	rs13362043	chr5:115596262	COMMD10	chr5:115420727-115628978:+	0.47	5.81	1.13E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs1337001	chr13:85732523	SLITRK6	chr13:86366922-86373483:-	-0.21	-3.76	0.000193	Bipolar disorder (mania)	
THCA	cis	1	rs1337002	chr13:85732771	SLITRK6	chr13:86366922-86373483:-	-0.21	-3.76	0.000193	Bipolar disorder (mania)	
THCA	cis	1	rs1337844	chr6:86677273	SNHG5	chr6:86386726-86388451:-	-0.48	-10.7	4.31E-24	Response to antipsychotic treatment	
THCA	cis	1	rs1337850	chr6:86729103	SNHG5	chr6:86386726-86388451:-	-0.49	-10.87	9.85E-25	Response to antipsychotic treatment	
THCA	cis	1	rs13380863	chr17:61780793	FTSJ3	chr17:61896795-61905031:-	0.32	5.84	9.83E-9	Body mass index	
THCA	cis	1	rs13380863	chr17:61780793	MAP3K3	chr17:61699775-61773669:+	0.27	5.31	1.68E-7	Body mass index	
THCA	cis	1	rs13380871	chr17:37936249	C17orf37	chr17:37885411-37886788:-	-0.26	-4.35	1.64E-5	Systemic lupus erythematosus	
THCA	cis	1	rs13382862	chr2:20882449	C2orf43	chr2:20883803-21022827:-	-0.25	-5.45	8.02E-8	Abdominal aortic aneurysm	
THCA	cis	1	rs13383762	chr2:38907001	GALM	chr2:38893052-38961908:+	0.28	3.49	0.000521	5-HTT brain serotonin transporter levels	
THCA	cis	1	rs13383871	chr2:73631779	ALMS1P	chr2:73872046-73912692:+	0.73	11.13	9.51E-26	Metabolite levels	
THCA	cis	1	rs13383871	chr2:73631779	NAT8	chr2:73867850-73869537:-	0.38	5.84	9.66E-9	Metabolite levels	
THCA	cis	1	rs13384952	chr2:73723959	ALMS1P	chr2:73872046-73912692:+	-0.61	-6.53	1.69E-10	Metabolite levels	
THCA	cis	1	rs13384952	chr2:73723959	NAT8	chr2:73867850-73869537:-	-0.31	-3.44	0.000635	Metabolite levels	
THCA	cis	1	rs13385191	chr2:20888265	C2orf43	chr2:20883803-21022827:-	-0.65	-15.24	5.09E-43	Prostate cancer	
THCA	cis	1	rs13386793	chr2:219972574	STK16	chr2:220110192-220115059:+	-0.2	-3.36	0.000833	Height	
THCA	cis	1	rs13387221	chr2:44135314	LRPPRC	chr2:44113363-44223144:-	-0.17	-6.78	3.62E-11	Intelligence (childhood)	
THCA	cis	1	rs13389106	chr2:30480750	LBH	chr2:30454397-30482899:+	-0.19	-3.51	0.000485	Systemic lupus erythematosus	
THCA	cis	1	rs13390702	chr2:86237935	LOC90784	chr2:86247339-86250991:-	-0.57	-6.66	7.37E-11	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs13393692	chr2:233442016	EIF4E2	chr2:233415357-233448349:+	-0.23	-4.5	8.44E-6	Height	
THCA	cis	1	rs13393800	chr2:233442091	EIF4E2	chr2:233415357-233448349:+	-0.23	-4.38	1.45E-5	Height	
THCA	cis	1	rs1339458	chr1:10328338	KIF1B	chr1:10270764-10441659:+	0.21	6.48	2.29E-10	Hepatocellular carcinoma	
THCA	cis	1	rs13394619	chr2:11727507	GREB1	chr2:11674242-11782912:+	-0.17	-3.75	0.000196	Endometriosis	
THCA	cis	1	rs13395110	chr2:218283303	DIRC3	chr2:218148748-218621316:-	-0.21	-5	8.0E-7	Height	
THCA	cis	1	rs13398075	chr2:202376269	PPIL3	chr2:201735680-201753999:-	0.61	6.98	1.01E-11	Rheumatoid arthritis	
THCA	cis	1	rs13398956	chr2:73720258	ALMS1P	chr2:73872046-73912692:+	0.76	11.81	2.11E-28	Metabolite levels	
THCA	cis	1	rs13398956	chr2:73720258	NAT8	chr2:73867850-73869537:-	0.4	6.15	1.63E-9	Metabolite levels	
THCA	cis	1	rs13401391	chr2:137340034	THSD7B	chr2:137523115-138435287:+	0.23	4.15	3.87E-5	Cognitive test performance	
THCA	cis	1	rs13401747	chr2:218284814	DIRC3	chr2:218148748-218621316:-	-0.21	-4.81	2.0E-6	Height	
THCA	cis	1	rs13404123	chr2:219916797	STK16	chr2:220110192-220115059:+	0.2	3.4	0.00074	Height	
THCA	cis	1	rs13405728	chr2:48978159	LHCGR	chr2:48913921-48982880:-	0.3	3.47	0.00056	Polycystic ovary syndrome	
THCA	cis	1	rs1340684	chr1:76471146	ACADM	chr1:76190043-76229353:+	-0.22	-4.52	7.88E-6	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs1340684	chr1:76471146	ST6GALNAC3	chr1:76540389-77096669:+	-0.29	-4.06	5.81E-5	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs13408294	chr2:202171573	CFLAR	chr2:201980816-202029001:+	-0.21	-3.72	0.000224	Rheumatoid arthritis	
THCA	cis	1	rs13408294	chr2:202171573	PPIL3	chr2:201735680-201753999:-	-0.6	-8.24	1.71E-15	Rheumatoid arthritis	
THCA	cis	1	rs13408569	chr2:102955056	IL1RL1	chr2:102927962-102968497:+	0.22	4.43	1.15E-5	Asthma	
THCA	cis	1	rs13408661	chr2:102955082	IL1RL1	chr2:102927962-102968497:+	0.22	4.4	1.32E-5	Asthma	
THCA	cis	1	rs13409250	chr2:37463642	CEBPZ	chr2:37428778-37458740:-	-0.2	-4.42	1.25E-5	Chronic lymphocytic leukemia	
THCA	cis	1	rs134144	chr22:26908970	ASPHD2	chr22:26825280-26840978:+	-0.32	-3.68	0.000261	Ischemic stroke	
THCA	cis	1	rs134144	chr22:26908970	HPS4	chr22:26847447-26879820:-	-0.31	-3.4	0.000726	Ischemic stroke	
THCA	cis	1	rs13415839	chr2:232126534	ARMC9	chr2:232063342-232238606:+	0.4	9.86	5.2E-21	Food antigen IgG levels	
THCA	cis	1	rs1341759	chr6:26195502	HIST1H2AE	chr6:26217148-26217711:+	-0.23	-3.69	0.000249	Renal underexcretion gout;Gout	
THCA	cis	1	rs1341759	chr6:26195502	HIST1H3E	chr6:26224427-26226589:+	0.43	7.04	6.71E-12	Renal underexcretion gout;Gout	
THCA	cis	1	rs13421462	chr2:73719875	ALMS1P	chr2:73872046-73912692:+	0.75	11.63	1.07E-27	Metabolite levels	
THCA	cis	1	rs13421462	chr2:73719875	NAT8	chr2:73867850-73869537:-	0.4	6.11	2.1E-9	Metabolite levels	
THCA	cis	1	rs13424612	chr2:240900121	NDUFA10	chr2:240900158-240964798:-	0.3	8.31	1.03E-15	Odorant perception (isobutyraldehyde)	
THCA	cis	1	rs13428235	chr2:73633430	ALMS1P	chr2:73872046-73912692:+	0.71	11.16	7.15E-26	Metabolite levels	
THCA	cis	1	rs13428235	chr2:73633430	NAT8	chr2:73867850-73869537:-	0.39	6.13	1.89E-9	Metabolite levels	
THCA	cis	1	rs13429341	chr2:24558258	C2orf84	chr2:24397531-24414566:+	-0.54	-3.63	0.000311	Response to antipsychotic treatment in schizophrenia (working memory)	
THCA	cis	1	rs13429341	chr2:24558258	LOC375190	chr2:24299728-24397519:+	0.56	5.56	4.45E-8	Response to antipsychotic treatment in schizophrenia (working memory)	
THCA	cis	1	rs13431267	chr2:73782200	ALMS1P	chr2:73872046-73912692:+	0.75	11.49	3.84E-27	Metabolite levels	
THCA	cis	1	rs13431267	chr2:73782200	NAT8	chr2:73867850-73869537:-	0.42	6.39	3.87E-10	Metabolite levels	
THCA	cis	1	rs13431828	chr2:102954653	IL1RL1	chr2:102927962-102968497:+	0.22	4.43	1.15E-5	Asthma	
THCA	cis	1	rs13432605	chr2:73810981	ALMS1P	chr2:73872046-73912692:+	0.75	11.55	2.21E-27	Metabolite levels	
THCA	cis	1	rs13432605	chr2:73810981	NAT8	chr2:73867850-73869537:-	0.42	6.41	3.41E-10	Metabolite levels	
THCA	cis	1	rs13432615	chr2:218283439	DIRC3	chr2:218148748-218621316:-	0.21	5.16	3.59E-7	Height	
THCA	cis	1	rs13437826	chr7:87390464	DBF4	chr7:87505544-87538856:+	-0.27	-3.75	0.000202	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs13438327	chr7:97620691	MGC72080	chr7:97503667-97601638:-	0.26	3.57	0.00039	Sudden cardiac arrest	
THCA	cis	1	rs13438394	chr7:87390330	DBF4	chr7:87505544-87538856:+	-0.27	-3.88	0.000117	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs13438651	chr7:87472022	DBF4	chr7:87505544-87538856:+	-0.27	-4.03	6.4E-5	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs1345467	chr16:51482321	SALL1	chr16:51169886-51185183:-	-0.24	-5.18	3.34E-7	Optic disc area;Optic disc parameters	
THCA	cis	1	rs1346618	chr2:227771988	COL4A4	chr2:227867435-228029275:-	-0.16	-4.05	6.07E-5	Pulmonary function	
THCA	cis	1	rs1346719	chr3:53077372	RFT1	chr3:53122503-53164470:-	0.56	7.21	2.23E-12	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs134869	chr22:42652074	C22orf32	chr22:42475699-42480287:+	0.2	5.14	4.0E-7	Cognitive function	
THCA	cis	1	rs134869	chr22:42652074	CCDC134	chr22:42196678-42222303:+	0.21	3.97	8.41E-5	Cognitive function	
THCA	cis	1	rs134869	chr22:42652074	CYP2D6	chr22:42522502-42526883:-	-0.41	-10.85	1.18E-24	Cognitive function	
THCA	cis	1	rs134869	chr22:42652074	NAGA	chr22:42454339-42466846:-	0.34	7.51	3.02E-13	Cognitive function	
THCA	cis	1	rs134869	chr22:42652074	WBP2NL	chr22:42120334-42454460:+	0.23	4.28	2.25E-5	Cognitive function	
THCA	cis	1	rs134873	chr22:42657566	C22orf32	chr22:42475699-42480287:+	0.18	4.73	2.91E-6	Cognitive function	
THCA	cis	1	rs134873	chr22:42657566	CCDC134	chr22:42196678-42222303:+	0.17	3.39	0.000768	Cognitive function	
THCA	cis	1	rs134873	chr22:42657566	CYP2D6	chr22:42522502-42526883:-	-0.41	-10.9	7.1E-25	Cognitive function	
THCA	cis	1	rs134873	chr22:42657566	NAGA	chr22:42454339-42466846:-	0.32	7	8.66E-12	Cognitive function	
THCA	cis	1	rs134873	chr22:42657566	WBP2NL	chr22:42120334-42454460:+	0.22	4.08	5.3E-5	Cognitive function	
THCA	cis	1	rs134882	chr22:42670965	C22orf32	chr22:42475699-42480287:+	0.15	3.91	0.000107	Cognitive function	
THCA	cis	1	rs134882	chr22:42670965	CYP2D6	chr22:42522502-42526883:-	-0.41	-10.98	3.49E-25	Cognitive function	
THCA	cis	1	rs134882	chr22:42670965	NAGA	chr22:42454339-42466846:-	0.32	7.05	6.21E-12	Cognitive function	
THCA	cis	1	rs134882	chr22:42670965	WBP2NL	chr22:42120334-42454460:+	0.23	4.36	1.62E-5	Cognitive function	
THCA	cis	1	rs134900	chr22:42683343	C22orf32	chr22:42475699-42480287:+	0.17	4.54	7.06E-6	Cognitive function	
THCA	cis	1	rs134900	chr22:42683343	CCDC134	chr22:42196678-42222303:+	0.17	3.34	0.000894	Cognitive function	
THCA	cis	1	rs134900	chr22:42683343	CYP2D6	chr22:42522502-42526883:-	-0.42	-11.54	2.48E-27	Cognitive function	
THCA	cis	1	rs134900	chr22:42683343	NAGA	chr22:42454339-42466846:-	0.32	7.09	4.85E-12	Cognitive function	
THCA	cis	1	rs134900	chr22:42683343	WBP2NL	chr22:42120334-42454460:+	0.22	4.28	2.25E-5	Cognitive function	
THCA	cis	1	rs134902	chr22:42683997	C22orf32	chr22:42475699-42480287:+	0.13	3.41	0.000715	Cognitive function	
THCA	cis	1	rs134902	chr22:42683997	CYP2D6	chr22:42522502-42526883:-	-0.42	-11.67	7.34E-28	Cognitive function	
THCA	cis	1	rs134902	chr22:42683997	NAGA	chr22:42454339-42466846:-	0.27	5.88	7.82E-9	Cognitive function	
THCA	cis	1	rs134902	chr22:42683997	WBP2NL	chr22:42120334-42454460:+	0.19	3.57	0.000387	Cognitive function	
THCA	cis	1	rs1349636	chr4:75712260	BTC	chr4:75671448-75719882:-	0.2	3.92	0.000103	Electroencephalogram traits	
THCA	cis	1	rs1351452	chr11:116943354	PCSK7	chr11:117075789-117102811:-	0.32	5.58	3.94E-8	Protein quantitative trait loci	
THCA	cis	1	rs1352433	chr4:48393680	OCIAD1	chr4:48833015-48863831:+	0.14	4.17	3.62E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs1352961	chr4:40379915	CHRNA9	chr4:40337469-40356973:+	-0.32	-3.37	0.000803	Body mass index (change over time)	
THCA	cis	1	rs1354521	chr8:89415173	MMP16	chr8:89049462-89339717:-	0.31	5.04	6.5E-7	Electrodermal activity	
THCA	cis	1	rs1354522	chr8:89415493	MMP16	chr8:89049462-89339717:-	0.31	5.04	6.5E-7	Electrodermal activity	
THCA	cis	1	rs1354523	chr8:89415541	MMP16	chr8:89049462-89339717:-	0.27	4.32	1.88E-5	Electrodermal activity	
THCA	cis	1	rs1354524	chr8:89415605	MMP16	chr8:89049462-89339717:-	0.31	5.04	6.5E-7	Electrodermal activity	
THCA	cis	1	rs1355412	chr8:29985683	LEPROTL1	chr8:29952922-29995222:+	0.17	3.68	0.000261	Migraine	
THCA	cis	1	rs1355412	chr8:29985683	MBOAT4	chr8:29989188-30002200:-	0.36	4.85	1.64E-6	Migraine	
THCA	cis	1	rs1357481	chr4:8496221	C4orf23	chr4:8440604-8495258:+	-0.34	-7.33	1.01E-12	Response to antineoplastic agents	
THCA	cis	1	rs1357762	chr3:134264859	ANAPC13	chr3:134196547-134204865:-	0.37	11.81	2.02E-28	Height	
THCA	cis	1	rs1357762	chr3:134264859	CEP63	chr3:134204575-134293852:+	0.3	6.54	1.6E-10	Height	
THCA	cis	1	rs1359781	chr6:33762104	LEMD2	chr6:33738991-33756906:-	-0.3	-6.89	1.72E-11	Crohn's disease	
THCA	cis	1	rs1360172	chr9:131907980	CRAT	chr9:131857075-131873070:-	0.28	6.83	2.56E-11	Blood metabolite ratios	
THCA	cis	1	rs1362756	chr16:51458290	SALL1	chr16:51169886-51185183:-	0.22	5.21	2.82E-7	Optic disc area;Optic disc parameters	
THCA	cis	1	rs1363055	chr7:65943275	ASL	chr7:65540776-65558321:+	-0.16	-4.22	2.91E-5	Aortic root size	
THCA	cis	1	rs1363055	chr7:65943275	GUSB	chr7:65425675-65447246:-	0.27	5.25	2.29E-7	Aortic root size	
THCA	cis	1	rs1363055	chr7:65943275	RABGEF1	chr7:66093890-66276446:+	0.65	14.05	8.4E-38	Aortic root size	
THCA	cis	1	rs1365505	chr15:50477138	SLC27A2	chr15:50474393-50528588:+	-0.19	-3.54	0.000444	Blood metabolite ratios	
THCA	cis	1	rs1366200	chr5:115321819	ATG12	chr5:115165818-115177520:-	-0.15	-3.42	0.000677	Refractive astigmatism	
THCA	cis	1	rs1368882	chr1:55107019	ACOT11	chr1:55007930-55100417:+	-0.3	-6.18	1.34E-9	Non-substance related behavioral disinhibition	
THCA	cis	1	rs1369313	chr15:66084255	DPP8	chr15:65737999-65810035:-	-0.1	-4.09	5.1E-5	Mean corpuscular hemoglobin	
THCA	cis	1	rs1369313	chr15:66084255	SLC24A1	chr15:65903704-65953256:+	-0.16	-3.73	0.000213	Mean corpuscular hemoglobin	
THCA	cis	1	rs1370964	chr5:110429955	TSLP	chr5:110405778-110413722:+	-0.35	-4.54	7.09E-6	Eosinophil counts	
THCA	cis	1	rs1370964	chr5:110429955	WDR36	chr5:110427870-110466201:+	0.2	3.66	0.000284	Eosinophil counts	
THCA	cis	1	rs1371135	chr15:90391270	AP3S2	chr15:90373832-90456222:-	-0.79	-19.95	7.08E-65	Type 2 diabetes	
THCA	cis	1	rs1371135	chr15:90391270	C15orf38	chr15:90443832-90456222:-	0.36	7.64	1.17E-13	Type 2 diabetes	
THCA	cis	1	rs137115	chr22:43011403	CYB5R3	chr22:43014814-43045405:-	-0.18	-3.45	0.000615	Parental extreme longevity (95 years and older)	
THCA	cis	1	rs1371553	chr2:26262948	GPR113	chr2:26531041-26569685:-	-0.43	-6.89	1.82E-11	Gut microbiome composition (summer)	
THCA	cis	1	rs1371834	chr1:47176894	CYP4B1	chr1:47264670-47285020:+	0.22	3.4	0.000719	Response to hepatitis C treatment	
THCA	cis	1	rs1371834	chr1:47176894	CYP4Z1	chr1:47533160-47583992:+	0.27	4.06	5.76E-5	Response to hepatitis C treatment	
THCA	cis	1	rs1371834	chr1:47176894	DMBX1	chr1:46972668-46979884:+	0.24	4.03	6.39E-5	Response to hepatitis C treatment	
THCA	cis	1	rs1371867	chr8:101330209	SPAG1	chr8:101170263-101254130:+	0.2	4.24	2.65E-5	Atrioventricular conduction	
THCA	cis	1	rs1373456	chr12:62521000	FAM19A2	chr12:62102043-62653925:-	-0.15	-3.36	0.000852	Post bronchodilator FEV1/FVC ratio in COPD	
THCA	cis	1	rs1374313	chr2:120145655	DBI	chr2:120124504-120130120:+	0.26	7.28	1.4E-12	Obesity-related traits	
THCA	cis	1	rs1374531	chr4:106523932	INTS12	chr4:106603787-106629881:-	-0.54	-4.67	3.85E-6	Post bronchodilator FEV1	
THCA	cis	1	rs137608	chr22:39696887	SMCR7L	chr22:39896105-39914136:+	-0.25	-3.38	0.000782	Sudden cardiac arrest	
THCA	cis	1	rs137610	chr22:39697793	SMCR7L	chr22:39896105-39914136:+	-0.25	-3.38	0.000782	Sudden cardiac arrest	
THCA	cis	1	rs1376842	chr8:82892518	SNX16	chr8:82711820-82754521:-	-0.15	-3.53	0.000462	Response to methotrexate in juvenile idiopathic arthritis	
THCA	cis	1	rs1376877	chr2:204272090	ICA1L	chr2:203637873-203736371:-	-0.14	-3.55	0.000418	Subclinical atherosclerosis traits (other)	
THCA	cis	1	rs1376903	chr5:101681225	SLCO4C1	chr5:101569694-101632253:-	0.25	5.62	3.21E-8	Schizophrenia	
THCA	cis	1	rs1376909	chr5:101778243	SLCO4C1	chr5:101569694-101632253:-	0.24	5.54	5.1E-8	Schizophrenia	
THCA	cis	1	rs1376910	chr5:101775267	SLCO4C1	chr5:101569694-101632253:-	0.25	5.62	3.21E-8	Schizophrenia	
THCA	cis	1	rs1376913	chr5:101774959	SLCO4C1	chr5:101569694-101632253:-	0.25	5.62	3.21E-8	Schizophrenia	
THCA	cis	1	rs1377032	chr4:75712104	BTC	chr4:75671448-75719882:-	0.21	4.01	7.1E-5	Electroencephalogram traits	
THCA	cis	1	rs1379299	chr5:110435661	TSLP	chr5:110405778-110413722:+	-0.35	-4.48	9.5E-6	Eosinophil counts	
THCA	cis	1	rs1379299	chr5:110435661	WDR36	chr5:110427870-110466201:+	0.2	3.63	0.000316	Eosinophil counts	
THCA	cis	1	rs1380293	chr4:18027235	DCAF16	chr4:17802280-17812381:-	-0.2	-4.59	5.61E-6	Height	
THCA	cis	1	rs138209	chr22:50539413	MLC1	chr22:50497820-50524358:-	-0.19	-3.66	0.000279	Gestational age at birth in labor-initiated deliveries (child effect)	
THCA	cis	1	rs138209	chr22:50539413	NCAPH2	chr22:50946645-50961911:+	-0.15	-3.4	0.000738	Gestational age at birth in labor-initiated deliveries (child effect)	
THCA	cis	1	rs1382339	chr5:115558163	COMMD10	chr5:115420727-115628978:+	0.48	5.89	7.35E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs1382340	chr5:115558161	COMMD10	chr5:115420727-115628978:+	0.48	5.89	7.35E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs1382426	chr3:161045933	NMD3	chr3:160939099-160971319:+	-0.11	-3.64	0.000304	Morning vs. evening chronotype	
THCA	cis	1	rs1382428	chr3:161032386	NMD3	chr3:160939099-160971319:+	-0.11	-3.64	0.000304	Morning vs. evening chronotype	
THCA	cis	1	rs1382430	chr2:218274288	DIRC3	chr2:218148748-218621316:-	0.22	5.14	3.91E-7	Height	
THCA	cis	1	rs1382431	chr2:218274423	DIRC3	chr2:218148748-218621316:-	0.22	5.14	3.91E-7	Height	
THCA	cis	1	rs138244	chr22:50565367	MLC1	chr22:50497820-50524358:-	-0.2	-3.72	0.000223	Gestational age at birth in labor-initiated deliveries (child effect)	
THCA	cis	1	rs138249	chr22:50569790	MLC1	chr22:50497820-50524358:-	-0.2	-3.71	0.000235	Gestational age at birth in labor-initiated deliveries (child effect)	
THCA	cis	1	rs138250	chr22:50570361	MLC1	chr22:50497820-50524358:-	-0.19	-3.63	0.000311	Gestational age at birth in labor-initiated deliveries (child effect)	
THCA	cis	1	rs138252	chr22:50570873	MLC1	chr22:50497820-50524358:-	-0.19	-3.54	0.000444	Gestational age at birth in labor-initiated deliveries (child effect)	
THCA	cis	1	rs1382879	chr5:76521868	PDE8B	chr5:76506706-76723226:+	0.11	3.59	0.000369	Thyroid hormone levels	
THCA	cis	1	rs1383251	chr3:51366840	HEMK1	chr3:50606583-50622419:+	0.18	3.79	0.00017	Melanoma	
THCA	cis	1	rs1383251	chr3:51366840	TEX264	chr3:51705222-51738338:+	-0.21	-5.92	6.31E-9	Melanoma	
THCA	cis	1	rs13837	chr4:119954533	C4orf3	chr4:120217575-120221968:-	0.23	3.79	0.000168	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs1384769	chr8:94084336	C8orf83	chr8:93895865-94029901:-	0.21	3.48	0.00054	Attention deficit hyperactivity disorder	
THCA	cis	1	rs1385374	chr12:129300694	GLT1D1	chr12:129338081-129469509:+	0.26	4.32	1.92E-5	Systemic lupus erythematosus	
THCA	cis	1	rs138544659	chr15:78900701	CHRNA5	chr15:78857906-78886458:+	-0.43	-8.72	4.74E-17	Post bronchodilator FEV1;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs1385499	chr8:119974708	COLEC10	chr8:120079424-120119195:+	-0.17	-3.43	0.000663	Bone mineral density (hip);Bone mineral density	
THCA	cis	1	rs1385600	chr11:77936166	NARS2	chr11:78147017-78285909:-	0.39	7.59	1.64E-13	Testicular germ cell tumor	
THCA	cis	1	rs1385601	chr11:77936064	NARS2	chr11:78147017-78285909:-	-0.41	-7.97	1.16E-14	Testicular germ cell tumor	
THCA	cis	1	rs138573550	chr3:127840025	EEFSEC	chr3:127872313-128127488:+	-0.25	-4.42	1.23E-5	Post bronchodilator FEV1	
THCA	cis	1	rs1386478	chr3:113680951	KIAA1407	chr3:113682986-113775460:-	0.12	3.57	0.000393	Crohn's disease and psoriasis	
THCA	cis	1	rs138702	chr22:39132601	JOSD1	chr22:39081549-39096459:-	0.14	3.6	0.000353	Resting heart rate	
THCA	cis	1	rs138702	chr22:39132601	LOC646851	chr22:38974125-39052634:-	-0.13	-3.49	0.000524	Resting heart rate	
THCA	cis	1	rs138702	chr22:39132601	TOMM22	chr22:39077954-39080763:+	0.17	3.67	0.000269	Resting heart rate	
THCA	cis	1	rs138704	chr22:39133410	LOC646851	chr22:38974125-39052634:-	0.14	3.75	0.000197	Resting heart rate	
THCA	cis	1	rs138705	chr22:39133803	LOC646851	chr22:38974125-39052634:-	0.16	4.04	6.31E-5	Resting heart rate	
THCA	cis	1	rs138706	chr22:39137834	LOC646851	chr22:38974125-39052634:-	0.16	4.28	2.31E-5	Resting heart rate	
THCA	cis	1	rs138706	chr22:39137834	SUN2	chr22:39130735-39190161:-	0.15	3.49	0.000519	Resting heart rate	
THCA	cis	1	rs138709	chr22:39139216	LOC646851	chr22:38974125-39052634:-	0.17	4.34	1.7E-5	Resting heart rate	
THCA	cis	1	rs138709	chr22:39139216	SUN2	chr22:39130735-39190161:-	0.15	3.48	0.000539	Resting heart rate	
THCA	cis	1	rs138712	chr22:39141600	LOC646851	chr22:38974125-39052634:-	0.17	4.37	1.52E-5	Resting heart rate	
THCA	cis	1	rs138713	chr22:39142615	LOC646851	chr22:38974125-39052634:-	0.18	4.62	4.92E-6	Resting heart rate	
THCA	cis	1	rs138713	chr22:39142615	SUN2	chr22:39130735-39190161:-	0.15	3.45	0.000611	Resting heart rate	
THCA	cis	1	rs138716	chr22:39146527	LOC646851	chr22:38974125-39052634:-	0.2	5.07	5.78E-7	Resting heart rate	
THCA	cis	1	rs138716	chr22:39146527	SUN2	chr22:39130735-39190161:-	0.17	3.84	0.000138	Resting heart rate	
THCA	cis	1	rs138740	chr22:35699582	HMGXB4	chr22:35653445-35691799:+	-0.11	-3.58	0.000375	Multiple myeloma and monoclonal gammopathy;Multiple myeloma	
THCA	cis	1	rs138774	chr22:35708799	HMGXB4	chr22:35653445-35691799:+	-0.11	-3.48	0.000539	Cholesterol, total	
THCA	cis	1	rs138775	chr22:35709065	HMGXB4	chr22:35653445-35691799:+	-0.11	-3.36	0.000856	Cholesterol, total	
THCA	cis	1	rs138777	chr22:35711098	HMGXB4	chr22:35653445-35691799:+	-0.12	-3.98	7.92E-5	Cholesterol, total	
THCA	cis	1	rs1388527	chr11:6948441	ZNF215	chr11:6947654-7005861:+	-0.28	-4.42	1.2E-5	Response to cytadine analogues (cytosine arabinoside)	
THCA	cis	1	rs138879185	chr17:6707261	FBXO39	chr17:6679552-6700420:+	-0.4	-7.73	6.59E-14	Mild influenza (H1N1) infection	
THCA	cis	1	rs1390006	chr17:56890663	SUPT4H1	chr17:56422539-56429563:-	0.16	4.05	5.97E-5	Cognitive test performance	
THCA	cis	1	rs1390968	chr14:52517629	NID2	chr14:52471521-52535946:-	0.18	3.91	0.000105	Pulmonary function	
THCA	cis	1	rs1392104	chr7:65759107	CCT6P1	chr7:65216092-65228661:+	-0.44	-6.92	1.49E-11	Diabetic kidney disease	
THCA	cis	1	rs1392104	chr7:65759107	CRCP	chr7:65579805-65619551:+	0.29	4.43	1.19E-5	Diabetic kidney disease	
THCA	cis	1	rs1392104	chr7:65759107	LOC493754	chr7:65993446-66057363:-	-0.3	-3.38	0.000785	Diabetic kidney disease	
THCA	cis	1	rs1392104	chr7:65759107	RABGEF1	chr7:66093890-66276446:+	-0.6	-7.44	4.68E-13	Diabetic kidney disease	
THCA	cis	1	rs1393058	chr3:190668617	UTS2D	chr3:190984945-191048325:-	-0.17	-3.34	0.000897	Alzheimer's disease biomarkers	
THCA	cis	1	rs1394510	chr8:89438952	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs1394515	chr8:89409993	MMP16	chr8:89049462-89339717:-	0.32	5.19	3.1E-7	Electrodermal activity	
THCA	cis	1	rs1395297	chr15:50878509	SPPL2A	chr15:50999739-51057910:-	-0.27	-7.34	9.02E-13	QT interval	
THCA	cis	1	rs1395	chr2:27424636	C2orf28	chr2:27434899-27440044:+	-0.17	-5.07	5.71E-7	Blood metabolite levels	
THCA	cis	1	rs1395	chr2:27424636	SLC5A6	chr2:27422459-27435071:-	0.31	6.47	2.44E-10	Blood metabolite levels	
THCA	cis	1	rs1398023	chr10:23665542	C10orf67	chr10:23605521-23633772:-	-0.24	-4.76	2.55E-6	Crohn's disease and sarcoidosis (combined)	
THCA	cis	1	rs1398024	chr10:23665438	C10orf67	chr10:23605521-23633772:-	-0.24	-4.65	4.31E-6	Crohn's disease and sarcoidosis (combined)	
THCA	cis	1	rs1399196	chr11:78071876	NARS2	chr11:78147017-78285909:-	-0.42	-8	9.31E-15	Testicular germ cell tumor	
THCA	cis	1	rs140244541	chr2:203808532	ALS2CR8	chr2:203776978-203851060:+	-0.15	-3.34	0.000905	LDL cholesterol	
THCA	cis	1	rs140244541	chr2:203808532	ICA1L	chr2:203637873-203736371:-	0.22	4.15	4.01E-5	LDL cholesterol	
THCA	cis	1	rs140296914	chr12:62505769	FAM19A2	chr12:62102043-62653925:-	-0.15	-3.34	0.000892	Post bronchodilator FEV1/FVC ratio in COPD	
THCA	cis	1	rs1403284	chr2:73726662	ALMS1P	chr2:73872046-73912692:+	-0.73	-11.04	2.1E-25	Metabolite levels	
THCA	cis	1	rs1403284	chr2:73726662	NAT8	chr2:73867850-73869537:-	-0.4	-6.07	2.6E-9	Metabolite levels	
THCA	cis	1	rs140330585	chr15:78866445	CHRNA5	chr15:78857906-78886458:+	-0.42	-8.33	8.84E-16	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs1404147	chr7:65264524	CCT6P1	chr7:65216092-65228661:+	0.4	6.76	3.94E-11	Diabetic kidney disease	
THCA	cis	1	rs1404147	chr7:65264524	CRCP	chr7:65579805-65619551:+	-0.27	-4.37	1.52E-5	Diabetic kidney disease	
THCA	cis	1	rs1404147	chr7:65264524	GUSB	chr7:65425675-65447246:-	0.26	3.43	0.000652	Diabetic kidney disease	
THCA	cis	1	rs1404147	chr7:65264524	LOC168474	chr7:64310071-64314178:-	0.25	3.37	0.000813	Diabetic kidney disease	
THCA	cis	1	rs1404147	chr7:65264524	RABGEF1	chr7:66093890-66276446:+	0.47	6.12	1.98E-9	Diabetic kidney disease	
THCA	cis	1	rs14047	chr20:3914215	MAVS	chr20:3827449-3856761:+	-0.23	-3.56	0.000403	Response to antidepressants in depression	
THCA	cis	1	rs1406947	chr20:33969530	CEP250	chr20:34042996-34099802:+	-0.15	-3.34	0.000897	Height	
THCA	cis	1	rs1406947	chr20:33969530	CPNE1	chr20:34213968-34262539:-	0.29	5.72	1.91E-8	Height	
THCA	cis	1	rs1406947	chr20:33969530	GDF5	chr20:33897002-34042568:-	-0.17	-3.66	0.000284	Height	
THCA	cis	1	rs1406947	chr20:33969530	UQCC	chr20:33890383-33999833:-	0.31	10.11	6.37E-22	Height	
THCA	cis	1	rs1407185	chr6:117733650	DCBLD1	chr6:117803820-117891018:+	0.47	10.31	1.21E-22	Lung cancer	
THCA	cis	1	rs1407185	chr6:117733650	GOPC	chr6:117639351-117923681:-	0.23	6.67	7.28E-11	Lung cancer	
THCA	cis	1	rs1407644	chr6:111802098	KIAA1919	chr6:111580482-111590259:+	-0.5	-6.06	2.81E-9	Psoriasis	
THCA	cis	1	rs1409306	chr10:25205965	PRTFDC1	chr10:25137554-25241533:-	0.25	3.39	0.000766	Metabolite levels (Pyroglutamine)	
THCA	cis	1	rs1409360	chr10:91385304	FLJ37201	chr10:91451057-91457685:-	-0.2	-4.13	4.22E-5	Metabolic traits	
THCA	cis	1	rs1411478	chr1:180962282	MR1	chr1:181003139-181024633:+	-0.13	-3.57	0.000399	Progressive supranuclear palsy	
THCA	cis	1	rs1411478	chr1:180962282	STX6	chr1:180913175-180992046:-	-0.2	-4.09	5.12E-5	Progressive supranuclear palsy	
THCA	cis	1	rs1412444	chr10:91002927	LIPA	chr10:90973328-91174382:-	0.3	7.62	1.4E-13	Fibrinogen levels	
THCA	cis	1	rs1412445	chr10:91002804	LIPA	chr10:90973328-91174382:-	0.29	7.42	5.46E-13	Fibrinogen levels	
THCA	cis	1	rs1414896	chr1:95692310	TMEM56	chr1:95582894-95663159:+	0.19	4.11	4.73E-5	Non-alcoholic fatty liver disease histology (AST)	
THCA	cis	1	rs141518190	chr15:78900647	CHRNA5	chr15:78857906-78886458:+	-0.43	-8.72	4.74E-17	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs1415753	chr6:86753074	SNHG5	chr6:86386726-86388451:-	-0.5	-10.77	2.34E-24	Response to antipsychotic treatment	
THCA	cis	1	rs1417437	chr1:70154441	LRRC7	chr1:70032868-70589169:+	-0.19	-3.35	0.000877	Orofacial clefts	
THCA	cis	1	rs1417823	chr10:102227886	SEC31B	chr10:102246403-102289636:-	0.3	10.16	4.33E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs14178	chr16:67969531	C16orf86	chr16:67700717-67702659:+	-0.34	-4.08	5.22E-5	Crohn's disease	
THCA	cis	1	rs14178	chr16:67969531	LRRC36	chr16:67360747-67419108:+	0.39	3.45	0.000614	Crohn's disease	
THCA	cis	1	rs14178	chr16:67969531	ZDHHC1	chr16:67428323-67450339:-	0.44	4.74	2.85E-6	Crohn's disease	
THCA	cis	1	rs1418410	chr9:115465282	C9orf110	chr9:115867006-115873957:-	0.21	3.63	0.000318	Age-related hearing impairment (interaction)	
THCA	cis	1	rs1419183	chr6:28242794	ZKSCAN3	chr6:28317691-28334523:+	-0.27	-5.25	2.35E-7	Depression	
THCA	cis	1	rs1419183	chr6:28242794	ZNF187	chr6:28234788-28245978:+	-0.34	-6.81	3.0E-11	Depression	
THCA	cis	1	rs1419183	chr6:28242794	ZNF193	chr6:28193067-28201260:+	0.2	3.76	0.000193	Depression	
THCA	cis	1	rs1419183	chr6:28242794	ZNF323	chr6:28292517-28324048:-	0.45	6.09	2.31E-9	Depression	
THCA	cis	1	rs1419183	chr6:28242794	ZNF389	chr6:28129551-28137375:+	-0.48	-6.8	3.1E-11	Depression	
THCA	cis	1	rs1419183	chr6:28242794	ZSCAN23	chr6:28393287-28411279:-	0.23	5.04	6.61E-7	Depression	
THCA	cis	1	rs142039564	chr1:119056258	WARS2	chr1:119573841-119683295:-	-0.22	-4.01	7.03E-5	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	
THCA	cis	1	rs1420993	chr16:51464898	SALL1	chr16:51169886-51185183:-	-0.24	-5.78	1.38E-8	Optic disc area;Optic disc parameters	
THCA	cis	1	rs1421371	chr6:46670822	CYP39A1	chr6:46517445-46620523:-	-0.28	-4.41	1.3E-5	Lipoprotein-associated phospholipase A2 activity and mass	
THCA	cis	1	rs1421371	chr6:46670822	TDRD6	chr6:46655866-46670149:+	0.16	3.42	0.000671	Lipoprotein-associated phospholipase A2 activity and mass	
THCA	cis	1	rs1422500	chr5:115569312	COMMD10	chr5:115420727-115628978:+	0.48	5.7	2.09E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs1423620	chr5:56100996	C5orf35	chr5:56205103-56213010:+	0.93	19.87	1.69E-64	Type 2 diabetes	
THCA	cis	1	rs1423621	chr5:56101035	C5orf35	chr5:56205103-56213010:+	0.97	21.91	3.64E-74	Type 2 diabetes	
THCA	cis	1	rs14239	chr7:44747903	OGDH	chr7:44646171-44748668:+	0.19	3.56	0.000403	Systolic blood pressure change trajectories	
THCA	cis	1	rs1428551	chr5:150259832	LOC134466	chr5:150310000-150326146:-	0.39	5.47	7.32E-8	Crohn's disease	
THCA	cis	1	rs1428552	chr5:150259831	LOC134466	chr5:150310000-150326146:-	0.38	5.27	2.11E-7	Crohn's disease	
THCA	cis	1	rs1428554	chr5:150257616	LOC134466	chr5:150310000-150326146:-	0.38	5.36	1.29E-7	Crohn's disease	
THCA	cis	1	rs1428555	chr5:150257391	LOC134466	chr5:150310000-150326146:-	-0.38	-5.33	1.48E-7	Crohn's disease	
THCA	cis	1	rs1429264	chr16:84623484	COTL1	chr16:84599206-84651669:-	0.14	3.57	0.000388	Epilepsy and lamotrigine-induced maculopapular eruptions	
THCA	cis	1	rs142958719	chr5:131232959	P4HA2	chr5:131528306-131563556:-	-0.26	-5	7.93E-7	Alzheimer's disease in APOE e4- carriers	
THCA	cis	1	rs1429904	chr1:207461884	CD55	chr1:207494817-207534309:+	0.19	7.75	5.5E-14	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs1429906	chr1:207420327	CD55	chr1:207494817-207534309:+	0.15	6.61	1.01E-10	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs143000161	chr2:165710540	SLC38A11	chr2:165754812-165812035:-	0.28	3.37	0.000823	Heschl's gyrus morphology	
THCA	cis	1	rs1432056	chr11:83285438	CCDC90B	chr11:82972506-82997414:-	0.16	3.87	0.000123	Subcortical brain region volumes	
THCA	cis	1	rs14347	chr16:15133889	NTAN1	chr16:15131717-15149833:-	0.13	3.9	0.000112	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs14347	chr16:15133889	PDXDC1	chr16:15068599-15233195:+	0.33	7.73	6.26E-14	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs1436963	chr15:62374593	VPS13C	chr15:62144592-62352647:-	-0.1	-3.79	0.000167	Height	
THCA	cis	1	rs1436964	chr15:62374487	VPS13C	chr15:62144592-62352647:-	-0.1	-3.79	0.000167	Height	
THCA	cis	1	rs1440487	chr1:47167075	CYP4B1	chr1:47264670-47285020:+	-0.22	-3.45	0.00061	Response to hepatitis C treatment	
THCA	cis	1	rs1440487	chr1:47167075	CYP4Z1	chr1:47533160-47583992:+	-0.27	-4.08	5.37E-5	Response to hepatitis C treatment	
THCA	cis	1	rs1440487	chr1:47167075	DMBX1	chr1:46972668-46979884:+	-0.24	-4.05	5.88E-5	Response to hepatitis C treatment	
THCA	cis	1	rs144098432	chr18:51816394	POLI	chr18:51795849-51824602:+	0.18	5.66	2.55E-8	Inflammatory skin disease	
THCA	cis	1	rs1442603	chr3:137269587	NCK1	chr3:136581073-136667967:+	0.13	3.57	0.000395	Glucocorticoid-induced osteonecrosis	
THCA	cis	1	rs1443438	chr9:100550028	C9orf156	chr9:100666772-100684852:-	0.14	3.69	0.000248	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	cis	1	rs1444249	chr12:62501196	FAM19A2	chr12:62102043-62653925:-	-0.15	-3.4	0.000737	Post bronchodilator FEV1/FVC ratio in COPD	
THCA	cis	1	rs1444250	chr12:62501174	FAM19A2	chr12:62102043-62653925:-	-0.15	-3.4	0.000737	Post bronchodilator FEV1/FVC ratio in COPD	
THCA	cis	1	rs144495862	chr7:48233391	CDC14C	chr7:48964157-48967049:+	0.13	3.4	0.000734	Cerebrospinal fluid clusterin levels	
THCA	cis	1	rs1447103	chr18:23738654	SS18	chr18:23596219-23671164:-	0.27	3.47	0.000573	Rhegmatogenous retinal detachment	
THCA	cis	1	rs1447276	chr5:15364484	FBXL7	chr5:15500305-15939900:+	0.17	3.65	0.000287	Obesity-related traits	
THCA	cis	1	rs1450472	chr4:121803292	C4orf31	chr4:121956782-121993673:-	0.2	3.72	0.000223	Fasting plasma glucose	
THCA	cis	1	rs1450868	chr7:32463666	AVL9	chr7:32535176-33079034:+	-0.16	-4.67	3.91E-6	Metabolite levels (HVA/MHPG ratio)	
THCA	cis	1	rs1451374	chr7:50622653	FIGNL1	chr7:50511834-50518088:-	-0.16	-4.33	1.82E-5	Malaria	
THCA	cis	1	rs1451375	chr7:50622712	FIGNL1	chr7:50511834-50518088:-	0.16	4.26	2.43E-5	Malaria	
THCA	cis	1	rs1451707	chr6:56801877	BEND6	chr6:56819773-56892138:+	-0.3	-6.17	1.49E-9	Menarche (age at onset)	
THCA	cis	1	rs1451707	chr6:56801877	KIAA1586	chr6:56911384-56920021:+	-0.32	-4.94	1.09E-6	Menarche (age at onset)	
THCA	cis	1	rs1451708	chr6:56802201	BEND6	chr6:56819773-56892138:+	-0.3	-6.13	1.88E-9	Menarche (age at onset)	
THCA	cis	1	rs1451708	chr6:56802201	KIAA1586	chr6:56911384-56920021:+	-0.32	-4.9	1.28E-6	Menarche (age at onset)	
THCA	cis	1	rs1452061	chr5:101727930	SLCO4C1	chr5:101569694-101632253:-	0.25	5.9	7.04E-9	Schizophrenia	
THCA	cis	1	rs1452062	chr5:101727677	SLCO4C1	chr5:101569694-101632253:-	0.25	5.9	7.04E-9	Schizophrenia	
THCA	cis	1	rs1452311	chr4:75715017	BTC	chr4:75671448-75719882:-	0.21	3.98	8.1E-5	Electroencephalogram traits	
THCA	cis	1	rs1452408	chr15:90891117	IQGAP1	chr15:90931473-91045475:+	0.12	4.18	3.52E-5	Rheumatoid arthritis	
THCA	cis	1	rs1452408	chr15:90891117	TTLL13	chr15:90792764-90815443:+	0.21	3.91	0.000104	Rheumatoid arthritis	
THCA	cis	1	rs1453560	chr17:38023441	C17orf37	chr17:37885411-37886788:-	-0.28	-4.71	3.21E-6	Systemic lupus erythematosus	
THCA	cis	1	rs1454499	chr2:70062939	SNRNP27	chr2:70121090-70132348:+	0.19	4.67	4.0E-6	Colorectal or endometrial cancer	
THCA	cis	1	rs1456391	chr4:154720485	RNF175	chr4:154631313-154681387:-	-0.19	-4.03	6.46E-5	Electrocardiographic conduction measures	
THCA	cis	1	rs1457493	chr6:70392625	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.44	0.000643	Sleep duration	
THCA	cis	1	rs1457494	chr6:70392175	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.44	0.000643	Sleep duration	
THCA	cis	1	rs145861664	chr12:62505458	FAM19A2	chr12:62102043-62653925:-	-0.15	-3.34	0.000892	Post bronchodilator FEV1/FVC ratio in COPD	
THCA	cis	1	rs1459242	chr3:48413537	ATRIP	chr3:48488141-48507708:+	-0.17	-3.82	0.00015	Longevity	
THCA	cis	1	rs1459242	chr3:48413537	TREX1	chr3:48501186-48509043:+	0.25	5.69	2.24E-8	Longevity	
THCA	cis	1	rs1459543	chr4:118650345	NDST3	chr4:118954773-119179786:+	-0.25	-4.7	3.39E-6	Neutrophil count	
THCA	cis	1	rs146009840	chr15:78906177	CHRNA5	chr15:78857906-78886458:+	-0.42	-8.23	1.75E-15	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs1460561	chr6:56797574	BEND6	chr6:56819773-56892138:+	-0.25	-5.01	7.53E-7	Menarche (age at onset)	
THCA	cis	1	rs1460561	chr6:56797574	KIAA1586	chr6:56911384-56920021:+	-0.29	-4.33	1.78E-5	Menarche (age at onset)	
THCA	cis	1	rs1464569	chr3:49460350	GMPPB	chr3:49758932-49761384:-	-0.18	-4.11	4.71E-5	Menarche (age at onset)	
THCA	cis	1	rs1464569	chr3:49460350	P4HTM	chr3:49027341-49044579:+	0.18	4.44	1.12E-5	Menarche (age at onset)	
THCA	cis	1	rs1464569	chr3:49460350	WDR6	chr3:49044637-49053386:+	-0.17	-3.6	0.000353	Menarche (age at onset)	
THCA	cis	1	rs1464761	chr7:54177306	SEC61G	chr7:54819941-54826939:-	-0.21	-3.34	0.000901	Periodontal disease-related phenotypes	
THCA	cis	1	rs146562	chr2:119663	SH3YL1	chr2:218138-264810:-	-0.27	-4.38	1.44E-5	Suicide attempts in bipolar disorder	
THCA	cis	1	rs146583707	chr4:123492417	KIAA1109	chr4:123091758-123283905:+	-0.15	-5.14	4.04E-7	Selective IgA deficiency	
THCA	cis	1	rs1465880	chr2:240932326	NDUFA10	chr2:240900158-240964798:-	0.31	8.73	4.14E-17	Odorant perception (isobutyraldehyde)	
THCA	cis	1	rs1466222	chr11:68832848	TPCN2	chr11:68816350-68929907:+	-0.16	-4.03	6.38E-5	Hair color	
THCA	cis	1	rs1466389	chr17:2096384	SRR	chr17:2207248-2228553:+	-0.79	-16.54	6.23E-49	Esophageal cancer (squamous cell)	
THCA	cis	1	rs1466661	chr4:155347496	DCHS2	chr4:155155527-155412930:-	0.16	3.45	0.000616	Alzheimer's disease (age of onset)	
THCA	cis	1	rs1466662	chr4:155347393	DCHS2	chr4:155155527-155412930:-	0.16	3.45	0.000616	Alzheimer's disease (age of onset)	
THCA	cis	1	rs1466788	chr1:110618730	ALX3	chr1:110602998-110613322:-	-0.31	-7.67	9.66E-14	Blood metabolite levels	
THCA	cis	1	rs1469024	chr19:18384544	KIAA1683	chr19:18367906-18385319:-	-0.25	-7.19	2.44E-12	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs1469712	chr19:19528821	HAPLN4	chr19:19366453-19384074:-	0.33	7.03	7.13E-12	Schizophrenia	
THCA	cis	1	rs1469712	chr19:19528821	KIAA0892	chr19:19431630-19469562:+	-0.15	-4.32	1.87E-5	Schizophrenia	
THCA	cis	1	rs1469712	chr19:19528821	TM6SF2	chr19:19375174-19384074:-	0.2	4.05	6.01E-5	Schizophrenia	
THCA	cis	1	rs1470097	chr2:26312840	GPR113	chr2:26531041-26569685:-	-0.42	-6.8	3.04E-11	Gut microbiome composition (summer)	
THCA	cis	1	rs147144681	chr15:78900908	CHRNA5	chr15:78857906-78886458:+	-0.43	-8.35	7.67E-16	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs1471552	chr15:84570734	LOC388152	chr15:84867600-84898920:-	-0.21	-3.99	7.52E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs1471553	chr15:84571038	LOC388152	chr15:84867600-84898920:-	-0.21	-4	7.19E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs1471633	chr1:145723739	NUDT17	chr1:145586494-145590461:-	0.18	4.14	4.07E-5	Urate levels;Urate levels in overweight individuals	
THCA	cis	1	rs1471633	chr1:145723739	PDZK1	chr1:145727726-145764073:+	-0.2	-3.36	0.000849	Urate levels;Urate levels in overweight individuals	
THCA	cis	1	rs1472001	chr11:46484685	PACSIN3	chr11:47199085-47207958:-	0.18	3.93	9.58E-5	Schizophrenia	
THCA	cis	1	rs1472746	chr8:94081082	C8orf83	chr8:93895865-94029901:-	0.28	4.48	9.51E-6	Attention deficit hyperactivity disorder	
THCA	cis	1	rs1472747	chr8:94081031	C8orf83	chr8:93895865-94029901:-	-0.28	-4.48	9.51E-6	Attention deficit hyperactivity disorder	
THCA	cis	1	rs1472748	chr8:94080831	C8orf83	chr8:93895865-94029901:-	0.28	4.67	3.96E-6	Attention deficit hyperactivity disorder	
THCA	cis	1	rs1472852	chr4:17910236	DCAF16	chr4:17802280-17812381:-	-0.21	-4.55	6.71E-6	Height	
THCA	cis	1	rs1473248	chr19:41923314	B3GNT8	chr19:41931265-41934635:-	0.36	8.42	4.58E-16	Height	
THCA	cis	1	rs1473248	chr19:41923314	EXOSC5	chr19:41892278-41903256:-	0.1	3.37	0.000815	Height	
THCA	cis	1	rs1474698	chr6:56064197	COL21A1	chr6:55921389-56258892:-	-0.77	-16.67	1.66E-49	Pulse pressure	
THCA	cis	1	rs147499554	chr15:78900650	CHRNA5	chr15:78857906-78886458:+	-0.43	-8.72	4.74E-17	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs1475695	chr9:100691168	C9orf156	chr9:100666772-100684852:-	-0.14	-3.63	0.000317	Quantitative traits	
THCA	cis	1	rs1475696	chr9:100691397	C9orf156	chr9:100666772-100684852:-	-0.14	-3.63	0.000317	Quantitative traits	
THCA	cis	1	rs1476029	chr22:36517932	APOL2	chr22:36622256-36636000:-	0.16	3.51	0.000496	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	
THCA	cis	1	rs1476029	chr22:36517932	APOL6	chr22:36044424-36064455:+	0.19	4.13	4.26E-5	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	
THCA	cis	1	rs1476029	chr22:36517932	EIF3D	chr22:36906898-36925277:-	0.23	3.74	0.000209	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	
THCA	cis	1	rs1476029	chr22:36517932	MCM5	chr22:35796116-35820494:+	0.2	3.57	0.000399	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	
THCA	cis	1	rs1476029	chr22:36517932	MPST	chr22:37415702-37425862:+	0.21	3.65	0.000287	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	
THCA	cis	1	rs1476029	chr22:36517932	TXN2	chr22:36863093-36877687:-	0.22	3.68	0.00026	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	
THCA	cis	1	rs1478565	chr3:161027464	NMD3	chr3:160939099-160971319:+	-0.11	-3.62	0.000321	Morning vs. evening chronotype	
THCA	cis	1	rs1478576	chr2:218284524	DIRC3	chr2:218148748-218621316:-	0.22	5.11	4.68E-7	Height	
THCA	cis	1	rs1480354	chr3:51364458	HEMK1	chr3:50606583-50622419:+	0.2	4.18	3.4E-5	Melanoma	
THCA	cis	1	rs1480354	chr3:51364458	TEX264	chr3:51705222-51738338:+	-0.22	-6.05	2.93E-9	Melanoma	
THCA	cis	1	rs1480823	chr15:84585746	LOC388152	chr15:84867600-84898920:-	-0.2	-3.75	0.000201	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs1480827	chr15:84577792	LOC388152	chr15:84867600-84898920:-	-0.21	-3.98	7.86E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs1481824	chr4:54241402	SCFD2	chr4:53739152-54232242:-	0.21	3.98	7.92E-5	DNA methylation (variation)	
THCA	cis	1	rs1484994	chr20:30305975	COX4I2	chr20:30225691-30232800:+	0.12	3.87	0.000124	Subcortical brain region volumes	
THCA	cis	1	rs1485483	chr11:77930138	NARS2	chr11:78147017-78285909:-	-0.39	-6.89	1.78E-11	Testicular germ cell tumor	
THCA	cis	1	rs148734725	chr3:49406708	IP6K2	chr3:48725437-48754920:-	-0.13	-4.18	3.51E-5	Educational attainment (college completion)	
THCA	cis	1	rs1488874	chr11:6350209	TAF10	chr11:6632073-6633445:-	-0.13	-3.35	0.000883	Smooth-surface caries	
THCA	cis	1	rs1491976	chr3:151183071	GPR87	chr3:151011876-151034636:-	-0.18	-3.66	0.000281	Response to abacavir-containing treatment in HIV-1 infection (virologic failure);Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	
THCA	cis	1	rs1497406	chr1:16505320	C1orf89	chr1:16558183-16563659:-	-0.17	-4.94	1.1E-6	Gamma gluatamyl transferase levels;Liver enzyme levels (gamma-glutamyl transferase)	
THCA	cis	1	rs14978	chr7:12273152	VWDE	chr7:12370509-12443852:-	-0.24	-4.21	3.0E-5	Response to amphetamines	
THCA	cis	1	rs1498312	chr1:76177849	ACADM	chr1:76190043-76229353:+	0.12	3.36	0.000836	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs1498312	chr1:76177849	MSH4	chr1:76262630-76378923:+	0.24	4.1	4.94E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs1498315	chr1:76159225	ACADM	chr1:76190043-76229353:+	0.12	3.38	0.000783	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs1498315	chr1:76159225	MSH4	chr1:76262630-76378923:+	0.24	4.12	4.42E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs1498316	chr1:76159198	MSH4	chr1:76262630-76378923:+	0.25	4.23	2.82E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs1498568	chr15:24594887	PWRN1	chr15:24778839-24832924:+	0.36	7.96	1.22E-14	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
THCA	cis	1	rs1498718	chr3:134205920	ANAPC13	chr3:134196547-134204865:-	0.37	11.73	4.17E-28	Height	
THCA	cis	1	rs1498718	chr3:134205920	CEP63	chr3:134204575-134293852:+	0.3	6.47	2.49E-10	Height	
THCA	cis	1	rs1499613	chr7:65730860	CCT6P1	chr7:65216092-65228661:+	-0.44	-6.91	1.6E-11	Diabetic kidney disease	
THCA	cis	1	rs1499613	chr7:65730860	CRCP	chr7:65579805-65619551:+	0.29	4.44	1.12E-5	Diabetic kidney disease	
THCA	cis	1	rs1499613	chr7:65730860	LOC493754	chr7:65993446-66057363:-	-0.29	-3.37	0.000808	Diabetic kidney disease	
THCA	cis	1	rs1499613	chr7:65730860	RABGEF1	chr7:66093890-66276446:+	-0.6	-7.42	5.51E-13	Diabetic kidney disease	
THCA	cis	1	rs1499614	chr7:65730798	CCT6P1	chr7:65216092-65228661:+	0.43	6.88	1.86E-11	Diabetic kidney disease	
THCA	cis	1	rs1499614	chr7:65730798	CRCP	chr7:65579805-65619551:+	-0.28	-4.33	1.85E-5	Diabetic kidney disease	
THCA	cis	1	rs1499614	chr7:65730798	RABGEF1	chr7:66093890-66276446:+	0.59	7.32	1.04E-12	Diabetic kidney disease	
THCA	cis	1	rs1501603	chr3:190667550	UTS2D	chr3:190984945-191048325:-	0.18	3.42	0.000674	Alzheimer's disease biomarkers	
THCA	cis	1	rs1503482	chr20:48023419	KCNB1	chr20:47988505-48100490:-	-0.17	-3.68	0.000262	Obesity-related traits	
THCA	cis	1	rs1503485	chr20:48018396	KCNB1	chr20:47988505-48100490:-	-0.16	-3.54	0.000441	Obesity-related traits	
THCA	cis	1	rs150380	chr5:36880871	C5orf42	chr5:37106330-37249530:-	-0.1	-3.79	0.000173	Height	
THCA	cis	1	rs1505572	chr1:31864721	ZCCHC17	chr1:31769842-31837780:+	-0.3	-5.66	2.61E-8	Schizophrenia	
THCA	cis	1	rs1507758	chr1:207507481	CD55	chr1:207494817-207534309:+	0.15	6.66	7.46E-11	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs1507760	chr1:207509365	CD55	chr1:207494817-207534309:+	-0.15	-6.67	6.98E-11	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs1507761	chr1:207509799	CD55	chr1:207494817-207534309:+	-0.16	-6.63	9.08E-11	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs1511218	chr2:160906390	LY75	chr2:160625141-160761262:-	0.21	4.97	9.57E-7	Idiopathic membranous nephropathy	
THCA	cis	1	rs1511823	chr10:23667523	C10orf67	chr10:23605521-23633772:-	-0.2	-4.13	4.3E-5	Crohn's disease and sarcoidosis (combined)	
THCA	cis	1	rs1511824	chr10:23667780	C10orf67	chr10:23605521-23633772:-	-0.21	-4.22	2.87E-5	Crohn's disease and sarcoidosis (combined)	
THCA	cis	1	rs151222	chr16:20674492	ACSM1	chr16:20634559-20709066:-	-0.44	-5.24	2.36E-7	Schizophrenia	
THCA	cis	1	rs151317012	chr4:106806194	INTS12	chr4:106603787-106629881:-	-0.62	-5.22	2.72E-7	Post bronchodilator FEV1	
THCA	cis	1	rs151964	chr5:96123666	CAST	chr5:95997777-96115291:+	-0.12	-4.1	4.9E-5	Ankylosing spondylitis	
THCA	cis	1	rs151964	chr5:96123666	ERAP1	chr5:96096515-96149837:-	-0.39	-11.47	4.44E-27	Ankylosing spondylitis	
THCA	cis	1	rs151964	chr5:96123666	ERAP2	chr5:96211644-96255398:+	0.53	9.44	1.64E-19	Ankylosing spondylitis	
THCA	cis	1	rs1520884	chr11:18309700	GTF2H1	chr11:18343816-18388590:+	-0.37	-10.03	1.24E-21	Pancreatic cancer	
THCA	cis	1	rs1522106	chr4:56307214	TMEM165	chr4:56262090-56292342:+	0.14	3.57	0.000393	Personality dimensions	
THCA	cis	1	rs1522108	chr4:56380733	TMEM165	chr4:56262090-56292342:+	-0.14	-3.41	0.000699	Personality dimensions	
THCA	cis	1	rs1522110	chr4:56380283	TMEM165	chr4:56262090-56292342:+	-0.15	-3.77	0.000181	Personality dimensions	
THCA	cis	1	rs1522111	chr4:56329563	TMEM165	chr4:56262090-56292342:+	-0.15	-3.66	0.000282	Personality dimensions	
THCA	cis	1	rs1526080	chr15:84589920	LOC388152	chr15:84867600-84898920:-	-0.2	-3.81	0.000157	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs1526081	chr15:84590066	LOC388152	chr15:84867600-84898920:-	-0.2	-3.81	0.000157	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs1528404	chr2:27846603	FNDC4	chr2:27714751-27718126:-	0.15	3.46	0.000592	Oral cavity cancer	
THCA	cis	1	rs1529195	chr9:102848687	LPPR1	chr9:103791031-104087416:+	0.24	3.45	0.000605	Preeclampsia	
THCA	cis	1	rs1529957	chr19:37739801	ZNF607	chr19:38187276-38210691:-	-0.23	-4.1	4.76E-5	Coronary artery calcification	
THCA	cis	1	rs1532423	chr8:86268313	LRRCC1	chr8:86019377-86058312:+	0.19	4.67	3.85E-6	Blood trace element (Zn levels)	
THCA	cis	1	rs1533266	chr7:143766714	ARHGEF35	chr7:143883677-143892736:-	-0.5	-10.59	1.08E-23	Obesity-related traits	
THCA	cis	1	rs1533266	chr7:143766714	OR2A1	chr7:144015236-144016148:+;chr7	-0.19	-4.03	6.58E-5	Obesity-related traits	
THCA	cis	1	rs1533266	chr7:143766714	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-6.58	1.28E-10	Obesity-related traits	
THCA	cis	1	rs1533267	chr7:143766440	ARHGEF35	chr7:143883677-143892736:-	-0.5	-10.63	7.6E-24	Obesity-related traits	
THCA	cis	1	rs1533267	chr7:143766440	OR2A1	chr7:144015236-144016148:+;chr7	-0.19	-4.04	6.15E-5	Obesity-related traits	
THCA	cis	1	rs1533267	chr7:143766440	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-6.57	1.35E-10	Obesity-related traits	
THCA	cis	1	rs1533268	chr7:143766358	ARHGEF35	chr7:143883677-143892736:-	-0.5	-10.59	1.08E-23	Obesity-related traits	
THCA	cis	1	rs1533268	chr7:143766358	OR2A1	chr7:144015236-144016148:+;chr7	-0.19	-4.03	6.58E-5	Obesity-related traits	
THCA	cis	1	rs1533268	chr7:143766358	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-6.58	1.28E-10	Obesity-related traits	
THCA	cis	1	rs1533642	chr9:111903349	C9orf5	chr9:111777416-111882225:-	0.19	3.56	0.000408	Information processing speed	
THCA	cis	1	rs1533825	chr11:214163	PSMD13	chr11:236808-252984:+	0.22	6.57	1.33E-10	Menarche (age at onset)	
THCA	cis	1	rs1534025	chr3:134313304	ANAPC13	chr3:134196547-134204865:-	-0.39	-12.22	4.44E-30	Height	
THCA	cis	1	rs1534025	chr3:134313304	CEP63	chr3:134204575-134293852:+	-0.31	-6.59	1.13E-10	Height	
THCA	cis	1	rs1534026	chr3:134284767	ANAPC13	chr3:134196547-134204865:-	0.4	12.83	1.37E-32	Height	
THCA	cis	1	rs1534026	chr3:134284767	CEP63	chr3:134204575-134293852:+	0.3	6.55	1.52E-10	Height	
THCA	cis	1	rs1534471	chr2:73647508	ALMS1P	chr2:73872046-73912692:+	0.69	10.89	8.37E-25	Metabolite levels	
THCA	cis	1	rs1534471	chr2:73647508	NAT8	chr2:73867850-73869537:-	0.36	5.67	2.52E-8	Metabolite levels	
THCA	cis	1	rs1534471	chr2:73647508	TPRKB	chr2:73956957-73964517:-	-0.18	-4.71	3.22E-6	Metabolite levels	
THCA	cis	1	rs1535277	chr6:26567802	BTN2A3	chr6:26422317-26431927:+	0.18	4.31	2.0E-5	Educational attainment	
THCA	cis	1	rs1535277	chr6:26567802	HCG11	chr6:26521934-26527610:+	-0.22	-4.28	2.24E-5	Educational attainment	
THCA	cis	1	rs1535277	chr6:26567802	HMGN4	chr6:26538572-26547162:+	-0.16	-4.13	4.35E-5	Educational attainment	
THCA	cis	1	rs1535277	chr6:26567802	LOC100270746	chr6:26987146-26988085:-	-0.15	-3.49	0.000531	Educational attainment	
THCA	cis	1	rs1535277	chr6:26567802	ZNF322A	chr6:26634612-26659963:-	-0.16	-4.63	4.82E-6	Educational attainment	
THCA	cis	1	rs1535500	chr6:39284050	KCNK17	chr6:39266778-39282237:-	0.18	4.32	1.88E-5	Type 2 diabetes	
THCA	cis	1	rs1535786	chr13:28170189	POLR1D	chr13:28194895-28241547:+	0.16	3.65	0.000292	Large B-cell lymphoma	
THCA	cis	1	rs1536263	chr1:10378914	KIF1B	chr1:10270764-10441659:+	0.2	6.13	1.87E-9	Hepatocellular carcinoma	
THCA	cis	1	rs1538767	chr3:195007852	C3orf21	chr3:194789015-194991895:-	0.29	6.74	4.51E-11	Body mass index	
THCA	cis	1	rs1539822	chr18:33695943	SLC39A6	chr18:33688495-33709357:-	0.14	3.95	8.81E-5	Esophageal squamous cell cancer (length of survival)	
THCA	cis	1	rs1540651	chr7:65650121	ASL	chr7:65540776-65558321:+	0.17	4.34	1.75E-5	Aortic root size	
THCA	cis	1	rs1540651	chr7:65650121	GUSB	chr7:65425675-65447246:-	-0.26	-5	8.15E-7	Aortic root size	
THCA	cis	1	rs1540651	chr7:65650121	LOC729156	chr7:66274980-66309813:-	-0.17	-3.6	0.000352	Aortic root size	
THCA	cis	1	rs1540651	chr7:65650121	RABGEF1	chr7:66093890-66276446:+	-0.67	-14.41	2.25E-39	Aortic root size	
THCA	cis	1	rs1540894	chr7:143767676	ARHGEF35	chr7:143883677-143892736:-	-0.51	-10.61	9.21E-24	Obesity-related traits	
THCA	cis	1	rs1540894	chr7:143767676	OR2A1	chr7:144015236-144016148:+;chr7	-0.17	-3.67	0.00027	Obesity-related traits	
THCA	cis	1	rs1540894	chr7:143767676	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-6.43	3.17E-10	Obesity-related traits	
THCA	cis	1	rs1540909	chr6:35488853	TULP1	chr6:35465653-35480647:-	-0.28	-3.85	0.000134	Hepatitis C induced liver fibrosis	
THCA	cis	1	rs1540927	chr20:33931344	CEP250	chr20:34042996-34099802:+	-0.15	-3.36	0.000835	Height	
THCA	cis	1	rs1540927	chr20:33931344	CPNE1	chr20:34213968-34262539:-	0.3	5.91	6.56E-9	Height	
THCA	cis	1	rs1540927	chr20:33931344	GDF5	chr20:33897002-34042568:-	-0.16	-3.53	0.000451	Height	
THCA	cis	1	rs1540927	chr20:33931344	UQCC	chr20:33890383-33999833:-	0.32	10.29	1.5E-22	Height	
THCA	cis	1	rs1541306	chr11:71708013	FAM86C	chr11:71498557-71512276:+	0.3	3.76	0.00019	Severe influenza A (H1N1) infection	
THCA	cis	1	rs1541853	chr2:203835177	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.69	2.21E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs1541853	chr2:203835177	ICA1L	chr2:203637873-203736371:-	0.27	4.48	9.33E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs1542574	chr3:51395571	HEMK1	chr3:50606583-50622419:+	0.15	3.49	0.000527	Melanoma	
THCA	cis	1	rs1542574	chr3:51395571	TEX264	chr3:51705222-51738338:+	-0.2	-5.8	1.23E-8	Melanoma	
THCA	cis	1	rs1542901	chr3:2474012	CNTN4	chr3:2140550-3099644:+	0.37	8.62	9.98E-17	Blood pressure (smoking interaction)	
THCA	cis	1	rs1543338	chr1:26031193	STMN1	chr1:26210678-26233368:-	0.2	3.34	0.000902	Nose morphology	
THCA	cis	1	rs1544549	chr7:66090663	ASL	chr7:65540776-65558321:+	0.14	3.64	0.000306	Aortic root size	
THCA	cis	1	rs1544549	chr7:66090663	GUSB	chr7:65425675-65447246:-	-0.26	-5.12	4.37E-7	Aortic root size	
THCA	cis	1	rs1544549	chr7:66090663	LOC729156	chr7:66274980-66309813:-	-0.16	-3.51	0.000498	Aortic root size	
THCA	cis	1	rs1544549	chr7:66090663	RABGEF1	chr7:66093890-66276446:+	-0.69	-15.23	5.81E-43	Aortic root size	
THCA	cis	1	rs1545206	chr1:47185082	CYP4B1	chr1:47264670-47285020:+	0.23	3.58	0.000377	Response to hepatitis C treatment	
THCA	cis	1	rs1545206	chr1:47185082	CYP4Z1	chr1:47533160-47583992:+	0.28	4.03	6.44E-5	Response to hepatitis C treatment	
THCA	cis	1	rs1545206	chr1:47185082	DMBX1	chr1:46972668-46979884:+	0.23	3.94	9.54E-5	Response to hepatitis C treatment	
THCA	cis	1	rs1545486	chr5:101729948	SLCO4C1	chr5:101569694-101632253:-	0.25	5.62	3.23E-8	Schizophrenia	
THCA	cis	1	rs1545487	chr5:101729829	SLCO4C1	chr5:101569694-101632253:-	-0.24	-5.59	3.79E-8	Schizophrenia	
THCA	cis	1	rs1546059	chr7:65654709	CCT6P1	chr7:65216092-65228661:+	-0.42	-6.79	3.36E-11	Diabetic kidney disease	
THCA	cis	1	rs1546059	chr7:65654709	CRCP	chr7:65579805-65619551:+	0.29	4.56	6.49E-6	Diabetic kidney disease	
THCA	cis	1	rs1546059	chr7:65654709	RABGEF1	chr7:66093890-66276446:+	-0.56	-6.99	9.07E-12	Diabetic kidney disease	
THCA	cis	1	rs154659	chr16:89667337	CPNE7	chr16:89642176-89663653:+	0.14	3.68	0.00026	Tanning	
THCA	cis	1	rs1546753	chr3:119557075	GSK3B	chr3:119540804-119813264:-	-0.14	-4.83	1.86E-6	HDL cholesterol	
THCA	cis	1	rs1548226	chr20:43983777	ZNF335	chr20:44577293-44600833:-	-0.15	-3.59	0.000359	Psoriasis	
THCA	cis	1	rs1548497	chr7:27174316	HOXA9	chr7:27202058-27205149:-	0.43	4.97	9.26E-7	Hypospadias	
THCA	cis	1	rs1548885	chr7:12279559	VWDE	chr7:12370509-12443852:-	-0.24	-4.15	3.9E-5	Response to amphetamines	
THCA	cis	1	rs1550381	chr2:26266946	GPR113	chr2:26531041-26569685:-	-0.43	-6.89	1.82E-11	Gut microbiome composition (summer)	
THCA	cis	1	rs1550382	chr2:26266877	GPR113	chr2:26531041-26569685:-	-0.43	-6.89	1.82E-11	Gut microbiome composition (summer)	
THCA	cis	1	rs1552244	chr3:10135577	C3orf10	chr3:10157333-10168873:+	-0.19	-4.21	3.11E-5	Alzheimer's disease	
THCA	cis	1	rs1552244	chr3:10135577	VHL	chr3:10183319-10193744:+	-0.16	-3.67	0.000267	Alzheimer's disease	
THCA	cis	1	rs1552515	chr11:6354524	TAF10	chr11:6632073-6633445:-	-0.14	-3.51	0.000486	Smooth-surface caries	
THCA	cis	1	rs1552994	chr1:152171461	FLG2	chr1:152321214-152332482:-	0.25	4.47	9.6E-6	Inflammatory skin disease	
THCA	cis	1	rs1552994	chr1:152171461	FLG	chr1:152274651-152297679:-	0.48	8.87	1.51E-17	Inflammatory skin disease	
THCA	cis	1	rs1552994	chr1:152171461	HRNR	chr1:152184558-152196669:-	-0.24	-3.7	0.000242	Inflammatory skin disease	
THCA	cis	1	rs1553174	chr7:65731194	CCT6P1	chr7:65216092-65228661:+	-0.44	-6.91	1.6E-11	Diabetic kidney disease	
THCA	cis	1	rs1553174	chr7:65731194	CRCP	chr7:65579805-65619551:+	0.29	4.44	1.12E-5	Diabetic kidney disease	
THCA	cis	1	rs1553174	chr7:65731194	LOC493754	chr7:65993446-66057363:-	-0.29	-3.37	0.000808	Diabetic kidney disease	
THCA	cis	1	rs1553174	chr7:65731194	RABGEF1	chr7:66093890-66276446:+	-0.6	-7.42	5.51E-13	Diabetic kidney disease	
THCA	cis	1	rs1553609	chr7:66197139	GUSB	chr7:65425675-65447246:-	0.33	6.7	5.72E-11	Aortic root size	
THCA	cis	1	rs1553609	chr7:66197139	RABGEF1	chr7:66093890-66276446:+	0.51	10.51	2.27E-23	Aortic root size	
THCA	cis	1	rs1553609	chr7:66197139	TYW1	chr7:66461817-66704496:+	0.18	3.97	8.44E-5	Aortic root size	
THCA	cis	1	rs1553610	chr7:66197233	GUSB	chr7:65425675-65447246:-	0.34	6.84	2.43E-11	Aortic root size	
THCA	cis	1	rs1553610	chr7:66197233	RABGEF1	chr7:66093890-66276446:+	0.52	10.69	4.74E-24	Aortic root size	
THCA	cis	1	rs1553610	chr7:66197233	TYW1	chr7:66461817-66704496:+	0.18	3.89	0.000116	Aortic root size	
THCA	cis	1	rs1555095	chr6:56003683	COL21A1	chr6:55921389-56258892:-	-0.62	-7.61	1.49E-13	Psychosis (atypical)	
THCA	cis	1	rs1555322	chr20:33849179	CPNE1	chr20:34213968-34262539:-	-0.33	-4.57	6.12E-6	Attention deficit hyperactivity disorder	
THCA	cis	1	rs1555322	chr20:33849179	MMP24	chr20:33814539-33864804:+	-0.2	-3.51	0.000488	Attention deficit hyperactivity disorder	
THCA	cis	1	rs1555337	chr20:61863641	BIRC7	chr20:61867276-61871853:+	-0.34	-4.02	6.64E-5	Response to cytadine analogues (cytosine arabinoside)	
THCA	cis	1	rs1555337	chr20:61863641	NKAIN4	chr20:61872137-61885892:-	-0.35	-3.76	0.000193	Response to cytadine analogues (cytosine arabinoside)	
THCA	cis	1	rs1555569	chr17:2149425	SRR	chr17:2207248-2228553:+	-0.83	-17.7	2.87E-54	Esophageal cancer (squamous cell)	
THCA	cis	1	rs1557503	chr22:51013072	CHKB	chr22:51017378-51021428:-	0.52	6.19	1.33E-9	Narcolepsy	
THCA	cis	1	rs1557503	chr22:51013072	CPT1B	chr22:51007291-51017096:-	-0.41	-8.21	2.1E-15	Narcolepsy	
THCA	cis	1	rs1558377	chr4:17650758	MED28	chr4:17616273-17629791:+	0.17	3.73	0.000215	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs1558378	chr4:17650351	MED28	chr4:17616273-17629791:+	0.17	3.73	0.000215	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs1559282	chr5:56099375	C5orf35	chr5:56205103-56213010:+	0.98	22.49	5.85E-77	Type 2 diabetes	
THCA	cis	1	rs1560104	chr16:12708208	CPPED1	chr16:12753657-12897744:-	0.15	4.02	6.8E-5	Obesity-related traits	
THCA	cis	1	rs1560396	chr4:39113712	KLHL5	chr4:39046659-39123828:+	-0.21	-5.73	1.77E-8	Uric acid levels	
THCA	cis	1	rs1560397	chr4:39113885	KLHL5	chr4:39046659-39123828:+	-0.21	-5.73	1.77E-8	Uric acid levels	
THCA	cis	1	rs1560706	chr19:10838004	SLC44A2	chr19:10713121-10755234:+	0.3	3.35	0.000858	LDL cholesterol	
THCA	cis	1	rs1560734	chr19:10841049	ILF3	chr19:10764937-10803093:+	-0.19	-3.35	0.000887	LDL cholesterol	
THCA	cis	1	rs1560734	chr19:10841049	LOC147727	chr19:10762539-10764548:-	-0.24	-3.47	0.000574	LDL cholesterol	
THCA	cis	1	rs1560868	chr2:26281459	GPR113	chr2:26531041-26569685:-	0.46	7.16	3.07E-12	Gut microbiome composition (summer)	
THCA	cis	1	rs1560868	chr2:26281459	HADHA	chr2:26413505-26467594:-	0.16	3.41	0.000708	Gut microbiome composition (summer)	
THCA	cis	1	rs1561288	chr2:25369002	POMC	chr2:25383722-25391559:-	0.22	3.69	0.000251	Body mass index	
THCA	cis	1	rs1561289	chr2:25369040	POMC	chr2:25383722-25391559:-	-0.25	-4.01	6.95E-5	Body mass index	
THCA	cis	1	rs1561328	chr2:86272758	LOC90784	chr2:86247339-86250991:-	-0.54	-6.38	4.22E-10	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs1561962	chr9:100546219	C9orf156	chr9:100666772-100684852:-	0.13	3.5	0.0005	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	cis	1	rs1563607	chr6:70497515	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.46	0.000579	Sleep duration	
THCA	cis	1	rs1563609	chr6:70497658	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.45	0.000609	Sleep duration	
THCA	cis	1	rs1563736	chr3:48436794	ATRIP	chr3:48488141-48507708:+	0.17	3.81	0.000155	Longevity	
THCA	cis	1	rs1563736	chr3:48436794	TREX1	chr3:48501186-48509043:+	-0.26	-5.97	4.57E-9	Longevity	
THCA	cis	1	rs15637	chr17:61772050	FTSJ3	chr17:61896795-61905031:-	0.31	5.82	1.06E-8	Body mass index	
THCA	cis	1	rs15637	chr17:61772050	MAP3K3	chr17:61699775-61773669:+	0.25	5.16	3.68E-7	Body mass index	
THCA	cis	1	rs156407	chr7:23315639	KLHL7	chr7:23145353-23215036:+	0.25	5.67	2.47E-8	Parkinson's disease	
THCA	cis	1	rs156421	chr7:23312487	KLHL7	chr7:23145353-23215036:+	0.25	5.75	1.56E-8	Parkinson's disease	
THCA	cis	1	rs156425	chr7:23309119	KLHL7	chr7:23145353-23215036:+	-0.25	-5.83	1.04E-8	Parkinson's disease	
THCA	cis	1	rs1564473	chr15:84569942	LOC388152	chr15:84867600-84898920:-	-0.21	-3.93	9.58E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs1564474	chr15:84570033	LOC388152	chr15:84867600-84898920:-	-0.21	-3.98	7.86E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs1564475	chr15:84572229	LOC388152	chr15:84867600-84898920:-	-0.21	-4	7.19E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs1564716	chr3:41862613	ULK4	chr3:41288091-42003660:-	1.04	19.87	1.7E-64	Diastolic blood pressure	
THCA	cis	1	rs1564892	chr12:104445742	NFYB	chr12:104510858-104532040:-	0.13	3.38	0.000785	Corneal structure	
THCA	cis	1	rs1565531	chr7:65663113	ASL	chr7:65540776-65558321:+	0.16	4.28	2.27E-5	Aortic root size	
THCA	cis	1	rs1565531	chr7:65663113	GUSB	chr7:65425675-65447246:-	-0.28	-5.36	1.33E-7	Aortic root size	
THCA	cis	1	rs1565531	chr7:65663113	LOC729156	chr7:66274980-66309813:-	-0.16	-3.47	0.000568	Aortic root size	
THCA	cis	1	rs1565531	chr7:65663113	RABGEF1	chr7:66093890-66276446:+	-0.65	-13.95	2.36E-37	Aortic root size	
THCA	cis	1	rs1566960	chr1:31873525	ZCCHC17	chr1:31769842-31837780:+	-0.32	-5.78	1.33E-8	Schizophrenia	
THCA	cis	1	rs15676	chr9:131572027	C9orf114	chr9:131584346-131592085:-	-0.29	-6.55	1.46E-10	Blood metabolite levels	
THCA	cis	1	rs15676	chr9:131572027	ENDOG	chr9:131580779-131584954:+	-0.43	-13.64	4.97E-36	Blood metabolite levels	
THCA	cis	1	rs1567865	chr20:47881967	DDX27	chr20:47835832-47860612:+	0.28	5.03	6.81E-7	Height	
THCA	cis	1	rs1567890	chr11:78101700	NARS2	chr11:78147017-78285909:-	-0.39	-7	8.63E-12	Testicular germ cell tumor	
THCA	cis	1	rs1569483	chr6:25614595	SCGN	chr6:25652429-25702006:+	-0.31	-5.98	4.44E-9	Uric acid levels	
THCA	cis	1	rs1569716	chr22:38998519	LOC646851	chr22:38974125-39052634:-	0.14	3.88	0.00012	Resting heart rate	
THCA	cis	1	rs1569716	chr22:38998519	TOMM22	chr22:39077954-39080763:+	-0.16	-3.63	0.000314	Resting heart rate	
THCA	cis	1	rs1570004	chr20:33958253	CEP250	chr20:34042996-34099802:+	-0.15	-3.41	0.000708	Height	
THCA	cis	1	rs1570004	chr20:33958253	CPNE1	chr20:34213968-34262539:-	0.31	5.96	4.92E-9	Height	
THCA	cis	1	rs1570004	chr20:33958253	GDF5	chr20:33897002-34042568:-	-0.17	-3.75	0.000197	Height	
THCA	cis	1	rs1570004	chr20:33958253	UQCC	chr20:33890383-33999833:-	0.32	10.37	7.33E-23	Height	
THCA	cis	1	rs1570979	chr13:24441561	C1QTNF9B	chr13:24465238-24471641:-	-0.35	-3.6	0.000357	3-hydroxypropylmercapturic acid levels in smokers	
THCA	cis	1	rs1571229	chr9:131913711	CRAT	chr9:131857075-131873070:-	0.29	7.1	4.57E-12	Blood metabolite ratios	
THCA	cis	1	rs1571388	chr14:61402545	SLC38A6	chr14:61447880-61550450:+	-0.32	-3.54	0.000447	Immune reponse to smallpox (secreted IFN-alpha)	
THCA	cis	1	rs157184	chr19:12128317	ZNF763	chr19:12035900-12091196:+	-0.31	-3.87	0.000122	Multiple sclerosis	
THCA	cis	1	rs1572275	chr1:207478980	CD55	chr1:207494817-207534309:+	-0.16	-6.99	9.29E-12	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs1573502	chr11:71747428	FAM86C	chr11:71498557-71512276:+	0.32	3.91	0.000107	Severe influenza A (H1N1) infection	
THCA	cis	1	rs1573897	chr1:247215054	OR2T8	chr1:248084320-248085256:+	-0.2	-3.86	0.000127	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs1573897	chr1:247215054	OR2W3	chr1:248031265-248060142:+	-0.17	-3.34	0.000905	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs1577767	chr13:85675903	SLITRK6	chr13:86366922-86373483:-	-0.22	-4.02	6.79E-5	Bipolar disorder (mania)	
THCA	cis	1	rs1577917	chr6:86691940	SNHG5	chr6:86386726-86388451:-	-0.51	-11.04	2.11E-25	Response to antipsychotic treatment	
THCA	cis	1	rs1577919	chr6:86757296	SNHG5	chr6:86386726-86388451:-	-0.49	-10.75	2.64E-24	Response to antipsychotic treatment	
THCA	cis	1	rs1580509	chr8:89464569	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs1583090	chr1:207435783	CD55	chr1:207494817-207534309:+	0.19	7.59	1.7E-13	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs1583233	chr15:27223811	GABRG3	chr15:27216517-27778134:+	0.18	3.76	0.000192	Hepatitis	
THCA	cis	1	rs1584346	chr4:87839844	C4orf36	chr4:87797359-87813575:-	0.22	4.82	1.97E-6	Amyotrophic lateral sclerosis	
THCA	cis	1	rs1584716	chr5:101682384	SLCO4C1	chr5:101569694-101632253:-	0.25	5.62	3.21E-8	Schizophrenia	
THCA	cis	1	rs1585333	chr4:18019025	DCAF16	chr4:17802280-17812381:-	-0.2	-4.52	7.89E-6	Height	
THCA	cis	1	rs1585334	chr4:18018944	DCAF16	chr4:17802280-17812381:-	-0.2	-4.52	7.89E-6	Height	
THCA	cis	1	rs158622	chr5:36887895	C5orf42	chr5:37106330-37249530:-	0.1	3.8	0.000166	Height	
THCA	cis	1	rs158623	chr5:36883019	C5orf42	chr5:37106330-37249530:-	-0.09	-3.74	0.000206	Height	
THCA	cis	1	rs158624	chr5:36865669	C5orf42	chr5:37106330-37249530:-	-0.1	-3.91	0.000106	Height	
THCA	cis	1	rs1586652	chr13:85745689	SLITRK6	chr13:86366922-86373483:-	-0.2	-3.91	0.000107	Bipolar disorder (mania)	
THCA	cis	1	rs1586936	chr1:76366877	ACADM	chr1:76190043-76229353:+	-0.25	-5.06	6.12E-7	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs158791	chr5:36948362	C5orf42	chr5:37106330-37249530:-	0.09	3.64	0.000302	Height	
THCA	cis	1	rs1587922	chr3:51918228	RAD54L2	chr3:51575596-51697610:+	-0.08	-3.6	0.000357	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs158796	chr5:36878780	C5orf42	chr5:37106330-37249530:-	-0.1	-3.79	0.000173	Height	
THCA	cis	1	rs1588635	chr9:100537802	C9orf156	chr9:100666772-100684852:-	0.14	3.56	0.000404	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	cis	1	rs1589166	chr11:93731459	HEPHL1	chr11:93754378-93847374:+	-0.39	-3.34	0.000891	Obesity-related traits	
THCA	cis	1	rs1590973	chr9:99246159	CDC14B	chr9:99262397-99382112:-	-0.17	-5.2	3.03E-7	Height	
THCA	cis	1	rs1591608	chr13:85745395	SLITRK6	chr13:86366922-86373483:-	-0.22	-3.91	0.000105	Bipolar disorder (mania)	
THCA	cis	1	rs1591882	chr1:121183313	HIST2H2BA	chr1:120906034-120914842:+	0.21	4.94	1.11E-6	Hip geometry	
THCA	cis	1	rs1592917	chr5:115569414	COMMD10	chr5:115420727-115628978:+	0.48	5.7	2.09E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs1594829	chr8:26206077	PPP2R2A	chr8:25230075-26228645:+	-0.19	-3.37	0.000807	Height	
THCA	cis	1	rs159751	chr5:36999998	C5orf42	chr5:37106330-37249530:-	-0.09	-3.63	0.00031	Height	
THCA	cis	1	rs159753	chr5:37007629	C5orf42	chr5:37106330-37249530:-	-0.09	-3.72	0.000225	Height	
THCA	cis	1	rs159755	chr5:36995205	C5orf42	chr5:37106330-37249530:-	-0.1	-3.8	0.000161	Height	
THCA	cis	1	rs1597773	chr5:101783090	SLCO4C1	chr5:101569694-101632253:-	0.25	5.62	3.21E-8	Schizophrenia	
THCA	cis	1	rs1598859	chr4:103506444	NFKB1	chr4:103422486-103538458:+	0.17	4.66	4.07E-6	Ulcerative colitis	
THCA	cis	1	rs159913	chr5:37053983	C5orf42	chr5:37106330-37249530:-	-0.09	-3.77	0.000186	Height	
THCA	cis	1	rs1599280	chr6:56792576	BEND6	chr6:56819773-56892138:+	-0.29	-6.19	1.33E-9	Menarche (age at onset)	
THCA	cis	1	rs1599280	chr6:56792576	KIAA1586	chr6:56911384-56920021:+	-0.34	-5.44	8.39E-8	Menarche (age at onset)	
THCA	cis	1	rs1599281	chr6:56789311	BEND6	chr6:56819773-56892138:+	0.28	5.89	7.17E-9	Menarche (age at onset)	
THCA	cis	1	rs1599281	chr6:56789311	KIAA1586	chr6:56911384-56920021:+	0.29	4.57	6.26E-6	Menarche (age at onset)	
THCA	cis	1	rs1599932	chr12:58177943	FAM119B	chr12:58166383-58176323:+	0.4	10.89	8.3E-25	Multiple sclerosis	
THCA	cis	1	rs1599932	chr12:58177943	METTL1	chr12:58162352-58165914:-	-0.19	-4.67	3.99E-6	Multiple sclerosis	
THCA	cis	1	rs1599932	chr12:58177943	TSFM	chr12:58176536-58191367:+	-0.59	-20.24	2.97E-66	Multiple sclerosis	
THCA	cis	1	rs1599932	chr12:58177943	XRCC6BP1	chr12:58335445-58351051:+	-0.22	-4.4	1.36E-5	Multiple sclerosis	
THCA	cis	1	rs1600209	chr3:161038217	NMD3	chr3:160939099-160971319:+	-0.11	-3.64	0.000304	Morning vs. evening chronotype	
THCA	cis	1	rs1600211	chr2:218279003	DIRC3	chr2:218148748-218621316:-	0.21	5.07	5.84E-7	Height	
THCA	cis	1	rs1601531	chr2:67598104	ETAA1	chr2:67624442-67637533:+	-0.17	-4.05	5.88E-5	Pancreatic cancer	
THCA	cis	1	rs1604921	chr8:89462984	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs1605070	chr3:51917015	RAD54L2	chr3:51575596-51697610:+	0.08	3.63	0.000309	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs1605292	chr11:93647354	HEPHL1	chr11:93754378-93847374:+	-0.41	-3.71	0.000229	Obesity-related traits	
THCA	cis	1	rs160633	chr7:65528228	CCT6P1	chr7:65216092-65228661:+	0.41	6.59	1.19E-10	Diabetic kidney disease	
THCA	cis	1	rs160633	chr7:65528228	CRCP	chr7:65579805-65619551:+	-0.31	-4.83	1.82E-6	Diabetic kidney disease	
THCA	cis	1	rs160633	chr7:65528228	LOC493754	chr7:65993446-66057363:-	0.3	3.49	0.000521	Diabetic kidney disease	
THCA	cis	1	rs160633	chr7:65528228	RABGEF1	chr7:66093890-66276446:+	0.52	6.39	3.86E-10	Diabetic kidney disease	
THCA	cis	1	rs160634	chr7:65528664	CCT6P1	chr7:65216092-65228661:+	-0.4	-6.57	1.35E-10	Diabetic kidney disease	
THCA	cis	1	rs160634	chr7:65528664	CRCP	chr7:65579805-65619551:+	0.29	4.63	4.64E-6	Diabetic kidney disease	
THCA	cis	1	rs160634	chr7:65528664	LOC493754	chr7:65993446-66057363:-	-0.29	-3.44	0.000637	Diabetic kidney disease	
THCA	cis	1	rs160634	chr7:65528664	RABGEF1	chr7:66093890-66276446:+	-0.52	-6.54	1.62E-10	Diabetic kidney disease	
THCA	cis	1	rs160637	chr7:65584318	CCT6P1	chr7:65216092-65228661:+	0.41	6.74	4.45E-11	Diabetic kidney disease	
THCA	cis	1	rs160637	chr7:65584318	CRCP	chr7:65579805-65619551:+	-0.3	-4.74	2.8E-6	Diabetic kidney disease	
THCA	cis	1	rs160637	chr7:65584318	LOC493754	chr7:65993446-66057363:-	0.3	3.58	0.000372	Diabetic kidney disease	
THCA	cis	1	rs160637	chr7:65584318	RABGEF1	chr7:66093890-66276446:+	0.53	6.78	3.48E-11	Diabetic kidney disease	
THCA	cis	1	rs160639	chr7:65579987	CCT6P1	chr7:65216092-65228661:+	0.4	6.56	1.43E-10	Diabetic kidney disease	
THCA	cis	1	rs160639	chr7:65579987	CRCP	chr7:65579805-65619551:+	-0.3	-4.75	2.68E-6	Diabetic kidney disease	
THCA	cis	1	rs160639	chr7:65579987	LOC493754	chr7:65993446-66057363:-	0.29	3.42	0.000682	Diabetic kidney disease	
THCA	cis	1	rs160639	chr7:65579987	RABGEF1	chr7:66093890-66276446:+	0.55	6.96	1.1E-11	Diabetic kidney disease	
THCA	cis	1	rs160642	chr7:65558373	CCT6P1	chr7:65216092-65228661:+	0.41	6.67	7.2E-11	Diabetic kidney disease	
THCA	cis	1	rs160642	chr7:65558373	CRCP	chr7:65579805-65619551:+	-0.3	-4.8	2.11E-6	Diabetic kidney disease	
THCA	cis	1	rs160642	chr7:65558373	LOC493754	chr7:65993446-66057363:-	0.3	3.6	0.000358	Diabetic kidney disease	
THCA	cis	1	rs160642	chr7:65558373	RABGEF1	chr7:66093890-66276446:+	0.52	6.65	8.06E-11	Diabetic kidney disease	
THCA	cis	1	rs160643	chr7:65558222	CCT6P1	chr7:65216092-65228661:+	0.41	6.66	7.57E-11	Diabetic kidney disease	
THCA	cis	1	rs160643	chr7:65558222	CRCP	chr7:65579805-65619551:+	-0.25	-3.85	0.000135	Diabetic kidney disease	
THCA	cis	1	rs160643	chr7:65558222	LOC493754	chr7:65993446-66057363:-	0.32	3.71	0.00023	Diabetic kidney disease	
THCA	cis	1	rs160643	chr7:65558222	RABGEF1	chr7:66093890-66276446:+	0.51	6.4	3.82E-10	Diabetic kidney disease	
THCA	cis	1	rs160644	chr7:65558186	CCT6P1	chr7:65216092-65228661:+	0.41	6.65	8.27E-11	Diabetic kidney disease	
THCA	cis	1	rs160644	chr7:65558186	CRCP	chr7:65579805-65619551:+	-0.3	-4.8	2.15E-6	Diabetic kidney disease	
THCA	cis	1	rs160644	chr7:65558186	LOC493754	chr7:65993446-66057363:-	0.3	3.6	0.000345	Diabetic kidney disease	
THCA	cis	1	rs160644	chr7:65558186	RABGEF1	chr7:66093890-66276446:+	0.53	6.68	6.54E-11	Diabetic kidney disease	
THCA	cis	1	rs160646	chr7:65556280	CCT6P1	chr7:65216092-65228661:+	0.41	6.68	6.75E-11	Diabetic kidney disease	
THCA	cis	1	rs160646	chr7:65556280	CRCP	chr7:65579805-65619551:+	-0.3	-4.67	3.99E-6	Diabetic kidney disease	
THCA	cis	1	rs160646	chr7:65556280	LOC493754	chr7:65993446-66057363:-	0.3	3.62	0.000328	Diabetic kidney disease	
THCA	cis	1	rs160646	chr7:65556280	RABGEF1	chr7:66093890-66276446:+	0.53	6.78	3.62E-11	Diabetic kidney disease	
THCA	cis	1	rs160648	chr7:65543384	CCT6P1	chr7:65216092-65228661:+	0.39	6.34	5.46E-10	Diabetic kidney disease	
THCA	cis	1	rs160648	chr7:65543384	CRCP	chr7:65579805-65619551:+	-0.3	-4.64	4.42E-6	Diabetic kidney disease	
THCA	cis	1	rs160648	chr7:65543384	GUSB	chr7:65425675-65447246:-	0.27	3.38	0.000793	Diabetic kidney disease	
THCA	cis	1	rs160648	chr7:65543384	RABGEF1	chr7:66093890-66276446:+	0.49	6.06	2.71E-9	Diabetic kidney disease	
THCA	cis	1	rs160652	chr7:65538431	CCT6P1	chr7:65216092-65228661:+	0.41	6.52	1.79E-10	Diabetic kidney disease	
THCA	cis	1	rs160652	chr7:65538431	CRCP	chr7:65579805-65619551:+	-0.3	-4.62	4.85E-6	Diabetic kidney disease	
THCA	cis	1	rs160652	chr7:65538431	RABGEF1	chr7:66093890-66276446:+	0.51	6.35	4.95E-10	Diabetic kidney disease	
THCA	cis	1	rs160655	chr7:65533214	CCT6P1	chr7:65216092-65228661:+	0.39	6.29	7.3E-10	Diabetic kidney disease	
THCA	cis	1	rs160655	chr7:65533214	CRCP	chr7:65579805-65619551:+	-0.3	-4.64	4.58E-6	Diabetic kidney disease	
THCA	cis	1	rs160655	chr7:65533214	GUSB	chr7:65425675-65447246:-	0.27	3.4	0.000726	Diabetic kidney disease	
THCA	cis	1	rs160655	chr7:65533214	RABGEF1	chr7:66093890-66276446:+	0.49	6.04	3.11E-9	Diabetic kidney disease	
THCA	cis	1	rs1606803	chr2:88933316	RPIA	chr2:88991176-89050451:+	0.35	6.63	8.86E-11	Height	
THCA	cis	1	rs1607908	chr3:41905196	ULK4	chr3:41288091-42003660:-	1.09	20.84	4.35E-69	Diastolic blood pressure	
THCA	cis	1	rs1609810	chr9:123642351	LOC253039	chr9:123605320-123616644:+	-0.5	-9.13	1.94E-18	Rheumatoid arthritis	
THCA	cis	1	rs1609810	chr9:123642351	PSMD5	chr9:123578334-123605206:-	-0.27	-5.21	2.84E-7	Rheumatoid arthritis	
THCA	cis	1	rs1609985	chr12:131320170	RAN	chr12:131356617-131360824:+	-0.14	-3.74	0.00021	Plasma plasminogen activator levels	
THCA	cis	1	rs1612124	chr3:41967893	ULK4	chr3:41288091-42003660:-	-1.05	-19.74	7.1E-64	Diastolic blood pressure	
THCA	cis	1	rs1612735	chr4:100258007	ADH1C	chr4:100257651-100273917:-	-0.18	-3.4	0.000742	Oral cavity and pharyngeal cancer	
THCA	cis	1	rs1613759	chr3:41906183	ULK4	chr3:41288091-42003660:-	1.09	20.84	4.35E-69	Diastolic blood pressure	
THCA	cis	1	rs1614223	chr12:120964043	COQ5	chr12:120941083-120966964:-	0.14	3.54	0.000444	Type 1 diabetes nephropathy	
THCA	cis	1	rs1614223	chr12:120964043	POP5	chr12:121016849-121019201:-	-0.16	-4.97	9.55E-7	Type 1 diabetes nephropathy	
THCA	cis	1	rs1614223	chr12:120964043	RNF10	chr12:120972132-121015396:+	0.21	3.51	0.000499	Type 1 diabetes nephropathy	
THCA	cis	1	rs1615243	chr3:41965234	ULK4	chr3:41288091-42003660:-	-1.1	-21.05	4.17E-70	Diastolic blood pressure	
THCA	cis	1	rs1615543	chr3:41906404	ULK4	chr3:41288091-42003660:-	1.09	20.84	4.35E-69	Diastolic blood pressure	
THCA	cis	1	rs1618893	chr7:66096119	CCT6P1	chr7:65216092-65228661:+	0.36	5.96	4.95E-9	Diabetic kidney disease	
THCA	cis	1	rs1618893	chr7:66096119	CRCP	chr7:65579805-65619551:+	-0.26	-4.31	2.02E-5	Diabetic kidney disease	
THCA	cis	1	rs1618893	chr7:66096119	LOC493754	chr7:65993446-66057363:-	0.3	3.72	0.000225	Diabetic kidney disease	
THCA	cis	1	rs1618893	chr7:66096119	RABGEF1	chr7:66093890-66276446:+	0.49	6.49	2.17E-10	Diabetic kidney disease	
THCA	cis	1	rs1625980	chr4:16152859	FLJ39653	chr4:16228286-16259810:+	-0.28	-3.89	0.000116	Kidney disease (early stage) in type 1 diabetes	
THCA	cis	1	rs1626853	chr7:23235342	NUPL2	chr7:23221446-23240629:+	-0.39	-5.44	8.44E-8	Chronic obstructive pulmonary disease	
THCA	cis	1	rs1628874	chr3:41955714	ULK4	chr3:41288091-42003660:-	-1.09	-20.75	1.16E-68	Diastolic blood pressure	
THCA	cis	1	rs1629270	chr4:100271306	ADH1C	chr4:100257651-100273917:-	-0.18	-3.36	0.00085	Oral cavity and pharyngeal cancer	
THCA	cis	1	rs1629460	chr3:41927449	ULK4	chr3:41288091-42003660:-	-1.09	-20.92	1.8E-69	Diastolic blood pressure	
THCA	cis	1	rs1631460	chr4:100264620	ADH1C	chr4:100257651-100273917:-	-0.18	-3.43	0.000663	Oral cavity and pharyngeal cancer	
THCA	cis	1	rs1633360	chr12:58108052	B4GALNT1	chr12:58019551-58026985:-	-0.16	-4.04	6.35E-5	Rheumatoid arthritis	
THCA	cis	1	rs1633360	chr12:58108052	FAM119B	chr12:58166383-58176323:+	-0.27	-8.06	5.99E-15	Rheumatoid arthritis	
THCA	cis	1	rs1633360	chr12:58108052	OS9	chr12:58087886-58115338:+	0.12	3.58	0.000378	Rheumatoid arthritis	
THCA	cis	1	rs1633360	chr12:58108052	TSFM	chr12:58176536-58191367:+	0.35	11.38	1.07E-26	Rheumatoid arthritis	
THCA	cis	1	rs1634409	chr17:18836177	FAM18B	chr17:18684582-18710026:+	-0.44	-10.89	8.14E-25	Educational attainment (years of education)	
THCA	cis	1	rs1634409	chr17:18836177	FBXW10	chr17:18647326-18682661:+	-0.23	-4.96	9.73E-7	Educational attainment (years of education)	
THCA	cis	1	rs1634411	chr17:18833810	FAM18B	chr17:18684582-18710026:+	-0.43	-10.89	8.2E-25	Educational attainment (years of education)	
THCA	cis	1	rs1634411	chr17:18833810	FBXW10	chr17:18647326-18682661:+	-0.24	-5.19	3.08E-7	Educational attainment (years of education)	
THCA	cis	1	rs1635393	chr16:3520493	CEMP1	chr16:2580036-2581419:-	-0.17	-3.71	0.000231	Tuberculosis	
THCA	cis	1	rs1635393	chr16:3520493	NAT15	chr16:3493668-3536962:+	-0.23	-4.14	4.03E-5	Tuberculosis	
THCA	cis	1	rs1635393	chr16:3520493	TRAP1	chr16:3708039-3767598:-	0.15	3.82	0.000148	Tuberculosis	
THCA	cis	1	rs1636744	chr7:16984280	AGR2	chr7:16832266-16844738:-	-0.23	-4.82	1.91E-6	Cutaneous malignant melanoma	
THCA	cis	1	rs1637214	chr7:23236842	NUPL2	chr7:23221446-23240629:+	-0.45	-6.22	1.06E-9	Chronic obstructive pulmonary disease	
THCA	cis	1	rs1637216	chr7:23236129	NUPL2	chr7:23221446-23240629:+	-0.39	-5.44	8.44E-8	Chronic obstructive pulmonary disease	
THCA	cis	1	rs1637220	chr7:23232851	NUPL2	chr7:23221446-23240629:+	-0.39	-5.44	8.44E-8	Chronic obstructive pulmonary disease	
THCA	cis	1	rs1637223	chr7:23228669	NUPL2	chr7:23221446-23240629:+	-0.39	-5.44	8.44E-8	Chronic obstructive pulmonary disease	
THCA	cis	1	rs1637224	chr7:23228400	NUPL2	chr7:23221446-23240629:+	-0.45	-6.22	1.06E-9	Chronic obstructive pulmonary disease	
THCA	cis	1	rs1638676	chr3:47327651	C3orf75	chr3:47537131-47555199:-	-0.09	-4.11	4.75E-5	Colorectal cancer	
THCA	cis	1	rs1638676	chr3:47327651	NBEAL2	chr3:47021173-47051193:+	-0.11	-3.38	0.000778	Colorectal cancer	
THCA	cis	1	rs1638676	chr3:47327651	PRSS45	chr3:46783582-46790130:-	-0.17	-3.88	0.00012	Colorectal cancer	
THCA	cis	1	rs1638731	chr7:66144679	CCT6P1	chr7:65216092-65228661:+	0.44	6.76	4.09E-11	Gout	
THCA	cis	1	rs1638731	chr7:66144679	CRCP	chr7:65579805-65619551:+	-0.3	-4.53	7.43E-6	Gout	
THCA	cis	1	rs1638731	chr7:66144679	GUSB	chr7:65425675-65447246:-	0.29	3.5	0.000507	Gout	
THCA	cis	1	rs1638731	chr7:66144679	RABGEF1	chr7:66093890-66276446:+	0.63	7.73	6.6E-14	Gout	
THCA	cis	1	rs1638734	chr7:66097539	CCT6P1	chr7:65216092-65228661:+	0.43	6.75	4.22E-11	Diabetic kidney disease	
THCA	cis	1	rs1638734	chr7:66097539	CRCP	chr7:65579805-65619551:+	-0.3	-4.58	6.02E-6	Diabetic kidney disease	
THCA	cis	1	rs1638734	chr7:66097539	GUSB	chr7:65425675-65447246:-	0.28	3.42	0.00068	Diabetic kidney disease	
THCA	cis	1	rs1638734	chr7:66097539	RABGEF1	chr7:66093890-66276446:+	0.63	7.75	5.5E-14	Diabetic kidney disease	
THCA	cis	1	rs164106	chr17:74290566	FAM100B	chr17:74261286-74267379:+	-0.21	-6.18	1.4E-9	White matter hyperintensities in ischemic stroke	
THCA	cis	1	rs1648348	chr15:50474766	SLC27A2	chr15:50474393-50528588:+	-0.19	-3.44	0.000643	Blood metabolite ratios	
THCA	cis	1	rs1652333	chr1:207470460	CD55	chr1:207494817-207534309:+	-0.17	-7.33	9.8E-13	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs1655841	chr15:65721043	DPP8	chr15:65737999-65810035:-	-0.1	-4.05	5.94E-5	Mean corpuscular hemoglobin	
THCA	cis	1	rs1655841	chr15:65721043	SLC24A1	chr15:65903704-65953256:+	-0.15	-3.57	0.000387	Mean corpuscular hemoglobin	
THCA	cis	1	rs1655843	chr15:65721261	DPP8	chr15:65737999-65810035:-	-0.1	-4.08	5.37E-5	Mean corpuscular hemoglobin	
THCA	cis	1	rs1655843	chr15:65721261	SLC24A1	chr15:65903704-65953256:+	-0.15	-3.57	0.00039	Mean corpuscular hemoglobin	
THCA	cis	1	rs1659685	chr2:27420690	C2orf28	chr2:27434899-27440044:+	-0.17	-5.13	4.26E-7	Blood metabolite levels	
THCA	cis	1	rs1659685	chr2:27420690	SLC5A6	chr2:27422459-27435071:-	0.31	6.65	7.97E-11	Blood metabolite levels	
THCA	cis	1	rs1659695	chr2:27406944	C2orf28	chr2:27434899-27440044:+	-0.17	-4.98	8.76E-7	Blood metabolite levels	
THCA	cis	1	rs1659695	chr2:27406944	SLC5A6	chr2:27422459-27435071:-	0.3	6.39	4.0E-10	Blood metabolite levels	
THCA	cis	1	rs1662051	chr4:100267239	ADH1C	chr4:100257651-100273917:-	-0.18	-3.36	0.00085	Oral cavity and pharyngeal cancer	
THCA	cis	1	rs1662058	chr4:100262759	ADH1C	chr4:100257651-100273917:-	-0.18	-3.39	0.000747	Oral cavity and pharyngeal cancer	
THCA	cis	1	rs1665982	chr3:47905079	CDC25A	chr3:48198668-48229801:-	-0.35	-7.05	6.24E-12	Educational attainment (years of education)	
THCA	cis	1	rs1665982	chr3:47905079	NME6	chr3:48335591-48342886:-	0.3	5.68	2.32E-8	Educational attainment (years of education)	
THCA	cis	1	rs1665982	chr3:47905079	ZNF589	chr3:48282596-48329113:+	-0.41	-8.42	4.57E-16	Educational attainment (years of education)	
THCA	cis	1	rs166663	chr7:23316742	KLHL7	chr7:23145353-23215036:+	0.27	5.95	5.2E-9	Parkinson's disease	
THCA	cis	1	rs1667583	chr12:122370206	WDR66	chr12:122356480-122441830:+	-0.23	-3.55	0.000421	Urinary metabolites	
THCA	cis	1	rs1668618	chr13:78386137	EDNRB	chr13:78469616-78549664:-	0.14	4.06	5.67E-5	Hair color	
THCA	cis	1	rs1668619	chr13:78385750	EDNRB	chr13:78469616-78549664:-	0.14	4.07	5.6E-5	Hair color	
THCA	cis	1	rs1668621	chr13:78384443	EDNRB	chr13:78469616-78549664:-	0.15	4.38	1.46E-5	Hair color	
THCA	cis	1	rs166870	chr15:80069762	MTHFS	chr15:80137320-80189370:-	0.24	6.78	3.54E-11	Disease-free survival in breast cancer	
THCA	cis	1	rs166925	chr19:41926098	B3GNT8	chr19:41931265-41934635:-	-0.36	-8.25	1.51E-15	Height	
THCA	cis	1	rs166925	chr19:41926098	EXOSC5	chr19:41892278-41903256:-	-0.11	-3.45	0.000608	Height	
THCA	cis	1	rs1669338	chr3:3199635	TRNT1	chr3:3168600-3192528:+	0.25	4.06	5.72E-5	White matter integrity	
THCA	cis	1	rs167282	chr2:117174	SH3YL1	chr2:218138-264810:-	-0.26	-4.31	2.01E-5	Suicide attempts in bipolar disorder	
THCA	cis	1	rs1678033	chr14:102435852	RAGE	chr14:102690838-102771531:-	-0.15	-4.76	2.53E-6	Menopause (age at onset)	
THCA	cis	1	rs1678542	chr12:57968715	FAM119B	chr12:58166383-58176323:+	-0.18	-4.78	2.29E-6	Rheumatoid arthritis	
THCA	cis	1	rs1678542	chr12:57968715	TSFM	chr12:58176536-58191367:+	0.25	6.76	3.93E-11	Rheumatoid arthritis	
THCA	cis	1	rs1678969	chr12:122371474	WDR66	chr12:122356480-122441830:+	-0.22	-3.5	0.000511	Urinary metabolites	
THCA	cis	1	rs1679381	chr12:75946124	GLIPR1L2	chr12:75784889-75825591:+	-0.4	-6.39	4.06E-10	Polycystic ovary syndrome	
THCA	cis	1	rs1679709	chr6:28228342	ZKSCAN3	chr6:28317691-28334523:+	0.27	5.25	2.35E-7	Depression	
THCA	cis	1	rs1679709	chr6:28228342	ZNF187	chr6:28234788-28245978:+	0.34	6.81	3.0E-11	Depression	
THCA	cis	1	rs1679709	chr6:28228342	ZNF193	chr6:28193067-28201260:+	-0.2	-3.76	0.000193	Depression	
THCA	cis	1	rs1679709	chr6:28228342	ZNF323	chr6:28292517-28324048:-	-0.45	-6.09	2.31E-9	Depression	
THCA	cis	1	rs1679709	chr6:28228342	ZNF389	chr6:28129551-28137375:+	0.48	6.8	3.1E-11	Depression	
THCA	cis	1	rs1679709	chr6:28228342	ZSCAN23	chr6:28393287-28411279:-	-0.23	-5.04	6.61E-7	Depression	
THCA	cis	1	rs1679732	chr6:28221264	ZKSCAN3	chr6:28317691-28334523:+	0.26	5.06	6.03E-7	Depression	
THCA	cis	1	rs1679732	chr6:28221264	ZNF187	chr6:28234788-28245978:+	0.34	6.8	3.08E-11	Depression	
THCA	cis	1	rs1679732	chr6:28221264	ZNF193	chr6:28193067-28201260:+	-0.2	-3.74	0.000209	Depression	
THCA	cis	1	rs1679732	chr6:28221264	ZNF323	chr6:28292517-28324048:-	-0.45	-6.05	2.88E-9	Depression	
THCA	cis	1	rs1679732	chr6:28221264	ZNF389	chr6:28129551-28137375:+	0.49	6.89	1.79E-11	Depression	
THCA	cis	1	rs1679732	chr6:28221264	ZSCAN23	chr6:28393287-28411279:-	-0.24	-5.08	5.53E-7	Depression	
THCA	cis	1	rs16826864	chr3:156580033	LEKR1	chr3:156544076-156763918:+	-0.54	-10.49	2.67E-23	Bone mineral density	
THCA	cis	1	rs16829980	chr3:119278468	ADPRH	chr3:119298523-119308791:+	-0.22	-3.6	0.000356	Vitiligo	
THCA	cis	1	rs16829988	chr3:119280390	ADPRH	chr3:119298523-119308791:+	-0.22	-3.6	0.000347	Vitiligo	
THCA	cis	1	rs16830092	chr1:200823498	DDX59	chr1:200610119-200639126:-	-0.23	-3.6	0.000349	Epilepsy	
THCA	cis	1	rs16830122	chr1:154685541	EFNA1	chr1:155100349-155107384:+	-0.22	-3.44	0.000634	Alzheimer's disease in APOE e4- carriers	
THCA	cis	1	rs16830122	chr1:154685541	EFNA3	chr1:155036213-155060006:+	-0.21	-3.46	0.000595	Alzheimer's disease in APOE e4- carriers	
THCA	cis	1	rs16830122	chr1:154685541	FLAD1	chr1:154955817-154965587:+	-0.19	-3.52	0.000481	Alzheimer's disease in APOE e4- carriers	
THCA	cis	1	rs16830920	chr2:135465466	TMEM163	chr2:135213331-135525334:-	-0.15	-3.35	0.000882	Gut microbiome composition (winter)	
THCA	cis	1	rs16832155	chr2:190749841	ASNSD1	chr2:190526125-190535556:+	-0.58	-6.04	3.17E-9	Subcutaneous adipose tissue	
THCA	cis	1	rs16832158	chr2:190758688	ASNSD1	chr2:190526125-190535556:+	-0.53	-5.54	5.01E-8	Subcutaneous adipose tissue	
THCA	cis	1	rs16832834	chr2:191554447	ORMDL1	chr2:190634994-190649097:-	-0.14	-3.38	0.000784	Primary biliary cirrhosis	
THCA	cis	1	rs16834280	chr1:31717050	ZCCHC17	chr1:31769842-31837780:+	-0.3	-5.61	3.52E-8	Schizophrenia	
THCA	cis	1	rs16834408	chr1:31837942	ZCCHC17	chr1:31769842-31837780:+	-0.3	-5.61	3.38E-8	Schizophrenia	
THCA	cis	1	rs16835604	chr2:137332789	THSD7B	chr2:137523115-138435287:+	-0.23	-4.78	2.37E-6	Cognitive test performance	
THCA	cis	1	rs16837131	chr2:202173812	CFLAR	chr2:201980816-202029001:+	0.25	3.98	7.94E-5	Rheumatoid arthritis	
THCA	cis	1	rs16837131	chr2:202173812	PPIL3	chr2:201735680-201753999:-	0.73	9.05	3.68E-18	Rheumatoid arthritis	
THCA	cis	1	rs1683811	chr3:128612113	ACAD9	chr3:128598333-128634910:+	-0.17	-3.39	0.000762	IgG glycosylation	
THCA	cis	1	rs16839793	chr3:132622657	NCRNA00119	chr3:132441186-132593050:+	-0.28	-4.3	2.07E-5	Number of pregnancies	
THCA	cis	1	rs16839793	chr3:132622657	NPHP3	chr3:132363641-132441276:-	-0.11	-3.59	0.000359	Number of pregnancies	
THCA	cis	1	rs16843590	chr2:242298228	ANO7	chr2:242127924-242164791:+	0.37	4.19	3.3E-5	Prostate cancer	
THCA	cis	1	rs16843590	chr2:242298228	SEPT2	chr2:242254723-242293439:+	-0.28	-4	7.35E-5	Prostate cancer	
THCA	cis	1	rs16844002	chr3:128053487	EEFSEC	chr3:127872313-128127488:+	-0.21	-3.71	0.000235	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs16844715	chr2:160915106	LY75	chr2:160625141-160761262:-	-0.22	-5.2	2.95E-7	Idiopathic membranous nephropathy	
THCA	cis	1	rs16847180	chr1:200731556	DDX59	chr1:200610119-200639126:-	-0.24	-3.72	0.000225	Epilepsy	
THCA	cis	1	rs16847183	chr1:200731955	DDX59	chr1:200610119-200639126:-	-0.24	-3.78	0.000178	Epilepsy	
THCA	cis	1	rs16847193	chr1:200739337	DDX59	chr1:200610119-200639126:-	-0.23	-3.6	0.000346	Epilepsy	
THCA	cis	1	rs16847251	chr1:200800081	DDX59	chr1:200610119-200639126:-	0.26	3.99	7.66E-5	Epilepsy	
THCA	cis	1	rs16847267	chr1:200820897	DDX59	chr1:200610119-200639126:-	-0.25	-3.89	0.000114	Epilepsy	
THCA	cis	1	rs16847284	chr1:200827638	DDX59	chr1:200610119-200639126:-	-0.24	-3.73	0.000213	Epilepsy	
THCA	cis	1	rs1684942	chr3:47900703	CDC25A	chr3:48198668-48229801:-	0.28	5.92	6.32E-9	Educational attainment (years of education)	
THCA	cis	1	rs1684942	chr3:47900703	NME6	chr3:48335591-48342886:-	-0.28	-5.74	1.7E-8	Educational attainment (years of education)	
THCA	cis	1	rs1684942	chr3:47900703	ZNF589	chr3:48282596-48329113:+	0.33	7.16	3.0E-12	Educational attainment (years of education)	
THCA	cis	1	rs16851720	chr3:141463298	RNF7	chr3:141457051-141465242:+	0.17	4.63	4.67E-6	Hepatitis C induced liver fibrosis	
THCA	cis	1	rs16852912	chr3:168686676	MECOM	chr3:168801287-169381563:-	-0.47	-5.29	1.82E-7	Aging (time to event)	
THCA	cis	1	rs16854186	chr1:179473704	C1orf125	chr1:179335107-179523868:+	0.55	5.69	2.16E-8	Multiple sclerosis (age of onset)	
THCA	cis	1	rs16860537	chr1:183180260	RNASEL	chr1:182542772-182558391:-	-0.32	-3.38	0.000779	Systemic lupus erythematosus and Systemic sclerosis	
THCA	cis	1	rs16860717	chr1:183240695	RNASEL	chr1:182542772-182558391:-	-0.34	-3.54	0.000435	Systemic lupus erythematosus and Systemic sclerosis	
THCA	cis	1	rs16862452	chr1:19332774	TMCO4	chr1:20008707-20126758:-	-0.17	-3.84	0.000139	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
THCA	cis	1	rs168662	chr5:36925735	C5orf42	chr5:37106330-37249530:-	-0.08	-3.35	0.000884	Height	
THCA	cis	1	rs16868145	chr6:70461662	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.42	0.000691	Sleep duration	
THCA	cis	1	rs16876529	chr6:86591202	SNHG5	chr6:86386726-86388451:-	-0.54	-12.7	4.73E-32	Response to antipsychotic treatment	
THCA	cis	1	rs16879557	chr8:32415818	FUT10	chr8:33228346-33330664:-	-0.36	-3.81	0.000159	Hirschsprung disease	
THCA	cis	1	rs16881745	chr8:89376806	MMP16	chr8:89049462-89339717:-	-0.3	-4.69	3.56E-6	Electrodermal activity	
THCA	cis	1	rs16882035	chr8:89404717	MMP16	chr8:89049462-89339717:-	0.31	5.04	6.5E-7	Electrodermal activity	
THCA	cis	1	rs16882273	chr8:89424350	MMP16	chr8:89049462-89339717:-	0.32	5.13	4.29E-7	Electrodermal activity	
THCA	cis	1	rs16882408	chr8:89432995	MMP16	chr8:89049462-89339717:-	0.32	5.19	3.04E-7	Electrodermal activity	
THCA	cis	1	rs16882464	chr8:89435664	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs16882621	chr8:89439610	MMP16	chr8:89049462-89339717:-	0.3	4.93	1.16E-6	Electrodermal activity	
THCA	cis	1	rs16882622	chr8:89439642	MMP16	chr8:89049462-89339717:-	0.3	5	7.87E-7	Electrodermal activity	
THCA	cis	1	rs16882905	chr8:89453959	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs16882914	chr8:89454231	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs16882925	chr8:89455407	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs16882945	chr8:89456145	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs16882947	chr8:89456247	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs16882948	chr8:89456851	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs16882949	chr8:89457287	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs16882951	chr8:89457398	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs16882953	chr8:89457480	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs16882960	chr8:89457884	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs16882980	chr8:89458652	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs16883006	chr8:89460425	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs16883010	chr8:89460453	MMP16	chr8:89049462-89339717:-	-0.32	-5.21	2.84E-7	Electrodermal activity	
THCA	cis	1	rs16884476	chr8:89584486	MMP16	chr8:89049462-89339717:-	0.16	3.69	0.000254	Body mass index and cholesterol (psychopharmacological treatment)	
THCA	cis	1	rs16887244	chr8:38031345	BAG4	chr8:38034106-38068537:+	-0.11	-3.44	0.000624	Schizophrenia	
THCA	cis	1	rs16887244	chr8:38031345	DDHD2	chr8:38089009-38120286:+	0.16	3.52	0.000465	Schizophrenia	
THCA	cis	1	rs16887244	chr8:38031345	LSM1	chr8:38020861-38034169:-	-0.15	-3.79	0.000172	Schizophrenia	
THCA	cis	1	rs16889317	chr6:159414843	RSPH3	chr6:159398268-159421198:-	0.28	5.96	4.98E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs16889320	chr6:159414899	RSPH3	chr6:159398268-159421198:-	0.28	5.96	4.98E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs16889325	chr6:159417132	RSPH3	chr6:159398268-159421198:-	0.28	5.96	4.98E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs16891378	chr6:26188864	HIST1H2AE	chr6:26217148-26217711:+	-0.24	-3.76	0.00019	Renal underexcretion gout;Gout	
THCA	cis	1	rs16891378	chr6:26188864	HIST1H3E	chr6:26224427-26226589:+	0.42	6.93	1.4E-11	Renal underexcretion gout;Gout	
THCA	cis	1	rs16891397	chr6:26200256	HIST1H2AE	chr6:26217148-26217711:+	-0.23	-3.64	0.000301	Renal underexcretion gout;Gout	
THCA	cis	1	rs16891397	chr6:26200256	HIST1H3E	chr6:26224427-26226589:+	0.43	7.08	5.04E-12	Renal underexcretion gout;Gout	
THCA	cis	1	rs16891401	chr6:26202337	HIST1H2AE	chr6:26217148-26217711:+	-0.23	-3.65	0.000294	Renal underexcretion gout;Gout	
THCA	cis	1	rs16891401	chr6:26202337	HIST1H3E	chr6:26224427-26226589:+	0.44	7.13	3.71E-12	Renal underexcretion gout;Gout	
THCA	cis	1	rs16891405	chr6:26204506	HIST1H2AE	chr6:26217148-26217711:+	-0.24	-3.72	0.000223	Renal underexcretion gout;Gout	
THCA	cis	1	rs16891405	chr6:26204506	HIST1H3E	chr6:26224427-26226589:+	0.45	7.32	1.08E-12	Renal underexcretion gout;Gout	
THCA	cis	1	rs16894446	chr5:65137461	TRIM23	chr5:64885509-64920187:-	-0.32	-3.81	0.000156	Trans fatty acid levels	
THCA	cis	1	rs16894959	chr6:34825662	C6orf106	chr6:34555066-34664625:-	0.21	3.37	0.000825	Pubertal anthropometrics	
THCA	cis	1	rs16895812	chr6:42495278	PRPH2	chr6:42664334-42690358:-	-0.26	-3.49	0.000524	Obesity-related traits	
THCA	cis	1	rs16895815	chr6:42495928	PRPH2	chr6:42664334-42690358:-	-0.26	-3.51	0.000494	Obesity-related traits	
THCA	cis	1	rs16895817	chr6:42495964	PRPH2	chr6:42664334-42690358:-	-0.27	-3.67	0.000271	Obesity-related traits	
THCA	cis	1	rs16895822	chr6:42500252	PRPH2	chr6:42664334-42690358:-	-0.29	-3.85	0.000135	Obesity-related traits	
THCA	cis	1	rs16896068	chr4:17944840	DCAF16	chr4:17802280-17812381:-	-0.2	-4.46	1.0E-5	Height	
THCA	cis	1	rs16896074	chr4:17947873	DCAF16	chr4:17802280-17812381:-	-0.19	-4.37	1.54E-5	Height	
THCA	cis	1	rs16896101	chr4:17950626	DCAF16	chr4:17802280-17812381:-	-0.2	-4.36	1.59E-5	Height	
THCA	cis	1	rs16896128	chr4:17953590	DCAF16	chr4:17802280-17812381:-	-0.2	-4.45	1.07E-5	Height	
THCA	cis	1	rs16896164	chr4:17967094	DCAF16	chr4:17802280-17812381:-	-0.2	-4.41	1.26E-5	Height	
THCA	cis	1	rs16896182	chr4:17973899	DCAF16	chr4:17802280-17812381:-	-0.2	-4.45	1.06E-5	Height	
THCA	cis	1	rs16896210	chr4:17992332	DCAF16	chr4:17802280-17812381:-	-0.2	-4.47	9.88E-6	Height	
THCA	cis	1	rs16896213	chr4:17994661	DCAF16	chr4:17802280-17812381:-	-0.2	-4.46	1.02E-5	Height	
THCA	cis	1	rs16896215	chr4:17995312	DCAF16	chr4:17802280-17812381:-	-0.2	-4.46	1.03E-5	Height	
THCA	cis	1	rs16896229	chr4:18002583	DCAF16	chr4:17802280-17812381:-	-0.17	-3.55	0.000424	Height	
THCA	cis	1	rs16896236	chr4:18003812	DCAF16	chr4:17802280-17812381:-	-0.2	-4.49	8.95E-6	Height	
THCA	cis	1	rs16896245	chr4:18005608	DCAF16	chr4:17802280-17812381:-	-0.2	-4.49	8.81E-6	Height	
THCA	cis	1	rs16896271	chr4:18012454	DCAF16	chr4:17802280-17812381:-	-0.2	-4.47	9.63E-6	Height	
THCA	cis	1	rs16896312	chr4:18030853	DCAF16	chr4:17802280-17812381:-	-0.2	-4.54	7.09E-6	Height	
THCA	cis	1	rs16898084	chr8:124190377	FAM83A	chr8:124191287-124222317:+	-0.3	-3.9	0.000108	Urinary uromodulin levels	
THCA	cis	1	rs16898086	chr8:124190445	FAM83A	chr8:124191287-124222317:+	-0.3	-3.9	0.000108	Urinary uromodulin levels	
THCA	cis	1	rs16898088	chr8:124190501	FAM83A	chr8:124191287-124222317:+	-0.3	-3.9	0.000108	Urinary uromodulin levels	
THCA	cis	1	rs16898095	chr8:124193523	FAM83A	chr8:124191287-124222317:+	-0.29	-3.98	7.99E-5	Urinary uromodulin levels	
THCA	cis	1	rs16898097	chr8:124195034	FAM83A	chr8:124191287-124222317:+	-0.3	-3.94	9.35E-5	Urinary uromodulin levels	
THCA	cis	1	rs16900476	chr6:158285635	SNX9	chr6:158244294-158366109:+	-0.25	-3.89	0.000114	Lipoprotein (a) - cholesterol levels	
THCA	cis	1	rs1690441	chr16:3517635	CEMP1	chr16:2580036-2581419:-	-0.16	-3.46	0.000596	Tuberculosis	
THCA	cis	1	rs1690441	chr16:3517635	NAT15	chr16:3493668-3536962:+	-0.22	-3.93	9.69E-5	Tuberculosis	
THCA	cis	1	rs1690441	chr16:3517635	TRAP1	chr16:3708039-3767598:-	0.16	4.21	3.01E-5	Tuberculosis	
THCA	cis	1	rs1690443	chr16:3517787	CEMP1	chr16:2580036-2581419:-	-0.17	-3.7	0.000242	Tuberculosis	
THCA	cis	1	rs1690443	chr16:3517787	NAT15	chr16:3493668-3536962:+	-0.23	-4.14	4.09E-5	Tuberculosis	
THCA	cis	1	rs1690443	chr16:3517787	TRAP1	chr16:3708039-3767598:-	0.15	3.89	0.000114	Tuberculosis	
THCA	cis	1	rs1690444	chr16:3518350	CEMP1	chr16:2580036-2581419:-	-0.17	-3.59	0.000363	Tuberculosis	
THCA	cis	1	rs1690444	chr16:3518350	HCFC1R1	chr16:3072626-3074287:-	0.14	3.43	0.000647	Tuberculosis	
THCA	cis	1	rs1690444	chr16:3518350	NAT15	chr16:3493668-3536962:+	-0.21	-3.73	0.000216	Tuberculosis	
THCA	cis	1	rs1690444	chr16:3518350	TRAP1	chr16:3708039-3767598:-	0.16	4.22	2.94E-5	Tuberculosis	
THCA	cis	1	rs16910180	chr11:22821843	SVIP	chr11:22843600-22851382:-	0.21	3.66	0.000282	Dialysis-related mortality	
THCA	cis	1	rs16914811	chr9:101076627	TBC1D2	chr9:100961281-101018003:-	0.2	5.17	3.46E-7	Schizophrenia	
THCA	cis	1	rs16915502	chr8:94081574	C8orf83	chr8:93895865-94029901:-	0.27	4.33	1.78E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs16915508	chr8:94081683	C8orf83	chr8:93895865-94029901:-	0.27	4.33	1.83E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs16915515	chr8:94082827	C8orf83	chr8:93895865-94029901:-	-0.28	-4.5	8.69E-6	Attention deficit hyperactivity disorder	
THCA	cis	1	rs16915517	chr8:94083119	C8orf83	chr8:93895865-94029901:-	0.27	4.29	2.21E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs16915526	chr8:94084429	C8orf83	chr8:93895865-94029901:-	0.27	4.25	2.56E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs16915550	chr8:94087031	C8orf83	chr8:93895865-94029901:-	0.27	4.25	2.56E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs16915560	chr8:94088851	C8orf83	chr8:93895865-94029901:-	0.27	3.55	0.000418	Attention deficit hyperactivity disorder	
THCA	cis	1	rs16915568	chr8:94089342	C8orf83	chr8:93895865-94029901:-	0.26	4.02	6.79E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs16916041	chr10:63146547	C10orf107	chr10:63422719-63526089:+	-0.39	-5.84	9.84E-9	Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	
THCA	cis	1	rs16917224	chr8:96030110	C8orf38	chr8:95908040-96088396:+	-0.25	-4.27	2.34E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs16917233	chr8:96044967	C8orf38	chr8:95908040-96088396:+	0.26	4.46	1.03E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs16918567	chr10:65294670	LOC84989	chr10:65224989-65226320:+	0.25	4.02	6.84E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs16918567	chr10:65294670	NRBF2	chr10:64893007-64914785:+	0.25	4.12	4.46E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs16918573	chr10:65300805	LOC84989	chr10:65224989-65226320:+	0.25	4.02	6.84E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs16918573	chr10:65300805	NRBF2	chr10:64893007-64914785:+	0.25	4.12	4.46E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs16918575	chr10:65301325	LOC84989	chr10:65224989-65226320:+	-0.25	-3.95	8.97E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs16918575	chr10:65301325	NRBF2	chr10:64893007-64914785:+	-0.25	-4.15	3.89E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs16918599	chr10:65320079	LOC84989	chr10:65224989-65226320:+	0.25	3.84	0.000142	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs16918599	chr10:65320079	NRBF2	chr10:64893007-64914785:+	0.23	3.62	0.000322	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs16925145	chr10:25198782	PRTFDC1	chr10:25137554-25241533:-	0.25	3.43	0.000644	Metabolite levels (Pyroglutamine)	
THCA	cis	1	rs1693426	chr4:100266330	ADH1C	chr4:100257651-100273917:-	-0.18	-3.37	0.000808	Oral cavity and pharyngeal cancer	
THCA	cis	1	rs1693430	chr4:100267668	ADH1C	chr4:100257651-100273917:-	-0.18	-3.36	0.00085	Oral cavity and pharyngeal cancer	
THCA	cis	1	rs1693471	chr4:100261952	ADH1C	chr4:100257651-100273917:-	-0.18	-3.39	0.000747	Oral cavity and pharyngeal cancer	
THCA	cis	1	rs1693477	chr4:100263062	ADH1C	chr4:100257651-100273917:-	-0.18	-3.39	0.000747	Oral cavity and pharyngeal cancer	
THCA	cis	1	rs16935424	chr11:18456737	LDHC	chr11:18433853-18472792:+	-0.3	-3.51	0.000484	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs16935432	chr11:18470487	LDHC	chr11:18433853-18472792:+	-0.33	-3.94	9.26E-5	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs16938506	chr11:46454313	PACSIN3	chr11:47199085-47207958:-	0.16	3.71	0.000231	Schizophrenia	
THCA	cis	1	rs16944254	chr15:90898527	IQGAP1	chr15:90931473-91045475:+	0.12	4.13	4.24E-5	Rheumatoid arthritis	
THCA	cis	1	rs16944254	chr15:90898527	TTLL13	chr15:90792764-90815443:+	0.19	3.4	0.000727	Rheumatoid arthritis	
THCA	cis	1	rs16947005	chr17:61702989	FTSJ3	chr17:61896795-61905031:-	-0.29	-5.7	2.06E-8	Body mass index	
THCA	cis	1	rs16947005	chr17:61702989	MAP3K3	chr17:61699775-61773669:+	-0.26	-5.53	5.26E-8	Body mass index	
THCA	cis	1	rs16947014	chr17:61719032	FTSJ3	chr17:61896795-61905031:-	0.31	6	3.88E-9	Body mass index	
THCA	cis	1	rs16947014	chr17:61719032	MAP3K3	chr17:61699775-61773669:+	0.26	5.48	6.75E-8	Body mass index	
THCA	cis	1	rs16947042	chr17:61766457	FTSJ3	chr17:61896795-61905031:-	0.31	5.82	1.06E-8	Body mass index	
THCA	cis	1	rs16947042	chr17:61766457	MAP3K3	chr17:61699775-61773669:+	0.25	5.16	3.68E-7	Body mass index	
THCA	cis	1	rs16948048	chr17:47440466	GNGT2	chr17:47283597-47286743:-	-0.16	-4.61	5.29E-6	Diastolic blood pressure	
THCA	cis	1	rs16948098	chr15:44219607	ADAL	chr15:43622872-43646094:+	-0.47	-6.88	1.89E-11	Serum albumin level	
THCA	cis	1	rs16948098	chr15:44219607	STRC	chr15:43891762-43924561:-	0.4	5.07	5.69E-7	Serum albumin level	
THCA	cis	1	rs16949788	chr15:66590037	TIPIN	chr15:66629008-66649054:-	-0.36	-3.55	0.000418	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs16949793	chr15:66593948	TIPIN	chr15:66629008-66649054:-	0.43	4.37	1.51E-5	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs16949849	chr15:66682709	TIPIN	chr15:66629008-66649054:-	-0.42	-4.34	1.71E-5	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs16950982	chr16:79702371	MAF	chr16:79627746-79634622:-	-0.21	-3.58	0.000384	Urate levels	
THCA	cis	1	rs16952009	chr17:2102437	SRR	chr17:2207248-2228553:+	-0.77	-16.15	3.77E-47	Esophageal cancer (squamous cell)	
THCA	cis	1	rs16952848	chr18:44597829	HDHD2	chr18:44633782-44676871:-	0.34	5.84	9.64E-9	Sitting height ratio	
THCA	cis	1	rs16954604	chr17:5294450	C1QBP	chr17:5336099-5342471:-	0.14	4.12	4.51E-5	Body mass index	
THCA	cis	1	rs16954604	chr17:5294450	NLRP1	chr17:5404719-5487832:-	-0.22	-4.42	1.24E-5	Body mass index	
THCA	cis	1	rs16954604	chr17:5294450	RABEP1	chr17:5185558-5289131:+	-0.13	-3.71	0.000227	Body mass index	
THCA	cis	1	rs16955471	chr17:53058807	STXBP4	chr17:53046126-53241449:+	-0.15	-4.2	3.2E-5	Breast cancer	
THCA	cis	1	rs16955471	chr17:53058807	TOM1L1	chr17:52978052-53039328:+	-0.13	-3.35	0.000871	Breast cancer	
THCA	cis	1	rs16956707	chr15:31641633	FAM7A2	chr15:30864758-30892900:+	-0.45	-4.06	5.85E-5	Survival in colorectal cancer (non-distant metastatic)	
THCA	cis	1	rs16956838	chr15:31819695	FAM7A2	chr15:30864758-30892900:+	-0.44	-4.28	2.22E-5	Survival in colorectal cancer (non-distant metastatic)	
THCA	cis	1	rs16956838	chr15:31819695	OTUD7A	chr15:31775330-32162992:-	-0.36	-3.67	0.000267	Survival in colorectal cancer (non-distant metastatic)	
THCA	cis	1	rs16957091	chr15:43017426	GANC	chr15:42565856-42645863:+	0.17	3.55	0.000428	MGMT methylation in smokers	
THCA	cis	1	rs16957480	chr16:82499064	CDH13	chr16:82660578-83830197:+	-0.23	-4.26	2.43E-5	D-dimer levels;White matter microstructure (global fractional anisotropy)	
THCA	cis	1	rs16957524	chr16:67798005	ZDHHC1	chr16:67428323-67450339:-	0.3	3.83	0.000147	Crohn's disease	
THCA	cis	1	rs16957529	chr16:82525388	CDH13	chr16:82660578-83830197:+	-0.21	-3.38	0.000788	D-dimer levels;White matter microstructure (global fractional anisotropy)	
THCA	cis	1	rs16957590	chr16:67934725	C16orf86	chr16:67700717-67702659:+	0.28	3.41	0.000712	Crohn's disease	
THCA	cis	1	rs16957590	chr16:67934725	LRRC36	chr16:67360747-67419108:+	-0.37	-3.45	0.00062	Crohn's disease	
THCA	cis	1	rs16957590	chr16:67934725	ZDHHC1	chr16:67428323-67450339:-	-0.41	-4.68	3.66E-6	Crohn's disease	
THCA	cis	1	rs16958432	chr18:44631773	HDHD2	chr18:44633782-44676871:-	0.28	5.21	2.84E-7	Sitting height ratio	
THCA	cis	1	rs16958432	chr18:44631773	PIAS2	chr18:44392061-44500123:-	-0.16	-3.35	0.000869	Sitting height ratio	
THCA	cis	1	rs16958440	chr18:44632884	HDHD2	chr18:44633782-44676871:-	0.28	5.21	2.84E-7	Sitting height ratio	
THCA	cis	1	rs16958440	chr18:44632884	PIAS2	chr18:44392061-44500123:-	-0.16	-3.35	0.000869	Sitting height ratio	
THCA	cis	1	rs16958701	chr18:44655241	HDHD2	chr18:44633782-44676871:-	0.26	4.87	1.54E-6	Sitting height ratio	
THCA	cis	1	rs16958701	chr18:44655241	PIAS2	chr18:44392061-44500123:-	-0.15	-3.44	0.000623	Sitting height ratio	
THCA	cis	1	rs16959799	chr16:58229628	C16orf80	chr16:58147497-58163296:-	0.26	3.35	0.000886	Telomere length	
THCA	cis	1	rs16959811	chr16:58241399	C16orf80	chr16:58147497-58163296:-	-0.28	-3.34	0.00089	Telomere length	
THCA	cis	1	rs16966947	chr16:15141045	NTAN1	chr16:15131717-15149833:-	0.13	3.73	0.000214	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs16966947	chr16:15141045	PDXDC1	chr16:15068599-15233195:+	0.31	7.01	8.07E-12	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs16966952	chr16:15135943	NTAN1	chr16:15131717-15149833:-	0.12	3.66	0.000282	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs16966952	chr16:15135943	PDXDC1	chr16:15068599-15233195:+	0.32	7.58	1.85E-13	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs16966953	chr16:15135854	NTAN1	chr16:15131717-15149833:-	0.13	3.96	8.63E-5	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs16966953	chr16:15135854	PDXDC1	chr16:15068599-15233195:+	0.33	7.72	6.89E-14	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs16967057	chr19:32914078	DPY19L3	chr19:32896677-32975236:+	-0.19	-5.28	1.93E-7	Bipolar disorder	
THCA	cis	1	rs16967057	chr19:32914078	ZNF507	chr19:32836514-32878571:+	-0.29	-7.23	1.9E-12	Bipolar disorder	
THCA	cis	1	rs16967141	chr19:32971223	DPY19L3	chr19:32896677-32975236:+	0.2	5.2	2.93E-7	Bipolar disorder	
THCA	cis	1	rs16967141	chr19:32971223	ZNF507	chr19:32836514-32878571:+	0.3	7.45	4.5E-13	Bipolar disorder	
THCA	cis	1	rs16970802	chr17:76086524	TMC6	chr17:76108999-76128488:-	0.21	3.93	9.92E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs16970811	chr17:76091180	TMC6	chr17:76108999-76128488:-	0.19	3.7	0.00024	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs16972767	chr19:39153044	LGALS7	chr19:39261608-39264157:-	-0.21	-4.21	3.01E-5	Heart rate	
THCA	cis	1	rs16975963	chr19:38325536	WDR87	chr19:38375472-38397317:-	-0.37	-6.27	8.3E-10	Longevity	
THCA	cis	1	rs16976792	chr15:56477485	MNS1	chr15:56720929-56757335:-	-0.25	-3.65	0.000289	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs16976792	chr15:56477485	TEX9	chr15:56657644-56738071:+	-0.35	-6.06	2.69E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs16976801	chr15:56487811	MNS1	chr15:56720929-56757335:-	-0.24	-3.57	0.000398	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs16976801	chr15:56487811	TEX9	chr15:56657644-56738071:+	-0.35	-6.04	3.07E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs16976821	chr15:56495555	TEX9	chr15:56657644-56738071:+	-0.34	-5.88	7.84E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs16976831	chr15:56522460	MNS1	chr15:56720929-56757335:-	-0.24	-3.51	0.000485	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs16976831	chr15:56522460	TEX9	chr15:56657644-56738071:+	-0.34	-5.81	1.12E-8	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs16976832	chr15:56526217	MNS1	chr15:56720929-56757335:-	-0.24	-3.51	0.000485	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs16976832	chr15:56526217	TEX9	chr15:56657644-56738071:+	-0.34	-5.81	1.12E-8	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs1697845	chr5:75922504	F2RL2	chr5:75911308-75919240:-	-0.26	-5.97	4.51E-9	Hearing impairment	
THCA	cis	1	rs1697978	chr5:642829	CEP72	chr5:612405-653664:+	-0.38	-7.41	5.93E-13	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs16979973	chr20:55056589	C20orf43	chr20:55043647-55093942:+	0.28	7.51	2.83E-13	Refractive astigmatism	
THCA	cis	1	rs16979973	chr20:55056589	CSTF1	chr20:54967427-54979582:+	0.17	3.53	0.000459	Refractive astigmatism	
THCA	cis	1	rs1698402	chr10:59936444	CISD1	chr10:60028895-60049018:+	-0.13	-3.41	0.000702	Inflammatory bowel disease	
THCA	cis	1	rs16985328	chr20:42857276	C20orf111	chr20:42825137-42839431:-	-0.24	-3.46	0.000598	Cognitive performance	
THCA	cis	1	rs16987832	chr22:29978749	NIPSNAP1	chr22:29950800-29977144:-	0.26	3.82	0.000153	Lipid traits	
THCA	cis	1	rs1699379	chr4:129992337	C4orf33	chr4:130014829-130033842:+	-0.6	-9.44	1.71E-19	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs1699389	chr4:130004079	C4orf33	chr4:130014829-130033842:+	-0.59	-9.39	2.44E-19	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs1699391	chr4:130005096	C4orf33	chr4:130014829-130033842:+	-0.59	-9.39	2.44E-19	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs1699392	chr4:130022347	C4orf33	chr4:130014829-130033842:+	-0.6	-9.78	1.07E-20	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs1699393	chr4:130019352	C4orf33	chr4:130014829-130033842:+	-0.6	-9.56	6.25E-20	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs1699394	chr4:130019312	C4orf33	chr4:130014829-130033842:+	-0.6	-9.7	2.04E-20	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs1700490	chr5:176402401	ZNF346	chr5:176449697-176508190:+	-0.16	-5.72	1.87E-8	Menopause (age at onset);Menarche and menopause (age at onset)	
THCA	cis	1	rs17007930	chr12:81445762	ACSS3	chr12:81471809-81649582:+	0.22	4.66	4.19E-6	Neuroticism	
THCA	cis	1	rs17009617	chr10:50453933	AGAP8	chr10:51224690-51371331:-	0.3	3.96	8.78E-5	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	
THCA	cis	1	rs17014208	chr1:108338498	VAV3	chr1:108113782-108507545:-	0.56	7.27	1.52E-12	Hypothyroidism	
THCA	cis	1	rs17016071	chr4:90644281	MMRN1	chr4:90816003-90875778:+	0.32	4.06	5.69E-5	Parkinson's disease	
THCA	cis	1	rs1701750	chr7:65467145	CCT6P1	chr7:65216092-65228661:+	0.39	6.11	2.1E-9	Diabetic kidney disease	
THCA	cis	1	rs1701750	chr7:65467145	CRCP	chr7:65579805-65619551:+	-0.26	-3.98	7.81E-5	Diabetic kidney disease	
THCA	cis	1	rs1701750	chr7:65467145	RABGEF1	chr7:66093890-66276446:+	0.55	6.84	2.4E-11	Diabetic kidney disease	
THCA	cis	1	rs1701758	chr7:65470201	CCT6P1	chr7:65216092-65228661:+	0.39	6.11	2.1E-9	Diabetic kidney disease	
THCA	cis	1	rs1701758	chr7:65470201	CRCP	chr7:65579805-65619551:+	-0.26	-3.98	7.81E-5	Diabetic kidney disease	
THCA	cis	1	rs1701758	chr7:65470201	RABGEF1	chr7:66093890-66276446:+	0.55	6.84	2.4E-11	Diabetic kidney disease	
THCA	cis	1	rs17018185	chr1:107579295	NTNG1	chr1:107682629-108024471:+	0.21	3.68	0.00026	AIDS	
THCA	cis	1	rs17020010	chr1:108321402	VAV3	chr1:108113782-108507545:-	0.49	6.75	4.26E-11	Hypothyroidism	
THCA	cis	1	rs17020011	chr1:108321541	VAV3	chr1:108113782-108507545:-	0.49	6.75	4.26E-11	Hypothyroidism	
THCA	cis	1	rs17020047	chr1:108332070	VAV3	chr1:108113782-108507545:-	0.5	6.87	1.97E-11	Hypothyroidism	
THCA	cis	1	rs17020122	chr1:108357391	VAV3	chr1:108113782-108507545:-	0.56	8.05	6.61E-15	Hypothyroidism	
THCA	cis	1	rs17020123	chr1:108357573	VAV3	chr1:108113782-108507545:-	0.56	8.05	6.61E-15	Hypothyroidism	
THCA	cis	1	rs17020124	chr1:108358011	VAV3	chr1:108113782-108507545:-	0.56	8.05	6.61E-15	Hypothyroidism	
THCA	cis	1	rs17020127	chr1:108358083	VAV3	chr1:108113782-108507545:-	0.56	8.02	7.99E-15	Hypothyroidism	
THCA	cis	1	rs17020139	chr1:108369483	VAV3	chr1:108113782-108507545:-	0.57	8.11	4.42E-15	Hypothyroidism	
THCA	cis	1	rs17020141	chr1:108369872	VAV3	chr1:108113782-108507545:-	-0.52	-7.63	1.29E-13	Hypothyroidism	
THCA	cis	1	rs17020146	chr1:108374702	VAV3	chr1:108113782-108507545:-	0.57	8.11	4.4E-15	Hypothyroidism	
THCA	cis	1	rs17020148	chr1:108375010	VAV3	chr1:108113782-108507545:-	0.57	8.13	3.63E-15	Hypothyroidism	
THCA	cis	1	rs17020149	chr1:108375289	VAV3	chr1:108113782-108507545:-	0.56	8.1	4.56E-15	Hypothyroidism	
THCA	cis	1	rs170213	chr17:3660864	GSG2	chr17:3627197-3629990:+	0.12	3.52	0.000472	Attention deficit hyperactivity disorder	
THCA	cis	1	rs170213	chr17:3660864	MED11	chr17:4634723-4636894:+	0.14	4.28	2.22E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs17026854	chr2:86280496	POLR1A	chr2:86253453-86333278:-	-0.33	-4.37	1.51E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs17027011	chr2:86406556	LOC90784	chr2:86247339-86250991:-	-0.38	-4.55	6.7E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs17027011	chr2:86406556	POLR1A	chr2:86253453-86333278:-	-0.21	-3.38	0.000797	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs1702831	chr18:72897368	ZADH2	chr18:72909279-72921281:-	0.3	4.88	1.46E-6	Vascular endothelial growth factor levels	
THCA	cis	1	rs17030434	chr4:154703596	RNF175	chr4:154631313-154681387:-	-0.19	-4.04	6.14E-5	Electrocardiographic conduction measures	
THCA	cis	1	rs17030613	chr1:113190807	MOV10	chr1:113217048-113243367:+	0.18	4.24	2.74E-5	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs17030613	chr1:113190807	ST7L	chr1:113066142-113162405:-	0.68	10.75	2.8E-24	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs17030651	chr1:113239382	MOV10	chr1:113217048-113243367:+	0.19	4.39	1.37E-5	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs17030651	chr1:113239382	ST7L	chr1:113066142-113162405:-	0.66	10.52	2.07E-23	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs17032268	chr3:10067972	C3orf10	chr3:10157333-10168873:+	-0.21	-4.35	1.7E-5	Alzheimer's disease	
THCA	cis	1	rs17032268	chr3:10067972	VHL	chr3:10183319-10193744:+	-0.19	-4.31	2.0E-5	Alzheimer's disease	
THCA	cis	1	rs17032276	chr3:10076975	C3orf10	chr3:10157333-10168873:+	-0.2	-4.3	2.08E-5	Alzheimer's disease	
THCA	cis	1	rs17032276	chr3:10076975	VHL	chr3:10183319-10193744:+	-0.19	-4.42	1.24E-5	Alzheimer's disease	
THCA	cis	1	rs17032277	chr3:10077023	C3orf10	chr3:10157333-10168873:+	-0.2	-4.3	2.08E-5	Alzheimer's disease	
THCA	cis	1	rs17032277	chr3:10077023	VHL	chr3:10183319-10193744:+	-0.19	-4.42	1.24E-5	Alzheimer's disease	
THCA	cis	1	rs17032278	chr3:10077955	C3orf10	chr3:10157333-10168873:+	-0.2	-4.3	2.08E-5	Alzheimer's disease	
THCA	cis	1	rs17032278	chr3:10077955	VHL	chr3:10183319-10193744:+	-0.19	-4.42	1.24E-5	Alzheimer's disease	
THCA	cis	1	rs17032283	chr3:10081545	C3orf10	chr3:10157333-10168873:+	-0.21	-4.47	9.7E-6	Alzheimer's disease	
THCA	cis	1	rs17032283	chr3:10081545	VHL	chr3:10183319-10193744:+	-0.19	-4.34	1.71E-5	Alzheimer's disease	
THCA	cis	1	rs17032295	chr3:10086680	C3orf10	chr3:10157333-10168873:+	-0.19	-4.12	4.4E-5	Alzheimer's disease	
THCA	cis	1	rs17032295	chr3:10086680	VHL	chr3:10183319-10193744:+	-0.19	-4.49	8.97E-6	Alzheimer's disease	
THCA	cis	1	rs17032299	chr3:10087638	C3orf10	chr3:10157333-10168873:+	-0.23	-4.89	1.37E-6	Alzheimer's disease	
THCA	cis	1	rs17032299	chr3:10087638	VHL	chr3:10183319-10193744:+	-0.21	-4.81	1.98E-6	Alzheimer's disease	
THCA	cis	1	rs17032396	chr3:10153559	C3orf10	chr3:10157333-10168873:+	0.21	4.45	1.07E-5	Alzheimer's disease	
THCA	cis	1	rs17032396	chr3:10153559	VHL	chr3:10183319-10193744:+	0.19	4.51	8.07E-6	Alzheimer's disease	
THCA	cis	1	rs17032414	chr3:10158302	C3orf10	chr3:10157333-10168873:+	-0.2	-4.27	2.39E-5	Alzheimer's disease	
THCA	cis	1	rs17032414	chr3:10158302	VHL	chr3:10183319-10193744:+	-0.16	-3.71	0.000231	Alzheimer's disease	
THCA	cis	1	rs17032850	chr4:103507703	NFKB1	chr4:103422486-103538458:+	0.16	4.56	6.41E-6	Ulcerative colitis	
THCA	cis	1	rs17033511	chr2:45576600	SRBD1	chr2:45615820-45838433:-	-0.3	-3.62	0.000331	Glaucoma	
THCA	cis	1	rs17035960	chr4:106531846	INTS12	chr4:106603787-106629881:-	-0.6	-4.87	1.5E-6	Post bronchodilator FEV1	
THCA	cis	1	rs17036105	chr4:106603272	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs17036120	chr4:106621508	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs17036123	chr4:106622190	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs17036125	chr4:106623674	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs17036129	chr4:106624529	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs17036139	chr4:106632657	INTS12	chr4:106603787-106629881:-	-0.6	-5.15	3.91E-7	Post bronchodilator FEV1	
THCA	cis	1	rs17036177	chr4:106672511	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs17036189	chr4:106687959	INTS12	chr4:106603787-106629881:-	-0.62	-5.3	1.78E-7	Post bronchodilator FEV1	
THCA	cis	1	rs17036225	chr4:106710092	INTS12	chr4:106603787-106629881:-	-0.62	-5.36	1.28E-7	Post bronchodilator FEV1	
THCA	cis	1	rs17036230	chr4:106715148	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs17036258	chr4:106737382	INTS12	chr4:106603787-106629881:-	-0.61	-5.18	3.25E-7	Post bronchodilator FEV1	
THCA	cis	1	rs17036308	chr4:106749593	INTS12	chr4:106603787-106629881:-	-0.61	-5.18	3.25E-7	Post bronchodilator FEV1	
THCA	cis	1	rs17036310	chr4:106752340	INTS12	chr4:106603787-106629881:-	-0.61	-5.18	3.25E-7	Post bronchodilator FEV1	
THCA	cis	1	rs17040322	chr2:26351274	GPR113	chr2:26531041-26569685:-	-0.42	-6.63	8.91E-11	Gut microbiome composition (summer)	
THCA	cis	1	rs17045711	chr2:54476678	C2orf73	chr2:54558071-54588714:+	0.31	4.54	7.1E-6	Telomere length	
THCA	cis	1	rs17052727	chr3:53070914	RFT1	chr3:53122503-53164470:-	0.56	7.07	5.55E-12	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs17058743	chr3:58009372	PDHB	chr3:58413355-58419565:-	0.15	3.37	0.000818	Optic cup area	
THCA	cis	1	rs17061431	chr3:41792655	ULK4	chr3:41288091-42003660:-	1.06	19.44	1.77E-62	Diastolic blood pressure	
THCA	cis	1	rs17062109	chr3:41810364	ULK4	chr3:41288091-42003660:-	1.07	19.66	1.63E-63	Diastolic blood pressure	
THCA	cis	1	rs17063584	chr3:41861463	ULK4	chr3:41288091-42003660:-	1.04	19.87	1.7E-64	Diastolic blood pressure	
THCA	cis	1	rs17063599	chr3:41861676	ULK4	chr3:41288091-42003660:-	1.04	19.87	1.7E-64	Diastolic blood pressure	
THCA	cis	1	rs17063649	chr3:41863406	ULK4	chr3:41288091-42003660:-	1.03	19.63	2.34E-63	Diastolic blood pressure	
THCA	cis	1	rs17064124	chr3:41890803	ULK4	chr3:41288091-42003660:-	1.09	20.95	1.23E-69	Diastolic blood pressure	
THCA	cis	1	rs17070580	chr6:109738714	AKD1	chr6:109814059-110012415:-	0.34	7.48	3.65E-13	Height	
THCA	cis	1	rs17070580	chr6:109738714	FIG4	chr6:110012424-110146634:+	0.2	4.08	5.17E-5	Height	
THCA	cis	1	rs17070580	chr6:109738714	SMPD2	chr6:109761931-109765121:+	-0.34	-8.67	6.91E-17	Height	
THCA	cis	1	rs17072683	chr6:111731210	KIAA1919	chr6:111580482-111590259:+	0.48	5.69	2.21E-8	Psoriasis	
THCA	cis	1	rs1707304	chr1:46598269	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.11	6.68E-22	Body mass index	
THCA	cis	1	rs1707304	chr1:46598269	GPBP1L1	chr1:46092978-46152302:-	0.13	3.4	0.000743	Body mass index	
THCA	cis	1	rs1707304	chr1:46598269	MMACHC	chr1:45965856-45976737:+	-0.2	-4.37	1.55E-5	Body mass index	
THCA	cis	1	rs1707304	chr1:46598269	MUTYH	chr1:45794915-45806142:-	0.28	7.36	7.86E-13	Body mass index	
THCA	cis	1	rs1707321	chr1:46505309	AKR1A1	chr1:46016498-46035720:+	-0.11	-3.36	0.000841	Body mass index	
THCA	cis	1	rs1707321	chr1:46505309	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.14	5.32E-22	Body mass index	
THCA	cis	1	rs1707321	chr1:46505309	GPBP1L1	chr1:46092978-46152302:-	0.14	3.5	0.0005	Body mass index	
THCA	cis	1	rs1707321	chr1:46505309	MMACHC	chr1:45965856-45976737:+	-0.22	-4.83	1.85E-6	Body mass index	
THCA	cis	1	rs1707321	chr1:46505309	MUTYH	chr1:45794915-45806142:-	0.3	7.89	2.11E-14	Body mass index	
THCA	cis	1	rs1707335	chr1:46571921	CCDC163P	chr1:45960581-45965646:-	-0.51	-9.9	3.88E-21	Body mass index	
THCA	cis	1	rs1707335	chr1:46571921	GPBP1L1	chr1:46092978-46152302:-	0.15	3.73	0.000214	Body mass index	
THCA	cis	1	rs1707335	chr1:46571921	MMACHC	chr1:45965856-45976737:+	-0.21	-4.53	7.42E-6	Body mass index	
THCA	cis	1	rs1707335	chr1:46571921	MUTYH	chr1:45794915-45806142:-	0.29	7.65	1.12E-13	Body mass index	
THCA	cis	1	rs1707336	chr1:46493460	CCDC163P	chr1:45960581-45965646:-	-0.53	-10.33	1.07E-22	Body mass index	
THCA	cis	1	rs1707336	chr1:46493460	GPBP1L1	chr1:46092978-46152302:-	0.15	3.91	0.000107	Body mass index	
THCA	cis	1	rs1707336	chr1:46493460	MMACHC	chr1:45965856-45976737:+	-0.22	-4.68	3.74E-6	Body mass index	
THCA	cis	1	rs1707336	chr1:46493460	MUTYH	chr1:45794915-45806142:-	0.31	8.12	3.91E-15	Body mass index	
THCA	cis	1	rs1707340	chr1:46514942	AKR1A1	chr1:46016498-46035720:+	-0.11	-3.36	0.000833	Body mass index	
THCA	cis	1	rs1707340	chr1:46514942	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.25	1.98E-22	Body mass index	
THCA	cis	1	rs1707340	chr1:46514942	GPBP1L1	chr1:46092978-46152302:-	0.13	3.46	0.000593	Body mass index	
THCA	cis	1	rs1707340	chr1:46514942	MMACHC	chr1:45965856-45976737:+	-0.22	-4.74	2.81E-6	Body mass index	
THCA	cis	1	rs1707340	chr1:46514942	MUTYH	chr1:45794915-45806142:-	0.3	7.88	2.19E-14	Body mass index	
THCA	cis	1	rs17079247	chr13:85665879	SLITRK6	chr13:86366922-86373483:-	-0.23	-4.3	2.07E-5	Bipolar disorder (mania)	
THCA	cis	1	rs17079304	chr13:85687549	SLITRK6	chr13:86366922-86373483:-	-0.21	-3.79	0.000171	Bipolar disorder (mania)	
THCA	cis	1	rs17079346	chr13:85713772	SLITRK6	chr13:86366922-86373483:-	-0.21	-3.75	0.000196	Bipolar disorder (mania)	
THCA	cis	1	rs17079521	chr6:150576650	RAET1K	chr6:150319157-150326280:-	0.48	3.57	0.000387	Pulmonary function;Pulmonary function (interaction)	
THCA	cis	1	rs17082782	chr4:54306440	SCFD2	chr4:53739152-54232242:-	0.2	3.92	0.000101	DNA methylation (variation)	
THCA	cis	1	rs17085665	chr5:95723381	RIOK2	chr5:96496572-96519005:-	0.16	3.5	0.000517	Body mass index	
THCA	cis	1	rs17085889	chr4:56402115	TMEM165	chr4:56262090-56292342:+	0.16	4.11	4.69E-5	Personality dimensions	
THCA	cis	1	rs17090837	chr6:111751853	KIAA1919	chr6:111580482-111590259:+	0.48	5.69	2.21E-8	Psoriasis	
THCA	cis	1	rs17092215	chr20:33595913	PROCR	chr20:33758727-33765164:+	-0.32	-5.37	1.21E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs17092215	chr20:33595913	TRPC4AP	chr20:33590215-33680618:-	0.28	3.55	0.000429	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs17092297	chr20:33703134	PROCR	chr20:33758727-33765164:+	0.34	6.07	2.58E-9	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs17092297	chr20:33703134	TRPC4AP	chr20:33590215-33680618:-	-0.29	-4.03	6.4E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs17093141	chr14:74326903	LIN52	chr14:74551656-74667117:+	0.25	4.66	4.11E-6	Morning vs. evening chronotype	
THCA	cis	1	rs17093141	chr14:74326903	PTGR2	chr14:74318534-74352166:+	0.22	3.51	0.000492	Morning vs. evening chronotype	
THCA	cis	1	rs17093141	chr14:74326903	ZNF410	chr14:74318674-74398803:+	0.24	4.01	6.94E-5	Morning vs. evening chronotype	
THCA	cis	1	rs17093474	chr14:74342413	LIN52	chr14:74551656-74667117:+	0.25	4.75	2.65E-6	Morning vs. evening chronotype	
THCA	cis	1	rs17093474	chr14:74342413	PTGR2	chr14:74318534-74352166:+	0.24	3.88	0.00012	Morning vs. evening chronotype	
THCA	cis	1	rs17093474	chr14:74342413	ZNF410	chr14:74318674-74398803:+	0.22	3.77	0.000182	Morning vs. evening chronotype	
THCA	cis	1	rs17094021	chr14:74394295	LIN52	chr14:74551656-74667117:+	0.24	4.45	1.09E-5	Morning vs. evening chronotype	
THCA	cis	1	rs17094021	chr14:74394295	PTGR2	chr14:74318534-74352166:+	0.22	3.45	0.000608	Morning vs. evening chronotype	
THCA	cis	1	rs17094021	chr14:74394295	ZNF410	chr14:74318674-74398803:+	0.22	3.64	0.000302	Morning vs. evening chronotype	
THCA	cis	1	rs17096228	chr14:74558669	C14orf45	chr14:74486059-74549566:+	0.16	4.63	4.78E-6	Common traits (Other)	
THCA	cis	1	rs17096228	chr14:74558669	COQ6	chr14:74416643-74429811:+	0.14	3.97	8.15E-5	Common traits (Other)	
THCA	cis	1	rs17096228	chr14:74558669	LIN52	chr14:74551656-74667117:+	0.5	13.48	2.58E-35	Common traits (Other)	
THCA	cis	1	rs17097836	chr1:76462006	ACADM	chr1:76190043-76229353:+	-0.22	-4.68	3.72E-6	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs17097836	chr1:76462006	ST6GALNAC3	chr1:76540389-77096669:+	-0.27	-3.73	0.000216	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs17097841	chr1:76462641	ACADM	chr1:76190043-76229353:+	-0.22	-4.68	3.72E-6	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs17097841	chr1:76462641	ST6GALNAC3	chr1:76540389-77096669:+	-0.27	-3.73	0.000216	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs17097863	chr1:76468787	ACADM	chr1:76190043-76229353:+	-0.2	-4.29	2.2E-5	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs17097863	chr1:76468787	ST6GALNAC3	chr1:76540389-77096669:+	-0.27	-3.86	0.00013	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs17102423	chr14:65604728	FNTB	chr14:65381140-65529369:+	-0.23	-4.73	2.97E-6	Obesity-related traits	
THCA	cis	1	rs171069	chr4:121801365	C4orf31	chr4:121956782-121993673:-	-0.21	-3.87	0.000123	Fasting plasma glucose	
THCA	cis	1	rs17109512	chr10:100127551	PYROXD2	chr10:100143323-100174978:-	0.48	4.74	2.86E-6	Aspartate aminotransferase	
THCA	cis	1	rs17111376	chr5:150226899	LOC134466	chr5:150310000-150326146:-	0.39	5.45	8.07E-8	Crohn's disease	
THCA	cis	1	rs17112431	chr14:20957490	PNP	chr14:20937542-20945246:+	0.33	5.37	1.23E-7	Response to antipsychotic therapy (extrapyramidal side effects)	
THCA	cis	1	rs17112431	chr14:20957490	RNASE10	chr14:20973696-20979314:+	0.43	5.98	4.42E-9	Response to antipsychotic therapy (extrapyramidal side effects)	
THCA	cis	1	rs17112431	chr14:20957490	RNASE11	chr14:21051054-21058417:-	0.27	4.18	3.53E-5	Response to antipsychotic therapy (extrapyramidal side effects)	
THCA	cis	1	rs17113137	chr10:102241998	SEC31B	chr10:102246403-102289636:-	-0.3	-9.91	3.39E-21	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs17113138	chr5:151731277	NMUR2	chr5:151771102-151784840:-	-0.51	-9.36	3.04E-19	Optic nerve measurement (cup area)	
THCA	cis	1	rs17113145	chr5:151733056	NMUR2	chr5:151771102-151784840:-	-0.51	-9.44	1.62E-19	Optic nerve measurement (cup area)	
THCA	cis	1	rs17115100	chr10:104591393	AS3MT	chr10:104613967-104661653:+	-0.28	-3.88	0.000121	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs17115100	chr10:104591393	C10orf26	chr10:104503727-104591851:+	-0.28	-5.01	7.55E-7	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs17115100	chr10:104591393	SFXN2	chr10:104474298-104498946:+	-0.38	-4.58	5.87E-6	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs17115100	chr10:104591393	SUFU	chr10:104263764-104393209:+	0.19	3.41	0.000696	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs17115231	chr12:75933675	GLIPR1L2	chr12:75784889-75825591:+	-0.39	-6.37	4.35E-10	Polycystic ovary syndrome	
THCA	cis	1	rs17117088	chr10:90961799	CH25H	chr10:90965696-90967071:-	0.48	8.11	4.38E-15	Heart failure	
THCA	cis	1	rs17117124	chr10:90963997	CH25H	chr10:90965696-90967071:-	0.47	7.94	1.48E-14	Heart failure	
THCA	cis	1	rs17117126	chr10:90964026	CH25H	chr10:90965696-90967071:-	0.48	8.12	4.13E-15	Heart failure	
THCA	cis	1	rs17120099	chr11:116735460	PCSK7	chr11:117075789-117102811:-	0.45	5.2	2.97E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs17120119	chr11:116747282	PCSK7	chr11:117075789-117102811:-	0.4	4.88	1.44E-6	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs17120131	chr11:116772486	PCSK7	chr11:117075789-117102811:-	0.43	5.23	2.51E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs17120132	chr11:116773318	PCSK7	chr11:117075789-117102811:-	0.43	5.27	2.03E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs17120136	chr11:116773761	PCSK7	chr11:117075789-117102811:-	0.43	5.27	2.03E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs17120157	chr11:116812628	PCSK7	chr11:117075789-117102811:-	-0.29	-3.69	0.000249	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs17120157	chr11:116812628	SIK3	chr11:116714120-116968993:-	0.23	3.54	0.000445	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs17120177	chr11:116827369	APOA4	chr11:116691418-116694011:-	0.24	3.38	0.000793	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs17120177	chr11:116827369	PCSK7	chr11:117075789-117102811:-	0.46	5.27	2.07E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs17121651	chr14:50097172	MGAT2	chr14:50087489-50090198:+	0.22	4.4	1.33E-5	Carotid intima media thickness	
THCA	cis	1	rs17121651	chr14:50097172	RPL36AL	chr14:50085407-50087349:-	0.54	15.56	1.75E-44	Carotid intima media thickness	
THCA	cis	1	rs17122021	chr11:118145686	AMICA1	chr11:118064442-118095809:-	0.08	3.9	0.000109	Pain	
THCA	cis	1	rs17122021	chr11:118145686	MPZL2	chr11:118124135-118135009:-	0.23	7.84	2.89E-14	Pain	
THCA	cis	1	rs17124700	chr14:88905629	SPATA7	chr14:88852012-88904802:+	-0.2	-4.12	4.53E-5	Coronary artery calcification	
THCA	cis	1	rs17125088	chr12:51326702	SLC11A2	chr12:51373319-51422058:-	0.22	4.4	1.32E-5	Type 2 diabetes	
THCA	cis	1	rs17125088	chr12:51326702	TFCP2	chr12:51488608-51566917:-	0.17	3.73	0.000211	Type 2 diabetes	
THCA	cis	1	rs17126877	chr10:111672786	DUSP5	chr10:112257625-112271300:+	-0.14	-3.68	0.000257	Biliary atresia	
THCA	cis	1	rs17127656	chr1:65943471	LEPR	chr1:65886318-66102820:+	-0.31	-4.47	9.69E-6	Obesity (early onset extreme)	
THCA	cis	1	rs17128050	chr14:55343879	GCH1	chr14:55308724-55369542:-	0.19	3.78	0.000176	Rheumatoid arthritis;Obesity-related traits	
THCA	cis	1	rs17132261	chr5:110008214	TMEM232	chr5:109624934-110062381:-	-0.47	-5.6	3.53E-8	Cardiac structure and function	
THCA	cis	1	rs17132442	chr5:110192122	TMEM232	chr5:109624934-110062381:-	-0.23	-4.54	6.98E-6	Asthma and hay fever	
THCA	cis	1	rs1713422	chr14:20940834	CHD8	chr14:21853358-21905404:-	-0.13	-3.85	0.000136	Interferon alpha levels in systemic lupus erythematosus	
THCA	cis	1	rs17138884	chr5:115425628	COMMD10	chr5:115420727-115628978:+	0.5	6.16	1.54E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs17138917	chr5:115469316	COMMD10	chr5:115420727-115628978:+	0.47	5.83	1.0E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs17139192	chr5:115561710	COMMD10	chr5:115420727-115628978:+	0.48	5.89	7.35E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs17139193	chr5:115562073	COMMD10	chr5:115420727-115628978:+	0.48	5.89	7.35E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs17139224	chr5:115568193	COMMD10	chr5:115420727-115628978:+	0.48	5.7	2.09E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs17139265	chr5:115578810	COMMD10	chr5:115420727-115628978:+	0.51	6.41	3.52E-10	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs17139314	chr5:115607127	COMMD10	chr5:115420727-115628978:+	0.48	5.7	2.09E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs17139457	chr5:115640603	COMMD10	chr5:115420727-115628978:+	-0.41	-5.08	5.37E-7	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs17140062	chr10:17202840	TRDMT1	chr10:17184983-17243681:-	-0.44	-9.92	3.21E-21	Homocysteine levels	
THCA	cis	1	rs17140062	chr10:17202840	VIM	chr10:17270258-17279592:+	-0.18	-3.37	0.000803	Homocysteine levels	
THCA	cis	1	rs17142067	chr6:6341287	F13A1	chr6:6144312-6320924:-	0.19	3.9	0.000111	End-stage coagulation	
THCA	cis	1	rs17145713	chr7:72904810	MLXIPL	chr7:73007524-73038870:-	0.21	3.83	0.000147	Triglycerides	
THCA	cis	1	rs17149161	chr7:75978229	STYXL1	chr7:75625656-75677321:-	-0.16	-3.98	8.12E-5	Multiple sclerosis	
THCA	cis	1	rs17149161	chr7:75978229	UPK3B	chr7:76139745-76157197:+	-0.27	-4.67	3.88E-6	Multiple sclerosis	
THCA	cis	1	rs17149810	chr7:87233989	DBF4	chr7:87505544-87538856:+	-0.24	-3.63	0.000309	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs17149824	chr7:87247779	DBF4	chr7:87505544-87538856:+	-0.24	-3.66	0.000283	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs17149864	chr7:87334384	DBF4	chr7:87505544-87538856:+	0.27	3.99	7.58E-5	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs17149894	chr7:12254939	VWDE	chr7:12370509-12443852:-	0.23	3.95	8.95E-5	Response to amphetamines	
THCA	cis	1	rs17150009	chr7:87517648	DBF4	chr7:87505544-87538856:+	-0.25	-3.86	0.000131	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs1715218	chr15:65721328	DPP8	chr15:65737999-65810035:-	-0.09	-3.94	9.21E-5	Mean corpuscular hemoglobin	
THCA	cis	1	rs1715218	chr15:65721328	SLC24A1	chr15:65903704-65953256:+	-0.15	-3.62	0.000324	Mean corpuscular hemoglobin	
THCA	cis	1	rs1715235	chr7:65488394	CCT6P1	chr7:65216092-65228661:+	0.41	6.48	2.28E-10	Diabetic kidney disease	
THCA	cis	1	rs1715235	chr7:65488394	CRCP	chr7:65579805-65619551:+	-0.29	-4.42	1.22E-5	Diabetic kidney disease	
THCA	cis	1	rs1715235	chr7:65488394	RABGEF1	chr7:66093890-66276446:+	0.53	6.66	7.52E-11	Diabetic kidney disease	
THCA	cis	1	rs17154671	chr5:125908203	ALDH7A1	chr5:125878918-125931082:-	0.44	6.7	5.89E-11	Osteoporosis	
THCA	cis	1	rs17154676	chr5:125912120	ALDH7A1	chr5:125878918-125931082:-	0.48	6.79	3.44E-11	Osteoporosis	
THCA	cis	1	rs17155886	chr10:1145182	IDI2	chr10:1064847-1071799:-	0.35	3.67	0.00027	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs17158807	chr15:84249460	ADAMTSL3	chr15:84322838-84708591:+	-0.5	-6.47	2.38E-10	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	
THCA	cis	1	rs17161966	chr11:71815308	FAM86C	chr11:71498557-71512276:+	-0.32	-3.91	0.000107	Severe influenza A (H1N1) infection	
THCA	cis	1	rs17161991	chr11:71839960	FAM86C	chr11:71498557-71512276:+	-0.29	-3.56	0.000408	Severe influenza A (H1N1) infection	
THCA	cis	1	rs17162311	chr1:27174966	PIGV	chr1:27114455-27124886:+	0.28	3.44	0.000624	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs17162311	chr1:27174966	ZDHHC18	chr1:27153201-27182207:+	-0.8	-8.89	1.24E-17	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs17162339	chr1:27252823	ZDHHC18	chr1:27153201-27182207:+	-0.67	-7.32	1.03E-12	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs17162387	chr1:27293356	ZDHHC18	chr1:27153201-27182207:+	0.61	6.7	5.74E-11	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs17164747	chr4:260587	ZNF718	chr4:53272-156488:+	0.49	9.17	1.37E-18	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs17164851	chr7:130003487	CPA5	chr7:129984630-130008571:+	0.45	7.14	3.41E-12	Age-related hearing impairment (interaction)	
THCA	cis	1	rs1716642	chr3:41965865	ULK4	chr3:41288091-42003660:-	-1.1	-21.05	4.17E-70	Diastolic blood pressure	
THCA	cis	1	rs1716644	chr3:41968028	ULK4	chr3:41288091-42003660:-	-1.05	-19.79	3.92E-64	Diastolic blood pressure	
THCA	cis	1	rs1716651	chr3:41975099	ULK4	chr3:41288091-42003660:-	-1.1	-21.05	4.17E-70	Diastolic blood pressure	
THCA	cis	1	rs1716657	chr3:41918456	ULK4	chr3:41288091-42003660:-	-1.08	-20.62	4.85E-68	Diastolic blood pressure	
THCA	cis	1	rs1716660	chr3:41929960	ULK4	chr3:41288091-42003660:-	-1.09	-20.92	1.8E-69	Diastolic blood pressure	
THCA	cis	1	rs1716661	chr3:41962818	ULK4	chr3:41288091-42003660:-	-1.09	-20.89	2.55E-69	Diastolic blood pressure	
THCA	cis	1	rs1716664	chr3:41948378	ULK4	chr3:41288091-42003660:-	-1.09	-20.92	1.8E-69	Diastolic blood pressure	
THCA	cis	1	rs1716668	chr3:41907850	ULK4	chr3:41288091-42003660:-	1.07	20.45	2.89E-67	Diastolic blood pressure	
THCA	cis	1	rs1716669	chr3:41908681	ULK4	chr3:41288091-42003660:-	1.07	20.45	2.89E-67	Diastolic blood pressure	
THCA	cis	1	rs1716676	chr3:41903208	ULK4	chr3:41288091-42003660:-	1.09	21.07	3.39E-70	Diastolic blood pressure	
THCA	cis	1	rs1716683	chr3:41923074	ULK4	chr3:41288091-42003660:-	-1.08	-20.85	3.78E-69	Diastolic blood pressure	
THCA	cis	1	rs1716685	chr3:41925301	ULK4	chr3:41288091-42003660:-	1.1	21.51	2.71E-72	Diastolic blood pressure	
THCA	cis	1	rs1716688	chr3:41926546	ULK4	chr3:41288091-42003660:-	-1.09	-20.92	1.8E-69	Diastolic blood pressure	
THCA	cis	1	rs1716690	chr3:41922102	ULK4	chr3:41288091-42003660:-	-1.08	-20.85	3.78E-69	Diastolic blood pressure	
THCA	cis	1	rs1716692	chr3:41983786	ULK4	chr3:41288091-42003660:-	-1.1	-21.12	1.9E-70	Diastolic blood pressure	
THCA	cis	1	rs1716693	chr3:41985600	ULK4	chr3:41288091-42003660:-	-1.1	-21.38	1.21E-71	Diastolic blood pressure	
THCA	cis	1	rs1716696	chr3:41935811	ULK4	chr3:41288091-42003660:-	-1.09	-20.92	1.8E-69	Diastolic blood pressure	
THCA	cis	1	rs1716984	chr3:41965532	ULK4	chr3:41288091-42003660:-	-1.1	-21.2	8.73E-71	Diastolic blood pressure	
THCA	cis	1	rs1716987	chr3:41970516	ULK4	chr3:41288091-42003660:-	-1.06	-19.9	1.19E-64	Diastolic blood pressure	
THCA	cis	1	rs1716993	chr3:41974556	ULK4	chr3:41288091-42003660:-	-1.06	-20.05	2.45E-65	Diastolic blood pressure	
THCA	cis	1	rs1716997	chr3:41924333	ULK4	chr3:41288091-42003660:-	-1.08	-20.85	3.78E-69	Diastolic blood pressure	
THCA	cis	1	rs1716999	chr3:41930041	ULK4	chr3:41288091-42003660:-	-1.09	-20.92	1.8E-69	Diastolic blood pressure	
THCA	cis	1	rs1717000	chr3:41930219	ULK4	chr3:41288091-42003660:-	-1.09	-20.92	1.8E-69	Diastolic blood pressure	
THCA	cis	1	rs1717001	chr3:41934949	ULK4	chr3:41288091-42003660:-	-1.09	-20.92	1.8E-69	Diastolic blood pressure	
THCA	cis	1	rs1717006	chr3:41940448	ULK4	chr3:41288091-42003660:-	1.09	21.01	6.56E-70	Diastolic blood pressure	
THCA	cis	1	rs1717009	chr3:41946308	ULK4	chr3:41288091-42003660:-	-1.09	-20.92	1.8E-69	Diastolic blood pressure	
THCA	cis	1	rs1717011	chr3:41980199	ULK4	chr3:41288091-42003660:-	-1.1	-21.05	4.17E-70	Diastolic blood pressure	
THCA	cis	1	rs1717014	chr3:41917395	ULK4	chr3:41288091-42003660:-	1.08	20.55	1.05E-67	Diastolic blood pressure	
THCA	cis	1	rs1717017	chr3:41915616	ULK4	chr3:41288091-42003660:-	1.07	20.45	2.89E-67	Diastolic blood pressure	
THCA	cis	1	rs1717020	chr3:41981490	ULK4	chr3:41288091-42003660:-	1.09	20.84	4.33E-69	Diastolic blood pressure	
THCA	cis	1	rs1717021	chr3:41983860	ULK4	chr3:41288091-42003660:-	-1.1	-21.12	1.9E-70	Diastolic blood pressure	
THCA	cis	1	rs1717024	chr3:41984888	ULK4	chr3:41288091-42003660:-	-1.09	-20.64	3.68E-68	Diastolic blood pressure	
THCA	cis	1	rs1717027	chr3:41987920	ULK4	chr3:41288091-42003660:-	-1.1	-21.38	1.21E-71	Diastolic blood pressure	
THCA	cis	1	rs1717031	chr3:41905791	ULK4	chr3:41288091-42003660:-	1.09	20.84	4.35E-69	Diastolic blood pressure	
THCA	cis	1	rs1717033	chr3:41910216	ULK4	chr3:41288091-42003660:-	1.07	20.45	2.89E-67	Diastolic blood pressure	
THCA	cis	1	rs17171307	chr7:38228578	STARD3NL	chr7:38217933-38270269:+	-0.52	-12.39	8.84E-31	Treatment response for severe sepsis	
THCA	cis	1	rs17171770	chr5:137514815	KLHL3	chr5:136953190-137071779:-	-0.13	-3.47	0.000577	Resting heart rate	
THCA	cis	1	rs17172291	chr7:54175453	SEC61G	chr7:54819941-54826939:-	0.22	3.38	0.000785	Periodontal disease-related phenotypes	
THCA	cis	1	rs17178045	chr14:71756358	SIPA1L1	chr14:71933902-72206118:+	0.28	5.58	4.02E-8	Mitral valve prolapse	
THCA	cis	1	rs17178206	chr14:71880093	SIPA1L1	chr14:71933902-72206118:+	0.27	5.53	5.21E-8	Mitral valve prolapse	
THCA	cis	1	rs1718417	chr3:196519545	PIGX	chr3:196439246-196462874:+	0.28	3.62	0.000323	Glucose homeostasis traits	
THCA	cis	1	rs17185907	chr1:119465793	WARS2	chr1:119573841-119683295:-	0.26	3.48	0.000543	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs17185933	chr1:119474772	WARS2	chr1:119573841-119683295:-	0.25	3.4	0.000723	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs17190683	chr6:101158143	ASCC3	chr6:100956609-101329224:-	0.12	4.81	2.04E-6	Menarche (age at onset)	
THCA	cis	1	rs17194199	chr2:218312376	IGFBP5	chr2:217536829-217560272:-	-0.23	-4.86	1.6E-6	Metabolite levels (MHPG)	
THCA	cis	1	rs17194392	chr3:2487275	CNTN4	chr3:2140550-3099644:+	0.35	8.21	2.08E-15	Blood pressure (smoking interaction)	
THCA	cis	1	rs1719890	chr3:119577868	GSK3B	chr3:119540804-119813264:-	-0.14	-4.93	1.11E-6	HDL cholesterol	
THCA	cis	1	rs1719894	chr3:119590322	GSK3B	chr3:119540804-119813264:-	-0.14	-4.82	1.94E-6	HDL cholesterol	
THCA	cis	1	rs17205407	chr15:62372827	VPS13C	chr15:62144592-62352647:-	0.11	4.08	5.27E-5	Height	
THCA	cis	1	rs17205463	chr15:62381413	VPS13C	chr15:62144592-62352647:-	-0.12	-4.46	1.04E-5	Height	
THCA	cis	1	rs17214441	chr2:207683777	MDH1B	chr2:207598943-207630050:-	0.44	5.47	7.31E-8	Episodic memory	
THCA	cis	1	rs17214621	chr20:3925924	MAVS	chr20:3827449-3856761:+	-0.24	-3.58	0.000381	Response to antidepressants in depression	
THCA	cis	1	rs17214949	chr20:3940952	MAVS	chr20:3827449-3856761:+	-0.23	-3.51	0.000484	Response to antidepressants in depression	
THCA	cis	1	rs17215054	chr20:3944779	MAVS	chr20:3827449-3856761:+	-0.23	-3.51	0.000484	Response to antidepressants in depression	
THCA	cis	1	rs17215340	chr20:3970173	MAVS	chr20:3827449-3856761:+	0.26	4.02	6.85E-5	Response to antidepressants in depression	
THCA	cis	1	rs17215529	chr20:3975402	MAVS	chr20:3827449-3856761:+	-0.23	-3.63	0.000312	Response to antidepressants in depression	
THCA	cis	1	rs17218267	chr6:55935111	COL21A1	chr6:55921389-56258892:-	-0.63	-7.77	4.85E-14	Psychosis (atypical)	
THCA	cis	1	rs17218309	chr6:55935196	COL21A1	chr6:55921389-56258892:-	-0.64	-7.91	1.86E-14	Psychosis (atypical)	
THCA	cis	1	rs17218770	chr6:55942956	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs17219063	chr6:56000228	COL21A1	chr6:55921389-56258892:-	-0.63	-7.74	5.81E-14	Psychosis (atypical)	
THCA	cis	1	rs17219126	chr6:56001681	COL21A1	chr6:55921389-56258892:-	-0.66	-8.09	4.8E-15	Psychosis (atypical)	
THCA	cis	1	rs17219382	chr6:56009638	COL21A1	chr6:55921389-56258892:-	0.73	9.34	3.61E-19	Psychosis (atypical)	
THCA	cis	1	rs17223420	chr12:983720	RAD52	chr12:1021255-1099219:-	-0.3	-4.84	1.76E-6	Colorectal cancer	
THCA	cis	1	rs1722360	chr7:148652383	ZNF786	chr7:148766733-148787869:-	-0.19	-3.46	0.000588	Height	
THCA	cis	1	rs1723267	chr7:65473314	CCT6P1	chr7:65216092-65228661:+	0.39	6.29	7.28E-10	Diabetic kidney disease	
THCA	cis	1	rs1723267	chr7:65473314	CRCP	chr7:65579805-65619551:+	-0.27	-4.16	3.72E-5	Diabetic kidney disease	
THCA	cis	1	rs1723267	chr7:65473314	RABGEF1	chr7:66093890-66276446:+	0.53	6.57	1.28E-10	Diabetic kidney disease	
THCA	cis	1	rs1723269	chr7:65472786	CCT6P1	chr7:65216092-65228661:+	0.41	6.45	2.69E-10	Diabetic kidney disease	
THCA	cis	1	rs1723269	chr7:65472786	CRCP	chr7:65579805-65619551:+	-0.29	-4.45	1.08E-5	Diabetic kidney disease	
THCA	cis	1	rs1723269	chr7:65472786	LOC493754	chr7:65993446-66057363:-	0.3	3.4	0.000728	Diabetic kidney disease	
THCA	cis	1	rs1723269	chr7:65472786	RABGEF1	chr7:66093890-66276446:+	0.53	6.49	2.18E-10	Diabetic kidney disease	
THCA	cis	1	rs1723270	chr7:65469830	CCT6P1	chr7:65216092-65228661:+	0.41	6.42	3.31E-10	Diabetic kidney disease	
THCA	cis	1	rs1723270	chr7:65469830	CRCP	chr7:65579805-65619551:+	-0.26	-3.96	8.64E-5	Diabetic kidney disease	
THCA	cis	1	rs1723270	chr7:65469830	RABGEF1	chr7:66093890-66276446:+	0.54	6.65	7.83E-11	Diabetic kidney disease	
THCA	cis	1	rs17239287	chr19:52022033	ZNF175	chr19:52074531-52092990:+	-0.36	-4.26	2.49E-5	Carotid intima media thickness	
THCA	cis	1	rs17246007	chr14:65865671	LOC645431	chr14:65877313-65879335:-	0.55	7.15	3.24E-12	Ischemic stroke	
THCA	cis	1	rs17246035	chr14:65874130	LOC645431	chr14:65877313-65879335:-	-0.58	-7.67	9.42E-14	Ischemic stroke	
THCA	cis	1	rs17246042	chr14:65874330	LOC645431	chr14:65877313-65879335:-	-0.6	-7.9	1.97E-14	Ischemic stroke	
THCA	cis	1	rs17246259	chr14:66075327	LOC645431	chr14:65877313-65879335:-	-0.51	-6.73	4.96E-11	Ischemic stroke	
THCA	cis	1	rs17255612	chr14:22722937	MMP14	chr14:23305793-23316802:+	-0.17	-3.49	0.000532	Periodontal disease-related phenotypes	
THCA	cis	1	rs17271431	chr15:62381016	VPS13C	chr15:62144592-62352647:-	-0.12	-4.36	1.61E-5	Height	
THCA	cis	1	rs17278115	chr13:45128221	CCDC122	chr13:44410491-44453826:-	0.32	3.52	0.00047	Antineutrophil cytoplasmic antibody-associated vasculitis	
THCA	cis	1	rs1728323	chr7:23232455	NUPL2	chr7:23221446-23240629:+	-0.44	-5.81	1.12E-8	Chronic obstructive pulmonary disease	
THCA	cis	1	rs1728327	chr7:23235483	NUPL2	chr7:23221446-23240629:+	-0.45	-6.22	1.06E-9	Chronic obstructive pulmonary disease	
THCA	cis	1	rs1728344	chr7:23250044	NUPL2	chr7:23221446-23240629:+	-0.43	-5.76	1.49E-8	Chronic obstructive pulmonary disease	
THCA	cis	1	rs17286349	chr20:3914302	MAVS	chr20:3827449-3856761:+	-0.25	-3.88	0.00012	Response to antidepressants in depression	
THCA	cis	1	rs17286768	chr20:3924569	MAVS	chr20:3827449-3856761:+	-0.24	-3.58	0.000381	Response to antidepressants in depression	
THCA	cis	1	rs17287486	chr20:3946267	MAVS	chr20:3827449-3856761:+	-0.23	-3.51	0.000484	Response to antidepressants in depression	
THCA	cis	1	rs17287822	chr20:3978536	MAVS	chr20:3827449-3856761:+	-0.25	-3.98	8.11E-5	Response to antidepressants in depression	
THCA	cis	1	rs17288338	chr19:46856421	PPP5C	chr19:46850294-46894103:+	-0.23	-4.01	6.92E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs1729245	chr2:233424891	EIF4E2	chr2:233415357-233448349:+	0.23	4.44	1.13E-5	Height	
THCA	cis	1	rs17301482	chr4:155349776	DCHS2	chr4:155155527-155412930:-	0.16	3.44	0.000634	Alzheimer's disease (age of onset)	
THCA	cis	1	rs17304569	chr19:24240905	LOC100101266	chr19:24344995-24346249:-	0.35	6.03	3.21E-9	Response to taxane treatment (placlitaxel)	
THCA	cis	1	rs17310286	chr8:26269032	PPP2R2A	chr8:25230075-26228645:+	-0.2	-3.85	0.000136	Schizophrenia	
THCA	cis	1	rs17310467	chr20:33545616	PROCR	chr20:33758727-33765164:+	-0.37	-5.66	2.58E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs17310467	chr20:33545616	TRPC4AP	chr20:33590215-33680618:-	0.33	3.87	0.000123	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs17311679	chr19:50521331	SIGLEC16	chr19:50472912-50479075:+	-0.62	-6.09	2.36E-9	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
THCA	cis	1	rs17317888	chr20:33594959	PROCR	chr20:33758727-33765164:+	-0.36	-5.75	1.55E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs17317888	chr20:33594959	TRPC4AP	chr20:33590215-33680618:-	0.32	3.88	0.000118	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs17318666	chr19:41940342	B3GNT8	chr19:41931265-41934635:-	0.34	7.76	5.33E-14	Height	
THCA	cis	1	rs17318666	chr19:41940342	EXOSC5	chr19:41892278-41903256:-	0.11	3.54	0.00044	Height	
THCA	cis	1	rs17319967	chr20:33693650	PROCR	chr20:33758727-33765164:+	-0.33	-5.74	1.66E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs17319967	chr20:33693650	TRPC4AP	chr20:33590215-33680618:-	0.35	4.56	6.41E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs1732170	chr3:119583676	GSK3B	chr3:119540804-119813264:-	-0.14	-4.93	1.11E-6	HDL cholesterol	
THCA	cis	1	rs17321999	chr2:30479857	LBH	chr2:30454397-30482899:+	0.19	3.5	0.000506	Systemic lupus erythematosus	
THCA	cis	1	rs17323510	chr8:124186089	FAM83A	chr8:124191287-124222317:+	0.33	4.19	3.34E-5	Urinary uromodulin levels	
THCA	cis	1	rs17331968	chr4:183820329	DCTD	chr4:183811245-183838630:-	0.24	5.01	7.73E-7	Obesity-related traits	
THCA	cis	1	rs17332243	chr20:43756071	STK4	chr20:43595120-43708591:+	-0.17	-4.1	4.94E-5	Parental longevity (mother's age at death)	
THCA	cis	1	rs173334	chr6:88080223	C6orf162	chr6:88032306-88052043:+	-0.19	-4.06	5.63E-5	Depressive episodes in bipolar disorder	
THCA	cis	1	rs173334	chr6:88080223	C6orf164	chr6:88032306-88109459:+	-0.32	-5.98	4.46E-9	Depressive episodes in bipolar disorder	
THCA	cis	1	rs173334	chr6:88080223	SLC35A1	chr6:88146444-88222051:+	0.17	3.37	0.000814	Depressive episodes in bipolar disorder	
THCA	cis	1	rs17338034	chr16:51357482	SALL1	chr16:51169886-51185183:-	-0.18	-3.64	0.0003	Left superior temporal gyrus thickness (schizophrenia interaction)	
THCA	cis	1	rs17338196	chr12:22562178	KIAA0528	chr12:22601526-22697452:-	0.22	3.79	0.000167	Coronary artery calcification	
THCA	cis	1	rs17340509	chr1:27274700	ZDHHC18	chr1:27153201-27182207:+	0.73	7.36	8.11E-13	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs17341301	chr2:160902420	LY75	chr2:160625141-160761262:-	0.22	5.04	6.46E-7	Idiopathic membranous nephropathy	
THCA	cis	1	rs17347505	chr7:23915283	C7orf46	chr7:23719749-23742268:+	0.13	3.89	0.000114	Schizophrenia	
THCA	cis	1	rs17347692	chr7:23918367	C7orf46	chr7:23719749-23742268:+	0.13	3.95	8.9E-5	Schizophrenia	
THCA	cis	1	rs17347733	chr7:23918510	C7orf46	chr7:23719749-23742268:+	0.13	3.89	0.000116	Schizophrenia	
THCA	cis	1	rs17350396	chr1:11900838	MTHFR	chr1:11845787-11866115:-	0.22	3.37	0.000808	Homocysteine levels	
THCA	cis	1	rs17356923	chr1:27282676	ZDHHC18	chr1:27153201-27182207:+	0.73	7.54	2.42E-13	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs17360994	chr1:27278573	ZDHHC18	chr1:27153201-27182207:+	0.73	7.36	8.11E-13	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs17361668	chr11:102720344	MMP1	chr11:102660641-102668966:-	0.32	3.52	0.000467	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs17373494	chr4:155349158	DCHS2	chr4:155155527-155412930:-	0.16	3.45	0.000606	Alzheimer's disease (age of onset)	
THCA	cis	1	rs1737944	chr17:18840433	FAM18B	chr17:18684582-18710026:+	-0.42	-10.49	2.62E-23	Educational attainment (years of education)	
THCA	cis	1	rs1737944	chr17:18840433	FBXW10	chr17:18647326-18682661:+	-0.22	-4.76	2.59E-6	Educational attainment (years of education)	
THCA	cis	1	rs1737947	chr17:18831432	FAM18B	chr17:18684582-18710026:+	0.32	7.35	8.7E-13	Pancreatic cancer	
THCA	cis	1	rs17385641	chr7:77362489	PTPN12	chr7:77166773-77269388:+	0.18	4.02	6.79E-5	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs17385641	chr7:77362489	RSBN1L	chr7:77325743-77409120:+	-0.15	-3.58	0.000382	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs17386555	chr2:242371825	ANO7	chr2:242127924-242164791:+	0.32	3.8	0.000165	Prostate cancer	
THCA	cis	1	rs17386555	chr2:242371825	SEPT2	chr2:242254723-242293439:+	-0.3	-4.55	6.95E-6	Prostate cancer	
THCA	cis	1	rs17386695	chr2:242379751	ANO7	chr2:242127924-242164791:+	-0.32	-3.74	0.000208	Prostate cancer	
THCA	cis	1	rs17386695	chr2:242379751	SEPT2	chr2:242254723-242293439:+	0.3	4.56	6.57E-6	Prostate cancer	
THCA	cis	1	rs17396122	chr2:48220336	FOXN2	chr2:48541795-48606434:+	0.23	3.97	8.24E-5	Schizophrenia	
THCA	cis	1	rs17396382	chr1:10290268	KIF1B	chr1:10270764-10441659:+	0.2	5.84	9.79E-9	Hepatocellular carcinoma	
THCA	cis	1	rs17396440	chr2:48270256	FOXN2	chr2:48541795-48606434:+	0.23	4.26	2.48E-5	Schizophrenia	
THCA	cis	1	rs17400427	chr15:49741071	DTWD1	chr15:49913226-49937332:+	-0.23	-5.29	1.87E-7	Thyroid volume	
THCA	cis	1	rs17400427	chr15:49741071	GALK2	chr15:49447976-49622002:+	0.17	3.55	0.000424	Thyroid volume	
THCA	cis	1	rs17400427	chr15:49741071	SECISBP2L	chr15:49280967-49338630:-	0.14	3.64	0.000306	Thyroid volume	
THCA	cis	1	rs17401737	chr20:33552642	PROCR	chr20:33758727-33765164:+	-0.36	-5.62	3.24E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs17401737	chr20:33552642	TRPC4AP	chr20:33590215-33680618:-	0.32	3.82	0.00015	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs17401924	chr1:10384439	KIF1B	chr1:10270764-10441659:+	0.2	6.15	1.68E-9	Hepatocellular carcinoma	
THCA	cis	1	rs17401966	chr1:10385471	KIF1B	chr1:10270764-10441659:+	-0.2	-6.12	1.94E-9	Hepatocellular carcinoma	
THCA	cis	1	rs17403088	chr7:107111373	DLD	chr7:107531586-107561642:+	0.15	3.59	0.000365	Osteoarthritis	
THCA	cis	1	rs17404153	chr3:132163200	NCRNA00119	chr3:132441186-132593050:+	0.31	3.54	0.000435	HDL cholesterol;LDL cholesterol	
THCA	cis	1	rs17410793	chr1:10391886	KIF1B	chr1:10270764-10441659:+	0.2	6.15	1.68E-9	Hepatocellular carcinoma	
THCA	cis	1	rs17411502	chr1:10431158	KIF1B	chr1:10270764-10441659:+	0.2	6.3	6.79E-10	Hepatocellular carcinoma	
THCA	cis	1	rs1741155	chr14:102428398	RAGE	chr14:102690838-102771531:-	-0.15	-4.75	2.71E-6	Menopause (age at onset)	
THCA	cis	1	rs17421511	chr1:11857788	MTHFR	chr1:11845787-11866115:-	0.23	3.45	0.000615	Homocysteine levels	
THCA	cis	1	rs17422573	chr12:22548865	KIAA0528	chr12:22601526-22697452:-	-0.2	-3.54	0.000439	Coronary artery calcification	
THCA	cis	1	rs17423416	chr20:43758144	STK4	chr20:43595120-43708591:+	-0.17	-3.88	0.000121	Parental longevity (mother's age at death)	
THCA	cis	1	rs17423617	chr20:43768050	STK4	chr20:43595120-43708591:+	-0.17	-3.99	7.57E-5	Parental longevity (mother's age at death)	
THCA	cis	1	rs17431934	chr9:100695776	C9orf156	chr9:100666772-100684852:-	-0.14	-3.63	0.000317	Quantitative traits	
THCA	cis	1	rs17433780	chr1:89474818	CCBL2	chr1:89401456-89458643:-	0.23	4.09	5.09E-5	Carotid intima media thickness	
THCA	cis	1	rs17433780	chr1:89474818	GBP2	chr1:89571843-89616258:-	0.11	3.48	0.000545	Carotid intima media thickness	
THCA	cis	1	rs17433780	chr1:89474818	GBP3	chr1:89472367-89488549:-	1	34.56	4.46E-132	Carotid intima media thickness	
THCA	cis	1	rs17433780	chr1:89474818	RBMXL1	chr1:89445140-89458643:-	0.15	3.95	8.99E-5	Carotid intima media thickness	
THCA	cis	1	rs17435444	chr4:122121494	C4orf31	chr4:121956782-121993673:-	0.4	4.37	1.53E-5	Breast cancer	
THCA	cis	1	rs17435590	chr7:97784061	BRI3	chr7:97910979-97922275:+	-0.11	-3.89	0.000113	Prostate cancer (gene x gene interaction);Prostate cancer	
THCA	cis	1	rs17435590	chr7:97784061	TECPR1	chr7:97846060-97881468:-	-0.14	-3.78	0.000173	Prostate cancer (gene x gene interaction);Prostate cancer	
THCA	cis	1	rs17435847	chr7:97792820	BRI3	chr7:97910979-97922275:+	-0.11	-3.89	0.000113	Prostate cancer (gene x gene interaction);Prostate cancer	
THCA	cis	1	rs17435847	chr7:97792820	TECPR1	chr7:97846060-97881468:-	-0.14	-3.88	0.00012	Prostate cancer (gene x gene interaction);Prostate cancer	
THCA	cis	1	rs1744122	chr6:86115218	NT5E	chr6:86159302-86205496:+	0.23	3.47	0.000568	Blood metabolite levels;Metabolic traits	
THCA	cis	1	rs17446828	chr5:151731007	NMUR2	chr5:151771102-151784840:-	-0.5	-8.96	7.06E-18	Optic nerve measurement (cup area)	
THCA	cis	1	rs17450853	chr6:56788004	BEND6	chr6:56819773-56892138:+	-0.28	-6.12	1.98E-9	Menarche (age at onset)	
THCA	cis	1	rs17450853	chr6:56788004	KIAA1586	chr6:56911384-56920021:+	-0.32	-5.25	2.25E-7	Menarche (age at onset)	
THCA	cis	1	rs17453752	chr2:9766171	IAH1	chr2:9614670-9636671:+	-0.16	-3.63	0.000312	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	
THCA	cis	1	rs174551	chr11:61573684	FADS2	chr11:61583728-61634825:+	0.42	9.3	5.16E-19	LDL cholesterol	
THCA	cis	1	rs17459044	chr9:131853624	CRAT	chr9:131857075-131873070:-	0.27	6.35	5.11E-10	Pelvic organ prolapse (moderate/severe)	
THCA	cis	1	rs17471869	chr10:70749869	KIAA1279	chr10:70748493-70776734:+	-0.15	-3.5	0.000508	Schizophrenia	
THCA	cis	1	rs1747683	chr10:13361976	PHYH	chr10:13319797-13344412:-	0.16	6.37	4.48E-10	IgG glycosylation	
THCA	cis	1	rs17481621	chr7:107113852	DLD	chr7:107531586-107561642:+	0.15	3.69	0.000245	Osteoarthritis	
THCA	cis	1	rs17482494	chr7:107168487	DLD	chr7:107531586-107561642:+	0.14	3.5	0.00051	Osteoarthritis	
THCA	cis	1	rs17482543	chr7:107169174	DLD	chr7:107531586-107561642:+	0.14	3.5	0.00051	Osteoarthritis	
THCA	cis	1	rs17492159	chr12:40808081	CNTN1	chr12:41086358-41464094:+	0.28	3.44	0.000633	Subjective well-being	
THCA	cis	1	rs17494056	chr2:160052731	TANC1	chr2:159825146-160089168:+	-0.13	-3.63	0.000309	Resting heart rate	
THCA	cis	1	rs17494056	chr2:160052731	WDSUB1	chr2:160092305-160143236:-	0.24	4.9	1.31E-6	Resting heart rate	
THCA	cis	1	rs17496332	chr1:107546375	PRMT6	chr1:107599267-107601907:+	0.48	8.32	9.13E-16	Sex hormone-binding globulin levels	
THCA	cis	1	rs17505830	chr7:117998621	ANKRD7	chr7:117864712-117882782:+	0.29	4.58	6.07E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs17507481	chr4:17620066	MED28	chr4:17616273-17629791:+	0.19	4.06	5.84E-5	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs17508864	chr4:39130645	KLHL5	chr4:39046659-39123828:+	-0.21	-5.77	1.46E-8	Uric acid levels	
THCA	cis	1	rs17510733	chr6:111710918	KIAA1919	chr6:111580482-111590259:+	0.48	5.6	3.62E-8	Psoriasis	
THCA	cis	1	rs17510761	chr6:111708583	KIAA1919	chr6:111580482-111590259:+	0.48	5.6	3.62E-8	Psoriasis	
THCA	cis	1	rs17513621	chr2:99246559	UNC50	chr2:99225042-99234975:+	-0.23	-4.45	1.07E-5	Bipolar disorder	
THCA	cis	1	rs17514360	chr8:17812577	PCM1	chr8:17780366-17887455:+	-0.09	-3.88	0.000117	Economic and political preferences	
THCA	cis	1	rs17520991	chr12:40806115	CNTN1	chr12:41086358-41464094:+	0.28	3.44	0.000633	Subjective well-being	
THCA	cis	1	rs1752435	chr14:59946094	C14orf149	chr14:59939406-59951126:-	-0.32	-3.94	9.23E-5	Schizophrenia	
THCA	cis	1	rs1752435	chr14:59946094	JKAMP	chr14:59951161-59972080:+	0.41	4.95	1.03E-6	Schizophrenia	
THCA	cis	1	rs17528859	chr11:59867379	MS4A14	chr11:60145958-60185226:+	0.16	4.27	2.38E-5	Alzheimer's disease (late onset)	
THCA	cis	1	rs17529983	chr11:59927039	MS4A14	chr11:60145958-60185226:+	0.17	4.35	1.63E-5	Alzheimer's disease (late onset)	
THCA	cis	1	rs17538840	chr2:61077817	C2orf74	chr2:61372243-61391964:+	-0.42	-6.47	2.47E-10	Inflammatory skin disease	
THCA	cis	1	rs175425	chr14:75626131	EIF2B2	chr14:75469612-75476292:+	-0.18	-4.95	1.04E-6	Height	
THCA	cis	1	rs175425	chr14:75626131	MLH3	chr14:75480467-75518235:-	-0.29	-8.51	2.24E-16	Height	
THCA	cis	1	rs175425	chr14:75626131	RPS6KL1	chr14:75372347-75389958:-	-0.29	-6.2	1.22E-9	Height	
THCA	cis	1	rs175426	chr14:75624134	EIF2B2	chr14:75469612-75476292:+	-0.19	-5.04	6.74E-7	Height	
THCA	cis	1	rs175426	chr14:75624134	MLH3	chr14:75480467-75518235:-	-0.29	-8.75	3.82E-17	Height	
THCA	cis	1	rs175426	chr14:75624134	RPS6KL1	chr14:75372347-75389958:-	-0.3	-6.38	4.29E-10	Height	
THCA	cis	1	rs175436	chr14:75608683	EIF2B2	chr14:75469612-75476292:+	-0.19	-5.02	7.19E-7	Height	
THCA	cis	1	rs175436	chr14:75608683	MLH3	chr14:75480467-75518235:-	-0.3	-9.02	4.68E-18	Height	
THCA	cis	1	rs175436	chr14:75608683	RPS6KL1	chr14:75372347-75389958:-	-0.3	-6.45	2.8E-10	Height	
THCA	cis	1	rs175442	chr14:75603564	EIF2B2	chr14:75469612-75476292:+	-0.18	-5.01	7.6E-7	Height	
THCA	cis	1	rs175442	chr14:75603564	MLH3	chr14:75480467-75518235:-	-0.3	-8.9	1.12E-17	Height	
THCA	cis	1	rs175442	chr14:75603564	RPS6KL1	chr14:75372347-75389958:-	-0.3	-6.41	3.51E-10	Height	
THCA	cis	1	rs175443	chr14:75601963	EIF2B2	chr14:75469612-75476292:+	-0.18	-4.99	8.6E-7	Height	
THCA	cis	1	rs175443	chr14:75601963	MLH3	chr14:75480467-75518235:-	-0.3	-9.02	4.46E-18	Height	
THCA	cis	1	rs175443	chr14:75601963	RPS6KL1	chr14:75372347-75389958:-	-0.3	-6.45	2.74E-10	Height	
THCA	cis	1	rs175449	chr14:75590846	EIF2B2	chr14:75469612-75476292:+	-0.18	-5.01	7.6E-7	Height	
THCA	cis	1	rs175449	chr14:75590846	MLH3	chr14:75480467-75518235:-	-0.3	-8.9	1.12E-17	Height	
THCA	cis	1	rs175449	chr14:75590846	RPS6KL1	chr14:75372347-75389958:-	-0.3	-6.41	3.51E-10	Height	
THCA	cis	1	rs17548631	chr22:24144125	C22orf43	chr22:23950640-23974487:-	-0.24	-3.73	0.000217	IgG glycosylation	
THCA	cis	1	rs175492	chr14:75545220	EIF2B2	chr14:75469612-75476292:+	0.18	5.04	6.63E-7	Height	
THCA	cis	1	rs175492	chr14:75545220	MLH3	chr14:75480467-75518235:-	0.29	8.92	1.03E-17	Height	
THCA	cis	1	rs175492	chr14:75545220	RPS6KL1	chr14:75372347-75389958:-	0.31	6.87	1.97E-11	Height	
THCA	cis	1	rs17549954	chr17:61707032	FTSJ3	chr17:61896795-61905031:-	0.31	5.7	2.1E-8	Body mass index	
THCA	cis	1	rs17549954	chr17:61707032	MAP3K3	chr17:61699775-61773669:+	0.28	5.63	3.13E-8	Body mass index	
THCA	cis	1	rs175512	chr14:75523382	EIF2B2	chr14:75469612-75476292:+	-0.18	-4.85	1.7E-6	Height	
THCA	cis	1	rs175512	chr14:75523382	MLH3	chr14:75480467-75518235:-	-0.29	-8.73	4.2E-17	Height	
THCA	cis	1	rs175512	chr14:75523382	RPS6KL1	chr14:75372347-75389958:-	-0.31	-6.72	5.18E-11	Height	
THCA	cis	1	rs17551370	chr5:110404185	TSLP	chr5:110405778-110413722:+	-0.3	-3.71	0.000236	Eosinophil counts	
THCA	cis	1	rs17551370	chr5:110404185	WDR36	chr5:110427870-110466201:+	0.19	3.42	0.000691	Eosinophil counts	
THCA	cis	1	rs17554547	chr16:3507802	NAT15	chr16:3493668-3536962:+	-0.24	-4.22	2.92E-5	Tuberculosis	
THCA	cis	1	rs17554547	chr16:3507802	TRAP1	chr16:3708039-3767598:-	0.14	3.37	0.0008	Tuberculosis	
THCA	cis	1	rs17566701	chr7:66193183	GUSB	chr7:65425675-65447246:-	0.3	6.02	3.56E-9	Aortic root size	
THCA	cis	1	rs17566701	chr7:66193183	RABGEF1	chr7:66093890-66276446:+	0.49	9.65	2.94E-20	Aortic root size	
THCA	cis	1	rs17566701	chr7:66193183	TYW1	chr7:66461817-66704496:+	0.21	4.56	6.39E-6	Aortic root size	
THCA	cis	1	rs17571940	chr1:41566191	SCMH1	chr1:41492875-41707788:-	0.2	4.69	3.61E-6	Height	
THCA	cis	1	rs1757924	chr4:130019599	C4orf33	chr4:130014829-130033842:+	-0.57	-9.21	1.03E-18	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs1757925	chr4:130020791	C4orf33	chr4:130014829-130033842:+	0.58	9.44	1.68E-19	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs1757927	chr4:130022069	C4orf33	chr4:130014829-130033842:+	-0.6	-9.74	1.44E-20	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs1757928	chr4:130022161	C4orf33	chr4:130014829-130033842:+	-0.6	-9.74	1.44E-20	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs1757930	chr4:130022356	C4orf33	chr4:130014829-130033842:+	-0.61	-9.63	3.41E-20	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs1757935	chr4:130023759	C4orf33	chr4:130014829-130033842:+	-0.6	-9.74	1.44E-20	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs17584024	chr7:117998472	ANKRD7	chr7:117864712-117882782:+	0.28	4.58	5.85E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs17584115	chr7:117998812	ANKRD7	chr7:117864712-117882782:+	0.27	4.5	8.46E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs17584143	chr7:118000283	ANKRD7	chr7:117864712-117882782:+	0.28	4.55	6.81E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs17584359	chr7:118006306	ANKRD7	chr7:117864712-117882782:+	-0.28	-4.53	7.3E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs17584578	chr2:86307624	LOC90784	chr2:86247339-86250991:-	0.46	4.86	1.62E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs17594362	chr13:42139245	C13orf15	chr13:42031542-42045013:+	0.15	3.58	0.000373	Multiple sclerosis	
THCA	cis	1	rs17596617	chr11:43690717	HSD17B12	chr11:43702143-43878160:+	-0.71	-15.04	4.08E-42	Forced vital capacity	
THCA	cis	1	rs17598927	chr6:26184640	HIST1H3E	chr6:26224427-26226589:+	-0.45	-7.13	3.72E-12	Renal underexcretion gout;Gout	
THCA	cis	1	rs1759973	chr13:78383914	EDNRB	chr13:78469616-78549664:-	0.14	4.14	4.07E-5	Hair color	
THCA	cis	1	rs1759975	chr13:78385158	EDNRB	chr13:78469616-78549664:-	0.14	3.94	9.36E-5	Hair color	
THCA	cis	1	rs1759977	chr13:78385208	EDNRB	chr13:78469616-78549664:-	0.14	4.07	5.54E-5	Hair color	
THCA	cis	1	rs1759979	chr13:78386854	EDNRB	chr13:78469616-78549664:-	0.14	4.06	5.67E-5	Hair color	
THCA	cis	1	rs17600551	chr15:85319258	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-3.69	0.000253	Schizophrenia	
THCA	cis	1	rs17600551	chr15:85319258	LOC388152	chr15:84867600-84898920:-	-0.48	-8.08	5.27E-15	Schizophrenia	
THCA	cis	1	rs17600551	chr15:85319258	NMB	chr15:85198362-85201802:-	0.35	7.39	6.74E-13	Schizophrenia	
THCA	cis	1	rs17601029	chr15:85347709	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.29	2.19E-5	Schizophrenia	
THCA	cis	1	rs17601029	chr15:85347709	LOC388152	chr15:84867600-84898920:-	-0.47	-8.03	7.71E-15	Schizophrenia	
THCA	cis	1	rs17601029	chr15:85347709	NMB	chr15:85198362-85201802:-	0.35	7.57	1.92E-13	Schizophrenia	
THCA	cis	1	rs17605685	chr19:50486741	SIGLEC16	chr19:50472912-50479075:+	0.64	6.05	3.01E-9	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
THCA	cis	1	rs17608059	chr17:13910549	CDRT15P	chr17:13927815-13928915:+	-0.52	-11.46	5.04E-27	Temperament	
THCA	cis	1	rs17618001	chr2:86289303	POLR1A	chr2:86253453-86333278:-	-0.34	-4.48	9.18E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs17632159	chr5:72431482	TMEM171	chr5:72416388-72427644:+	0.16	4.02	6.69E-5	Urate levels	
THCA	cis	1	rs17632	chr20:47713063	ARFGEF2	chr20:47538275-47653229:+	-0.12	-3.92	0.000102	Anger	
THCA	cis	1	rs17632	chr20:47713063	CSE1L	chr20:47662838-47713484:+	0.41	10.23	2.48E-22	Anger	
THCA	cis	1	rs17645523	chr15:50882645	SPPL2A	chr15:50999739-51057910:-	0.28	7.58	1.84E-13	QT interval	
THCA	cis	1	rs17645523	chr15:50882645	TRPM7	chr15:50852491-50978994:-	0.11	3.38	0.000788	QT interval	
THCA	cis	1	rs17645649	chr15:50900370	ATP8B4	chr15:50150436-50411419:-	-0.11	-3.38	0.000777	QT interval	
THCA	cis	1	rs17645649	chr15:50900370	SPPL2A	chr15:50999739-51057910:-	0.26	7.02	7.67E-12	QT interval	
THCA	cis	1	rs17645826	chr15:50950141	SPPL2A	chr15:50999739-51057910:-	0.29	7.52	2.66E-13	QT interval	
THCA	cis	1	rs1764625	chr1:197299000	CFHR3	chr1:196743930-196762872:+	0.25	5.12	4.46E-7	Lupus nephritis in systemic lupus erythematosus	
THCA	cis	1	rs1764786	chr1:197300496	CFHR3	chr1:196743930-196762872:+	0.26	5.26	2.19E-7	Lupus nephritis in systemic lupus erythematosus	
THCA	cis	1	rs17648477	chr5:169731858	KCNMB1	chr5:169805167-169816638:-	0.21	3.72	0.000219	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	
THCA	cis	1	rs17648477	chr5:169731858	LOC257358	chr5:169758435-169762104:+	0.22	3.47	0.00056	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	
THCA	cis	1	rs17656964	chr14:55175701	SAMD4A	chr14:55034637-55260033:+	-0.41	-4.16	3.73E-5	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs17657012	chr14:55176344	SAMD4A	chr14:55034637-55260033:+	-0.39	-3.92	0.000103	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs17661933	chr19:50534520	SIGLEC16	chr19:50472912-50479075:+	-0.45	-4.74	2.87E-6	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
THCA	cis	1	rs1766341	chr13:78384264	EDNRB	chr13:78469616-78549664:-	0.14	3.99	7.72E-5	Hair color	
THCA	cis	1	rs1766342	chr13:78384296	EDNRB	chr13:78469616-78549664:-	0.14	4.06	5.67E-5	Hair color	
THCA	cis	1	rs1766343	chr13:78384971	EDNRB	chr13:78469616-78549664:-	0.14	4.06	5.67E-5	Hair color	
THCA	cis	1	rs1766344	chr13:78385068	EDNRB	chr13:78469616-78549664:-	0.13	3.8	0.000163	Hair color	
THCA	cis	1	rs1766345	chr13:78387125	EDNRB	chr13:78469616-78549664:-	0.14	4.06	5.67E-5	Hair color	
THCA	cis	1	rs1766347	chr13:78387963	EDNRB	chr13:78469616-78549664:-	-0.16	-4.56	6.41E-6	Hair color	
THCA	cis	1	rs1766350	chr13:78388389	EDNRB	chr13:78469616-78549664:-	0.14	4.06	5.69E-5	Hair color	
THCA	cis	1	rs17671194	chr15:40667539	C15orf23	chr15:40674922-40686488:+	0.69	9.21	1.04E-18	Heschl's gyrus morphology	
THCA	cis	1	rs17671194	chr15:40667539	IVD	chr15:40697686-40713512:+	-0.56	-10	1.67E-21	Heschl's gyrus morphology	
THCA	cis	1	rs17671250	chr15:40673124	C15orf23	chr15:40674922-40686488:+	-0.58	-8.58	1.36E-16	Heschl's gyrus morphology	
THCA	cis	1	rs17671250	chr15:40673124	DISP2	chr15:40650434-40663256:+	0.28	3.5	0.000504	Heschl's gyrus morphology	
THCA	cis	1	rs17671250	chr15:40673124	IVD	chr15:40697686-40713512:+	0.55	11.1	1.21E-25	Heschl's gyrus morphology	
THCA	cis	1	rs17674998	chr17:41879544	MPP3	chr17:41878169-41910538:-	0.29	4.82	1.93E-6	Triglycerides	
THCA	cis	1	rs17675122	chr17:41886190	MPP3	chr17:41878169-41910538:-	0.29	4.75	2.66E-6	Triglycerides	
THCA	cis	1	rs17675398	chr4:53304552	KIAA0114	chr4:53578621-53580305:+	-0.17	-3.48	0.000548	Biochemical measures	
THCA	cis	1	rs17677510	chr7:29182574	CPVL	chr7:29035249-29234892:-	0.3	3.7	0.000245	Diabetes related insulin traits	
THCA	cis	1	rs1768208	chr3:39523003	RPSA	chr3:39448204-39454030:+	0.19	4.86	1.61E-6	Corticobasal degeneration;Progressive supranuclear palsy	
THCA	cis	1	rs17683841	chr6:55944441	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs17683846	chr6:55945010	COL21A1	chr6:55921389-56258892:-	-0.65	-8.19	2.34E-15	Psychosis (atypical)	
THCA	cis	1	rs17685143	chr6:56774788	BEND6	chr6:56819773-56892138:+	-0.32	-6.5	1.97E-10	Menarche (age at onset)	
THCA	cis	1	rs17685143	chr6:56774788	KIAA1586	chr6:56911384-56920021:+	-0.34	-5.17	3.45E-7	Menarche (age at onset)	
THCA	cis	1	rs1768803	chr1:46546208	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.17	4.03E-22	Body mass index	
THCA	cis	1	rs1768803	chr1:46546208	GPBP1L1	chr1:46092978-46152302:-	0.13	3.41	0.000705	Body mass index	
THCA	cis	1	rs1768803	chr1:46546208	MMACHC	chr1:45965856-45976737:+	-0.21	-4.48	9.32E-6	Body mass index	
THCA	cis	1	rs1768803	chr1:46546208	MUTYH	chr1:45794915-45806142:-	0.28	7.49	3.29E-13	Body mass index	
THCA	cis	1	rs1768816	chr1:46528599	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.12	5.92E-22	Body mass index	
THCA	cis	1	rs1768816	chr1:46528599	MMACHC	chr1:45965856-45976737:+	-0.21	-4.53	7.31E-6	Body mass index	
THCA	cis	1	rs1768816	chr1:46528599	MUTYH	chr1:45794915-45806142:-	0.29	7.55	2.23E-13	Body mass index	
THCA	cis	1	rs17691170	chr3:121357626	IQCB1	chr3:121488610-121553926:-	0.53	10.23	2.43E-22	Cognitive performance	
THCA	cis	1	rs17692461	chr12:82171755	PPFIA2	chr12:81652880-82153109:-	0.23	4.3	2.09E-5	Resting heart rate	
THCA	cis	1	rs17694011	chr3:134213981	ANAPC13	chr3:134196547-134204865:-	0.39	12.57	1.72E-31	Height	
THCA	cis	1	rs17694011	chr3:134213981	CEP63	chr3:134204575-134293852:+	0.29	6.4	3.83E-10	Height	
THCA	cis	1	rs17696958	chr16:77785013	NUDT7	chr16:77756411-77776153:+	0.37	5.12	4.51E-7	Obesity-related traits	
THCA	cis	1	rs1769756	chr10:80924404	LOC219347	chr10:81805991-81838949:-	0.21	3.79	0.000169	Sitting height ratio;Height	
THCA	cis	1	rs1769756	chr10:80924404	MBL1P	chr10:81664654-81710783:+	0.14	3.43	0.000657	Sitting height ratio;Height	
THCA	cis	1	rs1769763	chr10:80923352	LOC219347	chr10:81805991-81838949:-	0.2	3.65	0.000294	Sitting height ratio;Height	
THCA	cis	1	rs1769763	chr10:80923352	MBL1P	chr10:81664654-81710783:+	0.14	3.45	0.000614	Sitting height ratio;Height	
THCA	cis	1	rs17698817	chr14:88822976	SPATA7	chr14:88852012-88904802:+	-0.18	-3.71	0.00023	Coronary artery calcification	
THCA	cis	1	rs17699333	chr19:19831544	ZNF14	chr19:19821281-19843921:-	0.18	3.79	0.00017	Toenail selenium levels	
THCA	cis	1	rs17713396	chr2:227201	SH3YL1	chr2:218138-264810:-	-0.91	-23.63	2.3E-82	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs17713729	chr2:249092	SH3YL1	chr2:218138-264810:-	-0.93	-25.64	8.0E-92	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs17714252	chr2:285471	SH3YL1	chr2:218138-264810:-	-0.92	-25.41	9.63E-91	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs17714284	chr7:127147205	GRM8	chr7:126078652-126893147:-	-0.35	-3.59	0.000368	Medication adherence in chronic diseases	
THCA	cis	1	rs17716789	chr16:77769679	NUDT7	chr16:77756411-77776153:+	0.36	4.89	1.39E-6	Obesity-related traits	
THCA	cis	1	rs17716830	chr16:77771999	NUDT7	chr16:77756411-77776153:+	0.35	4.9	1.29E-6	Obesity-related traits	
THCA	cis	1	rs17718580	chr14:50973632	C14orf138	chr14:50575350-50583297:-	-0.26	-3.38	0.000771	Cognitive performance	
THCA	cis	1	rs17723470	chr11:45227567	PRDM11	chr11:45115564-45246902:+	0.15	3.61	0.00034	Thyroid hormone levels	
THCA	cis	1	rs17723470	chr11:45227567	SYT13	chr11:45261853-45307884:-	0.32	5.28	1.94E-7	Thyroid hormone levels	
THCA	cis	1	rs17727568	chr5:150244688	LOC134466	chr5:150310000-150326146:-	0.44	5.83	1.02E-8	Crohn's disease	
THCA	cis	1	rs17733640	chr3:38446742	EXOG	chr3:38537763-38567796:+	-0.16	-3.36	0.000829	Electrocardiographic conduction measures	
THCA	cis	1	rs17733640	chr3:38446742	LOC100128640	chr3:38492524-38496311:-	0.22	4.66	4.01E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs17733640	chr3:38446742	SCN5A	chr3:38589554-38691164:-	0.16	3.4	0.00073	Electrocardiographic conduction measures	
THCA	cis	1	rs17733640	chr3:38446742	XYLB	chr3:38388251-38456467:+	0.2	4.89	1.39E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs177377	chr14:73753519	HEATR4	chr14:73945193-74025651:-	-0.18	-3.55	0.000419	Bipolar disorder with mood-incongruent psychosis	
THCA	cis	1	rs17741826	chr5:151149262	SPARC	chr5:151041019-151066517:-	-0.13	-3.4	0.000726	Preschool internalizing problems	
THCA	cis	1	rs17742905	chr17:41891143	MPP3	chr17:41878169-41910538:-	0.29	4.73	2.97E-6	Triglycerides	
THCA	cis	1	rs17743459	chr8:117651586	EIF3H	chr8:117657056-117778494:-	-0.2	-3.53	0.000462	Body mass index	
THCA	cis	1	rs17743585	chr8:117667032	EIF3H	chr8:117657056-117778494:-	-0.2	-3.64	0.000297	Body mass index	
THCA	cis	1	rs17743793	chr8:117728155	EIF3H	chr8:117657056-117778494:-	-0.21	-3.79	0.000173	Body mass index	
THCA	cis	1	rs17745344	chr17:53048319	STXBP4	chr17:53046126-53241449:+	-0.15	-3.9	0.000108	Breast cancer	
THCA	cis	1	rs17745344	chr17:53048319	TOM1L1	chr17:52978052-53039328:+	-0.16	-4.12	4.44E-5	Breast cancer	
THCA	cis	1	rs17746014	chr10:102315354	SEC31B	chr10:102246403-102289636:-	-0.29	-9.24	8.08E-19	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs17748942	chr12:82170478	PPFIA2	chr12:81652880-82153109:-	0.21	3.89	0.000114	Resting heart rate	
THCA	cis	1	rs17749267	chr12:82178308	PPFIA2	chr12:81652880-82153109:-	-0.21	-3.96	8.79E-5	Resting heart rate	
THCA	cis	1	rs17749748	chr2:71605145	ZNF638	chr2:71503723-71662187:+	-0.17	-5.91	6.65E-9	Height	
THCA	cis	1	rs17750015	chr18:54397622	FECH	chr18:55212074-55253969:-	0.14	3.54	0.000441	Depression and alcohol dependence	
THCA	cis	1	rs17751067	chr6:55944196	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs17751085	chr6:55945212	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs17751143	chr6:55947368	COL21A1	chr6:55921389-56258892:-	-0.66	-8.1	4.59E-15	Psychosis (atypical)	
THCA	cis	1	rs1775148	chr1:205757824	PM20D1	chr1:205797154-205819245:-	-0.34	-5.97	4.56E-9	Prostate cancer	
THCA	cis	1	rs1775148	chr1:205757824	RAB7L1	chr1:205737115-205744610:-	0.29	8.26	1.48E-15	Prostate cancer	
THCA	cis	1	rs1775151	chr1:205745684	PM20D1	chr1:205797154-205819245:-	-0.21	-3.48	0.000556	Parkinson's disease	
THCA	cis	1	rs1775151	chr1:205745684	RAB7L1	chr1:205737115-205744610:-	0.24	6.4	3.75E-10	Parkinson's disease	
THCA	cis	1	rs17752459	chr6:56798755	BEND6	chr6:56819773-56892138:+	-0.28	-5.99	4.1E-9	Menarche (age at onset)	
THCA	cis	1	rs17752459	chr6:56798755	KIAA1586	chr6:56911384-56920021:+	-0.33	-5.23	2.49E-7	Menarche (age at onset)	
THCA	cis	1	rs17756240	chr4:57355192	SRP72	chr4:57333762-57369846:+	-0.26	-5.02	7.4E-7	Airflow obstruction	
THCA	cis	1	rs17761723	chr17:2107090	SRR	chr17:2207248-2228553:+	0.81	16.81	3.52E-50	Esophageal cancer (squamous cell)	
THCA	cis	1	rs17761864	chr17:2171637	SRR	chr17:2207248-2228553:+	-0.81	-17.01	4.25E-51	Esophageal cancer (squamous cell)	
THCA	cis	1	rs17767392	chr14:71764777	SIPA1L1	chr14:71933902-72206118:+	0.27	5.57	4.19E-8	Mitral valve prolapse	
THCA	cis	1	rs17767523	chr14:71880739	SIPA1L1	chr14:71933902-72206118:+	0.27	5.53	5.21E-8	Mitral valve prolapse	
THCA	cis	1	rs17769643	chr16:77784975	NUDT7	chr16:77756411-77776153:+	0.36	4.96	9.82E-7	Obesity-related traits	
THCA	cis	1	rs17772064	chr14:88822871	SPATA7	chr14:88852012-88904802:+	-0.17	-3.61	0.000333	Coronary artery calcification	
THCA	cis	1	rs17772222	chr14:88826482	SPATA7	chr14:88852012-88904802:+	0.19	3.88	0.000118	Coronary artery calcification	
THCA	cis	1	rs17776563	chr15:89119104	DET1	chr15:89054788-89089912:-	-0.22	-3.65	0.000288	Thyroid hormone levels	
THCA	cis	1	rs17779301	chr19:52539243	ZNF432	chr19:52536678-52552073:-	0.18	4.47	9.79E-6	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	
THCA	cis	1	rs17779494	chr15:43579223	STRC	chr15:43891762-43924561:-	-0.28	-5.72	1.87E-8	Lung cancer	
THCA	cis	1	rs17780080	chr17:30343146	C17orf79	chr17:30178885-30186326:-	-0.23	-5.32	1.58E-7	Height	
THCA	cis	1	rs17780086	chr17:30343282	C17orf79	chr17:30178885-30186326:-	-0.23	-5.32	1.58E-7	Height	
THCA	cis	1	rs1778508	chr6:28229881	ZKSCAN3	chr6:28317691-28334523:+	0.26	5.15	3.73E-7	Depression	
THCA	cis	1	rs1778508	chr6:28229881	ZNF187	chr6:28234788-28245978:+	0.33	6.82	2.72E-11	Depression	
THCA	cis	1	rs1778508	chr6:28229881	ZNF323	chr6:28292517-28324048:-	-0.45	-6.26	8.68E-10	Depression	
THCA	cis	1	rs1778508	chr6:28229881	ZNF389	chr6:28129551-28137375:+	0.45	6.49	2.17E-10	Depression	
THCA	cis	1	rs1778508	chr6:28229881	ZSCAN23	chr6:28393287-28411279:-	-0.23	-5.05	6.27E-7	Depression	
THCA	cis	1	rs1778511	chr6:28229411	ZKSCAN3	chr6:28317691-28334523:+	0.27	5.25	2.35E-7	Depression	
THCA	cis	1	rs1778511	chr6:28229411	ZNF187	chr6:28234788-28245978:+	0.34	6.81	3.0E-11	Depression	
THCA	cis	1	rs1778511	chr6:28229411	ZNF193	chr6:28193067-28201260:+	-0.2	-3.76	0.000193	Depression	
THCA	cis	1	rs1778511	chr6:28229411	ZNF323	chr6:28292517-28324048:-	-0.45	-6.09	2.31E-9	Depression	
THCA	cis	1	rs1778511	chr6:28229411	ZNF389	chr6:28129551-28137375:+	0.48	6.8	3.1E-11	Depression	
THCA	cis	1	rs1778511	chr6:28229411	ZSCAN23	chr6:28393287-28411279:-	-0.23	-5.04	6.61E-7	Depression	
THCA	cis	1	rs17789174	chr16:85103885	ZDHHC7	chr16:85008067-85045141:-	-0.29	-4.78	2.3E-6	Dysphagia	
THCA	cis	1	rs17800886	chr5:150309539	LOC134466	chr5:150310000-150326146:-	0.43	5.68	2.37E-8	Crohn's disease	
THCA	cis	1	rs17800987	chr5:150323428	LOC134466	chr5:150310000-150326146:-	0.45	5.99	4.06E-9	Crohn's disease	
THCA	cis	1	rs17805619	chr8:117652016	EIF3H	chr8:117657056-117778494:-	-0.19	-3.46	0.000591	Body mass index	
THCA	cis	1	rs17806990	chr2:218312398	IGFBP5	chr2:217536829-217560272:-	-0.24	-5	8.14E-7	Metabolite levels (MHPG)	
THCA	cis	1	rs17809330	chr15:65889250	DPP8	chr15:65737999-65810035:-	0.08	3.59	0.000369	Mean corpuscular hemoglobin	
THCA	cis	1	rs17818028	chr17:53062755	STXBP4	chr17:53046126-53241449:+	0.14	3.67	0.000272	Breast cancer	
THCA	cis	1	rs17818028	chr17:53062755	TOM1L1	chr17:52978052-53039328:+	0.17	4.27	2.31E-5	Breast cancer	
THCA	cis	1	rs17818151	chr6:55943812	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs17818399	chr2:46826026	ATP6V1E2	chr2:46738988-46769696:-	-0.3	-5.47	7.23E-8	Height	
THCA	cis	1	rs17818399	chr2:46826026	CRIPT	chr2:46844325-46852880:+	0.24	4.57	6.35E-6	Height	
THCA	cis	1	rs17818561	chr6:56007398	COL21A1	chr6:55921389-56258892:-	-0.71	-8.8	2.42E-17	Psychosis (atypical)	
THCA	cis	1	rs17818687	chr6:56010117	COL21A1	chr6:55921389-56258892:-	-0.71	-8.8	2.42E-17	Psychosis (atypical)	
THCA	cis	1	rs1782468	chr1:207470415	CD55	chr1:207494817-207534309:+	0.2	7.86	2.54E-14	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs17826057	chr12:66633164	LLPH	chr12:66516850-66563807:-	-0.28	-3.37	0.000819	Smooth-surface caries	
THCA	cis	1	rs17826448	chr14:65852017	LOC645431	chr14:65877313-65879335:-	0.43	5.67	2.46E-8	Ischemic stroke	
THCA	cis	1	rs17826466	chr14:65852170	LOC645431	chr14:65877313-65879335:-	-0.41	-5.29	1.85E-7	Ischemic stroke	
THCA	cis	1	rs17826580	chr14:65915262	LOC645431	chr14:65877313-65879335:-	-0.59	-7.8	4.04E-14	Ischemic stroke	
THCA	cis	1	rs17826724	chr14:66068320	LOC645431	chr14:65877313-65879335:-	-0.49	-6.32	5.91E-10	Ischemic stroke	
THCA	cis	1	rs17826736	chr14:66082202	LOC645431	chr14:65877313-65879335:-	-0.51	-6.59	1.19E-10	Ischemic stroke	
THCA	cis	1	rs17826790	chr14:66103427	LOC645431	chr14:65877313-65879335:-	-0.57	-7.44	4.58E-13	Ischemic stroke	
THCA	cis	1	rs17826796	chr14:66104187	LOC645431	chr14:65877313-65879335:-	-0.57	-7.35	8.77E-13	Ischemic stroke	
THCA	cis	1	rs17826820	chr14:66113837	LOC645431	chr14:65877313-65879335:-	-0.61	-7.91	1.79E-14	Ischemic stroke	
THCA	cis	1	rs17831161	chr2:160909360	LY75	chr2:160625141-160761262:-	0.21	4.97	9.51E-7	Idiopathic membranous nephropathy	
THCA	cis	1	rs17831191	chr2:160911332	LY75	chr2:160625141-160761262:-	0.21	4.97	9.51E-7	Idiopathic membranous nephropathy	
THCA	cis	1	rs17831251	chr2:160914156	LY75	chr2:160625141-160761262:-	0.2	4.64	4.54E-6	Idiopathic membranous nephropathy	
THCA	cis	1	rs17831583	chr15:24597222	PWRN1	chr15:24778839-24832924:+	0.43	9.24	8.01E-19	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
THCA	cis	1	rs17834627	chr17:2198892	SRR	chr17:2207248-2228553:+	-0.82	-16.73	8.56E-50	Esophageal cancer (squamous cell)	
THCA	cis	1	rs17835749	chr19:52578695	ZNF432	chr19:52536678-52552073:-	-0.18	-4.57	6.14E-6	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	
THCA	cis	1	rs17839567	chr16:31057945	C16orf93	chr16:30768753-30773542:-	-0.15	-4.38	1.49E-5	Response to metformin (IC50)	
THCA	cis	1	rs17839567	chr16:31057945	HSD3B7	chr16:30996519-31000473:+	0.47	12.5	3.3E-31	Response to metformin (IC50)	
THCA	cis	1	rs17839567	chr16:31057945	MYST1	chr16:31128985-31142713:+	0.17	5.59	3.92E-8	Response to metformin (IC50)	
THCA	cis	1	rs17839567	chr16:31057945	PRSS53	chr16:31094747-31106276:-	-0.14	-3.92	0.000104	Response to metformin (IC50)	
THCA	cis	1	rs1783961	chr11:71576095	FAM86C	chr11:71498557-71512276:+	-0.37	-4.65	4.39E-6	Severe influenza A (H1N1) infection	
THCA	cis	1	rs17848459	chr22:51012311	CHKB	chr22:51017378-51021428:-	0.52	6.32	6.14E-10	Narcolepsy	
THCA	cis	1	rs17848459	chr22:51012311	CPT1B	chr22:51007291-51017096:-	-0.41	-8.3	1.04E-15	Narcolepsy	
THCA	cis	1	rs1785914	chr18:33700796	SLC39A6	chr18:33688495-33709357:-	-0.14	-3.92	0.000103	Esophageal squamous cell cancer (length of survival)	
THCA	cis	1	rs1785916	chr18:33696156	SLC39A6	chr18:33688495-33709357:-	0.14	3.95	8.81E-5	Esophageal squamous cell cancer (length of survival)	
THCA	cis	1	rs1785919	chr18:33691964	SLC39A6	chr18:33688495-33709357:-	0.13	3.87	0.000122	Esophageal squamous cell cancer (length of survival)	
THCA	cis	1	rs17860606	chr6:170099561	C6orf70	chr6:170151721-170181617:+	0.25	5.07	5.62E-7	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs17860606	chr6:170099561	WDR27	chr6:169857307-170102159:-	-0.2	-6.12	1.94E-9	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs17878846	chr10:104630412	AS3MT	chr10:104613967-104661653:+	-0.29	-3.78	0.000174	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs17878846	chr10:104630412	C10orf26	chr10:104503727-104591851:+	-0.23	-3.9	0.000109	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs17878846	chr10:104630412	SFXN2	chr10:104474298-104498946:+	-0.37	-4.35	1.69E-5	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs1789504	chr18:33696772	SLC39A6	chr18:33688495-33709357:-	0.14	3.95	8.81E-5	Esophageal squamous cell cancer (length of survival)	
THCA	cis	1	rs1789514	chr18:33692654	SLC39A6	chr18:33688495-33709357:-	0.13	3.77	0.000183	Esophageal squamous cell cancer (length of survival)	
THCA	cis	1	rs1789550	chr18:33699553	SLC39A6	chr18:33688495-33709357:-	-0.15	-4.37	1.51E-5	Esophageal squamous cell cancer (length of survival)	
THCA	cis	1	rs1789892	chr4:100250658	ADH1C	chr4:100257651-100273917:-	-0.19	-3.49	0.000537	Oral cavity and pharyngeal cancer	
THCA	cis	1	rs1789898	chr4:100258336	ADH1C	chr4:100257651-100273917:-	-0.18	-3.41	0.000703	Oral cavity and pharyngeal cancer	
THCA	cis	1	rs1789903	chr4:100262041	ADH1C	chr4:100257651-100273917:-	-0.18	-3.34	0.000897	Oral cavity and pharyngeal cancer	
THCA	cis	1	rs1789906	chr4:100263219	ADH1C	chr4:100257651-100273917:-	-0.18	-3.36	0.00083	Oral cavity and pharyngeal cancer	
THCA	cis	1	rs1789911	chr4:100263778	ADH1C	chr4:100257651-100273917:-	-0.19	-3.66	0.000276	Oral cavity and pharyngeal cancer	
THCA	cis	1	rs1789917	chr4:100267164	ADH1C	chr4:100257651-100273917:-	-0.18	-3.36	0.00085	Oral cavity and pharyngeal cancer	
THCA	cis	1	rs1789919	chr4:100267719	ADH1C	chr4:100257651-100273917:-	-0.18	-3.36	0.00085	Oral cavity and pharyngeal cancer	
THCA	cis	1	rs1795379	chr12:75941042	GLIPR1L2	chr12:75784889-75825591:+	-0.42	-6.78	3.45E-11	Polycystic ovary syndrome	
THCA	cis	1	rs1795967	chr12:122344302	WDR66	chr12:122356480-122441830:+	-0.22	-3.59	0.000358	Urinary metabolites	
THCA	cis	1	rs1796220	chr7:66062100	CCT6P1	chr7:65216092-65228661:+	0.43	6.62	9.65E-11	Diabetic kidney disease	
THCA	cis	1	rs1796220	chr7:66062100	CRCP	chr7:65579805-65619551:+	-0.28	-4.24	2.66E-5	Diabetic kidney disease	
THCA	cis	1	rs1796220	chr7:66062100	GUSB	chr7:65425675-65447246:-	0.28	3.42	0.000676	Diabetic kidney disease	
THCA	cis	1	rs1796220	chr7:66062100	RABGEF1	chr7:66093890-66276446:+	0.63	7.72	6.86E-14	Diabetic kidney disease	
THCA	cis	1	rs1796228	chr7:66033084	CCT6P1	chr7:65216092-65228661:+	0.43	6.6	1.09E-10	Diabetic kidney disease	
THCA	cis	1	rs1796228	chr7:66033084	CRCP	chr7:65579805-65619551:+	-0.27	-3.99	7.67E-5	Diabetic kidney disease	
THCA	cis	1	rs1796228	chr7:66033084	GUSB	chr7:65425675-65447246:-	0.28	3.42	0.00069	Diabetic kidney disease	
THCA	cis	1	rs1796228	chr7:66033084	RABGEF1	chr7:66093890-66276446:+	0.63	7.67	9.47E-14	Diabetic kidney disease	
THCA	cis	1	rs1797052	chr1:145727683	GNRHR2	chr1:145509753-145516076:-	0.25	3.9	0.000111	Contrast sensitivity	
THCA	cis	1	rs1797313	chr15:50485464	SLC27A2	chr15:50474393-50528588:+	-0.18	-3.36	0.000844	Blood metabolite ratios	
THCA	cis	1	rs1799867	chr11:46747979	ZNF408	chr11:46722368-46727461:+	-0.18	-3.55	0.000424	HDL cholesterol	
THCA	cis	1	rs1799958	chr12:121176083	ACADS	chr12:121163571-121177810:+	0.12	3.37	0.000826	Urinary metabolites (H-NMR features)	
THCA	cis	1	rs1800615	chr1:15832281	C1orf144	chr1:16693583-16724639:+	0.2	3.45	0.000608	Glomerular filtration rate (creatinine)	
THCA	cis	1	rs1800615	chr1:15832281	CASP9	chr1:15817324-15851384:-	0.41	9.76	1.25E-20	Glomerular filtration rate (creatinine)	
THCA	cis	1	rs1800615	chr1:15832281	DNAJC16	chr1:15853352-15918872:+	0.24	5.75	1.59E-8	Glomerular filtration rate (creatinine)	
THCA	cis	1	rs1800615	chr1:15832281	SLC25A34	chr1:16062809-16067885:+	0.14	3.52	0.000481	Glomerular filtration rate (creatinine)	
THCA	cis	1	rs1800662	chr10:102289078	SEC31B	chr10:102246403-102289636:-	-0.28	-8.91	1.04E-17	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs1800794	chr2:113543273	IL1RN	chr2:113856937-113891592:+	-0.13	-3.52	0.000471	Response to antipsychotic treatment in schizophrenia (working memory)	
THCA	cis	1	rs1801085	chr7:27168590	HOXA9	chr7:27202058-27205149:-	-0.38	-4.37	1.55E-5	Hypospadias	
THCA	cis	1	rs1801516	chr11:108175462	ACAT1	chr11:107992258-108018889:+	-0.33	-7.22	2.11E-12	Melanoma	
THCA	cis	1	rs1801	chr4:103501054	NFKB1	chr4:103422486-103538458:+	-0.16	-4.5	8.42E-6	Ulcerative colitis	
THCA	cis	1	rs1802295	chr10:70931474	HKDC1	chr10:70980059-71027314:+	0.25	4.55	6.95E-6	Type 2 diabetes	
THCA	cis	1	rs1805165	chr2:88874891	RPIA	chr2:88991176-89050451:+	-0.36	-6.71	5.38E-11	Height	
THCA	cis	1	rs1806263	chr17:5317492	C1QBP	chr17:5336099-5342471:-	-0.15	-4.4	1.31E-5	Body mass index	
THCA	cis	1	rs1806263	chr17:5317492	NLRP1	chr17:5404719-5487832:-	0.22	4.6	5.51E-6	Body mass index	
THCA	cis	1	rs1806263	chr17:5317492	RABEP1	chr17:5185558-5289131:+	0.11	3.38	0.000791	Body mass index	
THCA	cis	1	rs1806618	chr1:146848796	FMO5	chr1:146655885-146697230:-	0.26	4.12	4.55E-5	Protein quantitative trait loci	
THCA	cis	1	rs180730	chr4:121801790	C4orf31	chr4:121956782-121993673:-	-0.2	-3.72	0.000223	Fasting plasma glucose	
THCA	cis	1	rs1807609	chr22:29131129	CHEK2	chr22:29083731-29137822:-	-0.17	-3.96	8.5E-5	Esophageal cancer and gastric cancer	
THCA	cis	1	rs1808382	chr19:39151034	LGALS7	chr19:39261608-39264157:-	-0.22	-4.41	1.29E-5	Heart rate	
THCA	cis	1	rs1808579	chr18:21104888	NPC1	chr18:21108363-21166581:-	0.15	4.94	1.09E-6	Body mass index	
THCA	cis	1	rs1810049	chr15:84576052	LOC388152	chr15:84867600-84898920:-	-0.21	-4	7.19E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs181099388	chr4:39462030	RPL9	chr4:39455747-39460568:-	-0.51	-4.01	7.06E-5	Classic bladder exstrophy	
THCA	cis	1	rs181099388	chr4:39462030	UGDH	chr4:39500375-39529211:-	-0.31	-3.4	0.000724	Classic bladder exstrophy	
THCA	cis	1	rs1813217	chr11:59872498	MS4A14	chr11:60145958-60185226:+	0.16	4.2	3.15E-5	Alzheimer's disease (late onset)	
THCA	cis	1	rs181394970	chr2:86776235	VPS24	chr2:86730554-86948245:-	0.22	4.59	5.74E-6	Glomerular filtration rate in chronic kidney disease	
THCA	cis	1	rs1814336	chr3:134200823	ANAPC13	chr3:134196547-134204865:-	0.4	12.87	8.95E-33	Height	
THCA	cis	1	rs1814336	chr3:134200823	CEP63	chr3:134204575-134293852:+	0.29	6.28	7.84E-10	Height	
THCA	cis	1	rs1814337	chr3:134200682	ANAPC13	chr3:134196547-134204865:-	0.39	12.72	3.83E-32	Height	
THCA	cis	1	rs1814337	chr3:134200682	CEP63	chr3:134204575-134293852:+	0.29	6.42	3.33E-10	Height	
THCA	cis	1	rs1815314	chr10:80928793	LOC219347	chr10:81805991-81838949:-	0.21	3.91	0.000106	Sitting height ratio;Height	
THCA	cis	1	rs1815314	chr10:80928793	MBL1P	chr10:81664654-81710783:+	0.14	3.38	0.000792	Sitting height ratio;Height	
THCA	cis	1	rs1815338	chr10:91376691	FLJ37201	chr10:91451057-91457685:-	-0.18	-3.74	0.000209	Metabolic traits	
THCA	cis	1	rs1815787	chr11:116921397	PCSK7	chr11:117075789-117102811:-	-0.3	-5.48	6.97E-8	Subjective well-being	
THCA	cis	1	rs1816256	chr5:150272853	LOC134466	chr5:150310000-150326146:-	0.41	5.69	2.26E-8	Crohn's disease	
THCA	cis	1	rs1817684	chr8:89464778	MMP16	chr8:89049462-89339717:-	0.33	5.33	1.52E-7	Electrodermal activity	
THCA	cis	1	rs1818950	chr15:84722521	GOLGA6L5	chr15:85047738-85060078:-	-0.2	-5.14	3.95E-7	Schizophrenia	
THCA	cis	1	rs1818950	chr15:84722521	LOC388152	chr15:84867600-84898920:-	-0.72	-13.09	1.09E-33	Schizophrenia	
THCA	cis	1	rs1818950	chr15:84722521	NMB	chr15:85198362-85201802:-	0.23	4.73	2.91E-6	Schizophrenia	
THCA	cis	1	rs1818950	chr15:84722521	SH3GL3	chr15:84116091-84287491:+	0.23	3.69	0.000247	Schizophrenia	
THCA	cis	1	rs1820682	chr5:150262142	LOC134466	chr5:150310000-150326146:-	0.38	5.28	2.01E-7	Crohn's disease	
THCA	cis	1	rs1823061	chr19:37800626	ZNF607	chr19:38187276-38210691:-	-0.21	-3.77	0.000185	Coronary artery calcification	
THCA	cis	1	rs1823694	chr5:101677341	SLCO4C1	chr5:101569694-101632253:-	0.25	5.62	3.21E-8	Schizophrenia	
THCA	cis	1	rs1823874	chr15:100357435	C15orf51	chr15:100330361-100347132:-	-0.45	-9.25	7.41E-19	IgG glycosylation	
THCA	cis	1	rs1824913	chr13:95867042	ABCC4	chr13:95672084-95953687:-	-0.19	-3.64	0.000303	Breast cancer	
THCA	cis	1	rs1825332	chr8:94086798	C8orf83	chr8:93895865-94029901:-	0.21	3.48	0.00054	Attention deficit hyperactivity disorder	
THCA	cis	1	rs1830074	chr7:6718674	C7orf28B	chr7:6838572-6865861:-	-0.26	-3.98	8.02E-5	Body mass index	
THCA	cis	1	rs1830074	chr7:6718674	PMS2CL	chr7:6749757-6793492:+	-0.45	-8.1	4.71E-15	Body mass index	
THCA	cis	1	rs1830074	chr7:6718674	ZNF12	chr7:6728064-6746566:-	-0.14	-3.76	0.000194	Body mass index	
THCA	cis	1	rs1830454	chr9:102718133	STX17	chr9:102668915-102736817:+	-0.16	-4.2	3.25E-5	Alopecia areata	
THCA	cis	1	rs1832558	chr1:121177380	HIST2H2BA	chr1:120906034-120914842:+	0.22	4.94	1.06E-6	Hip geometry	
THCA	cis	1	rs1833896	chr5:56097669	C5orf35	chr5:56205103-56213010:+	0.98	22.39	1.72E-76	Type 2 diabetes	
THCA	cis	1	rs1834481	chr11:112023827	BCO2	chr11:112046208-112095421:+	-0.22	-4.32	1.93E-5	Interleukin-18 levels	
THCA	cis	1	rs1834481	chr11:112023827	IL18	chr11:112013976-112034840:-	0.24	4.62	4.93E-6	Interleukin-18 levels	
THCA	cis	1	rs1835158	chr2:227763993	COL4A4	chr2:227867435-228029275:-	0.16	3.94	9.25E-5	Pulmonary function	
THCA	cis	1	rs1835307	chr1:207426565	CD55	chr1:207494817-207534309:+	0.15	6.72	5.14E-11	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs183618	chr17:53235974	COX11	chr17:53029259-53046064:-	0.21	5.11	4.68E-7	Menarche (age at onset)	
THCA	cis	1	rs1839622	chr12:7334534	PEX5	chr12:7341759-7371167:+	0.42	10	1.72E-21	IgG glycosylation	
THCA	cis	1	rs1839972	chr15:90891354	IQGAP1	chr15:90931473-91045475:+	0.12	4.23	2.85E-5	Rheumatoid arthritis	
THCA	cis	1	rs1839972	chr15:90891354	TTLL13	chr15:90792764-90815443:+	0.2	3.81	0.000158	Rheumatoid arthritis	
THCA	cis	1	rs1841777	chr3:38484819	LOC100128640	chr3:38492524-38496311:-	0.23	4.89	1.35E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs1841777	chr3:38484819	SCN5A	chr3:38589554-38691164:-	0.17	3.49	0.000531	Electrocardiographic conduction measures	
THCA	cis	1	rs1841777	chr3:38484819	XYLB	chr3:38388251-38456467:+	0.21	5.02	7.16E-7	Electrocardiographic conduction measures	
THCA	cis	1	rs184182	chr5:37005105	C5orf42	chr5:37106330-37249530:-	-0.09	-3.63	0.00031	Height	
THCA	cis	1	rs1844056	chr8:89460105	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs184668	chr4:121809967	C4orf31	chr4:121956782-121993673:-	-0.21	-3.87	0.000123	Fasting plasma glucose	
THCA	cis	1	rs1846803	chr13:85736057	SLITRK6	chr13:86366922-86373483:-	-0.2	-3.68	0.000262	Bipolar disorder (mania)	
THCA	cis	1	rs1847202	chr3:72934371	GXYLT2	chr3:72937385-73024520:+	0.24	5.2	2.93E-7	Motion sickness	
THCA	cis	1	rs1847575	chr8:89462925	MMP16	chr8:89049462-89339717:-	0.33	5.29	1.88E-7	Electrodermal activity	
THCA	cis	1	rs1848048	chr11:18468996	LDHC	chr11:18433853-18472792:+	-0.33	-3.94	9.26E-5	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs1848093	chr15:84755527	GOLGA6L5	chr15:85047738-85060078:-	-0.21	-5.39	1.1E-7	Schizophrenia	
THCA	cis	1	rs1848093	chr15:84755527	LOC388152	chr15:84867600-84898920:-	-0.72	-13.04	1.82E-33	Schizophrenia	
THCA	cis	1	rs1848093	chr15:84755527	NMB	chr15:85198362-85201802:-	0.23	4.54	7.12E-6	Schizophrenia	
THCA	cis	1	rs1848093	chr15:84755527	SH3GL3	chr15:84116091-84287491:+	0.24	3.77	0.000182	Schizophrenia	
THCA	cis	1	rs1849004	chr19:22142455	ZNF492	chr19:22817126-22850472:+	0.24	3.37	0.000806	Body mass index (change over time)	
THCA	cis	1	rs1852212	chr3:119279235	ADPRH	chr3:119298523-119308791:+	-0.22	-3.51	0.000482	Vitiligo	
THCA	cis	1	rs1852264	chr15:84589940	LOC388152	chr15:84867600-84898920:-	-0.2	-3.81	0.000157	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs1852863	chr9:102712416	STX17	chr9:102668915-102736817:+	-0.16	-4.17	3.68E-5	Alopecia areata	
THCA	cis	1	rs1853665	chr6:150298842	RAET1K	chr6:150319157-150326280:-	-0.33	-4.4	1.32E-5	Radiation response	
THCA	cis	1	rs1853665	chr6:150298842	ULBP1	chr6:150285143-150294844:+	-0.49	-7.48	3.58E-13	Radiation response	
THCA	cis	1	rs1853665	chr6:150298842	ULBP2	chr6:150263136-150270366:+	-0.32	-5.14	4.09E-7	Radiation response	
THCA	cis	1	rs1854774	chr4:129988405	C4orf33	chr4:130014829-130033842:+	-0.6	-9.44	1.62E-19	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs185538822	chr4:106803682	INTS12	chr4:106603787-106629881:-	-0.62	-5.22	2.72E-7	Post bronchodilator FEV1	
THCA	cis	1	rs1856572	chr1:121169579	HIST2H2BA	chr1:120906034-120914842:+	0.22	5.07	5.76E-7	Hip geometry	
THCA	cis	1	rs1856859	chr6:151860110	C6orf97	chr6:151815175-151942327:+	-0.27	-3.81	0.000157	Bone mineral density (spine)	
THCA	cis	1	rs1857344	chr10:30521180	KIAA1462	chr10:30301729-30404420:-	0.17	3.41	0.000706	Pancreatitis	
THCA	cis	1	rs1857964	chr6:86635994	SNHG5	chr6:86386726-86388451:-	-0.49	-10.88	8.91E-25	Response to antipsychotic treatment	
THCA	cis	1	rs1857965	chr6:86630776	SNHG5	chr6:86386726-86388451:-	-0.48	-10.64	6.96E-24	Response to antipsychotic treatment	
THCA	cis	1	rs1858001	chr1:207488004	CD55	chr1:207494817-207534309:+	-0.16	-7	8.85E-12	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs1858482	chr1:152306921	FLG	chr1:152274651-152297679:-	-0.29	-4.46	1.03E-5	Atopic dermatitis	
THCA	cis	1	rs1858482	chr1:152306921	HRNR	chr1:152184558-152196669:-	0.46	6.52	1.77E-10	Atopic dermatitis	
THCA	cis	1	rs1858821	chr22:31676454	RNF185	chr22:31556138-31603004:+	-0.28	-5.11	4.77E-7	Paclitaxel-induced neuropathy	
THCA	cis	1	rs185968827	chr6:56708510	BEND6	chr6:56819773-56892138:+	-0.19	-3.72	0.000227	Alzheimer disease and age of onset	
THCA	cis	1	rs1859690	chr7:99227172	ATP5J2	chr7:99055785-99063808:-	-0.18	-3.93	9.62E-5	Blood metabolite levels	
THCA	cis	1	rs1859690	chr7:99227172	ZNF655	chr7:99156045-99174074:+	-0.17	-3.46	0.000583	Blood metabolite levels	
THCA	cis	1	rs1860463	chr7:151119332	CRYGN	chr7:151127057-151137899:-	0.15	3.7	0.000242	Coronary heart disease	
THCA	cis	1	rs1860596	chr4:17660082	MED28	chr4:17616273-17629791:+	0.17	3.67	0.000275	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs1861444	chr2:37464511	CEBPZ	chr2:37428778-37458740:-	0.19	4.16	3.82E-5	Chronic lymphocytic leukemia	
THCA	cis	1	rs1861662	chr16:50107383	HEATR3	chr16:50099881-50139373:+	0.4	6.14	1.75E-9	Esophageal cancer (squamous cell)	
THCA	cis	1	rs1862619	chr5:56098256	C5orf35	chr5:56205103-56213010:+	0.98	22.39	1.72E-76	Type 2 diabetes	
THCA	cis	1	rs186378	chr7:65582058	CCT6P1	chr7:65216092-65228661:+	0.41	6.74	4.45E-11	Diabetic kidney disease	
THCA	cis	1	rs186378	chr7:65582058	CRCP	chr7:65579805-65619551:+	-0.3	-4.74	2.8E-6	Diabetic kidney disease	
THCA	cis	1	rs186378	chr7:65582058	LOC493754	chr7:65993446-66057363:-	0.3	3.58	0.000372	Diabetic kidney disease	
THCA	cis	1	rs186378	chr7:65582058	RABGEF1	chr7:66093890-66276446:+	0.53	6.78	3.48E-11	Diabetic kidney disease	
THCA	cis	1	rs1863808	chr2:137334985	THSD7B	chr2:137523115-138435287:+	0.21	3.87	0.000124	Cognitive test performance	
THCA	cis	1	rs1863913	chr3:134200205	ANAPC13	chr3:134196547-134204865:-	0.37	11.72	4.51E-28	Height	
THCA	cis	1	rs1863913	chr3:134200205	CEP63	chr3:134204575-134293852:+	0.3	6.45	2.68E-10	Height	
THCA	cis	1	rs1863998	chr5:150271753	LOC134466	chr5:150310000-150326146:-	0.4	5.5	6.21E-8	Crohn's disease	
THCA	cis	1	rs1864367	chr3:53111704	ITIH4	chr3:52847007-52866554:-	0.16	4.59	5.59E-6	Height	
THCA	cis	1	rs1864367	chr3:53111704	RFT1	chr3:53122503-53164470:-	-0.75	-18.37	2.05E-57	Height	
THCA	cis	1	rs1864395	chr10:43655697	CSGALNACT2	chr10:43633934-43680747:+	-0.19	-6.64	8.76E-11	Hirschsprung disease	
THCA	cis	1	rs1864399	chr10:43610455	CSGALNACT2	chr10:43633934-43680747:+	-0.21	-7.38	6.88E-13	Hirschsprung disease	
THCA	cis	1	rs1864410	chr10:43575625	CSGALNACT2	chr10:43633934-43680747:+	-0.16	-5.16	3.57E-7	Hirschsprung disease	
THCA	cis	1	rs1864498	chr11:4479216	TRIM68	chr11:4619902-4629437:-	0.15	3.37	0.000819	Amyotrophic lateral sclerosis	
THCA	cis	1	rs1865228	chr16:82498047	CDH13	chr16:82660578-83830197:+	-0.21	-4.11	4.69E-5	D-dimer levels;White matter microstructure (global fractional anisotropy)	
THCA	cis	1	rs1867146	chr15:75354971	ARID3B	chr15:74833548-74890470:+	-0.14	-3.7	0.000239	Blood trace element (Zn levels)	
THCA	cis	1	rs1867146	chr15:75354971	MAN2C1	chr15:75648135-75660941:-	0.15	3.56	0.000407	Blood trace element (Zn levels)	
THCA	cis	1	rs1867146	chr15:75354971	PPCDC	chr15:75315927-75343066:+	0.14	4.11	4.72E-5	Blood trace element (Zn levels)	
THCA	cis	1	rs1867146	chr15:75354971	SCAMP5	chr15:75287901-75313836:+	0.44	7.64	1.17E-13	Blood trace element (Zn levels)	
THCA	cis	1	rs1869103	chr5:101679449	SLCO4C1	chr5:101569694-101632253:-	0.25	5.62	3.21E-8	Schizophrenia	
THCA	cis	1	rs1869171	chr4:75718407	BTC	chr4:75671448-75719882:-	0.22	4.41	1.3E-5	Electroencephalogram traits	
THCA	cis	1	rs1869172	chr4:75718366	BTC	chr4:75671448-75719882:-	0.23	4.67	3.98E-6	Electroencephalogram traits	
THCA	cis	1	rs1869365	chr17:40293865	HSPB9	chr17:40274756-40275371:+	0.33	4.84	1.78E-6	Fibrinogen levels	
THCA	cis	1	rs1869596	chr1:110624104	ALX3	chr1:110602998-110613322:-	-0.31	-7.65	1.14E-13	Blood metabolite levels	
THCA	cis	1	rs1871541	chr8:145681713	KIFC2	chr8:145691738-145699498:+	-0.14	-4.27	2.37E-5	Age at first birth	
THCA	cis	1	rs1871541	chr8:145681713	LRRC14	chr8:145743391-145750557:+	0.18	5.17	3.4E-7	Age at first birth	
THCA	cis	1	rs1871541	chr8:145681713	RECQL4	chr8:145736672-145743200:-	0.15	3.48	0.000552	Age at first birth	
THCA	cis	1	rs1871541	chr8:145681713	ZNF34	chr8:145998503-146012725:-	0.15	4.01	6.9E-5	Age at first birth	
THCA	cis	1	rs1872329	chr2:54471823	C2orf73	chr2:54558071-54588714:+	0.31	4.4	1.33E-5	Telomere length	
THCA	cis	1	rs1872505	chr6:47480975	CD2AP	chr6:47445525-47594994:+	0.15	3.78	0.000177	Alzheimer's disease (late onset)	
THCA	cis	1	rs1872829	chr12:32535100	DENND5B	chr12:31535157-31743952:-	-0.18	-3.43	0.000662	Response to tocilizumab in rheumatoid arthritis	
THCA	cis	1	rs1872829	chr12:32535100	FGD4	chr12:32638906-32798982:+	-0.29	-7.52	2.66E-13	Response to tocilizumab in rheumatoid arthritis	
THCA	cis	1	rs1873494	chr7:65649899	CCT6P1	chr7:65216092-65228661:+	-0.42	-6.7	5.9E-11	Diabetic kidney disease	
THCA	cis	1	rs1873494	chr7:65649899	CRCP	chr7:65579805-65619551:+	0.3	4.63	4.66E-6	Diabetic kidney disease	
THCA	cis	1	rs1873494	chr7:65649899	LOC493754	chr7:65993446-66057363:-	-0.29	-3.36	0.000833	Diabetic kidney disease	
THCA	cis	1	rs1873494	chr7:65649899	RABGEF1	chr7:66093890-66276446:+	-0.57	-7.14	3.42E-12	Diabetic kidney disease	
THCA	cis	1	rs187455071	chr4:106805884	INTS12	chr4:106603787-106629881:-	-0.62	-5.22	2.72E-7	Post bronchodilator FEV1	
THCA	cis	1	rs1874883	chr3:134205071	ANAPC13	chr3:134196547-134204865:-	0.4	12.88	8.74E-33	Height	
THCA	cis	1	rs1874883	chr3:134205071	CEP63	chr3:134204575-134293852:+	0.29	6.25	9.04E-10	Height	
THCA	cis	1	rs1875124	chr12:58196802	FAM119B	chr12:58166383-58176323:+	0.4	10.89	8.3E-25	Multiple sclerosis	
THCA	cis	1	rs1875124	chr12:58196802	METTL1	chr12:58162352-58165914:-	-0.19	-4.67	3.99E-6	Multiple sclerosis	
THCA	cis	1	rs1875124	chr12:58196802	TSFM	chr12:58176536-58191367:+	-0.59	-20.24	2.97E-66	Multiple sclerosis	
THCA	cis	1	rs1875124	chr12:58196802	XRCC6BP1	chr12:58335445-58351051:+	-0.22	-4.4	1.36E-5	Multiple sclerosis	
THCA	cis	1	rs1875714	chr8:68427547	PREX2	chr8:68864348-69143897:+	-0.12	-3.51	0.000498	Educational attainment	
THCA	cis	1	rs1875903	chr8:89417410	MMP16	chr8:89049462-89339717:-	0.32	5.19	3.04E-7	Electrodermal activity	
THCA	cis	1	rs1876219	chr4:17961415	DCAF16	chr4:17802280-17812381:-	-0.2	-4.37	1.51E-5	Height	
THCA	cis	1	rs1876673	chr5:115450773	COMMD10	chr5:115420727-115628978:+	0.48	5.75	1.63E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs1876674	chr5:115450969	COMMD10	chr5:115420727-115628978:+	0.48	6.05	2.86E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs1877316	chr17:61766880	FTSJ3	chr17:61896795-61905031:-	0.3	5.7	2.11E-8	Body mass index	
THCA	cis	1	rs1877316	chr17:61766880	MAP3K3	chr17:61699775-61773669:+	0.25	5.18	3.23E-7	Body mass index	
THCA	cis	1	rs1879344	chr15:56488827	TEX9	chr15:56657644-56738071:+	-0.34	-5.88	7.84E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs1879345	chr15:56488934	TEX9	chr15:56657644-56738071:+	-0.34	-5.88	7.84E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs1879347	chr15:56489159	MNS1	chr15:56720929-56757335:-	0.23	3.39	0.000759	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs1879347	chr15:56489159	TEX9	chr15:56657644-56738071:+	0.34	6.07	2.68E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs1879349	chr15:56485061	MNS1	chr15:56720929-56757335:-	-0.24	-3.51	0.000493	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs1879349	chr15:56485061	TEX9	chr15:56657644-56738071:+	-0.35	-5.96	4.99E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs1879420	chr3:150466564	COMMD2	chr3:149456260-149470278:-	0.32	3.58	0.000379	Breast cancer	
THCA	cis	1	rs1880023	chr4:8480831	C4orf23	chr4:8440604-8495258:+	0.33	7.17	2.81E-12	Response to antineoplastic agents	
THCA	cis	1	rs1880376	chr3:134270347	ANAPC13	chr3:134196547-134204865:-	-0.39	-12.14	9.6E-30	Height	
THCA	cis	1	rs1880376	chr3:134270347	CEP63	chr3:134204575-134293852:+	-0.31	-6.6	1.07E-10	Height	
THCA	cis	1	rs1880377	chr3:134270468	ANAPC13	chr3:134196547-134204865:-	-0.39	-12.14	9.6E-30	Height	
THCA	cis	1	rs1880377	chr3:134270468	CEP63	chr3:134204575-134293852:+	-0.31	-6.6	1.07E-10	Height	
THCA	cis	1	rs1880730	chr15:84584184	LOC388152	chr15:84867600-84898920:-	-0.21	-3.98	7.86E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs1881123	chr7:1084706	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.02	7.29E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs1881245	chr2:73649928	ALMS1P	chr2:73872046-73912692:+	0.68	10.6	1.01E-23	Metabolite levels	
THCA	cis	1	rs1881245	chr2:73649928	NAT8	chr2:73867850-73869537:-	0.35	5.42	9.33E-8	Metabolite levels	
THCA	cis	1	rs1881245	chr2:73649928	TPRKB	chr2:73956957-73964517:-	-0.19	-4.77	2.41E-6	Metabolite levels	
THCA	cis	1	rs1882099	chr4:1352685	CRIPAK	chr4:1385340-1389782:+	0.34	6.84	2.41E-11	Systolic blood pressure	
THCA	cis	1	rs1882655	chr7:66147057	CCT6P1	chr7:65216092-65228661:+	-0.44	-6.76	4.09E-11	Gout	
THCA	cis	1	rs1882655	chr7:66147057	CRCP	chr7:65579805-65619551:+	0.3	4.53	7.43E-6	Gout	
THCA	cis	1	rs1882655	chr7:66147057	GUSB	chr7:65425675-65447246:-	-0.29	-3.5	0.000507	Gout	
THCA	cis	1	rs1882655	chr7:66147057	RABGEF1	chr7:66093890-66276446:+	-0.63	-7.73	6.6E-14	Gout	
THCA	cis	1	rs1884066	chr14:67452834	ATP6V1D	chr14:67761090-67826591:-	0.2	4.69	3.59E-6	Depression (quantitative trait)	
THCA	cis	1	rs1884066	chr14:67452834	EIF2S1	chr14:67827034-67853232:+	-0.23	-4.95	1.02E-6	Depression (quantitative trait)	
THCA	cis	1	rs1884418	chr20:55070076	C20orf43	chr20:55043647-55093942:+	0.28	7.58	1.84E-13	Refractive astigmatism	
THCA	cis	1	rs1884418	chr20:55070076	CSTF1	chr20:54967427-54979582:+	0.17	3.49	0.000525	Refractive astigmatism	
THCA	cis	1	rs1884946	chr6:26545308	BTN2A3	chr6:26422317-26431927:+	0.18	4.32	1.92E-5	Educational attainment	
THCA	cis	1	rs1884946	chr6:26545308	HCG11	chr6:26521934-26527610:+	-0.22	-4.33	1.81E-5	Educational attainment	
THCA	cis	1	rs1884946	chr6:26545308	HMGN4	chr6:26538572-26547162:+	-0.16	-4.02	6.82E-5	Educational attainment	
THCA	cis	1	rs1884946	chr6:26545308	ZNF322A	chr6:26634612-26659963:-	-0.14	-3.91	0.000108	Educational attainment	
THCA	cis	1	rs1884948	chr6:26567988	BTN2A3	chr6:26422317-26431927:+	0.18	4.31	2.0E-5	Educational attainment	
THCA	cis	1	rs1884948	chr6:26567988	HCG11	chr6:26521934-26527610:+	-0.22	-4.28	2.24E-5	Educational attainment	
THCA	cis	1	rs1884948	chr6:26567988	HMGN4	chr6:26538572-26547162:+	-0.16	-4.13	4.35E-5	Educational attainment	
THCA	cis	1	rs1884948	chr6:26567988	LOC100270746	chr6:26987146-26988085:-	-0.15	-3.49	0.000531	Educational attainment	
THCA	cis	1	rs1884948	chr6:26567988	ZNF322A	chr6:26634612-26659963:-	-0.16	-4.63	4.82E-6	Educational attainment	
THCA	cis	1	rs1884949	chr6:26568067	BTN2A3	chr6:26422317-26431927:+	0.17	4.08	5.32E-5	Educational attainment	
THCA	cis	1	rs1884949	chr6:26568067	HCG11	chr6:26521934-26527610:+	-0.21	-4.12	4.48E-5	Educational attainment	
THCA	cis	1	rs1884949	chr6:26568067	HMGN4	chr6:26538572-26547162:+	-0.16	-4.09	5.14E-5	Educational attainment	
THCA	cis	1	rs1884949	chr6:26568067	LOC100270746	chr6:26987146-26988085:-	-0.14	-3.42	0.000687	Educational attainment	
THCA	cis	1	rs1884949	chr6:26568067	ZNF322A	chr6:26634612-26659963:-	-0.16	-4.65	4.4E-6	Educational attainment	
THCA	cis	1	rs188541	chr5:37061261	C5orf42	chr5:37106330-37249530:-	-0.09	-3.76	0.000192	Height	
THCA	cis	1	rs1885986	chr17:2203175	SRR	chr17:2207248-2228553:+	-0.82	-16.67	1.58E-49	Esophageal cancer (squamous cell)	
THCA	cis	1	rs1886242	chr6:35117656	TCP11	chr6:35085849-35109187:-	0.22	3.48	0.000548	Airway responsiveness in chronic obstructive pulmonary disease	
THCA	cis	1	rs1886242	chr6:35117656	UHRF1BP1	chr6:34759794-34853117:+	0.11	3.81	0.000157	Airway responsiveness in chronic obstructive pulmonary disease	
THCA	cis	1	rs1886972	chr13:24436230	C1QTNF9B	chr13:24465238-24471641:-	-0.35	-3.53	0.00045	3-hydroxypropylmercapturic acid levels in smokers	
THCA	cis	1	rs1887761	chr6:158275007	SNX9	chr6:158244294-158366109:+	-0.22	-3.51	0.000497	Lipoprotein (a) - cholesterol levels	
THCA	cis	1	rs1888997	chr20:25298988	ENTPD6	chr20:25176339-25207360:+	0.31	7.15	3.38E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs1888997	chr20:25298988	FAM182A	chr20:26035250-26067552:+	0.19	3.45	0.000609	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs1888997	chr20:25298988	FAM182B	chr20:25744102-25848786:-	-0.25	-5.29	1.9E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs1888997	chr20:25298988	NINL	chr20:25433338-25566153:-	0.36	7.49	3.3E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs1888997	chr20:25298988	PYGB	chr20:25228706-25278647:+	0.15	3.74	0.000202	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs1888998	chr20:25291826	ENTPD6	chr20:25176339-25207360:+	0.31	6.96	1.09E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs1888998	chr20:25291826	FAM182A	chr20:26035250-26067552:+	0.18	3.41	0.000693	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs1888998	chr20:25291826	FAM182B	chr20:25744102-25848786:-	-0.26	-5.37	1.21E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs1888998	chr20:25291826	NINL	chr20:25433338-25566153:-	0.37	7.55	2.24E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs1888998	chr20:25291826	PYGB	chr20:25228706-25278647:+	0.15	3.71	0.000228	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs1888999	chr20:25291848	ENTPD6	chr20:25176339-25207360:+	-0.3	-6.76	4.05E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs1888999	chr20:25291848	FAM182B	chr20:25744102-25848786:-	0.25	5.33	1.55E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs1888999	chr20:25291848	NINL	chr20:25433338-25566153:-	-0.37	-7.55	2.3E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs1888999	chr20:25291848	PYGB	chr20:25228706-25278647:+	-0.14	-3.62	0.000329	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs1890473	chr1:47149794	CYP4Z1	chr1:47533160-47583992:+	0.23	3.42	0.000671	Response to hepatitis C treatment	
THCA	cis	1	rs1890967	chr1:76459544	ACADM	chr1:76190043-76229353:+	-0.22	-4.56	6.44E-6	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs1891801	chr10:132941219	TCERG1L	chr10:132890656-133109984:-	0.38	5.63	3.06E-8	Type 2 diabetes	
THCA	cis	1	rs189270	chr3:161063504	NMD3	chr3:160939099-160971319:+	-0.12	-3.86	0.000127	Morning vs. evening chronotype	
THCA	cis	1	rs1893033	chr11:119089055	CBL	chr11:119076990-119178858:+	-0.23	-4.62	5.02E-6	Platelet count	
THCA	cis	1	rs189339	chr12:66252294	RPSAP52	chr12:66151803-66220754:-	-0.15	-3.42	0.000676	Type 2 diabetes	
THCA	cis	1	rs1893447	chr11:77973182	NARS2	chr11:78147017-78285909:-	-0.38	-7.36	8.01E-13	Testicular germ cell tumor	
THCA	cis	1	rs1893448	chr11:77969180	NARS2	chr11:78147017-78285909:-	-0.4	-7.63	1.25E-13	Testicular germ cell tumor	
THCA	cis	1	rs1893767	chr11:123956466	SIAE	chr11:124505694-124543717:-	0.25	3.72	0.000226	Obesity-related traits	
THCA	cis	1	rs1896707	chr5:150245129	LOC134466	chr5:150310000-150326146:-	0.39	5.37	1.22E-7	Crohn's disease	
THCA	cis	1	rs1896708	chr5:150245076	LOC134466	chr5:150310000-150326146:-	0.39	5.5	6.19E-8	Crohn's disease	
THCA	cis	1	rs1896708	chr5:150245076	ZNF300	chr5:150273964-150284391:-	0.15	3.38	0.000775	Crohn's disease	
THCA	cis	1	rs1896709	chr5:150245032	LOC134466	chr5:150310000-150326146:-	0.38	5.36	1.31E-7	Crohn's disease	
THCA	cis	1	rs1897136	chr4:39132862	KLHL5	chr4:39046659-39123828:+	-0.21	-5.77	1.46E-8	Uric acid levels	
THCA	cis	1	rs1897137	chr4:39133007	KLHL5	chr4:39046659-39123828:+	-0.21	-5.77	1.46E-8	Uric acid levels	
THCA	cis	1	rs1900120	chr14:76626516	ESRRB	chr14:76837690-76968178:+	0.28	4.56	6.57E-6	Blood pressure	
THCA	cis	1	rs1900122	chr14:76629517	ESRRB	chr14:76837690-76968178:+	0.28	4.56	6.57E-6	Blood pressure	
THCA	cis	1	rs1900125	chr14:76657470	ESRRB	chr14:76837690-76968178:+	-0.31	-4.83	1.83E-6	Blood pressure	
THCA	cis	1	rs1900442	chr13:42505674	KIAA0564	chr13:42140962-42535221:-	-0.14	-3.64	0.000305	Tuberculosis	
THCA	cis	1	rs1901136	chr4:121802729	C4orf31	chr4:121956782-121993673:-	-0.2	-3.72	0.000223	Fasting plasma glucose	
THCA	cis	1	rs190113	chr10:64488223	ADO	chr10:64564516-64568238:+	-0.26	-5.32	1.61E-7	Vogt-Koyanagi-Harada syndrome	
THCA	cis	1	rs1901521	chr5:101746708	SLCO4C1	chr5:101569694-101632253:-	0.24	5.52	5.5E-8	Schizophrenia	
THCA	cis	1	rs1902654	chr6:70499104	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.46	0.000579	Sleep duration	
THCA	cis	1	rs1903330	chr6:56776985	BEND6	chr6:56819773-56892138:+	0.3	6.34	5.44E-10	Menarche (age at onset)	
THCA	cis	1	rs1903330	chr6:56776985	KIAA1586	chr6:56911384-56920021:+	0.34	5.37	1.26E-7	Menarche (age at onset)	
THCA	cis	1	rs190414	chr5:56116772	C5orf35	chr5:56205103-56213010:+	1	22.93	4.92E-79	Type 2 diabetes	
THCA	cis	1	rs1904295	chr10:64982876	LOC84989	chr10:65224989-65226320:+	-0.27	-4.39	1.38E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs1904295	chr10:64982876	NRBF2	chr10:64893007-64914785:+	-0.27	-4.6	5.46E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs1908331	chr10:75885817	VCL	chr10:75754951-75879912:+	-0.21	-3.82	0.000151	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs1911155	chr15:84787635	GOLGA6L5	chr15:85047738-85060078:-	-0.2	-5.21	2.76E-7	Schizophrenia	
THCA	cis	1	rs1911155	chr15:84787635	LOC388152	chr15:84867600-84898920:-	-0.72	-12.85	1.18E-32	Schizophrenia	
THCA	cis	1	rs1911155	chr15:84787635	NMB	chr15:85198362-85201802:-	0.23	4.54	7.12E-6	Schizophrenia	
THCA	cis	1	rs1911155	chr15:84787635	SH3GL3	chr15:84116091-84287491:+	0.23	3.59	0.000368	Schizophrenia	
THCA	cis	1	rs1911552	chr6:86638024	SNHG5	chr6:86386726-86388451:-	-0.54	-12.73	3.62E-32	Response to antipsychotic treatment	
THCA	cis	1	rs1911553	chr6:86630892	SNHG5	chr6:86386726-86388451:-	-0.48	-10.71	3.96E-24	Response to antipsychotic treatment	
THCA	cis	1	rs1914859	chr4:165906141	C4orf39	chr4:165878100-165880273:+	0.17	4.89	1.35E-6	Ovarian cancer in BRCA1 mutation carriers	
THCA	cis	1	rs1916326	chr4:8500023	C4orf23	chr4:8440604-8495258:+	0.35	7.42	5.46E-13	Response to antineoplastic agents	
THCA	cis	1	rs1917130	chr3:134313773	ANAPC13	chr3:134196547-134204865:-	-0.37	-11.33	1.63E-26	Height	
THCA	cis	1	rs1917130	chr3:134313773	CEP63	chr3:134204575-134293852:+	-0.3	-6.33	5.76E-10	Height	
THCA	cis	1	rs1919125	chr2:27801403	FNDC4	chr2:27714751-27718126:-	-0.16	-3.67	0.000271	Oral cavity cancer	
THCA	cis	1	rs1919126	chr2:27801418	FNDC4	chr2:27714751-27718126:-	-0.16	-3.67	0.000271	Oral cavity cancer	
THCA	cis	1	rs1919743	chr10:54348688	DKK1	chr10:54074041-54077416:+	-0.27	-4.96	9.88E-7	Metabolite levels  (X-11787)	
THCA	cis	1	rs1919948	chr7:143762843	ARHGEF35	chr7:143883677-143892736:-	-0.5	-10.6	1.01E-23	Obesity-related traits	
THCA	cis	1	rs1919948	chr7:143762843	OR2A1	chr7:144015236-144016148:+;chr7	-0.19	-4.04	6.32E-5	Obesity-related traits	
THCA	cis	1	rs1919948	chr7:143762843	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-6.57	1.3E-10	Obesity-related traits	
THCA	cis	1	rs1919949	chr7:143767723	ARHGEF35	chr7:143883677-143892736:-	-0.5	-10.55	1.56E-23	Obesity-related traits	
THCA	cis	1	rs1919949	chr7:143767723	OR2A1	chr7:144015236-144016148:+;chr7	-0.17	-3.6	0.000349	Obesity-related traits	
THCA	cis	1	rs1919949	chr7:143767723	OR2A9P	chr7:143991573-143997832:+;chr7	-0.29	-6.36	4.73E-10	Obesity-related traits	
THCA	cis	1	rs1919950	chr7:143767898	ARHGEF35	chr7:143883677-143892736:-	-0.5	-10.53	1.87E-23	Obesity-related traits	
THCA	cis	1	rs1919950	chr7:143767898	OR2A1	chr7:144015236-144016148:+;chr7	-0.18	-3.74	0.000203	Obesity-related traits	
THCA	cis	1	rs1919950	chr7:143767898	OR2A9P	chr7:143991573-143997832:+;chr7	-0.29	-6.4	3.64E-10	Obesity-related traits	
THCA	cis	1	rs1919951	chr7:143768891	ARHGEF35	chr7:143883677-143892736:-	-0.51	-10.62	8.49E-24	Obesity-related traits	
THCA	cis	1	rs1919951	chr7:143768891	OR2A1	chr7:144015236-144016148:+;chr7	-0.16	-3.36	0.000843	Obesity-related traits	
THCA	cis	1	rs1919951	chr7:143768891	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-6.37	4.37E-10	Obesity-related traits	
THCA	cis	1	rs1920120	chr3:169502180	LRRC34	chr3:169511266-169530720:-	-0.24	-4.66	4.14E-6	Multiple myeloma and monoclonal gammopathy;Interstitial lung disease	
THCA	cis	1	rs1920122	chr3:169506141	LRRC34	chr3:169511266-169530720:-	-0.24	-4.51	8.02E-6	Multiple myeloma and monoclonal gammopathy;Interstitial lung disease	
THCA	cis	1	rs1920123	chr3:169506173	LRRC34	chr3:169511266-169530720:-	-0.24	-4.51	8.02E-6	Multiple myeloma and monoclonal gammopathy;Interstitial lung disease	
THCA	cis	1	rs1921348	chr12:81458380	ACSS3	chr12:81471809-81649582:+	0.22	4.7	3.4E-6	Neuroticism	
THCA	cis	1	rs1921350	chr12:81458279	ACSS3	chr12:81471809-81649582:+	0.22	4.67	4.01E-6	Neuroticism	
THCA	cis	1	rs1921352	chr12:81456746	ACSS3	chr12:81471809-81649582:+	0.22	4.67	4.01E-6	Neuroticism	
THCA	cis	1	rs1923539	chr10:81694950	MBL1P	chr10:81664654-81710783:+	-0.22	-4.78	2.3E-6	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs1924383	chr13:94076848	GPC6	chr13:93879078-95060267:+	-0.27	-3.61	0.000342	Neuroticism	
THCA	cis	1	rs1925148	chr6:56095672	COL21A1	chr6:55921389-56258892:-	0.77	16.44	1.78E-48	Pulse pressure	
THCA	cis	1	rs1925152	chr6:56102709	COL21A1	chr6:55921389-56258892:-	0.75	16.09	7.11E-47	Pulse pressure	
THCA	cis	1	rs1925169	chr6:55996576	COL21A1	chr6:55921389-56258892:-	-0.66	-8.1	4.64E-15	Psychosis (atypical)	
THCA	cis	1	rs1925173	chr6:55999939	COL21A1	chr6:55921389-56258892:-	-0.66	-8.09	4.8E-15	Psychosis (atypical)	
THCA	cis	1	rs1925690	chr6:87867063	C6orf164	chr6:88032306-88109459:+	0.29	3.53	0.00045	Entorhinal cortical volume (Alzheimer's disease interaction)	
THCA	cis	1	rs1926656	chr13:95874942	ABCC4	chr13:95672084-95953687:-	-0.18	-3.51	0.000486	Breast cancer	
THCA	cis	1	rs1926657	chr13:95874956	ABCC4	chr13:95672084-95953687:-	0.18	3.5	0.0005	Breast cancer	
THCA	cis	1	rs1928020	chr13:36695968	SOHLH2	chr13:36742347-36871992:-	0.32	4.45	1.08E-5	Optic cup area	
THCA	cis	1	rs1929494	chr9:104236774	C9orf125	chr9:104237609-104249475:-	-0.2	-4.25	2.59E-5	Age-related cataracts	
THCA	cis	1	rs1933182	chr1:109999838	AMIGO1	chr1:110049447-110052336:-	-0.17	-4.76	2.62E-6	Chronic kidney disease	
THCA	cis	1	rs1933182	chr1:109999838	ATXN7L2	chr1:110026561-110035418:+	0.19	4.92	1.18E-6	Chronic kidney disease	
THCA	cis	1	rs1933182	chr1:109999838	SYPL2	chr1:110009100-110024763:+	0.23	5.98	4.4E-9	Chronic kidney disease	
THCA	cis	1	rs1934029	chr6:74866801	KHDC1	chr6:73919471-74019938:-	0.17	3.37	0.000806	Obesity-related traits	
THCA	cis	1	rs1935	chr10:64927823	NRBF2	chr10:64893007-64914785:+	-0.28	-6.62	9.68E-11	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs1936365	chr6:28268452	ZKSCAN3	chr6:28317691-28334523:+	0.26	5.22	2.69E-7	Depression	
THCA	cis	1	rs1936365	chr6:28268452	ZNF187	chr6:28234788-28245978:+	0.29	6.05	3.0E-9	Depression	
THCA	cis	1	rs1936365	chr6:28268452	ZNF323	chr6:28292517-28324048:-	-0.45	-6.32	6.07E-10	Depression	
THCA	cis	1	rs1936365	chr6:28268452	ZNF389	chr6:28129551-28137375:+	0.44	6.42	3.2E-10	Depression	
THCA	cis	1	rs1936365	chr6:28268452	ZSCAN23	chr6:28393287-28411279:-	-0.22	-4.88	1.48E-6	Depression	
THCA	cis	1	rs1939242	chr11:71753582	FAM86C	chr11:71498557-71512276:+	0.3	3.86	0.000129	Severe influenza A (H1N1) infection	
THCA	cis	1	rs1939245	chr11:71742532	FAM86C	chr11:71498557-71512276:+	0.32	3.91	0.000107	Severe influenza A (H1N1) infection	
THCA	cis	1	rs1939247	chr11:71740521	FAM86C	chr11:71498557-71512276:+	0.32	3.98	7.82E-5	Severe influenza A (H1N1) infection	
THCA	cis	1	rs1939768	chr11:62914709	SLC3A2	chr11:62623518-62656352:+	-0.29	-3.66	0.000279	Sex hormone levels	
THCA	cis	1	rs1942352	chr11:77970563	NARS2	chr11:78147017-78285909:-	-0.4	-7.44	4.64E-13	Testicular germ cell tumor	
THCA	cis	1	rs194577	chr7:117993966	ANKRD7	chr7:117864712-117882782:+	0.27	4.5	8.46E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs194579	chr7:117994536	ANKRD7	chr7:117864712-117882782:+	0.28	4.51	8.34E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs194582	chr7:117995340	ANKRD7	chr7:117864712-117882782:+	0.27	4.5	8.46E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs1947826	chr12:122305970	WDR66	chr12:122356480-122441830:+	-0.24	-4.03	6.41E-5	Urinary metabolites	
THCA	cis	1	rs1948806	chr5:101806762	SLCO4C1	chr5:101569694-101632253:-	0.24	5.54	5.1E-8	Schizophrenia	
THCA	cis	1	rs1948807	chr5:101806486	SLCO4C1	chr5:101569694-101632253:-	0.24	5.54	5.1E-8	Schizophrenia	
THCA	cis	1	rs1949510	chr2:17778129	GEN1	chr2:17935162-17966632:+	0.51	6.86	2.08E-11	Psychosis and Alzheimer's disease	
THCA	cis	1	rs1949733	chr4:8503359	C4orf23	chr4:8440604-8495258:+	0.34	7.34	9.55E-13	Response to antineoplastic agents	
THCA	cis	1	rs1950500	chr14:24830850	ADCY4	chr14:24787571-24804277:-	-0.13	-4.82	1.89E-6	Height	
THCA	cis	1	rs1950500	chr14:24830850	LTB4R	chr14:24780705-24787061:+	0.16	3.52	0.000479	Height	
THCA	cis	1	rs1950500	chr14:24830850	NFATC4	chr14:24836145-24848808:+	0.13	3.63	0.000319	Height	
THCA	cis	1	rs1951311	chr14:97312642	VRK1	chr14:97263684-97347950:+	0.17	3.85	0.000136	Neutrophil count	
THCA	cis	1	rs1951312	chr14:97334742	VRK1	chr14:97263684-97347950:+	0.16	3.7	0.000244	Neutrophil count	
THCA	cis	1	rs1951439	chr14:55174823	SAMD4A	chr14:55034637-55260033:+	0.38	4.14	4.08E-5	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs1951931	chr6:150296898	RAET1K	chr6:150319157-150326280:-	-0.31	-4.07	5.4E-5	Radiation response	
THCA	cis	1	rs1951931	chr6:150296898	ULBP1	chr6:150285143-150294844:+	-0.49	-7.47	3.76E-13	Radiation response	
THCA	cis	1	rs1951931	chr6:150296898	ULBP2	chr6:150263136-150270366:+	-0.31	-4.92	1.17E-6	Radiation response	
THCA	cis	1	rs1952012	chr14:50098896	MGAT2	chr14:50087489-50090198:+	0.22	4.39	1.37E-5	Carotid intima media thickness	
THCA	cis	1	rs1952012	chr14:50098896	RPL36AL	chr14:50085407-50087349:-	0.54	15.61	1.07E-44	Carotid intima media thickness	
THCA	cis	1	rs1953126	chr9:123640500	LOC253039	chr9:123605320-123616644:+	-0.53	-9.87	5.0E-21	Rheumatoid arthritis	
THCA	cis	1	rs1953126	chr9:123640500	PSMD5	chr9:123578334-123605206:-	-0.3	-5.99	4.07E-9	Rheumatoid arthritis	
THCA	cis	1	rs1953417	chr14:65878909	LOC645431	chr14:65877313-65879335:-	-0.59	-7.79	4.31E-14	Ischemic stroke	
THCA	cis	1	rs1953600	chr10:81911725	C10orf58	chr10:82168242-82196869:+	0.15	3.69	0.000248	Sarcoidosis	
THCA	cis	1	rs1953600	chr10:81911725	PLAC9	chr10:81892258-81904784:+	-0.11	-4.15	4.02E-5	Sarcoidosis	
THCA	cis	1	rs1955599	chr14:88825132	SPATA7	chr14:88852012-88904802:+	-0.17	-3.59	0.000368	Coronary artery calcification	
THCA	cis	1	rs1955600	chr14:88825384	SPATA7	chr14:88852012-88904802:+	-0.17	-3.51	0.000484	Coronary artery calcification	
THCA	cis	1	rs1957543	chr14:81777074	STON2	chr14:81727000-81893748:-	0.21	4.2	3.16E-5	Obesity-related traits	
THCA	cis	1	rs1957544	chr14:81773268	STON2	chr14:81727000-81893748:-	0.21	4.2	3.16E-5	Obesity-related traits	
THCA	cis	1	rs1957545	chr14:81772981	STON2	chr14:81727000-81893748:-	0.21	4.2	3.16E-5	Obesity-related traits	
THCA	cis	1	rs1957548	chr14:81781835	STON2	chr14:81727000-81893748:-	0.21	4.21	3.05E-5	Obesity-related traits	
THCA	cis	1	rs1957977	chr14:50090603	MGAT2	chr14:50087489-50090198:+	0.22	4.36	1.57E-5	Carotid intima media thickness	
THCA	cis	1	rs1957977	chr14:50090603	RPL36AL	chr14:50085407-50087349:-	0.56	16.39	3.23E-48	Carotid intima media thickness	
THCA	cis	1	rs1958589	chr14:34844376	C14orf147	chr14:34902145-34931468:-	-0.27	-4.28	2.28E-5	Celiac disease	
THCA	cis	1	rs1961319	chr11:108293879	ACAT1	chr11:107992258-108018889:+	-0.31	-6.95	1.2E-11	Melanoma	
THCA	cis	1	rs1962716	chr6:86648436	SNHG5	chr6:86386726-86388451:-	-0.51	-11.45	5.66E-27	Response to antipsychotic treatment	
THCA	cis	1	rs1962772	chr8:17370776	SLC7A2	chr8:17354600-17428073:+	0.25	4.85	1.65E-6	Plasma omega-6 polyunsaturated fatty acid levels (adrenic acid)	
THCA	cis	1	rs1964692	chr7:65454183	CCT6P1	chr7:65216092-65228661:+	0.4	6.29	6.99E-10	Diabetic kidney disease	
THCA	cis	1	rs1964692	chr7:65454183	CRCP	chr7:65579805-65619551:+	-0.26	-3.97	8.16E-5	Diabetic kidney disease	
THCA	cis	1	rs1964692	chr7:65454183	RABGEF1	chr7:66093890-66276446:+	0.54	6.66	7.75E-11	Diabetic kidney disease	
THCA	cis	1	rs1965517	chr7:54177112	SEC61G	chr7:54819941-54826939:-	-0.21	-3.34	0.000901	Periodontal disease-related phenotypes	
THCA	cis	1	rs1965518	chr7:54177071	SEC61G	chr7:54819941-54826939:-	0.21	3.34	0.000901	Periodontal disease-related phenotypes	
THCA	cis	1	rs1966423	chr2:202216661	ALS2CR12	chr2:202153148-202222101:-	-0.3	-5.95	5.04E-9	Basal cell carcinoma	
THCA	cis	1	rs1966423	chr2:202216661	PPIL3	chr2:201735680-201753999:-	-0.23	-4.93	1.16E-6	Basal cell carcinoma	
THCA	cis	1	rs1966839	chr7:50627101	FIGNL1	chr7:50511834-50518088:-	-0.17	-4.35	1.7E-5	Malaria	
THCA	cis	1	rs1967017	chr1:145723645	NUDT17	chr1:145586494-145590461:-	0.18	4.14	4.07E-5	Urate levels;Urate levels in overweight individuals	
THCA	cis	1	rs1967017	chr1:145723645	PDZK1	chr1:145727726-145764073:+	-0.2	-3.36	0.000849	Urate levels;Urate levels in overweight individuals	
THCA	cis	1	rs1968186	chr16:50125512	HEATR3	chr16:50099881-50139373:+	0.38	5.63	3.15E-8	Esophageal cancer (squamous cell)	
THCA	cis	1	rs1968225	chr7:65874773	ASL	chr7:65540776-65558321:+	-0.16	-4.16	3.75E-5	Aortic root size	
THCA	cis	1	rs1968225	chr7:65874773	GUSB	chr7:65425675-65447246:-	0.27	5.34	1.43E-7	Aortic root size	
THCA	cis	1	rs1968225	chr7:65874773	RABGEF1	chr7:66093890-66276446:+	0.65	14.09	5.98E-38	Aortic root size	
THCA	cis	1	rs1969253	chr3:183876512	ABCF3	chr3:183903863-183911795:+	0.18	4.17	3.6E-5	Major depressive disorder	
THCA	cis	1	rs1971762	chr12:54058238	SOAT2	chr12:53497274-53518322:+	-0.18	-4.06	5.63E-5	Height	
THCA	cis	1	rs1971898	chr15:90890836	IQGAP1	chr15:90931473-91045475:+	0.12	4.22	2.9E-5	Rheumatoid arthritis	
THCA	cis	1	rs1971898	chr15:90890836	TTLL13	chr15:90792764-90815443:+	0.2	3.84	0.000139	Rheumatoid arthritis	
THCA	cis	1	rs1972669	chr2:27767107	FNDC4	chr2:27714751-27718126:-	-0.15	-3.64	0.000304	Oral cavity cancer	
THCA	cis	1	rs1973312	chr11:6352121	TAF10	chr11:6632073-6633445:-	-0.14	-3.41	0.000696	Smooth-surface caries	
THCA	cis	1	rs1974624	chr4:17650281	MED28	chr4:17616273-17629791:+	0.17	3.77	0.000185	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs1974653	chr22:20134350	C22orf25	chr22:20004537-20053447:+	0.17	4.08	5.35E-5	Schizophrenia	
THCA	cis	1	rs1975174	chr19:22515251	ZNF492	chr19:22817126-22850472:+	0.22	3.94	9.45E-5	Telomere length	
THCA	cis	1	rs1975174	chr19:22515251	ZNF98	chr19:22573899-22605148:-	0.42	9.64	3.25E-20	Telomere length	
THCA	cis	1	rs1976053	chr17:65833002	C17orf58	chr17:65987218-65989765:-	0.25	5.1	5.03E-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs1976054	chr17:65833224	C17orf58	chr17:65987218-65989765:-	0.24	4.8	2.09E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs1977447	chr9:131868196	C9orf114	chr9:131584346-131592085:-	0.16	3.4	0.000718	Blood metabolite ratios	
THCA	cis	1	rs1977447	chr9:131868196	CRAT	chr9:131857075-131873070:-	-0.28	-6.56	1.37E-10	Blood metabolite ratios	
THCA	cis	1	rs1978968	chr22:18448113	MICAL3	chr22:18270418-18507325:-	0.21	4.27	2.35E-5	Presence of antiphospholipid antibodies	
THCA	cis	1	rs1979755	chr2:42708405	COX7A2L	chr2:42577647-42596150:-	-0.25	-6.67	7.12E-11	Body mass index	
THCA	cis	1	rs1979823	chr7:65704613	CCT6P1	chr7:65216092-65228661:+	-0.44	-6.89	1.74E-11	Diabetic kidney disease	
THCA	cis	1	rs1979823	chr7:65704613	CRCP	chr7:65579805-65619551:+	0.3	4.52	7.98E-6	Diabetic kidney disease	
THCA	cis	1	rs1979823	chr7:65704613	RABGEF1	chr7:66093890-66276446:+	-0.59	-7.26	1.54E-12	Diabetic kidney disease	
THCA	cis	1	rs1979	chr6:26377591	BTN3A2	chr6:26365398-26378546:+	-0.91	-17.81	8.24E-55	Schizophrenia	
THCA	cis	1	rs1979	chr6:26377591	GUSBL1	chr6:26839266-26924333:-	0.25	3.55	0.000428	Schizophrenia	
THCA	cis	1	rs1980045	chr2:111904541	BCL2L11	chr2:111878491-111926022:+	-0.13	-3.35	0.000867	Chronic lymphocytic leukemia	
THCA	cis	1	rs1980727	chr13:94077561	GPC6	chr13:93879078-95060267:+	-0.28	-3.68	0.000258	Neuroticism	
THCA	cis	1	rs1981798	chr7:65954903	ASL	chr7:65540776-65558321:+	-0.16	-4.2	3.25E-5	Aortic root size	
THCA	cis	1	rs1981798	chr7:65954903	GUSB	chr7:65425675-65447246:-	0.25	4.89	1.37E-6	Aortic root size	
THCA	cis	1	rs1981798	chr7:65954903	LOC729156	chr7:66274980-66309813:-	0.16	3.45	0.000602	Aortic root size	
THCA	cis	1	rs1981798	chr7:65954903	RABGEF1	chr7:66093890-66276446:+	0.66	14.23	1.46E-38	Aortic root size	
THCA	cis	1	rs1981898	chr14:76175565	TTLL5	chr14:76127621-76421421:+	0.19	4.84	1.75E-6	Large artery stroke	
THCA	cis	1	rs1982009	chr4:39124873	KLHL5	chr4:39046659-39123828:+	-0.21	-5.77	1.46E-8	Uric acid levels	
THCA	cis	1	rs1982861	chr3:49577665	GMPPB	chr3:49758932-49761384:-	-0.16	-3.58	0.000383	Menarche (age at onset)	
THCA	cis	1	rs1982861	chr3:49577665	P4HTM	chr3:49027341-49044579:+	0.17	4.26	2.43E-5	Menarche (age at onset)	
THCA	cis	1	rs1982861	chr3:49577665	WDR6	chr3:49044637-49053386:+	-0.17	-3.61	0.000334	Menarche (age at onset)	
THCA	cis	1	rs1982963	chr14:52509101	C14orf166	chr14:52456228-52471419:+	-0.12	-3.42	0.000691	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs1982963	chr14:52509101	NID2	chr14:52471521-52535946:-	-0.18	-3.71	0.000233	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs1983437	chr12:70723769	YEATS4	chr12:69753532-69784575:+	-0.24	-3.64	0.000308	Amyotrophic lateral sclerosis (age of onset)	
THCA	cis	1	rs1983853	chr1:85311192	DDAH1	chr1:85784169-86044046:-	0.24	3.51	0.000485	Type 1 diabetes	
THCA	cis	1	rs1983891	chr6:41536427	MDFI	chr6:41604930-41621981:+	-0.18	-5.39	1.13E-7	Prostate cancer	
THCA	cis	1	rs1984450	chr19:53013799	ZNF578	chr19:52956829-53020130:+	0.26	3.51	0.000482	Longitudinal alcohol consumption	
THCA	cis	1	rs1984598	chr2:242284824	SEPT2	chr2:242254723-242293439:+	-0.3	-5.12	4.39E-7	Prostate cancer	
THCA	cis	1	rs1985875	chr12:62508024	FAM19A2	chr12:62102043-62653925:-	-0.15	-3.34	0.000892	Post bronchodilator FEV1/FVC ratio in COPD	
THCA	cis	1	rs1986074	chr15:50857452	SPPL2A	chr15:50999739-51057910:-	0.28	7.36	8.21E-13	QT interval	
THCA	cis	1	rs1986111	chr1:121204788	HIST2H2BA	chr1:120906034-120914842:+	0.21	4.86	1.56E-6	Hip geometry	
THCA	cis	1	rs1986112	chr15:63540572	APH1B	chr15:63569749-63601324:+	-0.18	-4.37	1.5E-5	Schizophrenia	
THCA	cis	1	rs1986112	chr15:63540572	CA12	chr15:63615731-63674075:-	0.17	3.82	0.000152	Schizophrenia	
THCA	cis	1	rs1986112	chr15:63540572	LACTB	chr15:63414032-63434254:+	-0.12	-3.58	0.000377	Schizophrenia	
THCA	cis	1	rs1986112	chr15:63540572	RAB8B	chr15:63481728-63559971:+	-0.38	-9.98	1.94E-21	Schizophrenia	
THCA	cis	1	rs1986112	chr15:63540572	RPS27L	chr15:63445540-63449741:-	-0.21	-5.71	2.01E-8	Schizophrenia	
THCA	cis	1	rs1986557	chr4:283118	ZNF718	chr4:53272-156488:+	0.49	9.65	3.1E-20	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs1986987	chr1:146869283	FMO5	chr1:146655885-146697230:-	0.24	3.87	0.000125	Protein quantitative trait loci	
THCA	cis	1	rs198699	chr7:24184897	MPP6	chr7:24613085-24727497:+	0.14	3.37	0.000822	Aggressive periodontitis (sex interaction)	
THCA	cis	1	rs198806	chr6:26133616	BTN3A2	chr6:26365398-26378546:+	0.2	5	8.14E-7	Schizophrenia	
THCA	cis	1	rs198806	chr6:26133616	SCGN	chr6:25652429-25702006:+	-0.16	-3.34	0.00089	Schizophrenia	
THCA	cis	1	rs198811	chr6:26128446	BTN3A2	chr6:26365398-26378546:+	-0.19	-4.96	9.72E-7	Schizophrenia	
THCA	cis	1	rs198811	chr6:26128446	SCGN	chr6:25652429-25702006:+	0.17	3.4	0.000727	Schizophrenia	
THCA	cis	1	rs1990492	chr3:37124620	EPM2AIP1	chr3:37027358-37034795:-	0.13	3.91	0.000107	Cerebrospinal P-tau181p levels	
THCA	cis	1	rs1990492	chr3:37124620	LRRFIP2	chr3:37094117-37217851:-	0.51	13.99	1.54E-37	Cerebrospinal P-tau181p levels	
THCA	cis	1	rs1990674	chr17:53061075	STXBP4	chr17:53046126-53241449:+	-0.15	-4.18	3.4E-5	Breast cancer	
THCA	cis	1	rs1990674	chr17:53061075	TOM1L1	chr17:52978052-53039328:+	-0.13	-3.37	0.000824	Breast cancer	
THCA	cis	1	rs1991533	chr2:216908910	MREG	chr2:216807315-216878346:-	0.37	7.82	3.35E-14	Alcohol dependence	
THCA	cis	1	rs1991533	chr2:216908910	PECR	chr2:216861029-216946532:-	0.24	4.89	1.35E-6	Alcohol dependence	
THCA	cis	1	rs199347	chr7:23293746	KLHL7	chr7:23145353-23215036:+	0.24	5.41	9.74E-8	Parkinson's disease	
THCA	cis	1	rs1993483	chr6:70453576	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.4	0.000726	Sleep duration	
THCA	cis	1	rs199348	chr7:23293098	GPNMB	chr7:23286316-23314728:+	-0.16	-3.86	0.000128	Parkinson's disease	
THCA	cis	1	rs199348	chr7:23293098	KLHL7	chr7:23145353-23215036:+	0.27	5.97	4.59E-9	Parkinson's disease	
THCA	cis	1	rs199351	chr7:23300049	GPNMB	chr7:23286316-23314728:+	-0.14	-3.34	0.000891	Parkinson's disease	
THCA	cis	1	rs199351	chr7:23300049	KLHL7	chr7:23145353-23215036:+	0.25	5.54	4.97E-8	Parkinson's disease	
THCA	cis	1	rs199357	chr7:23288309	KLHL7	chr7:23145353-23215036:+	-0.25	-5.61	3.4E-8	Parkinson's disease	
THCA	cis	1	rs1993891	chr3:161047467	NMD3	chr3:160939099-160971319:+	-0.11	-3.64	0.000304	Morning vs. evening chronotype	
THCA	cis	1	rs1993901	chr17:20938791	USP22	chr17:20902908-20947073:-	-0.18	-3.86	0.000128	Blood trace element (Se levels)	
THCA	cis	1	rs1994157	chr3:41897482	ULK4	chr3:41288091-42003660:-	1.04	18.86	9.68E-60	Diastolic blood pressure	
THCA	cis	1	rs1995156	chr11:5566112	UBQLNL	chr11:5535624-5537956:-	-0.28	-6.55	1.47E-10	QRS duration in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs1995585	chr1:31855474	ZCCHC17	chr1:31769842-31837780:+	0.31	5.87	8.37E-9	Schizophrenia	
THCA	cis	1	rs1995688	chr6:86632319	SNHG5	chr6:86386726-86388451:-	-0.48	-10.71	3.96E-24	Response to antipsychotic treatment	
THCA	cis	1	rs1995980	chr10:23667595	C10orf67	chr10:23605521-23633772:-	0.23	4.32	1.92E-5	Crohn's disease and sarcoidosis (combined)	
THCA	cis	1	rs1996608	chr9:111857391	C9orf5	chr9:111777416-111882225:-	0.18	3.48	0.000547	Information processing speed	
THCA	cis	1	rs1997243	chr7:1083777	ZFAND2A	chr7:1192544-1199855:-	-0.33	-4.78	2.35E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs1997367	chr9:102713758	STX17	chr9:102668915-102736817:+	-0.16	-4.18	3.48E-5	Alopecia areata	
THCA	cis	1	rs1997368	chr9:102713580	STX17	chr9:102668915-102736817:+	-0.16	-4.18	3.48E-5	Alopecia areata	
THCA	cis	1	rs1997392	chr3:169509652	LRRC34	chr3:169511266-169530720:-	0.24	4.51	8.02E-6	Multiple myeloma and monoclonal gammopathy;Interstitial lung disease	
THCA	cis	1	rs1998035	chr14:66126230	LOC645431	chr14:65877313-65879335:-	-0.6	-7.74	5.91E-14	Ischemic stroke	
THCA	cis	1	rs1998207	chr14:94957714	DDX24	chr14:94517269-94547558:-	-0.18	-3.53	0.000463	Obesity-related traits	
THCA	cis	1	rs1998207	chr14:94957714	SERPINA9	chr14:94929060-94942670:-	-0.16	-4.12	4.54E-5	Obesity-related traits	
THCA	cis	1	rs1998615	chr6:87808289	C6orf164	chr6:88032306-88109459:+	0.23	4.53	7.59E-6	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	
THCA	cis	1	rs1998616	chr6:87808430	C6orf164	chr6:88032306-88109459:+	0.23	4.53	7.59E-6	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	
THCA	cis	1	rs1999852	chr6:86705738	SNHG5	chr6:86386726-86388451:-	-0.48	-10.73	3.19E-24	Response to antipsychotic treatment	
THCA	cis	1	rs2000614	chr11:116915742	PCSK7	chr11:117075789-117102811:-	-0.31	-5.56	4.5E-8	Protein quantitative trait loci	
THCA	cis	1	rs2000615	chr11:116915819	PCSK7	chr11:117075789-117102811:-	-0.29	-5.2	2.99E-7	Protein quantitative trait loci	
THCA	cis	1	rs2000616	chr11:116916529	PCSK7	chr11:117075789-117102811:-	-0.31	-5.53	5.24E-8	Protein quantitative trait loci	
THCA	cis	1	rs2000999	chr16:72108093	DHODH	chr16:72042643-72058954:+	0.23	4.7	3.48E-6	Haptoglobin levels;Cholesterol, total;LDL cholesterol	
THCA	cis	1	rs2000999	chr16:72108093	TXNL4B	chr16:72072001-72128215:-	0.2	3.45	0.000617	Haptoglobin levels;Cholesterol, total;LDL cholesterol	
THCA	cis	1	rs2003284	chr10:102202338	SEC31B	chr10:102246403-102289636:-	-0.3	-10.18	3.73E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2003301	chr7:66147656	GUSB	chr7:65425675-65447246:-	-0.33	-6.66	7.53E-11	Aortic root size	
THCA	cis	1	rs2003301	chr7:66147656	RABGEF1	chr7:66093890-66276446:+	-0.5	-10.31	1.22E-22	Aortic root size	
THCA	cis	1	rs2003301	chr7:66147656	TYW1	chr7:66461817-66704496:+	-0.18	-4.01	7.09E-5	Aortic root size	
THCA	cis	1	rs2004711	chr5:150225068	LOC134466	chr5:150310000-150326146:-	0.4	5.49	6.42E-8	Crohn's disease	
THCA	cis	1	rs2005199	chr19:52033206	ZNF175	chr19:52074531-52092990:+	-0.35	-4.15	3.89E-5	Carotid intima media thickness	
THCA	cis	1	rs2006751	chr11:43670501	HSD17B12	chr11:43702143-43878160:+	-0.69	-14.36	3.93E-39	Forced vital capacity	
THCA	cis	1	rs2007981	chr19:18567555	ELL	chr19:18553475-18632937:-	-0.25	-6.51	1.94E-10	Breast cancer	
THCA	cis	1	rs2007981	chr19:18567555	ISYNA1	chr19:18545625-18548943:-	0.12	4.61	5.29E-6	Breast cancer	
THCA	cis	1	rs2007981	chr19:18567555	LRRC25	chr19:18501955-18508421:-	-0.14	-4.85	1.68E-6	Breast cancer	
THCA	cis	1	rs2010648	chr14:35604892	FAM177A1	chr14:35514113-35552587:+	-0.2	-3.74	0.000209	Atopic dermatitis	
THCA	cis	1	rs2010648	chr14:35604892	KIAA0391	chr14:35591776-35786673:+	0.3	5.68	2.38E-8	Atopic dermatitis	
THCA	cis	1	rs2010648	chr14:35604892	PPP2R3C	chr14:35554679-35591679:-	0.52	9.98	2.01E-21	Atopic dermatitis	
THCA	cis	1	rs2011064	chr15:50957625	ATP8B4	chr15:50150436-50411419:-	-0.11	-3.48	0.000538	QT interval	
THCA	cis	1	rs2011064	chr15:50957625	SPPL2A	chr15:50999739-51057910:-	0.3	7.74	5.79E-14	QT interval	
THCA	cis	1	rs2011331	chr1:152286002	FLG	chr1:152274651-152297679:-	0.28	4.41	1.27E-5	Atopic dermatitis	
THCA	cis	1	rs2011331	chr1:152286002	HRNR	chr1:152184558-152196669:-	-0.52	-7.47	3.82E-13	Atopic dermatitis	
THCA	cis	1	rs2012353	chr19:32899293	DPY19L3	chr19:32896677-32975236:+	0.19	5.07	5.6E-7	Bipolar disorder	
THCA	cis	1	rs2012353	chr19:32899293	ZNF507	chr19:32836514-32878571:+	0.3	7.37	7.32E-13	Bipolar disorder	
THCA	cis	1	rs2012798	chr2:86182756	POLR1A	chr2:86253453-86333278:-	-0.29	-3.8	0.000161	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs2013288	chr17:61785904	FTSJ3	chr17:61896795-61905031:-	0.29	5.59	3.9E-8	Body mass index	
THCA	cis	1	rs2013288	chr17:61785904	MAP3K3	chr17:61699775-61773669:+	0.26	5.31	1.73E-7	Body mass index	
THCA	cis	1	rs2013561	chr19:19826177	ZNF14	chr19:19821281-19843921:-	0.23	4.66	4.12E-6	Toenail selenium levels	
THCA	cis	1	rs2014252	chr2:27462405	C2orf28	chr2:27434899-27440044:+	0.18	5.26	2.22E-7	Blood metabolite levels	
THCA	cis	1	rs2014252	chr2:27462405	SLC5A6	chr2:27422459-27435071:-	-0.31	-6.53	1.72E-10	Blood metabolite levels	
THCA	cis	1	rs2014355	chr12:121175524	ACADS	chr12:121163571-121177810:+	0.13	3.52	0.000476	Urinary metabolites (H-NMR features)	
THCA	cis	1	rs2014521	chr17:40283413	HSPB9	chr17:40274756-40275371:+	0.34	5.04	6.53E-7	Fibrinogen levels	
THCA	cis	1	rs2014572	chr19:57760018	ZNF460	chr19:57791419-57805436:+	-0.15	-3.49	0.000524	Hyperactive-impulsive symptoms	
THCA	cis	1	rs2015336	chr17:18073610	LLGL1	chr17:18128936-18148186:+	-0.15	-4.39	1.37E-5	Obesity-related traits	
THCA	cis	1	rs2015336	chr17:18073610	LOC220594	chr17:18414577-18445234:-	-0.27	-3.57	0.000394	Obesity-related traits	
THCA	cis	1	rs2015336	chr17:18073610	MYO15A	chr17:18012020-18083115:+	0.2	3.68	0.000265	Obesity-related traits	
THCA	cis	1	rs2015419	chr2:118385	SH3YL1	chr2:218138-264810:-	-0.27	-4.34	1.72E-5	Suicide attempts in bipolar disorder	
THCA	cis	1	rs2016366	chr1:2513678	MMEL1	chr1:2522081-2564481:-	-0.16	-4.28	2.27E-5	Ulcerative colitis	
THCA	cis	1	rs2016409	chr5:151126324	SPARC	chr5:151041019-151066517:-	-0.13	-3.37	0.000802	Preschool internalizing problems	
THCA	cis	1	rs2017760	chr1:207455421	CD55	chr1:207494817-207534309:+	0.17	7.23	1.91E-12	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs2017962	chr19:22208751	ZNF257	chr19:22235266-22273901:+	0.33	6.7	5.88E-11	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs2018002	chr20:31351623	MAPRE1	chr20:31407699-31438210:+	0.17	4.09	5.08E-5	Ulcerative colitis	
THCA	cis	1	rs2019097	chr2:202193463	CFLAR	chr2:201980816-202029001:+	-0.22	-3.8	0.000161	Rheumatoid arthritis	
THCA	cis	1	rs2019097	chr2:202193463	PPIL3	chr2:201735680-201753999:-	-0.58	-7.99	1.04E-14	Rheumatoid arthritis	
THCA	cis	1	rs2019144	chr3:119280688	ADPRH	chr3:119298523-119308791:+	-0.22	-3.6	0.000347	Vitiligo	
THCA	cis	1	rs2019814	chr11:93168885	CCDC67	chr11:93063156-93171634:+	-0.52	-7.28	1.38E-12	Pulmonary function decline	
THCA	cis	1	rs202053	chr6:13273643	TBC1D7	chr6:13266774-13328770:-	-0.19	-3.98	8.08E-5	HIV-1 viral setpoint	
THCA	cis	1	rs202074	chr6:13269363	TBC1D7	chr6:13266774-13328770:-	-0.2	-4.09	5.13E-5	HIV-1 viral setpoint	
THCA	cis	1	rs202077	chr6:13271438	TBC1D7	chr6:13266774-13328770:-	-0.19	-3.81	0.000155	HIV-1 viral setpoint	
THCA	cis	1	rs2023786	chr7:23915153	C7orf46	chr7:23719749-23742268:+	0.13	3.91	0.000106	Schizophrenia	
THCA	cis	1	rs2023787	chr7:23915140	C7orf46	chr7:23719749-23742268:+	0.13	3.9	0.000108	Schizophrenia	
THCA	cis	1	rs2024959	chr20:47695391	ARFGEF2	chr20:47538275-47653229:+	-0.12	-3.92	0.000102	Anger	
THCA	cis	1	rs2024959	chr20:47695391	CSE1L	chr20:47662838-47713484:+	0.41	10.23	2.48E-22	Anger	
THCA	cis	1	rs2026045	chr1:54685195	MRPL37	chr1:54665840-54691137:+	0.12	3.36	0.000832	Mitochondrial DNA levels	
THCA	cis	1	rs2026254	chr21:34688032	IFNAR1	chr21:34696734-34732126:+	0.22	5.26	2.22E-7	Narcolepsy	
THCA	cis	1	rs2027003	chr20:25350498	ENTPD6	chr20:25176339-25207360:+	0.3	6.72	5.25E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2027003	chr20:25350498	FAM182A	chr20:26035250-26067552:+	0.19	3.48	0.000538	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2027003	chr20:25350498	FAM182B	chr20:25744102-25848786:-	-0.26	-5.3	1.78E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2027003	chr20:25350498	NINL	chr20:25433338-25566153:-	0.36	7.34	9.3E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2027003	chr20:25350498	PYGB	chr20:25228706-25278647:+	0.14	3.57	0.000388	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2027004	chr20:25350618	ENTPD6	chr20:25176339-25207360:+	0.3	6.72	5.25E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2027004	chr20:25350618	FAM182A	chr20:26035250-26067552:+	0.19	3.48	0.000538	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2027004	chr20:25350618	FAM182B	chr20:25744102-25848786:-	-0.26	-5.3	1.78E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2027004	chr20:25350618	NINL	chr20:25433338-25566153:-	0.36	7.34	9.3E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2027004	chr20:25350618	PYGB	chr20:25228706-25278647:+	0.14	3.57	0.000388	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2027447	chr1:120440029	TBX15	chr1:119425666-119532179:-	0.23	3.39	0.000761	Crohn's disease	
THCA	cis	1	rs2028062	chr11:61745953	BEST1	chr11:61717356-61731939:+	-0.3	-6.15	1.61E-9	Phospholipid levels (plasma)	
THCA	cis	1	rs2028062	chr11:61745953	FADS2	chr11:61583728-61634825:+	-0.16	-3.57	0.000394	Phospholipid levels (plasma)	
THCA	cis	1	rs2028299	chr15:90374257	AP3S2	chr15:90373832-90456222:-	-0.76	-18.94	4.46E-60	Type 2 diabetes	
THCA	cis	1	rs2028299	chr15:90374257	C15orf38	chr15:90443832-90456222:-	0.36	7.65	1.13E-13	Type 2 diabetes	
THCA	cis	1	rs2029751	chr1:200698286	DDX59	chr1:200610119-200639126:-	-0.26	-4	7.28E-5	Epilepsy	
THCA	cis	1	rs2029975	chr14:52506070	C14orf166	chr14:52456228-52471419:+	-0.14	-3.98	8.05E-5	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs2030838	chr15:84583810	LOC388152	chr15:84867600-84898920:-	-0.21	-3.98	7.86E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs2030839	chr15:84583959	LOC388152	chr15:84867600-84898920:-	-0.21	-3.98	7.86E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs2030840	chr15:84584134	LOC388152	chr15:84867600-84898920:-	-0.21	-3.98	7.86E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs2031035	chr9:102711698	STX17	chr9:102668915-102736817:+	-0.17	-4.33	1.86E-5	Alopecia areata	
THCA	cis	1	rs2031365	chr6:87805592	C6orf164	chr6:88032306-88109459:+	0.22	4.42	1.22E-5	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	
THCA	cis	1	rs2031366	chr6:87805890	C6orf164	chr6:88032306-88109459:+	0.22	4.42	1.22E-5	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	
THCA	cis	1	rs2031367	chr6:87807180	C6orf164	chr6:88032306-88109459:+	0.24	4.84	1.73E-6	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	
THCA	cis	1	rs2031532	chr13:50080847	CAB39L	chr13:49882787-50018221:-	0.32	5.91	6.39E-9	Cardiac hypertrophy	
THCA	cis	1	rs2031532	chr13:50080847	RCBTB1	chr13:50106082-50159719:-	0.23	5.99	4.09E-9	Cardiac hypertrophy	
THCA	cis	1	rs2031532	chr13:50080847	SETDB2	chr13:50018429-50069138:+	0.27	6.77	3.74E-11	Cardiac hypertrophy	
THCA	cis	1	rs2032843	chr17:46847524	CALCOCO2	chr17:46908372-46942228:+	-0.13	-3.57	0.000392	Schizophrenia or bipolar disorder	
THCA	cis	1	rs2032843	chr17:46847524	SNF8	chr17:47007461-47022154:-	-0.25	-7.23	1.95E-12	Schizophrenia or bipolar disorder	
THCA	cis	1	rs2032843	chr17:46847524	UBE2Z	chr17:46985767-47006422:+	-0.19	-3.98	7.99E-5	Schizophrenia or bipolar disorder	
THCA	cis	1	rs2032844	chr17:46847364	CALCOCO2	chr17:46908372-46942228:+	-0.14	-3.69	0.000253	Schizophrenia or bipolar disorder	
THCA	cis	1	rs2032844	chr17:46847364	SNF8	chr17:47007461-47022154:-	-0.24	-6.97	1.08E-11	Schizophrenia or bipolar disorder	
THCA	cis	1	rs2032844	chr17:46847364	UBE2Z	chr17:46985767-47006422:+	-0.18	-3.88	0.00012	Schizophrenia or bipolar disorder	
THCA	cis	1	rs2034897	chr5:110441561	TSLP	chr5:110405778-110413722:+	-0.36	-4.64	4.59E-6	Eosinophil counts	
THCA	cis	1	rs2034897	chr5:110441561	WDR36	chr5:110427870-110466201:+	0.2	3.62	0.000332	Eosinophil counts	
THCA	cis	1	rs2036264	chr7:65799904	ASL	chr7:65540776-65558321:+	0.16	4.29	2.21E-5	Aortic root size	
THCA	cis	1	rs2036264	chr7:65799904	GUSB	chr7:65425675-65447246:-	-0.26	-5.09	5.27E-7	Aortic root size	
THCA	cis	1	rs2036264	chr7:65799904	LOC729156	chr7:66274980-66309813:-	-0.16	-3.53	0.000456	Aortic root size	
THCA	cis	1	rs2036264	chr7:65799904	RABGEF1	chr7:66093890-66276446:+	-0.67	-14.52	7.7E-40	Aortic root size	
THCA	cis	1	rs2036707	chr13:108484454	FAM155A	chr13:107820880-108519460:-	0.51	5.93	5.85E-9	Obesity-related traits	
THCA	cis	1	rs2036708	chr13:108485238	FAM155A	chr13:107820880-108519460:-	0.51	6.01	3.68E-9	Obesity-related traits	
THCA	cis	1	rs2037965	chr3:128025044	EEFSEC	chr3:127872313-128127488:+	0.2	3.53	0.000453	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2038227	chr16:539140	DECR2	chr16:451858-462486:+	-0.24	-5.2	3.01E-7	Venous thromboembolism (SNP x SNP interaction)	
THCA	cis	1	rs2039415	chr1:160854445	ITLN1	chr1:160846332-160854960:-	0.28	4.57	6.26E-6	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs2040533	chr22:31679110	RNF185	chr22:31556138-31603004:+	-0.27	-5.04	6.47E-7	Paclitaxel-induced neuropathy	
THCA	cis	1	rs2041837	chr2:37468564	CEBPZ	chr2:37428778-37458740:-	-0.19	-4.25	2.61E-5	Chronic lymphocytic leukemia	
THCA	cis	1	rs2041840	chr2:37467264	CEBPZ	chr2:37428778-37458740:-	-0.18	-3.96	8.78E-5	Chronic lymphocytic leukemia	
THCA	cis	1	rs2042133	chr7:65931922	ASL	chr7:65540776-65558321:+	-0.16	-4.29	2.19E-5	Aortic root size	
THCA	cis	1	rs2042133	chr7:65931922	GUSB	chr7:65425675-65447246:-	0.28	5.39	1.11E-7	Aortic root size	
THCA	cis	1	rs2042133	chr7:65931922	LOC729156	chr7:66274980-66309813:-	0.16	3.37	0.000811	Aortic root size	
THCA	cis	1	rs2042133	chr7:65931922	RABGEF1	chr7:66093890-66276446:+	0.66	14.25	1.21E-38	Aortic root size	
THCA	cis	1	rs2042947	chr19:12693103	RTBDN	chr19:12936293-12946230:-	0.21	3.7	0.000239	Bipolar disorder	
THCA	cis	1	rs2043298	chr19:52573067	ZNF432	chr19:52536678-52552073:-	0.18	4.62	4.94E-6	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	
THCA	cis	1	rs2044426	chr11:116756183	PCSK7	chr11:117075789-117102811:-	0.4	4.97	9.13E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs2045554	chr3:48494542	ATRIP	chr3:48488141-48507708:+	-0.2	-4.41	1.27E-5	Longevity	
THCA	cis	1	rs2045554	chr3:48494542	TREX1	chr3:48501186-48509043:+	0.23	5.53	5.18E-8	Longevity	
THCA	cis	1	rs2045554	chr3:48494542	ZNF589	chr3:48282596-48329113:+	-0.16	-3.59	0.000367	Longevity	
THCA	cis	1	rs2046045	chr5:76535811	PDE8B	chr5:76506706-76723226:+	-0.1	-3.35	0.000859	Thyroid hormone levels	
THCA	cis	1	rs2046120	chr15:84567762	LOC388152	chr15:84867600-84898920:-	-0.21	-3.94	9.21E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs2046323	chr17:65849927	C17orf58	chr17:65987218-65989765:-	0.2	3.95	8.87E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs2046383	chr12:30104142	TMTC1	chr12:29653759-29937692:-	-0.16	-3.49	0.000519	Heart failure	
THCA	cis	1	rs2046768	chr11:46396479	PACSIN3	chr11:47199085-47207958:-	0.17	3.91	0.000107	Schizophrenia	
THCA	cis	1	rs2052187	chr17:65834737	C17orf58	chr17:65987218-65989765:-	0.24	4.76	2.62E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs2053367	chr2:26293413	GPR113	chr2:26531041-26569685:-	-0.45	-7.05	6.42E-12	Gut microbiome composition (summer)	
THCA	cis	1	rs2054394	chr4:103268763	BANK1	chr4:102341118-102995967:+	-0.24	-3.44	0.000631	Erythrocyte cadmium concentration in never smokers	
THCA	cis	1	rs2054463	chr17:20919705	USP22	chr17:20902908-20947073:-	-0.18	-3.84	0.000138	Blood trace element (Se levels)	
THCA	cis	1	rs2055127	chr1:235598973	B3GALNT2	chr1:235610533-235667781:-	-0.24	-7.3	1.19E-12	Adiposity	
THCA	cis	1	rs2055127	chr1:235598973	TBCE	chr1:235530728-235612280:+	-0.12	-3.47	0.000565	Adiposity	
THCA	cis	1	rs2055619	chr5:176415964	ZNF346	chr5:176449697-176508190:+	-0.16	-5.52	5.64E-8	Menopause (age at onset);Menarche and menopause (age at onset)	
THCA	cis	1	rs2055682	chr7:66260289	GUSB	chr7:65425675-65447246:-	0.3	6.08	2.52E-9	Aortic root size	
THCA	cis	1	rs2055682	chr7:66260289	RABGEF1	chr7:66093890-66276446:+	0.48	9.8	8.96E-21	Aortic root size	
THCA	cis	1	rs2055682	chr7:66260289	TYW1	chr7:66461817-66704496:+	0.21	4.68	3.7E-6	Aortic root size	
THCA	cis	1	rs2055712	chr15:84581605	LOC388152	chr15:84867600-84898920:-	-0.21	-3.98	7.86E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs205632	chr2:74956316	LOC151534	chr2:74729744-74732192:+	-0.18	-3.37	0.000804	Myopia (pathological)	
THCA	cis	1	rs205632	chr2:74956316	MRPL53	chr2:74699110-74699923:-	0.14	4.41	1.25E-5	Myopia (pathological)	
THCA	cis	1	rs205632	chr2:74956316	TTC31	chr2:74710200-74721691:+	-0.16	-3.56	0.000404	Myopia (pathological)	
THCA	cis	1	rs205633	chr2:74955369	MRPL53	chr2:74699110-74699923:-	0.15	4.45	1.08E-5	Myopia (pathological)	
THCA	cis	1	rs205633	chr2:74955369	TTC31	chr2:74710200-74721691:+	-0.18	-3.99	7.66E-5	Myopia (pathological)	
THCA	cis	1	rs205634	chr2:74955353	MRPL53	chr2:74699110-74699923:-	0.15	4.45	1.08E-5	Myopia (pathological)	
THCA	cis	1	rs205634	chr2:74955353	TTC31	chr2:74710200-74721691:+	-0.18	-3.99	7.66E-5	Myopia (pathological)	
THCA	cis	1	rs205638	chr2:74950067	MRPL53	chr2:74699110-74699923:-	-0.13	-4.07	5.42E-5	Myopia (pathological)	
THCA	cis	1	rs205638	chr2:74950067	TTC31	chr2:74710200-74721691:+	0.18	3.98	7.96E-5	Myopia (pathological)	
THCA	cis	1	rs2056486	chr2:73717567	ALMS1P	chr2:73872046-73912692:+	0.7	11.19	5.71E-26	Metabolite levels	
THCA	cis	1	rs2056486	chr2:73717567	NAT8	chr2:73867850-73869537:-	0.37	5.82	1.1E-8	Metabolite levels	
THCA	cis	1	rs2056486	chr2:73717567	TPRKB	chr2:73956957-73964517:-	-0.18	-4.58	6.04E-6	Metabolite levels	
THCA	cis	1	rs2056544	chr15:76826003	SCAPER	chr15:76640529-77197744:-	-0.17	-5.46	7.48E-8	Blood metabolite levels	
THCA	cis	1	rs2056603	chr3:134312749	ANAPC13	chr3:134196547-134204865:-	0.38	12.06	2.05E-29	Height	
THCA	cis	1	rs2056603	chr3:134312749	CEP63	chr3:134204575-134293852:+	0.29	6.21	1.14E-9	Height	
THCA	cis	1	rs2056604	chr3:134312648	ANAPC13	chr3:134196547-134204865:-	0.37	11.55	2.1E-27	Height	
THCA	cis	1	rs2056604	chr3:134312648	CEP63	chr3:134204575-134293852:+	0.29	6.27	8.23E-10	Height	
THCA	cis	1	rs2056781	chr11:18444989	LDHC	chr11:18433853-18472792:+	-0.31	-3.77	0.000186	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs2056938	chr20:44022672	ZNF335	chr20:44577293-44600833:-	-0.15	-3.46	0.000586	Psoriasis	
THCA	cis	1	rs2057077	chr20:48023636	KCNB1	chr20:47988505-48100490:-	-0.17	-3.68	0.000261	Obesity-related traits	
THCA	cis	1	rs2058059	chr7:72311817	TYW1B	chr7:72023729-72298813:-	-0.53	-8.65	7.62E-17	Subcutaneous adipose tissue	
THCA	cis	1	rs2058339	chr4:17678456	MED28	chr4:17616273-17629791:+	0.16	3.49	0.000533	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs2058710	chr2:207121782	GPR1	chr2:207040044-207082771:-	0.17	3.34	0.0009	Bipolar disorder and schizophrenia	
THCA	cis	1	rs2058805	chr12:109998591	KCTD10	chr12:109886460-109915155:-	-0.23	-6.05	2.98E-9	HDL cholesterol	
THCA	cis	1	rs2058813	chr16:50129454	HEATR3	chr16:50099881-50139373:+	-0.33	-7.11	4.24E-12	Testicular germ cell tumor	
THCA	cis	1	rs20598	chr7:117965959	ANKRD7	chr7:117864712-117882782:+	0.29	4.72	3.14E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs2060222	chr5:138308466	SIL1	chr5:138282412-138534065:-	0.15	4.43	1.15E-5	Age-related hearing impairment (interaction)	
THCA	cis	1	rs2060836	chr5:101789802	SLCO4C1	chr5:101569694-101632253:-	0.24	5.54	5.1E-8	Schizophrenia	
THCA	cis	1	rs2060837	chr5:101789805	SLCO4C1	chr5:101569694-101632253:-	0.24	5.36	1.28E-7	Schizophrenia	
THCA	cis	1	rs2061164	chr11:18329006	GTF2H1	chr11:18343816-18388590:+	0.37	9.85	5.58E-21	Pancreatic cancer	
THCA	cis	1	rs2061807	chr2:218315342	IGFBP5	chr2:217536829-217560272:-	-0.2	-4.32	1.93E-5	Metabolite levels (MHPG)	
THCA	cis	1	rs2061909	chr5:76531648	PDE8B	chr5:76506706-76723226:+	0.11	3.41	0.000706	Thyroid hormone levels	
THCA	cis	1	rs2061999	chr15:84582740	LOC388152	chr15:84867600-84898920:-	-0.21	-3.98	7.86E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs2062340	chr2:54480245	C2orf73	chr2:54558071-54588714:+	0.32	4.55	6.86E-6	Telomere length	
THCA	cis	1	rs2064088	chr22:39053382	JOSD1	chr22:39081549-39096459:-	-0.15	-3.94	9.33E-5	Resting heart rate	
THCA	cis	1	rs2064088	chr22:39053382	TOMM22	chr22:39077954-39080763:+	-0.16	-3.58	0.000379	Resting heart rate	
THCA	cis	1	rs2066471	chr1:11860458	MTHFR	chr1:11845787-11866115:-	0.23	3.45	0.000615	Homocysteine levels	
THCA	cis	1	rs2066587	chr13:50685954	DLEU1	chr13:50656414-51102670:+	-0.19	-3.55	0.00042	Height	
THCA	cis	1	rs2066587	chr13:50685954	EBPL	chr13:50234811-50265623:-	-0.17	-3.68	0.00026	Height	
THCA	cis	1	rs2066587	chr13:50685954	PHF11	chr13:50069801-50103116:+	-0.17	-4.09	5.08E-5	Height	
THCA	cis	1	rs2066587	chr13:50685954	TRIM13	chr13:50571143-50592603:+	-0.28	-5.42	9.48E-8	Height	
THCA	cis	1	rs2066725	chr17:41891473	MPP3	chr17:41878169-41910538:-	0.29	4.88	1.44E-6	Triglycerides	
THCA	cis	1	rs2067482	chr11:46406767	PACSIN3	chr11:47199085-47207958:-	0.16	3.41	0.000717	Schizophrenia	
THCA	cis	1	rs2069502	chr12:58144665	FAM119B	chr12:58166383-58176323:+	-0.39	-10.5	2.36E-23	Multiple sclerosis	
THCA	cis	1	rs2069502	chr12:58144665	METTL1	chr12:58162352-58165914:-	0.17	4.15	3.87E-5	Multiple sclerosis	
THCA	cis	1	rs2069502	chr12:58144665	TSFM	chr12:58176536-58191367:+	0.58	19.15	4.31E-61	Multiple sclerosis	
THCA	cis	1	rs2069502	chr12:58144665	XRCC6BP1	chr12:58335445-58351051:+	0.22	4.46	1.02E-5	Multiple sclerosis	
THCA	cis	1	rs2069940	chr20:33759272	PROCR	chr20:33758727-33765164:+	-0.31	-5.01	7.79E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs2069940	chr20:33759272	TRPC4AP	chr20:33590215-33680618:-	0.31	3.86	0.000129	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs2070180	chr3:121351338	IQCB1	chr3:121488610-121553926:-	-0.52	-10.09	7.58E-22	Cognitive performance	
THCA	cis	1	rs2070488	chr3:38442490	LOC100128640	chr3:38492524-38496311:-	-0.23	-4.76	2.55E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs2070488	chr3:38442490	XYLB	chr3:38388251-38456467:+	-0.2	-4.84	1.72E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs2070970	chr11:59861983	MS4A14	chr11:60145958-60185226:+	0.17	4.45	1.06E-5	Alzheimer's disease (late onset)	
THCA	cis	1	rs2070997	chr9:133748083	FIBCD1	chr9:133777826-133814455:-	-0.27	-4.31	1.95E-5	Response to amphetamines	
THCA	cis	1	rs2072052	chr12:58146719	FAM119B	chr12:58166383-58176323:+	0.39	10.42	4.91E-23	Multiple sclerosis	
THCA	cis	1	rs2072052	chr12:58146719	METTL1	chr12:58162352-58165914:-	-0.18	-4.35	1.68E-5	Multiple sclerosis	
THCA	cis	1	rs2072052	chr12:58146719	TSFM	chr12:58176536-58191367:+	-0.58	-19.24	1.56E-61	Multiple sclerosis	
THCA	cis	1	rs2072052	chr12:58146719	XRCC6BP1	chr12:58335445-58351051:+	-0.23	-4.68	3.67E-6	Multiple sclerosis	
THCA	cis	1	rs2072293	chr14:74537885	C14orf45	chr14:74486059-74549566:+	0.17	4.9	1.35E-6	Common traits (Other)	
THCA	cis	1	rs2072293	chr14:74537885	COQ6	chr14:74416643-74429811:+	0.13	3.58	0.000377	Common traits (Other)	
THCA	cis	1	rs2072293	chr14:74537885	LIN52	chr14:74551656-74667117:+	0.5	13.17	5.31E-34	Common traits (Other)	
THCA	cis	1	rs2072435	chr7:75959188	STYXL1	chr7:75625656-75677321:-	-0.16	-3.98	8.12E-5	Multiple sclerosis	
THCA	cis	1	rs2072435	chr7:75959188	UPK3B	chr7:76139745-76157197:+	-0.27	-4.67	3.88E-6	Multiple sclerosis	
THCA	cis	1	rs2072499	chr1:156169610	PMF1	chr1:156182784-156209831:+	-0.15	-3.86	0.000127	Testicular germ cell tumor	
THCA	cis	1	rs2072794	chr22:39150543	LOC646851	chr22:38974125-39052634:-	0.17	4.41	1.27E-5	Resting heart rate	
THCA	cis	1	rs2072794	chr22:39150543	SUN2	chr22:39130735-39190161:-	0.15	3.61	0.000339	Resting heart rate	
THCA	cis	1	rs2072795	chr22:39064209	JOSD1	chr22:39081549-39096459:-	0.14	3.81	0.000156	Resting heart rate	
THCA	cis	1	rs2072795	chr22:39064209	LOC646851	chr22:38974125-39052634:-	-0.14	-3.72	0.000223	Resting heart rate	
THCA	cis	1	rs2072795	chr22:39064209	TOMM22	chr22:39077954-39080763:+	0.16	3.56	0.000415	Resting heart rate	
THCA	cis	1	rs2072796	chr22:39064230	JOSD1	chr22:39081549-39096459:-	-0.15	-4.04	6.14E-5	Resting heart rate	
THCA	cis	1	rs2072796	chr22:39064230	TOMM22	chr22:39077954-39080763:+	-0.17	-3.67	0.000272	Resting heart rate	
THCA	cis	1	rs2072798	chr22:39148483	LOC646851	chr22:38974125-39052634:-	0.18	4.58	5.99E-6	Resting heart rate	
THCA	cis	1	rs2072798	chr22:39148483	SUN2	chr22:39130735-39190161:-	0.15	3.58	0.000377	Resting heart rate	
THCA	cis	1	rs2072883	chr22:43435668	ARFGAP3	chr22:43192532-43253408:-	0.2	4.26	2.45E-5	Schizophrenia	
THCA	cis	1	rs2073294	chr14:66082493	LOC645431	chr14:65877313-65879335:-	-0.61	-7.85	2.79E-14	Ischemic stroke	
THCA	cis	1	rs2073857	chr22:31658281	RNF185	chr22:31556138-31603004:+	-0.27	-5.06	5.86E-7	Paclitaxel-induced neuropathy	
THCA	cis	1	rs2073985	chr7:87368731	DBF4	chr7:87505544-87538856:+	-0.31	-4.46	1.05E-5	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs2074771	chr2:242350944	SEPT2	chr2:242254723-242293439:+	1.04	21.8	1.15E-73	Chronic lymphocytic leukemia	
THCA	cis	1	rs2075060	chr17:36925750	PSMB3	chr17:36909002-36920477:+	-0.13	-5.2	2.96E-7	Height	
THCA	cis	1	rs2075292	chr11:116732512	PCSK7	chr11:117075789-117102811:-	-0.29	-4.94	1.07E-6	Protein quantitative trait loci	
THCA	cis	1	rs2075603	chr14:55609955	KIAA0831	chr14:55833110-55878576:-	-0.12	-3.37	0.000805	Protein biomarker	
THCA	cis	1	rs2075678	chr20:47701339	ARFGEF2	chr20:47538275-47653229:+	-0.11	-3.47	0.000563	Anger	
THCA	cis	1	rs2075678	chr20:47701339	CSE1L	chr20:47662838-47713484:+	0.41	9.87	5.09E-21	Anger	
THCA	cis	1	rs2076028	chr22:39150450	LOC646851	chr22:38974125-39052634:-	0.18	4.52	7.8E-6	Resting heart rate	
THCA	cis	1	rs2076028	chr22:39150450	SUN2	chr22:39130735-39190161:-	0.15	3.59	0.000359	Resting heart rate	
THCA	cis	1	rs2076474	chr6:56007082	COL21A1	chr6:55921389-56258892:-	-0.71	-8.8	2.42E-17	Psychosis (atypical)	
THCA	cis	1	rs2077393	chr6:25607365	SCGN	chr6:25652429-25702006:+	-0.3	-5.76	1.47E-8	Uric acid levels	
THCA	cis	1	rs2077593	chr7:65892530	ASL	chr7:65540776-65558321:+	-0.16	-4.18	3.49E-5	Aortic root size	
THCA	cis	1	rs2077593	chr7:65892530	GUSB	chr7:65425675-65447246:-	0.27	5.27	2.11E-7	Aortic root size	
THCA	cis	1	rs2077593	chr7:65892530	RABGEF1	chr7:66093890-66276446:+	0.65	14.02	1.14E-37	Aortic root size	
THCA	cis	1	rs2077808	chr1:45988115	AKR1A1	chr1:46016498-46035720:+	-0.14	-3.91	0.000108	Homocysteine levels	
THCA	cis	1	rs2077808	chr1:45988115	CCDC163P	chr1:45960581-45965646:-	-1.1	-31.76	7.21E-120	Homocysteine levels	
THCA	cis	1	rs2077808	chr1:45988115	MUTYH	chr1:45794915-45806142:-	0.21	5.1	4.79E-7	Homocysteine levels	
THCA	cis	1	rs2077808	chr1:45988115	PRDX1	chr1:45976708-45987609:-	-0.4	-10.2	3.08E-22	Homocysteine levels	
THCA	cis	1	rs2078089	chr19:22209753	ZNF257	chr19:22235266-22273901:+	0.33	6.7	5.88E-11	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs2078803	chr22:31652852	RNF185	chr22:31556138-31603004:+	-0.28	-5.09	5.17E-7	Paclitaxel-induced neuropathy	
THCA	cis	1	rs2079005	chr17:41865627	MPP3	chr17:41878169-41910538:-	0.31	5.02	7.14E-7	Triglycerides	
THCA	cis	1	rs2080303	chr2:202165206	ALS2CR12	chr2:202153148-202222101:-	-0.42	-8	9.32E-15	Basal cell carcinoma	
THCA	cis	1	rs2080303	chr2:202165206	PPIL3	chr2:201735680-201753999:-	-0.34	-6.99	9.34E-12	Basal cell carcinoma	
THCA	cis	1	rs2081302	chr2:23945355	LOC375190	chr2:24299728-24397519:+	0.29	6.85	2.23E-11	Obesity-related traits	
THCA	cis	1	rs2083485	chr1:47170091	CYP4B1	chr1:47264670-47285020:+	0.22	3.4	0.000719	Response to hepatitis C treatment	
THCA	cis	1	rs2083485	chr1:47170091	CYP4Z1	chr1:47533160-47583992:+	0.27	4.06	5.76E-5	Response to hepatitis C treatment	
THCA	cis	1	rs2083485	chr1:47170091	DMBX1	chr1:46972668-46979884:+	0.24	4.03	6.39E-5	Response to hepatitis C treatment	
THCA	cis	1	rs2083634	chr4:129976478	C4orf33	chr4:130014829-130033842:+	-0.6	-9.41	2.02E-19	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs2083729	chr15:45935159	SPATA5L1	chr15:45694519-45713614:+	0.3	4.92	1.19E-6	Obesity-related traits	
THCA	cis	1	rs2083731	chr15:75368538	ARID3B	chr15:74833548-74890470:+	-0.16	-4.11	4.67E-5	Blood trace element (Zn levels)	
THCA	cis	1	rs2083731	chr15:75368538	PPCDC	chr15:75315927-75343066:+	0.13	3.64	0.000307	Blood trace element (Zn levels)	
THCA	cis	1	rs2083731	chr15:75368538	SCAMP2	chr15:75136073-75165670:-	-0.16	-3.5	0.0005	Blood trace element (Zn levels)	
THCA	cis	1	rs2083731	chr15:75368538	SCAMP5	chr15:75287901-75313836:+	0.4	7.19	2.43E-12	Blood trace element (Zn levels)	
THCA	cis	1	rs2084220	chr11:18656932	SPTY2D1	chr11:18627949-18656020:-	-0.14	-4.62	5.01E-6	Cholesterol, total	
THCA	cis	1	rs2084761	chr19:52156057	ZNF577	chr19:52359056-52394145:-	-0.19	-3.4	0.000737	Plasma plasminogen levels	
THCA	cis	1	rs2084897	chr11:120026600	TRIM29	chr11:119981995-120008863:-	0.44	7.44	4.67E-13	Stroke (pediatric)	
THCA	cis	1	rs2084898	chr11:120026748	TRIM29	chr11:119981995-120008863:-	0.4	6.68	6.62E-11	Stroke (pediatric)	
THCA	cis	1	rs2084899	chr11:120026810	TRIM29	chr11:119981995-120008863:-	0.43	7.3	1.22E-12	Stroke (pediatric)	
THCA	cis	1	rs2085683	chr4:18007435	DCAF16	chr4:17802280-17812381:-	-0.2	-4.49	8.81E-6	Height	
THCA	cis	1	rs2087647	chr7:65593188	ASL	chr7:65540776-65558321:+	0.16	4.27	2.34E-5	Aortic root size	
THCA	cis	1	rs2087647	chr7:65593188	GUSB	chr7:65425675-65447246:-	-0.27	-5.31	1.66E-7	Aortic root size	
THCA	cis	1	rs2087647	chr7:65593188	LOC729156	chr7:66274980-66309813:-	-0.16	-3.49	0.000535	Aortic root size	
THCA	cis	1	rs2087647	chr7:65593188	RABGEF1	chr7:66093890-66276446:+	-0.66	-14.15	3.18E-38	Aortic root size	
THCA	cis	1	rs2087726	chr3:46208310	CCR3	chr3:46205096-46308162:+	0.19	3.9	0.000109	Behcet's disease	
THCA	cis	1	rs2087726	chr3:46208310	FYCO1	chr3:45959396-46037307:-	-0.13	-3.68	0.000257	Behcet's disease	
THCA	cis	1	rs2087772	chr4:40382922	CHRNA9	chr4:40337469-40356973:+	-0.32	-3.46	0.00059	Body mass index (change over time)	
THCA	cis	1	rs2089162	chr15:78739763	CHRNA5	chr15:78857906-78886458:+	-0.34	-6.42	3.38E-10	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2090117	chr4:54300591	SCFD2	chr4:53739152-54232242:-	-0.21	-3.93	9.86E-5	DNA methylation (variation)	
THCA	cis	1	rs2092990	chr20:3346338	ITPA	chr20:3190056-3204504:+	-0.24	-5.87	8.09E-9	IFN-related cytopenia	
THCA	cis	1	rs2093395	chr6:41155026	LOC221442	chr6:41068773-41108567:+	-0.23	-7.33	9.95E-13	Alzheimer's disease (late onset)	
THCA	cis	1	rs2093396	chr6:41155000	LOC221442	chr6:41068773-41108567:+	0.23	7.48	3.53E-13	Alzheimer's disease (late onset)	
THCA	cis	1	rs2096199	chr6:44096014	TMEM63B	chr6:44095376-44123255:+	0.17	3.82	0.000152	Major depressive disorder	
THCA	cis	1	rs2096464	chr21:34686049	IFNAR1	chr21:34696734-34732126:+	-0.22	-5.26	2.23E-7	Narcolepsy	
THCA	cis	1	rs2098297	chr14:75619118	EIF2B2	chr14:75469612-75476292:+	-0.18	-4.81	2.02E-6	Height	
THCA	cis	1	rs2098297	chr14:75619118	MLH3	chr14:75480467-75518235:-	-0.29	-8.52	2.09E-16	Height	
THCA	cis	1	rs2098297	chr14:75619118	RPS6KL1	chr14:75372347-75389958:-	-0.31	-6.7	6.05E-11	Height	
THCA	cis	1	rs2099880	chr15:45935074	SPATA5L1	chr15:45694519-45713614:+	0.3	4.92	1.19E-6	Obesity-related traits	
THCA	cis	1	rs2099942	chr22:18438314	MICAL3	chr22:18270418-18507325:-	-0.21	-4.49	9.02E-6	Presence of antiphospholipid antibodies	
THCA	cis	1	rs2099943	chr22:18438559	MICAL3	chr22:18270418-18507325:-	-0.21	-4.49	9.02E-6	Presence of antiphospholipid antibodies	
THCA	cis	1	rs2099944	chr22:18438578	MICAL3	chr22:18270418-18507325:-	-0.21	-4.49	9.02E-6	Presence of antiphospholipid antibodies	
THCA	cis	1	rs2099945	chr22:18438642	MICAL3	chr22:18270418-18507325:-	-0.2	-4.23	2.76E-5	Presence of antiphospholipid antibodies	
THCA	cis	1	rs2100076	chr2:120150778	DBI	chr2:120124504-120130120:+	0.26	7.56	2.02E-13	Obesity-related traits	
THCA	cis	1	rs2101017	chr12:122306857	WDR66	chr12:122356480-122441830:+	-0.24	-4.03	6.41E-5	Urinary metabolites	
THCA	cis	1	rs2103936	chr10:38253333	LOC399744	chr10:38717074-38741080:+	-0.27	-3.62	0.000322	Obesity (extreme)	
THCA	cis	1	rs2104125	chr1:236000305	LYST	chr1:235824345-236046940:-	-0.32	-9.69	2.17E-20	Systemic lupus erythematosus	
THCA	cis	1	rs2104506	chr6:41533579	MDFI	chr6:41604930-41621981:+	0.18	5.16	3.67E-7	Prostate cancer	
THCA	cis	1	rs210540	chr5:36804365	C5orf42	chr5:37106330-37249530:-	-0.09	-3.68	0.00026	Height	
THCA	cis	1	rs210617	chr6:117860058	DCBLD1	chr6:117803820-117891018:+	-0.24	-4.64	4.54E-6	Height	
THCA	cis	1	rs210617	chr6:117860058	GOPC	chr6:117639351-117923681:-	-0.17	-4.87	1.49E-6	Height	
THCA	cis	1	rs210633	chr6:117880699	DCBLD1	chr6:117803820-117891018:+	0.25	4.88	1.46E-6	Height	
THCA	cis	1	rs210633	chr6:117880699	GOPC	chr6:117639351-117923681:-	0.18	5	7.97E-7	Height	
THCA	cis	1	rs2106346	chr9:135784169	C9orf98	chr9:135600965-135754198:-	0.22	5.53	5.28E-8	Psoriasis	
THCA	cis	1	rs2106595	chr7:118159549	ANKRD7	chr7:117864712-117882782:+	-0.24	-4.06	5.82E-5	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs2106747	chr7:23911499	C7orf46	chr7:23719749-23742268:+	0.13	3.88	0.000119	Schizophrenia	
THCA	cis	1	rs2106748	chr7:23911313	C7orf46	chr7:23719749-23742268:+	0.13	3.88	0.000119	Schizophrenia	
THCA	cis	1	rs2109299	chr7:110901229	IMMP2L	chr7:110303110-111202538:-	-0.15	-3.43	0.000662	Schizophrenia	
THCA	cis	1	rs2110001	chr7:150517022	TMEM176A	chr7:150497854-150502208:+	0.21	5.38	1.17E-7	Height	
THCA	cis	1	rs2110001	chr7:150517022	TMEM176B	chr7:150488378-150498448:-	0.14	3.69	0.000247	Height	
THCA	cis	1	rs2110073	chr12:7075882	EMG1	chr12:7079944-7105520:+	0.17	3.81	0.000159	Red blood cell fatty acid levels	
THCA	cis	1	rs2110073	chr12:7075882	LRRC23	chr12:6982733-7023405:+	0.2	3.68	0.000258	Red blood cell fatty acid levels	
THCA	cis	1	rs2110073	chr12:7075882	SPSB2	chr12:6980101-6982501:-	0.21	3.64	0.000306	Red blood cell fatty acid levels	
THCA	cis	1	rs2110309	chr7:110953303	IMMP2L	chr7:110303110-111202538:-	0.16	3.49	0.000529	Schizophrenia	
THCA	cis	1	rs2111504	chr19:32917455	DPY19L3	chr19:32896677-32975236:+	0.18	4.89	1.36E-6	Bipolar disorder	
THCA	cis	1	rs2111504	chr19:32917455	ZNF507	chr19:32836514-32878571:+	0.27	6.7	5.72E-11	Bipolar disorder	
THCA	cis	1	rs2113078	chr5:56087190	C5orf35	chr5:56205103-56213010:+	1	22.49	6.28E-77	Type 2 diabetes	
THCA	cis	1	rs2113079	chr5:56157951	C5orf35	chr5:56205103-56213010:+	1	22.98	2.89E-79	Type 2 diabetes	
THCA	cis	1	rs2113422	chr2:23939007	LOC375190	chr2:24299728-24397519:+	0.31	7.82	3.44E-14	Obesity-related traits	
THCA	cis	1	rs2113423	chr2:23942287	LOC375190	chr2:24299728-24397519:+	0.31	7.82	3.44E-14	Obesity-related traits	
THCA	cis	1	rs2113832	chr2:218278692	DIRC3	chr2:218148748-218621316:-	0.21	5.07	5.84E-7	Height	
THCA	cis	1	rs2114585	chr2:231039341	SP110	chr2:231033645-231084827:-	0.24	4.97	9.31E-7	Obesity-related traits	
THCA	cis	1	rs2114646	chr2:170624221	PHOSPHO2	chr2:170550975-170558216:+	0.22	4.36	1.62E-5	Obesity-related traits	
THCA	cis	1	rs2115069	chr5:150252365	LOC134466	chr5:150310000-150326146:-	0.42	5.88	7.88E-9	Crohn's disease	
THCA	cis	1	rs2115069	chr5:150252365	ZNF300	chr5:150273964-150284391:-	0.16	3.45	0.000603	Crohn's disease	
THCA	cis	1	rs2115671	chr15:50956432	ATP8B4	chr15:50150436-50411419:-	-0.11	-3.53	0.000462	QT interval	
THCA	cis	1	rs2115671	chr15:50956432	SPPL2A	chr15:50999739-51057910:-	0.28	7.24	1.8E-12	QT interval	
THCA	cis	1	rs211718	chr1:76106675	ACADM	chr1:76190043-76229353:+	0.12	3.37	0.00081	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs211718	chr1:76106675	MSH4	chr1:76262630-76378923:+	0.24	4.12	4.4E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs211723	chr1:76103030	MSH4	chr1:76262630-76378923:+	-0.26	-4.23	2.79E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs2118521	chr2:86204379	POLR1A	chr2:86253453-86333278:-	-0.31	-4.33	1.83E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs2120019	chr15:75334184	ARID3B	chr15:74833548-74890470:+	-0.15	-3.81	0.000158	Blood trace element (Zn levels)	
THCA	cis	1	rs2120019	chr15:75334184	PPCDC	chr15:75315927-75343066:+	0.18	5.04	6.72E-7	Blood trace element (Zn levels)	
THCA	cis	1	rs2120019	chr15:75334184	SCAMP5	chr15:75287901-75313836:+	0.5	8.54	1.83E-16	Blood trace element (Zn levels)	
THCA	cis	1	rs2120107	chr15:76869789	SCAPER	chr15:76640529-77197744:-	-0.16	-5.08	5.56E-7	Blood metabolite levels	
THCA	cis	1	rs2121067	chr14:76617651	ESRRB	chr14:76837690-76968178:+	0.29	4.41	1.26E-5	Blood pressure	
THCA	cis	1	rs2121070	chr14:76650764	ESRRB	chr14:76837690-76968178:+	0.29	4.57	6.14E-6	Blood pressure	
THCA	cis	1	rs2121071	chr14:76665477	ESRRB	chr14:76837690-76968178:+	0.32	5.04	6.72E-7	Blood pressure	
THCA	cis	1	rs2121075	chr14:76675540	ESRRB	chr14:76837690-76968178:+	0.33	5.26	2.23E-7	Blood pressure	
THCA	cis	1	rs2121077	chr14:76676355	ESRRB	chr14:76837690-76968178:+	-0.33	-5.07	5.6E-7	Blood pressure	
THCA	cis	1	rs2123133	chr5:101771645	SLCO4C1	chr5:101569694-101632253:-	0.25	5.66	2.64E-8	Schizophrenia	
THCA	cis	1	rs2123134	chr5:101771971	SLCO4C1	chr5:101569694-101632253:-	0.25	5.62	3.21E-8	Schizophrenia	
THCA	cis	1	rs2125023	chr6:70499990	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.46	0.000579	Sleep duration	
THCA	cis	1	rs2125211	chr4:103559876	NFKB1	chr4:103422486-103538458:+	-0.15	-4.2	3.17E-5	Primary biliary cirrhosis	
THCA	cis	1	rs2125574	chr4:119954942	C4orf3	chr4:120217575-120221968:-	-0.25	-4.29	2.2E-5	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs2125654	chr4:18025368	DCAF16	chr4:17802280-17812381:-	-0.19	-4.37	1.54E-5	Height	
THCA	cis	1	rs2125747	chr1:108380533	VAV3	chr1:108113782-108507545:-	0.55	7.32	1.06E-12	Hypothyroidism	
THCA	cis	1	rs2126129	chr2:212548	SH3YL1	chr2:218138-264810:-	-0.91	-24.44	3.52E-86	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs2127093	chr17:20919703	USP22	chr17:20902908-20947073:-	-0.18	-3.79	0.000169	Blood trace element (Se levels)	
THCA	cis	1	rs2127094	chr17:20925319	USP22	chr17:20902908-20947073:-	-0.18	-3.88	0.000118	Blood trace element (Se levels)	
THCA	cis	1	rs2127387	chr5:76532571	PDE8B	chr5:76506706-76723226:+	0.11	3.41	0.000706	Thyroid hormone levels	
THCA	cis	1	rs2127905	chr11:117026374	PCSK7	chr11:117075789-117102811:-	-0.39	-6.81	2.96E-11	Protein quantitative trait loci	
THCA	cis	1	rs2128792	chr17:65857177	C17orf58	chr17:65987218-65989765:-	0.2	3.95	8.87E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs2128834	chr3:41862645	ULK4	chr3:41288091-42003660:-	1.04	19.87	1.7E-64	Diastolic blood pressure	
THCA	cis	1	rs2128835	chr3:41862873	ULK4	chr3:41288091-42003660:-	1.05	19.9	1.26E-64	Diastolic blood pressure	
THCA	cis	1	rs2129782	chr8:89459234	MMP16	chr8:89049462-89339717:-	0.32	5.2	2.96E-7	Electrodermal activity	
THCA	cis	1	rs213027	chr1:21651660	ECE1	chr1:21543740-21672034:-	0.12	3.52	0.000474	Obesity-related traits	
THCA	cis	1	rs213028	chr1:21652177	ECE1	chr1:21543740-21672034:-	-0.12	-3.69	0.000252	Obesity-related traits	
THCA	cis	1	rs213030	chr1:21653847	ECE1	chr1:21543740-21672034:-	0.14	4.04	6.24E-5	Obesity-related traits	
THCA	cis	1	rs213032	chr1:21654735	ECE1	chr1:21543740-21672034:-	0.12	3.55	0.00042	Obesity-related traits	
THCA	cis	1	rs2130392	chr4:185639169	CCDC111	chr4:185570767-185616112:+	0.27	6.59	1.14E-10	Kawasaki disease	
THCA	cis	1	rs2130392	chr4:185639169	MLF1IP	chr4:185615220-185655286:-	-0.4	-9.54	7.29E-20	Kawasaki disease	
THCA	cis	1	rs2130477	chr13:85745985	SLITRK6	chr13:86366922-86373483:-	-0.22	-3.91	0.000105	Bipolar disorder (mania)	
THCA	cis	1	rs2132238	chr3:184724335	C3orf70	chr3:184795840-184870802:-	-0.23	-4.62	4.96E-6	Heschl's gyrus morphology	
THCA	cis	1	rs2133134	chr1:76179587	MSH4	chr1:76262630-76378923:+	0.25	4.2	3.16E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs2134044	chr6:101075354	ASCC3	chr6:100956609-101329224:-	0.11	4.3	2.05E-5	Menarche (age at onset)	
THCA	cis	1	rs2134454	chr5:101803271	SLCO4C1	chr5:101569694-101632253:-	0.24	5.54	5.1E-8	Schizophrenia	
THCA	cis	1	rs2135507	chr4:83586671	TMEM150C	chr4:83405604-83483510:-	-0.25	-6.43	3.18E-10	Juvenile osteochondritis dissecans	
THCA	cis	1	rs2135509	chr4:17917818	DCAF16	chr4:17802280-17812381:-	-0.23	-5.51	5.96E-8	Height	
THCA	cis	1	rs2135880	chr15:84589613	LOC388152	chr15:84867600-84898920:-	-0.21	-3.98	7.86E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs213733	chr1:41576989	SCMH1	chr1:41492875-41707788:-	0.2	4.83	1.86E-6	Height	
THCA	cis	1	rs213734	chr1:41575699	SCMH1	chr1:41492875-41707788:-	0.2	4.83	1.86E-6	Height	
THCA	cis	1	rs213742	chr1:41621127	SCMH1	chr1:41492875-41707788:-	0.2	4.65	4.29E-6	Height	
THCA	cis	1	rs213747	chr1:41628738	SCMH1	chr1:41492875-41707788:-	0.2	4.65	4.29E-6	Height	
THCA	cis	1	rs213748	chr1:41628730	SCMH1	chr1:41492875-41707788:-	0.2	4.65	4.29E-6	Height	
THCA	cis	1	rs213754	chr1:41598848	SCMH1	chr1:41492875-41707788:-	0.2	4.61	5.06E-6	Height	
THCA	cis	1	rs2140195	chr2:73702344	ALMS1P	chr2:73872046-73912692:+	0.69	10.8	1.76E-24	Metabolite levels	
THCA	cis	1	rs2140195	chr2:73702344	NAT8	chr2:73867850-73869537:-	0.36	5.6	3.54E-8	Metabolite levels	
THCA	cis	1	rs2140195	chr2:73702344	TPRKB	chr2:73956957-73964517:-	-0.18	-4.68	3.66E-6	Metabolite levels	
THCA	cis	1	rs2140270	chr3:49439440	GMPPB	chr3:49758932-49761384:-	0.17	3.83	0.000148	Menarche (age at onset)	
THCA	cis	1	rs2140270	chr3:49439440	P4HTM	chr3:49027341-49044579:+	-0.17	-4.29	2.19E-5	Menarche (age at onset)	
THCA	cis	1	rs2140270	chr3:49439440	WDR6	chr3:49044637-49053386:+	0.17	3.59	0.000359	Menarche (age at onset)	
THCA	cis	1	rs2140337	chr4:8502112	C4orf23	chr4:8440604-8495258:+	-0.35	-7.42	5.46E-13	Response to antineoplastic agents	
THCA	cis	1	rs2141595	chr3:169503432	LRRC34	chr3:169511266-169530720:-	-0.24	-4.65	4.34E-6	Multiple myeloma and monoclonal gammopathy;Interstitial lung disease	
THCA	cis	1	rs2141924	chr7:66186246	CCT6P1	chr7:65216092-65228661:+	0.42	6.55	1.51E-10	Gout	
THCA	cis	1	rs2141924	chr7:66186246	CRCP	chr7:65579805-65619551:+	-0.29	-4.28	2.28E-5	Gout	
THCA	cis	1	rs2141924	chr7:66186246	GUSB	chr7:65425675-65447246:-	0.28	3.43	0.000655	Gout	
THCA	cis	1	rs2141924	chr7:66186246	RABGEF1	chr7:66093890-66276446:+	0.63	7.67	9.54E-14	Gout	
THCA	cis	1	rs2143062	chr6:27353852	ZNF184	chr6:27418522-27440897:-	-0.23	-4.96	9.79E-7	Glomerular filtration rate (creatinine)	
THCA	cis	1	rs2143062	chr6:27353852	ZNF391	chr6:27356524-27369227:+	0.2	5.21	2.85E-7	Glomerular filtration rate (creatinine)	
THCA	cis	1	rs2143230	chr20:32724345	RALY	chr20:32581732-32672675:+	0.14	4.24	2.72E-5	Tanning;Skin sensitivity to sun;Red vs. non-red hair color;Freckles;Burning and freckling	
THCA	cis	1	rs2143346	chr6:26198449	HIST1H2AE	chr6:26217148-26217711:+	0.23	3.69	0.000249	Renal underexcretion gout;Gout	
THCA	cis	1	rs2143346	chr6:26198449	HIST1H3E	chr6:26224427-26226589:+	-0.43	-7.04	6.71E-12	Renal underexcretion gout;Gout	
THCA	cis	1	rs2143347	chr6:26198494	HIST1H2AE	chr6:26217148-26217711:+	-0.22	-3.58	0.000373	Renal underexcretion gout;Gout	
THCA	cis	1	rs2143347	chr6:26198494	HIST1H3E	chr6:26224427-26226589:+	0.42	6.95	1.18E-11	Renal underexcretion gout;Gout	
THCA	cis	1	rs2143950	chr14:35572357	FAM177A1	chr14:35514113-35552587:+	-0.2	-3.82	0.000149	Atopic dermatitis	
THCA	cis	1	rs2143950	chr14:35572357	KIAA0391	chr14:35591776-35786673:+	0.31	5.71	1.99E-8	Atopic dermatitis	
THCA	cis	1	rs2143950	chr14:35572357	PPP2R3C	chr14:35554679-35591679:-	0.54	10.2	3.17E-22	Atopic dermatitis	
THCA	cis	1	rs2144845	chr10:38221519	LOC399744	chr10:38717074-38741080:+	-0.27	-3.68	0.000261	Obesity (extreme)	
THCA	cis	1	rs2144940	chr20:23050806	C20orf56	chr20:22541194-22559280:-	-0.3	-3.41	0.000708	Venous thromboembolism	
THCA	cis	1	rs2144940	chr20:23050806	FOXA2	chr20:22561643-22566101:-	-0.32	-3.63	0.000316	Venous thromboembolism	
THCA	cis	1	rs2145786	chr1:236035298	LYST	chr1:235824345-236046940:-	-0.32	-9.65	2.99E-20	Systemic lupus erythematosus	
THCA	cis	1	rs2147712	chr14:50091684	MGAT2	chr14:50087489-50090198:+	0.22	4.36	1.58E-5	Carotid intima media thickness	
THCA	cis	1	rs2147712	chr14:50091684	RPL36AL	chr14:50085407-50087349:-	0.56	16.38	3.31E-48	Carotid intima media thickness	
THCA	cis	1	rs2147972	chr14:55598030	KIAA0831	chr14:55833110-55878576:-	-0.12	-3.41	0.000709	Protein biomarker	
THCA	cis	1	rs2149423	chr13:36772381	SOHLH2	chr13:36742347-36871992:-	0.36	6.21	1.14E-9	Glucose homeostasis traits	
THCA	cis	1	rs2150410	chr21:40569779	HMGN1	chr21:40714247-40721270:-	-0.27	-3.75	0.000195	Temperament (bipolar disorder)	
THCA	cis	1	rs2152375	chr14:65915778	LOC645431	chr14:65877313-65879335:-	-0.59	-7.46	4.2E-13	Ischemic stroke	
THCA	cis	1	rs2153657	chr6:24321397	MRS2	chr6:24403153-24425809:+	-0.15	-3.4	0.000728	Uric acid levels	
THCA	cis	1	rs2154536	chr21:38492147	DSCR9	chr21:38580804-38594036:+	-0.19	-3.82	0.00015	Eye color traits	
THCA	cis	1	rs2154536	chr21:38492147	PIGP	chr21:38437664-38445458:-	-0.54	-15.23	5.33E-43	Eye color traits	
THCA	cis	1	rs2154536	chr21:38492147	TTC3	chr21:38445571-38575406:+	0.31	10.77	2.31E-24	Eye color traits	
THCA	cis	1	rs2155232	chr11:57041378	TIMM10	chr11:57295936-57298232:-	-0.21	-3.96	8.74E-5	Low high density lipoprotein cholesterol levels	
THCA	cis	1	rs2155233	chr11:57041992	TIMM10	chr11:57295936-57298232:-	-0.2	-3.7	0.00024	Low high density lipoprotein cholesterol levels	
THCA	cis	1	rs2155583	chr11:116915217	PCSK7	chr11:117075789-117102811:-	-0.3	-5.44	8.64E-8	Protein quantitative trait loci	
THCA	cis	1	rs2156257	chr6:163100710	PACRG	chr6:163148164-163736523:+	0.52	7.19	2.57E-12	Body mass index	
THCA	cis	1	rs2157586	chr22:26895061	ASPHD2	chr22:26825280-26840978:+	-0.27	-3.51	0.000497	Ischemic stroke	
THCA	cis	1	rs2157710	chr22:23457486	GNAZ	chr22:23412669-23467221:+	-0.26	-5.5	6.05E-8	Bone mineral density	
THCA	cis	1	rs2157926	chr7:87270500	DBF4	chr7:87505544-87538856:+	-0.23	-3.61	0.000341	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs2157929	chr7:87302140	DBF4	chr7:87505544-87538856:+	-0.29	-4.29	2.16E-5	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs2158100	chr17:18811479	FAM18B	chr17:18684582-18710026:+	0.31	7.08	5.21E-12	Pancreatic cancer	
THCA	cis	1	rs2158428	chr5:130751481	P4HA2	chr5:131528306-131563556:-	-0.26	-5.05	6.2E-7	Life satisfaction	
THCA	cis	1	rs2159400	chr3:47375890	C3orf75	chr3:47537131-47555199:-	0.09	4.27	2.39E-5	Colorectal cancer	
THCA	cis	1	rs2159400	chr3:47375890	NBEAL2	chr3:47021173-47051193:+	0.12	4.01	7.02E-5	Colorectal cancer	
THCA	cis	1	rs2159499	chr7:38228902	STARD3NL	chr7:38217933-38270269:+	-0.51	-12.02	2.9E-29	Treatment response for severe sepsis	
THCA	cis	1	rs2159501	chr7:38239276	STARD3NL	chr7:38217933-38270269:+	-0.52	-12.06	2.05E-29	Treatment response for severe sepsis	
THCA	cis	1	rs2159584	chr4:17620568	MED28	chr4:17616273-17629791:+	0.21	4.57	6.14E-6	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs2160301	chr16:51473736	SALL1	chr16:51169886-51185183:-	-0.22	-4.91	1.22E-6	Optic disc area;Optic disc parameters	
THCA	cis	1	rs2160392	chr2:37527393	CEBPZ	chr2:37428778-37458740:-	-0.19	-4.14	4.16E-5	Chronic lymphocytic leukemia	
THCA	cis	1	rs2160393	chr2:37516950	CEBPZ	chr2:37428778-37458740:-	-0.19	-4.14	4.15E-5	Chronic lymphocytic leukemia	
THCA	cis	1	rs2160395	chr2:37479862	CEBPZ	chr2:37428778-37458740:-	-0.18	-4.01	7.1E-5	Chronic lymphocytic leukemia	
THCA	cis	1	rs2160869	chr3:10079255	C3orf10	chr3:10157333-10168873:+	-0.2	-4.15	3.91E-5	Alzheimer's disease	
THCA	cis	1	rs2160869	chr3:10079255	VHL	chr3:10183319-10193744:+	-0.19	-4.38	1.48E-5	Alzheimer's disease	
THCA	cis	1	rs2162234	chr15:84382435	ADAMTSL3	chr15:84322838-84708591:+	0.23	3.53	0.000461	Age-related hearing impairment (interaction)	
THCA	cis	1	rs2162478	chr2:231038640	SP110	chr2:231033645-231084827:-	0.24	4.98	8.95E-7	Obesity-related traits	
THCA	cis	1	rs2162919	chr19:53381429	ZNF320	chr19:53367119-53400946:-	0.23	5.7	2.07E-8	Psychosis in Alzheimer's disease	
THCA	cis	1	rs2162919	chr19:53381429	ZNF468	chr19:53341786-53360902:-	0.15	3.99	7.6E-5	Psychosis in Alzheimer's disease	
THCA	cis	1	rs2163041	chr2:227772480	COL4A4	chr2:227867435-228029275:-	0.16	3.88	0.000117	Pulmonary function	
THCA	cis	1	rs2163167	chr3:53131772	ITIH4	chr3:52847007-52866554:-	0.16	4.52	7.66E-6	Height	
THCA	cis	1	rs2163167	chr3:53131772	RFT1	chr3:53122503-53164470:-	-0.76	-18.28	5.7E-57	Height	
THCA	cis	1	rs2163272	chr4:39114410	KLHL5	chr4:39046659-39123828:+	-0.21	-5.73	1.77E-8	Uric acid levels	
THCA	cis	1	rs2163273	chr4:39114455	KLHL5	chr4:39046659-39123828:+	-0.21	-5.73	1.77E-8	Uric acid levels	
THCA	cis	1	rs216345	chr9:33799370	NUDT2	chr9:34329504-34343695:+	-0.19	-4.38	1.44E-5	Bipolar disorder	
THCA	cis	1	rs216345	chr9:33799370	UBE2R2	chr9:33817182-33920399:+	0.21	4.06	5.83E-5	Bipolar disorder	
THCA	cis	1	rs2163813	chr19:19829101	ZNF14	chr19:19821281-19843921:-	0.23	4.72	3.12E-6	Toenail selenium levels	
THCA	cis	1	rs2163846	chr19:22505844	ZNF492	chr19:22817126-22850472:+	0.21	3.68	0.000262	Telomere length	
THCA	cis	1	rs2163846	chr19:22505844	ZNF98	chr19:22573899-22605148:-	0.41	9.67	2.59E-20	Telomere length	
THCA	cis	1	rs2164879	chr2:86261579	LOC90784	chr2:86247339-86250991:-	-0.56	-6.63	9.3E-11	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs216518	chr14:60683430	DHRS7	chr14:60611502-60636561:-	-0.23	-4.04	6.19E-5	Allergic rhinitis	
THCA	cis	1	rs2165525	chr11:59906792	MS4A14	chr11:60145958-60185226:+	0.16	4.23	2.85E-5	Alzheimer's disease (late onset)	
THCA	cis	1	rs2166663	chr6:86593896	SNHG5	chr6:86386726-86388451:-	-0.53	-12.33	1.6E-30	Response to antipsychotic treatment	
THCA	cis	1	rs2167505	chr8:1033877	DLGAP2	chr8:1449569-1656640:+	0.43	7.98	1.08E-14	Schizophrenia	
THCA	cis	1	rs2169387	chr8:9181395	SGK223	chr8:8175259-8239257:-	0.33	3.46	0.000586	Metabolite levels (small molecules and protein measures);LDL cholesterol	
THCA	cis	1	rs2169748	chr2:28957753	PPP1CB	chr2:28974612-29025805:+	-0.17	-4.25	2.55E-5	Body mass index	
THCA	cis	1	rs2169748	chr2:28957753	TRMT61B	chr2:29072690-29093175:-	0.51	10.21	2.9E-22	Body mass index	
THCA	cis	1	rs2169751	chr2:28966758	PPP1CB	chr2:28974612-29025805:+	0.17	4.27	2.37E-5	Body mass index	
THCA	cis	1	rs2169751	chr2:28966758	TRMT61B	chr2:29072690-29093175:-	-0.5	-10.1	7.32E-22	Body mass index	
THCA	cis	1	rs2169926	chr14:102425872	RAGE	chr14:102690838-102771531:-	-0.14	-4.59	5.78E-6	Menopause (age at onset)	
THCA	cis	1	rs2171481	chr8:89459614	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs2171667	chr11:46467092	PACSIN3	chr11:47199085-47207958:-	0.17	3.85	0.000136	Schizophrenia	
THCA	cis	1	rs217181	chr16:72114002	HP	chr16:72088508-72094957:+	0.28	4.35	1.68E-5	Metabolite levels (small molecules and protein measures)	
THCA	cis	1	rs2172252	chr3:49678307	MST1	chr3:49721381-49726196:-	0.13	3.99	7.74E-5	Crohn's disease;Ulcerative colitis	
THCA	cis	1	rs2172252	chr3:49678307	UBA7	chr3:49842639-49851391:-	0.16	3.65	0.000297	Crohn's disease;Ulcerative colitis	
THCA	cis	1	rs2174019	chr3:2472667	CNTN4	chr3:2140550-3099644:+	0.36	8.4	5.05E-16	Blood pressure (smoking interaction)	
THCA	cis	1	rs2174608	chr15:50871993	SPPL2A	chr15:50999739-51057910:-	0.28	7.41	5.66E-13	QT interval	
THCA	cis	1	rs2175366	chr19:22128279	ZNF257	chr19:22235266-22273901:+	0.32	6.52	1.77E-10	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs2175416	chr2:160904021	LY75	chr2:160625141-160761262:-	0.21	4.97	9.57E-7	Idiopathic membranous nephropathy	
THCA	cis	1	rs2176563	chr11:93723513	HEPHL1	chr11:93754378-93847374:+	-0.47	-3.85	0.000136	Obesity-related traits	
THCA	cis	1	rs2177129	chr4:56365414	TMEM165	chr4:56262090-56292342:+	-0.16	-4.1	4.79E-5	Personality dimensions	
THCA	cis	1	rs2177268	chr3:49439725	GMPPB	chr3:49758932-49761384:-	0.17	3.83	0.000148	Menarche (age at onset)	
THCA	cis	1	rs2177268	chr3:49439725	P4HTM	chr3:49027341-49044579:+	-0.17	-4.29	2.19E-5	Menarche (age at onset)	
THCA	cis	1	rs2177268	chr3:49439725	WDR6	chr3:49044637-49053386:+	0.17	3.59	0.000359	Menarche (age at onset)	
THCA	cis	1	rs2177601	chr3:134245434	ANAPC13	chr3:134196547-134204865:-	-0.39	-12.14	9.6E-30	Height	
THCA	cis	1	rs2177601	chr3:134245434	CEP63	chr3:134204575-134293852:+	-0.31	-6.6	1.07E-10	Height	
THCA	cis	1	rs2177703	chr7:65391717	CCT6P1	chr7:65216092-65228661:+	0.38	6	3.93E-9	Diabetic kidney disease	
THCA	cis	1	rs2177703	chr7:65391717	CRCP	chr7:65579805-65619551:+	-0.26	-4	7.24E-5	Diabetic kidney disease	
THCA	cis	1	rs2177703	chr7:65391717	RABGEF1	chr7:66093890-66276446:+	0.55	6.89	1.73E-11	Diabetic kidney disease	
THCA	cis	1	rs2179142	chr22:39037954	JOSD1	chr22:39081549-39096459:-	-0.13	-3.46	0.000587	Resting heart rate	
THCA	cis	1	rs2179142	chr22:39037954	LOC646851	chr22:38974125-39052634:-	0.14	3.61	0.00034	Resting heart rate	
THCA	cis	1	rs2179142	chr22:39037954	TOMM22	chr22:39077954-39080763:+	-0.16	-3.49	0.000529	Resting heart rate	
THCA	cis	1	rs2179699	chr6:159386594	RSPH3	chr6:159398268-159421198:-	0.29	6.05	2.96E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs2180782	chr20:55805127	BMP7	chr20:55743809-55841707:-	-0.17	-3.35	0.000871	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	
THCA	cis	1	rs2180896	chr14:97304453	VRK1	chr14:97263684-97347950:+	0.17	3.89	0.000114	Neutrophil count	
THCA	cis	1	rs2181043	chr10:17217803	TRDMT1	chr10:17184983-17243681:-	-0.45	-10.49	2.58E-23	Homocysteine levels	
THCA	cis	1	rs2181043	chr10:17217803	VIM	chr10:17270258-17279592:+	-0.19	-3.47	0.000558	Homocysteine levels	
THCA	cis	1	rs2182182	chr6:87911780	C6orf164	chr6:88032306-88109459:+	0.28	3.48	0.000543	Entorhinal cortical volume (Alzheimer's disease interaction)	
THCA	cis	1	rs2182652	chr10:7735876	ITIH5	chr10:7601636-7708934:-	0.18	3.57	0.000399	Ovarian reserve	
THCA	cis	1	rs2182953	chr13:85763126	SLITRK6	chr13:86366922-86373483:-	-0.22	-4.2	3.16E-5	Bipolar disorder (mania)	
THCA	cis	1	rs2184000	chr20:25395878	ENTPD6	chr20:25176339-25207360:+	0.32	7.27	1.44E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2184000	chr20:25395878	FAM182A	chr20:26035250-26067552:+	0.18	3.38	0.000797	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2184000	chr20:25395878	FAM182B	chr20:25744102-25848786:-	-0.26	-5.44	8.65E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2184000	chr20:25395878	NINL	chr20:25433338-25566153:-	0.34	6.94	1.27E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2184000	chr20:25395878	PYGB	chr20:25228706-25278647:+	0.16	4	7.42E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2184476	chr1:207504669	CD55	chr1:207494817-207534309:+	0.15	6.53	1.67E-10	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs2184602	chr14:65915672	LOC645431	chr14:65877313-65879335:-	-0.59	-7.8	4.04E-14	Ischemic stroke	
THCA	cis	1	rs2184877	chr1:40996932	DEM1	chr1:40974433-40982212:+	0.35	5.17	3.46E-7	Age-related hearing impairment (interaction)	
THCA	cis	1	rs2185281	chr1:121179991	HIST2H2BA	chr1:120906034-120914842:+	0.21	4.9	1.31E-6	Hip geometry	
THCA	cis	1	rs2186369	chr22:24170996	C22orf43	chr22:23950640-23974487:-	-0.22	-3.42	0.000689	IgG glycosylation	
THCA	cis	1	rs2186844	chr11:116896913	PCSK7	chr11:117075789-117102811:-	-0.45	-5.37	1.24E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs2188527	chr7:87337759	DBF4	chr7:87505544-87538856:+	-0.3	-4.34	1.76E-5	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs2188531	chr7:87328003	DBF4	chr7:87505544-87538856:+	-0.25	-3.73	0.000216	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs2188654	chr7:118179073	ANKRD7	chr7:117864712-117882782:+	0.25	4.08	5.34E-5	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs2188828	chr7:87405351	DBF4	chr7:87505544-87538856:+	-0.3	-4.39	1.37E-5	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs2189125	chr7:118007075	ANKRD7	chr7:117864712-117882782:+	0.27	4.41	1.28E-5	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs2192008	chr2:191545147	HIBCH	chr2:191069361-191184559:-	-0.19	-3.98	7.83E-5	Bone mineral density (Ward's triangle area)	
THCA	cis	1	rs2192233	chr7:118074563	ANKRD7	chr7:117864712-117882782:+	-0.26	-4.26	2.41E-5	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs2194736	chr2:218290971	DIRC3	chr2:218148748-218621316:-	0.2	4.74	2.82E-6	Height	
THCA	cis	1	rs2194737	chr2:218290669	DIRC3	chr2:218148748-218621316:-	0.2	4.74	2.78E-6	Height	
THCA	cis	1	rs2198042	chr4:129885499	C4orf33	chr4:130014829-130033842:+	0.62	9.59	4.95E-20	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs2198246	chr5:101692228	SLCO4C1	chr5:101569694-101632253:-	-0.25	-5.62	3.21E-8	Schizophrenia	
THCA	cis	1	rs2200578	chr2:99876244	LIPT1	chr2:99771418-99779611:+	0.2	3.91	0.000107	IgG glycosylation	
THCA	cis	1	rs2201867	chr11:5558273	UBQLNL	chr11:5535624-5537956:-	-0.28	-6.49	2.12E-10	QRS duration in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs2201868	chr11:5558211	UBQLNL	chr11:5535624-5537956:-	-0.28	-6.37	4.39E-10	QRS duration in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs2202019	chr1:76299181	ACADM	chr1:76190043-76229353:+	-0.25	-5.03	7.11E-7	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs2203793	chr11:93734006	HEPHL1	chr11:93754378-93847374:+	-0.4	-3.41	0.000697	Obesity-related traits	
THCA	cis	1	rs220470	chr17:3664975	GSG2	chr17:3627197-3629990:+	0.15	4.23	2.84E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs220470	chr17:3664975	MED11	chr17:4634723-4636894:+	0.15	4.39	1.37E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs220471	chr17:3665160	GSG2	chr17:3627197-3629990:+	0.13	3.77	0.000187	Attention deficit hyperactivity disorder	
THCA	cis	1	rs220471	chr17:3665160	MED11	chr17:4634723-4636894:+	0.14	4.27	2.39E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs220475	chr17:3660750	MED11	chr17:4634723-4636894:+	-0.14	-4.08	5.34E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs2205802	chr22:39046327	JOSD1	chr22:39081549-39096459:-	-0.15	-3.94	9.33E-5	Resting heart rate	
THCA	cis	1	rs2205802	chr22:39046327	TOMM22	chr22:39077954-39080763:+	-0.16	-3.58	0.000379	Resting heart rate	
THCA	cis	1	rs2208331	chr6:26507319	BTN2A3	chr6:26422317-26431927:+	0.2	4.64	4.57E-6	Educational attainment	
THCA	cis	1	rs2208331	chr6:26507319	HCG11	chr6:26521934-26527610:+	-0.23	-4.47	9.87E-6	Educational attainment	
THCA	cis	1	rs2208331	chr6:26507319	HMGN4	chr6:26538572-26547162:+	-0.16	-4.08	5.38E-5	Educational attainment	
THCA	cis	1	rs2208331	chr6:26507319	ZNF322A	chr6:26634612-26659963:-	-0.14	-3.78	0.000176	Educational attainment	
THCA	cis	1	rs2209875	chr9:91813461	CKS2	chr9:91926113-91931617:+	-0.24	-4.63	4.67E-6	Pelvic organ prolapse (moderate/severe)	
THCA	cis	1	rs2210913	chr1:157668993	FCRL3	chr1:157646278-157670775:-	0.28	8.99	5.94E-18	Type 1 diabetes autoantibodies	
THCA	cis	1	rs2214101	chr7:87269497	DBF4	chr7:87505544-87538856:+	-0.28	-3.98	7.94E-5	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs2214106	chr7:87337779	DBF4	chr7:87505544-87538856:+	-0.3	-4.34	1.76E-5	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs2214363	chr7:118001244	ANKRD7	chr7:117864712-117882782:+	0.28	4.51	8.34E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs2214366	chr7:118023272	ANKRD7	chr7:117864712-117882782:+	0.27	4.37	1.5E-5	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs2215450	chr4:17675394	MED28	chr4:17616273-17629791:+	0.18	3.98	8.08E-5	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs2216464	chr6:46662577	CYP39A1	chr6:46517445-46620523:-	-0.32	-4.86	1.61E-6	Lipoprotein-associated phospholipase A2 activity and mass	
THCA	cis	1	rs2217266	chr5:150272621	LOC134466	chr5:150310000-150326146:-	0.39	5.41	9.98E-8	Crohn's disease	
THCA	cis	1	rs2218191	chr1:47130628	CYP4Z1	chr1:47533160-47583992:+	0.2	3.39	0.000767	Response to hepatitis C treatment	
THCA	cis	1	rs2218191	chr1:47130628	DMBX1	chr1:46972668-46979884:+	0.18	3.44	0.000644	Response to hepatitis C treatment	
THCA	cis	1	rs2218803	chr3:161047973	NMD3	chr3:160939099-160971319:+	-0.12	-3.82	0.000149	Morning vs. evening chronotype	
THCA	cis	1	rs2220626	chr7:65546062	ASL	chr7:65540776-65558321:+	0.18	4.6	5.33E-6	Aortic root size	
THCA	cis	1	rs2220626	chr7:65546062	GUSB	chr7:65425675-65447246:-	-0.28	-5.22	2.72E-7	Aortic root size	
THCA	cis	1	rs2220626	chr7:65546062	RABGEF1	chr7:66093890-66276446:+	-0.64	-13.25	2.31E-34	Aortic root size	
THCA	cis	1	rs2222800	chr10:54341873	DKK1	chr10:54074041-54077416:+	-0.25	-4.67	3.91E-6	Metabolite levels  (X-11787)	
THCA	cis	1	rs2224380	chr6:26553943	BTN2A3	chr6:26422317-26431927:+	0.18	4.35	1.64E-5	Educational attainment	
THCA	cis	1	rs2224380	chr6:26553943	HCG11	chr6:26521934-26527610:+	-0.22	-4.27	2.41E-5	Educational attainment	
THCA	cis	1	rs2224380	chr6:26553943	HMGN4	chr6:26538572-26547162:+	-0.16	-4.03	6.61E-5	Educational attainment	
THCA	cis	1	rs2224380	chr6:26553943	LOC100270746	chr6:26987146-26988085:-	-0.15	-3.53	0.00046	Educational attainment	
THCA	cis	1	rs2224380	chr6:26553943	ZNF322A	chr6:26634612-26659963:-	-0.16	-4.53	7.46E-6	Educational attainment	
THCA	cis	1	rs2224949	chr14:50096560	MGAT2	chr14:50087489-50090198:+	-0.22	-4.52	7.83E-6	Carotid intima media thickness	
THCA	cis	1	rs2224949	chr14:50096560	RPL36AL	chr14:50085407-50087349:-	-0.53	-15.23	5.71E-43	Carotid intima media thickness	
THCA	cis	1	rs2227336	chr17:38174855	GSDMA	chr17:38119226-38134019:+	-0.32	-7.23	1.87E-12	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THCA	cis	1	rs2227336	chr17:38174855	ORMDL3	chr17:38077296-38083854:-	0.14	3.36	0.00083	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THCA	cis	1	rs2229384	chr6:49425521	CENPQ	chr6:49431096-49460820:+	0.31	6.61	1.04E-10	Homocysteine levels	
THCA	cis	1	rs2229687	chr1:10473196	KIF1B	chr1:10270764-10441659:+	0.23	7.33	9.79E-13	Hepatocellular carcinoma	
THCA	cis	1	rs2230532	chr14:97321689	VRK1	chr14:97263684-97347950:+	-0.17	-3.89	0.000116	Neutrophil count	
THCA	cis	1	rs2231626	chr20:44002665	ZNF335	chr20:44577293-44600833:-	-0.15	-3.53	0.000457	Psoriasis	
THCA	cis	1	rs2231940	chr19:41944237	B3GNT8	chr19:41931265-41934635:-	0.34	7.73	6.46E-14	Height	
THCA	cis	1	rs2231940	chr19:41944237	EXOSC5	chr19:41892278-41903256:-	0.11	3.53	0.000456	Height	
THCA	cis	1	rs2235230	chr22:39124467	JOSD1	chr22:39081549-39096459:-	0.15	3.77	0.000185	Resting heart rate	
THCA	cis	1	rs2235230	chr22:39124467	TOMM22	chr22:39077954-39080763:+	0.16	3.36	0.000851	Resting heart rate	
THCA	cis	1	rs2236087	chr20:3255905	ITPA	chr20:3190056-3204504:+	-0.26	-6.07	2.62E-9	IFN-related cytopenia	
THCA	cis	1	rs2236089	chr20:3257194	ITPA	chr20:3190056-3204504:+	-0.24	-5.87	8.02E-9	IFN-related cytopenia	
THCA	cis	1	rs2236092	chr20:3258188	ITPA	chr20:3190056-3204504:+	-0.24	-5.87	8.02E-9	IFN-related cytopenia	
THCA	cis	1	rs2236098	chr20:3267133	ITPA	chr20:3190056-3204504:+	-0.24	-5.92	6.32E-9	IFN-related cytopenia	
THCA	cis	1	rs2236104	chr20:3277602	ITPA	chr20:3190056-3204504:+	-0.24	-5.87	8.02E-9	IFN-related cytopenia	
THCA	cis	1	rs2236106	chr20:3278410	ITPA	chr20:3190056-3204504:+	-0.24	-5.92	6.32E-9	IFN-related cytopenia	
THCA	cis	1	rs2236107	chr20:3285821	ITPA	chr20:3190056-3204504:+	-0.25	-6.07	2.65E-9	IFN-related cytopenia	
THCA	cis	1	rs2236108	chr20:3286331	ITPA	chr20:3190056-3204504:+	-0.24	-5.92	6.32E-9	IFN-related cytopenia	
THCA	cis	1	rs2236117	chr20:3302021	ITPA	chr20:3190056-3204504:+	-0.24	-5.92	6.32E-9	IFN-related cytopenia	
THCA	cis	1	rs2236118	chr20:3302058	ITPA	chr20:3190056-3204504:+	-0.23	-5.61	3.51E-8	IFN-related cytopenia	
THCA	cis	1	rs2236122	chr20:3305240	ITPA	chr20:3190056-3204504:+	-0.24	-5.87	8.02E-9	IFN-related cytopenia	
THCA	cis	1	rs2236123	chr20:3305305	ITPA	chr20:3190056-3204504:+	0.24	5.71	1.99E-8	IFN-related cytopenia	
THCA	cis	1	rs2236718	chr18:33705135	SLC39A6	chr18:33688495-33709357:-	0.14	4.11	4.61E-5	Esophageal squamous cell cancer (length of survival)	
THCA	cis	1	rs2238297	chr15:89875066	MFGE8	chr15:89441916-89456663:-	0.14	3.5	0.000501	Menopause (age at onset)	
THCA	cis	1	rs2239557	chr14:74551970	C14orf45	chr14:74486059-74549566:+	0.16	4.61	5.23E-6	Common traits (Other)	
THCA	cis	1	rs2239557	chr14:74551970	COQ6	chr14:74416643-74429811:+	0.14	3.9	0.00011	Common traits (Other)	
THCA	cis	1	rs2239557	chr14:74551970	LIN52	chr14:74551656-74667117:+	0.5	13.35	8.82E-35	Common traits (Other)	
THCA	cis	1	rs2239815	chr22:29192670	RHBDD3	chr22:29655844-29663914:-	-0.14	-3.38	0.000775	Esophageal squamous cell carcinoma;Esophageal cancer (squamous cell)	
THCA	cis	1	rs2240009	chr17:40283142	HSPB9	chr17:40274756-40275371:+	0.34	4.97	9.22E-7	Fibrinogen levels	
THCA	cis	1	rs2240010	chr17:40278081	HSPB9	chr17:40274756-40275371:+	0.33	4.92	1.21E-6	Fibrinogen levels	
THCA	cis	1	rs224048	chr10:64491549	ADO	chr10:64564516-64568238:+	-0.26	-5.32	1.61E-7	Vogt-Koyanagi-Harada syndrome	
THCA	cis	1	rs224052	chr10:64494174	ADO	chr10:64564516-64568238:+	-0.26	-5.32	1.61E-7	Vogt-Koyanagi-Harada syndrome	
THCA	cis	1	rs224057	chr10:64497768	ADO	chr10:64564516-64568238:+	-0.26	-5.32	1.61E-7	Vogt-Koyanagi-Harada syndrome	
THCA	cis	1	rs224058	chr10:64498865	ADO	chr10:64564516-64568238:+	0.26	5.22	2.63E-7	Vogt-Koyanagi-Harada syndrome	
THCA	cis	1	rs224071	chr10:64508475	ADO	chr10:64564516-64568238:+	0.24	4.92	1.21E-6	Vogt-Koyanagi-Harada syndrome	
THCA	cis	1	rs2241106	chr1:156218910	BGLAP	chr1:156182784-156213112:+	0.22	5.17	3.38E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs2241106	chr1:156218910	C1orf85	chr1:156259882-156265449:-	-0.17	-3.85	0.000134	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs2241106	chr1:156218910	CCT3	chr1:156278752-156308195:-	-0.34	-7.3	1.2E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs2241106	chr1:156218910	PAQR6	chr1:156213207-156217843:-	-0.12	-3.58	0.000382	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs2241107	chr1:156182710	PMF1	chr1:156182784-156209831:+	0.15	3.8	0.000167	Testicular germ cell tumor	
THCA	cis	1	rs2241108	chr1:156181007	PMF1	chr1:156182784-156209831:+	-0.15	-3.7	0.000242	Testicular germ cell tumor	
THCA	cis	1	rs224139	chr10:64473716	ADO	chr10:64564516-64568238:+	-0.27	-5.39	1.09E-7	Vogt-Koyanagi-Harada syndrome	
THCA	cis	1	rs2241435	chr2:86360916	LOC90784	chr2:86247339-86250991:-	-0.43	-4.76	2.61E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs2241437	chr2:86360573	POLR1A	chr2:86253453-86333278:-	-0.37	-5.14	3.99E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs224148	chr10:64486639	ADO	chr10:64564516-64568238:+	-0.26	-5.32	1.61E-7	Vogt-Koyanagi-Harada syndrome	
THCA	cis	1	rs224149	chr10:64487073	ADO	chr10:64564516-64568238:+	-0.26	-5.32	1.61E-7	Vogt-Koyanagi-Harada syndrome	
THCA	cis	1	rs224150	chr10:64488087	ADO	chr10:64564516-64568238:+	-0.26	-5.32	1.61E-7	Vogt-Koyanagi-Harada syndrome	
THCA	cis	1	rs2241706	chr19:41912807	B3GNT8	chr19:41931265-41934635:-	-0.36	-8.29	1.13E-15	Height	
THCA	cis	1	rs2241706	chr19:41912807	EXOSC5	chr19:41892278-41903256:-	-0.1	-3.36	0.000832	Height	
THCA	cis	1	rs2241708	chr19:41912270	B3GNT8	chr19:41931265-41934635:-	-0.36	-8.38	6.04E-16	Height	
THCA	cis	1	rs2241708	chr19:41912270	EXOSC5	chr19:41892278-41903256:-	-0.1	-3.35	0.000871	Height	
THCA	cis	1	rs2241709	chr19:41912250	B3GNT8	chr19:41931265-41934635:-	-0.36	-8.47	3.13E-16	Height	
THCA	cis	1	rs2241710	chr19:41912092	B3GNT8	chr19:41931265-41934635:-	-0.36	-8.29	1.13E-15	Height	
THCA	cis	1	rs2241710	chr19:41912092	EXOSC5	chr19:41892278-41903256:-	-0.1	-3.36	0.000832	Height	
THCA	cis	1	rs2241711	chr19:41911980	B3GNT8	chr19:41931265-41934635:-	-0.36	-8.29	1.13E-15	Height	
THCA	cis	1	rs2241711	chr19:41911980	EXOSC5	chr19:41892278-41903256:-	-0.1	-3.36	0.000832	Height	
THCA	cis	1	rs2241774	chr16:58072153	C16orf57	chr16:58035305-58055521:+	-0.32	-4.74	2.79E-6	Pulmonary function;Pulmonary function (interaction)	
THCA	cis	1	rs2241774	chr16:58072153	MMP15	chr16:58059282-58080802:+	0.14	3.36	0.000837	Pulmonary function;Pulmonary function (interaction)	
THCA	cis	1	rs2241774	chr16:58072153	TEPP	chr16:58010339-58022015:+	-0.32	-4.63	4.77E-6	Pulmonary function;Pulmonary function (interaction)	
THCA	cis	1	rs2241774	chr16:58072153	ZNF319	chr16:58028573-58033762:-	-0.33	-4.82	1.89E-6	Pulmonary function;Pulmonary function (interaction)	
THCA	cis	1	rs2241784	chr3:51418348	HEMK1	chr3:50606583-50622419:+	0.17	4.27	2.4E-5	Melanoma	
THCA	cis	1	rs2241784	chr3:51418348	TEX264	chr3:51705222-51738338:+	-0.12	-4	7.44E-5	Melanoma	
THCA	cis	1	rs2242150	chr3:48505964	ATRIP	chr3:48488141-48507708:+	-0.19	-4.18	3.41E-5	Longevity	
THCA	cis	1	rs2242150	chr3:48505964	TREX1	chr3:48501186-48509043:+	0.24	5.64	2.88E-8	Longevity	
THCA	cis	1	rs2242330	chr4:68447249	CENPC1	chr4:68337989-68411256:-	0.26	5.82	1.09E-8	Parkinson's disease	
THCA	cis	1	rs2242471	chr4:76878716	NAAA	chr4:76831809-76862166:-	0.35	7.1	4.63E-12	Longevity	
THCA	cis	1	rs2242473	chr4:76878956	NAAA	chr4:76831809-76862166:-	0.35	7.05	6.11E-12	Longevity	
THCA	cis	1	rs2242474	chr4:76878982	NAAA	chr4:76831809-76862166:-	0.35	7.1	4.63E-12	Longevity	
THCA	cis	1	rs2242482	chr13:50655879	TRIM13	chr13:50571143-50592603:+	-0.19	-3.44	0.000625	Height	
THCA	cis	1	rs2243086	chr17:4834209	GP1BA	chr17:4835592-4838324:+	0.2	3.4	0.000719	Blood metabolite levels	
THCA	cis	1	rs2243086	chr17:4834209	SLC25A11	chr17:4840605-4843325:-	0.13	3.54	0.000438	Blood metabolite levels	
THCA	cis	1	rs224329	chr20:34019579	CPNE1	chr20:34213968-34262539:-	-0.31	-6.01	3.68E-9	Height	
THCA	cis	1	rs224329	chr20:34019579	UQCC	chr20:33890383-33999833:-	-0.31	-10.1	7.18E-22	Height	
THCA	cis	1	rs224333	chr20:34023962	CPNE1	chr20:34213968-34262539:-	-0.31	-5.97	4.65E-9	Height	
THCA	cis	1	rs224333	chr20:34023962	GDF5	chr20:33897002-34042568:-	0.17	3.7	0.00024	Height	
THCA	cis	1	rs224333	chr20:34023962	UQCC	chr20:33890383-33999833:-	-0.31	-9.66	2.75E-20	Height	
THCA	cis	1	rs2243378	chr6:117725578	DCBLD1	chr6:117803820-117891018:+	0.44	9.13	1.96E-18	Lung cancer	
THCA	cis	1	rs2243378	chr6:117725578	GOPC	chr6:117639351-117923681:-	0.2	5.82	1.1E-8	Lung cancer	
THCA	cis	1	rs2243480	chr7:65599196	CCT6P1	chr7:65216092-65228661:+	0.39	6.32	6.13E-10	Diabetic kidney disease	
THCA	cis	1	rs2243480	chr7:65599196	CRCP	chr7:65579805-65619551:+	-0.31	-4.82	1.92E-6	Diabetic kidney disease	
THCA	cis	1	rs2243480	chr7:65599196	LOC493754	chr7:65993446-66057363:-	0.31	3.7	0.000237	Diabetic kidney disease	
THCA	cis	1	rs2243480	chr7:65599196	RABGEF1	chr7:66093890-66276446:+	0.53	6.65	7.94E-11	Diabetic kidney disease	
THCA	cis	1	rs224446	chr12:51381718	SLC11A2	chr12:51373319-51422058:-	0.25	4.99	8.31E-7	Type 2 diabetes	
THCA	cis	1	rs224446	chr12:51381718	TFCP2	chr12:51488608-51566917:-	0.18	3.88	0.000119	Type 2 diabetes	
THCA	cis	1	rs2244508	chr11:77948515	NARS2	chr11:78147017-78285909:-	-0.4	-7.38	7.22E-13	Testicular germ cell tumor	
THCA	cis	1	rs224454	chr12:51393116	SLC11A2	chr12:51373319-51422058:-	-0.28	-5.47	7.37E-8	Type 2 diabetes	
THCA	cis	1	rs224454	chr12:51393116	TFCP2	chr12:51488608-51566917:-	-0.2	-4.1	4.79E-5	Type 2 diabetes	
THCA	cis	1	rs224567	chr12:51386527	SLC11A2	chr12:51373319-51422058:-	-0.25	-4.56	6.4E-6	Type 2 diabetes	
THCA	cis	1	rs224567	chr12:51386527	TFCP2	chr12:51488608-51566917:-	-0.18	-3.56	0.000414	Type 2 diabetes	
THCA	cis	1	rs224568	chr12:51386548	SLC11A2	chr12:51373319-51422058:-	-0.27	-5.37	1.26E-7	Type 2 diabetes	
THCA	cis	1	rs224568	chr12:51386548	TFCP2	chr12:51488608-51566917:-	-0.2	-4.14	4.14E-5	Type 2 diabetes	
THCA	cis	1	rs2245715	chr15:43818052	ADAL	chr15:43622872-43646094:+	-0.49	-11.5	3.4E-27	Tumor biomarkers	
THCA	cis	1	rs2245715	chr15:43818052	CATSPER2	chr15:43922774-43959900:-	-0.28	-5.09	5.18E-7	Tumor biomarkers	
THCA	cis	1	rs2245715	chr15:43818052	STRC	chr15:43891762-43924561:-	0.33	6.09	2.26E-9	Tumor biomarkers	
THCA	cis	1	rs2245717	chr20:43995880	ZNF335	chr20:44577293-44600833:-	-0.15	-3.63	0.000314	Psoriasis	
THCA	cis	1	rs2246749	chr21:46906690	SUMO3	chr21:46225532-46238044:-	0.35	3.69	0.000254	Alzheimer disease and age of onset	
THCA	cis	1	rs2246833	chr10:91005854	LIPA	chr10:90973328-91174382:-	0.31	7.78	4.38E-14	Fibrinogen levels	
THCA	cis	1	rs2246893	chr1:117472815	FAM46C	chr1:118148604-118171010:+	-0.27	-3.34	0.000891	Erectile dysfunction and prostate cancer treatment	
THCA	cis	1	rs2246942	chr10:91004886	LIPA	chr10:90973328-91174382:-	0.3	7.64	1.2E-13	Fibrinogen levels	
THCA	cis	1	rs2247037	chr20:44031295	ZNF335	chr20:44577293-44600833:-	-0.15	-3.7	0.000241	Psoriasis	
THCA	cis	1	rs2247139	chr12:122380274	WDR66	chr12:122356480-122441830:+	-0.22	-3.67	0.000273	Urinary metabolites	
THCA	cis	1	rs2247341	chr4:1701317	FAM53A	chr4:1641609-1685854:-	0.16	3.74	0.000209	Height	
THCA	cis	1	rs2247341	chr4:1701317	TMEM129	chr4:1717680-1723084:-	0.16	5.04	6.56E-7	Height	
THCA	cis	1	rs2247753	chr22:30022936	NIPSNAP1	chr22:29950800-29977144:-	0.27	4.04	6.23E-5	Lipid traits	
THCA	cis	1	rs2248393	chr20:33926103	CEP250	chr20:34042996-34099802:+	0.16	3.5	0.000503	Height	
THCA	cis	1	rs2248393	chr20:33926103	CPNE1	chr20:34213968-34262539:-	-0.32	-6.29	7.18E-10	Height	
THCA	cis	1	rs2248393	chr20:33926103	GDF5	chr20:33897002-34042568:-	0.18	3.83	0.000147	Height	
THCA	cis	1	rs2248393	chr20:33926103	UQCC	chr20:33890383-33999833:-	-0.31	-9.99	1.86E-21	Height	
THCA	cis	1	rs2248407	chr11:77937800	NARS2	chr11:78147017-78285909:-	-0.41	-7.76	5.09E-14	Testicular germ cell tumor	
THCA	cis	1	rs2248637	chr20:43997240	ZNF335	chr20:44577293-44600833:-	0.15	3.55	0.000417	Psoriasis	
THCA	cis	1	rs2248821	chr17:2268311	SMG6	chr17:1963133-2207069:-	-0.13	-3.43	0.000663	Proinsulin levels	
THCA	cis	1	rs2249296	chr1:86910264	CLCA2	chr1:86889769-86922238:+	0.23	3.69	0.000255	Crohn's disease-related phenotypes	
THCA	cis	1	rs2249296	chr1:86910264	ODF2L	chr1:86814412-86862003:-	0.16	3.67	0.000274	Crohn's disease-related phenotypes	
THCA	cis	1	rs2250752	chr12:51106091	DIP2B	chr12:50898768-51142448:+	0.11	3.63	0.000318	Fibrinogen	
THCA	cis	1	rs2250866	chr11:71804513	FAM86C	chr11:71498557-71512276:+	0.32	3.96	8.73E-5	Severe influenza A (H1N1) infection	
THCA	cis	1	rs2250886	chr11:6529642	FXC1	chr11:6502677-6505910:+	-0.16	-4.39	1.42E-5	DNA methylation (variation)	
THCA	cis	1	rs2250886	chr11:6529642	TRIM3	chr11:6469844-6495689:-	0.16	4	7.23E-5	DNA methylation (variation)	
THCA	cis	1	rs2251115	chr6:49446509	CENPQ	chr6:49431096-49460820:+	-0.32	-6.9	1.7E-11	Homocysteine levels	
THCA	cis	1	rs2251603	chr12:51049653	DIP2B	chr12:50898768-51142448:+	-0.12	-3.86	0.000128	Fibrinogen	
THCA	cis	1	rs2251844	chr15:43836478	ADAL	chr15:43622872-43646094:+	-0.49	-11.52	2.98E-27	Tumor biomarkers	
THCA	cis	1	rs2251844	chr15:43836478	CATSPER2	chr15:43922774-43959900:-	-0.26	-4.64	4.58E-6	Tumor biomarkers	
THCA	cis	1	rs2251844	chr15:43836478	STRC	chr15:43891762-43924561:-	0.33	6.19	1.32E-9	Tumor biomarkers	
THCA	cis	1	rs2251844	chr15:43836478	TUBGCP4	chr15:43663313-43698238:+	0.12	3.38	0.000793	Tumor biomarkers	
THCA	cis	1	rs2252259	chr20:47662823	ARFGEF2	chr20:47538275-47653229:+	0.13	4.06	5.77E-5	Anger	
THCA	cis	1	rs2252259	chr20:47662823	CSE1L	chr20:47662838-47713484:+	-0.41	-10.17	4.16E-22	Anger	
THCA	cis	1	rs2252313	chr1:86908149	CLCA2	chr1:86889769-86922238:+	-0.22	-3.68	0.000263	Crohn's disease-related phenotypes	
THCA	cis	1	rs2252313	chr1:86908149	ODF2L	chr1:86814412-86862003:-	-0.15	-3.53	0.000453	Crohn's disease-related phenotypes	
THCA	cis	1	rs2252502	chr7:158738634	ESYT2	chr7:158523689-158622319:-	-0.12	-3.68	0.000259	Height	
THCA	cis	1	rs2252502	chr7:158738634	WDR60	chr7:158649269-158738882:+	0.14	3.54	0.000438	Height	
THCA	cis	1	rs2252589	chr12:51041957	DIP2B	chr12:50898768-51142448:+	0.12	3.72	0.000219	Fibrinogen	
THCA	cis	1	rs2252930	chr21:34704201	IFNAR1	chr21:34696734-34732126:+	-0.23	-5.45	7.9E-8	Narcolepsy	
THCA	cis	1	rs2252931	chr21:34704320	IFNAR1	chr21:34696734-34732126:+	0.23	5.32	1.59E-7	Narcolepsy	
THCA	cis	1	rs2253105	chr20:44011301	ZNF335	chr20:44577293-44600833:-	-0.15	-3.49	0.000537	Psoriasis	
THCA	cis	1	rs2253209	chr3:53115160	ITIH4	chr3:52847007-52866554:-	0.17	4.69	3.62E-6	Height	
THCA	cis	1	rs2253209	chr3:53115160	RFT1	chr3:53122503-53164470:-	-0.75	-18.06	5.78E-56	Height	
THCA	cis	1	rs2253656	chr3:53119099	ITIH4	chr3:52847007-52866554:-	0.16	4.56	6.6E-6	Height	
THCA	cis	1	rs2253656	chr3:53119099	RFT1	chr3:53122503-53164470:-	-0.75	-18.22	1.07E-56	Height	
THCA	cis	1	rs2253685	chr3:53119703	ITIH4	chr3:52847007-52866554:-	0.16	4.58	6.06E-6	Height	
THCA	cis	1	rs2253685	chr3:53119703	RFT1	chr3:53122503-53164470:-	-0.75	-18.21	1.15E-56	Height	
THCA	cis	1	rs2253796	chr3:53120098	ITIH4	chr3:52847007-52866554:-	0.16	4.58	6.06E-6	Height	
THCA	cis	1	rs2253796	chr3:53120098	RFT1	chr3:53122503-53164470:-	-0.75	-18.21	1.15E-56	Height	
THCA	cis	1	rs2253809	chr1:156172125	PMF1	chr1:156182784-156209831:+	-0.15	-3.84	0.00014	Testicular germ cell tumor	
THCA	cis	1	rs2253998	chr14:102496352	RAGE	chr14:102690838-102771531:-	0.15	4.93	1.12E-6	Menopause (age at onset)	
THCA	cis	1	rs2254230	chr9:131905177	CRAT	chr9:131857075-131873070:-	-0.28	-6.55	1.52E-10	Blood metabolite ratios	
THCA	cis	1	rs2255042	chr15:43834318	ADAL	chr15:43622872-43646094:+	0.51	12.02	3.04E-29	Tumor biomarkers	
THCA	cis	1	rs2255042	chr15:43834318	CATSPER2	chr15:43922774-43959900:-	0.28	4.93	1.11E-6	Tumor biomarkers	
THCA	cis	1	rs2255042	chr15:43834318	STRC	chr15:43891762-43924561:-	-0.33	-6.07	2.65E-9	Tumor biomarkers	
THCA	cis	1	rs2255051	chr15:43846161	ADAL	chr15:43622872-43646094:+	-0.5	-11.55	2.26E-27	Tumor biomarkers	
THCA	cis	1	rs2255051	chr15:43846161	CATSPER2	chr15:43922774-43959900:-	-0.26	-4.67	3.84E-6	Tumor biomarkers	
THCA	cis	1	rs2255051	chr15:43846161	STRC	chr15:43891762-43924561:-	0.34	6.28	7.53E-10	Tumor biomarkers	
THCA	cis	1	rs2255051	chr15:43846161	TUBGCP4	chr15:43663313-43698238:+	0.12	3.39	0.000748	Tumor biomarkers	
THCA	cis	1	rs2255070	chr6:26501777	BTN2A3	chr6:26422317-26431927:+	0.19	4.52	7.84E-6	Educational attainment	
THCA	cis	1	rs2255070	chr6:26501777	HCG11	chr6:26521934-26527610:+	-0.23	-4.52	7.85E-6	Educational attainment	
THCA	cis	1	rs2255070	chr6:26501777	HMGN4	chr6:26538572-26547162:+	-0.16	-4.07	5.58E-5	Educational attainment	
THCA	cis	1	rs2255070	chr6:26501777	ZNF322A	chr6:26634612-26659963:-	-0.13	-3.76	0.00019	Educational attainment	
THCA	cis	1	rs2255440	chr15:43830467	ADAL	chr15:43622872-43646094:+	-0.5	-11.71	5.04E-28	Tumor biomarkers	
THCA	cis	1	rs2255440	chr15:43830467	CATSPER2	chr15:43922774-43959900:-	-0.27	-4.75	2.69E-6	Tumor biomarkers	
THCA	cis	1	rs2255440	chr15:43830467	STRC	chr15:43891762-43924561:-	0.33	6.15	1.66E-9	Tumor biomarkers	
THCA	cis	1	rs2255440	chr15:43830467	TUBGCP4	chr15:43663313-43698238:+	0.12	3.34	0.000891	Tumor biomarkers	
THCA	cis	1	rs2256051	chr11:77920457	NARS2	chr11:78147017-78285909:-	-0.42	-7.88	2.27E-14	Testicular germ cell tumor	
THCA	cis	1	rs2256187	chr11:77919768	NARS2	chr11:78147017-78285909:-	-0.38	-6.82	2.75E-11	Testicular germ cell tumor	
THCA	cis	1	rs2256464	chr11:77917305	NARS2	chr11:78147017-78285909:-	-0.43	-8.29	1.12E-15	Testicular germ cell tumor	
THCA	cis	1	rs2256686	chr20:44017331	ZNF335	chr20:44577293-44600833:-	-0.14	-3.46	0.000593	Psoriasis	
THCA	cis	1	rs2256920	chr11:6508124	FXC1	chr11:6502677-6505910:+	-0.17	-4.81	2.0E-6	DNA methylation (variation)	
THCA	cis	1	rs2256920	chr11:6508124	TRIM3	chr11:6469844-6495689:-	0.17	4.16	3.72E-5	DNA methylation (variation)	
THCA	cis	1	rs225712	chr6:142545280	VTA1	chr6:142468410-142542083:+	0.16	3.43	0.000651	Retinal vascular caliber	
THCA	cis	1	rs2257420	chr20:25275890	ENTPD6	chr20:25176339-25207360:+	-0.3	-6.88	1.89E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257420	chr20:25275890	FAM182A	chr20:26035250-26067552:+	-0.18	-3.42	0.00067	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257420	chr20:25275890	FAM182B	chr20:25744102-25848786:-	0.26	5.54	4.94E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257420	chr20:25275890	NINL	chr20:25433338-25566153:-	-0.35	-7.22	2.0E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257420	chr20:25275890	PYGB	chr20:25228706-25278647:+	-0.16	-3.98	7.97E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257432	chr20:25271086	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257432	chr20:25271086	FAM182A	chr20:26035250-26067552:+	-0.18	-3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257432	chr20:25271086	FAM182B	chr20:25744102-25848786:-	0.27	5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257432	chr20:25271086	NINL	chr20:25433338-25566153:-	-0.35	-7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257432	chr20:25271086	PYGB	chr20:25228706-25278647:+	-0.16	-4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257496	chr20:25279315	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257496	chr20:25279315	FAM182A	chr20:26035250-26067552:+	-0.18	-3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257496	chr20:25279315	FAM182B	chr20:25744102-25848786:-	0.27	5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257496	chr20:25279315	NINL	chr20:25433338-25566153:-	-0.35	-7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257496	chr20:25279315	PYGB	chr20:25228706-25278647:+	-0.16	-4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257790	chr7:65600450	CCT6P1	chr7:65216092-65228661:+	0.4	6.51	1.92E-10	Diabetic kidney disease	
THCA	cis	1	rs2257790	chr7:65600450	CRCP	chr7:65579805-65619551:+	-0.3	-4.64	4.48E-6	Diabetic kidney disease	
THCA	cis	1	rs2257790	chr7:65600450	RABGEF1	chr7:66093890-66276446:+	0.58	7.33	1.0E-12	Diabetic kidney disease	
THCA	cis	1	rs2257808	chr20:25266450	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257808	chr20:25266450	FAM182A	chr20:26035250-26067552:+	-0.18	-3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257808	chr20:25266450	FAM182B	chr20:25744102-25848786:-	0.27	5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257808	chr20:25266450	NINL	chr20:25433338-25566153:-	-0.35	-7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257808	chr20:25266450	PYGB	chr20:25228706-25278647:+	-0.16	-4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257809	chr20:25266476	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257809	chr20:25266476	FAM182A	chr20:26035250-26067552:+	-0.18	-3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257809	chr20:25266476	FAM182B	chr20:25744102-25848786:-	0.27	5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257809	chr20:25266476	NINL	chr20:25433338-25566153:-	-0.35	-7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257809	chr20:25266476	PYGB	chr20:25228706-25278647:+	-0.16	-4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257982	chr20:25269630	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257982	chr20:25269630	FAM182A	chr20:26035250-26067552:+	-0.18	-3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257982	chr20:25269630	FAM182B	chr20:25744102-25848786:-	0.27	5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257982	chr20:25269630	NINL	chr20:25433338-25566153:-	-0.35	-7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257982	chr20:25269630	PYGB	chr20:25228706-25278647:+	-0.16	-4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257985	chr20:25269743	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257985	chr20:25269743	FAM182A	chr20:26035250-26067552:+	-0.18	-3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257985	chr20:25269743	FAM182B	chr20:25744102-25848786:-	0.27	5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257985	chr20:25269743	NINL	chr20:25433338-25566153:-	-0.35	-7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257985	chr20:25269743	PYGB	chr20:25228706-25278647:+	-0.16	-4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257988	chr20:25270003	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257988	chr20:25270003	FAM182A	chr20:26035250-26067552:+	-0.18	-3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257988	chr20:25270003	FAM182B	chr20:25744102-25848786:-	0.27	5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257988	chr20:25270003	NINL	chr20:25433338-25566153:-	-0.35	-7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257988	chr20:25270003	PYGB	chr20:25228706-25278647:+	-0.16	-4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257991	chr20:25270339	ENTPD6	chr20:25176339-25207360:+	0.31	6.97	1.03E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257991	chr20:25270339	FAM182A	chr20:26035250-26067552:+	0.18	3.34	0.000904	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257991	chr20:25270339	FAM182B	chr20:25744102-25848786:-	-0.26	-5.37	1.23E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257991	chr20:25270339	NINL	chr20:25433338-25566153:-	0.34	6.9	1.7E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2257991	chr20:25270339	PYGB	chr20:25228706-25278647:+	0.16	4.05	5.87E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258066	chr20:25271326	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258066	chr20:25271326	FAM182A	chr20:26035250-26067552:+	-0.18	-3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258066	chr20:25271326	FAM182B	chr20:25744102-25848786:-	0.27	5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258066	chr20:25271326	NINL	chr20:25433338-25566153:-	-0.35	-7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258066	chr20:25271326	PYGB	chr20:25228706-25278647:+	-0.16	-4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258135	chr20:25272323	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258135	chr20:25272323	FAM182A	chr20:26035250-26067552:+	-0.18	-3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258135	chr20:25272323	FAM182B	chr20:25744102-25848786:-	0.27	5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258135	chr20:25272323	NINL	chr20:25433338-25566153:-	-0.35	-7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258135	chr20:25272323	PYGB	chr20:25228706-25278647:+	-0.16	-4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258201	chr20:25272490	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258201	chr20:25272490	FAM182A	chr20:26035250-26067552:+	-0.18	-3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258201	chr20:25272490	FAM182B	chr20:25744102-25848786:-	0.27	5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258201	chr20:25272490	NINL	chr20:25433338-25566153:-	-0.35	-7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258201	chr20:25272490	PYGB	chr20:25228706-25278647:+	-0.16	-4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258563	chr20:25273435	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258563	chr20:25273435	FAM182A	chr20:26035250-26067552:+	-0.18	-3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258563	chr20:25273435	FAM182B	chr20:25744102-25848786:-	0.27	5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258563	chr20:25273435	NINL	chr20:25433338-25566153:-	-0.35	-7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258563	chr20:25273435	PYGB	chr20:25228706-25278647:+	-0.16	-4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258617	chr20:25274318	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258617	chr20:25274318	FAM182A	chr20:26035250-26067552:+	-0.18	-3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258617	chr20:25274318	FAM182B	chr20:25744102-25848786:-	0.27	5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258617	chr20:25274318	NINL	chr20:25433338-25566153:-	-0.35	-7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258617	chr20:25274318	PYGB	chr20:25228706-25278647:+	-0.16	-4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258719	chr20:25275843	ENTPD6	chr20:25176339-25207360:+	-0.31	-7.06	5.77E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258719	chr20:25275843	FAM182A	chr20:26035250-26067552:+	-0.19	-3.49	0.000535	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258719	chr20:25275843	FAM182B	chr20:25744102-25848786:-	0.25	5.09	5.04E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258719	chr20:25275843	NINL	chr20:25433338-25566153:-	-0.37	-7.56	2.1E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258719	chr20:25275843	PYGB	chr20:25228706-25278647:+	-0.14	-3.5	0.000511	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258769	chr20:25276680	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258769	chr20:25276680	FAM182A	chr20:26035250-26067552:+	-0.18	-3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258769	chr20:25276680	FAM182B	chr20:25744102-25848786:-	0.27	5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258769	chr20:25276680	NINL	chr20:25433338-25566153:-	-0.35	-7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258769	chr20:25276680	PYGB	chr20:25228706-25278647:+	-0.16	-4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258879	chr20:25279213	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258879	chr20:25279213	FAM182A	chr20:26035250-26067552:+	-0.18	-3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258879	chr20:25279213	FAM182B	chr20:25744102-25848786:-	0.27	5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258879	chr20:25279213	NINL	chr20:25433338-25566153:-	-0.35	-7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258879	chr20:25279213	PYGB	chr20:25228706-25278647:+	-0.16	-4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258884	chr20:25279539	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258884	chr20:25279539	FAM182A	chr20:26035250-26067552:+	-0.18	-3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258884	chr20:25279539	FAM182B	chr20:25744102-25848786:-	0.27	5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258884	chr20:25279539	NINL	chr20:25433338-25566153:-	-0.35	-7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2258884	chr20:25279539	PYGB	chr20:25228706-25278647:+	-0.16	-4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2259837	chr20:25280205	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2259837	chr20:25280205	FAM182A	chr20:26035250-26067552:+	-0.18	-3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2259837	chr20:25280205	FAM182B	chr20:25744102-25848786:-	0.27	5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2259837	chr20:25280205	NINL	chr20:25433338-25566153:-	-0.35	-7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2259837	chr20:25280205	PYGB	chr20:25228706-25278647:+	-0.16	-4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2259873	chr20:25280781	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2259873	chr20:25280781	FAM182A	chr20:26035250-26067552:+	-0.18	-3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2259873	chr20:25280781	FAM182B	chr20:25744102-25848786:-	0.27	5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2259873	chr20:25280781	NINL	chr20:25433338-25566153:-	-0.35	-7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2259873	chr20:25280781	PYGB	chr20:25228706-25278647:+	-0.16	-4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2259926	chr20:25281733	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2259926	chr20:25281733	FAM182A	chr20:26035250-26067552:+	-0.18	-3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2259926	chr20:25281733	FAM182B	chr20:25744102-25848786:-	0.27	5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2259926	chr20:25281733	NINL	chr20:25433338-25566153:-	-0.35	-7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2259926	chr20:25281733	PYGB	chr20:25228706-25278647:+	-0.16	-4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2259928	chr20:25281834	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2259928	chr20:25281834	FAM182A	chr20:26035250-26067552:+	-0.18	-3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2259928	chr20:25281834	FAM182B	chr20:25744102-25848786:-	0.27	5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2259928	chr20:25281834	NINL	chr20:25433338-25566153:-	-0.35	-7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2259928	chr20:25281834	PYGB	chr20:25228706-25278647:+	-0.16	-4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2259956	chr20:25282433	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2259956	chr20:25282433	FAM182A	chr20:26035250-26067552:+	-0.18	-3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2259956	chr20:25282433	FAM182B	chr20:25744102-25848786:-	0.27	5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2259956	chr20:25282433	NINL	chr20:25433338-25566153:-	-0.35	-7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2259956	chr20:25282433	PYGB	chr20:25228706-25278647:+	-0.16	-4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2260160	chr15:43895643	ADAL	chr15:43622872-43646094:+	-0.43	-9.6	4.36E-20	Tumor biomarkers	
THCA	cis	1	rs2260160	chr15:43895643	CATSPER2	chr15:43922774-43959900:-	-0.28	-4.96	9.58E-7	Tumor biomarkers	
THCA	cis	1	rs2260160	chr15:43895643	STRC	chr15:43891762-43924561:-	0.38	7.13	3.62E-12	Tumor biomarkers	
THCA	cis	1	rs2260160	chr15:43895643	TUBGCP4	chr15:43663313-43698238:+	0.15	4.24	2.68E-5	Tumor biomarkers	
THCA	cis	1	rs2262909	chr19:22135270	ZNF257	chr19:22235266-22273901:+	0.31	6.11	2.04E-9	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs2263759	chr20:44011502	ZNF335	chr20:44577293-44600833:-	-0.15	-3.59	0.000363	Psoriasis	
THCA	cis	1	rs2263764	chr20:44025815	ZNF335	chr20:44577293-44600833:-	-0.16	-3.75	0.000196	Psoriasis	
THCA	cis	1	rs2263768	chr20:44031241	ZNF335	chr20:44577293-44600833:-	-0.15	-3.7	0.000241	Psoriasis	
THCA	cis	1	rs2267002	chr22:23456702	GNAZ	chr22:23412669-23467221:+	-0.26	-5.56	4.58E-8	Bone mineral density	
THCA	cis	1	rs2267003	chr22:23457098	GNAZ	chr22:23412669-23467221:+	-0.28	-6.09	2.3E-9	Bone mineral density	
THCA	cis	1	rs2267393	chr22:39101619	LOC646851	chr22:38974125-39052634:-	0.14	3.73	0.000215	Resting heart rate	
THCA	cis	1	rs2267394	chr22:39101633	LOC646851	chr22:38974125-39052634:-	0.14	3.73	0.000215	Resting heart rate	
THCA	cis	1	rs2267395	chr22:39113903	JOSD1	chr22:39081549-39096459:-	-0.13	-3.43	0.000666	Resting heart rate	
THCA	cis	1	rs2267395	chr22:39113903	LOC646851	chr22:38974125-39052634:-	0.13	3.55	0.000418	Resting heart rate	
THCA	cis	1	rs2267395	chr22:39113903	TOMM22	chr22:39077954-39080763:+	-0.16	-3.37	0.000811	Resting heart rate	
THCA	cis	1	rs2268617	chr14:75608728	EIF2B2	chr14:75469612-75476292:+	0.18	4.97	9.37E-7	Height	
THCA	cis	1	rs2268617	chr14:75608728	MLH3	chr14:75480467-75518235:-	0.29	8.7	5.25E-17	Height	
THCA	cis	1	rs2268617	chr14:75608728	RPS6KL1	chr14:75372347-75389958:-	0.32	6.81	3.0E-11	Height	
THCA	cis	1	rs2268753	chr3:38500189	LOC100128640	chr3:38492524-38496311:-	0.23	4.89	1.35E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs2268753	chr3:38500189	SCN5A	chr3:38589554-38691164:-	0.17	3.49	0.000531	Electrocardiographic conduction measures	
THCA	cis	1	rs2268753	chr3:38500189	XYLB	chr3:38388251-38456467:+	0.21	5.02	7.16E-7	Electrocardiographic conduction measures	
THCA	cis	1	rs2268757	chr3:38505853	EXOG	chr3:38537763-38567796:+	-0.16	-3.37	0.000811	Electrocardiographic conduction measures	
THCA	cis	1	rs2268757	chr3:38505853	LOC100128640	chr3:38492524-38496311:-	0.22	4.68	3.76E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs2268757	chr3:38505853	SCN5A	chr3:38589554-38691164:-	0.17	3.57	0.00039	Electrocardiographic conduction measures	
THCA	cis	1	rs2268757	chr3:38505853	XYLB	chr3:38388251-38456467:+	0.21	5.1	4.84E-7	Electrocardiographic conduction measures	
THCA	cis	1	rs2268758	chr3:38514049	LOC100128640	chr3:38492524-38496311:-	0.23	4.86	1.59E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs2268758	chr3:38514049	SCN5A	chr3:38589554-38691164:-	0.16	3.34	0.000893	Electrocardiographic conduction measures	
THCA	cis	1	rs2268758	chr3:38514049	XYLB	chr3:38388251-38456467:+	0.21	4.93	1.14E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs2268957	chr14:66113233	LOC645431	chr14:65877313-65879335:-	0.59	7.91	1.87E-14	Ischemic stroke	
THCA	cis	1	rs2268958	chr14:66128238	LOC645431	chr14:65877313-65879335:-	-0.61	-7.59	1.71E-13	Ischemic stroke	
THCA	cis	1	rs2268960	chr14:66145500	LOC645431	chr14:65877313-65879335:-	-0.51	-6.62	9.38E-11	Ischemic stroke	
THCA	cis	1	rs2268983	chr14:69408697	ACTN1	chr14:69340841-69446083:-	0.17	4.7	3.34E-6	Smoking behavior	
THCA	cis	1	rs2269381	chr22:51020069	ARSA	chr22:51063450-51066607:-	0.3	3.4	0.000719	Narcolepsy	
THCA	cis	1	rs2269381	chr22:51020069	CHKB	chr22:51017378-51021428:-	0.43	4.82	1.93E-6	Narcolepsy	
THCA	cis	1	rs2269381	chr22:51020069	CPT1B	chr22:51007291-51017096:-	-0.39	-7.32	1.04E-12	Narcolepsy	
THCA	cis	1	rs2269382	chr22:51018911	ARSA	chr22:51063450-51066607:-	0.3	3.39	0.000758	Narcolepsy	
THCA	cis	1	rs2269382	chr22:51018911	CHKB	chr22:51017378-51021428:-	0.43	4.83	1.81E-6	Narcolepsy	
THCA	cis	1	rs2269382	chr22:51018911	CPT1B	chr22:51007291-51017096:-	-0.39	-7.34	9.11E-13	Narcolepsy	
THCA	cis	1	rs2269384	chr22:51011115	CHKB	chr22:51017378-51021428:-	0.52	6.31	6.2E-10	Narcolepsy	
THCA	cis	1	rs2269384	chr22:51011115	CPT1B	chr22:51007291-51017096:-	-0.41	-8.28	1.25E-15	Narcolepsy	
THCA	cis	1	rs2269385	chr22:51010939	CHKB	chr22:51017378-51021428:-	0.52	6.31	6.2E-10	Narcolepsy	
THCA	cis	1	rs2269385	chr22:51010939	CPT1B	chr22:51007291-51017096:-	-0.41	-8.28	1.25E-15	Narcolepsy	
THCA	cis	1	rs2269558	chr16:682250	WFIKKN1	chr16:679239-684116:+	0.36	8.05	6.7E-15	Height	
THCA	cis	1	rs2269684	chr12:51417758	SLC11A2	chr12:51373319-51422058:-	-0.27	-5.38	1.15E-7	Type 2 diabetes	
THCA	cis	1	rs2269684	chr12:51417758	TFCP2	chr12:51488608-51566917:-	-0.2	-4.2	3.18E-5	Type 2 diabetes	
THCA	cis	1	rs2269685	chr12:51417671	SLC11A2	chr12:51373319-51422058:-	-0.25	-4.98	9.1E-7	Type 2 diabetes	
THCA	cis	1	rs2269685	chr12:51417671	TFCP2	chr12:51488608-51566917:-	-0.2	-4.34	1.76E-5	Type 2 diabetes	
THCA	cis	1	rs2270291	chr1:156244992	BGLAP	chr1:156182784-156213112:+	0.23	5.47	7.46E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs2270291	chr1:156244992	C1orf85	chr1:156259882-156265449:-	-0.17	-4.03	6.45E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs2270291	chr1:156244992	CCT3	chr1:156278752-156308195:-	-0.32	-6.99	9.47E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs227093	chr11:108233939	ATM	chr11:108093559-108239826:+	-0.11	-3.48	0.000548	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
THCA	cis	1	rs2271554	chr4:54252222	SCFD2	chr4:53739152-54232242:-	0.2	3.76	0.000189	DNA methylation (variation)	
THCA	cis	1	rs227163	chr1:7961206	UTS2	chr1:7903144-7973294:-	-0.22	-5.25	2.24E-7	Rheumatoid arthritis	
THCA	cis	1	rs2271976	chr12:123751726	C12orf65	chr12:123717841-123742481:+	-0.25	-4.19	3.39E-5	HDL cholesterol	
THCA	cis	1	rs2272006	chr3:41997059	ULK4	chr3:41288091-42003660:-	-1.1	-21.36	1.5E-71	Diastolic blood pressure	
THCA	cis	1	rs2272007	chr3:41996136	ULK4	chr3:41288091-42003660:-	-1.11	-21.74	2.19E-73	Diastolic blood pressure	
THCA	cis	1	rs2272123	chr3:10140115	C3orf10	chr3:10157333-10168873:+	-0.21	-4.31	2.02E-5	Alzheimer's disease	
THCA	cis	1	rs2272123	chr3:10140115	VHL	chr3:10183319-10193744:+	-0.18	-4.2	3.15E-5	Alzheimer's disease	
THCA	cis	1	rs2272125	chr3:10138069	C3orf10	chr3:10157333-10168873:+	-0.22	-4.71	3.26E-6	Alzheimer's disease	
THCA	cis	1	rs2272125	chr3:10138069	VHL	chr3:10183319-10193744:+	-0.19	-4.33	1.79E-5	Alzheimer's disease	
THCA	cis	1	rs2272180	chr12:70724007	YEATS4	chr12:69753532-69784575:+	-0.24	-3.64	0.000308	Amyotrophic lateral sclerosis (age of onset)	
THCA	cis	1	rs2272390	chr2:202195311	CFLAR	chr2:201980816-202029001:+	-0.25	-3.56	0.000401	Rheumatoid arthritis	
THCA	cis	1	rs2272390	chr2:202195311	PPIL3	chr2:201735680-201753999:-	-0.73	-8.16	2.88E-15	Rheumatoid arthritis	
THCA	cis	1	rs2272563	chr11:236871	PSMD13	chr11:236808-252984:+	-0.22	-6.75	4.25E-11	Menarche (age at onset)	
THCA	cis	1	rs2272563	chr11:236871	SIRT3	chr11:214625-236931:-	0.12	3.38	0.000785	Menarche (age at onset)	
THCA	cis	1	rs2272565	chr11:244414	PSMD13	chr11:236808-252984:+	-0.22	-6.73	4.91E-11	Menarche (age at onset)	
THCA	cis	1	rs2272565	chr11:244414	SIRT3	chr11:214625-236931:-	0.12	3.37	0.000812	Menarche (age at onset)	
THCA	cis	1	rs2272695	chr4:103555803	CISD2	chr4:103790135-103809913:+	-0.16	-3.62	0.000321	Primary biliary cirrhosis	
THCA	cis	1	rs2272695	chr4:103555803	NFKB1	chr4:103422486-103538458:+	0.15	4.2	3.16E-5	Primary biliary cirrhosis	
THCA	cis	1	rs2272696	chr4:103555821	CISD2	chr4:103790135-103809913:+	-0.16	-3.62	0.000321	Primary biliary cirrhosis	
THCA	cis	1	rs2272696	chr4:103555821	NFKB1	chr4:103422486-103538458:+	0.15	4.2	3.16E-5	Primary biliary cirrhosis	
THCA	cis	1	rs2272697	chr4:103555992	CISD2	chr4:103790135-103809913:+	-0.16	-3.62	0.000321	Primary biliary cirrhosis	
THCA	cis	1	rs2272697	chr4:103555992	NFKB1	chr4:103422486-103538458:+	0.15	4.2	3.16E-5	Primary biliary cirrhosis	
THCA	cis	1	rs2273145	chr20:47839591	CSE1L	chr20:47662838-47713484:+	-0.19	-3.34	0.000892	Height	
THCA	cis	1	rs2273145	chr20:47839591	DDX27	chr20:47835832-47860612:+	0.27	4.93	1.11E-6	Height	
THCA	cis	1	rs2273280	chr17:76103663	TMC6	chr17:76108999-76128488:-	0.19	3.65	0.000291	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs2273602	chr6:117730592	DCBLD1	chr6:117803820-117891018:+	0.45	9.8	8.72E-21	Lung cancer	
THCA	cis	1	rs2273602	chr6:117730592	GOPC	chr6:117639351-117923681:-	0.22	6.43	3.03E-10	Lung cancer	
THCA	cis	1	rs2273653	chr20:47770756	ARFGEF2	chr20:47538275-47653229:+	-0.11	-3.47	0.000562	Anger	
THCA	cis	1	rs2273653	chr20:47770756	CSE1L	chr20:47662838-47713484:+	0.4	9.72	1.7E-20	Anger	
THCA	cis	1	rs2273669	chr6:109285189	C6orf182	chr6:109416356-109485113:+	-0.26	-3.78	0.000178	Prostate cancer	
THCA	cis	1	rs2273694	chr10:102256496	SEC31B	chr10:102246403-102289636:-	-0.27	-8.73	4.17E-17	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2273695	chr10:102259568	SEC31B	chr10:102246403-102289636:-	-0.28	-8.88	1.35E-17	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2273832	chr1:156233143	BGLAP	chr1:156182784-156213112:+	0.23	5.38	1.17E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs2273832	chr1:156233143	C1orf85	chr1:156259882-156265449:-	-0.17	-4.04	6.35E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs2273832	chr1:156233143	CCT3	chr1:156278752-156308195:-	-0.34	-7.25	1.68E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs2273833	chr1:156233189	BGLAP	chr1:156182784-156213112:+	0.23	5.38	1.17E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs2273833	chr1:156233189	C1orf85	chr1:156259882-156265449:-	-0.17	-4.04	6.35E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs2273833	chr1:156233189	CCT3	chr1:156278752-156308195:-	-0.34	-7.25	1.68E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs2273	chr4:76889388	NAAA	chr4:76831809-76862166:-	0.35	7.06	6.07E-12	Longevity	
THCA	cis	1	rs2274292	chr13:96295321	DZIP1	chr13:96229329-96296957:-	0.2	3.91	0.000108	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
THCA	cis	1	rs2274292	chr13:96295321	UGGT2	chr13:96453838-96705736:-	-0.26	-3.88	0.000119	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
THCA	cis	1	rs2274459	chr6:33762242	IP6K3	chr6:33689443-33714762:-	0.41	6.7	6.04E-11	Obesity (extreme)	
THCA	cis	1	rs2275122	chr1:111726288	DRAM2	chr1:111659955-111682838:-	-0.26	-4.08	5.39E-5	Liver enzyme levels (gamma-glutamyl transferase)	
THCA	cis	1	rs2275192	chr1:200824186	DDX59	chr1:200610119-200639126:-	-0.24	-3.66	0.000277	Epilepsy	
THCA	cis	1	rs2275193	chr1:200824108	DDX59	chr1:200610119-200639126:-	-0.24	-3.73	0.000213	Epilepsy	
THCA	cis	1	rs2275194	chr1:200821924	DDX59	chr1:200610119-200639126:-	-0.24	-3.73	0.000213	Epilepsy	
THCA	cis	1	rs2275424	chr1:10356562	KIF1B	chr1:10270764-10441659:+	0.21	6.34	5.32E-10	Hepatocellular carcinoma	
THCA	cis	1	rs2275426	chr1:46487552	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.19	3.27E-22	Body mass index	
THCA	cis	1	rs2275426	chr1:46487552	GPBP1L1	chr1:46092978-46152302:-	0.15	3.78	0.000177	Body mass index	
THCA	cis	1	rs2275426	chr1:46487552	MMACHC	chr1:45965856-45976737:+	-0.21	-4.59	5.57E-6	Body mass index	
THCA	cis	1	rs2275426	chr1:46487552	MUTYH	chr1:45794915-45806142:-	0.3	8.16	3.01E-15	Body mass index	
THCA	cis	1	rs2276014	chr11:64081445	PRDX5	chr11:64085569-64089282:+	-0.17	-4.17	3.68E-5	Mean platelet volume	
THCA	cis	1	rs2276540	chr3:38512507	EXOG	chr3:38537763-38567796:+	-0.16	-3.39	0.000766	Electrocardiographic conduction measures	
THCA	cis	1	rs2276540	chr3:38512507	LOC100128640	chr3:38492524-38496311:-	0.23	4.85	1.68E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs2276540	chr3:38512507	XYLB	chr3:38388251-38456467:+	0.22	5.23	2.49E-7	Electrocardiographic conduction measures	
THCA	cis	1	rs2276547	chr2:28975107	PPP1CB	chr2:28974612-29025805:+	0.17	4.25	2.59E-5	Body mass index	
THCA	cis	1	rs2276547	chr2:28975107	TRMT61B	chr2:29072690-29093175:-	-0.51	-10.27	1.65E-22	Body mass index	
THCA	cis	1	rs2276834	chr3:52325759	NEK4	chr3:52744803-52804951:-	-0.12	-3.81	0.000155	Electroencephalogram traits	
THCA	cis	1	rs2276834	chr3:52325759	NT5DC2	chr3:52558386-52569093:-	-0.25	-5.89	7.41E-9	Electroencephalogram traits	
THCA	cis	1	rs2276834	chr3:52325759	PBRM1	chr3:52579368-52719866:-	0.13	5.05	6.3E-7	Electroencephalogram traits	
THCA	cis	1	rs2277862	chr20:34152782	CEP250	chr20:34042996-34099802:+	0.23	3.84	0.000142	Cholesterol, total	
THCA	cis	1	rs2277862	chr20:34152782	CPNE1	chr20:34213968-34262539:-	-0.73	-11.61	1.32E-27	Cholesterol, total	
THCA	cis	1	rs2277862	chr20:34152782	UQCC	chr20:33890383-33999833:-	-0.2	-4.32	1.89E-5	Cholesterol, total	
THCA	cis	1	rs2277869	chr12:1016910	RAD52	chr12:1021255-1099219:-	-0.3	-4.85	1.66E-6	Colorectal cancer	
THCA	cis	1	rs2277870	chr1:156246792	BGLAP	chr1:156182784-156213112:+	0.23	5.47	7.46E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs2277870	chr1:156246792	C1orf85	chr1:156259882-156265449:-	-0.17	-4.03	6.45E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs2277870	chr1:156246792	CCT3	chr1:156278752-156308195:-	-0.32	-6.99	9.47E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs2277871	chr1:156246742	BGLAP	chr1:156182784-156213112:+	0.23	5.47	7.46E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs2277871	chr1:156246742	C1orf85	chr1:156259882-156265449:-	-0.17	-4.03	6.45E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs2277871	chr1:156246742	CCT3	chr1:156278752-156308195:-	-0.32	-6.99	9.47E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs2278086	chr2:86281905	LOC90784	chr2:86247339-86250991:-	-0.63	-6.76	3.95E-11	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs2278087	chr2:86281946	LOC90784	chr2:86247339-86250991:-	-0.36	-3.49	0.000531	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs2278087	chr2:86281946	POLR1A	chr2:86253453-86333278:-	-0.3	-4.05	5.93E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs2278218	chr10:79680399	DLG5	chr10:79550551-79686348:-	0.23	4.01	6.94E-5	Liver enzyme levels (gamma-glutamyl transferase)	
THCA	cis	1	rs2278238	chr19:18576484	ELL	chr19:18553475-18632937:-	-0.26	-6.7	5.96E-11	Breast cancer	
THCA	cis	1	rs2278238	chr19:18576484	ISYNA1	chr19:18545625-18548943:-	0.13	4.82	1.91E-6	Breast cancer	
THCA	cis	1	rs2278238	chr19:18576484	LRRC25	chr19:18501955-18508421:-	-0.14	-4.89	1.4E-6	Breast cancer	
THCA	cis	1	rs2278491	chr8:117656871	EIF3H	chr8:117657056-117778494:-	-0.2	-3.61	0.000342	Body mass index	
THCA	cis	1	rs2278843	chr10:102056508	CWF19L1	chr10:101992055-102027437:-	-0.2	-3.74	0.000208	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	
THCA	cis	1	rs2279077	chr3:48474249	ATRIP	chr3:48488141-48507708:+	0.2	4.37	1.54E-5	Longevity	
THCA	cis	1	rs2279077	chr3:48474249	TREX1	chr3:48501186-48509043:+	-0.25	-5.77	1.43E-8	Longevity	
THCA	cis	1	rs2279077	chr3:48474249	ZNF589	chr3:48282596-48329113:+	0.15	3.36	0.000855	Longevity	
THCA	cis	1	rs2279144	chr19:39201781	LGALS7	chr19:39261608-39264157:-	-0.22	-4.7	3.34E-6	Heart rate	
THCA	cis	1	rs2279256	chr10:1132852	IDI2	chr10:1064847-1071799:-	0.35	3.72	0.000223	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs2279465	chr11:46399538	PACSIN3	chr11:47199085-47207958:-	0.17	3.9	0.000109	Schizophrenia	
THCA	cis	1	rs2279504	chr4:119954416	C4orf3	chr4:120217575-120221968:-	0.23	3.91	0.000104	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs2279581	chr15:40300092	SRP14	chr15:40327891-40331389:-	-0.18	-3.59	0.00036	Response to haloperidol in psychosis	
THCA	cis	1	rs2279648	chr10:75867193	VCL	chr10:75754951-75879912:+	-0.22	-3.83	0.000148	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs2280017	chr16:15151361	RRN3	chr16:15153881-15188158:-	0.21	5.35	1.37E-7	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid);Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	
THCA	cis	1	rs2280018	chr16:15150833	RRN3	chr16:15153881-15188158:-	-0.23	-5.84	9.47E-9	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid);Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	
THCA	cis	1	rs2280141	chr10:124193181	PLEKHA1	chr10:124134220-124191866:+	-0.18	-4.98	9.08E-7	Height	
THCA	cis	1	rs2281006	chr1:171110869	FMO3	chr1:171060018-171086957:+	-0.34	-5.84	9.65E-9	Blood metabolite levels	
THCA	cis	1	rs2281019	chr22:39064378	JOSD1	chr22:39081549-39096459:-	-0.15	-4.04	6.14E-5	Resting heart rate	
THCA	cis	1	rs2281019	chr22:39064378	TOMM22	chr22:39077954-39080763:+	-0.17	-3.67	0.000272	Resting heart rate	
THCA	cis	1	rs2281020	chr22:39064406	JOSD1	chr22:39081549-39096459:-	-0.15	-4.04	6.14E-5	Resting heart rate	
THCA	cis	1	rs2281020	chr22:39064406	TOMM22	chr22:39077954-39080763:+	-0.17	-3.67	0.000272	Resting heart rate	
THCA	cis	1	rs2281021	chr22:39064667	JOSD1	chr22:39081549-39096459:-	-0.15	-4	7.32E-5	Resting heart rate	
THCA	cis	1	rs2281021	chr22:39064667	TOMM22	chr22:39077954-39080763:+	-0.17	-3.65	0.000291	Resting heart rate	
THCA	cis	1	rs2281494	chr20:3235494	ITPA	chr20:3190056-3204504:+	-0.23	-5.56	4.42E-8	IFN-related cytopenia	
THCA	cis	1	rs2281497	chr20:3258874	ITPA	chr20:3190056-3204504:+	-0.24	-5.91	6.64E-9	IFN-related cytopenia	
THCA	cis	1	rs2281500	chr20:3262824	ITPA	chr20:3190056-3204504:+	-0.25	-6.24	9.9E-10	IFN-related cytopenia	
THCA	cis	1	rs2281503	chr20:3263636	ITPA	chr20:3190056-3204504:+	-0.24	-5.92	6.32E-9	IFN-related cytopenia	
THCA	cis	1	rs2281808	chr20:1610551	SIRPB1	chr20:1545030-1600689:-	0.15	3.67	0.000265	Type 1 diabetes	
THCA	cis	1	rs2283879	chr22:31638448	RNF185	chr22:31556138-31603004:+	-0.28	-5.13	4.29E-7	Paclitaxel-induced neuropathy	
THCA	cis	1	rs2283881	chr22:31638932	RNF185	chr22:31556138-31603004:+	-0.28	-5.11	4.68E-7	Paclitaxel-induced neuropathy	
THCA	cis	1	rs2284073	chr22:39105948	LOC646851	chr22:38974125-39052634:-	0.14	3.58	0.000376	Resting heart rate	
THCA	cis	1	rs2284073	chr22:39105948	TOMM22	chr22:39077954-39080763:+	-0.17	-3.63	0.00032	Resting heart rate	
THCA	cis	1	rs2285087	chr4:3088211	C4orf44	chr4:3250767-3265839:+	-0.34	-6.97	1.08E-11	Parental longevity (mother's age at death)	
THCA	cis	1	rs2285087	chr4:3088211	GRK4	chr4:2965343-3042474:+	-0.21	-3.62	0.000329	Parental longevity (mother's age at death)	
THCA	cis	1	rs2285649	chr7:87407431	DBF4	chr7:87505544-87538856:+	-0.27	-4.03	6.4E-5	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs2285657	chr17:40272594	HSPB9	chr17:40274756-40275371:+	0.34	5.07	5.66E-7	Fibrinogen levels	
THCA	cis	1	rs2285946	chr7:21583329	DNAH11	chr7:21582833-21941455:+	-0.26	-5.65	2.81E-8	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
THCA	cis	1	rs2285947	chr7:21584088	DNAH11	chr7:21582833-21941455:+	0.26	5.62	3.23E-8	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
THCA	cis	1	rs2285949	chr7:21584243	DNAH11	chr7:21582833-21941455:+	-0.26	-5.66	2.64E-8	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
THCA	cis	1	rs2285950	chr7:21584432	DNAH11	chr7:21582833-21941455:+	0.26	5.48	6.89E-8	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
THCA	cis	1	rs2286498	chr7:22857504	TOMM7	chr7:22852254-22862421:-	0.31	8.48	2.73E-16	Fibrinogen	
THCA	cis	1	rs2286499	chr7:22857477	TOMM7	chr7:22852254-22862421:-	-0.31	-8.51	2.29E-16	Fibrinogen	
THCA	cis	1	rs2286501	chr7:22856785	TOMM7	chr7:22852254-22862421:-	-0.3	-8.44	3.91E-16	Fibrinogen	
THCA	cis	1	rs2286503	chr7:22856606	TOMM7	chr7:22852254-22862421:-	-0.31	-8.46	3.23E-16	Fibrinogen	
THCA	cis	1	rs2286614	chr11:64068310	PRDX5	chr11:64085569-64089282:+	-0.18	-4.53	7.31E-6	Mean platelet volume	
THCA	cis	1	rs2286684	chr7:66129830	GUSB	chr7:65425675-65447246:-	-0.33	-6.8	3.22E-11	Aortic root size	
THCA	cis	1	rs2286684	chr7:66129830	RABGEF1	chr7:66093890-66276446:+	-0.51	-10.49	2.65E-23	Aortic root size	
THCA	cis	1	rs2286684	chr7:66129830	TYW1	chr7:66461817-66704496:+	-0.18	-3.93	9.79E-5	Aortic root size	
THCA	cis	1	rs2286809	chr11:22851455	SVIP	chr11:22843600-22851382:-	0.27	6.7	5.85E-11	Dialysis-related mortality	
THCA	cis	1	rs2287679	chr19:33600764	GPATCH1	chr19:33571786-33621318:+	0.36	8.74	3.94E-17	Bone properties (heel)	
THCA	cis	1	rs2287680	chr19:33608566	GPATCH1	chr19:33571786-33621318:+	-0.38	-9.23	9.05E-19	Bone properties (heel)	
THCA	cis	1	rs2287754	chr19:49496494	RUVBL2	chr19:49496819-49519182:+	-0.17	-3.51	0.000497	Follicule stimulating hormone	
THCA	cis	1	rs2287838	chr19:9959014	ZNF266	chr19:9523272-9546234:-	-0.19	-4.66	4.16E-6	Sleep duration	
THCA	cis	1	rs2287838	chr19:9959014	ZNF846	chr19:9862816-9879410:-	0.23	4.27	2.41E-5	Sleep duration	
THCA	cis	1	rs2287997	chr16:72140553	DHODH	chr16:72042643-72058954:+	0.22	4.51	8.12E-6	Haptoglobin levels;Cholesterol, total;LDL cholesterol	
THCA	cis	1	rs2288073	chr2:24413298	C2orf84	chr2:24397531-24414566:+	-0.29	-4.46	1.03E-5	Venous thromboembolism (SNP x SNP interaction)	
THCA	cis	1	rs2288073	chr2:24413298	LOC375190	chr2:24299728-24397519:+	0.37	8.31	9.89E-16	Venous thromboembolism (SNP x SNP interaction)	
THCA	cis	1	rs2288073	chr2:24413298	POMC	chr2:25383722-25391559:-	0.2	3.37	0.000807	Venous thromboembolism (SNP x SNP interaction)	
THCA	cis	1	rs2288871	chr19:41917868	B3GNT8	chr19:41931265-41934635:-	-0.36	-8.42	4.48E-16	Height	
THCA	cis	1	rs2288884	chr19:52532271	ZNF432	chr19:52536678-52552073:-	-0.17	-4.35	1.7E-5	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	
THCA	cis	1	rs2289022	chr2:26350136	GPR113	chr2:26531041-26569685:-	-0.42	-6.63	8.91E-11	Gut microbiome composition (summer)	
THCA	cis	1	rs2289130	chr18:44626630	HDHD2	chr18:44633782-44676871:-	0.28	5.21	2.84E-7	Sitting height ratio	
THCA	cis	1	rs2289130	chr18:44626630	PIAS2	chr18:44392061-44500123:-	-0.16	-3.35	0.000869	Sitting height ratio	
THCA	cis	1	rs2289131	chr18:44602864	HDHD2	chr18:44633782-44676871:-	0.35	6.36	4.71E-10	Sitting height ratio	
THCA	cis	1	rs2289132	chr18:44602292	HDHD2	chr18:44633782-44676871:-	0.35	6.36	4.71E-10	Sitting height ratio	
THCA	cis	1	rs2289237	chr2:86266274	POLR1A	chr2:86253453-86333278:-	0.36	4.76	2.62E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs2289329	chr15:40705159	C15orf23	chr15:40674922-40686488:+	-0.26	-5.22	2.68E-7	Blood metabolite levels;Blood metabolite ratios	
THCA	cis	1	rs2289329	chr15:40705159	DISP2	chr15:40650434-40663256:+	0.3	5.5	6.14E-8	Blood metabolite levels;Blood metabolite ratios	
THCA	cis	1	rs2289681	chr17:42989088	CCDC103	chr17:42977154-42982758:+	0.33	4.51	8.23E-6	Cognitive function	
THCA	cis	1	rs2289697	chr15:79221907	CHRNA5	chr15:78857906-78886458:+	0.29	3.35	0.000869	Bipolar disorder	
THCA	cis	1	rs2289836	chr14:76640125	ESRRB	chr14:76837690-76968178:+	-0.31	-4.75	2.75E-6	Blood pressure	
THCA	cis	1	rs2289890	chr11:116824620	PCSK7	chr11:117075789-117102811:-	0.45	5.41	1.01E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs2289892	chr11:116825240	PCSK7	chr11:117075789-117102811:-	0.45	5.41	1.01E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs2290402	chr4:941518	FGFRL1	chr4:1004940-1020685:+	-0.22	-3.54	0.000439	Type 2 diabetes	
THCA	cis	1	rs2290402	chr4:941518	IDUA	chr4:980785-998316:+	-0.21	-4.33	1.84E-5	Type 2 diabetes	
THCA	cis	1	rs2290402	chr4:941518	SLC26A1	chr4:972864-987224:-	0.3	5.17	3.51E-7	Type 2 diabetes	
THCA	cis	1	rs2290409	chr4:1067249	C4orf42	chr4:1243280-1282079:+	0.17	3.45	0.00062	Recombination rate (males)	
THCA	cis	1	rs2290659	chr19:52031153	ZNF175	chr19:52074531-52092990:+	-0.32	-3.85	0.000132	Carotid intima media thickness	
THCA	cis	1	rs2290661	chr19:52031316	ZNF175	chr19:52074531-52092990:+	-0.32	-3.85	0.000132	Carotid intima media thickness	
THCA	cis	1	rs2290822	chr3:48473204	ATRIP	chr3:48488141-48507708:+	0.19	4.24	2.73E-5	Longevity	
THCA	cis	1	rs2290822	chr3:48473204	TREX1	chr3:48501186-48509043:+	-0.25	-5.69	2.24E-8	Longevity	
THCA	cis	1	rs2290850	chr11:47807774	C1QTNF4	chr11:47611216-47615961:-	-0.31	-5.22	2.61E-7	Subjective well-being	
THCA	cis	1	rs2290883	chr11:46890197	DDB2	chr11:47236493-47260769:+	-0.22	-3.47	0.000559	HDL cholesterol	
THCA	cis	1	rs2290883	chr11:46890197	ZNF408	chr11:46722368-46727461:+	0.18	3.58	0.000375	HDL cholesterol	
THCA	cis	1	rs2290911	chr2:224919	SH3YL1	chr2:218138-264810:-	-0.95	-26.64	1.58E-96	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs2291036	chr17:20922702	USP22	chr17:20902908-20947073:-	-0.18	-3.83	0.000146	Blood trace element (Se levels)	
THCA	cis	1	rs2291350	chr12:129283711	GLT1D1	chr12:129338081-129469509:+	-0.23	-5.76	1.49E-8	Systemic lupus erythematosus	
THCA	cis	1	rs2291350	chr12:129283711	SLC15A4	chr12:129277739-129308541:-	-0.18	-4.49	8.91E-6	Systemic lupus erythematosus	
THCA	cis	1	rs2291394	chr17:80403894	C17orf62	chr17:80400520-80408694:-	-0.27	-6.72	5.17E-11	Protein quantitative trait loci	
THCA	cis	1	rs2291394	chr17:80403894	NARF	chr17:80416060-80446141:+	-0.17	-3.67	0.000267	Protein quantitative trait loci	
THCA	cis	1	rs2291447	chr17:43212963	PLCD3	chr17:43189009-43209891:-	-0.1	-3.42	0.000678	Economic and political preferences	
THCA	cis	1	rs2291542	chr3:49751585	CCDC36	chr3:49235861-49295537:+	0.19	3.88	0.00012	Resting heart rate	
THCA	cis	1	rs2291542	chr3:49751585	RBM6	chr3:49977592-50137484:+	-0.14	-4.18	3.4E-5	Resting heart rate	
THCA	cis	1	rs2292095	chr1:200826395	DDX59	chr1:200610119-200639126:-	-0.22	-3.59	0.000368	Epilepsy	
THCA	cis	1	rs2292096	chr1:200826769	DDX59	chr1:200610119-200639126:-	-0.24	-3.73	0.000213	Epilepsy	
THCA	cis	1	rs2292165	chr1:31732892	ZCCHC17	chr1:31769842-31837780:+	-0.3	-5.6	3.65E-8	Schizophrenia	
THCA	cis	1	rs2292174	chr15:50924956	ATP8B4	chr15:50150436-50411419:-	-0.11	-3.36	0.000845	QT interval	
THCA	cis	1	rs2292174	chr15:50924956	SPPL2A	chr15:50999739-51057910:-	0.27	7.04	6.74E-12	QT interval	
THCA	cis	1	rs2292239	chr12:56482180	RAB5B	chr12:56367760-56388478:+	0.23	4.28	2.27E-5	Cognitive function	
THCA	cis	1	rs2292239	chr12:56482180	RPS26	chr12:56435686-56438005:+	0.65	12.3	2.04E-30	Cognitive function	
THCA	cis	1	rs2292239	chr12:56482180	TMEM194A	chr12:57449427-57472574:-	0.18	4.49	8.86E-6	Cognitive function	
THCA	cis	1	rs2292255	chr5:176334195	ZNF346	chr5:176449697-176508190:+	-0.16	-5.49	6.63E-8	Menopause (age at onset);Menarche and menopause (age at onset)	
THCA	cis	1	rs2292256	chr5:176333126	ZNF346	chr5:176449697-176508190:+	-0.16	-5.58	3.98E-8	Menopause (age at onset);Menarche and menopause (age at onset)	
THCA	cis	1	rs2292572	chr11:78052864	NARS2	chr11:78147017-78285909:-	-0.39	-7.55	2.16E-13	Testicular germ cell tumor	
THCA	cis	1	rs2292573	chr11:78053139	NARS2	chr11:78147017-78285909:-	-0.41	-7.75	5.42E-14	Testicular germ cell tumor	
THCA	cis	1	rs2292626	chr10:124186714	PLEKHA1	chr10:124134220-124191866:+	-0.21	-5.86	8.42E-9	Height	
THCA	cis	1	rs2293072	chr2:220045454	NHEJ1	chr2:219940051-220034817:-	-0.32	-3.78	0.000174	Height	
THCA	cis	1	rs2293167	chr11:211644	PSMD13	chr11:236808-252984:+	0.21	6.51	1.86E-10	Menarche (age at onset)	
THCA	cis	1	rs2294008	chr8:143761931	C8orf55	chr8:143808621-143818350:+	0.35	8.14	3.4E-15	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2294008	chr8:143761931	LY6K	chr8:143781529-143785582:+	0.29	5.3	1.74E-7	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2294008	chr8:143761931	LYNX1	chr8:143845758-143859640:-	-0.21	-4.38	1.49E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2294008	chr8:143761931	PSCA	chr8:143761875-143764142:+	0.37	6.47	2.43E-10	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2294010	chr8:143762430	C8orf55	chr8:143808621-143818350:+	0.36	8.4	5.12E-16	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2294010	chr8:143762430	LY6K	chr8:143781529-143785582:+	0.29	5.27	2.07E-7	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2294010	chr8:143762430	LYNX1	chr8:143845758-143859640:-	-0.2	-4.32	1.94E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2294010	chr8:143762430	PSCA	chr8:143761875-143764142:+	0.36	6.41	3.4E-10	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2294296	chr22:39053049	JOSD1	chr22:39081549-39096459:-	-0.15	-3.94	9.33E-5	Resting heart rate	
THCA	cis	1	rs2294296	chr22:39053049	TOMM22	chr22:39077954-39080763:+	-0.16	-3.58	0.000379	Resting heart rate	
THCA	cis	1	rs2294693	chr6:41005502	UNC5CL	chr6:40994772-41039015:-	-0.13	-3.7	0.000238	Non-cardia gastric cancer;Gastric cancer	
THCA	cis	1	rs2295028	chr20:47582958	ARFGEF2	chr20:47538275-47653229:+	0.12	4.01	6.99E-5	Anger	
THCA	cis	1	rs2295028	chr20:47582958	CSE1L	chr20:47662838-47713484:+	-0.41	-10.12	6.25E-22	Anger	
THCA	cis	1	rs2295135	chr14:88894210	SPATA7	chr14:88852012-88904802:+	-0.19	-3.95	8.82E-5	Coronary artery calcification	
THCA	cis	1	rs2295700	chr20:33591627	PROCR	chr20:33758727-33765164:+	-0.36	-5.75	1.55E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs2295700	chr20:33591627	TRPC4AP	chr20:33590215-33680618:-	0.32	3.88	0.000118	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs2295714	chr20:47739814	ARFGEF2	chr20:47538275-47653229:+	-0.12	-3.85	0.000132	Anger	
THCA	cis	1	rs2295714	chr20:47739814	CSE1L	chr20:47662838-47713484:+	0.4	9.93	2.96E-21	Anger	
THCA	cis	1	rs2295770	chr10:102239829	SEC31B	chr10:102246403-102289636:-	-0.31	-10.2	3.07E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2295772	chr10:102265183	SEC31B	chr10:102246403-102289636:-	-0.28	-9.03	4.33E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2295773	chr10:102265815	SEC31B	chr10:102246403-102289636:-	-0.28	-9.03	4.33E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2295774	chr10:102265847	SEC31B	chr10:102246403-102289636:-	-0.28	-8.79	2.81E-17	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2295776	chr10:102295629	SEC31B	chr10:102246403-102289636:-	-0.28	-8.96	7.03E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2295779	chr10:102296061	SEC31B	chr10:102246403-102289636:-	-0.28	-8.96	7.03E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2295780	chr10:102305965	SEC31B	chr10:102246403-102289636:-	-0.29	-9.15	1.61E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2295872	chr10:38146218	LOC399744	chr10:38717074-38741080:+	0.29	3.95	8.97E-5	Obesity (extreme)	
THCA	cis	1	rs2295872	chr10:38146218	ZNF25	chr10:38238795-38265453:-	0.16	3.44	0.000625	Obesity (extreme)	
THCA	cis	1	rs2295888	chr20:33722863	MMP24	chr20:33814539-33864804:+	-0.22	-3.35	0.000885	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs2295888	chr20:33722863	PROCR	chr20:33758727-33765164:+	-0.29	-4.75	2.64E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs2296225	chr1:21031042	PLA2G2A	chr1:20301925-20306932:-	0.3	3.54	0.000437	Eosinophilic esophagitis	
THCA	cis	1	rs2296306	chr1:183191324	RNASEL	chr1:182542772-182558391:-	0.32	3.46	0.000579	Systemic lupus erythematosus and Systemic sclerosis	
THCA	cis	1	rs2296375	chr1:156309372	BGLAP	chr1:156182784-156213112:+	0.24	5.47	7.15E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs2296375	chr1:156309372	C1orf85	chr1:156259882-156265449:-	-0.19	-4.51	7.98E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs2296375	chr1:156309372	CCT3	chr1:156278752-156308195:-	-0.32	-6.81	2.93E-11	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs2296738	chr6:33656850	NUDT3	chr6:34256002-34360441:-	-0.18	-3.46	0.000591	Height	
THCA	cis	1	rs2296747	chr6:33744882	LEMD2	chr6:33738991-33756906:-	-0.31	-7.12	4.09E-12	Crohn's disease	
THCA	cis	1	rs2296748	chr6:33745071	LEMD2	chr6:33738991-33756906:-	-0.3	-7.03	7.39E-12	Crohn's disease	
THCA	cis	1	rs2296749	chr6:33763127	IP6K3	chr6:33689443-33714762:-	0.41	6.7	6.04E-11	Obesity (extreme)	
THCA	cis	1	rs2297112	chr9:131900180	CRAT	chr9:131857075-131873070:-	0.29	7.06	5.88E-12	Blood metabolite ratios	
THCA	cis	1	rs2297496	chr20:25295787	ENTPD6	chr20:25176339-25207360:+	0.31	6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2297496	chr20:25295787	FAM182A	chr20:26035250-26067552:+	0.18	3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2297496	chr20:25295787	FAM182B	chr20:25744102-25848786:-	-0.27	-5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2297496	chr20:25295787	NINL	chr20:25433338-25566153:-	0.35	7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2297496	chr20:25295787	PYGB	chr20:25228706-25278647:+	0.16	4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2297497	chr20:25297909	ENTPD6	chr20:25176339-25207360:+	0.31	6.99	9.23E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2297497	chr20:25297909	FAM182A	chr20:26035250-26067552:+	0.19	3.56	0.000413	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2297497	chr20:25297909	FAM182B	chr20:25744102-25848786:-	-0.27	-5.62	3.24E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2297497	chr20:25297909	NINL	chr20:25433338-25566153:-	0.35	7.17	2.87E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2297497	chr20:25297909	PYGB	chr20:25228706-25278647:+	0.16	3.97	8.27E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2298074	chr10:102247526	SEC31B	chr10:102246403-102289636:-	-0.3	-9.77	1.09E-20	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2298075	chr10:102247408	SEC31B	chr10:102246403-102289636:-	-0.3	-10.02	1.45E-21	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2298456	chr11:71730715	FAM86C	chr11:71498557-71512276:+	-0.33	-4.04	6.27E-5	Severe influenza A (H1N1) infection	
THCA	cis	1	rs2298457	chr11:71734211	FAM86C	chr11:71498557-71512276:+	0.32	3.89	0.000116	Severe influenza A (H1N1) infection	
THCA	cis	1	rs2298632	chr1:23710475	TCEA3	chr1:23707555-23751261:-	0.15	3.82	0.00015	QT interval	
THCA	cis	1	rs2298755	chr4:100261038	ADH1C	chr4:100257651-100273917:-	0.18	3.39	0.000747	Oral cavity and pharyngeal cancer	
THCA	cis	1	rs2298948	chr2:75926565	C2orf3	chr2:75889834-75938111:-	-0.18	-3.77	0.000185	Hippocampal atrophy	
THCA	cis	1	rs2298948	chr2:75926565	MRPL19	chr2:75873909-75897879:+	0.15	3.91	0.000105	Hippocampal atrophy	
THCA	cis	1	rs2299587	chr8:17800769	PCM1	chr8:17780366-17887455:+	-0.1	-4.33	1.78E-5	Economic and political preferences	
THCA	cis	1	rs2300206	chr20:32589808	RALY	chr20:32581732-32672675:+	0.16	4.71	3.27E-6	Cancer;Cancer (pleiotropy)	
THCA	cis	1	rs2300601	chr14:75639571	EIF2B2	chr14:75469612-75476292:+	0.17	4.49	8.98E-6	Height	
THCA	cis	1	rs2300601	chr14:75639571	MLH3	chr14:75480467-75518235:-	0.27	7.91	1.87E-14	Height	
THCA	cis	1	rs2300601	chr14:75639571	RPS6KL1	chr14:75372347-75389958:-	0.29	6.04	3.03E-9	Height	
THCA	cis	1	rs2300867	chr14:66129154	LOC645431	chr14:65877313-65879335:-	-0.57	-7.39	6.42E-13	Ischemic stroke	
THCA	cis	1	rs2300871	chr14:66147694	LOC645431	chr14:65877313-65879335:-	0.51	6.57	1.32E-10	Ischemic stroke	
THCA	cis	1	rs2300872	chr14:66147761	LOC645431	chr14:65877313-65879335:-	-0.59	-7.36	8.34E-13	Ischemic stroke	
THCA	cis	1	rs2301052	chr3:184953662	CHRD	chr3:184097861-184107619:+	-0.14	-3.77	0.000182	Cognitive performance	
THCA	cis	1	rs2302138	chr14:74363305	LIN52	chr14:74551656-74667117:+	0.24	4.52	7.8E-6	Morning vs. evening chronotype	
THCA	cis	1	rs2302138	chr14:74363305	PTGR2	chr14:74318534-74352166:+	0.22	3.53	0.000452	Morning vs. evening chronotype	
THCA	cis	1	rs2302138	chr14:74363305	ZNF410	chr14:74318674-74398803:+	0.23	3.82	0.000149	Morning vs. evening chronotype	
THCA	cis	1	rs2302139	chr14:74362935	LIN52	chr14:74551656-74667117:+	0.23	4.37	1.55E-5	Morning vs. evening chronotype	
THCA	cis	1	rs2302139	chr14:74362935	PTGR2	chr14:74318534-74352166:+	0.23	3.65	0.000293	Morning vs. evening chronotype	
THCA	cis	1	rs2302139	chr14:74362935	ZNF410	chr14:74318674-74398803:+	0.23	3.86	0.000128	Morning vs. evening chronotype	
THCA	cis	1	rs2302278	chr3:47361082	C3orf75	chr3:47537131-47555199:-	0.09	4.18	3.46E-5	Colorectal cancer	
THCA	cis	1	rs2302278	chr3:47361082	NBEAL2	chr3:47021173-47051193:+	0.11	3.51	0.000488	Colorectal cancer	
THCA	cis	1	rs2302507	chr3:37144535	EPM2AIP1	chr3:37027358-37034795:-	0.14	4.05	6.0E-5	Cerebrospinal P-tau181p levels	
THCA	cis	1	rs2302507	chr3:37144535	LRRFIP2	chr3:37094117-37217851:-	0.5	13.75	1.76E-36	Cerebrospinal P-tau181p levels	
THCA	cis	1	rs2302772	chr19:32902050	DPY19L3	chr19:32896677-32975236:+	0.19	5	8.25E-7	Bipolar disorder	
THCA	cis	1	rs2302772	chr19:32902050	ZNF507	chr19:32836514-32878571:+	0.28	7.03	7.36E-12	Bipolar disorder	
THCA	cis	1	rs2302773	chr19:32927311	DPY19L3	chr19:32896677-32975236:+	0.19	5.11	4.68E-7	Bipolar disorder	
THCA	cis	1	rs2302773	chr19:32927311	ZNF507	chr19:32836514-32878571:+	0.3	7.37	7.73E-13	Bipolar disorder	
THCA	cis	1	rs2303100	chr19:9968434	ZNF266	chr19:9523272-9546234:-	-0.19	-4.67	3.95E-6	Sleep duration	
THCA	cis	1	rs2303100	chr19:9968434	ZNF846	chr19:9862816-9879410:-	0.22	4.12	4.43E-5	Sleep duration	
THCA	cis	1	rs2303339	chr2:86346180	LOC90784	chr2:86247339-86250991:-	0.44	4.56	6.55E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs2303340	chr2:86333193	LOC90784	chr2:86247339-86250991:-	-0.44	-4.74	2.76E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs2303695	chr19:18562624	ELL	chr19:18553475-18632937:-	-0.26	-6.57	1.33E-10	Breast cancer	
THCA	cis	1	rs2303695	chr19:18562624	ISYNA1	chr19:18545625-18548943:-	0.13	4.72	3.14E-6	Breast cancer	
THCA	cis	1	rs2303695	chr19:18562624	LRRC25	chr19:18501955-18508421:-	-0.14	-4.73	2.91E-6	Breast cancer	
THCA	cis	1	rs2303697	chr19:18546678	ELL	chr19:18553475-18632937:-	-0.25	-6.35	4.94E-10	Breast cancer	
THCA	cis	1	rs2303697	chr19:18546678	ISYNA1	chr19:18545625-18548943:-	0.13	4.71	3.24E-6	Breast cancer	
THCA	cis	1	rs2303697	chr19:18546678	LRRC25	chr19:18501955-18508421:-	-0.14	-4.74	2.78E-6	Breast cancer	
THCA	cis	1	rs2303759	chr19:49869051	DKKL1	chr19:49867042-49878371:+	-0.26	-4.53	7.6E-6	Multiple sclerosis	
THCA	cis	1	rs2304242	chr19:41944616	B3GNT8	chr19:41931265-41934635:-	0.34	7.59	1.67E-13	Height	
THCA	cis	1	rs2304242	chr19:41944616	EXOSC5	chr19:41892278-41903256:-	0.11	3.5	0.000513	Height	
THCA	cis	1	rs2304389	chr9:101068580	TBC1D2	chr9:100961281-101018003:-	0.2	5.26	2.13E-7	Schizophrenia	
THCA	cis	1	rs2304390	chr9:101068649	TBC1D2	chr9:100961281-101018003:-	0.2	5.26	2.13E-7	Schizophrenia	
THCA	cis	1	rs2304513	chr3:100645475	NIT2	chr3:100053562-100074477:+	-0.16	-3.44	0.000626	Optic disc area	
THCA	cis	1	rs2304641	chr1:85513398	MCOLN2	chr1:85391267-85462796:-	-0.27	-5.83	9.97E-9	Serum sulfate level	
THCA	cis	1	rs2304668	chr2:239168448	LOC151174	chr2:239133754-239140318:-	0.55	5.79	1.3E-8	Irritable bowel syndrome	
THCA	cis	1	rs2305837	chr6:70423739	LMBRD1	chr6:70385751-70506888:-	-0.09	-3.35	0.000865	Sleep duration	
THCA	cis	1	rs2305838	chr6:70500451	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.37	0.000826	Sleep duration	
THCA	cis	1	rs2305839	chr6:70500463	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.37	0.000826	Sleep duration	
THCA	cis	1	rs2306028	chr11:46900659	DDB2	chr11:47236493-47260769:+	0.22	3.47	0.000574	HDL cholesterol	
THCA	cis	1	rs2306028	chr11:46900659	ZNF408	chr11:46722368-46727461:+	-0.19	-3.61	0.000335	HDL cholesterol	
THCA	cis	1	rs2306033	chr11:46897446	DDB2	chr11:47236493-47260769:+	0.22	3.4	0.000727	HDL cholesterol	
THCA	cis	1	rs2306033	chr11:46897446	ZNF408	chr11:46722368-46727461:+	-0.19	-3.62	0.000325	HDL cholesterol	
THCA	cis	1	rs2306937	chr1:113246506	MOV10	chr1:113217048-113243367:+	0.19	4.22	2.88E-5	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs2306937	chr1:113246506	ST7L	chr1:113066142-113162405:-	0.65	10.09	7.58E-22	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs2306940	chr1:113241052	MOV10	chr1:113217048-113243367:+	0.2	4.77	2.44E-6	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs2306940	chr1:113241052	ST7L	chr1:113066142-113162405:-	0.66	10.71	3.86E-24	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs2307021	chr3:49765483	CCDC36	chr3:49235861-49295537:+	0.19	4.02	6.85E-5	Resting heart rate	
THCA	cis	1	rs2307021	chr3:49765483	RBM6	chr3:49977592-50137484:+	-0.14	-4.32	1.89E-5	Resting heart rate	
THCA	cis	1	rs2310997	chr3:48678011	NCKIPSD	chr3:48711280-48723334:-	-0.37	-5.27	2.08E-7	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs2310997	chr3:48678011	SLC26A6	chr3:48663158-48672926:-	0.32	5.49	6.64E-8	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs2310997	chr3:48678011	ZNF589	chr3:48282596-48329113:+	-0.27	-3.62	0.000329	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs2311439	chr17:76080086	TMC6	chr17:76108999-76128488:-	0.21	3.93	9.92E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs2311440	chr17:76067285	TMC6	chr17:76108999-76128488:-	0.21	3.95	8.84E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs2312462	chr3:49601255	DALRD3	chr3:49052435-49058467:-	0.16	3.62	0.000329	Menarche (age at onset)	
THCA	cis	1	rs2312462	chr3:49601255	P4HTM	chr3:49027341-49044579:+	0.2	4.9	1.3E-6	Menarche (age at onset)	
THCA	cis	1	rs2315281	chr19:19480099	HAPLN4	chr19:19366453-19384074:-	-0.33	-6.98	9.86E-12	Schizophrenia	
THCA	cis	1	rs2315281	chr19:19480099	KIAA0892	chr19:19431630-19469562:+	0.15	4.4	1.31E-5	Schizophrenia	
THCA	cis	1	rs2315281	chr19:19480099	TM6SF2	chr19:19375174-19384074:-	-0.2	-4.06	5.83E-5	Schizophrenia	
THCA	cis	1	rs2315504	chr17:39046881	TMEM99	chr17:38975374-38992526:+	-0.21	-5.12	4.47E-7	Height	
THCA	cis	1	rs2315556	chr4:17670861	MED28	chr4:17616273-17629791:+	0.16	3.46	0.000599	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs2315560	chr4:17677305	MED28	chr4:17616273-17629791:+	0.16	3.49	0.000527	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs2315561	chr4:17679695	MED28	chr4:17616273-17629791:+	0.16	3.42	0.000684	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs2318131	chr2:237933966	CXCR7	chr2:237469424-237490992:+	0.13	3.42	0.000679	Motion sickness	
THCA	cis	1	rs2319398	chr3:119612942	GSK3B	chr3:119540804-119813264:-	0.14	4.93	1.16E-6	HDL cholesterol	
THCA	cis	1	rs2319399	chr3:119636207	GSK3B	chr3:119540804-119813264:-	0.14	4.81	2.06E-6	HDL cholesterol	
THCA	cis	1	rs2319969	chr1:121207335	HIST2H2BA	chr1:120906034-120914842:+	0.18	3.85	0.000133	Hip geometry	
THCA	cis	1	rs2324843	chr6:86617501	SNHG5	chr6:86386726-86388451:-	-0.51	-11.15	8.17E-26	Response to antipsychotic treatment	
THCA	cis	1	rs2326289	chr20:3952300	MAVS	chr20:3827449-3856761:+	-0.23	-3.51	0.000484	Response to antidepressants in depression	
THCA	cis	1	rs2326680	chr20:5942955	MCM8	chr20:5931298-5975829:+	-0.32	-7.18	2.69E-12	HIV-1 viral setpoint	
THCA	cis	1	rs2328547	chr6:20716570	SOX4	chr6:21593972-21598847:+	-0.12	-3.71	0.000234	Type 2 diabetes	
THCA	cis	1	rs2328548	chr6:20716958	SOX4	chr6:21593972-21598847:+	-0.13	-3.87	0.000126	Type 2 diabetes	
THCA	cis	1	rs2329340	chr7:50620229	FIGNL1	chr7:50511834-50518088:-	-0.18	-4.59	5.66E-6	Malaria	
THCA	cis	1	rs2329341	chr7:50620275	FIGNL1	chr7:50511834-50518088:-	-0.18	-4.59	5.66E-6	Malaria	
THCA	cis	1	rs2329342	chr7:50624971	FIGNL1	chr7:50511834-50518088:-	0.17	4.37	1.49E-5	Malaria	
THCA	cis	1	rs2331140	chr7:44750227	OGDH	chr7:44646171-44748668:+	-0.18	-3.46	0.000591	Systolic blood pressure change trajectories	
THCA	cis	1	rs2331903	chr1:180950869	MR1	chr1:181003139-181024633:+	-0.12	-3.39	0.000761	Progressive supranuclear palsy	
THCA	cis	1	rs2331903	chr1:180950869	STX6	chr1:180913175-180992046:-	-0.2	-4.08	5.22E-5	Progressive supranuclear palsy	
THCA	cis	1	rs2336540	chr3:52974589	RFT1	chr3:53122503-53164470:-	0.61	7.05	6.27E-12	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs2336540	chr3:52974589	TMEM110	chr3:52867139-52931547:-	0.36	4.16	3.72E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs2336541	chr3:52974630	RFT1	chr3:53122503-53164470:-	0.61	7.05	6.27E-12	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs2336541	chr3:52974630	TMEM110	chr3:52867139-52931547:-	0.36	4.16	3.72E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs2336696	chr8:1033802	DLGAP2	chr8:1449569-1656640:+	0.43	7.99	1.01E-14	Schizophrenia	
THCA	cis	1	rs2336723	chr3:53106047	ITIH4	chr3:52847007-52866554:-	0.15	4.26	2.48E-5	Height	
THCA	cis	1	rs2336723	chr3:53106047	RFT1	chr3:53122503-53164470:-	-0.74	-17.74	1.77E-54	Height	
THCA	cis	1	rs2336723	chr3:53106047	SFMBT1	chr3:52938628-53080070:-	0.12	3.44	0.000638	Height	
THCA	cis	1	rs2336880	chr5:139063728	SLC4A9	chr5:139739787-139754722:+	0.21	3.49	0.000525	Schizophrenia	
THCA	cis	1	rs2338555	chr1:152309380	FLG	chr1:152274651-152297679:-	0.29	4.44	1.12E-5	Atopic dermatitis	
THCA	cis	1	rs2338555	chr1:152309380	HRNR	chr1:152184558-152196669:-	-0.46	-6.49	2.11E-10	Atopic dermatitis	
THCA	cis	1	rs2338556	chr1:152309427	FLG	chr1:152274651-152297679:-	0.29	4.44	1.12E-5	Atopic dermatitis	
THCA	cis	1	rs2338556	chr1:152309427	HRNR	chr1:152184558-152196669:-	-0.46	-6.49	2.11E-10	Atopic dermatitis	
THCA	cis	1	rs2339683	chr10:52786418	PRKG1	chr10:52750945-54055274:+	-0.22	-5.1	4.84E-7	Migraine	
THCA	cis	1	rs2339688	chr10:52758008	PRKG1	chr10:52750945-54055274:+	-0.2	-4.65	4.3E-6	Migraine	
THCA	cis	1	rs2340536	chr8:96010435	C8orf38	chr8:95908040-96088396:+	-0.28	-4.48	9.26E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs2342310	chr17:41866199	MPP3	chr17:41878169-41910538:-	0.31	5.02	7.14E-7	Triglycerides	
THCA	cis	1	rs2342371	chr3:196187608	TCTEX1D2	chr3:196018090-196045159:-	-0.17	-4.01	7.18E-5	Fat distribution (HIV)	
THCA	cis	1	rs2344180	chr5:150267357	LOC134466	chr5:150310000-150326146:-	0.39	5.38	1.19E-7	Crohn's disease	
THCA	cis	1	rs2344181	chr5:150262574	LOC134466	chr5:150310000-150326146:-	0.39	5.38	1.19E-7	Crohn's disease	
THCA	cis	1	rs2345001	chr5:150266518	LOC134466	chr5:150310000-150326146:-	0.38	5.28	2.01E-7	Crohn's disease	
THCA	cis	1	rs2348114	chr2:201582193	PPIL3	chr2:201735680-201753999:-	0.26	3.4	0.00072	Intelligence	
THCA	cis	1	rs2349075	chr2:202223566	ALS2CR12	chr2:202153148-202222101:-	-0.36	-7.01	8.38E-12	Basal cell carcinoma	
THCA	cis	1	rs2349075	chr2:202223566	PPIL3	chr2:201735680-201753999:-	-0.23	-4.69	3.55E-6	Basal cell carcinoma	
THCA	cis	1	rs2351706	chr15:90384115	AP3S2	chr15:90373832-90456222:-	-0.77	-19.66	1.76E-63	Type 2 diabetes	
THCA	cis	1	rs2351706	chr15:90384115	C15orf38	chr15:90443832-90456222:-	0.35	7.4	6.27E-13	Type 2 diabetes	
THCA	cis	1	rs2351707	chr15:90384045	AP3S2	chr15:90373832-90456222:-	-0.77	-19.66	1.69E-63	Type 2 diabetes	
THCA	cis	1	rs2351707	chr15:90384045	C15orf38	chr15:90443832-90456222:-	0.35	7.48	3.59E-13	Type 2 diabetes	
THCA	cis	1	rs2353312	chr4:48369395	OCIAD1	chr4:48833015-48863831:+	0.14	4.12	4.5E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs2353605	chr4:219538	ZNF718	chr4:53272-156488:+	0.53	10.34	9.07E-23	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs2353605	chr4:219538	ZNF732	chr4:259482-299263:-	-0.24	-3.48	0.000556	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs2354550	chr6:107141943	QRSL1	chr6:107077441-107116290:+	-0.17	-4.37	1.51E-5	Daytime sleep phenotypes	
THCA	cis	1	rs2356559	chr1:45981512	AKR1A1	chr1:46016498-46035720:+	-0.13	-3.64	0.000307	Homocysteine levels	
THCA	cis	1	rs2356559	chr1:45981512	CCDC163P	chr1:45960581-45965646:-	-1.07	-29.6	3.66E-110	Homocysteine levels	
THCA	cis	1	rs2356559	chr1:45981512	MUTYH	chr1:45794915-45806142:-	0.21	5.07	5.77E-7	Homocysteine levels	
THCA	cis	1	rs2356559	chr1:45981512	PRDX1	chr1:45976708-45987609:-	-0.4	-10.09	8.05E-22	Homocysteine levels	
THCA	cis	1	rs2356561	chr1:45980862	CCDC163P	chr1:45960581-45965646:-	-1.01	-26.83	2.06E-97	Homocysteine levels	
THCA	cis	1	rs2356561	chr1:45980862	MUTYH	chr1:45794915-45806142:-	0.2	4.77	2.47E-6	Homocysteine levels	
THCA	cis	1	rs2356561	chr1:45980862	PRDX1	chr1:45976708-45987609:-	-0.4	-10.29	1.45E-22	Homocysteine levels	
THCA	cis	1	rs2358040	chr2:11731774	GREB1	chr2:11674242-11782912:+	-0.16	-3.53	0.000463	Endometriosis	
THCA	cis	1	rs2358628	chr14:74631757	C14orf45	chr14:74486059-74549566:+	-0.16	-4.41	1.26E-5	Common traits (Other)	
THCA	cis	1	rs2358628	chr14:74631757	LIN52	chr14:74551656-74667117:+	-0.48	-12.25	3.38E-30	Common traits (Other)	
THCA	cis	1	rs2358633	chr14:74647418	C14orf45	chr14:74486059-74549566:+	-0.15	-4.4	1.35E-5	Common traits (Other)	
THCA	cis	1	rs2358633	chr14:74647418	COQ6	chr14:74416643-74429811:+	-0.13	-3.55	0.000422	Common traits (Other)	
THCA	cis	1	rs2358633	chr14:74647418	LIN52	chr14:74551656-74667117:+	-0.51	-13.49	2.31E-35	Common traits (Other)	
THCA	cis	1	rs2359155	chr19:21671869	ZNF429	chr19:21688437-21739068:+	0.17	3.86	0.000128	Pain	
THCA	cis	1	rs2359821	chr19:22208314	ZNF257	chr19:22235266-22273901:+	0.33	6.74	4.6E-11	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs2360977	chr14:76654481	ESRRB	chr14:76837690-76968178:+	0.32	5.22	2.74E-7	Blood pressure	
THCA	cis	1	rs236104	chr20:5958960	MCM8	chr20:5931298-5975829:+	-0.31	-6.85	2.28E-11	HIV-1 viral setpoint	
THCA	cis	1	rs236114	chr20:5935385	CHGB	chr20:5891974-5906003:+	-0.26	-3.96	8.78E-5	Menopause (age at onset)	
THCA	cis	1	rs236121	chr20:5972594	MCM8	chr20:5931298-5975829:+	-0.32	-7.28	1.35E-12	HIV-1 viral setpoint	
THCA	cis	1	rs2362450	chr3:48461313	ATRIP	chr3:48488141-48507708:+	0.2	4.44	1.12E-5	Longevity	
THCA	cis	1	rs2362450	chr3:48461313	TREX1	chr3:48501186-48509043:+	-0.23	-5.46	7.77E-8	Longevity	
THCA	cis	1	rs2362450	chr3:48461313	ZNF589	chr3:48282596-48329113:+	0.16	3.51	0.000491	Longevity	
THCA	cis	1	rs2362452	chr3:48418214	ATRIP	chr3:48488141-48507708:+	-0.18	-4.03	6.45E-5	Longevity	
THCA	cis	1	rs2362452	chr3:48418214	TREX1	chr3:48501186-48509043:+	0.23	5.31	1.73E-7	Longevity	
THCA	cis	1	rs2362452	chr3:48418214	ZNF589	chr3:48282596-48329113:+	-0.16	-3.54	0.000436	Longevity	
THCA	cis	1	rs2362826	chr3:37203360	EPM2AIP1	chr3:37027358-37034795:-	0.13	3.82	0.000154	Cerebrospinal P-tau181p levels	
THCA	cis	1	rs2362826	chr3:37203360	LRRFIP2	chr3:37094117-37217851:-	0.51	14.12	4.37E-38	Cerebrospinal P-tau181p levels	
THCA	cis	1	rs2363286	chr7:1091625	ZFAND2A	chr7:1192544-1199855:-	-0.36	-5.23	2.51E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs2363731	chr2:88521793	KRCC1	chr2:88326724-88355248:-	-0.21	-3.37	0.000808	Plasma clusterin levels	
THCA	cis	1	rs2363731	chr2:88521793	THNSL2	chr2:88469835-88486145:+	-0.67	-8.64	8.4E-17	Plasma clusterin levels	
THCA	cis	1	rs2363736	chr11:71656967	FAM86C	chr11:71498557-71512276:+	0.31	3.89	0.000116	Severe influenza A (H1N1) infection	
THCA	cis	1	rs2363803	chr1:41637529	SCMH1	chr1:41492875-41707788:-	-0.2	-4.65	4.29E-6	Height	
THCA	cis	1	rs2364328	chr17:20939409	USP22	chr17:20902908-20947073:-	-0.18	-3.86	0.000128	Blood trace element (Se levels)	
THCA	cis	1	rs2364332	chr17:20909288	USP22	chr17:20902908-20947073:-	-0.18	-3.77	0.000184	Blood trace element (Se levels)	
THCA	cis	1	rs2364333	chr17:20909210	USP22	chr17:20902908-20947073:-	-0.18	-3.77	0.000184	Blood trace element (Se levels)	
THCA	cis	1	rs2364945	chr6:158286600	SNX9	chr6:158244294-158366109:+	-0.25	-3.89	0.000114	Lipoprotein (a) - cholesterol levels	
THCA	cis	1	rs2365468	chr17:65841318	C17orf58	chr17:65987218-65989765:-	0.25	5.06	5.99E-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs2365764	chr17:65857714	C17orf58	chr17:65987218-65989765:-	0.2	3.95	8.87E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs2367725	chr1:44215828	CCDC24	chr1:44457280-44462196:+	-0.1	-3.6	0.000352	Aging (time to event)	
THCA	cis	1	rs2367725	chr1:44215828	ST3GAL3	chr1:44171495-44396830:+	-0.16	-3.9	0.000111	Aging (time to event)	
THCA	cis	1	rs236918	chr11:117091609	PCSK7	chr11:117075789-117102811:-	0.33	5.67	2.49E-8	Protein quantitative trait loci	
THCA	cis	1	rs2370578	chr3:134199612	ANAPC13	chr3:134196547-134204865:-	0.39	12.44	5.93E-31	Height	
THCA	cis	1	rs2370578	chr3:134199612	CEP63	chr3:134204575-134293852:+	0.29	6.29	7.36E-10	Height	
THCA	cis	1	rs2370641	chr3:134222161	ANAPC13	chr3:134196547-134204865:-	0.39	12.55	2.02E-31	Height	
THCA	cis	1	rs2370641	chr3:134222161	CEP63	chr3:134204575-134293852:+	0.29	6.4	3.8E-10	Height	
THCA	cis	1	rs2370642	chr3:134222136	ANAPC13	chr3:134196547-134204865:-	0.4	12.83	1.41E-32	Height	
THCA	cis	1	rs2370642	chr3:134222136	CEP63	chr3:134204575-134293852:+	0.29	6.27	8.07E-10	Height	
THCA	cis	1	rs2371244	chr7:143757611	ARHGEF35	chr7:143883677-143892736:-	-0.5	-10.62	8.54E-24	Obesity-related traits	
THCA	cis	1	rs2371244	chr7:143757611	OR2A1	chr7:144015236-144016148:+;chr7	-0.19	-4.01	7.07E-5	Obesity-related traits	
THCA	cis	1	rs2371244	chr7:143757611	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-6.58	1.23E-10	Obesity-related traits	
THCA	cis	1	rs2371247	chr7:143764179	ARHGEF35	chr7:143883677-143892736:-	-0.5	-10.6	1.01E-23	Obesity-related traits	
THCA	cis	1	rs2371247	chr7:143764179	OR2A1	chr7:144015236-144016148:+;chr7	-0.19	-4.04	6.32E-5	Obesity-related traits	
THCA	cis	1	rs2371247	chr7:143764179	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-6.57	1.3E-10	Obesity-related traits	
THCA	cis	1	rs2371248	chr7:143764189	ARHGEF35	chr7:143883677-143892736:-	-0.5	-10.6	1.01E-23	Obesity-related traits	
THCA	cis	1	rs2371248	chr7:143764189	OR2A1	chr7:144015236-144016148:+;chr7	-0.19	-4.04	6.32E-5	Obesity-related traits	
THCA	cis	1	rs2371248	chr7:143764189	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-6.57	1.3E-10	Obesity-related traits	
THCA	cis	1	rs2371623	chr3:41761083	ULK4	chr3:41288091-42003660:-	1.06	19.75	6.57E-64	Diastolic blood pressure	
THCA	cis	1	rs2371627	chr3:41839219	ULK4	chr3:41288091-42003660:-	1.08	20.4	5.21E-67	Diastolic blood pressure	
THCA	cis	1	rs2373009	chr11:77945815	NARS2	chr11:78147017-78285909:-	-0.39	-6.74	4.69E-11	Testicular germ cell tumor	
THCA	cis	1	rs2373061	chr2:218289247	DIRC3	chr2:218148748-218621316:-	0.2	4.63	4.83E-6	Height	
THCA	cis	1	rs2373115	chr11:78091150	NARS2	chr11:78147017-78285909:-	-0.36	-6.71	5.52E-11	Testicular germ cell tumor	
THCA	cis	1	rs2373574	chr7:87340481	DBF4	chr7:87505544-87538856:+	-0.27	-3.76	0.000191	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs2373865	chr3:134291556	ANAPC13	chr3:134196547-134204865:-	-0.39	-12.33	1.64E-30	Height	
THCA	cis	1	rs2373865	chr3:134291556	CEP63	chr3:134204575-134293852:+	-0.31	-6.56	1.43E-10	Height	
THCA	cis	1	rs237711	chr20:47926856	DDX27	chr20:47835832-47860612:+	0.25	4.61	5.07E-6	Height	
THCA	cis	1	rs2377372	chr3:184946877	CHRD	chr3:184097861-184107619:+	0.13	3.44	0.000642	Cognitive performance	
THCA	cis	1	rs237741	chr20:47903680	DDX27	chr20:47835832-47860612:+	0.25	4.56	6.46E-6	Height	
THCA	cis	1	rs237743	chr20:47903019	DDX27	chr20:47835832-47860612:+	-0.26	-4.9	1.31E-6	Height	
THCA	cis	1	rs2377784	chr1:31860936	ZCCHC17	chr1:31769842-31837780:+	-0.3	-5.66	2.61E-8	Schizophrenia	
THCA	cis	1	rs2377785	chr1:31855683	ZCCHC17	chr1:31769842-31837780:+	-0.3	-5.82	1.09E-8	Schizophrenia	
THCA	cis	1	rs2378078	chr20:32714728	RALY	chr20:32581732-32672675:+	0.19	5.22	2.62E-7	Tanning;Skin sensitivity to sun;Red vs. non-red hair color;Freckles;Burning and freckling	
THCA	cis	1	rs2381284	chr4:39119596	KLHL5	chr4:39046659-39123828:+	-0.21	-5.77	1.47E-8	Uric acid levels	
THCA	cis	1	rs2381285	chr4:39114395	KLHL5	chr4:39046659-39123828:+	-0.21	-5.73	1.77E-8	Uric acid levels	
THCA	cis	1	rs238150	chr20:47851919	DDX27	chr20:47835832-47860612:+	0.26	4.84	1.79E-6	Height	
THCA	cis	1	rs238164	chr20:47844341	DDX27	chr20:47835832-47860612:+	0.25	4.71	3.23E-6	Height	
THCA	cis	1	rs238174	chr20:47879109	DDX27	chr20:47835832-47860612:+	0.25	4.6	5.31E-6	Height	
THCA	cis	1	rs238198	chr20:47899060	DDX27	chr20:47835832-47860612:+	0.25	4.6	5.31E-6	Height	
THCA	cis	1	rs238200	chr20:47899652	DDX27	chr20:47835832-47860612:+	0.24	4.42	1.2E-5	Height	
THCA	cis	1	rs238217	chr20:47871439	DDX27	chr20:47835832-47860612:+	0.25	4.6	5.31E-6	Height	
THCA	cis	1	rs238243	chr17:4849635	GP1BA	chr17:4835592-4838324:+	-0.22	-3.67	0.000266	Blood metabolite levels	
THCA	cis	1	rs238243	chr17:4849635	SLC25A11	chr17:4840605-4843325:-	-0.16	-4.3	2.1E-5	Blood metabolite levels	
THCA	cis	1	rs238245	chr17:4847443	SLC25A11	chr17:4840605-4843325:-	-0.15	-3.88	0.000119	Blood metabolite levels	
THCA	cis	1	rs238248	chr17:4844881	SLC25A11	chr17:4840605-4843325:-	-0.15	-4.03	6.46E-5	Blood metabolite levels	
THCA	cis	1	rs2384010	chr10:54349763	DKK1	chr10:54074041-54077416:+	-0.27	-4.96	9.88E-7	Metabolite levels  (X-11787)	
THCA	cis	1	rs2384207	chr12:113607502	C12orf52	chr12:113623555-113630119:+	-0.42	-8.09	5.13E-15	Response to fenofibrate (adiponectin levels)	
THCA	cis	1	rs2384321	chr2:26290054	GPR113	chr2:26531041-26569685:-	-0.47	-7.31	1.15E-12	Gut microbiome composition (summer)	
THCA	cis	1	rs2384321	chr2:26290054	HADHA	chr2:26413505-26467594:-	-0.17	-3.48	0.000549	Gut microbiome composition (summer)	
THCA	cis	1	rs2384322	chr2:26291146	GPR113	chr2:26531041-26569685:-	-0.47	-7.34	9.23E-13	Gut microbiome composition (summer)	
THCA	cis	1	rs2384322	chr2:26291146	HADHA	chr2:26413505-26467594:-	-0.17	-3.5	0.000503	Gut microbiome composition (summer)	
THCA	cis	1	rs2384323	chr2:26306473	GPR113	chr2:26531041-26569685:-	-0.44	-6.94	1.32E-11	Gut microbiome composition (summer)	
THCA	cis	1	rs2384654	chr2:27847364	FNDC4	chr2:27714751-27718126:-	-0.15	-3.4	0.000726	Oral cavity cancer	
THCA	cis	1	rs2385028	chr1:236035805	LYST	chr1:235824345-236046940:-	-0.32	-9.69	2.2E-20	Systemic lupus erythematosus	
THCA	cis	1	rs2387299	chr10:1163427	IDI2	chr10:1064847-1071799:-	0.39	3.99	7.52E-5	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs2387880	chr20:25377787	ENTPD6	chr20:25176339-25207360:+	0.32	7.23	1.88E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2387880	chr20:25377787	FAM182A	chr20:26035250-26067552:+	0.19	3.49	0.000536	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2387880	chr20:25377787	FAM182B	chr20:25744102-25848786:-	-0.26	-5.4	1.06E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2387880	chr20:25377787	NINL	chr20:25433338-25566153:-	0.33	6.9	1.7E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2387880	chr20:25377787	PYGB	chr20:25228706-25278647:+	0.16	4.03	6.5E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2387881	chr20:25378172	ENTPD6	chr20:25176339-25207360:+	0.29	6.5	1.97E-10	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2387881	chr20:25378172	FAM182B	chr20:25744102-25848786:-	-0.26	-5.47	7.19E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2387881	chr20:25378172	NINL	chr20:25433338-25566153:-	0.34	6.97	1.05E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2387881	chr20:25378172	PYGB	chr20:25228706-25278647:+	0.14	3.49	0.000529	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2387884	chr20:25379069	ENTPD6	chr20:25176339-25207360:+	0.32	7.23	1.88E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2387884	chr20:25379069	FAM182A	chr20:26035250-26067552:+	0.19	3.49	0.000536	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2387884	chr20:25379069	FAM182B	chr20:25744102-25848786:-	-0.26	-5.4	1.06E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2387884	chr20:25379069	NINL	chr20:25433338-25566153:-	0.33	6.9	1.7E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2387884	chr20:25379069	PYGB	chr20:25228706-25278647:+	0.16	4.03	6.5E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2389236	chr13:95971477	ABCC4	chr13:95672084-95953687:-	-0.15	-3.4	0.000721	Blood metabolite levels	
THCA	cis	1	rs2390847	chr7:23911701	C7orf46	chr7:23719749-23742268:+	0.13	3.91	0.000107	Schizophrenia	
THCA	cis	1	rs2393670	chr6:26535541	BTN2A3	chr6:26422317-26431927:+	0.19	4.52	7.72E-6	Educational attainment	
THCA	cis	1	rs2393670	chr6:26535541	HCG11	chr6:26521934-26527610:+	-0.23	-4.43	1.18E-5	Educational attainment	
THCA	cis	1	rs2393670	chr6:26535541	HMGN4	chr6:26538572-26547162:+	-0.16	-4.05	5.86E-5	Educational attainment	
THCA	cis	1	rs2393670	chr6:26535541	ZNF322A	chr6:26634612-26659963:-	-0.14	-3.77	0.000183	Educational attainment	
THCA	cis	1	rs2393969	chr10:65140440	NRBF2	chr10:64893007-64914785:+	-0.28	-6.71	5.6E-11	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2393980	chr10:65224510	LOC84989	chr10:65224989-65226320:+	0.27	4.29	2.17E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs2393980	chr10:65224510	NRBF2	chr10:64893007-64914785:+	0.26	4.37	1.5E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs2394724	chr10:72121606	NPFFR1	chr10:72014714-72026148:-	-0.39	-3.4	0.000742	Brain connectivity	
THCA	cis	1	rs2395077	chr10:75932001	VCL	chr10:75754951-75879912:+	-0.23	-4.03	6.45E-5	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs2395400	chr6:33770076	LEMD2	chr6:33738991-33756906:-	0.25	5.02	7.39E-7	Body mass index	
THCA	cis	1	rs2395449	chr6:33728755	LEMD2	chr6:33738991-33756906:-	-0.3	-6.67	6.94E-11	Crohn's disease	
THCA	cis	1	rs2396433	chr2:227772502	COL4A4	chr2:227867435-228029275:-	0.16	3.88	0.000117	Pulmonary function	
THCA	cis	1	rs2400795	chr5:101775339	SLCO4C1	chr5:101569694-101632253:-	-0.25	-5.69	2.28E-8	Schizophrenia	
THCA	cis	1	rs2400797	chr5:101781177	SLCO4C1	chr5:101569694-101632253:-	0.25	5.62	3.21E-8	Schizophrenia	
THCA	cis	1	rs2400798	chr5:101788155	SLCO4C1	chr5:101569694-101632253:-	0.25	5.57	4.29E-8	Schizophrenia	
THCA	cis	1	rs2400801	chr5:101728042	SLCO4C1	chr5:101569694-101632253:-	0.25	5.88	7.53E-9	Schizophrenia	
THCA	cis	1	rs2400865	chr12:81435638	ACSS3	chr12:81471809-81649582:+	0.22	4.67	4.01E-6	Neuroticism	
THCA	cis	1	rs2400866	chr12:81435788	ACSS3	chr12:81471809-81649582:+	0.22	4.67	4.01E-6	Neuroticism	
THCA	cis	1	rs2400979	chr12:82197353	PPFIA2	chr12:81652880-82153109:-	0.21	3.89	0.000115	Resting heart rate	
THCA	cis	1	rs2401004	chr12:82214822	PPFIA2	chr12:81652880-82153109:-	0.2	3.87	0.000124	Resting heart rate	
THCA	cis	1	rs2401172	chr15:84576957	LOC388152	chr15:84867600-84898920:-	-0.21	-3.98	7.86E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs2401173	chr15:84576970	LOC388152	chr15:84867600-84898920:-	-0.21	-3.98	7.86E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs2401174	chr15:84576992	LOC388152	chr15:84867600-84898920:-	-0.21	-3.98	7.86E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs2401175	chr15:84578217	LOC388152	chr15:84867600-84898920:-	0.21	3.98	7.86E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs2401176	chr15:84578364	LOC388152	chr15:84867600-84898920:-	-0.21	-3.98	7.86E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs2401179	chr15:84578948	LOC388152	chr15:84867600-84898920:-	-0.21	-3.98	7.86E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs2401180	chr15:84579186	LOC388152	chr15:84867600-84898920:-	-0.21	-3.98	7.86E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs2401195	chr21:44466887	PKNOX1	chr21:44394643-44453688:+	0.33	4.56	6.37E-6	Information processing speed	
THCA	cis	1	rs2402246	chr14:93596315	ITPK1	chr14:93403259-93582263:-	0.25	4.75	2.65E-6	Migraine;Thyroid hormone levels	
THCA	cis	1	rs2403015	chr14:102427560	RAGE	chr14:102690838-102771531:-	-0.14	-4.28	2.25E-5	Menopause (age at onset)	
THCA	cis	1	rs2403083	chr8:86108149	LRRCC1	chr8:86019377-86058312:+	0.36	8.89	1.24E-17	Plasma amyloid beta peptide concentrations (ABx-40)	
THCA	cis	1	rs2403205	chr14:104143385	KLC1	chr14:104029299-104167887:+	-0.22	-4.41	1.3E-5	Body mass index	
THCA	cis	1	rs2404602	chr15:77030792	SCAPER	chr15:76640529-77197744:-	-0.16	-5.32	1.59E-7	Blood metabolite levels	
THCA	cis	1	rs2404740	chr15:76852143	SCAPER	chr15:76640529-77197744:-	-0.17	-5.51	5.86E-8	Blood metabolite levels	
THCA	cis	1	rs2404741	chr15:76851735	SCAPER	chr15:76640529-77197744:-	-0.17	-5.51	5.86E-8	Blood metabolite levels	
THCA	cis	1	rs2409488	chr21:34688914	IFNAR1	chr21:34696734-34732126:+	0.22	5.35	1.39E-7	Narcolepsy	
THCA	cis	1	rs2411354	chr14:66062132	LOC645431	chr14:65877313-65879335:-	0.26	3.51	0.000487	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs2412459	chr15:40295959	SRP14	chr15:40327891-40331389:-	-0.18	-3.49	0.000528	Response to haloperidol in psychosis	
THCA	cis	1	rs2412488	chr4:54330867	SCFD2	chr4:53739152-54232242:-	0.2	3.77	0.000182	DNA methylation (variation)	
THCA	cis	1	rs2412770	chr4:57794660	C4orf14	chr4:57829517-57843826:-	-0.22	-4.04	6.28E-5	Response to bleomycin (chromatid breaks)	
THCA	cis	1	rs2413047	chr22:31666026	RNF185	chr22:31556138-31603004:+	-0.28	-5.08	5.4E-7	Paclitaxel-induced neuropathy	
THCA	cis	1	rs2413049	chr22:31686144	RNF185	chr22:31556138-31603004:+	-0.28	-5.22	2.7E-7	Paclitaxel-induced neuropathy	
THCA	cis	1	rs2413544	chr22:39059404	JOSD1	chr22:39081549-39096459:-	-0.15	-3.92	0.0001	Resting heart rate	
THCA	cis	1	rs2413544	chr22:39059404	TOMM22	chr22:39077954-39080763:+	-0.16	-3.57	0.000395	Resting heart rate	
THCA	cis	1	rs2413545	chr22:39092524	JOSD1	chr22:39081549-39096459:-	-0.14	-3.6	0.000355	Resting heart rate	
THCA	cis	1	rs2413545	chr22:39092524	LOC646851	chr22:38974125-39052634:-	0.14	3.67	0.00027	Resting heart rate	
THCA	cis	1	rs2413546	chr22:39107001	JOSD1	chr22:39081549-39096459:-	-0.15	-3.91	0.000105	Resting heart rate	
THCA	cis	1	rs2413546	chr22:39107001	TOMM22	chr22:39077954-39080763:+	-0.17	-3.61	0.000339	Resting heart rate	
THCA	cis	1	rs2413547	chr22:39107338	JOSD1	chr22:39081549-39096459:-	-0.15	-3.91	0.000105	Resting heart rate	
THCA	cis	1	rs2413547	chr22:39107338	TOMM22	chr22:39077954-39080763:+	-0.17	-3.61	0.000339	Resting heart rate	
THCA	cis	1	rs2413748	chr22:43530982	BIK	chr22:43506757-43525717:+	-0.38	-6.43	3.03E-10	Prostate cancer	
THCA	cis	1	rs2414060	chr15:50873262	SPPL2A	chr15:50999739-51057910:-	0.27	7.38	6.84E-13	QT interval	
THCA	cis	1	rs2414465	chr15:56505714	MNS1	chr15:56720929-56757335:-	-0.23	-3.41	0.000699	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs2414465	chr15:56505714	TEX9	chr15:56657644-56738071:+	-0.34	-5.84	9.5E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs2414467	chr15:56527163	MNS1	chr15:56720929-56757335:-	-0.25	-3.73	0.000211	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs2414467	chr15:56527163	TEX9	chr15:56657644-56738071:+	-0.34	-5.96	5.03E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs2414468	chr15:56527277	MNS1	chr15:56720929-56757335:-	-0.24	-3.46	0.000596	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs2414468	chr15:56527277	TEX9	chr15:56657644-56738071:+	-0.34	-5.86	8.66E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs2414471	chr15:56534504	MNS1	chr15:56720929-56757335:-	-0.25	-3.61	0.000342	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs2414471	chr15:56534504	TEX9	chr15:56657644-56738071:+	-0.35	-5.91	6.62E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs2414472	chr15:56534724	MNS1	chr15:56720929-56757335:-	-0.25	-3.61	0.000342	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs2414472	chr15:56534724	TEX9	chr15:56657644-56738071:+	-0.35	-5.91	6.62E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs2414884	chr15:66075872	DPP8	chr15:65737999-65810035:-	-0.1	-3.99	7.73E-5	Mean corpuscular hemoglobin	
THCA	cis	1	rs2414884	chr15:66075872	SLC24A1	chr15:65903704-65953256:+	-0.15	-3.62	0.000326	Mean corpuscular hemoglobin	
THCA	cis	1	rs2414885	chr15:66034624	DPP8	chr15:65737999-65810035:-	-0.1	-3.99	7.63E-5	Mean corpuscular hemoglobin	
THCA	cis	1	rs2414885	chr15:66034624	SLC24A1	chr15:65903704-65953256:+	-0.16	-3.82	0.000151	Mean corpuscular hemoglobin	
THCA	cis	1	rs2415253	chr15:75375699	ARID3B	chr15:74833548-74890470:+	-0.16	-4.22	2.98E-5	Blood trace element (Zn levels)	
THCA	cis	1	rs2415253	chr15:75375699	PPCDC	chr15:75315927-75343066:+	0.15	4.28	2.28E-5	Blood trace element (Zn levels)	
THCA	cis	1	rs2415253	chr15:75375699	SCAMP5	chr15:75287901-75313836:+	0.43	7.55	2.19E-13	Blood trace element (Zn levels)	
THCA	cis	1	rs2416257	chr5:110435490	TSLP	chr5:110405778-110413722:+	-0.35	-4.48	9.5E-6	Eosinophil counts	
THCA	cis	1	rs2416257	chr5:110435490	WDR36	chr5:110427870-110466201:+	0.2	3.63	0.000316	Eosinophil counts	
THCA	cis	1	rs2416935	chr9:102669557	STX17	chr9:102668915-102736817:+	-0.14	-3.51	0.000495	Alopecia areata	
THCA	cis	1	rs2416937	chr9:102680637	STX17	chr9:102668915-102736817:+	-0.17	-4.29	2.17E-5	Alopecia areata	
THCA	cis	1	rs2416942	chr9:102706489	STX17	chr9:102668915-102736817:+	-0.17	-4.33	1.86E-5	Alopecia areata	
THCA	cis	1	rs2417577	chr9:100701446	C9orf156	chr9:100666772-100684852:-	-0.14	-3.71	0.000228	Quantitative traits	
THCA	cis	1	rs241768	chr6:111492119	KIAA1919	chr6:111580482-111590259:+	-0.26	-5.49	6.38E-8	Blood metabolite levels;Amino acid levels	
THCA	cis	1	rs2420168	chr7:65630631	ASL	chr7:65540776-65558321:+	0.16	4.28	2.23E-5	Aortic root size	
THCA	cis	1	rs2420168	chr7:65630631	GUSB	chr7:65425675-65447246:-	-0.27	-5.32	1.61E-7	Aortic root size	
THCA	cis	1	rs2420168	chr7:65630631	LOC729156	chr7:66274980-66309813:-	-0.16	-3.47	0.000572	Aortic root size	
THCA	cis	1	rs2420168	chr7:65630631	RABGEF1	chr7:66093890-66276446:+	-0.66	-14.15	3.08E-38	Aortic root size	
THCA	cis	1	rs2420170	chr7:65656053	CCT6P1	chr7:65216092-65228661:+	-0.42	-6.79	3.36E-11	Diabetic kidney disease	
THCA	cis	1	rs2420170	chr7:65656053	CRCP	chr7:65579805-65619551:+	0.29	4.56	6.49E-6	Diabetic kidney disease	
THCA	cis	1	rs2420170	chr7:65656053	RABGEF1	chr7:66093890-66276446:+	-0.56	-6.99	9.07E-12	Diabetic kidney disease	
THCA	cis	1	rs2420171	chr7:65637760	CCT6P1	chr7:65216092-65228661:+	-0.42	-6.74	4.63E-11	Diabetic kidney disease	
THCA	cis	1	rs2420171	chr7:65637760	CRCP	chr7:65579805-65619551:+	0.3	4.62	4.83E-6	Diabetic kidney disease	
THCA	cis	1	rs2420171	chr7:65637760	LOC493754	chr7:65993446-66057363:-	-0.3	-3.47	0.000562	Diabetic kidney disease	
THCA	cis	1	rs2420171	chr7:65637760	RABGEF1	chr7:66093890-66276446:+	-0.57	-7.12	3.88E-12	Diabetic kidney disease	
THCA	cis	1	rs2420591	chr7:65912381	ASL	chr7:65540776-65558321:+	-0.16	-4.22	2.97E-5	Aortic root size	
THCA	cis	1	rs2420591	chr7:65912381	GUSB	chr7:65425675-65447246:-	0.27	5.25	2.25E-7	Aortic root size	
THCA	cis	1	rs2420591	chr7:65912381	RABGEF1	chr7:66093890-66276446:+	0.65	14.06	8.35E-38	Aortic root size	
THCA	cis	1	rs2420820	chr7:66091907	ASL	chr7:65540776-65558321:+	0.14	3.61	0.000333	Aortic root size	
THCA	cis	1	rs2420820	chr7:66091907	GUSB	chr7:65425675-65447246:-	-0.26	-5.11	4.72E-7	Aortic root size	
THCA	cis	1	rs2420820	chr7:66091907	LOC729156	chr7:66274980-66309813:-	-0.16	-3.48	0.000541	Aortic root size	
THCA	cis	1	rs2420820	chr7:66091907	RABGEF1	chr7:66093890-66276446:+	-0.69	-15.24	4.81E-43	Aortic root size	
THCA	cis	1	rs2420824	chr7:66131116	GUSB	chr7:65425675-65447246:-	-0.33	-6.69	6.3E-11	Aortic root size	
THCA	cis	1	rs2420824	chr7:66131116	RABGEF1	chr7:66093890-66276446:+	-0.49	-9.96	2.4E-21	Aortic root size	
THCA	cis	1	rs2420824	chr7:66131116	TYW1	chr7:66461817-66704496:+	-0.2	-4.31	2.02E-5	Aortic root size	
THCA	cis	1	rs2421016	chr10:124167512	PLEKHA1	chr10:124134220-124191866:+	-0.22	-6.18	1.4E-9	Height	
THCA	cis	1	rs2421017	chr10:124148167	PLEKHA1	chr10:124134220-124191866:+	-0.18	-5.07	5.69E-7	Height	
THCA	cis	1	rs2421021	chr10:124157046	PLEKHA1	chr10:124134220-124191866:+	-0.21	-5.8	1.22E-8	Height	
THCA	cis	1	rs2421143	chr10:124737546	C10orf88	chr10:124690419-124713919:-	-0.22	-4.08	5.37E-5	Migraine without aura	
THCA	cis	1	rs2421144	chr10:124733066	C10orf88	chr10:124690419-124713919:-	-0.22	-4.04	6.23E-5	Migraine without aura	
THCA	cis	1	rs2421145	chr10:124730565	C10orf88	chr10:124690419-124713919:-	-0.22	-4.07	5.44E-5	Migraine without aura	
THCA	cis	1	rs2421146	chr10:124730505	C10orf88	chr10:124690419-124713919:-	0.22	4.03	6.49E-5	Migraine without aura	
THCA	cis	1	rs2421147	chr10:124730432	C10orf88	chr10:124690419-124713919:-	-0.22	-4.06	5.67E-5	Migraine without aura	
THCA	cis	1	rs2421148	chr10:124728874	C10orf88	chr10:124690419-124713919:-	-0.23	-4.16	3.77E-5	Migraine without aura	
THCA	cis	1	rs2421155	chr10:124725481	C10orf88	chr10:124690419-124713919:-	-0.23	-4.22	2.9E-5	Migraine without aura	
THCA	cis	1	rs2421158	chr10:124721098	C10orf88	chr10:124690419-124713919:-	-0.23	-4.22	2.97E-5	Migraine without aura	
THCA	cis	1	rs2421332	chr2:61876965	C2orf74	chr2:61372243-61391964:+	-0.26	-4.26	2.48E-5	Homeostasis model assessment of beta-cell function (interaction)	
THCA	cis	1	rs2421555	chr2:73816955	ALMS1P	chr2:73872046-73912692:+	0.7	11.17	6.72E-26	Metabolite levels	
THCA	cis	1	rs2421555	chr2:73816955	NAT8	chr2:73867850-73869537:-	0.39	6.19	1.32E-9	Metabolite levels	
THCA	cis	1	rs2421555	chr2:73816955	TPRKB	chr2:73956957-73964517:-	-0.17	-4.27	2.35E-5	Metabolite levels	
THCA	cis	1	rs242271	chr6:88082029	C6orf162	chr6:88032306-88052043:+	-0.16	-3.58	0.000374	Depressive episodes in bipolar disorder	
THCA	cis	1	rs242271	chr6:88082029	C6orf164	chr6:88032306-88109459:+	-0.33	-6.33	5.77E-10	Depressive episodes in bipolar disorder	
THCA	cis	1	rs242271	chr6:88082029	SLC35A1	chr6:88146444-88222051:+	0.17	3.45	0.000608	Depressive episodes in bipolar disorder	
THCA	cis	1	rs2424700	chr20:25266513	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2424700	chr20:25266513	FAM182A	chr20:26035250-26067552:+	-0.18	-3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2424700	chr20:25266513	FAM182B	chr20:25744102-25848786:-	0.27	5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2424700	chr20:25266513	NINL	chr20:25433338-25566153:-	-0.35	-7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2424700	chr20:25266513	PYGB	chr20:25228706-25278647:+	-0.16	-4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2424704	chr20:25273929	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.96	1.11E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2424704	chr20:25273929	FAM182A	chr20:26035250-26067552:+	-0.19	-3.49	0.000533	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2424704	chr20:25273929	FAM182B	chr20:25744102-25848786:-	0.27	5.65	2.82E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2424704	chr20:25273929	NINL	chr20:25433338-25566153:-	-0.35	-7.19	2.43E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2424704	chr20:25273929	PYGB	chr20:25228706-25278647:+	-0.16	-4.13	4.34E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2424710	chr20:25283886	ENTPD6	chr20:25176339-25207360:+	-0.31	-7.15	3.38E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2424710	chr20:25283886	FAM182A	chr20:26035250-26067552:+	-0.19	-3.45	0.000609	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2424710	chr20:25283886	FAM182B	chr20:25744102-25848786:-	0.25	5.29	1.9E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2424710	chr20:25283886	NINL	chr20:25433338-25566153:-	-0.36	-7.49	3.3E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2424710	chr20:25283886	PYGB	chr20:25228706-25278647:+	-0.15	-3.74	0.000202	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2424712	chr20:25416942	ENTPD6	chr20:25176339-25207360:+	-0.32	-7.43	5.05E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2424712	chr20:25416942	FAM182A	chr20:26035250-26067552:+	-0.18	-3.44	0.000635	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2424712	chr20:25416942	FAM182B	chr20:25744102-25848786:-	0.25	5.25	2.3E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2424712	chr20:25416942	NINL	chr20:25433338-25566153:-	-0.34	-7.11	4.29E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2424712	chr20:25416942	PYGB	chr20:25228706-25278647:+	-0.15	-3.78	0.000174	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2424713	chr20:25418482	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.82	2.83E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2424713	chr20:25418482	FAM182A	chr20:26035250-26067552:+	-0.19	-3.4	0.00072	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2424713	chr20:25418482	FAM182B	chr20:25744102-25848786:-	0.25	5.09	5.15E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2424713	chr20:25418482	NINL	chr20:25433338-25566153:-	-0.37	-7.6	1.55E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2424716	chr20:25423538	ENTPD6	chr20:25176339-25207360:+	-0.3	-6.79	3.31E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2424716	chr20:25423538	FAM182A	chr20:26035250-26067552:+	-0.18	-3.4	0.000729	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2424716	chr20:25423538	FAM182B	chr20:25744102-25848786:-	0.25	5.23	2.5E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2424716	chr20:25423538	NINL	chr20:25433338-25566153:-	-0.36	-7.3	1.18E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2424900	chr20:31344342	MAPRE1	chr20:31407699-31438210:+	0.18	4.22	2.93E-5	Ulcerative colitis	
THCA	cis	1	rs2424901	chr20:31344512	MAPRE1	chr20:31407699-31438210:+	0.18	4.22	2.93E-5	Ulcerative colitis	
THCA	cis	1	rs2425027	chr20:33849390	CPNE1	chr20:34213968-34262539:-	-0.35	-4.72	3.09E-6	Attention deficit hyperactivity disorder	
THCA	cis	1	rs2425027	chr20:33849390	MMP24	chr20:33814539-33864804:+	-0.21	-3.5	0.000501	Attention deficit hyperactivity disorder	
THCA	cis	1	rs2425031	chr20:33855284	CPNE1	chr20:34213968-34262539:-	-0.35	-4.83	1.84E-6	Attention deficit hyperactivity disorder	
THCA	cis	1	rs2425031	chr20:33855284	MMP24	chr20:33814539-33864804:+	-0.19	-3.36	0.000844	Attention deficit hyperactivity disorder	
THCA	cis	1	rs2425032	chr20:33855454	CPNE1	chr20:34213968-34262539:-	-0.32	-4.38	1.46E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs2425032	chr20:33855454	MMP24	chr20:33814539-33864804:+	-0.2	-3.5	0.000515	Attention deficit hyperactivity disorder	
THCA	cis	1	rs2425034	chr20:33855814	CPNE1	chr20:34213968-34262539:-	-0.34	-4.78	2.37E-6	Attention deficit hyperactivity disorder	
THCA	cis	1	rs2425034	chr20:33855814	MMP24	chr20:33814539-33864804:+	-0.2	-3.57	0.000397	Attention deficit hyperactivity disorder	
THCA	cis	1	rs2425036	chr20:33855981	CPNE1	chr20:34213968-34262539:-	-0.34	-4.75	2.65E-6	Attention deficit hyperactivity disorder	
THCA	cis	1	rs2425036	chr20:33855981	MMP24	chr20:33814539-33864804:+	-0.2	-3.56	0.000401	Attention deficit hyperactivity disorder	
THCA	cis	1	rs2425037	chr20:33856429	CPNE1	chr20:34213968-34262539:-	0.34	4.73	2.98E-6	Attention deficit hyperactivity disorder	
THCA	cis	1	rs2425037	chr20:33856429	MMP24	chr20:33814539-33864804:+	0.19	3.41	0.000714	Attention deficit hyperactivity disorder	
THCA	cis	1	rs2425040	chr20:33858878	CPNE1	chr20:34213968-34262539:-	-0.34	-4.65	4.33E-6	Attention deficit hyperactivity disorder	
THCA	cis	1	rs2425040	chr20:33858878	MMP24	chr20:33814539-33864804:+	-0.21	-3.64	0.000298	Attention deficit hyperactivity disorder	
THCA	cis	1	rs2425041	chr20:33859013	CPNE1	chr20:34213968-34262539:-	-0.35	-4.65	4.31E-6	Attention deficit hyperactivity disorder	
THCA	cis	1	rs2425041	chr20:33859013	MMP24	chr20:33814539-33864804:+	-0.21	-3.56	0.000409	Attention deficit hyperactivity disorder	
THCA	cis	1	rs2425065	chr20:33926268	CEP250	chr20:34042996-34099802:+	0.15	3.37	0.000804	Height	
THCA	cis	1	rs2425065	chr20:33926268	CPNE1	chr20:34213968-34262539:-	-0.3	-5.95	5.17E-9	Height	
THCA	cis	1	rs2425065	chr20:33926268	GDF5	chr20:33897002-34042568:-	0.18	3.81	0.000154	Height	
THCA	cis	1	rs2425065	chr20:33926268	UQCC	chr20:33890383-33999833:-	-0.32	-10.23	2.48E-22	Height	
THCA	cis	1	rs2425066	chr20:33927006	CEP250	chr20:34042996-34099802:+	0.15	3.36	0.000835	Height	
THCA	cis	1	rs2425066	chr20:33927006	CPNE1	chr20:34213968-34262539:-	-0.3	-5.91	6.56E-9	Height	
THCA	cis	1	rs2425066	chr20:33927006	GDF5	chr20:33897002-34042568:-	0.16	3.53	0.000451	Height	
THCA	cis	1	rs2425066	chr20:33927006	UQCC	chr20:33890383-33999833:-	-0.32	-10.29	1.5E-22	Height	
THCA	cis	1	rs2425697	chr20:44025175	ZNF335	chr20:44577293-44600833:-	-0.15	-3.47	0.00056	Psoriasis	
THCA	cis	1	rs2426106	chr20:47639464	ARFGEF2	chr20:47538275-47653229:+	0.13	4.06	5.77E-5	Anger	
THCA	cis	1	rs2426106	chr20:47639464	CSE1L	chr20:47662838-47713484:+	-0.41	-10.17	4.16E-22	Anger	
THCA	cis	1	rs2426109	chr20:47662627	ARFGEF2	chr20:47538275-47653229:+	0.13	4.18	3.46E-5	Anger	
THCA	cis	1	rs2426109	chr20:47662627	CSE1L	chr20:47662838-47713484:+	-0.42	-10.3	1.38E-22	Anger	
THCA	cis	1	rs2426112	chr20:47690139	ARFGEF2	chr20:47538275-47653229:+	0.12	3.96	8.79E-5	Anger	
THCA	cis	1	rs2426112	chr20:47690139	CSE1L	chr20:47662838-47713484:+	-0.41	-10.21	2.82E-22	Anger	
THCA	cis	1	rs2426113	chr20:47690189	ARFGEF2	chr20:47538275-47653229:+	0.12	3.96	8.79E-5	Anger	
THCA	cis	1	rs2426113	chr20:47690189	CSE1L	chr20:47662838-47713484:+	-0.41	-10.21	2.82E-22	Anger	
THCA	cis	1	rs2426116	chr20:47693047	ARFGEF2	chr20:47538275-47653229:+	0.12	3.92	0.000102	Anger	
THCA	cis	1	rs2426116	chr20:47693047	CSE1L	chr20:47662838-47713484:+	-0.41	-10.23	2.48E-22	Anger	
THCA	cis	1	rs2429024	chr10:70740573	KIAA1279	chr10:70748493-70776734:+	-0.15	-3.57	0.000395	Schizophrenia	
THCA	cis	1	rs2429030	chr10:70751673	KIAA1279	chr10:70748493-70776734:+	-0.15	-3.46	0.000591	Schizophrenia	
THCA	cis	1	rs2429031	chr10:70755877	KIAA1279	chr10:70748493-70776734:+	-0.14	-3.41	0.000702	Schizophrenia	
THCA	cis	1	rs2430494	chr2:37463620	CEBPZ	chr2:37428778-37458740:-	-0.2	-4.28	2.31E-5	Chronic lymphocytic leukemia	
THCA	cis	1	rs2431349	chr5:75921330	F2RL2	chr5:75911308-75919240:-	-0.26	-5.82	1.07E-8	Hearing impairment	
THCA	cis	1	rs2432195	chr5:56120413	C5orf35	chr5:56205103-56213010:+	1.02	23.8	3.7E-83	Type 2 diabetes	
THCA	cis	1	rs2434422	chr19:52787471	ZNF836	chr19:52658127-52674896:-	0.29	4.07	5.45E-5	Cannabis use (initiation)	
THCA	cis	1	rs2435356	chr10:43583150	CSGALNACT2	chr10:43633934-43680747:+	0.15	4.79	2.25E-6	Hirschsprung disease	
THCA	cis	1	rs2435357	chr10:43582056	CSGALNACT2	chr10:43633934-43680747:+	-0.16	-5.31	1.71E-7	Hirschsprung disease	
THCA	cis	1	rs2435362	chr10:43578779	CSGALNACT2	chr10:43633934-43680747:+	-0.16	-5.13	4.31E-7	Hirschsprung disease	
THCA	cis	1	rs244286	chr17:53232594	COX11	chr17:53029259-53046064:-	-0.2	-4.97	9.37E-7	Menarche (age at onset)	
THCA	cis	1	rs244288	chr17:53231841	COX11	chr17:53029259-53046064:-	-0.2	-4.97	9.37E-7	Menarche (age at onset)	
THCA	cis	1	rs244289	chr17:53231788	COX11	chr17:53029259-53046064:-	-0.2	-4.97	9.37E-7	Menarche (age at onset)	
THCA	cis	1	rs244291	chr17:53231137	COX11	chr17:53029259-53046064:-	-0.19	-4.82	1.95E-6	Menarche (age at onset)	
THCA	cis	1	rs244292	chr17:53230734	COX11	chr17:53029259-53046064:-	-0.2	-4.97	9.37E-7	Menarche (age at onset)	
THCA	cis	1	rs244293	chr17:53230722	COX11	chr17:53029259-53046064:-	-0.19	-4.78	2.29E-6	Menarche (age at onset)	
THCA	cis	1	rs244295	chr17:53242899	COX11	chr17:53029259-53046064:-	-0.2	-4.87	1.5E-6	Menarche (age at onset)	
THCA	cis	1	rs244296	chr17:53242878	COX11	chr17:53029259-53046064:-	-0.2	-4.82	1.92E-6	Menarche (age at onset)	
THCA	cis	1	rs244299	chr17:53240266	COX11	chr17:53029259-53046064:-	0.19	4.74	2.85E-6	Menarche (age at onset)	
THCA	cis	1	rs244316	chr17:53215223	COX11	chr17:53029259-53046064:-	-0.21	-5.11	4.72E-7	Menarche (age at onset)	
THCA	cis	1	rs2444240	chr11:120040442	TRIM29	chr11:119981995-120008863:-	-0.14	-3.38	0.000777	Corneal curvature	
THCA	cis	1	rs2447196	chr15:43893818	ADAL	chr15:43622872-43646094:+	0.42	9.27	6.62E-19	Tumor biomarkers	
THCA	cis	1	rs2447196	chr15:43893818	CATSPER2	chr15:43922774-43959900:-	0.29	5.09	5.08E-7	Tumor biomarkers	
THCA	cis	1	rs2447196	chr15:43893818	STRC	chr15:43891762-43924561:-	-0.4	-7.49	3.34E-13	Tumor biomarkers	
THCA	cis	1	rs2447196	chr15:43893818	TUBGCP4	chr15:43663313-43698238:+	-0.13	-3.72	0.000225	Tumor biomarkers	
THCA	cis	1	rs2447208	chr15:43933895	ADAL	chr15:43622872-43646094:+	-0.41	-8.87	1.49E-17	Tumor biomarkers	
THCA	cis	1	rs2447208	chr15:43933895	CATSPER2	chr15:43922774-43959900:-	-0.31	-5.49	6.67E-8	Tumor biomarkers	
THCA	cis	1	rs2447208	chr15:43933895	STRC	chr15:43891762-43924561:-	0.41	7.57	2.0E-13	Tumor biomarkers	
THCA	cis	1	rs2447208	chr15:43933895	TUBGCP4	chr15:43663313-43698238:+	0.12	3.47	0.000561	Tumor biomarkers	
THCA	cis	1	rs2447211	chr15:43936351	ADAL	chr15:43622872-43646094:+	-0.42	-9.24	8.3E-19	Tumor biomarkers	
THCA	cis	1	rs2447211	chr15:43936351	CATSPER2	chr15:43922774-43959900:-	-0.31	-5.52	5.51E-8	Tumor biomarkers	
THCA	cis	1	rs2447211	chr15:43936351	STRC	chr15:43891762-43924561:-	0.42	7.7	7.69E-14	Tumor biomarkers	
THCA	cis	1	rs2447211	chr15:43936351	TUBGCP4	chr15:43663313-43698238:+	0.13	3.72	0.000222	Tumor biomarkers	
THCA	cis	1	rs2447820	chr5:122264736	PPIC	chr5:122359080-122372425:-	0.18	3.79	0.000173	Migraine	
THCA	cis	1	rs2448704	chr6:49453672	CENPQ	chr6:49431096-49460820:+	0.33	7.1	4.62E-12	Homocysteine levels	
THCA	cis	1	rs2448707	chr6:49446951	CENPQ	chr6:49431096-49460820:+	0.27	5.52	5.46E-8	Folate pathway vitamin levels	
THCA	cis	1	rs2448707	chr6:49446951	MUT	chr6:49398994-49431031:-	-0.28	-9.69	2.1E-20	Folate pathway vitamin levels	
THCA	cis	1	rs244899	chr5:167911040	FBLL1	chr5:167956582-167957638:+	0.48	8.85	1.66E-17	Response to platinum-based chemotherapy (carboplatin)	
THCA	cis	1	rs2450122	chr11:77930345	NARS2	chr11:78147017-78285909:-	-0.39	-7.02	7.74E-12	Testicular germ cell tumor	
THCA	cis	1	rs2450123	chr11:77952771	NARS2	chr11:78147017-78285909:-	-0.38	-6.64	8.3E-11	Testicular germ cell tumor	
THCA	cis	1	rs2450128	chr11:77940075	NARS2	chr11:78147017-78285909:-	-0.41	-7.68	8.99E-14	Testicular germ cell tumor	
THCA	cis	1	rs2450129	chr11:77940385	NARS2	chr11:78147017-78285909:-	-0.4	-7.32	1.07E-12	Testicular germ cell tumor	
THCA	cis	1	rs2450131	chr11:77944568	NARS2	chr11:78147017-78285909:-	-0.39	-6.89	1.77E-11	Testicular germ cell tumor	
THCA	cis	1	rs2455219	chr5:75922581	F2RL2	chr5:75911308-75919240:-	-0.26	-5.98	4.37E-9	Hearing impairment	
THCA	cis	1	rs2455331	chr5:643593	CEP72	chr5:612405-653664:+	-0.39	-7.58	1.83E-13	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs2455601	chr11:8899400	TMEM9B	chr11:8968840-8986481:-	-0.22	-4.44	1.13E-5	Schizophrenia	
THCA	cis	1	rs2456009	chr15:65840082	DPP8	chr15:65737999-65810035:-	0.09	3.79	0.000168	Mean corpuscular hemoglobin	
THCA	cis	1	rs2456009	chr15:65840082	SLC24A1	chr15:65903704-65953256:+	0.16	3.87	0.000126	Mean corpuscular hemoglobin	
THCA	cis	1	rs2460047	chr11:93678936	HEPHL1	chr11:93754378-93847374:+	-0.37	-3.57	0.000398	Obesity-related traits	
THCA	cis	1	rs2460065	chr11:93733538	HEPHL1	chr11:93754378-93847374:+	-0.4	-3.39	0.000745	Obesity-related traits	
THCA	cis	1	rs2460254	chr11:71570110	FAM86C	chr11:71498557-71512276:+	-0.39	-4.71	3.3E-6	Severe influenza A (H1N1) infection	
THCA	cis	1	rs2460346	chr8:12835986	C8orf79	chr8:12803151-12889011:+	0.17	3.5	0.000507	Post-traumatic stress disorder	
THCA	cis	1	rs2460347	chr8:12834706	C8orf79	chr8:12803151-12889011:+	0.16	3.37	0.000815	Post-traumatic stress disorder	
THCA	cis	1	rs2460422	chr7:65601505	CCT6P1	chr7:65216092-65228661:+	0.42	6.7	5.9E-11	Diabetic kidney disease	
THCA	cis	1	rs2460422	chr7:65601505	CRCP	chr7:65579805-65619551:+	-0.3	-4.63	4.66E-6	Diabetic kidney disease	
THCA	cis	1	rs2460422	chr7:65601505	LOC493754	chr7:65993446-66057363:-	0.29	3.36	0.000833	Diabetic kidney disease	
THCA	cis	1	rs2460422	chr7:65601505	RABGEF1	chr7:66093890-66276446:+	0.57	7.14	3.42E-12	Diabetic kidney disease	
THCA	cis	1	rs2460763	chr12:64979800	RASSF3	chr12:65004293-65089190:+	-0.12	-3.7	0.000237	Resting heart rate	
THCA	cis	1	rs2460882	chr12:53787953	PCBP2	chr12:53835433-53874945:+	-0.2	-3.48	0.000538	Percentage gas trapping	
THCA	cis	1	rs2460882	chr12:53787953	PRR13	chr12:53835433-53840426:+	-0.44	-8.33	8.76E-16	Percentage gas trapping	
THCA	cis	1	rs2462569	chr7:65474846	CCT6P1	chr7:65216092-65228661:+	-0.39	-6.33	5.81E-10	Diabetic kidney disease	
THCA	cis	1	rs2462569	chr7:65474846	CRCP	chr7:65579805-65619551:+	0.28	4.37	1.53E-5	Diabetic kidney disease	
THCA	cis	1	rs2462569	chr7:65474846	RABGEF1	chr7:66093890-66276446:+	-0.53	-6.64	8.5E-11	Diabetic kidney disease	
THCA	cis	1	rs2462735	chr11:93732558	HEPHL1	chr11:93754378-93847374:+	-0.43	-3.54	0.000432	Obesity-related traits	
THCA	cis	1	rs246454	chr5:96123264	CAST	chr5:95997777-96115291:+	-0.11	-4.09	5.11E-5	Ankylosing spondylitis	
THCA	cis	1	rs246454	chr5:96123264	ERAP1	chr5:96096515-96149837:-	-0.39	-11.58	1.64E-27	Ankylosing spondylitis	
THCA	cis	1	rs246454	chr5:96123264	ERAP2	chr5:96211644-96255398:+	0.53	9.43	1.82E-19	Ankylosing spondylitis	
THCA	cis	1	rs2465120	chr7:65620974	CCT6P1	chr7:65216092-65228661:+	0.42	6.7	5.9E-11	Diabetic kidney disease	
THCA	cis	1	rs2465120	chr7:65620974	CRCP	chr7:65579805-65619551:+	-0.3	-4.63	4.66E-6	Diabetic kidney disease	
THCA	cis	1	rs2465120	chr7:65620974	LOC493754	chr7:65993446-66057363:-	0.29	3.36	0.000833	Diabetic kidney disease	
THCA	cis	1	rs2465120	chr7:65620974	RABGEF1	chr7:66093890-66276446:+	0.57	7.14	3.42E-12	Diabetic kidney disease	
THCA	cis	1	rs2466067	chr8:32437994	NRG1	chr8:31497268-32622558:+	-0.31	-5.51	5.96E-8	Serum thyroid-stimulating hormone levels	
THCA	cis	1	rs2466096	chr8:32430732	NRG1	chr8:31497268-32622558:+	-0.62	-10.3	1.32E-22	Thyroid hormone levels	
THCA	cis	1	rs2466104	chr8:32410712	NRG1	chr8:31497268-32622558:+	0.42	6.11	2.09E-9	Emphysema imaging phenotypes;Post bronchodilator FEV1/FVC ratio in COPD	
THCA	cis	1	rs2466128	chr10:65208321	LOC84989	chr10:65224989-65226320:+	0.26	4.13	4.36E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs2466128	chr10:65208321	NRBF2	chr10:64893007-64914785:+	0.27	4.46	1.02E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs2466255	chr8:12834573	C8orf79	chr8:12803151-12889011:+	0.16	3.37	0.000815	Post-traumatic stress disorder	
THCA	cis	1	rs2468964	chr8:38333062	TM2D2	chr8:38846328-38854041:-	0.11	3.41	0.000706	Response to cognitive-behavioural therapy in anxiety disorder	
THCA	cis	1	rs2470134	chr15:43849886	ADAL	chr15:43622872-43646094:+	0.44	9.25	7.76E-19	Tumor biomarkers	
THCA	cis	1	rs2470134	chr15:43849886	CATSPER2	chr15:43922774-43959900:-	0.3	5.08	5.38E-7	Tumor biomarkers	
THCA	cis	1	rs2470134	chr15:43849886	STRC	chr15:43891762-43924561:-	-0.38	-6.8	3.06E-11	Tumor biomarkers	
THCA	cis	1	rs2470134	chr15:43849886	TUBGCP4	chr15:43663313-43698238:+	-0.14	-3.76	0.00019	Tumor biomarkers	
THCA	cis	1	rs2471851	chr11:113301069	TTC12	chr11:113185251-113244016:+	0.44	6.95	1.24E-11	Select biomarker traits	
THCA	cis	1	rs2471854	chr11:113299639	TTC12	chr11:113185251-113244016:+	-0.39	-6.32	6.11E-10	Select biomarker traits	
THCA	cis	1	rs2471857	chr11:113298339	TTC12	chr11:113185251-113244016:+	-0.39	-6.32	6.11E-10	Select biomarker traits	
THCA	cis	1	rs2471884	chr11:117010320	PCSK7	chr11:117075789-117102811:-	-0.36	-6.29	7.31E-10	Protein quantitative trait loci	
THCA	cis	1	rs2472476	chr9:107531956	NIPSNAP3A	chr9:107509969-107535189:+	0.16	4.26	2.43E-5	Obesity-related traits	
THCA	cis	1	rs2472478	chr9:107531361	NIPSNAP3A	chr9:107509969-107535189:+	0.16	4.29	2.2E-5	Obesity-related traits	
THCA	cis	1	rs2474549	chr10:38290772	LOC399744	chr10:38717074-38741080:+	-0.27	-3.65	0.000289	Obesity (extreme)	
THCA	cis	1	rs2474550	chr10:38290770	LOC399744	chr10:38717074-38741080:+	-0.27	-3.65	0.000289	Obesity (extreme)	
THCA	cis	1	rs2474777	chr20:25272633	ENTPD6	chr20:25176339-25207360:+	-0.32	-7.15	3.22E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2474777	chr20:25272633	FAM182A	chr20:26035250-26067552:+	-0.19	-3.49	0.000521	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2474777	chr20:25272633	FAM182B	chr20:25744102-25848786:-	0.26	5.52	5.48E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2474777	chr20:25272633	NINL	chr20:25433338-25566153:-	-0.36	-7.5	3.11E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2474777	chr20:25272633	PYGB	chr20:25228706-25278647:+	-0.16	-4	7.22E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs247771	chr19:19847882	ZNF14	chr19:19821281-19843921:-	0.18	3.67	0.000268	Toenail selenium levels	
THCA	cis	1	rs247772	chr19:19846458	ZNF14	chr19:19821281-19843921:-	0.18	3.65	0.000289	Toenail selenium levels	
THCA	cis	1	rs247776	chr19:19842615	ZNF14	chr19:19821281-19843921:-	0.21	4.32	1.89E-5	Toenail selenium levels	
THCA	cis	1	rs247778	chr19:19842053	ZNF14	chr19:19821281-19843921:-	0.22	4.36	1.6E-5	Toenail selenium levels	
THCA	cis	1	rs2482427	chr9:107532425	NIPSNAP3A	chr9:107509969-107535189:+	0.16	4.26	2.43E-5	Obesity-related traits	
THCA	cis	1	rs2482911	chr20:25395528	ENTPD6	chr20:25176339-25207360:+	0.3	6.84	2.38E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482911	chr20:25395528	FAM182A	chr20:26035250-26067552:+	0.18	3.38	0.000795	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482911	chr20:25395528	FAM182B	chr20:25744102-25848786:-	-0.25	-5.19	3.05E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482911	chr20:25395528	NINL	chr20:25433338-25566153:-	0.36	7.37	7.43E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482911	chr20:25395528	PYGB	chr20:25228706-25278647:+	0.14	3.51	0.000484	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482919	chr20:25299756	ENTPD6	chr20:25176339-25207360:+	0.31	6.96	1.09E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482919	chr20:25299756	FAM182A	chr20:26035250-26067552:+	0.18	3.41	0.000693	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482919	chr20:25299756	FAM182B	chr20:25744102-25848786:-	-0.26	-5.37	1.21E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482919	chr20:25299756	NINL	chr20:25433338-25566153:-	0.37	7.55	2.24E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482919	chr20:25299756	PYGB	chr20:25228706-25278647:+	0.15	3.71	0.000228	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482927	chr20:25327151	ENTPD6	chr20:25176339-25207360:+	0.3	6.76	4.04E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482927	chr20:25327151	FAM182A	chr20:26035250-26067552:+	0.18	3.38	0.000771	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482927	chr20:25327151	FAM182B	chr20:25744102-25848786:-	-0.26	-5.34	1.43E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482927	chr20:25327151	NINL	chr20:25433338-25566153:-	0.37	7.57	1.9E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482927	chr20:25327151	PYGB	chr20:25228706-25278647:+	0.15	3.74	0.000207	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482928	chr20:25331530	ENTPD6	chr20:25176339-25207360:+	0.3	6.86	2.18E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482928	chr20:25331530	FAM182A	chr20:26035250-26067552:+	0.19	3.46	0.00059	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482928	chr20:25331530	FAM182B	chr20:25744102-25848786:-	-0.25	-5.22	2.7E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482928	chr20:25331530	NINL	chr20:25433338-25566153:-	0.36	7.4	6.1E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482928	chr20:25331530	PYGB	chr20:25228706-25278647:+	0.15	3.69	0.000248	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482930	chr20:25334115	ENTPD6	chr20:25176339-25207360:+	0.3	6.9	1.63E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482930	chr20:25334115	FAM182A	chr20:26035250-26067552:+	0.19	3.52	0.00048	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482930	chr20:25334115	FAM182B	chr20:25744102-25848786:-	-0.25	-5.21	2.87E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482930	chr20:25334115	NINL	chr20:25433338-25566153:-	0.35	7.28	1.43E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482930	chr20:25334115	PYGB	chr20:25228706-25278647:+	0.14	3.61	0.000343	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482931	chr20:25334445	ENTPD6	chr20:25176339-25207360:+	0.3	6.72	5.05E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482931	chr20:25334445	FAM182A	chr20:26035250-26067552:+	0.19	3.48	0.000546	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482931	chr20:25334445	FAM182B	chr20:25744102-25848786:-	-0.26	-5.29	1.83E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482931	chr20:25334445	NINL	chr20:25433338-25566153:-	0.36	7.33	9.8E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482931	chr20:25334445	PYGB	chr20:25228706-25278647:+	0.14	3.58	0.000384	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482937	chr20:25340786	ENTPD6	chr20:25176339-25207360:+	0.3	6.9	1.63E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482937	chr20:25340786	FAM182A	chr20:26035250-26067552:+	0.19	3.52	0.00048	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482937	chr20:25340786	FAM182B	chr20:25744102-25848786:-	-0.25	-5.21	2.87E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482937	chr20:25340786	NINL	chr20:25433338-25566153:-	0.35	7.28	1.43E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482937	chr20:25340786	PYGB	chr20:25228706-25278647:+	0.14	3.61	0.000343	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482940	chr20:25349830	ENTPD6	chr20:25176339-25207360:+	0.3	6.72	5.25E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482940	chr20:25349830	FAM182A	chr20:26035250-26067552:+	0.19	3.48	0.000538	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482940	chr20:25349830	FAM182B	chr20:25744102-25848786:-	-0.26	-5.3	1.78E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482940	chr20:25349830	NINL	chr20:25433338-25566153:-	0.36	7.34	9.3E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482940	chr20:25349830	PYGB	chr20:25228706-25278647:+	0.14	3.57	0.000388	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482941	chr20:25361216	ENTPD6	chr20:25176339-25207360:+	0.3	6.72	5.25E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482941	chr20:25361216	FAM182A	chr20:26035250-26067552:+	0.19	3.48	0.000538	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482941	chr20:25361216	FAM182B	chr20:25744102-25848786:-	-0.26	-5.3	1.78E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482941	chr20:25361216	NINL	chr20:25433338-25566153:-	0.36	7.34	9.3E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482941	chr20:25361216	PYGB	chr20:25228706-25278647:+	0.14	3.57	0.000388	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482943	chr20:25380593	ENTPD6	chr20:25176339-25207360:+	0.3	6.62	9.87E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482943	chr20:25380593	FAM182A	chr20:26035250-26067552:+	0.19	3.44	0.000637	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482943	chr20:25380593	FAM182B	chr20:25744102-25848786:-	-0.25	-5.24	2.41E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482943	chr20:25380593	NINL	chr20:25433338-25566153:-	0.36	7.39	6.56E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2482943	chr20:25380593	PYGB	chr20:25228706-25278647:+	0.14	3.51	0.000499	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2486201	chr1:29367236	MECR	chr1:29519385-29557454:-	-0.15	-3.71	0.000233	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs2486447	chr1:46545724	CCDC163P	chr1:45960581-45965646:-	-0.51	-9.9	3.88E-21	Body mass index	
THCA	cis	1	rs2486447	chr1:46545724	GPBP1L1	chr1:46092978-46152302:-	0.15	3.73	0.000214	Body mass index	
THCA	cis	1	rs2486447	chr1:46545724	MMACHC	chr1:45965856-45976737:+	-0.21	-4.53	7.42E-6	Body mass index	
THCA	cis	1	rs2486447	chr1:46545724	MUTYH	chr1:45794915-45806142:-	0.29	7.65	1.12E-13	Body mass index	
THCA	cis	1	rs248652	chr5:130654837	P4HA2	chr5:131528306-131563556:-	-0.27	-5.11	4.65E-7	Life satisfaction	
THCA	cis	1	rs2487701	chr10:70746267	KIAA1279	chr10:70748493-70776734:+	-0.16	-3.79	0.000169	Schizophrenia	
THCA	cis	1	rs2487702	chr10:70750148	KIAA1279	chr10:70748493-70776734:+	-0.15	-3.5	0.000508	Schizophrenia	
THCA	cis	1	rs2487706	chr10:70764444	KIAA1279	chr10:70748493-70776734:+	-0.15	-3.6	0.000354	Schizophrenia	
THCA	cis	1	rs2487707	chr10:70765092	KIAA1279	chr10:70748493-70776734:+	-0.15	-3.6	0.000354	Schizophrenia	
THCA	cis	1	rs2487708	chr10:70767402	KIAA1279	chr10:70748493-70776734:+	-0.15	-3.6	0.000352	Schizophrenia	
THCA	cis	1	rs2487715	chr9:107532394	NIPSNAP3A	chr9:107509969-107535189:+	0.17	4.4	1.33E-5	Obesity-related traits	
THCA	cis	1	rs2489034	chr10:102319192	SEC31B	chr10:102246403-102289636:-	-0.28	-9.02	4.43E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2489035	chr10:102319395	SEC31B	chr10:102246403-102289636:-	-0.28	-8.9	1.19E-17	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2489036	chr10:102319581	SEC31B	chr10:102246403-102289636:-	-0.28	-9.02	4.43E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2489037	chr10:102319918	SEC31B	chr10:102246403-102289636:-	0.28	8.9	1.17E-17	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2489039	chr10:102328036	SEC31B	chr10:102246403-102289636:-	-0.3	-9.74	1.45E-20	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2489040	chr10:102331298	SEC31B	chr10:102246403-102289636:-	-0.29	-9.55	6.52E-20	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2489043	chr10:102334327	SEC31B	chr10:102246403-102289636:-	-0.28	-9.29	5.54E-19	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2489045	chr10:102344754	SEC31B	chr10:102246403-102289636:-	-0.29	-9.1	2.39E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2489046	chr10:102346282	SEC31B	chr10:102246403-102289636:-	-0.28	-8.96	7.29E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2489047	chr10:102347028	SEC31B	chr10:102246403-102289636:-	-0.29	-9.4	2.34E-19	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2489048	chr10:102348497	SEC31B	chr10:102246403-102289636:-	-0.28	-9.11	2.24E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2489049	chr10:102350732	SEC31B	chr10:102246403-102289636:-	-0.29	-9.47	1.34E-19	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2489050	chr10:102350898	SEC31B	chr10:102246403-102289636:-	-0.29	-9.13	2.0E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2489051	chr10:102351785	SEC31B	chr10:102246403-102289636:-	0.27	8.6	1.14E-16	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2489053	chr10:102353341	SEC31B	chr10:102246403-102289636:-	-0.26	-8.47	3.03E-16	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2490261	chr1:207477469	CD55	chr1:207494817-207534309:+	0.19	7.85	2.8E-14	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs2491023	chr10:70754071	KIAA1279	chr10:70748493-70776734:+	-0.14	-3.41	0.000716	Schizophrenia	
THCA	cis	1	rs2492859	chr6:34645266	C6orf106	chr6:34555066-34664625:-	0.26	4.09	5.14E-5	Pubertal anthropometrics	
THCA	cis	1	rs2492859	chr6:34645266	SNRPC	chr6:34725312-34741571:+	-0.15	-3.41	0.000709	Pubertal anthropometrics	
THCA	cis	1	rs2494112	chr1:201787833	SHISA4	chr1:201858032-201861426:+	-0.3	-6.49	2.12E-10	Body mass index	
THCA	cis	1	rs2495732	chr10:102357780	SEC31B	chr10:102246403-102289636:-	-0.28	-8.81	2.4E-17	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2495734	chr10:102338686	SEC31B	chr10:102246403-102289636:-	-0.28	-9.08	2.79E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2495736	chr10:102338410	SEC31B	chr10:102246403-102289636:-	-0.28	-8.96	7.31E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2495737	chr10:102338344	SEC31B	chr10:102246403-102289636:-	-0.28	-9.06	3.33E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2495739	chr10:102335507	SEC31B	chr10:102246403-102289636:-	-0.29	-9.3	5.18E-19	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2495741	chr10:102331795	SEC31B	chr10:102246403-102289636:-	-0.28	-9.17	1.46E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2495742	chr10:102331364	SEC31B	chr10:102246403-102289636:-	-0.29	-9.17	1.37E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2495743	chr10:102329739	SEC31B	chr10:102246403-102289636:-	-0.29	-9.08	2.85E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2495745	chr10:102329075	SEC31B	chr10:102246403-102289636:-	-0.29	-9.4	2.28E-19	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2495747	chr10:102328247	SEC31B	chr10:102246403-102289636:-	-0.29	-9.61	4.02E-20	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2495750	chr10:102327708	SEC31B	chr10:102246403-102289636:-	-0.3	-9.68	2.37E-20	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2495751	chr10:102327260	SEC31B	chr10:102246403-102289636:-	-0.3	-9.73	1.52E-20	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2495752	chr10:102326115	SEC31B	chr10:102246403-102289636:-	-0.29	-9.37	2.91E-19	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2495753	chr10:102325640	SEC31B	chr10:102246403-102289636:-	-0.29	-9.1	2.46E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2495754	chr10:102324812	SEC31B	chr10:102246403-102289636:-	-0.29	-9.37	2.91E-19	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2495755	chr10:102324649	SEC31B	chr10:102246403-102289636:-	-0.29	-9.25	7.73E-19	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2495758	chr10:102321900	SEC31B	chr10:102246403-102289636:-	-0.29	-9.02	4.68E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2495759	chr10:102320363	SEC31B	chr10:102246403-102289636:-	-0.3	-9.2	1.12E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2495760	chr10:102318771	SEC31B	chr10:102246403-102289636:-	-0.29	-9.18	1.29E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs2500404	chr20:25359758	ENTPD6	chr20:25176339-25207360:+	0.3	6.72	5.25E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500404	chr20:25359758	FAM182A	chr20:26035250-26067552:+	0.19	3.48	0.000538	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500404	chr20:25359758	FAM182B	chr20:25744102-25848786:-	-0.26	-5.3	1.78E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500404	chr20:25359758	NINL	chr20:25433338-25566153:-	0.36	7.34	9.3E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500404	chr20:25359758	PYGB	chr20:25228706-25278647:+	0.14	3.57	0.000388	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500405	chr20:25360826	ENTPD6	chr20:25176339-25207360:+	0.3	6.72	5.25E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500405	chr20:25360826	FAM182A	chr20:26035250-26067552:+	0.19	3.48	0.000538	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500405	chr20:25360826	FAM182B	chr20:25744102-25848786:-	-0.26	-5.3	1.78E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500405	chr20:25360826	NINL	chr20:25433338-25566153:-	0.36	7.34	9.3E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500405	chr20:25360826	PYGB	chr20:25228706-25278647:+	0.14	3.57	0.000388	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500418	chr20:25382268	ENTPD6	chr20:25176339-25207360:+	0.3	6.62	9.87E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500418	chr20:25382268	FAM182A	chr20:26035250-26067552:+	0.19	3.44	0.000637	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500418	chr20:25382268	FAM182B	chr20:25744102-25848786:-	-0.25	-5.24	2.41E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500418	chr20:25382268	NINL	chr20:25433338-25566153:-	0.36	7.39	6.56E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500418	chr20:25382268	PYGB	chr20:25228706-25278647:+	0.14	3.51	0.000499	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500424	chr20:25391969	ENTPD6	chr20:25176339-25207360:+	0.3	6.67	7.06E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500424	chr20:25391969	FAM182A	chr20:26035250-26067552:+	0.18	3.34	0.000892	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500424	chr20:25391969	FAM182B	chr20:25744102-25848786:-	-0.26	-5.39	1.14E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500424	chr20:25391969	NINL	chr20:25433338-25566153:-	0.36	7.32	1.05E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500424	chr20:25391969	PYGB	chr20:25228706-25278647:+	0.14	3.37	0.000823	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500432	chr20:25290512	ENTPD6	chr20:25176339-25207360:+	-0.32	-7.2	2.3E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500432	chr20:25290512	FAM182A	chr20:26035250-26067552:+	-0.19	-3.45	0.000611	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500432	chr20:25290512	FAM182B	chr20:25744102-25848786:-	0.24	5.12	4.47E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500432	chr20:25290512	NINL	chr20:25433338-25566153:-	-0.37	-7.64	1.17E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500432	chr20:25290512	PYGB	chr20:25228706-25278647:+	-0.14	-3.43	0.000648	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500436	chr20:25406366	ENTPD6	chr20:25176339-25207360:+	0.31	6.98	9.75E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500436	chr20:25406366	FAM182A	chr20:26035250-26067552:+	0.19	3.43	0.000647	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500436	chr20:25406366	FAM182B	chr20:25744102-25848786:-	-0.24	-5.02	7.29E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500436	chr20:25406366	NINL	chr20:25433338-25566153:-	0.37	7.53	2.6E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500443	chr20:25331442	ENTPD6	chr20:25176339-25207360:+	0.3	6.77	3.75E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500443	chr20:25331442	FAM182A	chr20:26035250-26067552:+	0.19	3.49	0.000523	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500443	chr20:25331442	FAM182B	chr20:25744102-25848786:-	-0.25	-5.26	2.18E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500443	chr20:25331442	NINL	chr20:25433338-25566153:-	0.36	7.47	3.84E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500443	chr20:25331442	PYGB	chr20:25228706-25278647:+	0.14	3.65	0.000292	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500446	chr20:25339664	ENTPD6	chr20:25176339-25207360:+	0.3	6.9	1.63E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500446	chr20:25339664	FAM182A	chr20:26035250-26067552:+	0.19	3.52	0.00048	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500446	chr20:25339664	FAM182B	chr20:25744102-25848786:-	-0.25	-5.21	2.87E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500446	chr20:25339664	NINL	chr20:25433338-25566153:-	0.35	7.28	1.43E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500446	chr20:25339664	PYGB	chr20:25228706-25278647:+	0.14	3.61	0.000343	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500448	chr20:25404027	ENTPD6	chr20:25176339-25207360:+	0.3	6.8	3.09E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500448	chr20:25404027	FAM182A	chr20:26035250-26067552:+	0.19	3.4	0.000734	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500448	chr20:25404027	FAM182B	chr20:25744102-25848786:-	-0.25	-5.11	4.66E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2500448	chr20:25404027	NINL	chr20:25433338-25566153:-	0.37	7.59	1.72E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2501276	chr1:22373624	HSPC157	chr1:22351707-22357713:+	0.4	3.5	0.000509	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs2501962	chr6:49453636	CENPQ	chr6:49431096-49460820:+	0.26	5.44	8.33E-8	Folate pathway vitamin levels	
THCA	cis	1	rs2501962	chr6:49453636	MUT	chr6:49398994-49431031:-	-0.29	-9.99	1.85E-21	Folate pathway vitamin levels	
THCA	cis	1	rs2501963	chr6:49454281	CENPQ	chr6:49431096-49460820:+	0.26	5.52	5.59E-8	Folate pathway vitamin levels	
THCA	cis	1	rs2501963	chr6:49454281	MUT	chr6:49398994-49431031:-	-0.29	-9.83	6.94E-21	Folate pathway vitamin levels	
THCA	cis	1	rs2502757	chr9:136586954	SARDH	chr9:136528686-136605077:-	-0.31	-5.98	4.48E-9	Asthma	
THCA	cis	1	rs2505998	chr10:43570925	CSGALNACT2	chr10:43633934-43680747:+	-0.16	-5.13	4.29E-7	Hirschsprung disease	
THCA	cis	1	rs2506006	chr10:43581501	CSGALNACT2	chr10:43633934-43680747:+	-0.16	-5.16	3.67E-7	Hirschsprung disease	
THCA	cis	1	rs250636	chr16:3510416	NAT15	chr16:3493668-3536962:+	-0.24	-4.25	2.6E-5	Tuberculosis	
THCA	cis	1	rs250636	chr16:3510416	TRAP1	chr16:3708039-3767598:-	0.14	3.42	0.00068	Tuberculosis	
THCA	cis	1	rs250637	chr16:3511007	NAT15	chr16:3493668-3536962:+	-0.23	-3.95	8.82E-5	Tuberculosis	
THCA	cis	1	rs250637	chr16:3511007	TRAP1	chr16:3708039-3767598:-	0.14	3.44	0.00063	Tuberculosis	
THCA	cis	1	rs2508858	chr11:71805405	FAM86C	chr11:71498557-71512276:+	-0.32	-3.91	0.000107	Severe influenza A (H1N1) infection	
THCA	cis	1	rs2510032	chr11:77968631	NARS2	chr11:78147017-78285909:-	-0.38	-6.77	3.81E-11	Testicular germ cell tumor	
THCA	cis	1	rs2510035	chr11:77953175	NARS2	chr11:78147017-78285909:-	-0.39	-6.76	4.07E-11	Testicular germ cell tumor	
THCA	cis	1	rs2510036	chr11:77966788	NARS2	chr11:78147017-78285909:-	-0.38	-6.85	2.31E-11	Testicular germ cell tumor	
THCA	cis	1	rs2510037	chr11:77966099	NARS2	chr11:78147017-78285909:-	-0.38	-7.32	1.03E-12	Testicular germ cell tumor	
THCA	cis	1	rs2510039	chr11:77944480	NARS2	chr11:78147017-78285909:-	-0.39	-6.75	4.35E-11	Testicular germ cell tumor	
THCA	cis	1	rs2510040	chr11:77944548	NARS2	chr11:78147017-78285909:-	-0.4	-7.11	4.15E-12	Testicular germ cell tumor	
THCA	cis	1	rs2510041	chr11:77945284	NARS2	chr11:78147017-78285909:-	-0.43	-8.23	1.75E-15	Testicular germ cell tumor	
THCA	cis	1	rs2510043	chr11:77977481	NARS2	chr11:78147017-78285909:-	-0.39	-7.45	4.41E-13	Testicular germ cell tumor	
THCA	cis	1	rs2510045	chr11:77920563	NARS2	chr11:78147017-78285909:-	-0.4	-7.21	2.21E-12	Testicular germ cell tumor	
THCA	cis	1	rs2510046	chr11:77988817	NARS2	chr11:78147017-78285909:-	-0.36	-6.51	1.87E-10	Testicular germ cell tumor	
THCA	cis	1	rs2510047	chr11:77988668	NARS2	chr11:78147017-78285909:-	0.37	7.12	3.9E-12	Testicular germ cell tumor	
THCA	cis	1	rs2510048	chr11:77987464	NARS2	chr11:78147017-78285909:-	-0.36	-6.43	3.06E-10	Testicular germ cell tumor	
THCA	cis	1	rs2510049	chr11:77985459	NARS2	chr11:78147017-78285909:-	-0.36	-6.43	3.06E-10	Testicular germ cell tumor	
THCA	cis	1	rs2510050	chr11:77982564	NARS2	chr11:78147017-78285909:-	-0.36	-6.5	1.97E-10	Testicular germ cell tumor	
THCA	cis	1	rs2510051	chr11:77981171	NARS2	chr11:78147017-78285909:-	-0.38	-6.95	1.17E-11	Testicular germ cell tumor	
THCA	cis	1	rs2510054	chr11:77959659	NARS2	chr11:78147017-78285909:-	0.4	7.56	2.02E-13	Testicular germ cell tumor	
THCA	cis	1	rs2510055	chr11:77961912	NARS2	chr11:78147017-78285909:-	-0.38	-6.69	6.29E-11	Testicular germ cell tumor	
THCA	cis	1	rs2510340	chr18:21142438	NPC1	chr18:21108363-21166581:-	0.15	4.82	1.97E-6	Body mass index	
THCA	cis	1	rs2511075	chr11:71780257	FAM86C	chr11:71498557-71512276:+	0.31	3.81	0.000158	Severe influenza A (H1N1) infection	
THCA	cis	1	rs2511076	chr11:71783827	FAM86C	chr11:71498557-71512276:+	0.31	3.81	0.000158	Severe influenza A (H1N1) infection	
THCA	cis	1	rs2511079	chr11:71804154	FAM86C	chr11:71498557-71512276:+	0.35	4.38	1.45E-5	Severe influenza A (H1N1) infection	
THCA	cis	1	rs2511114	chr11:71792147	FAM86C	chr11:71498557-71512276:+	0.31	3.81	0.000158	Severe influenza A (H1N1) infection	
THCA	cis	1	rs2511116	chr11:71802160	FAM86C	chr11:71498557-71512276:+	0.32	3.91	0.000107	Severe influenza A (H1N1) infection	
THCA	cis	1	rs2511155	chr11:77969223	NARS2	chr11:78147017-78285909:-	-0.4	-7.37	7.44E-13	Testicular germ cell tumor	
THCA	cis	1	rs2511156	chr11:77971167	NARS2	chr11:78147017-78285909:-	-0.38	-6.77	3.82E-11	Testicular germ cell tumor	
THCA	cis	1	rs2511157	chr11:77972632	NARS2	chr11:78147017-78285909:-	-0.38	-6.77	3.82E-11	Testicular germ cell tumor	
THCA	cis	1	rs2511158	chr11:77973980	NARS2	chr11:78147017-78285909:-	-0.38	-6.77	3.82E-11	Testicular germ cell tumor	
THCA	cis	1	rs2511166	chr11:77964331	NARS2	chr11:78147017-78285909:-	-0.41	-7.9	1.95E-14	Testicular germ cell tumor	
THCA	cis	1	rs2511168	chr11:77965081	NARS2	chr11:78147017-78285909:-	-0.4	-7.23	1.93E-12	Testicular germ cell tumor	
THCA	cis	1	rs2511169	chr11:77965321	NARS2	chr11:78147017-78285909:-	-0.4	-7.75	5.48E-14	Testicular germ cell tumor	
THCA	cis	1	rs2511170	chr11:77980582	NARS2	chr11:78147017-78285909:-	-0.36	-6.63	9.03E-11	Testicular germ cell tumor	
THCA	cis	1	rs2511171	chr11:77930935	NARS2	chr11:78147017-78285909:-	-0.38	-6.86	2.16E-11	Testicular germ cell tumor	
THCA	cis	1	rs2511175	chr11:77975081	NARS2	chr11:78147017-78285909:-	-0.37	-6.59	1.18E-10	Testicular germ cell tumor	
THCA	cis	1	rs2511177	chr11:77922960	NARS2	chr11:78147017-78285909:-	-0.45	-8.77	3.25E-17	Testicular germ cell tumor	
THCA	cis	1	rs2511178	chr11:77923220	NARS2	chr11:78147017-78285909:-	-0.38	-7.01	8.06E-12	Testicular germ cell tumor	
THCA	cis	1	rs2511180	chr11:77937255	NARS2	chr11:78147017-78285909:-	-0.4	-7.39	6.83E-13	Testicular germ cell tumor	
THCA	cis	1	rs2511182	chr11:77982130	NARS2	chr11:78147017-78285909:-	-0.37	-6.61	1.05E-10	Testicular germ cell tumor	
THCA	cis	1	rs2511185	chr11:77982496	NARS2	chr11:78147017-78285909:-	-0.38	-7.22	2.03E-12	Testicular germ cell tumor	
THCA	cis	1	rs2511186	chr11:77984306	NARS2	chr11:78147017-78285909:-	-0.38	-6.96	1.12E-11	Testicular germ cell tumor	
THCA	cis	1	rs2511187	chr11:77985849	NARS2	chr11:78147017-78285909:-	-0.37	-6.61	1.05E-10	Testicular germ cell tumor	
THCA	cis	1	rs2511190	chr11:77988310	NARS2	chr11:78147017-78285909:-	-0.37	-6.66	7.35E-11	Testicular germ cell tumor	
THCA	cis	1	rs2511411	chr11:93727757	HEPHL1	chr11:93754378-93847374:+	-0.42	-3.51	0.0005	Obesity-related traits	
THCA	cis	1	rs2512532	chr11:77968641	NARS2	chr11:78147017-78285909:-	-0.39	-7.06	5.72E-12	Testicular germ cell tumor	
THCA	cis	1	rs2512533	chr11:77968674	NARS2	chr11:78147017-78285909:-	-0.38	-6.78	3.61E-11	Testicular germ cell tumor	
THCA	cis	1	rs2512535	chr11:77971468	NARS2	chr11:78147017-78285909:-	-0.4	-7.63	1.25E-13	Testicular germ cell tumor	
THCA	cis	1	rs2512537	chr11:77971947	NARS2	chr11:78147017-78285909:-	-0.38	-6.77	3.82E-11	Testicular germ cell tumor	
THCA	cis	1	rs2512538	chr11:77972461	NARS2	chr11:78147017-78285909:-	-0.38	-6.77	3.82E-11	Testicular germ cell tumor	
THCA	cis	1	rs2512541	chr11:77981747	NARS2	chr11:78147017-78285909:-	-0.38	-6.96	1.12E-11	Testicular germ cell tumor	
THCA	cis	1	rs2512542	chr11:77981780	NARS2	chr11:78147017-78285909:-	-0.38	-7.4	6.19E-13	Testicular germ cell tumor	
THCA	cis	1	rs2512544	chr11:77986371	NARS2	chr11:78147017-78285909:-	-0.37	-6.58	1.22E-10	Testicular germ cell tumor	
THCA	cis	1	rs2512546	chr11:77957276	NARS2	chr11:78147017-78285909:-	-0.43	-8.18	2.56E-15	Testicular germ cell tumor	
THCA	cis	1	rs2512547	chr11:77960888	NARS2	chr11:78147017-78285909:-	-0.41	-7.66	1.03E-13	Testicular germ cell tumor	
THCA	cis	1	rs2512549	chr11:77940163	NARS2	chr11:78147017-78285909:-	0.4	7.82	3.3E-14	Testicular germ cell tumor	
THCA	cis	1	rs2512550	chr11:77943848	NARS2	chr11:78147017-78285909:-	-0.42	-7.95	1.39E-14	Testicular germ cell tumor	
THCA	cis	1	rs2513093	chr11:116806687	PCSK7	chr11:117075789-117102811:-	-0.29	-5.01	7.75E-7	Protein quantitative trait loci	
THCA	cis	1	rs2513095	chr11:116806269	PCSK7	chr11:117075789-117102811:-	-0.28	-4.77	2.5E-6	Protein quantitative trait loci	
THCA	cis	1	rs2516739	chr16:2097158	TELO2	chr16:1543352-1560459:+	0.11	3.38	0.000784	Longevity	
THCA	cis	1	rs2516740	chr16:2097110	TELO2	chr16:1543352-1560459:+	-0.11	-3.35	0.000879	Longevity	
THCA	cis	1	rs2524005	chr6:29899677	HCG4	chr6:29758809-29760850:-	-0.54	-8.19	2.41E-15	Bipolar disorder and schizophrenia	
THCA	cis	1	rs2524005	chr6:29899677	TRIM31	chr6:30070674-30080867:-	-0.35	-4.78	2.29E-6	Bipolar disorder and schizophrenia	
THCA	cis	1	rs2524005	chr6:29899677	ZFP57	chr6:29640171-29648887:-	0.66	10.24	2.25E-22	Bipolar disorder and schizophrenia	
THCA	cis	1	rs2524276	chr6:31408265	MICB	chr6:31462658-31478898:+	0.31	4.6	5.41E-6	Capecitabine sensitivity	
THCA	cis	1	rs2524300	chr17:39040877	TMEM99	chr17:38975374-38992526:+	0.21	4.98	8.95E-7	Height	
THCA	cis	1	rs2524306	chr17:39035811	TMEM99	chr17:38975374-38992526:+	0.21	5.09	5.22E-7	Height	
THCA	cis	1	rs2527199	chr7:158737113	ESYT2	chr7:158523689-158622319:-	-0.12	-3.4	0.00073	Height	
THCA	cis	1	rs2527199	chr7:158737113	WDR60	chr7:158649269-158738882:+	0.15	3.86	0.00013	Height	
THCA	cis	1	rs252887	chr5:56166188	C5orf35	chr5:56205103-56213010:+	1	23.23	1.8E-80	Type 2 diabetes	
THCA	cis	1	rs252898	chr5:56188931	C5orf35	chr5:56205103-56213010:+	1.03	24.81	6.44E-88	Type 2 diabetes	
THCA	cis	1	rs2529002	chr7:23233323	NUPL2	chr7:23221446-23240629:+	-0.39	-5.5	6.08E-8	Chronic obstructive pulmonary disease	
THCA	cis	1	rs252902	chr5:56116085	C5orf35	chr5:56205103-56213010:+	0.97	22.16	2.37E-75	Type 2 diabetes	
THCA	cis	1	rs252904	chr5:56118733	C5orf35	chr5:56205103-56213010:+	0.99	22.68	7.42E-78	Type 2 diabetes	
THCA	cis	1	rs252909	chr5:56121131	C5orf35	chr5:56205103-56213010:+	1.01	23.18	3.08E-80	Type 2 diabetes	
THCA	cis	1	rs252910	chr5:56192983	C5orf35	chr5:56205103-56213010:+	1.05	23.92	9.73E-84	Type 2 diabetes	
THCA	cis	1	rs252915	chr5:56121754	C5orf35	chr5:56205103-56213010:+	-1.01	-23.31	7.97E-81	Type 2 diabetes	
THCA	cis	1	rs252916	chr5:56121788	C5orf35	chr5:56205103-56213010:+	1.02	23.8	3.7E-83	Type 2 diabetes	
THCA	cis	1	rs252919	chr5:56124111	C5orf35	chr5:56205103-56213010:+	1.01	23.18	3.08E-80	Type 2 diabetes	
THCA	cis	1	rs252921	chr5:56137787	C5orf35	chr5:56205103-56213010:+	1.02	23.74	7.33E-83	Type 2 diabetes	
THCA	cis	1	rs252922	chr5:56136343	C5orf35	chr5:56205103-56213010:+	1.02	23.89	1.42E-83	Type 2 diabetes	
THCA	cis	1	rs2530664	chr22:30038152	NIPSNAP1	chr22:29950800-29977144:-	0.3	4.44	1.11E-5	Lipid traits	
THCA	cis	1	rs2531848	chr22:30032484	NIPSNAP1	chr22:29950800-29977144:-	0.27	4.07	5.42E-5	Lipid traits	
THCA	cis	1	rs2531849	chr22:30037900	NIPSNAP1	chr22:29950800-29977144:-	0.3	4.43	1.16E-5	Lipid traits	
THCA	cis	1	rs2531995	chr16:4013467	ADCY9	chr16:4012653-4166186:-	0.16	4.38	1.45E-5	Body mass index;Obesity	
THCA	cis	1	rs2533288	chr7:66056711	CCT6P1	chr7:65216092-65228661:+	0.43	6.71	5.52E-11	Diabetic kidney disease	
THCA	cis	1	rs2533288	chr7:66056711	CRCP	chr7:65579805-65619551:+	-0.28	-4.12	4.38E-5	Diabetic kidney disease	
THCA	cis	1	rs2533288	chr7:66056711	GUSB	chr7:65425675-65447246:-	0.28	3.36	0.000853	Diabetic kidney disease	
THCA	cis	1	rs2533288	chr7:66056711	LOC493754	chr7:65993446-66057363:-	0.3	3.34	0.000893	Diabetic kidney disease	
THCA	cis	1	rs2533288	chr7:66056711	RABGEF1	chr7:66093890-66276446:+	0.63	7.72	6.66E-14	Diabetic kidney disease	
THCA	cis	1	rs2540173	chr1:156188214	PMF1	chr1:156182784-156209831:+	-0.14	-3.63	0.000311	Testicular germ cell tumor	
THCA	cis	1	rs2540948	chr2:65284623	CEP68	chr2:65283495-65314141:+	-0.15	-3.91	0.000107	Triglycerides	
THCA	cis	1	rs2540949	chr2:65284231	CEP68	chr2:65283495-65314141:+	-0.16	-4.12	4.44E-5	Triglycerides	
THCA	cis	1	rs2540951	chr2:65276736	CEP68	chr2:65283495-65314141:+	-0.15	-3.93	9.85E-5	Triglycerides	
THCA	cis	1	rs2540977	chr2:37462228	CEBPZ	chr2:37428778-37458740:-	-0.19	-4.17	3.59E-5	Chronic lymphocytic leukemia	
THCA	cis	1	rs2541161	chr9:131884802	CRAT	chr9:131857075-131873070:-	-0.28	-6.61	1.01E-10	Blood metabolite ratios	
THCA	cis	1	rs2541164	chr9:131876908	CRAT	chr9:131857075-131873070:-	0.28	6.58	1.23E-10	Blood metabolite ratios	
THCA	cis	1	rs2543376	chr14:76609923	ESRRB	chr14:76837690-76968178:+	0.29	4.49	8.95E-6	Blood pressure	
THCA	cis	1	rs2543382	chr14:76624887	ESRRB	chr14:76837690-76968178:+	0.29	4.56	6.46E-6	Blood pressure	
THCA	cis	1	rs2543383	chr14:76626703	ESRRB	chr14:76837690-76968178:+	0.29	4.64	4.48E-6	Blood pressure	
THCA	cis	1	rs2543384	chr14:76627301	ESRRB	chr14:76837690-76968178:+	0.28	4.56	6.57E-6	Blood pressure	
THCA	cis	1	rs2543387	chr14:76629046	ESRRB	chr14:76837690-76968178:+	0.29	4.68	3.67E-6	Blood pressure	
THCA	cis	1	rs2548664	chr5:56133555	C5orf35	chr5:56205103-56213010:+	1.01	23.41	2.48E-81	Type 2 diabetes	
THCA	cis	1	rs2548665	chr5:56131805	C5orf35	chr5:56205103-56213010:+	1.01	23.41	2.48E-81	Type 2 diabetes	
THCA	cis	1	rs2549018	chr5:130698949	P4HA2	chr5:131528306-131563556:-	-0.26	-5.1	4.94E-7	Life satisfaction	
THCA	cis	1	rs2551036	chr5:130648994	P4HA2	chr5:131528306-131563556:-	0.26	5.01	7.64E-7	Life satisfaction	
THCA	cis	1	rs2554944	chr11:4479901	TRIM68	chr11:4619902-4629437:-	0.15	3.34	0.0009	Amyotrophic lateral sclerosis	
THCA	cis	1	rs2555154	chr11:6524556	FXC1	chr11:6502677-6505910:+	-0.16	-4.31	2.0E-5	DNA methylation (variation)	
THCA	cis	1	rs2555154	chr11:6524556	TRIM3	chr11:6469844-6495689:-	0.15	3.72	0.000223	DNA methylation (variation)	
THCA	cis	1	rs2555155	chr11:6522804	FXC1	chr11:6502677-6505910:+	-0.15	-4.15	3.87E-5	DNA methylation (variation)	
THCA	cis	1	rs2555155	chr11:6522804	TRIM3	chr11:6469844-6495689:-	0.15	3.69	0.000252	DNA methylation (variation)	
THCA	cis	1	rs2560903	chr19:52787583	ZNF836	chr19:52658127-52674896:-	0.28	3.95	9.15E-5	Cannabis use (initiation)	
THCA	cis	1	rs2562456	chr19:21666210	ZNF429	chr19:21688437-21739068:+	-0.16	-3.81	0.000157	Pain	
THCA	cis	1	rs2564921	chr3:53125585	ITIH4	chr3:52847007-52866554:-	-0.16	-4.54	7.16E-6	Height	
THCA	cis	1	rs2564921	chr3:53125585	RFT1	chr3:53122503-53164470:-	0.75	18.13	2.69E-56	Height	
THCA	cis	1	rs2564926	chr3:53094730	RFT1	chr3:53122503-53164470:-	-0.63	-8.28	1.25E-15	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs2564940	chr3:53107569	ITIH4	chr3:52847007-52866554:-	0.16	4.51	8.1E-6	Height	
THCA	cis	1	rs2564940	chr3:53107569	RFT1	chr3:53122503-53164470:-	-0.76	-18.37	2.01E-57	Height	
THCA	cis	1	rs2564956	chr3:53070462	GLYCTK	chr3:52321836-52329271:+	0.16	3.56	0.000407	Ulcerative colitis	
THCA	cis	1	rs2564973	chr1:207480104	CD55	chr1:207494817-207534309:+	0.19	7.66	1.03E-13	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs2564973	chr1:207480104	CR1	chr1:207669473-207815109:+	-0.14	-3.52	0.000475	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs2564974	chr1:207483445	CD55	chr1:207494817-207534309:+	-0.16	-6.96	1.15E-11	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs2564978	chr1:207494416	CD55	chr1:207494817-207534309:+	0.16	6.62	9.55E-11	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs256572	chr2:190717867	ASNSD1	chr2:190526125-190535556:+	-0.53	-8.25	1.51E-15	Subcutaneous adipose tissue	
THCA	cis	1	rs256572	chr2:190717867	ORMDL1	chr2:190634994-190649097:-	0.19	4.18	3.49E-5	Subcutaneous adipose tissue	
THCA	cis	1	rs2566264	chr11:4482143	TRIM68	chr11:4619902-4629437:-	0.17	3.65	0.000288	Amyotrophic lateral sclerosis	
THCA	cis	1	rs2569754	chr19:41936734	B3GNT8	chr19:41931265-41934635:-	-0.34	-7.74	5.84E-14	Height	
THCA	cis	1	rs2569754	chr19:41936734	EXOSC5	chr19:41892278-41903256:-	-0.11	-3.54	0.000432	Height	
THCA	cis	1	rs2572910	chr8:143770135	C8orf55	chr8:143808621-143818350:+	0.37	8.73	4.39E-17	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2572910	chr8:143770135	LY6K	chr8:143781529-143785582:+	0.3	5.6	3.57E-8	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2572910	chr8:143770135	LYNX1	chr8:143845758-143859640:-	-0.19	-4.17	3.6E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2572910	chr8:143770135	PSCA	chr8:143761875-143764142:+	0.36	6.39	3.85E-10	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2573346	chr10:81918041	C10orf58	chr10:82168242-82196869:+	-0.14	-3.35	0.000864	Sarcoidosis	
THCA	cis	1	rs2573346	chr10:81918041	PLAC9	chr10:81892258-81904784:+	0.11	4.17	3.58E-5	Sarcoidosis	
THCA	cis	1	rs257389	chr5:130744263	P4HA2	chr5:131528306-131563556:-	-0.23	-4.6	5.38E-6	Life satisfaction	
THCA	cis	1	rs257390	chr5:130740617	P4HA2	chr5:131528306-131563556:-	-0.24	-4.75	2.65E-6	Life satisfaction	
THCA	cis	1	rs2581782	chr3:53122257	ITIH4	chr3:52847007-52866554:-	0.16	4.58	6.06E-6	Height	
THCA	cis	1	rs2581782	chr3:53122257	RFT1	chr3:53122503-53164470:-	-0.75	-18.21	1.15E-56	Height	
THCA	cis	1	rs2581783	chr3:53122258	ITIH4	chr3:52847007-52866554:-	0.16	4.58	6.06E-6	Height	
THCA	cis	1	rs2581783	chr3:53122258	RFT1	chr3:53122503-53164470:-	-0.75	-18.21	1.15E-56	Height	
THCA	cis	1	rs2581786	chr3:53126143	ITIH4	chr3:52847007-52866554:-	0.16	4.58	6.06E-6	Height	
THCA	cis	1	rs2581786	chr3:53126143	RFT1	chr3:53122503-53164470:-	-0.75	-18.21	1.15E-56	Height	
THCA	cis	1	rs2581787	chr3:53127677	ITIH4	chr3:52847007-52866554:-	0.17	4.81	2.01E-6	Height	
THCA	cis	1	rs2581787	chr3:53127677	RFT1	chr3:53122503-53164470:-	-0.75	-17.73	1.99E-54	Height	
THCA	cis	1	rs2581794	chr3:53036206	NT5DC2	chr3:52558386-52569093:-	0.19	4.18	3.41E-5	Schizophrenia	
THCA	cis	1	rs2581794	chr3:53036206	PBRM1	chr3:52579368-52719866:-	-0.11	-4	7.19E-5	Schizophrenia	
THCA	cis	1	rs2581794	chr3:53036206	RFT1	chr3:53122503-53164470:-	-0.36	-6.67	6.94E-11	Schizophrenia	
THCA	cis	1	rs2581800	chr3:53109352	ITIH4	chr3:52847007-52866554:-	0.15	4.41	1.29E-5	Height	
THCA	cis	1	rs2581800	chr3:53109352	RFT1	chr3:53122503-53164470:-	-0.74	-17.71	2.45E-54	Height	
THCA	cis	1	rs2581817	chr3:53071797	GLYCTK	chr3:52321836-52329271:+	0.16	3.59	0.000363	Ulcerative colitis	
THCA	cis	1	rs2583471	chr11:59861814	MS4A14	chr11:60145958-60185226:+	0.17	4.45	1.06E-5	Alzheimer's disease (late onset)	
THCA	cis	1	rs2583930	chr12:66246181	RPSAP52	chr12:66151803-66220754:-	0.18	3.59	0.000367	Type 2 diabetes	
THCA	cis	1	rs2583938	chr12:66215214	RPSAP52	chr12:66151803-66220754:-	0.2	4	7.23E-5	Type 2 diabetes	
THCA	cis	1	rs2583939	chr12:66213521	RPSAP52	chr12:66151803-66220754:-	0.19	3.92	0.0001	Type 2 diabetes	
THCA	cis	1	rs2585179	chr8:143774193	C8orf55	chr8:143808621-143818350:+	0.37	8.73	4.21E-17	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2585179	chr8:143774193	LY6K	chr8:143781529-143785582:+	0.31	5.66	2.61E-8	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2585179	chr8:143774193	LYNX1	chr8:143845758-143859640:-	-0.2	-4.28	2.3E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2585179	chr8:143774193	PSCA	chr8:143761875-143764142:+	0.36	6.33	5.79E-10	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2587652	chr2:120312855	PCDP1	chr2:120302047-120414236:+	-0.14	-3.79	0.00017	Attention deficit hyperactivity disorder	
THCA	cis	1	rs2587687	chr2:120284152	PCDP1	chr2:120302047-120414236:+	-0.14	-3.73	0.000213	Attention deficit hyperactivity disorder	
THCA	cis	1	rs2587688	chr2:120284072	PCDP1	chr2:120302047-120414236:+	-0.14	-3.71	0.000235	Attention deficit hyperactivity disorder	
THCA	cis	1	rs2587695	chr2:120321817	PCDP1	chr2:120302047-120414236:+	0.14	3.73	0.000212	Attention deficit hyperactivity disorder	
THCA	cis	1	rs2591092	chr14:76630133	ESRRB	chr14:76837690-76968178:+	0.28	4.56	6.57E-6	Blood pressure	
THCA	cis	1	rs2591094	chr14:76632335	ESRRB	chr14:76837690-76968178:+	0.28	4.56	6.57E-6	Blood pressure	
THCA	cis	1	rs2592555	chr11:36371757	TRIM44	chr11:35684353-35830930:+	0.07	3.35	0.000872	Atopic dermatitis	
THCA	cis	1	rs259359	chr1:95709039	RWDD3	chr1:95583479-95712773:+	-0.24	-3.41	0.000711	Stearic acid (18:0) plasma levels	
THCA	cis	1	rs2595500	chr11:6963165	ZNF215	chr11:6947654-7005861:+	0.27	4.33	1.79E-5	Response to cytadine analogues (cytosine arabinoside)	
THCA	cis	1	rs2595501	chr11:6955340	ZNF215	chr11:6947654-7005861:+	-0.28	-4.37	1.55E-5	Response to cytadine analogues (cytosine arabinoside)	
THCA	cis	1	rs259991	chr20:57728348	GNASAS	chr20:57393974-57425958:-	-0.34	-3.44	0.000643	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs2604169	chr15:33388030	FMN1	chr15:33066347-33360085:-	-0.18	-4.3	2.09E-5	Age-related hearing impairment (interaction)	
THCA	cis	1	rs260461	chr19:58770883	ZNF544	chr19:58740070-58775006:+	-0.25	-3.57	0.000397	Attention deficit hyperactivity disorder	
THCA	cis	1	rs2605582	chr11:93163799	CCDC67	chr11:93063156-93171634:+	-0.49	-6.89	1.82E-11	Pulmonary function decline	
THCA	cis	1	rs2605583	chr11:93164957	CCDC67	chr11:93063156-93171634:+	-0.53	-7.36	7.99E-13	Pulmonary function decline	
THCA	cis	1	rs2605585	chr11:93171862	CCDC67	chr11:93063156-93171634:+	-0.48	-6.9	1.7E-11	Pulmonary function decline	
THCA	cis	1	rs2608216	chr11:93149172	CCDC67	chr11:93063156-93171634:+	-0.52	-7.33	1.02E-12	Pulmonary function decline	
THCA	cis	1	rs2613513	chr17:76105731	TMC6	chr17:76108999-76128488:-	-0.19	-3.59	0.000369	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs261360	chr20:5037774	C20orf30	chr20:5049130-5093733:-	-0.31	-8.69	5.7E-17	Hair morphology	
THCA	cis	1	rs2614811	chr15:43913487	ADAL	chr15:43622872-43646094:+	-0.41	-8.91	1.07E-17	Tumor biomarkers	
THCA	cis	1	rs2614811	chr15:43913487	CATSPER2	chr15:43922774-43959900:-	-0.28	-4.99	8.68E-7	Tumor biomarkers	
THCA	cis	1	rs2614811	chr15:43913487	STRC	chr15:43891762-43924561:-	0.39	7.31	1.1E-12	Tumor biomarkers	
THCA	cis	1	rs2614811	chr15:43913487	TUBGCP4	chr15:43663313-43698238:+	0.14	4.08	5.22E-5	Tumor biomarkers	
THCA	cis	1	rs2616629	chr10:65213816	LOC84989	chr10:65224989-65226320:+	0.26	4.13	4.36E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs2616629	chr10:65213816	NRBF2	chr10:64893007-64914785:+	0.27	4.46	1.02E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs2616630	chr10:65213339	LOC84989	chr10:65224989-65226320:+	0.26	4.13	4.36E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs2616630	chr10:65213339	NRBF2	chr10:64893007-64914785:+	0.27	4.46	1.02E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs2617170	chr12:10560957	KLRC1	chr12:10594863-10606984:-	0.16	3.5	0.000513	Behcet's disease	
THCA	cis	1	rs262147	chr7:158745142	WDR60	chr7:158649269-158738882:+	-0.34	-5.79	1.25E-8	Hippocampal volume	
THCA	cis	1	rs2622609	chr4:89088475	ABCG2	chr4:89011417-89152474:-	0.15	3.49	0.00052	Gout	
THCA	cis	1	rs2625667	chr3:41900951	ULK4	chr3:41288091-42003660:-	1.09	20.95	1.23E-69	Diastolic blood pressure	
THCA	cis	1	rs2625668	chr3:41905930	ULK4	chr3:41288091-42003660:-	1.09	20.84	4.35E-69	Diastolic blood pressure	
THCA	cis	1	rs2628313	chr17:53235352	COX11	chr17:53029259-53046064:-	-0.2	-4.92	1.2E-6	Menarche (age at onset)	
THCA	cis	1	rs2628314	chr17:53235182	COX11	chr17:53029259-53046064:-	-0.19	-4.77	2.5E-6	Menarche (age at onset)	
THCA	cis	1	rs2629540	chr10:126426148	METTL10	chr10:126447406-126480439:-	0.51	8.91	1.07E-17	Cocaine dependence	
THCA	cis	1	rs2629751	chr12:104421808	LOC253724	chr12:104237528-104323989:-	-0.16	-4.18	3.52E-5	Hepatitis C induced liver fibrosis	
THCA	cis	1	rs2630	chr15:50849399	ATP8B4	chr15:50150436-50411419:-	-0.11	-3.41	0.000707	QT interval	
THCA	cis	1	rs2630	chr15:50849399	SPPL2A	chr15:50999739-51057910:-	0.28	7.33	9.75E-13	QT interval	
THCA	cis	1	rs2631740	chr4:8484106	C4orf23	chr4:8440604-8495258:+	0.34	7.36	8.12E-13	Response to antineoplastic agents	
THCA	cis	1	rs2631745	chr4:8490530	C4orf23	chr4:8440604-8495258:+	0.34	7.34	9.05E-13	Response to antineoplastic agents	
THCA	cis	1	rs2631758	chr4:8495304	C4orf23	chr4:8440604-8495258:+	0.34	7.36	7.95E-13	Response to antineoplastic agents	
THCA	cis	1	rs2637678	chr6:116787378	FAM26F	chr6:116782556-116784933:+	0.17	5.77	1.46E-8	Ulcerative colitis	
THCA	cis	1	rs2638090	chr11:6955142	ZNF215	chr11:6947654-7005861:+	-0.28	-4.46	1.01E-5	Response to cytadine analogues (cytosine arabinoside)	
THCA	cis	1	rs2638092	chr11:6961746	ZNF215	chr11:6947654-7005861:+	-0.28	-4.42	1.2E-5	Response to cytadine analogues (cytosine arabinoside)	
THCA	cis	1	rs2638953	chr12:28534415	CCDC91	chr12:28332210-28703098:+	-0.23	-5.33	1.54E-7	Height	
THCA	cis	1	rs2643338	chr8:97247469	PTDSS1	chr8:97274167-97346774:+	0.2	4.36	1.58E-5	Lung function (FVC)	
THCA	cis	1	rs2643872	chr11:18450444	LDHC	chr11:18433853-18472792:+	-0.31	-3.71	0.000236	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs2644128	chr1:201793440	SHISA4	chr1:201858032-201861426:+	0.31	6.74	4.68E-11	Body mass index	
THCA	cis	1	rs2645424	chr8:11684463	CTSB	chr8:11700036-11725646:-	0.17	4.01	6.9E-5	Non-alcoholic fatty liver disease histology (lobular);Non-alcoholic fatty liver disease histology (other)	
THCA	cis	1	rs2650100	chr3:112998268	SIDT1	chr3:113251218-113348421:+	0.23	3.92	9.95E-5	Dental caries	
THCA	cis	1	rs26510	chr5:96125910	CAST	chr5:95997777-96115291:+	-0.11	-4.08	5.27E-5	Ankylosing spondylitis	
THCA	cis	1	rs26510	chr5:96125910	ERAP1	chr5:96096515-96149837:-	-0.39	-11.64	9.35E-28	Ankylosing spondylitis	
THCA	cis	1	rs26510	chr5:96125910	ERAP2	chr5:96211644-96255398:+	0.53	9.44	1.58E-19	Ankylosing spondylitis	
THCA	cis	1	rs2655310	chr4:130017919	C4orf33	chr4:130014829-130033842:+	-0.6	-9.77	1.15E-20	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs2657345	chr7:158744169	ESYT2	chr7:158523689-158622319:-	-0.12	-3.48	0.000545	Height	
THCA	cis	1	rs2657345	chr7:158744169	WDR60	chr7:158649269-158738882:+	0.14	3.49	0.000528	Height	
THCA	cis	1	rs2657365	chr7:158722753	WDR60	chr7:158649269-158738882:+	0.14	3.49	0.000518	Height	
THCA	cis	1	rs2657890	chr12:56938577	RPS26	chr12:56435686-56438005:+	-0.2	-3.4	0.000743	Adiponectin levels	
THCA	cis	1	rs2657932	chr19:52787453	ZNF836	chr19:52658127-52674896:-	0.29	4.14	4.13E-5	Cannabis use (initiation)	
THCA	cis	1	rs2658778	chr11:93148948	CCDC67	chr11:93063156-93171634:+	-0.51	-7.14	3.61E-12	Pulmonary function decline	
THCA	cis	1	rs2658779	chr11:93163137	CCDC67	chr11:93063156-93171634:+	0.52	7.26	1.61E-12	Pulmonary function decline	
THCA	cis	1	rs2658781	chr11:93166368	CCDC67	chr11:93063156-93171634:+	0.52	7.33	1.02E-12	Pulmonary function decline	
THCA	cis	1	rs2658782	chr11:93166731	CCDC67	chr11:93063156-93171634:+	-0.52	-7.33	1.02E-12	Pulmonary function decline	
THCA	cis	1	rs2659889	chr7:66217112	GUSB	chr7:65425675-65447246:-	0.33	6.7	5.72E-11	Aortic root size	
THCA	cis	1	rs2659889	chr7:66217112	RABGEF1	chr7:66093890-66276446:+	0.51	10.51	2.27E-23	Aortic root size	
THCA	cis	1	rs2659889	chr7:66217112	TYW1	chr7:66461817-66704496:+	0.18	3.97	8.44E-5	Aortic root size	
THCA	cis	1	rs2659903	chr7:66180931	CCT6P1	chr7:65216092-65228661:+	0.43	6.6	1.1E-10	Gout	
THCA	cis	1	rs2659903	chr7:66180931	CRCP	chr7:65579805-65619551:+	-0.29	-4.34	1.77E-5	Gout	
THCA	cis	1	rs2659903	chr7:66180931	GUSB	chr7:65425675-65447246:-	0.28	3.45	0.000613	Gout	
THCA	cis	1	rs2659903	chr7:66180931	RABGEF1	chr7:66093890-66276446:+	0.63	7.69	8.35E-14	Gout	
THCA	cis	1	rs2659906	chr7:66165310	GUSB	chr7:65425675-65447246:-	0.34	6.84	2.45E-11	Aortic root size	
THCA	cis	1	rs2659906	chr7:66165310	RABGEF1	chr7:66093890-66276446:+	0.52	10.67	5.33E-24	Aortic root size	
THCA	cis	1	rs2659906	chr7:66165310	TYW1	chr7:66461817-66704496:+	0.18	3.89	0.000114	Aortic root size	
THCA	cis	1	rs2659909	chr7:66160279	GUSB	chr7:65425675-65447246:-	0.33	6.73	4.81E-11	Aortic root size	
THCA	cis	1	rs2659909	chr7:66160279	RABGEF1	chr7:66093890-66276446:+	0.49	10.13	5.52E-22	Aortic root size	
THCA	cis	1	rs2659909	chr7:66160279	TYW1	chr7:66461817-66704496:+	0.2	4.27	2.36E-5	Aortic root size	
THCA	cis	1	rs2659911	chr7:66158420	CCT6P1	chr7:65216092-65228661:+	0.43	6.6	1.1E-10	Gout	
THCA	cis	1	rs2659911	chr7:66158420	CRCP	chr7:65579805-65619551:+	-0.29	-4.34	1.77E-5	Gout	
THCA	cis	1	rs2659911	chr7:66158420	GUSB	chr7:65425675-65447246:-	0.28	3.45	0.000613	Gout	
THCA	cis	1	rs2659911	chr7:66158420	RABGEF1	chr7:66093890-66276446:+	0.63	7.69	8.35E-14	Gout	
THCA	cis	1	rs2659912	chr7:66157999	GUSB	chr7:65425675-65447246:-	0.33	6.76	4.09E-11	Aortic root size	
THCA	cis	1	rs2659912	chr7:66157999	RABGEF1	chr7:66093890-66276446:+	0.51	10.45	3.59E-23	Aortic root size	
THCA	cis	1	rs2659912	chr7:66157999	TYW1	chr7:66461817-66704496:+	0.18	3.86	0.00013	Aortic root size	
THCA	cis	1	rs2659913	chr7:66157336	CCT6P1	chr7:65216092-65228661:+	0.43	6.6	1.1E-10	Gout	
THCA	cis	1	rs2659913	chr7:66157336	CRCP	chr7:65579805-65619551:+	-0.29	-4.34	1.77E-5	Gout	
THCA	cis	1	rs2659913	chr7:66157336	GUSB	chr7:65425675-65447246:-	0.28	3.45	0.000613	Gout	
THCA	cis	1	rs2659913	chr7:66157336	RABGEF1	chr7:66093890-66276446:+	0.63	7.69	8.35E-14	Gout	
THCA	cis	1	rs2659915	chr7:66153101	GUSB	chr7:65425675-65447246:-	0.32	6.47	2.45E-10	Aortic root size	
THCA	cis	1	rs2659915	chr7:66153101	RABGEF1	chr7:66093890-66276446:+	0.51	10.45	3.67E-23	Aortic root size	
THCA	cis	1	rs2659915	chr7:66153101	TYW1	chr7:66461817-66704496:+	0.19	4.06	5.66E-5	Aortic root size	
THCA	cis	1	rs2661357	chr1:207483938	CD55	chr1:207494817-207534309:+	0.19	7.51	2.99E-13	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs2661357	chr1:207483938	CR1	chr1:207669473-207815109:+	-0.14	-3.62	0.00033	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs2663905	chr15:81359137	C15orf26	chr15:81391749-81441515:+	-0.34	-5.82	1.08E-8	QT interval (interaction)	
THCA	cis	1	rs2665826	chr17:61944924	FTSJ3	chr17:61896795-61905031:-	0.31	5.93	5.75E-9	Body mass index	
THCA	cis	1	rs2665826	chr17:61944924	MAP3K3	chr17:61699775-61773669:+	0.27	5.59	3.88E-8	Body mass index	
THCA	cis	1	rs2667011	chr2:160867059	LY75	chr2:160625141-160761262:-	-0.27	-5.64	2.9E-8	Bilirubin levels	
THCA	cis	1	rs2667175	chr4:121803254	C4orf31	chr4:121956782-121993673:-	-0.2	-3.72	0.000223	Fasting plasma glucose	
THCA	cis	1	rs2667176	chr4:121802653	C4orf31	chr4:121956782-121993673:-	-0.2	-3.74	0.000208	Fasting plasma glucose	
THCA	cis	1	rs2675680	chr10:75658864	BMS1P4	chr10:75458909-75490272:-	0.24	5.62	3.33E-8	Inflammatory bowel disease	
THCA	cis	1	rs267736	chr1:150945607	PRPF3	chr1:150293928-150325703:+	0.22	3.56	0.000408	Congenital left-sided heart lesions	
THCA	cis	1	rs2683695	chr3:41914928	ULK4	chr3:41288091-42003660:-	1.07	20.45	2.89E-67	Diastolic blood pressure	
THCA	cis	1	rs2683696	chr3:41914898	ULK4	chr3:41288091-42003660:-	1.08	20.55	1.08E-67	Diastolic blood pressure	
THCA	cis	1	rs2684898	chr12:51046825	DIP2B	chr12:50898768-51142448:+	0.12	3.77	0.000185	Fibrinogen	
THCA	cis	1	rs2684900	chr12:51019556	DIP2B	chr12:50898768-51142448:+	0.12	3.91	0.000104	Fibrinogen	
THCA	cis	1	rs2687723	chr3:127865559	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.47	9.77E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2687730	chr3:127915457	EEFSEC	chr3:127872313-128127488:+	-0.24	-4.23	2.76E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2688223	chr4:8471398	C4orf23	chr4:8440604-8495258:+	-0.32	-6.72	5.35E-11	Response to antineoplastic agents	
THCA	cis	1	rs2688233	chr4:8491885	C4orf23	chr4:8440604-8495258:+	-0.34	-7.36	7.95E-13	Response to antineoplastic agents	
THCA	cis	1	rs2688608	chr10:75658349	BMS1P4	chr10:75458909-75490272:-	0.24	5.7	2.15E-8	Inflammatory bowel disease	
THCA	cis	1	rs2688610	chr10:75654931	BMS1P4	chr10:75458909-75490272:-	-0.23	-5.47	7.43E-8	Inflammatory bowel disease	
THCA	cis	1	rs2700479	chr12:51020471	DIP2B	chr12:50898768-51142448:+	0.12	3.91	0.000104	Fibrinogen	
THCA	cis	1	rs2700482	chr12:51083265	DIP2B	chr12:50898768-51142448:+	0.12	3.78	0.000179	Fibrinogen	
THCA	cis	1	rs2700485	chr12:51103992	DIP2B	chr12:50898768-51142448:+	0.11	3.63	0.000318	Fibrinogen	
THCA	cis	1	rs2707828	chr7:66171377	CCT6P1	chr7:65216092-65228661:+	0.43	6.6	1.1E-10	Gout	
THCA	cis	1	rs2707828	chr7:66171377	CRCP	chr7:65579805-65619551:+	-0.29	-4.34	1.77E-5	Gout	
THCA	cis	1	rs2707828	chr7:66171377	GUSB	chr7:65425675-65447246:-	0.28	3.45	0.000613	Gout	
THCA	cis	1	rs2707828	chr7:66171377	RABGEF1	chr7:66093890-66276446:+	0.63	7.69	8.35E-14	Gout	
THCA	cis	1	rs2707830	chr7:66167645	CCT6P1	chr7:65216092-65228661:+	0.43	6.6	1.1E-10	Gout	
THCA	cis	1	rs2707830	chr7:66167645	CRCP	chr7:65579805-65619551:+	-0.29	-4.34	1.77E-5	Gout	
THCA	cis	1	rs2707830	chr7:66167645	GUSB	chr7:65425675-65447246:-	0.28	3.45	0.000613	Gout	
THCA	cis	1	rs2707830	chr7:66167645	RABGEF1	chr7:66093890-66276446:+	0.63	7.69	8.35E-14	Gout	
THCA	cis	1	rs2707831	chr7:66062511	CCT6P1	chr7:65216092-65228661:+	0.43	6.62	9.65E-11	Diabetic kidney disease	
THCA	cis	1	rs2707831	chr7:66062511	CRCP	chr7:65579805-65619551:+	-0.28	-4.24	2.66E-5	Diabetic kidney disease	
THCA	cis	1	rs2707831	chr7:66062511	GUSB	chr7:65425675-65447246:-	0.28	3.42	0.000676	Diabetic kidney disease	
THCA	cis	1	rs2707831	chr7:66062511	RABGEF1	chr7:66093890-66276446:+	0.63	7.72	6.86E-14	Diabetic kidney disease	
THCA	cis	1	rs2707832	chr7:66136549	CCT6P1	chr7:65216092-65228661:+	0.44	6.94	1.29E-11	Gout	
THCA	cis	1	rs2707832	chr7:66136549	CRCP	chr7:65579805-65619551:+	-0.3	-4.61	5.09E-6	Gout	
THCA	cis	1	rs2707832	chr7:66136549	GUSB	chr7:65425675-65447246:-	0.28	3.46	0.000595	Gout	
THCA	cis	1	rs2707832	chr7:66136549	LOC493754	chr7:65993446-66057363:-	0.31	3.57	0.000387	Gout	
THCA	cis	1	rs2707832	chr7:66136549	RABGEF1	chr7:66093890-66276446:+	0.6	7.44	4.62E-13	Gout	
THCA	cis	1	rs2707836	chr7:66160435	GUSB	chr7:65425675-65447246:-	0.34	6.84	2.45E-11	Aortic root size	
THCA	cis	1	rs2707836	chr7:66160435	RABGEF1	chr7:66093890-66276446:+	0.52	10.67	5.33E-24	Aortic root size	
THCA	cis	1	rs2707836	chr7:66160435	TYW1	chr7:66461817-66704496:+	0.18	3.89	0.000114	Aortic root size	
THCA	cis	1	rs2707838	chr7:66159201	CCT6P1	chr7:65216092-65228661:+	0.43	6.6	1.1E-10	Gout	
THCA	cis	1	rs2707838	chr7:66159201	CRCP	chr7:65579805-65619551:+	-0.29	-4.34	1.77E-5	Gout	
THCA	cis	1	rs2707838	chr7:66159201	GUSB	chr7:65425675-65447246:-	0.28	3.45	0.000613	Gout	
THCA	cis	1	rs2707838	chr7:66159201	RABGEF1	chr7:66093890-66276446:+	0.63	7.69	8.35E-14	Gout	
THCA	cis	1	rs2707840	chr7:66158015	CCT6P1	chr7:65216092-65228661:+	0.43	6.61	1.0E-10	Gout	
THCA	cis	1	rs2707840	chr7:66158015	CRCP	chr7:65579805-65619551:+	-0.29	-4.36	1.59E-5	Gout	
THCA	cis	1	rs2707840	chr7:66158015	GUSB	chr7:65425675-65447246:-	0.28	3.44	0.000635	Gout	
THCA	cis	1	rs2707840	chr7:66158015	RABGEF1	chr7:66093890-66276446:+	0.63	7.65	1.1E-13	Gout	
THCA	cis	1	rs2707844	chr7:66059509	CCT6P1	chr7:65216092-65228661:+	0.43	6.62	9.65E-11	Diabetic kidney disease	
THCA	cis	1	rs2707844	chr7:66059509	CRCP	chr7:65579805-65619551:+	-0.28	-4.24	2.66E-5	Diabetic kidney disease	
THCA	cis	1	rs2707844	chr7:66059509	GUSB	chr7:65425675-65447246:-	0.28	3.42	0.000676	Diabetic kidney disease	
THCA	cis	1	rs2707844	chr7:66059509	RABGEF1	chr7:66093890-66276446:+	0.63	7.72	6.86E-14	Diabetic kidney disease	
THCA	cis	1	rs2707845	chr7:66198798	GUSB	chr7:65425675-65447246:-	0.34	6.84	2.43E-11	Aortic root size	
THCA	cis	1	rs2707845	chr7:66198798	RABGEF1	chr7:66093890-66276446:+	0.52	10.69	4.74E-24	Aortic root size	
THCA	cis	1	rs2707845	chr7:66198798	TYW1	chr7:66461817-66704496:+	0.18	3.89	0.000116	Aortic root size	
THCA	cis	1	rs2707850	chr7:66203870	GUSB	chr7:65425675-65447246:-	0.34	6.84	2.43E-11	Aortic root size	
THCA	cis	1	rs2707850	chr7:66203870	RABGEF1	chr7:66093890-66276446:+	0.52	10.69	4.74E-24	Aortic root size	
THCA	cis	1	rs2707850	chr7:66203870	TYW1	chr7:66461817-66704496:+	0.18	3.89	0.000116	Aortic root size	
THCA	cis	1	rs2707854	chr7:66212597	GUSB	chr7:65425675-65447246:-	0.34	6.84	2.43E-11	Aortic root size	
THCA	cis	1	rs2707854	chr7:66212597	RABGEF1	chr7:66093890-66276446:+	0.52	10.69	4.74E-24	Aortic root size	
THCA	cis	1	rs2707854	chr7:66212597	TYW1	chr7:66461817-66704496:+	0.18	3.89	0.000116	Aortic root size	
THCA	cis	1	rs2707856	chr7:66211010	GUSB	chr7:65425675-65447246:-	0.34	6.9	1.69E-11	Aortic root size	
THCA	cis	1	rs2707856	chr7:66211010	LOC493754	chr7:65993446-66057363:-	-0.19	-3.37	0.000818	Aortic root size	
THCA	cis	1	rs2707856	chr7:66211010	RABGEF1	chr7:66093890-66276446:+	0.52	10.87	9.75E-25	Aortic root size	
THCA	cis	1	rs2707856	chr7:66211010	TYW1	chr7:66461817-66704496:+	0.18	3.91	0.000108	Aortic root size	
THCA	cis	1	rs2714470	chr2:37486527	CEBPZ	chr2:37428778-37458740:-	-0.18	-4.05	6.09E-5	Chronic lymphocytic leukemia	
THCA	cis	1	rs271621	chr19:18631332	ELL	chr19:18553475-18632937:-	-0.25	-6.26	8.61E-10	Breast cancer	
THCA	cis	1	rs271621	chr19:18631332	ISYNA1	chr19:18545625-18548943:-	0.12	4.63	4.69E-6	Breast cancer	
THCA	cis	1	rs271621	chr19:18631332	LRRC25	chr19:18501955-18508421:-	-0.15	-5.29	1.85E-7	Breast cancer	
THCA	cis	1	rs271623	chr19:18628947	ELL	chr19:18553475-18632937:-	-0.25	-6.29	6.98E-10	Breast cancer	
THCA	cis	1	rs271623	chr19:18628947	ISYNA1	chr19:18545625-18548943:-	0.12	4.6	5.4E-6	Breast cancer	
THCA	cis	1	rs271623	chr19:18628947	LRRC25	chr19:18501955-18508421:-	-0.15	-5.09	5.21E-7	Breast cancer	
THCA	cis	1	rs271624	chr19:18627953	ELL	chr19:18553475-18632937:-	-0.25	-6.25	8.84E-10	Breast cancer	
THCA	cis	1	rs271624	chr19:18627953	ISYNA1	chr19:18545625-18548943:-	0.12	4.65	4.37E-6	Breast cancer	
THCA	cis	1	rs271624	chr19:18627953	LRRC25	chr19:18501955-18508421:-	-0.14	-4.86	1.6E-6	Breast cancer	
THCA	cis	1	rs2717562	chr8:143776668	C8orf55	chr8:143808621-143818350:+	0.37	8.62	9.81E-17	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2717562	chr8:143776668	LY6K	chr8:143781529-143785582:+	0.31	5.73	1.76E-8	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2717562	chr8:143776668	LYNX1	chr8:143845758-143859640:-	-0.2	-4.35	1.63E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2717562	chr8:143776668	PSCA	chr8:143761875-143764142:+	0.36	6.3	6.65E-10	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2719815	chr10:65210294	LOC84989	chr10:65224989-65226320:+	0.26	4.13	4.36E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs2719815	chr10:65210294	NRBF2	chr10:64893007-64914785:+	0.27	4.46	1.02E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs2721195	chr8:145677011	KIFC2	chr8:145691738-145699498:+	-0.13	-4.04	6.35E-5	Age at first birth	
THCA	cis	1	rs2721195	chr8:145677011	LRRC14	chr8:145743391-145750557:+	0.18	5.14	3.94E-7	Age at first birth	
THCA	cis	1	rs2721195	chr8:145677011	RECQL4	chr8:145736672-145743200:-	0.15	3.52	0.000479	Age at first birth	
THCA	cis	1	rs2721195	chr8:145677011	ZNF34	chr8:145998503-146012725:-	0.15	3.86	0.000127	Age at first birth	
THCA	cis	1	rs2723065	chr2:65279414	CEP68	chr2:65283495-65314141:+	-0.16	-4.03	6.49E-5	Triglycerides	
THCA	cis	1	rs2723620	chr11:6523657	FXC1	chr11:6502677-6505910:+	-0.16	-4.45	1.06E-5	DNA methylation (variation)	
THCA	cis	1	rs2723620	chr11:6523657	TRIM3	chr11:6469844-6495689:-	0.16	3.92	0.000102	DNA methylation (variation)	
THCA	cis	1	rs2727099	chr15:66063428	DPP8	chr15:65737999-65810035:-	-0.1	-4.11	4.57E-5	Mean corpuscular hemoglobin	
THCA	cis	1	rs2727099	chr15:66063428	SLC24A1	chr15:65903704-65953256:+	-0.15	-3.64	0.000303	Mean corpuscular hemoglobin	
THCA	cis	1	rs2730241	chr7:158723014	ESYT2	chr7:158523689-158622319:-	-0.12	-3.54	0.000437	Height	
THCA	cis	1	rs2730245	chr7:158724789	WDR60	chr7:158649269-158738882:+	0.15	3.86	0.000127	Height	
THCA	cis	1	rs2731434	chr12:51109875	DIP2B	chr12:50898768-51142448:+	0.11	3.65	0.000289	Fibrinogen	
THCA	cis	1	rs2731439	chr12:51060350	DIP2B	chr12:50898768-51142448:+	0.12	3.76	0.000188	Fibrinogen	
THCA	cis	1	rs2731440	chr12:51057627	DIP2B	chr12:50898768-51142448:+	0.12	3.76	0.000188	Fibrinogen	
THCA	cis	1	rs2731442	chr12:51054655	DIP2B	chr12:50898768-51142448:+	0.12	3.75	0.000199	Fibrinogen	
THCA	cis	1	rs2731443	chr12:51094138	DIP2B	chr12:50898768-51142448:+	0.11	3.47	0.000573	Fibrinogen	
THCA	cis	1	rs2734839	chr11:113286490	TTC12	chr11:113185251-113244016:+	-0.55	-10.98	3.69E-25	Information processing speed	
THCA	cis	1	rs2734839	chr11:113286490	ZW10	chr11:113603911-113644425:-	-0.13	-3.38	0.000781	Information processing speed	
THCA	cis	1	rs2736371	chr8:11105529	TDH	chr8:11197146-11225961:+	0.16	4.97	9.26E-7	Retinal vascular caliber	
THCA	cis	1	rs2738186	chr10:38255989	LOC399744	chr10:38717074-38741080:+	-0.27	-3.62	0.000322	Obesity (extreme)	
THCA	cis	1	rs2738187	chr10:38260305	LOC399744	chr10:38717074-38741080:+	-0.27	-3.62	0.000322	Obesity (extreme)	
THCA	cis	1	rs2738191	chr10:38265786	LOC399744	chr10:38717074-38741080:+	0.26	3.57	0.000393	Obesity (extreme)	
THCA	cis	1	rs2738209	chr10:38307214	LOC399744	chr10:38717074-38741080:+	-0.27	-3.65	0.000289	Obesity (extreme)	
THCA	cis	1	rs2738219	chr10:38158260	LOC399744	chr10:38717074-38741080:+	-0.29	-3.95	8.97E-5	Obesity (extreme)	
THCA	cis	1	rs2738219	chr10:38158260	ZNF25	chr10:38238795-38265453:-	-0.16	-3.44	0.000625	Obesity (extreme)	
THCA	cis	1	rs2738222	chr10:38183674	LOC399744	chr10:38717074-38741080:+	-0.28	-3.83	0.000146	Obesity (extreme)	
THCA	cis	1	rs2738223	chr10:38185898	LOC399744	chr10:38717074-38741080:+	-0.3	-4.1	4.94E-5	Obesity (extreme)	
THCA	cis	1	rs2738223	chr10:38185898	ZNF25	chr10:38238795-38265453:-	-0.16	-3.5	0.000512	Obesity (extreme)	
THCA	cis	1	rs2738225	chr10:38193129	LOC399744	chr10:38717074-38741080:+	-0.28	-3.69	0.000247	Obesity (extreme)	
THCA	cis	1	rs2738225	chr10:38193129	ZNF25	chr10:38238795-38265453:-	-0.17	-3.42	0.000691	Obesity (extreme)	
THCA	cis	1	rs2738413	chr14:64679960	MTHFD1	chr14:64854759-64926727:+	-0.2	-4.98	8.91E-7	Atrial fibrillation	
THCA	cis	1	rs2740508	chr13:50677237	TRIM13	chr13:50571143-50592603:+	-0.19	-3.43	0.000668	Height	
THCA	cis	1	rs2740	chr16:15132108	NTAN1	chr16:15131717-15149833:-	0.13	3.76	0.000193	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs2740	chr16:15132108	PDXDC1	chr16:15068599-15233195:+	0.32	7.56	2.09E-13	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs2741335	chr8:27337791	CHRNA2	chr8:27317279-27336813:-	-0.22	-3.49	0.000525	Response to zileuton treatment in asthma (FEV1 change interaction)	
THCA	cis	1	rs2741432	chr20:43989514	ZNF335	chr20:44577293-44600833:-	-0.15	-3.57	0.000388	Psoriasis	
THCA	cis	1	rs2741435	chr20:43988198	ZNF335	chr20:44577293-44600833:-	-0.15	-3.59	0.000371	Psoriasis	
THCA	cis	1	rs2741611	chr20:44020809	ZNF335	chr20:44577293-44600833:-	-0.14	-3.46	0.000593	Psoriasis	
THCA	cis	1	rs2741612	chr20:44019972	ZNF335	chr20:44577293-44600833:-	-0.14	-3.46	0.000593	Psoriasis	
THCA	cis	1	rs2741639	chr20:44008432	ZNF335	chr20:44577293-44600833:-	-0.15	-3.52	0.000473	Psoriasis	
THCA	cis	1	rs2741640	chr20:44008408	ZNF335	chr20:44577293-44600833:-	-0.15	-3.52	0.000473	Psoriasis	
THCA	cis	1	rs27421	chr5:130743771	P4HA2	chr5:131528306-131563556:-	-0.25	-4.79	2.27E-6	Life satisfaction	
THCA	cis	1	rs2742234	chr10:43612609	CSGALNACT2	chr10:43633934-43680747:+	0.2	6.9	1.63E-11	Hirschsprung disease	
THCA	cis	1	rs2743237	chr20:44026618	ZNF335	chr20:44577293-44600833:-	-0.17	-4.02	6.89E-5	Psoriasis	
THCA	cis	1	rs2743402	chr20:43985204	ZNF335	chr20:44577293-44600833:-	-0.14	-3.49	0.000529	Psoriasis	
THCA	cis	1	rs2743414	chr20:43991566	ZNF335	chr20:44577293-44600833:-	-0.15	-3.57	0.000388	Psoriasis	
THCA	cis	1	rs2743419	chr20:43992645	ZNF335	chr20:44577293-44600833:-	-0.15	-3.57	0.000388	Psoriasis	
THCA	cis	1	rs2743423	chr20:43993539	ZNF335	chr20:44577293-44600833:-	-0.15	-3.57	0.000388	Psoriasis	
THCA	cis	1	rs2743424	chr20:43993934	ZNF335	chr20:44577293-44600833:-	-0.15	-3.57	0.000388	Psoriasis	
THCA	cis	1	rs2743439	chr20:43999636	ZNF335	chr20:44577293-44600833:-	-0.14	-3.41	0.000699	Psoriasis	
THCA	cis	1	rs2744947	chr6:34657809	C6orf106	chr6:34555066-34664625:-	0.26	4.09	5.14E-5	Pubertal anthropometrics	
THCA	cis	1	rs2744947	chr6:34657809	SNRPC	chr6:34725312-34741571:+	-0.15	-3.41	0.000709	Pubertal anthropometrics	
THCA	cis	1	rs2744954	chr6:34621470	C6orf106	chr6:34555066-34664625:-	0.25	3.96	8.8E-5	Pubertal anthropometrics	
THCA	cis	1	rs2744955	chr6:34618958	C6orf106	chr6:34555066-34664625:-	0.24	3.89	0.000115	Pubertal anthropometrics	
THCA	cis	1	rs2744955	chr6:34618958	SNRPC	chr6:34725312-34741571:+	-0.14	-3.36	0.000834	Pubertal anthropometrics	
THCA	cis	1	rs2744956	chr6:34618937	C6orf106	chr6:34555066-34664625:-	0.27	4.18	3.54E-5	Pubertal anthropometrics	
THCA	cis	1	rs2744972	chr6:34659054	C6orf106	chr6:34555066-34664625:-	0.26	4.2	3.25E-5	Pubertal anthropometrics	
THCA	cis	1	rs2747725	chr6:126012397	HEY2	chr6:126068780-126082414:+	0.14	3.59	0.000367	Endometrial cancer	
THCA	cis	1	rs2748431	chr17:76105754	TMC6	chr17:76108999-76128488:-	0.21	3.85	0.000134	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs2749418	chr1:41509674	SCMH1	chr1:41492875-41707788:-	0.21	4.93	1.15E-6	Height	
THCA	cis	1	rs2749564	chr10:38178815	LOC399744	chr10:38717074-38741080:+	-0.29	-3.97	8.15E-5	Obesity (extreme)	
THCA	cis	1	rs2749564	chr10:38178815	ZNF25	chr10:38238795-38265453:-	-0.16	-3.39	0.000762	Obesity (extreme)	
THCA	cis	1	rs2749876	chr14:52504397	C14orf166	chr14:52456228-52471419:+	-0.14	-4.06	5.8E-5	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs27529	chr5:96126308	CAST	chr5:95997777-96115291:+	-0.12	-4.1	4.85E-5	Ankylosing spondylitis	
THCA	cis	1	rs27529	chr5:96126308	ERAP1	chr5:96096515-96149837:-	-0.4	-11.75	3.68E-28	Ankylosing spondylitis	
THCA	cis	1	rs27529	chr5:96126308	ERAP2	chr5:96211644-96255398:+	0.53	9.41	2.17E-19	Ankylosing spondylitis	
THCA	cis	1	rs2753878	chr10:38171504	LOC399744	chr10:38717074-38741080:+	-0.3	-4.1	4.94E-5	Obesity (extreme)	
THCA	cis	1	rs2753878	chr10:38171504	ZNF25	chr10:38238795-38265453:-	-0.16	-3.5	0.000512	Obesity (extreme)	
THCA	cis	1	rs2758322	chr6:160075188	MRPL18	chr6:160211022-160219460:+	-0.22	-6.08	2.4E-9	Age-related macular degeneration (GA)	
THCA	cis	1	rs2762092	chr13:94087465	GPC6	chr13:93879078-95060267:+	0.27	3.71	0.000227	Neuroticism	
THCA	cis	1	rs2762120	chr13:94045604	GPC6	chr13:93879078-95060267:+	0.33	4.57	6.13E-6	Neuroticism	
THCA	cis	1	rs2762353	chr6:25794431	TRIM38	chr6:25963071-25985350:+	-0.2	-4.17	3.66E-5	Blood metabolite levels	
THCA	cis	1	rs27663	chr5:130741438	P4HA2	chr5:131528306-131563556:-	-0.24	-4.74	2.8E-6	Life satisfaction	
THCA	cis	1	rs2768630	chr9:131866388	CRAT	chr9:131857075-131873070:-	-0.29	-6.62	9.43E-11	Blood metabolite ratios	
THCA	cis	1	rs27708	chr5:130743541	P4HA2	chr5:131528306-131563556:-	-0.25	-4.97	9.47E-7	Life satisfaction	
THCA	cis	1	rs27710	chr5:96126197	CAST	chr5:95997777-96115291:+	0.11	4.05	5.87E-5	Ankylosing spondylitis	
THCA	cis	1	rs27710	chr5:96126197	ERAP1	chr5:96096515-96149837:-	0.39	11.55	2.09E-27	Ankylosing spondylitis	
THCA	cis	1	rs27710	chr5:96126197	ERAP2	chr5:96211644-96255398:+	-0.53	-9.47	1.32E-19	Ankylosing spondylitis	
THCA	cis	1	rs2782828	chr1:207496999	CD55	chr1:207494817-207534309:+	0.16	6.75	4.17E-11	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs2782840	chr1:207484183	CD55	chr1:207494817-207534309:+	0.19	7.51	2.99E-13	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs2782840	chr1:207484183	CR1	chr1:207669473-207815109:+	-0.14	-3.62	0.00033	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs2782842	chr1:207483576	CD55	chr1:207494817-207534309:+	0.2	7.94	1.43E-14	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs2782846	chr1:207473840	CD55	chr1:207494817-207534309:+	0.19	7.71	7.47E-14	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs2782848	chr1:207466752	CD55	chr1:207494817-207534309:+	0.19	7.77	4.8E-14	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs2782850	chr1:207465437	CD55	chr1:207494817-207534309:+	0.19	7.75	5.5E-14	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs2782851	chr1:207465062	CD55	chr1:207494817-207534309:+	0.19	7.75	5.5E-14	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs2782854	chr1:207462714	CD55	chr1:207494817-207534309:+	0.19	7.73	6.34E-14	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs2783233	chr14:58366758	SLC35F4	chr14:58030640-58063615:-	0.21	4.17	3.55E-5	Pulmonary function	
THCA	cis	1	rs2786111	chr1:197306099	CFHR3	chr1:196743930-196762872:+	0.24	4.99	8.54E-7	Lupus nephritis in systemic lupus erythematosus	
THCA	cis	1	rs2786113	chr1:197304081	CFHR3	chr1:196743930-196762872:+	-0.23	-4.81	2.06E-6	Lupus nephritis in systemic lupus erythematosus	
THCA	cis	1	rs27873	chr5:130731151	P4HA2	chr5:131528306-131563556:-	-0.28	-5.32	1.59E-7	Life satisfaction	
THCA	cis	1	rs2788889	chr1:29351790	MECR	chr1:29519385-29557454:-	-0.15	-3.71	0.000233	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs2789679	chr10:81907884	C10orf58	chr10:82168242-82196869:+	-0.14	-3.51	0.000497	Sarcoidosis	
THCA	cis	1	rs2789679	chr10:81907884	PLAC9	chr10:81892258-81904784:+	0.12	4.3	2.04E-5	Sarcoidosis	
THCA	cis	1	rs2791464	chr1:86911543	CLCA2	chr1:86889769-86922238:+	-0.22	-3.67	0.000268	Crohn's disease-related phenotypes	
THCA	cis	1	rs2791464	chr1:86911543	ODF2L	chr1:86814412-86862003:-	-0.15	-3.59	0.000362	Crohn's disease-related phenotypes	
THCA	cis	1	rs279150	chr19:12095630	ZNF763	chr19:12035900-12091196:+	-0.29	-3.49	0.000524	Multiple sclerosis	
THCA	cis	1	rs2791603	chr3:195142939	C3orf21	chr3:194789015-194991895:-	-0.27	-6.11	2.08E-9	Body mass index	
THCA	cis	1	rs279170	chr19:12136523	ZNF763	chr19:12035900-12091196:+	-0.41	-5.4	1.08E-7	Multiple sclerosis	
THCA	cis	1	rs2793831	chr1:120523902	TBX15	chr1:119425666-119532179:-	0.21	3.36	0.000834	Crohn's disease	
THCA	cis	1	rs279465	chr8:94084223	C8orf83	chr8:93895865-94029901:-	0.21	3.5	0.000501	Attention deficit hyperactivity disorder	
THCA	cis	1	rs2799077	chr6:28234597	ZKSCAN3	chr6:28317691-28334523:+	-0.27	-5.19	3.09E-7	Depression	
THCA	cis	1	rs2799077	chr6:28234597	ZNF187	chr6:28234788-28245978:+	-0.33	-6.72	5.05E-11	Depression	
THCA	cis	1	rs2799077	chr6:28234597	ZNF193	chr6:28193067-28201260:+	0.21	3.84	0.000139	Depression	
THCA	cis	1	rs2799077	chr6:28234597	ZNF323	chr6:28292517-28324048:-	0.44	6.06	2.8E-9	Depression	
THCA	cis	1	rs2799077	chr6:28234597	ZNF389	chr6:28129551-28137375:+	-0.48	-6.83	2.6E-11	Depression	
THCA	cis	1	rs2799077	chr6:28234597	ZSCAN23	chr6:28393287-28411279:-	0.23	5.06	5.86E-7	Depression	
THCA	cis	1	rs2799079	chr6:28235176	ZKSCAN3	chr6:28317691-28334523:+	-0.28	-5.41	9.77E-8	Depression	
THCA	cis	1	rs2799079	chr6:28235176	ZNF187	chr6:28234788-28245978:+	-0.33	-6.57	1.32E-10	Depression	
THCA	cis	1	rs2799079	chr6:28235176	ZNF193	chr6:28193067-28201260:+	0.2	3.68	0.000259	Depression	
THCA	cis	1	rs2799079	chr6:28235176	ZNF323	chr6:28292517-28324048:-	0.44	6.08	2.48E-9	Depression	
THCA	cis	1	rs2799079	chr6:28235176	ZNF389	chr6:28129551-28137375:+	-0.48	-6.86	2.08E-11	Depression	
THCA	cis	1	rs2799079	chr6:28235176	ZSCAN23	chr6:28393287-28411279:-	0.23	4.99	8.66E-7	Depression	
THCA	cis	1	rs2799495	chr10:38237984	LOC399744	chr10:38717074-38741080:+	-0.28	-3.75	0.000198	Obesity (extreme)	
THCA	cis	1	rs2799495	chr10:38237984	ZNF25	chr10:38238795-38265453:-	-0.16	-3.39	0.000766	Obesity (extreme)	
THCA	cis	1	rs2799501	chr10:38167038	LOC399744	chr10:38717074-38741080:+	-0.28	-3.77	0.00018	Obesity (extreme)	
THCA	cis	1	rs2799501	chr10:38167038	ZNF25	chr10:38238795-38265453:-	-0.16	-3.39	0.000757	Obesity (extreme)	
THCA	cis	1	rs2799505	chr10:38223014	LOC399744	chr10:38717074-38741080:+	-0.27	-3.68	0.000261	Obesity (extreme)	
THCA	cis	1	rs2799507	chr10:38227064	LOC399744	chr10:38717074-38741080:+	-0.27	-3.68	0.000261	Obesity (extreme)	
THCA	cis	1	rs2802217	chr1:207482970	CD55	chr1:207494817-207534309:+	0.16	6.86	2.17E-11	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs2802232	chr1:207468151	CD55	chr1:207494817-207534309:+	0.19	7.77	4.8E-14	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs2802233	chr1:207471224	CD55	chr1:207494817-207534309:+	-0.16	-6.99	9.29E-12	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs2802234	chr1:207471589	CD55	chr1:207494817-207534309:+	0.16	7	8.73E-12	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs2802235	chr1:207471799	CD55	chr1:207494817-207534309:+	0.19	7.85	2.8E-14	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs2802236	chr1:207472189	CD55	chr1:207494817-207534309:+	-0.16	-6.98	9.71E-12	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs2802237	chr1:207474170	CD55	chr1:207494817-207534309:+	0.19	7.73	6.27E-14	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs2802238	chr1:207476141	CD55	chr1:207494817-207534309:+	0.16	6.84	2.47E-11	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs280603	chr4:129915063	C4orf33	chr4:130014829-130033842:+	-0.59	-9.42	1.88E-19	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs280604	chr4:129921170	C4orf33	chr4:130014829-130033842:+	-0.59	-9.46	1.4E-19	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs2811381	chr3:127997912	EEFSEC	chr3:127872313-128127488:+	0.26	4.53	7.38E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2811387	chr3:128015178	EEFSEC	chr3:127872313-128127488:+	0.27	4.79	2.19E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2811390	chr3:128021481	EEFSEC	chr3:127872313-128127488:+	0.2	3.57	0.000391	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2811391	chr3:128022368	EEFSEC	chr3:127872313-128127488:+	0.2	3.57	0.000391	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2811392	chr3:128023976	EEFSEC	chr3:127872313-128127488:+	0.22	3.83	0.000146	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2811393	chr3:128023999	EEFSEC	chr3:127872313-128127488:+	0.2	3.55	0.000431	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2811396	chr3:127987356	EEFSEC	chr3:127872313-128127488:+	0.27	4.82	1.91E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2811397	chr3:128027237	EEFSEC	chr3:127872313-128127488:+	0.2	3.53	0.000453	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2811414	chr3:127991177	EEFSEC	chr3:127872313-128127488:+	0.26	4.53	7.38E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2811416	chr3:127991938	EEFSEC	chr3:127872313-128127488:+	0.26	4.41	1.29E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2811511	chr3:127912988	EEFSEC	chr3:127872313-128127488:+	-0.25	-4.35	1.68E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2811518	chr3:128013645	EEFSEC	chr3:127872313-128127488:+	0.28	5.01	7.66E-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2811519	chr3:128012876	EEFSEC	chr3:127872313-128127488:+	0.28	5.01	7.66E-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2811522	chr3:128011423	EEFSEC	chr3:127872313-128127488:+	0.27	4.81	2.01E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2811523	chr3:128011397	EEFSEC	chr3:127872313-128127488:+	-0.25	-4.55	6.87E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2811525	chr3:127999430	EEFSEC	chr3:127872313-128127488:+	0.27	4.81	1.99E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2811526	chr3:127995718	EEFSEC	chr3:127872313-128127488:+	0.27	4.79	2.27E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2811527	chr3:127994604	EEFSEC	chr3:127872313-128127488:+	0.26	4.74	2.81E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2811528	chr3:127994436	EEFSEC	chr3:127872313-128127488:+	0.26	4.56	6.38E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2811530	chr3:127993166	EEFSEC	chr3:127872313-128127488:+	0.26	4.53	7.38E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2811533	chr3:127991729	EEFSEC	chr3:127872313-128127488:+	0.26	4.69	3.65E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2811534	chr3:127991108	EEFSEC	chr3:127872313-128127488:+	0.27	4.82	1.91E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2811536	chr3:127988919	EEFSEC	chr3:127872313-128127488:+	0.26	4.53	7.38E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2811537	chr3:127987924	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.73	2.96E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2811538	chr3:127986631	EEFSEC	chr3:127872313-128127488:+	0.27	4.79	2.27E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2811539	chr3:127986473	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.51	8.04E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2811540	chr3:127985569	EEFSEC	chr3:127872313-128127488:+	0.27	4.79	2.27E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2811541	chr3:127984794	EEFSEC	chr3:127872313-128127488:+	0.27	4.82	1.92E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2811542	chr3:127983800	EEFSEC	chr3:127872313-128127488:+	0.27	4.79	2.27E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2811543	chr3:127983796	EEFSEC	chr3:127872313-128127488:+	0.27	4.79	2.27E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2811544	chr3:127983495	EEFSEC	chr3:127872313-128127488:+	0.27	4.79	2.27E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2811545	chr3:127983148	EEFSEC	chr3:127872313-128127488:+	0.27	4.79	2.27E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2811549	chr3:127938708	EEFSEC	chr3:127872313-128127488:+	0.25	4.31	1.97E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2812972	chr6:86669880	SNHG5	chr6:86386726-86388451:-	-0.53	-12.62	1.06E-31	Response to antipsychotic treatment	
THCA	cis	1	rs2814993	chr6:34618893	C6orf106	chr6:34555066-34664625:-	-0.23	-3.67	0.000266	Pubertal anthropometrics	
THCA	cis	1	rs2814994	chr6:34620153	C6orf106	chr6:34555066-34664625:-	0.27	4.18	3.54E-5	Pubertal anthropometrics	
THCA	cis	1	rs2814996	chr6:34621314	C6orf106	chr6:34555066-34664625:-	0.25	3.94	9.53E-5	Pubertal anthropometrics	
THCA	cis	1	rs2814996	chr6:34621314	SNRPC	chr6:34725312-34741571:+	-0.15	-3.39	0.000746	Pubertal anthropometrics	
THCA	cis	1	rs2815005	chr6:34638847	C6orf106	chr6:34555066-34664625:-	0.25	3.95	9.04E-5	Pubertal anthropometrics	
THCA	cis	1	rs2815005	chr6:34638847	SNRPC	chr6:34725312-34741571:+	-0.15	-3.43	0.000655	Pubertal anthropometrics	
THCA	cis	1	rs2815033	chr6:39241686	KCNK16	chr6:39282475-39290330:-	0.13	3.44	0.00064	Cholesterol, total	
THCA	cis	1	rs2815059	chr6:39260467	KCNK16	chr6:39282475-39290330:-	0.13	3.34	0.000896	Cholesterol, total	
THCA	cis	1	rs2815060	chr6:39260797	KCNK16	chr6:39282475-39290330:-	0.14	3.47	0.000563	Cholesterol, total	
THCA	cis	1	rs2816815	chr6:86691656	SNHG5	chr6:86386726-86388451:-	-0.53	-12.59	1.3E-31	Response to antipsychotic treatment	
THCA	cis	1	rs2816821	chr6:86657084	SNHG5	chr6:86386726-86388451:-	-0.54	-12.73	3.62E-32	Response to antipsychotic treatment	
THCA	cis	1	rs2820292	chr1:201784287	SHISA4	chr1:201858032-201861426:+	-0.26	-5.59	3.76E-8	Body mass index	
THCA	cis	1	rs2821131	chr1:197302402	CFHR3	chr1:196743930-196762872:+	0.23	4.75	2.66E-6	Lupus nephritis in systemic lupus erythematosus	
THCA	cis	1	rs2822388	chr21:15408034	C21orf15	chr21:15215455-15220685:-	0.33	3.83	0.000146	Stroke	
THCA	cis	1	rs282802	chr15:80072820	MTHFS	chr15:80137320-80189370:-	0.2	5.97	4.54E-9	Disease-free survival in breast cancer	
THCA	cis	1	rs282804	chr15:80071108	MTHFS	chr15:80137320-80189370:-	-0.2	-5.96	4.95E-9	Disease-free survival in breast cancer	
THCA	cis	1	rs2832183	chr21:30482150	C21orf7	chr21:30449812-30548200:+	0.2	3.96	8.58E-5	Dental caries	
THCA	cis	1	rs2832184	chr21:30483265	C21orf7	chr21:30449812-30548200:+	0.2	3.96	8.73E-5	Dental caries	
THCA	cis	1	rs2832185	chr21:30483761	C21orf7	chr21:30449812-30548200:+	0.2	3.96	8.81E-5	Dental caries	
THCA	cis	1	rs2832189	chr21:30487414	C21orf7	chr21:30449812-30548200:+	0.2	4.03	6.49E-5	Dental caries	
THCA	cis	1	rs2832190	chr21:30488226	C21orf7	chr21:30449812-30548200:+	0.2	3.9	0.00011	Dental caries	
THCA	cis	1	rs2832191	chr21:30489300	C21orf7	chr21:30449812-30548200:+	0.2	4.03	6.37E-5	Dental caries	
THCA	cis	1	rs2832259	chr21:30584698	CCT8	chr21:30428650-30446010:-	0.49	7.87	2.39E-14	Response to mTOR inhibitor (everolimus)	
THCA	cis	1	rs2832267	chr21:30591662	CCT8	chr21:30428650-30446010:-	0.57	9.48	1.16E-19	Response to mTOR inhibitor (everolimus)	
THCA	cis	1	rs2832267	chr21:30591662	RWDD2B	chr21:30378082-30391685:-	0.3	3.68	0.000263	Response to mTOR inhibitor (everolimus)	
THCA	cis	1	rs2832270	chr21:30594532	CCT8	chr21:30428650-30446010:-	0.49	8.19	2.47E-15	Response to mTOR inhibitor (everolimus)	
THCA	cis	1	rs2832270	chr21:30594532	RWDD2B	chr21:30378082-30391685:-	0.3	3.78	0.000176	Response to mTOR inhibitor (everolimus)	
THCA	cis	1	rs2832272	chr21:30597403	CCT8	chr21:30428650-30446010:-	0.49	7.97	1.2E-14	Response to mTOR inhibitor (everolimus)	
THCA	cis	1	rs2833888	chr21:33927560	TCP10L	chr21:33947152-33957845:-	-0.51	-9.27	6.3E-19	Gastritis	
THCA	cis	1	rs2833889	chr21:33927768	TCP10L	chr21:33947152-33957845:-	0.5	9.32	4.14E-19	Gastritis	
THCA	cis	1	rs2833890	chr21:33927886	TCP10L	chr21:33947152-33957845:-	0.51	9.33	3.98E-19	Gastritis	
THCA	cis	1	rs2834187	chr21:34687410	IFNAR1	chr21:34696734-34732126:+	0.22	5.23	2.58E-7	Narcolepsy	
THCA	cis	1	rs2834188	chr21:34689253	IFNAR1	chr21:34696734-34732126:+	0.22	5.27	2.1E-7	Narcolepsy	
THCA	cis	1	rs2834190	chr21:34693011	IFNAR1	chr21:34696734-34732126:+	-0.22	-5.3	1.77E-7	Narcolepsy	
THCA	cis	1	rs2834288	chr21:35264397	ATP5O	chr21:35275758-35288158:-	-0.1	-3.97	8.21E-5	Gut microbiota (bacterial taxa)	
THCA	cis	1	rs2835607	chr21:38491973	DSCR9	chr21:38580804-38594036:+	-0.19	-3.82	0.00015	Eye color traits	
THCA	cis	1	rs2835607	chr21:38491973	PIGP	chr21:38437664-38445458:-	-0.54	-15.23	5.33E-43	Eye color traits	
THCA	cis	1	rs2835607	chr21:38491973	TTC3	chr21:38445571-38575406:+	0.31	10.77	2.31E-24	Eye color traits	
THCA	cis	1	rs2835608	chr21:38493455	DSCR9	chr21:38580804-38594036:+	-0.19	-3.82	0.00015	Eye color traits	
THCA	cis	1	rs2835608	chr21:38493455	PIGP	chr21:38437664-38445458:-	-0.54	-15.23	5.33E-43	Eye color traits	
THCA	cis	1	rs2835608	chr21:38493455	TTC3	chr21:38445571-38575406:+	0.31	10.77	2.31E-24	Eye color traits	
THCA	cis	1	rs28360546	chr6:163210973	PACRG	chr6:163148164-163736523:+	0.5	6.74	4.43E-11	Body mass index	
THCA	cis	1	rs28360661	chr21:40681972	HMGN1	chr21:40714247-40721270:-	-0.28	-6.61	1.06E-10	Cognitive function	
THCA	cis	1	rs28360661	chr21:40681972	LCA5L	chr21:40777772-40817731:-	0.14	3.44	0.000626	Cognitive function	
THCA	cis	1	rs28360661	chr21:40681972	PSMG1	chr21:40547390-40555440:-	-0.16	-3.97	8.28E-5	Cognitive function	
THCA	cis	1	rs28360661	chr21:40681972	SH3BGR	chr21:40817797-40887426:+	0.29	5.95	5.1E-9	Cognitive function	
THCA	cis	1	rs28360661	chr21:40681972	WRB	chr21:40752213-40769814:+	0.29	5.48	7.0E-8	Cognitive function	
THCA	cis	1	rs28362672	chr2:70056866	SNRNP27	chr2:70121090-70132348:+	0.17	3.88	0.00012	Colorectal or endometrial cancer	
THCA	cis	1	rs28363725	chr8:96027108	C8orf38	chr8:95908040-96088396:+	-0.25	-4.26	2.48E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs28365850	chr14:35591316	FAM177A1	chr14:35514113-35552587:+	-0.19	-3.49	0.00053	Atopic dermatitis	
THCA	cis	1	rs28365850	chr14:35591316	KIAA0391	chr14:35591776-35786673:+	0.32	5.94	5.64E-9	Atopic dermatitis	
THCA	cis	1	rs28365850	chr14:35591316	PPP2R3C	chr14:35554679-35591679:-	0.55	10.23	2.38E-22	Atopic dermatitis	
THCA	cis	1	rs28367503	chr16:67854534	C16orf86	chr16:67700717-67702659:+	-0.28	-3.41	0.000704	Crohn's disease	
THCA	cis	1	rs28367503	chr16:67854534	ZDHHC1	chr16:67428323-67450339:-	0.42	4.73	3.03E-6	Crohn's disease	
THCA	cis	1	rs2836950	chr21:40604429	HMGN1	chr21:40714247-40721270:-	0.25	5.94	5.42E-9	Menarche (age at onset)	
THCA	cis	1	rs2836950	chr21:40604429	SH3BGR	chr21:40817797-40887426:+	-0.2	-4.22	2.91E-5	Menarche (age at onset)	
THCA	cis	1	rs2836950	chr21:40604429	WRB	chr21:40752213-40769814:+	-0.2	-3.79	0.000169	Menarche (age at onset)	
THCA	cis	1	rs2836974	chr21:40663181	HMGN1	chr21:40714247-40721270:-	0.27	6.4	3.73E-10	Cognitive function	
THCA	cis	1	rs2836974	chr21:40663181	PSMG1	chr21:40547390-40555440:-	0.16	3.94	9.26E-5	Cognitive function	
THCA	cis	1	rs2836974	chr21:40663181	SH3BGR	chr21:40817797-40887426:+	-0.27	-5.63	3.03E-8	Cognitive function	
THCA	cis	1	rs2836974	chr21:40663181	WRB	chr21:40752213-40769814:+	-0.28	-5.45	8.21E-8	Cognitive function	
THCA	cis	1	rs28371412	chr4:68415525	CENPC1	chr4:68337989-68411256:-	0.3	6.65	7.8E-11	Parkinson's disease	
THCA	cis	1	rs28371583	chr1:207494679	CD55	chr1:207494817-207534309:+	0.18	7.48	3.53E-13	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs28371583	chr1:207494679	CR1	chr1:207669473-207815109:+	-0.14	-3.53	0.000461	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs28371597	chr1:207496896	CD55	chr1:207494817-207534309:+	0.19	7.35	8.38E-13	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs28371597	chr1:207496896	CR1	chr1:207669473-207815109:+	-0.14	-3.5	0.000508	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs28371614	chr1:207505274	CD55	chr1:207494817-207534309:+	0.18	7.26	1.57E-12	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs28371614	chr1:207505274	CR1	chr1:207669473-207815109:+	-0.14	-3.73	0.00021	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs28372828	chr1:156253031	BGLAP	chr1:156182784-156213112:+	0.23	5.47	7.3E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs28372828	chr1:156253031	C1orf85	chr1:156259882-156265449:-	-0.17	-3.96	8.8E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs28372828	chr1:156253031	CCT3	chr1:156278752-156308195:-	-0.32	-7.02	7.8E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs28374715	chr15:41563950	CHP	chr15:41523437-41574081:+	-0.2	-4.36	1.58E-5	Ulcerative colitis	
THCA	cis	1	rs28374715	chr15:41563950	NDUFAF1	chr15:41679553-41694642:-	0.43	8.92	9.62E-18	Ulcerative colitis	
THCA	cis	1	rs28374715	chr15:41563950	RTF1	chr15:41709302-41775760:+	-0.21	-4.03	6.59E-5	Ulcerative colitis	
THCA	cis	1	rs28378156	chr8:96027127	C8orf38	chr8:95908040-96088396:+	-0.25	-4.26	2.48E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs28378477	chr16:20406481	ACSM1	chr16:20634559-20709066:-	0.28	3.61	0.000338	Urinary uromodulin levels	
THCA	cis	1	rs28379681	chr7:1070539	ZFAND2A	chr7:1192544-1199855:-	-0.3	-4.4	1.33E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs2838009	chr21:42694284	FAM3B	chr21:42676177-42729654:+	-0.5	-7.54	2.32E-13	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
THCA	cis	1	rs28380602	chr15:24778146	PWRN1	chr15:24778839-24832924:+	0.25	5.69	2.17E-8	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
THCA	cis	1	rs2838517	chr21:45613825	ICOSLG	chr21:45646724-45660834:-	0.19	4.03	6.61E-5	Inflammatory bowel disease	
THCA	cis	1	rs2838517	chr21:45613825	PWP2	chr21:45527208-45551062:+	0.26	4.65	4.24E-6	Inflammatory bowel disease	
THCA	cis	1	rs2838941	chr21:46901060	SUMO3	chr21:46225532-46238044:-	-0.37	-3.71	0.000232	Alzheimer disease and age of onset	
THCA	cis	1	rs28391259	chr4:107014012	TBCK	chr4:106967233-107237861:-	0.36	7.35	8.37E-13	Airflow obstruction	
THCA	cis	1	rs2839181	chr21:47685939	C21orf57	chr21:47706267-47717664:+	-0.5	-13.76	1.51E-36	Testicular germ cell tumor	
THCA	cis	1	rs2839181	chr21:47685939	MCM3APAS	chr21:47649158-47671743:+	0.23	5.53	5.26E-8	Testicular germ cell tumor	
THCA	cis	1	rs2839181	chr21:47685939	MCM3AP	chr21:47655048-47705236:-	0.2	4.73	3.03E-6	Testicular germ cell tumor	
THCA	cis	1	rs2839186	chr21:47690068	C21orf57	chr21:47706267-47717664:+	-0.51	-14.22	1.67E-38	Testicular germ cell tumor	
THCA	cis	1	rs2839186	chr21:47690068	LSS	chr21:47608361-47648738:-	0.18	3.36	0.000828	Testicular germ cell tumor	
THCA	cis	1	rs2839186	chr21:47690068	MCM3APAS	chr21:47649158-47671743:+	0.22	5.32	1.62E-7	Testicular germ cell tumor	
THCA	cis	1	rs2839186	chr21:47690068	MCM3AP	chr21:47655048-47705236:-	0.22	5.16	3.7E-7	Testicular germ cell tumor	
THCA	cis	1	rs2839337	chr21:47987167	C21orf56	chr21:47581063-47604373:-	0.26	4.74	2.84E-6	Lymphocyte counts	
THCA	cis	1	rs2839337	chr21:47987167	C21orf57	chr21:47706267-47717664:+	0.16	3.56	0.000413	Lymphocyte counts	
THCA	cis	1	rs2839618	chr21:44433454	PKNOX1	chr21:44394643-44453688:+	0.34	4.58	5.89E-6	Information processing speed	
THCA	cis	1	rs2839619	chr21:44436177	CBS	chr21:44473301-44496472:-	0.19	4.1	4.91E-5	Biochemical measures	
THCA	cis	1	rs2839627	chr21:44448718	PKNOX1	chr21:44394643-44453688:+	-0.39	-5.12	4.5E-7	Information processing speed	
THCA	cis	1	rs28399702	chr14:35625217	FAM177A1	chr14:35514113-35552587:+	-0.19	-3.66	0.000281	Atopic dermatitis	
THCA	cis	1	rs28399702	chr14:35625217	KIAA0391	chr14:35591776-35786673:+	0.28	5.37	1.2E-7	Atopic dermatitis	
THCA	cis	1	rs28399702	chr14:35625217	PPP2R3C	chr14:35554679-35591679:-	0.51	9.74	1.41E-20	Atopic dermatitis	
THCA	cis	1	rs28399710	chr7:1070631	ZFAND2A	chr7:1192544-1199855:-	-0.3	-4.4	1.33E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs28401	chr16:3515354	CEMP1	chr16:2580036-2581419:-	-0.17	-3.67	0.000269	Tuberculosis	
THCA	cis	1	rs28401	chr16:3515354	NAT15	chr16:3493668-3536962:+	-0.24	-4.26	2.45E-5	Tuberculosis	
THCA	cis	1	rs28401	chr16:3515354	TRAP1	chr16:3708039-3767598:-	0.16	3.9	0.00011	Tuberculosis	
THCA	cis	1	rs28406132	chr8:96030377	C8orf38	chr8:95908040-96088396:+	-0.26	-4.4	1.31E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs28407694	chr8:66861738	PDE7A	chr8:66629906-66753755:-	0.16	3.6	0.000356	Myopia (pathological)	
THCA	cis	1	rs28409322	chr3:134252385	ANAPC13	chr3:134196547-134204865:-	-0.39	-12.14	9.6E-30	Height	
THCA	cis	1	rs28409322	chr3:134252385	CEP63	chr3:134204575-134293852:+	-0.31	-6.6	1.07E-10	Height	
THCA	cis	1	rs28409655	chr4:48391379	OCIAD1	chr4:48833015-48863831:+	0.14	4.36	1.6E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs28410096	chr12:123880862	C12orf65	chr12:123717841-123742481:+	0.23	3.84	0.000139	HDL cholesterol	
THCA	cis	1	rs28414285	chr8:89427336	MMP16	chr8:89049462-89339717:-	0.32	5.19	3.04E-7	Electrodermal activity	
THCA	cis	1	rs28416221	chr4:75710773	BTC	chr4:75671448-75719882:-	0.2	3.92	0.000103	Electroencephalogram traits	
THCA	cis	1	rs28416696	chr2:54484326	C2orf73	chr2:54558071-54588714:+	0.31	4.55	6.89E-6	Telomere length	
THCA	cis	1	rs28417694	chr3:58373939	PXK	chr3:58318617-58410878:+	0.34	6.01	3.64E-9	Cholesterol, total	
THCA	cis	1	rs28427306	chr16:20406688	ACSM1	chr16:20634559-20709066:-	0.27	3.59	0.000368	Urinary uromodulin levels	
THCA	cis	1	rs28428724	chr4:75711826	BTC	chr4:75671448-75719882:-	0.2	3.92	0.000103	Electroencephalogram traits	
THCA	cis	1	rs2842992	chr6:160071159	MRPL18	chr6:160211022-160219460:+	-0.22	-6	3.9E-9	Age-related macular degeneration (GA)	
THCA	cis	1	rs28433617	chr4:122664138	EXOSC9	chr4:122722472-122738175:+	0.15	4.05	5.86E-5	Type 2 diabetes	
THCA	cis	1	rs28434757	chr22:18451554	MICAL3	chr22:18270418-18507325:-	-0.2	-4.16	3.77E-5	Presence of antiphospholipid antibodies	
THCA	cis	1	rs28436199	chr17:18751730	FAM18B	chr17:18684582-18710026:+	-0.42	-10.74	2.91E-24	Educational attainment (years of education)	
THCA	cis	1	rs28436199	chr17:18751730	FBXW10	chr17:18647326-18682661:+	-0.22	-4.81	1.98E-6	Educational attainment (years of education)	
THCA	cis	1	rs2843994	chr21:34706870	IFNAR1	chr21:34696734-34732126:+	0.23	5.47	7.3E-8	Narcolepsy	
THCA	cis	1	rs28440026	chr8:96026744	C8orf38	chr8:95908040-96088396:+	-0.25	-4.26	2.48E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs28444423	chr15:65982141	DPP8	chr15:65737999-65810035:-	-0.1	-4.08	5.35E-5	Mean corpuscular hemoglobin	
THCA	cis	1	rs28444423	chr15:65982141	SLC24A1	chr15:65903704-65953256:+	-0.16	-3.78	0.000175	Mean corpuscular hemoglobin	
THCA	cis	1	rs28446827	chr8:89420016	MMP16	chr8:89049462-89339717:-	0.32	5.19	3.04E-7	Electrodermal activity	
THCA	cis	1	rs28448438	chr4:56416665	TMEM165	chr4:56262090-56292342:+	0.14	3.6	0.000352	Personality dimensions	
THCA	cis	1	rs28449219	chr7:87480345	DBF4	chr7:87505544-87538856:+	-0.3	-4.47	9.7E-6	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs28453840	chr2:136522941	DARS	chr2:136664254-136743222:-	-0.23	-4.58	5.84E-6	Cholesterol, total	
THCA	cis	1	rs28456975	chr15:24824729	PWRN1	chr15:24778839-24832924:+	0.4	8.39	5.45E-16	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
THCA	cis	1	rs2845857	chr11:71715215	FAM86C	chr11:71498557-71512276:+	0.3	3.72	0.000219	Severe influenza A (H1N1) infection	
THCA	cis	1	rs2845885	chr11:63869062	VEGFB	chr11:64002266-64006258:+	-0.15	-3.42	0.000687	Body mass index	
THCA	cis	1	rs28463311	chr17:61919643	FTSJ3	chr17:61896795-61905031:-	0.3	5.49	6.61E-8	Body mass index	
THCA	cis	1	rs28463311	chr17:61919643	MAP3K3	chr17:61699775-61773669:+	0.26	5.13	4.28E-7	Body mass index	
THCA	cis	1	rs28463765	chr4:56412434	TMEM165	chr4:56262090-56292342:+	0.14	3.51	0.000493	Personality dimensions	
THCA	cis	1	rs284648	chr19:41926790	B3GNT8	chr19:41931265-41934635:-	-0.36	-8.29	1.13E-15	Height	
THCA	cis	1	rs284648	chr19:41926790	EXOSC5	chr19:41892278-41903256:-	-0.11	-3.63	0.00031	Height	
THCA	cis	1	rs284649	chr19:41926838	B3GNT8	chr19:41931265-41934635:-	-0.36	-8.29	1.13E-15	Height	
THCA	cis	1	rs284649	chr19:41926838	EXOSC5	chr19:41892278-41903256:-	-0.11	-3.63	0.00031	Height	
THCA	cis	1	rs284650	chr19:41927129	B3GNT8	chr19:41931265-41934635:-	-0.36	-8.29	1.13E-15	Height	
THCA	cis	1	rs284650	chr19:41927129	EXOSC5	chr19:41892278-41903256:-	-0.11	-3.63	0.00031	Height	
THCA	cis	1	rs284651	chr19:41928336	B3GNT8	chr19:41931265-41934635:-	-0.36	-8.36	7.07E-16	Height	
THCA	cis	1	rs284651	chr19:41928336	EXOSC5	chr19:41892278-41903256:-	-0.11	-3.63	0.000318	Height	
THCA	cis	1	rs284652	chr19:41928652	B3GNT8	chr19:41931265-41934635:-	-0.36	-8.29	1.13E-15	Height	
THCA	cis	1	rs284652	chr19:41928652	EXOSC5	chr19:41892278-41903256:-	-0.11	-3.63	0.00031	Height	
THCA	cis	1	rs284654	chr19:41928724	B3GNT8	chr19:41931265-41934635:-	-0.36	-8.35	7.61E-16	Height	
THCA	cis	1	rs284654	chr19:41928724	EXOSC5	chr19:41892278-41903256:-	-0.11	-3.6	0.000348	Height	
THCA	cis	1	rs28465556	chr4:39121189	KLHL5	chr4:39046659-39123828:+	-0.21	-5.77	1.47E-8	Uric acid levels	
THCA	cis	1	rs284655	chr19:41928765	B3GNT8	chr19:41931265-41934635:-	-0.36	-8.37	6.63E-16	Height	
THCA	cis	1	rs284655	chr19:41928765	EXOSC5	chr19:41892278-41903256:-	-0.11	-3.72	0.000219	Height	
THCA	cis	1	rs284656	chr19:41929251	B3GNT8	chr19:41931265-41934635:-	-0.36	-8.29	1.13E-15	Height	
THCA	cis	1	rs284656	chr19:41929251	EXOSC5	chr19:41892278-41903256:-	-0.11	-3.63	0.00031	Height	
THCA	cis	1	rs284657	chr19:41929915	B3GNT8	chr19:41931265-41934635:-	-0.36	-8.5	2.43E-16	Height	
THCA	cis	1	rs284657	chr19:41929915	EXOSC5	chr19:41892278-41903256:-	-0.11	-3.7	0.000237	Height	
THCA	cis	1	rs284658	chr19:41929988	B3GNT8	chr19:41931265-41934635:-	-0.36	-8.44	3.82E-16	Height	
THCA	cis	1	rs284658	chr19:41929988	EXOSC5	chr19:41892278-41903256:-	-0.11	-3.75	0.0002	Height	
THCA	cis	1	rs284663	chr19:41932612	B3GNT8	chr19:41931265-41934635:-	-0.35	-7.88	2.25E-14	Height	
THCA	cis	1	rs284663	chr19:41932612	EXOSC5	chr19:41892278-41903256:-	-0.11	-3.53	0.000462	Height	
THCA	cis	1	rs28469723	chr20:33700717	PROCR	chr20:33758727-33765164:+	-0.34	-6.02	3.44E-9	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs28469723	chr20:33700717	TRPC4AP	chr20:33590215-33680618:-	0.34	4.53	7.32E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs28473160	chr4:75700409	BTC	chr4:75671448-75719882:-	0.2	3.76	0.000191	Electroencephalogram traits	
THCA	cis	1	rs2847655	chr11:59865671	MS4A14	chr11:60145958-60185226:+	0.18	4.59	5.69E-6	Alzheimer's disease (late onset)	
THCA	cis	1	rs2847666	chr11:59859576	MS4A14	chr11:60145958-60185226:+	0.17	4.47	9.95E-6	Alzheimer's disease (late onset)	
THCA	cis	1	rs2847667	chr11:59859609	MS4A14	chr11:60145958-60185226:+	0.18	4.53	7.46E-6	Alzheimer's disease (late onset)	
THCA	cis	1	rs2847668	chr11:59862261	MS4A14	chr11:60145958-60185226:+	0.17	4.45	1.06E-5	Alzheimer's disease (late onset)	
THCA	cis	1	rs28477407	chr14:55344901	GCH1	chr14:55308724-55369542:-	-0.21	-4.53	7.53E-6	Rheumatoid arthritis;Obesity-related traits	
THCA	cis	1	rs28477467	chr8:96032905	C8orf38	chr8:95908040-96088396:+	-0.25	-4.29	2.19E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs28480159	chr4:17685707	MED28	chr4:17616273-17629791:+	0.16	3.43	0.000645	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs28480595	chr19:52787905	ZNF836	chr19:52658127-52674896:-	0.31	4.51	8.06E-6	Cannabis use (initiation)	
THCA	cis	1	rs28485881	chr17:80690014	FN3KRP	chr17:80674582-80685889:+	-0.54	-10.3	1.37E-22	Glycated hemoglobin levels	
THCA	cis	1	rs28488297	chr4:106767226	INTS12	chr4:106603787-106629881:-	-0.46	-4.34	1.74E-5	Post bronchodilator FEV1	
THCA	cis	1	rs28489285	chr9:99543229	FAM22G	chr9:99690592-99704572:+	0.98	7.96	1.27E-14	Height	
THCA	cis	1	rs28489285	chr9:99543229	HIATL2	chr9:99695549-99775862:-	0.71	5.75	1.6E-8	Height	
THCA	cis	1	rs28489285	chr9:99543229	LOC441454	chr9:99671357-99672736:+	0.44	3.89	0.000113	Height	
THCA	cis	1	rs28489489	chr3:58443755	PXK	chr3:58318617-58410878:+	0.32	5.75	1.64E-8	Cholesterol, total	
THCA	cis	1	rs28494067	chr15:50908272	SPPL2A	chr15:50999739-51057910:-	0.26	7.03	7.33E-12	QT interval	
THCA	cis	1	rs28496357	chr8:96030511	C8orf38	chr8:95908040-96088396:+	-0.25	-4.26	2.49E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs28497813	chr4:17685503	MED28	chr4:17616273-17629791:+	0.16	3.43	0.000645	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs28501387	chr14:81772667	STON2	chr14:81727000-81893748:-	0.21	4.2	3.16E-5	Obesity-related traits	
THCA	cis	1	rs28502530	chr14:65850968	LOC645431	chr14:65877313-65879335:-	-0.39	-5.08	5.52E-7	Ischemic stroke	
THCA	cis	1	rs28504107	chr11:71832519	FAM86C	chr11:71498557-71512276:+	-0.3	-3.83	0.000147	Severe influenza A (H1N1) infection	
THCA	cis	1	rs28505711	chr1:19329712	TMCO4	chr1:20008707-20126758:-	-0.15	-3.34	0.000906	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
THCA	cis	1	rs28510818	chr5:176982662	DOK3	chr5:176928915-176937427:-	0.29	6.6	1.07E-10	Alzheimer disease and age of onset	
THCA	cis	1	rs28512382	chr10:1092195	IDI2	chr10:1064847-1071799:-	-0.23	-3.44	0.000642	Response to angiotensin II receptor blocker therapy	
THCA	cis	1	rs28513831	chr8:124189208	FAM83A	chr8:124191287-124222317:+	-0.33	-4.38	1.46E-5	Urinary uromodulin levels	
THCA	cis	1	rs28514423	chr4:56429239	TMEM165	chr4:56262090-56292342:+	0.16	4.02	6.65E-5	Personality dimensions	
THCA	cis	1	rs28515190	chr3:161028605	NMD3	chr3:160939099-160971319:+	-0.11	-3.64	0.000304	Morning vs. evening chronotype	
THCA	cis	1	rs28517362	chr6:151876387	C6orf97	chr6:151815175-151942327:+	0.33	4.64	4.43E-6	Bone mineral density (spine)	
THCA	cis	1	rs28522614	chr10:102323141	SEC31B	chr10:102246403-102289636:-	-0.28	-8.87	1.42E-17	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs28527299	chr3:150994070	GPR87	chr3:151011876-151034636:-	0.2	4.61	5.13E-6	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs28527299	chr3:150994070	P2RY14	chr3:150929905-150996230:-	-0.18	-3.9	0.000111	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs28528096	chr7:1070912	ZFAND2A	chr7:1192544-1199855:-	-0.3	-4.4	1.33E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs28529552	chr4:75705581	BTC	chr4:75671448-75719882:-	0.21	3.93	9.95E-5	Electroencephalogram traits	
THCA	cis	1	rs28532037	chr12:123883406	C12orf65	chr12:123717841-123742481:+	0.26	4.07	5.61E-5	HDL cholesterol	
THCA	cis	1	rs28532673	chr4:122664323	EXOSC9	chr4:122722472-122738175:+	-0.15	-3.97	8.17E-5	Type 2 diabetes	
THCA	cis	1	rs28537152	chr8:124189071	FAM83A	chr8:124191287-124222317:+	-0.33	-4.38	1.46E-5	Urinary uromodulin levels	
THCA	cis	1	rs28537604	chr7:87487688	DBF4	chr7:87505544-87538856:+	-0.27	-3.83	0.000143	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs28539246	chr17:29226630	SUZ12P	chr17:29035714-29097067:+	-0.16	-4.61	5.22E-6	Height	
THCA	cis	1	rs28540190	chr19:49135043	SEC1	chr19:49141296-49185501:+	-0.66	-7.18	2.66E-12	Elevated serum carcinoembryonic antigen levels	
THCA	cis	1	rs28542077	chr8:124190896	FAM83A	chr8:124191287-124222317:+	-0.3	-3.9	0.000108	Urinary uromodulin levels	
THCA	cis	1	rs2854218	chr17:61942940	FTSJ3	chr17:61896795-61905031:-	0.31	5.76	1.51E-8	Body mass index	
THCA	cis	1	rs2854218	chr17:61942940	MAP3K3	chr17:61699775-61773669:+	0.26	5.17	3.51E-7	Body mass index	
THCA	cis	1	rs2854219	chr17:61942682	FTSJ3	chr17:61896795-61905031:-	0.3	5.64	2.85E-8	Body mass index	
THCA	cis	1	rs2854219	chr17:61942682	MAP3K3	chr17:61699775-61773669:+	0.25	5.1	5.02E-7	Body mass index	
THCA	cis	1	rs28542204	chr15:62366049	VPS13C	chr15:62144592-62352647:-	-0.11	-4.1	4.87E-5	Height	
THCA	cis	1	rs2854223	chr17:61939014	FTSJ3	chr17:61896795-61905031:-	0.3	5.6	3.68E-8	Body mass index	
THCA	cis	1	rs2854223	chr17:61939014	MAP3K3	chr17:61699775-61773669:+	0.22	4.51	8.33E-6	Body mass index	
THCA	cis	1	rs28542689	chr8:10813054	CTSB	chr8:11700036-11725646:-	0.22	3.5	0.000501	Asthma and hay fever	
THCA	cis	1	rs28546778	chr7:87517427	DBF4	chr7:87505544-87538856:+	-0.27	-3.74	0.000203	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs28549876	chr15:43025524	GANC	chr15:42565856-42645863:+	-0.18	-3.84	0.000142	MGMT methylation in smokers	
THCA	cis	1	rs2855017	chr11:59866309	MS4A14	chr11:60145958-60185226:+	0.17	4.36	1.57E-5	Alzheimer's disease (late onset)	
THCA	cis	1	rs2855036	chr11:5272682	HBG1	chr11:5269502-5271087:-	0.26	4.09	5.05E-5	Hemoglobin levels	
THCA	cis	1	rs2855036	chr11:5272682	HBG2	chr11:5269502-5667011:-	0.28	4.39	1.38E-5	Hemoglobin levels	
THCA	cis	1	rs2855039	chr11:5271671	HBG1	chr11:5269502-5271087:-	0.26	4.15	3.95E-5	Hemoglobin levels	
THCA	cis	1	rs2855039	chr11:5271671	HBG2	chr11:5269502-5667011:-	0.29	4.53	7.29E-6	Hemoglobin levels	
THCA	cis	1	rs28550569	chr16:20404822	ACSM1	chr16:20634559-20709066:-	0.26	3.39	0.000756	Urinary uromodulin levels	
THCA	cis	1	rs2855121	chr11:5277291	HBG1	chr11:5269502-5271087:-	0.27	4.21	2.99E-5	Hemoglobin levels	
THCA	cis	1	rs2855121	chr11:5277291	HBG2	chr11:5269502-5667011:-	0.28	4.42	1.23E-5	Hemoglobin levels	
THCA	cis	1	rs28552744	chr4:17620165	MED28	chr4:17616273-17629791:+	0.15	3.34	0.000888	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs28556680	chr15:66023799	DPP8	chr15:65737999-65810035:-	-0.1	-4.04	6.29E-5	Mean corpuscular hemoglobin	
THCA	cis	1	rs28556680	chr15:66023799	SLC24A1	chr15:65903704-65953256:+	-0.16	-3.84	0.000138	Mean corpuscular hemoglobin	
THCA	cis	1	rs28558133	chr6:26531433	BTN2A3	chr6:26422317-26431927:+	0.19	4.52	7.72E-6	Educational attainment	
THCA	cis	1	rs28558133	chr6:26531433	HCG11	chr6:26521934-26527610:+	-0.23	-4.43	1.18E-5	Educational attainment	
THCA	cis	1	rs28558133	chr6:26531433	HMGN4	chr6:26538572-26547162:+	-0.16	-4.05	5.86E-5	Educational attainment	
THCA	cis	1	rs28558133	chr6:26531433	ZNF322A	chr6:26634612-26659963:-	-0.14	-3.77	0.000183	Educational attainment	
THCA	cis	1	rs28558726	chr17:53058676	STXBP4	chr17:53046126-53241449:+	-0.16	-4.25	2.6E-5	Breast cancer	
THCA	cis	1	rs28558726	chr17:53058676	TOM1L1	chr17:52978052-53039328:+	-0.13	-3.39	0.000765	Breast cancer	
THCA	cis	1	rs28562777	chr19:32900819	DPY19L3	chr19:32896677-32975236:+	0.19	5	8.25E-7	Bipolar disorder	
THCA	cis	1	rs28562777	chr19:32900819	ZNF507	chr19:32836514-32878571:+	0.28	7.03	7.36E-12	Bipolar disorder	
THCA	cis	1	rs28562875	chr18:23610474	SS18	chr18:23596219-23671164:-	0.26	3.36	0.000841	Rhegmatogenous retinal detachment	
THCA	cis	1	rs28564902	chr4:56479491	KDR	chr4:55944427-55991762:-	-0.11	-3.49	0.00052	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs28564902	chr4:56479491	NMU	chr4:56461405-56502465:-	0.2	3.59	0.000361	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs28564902	chr4:56479491	PDCL2	chr4:56422693-56458379:-	0.31	4.81	2.0E-6	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs28567450	chr6:34747409	C6orf106	chr6:34555066-34664625:-	0.2	3.42	0.000689	Pubertal anthropometrics	
THCA	cis	1	rs28567450	chr6:34747409	SNRPC	chr6:34725312-34741571:+	-0.14	-3.47	0.000571	Pubertal anthropometrics	
THCA	cis	1	rs2856	chr20:25433536	ENTPD6	chr20:25176339-25207360:+	-0.32	-7.44	4.57E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2856	chr20:25433536	FAM182A	chr20:26035250-26067552:+	-0.19	-3.53	0.000462	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2856	chr20:25433536	FAM182B	chr20:25744102-25848786:-	0.25	5.27	2.02E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2856	chr20:25433536	NINL	chr20:25433338-25566153:-	-0.34	-7.12	3.98E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs2856	chr20:25433536	PYGB	chr20:25228706-25278647:+	-0.15	-3.85	0.000132	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs28572116	chr4:56424344	TMEM165	chr4:56262090-56292342:+	0.14	3.59	0.000366	Personality dimensions	
THCA	cis	1	rs28572537	chr19:18552208	ELL	chr19:18553475-18632937:-	-0.25	-6.47	2.38E-10	Breast cancer	
THCA	cis	1	rs28572537	chr19:18552208	ISYNA1	chr19:18545625-18548943:-	0.12	4.69	3.53E-6	Breast cancer	
THCA	cis	1	rs28572537	chr19:18552208	LRRC25	chr19:18501955-18508421:-	-0.15	-5.04	6.78E-7	Breast cancer	
THCA	cis	1	rs28575371	chr4:75699537	BTC	chr4:75671448-75719882:-	0.2	3.9	0.000111	Electroencephalogram traits	
THCA	cis	1	rs2857891	chr11:6962957	ZNF215	chr11:6947654-7005861:+	-0.28	-4.42	1.24E-5	Response to cytadine analogues (cytosine arabinoside)	
THCA	cis	1	rs28581530	chr14:100872263	WDR25	chr14:100842755-100996638:+	0.38	8.71	5.09E-17	Menarche (age at onset)	
THCA	cis	1	rs28581850	chr12:123871717	C12orf65	chr12:123717841-123742481:+	0.24	3.99	7.66E-5	HDL cholesterol	
THCA	cis	1	rs28581869	chr8:89427256	MMP16	chr8:89049462-89339717:-	0.32	5.19	3.04E-7	Electrodermal activity	
THCA	cis	1	rs28582059	chr4:56408404	TMEM165	chr4:56262090-56292342:+	0.16	4.01	7.13E-5	Personality dimensions	
THCA	cis	1	rs28583584	chr17:17483297	ATPAF2	chr17:17918373-17942480:-	-0.24	-3.83	0.000146	Obsessive-compulsive symptoms	
THCA	cis	1	rs28591316	chr8:41524425	ANK1	chr8:41510745-41754280:-	-0.23	-4.69	3.51E-6	Type 2 diabetes	
THCA	cis	1	rs28592032	chr12:123879445	C12orf65	chr12:123717841-123742481:+	0.23	3.86	0.000129	HDL cholesterol	
THCA	cis	1	rs2859998	chr8:59324162	UBXN2B	chr8:59323823-59364059:+	-0.36	-9.68	2.29E-20	Narcolepsy with cataplexy	
THCA	cis	1	rs28600316	chr4:75711790	BTC	chr4:75671448-75719882:-	0.2	3.92	0.000103	Electroencephalogram traits	
THCA	cis	1	rs28600861	chr8:124189063	FAM83A	chr8:124191287-124222317:+	-0.33	-4.38	1.46E-5	Urinary uromodulin levels	
THCA	cis	1	rs28602663	chr1:76235355	ACADM	chr1:76190043-76229353:+	0.13	3.62	0.000326	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs28602663	chr1:76235355	MSH4	chr1:76262630-76378923:+	0.26	4.42	1.25E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs28602970	chr8:41524505	ANK1	chr8:41510745-41754280:-	-0.23	-4.69	3.51E-6	Type 2 diabetes	
THCA	cis	1	rs28607301	chr4:39138080	KLHL5	chr4:39046659-39123828:+	-0.21	-5.94	5.51E-9	Uric acid levels	
THCA	cis	1	rs28608578	chr4:75713550	BTC	chr4:75671448-75719882:-	0.2	3.92	0.000103	Electroencephalogram traits	
THCA	cis	1	rs28616734	chr8:96021443	C8orf38	chr8:95908040-96088396:+	-0.27	-4.56	6.65E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs28618203	chr4:122663935	EXOSC9	chr4:122722472-122738175:+	0.15	4.02	6.64E-5	Type 2 diabetes	
THCA	cis	1	rs28624331	chr8:124190768	FAM83A	chr8:124191287-124222317:+	-0.3	-3.9	0.000108	Urinary uromodulin levels	
THCA	cis	1	rs28624565	chr4:75713287	BTC	chr4:75671448-75719882:-	0.2	3.92	0.000103	Electroencephalogram traits	
THCA	cis	1	rs28625349	chr15:24832473	PWRN1	chr15:24778839-24832924:+	0.4	8.32	9.28E-16	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
THCA	cis	1	rs28626045	chr14:75589195	EIF2B2	chr14:75469612-75476292:+	0.19	5.12	4.49E-7	Height	
THCA	cis	1	rs28626045	chr14:75589195	MLH3	chr14:75480467-75518235:-	0.3	8.98	6.21E-18	Height	
THCA	cis	1	rs28626045	chr14:75589195	RPS6KL1	chr14:75372347-75389958:-	0.32	6.87	1.95E-11	Height	
THCA	cis	1	rs28626602	chr3:58409786	PXK	chr3:58318617-58410878:+	0.34	5.98	4.47E-9	Cholesterol, total	
THCA	cis	1	rs28627774	chr7:87517135	DBF4	chr7:87505544-87538856:+	-0.27	-3.74	0.000203	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs2862961	chr11:43656535	HSD17B12	chr11:43702143-43878160:+	0.68	14.09	5.68E-38	Forced vital capacity	
THCA	cis	1	rs2862963	chr11:43640115	HSD17B12	chr11:43702143-43878160:+	0.68	14.07	7.42E-38	Forced vital capacity	
THCA	cis	1	rs2862996	chr11:43653833	HSD17B12	chr11:43702143-43878160:+	-0.68	-14.23	1.51E-38	Forced vital capacity	
THCA	cis	1	rs28636952	chr17:17462506	ATPAF2	chr17:17918373-17942480:-	-0.2	-3.42	0.000684	Obsessive-compulsive symptoms	
THCA	cis	1	rs28637863	chr4:75706357	BTC	chr4:75671448-75719882:-	0.22	4.14	4.13E-5	Electroencephalogram traits	
THCA	cis	1	rs28640237	chr15:66070962	DPP8	chr15:65737999-65810035:-	-0.1	-4.25	2.62E-5	Mean corpuscular hemoglobin	
THCA	cis	1	rs28640237	chr15:66070962	SLC24A1	chr15:65903704-65953256:+	-0.16	-3.76	0.000189	Mean corpuscular hemoglobin	
THCA	cis	1	rs2864076	chr11:46460038	PACSIN3	chr11:47199085-47207958:-	0.16	3.67	0.000274	Schizophrenia	
THCA	cis	1	rs28640980	chr4:122664284	EXOSC9	chr4:122722472-122738175:+	0.15	3.96	8.49E-5	Type 2 diabetes	
THCA	cis	1	rs28645115	chr7:87385943	DBF4	chr7:87505544-87538856:+	-0.26	-3.96	8.74E-5	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs28647657	chr4:75713724	BTC	chr4:75671448-75719882:-	0.2	3.89	0.000113	Electroencephalogram traits	
THCA	cis	1	rs28649132	chr16:20406762	ACSM1	chr16:20634559-20709066:-	0.28	3.61	0.000338	Urinary uromodulin levels	
THCA	cis	1	rs2864	chr5:137523430	KLHL3	chr5:136953190-137071779:-	-0.13	-3.52	0.000475	Resting heart rate	
THCA	cis	1	rs28651964	chr8:96026781	C8orf38	chr8:95908040-96088396:+	-0.25	-4.32	1.88E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs28660993	chr12:123875394	C12orf65	chr12:123717841-123742481:+	0.24	3.99	7.66E-5	HDL cholesterol	
THCA	cis	1	rs28661978	chr3:156579739	LEKR1	chr3:156544076-156763918:+	-0.54	-10.49	2.67E-23	Bone mineral density	
THCA	cis	1	rs2866406	chr4:103554019	CISD2	chr4:103790135-103809913:+	-0.15	-3.5	0.000512	Primary biliary cirrhosis	
THCA	cis	1	rs2866406	chr4:103554019	NFKB1	chr4:103422486-103538458:+	0.14	4.04	6.17E-5	Primary biliary cirrhosis	
THCA	cis	1	rs2866407	chr4:103554108	CISD2	chr4:103790135-103809913:+	-0.15	-3.5	0.000512	Primary biliary cirrhosis	
THCA	cis	1	rs2866407	chr4:103554108	NFKB1	chr4:103422486-103538458:+	0.14	4.04	6.17E-5	Primary biliary cirrhosis	
THCA	cis	1	rs2866408	chr4:103554113	CISD2	chr4:103790135-103809913:+	-0.15	-3.5	0.000512	Primary biliary cirrhosis	
THCA	cis	1	rs2866408	chr4:103554113	NFKB1	chr4:103422486-103538458:+	0.14	4.04	6.17E-5	Primary biliary cirrhosis	
THCA	cis	1	rs2866409	chr4:103554261	CISD2	chr4:103790135-103809913:+	-0.16	-3.6	0.000354	Primary biliary cirrhosis	
THCA	cis	1	rs2866409	chr4:103554261	NFKB1	chr4:103422486-103538458:+	0.15	4.18	3.48E-5	Primary biliary cirrhosis	
THCA	cis	1	rs2866413	chr4:103557077	CISD2	chr4:103790135-103809913:+	-0.16	-3.62	0.000321	Primary biliary cirrhosis	
THCA	cis	1	rs2866413	chr4:103557077	NFKB1	chr4:103422486-103538458:+	0.15	4.2	3.16E-5	Primary biliary cirrhosis	
THCA	cis	1	rs2866414	chr4:103557219	CISD2	chr4:103790135-103809913:+	-0.16	-3.62	0.000321	Primary biliary cirrhosis	
THCA	cis	1	rs2866414	chr4:103557219	NFKB1	chr4:103422486-103538458:+	0.15	4.2	3.16E-5	Primary biliary cirrhosis	
THCA	cis	1	rs28664971	chr17:28437410	ANKRD13B	chr17:27916801-27941778:+	0.29	7.23	1.98E-12	Coffee consumption (cups per day)	
THCA	cis	1	rs28664971	chr17:28437410	CORO6	chr17:27941774-27948441:-	0.47	11.34	1.45E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs28664971	chr17:28437410	EFCAB5	chr17:28256874-28435469:+	0.56	11.04	2.13E-25	Coffee consumption (cups per day)	
THCA	cis	1	rs28664971	chr17:28437410	GIT1	chr17:27900487-27916610:-	0.28	6.67	7.08E-11	Coffee consumption (cups per day)	
THCA	cis	1	rs28664971	chr17:28437410	LRRC37B2	chr17:28903483-28992715:+	0.17	3.75	0.000196	Coffee consumption (cups per day)	
THCA	cis	1	rs28664971	chr17:28437410	SSH2	chr17:27952965-28257018:-	0.36	8.43	4.21E-16	Coffee consumption (cups per day)	
THCA	cis	1	rs28664971	chr17:28437410	TP53I13	chr17:27895739-27900174:+	0.17	4.56	6.46E-6	Coffee consumption (cups per day)	
THCA	cis	1	rs28668389	chr3:58323942	PXK	chr3:58318617-58410878:+	0.3	5.58	3.94E-8	Cholesterol, total	
THCA	cis	1	rs28670674	chr4:56407103	TMEM165	chr4:56262090-56292342:+	0.15	3.66	0.000284	Personality dimensions	
THCA	cis	1	rs28670850	chr8:124189125	FAM83A	chr8:124191287-124222317:+	-0.33	-4.38	1.46E-5	Urinary uromodulin levels	
THCA	cis	1	rs28672356	chr19:32907843	DPY19L3	chr19:32896677-32975236:+	0.19	5.12	4.38E-7	Bipolar disorder	
THCA	cis	1	rs28672356	chr19:32907843	ZNF507	chr19:32836514-32878571:+	0.3	7.3	1.2E-12	Bipolar disorder	
THCA	cis	1	rs2867318	chr19:52363472	ZNF577	chr19:52359056-52394145:-	-0.24	-5.66	2.56E-8	Breast cancer	
THCA	cis	1	rs2867318	chr19:52363472	ZNF649	chr19:52392489-52408247:-	-0.18	-3.76	0.000194	Breast cancer	
THCA	cis	1	rs28674915	chr16:69471857	CYB5B	chr16:69458498-69500167:+	-0.23	-3.99	7.7E-5	Blood pressure (smoking interaction)	
THCA	cis	1	rs28675749	chr1:19332725	TMCO4	chr1:20008707-20126758:-	-0.17	-3.83	0.000145	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
THCA	cis	1	rs28678226	chr9:99548146	FAM22G	chr9:99690592-99704572:+	0.96	8.66	7.31E-17	Height	
THCA	cis	1	rs28678226	chr9:99548146	HIATL2	chr9:99695549-99775862:-	0.71	6.39	4.04E-10	Height	
THCA	cis	1	rs28678226	chr9:99548146	LOC441454	chr9:99671357-99672736:+	0.42	4.03	6.49E-5	Height	
THCA	cis	1	rs28679372	chr16:67882932	ZDHHC1	chr16:67428323-67450339:-	-0.31	-3.58	0.00038	Crohn's disease	
THCA	cis	1	rs28683528	chr12:123845351	CDK2AP1	chr12:123745542-123756687:-	-0.23	-6.62	9.41E-11	Educational attainment;Height;Head circumference (infant)	
THCA	cis	1	rs28683528	chr12:123845351	MPHOSPH9	chr12:123640948-123717658:-	0.18	5.27	2.08E-7	Educational attainment;Height;Head circumference (infant)	
THCA	cis	1	rs28683528	chr12:123845351	PITPNM2	chr12:123468027-123635285:-	0.26	5.28	1.98E-7	Educational attainment;Height;Head circumference (infant)	
THCA	cis	1	rs28684871	chr3:10072635	C3orf10	chr3:10157333-10168873:+	-0.2	-4.29	2.14E-5	Alzheimer's disease	
THCA	cis	1	rs28684871	chr3:10072635	VHL	chr3:10183319-10193744:+	-0.17	-3.86	0.00013	Alzheimer's disease	
THCA	cis	1	rs28694222	chr8:124195017	FAM83A	chr8:124191287-124222317:+	-0.31	-4.09	4.97E-5	Urinary uromodulin levels	
THCA	cis	1	rs28695767	chr4:75697131	BTC	chr4:75671448-75719882:-	0.19	3.72	0.000224	Electroencephalogram traits	
THCA	cis	1	rs2869716	chr20:47779340	ARFGEF2	chr20:47538275-47653229:+	-0.11	-3.46	0.000583	Anger	
THCA	cis	1	rs2869716	chr20:47779340	CSE1L	chr20:47662838-47713484:+	0.41	9.81	8.03E-21	Anger	
THCA	cis	1	rs28702390	chr3:41889920	ULK4	chr3:41288091-42003660:-	1.04	18.86	9.68E-60	Diastolic blood pressure	
THCA	cis	1	rs28712702	chr8:96026980	C8orf38	chr8:95908040-96088396:+	-0.25	-4.26	2.48E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs28715816	chr15:24824508	PWRN1	chr15:24778839-24832924:+	0.4	8.39	5.45E-16	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
THCA	cis	1	rs28718130	chr15:50909489	SPPL2A	chr15:50999739-51057910:-	0.26	7.03	7.33E-12	QT interval	
THCA	cis	1	rs28729153	chr19:32907578	DPY19L3	chr19:32896677-32975236:+	0.19	5.11	4.71E-7	Bipolar disorder	
THCA	cis	1	rs28729153	chr19:32907578	ZNF507	chr19:32836514-32878571:+	0.3	7.3	1.23E-12	Bipolar disorder	
THCA	cis	1	rs28730640	chr4:99994053	ADH5	chr4:99992132-100009931:-	0.21	3.42	0.000678	Smoking initiation	
THCA	cis	1	rs2873094	chr9:91800274	CKS2	chr9:91926113-91931617:+	0.24	4.72	3.1E-6	Pelvic organ prolapse (moderate/severe)	
THCA	cis	1	rs28733681	chr3:41863444	ULK4	chr3:41288091-42003660:-	1.03	19.63	2.34E-63	Diastolic blood pressure	
THCA	cis	1	rs2874121	chr17:61731024	FTSJ3	chr17:61896795-61905031:-	0.31	6	3.88E-9	Body mass index	
THCA	cis	1	rs2874121	chr17:61731024	MAP3K3	chr17:61699775-61773669:+	0.26	5.48	6.75E-8	Body mass index	
THCA	cis	1	rs2874490	chr3:156635513	LEKR1	chr3:156544076-156763918:+	-0.55	-11.05	1.96E-25	Bone mineral density	
THCA	cis	1	rs2874491	chr3:156649111	LEKR1	chr3:156544076-156763918:+	-0.55	-10.91	6.59E-25	Bone mineral density	
THCA	cis	1	rs28755797	chr3:41774446	ULK4	chr3:41288091-42003660:-	1.02	17.82	7.59E-55	Diastolic blood pressure	
THCA	cis	1	rs2876629	chr6:55981048	COL21A1	chr6:55921389-56258892:-	-0.67	-8.31	1.01E-15	Psychosis (atypical)	
THCA	cis	1	rs28768402	chr8:89412652	MMP16	chr8:89049462-89339717:-	0.31	5.04	6.5E-7	Electrodermal activity	
THCA	cis	1	rs28770330	chr15:56248743	ZNF280D	chr15:56922376-57210697:-	-0.12	-3.8	0.000163	Keloid	
THCA	cis	1	rs28773028	chr15:56262339	ZNF280D	chr15:56922376-57210697:-	-0.12	-3.84	0.000139	Keloid	
THCA	cis	1	rs28773168	chr4:75709804	BTC	chr4:75671448-75719882:-	0.21	4.04	6.11E-5	Electroencephalogram traits	
THCA	cis	1	rs28786136	chr15:24832114	PWRN1	chr15:24778839-24832924:+	0.4	8.32	9.28E-16	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
THCA	cis	1	rs28786462	chr9:99592991	FAM22G	chr9:99690592-99704572:+	0.96	7.5	3.08E-13	Height	
THCA	cis	1	rs28786462	chr9:99592991	HIATL2	chr9:99695549-99775862:-	0.7	5.46	7.65E-8	Height	
THCA	cis	1	rs28786462	chr9:99592991	LOC441454	chr9:99671357-99672736:+	0.42	3.56	0.000408	Height	
THCA	cis	1	rs2879550	chr10:52755224	PRKG1	chr10:52750945-54055274:+	-0.19	-4.38	1.47E-5	Migraine	
THCA	cis	1	rs2879982	chr13:85734953	SLITRK6	chr13:86366922-86373483:-	-0.2	-3.68	0.000262	Bipolar disorder (mania)	
THCA	cis	1	rs2880329	chr17:41866168	MPP3	chr17:41878169-41910538:-	0.31	5.02	7.14E-7	Triglycerides	
THCA	cis	1	rs2880791	chr5:150267376	LOC134466	chr5:150310000-150326146:-	0.38	5.28	2.01E-7	Crohn's disease	
THCA	cis	1	rs2881080	chr6:70460172	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.47	0.000576	Sleep duration	
THCA	cis	1	rs28817917	chr15:50965846	SPPL2A	chr15:50999739-51057910:-	0.28	7.46	4.1E-13	QT interval	
THCA	cis	1	rs28824259	chr3:48425675	ATRIP	chr3:48488141-48507708:+	0.17	3.81	0.000155	Longevity	
THCA	cis	1	rs28824259	chr3:48425675	TREX1	chr3:48501186-48509043:+	-0.26	-5.97	4.57E-9	Longevity	
THCA	cis	1	rs2882667	chr5:138314106	SIL1	chr5:138282412-138534065:-	0.15	4.31	2.0E-5	Age-related hearing impairment (interaction)	
THCA	cis	1	rs28829049	chr1:19349281	KIAA0090	chr1:19544585-19578046:-	-0.14	-3.79	0.000168	QRS duration in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs28836882	chr6:55998918	COL21A1	chr6:55921389-56258892:-	-0.65	-7.66	1.01E-13	Psychosis (atypical)	
THCA	cis	1	rs2884374	chr2:11731846	GREB1	chr2:11674242-11782912:+	-0.17	-3.59	0.000369	Endometriosis	
THCA	cis	1	rs28844439	chr9:99597385	FAM22G	chr9:99690592-99704572:+	0.96	7.5	3.08E-13	Height	
THCA	cis	1	rs28844439	chr9:99597385	HIATL2	chr9:99695549-99775862:-	0.7	5.46	7.65E-8	Height	
THCA	cis	1	rs28844439	chr9:99597385	LOC441454	chr9:99671357-99672736:+	0.42	3.56	0.000408	Height	
THCA	cis	1	rs2885510	chr3:48418226	ATRIP	chr3:48488141-48507708:+	-0.18	-3.93	9.71E-5	Longevity	
THCA	cis	1	rs2885510	chr3:48418226	TREX1	chr3:48501186-48509043:+	0.24	5.61	3.42E-8	Longevity	
THCA	cis	1	rs2885880	chr11:71655847	FAM86C	chr11:71498557-71512276:+	0.31	3.89	0.000116	Severe influenza A (H1N1) infection	
THCA	cis	1	rs28877640	chr8:89412955	MMP16	chr8:89049462-89339717:-	0.31	5.04	6.5E-7	Electrodermal activity	
THCA	cis	1	rs2887797	chr3:134202506	ANAPC13	chr3:134196547-134204865:-	0.4	13.01	2.47E-33	Height	
THCA	cis	1	rs2887797	chr3:134202506	CEP63	chr3:134204575-134293852:+	0.29	6.32	6.04E-10	Height	
THCA	cis	1	rs28878014	chr16:69472141	CYB5B	chr16:69458498-69500167:+	-0.23	-3.99	7.7E-5	Blood pressure (smoking interaction)	
THCA	cis	1	rs2888674	chr7:150510915	TMEM176A	chr7:150497854-150502208:+	0.18	4.98	8.75E-7	Forced expiratory volume in 1 second (environmental interaction)	
THCA	cis	1	rs2888674	chr7:150510915	TMEM176B	chr7:150488378-150498448:-	0.13	3.74	0.000206	Forced expiratory volume in 1 second (environmental interaction)	
THCA	cis	1	rs28889328	chr3:184705379	C3orf70	chr3:184795840-184870802:-	-0.2	-4.01	6.96E-5	Heschl's gyrus morphology	
THCA	cis	1	rs28897193	chr4:107005529	TBCK	chr4:106967233-107237861:-	0.34	7.04	6.57E-12	Airflow obstruction	
THCA	cis	1	rs2889873	chr20:33646841	PROCR	chr20:33758727-33765164:+	-0.34	-5.36	1.27E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs2889873	chr20:33646841	TRPC4AP	chr20:33590215-33680618:-	0.32	3.86	0.000128	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs2890659	chr4:39127021	KLHL5	chr4:39046659-39123828:+	-0.21	-5.77	1.46E-8	Uric acid levels	
THCA	cis	1	rs2891387	chr10:54362563	DKK1	chr10:54074041-54077416:+	-0.27	-5.05	6.33E-7	Metabolite levels  (X-11787)	
THCA	cis	1	rs2891490	chr2:26325927	GPR113	chr2:26531041-26569685:-	-0.42	-6.71	5.42E-11	Gut microbiome composition (summer)	
THCA	cis	1	rs2891586	chr10:38101643	LOC399744	chr10:38717074-38741080:+	0.32	4.41	1.27E-5	Obesity (extreme)	
THCA	cis	1	rs2891586	chr10:38101643	ZNF25	chr10:38238795-38265453:-	0.16	3.35	0.000861	Obesity (extreme)	
THCA	cis	1	rs2891663	chr1:236034274	LYST	chr1:235824345-236046940:-	-0.32	-9.7	2.03E-20	Systemic lupus erythematosus	
THCA	cis	1	rs2893922	chr10:65247019	LOC84989	chr10:65224989-65226320:+	-0.24	-3.92	0.000101	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs2893922	chr10:65247019	NRBF2	chr10:64893007-64914785:+	-0.26	-4.41	1.29E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs2896954	chr15:76851692	SCAPER	chr15:76640529-77197744:-	-0.17	-5.64	2.9E-8	Blood metabolite levels	
THCA	cis	1	rs2898816	chr14:66008160	LOC645431	chr14:65877313-65879335:-	0.25	3.38	0.000789	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs2899462	chr15:50939254	SPPL2A	chr15:50999739-51057910:-	0.28	7.34	9.23E-13	QT interval	
THCA	cis	1	rs2899462	chr15:50939254	TRPM7	chr15:50852491-50978994:-	0.11	3.4	0.000721	QT interval	
THCA	cis	1	rs2899596	chr15:56502586	MNS1	chr15:56720929-56757335:-	-0.23	-3.4	0.000723	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs2899596	chr15:56502586	TEX9	chr15:56657644-56738071:+	-0.34	-5.91	6.66E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs2899597	chr15:56502930	MNS1	chr15:56720929-56757335:-	-0.23	-3.41	0.000699	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs2899597	chr15:56502930	TEX9	chr15:56657644-56738071:+	-0.34	-5.84	9.5E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs2899832	chr14:35740941	KIAA0391	chr14:35591776-35786673:+	-0.29	-5.35	1.4E-7	Response to zileuton treatment in asthma (FEV1 change interaction)	
THCA	cis	1	rs2901354	chr10:124733038	C10orf88	chr10:124690419-124713919:-	-0.21	-3.83	0.000144	Migraine without aura	
THCA	cis	1	rs2901355	chr10:124731766	C10orf88	chr10:124690419-124713919:-	-0.22	-4.02	6.65E-5	Migraine without aura	
THCA	cis	1	rs2901438	chr2:73665656	ALMS1P	chr2:73872046-73912692:+	0.71	11.45	5.41E-27	Metabolite levels	
THCA	cis	1	rs2901438	chr2:73665656	NAT8	chr2:73867850-73869537:-	0.38	6.09	2.33E-9	Metabolite levels	
THCA	cis	1	rs2901438	chr2:73665656	TPRKB	chr2:73956957-73964517:-	-0.17	-4.35	1.7E-5	Metabolite levels	
THCA	cis	1	rs2902858	chr11:46524013	PACSIN3	chr11:47199085-47207958:-	0.16	3.69	0.00025	Schizophrenia	
THCA	cis	1	rs2903283	chr4:103557753	CISD2	chr4:103790135-103809913:+	-0.16	-3.62	0.000321	Primary biliary cirrhosis	
THCA	cis	1	rs2903283	chr4:103557753	NFKB1	chr4:103422486-103538458:+	0.15	4.2	3.16E-5	Primary biliary cirrhosis	
THCA	cis	1	rs2904804	chr10:5009759	AKR1C1	chr10:4934796-5020157:+	-0.29	-6.08	2.5E-9	Economic and political preferences (immigration/crime)	
THCA	cis	1	rs2904804	chr10:5009759	AKR1C2	chr10:4964715-5060207:-	-0.17	-3.69	0.000252	Economic and political preferences (immigration/crime)	
THCA	cis	1	rs2904804	chr10:5009759	AKR1C3	chr10:5005454-5149876:+	-0.17	-3.51	0.000489	Economic and political preferences (immigration/crime)	
THCA	cis	1	rs2905425	chr19:19475717	HAPLN4	chr19:19366453-19384074:-	-0.34	-7.25	1.7E-12	Schizophrenia	
THCA	cis	1	rs2905425	chr19:19475717	KIAA0892	chr19:19431630-19469562:+	0.16	4.63	4.65E-6	Schizophrenia	
THCA	cis	1	rs2905425	chr19:19475717	TM6SF2	chr19:19375174-19384074:-	-0.21	-4.32	1.9E-5	Schizophrenia	
THCA	cis	1	rs2906127	chr5:137539466	KLHL3	chr5:136953190-137071779:-	-0.13	-3.52	0.000475	Resting heart rate	
THCA	cis	1	rs2906128	chr5:137550054	KLHL3	chr5:136953190-137071779:-	-0.13	-3.53	0.000462	Resting heart rate	
THCA	cis	1	rs2914937	chr1:207488768	CD55	chr1:207494817-207534309:+	0.16	6.96	1.11E-11	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs2915038	chr11:4477739	TRIM68	chr11:4619902-4629437:-	0.16	3.38	0.000773	Amyotrophic lateral sclerosis	
THCA	cis	1	rs2915878	chr5:151149662	SPARC	chr5:151041019-151066517:-	0.14	3.87	0.000123	Preschool internalizing problems	
THCA	cis	1	rs2915880	chr5:151147334	SPARC	chr5:151041019-151066517:-	0.13	3.46	0.000596	Preschool internalizing problems	
THCA	cis	1	rs2915882	chr5:151145436	SPARC	chr5:151041019-151066517:-	0.13	3.46	0.000596	Preschool internalizing problems	
THCA	cis	1	rs2916068	chr19:19516433	HAPLN4	chr19:19366453-19384074:-	0.34	7.05	6.29E-12	Schizophrenia	
THCA	cis	1	rs2916068	chr19:19516433	KIAA0892	chr19:19431630-19469562:+	-0.16	-4.61	5.2E-6	Schizophrenia	
THCA	cis	1	rs2916068	chr19:19516433	TM6SF2	chr19:19375174-19384074:-	0.2	3.98	8.06E-5	Schizophrenia	
THCA	cis	1	rs2919009	chr10:122591373	WDR11	chr10:122610695-122669035:+	0.16	4.36	1.56E-5	Obesity-related traits	
THCA	cis	1	rs2920280	chr8:143761144	C8orf55	chr8:143808621-143818350:+	0.3	6.69	6.19E-11	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920280	chr8:143761144	LY6K	chr8:143781529-143785582:+	0.29	5.24	2.47E-7	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920280	chr8:143761144	LYNX1	chr8:143845758-143859640:-	-0.2	-4.15	3.97E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920280	chr8:143761144	PSCA	chr8:143761875-143764142:+	0.34	5.97	4.66E-9	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920282	chr8:143757763	C8orf55	chr8:143808621-143818350:+	0.36	8.33	8.31E-16	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920282	chr8:143757763	LY6K	chr8:143781529-143785582:+	0.29	5.27	2.06E-7	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920282	chr8:143757763	LYNX1	chr8:143845758-143859640:-	-0.21	-4.42	1.2E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920282	chr8:143757763	PSCA	chr8:143761875-143764142:+	0.37	6.49	2.13E-10	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920283	chr8:143757037	C8orf55	chr8:143808621-143818350:+	0.36	8.24	1.65E-15	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920283	chr8:143757037	LY6K	chr8:143781529-143785582:+	0.29	5.15	3.9E-7	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920283	chr8:143757037	LYNX1	chr8:143845758-143859640:-	-0.21	-4.38	1.44E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920283	chr8:143757037	PSCA	chr8:143761875-143764142:+	0.37	6.38	4.12E-10	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920292	chr8:143765699	C8orf55	chr8:143808621-143818350:+	0.37	8.68	6.36E-17	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920292	chr8:143765699	LY6K	chr8:143781529-143785582:+	0.3	5.46	7.77E-8	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920292	chr8:143765699	LYNX1	chr8:143845758-143859640:-	-0.19	-4.12	4.45E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920292	chr8:143765699	PSCA	chr8:143761875-143764142:+	0.36	6.46	2.54E-10	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920293	chr8:143765414	C8orf55	chr8:143808621-143818350:+	0.37	8.68	6.36E-17	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920293	chr8:143765414	LY6K	chr8:143781529-143785582:+	0.3	5.46	7.77E-8	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920293	chr8:143765414	LYNX1	chr8:143845758-143859640:-	-0.19	-4.12	4.45E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920293	chr8:143765414	PSCA	chr8:143761875-143764142:+	0.36	6.46	2.54E-10	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920294	chr8:143765326	C8orf55	chr8:143808621-143818350:+	0.37	8.68	6.36E-17	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920294	chr8:143765326	LY6K	chr8:143781529-143785582:+	0.3	5.46	7.77E-8	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920294	chr8:143765326	LYNX1	chr8:143845758-143859640:-	-0.19	-4.12	4.45E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920294	chr8:143765326	PSCA	chr8:143761875-143764142:+	0.36	6.46	2.54E-10	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920295	chr8:143764937	C8orf55	chr8:143808621-143818350:+	0.37	8.56	1.5E-16	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920295	chr8:143764937	LY6K	chr8:143781529-143785582:+	0.3	5.41	9.76E-8	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920295	chr8:143764937	LYNX1	chr8:143845758-143859640:-	-0.21	-4.45	1.08E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920295	chr8:143764937	PSCA	chr8:143761875-143764142:+	0.36	6.33	5.57E-10	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920296	chr8:143763109	C8orf55	chr8:143808621-143818350:+	0.36	8.46	3.29E-16	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920296	chr8:143763109	LY6K	chr8:143781529-143785582:+	0.29	5.25	2.28E-7	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920296	chr8:143763109	LYNX1	chr8:143845758-143859640:-	-0.19	-4.18	3.44E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920296	chr8:143763109	PSCA	chr8:143761875-143764142:+	0.36	6.41	3.48E-10	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920297	chr8:143763083	C8orf55	chr8:143808621-143818350:+	0.36	8.46	3.29E-16	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920297	chr8:143763083	LY6K	chr8:143781529-143785582:+	0.29	5.25	2.28E-7	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920297	chr8:143763083	LYNX1	chr8:143845758-143859640:-	-0.19	-4.18	3.44E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920297	chr8:143763083	PSCA	chr8:143761875-143764142:+	0.36	6.41	3.48E-10	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920298	chr8:143763043	C8orf55	chr8:143808621-143818350:+	0.36	8.46	3.29E-16	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920298	chr8:143763043	LY6K	chr8:143781529-143785582:+	0.29	5.25	2.28E-7	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920298	chr8:143763043	LYNX1	chr8:143845758-143859640:-	-0.19	-4.18	3.44E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920298	chr8:143763043	PSCA	chr8:143761875-143764142:+	0.36	6.41	3.48E-10	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2920781	chr15:43924682	ADAL	chr15:43622872-43646094:+	-0.42	-9.24	8.3E-19	Tumor biomarkers	
THCA	cis	1	rs2920781	chr15:43924682	CATSPER2	chr15:43922774-43959900:-	-0.31	-5.52	5.51E-8	Tumor biomarkers	
THCA	cis	1	rs2920781	chr15:43924682	STRC	chr15:43891762-43924561:-	0.42	7.7	7.69E-14	Tumor biomarkers	
THCA	cis	1	rs2920781	chr15:43924682	TUBGCP4	chr15:43663313-43698238:+	0.13	3.72	0.000222	Tumor biomarkers	
THCA	cis	1	rs292168	chr5:36807189	C5orf42	chr5:37106330-37249530:-	-0.1	-3.83	0.000146	Height	
THCA	cis	1	rs292182	chr5:36954812	C5orf42	chr5:37106330-37249530:-	-0.09	-3.76	0.000191	Height	
THCA	cis	1	rs292184	chr5:36963805	C5orf42	chr5:37106330-37249530:-	-0.1	-3.83	0.000146	Height	
THCA	cis	1	rs292194	chr5:36941767	C5orf42	chr5:37106330-37249530:-	0.1	4.04	6.2E-5	Height	
THCA	cis	1	rs2927072	chr15:43922398	ADAL	chr15:43622872-43646094:+	-0.42	-9.24	8.3E-19	Tumor biomarkers	
THCA	cis	1	rs2927072	chr15:43922398	CATSPER2	chr15:43922774-43959900:-	-0.31	-5.52	5.51E-8	Tumor biomarkers	
THCA	cis	1	rs2927072	chr15:43922398	STRC	chr15:43891762-43924561:-	0.42	7.7	7.69E-14	Tumor biomarkers	
THCA	cis	1	rs2927072	chr15:43922398	TUBGCP4	chr15:43663313-43698238:+	0.13	3.72	0.000222	Tumor biomarkers	
THCA	cis	1	rs2929282	chr15:44245931	ADAL	chr15:43622872-43646094:+	-0.43	-6.55	1.47E-10	Triglycerides	
THCA	cis	1	rs2929282	chr15:44245931	STRC	chr15:43891762-43924561:-	0.33	4.28	2.21E-5	Triglycerides	
THCA	cis	1	rs2929859	chr3:128608341	ACAD9	chr3:128598333-128634910:+	-0.17	-3.38	0.000771	IgG glycosylation	
THCA	cis	1	rs2932538	chr1:113216543	ST7L	chr1:113066142-113162405:-	-0.53	-8.51	2.22E-16	Systolic blood pressure;Hypertension;Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs2933343	chr3:128658492	ACAD9	chr3:128598333-128634910:+	-0.17	-3.38	0.000783	IgG glycosylation	
THCA	cis	1	rs2935183	chr17:45607572	TBKBP1	chr17:45772630-45789427:+	0.37	10.31	1.2E-22	Multiple sclerosis or amyotrophic lateral sclerosis	
THCA	cis	1	rs2938670	chr15:78740688	CHRNA5	chr15:78857906-78886458:+	-0.32	-6.43	3.09E-10	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1 in COPD;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2945232	chr8:8098038	SGK223	chr8:8175259-8239257:-	-0.44	-9.14	1.73E-18	Schizophrenia	
THCA	cis	1	rs2947494	chr15:41375741	INO80	chr15:41271081-41408340:-	0.14	3.87	0.000124	Glomerular filtration rate (creatinine)	
THCA	cis	1	rs2947494	chr15:41375741	RTF1	chr15:41709302-41775760:+	-0.18	-4.11	4.75E-5	Glomerular filtration rate (creatinine)	
THCA	cis	1	rs2947794	chr12:66206598	RPSAP52	chr12:66151803-66220754:-	0.18	3.58	0.000377	Type 2 diabetes	
THCA	cis	1	rs2951308	chr7:143767149	ARHGEF35	chr7:143883677-143892736:-	0.5	10.49	2.59E-23	Obesity-related traits	
THCA	cis	1	rs2951308	chr7:143767149	OR2A1	chr7:144015236-144016148:+;chr7	0.18	3.88	0.000118	Obesity-related traits	
THCA	cis	1	rs2951308	chr7:143767149	OR2A9P	chr7:143991573-143997832:+;chr7	0.29	6.53	1.73E-10	Obesity-related traits	
THCA	cis	1	rs2951353	chr7:143761116	ARHGEF35	chr7:143883677-143892736:-	-0.5	-10.6	1.01E-23	Obesity-related traits	
THCA	cis	1	rs2951353	chr7:143761116	OR2A1	chr7:144015236-144016148:+;chr7	-0.19	-4.04	6.32E-5	Obesity-related traits	
THCA	cis	1	rs2951353	chr7:143761116	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-6.57	1.3E-10	Obesity-related traits	
THCA	cis	1	rs2951354	chr7:143761001	ARHGEF35	chr7:143883677-143892736:-	-0.5	-10.6	1.01E-23	Obesity-related traits	
THCA	cis	1	rs2951354	chr7:143761001	OR2A1	chr7:144015236-144016148:+;chr7	-0.19	-4.04	6.32E-5	Obesity-related traits	
THCA	cis	1	rs2951354	chr7:143761001	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-6.57	1.3E-10	Obesity-related traits	
THCA	cis	1	rs2951360	chr7:143757349	ARHGEF35	chr7:143883677-143892736:-	-0.51	-10.58	1.18E-23	Obesity-related traits	
THCA	cis	1	rs2951360	chr7:143757349	OR2A1	chr7:144015236-144016148:+;chr7	-0.18	-3.88	0.00012	Obesity-related traits	
THCA	cis	1	rs2951360	chr7:143757349	OR2A9P	chr7:143991573-143997832:+;chr7	-0.29	-6.39	3.86E-10	Obesity-related traits	
THCA	cis	1	rs2951363	chr7:143754724	ARHGEF35	chr7:143883677-143892736:-	-0.51	-10.74	2.94E-24	Obesity-related traits	
THCA	cis	1	rs2951363	chr7:143754724	OR2A1	chr7:144015236-144016148:+;chr7	-0.19	-4.11	4.59E-5	Obesity-related traits	
THCA	cis	1	rs2951363	chr7:143754724	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-6.62	9.51E-11	Obesity-related traits	
THCA	cis	1	rs2951364	chr7:143754483	ARHGEF35	chr7:143883677-143892736:-	-0.51	-10.69	4.83E-24	Obesity-related traits	
THCA	cis	1	rs2951364	chr7:143754483	OR2A1	chr7:144015236-144016148:+;chr7	-0.19	-4.07	5.46E-5	Obesity-related traits	
THCA	cis	1	rs2951364	chr7:143754483	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-6.56	1.38E-10	Obesity-related traits	
THCA	cis	1	rs2951368	chr7:143752821	ARHGEF35	chr7:143883677-143892736:-	-0.51	-10.69	4.83E-24	Obesity-related traits	
THCA	cis	1	rs2951368	chr7:143752821	OR2A1	chr7:144015236-144016148:+;chr7	-0.19	-4.07	5.46E-5	Obesity-related traits	
THCA	cis	1	rs2951368	chr7:143752821	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-6.56	1.38E-10	Obesity-related traits	
THCA	cis	1	rs2951369	chr7:143752638	ARHGEF35	chr7:143883677-143892736:-	-0.51	-10.69	4.83E-24	Obesity-related traits	
THCA	cis	1	rs2951369	chr7:143752638	OR2A1	chr7:144015236-144016148:+;chr7	-0.19	-4.07	5.46E-5	Obesity-related traits	
THCA	cis	1	rs2951369	chr7:143752638	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-6.56	1.38E-10	Obesity-related traits	
THCA	cis	1	rs2951372	chr7:143749503	ARHGEF35	chr7:143883677-143892736:-	-0.51	-10.69	4.83E-24	Obesity-related traits	
THCA	cis	1	rs2951372	chr7:143749503	OR2A1	chr7:144015236-144016148:+;chr7	-0.19	-4.07	5.46E-5	Obesity-related traits	
THCA	cis	1	rs2951372	chr7:143749503	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-6.56	1.38E-10	Obesity-related traits	
THCA	cis	1	rs2953176	chr2:241520754	GPR35	chr2:241544848-241570675:+	0.25	4.71	3.3E-6	Bipolar disorder	
THCA	cis	1	rs295428	chr3:47359262	C3orf75	chr3:47537131-47555199:-	-0.09	-4.19	3.37E-5	Colorectal cancer	
THCA	cis	1	rs295428	chr3:47359262	NBEAL2	chr3:47021173-47051193:+	-0.11	-3.52	0.000474	Colorectal cancer	
THCA	cis	1	rs295428	chr3:47359262	PRSS45	chr3:46783582-46790130:-	-0.16	-3.59	0.000359	Colorectal cancer	
THCA	cis	1	rs295442	chr3:47335881	C3orf75	chr3:47537131-47555199:-	-0.09	-4.29	2.21E-5	Colorectal cancer	
THCA	cis	1	rs295442	chr3:47335881	NBEAL2	chr3:47021173-47051193:+	-0.11	-3.43	0.00066	Colorectal cancer	
THCA	cis	1	rs295442	chr3:47335881	PRSS45	chr3:46783582-46790130:-	-0.16	-3.51	0.000493	Colorectal cancer	
THCA	cis	1	rs295449	chr3:47375955	C3orf75	chr3:47537131-47555199:-	-0.09	-4.1	4.84E-5	Colorectal cancer	
THCA	cis	1	rs295449	chr3:47375955	NBEAL2	chr3:47021173-47051193:+	-0.11	-3.67	0.00027	Colorectal cancer	
THCA	cis	1	rs295449	chr3:47375955	PRSS45	chr3:46783582-46790130:-	-0.16	-3.58	0.000374	Colorectal cancer	
THCA	cis	1	rs295458	chr3:47385585	C3orf75	chr3:47537131-47555199:-	-0.09	-4.2	3.19E-5	Colorectal cancer	
THCA	cis	1	rs295458	chr3:47385585	NBEAL2	chr3:47021173-47051193:+	-0.11	-3.56	0.000411	Colorectal cancer	
THCA	cis	1	rs295458	chr3:47385585	PRSS45	chr3:46783582-46790130:-	-0.16	-3.58	0.000374	Colorectal cancer	
THCA	cis	1	rs295461	chr3:47368010	C3orf75	chr3:47537131-47555199:-	-0.09	-4.09	5.0E-5	Colorectal cancer	
THCA	cis	1	rs295461	chr3:47368010	NBEAL2	chr3:47021173-47051193:+	-0.11	-3.66	0.000276	Colorectal cancer	
THCA	cis	1	rs295461	chr3:47368010	PRSS45	chr3:46783582-46790130:-	-0.16	-3.57	0.00039	Colorectal cancer	
THCA	cis	1	rs2955077	chr3:127958869	EEFSEC	chr3:127872313-128127488:+	0.26	4.56	6.53E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2955078	chr3:127959186	EEFSEC	chr3:127872313-128127488:+	0.26	4.56	6.53E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2955079	chr3:127959824	EEFSEC	chr3:127872313-128127488:+	0.27	4.82	1.97E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2955080	chr3:127959865	EEFSEC	chr3:127872313-128127488:+	0.27	4.82	1.97E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2955081	chr3:127960299	EEFSEC	chr3:127872313-128127488:+	0.26	4.56	6.53E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2955082	chr3:127960334	EEFSEC	chr3:127872313-128127488:+	0.27	4.82	1.97E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2955083	chr3:127961178	EEFSEC	chr3:127872313-128127488:+	0.26	4.48	9.53E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2955085	chr3:127962757	EEFSEC	chr3:127872313-128127488:+	0.26	4.56	6.53E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2955086	chr3:127963191	EEFSEC	chr3:127872313-128127488:+	0.27	4.82	1.97E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2955088	chr3:127963710	EEFSEC	chr3:127872313-128127488:+	0.26	4.56	6.53E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2955089	chr3:127969330	EEFSEC	chr3:127872313-128127488:+	0.27	4.8	2.14E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2955090	chr3:127969371	EEFSEC	chr3:127872313-128127488:+	0.27	4.8	2.14E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2955091	chr3:127971361	EEFSEC	chr3:127872313-128127488:+	0.28	5.07	5.78E-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2955095	chr3:127977665	EEFSEC	chr3:127872313-128127488:+	-0.25	-4.56	6.47E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2955096	chr3:127977866	EEFSEC	chr3:127872313-128127488:+	-0.27	-4.72	3.06E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2955097	chr3:127978505	EEFSEC	chr3:127872313-128127488:+	0.26	4.57	6.18E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2955099	chr3:127979654	EEFSEC	chr3:127872313-128127488:+	0.27	4.79	2.27E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2955100	chr3:127993325	EEFSEC	chr3:127872313-128127488:+	0.27	4.82	1.91E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2955101	chr3:128009612	EEFSEC	chr3:127872313-128127488:+	0.27	4.79	2.27E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2955126	chr3:127926254	EEFSEC	chr3:127872313-128127488:+	0.25	4.38	1.47E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2955129	chr3:127929207	EEFSEC	chr3:127872313-128127488:+	0.25	4.3	2.07E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2955130	chr3:127937814	EEFSEC	chr3:127872313-128127488:+	0.25	4.31	1.97E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2961102	chr7:65424658	CCT6P1	chr7:65216092-65228661:+	0.42	6.54	1.55E-10	Diabetic kidney disease	
THCA	cis	1	rs2961102	chr7:65424658	CRCP	chr7:65579805-65619551:+	-0.29	-4.37	1.49E-5	Diabetic kidney disease	
THCA	cis	1	rs2961102	chr7:65424658	RABGEF1	chr7:66093890-66276446:+	0.52	6.34	5.46E-10	Diabetic kidney disease	
THCA	cis	1	rs2961115	chr7:143753371	ARHGEF35	chr7:143883677-143892736:-	-0.51	-10.69	4.83E-24	Obesity-related traits	
THCA	cis	1	rs2961115	chr7:143753371	OR2A1	chr7:144015236-144016148:+;chr7	-0.19	-4.07	5.46E-5	Obesity-related traits	
THCA	cis	1	rs2961115	chr7:143753371	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-6.56	1.38E-10	Obesity-related traits	
THCA	cis	1	rs2961117	chr7:143755253	ARHGEF35	chr7:143883677-143892736:-	-0.52	-10.81	1.6E-24	Obesity-related traits	
THCA	cis	1	rs2961117	chr7:143755253	OR2A1	chr7:144015236-144016148:+;chr7	-0.18	-3.9	0.000112	Obesity-related traits	
THCA	cis	1	rs2961117	chr7:143755253	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-6.62	9.58E-11	Obesity-related traits	
THCA	cis	1	rs2961118	chr7:143755443	ARHGEF35	chr7:143883677-143892736:-	-0.5	-10.61	9.18E-24	Obesity-related traits	
THCA	cis	1	rs2961118	chr7:143755443	OR2A1	chr7:144015236-144016148:+;chr7	-0.19	-4.02	6.87E-5	Obesity-related traits	
THCA	cis	1	rs2961118	chr7:143755443	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-6.57	1.34E-10	Obesity-related traits	
THCA	cis	1	rs2961119	chr7:143755852	ARHGEF35	chr7:143883677-143892736:-	-0.5	-10.61	9.18E-24	Obesity-related traits	
THCA	cis	1	rs2961119	chr7:143755852	OR2A1	chr7:144015236-144016148:+;chr7	-0.19	-4.02	6.87E-5	Obesity-related traits	
THCA	cis	1	rs2961119	chr7:143755852	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-6.57	1.34E-10	Obesity-related traits	
THCA	cis	1	rs2961120	chr7:143756585	ARHGEF35	chr7:143883677-143892736:-	-0.51	-10.58	1.18E-23	Obesity-related traits	
THCA	cis	1	rs2961120	chr7:143756585	OR2A1	chr7:144015236-144016148:+;chr7	-0.18	-3.88	0.00012	Obesity-related traits	
THCA	cis	1	rs2961120	chr7:143756585	OR2A9P	chr7:143991573-143997832:+;chr7	-0.29	-6.39	3.86E-10	Obesity-related traits	
THCA	cis	1	rs2961125	chr7:143761770	ARHGEF35	chr7:143883677-143892736:-	-0.5	-10.6	1.01E-23	Obesity-related traits	
THCA	cis	1	rs2961125	chr7:143761770	OR2A1	chr7:144015236-144016148:+;chr7	-0.19	-4.04	6.32E-5	Obesity-related traits	
THCA	cis	1	rs2961125	chr7:143761770	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-6.57	1.3E-10	Obesity-related traits	
THCA	cis	1	rs2961126	chr7:143762736	ARHGEF35	chr7:143883677-143892736:-	-0.5	-10.6	1.01E-23	Obesity-related traits	
THCA	cis	1	rs2961126	chr7:143762736	OR2A1	chr7:144015236-144016148:+;chr7	-0.19	-4.04	6.32E-5	Obesity-related traits	
THCA	cis	1	rs2961126	chr7:143762736	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-6.57	1.3E-10	Obesity-related traits	
THCA	cis	1	rs2961128	chr7:143763483	ARHGEF35	chr7:143883677-143892736:-	-0.5	-10.6	1.01E-23	Obesity-related traits	
THCA	cis	1	rs2961128	chr7:143763483	OR2A1	chr7:144015236-144016148:+;chr7	-0.19	-4.04	6.32E-5	Obesity-related traits	
THCA	cis	1	rs2961128	chr7:143763483	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-6.57	1.3E-10	Obesity-related traits	
THCA	cis	1	rs2961132	chr7:143768128	ARHGEF35	chr7:143883677-143892736:-	-0.5	-10.51	2.29E-23	Obesity-related traits	
THCA	cis	1	rs2961132	chr7:143768128	OR2A1	chr7:144015236-144016148:+;chr7	-0.18	-3.74	0.000209	Obesity-related traits	
THCA	cis	1	rs2961132	chr7:143768128	OR2A9P	chr7:143991573-143997832:+;chr7	-0.29	-6.37	4.53E-10	Obesity-related traits	
THCA	cis	1	rs2961134	chr7:143771062	ARHGEF35	chr7:143883677-143892736:-	-0.49	-10.08	8.17E-22	Obesity-related traits	
THCA	cis	1	rs2961134	chr7:143771062	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-6.1	2.14E-9	Obesity-related traits	
THCA	cis	1	rs2961144	chr7:143747870	ARHGEF35	chr7:143883677-143892736:-	0.51	10.72	3.62E-24	Obesity-related traits	
THCA	cis	1	rs2961144	chr7:143747870	OR2A1	chr7:144015236-144016148:+;chr7	0.19	4.13	4.28E-5	Obesity-related traits	
THCA	cis	1	rs2961144	chr7:143747870	OR2A9P	chr7:143991573-143997832:+;chr7	0.3	6.59	1.19E-10	Obesity-related traits	
THCA	cis	1	rs2964578	chr5:151147198	SPARC	chr5:151041019-151066517:-	0.13	3.41	0.000693	Preschool internalizing problems	
THCA	cis	1	rs2964584	chr5:151142878	SPARC	chr5:151041019-151066517:-	0.14	3.88	0.00012	Preschool internalizing problems	
THCA	cis	1	rs2964585	chr5:151141895	SPARC	chr5:151041019-151066517:-	0.13	3.41	0.000693	Preschool internalizing problems	
THCA	cis	1	rs2964991	chr1:218685232	TGFB2	chr1:218519391-218617959:+	-0.2	-3.99	7.53E-5	Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2965188	chr19:19522557	HAPLN4	chr19:19366453-19384074:-	0.33	7.03	7.13E-12	Schizophrenia	
THCA	cis	1	rs2965188	chr19:19522557	KIAA0892	chr19:19431630-19469562:+	-0.15	-4.32	1.87E-5	Schizophrenia	
THCA	cis	1	rs2965188	chr19:19522557	TM6SF2	chr19:19375174-19384074:-	0.2	4.05	6.01E-5	Schizophrenia	
THCA	cis	1	rs2965198	chr19:19473030	ARMC6	chr19:19144471-19170310:+	0.12	3.38	0.000774	Schizophrenia	
THCA	cis	1	rs2965198	chr19:19473030	HAPLN4	chr19:19366453-19384074:-	-0.35	-7.31	1.14E-12	Schizophrenia	
THCA	cis	1	rs2965198	chr19:19473030	KIAA0892	chr19:19431630-19469562:+	0.17	4.72	3.04E-6	Schizophrenia	
THCA	cis	1	rs2965198	chr19:19473030	TM6SF2	chr19:19375174-19384074:-	-0.21	-4.23	2.84E-5	Schizophrenia	
THCA	cis	1	rs2967781	chr5:137557609	KLHL3	chr5:136953190-137071779:-	-0.13	-3.5	0.000507	Resting heart rate	
THCA	cis	1	rs2967784	chr5:137539239	KLHL3	chr5:136953190-137071779:-	-0.13	-3.52	0.000475	Resting heart rate	
THCA	cis	1	rs296847	chr9:4793798	RCL1	chr9:4792834-4885917:+	0.25	5.61	3.46E-8	Platelet count	
THCA	cis	1	rs296962	chr5:36990483	C5orf42	chr5:37106330-37249530:-	-0.1	-3.78	0.000178	Height	
THCA	cis	1	rs2970334	chr11:14329355	RRAS2	chr11:14299467-14380729:-	0.17	4.05	5.88E-5	Mitochondrial DNA levels	
THCA	cis	1	rs2970335	chr11:14325401	RRAS2	chr11:14299467-14380729:-	-0.16	-3.94	9.52E-5	Mitochondrial DNA levels	
THCA	cis	1	rs2975754	chr2:241522634	GPR35	chr2:241544848-241570675:+	0.25	4.87	1.53E-6	Bipolar disorder	
THCA	cis	1	rs2976237	chr17:3665695	GSG2	chr17:3627197-3629990:+	-0.14	-3.97	8.26E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs2976237	chr17:3665695	MED11	chr17:4634723-4636894:+	-0.15	-4.39	1.41E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs2976388	chr8:143760256	C8orf55	chr8:143808621-143818350:+	0.3	6.68	6.78E-11	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2976388	chr8:143760256	LY6K	chr8:143781529-143785582:+	0.3	5.39	1.09E-7	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2976388	chr8:143760256	LYNX1	chr8:143845758-143859640:-	-0.21	-4.35	1.69E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2976388	chr8:143760256	PSCA	chr8:143761875-143764142:+	0.35	6.08	2.5E-9	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2976392	chr8:143762932	C8orf55	chr8:143808621-143818350:+	0.36	8.4	5.12E-16	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2976392	chr8:143762932	LY6K	chr8:143781529-143785582:+	0.29	5.27	2.07E-7	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2976392	chr8:143762932	LYNX1	chr8:143845758-143859640:-	-0.2	-4.32	1.94E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2976392	chr8:143762932	PSCA	chr8:143761875-143764142:+	0.36	6.41	3.4E-10	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2976394	chr8:143763622	C8orf55	chr8:143808621-143818350:+	0.36	8.46	3.29E-16	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2976394	chr8:143763622	LY6K	chr8:143781529-143785582:+	0.29	5.25	2.28E-7	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2976394	chr8:143763622	LYNX1	chr8:143845758-143859640:-	-0.19	-4.18	3.44E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2976394	chr8:143763622	PSCA	chr8:143761875-143764142:+	0.36	6.41	3.48E-10	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2976396	chr8:143764001	C8orf55	chr8:143808621-143818350:+	-0.36	-8.18	2.58E-15	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2976396	chr8:143764001	LY6K	chr8:143781529-143785582:+	-0.28	-5	8.15E-7	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2976396	chr8:143764001	LYNX1	chr8:143845758-143859640:-	0.2	4.18	3.49E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2976396	chr8:143764001	PSCA	chr8:143761875-143764142:+	-0.37	-6.46	2.64E-10	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2976398	chr8:143764879	C8orf55	chr8:143808621-143818350:+	0.37	8.68	6.36E-17	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2976398	chr8:143764879	LY6K	chr8:143781529-143785582:+	0.3	5.46	7.77E-8	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2976398	chr8:143764879	LYNX1	chr8:143845758-143859640:-	-0.19	-4.12	4.45E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2976398	chr8:143764879	PSCA	chr8:143761875-143764142:+	0.36	6.46	2.54E-10	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2977993	chr9:131608786	C9orf114	chr9:131584346-131592085:-	0.32	7.15	3.32E-12	Schizophrenia	
THCA	cis	1	rs2977993	chr9:131608786	CCBL1	chr9:131595393-131644354:-	-0.17	-3.59	0.000367	Schizophrenia	
THCA	cis	1	rs2977993	chr9:131608786	ENDOG	chr9:131580779-131584954:+	0.43	14.04	9.48E-38	Schizophrenia	
THCA	cis	1	rs2978982	chr8:143763490	C8orf55	chr8:143808621-143818350:+	0.36	8.4	5.12E-16	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2978982	chr8:143763490	LY6K	chr8:143781529-143785582:+	0.29	5.27	2.07E-7	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2978982	chr8:143763490	LYNX1	chr8:143845758-143859640:-	-0.2	-4.32	1.94E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2978982	chr8:143763490	PSCA	chr8:143761875-143764142:+	0.36	6.41	3.4E-10	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THCA	cis	1	rs2983511	chr6:166043959	PDE10A	chr6:165740779-166075584:-	0.28	5.65	2.73E-8	Thyroid hormone levels	
THCA	cis	1	rs2985334	chr1:29345027	MECR	chr1:29519385-29557454:-	-0.15	-3.71	0.000233	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs2985340	chr1:29371499	MECR	chr1:29519385-29557454:-	-0.15	-3.6	0.000348	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs2985684	chr14:50101682	MGAT2	chr14:50087489-50090198:+	0.22	4.41	1.28E-5	Carotid intima media thickness	
THCA	cis	1	rs2985684	chr14:50101682	RPL36AL	chr14:50085407-50087349:-	0.54	15.55	2.03E-44	Carotid intima media thickness	
THCA	cis	1	rs2985687	chr14:50100386	MGAT2	chr14:50087489-50090198:+	0.22	4.41	1.28E-5	Carotid intima media thickness	
THCA	cis	1	rs2985687	chr14:50100386	RPL36AL	chr14:50085407-50087349:-	0.54	15.55	2.03E-44	Carotid intima media thickness	
THCA	cis	1	rs2985696	chr14:50094913	MGAT2	chr14:50087489-50090198:+	0.22	4.39	1.4E-5	Carotid intima media thickness	
THCA	cis	1	rs2985696	chr14:50094913	RPL36AL	chr14:50085407-50087349:-	0.56	16.31	7.43E-48	Carotid intima media thickness	
THCA	cis	1	rs2985697	chr14:50092902	MGAT2	chr14:50087489-50090198:+	0.21	4.29	2.16E-5	Carotid intima media thickness	
THCA	cis	1	rs2985697	chr14:50092902	RPL36AL	chr14:50085407-50087349:-	0.56	16.06	9.75E-47	Carotid intima media thickness	
THCA	cis	1	rs2993207	chr1:155873314	FDPS	chr1:155278539-155290457:+	-0.23	-4.67	3.92E-6	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs2993207	chr1:155873314	RIT1	chr1:155867601-155881177:-	0.15	3.48	0.000554	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs2993259	chr1:46001550	AKR1A1	chr1:46016498-46035720:+	-0.13	-3.46	0.000599	Homocysteine levels	
THCA	cis	1	rs2993259	chr1:46001550	CCDC163P	chr1:45960581-45965646:-	-1.07	-30.02	4.69E-112	Homocysteine levels	
THCA	cis	1	rs2993259	chr1:46001550	MUTYH	chr1:45794915-45806142:-	0.21	4.92	1.21E-6	Homocysteine levels	
THCA	cis	1	rs2993259	chr1:46001550	PRDX1	chr1:45976708-45987609:-	-0.39	-9.94	2.83E-21	Homocysteine levels	
THCA	cis	1	rs2993712	chr1:29345279	MECR	chr1:29519385-29557454:-	-0.15	-3.71	0.000233	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs2993715	chr1:29356050	MECR	chr1:29519385-29557454:-	-0.15	-3.6	0.000345	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs2996027	chr12:120164283	TMEM233	chr12:120031264-120079363:+	-0.25	-6.14	1.74E-9	Urgency urinary incontinence	
THCA	cis	1	rs2996029	chr12:120165182	TMEM233	chr12:120031264-120079363:+	-0.24	-5.71	1.95E-8	Urgency urinary incontinence	
THCA	cis	1	rs2996077	chr10:132952038	TCERG1L	chr10:132890656-133109984:-	0.39	5.94	5.57E-9	Type 2 diabetes	
THCA	cis	1	rs2999061	chr3:127993623	EEFSEC	chr3:127872313-128127488:+	-0.27	-4.74	2.81E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2999062	chr3:127993606	EEFSEC	chr3:127872313-128127488:+	0.27	4.8	2.13E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2999065	chr3:127981438	EEFSEC	chr3:127872313-128127488:+	0.27	4.79	2.27E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2999066	chr3:127980286	EEFSEC	chr3:127872313-128127488:+	0.27	4.79	2.27E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2999067	chr3:127978531	EEFSEC	chr3:127872313-128127488:+	0.27	4.79	2.27E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2999068	chr3:127977978	EEFSEC	chr3:127872313-128127488:+	0.27	4.79	2.27E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2999069	chr3:127971609	EEFSEC	chr3:127872313-128127488:+	0.27	4.79	2.27E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2999070	chr3:127964651	EEFSEC	chr3:127872313-128127488:+	0.27	4.82	1.97E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2999071	chr3:127963615	EEFSEC	chr3:127872313-128127488:+	0.27	4.82	1.97E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2999072	chr3:127962876	EEFSEC	chr3:127872313-128127488:+	0.26	4.56	6.53E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2999073	chr3:127962329	EEFSEC	chr3:127872313-128127488:+	0.27	4.82	1.97E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2999076	chr3:127958692	EEFSEC	chr3:127872313-128127488:+	0.27	4.81	2.07E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2999077	chr3:127958414	EEFSEC	chr3:127872313-128127488:+	0.26	4.55	6.91E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2999079	chr3:127957232	EEFSEC	chr3:127872313-128127488:+	0.27	4.82	1.97E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2999084	chr3:127952488	EEFSEC	chr3:127872313-128127488:+	0.27	4.82	1.97E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2999085	chr3:127951559	EEFSEC	chr3:127872313-128127488:+	0.27	4.82	1.97E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2999086	chr3:127951248	EEFSEC	chr3:127872313-128127488:+	0.27	4.82	1.97E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2999089	chr3:127935159	EEFSEC	chr3:127872313-128127488:+	0.25	4.22	2.87E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs2999090	chr3:127931340	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.43	1.19E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs300049	chr5:37084073	C5orf42	chr5:37106330-37249530:-	-0.09	-3.34	0.000895	Height	
THCA	cis	1	rs300055	chr5:37072824	C5orf42	chr5:37106330-37249530:-	-0.1	-3.81	0.000156	Height	
THCA	cis	1	rs300058	chr5:37053976	C5orf42	chr5:37106330-37249530:-	-0.09	-3.76	0.00019	Height	
THCA	cis	1	rs300060	chr5:37019354	C5orf42	chr5:37106330-37249530:-	-0.09	-3.55	0.000419	Height	
THCA	cis	1	rs300061	chr5:37022775	C5orf42	chr5:37106330-37249530:-	-0.09	-3.53	0.000452	Height	
THCA	cis	1	rs300063	chr5:37023898	C5orf42	chr5:37106330-37249530:-	-0.09	-3.54	0.000444	Height	
THCA	cis	1	rs300064	chr5:37025871	C5orf42	chr5:37106330-37249530:-	0.09	3.69	0.00025	Height	
THCA	cis	1	rs300065	chr5:36997827	C5orf42	chr5:37106330-37249530:-	-0.1	-3.77	0.000181	Height	
THCA	cis	1	rs3002702	chr20:25268920	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs3002702	chr20:25268920	FAM182A	chr20:26035250-26067552:+	-0.18	-3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs3002702	chr20:25268920	FAM182B	chr20:25744102-25848786:-	0.27	5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs3002702	chr20:25268920	NINL	chr20:25433338-25566153:-	-0.35	-7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs3002702	chr20:25268920	PYGB	chr20:25228706-25278647:+	-0.16	-4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs3003214	chr1:244605036	C1orf101	chr1:244617679-244803660:+	0.2	4.51	8.28E-6	Dementia and core Alzheimer's disease neuropathologic changes	
THCA	cis	1	rs300692	chr2:181415	SH3YL1	chr2:218138-264810:-	-0.24	-3.7	0.000245	Suicide attempts in bipolar disorder	
THCA	cis	1	rs3007030	chr14:50086563	MGAT2	chr14:50087489-50090198:+	0.23	4.46	1.04E-5	Carotid intima media thickness	
THCA	cis	1	rs3007030	chr14:50086563	RPL36AL	chr14:50085407-50087349:-	0.55	15.21	7.13E-43	Carotid intima media thickness	
THCA	cis	1	rs3007031	chr14:50102269	MGAT2	chr14:50087489-50090198:+	0.22	4.43	1.19E-5	Carotid intima media thickness	
THCA	cis	1	rs3007031	chr14:50102269	RPL36AL	chr14:50085407-50087349:-	0.52	15.07	2.86E-42	Carotid intima media thickness	
THCA	cis	1	rs300772	chr2:117230	SH3YL1	chr2:218138-264810:-	-0.27	-4.37	1.52E-5	Suicide attempts in bipolar disorder	
THCA	cis	1	rs300773	chr2:115035	SH3YL1	chr2:218138-264810:-	-0.25	-4.17	3.63E-5	Suicide attempts in bipolar disorder	
THCA	cis	1	rs300774	chr2:112496	SH3YL1	chr2:218138-264810:-	0.24	3.89	0.000116	Suicide attempts in bipolar disorder	
THCA	cis	1	rs300777	chr2:112026	SH3YL1	chr2:218138-264810:-	-0.27	-4.3	2.05E-5	Suicide attempts in bipolar disorder	
THCA	cis	1	rs300778	chr2:111964	SH3YL1	chr2:218138-264810:-	-0.26	-4.23	2.76E-5	Suicide attempts in bipolar disorder	
THCA	cis	1	rs300781	chr2:110385	SH3YL1	chr2:218138-264810:-	-0.27	-4.3	2.05E-5	Suicide attempts in bipolar disorder	
THCA	cis	1	rs300782	chr2:110345	SH3YL1	chr2:218138-264810:-	-0.27	-4.28	2.27E-5	Suicide attempts in bipolar disorder	
THCA	cis	1	rs300793	chr2:108411	SH3YL1	chr2:218138-264810:-	-0.27	-4.29	2.18E-5	Suicide attempts in bipolar disorder	
THCA	cis	1	rs300797	chr2:107140	SH3YL1	chr2:218138-264810:-	-0.26	-4.17	3.66E-5	Suicide attempts in bipolar disorder	
THCA	cis	1	rs300799	chr2:105514	SH3YL1	chr2:218138-264810:-	-0.25	-4.11	4.64E-5	Suicide attempts in bipolar disorder	
THCA	cis	1	rs300802	chr2:104762	SH3YL1	chr2:218138-264810:-	-0.25	-4.11	4.64E-5	Suicide attempts in bipolar disorder	
THCA	cis	1	rs3008034	chr6:166043862	PDE10A	chr6:165740779-166075584:-	0.28	5.72	1.87E-8	Thyroid hormone levels	
THCA	cis	1	rs300890	chr4:144249770	GAB1	chr4:144257983-144395717:+	-0.17	-3.92	0.000101	Nasopharyngeal carcinoma	
THCA	cis	1	rs300891	chr4:144250211	GAB1	chr4:144257983-144395717:+	-0.17	-3.92	0.000101	Nasopharyngeal carcinoma	
THCA	cis	1	rs300893	chr4:144257116	GAB1	chr4:144257983-144395717:+	-0.17	-3.92	0.000101	Nasopharyngeal carcinoma	
THCA	cis	1	rs300895	chr4:144255838	GAB1	chr4:144257983-144395717:+	-0.17	-3.87	0.000122	Nasopharyngeal carcinoma	
THCA	cis	1	rs300904	chr4:144239825	GAB1	chr4:144257983-144395717:+	0.16	3.71	0.000234	Nasopharyngeal carcinoma	
THCA	cis	1	rs300905	chr4:144240473	GAB1	chr4:144257983-144395717:+	0.17	4.01	6.99E-5	Nasopharyngeal carcinoma	
THCA	cis	1	rs3018301	chr11:71792071	FAM86C	chr11:71498557-71512276:+	0.29	3.73	0.000216	Severe influenza A (H1N1) infection	
THCA	cis	1	rs3018302	chr11:71790942	FAM86C	chr11:71498557-71512276:+	0.31	3.81	0.000158	Severe influenza A (H1N1) infection	
THCA	cis	1	rs301859	chr5:37045841	C5orf42	chr5:37106330-37249530:-	-0.1	-3.8	0.000164	Height	
THCA	cis	1	rs30187	chr5:96124330	CAST	chr5:95997777-96115291:+	-0.11	-4.09	5.11E-5	Ankylosing spondylitis	
THCA	cis	1	rs30187	chr5:96124330	ERAP1	chr5:96096515-96149837:-	-0.39	-11.58	1.64E-27	Ankylosing spondylitis	
THCA	cis	1	rs30187	chr5:96124330	ERAP2	chr5:96211644-96255398:+	0.53	9.43	1.82E-19	Ankylosing spondylitis	
THCA	cis	1	rs301901	chr5:37046626	C5orf42	chr5:37106330-37249530:-	-0.1	-3.84	0.000137	Height	
THCA	cis	1	rs3021	chr20:47874005	DDX27	chr20:47835832-47860612:+	0.28	5.11	4.7E-7	Height	
THCA	cis	1	rs3026101	chr17:5280440	C1QBP	chr17:5336099-5342471:-	0.13	3.73	0.000212	Body mass index	
THCA	cis	1	rs3026101	chr17:5280440	NLRP1	chr17:5404719-5487832:-	-0.21	-4.31	1.94E-5	Body mass index	
THCA	cis	1	rs3026101	chr17:5280440	RABEP1	chr17:5185558-5289131:+	-0.12	-3.48	0.000548	Body mass index	
THCA	cis	1	rs30378	chr5:96121994	CAST	chr5:95997777-96115291:+	-0.11	-3.89	0.000116	Ankylosing spondylitis	
THCA	cis	1	rs30378	chr5:96121994	ERAP1	chr5:96096515-96149837:-	-0.39	-11.51	3.1E-27	Ankylosing spondylitis	
THCA	cis	1	rs30378	chr5:96121994	ERAP2	chr5:96211644-96255398:+	0.53	9.37	2.89E-19	Ankylosing spondylitis	
THCA	cis	1	rs30379	chr5:96122260	CAST	chr5:95997777-96115291:+	-0.11	-4.08	5.33E-5	Ankylosing spondylitis	
THCA	cis	1	rs30379	chr5:96122260	ERAP1	chr5:96096515-96149837:-	-0.39	-11.6	1.36E-27	Ankylosing spondylitis	
THCA	cis	1	rs30379	chr5:96122260	ERAP2	chr5:96211644-96255398:+	0.53	9.46	1.4E-19	Ankylosing spondylitis	
THCA	cis	1	rs30380	chr5:96122281	CAST	chr5:95997777-96115291:+	-0.11	-4.08	5.33E-5	Ankylosing spondylitis	
THCA	cis	1	rs30380	chr5:96122281	ERAP1	chr5:96096515-96149837:-	-0.39	-11.6	1.36E-27	Ankylosing spondylitis	
THCA	cis	1	rs30380	chr5:96122281	ERAP2	chr5:96211644-96255398:+	0.53	9.46	1.4E-19	Ankylosing spondylitis	
THCA	cis	1	rs30736	chr5:130724240	P4HA2	chr5:131528306-131563556:-	-0.26	-5.03	6.86E-7	Life satisfaction	
THCA	cis	1	rs3088303	chr12:123779489	C12orf65	chr12:123717841-123742481:+	-0.25	-4.25	2.62E-5	HDL cholesterol	
THCA	cis	1	rs3091242	chr1:25674785	RHCE	chr1:25688741-25756683:-	0.7	15.12	1.73E-42	Erythrocyte sedimentation rate	
THCA	cis	1	rs3091242	chr1:25674785	RHD	chr1:25598981-25656935:+	-0.63	-12.29	2.43E-30	Erythrocyte sedimentation rate	
THCA	cis	1	rs3091242	chr1:25674785	TMEM57	chr1:25757388-25826696:+	0.2	5.08	5.4E-7	Erythrocyte sedimentation rate	
THCA	cis	1	rs3091497	chr20:47645427	ARFGEF2	chr20:47538275-47653229:+	0.11	3.59	0.000371	Anger	
THCA	cis	1	rs3091497	chr20:47645427	CSE1L	chr20:47662838-47713484:+	-0.41	-9.8	8.73E-21	Anger	
THCA	cis	1	rs3091529	chr20:47647068	ARFGEF2	chr20:47538275-47653229:+	0.12	3.97	8.3E-5	Anger	
THCA	cis	1	rs3091529	chr20:47647068	CSE1L	chr20:47662838-47713484:+	-0.41	-10.14	5.2E-22	Anger	
THCA	cis	1	rs3091866	chr20:47648353	ARFGEF2	chr20:47538275-47653229:+	0.13	4.06	5.77E-5	Anger	
THCA	cis	1	rs3091866	chr20:47648353	CSE1L	chr20:47662838-47713484:+	-0.41	-10.17	4.16E-22	Anger	
THCA	cis	1	rs3092039	chr20:47678770	ARFGEF2	chr20:47538275-47653229:+	0.12	3.96	8.5E-5	Anger	
THCA	cis	1	rs3092039	chr20:47678770	CSE1L	chr20:47662838-47713484:+	-0.41	-10.22	2.51E-22	Anger	
THCA	cis	1	rs3092374	chr20:47663944	ARFGEF2	chr20:47538275-47653229:+	0.12	3.93	9.75E-5	Anger	
THCA	cis	1	rs3092374	chr20:47663944	CSE1L	chr20:47662838-47713484:+	-0.4	-9.89	4.26E-21	Anger	
THCA	cis	1	rs3092411	chr20:47690591	ARFGEF2	chr20:47538275-47653229:+	0.12	3.96	8.79E-5	Anger	
THCA	cis	1	rs3092411	chr20:47690591	CSE1L	chr20:47662838-47713484:+	-0.41	-10.21	2.82E-22	Anger	
THCA	cis	1	rs3092720	chr20:47640466	ARFGEF2	chr20:47538275-47653229:+	0.13	4.06	5.77E-5	Anger	
THCA	cis	1	rs3092720	chr20:47640466	CSE1L	chr20:47662838-47713484:+	-0.41	-10.17	4.16E-22	Anger	
THCA	cis	1	rs3092744	chr20:44025282	ZNF335	chr20:44577293-44600833:-	-0.17	-4.05	6.06E-5	Psoriasis	
THCA	cis	1	rs3092991	chr11:108140516	ACAT1	chr11:107992258-108018889:+	-0.34	-7.44	4.66E-13	Melanoma	
THCA	cis	1	rs3097417	chr3:53088601	RFT1	chr3:53122503-53164470:-	-0.63	-7.88	2.2E-14	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs3099459	chr5:56137170	C5orf35	chr5:56205103-56213010:+	1.01	23.37	3.92E-81	Type 2 diabetes	
THCA	cis	1	rs3099899	chr4:129917368	C4orf33	chr4:130014829-130033842:+	-0.59	-9.46	1.4E-19	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs310124	chr1:153020275	SPRR3	chr1:152974223-152976332:+	-0.15	-3.4	0.000737	Inflammatory skin disease	
THCA	cis	1	rs3101443	chr15:43912372	ADAL	chr15:43622872-43646094:+	-0.41	-8.91	1.07E-17	Tumor biomarkers	
THCA	cis	1	rs3101443	chr15:43912372	CATSPER2	chr15:43922774-43959900:-	-0.28	-4.99	8.68E-7	Tumor biomarkers	
THCA	cis	1	rs3101443	chr15:43912372	STRC	chr15:43891762-43924561:-	0.39	7.31	1.1E-12	Tumor biomarkers	
THCA	cis	1	rs3101443	chr15:43912372	TUBGCP4	chr15:43663313-43698238:+	0.14	4.08	5.22E-5	Tumor biomarkers	
THCA	cis	1	rs3101852	chr15:50848370	SPPL2A	chr15:50999739-51057910:-	-0.28	-7.54	2.34E-13	QT interval	
THCA	cis	1	rs3101853	chr15:50848382	ATP8B4	chr15:50150436-50411419:-	0.1	3.34	0.000899	QT interval	
THCA	cis	1	rs3101853	chr15:50848382	SPPL2A	chr15:50999739-51057910:-	-0.28	-7.38	6.99E-13	QT interval	
THCA	cis	1	rs3101855	chr15:50859874	SPPL2A	chr15:50999739-51057910:-	0.28	7.37	7.74E-13	QT interval	
THCA	cis	1	rs3102460	chr1:244576717	C1orf101	chr1:244617679-244803660:+	-0.17	-3.48	0.00055	Obesity-related traits	
THCA	cis	1	rs3103067	chr4:8511223	C4orf23	chr4:8440604-8495258:+	-0.3	-6.46	2.66E-10	Response to antineoplastic agents	
THCA	cis	1	rs3103071	chr4:8508579	C4orf23	chr4:8440604-8495258:+	0.34	7.31	1.12E-12	Response to antineoplastic agents	
THCA	cis	1	rs3103072	chr4:8508431	C4orf23	chr4:8440604-8495258:+	0.34	7.25	1.71E-12	Response to antineoplastic agents	
THCA	cis	1	rs3103099	chr4:8511567	C4orf23	chr4:8440604-8495258:+	0.33	6.8	3.07E-11	Response to antineoplastic agents	
THCA	cis	1	rs3103778	chr1:40433771	TRIT1	chr1:40306708-40349177:-	-0.15	-3.82	0.000151	PR interval	
THCA	cis	1	rs3105369	chr4:130022448	C4orf33	chr4:130014829-130033842:+	-0.6	-9.74	1.44E-20	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs3105590	chr15:50864145	SPPL2A	chr15:50999739-51057910:-	0.28	7.4	6.1E-13	QT interval	
THCA	cis	1	rs3105591	chr15:50869042	SPPL2A	chr15:50999739-51057910:-	0.29	7.68	9.38E-14	QT interval	
THCA	cis	1	rs3105593	chr15:50845018	SPPL2A	chr15:50999739-51057910:-	0.21	5.89	7.34E-9	QT interval	
THCA	cis	1	rs3106134	chr4:95128091	PDLIM5	chr4:95373038-95589376:+	0.12	3.53	0.000464	Capecitabine sensitivity	
THCA	cis	1	rs3106313	chr4:121803970	C4orf31	chr4:121956782-121993673:-	-0.2	-3.72	0.000223	Fasting plasma glucose	
THCA	cis	1	rs3107669	chr3:119567101	GSK3B	chr3:119540804-119813264:-	-0.13	-4.38	1.48E-5	HDL cholesterol	
THCA	cis	1	rs3109878	chr15:50836243	SPPL2A	chr15:50999739-51057910:-	0.21	5.91	6.64E-9	QT interval	
THCA	cis	1	rs3109879	chr15:50837618	ATP8B4	chr15:50150436-50411419:-	-0.11	-3.47	0.000562	QT interval	
THCA	cis	1	rs3109879	chr15:50837618	SPPL2A	chr15:50999739-51057910:-	0.28	7.32	1.06E-12	QT interval	
THCA	cis	1	rs3109880	chr15:50837812	ATP8B4	chr15:50150436-50411419:-	-0.11	-3.53	0.000462	QT interval	
THCA	cis	1	rs3109880	chr15:50837812	SPPL2A	chr15:50999739-51057910:-	0.28	7.38	6.91E-13	QT interval	
THCA	cis	1	rs3109881	chr15:50839272	ATP8B4	chr15:50150436-50411419:-	-0.12	-3.75	0.000201	QT interval	
THCA	cis	1	rs3109881	chr15:50839272	SPPL2A	chr15:50999739-51057910:-	0.28	7.3	1.19E-12	QT interval	
THCA	cis	1	rs3109888	chr15:50860694	SPPL2A	chr15:50999739-51057910:-	0.28	7.37	7.74E-13	QT interval	
THCA	cis	1	rs3109892	chr15:50877011	SPPL2A	chr15:50999739-51057910:-	0.27	7.37	7.31E-13	QT interval	
THCA	cis	1	rs3109894	chr15:50878574	SPPL2A	chr15:50999739-51057910:-	0.26	6.87	1.97E-11	QT interval	
THCA	cis	1	rs3109895	chr15:50880560	SPPL2A	chr15:50999739-51057910:-	0.28	7.49	3.31E-13	QT interval	
THCA	cis	1	rs3110496	chr17:27917771	EFCAB5	chr17:28256874-28435469:+	0.25	4.37	1.54E-5	Height	
THCA	cis	1	rs3110496	chr17:27917771	TP53I13	chr17:27895739-27900174:+	0.25	6.7	6.01E-11	Height	
THCA	cis	1	rs3110564	chr18:33701589	SLC39A6	chr18:33688495-33709357:-	-0.13	-3.74	0.000204	Esophageal squamous cell cancer (length of survival)	
THCA	cis	1	rs3113489	chr4:129961179	C4orf33	chr4:130014829-130033842:+	-0.6	-9.56	6.2E-20	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs3113494	chr4:87832601	C4orf36	chr4:87797359-87813575:-	0.2	4.53	7.39E-6	Amyotrophic lateral sclerosis	
THCA	cis	1	rs3114955	chr4:121805990	C4orf31	chr4:121956782-121993673:-	-0.21	-3.85	0.000134	Fasting plasma glucose	
THCA	cis	1	rs3115314	chr4:121809776	C4orf31	chr4:121956782-121993673:-	-0.21	-3.87	0.000123	Fasting plasma glucose	
THCA	cis	1	rs3118181	chr1:183166970	LAMC1	chr1:182992595-183114726:+	0.12	3.41	0.000699	Hypertriglyceridemia	
THCA	cis	1	rs3118625	chr9:131873256	C9orf114	chr9:131584346-131592085:-	0.16	3.48	0.000539	Blood metabolite ratios	
THCA	cis	1	rs3118625	chr9:131873256	CRAT	chr9:131857075-131873070:-	-0.28	-6.58	1.25E-10	Blood metabolite ratios	
THCA	cis	1	rs3118632	chr9:131901284	CRAT	chr9:131857075-131873070:-	-0.29	-6.93	1.36E-11	Blood metabolite ratios	
THCA	cis	1	rs3120662	chr1:152302865	FLG	chr1:152274651-152297679:-	0.28	4.41	1.26E-5	Atopic dermatitis	
THCA	cis	1	rs3120662	chr1:152302865	HRNR	chr1:152184558-152196669:-	-0.46	-6.48	2.35E-10	Atopic dermatitis	
THCA	cis	1	rs3121446	chr6:107140866	QRSL1	chr6:107077441-107116290:+	-0.15	-3.86	0.000131	Daytime sleep phenotypes	
THCA	cis	1	rs3124510	chr9:131899690	CRAT	chr9:131857075-131873070:-	-0.29	-6.94	1.26E-11	Blood metabolite ratios	
THCA	cis	1	rs3124511	chr9:131901458	CRAT	chr9:131857075-131873070:-	-0.29	-6.75	4.35E-11	Blood metabolite ratios	
THCA	cis	1	rs3124512	chr9:131903881	CRAT	chr9:131857075-131873070:-	-0.31	-7.14	3.39E-12	Blood metabolite ratios	
THCA	cis	1	rs3124513	chr9:131904593	CRAT	chr9:131857075-131873070:-	-0.29	-6.78	3.56E-11	Blood metabolite ratios	
THCA	cis	1	rs3124514	chr9:131904608	CRAT	chr9:131857075-131873070:-	-0.29	-6.78	3.56E-11	Blood metabolite ratios	
THCA	cis	1	rs3126085	chr1:152300817	FLG	chr1:152274651-152297679:-	0.28	4.38	1.45E-5	Atopic dermatitis	
THCA	cis	1	rs3126085	chr1:152300817	HRNR	chr1:152184558-152196669:-	-0.46	-6.45	2.77E-10	Atopic dermatitis	
THCA	cis	1	rs3126092	chr1:152307955	FLG	chr1:152274651-152297679:-	0.29	4.44	1.12E-5	Atopic dermatitis	
THCA	cis	1	rs3126092	chr1:152307955	HRNR	chr1:152184558-152196669:-	-0.46	-6.49	2.11E-10	Atopic dermatitis	
THCA	cis	1	rs3126095	chr1:152309683	FLG	chr1:152274651-152297679:-	0.29	4.44	1.12E-5	Atopic dermatitis	
THCA	cis	1	rs3126095	chr1:152309683	HRNR	chr1:152184558-152196669:-	-0.46	-6.49	2.11E-10	Atopic dermatitis	
THCA	cis	1	rs3126097	chr1:152311026	FLG	chr1:152274651-152297679:-	0.32	5.04	6.56E-7	Atopic dermatitis	
THCA	cis	1	rs3126097	chr1:152311026	HRNR	chr1:152184558-152196669:-	-0.49	-7.07	5.37E-12	Atopic dermatitis	
THCA	cis	1	rs3126098	chr1:152311923	FLG	chr1:152274651-152297679:-	0.28	4.38	1.46E-5	Atopic dermatitis	
THCA	cis	1	rs3126098	chr1:152311923	HRNR	chr1:152184558-152196669:-	-0.46	-6.48	2.31E-10	Atopic dermatitis	
THCA	cis	1	rs3127447	chr10:79253261	KCNMA1	chr10:78629359-79397577:-	0.23	5.04	6.66E-7	Educational attainment	
THCA	cis	1	rs3127661	chr6:107141927	QRSL1	chr6:107077441-107116290:+	-0.15	-3.91	0.000105	Daytime sleep phenotypes	
THCA	cis	1	rs3131573	chr15:50869601	SPPL2A	chr15:50999739-51057910:-	0.28	7.36	7.87E-13	QT interval	
THCA	cis	1	rs3131577	chr15:50863516	SPPL2A	chr15:50999739-51057910:-	0.28	7.38	7.1E-13	QT interval	
THCA	cis	1	rs3131578	chr15:50861470	SPPL2A	chr15:50999739-51057910:-	-0.28	-7.4	6.04E-13	QT interval	
THCA	cis	1	rs3131580	chr15:50854926	SPPL2A	chr15:50999739-51057910:-	0.27	7.31	1.12E-12	QT interval	
THCA	cis	1	rs3131582	chr15:50879670	SPPL2A	chr15:50999739-51057910:-	0.28	7.43	5.14E-13	QT interval	
THCA	cis	1	rs3131582	chr15:50879670	TRPM7	chr15:50852491-50978994:-	0.11	3.47	0.000559	QT interval	
THCA	cis	1	rs3131584	chr15:50847401	SPPL2A	chr15:50999739-51057910:-	0.28	7.46	4.25E-13	QT interval	
THCA	cis	1	rs3131585	chr15:50845796	SPPL2A	chr15:50999739-51057910:-	0.27	7.3	1.19E-12	QT interval	
THCA	cis	1	rs3131586	chr15:50845236	SPPL2A	chr15:50999739-51057910:-	0.28	7.31	1.15E-12	QT interval	
THCA	cis	1	rs3131587	chr15:50845101	SPPL2A	chr15:50999739-51057910:-	0.28	7.34	9.57E-13	QT interval	
THCA	cis	1	rs3131589	chr15:50841053	ATP8B4	chr15:50150436-50411419:-	-0.12	-3.74	0.000209	QT interval	
THCA	cis	1	rs3131589	chr15:50841053	SPPL2A	chr15:50999739-51057910:-	0.28	7.43	5.18E-13	QT interval	
THCA	cis	1	rs3131590	chr15:50840955	SPPL2A	chr15:50999739-51057910:-	0.28	7.4	6.17E-13	QT interval	
THCA	cis	1	rs3131596	chr15:50877575	SPPL2A	chr15:50999739-51057910:-	0.28	7.36	7.92E-13	QT interval	
THCA	cis	1	rs3135071	chr4:2406321	TMEM129	chr4:1717680-1723084:-	-0.18	-3.65	0.000296	Influenza A (H1N1) severity	
THCA	cis	1	rs3136441	chr11:46743247	ZNF408	chr11:46722368-46727461:+	-0.18	-3.5	0.000508	HDL cholesterol	
THCA	cis	1	rs3136449	chr11:46744470	ZNF408	chr11:46722368-46727461:+	-0.18	-3.5	0.000508	HDL cholesterol	
THCA	cis	1	rs3136457	chr11:46746258	ZNF408	chr11:46722368-46727461:+	-0.18	-3.5	0.000508	HDL cholesterol	
THCA	cis	1	rs313798	chr7:65493031	CCT6P1	chr7:65216092-65228661:+	0.42	6.65	8.13E-11	Diabetic kidney disease	
THCA	cis	1	rs313798	chr7:65493031	CRCP	chr7:65579805-65619551:+	-0.31	-4.71	3.26E-6	Diabetic kidney disease	
THCA	cis	1	rs313798	chr7:65493031	RABGEF1	chr7:66093890-66276446:+	0.54	6.57	1.3E-10	Diabetic kidney disease	
THCA	cis	1	rs313799	chr7:65494330	CCT6P1	chr7:65216092-65228661:+	0.39	6.3	6.96E-10	Diabetic kidney disease	
THCA	cis	1	rs313799	chr7:65494330	CRCP	chr7:65579805-65619551:+	-0.29	-4.43	1.16E-5	Diabetic kidney disease	
THCA	cis	1	rs313799	chr7:65494330	RABGEF1	chr7:66093890-66276446:+	0.55	6.85	2.32E-11	Diabetic kidney disease	
THCA	cis	1	rs313802	chr7:65516373	CCT6P1	chr7:65216092-65228661:+	0.4	6.41	3.43E-10	Diabetic kidney disease	
THCA	cis	1	rs313802	chr7:65516373	CRCP	chr7:65579805-65619551:+	-0.28	-4.3	2.07E-5	Diabetic kidney disease	
THCA	cis	1	rs313802	chr7:65516373	RABGEF1	chr7:66093890-66276446:+	0.57	7.06	5.74E-12	Diabetic kidney disease	
THCA	cis	1	rs313803	chr7:65514731	CCT6P1	chr7:65216092-65228661:+	0.4	6.41	3.43E-10	Diabetic kidney disease	
THCA	cis	1	rs313803	chr7:65514731	CRCP	chr7:65579805-65619551:+	-0.28	-4.3	2.07E-5	Diabetic kidney disease	
THCA	cis	1	rs313803	chr7:65514731	RABGEF1	chr7:66093890-66276446:+	0.57	7.06	5.74E-12	Diabetic kidney disease	
THCA	cis	1	rs313807	chr7:65499481	CCT6P1	chr7:65216092-65228661:+	0.39	6.15	1.59E-9	Diabetic kidney disease	
THCA	cis	1	rs313807	chr7:65499481	CRCP	chr7:65579805-65619551:+	-0.28	-4.34	1.73E-5	Diabetic kidney disease	
THCA	cis	1	rs313807	chr7:65499481	RABGEF1	chr7:66093890-66276446:+	0.57	7.16	3.07E-12	Diabetic kidney disease	
THCA	cis	1	rs313809	chr7:65499983	CCT6P1	chr7:65216092-65228661:+	0.41	6.5	2.01E-10	Diabetic kidney disease	
THCA	cis	1	rs313809	chr7:65499983	CRCP	chr7:65579805-65619551:+	-0.3	-4.61	5.07E-6	Diabetic kidney disease	
THCA	cis	1	rs313809	chr7:65499983	RABGEF1	chr7:66093890-66276446:+	0.56	6.89	1.8E-11	Diabetic kidney disease	
THCA	cis	1	rs313813	chr7:65503500	CCT6P1	chr7:65216092-65228661:+	0.39	6.19	1.32E-9	Diabetic kidney disease	
THCA	cis	1	rs313813	chr7:65503500	CRCP	chr7:65579805-65619551:+	-0.28	-4.31	1.98E-5	Diabetic kidney disease	
THCA	cis	1	rs313813	chr7:65503500	RABGEF1	chr7:66093890-66276446:+	0.58	7.24	1.81E-12	Diabetic kidney disease	
THCA	cis	1	rs3138144	chr12:56114769	RDH5	chr12:56114151-56118525:+	-0.13	-4.04	6.23E-5	Refractive error	
THCA	cis	1	rs313814	chr7:65503293	CCT6P1	chr7:65216092-65228661:+	0.4	6.31	6.37E-10	Diabetic kidney disease	
THCA	cis	1	rs313814	chr7:65503293	CRCP	chr7:65579805-65619551:+	-0.28	-4.3	2.1E-5	Diabetic kidney disease	
THCA	cis	1	rs313814	chr7:65503293	RABGEF1	chr7:66093890-66276446:+	0.58	7.24	1.82E-12	Diabetic kidney disease	
THCA	cis	1	rs313820	chr7:65574466	CCT6P1	chr7:65216092-65228661:+	0.41	6.77	3.84E-11	Diabetic kidney disease	
THCA	cis	1	rs313820	chr7:65574466	CRCP	chr7:65579805-65619551:+	-0.3	-4.72	3.13E-6	Diabetic kidney disease	
THCA	cis	1	rs313820	chr7:65574466	LOC493754	chr7:65993446-66057363:-	0.3	3.61	0.000334	Diabetic kidney disease	
THCA	cis	1	rs313820	chr7:65574466	RABGEF1	chr7:66093890-66276446:+	0.54	6.82	2.84E-11	Diabetic kidney disease	
THCA	cis	1	rs313824	chr7:65581207	CCT6P1	chr7:65216092-65228661:+	0.41	6.74	4.45E-11	Diabetic kidney disease	
THCA	cis	1	rs313824	chr7:65581207	CRCP	chr7:65579805-65619551:+	-0.3	-4.74	2.8E-6	Diabetic kidney disease	
THCA	cis	1	rs313824	chr7:65581207	LOC493754	chr7:65993446-66057363:-	0.3	3.58	0.000372	Diabetic kidney disease	
THCA	cis	1	rs313824	chr7:65581207	RABGEF1	chr7:66093890-66276446:+	0.53	6.78	3.48E-11	Diabetic kidney disease	
THCA	cis	1	rs313831	chr7:65551226	CCT6P1	chr7:65216092-65228661:+	0.4	6.41	3.54E-10	Diabetic kidney disease	
THCA	cis	1	rs313831	chr7:65551226	CRCP	chr7:65579805-65619551:+	-0.3	-4.76	2.59E-6	Diabetic kidney disease	
THCA	cis	1	rs313831	chr7:65551226	LOC493754	chr7:65993446-66057363:-	0.3	3.5	0.000506	Diabetic kidney disease	
THCA	cis	1	rs313831	chr7:65551226	RABGEF1	chr7:66093890-66276446:+	0.52	6.49	2.12E-10	Diabetic kidney disease	
THCA	cis	1	rs313832	chr7:65550891	CCT6P1	chr7:65216092-65228661:+	0.39	6.37	4.38E-10	Diabetic kidney disease	
THCA	cis	1	rs313832	chr7:65550891	CRCP	chr7:65579805-65619551:+	-0.3	-4.76	2.57E-6	Diabetic kidney disease	
THCA	cis	1	rs313832	chr7:65550891	LOC493754	chr7:65993446-66057363:-	0.3	3.5	0.000512	Diabetic kidney disease	
THCA	cis	1	rs313832	chr7:65550891	RABGEF1	chr7:66093890-66276446:+	0.51	6.43	3.07E-10	Diabetic kidney disease	
THCA	cis	1	rs313839	chr19:47221557	FKRP	chr19:47249303-47261832:+	0.55	6.44	2.89E-10	Type 1 diabetes	
THCA	cis	1	rs313839	chr19:47221557	PRKD2	chr19:47177574-47220384:-	0.19	4.24	2.72E-5	Type 1 diabetes	
THCA	cis	1	rs314370	chr7:100453208	ACHE	chr7:100487616-100494539:-	0.25	4	7.3E-5	Resting heart rate	
THCA	cis	1	rs315135	chr12:69762987	YEATS4	chr12:69753532-69784575:+	1.12	11.37	1.11E-26	Response to diuretic therapy	
THCA	cis	1	rs316304	chr7:65616894	CCT6P1	chr7:65216092-65228661:+	0.42	6.7	5.9E-11	Diabetic kidney disease	
THCA	cis	1	rs316304	chr7:65616894	CRCP	chr7:65579805-65619551:+	-0.3	-4.63	4.66E-6	Diabetic kidney disease	
THCA	cis	1	rs316304	chr7:65616894	LOC493754	chr7:65993446-66057363:-	0.29	3.36	0.000833	Diabetic kidney disease	
THCA	cis	1	rs316304	chr7:65616894	RABGEF1	chr7:66093890-66276446:+	0.57	7.14	3.42E-12	Diabetic kidney disease	
THCA	cis	1	rs316307	chr7:65570171	CCT6P1	chr7:65216092-65228661:+	0.41	6.71	5.36E-11	Diabetic kidney disease	
THCA	cis	1	rs316307	chr7:65570171	CRCP	chr7:65579805-65619551:+	-0.3	-4.76	2.56E-6	Diabetic kidney disease	
THCA	cis	1	rs316307	chr7:65570171	LOC493754	chr7:65993446-66057363:-	0.3	3.6	0.00035	Diabetic kidney disease	
THCA	cis	1	rs316307	chr7:65570171	RABGEF1	chr7:66093890-66276446:+	0.54	6.78	3.54E-11	Diabetic kidney disease	
THCA	cis	1	rs316312	chr7:65596491	CCT6P1	chr7:65216092-65228661:+	0.42	6.7	5.9E-11	Diabetic kidney disease	
THCA	cis	1	rs316312	chr7:65596491	CRCP	chr7:65579805-65619551:+	-0.3	-4.63	4.66E-6	Diabetic kidney disease	
THCA	cis	1	rs316312	chr7:65596491	LOC493754	chr7:65993446-66057363:-	0.29	3.36	0.000833	Diabetic kidney disease	
THCA	cis	1	rs316312	chr7:65596491	RABGEF1	chr7:66093890-66276446:+	0.57	7.14	3.42E-12	Diabetic kidney disease	
THCA	cis	1	rs316313	chr7:65593548	CCT6P1	chr7:65216092-65228661:+	0.42	6.7	5.9E-11	Diabetic kidney disease	
THCA	cis	1	rs316313	chr7:65593548	CRCP	chr7:65579805-65619551:+	-0.3	-4.63	4.66E-6	Diabetic kidney disease	
THCA	cis	1	rs316313	chr7:65593548	LOC493754	chr7:65993446-66057363:-	0.29	3.36	0.000833	Diabetic kidney disease	
THCA	cis	1	rs316313	chr7:65593548	RABGEF1	chr7:66093890-66276446:+	0.57	7.14	3.42E-12	Diabetic kidney disease	
THCA	cis	1	rs316315	chr7:65591205	CCT6P1	chr7:65216092-65228661:+	-0.34	-6.16	1.59E-9	Diabetic kidney disease	
THCA	cis	1	rs316315	chr7:65591205	CRCP	chr7:65579805-65619551:+	0.24	4.18	3.46E-5	Diabetic kidney disease	
THCA	cis	1	rs316315	chr7:65591205	RABGEF1	chr7:66093890-66276446:+	-0.45	-6.4	3.66E-10	Diabetic kidney disease	
THCA	cis	1	rs316317	chr7:65613637	CCT6P1	chr7:65216092-65228661:+	0.42	6.7	5.9E-11	Diabetic kidney disease	
THCA	cis	1	rs316317	chr7:65613637	CRCP	chr7:65579805-65619551:+	-0.3	-4.63	4.66E-6	Diabetic kidney disease	
THCA	cis	1	rs316317	chr7:65613637	LOC493754	chr7:65993446-66057363:-	0.29	3.36	0.000833	Diabetic kidney disease	
THCA	cis	1	rs316317	chr7:65613637	RABGEF1	chr7:66093890-66276446:+	0.57	7.14	3.42E-12	Diabetic kidney disease	
THCA	cis	1	rs316318	chr7:65612904	CCT6P1	chr7:65216092-65228661:+	0.42	6.7	5.9E-11	Diabetic kidney disease	
THCA	cis	1	rs316318	chr7:65612904	CRCP	chr7:65579805-65619551:+	-0.3	-4.63	4.66E-6	Diabetic kidney disease	
THCA	cis	1	rs316318	chr7:65612904	LOC493754	chr7:65993446-66057363:-	0.29	3.36	0.000833	Diabetic kidney disease	
THCA	cis	1	rs316318	chr7:65612904	RABGEF1	chr7:66093890-66276446:+	0.57	7.14	3.42E-12	Diabetic kidney disease	
THCA	cis	1	rs316321	chr7:65611613	CCT6P1	chr7:65216092-65228661:+	0.42	6.7	5.9E-11	Diabetic kidney disease	
THCA	cis	1	rs316321	chr7:65611613	CRCP	chr7:65579805-65619551:+	-0.3	-4.63	4.66E-6	Diabetic kidney disease	
THCA	cis	1	rs316321	chr7:65611613	LOC493754	chr7:65993446-66057363:-	0.29	3.36	0.000833	Diabetic kidney disease	
THCA	cis	1	rs316321	chr7:65611613	RABGEF1	chr7:66093890-66276446:+	0.57	7.14	3.42E-12	Diabetic kidney disease	
THCA	cis	1	rs316322	chr7:65611233	CCT6P1	chr7:65216092-65228661:+	0.42	6.72	5.21E-11	Diabetic kidney disease	
THCA	cis	1	rs316322	chr7:65611233	CRCP	chr7:65579805-65619551:+	-0.3	-4.62	5.05E-6	Diabetic kidney disease	
THCA	cis	1	rs316322	chr7:65611233	LOC493754	chr7:65993446-66057363:-	0.29	3.38	0.000791	Diabetic kidney disease	
THCA	cis	1	rs316322	chr7:65611233	RABGEF1	chr7:66093890-66276446:+	0.57	7.11	4.28E-12	Diabetic kidney disease	
THCA	cis	1	rs316325	chr7:65609518	CCT6P1	chr7:65216092-65228661:+	0.42	6.7	5.9E-11	Diabetic kidney disease	
THCA	cis	1	rs316325	chr7:65609518	CRCP	chr7:65579805-65619551:+	-0.3	-4.63	4.66E-6	Diabetic kidney disease	
THCA	cis	1	rs316325	chr7:65609518	LOC493754	chr7:65993446-66057363:-	0.29	3.36	0.000833	Diabetic kidney disease	
THCA	cis	1	rs316325	chr7:65609518	RABGEF1	chr7:66093890-66276446:+	0.57	7.14	3.42E-12	Diabetic kidney disease	
THCA	cis	1	rs316326	chr7:65609453	CCT6P1	chr7:65216092-65228661:+	0.42	6.7	5.9E-11	Diabetic kidney disease	
THCA	cis	1	rs316326	chr7:65609453	CRCP	chr7:65579805-65619551:+	-0.3	-4.63	4.66E-6	Diabetic kidney disease	
THCA	cis	1	rs316326	chr7:65609453	LOC493754	chr7:65993446-66057363:-	0.29	3.36	0.000833	Diabetic kidney disease	
THCA	cis	1	rs316326	chr7:65609453	RABGEF1	chr7:66093890-66276446:+	0.57	7.14	3.42E-12	Diabetic kidney disease	
THCA	cis	1	rs316327	chr7:65609201	CCT6P1	chr7:65216092-65228661:+	-0.42	-6.71	5.52E-11	Diabetic kidney disease	
THCA	cis	1	rs316327	chr7:65609201	CRCP	chr7:65579805-65619551:+	0.3	4.75	2.71E-6	Diabetic kidney disease	
THCA	cis	1	rs316327	chr7:65609201	RABGEF1	chr7:66093890-66276446:+	-0.57	-7.21	2.18E-12	Diabetic kidney disease	
THCA	cis	1	rs316329	chr7:65608416	CCT6P1	chr7:65216092-65228661:+	0.42	6.72	5.21E-11	Diabetic kidney disease	
THCA	cis	1	rs316329	chr7:65608416	CRCP	chr7:65579805-65619551:+	-0.29	-4.55	6.7E-6	Diabetic kidney disease	
THCA	cis	1	rs316329	chr7:65608416	LOC493754	chr7:65993446-66057363:-	0.29	3.39	0.00077	Diabetic kidney disease	
THCA	cis	1	rs316329	chr7:65608416	RABGEF1	chr7:66093890-66276446:+	0.57	7.22	2.11E-12	Diabetic kidney disease	
THCA	cis	1	rs316330	chr7:65605372	CCT6P1	chr7:65216092-65228661:+	0.42	6.7	5.9E-11	Diabetic kidney disease	
THCA	cis	1	rs316330	chr7:65605372	CRCP	chr7:65579805-65619551:+	-0.3	-4.63	4.66E-6	Diabetic kidney disease	
THCA	cis	1	rs316330	chr7:65605372	LOC493754	chr7:65993446-66057363:-	0.29	3.36	0.000833	Diabetic kidney disease	
THCA	cis	1	rs316330	chr7:65605372	RABGEF1	chr7:66093890-66276446:+	0.57	7.14	3.42E-12	Diabetic kidney disease	
THCA	cis	1	rs316331	chr7:65604622	CCT6P1	chr7:65216092-65228661:+	-0.41	-6.64	8.7E-11	Diabetic kidney disease	
THCA	cis	1	rs316331	chr7:65604622	CRCP	chr7:65579805-65619551:+	0.29	4.59	5.71E-6	Diabetic kidney disease	
THCA	cis	1	rs316331	chr7:65604622	LOC493754	chr7:65993446-66057363:-	-0.3	-3.5	0.000514	Diabetic kidney disease	
THCA	cis	1	rs316331	chr7:65604622	RABGEF1	chr7:66093890-66276446:+	-0.54	-6.75	4.27E-11	Diabetic kidney disease	
THCA	cis	1	rs316332	chr7:65604299	CCT6P1	chr7:65216092-65228661:+	0.4	6.51	1.92E-10	Diabetic kidney disease	
THCA	cis	1	rs316332	chr7:65604299	CRCP	chr7:65579805-65619551:+	-0.3	-4.64	4.48E-6	Diabetic kidney disease	
THCA	cis	1	rs316332	chr7:65604299	RABGEF1	chr7:66093890-66276446:+	0.58	7.33	1.0E-12	Diabetic kidney disease	
THCA	cis	1	rs316334	chr7:65602126	CCT6P1	chr7:65216092-65228661:+	0.42	6.7	5.9E-11	Diabetic kidney disease	
THCA	cis	1	rs316334	chr7:65602126	CRCP	chr7:65579805-65619551:+	-0.3	-4.63	4.66E-6	Diabetic kidney disease	
THCA	cis	1	rs316334	chr7:65602126	LOC493754	chr7:65993446-66057363:-	0.29	3.36	0.000833	Diabetic kidney disease	
THCA	cis	1	rs316334	chr7:65602126	RABGEF1	chr7:66093890-66276446:+	0.57	7.14	3.42E-12	Diabetic kidney disease	
THCA	cis	1	rs316338	chr6:2837846	SERPINB1	chr6:2833736-2842081:-	-0.23	-6.06	2.73E-9	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	
THCA	cis	1	rs3172494	chr3:48731487	IP6K2	chr3:48725437-48754920:-	-0.18	-4.11	4.63E-5	Educational attainment (years of education)	
THCA	cis	1	rs317689	chr12:69727190	YEATS4	chr12:69753532-69784575:+	-0.22	-3.9	0.000109	Response to diuretic therapy	
THCA	cis	1	rs3177243	chr22:24179922	C22orf43	chr22:23950640-23974487:-	-0.23	-3.48	0.000552	IgG glycosylation	
THCA	cis	1	rs317864	chr4:16157821	FLJ39653	chr4:16228286-16259810:+	-0.3	-4.18	3.43E-5	Kidney disease (early stage) in type 1 diabetes	
THCA	cis	1	rs317865	chr4:16156666	FLJ39653	chr4:16228286-16259810:+	-0.33	-4.36	1.58E-5	Kidney disease (early stage) in type 1 diabetes	
THCA	cis	1	rs3180872	chr22:51017394	CHKB	chr22:51017378-51021428:-	0.51	6.13	1.87E-9	Narcolepsy	
THCA	cis	1	rs3180872	chr22:51017394	CPT1B	chr22:51007291-51017096:-	-0.43	-8.55	1.69E-16	Narcolepsy	
THCA	cis	1	rs3183928	chr9:100684719	C9orf156	chr9:100666772-100684852:-	-0.14	-3.82	0.00015	Quantitative traits	
THCA	cis	1	rs31872	chr5:140372222	WDR55	chr5:140044384-140050551:+	0.19	4.62	5.05E-6	Visceral adipose tissue adjusted for BMI	
THCA	cis	1	rs3194585	chr4:103553090	CISD2	chr4:103790135-103809913:+	-0.15	-3.5	0.000517	Primary biliary cirrhosis	
THCA	cis	1	rs3194585	chr4:103553090	NFKB1	chr4:103422486-103538458:+	0.14	4.04	6.22E-5	Primary biliary cirrhosis	
THCA	cis	1	rs3196769	chr3:58409361	PXK	chr3:58318617-58410878:+	0.34	5.98	4.47E-9	Cholesterol, total	
THCA	cis	1	rs319680	chr3:47898307	CDC25A	chr3:48198668-48229801:-	0.33	6.91	1.57E-11	Educational attainment (years of education)	
THCA	cis	1	rs319680	chr3:47898307	NME6	chr3:48335591-48342886:-	-0.28	-5.49	6.5E-8	Educational attainment (years of education)	
THCA	cis	1	rs319680	chr3:47898307	ZNF589	chr3:48282596-48329113:+	0.4	8.5	2.47E-16	Educational attainment (years of education)	
THCA	cis	1	rs319690	chr3:47927484	CDC25A	chr3:48198668-48229801:-	0.27	5.77	1.4E-8	Blood pressure	
THCA	cis	1	rs319690	chr3:47927484	NME6	chr3:48335591-48342886:-	-0.28	-5.75	1.57E-8	Blood pressure	
THCA	cis	1	rs319690	chr3:47927484	ZNF589	chr3:48282596-48329113:+	0.32	7.02	7.41E-12	Blood pressure	
THCA	cis	1	rs3197999	chr3:49721532	MST1	chr3:49721381-49726196:-	0.14	4.17	3.65E-5	Crohn's disease;Ulcerative colitis	
THCA	cis	1	rs3204270	chr17:79682051	ARL16	chr17:79648234-79650954:-	-0.66	-10.06	1.04E-21	Dental caries	
THCA	cis	1	rs3204270	chr17:79682051	MAFG	chr17:79876147-79885588:-	0.27	3.39	0.000764	Dental caries	
THCA	cis	1	rs3204270	chr17:79682051	SLC25A10	chr17:79670407-79688041:+	0.36	4.92	1.21E-6	Dental caries	
THCA	cis	1	rs3206817	chr17:65892834	C17orf58	chr17:65987218-65989765:-	0.19	3.74	0.000204	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs3213445	chr22:51015838	CHKB	chr22:51017378-51021428:-	0.53	6.33	5.66E-10	Narcolepsy	
THCA	cis	1	rs3213445	chr22:51015838	CPT1B	chr22:51007291-51017096:-	-0.43	-8.54	1.74E-16	Narcolepsy	
THCA	cis	1	rs3213446	chr22:51015674	CHKB	chr22:51017378-51021428:-	0.52	6.21	1.13E-9	Narcolepsy	
THCA	cis	1	rs3213446	chr22:51015674	CPT1B	chr22:51007291-51017096:-	-0.42	-8.49	2.68E-16	Narcolepsy	
THCA	cis	1	rs3213662	chr7:44737922	OGDH	chr7:44646171-44748668:+	0.18	3.44	0.000633	Systolic blood pressure change trajectories	
THCA	cis	1	rs3213762	chr17:38178627	GSDMA	chr17:38119226-38134019:+	-0.32	-7.25	1.7E-12	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THCA	cis	1	rs3213762	chr17:38178627	ORMDL3	chr17:38077296-38083854:-	0.14	3.45	0.000619	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THCA	cis	1	rs3213861	chr19:41919944	B3GNT8	chr19:41931265-41934635:-	-0.35	-8.18	2.68E-15	Height	
THCA	cis	1	rs3214041	chr3:48454468	ATRIP	chr3:48488141-48507708:+	0.18	3.87	0.000122	Longevity	
THCA	cis	1	rs3214041	chr3:48454468	TREX1	chr3:48501186-48509043:+	-0.26	-5.94	5.55E-9	Longevity	
THCA	cis	1	rs321622	chr4:48024380	CNGA1	chr4:47937996-48018610:-	0.55	9.82	7.53E-21	Renal underexcretion gout;Gout	
THCA	cis	1	rs321622	chr4:48024380	FRYL	chr4:48499380-48782316:-	0.12	3.62	0.000327	Renal underexcretion gout;Gout	
THCA	cis	1	rs321622	chr4:48024380	NIPAL1	chr4:48018791-48039078:+	0.3	9.89	4.21E-21	Renal underexcretion gout;Gout	
THCA	cis	1	rs321908	chr19:52788044	ZNF836	chr19:52658127-52674896:-	0.28	4.17	3.58E-5	Cannabis use (initiation)	
THCA	cis	1	rs3229	chr12:42475888	GXYLT1	chr12:42475650-42538673:-	-0.15	-3.89	0.000116	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	
THCA	cis	1	rs3229	chr12:42475888	PPHLN1	chr12:42632249-42853517:+	-0.13	-3.54	0.000437	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	
THCA	cis	1	rs324017	chr12:57487814	STAT6	chr12:57489195-57522883:-	0.16	4.21	3.02E-5	Schizophrenia	
THCA	cis	1	rs324017	chr12:57487814	TMEM194A	chr12:57449427-57472574:-	0.15	3.7	0.000239	Schizophrenia	
THCA	cis	1	rs3310	chr20:3237232	ITPA	chr20:3190056-3204504:+	-0.24	-5.87	8.02E-9	IFN-related cytopenia	
THCA	cis	1	rs331524	chr11:4479954	TRIM68	chr11:4619902-4629437:-	0.16	3.42	0.00067	Amyotrophic lateral sclerosis	
THCA	cis	1	rs331525	chr11:4479835	TRIM68	chr11:4619902-4629437:-	0.16	3.39	0.000751	Amyotrophic lateral sclerosis	
THCA	cis	1	rs331526	chr11:4479696	TRIM68	chr11:4619902-4629437:-	0.16	3.57	0.000393	Amyotrophic lateral sclerosis	
THCA	cis	1	rs331534	chr11:4477080	TRIM68	chr11:4619902-4629437:-	0.16	3.38	0.000773	Amyotrophic lateral sclerosis	
THCA	cis	1	rs33322	chr5:56175226	C5orf35	chr5:56205103-56213010:+	1	23.23	1.8E-80	Type 2 diabetes	
THCA	cis	1	rs33325	chr5:56142547	C5orf35	chr5:56205103-56213010:+	1.02	23.74	7.33E-83	Type 2 diabetes	
THCA	cis	1	rs33326	chr5:56142601	C5orf35	chr5:56205103-56213010:+	1.01	23.14	4.9E-80	Type 2 diabetes	
THCA	cis	1	rs334698	chr1:61620993	NFIA	chr1:61542946-61928459:+	-0.22	-4	7.46E-5	Thyroid hormone levels	
THCA	cis	1	rs334699	chr1:61620496	NFIA	chr1:61542946-61928459:+	-0.23	-4.03	6.5E-5	Thyroid hormone levels	
THCA	cis	1	rs334700	chr1:61619463	NFIA	chr1:61542946-61928459:+	0.24	4.2	3.24E-5	Thyroid hormone levels	
THCA	cis	1	rs334703	chr1:61617519	NFIA	chr1:61542946-61928459:+	-0.21	-3.82	0.000153	Thyroid hormone levels	
THCA	cis	1	rs334704	chr1:61617094	NFIA	chr1:61542946-61928459:+	-0.23	-4.03	6.5E-5	Thyroid hormone levels	
THCA	cis	1	rs334706	chr1:61616247	NFIA	chr1:61542946-61928459:+	0.23	4.03	6.5E-5	Thyroid hormone levels	
THCA	cis	1	rs334725	chr1:61610049	NFIA	chr1:61542946-61928459:+	0.24	4.2	3.24E-5	Thyroid hormone levels	
THCA	cis	1	rs334726	chr1:61609529	NFIA	chr1:61542946-61928459:+	0.25	4.25	2.61E-5	Thyroid hormone levels	
THCA	cis	1	rs334727	chr1:61609187	NFIA	chr1:61542946-61928459:+	0.25	4.25	2.61E-5	Thyroid hormone levels	
THCA	cis	1	rs334728	chr1:61609007	NFIA	chr1:61542946-61928459:+	-0.23	-4.03	6.5E-5	Thyroid hormone levels	
THCA	cis	1	rs335422	chr5:176977052	DOK3	chr5:176928915-176937427:-	-0.25	-5.86	8.86E-9	Alzheimer disease and age of onset	
THCA	cis	1	rs335423	chr5:176975693	DOK3	chr5:176928915-176937427:-	-0.25	-5.86	8.86E-9	Alzheimer disease and age of onset	
THCA	cis	1	rs335454	chr5:176973151	DOK3	chr5:176928915-176937427:-	-0.26	-5.83	1.02E-8	Alzheimer disease and age of onset	
THCA	cis	1	rs335472	chr5:176984163	DOK3	chr5:176928915-176937427:-	-0.26	-5.88	7.87E-9	Alzheimer disease and age of onset	
THCA	cis	1	rs335473	chr5:176986424	DOK3	chr5:176928915-176937427:-	0.27	5.99	4.09E-9	Alzheimer disease and age of onset	
THCA	cis	1	rs335480	chr5:176987724	DOK3	chr5:176928915-176937427:-	0.27	6.09	2.3E-9	Alzheimer disease and age of onset	
THCA	cis	1	rs336543	chr3:161061080	NMD3	chr3:160939099-160971319:+	0.12	3.89	0.000114	Morning vs. evening chronotype	
THCA	cis	1	rs336548	chr3:161058412	NMD3	chr3:160939099-160971319:+	-0.11	-3.64	0.000304	Morning vs. evening chronotype	
THCA	cis	1	rs336567	chr3:161073046	NMD3	chr3:160939099-160971319:+	-0.11	-3.55	0.000416	Morning vs. evening chronotype	
THCA	cis	1	rs336569	chr3:161072346	NMD3	chr3:160939099-160971319:+	-0.1	-3.48	0.000551	Morning vs. evening chronotype	
THCA	cis	1	rs336570	chr3:161072054	NMD3	chr3:160939099-160971319:+	0.12	3.83	0.000144	Morning vs. evening chronotype	
THCA	cis	1	rs336577	chr3:161066294	NMD3	chr3:160939099-160971319:+	-0.11	-3.7	0.00024	Morning vs. evening chronotype	
THCA	cis	1	rs336583	chr3:161081981	NMD3	chr3:160939099-160971319:+	0.11	3.61	0.000345	Morning vs. evening chronotype	
THCA	cis	1	rs336585	chr3:161081670	NMD3	chr3:160939099-160971319:+	-0.11	-3.73	0.000215	Morning vs. evening chronotype	
THCA	cis	1	rs336590	chr3:161079583	NMD3	chr3:160939099-160971319:+	-0.11	-3.54	0.000443	Morning vs. evening chronotype	
THCA	cis	1	rs337156	chr1:220916683	C1orf115	chr1:220863628-220872499:+	0.2	4.69	3.65E-6	Response to antipsychotic therapy (extrapyramidal side effects)	
THCA	cis	1	rs337156	chr1:220916683	MARK1	chr1:220701568-220837798:+	-0.28	-4.63	4.7E-6	Response to antipsychotic therapy (extrapyramidal side effects)	
THCA	cis	1	rs337156	chr1:220916683	MOSC1	chr1:220960039-220987740:+	-0.24	-4.5	8.73E-6	Response to antipsychotic therapy (extrapyramidal side effects)	
THCA	cis	1	rs337157	chr1:220916558	C1orf115	chr1:220863628-220872499:+	0.2	4.56	6.48E-6	Response to antipsychotic therapy (extrapyramidal side effects)	
THCA	cis	1	rs337157	chr1:220916558	MARK1	chr1:220701568-220837798:+	-0.27	-4.46	1.03E-5	Response to antipsychotic therapy (extrapyramidal side effects)	
THCA	cis	1	rs337157	chr1:220916558	MOSC1	chr1:220960039-220987740:+	-0.25	-4.65	4.38E-6	Response to antipsychotic therapy (extrapyramidal side effects)	
THCA	cis	1	rs337158	chr1:220915835	C1orf115	chr1:220863628-220872499:+	0.2	4.56	6.57E-6	Response to antipsychotic therapy (extrapyramidal side effects)	
THCA	cis	1	rs337158	chr1:220915835	MARK1	chr1:220701568-220837798:+	-0.28	-4.65	4.35E-6	Response to antipsychotic therapy (extrapyramidal side effects)	
THCA	cis	1	rs337158	chr1:220915835	MOSC1	chr1:220960039-220987740:+	-0.24	-4.44	1.11E-5	Response to antipsychotic therapy (extrapyramidal side effects)	
THCA	cis	1	rs337159	chr1:220915423	C1orf115	chr1:220863628-220872499:+	0.2	4.69	3.65E-6	Response to antipsychotic therapy (extrapyramidal side effects)	
THCA	cis	1	rs337159	chr1:220915423	MARK1	chr1:220701568-220837798:+	-0.28	-4.63	4.7E-6	Response to antipsychotic therapy (extrapyramidal side effects)	
THCA	cis	1	rs337159	chr1:220915423	MOSC1	chr1:220960039-220987740:+	-0.24	-4.5	8.73E-6	Response to antipsychotic therapy (extrapyramidal side effects)	
THCA	cis	1	rs337160	chr1:220914947	C1orf115	chr1:220863628-220872499:+	0.2	4.51	8.15E-6	Response to antipsychotic therapy (extrapyramidal side effects)	
THCA	cis	1	rs337160	chr1:220914947	MARK1	chr1:220701568-220837798:+	-0.28	-4.69	3.6E-6	Response to antipsychotic therapy (extrapyramidal side effects)	
THCA	cis	1	rs337160	chr1:220914947	MOSC1	chr1:220960039-220987740:+	-0.24	-4.45	1.08E-5	Response to antipsychotic therapy (extrapyramidal side effects)	
THCA	cis	1	rs337161	chr1:220914920	C1orf115	chr1:220863628-220872499:+	0.2	4.51	8.15E-6	Response to antipsychotic therapy (extrapyramidal side effects)	
THCA	cis	1	rs337161	chr1:220914920	MARK1	chr1:220701568-220837798:+	-0.28	-4.69	3.6E-6	Response to antipsychotic therapy (extrapyramidal side effects)	
THCA	cis	1	rs337161	chr1:220914920	MOSC1	chr1:220960039-220987740:+	-0.24	-4.45	1.08E-5	Response to antipsychotic therapy (extrapyramidal side effects)	
THCA	cis	1	rs337162	chr1:220914866	C1orf115	chr1:220863628-220872499:+	0.2	4.64	4.52E-6	Response to antipsychotic therapy (extrapyramidal side effects)	
THCA	cis	1	rs337162	chr1:220914866	MARK1	chr1:220701568-220837798:+	-0.28	-4.67	3.91E-6	Response to antipsychotic therapy (extrapyramidal side effects)	
THCA	cis	1	rs337162	chr1:220914866	MOSC1	chr1:220960039-220987740:+	-0.24	-4.5	8.45E-6	Response to antipsychotic therapy (extrapyramidal side effects)	
THCA	cis	1	rs337351	chr5:176974019	DOK3	chr5:176928915-176937427:-	-0.25	-5.82	1.06E-8	Alzheimer disease and age of onset	
THCA	cis	1	rs33917318	chr3:10067797	C3orf10	chr3:10157333-10168873:+	-0.2	-4.26	2.51E-5	Alzheimer's disease	
THCA	cis	1	rs33917318	chr3:10067797	VHL	chr3:10183319-10193744:+	-0.19	-4.32	1.89E-5	Alzheimer's disease	
THCA	cis	1	rs33988592	chr3:121415610	IQCB1	chr3:121488610-121553926:-	0.54	10.57	1.27E-23	Cognitive performance	
THCA	cis	1	rs33993216	chr10:17204139	TRDMT1	chr10:17184983-17243681:-	-0.44	-10.08	8.75E-22	Homocysteine levels	
THCA	cis	1	rs33998546	chr3:127831038	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.62	5.04E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs33999310	chr3:52883332	RFT1	chr3:53122503-53164470:-	0.52	5.93	5.96E-9	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs33999310	chr3:52883332	TMEM110	chr3:52867139-52931547:-	0.41	4.82	1.92E-6	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs34010330	chr19:18559657	ELL	chr19:18553475-18632937:-	-0.25	-6.35	5.11E-10	Breast cancer	
THCA	cis	1	rs34010330	chr19:18559657	ISYNA1	chr19:18545625-18548943:-	0.13	4.72	3.12E-6	Breast cancer	
THCA	cis	1	rs34010330	chr19:18559657	LRRC25	chr19:18501955-18508421:-	-0.13	-4.27	2.4E-5	Breast cancer	
THCA	cis	1	rs34011442	chr14:71779083	SIPA1L1	chr14:71933902-72206118:+	0.27	5.46	7.67E-8	Mitral valve prolapse	
THCA	cis	1	rs34025766	chr4:17968811	DCAF16	chr4:17802280-17812381:-	-0.2	-4.41	1.26E-5	Height	
THCA	cis	1	rs34026879	chr1:27068238	ZDHHC18	chr1:27153201-27182207:+	0.8	8.6	1.18E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs34029977	chr7:118018673	ANKRD7	chr7:117864712-117882782:+	0.28	4.53	7.43E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs34030940	chr1:31857202	ZCCHC17	chr1:31769842-31837780:+	-0.3	-5.75	1.58E-8	Schizophrenia	
THCA	cis	1	rs34031374	chr12:82235615	PPFIA2	chr12:81652880-82153109:-	0.21	4.03	6.57E-5	Resting heart rate	
THCA	cis	1	rs34034766	chr2:231036768	SP110	chr2:231033645-231084827:-	0.24	4.95	1.05E-6	Obesity-related traits	
THCA	cis	1	rs34042070	chr16:72101525	DHODH	chr16:72042643-72058954:+	0.21	4.38	1.48E-5	Haptoglobin levels;Cholesterol, total;LDL cholesterol	
THCA	cis	1	rs34042070	chr16:72101525	TXNL4B	chr16:72072001-72128215:-	0.22	3.76	0.000189	Haptoglobin levels;Cholesterol, total;LDL cholesterol	
THCA	cis	1	rs34049648	chr4:1697337	FAM53A	chr4:1641609-1685854:-	0.17	3.84	0.00014	Height	
THCA	cis	1	rs34049648	chr4:1697337	TMEM129	chr4:1717680-1723084:-	0.16	5.17	3.51E-7	Height	
THCA	cis	1	rs34052221	chr6:163160803	PACRG	chr6:163148164-163736523:+	0.53	7.33	9.72E-13	Body mass index	
THCA	cis	1	rs34055941	chr9:131895076	CRAT	chr9:131857075-131873070:-	0.28	6.78	3.53E-11	Blood metabolite ratios	
THCA	cis	1	rs34057981	chr14:71823981	SIPA1L1	chr14:71933902-72206118:+	0.26	5.37	1.22E-7	Mitral valve prolapse	
THCA	cis	1	rs34066731	chr6:163011047	PACRG	chr6:163148164-163736523:+	0.45	7.03	7.07E-12	Body mass index	
THCA	cis	1	rs34072732	chr4:106604364	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs34084277	chr19:17387176	ABHD8	chr19:17402941-17414282:-	0.23	3.94	9.35E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs34084277	chr19:17387176	ANKLE1	chr19:17392454-17398454:+	0.29	5.07	5.57E-7	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs34084277	chr19:17387176	OCEL1	chr19:17337055-17340027:+	0.22	4.48	9.34E-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs34086988	chr3:121352745	IQCB1	chr3:121488610-121553926:-	0.52	10.19	3.36E-22	Cognitive performance	
THCA	cis	1	rs34096515	chr15:62379449	VPS13C	chr15:62144592-62352647:-	-0.12	-4.32	1.88E-5	Height	
THCA	cis	1	rs34102169	chr1:46424864	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.14	5.21E-22	Body mass index	
THCA	cis	1	rs34102169	chr1:46424864	GPBP1L1	chr1:46092978-46152302:-	0.15	3.83	0.000146	Body mass index	
THCA	cis	1	rs34102169	chr1:46424864	MMACHC	chr1:45965856-45976737:+	-0.21	-4.57	6.3E-6	Body mass index	
THCA	cis	1	rs34102169	chr1:46424864	MUTYH	chr1:45794915-45806142:-	0.3	8.13	3.66E-15	Body mass index	
THCA	cis	1	rs34106666	chr6:86676258	SNHG5	chr6:86386726-86388451:-	-0.48	-10.72	3.68E-24	Response to antipsychotic treatment	
THCA	cis	1	rs34121720	chr3:53072167	RFT1	chr3:53122503-53164470:-	0.57	6.71	5.53E-11	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs34121720	chr3:53072167	TMEM110	chr3:52867139-52931547:-	0.34	4.03	6.36E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs34122378	chr2:231040163	SP110	chr2:231033645-231084827:-	0.26	5.22	2.73E-7	Obesity-related traits	
THCA	cis	1	rs34128973	chr11:47851376	C1QTNF4	chr11:47611216-47615961:-	-0.31	-5.36	1.28E-7	Subjective well-being	
THCA	cis	1	rs34136756	chr7:65381256	CCT6P1	chr7:65216092-65228661:+	0.39	6.18	1.36E-9	Diabetic kidney disease	
THCA	cis	1	rs34136756	chr7:65381256	CRCP	chr7:65579805-65619551:+	-0.26	-3.99	7.58E-5	Diabetic kidney disease	
THCA	cis	1	rs34136756	chr7:65381256	RABGEF1	chr7:66093890-66276446:+	0.54	6.71	5.64E-11	Diabetic kidney disease	
THCA	cis	1	rs34138336	chr6:163144929	PACRG	chr6:163148164-163736523:+	0.55	7.6	1.62E-13	Body mass index	
THCA	cis	1	rs34139049	chr6:33716784	IP6K3	chr6:33689443-33714762:-	0.4	6.48	2.29E-10	Obesity (extreme)	
THCA	cis	1	rs34156253	chr5:150226230	LOC134466	chr5:150310000-150326146:-	0.38	5.23	2.51E-7	Crohn's disease	
THCA	cis	1	rs34156351	chr4:17983055	DCAF16	chr4:17802280-17812381:-	-0.2	-4.39	1.38E-5	Height	
THCA	cis	1	rs34171762	chr19:18559410	ELL	chr19:18553475-18632937:-	-0.25	-6.37	4.47E-10	Breast cancer	
THCA	cis	1	rs34171762	chr19:18559410	ISYNA1	chr19:18545625-18548943:-	0.12	4.62	4.88E-6	Breast cancer	
THCA	cis	1	rs34171762	chr19:18559410	LRRC25	chr19:18501955-18508421:-	-0.14	-4.71	3.25E-6	Breast cancer	
THCA	cis	1	rs34174370	chr3:127849744	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.47	9.77E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs34174778	chr20:33544277	PROCR	chr20:33758727-33765164:+	-0.36	-5.52	5.69E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs34174778	chr20:33544277	TRPC4AP	chr20:33590215-33680618:-	0.34	4.01	7.06E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs34175245	chr1:27001711	ZDHHC18	chr1:27153201-27182207:+	0.79	8.58	1.32E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs34177053	chr6:163007772	PACRG	chr6:163148164-163736523:+	0.44	6.84	2.4E-11	Body mass index	
THCA	cis	1	rs34179822	chr3:10140017	C3orf10	chr3:10157333-10168873:+	-0.2	-4.29	2.2E-5	Alzheimer's disease	
THCA	cis	1	rs34179822	chr3:10140017	VHL	chr3:10183319-10193744:+	-0.18	-4.19	3.32E-5	Alzheimer's disease	
THCA	cis	1	rs34192067	chr7:65887657	CCT6P1	chr7:65216092-65228661:+	0.43	6.71	5.64E-11	Diabetic kidney disease	
THCA	cis	1	rs34192067	chr7:65887657	CRCP	chr7:65579805-65619551:+	-0.27	-3.97	8.2E-5	Diabetic kidney disease	
THCA	cis	1	rs34192067	chr7:65887657	RABGEF1	chr7:66093890-66276446:+	0.63	7.65	1.11E-13	Diabetic kidney disease	
THCA	cis	1	rs34192365	chr6:163012382	PACRG	chr6:163148164-163736523:+	0.45	7	8.92E-12	Body mass index	
THCA	cis	1	rs34193460	chr7:65393110	CCT6P1	chr7:65216092-65228661:+	0.41	6.45	2.67E-10	Diabetic kidney disease	
THCA	cis	1	rs34193460	chr7:65393110	CRCP	chr7:65579805-65619551:+	-0.28	-4.24	2.64E-5	Diabetic kidney disease	
THCA	cis	1	rs34193460	chr7:65393110	RABGEF1	chr7:66093890-66276446:+	0.53	6.38	4.25E-10	Diabetic kidney disease	
THCA	cis	1	rs34196947	chr5:2786964	IRX2	chr5:2746281-2751769:-	-0.26	-4.02	6.85E-5	Toenail selenium levels	
THCA	cis	1	rs34201939	chr1:27093711	PIGV	chr1:27114455-27124886:+	-0.29	-3.46	0.000583	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs34201939	chr1:27093711	ZDHHC18	chr1:27153201-27182207:+	0.81	8.63	9.02E-17	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs34209421	chr4:18031110	DCAF16	chr4:17802280-17812381:-	-0.22	-4.37	1.52E-5	Height	
THCA	cis	1	rs34216334	chr1:27063419	PIGV	chr1:27114455-27124886:+	-0.29	-3.36	0.000843	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs34216334	chr1:27063419	ZDHHC18	chr1:27153201-27182207:+	0.8	8.59	1.26E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs34217609	chr1:27008267	PIGV	chr1:27114455-27124886:+	-0.29	-3.37	0.000827	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs34217609	chr1:27008267	ZDHHC18	chr1:27153201-27182207:+	0.8	8.59	1.26E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs34228187	chr3:127816433	EEFSEC	chr3:127872313-128127488:+	-0.25	-4.43	1.19E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs34228197	chr6:163008232	PACRG	chr6:163148164-163736523:+	0.44	6.84	2.4E-11	Body mass index	
THCA	cis	1	rs34234989	chr20:33774533	PROCR	chr20:33758727-33765164:+	-0.13	-3.4	0.000726	Thrombosis	
THCA	cis	1	rs34234989	chr20:33774533	UQCC	chr20:33890383-33999833:-	-0.15	-4.29	2.15E-5	Thrombosis	
THCA	cis	1	rs34237279	chr15:75361121	ARID3B	chr15:74833548-74890470:+	-0.15	-3.95	9.09E-5	Blood trace element (Zn levels)	
THCA	cis	1	rs34237279	chr15:75361121	PPCDC	chr15:75315927-75343066:+	0.15	4.28	2.27E-5	Blood trace element (Zn levels)	
THCA	cis	1	rs34237279	chr15:75361121	SCAMP5	chr15:75287901-75313836:+	0.44	7.81	3.56E-14	Blood trace element (Zn levels)	
THCA	cis	1	rs34244302	chr3:53102236	RFT1	chr3:53122503-53164470:-	0.64	7.49	3.42E-13	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs34244302	chr3:53102236	SFMBT1	chr3:52938628-53080070:-	-0.2	-3.41	0.000694	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs34246550	chr8:89585399	MMP16	chr8:89049462-89339717:-	0.16	3.59	0.000358	Body mass index and cholesterol (psychopharmacological treatment)	
THCA	cis	1	rs34252323	chr2:135486302	TMEM163	chr2:135213331-135525334:-	-0.18	-3.82	0.000153	Gut microbiome composition (winter)	
THCA	cis	1	rs34256197	chr19:18606472	ELL	chr19:18553475-18632937:-	-0.26	-6.55	1.48E-10	Breast cancer	
THCA	cis	1	rs34256197	chr19:18606472	ISYNA1	chr19:18545625-18548943:-	0.13	4.74	2.77E-6	Breast cancer	
THCA	cis	1	rs34256197	chr19:18606472	LRRC25	chr19:18501955-18508421:-	-0.14	-4.8	2.17E-6	Breast cancer	
THCA	cis	1	rs34258593	chr3:38464565	LOC100128640	chr3:38492524-38496311:-	0.23	4.89	1.35E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs34258593	chr3:38464565	SCN5A	chr3:38589554-38691164:-	0.17	3.49	0.000531	Electrocardiographic conduction measures	
THCA	cis	1	rs34258593	chr3:38464565	XYLB	chr3:38388251-38456467:+	0.21	5.02	7.15E-7	Electrocardiographic conduction measures	
THCA	cis	1	rs34263535	chr13:42154237	C13orf15	chr13:42031542-42045013:+	0.15	3.5	0.000503	Multiple sclerosis	
THCA	cis	1	rs34275373	chr5:125915744	ALDH7A1	chr5:125878918-125931082:-	0.47	6.61	1.04E-10	Osteoporosis	
THCA	cis	1	rs34281561	chr6:86701872	SNHG5	chr6:86386726-86388451:-	-0.49	-10.88	8.91E-25	Response to antipsychotic treatment	
THCA	cis	1	rs34286592	chr16:29820480	MAPK3	chr16:30125427-30134630:-	-0.24	-3.36	0.000848	Multiple sclerosis	
THCA	cis	1	rs34292685	chr11:64049021	PRDX5	chr11:64085569-64089282:+	-0.19	-4.85	1.7E-6	Mean platelet volume	
THCA	cis	1	rs34304649	chr9:99247301	CDC14B	chr9:99262397-99382112:-	-0.17	-5.1	5.0E-7	Height	
THCA	cis	1	rs34305567	chr22:29853562	NIPSNAP1	chr22:29950800-29977144:-	0.32	4.11	4.65E-5	Carotid atherosclerosis in HIV infection	
THCA	cis	1	rs34305567	chr22:29853562	THOC5	chr22:29904157-29949736:-	0.21	3.9	0.000111	Carotid atherosclerosis in HIV infection	
THCA	cis	1	rs343087	chr12:66260924	RPSAP52	chr12:66151803-66220754:-	-0.18	-3.71	0.000235	Type 2 diabetes	
THCA	cis	1	rs343092	chr12:66250940	RPSAP52	chr12:66151803-66220754:-	-0.18	-3.63	0.000314	Type 2 diabetes	
THCA	cis	1	rs34311452	chr7:151113143	CRYGN	chr7:151127057-151137899:-	0.15	3.78	0.000174	Coronary heart disease	
THCA	cis	1	rs34313230	chr20:43755858	STK4	chr20:43595120-43708591:+	-0.17	-4.1	4.94E-5	Parental longevity (mother's age at death)	
THCA	cis	1	rs34313969	chr3:52995166	RFT1	chr3:53122503-53164470:-	0.62	7.15	3.23E-12	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs34313969	chr3:52995166	TMEM110	chr3:52867139-52931547:-	0.36	4.1	4.84E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs343166	chr4:121818722	C4orf31	chr4:121956782-121993673:-	-0.19	-3.46	0.000587	Fasting plasma glucose	
THCA	cis	1	rs34319345	chr16:58820592	GOT2	chr16:58741035-58768246:-	-0.27	-7.74	5.99E-14	Blood metabolite ratios	
THCA	cis	1	rs34319345	chr16:58820592	SLC38A7	chr16:58700298-58718674:-	-0.15	-5.09	5.15E-7	Blood metabolite ratios	
THCA	cis	1	rs343195	chr4:121800466	C4orf31	chr4:121956782-121993673:-	-0.2	-3.72	0.000223	Fasting plasma glucose	
THCA	cis	1	rs343197	chr4:121798485	C4orf31	chr4:121956782-121993673:-	0.21	3.87	0.000123	Fasting plasma glucose	
THCA	cis	1	rs343198	chr4:121798186	C4orf31	chr4:121956782-121993673:-	-0.21	-3.89	0.000115	Fasting plasma glucose	
THCA	cis	1	rs34320230	chr7:97785500	BRI3	chr7:97910979-97922275:+	-0.11	-3.89	0.000113	Prostate cancer (gene x gene interaction);Prostate cancer	
THCA	cis	1	rs34320230	chr7:97785500	TECPR1	chr7:97846060-97881468:-	-0.14	-3.78	0.000173	Prostate cancer (gene x gene interaction);Prostate cancer	
THCA	cis	1	rs34329423	chr1:31857177	ZCCHC17	chr1:31769842-31837780:+	-0.3	-5.79	1.3E-8	Schizophrenia	
THCA	cis	1	rs34333482	chr6:116855952	FAM26F	chr6:116782556-116784933:+	0.14	4.83	1.88E-6	Pelvic organ prolapse (moderate/severe)	
THCA	cis	1	rs34339105	chr6:33723457	IP6K3	chr6:33689443-33714762:-	0.4	6.44	2.92E-10	Obesity (extreme)	
THCA	cis	1	rs34340609	chr3:53077276	RFT1	chr3:53122503-53164470:-	0.56	7.35	8.92E-13	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs34344888	chr14:23387585	HAUS4	chr14:23415438-23426335:-	-0.38	-9.31	4.72E-19	Educational attainment (years of education)	
THCA	cis	1	rs34344888	chr14:23387585	RBM23	chr14:23369855-23388396:-	0.23	4.72	3.05E-6	Educational attainment (years of education)	
THCA	cis	1	rs34344906	chr6:162993378	PACRG	chr6:163148164-163736523:+	0.45	6.98	9.72E-12	Body mass index	
THCA	cis	1	rs34347156	chr3:151008715	GPR87	chr3:151011876-151034636:-	0.21	4.59	5.62E-6	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs34347156	chr3:151008715	P2RY14	chr3:150929905-150996230:-	-0.2	-4.32	1.9E-5	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs34373625	chr10:4981201	AKR1C2	chr10:4964715-5060207:-	0.32	4.2	3.25E-5	Height	
THCA	cis	1	rs34375435	chr2:75914044	C2orf3	chr2:75889834-75938111:-	-0.17	-3.55	0.000419	Hippocampal atrophy	
THCA	cis	1	rs34375435	chr2:75914044	MRPL19	chr2:75873909-75897879:+	0.16	4.18	3.53E-5	Hippocampal atrophy	
THCA	cis	1	rs34382476	chr6:111744754	KIAA1919	chr6:111580482-111590259:+	0.48	5.66	2.55E-8	Psoriasis	
THCA	cis	1	rs34394661	chr3:119279148	ADPRH	chr3:119298523-119308791:+	-0.22	-3.6	0.000347	Vitiligo	
THCA	cis	1	rs34396223	chr1:95697828	RWDD3	chr1:95583479-95712773:+	0.27	3.54	0.000432	Stearic acid (18:0) plasma levels	
THCA	cis	1	rs34398656	chr6:162999612	PACRG	chr6:163148164-163736523:+	0.44	6.89	1.77E-11	Body mass index	
THCA	cis	1	rs34400805	chr1:31826396	ZCCHC17	chr1:31769842-31837780:+	-0.3	-5.74	1.7E-8	Schizophrenia	
THCA	cis	1	rs34401800	chr15:56469488	MNS1	chr15:56720929-56757335:-	-0.25	-3.58	0.000385	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs34401800	chr15:56469488	TEX9	chr15:56657644-56738071:+	-0.35	-5.99	4.06E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs34403909	chr3:127810445	EEFSEC	chr3:127872313-128127488:+	-0.25	-4.42	1.23E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs34405766	chr2:135486189	TMEM163	chr2:135213331-135525334:-	-0.18	-3.82	0.000153	Gut microbiome composition (winter)	
THCA	cis	1	rs34406563	chr11:46398916	PACSIN3	chr11:47199085-47207958:-	0.17	3.87	0.000122	Schizophrenia	
THCA	cis	1	rs344081	chr3:156555984	LEKR1	chr3:156544076-156763918:+	-0.55	-11.08	1.48E-25	Bone mineral density	
THCA	cis	1	rs344088	chr3:156561361	LEKR1	chr3:156544076-156763918:+	-0.56	-11.28	2.62E-26	Bone mineral density	
THCA	cis	1	rs344090	chr3:156563140	LEKR1	chr3:156544076-156763918:+	-0.56	-11.28	2.62E-26	Bone mineral density	
THCA	cis	1	rs34409160	chr2:28943865	PPP1CB	chr2:28974612-29025805:+	-0.17	-4.12	4.42E-5	Body mass index	
THCA	cis	1	rs34409160	chr2:28943865	TRMT61B	chr2:29072690-29093175:-	0.5	9.94	2.64E-21	Body mass index	
THCA	cis	1	rs34409786	chr3:127888175	EEFSEC	chr3:127872313-128127488:+	-0.25	-4.27	2.32E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs34413965	chr2:218279471	DIRC3	chr2:218148748-218621316:-	0.21	5.07	5.84E-7	Height	
THCA	cis	1	rs34414970	chr5:76534038	PDE8B	chr5:76506706-76723226:+	0.11	3.41	0.000706	Thyroid hormone levels	
THCA	cis	1	rs34428306	chr1:152184316	FLG2	chr1:152321214-152332482:-	0.25	4.46	1.01E-5	Inflammatory skin disease	
THCA	cis	1	rs34428306	chr1:152184316	FLG	chr1:152274651-152297679:-	0.48	8.83	2.02E-17	Inflammatory skin disease	
THCA	cis	1	rs34428306	chr1:152184316	HRNR	chr1:152184558-152196669:-	-0.24	-3.73	0.000218	Inflammatory skin disease	
THCA	cis	1	rs34434809	chr10:17187634	TRDMT1	chr10:17184983-17243681:-	-0.44	-9.83	6.67E-21	Homocysteine levels	
THCA	cis	1	rs34443622	chr6:163208214	PACRG	chr6:163148164-163736523:+	0.52	7.1	4.63E-12	Body mass index	
THCA	cis	1	rs34446316	chr4:183820101	DCTD	chr4:183811245-183838630:-	0.24	5.01	7.73E-7	Obesity-related traits	
THCA	cis	1	rs34453673	chr5:434722	C5orf55	chr5:441645-443258:-	0.34	8.49	2.61E-16	Cystic fibrosis severity	
THCA	cis	1	rs34454389	chr1:41663236	SCMH1	chr1:41492875-41707788:-	-0.2	-4.65	4.29E-6	Height	
THCA	cis	1	rs34460334	chr1:27215079	ZDHHC18	chr1:27153201-27182207:+	0.76	7.94	1.5E-14	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs34460651	chr6:33731312	IP6K3	chr6:33689443-33714762:-	0.4	6.33	5.59E-10	Obesity (extreme)	
THCA	cis	1	rs34460651	chr6:33731312	PSMB8	chr6:32808497-32812712:-	-0.12	-3.39	0.000749	Obesity (extreme)	
THCA	cis	1	rs34473788	chr1:27271519	ZDHHC18	chr1:27153201-27182207:+	0.61	6.61	1.03E-10	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs3448	chr3:49396751	GMPPB	chr3:49758932-49761384:-	-0.17	-3.74	0.000208	Menarche (age at onset)	
THCA	cis	1	rs3448	chr3:49396751	P4HTM	chr3:49027341-49044579:+	0.17	4.25	2.57E-5	Menarche (age at onset)	
THCA	cis	1	rs3448	chr3:49396751	WDR6	chr3:49044637-49053386:+	-0.18	-3.68	0.000257	Menarche (age at onset)	
THCA	cis	1	rs344924	chr1:68105453	DIRAS3	chr1:68511647-68516460:-	0.25	3.54	0.000443	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs34496143	chr10:37992658	LOC399744	chr10:38717074-38741080:+	0.25	3.44	0.000625	Obesity (extreme)	
THCA	cis	1	rs34500464	chr10:17191996	TRDMT1	chr10:17184983-17243681:-	-0.43	-9.87	4.78E-21	Homocysteine levels	
THCA	cis	1	rs34500464	chr10:17191996	VIM	chr10:17270258-17279592:+	-0.19	-3.46	0.000594	Homocysteine levels	
THCA	cis	1	rs34510678	chr5:139064835	SLC4A9	chr5:139739787-139754722:+	-0.21	-3.37	0.000824	Schizophrenia	
THCA	cis	1	rs34514856	chr1:27287560	ZDHHC18	chr1:27153201-27182207:+	0.73	7.54	2.42E-13	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs34516452	chr6:70582018	COL19A1	chr6:70576448-70922157:+	-0.27	-4.25	2.57E-5	Subjective well-being	
THCA	cis	1	rs34524083	chr14:71858372	SIPA1L1	chr14:71933902-72206118:+	0.27	5.49	6.48E-8	Mitral valve prolapse	
THCA	cis	1	rs34528013	chr14:71767848	SIPA1L1	chr14:71933902-72206118:+	0.27	5.57	4.19E-8	Mitral valve prolapse	
THCA	cis	1	rs34528131	chr14:71861278	SIPA1L1	chr14:71933902-72206118:+	0.27	5.4	1.04E-7	Mitral valve prolapse	
THCA	cis	1	rs34529418	chr7:65403209	CCT6P1	chr7:65216092-65228661:+	0.38	6	3.93E-9	Diabetic kidney disease	
THCA	cis	1	rs34529418	chr7:65403209	CRCP	chr7:65579805-65619551:+	-0.26	-4	7.24E-5	Diabetic kidney disease	
THCA	cis	1	rs34529418	chr7:65403209	RABGEF1	chr7:66093890-66276446:+	0.55	6.89	1.73E-11	Diabetic kidney disease	
THCA	cis	1	rs34530577	chr3:53103796	ITIH4	chr3:52847007-52866554:-	0.16	4.5	8.63E-6	Height	
THCA	cis	1	rs34530577	chr3:53103796	RFT1	chr3:53122503-53164470:-	-0.76	-18.43	1.07E-57	Height	
THCA	cis	1	rs34544865	chr19:37801242	ZNF607	chr19:38187276-38210691:-	-0.21	-3.34	0.000894	Coronary artery calcification	
THCA	cis	1	rs34552628	chr20:55070268	C20orf43	chr20:55043647-55093942:+	0.3	7.28	1.34E-12	Refractive astigmatism	
THCA	cis	1	rs34552628	chr20:55070268	CSTF1	chr20:54967427-54979582:+	0.18	3.34	0.000902	Refractive astigmatism	
THCA	cis	1	rs34556682	chr1:27186149	ZDHHC18	chr1:27153201-27182207:+	0.79	8.29	1.13E-15	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs34558323	chr10:17184228	TRDMT1	chr10:17184983-17243681:-	-0.42	-9.63	3.46E-20	Homocysteine levels	
THCA	cis	1	rs34560516	chr7:65404092	CCT6P1	chr7:65216092-65228661:+	0.41	6.41	3.44E-10	Diabetic kidney disease	
THCA	cis	1	rs34560516	chr7:65404092	CRCP	chr7:65579805-65619551:+	-0.26	-3.95	9.06E-5	Diabetic kidney disease	
THCA	cis	1	rs34560516	chr7:65404092	RABGEF1	chr7:66093890-66276446:+	0.53	6.46	2.51E-10	Diabetic kidney disease	
THCA	cis	1	rs34562493	chr3:127817022	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.61	5.13E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs34570071	chr15:85280212	GOLGA6L5	chr15:85047738-85060078:-	-0.15	-3.9	0.00011	Schizophrenia	
THCA	cis	1	rs34570071	chr15:85280212	LOC388152	chr15:84867600-84898920:-	-0.47	-7.84	2.86E-14	Schizophrenia	
THCA	cis	1	rs34570071	chr15:85280212	NMB	chr15:85198362-85201802:-	0.36	7.62	1.34E-13	Schizophrenia	
THCA	cis	1	rs34576193	chr1:27054780	PIGV	chr1:27114455-27124886:+	-0.29	-3.36	0.000843	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs34576193	chr1:27054780	ZDHHC18	chr1:27153201-27182207:+	0.8	8.59	1.26E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs34577383	chr7:65385726	CCT6P1	chr7:65216092-65228661:+	0.38	6	3.93E-9	Diabetic kidney disease	
THCA	cis	1	rs34577383	chr7:65385726	CRCP	chr7:65579805-65619551:+	-0.26	-4	7.24E-5	Diabetic kidney disease	
THCA	cis	1	rs34577383	chr7:65385726	RABGEF1	chr7:66093890-66276446:+	0.55	6.89	1.73E-11	Diabetic kidney disease	
THCA	cis	1	rs34580798	chr20:47899957	CSE1L	chr20:47662838-47713484:+	-0.19	-3.36	0.00084	Height	
THCA	cis	1	rs34580798	chr20:47899957	DDX27	chr20:47835832-47860612:+	0.26	4.76	2.53E-6	Height	
THCA	cis	1	rs34581302	chr6:86705948	SNHG5	chr6:86386726-86388451:-	-0.49	-10.85	1.15E-24	Response to antipsychotic treatment	
THCA	cis	1	rs34583567	chr15:67983281	IQCH	chr15:67547188-67794139:+	0.17	5.24	2.47E-7	Motion sickness	
THCA	cis	1	rs34583567	chr15:67983281	MAP2K5	chr15:67835021-68099451:+	0.15	3.6	0.000348	Motion sickness	
THCA	cis	1	rs34585496	chr1:27025940	ZDHHC18	chr1:27153201-27182207:+	0.8	8.6	1.15E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs34587942	chr2:70081501	SNRNP27	chr2:70121090-70132348:+	0.16	3.8	0.000162	Colorectal or endometrial cancer	
THCA	cis	1	rs34588175	chr4:17967114	DCAF16	chr4:17802280-17812381:-	-0.2	-4.42	1.24E-5	Height	
THCA	cis	1	rs34591938	chr6:163087003	PACRG	chr6:163148164-163736523:+	0.54	7.36	8.27E-13	Body mass index	
THCA	cis	1	rs34594435	chr7:72977249	MLXIPL	chr7:73007524-73038870:-	0.24	4.39	1.42E-5	Triglycerides	
THCA	cis	1	rs34594856	chr6:163051845	PACRG	chr6:163148164-163736523:+	0.51	7.18	2.74E-12	Body mass index	
THCA	cis	1	rs34596352	chr1:200785330	DDX59	chr1:200610119-200639126:-	-0.25	-3.89	0.000115	Epilepsy	
THCA	cis	1	rs34602589	chr20:43768734	STK4	chr20:43595120-43708591:+	-0.17	-3.99	7.57E-5	Parental longevity (mother's age at death)	
THCA	cis	1	rs34610643	chr17:40574388	NAGLU	chr17:40687951-40696464:+	-0.23	-4.92	1.17E-6	Crohn's disease	
THCA	cis	1	rs34610643	chr17:40574388	TUBG2	chr17:40811266-40819023:+	-0.23	-5.54	5.12E-8	Crohn's disease	
THCA	cis	1	rs34614532	chr16:15132908	NTAN1	chr16:15131717-15149833:-	0.13	3.93	9.87E-5	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs34614532	chr16:15132908	PDXDC1	chr16:15068599-15233195:+	0.33	7.74	6.14E-14	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs34619021	chr6:163029767	PACRG	chr6:163148164-163736523:+	0.48	7.13	3.68E-12	Body mass index	
THCA	cis	1	rs34622539	chr20:43756548	STK4	chr20:43595120-43708591:+	-0.17	-3.88	0.000121	Parental longevity (mother's age at death)	
THCA	cis	1	rs34622557	chr6:86630852	SNHG5	chr6:86386726-86388451:-	-0.48	-10.71	3.96E-24	Response to antipsychotic treatment	
THCA	cis	1	rs34629498	chr19:23060720	ZNF492	chr19:22817126-22850472:+	-0.43	-6.23	1.05E-9	Bronchopulmonary dysplasia	
THCA	cis	1	rs34637087	chr6:163004064	PACRG	chr6:163148164-163736523:+	0.46	7.08	5.13E-12	Body mass index	
THCA	cis	1	rs34637256	chr7:65360131	CCT6P1	chr7:65216092-65228661:+	0.39	6.26	8.62E-10	Diabetic kidney disease	
THCA	cis	1	rs34637256	chr7:65360131	CRCP	chr7:65579805-65619551:+	-0.26	-4.07	5.61E-5	Diabetic kidney disease	
THCA	cis	1	rs34637256	chr7:65360131	RABGEF1	chr7:66093890-66276446:+	0.53	6.6	1.12E-10	Diabetic kidney disease	
THCA	cis	1	rs34638686	chr3:48682658	NCKIPSD	chr3:48711280-48723334:-	-0.36	-5.05	6.32E-7	Educational attainment (years of education)	
THCA	cis	1	rs34638686	chr3:48682658	SLC26A6	chr3:48663158-48672926:-	0.3	4.99	8.46E-7	Educational attainment (years of education)	
THCA	cis	1	rs34638860	chr20:43765839	STK4	chr20:43595120-43708591:+	-0.17	-4.12	4.42E-5	Parental longevity (mother's age at death)	
THCA	cis	1	rs34640283	chr20:3989576	MAVS	chr20:3827449-3856761:+	-0.24	-3.7	0.000241	Response to antidepressants in depression	
THCA	cis	1	rs34645895	chr20:25368373	ENTPD6	chr20:25176339-25207360:+	0.32	7.23	1.88E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs34645895	chr20:25368373	FAM182A	chr20:26035250-26067552:+	0.19	3.49	0.000536	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs34645895	chr20:25368373	FAM182B	chr20:25744102-25848786:-	-0.26	-5.4	1.06E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs34645895	chr20:25368373	NINL	chr20:25433338-25566153:-	0.33	6.9	1.7E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs34645895	chr20:25368373	PYGB	chr20:25228706-25278647:+	0.16	4.03	6.5E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs34653853	chr6:163114362	PACRG	chr6:163148164-163736523:+	0.52	7.19	2.57E-12	Body mass index	
THCA	cis	1	rs34655790	chr6:163202739	PACRG	chr6:163148164-163736523:+	0.51	7.2	2.43E-12	Body mass index	
THCA	cis	1	rs34667713	chr1:27292678	ZDHHC18	chr1:27153201-27182207:+	0.74	7.5	3.04E-13	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs34674149	chr14:71777093	SIPA1L1	chr14:71933902-72206118:+	0.27	5.46	7.67E-8	Mitral valve prolapse	
THCA	cis	1	rs346785	chr17:74283769	FAM100B	chr17:74261286-74267379:+	0.21	6.37	4.52E-10	White matter hyperintensities in ischemic stroke	
THCA	cis	1	rs34681611	chr1:27089446	PIGV	chr1:27114455-27124886:+	-0.29	-3.4	0.000724	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs34681611	chr1:27089446	ZDHHC18	chr1:27153201-27182207:+	0.8	8.61	1.06E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs34683079	chr4:17939302	DCAF16	chr4:17802280-17812381:-	-0.2	-4.48	9.3E-6	Height	
THCA	cis	1	rs34684276	chr15:78813155	CHRNA5	chr15:78857906-78886458:+	-0.43	-8.28	1.26E-15	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio;Nicotine dependence	
THCA	cis	1	rs34687290	chr1:31857332	SNRNP40	chr1:31732417-31769644:-	-0.17	-3.36	0.000856	Schizophrenia	
THCA	cis	1	rs34687290	chr1:31857332	ZCCHC17	chr1:31769842-31837780:+	-0.33	-6.41	3.47E-10	Schizophrenia	
THCA	cis	1	rs34693293	chr1:27068971	ZDHHC18	chr1:27153201-27182207:+	0.8	8.6	1.15E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs34697913	chr6:163000187	PACRG	chr6:163148164-163736523:+	0.46	7.08	5.13E-12	Body mass index	
THCA	cis	1	rs34700722	chr8:96021876	C8orf38	chr8:95908040-96088396:+	-0.25	-4.3	2.03E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs34702770	chr7:65344823	CCT6P1	chr7:65216092-65228661:+	0.39	6.26	8.62E-10	Diabetic kidney disease	
THCA	cis	1	rs34702770	chr7:65344823	CRCP	chr7:65579805-65619551:+	-0.26	-4.07	5.61E-5	Diabetic kidney disease	
THCA	cis	1	rs34702770	chr7:65344823	RABGEF1	chr7:66093890-66276446:+	0.53	6.6	1.12E-10	Diabetic kidney disease	
THCA	cis	1	rs34703416	chr7:65300642	CCT6P1	chr7:65216092-65228661:+	0.39	6.21	1.14E-9	Diabetic kidney disease	
THCA	cis	1	rs34703416	chr7:65300642	CRCP	chr7:65579805-65619551:+	-0.27	-4.19	3.27E-5	Diabetic kidney disease	
THCA	cis	1	rs34703416	chr7:65300642	LOC493754	chr7:65993446-66057363:-	0.29	3.39	0.000745	Diabetic kidney disease	
THCA	cis	1	rs34703416	chr7:65300642	RABGEF1	chr7:66093890-66276446:+	0.53	6.55	1.52E-10	Diabetic kidney disease	
THCA	cis	1	rs34708625	chr12:121180019	ACADS	chr12:121163571-121177810:+	0.13	3.37	0.000819	Urinary metabolites (H-NMR features)	
THCA	cis	1	rs34708786	chr3:151017416	GPR87	chr3:151011876-151034636:-	0.21	4.65	4.36E-6	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs34708786	chr3:151017416	P2RY14	chr3:150929905-150996230:-	-0.2	-4.28	2.25E-5	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs34709844	chr3:127818869	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.61	5.13E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs34714518	chr6:163080778	PACRG	chr6:163148164-163736523:+	0.52	7.27	1.47E-12	Body mass index	
THCA	cis	1	rs34725898	chr6:163127302	PACRG	chr6:163148164-163736523:+	0.52	7.19	2.57E-12	Body mass index	
THCA	cis	1	rs34728853	chr1:27000579	ZDHHC18	chr1:27153201-27182207:+	0.8	8.6	1.15E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs34732195	chr4:139130911	SLC7A11	chr4:139085248-139163503:-	0.22	4.47	9.9E-6	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	
THCA	cis	1	rs34746156	chr14:71752360	SIPA1L1	chr14:71933902-72206118:+	0.28	5.77	1.44E-8	Mitral valve prolapse	
THCA	cis	1	rs34746918	chr19:18539744	ELL	chr19:18553475-18632937:-	-0.25	-6.45	2.78E-10	Breast cancer	
THCA	cis	1	rs34746918	chr19:18539744	ISYNA1	chr19:18545625-18548943:-	0.13	4.74	2.79E-6	Breast cancer	
THCA	cis	1	rs34746918	chr19:18539744	LRRC25	chr19:18501955-18508421:-	-0.15	-4.93	1.14E-6	Breast cancer	
THCA	cis	1	rs34748537	chr14:71831683	SIPA1L1	chr14:71933902-72206118:+	0.26	5.36	1.27E-7	Mitral valve prolapse	
THCA	cis	1	rs34751999	chr15:84758419	GOLGA6L5	chr15:85047738-85060078:-	-0.21	-5.39	1.1E-7	Schizophrenia	
THCA	cis	1	rs34751999	chr15:84758419	LOC388152	chr15:84867600-84898920:-	-0.72	-13.03	2.08E-33	Schizophrenia	
THCA	cis	1	rs34751999	chr15:84758419	NMB	chr15:85198362-85201802:-	0.23	4.56	6.37E-6	Schizophrenia	
THCA	cis	1	rs34751999	chr15:84758419	SH3GL3	chr15:84116091-84287491:+	0.24	3.82	0.000153	Schizophrenia	
THCA	cis	1	rs34756176	chr13:42152545	C13orf15	chr13:42031542-42045013:+	0.15	3.65	0.000286	Multiple sclerosis	
THCA	cis	1	rs34756249	chr2:218279486	DIRC3	chr2:218148748-218621316:-	0.21	5.07	5.84E-7	Height	
THCA	cis	1	rs34758895	chr17:37925468	C17orf37	chr17:37885411-37886788:-	-0.26	-4.4	1.35E-5	Systemic lupus erythematosus	
THCA	cis	1	rs34762726	chr3:49689210	MST1	chr3:49721381-49726196:-	0.13	3.88	0.000117	Crohn's disease;Ulcerative colitis	
THCA	cis	1	rs34771104	chr4:39129052	KLHL5	chr4:39046659-39123828:+	-0.21	-5.77	1.46E-8	Uric acid levels	
THCA	cis	1	rs34773528	chr6:163088796	PACRG	chr6:163148164-163736523:+	0.52	7.09	4.72E-12	Body mass index	
THCA	cis	1	rs34804433	chr20:47896187	DDX27	chr20:47835832-47860612:+	0.27	4.94	1.06E-6	Height	
THCA	cis	1	rs34811768	chr20:43765800	STK4	chr20:43595120-43708591:+	-0.17	-4.12	4.42E-5	Parental longevity (mother's age at death)	
THCA	cis	1	rs34812189	chr6:56806727	BEND6	chr6:56819773-56892138:+	-0.31	-6.3	6.74E-10	Menarche (age at onset)	
THCA	cis	1	rs34812189	chr6:56806727	KIAA1586	chr6:56911384-56920021:+	-0.34	-5.2	2.91E-7	Menarche (age at onset)	
THCA	cis	1	rs34815098	chr7:65292254	CCT6P1	chr7:65216092-65228661:+	0.38	6.13	1.82E-9	Diabetic kidney disease	
THCA	cis	1	rs34815098	chr7:65292254	CRCP	chr7:65579805-65619551:+	-0.27	-4.15	3.94E-5	Diabetic kidney disease	
THCA	cis	1	rs34815098	chr7:65292254	RABGEF1	chr7:66093890-66276446:+	0.54	6.73	5.02E-11	Diabetic kidney disease	
THCA	cis	1	rs34817706	chr3:127861058	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.47	9.77E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs34822023	chr11:5555244	UBQLNL	chr11:5535624-5537956:-	-0.28	-6.6	1.11E-10	QRS duration in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs34847072	chr5:437862	C5orf55	chr5:441645-443258:-	0.33	8.44	3.87E-16	Cystic fibrosis severity	
THCA	cis	1	rs34847140	chr7:117991638	ANKRD7	chr7:117864712-117882782:+	0.27	4.5	8.46E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs34848593	chr1:113240106	MOV10	chr1:113217048-113243367:+	0.2	4.82	1.92E-6	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs34848593	chr1:113240106	ST7L	chr1:113066142-113162405:-	0.66	10.76	2.44E-24	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs34849118	chr2:240919912	NDUFA10	chr2:240900158-240964798:-	0.31	8.85	1.73E-17	Odorant perception (isobutyraldehyde)	
THCA	cis	1	rs34852683	chr6:86702330	SNHG5	chr6:86386726-86388451:-	-0.48	-10.71	3.96E-24	Response to antipsychotic treatment	
THCA	cis	1	rs34864242	chr22:24175440	C22orf43	chr22:23950640-23974487:-	-0.22	-3.42	0.000671	IgG glycosylation	
THCA	cis	1	rs34869648	chr6:33724059	IP6K3	chr6:33689443-33714762:-	0.4	6.44	2.92E-10	Obesity (extreme)	
THCA	cis	1	rs34872586	chr17:65863466	C17orf58	chr17:65987218-65989765:-	0.2	3.95	8.87E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs34873919	chr14:71780741	SIPA1L1	chr14:71933902-72206118:+	0.27	5.46	7.67E-8	Mitral valve prolapse	
THCA	cis	1	rs34878139	chr12:124446253	DNAH10	chr12:124247042-124420265:+	0.18	3.79	0.000167	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs34878139	chr12:124446253	ZNF664	chr12:124457670-124499967:+	-0.17	-4.95	1.04E-6	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs34884883	chr6:33768726	IP6K3	chr6:33689443-33714762:-	0.41	6.72	5.21E-11	Obesity (extreme)	
THCA	cis	1	rs34885854	chr1:27086249	PIGV	chr1:27114455-27124886:+	-0.29	-3.4	0.000724	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs34885854	chr1:27086249	ZDHHC18	chr1:27153201-27182207:+	0.8	8.61	1.06E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs34889675	chr1:37965851	SNIP1	chr1:38002145-38019903:-	-0.18	-3.37	0.00082	Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs34889971	chr1:27188057	ZDHHC18	chr1:27153201-27182207:+	0.79	8.29	1.13E-15	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs34894912	chr12:82228721	PPFIA2	chr12:81652880-82153109:-	0.22	4.06	5.72E-5	Resting heart rate	
THCA	cis	1	rs34897410	chr2:239182123	LOC151174	chr2:239133754-239140318:-	0.5	5.46	7.53E-8	Irritable bowel syndrome	
THCA	cis	1	rs34897866	chr2:231036754	SP110	chr2:231033645-231084827:-	0.24	4.95	1.05E-6	Obesity-related traits	
THCA	cis	1	rs34900908	chr15:85257599	GOLGA6L5	chr15:85047738-85060078:-	-0.15	-3.86	0.000128	Schizophrenia	
THCA	cis	1	rs34900908	chr15:85257599	LOC388152	chr15:84867600-84898920:-	-0.48	-8.09	5.01E-15	Schizophrenia	
THCA	cis	1	rs34900908	chr15:85257599	NMB	chr15:85198362-85201802:-	0.37	7.72	6.74E-14	Schizophrenia	
THCA	cis	1	rs34902959	chr2:160037557	WDSUB1	chr2:160092305-160143236:-	-0.22	-4.56	6.65E-6	Resting heart rate	
THCA	cis	1	rs34910028	chr11:47758449	C1QTNF4	chr11:47611216-47615961:-	-0.31	-5.27	2.05E-7	Subjective well-being	
THCA	cis	1	rs34910254	chr6:55963885	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs34918316	chr6:163005386	PACRG	chr6:163148164-163736523:+	0.46	7.08	5.13E-12	Body mass index	
THCA	cis	1	rs34919068	chr20:43755830	STK4	chr20:43595120-43708591:+	-0.17	-4.1	4.94E-5	Parental longevity (mother's age at death)	
THCA	cis	1	rs34931503	chr6:163003876	PACRG	chr6:163148164-163736523:+	0.46	7.08	5.13E-12	Body mass index	
THCA	cis	1	rs34933390	chr3:53006265	RFT1	chr3:53122503-53164470:-	0.64	7.33	1.01E-12	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs34933390	chr3:53006265	TMEM110	chr3:52867139-52931547:-	0.36	4.13	4.35E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs34933526	chr7:65383199	CCT6P1	chr7:65216092-65228661:+	0.39	6.18	1.36E-9	Diabetic kidney disease	
THCA	cis	1	rs34933526	chr7:65383199	CRCP	chr7:65579805-65619551:+	-0.26	-3.99	7.58E-5	Diabetic kidney disease	
THCA	cis	1	rs34933526	chr7:65383199	RABGEF1	chr7:66093890-66276446:+	0.54	6.71	5.64E-11	Diabetic kidney disease	
THCA	cis	1	rs34934312	chr4:17950172	DCAF16	chr4:17802280-17812381:-	-0.2	-4.36	1.59E-5	Height	
THCA	cis	1	rs34941652	chr13:85673967	SLITRK6	chr13:86366922-86373483:-	-0.2	-3.66	0.000279	Bipolar disorder (mania)	
THCA	cis	1	rs34943350	chr3:53012888	RFT1	chr3:53122503-53164470:-	0.63	7.07	5.61E-12	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs34943350	chr3:53012888	TMEM110	chr3:52867139-52931547:-	0.38	4.22	2.92E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs34943654	chr2:218313717	IGFBP5	chr2:217536829-217560272:-	-0.23	-4.65	4.34E-6	Metabolite levels (MHPG)	
THCA	cis	1	rs34945223	chr18:77575871	C18orf22	chr18:77794358-77853788:+	0.13	3.4	0.000724	Schizophrenia	
THCA	cis	1	rs34947476	chr2:135486150	TMEM163	chr2:135213331-135525334:-	-0.18	-3.82	0.000149	Gut microbiome composition (winter)	
THCA	cis	1	rs34949904	chr22:24695298	CYTSA	chr22:24666786-24813707:+	-0.15	-3.65	0.000294	Gut microbiome composition (summer)	
THCA	cis	1	rs34949904	chr22:24695298	GGT5	chr22:24615623-24641110:-	-0.22	-4.44	1.1E-5	Gut microbiome composition (summer)	
THCA	cis	1	rs34949904	chr22:24695298	POM121L9P	chr22:24647589-24661490:+	-0.42	-9.55	6.72E-20	Gut microbiome composition (summer)	
THCA	cis	1	rs34952897	chr4:122664409	EXOSC9	chr4:122722472-122738175:+	0.15	3.98	7.83E-5	Type 2 diabetes	
THCA	cis	1	rs34953792	chr20:55086281	C20orf43	chr20:55043647-55093942:+	0.28	7.42	5.55E-13	Refractive astigmatism	
THCA	cis	1	rs34955225	chr3:127825078	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.62	4.96E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs34959140	chr15:31725223	FAM7A2	chr15:30864758-30892900:+	-0.49	-4.48	9.49E-6	Survival in colorectal cancer (non-distant metastatic)	
THCA	cis	1	rs34970380	chr7:65431493	CCT6P1	chr7:65216092-65228661:+	0.41	6.42	3.31E-10	Diabetic kidney disease	
THCA	cis	1	rs34970380	chr7:65431493	CRCP	chr7:65579805-65619551:+	-0.26	-3.96	8.64E-5	Diabetic kidney disease	
THCA	cis	1	rs34970380	chr7:65431493	RABGEF1	chr7:66093890-66276446:+	0.54	6.65	7.83E-11	Diabetic kidney disease	
THCA	cis	1	rs34974928	chr7:65364006	CCT6P1	chr7:65216092-65228661:+	0.38	6.07	2.54E-9	Diabetic kidney disease	
THCA	cis	1	rs34974928	chr7:65364006	CRCP	chr7:65579805-65619551:+	-0.26	-4.08	5.37E-5	Diabetic kidney disease	
THCA	cis	1	rs34974928	chr7:65364006	RABGEF1	chr7:66093890-66276446:+	0.54	6.78	3.55E-11	Diabetic kidney disease	
THCA	cis	1	rs34976021	chr1:27298564	ZDHHC18	chr1:27153201-27182207:+	0.61	6.7	5.74E-11	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs34979715	chr3:53048960	RFT1	chr3:53122503-53164470:-	0.63	6.98	9.84E-12	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs34979715	chr3:53048960	TMEM110	chr3:52867139-52931547:-	0.38	4.21	3.09E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs34983295	chr20:55079380	C20orf43	chr20:55043647-55093942:+	0.28	7.52	2.69E-13	Refractive astigmatism	
THCA	cis	1	rs34983295	chr20:55079380	CSTF1	chr20:54967427-54979582:+	0.17	3.42	0.000677	Refractive astigmatism	
THCA	cis	1	rs34988504	chr17:37957632	C17orf37	chr17:37885411-37886788:-	-0.26	-4.15	3.91E-5	Systemic lupus erythematosus	
THCA	cis	1	rs35000415	chr7:128585616	IRF5	chr7:128577769-128590086:+	0.31	5.34	1.44E-7	Systemic lupus erythematosus	
THCA	cis	1	rs35002543	chr2:70091299	SNRNP27	chr2:70121090-70132348:+	0.16	3.88	0.000121	Colorectal or endometrial cancer	
THCA	cis	1	rs35006492	chr4:129878342	C4orf33	chr4:130014829-130033842:+	0.56	8.91	1.04E-17	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs35017019	chr6:162982581	PACRG	chr6:163148164-163736523:+	0.44	6.92	1.44E-11	Body mass index	
THCA	cis	1	rs35021112	chr7:118198815	ANKRD7	chr7:117864712-117882782:+	0.23	3.78	0.000173	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs35021342	chr1:27086227	PIGV	chr1:27114455-27124886:+	-0.29	-3.46	0.000583	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs35021342	chr1:27086227	ZDHHC18	chr1:27153201-27182207:+	0.81	8.63	9.02E-17	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs35022800	chr6:169735072	PHF10	chr6:170104004-170124106:-	-0.14	-3.77	0.000182	Obesity-related traits	
THCA	cis	1	rs35025342	chr6:151876661	C6orf97	chr6:151815175-151942327:+	0.33	4.64	4.43E-6	Bone mineral density (spine)	
THCA	cis	1	rs35033009	chr1:31857236	ZCCHC17	chr1:31769842-31837780:+	-0.3	-5.79	1.3E-8	Schizophrenia	
THCA	cis	1	rs35041418	chr1:27048983	ZDHHC18	chr1:27153201-27182207:+	0.8	8.62	1.01E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs35044651	chr6:163004142	PACRG	chr6:163148164-163736523:+	0.46	7.11	4.15E-12	Body mass index	
THCA	cis	1	rs35045998	chr1:200719186	DDX59	chr1:200610119-200639126:-	-0.24	-3.78	0.000178	Epilepsy	
THCA	cis	1	rs35046236	chr7:65408613	CCT6P1	chr7:65216092-65228661:+	0.39	6.18	1.36E-9	Diabetic kidney disease	
THCA	cis	1	rs35046236	chr7:65408613	CRCP	chr7:65579805-65619551:+	-0.26	-3.99	7.58E-5	Diabetic kidney disease	
THCA	cis	1	rs35046236	chr7:65408613	RABGEF1	chr7:66093890-66276446:+	0.54	6.71	5.64E-11	Diabetic kidney disease	
THCA	cis	1	rs35049594	chr18:47211067	CXXC1	chr18:47808715-47814692:-	-0.09	-3.54	0.000444	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	
THCA	cis	1	rs35056702	chr6:109736326	AKD1	chr6:109814059-110012415:-	-0.34	-7.71	7.61E-14	Height	
THCA	cis	1	rs35056702	chr6:109736326	FIG4	chr6:110012424-110146634:+	-0.19	-3.85	0.000136	Height	
THCA	cis	1	rs35056702	chr6:109736326	SMPD2	chr6:109761931-109765121:+	0.33	8.27	1.31E-15	Height	
THCA	cis	1	rs35058610	chr7:65390925	CCT6P1	chr7:65216092-65228661:+	0.39	6.18	1.36E-9	Diabetic kidney disease	
THCA	cis	1	rs35058610	chr7:65390925	CRCP	chr7:65579805-65619551:+	-0.26	-3.99	7.58E-5	Diabetic kidney disease	
THCA	cis	1	rs35058610	chr7:65390925	RABGEF1	chr7:66093890-66276446:+	0.54	6.71	5.64E-11	Diabetic kidney disease	
THCA	cis	1	rs35060985	chr11:43693110	HSD17B12	chr11:43702143-43878160:+	-0.72	-15.4	1.0E-43	Forced vital capacity	
THCA	cis	1	rs35062783	chr10:17202869	TRDMT1	chr10:17184983-17243681:-	-0.44	-9.92	3.21E-21	Homocysteine levels	
THCA	cis	1	rs35062783	chr10:17202869	VIM	chr10:17270258-17279592:+	-0.18	-3.37	0.000803	Homocysteine levels	
THCA	cis	1	rs35063358	chr8:57156177	LYN	chr8:56792386-56923936:+	-0.15	-3.83	0.000145	Height	
THCA	cis	1	rs35081654	chr4:18017938	DCAF16	chr4:17802280-17812381:-	-0.2	-4.52	7.89E-6	Height	
THCA	cis	1	rs35084691	chr2:70094137	SNRNP27	chr2:70121090-70132348:+	0.16	3.88	0.000118	Colorectal or endometrial cancer	
THCA	cis	1	rs35092540	chr6:163090778	PACRG	chr6:163148164-163736523:+	0.54	7.4	6.24E-13	Body mass index	
THCA	cis	1	rs35099099	chr6:39284857	KCNK16	chr6:39282475-39290330:-	0.11	3.38	0.00079	Type 2 diabetes	
THCA	cis	1	rs35099099	chr6:39284857	KCNK17	chr6:39266778-39282237:-	0.18	4.18	3.44E-5	Type 2 diabetes	
THCA	cis	1	rs35103567	chr6:163183400	PACRG	chr6:163148164-163736523:+	0.52	7.23	1.87E-12	Body mass index	
THCA	cis	1	rs35106985	chr10:102307542	SEC31B	chr10:102246403-102289636:-	-0.28	-8.79	2.75E-17	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs35108146	chr1:27248440	ZDHHC18	chr1:27153201-27182207:+	0.74	7.81	3.78E-14	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs35115612	chr5:125926839	ALDH7A1	chr5:125878918-125931082:-	0.44	6.43	3.15E-10	Osteoporosis	
THCA	cis	1	rs35116118	chr4:39128913	KLHL5	chr4:39046659-39123828:+	-0.21	-5.86	8.65E-9	Uric acid levels	
THCA	cis	1	rs35122644	chr14:71780768	SIPA1L1	chr14:71933902-72206118:+	0.27	5.46	7.67E-8	Mitral valve prolapse	
THCA	cis	1	rs35123781	chr5:139065180	SLC4A9	chr5:139739787-139754722:+	-0.21	-3.35	0.000872	Schizophrenia	
THCA	cis	1	rs35126854	chr6:163012443	PACRG	chr6:163148164-163736523:+	0.44	6.84	2.4E-11	Body mass index	
THCA	cis	1	rs35144003	chr3:151037770	GPR87	chr3:151011876-151034636:-	0.21	4.64	4.5E-6	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs35144003	chr3:151037770	P2RY14	chr3:150929905-150996230:-	-0.2	-4.31	2.02E-5	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs35145572	chr3:127847418	EEFSEC	chr3:127872313-128127488:+	-0.27	-4.72	3.17E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs35149210	chr7:65929925	ASL	chr7:65540776-65558321:+	-0.16	-4.17	3.67E-5	Aortic root size	
THCA	cis	1	rs35149210	chr7:65929925	GUSB	chr7:65425675-65447246:-	0.27	5.28	1.96E-7	Aortic root size	
THCA	cis	1	rs35149210	chr7:65929925	RABGEF1	chr7:66093890-66276446:+	0.65	14.01	1.34E-37	Aortic root size	
THCA	cis	1	rs35151650	chr6:111757727	KIAA1919	chr6:111580482-111590259:+	0.48	5.69	2.21E-8	Psoriasis	
THCA	cis	1	rs35160687	chr2:86472114	IMMT	chr2:86371056-86422893:-	-0.18	-4.78	2.35E-6	Night sleep phenotypes	
THCA	cis	1	rs35160687	chr2:86472114	LOC90784	chr2:86247339-86250991:-	0.17	3.41	0.000717	Night sleep phenotypes	
THCA	cis	1	rs35160687	chr2:86472114	REEP1	chr2:86441122-86564777:-	0.17	4.23	2.85E-5	Night sleep phenotypes	
THCA	cis	1	rs35163227	chr3:53127876	RFT1	chr3:53122503-53164470:-	0.62	7.24	1.78E-12	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs35163227	chr3:53127876	SFMBT1	chr3:52938628-53080070:-	-0.2	-3.39	0.000753	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs35174175	chr3:53041509	RFT1	chr3:53122503-53164470:-	0.62	6.93	1.34E-11	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs35174175	chr3:53041509	TMEM110	chr3:52867139-52931547:-	0.37	4.15	3.91E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs35184536	chr11:116778813	PCSK7	chr11:117075789-117102811:-	0.46	5.37	1.21E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs35184688	chr17:40272406	HSPB9	chr17:40274756-40275371:+	0.34	5.07	5.66E-7	Fibrinogen levels	
THCA	cis	1	rs35190023	chr4:155345395	DCHS2	chr4:155155527-155412930:-	0.16	3.42	0.000691	Alzheimer's disease (age of onset)	
THCA	cis	1	rs35194524	chr12:62507200	FAM19A2	chr12:62102043-62653925:-	-0.15	-3.34	0.000892	Post bronchodilator FEV1/FVC ratio in COPD	
THCA	cis	1	rs35198334	chr3:10104553	C3orf10	chr3:10157333-10168873:+	-0.2	-4.22	2.93E-5	Alzheimer's disease	
THCA	cis	1	rs35198334	chr3:10104553	VHL	chr3:10183319-10193744:+	-0.19	-4.44	1.1E-5	Alzheimer's disease	
THCA	cis	1	rs35202312	chr6:56788937	BEND6	chr6:56819773-56892138:+	-0.31	-6.73	4.87E-11	Menarche (age at onset)	
THCA	cis	1	rs35202312	chr6:56788937	KIAA1586	chr6:56911384-56920021:+	-0.34	-5.52	5.55E-8	Menarche (age at onset)	
THCA	cis	1	rs35208445	chr6:111756147	KIAA1919	chr6:111580482-111590259:+	0.48	5.69	2.21E-8	Psoriasis	
THCA	cis	1	rs35210497	chr4:17985374	DCAF16	chr4:17802280-17812381:-	-0.2	-4.39	1.41E-5	Height	
THCA	cis	1	rs35212307	chr2:203765756	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.94	5.6E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs35212307	chr2:203765756	ICA1L	chr2:203637873-203736371:-	0.25	4.21	3.08E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs35220123	chr3:10083169	C3orf10	chr3:10157333-10168873:+	-0.21	-4.32	1.87E-5	Alzheimer's disease	
THCA	cis	1	rs35220123	chr3:10083169	VHL	chr3:10183319-10193744:+	-0.2	-4.51	8.05E-6	Alzheimer's disease	
THCA	cis	1	rs35224452	chr4:122664677	EXOSC9	chr4:122722472-122738175:+	0.15	3.98	7.94E-5	Type 2 diabetes	
THCA	cis	1	rs35227660	chr20:43756697	STK4	chr20:43595120-43708591:+	-0.17	-4.05	5.98E-5	Parental longevity (mother's age at death)	
THCA	cis	1	rs35243555	chr17:65876477	C17orf58	chr17:65987218-65989765:-	0.2	3.97	8.17E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs35244261	chr11:108283808	ATM	chr11:108093559-108239826:+	0.11	3.6	0.000352	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
THCA	cis	1	rs352476	chr15:65805389	DPP8	chr15:65737999-65810035:-	0.09	3.7	0.000244	Mean corpuscular hemoglobin	
THCA	cis	1	rs352476	chr15:65805389	SLC24A1	chr15:65903704-65953256:+	0.15	3.63	0.000318	Mean corpuscular hemoglobin	
THCA	cis	1	rs352479	chr15:65803428	DPP8	chr15:65737999-65810035:-	0.09	3.7	0.000244	Mean corpuscular hemoglobin	
THCA	cis	1	rs352479	chr15:65803428	SLC24A1	chr15:65903704-65953256:+	0.15	3.63	0.000319	Mean corpuscular hemoglobin	
THCA	cis	1	rs35248830	chr6:111756750	KIAA1919	chr6:111580482-111590259:+	0.48	5.69	2.21E-8	Psoriasis	
THCA	cis	1	rs35249024	chr4:122664538	EXOSC9	chr4:122722472-122738175:+	0.15	3.99	7.6E-5	Type 2 diabetes	
THCA	cis	1	rs35256560	chr1:27054016	ZDHHC18	chr1:27153201-27182207:+	0.8	8.6	1.15E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs35258216	chr10:38018220	LOC399744	chr10:38717074-38741080:+	0.28	3.87	0.000123	Obesity (extreme)	
THCA	cis	1	rs35260692	chr14:71831665	SIPA1L1	chr14:71933902-72206118:+	0.26	5.37	1.22E-7	Mitral valve prolapse	
THCA	cis	1	rs35261210	chr17:40588316	NAGLU	chr17:40687951-40696464:+	-0.24	-5.05	6.36E-7	Crohn's disease	
THCA	cis	1	rs35261210	chr17:40588316	TUBG2	chr17:40811266-40819023:+	-0.23	-5.4	1.06E-7	Crohn's disease	
THCA	cis	1	rs35272895	chr17:40580669	NAGLU	chr17:40687951-40696464:+	-0.23	-4.83	1.84E-6	Crohn's disease	
THCA	cis	1	rs35272895	chr17:40580669	TUBG2	chr17:40811266-40819023:+	-0.23	-5.37	1.26E-7	Crohn's disease	
THCA	cis	1	rs35273426	chr8:41524688	ANK1	chr8:41510745-41754280:-	-0.22	-4.63	4.66E-6	Type 2 diabetes	
THCA	cis	1	rs35274562	chr6:33716831	IP6K3	chr6:33689443-33714762:-	0.4	6.48	2.29E-10	Obesity (extreme)	
THCA	cis	1	rs35283677	chr7:65359233	CCT6P1	chr7:65216092-65228661:+	0.41	6.5	2.08E-10	Diabetic kidney disease	
THCA	cis	1	rs35283677	chr7:65359233	CRCP	chr7:65579805-65619551:+	-0.26	-4.02	6.63E-5	Diabetic kidney disease	
THCA	cis	1	rs35283677	chr7:65359233	RABGEF1	chr7:66093890-66276446:+	0.52	6.35	4.89E-10	Diabetic kidney disease	
THCA	cis	1	rs35284261	chr4:66481787	EPHA5	chr4:66185282-66535653:-	0.19	3.36	0.000847	HIV-1 viral setpoint	
THCA	cis	1	rs35297609	chr15:84772896	GOLGA6L5	chr15:85047738-85060078:-	-0.21	-5.39	1.11E-7	Schizophrenia	
THCA	cis	1	rs35297609	chr15:84772896	LOC388152	chr15:84867600-84898920:-	-0.71	-12.9	6.74E-33	Schizophrenia	
THCA	cis	1	rs35297609	chr15:84772896	NMB	chr15:85198362-85201802:-	0.23	4.68	3.66E-6	Schizophrenia	
THCA	cis	1	rs35297609	chr15:84772896	SH3GL3	chr15:84116091-84287491:+	0.24	3.8	0.000162	Schizophrenia	
THCA	cis	1	rs35303215	chr22:24801535	C22orf45	chr22:24825178-24826344:-;chr22	0.23	3.64	0.000301	Gut microbiome composition (summer)	
THCA	cis	1	rs35303215	chr22:24801535	GGT5	chr22:24615623-24641110:-	-0.22	-4.37	1.51E-5	Gut microbiome composition (summer)	
THCA	cis	1	rs35303215	chr22:24801535	POM121L9P	chr22:24647589-24661490:+	-0.4	-8.68	6.23E-17	Gut microbiome composition (summer)	
THCA	cis	1	rs35309975	chr2:218314083	IGFBP5	chr2:217536829-217560272:-	-0.23	-4.65	4.34E-6	Metabolite levels (MHPG)	
THCA	cis	1	rs35316992	chr15:85248133	GOLGA6L5	chr15:85047738-85060078:-	-0.15	-3.87	0.000124	Schizophrenia	
THCA	cis	1	rs35316992	chr15:85248133	LOC388152	chr15:84867600-84898920:-	-0.48	-8.06	6.15E-15	Schizophrenia	
THCA	cis	1	rs35316992	chr15:85248133	NMB	chr15:85198362-85201802:-	0.37	7.72	6.82E-14	Schizophrenia	
THCA	cis	1	rs35317957	chr4:17986863	DCAF16	chr4:17802280-17812381:-	-0.2	-4.39	1.41E-5	Height	
THCA	cis	1	rs35324226	chr15:24609999	PWRN1	chr15:24778839-24832924:+	0.36	7.89	2.09E-14	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
THCA	cis	1	rs35332070	chr19:23034266	ZNF492	chr19:22817126-22850472:+	-0.43	-6.41	3.53E-10	Bronchopulmonary dysplasia	
THCA	cis	1	rs35334289	chr9:99540291	FAM22G	chr9:99690592-99704572:+	-0.89	-8.2	2.16E-15	Height	
THCA	cis	1	rs35334289	chr9:99540291	HIATL2	chr9:99695549-99775862:-	-0.66	-6.1	2.23E-9	Height	
THCA	cis	1	rs35334289	chr9:99540291	LOC441454	chr9:99671357-99672736:+	-0.4	-3.98	7.82E-5	Height	
THCA	cis	1	rs35337492	chr18:47210824	CXXC1	chr18:47808715-47814692:-	-0.1	-3.62	0.000324	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	
THCA	cis	1	rs35341359	chr3:112994937	SIDT1	chr3:113251218-113348421:+	0.22	3.74	0.00021	Dental caries	
THCA	cis	1	rs35341640	chr17:18818228	FAM18B	chr17:18684582-18710026:+	0.31	7.06	6.01E-12	Pancreatic cancer	
THCA	cis	1	rs353464	chr5:176403023	ZNF346	chr5:176449697-176508190:+	-0.16	-5.63	3.0E-8	Menopause (age at onset);Menarche and menopause (age at onset)	
THCA	cis	1	rs353467	chr5:176445698	ZNF346	chr5:176449697-176508190:+	-0.15	-5.32	1.6E-7	Menopause (age at onset);Menarche and menopause (age at onset)	
THCA	cis	1	rs353468	chr5:176445494	ZNF346	chr5:176449697-176508190:+	-0.15	-5.32	1.6E-7	Menopause (age at onset);Menarche and menopause (age at onset)	
THCA	cis	1	rs353478	chr5:176370988	ZNF346	chr5:176449697-176508190:+	-0.16	-5.47	7.35E-8	Menopause (age at onset);Menarche and menopause (age at onset)	
THCA	cis	1	rs35348660	chr4:17988635	DCAF16	chr4:17802280-17812381:-	-0.2	-4.39	1.4E-5	Height	
THCA	cis	1	rs353490	chr5:176433063	ZNF346	chr5:176449697-176508190:+	-0.16	-5.42	9.53E-8	Menopause (age at onset);Menarche and menopause (age at onset)	
THCA	cis	1	rs353493	chr5:176432585	ZNF346	chr5:176449697-176508190:+	-0.16	-5.52	5.64E-8	Menopause (age at onset);Menarche and menopause (age at onset)	
THCA	cis	1	rs35370743	chr4:106604190	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs35371323	chr15:56379166	MNS1	chr15:56720929-56757335:-	-0.3	-4.21	3.04E-5	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs35371323	chr15:56379166	TEX9	chr15:56657644-56738071:+	-0.36	-6.07	2.67E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs35382009	chr7:117991641	ANKRD7	chr7:117864712-117882782:+	0.28	4.51	8.04E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs35383933	chr6:163002869	PACRG	chr6:163148164-163736523:+	0.46	7.08	5.13E-12	Body mass index	
THCA	cis	1	rs35385043	chr6:86648546	SNHG5	chr6:86386726-86388451:-	-0.53	-12.62	1.01E-31	Response to antipsychotic treatment	
THCA	cis	1	rs35387764	chr20:47902841	DDX27	chr20:47835832-47860612:+	0.27	4.94	1.06E-6	Height	
THCA	cis	1	rs35391607	chr7:65360829	CCT6P1	chr7:65216092-65228661:+	0.38	6.07	2.54E-9	Diabetic kidney disease	
THCA	cis	1	rs35391607	chr7:65360829	CRCP	chr7:65579805-65619551:+	-0.26	-4.08	5.37E-5	Diabetic kidney disease	
THCA	cis	1	rs35391607	chr7:65360829	RABGEF1	chr7:66093890-66276446:+	0.54	6.78	3.55E-11	Diabetic kidney disease	
THCA	cis	1	rs35395156	chr15:67962763	C15orf61	chr15:67813522-67819638:+	0.12	3.35	0.000873	Motion sickness	
THCA	cis	1	rs35395156	chr15:67962763	IQCH	chr15:67547188-67794139:+	0.17	5.26	2.12E-7	Motion sickness	
THCA	cis	1	rs35395156	chr15:67962763	MAP2K5	chr15:67835021-68099451:+	0.15	3.57	0.000392	Motion sickness	
THCA	cis	1	rs35396113	chr7:65495461	CCT6P1	chr7:65216092-65228661:+	0.41	6.54	1.54E-10	Diabetic kidney disease	
THCA	cis	1	rs35396113	chr7:65495461	CRCP	chr7:65579805-65619551:+	-0.29	-4.43	1.16E-5	Diabetic kidney disease	
THCA	cis	1	rs35396113	chr7:65495461	RABGEF1	chr7:66093890-66276446:+	0.54	6.74	4.58E-11	Diabetic kidney disease	
THCA	cis	1	rs35398388	chr19:37740358	ZNF607	chr19:38187276-38210691:-	-0.21	-3.61	0.000337	Coronary artery calcification	
THCA	cis	1	rs35398388	chr19:37740358	ZNF793	chr19:37997841-38034237:+	0.15	3.41	0.000693	Coronary artery calcification	
THCA	cis	1	rs35407375	chr1:27041218	ZDHHC18	chr1:27153201-27182207:+	0.8	8.6	1.15E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs35419329	chr6:86702291	SNHG5	chr6:86386726-86388451:-	-0.49	-10.88	8.91E-25	Response to antipsychotic treatment	
THCA	cis	1	rs35421223	chr3:127829879	EEFSEC	chr3:127872313-128127488:+	-0.25	-4.37	1.5E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs35421653	chr7:65363429	CCT6P1	chr7:65216092-65228661:+	0.41	6.5	2.08E-10	Diabetic kidney disease	
THCA	cis	1	rs35421653	chr7:65363429	CRCP	chr7:65579805-65619551:+	-0.26	-4.02	6.63E-5	Diabetic kidney disease	
THCA	cis	1	rs35421653	chr7:65363429	RABGEF1	chr7:66093890-66276446:+	0.52	6.35	4.89E-10	Diabetic kidney disease	
THCA	cis	1	rs35424047	chr6:163029715	PACRG	chr6:163148164-163736523:+	0.48	7.13	3.68E-12	Body mass index	
THCA	cis	1	rs35432774	chr7:65393019	CCT6P1	chr7:65216092-65228661:+	0.38	6	3.93E-9	Diabetic kidney disease	
THCA	cis	1	rs35432774	chr7:65393019	CRCP	chr7:65579805-65619551:+	-0.26	-4	7.24E-5	Diabetic kidney disease	
THCA	cis	1	rs35432774	chr7:65393019	RABGEF1	chr7:66093890-66276446:+	0.55	6.89	1.73E-11	Diabetic kidney disease	
THCA	cis	1	rs35435780	chr17:79579602	ARL16	chr17:79648234-79650954:-	-0.12	-3.39	0.000748	Eye color traits	
THCA	cis	1	rs35435780	chr17:79579602	TSPAN10	chr17:79609349-79615778:+	0.8	17.82	7.47E-55	Eye color traits	
THCA	cis	1	rs35437629	chr4:39133332	KLHL5	chr4:39046659-39123828:+	-0.21	-5.77	1.46E-8	Uric acid levels	
THCA	cis	1	rs35437840	chr3:127825306	EEFSEC	chr3:127872313-128127488:+	-0.25	-4.42	1.23E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs35442900	chr1:200779144	DDX59	chr1:200610119-200639126:-	-0.25	-3.89	0.000115	Epilepsy	
THCA	cis	1	rs35445446	chr6:33716745	IP6K3	chr6:33689443-33714762:-	0.41	6.46	2.55E-10	Obesity (extreme)	
THCA	cis	1	rs35445446	chr6:33716745	PSMB8	chr6:32808497-32812712:-	-0.12	-3.34	0.000902	Obesity (extreme)	
THCA	cis	1	rs35449999	chr6:163023465	PACRG	chr6:163148164-163736523:+	0.5	7.71	7.53E-14	Body mass index	
THCA	cis	1	rs35454259	chr6:27254475	BTN3A2	chr6:26365398-26378546:+	-0.36	-7.66	1.08E-13	Schizophrenia	
THCA	cis	1	rs35464459	chr10:4964640	AKR1C2	chr10:4964715-5060207:-	0.35	4.54	7.21E-6	Height	
THCA	cis	1	rs35467789	chr2:218314047	IGFBP5	chr2:217536829-217560272:-	-0.23	-4.65	4.34E-6	Metabolite levels (MHPG)	
THCA	cis	1	rs35468197	chr10:4978256	AKR1C2	chr10:4964715-5060207:-	0.32	4.2	3.25E-5	Height	
THCA	cis	1	rs35468353	chr16:31056433	C16orf93	chr16:30768753-30773542:-	-0.15	-4.35	1.65E-5	Response to metformin (IC50)	
THCA	cis	1	rs35468353	chr16:31056433	HSD3B7	chr16:30996519-31000473:+	0.47	12.48	3.96E-31	Response to metformin (IC50)	
THCA	cis	1	rs35468353	chr16:31056433	MYST1	chr16:31128985-31142713:+	0.16	5.51	5.8E-8	Response to metformin (IC50)	
THCA	cis	1	rs35468353	chr16:31056433	PRSS53	chr16:31094747-31106276:-	-0.14	-3.96	8.58E-5	Response to metformin (IC50)	
THCA	cis	1	rs35485559	chr12:81441066	ACSS3	chr12:81471809-81649582:+	0.22	4.67	4.01E-6	Neuroticism	
THCA	cis	1	rs35499647	chr15:27227720	GABRG3	chr15:27216517-27778134:+	0.17	3.37	0.000817	Hepatitis	
THCA	cis	1	rs35506374	chr20:47927883	DDX27	chr20:47835832-47860612:+	0.28	5.04	6.57E-7	Height	
THCA	cis	1	rs35507120	chr3:53053924	RFT1	chr3:53122503-53164470:-	0.63	7.01	8.27E-12	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs35507120	chr3:53053924	TMEM110	chr3:52867139-52931547:-	0.37	4.13	4.33E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs35515217	chr3:127813811	EEFSEC	chr3:127872313-128127488:+	-0.25	-4.26	2.49E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs35516249	chr13:42146217	C13orf15	chr13:42031542-42045013:+	0.14	3.47	0.000565	Multiple sclerosis	
THCA	cis	1	rs35522482	chr22:39063015	JOSD1	chr22:39081549-39096459:-	-0.15	-4.04	6.14E-5	Resting heart rate	
THCA	cis	1	rs35522482	chr22:39063015	TOMM22	chr22:39077954-39080763:+	-0.17	-3.67	0.000272	Resting heart rate	
THCA	cis	1	rs35524990	chr15:85258203	GOLGA6L5	chr15:85047738-85060078:-	-0.15	-3.86	0.000128	Schizophrenia	
THCA	cis	1	rs35524990	chr15:85258203	LOC388152	chr15:84867600-84898920:-	-0.48	-8.09	5.01E-15	Schizophrenia	
THCA	cis	1	rs35524990	chr15:85258203	NMB	chr15:85198362-85201802:-	0.37	7.72	6.74E-14	Schizophrenia	
THCA	cis	1	rs35527216	chr6:56791278	BEND6	chr6:56819773-56892138:+	-0.28	-5.94	5.38E-9	Menarche (age at onset)	
THCA	cis	1	rs35527216	chr6:56791278	KIAA1586	chr6:56911384-56920021:+	-0.33	-5.41	1.02E-7	Menarche (age at onset)	
THCA	cis	1	rs35531186	chr3:127841060	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.61	5.13E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs35532491	chr22:34329603	LARGE	chr22:33669063-34318584:-	0.55	8.06	6.28E-15	Educational attainment (years of education)	
THCA	cis	1	rs35542501	chr7:65431215	CCT6P1	chr7:65216092-65228661:+	0.38	6	3.99E-9	Diabetic kidney disease	
THCA	cis	1	rs35542501	chr7:65431215	CRCP	chr7:65579805-65619551:+	-0.26	-4.01	6.98E-5	Diabetic kidney disease	
THCA	cis	1	rs35542501	chr7:65431215	RABGEF1	chr7:66093890-66276446:+	0.56	7.11	4.19E-12	Diabetic kidney disease	
THCA	cis	1	rs35542947	chr3:58323244	PXK	chr3:58318617-58410878:+	0.34	6.03	3.22E-9	Cholesterol, total	
THCA	cis	1	rs35547195	chr7:118007795	ANKRD7	chr7:117864712-117882782:+	0.27	4.41	1.28E-5	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs35552264	chr20:33544973	PROCR	chr20:33758727-33765164:+	-0.37	-5.66	2.58E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs35552264	chr20:33544973	TRPC4AP	chr20:33590215-33680618:-	0.33	3.87	0.000123	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs35560426	chr1:27069169	ZDHHC18	chr1:27153201-27182207:+	0.8	8.6	1.15E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs35564624	chr6:151876494	C6orf97	chr6:151815175-151942327:+	0.33	4.66	4.07E-6	Bone mineral density (spine)	
THCA	cis	1	rs35565383	chr4:17984874	DCAF16	chr4:17802280-17812381:-	-0.2	-4.39	1.41E-5	Height	
THCA	cis	1	rs35565791	chr22:39063011	JOSD1	chr22:39081549-39096459:-	-0.15	-4.04	6.14E-5	Resting heart rate	
THCA	cis	1	rs35565791	chr22:39063011	TOMM22	chr22:39077954-39080763:+	-0.17	-3.67	0.000272	Resting heart rate	
THCA	cis	1	rs35574015	chr16:15146061	NTAN1	chr16:15131717-15149833:-	0.13	3.8	0.00016	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs35574015	chr16:15146061	PDXDC1	chr16:15068599-15233195:+	0.32	7.19	2.51E-12	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs35575481	chr6:163007746	PACRG	chr6:163148164-163736523:+	0.45	7	8.92E-12	Body mass index	
THCA	cis	1	rs35576914	chr3:53092270	RFT1	chr3:53122503-53164470:-	0.64	7.59	1.65E-13	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs35576914	chr3:53092270	TMEM110	chr3:52867139-52931547:-	0.32	3.77	0.000184	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs35577967	chr15:75354621	ARID3B	chr15:74833548-74890470:+	-0.14	-3.7	0.000239	Blood trace element (Zn levels)	
THCA	cis	1	rs35577967	chr15:75354621	MAN2C1	chr15:75648135-75660941:-	0.15	3.56	0.000407	Blood trace element (Zn levels)	
THCA	cis	1	rs35577967	chr15:75354621	PPCDC	chr15:75315927-75343066:+	0.14	4.11	4.72E-5	Blood trace element (Zn levels)	
THCA	cis	1	rs35577967	chr15:75354621	SCAMP5	chr15:75287901-75313836:+	0.44	7.64	1.17E-13	Blood trace element (Zn levels)	
THCA	cis	1	rs35583548	chr1:27140149	PIGV	chr1:27114455-27124886:+	-0.29	-3.39	0.00075	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs35583548	chr1:27140149	ZDHHC18	chr1:27153201-27182207:+	0.81	8.67	6.98E-17	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs35587956	chr4:17944743	DCAF16	chr4:17802280-17812381:-	-0.22	-4.42	1.25E-5	Height	
THCA	cis	1	rs35593189	chr11:18468378	LDHC	chr11:18433853-18472792:+	-0.34	-4.05	6.04E-5	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs35593345	chr6:163174981	PACRG	chr6:163148164-163736523:+	0.54	7.34	9.06E-13	Body mass index	
THCA	cis	1	rs35601051	chr11:5555247	UBQLNL	chr11:5535624-5537956:-	-0.28	-6.6	1.11E-10	QRS duration in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs35607436	chr15:56518208	MNS1	chr15:56720929-56757335:-	-0.24	-3.5	0.000514	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs35607436	chr15:56518208	TEX9	chr15:56657644-56738071:+	-0.34	-5.75	1.58E-8	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs35610147	chr1:31857206	ZCCHC17	chr1:31769842-31837780:+	-0.3	-5.75	1.58E-8	Schizophrenia	
THCA	cis	1	rs35615194	chr1:27118171	PIGV	chr1:27114455-27124886:+	-0.29	-3.42	0.000674	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs35615194	chr1:27118171	ZDHHC18	chr1:27153201-27182207:+	0.82	8.7	5.31E-17	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs35617712	chr1:27051223	ZDHHC18	chr1:27153201-27182207:+	0.79	8.55	1.69E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs35621601	chr3:58323174	PXK	chr3:58318617-58410878:+	0.33	5.99	4.17E-9	Cholesterol, total	
THCA	cis	1	rs35621718	chr14:71780758	SIPA1L1	chr14:71933902-72206118:+	0.27	5.46	7.67E-8	Mitral valve prolapse	
THCA	cis	1	rs35623865	chr11:46631181	PACSIN3	chr11:47199085-47207958:-	0.17	3.86	0.000131	Schizophrenia	
THCA	cis	1	rs35624992	chr11:47615798	C1QTNF4	chr11:47611216-47615961:-	-0.3	-5.35	1.39E-7	Subjective well-being	
THCA	cis	1	rs35630683	chr15:85349231	GOLGA6L5	chr15:85047738-85060078:-	-0.15	-4	7.44E-5	Schizophrenia	
THCA	cis	1	rs35630683	chr15:85349231	LOC388152	chr15:84867600-84898920:-	-0.47	-7.81	3.69E-14	Schizophrenia	
THCA	cis	1	rs35630683	chr15:85349231	NMB	chr15:85198362-85201802:-	0.37	7.8	3.92E-14	Schizophrenia	
THCA	cis	1	rs35630951	chr10:17215649	TRDMT1	chr10:17184983-17243681:-	-0.45	-10.46	3.3E-23	Homocysteine levels	
THCA	cis	1	rs35646598	chr6:33717416	IP6K3	chr6:33689443-33714762:-	0.4	6.48	2.29E-10	Obesity (extreme)	
THCA	cis	1	rs35648189	chr15:84740748	GOLGA6L5	chr15:85047738-85060078:-	-0.21	-5.39	1.1E-7	Schizophrenia	
THCA	cis	1	rs35648189	chr15:84740748	LOC388152	chr15:84867600-84898920:-	-0.72	-13.04	1.82E-33	Schizophrenia	
THCA	cis	1	rs35648189	chr15:84740748	NMB	chr15:85198362-85201802:-	0.23	4.54	7.12E-6	Schizophrenia	
THCA	cis	1	rs35648189	chr15:84740748	SH3GL3	chr15:84116091-84287491:+	0.24	3.77	0.000182	Schizophrenia	
THCA	cis	1	rs35648280	chr4:155347767	DCHS2	chr4:155155527-155412930:-	0.16	3.49	0.000526	Alzheimer's disease (age of onset)	
THCA	cis	1	rs35648651	chr2:239133843	LOC151174	chr2:239133754-239140318:-	0.54	5.67	2.45E-8	Irritable bowel syndrome	
THCA	cis	1	rs35649870	chr1:102730532	OLFM3	chr1:102268127-102462790:-	-0.28	-3.35	0.000863	Glomerular filtration rate	
THCA	cis	1	rs35654348	chr4:17933639	DCAF16	chr4:17802280-17812381:-	-0.22	-4.49	8.81E-6	Height	
THCA	cis	1	rs35658069	chr15:84780146	GOLGA6L5	chr15:85047738-85060078:-	-0.21	-5.43	8.9E-8	Schizophrenia	
THCA	cis	1	rs35658069	chr15:84780146	LOC388152	chr15:84867600-84898920:-	-0.72	-13.06	1.57E-33	Schizophrenia	
THCA	cis	1	rs35658069	chr15:84780146	NMB	chr15:85198362-85201802:-	0.24	4.76	2.54E-6	Schizophrenia	
THCA	cis	1	rs35658069	chr15:84780146	SH3GL3	chr15:84116091-84287491:+	0.24	3.75	0.000201	Schizophrenia	
THCA	cis	1	rs35659126	chr7:72988069	MLXIPL	chr7:73007524-73038870:-	0.24	4.44	1.14E-5	Triglycerides	
THCA	cis	1	rs35672725	chr8:89581838	MMP16	chr8:89049462-89339717:-	0.17	3.74	0.000206	Body mass index and cholesterol (psychopharmacological treatment)	
THCA	cis	1	rs35674337	chr3:38878881	WDR48	chr3:39093507-39138149:+	0.28	3.7	0.000236	Social communication problems	
THCA	cis	1	rs35681818	chr5:2791777	C5orf38	chr5:2752262-2755512:+	-0.24	-3.47	0.000575	Toenail selenium levels	
THCA	cis	1	rs35681818	chr5:2791777	IRX2	chr5:2746281-2751769:-	-0.28	-4.23	2.8E-5	Toenail selenium levels	
THCA	cis	1	rs35682316	chr7:29181260	CPVL	chr7:29035249-29234892:-	0.3	3.7	0.000245	Diabetes related insulin traits	
THCA	cis	1	rs35687916	chr1:200725163	DDX59	chr1:200610119-200639126:-	-0.25	-3.83	0.000148	Epilepsy	
THCA	cis	1	rs35696109	chr5:115527756	COMMD10	chr5:115420727-115628978:+	0.48	5.7	2.09E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs35703976	chr2:135486350	TMEM163	chr2:135213331-135525334:-	-0.18	-3.82	0.000153	Gut microbiome composition (winter)	
THCA	cis	1	rs35715471	chr8:89582284	MMP16	chr8:89049462-89339717:-	0.16	3.73	0.000213	Body mass index and cholesterol (psychopharmacological treatment)	
THCA	cis	1	rs35718987	chr3:134272783	ANAPC13	chr3:134196547-134204865:-	-0.39	-12.14	9.6E-30	Height	
THCA	cis	1	rs35718987	chr3:134272783	CEP63	chr3:134204575-134293852:+	-0.31	-6.6	1.07E-10	Height	
THCA	cis	1	rs35720014	chr3:52982110	RFT1	chr3:53122503-53164470:-	0.63	7.09	4.83E-12	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs35720014	chr3:52982110	TMEM110	chr3:52867139-52931547:-	0.38	4.21	3.11E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs35721478	chr6:33725129	IP6K3	chr6:33689443-33714762:-	0.38	6.11	2.06E-9	Obesity (extreme)	
THCA	cis	1	rs35723993	chr6:163008197	PACRG	chr6:163148164-163736523:+	0.45	7.03	7.07E-12	Body mass index	
THCA	cis	1	rs35724792	chr3:127809616	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.61	5.13E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs35726233	chr15:85337800	GOLGA6L5	chr15:85047738-85060078:-	-0.15	-4.03	6.61E-5	Schizophrenia	
THCA	cis	1	rs35726233	chr15:85337800	LOC388152	chr15:84867600-84898920:-	-0.48	-8.23	1.75E-15	Schizophrenia	
THCA	cis	1	rs35726233	chr15:85337800	NMB	chr15:85198362-85201802:-	0.35	7.53	2.63E-13	Schizophrenia	
THCA	cis	1	rs35735127	chr7:65300423	CCT6P1	chr7:65216092-65228661:+	0.38	6.13	1.82E-9	Diabetic kidney disease	
THCA	cis	1	rs35735127	chr7:65300423	CRCP	chr7:65579805-65619551:+	-0.27	-4.15	3.94E-5	Diabetic kidney disease	
THCA	cis	1	rs35735127	chr7:65300423	RABGEF1	chr7:66093890-66276446:+	0.54	6.73	5.02E-11	Diabetic kidney disease	
THCA	cis	1	rs35736167	chr15:75332002	ARID3B	chr15:74833548-74890470:+	-0.16	-3.91	0.000108	Blood trace element (Zn levels)	
THCA	cis	1	rs35736167	chr15:75332002	PPCDC	chr15:75315927-75343066:+	0.19	5.1	5.02E-7	Blood trace element (Zn levels)	
THCA	cis	1	rs35736167	chr15:75332002	SCAMP5	chr15:75287901-75313836:+	0.51	8.64	8.69E-17	Blood trace element (Zn levels)	
THCA	cis	1	rs35737577	chr3:53002557	RFT1	chr3:53122503-53164470:-	0.62	7.17	2.9E-12	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs35737577	chr3:53002557	TMEM110	chr3:52867139-52931547:-	0.36	4.1	4.9E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs35741213	chr3:10087661	C3orf10	chr3:10157333-10168873:+	-0.21	-4.33	1.8E-5	Alzheimer's disease	
THCA	cis	1	rs35741213	chr3:10087661	VHL	chr3:10183319-10193744:+	-0.2	-4.56	6.42E-6	Alzheimer's disease	
THCA	cis	1	rs35754151	chr6:163074867	PACRG	chr6:163148164-163736523:+	0.52	7.04	6.74E-12	Body mass index	
THCA	cis	1	rs35755401	chr1:200795183	DDX59	chr1:200610119-200639126:-	-0.25	-3.84	0.000137	Epilepsy	
THCA	cis	1	rs35759030	chr20:47858290	DDX27	chr20:47835832-47860612:+	0.27	4.94	1.08E-6	Height	
THCA	cis	1	rs35760725	chr6:86648985	SNHG5	chr6:86386726-86388451:-	-0.53	-12.62	1.01E-31	Response to antipsychotic treatment	
THCA	cis	1	rs35761942	chr6:86629504	SNHG5	chr6:86386726-86388451:-	-0.51	-11.15	8.37E-26	Response to antipsychotic treatment	
THCA	cis	1	rs35766535	chr1:10284659	KIF1B	chr1:10270764-10441659:+	0.21	6.59	1.14E-10	Hepatocellular carcinoma	
THCA	cis	1	rs35767091	chr4:56346723	TMEM165	chr4:56262090-56292342:+	-0.15	-3.66	0.000282	Personality dimensions	
THCA	cis	1	rs35792042	chr3:58409668	PXK	chr3:58318617-58410878:+	0.36	6.15	1.6E-9	Cholesterol, total	
THCA	cis	1	rs35797755	chr6:86706554	SNHG5	chr6:86386726-86388451:-	-0.48	-10.73	3.19E-24	Response to antipsychotic treatment	
THCA	cis	1	rs35808647	chr15:85377441	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.24	2.7E-5	Schizophrenia	
THCA	cis	1	rs35808647	chr15:85377441	LOC388152	chr15:84867600-84898920:-	-0.47	-7.9	1.98E-14	Schizophrenia	
THCA	cis	1	rs35808647	chr15:85377441	NMB	chr15:85198362-85201802:-	0.36	7.63	1.25E-13	Schizophrenia	
THCA	cis	1	rs35808787	chr4:106681179	INTS12	chr4:106603787-106629881:-	-0.62	-5.3	1.78E-7	Post bronchodilator FEV1	
THCA	cis	1	rs35813681	chr5:2787631	C5orf38	chr5:2752262-2755512:+	-0.27	-3.88	0.000121	Toenail selenium levels	
THCA	cis	1	rs35813681	chr5:2787631	IRX2	chr5:2746281-2751769:-	-0.3	-4.5	8.73E-6	Toenail selenium levels	
THCA	cis	1	rs35818596	chr6:163001874	PACRG	chr6:163148164-163736523:+	0.46	7.08	5.13E-12	Body mass index	
THCA	cis	1	rs35820085	chr7:65442758	CCT6P1	chr7:65216092-65228661:+	0.41	6.45	2.68E-10	Diabetic kidney disease	
THCA	cis	1	rs35820085	chr7:65442758	CRCP	chr7:65579805-65619551:+	-0.28	-4.25	2.53E-5	Diabetic kidney disease	
THCA	cis	1	rs35820085	chr7:65442758	RABGEF1	chr7:66093890-66276446:+	0.54	6.57	1.3E-10	Diabetic kidney disease	
THCA	cis	1	rs35820211	chr6:163046252	PACRG	chr6:163148164-163736523:+	0.52	7.28	1.42E-12	Body mass index	
THCA	cis	1	rs35825738	chr7:65318027	CCT6P1	chr7:65216092-65228661:+	0.38	6.13	1.82E-9	Diabetic kidney disease	
THCA	cis	1	rs35825738	chr7:65318027	CRCP	chr7:65579805-65619551:+	-0.27	-4.15	3.94E-5	Diabetic kidney disease	
THCA	cis	1	rs35825738	chr7:65318027	RABGEF1	chr7:66093890-66276446:+	0.54	6.73	5.02E-11	Diabetic kidney disease	
THCA	cis	1	rs35835884	chr10:127708468	DHX32	chr10:127524909-127585027:-	-0.26	-5.68	2.36E-8	Visceral fat	
THCA	cis	1	rs35835884	chr10:127708468	UROS	chr10:127477148-127511837:-	-0.31	-7.72	7.04E-14	Visceral fat	
THCA	cis	1	rs35837142	chr1:10322358	KIF1B	chr1:10270764-10441659:+	0.21	6.36	4.75E-10	Hepatocellular carcinoma	
THCA	cis	1	rs35837300	chr9:79043994	RFK	chr9:79000433-79009444:-	-0.16	-3.34	0.000899	Dialysis-related mortality	
THCA	cis	1	rs35838363	chr17:17466572	ATPAF2	chr17:17918373-17942480:-	-0.24	-3.99	7.53E-5	Obsessive-compulsive symptoms	
THCA	cis	1	rs35841610	chr5:109732832	TMEM232	chr5:109624934-110062381:-	0.4	4.38	1.45E-5	Cardiac structure and function	
THCA	cis	1	rs35849389	chr3:53005235	RFT1	chr3:53122503-53164470:-	0.62	7.17	2.9E-12	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs35849389	chr3:53005235	TMEM110	chr3:52867139-52931547:-	0.36	4.1	4.9E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs35854505	chr14:71841477	SIPA1L1	chr14:71933902-72206118:+	0.27	5.46	7.8E-8	Mitral valve prolapse	
THCA	cis	1	rs35856111	chr6:111773468	KIAA1919	chr6:111580482-111590259:+	0.48	5.65	2.74E-8	Psoriasis	
THCA	cis	1	rs35861275	chr1:47171909	CYP4B1	chr1:47264670-47285020:+	-0.23	-3.61	0.000343	Response to hepatitis C treatment	
THCA	cis	1	rs35861275	chr1:47171909	CYP4Z1	chr1:47533160-47583992:+	-0.29	-4.19	3.28E-5	Response to hepatitis C treatment	
THCA	cis	1	rs35861275	chr1:47171909	DMBX1	chr1:46972668-46979884:+	-0.24	-3.99	7.64E-5	Response to hepatitis C treatment	
THCA	cis	1	rs35882692	chr20:43763968	STK4	chr20:43595120-43708591:+	-0.17	-3.86	0.00013	Parental longevity (mother's age at death)	
THCA	cis	1	rs35901586	chr4:122664757	EXOSC9	chr4:122722472-122738175:+	0.15	3.98	8.04E-5	Type 2 diabetes	
THCA	cis	1	rs35902101	chr11:47795169	C1QTNF4	chr11:47611216-47615961:-	-0.3	-5.23	2.59E-7	Subjective well-being	
THCA	cis	1	rs35911566	chr6:162994154	PACRG	chr6:163148164-163736523:+	0.45	6.98	9.72E-12	Body mass index	
THCA	cis	1	rs35917448	chr1:27017325	PIGV	chr1:27114455-27124886:+	-0.3	-3.43	0.000663	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs35917448	chr1:27017325	ZDHHC18	chr1:27153201-27182207:+	0.79	8.34	7.97E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs35941126	chr3:2477382	CNTN4	chr3:2140550-3099644:+	0.37	8.63	9.18E-17	Blood pressure (smoking interaction)	
THCA	cis	1	rs35947214	chr3:127833231	EEFSEC	chr3:127872313-128127488:+	-0.25	-4.42	1.23E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs35951606	chr10:38088347	LOC399744	chr10:38717074-38741080:+	0.28	3.69	0.000251	Obesity (extreme)	
THCA	cis	1	rs35960805	chr15:85343980	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.2	3.18E-5	Schizophrenia	
THCA	cis	1	rs35960805	chr15:85343980	LOC388152	chr15:84867600-84898920:-	-0.48	-8.12	3.93E-15	Schizophrenia	
THCA	cis	1	rs35960805	chr15:85343980	NMB	chr15:85198362-85201802:-	0.36	7.6	1.55E-13	Schizophrenia	
THCA	cis	1	rs35962538	chr12:22560743	KIAA0528	chr12:22601526-22697452:-	0.22	3.79	0.000167	Coronary artery calcification	
THCA	cis	1	rs35962879	chr1:27283456	ZDHHC18	chr1:27153201-27182207:+	0.61	6.72	5.28E-11	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs35969145	chr1:27259392	ZDHHC18	chr1:27153201-27182207:+	0.73	7.36	8.11E-13	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs35977534	chr5:176335231	ZNF346	chr5:176449697-176508190:+	-0.16	-5.62	3.17E-8	Menopause (age at onset);Menarche and menopause (age at onset)	
THCA	cis	1	rs35988617	chr3:121432902	IQCB1	chr3:121488610-121553926:-	0.55	10.61	9.27E-24	Cognitive performance	
THCA	cis	1	rs35989952	chr1:27005154	PIGV	chr1:27114455-27124886:+	-0.29	-3.41	0.000716	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs35989952	chr1:27005154	ZDHHC18	chr1:27153201-27182207:+	0.79	8.36	6.69E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs35993975	chr3:10067794	C3orf10	chr3:10157333-10168873:+	-0.19	-3.91	0.000105	Alzheimer's disease	
THCA	cis	1	rs35993975	chr3:10067794	VHL	chr3:10183319-10193744:+	-0.2	-4.36	1.62E-5	Alzheimer's disease	
THCA	cis	1	rs35996687	chr11:458595	IRF7	chr11:612556-615999:-	0.23	3.49	0.000524	Body mass index	
THCA	cis	1	rs35997004	chr7:38225683	STARD3NL	chr7:38217933-38270269:+	-0.52	-12.39	8.84E-31	Treatment response for severe sepsis	
THCA	cis	1	rs35998242	chr1:31835901	ZCCHC17	chr1:31769842-31837780:+	-0.3	-5.61	3.38E-8	Schizophrenia	
THCA	cis	1	rs36000835	chr10:4979788	AKR1C2	chr10:4964715-5060207:-	0.37	4.78	2.39E-6	Height	
THCA	cis	1	rs36004835	chr15:67951542	IQCH	chr15:67547188-67794139:+	0.17	5.12	4.42E-7	Motion sickness	
THCA	cis	1	rs36004835	chr15:67951542	MAP2K5	chr15:67835021-68099451:+	0.15	3.67	0.000269	Motion sickness	
THCA	cis	1	rs36006749	chr3:38443312	ACVR2B	chr3:38495790-38534631:+	0.13	3.37	0.000801	Electrocardiographic conduction measures	
THCA	cis	1	rs36006749	chr3:38443312	LOC100128640	chr3:38492524-38496311:-	0.22	4.7	3.38E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs36006749	chr3:38443312	XYLB	chr3:38388251-38456467:+	0.2	4.8	2.16E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs36006965	chr19:19830051	ZNF14	chr19:19821281-19843921:-	0.23	4.66	4.12E-6	Toenail selenium levels	
THCA	cis	1	rs36007635	chr6:163009335	PACRG	chr6:163148164-163736523:+	0.45	7.03	7.07E-12	Body mass index	
THCA	cis	1	rs36016605	chr20:47896145	DDX27	chr20:47835832-47860612:+	0.27	5.01	7.52E-7	Height	
THCA	cis	1	rs36033484	chr7:65390558	CCT6P1	chr7:65216092-65228661:+	0.41	6.41	3.44E-10	Diabetic kidney disease	
THCA	cis	1	rs36033484	chr7:65390558	CRCP	chr7:65579805-65619551:+	-0.26	-3.95	9.06E-5	Diabetic kidney disease	
THCA	cis	1	rs36033484	chr7:65390558	RABGEF1	chr7:66093890-66276446:+	0.53	6.46	2.51E-10	Diabetic kidney disease	
THCA	cis	1	rs36033486	chr15:85319692	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-3.69	0.000253	Schizophrenia	
THCA	cis	1	rs36033486	chr15:85319692	LOC388152	chr15:84867600-84898920:-	-0.48	-8.08	5.27E-15	Schizophrenia	
THCA	cis	1	rs36033486	chr15:85319692	NMB	chr15:85198362-85201802:-	0.35	7.39	6.74E-13	Schizophrenia	
THCA	cis	1	rs36035949	chr6:109736614	AKD1	chr6:109814059-110012415:-	-0.37	-8.56	1.59E-16	Height	
THCA	cis	1	rs36035949	chr6:109736614	FIG4	chr6:110012424-110146634:+	-0.2	-4.11	4.58E-5	Height	
THCA	cis	1	rs36035949	chr6:109736614	SMPD2	chr6:109761931-109765121:+	0.33	8.55	1.66E-16	Height	
THCA	cis	1	rs36037390	chr3:58321954	PXK	chr3:58318617-58410878:+	0.33	5.99	4.17E-9	Cholesterol, total	
THCA	cis	1	rs36042757	chr6:163004744	PACRG	chr6:163148164-163736523:+	0.44	6.89	1.77E-11	Body mass index	
THCA	cis	1	rs36053186	chr8:89583242	MMP16	chr8:89049462-89339717:-	0.16	3.69	0.000254	Body mass index and cholesterol (psychopharmacological treatment)	
THCA	cis	1	rs36053809	chr1:27083093	ZDHHC18	chr1:27153201-27182207:+	0.79	8.55	1.66E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs36059338	chr3:127815927	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.61	5.13E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs36068983	chr7:65408991	CCT6P1	chr7:65216092-65228661:+	0.39	6.18	1.36E-9	Diabetic kidney disease	
THCA	cis	1	rs36068983	chr7:65408991	CRCP	chr7:65579805-65619551:+	-0.26	-3.99	7.58E-5	Diabetic kidney disease	
THCA	cis	1	rs36068983	chr7:65408991	RABGEF1	chr7:66093890-66276446:+	0.54	6.71	5.64E-11	Diabetic kidney disease	
THCA	cis	1	rs36070619	chr10:37953007	LOC399744	chr10:38717074-38741080:+	0.25	3.37	0.0008	Obesity (extreme)	
THCA	cis	1	rs36089715	chr18:47213022	CXXC1	chr18:47808715-47814692:-	-0.09	-3.55	0.000423	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	
THCA	cis	1	rs36090629	chr4:39138815	KLHL5	chr4:39046659-39123828:+	-0.21	-5.94	5.51E-9	Uric acid levels	
THCA	cis	1	rs36090640	chr13:33691171	STARD13	chr13:33677273-34250932:-	0.13	3.35	0.000879	Intracranial aneurysm	
THCA	cis	1	rs36090694	chr3:53010742	RFT1	chr3:53122503-53164470:-	0.64	7.38	6.89E-13	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs36090694	chr3:53010742	TMEM110	chr3:52867139-52931547:-	0.36	4.15	3.98E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs36096746	chr10:4975353	AKR1C2	chr10:4964715-5060207:-	0.33	4.36	1.6E-5	Height	
THCA	cis	1	rs36096931	chr6:86693134	SNHG5	chr6:86386726-86388451:-	-0.48	-10.64	6.96E-24	Response to antipsychotic treatment	
THCA	cis	1	rs36097398	chr3:58367330	PXK	chr3:58318617-58410878:+	0.36	6.22	1.08E-9	Cholesterol, total	
THCA	cis	1	rs36107456	chr6:162997399	PACRG	chr6:163148164-163736523:+	0.44	6.84	2.37E-11	Body mass index	
THCA	cis	1	rs36111323	chr11:101359750	TRPC6	chr11:101322296-101454659:-	-0.25	-4.13	4.3E-5	Facial depth	
THCA	cis	1	rs36113695	chr6:163004733	PACRG	chr6:163148164-163736523:+	0.46	7.08	5.13E-12	Body mass index	
THCA	cis	1	rs36122085	chr6:33765255	IP6K3	chr6:33689443-33714762:-	0.41	6.72	5.28E-11	Obesity (extreme)	
THCA	cis	1	rs3612	chr17:20905084	USP22	chr17:20902908-20947073:-	-0.18	-3.81	0.000154	Blood trace element (Se levels)	
THCA	cis	1	rs36216559	chr2:262335	SH3YL1	chr2:218138-264810:-	-0.95	-26.54	4.48E-96	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs365132	chr5:176378574	ZNF346	chr5:176449697-176508190:+	-0.16	-5.64	2.96E-8	Menopause (age at onset);Menarche and menopause (age at onset)	
THCA	cis	1	rs365323	chr19:12112949	ZNF763	chr19:12035900-12091196:+	-0.31	-3.81	0.000156	Multiple sclerosis	
THCA	cis	1	rs367027	chr3:41133421	ZNF620	chr3:40547530-40559197:+	0.17	3.35	0.000865	Bone mineral density (hip)	
THCA	cis	1	rs369801	chr1:214829916	KCNK2	chr1:215178885-215410435:+	0.16	3.49	0.000521	Response to antineoplastic agents	
THCA	cis	1	rs371674	chr21:42695445	FAM3B	chr21:42676177-42729654:+	0.48	7.28	1.34E-12	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
THCA	cis	1	rs371883	chr5:122263970	PPIC	chr5:122359080-122372425:-	-0.17	-3.43	0.000665	Migraine	
THCA	cis	1	rs372883	chr21:30717737	BACH1	chr21:30671220-30734217:+	0.11	4.01	7.12E-5	Pancreatic cancer	
THCA	cis	1	rs372883	chr21:30717737	N6AMT1	chr21:30244513-30257693:-	-0.21	-4.32	1.87E-5	Pancreatic cancer	
THCA	cis	1	rs3729931	chr3:12626516	MKRN2	chr3:12598594-12625208:+	-0.15	-3.65	0.00029	Cardiac hypertrophy	
THCA	cis	1	rs3729931	chr3:12626516	RAF1	chr3:12625102-12705700:-	0.24	4.05	5.92E-5	Cardiac hypertrophy	
THCA	cis	1	rs3730658	chr18:51794699	POLI	chr18:51795849-51824602:+	0.18	5.29	1.85E-7	Psoriasis	
THCA	cis	1	rs3730682	chr18:51797332	POLI	chr18:51795849-51824602:+	0.19	5.34	1.47E-7	Psoriasis	
THCA	cis	1	rs3730688	chr18:51797948	POLI	chr18:51795849-51824602:+	0.19	5.34	1.47E-7	Psoriasis	
THCA	cis	1	rs3730721	chr18:51802928	POLI	chr18:51795849-51824602:+	0.18	5.29	1.85E-7	Psoriasis	
THCA	cis	1	rs3730729	chr18:51804702	POLI	chr18:51795849-51824602:+	-0.19	-5.4	1.07E-7	Psoriasis	
THCA	cis	1	rs3730758	chr18:51812048	POLI	chr18:51795849-51824602:+	0.18	5.29	1.85E-7	Psoriasis	
THCA	cis	1	rs3730764	chr18:51812814	POLI	chr18:51795849-51824602:+	0.18	5.23	2.59E-7	Psoriasis	
THCA	cis	1	rs3730767	chr18:51813363	POLI	chr18:51795849-51824602:+	0.18	5.29	1.85E-7	Psoriasis	
THCA	cis	1	rs3730787	chr18:51815443	POLI	chr18:51795849-51824602:+	0.18	5.23	2.59E-7	Psoriasis	
THCA	cis	1	rs3730814	chr18:51818901	POLI	chr18:51795849-51824602:+	0.18	5.29	1.85E-7	Psoriasis	
THCA	cis	1	rs3730818	chr18:51819101	POLI	chr18:51795849-51824602:+	0.18	5.29	1.85E-7	Psoriasis	
THCA	cis	1	rs3731593	chr2:227773924	COL4A4	chr2:227867435-228029275:-	0.15	3.85	0.000135	Pulmonary function	
THCA	cis	1	rs3731714	chr2:202060820	CASP10	chr2:202047621-202094110:+	0.2	4.33	1.81E-5	Trans fatty acid levels	
THCA	cis	1	rs3731714	chr2:202060820	PPIL3	chr2:201735680-201753999:-	0.29	5.53	5.37E-8	Trans fatty acid levels	
THCA	cis	1	rs3731819	chr2:86368641	POLR1A	chr2:86253453-86333278:-	-0.27	-3.58	0.000385	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs3732269	chr2:70046255	SNRNP27	chr2:70121090-70132348:+	0.15	3.48	0.000554	Colorectal or endometrial cancer	
THCA	cis	1	rs3732276	chr2:242343404	SEPT2	chr2:242254723-242293439:+	1.05	22.17	2.07E-75	Chronic lymphocytic leukemia	
THCA	cis	1	rs3732361	chr3:119542297	GSK3B	chr3:119540804-119813264:-	-0.12	-4.35	1.68E-5	HDL cholesterol	
THCA	cis	1	rs3732408	chr3:121421179	IQCB1	chr3:121488610-121553926:-	0.54	10.57	1.27E-23	Cognitive performance	
THCA	cis	1	rs3733202	chr4:103556861	NFKB1	chr4:103422486-103538458:+	0.15	4.14	4.15E-5	Primary biliary cirrhosis	
THCA	cis	1	rs3733274	chr4:39122577	KLHL5	chr4:39046659-39123828:+	-0.21	-5.77	1.47E-8	Uric acid levels	
THCA	cis	1	rs3733276	chr4:39116911	KLHL5	chr4:39046659-39123828:+	-0.21	-5.73	1.77E-8	Uric acid levels	
THCA	cis	1	rs3733277	chr4:39117103	KLHL5	chr4:39046659-39123828:+	-0.21	-5.73	1.77E-8	Uric acid levels	
THCA	cis	1	rs3733278	chr4:39117235	KLHL5	chr4:39046659-39123828:+	-0.21	-5.73	1.77E-8	Uric acid levels	
THCA	cis	1	rs3733279	chr4:39117245	KLHL5	chr4:39046659-39123828:+	-0.21	-5.73	1.77E-8	Uric acid levels	
THCA	cis	1	rs3734266	chr6:34823187	UHRF1BP1	chr6:34759794-34853117:+	0.16	3.83	0.000148	Systemic lupus erythematosus	
THCA	cis	1	rs3734530	chr6:26195408	HIST1H2AE	chr6:26217148-26217711:+	-0.23	-3.69	0.000249	Renal underexcretion gout;Gout	
THCA	cis	1	rs3734530	chr6:26195408	HIST1H3E	chr6:26224427-26226589:+	0.43	7.04	6.71E-12	Renal underexcretion gout;Gout	
THCA	cis	1	rs3734618	chr6:39284184	KCNK16	chr6:39282475-39290330:-	0.11	3.39	0.000759	Type 2 diabetes	
THCA	cis	1	rs3734618	chr6:39284184	KCNK17	chr6:39266778-39282237:-	0.17	4.14	4.19E-5	Type 2 diabetes	
THCA	cis	1	rs3734730	chr6:150570940	RAET1K	chr6:150319157-150326280:-	0.45	3.4	0.00074	Pulmonary function;Pulmonary function (interaction)	
THCA	cis	1	rs3735148	chr7:65971009	ASL	chr7:65540776-65558321:+	-0.16	-4.21	3.08E-5	Aortic root size	
THCA	cis	1	rs3735148	chr7:65971009	GUSB	chr7:65425675-65447246:-	0.27	5.32	1.62E-7	Aortic root size	
THCA	cis	1	rs3735148	chr7:65971009	RABGEF1	chr7:66093890-66276446:+	0.66	14.12	4.35E-38	Aortic root size	
THCA	cis	1	rs3736544	chr4:56309992	TMEM165	chr4:56262090-56292342:+	-0.15	-3.71	0.000231	Personality dimensions	
THCA	cis	1	rs3736582	chr10:124742895	C10orf88	chr10:124690419-124713919:-	-0.22	-4.08	5.37E-5	Migraine without aura	
THCA	cis	1	rs3736583	chr10:124742792	C10orf88	chr10:124690419-124713919:-	-0.22	-4.08	5.37E-5	Migraine without aura	
THCA	cis	1	rs3736584	chr10:124742683	C10orf88	chr10:124690419-124713919:-	-0.22	-4.08	5.37E-5	Migraine without aura	
THCA	cis	1	rs3736585	chr10:124742586	C10orf88	chr10:124690419-124713919:-	-0.22	-4.08	5.37E-5	Migraine without aura	
THCA	cis	1	rs3736781	chr6:26505362	BTN2A3	chr6:26422317-26431927:+	0.2	4.64	4.57E-6	Educational attainment	
THCA	cis	1	rs3736781	chr6:26505362	HCG11	chr6:26521934-26527610:+	-0.23	-4.47	9.87E-6	Educational attainment	
THCA	cis	1	rs3736781	chr6:26505362	HMGN4	chr6:26538572-26547162:+	-0.16	-4.08	5.38E-5	Educational attainment	
THCA	cis	1	rs3736781	chr6:26505362	ZNF322A	chr6:26634612-26659963:-	-0.14	-3.78	0.000176	Educational attainment	
THCA	cis	1	rs3736782	chr6:26505403	BTN2A3	chr6:26422317-26431927:+	0.2	4.64	4.57E-6	Educational attainment	
THCA	cis	1	rs3736782	chr6:26505403	HCG11	chr6:26521934-26527610:+	-0.23	-4.47	9.87E-6	Educational attainment	
THCA	cis	1	rs3736782	chr6:26505403	HMGN4	chr6:26538572-26547162:+	-0.16	-4.08	5.38E-5	Educational attainment	
THCA	cis	1	rs3736782	chr6:26505403	ZNF322A	chr6:26634612-26659963:-	-0.14	-3.78	0.000176	Educational attainment	
THCA	cis	1	rs3738471	chr1:41006545	DEM1	chr1:40974433-40982212:+	0.36	4.99	8.6E-7	Age-related hearing impairment (interaction)	
THCA	cis	1	rs3738814	chr1:17331676	ATP13A2	chr1:17312453-17338423:-	-0.28	-6.42	3.2E-10	Height	
THCA	cis	1	rs3738814	chr1:17331676	CROCC	chr1:17066768-17299474:+	0.12	3.41	0.000714	Height	
THCA	cis	1	rs3738814	chr1:17331676	ESPNP	chr1:17017713-17046652:-	0.17	3.59	0.000372	Height	
THCA	cis	1	rs3738814	chr1:17331676	MST1P2	chr1:16972069-16976914:+	-0.13	-3.94	9.42E-5	Height	
THCA	cis	1	rs3738848	chr2:73761881	ALMS1P	chr2:73872046-73912692:+	0.71	11.26	3.04E-26	Metabolite levels	
THCA	cis	1	rs3738848	chr2:73761881	NAT8	chr2:73867850-73869537:-	0.39	6.13	1.89E-9	Metabolite levels	
THCA	cis	1	rs3738848	chr2:73761881	TPRKB	chr2:73956957-73964517:-	-0.17	-4.35	1.68E-5	Metabolite levels	
THCA	cis	1	rs3739034	chr2:135483381	TMEM163	chr2:135213331-135525334:-	0.16	3.52	0.000473	Gut microbiome composition (winter)	
THCA	cis	1	rs3739036	chr2:135483534	TMEM163	chr2:135213331-135525334:-	0.17	3.76	0.000192	Gut microbiome composition (winter)	
THCA	cis	1	rs3739821	chr9:130702477	DPM2	chr9:130697374-130700763:-	-0.2	-6.32	6.03E-10	Glaucoma (primary angle closure)	
THCA	cis	1	rs3739843	chr9:131882961	CRAT	chr9:131857075-131873070:-	0.28	6.88	1.84E-11	Blood metabolite ratios	
THCA	cis	1	rs3739847	chr9:131911574	CRAT	chr9:131857075-131873070:-	-0.29	-6.95	1.22E-11	Blood metabolite ratios	
THCA	cis	1	rs3740365	chr10:96053239	TMEM20	chr10:95653730-95713998:+	-0.17	-3.38	0.00078	Sudden cardiac arrest	
THCA	cis	1	rs3740711	chr11:18379839	GTF2H1	chr11:18343816-18388590:+	0.33	8.79	2.64E-17	Pancreatic cancer	
THCA	cis	1	rs3740713	chr11:18451096	LDHC	chr11:18433853-18472792:+	-0.34	-3.9	0.000111	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs3740974	chr11:46397323	PACSIN3	chr11:47199085-47207958:-	0.17	3.88	0.00012	Schizophrenia	
THCA	cis	1	rs3741578	chr12:57394635	FAM119B	chr12:58166383-58176323:+	-0.27	-3.99	7.64E-5	Asthma	
THCA	cis	1	rs3741578	chr12:57394635	TSFM	chr12:58176536-58191367:+	0.23	3.4	0.000741	Asthma	
THCA	cis	1	rs3742320	chr13:33164418	CG030	chr13:33078645-33083532:-	-0.12	-3.36	0.000847	Body mass index	
THCA	cis	1	rs3742320	chr13:33164418	N4BP2L2	chr13:33006930-33112936:-	0.26	7.59	1.72E-13	Body mass index	
THCA	cis	1	rs3742500	chr14:24611978	FAM158A	chr14:24608175-24610797:-	-0.6	-24.14	8.78E-85	IgG glycosylation	
THCA	cis	1	rs3742536	chr14:52507429	C14orf166	chr14:52456228-52471419:+	0.14	3.97	8.28E-5	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs3742536	chr14:52507429	NID2	chr14:52471521-52535946:-	0.18	3.74	0.000203	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs3742773	chr14:75579643	EIF2B2	chr14:75469612-75476292:+	0.18	4.97	9.38E-7	Height	
THCA	cis	1	rs3742773	chr14:75579643	MLH3	chr14:75480467-75518235:-	0.29	8.7	5.27E-17	Height	
THCA	cis	1	rs3742773	chr14:75579643	RPS6KL1	chr14:75372347-75389958:-	0.32	6.81	2.99E-11	Height	
THCA	cis	1	rs3742778	chr14:75538217	EIF2B2	chr14:75469612-75476292:+	-0.17	-4.67	4.01E-6	Height	
THCA	cis	1	rs3742778	chr14:75538217	MLH3	chr14:75480467-75518235:-	-0.29	-8.61	1.11E-16	Height	
THCA	cis	1	rs3742778	chr14:75538217	RPS6KL1	chr14:75372347-75389958:-	-0.31	-6.69	6.39E-11	Height	
THCA	cis	1	rs3742780	chr14:75505008	EIF2B2	chr14:75469612-75476292:+	0.18	4.94	1.06E-6	Height	
THCA	cis	1	rs3742780	chr14:75505008	MLH3	chr14:75480467-75518235:-	0.29	8.75	3.8E-17	Height	
THCA	cis	1	rs3742780	chr14:75505008	RPS6KL1	chr14:75372347-75389958:-	0.33	7.13	3.62E-12	Height	
THCA	cis	1	rs374283	chr6:5073845	LYRM4	chr6:5108654-5261168:-	0.15	3.47	0.000571	Venous thromboembolism (SNP x SNP interaction)	
THCA	cis	1	rs3742987	chr15:43016547	GANC	chr15:42565856-42645863:+	-0.18	-3.89	0.000116	MGMT methylation in smokers	
THCA	cis	1	rs3743161	chr15:85430838	LOC388152	chr15:84867600-84898920:-	-0.3	-4.75	2.66E-6	Alzheimer's disease (age of onset)	
THCA	cis	1	rs3743161	chr15:85430838	NMB	chr15:85198362-85201802:-	0.24	4.74	2.84E-6	Alzheimer's disease (age of onset)	
THCA	cis	1	rs3743161	chr15:85430838	WDR73	chr15:85186012-85197524:-	-0.18	-3.42	0.000686	Alzheimer's disease (age of onset)	
THCA	cis	1	rs3743162	chr15:85430969	LOC388152	chr15:84867600-84898920:-	-0.31	-4.9	1.33E-6	Alzheimer's disease (age of onset)	
THCA	cis	1	rs3743162	chr15:85430969	NMB	chr15:85198362-85201802:-	0.24	4.83	1.83E-6	Alzheimer's disease (age of onset)	
THCA	cis	1	rs3743162	chr15:85430969	WDR73	chr15:85186012-85197524:-	-0.19	-3.59	0.000368	Alzheimer's disease (age of onset)	
THCA	cis	1	rs3743772	chr16:53537423	AKTIP	chr16:53525193-53537170:-	-0.32	-4.48	9.2E-6	Depressive symptoms (SSRI exposure interaction)	
THCA	cis	1	rs3745734	chr19:49134388	SEC1	chr19:49141296-49185501:+	-0.66	-7.18	2.66E-12	Elevated serum carcinoembryonic antigen levels	
THCA	cis	1	rs3745859	chr19:39196745	LGALS7	chr19:39261608-39264157:-	-0.23	-4.77	2.46E-6	Heart rate	
THCA	cis	1	rs3745937	chr19:42071289	CEACAM21	chr19:42055886-42093196:+	0.61	15.42	7.92E-44	Schizophrenia	
THCA	cis	1	rs3746016	chr19:32877259	DPY19L3	chr19:32896677-32975236:+	0.18	4.87	1.55E-6	Bipolar disorder	
THCA	cis	1	rs3746016	chr19:32877259	ZNF507	chr19:32836514-32878571:+	0.29	7.1	4.45E-12	Bipolar disorder	
THCA	cis	1	rs3746231	chr19:57760057	ZNF460	chr19:57791419-57805436:+	-0.15	-3.45	0.00061	Hyperactive-impulsive symptoms	
THCA	cis	1	rs3746665	chr20:3910406	MAVS	chr20:3827449-3856761:+	0.24	3.76	0.000188	Response to antidepressants in depression	
THCA	cis	1	rs3746666	chr20:3910861	MAVS	chr20:3827449-3856761:+	-0.25	-3.81	0.000154	Response to antidepressants in depression	
THCA	cis	1	rs3746722	chr20:1610939	SIRPB1	chr20:1545030-1600689:-	0.15	3.75	0.000199	Type 1 diabetes	
THCA	cis	1	rs3747113	chr22:24717518	CYTSA	chr22:24666786-24813707:+	0.16	4.18	3.51E-5	Gut microbiome composition (summer)	
THCA	cis	1	rs3747113	chr22:24717518	GGT5	chr22:24615623-24641110:-	0.22	4.71	3.25E-6	Gut microbiome composition (summer)	
THCA	cis	1	rs3747113	chr22:24717518	POM121L9P	chr22:24647589-24661490:+	0.37	8.54	1.79E-16	Gut microbiome composition (summer)	
THCA	cis	1	rs3747170	chr22:39067331	JOSD1	chr22:39081549-39096459:-	-0.15	-4.02	6.87E-5	Resting heart rate	
THCA	cis	1	rs3747170	chr22:39067331	TOMM22	chr22:39077954-39080763:+	-0.17	-3.71	0.00023	Resting heart rate	
THCA	cis	1	rs3747172	chr22:39067524	JOSD1	chr22:39081549-39096459:-	-0.15	-3.86	0.000127	Resting heart rate	
THCA	cis	1	rs3747172	chr22:39067524	LOC646851	chr22:38974125-39052634:-	0.13	3.43	0.000646	Resting heart rate	
THCA	cis	1	rs3747172	chr22:39067524	TOMM22	chr22:39077954-39080763:+	-0.16	-3.49	0.000525	Resting heart rate	
THCA	cis	1	rs3747174	chr22:39069181	JOSD1	chr22:39081549-39096459:-	-0.15	-3.86	0.000127	Resting heart rate	
THCA	cis	1	rs3747174	chr22:39069181	LOC646851	chr22:38974125-39052634:-	0.13	3.43	0.000646	Resting heart rate	
THCA	cis	1	rs3747174	chr22:39069181	TOMM22	chr22:39077954-39080763:+	-0.16	-3.49	0.000525	Resting heart rate	
THCA	cis	1	rs3747957	chr1:180953853	MR1	chr1:181003139-181024633:+	-0.13	-3.53	0.000451	Progressive supranuclear palsy	
THCA	cis	1	rs3747957	chr1:180953853	STX6	chr1:180913175-180992046:-	-0.2	-4.11	4.74E-5	Progressive supranuclear palsy	
THCA	cis	1	rs3748578	chr1:10420918	KIF1B	chr1:10270764-10441659:+	-0.21	-6.43	3.04E-10	Hepatocellular carcinoma	
THCA	cis	1	rs3748656	chr1:113236681	MOV10	chr1:113217048-113243367:+	0.2	4.8	2.1E-6	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs3748656	chr1:113236681	ST7L	chr1:113066142-113162405:-	0.66	10.75	2.66E-24	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs3748682	chr1:38279987	FHL3	chr1:38462444-38471234:-	0.16	4.67	4.0E-6	Hypothyroidism	
THCA	cis	1	rs3748682	chr1:38279987	SF3A3	chr1:38422654-38455761:-	0.18	4.44	1.1E-5	Hypothyroidism	
THCA	cis	1	rs3749237	chr3:49770032	CCDC36	chr3:49235861-49295537:+	0.18	3.78	0.000179	Resting heart rate	
THCA	cis	1	rs3749237	chr3:49770032	RBM6	chr3:49977592-50137484:+	-0.14	-4.19	3.28E-5	Resting heart rate	
THCA	cis	1	rs374934	chr1:214828350	KCNK2	chr1:215178885-215410435:+	-0.18	-3.74	0.000209	Response to antineoplastic agents	
THCA	cis	1	rs3750082	chr7:32919927	KBTBD2	chr7:32907778-32931468:-	0.15	3.79	0.00017	Glomerular filtration rate (creatinine)	
THCA	cis	1	rs3750626	chr10:102266316	SEC31B	chr10:102246403-102289636:-	-0.27	-8.72	4.52E-17	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs3750627	chr10:102275642	SEC31B	chr10:102246403-102289636:-	-0.28	-9.09	2.64E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs3750629	chr10:102275727	SEC31B	chr10:102246403-102289636:-	-0.27	-8.79	2.65E-17	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs3750630	chr10:102275780	SEC31B	chr10:102246403-102289636:-	-0.27	-8.68	6.2E-17	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs3750633	chr10:102308214	SEC31B	chr10:102246403-102289636:-	-0.28	-8.93	9.05E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs3750719	chr10:102248950	SEC31B	chr10:102246403-102289636:-	-0.31	-10.06	1.03E-21	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs3750720	chr10:102248884	SEC31B	chr10:102246403-102289636:-	-0.31	-10.05	1.07E-21	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs3750908	chr11:71822401	FAM86C	chr11:71498557-71512276:+	-0.32	-3.91	0.000107	Severe influenza A (H1N1) infection	
THCA	cis	1	rs3750965	chr11:68840160	TPCN2	chr11:68816350-68929907:+	-0.17	-4.14	4.03E-5	Hair color	
THCA	cis	1	rs3751913	chr17:80405552	C17orf62	chr17:80400520-80408694:-	-0.26	-6.56	1.43E-10	Protein quantitative trait loci	
THCA	cis	1	rs3751913	chr17:80405552	NARF	chr17:80416060-80446141:+	-0.16	-3.45	0.00061	Protein quantitative trait loci	
THCA	cis	1	rs3751962	chr17:76098719	TMC6	chr17:76108999-76128488:-	0.2	3.77	0.000183	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs3751972	chr17:26206414	C17orf108	chr17:26205341-26220409:-	0.2	5.97	4.74E-9	Fractional exhaled nitric oxide (childhood)	
THCA	cis	1	rs3751972	chr17:26206414	NOS2	chr17:26083793-26220409:-	-0.51	-7.68	9.25E-14	Fractional exhaled nitric oxide (childhood)	
THCA	cis	1	rs3752790	chr6:70507133	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.37	0.000809	Sleep duration	
THCA	cis	1	rs3752950	chr10:17203356	TRDMT1	chr10:17184983-17243681:-	-0.44	-10.04	1.23E-21	Homocysteine levels	
THCA	cis	1	rs3752950	chr10:17203356	VIM	chr10:17270258-17279592:+	-0.18	-3.42	0.000692	Homocysteine levels	
THCA	cis	1	rs3753037	chr1:10355834	KIF1B	chr1:10270764-10441659:+	0.21	6.48	2.35E-10	Hepatocellular carcinoma	
THCA	cis	1	rs3753953	chr1:200829359	DDX59	chr1:200610119-200639126:-	-0.23	-3.62	0.000327	Epilepsy	
THCA	cis	1	rs3754439	chr1:110615094	ALX3	chr1:110602998-110613322:-	-0.32	-7.76	5.18E-14	Blood metabolite levels	
THCA	cis	1	rs3754440	chr1:110613674	ALX3	chr1:110602998-110613322:-	-0.31	-7.61	1.49E-13	Blood metabolite levels	
THCA	cis	1	rs3755934	chr4:1236083	KIAA1530	chr4:1341104-1381836:+	-0.21	-3.6	0.000353	Type 2 diabetes	
THCA	cis	1	rs3756054	chr4:90674451	MMRN1	chr4:90816003-90875778:+	-0.32	-4	7.3E-5	Parkinson's disease	
THCA	cis	1	rs3756416	chr5:43383502	C5orf34	chr5:43486810-43515187:-	-0.17	-3.87	0.000124	Metabolite levels  (X-11787)	
THCA	cis	1	rs3757135	chr6:26200707	HIST1H2AE	chr6:26217148-26217711:+	-0.23	-3.69	0.000249	Renal underexcretion gout;Gout	
THCA	cis	1	rs3757135	chr6:26200707	HIST1H3E	chr6:26224427-26226589:+	0.43	7.04	6.71E-12	Renal underexcretion gout;Gout	
THCA	cis	1	rs3757241	chr6:46623698	CYP39A1	chr6:46517445-46620523:-	-0.31	-4.86	1.62E-6	Lipoprotein-associated phospholipase A2 activity and mass	
THCA	cis	1	rs3758253	chr9:100700654	C9orf156	chr9:100666772-100684852:-	-0.14	-3.71	0.000228	Quantitative traits	
THCA	cis	1	rs3758254	chr9:100701001	C9orf156	chr9:100666772-100684852:-	-0.14	-3.71	0.000228	Quantitative traits	
THCA	cis	1	rs3758723	chr11:45243512	PRDM11	chr11:45115564-45246902:+	-0.16	-3.96	8.63E-5	Thyroid hormone levels	
THCA	cis	1	rs3758723	chr11:45243512	SYT13	chr11:45261853-45307884:-	-0.31	-5.25	2.27E-7	Thyroid hormone levels	
THCA	cis	1	rs3758927	chr11:133829644	IGSF9B	chr11:133785186-133826880:-	-0.24	-5	8.23E-7	Schizophrenia	
THCA	cis	1	rs3758927	chr11:133829644	LOC283174	chr11:133766330-133771635:-	-0.21	-3.98	7.89E-5	Schizophrenia	
THCA	cis	1	rs3758977	chr11:61737244	BEST1	chr11:61717356-61731939:+	0.3	5.99	4.12E-9	Phospholipid levels (plasma)	
THCA	cis	1	rs3758977	chr11:61737244	FADS2	chr11:61583728-61634825:+	0.18	3.92	9.95E-5	Phospholipid levels (plasma)	
THCA	cis	1	rs3760707	chr19:50084454	PRRG2	chr19:50084587-50094265:+	-0.17	-3.61	0.000333	Fibrinogen levels	
THCA	cis	1	rs3760891	chr19:33599708	GPATCH1	chr19:33571786-33621318:+	0.36	8.74	3.94E-17	Bone properties (heel)	
THCA	cis	1	rs3760982	chr19:44286513	LYPD5	chr19:44300080-44324808:-	-0.24	-5.16	3.62E-7	Breast cancer	
THCA	cis	1	rs3760982	chr19:44286513	ZNF155	chr19:44488355-44502477:+	-0.25	-5.63	3.04E-8	Breast cancer	
THCA	cis	1	rs3760982	chr19:44286513	ZNF404	chr19:44376516-44384288:-	-0.26	-6.77	3.75E-11	Breast cancer	
THCA	cis	1	rs3760983	chr19:44286660	LYPD5	chr19:44300080-44324808:-	0.23	4.99	8.63E-7	Breast cancer	
THCA	cis	1	rs3760983	chr19:44286660	ZNF155	chr19:44488355-44502477:+	0.25	5.73	1.82E-8	Breast cancer	
THCA	cis	1	rs3760983	chr19:44286660	ZNF404	chr19:44376516-44384288:-	0.26	6.94	1.28E-11	Breast cancer	
THCA	cis	1	rs3761117	chr20:25388070	ENTPD6	chr20:25176339-25207360:+	0.31	7.15	3.24E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs3761117	chr20:25388070	FAM182A	chr20:26035250-26067552:+	0.18	3.35	0.000885	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs3761117	chr20:25388070	FAM182B	chr20:25744102-25848786:-	-0.26	-5.45	7.96E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs3761117	chr20:25388070	NINL	chr20:25433338-25566153:-	0.34	6.91	1.51E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs3761117	chr20:25388070	PYGB	chr20:25228706-25278647:+	0.15	3.89	0.000116	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs3761454	chr22:39066820	JOSD1	chr22:39081549-39096459:-	-0.15	-4.02	6.87E-5	Resting heart rate	
THCA	cis	1	rs3761454	chr22:39066820	TOMM22	chr22:39077954-39080763:+	-0.17	-3.71	0.00023	Resting heart rate	
THCA	cis	1	rs3761959	chr1:157669278	FCRL3	chr1:157646278-157670775:-	0.28	9.26	7.07E-19	Type 1 diabetes autoantibodies	
THCA	cis	1	rs3763695	chr10:102269206	SEC31B	chr10:102246403-102289636:-	-0.28	-9.03	4.33E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs3763947	chr11:22835069	SVIP	chr11:22843600-22851382:-	-0.2	-3.46	0.000584	Dialysis-related mortality	
THCA	cis	1	rs3764377	chr17:76087754	TMC6	chr17:76108999-76128488:-	0.21	3.93	9.92E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs3764419	chr17:29164023	SUZ12P	chr17:29035714-29097067:+	-0.16	-4.71	3.31E-6	Height	
THCA	cis	1	rs3764540	chr19:52380681	ZNF577	chr19:52359056-52394145:-	-0.19	-4.22	2.88E-5	Breast cancer	
THCA	cis	1	rs3764540	chr19:52380681	ZNF649	chr19:52392489-52408247:-	-0.2	-3.97	8.31E-5	Breast cancer	
THCA	cis	1	rs3764796	chr8:17157677	VPS37A	chr8:17104401-17155532:+	-0.22	-3.71	0.000232	Calcium levels	
THCA	cis	1	rs3765158	chr4:54327584	SCFD2	chr4:53739152-54232242:-	0.2	3.92	0.000101	DNA methylation (variation)	
THCA	cis	1	rs3766287	chr1:31765685	ZCCHC17	chr1:31769842-31837780:+	-0.3	-5.58	4.03E-8	Schizophrenia	
THCA	cis	1	rs376776	chr1:214830142	KCNK2	chr1:215178885-215410435:+	0.16	3.49	0.000521	Response to antineoplastic agents	
THCA	cis	1	rs3768592	chr1:183214426	RNASEL	chr1:182542772-182558391:-	-0.33	-3.68	0.000259	Systemic lupus erythematosus and Systemic sclerosis	
THCA	cis	1	rs3768598	chr1:183194410	RNASEL	chr1:182542772-182558391:-	0.33	3.59	0.000371	Systemic lupus erythematosus and Systemic sclerosis	
THCA	cis	1	rs3768707	chr2:215645135	BARD1	chr2:215593275-215674428:-	-0.2	-5.65	2.82E-8	Neuroblastoma	
THCA	cis	1	rs3769143	chr2:27450724	C2orf28	chr2:27434899-27440044:+	-0.16	-4.84	1.76E-6	Blood metabolite levels	
THCA	cis	1	rs3769143	chr2:27450724	SLC5A6	chr2:27422459-27435071:-	0.33	7.11	4.39E-12	Blood metabolite levels	
THCA	cis	1	rs3769678	chr2:204276327	ICA1L	chr2:203637873-203736371:-	-0.14	-3.55	0.000418	Subclinical atherosclerosis traits (other)	
THCA	cis	1	rs3769693	chr2:99259346	UNC50	chr2:99225042-99234975:+	-0.22	-4.36	1.63E-5	Bipolar disorder	
THCA	cis	1	rs3769694	chr2:99259239	UNC50	chr2:99225042-99234975:+	-0.23	-4.51	8.14E-6	Bipolar disorder	
THCA	cis	1	rs3769696	chr2:99258927	UNC50	chr2:99225042-99234975:+	-0.23	-4.66	4.16E-6	Bipolar disorder	
THCA	cis	1	rs3769697	chr2:99242580	UNC50	chr2:99225042-99234975:+	-0.23	-4.67	3.9E-6	Bipolar disorder	
THCA	cis	1	rs3769825	chr2:202111380	PPIL3	chr2:201735680-201753999:-	-0.19	-3.92	9.99E-5	Chronic lymphocytic leukemia	
THCA	cis	1	rs3770066	chr2:86392350	LOC90784	chr2:86247339-86250991:-	-0.37	-3.99	7.68E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs3770081	chr2:86280925	LOC90784	chr2:86247339-86250991:-	-0.36	-3.49	0.000531	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs3770081	chr2:86280925	POLR1A	chr2:86253453-86333278:-	-0.3	-4.05	5.93E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs3770082	chr2:86280922	LOC90784	chr2:86247339-86250991:-	-0.36	-3.49	0.000531	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs3770082	chr2:86280922	POLR1A	chr2:86253453-86333278:-	-0.3	-4.05	5.93E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs3770087	chr2:86267068	LOC90784	chr2:86247339-86250991:-	-0.56	-6.6	1.09E-10	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs3770089	chr2:86263815	POLR1A	chr2:86253453-86333278:-	-0.33	-4.54	7.15E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs3770090	chr2:86263288	LOC90784	chr2:86247339-86250991:-	-0.56	-6.63	9.3E-11	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs3770264	chr2:45683516	SRBD1	chr2:45615820-45838433:-	-0.32	-3.58	0.00038	Glaucoma	
THCA	cis	1	rs3770752	chr2:37576136	CEBPZ	chr2:37428778-37458740:-	0.35	7.89	2.11E-14	Schizophrenia	
THCA	cis	1	rs3771175	chr2:102960210	IL1RL1	chr2:102927962-102968497:+	-0.21	-4.18	3.54E-5	Asthma	
THCA	cis	1	rs3771180	chr2:102953617	IL1RL1	chr2:102927962-102968497:+	0.22	4.43	1.15E-5	Asthma	
THCA	cis	1	rs3771564	chr2:242355701	ANO7	chr2:242127924-242164791:+	0.33	3.96	8.73E-5	Prostate cancer	
THCA	cis	1	rs3771564	chr2:242355701	SEPT2	chr2:242254723-242293439:+	-0.28	-4.34	1.71E-5	Prostate cancer	
THCA	cis	1	rs3771570	chr2:242382864	ANO7	chr2:242127924-242164791:+	0.32	3.71	0.000234	Prostate cancer	
THCA	cis	1	rs3771570	chr2:242382864	SEPT2	chr2:242254723-242293439:+	-0.3	-4.46	1.01E-5	Prostate cancer	
THCA	cis	1	rs3772128	chr3:121345094	IQCB1	chr3:121488610-121553926:-	0.53	10.32	1.09E-22	Cognitive performance	
THCA	cis	1	rs3772130	chr3:121344140	IQCB1	chr3:121488610-121553926:-	0.53	10.32	1.09E-22	Cognitive performance	
THCA	cis	1	rs3773621	chr3:150996434	GPR87	chr3:151011876-151034636:-	0.2	4.64	4.6E-6	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs3773621	chr3:150996434	P2RY14	chr3:150929905-150996230:-	-0.19	-4.19	3.3E-5	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs3774261	chr3:186571559	RTP4	chr3:187086168-187089367:+	0.15	3.49	0.000519	Adiponectin levels	
THCA	cis	1	rs3774372	chr3:41877414	ULK4	chr3:41288091-42003660:-	1.04	18.94	4.33E-60	Diastolic blood pressure	
THCA	cis	1	rs377457	chr16:85735652	GINS2	chr16:85711281-85722588:-	0.2	4	7.32E-5	Type 2 diabetes	
THCA	cis	1	rs3774808	chr3:48481647	ATRIP	chr3:48488141-48507708:+	0.2	4.36	1.57E-5	Longevity	
THCA	cis	1	rs3774808	chr3:48481647	TREX1	chr3:48501186-48509043:+	-0.25	-5.84	9.47E-9	Longevity	
THCA	cis	1	rs3774957	chr4:103509025	NFKB1	chr4:103422486-103538458:+	0.16	4.56	6.41E-6	Ulcerative colitis	
THCA	cis	1	rs3774959	chr4:103511114	NFKB1	chr4:103422486-103538458:+	-0.17	-4.53	7.52E-6	Ulcerative colitis	
THCA	cis	1	rs3775422	chr4:90654664	MMRN1	chr4:90816003-90875778:+	0.31	3.89	0.000115	Parkinson's disease	
THCA	cis	1	rs3775423	chr4:90657491	MMRN1	chr4:90816003-90875778:+	0.31	3.89	0.000115	Parkinson's disease	
THCA	cis	1	rs3775870	chr4:68446421	CENPC1	chr4:68337989-68411256:-	0.25	5.66	2.58E-8	Parkinson's disease	
THCA	cis	1	rs37767	chr16:3514962	CEMP1	chr16:2580036-2581419:-	-0.17	-3.66	0.00028	Tuberculosis	
THCA	cis	1	rs37767	chr16:3514962	NAT15	chr16:3493668-3536962:+	-0.24	-4.29	2.13E-5	Tuberculosis	
THCA	cis	1	rs37767	chr16:3514962	TRAP1	chr16:3708039-3767598:-	0.15	3.86	0.00013	Tuberculosis	
THCA	cis	1	rs37768	chr16:3514777	NAT15	chr16:3493668-3536962:+	-0.23	-4.04	6.11E-5	Tuberculosis	
THCA	cis	1	rs37768	chr16:3514777	TRAP1	chr16:3708039-3767598:-	0.16	3.86	0.000129	Tuberculosis	
THCA	cis	1	rs37769	chr16:3514580	CEMP1	chr16:2580036-2581419:-	-0.17	-3.65	0.000291	Tuberculosis	
THCA	cis	1	rs37769	chr16:3514580	NAT15	chr16:3493668-3536962:+	-0.25	-4.32	1.92E-5	Tuberculosis	
THCA	cis	1	rs37769	chr16:3514580	TRAP1	chr16:3708039-3767598:-	0.15	3.87	0.000126	Tuberculosis	
THCA	cis	1	rs37771	chr16:3512866	CEMP1	chr16:2580036-2581419:-	-0.17	-3.49	0.000531	Tuberculosis	
THCA	cis	1	rs37771	chr16:3512866	NAT15	chr16:3493668-3536962:+	-0.23	-4.05	5.87E-5	Tuberculosis	
THCA	cis	1	rs37771	chr16:3512866	TRAP1	chr16:3708039-3767598:-	0.16	3.9	0.00011	Tuberculosis	
THCA	cis	1	rs3777981	chr6:117735255	DCBLD1	chr6:117803820-117891018:+	-0.35	-7.54	2.46E-13	Lung cancer	
THCA	cis	1	rs3777981	chr6:117735255	GOPC	chr6:117639351-117923681:-	-0.16	-4.84	1.78E-6	Lung cancer	
THCA	cis	1	rs3778242	chr6:70466916	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.4	0.000737	Sleep duration	
THCA	cis	1	rs3778244	chr6:70484738	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.45	0.000602	Sleep duration	
THCA	cis	1	rs3778483	chr6:46627100	CYP39A1	chr6:46517445-46620523:-	-0.42	-9.87	4.98E-21	QRS complex (Sokolow-Lyon)	
THCA	cis	1	rs3778483	chr6:46627100	SLC25A27	chr6:46620679-46645925:+	-0.18	-6.69	6.35E-11	QRS complex (Sokolow-Lyon)	
THCA	cis	1	rs3778483	chr6:46627100	TDRD6	chr6:46655866-46670149:+	0.18	5.12	4.38E-7	QRS complex (Sokolow-Lyon)	
THCA	cis	1	rs3778909	chr7:66255646	GUSB	chr7:65425675-65447246:-	0.33	6.79	3.37E-11	Aortic root size	
THCA	cis	1	rs3778909	chr7:66255646	RABGEF1	chr7:66093890-66276446:+	0.52	10.71	3.98E-24	Aortic root size	
THCA	cis	1	rs3778909	chr7:66255646	TYW1	chr7:66461817-66704496:+	0.18	3.96	8.54E-5	Aortic root size	
THCA	cis	1	rs3779195	chr7:97993362	BAIAP2L1	chr7:97920964-98030427:-	0.31	5.84	9.44E-9	Sex hormone-binding globulin levels	
THCA	cis	1	rs3780444	chr9:101071735	TBC1D2	chr9:100961281-101018003:-	0.19	4.75	2.71E-6	Schizophrenia	
THCA	cis	1	rs3780445	chr9:101071606	TBC1D2	chr9:100961281-101018003:-	0.19	4.75	2.71E-6	Schizophrenia	
THCA	cis	1	rs3780480	chr9:33163486	B4GALT1	chr9:33110639-33167356:-	0.27	6.18	1.39E-9	IgG glycosylation	
THCA	cis	1	rs3780486	chr9:33139453	B4GALT1	chr9:33110639-33167356:-	0.28	6.38	4.12E-10	IgG glycosylation	
THCA	cis	1	rs3780551	chr9:99539739	FAM22G	chr9:99690592-99704572:+	0.94	8.56	1.54E-16	Height	
THCA	cis	1	rs3780551	chr9:99539739	HIATL2	chr9:99695549-99775862:-	0.69	6.25	9.03E-10	Height	
THCA	cis	1	rs3780551	chr9:99539739	LOC441454	chr9:99671357-99672736:+	0.42	4.05	5.88E-5	Height	
THCA	cis	1	rs3781001	chr10:127706028	DHX32	chr10:127524909-127585027:-	-0.26	-5.68	2.32E-8	Visceral fat	
THCA	cis	1	rs3781001	chr10:127706028	UROS	chr10:127477148-127511837:-	-0.31	-7.63	1.3E-13	Visceral fat	
THCA	cis	1	rs3781264	chr10:96070375	TBC1D12	chr10:96162186-96296089:+	-0.17	-3.79	0.00017	Esophageal cancer and gastric cancer	
THCA	cis	1	rs3781266	chr10:96052747	TMEM20	chr10:95653730-95713998:+	-0.17	-3.4	0.000736	Sudden cardiac arrest	
THCA	cis	1	rs3782089	chr11:65336819	NEAT1	chr11:65190245-65207625:+	0.22	3.75	0.000196	Height	
THCA	cis	1	rs3782130	chr12:58161898	FAM119B	chr12:58166383-58176323:+	0.39	10.58	1.16E-23	Multiple sclerosis	
THCA	cis	1	rs3782130	chr12:58161898	METTL1	chr12:58162352-58165914:-	-0.18	-4.48	9.29E-6	Multiple sclerosis	
THCA	cis	1	rs3782130	chr12:58161898	TSFM	chr12:58176536-58191367:+	-0.57	-19.27	1.2E-61	Multiple sclerosis	
THCA	cis	1	rs3782130	chr12:58161898	XRCC6BP1	chr12:58335445-58351051:+	-0.22	-4.46	1.02E-5	Multiple sclerosis	
THCA	cis	1	rs378259	chr6:5073836	LYRM4	chr6:5108654-5261168:-	0.15	3.47	0.000571	Venous thromboembolism (SNP x SNP interaction)	
THCA	cis	1	rs3782894	chr12:110026024	KCTD10	chr12:109886460-109915155:-	-0.23	-6.06	2.74E-9	HDL cholesterol	
THCA	cis	1	rs3782963	chr13:95863446	ABCC4	chr13:95672084-95953687:-	-0.19	-3.73	0.000212	Breast cancer	
THCA	cis	1	rs3782965	chr13:95863505	ABCC4	chr13:95672084-95953687:-	-0.19	-3.73	0.000212	Breast cancer	
THCA	cis	1	rs3782966	chr13:95863659	ABCC4	chr13:95672084-95953687:-	-0.19	-3.73	0.000212	Breast cancer	
THCA	cis	1	rs3782968	chr13:95863771	ABCC4	chr13:95672084-95953687:-	-0.19	-3.73	0.000212	Breast cancer	
THCA	cis	1	rs3783404	chr14:104118498	KLC1	chr14:104029299-104167887:+	-0.22	-4.55	6.7E-6	Body mass index	
THCA	cis	1	rs3783637	chr14:55348118	GCH1	chr14:55308724-55369542:-	-0.23	-4.61	5.16E-6	Rheumatoid arthritis;Obesity-related traits	
THCA	cis	1	rs3783638	chr14:55348373	GCH1	chr14:55308724-55369542:-	0.21	4.51	8.03E-6	Rheumatoid arthritis;Obesity-related traits	
THCA	cis	1	rs37837	chr16:3508616	NAT15	chr16:3493668-3536962:+	-0.23	-4.02	6.64E-5	Tuberculosis	
THCA	cis	1	rs37837	chr16:3508616	TRAP1	chr16:3708039-3767598:-	0.14	3.45	0.000605	Tuberculosis	
THCA	cis	1	rs37839	chr16:3510310	NAT15	chr16:3493668-3536962:+	-0.24	-4.25	2.6E-5	Tuberculosis	
THCA	cis	1	rs37839	chr16:3510310	TRAP1	chr16:3708039-3767598:-	0.14	3.42	0.00068	Tuberculosis	
THCA	cis	1	rs3784540	chr15:79219332	CHRNA5	chr15:78857906-78886458:+	0.29	3.38	0.000796	Bipolar disorder	
THCA	cis	1	rs378456	chr2:119346	SH3YL1	chr2:218138-264810:-	-0.26	-4.3	2.07E-5	Suicide attempts in bipolar disorder	
THCA	cis	1	rs3786835	chr19:39155880	LGALS7	chr19:39261608-39264157:-	-0.22	-4.42	1.21E-5	Heart rate	
THCA	cis	1	rs3786839	chr19:39182565	LGALS7	chr19:39261608-39264157:-	-0.22	-4.41	1.26E-5	Heart rate	
THCA	cis	1	rs3786845	chr19:39195083	LGALS7	chr19:39261608-39264157:-	-0.22	-4.66	4.17E-6	Heart rate	
THCA	cis	1	rs3786848	chr19:39207329	LGALS7	chr19:39261608-39264157:-	-0.22	-4.69	3.58E-6	Heart rate	
THCA	cis	1	rs3786851	chr19:39215333	LGALS7	chr19:39261608-39264157:-	-0.23	-4.75	2.67E-6	Heart rate	
THCA	cis	1	rs3786933	chr19:33602881	GPATCH1	chr19:33571786-33621318:+	0.36	8.74	3.94E-17	Bone properties (heel)	
THCA	cis	1	rs3787395	chr20:55078573	C20orf43	chr20:55043647-55093942:+	-0.28	-7.51	3.01E-13	Refractive astigmatism	
THCA	cis	1	rs3787395	chr20:55078573	CSTF1	chr20:54967427-54979582:+	-0.17	-3.47	0.000578	Refractive astigmatism	
THCA	cis	1	rs3788042	chr21:44442388	PKNOX1	chr21:44394643-44453688:+	0.35	4.67	3.89E-6	Information processing speed	
THCA	cis	1	rs3788544	chr22:39064966	JOSD1	chr22:39081549-39096459:-	-0.15	-4.04	6.14E-5	Resting heart rate	
THCA	cis	1	rs3788544	chr22:39064966	TOMM22	chr22:39077954-39080763:+	-0.18	-3.81	0.000156	Resting heart rate	
THCA	cis	1	rs3788545	chr22:39065172	JOSD1	chr22:39081549-39096459:-	-0.15	-4.04	6.1E-5	Resting heart rate	
THCA	cis	1	rs3788545	chr22:39065172	LOC646851	chr22:38974125-39052634:-	0.13	3.38	0.000786	Resting heart rate	
THCA	cis	1	rs3788545	chr22:39065172	TOMM22	chr22:39077954-39080763:+	-0.17	-3.6	0.000346	Resting heart rate	
THCA	cis	1	rs3789362	chr1:180951692	MR1	chr1:181003139-181024633:+	-0.13	-3.58	0.000381	Progressive supranuclear palsy	
THCA	cis	1	rs3789362	chr1:180951692	STX6	chr1:180913175-180992046:-	-0.19	-3.9	0.000108	Progressive supranuclear palsy	
THCA	cis	1	rs3789364	chr1:180951043	MR1	chr1:181003139-181024633:+	-0.13	-3.47	0.000576	Progressive supranuclear palsy	
THCA	cis	1	rs3789364	chr1:180951043	STX6	chr1:180913175-180992046:-	-0.2	-4.07	5.53E-5	Progressive supranuclear palsy	
THCA	cis	1	rs3789967	chr12:124447339	DNAH10	chr12:124247042-124420265:+	0.18	3.84	0.000137	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs3789967	chr12:124447339	ZNF664	chr12:124457670-124499967:+	-0.17	-4.91	1.23E-6	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs3790012	chr13:36773489	SOHLH2	chr13:36742347-36871992:-	0.36	6.24	9.54E-10	Glucose homeostasis traits	
THCA	cis	1	rs3790767	chr1:19698546	CAPZB	chr1:19665274-19811992:-	0.14	3.79	0.000168	Crohn's disease and psoriasis	
THCA	cis	1	rs3791185	chr1:107600869	NTNG1	chr1:107682629-108024471:+	0.2	3.36	0.000849	AIDS	
THCA	cis	1	rs3791220	chr2:227066	SH3YL1	chr2:218138-264810:-	-0.93	-25.82	1.07E-92	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs3791221	chr2:226933	SH3YL1	chr2:218138-264810:-	-0.93	-25.85	7.88E-93	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs3791223	chr2:222336	SH3YL1	chr2:218138-264810:-	-0.93	-25.97	2.23E-93	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs3791224	chr2:221981	SH3YL1	chr2:218138-264810:-	-0.91	-25.21	7.59E-90	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs3792527	chr3:38493212	LOC100128640	chr3:38492524-38496311:-	0.23	4.89	1.35E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs3792527	chr3:38493212	SCN5A	chr3:38589554-38691164:-	0.17	3.49	0.000531	Electrocardiographic conduction measures	
THCA	cis	1	rs3792527	chr3:38493212	XYLB	chr3:38388251-38456467:+	0.21	5.02	7.16E-7	Electrocardiographic conduction measures	
THCA	cis	1	rs3792528	chr3:38493303	LOC100128640	chr3:38492524-38496311:-	0.23	4.89	1.36E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs3792528	chr3:38493303	XYLB	chr3:38388251-38456467:+	0.19	4.63	4.8E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs3792574	chr7:134254029	AKR1B1	chr7:134127107-134143888:-	0.2	4.36	1.63E-5	Longevity	
THCA	cis	1	rs3792933	chr6:158290680	SNX9	chr6:158244294-158366109:+	-0.24	-3.7	0.000237	Lipoprotein (a) - cholesterol levels	
THCA	cis	1	rs3792934	chr6:158290725	SNX9	chr6:158244294-158366109:+	-0.24	-3.7	0.000237	Lipoprotein (a) - cholesterol levels	
THCA	cis	1	rs3793079	chr6:33767788	LEMD2	chr6:33738991-33756906:-	-0.3	-7.04	6.72E-12	Crohn's disease	
THCA	cis	1	rs3793080	chr6:33767803	IP6K3	chr6:33689443-33714762:-	-0.36	-6.14	1.75E-9	Obesity (extreme)	
THCA	cis	1	rs3793427	chr8:17143830	MTMR7	chr8:17154308-17271040:-	-0.18	-3.73	0.000215	Tonometry	
THCA	cis	1	rs3793427	chr8:17143830	VPS37A	chr8:17104401-17155532:+	-0.22	-5.33	1.49E-7	Tonometry	
THCA	cis	1	rs3793706	chr10:102269085	SEC31B	chr10:102246403-102289636:-	0.27	8.81	2.39E-17	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs3793771	chr10:102222957	SEC31B	chr10:102246403-102289636:-	-0.3	-10.22	2.53E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs3793772	chr10:102222825	SEC31B	chr10:102246403-102289636:-	-0.3	-10.24	2.25E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs3793938	chr11:71823133	FAM86C	chr11:71498557-71512276:+	-0.32	-3.91	0.000107	Severe influenza A (H1N1) infection	
THCA	cis	1	rs3794695	chr16:72097827	DHODH	chr16:72042643-72058954:+	0.22	4.53	7.59E-6	Haptoglobin levels;Cholesterol, total;LDL cholesterol	
THCA	cis	1	rs3794695	chr16:72097827	TXNL4B	chr16:72072001-72128215:-	0.21	3.45	0.000606	Haptoglobin levels;Cholesterol, total;LDL cholesterol	
THCA	cis	1	rs3794742	chr17:76165548	SYNGR2	chr17:76164671-76169009:+	-0.12	-3.91	0.000104	Adenocarcinoma;Lung cancer	
THCA	cis	1	rs3795432	chr1:31829873	SNRNP40	chr1:31732417-31769644:-	0.18	3.39	0.000766	Schizophrenia	
THCA	cis	1	rs3795432	chr1:31829873	ZCCHC17	chr1:31769842-31837780:+	0.32	6.32	5.83E-10	Schizophrenia	
THCA	cis	1	rs3795819	chr1:113234179	MOV10	chr1:113217048-113243367:+	-0.19	-4.62	4.87E-6	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs3795819	chr1:113234179	ST7L	chr1:113066142-113162405:-	-0.66	-10.7	4.43E-24	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs3796352	chr3:52913279	RFT1	chr3:53122503-53164470:-	0.61	6.95	1.18E-11	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs3796352	chr3:52913279	TMEM110	chr3:52867139-52931547:-	0.41	4.71	3.28E-6	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs3796509	chr4:39110186	KLHL5	chr4:39046659-39123828:+	-0.21	-5.77	1.46E-8	Uric acid levels	
THCA	cis	1	rs3796511	chr4:39122206	KLHL5	chr4:39046659-39123828:+	-0.21	-5.77	1.47E-8	Uric acid levels	
THCA	cis	1	rs3796689	chr4:185649866	CCDC111	chr4:185570767-185616112:+	0.28	6.37	4.58E-10	Kawasaki disease	
THCA	cis	1	rs3796689	chr4:185649866	MLF1IP	chr4:185615220-185655286:-	-0.43	-9.49	1.12E-19	Kawasaki disease	
THCA	cis	1	rs3798390	chr6:117726553	DCBLD1	chr6:117803820-117891018:+	0.46	10.17	3.85E-22	Lung cancer	
THCA	cis	1	rs3798390	chr6:117726553	GOPC	chr6:117639351-117923681:-	0.23	6.66	7.78E-11	Lung cancer	
THCA	cis	1	rs3798393	chr6:117731968	DCBLD1	chr6:117803820-117891018:+	0.46	10.18	3.63E-22	Lung cancer	
THCA	cis	1	rs3798393	chr6:117731968	GOPC	chr6:117639351-117923681:-	0.22	6.5	2.05E-10	Lung cancer	
THCA	cis	1	rs3798394	chr6:117732362	DCBLD1	chr6:117803820-117891018:+	0.46	10.19	3.46E-22	Lung cancer	
THCA	cis	1	rs3798394	chr6:117732362	GOPC	chr6:117639351-117923681:-	0.22	6.51	1.9E-10	Lung cancer	
THCA	cis	1	rs3798696	chr6:10403650	ELOVL2	chr6:10980995-11044624:-	0.21	3.36	0.000847	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs3799105	chr6:70404281	LMBRD1	chr6:70385751-70506888:-	-0.09	-3.35	0.000882	Sleep duration	
THCA	cis	1	rs3799106	chr6:70404764	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.37	0.000823	Sleep duration	
THCA	cis	1	rs3799119	chr6:70493869	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.37	0.000826	Sleep duration	
THCA	cis	1	rs3799120	chr6:70496712	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.41	0.000704	Sleep duration	
THCA	cis	1	rs3799277	chr6:46657057	CYP39A1	chr6:46517445-46620523:-	-0.32	-4.93	1.14E-6	Lipoprotein-associated phospholipase A2 activity and mass	
THCA	cis	1	rs3800316	chr6:27256102	BTN3A2	chr6:26365398-26378546:+	-0.27	-6.57	1.35E-10	Schizophrenia	
THCA	cis	1	rs3800457	chr6:34663598	C6orf106	chr6:34555066-34664625:-	-0.26	-4.09	5.14E-5	Pubertal anthropometrics	
THCA	cis	1	rs3800457	chr6:34663598	SNRPC	chr6:34725312-34741571:+	0.15	3.41	0.000709	Pubertal anthropometrics	
THCA	cis	1	rs3800812	chr7:66223461	GUSB	chr7:65425675-65447246:-	0.34	6.84	2.43E-11	Aortic root size	
THCA	cis	1	rs3800812	chr7:66223461	RABGEF1	chr7:66093890-66276446:+	0.52	10.69	4.74E-24	Aortic root size	
THCA	cis	1	rs3800812	chr7:66223461	TYW1	chr7:66461817-66704496:+	0.18	3.89	0.000116	Aortic root size	
THCA	cis	1	rs3802315	chr8:41528178	ANK1	chr8:41510745-41754280:-	-0.23	-4.68	3.78E-6	Type 2 diabetes	
THCA	cis	1	rs3802316	chr8:41528228	ANK1	chr8:41510745-41754280:-	-0.22	-4.59	5.61E-6	Type 2 diabetes	
THCA	cis	1	rs3802840	chr11:111171646	C11orf92	chr11:111164171-111175770:-	0.18	3.88	0.000117	Colorectal cancer	
THCA	cis	1	rs3802841	chr11:111171672	C11orf92	chr11:111164171-111175770:-	-0.18	-3.88	0.000117	Colorectal cancer	
THCA	cis	1	rs3802842	chr11:111171709	C11orf92	chr11:111164171-111175770:-	-0.18	-3.88	0.000117	Colorectal cancer	
THCA	cis	1	rs3802888	chr11:46515902	PACSIN3	chr11:47199085-47207958:-	0.16	3.55	0.000421	Schizophrenia	
THCA	cis	1	rs3802924	chr11:133827733	IGSF9B	chr11:133785186-133826880:-	0.24	4.88	1.48E-6	Schizophrenia	
THCA	cis	1	rs3802924	chr11:133827733	LOC283174	chr11:133766330-133771635:-	0.21	3.73	0.000214	Schizophrenia	
THCA	cis	1	rs3802999	chr12:124414098	ZNF664	chr12:124457670-124499967:+	-0.17	-4.81	2.07E-6	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs3803405	chr15:85383640	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.21	3.11E-5	Schizophrenia	
THCA	cis	1	rs3803405	chr15:85383640	LOC388152	chr15:84867600-84898920:-	-0.46	-7.59	1.66E-13	Schizophrenia	
THCA	cis	1	rs3803405	chr15:85383640	NMB	chr15:85198362-85201802:-	0.36	7.55	2.15E-13	Schizophrenia	
THCA	cis	1	rs3803459	chr15:56387859	MNS1	chr15:56720929-56757335:-	-0.25	-3.68	0.000255	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs3803459	chr15:56387859	TEX9	chr15:56657644-56738071:+	-0.36	-6.28	7.84E-10	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs3803538	chr15:90891771	IQGAP1	chr15:90931473-91045475:+	0.12	4.2	3.22E-5	Rheumatoid arthritis	
THCA	cis	1	rs3803538	chr15:90891771	TTLL13	chr15:90792764-90815443:+	0.2	3.78	0.000176	Rheumatoid arthritis	
THCA	cis	1	rs3803539	chr15:90891982	IQGAP1	chr15:90931473-91045475:+	0.15	4.72	3.05E-6	Rheumatoid arthritis	
THCA	cis	1	rs3803539	chr15:90891982	TTLL13	chr15:90792764-90815443:+	0.28	4.71	3.25E-6	Rheumatoid arthritis	
THCA	cis	1	rs3803575	chr16:15138447	NTAN1	chr16:15131717-15149833:-	0.13	3.83	0.000147	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs3803575	chr16:15138447	PDXDC1	chr16:15068599-15233195:+	0.32	7.6	1.62E-13	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs3804105	chr6:25612683	SCGN	chr6:25652429-25702006:+	-0.31	-5.98	4.44E-9	Uric acid levels	
THCA	cis	1	rs3804106	chr6:25608374	SCGN	chr6:25652429-25702006:+	-0.3	-5.78	1.36E-8	Uric acid levels	
THCA	cis	1	rs3804108	chr6:25608215	SCGN	chr6:25652429-25702006:+	-0.3	-5.78	1.36E-8	Uric acid levels	
THCA	cis	1	rs3804109	chr6:25608009	SCGN	chr6:25652429-25702006:+	-0.3	-5.78	1.36E-8	Uric acid levels	
THCA	cis	1	rs3804118	chr6:25592651	SCGN	chr6:25652429-25702006:+	-0.29	-5.69	2.21E-8	Uric acid levels	
THCA	cis	1	rs3804508	chr6:52289961	EFHC1	chr6:52284994-52387892:+	0.14	4.37	1.55E-5	Atopic march	
THCA	cis	1	rs3805152	chr4:56359658	TMEM165	chr4:56262090-56292342:+	-0.14	-3.54	0.000445	Personality dimensions	
THCA	cis	1	rs3805154	chr4:56363927	TMEM165	chr4:56262090-56292342:+	-0.15	-3.71	0.000229	Personality dimensions	
THCA	cis	1	rs3805157	chr4:56364103	TMEM165	chr4:56262090-56292342:+	-0.16	-4.1	4.79E-5	Personality dimensions	
THCA	cis	1	rs3805383	chr4:56475338	KDR	chr4:55944427-55991762:-	-0.11	-3.48	0.000542	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs3805383	chr4:56475338	NMU	chr4:56461405-56502465:-	0.2	3.6	0.000354	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs3805383	chr4:56475338	PDCL2	chr4:56422693-56458379:-	0.31	4.83	1.88E-6	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs3805389	chr4:56482750	KDR	chr4:55944427-55991762:-	-0.1	-3.35	0.000886	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs3805389	chr4:56482750	NMU	chr4:56461405-56502465:-	0.2	3.52	0.000474	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs3805389	chr4:56482750	PDCL2	chr4:56422693-56458379:-	0.31	4.74	2.82E-6	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs3805765	chr6:158284372	SNX9	chr6:158244294-158366109:+	-0.25	-3.89	0.000114	Lipoprotein (a) - cholesterol levels	
THCA	cis	1	rs3805766	chr6:158289799	SNX9	chr6:158244294-158366109:+	-0.23	-3.58	0.000375	Lipoprotein (a) - cholesterol levels	
THCA	cis	1	rs3806107	chr6:33767413	IP6K3	chr6:33689443-33714762:-	0.37	6.46	2.57E-10	Obesity (extreme)	
THCA	cis	1	rs3806108	chr6:33767579	LEMD2	chr6:33738991-33756906:-	-0.3	-7.04	6.62E-12	Crohn's disease	
THCA	cis	1	rs3806407	chr1:156251742	BGLAP	chr1:156182784-156213112:+	0.23	5.47	7.46E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs3806407	chr1:156251742	C1orf85	chr1:156259882-156265449:-	-0.17	-4.03	6.45E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs3806407	chr1:156251742	CCT3	chr1:156278752-156308195:-	-0.32	-6.99	9.47E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs3806408	chr1:156252137	BGLAP	chr1:156182784-156213112:+	0.23	5.32	1.63E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs3806408	chr1:156252137	C1orf85	chr1:156259882-156265449:-	-0.17	-3.99	7.72E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs3806408	chr1:156252137	CCT3	chr1:156278752-156308195:-	-0.32	-6.95	1.24E-11	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs3806409	chr1:156252291	BGLAP	chr1:156182784-156213112:+	0.23	5.32	1.63E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs3806409	chr1:156252291	C1orf85	chr1:156259882-156265449:-	-0.17	-3.99	7.72E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs3806409	chr1:156252291	CCT3	chr1:156278752-156308195:-	-0.32	-6.95	1.24E-11	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs3806417	chr1:156711623	C1orf66	chr1:156698263-156706751:+	0.13	3.41	0.000706	HDL cholesterol	
THCA	cis	1	rs3806636	chr3:151036514	GPR87	chr3:151011876-151034636:-	0.21	4.64	4.5E-6	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs3806636	chr3:151036514	P2RY14	chr3:150929905-150996230:-	-0.2	-4.31	2.02E-5	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs3806692	chr3:53080987	RFT1	chr3:53122503-53164470:-	0.6	7.69	8.41E-14	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs3806988	chr6:49431569	CENPQ	chr6:49431096-49460820:+	-0.26	-5.35	1.38E-7	Folate pathway vitamin levels	
THCA	cis	1	rs3806988	chr6:49431569	MUT	chr6:49398994-49431031:-	0.29	9.97	2.14E-21	Folate pathway vitamin levels	
THCA	cis	1	rs3808581	chr8:26250047	PPP2R2A	chr8:25230075-26228645:+	0.19	3.61	0.000339	Schizophrenia	
THCA	cis	1	rs3808894	chr9:100686129	C9orf156	chr9:100666772-100684852:-	-0.14	-3.64	0.000306	Quantitative traits	
THCA	cis	1	rs3809868	chr17:45750596	TBKBP1	chr17:45772630-45789427:+	0.39	10.83	1.38E-24	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
THCA	cis	1	rs3810174	chr19:41904165	B3GNT8	chr19:41931265-41934635:-	-0.34	-8	9.34E-15	Height	
THCA	cis	1	rs3810174	chr19:41904165	EXOSC5	chr19:41892278-41903256:-	-0.1	-3.45	0.000599	Height	
THCA	cis	1	rs3810175	chr19:41904396	B3GNT8	chr19:41931265-41934635:-	0.34	7.99	9.89E-15	Height	
THCA	cis	1	rs3810175	chr19:41904396	EXOSC5	chr19:41892278-41903256:-	0.11	3.56	0.000407	Height	
THCA	cis	1	rs3810429	chr19:18543270	ELL	chr19:18553475-18632937:-	-0.25	-6.26	8.35E-10	Breast cancer	
THCA	cis	1	rs3810429	chr19:18543270	ISYNA1	chr19:18545625-18548943:-	0.12	4.57	6.35E-6	Breast cancer	
THCA	cis	1	rs3810429	chr19:18543270	LRRC25	chr19:18501955-18508421:-	-0.14	-4.63	4.71E-6	Breast cancer	
THCA	cis	1	rs3810827	chr2:86334386	POLR1A	chr2:86253453-86333278:-	-0.32	-4.29	2.19E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs3811782	chr4:54243905	SCFD2	chr4:53739152-54232242:-	0.2	3.76	0.000189	DNA methylation (variation)	
THCA	cis	1	rs381262	chr20:47933479	CSE1L	chr20:47662838-47713484:+	-0.19	-3.67	0.000268	Height	
THCA	cis	1	rs381262	chr20:47933479	DDX27	chr20:47835832-47860612:+	0.22	4.31	1.96E-5	Height	
THCA	cis	1	rs3812638	chr10:75896072	VCL	chr10:75754951-75879912:+	-0.22	-3.67	0.000273	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs3812762	chr11:8751640	TRIM66	chr11:8633586-8693413:-	-0.27	-6.77	3.77E-11	Hypospadias	
THCA	cis	1	rs3813227	chr2:73651967	ALMS1P	chr2:73872046-73912692:+	-0.67	-10.59	1.13E-23	Metabolite levels	
THCA	cis	1	rs3813227	chr2:73651967	NAT8	chr2:73867850-73869537:-	-0.35	-5.48	7.04E-8	Metabolite levels	
THCA	cis	1	rs3813227	chr2:73651967	TPRKB	chr2:73956957-73964517:-	0.17	4.24	2.64E-5	Metabolite levels	
THCA	cis	1	rs3813347	chr6:133119778	C6orf192	chr6:133090507-133119747:-	-0.24	-3.92	0.000102	Type 2 diabetes nephropathy	
THCA	cis	1	rs3814184	chr10:69966251	PBLD	chr10:70042417-70092684:-	0.26	3.63	0.000311	Optic nerve measurement (disc area)	
THCA	cis	1	rs3814492	chr9:131873222	CRAT	chr9:131857075-131873070:-	0.27	6.57	1.31E-10	Blood metabolite ratios	
THCA	cis	1	rs3814721	chr11:71709272	FAM86C	chr11:71498557-71512276:+	0.29	3.61	0.000336	Severe influenza A (H1N1) infection	
THCA	cis	1	rs3814855	chr14:88933360	SPATA7	chr14:88852012-88904802:+	-0.2	-4.16	3.83E-5	Coronary artery calcification	
THCA	cis	1	rs3815413	chr4:17654648	MED28	chr4:17616273-17629791:+	0.17	3.73	0.000215	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs3816037	chr19:41918009	B3GNT8	chr19:41931265-41934635:-	-0.36	-8.42	4.48E-16	Height	
THCA	cis	1	rs3816063	chr8:142161064	DENND3	chr8:142138720-142205906:+	0.23	4.83	1.86E-6	Obesity-related traits	
THCA	cis	1	rs3816491	chr2:70048534	SNRNP27	chr2:70121090-70132348:+	-0.15	-3.61	0.000337	Colorectal or endometrial cancer	
THCA	cis	1	rs3816587	chr4:25417244	ZCCHC4	chr4:25314396-25372003:+	-0.17	-3.84	0.000139	Rheumatoid arthritis	
THCA	cis	1	rs3816899	chr15:40314526	SRP14	chr15:40327891-40331389:-	-0.21	-4.07	5.44E-5	Response to haloperidol in psychosis	
THCA	cis	1	rs3817181	chr17:61776538	FTSJ3	chr17:61896795-61905031:-	0.31	5.69	2.17E-8	Body mass index	
THCA	cis	1	rs3817181	chr17:61776538	MAP3K3	chr17:61699775-61773669:+	0.27	5.32	1.6E-7	Body mass index	
THCA	cis	1	rs3818187	chr14:52509788	C14orf166	chr14:52456228-52471419:+	0.13	3.7	0.000241	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs3818187	chr14:52509788	NID2	chr14:52471521-52535946:-	0.19	3.85	0.000136	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs3818233	chr6:101086372	ASCC3	chr6:100956609-101329224:-	-0.11	-4.43	1.17E-5	Menarche (age at onset)	
THCA	cis	1	rs3818233	chr6:101086372	GRIK2	chr6:101846905-102517957:+	-0.14	-3.34	0.000906	Menarche (age at onset)	
THCA	cis	1	rs3818262	chr20:47741556	ARFGEF2	chr20:47538275-47653229:+	-0.12	-3.82	0.000154	Anger	
THCA	cis	1	rs3818262	chr20:47741556	CSE1L	chr20:47662838-47713484:+	0.4	10.1	7.32E-22	Anger	
THCA	cis	1	rs3818655	chr21:46901150	SUMO3	chr21:46225532-46238044:-	-0.37	-3.72	0.000221	Alzheimer disease and age of onset	
THCA	cis	1	rs3820443	chr1:111892905	CHIA	chr1:111833484-111863184:+	-0.27	-4.16	3.82E-5	Late-onset Alzheimer's disease	
THCA	cis	1	rs3820927	chr2:227779191	COL4A4	chr2:227867435-228029275:-	0.16	4.01	6.91E-5	Pulmonary function	
THCA	cis	1	rs3820928	chr2:227773466	COL4A4	chr2:227867435-228029275:-	0.16	3.88	0.000117	Pulmonary function	
THCA	cis	1	rs3821383	chr3:169489946	LRRC34	chr3:169511266-169530720:-	-0.23	-4.43	1.19E-5	Multiple myeloma and monoclonal gammopathy;Interstitial lung disease	
THCA	cis	1	rs3822086	chr4:90664794	MMRN1	chr4:90816003-90875778:+	0.3	3.83	0.000143	Parkinson's disease	
THCA	cis	1	rs3822651	chr5:109765661	TMEM232	chr5:109624934-110062381:-	0.39	4.28	2.26E-5	Cardiac structure and function	
THCA	cis	1	rs3823111	chr6:53517035	KLHL31	chr6:53512700-53530506:-	-0.27	-3.34	0.000896	Obesity-related traits	
THCA	cis	1	rs3823114	chr6:49431720	CENPQ	chr6:49431096-49460820:+	-0.26	-5.53	5.2E-8	Folate pathway vitamin levels	
THCA	cis	1	rs3823114	chr6:49431720	MUT	chr6:49398994-49431031:-	0.29	9.93	3.01E-21	Folate pathway vitamin levels	
THCA	cis	1	rs3824430	chr9:4847168	RCL1	chr9:4792834-4885917:+	-0.19	-3.43	0.000654	Red blood cell traits;Mean corpuscular hemoglobin;Mean corpuscular volume	
THCA	cis	1	rs3824451	chr9:101071522	TBC1D2	chr9:100961281-101018003:-	0.18	4.63	4.73E-6	Schizophrenia	
THCA	cis	1	rs3824482	chr9:99539449	FAM22G	chr9:99690592-99704572:+	0.94	8.56	1.54E-16	Height	
THCA	cis	1	rs3824482	chr9:99539449	HIATL2	chr9:99695549-99775862:-	0.69	6.25	9.03E-10	Height	
THCA	cis	1	rs3824482	chr9:99539449	LOC441454	chr9:99671357-99672736:+	0.42	4.05	5.88E-5	Height	
THCA	cis	1	rs3824496	chr9:100684645	C9orf156	chr9:100666772-100684852:-	-0.14	-3.64	0.000306	Quantitative traits	
THCA	cis	1	rs3824584	chr10:38091309	LOC399744	chr10:38717074-38741080:+	0.28	3.72	0.000225	Obesity (extreme)	
THCA	cis	1	rs3824585	chr10:38109421	LOC399744	chr10:38717074-38741080:+	0.32	4.37	1.54E-5	Obesity (extreme)	
THCA	cis	1	rs3824585	chr10:38109421	ZNF25	chr10:38238795-38265453:-	0.17	3.6	0.000353	Obesity (extreme)	
THCA	cis	1	rs3824754	chr10:104614350	C10orf26	chr10:104503727-104591851:+	-0.27	-4.56	6.52E-6	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs3824754	chr10:104614350	INA	chr10:105036920-105050106:+	-0.26	-3.36	0.000843	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs3824754	chr10:104614350	SFXN2	chr10:104474298-104498946:+	-0.38	-4.47	9.98E-6	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs3824755	chr10:104595849	AS3MT	chr10:104613967-104661653:+	-0.27	-3.88	0.000119	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs3824755	chr10:104595849	C10orf26	chr10:104503727-104591851:+	-0.23	-4.22	2.92E-5	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs3824755	chr10:104595849	INA	chr10:105036920-105050106:+	-0.25	-3.54	0.000445	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs3824755	chr10:104595849	SFXN2	chr10:104474298-104498946:+	-0.34	-4.2	3.23E-5	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs3825079	chr12:58203354	FAM119B	chr12:58166383-58176323:+	0.4	10.94	5.31E-25	Multiple sclerosis	
THCA	cis	1	rs3825079	chr12:58203354	METTL1	chr12:58162352-58165914:-	-0.19	-4.49	8.79E-6	Multiple sclerosis	
THCA	cis	1	rs3825079	chr12:58203354	TSFM	chr12:58176536-58191367:+	-0.59	-20.41	4.53E-67	Multiple sclerosis	
THCA	cis	1	rs3825079	chr12:58203354	XRCC6BP1	chr12:58335445-58351051:+	-0.23	-4.75	2.75E-6	Multiple sclerosis	
THCA	cis	1	rs3825180	chr12:129279242	GLT1D1	chr12:129338081-129469509:+	0.21	5.36	1.33E-7	Systemic lupus erythematosus	
THCA	cis	1	rs3825180	chr12:129279242	SLC15A4	chr12:129277739-129308541:-	0.19	4.63	4.78E-6	Systemic lupus erythematosus	
THCA	cis	1	rs3825611	chr14:55348837	GCH1	chr14:55308724-55369542:-	-0.22	-4.55	6.68E-6	Rheumatoid arthritis;Obesity-related traits	
THCA	cis	1	rs3825613	chr14:55593172	KIAA0831	chr14:55833110-55878576:-	-0.12	-3.47	0.000574	Protein biomarker	
THCA	cis	1	rs3825931	chr15:79219372	CHRNA5	chr15:78857906-78886458:+	0.29	3.38	0.000796	Bipolar disorder	
THCA	cis	1	rs3826061	chr16:88927221	GALNS	chr16:88880143-88923374:-	-0.27	-4.99	8.28E-7	Parkinson disease and lewy body pathology	
THCA	cis	1	rs3826061	chr16:88927221	TRAPPC2L	chr16:88922628-88927591:+	-0.31	-11.55	2.14E-27	Parkinson disease and lewy body pathology	
THCA	cis	1	rs3826331	chr17:38150492	GSDMA	chr17:38119226-38134019:+	0.3	6.93	1.39E-11	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THCA	cis	1	rs3826331	chr17:38150492	ORMDL3	chr17:38077296-38083854:-	-0.14	-3.35	0.000876	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THCA	cis	1	rs3826	chr3:10141065	C3orf10	chr3:10157333-10168873:+	-0.2	-4.29	2.2E-5	Alzheimer's disease	
THCA	cis	1	rs3826	chr3:10141065	VHL	chr3:10183319-10193744:+	-0.18	-4.19	3.32E-5	Alzheimer's disease	
THCA	cis	1	rs3827066	chr20:44586023	KCNS1	chr20:43720951-43729753:-	-0.3	-4.41	1.26E-5	Abdominal aortic aneurysm	
THCA	cis	1	rs3827066	chr20:44586023	WFDC3	chr20:44402847-44420547:-	-0.43	-5.84	9.46E-9	Abdominal aortic aneurysm	
THCA	cis	1	rs3827107	chr20:55070539	C20orf43	chr20:55043647-55093942:+	0.28	7.58	1.84E-13	Refractive astigmatism	
THCA	cis	1	rs3827107	chr20:55070539	CSTF1	chr20:54967427-54979582:+	0.17	3.49	0.000525	Refractive astigmatism	
THCA	cis	1	rs3827316	chr22:23468538	GNAZ	chr22:23412669-23467221:+	-0.27	-5.75	1.58E-8	Bone mineral density	
THCA	cis	1	rs3827357	chr22:39079413	JOSD1	chr22:39081549-39096459:-	-0.14	-3.77	0.000186	Resting heart rate	
THCA	cis	1	rs3827357	chr22:39079413	LOC646851	chr22:38974125-39052634:-	0.13	3.45	0.000604	Resting heart rate	
THCA	cis	1	rs3827357	chr22:39079413	TOMM22	chr22:39077954-39080763:+	-0.16	-3.39	0.000759	Resting heart rate	
THCA	cis	1	rs3827500	chr6:25607908	SCGN	chr6:25652429-25702006:+	-0.3	-5.78	1.36E-8	Uric acid levels	
THCA	cis	1	rs3827959	chr20:21179145	PLK1S1	chr20:21106624-21227256:+	0.21	5.35	1.36E-7	Height	
THCA	cis	1	rs3828165	chr2:220889	SH3YL1	chr2:218138-264810:-	-0.93	-25.61	1.09E-91	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs3828267	chr2:190531615	ASNSD1	chr2:190526125-190535556:+	-0.74	-8.15	3.3E-15	Subcutaneous adipose tissue	
THCA	cis	1	rs3828267	chr2:190531615	ORMDL1	chr2:190634994-190649097:-	0.22	3.45	0.000617	Subcutaneous adipose tissue	
THCA	cis	1	rs3828496	chr4:48388292	OCIAD1	chr4:48833015-48863831:+	0.14	4.31	2.0E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs3829251	chr11:71194559	NADSYN1	chr11:71164217-71212579:+	0.2	4.54	7.15E-6	Vitamin D levels	
THCA	cis	1	rs383402	chr7:65586653	CCT6P1	chr7:65216092-65228661:+	-0.41	-6.73	4.74E-11	Diabetic kidney disease	
THCA	cis	1	rs383402	chr7:65586653	CRCP	chr7:65579805-65619551:+	0.29	4.5	8.51E-6	Diabetic kidney disease	
THCA	cis	1	rs383402	chr7:65586653	LOC493754	chr7:65993446-66057363:-	-0.3	-3.54	0.000438	Diabetic kidney disease	
THCA	cis	1	rs383402	chr7:65586653	RABGEF1	chr7:66093890-66276446:+	-0.54	-6.8	3.06E-11	Diabetic kidney disease	
THCA	cis	1	rs3843061	chr5:110160392	TMEM232	chr5:109624934-110062381:-	0.2	3.99	7.74E-5	Asthma and hay fever	
THCA	cis	1	rs3845800	chr2:203734365	ALS2CR8	chr2:203776978-203851060:+	0.25	5.09	5.21E-7	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs3845800	chr2:203734365	ICA1L	chr2:203637873-203736371:-	-0.22	-3.6	0.000352	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs3846055	chr3:134203973	ANAPC13	chr3:134196547-134204865:-	0.4	12.7	5.0E-32	Height	
THCA	cis	1	rs3846055	chr3:134203973	CEP63	chr3:134204575-134293852:+	0.29	6.27	8.19E-10	Height	
THCA	cis	1	rs3846056	chr3:134227292	ANAPC13	chr3:134196547-134204865:-	0.39	12.57	1.72E-31	Height	
THCA	cis	1	rs3846056	chr3:134227292	CEP63	chr3:134204575-134293852:+	0.29	6.4	3.83E-10	Height	
THCA	cis	1	rs3846177	chr3:10068572	C3orf10	chr3:10157333-10168873:+	-0.21	-4.35	1.7E-5	Alzheimer's disease	
THCA	cis	1	rs3846177	chr3:10068572	VHL	chr3:10183319-10193744:+	-0.19	-4.31	2.0E-5	Alzheimer's disease	
THCA	cis	1	rs3846926	chr6:56092186	COL21A1	chr6:55921389-56258892:-	0.77	16.44	1.78E-48	Pulse pressure	
THCA	cis	1	rs3847669	chr12:75949158	GLIPR1L2	chr12:75784889-75825591:+	-0.4	-6.52	1.8E-10	Polycystic ovary syndrome	
THCA	cis	1	rs3848129	chr15:50892064	SPPL2A	chr15:50999739-51057910:-	0.28	7.49	3.31E-13	QT interval	
THCA	cis	1	rs3848130	chr15:50892111	SPPL2A	chr15:50999739-51057910:-	0.28	7.45	4.5E-13	QT interval	
THCA	cis	1	rs3848130	chr15:50892111	TRPM7	chr15:50852491-50978994:-	0.11	3.49	0.000536	QT interval	
THCA	cis	1	rs3848562	chr19:52379835	ZNF577	chr19:52359056-52394145:-	0.24	5.9	7.04E-9	Breast cancer	
THCA	cis	1	rs3848562	chr19:52379835	ZNF649	chr19:52392489-52408247:-	0.2	4.27	2.33E-5	Breast cancer	
THCA	cis	1	rs3849524	chr3:161015589	NMD3	chr3:160939099-160971319:+	-0.12	-3.86	0.000131	Morning vs. evening chronotype	
THCA	cis	1	rs3850304	chr14:59895019	C14orf149	chr14:59939406-59951126:-	-0.43	-4.87	1.51E-6	Schizophrenia	
THCA	cis	1	rs3850304	chr14:59895019	JKAMP	chr14:59951161-59972080:+	0.45	5.11	4.56E-7	Schizophrenia	
THCA	cis	1	rs3851234	chr7:54176406	SEC61G	chr7:54819941-54826939:-	-0.2	-3.46	0.000596	Periodontal disease-related phenotypes	
THCA	cis	1	rs3851296	chr1:205253839	CNTN2	chr1:205012065-205047136:+	-0.17	-3.44	0.000642	Mean platelet volume	
THCA	cis	1	rs3853750	chr5:110154309	TMEM232	chr5:109624934-110062381:-	0.2	4.04	6.15E-5	Asthma and hay fever	
THCA	cis	1	rs3857051	chr4:90643697	MMRN1	chr4:90816003-90875778:+	0.32	4.06	5.69E-5	Parkinson's disease	
THCA	cis	1	rs3857052	chr4:90643857	MMRN1	chr4:90816003-90875778:+	0.26	3.58	0.000382	Parkinson's disease	
THCA	cis	1	rs3857053	chr4:90645674	MMRN1	chr4:90816003-90875778:+	0.3	3.82	0.000151	Parkinson's disease	
THCA	cis	1	rs3857061	chr4:90686742	MMRN1	chr4:90816003-90875778:+	0.29	3.75	0.000195	Parkinson's disease	
THCA	cis	1	rs3857422	chr5:150268609	LOC134466	chr5:150310000-150326146:-	0.38	5.28	2.01E-7	Crohn's disease	
THCA	cis	1	rs3857610	chr6:56012458	COL21A1	chr6:55921389-56258892:-	-0.71	-8.8	2.42E-17	Psychosis (atypical)	
THCA	cis	1	rs3857688	chr7:66127806	GUSB	chr7:65425675-65447246:-	-0.33	-6.8	3.22E-11	Aortic root size	
THCA	cis	1	rs3857688	chr7:66127806	RABGEF1	chr7:66093890-66276446:+	-0.51	-10.49	2.65E-23	Aortic root size	
THCA	cis	1	rs3857688	chr7:66127806	TYW1	chr7:66461817-66704496:+	-0.18	-3.93	9.79E-5	Aortic root size	
THCA	cis	1	rs3858534	chr12:75947084	GLIPR1L2	chr12:75784889-75825591:+	-0.43	-6.92	1.45E-11	Polycystic ovary syndrome	
THCA	cis	1	rs3860055	chr2:17775828	GEN1	chr2:17935162-17966632:+	0.52	6.87	1.96E-11	Psychosis and Alzheimer's disease	
THCA	cis	1	rs3861802	chr13:85742365	SLITRK6	chr13:86366922-86373483:-	-0.2	-3.9	0.000111	Bipolar disorder (mania)	
THCA	cis	1	rs3864639	chr7:76738591	POMZP3	chr7:76239304-76256620:-	0.29	4.3	2.08E-5	Obesity-related traits	
THCA	cis	1	rs3866330	chr3:49582994	GMPPB	chr3:49758932-49761384:-	-0.18	-3.99	7.49E-5	Menarche (age at onset)	
THCA	cis	1	rs3866330	chr3:49582994	P4HTM	chr3:49027341-49044579:+	0.17	4.34	1.71E-5	Menarche (age at onset)	
THCA	cis	1	rs3866330	chr3:49582994	WDR6	chr3:49044637-49053386:+	-0.18	-3.75	0.000196	Menarche (age at onset)	
THCA	cis	1	rs3870339	chr3:49536863	GMPPB	chr3:49758932-49761384:-	-0.18	-4.05	5.9E-5	Menarche (age at onset)	
THCA	cis	1	rs3870339	chr3:49536863	P4HTM	chr3:49027341-49044579:+	0.17	4.28	2.28E-5	Menarche (age at onset)	
THCA	cis	1	rs3870339	chr3:49536863	WDR6	chr3:49044637-49053386:+	-0.18	-3.84	0.000138	Menarche (age at onset)	
THCA	cis	1	rs3870341	chr3:49584745	GMPPB	chr3:49758932-49761384:-	-0.18	-3.99	7.49E-5	Menarche (age at onset)	
THCA	cis	1	rs3870341	chr3:49584745	P4HTM	chr3:49027341-49044579:+	0.17	4.34	1.71E-5	Menarche (age at onset)	
THCA	cis	1	rs3870341	chr3:49584745	WDR6	chr3:49044637-49053386:+	-0.18	-3.75	0.000196	Menarche (age at onset)	
THCA	cis	1	rs38752	chr7:111078912	IMMP2L	chr7:110303110-111202538:-	0.17	3.73	0.000213	Schizophrenia	
THCA	cis	1	rs387535	chr1:214829010	KCNK2	chr1:215178885-215410435:+	0.18	3.76	0.000191	Response to antineoplastic agents	
THCA	cis	1	rs387676	chr7:65598220	CCT6P1	chr7:65216092-65228661:+	0.42	6.7	5.9E-11	Diabetic kidney disease	
THCA	cis	1	rs387676	chr7:65598220	CRCP	chr7:65579805-65619551:+	-0.3	-4.63	4.66E-6	Diabetic kidney disease	
THCA	cis	1	rs387676	chr7:65598220	LOC493754	chr7:65993446-66057363:-	0.29	3.36	0.000833	Diabetic kidney disease	
THCA	cis	1	rs387676	chr7:65598220	RABGEF1	chr7:66093890-66276446:+	0.57	7.14	3.42E-12	Diabetic kidney disease	
THCA	cis	1	rs388098	chr5:37068544	C5orf42	chr5:37106330-37249530:-	-0.09	-3.76	0.000192	Height	
THCA	cis	1	rs388355	chr1:214829091	KCNK2	chr1:215178885-215410435:+	0.18	3.76	0.000191	Response to antineoplastic agents	
THCA	cis	1	rs3885053	chr12:40789380	CNTN1	chr12:41086358-41464094:+	0.28	3.46	0.000584	Subjective well-being	
THCA	cis	1	rs3885839	chr7:65290403	CCT6P1	chr7:65216092-65228661:+	0.41	6.56	1.43E-10	Diabetic kidney disease	
THCA	cis	1	rs3885839	chr7:65290403	CRCP	chr7:65579805-65619551:+	-0.27	-4.1	4.83E-5	Diabetic kidney disease	
THCA	cis	1	rs3885839	chr7:65290403	LOC168474	chr7:64310071-64314178:-	0.27	3.46	0.000587	Diabetic kidney disease	
THCA	cis	1	rs3885839	chr7:65290403	RABGEF1	chr7:66093890-66276446:+	0.51	6.3	6.87E-10	Diabetic kidney disease	
THCA	cis	1	rs3886589	chr11:71669487	FAM86C	chr11:71498557-71512276:+	0.34	4.11	4.59E-5	Severe influenza A (H1N1) infection	
THCA	cis	1	rs3890604	chr3:41760625	ULK4	chr3:41288091-42003660:-	1.06	19.75	6.57E-64	Diastolic blood pressure	
THCA	cis	1	rs3892630	chr19:33181484	C19orf40	chr19:33463148-33467955:+	0.34	5.17	3.51E-7	Red blood cell traits	
THCA	cis	1	rs3892630	chr19:33181484	NUDT19	chr19:33182867-33204701:+	0.34	5.77	1.45E-8	Red blood cell traits	
THCA	cis	1	rs3892630	chr19:33181484	SLC7A9	chr19:33321421-33360683:-	0.25	4.26	2.48E-5	Red blood cell traits	
THCA	cis	1	rs3892761	chr12:54070445	SOAT2	chr12:53497274-53518322:+	-0.19	-4.2	3.15E-5	Height	
THCA	cis	1	rs3895942	chr3:10108745	C3orf10	chr3:10157333-10168873:+	-0.19	-4.06	5.64E-5	Alzheimer's disease	
THCA	cis	1	rs3895942	chr3:10108745	VHL	chr3:10183319-10193744:+	-0.19	-4.39	1.37E-5	Alzheimer's disease	
THCA	cis	1	rs3897478	chr1:120451190	HMGCS2	chr1:120291005-120311518:-	0.24	3.36	0.00085	Crohn's disease	
THCA	cis	1	rs3900064	chr5:150264414	LOC134466	chr5:150310000-150326146:-	-0.39	-5.48	6.79E-8	Crohn's disease	
THCA	cis	1	rs390110	chr1:214828433	KCNK2	chr1:215178885-215410435:+	0.16	3.48	0.000542	Response to antineoplastic agents	
THCA	cis	1	rs3902027	chr7:54176365	SEC61G	chr7:54819941-54826939:-	-0.22	-3.38	0.000785	Periodontal disease-related phenotypes	
THCA	cis	1	rs3905330	chr3:49550774	GMPPB	chr3:49758932-49761384:-	-0.18	-4.1	4.95E-5	Menarche (age at onset)	
THCA	cis	1	rs3905330	chr3:49550774	P4HTM	chr3:49027341-49044579:+	0.17	4.37	1.52E-5	Menarche (age at onset)	
THCA	cis	1	rs3905330	chr3:49550774	WDR6	chr3:49044637-49053386:+	-0.18	-3.76	0.00019	Menarche (age at onset)	
THCA	cis	1	rs3906527	chr5:150266392	LOC134466	chr5:150310000-150326146:-	0.38	5.28	2.01E-7	Crohn's disease	
THCA	cis	1	rs3906528	chr5:150266718	LOC134466	chr5:150310000-150326146:-	0.38	5.28	2.01E-7	Crohn's disease	
THCA	cis	1	rs390966	chr2:71255691	OR7E91P	chr2:71251205-71257058:+	-0.25	-4.57	6.21E-6	Erythema nodosum in inflammatory bowel disease	
THCA	cis	1	rs3910272	chr2:26287842	GPR113	chr2:26531041-26569685:-	-0.47	-7.31	1.15E-12	Gut microbiome composition (summer)	
THCA	cis	1	rs3910272	chr2:26287842	HADHA	chr2:26413505-26467594:-	-0.17	-3.48	0.000549	Gut microbiome composition (summer)	
THCA	cis	1	rs3910516	chr2:216303053	ATIC	chr2:216176692-216214477:+	0.16	3.96	8.6E-5	Cholesterol, total;LDL cholesterol	
THCA	cis	1	rs3911729	chr15:53958400	WDR72	chr15:53805938-54051859:-	0.16	3.68	0.000259	Chronic kidney disease;Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs391396	chr4:130037653	C4orf33	chr4:130014829-130033842:+	-0.61	-9.62	3.73E-20	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs3915165	chr3:119279351	ADPRH	chr3:119298523-119308791:+	-0.22	-3.51	0.000482	Vitiligo	
THCA	cis	1	rs3915166	chr3:119279281	ADPRH	chr3:119298523-119308791:+	-0.22	-3.51	0.000482	Vitiligo	
THCA	cis	1	rs3915733	chr14:104147353	KLC1	chr14:104029299-104167887:+	-0.23	-4.5	8.38E-6	Body mass index	
THCA	cis	1	rs3916	chr12:121177272	ACADS	chr12:121163571-121177810:+	0.13	3.45	0.000609	Urinary metabolites (H-NMR features)	
THCA	cis	1	rs3925074	chr16:31347807	HSD3B7	chr16:30996519-31000473:+	-0.15	-3.83	0.000148	IgA nephropathy	
THCA	cis	1	rs3925075	chr16:31347748	HSD3B7	chr16:30996519-31000473:+	0.16	3.95	9.02E-5	IgA nephropathy	
THCA	cis	1	rs3931020	chr1:75235317	CRYZ	chr1:75171175-75199092:-	-0.43	-7.42	5.23E-13	Resistin levels	
THCA	cis	1	rs3932818	chr3:134206069	ANAPC13	chr3:134196547-134204865:-	0.37	11.73	4.17E-28	Height	
THCA	cis	1	rs3932818	chr3:134206069	CEP63	chr3:134204575-134293852:+	0.3	6.47	2.49E-10	Height	
THCA	cis	1	rs3933453	chr4:17636319	MED28	chr4:17616273-17629791:+	0.18	3.98	7.98E-5	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs3934103	chr3:41977214	ULK4	chr3:41288091-42003660:-	-1.06	-19.95	6.96E-65	Diastolic blood pressure	
THCA	cis	1	rs3934135	chr15:84583799	LOC388152	chr15:84867600-84898920:-	-0.21	-3.98	7.86E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs3935543	chr17:79579874	ARL16	chr17:79648234-79650954:-	-0.12	-3.39	0.000748	Eye color traits	
THCA	cis	1	rs3935543	chr17:79579874	TSPAN10	chr17:79609349-79615778:+	0.8	17.82	7.47E-55	Eye color traits	
THCA	cis	1	rs3935969	chr17:65881959	C17orf58	chr17:65987218-65989765:-	0.24	4.78	2.28E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs3936203	chr2:241834654	C2orf54	chr2:241825466-241835573:-	-0.3	-6.42	3.32E-10	Urinary metabolites	
THCA	cis	1	rs3942897	chr16:69480552	CYB5B	chr16:69458498-69500167:+	-0.23	-4	7.35E-5	Blood pressure (smoking interaction)	
THCA	cis	1	rs3943299	chr17:20920611	USP22	chr17:20902908-20947073:-	-0.18	-3.8	0.000162	Blood trace element (Se levels)	
THCA	cis	1	rs39474	chr7:118128820	ANKRD7	chr7:117864712-117882782:+	0.27	4.29	2.16E-5	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs39481	chr7:118134635	ANKRD7	chr7:117864712-117882782:+	0.27	4.3	2.11E-5	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs39485	chr7:118143329	ANKRD7	chr7:117864712-117882782:+	0.29	4.72	3.16E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs39486	chr7:118144823	ANKRD7	chr7:117864712-117882782:+	0.27	4.37	1.55E-5	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs39489	chr7:118151455	ANKRD7	chr7:117864712-117882782:+	0.26	4.29	2.15E-5	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs3950155	chr6:55936254	COL21A1	chr6:55921389-56258892:-	-0.64	-7.91	1.86E-14	Psychosis (atypical)	
THCA	cis	1	rs3952507	chr10:54348152	DKK1	chr10:54074041-54077416:+	-0.28	-5.13	4.28E-7	Metabolite levels  (X-11787)	
THCA	cis	1	rs3958122	chr4:1693931	FAM53A	chr4:1641609-1685854:-	0.16	3.74	0.000209	Height	
THCA	cis	1	rs3958122	chr4:1693931	TMEM129	chr4:1717680-1723084:-	0.16	5.06	6.09E-7	Height	
THCA	cis	1	rs3960018	chr15:90383307	AP3S2	chr15:90373832-90456222:-	-0.77	-19.66	1.76E-63	Type 2 diabetes	
THCA	cis	1	rs3960018	chr15:90383307	C15orf38	chr15:90443832-90456222:-	0.35	7.4	6.27E-13	Type 2 diabetes	
THCA	cis	1	rs396508	chr16:20682354	ACSM1	chr16:20634559-20709066:-	-0.51	-10.64	7.4E-24	Schizophrenia	
THCA	cis	1	rs396508	chr16:20682354	ACSM3	chr16:20775312-20808478:+	0.19	3.66	0.000276	Schizophrenia	
THCA	cis	1	rs397119	chr20:25440187	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.86	2.15E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs397119	chr20:25440187	FAM182A	chr20:26035250-26067552:+	-0.19	-3.45	0.000604	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs397119	chr20:25440187	FAM182B	chr20:25744102-25848786:-	0.25	5.23	2.6E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs397119	chr20:25440187	NINL	chr20:25433338-25566153:-	-0.36	-7.27	1.45E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs397119	chr20:25440187	PYGB	chr20:25228706-25278647:+	-0.13	-3.35	0.000876	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs3979179	chr1:16306846	CLCNKA	chr1:16345370-16360544:+	-0.12	-3.49	0.000521	Dilated cardiomyopathy	
THCA	cis	1	rs3979179	chr1:16306846	HSPB7	chr1:16340523-16346089:-	-0.55	-11.02	2.47E-25	Dilated cardiomyopathy	
THCA	cis	1	rs398036	chr20:25439850	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.86	2.15E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs398036	chr20:25439850	FAM182A	chr20:26035250-26067552:+	-0.19	-3.45	0.000604	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs398036	chr20:25439850	FAM182B	chr20:25744102-25848786:-	0.25	5.23	2.6E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs398036	chr20:25439850	NINL	chr20:25433338-25566153:-	-0.36	-7.27	1.45E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs398036	chr20:25439850	PYGB	chr20:25228706-25278647:+	-0.13	-3.35	0.000876	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs3981131	chr7:65951677	ASL	chr7:65540776-65558321:+	-0.16	-4.14	4.03E-5	Aortic root size	
THCA	cis	1	rs3981131	chr7:65951677	GUSB	chr7:65425675-65447246:-	0.27	5.22	2.63E-7	Aortic root size	
THCA	cis	1	rs3981131	chr7:65951677	RABGEF1	chr7:66093890-66276446:+	0.63	13.19	4.24E-34	Aortic root size	
THCA	cis	1	rs3981351	chr10:115515120	CASP7	chr10:115438935-115490662:+	0.42	10.05	1.11E-21	Obesity-related traits	
THCA	cis	1	rs39841	chr5:96120170	ERAP1	chr5:96096515-96149837:-	-0.35	-9.2	1.15E-18	Inflammatory skin disease	
THCA	cis	1	rs39841	chr5:96120170	ERAP2	chr5:96211644-96255398:+	0.51	8.36	7.01E-16	Inflammatory skin disease	
THCA	cis	1	rs3997734	chr6:35503475	TULP1	chr6:35465653-35480647:-	-0.28	-3.79	0.00017	Hepatitis C induced liver fibrosis	
THCA	cis	1	rs400736	chr1:8078309	PARK7	chr1:8021714-8045341:+	0.13	5.89	7.1E-9	Response to antidepressants and depression	
THCA	cis	1	rs400978	chr2:119437	SH3YL1	chr2:218138-264810:-	-0.27	-4.38	1.44E-5	Suicide attempts in bipolar disorder	
THCA	cis	1	rs401166	chr20:25446308	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.86	2.13E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs401166	chr20:25446308	FAM182A	chr20:26035250-26067552:+	-0.19	-3.44	0.000643	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs401166	chr20:25446308	FAM182B	chr20:25744102-25848786:-	0.26	5.33	1.52E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs401166	chr20:25446308	NINL	chr20:25433338-25566153:-	-0.35	-7.19	2.46E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs401166	chr20:25446308	PYGB	chr20:25228706-25278647:+	-0.15	-3.67	0.000272	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4013	chr4:103552813	CISD2	chr4:103790135-103809913:+	-0.15	-3.49	0.000525	Primary biliary cirrhosis	
THCA	cis	1	rs4013	chr4:103552813	NFKB1	chr4:103422486-103538458:+	0.14	4.05	6.05E-5	Primary biliary cirrhosis	
THCA	cis	1	rs401680	chr3:41127094	ZNF620	chr3:40547530-40559197:+	0.17	3.35	0.000883	Bone mineral density (hip)	
THCA	cis	1	rs401897	chr20:55029758	C20orf43	chr20:55043647-55093942:+	0.29	7.75	5.53E-14	Refractive astigmatism	
THCA	cis	1	rs402418	chr7:65509469	CCT6P1	chr7:65216092-65228661:+	0.4	6.38	4.13E-10	Diabetic kidney disease	
THCA	cis	1	rs402418	chr7:65509469	CRCP	chr7:65579805-65619551:+	-0.28	-4.26	2.45E-5	Diabetic kidney disease	
THCA	cis	1	rs402418	chr7:65509469	RABGEF1	chr7:66093890-66276446:+	0.57	7.12	3.87E-12	Diabetic kidney disease	
THCA	cis	1	rs402511	chr5:176434440	ZNF346	chr5:176449697-176508190:+	-0.16	-5.52	5.64E-8	Menopause (age at onset);Menarche and menopause (age at onset)	
THCA	cis	1	rs403439	chr19:18142075	ABHD8	chr19:17402941-17414282:-	-0.22	-3.52	0.000466	Pulmonary function in asthmatics	
THCA	cis	1	rs4038129	chr2:17774746	GEN1	chr2:17935162-17966632:+	0.5	6.67	7.04E-11	Psychosis and Alzheimer's disease	
THCA	cis	1	rs4038130	chr2:17774912	GEN1	chr2:17935162-17966632:+	-0.5	-6.72	5.27E-11	Psychosis and Alzheimer's disease	
THCA	cis	1	rs4038131	chr2:17775032	GEN1	chr2:17935162-17966632:+	0.44	6.3	6.81E-10	Psychosis and Alzheimer's disease	
THCA	cis	1	rs40396	chr5:130708044	P4HA2	chr5:131528306-131563556:-	-0.26	-5.02	7.16E-7	Life satisfaction	
THCA	cis	1	rs404394	chr20:25447896	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.86	2.13E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs404394	chr20:25447896	FAM182A	chr20:26035250-26067552:+	-0.19	-3.44	0.000643	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs404394	chr20:25447896	FAM182B	chr20:25744102-25848786:-	0.26	5.33	1.52E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs404394	chr20:25447896	NINL	chr20:25433338-25566153:-	-0.35	-7.19	2.46E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs404394	chr20:25447896	PYGB	chr20:25228706-25278647:+	-0.15	-3.67	0.000272	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4045344	chr5:595870	CEP72	chr5:612405-653664:+	0.39	7.59	1.73E-13	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs4057984	chr4:17957200	DCAF16	chr4:17802280-17812381:-	-0.19	-4.34	1.7E-5	Height	
THCA	cis	1	rs406900	chr6:88085447	C6orf162	chr6:88032306-88052043:+	-0.18	-3.91	0.000105	Depressive episodes in bipolar disorder	
THCA	cis	1	rs406900	chr6:88085447	C6orf164	chr6:88032306-88109459:+	-0.32	-5.91	6.54E-9	Depressive episodes in bipolar disorder	
THCA	cis	1	rs4073054	chr1:161200487	ADAMTS4	chr1:161159539-161168845:-	0.19	3.49	0.000536	Blood metabolite levels	
THCA	cis	1	rs4073846	chr1:46462881	CCDC163P	chr1:45960581-45965646:-	0.51	9.99	1.78E-21	Body mass index	
THCA	cis	1	rs4073846	chr1:46462881	GPBP1L1	chr1:46092978-46152302:-	-0.16	-3.98	7.82E-5	Body mass index	
THCA	cis	1	rs4073846	chr1:46462881	MMACHC	chr1:45965856-45976737:+	0.21	4.49	8.83E-6	Body mass index	
THCA	cis	1	rs4073846	chr1:46462881	MUTYH	chr1:45794915-45806142:-	-0.3	-8.08	5.46E-15	Body mass index	
THCA	cis	1	rs4074170	chr17:28381141	ANKRD13B	chr17:27916801-27941778:+	-0.36	-8.85	1.7E-17	Coffee consumption (cups per day)	
THCA	cis	1	rs4074170	chr17:28381141	CORO6	chr17:27941774-27948441:-	-0.51	-11.7	5.47E-28	Coffee consumption (cups per day)	
THCA	cis	1	rs4074170	chr17:28381141	EFCAB5	chr17:28256874-28435469:+	-0.6	-11.3	2.02E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs4074170	chr17:28381141	GIT1	chr17:27900487-27916610:-	-0.29	-6.8	3.15E-11	Coffee consumption (cups per day)	
THCA	cis	1	rs4074170	chr17:28381141	LRRC37B2	chr17:28903483-28992715:+	-0.18	-3.84	0.000141	Coffee consumption (cups per day)	
THCA	cis	1	rs4074170	chr17:28381141	SSH2	chr17:27952965-28257018:-	-0.34	-7.64	1.18E-13	Coffee consumption (cups per day)	
THCA	cis	1	rs4074170	chr17:28381141	TP53I13	chr17:27895739-27900174:+	-0.2	-5.3	1.81E-7	Coffee consumption (cups per day)	
THCA	cis	1	rs4074232	chr11:977682	TSPAN4	chr11:842824-867116:+	0.16	3.84	0.000137	Alzheimer's disease (late onset)	
THCA	cis	1	rs4074494	chr1:231172249	EXOC8	chr1:231468483-231473578:-	0.15	3.41	0.000713	Carotid plaque burden (smoking interaction)	
THCA	cis	1	rs4074915	chr17:79579230	ARL16	chr17:79648234-79650954:-	0.12	3.39	0.000747	Eye color traits	
THCA	cis	1	rs4074915	chr17:79579230	TSPAN10	chr17:79609349-79615778:+	-0.8	-17.82	7.38E-55	Eye color traits	
THCA	cis	1	rs4074916	chr17:79579248	ARL16	chr17:79648234-79650954:-	0.12	3.39	0.000748	Eye color traits	
THCA	cis	1	rs4074916	chr17:79579248	TSPAN10	chr17:79609349-79615778:+	-0.8	-17.82	7.47E-55	Eye color traits	
THCA	cis	1	rs4075403	chr3:58411445	PXK	chr3:58318617-58410878:+	0.34	5.98	4.47E-9	Cholesterol, total	
THCA	cis	1	rs4075623	chr17:28386526	ANKRD13B	chr17:27916801-27941778:+	-0.36	-8.84	1.85E-17	Coffee consumption (cups per day)	
THCA	cis	1	rs4075623	chr17:28386526	CORO6	chr17:27941774-27948441:-	-0.51	-11.74	4.02E-28	Coffee consumption (cups per day)	
THCA	cis	1	rs4075623	chr17:28386526	EFCAB5	chr17:28256874-28435469:+	-0.6	-11.33	1.63E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs4075623	chr17:28386526	GIT1	chr17:27900487-27916610:-	-0.29	-6.79	3.24E-11	Coffee consumption (cups per day)	
THCA	cis	1	rs4075623	chr17:28386526	LRRC37B2	chr17:28903483-28992715:+	-0.18	-3.94	9.28E-5	Coffee consumption (cups per day)	
THCA	cis	1	rs4075623	chr17:28386526	SSH2	chr17:27952965-28257018:-	-0.34	-7.67	9.71E-14	Coffee consumption (cups per day)	
THCA	cis	1	rs4075623	chr17:28386526	TP53I13	chr17:27895739-27900174:+	-0.2	-5.29	1.87E-7	Coffee consumption (cups per day)	
THCA	cis	1	rs4076006	chr1:46438076	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.14	5.21E-22	Body mass index	
THCA	cis	1	rs4076006	chr1:46438076	GPBP1L1	chr1:46092978-46152302:-	0.15	3.83	0.000146	Body mass index	
THCA	cis	1	rs4076006	chr1:46438076	MMACHC	chr1:45965856-45976737:+	-0.21	-4.57	6.3E-6	Body mass index	
THCA	cis	1	rs4076006	chr1:46438076	MUTYH	chr1:45794915-45806142:-	0.3	8.13	3.66E-15	Body mass index	
THCA	cis	1	rs4076318	chr4:75701081	BTC	chr4:75671448-75719882:-	0.2	3.9	0.000111	Electroencephalogram traits	
THCA	cis	1	rs4076557	chr11:46764649	ZNF408	chr11:46722368-46727461:+	-0.19	-3.69	0.00025	HDL cholesterol	
THCA	cis	1	rs4077468	chr1:205914757	PM20D1	chr1:205797154-205819245:-	0.24	4.41	1.27E-5	Cystic fibrosis-related diabetes	
THCA	cis	1	rs4077469	chr1:205914885	PM20D1	chr1:205797154-205819245:-	0.24	4.38	1.48E-5	Cystic fibrosis-related diabetes	
THCA	cis	1	rs4078160	chr10:52565940	ASAH2B	chr10:52499696-52514567:+	-0.25	-3.91	0.000106	Urate levels in lean individuals	
THCA	cis	1	rs4078387	chr16:69814047	COG4	chr16:70514473-70557457:-	-0.19	-3.94	9.44E-5	IgE levels	
THCA	cis	1	rs409035	chr20:5943649	MCM8	chr20:5931298-5975829:+	-0.32	-7.02	7.45E-12	HIV-1 viral setpoint	
THCA	cis	1	rs4097354	chr1:47187073	CYP4B1	chr1:47264670-47285020:+	0.22	3.37	0.000825	Response to hepatitis C treatment	
THCA	cis	1	rs4097354	chr1:47187073	CYP4Z1	chr1:47533160-47583992:+	0.28	3.94	9.36E-5	Response to hepatitis C treatment	
THCA	cis	1	rs4097354	chr1:47187073	DMBX1	chr1:46972668-46979884:+	0.24	3.93	9.59E-5	Response to hepatitis C treatment	
THCA	cis	1	rs4099209	chr5:110162262	TMEM232	chr5:109624934-110062381:-	0.21	4.14	4.1E-5	Asthma and hay fever	
THCA	cis	1	rs410128	chr7:65603173	CCT6P1	chr7:65216092-65228661:+	0.43	6.76	4.09E-11	Diabetic kidney disease	
THCA	cis	1	rs410128	chr7:65603173	CRCP	chr7:65579805-65619551:+	-0.31	-4.62	4.93E-6	Diabetic kidney disease	
THCA	cis	1	rs410128	chr7:65603173	LOC493754	chr7:65993446-66057363:-	0.3	3.45	0.000613	Diabetic kidney disease	
THCA	cis	1	rs410128	chr7:65603173	RABGEF1	chr7:66093890-66276446:+	0.57	6.91	1.57E-11	Diabetic kidney disease	
THCA	cis	1	rs4114686	chr5:101681949	SLCO4C1	chr5:101569694-101632253:-	0.25	5.62	3.21E-8	Schizophrenia	
THCA	cis	1	rs4118325	chr1:107577832	NTNG1	chr1:107682629-108024471:+	0.21	3.69	0.000247	AIDS	
THCA	cis	1	rs4121395	chr11:71669242	FAM86C	chr11:71498557-71512276:+	0.34	4.11	4.59E-5	Severe influenza A (H1N1) infection	
THCA	cis	1	rs41265383	chr6:170068025	C6orf70	chr6:170151721-170181617:+	0.27	5.27	2.11E-7	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs41265383	chr6:170068025	WDR27	chr6:169857307-170102159:-	-0.2	-5.99	4.22E-9	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs41266807	chr6:26199822	HIST1H2AE	chr6:26217148-26217711:+	-0.23	-3.64	0.000301	Renal underexcretion gout;Gout	
THCA	cis	1	rs41266807	chr6:26199822	HIST1H3E	chr6:26224427-26226589:+	0.43	7.08	5.04E-12	Renal underexcretion gout;Gout	
THCA	cis	1	rs41266839	chr6:26409890	BTN3A2	chr6:26365398-26378546:+	-0.87	-10.52	2.0E-23	Schizophrenia	
THCA	cis	1	rs41266959	chr2:242275579	ANO7	chr2:242127924-242164791:+	0.36	4.13	4.26E-5	Prostate cancer	
THCA	cis	1	rs41266959	chr2:242275579	SEPT2	chr2:242254723-242293439:+	-0.29	-4.17	3.59E-5	Prostate cancer	
THCA	cis	1	rs41271355	chr3:113004155	SIDT1	chr3:113251218-113348421:+	0.21	3.63	0.000316	Dental caries	
THCA	cis	1	rs41271391	chr3:119278457	ADPRH	chr3:119298523-119308791:+	-0.23	-3.67	0.000269	Vitiligo	
THCA	cis	1	rs41271393	chr3:119278693	ADPRH	chr3:119298523-119308791:+	-0.23	-3.71	0.000229	Vitiligo	
THCA	cis	1	rs41271844	chr6:55988932	COL21A1	chr6:55921389-56258892:-	-0.64	-7.96	1.24E-14	Psychosis (atypical)	
THCA	cis	1	rs41275764	chr19:46857257	PPP5C	chr19:46850294-46894103:+	-0.23	-3.99	7.77E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs41277668	chr13:96295824	DZIP1	chr13:96229329-96296957:-	0.2	3.91	0.000108	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
THCA	cis	1	rs41277668	chr13:96295824	UGGT2	chr13:96453838-96705736:-	-0.26	-3.88	0.000119	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
THCA	cis	1	rs41280035	chr22:38054038	LGALS2	chr22:37966254-37976024:-	0.14	3.81	0.000156	Fat distribution (HIV)	
THCA	cis	1	rs41280035	chr22:38054038	SH3BP1	chr22:38030661-38062939:+	0.12	3.83	0.000145	Fat distribution (HIV)	
THCA	cis	1	rs4128206	chr11:78015952	NARS2	chr11:78147017-78285909:-	-0.39	-7.51	2.94E-13	Testicular germ cell tumor	
THCA	cis	1	rs41294396	chr11:64078581	PRDX5	chr11:64085569-64089282:+	-0.17	-4.17	3.68E-5	Mean platelet volume	
THCA	cis	1	rs4129956	chr4:302008	ZNF718	chr4:53272-156488:+	0.49	9.06	3.32E-18	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs41303629	chr1:27057621	PIGV	chr1:27114455-27124886:+	-0.29	-3.36	0.000843	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs41303629	chr1:27057621	ZDHHC18	chr1:27153201-27182207:+	0.8	8.59	1.26E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs41304261	chr1:183220539	RNASEL	chr1:182542772-182558391:-	0.33	3.56	0.000401	Systemic lupus erythematosus and Systemic sclerosis	
THCA	cis	1	rs4130590	chr9:130107964	RPL12	chr9:130209955-130213684:-	-0.16	-5.23	2.59E-7	Bipolar disorder	
THCA	cis	1	rs41306345	chr15:66782048	TIPIN	chr15:66629008-66649054:-	-0.41	-4.17	3.61E-5	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs41307935	chr1:27181067	ZDHHC18	chr1:27153201-27182207:+	0.79	8.45	3.61E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs41313321	chr9:131051316	URM1	chr9:131133598-131153015:+	-0.27	-4.58	6.02E-6	Coenzyme Q10 levels	
THCA	cis	1	rs41315964	chr15:66779698	TIPIN	chr15:66629008-66649054:-	-0.41	-4.17	3.61E-5	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs4133250	chr10:65092405	LOC84989	chr10:65224989-65226320:+	-0.27	-4.35	1.64E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs4133250	chr10:65092405	NRBF2	chr10:64893007-64914785:+	-0.28	-4.77	2.41E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs4133914	chr17:20922023	USP22	chr17:20902908-20947073:-	-0.18	-3.8	0.000162	Blood trace element (Se levels)	
THCA	cis	1	rs4134379	chr11:77992588	NARS2	chr11:78147017-78285909:-	-0.38	-7.39	6.55E-13	Testicular germ cell tumor	
THCA	cis	1	rs4134386	chr1:46395089	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.14	4.96E-22	Body mass index	
THCA	cis	1	rs4134386	chr1:46395089	GPBP1L1	chr1:46092978-46152302:-	0.15	3.83	0.000147	Body mass index	
THCA	cis	1	rs4134386	chr1:46395089	MMACHC	chr1:45965856-45976737:+	-0.21	-4.56	6.37E-6	Body mass index	
THCA	cis	1	rs4134386	chr1:46395089	MUTYH	chr1:45794915-45806142:-	0.3	8.15	3.33E-15	Body mass index	
THCA	cis	1	rs414013	chr6:88085866	C6orf162	chr6:88032306-88052043:+	-0.18	-3.91	0.000105	Depressive episodes in bipolar disorder	
THCA	cis	1	rs414013	chr6:88085866	C6orf164	chr6:88032306-88109459:+	-0.32	-5.91	6.54E-9	Depressive episodes in bipolar disorder	
THCA	cis	1	rs4140574	chr6:56099424	COL21A1	chr6:55921389-56258892:-	0.75	16.14	4.29E-47	Pulse pressure	
THCA	cis	1	rs4140575	chr6:56099222	COL21A1	chr6:55921389-56258892:-	0.78	16.78	5.27E-50	Pulse pressure	
THCA	cis	1	rs4141404	chr22:31675185	RNF185	chr22:31556138-31603004:+	-0.28	-5.11	4.77E-7	Paclitaxel-induced neuropathy	
THCA	cis	1	rs4142481	chr15:56392275	MNS1	chr15:56720929-56757335:-	-0.24	-3.61	0.000341	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs4142481	chr15:56392275	TEX9	chr15:56657644-56738071:+	-0.35	-6.17	1.42E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs4144027	chr14:104357638	PPP1R13B	chr14:104200088-104313927:-	0.13	3.61	0.000343	Blood metabolite levels	
THCA	cis	1	rs4144027	chr14:104357638	XRCC3	chr14:104163955-104181823:-	0.16	3.95	9.05E-5	Blood metabolite levels	
THCA	cis	1	rs4144829	chr4:17903654	DCAF16	chr4:17802280-17812381:-	-0.24	-5.61	3.4E-8	Height	
THCA	cis	1	rs4144937	chr6:46628516	CYP39A1	chr6:46517445-46620523:-	-0.42	-9.87	4.86E-21	QRS complex (Sokolow-Lyon)	
THCA	cis	1	rs4144937	chr6:46628516	SLC25A27	chr6:46620679-46645925:+	-0.18	-6.69	6.37E-11	QRS complex (Sokolow-Lyon)	
THCA	cis	1	rs4144937	chr6:46628516	TDRD6	chr6:46655866-46670149:+	0.18	5.13	4.33E-7	QRS complex (Sokolow-Lyon)	
THCA	cis	1	rs4145008	chr7:65647511	CCT6P1	chr7:65216092-65228661:+	-0.42	-6.7	5.9E-11	Diabetic kidney disease	
THCA	cis	1	rs4145008	chr7:65647511	CRCP	chr7:65579805-65619551:+	0.3	4.63	4.66E-6	Diabetic kidney disease	
THCA	cis	1	rs4145008	chr7:65647511	LOC493754	chr7:65993446-66057363:-	-0.29	-3.36	0.000833	Diabetic kidney disease	
THCA	cis	1	rs4145008	chr7:65647511	RABGEF1	chr7:66093890-66276446:+	-0.57	-7.14	3.42E-12	Diabetic kidney disease	
THCA	cis	1	rs4146610	chr4:103265177	BANK1	chr4:102341118-102995967:+	-0.25	-3.61	0.000343	Erythrocyte cadmium concentration in never smokers	
THCA	cis	1	rs4146667	chr1:95703597	TMEM56	chr1:95582894-95663159:+	0.2	4.31	1.97E-5	Non-alcoholic fatty liver disease histology (AST)	
THCA	cis	1	rs4146894	chr10:124155381	PLEKHA1	chr10:124134220-124191866:+	-0.21	-5.74	1.7E-8	Height	
THCA	cis	1	rs4147024	chr3:38456664	EXOG	chr3:38537763-38567796:+	-0.16	-3.39	0.000756	Electrocardiographic conduction measures	
THCA	cis	1	rs4147024	chr3:38456664	LOC100128640	chr3:38492524-38496311:-	0.22	4.68	3.68E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs4147024	chr3:38456664	SCN5A	chr3:38589554-38691164:-	0.16	3.35	0.000881	Electrocardiographic conduction measures	
THCA	cis	1	rs4147024	chr3:38456664	XYLB	chr3:38388251-38456467:+	0.21	5.04	6.7E-7	Electrocardiographic conduction measures	
THCA	cis	1	rs4147025	chr3:38456531	EXOG	chr3:38537763-38567796:+	-0.16	-3.36	0.000854	Electrocardiographic conduction measures	
THCA	cis	1	rs4147025	chr3:38456531	LOC100128640	chr3:38492524-38496311:-	0.23	4.73	3.02E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs4147025	chr3:38456531	SCN5A	chr3:38589554-38691164:-	0.16	3.42	0.00068	Electrocardiographic conduction measures	
THCA	cis	1	rs4147025	chr3:38456531	XYLB	chr3:38388251-38456467:+	0.2	4.9	1.34E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs4147302	chr1:108319389	VAV3	chr1:108113782-108507545:-	0.38	5.39	1.08E-7	Hypothyroidism	
THCA	cis	1	rs4148463	chr13:95869408	ABCC4	chr13:95672084-95953687:-	-0.19	-3.62	0.000328	Breast cancer	
THCA	cis	1	rs4148465	chr13:95869131	ABCC4	chr13:95672084-95953687:-	0.19	3.62	0.000328	Breast cancer	
THCA	cis	1	rs4148467	chr13:95868330	ABCC4	chr13:95672084-95953687:-	-0.19	-3.64	0.000303	Breast cancer	
THCA	cis	1	rs4148469	chr13:95863358	ABCC4	chr13:95672084-95953687:-	-0.19	-3.71	0.000233	Breast cancer	
THCA	cis	1	rs4148470	chr13:95863281	ABCC4	chr13:95672084-95953687:-	-0.19	-3.72	0.000227	Breast cancer	
THCA	cis	1	rs4149468	chr7:65825690	CCT6P1	chr7:65216092-65228661:+	0.42	6.64	8.46E-11	Diabetic kidney disease	
THCA	cis	1	rs4149468	chr7:65825690	CRCP	chr7:65579805-65619551:+	-0.25	-3.82	0.000149	Diabetic kidney disease	
THCA	cis	1	rs4149468	chr7:65825690	RABGEF1	chr7:66093890-66276446:+	0.61	7.59	1.65E-13	Diabetic kidney disease	
THCA	cis	1	rs4149547	chr2:240933308	NDUFA10	chr2:240900158-240964798:-	0.3	8.53	1.92E-16	Odorant perception (isobutyraldehyde)	
THCA	cis	1	rs4149551	chr2:240921463	NDUFA10	chr2:240900158-240964798:-	0.31	8.66	7.57E-17	Odorant perception (isobutyraldehyde)	
THCA	cis	1	rs4149556	chr2:240915307	NDUFA10	chr2:240900158-240964798:-	0.3	8.39	5.34E-16	Odorant perception (isobutyraldehyde)	
THCA	cis	1	rs4150161	chr16:84214236	ADAD2	chr16:84224723-84230772:+	-0.29	-3.56	0.000401	Systolic blood pressure response to hydrochlorothiazide in hypertension	
THCA	cis	1	rs4150161	chr16:84214236	TAF1C	chr16:84211462-84220662:-	-0.16	-3.99	7.62E-5	Systolic blood pressure response to hydrochlorothiazide in hypertension	
THCA	cis	1	rs4150550	chr11:18350898	GTF2H1	chr11:18343816-18388590:+	0.35	9.69	2.17E-20	Pancreatic cancer	
THCA	cis	1	rs4150562	chr11:18354995	GTF2H1	chr11:18343816-18388590:+	0.35	9.45	1.47E-19	Pancreatic cancer	
THCA	cis	1	rs4150564	chr11:18355308	GTF2H1	chr11:18343816-18388590:+	0.38	10.31	1.2E-22	Pancreatic cancer	
THCA	cis	1	rs4150566	chr11:18355599	GTF2H1	chr11:18343816-18388590:+	0.34	9.37	2.86E-19	Pancreatic cancer	
THCA	cis	1	rs4150575	chr11:18356466	GTF2H1	chr11:18343816-18388590:+	0.34	9.36	3.2E-19	Pancreatic cancer	
THCA	cis	1	rs4150579	chr11:18357180	GTF2H1	chr11:18343816-18388590:+	-0.35	-9.66	2.73E-20	Pancreatic cancer	
THCA	cis	1	rs4150610	chr11:18364140	GTF2H1	chr11:18343816-18388590:+	0.38	10.32	1.1E-22	Pancreatic cancer	
THCA	cis	1	rs4150612	chr11:18364358	GTF2H1	chr11:18343816-18388590:+	0.34	9.36	3.13E-19	Pancreatic cancer	
THCA	cis	1	rs4150615	chr11:18365028	GTF2H1	chr11:18343816-18388590:+	-0.34	-9.16	1.53E-18	Pancreatic cancer	
THCA	cis	1	rs4150622	chr11:18365710	GTF2H1	chr11:18343816-18388590:+	0.37	9.94	2.8E-21	Pancreatic cancer	
THCA	cis	1	rs4150641	chr11:18370739	GTF2H1	chr11:18343816-18388590:+	0.34	9.48	1.14E-19	Pancreatic cancer	
THCA	cis	1	rs4150650	chr11:18374279	GTF2H1	chr11:18343816-18388590:+	0.35	9.43	1.71E-19	Pancreatic cancer	
THCA	cis	1	rs4150651	chr11:18374425	GTF2H1	chr11:18343816-18388590:+	0.35	9.43	1.71E-19	Pancreatic cancer	
THCA	cis	1	rs4150655	chr11:18375164	GTF2H1	chr11:18343816-18388590:+	-0.33	-8.93	9.32E-18	Pancreatic cancer	
THCA	cis	1	rs4150661	chr11:18379629	GTF2H1	chr11:18343816-18388590:+	0.32	8.72	4.76E-17	Pancreatic cancer	
THCA	cis	1	rs4150673	chr11:18383449	GTF2H1	chr11:18343816-18388590:+	0.33	8.76	3.51E-17	Pancreatic cancer	
THCA	cis	1	rs416451	chr5:75922072	F2RL2	chr5:75911308-75919240:-	-0.25	-5.74	1.64E-8	Hearing impairment	
THCA	cis	1	rs417844	chr1:214830908	KCNK2	chr1:215178885-215410435:+	0.17	3.53	0.000464	Response to antineoplastic agents	
THCA	cis	1	rs41945	chr7:117961810	ANKRD7	chr7:117864712-117882782:+	-0.29	-4.73	2.89E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs41950	chr7:117964293	ANKRD7	chr7:117864712-117882782:+	0.27	4.5	8.46E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs41953	chr7:117965390	ANKRD7	chr7:117864712-117882782:+	0.27	4.5	8.46E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs41955	chr7:117970074	ANKRD7	chr7:117864712-117882782:+	0.28	4.51	8.34E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs41956	chr7:117970264	ANKRD7	chr7:117864712-117882782:+	0.27	4.5	8.46E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs41957	chr7:117972595	ANKRD7	chr7:117864712-117882782:+	0.27	4.5	8.46E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs419603	chr7:65597341	CCT6P1	chr7:65216092-65228661:+	0.42	6.7	5.9E-11	Diabetic kidney disease	
THCA	cis	1	rs419603	chr7:65597341	CRCP	chr7:65579805-65619551:+	-0.3	-4.63	4.66E-6	Diabetic kidney disease	
THCA	cis	1	rs419603	chr7:65597341	LOC493754	chr7:65993446-66057363:-	0.29	3.36	0.000833	Diabetic kidney disease	
THCA	cis	1	rs419603	chr7:65597341	RABGEF1	chr7:66093890-66276446:+	0.57	7.14	3.42E-12	Diabetic kidney disease	
THCA	cis	1	rs41961	chr7:117975259	ANKRD7	chr7:117864712-117882782:+	0.28	4.51	8.34E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs41970	chr7:117980884	ANKRD7	chr7:117864712-117882782:+	0.27	4.5	8.46E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs41977	chr7:117984592	ANKRD7	chr7:117864712-117882782:+	0.28	4.51	8.34E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs41978	chr7:117984828	ANKRD7	chr7:117864712-117882782:+	0.27	4.5	8.46E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs41982	chr7:117986026	ANKRD7	chr7:117864712-117882782:+	0.27	4.5	8.46E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs41984	chr7:117987631	ANKRD7	chr7:117864712-117882782:+	0.27	4.5	8.46E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs41986	chr7:117988236	ANKRD7	chr7:117864712-117882782:+	0.28	4.51	8.34E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs41987	chr7:117989233	ANKRD7	chr7:117864712-117882782:+	0.28	4.51	8.34E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs41988	chr7:117989281	ANKRD7	chr7:117864712-117882782:+	-0.27	-4.51	8.08E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs41991	chr7:117989739	ANKRD7	chr7:117864712-117882782:+	0.27	4.5	8.46E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs41993	chr7:117990723	ANKRD7	chr7:117864712-117882782:+	0.27	4.5	8.46E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs41994	chr7:117991231	ANKRD7	chr7:117864712-117882782:+	0.27	4.5	8.46E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs41995	chr7:117991339	ANKRD7	chr7:117864712-117882782:+	0.27	4.51	8.32E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs41996	chr7:117991556	ANKRD7	chr7:117864712-117882782:+	0.28	4.6	5.34E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs41997	chr7:117991895	ANKRD7	chr7:117864712-117882782:+	0.28	4.68	3.75E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs420259	chr16:23634026	COG7	chr16:23399816-23464503:-	-0.23	-5.24	2.43E-7	Bipolar disorder	
THCA	cis	1	rs420259	chr16:23634026	DCTN5	chr16:23652807-23681182:+	-0.31	-8.04	7.28E-15	Bipolar disorder	
THCA	cis	1	rs420259	chr16:23634026	EARS2	chr16:23533335-23568696:-	0.18	4.52	7.88E-6	Bipolar disorder	
THCA	cis	1	rs421273	chr6:5073919	LYRM4	chr6:5108654-5261168:-	0.15	3.45	0.000613	Venous thromboembolism (SNP x SNP interaction)	
THCA	cis	1	rs422164	chr7:65586605	CCT6P1	chr7:65216092-65228661:+	0.42	6.7	5.9E-11	Diabetic kidney disease	
THCA	cis	1	rs422164	chr7:65586605	CRCP	chr7:65579805-65619551:+	-0.3	-4.63	4.66E-6	Diabetic kidney disease	
THCA	cis	1	rs422164	chr7:65586605	LOC493754	chr7:65993446-66057363:-	0.29	3.36	0.000833	Diabetic kidney disease	
THCA	cis	1	rs422164	chr7:65586605	RABGEF1	chr7:66093890-66276446:+	0.57	7.14	3.42E-12	Diabetic kidney disease	
THCA	cis	1	rs42234	chr7:117970148	ANKRD7	chr7:117864712-117882782:+	0.27	4.5	8.46E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs422424	chr20:25445446	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.86	2.13E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs422424	chr20:25445446	FAM182A	chr20:26035250-26067552:+	-0.19	-3.44	0.000643	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs422424	chr20:25445446	FAM182B	chr20:25744102-25848786:-	0.26	5.33	1.52E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs422424	chr20:25445446	NINL	chr20:25433338-25566153:-	-0.35	-7.19	2.46E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs422424	chr20:25445446	PYGB	chr20:25228706-25278647:+	-0.15	-3.67	0.000272	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs422844	chr20:25445591	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.86	2.13E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs422844	chr20:25445591	FAM182A	chr20:26035250-26067552:+	-0.19	-3.44	0.000643	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs422844	chr20:25445591	FAM182B	chr20:25744102-25848786:-	0.26	5.33	1.52E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs422844	chr20:25445591	NINL	chr20:25433338-25566153:-	-0.35	-7.19	2.46E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs422844	chr20:25445591	PYGB	chr20:25228706-25278647:+	-0.15	-3.67	0.000272	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4233708	chr2:26291345	GPR113	chr2:26531041-26569685:-	-0.44	-7.03	7.17E-12	Gut microbiome composition (summer)	
THCA	cis	1	rs4233709	chr2:26291493	GPR113	chr2:26531041-26569685:-	0.41	6.43	3.18E-10	Gut microbiome composition (summer)	
THCA	cis	1	rs4233710	chr2:26291565	GPR113	chr2:26531041-26569685:-	-0.47	-7.3	1.18E-12	Gut microbiome composition (summer)	
THCA	cis	1	rs4233710	chr2:26291565	HADHA	chr2:26413505-26467594:-	-0.17	-3.48	0.000541	Gut microbiome composition (summer)	
THCA	cis	1	rs4234797	chr4:7219907	SORCS2	chr4:7194374-7744563:+	-0.36	-9.1	2.44E-18	Insulin-like growth factors	
THCA	cis	1	rs4234798	chr4:7219933	SORCS2	chr4:7194374-7744563:+	0.35	9.11	2.23E-18	Insulin-like growth factors	
THCA	cis	1	rs4237643	chr11:43648368	HSD17B12	chr11:43702143-43878160:+	0.68	14.11	4.87E-38	Forced vital capacity	
THCA	cis	1	rs42376	chr7:117981820	ANKRD7	chr7:117864712-117882782:+	0.27	4.5	8.46E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs4239227	chr17:28389103	ANKRD13B	chr17:27916801-27941778:+	-0.36	-8.84	1.85E-17	Coffee consumption (cups per day)	
THCA	cis	1	rs4239227	chr17:28389103	CORO6	chr17:27941774-27948441:-	-0.51	-11.74	4.02E-28	Coffee consumption (cups per day)	
THCA	cis	1	rs4239227	chr17:28389103	EFCAB5	chr17:28256874-28435469:+	-0.6	-11.33	1.63E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs4239227	chr17:28389103	GIT1	chr17:27900487-27916610:-	-0.29	-6.79	3.24E-11	Coffee consumption (cups per day)	
THCA	cis	1	rs4239227	chr17:28389103	LRRC37B2	chr17:28903483-28992715:+	-0.18	-3.94	9.28E-5	Coffee consumption (cups per day)	
THCA	cis	1	rs4239227	chr17:28389103	SSH2	chr17:27952965-28257018:-	-0.34	-7.67	9.71E-14	Coffee consumption (cups per day)	
THCA	cis	1	rs4239227	chr17:28389103	TP53I13	chr17:27895739-27900174:+	-0.2	-5.29	1.87E-7	Coffee consumption (cups per day)	
THCA	cis	1	rs4240624	chr8:9184231	SGK223	chr8:8175259-8239257:-	0.32	3.35	0.00086	C-reactive protein levels or triglyceride levels (pleiotropy);HDL cholesterol;HDL Cholesterol - Triglycerides (HDLC-TG);C-reactive protein levels or LDL-cholesterol levels (pleiotropy);Cholesterol, total;C-reactive protein levels;C-reactive protein levels or HDL-cholesterol levels (pleiotropy);Metab	
THCA	cis	1	rs4241407	chr3:49600319	GMPPB	chr3:49758932-49761384:-	-0.16	-3.68	0.00026	Menarche (age at onset)	
THCA	cis	1	rs4241407	chr3:49600319	P4HTM	chr3:49027341-49044579:+	0.17	4.29	2.16E-5	Menarche (age at onset)	
THCA	cis	1	rs4241407	chr3:49600319	WDR6	chr3:49044637-49053386:+	-0.17	-3.62	0.000324	Menarche (age at onset)	
THCA	cis	1	rs4241939	chr4:139119585	SLC7A11	chr4:139085248-139163503:-	0.22	4.58	5.93E-6	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	
THCA	cis	1	rs4241940	chr4:139119714	SLC7A11	chr4:139085248-139163503:-	0.23	4.71	3.19E-6	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	
THCA	cis	1	rs4242434	chr8:22501830	BIN3	chr8:22477949-22526661:-	0.16	4.27	2.35E-5	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	
THCA	cis	1	rs4242434	chr8:22501830	C8orf58	chr8:22457122-22461660:+	0.23	5.96	4.79E-9	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	
THCA	cis	1	rs4244338	chr10:102272802	SEC31B	chr10:102246403-102289636:-	-0.27	-8.76	3.52E-17	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs4244340	chr10:102499268	FBXW4	chr10:103370422-103454743:-	-0.17	-3.36	0.000845	Alzheimer's disease	
THCA	cis	1	rs4245128	chr11:112791983	NCAM1	chr11:112831995-113149157:+	0.2	4.79	2.28E-6	Life satisfaction	
THCA	cis	1	rs4245180	chr11:118144512	AMICA1	chr11:118064442-118095809:-	0.09	4.04	6.14E-5	Pain	
THCA	cis	1	rs4245180	chr11:118144512	MPZL2	chr11:118124135-118135009:-	0.23	7.76	5.29E-14	Pain	
THCA	cis	1	rs4245180	chr11:118144512	TREH	chr11:118528942-118550381:-	-0.17	-3.42	0.000689	Pain	
THCA	cis	1	rs4245459	chr11:78065959	NARS2	chr11:78147017-78285909:-	-0.39	-6.92	1.49E-11	Testicular germ cell tumor	
THCA	cis	1	rs4246215	chr11:61564299	FADS2	chr11:61583728-61634825:+	0.42	9.4	2.3E-19	Phospholipid levels (plasma);Platelet count;Red blood cell fatty acid levels;Trans fatty acid levels;Inflammatory bowel disease	
THCA	cis	1	rs425105	chr19:47208481	FKRP	chr19:47249303-47261832:+	0.54	7.01	8.35E-12	Type 1 diabetes	
THCA	cis	1	rs425105	chr19:47208481	PRKD2	chr19:47177574-47220384:-	0.21	5.17	3.44E-7	Type 1 diabetes	
THCA	cis	1	rs4253766	chr22:46623905	PKDREJ	chr22:46651561-46659219:-	-0.45	-5.54	4.94E-8	Cholesterol, total;LDL cholesterol	
THCA	cis	1	rs4253772	chr22:46627603	PKDREJ	chr22:46651561-46659219:-	-0.5	-5.8	1.18E-8	Cholesterol, total;LDL cholesterol	
THCA	cis	1	rs4256922	chr10:52568616	ASAH2B	chr10:52499696-52514567:+	-0.26	-3.97	8.19E-5	Urate levels in lean individuals	
THCA	cis	1	rs4260416	chr3:10125283	C3orf10	chr3:10157333-10168873:+	-0.2	-4.19	3.33E-5	Alzheimer's disease	
THCA	cis	1	rs4260416	chr3:10125283	VHL	chr3:10183319-10193744:+	-0.19	-4.37	1.54E-5	Alzheimer's disease	
THCA	cis	1	rs4260737	chr6:163137746	PACRG	chr6:163148164-163736523:+	0.54	7.47	3.95E-13	Body mass index	
THCA	cis	1	rs4261510	chr15:90890606	IQGAP1	chr15:90931473-91045475:+	0.15	4.63	4.67E-6	Rheumatoid arthritis	
THCA	cis	1	rs4261510	chr15:90890606	TTLL13	chr15:90792764-90815443:+	0.3	5.15	3.83E-7	Rheumatoid arthritis	
THCA	cis	1	rs4261913	chr3:119546197	GSK3B	chr3:119540804-119813264:-	-0.14	-4.9	1.32E-6	HDL cholesterol	
THCA	cis	1	rs4263408	chr4:39785276	RPL9	chr4:39455747-39460568:-	-0.43	-7.98	1.08E-14	Plasma amyloid beta peptide concentrations (ABx-40)	
THCA	cis	1	rs4263408	chr4:39785276	UBE2K	chr4:39699664-39784408:+	-0.16	-3.92	0.000102	Plasma amyloid beta peptide concentrations (ABx-40)	
THCA	cis	1	rs42648	chr7:89977760	GTPBP10	chr7:89969690-90016650:+	0.19	4.86	1.61E-6	Homocysteine levels	
THCA	cis	1	rs42649	chr7:89977789	GTPBP10	chr7:89969690-90016650:+	0.19	4.78	2.32E-6	Homocysteine levels	
THCA	cis	1	rs4265148	chr8:10816503	CTSB	chr8:11700036-11725646:-	0.22	3.47	0.000575	Asthma and hay fever	
THCA	cis	1	rs42656	chr7:89981636	GTPBP10	chr7:89969690-90016650:+	0.2	4.99	8.62E-7	Homocysteine levels	
THCA	cis	1	rs4265793	chr16:19028549	COQ7	chr16:19078927-19091350:+	-0.29	-3.76	0.000188	Response to angiotensin II receptor blocker therapy	
THCA	cis	1	rs42658	chr7:89981915	GTPBP10	chr7:89969690-90016650:+	0.18	4.75	2.74E-6	Homocysteine levels	
THCA	cis	1	rs4267943	chr6:49439805	CENPQ	chr6:49431096-49460820:+	0.24	5.02	7.46E-7	Folate pathway vitamin levels	
THCA	cis	1	rs4267943	chr6:49439805	MUT	chr6:49398994-49431031:-	-0.28	-9.42	1.93E-19	Folate pathway vitamin levels	
THCA	cis	1	rs4268415	chr10:4983590	AKR1C2	chr10:4964715-5060207:-	0.27	3.72	0.000226	Height	
THCA	cis	1	rs4269070	chr3:10126083	C3orf10	chr3:10157333-10168873:+	-0.2	-4.19	3.33E-5	Alzheimer's disease	
THCA	cis	1	rs4269070	chr3:10126083	VHL	chr3:10183319-10193744:+	-0.19	-4.37	1.54E-5	Alzheimer's disease	
THCA	cis	1	rs4269248	chr4:118650663	NDST3	chr4:118954773-119179786:+	-0.25	-4.79	2.27E-6	Neutrophil count	
THCA	cis	1	rs4270096	chr14:97315536	VRK1	chr14:97263684-97347950:+	0.17	3.87	0.000122	Neutrophil count	
THCA	cis	1	rs4270120	chr15:45936234	SPATA5L1	chr15:45694519-45713614:+	0.3	4.92	1.21E-6	Obesity-related traits	
THCA	cis	1	rs427044	chr7:65508545	CCT6P1	chr7:65216092-65228661:+	0.39	6.25	9.2E-10	Diabetic kidney disease	
THCA	cis	1	rs427044	chr7:65508545	CRCP	chr7:65579805-65619551:+	-0.28	-4.29	2.19E-5	Diabetic kidney disease	
THCA	cis	1	rs427044	chr7:65508545	RABGEF1	chr7:66093890-66276446:+	0.57	7.16	3.09E-12	Diabetic kidney disease	
THCA	cis	1	rs4271550	chr15:45936266	SPATA5L1	chr15:45694519-45713614:+	0.3	4.85	1.7E-6	Obesity-related traits	
THCA	cis	1	rs4271626	chr17:65930133	C17orf58	chr17:65987218-65989765:-	0.19	3.84	0.00014	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs4273380	chr3:160950314	NMD3	chr3:160939099-160971319:+	-0.11	-3.71	0.000231	Morning vs. evening chronotype	
THCA	cis	1	rs4274254	chr12:81458128	ACSS3	chr12:81471809-81649582:+	0.22	4.67	4.01E-6	Neuroticism	
THCA	cis	1	rs4277047	chr10:102499416	FBXW4	chr10:103370422-103454743:-	-0.17	-3.35	0.000873	Alzheimer's disease	
THCA	cis	1	rs4279493	chr7:66226620	GUSB	chr7:65425675-65447246:-	0.34	6.84	2.43E-11	Aortic root size	
THCA	cis	1	rs4279493	chr7:66226620	RABGEF1	chr7:66093890-66276446:+	0.52	10.69	4.74E-24	Aortic root size	
THCA	cis	1	rs4279493	chr7:66226620	TYW1	chr7:66461817-66704496:+	0.18	3.89	0.000116	Aortic root size	
THCA	cis	1	rs4279530	chr7:118070771	ANKRD7	chr7:117864712-117882782:+	-0.27	-4.47	9.57E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs4280164	chr14:24771285	ADCY4	chr14:24787571-24804277:-	0.23	6.76	4.12E-11	Parent of origin effect on language impairment (paternal)	
THCA	cis	1	rs4280164	chr14:24771285	LTB4R2	chr14:24778161-24781259:+	-0.25	-3.95	9.1E-5	Parent of origin effect on language impairment (paternal)	
THCA	cis	1	rs4280164	chr14:24771285	LTB4R	chr14:24780705-24787061:+	-0.3	-5.39	1.11E-7	Parent of origin effect on language impairment (paternal)	
THCA	cis	1	rs4280164	chr14:24771285	RABGGTA	chr14:24734746-24740803:-	-0.16	-3.6	0.000355	Parent of origin effect on language impairment (paternal)	
THCA	cis	1	rs4280918	chr5:110162078	TMEM232	chr5:109624934-110062381:-	0.2	4.01	7.14E-5	Asthma and hay fever	
THCA	cis	1	rs4282209	chr4:76919536	NAAA	chr4:76831809-76862166:-	-0.33	-6.54	1.61E-10	Longevity	
THCA	cis	1	rs4282551	chr8:124185916	FAM83A	chr8:124191287-124222317:+	-0.34	-4.19	3.33E-5	Urinary uromodulin levels	
THCA	cis	1	rs4282626	chr9:102690180	STX17	chr9:102668915-102736817:+	-0.17	-4.33	1.86E-5	Alopecia areata	
THCA	cis	1	rs4283605	chr3:49678651	MST1	chr3:49721381-49726196:-	0.13	3.77	0.000183	Crohn's disease;Ulcerative colitis	
THCA	cis	1	rs4283834	chr5:115521463	COMMD10	chr5:115420727-115628978:+	0.48	5.84	9.44E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs428445	chr20:55036547	C20orf43	chr20:55043647-55093942:+	-0.29	-7.75	5.4E-14	Refractive astigmatism	
THCA	cis	1	rs428445	chr20:55036547	CSTF1	chr20:54967427-54979582:+	-0.16	-3.37	0.000823	Refractive astigmatism	
THCA	cis	1	rs4285028	chr3:121660664	IQCB1	chr3:121488610-121553926:-	-0.36	-6.56	1.43E-10	Multiple sclerosis	
THCA	cis	1	rs4285028	chr3:121660664	SLC15A2	chr3:121613171-121663034:+	0.23	4.51	8.22E-6	Multiple sclerosis	
THCA	cis	1	rs4285139	chr4:139120053	SLC7A11	chr4:139085248-139163503:-	0.22	4.44	1.12E-5	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	
THCA	cis	1	rs4286716	chr5:115519697	COMMD10	chr5:115420727-115628978:+	-0.47	-6.01	3.78E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs4287250	chr10:23664391	C10orf67	chr10:23605521-23633772:-	-0.23	-4.51	8.16E-6	Crohn's disease and sarcoidosis (combined)	
THCA	cis	1	rs4293565	chr2:241834770	C2orf54	chr2:241825466-241835573:-	0.29	6.1	2.22E-9	Urinary metabolites	
THCA	cis	1	rs4294134	chr7:135293128	PL-5283	chr7:135347221-135378160:+	0.68	15.63	8.49E-45	Paget's disease	
THCA	cis	1	rs4294134	chr7:135293128	SLC13A4	chr7:135365993-135412933:-	-0.68	-11.27	2.82E-26	Paget's disease	
THCA	cis	1	rs4295483	chr6:55965456	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs4295484	chr6:55965646	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs429657	chr15:65813764	DPP8	chr15:65737999-65810035:-	0.09	3.7	0.000244	Mean corpuscular hemoglobin	
THCA	cis	1	rs429657	chr15:65813764	SLC24A1	chr15:65903704-65953256:+	0.15	3.63	0.000318	Mean corpuscular hemoglobin	
THCA	cis	1	rs4297570	chr13:36755179	SOHLH2	chr13:36742347-36871992:-	-0.39	-6.67	7.2E-11	Glucose homeostasis traits	
THCA	cis	1	rs4299518	chr3:45809273	LARS2	chr3:45430075-45590328:+	0.12	3.56	0.000412	Hirschsprung disease	
THCA	cis	1	rs4299518	chr3:45809273	SACM1L	chr3:45730754-45786900:+	0.13	4.39	1.37E-5	Hirschsprung disease	
THCA	cis	1	rs4303338	chr13:95876101	ABCC4	chr13:95672084-95953687:-	0.18	3.51	0.000499	Breast cancer	
THCA	cis	1	rs4304115	chr5:110403346	TSLP	chr5:110405778-110413722:+	-0.28	-3.53	0.000451	Eosinophil counts	
THCA	cis	1	rs4304115	chr5:110403346	WDR36	chr5:110427870-110466201:+	0.22	4	7.45E-5	Eosinophil counts	
THCA	cis	1	rs4304126	chr6:70512767	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.44	0.000626	Sleep duration	
THCA	cis	1	rs4304957	chr14:76647572	ESRRB	chr14:76837690-76968178:+	0.28	4.51	8.12E-6	Blood pressure	
THCA	cis	1	rs4307563	chr1:16313788	CLCNKA	chr1:16345370-16360544:+	0.13	3.67	0.000267	Dilated cardiomyopathy	
THCA	cis	1	rs4307563	chr1:16313788	HSPB7	chr1:16340523-16346089:-	0.55	11.19	5.77E-26	Dilated cardiomyopathy	
THCA	cis	1	rs4309773	chr3:134277301	ANAPC13	chr3:134196547-134204865:-	0.39	12.58	1.56E-31	Height	
THCA	cis	1	rs4309773	chr3:134277301	CEP63	chr3:134204575-134293852:+	0.3	6.54	1.63E-10	Height	
THCA	cis	1	rs4310508	chr10:65138573	NRBF2	chr10:64893007-64914785:+	-0.29	-6.82	2.69E-11	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs431076	chr7:65600320	CCT6P1	chr7:65216092-65228661:+	0.42	6.7	5.9E-11	Diabetic kidney disease	
THCA	cis	1	rs431076	chr7:65600320	CRCP	chr7:65579805-65619551:+	-0.3	-4.63	4.66E-6	Diabetic kidney disease	
THCA	cis	1	rs431076	chr7:65600320	LOC493754	chr7:65993446-66057363:-	0.29	3.36	0.000833	Diabetic kidney disease	
THCA	cis	1	rs431076	chr7:65600320	RABGEF1	chr7:66093890-66276446:+	0.57	7.14	3.42E-12	Diabetic kidney disease	
THCA	cis	1	rs4311055	chr2:241821017	C2orf54	chr2:241825466-241835573:-	0.3	6.54	1.56E-10	Urinary metabolites	
THCA	cis	1	rs4311997	chr10:124179299	PLEKHA1	chr10:124134220-124191866:+	-0.21	-5.76	1.47E-8	Height	
THCA	cis	1	rs431318	chr7:65511597	CCT6P1	chr7:65216092-65228661:+	0.4	6.41	3.43E-10	Diabetic kidney disease	
THCA	cis	1	rs431318	chr7:65511597	CRCP	chr7:65579805-65619551:+	-0.28	-4.3	2.07E-5	Diabetic kidney disease	
THCA	cis	1	rs431318	chr7:65511597	RABGEF1	chr7:66093890-66276446:+	0.57	7.06	5.74E-12	Diabetic kidney disease	
THCA	cis	1	rs431328	chr19:22222236	ZNF257	chr19:22235266-22273901:+	0.31	6.35	5.0E-10	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs4318247	chr17:65882172	C17orf58	chr17:65987218-65989765:-	0.2	3.98	7.9E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs43184	chr5:56141777	C5orf35	chr5:56205103-56213010:+	1	22.99	2.46E-79	Type 2 diabetes	
THCA	cis	1	rs4322591	chr14:75600697	EIF2B2	chr14:75469612-75476292:+	0.19	5.12	4.49E-7	Height	
THCA	cis	1	rs4322591	chr14:75600697	MLH3	chr14:75480467-75518235:-	0.3	8.98	6.21E-18	Height	
THCA	cis	1	rs4322591	chr14:75600697	RPS6KL1	chr14:75372347-75389958:-	0.32	6.87	1.95E-11	Height	
THCA	cis	1	rs4323442	chr8:96022986	C8orf38	chr8:95908040-96088396:+	-0.25	-4.3	2.03E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs4323544	chr9:123647377	LOC253039	chr9:123605320-123616644:+	-0.5	-9.21	1.01E-18	Rheumatoid arthritis	
THCA	cis	1	rs4323544	chr9:123647377	PSMD5	chr9:123578334-123605206:-	-0.27	-5.21	2.79E-7	Rheumatoid arthritis	
THCA	cis	1	rs4325265	chr10:81733655	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs4326865	chr12:81458579	ACSS3	chr12:81471809-81649582:+	0.22	4.67	4.01E-6	Neuroticism	
THCA	cis	1	rs4328498	chr17:28344276	ANKRD13B	chr17:27916801-27941778:+	-0.37	-9.08	2.9E-18	Coffee consumption (cups per day)	
THCA	cis	1	rs4328498	chr17:28344276	CORO6	chr17:27941774-27948441:-	-0.5	-11.58	1.65E-27	Coffee consumption (cups per day)	
THCA	cis	1	rs4328498	chr17:28344276	EFCAB5	chr17:28256874-28435469:+	-0.59	-11.22	4.19E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs4328498	chr17:28344276	GIT1	chr17:27900487-27916610:-	-0.29	-6.75	4.24E-11	Coffee consumption (cups per day)	
THCA	cis	1	rs4328498	chr17:28344276	LRRC37B2	chr17:28903483-28992715:+	-0.17	-3.8	0.000161	Coffee consumption (cups per day)	
THCA	cis	1	rs4328498	chr17:28344276	SSH2	chr17:27952965-28257018:-	-0.34	-7.56	2.12E-13	Coffee consumption (cups per day)	
THCA	cis	1	rs4328498	chr17:28344276	TP53I13	chr17:27895739-27900174:+	-0.2	-5.41	9.75E-8	Coffee consumption (cups per day)	
THCA	cis	1	rs4330287	chr3:119288848	ADPRH	chr3:119298523-119308791:+	-0.21	-3.47	0.000565	Vitiligo	
THCA	cis	1	rs4332428	chr10:4965434	AKR1C2	chr10:4964715-5060207:-	0.3	3.98	8.11E-5	Height	
THCA	cis	1	rs4333673	chr9:109610456	ZNF462	chr9:109625378-109773789:+	-0.12	-3.9	0.000112	Height	
THCA	cis	1	rs4334136	chr13:95866778	ABCC4	chr13:95672084-95953687:-	-0.19	-3.64	0.000303	Breast cancer	
THCA	cis	1	rs4334685	chr3:134304335	ANAPC13	chr3:134196547-134204865:-	0.37	11.48	4.06E-27	Height	
THCA	cis	1	rs4334685	chr3:134304335	CEP63	chr3:134204575-134293852:+	0.3	6.4	3.75E-10	Height	
THCA	cis	1	rs4335481	chr10:81733840	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs433598	chr16:20680206	ACSM1	chr16:20634559-20709066:-	0.54	11.33	1.6E-26	Schizophrenia	
THCA	cis	1	rs433598	chr16:20680206	ACSM3	chr16:20775312-20808478:+	-0.18	-3.45	0.000602	Schizophrenia	
THCA	cis	1	rs4336432	chr6:55946490	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs4338555	chr11:71755696	FAM86C	chr11:71498557-71512276:+	0.32	3.91	0.000107	Severe influenza A (H1N1) infection	
THCA	cis	1	rs4338740	chr15:49735297	DTWD1	chr15:49913226-49937332:+	-0.17	-3.98	7.9E-5	Thyroid volume	
THCA	cis	1	rs4338740	chr15:49735297	GALK2	chr15:49447976-49622002:+	0.17	3.74	0.000206	Thyroid volume	
THCA	cis	1	rs4338740	chr15:49735297	SECISBP2L	chr15:49280967-49338630:-	0.16	4.48	9.29E-6	Thyroid volume	
THCA	cis	1	rs4338740	chr15:49735297	SLC27A2	chr15:50474393-50528588:+	0.21	3.4	0.000735	Thyroid volume	
THCA	cis	1	rs4341440	chr10:4965293	AKR1C2	chr10:4964715-5060207:-	0.3	3.97	8.28E-5	Height	
THCA	cis	1	rs4342423	chr6:33732679	LEMD2	chr6:33738991-33756906:-	-0.3	-6.8	3.22E-11	Crohn's disease	
THCA	cis	1	rs4344199	chr9:99549449	FAM22G	chr9:99690592-99704572:+	0.84	7.08	5.04E-12	Height	
THCA	cis	1	rs4344199	chr9:99549449	HIATL2	chr9:99695549-99775862:-	0.6	5.1	4.83E-7	Height	
THCA	cis	1	rs4344199	chr9:99549449	NCBP1	chr9:100395705-100436027:+	-0.29	-3.85	0.000135	Height	
THCA	cis	1	rs4344931	chr2:241818527	C2orf54	chr2:241825466-241835573:-	0.3	6.57	1.29E-10	Urinary metabolites	
THCA	cis	1	rs4345885	chr10:135191311	ECHS1	chr10:135175988-135186908:-	0.52	7.16	3.05E-12	Lifespan	
THCA	cis	1	rs4346380	chr2:242263223	ANO7	chr2:242127924-242164791:+	0.38	4.33	1.85E-5	Prostate cancer	
THCA	cis	1	rs4346380	chr2:242263223	SEPT2	chr2:242254723-242293439:+	-0.29	-4.09	5.0E-5	Prostate cancer	
THCA	cis	1	rs4346698	chr4:139119793	SLC7A11	chr4:139085248-139163503:-	0.22	4.47	9.97E-6	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	
THCA	cis	1	rs4348727	chr1:10265606	KIF1B	chr1:10270764-10441659:+	0.2	6.11	2.03E-9	Hepatocellular carcinoma	
THCA	cis	1	rs435043	chr1:214828812	KCNK2	chr1:215178885-215410435:+	0.17	3.58	0.000372	Response to antineoplastic agents	
THCA	cis	1	rs4350617	chr17:28423088	ANKRD13B	chr17:27916801-27941778:+	0.36	8.9	1.2E-17	Coffee consumption (cups per day)	
THCA	cis	1	rs4350617	chr17:28423088	CORO6	chr17:27941774-27948441:-	0.51	11.83	1.64E-28	Coffee consumption (cups per day)	
THCA	cis	1	rs4350617	chr17:28423088	EFCAB5	chr17:28256874-28435469:+	0.59	11.17	6.8E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs4350617	chr17:28423088	GIT1	chr17:27900487-27916610:-	0.29	6.78	3.53E-11	Coffee consumption (cups per day)	
THCA	cis	1	rs4350617	chr17:28423088	LRRC37B2	chr17:28903483-28992715:+	0.17	3.78	0.000176	Coffee consumption (cups per day)	
THCA	cis	1	rs4350617	chr17:28423088	SSH2	chr17:27952965-28257018:-	0.37	8.34	7.97E-16	Coffee consumption (cups per day)	
THCA	cis	1	rs4350617	chr17:28423088	TP53I13	chr17:27895739-27900174:+	0.21	5.6	3.54E-8	Coffee consumption (cups per day)	
THCA	cis	1	rs4350933	chr3:160955879	NMD3	chr3:160939099-160971319:+	-0.11	-3.59	0.000363	Morning vs. evening chronotype	
THCA	cis	1	rs4351285	chr6:159384673	RSPH3	chr6:159398268-159421198:-	0.29	6.05	2.96E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs4351999	chr15:65992380	DPP8	chr15:65737999-65810035:-	-0.09	-3.92	0.000103	Mean corpuscular hemoglobin	
THCA	cis	1	rs4351999	chr15:65992380	SLC24A1	chr15:65903704-65953256:+	-0.16	-3.83	0.000148	Mean corpuscular hemoglobin	
THCA	cis	1	rs4353250	chr11:18323517	GTF2H1	chr11:18343816-18388590:+	0.37	9.94	2.7E-21	Pancreatic cancer	
THCA	cis	1	rs4356975	chr4:69972463	UGT2B11	chr4:70066053-70080449:-	-0.19	-3.65	0.000294	Obesity-related traits	
THCA	cis	1	rs4358460	chr4:111382685	ENPEP	chr4:111397229-111484491:+	0.17	4.09	4.99E-5	Blood pressure	
THCA	cis	1	rs4359051	chr1:108373414	VAV3	chr1:108113782-108507545:-	0.57	8.13	3.62E-15	Hypothyroidism	
THCA	cis	1	rs436039	chr19:22214873	ZNF257	chr19:22235266-22273901:+	0.33	6.68	6.87E-11	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs4362735	chr3:58429893	PXK	chr3:58318617-58410878:+	0.32	5.87	8.34E-9	Cholesterol, total	
THCA	cis	1	rs4363385	chr1:152989321	SPRR3	chr1:152974223-152976332:+	-0.15	-3.36	0.000833	Inflammatory skin disease	
THCA	cis	1	rs4363822	chr15:67992583	C15orf61	chr15:67813522-67819638:+	0.12	3.36	0.00084	Motion sickness	
THCA	cis	1	rs4363822	chr15:67992583	IQCH	chr15:67547188-67794139:+	0.17	5.27	2.09E-7	Motion sickness	
THCA	cis	1	rs4363822	chr15:67992583	MAP2K5	chr15:67835021-68099451:+	0.15	3.64	0.000308	Motion sickness	
THCA	cis	1	rs436446	chr2:106409	SH3YL1	chr2:218138-264810:-	-0.27	-4.27	2.36E-5	Suicide attempts in bipolar disorder	
THCA	cis	1	rs4366668	chr15:65903398	DPP8	chr15:65737999-65810035:-	-0.1	-4.19	3.35E-5	Mean corpuscular hemoglobin	
THCA	cis	1	rs4366668	chr15:65903398	SLC24A1	chr15:65903704-65953256:+	-0.16	-3.88	0.000117	Mean corpuscular hemoglobin	
THCA	cis	1	rs4366964	chr20:42895906	C20orf111	chr20:42825137-42839431:-	-0.24	-3.48	0.000546	Cognitive performance	
THCA	cis	1	rs4367085	chr3:58389235	PXK	chr3:58318617-58410878:+	0.34	5.99	4.19E-9	Cholesterol, total	
THCA	cis	1	rs4367113	chr3:134287975	ANAPC13	chr3:134196547-134204865:-	0.4	12.93	5.06E-33	Height	
THCA	cis	1	rs4367113	chr3:134287975	CEP63	chr3:134204575-134293852:+	0.31	6.72	5.18E-11	Height	
THCA	cis	1	rs4367688	chr9:135791103	C9orf98	chr9:135600965-135754198:-	0.23	5.77	1.44E-8	Psoriasis	
THCA	cis	1	rs4368544	chr3:134300014	ANAPC13	chr3:134196547-134204865:-	-0.39	-12.22	4.44E-30	Height	
THCA	cis	1	rs4368544	chr3:134300014	CEP63	chr3:134204575-134293852:+	-0.31	-6.59	1.13E-10	Height	
THCA	cis	1	rs4369337	chr10:81733742	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs4370045	chr3:160943865	NMD3	chr3:160939099-160971319:+	-0.12	-3.76	0.000192	Morning vs. evening chronotype	
THCA	cis	1	rs4372836	chr2:28973883	PPP1CB	chr2:28974612-29025805:+	0.17	4.16	3.82E-5	Body mass index	
THCA	cis	1	rs4372836	chr2:28973883	TRMT61B	chr2:29072690-29093175:-	-0.51	-10.21	2.93E-22	Body mass index	
THCA	cis	1	rs437298	chr1:76113770	MSH4	chr1:76262630-76378923:+	-0.25	-4.24	2.74E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs4373160	chr4:106648641	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs4374383	chr2:112770770	MERTK	chr2:112656191-112786945:+	-0.16	-3.6	0.000355	Hepatitis C induced liver fibrosis	
THCA	cis	1	rs4375701	chr17:45712218	TBKBP1	chr17:45772630-45789427:+	-0.38	-10.63	7.68E-24	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
THCA	cis	1	rs4376175	chr4:77057905	NUP54	chr4:77035818-77069655:-	-0.17	-3.7	0.00024	Body mass index	
THCA	cis	1	rs4376778	chr1:46288846	CCDC163P	chr1:45960581-45965646:-	-0.51	-10.03	1.24E-21	Body mass index	
THCA	cis	1	rs4376778	chr1:46288846	GPBP1L1	chr1:46092978-46152302:-	0.16	4.07	5.54E-5	Body mass index	
THCA	cis	1	rs4376778	chr1:46288846	MMACHC	chr1:45965856-45976737:+	-0.19	-4.28	2.28E-5	Body mass index	
THCA	cis	1	rs4376778	chr1:46288846	MUTYH	chr1:45794915-45806142:-	0.31	8.34	7.97E-16	Body mass index	
THCA	cis	1	rs4377946	chr8:124185887	FAM83A	chr8:124191287-124222317:+	-0.34	-4.19	3.33E-5	Urinary uromodulin levels	
THCA	cis	1	rs437889	chr7:65509234	CCT6P1	chr7:65216092-65228661:+	0.4	6.39	3.94E-10	Diabetic kidney disease	
THCA	cis	1	rs437889	chr7:65509234	CRCP	chr7:65579805-65619551:+	-0.28	-4.27	2.41E-5	Diabetic kidney disease	
THCA	cis	1	rs437889	chr7:65509234	RABGEF1	chr7:66093890-66276446:+	0.57	7.14	3.48E-12	Diabetic kidney disease	
THCA	cis	1	rs4379723	chr10:64963449	NRBF2	chr10:64893007-64914785:+	-0.29	-6.95	1.22E-11	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4379	chr22:38569171	PLA2G6	chr22:38507502-38577836:-	0.09	3.35	0.000879	Cutaneous nevi	
THCA	cis	1	rs438034	chr1:214830617	KCNK2	chr1:215178885-215410435:+	0.17	3.57	0.000397	Response to antineoplastic agents	
THCA	cis	1	rs4381	chr22:38570791	PLA2G6	chr22:38507502-38577836:-	0.1	3.67	0.000273	Cutaneous nevi	
THCA	cis	1	rs4382	chr22:38570842	PLA2G6	chr22:38507502-38577836:-	0.1	3.67	0.000273	Cutaneous nevi	
THCA	cis	1	rs4385200	chr5:130487658	HINT1	chr5:130494875-130501034:-	-0.25	-3.5	0.000516	Diisocyanate-induced asthma	
THCA	cis	1	rs4387956	chr3:51915619	RAD54L2	chr3:51575596-51697610:+	0.08	3.68	0.000257	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs4388288	chr6:55948205	COL21A1	chr6:55921389-56258892:-	-0.66	-8.1	4.59E-15	Psychosis (atypical)	
THCA	cis	1	rs439295	chr3:156572455	LEKR1	chr3:156544076-156763918:+	-0.56	-11.28	2.62E-26	Bone mineral density	
THCA	cis	1	rs4394010	chr4:129894649	C4orf33	chr4:130014829-130033842:+	0.6	9.47	1.26E-19	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs4394894	chr12:81464831	ACSS3	chr12:81471809-81649582:+	0.24	5.07	5.74E-7	Neuroticism	
THCA	cis	1	rs4394895	chr12:81464942	ACSS3	chr12:81471809-81649582:+	0.24	5.07	5.74E-7	Neuroticism	
THCA	cis	1	rs4397735	chr10:4965543	AKR1C2	chr10:4964715-5060207:-	0.35	4.54	7.21E-6	Height	
THCA	cis	1	rs4398671	chr5:115557842	COMMD10	chr5:115420727-115628978:+	0.48	5.89	7.35E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs4399232	chr10:64999490	NRBF2	chr10:64893007-64914785:+	-0.28	-6.64	8.31E-11	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4399760	chr2:55157492	RTN4	chr2:55199329-55277734:-	-0.25	-5.01	7.5E-7	Obesity (extreme)	
THCA	cis	1	rs4400684	chr10:65012687	NRBF2	chr10:64893007-64914785:+	-0.28	-6.73	4.85E-11	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4404602	chr4:66470813	EPHA5	chr4:66185282-66535653:-	0.2	3.46	0.00059	HIV-1 viral setpoint	
THCA	cis	1	rs4404834	chr7:151116702	CRYGN	chr7:151127057-151137899:-	0.15	3.67	0.000273	Coronary heart disease	
THCA	cis	1	rs4405410	chr12:124435788	ZNF664	chr12:124457670-124499967:+	-0.17	-5.03	6.81E-7	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs4407214	chr2:29118258	TRMT61B	chr2:29072690-29093175:-	0.39	6.83	2.55E-11	Breast cancer (estrogen-receptor negative);Breast cancer	
THCA	cis	1	rs4407429	chr3:119288897	ADPRH	chr3:119298523-119308791:+	0.21	3.53	0.000458	Vitiligo	
THCA	cis	1	rs4408796	chr21:34698741	IFNAR1	chr21:34696734-34732126:+	-0.22	-5.3	1.82E-7	Narcolepsy	
THCA	cis	1	rs4408846	chr3:41753679	ULK4	chr3:41288091-42003660:-	1.05	18.74	3.91E-59	Diastolic blood pressure	
THCA	cis	1	rs4409766	chr10:104616663	AS3MT	chr10:104613967-104661653:+	-0.27	-3.83	0.000145	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs4409766	chr10:104616663	C10orf26	chr10:104503727-104591851:+	-0.19	-3.37	0.00082	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs4409766	chr10:104616663	INA	chr10:105036920-105050106:+	-0.24	-3.36	0.000834	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs4409766	chr10:104616663	SFXN2	chr10:104474298-104498946:+	-0.32	-3.93	9.77E-5	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs4410378	chr22:18451391	MICAL3	chr22:18270418-18507325:-	-0.2	-4.07	5.46E-5	Presence of antiphospholipid antibodies	
THCA	cis	1	rs441109	chr1:76120430	MSH4	chr1:76262630-76378923:+	-0.25	-4.24	2.73E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs441144	chr6:5073292	LYRM4	chr6:5108654-5261168:-	0.15	3.59	0.000368	Venous thromboembolism (SNP x SNP interaction)	
THCA	cis	1	rs4411512	chr16:31347445	HSD3B7	chr16:30996519-31000473:+	-0.16	-3.93	9.81E-5	IgA nephropathy	
THCA	cis	1	rs4416207	chr2:229016839	SPHKAP	chr2:228844670-229046361:-	-0.22	-3.35	0.00086	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	
THCA	cis	1	rs4417886	chr3:20108511	EFHB	chr3:19920968-19988501:-	0.24	3.47	0.000563	Bipolar disorder and schizophrenia	
THCA	cis	1	rs4417907	chr3:134291363	ANAPC13	chr3:134196547-134204865:-	0.4	12.7	4.92E-32	Height	
THCA	cis	1	rs4417907	chr3:134291363	CEP63	chr3:134204575-134293852:+	0.3	6.31	6.53E-10	Height	
THCA	cis	1	rs441810	chr21:42698907	FAM3B	chr21:42676177-42729654:+	0.49	7.48	3.59E-13	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
THCA	cis	1	rs4418153	chr6:70512679	LMBRD1	chr6:70385751-70506888:-	-0.09	-3.36	0.00085	Sleep duration	
THCA	cis	1	rs4420500	chr15:78962964	CHRNA5	chr15:78857906-78886458:+	-0.19	-3.53	0.000449	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs4420500	chr15:78962964	CHRNB4	chr15:78916636-78952874:-	0.19	3.52	0.00047	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs4422476	chr4:118651823	NDST3	chr4:118954773-119179786:+	-0.25	-4.79	2.27E-6	Neutrophil count	
THCA	cis	1	rs442309	chr10:64490495	ADO	chr10:64564516-64568238:+	-0.26	-5.32	1.61E-7	Vogt-Koyanagi-Harada syndrome	
THCA	cis	1	rs4423809	chr3:134300107	ANAPC13	chr3:134196547-134204865:-	-0.37	-11.34	1.51E-26	Height	
THCA	cis	1	rs4423809	chr3:134300107	CEP63	chr3:134204575-134293852:+	-0.3	-6.49	2.16E-10	Height	
THCA	cis	1	rs442446	chr19:12110074	ZNF763	chr19:12035900-12091196:+	-0.32	-3.88	0.000118	Multiple sclerosis	
THCA	cis	1	rs4426336	chr16:19027262	COQ7	chr16:19078927-19091350:+	-0.29	-3.91	0.000105	Response to angiotensin II receptor blocker therapy	
THCA	cis	1	rs4428327	chr4:40380204	CHRNA9	chr4:40337469-40356973:+	-0.32	-3.37	0.000803	Body mass index (change over time)	
THCA	cis	1	rs4431687	chr9:130111697	RPL12	chr9:130209955-130213684:-	0.12	3.63	0.000312	Metabolite levels (HVA)	
THCA	cis	1	rs4431687	chr9:130111697	SLC2A8	chr9:130159465-130170161:+	-0.13	-3.42	0.000684	Metabolite levels (HVA)	
THCA	cis	1	rs4442739	chr14:76647645	ESRRB	chr14:76837690-76968178:+	0.26	4.3	2.09E-5	Blood pressure	
THCA	cis	1	rs4443100	chr22:23372864	BCR	chr22:23522552-23660223:+	0.19	3.76	0.000193	Serum parathyroid hormone levels	
THCA	cis	1	rs4448568	chr1:146849017	FMO5	chr1:146655885-146697230:-	0.26	4.14	4.16E-5	Protein quantitative trait loci	
THCA	cis	1	rs444971	chr1:214831429	KCNK2	chr1:215178885-215410435:+	0.16	3.38	0.000771	Response to antineoplastic agents	
THCA	cis	1	rs4450360	chr15:31682030	FAM7A2	chr15:30864758-30892900:+	-0.52	-4.56	6.62E-6	Survival in colorectal cancer (non-distant metastatic)	
THCA	cis	1	rs4452748	chr7:50625056	FIGNL1	chr7:50511834-50518088:-	0.17	4.36	1.61E-5	Malaria	
THCA	cis	1	rs4452862	chr9:102706745	STX17	chr9:102668915-102736817:+	-0.17	-4.33	1.86E-5	Alopecia areata	
THCA	cis	1	rs4453193	chr11:46787406	DDB2	chr11:47236493-47260769:+	0.22	3.48	0.000544	HDL cholesterol	
THCA	cis	1	rs4453193	chr11:46787406	ZNF408	chr11:46722368-46727461:+	-0.19	-3.61	0.000338	HDL cholesterol	
THCA	cis	1	rs4453791	chr3:38882519	WDR48	chr3:39093507-39138149:+	0.28	3.65	0.000287	Social communication problems	
THCA	cis	1	rs4456560	chr17:5140399	C17orf87	chr17:5113901-5138083:-	0.16	3.68	0.000258	Alzheimer's disease (late onset)	
THCA	cis	1	rs4456560	chr17:5140399	SPNS2	chr17:4402129-4443228:+	0.19	3.92	9.95E-5	Alzheimer's disease (late onset)	
THCA	cis	1	rs4456560	chr17:5140399	ZNF232	chr17:5008839-5026397:-	-0.29	-3.81	0.000155	Alzheimer's disease (late onset)	
THCA	cis	1	rs4459386	chr12:50594947	C12orf62	chr12:50505900-50514234:+	0.11	4.28	2.26E-5	Schizophrenia	
THCA	cis	1	rs4460230	chr6:159369990	RSPH3	chr6:159398268-159421198:-	0.28	6	3.97E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs4464069	chr16:69816284	COG4	chr16:70514473-70557457:-	-0.22	-4.41	1.26E-5	IgE levels	
THCA	cis	1	rs4465649	chr17:28394747	ANKRD13B	chr17:27916801-27941778:+	-0.36	-8.96	7.37E-18	Coffee consumption (cups per day)	
THCA	cis	1	rs4465649	chr17:28394747	CORO6	chr17:27941774-27948441:-	-0.5	-11.6	1.33E-27	Coffee consumption (cups per day)	
THCA	cis	1	rs4465649	chr17:28394747	EFCAB5	chr17:28256874-28435469:+	-0.59	-11.24	3.52E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs4465649	chr17:28394747	GIT1	chr17:27900487-27916610:-	-0.28	-6.57	1.35E-10	Coffee consumption (cups per day)	
THCA	cis	1	rs4465649	chr17:28394747	LRRC37B2	chr17:28903483-28992715:+	-0.18	-3.85	0.000134	Coffee consumption (cups per day)	
THCA	cis	1	rs4465649	chr17:28394747	SSH2	chr17:27952965-28257018:-	-0.33	-7.54	2.31E-13	Coffee consumption (cups per day)	
THCA	cis	1	rs4465649	chr17:28394747	TP53I13	chr17:27895739-27900174:+	-0.2	-5.29	1.87E-7	Coffee consumption (cups per day)	
THCA	cis	1	rs4465650	chr17:28396721	ANKRD13B	chr17:27916801-27941778:+	0.36	8.9	1.16E-17	Coffee consumption (cups per day)	
THCA	cis	1	rs4465650	chr17:28396721	CORO6	chr17:27941774-27948441:-	0.51	11.91	7.85E-29	Coffee consumption (cups per day)	
THCA	cis	1	rs4465650	chr17:28396721	EFCAB5	chr17:28256874-28435469:+	0.6	11.44	5.96E-27	Coffee consumption (cups per day)	
THCA	cis	1	rs4465650	chr17:28396721	GIT1	chr17:27900487-27916610:-	0.29	6.74	4.71E-11	Coffee consumption (cups per day)	
THCA	cis	1	rs4465650	chr17:28396721	LRRC37B2	chr17:28903483-28992715:+	0.18	3.88	0.000117	Coffee consumption (cups per day)	
THCA	cis	1	rs4465650	chr17:28396721	SSH2	chr17:27952965-28257018:-	0.34	7.7	7.96E-14	Coffee consumption (cups per day)	
THCA	cis	1	rs4465650	chr17:28396721	TP53I13	chr17:27895739-27900174:+	0.2	5.39	1.13E-7	Coffee consumption (cups per day)	
THCA	cis	1	rs4465830	chr20:44585420	WFDC3	chr20:44402847-44420547:-	-0.28	-4.05	5.91E-5	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
THCA	cis	1	rs4465	chr22:35708790	HMGXB4	chr22:35653445-35691799:+	-0.11	-3.35	0.000887	Cholesterol, total	
THCA	cis	1	rs4466058	chr4:129923879	C4orf33	chr4:130014829-130033842:+	-0.59	-9.37	2.94E-19	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs4466712	chr10:64933268	LOC84989	chr10:65224989-65226320:+	0.27	4.33	1.86E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs4466712	chr10:64933268	NRBF2	chr10:64893007-64914785:+	0.28	4.71	3.22E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs4466773	chr10:81733564	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs4466774	chr10:81733786	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs4469291	chr6:49440614	CENPQ	chr6:49431096-49460820:+	-0.27	-5.52	5.46E-8	Folate pathway vitamin levels	
THCA	cis	1	rs4469291	chr6:49440614	MUT	chr6:49398994-49431031:-	0.28	9.69	2.1E-20	Folate pathway vitamin levels	
THCA	cis	1	rs4469774	chr10:65309777	LOC84989	chr10:65224989-65226320:+	0.23	3.65	0.000286	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs4469774	chr10:65309777	NRBF2	chr10:64893007-64914785:+	0.25	4.09	5.08E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs4473887	chr6:159369470	RSPH3	chr6:159398268-159421198:-	0.28	6	3.97E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs447722	chr20:25443510	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.86	2.13E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs447722	chr20:25443510	FAM182A	chr20:26035250-26067552:+	-0.19	-3.44	0.000643	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs447722	chr20:25443510	FAM182B	chr20:25744102-25848786:-	0.26	5.33	1.52E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs447722	chr20:25443510	NINL	chr20:25433338-25566153:-	-0.35	-7.19	2.46E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs447722	chr20:25443510	PYGB	chr20:25228706-25278647:+	-0.15	-3.67	0.000272	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4478072	chr3:53106125	RFT1	chr3:53122503-53164470:-	0.58	7.28	1.41E-12	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs448396	chr20:25440269	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.86	2.13E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs448396	chr20:25440269	FAM182A	chr20:26035250-26067552:+	-0.19	-3.44	0.000643	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs448396	chr20:25440269	FAM182B	chr20:25744102-25848786:-	0.26	5.33	1.52E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs448396	chr20:25440269	NINL	chr20:25433338-25566153:-	-0.35	-7.19	2.46E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs448396	chr20:25440269	PYGB	chr20:25228706-25278647:+	-0.15	-3.67	0.000272	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs448617	chr1:214831287	KCNK2	chr1:215178885-215410435:+	0.17	3.46	0.000597	Response to antineoplastic agents	
THCA	cis	1	rs4486677	chr12:8669116	CLEC4D	chr12:8666136-8674958:+	0.22	3.99	7.54E-5	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	
THCA	cis	1	rs4489133	chr6:163137793	PACRG	chr6:163148164-163736523:+	0.54	7.47	3.95E-13	Body mass index	
THCA	cis	1	rs4490383	chr3:48484683	ATRIP	chr3:48488141-48507708:+	0.19	4.22	2.93E-5	Longevity	
THCA	cis	1	rs4490383	chr3:48484683	TREX1	chr3:48501186-48509043:+	-0.25	-5.72	1.88E-8	Longevity	
THCA	cis	1	rs449043	chr21:42700410	FAM3B	chr21:42676177-42729654:+	-0.53	-7.9	1.88E-14	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
THCA	cis	1	rs4490669	chr6:56789465	BEND6	chr6:56819773-56892138:+	-0.28	-6.1	2.26E-9	Menarche (age at onset)	
THCA	cis	1	rs4490669	chr6:56789465	KIAA1586	chr6:56911384-56920021:+	-0.32	-5.26	2.14E-7	Menarche (age at onset)	
THCA	cis	1	rs4491945	chr3:119598725	GSK3B	chr3:119540804-119813264:-	-0.14	-4.93	1.11E-6	HDL cholesterol	
THCA	cis	1	rs4492844	chr11:78026516	NARS2	chr11:78147017-78285909:-	-0.35	-6.07	2.61E-9	Testicular germ cell tumor	
THCA	cis	1	rs449303	chr14:60605788	DHRS7	chr14:60611502-60636561:-	-0.51	-10.77	2.26E-24	Age-related hearing impairment (interaction)	
THCA	cis	1	rs4493587	chr4:185000525	ENPP6	chr4:185009860-185139114:-	-0.17	-3.38	0.000798	Serum dimethylarginine levels (asymmetric/symetric ratio)	
THCA	cis	1	rs4493873	chr8:92075643	LRRC69	chr8:92114847-92231464:+	-0.22	-3.66	0.000278	Migraine - clinic-based	
THCA	cis	1	rs4497676	chr16:69814950	COG4	chr16:70514473-70557457:-	-0.2	-4.01	7.08E-5	IgE levels	
THCA	cis	1	rs4497901	chr2:239969	SH3YL1	chr2:218138-264810:-	-0.93	-25.53	2.54E-91	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs4498009	chr3:134198008	ANAPC13	chr3:134196547-134204865:-	0.39	12.44	5.93E-31	Height	
THCA	cis	1	rs4498009	chr3:134198008	CEP63	chr3:134204575-134293852:+	0.29	6.29	7.36E-10	Height	
THCA	cis	1	rs4500718	chr16:68754312	NFATC3	chr16:68118654-68260837:+	-0.12	-3.37	0.000821	Colorectal cancer	
THCA	cis	1	rs4500751	chr16:15140211	NTAN1	chr16:15131717-15149833:-	0.14	4.07	5.48E-5	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs4500751	chr16:15140211	PDXDC1	chr16:15068599-15233195:+	0.31	7.32	1.04E-12	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs4502963	chr6:159369462	RSPH3	chr6:159398268-159421198:-	0.28	6	3.97E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs4504964	chr10:25208507	PRTFDC1	chr10:25137554-25241533:-	0.25	3.43	0.000644	Metabolite levels (Pyroglutamine)	
THCA	cis	1	rs4505186	chr13:95878852	ABCC4	chr13:95672084-95953687:-	-0.18	-3.41	0.000692	Breast cancer	
THCA	cis	1	rs4506917	chr16:31347350	HSD3B7	chr16:30996519-31000473:+	-0.16	-3.93	9.81E-5	IgA nephropathy	
THCA	cis	1	rs4508401	chr15:91514721	HDDC3	chr15:91474157-91475774:-	-0.15	-4.27	2.39E-5	Type 2 diabetes	
THCA	cis	1	rs4509126	chr6:170068058	C6orf70	chr6:170151721-170181617:+	0.27	5.27	2.05E-7	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs4509126	chr6:170068058	WDR27	chr6:169857307-170102159:-	-0.2	-6	3.97E-9	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs4509157	chr6:111835078	KIAA1919	chr6:111580482-111590259:+	0.44	5.61	3.39E-8	Psoriasis	
THCA	cis	1	rs4509693	chr10:102501571	FBXW4	chr10:103370422-103454743:-	-0.17	-3.35	0.000873	Alzheimer's disease	
THCA	cis	1	rs4509958	chr15:50894175	SPPL2A	chr15:50999739-51057910:-	0.28	7.43	5.07E-13	QT interval	
THCA	cis	1	rs4509958	chr15:50894175	TRPM7	chr15:50852491-50978994:-	0.11	3.47	0.000558	QT interval	
THCA	cis	1	rs4510208	chr2:203734866	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.93	5.93E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs4510208	chr2:203734866	ICA1L	chr2:203637873-203736371:-	0.25	4.18	3.49E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs4510228	chr2:17774685	GEN1	chr2:17935162-17966632:+	0.5	6.67	7.04E-11	Psychosis and Alzheimer's disease	
THCA	cis	1	rs4510229	chr2:17774701	GEN1	chr2:17935162-17966632:+	0.5	6.64	8.64E-11	Psychosis and Alzheimer's disease	
THCA	cis	1	rs451396	chr7:65484074	CCT6P1	chr7:65216092-65228661:+	0.41	6.48	2.28E-10	Diabetic kidney disease	
THCA	cis	1	rs451396	chr7:65484074	CRCP	chr7:65579805-65619551:+	-0.29	-4.42	1.22E-5	Diabetic kidney disease	
THCA	cis	1	rs451396	chr7:65484074	RABGEF1	chr7:66093890-66276446:+	0.53	6.66	7.52E-11	Diabetic kidney disease	
THCA	cis	1	rs4514789	chr19:52365654	ZNF577	chr19:52359056-52394145:-	-0.25	-5.97	4.54E-9	Breast cancer	
THCA	cis	1	rs4514789	chr19:52365654	ZNF649	chr19:52392489-52408247:-	-0.19	-3.9	0.000112	Breast cancer	
THCA	cis	1	rs4515917	chr10:52758948	PRKG1	chr10:52750945-54055274:+	-0.2	-4.65	4.3E-6	Migraine	
THCA	cis	1	rs4520624	chr11:111172210	C11orf92	chr11:111164171-111175770:-	-0.18	-3.84	0.000138	Colorectal cancer	
THCA	cis	1	rs4520712	chr13:95878940	ABCC4	chr13:95672084-95953687:-	-0.18	-3.45	0.000609	Breast cancer	
THCA	cis	1	rs4525102	chr10:65086273	LOC84989	chr10:65224989-65226320:+	-0.27	-4.33	1.8E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs4525102	chr10:65086273	NRBF2	chr10:64893007-64914785:+	-0.28	-4.66	4.04E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs4525554	chr17:30312819	C17orf79	chr17:30178885-30186326:-	-0.2	-4.54	7.17E-6	Height	
THCA	cis	1	rs4525561	chr18:51835955	POLI	chr18:51795849-51824602:+	0.18	5.29	1.85E-7	Psoriasis	
THCA	cis	1	rs4531856	chr19:18388383	KIAA1683	chr19:18367906-18385319:-	-0.27	-7.94	1.47E-14	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs4531962	chr2:190526683	ASNSD1	chr2:190526125-190535556:+	-0.76	-8.25	1.55E-15	Subcutaneous adipose tissue	
THCA	cis	1	rs453329	chr20:25440593	ENTPD6	chr20:25176339-25207360:+	-0.31	-7.04	6.61E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs453329	chr20:25440593	FAM182A	chr20:26035250-26067552:+	-0.19	-3.5	0.000518	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs453329	chr20:25440593	FAM182B	chr20:25744102-25848786:-	0.26	5.31	1.73E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs453329	chr20:25440593	NINL	chr20:25433338-25566153:-	-0.36	-7.37	7.51E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs453329	chr20:25440593	PYGB	chr20:25228706-25278647:+	-0.15	-3.66	0.000282	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4533340	chr17:28277951	ANKRD13B	chr17:27916801-27941778:+	0.37	9.07	3.02E-18	Coffee consumption (cups per day)	
THCA	cis	1	rs4533340	chr17:28277951	CORO6	chr17:27941774-27948441:-	0.52	12.22	4.41E-30	Coffee consumption (cups per day)	
THCA	cis	1	rs4533340	chr17:28277951	EFCAB5	chr17:28256874-28435469:+	0.6	11.36	1.18E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs4533340	chr17:28277951	GIT1	chr17:27900487-27916610:-	0.31	7.22	2.07E-12	Coffee consumption (cups per day)	
THCA	cis	1	rs4533340	chr17:28277951	LRRC37B2	chr17:28903483-28992715:+	0.18	4.03	6.62E-5	Coffee consumption (cups per day)	
THCA	cis	1	rs4533340	chr17:28277951	SSH2	chr17:27952965-28257018:-	0.34	7.72	6.87E-14	Coffee consumption (cups per day)	
THCA	cis	1	rs4533340	chr17:28277951	TP53I13	chr17:27895739-27900174:+	0.2	5.46	7.57E-8	Coffee consumption (cups per day)	
THCA	cis	1	rs4534636	chr12:8666801	CLEC4D	chr12:8666136-8674958:+	0.21	3.68	0.000258	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	
THCA	cis	1	rs4535272	chr3:134299916	ANAPC13	chr3:134196547-134204865:-	-0.39	-12.53	2.41E-31	Height	
THCA	cis	1	rs4535272	chr3:134299916	CEP63	chr3:134204575-134293852:+	-0.3	-6.48	2.33E-10	Height	
THCA	cis	1	rs4538799	chr7:118066964	ANKRD7	chr7:117864712-117882782:+	-0.27	-4.36	1.58E-5	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs45439091	chr11:119054208	CBL	chr11:119076990-119178858:+	-0.22	-4.35	1.64E-5	Platelet count	
THCA	cis	1	rs4544218	chr15:91520373	HDDC3	chr15:91474157-91475774:-	-0.15	-3.99	7.68E-5	Type 2 diabetes	
THCA	cis	1	rs454422	chr20:5943693	MCM8	chr20:5931298-5975829:+	-0.32	-7.17	2.81E-12	HIV-1 viral setpoint	
THCA	cis	1	rs4544908	chr6:55946166	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs45449597	chr1:11857925	MTHFR	chr1:11845787-11866115:-	0.23	3.45	0.000615	Homocysteine levels	
THCA	cis	1	rs4545281	chr1:46360054	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.28	1.58E-22	Body mass index	
THCA	cis	1	rs4545281	chr1:46360054	GPBP1L1	chr1:46092978-46152302:-	0.16	4.06	5.76E-5	Body mass index	
THCA	cis	1	rs4545281	chr1:46360054	MMACHC	chr1:45965856-45976737:+	-0.2	-4.48	9.17E-6	Body mass index	
THCA	cis	1	rs4545281	chr1:46360054	MUTYH	chr1:45794915-45806142:-	0.32	8.59	1.24E-16	Body mass index	
THCA	cis	1	rs45469101	chr20:61875007	BIRC7	chr20:61867276-61871853:+	0.36	4.22	2.95E-5	Response to cytadine analogues (cytosine arabinoside)	
THCA	cis	1	rs45469101	chr20:61875007	NKAIN4	chr20:61872137-61885892:-	0.37	3.9	0.000111	Response to cytadine analogues (cytosine arabinoside)	
THCA	cis	1	rs45472399	chr10:17209967	TRDMT1	chr10:17184983-17243681:-	-0.44	-10.32	1.08E-22	Homocysteine levels	
THCA	cis	1	rs45472399	chr10:17209967	VIM	chr10:17270258-17279592:+	-0.19	-3.52	0.000466	Homocysteine levels	
THCA	cis	1	rs4547797	chr4:103557192	CISD2	chr4:103790135-103809913:+	-0.16	-3.62	0.000321	Primary biliary cirrhosis	
THCA	cis	1	rs4547797	chr4:103557192	NFKB1	chr4:103422486-103538458:+	0.15	4.2	3.16E-5	Primary biliary cirrhosis	
THCA	cis	1	rs4548056	chr7:65298873	CCT6P1	chr7:65216092-65228661:+	0.39	6.13	1.83E-9	Diabetic kidney disease	
THCA	cis	1	rs4548056	chr7:65298873	CRCP	chr7:65579805-65619551:+	-0.26	-4.07	5.41E-5	Diabetic kidney disease	
THCA	cis	1	rs4548056	chr7:65298873	RABGEF1	chr7:66093890-66276446:+	0.54	6.68	6.63E-11	Diabetic kidney disease	
THCA	cis	1	rs4549034	chr2:28972579	PPP1CB	chr2:28974612-29025805:+	0.17	4.16	3.82E-5	Body mass index	
THCA	cis	1	rs4549034	chr2:28972579	TRMT61B	chr2:29072690-29093175:-	-0.51	-10.21	2.93E-22	Body mass index	
THCA	cis	1	rs4549329	chr4:239785	ZNF718	chr4:53272-156488:+	0.52	10.26	1.82E-22	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs45504202	chr1:11858550	MTHFR	chr1:11845787-11866115:-	0.23	3.45	0.000615	Homocysteine levels	
THCA	cis	1	rs4552585	chr5:137533159	KLHL3	chr5:136953190-137071779:-	-0.13	-3.52	0.000475	Resting heart rate	
THCA	cis	1	rs4553120	chr1:47165729	CYP4B1	chr1:47264670-47285020:+	0.22	3.45	0.00061	Response to hepatitis C treatment	
THCA	cis	1	rs4553120	chr1:47165729	CYP4Z1	chr1:47533160-47583992:+	0.27	4.08	5.37E-5	Response to hepatitis C treatment	
THCA	cis	1	rs4553120	chr1:47165729	DMBX1	chr1:46972668-46979884:+	0.24	4.05	5.88E-5	Response to hepatitis C treatment	
THCA	cis	1	rs4553560	chr14:75334199	MLH3	chr14:75480467-75518235:-	-0.13	-3.47	0.000567	Caffeine consumption	
THCA	cis	1	rs4553560	chr14:75334199	RPS6KL1	chr14:75372347-75389958:-	-0.33	-6.76	3.98E-11	Caffeine consumption	
THCA	cis	1	rs4553671	chr17:46848272	CALCOCO2	chr17:46908372-46942228:+	-0.13	-3.51	0.000487	Schizophrenia or bipolar disorder	
THCA	cis	1	rs4553671	chr17:46848272	SNF8	chr17:47007461-47022154:-	-0.25	-7.19	2.47E-12	Schizophrenia or bipolar disorder	
THCA	cis	1	rs4553671	chr17:46848272	UBE2Z	chr17:46985767-47006422:+	-0.19	-3.95	9.16E-5	Schizophrenia or bipolar disorder	
THCA	cis	1	rs45559033	chr14:74341124	LIN52	chr14:74551656-74667117:+	0.25	4.56	6.56E-6	Morning vs. evening chronotype	
THCA	cis	1	rs45559033	chr14:74341124	PTGR2	chr14:74318534-74352166:+	0.22	3.57	0.000387	Morning vs. evening chronotype	
THCA	cis	1	rs45559033	chr14:74341124	ZNF410	chr14:74318674-74398803:+	0.22	3.74	0.000205	Morning vs. evening chronotype	
THCA	cis	1	rs45559535	chr6:70447993	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.47	0.000566	Sleep duration	
THCA	cis	1	rs4558117	chr10:52780284	PRKG1	chr10:52750945-54055274:+	-0.22	-5.01	7.75E-7	Migraine	
THCA	cis	1	rs45587933	chr19:46886234	CCDC8	chr19:46913587-46916919:-	-0.2	-3.37	0.000827	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs4559448	chr1:76203456	ACADM	chr1:76190043-76229353:+	0.13	3.69	0.000254	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs4559448	chr1:76203456	MSH4	chr1:76262630-76378923:+	0.24	4.03	6.58E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs4560537	chr5:150262586	LOC134466	chr5:150310000-150326146:-	0.38	5.4	1.04E-7	Crohn's disease	
THCA	cis	1	rs45608437	chr1:11857926	MTHFR	chr1:11845787-11866115:-	0.23	3.64	0.000304	Homocysteine levels	
THCA	cis	1	rs4560868	chr9:115985499	ALAD	chr9:116148593-116163618:-	-0.14	-3.49	0.000521	Hematology traits	
THCA	cis	1	rs4560868	chr9:115985499	BSPRY	chr9:116111812-116133512:+	-0.12	-3.62	0.000323	Hematology traits	
THCA	cis	1	rs4560868	chr9:115985499	CDC26	chr9:116029290-116037869:-	0.49	11.11	1.17E-25	Hematology traits	
THCA	cis	1	rs4560868	chr9:115985499	PRPF4	chr9:116037974-116055054:+	-0.19	-4.61	5.06E-6	Hematology traits	
THCA	cis	1	rs45615636	chr10:17210591	TRDMT1	chr10:17184983-17243681:-	-0.44	-10.18	3.77E-22	Homocysteine levels	
THCA	cis	1	rs45615636	chr10:17210591	VIM	chr10:17270258-17279592:+	-0.18	-3.36	0.00085	Homocysteine levels	
THCA	cis	1	rs4564516	chr15:62365107	VPS13C	chr15:62144592-62352647:-	-0.11	-4.12	4.5E-5	Height	
THCA	cis	1	rs4564643	chr17:76077894	TMC6	chr17:76108999-76128488:-	0.21	3.93	9.56E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs456611	chr3:161097268	NMD3	chr3:160939099-160971319:+	-0.1	-3.37	0.000801	Morning vs. evening chronotype	
THCA	cis	1	rs4568579	chr8:92072144	LRRC69	chr8:92114847-92231464:+	-0.23	-3.71	0.000231	Migraine - clinic-based	
THCA	cis	1	rs4569324	chr17:65872750	C17orf58	chr17:65987218-65989765:-	0.2	3.97	8.17E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs4572812	chr3:134291177	ANAPC13	chr3:134196547-134204865:-	-0.39	-12.33	1.64E-30	Height	
THCA	cis	1	rs4572812	chr3:134291177	CEP63	chr3:134204575-134293852:+	-0.31	-6.56	1.43E-10	Height	
THCA	cis	1	rs4575590	chr17:28361969	ANKRD13B	chr17:27916801-27941778:+	-0.36	-8.85	1.7E-17	Coffee consumption (cups per day)	
THCA	cis	1	rs4575590	chr17:28361969	CORO6	chr17:27941774-27948441:-	-0.51	-11.7	5.47E-28	Coffee consumption (cups per day)	
THCA	cis	1	rs4575590	chr17:28361969	EFCAB5	chr17:28256874-28435469:+	-0.6	-11.3	2.02E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs4575590	chr17:28361969	GIT1	chr17:27900487-27916610:-	-0.29	-6.8	3.15E-11	Coffee consumption (cups per day)	
THCA	cis	1	rs4575590	chr17:28361969	LRRC37B2	chr17:28903483-28992715:+	-0.18	-3.84	0.000141	Coffee consumption (cups per day)	
THCA	cis	1	rs4575590	chr17:28361969	SSH2	chr17:27952965-28257018:-	-0.34	-7.64	1.18E-13	Coffee consumption (cups per day)	
THCA	cis	1	rs4575590	chr17:28361969	TP53I13	chr17:27895739-27900174:+	-0.2	-5.3	1.81E-7	Coffee consumption (cups per day)	
THCA	cis	1	rs4579121	chr4:103558169	CISD2	chr4:103790135-103809913:+	-0.16	-3.62	0.000321	Primary biliary cirrhosis	
THCA	cis	1	rs4579121	chr4:103558169	NFKB1	chr4:103422486-103538458:+	0.15	4.2	3.16E-5	Primary biliary cirrhosis	
THCA	cis	1	rs4579248	chr5:150268151	LOC134466	chr5:150310000-150326146:-	0.43	5.7	2.1E-8	Crohn's disease	
THCA	cis	1	rs4579248	chr5:150268151	ZNF300	chr5:150273964-150284391:-	0.16	3.35	0.000867	Crohn's disease	
THCA	cis	1	rs4580150	chr16:69814953	COG4	chr16:70514473-70557457:-	-0.19	-3.95	9.15E-5	IgE levels	
THCA	cis	1	rs4580699	chr4:139120444	SLC7A11	chr4:139085248-139163503:-	0.22	4.47	9.97E-6	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	
THCA	cis	1	rs4580704	chr4:56326707	TMEM165	chr4:56262090-56292342:+	0.15	3.67	0.000266	Personality dimensions	
THCA	cis	1	rs4580915	chr6:111760764	KIAA1919	chr6:111580482-111590259:+	0.48	5.69	2.21E-8	Psoriasis	
THCA	cis	1	rs4581755	chr17:28427898	ANKRD13B	chr17:27916801-27941778:+	0.36	8.85	1.71E-17	Coffee consumption (cups per day)	
THCA	cis	1	rs4581755	chr17:28427898	CORO6	chr17:27941774-27948441:-	0.51	12.07	1.87E-29	Coffee consumption (cups per day)	
THCA	cis	1	rs4581755	chr17:28427898	EFCAB5	chr17:28256874-28435469:+	0.59	11.31	1.99E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs4581755	chr17:28427898	GIT1	chr17:27900487-27916610:-	0.28	6.71	5.4E-11	Coffee consumption (cups per day)	
THCA	cis	1	rs4581755	chr17:28427898	LRRC37B2	chr17:28903483-28992715:+	0.16	3.54	0.000433	Coffee consumption (cups per day)	
THCA	cis	1	rs4581755	chr17:28427898	SSH2	chr17:27952965-28257018:-	0.36	8.18	2.52E-15	Coffee consumption (cups per day)	
THCA	cis	1	rs4581755	chr17:28427898	TP53I13	chr17:27895739-27900174:+	0.2	5.29	1.88E-7	Coffee consumption (cups per day)	
THCA	cis	1	rs458196	chr22:29978026	NIPSNAP1	chr22:29950800-29977144:-	0.27	3.91	0.000104	Lipid traits	
THCA	cis	1	rs4582105	chr4:246342	ZNF718	chr4:53272-156488:+	0.51	9.47	1.25E-19	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs458291	chr7:65520479	CCT6P1	chr7:65216092-65228661:+	0.4	6.41	3.43E-10	Diabetic kidney disease	
THCA	cis	1	rs458291	chr7:65520479	CRCP	chr7:65579805-65619551:+	-0.28	-4.3	2.07E-5	Diabetic kidney disease	
THCA	cis	1	rs458291	chr7:65520479	RABGEF1	chr7:66093890-66276446:+	0.57	7.06	5.74E-12	Diabetic kidney disease	
THCA	cis	1	rs4585221	chr3:58415567	PXK	chr3:58318617-58410878:+	0.33	5.77	1.42E-8	Cholesterol, total	
THCA	cis	1	rs4585797	chr9:102674147	STX17	chr9:102668915-102736817:+	-0.17	-4.29	2.17E-5	Alopecia areata	
THCA	cis	1	rs4586937	chr4:103556462	NFKB1	chr4:103422486-103538458:+	-0.14	-3.91	0.000105	Primary biliary cirrhosis	
THCA	cis	1	rs459048	chr6:111689632	KIAA1919	chr6:111580482-111590259:+	0.48	5.6	3.62E-8	Psoriasis	
THCA	cis	1	rs4590755	chr10:23664813	C10orf67	chr10:23605521-23633772:-	-0.24	-4.69	3.61E-6	Crohn's disease and sarcoidosis (combined)	
THCA	cis	1	rs4590831	chr11:93640908	HEPHL1	chr11:93754378-93847374:+	-0.47	-4.09	5.14E-5	Obesity-related traits	
THCA	cis	1	rs4594164	chr14:35509571	FAM177A1	chr14:35514113-35552587:+	-0.22	-4.19	3.33E-5	Atopic dermatitis	
THCA	cis	1	rs4594164	chr14:35509571	KIAA0391	chr14:35591776-35786673:+	0.29	5.32	1.6E-7	Atopic dermatitis	
THCA	cis	1	rs4594164	chr14:35509571	PPP2R3C	chr14:35554679-35591679:-	0.52	9.83	6.81E-21	Atopic dermatitis	
THCA	cis	1	rs459498	chr21:42795027	MX1	chr21:42792520-42831140:+	-0.19	-3.76	0.00019	IgG glycosylation	
THCA	cis	1	rs459498	chr21:42795027	TFF2	chr21:43766469-43771208:-	-0.13	-3.42	0.00067	IgG glycosylation	
THCA	cis	1	rs4595427	chr10:65012944	NRBF2	chr10:64893007-64914785:+	-0.28	-6.73	4.85E-11	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4595905	chr19:18547305	ELL	chr19:18553475-18632937:-	-0.25	-6.49	2.2E-10	Breast cancer	
THCA	cis	1	rs4595905	chr19:18547305	ISYNA1	chr19:18545625-18548943:-	0.13	4.8	2.12E-6	Breast cancer	
THCA	cis	1	rs4595905	chr19:18547305	LRRC25	chr19:18501955-18508421:-	-0.14	-4.81	2.03E-6	Breast cancer	
THCA	cis	1	rs459697	chr3:161093420	NMD3	chr3:160939099-160971319:+	-0.11	-3.58	0.000377	Morning vs. evening chronotype	
THCA	cis	1	rs4597304	chr16:85055741	ZDHHC7	chr16:85008067-85045141:-	0.33	5.5	6.25E-8	Dysphagia	
THCA	cis	1	rs4597724	chr3:160963110	NMD3	chr3:160939099-160971319:+	-0.11	-3.72	0.000221	Morning vs. evening chronotype	
THCA	cis	1	rs459888	chr6:111651156	KIAA1919	chr6:111580482-111590259:+	-0.43	-5.15	3.72E-7	Psoriasis	
THCA	cis	1	rs4601178	chr6:109611246	CD164	chr6:109687718-109703762:-	0.13	3.41	0.000702	Red blood cell traits	
THCA	cis	1	rs4603880	chr22:31744721	RNF185	chr22:31556138-31603004:+	0.25	4.62	4.84E-6	Paclitaxel-induced neuropathy	
THCA	cis	1	rs4604102	chr4:139119779	SLC7A11	chr4:139085248-139163503:-	0.23	4.71	3.19E-6	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	
THCA	cis	1	rs4604805	chr10:102261409	SEC31B	chr10:102246403-102289636:-	-0.27	-8.82	2.11E-17	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs4604928	chr11:117044203	PCSK7	chr11:117075789-117102811:-	-0.4	-6.89	1.82E-11	Protein quantitative trait loci	
THCA	cis	1	rs460508	chr3:161091089	NMD3	chr3:160939099-160971319:+	0.11	3.67	0.000266	Morning vs. evening chronotype	
THCA	cis	1	rs4605213	chr17:49244747	NME1-NME2	chr17:49230920-49249104:+	0.32	6.46	2.66E-10	Height	
THCA	cis	1	rs4605213	chr17:49244747	NME2	chr17:49242891-49249104:+	-0.14	-5.15	3.81E-7	Height	
THCA	cis	1	rs4605709	chr4:139119926	SLC7A11	chr4:139085248-139163503:-	0.22	4.45	1.09E-5	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	
THCA	cis	1	rs4606360	chr1:173699007	KLHL20	chr1:173684080-173755838:+	0.12	3.41	0.000694	Subjective well-being	
THCA	cis	1	rs4606360	chr1:173699007	RABGAP1L	chr1:174128634-174959724:+	0.14	3.53	0.000449	Subjective well-being	
THCA	cis	1	rs4606360	chr1:173699007	SERPINC1	chr1:173872943-173886516:-	0.3	4.97	9.31E-7	Subjective well-being	
THCA	cis	1	rs4606536	chr12:45928887	LOC400027	chr12:46119810-46121530:-	0.13	3.52	0.000476	Hypertension	
THCA	cis	1	rs4608502	chr2:228134155	MFF	chr2:228189978-228222547:+	-0.23	-4.99	8.35E-7	Corneal structure	
THCA	cis	1	rs4609941	chr18:44645491	HDHD2	chr18:44633782-44676871:-	0.26	4.98	8.99E-7	Sitting height ratio	
THCA	cis	1	rs4609941	chr18:44645491	PIAS2	chr18:44392061-44500123:-	-0.15	-3.37	0.000804	Sitting height ratio	
THCA	cis	1	rs4611808	chr3:51469107	HEMK1	chr3:50606583-50622419:+	0.21	4.17	3.61E-5	Melanoma	
THCA	cis	1	rs4611808	chr3:51469107	TEX264	chr3:51705222-51738338:+	-0.23	-5.8	1.19E-8	Melanoma	
THCA	cis	1	rs4612933	chr13:95875614	ABCC4	chr13:95672084-95953687:-	-0.18	-3.46	0.000596	Breast cancer	
THCA	cis	1	rs4613123	chr17:20929295	USP22	chr17:20902908-20947073:-	-0.18	-3.85	0.000135	Blood trace element (Se levels)	
THCA	cis	1	rs4623374	chr8:10816520	CTSB	chr8:11700036-11725646:-	0.22	3.4	0.000738	Asthma and hay fever	
THCA	cis	1	rs4625780	chr17:30249214	C17orf79	chr17:30178885-30186326:-	-0.17	-4.37	1.55E-5	Height	
THCA	cis	1	rs4626559	chr8:10816487	CTSB	chr8:11700036-11725646:-	0.22	3.46	0.000578	Asthma and hay fever	
THCA	cis	1	rs4627050	chr11:18822037	PTPN5	chr11:18749478-18813389:-	-0.29	-5.93	5.92E-9	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	
THCA	cis	1	rs4627115	chr11:78007873	NARS2	chr11:78147017-78285909:-	-0.36	-6.41	3.42E-10	Testicular germ cell tumor	
THCA	cis	1	rs462853	chr7:65558167	CCT6P1	chr7:65216092-65228661:+	0.41	6.67	7.2E-11	Diabetic kidney disease	
THCA	cis	1	rs462853	chr7:65558167	CRCP	chr7:65579805-65619551:+	-0.3	-4.8	2.11E-6	Diabetic kidney disease	
THCA	cis	1	rs462853	chr7:65558167	LOC493754	chr7:65993446-66057363:-	0.3	3.6	0.000358	Diabetic kidney disease	
THCA	cis	1	rs462853	chr7:65558167	RABGEF1	chr7:66093890-66276446:+	0.52	6.65	8.06E-11	Diabetic kidney disease	
THCA	cis	1	rs4628584	chr10:4972697	AKR1C2	chr10:4964715-5060207:-	0.33	4.38	1.45E-5	Height	
THCA	cis	1	rs4631576	chr9:100705210	C9orf156	chr9:100666772-100684852:-	-0.16	-4.09	5.07E-5	Quantitative traits	
THCA	cis	1	rs4633	chr22:19950235	DGCR9	chr22:19005347-19007760:+	-0.17	-3.43	0.000645	Blood metabolite levels	
THCA	cis	1	rs4633	chr22:19950235	GNB1L	chr22:19775934-19842462:-	-0.16	-3.85	0.000136	Blood metabolite levels	
THCA	cis	1	rs4634872	chr1:29371390	MECR	chr1:29519385-29557454:-	-0.15	-3.71	0.000233	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs463543	chr6:111667552	KIAA1919	chr6:111580482-111590259:+	0.48	5.69	2.21E-8	Psoriasis	
THCA	cis	1	rs4635863	chr4:139120085	SLC7A11	chr4:139085248-139163503:-	0.22	4.46	1.01E-5	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	
THCA	cis	1	rs4638651	chr18:51829870	POLI	chr18:51795849-51824602:+	0.19	5.46	7.59E-8	Psoriasis	
THCA	cis	1	rs4640348	chr2:28965479	PPP1CB	chr2:28974612-29025805:+	0.17	4.28	2.24E-5	Body mass index	
THCA	cis	1	rs4640348	chr2:28965479	TRMT61B	chr2:29072690-29093175:-	-0.5	-10.11	6.85E-22	Body mass index	
THCA	cis	1	rs4641365	chr10:23666262	C10orf67	chr10:23605521-23633772:-	-0.24	-4.94	1.06E-6	Crohn's disease and sarcoidosis (combined)	
THCA	cis	1	rs4642101	chr3:12842223	CAND2	chr3:12838171-12876313:+	-0.17	-3.55	0.00043	QRS complex (12-leadsum)	
THCA	cis	1	rs4642241	chr4:17617111	MED28	chr4:17616273-17629791:+	0.16	3.51	0.000497	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs4642247	chr4:17957158	DCAF16	chr4:17802280-17812381:-	-0.2	-4.37	1.51E-5	Height	
THCA	cis	1	rs4643132	chr12:81458555	ACSS3	chr12:81471809-81649582:+	0.22	4.67	4.01E-6	Neuroticism	
THCA	cis	1	rs4643294	chr15:85250253	GOLGA6L5	chr15:85047738-85060078:-	-0.15	-3.86	0.000128	Schizophrenia	
THCA	cis	1	rs4643294	chr15:85250253	LOC388152	chr15:84867600-84898920:-	-0.48	-8.09	5.01E-15	Schizophrenia	
THCA	cis	1	rs4643294	chr15:85250253	NMB	chr15:85198362-85201802:-	0.37	7.72	6.74E-14	Schizophrenia	
THCA	cis	1	rs4643535	chr2:228133809	MFF	chr2:228189978-228222547:+	-0.23	-5.03	7.03E-7	Corneal structure	
THCA	cis	1	rs4643578	chr2:190526684	ASNSD1	chr2:190526125-190535556:+	-0.76	-8.25	1.55E-15	Subcutaneous adipose tissue	
THCA	cis	1	rs4644	chr14:55604935	KIAA0831	chr14:55833110-55878576:-	-0.12	-3.36	0.000854	Protein biomarker	
THCA	cis	1	rs4645525	chr8:10816174	CTSB	chr8:11700036-11725646:-	0.22	3.46	0.000578	Asthma and hay fever	
THCA	cis	1	rs4646457	chr7:99245080	ATP5J2	chr7:99055785-99063808:-	-0.18	-3.82	0.000152	Blood metabolite levels	
THCA	cis	1	rs4646457	chr7:99245080	ZNF655	chr7:99156045-99174074:+	-0.17	-3.51	0.000492	Blood metabolite levels	
THCA	cis	1	rs4646492	chr1:47281183	NSUN4	chr1:46806390-46830690:+	0.22	3.38	0.000772	Blood metabolite levels	
THCA	cis	1	rs4646536	chr12:58157988	FAM119B	chr12:58166383-58176323:+	0.38	10.71	4.0E-24	Multiple sclerosis	
THCA	cis	1	rs4646536	chr12:58157988	METTL1	chr12:58162352-58165914:-	-0.17	-4.35	1.69E-5	Multiple sclerosis	
THCA	cis	1	rs4646536	chr12:58157988	TSFM	chr12:58176536-58191367:+	-0.54	-18.57	2.47E-58	Multiple sclerosis	
THCA	cis	1	rs4646536	chr12:58157988	XRCC6BP1	chr12:58335445-58351051:+	-0.24	-4.9	1.31E-6	Multiple sclerosis	
THCA	cis	1	rs4646961	chr1:76217169	ACADM	chr1:76190043-76229353:+	0.13	3.68	0.000262	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs4646961	chr1:76217169	MSH4	chr1:76262630-76378923:+	0.25	4.13	4.3E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs4647277	chr3:37058509	EPM2AIP1	chr3:37027358-37034795:-	0.12	3.46	0.00058	Cerebrospinal P-tau181p levels	
THCA	cis	1	rs4647277	chr3:37058509	LRRFIP2	chr3:37094117-37217851:-	0.49	13.73	2.17E-36	Cerebrospinal P-tau181p levels	
THCA	cis	1	rs464766	chr3:161087592	NMD3	chr3:160939099-160971319:+	-0.1	-3.36	0.000846	Morning vs. evening chronotype	
THCA	cis	1	rs464783	chr21:42796480	MX1	chr21:42792520-42831140:+	0.18	3.73	0.000212	IgG glycosylation	
THCA	cis	1	rs464783	chr21:42796480	TFF2	chr21:43766469-43771208:-	0.14	3.59	0.00036	IgG glycosylation	
THCA	cis	1	rs4647934	chr4:1016279	DGKQ	chr4:952676-967344:-	-0.23	-3.65	0.000288	Bone mineral density	
THCA	cis	1	rs4647934	chr4:1016279	FGFRL1	chr4:1004940-1020685:+	-0.25	-3.91	0.000107	Bone mineral density	
THCA	cis	1	rs464895	chr7:65527106	CCT6P1	chr7:65216092-65228661:+	0.4	6.41	3.43E-10	Diabetic kidney disease	
THCA	cis	1	rs464895	chr7:65527106	CRCP	chr7:65579805-65619551:+	-0.28	-4.3	2.07E-5	Diabetic kidney disease	
THCA	cis	1	rs464895	chr7:65527106	RABGEF1	chr7:66093890-66276446:+	0.57	7.06	5.74E-12	Diabetic kidney disease	
THCA	cis	1	rs4652545	chr1:180947608	MR1	chr1:181003139-181024633:+	-0.12	-3.39	0.000761	Progressive supranuclear palsy	
THCA	cis	1	rs4652545	chr1:180947608	STX6	chr1:180913175-180992046:-	-0.2	-4.08	5.22E-5	Progressive supranuclear palsy	
THCA	cis	1	rs4652547	chr1:180954089	MR1	chr1:181003139-181024633:+	-0.13	-3.54	0.000438	Progressive supranuclear palsy	
THCA	cis	1	rs4652547	chr1:180954089	STX6	chr1:180913175-180992046:-	-0.2	-4.11	4.69E-5	Progressive supranuclear palsy	
THCA	cis	1	rs4652548	chr1:180954130	MR1	chr1:181003139-181024633:+	-0.13	-3.54	0.000438	Progressive supranuclear palsy	
THCA	cis	1	rs4652548	chr1:180954130	STX6	chr1:180913175-180992046:-	-0.2	-4.11	4.69E-5	Progressive supranuclear palsy	
THCA	cis	1	rs465359	chr7:65558164	CCT6P1	chr7:65216092-65228661:+	0.41	6.67	7.2E-11	Diabetic kidney disease	
THCA	cis	1	rs465359	chr7:65558164	CRCP	chr7:65579805-65619551:+	-0.3	-4.8	2.11E-6	Diabetic kidney disease	
THCA	cis	1	rs465359	chr7:65558164	LOC493754	chr7:65993446-66057363:-	0.3	3.6	0.000358	Diabetic kidney disease	
THCA	cis	1	rs465359	chr7:65558164	RABGEF1	chr7:66093890-66276446:+	0.52	6.65	8.06E-11	Diabetic kidney disease	
THCA	cis	1	rs4654863	chr1:20902244	CDA	chr1:20915444-20945398:+	-0.23	-4.7	3.46E-6	Age-related hearing impairment (interaction)	
THCA	cis	1	rs4654863	chr1:20902244	FAM43B	chr1:20878932-20881512:+	0.2	3.83	0.000148	Age-related hearing impairment (interaction)	
THCA	cis	1	rs4655684	chr1:67611772	WDR78	chr1:67278574-67390570:-	0.13	3.37	0.000814	Psoriasis	
THCA	cis	1	rs4656958	chr1:160856964	ITLN1	chr1:160846332-160854960:-	0.29	4.7	3.48E-6	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs4657039	chr1:161462728	FCGR2C	chr1:161551129-161570031:+	-0.11	-4.17	3.68E-5	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	
THCA	cis	1	rs465742	chr22:29959335	NIPSNAP1	chr22:29950800-29977144:-	-0.27	-3.7	0.000239	Lipid traits	
THCA	cis	1	rs4658875	chr1:231168994	EXOC8	chr1:231468483-231473578:-	-0.16	-3.76	0.000191	Carotid plaque burden (smoking interaction)	
THCA	cis	1	rs4659612	chr1:236033290	LYST	chr1:235824345-236046940:-	-0.3	-9.57	5.62E-20	Systemic lupus erythematosus	
THCA	cis	1	rs4659613	chr1:236033329	LYST	chr1:235824345-236046940:-	0.31	9.27	6.18E-19	Systemic lupus erythematosus	
THCA	cis	1	rs465969	chr6:111655530	KIAA1919	chr6:111580482-111590259:+	0.4	5.53	5.16E-8	Psoriasis	
THCA	cis	1	rs4660116	chr1:236028841	LYST	chr1:235824345-236046940:-	-0.32	-9.66	2.78E-20	Systemic lupus erythematosus	
THCA	cis	1	rs4660117	chr1:236031533	LYST	chr1:235824345-236046940:-	-0.31	-9.89	4.2E-21	Systemic lupus erythematosus	
THCA	cis	1	rs4660303	chr1:40060473	PABPC4	chr1:40026485-40042521:-	-0.28	-4.91	1.23E-6	C-reactive protein levels or triglyceride levels (pleiotropy)	
THCA	cis	1	rs4660306	chr1:45978675	AKR1A1	chr1:46016498-46035720:+	0.14	3.79	0.000169	Homocysteine levels	
THCA	cis	1	rs4660306	chr1:45978675	CCDC163P	chr1:45960581-45965646:-	1.1	31.61	3.27E-119	Homocysteine levels	
THCA	cis	1	rs4660306	chr1:45978675	MUTYH	chr1:45794915-45806142:-	-0.21	-5.11	4.55E-7	Homocysteine levels	
THCA	cis	1	rs4660306	chr1:45978675	PRDX1	chr1:45976708-45987609:-	0.4	10.31	1.26E-22	Homocysteine levels	
THCA	cis	1	rs4660317	chr1:46326226	CCDC163P	chr1:45960581-45965646:-	-0.51	-10.1	7.22E-22	Body mass index	
THCA	cis	1	rs4660317	chr1:46326226	GPBP1L1	chr1:46092978-46152302:-	0.16	4.05	5.93E-5	Body mass index	
THCA	cis	1	rs4660317	chr1:46326226	MMACHC	chr1:45965856-45976737:+	-0.2	-4.4	1.34E-5	Body mass index	
THCA	cis	1	rs4660317	chr1:46326226	MUTYH	chr1:45794915-45806142:-	0.31	8.53	1.99E-16	Body mass index	
THCA	cis	1	rs4660319	chr1:46341623	CCDC163P	chr1:45960581-45965646:-	-0.51	-10.06	9.97E-22	Body mass index	
THCA	cis	1	rs4660319	chr1:46341623	GPBP1L1	chr1:46092978-46152302:-	0.16	4.06	5.77E-5	Body mass index	
THCA	cis	1	rs4660319	chr1:46341623	MMACHC	chr1:45965856-45976737:+	-0.2	-4.32	1.87E-5	Body mass index	
THCA	cis	1	rs4660319	chr1:46341623	MUTYH	chr1:45794915-45806142:-	0.31	8.43	4.17E-16	Body mass index	
THCA	cis	1	rs4660321	chr1:46366760	CCDC163P	chr1:45960581-45965646:-	-0.51	-10.11	6.85E-22	Body mass index	
THCA	cis	1	rs4660321	chr1:46366760	GPBP1L1	chr1:46092978-46152302:-	0.16	4.04	6.11E-5	Body mass index	
THCA	cis	1	rs4660321	chr1:46366760	MMACHC	chr1:45965856-45976737:+	-0.2	-4.41	1.3E-5	Body mass index	
THCA	cis	1	rs4660321	chr1:46366760	MUTYH	chr1:45794915-45806142:-	0.31	8.54	1.77E-16	Body mass index	
THCA	cis	1	rs4660456	chr1:41239511	LOC100130557	chr1:41154752-41157933:-	0.22	5.61	3.51E-8	Platelet count	
THCA	cis	1	rs4660456	chr1:41239511	NFYC	chr1:41157242-41237273:+	-0.23	-6.28	7.49E-10	Platelet count	
THCA	cis	1	rs4660870	chr1:45995231	CCDC163P	chr1:45960581-45965646:-	-1.01	-26.66	1.22E-96	Homocysteine levels	
THCA	cis	1	rs4660870	chr1:45995231	MUTYH	chr1:45794915-45806142:-	0.2	4.88	1.43E-6	Homocysteine levels	
THCA	cis	1	rs4660870	chr1:45995231	PRDX1	chr1:45976708-45987609:-	-0.38	-9.83	6.82E-21	Homocysteine levels	
THCA	cis	1	rs4660898	chr1:46402171	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.14	5.21E-22	Body mass index	
THCA	cis	1	rs4660898	chr1:46402171	GPBP1L1	chr1:46092978-46152302:-	0.15	3.83	0.000146	Body mass index	
THCA	cis	1	rs4660898	chr1:46402171	MMACHC	chr1:45965856-45976737:+	-0.21	-4.57	6.3E-6	Body mass index	
THCA	cis	1	rs4660898	chr1:46402171	MUTYH	chr1:45794915-45806142:-	0.3	8.13	3.66E-15	Body mass index	
THCA	cis	1	rs4660910	chr1:46548402	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.17	4.03E-22	Body mass index	
THCA	cis	1	rs4660910	chr1:46548402	GPBP1L1	chr1:46092978-46152302:-	0.13	3.41	0.000705	Body mass index	
THCA	cis	1	rs4660910	chr1:46548402	MMACHC	chr1:45965856-45976737:+	-0.21	-4.48	9.32E-6	Body mass index	
THCA	cis	1	rs4660910	chr1:46548402	MUTYH	chr1:45794915-45806142:-	0.28	7.49	3.29E-13	Body mass index	
THCA	cis	1	rs4660956	chr1:47158486	CYP4B1	chr1:47264670-47285020:+	0.23	3.54	0.000446	Response to hepatitis C treatment	
THCA	cis	1	rs4660956	chr1:47158486	CYP4Z1	chr1:47533160-47583992:+	0.28	4.06	5.63E-5	Response to hepatitis C treatment	
THCA	cis	1	rs4660956	chr1:47158486	DMBX1	chr1:46972668-46979884:+	0.23	3.9	0.000108	Response to hepatitis C treatment	
THCA	cis	1	rs4661151	chr1:155903408	FDPS	chr1:155278539-155290457:+	-0.21	-4.26	2.41E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs4661151	chr1:155903408	RIT1	chr1:155867601-155881177:-	0.17	3.89	0.000114	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs4661175	chr1:155931368	FDPS	chr1:155278539-155290457:+	-0.21	-4.25	2.55E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs4661175	chr1:155931368	RIT1	chr1:155867601-155881177:-	0.18	4.16	3.7E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs4661175	chr1:155931368	SLC25A44	chr1:156163730-156182586:+	0.2	3.78	0.000177	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs4663300	chr2:239181491	LOC151174	chr2:239133754-239140318:-	0.48	5.25	2.24E-7	Irritable bowel syndrome	
THCA	cis	1	rs4663865	chr2:239145960	LOC151174	chr2:239133754-239140318:-	-0.51	-5.59	3.86E-8	Irritable bowel syndrome	
THCA	cis	1	rs4663866	chr2:239150815	LOC151174	chr2:239133754-239140318:-	0.49	5.27	2.07E-7	Irritable bowel syndrome	
THCA	cis	1	rs4663867	chr2:239159964	LOC151174	chr2:239133754-239140318:-	0.5	5.41	9.97E-8	Irritable bowel syndrome	
THCA	cis	1	rs4663868	chr2:239161091	LOC151174	chr2:239133754-239140318:-	0.49	5.34	1.41E-7	Irritable bowel syndrome	
THCA	cis	1	rs4664308	chr2:160917497	LY75	chr2:160625141-160761262:-	0.21	4.84	1.8E-6	Idiopathic membranous nephropathy	
THCA	cis	1	rs4665147	chr2:160917062	LY75	chr2:160625141-160761262:-	0.21	4.82	1.95E-6	Idiopathic membranous nephropathy	
THCA	cis	1	rs4665238	chr2:23942446	C2orf84	chr2:24397531-24414566:+	-0.2	-3.36	0.000835	Obesity-related traits	
THCA	cis	1	rs4665238	chr2:23942446	LOC375190	chr2:24299728-24397519:+	0.31	7.89	2.12E-14	Obesity-related traits	
THCA	cis	1	rs4665298	chr2:26256378	GPR113	chr2:26531041-26569685:-	-0.41	-6.52	1.79E-10	Gut microbiome composition (summer)	
THCA	cis	1	rs4665299	chr2:26256840	GPR113	chr2:26531041-26569685:-	-0.48	-7.38	6.94E-13	Gut microbiome composition (summer)	
THCA	cis	1	rs4665299	chr2:26256840	HADHA	chr2:26413505-26467594:-	-0.16	-3.35	0.000877	Gut microbiome composition (summer)	
THCA	cis	1	rs4665304	chr2:26313406	GPR113	chr2:26531041-26569685:-	-0.42	-6.8	3.04E-11	Gut microbiome composition (summer)	
THCA	cis	1	rs4665305	chr2:26313524	GPR113	chr2:26531041-26569685:-	-0.41	-6.58	1.25E-10	Gut microbiome composition (summer)	
THCA	cis	1	rs4665305	chr2:26313524	HADHA	chr2:26413505-26467594:-	-0.16	-3.38	0.000787	Gut microbiome composition (summer)	
THCA	cis	1	rs4665306	chr2:26319124	GPR113	chr2:26531041-26569685:-	-0.45	-7.05	6.34E-12	Gut microbiome composition (summer)	
THCA	cis	1	rs4665308	chr2:26330514	GPR113	chr2:26531041-26569685:-	-0.42	-6.71	5.42E-11	Gut microbiome composition (summer)	
THCA	cis	1	rs4665309	chr2:26335502	GPR113	chr2:26531041-26569685:-	-0.42	-6.71	5.42E-11	Gut microbiome composition (summer)	
THCA	cis	1	rs4665381	chr2:27757150	FNDC4	chr2:27714751-27718126:-	-0.15	-3.54	0.000436	Oral cavity cancer	
THCA	cis	1	rs4665768	chr2:25372229	POMC	chr2:25383722-25391559:-	0.25	4.1	4.91E-5	Body mass index	
THCA	cis	1	rs4665809	chr2:26251361	GPR113	chr2:26531041-26569685:-	0.44	6.98	9.61E-12	Gut microbiome composition (summer)	
THCA	cis	1	rs4665811	chr2:26260017	GPR113	chr2:26531041-26569685:-	-0.43	-6.74	4.43E-11	Gut microbiome composition (summer)	
THCA	cis	1	rs4665811	chr2:26260017	HADHA	chr2:26413505-26467594:-	-0.16	-3.35	0.000874	Gut microbiome composition (summer)	
THCA	cis	1	rs4665816	chr2:26305094	GPR113	chr2:26531041-26569685:-	-0.42	-6.7	5.97E-11	Gut microbiome composition (summer)	
THCA	cis	1	rs4665816	chr2:26305094	HADHA	chr2:26413505-26467594:-	-0.16	-3.35	0.00088	Gut microbiome composition (summer)	
THCA	cis	1	rs4665817	chr2:26305167	GPR113	chr2:26531041-26569685:-	-0.48	-7.36	8.07E-13	Gut microbiome composition (summer)	
THCA	cis	1	rs4665817	chr2:26305167	HADHA	chr2:26413505-26467594:-	-0.17	-3.44	0.000643	Gut microbiome composition (summer)	
THCA	cis	1	rs4665819	chr2:26309073	GPR113	chr2:26531041-26569685:-	-0.45	-7.05	6.34E-12	Gut microbiome composition (summer)	
THCA	cis	1	rs4665820	chr2:26309150	GPR113	chr2:26531041-26569685:-	-0.45	-7.05	6.34E-12	Gut microbiome composition (summer)	
THCA	cis	1	rs4665821	chr2:26309949	GPR113	chr2:26531041-26569685:-	-0.45	-7.05	6.34E-12	Gut microbiome composition (summer)	
THCA	cis	1	rs4665823	chr2:26312723	GPR113	chr2:26531041-26569685:-	-0.45	-7.05	6.34E-12	Gut microbiome composition (summer)	
THCA	cis	1	rs4665958	chr2:27443196	C2orf28	chr2:27434899-27440044:+	0.16	4.82	1.89E-6	Blood metabolite levels	
THCA	cis	1	rs4665958	chr2:27443196	SLC5A6	chr2:27422459-27435071:-	-0.32	-6.86	2.2E-11	Blood metabolite levels	
THCA	cis	1	rs4666009	chr2:27857992	FNDC4	chr2:27714751-27718126:-	-0.15	-3.52	0.00047	Oral cavity cancer	
THCA	cis	1	rs4666118	chr2:28951698	PPP1CB	chr2:28974612-29025805:+	0.17	4.14	4.03E-5	Body mass index	
THCA	cis	1	rs4666118	chr2:28951698	TRMT61B	chr2:29072690-29093175:-	-0.51	-10.2	3.13E-22	Body mass index	
THCA	cis	1	rs4666119	chr2:28975690	PPP1CB	chr2:28974612-29025805:+	0.17	4.26	2.5E-5	Body mass index	
THCA	cis	1	rs4666119	chr2:28975690	TRMT61B	chr2:29072690-29093175:-	-0.53	-10.65	6.52E-24	Body mass index	
THCA	cis	1	rs4667304	chr2:190587103	ASNSD1	chr2:190526125-190535556:+	-0.69	-6.75	4.18E-11	Subcutaneous adipose tissue	
THCA	cis	1	rs4669752	chr2:11727988	GREB1	chr2:11674242-11782912:+	0.17	3.68	0.000259	Endometriosis	
THCA	cis	1	rs466983	chr7:65520496	CCT6P1	chr7:65216092-65228661:+	0.41	6.46	2.51E-10	Diabetic kidney disease	
THCA	cis	1	rs466983	chr7:65520496	CRCP	chr7:65579805-65619551:+	-0.29	-4.49	9.03E-6	Diabetic kidney disease	
THCA	cis	1	rs466983	chr7:65520496	RABGEF1	chr7:66093890-66276446:+	0.57	7.05	6.23E-12	Diabetic kidney disease	
THCA	cis	1	rs4671400	chr2:61472632	AHSA2	chr2:61404553-61414058:+	-0.17	-4.07	5.6E-5	3-hydroxypropylmercapturic acid levels in smokers	
THCA	cis	1	rs4671400	chr2:61472632	C2orf74	chr2:61372243-61391964:+	0.4	4.68	3.78E-6	3-hydroxypropylmercapturic acid levels in smokers	
THCA	cis	1	rs4671458	chr2:63374063	C2orf86	chr2:63348537-63815851:-	-0.19	-3.88	0.000119	Subjective well-being	
THCA	cis	1	rs4671459	chr2:63392872	C2orf86	chr2:63348537-63815851:-	-0.19	-3.9	0.00011	Subjective well-being	
THCA	cis	1	rs4671460	chr2:63397203	C2orf86	chr2:63348537-63815851:-	-0.19	-3.87	0.000124	Subjective well-being	
THCA	cis	1	rs4671461	chr2:63406800	C2orf86	chr2:63348537-63815851:-	-0.19	-3.87	0.000124	Subjective well-being	
THCA	cis	1	rs4671794	chr2:67566658	ETAA1	chr2:67624442-67637533:+	-0.18	-4.25	2.56E-5	Pancreatic cancer	
THCA	cis	1	rs4673173	chr2:227769493	COL4A4	chr2:227867435-228029275:-	0.16	4.06	5.82E-5	Pulmonary function	
THCA	cis	1	rs4674048	chr2:216900023	MREG	chr2:216807315-216878346:-	0.38	8.04	7.33E-15	Alcohol dependence	
THCA	cis	1	rs4674048	chr2:216900023	PECR	chr2:216861029-216946532:-	0.24	5.02	7.32E-7	Alcohol dependence	
THCA	cis	1	rs4674051	chr2:216907512	MREG	chr2:216807315-216878346:-	0.37	7.85	2.76E-14	Alcohol dependence	
THCA	cis	1	rs4674051	chr2:216907512	PECR	chr2:216861029-216946532:-	0.24	4.97	9.48E-7	Alcohol dependence	
THCA	cis	1	rs4674058	chr2:216909368	MREG	chr2:216807315-216878346:-	0.37	7.73	6.41E-14	Alcohol dependence	
THCA	cis	1	rs4674058	chr2:216909368	PECR	chr2:216861029-216946532:-	0.24	4.88	1.44E-6	Alcohol dependence	
THCA	cis	1	rs4674164	chr2:218274897	DIRC3	chr2:218148748-218621316:-	0.22	5.17	3.52E-7	Height	
THCA	cis	1	rs4674165	chr2:218274943	DIRC3	chr2:218148748-218621316:-	0.22	5.22	2.71E-7	Height	
THCA	cis	1	rs4674167	chr2:218275370	DIRC3	chr2:218148748-218621316:-	0.22	5.16	3.55E-7	Height	
THCA	cis	1	rs4674169	chr2:218276240	DIRC3	chr2:218148748-218621316:-	-0.21	-4.95	1.04E-6	Height	
THCA	cis	1	rs4674	chr19:41930396	B3GNT8	chr19:41931265-41934635:-	-0.35	-8.12	4.11E-15	Height	
THCA	cis	1	rs4674	chr19:41930396	EXOSC5	chr19:41892278-41903256:-	-0.11	-3.65	0.000292	Height	
THCA	cis	1	rs4675115	chr2:227769123	COL4A4	chr2:227867435-228029275:-	0.15	3.56	0.000413	Pulmonary function	
THCA	cis	1	rs4675116	chr2:227769607	COL4A4	chr2:227867435-228029275:-	0.16	3.87	0.000122	Pulmonary function	
THCA	cis	1	rs4675119	chr2:227774635	COL4A4	chr2:227867435-228029275:-	0.14	3.56	0.000415	Pulmonary function	
THCA	cis	1	rs4675120	chr2:227774888	COL4A4	chr2:227867435-228029275:-	0.15	3.79	0.00017	Pulmonary function	
THCA	cis	1	rs4675310	chr2:203880834	ALS2CR8	chr2:203776978-203851060:+	0.27	5.29	1.89E-7	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs4675310	chr2:203880834	ICA1L	chr2:203637873-203736371:-	-0.26	-4.31	2.0E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs4675811	chr2:242402062	SEPT2	chr2:242254723-242293439:+	-0.29	-5.3	1.81E-7	Prostate cancer	
THCA	cis	1	rs4675860	chr2:241840417	C2orf54	chr2:241825466-241835573:-	0.29	6.22	1.06E-9	Urinary metabolites	
THCA	cis	1	rs4675863	chr2:241830763	C2orf54	chr2:241825466-241835573:-	0.29	6.38	4.11E-10	Urinary metabolites	
THCA	cis	1	rs4675868	chr2:241828542	C2orf54	chr2:241825466-241835573:-	0.29	6.38	4.11E-10	Urinary metabolites	
THCA	cis	1	rs4675874	chr2:241819796	C2orf54	chr2:241825466-241835573:-	-0.3	-6.4	3.61E-10	Urinary metabolites	
THCA	cis	1	rs4677834	chr3:195093631	C3orf21	chr3:194789015-194991895:-	-0.28	-6.48	2.28E-10	Body mass index	
THCA	cis	1	rs4678176	chr3:122009175	PARP15	chr3:122296449-122355536:+	0.22	3.51	0.000498	Calcium levels	
THCA	cis	1	rs4680307	chr3:151000939	GPR87	chr3:151011876-151034636:-	0.2	4.61	5.17E-6	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs4680307	chr3:151000939	P2RY14	chr3:150929905-150996230:-	-0.18	-3.81	0.000156	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs4680356	chr3:151051100	GPR87	chr3:151011876-151034636:-	0.19	4.22	2.95E-5	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs4680356	chr3:151051100	P2RY14	chr3:150929905-150996230:-	-0.21	-4.5	8.58E-6	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs4680	chr22:19951271	DGCR9	chr22:19005347-19007760:+	-0.16	-3.42	0.000677	Blood metabolite levels	
THCA	cis	1	rs4683184	chr3:46187707	CCR3	chr3:46205096-46308162:+	0.2	3.98	7.96E-5	Behcet's disease	
THCA	cis	1	rs4683184	chr3:46187707	FYCO1	chr3:45959396-46037307:-	-0.13	-3.72	0.000221	Behcet's disease	
THCA	cis	1	rs4686792	chr3:184552325	C3orf70	chr3:184795840-184870802:-	-0.26	-5.02	7.19E-7	Heschl's gyrus morphology	
THCA	cis	1	rs4686865	chr3:184614436	C3orf70	chr3:184795840-184870802:-	-0.25	-4.92	1.17E-6	Heschl's gyrus morphology	
THCA	cis	1	rs4687207	chr3:190998437	UTS2D	chr3:190984945-191048325:-	0.17	3.43	0.000646	Total ventricular volume (Alzheimer's disease interaction)	
THCA	cis	1	rs4687552	chr3:52838402	GLYCTK	chr3:52321836-52329271:+	-0.17	-3.69	0.000253	Bipolar disorder	
THCA	cis	1	rs4687552	chr3:52838402	ITIH4	chr3:52847007-52866554:-	0.23	6.1	2.18E-9	Bipolar disorder	
THCA	cis	1	rs4687552	chr3:52838402	NEK4	chr3:52744803-52804951:-	-0.15	-4.34	1.74E-5	Bipolar disorder	
THCA	cis	1	rs4687552	chr3:52838402	NT5DC2	chr3:52558386-52569093:-	-0.29	-6.27	7.92E-10	Bipolar disorder	
THCA	cis	1	rs4687552	chr3:52838402	PBRM1	chr3:52579368-52719866:-	0.16	5.53	5.3E-8	Bipolar disorder	
THCA	cis	1	rs4687552	chr3:52838402	RFT1	chr3:53122503-53164470:-	-0.23	-3.93	9.92E-5	Bipolar disorder	
THCA	cis	1	rs4687697	chr3:53090490	GLYCTK	chr3:52321836-52329271:+	-0.17	-3.79	0.000167	Ulcerative colitis	
THCA	cis	1	rs4687697	chr3:53090490	NT5DC2	chr3:52558386-52569093:-	-0.15	-3.4	0.000737	Ulcerative colitis	
THCA	cis	1	rs4687701	chr3:53121276	ITIH4	chr3:52847007-52866554:-	-0.16	-4.48	9.23E-6	Height	
THCA	cis	1	rs4687701	chr3:53121276	RFT1	chr3:53122503-53164470:-	0.74	17.76	1.43E-54	Height	
THCA	cis	1	rs4687721	chr3:51598254	HEMK1	chr3:50606583-50622419:+	0.17	3.73	0.000216	Melanoma	
THCA	cis	1	rs4687721	chr3:51598254	TEX264	chr3:51705222-51738338:+	-0.18	-5.17	3.5E-7	Melanoma	
THCA	cis	1	rs468795	chr22:29955450	NIPSNAP1	chr22:29950800-29977144:-	-0.34	-5.11	4.7E-7	Lipid traits	
THCA	cis	1	rs468852	chr22:29956156	NIPSNAP1	chr22:29950800-29977144:-	-0.32	-4.74	2.83E-6	Lipid traits	
THCA	cis	1	rs4689088	chr4:7222253	SORCS2	chr4:7194374-7744563:+	-0.35	-8.95	8.17E-18	Insulin-like growth factors	
THCA	cis	1	rs4689653	chr4:7223319	SORCS2	chr4:7194374-7744563:+	-0.34	-8.73	4.4E-17	Insulin-like growth factors	
THCA	cis	1	rs4690071	chr4:3086753	C4orf44	chr4:3250767-3265839:+	-0.32	-6.56	1.43E-10	Parental longevity (mother's age at death)	
THCA	cis	1	rs4690071	chr4:3086753	GRK4	chr4:2965343-3042474:+	-0.23	-3.87	0.000126	Parental longevity (mother's age at death)	
THCA	cis	1	rs4690909	chr4:159629151	ETFDH	chr4:159593277-159629839:+	-0.18	-4.48	9.36E-6	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
THCA	cis	1	rs4690909	chr4:159629151	PPID	chr4:159630280-159644552:-	0.2	3.81	0.000158	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
THCA	cis	1	rs4691139	chr4:165908721	C4orf39	chr4:165878100-165880273:+	0.19	5.25	2.29E-7	Ovarian cancer in BRCA1 mutation carriers	
THCA	cis	1	rs4693089	chr4:84373622	MRPS18C	chr4:84377118-84389352:+	-0.27	-7.46	4.09E-13	Menopause (age at onset)	
THCA	cis	1	rs4696572	chr4:155354916	DCHS2	chr4:155155527-155412930:-	0.16	3.46	0.000596	Alzheimer's disease (age of onset)	
THCA	cis	1	rs469758	chr5:96121715	CAST	chr5:95997777-96115291:+	-0.11	-3.92	0.000102	Ankylosing spondylitis	
THCA	cis	1	rs469758	chr5:96121715	ERAP1	chr5:96096515-96149837:-	-0.39	-11.58	1.63E-27	Ankylosing spondylitis	
THCA	cis	1	rs469758	chr5:96121715	ERAP2	chr5:96211644-96255398:+	0.53	9.29	5.44E-19	Ankylosing spondylitis	
THCA	cis	1	rs4698635	chr4:17630242	MED28	chr4:17616273-17629791:+	0.2	4.42	1.24E-5	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs4698641	chr4:17642630	MED28	chr4:17616273-17629791:+	0.17	3.75	0.000202	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs4698648	chr4:17692715	MED28	chr4:17616273-17629791:+	0.16	3.43	0.000665	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs4698649	chr4:17692782	MED28	chr4:17616273-17629791:+	0.16	3.43	0.000665	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs4698651	chr4:17694223	MED28	chr4:17616273-17629791:+	0.15	3.39	0.00076	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs4698775	chr4:110590479	CASP6	chr4:110609785-110624629:-	-0.14	-3.49	0.000523	Age-related macular degeneration	
THCA	cis	1	rs4699052	chr4:104137790	BDH2	chr4:103998783-104021024:-	0.26	5.93	5.66E-9	Testicular germ cell tumor	
THCA	cis	1	rs4699052	chr4:104137790	CISD2	chr4:103790135-103809913:+	-0.15	-3.59	0.000369	Testicular germ cell tumor	
THCA	cis	1	rs4699052	chr4:104137790	MANBA	chr4:103552644-103682151:-	0.16	4.1	4.91E-5	Testicular germ cell tumor	
THCA	cis	1	rs4699055	chr4:104154500	BDH2	chr4:103998783-104021024:-	0.26	5.95	5.29E-9	Testicular germ cell tumor	
THCA	cis	1	rs4699055	chr4:104154500	CISD2	chr4:103790135-103809913:+	-0.15	-3.6	0.000355	Testicular germ cell tumor	
THCA	cis	1	rs4699055	chr4:104154500	MANBA	chr4:103552644-103682151:-	0.16	4.05	5.91E-5	Testicular germ cell tumor	
THCA	cis	1	rs470119	chr22:50966914	SCO2	chr22:50961999-50964034:-	0.15	5.03	6.96E-7	Mean corpuscular hemoglobin	
THCA	cis	1	rs470119	chr22:50966914	TYMP	chr22:50964184-50968514:-	-0.14	-4.45	1.05E-5	Mean corpuscular hemoglobin	
THCA	cis	1	rs4703229	chr5:101764856	SLCO4C1	chr5:101569694-101632253:-	0.25	5.62	3.21E-8	Schizophrenia	
THCA	cis	1	rs4703232	chr5:101811346	SLCO4C1	chr5:101569694-101632253:-	0.24	5.56	4.4E-8	Schizophrenia	
THCA	cis	1	rs4706254	chr6:86602813	SNHG5	chr6:86386726-86388451:-	-0.53	-12.54	2.11E-31	Response to antipsychotic treatment	
THCA	cis	1	rs4706273	chr6:70391640	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.53	0.000462	Sleep duration	
THCA	cis	1	rs4707239	chr6:86610717	SNHG5	chr6:86386726-86388451:-	-0.54	-12.73	3.62E-32	Response to antipsychotic treatment	
THCA	cis	1	rs4707289	chr6:70391588	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.44	0.000643	Sleep duration	
THCA	cis	1	rs4707343	chr6:70457821	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.37	0.000799	Sleep duration	
THCA	cis	1	rs4707392	chr6:70513826	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.49	0.000531	Sleep duration	
THCA	cis	1	rs4709248	chr6:159355637	RSPH3	chr6:159398268-159421198:-	0.24	5.01	7.65E-7	Bladder cancer (smoking interaction)	
THCA	cis	1	rs4709251	chr6:159380322	RSPH3	chr6:159398268-159421198:-	0.29	6.05	2.96E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs4709252	chr6:159380384	RSPH3	chr6:159398268-159421198:-	0.29	6.05	2.96E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs4709254	chr6:159408597	RSPH3	chr6:159398268-159421198:-	0.29	6.05	2.96E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs4709256	chr6:159409058	RSPH3	chr6:159398268-159421198:-	0.29	6.05	2.96E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs4709258	chr6:159412010	RSPH3	chr6:159398268-159421198:-	0.29	6.05	2.96E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs4709259	chr6:159419584	RSPH3	chr6:159398268-159421198:-	0.28	5.96	4.79E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs4711346	chr6:33730996	LEMD2	chr6:33738991-33756906:-	0.24	4.85	1.68E-6	Body mass index	
THCA	cis	1	rs4711351	chr6:33754592	LEMD2	chr6:33738991-33756906:-	-0.31	-7.09	4.95E-12	Crohn's disease	
THCA	cis	1	rs471144	chr1:152454255	FLG	chr1:152274651-152297679:-	-0.38	-3.98	8.04E-5	Inflammatory skin disease	
THCA	cis	1	rs4711589	chr6:39230571	KCNK16	chr6:39282475-39290330:-	0.14	3.43	0.000647	Cholesterol, total	
THCA	cis	1	rs4711880	chr6:47480676	CD2AP	chr6:47445525-47594994:+	0.13	3.42	0.000676	Alzheimer's disease (late onset)	
THCA	cis	1	rs4712120	chr6:56092916	COL21A1	chr6:55921389-56258892:-	0.75	16.06	1.01E-46	Pulse pressure	
THCA	cis	1	rs4713006	chr6:26519872	BTN2A3	chr6:26422317-26431927:+	0.19	4.52	7.82E-6	Educational attainment	
THCA	cis	1	rs4713006	chr6:26519872	HCG11	chr6:26521934-26527610:+	-0.23	-4.43	1.19E-5	Educational attainment	
THCA	cis	1	rs4713006	chr6:26519872	HMGN4	chr6:26538572-26547162:+	-0.16	-4.05	5.86E-5	Educational attainment	
THCA	cis	1	rs4713006	chr6:26519872	ZNF322A	chr6:26634612-26659963:-	-0.14	-3.77	0.00018	Educational attainment	
THCA	cis	1	rs4713008	chr6:26538268	BTN2A3	chr6:26422317-26431927:+	0.18	4.32	1.87E-5	Educational attainment	
THCA	cis	1	rs4713008	chr6:26538268	HCG11	chr6:26521934-26527610:+	-0.22	-4.34	1.77E-5	Educational attainment	
THCA	cis	1	rs4713008	chr6:26538268	HMGN4	chr6:26538572-26547162:+	-0.16	-4.04	6.24E-5	Educational attainment	
THCA	cis	1	rs4713008	chr6:26538268	ZNF322A	chr6:26634612-26659963:-	-0.14	-3.9	0.000108	Educational attainment	
THCA	cis	1	rs4713039	chr6:10906256	SYCP2L	chr6:10747995-10974539:+	-0.24	-3.87	0.000126	Allergic rhinitis	
THCA	cis	1	rs4713682	chr6:33757047	LEMD2	chr6:33738991-33756906:-	-0.31	-7.07	5.54E-12	Crohn's disease	
THCA	cis	1	rs4713684	chr6:33766488	LEMD2	chr6:33738991-33756906:-	-0.3	-6.97	1.03E-11	Crohn's disease	
THCA	cis	1	rs4713882	chr6:35501370	TULP1	chr6:35465653-35480647:-	-0.27	-3.76	0.000195	Hepatitis C induced liver fibrosis	
THCA	cis	1	rs4713	chr9:131910805	CRAT	chr9:131857075-131873070:-	-0.28	-6.79	3.29E-11	Blood metabolite ratios	
THCA	cis	1	rs4714483	chr6:41528214	MDFI	chr6:41604930-41621981:+	0.18	5.24	2.37E-7	Prostate cancer	
THCA	cis	1	rs4714485	chr6:41536587	MDFI	chr6:41604930-41621981:+	0.19	5.45	8.11E-8	Prostate cancer	
THCA	cis	1	rs4714486	chr6:41542417	MDFI	chr6:41604930-41621981:+	0.19	5.58	4.11E-8	Prostate cancer	
THCA	cis	1	rs4715025	chr6:47483653	CD2AP	chr6:47445525-47594994:+	0.13	3.42	0.000676	Alzheimer's disease (late onset)	
THCA	cis	1	rs4715129	chr6:49415043	CENPQ	chr6:49431096-49460820:+	-0.27	-5.67	2.41E-8	Folate pathway vitamin levels	
THCA	cis	1	rs4715129	chr6:49415043	MUT	chr6:49398994-49431031:-	0.28	9.36	3.11E-19	Folate pathway vitamin levels	
THCA	cis	1	rs4715130	chr6:49416825	CENPQ	chr6:49431096-49460820:+	-0.27	-5.65	2.7E-8	Folate pathway vitamin levels	
THCA	cis	1	rs4715130	chr6:49416825	MUT	chr6:49398994-49431031:-	0.28	9.58	5.24E-20	Folate pathway vitamin levels	
THCA	cis	1	rs4715590	chr6:56060017	COL21A1	chr6:55921389-56258892:-	0.77	16.29	8.85E-48	Pulse pressure	
THCA	cis	1	rs471584	chr11:64149252	GPR137	chr11:64037534-64056965:+	0.15	3.48	0.00055	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs471584	chr11:64149252	VEGFB	chr11:64002266-64006258:+	0.13	3.5	0.0005	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs4716375	chr6:170071218	C6orf70	chr6:170151721-170181617:+	0.27	5.21	2.84E-7	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs4716375	chr6:170071218	WDR27	chr6:169857307-170102159:-	-0.2	-5.94	5.36E-9	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs4716378	chr6:170086568	C6orf70	chr6:170151721-170181617:+	0.27	5.27	2.02E-7	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs4716378	chr6:170086568	WDR27	chr6:169857307-170102159:-	-0.19	-5.76	1.49E-8	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs4716380	chr6:170090399	C6orf70	chr6:170151721-170181617:+	0.27	5.36	1.27E-7	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs4716380	chr6:170090399	WDR27	chr6:169857307-170102159:-	-0.19	-5.77	1.45E-8	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs4717292	chr7:65895598	ASL	chr7:65540776-65558321:+	-0.16	-4.18	3.49E-5	Aortic root size	
THCA	cis	1	rs4717292	chr7:65895598	GUSB	chr7:65425675-65447246:-	0.27	5.27	2.11E-7	Aortic root size	
THCA	cis	1	rs4717292	chr7:65895598	RABGEF1	chr7:66093890-66276446:+	0.65	14.02	1.14E-37	Aortic root size	
THCA	cis	1	rs4717300	chr7:65947380	ASL	chr7:65540776-65558321:+	-0.16	-4.21	3.02E-5	Aortic root size	
THCA	cis	1	rs4717300	chr7:65947380	GUSB	chr7:65425675-65447246:-	0.27	5.25	2.33E-7	Aortic root size	
THCA	cis	1	rs4717300	chr7:65947380	RABGEF1	chr7:66093890-66276446:+	0.65	14.04	9.5E-38	Aortic root size	
THCA	cis	1	rs4717310	chr7:66161007	GUSB	chr7:65425675-65447246:-	0.33	6.7	5.78E-11	Aortic root size	
THCA	cis	1	rs4717310	chr7:66161007	RABGEF1	chr7:66093890-66276446:+	0.51	10.49	2.54E-23	Aortic root size	
THCA	cis	1	rs4717310	chr7:66161007	TYW1	chr7:66461817-66704496:+	0.18	3.97	8.27E-5	Aortic root size	
THCA	cis	1	rs4717319	chr7:66242593	GUSB	chr7:65425675-65447246:-	0.34	6.88	1.88E-11	Aortic root size	
THCA	cis	1	rs4717319	chr7:66242593	RABGEF1	chr7:66093890-66276446:+	0.52	10.72	3.69E-24	Aortic root size	
THCA	cis	1	rs4717319	chr7:66242593	TYW1	chr7:66461817-66704496:+	0.18	3.96	8.52E-5	Aortic root size	
THCA	cis	1	rs4718269	chr7:65200778	CCT6P1	chr7:65216092-65228661:+	-0.41	-6.62	9.93E-11	Diabetic kidney disease	
THCA	cis	1	rs4718269	chr7:65200778	CRCP	chr7:65579805-65619551:+	0.28	4.4	1.36E-5	Diabetic kidney disease	
THCA	cis	1	rs4718269	chr7:65200778	RABGEF1	chr7:66093890-66276446:+	-0.53	-6.63	9.33E-11	Diabetic kidney disease	
THCA	cis	1	rs4718270	chr7:65202407	CCT6P1	chr7:65216092-65228661:+	0.41	6.62	9.93E-11	Diabetic kidney disease	
THCA	cis	1	rs4718270	chr7:65202407	CRCP	chr7:65579805-65619551:+	-0.28	-4.4	1.36E-5	Diabetic kidney disease	
THCA	cis	1	rs4718270	chr7:65202407	RABGEF1	chr7:66093890-66276446:+	0.53	6.63	9.33E-11	Diabetic kidney disease	
THCA	cis	1	rs4718307	chr7:65610988	ASL	chr7:65540776-65558321:+	0.16	4.28	2.23E-5	Aortic root size	
THCA	cis	1	rs4718307	chr7:65610988	GUSB	chr7:65425675-65447246:-	-0.27	-5.32	1.61E-7	Aortic root size	
THCA	cis	1	rs4718307	chr7:65610988	LOC729156	chr7:66274980-66309813:-	-0.16	-3.47	0.000572	Aortic root size	
THCA	cis	1	rs4718307	chr7:65610988	RABGEF1	chr7:66093890-66276446:+	-0.66	-14.15	3.08E-38	Aortic root size	
THCA	cis	1	rs4718309	chr7:65627764	CCT6P1	chr7:65216092-65228661:+	-0.42	-6.7	5.9E-11	Diabetic kidney disease	
THCA	cis	1	rs4718309	chr7:65627764	CRCP	chr7:65579805-65619551:+	0.3	4.63	4.66E-6	Diabetic kidney disease	
THCA	cis	1	rs4718309	chr7:65627764	LOC493754	chr7:65993446-66057363:-	-0.29	-3.36	0.000833	Diabetic kidney disease	
THCA	cis	1	rs4718309	chr7:65627764	RABGEF1	chr7:66093890-66276446:+	-0.57	-7.14	3.42E-12	Diabetic kidney disease	
THCA	cis	1	rs4718315	chr7:65648541	CCT6P1	chr7:65216092-65228661:+	-0.42	-6.7	5.9E-11	Diabetic kidney disease	
THCA	cis	1	rs4718315	chr7:65648541	CRCP	chr7:65579805-65619551:+	0.3	4.63	4.66E-6	Diabetic kidney disease	
THCA	cis	1	rs4718315	chr7:65648541	LOC493754	chr7:65993446-66057363:-	-0.29	-3.36	0.000833	Diabetic kidney disease	
THCA	cis	1	rs4718315	chr7:65648541	RABGEF1	chr7:66093890-66276446:+	-0.57	-7.14	3.42E-12	Diabetic kidney disease	
THCA	cis	1	rs4718316	chr7:65648731	CCT6P1	chr7:65216092-65228661:+	-0.42	-6.7	5.9E-11	Diabetic kidney disease	
THCA	cis	1	rs4718316	chr7:65648731	CRCP	chr7:65579805-65619551:+	0.3	4.63	4.66E-6	Diabetic kidney disease	
THCA	cis	1	rs4718316	chr7:65648731	LOC493754	chr7:65993446-66057363:-	-0.29	-3.36	0.000833	Diabetic kidney disease	
THCA	cis	1	rs4718316	chr7:65648731	RABGEF1	chr7:66093890-66276446:+	-0.57	-7.14	3.42E-12	Diabetic kidney disease	
THCA	cis	1	rs4718317	chr7:65648901	CCT6P1	chr7:65216092-65228661:+	-0.41	-6.63	9.28E-11	Diabetic kidney disease	
THCA	cis	1	rs4718317	chr7:65648901	CRCP	chr7:65579805-65619551:+	0.3	4.66	4.1E-6	Diabetic kidney disease	
THCA	cis	1	rs4718317	chr7:65648901	LOC493754	chr7:65993446-66057363:-	-0.29	-3.43	0.000654	Diabetic kidney disease	
THCA	cis	1	rs4718317	chr7:65648901	RABGEF1	chr7:66093890-66276446:+	-0.55	-6.87	1.95E-11	Diabetic kidney disease	
THCA	cis	1	rs4718333	chr7:65772758	CCT6P1	chr7:65216092-65228661:+	-0.42	-6.62	9.41E-11	Diabetic kidney disease	
THCA	cis	1	rs4718333	chr7:65772758	CRCP	chr7:65579805-65619551:+	0.28	4.19	3.25E-5	Diabetic kidney disease	
THCA	cis	1	rs4718333	chr7:65772758	LOC493754	chr7:65993446-66057363:-	-0.29	-3.34	0.000897	Diabetic kidney disease	
THCA	cis	1	rs4718333	chr7:65772758	RABGEF1	chr7:66093890-66276446:+	-0.6	-7.29	1.25E-12	Diabetic kidney disease	
THCA	cis	1	rs4718334	chr7:65789454	CCT6P1	chr7:65216092-65228661:+	-0.42	-6.56	1.43E-10	Diabetic kidney disease	
THCA	cis	1	rs4718334	chr7:65789454	CRCP	chr7:65579805-65619551:+	0.27	4.07	5.4E-5	Diabetic kidney disease	
THCA	cis	1	rs4718334	chr7:65789454	LOC493754	chr7:65993446-66057363:-	-0.3	-3.39	0.000744	Diabetic kidney disease	
THCA	cis	1	rs4718334	chr7:65789454	RABGEF1	chr7:66093890-66276446:+	-0.6	-7.42	5.44E-13	Diabetic kidney disease	
THCA	cis	1	rs4718343	chr7:65874288	ASL	chr7:65540776-65558321:+	-0.16	-4.16	3.75E-5	Aortic root size	
THCA	cis	1	rs4718343	chr7:65874288	GUSB	chr7:65425675-65447246:-	0.27	5.34	1.43E-7	Aortic root size	
THCA	cis	1	rs4718343	chr7:65874288	RABGEF1	chr7:66093890-66276446:+	0.65	14.09	5.98E-38	Aortic root size	
THCA	cis	1	rs4718344	chr7:65874381	ASL	chr7:65540776-65558321:+	-0.16	-4.27	2.36E-5	Aortic root size	
THCA	cis	1	rs4718344	chr7:65874381	GUSB	chr7:65425675-65447246:-	0.28	5.47	7.42E-8	Aortic root size	
THCA	cis	1	rs4718344	chr7:65874381	RABGEF1	chr7:66093890-66276446:+	0.66	14.31	6.19E-39	Aortic root size	
THCA	cis	1	rs4718357	chr7:65960878	ASL	chr7:65540776-65558321:+	-0.16	-4.23	2.81E-5	Aortic root size	
THCA	cis	1	rs4718357	chr7:65960878	GUSB	chr7:65425675-65447246:-	0.27	5.3	1.8E-7	Aortic root size	
THCA	cis	1	rs4718357	chr7:65960878	RABGEF1	chr7:66093890-66276446:+	0.66	14.11	4.76E-38	Aortic root size	
THCA	cis	1	rs4722286	chr7:23913624	C7orf46	chr7:23719749-23742268:+	-0.12	-3.74	0.000209	Schizophrenia	
THCA	cis	1	rs4723733	chr7:38223613	STARD3NL	chr7:38217933-38270269:+	0.52	12.37	1.13E-30	Treatment response for severe sepsis	
THCA	cis	1	rs4723734	chr7:38232061	STARD3NL	chr7:38217933-38270269:+	-0.52	-12.38	9.54E-31	Treatment response for severe sepsis	
THCA	cis	1	rs4723738	chr7:38240908	STARD3NL	chr7:38217933-38270269:+	-0.52	-12.16	8.05E-30	Treatment response for severe sepsis	
THCA	cis	1	rs472402	chr5:6635591	NSUN2	chr5:6599355-6633157:-	0.19	4.15	3.88E-5	Response to amphetamines	
THCA	cis	1	rs472415	chr11:83267166	CCDC90B	chr11:82972506-82997414:-	0.16	3.94	9.5E-5	Subcortical brain region volumes	
THCA	cis	1	rs4726669	chr7:143758191	ARHGEF35	chr7:143883677-143892736:-	-0.5	-10.62	8.54E-24	Obesity-related traits	
THCA	cis	1	rs4726669	chr7:143758191	OR2A1	chr7:144015236-144016148:+;chr7	-0.19	-4.01	7.07E-5	Obesity-related traits	
THCA	cis	1	rs4726669	chr7:143758191	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-6.58	1.23E-10	Obesity-related traits	
THCA	cis	1	rs4727443	chr7:99593346	TRIM4	chr7:99488037-99517154:-	-0.3	-5.81	1.13E-8	Interstitial lung disease	
THCA	cis	1	rs4727865	chr7:118005595	ANKRD7	chr7:117864712-117882782:+	-0.28	-4.65	4.24E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs4727867	chr7:118051152	ANKRD7	chr7:117864712-117882782:+	-0.28	-4.51	8.19E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs4728142	chr7:128573967	IRF5	chr7:128577769-128590086:+	0.35	10.91	6.94E-25	Systemic lupus erythematosus;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs4728709	chr7:87233602	DBF4	chr7:87505544-87538856:+	0.23	3.52	0.00048	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs473005	chr4:56288125	TMEM165	chr4:56262090-56292342:+	-0.15	-3.8	0.000164	Personality dimensions	
THCA	cis	1	rs4730250	chr7:107207695	DLD	chr7:107531586-107561642:+	0.14	3.42	0.000676	Osteoarthritis	
THCA	cis	1	rs473073	chr10:131429646	MGMT	chr10:131265454-131565783:+	0.38	11.35	1.29E-26	Response to temozolomide	
THCA	cis	1	rs4730871	chr7:118079738	ANKRD7	chr7:117864712-117882782:+	-0.27	-4.41	1.28E-5	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs4731205	chr7:124385442	POT1	chr7:124462441-124570037:-	0.15	3.42	0.000688	Reading and spelling	
THCA	cis	1	rs473188	chr11:116812029	PCSK7	chr11:117075789-117102811:-	-0.29	-5.06	5.99E-7	Protein quantitative trait loci	
THCA	cis	1	rs4732038	chr7:134250322	AKR1B1	chr7:134127107-134143888:-	0.21	4.49	9.09E-6	Longevity	
THCA	cis	1	rs4733384	chr8:29985381	LEPROTL1	chr8:29952922-29995222:+	0.16	3.53	0.000464	Migraine	
THCA	cis	1	rs4733384	chr8:29985381	MBOAT4	chr8:29989188-30002200:-	0.4	5.24	2.47E-7	Migraine	
THCA	cis	1	rs4733384	chr8:29985381	TMEM66	chr8:29920632-29940649:-	-0.17	-3.34	0.000902	Migraine	
THCA	cis	1	rs4734494	chr8:101917721	YWHAZ	chr8:101930804-101965623:-	-0.17	-4.46	1.04E-5	Attention deficit hyperactivity disorder and conduct disorder	
THCA	cis	1	rs4734495	chr8:101917817	YWHAZ	chr8:101930804-101965623:-	-0.17	-4.51	8.21E-6	Attention deficit hyperactivity disorder and conduct disorder	
THCA	cis	1	rs473651	chr2:239335401	ASB1	chr2:239335626-239360890:+	-0.13	-3.59	0.000359	Multiple system atrophy	
THCA	cis	1	rs473771	chr10:131408155	MGMT	chr10:131265454-131565783:+	0.39	11.66	8.39E-28	Response to temozolomide	
THCA	cis	1	rs4742777	chr9:102679173	STX17	chr9:102668915-102736817:+	-0.17	-4.29	2.17E-5	Alopecia areata	
THCA	cis	1	rs4742778	chr9:102701967	STX17	chr9:102668915-102736817:+	-0.17	-4.29	2.21E-5	Alopecia areata	
THCA	cis	1	rs4743130	chr9:100546040	C9orf156	chr9:100666772-100684852:-	0.13	3.54	0.000443	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	cis	1	rs4743131	chr9:100554907	C9orf156	chr9:100666772-100684852:-	0.13	3.65	0.000295	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	cis	1	rs4743197	chr9:101067734	TBC1D2	chr9:100961281-101018003:-	0.21	5.41	1.02E-7	Schizophrenia	
THCA	cis	1	rs4743199	chr9:101067992	TBC1D2	chr9:100961281-101018003:-	0.21	5.41	1.02E-7	Schizophrenia	
THCA	cis	1	rs4743762	chr9:107592189	SMC2	chr9:106856541-106903693:+	-0.16	-3.45	0.000604	Myopia (pathological)	
THCA	cis	1	rs4745706	chr10:65159580	LOC84989	chr10:65224989-65226320:+	0.28	4.46	1.03E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs4745706	chr10:65159580	NRBF2	chr10:64893007-64914785:+	0.28	4.65	4.26E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs4745729	chr10:65277083	LOC84989	chr10:65224989-65226320:+	0.27	4.22	2.88E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs4745729	chr10:65277083	NRBF2	chr10:64893007-64914785:+	0.26	4.38	1.43E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs4745740	chr10:75942469	VCL	chr10:75754951-75879912:+	-0.19	-3.58	0.000374	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs4746112	chr10:74042995	DNAJB12	chr10:74092588-74114907:-	0.2	4.78	2.31E-6	Heschl's gyrus morphology	
THCA	cis	1	rs4746119	chr10:65129917	LOC84989	chr10:65224989-65226320:+	0.27	4.44	1.14E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs4746119	chr10:65129917	NRBF2	chr10:64893007-64914785:+	0.28	4.67	3.88E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs4746138	chr10:65241741	LOC84989	chr10:65224989-65226320:+	0.25	4.08	5.18E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs4746138	chr10:65241741	NRBF2	chr10:64893007-64914785:+	0.26	4.32	1.92E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs4746149	chr10:65257393	LOC84989	chr10:65224989-65226320:+	-0.25	-4.04	6.1E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs4746149	chr10:65257393	NRBF2	chr10:64893007-64914785:+	-0.24	-4.09	4.96E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs4746195	chr10:65307653	LOC84989	chr10:65224989-65226320:+	0.23	3.7	0.00024	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs4746195	chr10:65307653	NRBF2	chr10:64893007-64914785:+	0.25	4.1	4.79E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs4746974	chr10:64892052	LOC84989	chr10:65224989-65226320:+	0.27	4.47	9.93E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs4746974	chr10:64892052	NRBF2	chr10:64893007-64914785:+	0.27	4.55	6.73E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs4746994	chr10:64905324	LOC84989	chr10:65224989-65226320:+	0.27	4.36	1.62E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs4746994	chr10:64905324	NRBF2	chr10:64893007-64914785:+	0.27	4.57	6.28E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs4747011	chr10:72114378	NPFFR1	chr10:72014714-72026148:-	-0.39	-3.78	0.000178	Brain connectivity	
THCA	cis	1	rs4747045	chr10:64926482	LOC84989	chr10:65224989-65226320:+	0.27	4.33	1.86E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs4747045	chr10:64926482	NRBF2	chr10:64893007-64914785:+	0.28	4.71	3.22E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs4747241	chr10:74036429	ASCC1	chr10:73856278-73976892:-	0.19	3.45	0.000618	Heschl's gyrus morphology	
THCA	cis	1	rs4747241	chr10:74036429	DNAJB12	chr10:74092588-74114907:-	0.21	5	8.17E-7	Heschl's gyrus morphology	
THCA	cis	1	rs4747242	chr10:74037193	ASCC1	chr10:73856278-73976892:-	0.18	3.36	0.00084	Heschl's gyrus morphology	
THCA	cis	1	rs4747242	chr10:74037193	DNAJB12	chr10:74092588-74114907:-	0.21	4.82	1.91E-6	Heschl's gyrus morphology	
THCA	cis	1	rs4750759	chr10:131436603	MGMT	chr10:131265454-131565783:+	-0.37	-11.28	2.44E-26	Response to temozolomide	
THCA	cis	1	rs4752797	chr11:47874364	C1QTNF4	chr11:47611216-47615961:-	-0.3	-5.22	2.61E-7	Subjective well-being	
THCA	cis	1	rs4752856	chr11:47648042	C1QTNF4	chr11:47611216-47615961:-	-0.3	-5.22	2.61E-7	Subjective well-being	
THCA	cis	1	rs4752857	chr11:47655752	C1QTNF4	chr11:47611216-47615961:-	-0.31	-5.49	6.49E-8	Subjective well-being	
THCA	cis	1	rs4752873	chr11:47857520	C1QTNF4	chr11:47611216-47615961:-	-0.31	-5.36	1.31E-7	Subjective well-being	
THCA	cis	1	rs4752931	chr11:46762516	ZNF408	chr11:46722368-46727461:+	-0.19	-3.63	0.000313	HDL cholesterol	
THCA	cis	1	rs4752932	chr11:46773354	DDB2	chr11:47236493-47260769:+	0.23	3.54	0.000434	HDL cholesterol	
THCA	cis	1	rs4752932	chr11:46773354	ZNF408	chr11:46722368-46727461:+	-0.18	-3.55	0.000421	HDL cholesterol	
THCA	cis	1	rs4752933	chr11:46803785	DDB2	chr11:47236493-47260769:+	0.22	3.48	0.000544	HDL cholesterol	
THCA	cis	1	rs4752933	chr11:46803785	ZNF408	chr11:46722368-46727461:+	-0.19	-3.61	0.000338	HDL cholesterol	
THCA	cis	1	rs4752940	chr11:46847715	DDB2	chr11:47236493-47260769:+	0.22	3.53	0.000459	HDL cholesterol	
THCA	cis	1	rs4752940	chr11:46847715	ZNF408	chr11:46722368-46727461:+	-0.18	-3.52	0.000472	HDL cholesterol	
THCA	cis	1	rs4752946	chr11:46896908	DDB2	chr11:47236493-47260769:+	0.21	3.47	0.000561	HDL cholesterol	
THCA	cis	1	rs4752947	chr11:46901156	DDB2	chr11:47236493-47260769:+	0.22	3.47	0.000574	HDL cholesterol	
THCA	cis	1	rs4752947	chr11:46901156	ZNF408	chr11:46722368-46727461:+	-0.19	-3.61	0.000335	HDL cholesterol	
THCA	cis	1	rs4755726	chr11:43642130	HSD17B12	chr11:43702143-43878160:+	-0.68	-14.09	6.08E-38	Forced vital capacity	
THCA	cis	1	rs4757676	chr11:18640477	SPTY2D1	chr11:18627949-18656020:-	-0.14	-4.64	4.5E-6	Cholesterol, total	
THCA	cis	1	rs4759042	chr12:57377347	STAT6	chr12:57489195-57522883:-	0.16	3.86	0.000129	Migraine	
THCA	cis	1	rs4759042	chr12:57377347	TMEM194A	chr12:57449427-57472574:-	0.16	3.85	0.000135	Migraine	
THCA	cis	1	rs4759229	chr12:56474480	RAB5B	chr12:56367760-56388478:+	-0.24	-4.3	2.06E-5	Cognitive function	
THCA	cis	1	rs4759229	chr12:56474480	RPS26	chr12:56435686-56438005:+	-0.7	-13.48	2.52E-35	Cognitive function	
THCA	cis	1	rs4759318	chr12:54420098	SMUG1	chr12:54573783-54582757:-	-0.1	-3.35	0.000864	Bone mineral density	
THCA	cis	1	rs4759375	chr12:123796238	C12orf65	chr12:123717841-123742481:+	-0.25	-3.91	0.000106	HDL cholesterol	
THCA	cis	1	rs4759377	chr12:123796849	C12orf65	chr12:123717841-123742481:+	-0.24	-4.1	4.9E-5	HDL cholesterol	
THCA	cis	1	rs4759787	chr12:131290180	STX2	chr12:131274149-131323811:-	-0.67	-10.17	4.07E-22	Plasma plasminogen activator levels	
THCA	cis	1	rs4763555	chr12:10721456	KLRA1	chr12:10741078-10752434:-	0.12	3.62	0.000328	Cognitive function	
THCA	cis	1	rs4763555	chr12:10721456	MAGOHB	chr12:10756794-10766183:-	-0.16	-3.74	0.000208	Cognitive function	
THCA	cis	1	rs4763879	chr12:9910164	CLECL1	chr12:9868457-9885860:-	-0.26	-8.67	6.6E-17	Type 1 diabetes	
THCA	cis	1	rs4764124	chr12:14966604	C12orf60	chr12:14956506-14976789:+	-0.41	-10.26	1.94E-22	Pubertal anthropometrics	
THCA	cis	1	rs4764124	chr12:14966604	ERP27	chr12:15066977-15091463:-	-0.25	-4.84	1.77E-6	Pubertal anthropometrics	
THCA	cis	1	rs4765219	chr12:124440110	ZNF664	chr12:124457670-124499967:+	-0.18	-5.15	3.78E-7	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs4765305	chr12:124430612	DNAH10	chr12:124247042-124420265:+	0.18	3.87	0.000126	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs4765305	chr12:124430612	ZNF664	chr12:124457670-124499967:+	-0.16	-4.81	1.98E-6	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs476633	chr15:41392134	INO80	chr15:41271081-41408340:-	0.14	3.81	0.000159	Glomerular filtration rate (creatinine)	
THCA	cis	1	rs476633	chr15:41392134	RTF1	chr15:41709302-41775760:+	-0.18	-4.23	2.83E-5	Glomerular filtration rate (creatinine)	
THCA	cis	1	rs4766428	chr12:110723245	C12orf24	chr12:110906229-110928191:+	0.18	3.9	0.000108	Schizophrenia	
THCA	cis	1	rs4766428	chr12:110723245	VPS29	chr12:110929331-110939916:-	-0.13	-3.47	0.000567	Schizophrenia	
THCA	cis	1	rs4766947	chr12:120161401	TMEM233	chr12:120031264-120079363:+	-0.21	-5.12	4.47E-7	Urgency urinary incontinence	
THCA	cis	1	rs4767839	chr12:120160122	TMEM233	chr12:120031264-120079363:+	-0.23	-5.72	1.9E-8	Urgency urinary incontinence	
THCA	cis	1	rs4767841	chr12:120162199	TMEM233	chr12:120031264-120079363:+	-0.22	-5.42	9.61E-8	Urgency urinary incontinence	
THCA	cis	1	rs4768866	chr12:51156580	DIP2B	chr12:50898768-51142448:+	-0.23	-8.31	1.01E-15	Colorectal cancer	
THCA	cis	1	rs4768942	chr12:51355701	SLC11A2	chr12:51373319-51422058:-	-0.24	-4.8	2.17E-6	Type 2 diabetes	
THCA	cis	1	rs4768942	chr12:51355701	TFCP2	chr12:51488608-51566917:-	-0.21	-4.35	1.68E-5	Type 2 diabetes	
THCA	cis	1	rs4768943	chr12:51355939	SLC11A2	chr12:51373319-51422058:-	-0.24	-4.74	2.88E-6	Type 2 diabetes	
THCA	cis	1	rs4768943	chr12:51355939	TFCP2	chr12:51488608-51566917:-	-0.2	-4.29	2.15E-5	Type 2 diabetes	
THCA	cis	1	rs4768	chr3:49758764	CCDC36	chr3:49235861-49295537:+	0.18	3.78	0.000179	Resting heart rate	
THCA	cis	1	rs4768	chr3:49758764	RBM6	chr3:49977592-50137484:+	-0.14	-4.19	3.28E-5	Resting heart rate	
THCA	cis	1	rs477046	chr11:83324190	CCDC90B	chr11:82972506-82997414:-	0.17	4	7.34E-5	Subcortical brain region volumes	
THCA	cis	1	rs4770506	chr13:24434703	C1QTNF9B	chr13:24465238-24471641:-	-0.35	-3.53	0.00045	3-hydroxypropylmercapturic acid levels in smokers	
THCA	cis	1	rs4770507	chr13:24434744	C1QTNF9B	chr13:24465238-24471641:-	-0.35	-3.53	0.00045	3-hydroxypropylmercapturic acid levels in smokers	
THCA	cis	1	rs4770509	chr13:24438643	C1QTNF9B	chr13:24465238-24471641:-	-0.35	-3.6	0.000357	3-hydroxypropylmercapturic acid levels in smokers	
THCA	cis	1	rs4771705	chr13:111321757	CARS2	chr13:111293757-111365950:-	0.21	6.05	2.86E-9	Diastolic blood pressure	
THCA	cis	1	rs4771907	chr13:95868980	ABCC4	chr13:95672084-95953687:-	-0.19	-3.62	0.000328	Breast cancer	
THCA	cis	1	rs4771908	chr13:95872411	ABCC4	chr13:95672084-95953687:-	-0.18	-3.47	0.000558	Breast cancer	
THCA	cis	1	rs4773747	chr13:94075872	GPC6	chr13:93879078-95060267:+	-0.27	-3.61	0.000336	Neuroticism	
THCA	cis	1	rs4773847	chr13:95868009	ABCC4	chr13:95672084-95953687:-	-0.19	-3.64	0.000303	Breast cancer	
THCA	cis	1	rs4773848	chr13:95873394	ABCC4	chr13:95672084-95953687:-	-0.18	-3.51	0.000493	Breast cancer	
THCA	cis	1	rs4773854	chr13:95879410	ABCC4	chr13:95672084-95953687:-	-0.19	-3.49	0.000525	Breast cancer	
THCA	cis	1	rs4773857	chr13:95884048	ABCC4	chr13:95672084-95953687:-	-0.19	-3.5	0.000505	Breast cancer	
THCA	cis	1	rs4775457	chr15:62374915	VPS13C	chr15:62144592-62352647:-	-0.1	-3.79	0.000167	Height	
THCA	cis	1	rs4775458	chr15:62375036	VPS13C	chr15:62144592-62352647:-	-0.1	-3.79	0.000167	Height	
THCA	cis	1	rs4775893	chr15:50898695	SPPL2A	chr15:50999739-51057910:-	0.26	7.11	4.24E-12	QT interval	
THCA	cis	1	rs4775897	chr15:50944066	SPPL2A	chr15:50999739-51057910:-	0.28	7.34	9.28E-13	QT interval	
THCA	cis	1	rs4775897	chr15:50944066	TRPM7	chr15:50852491-50978994:-	0.11	3.43	0.000663	QT interval	
THCA	cis	1	rs477692	chr10:131426022	MGMT	chr10:131265454-131565783:+	0.38	11.84	1.57E-28	Response to temozolomide	
THCA	cis	1	rs477895	chr11:64048912	PRDX5	chr11:64085569-64089282:+	0.16	4.47	9.86E-6	Mean platelet volume	
THCA	cis	1	rs477930	chr5:6635882	NSUN2	chr5:6599355-6633157:-	0.19	4.15	3.88E-5	Response to amphetamines	
THCA	cis	1	rs4780465	chr16:12707523	CPPED1	chr16:12753657-12897744:-	0.16	4.02	6.64E-5	Obesity-related traits	
THCA	cis	1	rs478048	chr11:83324320	CCDC90B	chr11:82972506-82997414:-	-0.16	-3.84	0.000139	Subcortical brain region volumes	
THCA	cis	1	rs4782193	chr16:19035682	COQ7	chr16:19078927-19091350:+	-0.29	-3.94	9.54E-5	Response to angiotensin II receptor blocker therapy	
THCA	cis	1	rs4784054	chr16:58776314	GOT2	chr16:58741035-58768246:-	0.19	3.81	0.000157	Blood metabolite levels	
THCA	cis	1	rs4784295	chr16:51471432	SALL1	chr16:51169886-51185183:-	0.22	5.13	4.23E-7	Optic disc area;Optic disc parameters	
THCA	cis	1	rs4784934	chr16:58459926	CCDC135	chr16:57728713-57765366:+	-0.21	-3.9	0.000109	QT interval	
THCA	cis	1	rs4785202	chr16:50095995	HEATR3	chr16:50099881-50139373:+	-0.4	-6.49	2.13E-10	Esophageal cancer (squamous cell)	
THCA	cis	1	rs4785203	chr16:50096065	HEATR3	chr16:50099881-50139373:+	-0.4	-6.49	2.13E-10	Esophageal cancer (squamous cell)	
THCA	cis	1	rs4785204	chr16:50103734	HEATR3	chr16:50099881-50139373:+	-0.37	-5.83	1.02E-8	Esophageal cancer (squamous cell)	
THCA	cis	1	rs4785379	chr16:50089373	HEATR3	chr16:50099881-50139373:+	-0.4	-6.21	1.16E-9	Esophageal cancer (squamous cell)	
THCA	cis	1	rs4785381	chr16:50133789	HEATR3	chr16:50099881-50139373:+	0.33	6.91	1.52E-11	Testicular germ cell tumor	
THCA	cis	1	rs4787491	chr16:30015337	FAM57B	chr16:30035749-30042186:-	-0.27	-5.01	7.64E-7	Body mass index	
THCA	cis	1	rs4787491	chr16:30015337	TBX6	chr16:30097117-30103208:-	0.2	4.68	3.7E-6	Body mass index	
THCA	cis	1	rs4788187	chr16:29845685	MAPK3	chr16:30125427-30134630:-	0.23	3.48	0.000541	Multiple sclerosis	
THCA	cis	1	rs4788187	chr16:29845685	MVP	chr16:29831787-29859342:+	0.12	3.46	0.000593	Multiple sclerosis	
THCA	cis	1	rs4788188	chr16:29860863	MAPK3	chr16:30125427-30134630:-	-0.24	-3.52	0.00047	Multiple sclerosis	
THCA	cis	1	rs4788196	chr16:29967434	FAM57B	chr16:30035749-30042186:-	-0.25	-4.76	2.59E-6	Pubertal anthropometrics	
THCA	cis	1	rs4788196	chr16:29967434	LOC595101	chr16:30278914-30346695:-	-0.2	-3.75	0.000198	Pubertal anthropometrics	
THCA	cis	1	rs4788196	chr16:29967434	RUNDC2C	chr16:29339874-29418349:+	0.15	3.5	0.000502	Pubertal anthropometrics	
THCA	cis	1	rs4788196	chr16:29967434	TBX6	chr16:30097117-30103208:-	0.19	4.56	6.38E-6	Pubertal anthropometrics	
THCA	cis	1	rs4788815	chr16:71634811	MARVELD3	chr16:71660070-71675866:+	-0.15	-3.35	0.000877	Metabolite levels	
THCA	cis	1	rs478946	chr11:83297563	CCDC90B	chr11:82972506-82997414:-	0.16	3.87	0.000124	Subcortical brain region volumes	
THCA	cis	1	rs4789693	chr17:80421870	NARF	chr17:80416060-80446141:+	-0.15	-3.74	0.000203	Glucocorticoid-induced osteonecrosis	
THCA	cis	1	rs4790881	chr17:2068932	SRR	chr17:2207248-2228553:+	-0.39	-6.72	5.07E-11	Bone mineral density	
THCA	cis	1	rs4790908	chr17:65852907	C17orf58	chr17:65987218-65989765:-	0.24	4.84	1.75E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs4791212	chr17:65975385	C17orf58	chr17:65987218-65989765:-	0.2	3.91	0.000105	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs4791299	chr17:65930937	C17orf58	chr17:65987218-65989765:-	0.24	4.84	1.76E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs4791641	chr17:8161149	C17orf44	chr17:8123949-8127361:-	0.17	3.45	0.000604	LDL cholesterol	
THCA	cis	1	rs4791641	chr17:8161149	PFAS	chr17:8152596-8173808:+	-0.21	-5.66	2.68E-8	LDL cholesterol	
THCA	cis	1	rs4793035	chr17:41887753	MPP3	chr17:41878169-41910538:-	0.29	4.77	2.44E-6	Triglycerides	
THCA	cis	1	rs479343	chr6:111690904	KIAA1919	chr6:111580482-111590259:+	0.48	5.6	3.62E-8	Psoriasis	
THCA	cis	1	rs4794016	chr17:45725931	TBKBP1	chr17:45772630-45789427:+	0.36	10.23	2.48E-22	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
THCA	cis	1	rs4794048	chr17:45763073	TBKBP1	chr17:45772630-45789427:+	-0.4	-11.17	6.45E-26	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
THCA	cis	1	rs4794202	chr17:45930539	SCRN2	chr17:45915049-45918699:-	-0.28	-6.2	1.22E-9	Alzheimer's disease (cognitive decline)	
THCA	cis	1	rs479478	chr10:131428959	MGMT	chr10:131265454-131565783:+	0.38	11.35	1.29E-26	Response to temozolomide	
THCA	cis	1	rs4794823	chr17:38166265	GSDMA	chr17:38119226-38134019:+	-0.31	-7.25	1.71E-12	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THCA	cis	1	rs4794824	chr17:38179290	GSDMA	chr17:38119226-38134019:+	-0.33	-7.58	1.87E-13	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THCA	cis	1	rs479493	chr1:41567202	SCMH1	chr1:41492875-41707788:-	0.2	4.7	3.35E-6	Height	
THCA	cis	1	rs4795412	chr17:38150604	GSDMA	chr17:38119226-38134019:+	-0.32	-7.26	1.6E-12	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THCA	cis	1	rs4795412	chr17:38150604	ORMDL3	chr17:38077296-38083854:-	0.14	3.41	0.000702	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THCA	cis	1	rs4795415	chr17:38157995	GSDMA	chr17:38119226-38134019:+	-0.32	-7.28	1.39E-12	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THCA	cis	1	rs4795416	chr17:38158133	GSDMA	chr17:38119226-38134019:+	-0.32	-7.28	1.39E-12	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THCA	cis	1	rs4795418	chr17:38164851	GSDMA	chr17:38119226-38134019:+	-0.31	-7.25	1.71E-12	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THCA	cis	1	rs4795525	chr17:28388487	ANKRD13B	chr17:27916801-27941778:+	-0.36	-8.84	1.85E-17	Coffee consumption (cups per day)	
THCA	cis	1	rs4795525	chr17:28388487	CORO6	chr17:27941774-27948441:-	-0.51	-11.74	4.02E-28	Coffee consumption (cups per day)	
THCA	cis	1	rs4795525	chr17:28388487	EFCAB5	chr17:28256874-28435469:+	-0.6	-11.33	1.63E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs4795525	chr17:28388487	GIT1	chr17:27900487-27916610:-	-0.29	-6.79	3.24E-11	Coffee consumption (cups per day)	
THCA	cis	1	rs4795525	chr17:28388487	LRRC37B2	chr17:28903483-28992715:+	-0.18	-3.94	9.28E-5	Coffee consumption (cups per day)	
THCA	cis	1	rs4795525	chr17:28388487	SSH2	chr17:27952965-28257018:-	-0.34	-7.67	9.71E-14	Coffee consumption (cups per day)	
THCA	cis	1	rs4795525	chr17:28388487	TP53I13	chr17:27895739-27900174:+	-0.2	-5.29	1.87E-7	Coffee consumption (cups per day)	
THCA	cis	1	rs479879	chr10:105945985	C10orf79	chr10:105889647-105992120:-	0.26	8.51	2.23E-16	Attention deficit hyperactivity disorder	
THCA	cis	1	rs4800243	chr18:23719196	SS18	chr18:23596219-23671164:-	0.29	3.74	0.000205	Rhegmatogenous retinal detachment	
THCA	cis	1	rs4800244	chr18:23729222	SS18	chr18:23596219-23671164:-	0.28	3.51	0.000493	Rhegmatogenous retinal detachment	
THCA	cis	1	rs4800719	chr18:23719536	SS18	chr18:23596219-23671164:-	0.28	3.55	0.000425	Rhegmatogenous retinal detachment	
THCA	cis	1	rs4801872	chr19:52025017	SIGLEC6	chr19:52022784-52035064:-	-0.31	-3.85	0.000136	Carotid intima media thickness	
THCA	cis	1	rs4801872	chr19:52025017	ZNF175	chr19:52074531-52092990:+	-0.37	-4.55	6.78E-6	Carotid intima media thickness	
THCA	cis	1	rs4801958	chr19:53667804	ZNF665	chr19:53666552-53696619:-	-0.15	-4.1	4.83E-5	Yu-Zhi constitution type in type 2 diabetes	
THCA	cis	1	rs4801961	chr19:53676430	ZNF665	chr19:53666552-53696619:-	-0.16	-4.5	8.72E-6	Yu-Zhi constitution type in type 2 diabetes	
THCA	cis	1	rs4802200	chr19:44289518	LYPD5	chr19:44300080-44324808:-	-0.24	-5.19	3.05E-7	Breast cancer	
THCA	cis	1	rs4802200	chr19:44289518	ZNF155	chr19:44488355-44502477:+	-0.25	-5.62	3.33E-8	Breast cancer	
THCA	cis	1	rs4802200	chr19:44289518	ZNF404	chr19:44376516-44384288:-	-0.25	-6.53	1.65E-10	Breast cancer	
THCA	cis	1	rs4802307	chr19:46849806	PPP5C	chr19:46850294-46894103:+	-0.24	-4.22	2.92E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs4802803	chr19:52027587	SIGLEC6	chr19:52022784-52035064:-	-0.28	-3.36	0.000838	Carotid intima media thickness	
THCA	cis	1	rs4802803	chr19:52027587	ZNF175	chr19:52074531-52092990:+	-0.38	-4.54	7.26E-6	Carotid intima media thickness	
THCA	cis	1	rs4803463	chr19:41911040	B3GNT8	chr19:41931265-41934635:-	-0.36	-8.3	1.05E-15	Height	
THCA	cis	1	rs4803463	chr19:41911040	EXOSC5	chr19:41892278-41903256:-	-0.1	-3.4	0.000731	Height	
THCA	cis	1	rs4803465	chr19:41918158	B3GNT8	chr19:41931265-41934635:-	0.36	8.53	1.91E-16	Height	
THCA	cis	1	rs4803468	chr19:41922352	B3GNT8	chr19:41931265-41934635:-	-0.36	-8.33	8.76E-16	Height	
THCA	cis	1	rs4803469	chr19:41922775	B3GNT8	chr19:41931265-41934635:-	-0.36	-8.33	8.76E-16	Height	
THCA	cis	1	rs4803480	chr19:42066279	CEACAM21	chr19:42055886-42093196:+	0.59	14.76	7.13E-41	Schizophrenia	
THCA	cis	1	rs4803658	chr19:44290013	LYPD5	chr19:44300080-44324808:-	-0.24	-5.01	7.69E-7	Breast cancer	
THCA	cis	1	rs4803658	chr19:44290013	ZNF155	chr19:44488355-44502477:+	-0.25	-5.62	3.23E-8	Breast cancer	
THCA	cis	1	rs4803658	chr19:44290013	ZNF404	chr19:44376516-44384288:-	-0.26	-6.77	3.83E-11	Breast cancer	
THCA	cis	1	rs4804411	chr19:7222377	ZNF557	chr19:7069471-7087976:+	-0.18	-3.77	0.000181	Triglycerides	
THCA	cis	1	rs4805754	chr19:32837166	DPY19L3	chr19:32896677-32975236:+	0.17	4.52	7.86E-6	Bipolar disorder	
THCA	cis	1	rs4805754	chr19:32837166	ZNF507	chr19:32836514-32878571:+	0.33	8.31	9.71E-16	Bipolar disorder	
THCA	cis	1	rs4805755	chr19:32854470	DPY19L3	chr19:32896677-32975236:+	-0.19	-5.48	6.76E-8	Bipolar disorder	
THCA	cis	1	rs4805755	chr19:32854470	ZNF507	chr19:32836514-32878571:+	-0.31	-7.96	1.26E-14	Bipolar disorder	
THCA	cis	1	rs4805758	chr19:32866424	DPY19L3	chr19:32896677-32975236:+	0.2	5.53	5.41E-8	Bipolar disorder	
THCA	cis	1	rs4805758	chr19:32866424	ZNF507	chr19:32836514-32878571:+	0.32	8.11	4.16E-15	Bipolar disorder	
THCA	cis	1	rs4805762	chr19:32963954	DPY19L3	chr19:32896677-32975236:+	0.18	4.96	9.87E-7	Bipolar disorder	
THCA	cis	1	rs4805762	chr19:32963954	ZNF507	chr19:32836514-32878571:+	0.3	7.54	2.42E-13	Bipolar disorder	
THCA	cis	1	rs4805834	chr19:33453659	SLC7A9	chr19:33321421-33360683:-	-0.24	-3.59	0.000363	Creatinine levels	
THCA	cis	1	rs480643	chr10:131400308	MGMT	chr10:131265454-131565783:+	0.38	11.21	4.67E-26	Response to temozolomide	
THCA	cis	1	rs4807790	chr19:5584614	C19orf70	chr19:5678433-5680911:-	-0.14	-3.56	0.000407	vWF and FVIII levels	
THCA	cis	1	rs4807790	chr19:5584614	NDUFA11	chr19:5891287-5904025:-	-0.16	-3.61	0.000338	vWF and FVIII levels	
THCA	cis	1	rs4808133	chr19:18608518	ELL	chr19:18553475-18632937:-	-0.26	-6.56	1.44E-10	Breast cancer	
THCA	cis	1	rs4808133	chr19:18608518	ISYNA1	chr19:18545625-18548943:-	0.12	4.69	3.63E-6	Breast cancer	
THCA	cis	1	rs4808133	chr19:18608518	LRRC25	chr19:18501955-18508421:-	-0.13	-4.56	6.37E-6	Breast cancer	
THCA	cis	1	rs4808134	chr19:18608579	ELL	chr19:18553475-18632937:-	-0.26	-6.56	1.44E-10	Breast cancer	
THCA	cis	1	rs4808134	chr19:18608579	ISYNA1	chr19:18545625-18548943:-	0.12	4.69	3.63E-6	Breast cancer	
THCA	cis	1	rs4808134	chr19:18608579	LRRC25	chr19:18501955-18508421:-	-0.13	-4.56	6.37E-6	Breast cancer	
THCA	cis	1	rs4808136	chr19:18618867	ELL	chr19:18553475-18632937:-	0.27	6.88	1.83E-11	Breast cancer	
THCA	cis	1	rs4808136	chr19:18618867	ISYNA1	chr19:18545625-18548943:-	-0.12	-4.48	9.37E-6	Breast cancer	
THCA	cis	1	rs4808136	chr19:18618867	LRRC25	chr19:18501955-18508421:-	0.15	4.99	8.67E-7	Breast cancer	
THCA	cis	1	rs4808200	chr19:19554803	HAPLN4	chr19:19366453-19384074:-	0.33	7.12	3.99E-12	Schizophrenia	
THCA	cis	1	rs4808200	chr19:19554803	KIAA0892	chr19:19431630-19469562:+	-0.14	-4.05	5.99E-5	Schizophrenia	
THCA	cis	1	rs4808200	chr19:19554803	TM6SF2	chr19:19375174-19384074:-	0.2	4.18	3.41E-5	Schizophrenia	
THCA	cis	1	rs4808801	chr19:18571141	ELL	chr19:18553475-18632937:-	-0.26	-6.58	1.23E-10	Breast cancer	
THCA	cis	1	rs4808801	chr19:18571141	ISYNA1	chr19:18545625-18548943:-	0.12	4.55	6.68E-6	Breast cancer	
THCA	cis	1	rs4808801	chr19:18571141	LRRC25	chr19:18501955-18508421:-	-0.13	-4.55	6.82E-6	Breast cancer	
THCA	cis	1	rs4808804	chr19:18585325	ELL	chr19:18553475-18632937:-	-0.25	-6.27	7.97E-10	Breast cancer	
THCA	cis	1	rs4808804	chr19:18585325	ISYNA1	chr19:18545625-18548943:-	0.12	4.65	4.26E-6	Breast cancer	
THCA	cis	1	rs4808804	chr19:18585325	LRRC25	chr19:18501955-18508421:-	-0.14	-4.69	3.55E-6	Breast cancer	
THCA	cis	1	rs4809219	chr20:62303115	ZGPAT	chr20:62338794-62370459:+	0.15	4.56	6.45E-6	Atopic dermatitis	
THCA	cis	1	rs4810486	chr20:44766403	CD40	chr20:44746906-44758384:+	-0.18	-3.43	0.00066	Kawasaki disease	
THCA	cis	1	rs4810909	chr20:47621372	ARFGEF2	chr20:47538275-47653229:+	0.11	3.56	0.000407	Anger	
THCA	cis	1	rs4810909	chr20:47621372	CSE1L	chr20:47662838-47713484:+	-0.41	-9.81	8.33E-21	Anger	
THCA	cis	1	rs4811694	chr20:55029388	C20orf43	chr20:55043647-55093942:+	0.3	8.09	5.03E-15	Refractive astigmatism	
THCA	cis	1	rs4812048	chr20:57587771	TH1L	chr20:57556311-57570186:+	-0.18	-4.3	2.06E-5	Mean platelet volume	
THCA	cis	1	rs4813001	chr20:44762857	CD40	chr20:44746906-44758384:+	-0.19	-3.6	0.000346	Kawasaki disease	
THCA	cis	1	rs4813002	chr20:44763187	CD40	chr20:44746906-44758384:+	-0.19	-3.73	0.000211	Kawasaki disease	
THCA	cis	1	rs4813003	chr20:44763284	CD40	chr20:44746906-44758384:+	-0.2	-3.8	0.000165	Kawasaki disease	
THCA	cis	1	rs4813562	chr20:25352588	ENTPD6	chr20:25176339-25207360:+	0.32	7.23	1.88E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4813562	chr20:25352588	FAM182A	chr20:26035250-26067552:+	0.19	3.49	0.000536	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4813562	chr20:25352588	FAM182B	chr20:25744102-25848786:-	-0.26	-5.4	1.06E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4813562	chr20:25352588	NINL	chr20:25433338-25566153:-	0.33	6.9	1.7E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4813562	chr20:25352588	PYGB	chr20:25228706-25278647:+	0.16	4.03	6.5E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4813563	chr20:25365340	ENTPD6	chr20:25176339-25207360:+	0.3	6.69	6.1E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4813563	chr20:25365340	FAM182A	chr20:26035250-26067552:+	0.19	3.48	0.000547	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4813563	chr20:25365340	FAM182B	chr20:25744102-25848786:-	-0.26	-5.44	8.47E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4813563	chr20:25365340	NINL	chr20:25433338-25566153:-	0.34	7.05	6.43E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4813563	chr20:25365340	PYGB	chr20:25228706-25278647:+	0.14	3.59	0.000363	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4813566	chr20:25386465	ENTPD6	chr20:25176339-25207360:+	0.32	7.24	1.85E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4813566	chr20:25386465	FAM182A	chr20:26035250-26067552:+	0.19	3.48	0.000546	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4813566	chr20:25386465	FAM182B	chr20:25744102-25848786:-	-0.26	-5.4	1.05E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4813566	chr20:25386465	NINL	chr20:25433338-25566153:-	0.33	6.9	1.67E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4813566	chr20:25386465	PYGB	chr20:25228706-25278647:+	0.16	4.03	6.53E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815404	chr20:25301845	ENTPD6	chr20:25176339-25207360:+	0.31	6.94	1.26E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815404	chr20:25301845	FAM182A	chr20:26035250-26067552:+	0.18	3.41	0.000699	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815404	chr20:25301845	FAM182B	chr20:25744102-25848786:-	-0.26	-5.52	5.64E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815404	chr20:25301845	NINL	chr20:25433338-25566153:-	0.35	7.26	1.6E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815404	chr20:25301845	PYGB	chr20:25228706-25278647:+	0.15	3.73	0.000212	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815405	chr20:25317492	ENTPD6	chr20:25176339-25207360:+	0.31	6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815405	chr20:25317492	FAM182A	chr20:26035250-26067552:+	0.18	3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815405	chr20:25317492	FAM182B	chr20:25744102-25848786:-	-0.27	-5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815405	chr20:25317492	NINL	chr20:25433338-25566153:-	0.35	7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815405	chr20:25317492	PYGB	chr20:25228706-25278647:+	0.16	4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815406	chr20:25341316	ENTPD6	chr20:25176339-25207360:+	0.32	7.24	1.84E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815406	chr20:25341316	FAM182A	chr20:26035250-26067552:+	0.19	3.48	0.000539	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815406	chr20:25341316	FAM182B	chr20:25744102-25848786:-	-0.26	-5.4	1.08E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815406	chr20:25341316	NINL	chr20:25433338-25566153:-	0.33	6.89	1.74E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815406	chr20:25341316	PYGB	chr20:25228706-25278647:+	0.16	4.03	6.46E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815407	chr20:25341478	ENTPD6	chr20:25176339-25207360:+	0.3	6.7	5.92E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815407	chr20:25341478	FAM182A	chr20:26035250-26067552:+	0.19	3.48	0.000553	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815407	chr20:25341478	FAM182B	chr20:25744102-25848786:-	-0.26	-5.44	8.66E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815407	chr20:25341478	NINL	chr20:25433338-25566153:-	0.34	7.04	6.69E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815407	chr20:25341478	PYGB	chr20:25228706-25278647:+	0.14	3.59	0.000359	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815408	chr20:25346678	ENTPD6	chr20:25176339-25207360:+	0.3	6.84	2.39E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815408	chr20:25346678	FAM182A	chr20:26035250-26067552:+	0.2	3.62	0.00032	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815408	chr20:25346678	FAM182B	chr20:25744102-25848786:-	-0.26	-5.5	6.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815408	chr20:25346678	NINL	chr20:25433338-25566153:-	0.34	7.03	7.08E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815408	chr20:25346678	PYGB	chr20:25228706-25278647:+	0.15	3.67	0.000274	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815409	chr20:25346697	ENTPD6	chr20:25176339-25207360:+	0.32	7.23	1.88E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815409	chr20:25346697	FAM182A	chr20:26035250-26067552:+	0.19	3.49	0.000536	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815409	chr20:25346697	FAM182B	chr20:25744102-25848786:-	-0.26	-5.4	1.06E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815409	chr20:25346697	NINL	chr20:25433338-25566153:-	0.33	6.9	1.7E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815409	chr20:25346697	PYGB	chr20:25228706-25278647:+	0.16	4.03	6.5E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815411	chr20:25350223	ENTPD6	chr20:25176339-25207360:+	0.31	7.11	4.23E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815411	chr20:25350223	FAM182A	chr20:26035250-26067552:+	0.19	3.46	0.000585	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815411	chr20:25350223	FAM182B	chr20:25744102-25848786:-	-0.26	-5.45	8.06E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815411	chr20:25350223	NINL	chr20:25433338-25566153:-	0.34	7.08	5.02E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815411	chr20:25350223	PYGB	chr20:25228706-25278647:+	0.16	4.08	5.35E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815412	chr20:25350325	ENTPD6	chr20:25176339-25207360:+	-0.32	-7.44	4.84E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815412	chr20:25350325	FAM182A	chr20:26035250-26067552:+	-0.2	-3.71	0.000231	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815412	chr20:25350325	FAM182B	chr20:25744102-25848786:-	0.25	5.21	2.82E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815412	chr20:25350325	NINL	chr20:25433338-25566153:-	-0.34	-7.05	6.18E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815412	chr20:25350325	PYGB	chr20:25228706-25278647:+	-0.15	-3.74	0.000209	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815417	chr20:25379526	ENTPD6	chr20:25176339-25207360:+	0.32	7.36	8.31E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815417	chr20:25379526	FAM182A	chr20:26035250-26067552:+	0.19	3.46	0.000595	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815417	chr20:25379526	FAM182B	chr20:25744102-25848786:-	-0.26	-5.36	1.29E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815417	chr20:25379526	NINL	chr20:25433338-25566153:-	0.35	7.19	2.44E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815417	chr20:25379526	PYGB	chr20:25228706-25278647:+	0.15	3.73	0.000218	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815418	chr20:25382211	ENTPD6	chr20:25176339-25207360:+	0.32	7.24	1.85E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815418	chr20:25382211	FAM182A	chr20:26035250-26067552:+	0.19	3.48	0.000546	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815418	chr20:25382211	FAM182B	chr20:25744102-25848786:-	-0.26	-5.4	1.05E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815418	chr20:25382211	NINL	chr20:25433338-25566153:-	0.33	6.9	1.67E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815418	chr20:25382211	PYGB	chr20:25228706-25278647:+	0.16	4.03	6.53E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815420	chr20:25383979	ENTPD6	chr20:25176339-25207360:+	0.32	7.22	2.08E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815420	chr20:25383979	FAM182B	chr20:25744102-25848786:-	-0.26	-5.55	4.67E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815420	chr20:25383979	NINL	chr20:25433338-25566153:-	0.34	6.91	1.53E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815420	chr20:25383979	PYGB	chr20:25228706-25278647:+	0.16	4	7.34E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815421	chr20:25386509	ENTPD6	chr20:25176339-25207360:+	0.32	7.24	1.85E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815421	chr20:25386509	FAM182A	chr20:26035250-26067552:+	0.19	3.48	0.000546	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815421	chr20:25386509	FAM182B	chr20:25744102-25848786:-	-0.26	-5.4	1.05E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815421	chr20:25386509	NINL	chr20:25433338-25566153:-	0.33	6.9	1.67E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815421	chr20:25386509	PYGB	chr20:25228706-25278647:+	0.16	4.03	6.53E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815424	chr20:25390284	ENTPD6	chr20:25176339-25207360:+	0.3	6.64	8.57E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815424	chr20:25390284	FAM182B	chr20:25744102-25848786:-	-0.26	-5.43	9.22E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815424	chr20:25390284	NINL	chr20:25433338-25566153:-	0.35	7.14	3.59E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815424	chr20:25390284	PYGB	chr20:25228706-25278647:+	0.14	3.5	0.000507	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815426	chr20:25405186	ENTPD6	chr20:25176339-25207360:+	0.32	7.43	5.2E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815426	chr20:25405186	FAM182A	chr20:26035250-26067552:+	0.18	3.44	0.000637	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815426	chr20:25405186	FAM182B	chr20:25744102-25848786:-	-0.25	-5.26	2.22E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815426	chr20:25405186	NINL	chr20:25433338-25566153:-	0.34	7.1	4.42E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4815426	chr20:25405186	PYGB	chr20:25228706-25278647:+	0.15	3.79	0.000167	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs4819388	chr21:45647421	ICOSLG	chr21:45646724-45660834:-	-0.23	-4.71	3.25E-6	Celiac disease	
THCA	cis	1	rs4820043	chr22:31647094	RNF185	chr22:31556138-31603004:+	-0.28	-5.18	3.21E-7	Paclitaxel-induced neuropathy	
THCA	cis	1	rs482013	chr11:71803962	FAM86C	chr11:71498557-71512276:+	0.32	3.91	0.000107	Severe influenza A (H1N1) infection	
THCA	cis	1	rs4820294	chr22:38071043	LGALS2	chr22:37966254-37976024:-	0.14	3.78	0.000174	Fat distribution (HIV)	
THCA	cis	1	rs4820294	chr22:38071043	PDXP	chr22:38054737-38062939:+	-0.18	-3.35	0.00086	Fat distribution (HIV)	
THCA	cis	1	rs4820294	chr22:38071043	SH3BP1	chr22:38030661-38062939:+	0.12	3.79	0.000168	Fat distribution (HIV)	
THCA	cis	1	rs4820345	chr22:39091151	JOSD1	chr22:39081549-39096459:-	-0.14	-3.72	0.000225	Resting heart rate	
THCA	cis	1	rs4820345	chr22:39091151	LOC646851	chr22:38974125-39052634:-	0.13	3.47	0.000558	Resting heart rate	
THCA	cis	1	rs4820345	chr22:39091151	TOMM22	chr22:39077954-39080763:+	-0.17	-3.52	0.000464	Resting heart rate	
THCA	cis	1	rs4820539	chr22:23477970	GNAZ	chr22:23412669-23467221:+	0.27	5.91	6.66E-9	Bone mineral density	
THCA	cis	1	rs4820539	chr22:23477970	RAB36	chr22:23487513-23506531:+	-0.17	-3.38	0.000786	Bone mineral density	
THCA	cis	1	rs4820834	chr22:30751627	MTP18	chr22:30805176-30825041:+	0.23	3.36	0.00083	Coronary artery calcification	
THCA	cis	1	rs4820963	chr22:31698166	RNF185	chr22:31556138-31603004:+	-0.29	-5.39	1.13E-7	Paclitaxel-induced neuropathy	
THCA	cis	1	rs4821798	chr22:39021165	JOSD1	chr22:39081549-39096459:-	-0.13	-3.47	0.000561	Resting heart rate	
THCA	cis	1	rs4821798	chr22:39021165	LOC646851	chr22:38974125-39052634:-	0.13	3.67	0.000272	Resting heart rate	
THCA	cis	1	rs4821798	chr22:39021165	TOMM22	chr22:39077954-39080763:+	-0.17	-3.91	0.000106	Resting heart rate	
THCA	cis	1	rs4821808	chr22:39065739	JOSD1	chr22:39081549-39096459:-	-0.15	-4.03	6.54E-5	Resting heart rate	
THCA	cis	1	rs4821808	chr22:39065739	TOMM22	chr22:39077954-39080763:+	-0.17	-3.69	0.000246	Resting heart rate	
THCA	cis	1	rs4821809	chr22:39065743	JOSD1	chr22:39081549-39096459:-	-0.15	-4.03	6.54E-5	Resting heart rate	
THCA	cis	1	rs4821809	chr22:39065743	TOMM22	chr22:39077954-39080763:+	-0.17	-3.69	0.000246	Resting heart rate	
THCA	cis	1	rs4821810	chr22:39072098	LOC646851	chr22:38974125-39052634:-	0.14	3.67	0.00027	Resting heart rate	
THCA	cis	1	rs4821810	chr22:39072098	TOMM22	chr22:39077954-39080763:+	-0.17	-3.71	0.000236	Resting heart rate	
THCA	cis	1	rs4821811	chr22:39075145	JOSD1	chr22:39081549-39096459:-	-0.14	-3.69	0.000249	Resting heart rate	
THCA	cis	1	rs4821811	chr22:39075145	LOC646851	chr22:38974125-39052634:-	0.14	3.57	0.000395	Resting heart rate	
THCA	cis	1	rs4821812	chr22:39075235	JOSD1	chr22:39081549-39096459:-	-0.14	-3.78	0.000179	Resting heart rate	
THCA	cis	1	rs4821812	chr22:39075235	LOC646851	chr22:38974125-39052634:-	0.13	3.45	0.000607	Resting heart rate	
THCA	cis	1	rs4821812	chr22:39075235	TOMM22	chr22:39077954-39080763:+	-0.16	-3.39	0.000768	Resting heart rate	
THCA	cis	1	rs4821816	chr22:39113134	JOSD1	chr22:39081549-39096459:-	-0.14	-3.51	0.000499	Resting heart rate	
THCA	cis	1	rs4821816	chr22:39113134	LOC646851	chr22:38974125-39052634:-	0.14	3.56	0.000407	Resting heart rate	
THCA	cis	1	rs4822357	chr22:23473231	GNAZ	chr22:23412669-23467221:+	-0.26	-5.46	7.84E-8	Bone mineral density	
THCA	cis	1	rs4822358	chr22:23474795	GNAZ	chr22:23412669-23467221:+	-0.25	-5.37	1.26E-7	Bone mineral density	
THCA	cis	1	rs4822360	chr22:23482460	GNAZ	chr22:23412669-23467221:+	-0.26	-5.66	2.56E-8	Bone mineral density	
THCA	cis	1	rs4822360	chr22:23482460	RAB36	chr22:23487513-23506531:+	0.18	3.57	0.00039	Bone mineral density	
THCA	cis	1	rs4822361	chr22:23482718	GNAZ	chr22:23412669-23467221:+	0.22	4.73	2.98E-6	Bone mineral density	
THCA	cis	1	rs4822361	chr22:23482718	RAB36	chr22:23487513-23506531:+	-0.21	-4.07	5.57E-5	Bone mineral density	
THCA	cis	1	rs4822362	chr22:23482744	GNAZ	chr22:23412669-23467221:+	-0.24	-5.04	6.5E-7	Bone mineral density	
THCA	cis	1	rs4822362	chr22:23482744	RAB36	chr22:23487513-23506531:+	0.2	3.87	0.000126	Bone mineral density	
THCA	cis	1	rs4823006	chr22:29451671	C22orf31	chr22:29454660-29457907:-	0.21	4.37	1.52E-5	Waist-hip ratio	
THCA	cis	1	rs4835671	chr5:137511801	KLHL3	chr5:136953190-137071779:-	-0.13	-3.54	0.000435	Resting heart rate	
THCA	cis	1	rs4838890	chr1:110616679	ALX3	chr1:110602998-110613322:-	-0.3	-7.48	3.67E-13	Blood metabolite levels	
THCA	cis	1	rs4839103	chr1:110620701	ALX3	chr1:110602998-110613322:-	-0.3	-7.52	2.81E-13	Blood metabolite levels	
THCA	cis	1	rs4839104	chr1:111708627	DRAM2	chr1:111659955-111682838:-	-0.25	-3.77	0.000186	Liver enzyme levels (gamma-glutamyl transferase)	
THCA	cis	1	rs4839125	chr1:111893390	CHIA	chr1:111833484-111863184:+	-0.27	-4.13	4.21E-5	Late-onset Alzheimer's disease	
THCA	cis	1	rs4839126	chr1:111893417	CHIA	chr1:111833484-111863184:+	-0.27	-4.13	4.21E-5	Late-onset Alzheimer's disease	
THCA	cis	1	rs4840351	chr8:8573148	SGK223	chr8:8175259-8239257:-	-0.3	-5.56	4.45E-8	Obesity-related traits	
THCA	cis	1	rs4840352	chr8:8573508	SGK223	chr8:8175259-8239257:-	-0.3	-5.44	8.49E-8	Obesity-related traits	
THCA	cis	1	rs4841016	chr8:8572561	SGK223	chr8:8175259-8239257:-	-0.3	-5.44	8.49E-8	Obesity-related traits	
THCA	cis	1	rs4841017	chr8:8577093	SGK223	chr8:8175259-8239257:-	-0.31	-5.62	3.25E-8	Obesity-related traits	
THCA	cis	1	rs4842838	chr15:84582124	LOC388152	chr15:84867600-84898920:-	0.21	3.96	8.74E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs4842923	chr15:84581904	LOC388152	chr15:84867600-84898920:-	-0.2	-3.72	0.000226	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs4842924	chr15:84587607	LOC388152	chr15:84867600-84898920:-	0.2	3.8	0.000164	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs4843575	chr16:85735642	GINS2	chr16:85711281-85722588:-	-0.21	-4.21	3.07E-5	Type 2 diabetes	
THCA	cis	1	rs4844380	chr1:121193620	HIST2H2BA	chr1:120906034-120914842:+	0.21	4.87	1.55E-6	Hip geometry	
THCA	cis	1	rs4844381	chr1:121184898	HIST2H2BA	chr1:120906034-120914842:+	0.22	4.98	9.02E-7	Hip geometry	
THCA	cis	1	rs4844588	chr1:207429668	CD55	chr1:207494817-207534309:+	0.19	7.47	3.96E-13	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs4844590	chr1:207496129	CD55	chr1:207494817-207534309:+	0.19	7.44	4.83E-13	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs4844590	chr1:207496129	CR1	chr1:207669473-207815109:+	-0.13	-3.41	0.000701	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs4844591	chr1:207500293	CD55	chr1:207494817-207534309:+	0.15	6.69	6.37E-11	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs4844592	chr1:207501211	CD55	chr1:207494817-207534309:+	0.15	6.6	1.12E-10	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs4844607	chr1:121184059	HIST2H2BA	chr1:120906034-120914842:+	-0.19	-4.5	8.72E-6	Hip geometry	
THCA	cis	1	rs4844616	chr1:121171208	HIST2H2BA	chr1:120906034-120914842:+	0.23	5.14	4.09E-7	Hip geometry	
THCA	cis	1	rs4845756	chr1:152254919	FLG	chr1:152274651-152297679:-	-0.3	-4.71	3.27E-6	Atopic dermatitis	
THCA	cis	1	rs4845756	chr1:152254919	HRNR	chr1:152184558-152196669:-	0.5	7.22	2.04E-12	Atopic dermatitis	
THCA	cis	1	rs4845934	chr1:10468946	KIF1B	chr1:10270764-10441659:+	0.21	6.36	4.74E-10	Hepatocellular carcinoma	
THCA	cis	1	rs4846208	chr1:10313839	KIF1B	chr1:10270764-10441659:+	0.21	6.36	4.75E-10	Hepatocellular carcinoma	
THCA	cis	1	rs4846210	chr1:10322153	KIF1B	chr1:10270764-10441659:+	0.21	6.36	4.75E-10	Hepatocellular carcinoma	
THCA	cis	1	rs4852892	chr2:69866769	AAK1	chr2:69685127-69870977:-	-0.23	-4.71	3.19E-6	Serum thyroid-stimulating hormone levels	
THCA	cis	1	rs4853036	chr2:70059824	SNRNP27	chr2:70121090-70132348:+	0.18	4.59	5.6E-6	Colorectal or endometrial cancer	
THCA	cis	1	rs4853634	chr2:190779231	ASNSD1	chr2:190526125-190535556:+	-0.58	-6.01	3.77E-9	Subcutaneous adipose tissue	
THCA	cis	1	rs4854058	chr2:240923677	NDUFA10	chr2:240900158-240964798:-	0.3	8.47	3.1E-16	Odorant perception (isobutyraldehyde)	
THCA	cis	1	rs485576	chr10:131425496	MGMT	chr10:131265454-131565783:+	0.38	11.84	1.57E-28	Response to temozolomide	
THCA	cis	1	rs4858793	chr3:48415007	ATRIP	chr3:48488141-48507708:+	-0.16	-3.53	0.000452	Longevity	
THCA	cis	1	rs4858793	chr3:48415007	TREX1	chr3:48501186-48509043:+	0.23	5.26	2.2E-7	Longevity	
THCA	cis	1	rs4858817	chr3:48416756	ATRIP	chr3:48488141-48507708:+	-0.18	-3.98	8.05E-5	Longevity	
THCA	cis	1	rs4858817	chr3:48416756	TREX1	chr3:48501186-48509043:+	0.24	5.62	3.17E-8	Longevity	
THCA	cis	1	rs4858888	chr3:47405305	C3orf75	chr3:47537131-47555199:-	0.1	4.39	1.41E-5	Colorectal cancer	
THCA	cis	1	rs4858888	chr3:47405305	NBEAL2	chr3:47021173-47051193:+	0.12	3.66	0.000276	Colorectal cancer	
THCA	cis	1	rs4859413	chr4:76898250	NAAA	chr4:76831809-76862166:-	0.36	7.17	2.8E-12	Longevity	
THCA	cis	1	rs4859581	chr4:76906974	NAAA	chr4:76831809-76862166:-	-0.35	-7.04	6.71E-12	Longevity	
THCA	cis	1	rs4859582	chr4:76907213	NAAA	chr4:76831809-76862166:-	-0.35	-7.04	6.71E-12	Longevity	
THCA	cis	1	rs4862406	chr4:185629339	CCDC111	chr4:185570767-185616112:+	-0.31	-7.31	1.1E-12	Kawasaki disease	
THCA	cis	1	rs4862406	chr4:185629339	MLF1IP	chr4:185615220-185655286:-	0.47	10.79	1.91E-24	Kawasaki disease	
THCA	cis	1	rs486301	chr15:43836949	ADAL	chr15:43622872-43646094:+	-0.49	-11.39	8.93E-27	Tumor biomarkers	
THCA	cis	1	rs486301	chr15:43836949	CATSPER2	chr15:43922774-43959900:-	-0.26	-4.72	3.16E-6	Tumor biomarkers	
THCA	cis	1	rs486301	chr15:43836949	STRC	chr15:43891762-43924561:-	0.32	5.96	4.8E-9	Tumor biomarkers	
THCA	cis	1	rs486301	chr15:43836949	TUBGCP4	chr15:43663313-43698238:+	0.12	3.52	0.000465	Tumor biomarkers	
THCA	cis	1	rs4863772	chr4:139120683	SLC7A11	chr4:139085248-139163503:-	-0.22	-4.47	9.67E-6	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	
THCA	cis	1	rs4864759	chr4:54259408	SCFD2	chr4:53739152-54232242:-	0.2	3.85	0.000132	DNA methylation (variation)	
THCA	cis	1	rs4864998	chr4:56332606	TMEM165	chr4:56262090-56292342:+	-0.14	-3.55	0.000427	Personality dimensions	
THCA	cis	1	rs4865008	chr4:56410855	TMEM165	chr4:56262090-56292342:+	0.15	3.65	0.000296	Personality dimensions	
THCA	cis	1	rs4865010	chr4:56414962	TMEM165	chr4:56262090-56292342:+	0.14	3.64	0.000306	Personality dimensions	
THCA	cis	1	rs4869313	chr5:96223880	ERAP2	chr5:96211644-96255398:+	-1.11	-35.76	3.5E-137	Pediatric autoimmune diseases	
THCA	cis	1	rs4869660	chr5:36424281	UGT3A2	chr5:36035124-36066984:-	-0.2	-3.78	0.000176	Hypertension	
THCA	cis	1	rs4870040	chr6:151872090	C6orf97	chr6:151815175-151942327:+	0.3	4.29	2.13E-5	Bone mineral density (spine)	
THCA	cis	1	rs4870041	chr6:151872324	C6orf97	chr6:151815175-151942327:+	0.3	4.33	1.84E-5	Bone mineral density (spine)	
THCA	cis	1	rs4871	chr6:26545632	BTN2A3	chr6:26422317-26431927:+	0.18	4.31	1.98E-5	Educational attainment	
THCA	cis	1	rs4871	chr6:26545632	HCG11	chr6:26521934-26527610:+	-0.22	-4.33	1.85E-5	Educational attainment	
THCA	cis	1	rs4871	chr6:26545632	HMGN4	chr6:26538572-26547162:+	-0.16	-4.04	6.18E-5	Educational attainment	
THCA	cis	1	rs4871	chr6:26545632	ZNF322A	chr6:26634612-26659963:-	-0.14	-3.91	0.000107	Educational attainment	
THCA	cis	1	rs4879620	chr9:32863942	TAF1L	chr9:32629452-32635667:-	0.1	3.39	0.000748	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs4879901	chr9:35518997	FAM166B	chr9:35561945-35563896:-	0.27	5.74	1.69E-8	Schizophrenia	
THCA	cis	1	rs4879902	chr9:35519359	FAM166B	chr9:35561945-35563896:-	-0.28	-5.75	1.56E-8	Schizophrenia	
THCA	cis	1	rs488079	chr1:155890581	FDPS	chr1:155278539-155290457:+	-0.21	-4.32	1.89E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs488079	chr1:155890581	RIT1	chr1:155867601-155881177:-	0.17	3.86	0.00013	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs4883201	chr12:9082581	KLRG1	chr12:9142221-9163338:+	-0.21	-3.94	9.3E-5	Cholesterol, total	
THCA	cis	1	rs4883201	chr12:9082581	LOC144571	chr12:9217773-9220651:+	-0.21	-4.69	3.56E-6	Cholesterol, total	
THCA	cis	1	rs4883201	chr12:9082581	M6PR	chr12:9092965-9102252:-	-0.57	-10.29	1.42E-22	Cholesterol, total	
THCA	cis	1	rs4886018	chr13:52990717	CKAP2	chr13:53029495-53050763:+	-0.65	-17.65	4.62E-54	Lewy body disease	
THCA	cis	1	rs4886018	chr13:52990717	NEK3	chr13:52706780-52733996:-	0.2	4.89	1.36E-6	Lewy body disease	
THCA	cis	1	rs4886018	chr13:52990717	VPS36	chr13:52986739-53024763:-	0.19	4.85	1.69E-6	Lewy body disease	
THCA	cis	1	rs4886615	chr15:75131661	CSK	chr15:75074425-75095539:+	-0.1	-3.47	0.000562	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
THCA	cis	1	rs4886615	chr15:75131661	MPI	chr15:75182410-75190565:+	0.32	6.82	2.72E-11	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
THCA	cis	1	rs4886615	chr15:75131661	ULK3	chr15:75128459-75135552:-	-0.16	-4.74	2.89E-6	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
THCA	cis	1	rs4886818	chr15:76880939	SCAPER	chr15:76640529-77197744:-	-0.17	-5.62	3.28E-8	Blood metabolite levels	
THCA	cis	1	rs4887067	chr15:78886947	CHRNA5	chr15:78857906-78886458:+	-0.42	-8.3	1.08E-15	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs4887783	chr16:74700743	RFWD3	chr16:74655298-74700779:-	-0.31	-8.21	2.1E-15	Testicular germ cell tumor	
THCA	cis	1	rs488799	chr11:71561686	FAM86C	chr11:71498557-71512276:+	-0.37	-4.34	1.73E-5	Severe influenza A (H1N1) infection	
THCA	cis	1	rs4888262	chr16:74670458	RFWD3	chr16:74655298-74700779:-	-0.3	-7.86	2.53E-14	Testicular germ cell tumor	
THCA	cis	1	rs4888264	chr16:74681632	RFWD3	chr16:74655298-74700779:-	-0.31	-7.96	1.29E-14	Testicular germ cell tumor	
THCA	cis	1	rs4888265	chr16:74683737	RFWD3	chr16:74655298-74700779:-	-0.3	-7.62	1.39E-13	Testicular germ cell tumor	
THCA	cis	1	rs4888667	chr16:77779480	NUDT7	chr16:77756411-77776153:+	0.37	5	8.06E-7	Obesity-related traits	
THCA	cis	1	rs4888668	chr16:77779481	NUDT7	chr16:77756411-77776153:+	0.37	5	8.06E-7	Obesity-related traits	
THCA	cis	1	rs4888671	chr16:77783580	NUDT7	chr16:77756411-77776153:+	0.36	4.94	1.09E-6	Obesity-related traits	
THCA	cis	1	rs4888672	chr16:77783666	NUDT7	chr16:77756411-77776153:+	0.36	4.94	1.09E-6	Obesity-related traits	
THCA	cis	1	rs4888673	chr16:77783703	NUDT7	chr16:77756411-77776153:+	0.36	4.95	1.04E-6	Obesity-related traits	
THCA	cis	1	rs4888674	chr16:77783749	NUDT7	chr16:77756411-77776153:+	0.36	4.95	1.04E-6	Obesity-related traits	
THCA	cis	1	rs4888675	chr16:77783757	NUDT7	chr16:77756411-77776153:+	0.36	4.95	1.04E-6	Obesity-related traits	
THCA	cis	1	rs4888676	chr16:77783896	NUDT7	chr16:77756411-77776153:+	0.36	4.94	1.09E-6	Obesity-related traits	
THCA	cis	1	rs4889543	chr16:31340216	HSD3B7	chr16:30996519-31000473:+	-0.17	-4.17	3.59E-5	IgA nephropathy	
THCA	cis	1	rs4889543	chr16:31340216	MYST1	chr16:31128985-31142713:+	-0.1	-3.52	0.00047	IgA nephropathy	
THCA	cis	1	rs4889543	chr16:31340216	ZNF843	chr16:31446885-31454348:-	-0.17	-3.53	0.000452	IgA nephropathy	
THCA	cis	1	rs4889609	chr16:31026427	C16orf93	chr16:30768753-30773542:-	-0.15	-4.35	1.66E-5	Response to metformin (IC50)	
THCA	cis	1	rs4889609	chr16:31026427	HSD3B7	chr16:30996519-31000473:+	0.48	12.46	4.82E-31	Response to metformin (IC50)	
THCA	cis	1	rs4889609	chr16:31026427	MYST1	chr16:31128985-31142713:+	0.16	5.39	1.13E-7	Response to metformin (IC50)	
THCA	cis	1	rs4889609	chr16:31026427	PRSS53	chr16:31094747-31106276:-	-0.15	-4.14	4.1E-5	Response to metformin (IC50)	
THCA	cis	1	rs4898847	chr14:55170103	SAMD4A	chr14:55034637-55260033:+	-0.28	-3.58	0.000385	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs4899544	chr14:75546556	EIF2B2	chr14:75469612-75476292:+	0.19	5.13	4.3E-7	Height	
THCA	cis	1	rs4899544	chr14:75546556	MLH3	chr14:75480467-75518235:-	0.3	9.04	3.85E-18	Height	
THCA	cis	1	rs4899544	chr14:75546556	RPS6KL1	chr14:75372347-75389958:-	0.32	6.92	1.5E-11	Height	
THCA	cis	1	rs4899546	chr14:75594946	EIF2B2	chr14:75469612-75476292:+	0.19	5.12	4.5E-7	Height	
THCA	cis	1	rs4899546	chr14:75594946	MLH3	chr14:75480467-75518235:-	0.3	8.98	6.21E-18	Height	
THCA	cis	1	rs4899546	chr14:75594946	RPS6KL1	chr14:75372347-75389958:-	0.32	6.87	1.95E-11	Height	
THCA	cis	1	rs4899586	chr14:76660856	ESRRB	chr14:76837690-76968178:+	0.32	5.22	2.74E-7	Blood pressure	
THCA	cis	1	rs4900349	chr14:97278022	VRK1	chr14:97263684-97347950:+	0.17	3.99	7.51E-5	Neutrophil count	
THCA	cis	1	rs4901186	chr14:52509484	C14orf166	chr14:52456228-52471419:+	-0.13	-3.83	0.000148	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs4901186	chr14:52509484	NID2	chr14:52471521-52535946:-	-0.18	-3.66	0.000279	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs4902364	chr14:65602006	FNTB	chr14:65381140-65529369:+	-0.23	-4.56	6.43E-6	Obesity-related traits	
THCA	cis	1	rs4902365	chr14:65602064	FNTB	chr14:65381140-65529369:+	-0.22	-4.54	7.18E-6	Obesity-related traits	
THCA	cis	1	rs4902408	chr14:66111901	LOC645431	chr14:65877313-65879335:-	0.26	3.77	0.000185	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs4903201	chr14:74659690	C14orf45	chr14:74486059-74549566:+	-0.16	-4.58	6.0E-6	Common traits (Other)	
THCA	cis	1	rs4903201	chr14:74659690	COQ6	chr14:74416643-74429811:+	-0.13	-3.62	0.000329	Common traits (Other)	
THCA	cis	1	rs4903201	chr14:74659690	LIN52	chr14:74551656-74667117:+	-0.51	-13.7	2.72E-36	Common traits (Other)	
THCA	cis	1	rs4903202	chr14:74660302	C14orf45	chr14:74486059-74549566:+	-0.16	-4.58	6.0E-6	Common traits (Other)	
THCA	cis	1	rs4903202	chr14:74660302	COQ6	chr14:74416643-74429811:+	-0.13	-3.62	0.000329	Common traits (Other)	
THCA	cis	1	rs4903202	chr14:74660302	LIN52	chr14:74551656-74667117:+	-0.51	-13.7	2.72E-36	Common traits (Other)	
THCA	cis	1	rs4903203	chr14:74660508	C14orf45	chr14:74486059-74549566:+	-0.16	-4.58	6.0E-6	Common traits (Other)	
THCA	cis	1	rs4903203	chr14:74660508	COQ6	chr14:74416643-74429811:+	-0.13	-3.62	0.000329	Common traits (Other)	
THCA	cis	1	rs4903203	chr14:74660508	LIN52	chr14:74551656-74667117:+	-0.51	-13.7	2.72E-36	Common traits (Other)	
THCA	cis	1	rs4903275	chr14:75512509	EIF2B2	chr14:75469612-75476292:+	0.18	5	7.94E-7	Height	
THCA	cis	1	rs4903275	chr14:75512509	MLH3	chr14:75480467-75518235:-	0.3	8.98	6.04E-18	Height	
THCA	cis	1	rs4903275	chr14:75512509	RPS6KL1	chr14:75372347-75389958:-	0.33	7.21	2.26E-12	Height	
THCA	cis	1	rs4903279	chr14:75546583	EIF2B2	chr14:75469612-75476292:+	0.19	5.13	4.3E-7	Height	
THCA	cis	1	rs4903279	chr14:75546583	MLH3	chr14:75480467-75518235:-	0.3	9.04	3.85E-18	Height	
THCA	cis	1	rs4903279	chr14:75546583	RPS6KL1	chr14:75372347-75389958:-	0.32	6.92	1.5E-11	Height	
THCA	cis	1	rs4903281	chr14:75554361	EIF2B2	chr14:75469612-75476292:+	0.18	4.99	8.36E-7	Height	
THCA	cis	1	rs4903281	chr14:75554361	MLH3	chr14:75480467-75518235:-	0.29	8.72	4.78E-17	Height	
THCA	cis	1	rs4903281	chr14:75554361	RPS6KL1	chr14:75372347-75389958:-	0.32	6.82	2.82E-11	Height	
THCA	cis	1	rs4903284	chr14:75592483	EIF2B2	chr14:75469612-75476292:+	0.19	5.1	4.83E-7	Height	
THCA	cis	1	rs4903284	chr14:75592483	MLH3	chr14:75480467-75518235:-	0.3	9.03	4.27E-18	Height	
THCA	cis	1	rs4903284	chr14:75592483	RPS6KL1	chr14:75372347-75389958:-	0.32	6.91	1.57E-11	Height	
THCA	cis	1	rs4903289	chr14:75623988	EIF2B2	chr14:75469612-75476292:+	-0.2	-5.36	1.3E-7	Height	
THCA	cis	1	rs4903289	chr14:75623988	MLH3	chr14:75480467-75518235:-	-0.3	-8.86	1.61E-17	Height	
THCA	cis	1	rs4903289	chr14:75623988	RPS6KL1	chr14:75372347-75389958:-	-0.32	-6.86	2.15E-11	Height	
THCA	cis	1	rs4903386	chr14:76669658	ESRRB	chr14:76837690-76968178:+	0.32	5.18	3.21E-7	Blood pressure	
THCA	cis	1	rs4903977	chr14:81772095	STON2	chr14:81727000-81893748:-	0.21	4.2	3.16E-5	Obesity-related traits	
THCA	cis	1	rs4903979	chr14:81778158	STON2	chr14:81727000-81893748:-	0.21	4.2	3.16E-5	Obesity-related traits	
THCA	cis	1	rs4903980	chr14:81778263	STON2	chr14:81727000-81893748:-	0.21	4.2	3.16E-5	Obesity-related traits	
THCA	cis	1	rs4905546	chr14:97278652	VRK1	chr14:97263684-97347950:+	0.17	3.99	7.51E-5	Neutrophil count	
THCA	cis	1	rs4905552	chr14:97307224	VRK1	chr14:97263684-97347950:+	0.17	3.89	0.000114	Neutrophil count	
THCA	cis	1	rs4905553	chr14:97316102	VRK1	chr14:97263684-97347950:+	0.17	3.87	0.000122	Neutrophil count	
THCA	cis	1	rs4905555	chr14:97336535	VRK1	chr14:97263684-97347950:+	0.17	3.97	8.34E-5	Neutrophil count	
THCA	cis	1	rs4905558	chr14:97345806	VRK1	chr14:97263684-97347950:+	0.17	3.98	7.97E-5	Neutrophil count	
THCA	cis	1	rs4905560	chr14:97354740	VRK1	chr14:97263684-97347950:+	0.17	3.96	8.49E-5	Neutrophil count	
THCA	cis	1	rs4906172	chr14:102454933	RAGE	chr14:102690838-102771531:-	-0.15	-4.72	3.05E-6	Menopause (age at onset)	
THCA	cis	1	rs4906174	chr14:102495144	RAGE	chr14:102690838-102771531:-	-0.15	-4.76	2.59E-6	Menopause (age at onset)	
THCA	cis	1	rs4906205	chr14:102932447	ANKRD9	chr14:102973198-102976128:-	0.15	3.37	0.000821	QT interval	
THCA	cis	1	rs4907240	chr2:97228039	ANKRD36B	chr2:98109130-98206428:-	0.18	3.6	0.000353	Event-related brain oscillations	
THCA	cis	1	rs491098	chr13:113769346	F7	chr13:113760105-113774994:+	0.26	3.79	0.000169	End-stage coagulation	
THCA	cis	1	rs4911178	chr20:33952620	CEP250	chr20:34042996-34099802:+	-0.15	-3.37	0.000804	Height	
THCA	cis	1	rs4911178	chr20:33952620	CPNE1	chr20:34213968-34262539:-	0.3	5.95	5.17E-9	Height	
THCA	cis	1	rs4911178	chr20:33952620	GDF5	chr20:33897002-34042568:-	-0.18	-3.81	0.000154	Height	
THCA	cis	1	rs4911178	chr20:33952620	UQCC	chr20:33890383-33999833:-	0.32	10.23	2.48E-22	Height	
THCA	cis	1	rs4911180	chr20:33972948	CEP250	chr20:34042996-34099802:+	-0.15	-3.4	0.00073	Height	
THCA	cis	1	rs4911180	chr20:33972948	CPNE1	chr20:34213968-34262539:-	0.31	5.99	4.19E-9	Height	
THCA	cis	1	rs4911180	chr20:33972948	GDF5	chr20:33897002-34042568:-	-0.18	-3.83	0.000146	Height	
THCA	cis	1	rs4911180	chr20:33972948	UQCC	chr20:33890383-33999833:-	0.32	10.13	5.71E-22	Height	
THCA	cis	1	rs4911409	chr20:32710710	RALY	chr20:32581732-32672675:+	0.14	4.32	1.89E-5	Tanning;Skin sensitivity to sun;Red vs. non-red hair color;Freckles;Burning and freckling	
THCA	cis	1	rs4911410	chr20:32710974	RALY	chr20:32581732-32672675:+	0.14	4.34	1.77E-5	Tanning;Skin sensitivity to sun;Red vs. non-red hair color;Freckles;Burning and freckling	
THCA	cis	1	rs4911412	chr20:32716435	RALY	chr20:32581732-32672675:+	0.14	4.26	2.44E-5	Tanning;Skin sensitivity to sun;Red vs. non-red hair color;Freckles;Burning and freckling	
THCA	cis	1	rs4911414	chr20:32729444	RALY	chr20:32581732-32672675:+	0.14	4.24	2.69E-5	Tanning;Skin sensitivity to sun;Red vs. non-red hair color;Freckles;Burning and freckling	
THCA	cis	1	rs4911491	chr20:33947285	CEP250	chr20:34042996-34099802:+	-0.15	-3.37	0.000804	Height	
THCA	cis	1	rs4911491	chr20:33947285	CPNE1	chr20:34213968-34262539:-	0.3	5.95	5.17E-9	Height	
THCA	cis	1	rs4911491	chr20:33947285	GDF5	chr20:33897002-34042568:-	-0.18	-3.81	0.000154	Height	
THCA	cis	1	rs4911491	chr20:33947285	UQCC	chr20:33890383-33999833:-	0.32	10.23	2.48E-22	Height	
THCA	cis	1	rs4911492	chr20:33951799	CEP250	chr20:34042996-34099802:+	-0.15	-3.38	0.000792	Height	
THCA	cis	1	rs4911492	chr20:33951799	CPNE1	chr20:34213968-34262539:-	0.3	5.92	6.1E-9	Height	
THCA	cis	1	rs4911492	chr20:33951799	GDF5	chr20:33897002-34042568:-	-0.18	-3.82	0.000152	Height	
THCA	cis	1	rs4911492	chr20:33951799	UQCC	chr20:33890383-33999833:-	0.32	10.21	2.76E-22	Height	
THCA	cis	1	rs4911494	chr20:33971914	CEP250	chr20:34042996-34099802:+	-0.15	-3.37	0.000804	Height	
THCA	cis	1	rs4911494	chr20:33971914	CPNE1	chr20:34213968-34262539:-	0.3	5.95	5.17E-9	Height	
THCA	cis	1	rs4911494	chr20:33971914	GDF5	chr20:33897002-34042568:-	-0.18	-3.81	0.000154	Height	
THCA	cis	1	rs4911494	chr20:33971914	UQCC	chr20:33890383-33999833:-	0.32	10.23	2.48E-22	Height	
THCA	cis	1	rs4911496	chr20:33972053	CPNE1	chr20:34213968-34262539:-	-0.24	-4.91	1.27E-6	Height	
THCA	cis	1	rs4911496	chr20:33972053	GDF5	chr20:33897002-34042568:-	0.16	3.6	0.000347	Height	
THCA	cis	1	rs4911496	chr20:33972053	UQCC	chr20:33890383-33999833:-	-0.28	-9.6	4.6E-20	Height	
THCA	cis	1	rs4915073	chr1:108325879	VAV3	chr1:108113782-108507545:-	0.49	6.69	6.44E-11	Hypothyroidism	
THCA	cis	1	rs4915076	chr1:108359505	VAV3	chr1:108113782-108507545:-	0.56	8.05	6.58E-15	Hypothyroidism	
THCA	cis	1	rs4915077	chr1:108366016	VAV3	chr1:108113782-108507545:-	0.57	8.13	3.62E-15	Hypothyroidism	
THCA	cis	1	rs491567	chr15:53946593	WDR72	chr15:53805938-54051859:-	0.14	3.44	0.000644	Chronic kidney disease;Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs4917385	chr10:105003721	C10orf32	chr10:104613967-104624718:+	-0.18	-5.13	4.25E-7	Systemic lupus erythematosus	
THCA	cis	1	rs4917901	chr10:102201773	SEC31B	chr10:102246403-102289636:-	-0.3	-10.18	3.73E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs4917908	chr10:102502674	FBXW4	chr10:103370422-103454743:-	-0.17	-3.35	0.000873	Alzheimer's disease	
THCA	cis	1	rs4919429	chr10:101938630	BLOC1S2	chr10:102033713-102046439:-	-0.66	-8.26	1.43E-15	Schizophrenia	
THCA	cis	1	rs4919429	chr10:101938630	CWF19L1	chr10:101992055-102027437:-	-0.58	-5.9	6.84E-9	Schizophrenia	
THCA	cis	1	rs4919464	chr10:102221195	SEC31B	chr10:102246403-102289636:-	-0.3	-10.24	2.25E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs4919465	chr10:102221703	SEC31B	chr10:102246403-102289636:-	-0.3	-10.24	2.25E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs4919466	chr10:102241213	SEC31B	chr10:102246403-102289636:-	-0.3	-10.08	8.78E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs4919468	chr10:102288343	SEC31B	chr10:102246403-102289636:-	-0.29	-9.16	1.51E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs4919469	chr10:102298855	SEC31B	chr10:102246403-102289636:-	-0.28	-8.96	7.03E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs4919470	chr10:102298920	SEC31B	chr10:102246403-102289636:-	-0.28	-9.08	2.85E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs4919471	chr10:102299239	SEC31B	chr10:102246403-102289636:-	-0.28	-8.84	1.79E-17	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs4919472	chr10:102315864	SEC31B	chr10:102246403-102289636:-	-0.29	-9.24	8.08E-19	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs4919690	chr10:104616500	AS3MT	chr10:104613967-104661653:+	0.29	5.01	7.86E-7	Arsenic metabolism	
THCA	cis	1	rs4919690	chr10:104616500	C10orf32	chr10:104613967-104624718:+	0.49	12.72	4.08E-32	Arsenic metabolism	
THCA	cis	1	rs4920660	chr2:190744666	ASNSD1	chr2:190526125-190535556:+	-0.58	-6.09	2.35E-9	Subcutaneous adipose tissue	
THCA	cis	1	rs4924935	chr17:18753870	FAM18B	chr17:18684582-18710026:+	-0.3	-6.87	2.01E-11	Pancreatic cancer	
THCA	cis	1	rs4925166	chr17:18210810	EVPLL	chr17:18281079-18292958:+	-0.3	-5.43	8.9E-8	Multiple sclerosis	
THCA	cis	1	rs4925166	chr17:18210810	FAM106A	chr17:18427880-18430160:-	-0.22	-3.87	0.000123	Multiple sclerosis	
THCA	cis	1	rs4925166	chr17:18210810	FAM18B	chr17:18684582-18710026:+	-0.15	-3.43	0.000661	Multiple sclerosis	
THCA	cis	1	rs4925166	chr17:18210810	LOC220594	chr17:18414577-18445234:-	-0.39	-6.34	5.36E-10	Multiple sclerosis	
THCA	cis	1	rs4925166	chr17:18210810	TOP3A	chr17:18177235-18218321:-	-0.16	-3.7	0.000242	Multiple sclerosis	
THCA	cis	1	rs4925540	chr1:247214878	OR2T8	chr1:248084320-248085256:+	-0.18	-3.43	0.000647	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs4925540	chr1:247214878	OR2W3	chr1:248031265-248060142:+	-0.18	-3.57	0.00039	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs4925540	chr1:247214878	TRIM58	chr1:248020501-248043436:+	-0.15	-3.35	0.000879	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs492607	chr11:83295311	CCDC90B	chr11:82972506-82997414:-	0.17	3.92	9.97E-5	Subcortical brain region volumes	
THCA	cis	1	rs4926400	chr1:149931541	FCGR1C	chr1:149369294-149378295:+	-0.17	-3.5	0.000504	Height	
THCA	cis	1	rs4926400	chr1:149931541	SV2A	chr1:149874876-149889434:-	0.16	3.35	0.000886	Height	
THCA	cis	1	rs4929949	chr11:8604593	STK33	chr11:8413418-8615775:-	0.25	6.08	2.45E-9	Body mass index	
THCA	cis	1	rs4929949	chr11:8604593	TRIM66	chr11:8633586-8693413:-	0.21	5.28	1.94E-7	Body mass index	
THCA	cis	1	rs4929983	chr11:2024579	LOC100133545	chr11:2004440-2011150:-	-0.16	-3.74	0.00021	DNA methylation (variation);DNA methylation (parent-of-origin)	
THCA	cis	1	rs4930103	chr11:2024544	LOC100133545	chr11:2004440-2011150:-	-0.17	-3.89	0.000117	DNA methylation (variation);DNA methylation (parent-of-origin)	
THCA	cis	1	rs4930643	chr11:68818936	TPCN2	chr11:68816350-68929907:+	-0.15	-3.63	0.000315	Hair color	
THCA	cis	1	rs493065	chr11:71796929	FAM86C	chr11:71498557-71512276:+	0.31	3.81	0.000158	Severe influenza A (H1N1) infection	
THCA	cis	1	rs4930723	chr12:124423600	ZNF664	chr12:124457670-124499967:+	-0.18	-5.03	7.04E-7	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs4930725	chr12:124428162	ZNF664	chr12:124457670-124499967:+	-0.17	-4.8	2.16E-6	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs4930726	chr12:124428331	DNAH10	chr12:124247042-124420265:+	0.18	3.77	0.000182	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs4930726	chr12:124428331	ZNF664	chr12:124457670-124499967:+	-0.17	-4.91	1.27E-6	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs4932143	chr15:90372067	AP3S2	chr15:90373832-90456222:-	-0.73	-18.17	1.74E-56	Type 2 diabetes	
THCA	cis	1	rs4932143	chr15:90372067	C15orf38	chr15:90443832-90456222:-	0.35	7.46	4.08E-13	Type 2 diabetes	
THCA	cis	1	rs4932148	chr15:90394356	AP3S2	chr15:90373832-90456222:-	-0.78	-19.51	8.88E-63	Type 2 diabetes	
THCA	cis	1	rs4932148	chr15:90394356	C15orf38	chr15:90443832-90456222:-	0.36	7.58	1.77E-13	Type 2 diabetes	
THCA	cis	1	rs4935969	chr11:126296589	FOXRED1	chr11:126139055-126148026:+	-0.14	-3.58	0.000374	Hair color	
THCA	cis	1	rs4936323	chr11:115091119	CADM1	chr11:115039953-115375241:-	-0.14	-3.35	0.000878	Response to cytadine analogues (cytosine arabinoside)	
THCA	cis	1	rs4936444	chr11:118743338	TREH	chr11:118528942-118550381:-	0.22	3.66	0.000275	Primary biliary cirrhosis	
THCA	cis	1	rs4938493	chr11:118144804	AMICA1	chr11:118064442-118095809:-	0.09	4.11	4.72E-5	Pain	
THCA	cis	1	rs4938493	chr11:118144804	MPZL2	chr11:118124135-118135009:-	0.23	7.78	4.48E-14	Pain	
THCA	cis	1	rs4938493	chr11:118144804	TREH	chr11:118528942-118550381:-	-0.17	-3.38	0.000783	Pain	
THCA	cis	1	rs4938637	chr11:119075323	CBL	chr11:119076990-119178858:+	-0.22	-4.37	1.55E-5	Platelet count	
THCA	cis	1	rs4938642	chr11:119099906	CBL	chr11:119076990-119178858:+	-0.23	-4.54	6.98E-6	Platelet count	
THCA	cis	1	rs4938644	chr11:119153359	CBL	chr11:119076990-119178858:+	-0.21	-4.02	6.71E-5	Platelet count	
THCA	cis	1	rs4939311	chr11:59877967	MS4A14	chr11:60145958-60185226:+	0.18	4.67	3.95E-6	Alzheimer's disease (late onset)	
THCA	cis	1	rs4939312	chr11:59900106	MS4A14	chr11:60145958-60185226:+	-0.17	-4.41	1.3E-5	Alzheimer's disease (late onset)	
THCA	cis	1	rs4939314	chr11:59900575	MS4A14	chr11:60145958-60185226:+	0.17	4.38	1.46E-5	Alzheimer's disease (late onset)	
THCA	cis	1	rs494003	chr11:65542298	CTSW	chr11:65647284-65651212:+	-0.23	-4.76	2.59E-6	Systemic lupus erythematosus	
THCA	cis	1	rs494003	chr11:65542298	RNASEH2C	chr11:65485146-65488409:-	-0.18	-4.53	7.34E-6	Systemic lupus erythematosus	
THCA	cis	1	rs494003	chr11:65542298	SNX32	chr11:65601410-65621170:+	0.39	5.22	2.71E-7	Systemic lupus erythematosus	
THCA	cis	1	rs4943821	chr11:71813747	FAM86C	chr11:71498557-71512276:+	-0.32	-4.06	5.81E-5	Severe influenza A (H1N1) infection	
THCA	cis	1	rs4944195	chr11:78003499	NARS2	chr11:78147017-78285909:-	-0.36	-6.41	3.42E-10	Testicular germ cell tumor	
THCA	cis	1	rs4944198	chr11:78032605	NARS2	chr11:78147017-78285909:-	-0.39	-7.04	6.66E-12	Testicular germ cell tumor	
THCA	cis	1	rs4944232	chr11:71642258	FAM86C	chr11:71498557-71512276:+	-0.34	-4.28	2.28E-5	Severe influenza A (H1N1) infection	
THCA	cis	1	rs4944242	chr11:71667141	FAM86C	chr11:71498557-71512276:+	0.34	4.1	4.89E-5	Severe influenza A (H1N1) infection	
THCA	cis	1	rs4944258	chr11:71743393	FAM86C	chr11:71498557-71512276:+	0.32	3.91	0.000107	Severe influenza A (H1N1) infection	
THCA	cis	1	rs4945261	chr11:77990260	NARS2	chr11:78147017-78285909:-	0.36	6.49	2.15E-10	Testicular germ cell tumor	
THCA	cis	1	rs4945267	chr11:78037933	NARS2	chr11:78147017-78285909:-	-0.39	-6.92	1.48E-11	Testicular germ cell tumor	
THCA	cis	1	rs4945268	chr11:78037936	NARS2	chr11:78147017-78285909:-	-0.39	-6.92	1.48E-11	Testicular germ cell tumor	
THCA	cis	1	rs4945270	chr11:78068216	NARS2	chr11:78147017-78285909:-	-0.39	-7	8.63E-12	Testicular germ cell tumor	
THCA	cis	1	rs4945274	chr11:78109260	NARS2	chr11:78147017-78285909:-	-0.4	-7.5	3.07E-13	Testicular germ cell tumor	
THCA	cis	1	rs4945426	chr11:71748146	FAM86C	chr11:71498557-71512276:+	-0.32	-3.91	0.000107	Severe influenza A (H1N1) infection	
THCA	cis	1	rs4945434	chr11:71759087	FAM86C	chr11:71498557-71512276:+	-0.32	-3.91	0.000107	Severe influenza A (H1N1) infection	
THCA	cis	1	rs4945435	chr11:71759219	FAM86C	chr11:71498557-71512276:+	0.31	3.9	0.000111	Severe influenza A (H1N1) infection	
THCA	cis	1	rs4945584	chr6:117750980	DCBLD1	chr6:117803820-117891018:+	0.51	11.14	9.16E-26	Lung cancer	
THCA	cis	1	rs4945584	chr6:117750980	GOPC	chr6:117639351-117923681:-	0.24	7.01	7.92E-12	Lung cancer	
THCA	cis	1	rs494562	chr6:86117129	NT5E	chr6:86159302-86205496:+	0.23	3.66	0.000284	Blood metabolite levels;Metabolic traits	
THCA	cis	1	rs4947015	chr6:110052515	AKD1	chr6:109814059-110012415:-	-0.45	-6.79	3.28E-11	Hematological parameters	
THCA	cis	1	rs4947015	chr6:110052515	FIG4	chr6:110012424-110146634:+	-0.26	-3.6	0.00035	Hematological parameters	
THCA	cis	1	rs4947019	chr6:110090049	AKD1	chr6:109814059-110012415:-	-0.45	-6.86	2.1E-11	Hematological parameters	
THCA	cis	1	rs4947019	chr6:110090049	FIG4	chr6:110012424-110146634:+	-0.29	-4.16	3.8E-5	Hematological parameters	
THCA	cis	1	rs4947534	chr7:56079094	GBAS	chr7:56032296-56067871:+	-0.3	-8.19	2.38E-15	Blood metabolite levels;Amino acid levels	
THCA	cis	1	rs4947534	chr7:56079094	PHKG1	chr7:56148675-56160689:-	-0.29	-5.41	1.02E-7	Blood metabolite levels;Amino acid levels	
THCA	cis	1	rs4948102	chr7:56097265	GBAS	chr7:56032296-56067871:+	-0.31	-8.38	5.85E-16	Plasma homocysteine levels (post-methionine load test)	
THCA	cis	1	rs4948102	chr7:56097265	PHKG1	chr7:56148675-56160689:-	-0.29	-5.36	1.28E-7	Plasma homocysteine levels (post-methionine load test)	
THCA	cis	1	rs4949371	chr1:31735880	ZCCHC17	chr1:31769842-31837780:+	-0.3	-5.61	3.47E-8	Schizophrenia	
THCA	cis	1	rs4949377	chr1:31758467	ZCCHC17	chr1:31769842-31837780:+	-0.3	-5.6	3.65E-8	Schizophrenia	
THCA	cis	1	rs4949391	chr1:31833706	ZCCHC17	chr1:31769842-31837780:+	0.31	6.19	1.27E-9	Schizophrenia	
THCA	cis	1	rs494965	chr11:120053650	TRIM29	chr11:119981995-120008863:-	-0.15	-3.78	0.000174	Corneal curvature	
THCA	cis	1	rs4949674	chr1:76213715	ACADM	chr1:76190043-76229353:+	0.13	3.68	0.000262	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs4949674	chr1:76213715	MSH4	chr1:76262630-76378923:+	0.25	4.13	4.3E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs4949872	chr1:76131392	MSH4	chr1:76262630-76378923:+	0.26	4.37	1.51E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs4949874	chr1:76161889	ACADM	chr1:76190043-76229353:+	0.12	3.38	0.000783	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs4949874	chr1:76161889	MSH4	chr1:76262630-76378923:+	0.24	4.12	4.42E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs4949875	chr1:76173080	MSH4	chr1:76262630-76378923:+	0.25	4.2	3.16E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs4949876	chr1:76173377	ACADM	chr1:76190043-76229353:+	0.12	3.36	0.000836	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs4949876	chr1:76173377	MSH4	chr1:76262630-76378923:+	0.24	4.1	4.94E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs4949879	chr1:76237143	ACADM	chr1:76190043-76229353:+	0.13	3.59	0.000361	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs4949879	chr1:76237143	MSH4	chr1:76262630-76378923:+	0.25	4.29	2.2E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs4950322	chr1:146854836	FMO5	chr1:146655885-146697230:-	-0.26	-4.09	5.08E-5	Protein quantitative trait loci	
THCA	cis	1	rs4950429	chr1:146871957	FMO5	chr1:146655885-146697230:-	0.24	3.87	0.000125	Protein quantitative trait loci	
THCA	cis	1	rs4951261	chr1:205717823	PM20D1	chr1:205797154-205819245:-	0.34	5.95	5.21E-9	Menarche (age at onset)	
THCA	cis	1	rs4951261	chr1:205717823	RAB7L1	chr1:205737115-205744610:-	-0.3	-8.63	8.93E-17	Menarche (age at onset)	
THCA	cis	1	rs4952589	chr2:42276606	COX7A2L	chr2:42577647-42596150:-	0.19	3.35	0.000866	Atopy	
THCA	cis	1	rs495469	chr6:86117025	NT5E	chr6:86159302-86205496:+	0.24	3.76	0.000191	Blood metabolite levels;Metabolic traits	
THCA	cis	1	rs495472	chr6:86117021	NT5E	chr6:86159302-86205496:+	0.24	3.76	0.000191	Blood metabolite levels;Metabolic traits	
THCA	cis	1	rs4955485	chr3:134295843	ANAPC13	chr3:134196547-134204865:-	0.36	11.4	8.25E-27	Height	
THCA	cis	1	rs4955485	chr3:134295843	CEP63	chr3:134204575-134293852:+	0.3	6.62	9.81E-11	Height	
THCA	cis	1	rs4955555	chr3:134286427	ANAPC13	chr3:134196547-134204865:-	0.4	12.9	7.22E-33	Height	
THCA	cis	1	rs4955555	chr3:134286427	CEP63	chr3:134204575-134293852:+	0.3	6.55	1.51E-10	Height	
THCA	cis	1	rs495567	chr11:71795488	FAM86C	chr11:71498557-71512276:+	0.31	3.97	8.36E-5	Severe influenza A (H1N1) infection	
THCA	cis	1	rs4957901	chr5:109707457	TMEM232	chr5:109624934-110062381:-	0.38	4.51	8.32E-6	Cardiac structure and function	
THCA	cis	1	rs4958422	chr5:150186734	LOC134466	chr5:150310000-150326146:-	0.45	5.77	1.39E-8	Crohn's disease	
THCA	cis	1	rs4958422	chr5:150186734	ZNF300	chr5:150273964-150284391:-	0.18	3.63	0.00032	Crohn's disease	
THCA	cis	1	rs4958424	chr5:150225036	LOC134466	chr5:150310000-150326146:-	0.39	5.45	8.07E-8	Crohn's disease	
THCA	cis	1	rs4958426	chr5:150278346	LOC134466	chr5:150310000-150326146:-	0.47	6.05	2.88E-9	Crohn's disease	
THCA	cis	1	rs4958842	chr5:150224877	LOC134466	chr5:150310000-150326146:-	0.47	6.2	1.23E-9	Crohn's disease	
THCA	cis	1	rs4958842	chr5:150224877	ZNF300	chr5:150273964-150284391:-	0.17	3.42	0.000689	Crohn's disease	
THCA	cis	1	rs4958843	chr5:150224924	LOC134466	chr5:150310000-150326146:-	0.39	5.45	8.07E-8	Crohn's disease	
THCA	cis	1	rs4958848	chr5:150271122	LOC134466	chr5:150310000-150326146:-	0.38	5.28	2.01E-7	Crohn's disease	
THCA	cis	1	rs4958852	chr5:150330631	LOC134466	chr5:150310000-150326146:-	0.44	5.48	6.9E-8	Crohn's disease	
THCA	cis	1	rs4961372	chr8:142358865	TRAPPC9	chr8:140742586-141468678:-	0.13	3.36	0.000844	Bipolar disorder and schizophrenia	
THCA	cis	1	rs496584	chr15:43831923	ADAL	chr15:43622872-43646094:+	-0.5	-11.36	1.28E-26	Tumor biomarkers	
THCA	cis	1	rs496584	chr15:43831923	CATSPER2	chr15:43922774-43959900:-	-0.27	-4.8	2.11E-6	Tumor biomarkers	
THCA	cis	1	rs496584	chr15:43831923	STRC	chr15:43891762-43924561:-	0.34	6.22	1.1E-9	Tumor biomarkers	
THCA	cis	1	rs496584	chr15:43831923	TUBGCP4	chr15:43663313-43698238:+	0.12	3.37	0.000819	Tumor biomarkers	
THCA	cis	1	rs4970941	chr1:151068546	BNIPL	chr1:151009029-151020076:+	-0.18	-3.65	0.000292	Body mass index	
THCA	cis	1	rs4971316	chr1:247210903	OR2T8	chr1:248084320-248085256:+	-0.18	-3.43	0.000665	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs4971316	chr1:247210903	OR2W3	chr1:248031265-248060142:+	-0.18	-3.62	0.000328	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs4971316	chr1:247210903	TRIM58	chr1:248020501-248043436:+	-0.15	-3.38	0.000771	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs4971319	chr1:247211565	OR2T8	chr1:248084320-248085256:+	-0.18	-3.43	0.000665	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs4971319	chr1:247211565	OR2W3	chr1:248031265-248060142:+	-0.18	-3.62	0.000328	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs4971319	chr1:247211565	TRIM58	chr1:248020501-248043436:+	-0.15	-3.38	0.000771	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs497261	chr11:68192244	LOC645332	chr11:67559240-67572807:-	0.16	3.5	0.000514	Bone mineral density (spine)	
THCA	cis	1	rs4973991	chr3:41927273	ULK4	chr3:41288091-42003660:-	-1.09	-20.92	1.8E-69	Diastolic blood pressure	
THCA	cis	1	rs4974105	chr3:51369574	HEMK1	chr3:50606583-50622419:+	0.2	4.18	3.4E-5	Melanoma	
THCA	cis	1	rs4974105	chr3:51369574	TEX264	chr3:51705222-51738338:+	-0.22	-6.05	2.93E-9	Melanoma	
THCA	cis	1	rs4974483	chr3:134219001	ANAPC13	chr3:134196547-134204865:-	0.37	11.71	4.87E-28	Height	
THCA	cis	1	rs4974483	chr3:134219001	CEP63	chr3:134204575-134293852:+	0.29	6.38	4.28E-10	Height	
THCA	cis	1	rs4974484	chr3:134219019	ANAPC13	chr3:134196547-134204865:-	0.39	12.35	1.27E-30	Height	
THCA	cis	1	rs4974484	chr3:134219019	CEP63	chr3:134204575-134293852:+	0.29	6.33	5.5E-10	Height	
THCA	cis	1	rs4974493	chr3:134219993	ANAPC13	chr3:134196547-134204865:-	0.4	12.84	1.2E-32	Height	
THCA	cis	1	rs4974493	chr3:134219993	CEP63	chr3:134204575-134293852:+	0.29	6.27	8.12E-10	Height	
THCA	cis	1	rs4974559	chr4:1380848	CRIPAK	chr4:1385340-1389782:+	-0.34	-7.05	6.31E-12	Systolic blood pressure	
THCA	cis	1	rs4974931	chr4:39110516	KLHL5	chr4:39046659-39123828:+	-0.21	-5.75	1.55E-8	Uric acid levels	
THCA	cis	1	rs4974997	chr4:39110771	KLHL5	chr4:39046659-39123828:+	-0.21	-5.77	1.46E-8	Uric acid levels	
THCA	cis	1	rs4974998	chr4:39110749	KLHL5	chr4:39046659-39123828:+	-0.21	-5.78	1.38E-8	Uric acid levels	
THCA	cis	1	rs4975193	chr4:129980630	C4orf33	chr4:130014829-130033842:+	-0.6	-9.44	1.71E-19	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs4975194	chr4:129982377	C4orf33	chr4:130014829-130033842:+	-0.6	-9.44	1.71E-19	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs4980171	chr10:124743200	C10orf88	chr10:124690419-124713919:-	-0.23	-4.27	2.36E-5	Migraine without aura	
THCA	cis	1	rs4980239	chr10:124741184	C10orf88	chr10:124690419-124713919:-	-0.22	-4.08	5.37E-5	Migraine without aura	
THCA	cis	1	rs4982731	chr14:23585333	C14orf119	chr14:23564788-23569664:+	0.15	3.61	0.000343	Acute lymphoblastic leukemia (childhood)	
THCA	cis	1	rs4982731	chr14:23585333	CDH24	chr14:23516271-23526747:-	0.16	3.74	0.00021	Acute lymphoblastic leukemia (childhood)	
THCA	cis	1	rs4985124	chr16:15125441	NTAN1	chr16:15131717-15149833:-	0.15	4.28	2.22E-5	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs4985124	chr16:15125441	PDXDC1	chr16:15068599-15233195:+	0.33	7.6	1.56E-13	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs4985154	chr16:15131642	NTAN1	chr16:15131717-15149833:-	0.13	3.93	9.87E-5	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs4985154	chr16:15131642	PDXDC1	chr16:15068599-15233195:+	0.33	7.74	6.14E-14	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs4985518	chr16:69787158	COG4	chr16:70514473-70557457:-	-0.19	-3.88	0.000118	IgE levels	
THCA	cis	1	rs4985523	chr16:69797192	COG4	chr16:70514473-70557457:-	-0.18	-3.62	0.000332	IgE levels	
THCA	cis	1	rs4985813	chr17:20901001	USP22	chr17:20902908-20947073:-	-0.17	-3.61	0.000342	Blood trace element (Se levels)	
THCA	cis	1	rs4985820	chr17:20931660	USP22	chr17:20902908-20947073:-	-0.18	-3.75	0.0002	Blood trace element (Se levels)	
THCA	cis	1	rs4985953	chr17:20897584	USP22	chr17:20902908-20947073:-	-0.17	-3.69	0.000251	Blood trace element (Se levels)	
THCA	cis	1	rs4985954	chr17:20897952	USP22	chr17:20902908-20947073:-	-0.17	-3.69	0.000255	Blood trace element (Se levels)	
THCA	cis	1	rs4985955	chr17:20898014	USP22	chr17:20902908-20947073:-	0.18	3.73	0.000215	Blood trace element (Se levels)	
THCA	cis	1	rs4985962	chr17:20916035	USP22	chr17:20902908-20947073:-	-0.18	-3.79	0.000171	Blood trace element (Se levels)	
THCA	cis	1	rs4988359	chr11:112025915	BCO2	chr11:112046208-112095421:+	0.23	4.59	5.61E-6	Interleukin-18 levels	
THCA	cis	1	rs4988359	chr11:112025915	IL18	chr11:112013976-112034840:-	-0.24	-4.51	8.25E-6	Interleukin-18 levels	
THCA	cis	1	rs498872	chr11:118477367	IFT46	chr11:118415259-118436750:-	-0.17	-3.78	0.000178	Glioma	
THCA	cis	1	rs498872	chr11:118477367	TREH	chr11:118528942-118550381:-	0.3	5.34	1.44E-7	Glioma	
THCA	cis	1	rs4990365	chr6:159375553	RSPH3	chr6:159398268-159421198:-	0.28	6	3.97E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs4992989	chr15:24821481	PWRN1	chr15:24778839-24832924:+	0.44	9.05	3.74E-18	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
THCA	cis	1	rs4996257	chr2:219162836	TMBIM1	chr2:219138917-219157280:-	0.16	3.67	0.000272	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs500059	chr11:83283859	CCDC90B	chr11:82972506-82997414:-	-0.15	-3.65	0.000289	Subcortical brain region volumes	
THCA	cis	1	rs500571	chr11:83305542	CCDC90B	chr11:82972506-82997414:-	0.16	3.71	0.000235	Subcortical brain region volumes	
THCA	cis	1	rs5005801	chr17:20944154	USP22	chr17:20902908-20947073:-	-0.18	-3.83	0.000146	Blood trace element (Se levels)	
THCA	cis	1	rs5006218	chr6:133126220	C6orf192	chr6:133090507-133119747:-	-0.24	-4	7.46E-5	Type 2 diabetes nephropathy	
THCA	cis	1	rs5011018	chr10:4967006	AKR1C2	chr10:4964715-5060207:-	0.31	3.98	7.98E-5	Height	
THCA	cis	1	rs501220	chr6:25873025	BTN3A2	chr6:26365398-26378546:+	-0.25	-4.64	4.46E-6	Homocysteine levels	
THCA	cis	1	rs5013012	chr22:18450149	MICAL3	chr22:18270418-18507325:-	-0.2	-3.98	7.86E-5	Presence of antiphospholipid antibodies	
THCA	cis	1	rs5013014	chr22:18449927	MICAL3	chr22:18270418-18507325:-	-0.2	-3.98	7.86E-5	Presence of antiphospholipid antibodies	
THCA	cis	1	rs501999	chr5:6635601	NSUN2	chr5:6599355-6633157:-	0.19	4.15	3.88E-5	Response to amphetamines	
THCA	cis	1	rs5024798	chr13:24440203	C1QTNF9B	chr13:24465238-24471641:-	-0.36	-3.71	0.00023	3-hydroxypropylmercapturic acid levels in smokers	
THCA	cis	1	rs5026472	chr4:103554773	CISD2	chr4:103790135-103809913:+	-0.16	-3.72	0.000219	Primary biliary cirrhosis	
THCA	cis	1	rs5026472	chr4:103554773	NFKB1	chr4:103422486-103538458:+	0.15	4.13	4.2E-5	Primary biliary cirrhosis	
THCA	cis	1	rs5026473	chr4:103554793	CISD2	chr4:103790135-103809913:+	-0.17	-3.92	9.97E-5	Primary biliary cirrhosis	
THCA	cis	1	rs5026473	chr4:103554793	NFKB1	chr4:103422486-103538458:+	0.15	4.23	2.8E-5	Primary biliary cirrhosis	
THCA	cis	1	rs5026476	chr4:103554910	CISD2	chr4:103790135-103809913:+	-0.16	-3.62	0.000321	Primary biliary cirrhosis	
THCA	cis	1	rs5026476	chr4:103554910	NFKB1	chr4:103422486-103538458:+	0.15	4.2	3.16E-5	Primary biliary cirrhosis	
THCA	cis	1	rs5028338	chr4:139129127	SLC7A11	chr4:139085248-139163503:-	0.23	4.55	6.95E-6	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	
THCA	cis	1	rs503660	chr10:131418999	MGMT	chr10:131265454-131565783:+	0.38	11.55	2.2E-27	Response to temozolomide	
THCA	cis	1	rs505564	chr11:83277912	CCDC90B	chr11:82972506-82997414:-	0.16	3.86	0.00013	Subcortical brain region volumes	
THCA	cis	1	rs505621	chr11:83277927	CCDC90B	chr11:82972506-82997414:-	0.17	4.05	5.96E-5	Subcortical brain region volumes	
THCA	cis	1	rs505998	chr11:83315597	CCDC90B	chr11:82972506-82997414:-	0.16	3.77	0.000182	Subcortical brain region volumes	
THCA	cis	1	rs506274	chr10:131409392	MGMT	chr10:131265454-131565783:+	0.38	11.43	6.49E-27	Response to temozolomide	
THCA	cis	1	rs507080	chr11:118549582	TREH	chr11:118528942-118550381:-	0.48	9.57	5.97E-20	Serum metabolite levels	
THCA	cis	1	rs508303	chr10:131424996	MGMT	chr10:131265454-131565783:+	-0.37	-11.24	3.62E-26	Response to temozolomide	
THCA	cis	1	rs508970	chr11:60906450	CD5	chr11:60869930-60895321:+	-0.09	-3.63	0.000314	Rheumatoid arthritis	
THCA	cis	1	rs508970	chr11:60906450	PGA3	chr11:60970984-60993916:+	0.19	3.41	0.000706	Rheumatoid arthritis	
THCA	cis	1	rs510988	chr11:116813804	PCSK7	chr11:117075789-117102811:-	-0.28	-4.77	2.43E-6	Protein quantitative trait loci	
THCA	cis	1	rs511676	chr11:116824884	PCSK7	chr11:117075789-117102811:-	-0.26	-4.57	6.15E-6	Protein quantitative trait loci	
THCA	cis	1	rs512140	chr6:84230653	SNAP91	chr6:84262607-84419127:-	0.2	4	7.25E-5	Bipolar disorder with mood-incongruent psychosis	
THCA	cis	1	rs513736	chr10:131406489	MGMT	chr10:131265454-131565783:+	0.38	11.31	1.85E-26	Response to temozolomide	
THCA	cis	1	rs514591	chr1:196640320	CFHR3	chr1:196743930-196762872:+	0.24	4.66	4.04E-6	Circulating myeloperoxidase levels (serum)	
THCA	cis	1	rs515071	chr8:41519462	ANK1	chr8:41510745-41754280:-	-0.22	-4.65	4.21E-6	Type 2 diabetes	
THCA	cis	1	rs515910	chr10:105966404	C10orf79	chr10:105889647-105992120:-	0.25	8.01	8.87E-15	Attention deficit hyperactivity disorder	
THCA	cis	1	rs516704	chr10:131419879	MGMT	chr10:131265454-131565783:+	0.38	11.47	4.34E-27	Response to temozolomide	
THCA	cis	1	rs516946	chr8:41519248	ANK1	chr8:41510745-41754280:-	-0.23	-4.71	3.19E-6	Type 2 diabetes	
THCA	cis	1	rs517837	chr11:71802359	FAM86C	chr11:71498557-71512276:+	0.32	3.97	8.36E-5	Severe influenza A (H1N1) infection	
THCA	cis	1	rs520025	chr11:71562832	FAM86C	chr11:71498557-71512276:+	-0.37	-4.34	1.73E-5	Severe influenza A (H1N1) infection	
THCA	cis	1	rs5219	chr11:17409572	DKFZp686O24166	chr11:17373317-17398869:+	0.12	3.59	0.000366	Type 2 diabetes	
THCA	cis	1	rs522891	chr10:131430916	MGMT	chr10:131265454-131565783:+	-0.38	-11.33	1.55E-26	Response to temozolomide	
THCA	cis	1	rs523340	chr9:111854246	C9orf5	chr9:111777416-111882225:-	-0.19	-3.55	0.000424	Information processing speed	
THCA	cis	1	rs523494	chr11:83312379	CCDC90B	chr11:82972506-82997414:-	0.17	3.89	0.000116	Subcortical brain region volumes	
THCA	cis	1	rs525592	chr11:68195104	LOC645332	chr11:67559240-67572807:-	0.17	3.76	0.000195	Bone mineral density	
THCA	cis	1	rs527154	chr10:105943683	C10orf79	chr10:105889647-105992120:-	0.25	8.06	6.05E-15	Attention deficit hyperactivity disorder	
THCA	cis	1	rs527670	chr6:86115779	NT5E	chr6:86159302-86205496:+	0.23	3.51	0.000492	Blood metabolite levels;Metabolic traits	
THCA	cis	1	rs530466	chr10:131427717	MGMT	chr10:131265454-131565783:+	0.39	11.91	7.79E-29	Response to temozolomide	
THCA	cis	1	rs531326	chr11:71570656	FAM86C	chr11:71498557-71512276:+	-0.36	-4.43	1.19E-5	Severe influenza A (H1N1) infection	
THCA	cis	1	rs531572	chr10:131427569	MGMT	chr10:131265454-131565783:+	-0.38	-11.84	1.56E-28	Response to temozolomide	
THCA	cis	1	rs531676	chr10:99637578	CRTAC1	chr10:99624758-99790585:-	0.19	3.47	0.000577	Metabolic syndrome	
THCA	cis	1	rs534417	chr1:23784965	ASAP3	chr1:23755056-23811057:-	0.31	5.04	6.62E-7	Cholesterol, total	
THCA	cis	1	rs534417	chr1:23784965	TCEA3	chr1:23707555-23751261:-	0.23	4.33	1.82E-5	Cholesterol, total	
THCA	cis	1	rs535112	chr1:70889476	ZRANB2	chr1:71528975-71546745:-	0.11	3.39	0.000759	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	
THCA	cis	1	rs538969	chr10:131410608	MGMT	chr10:131265454-131565783:+	0.38	11.44	6.2E-27	Response to temozolomide	
THCA	cis	1	rs539602	chr1:155899020	FDPS	chr1:155278539-155290457:+	-0.21	-4.26	2.51E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs539602	chr1:155899020	RIT1	chr1:155867601-155881177:-	0.17	3.9	0.000112	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs541022	chr11:71783056	FAM86C	chr11:71498557-71512276:+	0.29	3.66	0.000278	Severe influenza A (H1N1) infection	
THCA	cis	1	rs541126	chr12:120972396	COQ5	chr12:120941083-120966964:-	-0.15	-3.69	0.000254	Type 1 diabetes nephropathy	
THCA	cis	1	rs541126	chr12:120972396	POP5	chr12:121016849-121019201:-	0.16	4.94	1.08E-6	Type 1 diabetes nephropathy	
THCA	cis	1	rs541126	chr12:120972396	RNF10	chr12:120972132-121015396:+	-0.22	-3.66	0.000282	Type 1 diabetes nephropathy	
THCA	cis	1	rs542752	chr11:71810644	FAM86C	chr11:71498557-71512276:+	-0.32	-3.89	0.000113	Severe influenza A (H1N1) infection	
THCA	cis	1	rs543030	chr19:6081667	RFX2	chr19:5993176-6110664:-	0.35	3.75	0.000199	Bipolar disorder and schizophrenia	
THCA	cis	1	rs543725	chr11:57483039	MED19	chr11:57471182-57479673:-	-0.21	-4.47	9.71E-6	Schizophrenia	
THCA	cis	1	rs543725	chr11:57483039	TIMM10	chr11:57295936-57298232:-	-0.26	-6.36	4.61E-10	Schizophrenia	
THCA	cis	1	rs546131	chr11:34851760	PDHX	chr11:34937677-35017674:+	-0.17	-4.4	1.32E-5	Lung disease severity in cystic fibrosis	
THCA	cis	1	rs548127	chr11:71575294	FAM86C	chr11:71498557-71512276:+	0.34	4.15	4.0E-5	Severe influenza A (H1N1) infection	
THCA	cis	1	rs548181	chr11:125461709	PUS3	chr11:125763380-125773116:-	-0.25	-3.4	0.000719	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);Schizophrenia	
THCA	cis	1	rs548390	chr10:131417427	MGMT	chr10:131265454-131565783:+	0.38	11.35	1.28E-26	Response to temozolomide	
THCA	cis	1	rs548961	chr11:71793887	FAM86C	chr11:71498557-71512276:+	0.3	3.69	0.000248	Severe influenza A (H1N1) infection	
THCA	cis	1	rs550098	chr1:197297408	CFHR3	chr1:196743930-196762872:+	0.25	5.1	4.88E-7	Lupus nephritis in systemic lupus erythematosus	
THCA	cis	1	rs550213	chr17:30317518	C17orf79	chr17:30178885-30186326:-	-0.18	-4.32	1.93E-5	Height	
THCA	cis	1	rs551397	chr1:196642072	CFHR3	chr1:196743930-196762872:+	0.25	4.73	3.03E-6	Circulating myeloperoxidase levels (serum)	
THCA	cis	1	rs553371	chr10:131413676	MGMT	chr10:131265454-131565783:+	0.38	11.44	6.05E-27	Response to temozolomide	
THCA	cis	1	rs553989	chr3:47400328	C3orf75	chr3:47537131-47555199:-	0.09	4.25	2.6E-5	Colorectal cancer	
THCA	cis	1	rs553989	chr3:47400328	NBEAL2	chr3:47021173-47051193:+	0.12	3.7	0.000245	Colorectal cancer	
THCA	cis	1	rs553989	chr3:47400328	PRSS45	chr3:46783582-46790130:-	0.16	3.53	0.00045	Colorectal cancer	
THCA	cis	1	rs554734	chr11:68192518	LOC645332	chr11:67559240-67572807:-	0.16	3.5	0.000514	Bone mineral density (spine)	
THCA	cis	1	rs554792	chr10:131423181	MGMT	chr10:131265454-131565783:+	0.38	11.31	1.9E-26	Response to temozolomide	
THCA	cis	1	rs555044	chr12:335922	CCDC77	chr12:498516-551804:+	-0.23	-3.71	0.000229	Serum metabolite levels	
THCA	cis	1	rs555152	chr11:95016478	KDM4D	chr11:94706845-94732674:+	-0.16	-3.34	0.000903	Positive affect	
THCA	cis	1	rs556199	chr11:83276006	CCDC90B	chr11:82972506-82997414:-	0.16	3.94	9.49E-5	Subcortical brain region volumes	
THCA	cis	1	rs556292	chr10:105961957	C10orf79	chr10:105889647-105992120:-	0.25	8.04	6.92E-15	Attention deficit hyperactivity disorder	
THCA	cis	1	rs55634485	chr2:242268994	ANO7	chr2:242127924-242164791:+	0.36	4.13	4.26E-5	Prostate cancer	
THCA	cis	1	rs55634485	chr2:242268994	SEPT2	chr2:242254723-242293439:+	-0.29	-4.17	3.59E-5	Prostate cancer	
THCA	cis	1	rs55638602	chr1:207428942	CD55	chr1:207494817-207534309:+	0.19	7.47	3.96E-13	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs55645375	chr2:242269024	ANO7	chr2:242127924-242164791:+	0.36	4.13	4.26E-5	Prostate cancer	
THCA	cis	1	rs55645375	chr2:242269024	SEPT2	chr2:242254723-242293439:+	-0.29	-4.17	3.59E-5	Prostate cancer	
THCA	cis	1	rs55647424	chr16:50092495	HEATR3	chr16:50099881-50139373:+	-0.4	-6.21	1.16E-9	Esophageal cancer (squamous cell)	
THCA	cis	1	rs55657382	chr11:46634963	PACSIN3	chr11:47199085-47207958:-	0.18	4.13	4.22E-5	Schizophrenia	
THCA	cis	1	rs55661361	chr11:124613957	NRGN	chr11:124609829-124617102:+	0.27	7.73	6.44E-14	Schizophrenia	
THCA	cis	1	rs55664904	chr8:94081319	C8orf83	chr8:93895865-94029901:-	0.26	4.14	4.03E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs55674647	chr17:61794195	FTSJ3	chr17:61896795-61905031:-	0.31	5.59	3.75E-8	Body mass index	
THCA	cis	1	rs55674647	chr17:61794195	MAP3K3	chr17:61699775-61773669:+	0.26	5.05	6.4E-7	Body mass index	
THCA	cis	1	rs55675294	chr3:128043050	EEFSEC	chr3:127872313-128127488:+	-0.19	-3.44	0.000634	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs55683820	chr10:111665376	DUSP5	chr10:112257625-112271300:+	-0.14	-3.71	0.000232	Biliary atresia	
THCA	cis	1	rs55684215	chr3:127812792	EEFSEC	chr3:127872313-128127488:+	-0.25	-4.42	1.23E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs55696836	chr20:33549887	PROCR	chr20:33758727-33765164:+	-0.36	-5.62	3.24E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs55696836	chr20:33549887	TRPC4AP	chr20:33590215-33680618:-	0.32	3.82	0.00015	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs55703459	chr5:101691754	SLCO4C1	chr5:101569694-101632253:-	0.25	5.62	3.21E-8	Schizophrenia	
THCA	cis	1	rs55705054	chr3:151007278	GPR87	chr3:151011876-151034636:-	0.2	4.56	6.41E-6	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs55705054	chr3:151007278	P2RY14	chr3:150929905-150996230:-	-0.2	-4.22	2.95E-5	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs55707752	chr16:50133570	HEATR3	chr16:50099881-50139373:+	-0.41	-5.8	1.18E-8	Esophageal cancer (squamous cell)	
THCA	cis	1	rs55722539	chr14:88878035	SPATA7	chr14:88852012-88904802:+	-0.19	-4.03	6.6E-5	Coronary artery calcification	
THCA	cis	1	rs55727637	chr16:15145252	NTAN1	chr16:15131717-15149833:-	0.12	3.62	0.000322	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs55727637	chr16:15145252	PDXDC1	chr16:15068599-15233195:+	0.3	7.03	6.94E-12	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs55734215	chr20:33585437	PROCR	chr20:33758727-33765164:+	-0.36	-5.75	1.55E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs55734215	chr20:33585437	TRPC4AP	chr20:33590215-33680618:-	0.32	3.88	0.000118	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs55737216	chr9:100695901	C9orf156	chr9:100666772-100684852:-	-0.14	-3.82	0.000153	Quantitative traits	
THCA	cis	1	rs55742763	chr16:31340368	HSD3B7	chr16:30996519-31000473:+	-0.16	-4.06	5.8E-5	IgA nephropathy	
THCA	cis	1	rs55742763	chr16:31340368	ZNF843	chr16:31446885-31454348:-	-0.16	-3.35	0.000883	IgA nephropathy	
THCA	cis	1	rs55744181	chr14:81777794	STON2	chr14:81727000-81893748:-	0.21	4.2	3.16E-5	Obesity-related traits	
THCA	cis	1	rs55744319	chr19:15981821	CYP4F11	chr19:16023180-16045676:-	-0.24	-3.71	0.000229	Acenocoumarol maintenance dosage;Vitamin E levels;Circulating phylloquinone levels;Metabolite levels;Response to Vitamin E supplementation;Warfarin maintenance dose	
THCA	cis	1	rs55748686	chr7:127148595	GRM8	chr7:126078652-126893147:-	-0.35	-3.57	0.000398	Medication adherence in chronic diseases	
THCA	cis	1	rs55749333	chr17:7371932	CHRNB1	chr17:7348406-7360931:+	-0.19	-3.84	0.000137	Height	
THCA	cis	1	rs55753056	chr2:243929	SH3YL1	chr2:218138-264810:-	-0.93	-25.94	2.93E-93	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs55761949	chr11:77993860	NARS2	chr11:78147017-78285909:-	-0.38	-6.98	1.02E-11	Testicular germ cell tumor	
THCA	cis	1	rs55762931	chr3:127847675	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.52	7.8E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs55767108	chr2:137313594	THSD7B	chr2:137523115-138435287:+	0.22	4.08	5.39E-5	Cognitive test performance	
THCA	cis	1	rs557675	chr11:65566719	SNX32	chr11:65601410-65621170:+	0.21	3.66	0.00028	Urate levels	
THCA	cis	1	rs55775340	chr6:33751784	LEMD2	chr6:33738991-33756906:-	0.23	4.77	2.39E-6	Body mass index	
THCA	cis	1	rs55781567	chr15:78857986	CHRNA5	chr15:78857906-78886458:+	-0.44	-8.5	2.4E-16	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs55786720	chr6:56783647	BEND6	chr6:56819773-56892138:+	-0.31	-6.73	4.73E-11	Menarche (age at onset)	
THCA	cis	1	rs55786720	chr6:56783647	KIAA1586	chr6:56911384-56920021:+	-0.34	-5.49	6.68E-8	Menarche (age at onset)	
THCA	cis	1	rs55791720	chr12:1066834	ERC1	chr12:1100404-1605099:+	0.09	3.45	0.000608	Lung cancer	
THCA	cis	1	rs55791720	chr12:1066834	RAD52	chr12:1021255-1099219:-	0.31	6.73	4.87E-11	Lung cancer	
THCA	cis	1	rs55804343	chr6:39234907	KCNK16	chr6:39282475-39290330:-	0.14	3.45	0.000612	Cholesterol, total	
THCA	cis	1	rs558104	chr11:83276244	CCDC90B	chr11:82972506-82997414:-	0.17	3.97	8.36E-5	Subcortical brain region volumes	
THCA	cis	1	rs55821258	chr8:96292041	C8orf37	chr8:96258235-96281437:-	0.29	3.87	0.000126	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	
THCA	cis	1	rs55822577	chr6:163069710	PACRG	chr6:163148164-163736523:+	0.52	7.21	2.27E-12	Body mass index	
THCA	cis	1	rs55822690	chr3:10128003	C3orf10	chr3:10157333-10168873:+	-0.2	-4.24	2.72E-5	Alzheimer's disease	
THCA	cis	1	rs55822690	chr3:10128003	VHL	chr3:10183319-10193744:+	-0.18	-4.11	4.6E-5	Alzheimer's disease	
THCA	cis	1	rs55825352	chr11:78034424	NARS2	chr11:78147017-78285909:-	-0.4	-6.99	9.16E-12	Testicular germ cell tumor	
THCA	cis	1	rs55829773	chr6:3291397	PSMG4	chr6:3259162-3268300:+	-0.33	-5.53	5.34E-8	Survival in rectal cancer	
THCA	cis	1	rs55835850	chr2:28949296	PPP1CB	chr2:28974612-29025805:+	-0.17	-4.23	2.81E-5	Body mass index	
THCA	cis	1	rs55835850	chr2:28949296	TRMT61B	chr2:29072690-29093175:-	0.5	10.02	1.36E-21	Body mass index	
THCA	cis	1	rs55842567	chr5:437586	C5orf55	chr5:441645-443258:-	0.33	8.44	3.87E-16	Cystic fibrosis severity	
THCA	cis	1	rs55847558	chr11:59903793	MS4A14	chr11:60145958-60185226:+	0.16	4.24	2.65E-5	Alzheimer's disease (late onset)	
THCA	cis	1	rs55847707	chr6:163003414	PACRG	chr6:163148164-163736523:+	0.46	7.08	5.13E-12	Body mass index	
THCA	cis	1	rs55848977	chr8:89444200	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs55857306	chr1:11895795	CLCN6	chr1:11866207-11907674:+	0.16	3.51	0.000496	QRS complex (12-leadsum)	
THCA	cis	1	rs55863174	chr16:69819996	COG4	chr16:70514473-70557457:-	-0.19	-3.93	9.78E-5	IgE levels	
THCA	cis	1	rs55868506	chr17:61851686	FTSJ3	chr17:61896795-61905031:-	0.3	5.82	1.06E-8	Body mass index	
THCA	cis	1	rs55868506	chr17:61851686	MAP3K3	chr17:61699775-61773669:+	0.27	5.5	6.12E-8	Body mass index	
THCA	cis	1	rs55873072	chr8:94090072	C8orf83	chr8:93895865-94029901:-	0.27	4.13	4.34E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs558764	chr10:131426957	MGMT	chr10:131265454-131565783:+	-0.39	-11.59	1.47E-27	Response to temozolomide	
THCA	cis	1	rs55879323	chr1:152168740	FLG2	chr1:152321214-152332482:-	-0.2	-4.08	5.27E-5	Inflammatory skin disease	
THCA	cis	1	rs55879323	chr1:152168740	FLG	chr1:152274651-152297679:-	-0.56	-12.61	1.16E-31	Inflammatory skin disease	
THCA	cis	1	rs55879323	chr1:152168740	HRNR	chr1:152184558-152196669:-	0.48	9.08	2.83E-18	Inflammatory skin disease	
THCA	cis	1	rs55882090	chr3:10139082	C3orf10	chr3:10157333-10168873:+	-0.2	-4.29	2.2E-5	Alzheimer's disease	
THCA	cis	1	rs55882090	chr3:10139082	VHL	chr3:10183319-10193744:+	-0.18	-4.19	3.32E-5	Alzheimer's disease	
THCA	cis	1	rs55883249	chr2:9741535	IAH1	chr2:9614670-9636671:+	0.16	3.44	0.000631	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	
THCA	cis	1	rs55885592	chr14:104126024	KLC1	chr14:104029299-104167887:+	-0.22	-4.55	6.7E-6	Body mass index	
THCA	cis	1	rs55895244	chr7:65387678	CCT6P1	chr7:65216092-65228661:+	0.38	6	3.93E-9	Diabetic kidney disease	
THCA	cis	1	rs55895244	chr7:65387678	CRCP	chr7:65579805-65619551:+	-0.26	-4	7.24E-5	Diabetic kidney disease	
THCA	cis	1	rs55895244	chr7:65387678	RABGEF1	chr7:66093890-66276446:+	0.55	6.89	1.73E-11	Diabetic kidney disease	
THCA	cis	1	rs55896768	chr17:65913358	C17orf58	chr17:65987218-65989765:-	0.25	5.02	7.36E-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs55905547	chr20:57589995	TH1L	chr20:57556311-57570186:+	-0.17	-3.84	0.000139	Mean platelet volume	
THCA	cis	1	rs55909363	chr20:33549407	PROCR	chr20:33758727-33765164:+	-0.36	-5.62	3.24E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs55909363	chr20:33549407	TRPC4AP	chr20:33590215-33680618:-	0.32	3.82	0.00015	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs55913793	chr3:134285968	ANAPC13	chr3:134196547-134204865:-	0.4	12.9	7.22E-33	Height	
THCA	cis	1	rs55913793	chr3:134285968	CEP63	chr3:134204575-134293852:+	0.3	6.55	1.51E-10	Height	
THCA	cis	1	rs55914901	chr19:50528346	SIGLEC16	chr19:50472912-50479075:+	0.55	5.36	1.31E-7	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
THCA	cis	1	rs55918136	chr8:94081231	C8orf83	chr8:93895865-94029901:-	0.27	4.33	1.78E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs55920307	chr11:120042846	TRIM29	chr11:119981995-120008863:-	0.42	6.97	1.03E-11	Stroke (pediatric)	
THCA	cis	1	rs55921267	chr7:127148361	GRM8	chr7:126078652-126893147:-	-0.35	-3.57	0.000398	Medication adherence in chronic diseases	
THCA	cis	1	rs55925538	chr3:128042877	EEFSEC	chr3:127872313-128127488:+	-0.21	-3.7	0.000237	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs55934348	chr2:99246885	UNC50	chr2:99225042-99234975:+	-0.23	-4.53	7.44E-6	Bipolar disorder	
THCA	cis	1	rs55936726	chr2:258210	SH3YL1	chr2:218138-264810:-	-0.95	-26.61	2.24E-96	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs55939964	chr17:65869297	C17orf58	chr17:65987218-65989765:-	0.2	3.97	8.17E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs55940502	chr11:4484737	TRIM68	chr11:4619902-4629437:-	0.16	3.69	0.000253	Amyotrophic lateral sclerosis	
THCA	cis	1	rs55942364	chr15:56512961	MNS1	chr15:56720929-56757335:-	-0.23	-3.41	0.000699	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs55942364	chr15:56512961	TEX9	chr15:56657644-56738071:+	-0.34	-5.84	9.5E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs55942533	chr4:53372881	KIAA0114	chr4:53578621-53580305:+	0.17	3.42	0.000674	Biochemical measures	
THCA	cis	1	rs55942649	chr1:179482604	C1orf125	chr1:179335107-179523868:+	0.33	3.81	0.00016	Multiple sclerosis (age of onset)	
THCA	cis	1	rs55946144	chr20:33629610	PROCR	chr20:33758727-33765164:+	-0.34	-5.59	3.77E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs55946144	chr20:33629610	TRPC4AP	chr20:33590215-33680618:-	0.27	3.37	0.000808	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs55946380	chr2:268293	SH3YL1	chr2:218138-264810:-	-0.95	-26.48	8.61E-96	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs55957623	chr1:152223196	FLG	chr1:152274651-152297679:-	0.28	4.27	2.36E-5	Atopic dermatitis	
THCA	cis	1	rs55957623	chr1:152223196	HRNR	chr1:152184558-152196669:-	-0.42	-5.68	2.36E-8	Atopic dermatitis	
THCA	cis	1	rs55957636	chr15:56526620	MNS1	chr15:56720929-56757335:-	-0.24	-3.51	0.000485	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs55957636	chr15:56526620	TEX9	chr15:56657644-56738071:+	-0.34	-5.81	1.12E-8	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs55958006	chr8:10812144	CTSB	chr8:11700036-11725646:-	0.22	3.5	0.000501	Asthma and hay fever	
THCA	cis	1	rs55962025	chr4:3112109	C4orf44	chr4:3250767-3265839:+	-0.32	-6.72	5.23E-11	Parental longevity (mother's age at death)	
THCA	cis	1	rs55962025	chr4:3112109	GRK4	chr4:2965343-3042474:+	-0.2	-3.46	0.000599	Parental longevity (mother's age at death)	
THCA	cis	1	rs55962648	chr7:65625751	ASL	chr7:65540776-65558321:+	0.16	4.28	2.23E-5	Aortic root size	
THCA	cis	1	rs55962648	chr7:65625751	GUSB	chr7:65425675-65447246:-	-0.27	-5.32	1.61E-7	Aortic root size	
THCA	cis	1	rs55962648	chr7:65625751	LOC729156	chr7:66274980-66309813:-	-0.16	-3.47	0.000572	Aortic root size	
THCA	cis	1	rs55962648	chr7:65625751	RABGEF1	chr7:66093890-66276446:+	-0.66	-14.15	3.08E-38	Aortic root size	
THCA	cis	1	rs55971458	chr17:28427016	ANKRD13B	chr17:27916801-27941778:+	0.36	8.9	1.2E-17	Coffee consumption (cups per day)	
THCA	cis	1	rs55971458	chr17:28427016	CORO6	chr17:27941774-27948441:-	0.51	11.83	1.64E-28	Coffee consumption (cups per day)	
THCA	cis	1	rs55971458	chr17:28427016	EFCAB5	chr17:28256874-28435469:+	0.59	11.17	6.8E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs55971458	chr17:28427016	GIT1	chr17:27900487-27916610:-	0.29	6.78	3.53E-11	Coffee consumption (cups per day)	
THCA	cis	1	rs55971458	chr17:28427016	LRRC37B2	chr17:28903483-28992715:+	0.17	3.78	0.000176	Coffee consumption (cups per day)	
THCA	cis	1	rs55971458	chr17:28427016	SSH2	chr17:27952965-28257018:-	0.37	8.34	7.97E-16	Coffee consumption (cups per day)	
THCA	cis	1	rs55971458	chr17:28427016	TP53I13	chr17:27895739-27900174:+	0.21	5.6	3.54E-8	Coffee consumption (cups per day)	
THCA	cis	1	rs55972015	chr11:71642576	FAM86C	chr11:71498557-71512276:+	0.32	3.96	8.7E-5	Severe influenza A (H1N1) infection	
THCA	cis	1	rs55979739	chr16:31049155	C16orf93	chr16:30768753-30773542:-	-0.15	-4.1	4.86E-5	Response to metformin (IC50)	
THCA	cis	1	rs55979739	chr16:31049155	HSD3B7	chr16:30996519-31000473:+	0.43	11.09	1.41E-25	Response to metformin (IC50)	
THCA	cis	1	rs55979739	chr16:31049155	MYST1	chr16:31128985-31142713:+	0.15	4.8	2.15E-6	Response to metformin (IC50)	
THCA	cis	1	rs55979739	chr16:31049155	PRSS53	chr16:31094747-31106276:-	-0.15	-4.02	6.7E-5	Response to metformin (IC50)	
THCA	cis	1	rs55985317	chr11:108110663	ACAT1	chr11:107992258-108018889:+	-0.33	-7.26	1.59E-12	Melanoma	
THCA	cis	1	rs55986560	chr19:41939835	B3GNT8	chr19:41931265-41934635:-	0.35	8.02	8.45E-15	Height	
THCA	cis	1	rs55986560	chr19:41939835	EXOSC5	chr19:41892278-41903256:-	0.11	3.63	0.000309	Height	
THCA	cis	1	rs55989768	chr3:128043004	EEFSEC	chr3:127872313-128127488:+	-0.19	-3.44	0.000634	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs55990776	chr12:124447466	ZNF664	chr12:124457670-124499967:+	-0.18	-5.07	5.57E-7	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs55992518	chr16:69821407	COG4	chr16:70514473-70557457:-	-0.19	-3.93	9.82E-5	IgE levels	
THCA	cis	1	rs559928	chr11:64150370	GPR137	chr11:64037534-64056965:+	0.15	3.63	0.00031	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs559928	chr11:64150370	VEGFB	chr11:64002266-64006258:+	0.16	4.37	1.54E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs55998153	chr1:179453824	C1orf125	chr1:179335107-179523868:+	0.58	6.12	1.94E-9	Multiple sclerosis (age of onset)	
THCA	cis	1	rs56004802	chr10:1159187	IDI2	chr10:1064847-1071799:-	0.41	4.18	3.41E-5	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs56005196	chr15:56519009	MNS1	chr15:56720929-56757335:-	-0.24	-3.51	0.000485	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs56005196	chr15:56519009	TEX9	chr15:56657644-56738071:+	-0.34	-5.81	1.12E-8	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs56015036	chr10:17226767	TRDMT1	chr10:17184983-17243681:-	-0.44	-10.26	1.88E-22	Homocysteine levels	
THCA	cis	1	rs56015036	chr10:17226767	VIM	chr10:17270258-17279592:+	-0.19	-3.5	0.000503	Homocysteine levels	
THCA	cis	1	rs56015123	chr15:50977228	SPPL2A	chr15:50999739-51057910:-	0.28	7.46	4.24E-13	QT interval	
THCA	cis	1	rs56016656	chr7:65383481	CCT6P1	chr7:65216092-65228661:+	0.41	6.41	3.44E-10	Diabetic kidney disease	
THCA	cis	1	rs56016656	chr7:65383481	CRCP	chr7:65579805-65619551:+	-0.26	-3.95	9.06E-5	Diabetic kidney disease	
THCA	cis	1	rs56016656	chr7:65383481	RABGEF1	chr7:66093890-66276446:+	0.53	6.46	2.51E-10	Diabetic kidney disease	
THCA	cis	1	rs56026460	chr6:3291264	PSMG4	chr6:3259162-3268300:+	-0.33	-5.54	5.09E-8	Survival in rectal cancer	
THCA	cis	1	rs56028644	chr19:17388790	ABHD8	chr19:17402941-17414282:-	0.25	4.1	4.94E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs56028644	chr19:17388790	ANKLE1	chr19:17392454-17398454:+	0.29	4.96	1.0E-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs56028644	chr19:17388790	OCEL1	chr19:17337055-17340027:+	0.21	4.2	3.21E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs56030203	chr6:56783857	BEND6	chr6:56819773-56892138:+	-0.31	-6.73	4.73E-11	Menarche (age at onset)	
THCA	cis	1	rs56030203	chr6:56783857	KIAA1586	chr6:56911384-56920021:+	-0.34	-5.49	6.68E-8	Menarche (age at onset)	
THCA	cis	1	rs56040780	chr16:28861881	EIF3C	chr16:28722782-28747052:+;chr16	0.3	5.41	9.72E-8	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
THCA	cis	1	rs56040780	chr16:28861881	EIF3CL	chr16:28699879-28747052:+;chr16	0.52	10.48	2.77E-23	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
THCA	cis	1	rs56040780	chr16:28861881	SULT1A1	chr16:28616918-28634866:-	-0.17	-4.05	5.87E-5	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
THCA	cis	1	rs56040780	chr16:28861881	TUFM	chr16:28853732-28857729:-	0.31	11.07	1.62E-25	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
THCA	cis	1	rs56040865	chr7:127152442	GRM8	chr7:126078652-126893147:-	-0.35	-3.57	0.000394	Medication adherence in chronic diseases	
THCA	cis	1	rs56042615	chr5:437667	C5orf55	chr5:441645-443258:-	0.33	8.44	3.87E-16	Cystic fibrosis severity	
THCA	cis	1	rs56043407	chr17:2166078	SRR	chr17:2207248-2228553:+	-0.84	-17.62	6.87E-54	Esophageal cancer (squamous cell)	
THCA	cis	1	rs56052835	chr2:242243251	ANO7	chr2:242127924-242164791:+	0.36	4.22	2.97E-5	Prostate cancer	
THCA	cis	1	rs56052835	chr2:242243251	SEPT2	chr2:242254723-242293439:+	-0.29	-4.3	2.06E-5	Prostate cancer	
THCA	cis	1	rs56057198	chr17:61733332	FTSJ3	chr17:61896795-61905031:-	0.32	5.58	3.93E-8	Body mass index	
THCA	cis	1	rs56057198	chr17:61733332	MAP3K3	chr17:61699775-61773669:+	0.26	5.04	6.65E-7	Body mass index	
THCA	cis	1	rs56060721	chr7:127148448	GRM8	chr7:126078652-126893147:-	-0.35	-3.57	0.000398	Medication adherence in chronic diseases	
THCA	cis	1	rs56069856	chr20:3965709	MAVS	chr20:3827449-3856761:+	-0.22	-3.46	0.000596	Response to antidepressants in depression	
THCA	cis	1	rs56069965	chr15:50966973	SPPL2A	chr15:50999739-51057910:-	0.28	7.46	4.1E-13	QT interval	
THCA	cis	1	rs56077333	chr15:78899003	CHRNA5	chr15:78857906-78886458:+	-0.43	-8.72	4.74E-17	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs56080166	chr8:66795198	PDE7A	chr8:66629906-66753755:-	0.16	3.57	0.000391	Myopia (pathological)	
THCA	cis	1	rs56080544	chr15:50950970	SPPL2A	chr15:50999739-51057910:-	0.29	7.51	2.88E-13	QT interval	
THCA	cis	1	rs56083605	chr15:56512949	MNS1	chr15:56720929-56757335:-	-0.23	-3.41	0.000699	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs56083605	chr15:56512949	TEX9	chr15:56657644-56738071:+	-0.34	-5.84	9.5E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs56093876	chr19:19819115	ZNF14	chr19:19821281-19843921:-	0.24	4.74	2.84E-6	Toenail selenium levels	
THCA	cis	1	rs56098064	chr14:50105849	MGAT2	chr14:50087489-50090198:+	0.22	4.47	9.67E-6	Carotid intima media thickness	
THCA	cis	1	rs56098064	chr14:50105849	RPL36AL	chr14:50085407-50087349:-	0.53	15.51	3.15E-44	Carotid intima media thickness	
THCA	cis	1	rs56101873	chr1:119474790	WARS2	chr1:119573841-119683295:-	0.26	3.49	0.000532	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs56104203	chr2:86336256	LOC90784	chr2:86247339-86250991:-	-0.42	-4.38	1.49E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs56104584	chr5:437542	C5orf55	chr5:441645-443258:-	0.33	8.44	3.87E-16	Cystic fibrosis severity	
THCA	cis	1	rs56105592	chr2:17779641	GEN1	chr2:17935162-17966632:+	0.58	7.52	2.66E-13	Psychosis and Alzheimer's disease	
THCA	cis	1	rs56113315	chr19:39184166	LGALS7	chr19:39261608-39264157:-	-0.22	-4.61	5.1E-6	Heart rate	
THCA	cis	1	rs56118429	chr15:50923849	SPPL2A	chr15:50999739-51057910:-	0.26	7.04	6.76E-12	QT interval	
THCA	cis	1	rs56119980	chr4:39141010	KLHL5	chr4:39046659-39123828:+	-0.22	-6.04	3.18E-9	Uric acid levels	
THCA	cis	1	rs56121764	chr3:41883975	ULK4	chr3:41288091-42003660:-	1.04	19.01	1.99E-60	Diastolic blood pressure	
THCA	cis	1	rs56124423	chr3:119278163	ADPRH	chr3:119298523-119308791:+	-0.22	-3.66	0.000283	Vitiligo	
THCA	cis	1	rs56127630	chr3:49438036	GMPPB	chr3:49758932-49761384:-	0.17	3.86	0.000127	Menarche (age at onset)	
THCA	cis	1	rs56127630	chr3:49438036	P4HTM	chr3:49027341-49044579:+	-0.17	-4.27	2.4E-5	Menarche (age at onset)	
THCA	cis	1	rs56127630	chr3:49438036	WDR6	chr3:49044637-49053386:+	0.17	3.58	0.000384	Menarche (age at onset)	
THCA	cis	1	rs56128769	chr19:18302261	IL12RB1	chr19:18170371-18209626:-	-0.09	-3.35	0.000861	Multiple sclerosis	
THCA	cis	1	rs56131635	chr20:47774343	ARFGEF2	chr20:47538275-47653229:+	-0.12	-3.82	0.000154	Anger	
THCA	cis	1	rs56131635	chr20:47774343	CSE1L	chr20:47662838-47713484:+	0.4	10.02	1.36E-21	Anger	
THCA	cis	1	rs56139710	chr1:27269788	ZDHHC18	chr1:27153201-27182207:+	0.61	6.61	1.03E-10	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs56141565	chr20:3998603	C20orf194	chr20:3229948-3388587:-	-0.19	-3.36	0.000827	Response to antidepressants in depression	
THCA	cis	1	rs56141565	chr20:3998603	MAVS	chr20:3827449-3856761:+	-0.26	-3.8	0.000162	Response to antidepressants in depression	
THCA	cis	1	rs56145559	chr2:73623439	ALMS1P	chr2:73872046-73912692:+	0.7	10.8	1.8E-24	Schizophrenia	
THCA	cis	1	rs56145559	chr2:73623439	NAT8	chr2:73867850-73869537:-	0.38	5.92	6.12E-9	Schizophrenia	
THCA	cis	1	rs56148300	chr17:65892752	C17orf58	chr17:65987218-65989765:-	0.24	4.96	9.81E-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs56153133	chr1:11885647	CLCN6	chr1:11866207-11907674:+	0.16	3.51	0.000484	QRS complex (12-leadsum)	
THCA	cis	1	rs56154726	chr2:73721767	ALMS1P	chr2:73872046-73912692:+	0.76	11.76	3.13E-28	Metabolite levels	
THCA	cis	1	rs56154726	chr2:73721767	NAT8	chr2:73867850-73869537:-	0.4	6.16	1.55E-9	Metabolite levels	
THCA	cis	1	rs56156035	chr2:242205955	ANO7	chr2:242127924-242164791:+	0.37	4.34	1.76E-5	Prostate cancer	
THCA	cis	1	rs56156035	chr2:242205955	SEPT2	chr2:242254723-242293439:+	-0.28	-4.27	2.35E-5	Prostate cancer	
THCA	cis	1	rs56156930	chr15:56485411	MNS1	chr15:56720929-56757335:-	-0.24	-3.51	0.000493	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs56156930	chr15:56485411	TEX9	chr15:56657644-56738071:+	-0.35	-5.96	4.99E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs56158380	chr3:41885588	ULK4	chr3:41288091-42003660:-	1.04	19.01	1.99E-60	Diastolic blood pressure	
THCA	cis	1	rs56159542	chr19:19682971	HAPLN4	chr19:19366453-19384074:-	-0.31	-5.17	3.51E-7	Attention deficit hyperactivity disorder symptom score	
THCA	cis	1	rs56159542	chr19:19682971	YJEFN3	chr19:19639720-19648393:+	0.23	5.38	1.15E-7	Attention deficit hyperactivity disorder symptom score	
THCA	cis	1	rs56160723	chr10:91373631	FLJ37201	chr10:91451057-91457685:-	-0.17	-3.64	0.000301	Metabolic traits	
THCA	cis	1	rs56167434	chr2:282137	SH3YL1	chr2:218138-264810:-	-0.94	-25.62	9.65E-92	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs56167534	chr5:110431551	TSLP	chr5:110405778-110413722:+	-0.34	-4.41	1.25E-5	Eosinophil counts	
THCA	cis	1	rs56167534	chr5:110431551	WDR36	chr5:110427870-110466201:+	0.2	3.71	0.000234	Eosinophil counts	
THCA	cis	1	rs56168551	chr6:44104306	TMEM63B	chr6:44095376-44123255:+	0.15	3.46	0.000599	Major depressive disorder	
THCA	cis	1	rs56184857	chr1:119468861	WARS2	chr1:119573841-119683295:-	0.26	3.49	0.000532	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs56207540	chr3:41976627	ULK4	chr3:41288091-42003660:-	1.07	15.39	1.05E-43	Diastolic blood pressure	
THCA	cis	1	rs56215018	chr15:56526648	MNS1	chr15:56720929-56757335:-	-0.24	-3.51	0.000485	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs56215018	chr15:56526648	TEX9	chr15:56657644-56738071:+	-0.34	-5.81	1.12E-8	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs562179	chr11:116805204	PCSK7	chr11:117075789-117102811:-	-0.28	-4.96	9.75E-7	Protein quantitative trait loci	
THCA	cis	1	rs56221251	chr5:151733019	NMUR2	chr5:151771102-151784840:-	-0.51	-9.44	1.62E-19	Optic nerve measurement (cup area)	
THCA	cis	1	rs56222556	chr2:242364119	ANO7	chr2:242127924-242164791:+	0.32	3.8	0.000164	Prostate cancer	
THCA	cis	1	rs56222556	chr2:242364119	SEPT2	chr2:242254723-242293439:+	-0.31	-4.57	6.31E-6	Prostate cancer	
THCA	cis	1	rs56223710	chr2:70049715	SNRNP27	chr2:70121090-70132348:+	0.15	3.54	0.000434	Colorectal or endometrial cancer	
THCA	cis	1	rs56224502	chr7:118015311	ANKRD7	chr7:117864712-117882782:+	0.27	4.41	1.26E-5	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs56227395	chr2:54487496	C2orf73	chr2:54558071-54588714:+	0.33	4.93	1.15E-6	Telomere length	
THCA	cis	1	rs562469	chr11:71569843	FAM86C	chr11:71498557-71512276:+	-0.38	-4.6	5.47E-6	Severe influenza A (H1N1) infection	
THCA	cis	1	rs56255908	chr1:200724009	DDX59	chr1:200610119-200639126:-	-0.28	-4.16	3.79E-5	Epilepsy	
THCA	cis	1	rs56256440	chr10:79698207	DLG5	chr10:79550551-79686348:-	0.22	3.56	0.000404	Liver enzyme levels (gamma-glutamyl transferase)	
THCA	cis	1	rs56261906	chr8:57158479	LYN	chr8:56792386-56923936:+	-0.15	-3.86	0.000127	Height	
THCA	cis	1	rs56270432	chr3:10087517	C3orf10	chr3:10157333-10168873:+	-0.19	-4.12	4.51E-5	Alzheimer's disease	
THCA	cis	1	rs56270432	chr3:10087517	VHL	chr3:10183319-10193744:+	-0.17	-4.04	6.27E-5	Alzheimer's disease	
THCA	cis	1	rs56273250	chr1:111675762	DRAM2	chr1:111659955-111682838:-	-0.29	-4.47	9.79E-6	Liver enzyme levels (gamma-glutamyl transferase)	
THCA	cis	1	rs56280226	chr17:28429575	ANKRD13B	chr17:27916801-27941778:+	0.36	8.87	1.41E-17	Coffee consumption (cups per day)	
THCA	cis	1	rs56280226	chr17:28429575	CORO6	chr17:27941774-27948441:-	0.51	12.06	1.98E-29	Coffee consumption (cups per day)	
THCA	cis	1	rs56280226	chr17:28429575	EFCAB5	chr17:28256874-28435469:+	0.59	11.31	2.0E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs56280226	chr17:28429575	GIT1	chr17:27900487-27916610:-	0.28	6.66	7.53E-11	Coffee consumption (cups per day)	
THCA	cis	1	rs56280226	chr17:28429575	LRRC37B2	chr17:28903483-28992715:+	0.17	3.65	0.000288	Coffee consumption (cups per day)	
THCA	cis	1	rs56280226	chr17:28429575	SSH2	chr17:27952965-28257018:-	0.35	8.14	3.41E-15	Coffee consumption (cups per day)	
THCA	cis	1	rs56280226	chr17:28429575	TP53I13	chr17:27895739-27900174:+	0.19	5.21	2.88E-7	Coffee consumption (cups per day)	
THCA	cis	1	rs56287882	chr3:128030343	EEFSEC	chr3:127872313-128127488:+	-0.22	-3.87	0.000123	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs56291018	chr7:65390339	CCT6P1	chr7:65216092-65228661:+	0.41	6.41	3.44E-10	Diabetic kidney disease	
THCA	cis	1	rs56291018	chr7:65390339	CRCP	chr7:65579805-65619551:+	-0.26	-3.95	9.06E-5	Diabetic kidney disease	
THCA	cis	1	rs56291018	chr7:65390339	RABGEF1	chr7:66093890-66276446:+	0.53	6.46	2.51E-10	Diabetic kidney disease	
THCA	cis	1	rs56295584	chr12:45931742	LOC400027	chr12:46119810-46121530:-	0.12	3.35	0.000867	Hypertension	
THCA	cis	1	rs56295991	chr7:118196744	ANKRD7	chr7:117864712-117882782:+	0.23	3.78	0.000173	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs56297666	chr2:160902023	LY75	chr2:160625141-160761262:-	0.21	4.84	1.74E-6	Idiopathic membranous nephropathy	
THCA	cis	1	rs56306402	chr20:33937704	CPNE1	chr20:34213968-34262539:-	0.3	5.88	7.84E-9	Height	
THCA	cis	1	rs56306402	chr20:33937704	GDF5	chr20:33897002-34042568:-	-0.17	-3.74	0.000207	Height	
THCA	cis	1	rs56306402	chr20:33937704	UQCC	chr20:33890383-33999833:-	0.32	10.18	3.81E-22	Height	
THCA	cis	1	rs56314138	chr3:121356656	IQCB1	chr3:121488610-121553926:-	0.53	10.23	2.43E-22	Cognitive performance	
THCA	cis	1	rs56317427	chr10:81861934	MBL1P	chr10:81664654-81710783:+	0.35	5.41	9.95E-8	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs56317427	chr10:81861934	PLAC9	chr10:81892258-81904784:+	-0.23	-4.95	1.03E-6	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs56317427	chr10:81861934	SFTPD	chr10:81697498-81708861:-	0.27	3.4	0.000733	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs56317427	chr10:81861934	TSPAN14	chr10:82214038-82282390:+	0.22	3.49	0.000537	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs56321614	chr2:268191	SH3YL1	chr2:218138-264810:-	-0.93	-25.71	3.43E-92	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs56324438	chr8:89440456	MMP16	chr8:89049462-89339717:-	0.33	5.32	1.57E-7	Electrodermal activity	
THCA	cis	1	rs56324992	chr20:3978153	MAVS	chr20:3827449-3856761:+	-0.25	-3.94	9.33E-5	Response to antidepressants in depression	
THCA	cis	1	rs56326127	chr2:86212201	POLR1A	chr2:86253453-86333278:-	-0.27	-3.68	0.000256	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs56328893	chr3:128041830	EEFSEC	chr3:127872313-128127488:+	-0.22	-3.76	0.000188	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs56335217	chr20:47871197	DDX27	chr20:47835832-47860612:+	0.27	4.9	1.33E-6	Height	
THCA	cis	1	rs56336128	chr11:8908299	TMEM9B	chr11:8968840-8986481:-	-0.24	-4.47	9.9E-6	Schizophrenia	
THCA	cis	1	rs56337141	chr16:50092690	HEATR3	chr16:50099881-50139373:+	-0.4	-6.21	1.16E-9	Esophageal cancer (squamous cell)	
THCA	cis	1	rs56348638	chr17:53064550	STXBP4	chr17:53046126-53241449:+	-0.15	-4.18	3.4E-5	Breast cancer	
THCA	cis	1	rs56348638	chr17:53064550	TOM1L1	chr17:52978052-53039328:+	-0.13	-3.37	0.000824	Breast cancer	
THCA	cis	1	rs56352995	chr6:42500457	PRPH2	chr6:42664334-42690358:-	-0.29	-3.85	0.000135	Obesity-related traits	
THCA	cis	1	rs56363214	chr2:242227157	ANO7	chr2:242127924-242164791:+	0.36	4.22	2.97E-5	Prostate cancer	
THCA	cis	1	rs56363214	chr2:242227157	SEPT2	chr2:242254723-242293439:+	-0.29	-4.3	2.06E-5	Prostate cancer	
THCA	cis	1	rs56363533	chr20:33626005	PROCR	chr20:33758727-33765164:+	-0.34	-5.57	4.16E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs56364559	chr7:77480561	PTPN12	chr7:77166773-77269388:+	-0.17	-3.74	0.000207	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs56364559	chr7:77480561	RSBN1L	chr7:77325743-77409120:+	0.15	3.66	0.000282	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs56372340	chr2:9741536	IAH1	chr2:9614670-9636671:+	0.16	3.42	0.000688	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	
THCA	cis	1	rs56383420	chr2:242219281	ANO7	chr2:242127924-242164791:+	0.36	4.22	2.97E-5	Prostate cancer	
THCA	cis	1	rs56383420	chr2:242219281	SEPT2	chr2:242254723-242293439:+	-0.29	-4.3	2.06E-5	Prostate cancer	
THCA	cis	1	rs56383601	chr17:61929968	FTSJ3	chr17:61896795-61905031:-	0.3	5.59	3.92E-8	Body mass index	
THCA	cis	1	rs56383601	chr17:61929968	MAP3K3	chr17:61699775-61773669:+	0.26	5.13	4.21E-7	Body mass index	
THCA	cis	1	rs56386221	chr3:69796492	MITF	chr3:69788633-70017486:+	0.3	5.17	3.46E-7	QRS complex (12-leadsum)	
THCA	cis	1	rs56390833	chr15:78877381	CHRNA5	chr15:78857906-78886458:+	-0.42	-8.23	1.73E-15	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs56391092	chr11:120010550	TRIM29	chr11:119981995-120008863:-	0.41	6.38	4.24E-10	Stroke (pediatric)	
THCA	cis	1	rs563920	chr12:121017439	COQ5	chr12:120941083-120966964:-	0.14	3.54	0.000439	Type 1 diabetes nephropathy	
THCA	cis	1	rs563920	chr12:121017439	POP5	chr12:121016849-121019201:-	-0.16	-4.85	1.69E-6	Type 1 diabetes nephropathy	
THCA	cis	1	rs56392198	chr1:179451124	C1orf125	chr1:179335107-179523868:+	0.58	6.12	1.94E-9	Multiple sclerosis (age of onset)	
THCA	cis	1	rs56393562	chr17:65933918	C17orf58	chr17:65987218-65989765:-	0.19	3.8	0.000161	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs56394211	chr10:17186447	TRDMT1	chr10:17184983-17243681:-	-0.42	-9.61	4.08E-20	Homocysteine levels	
THCA	cis	1	rs56394721	chr3:10150795	C3orf10	chr3:10157333-10168873:+	-0.21	-4.44	1.14E-5	Alzheimer's disease	
THCA	cis	1	rs56394721	chr3:10150795	VHL	chr3:10183319-10193744:+	-0.2	-4.5	8.62E-6	Alzheimer's disease	
THCA	cis	1	rs56396205	chr15:31678385	CHRFAM7A	chr15:30653443-30685864:-	-0.35	-3.5	0.00051	Survival in colorectal cancer (non-distant metastatic)	
THCA	cis	1	rs56396205	chr15:31678385	FAM7A2	chr15:30864758-30892900:+	-0.51	-4.54	7.03E-6	Survival in colorectal cancer (non-distant metastatic)	
THCA	cis	1	rs56396864	chr15:53957539	WDR72	chr15:53805938-54051859:-	0.16	3.74	0.000203	Chronic kidney disease;Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs56397023	chr5:125915779	ALDH7A1	chr5:125878918-125931082:-	0.45	6.56	1.38E-10	Osteoporosis	
THCA	cis	1	rs56398703	chr15:56519486	MNS1	chr15:56720929-56757335:-	-0.24	-3.51	0.000485	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs56398703	chr15:56519486	TEX9	chr15:56657644-56738071:+	-0.34	-5.81	1.12E-8	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs56400413	chr7:77340821	PTPN12	chr7:77166773-77269388:+	-0.17	-3.97	8.42E-5	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs56402416	chr12:51357791	SLC11A2	chr12:51373319-51422058:-	-0.24	-4.83	1.87E-6	Type 2 diabetes	
THCA	cis	1	rs56402416	chr12:51357791	TFCP2	chr12:51488608-51566917:-	-0.2	-4.28	2.25E-5	Type 2 diabetes	
THCA	cis	1	rs56404791	chr17:65893019	C17orf58	chr17:65987218-65989765:-	0.24	4.98	8.83E-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs565974	chr10:131423274	MGMT	chr10:131265454-131565783:+	0.38	11.31	1.9E-26	Response to temozolomide	
THCA	cis	1	rs56660916	chr14:104126137	KLC1	chr14:104029299-104167887:+	-0.22	-4.55	6.7E-6	Body mass index	
THCA	cis	1	rs56672945	chr2:73622663	ALMS1P	chr2:73872046-73912692:+	0.7	11.05	1.95E-25	Metabolite levels	
THCA	cis	1	rs56672945	chr2:73622663	NAT8	chr2:73867850-73869537:-	0.39	6.11	2.09E-9	Metabolite levels	
THCA	cis	1	rs56702977	chr15:42671308	LRRC57	chr15:42834722-42841002:-	0.19	3.81	0.000155	Fibrinogen levels	
THCA	cis	1	rs56763150	chr6:24482999	GPLD1	chr6:24428405-24489850:-	0.2	3.75	0.0002	Hematological and biochemical traits	
THCA	cis	1	rs56763150	chr6:24482999	MRS2	chr6:24403153-24425809:+	0.24	5.35	1.35E-7	Hematological and biochemical traits	
THCA	cis	1	rs567700	chr10:131423126	MGMT	chr10:131265454-131565783:+	0.38	11.31	1.9E-26	Response to temozolomide	
THCA	cis	1	rs56775891	chr18:77575613	C18orf22	chr18:77794358-77853788:+	0.14	3.69	0.000249	Schizophrenia	
THCA	cis	1	rs56776628	chr3:41866856	ULK4	chr3:41288091-42003660:-	1.05	19.9	1.26E-64	Diastolic blood pressure	
THCA	cis	1	rs56808319	chr19:52577874	ZNF432	chr19:52536678-52552073:-	-0.18	-4.57	6.29E-6	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	
THCA	cis	1	rs568129	chr6:84229114	SNAP91	chr6:84262607-84419127:-	-0.18	-3.71	0.000232	Bipolar disorder with mood-incongruent psychosis	
THCA	cis	1	rs56818101	chr2:17776053	GEN1	chr2:17935162-17966632:+	0.51	6.86	2.08E-11	Psychosis and Alzheimer's disease	
THCA	cis	1	rs568489	chr12:121094241	P2RX4	chr12:121647664-121671907:+	0.16	3.48	0.00055	C-reactive protein levels or triglyceride levels (pleiotropy)	
THCA	cis	1	rs56850662	chr3:128061922	EEFSEC	chr3:127872313-128127488:+	-0.23	-3.99	7.56E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs568617	chr11:65653242	CTSW	chr11:65647284-65651212:+	-0.6	-15.88	6.69E-46	Crohn's disease	
THCA	cis	1	rs568617	chr11:65653242	SNX32	chr11:65601410-65621170:+	0.63	9.47	1.33E-19	Crohn's disease	
THCA	cis	1	rs56864281	chr15:85357649	GOLGA6L5	chr15:85047738-85060078:-	-0.15	-4	7.44E-5	Schizophrenia	
THCA	cis	1	rs56864281	chr15:85357649	LOC388152	chr15:84867600-84898920:-	-0.47	-7.81	3.69E-14	Schizophrenia	
THCA	cis	1	rs56864281	chr15:85357649	NMB	chr15:85198362-85201802:-	0.37	7.8	3.92E-14	Schizophrenia	
THCA	cis	1	rs56884994	chr1:247211057	OR2T8	chr1:248084320-248085256:+	-0.19	-3.64	0.000299	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs56884994	chr1:247211057	OR2W3	chr1:248031265-248060142:+	-0.17	-3.34	0.000889	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs56901035	chr8:96043188	C8orf38	chr8:95908040-96088396:+	-0.26	-4.56	6.5E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs569044	chr11:119999191	TRIM29	chr11:119981995-120008863:-	-0.39	-5.77	1.44E-8	Stroke (pediatric)	
THCA	cis	1	rs56912549	chr8:89365835	MMP16	chr8:89049462-89339717:-	0.31	4.88	1.48E-6	Electrodermal activity	
THCA	cis	1	rs569214	chr8:27487790	PNOC	chr8:28174649-28200866:+	-0.13	-3.75	0.000199	Alzheimer's disease	
THCA	cis	1	rs56922390	chr17:38157021	GSDMA	chr17:38119226-38134019:+	-0.32	-7.28	1.39E-12	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THCA	cis	1	rs569235	chr10:131411620	MGMT	chr10:131265454-131565783:+	0.38	11.44	5.83E-27	Response to temozolomide	
THCA	cis	1	rs56932185	chr1:27056643	ZDHHC18	chr1:27153201-27182207:+	0.8	8.6	1.15E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs56945350	chr14:55176082	SAMD4A	chr14:55034637-55260033:+	-0.4	-4.44	1.11E-5	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs56949084	chr7:107157387	DLD	chr7:107531586-107561642:+	0.14	3.43	0.000644	Osteoarthritis	
THCA	cis	1	rs569557	chr13:113769917	F7	chr13:113760105-113774994:+	-0.27	-3.91	0.000106	End-stage coagulation	
THCA	cis	1	rs569856	chr10:105942304	C10orf79	chr10:105889647-105992120:-	0.25	8.09	4.8E-15	Attention deficit hyperactivity disorder	
THCA	cis	1	rs56985706	chr7:65394562	CCT6P1	chr7:65216092-65228661:+	0.38	6	3.93E-9	Diabetic kidney disease	
THCA	cis	1	rs56985706	chr7:65394562	CRCP	chr7:65579805-65619551:+	-0.26	-4	7.24E-5	Diabetic kidney disease	
THCA	cis	1	rs56985706	chr7:65394562	RABGEF1	chr7:66093890-66276446:+	0.55	6.89	1.73E-11	Diabetic kidney disease	
THCA	cis	1	rs56987357	chr14:88824363	SPATA7	chr14:88852012-88904802:+	-0.17	-3.48	0.000542	Coronary artery calcification	
THCA	cis	1	rs569967	chr10:105942337	C10orf79	chr10:105889647-105992120:-	0.25	8.09	4.8E-15	Attention deficit hyperactivity disorder	
THCA	cis	1	rs57001853	chr5:150272452	LOC134466	chr5:150310000-150326146:-	0.39	5.41	9.98E-8	Crohn's disease	
THCA	cis	1	rs57002197	chr15:50873760	SPPL2A	chr15:50999739-51057910:-	0.28	7.33	9.59E-13	QT interval	
THCA	cis	1	rs57012661	chr14:66172750	LOC645431	chr14:65877313-65879335:-	-0.51	-6.65	8.22E-11	Ischemic stroke	
THCA	cis	1	rs57012996	chr11:47194924	MADD	chr11:47290927-47351582:+	0.28	3.44	0.00063	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs57025426	chr10:102205868	SEC31B	chr10:102246403-102289636:-	-0.3	-10.21	2.82E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs57040657	chr8:89414990	MMP16	chr8:89049462-89339717:-	0.32	4.96	9.78E-7	Electrodermal activity	
THCA	cis	1	rs57053582	chr8:94071156	C8orf83	chr8:93895865-94029901:-	0.27	4.43	1.19E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs57057549	chr7:65405738	CCT6P1	chr7:65216092-65228661:+	0.41	6.45	2.67E-10	Diabetic kidney disease	
THCA	cis	1	rs57057549	chr7:65405738	CRCP	chr7:65579805-65619551:+	-0.28	-4.24	2.64E-5	Diabetic kidney disease	
THCA	cis	1	rs57057549	chr7:65405738	RABGEF1	chr7:66093890-66276446:+	0.53	6.38	4.25E-10	Diabetic kidney disease	
THCA	cis	1	rs57060498	chr2:54479230	C2orf73	chr2:54558071-54588714:+	0.29	4.14	4.1E-5	Telomere length	
THCA	cis	1	rs57075379	chr14:35577801	FAM177A1	chr14:35514113-35552587:+	-0.2	-3.76	0.000191	Atopic dermatitis	
THCA	cis	1	rs57075379	chr14:35577801	KIAA0391	chr14:35591776-35786673:+	0.31	5.74	1.65E-8	Atopic dermatitis	
THCA	cis	1	rs57075379	chr14:35577801	PPP2R3C	chr14:35554679-35591679:-	0.54	10.32	1.13E-22	Atopic dermatitis	
THCA	cis	1	rs57083584	chr2:86283648	POLR1A	chr2:86253453-86333278:-	-0.3	-3.78	0.000177	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs57092235	chr8:89451205	MMP16	chr8:89049462-89339717:-	0.32	5.23	2.52E-7	Electrodermal activity	
THCA	cis	1	rs57110085	chr16:77783313	NUDT7	chr16:77756411-77776153:+	0.36	4.92	1.21E-6	Obesity-related traits	
THCA	cis	1	rs57139546	chr6:44067745	TMEM63B	chr6:44095376-44123255:+	0.16	3.57	0.000397	Major depressive disorder	
THCA	cis	1	rs57165742	chr8:124184559	FAM83A	chr8:124191287-124222317:+	-0.34	-4.25	2.56E-5	Urinary uromodulin levels	
THCA	cis	1	rs57185954	chr17:46844961	CALCOCO2	chr17:46908372-46942228:+	-0.13	-3.5	0.000501	Schizophrenia or bipolar disorder	
THCA	cis	1	rs57185954	chr17:46844961	SNF8	chr17:47007461-47022154:-	-0.25	-7.39	6.82E-13	Schizophrenia or bipolar disorder	
THCA	cis	1	rs57185954	chr17:46844961	UBE2Z	chr17:46985767-47006422:+	-0.19	-4.01	6.91E-5	Schizophrenia or bipolar disorder	
THCA	cis	1	rs57196672	chr2:242235193	ANO7	chr2:242127924-242164791:+	0.36	4.26	2.5E-5	Prostate cancer	
THCA	cis	1	rs57196672	chr2:242235193	SEPT2	chr2:242254723-242293439:+	-0.28	-4.22	2.9E-5	Prostate cancer	
THCA	cis	1	rs57201867	chr14:66093872	LOC645431	chr14:65877313-65879335:-	-0.61	-7.58	1.81E-13	Ischemic stroke	
THCA	cis	1	rs57214110	chr11:93668910	HEPHL1	chr11:93754378-93847374:+	0.43	3.86	0.000131	Obesity-related traits	
THCA	cis	1	rs57217461	chr1:27027916	ZDHHC18	chr1:27153201-27182207:+	0.8	8.35	7.37E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs57218990	chr14:104128007	KLC1	chr14:104029299-104167887:+	-0.22	-4.37	1.55E-5	Body mass index	
THCA	cis	1	rs57228217	chr6:42498342	PRPH2	chr6:42664334-42690358:-	-0.29	-3.85	0.000135	Obesity-related traits	
THCA	cis	1	rs57234614	chr2:9756379	IAH1	chr2:9614670-9636671:+	0.16	3.53	0.000461	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	
THCA	cis	1	rs57269846	chr5:76529965	PDE8B	chr5:76506706-76723226:+	0.11	3.55	0.000419	Thyroid hormone levels	
THCA	cis	1	rs57283474	chr8:89410289	MMP16	chr8:89049462-89339717:-	0.31	5.04	6.5E-7	Electrodermal activity	
THCA	cis	1	rs57294261	chr10:81729342	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs57307201	chr17:40572793	NAGLU	chr17:40687951-40696464:+	-0.23	-4.91	1.23E-6	Crohn's disease	
THCA	cis	1	rs57307201	chr17:40572793	TUBG2	chr17:40811266-40819023:+	-0.23	-5.54	4.99E-8	Crohn's disease	
THCA	cis	1	rs57311533	chr8:89582889	MMP16	chr8:89049462-89339717:-	0.16	3.69	0.000254	Body mass index and cholesterol (psychopharmacological treatment)	
THCA	cis	1	rs57311859	chr11:18454410	LDHC	chr11:18433853-18472792:+	-0.3	-3.51	0.000484	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs573211	chr11:120044762	TRIM29	chr11:119981995-120008863:-	-0.14	-3.38	0.000777	Corneal curvature	
THCA	cis	1	rs57322232	chr8:124193532	FAM83A	chr8:124191287-124222317:+	-0.29	-3.98	7.99E-5	Urinary uromodulin levels	
THCA	cis	1	rs57367718	chr11:93668567	HEPHL1	chr11:93754378-93847374:+	0.47	4.13	4.27E-5	Obesity-related traits	
THCA	cis	1	rs573890	chr11:108251363	ATM	chr11:108093559-108239826:+	0.11	3.67	0.00027	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
THCA	cis	1	rs57398459	chr2:86291326	LOC90784	chr2:86247339-86250991:-	-0.36	-3.43	0.000645	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs57398459	chr2:86291326	POLR1A	chr2:86253453-86333278:-	-0.29	-3.78	0.000176	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs57411618	chr17:28273052	ANKRD13B	chr17:27916801-27941778:+	0.37	9.19	1.19E-18	Coffee consumption (cups per day)	
THCA	cis	1	rs57411618	chr17:28273052	CORO6	chr17:27941774-27948441:-	0.51	12.08	1.59E-29	Coffee consumption (cups per day)	
THCA	cis	1	rs57411618	chr17:28273052	EFCAB5	chr17:28256874-28435469:+	0.59	11.28	2.54E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs57411618	chr17:28273052	GIT1	chr17:27900487-27916610:-	0.3	6.98	9.68E-12	Coffee consumption (cups per day)	
THCA	cis	1	rs57411618	chr17:28273052	LRRC37B2	chr17:28903483-28992715:+	0.18	3.93	9.65E-5	Coffee consumption (cups per day)	
THCA	cis	1	rs57411618	chr17:28273052	SSH2	chr17:27952965-28257018:-	0.33	7.59	1.64E-13	Coffee consumption (cups per day)	
THCA	cis	1	rs57411618	chr17:28273052	TP53I13	chr17:27895739-27900174:+	0.2	5.46	7.66E-8	Coffee consumption (cups per day)	
THCA	cis	1	rs57415683	chr13:36684221	SOHLH2	chr13:36742347-36871992:-	0.32	4.34	1.72E-5	Optic cup area	
THCA	cis	1	rs5743030	chr2:190678545	ASNSD1	chr2:190526125-190535556:+	-0.69	-7.33	9.94E-13	Subcutaneous adipose tissue	
THCA	cis	1	rs5743030	chr2:190678545	ORMDL1	chr2:190634994-190649097:-	0.23	3.42	0.000686	Subcutaneous adipose tissue	
THCA	cis	1	rs5743044	chr2:190683265	ASNSD1	chr2:190526125-190535556:+	-0.68	-6.62	9.54E-11	Subcutaneous adipose tissue	
THCA	cis	1	rs5743112	chr2:190708982	ASNSD1	chr2:190526125-190535556:+	-0.57	-5.94	5.52E-9	Subcutaneous adipose tissue	
THCA	cis	1	rs5743117	chr2:190714245	ASNSD1	chr2:190526125-190535556:+	-0.59	-6.38	4.25E-10	Subcutaneous adipose tissue	
THCA	cis	1	rs5743202	chr2:190742666	ASNSD1	chr2:190526125-190535556:+	-0.6	-5.85	8.96E-9	Subcutaneous adipose tissue	
THCA	cis	1	rs5743208	chr2:190743048	ASNSD1	chr2:190526125-190535556:+	0.54	5.86	8.48E-9	Subcutaneous adipose tissue	
THCA	cis	1	rs57434520	chr5:115648765	COMMD10	chr5:115420727-115628978:+	0.39	6.08	2.39E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs5744249	chr11:112025306	BCO2	chr11:112046208-112095421:+	0.22	4.36	1.59E-5	Interleukin-18 levels	
THCA	cis	1	rs5744249	chr11:112025306	IL18	chr11:112013976-112034840:-	-0.24	-4.45	1.06E-5	Interleukin-18 levels	
THCA	cis	1	rs5744256	chr11:112022848	BCO2	chr11:112046208-112095421:+	0.23	4.59	5.61E-6	Interleukin-18 levels	
THCA	cis	1	rs5744256	chr11:112022848	IL18	chr11:112013976-112034840:-	-0.24	-4.51	8.25E-6	Interleukin-18 levels	
THCA	cis	1	rs5744258	chr11:112021767	BCO2	chr11:112046208-112095421:+	0.23	4.54	7.15E-6	Interleukin-18 levels	
THCA	cis	1	rs5744258	chr11:112021767	IL18	chr11:112013976-112034840:-	-0.24	-4.54	7.12E-6	Interleukin-18 levels	
THCA	cis	1	rs5745327	chr1:76270040	ACADM	chr1:76190043-76229353:+	0.22	4.56	6.6E-6	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs5745343	chr1:76273805	ACADM	chr1:76190043-76229353:+	0.23	4.84	1.77E-6	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs5745354	chr1:76275178	ACADM	chr1:76190043-76229353:+	0.22	4.68	3.66E-6	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs5745392	chr1:76306809	ACADM	chr1:76190043-76229353:+	-0.25	-5.03	6.99E-7	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs5745542	chr1:76365073	ACADM	chr1:76190043-76229353:+	-0.25	-5.04	6.74E-7	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs5745568	chr6:33548394	C6orf227	chr6:33553883-33561115:-	-0.23	-3.98	8.1E-5	Platelet count	
THCA	cis	1	rs5745582	chr6:33546498	C6orf227	chr6:33553883-33561115:-	-0.21	-3.75	0.000197	Platelet count	
THCA	cis	1	rs57461652	chr11:118146197	AMICA1	chr11:118064442-118095809:-	0.08	4.01	7.05E-5	Pain	
THCA	cis	1	rs57461652	chr11:118146197	MPZL2	chr11:118124135-118135009:-	0.23	7.86	2.62E-14	Pain	
THCA	cis	1	rs57461652	chr11:118146197	TREH	chr11:118528942-118550381:-	-0.17	-3.39	0.000746	Pain	
THCA	cis	1	rs57479675	chr3:41798038	ULK4	chr3:41288091-42003660:-	1.09	19.98	5.2E-65	Diastolic blood pressure	
THCA	cis	1	rs57493332	chr11:96115556	CCDC82	chr11:96085930-96123083:-	-0.24	-3.59	0.000363	Parkinson's disease	
THCA	cis	1	rs5750621	chr22:38956166	JOSD1	chr22:39081549-39096459:-	-0.16	-4.11	4.7E-5	Resting heart rate	
THCA	cis	1	rs5750621	chr22:38956166	TOMM22	chr22:39077954-39080763:+	-0.2	-4.35	1.67E-5	Resting heart rate	
THCA	cis	1	rs5750622	chr22:38956464	JOSD1	chr22:39081549-39096459:-	-0.15	-4.04	6.14E-5	Resting heart rate	
THCA	cis	1	rs5750622	chr22:38956464	TOMM22	chr22:39077954-39080763:+	-0.19	-4.23	2.76E-5	Resting heart rate	
THCA	cis	1	rs5750626	chr22:38977890	JOSD1	chr22:39081549-39096459:-	-0.14	-3.66	0.000276	Resting heart rate	
THCA	cis	1	rs5750626	chr22:38977890	LOC646851	chr22:38974125-39052634:-	0.13	3.5	0.000506	Resting heart rate	
THCA	cis	1	rs5750626	chr22:38977890	TOMM22	chr22:39077954-39080763:+	-0.17	-3.68	0.00026	Resting heart rate	
THCA	cis	1	rs5750627	chr22:38982321	LOC646851	chr22:38974125-39052634:-	0.14	3.74	0.000209	Resting heart rate	
THCA	cis	1	rs5750627	chr22:38982321	TOMM22	chr22:39077954-39080763:+	-0.17	-3.82	0.000149	Resting heart rate	
THCA	cis	1	rs5750630	chr22:38985818	JOSD1	chr22:39081549-39096459:-	-0.16	-4.24	2.72E-5	Resting heart rate	
THCA	cis	1	rs5750630	chr22:38985818	TOMM22	chr22:39077954-39080763:+	-0.2	-4.3	2.08E-5	Resting heart rate	
THCA	cis	1	rs5750633	chr22:38993467	LOC646851	chr22:38974125-39052634:-	0.14	3.86	0.000131	Resting heart rate	
THCA	cis	1	rs5750633	chr22:38993467	TOMM22	chr22:39077954-39080763:+	-0.16	-3.52	0.000471	Resting heart rate	
THCA	cis	1	rs57506367	chr11:118141993	AMICA1	chr11:118064442-118095809:-	0.09	4.1	4.81E-5	Pain	
THCA	cis	1	rs57506367	chr11:118141993	MPZL2	chr11:118124135-118135009:-	0.23	7.67	9.93E-14	Pain	
THCA	cis	1	rs57506367	chr11:118141993	TREH	chr11:118528942-118550381:-	-0.17	-3.37	0.000816	Pain	
THCA	cis	1	rs5750649	chr22:39036769	LOC646851	chr22:38974125-39052634:-	0.13	3.54	0.000435	Resting heart rate	
THCA	cis	1	rs5750649	chr22:39036769	TOMM22	chr22:39077954-39080763:+	-0.17	-3.67	0.000267	Resting heart rate	
THCA	cis	1	rs5750652	chr22:39048316	LOC646851	chr22:38974125-39052634:-	0.13	3.54	0.000435	Resting heart rate	
THCA	cis	1	rs5750652	chr22:39048316	TOMM22	chr22:39077954-39080763:+	-0.17	-3.67	0.000267	Resting heart rate	
THCA	cis	1	rs5750659	chr22:39068789	JOSD1	chr22:39081549-39096459:-	-0.15	-3.86	0.000127	Resting heart rate	
THCA	cis	1	rs5750659	chr22:39068789	LOC646851	chr22:38974125-39052634:-	0.13	3.43	0.000646	Resting heart rate	
THCA	cis	1	rs5750659	chr22:39068789	TOMM22	chr22:39077954-39080763:+	-0.16	-3.49	0.000525	Resting heart rate	
THCA	cis	1	rs5750662	chr22:39072472	JOSD1	chr22:39081549-39096459:-	-0.15	-3.89	0.000115	Resting heart rate	
THCA	cis	1	rs5750662	chr22:39072472	LOC646851	chr22:38974125-39052634:-	0.13	3.4	0.000739	Resting heart rate	
THCA	cis	1	rs5750662	chr22:39072472	TOMM22	chr22:39077954-39080763:+	-0.16	-3.55	0.000423	Resting heart rate	
THCA	cis	1	rs5750664	chr22:39072769	JOSD1	chr22:39081549-39096459:-	-0.15	-3.89	0.000115	Resting heart rate	
THCA	cis	1	rs5750664	chr22:39072769	LOC646851	chr22:38974125-39052634:-	0.13	3.4	0.000739	Resting heart rate	
THCA	cis	1	rs5750664	chr22:39072769	TOMM22	chr22:39077954-39080763:+	-0.16	-3.55	0.000423	Resting heart rate	
THCA	cis	1	rs5750668	chr22:39079964	JOSD1	chr22:39081549-39096459:-	-0.15	-3.84	0.000138	Resting heart rate	
THCA	cis	1	rs5750668	chr22:39079964	LOC646851	chr22:38974125-39052634:-	0.13	3.36	0.000836	Resting heart rate	
THCA	cis	1	rs5750668	chr22:39079964	TOMM22	chr22:39077954-39080763:+	-0.16	-3.44	0.000633	Resting heart rate	
THCA	cis	1	rs5750669	chr22:39080638	JOSD1	chr22:39081549-39096459:-	-0.14	-3.59	0.000366	Resting heart rate	
THCA	cis	1	rs5750669	chr22:39080638	LOC646851	chr22:38974125-39052634:-	0.14	3.62	0.00033	Resting heart rate	
THCA	cis	1	rs5750671	chr22:39094619	LOC646851	chr22:38974125-39052634:-	0.14	3.64	0.000308	Resting heart rate	
THCA	cis	1	rs5750671	chr22:39094619	TOMM22	chr22:39077954-39080763:+	-0.16	-3.45	0.000615	Resting heart rate	
THCA	cis	1	rs5750672	chr22:39104168	GTPBP1	chr22:39101807-39129590:+	0.16	3.59	0.000363	Resting heart rate	
THCA	cis	1	rs5750672	chr22:39104168	JOSD1	chr22:39081549-39096459:-	0.19	5.24	2.46E-7	Resting heart rate	
THCA	cis	1	rs5750672	chr22:39104168	TOMM22	chr22:39077954-39080763:+	0.25	5.48	6.77E-8	Resting heart rate	
THCA	cis	1	rs5750673	chr22:39110124	JOSD1	chr22:39081549-39096459:-	-0.16	-4.04	6.27E-5	Resting heart rate	
THCA	cis	1	rs5750673	chr22:39110124	TOMM22	chr22:39077954-39080763:+	-0.16	-3.37	0.000827	Resting heart rate	
THCA	cis	1	rs5750677	chr22:39147715	LOC646851	chr22:38974125-39052634:-	0.18	4.58	5.99E-6	Resting heart rate	
THCA	cis	1	rs5750677	chr22:39147715	SUN2	chr22:39130735-39190161:-	0.15	3.58	0.000377	Resting heart rate	
THCA	cis	1	rs5751255	chr22:42648408	C22orf32	chr22:42475699-42480287:+	0.2	5.29	1.85E-7	Cognitive function	
THCA	cis	1	rs5751255	chr22:42648408	CCDC134	chr22:42196678-42222303:+	0.21	3.97	8.28E-5	Cognitive function	
THCA	cis	1	rs5751255	chr22:42648408	CYP2D6	chr22:42522502-42526883:-	-0.41	-10.76	2.6E-24	Cognitive function	
THCA	cis	1	rs5751255	chr22:42648408	NAGA	chr22:42454339-42466846:-	0.35	7.6	1.55E-13	Cognitive function	
THCA	cis	1	rs5751255	chr22:42648408	WBP2NL	chr22:42120334-42454460:+	0.23	4.31	2.02E-5	Cognitive function	
THCA	cis	1	rs57512806	chr2:17776078	GEN1	chr2:17935162-17966632:+	0.51	6.8	3.05E-11	Psychosis and Alzheimer's disease	
THCA	cis	1	rs57514701	chr10:1146169	IDI2	chr10:1064847-1071799:-	0.34	3.55	0.000417	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs5751589	chr22:23475762	GNAZ	chr22:23412669-23467221:+	0.29	6.19	1.26E-9	Bone mineral density	
THCA	cis	1	rs5751901	chr22:24992266	GGT1	chr22:24979718-25024972:+	-0.37	-7.32	1.06E-12	Protein quantitative trait loci	
THCA	cis	1	rs5751901	chr22:24992266	LOC644165	chr22:25028882-25049326:+	0.21	6.01	3.62E-9	Protein quantitative trait loci	
THCA	cis	1	rs5752326	chr22:26843990	HPS4	chr22:26847447-26879820:-	0.3	3.76	0.000195	Ischemic stroke	
THCA	cis	1	rs5752327	chr22:26844070	HPS4	chr22:26847447-26879820:-	0.3	3.75	0.000201	Ischemic stroke	
THCA	cis	1	rs5753521	chr22:31638027	RNF185	chr22:31556138-31603004:+	-0.27	-4.98	8.82E-7	Paclitaxel-induced neuropathy	
THCA	cis	1	rs57535407	chr11:46570286	PACSIN3	chr11:47199085-47207958:-	0.18	4.13	4.29E-5	Schizophrenia	
THCA	cis	1	rs5753543	chr22:31685458	RNF185	chr22:31556138-31603004:+	-0.28	-5.22	2.7E-7	Paclitaxel-induced neuropathy	
THCA	cis	1	rs57542652	chr2:228088	SH3YL1	chr2:218138-264810:-	-0.94	-24.47	2.41E-86	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs5756813	chr22:38175477	LGALS2	chr22:37966254-37976024:-	0.16	4.48	9.16E-6	Optic cup area;Vertical cup-disc ratio	
THCA	cis	1	rs5756813	chr22:38175477	TRIOBP	chr22:38082344-38172562:+	-0.38	-10.78	2.04E-24	Optic cup area;Vertical cup-disc ratio	
THCA	cis	1	rs5757141	chr22:38957483	JOSD1	chr22:39081549-39096459:-	-0.15	-3.95	8.9E-5	Resting heart rate	
THCA	cis	1	rs5757141	chr22:38957483	TOMM22	chr22:39077954-39080763:+	-0.19	-4.19	3.35E-5	Resting heart rate	
THCA	cis	1	rs5757162	chr22:38993370	JOSD1	chr22:39081549-39096459:-	-0.14	-3.67	0.000268	Resting heart rate	
THCA	cis	1	rs5757162	chr22:38993370	LOC646851	chr22:38974125-39052634:-	0.13	3.59	0.000369	Resting heart rate	
THCA	cis	1	rs5757162	chr22:38993370	TOMM22	chr22:39077954-39080763:+	-0.16	-3.5	0.000516	Resting heart rate	
THCA	cis	1	rs5757166	chr22:38995385	LOC646851	chr22:38974125-39052634:-	0.14	3.86	0.000131	Resting heart rate	
THCA	cis	1	rs5757166	chr22:38995385	TOMM22	chr22:39077954-39080763:+	-0.16	-3.52	0.000471	Resting heart rate	
THCA	cis	1	rs5757181	chr22:39013522	JOSD1	chr22:39081549-39096459:-	-0.14	-3.68	0.00026	Resting heart rate	
THCA	cis	1	rs5757181	chr22:39013522	LOC646851	chr22:38974125-39052634:-	0.14	3.68	0.000262	Resting heart rate	
THCA	cis	1	rs5757187	chr22:39021522	JOSD1	chr22:39081549-39096459:-	0.15	4.16	3.82E-5	Resting heart rate	
THCA	cis	1	rs5757187	chr22:39021522	LOC646851	chr22:38974125-39052634:-	-0.12	-3.34	0.000899	Resting heart rate	
THCA	cis	1	rs5757187	chr22:39021522	TOMM22	chr22:39077954-39080763:+	0.17	3.87	0.000123	Resting heart rate	
THCA	cis	1	rs5757193	chr22:39034867	JOSD1	chr22:39081549-39096459:-	0.15	3.88	0.00012	Resting heart rate	
THCA	cis	1	rs5757193	chr22:39034867	TOMM22	chr22:39077954-39080763:+	0.18	3.83	0.000145	Resting heart rate	
THCA	cis	1	rs5757196	chr22:39039855	JOSD1	chr22:39081549-39096459:-	-0.15	-3.94	9.33E-5	Resting heart rate	
THCA	cis	1	rs5757196	chr22:39039855	TOMM22	chr22:39077954-39080763:+	-0.16	-3.58	0.000379	Resting heart rate	
THCA	cis	1	rs5757200	chr22:39043491	JOSD1	chr22:39081549-39096459:-	-0.15	-3.94	9.33E-5	Resting heart rate	
THCA	cis	1	rs5757200	chr22:39043491	TOMM22	chr22:39077954-39080763:+	-0.16	-3.58	0.000379	Resting heart rate	
THCA	cis	1	rs5757203	chr22:39044152	JOSD1	chr22:39081549-39096459:-	-0.15	-3.94	9.33E-5	Resting heart rate	
THCA	cis	1	rs5757203	chr22:39044152	TOMM22	chr22:39077954-39080763:+	-0.16	-3.58	0.000379	Resting heart rate	
THCA	cis	1	rs5757204	chr22:39046700	JOSD1	chr22:39081549-39096459:-	-0.15	-3.94	9.33E-5	Resting heart rate	
THCA	cis	1	rs5757204	chr22:39046700	TOMM22	chr22:39077954-39080763:+	-0.16	-3.58	0.000379	Resting heart rate	
THCA	cis	1	rs5757208	chr22:39049230	JOSD1	chr22:39081549-39096459:-	-0.15	-3.94	9.33E-5	Resting heart rate	
THCA	cis	1	rs5757208	chr22:39049230	TOMM22	chr22:39077954-39080763:+	-0.16	-3.58	0.000379	Resting heart rate	
THCA	cis	1	rs5757211	chr22:39051705	JOSD1	chr22:39081549-39096459:-	-0.15	-3.94	9.33E-5	Resting heart rate	
THCA	cis	1	rs5757211	chr22:39051705	TOMM22	chr22:39077954-39080763:+	-0.16	-3.58	0.000379	Resting heart rate	
THCA	cis	1	rs5757213	chr22:39053888	JOSD1	chr22:39081549-39096459:-	-0.15	-3.94	9.33E-5	Resting heart rate	
THCA	cis	1	rs5757213	chr22:39053888	TOMM22	chr22:39077954-39080763:+	-0.16	-3.58	0.000379	Resting heart rate	
THCA	cis	1	rs5757226	chr22:39070550	JOSD1	chr22:39081549-39096459:-	-0.15	-3.86	0.000127	Resting heart rate	
THCA	cis	1	rs5757226	chr22:39070550	LOC646851	chr22:38974125-39052634:-	0.13	3.43	0.000646	Resting heart rate	
THCA	cis	1	rs5757226	chr22:39070550	TOMM22	chr22:39077954-39080763:+	-0.16	-3.49	0.000525	Resting heart rate	
THCA	cis	1	rs5757231	chr22:39071658	JOSD1	chr22:39081549-39096459:-	0.16	4.3	2.09E-5	Resting heart rate	
THCA	cis	1	rs5757231	chr22:39071658	TOMM22	chr22:39077954-39080763:+	0.18	3.97	8.3E-5	Resting heart rate	
THCA	cis	1	rs5757232	chr22:39071677	JOSD1	chr22:39081549-39096459:-	-0.15	-3.89	0.000115	Resting heart rate	
THCA	cis	1	rs5757232	chr22:39071677	LOC646851	chr22:38974125-39052634:-	0.13	3.4	0.000739	Resting heart rate	
THCA	cis	1	rs5757232	chr22:39071677	TOMM22	chr22:39077954-39080763:+	-0.16	-3.55	0.000423	Resting heart rate	
THCA	cis	1	rs5757234	chr22:39072686	LOC646851	chr22:38974125-39052634:-	0.14	3.67	0.00027	Resting heart rate	
THCA	cis	1	rs5757234	chr22:39072686	TOMM22	chr22:39077954-39080763:+	-0.17	-3.71	0.000236	Resting heart rate	
THCA	cis	1	rs5757253	chr22:39104320	JOSD1	chr22:39081549-39096459:-	-0.13	-3.34	0.000893	Resting heart rate	
THCA	cis	1	rs5757253	chr22:39104320	LOC646851	chr22:38974125-39052634:-	0.13	3.53	0.00046	Resting heart rate	
THCA	cis	1	rs5757253	chr22:39104320	TOMM22	chr22:39077954-39080763:+	-0.16	-3.57	0.000391	Resting heart rate	
THCA	cis	1	rs57576544	chr6:44072726	TMEM63B	chr6:44095376-44123255:+	0.16	3.49	0.000524	Major depressive disorder	
THCA	cis	1	rs57576577	chr16:31036367	C16orf93	chr16:30768753-30773542:-	-0.15	-4.34	1.77E-5	Response to metformin (IC50)	
THCA	cis	1	rs57576577	chr16:31036367	HSD3B7	chr16:30996519-31000473:+	0.48	12.46	4.53E-31	Response to metformin (IC50)	
THCA	cis	1	rs57576577	chr16:31036367	MYST1	chr16:31128985-31142713:+	0.16	5.39	1.1E-7	Response to metformin (IC50)	
THCA	cis	1	rs57576577	chr16:31036367	PRSS53	chr16:31094747-31106276:-	-0.15	-4.15	3.92E-5	Response to metformin (IC50)	
THCA	cis	1	rs5758659	chr22:42622003	C22orf32	chr22:42475699-42480287:+	0.2	5.08	5.37E-7	Cognitive function	
THCA	cis	1	rs5758659	chr22:42622003	CCDC134	chr22:42196678-42222303:+	0.21	3.92	0.000103	Cognitive function	
THCA	cis	1	rs5758659	chr22:42622003	CYP2D6	chr22:42522502-42526883:-	-0.41	-10.64	7.28E-24	Cognitive function	
THCA	cis	1	rs5758659	chr22:42622003	NAGA	chr22:42454339-42466846:-	0.35	7.49	3.29E-13	Cognitive function	
THCA	cis	1	rs5758659	chr22:42622003	WBP2NL	chr22:42120334-42454460:+	0.25	4.58	6.0E-6	Cognitive function	
THCA	cis	1	rs5758660	chr22:42623718	C22orf32	chr22:42475699-42480287:+	0.2	5.31	1.73E-7	Cognitive function	
THCA	cis	1	rs5758660	chr22:42623718	CCDC134	chr22:42196678-42222303:+	0.21	4.09	5.17E-5	Cognitive function	
THCA	cis	1	rs5758660	chr22:42623718	CYP2D6	chr22:42522502-42526883:-	-0.41	-10.57	1.3E-23	Cognitive function	
THCA	cis	1	rs5758660	chr22:42623718	NAGA	chr22:42454339-42466846:-	0.36	7.73	6.33E-14	Cognitive function	
THCA	cis	1	rs5758660	chr22:42623718	WBP2NL	chr22:42120334-42454460:+	0.25	4.53	7.29E-6	Cognitive function	
THCA	cis	1	rs5758677	chr22:42643039	C22orf32	chr22:42475699-42480287:+	0.2	5.22	2.69E-7	Cognitive function	
THCA	cis	1	rs5758677	chr22:42643039	CCDC134	chr22:42196678-42222303:+	0.21	3.98	8.0E-5	Cognitive function	
THCA	cis	1	rs5758677	chr22:42643039	CYP2D6	chr22:42522502-42526883:-	-0.41	-10.76	2.44E-24	Cognitive function	
THCA	cis	1	rs5758677	chr22:42643039	NAGA	chr22:42454339-42466846:-	0.34	7.42	5.57E-13	Cognitive function	
THCA	cis	1	rs5758677	chr22:42643039	WBP2NL	chr22:42120334-42454460:+	0.24	4.5	8.45E-6	Cognitive function	
THCA	cis	1	rs5759113	chr22:43443952	ARFGAP3	chr22:43192532-43253408:-	0.22	4.86	1.61E-6	Schizophrenia	
THCA	cis	1	rs5759595	chr22:23471624	GNAZ	chr22:23412669-23467221:+	-0.25	-5.4	1.05E-7	Bone mineral density	
THCA	cis	1	rs5759596	chr22:23475750	GNAZ	chr22:23412669-23467221:+	-0.25	-5.36	1.26E-7	Bone mineral density	
THCA	cis	1	rs5759598	chr22:23480962	GNAZ	chr22:23412669-23467221:+	-0.26	-5.66	2.55E-8	Bone mineral density	
THCA	cis	1	rs5759598	chr22:23480962	RAB36	chr22:23487513-23506531:+	0.18	3.5	0.0005	Bone mineral density	
THCA	cis	1	rs5760216	chr22:24539734	SUSD2	chr22:24577444-24585074:+	0.29	3.4	0.000731	Amyotrophic lateral sclerosis	
THCA	cis	1	rs5760220	chr22:24542480	SUSD2	chr22:24577444-24585074:+	0.32	3.77	0.000182	Amyotrophic lateral sclerosis	
THCA	cis	1	rs5760229	chr22:24560254	SUSD2	chr22:24577444-24585074:+	0.32	3.82	0.000152	Amyotrophic lateral sclerosis	
THCA	cis	1	rs5761529	chr22:26843708	HPS4	chr22:26847447-26879820:-	0.3	3.76	0.000195	Ischemic stroke	
THCA	cis	1	rs5761530	chr22:26843916	HPS4	chr22:26847447-26879820:-	0.32	4.32	1.91E-5	Ischemic stroke	
THCA	cis	1	rs57631744	chr3:10118962	C3orf10	chr3:10157333-10168873:+	-0.2	-4.18	3.51E-5	Alzheimer's disease	
THCA	cis	1	rs57631744	chr3:10118962	VHL	chr3:10183319-10193744:+	-0.19	-4.37	1.54E-5	Alzheimer's disease	
THCA	cis	1	rs5763305	chr22:29930195	NIPSNAP1	chr22:29950800-29977144:-	-0.24	-3.6	0.000346	Lipid traits	
THCA	cis	1	rs57672368	chr17:65358688	PSMD12	chr17:65336620-65362721:-	-0.17	-3.41	0.000698	Diisocyanate-induced asthma	
THCA	cis	1	rs576779	chr4:56274307	TMEM165	chr4:56262090-56292342:+	-0.16	-4.13	4.25E-5	Personality dimensions	
THCA	cis	1	rs57678958	chr16:77785315	NUDT7	chr16:77756411-77776153:+	0.36	4.91	1.25E-6	Obesity-related traits	
THCA	cis	1	rs57690120	chr20:33731437	MMP24	chr20:33814539-33864804:+	-0.21	-3.36	0.00084	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs57690120	chr20:33731437	PROCR	chr20:33758727-33765164:+	-0.3	-5.19	3.07E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs57690120	chr20:33731437	TRPC4AP	chr20:33590215-33680618:-	0.29	3.79	0.000168	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs57699322	chr3:128065313	EEFSEC	chr3:127872313-128127488:+	-0.2	-3.49	0.00053	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs57704144	chr11:46770359	ZNF408	chr11:46722368-46727461:+	-0.18	-3.59	0.000368	HDL cholesterol	
THCA	cis	1	rs5770911	chr22:51011241	ARSA	chr22:51063450-51066607:-	0.3	3.41	0.000704	Narcolepsy	
THCA	cis	1	rs5770911	chr22:51011241	CHKB	chr22:51017378-51021428:-	0.46	5.07	5.64E-7	Narcolepsy	
THCA	cis	1	rs5770911	chr22:51011241	CPT1B	chr22:51007291-51017096:-	-0.39	-7.28	1.43E-12	Narcolepsy	
THCA	cis	1	rs5770917	chr22:51017353	CHKB	chr22:51017378-51021428:-	0.43	4.87	1.55E-6	Narcolepsy	
THCA	cis	1	rs5770917	chr22:51017353	CPT1B	chr22:51007291-51017096:-	-0.35	-6.61	1.04E-10	Narcolepsy	
THCA	cis	1	rs5770922	chr22:51023408	ARSA	chr22:51063450-51066607:-	0.31	3.44	0.000622	Narcolepsy	
THCA	cis	1	rs5770922	chr22:51023408	CHKB	chr22:51017378-51021428:-	0.45	4.92	1.2E-6	Narcolepsy	
THCA	cis	1	rs5770922	chr22:51023408	CPT1B	chr22:51007291-51017096:-	-0.38	-7	8.45E-12	Narcolepsy	
THCA	cis	1	rs5770924	chr22:51024542	CHKB	chr22:51017378-51021428:-	0.41	4.49	8.77E-6	Narcolepsy	
THCA	cis	1	rs5770924	chr22:51024542	CPT1B	chr22:51007291-51017096:-	-0.37	-6.81	2.91E-11	Narcolepsy	
THCA	cis	1	rs577227	chr10:131404528	MGMT	chr10:131265454-131565783:+	0.38	11.47	4.41E-27	Response to temozolomide	
THCA	cis	1	rs57735707	chr3:128065815	EEFSEC	chr3:127872313-128127488:+	-0.22	-3.79	0.000173	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs57738705	chr11:77994489	NARS2	chr11:78147017-78285909:-	-0.38	-6.98	1.02E-11	Testicular germ cell tumor	
THCA	cis	1	rs57771217	chr8:89411860	MMP16	chr8:89049462-89339717:-	0.31	5.04	6.5E-7	Electrodermal activity	
THCA	cis	1	rs57804141	chr3:129962512	COL6A4P2	chr3:129931663-129992648:+	0.24	4.63	4.81E-6	Response to amphetamines	
THCA	cis	1	rs57804141	chr3:129962512	LOC729375	chr3:129816625-129830276:-	0.24	4.33	1.79E-5	Response to amphetamines	
THCA	cis	1	rs578056	chr11:65514874	CTSW	chr11:65647284-65651212:+	-0.24	-4.89	1.38E-6	Systemic lupus erythematosus	
THCA	cis	1	rs578056	chr11:65514874	RNASEH2C	chr11:65485146-65488409:-	-0.18	-4.55	6.67E-6	Systemic lupus erythematosus	
THCA	cis	1	rs578056	chr11:65514874	SNX32	chr11:65601410-65621170:+	0.39	5.18	3.35E-7	Systemic lupus erythematosus	
THCA	cis	1	rs57807215	chr8:89455068	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs57817160	chr2:228179238	MFF	chr2:228189978-228222547:+	0.22	4.83	1.85E-6	Corneal structure	
THCA	cis	1	rs57832572	chr12:8668281	CLEC4D	chr12:8666136-8674958:+	0.22	3.95	9.09E-5	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	
THCA	cis	1	rs57844481	chr14:76684493	ESRRB	chr14:76837690-76968178:+	-0.33	-5.05	6.33E-7	Blood pressure	
THCA	cis	1	rs57862275	chr11:22822055	SVIP	chr11:22843600-22851382:-	0.2	3.51	0.00049	Dialysis-related mortality	
THCA	cis	1	rs57862518	chr8:94070803	C8orf83	chr8:93895865-94029901:-	0.27	4.43	1.19E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs57866349	chr4:155349420	DCHS2	chr4:155155527-155412930:-	0.16	3.46	0.000595	Alzheimer's disease (age of onset)	
THCA	cis	1	rs57902736	chr8:124189893	FAM83A	chr8:124191287-124222317:+	-0.34	-4.31	1.99E-5	Urinary uromodulin levels	
THCA	cis	1	rs57925408	chr8:96062930	C8orf38	chr8:95908040-96088396:+	-0.25	-4.32	1.93E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs57928699	chr18:44645593	HDHD2	chr18:44633782-44676871:-	0.26	4.98	8.99E-7	Sitting height ratio	
THCA	cis	1	rs57928699	chr18:44645593	PIAS2	chr18:44392061-44500123:-	-0.15	-3.37	0.000804	Sitting height ratio	
THCA	cis	1	rs57935196	chr16:77785314	NUDT7	chr16:77756411-77776153:+	0.36	4.91	1.25E-6	Obesity-related traits	
THCA	cis	1	rs57970196	chr14:55600405	KIAA0831	chr14:55833110-55878576:-	-0.12	-3.41	0.000709	Protein biomarker	
THCA	cis	1	rs579890	chr11:116798963	PCSK7	chr11:117075789-117102811:-	-0.32	-5.46	7.62E-8	Protein quantitative trait loci	
THCA	cis	1	rs57994353	chr9:139356987	INPP5E	chr9:139323075-139334256:-	-0.2	-4.65	4.26E-6	cutaneous squamous cell carcinoma	
THCA	cis	1	rs57994353	chr9:139356987	SDCCAG3	chr9:139296375-139305054:-	-0.27	-5.69	2.19E-8	cutaneous squamous cell carcinoma	
THCA	cis	1	rs580016	chr12:120933977	POP5	chr12:121016849-121019201:-	0.14	4	7.29E-5	Type 1 diabetes nephropathy	
THCA	cis	1	rs580067	chr1:197298373	CFHR3	chr1:196743930-196762872:+	0.25	5.22	2.73E-7	Lupus nephritis in systemic lupus erythematosus	
THCA	cis	1	rs58036957	chr15:56373056	MNS1	chr15:56720929-56757335:-	-0.25	-3.7	0.00024	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs58036957	chr15:56373056	TEX9	chr15:56657644-56738071:+	-0.35	-5.96	4.81E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs58053556	chr1:10442903	KIF1B	chr1:10270764-10441659:+	0.21	6.13	1.8E-9	Hepatocellular carcinoma	
THCA	cis	1	rs58059872	chr8:89451134	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs58061411	chr8:94077680	C8orf83	chr8:93895865-94029901:-	0.28	4.45	1.07E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs58062456	chr7:65394852	CCT6P1	chr7:65216092-65228661:+	0.38	6	3.93E-9	Diabetic kidney disease	
THCA	cis	1	rs58062456	chr7:65394852	CRCP	chr7:65579805-65619551:+	-0.26	-4	7.24E-5	Diabetic kidney disease	
THCA	cis	1	rs58062456	chr7:65394852	RABGEF1	chr7:66093890-66276446:+	0.55	6.89	1.73E-11	Diabetic kidney disease	
THCA	cis	1	rs58069930	chr16:50067031	HEATR3	chr16:50099881-50139373:+	-0.4	-6.11	2.09E-9	Esophageal cancer (squamous cell)	
THCA	cis	1	rs58073287	chr19:41666680	BCKDHA	chr19:41882438-41930909:+	-0.18	-3.41	0.000694	Prion diseases	
THCA	cis	1	rs580745	chr10:131414401	MGMT	chr10:131265454-131565783:+	0.38	11.42	7.4E-27	Response to temozolomide	
THCA	cis	1	rs58088385	chr20:33748229	PROCR	chr20:33758727-33765164:+	-0.32	-5.35	1.36E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs58088385	chr20:33748229	TRPC4AP	chr20:33590215-33680618:-	0.32	4.15	3.92E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs58115860	chr14:66057626	LOC645431	chr14:65877313-65879335:-	-0.6	-7.74	6.15E-14	Ischemic stroke	
THCA	cis	1	rs58122682	chr17:65876915	C17orf58	chr17:65987218-65989765:-	0.2	3.97	8.17E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs58133129	chr14:104104759	KLC1	chr14:104029299-104167887:+	-0.21	-4.22	2.87E-5	Body mass index	
THCA	cis	1	rs58162302	chr11:118146199	AMICA1	chr11:118064442-118095809:-	0.08	4.01	7.05E-5	Pain	
THCA	cis	1	rs58162302	chr11:118146199	MPZL2	chr11:118124135-118135009:-	0.23	7.86	2.62E-14	Pain	
THCA	cis	1	rs58162302	chr11:118146199	TREH	chr11:118528942-118550381:-	-0.17	-3.39	0.000746	Pain	
THCA	cis	1	rs58164144	chr8:89437770	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs581686	chr10:105983356	C10orf79	chr10:105889647-105992120:-	0.24	7.76	5.25E-14	Attention deficit hyperactivity disorder	
THCA	cis	1	rs58177772	chr8:124188067	FAM83A	chr8:124191287-124222317:+	-0.34	-4.39	1.41E-5	Urinary uromodulin levels	
THCA	cis	1	rs58189203	chr8:124184739	FAM83A	chr8:124191287-124222317:+	-0.34	-4.25	2.56E-5	Urinary uromodulin levels	
THCA	cis	1	rs58189451	chr6:149921388	C6orf72	chr6:149887528-149912067:+	-0.19	-5.17	3.46E-7	Lung cancer	
THCA	cis	1	rs58189451	chr6:149921388	NUP43	chr6:150045453-150067688:-	-0.26	-4.56	6.51E-6	Lung cancer	
THCA	cis	1	rs58189451	chr6:149921388	RAET1E	chr6:150204512-150217195:-	0.22	4.86	1.61E-6	Lung cancer	
THCA	cis	1	rs58189451	chr6:149921388	RAET1K	chr6:150319157-150326280:-	-0.22	-3.46	0.000581	Lung cancer	
THCA	cis	1	rs58204112	chr14:74359417	LIN52	chr14:74551656-74667117:+	0.24	4.54	7.28E-6	Morning vs. evening chronotype	
THCA	cis	1	rs58204112	chr14:74359417	PTGR2	chr14:74318534-74352166:+	0.22	3.56	0.000415	Morning vs. evening chronotype	
THCA	cis	1	rs58204112	chr14:74359417	ZNF410	chr14:74318674-74398803:+	0.24	4	7.31E-5	Morning vs. evening chronotype	
THCA	cis	1	rs58235466	chr11:78030886	NARS2	chr11:78147017-78285909:-	-0.4	-7.65	1.08E-13	Testicular germ cell tumor	
THCA	cis	1	rs58242818	chr4:75699164	BTC	chr4:75671448-75719882:-	0.21	3.92	0.000102	Electroencephalogram traits	
THCA	cis	1	rs58275763	chr3:10143274	C3orf10	chr3:10157333-10168873:+	-0.21	-4.38	1.45E-5	Alzheimer's disease	
THCA	cis	1	rs58275763	chr3:10143274	VHL	chr3:10183319-10193744:+	-0.19	-4.25	2.55E-5	Alzheimer's disease	
THCA	cis	1	rs58289747	chr8:89414691	MMP16	chr8:89049462-89339717:-	0.31	4.94	1.08E-6	Electrodermal activity	
THCA	cis	1	rs58336952	chr19:12057916	ZNF763	chr19:12035900-12091196:+	-0.4	-4.82	1.91E-6	Multiple sclerosis	
THCA	cis	1	rs58337229	chr8:89390073	MMP16	chr8:89049462-89339717:-	0.32	4.95	1.04E-6	Electrodermal activity	
THCA	cis	1	rs58351927	chr17:5297038	C1QBP	chr17:5336099-5342471:-	0.15	4.29	2.14E-5	Body mass index	
THCA	cis	1	rs58351927	chr17:5297038	NLRP1	chr17:5404719-5487832:-	-0.22	-4.58	5.92E-6	Body mass index	
THCA	cis	1	rs58351927	chr17:5297038	RABEP1	chr17:5185558-5289131:+	-0.12	-3.6	0.000354	Body mass index	
THCA	cis	1	rs583583	chr1:147083114	ACP6	chr1:147119168-147142634:-	0.75	15.95	3.3E-46	Schizophrenia (negative symptoms)	
THCA	cis	1	rs58365138	chr2:86213105	POLR1A	chr2:86253453-86333278:-	-0.29	-3.9	0.000112	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs58381542	chr2:86203685	POLR1A	chr2:86253453-86333278:-	-0.32	-4.38	1.45E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs58399951	chr8:89437490	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs58416181	chr15:85264461	GOLGA6L5	chr15:85047738-85060078:-	-0.15	-3.84	0.000138	Schizophrenia	
THCA	cis	1	rs58416181	chr15:85264461	LOC388152	chr15:84867600-84898920:-	-0.47	-7.96	1.24E-14	Schizophrenia	
THCA	cis	1	rs58416181	chr15:85264461	NMB	chr15:85198362-85201802:-	0.36	7.48	3.54E-13	Schizophrenia	
THCA	cis	1	rs58421016	chr1:27070529	ZDHHC18	chr1:27153201-27182207:+	0.8	8.6	1.15E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs584309	chr10:105956776	C10orf79	chr10:105889647-105992120:-	0.25	7.93	1.54E-14	Attention deficit hyperactivity disorder	
THCA	cis	1	rs58436485	chr15:90900633	IQGAP1	chr15:90931473-91045475:+	0.15	4.63	4.67E-6	Rheumatoid arthritis	
THCA	cis	1	rs58436485	chr15:90900633	TTLL13	chr15:90792764-90815443:+	0.27	4.57	6.24E-6	Rheumatoid arthritis	
THCA	cis	1	rs58453379	chr8:89438243	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs58453750	chr2:17778329	GEN1	chr2:17935162-17966632:+	0.58	7.52	2.66E-13	Psychosis and Alzheimer's disease	
THCA	cis	1	rs58461606	chr2:267367	SH3YL1	chr2:218138-264810:-	-0.95	-26.36	3.27E-95	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs58479700	chr6:24483199	GPLD1	chr6:24428405-24489850:-	0.2	3.75	0.0002	Hematological and biochemical traits	
THCA	cis	1	rs58479700	chr6:24483199	MRS2	chr6:24403153-24425809:+	0.24	5.35	1.35E-7	Hematological and biochemical traits	
THCA	cis	1	rs58484838	chr16:77783137	NUDT7	chr16:77756411-77776153:+	0.36	4.95	1.04E-6	Obesity-related traits	
THCA	cis	1	rs58507982	chr11:118146510	AMICA1	chr11:118064442-118095809:-	0.08	4.01	7.05E-5	Pain	
THCA	cis	1	rs58507982	chr11:118146510	MPZL2	chr11:118124135-118135009:-	0.23	7.86	2.62E-14	Pain	
THCA	cis	1	rs58507982	chr11:118146510	TREH	chr11:118528942-118550381:-	-0.17	-3.39	0.000746	Pain	
THCA	cis	1	rs585101	chr5:139058454	DNAJC18	chr5:138747381-138775139:-	0.16	3.5	0.000508	Schizophrenia	
THCA	cis	1	rs58514314	chr14:97338825	VRK1	chr14:97263684-97347950:+	-0.17	-3.86	0.00013	Neutrophil count	
THCA	cis	1	rs58515922	chr2:86173037	POLR1A	chr2:86253453-86333278:-	-0.23	-3.64	0.000302	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs585228	chr11:71773289	FAM86C	chr11:71498557-71512276:+	0.32	3.91	0.000107	Severe influenza A (H1N1) infection	
THCA	cis	1	rs58549151	chr1:10314657	KIF1B	chr1:10270764-10441659:+	0.21	6.36	4.75E-10	Hepatocellular carcinoma	
THCA	cis	1	rs58551145	chr17:65837235	C17orf58	chr17:65987218-65989765:-	0.2	3.89	0.000114	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs58565853	chr11:78036707	NARS2	chr11:78147017-78285909:-	-0.37	-6.82	2.72E-11	Testicular germ cell tumor	
THCA	cis	1	rs58591218	chr19:32890782	DPY19L3	chr19:32896677-32975236:+	0.2	5.29	1.82E-7	Bipolar disorder	
THCA	cis	1	rs58591218	chr19:32890782	ZNF507	chr19:32836514-32878571:+	0.32	7.85	2.85E-14	Bipolar disorder	
THCA	cis	1	rs58602070	chr14:65849242	LOC645431	chr14:65877313-65879335:-	-0.36	-4.69	3.51E-6	Ischemic stroke	
THCA	cis	1	rs58603761	chr2:73726605	ALMS1P	chr2:73872046-73912692:+	0.69	10.91	6.53E-25	Metabolite levels	
THCA	cis	1	rs58603761	chr2:73726605	NAT8	chr2:73867850-73869537:-	0.36	5.67	2.48E-8	Metabolite levels	
THCA	cis	1	rs58603761	chr2:73726605	TPRKB	chr2:73956957-73964517:-	-0.16	-4.22	2.91E-5	Metabolite levels	
THCA	cis	1	rs58638862	chr7:87524860	DBF4	chr7:87505544-87538856:+	-0.25	-3.86	0.000131	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs58660500	chr3:53086573	RFT1	chr3:53122503-53164470:-	0.64	7.59	1.65E-13	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs58660500	chr3:53086573	TMEM110	chr3:52867139-52931547:-	0.32	3.77	0.000184	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs58669269	chr7:65951953	CCT6P1	chr7:65216092-65228661:+	0.44	6.73	4.96E-11	Diabetic kidney disease	
THCA	cis	1	rs58669269	chr7:65951953	CRCP	chr7:65579805-65619551:+	-0.26	-3.81	0.000156	Diabetic kidney disease	
THCA	cis	1	rs58669269	chr7:65951953	RABGEF1	chr7:66093890-66276446:+	0.63	7.63	1.32E-13	Diabetic kidney disease	
THCA	cis	1	rs58704470	chr10:81729390	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs58717741	chr5:150284936	LOC134466	chr5:150310000-150326146:-	0.45	6.01	3.62E-9	Crohn's disease	
THCA	cis	1	rs58717741	chr5:150284936	ZNF300	chr5:150273964-150284391:-	0.16	3.43	0.000668	Crohn's disease	
THCA	cis	1	rs58729171	chr16:77786018	NUDT7	chr16:77756411-77776153:+	0.36	4.91	1.25E-6	Obesity-related traits	
THCA	cis	1	rs58741168	chr8:124191852	FAM83A	chr8:124191287-124222317:+	-0.27	-3.66	0.000276	Urinary uromodulin levels	
THCA	cis	1	rs58749629	chr20:44571317	KCNS1	chr20:43720951-43729753:-	-0.29	-4.28	2.27E-5	Abdominal aortic aneurysm	
THCA	cis	1	rs58749629	chr20:44571317	WFDC3	chr20:44402847-44420547:-	-0.42	-5.78	1.35E-8	Abdominal aortic aneurysm	
THCA	cis	1	rs58754325	chr8:89441440	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs58806855	chr13:108484069	FAM155A	chr13:107820880-108519460:-	0.48	5.61	3.46E-8	Obesity-related traits	
THCA	cis	1	rs58813232	chr8:94080505	C8orf83	chr8:93895865-94029901:-	0.28	4.45	1.07E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs58817690	chr19:52536692	ZNF432	chr19:52536678-52552073:-	-0.18	-4.53	7.59E-6	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	
THCA	cis	1	rs58832890	chr6:133127139	C6orf192	chr6:133090507-133119747:-	-0.24	-3.93	9.74E-5	Type 2 diabetes nephropathy	
THCA	cis	1	rs58858275	chr8:94080504	C8orf83	chr8:93895865-94029901:-	0.26	4.07	5.41E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs588918	chr11:116856642	PCSK7	chr11:117075789-117102811:-	-0.32	-5.63	3.06E-8	Protein quantitative trait loci	
THCA	cis	1	rs58898686	chr2:86216909	POLR1A	chr2:86253453-86333278:-	-0.33	-4.53	7.35E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs589153	chr5:139057548	DNAJC18	chr5:138747381-138775139:-	0.16	3.73	0.000218	Schizophrenia	
THCA	cis	1	rs58922799	chr11:46725196	ARHGAP1	chr11:46698634-46722120:-	-0.18	-3.37	0.000803	HDL cholesterol	
THCA	cis	1	rs58922799	chr11:46725196	ZNF408	chr11:46722368-46727461:+	-0.18	-3.42	0.000672	HDL cholesterol	
THCA	cis	1	rs58934221	chr15:56516381	MNS1	chr15:56720929-56757335:-	-0.24	-3.5	0.000511	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs58934221	chr15:56516381	TEX9	chr15:56657644-56738071:+	-0.34	-5.8	1.21E-8	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs58952297	chr20:44560820	WFDC3	chr20:44402847-44420547:-	-0.27	-3.89	0.000114	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
THCA	cis	1	rs5896	chr11:46745003	ZNF408	chr11:46722368-46727461:+	-0.18	-3.5	0.000508	HDL cholesterol	
THCA	cis	1	rs589756	chr6:132643117	MOXD1	chr6:132617195-132722664:-	0.27	4.67	3.99E-6	Obesity-related traits	
THCA	cis	1	rs58986862	chr3:128061689	EEFSEC	chr3:127872313-128127488:+	-0.23	-3.99	7.56E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs58991229	chr11:71839878	FAM86C	chr11:71498557-71512276:+	-0.29	-3.56	0.000408	Severe influenza A (H1N1) infection	
THCA	cis	1	rs58994609	chr8:89438194	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs58999537	chr12:51357104	SLC11A2	chr12:51373319-51422058:-	-0.24	-4.83	1.87E-6	Type 2 diabetes	
THCA	cis	1	rs58999537	chr12:51357104	TFCP2	chr12:51488608-51566917:-	-0.2	-4.28	2.25E-5	Type 2 diabetes	
THCA	cis	1	rs59025920	chr15:56409172	MNS1	chr15:56720929-56757335:-	-0.25	-3.65	0.000287	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs59025920	chr15:56409172	TEX9	chr15:56657644-56738071:+	-0.35	-6.01	3.6E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs59030724	chr8:89414702	MMP16	chr8:89049462-89339717:-	0.32	5.1	4.9E-7	Electrodermal activity	
THCA	cis	1	rs59035163	chr10:65292043	LOC84989	chr10:65224989-65226320:+	0.26	4.18	3.5E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs59035163	chr10:65292043	NRBF2	chr10:64893007-64914785:+	0.26	4.36	1.59E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs59043278	chr8:89444592	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs59044152	chr17:41888747	MPP3	chr17:41878169-41910538:-	0.3	4.83	1.85E-6	Triglycerides	
THCA	cis	1	rs59045389	chr16:77782863	NUDT7	chr16:77756411-77776153:+	0.35	4.82	1.9E-6	Obesity-related traits	
THCA	cis	1	rs59049611	chr11:118139403	AMICA1	chr11:118064442-118095809:-	0.08	3.79	0.000167	Pain	
THCA	cis	1	rs59049611	chr11:118139403	MPZL2	chr11:118124135-118135009:-	0.23	7.5	3.11E-13	Pain	
THCA	cis	1	rs59058733	chr7:87502048	DBF4	chr7:87505544-87538856:+	-0.29	-4.36	1.57E-5	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs59093593	chr1:108349457	VAV3	chr1:108113782-108507545:-	0.54	7.33	1.02E-12	Hypothyroidism	
THCA	cis	1	rs590958	chr15:65735707	DPP8	chr15:65737999-65810035:-	-0.09	-3.9	0.000111	Mean corpuscular hemoglobin	
THCA	cis	1	rs590958	chr15:65735707	SLC24A1	chr15:65903704-65953256:+	-0.17	-4.03	6.5E-5	Mean corpuscular hemoglobin	
THCA	cis	1	rs59104589	chr2:242237902	HDLBP	chr2:242166679-242255254:-	-0.18	-3.97	8.2E-5	Fibrinogen levels	
THCA	cis	1	rs59104589	chr2:242237902	SEPT2	chr2:242254723-242293439:+	-0.18	-3.65	0.000295	Fibrinogen levels	
THCA	cis	1	rs591058	chr11:102711338	MMP1	chr11:102660641-102668966:-	0.24	4.29	2.15E-5	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	
THCA	cis	1	rs59107062	chr8:89405172	MMP16	chr8:89049462-89339717:-	0.31	5.04	6.5E-7	Electrodermal activity	
THCA	cis	1	rs59117465	chr14:66052472	LOC645431	chr14:65877313-65879335:-	-0.61	-7.58	1.81E-13	Ischemic stroke	
THCA	cis	1	rs59123962	chr4:103512451	NFKB1	chr4:103422486-103538458:+	0.16	4.56	6.41E-6	Ulcerative colitis	
THCA	cis	1	rs59150578	chr11:18340862	GTF2H1	chr11:18343816-18388590:+	0.33	8.99	5.98E-18	Pancreatic cancer	
THCA	cis	1	rs591784	chr10:105936290	C10orf79	chr10:105889647-105992120:-	0.25	8	9.29E-15	Attention deficit hyperactivity disorder	
THCA	cis	1	rs59181394	chr16:77785955	NUDT7	chr16:77756411-77776153:+	0.36	4.91	1.25E-6	Obesity-related traits	
THCA	cis	1	rs591992	chr12:121019323	COQ5	chr12:120941083-120966964:-	0.14	3.51	0.000487	Type 1 diabetes nephropathy	
THCA	cis	1	rs591992	chr12:121019323	POP5	chr12:121016849-121019201:-	-0.16	-4.88	1.45E-6	Type 1 diabetes nephropathy	
THCA	cis	1	rs59204447	chr14:66106727	LOC645431	chr14:65877313-65879335:-	-0.61	-7.9	1.91E-14	Ischemic stroke	
THCA	cis	1	rs59226697	chr22:25870037	CRYBB2	chr22:25615612-25627836:+	0.76	8.18	2.58E-15	Bipolar disorder with mood-incongruent psychosis	
THCA	cis	1	rs59233487	chr10:81729450	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs59244547	chr3:156582997	LEKR1	chr3:156544076-156763918:+	-0.54	-10.49	2.67E-23	Bone mineral density	
THCA	cis	1	rs59246603	chr10:65233942	LOC84989	chr10:65224989-65226320:+	0.25	4.08	5.18E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs59246603	chr10:65233942	NRBF2	chr10:64893007-64914785:+	0.26	4.32	1.92E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs59257065	chr2:228179328	MFF	chr2:228189978-228222547:+	0.22	4.87	1.53E-6	Corneal structure	
THCA	cis	1	rs59274738	chr17:28437635	ANKRD13B	chr17:27916801-27941778:+	0.35	8.82	2.19E-17	Coffee consumption (cups per day)	
THCA	cis	1	rs59274738	chr17:28437635	CORO6	chr17:27941774-27948441:-	0.51	12.02	2.86E-29	Coffee consumption (cups per day)	
THCA	cis	1	rs59274738	chr17:28437635	EFCAB5	chr17:28256874-28435469:+	0.59	11.34	1.53E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs59274738	chr17:28437635	GIT1	chr17:27900487-27916610:-	0.28	6.61	1.04E-10	Coffee consumption (cups per day)	
THCA	cis	1	rs59274738	chr17:28437635	LRRC37B2	chr17:28903483-28992715:+	0.17	3.73	0.000215	Coffee consumption (cups per day)	
THCA	cis	1	rs59274738	chr17:28437635	SSH2	chr17:27952965-28257018:-	0.35	8.15	3.32E-15	Coffee consumption (cups per day)	
THCA	cis	1	rs59274738	chr17:28437635	TP53I13	chr17:27895739-27900174:+	0.19	5.28	1.94E-7	Coffee consumption (cups per day)	
THCA	cis	1	rs59290812	chr8:89441796	MMP16	chr8:89049462-89339717:-	0.33	5.29	1.91E-7	Electrodermal activity	
THCA	cis	1	rs593126	chr15:45935777	SPATA5L1	chr15:45694519-45713614:+	0.31	4.98	9.04E-7	Obesity-related traits	
THCA	cis	1	rs593151	chr10:105935979	C10orf79	chr10:105889647-105992120:-	0.25	8	9.29E-15	Attention deficit hyperactivity disorder	
THCA	cis	1	rs59329875	chr20:44547672	WFDC3	chr20:44402847-44420547:-	-0.27	-3.85	0.000132	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
THCA	cis	1	rs59343240	chr16:67850529	C16orf86	chr16:67700717-67702659:+	-0.28	-3.41	0.000704	Crohn's disease	
THCA	cis	1	rs59343240	chr16:67850529	ZDHHC1	chr16:67428323-67450339:-	0.42	4.73	3.03E-6	Crohn's disease	
THCA	cis	1	rs59343384	chr11:71828038	FAM86C	chr11:71498557-71512276:+	-0.31	-3.95	8.86E-5	Severe influenza A (H1N1) infection	
THCA	cis	1	rs59363432	chr14:74397545	LIN52	chr14:74551656-74667117:+	0.24	4.51	8.26E-6	Morning vs. evening chronotype	
THCA	cis	1	rs59363432	chr14:74397545	PTGR2	chr14:74318534-74352166:+	0.22	3.55	0.000429	Morning vs. evening chronotype	
THCA	cis	1	rs59363432	chr14:74397545	ZNF410	chr14:74318674-74398803:+	0.24	4.02	6.81E-5	Morning vs. evening chronotype	
THCA	cis	1	rs59370060	chr8:39398365	ADAM32	chr8:38965050-39142435:+	0.24	3.37	0.00081	Visceral adipose tissue/subcutaneous adipose tissue ratio	
THCA	cis	1	rs59374417	chr3:119288414	ADPRH	chr3:119298523-119308791:+	-0.21	-3.47	0.000565	Vitiligo	
THCA	cis	1	rs59375902	chr12:81441561	ACSS3	chr12:81471809-81649582:+	0.22	4.67	4.01E-6	Neuroticism	
THCA	cis	1	rs59376497	chr16:67681170	C16orf86	chr16:67700717-67702659:+	-0.32	-3.85	0.000137	Crohn's disease	
THCA	cis	1	rs59376497	chr16:67681170	LRRC36	chr16:67360747-67419108:+	0.4	3.57	0.000395	Crohn's disease	
THCA	cis	1	rs59376497	chr16:67681170	ZDHHC1	chr16:67428323-67450339:-	0.39	4.27	2.4E-5	Crohn's disease	
THCA	cis	1	rs59377495	chr10:1157019	IDI2	chr10:1064847-1071799:-	0.35	3.75	0.000197	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs59394709	chr1:162427943	HSD17B7	chr1:162760496-162782607:+	0.29	3.46	0.000594	Discordance in emotional problems in monozygotic twins	
THCA	cis	1	rs594074	chr6:6552994	LY86	chr6:6588934-6655216:+	0.12	3.54	0.000442	Diabetic kidney disease	
THCA	cis	1	rs59421433	chr6:42495344	PRPH2	chr6:42664334-42690358:-	-0.28	-3.78	0.000177	Obesity-related traits	
THCA	cis	1	rs59425875	chr8:89411899	MMP16	chr8:89049462-89339717:-	0.31	5.04	6.5E-7	Electrodermal activity	
THCA	cis	1	rs59428599	chr10:4970849	AKR1C2	chr10:4964715-5060207:-	0.33	4.38	1.45E-5	Height	
THCA	cis	1	rs59430846	chr8:89411781	MMP16	chr8:89049462-89339717:-	0.31	5.04	6.5E-7	Electrodermal activity	
THCA	cis	1	rs59459704	chr6:70424585	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.37	0.000799	Sleep duration	
THCA	cis	1	rs59468948	chr1:156288058	BGLAP	chr1:156182784-156213112:+	0.23	5.55	4.68E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs59468948	chr1:156288058	C1orf85	chr1:156259882-156265449:-	-0.17	-4.16	3.82E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs59468948	chr1:156288058	CCT3	chr1:156278752-156308195:-	-0.33	-7.21	2.16E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs59484067	chr8:89409343	MMP16	chr8:89049462-89339717:-	0.34	5.25	2.25E-7	Electrodermal activity	
THCA	cis	1	rs59495340	chr8:89452311	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs59496049	chr2:242260756	SEPT2	chr2:242254723-242293439:+	-0.28	-4.71	3.32E-6	Prostate cancer	
THCA	cis	1	rs59498179	chr1:146872147	FMO5	chr1:146655885-146697230:-	0.24	3.87	0.000125	Protein quantitative trait loci	
THCA	cis	1	rs59510607	chr6:70482983	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.55	0.000425	Sleep duration	
THCA	cis	1	rs59531858	chr5:150247063	LOC134466	chr5:150310000-150326146:-	0.44	5.85	9.03E-9	Crohn's disease	
THCA	cis	1	rs59531858	chr5:150247063	ZNF300	chr5:150273964-150284391:-	0.16	3.39	0.000744	Crohn's disease	
THCA	cis	1	rs59536819	chr2:242272388	ANO7	chr2:242127924-242164791:+	0.36	4.13	4.26E-5	Prostate cancer	
THCA	cis	1	rs59536819	chr2:242272388	SEPT2	chr2:242254723-242293439:+	-0.29	-4.17	3.59E-5	Prostate cancer	
THCA	cis	1	rs59546367	chr12:51345373	SLC11A2	chr12:51373319-51422058:-	-0.23	-4.64	4.46E-6	Type 2 diabetes	
THCA	cis	1	rs59546367	chr12:51345373	TFCP2	chr12:51488608-51566917:-	-0.19	-4.07	5.58E-5	Type 2 diabetes	
THCA	cis	1	rs59561356	chr14:66020022	LOC645431	chr14:65877313-65879335:-	-0.58	-7.31	1.13E-12	Ischemic stroke	
THCA	cis	1	rs59580800	chr8:89437373	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs59583591	chr3:53119581	RFT1	chr3:53122503-53164470:-	0.59	7.31	1.17E-12	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs59601467	chr8:124193488	FAM83A	chr8:124191287-124222317:+	-0.3	-4.02	6.9E-5	Urinary uromodulin levels	
THCA	cis	1	rs59606579	chr6:25608370	SCGN	chr6:25652429-25702006:+	-0.3	-5.81	1.12E-8	Uric acid levels	
THCA	cis	1	rs59630213	chr16:77777030	NUDT7	chr16:77756411-77776153:+	0.37	5.15	3.83E-7	Obesity-related traits	
THCA	cis	1	rs59645827	chr8:89436001	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs59663729	chr5:110433789	TSLP	chr5:110405778-110413722:+	-0.33	-4.42	1.24E-5	Eosinophil counts	
THCA	cis	1	rs59663729	chr5:110433789	WDR36	chr5:110427870-110466201:+	0.19	3.58	0.00038	Eosinophil counts	
THCA	cis	1	rs59676254	chr14:65942840	LOC645431	chr14:65877313-65879335:-	-0.59	-7.8	4.04E-14	Ischemic stroke	
THCA	cis	1	rs59682951	chr17:18800766	FAM18B	chr17:18684582-18710026:+	-0.42	-10.43	4.53E-23	Educational attainment (years of education)	
THCA	cis	1	rs59682951	chr17:18800766	FBXW10	chr17:18647326-18682661:+	-0.25	-5.39	1.08E-7	Educational attainment (years of education)	
THCA	cis	1	rs59685862	chr14:66080130	LOC645431	chr14:65877313-65879335:-	-0.62	-7.96	1.24E-14	Ischemic stroke	
THCA	cis	1	rs59689949	chr11:93706695	HEPHL1	chr11:93754378-93847374:+	0.49	3.95	8.96E-5	Obesity-related traits	
THCA	cis	1	rs59715646	chr19:10839447	SLC44A2	chr19:10713121-10755234:+	0.3	3.4	0.000743	LDL cholesterol	
THCA	cis	1	rs59715748	chr5:150189287	LOC134466	chr5:150310000-150326146:-	0.45	5.75	1.55E-8	Crohn's disease	
THCA	cis	1	rs59715748	chr5:150189287	ZNF300	chr5:150273964-150284391:-	0.18	3.71	0.000236	Crohn's disease	
THCA	cis	1	rs59715866	chr1:27079176	ZDHHC18	chr1:27153201-27182207:+	0.8	8.63	9.37E-17	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs59725465	chr8:89410497	MMP16	chr8:89049462-89339717:-	0.31	5.04	6.5E-7	Electrodermal activity	
THCA	cis	1	rs59738216	chr6:70492176	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.41	0.000704	Sleep duration	
THCA	cis	1	rs59745808	chr8:89452576	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs59762006	chr3:119280625	ADPRH	chr3:119298523-119308791:+	-0.22	-3.59	0.000366	Vitiligo	
THCA	cis	1	rs59770215	chr6:159371062	RSPH3	chr6:159398268-159421198:-	0.28	6	3.97E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs59784306	chr20:61859596	BIRC7	chr20:61867276-61871853:+	0.32	3.88	0.00012	Response to cytadine analogues (cytosine arabinoside)	
THCA	cis	1	rs59784306	chr20:61859596	NKAIN4	chr20:61872137-61885892:-	0.31	3.37	0.000819	Response to cytadine analogues (cytosine arabinoside)	
THCA	cis	1	rs59793398	chr11:93717927	HEPHL1	chr11:93754378-93847374:+	0.43	3.48	0.000553	Obesity-related traits	
THCA	cis	1	rs59794892	chr7:65415873	CCT6P1	chr7:65216092-65228661:+	0.38	6.08	2.41E-9	Diabetic kidney disease	
THCA	cis	1	rs59794892	chr7:65415873	CRCP	chr7:65579805-65619551:+	-0.27	-4.13	4.33E-5	Diabetic kidney disease	
THCA	cis	1	rs59794892	chr7:65415873	RABGEF1	chr7:66093890-66276446:+	0.54	6.85	2.3E-11	Diabetic kidney disease	
THCA	cis	1	rs59804446	chr4:56429541	TMEM165	chr4:56262090-56292342:+	0.14	3.51	0.000497	Personality dimensions	
THCA	cis	1	rs59808242	chr5:130754894	P4HA2	chr5:131528306-131563556:-	-0.25	-4.92	1.21E-6	Life satisfaction	
THCA	cis	1	rs59822422	chr14:65889566	LOC645431	chr14:65877313-65879335:-	-0.6	-7.88	2.31E-14	Ischemic stroke	
THCA	cis	1	rs59834873	chr8:124188824	FAM83A	chr8:124191287-124222317:+	-0.33	-4.38	1.46E-5	Urinary uromodulin levels	
THCA	cis	1	rs59904960	chr2:227761269	COL4A4	chr2:227867435-228029275:-	0.16	3.97	8.32E-5	Pulmonary function	
THCA	cis	1	rs59907625	chr19:6079598	RFX2	chr19:5993176-6110664:-	0.37	3.91	0.000107	Bipolar disorder and schizophrenia	
THCA	cis	1	rs599083	chr11:68192346	LOC645332	chr11:67559240-67572807:-	0.16	3.5	0.000514	Bone mineral density (spine)	
THCA	cis	1	rs5992135	chr22:18447114	MICAL3	chr22:18270418-18507325:-	-0.2	-4.13	4.32E-5	Presence of antiphospholipid antibodies	
THCA	cis	1	rs59921977	chr14:66018659	LOC645431	chr14:65877313-65879335:-	-0.6	-7.55	2.21E-13	Ischemic stroke	
THCA	cis	1	rs59925331	chr17:38169273	GSDMA	chr17:38119226-38134019:+	-0.31	-7.24	1.75E-12	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THCA	cis	1	rs5992917	chr22:18443699	MICAL3	chr22:18270418-18507325:-	-0.21	-4.27	2.33E-5	Presence of antiphospholipid antibodies	
THCA	cis	1	rs5992919	chr22:18443855	MICAL3	chr22:18270418-18507325:-	-0.21	-4.27	2.33E-5	Presence of antiphospholipid antibodies	
THCA	cis	1	rs5992921	chr22:18445263	MICAL3	chr22:18270418-18507325:-	-0.19	-3.96	8.62E-5	Presence of antiphospholipid antibodies	
THCA	cis	1	rs5992922	chr22:18445287	MICAL3	chr22:18270418-18507325:-	-0.19	-3.96	8.62E-5	Presence of antiphospholipid antibodies	
THCA	cis	1	rs5992926	chr22:18449876	MICAL3	chr22:18270418-18507325:-	-0.2	-3.98	7.86E-5	Presence of antiphospholipid antibodies	
THCA	cis	1	rs5992928	chr22:18451438	MICAL3	chr22:18270418-18507325:-	-0.2	-3.97	8.38E-5	Presence of antiphospholipid antibodies	
THCA	cis	1	rs59937473	chr2:271797	SH3YL1	chr2:218138-264810:-	-0.93	-25.8	1.3E-92	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs5994434	chr22:32229649	SFI1	chr22:31892261-32014533:+	-0.24	-4.58	5.87E-6	Intelligence	
THCA	cis	1	rs59945106	chr16:77780154	NUDT7	chr16:77756411-77776153:+	0.36	4.99	8.33E-7	Obesity-related traits	
THCA	cis	1	rs59947468	chr2:86289436	LOC90784	chr2:86247339-86250991:-	-0.61	-6.49	2.17E-10	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs59948050	chr1:15915157	SLC25A34	chr1:16062809-16067885:+	-0.18	-3.8	0.000162	Morning vs. evening chronotype	
THCA	cis	1	rs59950564	chr17:65860859	C17orf58	chr17:65987218-65989765:-	0.2	3.95	8.87E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs59951423	chr8:89372154	MMP16	chr8:89049462-89339717:-	0.31	4.88	1.48E-6	Electrodermal activity	
THCA	cis	1	rs5995610	chr22:39064681	JOSD1	chr22:39081549-39096459:-	-0.15	-4	7.32E-5	Resting heart rate	
THCA	cis	1	rs5995610	chr22:39064681	TOMM22	chr22:39077954-39080763:+	-0.17	-3.65	0.000291	Resting heart rate	
THCA	cis	1	rs5996946	chr22:25875988	CRYBB2	chr22:25615612-25627836:+	0.84	12.8	1.88E-32	Bipolar disorder with mood-incongruent psychosis	
THCA	cis	1	rs59980321	chr5:150241813	LOC134466	chr5:150310000-150326146:-	0.42	5.86	8.57E-9	Crohn's disease	
THCA	cis	1	rs59980321	chr5:150241813	ZNF300	chr5:150273964-150284391:-	0.16	3.46	0.000586	Crohn's disease	
THCA	cis	1	rs59989824	chr7:118175322	ANKRD7	chr7:117864712-117882782:+	0.25	4.11	4.74E-5	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs599946	chr5:139057461	DNAJC18	chr5:138747381-138775139:-	0.16	3.66	0.000278	Schizophrenia	
THCA	cis	1	rs60000965	chr10:81729165	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs6001173	chr22:39015302	JOSD1	chr22:39081549-39096459:-	-0.13	-3.49	0.000522	Resting heart rate	
THCA	cis	1	rs6001173	chr22:39015302	LOC646851	chr22:38974125-39052634:-	0.15	3.91	0.000106	Resting heart rate	
THCA	cis	1	rs6001173	chr22:39015302	TOMM22	chr22:39077954-39080763:+	-0.17	-3.76	0.00019	Resting heart rate	
THCA	cis	1	rs6001175	chr22:39018334	JOSD1	chr22:39081549-39096459:-	-0.14	-3.7	0.000242	Resting heart rate	
THCA	cis	1	rs6001175	chr22:39018334	LOC646851	chr22:38974125-39052634:-	0.14	3.76	0.000192	Resting heart rate	
THCA	cis	1	rs6001175	chr22:39018334	TOMM22	chr22:39077954-39080763:+	-0.18	-3.98	8.08E-5	Resting heart rate	
THCA	cis	1	rs6001182	chr22:39047443	JOSD1	chr22:39081549-39096459:-	-0.15	-3.94	9.33E-5	Resting heart rate	
THCA	cis	1	rs6001182	chr22:39047443	TOMM22	chr22:39077954-39080763:+	-0.16	-3.58	0.000379	Resting heart rate	
THCA	cis	1	rs6001184	chr22:39052116	JOSD1	chr22:39081549-39096459:-	-0.15	-3.94	9.33E-5	Resting heart rate	
THCA	cis	1	rs6001184	chr22:39052116	TOMM22	chr22:39077954-39080763:+	-0.16	-3.58	0.000379	Resting heart rate	
THCA	cis	1	rs6001185	chr22:39052155	JOSD1	chr22:39081549-39096459:-	-0.15	-3.94	9.33E-5	Resting heart rate	
THCA	cis	1	rs6001185	chr22:39052155	TOMM22	chr22:39077954-39080763:+	-0.16	-3.58	0.000379	Resting heart rate	
THCA	cis	1	rs6001188	chr22:39062194	JOSD1	chr22:39081549-39096459:-	-0.15	-3.88	0.000121	Resting heart rate	
THCA	cis	1	rs6001188	chr22:39062194	TOMM22	chr22:39077954-39080763:+	-0.16	-3.56	0.000406	Resting heart rate	
THCA	cis	1	rs6001191	chr22:39074452	JOSD1	chr22:39081549-39096459:-	-0.15	-3.89	0.000115	Resting heart rate	
THCA	cis	1	rs6001191	chr22:39074452	LOC646851	chr22:38974125-39052634:-	0.13	3.4	0.000739	Resting heart rate	
THCA	cis	1	rs6001191	chr22:39074452	TOMM22	chr22:39077954-39080763:+	-0.16	-3.55	0.000423	Resting heart rate	
THCA	cis	1	rs6001204	chr22:39100239	LOC646851	chr22:38974125-39052634:-	0.13	3.59	0.000361	Resting heart rate	
THCA	cis	1	rs6001204	chr22:39100239	TOMM22	chr22:39077954-39080763:+	-0.16	-3.5	0.000515	Resting heart rate	
THCA	cis	1	rs6001214	chr22:39149155	LOC646851	chr22:38974125-39052634:-	0.18	4.61	5.15E-6	Resting heart rate	
THCA	cis	1	rs6001214	chr22:39149155	SUN2	chr22:39130735-39190161:-	0.15	3.55	0.000427	Resting heart rate	
THCA	cis	1	rs600193	chr15:65729409	DPP8	chr15:65737999-65810035:-	0.09	3.86	0.000126	Mean corpuscular hemoglobin	
THCA	cis	1	rs600193	chr15:65729409	SLC24A1	chr15:65903704-65953256:+	0.16	3.79	0.000167	Mean corpuscular hemoglobin	
THCA	cis	1	rs60025964	chr2:99880577	LIPT1	chr2:99771418-99779611:+	0.2	3.89	0.000116	IgG glycosylation	
THCA	cis	1	rs60029373	chr2:233456262	EIF4E2	chr2:233415357-233448349:+	-0.23	-4.34	1.72E-5	Height	
THCA	cis	1	rs60030116	chr8:94071004	C8orf83	chr8:93895865-94029901:-	0.27	4.43	1.19E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs6003518	chr22:23471533	GNAZ	chr22:23412669-23467221:+	-0.27	-5.8	1.23E-8	Bone mineral density	
THCA	cis	1	rs60043652	chr2:17778944	GEN1	chr2:17935162-17966632:+	0.51	6.86	2.08E-11	Psychosis and Alzheimer's disease	
THCA	cis	1	rs6004667	chr22:25874464	CRYBB2	chr22:25615612-25627836:+	-0.83	-12.71	4.24E-32	Bipolar disorder with mood-incongruent psychosis	
THCA	cis	1	rs6004669	chr22:25875803	CRYBB2	chr22:25615612-25627836:+	0.82	12.49	3.48E-31	Bipolar disorder with mood-incongruent psychosis	
THCA	cis	1	rs6004673	chr22:25885353	CRYBB2	chr22:25615612-25627836:+	0.75	12.17	7.22E-30	Bipolar disorder with mood-incongruent psychosis	
THCA	cis	1	rs60072763	chr9:99547980	FAM22G	chr9:99690592-99704572:+	0.98	7.96	1.22E-14	Height	
THCA	cis	1	rs60072763	chr9:99547980	HIATL2	chr9:99695549-99775862:-	0.71	5.74	1.66E-8	Height	
THCA	cis	1	rs60072763	chr9:99547980	LOC441454	chr9:99671357-99672736:+	0.44	3.92	0.0001	Height	
THCA	cis	1	rs600848	chr5:139057270	DNAJC18	chr5:138747381-138775139:-	0.16	3.62	0.000321	Schizophrenia	
THCA	cis	1	rs601019	chr10:105976452	C10orf79	chr10:105889647-105992120:-	-0.24	-7.91	1.85E-14	Attention deficit hyperactivity disorder	
THCA	cis	1	rs60105040	chr17:76098948	TMC6	chr17:76108999-76128488:-	0.18	3.54	0.000434	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs601060	chr1:47139580	CYP4B1	chr1:47264670-47285020:+	-0.21	-3.36	0.000849	Response to hepatitis C treatment	
THCA	cis	1	rs601060	chr1:47139580	CYP4Z1	chr1:47533160-47583992:+	-0.26	-3.95	8.97E-5	Response to hepatitis C treatment	
THCA	cis	1	rs601060	chr1:47139580	DMBX1	chr1:46972668-46979884:+	-0.23	-4.04	6.11E-5	Response to hepatitis C treatment	
THCA	cis	1	rs6011691	chr20:61867454	BIRC7	chr20:61867276-61871853:+	0.31	3.82	0.000149	Response to cytadine analogues (cytosine arabinoside)	
THCA	cis	1	rs6011691	chr20:61867454	NKAIN4	chr20:61872137-61885892:-	0.31	3.5	0.000511	Response to cytadine analogues (cytosine arabinoside)	
THCA	cis	1	rs60120959	chr8:66799706	PDE7A	chr8:66629906-66753755:-	0.16	3.58	0.000383	Myopia (pathological)	
THCA	cis	1	rs6012564	chr20:47541600	ARFGEF2	chr20:47538275-47653229:+	-0.12	-3.92	0.000103	Anger	
THCA	cis	1	rs6012564	chr20:47541600	CSE1L	chr20:47662838-47713484:+	0.41	10.17	3.84E-22	Anger	
THCA	cis	1	rs6012617	chr20:47837126	DDX27	chr20:47835832-47860612:+	-0.25	-4.59	5.56E-6	Height	
THCA	cis	1	rs60126902	chr4:75710822	BTC	chr4:75671448-75719882:-	0.2	3.92	0.000103	Electroencephalogram traits	
THCA	cis	1	rs601324	chr5:139057179	DNAJC18	chr5:138747381-138775139:-	0.16	3.62	0.000321	Schizophrenia	
THCA	cis	1	rs601336	chr5:139057167	DNAJC18	chr5:138747381-138775139:-	0.16	3.58	0.000373	Schizophrenia	
THCA	cis	1	rs60134818	chr5:150261043	LOC134466	chr5:150310000-150326146:-	0.38	5.29	1.84E-7	Crohn's disease	
THCA	cis	1	rs60144605	chr1:76359699	ACADM	chr1:76190043-76229353:+	-0.26	-5.3	1.73E-7	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs60146975	chr6:159358206	RSPH3	chr6:159398268-159421198:-	0.26	5.49	6.43E-8	Bladder cancer (smoking interaction)	
THCA	cis	1	rs6014859	chr20:55454584	CBLN4	chr20:54572497-54580012:-	-0.21	-3.49	0.000536	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs60149603	chr2:285421	SH3YL1	chr2:218138-264810:-	-0.94	-26.08	6.91E-94	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs601728	chr5:139057076	DNAJC18	chr5:138747381-138775139:-	0.16	3.62	0.000321	Schizophrenia	
THCA	cis	1	rs6017495	chr20:43756955	STK4	chr20:43595120-43708591:+	-0.17	-4.05	5.98E-5	Parental longevity (mother's age at death)	
THCA	cis	1	rs60178264	chr4:17685308	MED28	chr4:17616273-17629791:+	0.16	3.43	0.000658	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs60184524	chr19:44294215	LYPD5	chr19:44300080-44324808:-	-0.24	-5.05	6.18E-7	Breast cancer	
THCA	cis	1	rs60184524	chr19:44294215	ZNF155	chr19:44488355-44502477:+	-0.25	-5.66	2.58E-8	Breast cancer	
THCA	cis	1	rs60184524	chr19:44294215	ZNF404	chr19:44376516-44384288:-	-0.26	-6.8	3.16E-11	Breast cancer	
THCA	cis	1	rs601923	chr5:176417386	ZNF346	chr5:176449697-176508190:+	-0.16	-5.51	5.99E-8	Menopause (age at onset);Menarche and menopause (age at onset)	
THCA	cis	1	rs60209440	chr2:242260340	ANO7	chr2:242127924-242164791:+	0.36	4.13	4.26E-5	Prostate cancer	
THCA	cis	1	rs60209440	chr2:242260340	SEPT2	chr2:242254723-242293439:+	-0.29	-4.17	3.59E-5	Prostate cancer	
THCA	cis	1	rs60210425	chr15:56494711	TEX9	chr15:56657644-56738071:+	-0.34	-5.88	7.84E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs602128	chr11:102713465	MMP1	chr11:102660641-102668966:-	0.25	4.48	9.55E-6	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	
THCA	cis	1	rs60228288	chr18:44640412	HDHD2	chr18:44633782-44676871:-	0.26	4.99	8.46E-7	Sitting height ratio	
THCA	cis	1	rs60228288	chr18:44640412	PIAS2	chr18:44392061-44500123:-	-0.15	-3.36	0.000847	Sitting height ratio	
THCA	cis	1	rs60231938	chr16:69830415	COG4	chr16:70514473-70557457:-	-0.19	-3.83	0.000144	IgE levels	
THCA	cis	1	rs60245117	chr8:89438405	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs60251819	chr6:24468648	GMNN	chr6:24775159-24786276:+	-0.28	-3.74	0.000203	Hematological and biochemical traits	
THCA	cis	1	rs60251819	chr6:24468648	GPLD1	chr6:24428405-24489850:-	0.25	4.7	3.46E-6	Hematological and biochemical traits	
THCA	cis	1	rs60251819	chr6:24468648	MRS2	chr6:24403153-24425809:+	0.24	5.44	8.49E-8	Hematological and biochemical traits	
THCA	cis	1	rs6025229	chr20:55452397	CBLN4	chr20:54572497-54580012:-	0.21	3.5	0.000514	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs60253563	chr6:170083019	C6orf70	chr6:170151721-170181617:+	0.27	5.21	2.78E-7	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs60253563	chr6:170083019	WDR27	chr6:169857307-170102159:-	-0.2	-5.91	6.66E-9	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs60258162	chr8:66845886	PDE7A	chr8:66629906-66753755:-	0.17	3.82	0.000154	Myopia (pathological)	
THCA	cis	1	rs60267481	chr6:3291109	PSMG4	chr6:3259162-3268300:+	-0.33	-5.52	5.44E-8	Survival in rectal cancer	
THCA	cis	1	rs6028335	chr20:37845477	DHX35	chr20:37591000-37668363:+	-0.26	-6.23	1.0E-9	Alcohol and nictotine co-dependence	
THCA	cis	1	rs6030712	chr20:35637398	RPN2	chr20:35807456-35870023:+	-0.24	-4.12	4.47E-5	Height	
THCA	cis	1	rs60310240	chr14:88822709	SPATA7	chr14:88852012-88904802:+	-0.18	-3.65	0.000291	Coronary artery calcification	
THCA	cis	1	rs60319753	chr2:9767944	IAH1	chr2:9614670-9636671:+	0.16	3.57	0.000389	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	
THCA	cis	1	rs6032006	chr20:43755053	STK4	chr20:43595120-43708591:+	-0.17	-4.03	6.46E-5	Parental longevity (mother's age at death)	
THCA	cis	1	rs60326618	chr7:66166358	CCT6P1	chr7:65216092-65228661:+	0.43	6.6	1.1E-10	Gout	
THCA	cis	1	rs60326618	chr7:66166358	CRCP	chr7:65579805-65619551:+	-0.29	-4.34	1.77E-5	Gout	
THCA	cis	1	rs60326618	chr7:66166358	GUSB	chr7:65425675-65447246:-	0.28	3.45	0.000613	Gout	
THCA	cis	1	rs60326618	chr7:66166358	RABGEF1	chr7:66093890-66276446:+	0.63	7.69	8.35E-14	Gout	
THCA	cis	1	rs60336907	chr8:89476919	MMP16	chr8:89049462-89339717:-	0.33	5.11	4.7E-7	Electrodermal activity	
THCA	cis	1	rs60340200	chr1:27287716	ZDHHC18	chr1:27153201-27182207:+	0.73	7.54	2.42E-13	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs6034489	chr20:16456812	KIF16B	chr20:16252749-16554078:-	-0.16	-3.77	0.000186	Intelligence	
THCA	cis	1	rs6034490	chr20:16457021	KIF16B	chr20:16252749-16554078:-	-0.16	-3.77	0.000186	Intelligence	
THCA	cis	1	rs60350282	chr8:89460917	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs60362869	chr8:124189971	FAM83A	chr8:124191287-124222317:+	-0.3	-3.9	0.000108	Urinary uromodulin levels	
THCA	cis	1	rs6037086	chr20:25306338	ENTPD6	chr20:25176339-25207360:+	0.31	6.96	1.09E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6037086	chr20:25306338	FAM182A	chr20:26035250-26067552:+	0.18	3.41	0.000693	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6037086	chr20:25306338	FAM182B	chr20:25744102-25848786:-	-0.26	-5.37	1.21E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6037086	chr20:25306338	NINL	chr20:25433338-25566153:-	0.37	7.55	2.24E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6037086	chr20:25306338	PYGB	chr20:25228706-25278647:+	0.15	3.71	0.000228	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6037095	chr20:25335687	ENTPD6	chr20:25176339-25207360:+	0.3	6.7	5.92E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6037095	chr20:25335687	FAM182A	chr20:26035250-26067552:+	0.19	3.48	0.000553	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6037095	chr20:25335687	FAM182B	chr20:25744102-25848786:-	-0.26	-5.44	8.66E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6037095	chr20:25335687	NINL	chr20:25433338-25566153:-	0.34	7.04	6.69E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6037095	chr20:25335687	PYGB	chr20:25228706-25278647:+	0.14	3.59	0.000359	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6037099	chr20:25356876	ENTPD6	chr20:25176339-25207360:+	0.32	7.23	1.88E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6037099	chr20:25356876	FAM182A	chr20:26035250-26067552:+	0.19	3.49	0.000536	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6037099	chr20:25356876	FAM182B	chr20:25744102-25848786:-	-0.26	-5.4	1.06E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6037099	chr20:25356876	NINL	chr20:25433338-25566153:-	0.33	6.9	1.7E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6037099	chr20:25356876	PYGB	chr20:25228706-25278647:+	0.16	4.03	6.5E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6037105	chr20:25374199	ENTPD6	chr20:25176339-25207360:+	0.32	7.23	1.88E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6037105	chr20:25374199	FAM182A	chr20:26035250-26067552:+	0.19	3.49	0.000536	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6037105	chr20:25374199	FAM182B	chr20:25744102-25848786:-	-0.26	-5.4	1.06E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6037105	chr20:25374199	NINL	chr20:25433338-25566153:-	0.33	6.9	1.7E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6037105	chr20:25374199	PYGB	chr20:25228706-25278647:+	0.16	4.03	6.5E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6037121	chr20:25428311	ENTPD6	chr20:25176339-25207360:+	-0.32	-7.43	5.05E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6037121	chr20:25428311	FAM182A	chr20:26035250-26067552:+	-0.18	-3.44	0.000635	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6037121	chr20:25428311	FAM182B	chr20:25744102-25848786:-	0.25	5.25	2.3E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6037121	chr20:25428311	NINL	chr20:25433338-25566153:-	-0.34	-7.11	4.29E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6037121	chr20:25428311	PYGB	chr20:25228706-25278647:+	-0.15	-3.78	0.000174	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6037526	chr20:3251248	ITPA	chr20:3190056-3204504:+	-0.24	-5.87	8.02E-9	IFN-related cytopenia	
THCA	cis	1	rs6037532	chr20:3267911	ITPA	chr20:3190056-3204504:+	-0.24	-5.92	6.32E-9	IFN-related cytopenia	
THCA	cis	1	rs6037533	chr20:3268817	ITPA	chr20:3190056-3204504:+	-0.24	-5.92	6.32E-9	IFN-related cytopenia	
THCA	cis	1	rs6037535	chr20:3270621	ITPA	chr20:3190056-3204504:+	-0.25	-6.07	2.6E-9	IFN-related cytopenia	
THCA	cis	1	rs6037538	chr20:3282978	ITPA	chr20:3190056-3204504:+	-0.24	-5.88	7.83E-9	IFN-related cytopenia	
THCA	cis	1	rs6037547	chr20:3299228	ITPA	chr20:3190056-3204504:+	-0.24	-5.87	8.02E-9	IFN-related cytopenia	
THCA	cis	1	rs6037551	chr20:3306690	ITPA	chr20:3190056-3204504:+	-0.25	-6.07	2.6E-9	IFN-related cytopenia	
THCA	cis	1	rs6037553	chr20:3313884	ITPA	chr20:3190056-3204504:+	-0.25	-6.07	2.6E-9	IFN-related cytopenia	
THCA	cis	1	rs6037554	chr20:3315613	ITPA	chr20:3190056-3204504:+	-0.24	-5.83	1.0E-8	IFN-related cytopenia	
THCA	cis	1	rs6037556	chr20:3317890	ITPA	chr20:3190056-3204504:+	-0.24	-5.83	1.0E-8	IFN-related cytopenia	
THCA	cis	1	rs6037560	chr20:3323055	ITPA	chr20:3190056-3204504:+	-0.23	-5.6	3.57E-8	IFN-related cytopenia	
THCA	cis	1	rs6037562	chr20:3326141	ITPA	chr20:3190056-3204504:+	-0.23	-5.69	2.21E-8	IFN-related cytopenia	
THCA	cis	1	rs6037567	chr20:3332160	ITPA	chr20:3190056-3204504:+	-0.23	-5.69	2.21E-8	IFN-related cytopenia	
THCA	cis	1	rs6037579	chr20:3347980	ITPA	chr20:3190056-3204504:+	-0.24	-5.85	9.27E-9	IFN-related cytopenia	
THCA	cis	1	rs6037583	chr20:3360632	ITPA	chr20:3190056-3204504:+	-0.24	-5.92	6.32E-9	IFN-related cytopenia	
THCA	cis	1	rs6037590	chr20:3374085	ITPA	chr20:3190056-3204504:+	-0.25	-6.08	2.52E-9	IFN-related cytopenia	
THCA	cis	1	rs60376560	chr11:18453742	LDHC	chr11:18433853-18472792:+	-0.33	-3.87	0.000123	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs6037708	chr20:3961253	MAVS	chr20:3827449-3856761:+	-0.23	-3.64	0.000303	Response to antidepressants in depression	
THCA	cis	1	rs60399786	chr3:128062070	EEFSEC	chr3:127872313-128127488:+	-0.23	-3.99	7.56E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs60401377	chr1:27052247	ZDHHC18	chr1:27153201-27182207:+	0.8	8.6	1.15E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs60422392	chr18:44621473	HDHD2	chr18:44633782-44676871:-	0.28	5.21	2.84E-7	Sitting height ratio	
THCA	cis	1	rs60422392	chr18:44621473	PIAS2	chr18:44392061-44500123:-	-0.16	-3.35	0.000869	Sitting height ratio	
THCA	cis	1	rs6042314	chr20:13696129	C20orf7	chr20:13765682-13797872:+	-0.19	-4.06	5.81E-5	Intelligence (childhood)	
THCA	cis	1	rs60425110	chr15:75333000	ARID3B	chr15:74833548-74890470:+	-0.16	-3.91	0.000108	Blood trace element (Zn levels)	
THCA	cis	1	rs60425110	chr15:75333000	PPCDC	chr15:75315927-75343066:+	0.19	5.1	5.02E-7	Blood trace element (Zn levels)	
THCA	cis	1	rs60425110	chr15:75333000	SCAMP5	chr15:75287901-75313836:+	0.51	8.64	8.69E-17	Blood trace element (Zn levels)	
THCA	cis	1	rs6042	chr13:113770068	F7	chr13:113760105-113774994:+	-0.28	-3.94	9.32E-5	End-stage coagulation	
THCA	cis	1	rs60432293	chr17:65860407	C17orf58	chr17:65987218-65989765:-	0.24	4.89	1.41E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs6043988	chr20:16455165	KIF16B	chr20:16252749-16554078:-	-0.16	-3.77	0.000186	Intelligence	
THCA	cis	1	rs6043989	chr20:16455389	KIF16B	chr20:16252749-16554078:-	-0.16	-3.77	0.000186	Intelligence	
THCA	cis	1	rs6043991	chr20:16457369	KIF16B	chr20:16252749-16554078:-	-0.16	-3.77	0.000186	Intelligence	
THCA	cis	1	rs6044111	chr20:16536324	KIF16B	chr20:16252749-16554078:-	0.26	5.09	5.28E-7	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs6044112	chr20:16536414	KIF16B	chr20:16252749-16554078:-	0.26	5.04	6.52E-7	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs60469280	chr8:89452250	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs6047116	chr20:20848968	RALGAPA2	chr20:20373412-20693266:-	0.11	4.09	4.99E-5	Cognitive function	
THCA	cis	1	rs60479377	chr2:86283948	LOC90784	chr2:86247339-86250991:-	-0.61	-6.49	2.17E-10	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs60482040	chr17:80403059	C17orf62	chr17:80400520-80408694:-	-0.27	-6.55	1.53E-10	Protein quantitative trait loci	
THCA	cis	1	rs60484953	chr2:221560	SH3YL1	chr2:218138-264810:-	-0.93	-25.81	1.24E-92	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs6050542	chr20:25318879	ENTPD6	chr20:25176339-25207360:+	0.31	6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050542	chr20:25318879	FAM182A	chr20:26035250-26067552:+	0.18	3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050542	chr20:25318879	FAM182B	chr20:25744102-25848786:-	-0.27	-5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050542	chr20:25318879	NINL	chr20:25433338-25566153:-	0.35	7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050542	chr20:25318879	PYGB	chr20:25228706-25278647:+	0.16	4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050544	chr20:25320228	ENTPD6	chr20:25176339-25207360:+	0.3	6.79	3.43E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050544	chr20:25320228	FAM182A	chr20:26035250-26067552:+	0.19	3.44	0.000633	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050544	chr20:25320228	FAM182B	chr20:25744102-25848786:-	-0.26	-5.47	7.25E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050544	chr20:25320228	NINL	chr20:25433338-25566153:-	0.35	7.15	3.21E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050544	chr20:25320228	PYGB	chr20:25228706-25278647:+	0.15	3.68	0.000264	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050547	chr20:25326012	ENTPD6	chr20:25176339-25207360:+	0.3	6.79	3.36E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050547	chr20:25326012	FAM182B	chr20:25744102-25848786:-	-0.27	-5.64	2.97E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050547	chr20:25326012	NINL	chr20:25433338-25566153:-	0.36	7.3	1.21E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050547	chr20:25326012	PYGB	chr20:25228706-25278647:+	0.16	4.02	6.84E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050555	chr20:25328543	ENTPD6	chr20:25176339-25207360:+	0.31	6.91	1.58E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050555	chr20:25328543	FAM182B	chr20:25744102-25848786:-	-0.27	-5.52	5.71E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050555	chr20:25328543	NINL	chr20:25433338-25566153:-	0.34	6.95	1.2E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050555	chr20:25328543	PYGB	chr20:25228706-25278647:+	0.17	4.15	3.9E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050559	chr20:25329915	ENTPD6	chr20:25176339-25207360:+	-0.29	-6.57	1.32E-10	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050559	chr20:25329915	FAM182A	chr20:26035250-26067552:+	-0.19	-3.45	0.000602	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050559	chr20:25329915	FAM182B	chr20:25744102-25848786:-	0.26	5.49	6.49E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050559	chr20:25329915	NINL	chr20:25433338-25566153:-	-0.35	-7.23	1.88E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050559	chr20:25329915	PYGB	chr20:25228706-25278647:+	-0.14	-3.64	0.000306	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050561	chr20:25334855	ENTPD6	chr20:25176339-25207360:+	0.32	7.24	1.84E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050561	chr20:25334855	FAM182A	chr20:26035250-26067552:+	0.19	3.48	0.000539	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050561	chr20:25334855	FAM182B	chr20:25744102-25848786:-	-0.26	-5.4	1.08E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050561	chr20:25334855	NINL	chr20:25433338-25566153:-	0.33	6.89	1.74E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050561	chr20:25334855	PYGB	chr20:25228706-25278647:+	0.16	4.03	6.46E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050562	chr20:25336186	ENTPD6	chr20:25176339-25207360:+	0.3	6.7	5.92E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050562	chr20:25336186	FAM182A	chr20:26035250-26067552:+	0.19	3.48	0.000553	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050562	chr20:25336186	FAM182B	chr20:25744102-25848786:-	-0.26	-5.44	8.66E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050562	chr20:25336186	NINL	chr20:25433338-25566153:-	0.34	7.04	6.69E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050562	chr20:25336186	PYGB	chr20:25228706-25278647:+	0.14	3.59	0.000359	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050564	chr20:25344231	ENTPD6	chr20:25176339-25207360:+	0.32	7.24	1.84E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050564	chr20:25344231	FAM182A	chr20:26035250-26067552:+	0.19	3.48	0.000539	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050564	chr20:25344231	FAM182B	chr20:25744102-25848786:-	-0.26	-5.4	1.08E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050564	chr20:25344231	NINL	chr20:25433338-25566153:-	0.33	6.89	1.74E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050564	chr20:25344231	PYGB	chr20:25228706-25278647:+	0.16	4.03	6.46E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050565	chr20:25347563	ENTPD6	chr20:25176339-25207360:+	0.32	7.31	1.17E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050565	chr20:25347563	FAM182A	chr20:26035250-26067552:+	0.18	3.41	0.000703	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050565	chr20:25347563	FAM182B	chr20:25744102-25848786:-	-0.25	-5.15	3.85E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050565	chr20:25347563	NINL	chr20:25433338-25566153:-	0.33	6.73	4.92E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050565	chr20:25347563	PYGB	chr20:25228706-25278647:+	0.16	3.96	8.64E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050566	chr20:25351071	ENTPD6	chr20:25176339-25207360:+	0.3	6.69	6.1E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050566	chr20:25351071	FAM182A	chr20:26035250-26067552:+	0.19	3.48	0.000547	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050566	chr20:25351071	FAM182B	chr20:25744102-25848786:-	-0.26	-5.44	8.47E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050566	chr20:25351071	NINL	chr20:25433338-25566153:-	0.34	7.05	6.43E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050566	chr20:25351071	PYGB	chr20:25228706-25278647:+	0.14	3.59	0.000363	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050573	chr20:25366065	ENTPD6	chr20:25176339-25207360:+	-0.32	-7.36	8.11E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050573	chr20:25366065	FAM182A	chr20:26035250-26067552:+	-0.19	-3.49	0.000534	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050573	chr20:25366065	FAM182B	chr20:25744102-25848786:-	0.25	5.29	1.86E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050573	chr20:25366065	NINL	chr20:25433338-25566153:-	-0.33	-6.77	3.69E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050573	chr20:25366065	PYGB	chr20:25228706-25278647:+	-0.16	-4.03	6.61E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050590	chr20:25384994	ENTPD6	chr20:25176339-25207360:+	0.32	7.24	1.82E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050590	chr20:25384994	FAM182A	chr20:26035250-26067552:+	0.19	3.48	0.000541	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050590	chr20:25384994	FAM182B	chr20:25744102-25848786:-	-0.26	-5.4	1.07E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050590	chr20:25384994	NINL	chr20:25433338-25566153:-	0.33	6.9	1.65E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050590	chr20:25384994	PYGB	chr20:25228706-25278647:+	0.16	4.03	6.52E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050598	chr20:25397257	ENTPD6	chr20:25176339-25207360:+	-0.31	-7.19	2.5E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050598	chr20:25397257	FAM182A	chr20:26035250-26067552:+	-0.18	-3.43	0.000654	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050598	chr20:25397257	FAM182B	chr20:25744102-25848786:-	0.26	5.41	9.89E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050598	chr20:25397257	NINL	chr20:25433338-25566153:-	-0.34	-7.02	7.59E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050598	chr20:25397257	PYGB	chr20:25228706-25278647:+	-0.16	-4.12	4.51E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050599	chr20:25400240	ENTPD6	chr20:25176339-25207360:+	0.32	7.43	5.2E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050599	chr20:25400240	FAM182A	chr20:26035250-26067552:+	0.18	3.44	0.000637	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050599	chr20:25400240	FAM182B	chr20:25744102-25848786:-	-0.25	-5.26	2.22E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050599	chr20:25400240	NINL	chr20:25433338-25566153:-	0.34	7.1	4.42E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050599	chr20:25400240	PYGB	chr20:25228706-25278647:+	0.15	3.79	0.000167	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050602	chr20:25401203	ENTPD6	chr20:25176339-25207360:+	0.32	7.43	5.2E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050602	chr20:25401203	FAM182A	chr20:26035250-26067552:+	0.18	3.44	0.000637	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050602	chr20:25401203	FAM182B	chr20:25744102-25848786:-	-0.25	-5.26	2.22E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050602	chr20:25401203	NINL	chr20:25433338-25566153:-	0.34	7.1	4.42E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050602	chr20:25401203	PYGB	chr20:25228706-25278647:+	0.15	3.79	0.000167	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050609	chr20:25411751	ENTPD6	chr20:25176339-25207360:+	0.32	7.43	5.05E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050609	chr20:25411751	FAM182A	chr20:26035250-26067552:+	0.18	3.44	0.000635	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050609	chr20:25411751	FAM182B	chr20:25744102-25848786:-	-0.25	-5.25	2.3E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050609	chr20:25411751	NINL	chr20:25433338-25566153:-	0.34	7.11	4.29E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050609	chr20:25411751	PYGB	chr20:25228706-25278647:+	0.15	3.78	0.000174	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050617	chr20:25421648	ENTPD6	chr20:25176339-25207360:+	-0.32	-7.43	5.05E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050617	chr20:25421648	FAM182A	chr20:26035250-26067552:+	-0.18	-3.44	0.000635	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050617	chr20:25421648	FAM182B	chr20:25744102-25848786:-	0.25	5.25	2.3E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050617	chr20:25421648	NINL	chr20:25433338-25566153:-	-0.34	-7.11	4.29E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050617	chr20:25421648	PYGB	chr20:25228706-25278647:+	-0.15	-3.78	0.000174	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050626	chr20:25428261	ENTPD6	chr20:25176339-25207360:+	-0.32	-7.43	5.05E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050626	chr20:25428261	FAM182A	chr20:26035250-26067552:+	-0.18	-3.44	0.000635	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050626	chr20:25428261	FAM182B	chr20:25744102-25848786:-	0.25	5.25	2.3E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050626	chr20:25428261	NINL	chr20:25433338-25566153:-	-0.34	-7.11	4.29E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050626	chr20:25428261	PYGB	chr20:25228706-25278647:+	-0.15	-3.78	0.000174	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050629	chr20:25430680	ENTPD6	chr20:25176339-25207360:+	-0.32	-7.43	5.05E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050629	chr20:25430680	FAM182A	chr20:26035250-26067552:+	-0.18	-3.44	0.000635	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050629	chr20:25430680	FAM182B	chr20:25744102-25848786:-	0.25	5.25	2.3E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050629	chr20:25430680	NINL	chr20:25433338-25566153:-	-0.34	-7.11	4.29E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050629	chr20:25430680	PYGB	chr20:25228706-25278647:+	-0.15	-3.78	0.000174	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050630	chr20:25430745	ENTPD6	chr20:25176339-25207360:+	-0.32	-7.43	5.05E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050630	chr20:25430745	FAM182A	chr20:26035250-26067552:+	-0.18	-3.44	0.000635	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050630	chr20:25430745	FAM182B	chr20:25744102-25848786:-	0.25	5.25	2.3E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050630	chr20:25430745	NINL	chr20:25433338-25566153:-	-0.34	-7.11	4.29E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050630	chr20:25430745	PYGB	chr20:25228706-25278647:+	-0.15	-3.78	0.000174	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050631	chr20:25431749	ENTPD6	chr20:25176339-25207360:+	-0.3	-6.79	3.27E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050631	chr20:25431749	FAM182A	chr20:26035250-26067552:+	-0.18	-3.4	0.000731	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050631	chr20:25431749	FAM182B	chr20:25744102-25848786:-	0.25	5.24	2.43E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050631	chr20:25431749	NINL	chr20:25433338-25566153:-	-0.36	-7.3	1.22E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050632	chr20:25432601	ENTPD6	chr20:25176339-25207360:+	-0.32	-7.43	5.05E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050632	chr20:25432601	FAM182A	chr20:26035250-26067552:+	-0.18	-3.44	0.000635	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050632	chr20:25432601	FAM182B	chr20:25744102-25848786:-	0.25	5.25	2.3E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050632	chr20:25432601	NINL	chr20:25433338-25566153:-	-0.34	-7.11	4.29E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6050632	chr20:25432601	PYGB	chr20:25228706-25278647:+	-0.15	-3.78	0.000174	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6051080	chr20:25975674	FAM182A	chr20:26035250-26067552:+	0.19	3.59	0.000369	Colorectal or endometrial cancer	
THCA	cis	1	rs6051080	chr20:25975674	FAM182B	chr20:25744102-25848786:-	0.59	14.87	2.25E-41	Colorectal or endometrial cancer	
THCA	cis	1	rs60512868	chr3:48483445	ATRIP	chr3:48488141-48507708:+	0.19	4.22	2.93E-5	Longevity	
THCA	cis	1	rs60512868	chr3:48483445	TREX1	chr3:48501186-48509043:+	-0.25	-5.72	1.88E-8	Longevity	
THCA	cis	1	rs6051672	chr20:3224819	ITPA	chr20:3190056-3204504:+	-0.24	-5.76	1.54E-8	IFN-related cytopenia	
THCA	cis	1	rs6051702	chr20:3251924	ITPA	chr20:3190056-3204504:+	-0.24	-5.87	8.02E-9	IFN-related cytopenia	
THCA	cis	1	rs6051703	chr20:3252347	ITPA	chr20:3190056-3204504:+	-0.24	-5.87	8.02E-9	IFN-related cytopenia	
THCA	cis	1	rs6051705	chr20:3253143	ITPA	chr20:3190056-3204504:+	-0.24	-5.87	8.02E-9	IFN-related cytopenia	
THCA	cis	1	rs6051708	chr20:3262493	ITPA	chr20:3190056-3204504:+	-0.24	-5.74	1.66E-8	IFN-related cytopenia	
THCA	cis	1	rs6051709	chr20:3263685	ITPA	chr20:3190056-3204504:+	-0.24	-5.92	6.32E-9	IFN-related cytopenia	
THCA	cis	1	rs6051712	chr20:3265029	ITPA	chr20:3190056-3204504:+	-0.24	-5.92	6.32E-9	IFN-related cytopenia	
THCA	cis	1	rs6051713	chr20:3265779	ITPA	chr20:3190056-3204504:+	0.23	5.65	2.76E-8	IFN-related cytopenia	
THCA	cis	1	rs6051715	chr20:3266548	ITPA	chr20:3190056-3204504:+	-0.24	-5.92	6.32E-9	IFN-related cytopenia	
THCA	cis	1	rs6051716	chr20:3267736	ITPA	chr20:3190056-3204504:+	-0.25	-6.07	2.65E-9	IFN-related cytopenia	
THCA	cis	1	rs6051718	chr20:3270370	ITPA	chr20:3190056-3204504:+	-0.25	-6.07	2.6E-9	IFN-related cytopenia	
THCA	cis	1	rs6051722	chr20:3274435	ITPA	chr20:3190056-3204504:+	-0.24	-5.87	8.02E-9	IFN-related cytopenia	
THCA	cis	1	rs6051723	chr20:3278512	ITPA	chr20:3190056-3204504:+	-0.25	-6.07	2.6E-9	IFN-related cytopenia	
THCA	cis	1	rs6051724	chr20:3279338	ITPA	chr20:3190056-3204504:+	-0.24	-5.92	6.32E-9	IFN-related cytopenia	
THCA	cis	1	rs6051732	chr20:3294182	ITPA	chr20:3190056-3204504:+	-0.25	-6.07	2.6E-9	IFN-related cytopenia	
THCA	cis	1	rs6051736	chr20:3296898	ITPA	chr20:3190056-3204504:+	-0.24	-5.87	8.02E-9	IFN-related cytopenia	
THCA	cis	1	rs6051737	chr20:3296992	ITPA	chr20:3190056-3204504:+	-0.24	-5.92	6.32E-9	IFN-related cytopenia	
THCA	cis	1	rs6051745	chr20:3307243	ITPA	chr20:3190056-3204504:+	-0.24	-5.87	8.02E-9	IFN-related cytopenia	
THCA	cis	1	rs6051747	chr20:3307945	ITPA	chr20:3190056-3204504:+	-0.24	-5.92	6.32E-9	IFN-related cytopenia	
THCA	cis	1	rs6051751	chr20:3310049	ITPA	chr20:3190056-3204504:+	-0.24	-5.87	8.02E-9	IFN-related cytopenia	
THCA	cis	1	rs6051753	chr20:3315513	ITPA	chr20:3190056-3204504:+	-0.24	-5.85	9.19E-9	IFN-related cytopenia	
THCA	cis	1	rs6051762	chr20:3321590	ITPA	chr20:3190056-3204504:+	-0.24	-5.79	1.28E-8	IFN-related cytopenia	
THCA	cis	1	rs6051763	chr20:3321616	ITPA	chr20:3190056-3204504:+	-0.23	-5.6	3.57E-8	IFN-related cytopenia	
THCA	cis	1	rs6051764	chr20:3321807	ITPA	chr20:3190056-3204504:+	0.21	5.13	4.22E-7	IFN-related cytopenia	
THCA	cis	1	rs6051779	chr20:3333449	ITPA	chr20:3190056-3204504:+	-0.23	-5.77	1.41E-8	IFN-related cytopenia	
THCA	cis	1	rs6051790	chr20:3342994	ITPA	chr20:3190056-3204504:+	-0.24	-5.89	7.16E-9	IFN-related cytopenia	
THCA	cis	1	rs6051792	chr20:3343519	ITPA	chr20:3190056-3204504:+	-0.24	-5.87	8.09E-9	IFN-related cytopenia	
THCA	cis	1	rs6051806	chr20:3350319	ITPA	chr20:3190056-3204504:+	-0.25	-6.03	3.35E-9	IFN-related cytopenia	
THCA	cis	1	rs6051807	chr20:3350485	ITPA	chr20:3190056-3204504:+	-0.25	-6.02	3.4E-9	IFN-related cytopenia	
THCA	cis	1	rs6051808	chr20:3350697	ITPA	chr20:3190056-3204504:+	-0.24	-5.79	1.28E-8	IFN-related cytopenia	
THCA	cis	1	rs6051809	chr20:3352551	ITPA	chr20:3190056-3204504:+	-0.24	-5.88	7.62E-9	IFN-related cytopenia	
THCA	cis	1	rs6051810	chr20:3355384	ITPA	chr20:3190056-3204504:+	-0.24	-5.92	6.32E-9	IFN-related cytopenia	
THCA	cis	1	rs6051827	chr20:3372007	ITPA	chr20:3190056-3204504:+	-0.24	-5.96	4.9E-9	IFN-related cytopenia	
THCA	cis	1	rs6051831	chr20:3373712	ITPA	chr20:3190056-3204504:+	0.24	5.8	1.21E-8	IFN-related cytopenia	
THCA	cis	1	rs6051838	chr20:3389012	ITPA	chr20:3190056-3204504:+	-0.23	-5.85	9.18E-9	IFN-related cytopenia	
THCA	cis	1	rs6052196	chr20:3945824	MAVS	chr20:3827449-3856761:+	-0.23	-3.56	0.000403	Response to antidepressants in depression	
THCA	cis	1	rs6052209	chr20:3961747	MAVS	chr20:3827449-3856761:+	-0.23	-3.56	0.000403	Response to antidepressants in depression	
THCA	cis	1	rs6052217	chr20:3970211	MAVS	chr20:3827449-3856761:+	-0.23	-3.56	0.000414	Response to antidepressants in depression	
THCA	cis	1	rs6052218	chr20:3970212	MAVS	chr20:3827449-3856761:+	-0.23	-3.56	0.000414	Response to antidepressants in depression	
THCA	cis	1	rs6052220	chr20:3970594	MAVS	chr20:3827449-3856761:+	-0.22	-3.49	0.00052	Response to antidepressants in depression	
THCA	cis	1	rs60529510	chr17:80407480	C17orf62	chr17:80400520-80408694:-	-0.27	-6.49	2.17E-10	Protein quantitative trait loci	
THCA	cis	1	rs60529510	chr17:80407480	NARF	chr17:80416060-80446141:+	-0.17	-3.37	0.000798	Protein quantitative trait loci	
THCA	cis	1	rs6053815	chr20:5970438	MCM8	chr20:5931298-5975829:+	-0.31	-6.79	3.26E-11	HIV-1 viral setpoint	
THCA	cis	1	rs6053816	chr20:5970750	MCM8	chr20:5931298-5975829:+	-0.32	-7.28	1.35E-12	HIV-1 viral setpoint	
THCA	cis	1	rs60554055	chr14:66068285	LOC645431	chr14:65877313-65879335:-	-0.53	-6.89	1.79E-11	Ischemic stroke	
THCA	cis	1	rs60561577	chr16:50128572	HEATR3	chr16:50099881-50139373:+	-0.4	-6.06	2.77E-9	Esophageal cancer (squamous cell)	
THCA	cis	1	rs60576041	chr1:162413640	HSD17B7	chr1:162760496-162782607:+	0.31	3.67	0.00027	Discordance in emotional problems in monozygotic twins	
THCA	cis	1	rs60579513	chr6:42505472	PRPH2	chr6:42664334-42690358:-	-0.29	-3.91	0.000105	Obesity-related traits	
THCA	cis	1	rs6058219	chr20:33859244	CPNE1	chr20:34213968-34262539:-	-0.34	-4.7	3.38E-6	Attention deficit hyperactivity disorder	
THCA	cis	1	rs6058219	chr20:33859244	MMP24	chr20:33814539-33864804:+	-0.21	-3.6	0.000346	Attention deficit hyperactivity disorder	
THCA	cis	1	rs6058352	chr20:30269179	COX4I2	chr20:30225691-30232800:+	0.12	3.86	0.000126	Subcortical brain region volumes	
THCA	cis	1	rs6058465	chr20:30397691	COX4I2	chr20:30225691-30232800:+	0.12	3.94	9.25E-5	Subcortical brain region volumes	
THCA	cis	1	rs6058468	chr20:30406448	COX4I2	chr20:30225691-30232800:+	0.12	3.88	0.000118	Subcortical brain region volumes	
THCA	cis	1	rs6059672	chr20:32705468	RALY	chr20:32581732-32672675:+	0.15	4.36	1.62E-5	Tanning;Skin sensitivity to sun;Red vs. non-red hair color;Freckles;Burning and freckling	
THCA	cis	1	rs6059673	chr20:32705561	RALY	chr20:32581732-32672675:+	0.14	4.23	2.82E-5	Tanning;Skin sensitivity to sun;Red vs. non-red hair color;Freckles;Burning and freckling	
THCA	cis	1	rs6059681	chr20:32723341	RALY	chr20:32581732-32672675:+	0.14	4.17	3.59E-5	Tanning;Skin sensitivity to sun;Red vs. non-red hair color;Freckles;Burning and freckling	
THCA	cis	1	rs6060222	chr20:33682570	PROCR	chr20:33758727-33765164:+	-0.34	-5.98	4.36E-9	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs6060222	chr20:33682570	TRPC4AP	chr20:33590215-33680618:-	0.3	4	7.46E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs6060230	chr20:33689308	PROCR	chr20:33758727-33765164:+	0.33	5.78	1.34E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs6060230	chr20:33689308	TRPC4AP	chr20:33590215-33680618:-	-0.29	-3.93	9.84E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs6060235	chr20:33691652	PROCR	chr20:33758727-33765164:+	-0.33	-5.74	1.66E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs6060235	chr20:33691652	TRPC4AP	chr20:33590215-33680618:-	0.35	4.56	6.41E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs6060236	chr20:33692618	PROCR	chr20:33758727-33765164:+	-0.33	-5.64	2.88E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs6060236	chr20:33692618	TRPC4AP	chr20:33590215-33680618:-	0.34	4.45	1.09E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs6060244	chr20:33699435	PROCR	chr20:33758727-33765164:+	0.29	5.27	2.08E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs6060244	chr20:33699435	TRPC4AP	chr20:33590215-33680618:-	-0.31	-4.22	2.92E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs6060245	chr20:33699625	PROCR	chr20:33758727-33765164:+	-0.34	-6.02	3.44E-9	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs6060245	chr20:33699625	TRPC4AP	chr20:33590215-33680618:-	0.34	4.53	7.32E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs6060246	chr20:33701107	PROCR	chr20:33758727-33765164:+	-0.24	-5.07	5.58E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs6060246	chr20:33701107	TRPC4AP	chr20:33590215-33680618:-	0.21	3.5	0.000501	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs6060401	chr20:34005214	CEP250	chr20:34042996-34099802:+	-0.16	-3.63	0.000318	Height	
THCA	cis	1	rs6060401	chr20:34005214	CPNE1	chr20:34213968-34262539:-	0.31	6.03	3.35E-9	Height	
THCA	cis	1	rs6060401	chr20:34005214	GDF5	chr20:33897002-34042568:-	-0.18	-3.82	0.000154	Height	
THCA	cis	1	rs6060401	chr20:34005214	UQCC	chr20:33890383-33999833:-	0.31	9.98	1.9E-21	Height	
THCA	cis	1	rs6060402	chr20:34005240	CEP250	chr20:34042996-34099802:+	-0.16	-3.5	0.000503	Height	
THCA	cis	1	rs6060402	chr20:34005240	CPNE1	chr20:34213968-34262539:-	0.3	5.93	5.76E-9	Height	
THCA	cis	1	rs6060402	chr20:34005240	GDF5	chr20:33897002-34042568:-	-0.17	-3.72	0.000221	Height	
THCA	cis	1	rs6060402	chr20:34005240	UQCC	chr20:33890383-33999833:-	0.32	10.15	4.58E-22	Height	
THCA	cis	1	rs60604866	chr2:242352257	ANO7	chr2:242127924-242164791:+	0.32	3.8	0.000164	Prostate cancer	
THCA	cis	1	rs60604866	chr2:242352257	SEPT2	chr2:242254723-242293439:+	-0.31	-4.57	6.31E-6	Prostate cancer	
THCA	cis	1	rs6060599	chr20:30257754	COX4I2	chr20:30225691-30232800:+	0.12	3.78	0.00018	Subcortical brain region volumes	
THCA	cis	1	rs6060621	chr20:30261562	COX4I2	chr20:30225691-30232800:+	0.12	3.85	0.000133	Subcortical brain region volumes	
THCA	cis	1	rs6060716	chr20:30274847	COX4I2	chr20:30225691-30232800:+	0.12	3.98	7.89E-5	Subcortical brain region volumes	
THCA	cis	1	rs6060857	chr20:30300222	COX4I2	chr20:30225691-30232800:+	0.12	3.87	0.000124	Subcortical brain region volumes	
THCA	cis	1	rs6060915	chr20:30330306	COX4I2	chr20:30225691-30232800:+	0.12	3.82	0.000154	Subcortical brain region volumes	
THCA	cis	1	rs6060919	chr20:30331922	COX4I2	chr20:30225691-30232800:+	0.12	4.03	6.5E-5	Subcortical brain region volumes	
THCA	cis	1	rs6060922	chr20:30333909	COX4I2	chr20:30225691-30232800:+	0.12	4.03	6.5E-5	Subcortical brain region volumes	
THCA	cis	1	rs6060932	chr20:30350545	COX4I2	chr20:30225691-30232800:+	0.12	4.03	6.51E-5	Subcortical brain region volumes	
THCA	cis	1	rs6060933	chr20:30351903	COX4I2	chr20:30225691-30232800:+	0.12	3.93	9.69E-5	Subcortical brain region volumes	
THCA	cis	1	rs6060944	chr20:30372114	COX4I2	chr20:30225691-30232800:+	0.12	4.03	6.51E-5	Subcortical brain region volumes	
THCA	cis	1	rs6060950	chr20:30378031	COX4I2	chr20:30225691-30232800:+	0.12	4.05	5.97E-5	Subcortical brain region volumes	
THCA	cis	1	rs6060962	chr20:30397847	COX4I2	chr20:30225691-30232800:+	0.12	3.94	9.25E-5	Subcortical brain region volumes	
THCA	cis	1	rs60622165	chr8:89599455	MMP16	chr8:89049462-89339717:-	0.16	3.65	0.000292	Body mass index and cholesterol (psychopharmacological treatment)	
THCA	cis	1	rs60628766	chr2:23423269	FKBP1B	chr2:24272584-24286548:+	0.18	3.41	0.000715	Depression (quantitative trait)	
THCA	cis	1	rs6063352	chr20:47718594	ARFGEF2	chr20:47538275-47653229:+	-0.13	-4.12	4.47E-5	Anger	
THCA	cis	1	rs6063352	chr20:47718594	CSE1L	chr20:47662838-47713484:+	0.41	10.23	2.31E-22	Anger	
THCA	cis	1	rs6063353	chr20:47719810	ARFGEF2	chr20:47538275-47653229:+	-0.13	-4.12	4.47E-5	Anger	
THCA	cis	1	rs6063353	chr20:47719810	CSE1L	chr20:47662838-47713484:+	0.41	10.23	2.31E-22	Anger	
THCA	cis	1	rs6063354	chr20:47719949	ARFGEF2	chr20:47538275-47653229:+	-0.13	-4.12	4.47E-5	Anger	
THCA	cis	1	rs6063354	chr20:47719949	CSE1L	chr20:47662838-47713484:+	0.41	10.23	2.31E-22	Anger	
THCA	cis	1	rs6063360	chr20:47748375	ARFGEF2	chr20:47538275-47653229:+	-0.12	-3.92	0.0001	Anger	
THCA	cis	1	rs6063360	chr20:47748375	CSE1L	chr20:47662838-47713484:+	0.41	10.23	2.43E-22	Anger	
THCA	cis	1	rs6063361	chr20:47757963	ARFGEF2	chr20:47538275-47653229:+	-0.12	-3.83	0.000145	Anger	
THCA	cis	1	rs6063361	chr20:47757963	CSE1L	chr20:47662838-47713484:+	0.41	10.13	5.59E-22	Anger	
THCA	cis	1	rs6063399	chr20:48019818	KCNB1	chr20:47988505-48100490:-	-0.17	-3.6	0.000357	Obesity-related traits	
THCA	cis	1	rs6064401	chr20:55057904	C20orf43	chr20:55043647-55093942:+	0.28	7.59	1.69E-13	Refractive astigmatism	
THCA	cis	1	rs6064404	chr20:55070798	C20orf43	chr20:55043647-55093942:+	0.24	6.56	1.38E-10	Refractive astigmatism	
THCA	cis	1	rs6064405	chr20:55070946	C20orf43	chr20:55043647-55093942:+	0.28	7.58	1.87E-13	Refractive astigmatism	
THCA	cis	1	rs6064405	chr20:55070946	CSTF1	chr20:54967427-54979582:+	0.17	3.52	0.000481	Refractive astigmatism	
THCA	cis	1	rs60649958	chr2:86283000	LOC90784	chr2:86247339-86250991:-	-0.36	-3.49	0.000531	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs60649958	chr2:86283000	POLR1A	chr2:86253453-86333278:-	-0.3	-4.05	5.93E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs60652129	chr2:207649313	MDH1B	chr2:207598943-207630050:-	0.47	6.03	3.19E-9	Episodic memory	
THCA	cis	1	rs60652743	chr19:47205707	FKRP	chr19:47249303-47261832:+	0.54	6.93	1.39E-11	Type 1 diabetes	
THCA	cis	1	rs60652743	chr19:47205707	PRKD2	chr19:47177574-47220384:-	0.21	5.13	4.18E-7	Type 1 diabetes	
THCA	cis	1	rs60654041	chr20:55077917	C20orf43	chr20:55043647-55093942:+	0.28	7.45	4.42E-13	Refractive astigmatism	
THCA	cis	1	rs60654041	chr20:55077917	CSTF1	chr20:54967427-54979582:+	0.16	3.37	0.00081	Refractive astigmatism	
THCA	cis	1	rs6065906	chr20:44554015	WFDC3	chr20:44402847-44420547:-	-0.28	-4.15	3.95E-5	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
THCA	cis	1	rs60659886	chr1:26994245	PIGV	chr1:27114455-27124886:+	-0.32	-4.08	5.32E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs60659886	chr1:26994245	ZDHHC18	chr1:27153201-27182207:+	0.93	11.37	1.15E-26	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs6066968	chr20:47727341	ARFGEF2	chr20:47538275-47653229:+	-0.13	-4.09	5.13E-5	Anger	
THCA	cis	1	rs6066968	chr20:47727341	CSE1L	chr20:47662838-47713484:+	0.41	10.23	2.32E-22	Anger	
THCA	cis	1	rs6066975	chr20:47750377	ARFGEF2	chr20:47538275-47653229:+	0.12	3.73	0.000215	Anger	
THCA	cis	1	rs6066975	chr20:47750377	CSE1L	chr20:47662838-47713484:+	-0.41	-9.84	6.48E-21	Anger	
THCA	cis	1	rs6066977	chr20:47755075	ARFGEF2	chr20:47538275-47653229:+	-0.12	-3.68	0.000263	Anger	
THCA	cis	1	rs6066977	chr20:47755075	CSE1L	chr20:47662838-47713484:+	0.4	9.98	2.0E-21	Anger	
THCA	cis	1	rs6066978	chr20:47755742	ARFGEF2	chr20:47538275-47653229:+	-0.12	-3.83	0.000145	Anger	
THCA	cis	1	rs6066978	chr20:47755742	CSE1L	chr20:47662838-47713484:+	0.41	10.13	5.59E-22	Anger	
THCA	cis	1	rs6066982	chr20:47763558	ARFGEF2	chr20:47538275-47653229:+	-0.12	-3.94	9.39E-5	Anger	
THCA	cis	1	rs6066982	chr20:47763558	CSE1L	chr20:47662838-47713484:+	0.41	10.23	2.37E-22	Anger	
THCA	cis	1	rs60683927	chr7:65394768	CCT6P1	chr7:65216092-65228661:+	0.38	6	3.93E-9	Diabetic kidney disease	
THCA	cis	1	rs60683927	chr7:65394768	CRCP	chr7:65579805-65619551:+	-0.26	-4	7.24E-5	Diabetic kidney disease	
THCA	cis	1	rs60683927	chr7:65394768	RABGEF1	chr7:66093890-66276446:+	0.55	6.89	1.73E-11	Diabetic kidney disease	
THCA	cis	1	rs60693825	chr14:35514456	FAM177A1	chr14:35514113-35552587:+	-0.23	-4.32	1.91E-5	Atopic dermatitis	
THCA	cis	1	rs60693825	chr14:35514456	KIAA0391	chr14:35591776-35786673:+	0.28	5.34	1.42E-7	Atopic dermatitis	
THCA	cis	1	rs60693825	chr14:35514456	PPP2R3C	chr14:35554679-35591679:-	0.53	9.99	1.74E-21	Atopic dermatitis	
THCA	cis	1	rs60697554	chr19:12057759	ZNF763	chr19:12035900-12091196:+	-0.4	-4.82	1.91E-6	Multiple sclerosis	
THCA	cis	1	rs6069758	chr20:55046735	C20orf43	chr20:55043647-55093942:+	0.28	7.42	5.23E-13	Refractive astigmatism	
THCA	cis	1	rs6069758	chr20:55046735	CSTF1	chr20:54967427-54979582:+	0.17	3.54	0.000438	Refractive astigmatism	
THCA	cis	1	rs6069763	chr20:55071639	C20orf43	chr20:55043647-55093942:+	-0.29	-7.56	2.09E-13	Refractive astigmatism	
THCA	cis	1	rs6069763	chr20:55071639	CSTF1	chr20:54967427-54979582:+	-0.17	-3.4	0.000727	Refractive astigmatism	
THCA	cis	1	rs6069766	chr20:55079036	C20orf43	chr20:55043647-55093942:+	0.28	7.54	2.37E-13	Refractive astigmatism	
THCA	cis	1	rs6069766	chr20:55079036	CSTF1	chr20:54967427-54979582:+	0.17	3.43	0.000649	Refractive astigmatism	
THCA	cis	1	rs6069767	chr20:55083478	C20orf43	chr20:55043647-55093942:+	0.23	6.19	1.32E-9	Refractive astigmatism	
THCA	cis	1	rs6069767	chr20:55083478	CSTF1	chr20:54967427-54979582:+	0.16	3.38	0.000797	Refractive astigmatism	
THCA	cis	1	rs6070692	chr20:57586374	TH1L	chr20:57556311-57570186:+	-0.19	-4.37	1.52E-5	Mean platelet volume	
THCA	cis	1	rs6070696	chr20:57597645	TH1L	chr20:57556311-57570186:+	-0.15	-3.74	0.000203	Mean platelet volume	
THCA	cis	1	rs6070697	chr20:57599402	TH1L	chr20:57556311-57570186:+	-0.16	-3.9	0.00011	Mean platelet volume	
THCA	cis	1	rs60719662	chr6:163006643	PACRG	chr6:163148164-163736523:+	0.44	6.84	2.4E-11	Body mass index	
THCA	cis	1	rs60721872	chr10:81728044	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs60722866	chr11:46650438	PACSIN3	chr11:47199085-47207958:-	0.17	3.86	0.000131	Schizophrenia	
THCA	cis	1	rs60738472	chr8:32421472	NRG1	chr8:31497268-32622558:+	0.63	10.06	1.03E-21	Thyroid hormone levels	
THCA	cis	1	rs6073957	chr20:44549476	WFDC3	chr20:44402847-44420547:-	-0.3	-4.19	3.28E-5	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
THCA	cis	1	rs6073971	chr20:44589970	WFDC3	chr20:44402847-44420547:-	-0.28	-4.13	4.2E-5	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
THCA	cis	1	rs6073972	chr20:44590298	WFDC3	chr20:44402847-44420547:-	0.29	4.19	3.35E-5	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
THCA	cis	1	rs6074022	chr20:44740196	CD40	chr20:44746906-44758384:+	0.19	4.31	2.0E-5	Crohn's disease;Inflammatory bowel disease;Multiple sclerosis	
THCA	cis	1	rs60743860	chr1:10442926	KIF1B	chr1:10270764-10441659:+	0.2	6.16	1.59E-9	Hepatocellular carcinoma	
THCA	cis	1	rs607446	chr11:71789252	FAM86C	chr11:71498557-71512276:+	0.31	3.81	0.000158	Severe influenza A (H1N1) infection	
THCA	cis	1	rs6075068	chr20:16517950	KIF16B	chr20:16252749-16554078:-	0.28	5.34	1.46E-7	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs6075069	chr20:16528914	KIF16B	chr20:16252749-16554078:-	-0.26	-4.87	1.5E-6	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs607541	chr15:45934869	SPATA5L1	chr15:45694519-45713614:+	0.3	4.93	1.15E-6	Obesity-related traits	
THCA	cis	1	rs60755785	chr19:10839494	SLC44A2	chr19:10713121-10755234:+	0.3	3.4	0.000743	LDL cholesterol	
THCA	cis	1	rs607594	chr15:45934840	SPATA5L1	chr15:45694519-45713614:+	0.3	4.93	1.15E-6	Obesity-related traits	
THCA	cis	1	rs6076336	chr20:25319212	ENTPD6	chr20:25176339-25207360:+	0.31	6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6076336	chr20:25319212	FAM182A	chr20:26035250-26067552:+	0.18	3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6076336	chr20:25319212	FAM182B	chr20:25744102-25848786:-	-0.27	-5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6076336	chr20:25319212	NINL	chr20:25433338-25566153:-	0.35	7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6076336	chr20:25319212	PYGB	chr20:25228706-25278647:+	0.16	4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6076339	chr20:25348712	ENTPD6	chr20:25176339-25207360:+	0.31	7.01	8.16E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6076339	chr20:25348712	FAM182A	chr20:26035250-26067552:+	0.18	3.43	0.000655	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6076339	chr20:25348712	FAM182B	chr20:25744102-25848786:-	-0.26	-5.45	7.92E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6076339	chr20:25348712	NINL	chr20:25433338-25566153:-	0.33	6.9	1.62E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6076339	chr20:25348712	PYGB	chr20:25228706-25278647:+	0.16	3.98	8.02E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6076345	chr20:25381895	ENTPD6	chr20:25176339-25207360:+	0.32	7.24	1.85E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6076345	chr20:25381895	FAM182A	chr20:26035250-26067552:+	0.19	3.48	0.000546	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6076345	chr20:25381895	FAM182B	chr20:25744102-25848786:-	-0.26	-5.4	1.05E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6076345	chr20:25381895	NINL	chr20:25433338-25566153:-	0.33	6.9	1.67E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6076345	chr20:25381895	PYGB	chr20:25228706-25278647:+	0.16	4.03	6.53E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs60779425	chr8:89437611	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs6080295	chr20:16521334	KIF16B	chr20:16252749-16554078:-	0.29	5.34	1.46E-7	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs6080296	chr20:16521528	KIF16B	chr20:16252749-16554078:-	0.29	5.34	1.46E-7	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs6080297	chr20:16524711	KIF16B	chr20:16252749-16554078:-	0.29	5.4	1.07E-7	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs6080301	chr20:16535666	KIF16B	chr20:16252749-16554078:-	0.26	5.09	5.28E-7	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs60823703	chr10:81729345	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs60827294	chr8:124187842	FAM83A	chr8:124191287-124222317:+	-0.34	-4.39	1.41E-5	Urinary uromodulin levels	
THCA	cis	1	rs6083804	chr20:25317060	ENTPD6	chr20:25176339-25207360:+	0.31	6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083804	chr20:25317060	FAM182A	chr20:26035250-26067552:+	0.18	3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083804	chr20:25317060	FAM182B	chr20:25744102-25848786:-	-0.27	-5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083804	chr20:25317060	NINL	chr20:25433338-25566153:-	0.35	7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083804	chr20:25317060	PYGB	chr20:25228706-25278647:+	0.16	4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083805	chr20:25317356	ENTPD6	chr20:25176339-25207360:+	0.31	6.94	1.26E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083805	chr20:25317356	FAM182A	chr20:26035250-26067552:+	0.18	3.41	0.000699	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083805	chr20:25317356	FAM182B	chr20:25744102-25848786:-	-0.26	-5.52	5.64E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083805	chr20:25317356	NINL	chr20:25433338-25566153:-	0.35	7.26	1.6E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083805	chr20:25317356	PYGB	chr20:25228706-25278647:+	0.15	3.73	0.000212	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083809	chr20:25329309	ENTPD6	chr20:25176339-25207360:+	0.32	7.29	1.31E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083809	chr20:25329309	FAM182A	chr20:26035250-26067552:+	0.18	3.39	0.000746	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083809	chr20:25329309	FAM182B	chr20:25744102-25848786:-	-0.26	-5.44	8.59E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083809	chr20:25329309	NINL	chr20:25433338-25566153:-	0.34	7.13	3.83E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083809	chr20:25329309	PYGB	chr20:25228706-25278647:+	0.17	4.21	3.08E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083813	chr20:25337671	ENTPD6	chr20:25176339-25207360:+	0.32	7.24	1.84E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083813	chr20:25337671	FAM182A	chr20:26035250-26067552:+	0.19	3.48	0.000539	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083813	chr20:25337671	FAM182B	chr20:25744102-25848786:-	-0.26	-5.4	1.08E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083813	chr20:25337671	NINL	chr20:25433338-25566153:-	0.33	6.89	1.74E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083813	chr20:25337671	PYGB	chr20:25228706-25278647:+	0.16	4.03	6.46E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083825	chr20:25366424	ENTPD6	chr20:25176339-25207360:+	0.32	7.23	1.88E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083825	chr20:25366424	FAM182A	chr20:26035250-26067552:+	0.19	3.49	0.000536	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083825	chr20:25366424	FAM182B	chr20:25744102-25848786:-	-0.26	-5.4	1.06E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083825	chr20:25366424	NINL	chr20:25433338-25566153:-	0.33	6.9	1.7E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083825	chr20:25366424	PYGB	chr20:25228706-25278647:+	0.16	4.03	6.5E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083828	chr20:25369918	ENTPD6	chr20:25176339-25207360:+	0.32	7.41	5.68E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083828	chr20:25369918	FAM182A	chr20:26035250-26067552:+	0.19	3.54	0.000434	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083828	chr20:25369918	FAM182B	chr20:25744102-25848786:-	-0.25	-5.37	1.22E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083828	chr20:25369918	NINL	chr20:25433338-25566153:-	0.34	7.07	5.7E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083828	chr20:25369918	PYGB	chr20:25228706-25278647:+	0.16	4.02	6.78E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083844	chr20:25386832	ENTPD6	chr20:25176339-25207360:+	0.31	7.01	8.3E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083844	chr20:25386832	FAM182B	chr20:25744102-25848786:-	-0.26	-5.44	8.53E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083844	chr20:25386832	NINL	chr20:25433338-25566153:-	0.33	6.78	3.5E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083844	chr20:25386832	PYGB	chr20:25228706-25278647:+	0.15	3.85	0.000134	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083856	chr20:25407585	ENTPD6	chr20:25176339-25207360:+	0.31	6.98	9.75E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083856	chr20:25407585	FAM182A	chr20:26035250-26067552:+	0.19	3.43	0.000647	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083856	chr20:25407585	FAM182B	chr20:25744102-25848786:-	-0.24	-5.02	7.29E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083856	chr20:25407585	NINL	chr20:25433338-25566153:-	0.37	7.53	2.6E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083862	chr20:25411086	ENTPD6	chr20:25176339-25207360:+	0.33	7.5	3.23E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083862	chr20:25411086	FAM182A	chr20:26035250-26067552:+	0.19	3.55	0.000427	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083862	chr20:25411086	FAM182B	chr20:25744102-25848786:-	-0.25	-5.11	4.56E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083862	chr20:25411086	NINL	chr20:25433338-25566153:-	0.36	7.41	5.88E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6083862	chr20:25411086	PYGB	chr20:25228706-25278647:+	0.15	3.83	0.000145	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs60844734	chr2:73623205	ALMS1P	chr2:73872046-73912692:+	0.71	11.16	7.15E-26	Metabolite levels	
THCA	cis	1	rs60844734	chr2:73623205	NAT8	chr2:73867850-73869537:-	0.39	6.13	1.89E-9	Metabolite levels	
THCA	cis	1	rs60854219	chr18:44646664	HDHD2	chr18:44633782-44676871:-	0.26	4.98	8.99E-7	Sitting height ratio	
THCA	cis	1	rs60854219	chr18:44646664	PIAS2	chr18:44392061-44500123:-	-0.15	-3.37	0.000804	Sitting height ratio	
THCA	cis	1	rs60866116	chr20:33726150	MMP24	chr20:33814539-33864804:+	-0.22	-3.39	0.000753	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs60866116	chr20:33726150	PROCR	chr20:33758727-33765164:+	-0.29	-4.75	2.72E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs60867652	chr3:184759421	C3orf70	chr3:184795840-184870802:-	-0.23	-4.5	8.59E-6	Heschl's gyrus morphology	
THCA	cis	1	rs6087698	chr20:33948919	CEP250	chr20:34042996-34099802:+	-0.15	-3.37	0.000804	Height	
THCA	cis	1	rs6087698	chr20:33948919	CPNE1	chr20:34213968-34262539:-	0.3	5.95	5.17E-9	Height	
THCA	cis	1	rs6087698	chr20:33948919	GDF5	chr20:33897002-34042568:-	-0.18	-3.81	0.000154	Height	
THCA	cis	1	rs6087698	chr20:33948919	UQCC	chr20:33890383-33999833:-	0.32	10.23	2.48E-22	Height	
THCA	cis	1	rs6087702	chr20:33995945	CEP250	chr20:34042996-34099802:+	-0.15	-3.42	0.000679	Height	
THCA	cis	1	rs6087702	chr20:33995945	CPNE1	chr20:34213968-34262539:-	0.31	5.95	5.06E-9	Height	
THCA	cis	1	rs6087702	chr20:33995945	GDF5	chr20:33897002-34042568:-	-0.17	-3.76	0.000194	Height	
THCA	cis	1	rs6087702	chr20:33995945	UQCC	chr20:33890383-33999833:-	0.32	10.38	6.88E-23	Height	
THCA	cis	1	rs6087703	chr20:33996433	CPNE1	chr20:34213968-34262539:-	0.3	5.92	6.14E-9	Height	
THCA	cis	1	rs6087703	chr20:33996433	GDF5	chr20:33897002-34042568:-	-0.18	-3.96	8.55E-5	Height	
THCA	cis	1	rs6087703	chr20:33996433	UQCC	chr20:33890383-33999833:-	0.32	10.26	1.86E-22	Height	
THCA	cis	1	rs6087704	chr20:34001058	CPNE1	chr20:34213968-34262539:-	0.3	5.93	5.97E-9	Height	
THCA	cis	1	rs6087704	chr20:34001058	GDF5	chr20:33897002-34042568:-	-0.18	-3.96	8.7E-5	Height	
THCA	cis	1	rs6087704	chr20:34001058	UQCC	chr20:33890383-33999833:-	0.32	10.25	1.96E-22	Height	
THCA	cis	1	rs6087705	chr20:34001250	CPNE1	chr20:34213968-34262539:-	0.31	5.93	5.91E-9	Height	
THCA	cis	1	rs6087705	chr20:34001250	GDF5	chr20:33897002-34042568:-	-0.17	-3.7	0.000236	Height	
THCA	cis	1	rs6087705	chr20:34001250	UQCC	chr20:33890383-33999833:-	0.33	10.46	3.48E-23	Height	
THCA	cis	1	rs6087771	chr20:30306724	COX4I2	chr20:30225691-30232800:+	0.12	4.05	5.86E-5	Subcortical brain region volumes	
THCA	cis	1	rs6087779	chr20:30370566	COX4I2	chr20:30225691-30232800:+	0.12	4.03	6.51E-5	Subcortical brain region volumes	
THCA	cis	1	rs6087782	chr20:30391580	COX4I2	chr20:30225691-30232800:+	0.12	3.94	9.25E-5	Subcortical brain region volumes	
THCA	cis	1	rs6087990	chr20:31349908	MAPRE1	chr20:31407699-31438210:+	0.17	4.13	4.36E-5	Ulcerative colitis	
THCA	cis	1	rs6088799	chr20:33934301	CEP250	chr20:34042996-34099802:+	-0.15	-3.37	0.000804	Height	
THCA	cis	1	rs6088799	chr20:33934301	CPNE1	chr20:34213968-34262539:-	0.3	5.95	5.17E-9	Height	
THCA	cis	1	rs6088799	chr20:33934301	GDF5	chr20:33897002-34042568:-	-0.18	-3.81	0.000154	Height	
THCA	cis	1	rs6088799	chr20:33934301	UQCC	chr20:33890383-33999833:-	0.32	10.23	2.48E-22	Height	
THCA	cis	1	rs6088812	chr20:33974163	CEP250	chr20:34042996-34099802:+	-0.15	-3.37	0.000804	Height	
THCA	cis	1	rs6088812	chr20:33974163	CPNE1	chr20:34213968-34262539:-	0.3	5.95	5.17E-9	Height	
THCA	cis	1	rs6088812	chr20:33974163	GDF5	chr20:33897002-34042568:-	-0.18	-3.81	0.000154	Height	
THCA	cis	1	rs6088812	chr20:33974163	UQCC	chr20:33890383-33999833:-	0.32	10.23	2.48E-22	Height	
THCA	cis	1	rs6088813	chr20:33975181	CEP250	chr20:34042996-34099802:+	-0.15	-3.37	0.000804	Height	
THCA	cis	1	rs6088813	chr20:33975181	CPNE1	chr20:34213968-34262539:-	0.3	5.95	5.17E-9	Height	
THCA	cis	1	rs6088813	chr20:33975181	GDF5	chr20:33897002-34042568:-	-0.18	-3.81	0.000154	Height	
THCA	cis	1	rs6088813	chr20:33975181	UQCC	chr20:33890383-33999833:-	0.32	10.23	2.48E-22	Height	
THCA	cis	1	rs6088815	chr20:33976474	CEP250	chr20:34042996-34099802:+	-0.15	-3.37	0.000804	Height	
THCA	cis	1	rs6088815	chr20:33976474	CPNE1	chr20:34213968-34262539:-	0.3	5.89	7.12E-9	Height	
THCA	cis	1	rs6088815	chr20:33976474	GDF5	chr20:33897002-34042568:-	-0.16	-3.55	0.000429	Height	
THCA	cis	1	rs6088815	chr20:33976474	UQCC	chr20:33890383-33999833:-	0.32	10.28	1.62E-22	Height	
THCA	cis	1	rs6088816	chr20:33982435	CEP250	chr20:34042996-34099802:+	-0.15	-3.46	0.000592	Height	
THCA	cis	1	rs6088816	chr20:33982435	CPNE1	chr20:34213968-34262539:-	0.31	6.02	3.39E-9	Height	
THCA	cis	1	rs6088816	chr20:33982435	GDF5	chr20:33897002-34042568:-	-0.19	-4.13	4.21E-5	Height	
THCA	cis	1	rs6088816	chr20:33982435	UQCC	chr20:33890383-33999833:-	0.32	10.23	2.44E-22	Height	
THCA	cis	1	rs6088820	chr20:33987298	CPNE1	chr20:34213968-34262539:-	0.31	5.96	4.77E-9	Height	
THCA	cis	1	rs6088820	chr20:33987298	GDF5	chr20:33897002-34042568:-	-0.18	-3.93	9.73E-5	Height	
THCA	cis	1	rs6088820	chr20:33987298	UQCC	chr20:33890383-33999833:-	0.32	10.16	4.41E-22	Height	
THCA	cis	1	rs6088821	chr20:33987576	CPNE1	chr20:34213968-34262539:-	0.3	5.93	5.9E-9	Height	
THCA	cis	1	rs6088821	chr20:33987576	GDF5	chr20:33897002-34042568:-	-0.18	-4.01	7.04E-5	Height	
THCA	cis	1	rs6088821	chr20:33987576	UQCC	chr20:33890383-33999833:-	0.32	10.27	1.7E-22	Height	
THCA	cis	1	rs6088823	chr20:33994265	CPNE1	chr20:34213968-34262539:-	0.3	5.93	5.9E-9	Height	
THCA	cis	1	rs6088823	chr20:33994265	GDF5	chr20:33897002-34042568:-	-0.18	-4.01	7.04E-5	Height	
THCA	cis	1	rs6088823	chr20:33994265	UQCC	chr20:33890383-33999833:-	0.32	10.27	1.7E-22	Height	
THCA	cis	1	rs6088825	chr20:33995972	CEP250	chr20:34042996-34099802:+	-0.15	-3.45	0.00061	Height	
THCA	cis	1	rs6088825	chr20:33995972	CPNE1	chr20:34213968-34262539:-	0.31	6.02	3.54E-9	Height	
THCA	cis	1	rs6088825	chr20:33995972	GDF5	chr20:33897002-34042568:-	-0.19	-4.09	5.15E-5	Height	
THCA	cis	1	rs6088825	chr20:33995972	UQCC	chr20:33890383-33999833:-	0.32	10.22	2.67E-22	Height	
THCA	cis	1	rs60894020	chr8:89450964	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs60895850	chr8:89412554	MMP16	chr8:89049462-89339717:-	0.31	5.04	6.5E-7	Electrodermal activity	
THCA	cis	1	rs6089828	chr20:61668998	ADRM1	chr20:60878027-60883916:+	0.09	3.55	0.00043	Prostate cancer (gene x gene interaction)	
THCA	cis	1	rs6089829	chr20:61669036	ADRM1	chr20:60878027-60883916:+	-0.09	-3.54	0.000444	Prostate cancer (gene x gene interaction)	
THCA	cis	1	rs60907095	chr6:42496096	PRPH2	chr6:42664334-42690358:-	-0.26	-3.51	0.000494	Obesity-related traits	
THCA	cis	1	rs60923631	chr16:77783369	NUDT7	chr16:77756411-77776153:+	0.36	4.94	1.09E-6	Obesity-related traits	
THCA	cis	1	rs60927973	chr14:65897331	LOC645431	chr14:65877313-65879335:-	-0.6	-7.69	8.6E-14	Ischemic stroke	
THCA	cis	1	rs609303	chr18:72895242	ZADH2	chr18:72909279-72921281:-	0.27	4.57	6.17E-6	Vascular endothelial growth factor levels	
THCA	cis	1	rs60932020	chr4:75712138	BTC	chr4:75671448-75719882:-	0.2	3.89	0.000113	Electroencephalogram traits	
THCA	cis	1	rs60932698	chr11:46652582	PACSIN3	chr11:47199085-47207958:-	0.18	4.08	5.26E-5	Schizophrenia	
THCA	cis	1	rs60936033	chr14:65856983	LOC645431	chr14:65877313-65879335:-	-0.44	-5.62	3.25E-8	Ischemic stroke	
THCA	cis	1	rs60936046	chr8:89453182	MMP16	chr8:89049462-89339717:-	0.33	5.11	4.7E-7	Electrodermal activity	
THCA	cis	1	rs60942590	chr3:53016421	RFT1	chr3:53122503-53164470:-	0.64	7.35	8.57E-13	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs60942590	chr3:53016421	TMEM110	chr3:52867139-52931547:-	0.36	4.14	4.19E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs60942639	chr14:66107636	LOC645431	chr14:65877313-65879335:-	-0.61	-7.58	1.81E-13	Ischemic stroke	
THCA	cis	1	rs60953371	chr8:89444177	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs6095357	chr20:47523865	ARFGEF2	chr20:47538275-47653229:+	0.11	3.4	0.000739	Schizophrenia	
THCA	cis	1	rs6095357	chr20:47523865	CSE1L	chr20:47662838-47713484:+	-0.39	-9.01	4.9E-18	Schizophrenia	
THCA	cis	1	rs60957376	chr15:85280792	GOLGA6L5	chr15:85047738-85060078:-	-0.15	-3.88	0.00012	Schizophrenia	
THCA	cis	1	rs60957376	chr15:85280792	LOC388152	chr15:84867600-84898920:-	-0.47	-8	9.7E-15	Schizophrenia	
THCA	cis	1	rs60957376	chr15:85280792	NMB	chr15:85198362-85201802:-	0.36	7.73	6.62E-14	Schizophrenia	
THCA	cis	1	rs60967688	chr17:28437052	ANKRD13B	chr17:27916801-27941778:+	0.33	8.2	2.17E-15	Coffee consumption (cups per day)	
THCA	cis	1	rs60967688	chr17:28437052	CORO6	chr17:27941774-27948441:-	0.48	11.62	1.19E-27	Coffee consumption (cups per day)	
THCA	cis	1	rs60967688	chr17:28437052	EFCAB5	chr17:28256874-28435469:+	0.57	11.3	2.01E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs60967688	chr17:28437052	GIT1	chr17:27900487-27916610:-	0.26	6.38	4.07E-10	Coffee consumption (cups per day)	
THCA	cis	1	rs60967688	chr17:28437052	LRRC37B2	chr17:28903483-28992715:+	0.18	3.99	7.66E-5	Coffee consumption (cups per day)	
THCA	cis	1	rs60967688	chr17:28437052	SSH2	chr17:27952965-28257018:-	0.34	8.11	4.36E-15	Coffee consumption (cups per day)	
THCA	cis	1	rs60967688	chr17:28437052	TP53I13	chr17:27895739-27900174:+	0.17	4.83	1.83E-6	Coffee consumption (cups per day)	
THCA	cis	1	rs60982898	chr6:49385806	CENPQ	chr6:49431096-49460820:+	-0.26	-5.43	8.84E-8	Folate pathway vitamin levels	
THCA	cis	1	rs60982898	chr6:49385806	MUT	chr6:49398994-49431031:-	0.28	9.54	7.4E-20	Folate pathway vitamin levels	
THCA	cis	1	rs6099171	chr20:55071253	C20orf43	chr20:55043647-55093942:+	0.28	7.58	1.84E-13	Refractive astigmatism	
THCA	cis	1	rs6099171	chr20:55071253	CSTF1	chr20:54967427-54979582:+	0.17	3.49	0.000525	Refractive astigmatism	
THCA	cis	1	rs6099184	chr20:55097478	C20orf43	chr20:55043647-55093942:+	0.28	7.47	3.82E-13	Refractive astigmatism	
THCA	cis	1	rs6099184	chr20:55097478	CSTF1	chr20:54967427-54979582:+	0.17	3.5	0.000511	Refractive astigmatism	
THCA	cis	1	rs6099314	chr20:55454659	CBLN4	chr20:54572497-54580012:-	-0.21	-3.57	0.000393	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs610041	chr11:71797968	FAM86C	chr11:71498557-71512276:+	0.31	3.81	0.000158	Severe influenza A (H1N1) infection	
THCA	cis	1	rs61032876	chr4:90641403	MMRN1	chr4:90816003-90875778:+	0.32	4.07	5.5E-5	Parkinson's disease	
THCA	cis	1	rs61037750	chr11:43681372	HSD17B12	chr11:43702143-43878160:+	-0.69	-14.35	4.51E-39	Forced vital capacity	
THCA	cis	1	rs61038704	chr14:66172300	LOC645431	chr14:65877313-65879335:-	-0.48	-6.02	3.52E-9	Ischemic stroke	
THCA	cis	1	rs61041336	chr16:58733162	GOT2	chr16:58741035-58768246:-	0.22	4.85	1.71E-6	Neuritic plaque	
THCA	cis	1	rs61044849	chr3:128065466	EEFSEC	chr3:127872313-128127488:+	-0.22	-3.79	0.000173	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs61052895	chr3:10147516	C3orf10	chr3:10157333-10168873:+	-0.21	-4.52	7.91E-6	Alzheimer's disease	
THCA	cis	1	rs61052895	chr3:10147516	VHL	chr3:10183319-10193744:+	-0.19	-4.52	7.86E-6	Alzheimer's disease	
THCA	cis	1	rs6105609	chr20:16457330	KIF16B	chr20:16252749-16554078:-	-0.16	-3.77	0.000186	Intelligence	
THCA	cis	1	rs6105610	chr20:16457333	KIF16B	chr20:16252749-16554078:-	-0.16	-3.74	0.000204	Intelligence	
THCA	cis	1	rs6105612	chr20:16458404	KIF16B	chr20:16252749-16554078:-	-0.17	-3.85	0.000136	Intelligence	
THCA	cis	1	rs61067328	chr2:227761256	COL4A4	chr2:227867435-228029275:-	0.16	3.91	0.000105	Pulmonary function	
THCA	cis	1	rs6107033	chr20:25363591	ENTPD6	chr20:25176339-25207360:+	0.3	6.96	1.11E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6107033	chr20:25363591	FAM182A	chr20:26035250-26067552:+	0.18	3.42	0.000686	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6107033	chr20:25363591	FAM182B	chr20:25744102-25848786:-	-0.25	-5.37	1.26E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6107033	chr20:25363591	NINL	chr20:25433338-25566153:-	0.33	6.83	2.55E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6107033	chr20:25363591	PYGB	chr20:25228706-25278647:+	0.16	4.03	6.43E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6107045	chr20:25441936	ENTPD6	chr20:25176339-25207360:+	-0.31	-7.06	5.79E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6107045	chr20:25441936	FAM182A	chr20:26035250-26067552:+	-0.19	-3.49	0.000526	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6107045	chr20:25441936	FAM182B	chr20:25744102-25848786:-	0.24	4.99	8.32E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6107045	chr20:25441936	NINL	chr20:25433338-25566153:-	-0.37	-7.51	2.94E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6107045	chr20:25441936	PYGB	chr20:25228706-25278647:+	-0.13	-3.36	0.00084	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6107046	chr20:25442049	ENTPD6	chr20:25176339-25207360:+	-0.31	-7.06	5.79E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6107046	chr20:25442049	FAM182A	chr20:26035250-26067552:+	-0.19	-3.49	0.000526	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6107046	chr20:25442049	FAM182B	chr20:25744102-25848786:-	0.24	4.99	8.32E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6107046	chr20:25442049	NINL	chr20:25433338-25566153:-	-0.37	-7.51	2.94E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6107046	chr20:25442049	PYGB	chr20:25228706-25278647:+	-0.13	-3.36	0.00084	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6107047	chr20:25442097	ENTPD6	chr20:25176339-25207360:+	-0.31	-7.06	5.79E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6107047	chr20:25442097	FAM182A	chr20:26035250-26067552:+	-0.19	-3.49	0.000526	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6107047	chr20:25442097	FAM182B	chr20:25744102-25848786:-	0.24	4.99	8.32E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6107047	chr20:25442097	NINL	chr20:25433338-25566153:-	-0.37	-7.51	2.94E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6107047	chr20:25442097	PYGB	chr20:25228706-25278647:+	-0.13	-3.36	0.00084	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6107386	chr20:3972756	MAVS	chr20:3827449-3856761:+	-0.24	-3.61	0.000336	Response to antidepressants in depression	
THCA	cis	1	rs6107391	chr20:3983083	MAVS	chr20:3827449-3856761:+	-0.23	-3.55	0.000419	Response to antidepressants in depression	
THCA	cis	1	rs6107393	chr20:3987738	MAVS	chr20:3827449-3856761:+	-0.24	-3.73	0.000212	Response to antidepressants in depression	
THCA	cis	1	rs61077902	chr3:10126153	C3orf10	chr3:10157333-10168873:+	-0.2	-4.27	2.4E-5	Alzheimer's disease	
THCA	cis	1	rs61077902	chr3:10126153	VHL	chr3:10183319-10193744:+	-0.18	-4.13	4.3E-5	Alzheimer's disease	
THCA	cis	1	rs61081934	chr11:18454317	LDHC	chr11:18433853-18472792:+	-0.3	-3.57	0.000386	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs61087653	chr8:89418326	MMP16	chr8:89049462-89339717:-	0.32	4.99	8.29E-7	Electrodermal activity	
THCA	cis	1	rs61088422	chr8:89438875	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs61102033	chr1:46382441	CCDC163P	chr1:45960581-45965646:-	-0.51	-10.03	1.29E-21	Body mass index	
THCA	cis	1	rs61102033	chr1:46382441	GPBP1L1	chr1:46092978-46152302:-	0.16	4.1	4.85E-5	Body mass index	
THCA	cis	1	rs61102033	chr1:46382441	MMACHC	chr1:45965856-45976737:+	-0.21	-4.48	9.43E-6	Body mass index	
THCA	cis	1	rs61102033	chr1:46382441	MUTYH	chr1:45794915-45806142:-	0.31	8.43	4.2E-16	Body mass index	
THCA	cis	1	rs61109805	chr8:89435101	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs6111151	chr20:16456032	KIF16B	chr20:16252749-16554078:-	-0.16	-3.67	0.000274	Intelligence	
THCA	cis	1	rs6111152	chr20:16456088	KIF16B	chr20:16252749-16554078:-	-0.17	-3.75	0.000196	Intelligence	
THCA	cis	1	rs6111153	chr20:16456113	KIF16B	chr20:16252749-16554078:-	-0.17	-3.77	0.000185	Intelligence	
THCA	cis	1	rs6111154	chr20:16456201	KIF16B	chr20:16252749-16554078:-	-0.16	-3.77	0.000186	Intelligence	
THCA	cis	1	rs6111155	chr20:16456461	KIF16B	chr20:16252749-16554078:-	-0.16	-3.73	0.000213	Intelligence	
THCA	cis	1	rs61142792	chr5:176983463	DOK3	chr5:176928915-176937427:-	0.27	6.07	2.67E-9	Alzheimer disease and age of onset	
THCA	cis	1	rs6115140	chr20:25285507	ENTPD6	chr20:25176339-25207360:+	-0.31	-7.15	3.38E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115140	chr20:25285507	FAM182A	chr20:26035250-26067552:+	-0.19	-3.45	0.000609	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115140	chr20:25285507	FAM182B	chr20:25744102-25848786:-	0.25	5.29	1.9E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115140	chr20:25285507	NINL	chr20:25433338-25566153:-	-0.36	-7.49	3.3E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115140	chr20:25285507	PYGB	chr20:25228706-25278647:+	-0.15	-3.74	0.000202	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115146	chr20:25304507	ENTPD6	chr20:25176339-25207360:+	0.31	6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115146	chr20:25304507	FAM182A	chr20:26035250-26067552:+	0.18	3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115146	chr20:25304507	FAM182B	chr20:25744102-25848786:-	-0.27	-5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115146	chr20:25304507	NINL	chr20:25433338-25566153:-	0.35	7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115146	chr20:25304507	PYGB	chr20:25228706-25278647:+	0.16	4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115153	chr20:25325567	ENTPD6	chr20:25176339-25207360:+	0.32	7.29	1.31E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115153	chr20:25325567	FAM182A	chr20:26035250-26067552:+	0.18	3.39	0.000746	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115153	chr20:25325567	FAM182B	chr20:25744102-25848786:-	-0.26	-5.44	8.59E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115153	chr20:25325567	NINL	chr20:25433338-25566153:-	0.34	7.13	3.83E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115153	chr20:25325567	PYGB	chr20:25228706-25278647:+	0.17	4.21	3.08E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115159	chr20:25350944	ENTPD6	chr20:25176339-25207360:+	0.32	7.23	1.88E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115159	chr20:25350944	FAM182A	chr20:26035250-26067552:+	0.19	3.49	0.000536	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115159	chr20:25350944	FAM182B	chr20:25744102-25848786:-	-0.26	-5.4	1.06E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115159	chr20:25350944	NINL	chr20:25433338-25566153:-	0.33	6.9	1.7E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115159	chr20:25350944	PYGB	chr20:25228706-25278647:+	0.16	4.03	6.5E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115168	chr20:25372891	ENTPD6	chr20:25176339-25207360:+	0.32	7.23	1.88E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115168	chr20:25372891	FAM182A	chr20:26035250-26067552:+	0.19	3.49	0.000536	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115168	chr20:25372891	FAM182B	chr20:25744102-25848786:-	-0.26	-5.4	1.06E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115168	chr20:25372891	NINL	chr20:25433338-25566153:-	0.33	6.9	1.7E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115168	chr20:25372891	PYGB	chr20:25228706-25278647:+	0.16	4.03	6.5E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115182	chr20:25410259	ENTPD6	chr20:25176339-25207360:+	0.32	7.43	4.95E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115182	chr20:25410259	FAM182A	chr20:26035250-26067552:+	0.18	3.44	0.000631	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115182	chr20:25410259	FAM182B	chr20:25744102-25848786:-	-0.25	-5.25	2.33E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115182	chr20:25410259	NINL	chr20:25433338-25566153:-	0.34	7.11	4.21E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115182	chr20:25410259	PYGB	chr20:25228706-25278647:+	0.15	3.78	0.000175	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115191	chr20:25440478	ENTPD6	chr20:25176339-25207360:+	-0.31	-7.06	5.79E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115191	chr20:25440478	FAM182A	chr20:26035250-26067552:+	-0.19	-3.49	0.000526	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115191	chr20:25440478	FAM182B	chr20:25744102-25848786:-	0.24	4.99	8.32E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115191	chr20:25440478	NINL	chr20:25433338-25566153:-	-0.37	-7.51	2.94E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6115191	chr20:25440478	PYGB	chr20:25228706-25278647:+	-0.13	-3.36	0.00084	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6116130	chr20:3947026	MAVS	chr20:3827449-3856761:+	-0.23	-3.54	0.000436	Response to antidepressants in depression	
THCA	cis	1	rs61172708	chr3:52996052	RFT1	chr3:53122503-53164470:-	0.62	7.15	3.23E-12	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs61172708	chr3:52996052	TMEM110	chr3:52867139-52931547:-	0.36	4.1	4.84E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs61177731	chr8:89435708	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs6119338	chr20:31770631	C20orf70	chr20:31755960-31769223:+	-0.39	-3.52	0.000466	Smooth-surface caries	
THCA	cis	1	rs6119650	chr20:30258480	COX4I2	chr20:30225691-30232800:+	0.12	3.88	0.000118	Subcortical brain region volumes	
THCA	cis	1	rs6119652	chr20:30259445	COX4I2	chr20:30225691-30232800:+	0.12	3.85	0.000133	Subcortical brain region volumes	
THCA	cis	1	rs61200368	chr6:55943942	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs6120128	chr20:31752141	C20orf70	chr20:31755960-31769223:+	-0.45	-3.87	0.000124	Smooth-surface caries	
THCA	cis	1	rs6120144	chr20:31770583	C20orf70	chr20:31755960-31769223:+	-0.39	-3.52	0.000466	Smooth-surface caries	
THCA	cis	1	rs6120974	chr20:34126827	CEP250	chr20:34042996-34099802:+	0.21	3.53	0.000459	Triglycerides	
THCA	cis	1	rs6120974	chr20:34126827	CPNE1	chr20:34213968-34262539:-	-0.71	-10.98	3.69E-25	Triglycerides	
THCA	cis	1	rs6120974	chr20:34126827	UQCC	chr20:33890383-33999833:-	-0.21	-4.71	3.22E-6	Triglycerides	
THCA	cis	1	rs6121038	chr20:30254773	COX4I2	chr20:30225691-30232800:+	0.12	3.9	0.00011	Subcortical brain region volumes	
THCA	cis	1	rs6121172	chr20:30296095	COX4I2	chr20:30225691-30232800:+	0.12	3.87	0.000124	Subcortical brain region volumes	
THCA	cis	1	rs6121243	chr20:30415094	COX4I2	chr20:30225691-30232800:+	0.12	3.91	0.000107	Subcortical brain region volumes	
THCA	cis	1	rs61221126	chr16:79733274	MAF	chr16:79627746-79634622:-	-0.26	-4.38	1.48E-5	Urate levels	
THCA	cis	1	rs6122763	chr20:47797653	ARFGEF2	chr20:47538275-47653229:+	0.13	4.08	5.27E-5	Anger	
THCA	cis	1	rs6122763	chr20:47797653	CSE1L	chr20:47662838-47713484:+	-0.41	-10.35	8.77E-23	Anger	
THCA	cis	1	rs61230354	chr1:146869891	FMO5	chr1:146655885-146697230:-	0.24	3.87	0.000125	Protein quantitative trait loci	
THCA	cis	1	rs6123048	chr20:50147400	ATP9A	chr20:50213314-50384908:-	-0.24	-4.09	5.1E-5	Self-reported allergy	
THCA	cis	1	rs61234864	chr8:89445857	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs6125539	chr20:47703810	ARFGEF2	chr20:47538275-47653229:+	-0.12	-3.59	0.000368	Anger	
THCA	cis	1	rs6125539	chr20:47703810	CSE1L	chr20:47662838-47713484:+	0.41	9.78	1.07E-20	Anger	
THCA	cis	1	rs6125540	chr20:47704039	ARFGEF2	chr20:47538275-47653229:+	-0.13	-4.31	1.95E-5	Anger	
THCA	cis	1	rs6125540	chr20:47704039	CSE1L	chr20:47662838-47713484:+	0.38	9.46	1.36E-19	Anger	
THCA	cis	1	rs6125576	chr20:47776919	ARFGEF2	chr20:47538275-47653229:+	-0.11	-3.48	0.000539	Anger	
THCA	cis	1	rs6125576	chr20:47776919	CSE1L	chr20:47662838-47713484:+	0.4	9.74	1.49E-20	Anger	
THCA	cis	1	rs6125643	chr20:48012538	KCNB1	chr20:47988505-48100490:-	-0.16	-3.43	0.000666	Obesity-related traits	
THCA	cis	1	rs6126249	chr20:50142623	ATP9A	chr20:50213314-50384908:-	-0.24	-3.7	0.00024	Self-reported allergy	
THCA	cis	1	rs61270078	chr15:56478983	MNS1	chr15:56720929-56757335:-	-0.24	-3.56	0.000414	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs61270078	chr15:56478983	TEX9	chr15:56657644-56738071:+	-0.35	-6.03	3.21E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs61270113	chr5:150226263	LOC134466	chr5:150310000-150326146:-	0.38	5.23	2.51E-7	Crohn's disease	
THCA	cis	1	rs6127978	chr20:55819173	BMP7	chr20:55743809-55841707:-	-0.21	-3.94	9.32E-5	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	
THCA	cis	1	rs61280878	chr6:24468741	GMNN	chr6:24775159-24786276:+	-0.28	-3.81	0.000159	Hematological and biochemical traits	
THCA	cis	1	rs61280878	chr6:24468741	GPLD1	chr6:24428405-24489850:-	0.25	4.7	3.49E-6	Hematological and biochemical traits	
THCA	cis	1	rs61280878	chr6:24468741	MRS2	chr6:24403153-24425809:+	0.24	5.47	7.34E-8	Hematological and biochemical traits	
THCA	cis	1	rs61315421	chr14:66076603	LOC645431	chr14:65877313-65879335:-	-0.61	-7.61	1.43E-13	Ischemic stroke	
THCA	cis	1	rs61316646	chr18:44610670	HDHD2	chr18:44633782-44676871:-	0.35	6.36	4.71E-10	Sitting height ratio	
THCA	cis	1	rs61320020	chr8:89414644	MMP16	chr8:89049462-89339717:-	0.32	5.1	4.9E-7	Electrodermal activity	
THCA	cis	1	rs6132678	chr20:23842323	CST5	chr20:23856572-23860380:-	0.13	3.42	0.000685	Response to TNF antagonist treatment	
THCA	cis	1	rs6132679	chr20:23842400	CST5	chr20:23856572-23860380:-	0.13	3.42	0.000685	Response to TNF antagonist treatment	
THCA	cis	1	rs6132835	chr20:25434667	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.86	2.2E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6132835	chr20:25434667	FAM182A	chr20:26035250-26067552:+	-0.18	-3.39	0.000749	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6132835	chr20:25434667	FAM182B	chr20:25744102-25848786:-	0.26	5.32	1.6E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6132835	chr20:25434667	NINL	chr20:25433338-25566153:-	-0.35	-7.17	2.81E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6132835	chr20:25434667	PYGB	chr20:25228706-25278647:+	-0.15	-3.73	0.000215	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6133036	chr20:3349682	ITPA	chr20:3190056-3204504:+	-0.24	-5.87	8.09E-9	IFN-related cytopenia	
THCA	cis	1	rs61360320	chr17:61800392	FTSJ3	chr17:61896795-61905031:-	0.3	5.78	1.32E-8	Body mass index	
THCA	cis	1	rs61360320	chr17:61800392	MAP3K3	chr17:61699775-61773669:+	0.26	5.37	1.26E-7	Body mass index	
THCA	cis	1	rs6137287	chr20:21180259	PLK1S1	chr20:21106624-21227256:+	0.21	5.37	1.24E-7	Height	
THCA	cis	1	rs61373424	chr15:56393235	MNS1	chr15:56720929-56757335:-	-0.24	-3.61	0.000338	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs61373424	chr15:56393235	TEX9	chr15:56657644-56738071:+	-0.35	-6.2	1.26E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs61378129	chr13:36684353	SOHLH2	chr13:36742347-36871992:-	0.32	4.34	1.72E-5	Optic cup area	
THCA	cis	1	rs61378130	chr6:42499683	PRPH2	chr6:42664334-42690358:-	-0.29	-3.85	0.000135	Obesity-related traits	
THCA	cis	1	rs6138139	chr20:23827431	CST5	chr20:23856572-23860380:-	0.13	3.4	0.000738	Response to TNF antagonist treatment	
THCA	cis	1	rs6138150	chr20:23847009	CST5	chr20:23856572-23860380:-	0.12	3.35	0.000872	Response to TNF antagonist treatment	
THCA	cis	1	rs6138151	chr20:23847180	CST5	chr20:23856572-23860380:-	0.13	3.43	0.000666	Response to TNF antagonist treatment	
THCA	cis	1	rs6138572	chr20:25435934	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.88	1.84E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6138572	chr20:25435934	FAM182A	chr20:26035250-26067552:+	-0.19	-3.46	0.000596	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6138572	chr20:25435934	FAM182B	chr20:25744102-25848786:-	0.25	5.08	5.38E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6138572	chr20:25435934	NINL	chr20:25433338-25566153:-	-0.37	-7.57	1.93E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6138575	chr20:25438952	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.88	1.84E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6138575	chr20:25438952	FAM182A	chr20:26035250-26067552:+	-0.19	-3.46	0.000596	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6138575	chr20:25438952	FAM182B	chr20:25744102-25848786:-	0.25	5.08	5.38E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6138575	chr20:25438952	NINL	chr20:25433338-25566153:-	-0.37	-7.57	1.93E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6139064	chr20:3277050	ITPA	chr20:3190056-3204504:+	-0.24	-5.92	6.32E-9	IFN-related cytopenia	
THCA	cis	1	rs6139068	chr20:3284393	ITPA	chr20:3190056-3204504:+	-0.25	-6.07	2.6E-9	IFN-related cytopenia	
THCA	cis	1	rs6139088	chr20:3329063	ITPA	chr20:3190056-3204504:+	-0.23	-5.69	2.21E-8	IFN-related cytopenia	
THCA	cis	1	rs6139103	chr20:3361140	ITPA	chr20:3190056-3204504:+	-0.24	-5.87	8.02E-9	IFN-related cytopenia	
THCA	cis	1	rs6139117	chr20:3387785	ITPA	chr20:3190056-3204504:+	-0.28	-6.72	5.28E-11	IFN-related cytopenia	
THCA	cis	1	rs61394483	chr6:33751945	LEMD2	chr6:33738991-33756906:-	0.25	5.02	7.4E-7	Body mass index	
THCA	cis	1	rs61402842	chr16:77780398	NUDT7	chr16:77756411-77776153:+	0.36	4.99	8.33E-7	Obesity-related traits	
THCA	cis	1	rs6141546	chr20:33949282	CEP250	chr20:34042996-34099802:+	-0.15	-3.37	0.000804	Height	
THCA	cis	1	rs6141546	chr20:33949282	CPNE1	chr20:34213968-34262539:-	0.3	5.95	5.17E-9	Height	
THCA	cis	1	rs6141546	chr20:33949282	GDF5	chr20:33897002-34042568:-	-0.18	-3.81	0.000154	Height	
THCA	cis	1	rs6141546	chr20:33949282	UQCC	chr20:33890383-33999833:-	0.32	10.23	2.48E-22	Height	
THCA	cis	1	rs6141548	chr20:33971085	CEP250	chr20:34042996-34099802:+	-0.15	-3.37	0.000804	Height	
THCA	cis	1	rs6141548	chr20:33971085	CPNE1	chr20:34213968-34262539:-	0.3	5.95	5.17E-9	Height	
THCA	cis	1	rs6141548	chr20:33971085	GDF5	chr20:33897002-34042568:-	-0.18	-3.81	0.000154	Height	
THCA	cis	1	rs6141548	chr20:33971085	UQCC	chr20:33890383-33999833:-	0.32	10.23	2.48E-22	Height	
THCA	cis	1	rs6141549	chr20:33974051	CEP250	chr20:34042996-34099802:+	-0.15	-3.37	0.000804	Height	
THCA	cis	1	rs6141549	chr20:33974051	CPNE1	chr20:34213968-34262539:-	0.3	5.95	5.17E-9	Height	
THCA	cis	1	rs6141549	chr20:33974051	GDF5	chr20:33897002-34042568:-	-0.18	-3.81	0.000154	Height	
THCA	cis	1	rs6141549	chr20:33974051	UQCC	chr20:33890383-33999833:-	0.32	10.23	2.48E-22	Height	
THCA	cis	1	rs61417737	chr6:3291251	PSMG4	chr6:3259162-3268300:+	-0.33	-5.54	5.09E-8	Survival in rectal cancer	
THCA	cis	1	rs6141	chr3:184090266	PSMD2	chr3:184017022-184026840:+	0.12	3.79	0.000172	Platelet count;Diisocyanate-induced asthma	
THCA	cis	1	rs6142102	chr20:32704627	RALY	chr20:32581732-32672675:+	0.15	4.49	9.06E-6	Tanning;Skin sensitivity to sun;Red vs. non-red hair color;Freckles;Burning and freckling	
THCA	cis	1	rs61422480	chr8:124188940	FAM83A	chr8:124191287-124222317:+	-0.33	-4.38	1.46E-5	Urinary uromodulin levels	
THCA	cis	1	rs614226	chr12:120974510	COQ5	chr12:120941083-120966964:-	-0.15	-3.7	0.000236	Type 1 diabetes nephropathy	
THCA	cis	1	rs614226	chr12:120974510	POP5	chr12:121016849-121019201:-	0.16	4.95	1.02E-6	Type 1 diabetes nephropathy	
THCA	cis	1	rs614226	chr12:120974510	RNF10	chr12:120972132-121015396:+	-0.22	-3.63	0.000313	Type 1 diabetes nephropathy	
THCA	cis	1	rs6142358	chr20:33960308	CPNE1	chr20:34213968-34262539:-	-0.31	-6	3.94E-9	Height	
THCA	cis	1	rs6142358	chr20:33960308	GDF5	chr20:33897002-34042568:-	0.17	3.64	0.000297	Height	
THCA	cis	1	rs6142358	chr20:33960308	UQCC	chr20:33890383-33999833:-	-0.32	-10.28	1.56E-22	Height	
THCA	cis	1	rs6142359	chr20:33960450	CEP250	chr20:34042996-34099802:+	-0.15	-3.37	0.000804	Height	
THCA	cis	1	rs6142359	chr20:33960450	CPNE1	chr20:34213968-34262539:-	0.3	5.95	5.17E-9	Height	
THCA	cis	1	rs6142359	chr20:33960450	GDF5	chr20:33897002-34042568:-	-0.18	-3.81	0.000154	Height	
THCA	cis	1	rs6142359	chr20:33960450	UQCC	chr20:33890383-33999833:-	0.32	10.23	2.48E-22	Height	
THCA	cis	1	rs6142360	chr20:33960486	CPNE1	chr20:34213968-34262539:-	0.3	5.78	1.31E-8	Height	
THCA	cis	1	rs6142360	chr20:33960486	GDF5	chr20:33897002-34042568:-	-0.18	-3.77	0.000187	Height	
THCA	cis	1	rs6142360	chr20:33960486	UQCC	chr20:33890383-33999833:-	0.32	10.17	4.02E-22	Height	
THCA	cis	1	rs6142369	chr20:33973315	CPNE1	chr20:34213968-34262539:-	0.3	5.88	7.84E-9	Height	
THCA	cis	1	rs6142369	chr20:33973315	GDF5	chr20:33897002-34042568:-	-0.17	-3.74	0.000207	Height	
THCA	cis	1	rs6142369	chr20:33973315	UQCC	chr20:33890383-33999833:-	0.32	10.18	3.81E-22	Height	
THCA	cis	1	rs6142370	chr20:33973378	CEP250	chr20:34042996-34099802:+	-0.15	-3.37	0.000804	Height	
THCA	cis	1	rs6142370	chr20:33973378	CPNE1	chr20:34213968-34262539:-	0.3	5.95	5.17E-9	Height	
THCA	cis	1	rs6142370	chr20:33973378	GDF5	chr20:33897002-34042568:-	-0.18	-3.81	0.000154	Height	
THCA	cis	1	rs6142370	chr20:33973378	UQCC	chr20:33890383-33999833:-	0.32	10.23	2.48E-22	Height	
THCA	cis	1	rs6142373	chr20:33983314	CEP250	chr20:34042996-34099802:+	-0.15	-3.43	0.000658	Height	
THCA	cis	1	rs6142373	chr20:33983314	CPNE1	chr20:34213968-34262539:-	0.31	5.96	4.83E-9	Height	
THCA	cis	1	rs6142373	chr20:33983314	GDF5	chr20:33897002-34042568:-	-0.18	-3.81	0.000159	Height	
THCA	cis	1	rs6142373	chr20:33983314	UQCC	chr20:33890383-33999833:-	0.32	10.39	6.2E-23	Height	
THCA	cis	1	rs6142374	chr20:33985568	CPNE1	chr20:34213968-34262539:-	0.3	5.93	5.9E-9	Height	
THCA	cis	1	rs6142374	chr20:33985568	GDF5	chr20:33897002-34042568:-	-0.18	-4.01	7.04E-5	Height	
THCA	cis	1	rs6142374	chr20:33985568	UQCC	chr20:33890383-33999833:-	0.32	10.27	1.7E-22	Height	
THCA	cis	1	rs6142376	chr20:33992761	CEP250	chr20:34042996-34099802:+	-0.15	-3.46	0.000592	Height	
THCA	cis	1	rs6142376	chr20:33992761	CPNE1	chr20:34213968-34262539:-	0.31	6.02	3.39E-9	Height	
THCA	cis	1	rs6142376	chr20:33992761	GDF5	chr20:33897002-34042568:-	-0.19	-4.13	4.21E-5	Height	
THCA	cis	1	rs6142376	chr20:33992761	UQCC	chr20:33890383-33999833:-	0.32	10.23	2.44E-22	Height	
THCA	cis	1	rs6142379	chr20:33999267	CPNE1	chr20:34213968-34262539:-	0.3	5.93	5.97E-9	Height	
THCA	cis	1	rs6142379	chr20:33999267	GDF5	chr20:33897002-34042568:-	-0.18	-3.96	8.7E-5	Height	
THCA	cis	1	rs6142379	chr20:33999267	UQCC	chr20:33890383-33999833:-	0.32	10.25	1.96E-22	Height	
THCA	cis	1	rs61439128	chr6:3291116	PSMG4	chr6:3259162-3268300:+	-0.33	-5.52	5.44E-8	Survival in rectal cancer	
THCA	cis	1	rs61457762	chr1:27284157	ZDHHC18	chr1:27153201-27182207:+	0.61	6.72	5.28E-11	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs61477982	chr2:86160532	REEP1	chr2:86441122-86564777:-	0.25	3.41	0.000712	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs61498756	chr8:89455192	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs61505517	chr5:176982391	DOK3	chr5:176928915-176937427:-	0.27	6.07	2.67E-9	Alzheimer disease and age of onset	
THCA	cis	1	rs61508494	chr14:55587297	FBXO34	chr14:55738021-55893431:+	-0.14	-3.49	0.000526	Protein biomarker	
THCA	cis	1	rs61508494	chr14:55587297	KIAA0831	chr14:55833110-55878576:-	-0.13	-3.77	0.000187	Protein biomarker	
THCA	cis	1	rs6151429	chr22:51063477	ARSA	chr22:51063450-51066607:-	-1.09	-14.85	2.74E-41	Blood metabolite levels	
THCA	cis	1	rs61515309	chr8:94080589	C8orf83	chr8:93895865-94029901:-	0.28	4.45	1.07E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs61517255	chr10:17208918	TRDMT1	chr10:17184983-17243681:-	-0.43	-10.11	6.61E-22	Homocysteine levels	
THCA	cis	1	rs61517255	chr10:17208918	VIM	chr10:17270258-17279592:+	-0.19	-3.49	0.000534	Homocysteine levels	
THCA	cis	1	rs61524473	chr15:45646283	DUOXA1	chr15:45409688-45422075:-	0.13	4.12	4.41E-5	Metabolite levels (small molecules and protein measures)	
THCA	cis	1	rs61524473	chr15:45646283	GATM	chr15:45653324-45670980:-	-0.17	-4.07	5.62E-5	Metabolite levels (small molecules and protein measures)	
THCA	cis	1	rs61524473	chr15:45646283	SPATA5L1	chr15:45694519-45713614:+	0.72	16.12	5.47E-47	Metabolite levels (small molecules and protein measures)	
THCA	cis	1	rs615284	chr13:28192930	POLR1D	chr13:28194895-28241547:+	-0.18	-4.13	4.27E-5	Large B-cell lymphoma	
THCA	cis	1	rs61530785	chr5:150261364	LOC134466	chr5:150310000-150326146:-	0.44	5.86	8.45E-9	Crohn's disease	
THCA	cis	1	rs61533446	chr8:89455017	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs61573157	chr10:72520259	TYSND1	chr10:71897735-71906496:-	0.21	3.4	0.000736	Prion diseases	
THCA	cis	1	rs61577980	chr12:51345370	SLC11A2	chr12:51373319-51422058:-	-0.24	-4.7	3.46E-6	Type 2 diabetes	
THCA	cis	1	rs61577980	chr12:51345370	TFCP2	chr12:51488608-51566917:-	-0.19	-4.08	5.23E-5	Type 2 diabetes	
THCA	cis	1	rs61578106	chr8:94070980	C8orf83	chr8:93895865-94029901:-	0.27	4.43	1.19E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs61579729	chr10:65319313	LOC84989	chr10:65224989-65226320:+	0.25	3.84	0.000142	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs61579729	chr10:65319313	NRBF2	chr10:64893007-64914785:+	0.23	3.62	0.000322	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs61596977	chr8:95997165	C8orf38	chr8:95908040-96088396:+	-0.28	-4.52	7.88E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs61601271	chr10:81727941	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs616147	chr3:39534481	RPSA	chr3:39448204-39454030:+	0.21	5.27	2.06E-7	Corticobasal degeneration;Progressive supranuclear palsy	
THCA	cis	1	rs616157	chr12:120925795	POP5	chr12:121016849-121019201:-	0.14	4.1	4.9E-5	Type 1 diabetes nephropathy	
THCA	cis	1	rs616157	chr12:120925795	RNF10	chr12:120972132-121015396:+	-0.21	-3.35	0.000886	Type 1 diabetes nephropathy	
THCA	cis	1	rs61634114	chr19:17387254	ABHD8	chr19:17402941-17414282:-	0.26	4.2	3.14E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs61634114	chr19:17387254	ANKLE1	chr19:17392454-17398454:+	0.28	4.69	3.51E-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs61634114	chr19:17387254	OCEL1	chr19:17337055-17340027:+	0.21	4.06	5.76E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs61662306	chr6:33746697	LEMD2	chr6:33738991-33756906:-	0.25	5.07	5.68E-7	Body mass index	
THCA	cis	1	rs61667532	chr8:89454997	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs61671299	chr8:89453431	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs61683331	chr8:89455046	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs61692996	chr3:119280368	ADPRH	chr3:119298523-119308791:+	-0.22	-3.51	0.000482	Vitiligo	
THCA	cis	1	rs617219	chr5:78429594	BHMT	chr5:78407604-78428112:+	-0.3	-5.42	9.23E-8	Betaine levels in individuals undergoing cardiac evaluation	
THCA	cis	1	rs617219	chr5:78429594	DMGDH	chr5:78293430-78365449:-	-0.21	-3.83	0.000142	Betaine levels in individuals undergoing cardiac evaluation	
THCA	cis	1	rs617219	chr5:78429594	JMY	chr5:78531954-78623036:+	-0.17	-4.72	3.03E-6	Betaine levels in individuals undergoing cardiac evaluation	
THCA	cis	1	rs61731371	chr4:186272721	C4orf47	chr4:186350545-186370821:+	-0.28	-3.43	0.000652	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;3-hydroxypropylmercapturic acid levels in smokers	
THCA	cis	1	rs61734973	chr12:53547199	SOAT2	chr12:53497274-53518322:+	-0.22	-3.55	0.000426	Obesity-related traits	
THCA	cis	1	rs61744385	chr3:41756986	ULK4	chr3:41288091-42003660:-	1.04	18.65	9.55E-59	Diastolic blood pressure	
THCA	cis	1	rs61744388	chr3:41756965	ULK4	chr3:41288091-42003660:-	1.04	18.65	9.55E-59	Diastolic blood pressure	
THCA	cis	1	rs61780780	chr1:31864183	ZCCHC17	chr1:31769842-31837780:+	-0.31	-6.02	3.47E-9	Schizophrenia	
THCA	cis	1	rs617819	chr11:102714716	MMP1	chr11:102660641-102668966:-	0.25	4.49	8.77E-6	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	
THCA	cis	1	rs61783200	chr1:46297403	CCDC163P	chr1:45960581-45965646:-	-0.51	-10.03	1.26E-21	Body mass index	
THCA	cis	1	rs61783200	chr1:46297403	GPBP1L1	chr1:46092978-46152302:-	0.16	4.07	5.44E-5	Body mass index	
THCA	cis	1	rs61783200	chr1:46297403	MMACHC	chr1:45965856-45976737:+	-0.19	-4.28	2.24E-5	Body mass index	
THCA	cis	1	rs61783200	chr1:46297403	MUTYH	chr1:45794915-45806142:-	0.31	8.34	7.9E-16	Body mass index	
THCA	cis	1	rs61783220	chr1:46335312	CCDC163P	chr1:45960581-45965646:-	-0.51	-10.1	7.22E-22	Body mass index	
THCA	cis	1	rs61783220	chr1:46335312	GPBP1L1	chr1:46092978-46152302:-	0.16	4.05	5.93E-5	Body mass index	
THCA	cis	1	rs61783220	chr1:46335312	MMACHC	chr1:45965856-45976737:+	-0.2	-4.4	1.34E-5	Body mass index	
THCA	cis	1	rs61783220	chr1:46335312	MUTYH	chr1:45794915-45806142:-	0.31	8.53	1.99E-16	Body mass index	
THCA	cis	1	rs61789695	chr1:28255693	RPA2	chr1:28218049-28241236:-	0.45	8.92	9.73E-18	Corneal astigmatism	
THCA	cis	1	rs61792114	chr4:289139	ZNF718	chr4:53272-156488:+	0.52	10.23	2.47E-22	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs61792116	chr4:301077	ZNF718	chr4:53272-156488:+	0.5	9.18	1.25E-18	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs61794996	chr4:209328	ZNF718	chr4:53272-156488:+	0.51	9.44	1.68E-19	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs61794996	chr4:209328	ZNF732	chr4:259482-299263:-	-0.24	-3.41	0.000698	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs61794997	chr4:222103	ZNF718	chr4:53272-156488:+	0.51	9.54	7.09E-20	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs61795001	chr4:242057	ZNF718	chr4:53272-156488:+	0.51	9.49	1.14E-19	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs61795002	chr4:242797	ZNF718	chr4:53272-156488:+	0.51	9.49	1.14E-19	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs61795006	chr4:253601	ZNF718	chr4:53272-156488:+	0.51	9.89	4.07E-21	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs61795007	chr4:255264	ZNF718	chr4:53272-156488:+	0.51	9.89	4.07E-21	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs61803655	chr1:153769332	CREB3L4	chr1:153940379-153946832:+	-0.28	-6.22	1.11E-9	Lentiform nucleus volume	
THCA	cis	1	rs61805898	chr1:111684719	DRAM2	chr1:111659955-111682838:-	-0.28	-4.27	2.31E-5	Liver enzyme levels (gamma-glutamyl transferase)	
THCA	cis	1	rs61806199	chr1:119450102	WARS2	chr1:119573841-119683295:-	0.27	3.43	0.000652	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs61806202	chr1:119465457	WARS2	chr1:119573841-119683295:-	0.26	3.48	0.000543	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs61806205	chr1:119482315	WARS2	chr1:119573841-119683295:-	0.25	3.42	0.000673	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs61806231	chr1:119496482	WARS2	chr1:119573841-119683295:-	0.26	3.51	0.000486	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs61818802	chr1:113181739	MOV10	chr1:113217048-113243367:+	0.18	4.11	4.66E-5	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs61818802	chr1:113181739	ST7L	chr1:113066142-113162405:-	0.68	10.74	3.12E-24	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs61819219	chr1:151084375	BNIPL	chr1:151009029-151020076:+	-0.18	-3.63	0.000314	Body mass index	
THCA	cis	1	rs61822669	chr1:207421214	CD55	chr1:207494817-207534309:+	0.19	7.57	1.91E-13	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs61822674	chr1:207436723	CD55	chr1:207494817-207534309:+	0.19	7.52	2.67E-13	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs61822697	chr1:207485164	CD55	chr1:207494817-207534309:+	0.2	7.6	1.59E-13	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs61822697	chr1:207485164	CR1	chr1:207669473-207815109:+	-0.14	-3.44	0.000631	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs61826828	chr1:174015261	SERPINC1	chr1:173872943-173886516:-	0.58	8.64	8.47E-17	Schizophrenia	
THCA	cis	1	rs618505	chr1:47144532	CYP4Z1	chr1:47533160-47583992:+	0.26	3.89	0.000112	Response to hepatitis C treatment	
THCA	cis	1	rs618505	chr1:47144532	DMBX1	chr1:46972668-46979884:+	0.23	4.04	6.19E-5	Response to hepatitis C treatment	
THCA	cis	1	rs61852630	chr1:247210193	OR2T8	chr1:248084320-248085256:+	-0.18	-3.43	0.000665	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs61852630	chr1:247210193	OR2W3	chr1:248031265-248060142:+	-0.18	-3.62	0.000328	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs61852630	chr1:247210193	TRIM58	chr1:248020501-248043436:+	-0.15	-3.38	0.000771	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs61852637	chr1:247219636	OR2T8	chr1:248084320-248085256:+	-0.19	-3.56	0.000405	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs61852637	chr1:247219636	OR2W3	chr1:248031265-248060142:+	-0.18	-3.61	0.000336	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs61852637	chr1:247219636	TRIM58	chr1:248020501-248043436:+	-0.15	-3.34	0.000894	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs61853072	chr10:90961500	CH25H	chr10:90965696-90967071:-	0.48	8.11	4.38E-15	Heart failure	
THCA	cis	1	rs61853336	chr10:64899875	LOC84989	chr10:65224989-65226320:+	0.27	4.37	1.49E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs61853336	chr10:64899875	NRBF2	chr10:64893007-64914785:+	0.27	4.62	5.02E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs61853589	chr10:65187111	LOC84989	chr10:65224989-65226320:+	0.26	4.13	4.27E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs61853589	chr10:65187111	NRBF2	chr10:64893007-64914785:+	0.27	4.45	1.09E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs61853635	chr10:65276510	LOC84989	chr10:65224989-65226320:+	0.27	4.31	1.98E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs61853635	chr10:65276510	NRBF2	chr10:64893007-64914785:+	0.27	4.42	1.2E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs61854764	chr10:69965475	PBLD	chr10:70042417-70092684:-	0.3	4	7.41E-5	Optic nerve measurement (disc area)	
THCA	cis	1	rs61855465	chr10:64956607	LOC84989	chr10:65224989-65226320:+	0.27	4.38	1.44E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs61855465	chr10:64956607	NRBF2	chr10:64893007-64914785:+	0.28	4.68	3.68E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs61857913	chr10:37923705	LOC399744	chr10:38717074-38741080:+	0.24	3.34	0.000897	Obesity (extreme)	
THCA	cis	1	rs61858625	chr10:38002042	LOC399744	chr10:38717074-38741080:+	0.26	3.48	0.000544	Obesity (extreme)	
THCA	cis	1	rs61858629	chr10:38014770	LOC399744	chr10:38717074-38741080:+	0.28	3.87	0.000123	Obesity (extreme)	
THCA	cis	1	rs61858886	chr10:38360701	LOC399744	chr10:38717074-38741080:+	0.25	3.36	0.000856	Obesity (extreme)	
THCA	cis	1	rs61859667	chr10:38016379	LOC399744	chr10:38717074-38741080:+	0.28	3.67	0.000274	Obesity (extreme)	
THCA	cis	1	rs61872688	chr10:101273546	NKX2-3	chr10:101292690-101296278:+	-0.31	-5.56	4.6E-8	Dental caries	
THCA	cis	1	rs61876333	chr11:487136	IRF7	chr11:612556-615999:-	0.25	3.63	0.00031	Body mass index	
THCA	cis	1	rs61877775	chr11:521462	ANO9	chr11:417930-442011:-	0.29	3.54	0.000433	Body mass index	
THCA	cis	1	rs61879300	chr11:22117880	ANO5	chr11:22214722-22304913:+	0.35	6.55	1.49E-10	Parkinson's disease	
THCA	cis	1	rs61881024	chr11:68837794	TPCN2	chr11:68816350-68929907:+	-0.16	-4.02	6.66E-5	Hair color	
THCA	cis	1	rs61882678	chr11:46368241	PACSIN3	chr11:47199085-47207958:-	0.18	3.96	8.8E-5	Schizophrenia	
THCA	cis	1	rs61882701	chr11:46443275	PACSIN3	chr11:47199085-47207958:-	0.18	4.1	4.93E-5	Schizophrenia	
THCA	cis	1	rs61882710	chr11:46473942	PACSIN3	chr11:47199085-47207958:-	0.16	3.4	0.000728	Schizophrenia	
THCA	cis	1	rs61882712	chr11:46483948	PACSIN3	chr11:47199085-47207958:-	0.16	3.4	0.000722	Schizophrenia	
THCA	cis	1	rs61882746	chr11:46567475	PACSIN3	chr11:47199085-47207958:-	0.17	3.86	0.000128	Schizophrenia	
THCA	cis	1	rs61882750	chr11:46584227	PACSIN3	chr11:47199085-47207958:-	0.16	3.59	0.000359	Schizophrenia	
THCA	cis	1	rs61882758	chr11:46611805	PACSIN3	chr11:47199085-47207958:-	0.18	3.97	8.24E-5	Schizophrenia	
THCA	cis	1	rs61884262	chr11:46631299	PACSIN3	chr11:47199085-47207958:-	0.18	4.13	4.22E-5	Schizophrenia	
THCA	cis	1	rs61884264	chr11:46639582	PACSIN3	chr11:47199085-47207958:-	0.17	3.86	0.000131	Schizophrenia	
THCA	cis	1	rs61888887	chr11:57099051	TIMM10	chr11:57295936-57298232:-	-0.23	-4.19	3.34E-5	Low high density lipoprotein cholesterol levels	
THCA	cis	1	rs61897851	chr11:47201981	MADD	chr11:47290927-47351582:+	0.28	3.4	0.000734	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs61897852	chr11:47203155	MADD	chr11:47290927-47351582:+	0.28	3.44	0.00063	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs61900635	chr11:74359010	POLD3	chr11:74303629-74353765:+	-0.24	-3.92	0.000101	Response to metformin (IC50)	
THCA	cis	1	rs61900636	chr11:74359591	POLD3	chr11:74303629-74353765:+	-0.24	-3.86	0.000131	Response to metformin (IC50)	
THCA	cis	1	rs61901691	chr11:59902799	MS4A14	chr11:60145958-60185226:+	0.18	4.47	9.6E-6	Alzheimer's disease (late onset)	
THCA	cis	1	rs61934658	chr12:81445968	ACSS3	chr12:81471809-81649582:+	0.22	4.67	4.01E-6	Neuroticism	
THCA	cis	1	rs61947991	chr13:45128009	CCDC122	chr13:44410491-44453826:-	0.35	3.78	0.000178	Antineutrophil cytoplasmic antibody-associated vasculitis	
THCA	cis	1	rs61953394	chr12:123753372	C12orf65	chr12:123717841-123742481:+	-0.25	-4.19	3.39E-5	HDL cholesterol	
THCA	cis	1	rs61960240	chr13:85765007	SLITRK6	chr13:86366922-86373483:-	-0.22	-3.91	0.000105	Bipolar disorder (mania)	
THCA	cis	1	rs61976983	chr14:55172764	SAMD4A	chr14:55034637-55260033:+	-0.38	-3.82	0.000152	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs61976985	chr14:55176593	SAMD4A	chr14:55034637-55260033:+	-0.39	-3.92	0.000103	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs61976986	chr14:55176860	SAMD4A	chr14:55034637-55260033:+	-0.39	-3.92	0.000103	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs61977049	chr14:88827000	SPATA7	chr14:88852012-88904802:+	-0.17	-3.58	0.000384	Coronary artery calcification	
THCA	cis	1	rs61977058	chr14:88881915	SPATA7	chr14:88852012-88904802:+	-0.18	-3.82	0.000149	Coronary artery calcification	
THCA	cis	1	rs61987807	chr14:66207050	LOC645431	chr14:65877313-65879335:-	0.26	3.46	0.000592	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs61991203	chr14:71767841	SIPA1L1	chr14:71933902-72206118:+	0.27	5.57	4.19E-8	Mitral valve prolapse	
THCA	cis	1	rs61991204	chr14:71768073	SIPA1L1	chr14:71933902-72206118:+	0.27	5.57	4.19E-8	Mitral valve prolapse	
THCA	cis	1	rs61991205	chr14:71771921	SIPA1L1	chr14:71933902-72206118:+	0.27	5.56	4.45E-8	Mitral valve prolapse	
THCA	cis	1	rs61991248	chr14:71860529	SIPA1L1	chr14:71933902-72206118:+	0.27	5.4	1.04E-7	Mitral valve prolapse	
THCA	cis	1	rs61991250	chr14:71869684	SIPA1L1	chr14:71933902-72206118:+	0.27	5.49	6.48E-8	Mitral valve prolapse	
THCA	cis	1	rs61995780	chr14:104120612	KLC1	chr14:104029299-104167887:+	-0.22	-4.37	1.55E-5	Body mass index	
THCA	cis	1	rs62008532	chr15:62365877	VPS13C	chr15:62144592-62352647:-	-0.1	-3.66	0.000284	Height	
THCA	cis	1	rs62017189	chr15:50922032	SPPL2A	chr15:50999739-51057910:-	0.26	7.04	6.76E-12	QT interval	
THCA	cis	1	rs62017206	chr15:50955626	SPPL2A	chr15:50999739-51057910:-	0.29	7.44	4.83E-13	QT interval	
THCA	cis	1	rs62017210	chr15:50960620	ATP8B4	chr15:50150436-50411419:-	-0.11	-3.43	0.000665	QT interval	
THCA	cis	1	rs62017210	chr15:50960620	SPPL2A	chr15:50999739-51057910:-	0.28	7.36	7.95E-13	QT interval	
THCA	cis	1	rs62019464	chr15:85294469	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-3.75	0.0002	Schizophrenia	
THCA	cis	1	rs62019464	chr15:85294469	LOC388152	chr15:84867600-84898920:-	-0.47	-7.95	1.35E-14	Schizophrenia	
THCA	cis	1	rs62019464	chr15:85294469	NMB	chr15:85198362-85201802:-	0.36	7.69	8.22E-14	Schizophrenia	
THCA	cis	1	rs62019469	chr15:85321220	GOLGA6L5	chr15:85047738-85060078:-	-0.15	-3.81	0.000156	Schizophrenia	
THCA	cis	1	rs62019469	chr15:85321220	LOC388152	chr15:84867600-84898920:-	-0.48	-8.08	5.36E-15	Schizophrenia	
THCA	cis	1	rs62019469	chr15:85321220	NMB	chr15:85198362-85201802:-	0.35	7.43	5.01E-13	Schizophrenia	
THCA	cis	1	rs62021219	chr15:85256159	GOLGA6L5	chr15:85047738-85060078:-	-0.15	-3.86	0.000128	Schizophrenia	
THCA	cis	1	rs62021219	chr15:85256159	LOC388152	chr15:84867600-84898920:-	-0.48	-8.09	5.01E-15	Schizophrenia	
THCA	cis	1	rs62021219	chr15:85256159	NMB	chr15:85198362-85201802:-	0.37	7.72	6.74E-14	Schizophrenia	
THCA	cis	1	rs62026530	chr15:84775840	GOLGA6L5	chr15:85047738-85060078:-	-0.21	-5.4	1.07E-7	Schizophrenia	
THCA	cis	1	rs62026530	chr15:84775840	LOC388152	chr15:84867600-84898920:-	-0.71	-12.88	8.25E-33	Schizophrenia	
THCA	cis	1	rs62026530	chr15:84775840	NMB	chr15:85198362-85201802:-	0.23	4.68	3.7E-6	Schizophrenia	
THCA	cis	1	rs62026530	chr15:84775840	SH3GL3	chr15:84116091-84287491:+	0.24	3.76	0.000193	Schizophrenia	
THCA	cis	1	rs62048488	chr16:53453939	AKTIP	chr16:53525193-53537170:-	-0.39	-5.24	2.45E-7	Depressive symptoms (SSRI exposure interaction)	
THCA	cis	1	rs62055045	chr16:71396661	CALB2	chr16:71392626-71424339:+	0.43	5.34	1.4E-7	Schizophrenia	
THCA	cis	1	rs62055045	chr16:71396661	HPR	chr16:72097125-72111144:+	-0.31	-3.89	0.000114	Schizophrenia	
THCA	cis	1	rs62055047	chr16:71401027	CALB2	chr16:71392626-71424339:+	0.45	5.54	5.03E-8	Schizophrenia	
THCA	cis	1	rs62055047	chr16:71401027	HPR	chr16:72097125-72111144:+	-0.33	-4.11	4.58E-5	Schizophrenia	
THCA	cis	1	rs62056375	chr16:29857901	MAPK3	chr16:30125427-30134630:-	-0.24	-3.38	0.000779	Multiple sclerosis	
THCA	cis	1	rs62058157	chr17:55745687	BZRAP1	chr17:56378596-56406152:-	0.18	4.22	2.95E-5	Coronary artery calcification	
THCA	cis	1	rs62070270	chr17:28263980	ANKRD13B	chr17:27916801-27941778:+	0.36	8.96	7.45E-18	Coffee consumption (cups per day)	
THCA	cis	1	rs62070270	chr17:28263980	CORO6	chr17:27941774-27948441:-	0.51	11.99	3.97E-29	Coffee consumption (cups per day)	
THCA	cis	1	rs62070270	chr17:28263980	EFCAB5	chr17:28256874-28435469:+	0.58	11.15	8.21E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs62070270	chr17:28263980	GIT1	chr17:27900487-27916610:-	0.31	7.43	4.88E-13	Coffee consumption (cups per day)	
THCA	cis	1	rs62070270	chr17:28263980	LRRC37B2	chr17:28903483-28992715:+	0.19	4.18	3.42E-5	Coffee consumption (cups per day)	
THCA	cis	1	rs62070270	chr17:28263980	SSH2	chr17:27952965-28257018:-	0.33	7.38	7.23E-13	Coffee consumption (cups per day)	
THCA	cis	1	rs62070270	chr17:28263980	TP53I13	chr17:27895739-27900174:+	0.2	5.42	9.29E-8	Coffee consumption (cups per day)	
THCA	cis	1	rs62070312	chr17:28438877	ANKRD13B	chr17:27916801-27941778:+	0.36	8.84	1.89E-17	Coffee consumption (cups per day)	
THCA	cis	1	rs62070312	chr17:28438877	CORO6	chr17:27941774-27948441:-	0.5	11.79	2.38E-28	Coffee consumption (cups per day)	
THCA	cis	1	rs62070312	chr17:28438877	EFCAB5	chr17:28256874-28435469:+	0.59	11.2	5.24E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs62070312	chr17:28438877	GIT1	chr17:27900487-27916610:-	0.29	6.73	4.98E-11	Coffee consumption (cups per day)	
THCA	cis	1	rs62070312	chr17:28438877	LRRC37B2	chr17:28903483-28992715:+	0.18	3.86	0.00013	Coffee consumption (cups per day)	
THCA	cis	1	rs62070312	chr17:28438877	SSH2	chr17:27952965-28257018:-	0.36	8.34	7.84E-16	Coffee consumption (cups per day)	
THCA	cis	1	rs62070312	chr17:28438877	TP53I13	chr17:27895739-27900174:+	0.21	5.68	2.31E-8	Coffee consumption (cups per day)	
THCA	cis	1	rs62073605	chr17:18066791	FAM106A	chr17:18427880-18430160:-	-0.26	-3.72	0.000219	Obesity-related traits	
THCA	cis	1	rs62073605	chr17:18066791	FAM83G	chr17:18874382-18908060:-	-0.13	-3.4	0.000718	Obesity-related traits	
THCA	cis	1	rs62073605	chr17:18066791	LLGL1	chr17:18128936-18148186:+	-0.14	-4.03	6.56E-5	Obesity-related traits	
THCA	cis	1	rs62073605	chr17:18066791	LOC220594	chr17:18414577-18445234:-	-0.32	-4.09	5.03E-5	Obesity-related traits	
THCA	cis	1	rs62073605	chr17:18066791	MYO15A	chr17:18012020-18083115:+	0.2	3.64	0.000303	Obesity-related traits	
THCA	cis	1	rs62073606	chr17:18069142	FAM106A	chr17:18427880-18430160:-	-0.26	-3.72	0.000219	Obesity-related traits	
THCA	cis	1	rs62073606	chr17:18069142	FAM83G	chr17:18874382-18908060:-	-0.13	-3.4	0.000718	Obesity-related traits	
THCA	cis	1	rs62073606	chr17:18069142	LLGL1	chr17:18128936-18148186:+	-0.14	-4.03	6.56E-5	Obesity-related traits	
THCA	cis	1	rs62073606	chr17:18069142	LOC220594	chr17:18414577-18445234:-	-0.32	-4.09	5.03E-5	Obesity-related traits	
THCA	cis	1	rs62073606	chr17:18069142	MYO15A	chr17:18012020-18083115:+	0.2	3.64	0.000303	Obesity-related traits	
THCA	cis	1	rs62084208	chr17:65827443	C17orf58	chr17:65987218-65989765:-	0.18	3.55	0.000431	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs62084210	chr17:65828710	C17orf58	chr17:65987218-65989765:-	0.18	3.5	0.000517	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs62084213	chr17:65842016	C17orf58	chr17:65987218-65989765:-	0.2	3.95	8.87E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs62084214	chr17:65843325	C17orf58	chr17:65987218-65989765:-	0.2	3.95	8.87E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs62084238	chr17:65856573	C17orf58	chr17:65987218-65989765:-	0.19	3.66	0.000283	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs62084240	chr17:65859233	C17orf58	chr17:65987218-65989765:-	0.21	3.97	8.41E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs62084246	chr17:65867911	C17orf58	chr17:65987218-65989765:-	0.2	3.95	8.87E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs62084248	chr17:65874541	C17orf58	chr17:65987218-65989765:-	0.2	3.97	8.17E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs62084249	chr17:65874998	C17orf58	chr17:65987218-65989765:-	0.2	3.97	8.17E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs62084251	chr17:65878736	C17orf58	chr17:65987218-65989765:-	0.2	3.97	8.17E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs62085992	chr17:65923083	C17orf58	chr17:65987218-65989765:-	0.21	4.07	5.45E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs62085993	chr17:65923152	C17orf58	chr17:65987218-65989765:-	0.19	3.81	0.000159	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs62096463	chr18:44628928	HDHD2	chr18:44633782-44676871:-	0.28	5.21	2.84E-7	Sitting height ratio	
THCA	cis	1	rs62096463	chr18:44628928	PIAS2	chr18:44392061-44500123:-	-0.16	-3.35	0.000869	Sitting height ratio	
THCA	cis	1	rs62096464	chr18:44629207	HDHD2	chr18:44633782-44676871:-	0.28	5.21	2.84E-7	Sitting height ratio	
THCA	cis	1	rs62096464	chr18:44629207	PIAS2	chr18:44392061-44500123:-	-0.16	-3.35	0.000869	Sitting height ratio	
THCA	cis	1	rs62096466	chr18:44636171	HDHD2	chr18:44633782-44676871:-	0.28	5.2	3.0E-7	Sitting height ratio	
THCA	cis	1	rs62096466	chr18:44636171	PIAS2	chr18:44392061-44500123:-	-0.16	-3.36	0.000832	Sitting height ratio	
THCA	cis	1	rs62096468	chr18:44637566	HDHD2	chr18:44633782-44676871:-	0.26	4.9	1.34E-6	Sitting height ratio	
THCA	cis	1	rs62096469	chr18:44638298	HDHD2	chr18:44633782-44676871:-	0.26	4.99	8.46E-7	Sitting height ratio	
THCA	cis	1	rs62096469	chr18:44638298	PIAS2	chr18:44392061-44500123:-	-0.15	-3.36	0.000847	Sitting height ratio	
THCA	cis	1	rs62096470	chr18:44641466	HDHD2	chr18:44633782-44676871:-	0.26	4.99	8.46E-7	Sitting height ratio	
THCA	cis	1	rs62096470	chr18:44641466	PIAS2	chr18:44392061-44500123:-	-0.15	-3.36	0.000847	Sitting height ratio	
THCA	cis	1	rs62096471	chr18:44643814	HDHD2	chr18:44633782-44676871:-	0.26	4.98	8.99E-7	Sitting height ratio	
THCA	cis	1	rs62096471	chr18:44643814	PIAS2	chr18:44392061-44500123:-	-0.15	-3.37	0.000804	Sitting height ratio	
THCA	cis	1	rs62096474	chr18:44647504	HDHD2	chr18:44633782-44676871:-	0.26	4.98	8.99E-7	Sitting height ratio	
THCA	cis	1	rs62096474	chr18:44647504	PIAS2	chr18:44392061-44500123:-	-0.15	-3.37	0.000804	Sitting height ratio	
THCA	cis	1	rs62096476	chr18:44658621	HDHD2	chr18:44633782-44676871:-	0.26	4.94	1.1E-6	Sitting height ratio	
THCA	cis	1	rs62096476	chr18:44658621	PIAS2	chr18:44392061-44500123:-	-0.16	-3.5	0.000508	Sitting height ratio	
THCA	cis	1	rs62096478	chr18:44662409	HDHD2	chr18:44633782-44676871:-	0.26	4.94	1.1E-6	Sitting height ratio	
THCA	cis	1	rs62096478	chr18:44662409	PIAS2	chr18:44392061-44500123:-	-0.16	-3.5	0.000508	Sitting height ratio	
THCA	cis	1	rs62101780	chr18:47211344	CXXC1	chr18:47808715-47814692:-	-0.09	-3.54	0.000444	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	
THCA	cis	1	rs62101781	chr18:47211860	CXXC1	chr18:47808715-47814692:-	-0.1	-3.62	0.000324	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	
THCA	cis	1	rs62103177	chr18:77624479	HSBP1L1	chr18:77724582-77730820:+	0.17	3.39	0.000746	Opioid sensitivity	
THCA	cis	1	rs62103177	chr18:77624479	TXNL4A	chr18:77732869-77793915:-	0.15	4.26	2.49E-5	Opioid sensitivity	
THCA	cis	1	rs62107762	chr19:15982538	CYP4F11	chr19:16023180-16045676:-	-0.24	-3.71	0.000236	Acenocoumarol maintenance dosage;Vitamin E levels;Circulating phylloquinone levels;Metabolite levels;Response to Vitamin E supplementation;Warfarin maintenance dose	
THCA	cis	1	rs62112917	chr19:22226580	ZNF492	chr19:22817126-22850472:+	0.25	3.36	0.000854	Body mass index (change over time)	
THCA	cis	1	rs62113284	chr19:52031926	ZNF175	chr19:52074531-52092990:+	-0.32	-3.85	0.000132	Carotid intima media thickness	
THCA	cis	1	rs62114497	chr2:214837	SH3YL1	chr2:218138-264810:-	-0.91	-24.48	2.28E-86	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs62114501	chr2:231741	SH3YL1	chr2:218138-264810:-	-0.95	-26.63	1.87E-96	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs62114505	chr2:242426	SH3YL1	chr2:218138-264810:-	-0.96	-26.75	5.11E-97	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs62114544	chr2:269679	SH3YL1	chr2:218138-264810:-	-0.95	-26.48	8.61E-96	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs62114548	chr2:274672	SH3YL1	chr2:218138-264810:-	-0.95	-25.64	7.23E-92	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs62114762	chr19:24233868	LOC100101266	chr19:24344995-24346249:-	0.37	6.21	1.17E-9	Response to taxane treatment (placlitaxel)	
THCA	cis	1	rs62115530	chr19:53669962	ZNF665	chr19:53666552-53696619:-	-0.15	-4.15	3.87E-5	Yu-Zhi constitution type in type 2 diabetes	
THCA	cis	1	rs62115531	chr19:53670029	ZNF665	chr19:53666552-53696619:-	-0.15	-4.1	4.83E-5	Yu-Zhi constitution type in type 2 diabetes	
THCA	cis	1	rs62116203	chr19:52023841	SIGLEC6	chr19:52022784-52035064:-	-0.28	-3.34	0.000892	Carotid intima media thickness	
THCA	cis	1	rs62116203	chr19:52023841	ZNF175	chr19:52074531-52092990:+	-0.38	-4.54	7.04E-6	Carotid intima media thickness	
THCA	cis	1	rs62116204	chr19:52024375	ZNF175	chr19:52074531-52092990:+	-0.36	-4.26	2.49E-5	Carotid intima media thickness	
THCA	cis	1	rs62116205	chr19:52025634	ZNF175	chr19:52074531-52092990:+	-0.36	-4.26	2.49E-5	Carotid intima media thickness	
THCA	cis	1	rs62117633	chr19:24219474	LOC100101266	chr19:24344995-24346249:-	0.36	6.07	2.55E-9	Response to taxane treatment (placlitaxel)	
THCA	cis	1	rs62119422	chr2:9726599	IAH1	chr2:9614670-9636671:+	0.16	3.42	0.000678	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	
THCA	cis	1	rs62119423	chr2:9726601	IAH1	chr2:9614670-9636671:+	0.16	3.42	0.000678	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	
THCA	cis	1	rs62119428	chr2:9743332	IAH1	chr2:9614670-9636671:+	0.16	3.38	0.000786	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	
THCA	cis	1	rs62119429	chr2:9743585	IAH1	chr2:9614670-9636671:+	0.16	3.38	0.000786	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	
THCA	cis	1	rs62120832	chr19:23064264	ZNF492	chr19:22817126-22850472:+	-0.43	-6.28	7.83E-10	Bronchopulmonary dysplasia	
THCA	cis	1	rs62121818	chr19:39167760	LGALS7	chr19:39261608-39264157:-	-0.22	-4.4	1.34E-5	Heart rate	
THCA	cis	1	rs62132091	chr2:17770276	GEN1	chr2:17935162-17966632:+	0.5	6.53	1.65E-10	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62132092	chr2:17770893	GEN1	chr2:17935162-17966632:+	0.61	6.92	1.45E-11	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62132093	chr2:17771207	GEN1	chr2:17935162-17966632:+	0.61	6.92	1.45E-11	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62132125	chr2:17776997	GEN1	chr2:17935162-17966632:+	0.51	6.86	2.08E-11	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62132127	chr2:17778708	GEN1	chr2:17935162-17966632:+	0.58	7.52	2.66E-13	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62132129	chr2:17778782	GEN1	chr2:17935162-17966632:+	0.61	7.1	4.67E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62132133	chr2:17780483	GEN1	chr2:17935162-17966632:+	0.61	7.08	5.1E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62132135	chr2:17783190	GEN1	chr2:17935162-17966632:+	0.61	7.08	5.1E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62132137	chr2:17784194	GEN1	chr2:17935162-17966632:+	0.61	7.08	5.1E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62132138	chr2:17784781	GEN1	chr2:17935162-17966632:+	0.61	7.08	5.1E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62132139	chr2:17785987	GEN1	chr2:17935162-17966632:+	0.61	7.13	3.63E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62132140	chr2:17786559	GEN1	chr2:17935162-17966632:+	0.61	7.13	3.63E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62132141	chr2:17786758	GEN1	chr2:17935162-17966632:+	0.61	7.13	3.63E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62132142	chr2:17788469	GEN1	chr2:17935162-17966632:+	0.61	7.13	3.63E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62132143	chr2:17788743	GEN1	chr2:17935162-17966632:+	0.61	7.13	3.63E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62132144	chr2:17788790	GEN1	chr2:17935162-17966632:+	0.61	7.13	3.63E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62132145	chr2:17789253	GEN1	chr2:17935162-17966632:+	0.61	7.13	3.63E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62132146	chr2:17790133	GEN1	chr2:17935162-17966632:+	0.61	7.13	3.67E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62132147	chr2:17790876	GEN1	chr2:17935162-17966632:+	0.61	7.14	3.5E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62132148	chr2:17791048	GEN1	chr2:17935162-17966632:+	0.61	7.14	3.5E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62132150	chr2:17792359	GEN1	chr2:17935162-17966632:+	0.62	7.1	4.41E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62132151	chr2:17792698	GEN1	chr2:17935162-17966632:+	0.61	7.02	7.88E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62132152	chr2:17794404	GEN1	chr2:17935162-17966632:+	0.6	6.99	9.04E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62133576	chr2:17795297	GEN1	chr2:17935162-17966632:+	0.6	6.99	9.04E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62133577	chr2:17798777	GEN1	chr2:17935162-17966632:+	0.6	7.03	7.16E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62133578	chr2:17799575	GEN1	chr2:17935162-17966632:+	0.6	7.03	7.16E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62133579	chr2:17800196	GEN1	chr2:17935162-17966632:+	0.6	7.03	7.16E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62133583	chr2:17805779	GEN1	chr2:17935162-17966632:+	0.6	7.03	7.16E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62133584	chr2:17805944	GEN1	chr2:17935162-17966632:+	0.6	7.03	7.16E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62133586	chr2:17806579	GEN1	chr2:17935162-17966632:+	0.6	7.03	7.16E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62133587	chr2:17806654	GEN1	chr2:17935162-17966632:+	0.6	7.03	7.16E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62133588	chr2:17807469	GEN1	chr2:17935162-17966632:+	0.6	7.03	7.16E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62133589	chr2:17807626	GEN1	chr2:17935162-17966632:+	0.6	7.03	7.16E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62133590	chr2:17811126	GEN1	chr2:17935162-17966632:+	0.63	7.2	2.42E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs62134006	chr2:70050641	SNRNP27	chr2:70121090-70132348:+	0.17	4	7.29E-5	Colorectal or endometrial cancer	
THCA	cis	1	rs62134009	chr2:70054296	SNRNP27	chr2:70121090-70132348:+	0.18	4.12	4.41E-5	Colorectal or endometrial cancer	
THCA	cis	1	rs62136099	chr19:46847901	PPP5C	chr19:46850294-46894103:+	-0.24	-4.29	2.13E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs62136101	chr19:46854055	PPP5C	chr19:46850294-46894103:+	-0.23	-3.92	9.99E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs62136864	chr2:46829124	ATP6V1E2	chr2:46738988-46769696:-	-0.29	-5.27	2.02E-7	Height	
THCA	cis	1	rs62136864	chr2:46829124	CRIPT	chr2:46844325-46852880:+	0.24	4.43	1.14E-5	Height	
THCA	cis	1	rs62136864	chr2:46829124	PIGF	chr2:46808414-46844251:-	0.17	3.54	0.000447	Height	
THCA	cis	1	rs62138361	chr2:53225074	CHAC2	chr2:53994929-54002287:+	0.23	3.59	0.000363	Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs62138362	chr2:53229061	CHAC2	chr2:53994929-54002287:+	0.23	3.53	0.000457	Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs62139200	chr2:54475507	C2orf73	chr2:54558071-54588714:+	0.29	4.09	5.07E-5	Telomere length	
THCA	cis	1	rs62139251	chr2:54478605	C2orf73	chr2:54558071-54588714:+	0.34	4.68	3.76E-6	Telomere length	
THCA	cis	1	rs62139254	chr2:54480336	C2orf73	chr2:54558071-54588714:+	0.32	4.55	6.86E-6	Telomere length	
THCA	cis	1	rs62151652	chr2:73700131	ALMS1P	chr2:73872046-73912692:+	0.75	11.65	8.42E-28	Metabolite levels	
THCA	cis	1	rs62151652	chr2:73700131	NAT8	chr2:73867850-73869537:-	0.41	6.23	1.04E-9	Metabolite levels	
THCA	cis	1	rs62153845	chr2:99887162	LIPT1	chr2:99771418-99779611:+	0.2	3.91	0.000105	IgG glycosylation	
THCA	cis	1	rs62157778	chr2:88934090	RPIA	chr2:88991176-89050451:+	0.36	6.68	6.65E-11	Height	
THCA	cis	1	rs62175475	chr2:218290358	DIRC3	chr2:218148748-218621316:-	0.2	4.65	4.27E-6	Height	
THCA	cis	1	rs62175515	chr2:160909524	LY75	chr2:160625141-160761262:-	0.21	4.97	9.51E-7	Idiopathic membranous nephropathy	
THCA	cis	1	rs62175517	chr2:160911575	LY75	chr2:160625141-160761262:-	0.21	4.97	9.51E-7	Idiopathic membranous nephropathy	
THCA	cis	1	rs62180307	chr2:63341015	C2orf86	chr2:63348537-63815851:-	0.25	5.73	1.8E-8	Prostate cancer	
THCA	cis	1	rs62184315	chr2:190771945	ASNSD1	chr2:190526125-190535556:+	-0.45	-6.75	4.34E-11	Alcohol dependence (age at onset)	
THCA	cis	1	rs62184315	chr2:190771945	ORMDL1	chr2:190634994-190649097:-	0.25	5.43	8.77E-8	Alcohol dependence (age at onset)	
THCA	cis	1	rs62186400	chr2:242226700	ANO7	chr2:242127924-242164791:+	0.35	4.19	3.3E-5	Prostate cancer	
THCA	cis	1	rs62186400	chr2:242226700	SEPT2	chr2:242254723-242293439:+	-0.29	-4.32	1.86E-5	Prostate cancer	
THCA	cis	1	rs62186411	chr2:242236667	ANO7	chr2:242127924-242164791:+	0.36	4.22	2.97E-5	Prostate cancer	
THCA	cis	1	rs62186411	chr2:242236667	SEPT2	chr2:242254723-242293439:+	-0.29	-4.3	2.06E-5	Prostate cancer	
THCA	cis	1	rs62186422	chr2:242249499	ANO7	chr2:242127924-242164791:+	0.36	4.22	2.97E-5	Prostate cancer	
THCA	cis	1	rs62186422	chr2:242249499	SEPT2	chr2:242254723-242293439:+	-0.29	-4.3	2.06E-5	Prostate cancer	
THCA	cis	1	rs62190367	chr2:242376276	ANO7	chr2:242127924-242164791:+	0.32	3.8	0.000164	Prostate cancer	
THCA	cis	1	rs62190367	chr2:242376276	SEPT2	chr2:242254723-242293439:+	-0.31	-4.57	6.31E-6	Prostate cancer	
THCA	cis	1	rs62190370	chr2:242384194	ANO7	chr2:242127924-242164791:+	0.32	3.7	0.000239	Prostate cancer	
THCA	cis	1	rs62190370	chr2:242384194	SEPT2	chr2:242254723-242293439:+	-0.3	-4.49	9.03E-6	Prostate cancer	
THCA	cis	1	rs62193171	chr2:242276523	ANO7	chr2:242127924-242164791:+	0.36	4.13	4.26E-5	Prostate cancer	
THCA	cis	1	rs62193171	chr2:242276523	SEPT2	chr2:242254723-242293439:+	-0.29	-4.17	3.59E-5	Prostate cancer	
THCA	cis	1	rs62193175	chr2:242284405	ANO7	chr2:242127924-242164791:+	0.36	4.13	4.26E-5	Prostate cancer	
THCA	cis	1	rs62193175	chr2:242284405	SEPT2	chr2:242254723-242293439:+	-0.29	-4.17	3.59E-5	Prostate cancer	
THCA	cis	1	rs62193197	chr2:242294301	ANO7	chr2:242127924-242164791:+	0.35	4.06	5.82E-5	Prostate cancer	
THCA	cis	1	rs62193197	chr2:242294301	SEPT2	chr2:242254723-242293439:+	-0.29	-4.24	2.71E-5	Prostate cancer	
THCA	cis	1	rs62193202	chr2:242303717	ANO7	chr2:242127924-242164791:+	0.37	4.19	3.3E-5	Prostate cancer	
THCA	cis	1	rs62193202	chr2:242303717	SEPT2	chr2:242254723-242293439:+	-0.28	-4	7.35E-5	Prostate cancer	
THCA	cis	1	rs62193204	chr2:242315443	ANO7	chr2:242127924-242164791:+	0.33	3.85	0.000134	Prostate cancer	
THCA	cis	1	rs62193204	chr2:242315443	SEPT2	chr2:242254723-242293439:+	-0.3	-4.5	8.43E-6	Prostate cancer	
THCA	cis	1	rs62193205	chr2:242316512	ANO7	chr2:242127924-242164791:+	0.33	3.88	0.000117	Prostate cancer	
THCA	cis	1	rs62193205	chr2:242316512	SEPT2	chr2:242254723-242293439:+	-0.3	-4.51	8.18E-6	Prostate cancer	
THCA	cis	1	rs62193207	chr2:242318501	ANO7	chr2:242127924-242164791:+	0.33	3.85	0.000134	Prostate cancer	
THCA	cis	1	rs62193207	chr2:242318501	SEPT2	chr2:242254723-242293439:+	-0.3	-4.5	8.43E-6	Prostate cancer	
THCA	cis	1	rs62193208	chr2:242322430	ANO7	chr2:242127924-242164791:+	0.33	3.82	0.000149	Prostate cancer	
THCA	cis	1	rs62193208	chr2:242322430	SEPT2	chr2:242254723-242293439:+	-0.3	-4.44	1.14E-5	Prostate cancer	
THCA	cis	1	rs62193209	chr2:242323523	ANO7	chr2:242127924-242164791:+	0.37	3.88	0.000117	Prostate cancer	
THCA	cis	1	rs62193209	chr2:242323523	SEPT2	chr2:242254723-242293439:+	-0.29	-3.82	0.000149	Prostate cancer	
THCA	cis	1	rs62193210	chr2:242323616	ANO7	chr2:242127924-242164791:+	0.33	3.82	0.000149	Prostate cancer	
THCA	cis	1	rs62193210	chr2:242323616	SEPT2	chr2:242254723-242293439:+	-0.3	-4.44	1.14E-5	Prostate cancer	
THCA	cis	1	rs62193221	chr2:242354632	ANO7	chr2:242127924-242164791:+	0.33	3.88	0.00012	Prostate cancer	
THCA	cis	1	rs62193221	chr2:242354632	SEPT2	chr2:242254723-242293439:+	-0.3	-4.55	6.92E-6	Prostate cancer	
THCA	cis	1	rs62193256	chr2:242362168	ANO7	chr2:242127924-242164791:+	0.32	3.8	0.000164	Prostate cancer	
THCA	cis	1	rs62193256	chr2:242362168	SEPT2	chr2:242254723-242293439:+	-0.31	-4.57	6.31E-6	Prostate cancer	
THCA	cis	1	rs62206437	chr20:43759316	STK4	chr20:43595120-43708591:+	-0.17	-3.9	0.00011	Parental longevity (mother's age at death)	
THCA	cis	1	rs62207535	chr20:61669187	ADRM1	chr20:60878027-60883916:+	0.09	3.55	0.000421	Prostate cancer (gene x gene interaction)	
THCA	cis	1	rs62207635	chr20:47951583	C20orf199	chr20:47894715-47905793:+	0.29	4.06	5.75E-5	QT interval	
THCA	cis	1	rs62210663	chr20:55067481	C20orf43	chr20:55043647-55093942:+	0.24	6.55	1.45E-10	Refractive astigmatism	
THCA	cis	1	rs62211529	chr20:33959315	CPNE1	chr20:34213968-34262539:-	0.3	5.88	7.84E-9	Height	
THCA	cis	1	rs62211529	chr20:33959315	GDF5	chr20:33897002-34042568:-	-0.17	-3.74	0.000207	Height	
THCA	cis	1	rs62211529	chr20:33959315	UQCC	chr20:33890383-33999833:-	0.32	10.18	3.81E-22	Height	
THCA	cis	1	rs62233805	chr3:2474385	CNTN4	chr3:2140550-3099644:+	0.37	8.62	1.01E-16	Blood pressure (smoking interaction)	
THCA	cis	1	rs62233806	chr3:2475478	CNTN4	chr3:2140550-3099644:+	0.36	8.43	4.08E-16	Blood pressure (smoking interaction)	
THCA	cis	1	rs62236665	chr22:38059847	LGALS2	chr22:37966254-37976024:-	0.14	3.71	0.000232	Fat distribution (HIV)	
THCA	cis	1	rs62236665	chr22:38059847	PDXP	chr22:38054737-38062939:+	-0.18	-3.34	0.000892	Fat distribution (HIV)	
THCA	cis	1	rs62236665	chr22:38059847	SH3BP1	chr22:38030661-38062939:+	0.12	3.74	0.00021	Fat distribution (HIV)	
THCA	cis	1	rs62236667	chr22:38061520	LGALS2	chr22:37966254-37976024:-	0.13	3.52	0.000477	Fat distribution (HIV)	
THCA	cis	1	rs62236667	chr22:38061520	PDXP	chr22:38054737-38062939:+	-0.18	-3.38	0.000775	Fat distribution (HIV)	
THCA	cis	1	rs62236667	chr22:38061520	SH3BP1	chr22:38030661-38062939:+	0.11	3.56	0.000403	Fat distribution (HIV)	
THCA	cis	1	rs62236668	chr22:38063870	LGALS2	chr22:37966254-37976024:-	0.13	3.52	0.000477	Fat distribution (HIV)	
THCA	cis	1	rs62236668	chr22:38063870	PDXP	chr22:38054737-38062939:+	-0.18	-3.38	0.000775	Fat distribution (HIV)	
THCA	cis	1	rs62236668	chr22:38063870	SH3BP1	chr22:38030661-38062939:+	0.11	3.56	0.000403	Fat distribution (HIV)	
THCA	cis	1	rs62259933	chr3:49469703	GMPPB	chr3:49758932-49761384:-	0.16	3.72	0.000221	Menarche (age at onset)	
THCA	cis	1	rs62259933	chr3:49469703	P4HTM	chr3:49027341-49044579:+	-0.17	-4.27	2.36E-5	Menarche (age at onset)	
THCA	cis	1	rs62259933	chr3:49469703	WDR6	chr3:49044637-49053386:+	0.18	3.69	0.000251	Menarche (age at onset)	
THCA	cis	1	rs62259944	chr3:49430883	GMPPB	chr3:49758932-49761384:-	0.18	3.88	0.000119	Menarche (age at onset)	
THCA	cis	1	rs62259944	chr3:49430883	P4HTM	chr3:49027341-49044579:+	-0.19	-4.6	5.36E-6	Menarche (age at onset)	
THCA	cis	1	rs62259947	chr3:49439924	GMPPB	chr3:49758932-49761384:-	0.17	3.73	0.000218	Menarche (age at onset)	
THCA	cis	1	rs62259947	chr3:49439924	P4HTM	chr3:49027341-49044579:+	-0.19	-4.65	4.33E-6	Menarche (age at onset)	
THCA	cis	1	rs62261249	chr3:49594060	GMPPB	chr3:49758932-49761384:-	0.16	3.62	0.000325	Menarche (age at onset)	
THCA	cis	1	rs62261249	chr3:49594060	P4HTM	chr3:49027341-49044579:+	-0.18	-4.5	8.6E-6	Menarche (age at onset)	
THCA	cis	1	rs62265556	chr3:94243253	STX19	chr3:93733215-93747454:-	0.28	3.43	0.000664	Blood pressure measurement (high sodium intervention)	
THCA	cis	1	rs62268732	chr3:121370455	HCLS1	chr3:121350247-121379791:-	-0.07	-3.42	0.000668	Cognitive performance	
THCA	cis	1	rs62268732	chr3:121370455	IQCB1	chr3:121488610-121553926:-	0.53	10.21	2.95E-22	Cognitive performance	
THCA	cis	1	rs62269547	chr3:134214042	ANAPC13	chr3:134196547-134204865:-	0.39	12.57	1.72E-31	Height	
THCA	cis	1	rs62269547	chr3:134214042	CEP63	chr3:134204575-134293852:+	0.29	6.4	3.83E-10	Height	
THCA	cis	1	rs62271513	chr3:134298412	ANAPC13	chr3:134196547-134204865:-	-0.37	-11.34	1.51E-26	Height	
THCA	cis	1	rs62271513	chr3:134298412	CEP63	chr3:134204575-134293852:+	-0.3	-6.49	2.16E-10	Height	
THCA	cis	1	rs62271514	chr3:134298554	ANAPC13	chr3:134196547-134204865:-	-0.37	-11.34	1.51E-26	Height	
THCA	cis	1	rs62271514	chr3:134298554	CEP63	chr3:134204575-134293852:+	-0.3	-6.49	2.16E-10	Height	
THCA	cis	1	rs62271515	chr3:134300507	ANAPC13	chr3:134196547-134204865:-	0.37	11.55	2.1E-27	Height	
THCA	cis	1	rs62271515	chr3:134300507	CEP63	chr3:134204575-134293852:+	0.29	6.27	8.23E-10	Height	
THCA	cis	1	rs62279162	chr2:228162280	MFF	chr2:228189978-228222547:+	0.23	4.92	1.19E-6	Corneal structure	
THCA	cis	1	rs62279163	chr2:228168099	MFF	chr2:228189978-228222547:+	0.22	4.75	2.76E-6	Corneal structure	
THCA	cis	1	rs62279921	chr3:161065441	NMD3	chr3:160939099-160971319:+	-0.1	-3.34	0.000896	Morning vs. evening chronotype	
THCA	cis	1	rs62283022	chr3:151005481	GPR87	chr3:151011876-151034636:-	0.21	4.71	3.3E-6	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs62283022	chr3:151005481	P2RY14	chr3:150929905-150996230:-	-0.2	-4.19	3.31E-5	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs62295634	chr4:17685346	MED28	chr4:17616273-17629791:+	0.16	3.42	0.000687	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs62309960	chr4:89152616	ABCG2	chr4:89011417-89152474:-	-0.22	-3.6	0.000354	Metabolite levels (small molecules and protein measures)	
THCA	cis	1	rs62309962	chr4:89152990	ABCG2	chr4:89011417-89152474:-	-0.19	-3.38	0.000786	Metabolite levels (small molecules and protein measures)	
THCA	cis	1	rs62310332	chr4:39114559	KLHL5	chr4:39046659-39123828:+	-0.21	-5.73	1.77E-8	Uric acid levels	
THCA	cis	1	rs62321365	chr4:107013723	TBCK	chr4:106967233-107237861:-	0.35	7.21	2.22E-12	Airflow obstruction	
THCA	cis	1	rs62322549	chr4:71319058	AMTN	chr4:71384298-71398459:+	0.22	5.31	1.68E-7	Alcoholism (heaviness of drinking)	
THCA	cis	1	rs62324382	chr4:139125762	SLC7A11	chr4:139085248-139163503:-	0.23	4.6	5.34E-6	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	
THCA	cis	1	rs62329461	chr4:103261217	BANK1	chr4:102341118-102995967:+	-0.24	-3.4	0.000729	Erythrocyte cadmium concentration in never smokers	
THCA	cis	1	rs62329462	chr4:103264105	BANK1	chr4:102341118-102995967:+	-0.25	-3.61	0.000342	Erythrocyte cadmium concentration in never smokers	
THCA	cis	1	rs62331930	chr4:155349319	DCHS2	chr4:155155527-155412930:-	0.16	3.49	0.000526	Alzheimer's disease (age of onset)	
THCA	cis	1	rs6234	chr5:95728974	RIOK2	chr5:96496572-96519005:-	0.17	3.63	0.000313	Body mass index	
THCA	cis	1	rs6235	chr5:95728898	RIOK2	chr5:96496572-96519005:-	0.18	3.66	0.000281	Body mass index	
THCA	cis	1	rs62384189	chr5:115510391	COMMD10	chr5:115420727-115628978:+	0.47	5.68	2.31E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs62384212	chr5:115521667	COMMD10	chr5:115420727-115628978:+	0.48	5.84	9.44E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs62384213	chr5:115526795	COMMD10	chr5:115420727-115628978:+	0.48	5.7	2.09E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs62384215	chr5:115528198	COMMD10	chr5:115420727-115628978:+	0.48	5.7	2.09E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs62384231	chr5:115530304	COMMD10	chr5:115420727-115628978:+	0.48	5.84	9.44E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs62384233	chr5:115533597	COMMD10	chr5:115420727-115628978:+	0.48	5.84	9.44E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs62384235	chr5:115534234	COMMD10	chr5:115420727-115628978:+	0.48	5.7	2.09E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs62384236	chr5:115534637	COMMD10	chr5:115420727-115628978:+	0.48	5.7	2.09E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs62384237	chr5:115540222	COMMD10	chr5:115420727-115628978:+	0.46	5.62	3.33E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs62384238	chr5:115542531	COMMD10	chr5:115420727-115628978:+	0.48	5.7	2.09E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs62384253	chr5:115563415	COMMD10	chr5:115420727-115628978:+	0.48	5.7	2.09E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs62384468	chr5:115623850	COMMD10	chr5:115420727-115628978:+	0.47	5.68	2.34E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs62384469	chr5:115624964	COMMD10	chr5:115420727-115628978:+	0.41	5.07	5.7E-7	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs62384471	chr5:115631273	COMMD10	chr5:115420727-115628978:+	0.44	5.58	4.06E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs62384476	chr5:115649509	COMMD10	chr5:115420727-115628978:+	0.48	5.7	2.09E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs62384493	chr5:115673448	COMMD10	chr5:115420727-115628978:+	0.47	5.66	2.61E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs62384678	chr5:115422688	COMMD10	chr5:115420727-115628978:+	0.48	5.91	6.38E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs62384697	chr5:115438284	COMMD10	chr5:115420727-115628978:+	0.5	6.16	1.54E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs62384700	chr5:115443805	COMMD10	chr5:115420727-115628978:+	0.5	6.16	1.54E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs62384714	chr5:115452597	COMMD10	chr5:115420727-115628978:+	0.46	5.65	2.8E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs62385074	chr5:169731617	KCNMB1	chr5:169805167-169816638:-	0.21	3.7	0.000242	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	
THCA	cis	1	rs62385177	chr5:115480480	COMMD10	chr5:115420727-115628978:+	0.48	5.89	7.35E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs62385980	chr5:115592908	COMMD10	chr5:115420727-115628978:+	0.48	5.7	2.09E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs62385993	chr5:115602254	COMMD10	chr5:115420727-115628978:+	0.48	5.7	2.09E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs62391527	chr5:125904970	ALDH7A1	chr5:125878918-125931082:-	0.45	6.44	2.92E-10	Osteoporosis	
THCA	cis	1	rs62391531	chr5:125914726	ALDH7A1	chr5:125878918-125931082:-	0.45	6.59	1.18E-10	Osteoporosis	
THCA	cis	1	rs62402013	chr6:26915000	BTN3A2	chr6:26365398-26378546:+	0.16	3.9	0.00011	Schizophrenia	
THCA	cis	1	rs62402013	chr6:26915000	HCG11	chr6:26521934-26527610:+	-0.21	-3.97	8.4E-5	Schizophrenia	
THCA	cis	1	rs62402013	chr6:26915000	LOC100270746	chr6:26987146-26988085:-	-0.26	-6.17	1.43E-9	Schizophrenia	
THCA	cis	1	rs62404566	chr6:35118432	TCP11	chr6:35085849-35109187:-	-0.25	-4.11	4.75E-5	Airway responsiveness in chronic obstructive pulmonary disease	
THCA	cis	1	rs62404862	chr6:55943199	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs62404863	chr6:55943202	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs62404865	chr6:55944559	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs62404866	chr6:55956146	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs62404867	chr6:55957970	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs62404868	chr6:55958119	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs62404869	chr6:55958205	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs62404893	chr6:55961216	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs62404894	chr6:55961287	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs62404895	chr6:55961427	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs62404896	chr6:55962092	COL21A1	chr6:55921389-56258892:-	-0.65	-8.06	5.95E-15	Psychosis (atypical)	
THCA	cis	1	rs62406152	chr6:55932036	COL21A1	chr6:55921389-56258892:-	-0.63	-7.81	3.68E-14	Psychosis (atypical)	
THCA	cis	1	rs62406153	chr6:55935232	COL21A1	chr6:55921389-56258892:-	-0.64	-7.91	1.86E-14	Psychosis (atypical)	
THCA	cis	1	rs62406155	chr6:55937492	COL21A1	chr6:55921389-56258892:-	-0.65	-8.03	7.92E-15	Psychosis (atypical)	
THCA	cis	1	rs62406156	chr6:55941887	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs62406157	chr6:55941999	COL21A1	chr6:55921389-56258892:-	-0.65	-8.11	4.22E-15	Psychosis (atypical)	
THCA	cis	1	rs62408999	chr6:70472660	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.43	0.00066	Sleep duration	
THCA	cis	1	rs62411452	chr6:55964425	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs62411455	chr6:55968366	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs62411456	chr6:55968420	COL21A1	chr6:55921389-56258892:-	-0.63	-7.84	2.89E-14	Psychosis (atypical)	
THCA	cis	1	rs62411457	chr6:55968487	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.8E-15	Psychosis (atypical)	
THCA	cis	1	rs62412799	chr6:55977839	COL21A1	chr6:55921389-56258892:-	-0.67	-8.31	1.01E-15	Psychosis (atypical)	
THCA	cis	1	rs62412803	chr6:55986547	COL21A1	chr6:55921389-56258892:-	-0.67	-8.37	6.49E-16	Psychosis (atypical)	
THCA	cis	1	rs62412804	chr6:55986975	COL21A1	chr6:55921389-56258892:-	-0.65	-7.76	5.03E-14	Psychosis (atypical)	
THCA	cis	1	rs62412805	chr6:55986986	COL21A1	chr6:55921389-56258892:-	-0.65	-7.82	3.44E-14	Psychosis (atypical)	
THCA	cis	1	rs62412806	chr6:55987105	COL21A1	chr6:55921389-56258892:-	-0.67	-8.28	1.22E-15	Psychosis (atypical)	
THCA	cis	1	rs62412807	chr6:55987693	COL21A1	chr6:55921389-56258892:-	-0.67	-8.28	1.22E-15	Psychosis (atypical)	
THCA	cis	1	rs62412808	chr6:55987806	COL21A1	chr6:55921389-56258892:-	-0.67	-8.28	1.22E-15	Psychosis (atypical)	
THCA	cis	1	rs62412809	chr6:55987863	COL21A1	chr6:55921389-56258892:-	-0.67	-8.28	1.22E-15	Psychosis (atypical)	
THCA	cis	1	rs62412810	chr6:55988047	COL21A1	chr6:55921389-56258892:-	-0.67	-8.28	1.22E-15	Psychosis (atypical)	
THCA	cis	1	rs62412811	chr6:55988062	COL21A1	chr6:55921389-56258892:-	-0.67	-8.28	1.22E-15	Psychosis (atypical)	
THCA	cis	1	rs62412813	chr6:55988257	COL21A1	chr6:55921389-56258892:-	-0.67	-8.28	1.22E-15	Psychosis (atypical)	
THCA	cis	1	rs62412814	chr6:55988296	COL21A1	chr6:55921389-56258892:-	-0.65	-8.07	5.69E-15	Psychosis (atypical)	
THCA	cis	1	rs62412818	chr6:55989784	COL21A1	chr6:55921389-56258892:-	-0.64	-7.96	1.24E-14	Psychosis (atypical)	
THCA	cis	1	rs62412819	chr6:55992889	COL21A1	chr6:55921389-56258892:-	-0.65	-8.05	6.7E-15	Psychosis (atypical)	
THCA	cis	1	rs62412820	chr6:55992934	COL21A1	chr6:55921389-56258892:-	-0.65	-8.05	6.7E-15	Psychosis (atypical)	
THCA	cis	1	rs62412822	chr6:55993174	COL21A1	chr6:55921389-56258892:-	-0.65	-8.05	6.7E-15	Psychosis (atypical)	
THCA	cis	1	rs62413465	chr6:55998202	COL21A1	chr6:55921389-56258892:-	-0.66	-8.1	4.64E-15	Psychosis (atypical)	
THCA	cis	1	rs62413470	chr6:55999537	COL21A1	chr6:55921389-56258892:-	-0.5	-6.44	2.98E-10	Psychosis (atypical)	
THCA	cis	1	rs62413472	chr6:56000117	COL21A1	chr6:55921389-56258892:-	-0.66	-8.09	4.8E-15	Psychosis (atypical)	
THCA	cis	1	rs62413473	chr6:56000463	COL21A1	chr6:55921389-56258892:-	-0.66	-8.09	4.8E-15	Psychosis (atypical)	
THCA	cis	1	rs62413474	chr6:56001074	COL21A1	chr6:55921389-56258892:-	-0.66	-8.09	4.8E-15	Psychosis (atypical)	
THCA	cis	1	rs62413475	chr6:56001075	COL21A1	chr6:55921389-56258892:-	-0.66	-8.09	4.8E-15	Psychosis (atypical)	
THCA	cis	1	rs62413476	chr6:56001918	COL21A1	chr6:55921389-56258892:-	-0.66	-8.09	4.8E-15	Psychosis (atypical)	
THCA	cis	1	rs62413477	chr6:56002434	COL21A1	chr6:55921389-56258892:-	-0.66	-8.09	4.8E-15	Psychosis (atypical)	
THCA	cis	1	rs62413478	chr6:56002867	COL21A1	chr6:55921389-56258892:-	-0.66	-8.07	5.71E-15	Psychosis (atypical)	
THCA	cis	1	rs62413479	chr6:56004203	COL21A1	chr6:55921389-56258892:-	-0.66	-8.13	3.85E-15	Psychosis (atypical)	
THCA	cis	1	rs624159	chr10:105939451	C10orf79	chr10:105889647-105992120:-	0.25	8	9.29E-15	Attention deficit hyperactivity disorder	
THCA	cis	1	rs624189	chr4:144245363	GAB1	chr4:144257983-144395717:+	-0.17	-3.99	7.58E-5	Nasopharyngeal carcinoma	
THCA	cis	1	rs62420119	chr6:70583953	COL19A1	chr6:70576448-70922157:+	-0.28	-4.31	2.0E-5	Subjective well-being	
THCA	cis	1	rs62427470	chr6:155910279	TFB1M	chr6:155578791-155635626:-	0.23	3.36	0.000845	Schizophrenia	
THCA	cis	1	rs62460739	chr7:77406747	PTPN12	chr7:77166773-77269388:+	-0.17	-3.84	0.00014	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs62460739	chr7:77406747	RSBN1L	chr7:77325743-77409120:+	0.15	3.66	0.000284	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs62460740	chr7:77409439	PTPN12	chr7:77166773-77269388:+	-0.17	-3.72	0.000222	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs62460740	chr7:77409439	RSBN1L	chr7:77325743-77409120:+	0.14	3.47	0.000561	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs62465144	chr7:72883106	MLXIPL	chr7:73007524-73038870:-	0.21	3.93	9.6E-5	Triglycerides	
THCA	cis	1	rs62466793	chr7:66191517	GUSB	chr7:65425675-65447246:-	0.34	6.84	2.39E-11	Aortic root size	
THCA	cis	1	rs62466793	chr7:66191517	RABGEF1	chr7:66093890-66276446:+	0.52	10.68	5.06E-24	Aortic root size	
THCA	cis	1	rs62466793	chr7:66191517	TYW1	chr7:66461817-66704496:+	0.18	3.88	0.000118	Aortic root size	
THCA	cis	1	rs62466794	chr7:66191579	GUSB	chr7:65425675-65447246:-	0.33	6.71	5.64E-11	Aortic root size	
THCA	cis	1	rs62466794	chr7:66191579	RABGEF1	chr7:66093890-66276446:+	0.51	10.5	2.42E-23	Aortic root size	
THCA	cis	1	rs62466794	chr7:66191579	TYW1	chr7:66461817-66704496:+	0.18	3.96	8.55E-5	Aortic root size	
THCA	cis	1	rs624976	chr19:12110238	ZNF763	chr19:12035900-12091196:+	0.36	4.61	5.19E-6	Multiple sclerosis	
THCA	cis	1	rs62521826	chr8:124186668	FAM83A	chr8:124191287-124222317:+	-0.34	-4.22	2.89E-5	Urinary uromodulin levels	
THCA	cis	1	rs62521841	chr8:124194625	FAM83A	chr8:124191287-124222317:+	-0.33	-4.06	5.83E-5	Urinary uromodulin levels	
THCA	cis	1	rs625658	chr1:155891045	FDPS	chr1:155278539-155290457:+	-0.21	-4.43	1.15E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs625658	chr1:155891045	RIT1	chr1:155867601-155881177:-	0.17	3.83	0.000143	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs62574275	chr9:100985311	TBC1D2	chr9:100961281-101018003:-	0.28	7.01	8.42E-12	Post-traumatic stress disorder	
THCA	cis	1	rs62574275	chr9:100985311	TSTD2	chr9:100362364-100395962:-	0.16	3.56	0.000415	Post-traumatic stress disorder	
THCA	cis	1	rs62625008	chr1:95702582	RWDD3	chr1:95583479-95712773:+	0.27	3.54	0.000432	Stearic acid (18:0) plasma levels	
THCA	cis	1	rs627460	chr6:132640030	MOXD1	chr6:132617195-132722664:-	0.25	4.41	1.27E-5	Obesity-related traits	
THCA	cis	1	rs627804	chr15:65734040	DPP8	chr15:65737999-65810035:-	-0.09	-3.78	0.000176	Mean corpuscular hemoglobin	
THCA	cis	1	rs627804	chr15:65734040	SLC24A1	chr15:65903704-65953256:+	-0.15	-3.75	0.000195	Mean corpuscular hemoglobin	
THCA	cis	1	rs627817	chr5:139054506	DNAJC18	chr5:138747381-138775139:-	0.17	3.81	0.000158	Schizophrenia	
THCA	cis	1	rs629301	chr1:109818306	SYPL2	chr1:110009100-110024763:+	0.15	3.39	0.000767	Cholesterol, total;Myocardial infarction;Coronary artery disease;Lipoprotein-associated phospholipase A2 activity and mass	
THCA	cis	1	rs632157	chr18:72911548	ZADH2	chr18:72909279-72921281:-	0.29	4.67	3.86E-6	Vascular endothelial growth factor levels	
THCA	cis	1	rs633400	chr10:38329421	LOC399744	chr10:38717074-38741080:+	0.28	3.85	0.000133	Obesity (extreme)	
THCA	cis	1	rs633400	chr10:38329421	ZNF25	chr10:38238795-38265453:-	0.16	3.46	0.000596	Obesity (extreme)	
THCA	cis	1	rs633554	chr6:84265708	SNAP91	chr6:84262607-84419127:-	-0.19	-3.71	0.00023	Bipolar disorder with mood-incongruent psychosis	
THCA	cis	1	rs634368	chr11:83324911	CCDC90B	chr11:82972506-82997414:-	0.15	3.68	0.000257	Subcortical brain region volumes	
THCA	cis	1	rs635400	chr12:123171089	EIF2B1	chr12:124105571-124118247:-	0.17	3.35	0.000876	Adiponectin levels	
THCA	cis	1	rs63749191	chr10:65119887	LOC84989	chr10:65224989-65226320:+	0.27	4.39	1.39E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs63749191	chr10:65119887	NRBF2	chr10:64893007-64914785:+	0.28	4.77	2.5E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs638076	chr11:68202580	LOC645332	chr11:67559240-67572807:-	0.19	4.09	5.16E-5	Bone mineral density (spine)	
THCA	cis	1	rs641018	chr11:65655393	CTSW	chr11:65647284-65651212:+	-0.6	-15.88	6.69E-46	Crohn's disease	
THCA	cis	1	rs641018	chr11:65655393	SNX32	chr11:65601410-65621170:+	0.63	9.47	1.33E-19	Crohn's disease	
THCA	cis	1	rs641168	chr11:64146289	GPR137	chr11:64037534-64056965:+	0.16	3.81	0.000154	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs641168	chr11:64146289	VEGFB	chr11:64002266-64006258:+	0.14	3.85	0.000132	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs6413523	chr10:81706135	LOC219347	chr10:81805991-81838949:-	-0.52	-5.52	5.7E-8	Rheumatoid arthritis	
THCA	cis	1	rs6414438	chr3:10073824	C3orf10	chr3:10157333-10168873:+	-0.2	-4.24	2.65E-5	Alzheimer's disease	
THCA	cis	1	rs6414438	chr3:10073824	VHL	chr3:10183319-10193744:+	-0.17	-3.95	8.96E-5	Alzheimer's disease	
THCA	cis	1	rs6421571	chr11:118743772	TREH	chr11:118528942-118550381:-	0.23	3.75	0.000199	Primary biliary cirrhosis	
THCA	cis	1	rs6425657	chr1:180956905	MR1	chr1:181003139-181024633:+	-0.13	-3.59	0.000363	Progressive supranuclear palsy	
THCA	cis	1	rs6425657	chr1:180956905	STX6	chr1:180913175-180992046:-	-0.2	-4.13	4.32E-5	Progressive supranuclear palsy	
THCA	cis	1	rs6425658	chr1:180956985	MR1	chr1:181003139-181024633:+	-0.13	-3.45	0.000602	Progressive supranuclear palsy	
THCA	cis	1	rs6425658	chr1:180956985	STX6	chr1:180913175-180992046:-	-0.19	-3.9	0.000108	Progressive supranuclear palsy	
THCA	cis	1	rs642573	chr11:71780854	FAM86C	chr11:71498557-71512276:+	0.3	3.78	0.000176	Severe influenza A (H1N1) infection	
THCA	cis	1	rs6425747	chr1:31869978	ZCCHC17	chr1:31769842-31837780:+	-0.29	-5.28	1.92E-7	Schizophrenia	
THCA	cis	1	rs6426622	chr1:19331891	TMCO4	chr1:20008707-20126758:-	-0.16	-3.64	0.000303	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
THCA	cis	1	rs6427553	chr1:160855813	CD244	chr1:160799951-160832645:-	-0.12	-3.38	0.000782	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs6427553	chr1:160855813	ITLN1	chr1:160846332-160854960:-	0.2	3.35	0.000868	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs6427860	chr1:200833995	DDX59	chr1:200610119-200639126:-	-0.22	-3.42	0.000687	Epilepsy	
THCA	cis	1	rs642803	chr11:65560620	NAALADL1	chr11:64812297-64826014:-	-0.12	-3.39	0.00077	Urate levels	
THCA	cis	1	rs642803	chr11:65560620	SNX32	chr11:65601410-65621170:+	-0.21	-3.72	0.000227	Urate levels	
THCA	cis	1	rs6428476	chr1:89126005	CCBL2	chr1:89401456-89458643:-	0.64	14.16	2.88E-38	Height	
THCA	cis	1	rs6429082	chr1:235600129	B3GALNT2	chr1:235610533-235667781:-	0.2	6.14	1.71E-9	Adiposity	
THCA	cis	1	rs6429082	chr1:235600129	GPR137B	chr1:236305832-236372208:+	0.19	3.35	0.000865	Adiposity	
THCA	cis	1	rs6429082	chr1:235600129	TBCE	chr1:235530728-235612280:+	0.13	3.87	0.000122	Adiposity	
THCA	cis	1	rs6429567	chr1:45956700	AKR1A1	chr1:46016498-46035720:+	-0.14	-3.78	0.000174	Homocysteine levels	
THCA	cis	1	rs6429567	chr1:45956700	CCDC163P	chr1:45960581-45965646:-	-1.11	-31.32	6.93E-118	Homocysteine levels	
THCA	cis	1	rs6429567	chr1:45956700	MUTYH	chr1:45794915-45806142:-	0.22	5.12	4.48E-7	Homocysteine levels	
THCA	cis	1	rs6429567	chr1:45956700	PRDX1	chr1:45976708-45987609:-	-0.4	-10.18	3.59E-22	Homocysteine levels	
THCA	cis	1	rs6429569	chr1:46001330	CCDC163P	chr1:45960581-45965646:-	-1	-26.32	5.01E-95	Homocysteine levels	
THCA	cis	1	rs6429569	chr1:46001330	MUTYH	chr1:45794915-45806142:-	0.2	4.8	2.11E-6	Homocysteine levels	
THCA	cis	1	rs6429569	chr1:46001330	PRDX1	chr1:45976708-45987609:-	-0.37	-9.47	1.27E-19	Homocysteine levels	
THCA	cis	1	rs6429582	chr1:46321843	CCDC163P	chr1:45960581-45965646:-	0.48	9.32	4.43E-19	Body mass index	
THCA	cis	1	rs6429582	chr1:46321843	GPBP1L1	chr1:46092978-46152302:-	-0.16	-4.14	4.05E-5	Body mass index	
THCA	cis	1	rs6429582	chr1:46321843	MMACHC	chr1:45965856-45976737:+	0.18	4.05	6.07E-5	Body mass index	
THCA	cis	1	rs6429582	chr1:46321843	MUTYH	chr1:45794915-45806142:-	-0.29	-7.95	1.35E-14	Body mass index	
THCA	cis	1	rs643025	chr1:197298860	CFHR3	chr1:196743930-196762872:+	-0.25	-5.2	2.97E-7	Lupus nephritis in systemic lupus erythematosus	
THCA	cis	1	rs6430585	chr2:136506927	DARS	chr2:136664254-136743222:-	-0.34	-6.27	8.2E-10	Corneal structure	
THCA	cis	1	rs6435079	chr2:202200331	ALS2CR12	chr2:202153148-202222101:-	-0.37	-7.29	1.28E-12	Basal cell carcinoma	
THCA	cis	1	rs6435079	chr2:202200331	PPIL3	chr2:201735680-201753999:-	-0.22	-4.55	6.84E-6	Basal cell carcinoma	
THCA	cis	1	rs6435081	chr2:202220623	ALS2CR12	chr2:202153148-202222101:-	-0.36	-7.19	2.54E-12	Basal cell carcinoma	
THCA	cis	1	rs6435081	chr2:202220623	PPIL3	chr2:201735680-201753999:-	-0.24	-4.92	1.19E-6	Basal cell carcinoma	
THCA	cis	1	rs6435169	chr2:203753016	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.93	5.93E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs6435169	chr2:203753016	ICA1L	chr2:203637873-203736371:-	0.25	4.18	3.49E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs6435930	chr2:216885852	MREG	chr2:216807315-216878346:-	0.38	7.95	1.4E-14	Alcohol dependence	
THCA	cis	1	rs6435930	chr2:216885852	PECR	chr2:216861029-216946532:-	0.25	5.07	5.84E-7	Alcohol dependence	
THCA	cis	1	rs6435984	chr2:218314788	IGFBP5	chr2:217536829-217560272:-	-0.21	-4.43	1.19E-5	Metabolite levels (MHPG)	
THCA	cis	1	rs643632	chr9:111839949	C9orf5	chr9:111777416-111882225:-	-0.18	-3.42	0.000681	Information processing speed	
THCA	cis	1	rs6438537	chr3:119277846	ADPRH	chr3:119298523-119308791:+	-0.23	-3.66	0.000277	Vitiligo	
THCA	cis	1	rs6438552	chr3:119631814	GSK3B	chr3:119540804-119813264:-	0.14	4.92	1.19E-6	HDL cholesterol	
THCA	cis	1	rs6438553	chr3:119640029	GSK3B	chr3:119540804-119813264:-	0.14	4.99	8.65E-7	HDL cholesterol	
THCA	cis	1	rs6439116	chr3:127849067	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.47	9.77E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs6439124	chr3:128007466	EEFSEC	chr3:127872313-128127488:+	0.27	4.82	1.91E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs6439484	chr3:134249899	ANAPC13	chr3:134196547-134204865:-	0.39	12.58	1.56E-31	Height	
THCA	cis	1	rs6439484	chr3:134249899	CEP63	chr3:134204575-134293852:+	0.3	6.54	1.63E-10	Height	
THCA	cis	1	rs6439487	chr3:134260860	ANAPC13	chr3:134196547-134204865:-	0.39	12.58	1.56E-31	Height	
THCA	cis	1	rs6439487	chr3:134260860	CEP63	chr3:134204575-134293852:+	0.3	6.54	1.63E-10	Height	
THCA	cis	1	rs6439649	chr3:136371691	PCCB	chr3:135969167-136056737:+	-0.2	-5.86	8.62E-9	Schizophrenia	
THCA	cis	1	rs6441104	chr3:156681441	LEKR1	chr3:156544076-156763918:+	-0.54	-10.52	1.94E-23	Bone mineral density	
THCA	cis	1	rs6441373	chr3:161026717	NMD3	chr3:160939099-160971319:+	-0.11	-3.62	0.000321	Morning vs. evening chronotype	
THCA	cis	1	rs644148	chr19:44970935	ZNF285	chr19:44889809-44905777:-	0.17	3.6	0.000354	Personality dimensions	
THCA	cis	1	rs6442117	chr3:48419897	ATRIP	chr3:48488141-48507708:+	-0.18	-3.95	9.14E-5	Longevity	
THCA	cis	1	rs6442117	chr3:48419897	TREX1	chr3:48501186-48509043:+	0.25	5.8	1.23E-8	Longevity	
THCA	cis	1	rs6442118	chr3:48440047	ATRIP	chr3:48488141-48507708:+	0.17	3.78	0.000179	Longevity	
THCA	cis	1	rs6442118	chr3:48440047	TREX1	chr3:48501186-48509043:+	-0.26	-6.05	2.91E-9	Longevity	
THCA	cis	1	rs6442119	chr3:48440178	ATRIP	chr3:48488141-48507708:+	0.17	3.82	0.000153	Longevity	
THCA	cis	1	rs6442119	chr3:48440178	TREX1	chr3:48501186-48509043:+	-0.25	-5.91	6.4E-9	Longevity	
THCA	cis	1	rs6442120	chr3:48464503	ATRIP	chr3:48488141-48507708:+	0.2	4.37	1.51E-5	Longevity	
THCA	cis	1	rs6442120	chr3:48464503	TREX1	chr3:48501186-48509043:+	-0.25	-5.82	1.09E-8	Longevity	
THCA	cis	1	rs6442123	chr3:48500286	ATRIP	chr3:48488141-48507708:+	0.19	4.15	3.93E-5	Longevity	
THCA	cis	1	rs6442123	chr3:48500286	TREX1	chr3:48501186-48509043:+	-0.25	-5.73	1.81E-8	Longevity	
THCA	cis	1	rs6442146	chr3:10073544	C3orf10	chr3:10157333-10168873:+	-0.2	-4.15	3.91E-5	Alzheimer's disease	
THCA	cis	1	rs6442146	chr3:10073544	VHL	chr3:10183319-10193744:+	-0.19	-4.38	1.48E-5	Alzheimer's disease	
THCA	cis	1	rs6442147	chr3:10078247	C3orf10	chr3:10157333-10168873:+	-0.19	-4.19	3.3E-5	Alzheimer's disease	
THCA	cis	1	rs6442147	chr3:10078247	VHL	chr3:10183319-10193744:+	-0.17	-3.92	0.000103	Alzheimer's disease	
THCA	cis	1	rs6442148	chr3:10078289	C3orf10	chr3:10157333-10168873:+	-0.2	-4.15	3.91E-5	Alzheimer's disease	
THCA	cis	1	rs6442148	chr3:10078289	VHL	chr3:10183319-10193744:+	-0.19	-4.38	1.48E-5	Alzheimer's disease	
THCA	cis	1	rs6442150	chr3:10122575	C3orf10	chr3:10157333-10168873:+	-0.21	-4.33	1.85E-5	Alzheimer's disease	
THCA	cis	1	rs6442150	chr3:10122575	VHL	chr3:10183319-10193744:+	-0.19	-4.41	1.28E-5	Alzheimer's disease	
THCA	cis	1	rs6444533	chr3:190999790	UTS2D	chr3:190984945-191048325:-	0.18	3.56	0.000414	Total ventricular volume (Alzheimer's disease interaction)	
THCA	cis	1	rs6444534	chr3:190999872	UTS2D	chr3:190984945-191048325:-	0.18	3.56	0.000414	Total ventricular volume (Alzheimer's disease interaction)	
THCA	cis	1	rs6444535	chr3:190999990	UTS2D	chr3:190984945-191048325:-	0.18	3.56	0.000414	Total ventricular volume (Alzheimer's disease interaction)	
THCA	cis	1	rs644493	chr15:45935816	SPATA5L1	chr15:45694519-45713614:+	0.31	4.98	9.04E-7	Obesity-related traits	
THCA	cis	1	rs6445358	chr3:52308845	NEK4	chr3:52744803-52804951:-	-0.12	-3.84	0.000141	Electroencephalogram traits	
THCA	cis	1	rs6445358	chr3:52308845	NT5DC2	chr3:52558386-52569093:-	-0.24	-5.71	2.0E-8	Electroencephalogram traits	
THCA	cis	1	rs6445358	chr3:52308845	PBRM1	chr3:52579368-52719866:-	0.13	5.06	6.03E-7	Electroencephalogram traits	
THCA	cis	1	rs6445557	chr3:53083969	RFT1	chr3:53122503-53164470:-	-0.59	-7.99	1.0E-14	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs6445622	chr3:51356823	HEMK1	chr3:50606583-50622419:+	0.2	4.18	3.4E-5	Melanoma	
THCA	cis	1	rs6445622	chr3:51356823	TEX264	chr3:51705222-51738338:+	-0.22	-6.05	2.93E-9	Melanoma	
THCA	cis	1	rs6446262	chr3:49401153	GMPPB	chr3:49758932-49761384:-	-0.17	-3.73	0.000218	Menarche (age at onset)	
THCA	cis	1	rs6446262	chr3:49401153	P4HTM	chr3:49027341-49044579:+	0.19	4.65	4.33E-6	Menarche (age at onset)	
THCA	cis	1	rs6446268	chr3:49445695	CCDC51	chr3:48473582-48481529:-	-0.15	-3.59	0.00037	Menarche (age at onset)	
THCA	cis	1	rs6446268	chr3:49445695	GMPPB	chr3:49758932-49761384:-	0.17	3.85	0.000133	Menarche (age at onset)	
THCA	cis	1	rs6446268	chr3:49445695	P4HTM	chr3:49027341-49044579:+	-0.16	-3.99	7.6E-5	Menarche (age at onset)	
THCA	cis	1	rs6446268	chr3:49445695	WDR6	chr3:49044637-49053386:+	0.19	3.88	0.000121	Menarche (age at onset)	
THCA	cis	1	rs6446275	chr3:49466871	GMPPB	chr3:49758932-49761384:-	0.16	3.72	0.000221	Menarche (age at onset)	
THCA	cis	1	rs6446275	chr3:49466871	P4HTM	chr3:49027341-49044579:+	-0.17	-4.27	2.36E-5	Menarche (age at onset)	
THCA	cis	1	rs6446275	chr3:49466871	WDR6	chr3:49044637-49053386:+	0.18	3.69	0.000251	Menarche (age at onset)	
THCA	cis	1	rs6447634	chr4:48413511	OCIAD1	chr4:48833015-48863831:+	-0.14	-4.21	3.0E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs6447650	chr4:40381210	CHRNA9	chr4:40337469-40356973:+	0.32	3.36	0.000848	Body mass index (change over time)	
THCA	cis	1	rs6447875	chr4:8503206	C4orf23	chr4:8440604-8495258:+	-0.35	-7.43	5.08E-13	Response to antineoplastic agents	
THCA	cis	1	rs6449319	chr4:17640283	MED28	chr4:17616273-17629791:+	0.17	3.74	0.000204	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs6449345	chr4:17934394	DCAF16	chr4:17802280-17812381:-	-0.21	-4.8	2.08E-6	Height	
THCA	cis	1	rs6449346	chr4:17934461	DCAF16	chr4:17802280-17812381:-	-0.21	-4.8	2.08E-6	Height	
THCA	cis	1	rs6449350	chr4:17977535	DCAF16	chr4:17802280-17812381:-	-0.2	-4.41	1.26E-5	Height	
THCA	cis	1	rs6449353	chr4:18033488	DCAF16	chr4:17802280-17812381:-	-0.21	-4.62	4.99E-6	Height	
THCA	cis	1	rs6450408	chr5:56098146	C5orf35	chr5:56205103-56213010:+	0.99	22.67	8.08E-78	Type 2 diabetes	
THCA	cis	1	rs6450409	chr5:56101399	C5orf35	chr5:56205103-56213010:+	0.98	22.5	5.57E-77	Type 2 diabetes	
THCA	cis	1	rs6453278	chr5:76417042	LOC728723	chr5:76382623-76444175:+	0.2	4.48	9.35E-6	Autism	
THCA	cis	1	rs6453279	chr5:76417074	LOC728723	chr5:76382623-76444175:+	-0.21	-4.77	2.47E-6	Autism	
THCA	cis	1	rs6454513	chr6:86720049	SNHG5	chr6:86386726-86388451:-	0.54	12.75	2.84E-32	Response to antipsychotic treatment	
THCA	cis	1	rs6455865	chr6:158298154	SNX9	chr6:158244294-158366109:+	-0.23	-3.67	0.00027	Lipoprotein (a) - cholesterol levels	
THCA	cis	1	rs6455870	chr6:158302369	SNX9	chr6:158244294-158366109:+	-0.23	-3.67	0.00027	Lipoprotein (a) - cholesterol levels	
THCA	cis	1	rs6456371	chr6:20714466	SOX4	chr6:21593972-21598847:+	-0.12	-3.78	0.000175	Type 2 diabetes	
THCA	cis	1	rs6456617	chr6:24480769	GPLD1	chr6:24428405-24489850:-	0.2	3.58	0.000373	Hematological and biochemical traits	
THCA	cis	1	rs6456617	chr6:24480769	MRS2	chr6:24403153-24425809:+	0.27	5.86	8.47E-9	Hematological and biochemical traits	
THCA	cis	1	rs6456733	chr6:26566804	BTN2A3	chr6:26422317-26431927:+	0.18	4.31	2.0E-5	Educational attainment	
THCA	cis	1	rs6456733	chr6:26566804	HCG11	chr6:26521934-26527610:+	-0.22	-4.28	2.24E-5	Educational attainment	
THCA	cis	1	rs6456733	chr6:26566804	HMGN4	chr6:26538572-26547162:+	-0.16	-4.13	4.35E-5	Educational attainment	
THCA	cis	1	rs6456733	chr6:26566804	LOC100270746	chr6:26987146-26988085:-	-0.15	-3.49	0.000531	Educational attainment	
THCA	cis	1	rs6456733	chr6:26566804	ZNF322A	chr6:26634612-26659963:-	-0.16	-4.63	4.82E-6	Educational attainment	
THCA	cis	1	rs6456734	chr6:26566965	BTN2A3	chr6:26422317-26431927:+	0.18	4.31	2.0E-5	Educational attainment	
THCA	cis	1	rs6456734	chr6:26566965	HCG11	chr6:26521934-26527610:+	-0.22	-4.28	2.24E-5	Educational attainment	
THCA	cis	1	rs6456734	chr6:26566965	HMGN4	chr6:26538572-26547162:+	-0.16	-4.13	4.35E-5	Educational attainment	
THCA	cis	1	rs6456734	chr6:26566965	LOC100270746	chr6:26987146-26988085:-	-0.15	-3.49	0.000531	Educational attainment	
THCA	cis	1	rs6456734	chr6:26566965	ZNF322A	chr6:26634612-26659963:-	-0.16	-4.63	4.82E-6	Educational attainment	
THCA	cis	1	rs6457805	chr6:35120443	UHRF1BP1	chr6:34759794-34853117:+	-0.11	-3.74	0.000203	Airway responsiveness in chronic obstructive pulmonary disease	
THCA	cis	1	rs6458228	chr6:41543793	MDFI	chr6:41604930-41621981:+	0.18	5.44	8.71E-8	Prostate cancer	
THCA	cis	1	rs6458685	chr6:49379536	CENPQ	chr6:49431096-49460820:+	-0.32	-6.8	3.23E-11	Homocysteine levels	
THCA	cis	1	rs6458688	chr6:49406056	CENPQ	chr6:49431096-49460820:+	-0.32	-6.85	2.3E-11	Homocysteine levels	
THCA	cis	1	rs6458690	chr6:49411619	CENPQ	chr6:49431096-49460820:+	-0.26	-5.49	6.51E-8	Folate pathway vitamin levels	
THCA	cis	1	rs6458690	chr6:49411619	MUT	chr6:49398994-49431031:-	0.28	9.74	1.42E-20	Folate pathway vitamin levels	
THCA	cis	1	rs6458694	chr6:49445306	CENPQ	chr6:49431096-49460820:+	-0.27	-5.52	5.46E-8	Folate pathway vitamin levels	
THCA	cis	1	rs6458694	chr6:49445306	MUT	chr6:49398994-49431031:-	0.28	9.69	2.1E-20	Folate pathway vitamin levels	
THCA	cis	1	rs6459657	chr6:170136454	C6orf70	chr6:170151721-170181617:+	0.26	5.27	2.11E-7	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs6459657	chr6:170136454	WDR27	chr6:169857307-170102159:-	-0.17	-5.28	1.92E-7	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs6460260	chr7:65215455	CCT6P1	chr7:65216092-65228661:+	-0.42	-6.66	7.61E-11	Diabetic kidney disease	
THCA	cis	1	rs6460260	chr7:65215455	CRCP	chr7:65579805-65619551:+	0.31	4.7	3.45E-6	Diabetic kidney disease	
THCA	cis	1	rs6460260	chr7:65215455	RABGEF1	chr7:66093890-66276446:+	-0.53	-6.54	1.58E-10	Diabetic kidney disease	
THCA	cis	1	rs6460261	chr7:65215580	CCT6P1	chr7:65216092-65228661:+	-0.42	-6.66	7.61E-11	Diabetic kidney disease	
THCA	cis	1	rs6460261	chr7:65215580	CRCP	chr7:65579805-65619551:+	0.31	4.7	3.45E-6	Diabetic kidney disease	
THCA	cis	1	rs6460261	chr7:65215580	RABGEF1	chr7:66093890-66276446:+	-0.53	-6.54	1.58E-10	Diabetic kidney disease	
THCA	cis	1	rs6460274	chr7:65628484	CCT6P1	chr7:65216092-65228661:+	-0.42	-6.7	5.9E-11	Diabetic kidney disease	
THCA	cis	1	rs6460274	chr7:65628484	CRCP	chr7:65579805-65619551:+	0.3	4.63	4.66E-6	Diabetic kidney disease	
THCA	cis	1	rs6460274	chr7:65628484	LOC493754	chr7:65993446-66057363:-	-0.29	-3.36	0.000833	Diabetic kidney disease	
THCA	cis	1	rs6460274	chr7:65628484	RABGEF1	chr7:66093890-66276446:+	-0.57	-7.14	3.42E-12	Diabetic kidney disease	
THCA	cis	1	rs6460292	chr7:65810075	ASL	chr7:65540776-65558321:+	0.16	4.29	2.13E-5	Aortic root size	
THCA	cis	1	rs6460292	chr7:65810075	GUSB	chr7:65425675-65447246:-	-0.28	-5.51	5.99E-8	Aortic root size	
THCA	cis	1	rs6460292	chr7:65810075	RABGEF1	chr7:66093890-66276446:+	-0.66	-14.21	1.73E-38	Aortic root size	
THCA	cis	1	rs6460295	chr7:65882728	ASL	chr7:65540776-65558321:+	-0.16	-4.16	3.75E-5	Aortic root size	
THCA	cis	1	rs6460295	chr7:65882728	GUSB	chr7:65425675-65447246:-	0.27	5.34	1.43E-7	Aortic root size	
THCA	cis	1	rs6460295	chr7:65882728	RABGEF1	chr7:66093890-66276446:+	0.65	14.09	5.98E-38	Aortic root size	
THCA	cis	1	rs6460296	chr7:65895139	ASL	chr7:65540776-65558321:+	-0.16	-4.29	2.19E-5	Aortic root size	
THCA	cis	1	rs6460296	chr7:65895139	GUSB	chr7:65425675-65447246:-	0.28	5.39	1.11E-7	Aortic root size	
THCA	cis	1	rs6460296	chr7:65895139	LOC729156	chr7:66274980-66309813:-	0.16	3.37	0.000811	Aortic root size	
THCA	cis	1	rs6460296	chr7:65895139	RABGEF1	chr7:66093890-66276446:+	0.66	14.25	1.21E-38	Aortic root size	
THCA	cis	1	rs6461985	chr7:27150634	HOXA9	chr7:27202058-27205149:-	-0.37	-4.16	3.85E-5	Hypospadias	
THCA	cis	1	rs6462363	chr7:32464759	AVL9	chr7:32535176-33079034:+	-0.16	-4.68	3.82E-6	Metabolite levels (HVA/MHPG ratio)	
THCA	cis	1	rs6462364	chr7:32464776	AVL9	chr7:32535176-33079034:+	-0.16	-4.68	3.82E-6	Metabolite levels (HVA/MHPG ratio)	
THCA	cis	1	rs6462817	chr7:38250865	STARD3NL	chr7:38217933-38270269:+	-0.53	-12.48	3.93E-31	Treatment response for severe sepsis	
THCA	cis	1	rs6464573	chr7:143748098	ARHGEF35	chr7:143883677-143892736:-	0.51	10.71	3.82E-24	Obesity-related traits	
THCA	cis	1	rs6464573	chr7:143748098	OR2A1	chr7:144015236-144016148:+;chr7	0.19	4.18	3.41E-5	Obesity-related traits	
THCA	cis	1	rs6464573	chr7:143748098	OR2A9P	chr7:143991573-143997832:+;chr7	0.3	6.62	9.84E-11	Obesity-related traits	
THCA	cis	1	rs6464574	chr7:143748257	ARHGEF35	chr7:143883677-143892736:-	-0.51	-10.2	3.04E-22	Obesity-related traits	
THCA	cis	1	rs6464574	chr7:143748257	OR2A1	chr7:144015236-144016148:+;chr7	-0.17	-3.55	0.00042	Obesity-related traits	
THCA	cis	1	rs6464574	chr7:143748257	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-5.94	5.55E-9	Obesity-related traits	
THCA	cis	1	rs6465117	chr7:87293493	DBF4	chr7:87505544-87538856:+	-0.28	-3.82	0.000149	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs6465118	chr7:87330423	DBF4	chr7:87505544-87538856:+	-0.27	-3.71	0.000233	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs6465657	chr7:97816327	BRI3	chr7:97910979-97922275:+	-0.11	-4.02	6.89E-5	Prostate cancer (gene x gene interaction);Prostate cancer	
THCA	cis	1	rs6465657	chr7:97816327	TECPR1	chr7:97846060-97881468:-	-0.13	-3.72	0.000225	Prostate cancer (gene x gene interaction);Prostate cancer	
THCA	cis	1	rs6465658	chr7:97816638	BRI3	chr7:97910979-97922275:+	-0.1	-3.76	0.000192	Prostate cancer (gene x gene interaction);Prostate cancer	
THCA	cis	1	rs6465658	chr7:97816638	TECPR1	chr7:97846060-97881468:-	-0.13	-3.52	0.00047	Prostate cancer (gene x gene interaction);Prostate cancer	
THCA	cis	1	rs6466656	chr7:118042177	ANKRD7	chr7:117864712-117882782:+	-0.28	-4.56	6.55E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs646776	chr1:109818530	SYPL2	chr1:110009100-110024763:+	0.15	3.41	0.000697	Cholesterol, total;Myocardial infarction;Coronary artery disease;Lipoprotein-associated phospholipase A2 activity and mass	
THCA	cis	1	rs6468131	chr8:29981020	LEPROTL1	chr8:29952922-29995222:+	-0.19	-4.19	3.38E-5	Migraine	
THCA	cis	1	rs6468131	chr8:29981020	MBOAT4	chr8:29989188-30002200:-	-0.34	-4.55	6.95E-6	Migraine	
THCA	cis	1	rs6468131	chr8:29981020	TMEM66	chr8:29920632-29940649:-	0.19	3.76	0.00019	Migraine	
THCA	cis	1	rs6468495	chr8:97259953	PTDSS1	chr8:97274167-97346774:+	0.18	3.92	0.000101	Lung function (FVC)	
THCA	cis	1	rs646867	chr1:25709258	RHCE	chr1:25688741-25756683:-	0.7	15.44	6.09E-44	Erythrocyte sedimentation rate	
THCA	cis	1	rs646867	chr1:25709258	RHD	chr1:25598981-25656935:+	-0.6	-11.59	1.52E-27	Erythrocyte sedimentation rate	
THCA	cis	1	rs646867	chr1:25709258	TMEM57	chr1:25757388-25826696:+	0.18	4.59	5.6E-6	Erythrocyte sedimentation rate	
THCA	cis	1	rs6468694	chr8:100865836	VPS13B	chr8:100025494-100889807:+	-0.12	-3.54	0.000432	Glucose homeostasis traits	
THCA	cis	1	rs6472232	chr8:66792632	PDE7A	chr8:66629906-66753755:-	0.15	3.34	0.000897	Myopia (pathological)	
THCA	cis	1	rs6472238	chr8:66850203	PDE7A	chr8:66629906-66753755:-	0.17	3.69	0.00025	Myopia (pathological)	
THCA	cis	1	rs6477692	chr9:111904758	C9orf5	chr9:111777416-111882225:-	0.2	3.73	0.000214	Information processing speed	
THCA	cis	1	rs6477998	chr9:115997249	AMBP	chr9:116822410-116840752:-	0.16	3.38	0.000795	Hematology traits	
THCA	cis	1	rs6477998	chr9:115997249	CDC26	chr9:116029290-116037869:-	0.4	9.07	3.11E-18	Hematology traits	
THCA	cis	1	rs6477998	chr9:115997249	PRPF4	chr9:116037974-116055054:+	-0.17	-4.08	5.34E-5	Hematology traits	
THCA	cis	1	rs6478484	chr9:123652380	LOC253039	chr9:123605320-123616644:+	-0.5	-9.21	1.07E-18	Rheumatoid arthritis	
THCA	cis	1	rs6478484	chr9:123652380	PSMD5	chr9:123578334-123605206:-	-0.26	-5.19	3.06E-7	Rheumatoid arthritis	
THCA	cis	1	rs6478486	chr9:123655329	LOC253039	chr9:123605320-123616644:+	-0.5	-9.11	2.3E-18	Rheumatoid arthritis	
THCA	cis	1	rs6478486	chr9:123655329	PSMD5	chr9:123578334-123605206:-	-0.27	-5.21	2.76E-7	Rheumatoid arthritis	
THCA	cis	1	rs6478867	chr9:131903923	CRAT	chr9:131857075-131873070:-	-0.28	-6.6	1.12E-10	Blood metabolite ratios	
THCA	cis	1	rs6478987	chr9:102690883	STX17	chr9:102668915-102736817:+	-0.17	-4.33	1.86E-5	Alopecia areata	
THCA	cis	1	rs6479800	chr10:64036881	ADO	chr10:64564516-64568238:+	0.19	3.37	0.000825	Rheumatoid arthritis	
THCA	cis	1	rs6479840	chr10:52756901	PRKG1	chr10:52750945-54055274:+	-0.2	-4.65	4.3E-6	Migraine	
THCA	cis	1	rs6479841	chr10:52761966	PRKG1	chr10:52750945-54055274:+	-0.23	-5.09	5.2E-7	Migraine	
THCA	cis	1	rs6479862	chr10:52780881	PRKG1	chr10:52750945-54055274:+	-0.22	-5.01	7.86E-7	Migraine	
THCA	cis	1	rs6479874	chr10:52789355	PRKG1	chr10:52750945-54055274:+	0.2	4.96	9.79E-7	Migraine	
THCA	cis	1	rs6479891	chr10:65006456	LOC84989	chr10:65224989-65226320:+	0.22	3.43	0.000667	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs6479891	chr10:65006456	NRBF2	chr10:64893007-64914785:+	0.25	3.95	9.14E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs6479894	chr10:65098741	LOC84989	chr10:65224989-65226320:+	-0.27	-4.35	1.64E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs6479894	chr10:65098741	NRBF2	chr10:64893007-64914785:+	-0.28	-4.77	2.41E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs6479899	chr10:65139047	LOC84989	chr10:65224989-65226320:+	-0.28	-4.6	5.46E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs6479899	chr10:65139047	NRBF2	chr10:64893007-64914785:+	-0.27	-4.67	3.89E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs6480314	chr10:69967447	PBLD	chr10:70042417-70092684:-	-0.26	-3.7	0.000236	Optic nerve measurement (disc area)	
THCA	cis	1	rs6482455	chr10:25200457	PRTFDC1	chr10:25137554-25241533:-	0.27	3.62	0.000329	Metabolite levels (Pyroglutamine)	
THCA	cis	1	rs6483278	chr11:93640502	HEPHL1	chr11:93754378-93847374:+	-0.49	-4.27	2.4E-5	Obesity-related traits	
THCA	cis	1	rs6483501	chr11:96108061	CCDC82	chr11:96085930-96123083:-	-0.24	-3.81	0.000157	Parkinson's disease	
THCA	cis	1	rs6483880	chr11:22852740	SVIP	chr11:22843600-22851382:-	0.27	6.45	2.71E-10	Dialysis-related mortality	
THCA	cis	1	rs6485438	chr11:43686618	HSD17B12	chr11:43702143-43878160:+	-0.7	-14.66	1.94E-40	Forced vital capacity	
THCA	cis	1	rs6485443	chr11:43696316	HSD17B12	chr11:43702143-43878160:+	0.72	15.11	1.83E-42	Forced vital capacity	
THCA	cis	1	rs6485682	chr11:46446264	PACSIN3	chr11:47199085-47207958:-	-0.16	-3.64	0.000299	Schizophrenia	
THCA	cis	1	rs6485784	chr11:47832260	FAM180B	chr11:47608245-47610746:+	0.2	3.39	0.000753	Intraocular pressure	
THCA	cis	1	rs6485788	chr11:47873883	FAM180B	chr11:47608245-47610746:+	-0.2	-3.39	0.000752	Intraocular pressure	
THCA	cis	1	rs6486190	chr11:14401216	RRAS2	chr11:14299467-14380729:-	-0.17	-4.19	3.38E-5	Mitochondrial DNA levels	
THCA	cis	1	rs6487679	chr12:9371332	DDX12	chr12:9570288-9600768:-	0.16	3.56	0.000403	Non-alcoholic fatty liver disease histology (AST)	
THCA	cis	1	rs6487679	chr12:9371332	LOC144571	chr12:9217773-9220651:+	0.14	3.47	0.000562	Non-alcoholic fatty liver disease histology (AST)	
THCA	cis	1	rs6487679	chr12:9371332	LOC642846	chr12:9436253-9466684:+	0.42	8.18	2.59E-15	Non-alcoholic fatty liver disease histology (AST)	
THCA	cis	1	rs6488051	chr12:32532733	DENND5B	chr12:31535157-31743952:-	-0.17	-3.4	0.000739	Response to tocilizumab in rheumatoid arthritis	
THCA	cis	1	rs6488051	chr12:32532733	FGD4	chr12:32638906-32798982:+	-0.29	-7.59	1.68E-13	Response to tocilizumab in rheumatoid arthritis	
THCA	cis	1	rs6492769	chr13:95870022	ABCC4	chr13:95672084-95953687:-	-0.18	-3.56	0.000409	Breast cancer	
THCA	cis	1	rs6492925	chr15:40304170	SRP14	chr15:40327891-40331389:-	-0.2	-3.86	0.000128	Response to haloperidol in psychosis	
THCA	cis	1	rs6493858	chr15:56736478	TEX9	chr15:56657644-56738071:+	0.3	7.53	2.62E-13	Relative hand skill in reading disability	
THCA	cis	1	rs6494521	chr15:65739928	DPP8	chr15:65737999-65810035:-	-0.09	-3.95	8.88E-5	Mean corpuscular hemoglobin	
THCA	cis	1	rs6494521	chr15:65739928	SLC24A1	chr15:65903704-65953256:+	-0.16	-3.86	0.00013	Mean corpuscular hemoglobin	
THCA	cis	1	rs6494528	chr15:65865632	DPP8	chr15:65737999-65810035:-	-0.09	-3.94	9.34E-5	Mean corpuscular hemoglobin	
THCA	cis	1	rs6494528	chr15:65865632	SLC24A1	chr15:65903704-65953256:+	-0.16	-3.92	0.000103	Mean corpuscular hemoglobin	
THCA	cis	1	rs6494529	chr15:65902922	DPP8	chr15:65737999-65810035:-	-0.1	-4.13	4.24E-5	Mean corpuscular hemoglobin	
THCA	cis	1	rs6494529	chr15:65902922	SLC24A1	chr15:65903704-65953256:+	-0.16	-3.95	8.94E-5	Mean corpuscular hemoglobin	
THCA	cis	1	rs6494532	chr15:65975798	DPP8	chr15:65737999-65810035:-	-0.09	-3.8	0.000167	Mean corpuscular hemoglobin	
THCA	cis	1	rs6494532	chr15:65975798	SLC24A1	chr15:65903704-65953256:+	-0.16	-3.82	0.000153	Mean corpuscular hemoglobin	
THCA	cis	1	rs6494537	chr15:66051345	DPP8	chr15:65737999-65810035:-	-0.1	-4.13	4.31E-5	Mean corpuscular hemoglobin	
THCA	cis	1	rs6494537	chr15:66051345	SLC24A1	chr15:65903704-65953256:+	-0.15	-3.67	0.000275	Mean corpuscular hemoglobin	
THCA	cis	1	rs6495206	chr15:76870963	SCAPER	chr15:76640529-77197744:-	-0.16	-5.23	2.55E-7	Blood metabolite levels	
THCA	cis	1	rs6496609	chr15:90379632	AP3S2	chr15:90373832-90456222:-	-0.77	-19.51	9.17E-63	Type 2 diabetes	
THCA	cis	1	rs6496609	chr15:90379632	C15orf38	chr15:90443832-90456222:-	0.35	7.33	9.74E-13	Type 2 diabetes	
THCA	cis	1	rs6496665	chr15:90891615	IQGAP1	chr15:90931473-91045475:+	0.13	4.28	2.23E-5	Rheumatoid arthritis	
THCA	cis	1	rs6496665	chr15:90891615	TTLL13	chr15:90792764-90815443:+	0.2	3.77	0.000182	Rheumatoid arthritis	
THCA	cis	1	rs6496666	chr15:90891662	IQGAP1	chr15:90931473-91045475:+	0.14	4.58	5.84E-6	Rheumatoid arthritis	
THCA	cis	1	rs6496666	chr15:90891662	TTLL13	chr15:90792764-90815443:+	0.27	4.79	2.18E-6	Rheumatoid arthritis	
THCA	cis	1	rs6496667	chr15:90893668	IQGAP1	chr15:90931473-91045475:+	0.13	4.2	3.14E-5	Rheumatoid arthritis	
THCA	cis	1	rs6496667	chr15:90893668	TTLL13	chr15:90792764-90815443:+	0.19	3.49	0.000519	Rheumatoid arthritis	
THCA	cis	1	rs6496668	chr15:90893704	IQGAP1	chr15:90931473-91045475:+	0.15	4.48	9.53E-6	Rheumatoid arthritis	
THCA	cis	1	rs6496668	chr15:90893704	TTLL13	chr15:90792764-90815443:+	0.26	4.38	1.44E-5	Rheumatoid arthritis	
THCA	cis	1	rs6496669	chr15:90895265	IQGAP1	chr15:90931473-91045475:+	-0.13	-4.28	2.22E-5	Rheumatoid arthritis	
THCA	cis	1	rs6496669	chr15:90895265	TTLL13	chr15:90792764-90815443:+	-0.25	-4.4	1.34E-5	Rheumatoid arthritis	
THCA	cis	1	rs6496743	chr15:91528358	HDDC3	chr15:91474157-91475774:-	-0.15	-4.18	3.44E-5	Type 2 diabetes	
THCA	cis	1	rs6496768	chr15:85702932	LOC388152	chr15:84867600-84898920:-	0.24	4.25	2.6E-5	Bulimia nervosa	
THCA	cis	1	rs6498540	chr16:15130594	NTAN1	chr16:15131717-15149833:-	0.13	3.73	0.000218	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs6498540	chr16:15130594	PDXDC1	chr16:15068599-15233195:+	0.32	7.49	3.32E-13	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs6498541	chr16:15140657	NTAN1	chr16:15131717-15149833:-	0.14	4.18	3.46E-5	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs6498541	chr16:15140657	PDXDC1	chr16:15068599-15233195:+	0.32	7.48	3.62E-13	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs6499253	chr16:69802672	COG4	chr16:70514473-70557457:-	-0.19	-3.84	0.000139	IgE levels	
THCA	cis	1	rs6499255	chr16:69830328	COG4	chr16:70514473-70557457:-	-0.2	-4.18	3.42E-5	IgE levels	
THCA	cis	1	rs6499508	chr16:71396290	CALB2	chr16:71392626-71424339:+	0.41	5.57	4.2E-8	Schizophrenia	
THCA	cis	1	rs6499508	chr16:71396290	HPR	chr16:72097125-72111144:+	-0.32	-4.27	2.33E-5	Schizophrenia	
THCA	cis	1	rs6499983	chr16:58843909	GOT2	chr16:58741035-58768246:-	-0.26	-7.32	1.05E-12	Blood metabolite ratios	
THCA	cis	1	rs6499983	chr16:58843909	SLC38A7	chr16:58700298-58718674:-	-0.14	-4.98	8.9E-7	Blood metabolite ratios	
THCA	cis	1	rs6500602	chr16:4497451	C16orf5	chr16:4560679-4588816:-	0.24	6.22	1.07E-9	Schizophrenia	
THCA	cis	1	rs6502050	chr17:80058236	DCXR	chr17:79993758-79995573:-	0.13	3.77	0.000183	Life satisfaction	
THCA	cis	1	rs6502674	chr17:18776897	FAM18B	chr17:18684582-18710026:+	-0.32	-7.37	7.4E-13	Pancreatic cancer	
THCA	cis	1	rs6502677	chr17:18803658	FAM18B	chr17:18684582-18710026:+	-0.42	-10.68	5.05E-24	Educational attainment (years of education)	
THCA	cis	1	rs6502677	chr17:18803658	FBXW10	chr17:18647326-18682661:+	-0.23	-4.97	9.44E-7	Educational attainment (years of education)	
THCA	cis	1	rs6503530	chr17:38161823	GSDMA	chr17:38119226-38134019:+	-0.31	-7.25	1.71E-12	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THCA	cis	1	rs6503703	chr17:40592207	HSD17B1	chr17:40703984-40707224:+	-0.12	-3.36	0.000843	Crohn's disease	
THCA	cis	1	rs6503703	chr17:40592207	NAGLU	chr17:40687951-40696464:+	-0.22	-4.7	3.4E-6	Crohn's disease	
THCA	cis	1	rs6503703	chr17:40592207	TUBG2	chr17:40811266-40819023:+	-0.24	-5.63	3.08E-8	Crohn's disease	
THCA	cis	1	rs6503704	chr17:40592253	NAGLU	chr17:40687951-40696464:+	-0.22	-4.65	4.28E-6	Crohn's disease	
THCA	cis	1	rs6503704	chr17:40592253	TUBG2	chr17:40811266-40819023:+	-0.23	-5.45	8.03E-8	Crohn's disease	
THCA	cis	1	rs6503877	chr17:56841948	SUPT4H1	chr17:56422539-56429563:-	-0.17	-4.21	3.07E-5	Cognitive test performance	
THCA	cis	1	rs6503882	chr17:56915761	SUPT4H1	chr17:56422539-56429563:-	-0.16	-3.9	0.000109	Cognitive test performance	
THCA	cis	1	rs6504167	chr17:61693194	FTSJ3	chr17:61896795-61905031:-	0.32	5.99	4.06E-9	Body mass index	
THCA	cis	1	rs6504167	chr17:61693194	MAP3K3	chr17:61699775-61773669:+	0.28	5.59	3.79E-8	Body mass index	
THCA	cis	1	rs6504168	chr17:61697469	FTSJ3	chr17:61896795-61905031:-	0.34	6.35	5.09E-10	Body mass index	
THCA	cis	1	rs6504168	chr17:61697469	MAP3K3	chr17:61699775-61773669:+	0.28	5.74	1.7E-8	Body mass index	
THCA	cis	1	rs6504169	chr17:61709145	FTSJ3	chr17:61896795-61905031:-	0.32	6.01	3.7E-9	Body mass index	
THCA	cis	1	rs6504169	chr17:61709145	MAP3K3	chr17:61699775-61773669:+	0.28	5.66	2.63E-8	Body mass index	
THCA	cis	1	rs6504170	chr17:61709168	FTSJ3	chr17:61896795-61905031:-	0.31	5.97	4.53E-9	Body mass index	
THCA	cis	1	rs6504170	chr17:61709168	MAP3K3	chr17:61699775-61773669:+	0.27	5.61	3.35E-8	Body mass index	
THCA	cis	1	rs6504171	chr17:61710010	FTSJ3	chr17:61896795-61905031:-	0.3	5.78	1.32E-8	Body mass index	
THCA	cis	1	rs6504171	chr17:61710010	MAP3K3	chr17:61699775-61773669:+	0.26	5.33	1.5E-7	Body mass index	
THCA	cis	1	rs6504173	chr17:61735056	FTSJ3	chr17:61896795-61905031:-	0.31	5.84	9.54E-9	Body mass index	
THCA	cis	1	rs6504173	chr17:61735056	MAP3K3	chr17:61699775-61773669:+	0.26	5.28	2.0E-7	Body mass index	
THCA	cis	1	rs6504182	chr17:61823672	FTSJ3	chr17:61896795-61905031:-	0.31	6	3.81E-9	Body mass index	
THCA	cis	1	rs6504182	chr17:61823672	MAP3K3	chr17:61699775-61773669:+	0.26	5.35	1.35E-7	Body mass index	
THCA	cis	1	rs650446	chr5:139054510	DNAJC18	chr5:138747381-138775139:-	0.17	3.81	0.000158	Schizophrenia	
THCA	cis	1	rs6504542	chr17:65836642	C17orf58	chr17:65987218-65989765:-	0.24	4.78	2.36E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs6504543	chr17:65837659	C17orf58	chr17:65987218-65989765:-	0.25	5	7.95E-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs6504548	chr17:65886048	C17orf58	chr17:65987218-65989765:-	0.25	5.15	3.9E-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs6504549	chr17:65888784	C17orf58	chr17:65987218-65989765:-	0.26	5.22	2.7E-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs6504555	chr17:65940727	C17orf58	chr17:65987218-65989765:-	-0.24	-4.88	1.45E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs6504661	chr17:48580126	MYCBPAP	chr17:48585745-48608861:+	0.31	5.7	2.08E-8	Visceral fat	
THCA	cis	1	rs6504661	chr17:48580126	SPATA20	chr17:48620419-48633211:+	0.17	3.86	0.000128	Visceral fat	
THCA	cis	1	rs6504948	chr17:53049987	STXBP4	chr17:53046126-53241449:+	-0.15	-4.2	3.2E-5	Breast cancer	
THCA	cis	1	rs6504948	chr17:53049987	TOM1L1	chr17:52978052-53039328:+	-0.13	-3.35	0.000871	Breast cancer	
THCA	cis	1	rs6504949	chr17:53050133	STXBP4	chr17:53046126-53241449:+	-0.15	-4.2	3.2E-5	Breast cancer	
THCA	cis	1	rs6504949	chr17:53050133	TOM1L1	chr17:52978052-53039328:+	-0.13	-3.35	0.000871	Breast cancer	
THCA	cis	1	rs6504950	chr17:53056471	STXBP4	chr17:53046126-53241449:+	-0.15	-4.2	3.2E-5	Breast cancer	
THCA	cis	1	rs6504950	chr17:53056471	TOM1L1	chr17:52978052-53039328:+	-0.13	-3.35	0.000871	Breast cancer	
THCA	cis	1	rs6504951	chr17:53056975	STXBP4	chr17:53046126-53241449:+	-0.15	-4.2	3.2E-5	Breast cancer	
THCA	cis	1	rs6504951	chr17:53056975	TOM1L1	chr17:52978052-53039328:+	-0.13	-3.35	0.000871	Breast cancer	
THCA	cis	1	rs6505152	chr17:28331466	ANKRD13B	chr17:27916801-27941778:+	-0.36	-8.85	1.7E-17	Coffee consumption (cups per day)	
THCA	cis	1	rs6505152	chr17:28331466	CORO6	chr17:27941774-27948441:-	-0.51	-11.7	5.47E-28	Coffee consumption (cups per day)	
THCA	cis	1	rs6505152	chr17:28331466	EFCAB5	chr17:28256874-28435469:+	-0.6	-11.3	2.02E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs6505152	chr17:28331466	GIT1	chr17:27900487-27916610:-	-0.29	-6.8	3.15E-11	Coffee consumption (cups per day)	
THCA	cis	1	rs6505152	chr17:28331466	LRRC37B2	chr17:28903483-28992715:+	-0.18	-3.84	0.000141	Coffee consumption (cups per day)	
THCA	cis	1	rs6505152	chr17:28331466	SSH2	chr17:27952965-28257018:-	-0.34	-7.64	1.18E-13	Coffee consumption (cups per day)	
THCA	cis	1	rs6505152	chr17:28331466	TP53I13	chr17:27895739-27900174:+	-0.2	-5.3	1.81E-7	Coffee consumption (cups per day)	
THCA	cis	1	rs6505158	chr17:28403348	ANKRD13B	chr17:27916801-27941778:+	-0.36	-8.87	1.43E-17	Coffee consumption (cups per day)	
THCA	cis	1	rs6505158	chr17:28403348	CORO6	chr17:27941774-27948441:-	-0.5	-11.54	2.46E-27	Coffee consumption (cups per day)	
THCA	cis	1	rs6505158	chr17:28403348	EFCAB5	chr17:28256874-28435469:+	-0.6	-11.36	1.24E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs6505158	chr17:28403348	GIT1	chr17:27900487-27916610:-	-0.28	-6.64	8.47E-11	Coffee consumption (cups per day)	
THCA	cis	1	rs6505158	chr17:28403348	LRRC37B2	chr17:28903483-28992715:+	-0.18	-3.94	9.46E-5	Coffee consumption (cups per day)	
THCA	cis	1	rs6505158	chr17:28403348	SSH2	chr17:27952965-28257018:-	-0.35	-7.82	3.51E-14	Coffee consumption (cups per day)	
THCA	cis	1	rs6505158	chr17:28403348	TP53I13	chr17:27895739-27900174:+	-0.2	-5.48	6.87E-8	Coffee consumption (cups per day)	
THCA	cis	1	rs6508409	chr18:23617290	SS18	chr18:23596219-23671164:-	0.26	3.36	0.000841	Rhegmatogenous retinal detachment	
THCA	cis	1	rs6508710	chr19:37749886	ZNF607	chr19:38187276-38210691:-	-0.21	-3.63	0.000311	Coronary artery calcification	
THCA	cis	1	rs6508977	chr19:41909346	B3GNT8	chr19:41931265-41934635:-	-0.36	-8.3	1.05E-15	Height	
THCA	cis	1	rs6508977	chr19:41909346	EXOSC5	chr19:41892278-41903256:-	-0.1	-3.4	0.000731	Height	
THCA	cis	1	rs6509581	chr19:52363882	ZNF577	chr19:52359056-52394145:-	-0.24	-5.66	2.56E-8	Breast cancer	
THCA	cis	1	rs6509581	chr19:52363882	ZNF649	chr19:52392489-52408247:-	-0.18	-3.76	0.000194	Breast cancer	
THCA	cis	1	rs6509600	chr19:52442589	ZNF577	chr19:52359056-52394145:-	-0.21	-4.6	5.38E-6	Survival in endocrine treated breast cancer (estrogen-receptor positive)	
THCA	cis	1	rs6509701	chr19:53384185	ZNF320	chr19:53367119-53400946:-	-0.23	-5.51	5.94E-8	Psychosis in Alzheimer's disease	
THCA	cis	1	rs6509701	chr19:53384185	ZNF468	chr19:53341786-53360902:-	-0.16	-4.37	1.55E-5	Psychosis in Alzheimer's disease	
THCA	cis	1	rs6510348	chr19:33601946	GPATCH1	chr19:33571786-33621318:+	0.36	8.74	3.94E-17	Bone properties (heel)	
THCA	cis	1	rs6512577	chr20:47865784	DDX27	chr20:47835832-47860612:+	0.27	4.94	1.06E-6	Height	
THCA	cis	1	rs6515651	chr20:25414539	ENTPD6	chr20:25176339-25207360:+	0.3	6.79	3.31E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6515651	chr20:25414539	FAM182A	chr20:26035250-26067552:+	0.18	3.4	0.000729	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6515651	chr20:25414539	FAM182B	chr20:25744102-25848786:-	-0.25	-5.23	2.5E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6515651	chr20:25414539	NINL	chr20:25433338-25566153:-	0.36	7.3	1.18E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs6515773	chr20:3174105	DDRGK1	chr20:3171018-3185295:-	-0.15	-3.81	0.000159	Night sleep phenotypes	
THCA	cis	1	rs6515773	chr20:3174105	ITPA	chr20:3190056-3204504:+	0.15	4.45	1.05E-5	Night sleep phenotypes	
THCA	cis	1	rs6516891	chr21:30483070	C21orf7	chr21:30449812-30548200:+	0.2	3.96	8.73E-5	Dental caries	
THCA	cis	1	rs6517531	chr21:40637647	HMGN1	chr21:40714247-40721270:-	-0.26	-3.64	0.000299	Temperament (bipolar disorder)	
THCA	cis	1	rs651907	chr3:101600724	LOC152225	chr3:101659703-101716770:+	0.16	3.39	0.000767	Colorectal cancer	
THCA	cis	1	rs6519119	chr22:38989007	JOSD1	chr22:39081549-39096459:-	-0.14	-3.71	0.00023	Resting heart rate	
THCA	cis	1	rs6519119	chr22:38989007	LOC646851	chr22:38974125-39052634:-	0.13	3.54	0.000447	Resting heart rate	
THCA	cis	1	rs6519119	chr22:38989007	TOMM22	chr22:39077954-39080763:+	-0.16	-3.55	0.000416	Resting heart rate	
THCA	cis	1	rs6519120	chr22:38991393	JOSD1	chr22:39081549-39096459:-	0.15	3.88	0.000117	Resting heart rate	
THCA	cis	1	rs6519120	chr22:38991393	LOC646851	chr22:38974125-39052634:-	-0.13	-3.59	0.000367	Resting heart rate	
THCA	cis	1	rs6519124	chr22:39045099	LOC646851	chr22:38974125-39052634:-	0.13	3.54	0.000435	Resting heart rate	
THCA	cis	1	rs6519124	chr22:39045099	TOMM22	chr22:39077954-39080763:+	-0.17	-3.67	0.000267	Resting heart rate	
THCA	cis	1	rs6532078	chr4:76920809	NAAA	chr4:76831809-76862166:-	-0.33	-6.54	1.61E-10	Longevity	
THCA	cis	1	rs6532432	chr4:75696811	BTC	chr4:75671448-75719882:-	0.2	3.77	0.000186	Electroencephalogram traits	
THCA	cis	1	rs6533059	chr4:104133376	BDH2	chr4:103998783-104021024:-	0.26	6.04	3.18E-9	Testicular germ cell tumor	
THCA	cis	1	rs6533059	chr4:104133376	CISD2	chr4:103790135-103809913:+	-0.15	-3.42	0.000676	Testicular germ cell tumor	
THCA	cis	1	rs6533059	chr4:104133376	MANBA	chr4:103552644-103682151:-	0.16	4.05	6.04E-5	Testicular germ cell tumor	
THCA	cis	1	rs6533060	chr4:104139996	BDH2	chr4:103998783-104021024:-	0.26	6.09	2.28E-9	Testicular germ cell tumor	
THCA	cis	1	rs6533060	chr4:104139996	CISD2	chr4:103790135-103809913:+	-0.15	-3.4	0.000737	Testicular germ cell tumor	
THCA	cis	1	rs6533060	chr4:104139996	MANBA	chr4:103552644-103682151:-	0.16	4.07	5.46E-5	Testicular germ cell tumor	
THCA	cis	1	rs653554	chr1:48022641	FOXD2	chr1:47901689-47906362:+	0.23	4	7.21E-5	Obesity-related traits	
THCA	cis	1	rs653554	chr1:48022641	MGC12982	chr1:47897808-47900313:-	0.21	4.34	1.7E-5	Obesity-related traits	
THCA	cis	1	rs6536365	chr4:159632293	ETFDH	chr4:159593277-159629839:+	0.17	4.27	2.4E-5	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
THCA	cis	1	rs6536365	chr4:159632293	PPID	chr4:159630280-159644552:-	-0.26	-4.92	1.18E-6	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
THCA	cis	1	rs6536882	chr4:165900680	C4orf39	chr4:165878100-165880273:+	0.2	5.54	5.14E-8	Ovarian cancer in BRCA1 mutation carriers	
THCA	cis	1	rs6536883	chr4:165900704	C4orf39	chr4:165878100-165880273:+	0.2	5.54	5.14E-8	Ovarian cancer in BRCA1 mutation carriers	
THCA	cis	1	rs6537243	chr4:139129215	SLC7A11	chr4:139085248-139163503:-	0.23	4.55	6.95E-6	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	
THCA	cis	1	rs6539545	chr12:81433197	ACSS3	chr12:81471809-81649582:+	0.22	4.7	3.37E-6	Neuroticism	
THCA	cis	1	rs6540893	chr1:207435727	CD55	chr1:207494817-207534309:+	0.19	7.52	2.67E-13	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs6540896	chr1:207440851	CD55	chr1:207494817-207534309:+	0.15	6.72	5.14E-11	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs6542334	chr2:111907214	BCL2L11	chr2:111878491-111926022:+	-0.14	-3.4	0.000732	Chronic lymphocytic leukemia	
THCA	cis	1	rs6542527	chr2:120148080	DBI	chr2:120124504-120130120:+	-0.24	-6.77	3.71E-11	Obesity-related traits	
THCA	cis	1	rs6544065	chr2:37497417	CEBPZ	chr2:37428778-37458740:-	-0.18	-3.92	0.000102	Chronic lymphocytic leukemia	
THCA	cis	1	rs6545883	chr2:61772257	AHSA2	chr2:61404553-61414058:+	-0.23	-9.58	5.49E-20	Tuberculosis	
THCA	cis	1	rs6545883	chr2:61772257	C2orf74	chr2:61372243-61391964:+	0.54	11.82	1.93E-28	Tuberculosis	
THCA	cis	1	rs6546294	chr2:67562230	ETAA1	chr2:67624442-67637533:+	-0.18	-4.24	2.74E-5	Pancreatic cancer	
THCA	cis	1	rs6546553	chr2:70111711	ASPRV1	chr2:70187226-70314147:-	-0.13	-3.5	0.000516	Carotid plaque burden (smoking interaction)	
THCA	cis	1	rs6546726	chr2:26275116	GPR113	chr2:26531041-26569685:-	-0.43	-6.89	1.76E-11	Gut microbiome composition (summer)	
THCA	cis	1	rs6546727	chr2:26275282	GPR113	chr2:26531041-26569685:-	-0.42	-6.78	3.54E-11	Gut microbiome composition (summer)	
THCA	cis	1	rs6546728	chr2:26276531	GPR113	chr2:26531041-26569685:-	-0.47	-7.31	1.15E-12	Gut microbiome composition (summer)	
THCA	cis	1	rs6546728	chr2:26276531	HADHA	chr2:26413505-26467594:-	-0.17	-3.48	0.000549	Gut microbiome composition (summer)	
THCA	cis	1	rs6546736	chr2:26293878	GPR113	chr2:26531041-26569685:-	0.45	7.1	4.54E-12	Gut microbiome composition (summer)	
THCA	cis	1	rs6546744	chr2:26302161	GPR113	chr2:26531041-26569685:-	-0.45	-7.05	6.34E-12	Gut microbiome composition (summer)	
THCA	cis	1	rs6546766	chr2:26328680	GPR113	chr2:26531041-26569685:-	-0.42	-6.71	5.42E-11	Gut microbiome composition (summer)	
THCA	cis	1	rs6546767	chr2:26328746	GPR113	chr2:26531041-26569685:-	-0.42	-6.71	5.42E-11	Gut microbiome composition (summer)	
THCA	cis	1	rs6546768	chr2:26328800	GPR113	chr2:26531041-26569685:-	-0.42	-6.71	5.42E-11	Gut microbiome composition (summer)	
THCA	cis	1	rs6546835	chr2:73664715	ALMS1P	chr2:73872046-73912692:+	0.71	11.37	1.08E-26	Metabolite levels	
THCA	cis	1	rs6546835	chr2:73664715	NAT8	chr2:73867850-73869537:-	0.38	6.07	2.54E-9	Metabolite levels	
THCA	cis	1	rs6546835	chr2:73664715	TPRKB	chr2:73956957-73964517:-	-0.17	-4.3	2.12E-5	Metabolite levels	
THCA	cis	1	rs6546836	chr2:73677833	ALMS1P	chr2:73872046-73912692:+	0.73	11.71	4.93E-28	Metabolite levels	
THCA	cis	1	rs6546836	chr2:73677833	NAT8	chr2:73867850-73869537:-	0.37	5.92	6.26E-9	Metabolite levels	
THCA	cis	1	rs6546836	chr2:73677833	TPRKB	chr2:73956957-73964517:-	-0.17	-4.38	1.44E-5	Metabolite levels	
THCA	cis	1	rs6546837	chr2:73677898	ALMS1P	chr2:73872046-73912692:+	0.69	11.05	2.0E-25	Metabolite levels	
THCA	cis	1	rs6546837	chr2:73677898	NAT8	chr2:73867850-73869537:-	0.37	5.86	8.81E-9	Metabolite levels	
THCA	cis	1	rs6546837	chr2:73677898	TPRKB	chr2:73956957-73964517:-	-0.17	-4.24	2.72E-5	Metabolite levels	
THCA	cis	1	rs6546838	chr2:73679280	ALMS1P	chr2:73872046-73912692:+	0.71	11.27	2.76E-26	Metabolite levels	
THCA	cis	1	rs6546838	chr2:73679280	NAT8	chr2:73867850-73869537:-	0.38	6.02	3.55E-9	Metabolite levels	
THCA	cis	1	rs6546838	chr2:73679280	TPRKB	chr2:73956957-73964517:-	-0.17	-4.38	1.45E-5	Metabolite levels	
THCA	cis	1	rs6546839	chr2:73680508	ALMS1P	chr2:73872046-73912692:+	0.69	11	2.99E-25	Metabolite levels	
THCA	cis	1	rs6546839	chr2:73680508	NAT8	chr2:73867850-73869537:-	0.37	5.87	8.35E-9	Metabolite levels	
THCA	cis	1	rs6546839	chr2:73680508	TPRKB	chr2:73956957-73964517:-	-0.17	-4.23	2.82E-5	Metabolite levels	
THCA	cis	1	rs6547705	chr2:87044316	LOC285074	chr2:87257799-87303536:-	-0.25	-3.93	9.76E-5	Progressive supranuclear palsy	
THCA	cis	1	rs6547734	chr2:27830990	FNDC4	chr2:27714751-27718126:-	-0.15	-3.64	0.000306	Oral cavity cancer	
THCA	cis	1	rs6547740	chr2:27854369	ZNF512	chr2:27805893-27858101:+	-0.14	-3.44	0.000635	Oral cavity cancer	
THCA	cis	1	rs6547872	chr2:28978074	PPP1CB	chr2:28974612-29025805:+	0.17	4.24	2.68E-5	Body mass index	
THCA	cis	1	rs6547872	chr2:28978074	TRMT61B	chr2:29072690-29093175:-	-0.52	-10.52	2.1E-23	Body mass index	
THCA	cis	1	rs6550450	chr3:37123099	EPM2AIP1	chr3:37027358-37034795:-	0.13	3.94	9.51E-5	Cerebrospinal P-tau181p levels	
THCA	cis	1	rs6550450	chr3:37123099	LRRFIP2	chr3:37094117-37217851:-	0.5	13.83	8.11E-37	Cerebrospinal P-tau181p levels	
THCA	cis	1	rs655156	chr18:72898181	ZADH2	chr18:72909279-72921281:-	0.3	4.89	1.36E-6	Vascular endothelial growth factor levels	
THCA	cis	1	rs6554100	chr4:54240108	SCFD2	chr4:53739152-54232242:-	0.2	3.82	0.000154	DNA methylation (variation)	
THCA	cis	1	rs6554106	chr4:54292791	SCFD2	chr4:53739152-54232242:-	0.2	3.92	0.000101	DNA methylation (variation)	
THCA	cis	1	rs6554286	chr4:56400304	TMEM165	chr4:56262090-56292342:+	0.15	3.78	0.000176	Personality dimensions	
THCA	cis	1	rs6559	chr17:4848450	GP1BA	chr17:4835592-4838324:+	-0.21	-3.65	0.000296	Blood metabolite levels	
THCA	cis	1	rs6559	chr17:4848450	SLC25A11	chr17:4840605-4843325:-	-0.16	-4.27	2.38E-5	Blood metabolite levels	
THCA	cis	1	rs6559	chr17:4848450	VMO1	chr17:4688581-4689729:-	0.17	3.35	0.000876	Blood metabolite levels	
THCA	cis	1	rs6560517	chr9:79038170	GCNT1	chr9:79034752-79122330:+	0.15	3.46	0.000584	Dialysis-related mortality	
THCA	cis	1	rs6560517	chr9:79038170	PCSK5	chr9:78505560-78808338:+	0.15	3.39	0.00077	Dialysis-related mortality	
THCA	cis	1	rs6560517	chr9:79038170	RFK	chr9:79000433-79009444:-	0.18	3.82	0.000152	Dialysis-related mortality	
THCA	cis	1	rs6563380	chr13:36770422	SOHLH2	chr13:36742347-36871992:-	0.36	6.23	1.02E-9	Glucose homeostasis traits	
THCA	cis	1	rs656640	chr11:71781710	FAM86C	chr11:71498557-71512276:+	0.31	3.81	0.000158	Severe influenza A (H1N1) infection	
THCA	cis	1	rs656917	chr1:41569708	SCMH1	chr1:41492875-41707788:-	0.2	4.66	4.14E-6	Height	
THCA	cis	1	rs656980	chr11:65656282	CTSW	chr11:65647284-65651212:+	-0.6	-15.88	6.69E-46	Crohn's disease	
THCA	cis	1	rs656980	chr11:65656282	SNX32	chr11:65601410-65621170:+	0.63	9.47	1.33E-19	Crohn's disease	
THCA	cis	1	rs6570043	chr6:136134098	C6orf217	chr6:135818939-136037192:+	-0.36	-10.1	7.29E-22	Phosphorus levels	
THCA	cis	1	rs6571221	chr6:105621189	BVES	chr6:105544700-105585049:-	0.23	3.78	0.000179	Multiple sclerosis	
THCA	cis	1	rs6573006	chr14:55610432	FBXO34	chr14:55738021-55893431:+	-0.15	-3.52	0.000479	Protein biomarker	
THCA	cis	1	rs6573006	chr14:55610432	KIAA0831	chr14:55833110-55878576:-	-0.13	-3.68	0.000262	Protein biomarker	
THCA	cis	1	rs6573911	chr14:25100933	GZMB	chr14:25100161-25103432:-	0.16	4.01	6.96E-5	Vitiligo	
THCA	cis	1	rs6574278	chr14:76663838	ESRRB	chr14:76837690-76968178:+	0.32	5.2	3.01E-7	Blood pressure	
THCA	cis	1	rs6574639	chr14:81771541	STON2	chr14:81727000-81893748:-	0.21	4.27	2.34E-5	Obesity-related traits	
THCA	cis	1	rs6574641	chr14:81774111	STON2	chr14:81727000-81893748:-	0.21	4.2	3.16E-5	Obesity-related traits	
THCA	cis	1	rs6574642	chr14:81774316	STON2	chr14:81727000-81893748:-	0.21	4.2	3.16E-5	Obesity-related traits	
THCA	cis	1	rs6574643	chr14:81774402	STON2	chr14:81727000-81893748:-	0.21	4.2	3.16E-5	Obesity-related traits	
THCA	cis	1	rs6574644	chr14:81778644	STON2	chr14:81727000-81893748:-	0.21	4.2	3.16E-5	Obesity-related traits	
THCA	cis	1	rs6576986	chr2:97508320	LOC729234	chr2:96676299-96688882:+	-0.24	-3.35	0.000862	Erectile dysfunction and prostate cancer treatment	
THCA	cis	1	rs6579083	chr20:31760708	C20orf70	chr20:31755960-31769223:+	-0.46	-3.99	7.71E-5	Smooth-surface caries	
THCA	cis	1	rs6579208	chr20:33598612	PROCR	chr20:33758727-33765164:+	-0.34	-5.65	2.75E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs6579208	chr20:33598612	TRPC4AP	chr20:33590215-33680618:-	0.28	3.48	0.000549	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs6579210	chr20:33605802	PROCR	chr20:33758727-33765164:+	-0.32	-5.28	1.92E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs6579211	chr20:33605857	PROCR	chr20:33758727-33765164:+	-0.36	-5.7	2.14E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs6579211	chr20:33605857	TRPC4AP	chr20:33590215-33680618:-	0.31	3.77	0.000182	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs6579234	chr20:33983485	CEP250	chr20:34042996-34099802:+	-0.15	-3.43	0.000658	Height	
THCA	cis	1	rs6579234	chr20:33983485	CPNE1	chr20:34213968-34262539:-	0.31	5.96	4.83E-9	Height	
THCA	cis	1	rs6579234	chr20:33983485	GDF5	chr20:33897002-34042568:-	-0.18	-3.81	0.000159	Height	
THCA	cis	1	rs6579234	chr20:33983485	UQCC	chr20:33890383-33999833:-	0.32	10.39	6.2E-23	Height	
THCA	cis	1	rs6579245	chr20:34125271	CEP250	chr20:34042996-34099802:+	0.21	3.52	0.000481	Cholesterol, total	
THCA	cis	1	rs6579245	chr20:34125271	CPNE1	chr20:34213968-34262539:-	-0.69	-10.95	4.83E-25	Cholesterol, total	
THCA	cis	1	rs6579245	chr20:34125271	UQCC	chr20:33890383-33999833:-	-0.2	-4.52	7.71E-6	Cholesterol, total	
THCA	cis	1	rs6579803	chr5:150255559	LOC134466	chr5:150310000-150326146:-	0.37	5.2	2.97E-7	Crohn's disease	
THCA	cis	1	rs6579803	chr5:150255559	ZNF300	chr5:150273964-150284391:-	0.15	3.4	0.000719	Crohn's disease	
THCA	cis	1	rs6579804	chr5:150255931	LOC134466	chr5:150310000-150326146:-	0.37	5.2	2.97E-7	Crohn's disease	
THCA	cis	1	rs6579804	chr5:150255931	ZNF300	chr5:150273964-150284391:-	0.15	3.4	0.000719	Crohn's disease	
THCA	cis	1	rs6579806	chr5:150271084	LOC134466	chr5:150310000-150326146:-	0.38	5.28	2.01E-7	Crohn's disease	
THCA	cis	1	rs6581155	chr12:58178162	FAM119B	chr12:58166383-58176323:+	0.39	10.79	1.88E-24	Multiple sclerosis	
THCA	cis	1	rs6581155	chr12:58178162	METTL1	chr12:58162352-58165914:-	-0.18	-4.36	1.58E-5	Multiple sclerosis	
THCA	cis	1	rs6581155	chr12:58178162	TSFM	chr12:58176536-58191367:+	-0.56	-19.03	1.55E-60	Multiple sclerosis	
THCA	cis	1	rs6581155	chr12:58178162	XRCC6BP1	chr12:58335445-58351051:+	-0.23	-4.65	4.28E-6	Multiple sclerosis	
THCA	cis	1	rs6584278	chr10:101278099	NKX2-3	chr10:101292690-101296278:+	-0.31	-5.5	6.21E-8	Dental caries	
THCA	cis	1	rs6584347	chr10:101906963	BLOC1S2	chr10:102033713-102046439:-	-0.43	-6.42	3.31E-10	Schizophrenia	
THCA	cis	1	rs6584347	chr10:101906963	CWF19L1	chr10:101992055-102027437:-	-0.43	-5.27	2.04E-7	Schizophrenia	
THCA	cis	1	rs6584379	chr10:102224490	SEC31B	chr10:102246403-102289636:-	-0.3	-10.24	2.25E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs6584383	chr10:102303065	SEC31B	chr10:102246403-102289636:-	-0.28	-8.89	1.29E-17	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs6584392	chr10:102497166	FBXW4	chr10:103370422-103454743:-	-0.17	-3.35	0.000867	Alzheimer's disease	
THCA	cis	1	rs6585827	chr10:124165615	PLEKHA1	chr10:124134220-124191866:+	-0.21	-5.73	1.78E-8	Height	
THCA	cis	1	rs6587109	chr17:20917818	USP22	chr17:20902908-20947073:-	-0.18	-3.75	0.000201	Blood trace element (Se levels)	
THCA	cis	1	rs6589575	chr11:116733310	PCSK7	chr11:117075789-117102811:-	-0.3	-5.14	4.02E-7	Protein quantitative trait loci	
THCA	cis	1	rs6589576	chr11:116735788	PCSK7	chr11:117075789-117102811:-	0.26	4.53	7.32E-6	Protein quantitative trait loci	
THCA	cis	1	rs6589589	chr11:116932428	PCSK7	chr11:117075789-117102811:-	-0.29	-5.03	6.88E-7	Protein quantitative trait loci	
THCA	cis	1	rs6592284	chr11:86055901	C11orf73	chr11:86013253-86056984:+	0.23	5.36	1.33E-7	Cognitive performance	
THCA	cis	1	rs6592284	chr11:86055901	CCDC81	chr11:86085778-86134150:+	-0.22	-3.86	0.000129	Cognitive performance	
THCA	cis	1	rs6592448	chr11:71670044	FAM86C	chr11:71498557-71512276:+	-0.33	-4.04	6.34E-5	Severe influenza A (H1N1) infection	
THCA	cis	1	rs6592450	chr11:71671166	FAM86C	chr11:71498557-71512276:+	0.31	4.01	7.05E-5	Severe influenza A (H1N1) infection	
THCA	cis	1	rs6592453	chr11:71683231	FAM86C	chr11:71498557-71512276:+	0.32	3.89	0.000116	Severe influenza A (H1N1) infection	
THCA	cis	1	rs6592455	chr11:71689541	FAM86C	chr11:71498557-71512276:+	-0.37	-4.54	7.13E-6	Severe influenza A (H1N1) infection	
THCA	cis	1	rs6592772	chr11:78015563	NARS2	chr11:78147017-78285909:-	-0.36	-6.48	2.25E-10	Testicular germ cell tumor	
THCA	cis	1	rs6593585	chr1:76140273	MSH4	chr1:76262630-76378923:+	0.25	4.19	3.29E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs6593	chr14:104163282	KLC1	chr14:104029299-104167887:+	-0.21	-4.11	4.7E-5	Body mass index	
THCA	cis	1	rs6594480	chr5:110173859	TMEM232	chr5:109624934-110062381:-	0.2	3.88	0.000119	Asthma and hay fever	
THCA	cis	1	rs6594906	chr5:115171435	ATG12	chr5:115165818-115177520:-	0.27	5.63	3.05E-8	IgG glycosylation	
THCA	cis	1	rs6594906	chr5:115171435	CCDC112	chr5:114602885-114632458:-	0.18	3.61	0.000342	IgG glycosylation	
THCA	cis	1	rs6594906	chr5:115171435	CDO1	chr5:115140432-115152405:-	0.37	7.28	1.42E-12	IgG glycosylation	
THCA	cis	1	rs659513	chr11:71812411	FAM86C	chr11:71498557-71512276:+	-0.33	-3.94	9.21E-5	Severe influenza A (H1N1) infection	
THCA	cis	1	rs6596482	chr5:101736641	SLCO4C1	chr5:101569694-101632253:-	0.24	5.54	5.12E-8	Schizophrenia	
THCA	cis	1	rs6596484	chr5:101750196	SLCO4C1	chr5:101569694-101632253:-	0.24	5.61	3.48E-8	Schizophrenia	
THCA	cis	1	rs6596490	chr5:101768045	SLCO4C1	chr5:101569694-101632253:-	0.24	5.54	5.1E-8	Schizophrenia	
THCA	cis	1	rs6596492	chr5:101772270	SLCO4C1	chr5:101569694-101632253:-	0.24	5.54	5.1E-8	Schizophrenia	
THCA	cis	1	rs6596495	chr5:101777273	SLCO4C1	chr5:101569694-101632253:-	0.24	5.54	5.1E-8	Schizophrenia	
THCA	cis	1	rs6596496	chr5:101780661	SLCO4C1	chr5:101569694-101632253:-	0.24	5.54	5.1E-8	Schizophrenia	
THCA	cis	1	rs6596498	chr5:101809845	SLCO4C1	chr5:101569694-101632253:-	0.26	5.94	5.36E-9	Schizophrenia	
THCA	cis	1	rs6597645	chr9:133745487	FIBCD1	chr9:133777826-133814455:-	-0.29	-4.86	1.57E-6	Response to amphetamines	
THCA	cis	1	rs6597965	chr11:964476	TSPAN4	chr11:842824-867116:+	0.15	3.69	0.000254	Alzheimer's disease (late onset)	
THCA	cis	1	rs6597972	chr11:928402	TSPAN4	chr11:842824-867116:+	0.15	3.67	0.00027	Alzheimer's disease (late onset)	
THCA	cis	1	rs6598060	chr11:243987	PSMD13	chr11:236808-252984:+	-0.22	-6.78	3.58E-11	Menarche (age at onset)	
THCA	cis	1	rs6598060	chr11:243987	SIRT3	chr11:214625-236931:-	0.12	3.39	0.000756	Menarche (age at onset)	
THCA	cis	1	rs6598061	chr11:243853	PSMD13	chr11:236808-252984:+	-0.22	-6.73	4.91E-11	Menarche (age at onset)	
THCA	cis	1	rs6598061	chr11:243853	SIRT3	chr11:214625-236931:-	0.12	3.37	0.000812	Menarche (age at onset)	
THCA	cis	1	rs6598062	chr11:243712	PSMD13	chr11:236808-252984:+	-0.22	-6.73	4.91E-11	Menarche (age at onset)	
THCA	cis	1	rs6598062	chr11:243712	SIRT3	chr11:214625-236931:-	0.12	3.37	0.000812	Menarche (age at onset)	
THCA	cis	1	rs6598063	chr11:243672	PSMD13	chr11:236808-252984:+	-0.22	-6.73	4.91E-11	Menarche (age at onset)	
THCA	cis	1	rs6598063	chr11:243672	SIRT3	chr11:214625-236931:-	0.12	3.37	0.000812	Menarche (age at onset)	
THCA	cis	1	rs6598065	chr11:243211	PSMD13	chr11:236808-252984:+	-0.22	-6.72	5.21E-11	Menarche (age at onset)	
THCA	cis	1	rs6598065	chr11:243211	SIRT3	chr11:214625-236931:-	0.12	3.41	0.000702	Menarche (age at onset)	
THCA	cis	1	rs6598066	chr11:243185	PSMD13	chr11:236808-252984:+	-0.22	-6.67	7.15E-11	Menarche (age at onset)	
THCA	cis	1	rs6598066	chr11:243185	SIRT3	chr11:214625-236931:-	0.12	3.49	0.000534	Menarche (age at onset)	
THCA	cis	1	rs6598069	chr11:240664	PSMD13	chr11:236808-252984:+	-0.22	-6.75	4.25E-11	Menarche (age at onset)	
THCA	cis	1	rs6598069	chr11:240664	SIRT3	chr11:214625-236931:-	0.12	3.38	0.000785	Menarche (age at onset)	
THCA	cis	1	rs6598074	chr11:219398	PSMD13	chr11:236808-252984:+	-0.21	-6.41	3.55E-10	Menarche (age at onset)	
THCA	cis	1	rs6598074	chr11:219398	SIRT3	chr11:214625-236931:-	0.12	3.54	0.000435	Menarche (age at onset)	
THCA	cis	1	rs6598955	chr1:26619649	CNKSR1	chr1:26503981-26516373:+	-0.15	-4.23	2.86E-5	Obesity-related traits	
THCA	cis	1	rs6598955	chr1:26619649	ZNF593	chr1:26496388-26497362:+	0.14	4.22	2.98E-5	Obesity-related traits	
THCA	cis	1	rs6599170	chr3:41772718	ULK4	chr3:41288091-42003660:-	1.05	19.38	3.47E-62	Diastolic blood pressure	
THCA	cis	1	rs6599175	chr3:41786009	ULK4	chr3:41288091-42003660:-	-1.07	-19.74	7.34E-64	Diastolic blood pressure	
THCA	cis	1	rs6599176	chr3:41788492	ULK4	chr3:41288091-42003660:-	-1.04	-19.1	7.92E-61	Diastolic blood pressure	
THCA	cis	1	rs6599178	chr3:41842129	ULK4	chr3:41288091-42003660:-	1.09	20.79	7.26E-69	Diastolic blood pressure	
THCA	cis	1	rs6599179	chr3:41855284	ULK4	chr3:41288091-42003660:-	1.09	21.2	8.24E-71	Diastolic blood pressure	
THCA	cis	1	rs6599318	chr4:243968	ZNF718	chr4:53272-156488:+	0.51	9.45	1.46E-19	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs6599530	chr8:145677418	KIFC2	chr8:145691738-145699498:+	-0.13	-3.97	8.36E-5	Age at first birth	
THCA	cis	1	rs6599530	chr8:145677418	LRRC14	chr8:145743391-145750557:+	0.18	5.11	4.66E-7	Age at first birth	
THCA	cis	1	rs6599530	chr8:145677418	RECQL4	chr8:145736672-145743200:-	0.16	3.57	0.000399	Age at first birth	
THCA	cis	1	rs6599530	chr8:145677418	ZNF34	chr8:145998503-146012725:-	0.15	3.81	0.000155	Age at first birth	
THCA	cis	1	rs6599639	chr10:124743751	C10orf88	chr10:124690419-124713919:-	-0.22	-4.01	7.03E-5	Migraine without aura	
THCA	cis	1	rs659969	chr11:118549803	TREH	chr11:118528942-118550381:-	0.48	9.71	1.81E-20	Serum metabolite levels	
THCA	cis	1	rs6600365	chr1:41556253	SCMH1	chr1:41492875-41707788:-	0.2	4.72	3.09E-6	Height	
THCA	cis	1	rs6600669	chr1:121213639	HIST2H2BA	chr1:120906034-120914842:+	0.21	4.86	1.57E-6	Hip geometry	
THCA	cis	1	rs6600671	chr1:121200490	HIST2H2BA	chr1:120906034-120914842:+	-0.18	-4.04	6.29E-5	Hip geometry	
THCA	cis	1	rs6601540	chr8:10816873	CTSB	chr8:11700036-11725646:-	0.21	3.36	0.000834	Asthma and hay fever	
THCA	cis	1	rs6602175	chr10:17142526	CUBN	chr10:16865966-17171816:-	0.21	4.89	1.4E-6	Whole-brain volume	
THCA	cis	1	rs6603003	chr15:84565602	LOC388152	chr15:84867600-84898920:-	-0.21	-3.9	0.000111	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs6603004	chr15:84568504	LOC388152	chr15:84867600-84898920:-	0.2	3.82	0.000153	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs6603033	chr15:83335875	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.14	4.23	2.76E-5	Schizophrenia	
THCA	cis	1	rs661242	chr11:71579229	FAM86C	chr11:71498557-71512276:+	-0.31	-3.97	8.4E-5	Severe influenza A (H1N1) infection	
THCA	cis	1	rs662099	chr15:65726693	DPP8	chr15:65737999-65810035:-	-0.1	-4.13	4.21E-5	Mean corpuscular hemoglobin	
THCA	cis	1	rs662099	chr15:65726693	SLC24A1	chr15:65903704-65953256:+	-0.16	-3.84	0.00014	Mean corpuscular hemoglobin	
THCA	cis	1	rs662545	chr11:83267886	CCDC90B	chr11:82972506-82997414:-	0.17	4.09	5.15E-5	Subcortical brain region volumes	
THCA	cis	1	rs66480929	chr11:93696650	HEPHL1	chr11:93754378-93847374:+	0.56	4.59	5.71E-6	Obesity-related traits	
THCA	cis	1	rs6648	chr20:47895242	DDX27	chr20:47835832-47860612:+	0.25	4.6	5.31E-6	Height	
THCA	cis	1	rs6650153	chr10:5019320	AKR1C2	chr10:4964715-5060207:-	0.4	5.29	1.86E-7	Height	
THCA	cis	1	rs6651271	chr8:96047621	C8orf38	chr8:95908040-96088396:+	-0.27	-4.61	5.09E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs6651272	chr8:96047933	C8orf38	chr8:95908040-96088396:+	0.27	4.61	5.09E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs66518523	chr3:113004759	SIDT1	chr3:113251218-113348421:+	0.2	3.35	0.000858	Dental caries	
THCA	cis	1	rs66518563	chr12:51358252	SLC11A2	chr12:51373319-51422058:-	-0.24	-4.83	1.87E-6	Type 2 diabetes	
THCA	cis	1	rs66518563	chr12:51358252	TFCP2	chr12:51488608-51566917:-	-0.2	-4.28	2.25E-5	Type 2 diabetes	
THCA	cis	1	rs66524723	chr3:151037061	GPR87	chr3:151011876-151034636:-	0.21	4.64	4.5E-6	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs66524723	chr3:151037061	P2RY14	chr3:150929905-150996230:-	-0.2	-4.31	2.02E-5	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs66528719	chr4:139122577	SLC7A11	chr4:139085248-139163503:-	0.22	4.53	7.48E-6	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	
THCA	cis	1	rs66529337	chr6:163005662	PACRG	chr6:163148164-163736523:+	0.44	6.89	1.77E-11	Body mass index	
THCA	cis	1	rs66530019	chr1:200813692	DDX59	chr1:200610119-200639126:-	-0.26	-3.96	8.59E-5	Epilepsy	
THCA	cis	1	rs66530521	chr1:200782949	DDX59	chr1:200610119-200639126:-	-0.27	-4.08	5.33E-5	Epilepsy	
THCA	cis	1	rs66534347	chr2:240899346	NDUFA10	chr2:240900158-240964798:-	0.3	8.47	3.03E-16	Odorant perception (isobutyraldehyde)	
THCA	cis	1	rs66534429	chr6:163003322	PACRG	chr6:163148164-163736523:+	0.44	6.89	1.77E-11	Body mass index	
THCA	cis	1	rs66538341	chr11:93762532	HEPHL1	chr11:93754378-93847374:+	0.43	3.43	0.000648	Obesity-related traits	
THCA	cis	1	rs6656450	chr1:151089602	BNIPL	chr1:151009029-151020076:+	-0.18	-3.68	0.000258	Body mass index	
THCA	cis	1	rs6656815	chr1:27292462	ZDHHC18	chr1:27153201-27182207:+	0.61	6.61	9.99E-11	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs6656992	chr1:46333068	CCDC163P	chr1:45960581-45965646:-	-0.51	-10.1	7.22E-22	Body mass index	
THCA	cis	1	rs6656992	chr1:46333068	GPBP1L1	chr1:46092978-46152302:-	0.16	4.05	5.93E-5	Body mass index	
THCA	cis	1	rs6656992	chr1:46333068	MMACHC	chr1:45965856-45976737:+	-0.2	-4.4	1.34E-5	Body mass index	
THCA	cis	1	rs6656992	chr1:46333068	MUTYH	chr1:45794915-45806142:-	0.31	8.53	1.99E-16	Body mass index	
THCA	cis	1	rs66581165	chr15:31743767	FAM7A2	chr15:30864758-30892900:+	-0.42	-3.78	0.000174	Survival in colorectal cancer (non-distant metastatic)	
THCA	cis	1	rs6658406	chr1:236029475	LYST	chr1:235824345-236046940:-	-0.32	-9.71	1.88E-20	Systemic lupus erythematosus	
THCA	cis	1	rs6658596	chr1:200748921	DDX59	chr1:200610119-200639126:-	0.25	3.85	0.000135	Epilepsy	
THCA	cis	1	rs6658718	chr1:207458906	CD55	chr1:207494817-207534309:+	0.19	7.71	7.53E-14	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs6659176	chr1:27239920	ZDHHC18	chr1:27153201-27182207:+	0.72	7.46	4.13E-13	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs66594243	chr6:163169024	PACRG	chr6:163148164-163736523:+	0.54	7.55	2.17E-13	Body mass index	
THCA	cis	1	rs66597435	chr12:50945269	DIP2B	chr12:50898768-51142448:+	0.12	3.8	0.000164	Fibrinogen	
THCA	cis	1	rs66598018	chr2:61878318	C2orf74	chr2:61372243-61391964:+	0.24	3.87	0.000122	Homeostasis model assessment of beta-cell function (interaction)	
THCA	cis	1	rs6660197	chr1:200703541	DDX59	chr1:200610119-200639126:-	-0.25	-3.82	0.00015	Epilepsy	
THCA	cis	1	rs6660254	chr1:207446091	CD55	chr1:207494817-207534309:+	0.19	7.63	1.27E-13	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs6660557	chr1:207454596	CD55	chr1:207494817-207534309:+	0.19	7.69	8.48E-14	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs6661910	chr1:46290632	CCDC163P	chr1:45960581-45965646:-	-0.51	-10	1.73E-21	Body mass index	
THCA	cis	1	rs6661910	chr1:46290632	GPBP1L1	chr1:46092978-46152302:-	0.16	4.12	4.55E-5	Body mass index	
THCA	cis	1	rs6661910	chr1:46290632	MMACHC	chr1:45965856-45976737:+	-0.2	-4.33	1.83E-5	Body mass index	
THCA	cis	1	rs6661910	chr1:46290632	MUTYH	chr1:45794915-45806142:-	0.31	8.37	6.29E-16	Body mass index	
THCA	cis	1	rs6661980	chr1:200830990	DDX59	chr1:200610119-200639126:-	-0.22	-3.45	0.000619	Epilepsy	
THCA	cis	1	rs6662070	chr1:207505709	CD55	chr1:207494817-207534309:+	0.15	6.59	1.2E-10	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs66624122	chr10:4981039	AKR1C2	chr10:4964715-5060207:-	0.32	4.2	3.25E-5	Height	
THCA	cis	1	rs6662641	chr1:46571509	CCDC163P	chr1:45960581-45965646:-	-0.51	-9.9	3.88E-21	Body mass index	
THCA	cis	1	rs6662641	chr1:46571509	GPBP1L1	chr1:46092978-46152302:-	0.15	3.73	0.000214	Body mass index	
THCA	cis	1	rs6662641	chr1:46571509	MMACHC	chr1:45965856-45976737:+	-0.21	-4.53	7.42E-6	Body mass index	
THCA	cis	1	rs6662641	chr1:46571509	MUTYH	chr1:45794915-45806142:-	0.29	7.65	1.12E-13	Body mass index	
THCA	cis	1	rs66629131	chr6:44101468	TMEM63B	chr6:44095376-44123255:+	0.16	3.55	0.000427	Major depressive disorder	
THCA	cis	1	rs6663565	chr1:41563688	SCMH1	chr1:41492875-41707788:-	0.2	4.7	3.36E-6	Height	
THCA	cis	1	rs6663779	chr1:31835527	ZCCHC17	chr1:31769842-31837780:+	-0.3	-5.61	3.38E-8	Schizophrenia	
THCA	cis	1	rs66644594	chr12:50932983	DIP2B	chr12:50898768-51142448:+	0.12	3.82	0.000151	Fibrinogen	
THCA	cis	1	rs66646148	chr12:82248520	PPFIA2	chr12:81652880-82153109:-	0.22	4.13	4.25E-5	Resting heart rate	
THCA	cis	1	rs6664760	chr1:3648268	KIAA0495	chr1:3652550-3663886:-	0.27	3.67	0.000272	Visceral adipose tissue adjusted for BMI	
THCA	cis	1	rs6664815	chr1:207415563	CD55	chr1:207494817-207534309:+	0.14	6.46	2.66E-10	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs66651343	chr15:43558004	STRC	chr15:43891762-43924561:-	0.28	5.87	8.01E-9	Lung cancer	
THCA	cis	1	rs6665134	chr1:180949628	MR1	chr1:181003139-181024633:+	-0.12	-3.42	0.00068	Progressive supranuclear palsy	
THCA	cis	1	rs6665134	chr1:180949628	STX6	chr1:180913175-180992046:-	-0.2	-4.08	5.32E-5	Progressive supranuclear palsy	
THCA	cis	1	rs6665949	chr1:31862537	ZCCHC17	chr1:31769842-31837780:+	-0.3	-5.66	2.61E-8	Schizophrenia	
THCA	cis	1	rs66670017	chr6:33763563	IP6K3	chr6:33689443-33714762:-	0.41	6.7	6.04E-11	Obesity (extreme)	
THCA	cis	1	rs66670902	chr15:56375132	MNS1	chr15:56720929-56757335:-	-0.27	-3.96	8.54E-5	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs66670902	chr15:56375132	TEX9	chr15:56657644-56738071:+	-0.36	-6.19	1.3E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs6667191	chr1:45982844	AKR1A1	chr1:46016498-46035720:+	-0.14	-3.8	0.000161	Homocysteine levels	
THCA	cis	1	rs6667191	chr1:45982844	CCDC163P	chr1:45960581-45965646:-	-1.11	-31.35	5.06E-118	Homocysteine levels	
THCA	cis	1	rs6667191	chr1:45982844	MUTYH	chr1:45794915-45806142:-	0.22	5.11	4.75E-7	Homocysteine levels	
THCA	cis	1	rs6667191	chr1:45982844	PRDX1	chr1:45976708-45987609:-	-0.4	-10.1	7.11E-22	Homocysteine levels	
THCA	cis	1	rs6668242	chr1:236001779	LYST	chr1:235824345-236046940:-	-0.32	-9.69	2.17E-20	Systemic lupus erythematosus	
THCA	cis	1	rs6668284	chr1:46354510	CCDC163P	chr1:45960581-45965646:-	-0.51	-10.11	6.85E-22	Body mass index	
THCA	cis	1	rs6668284	chr1:46354510	GPBP1L1	chr1:46092978-46152302:-	0.16	4.04	6.11E-5	Body mass index	
THCA	cis	1	rs6668284	chr1:46354510	MMACHC	chr1:45965856-45976737:+	-0.2	-4.41	1.3E-5	Body mass index	
THCA	cis	1	rs6668284	chr1:46354510	MUTYH	chr1:45794915-45806142:-	0.31	8.54	1.77E-16	Body mass index	
THCA	cis	1	rs666845	chr11:83277544	CCDC90B	chr11:82972506-82997414:-	0.16	3.86	0.00013	Subcortical brain region volumes	
THCA	cis	1	rs6668683	chr1:207459191	CD55	chr1:207494817-207534309:+	0.19	7.72	6.89E-14	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs6669371	chr1:11882142	CLCN6	chr1:11866207-11907674:+	0.16	3.4	0.000741	QRS complex (12-leadsum)	
THCA	cis	1	rs6669434	chr1:162413093	HSD17B7	chr1:162760496-162782607:+	0.39	4.12	4.42E-5	Discordance in emotional problems in monozygotic twins	
THCA	cis	1	rs6669522	chr1:46397941	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.14	4.96E-22	Body mass index	
THCA	cis	1	rs6669522	chr1:46397941	GPBP1L1	chr1:46092978-46152302:-	0.15	3.83	0.000147	Body mass index	
THCA	cis	1	rs6669522	chr1:46397941	MMACHC	chr1:45965856-45976737:+	-0.21	-4.56	6.37E-6	Body mass index	
THCA	cis	1	rs6669522	chr1:46397941	MUTYH	chr1:45794915-45806142:-	0.3	8.15	3.33E-15	Body mass index	
THCA	cis	1	rs6672180	chr1:76123973	MSH4	chr1:76262630-76378923:+	0.25	4.26	2.42E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs6672898	chr1:46290588	CCDC163P	chr1:45960581-45965646:-	-0.51	-10.03	1.24E-21	Body mass index	
THCA	cis	1	rs6672898	chr1:46290588	GPBP1L1	chr1:46092978-46152302:-	0.16	4.07	5.54E-5	Body mass index	
THCA	cis	1	rs6672898	chr1:46290588	MMACHC	chr1:45965856-45976737:+	-0.19	-4.28	2.28E-5	Body mass index	
THCA	cis	1	rs6672898	chr1:46290588	MUTYH	chr1:45794915-45806142:-	0.31	8.34	7.97E-16	Body mass index	
THCA	cis	1	rs6673218	chr1:236041062	LYST	chr1:235824345-236046940:-	-0.32	-9.66	2.81E-20	Systemic lupus erythematosus	
THCA	cis	1	rs6673237	chr1:236041129	LYST	chr1:235824345-236046940:-	0.31	9.71	1.91E-20	Systemic lupus erythematosus	
THCA	cis	1	rs6673333	chr1:207459147	CD55	chr1:207494817-207534309:+	0.2	7.71	7.34E-14	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs66744607	chr12:51336491	SLC11A2	chr12:51373319-51422058:-	-0.23	-4.7	3.34E-6	Type 2 diabetes	
THCA	cis	1	rs66744607	chr12:51336491	TFCP2	chr12:51488608-51566917:-	-0.19	-4.01	6.94E-5	Type 2 diabetes	
THCA	cis	1	rs6674970	chr1:151116279	BNIPL	chr1:151009029-151020076:+	-0.18	-3.79	0.000172	Body mass index	
THCA	cis	1	rs66753001	chr19:17394839	ABHD8	chr19:17402941-17414282:-	0.26	4.18	3.47E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs66753001	chr19:17394839	ANKLE1	chr19:17392454-17398454:+	0.3	5.01	7.69E-7	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs66753001	chr19:17394839	OCEL1	chr19:17337055-17340027:+	0.21	4.04	6.31E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs66754062	chr20:23839051	CST5	chr20:23856572-23860380:-	0.13	3.48	0.000543	Response to TNF antagonist treatment	
THCA	cis	1	rs6675726	chr1:46560643	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.17	4.03E-22	Body mass index	
THCA	cis	1	rs6675726	chr1:46560643	GPBP1L1	chr1:46092978-46152302:-	0.13	3.41	0.000705	Body mass index	
THCA	cis	1	rs6675726	chr1:46560643	MMACHC	chr1:45965856-45976737:+	-0.21	-4.48	9.32E-6	Body mass index	
THCA	cis	1	rs6675726	chr1:46560643	MUTYH	chr1:45794915-45806142:-	0.28	7.49	3.29E-13	Body mass index	
THCA	cis	1	rs6675828	chr1:147086967	ACP6	chr1:147119168-147142634:-	0.24	3.81	0.000159	Warfarin maintenance dose	
THCA	cis	1	rs6675946	chr1:46371774	CCDC163P	chr1:45960581-45965646:-	-0.51	-9.9	3.85E-21	Body mass index	
THCA	cis	1	rs6675946	chr1:46371774	GPBP1L1	chr1:46092978-46152302:-	0.16	4.07	5.57E-5	Body mass index	
THCA	cis	1	rs6675946	chr1:46371774	MMACHC	chr1:45965856-45976737:+	-0.2	-4.36	1.56E-5	Body mass index	
THCA	cis	1	rs6675946	chr1:46371774	MUTYH	chr1:45794915-45806142:-	0.31	8.51	2.27E-16	Body mass index	
THCA	cis	1	rs6676190	chr1:151079317	BNIPL	chr1:151009029-151020076:+	-0.17	-3.59	0.000371	Body mass index	
THCA	cis	1	rs66769776	chr1:200782904	DDX59	chr1:200610119-200639126:-	-0.28	-4.16	3.79E-5	Epilepsy	
THCA	cis	1	rs6677007	chr1:46400590	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.14	5.21E-22	Body mass index	
THCA	cis	1	rs6677007	chr1:46400590	GPBP1L1	chr1:46092978-46152302:-	0.15	3.83	0.000146	Body mass index	
THCA	cis	1	rs6677007	chr1:46400590	MMACHC	chr1:45965856-45976737:+	-0.21	-4.57	6.3E-6	Body mass index	
THCA	cis	1	rs6677007	chr1:46400590	MUTYH	chr1:45794915-45806142:-	0.3	8.13	3.66E-15	Body mass index	
THCA	cis	1	rs66775662	chr6:151876216	C6orf97	chr6:151815175-151942327:+	0.33	4.62	4.98E-6	Bone mineral density (spine)	
THCA	cis	1	rs66789102	chr6:163104432	PACRG	chr6:163148164-163736523:+	0.52	7.28	1.37E-12	Body mass index	
THCA	cis	1	rs6679002	chr1:63199936	DOCK7	chr1:62920398-63153969:-	0.1	4.05	5.92E-5	Blood metabolite levels	
THCA	cis	1	rs6679005	chr1:31865615	ZCCHC17	chr1:31769842-31837780:+	-0.29	-5.42	9.55E-8	Schizophrenia	
THCA	cis	1	rs6679073	chr1:205756484	PM20D1	chr1:205797154-205819245:-	-0.43	-7.04	6.67E-12	Prostate-specific antigen levels	
THCA	cis	1	rs6679145	chr1:156256000	BGLAP	chr1:156182784-156213112:+	0.23	5.32	1.63E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs6679145	chr1:156256000	C1orf85	chr1:156259882-156265449:-	-0.17	-3.99	7.72E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs6679145	chr1:156256000	CCT3	chr1:156278752-156308195:-	-0.32	-6.95	1.24E-11	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs66797209	chr3:10078526	C3orf10	chr3:10157333-10168873:+	-0.2	-4.3	2.08E-5	Alzheimer's disease	
THCA	cis	1	rs66797209	chr3:10078526	VHL	chr3:10183319-10193744:+	-0.19	-4.42	1.24E-5	Alzheimer's disease	
THCA	cis	1	rs66797613	chr10:1090469	IDI2	chr10:1064847-1071799:-	-0.24	-3.46	0.000597	Response to angiotensin II receptor blocker therapy	
THCA	cis	1	rs66797637	chr3:119279658	ADPRH	chr3:119298523-119308791:+	-0.22	-3.51	0.000482	Vitiligo	
THCA	cis	1	rs66798645	chr2:23416836	FKBP1B	chr2:24272584-24286548:+	0.18	3.5	0.000507	Depression (quantitative trait)	
THCA	cis	1	rs6679	chr1:113243048	MOV10	chr1:113217048-113243367:+	0.19	4.51	8.17E-6	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs6679	chr1:113243048	ST7L	chr1:113066142-113162405:-	0.65	10.15	4.9E-22	Diastolic blood pressure;Blood pressure	
THCA	cis	1	rs66801518	chr16:4073188	NAT15	chr16:3493668-3536962:+	-0.29	-3.56	0.000406	Diisocyanate-induced asthma	
THCA	cis	1	rs6680380	chr1:46300189	CCDC163P	chr1:45960581-45965646:-	-0.51	-10.03	1.26E-21	Body mass index	
THCA	cis	1	rs6680380	chr1:46300189	GPBP1L1	chr1:46092978-46152302:-	0.16	4.07	5.44E-5	Body mass index	
THCA	cis	1	rs6680380	chr1:46300189	MMACHC	chr1:45965856-45976737:+	-0.19	-4.28	2.24E-5	Body mass index	
THCA	cis	1	rs6680380	chr1:46300189	MUTYH	chr1:45794915-45806142:-	0.31	8.34	7.9E-16	Body mass index	
THCA	cis	1	rs668092	chr1:35687203	ZMYM4	chr1:35734568-35887544:+	-0.13	-3.46	0.000583	Endometrial cancer	
THCA	cis	1	rs66838678	chr3:10150350	C3orf10	chr3:10157333-10168873:+	-0.21	-4.51	8.24E-6	Alzheimer's disease	
THCA	cis	1	rs66838678	chr3:10150350	VHL	chr3:10183319-10193744:+	-0.19	-4.44	1.13E-5	Alzheimer's disease	
THCA	cis	1	rs6684514	chr1:156255456	BGLAP	chr1:156182784-156213112:+	0.23	5.47	7.46E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs6684514	chr1:156255456	C1orf85	chr1:156259882-156265449:-	-0.17	-4.03	6.45E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs6684514	chr1:156255456	CCT3	chr1:156278752-156308195:-	-0.32	-6.99	9.47E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs6684571	chr1:107623224	NTNG1	chr1:107682629-108024471:+	0.21	3.61	0.000334	AIDS	
THCA	cis	1	rs6684804	chr1:207439015	CD55	chr1:207494817-207534309:+	0.19	7.52	2.67E-13	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs6686643	chr1:165616588	ALDH9A1	chr1:165631449-165667900:-	0.13	3.71	0.000236	Total ventricular volume	
THCA	cis	1	rs6686643	chr1:165616588	MGST3	chr1:165600450-165624853:+	0.16	3.9	0.000109	Total ventricular volume	
THCA	cis	1	rs6686842	chr1:41530871	SCMH1	chr1:41492875-41707788:-	-0.21	-4.74	2.86E-6	Height	
THCA	cis	1	rs6687813	chr1:169477574	NME7	chr1:169101771-169337186:-	-0.4	-4.25	2.54E-5	D-dimer levels	
THCA	cis	1	rs66885174	chr10:4975650	AKR1C2	chr10:4964715-5060207:-	0.38	4.95	1.02E-6	Height	
THCA	cis	1	rs6690097	chr1:19323050	TMCO4	chr1:20008707-20126758:-	-0.15	-3.35	0.000859	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
THCA	cis	1	rs6690464	chr1:85466369	MCOLN2	chr1:85391267-85462796:-	0.25	5.93	5.91E-9	Serum sulfate level	
THCA	cis	1	rs6690583	chr1:85466337	MCOLN2	chr1:85391267-85462796:-	0.25	5.97	4.7E-9	Serum sulfate level	
THCA	cis	1	rs6691722	chr1:24673866	C1orf201	chr1:24683490-24741587:-	-0.2	-4.08	5.22E-5	Response to interferon beta in multiple sclerosis	
THCA	cis	1	rs66918645	chr11:93696557	HEPHL1	chr11:93754378-93847374:+	0.56	4.59	5.71E-6	Obesity-related traits	
THCA	cis	1	rs6692729	chr1:227018919	PSEN2	chr1:227058273-227083804:+	-0.25	-5.26	2.23E-7	Electrodermal activity	
THCA	cis	1	rs66927386	chr3:151018968	GPR87	chr3:151011876-151034636:-	0.21	4.68	3.83E-6	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs66927386	chr3:151018968	P2RY14	chr3:150929905-150996230:-	-0.2	-4.35	1.68E-5	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs6695352	chr1:214954939	KCNK2	chr1:215178885-215410435:+	0.2	4.4	1.35E-5	Migraine without aura	
THCA	cis	1	rs6695809	chr1:46285461	CCDC163P	chr1:45960581-45965646:-	-0.51	-10.03	1.24E-21	Body mass index	
THCA	cis	1	rs6695809	chr1:46285461	GPBP1L1	chr1:46092978-46152302:-	0.16	4.07	5.54E-5	Body mass index	
THCA	cis	1	rs6695809	chr1:46285461	MMACHC	chr1:45965856-45976737:+	-0.19	-4.28	2.28E-5	Body mass index	
THCA	cis	1	rs6695809	chr1:46285461	MUTYH	chr1:45794915-45806142:-	0.31	8.34	7.97E-16	Body mass index	
THCA	cis	1	rs66965793	chr1:156285814	BGLAP	chr1:156182784-156213112:+	0.23	5.55	4.68E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs66965793	chr1:156285814	C1orf85	chr1:156259882-156265449:-	-0.17	-4.16	3.82E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs66965793	chr1:156285814	CCT3	chr1:156278752-156308195:-	-0.33	-7.21	2.16E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs66968227	chr11:64070930	PRDX5	chr11:64085569-64089282:+	-0.18	-4.53	7.56E-6	Mean platelet volume	
THCA	cis	1	rs66977226	chr11:93704937	HEPHL1	chr11:93754378-93847374:+	0.48	3.87	0.000126	Obesity-related traits	
THCA	cis	1	rs6698579	chr1:31861710	ZCCHC17	chr1:31769842-31837780:+	-0.3	-5.66	2.61E-8	Schizophrenia	
THCA	cis	1	rs66987356	chr3:127841098	EEFSEC	chr3:127872313-128127488:+	-0.25	-4.37	1.5E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs66990486	chr9:100680919	C9orf156	chr9:100666772-100684852:-	-0.13	-3.48	0.000538	Quantitative traits	
THCA	cis	1	rs6699417	chr1:89123443	CCBL2	chr1:89401456-89458643:-	-0.62	-13.76	1.55E-36	Height	
THCA	cis	1	rs6700079	chr1:207501872	CD55	chr1:207494817-207534309:+	0.15	6.66	7.54E-11	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs6700168	chr1:207502534	CD55	chr1:207494817-207534309:+	-0.16	-6.87	2.06E-11	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs67001808	chr11:93710531	HEPHL1	chr11:93754378-93847374:+	0.44	3.58	0.000379	Obesity-related traits	
THCA	cis	1	rs6700597	chr1:46284246	CCDC163P	chr1:45960581-45965646:-	-0.51	-10.03	1.24E-21	Body mass index	
THCA	cis	1	rs6700597	chr1:46284246	GPBP1L1	chr1:46092978-46152302:-	0.16	4.07	5.54E-5	Body mass index	
THCA	cis	1	rs6700597	chr1:46284246	MMACHC	chr1:45965856-45976737:+	-0.19	-4.28	2.28E-5	Body mass index	
THCA	cis	1	rs6700597	chr1:46284246	MUTYH	chr1:45794915-45806142:-	0.31	8.34	7.97E-16	Body mass index	
THCA	cis	1	rs67006488	chr3:10152993	C3orf10	chr3:10157333-10168873:+	-0.21	-4.49	8.8E-6	Alzheimer's disease	
THCA	cis	1	rs67006488	chr3:10152993	VHL	chr3:10183319-10193744:+	-0.19	-4.42	1.21E-5	Alzheimer's disease	
THCA	cis	1	rs6700866	chr1:10306038	KIF1B	chr1:10270764-10441659:+	0.21	6.64	8.67E-11	Hepatocellular carcinoma	
THCA	cis	1	rs6701614	chr1:46309420	CCDC163P	chr1:45960581-45965646:-	-0.51	-10.03	1.26E-21	Body mass index	
THCA	cis	1	rs6701614	chr1:46309420	GPBP1L1	chr1:46092978-46152302:-	0.16	4.07	5.44E-5	Body mass index	
THCA	cis	1	rs6701614	chr1:46309420	MMACHC	chr1:45965856-45976737:+	-0.19	-4.28	2.24E-5	Body mass index	
THCA	cis	1	rs6701614	chr1:46309420	MUTYH	chr1:45794915-45806142:-	0.31	8.34	7.9E-16	Body mass index	
THCA	cis	1	rs6702530	chr1:19329545	TMCO4	chr1:20008707-20126758:-	-0.15	-3.34	0.000906	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
THCA	cis	1	rs67025553	chr6:163011552	PACRG	chr6:163148164-163736523:+	0.45	7	8.92E-12	Body mass index	
THCA	cis	1	rs6702997	chr1:207502347	CD55	chr1:207494817-207534309:+	0.15	6.66	7.54E-11	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs6703002	chr1:207502372	CD55	chr1:207494817-207534309:+	0.15	6.6	1.11E-10	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs6703129	chr1:19324092	TMCO4	chr1:20008707-20126758:-	-0.15	-3.36	0.00083	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
THCA	cis	1	rs67034206	chr1:156270260	BGLAP	chr1:156182784-156213112:+	0.23	5.55	4.68E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs67034206	chr1:156270260	C1orf85	chr1:156259882-156265449:-	-0.17	-4.16	3.82E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs67034206	chr1:156270260	CCT3	chr1:156278752-156308195:-	-0.33	-7.21	2.16E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs6703857	chr1:207443553	CD55	chr1:207494817-207534309:+	0.14	6.55	1.46E-10	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs6703923	chr1:108352252	VAV3	chr1:108113782-108507545:-	0.45	7.37	7.73E-13	Hypothyroidism	
THCA	cis	1	rs67042566	chr6:163006541	PACRG	chr6:163148164-163736523:+	0.46	7.08	5.13E-12	Body mass index	
THCA	cis	1	rs67046187	chr6:163068532	PACRG	chr6:163148164-163736523:+	0.52	7.34	9.39E-13	Body mass index	
THCA	cis	1	rs6704770	chr2:232109816	ARMC9	chr2:232063342-232238606:+	0.43	10.4	5.65E-23	Food antigen IgG levels	
THCA	cis	1	rs6704930	chr2:26325705	GPR113	chr2:26531041-26569685:-	-0.42	-6.71	5.42E-11	Gut microbiome composition (summer)	
THCA	cis	1	rs6705122	chr2:86176258	LOC90784	chr2:86247339-86250991:-	-0.29	-3.39	0.000754	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs6705122	chr2:86176258	POLR1A	chr2:86253453-86333278:-	-0.21	-3.35	0.000878	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs670523	chr1:155878732	FDPS	chr1:155278539-155290457:+	-0.21	-4.33	1.81E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs670523	chr1:155878732	RIT1	chr1:155867601-155881177:-	0.19	4.16	3.84E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs6705489	chr2:73648811	ALMS1P	chr2:73872046-73912692:+	0.74	11.44	6.03E-27	Metabolite levels	
THCA	cis	1	rs6705489	chr2:73648811	NAT8	chr2:73867850-73869537:-	0.39	5.99	4.21E-9	Metabolite levels	
THCA	cis	1	rs67059283	chr10:79683235	DLG5	chr10:79550551-79686348:-	0.23	4.01	6.94E-5	Liver enzyme levels (gamma-glutamyl transferase)	
THCA	cis	1	rs6706610	chr2:27778091	FNDC4	chr2:27714751-27718126:-	-0.15	-3.51	0.000486	Oral cavity cancer	
THCA	cis	1	rs67073037	chr2:29119585	TRMT61B	chr2:29072690-29093175:-	0.39	6.83	2.55E-11	Breast cancer (estrogen-receptor negative);Breast cancer	
THCA	cis	1	rs6707458	chr2:160914540	LY75	chr2:160625141-160761262:-	0.21	4.89	1.35E-6	Idiopathic membranous nephropathy	
THCA	cis	1	rs6707722	chr2:73654363	ALMS1P	chr2:73872046-73912692:+	0.71	11.38	9.89E-27	Metabolite levels	
THCA	cis	1	rs6707722	chr2:73654363	NAT8	chr2:73867850-73869537:-	0.38	6.04	3.13E-9	Metabolite levels	
THCA	cis	1	rs6707722	chr2:73654363	TPRKB	chr2:73956957-73964517:-	-0.18	-4.59	5.76E-6	Metabolite levels	
THCA	cis	1	rs6707848	chr2:28988083	PPP1CB	chr2:28974612-29025805:+	0.16	4.09	5.15E-5	Body mass index	
THCA	cis	1	rs6707848	chr2:28988083	TRMT61B	chr2:29072690-29093175:-	-0.53	-10.76	2.47E-24	Body mass index	
THCA	cis	1	rs6707903	chr2:218276836	DIRC3	chr2:218148748-218621316:-	0.21	5.07	5.67E-7	Height	
THCA	cis	1	rs6708328	chr2:24412413	C2orf84	chr2:24397531-24414566:+	0.3	4.55	6.73E-6	Venous thromboembolism (SNP x SNP interaction)	
THCA	cis	1	rs6708328	chr2:24412413	LOC375190	chr2:24299728-24397519:+	-0.35	-8.13	3.7E-15	Venous thromboembolism (SNP x SNP interaction)	
THCA	cis	1	rs6708328	chr2:24412413	POMC	chr2:25383722-25391559:-	-0.21	-3.58	0.00038	Venous thromboembolism (SNP x SNP interaction)	
THCA	cis	1	rs67094146	chr6:163145412	PACRG	chr6:163148164-163736523:+	0.45	6.4	3.62E-10	Body mass index	
THCA	cis	1	rs6709534	chr2:217334	SH3YL1	chr2:218138-264810:-	-0.92	-25.2	8.48E-90	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs6709595	chr2:26259885	GPR113	chr2:26531041-26569685:-	-0.41	-6.54	1.54E-10	Gut microbiome composition (summer)	
THCA	cis	1	rs67098772	chr14:55595242	KIAA0831	chr14:55833110-55878576:-	-0.12	-3.45	0.000615	Protein biomarker	
THCA	cis	1	rs6710438	chr2:73820108	ALMS1P	chr2:73872046-73912692:+	-0.73	-11.44	5.81E-27	Metabolite levels	
THCA	cis	1	rs6710438	chr2:73820108	NAT8	chr2:73867850-73869537:-	-0.4	-6.25	9.05E-10	Metabolite levels	
THCA	cis	1	rs6710438	chr2:73820108	TPRKB	chr2:73956957-73964517:-	0.15	3.68	0.000264	Metabolite levels	
THCA	cis	1	rs6710467	chr2:127889932	BIN1	chr2:127805607-127864864:-	-0.29	-5.38	1.17E-7	Alzheimer's disease (late onset)	
THCA	cis	1	rs6710832	chr2:67601942	ETAA1	chr2:67624442-67637533:+	-0.18	-4.29	2.18E-5	Pancreatic cancer	
THCA	cis	1	rs6710959	chr2:28958603	PPP1CB	chr2:28974612-29025805:+	0.17	4.28	2.24E-5	Body mass index	
THCA	cis	1	rs6710959	chr2:28958603	TRMT61B	chr2:29072690-29093175:-	-0.5	-10.11	6.85E-22	Body mass index	
THCA	cis	1	rs6711033	chr2:73746643	ALMS1P	chr2:73872046-73912692:+	0.72	11.08	1.5E-25	Metabolite levels	
THCA	cis	1	rs6711033	chr2:73746643	NAT8	chr2:73867850-73869537:-	0.37	5.64	2.97E-8	Metabolite levels	
THCA	cis	1	rs6711033	chr2:73746643	TPRKB	chr2:73956957-73964517:-	-0.17	-4.18	3.5E-5	Metabolite levels	
THCA	cis	1	rs6711127	chr2:202213515	CFLAR	chr2:201980816-202029001:+	-0.25	-3.7	0.000243	Rheumatoid arthritis	
THCA	cis	1	rs6711127	chr2:202213515	PPIL3	chr2:201735680-201753999:-	-0.7	-7.95	1.36E-14	Rheumatoid arthritis	
THCA	cis	1	rs6711312	chr2:232122348	ARMC9	chr2:232063342-232238606:+	0.43	10.54	1.66E-23	Food antigen IgG levels	
THCA	cis	1	rs67113817	chr4:17985189	DCAF16	chr4:17802280-17812381:-	-0.2	-4.39	1.41E-5	Height	
THCA	cis	1	rs6711941	chr2:202178130	CFLAR	chr2:201980816-202029001:+	-0.25	-3.97	8.26E-5	Rheumatoid arthritis	
THCA	cis	1	rs6711941	chr2:202178130	PPIL3	chr2:201735680-201753999:-	-0.71	-8.87	1.44E-17	Rheumatoid arthritis	
THCA	cis	1	rs67134728	chr3:10151431	C3orf10	chr3:10157333-10168873:+	-0.21	-4.51	8.24E-6	Alzheimer's disease	
THCA	cis	1	rs67134728	chr3:10151431	VHL	chr3:10183319-10193744:+	-0.19	-4.44	1.13E-5	Alzheimer's disease	
THCA	cis	1	rs67135646	chr17:37967872	C17orf37	chr17:37885411-37886788:-	-0.27	-4.45	1.09E-5	Systemic lupus erythematosus	
THCA	cis	1	rs6714736	chr2:202214148	ALS2CR12	chr2:202153148-202222101:-	0.37	7.24	1.82E-12	Basal cell carcinoma	
THCA	cis	1	rs6714736	chr2:202214148	PPIL3	chr2:201735680-201753999:-	0.23	4.83	1.81E-6	Basal cell carcinoma	
THCA	cis	1	rs6715284	chr2:202154397	CFLAR	chr2:201980816-202029001:+	-0.22	-3.94	9.48E-5	Rheumatoid arthritis	
THCA	cis	1	rs6715284	chr2:202154397	PPIL3	chr2:201735680-201753999:-	-0.6	-8.2	2.25E-15	Rheumatoid arthritis	
THCA	cis	1	rs6715380	chr2:202214505	CFLAR	chr2:201980816-202029001:+	-0.27	-3.9	0.00011	Rheumatoid arthritis	
THCA	cis	1	rs6715380	chr2:202214505	PPIL3	chr2:201735680-201753999:-	-0.71	-8.03	7.52E-15	Rheumatoid arthritis	
THCA	cis	1	rs6715819	chr2:73772309	ALMS1P	chr2:73872046-73912692:+	0.72	11.1	1.28E-25	Metabolite levels	
THCA	cis	1	rs6715819	chr2:73772309	NAT8	chr2:73867850-73869537:-	0.37	5.74	1.71E-8	Metabolite levels	
THCA	cis	1	rs6715819	chr2:73772309	TPRKB	chr2:73956957-73964517:-	-0.15	-3.66	0.000283	Metabolite levels	
THCA	cis	1	rs671681	chr11:71782812	FAM86C	chr11:71498557-71512276:+	0.31	3.81	0.000158	Severe influenza A (H1N1) infection	
THCA	cis	1	rs6717980	chr2:27452784	C2orf28	chr2:27434899-27440044:+	0.16	4.83	1.84E-6	Blood metabolite levels	
THCA	cis	1	rs6717980	chr2:27452784	SLC5A6	chr2:27422459-27435071:-	-0.32	-6.9	1.64E-11	Blood metabolite levels	
THCA	cis	1	rs6718012	chr2:70078258	SNRNP27	chr2:70121090-70132348:+	0.17	3.94	9.34E-5	Colorectal or endometrial cancer	
THCA	cis	1	rs6718083	chr2:25362194	POMC	chr2:25383722-25391559:-	0.24	3.95	9.06E-5	Body mass index	
THCA	cis	1	rs67180937	chr1:222823743	AIDA	chr1:222841357-222886526:-	0.18	4.7	3.4E-6	Coronary artery disease	
THCA	cis	1	rs67180937	chr1:222823743	TAF1A	chr1:222731244-222763255:-	0.15	3.61	0.000339	Coronary artery disease	
THCA	cis	1	rs6718128	chr2:27833752	FNDC4	chr2:27714751-27718126:-	0.15	3.46	0.000598	Oral cavity cancer	
THCA	cis	1	rs67186984	chr14:51169287	SAV1	chr14:51100360-51135023:-	0.31	6.5	2.01E-10	Cognitive performance	
THCA	cis	1	rs6719686	chr2:160908292	LY75	chr2:160625141-160761262:-	0.21	4.95	1.02E-6	Idiopathic membranous nephropathy	
THCA	cis	1	rs6720314	chr2:26334852	GPR113	chr2:26531041-26569685:-	-0.47	-7.22	2.05E-12	Gut microbiome composition (summer)	
THCA	cis	1	rs6720314	chr2:26334852	HADHA	chr2:26413505-26467594:-	-0.17	-3.58	0.000375	Gut microbiome composition (summer)	
THCA	cis	1	rs67205460	chr10:1090366	IDI2	chr10:1064847-1071799:-	-0.24	-3.46	0.000597	Response to angiotensin II receptor blocker therapy	
THCA	cis	1	rs67207208	chr10:23665914	C10orf67	chr10:23605521-23633772:-	-0.24	-4.72	3.12E-6	Crohn's disease and sarcoidosis (combined)	
THCA	cis	1	rs6720809	chr2:88528943	KRCC1	chr2:88326724-88355248:-	-0.25	-4.05	5.99E-5	Plasma clusterin levels	
THCA	cis	1	rs6720809	chr2:88528943	THNSL2	chr2:88469835-88486145:+	-0.62	-7.83	3.22E-14	Plasma clusterin levels	
THCA	cis	1	rs6720977	chr2:218273375	DIRC3	chr2:218148748-218621316:-	0.22	5.14	3.91E-7	Height	
THCA	cis	1	rs6721000	chr2:218273453	DIRC3	chr2:218148748-218621316:-	0.22	5.14	3.91E-7	Height	
THCA	cis	1	rs67214274	chr20:47898561	DDX27	chr20:47835832-47860612:+	0.27	4.94	1.06E-6	Height	
THCA	cis	1	rs6721652	chr2:100377321	TSGA10	chr2:99613725-99771187:-	0.17	3.36	0.000843	Cannabis dependence	
THCA	cis	1	rs672203	chr1:70887099	ZRANB2	chr1:71528975-71546745:-	-0.11	-3.35	0.000864	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	
THCA	cis	1	rs6722069	chr2:88533151	KRCC1	chr2:88326724-88355248:-	-0.25	-3.86	0.000128	Plasma clusterin levels	
THCA	cis	1	rs6722069	chr2:88533151	THNSL2	chr2:88469835-88486145:+	-0.63	-7.82	3.32E-14	Plasma clusterin levels	
THCA	cis	1	rs6722203	chr2:67569193	ETAA1	chr2:67624442-67637533:+	-0.17	-4.07	5.6E-5	Pancreatic cancer	
THCA	cis	1	rs6722332	chr2:203745327	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.93	5.93E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs6722332	chr2:203745327	ICA1L	chr2:203637873-203736371:-	0.25	4.18	3.49E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs672343	chr6:132635391	MOXD1	chr6:132617195-132722664:-	0.27	4.69	3.52E-6	Obesity-related traits	
THCA	cis	1	rs6723704	chr2:203738664	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.93	5.93E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs6723704	chr2:203738664	ICA1L	chr2:203637873-203736371:-	0.25	4.18	3.49E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs6723774	chr2:227770592	COL4A4	chr2:227867435-228029275:-	-0.15	-3.85	0.000135	Pulmonary function	
THCA	cis	1	rs67239267	chr7:143745116	ARHGEF35	chr7:143883677-143892736:-	-0.52	-10.76	2.43E-24	Obesity-related traits	
THCA	cis	1	rs67239267	chr7:143745116	OR2A1	chr7:144015236-144016148:+;chr7	-0.19	-4.14	4.12E-5	Obesity-related traits	
THCA	cis	1	rs67239267	chr7:143745116	OR2A9P	chr7:143991573-143997832:+;chr7	-0.31	-6.76	4.08E-11	Obesity-related traits	
THCA	cis	1	rs6724025	chr2:86200835	LOC90784	chr2:86247339-86250991:-	-0.43	-4.74	2.82E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs6724253	chr2:232121998	ARMC9	chr2:232063342-232238606:+	0.44	10.58	1.18E-23	Food antigen IgG levels	
THCA	cis	1	rs6724662	chr2:241831560	C2orf54	chr2:241825466-241835573:-	0.29	6.38	4.1E-10	Urinary metabolites	
THCA	cis	1	rs6724782	chr2:73679990	ALMS1P	chr2:73872046-73912692:+	0.69	11	2.99E-25	Metabolite levels	
THCA	cis	1	rs6724782	chr2:73679990	NAT8	chr2:73867850-73869537:-	0.37	5.87	8.35E-9	Metabolite levels	
THCA	cis	1	rs6724782	chr2:73679990	TPRKB	chr2:73956957-73964517:-	-0.17	-4.23	2.82E-5	Metabolite levels	
THCA	cis	1	rs67257959	chr19:17158145	EPS15L1	chr19:16466061-16582762:-	-0.2	-3.54	0.000432	Selective IgA deficiency	
THCA	cis	1	rs67257959	chr19:17158145	HAUS8	chr19:17160573-17186343:-	-0.15	-4.29	2.12E-5	Selective IgA deficiency	
THCA	cis	1	rs6725887	chr2:203745885	ALS2CR8	chr2:203776978-203851060:+	0.28	5.75	1.58E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs6725887	chr2:203745885	ICA1L	chr2:203637873-203736371:-	-0.22	-3.76	0.000194	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs6726292	chr2:55156630	RPL23AP32	chr2:54756359-54756978:+	0.19	3.48	0.00055	Obesity (extreme)	
THCA	cis	1	rs6726292	chr2:55156630	RTN4	chr2:55199329-55277734:-	0.26	5.32	1.58E-7	Obesity (extreme)	
THCA	cis	1	rs6727994	chr2:204157238	ALS2CR8	chr2:203776978-203851060:+	-0.25	-3.88	0.00012	Height	
THCA	cis	1	rs6729080	chr2:26301282	GPR113	chr2:26531041-26569685:-	-0.45	-7.05	6.34E-12	Gut microbiome composition (summer)	
THCA	cis	1	rs6729757	chr2:26285102	GPR113	chr2:26531041-26569685:-	-0.44	-7.03	7.11E-12	Gut microbiome composition (summer)	
THCA	cis	1	rs6729757	chr2:26285102	HADHA	chr2:26413505-26467594:-	-0.16	-3.34	0.000904	Gut microbiome composition (summer)	
THCA	cis	1	rs6730503	chr2:37528478	CEBPZ	chr2:37428778-37458740:-	0.18	4.01	6.97E-5	Chronic lymphocytic leukemia	
THCA	cis	1	rs67308532	chr5:125908599	ALDH7A1	chr5:125878918-125931082:-	0.44	6.2	1.25E-9	Osteoporosis	
THCA	cis	1	rs6732236	chr2:136501509	DARS	chr2:136664254-136743222:-	0.37	6.68	6.84E-11	Corneal structure	
THCA	cis	1	rs6732241	chr2:30479927	LBH	chr2:30454397-30482899:+	-0.18	-3.4	0.000721	Systemic lupus erythematosus	
THCA	cis	1	rs67325097	chr2:69725982	AAK1	chr2:69685127-69870977:-	-0.22	-4.56	6.61E-6	Parkinson's disease (age of onset)	
THCA	cis	1	rs67325097	chr2:69725982	NFU1	chr2:69623255-69664753:-	-0.16	-3.55	0.000431	Parkinson's disease (age of onset)	
THCA	cis	1	rs67335251	chr16:4071722	NAT15	chr16:3493668-3536962:+	-0.32	-3.76	0.000192	Diisocyanate-induced asthma	
THCA	cis	1	rs6734238	chr2:113841030	IL1B	chr2:113587337-113594356:-	-0.17	-3.4	0.000722	C-reactive protein levels or total cholesterol levels (pleiotropy);C-reactive protein;White blood cell count;Fibrinogen;C-reactive protein levels;Fibrinogen levels	
THCA	cis	1	rs6734408	chr2:239137481	LOC151174	chr2:239133754-239140318:-	0.56	5.85	8.99E-9	Irritable bowel syndrome	
THCA	cis	1	rs673604	chr1:35687815	ZMYM4	chr1:35734568-35887544:+	-0.14	-3.77	0.000185	Endometrial cancer	
THCA	cis	1	rs673632	chr5:139057237	DNAJC18	chr5:138747381-138775139:-	0.16	3.58	0.000383	Schizophrenia	
THCA	cis	1	rs6736360	chr2:190748749	ASNSD1	chr2:190526125-190535556:+	-0.55	-5.72	1.9E-8	Subcutaneous adipose tissue	
THCA	cis	1	rs6736866	chr2:73661986	ALMS1P	chr2:73872046-73912692:+	0.76	11.68	6.48E-28	Metabolite levels	
THCA	cis	1	rs6736866	chr2:73661986	NAT8	chr2:73867850-73869537:-	0.42	6.45	2.72E-10	Metabolite levels	
THCA	cis	1	rs6737085	chr2:202221441	ALS2CR12	chr2:202153148-202222101:-	-0.36	-7.19	2.54E-12	Basal cell carcinoma	
THCA	cis	1	rs6737085	chr2:202221441	PPIL3	chr2:201735680-201753999:-	-0.24	-4.92	1.19E-6	Basal cell carcinoma	
THCA	cis	1	rs67375757	chr20:47916295	DDX27	chr20:47835832-47860612:+	0.27	4.94	1.08E-6	Height	
THCA	cis	1	rs6737921	chr2:27839107	FNDC4	chr2:27714751-27718126:-	-0.14	-3.41	0.000717	Oral cavity cancer	
THCA	cis	1	rs67385638	chr11:5290370	HBG2	chr11:5269502-5667011:-	0.25	3.88	0.000121	Hemoglobin levels	
THCA	cis	1	rs6738618	chr2:203749439	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.93	5.93E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs6738618	chr2:203749439	ICA1L	chr2:203637873-203736371:-	0.25	4.18	3.49E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs6739061	chr2:26256147	GPR113	chr2:26531041-26569685:-	-0.41	-6.51	1.92E-10	Gut microbiome composition (summer)	
THCA	cis	1	rs6739392	chr2:67601971	ETAA1	chr2:67624442-67637533:+	-0.18	-4.19	3.33E-5	Pancreatic cancer	
THCA	cis	1	rs6739772	chr2:241840711	C2orf54	chr2:241825466-241835573:-	0.3	6.31	6.41E-10	Urinary metabolites	
THCA	cis	1	rs67401267	chr22:30750209	MTP18	chr22:30805176-30825041:+	0.23	3.36	0.00083	Coronary artery calcification	
THCA	cis	1	rs6740223	chr2:73653332	ALMS1P	chr2:73872046-73912692:+	0.71	11.38	9.89E-27	Metabolite levels	
THCA	cis	1	rs6740223	chr2:73653332	NAT8	chr2:73867850-73869537:-	0.38	6.04	3.13E-9	Metabolite levels	
THCA	cis	1	rs6740223	chr2:73653332	TPRKB	chr2:73956957-73964517:-	-0.18	-4.59	5.76E-6	Metabolite levels	
THCA	cis	1	rs6740641	chr2:54482989	C2orf73	chr2:54558071-54588714:+	0.3	4.43	1.15E-5	Telomere length	
THCA	cis	1	rs67411574	chr17:18797337	FAM18B	chr17:18684582-18710026:+	-0.42	-10.71	3.77E-24	Educational attainment (years of education)	
THCA	cis	1	rs67411574	chr17:18797337	FBXW10	chr17:18647326-18682661:+	-0.23	-4.98	8.93E-7	Educational attainment (years of education)	
THCA	cis	1	rs6741172	chr2:106440059	MRPS9	chr2:105654483-105716417:+	-0.14	-3.36	0.000836	Addiction	
THCA	cis	1	rs67412075	chr19:17385502	ABHD8	chr19:17402941-17414282:-	0.25	4.1	4.84E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs67412075	chr19:17385502	ANKLE1	chr19:17392454-17398454:+	0.29	4.91	1.28E-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs67412075	chr19:17385502	OCEL1	chr19:17337055-17340027:+	0.21	4.21	3.04E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs67412659	chr11:93714389	HEPHL1	chr11:93754378-93847374:+	0.43	3.55	0.00042	Obesity-related traits	
THCA	cis	1	rs6741269	chr2:239179418	LOC151174	chr2:239133754-239140318:-	0.49	5.35	1.35E-7	Irritable bowel syndrome	
THCA	cis	1	rs67420027	chr12:51349847	SLC11A2	chr12:51373319-51422058:-	-0.23	-4.62	4.84E-6	Type 2 diabetes	
THCA	cis	1	rs67420027	chr12:51349847	TFCP2	chr12:51488608-51566917:-	-0.2	-4.19	3.3E-5	Type 2 diabetes	
THCA	cis	1	rs6742276	chr2:61768745	AHSA2	chr2:61404553-61414058:+	-0.23	-9.33	3.86E-19	Tuberculosis	
THCA	cis	1	rs6742276	chr2:61768745	C2orf74	chr2:61372243-61391964:+	0.6	12.97	3.47E-33	Tuberculosis	
THCA	cis	1	rs6743139	chr2:87018452	LOC285074	chr2:87257799-87303536:-	-0.24	-3.92	0.000103	Progressive supranuclear palsy	
THCA	cis	1	rs67438720	chr6:70475251	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.47	0.000574	Sleep duration	
THCA	cis	1	rs67445790	chr6:151876730	C6orf97	chr6:151815175-151942327:+	0.33	4.64	4.43E-6	Bone mineral density (spine)	
THCA	cis	1	rs6745368	chr2:73809974	ALMS1P	chr2:73872046-73912692:+	0.76	11.69	6.08E-28	Metabolite levels	
THCA	cis	1	rs6745368	chr2:73809974	NAT8	chr2:73867850-73869537:-	0.42	6.45	2.82E-10	Metabolite levels	
THCA	cis	1	rs674568	chr15:45936587	SPATA5L1	chr15:45694519-45713614:+	0.3	4.98	8.85E-7	Obesity-related traits	
THCA	cis	1	rs6746564	chr2:45608409	SRBD1	chr2:45615820-45838433:-	-0.35	-4.32	1.86E-5	Glaucoma	
THCA	cis	1	rs67466576	chr10:4977394	AKR1C2	chr10:4964715-5060207:-	0.31	4.1	4.91E-5	Height	
THCA	cis	1	rs67487119	chr6:163102657	PACRG	chr6:163148164-163736523:+	0.54	7.47	3.95E-13	Body mass index	
THCA	cis	1	rs6748734	chr2:241837452	C2orf54	chr2:241825466-241835573:-	0.29	6.3	6.89E-10	Urinary metabolites	
THCA	cis	1	rs6749052	chr2:27772879	FNDC4	chr2:27714751-27718126:-	-0.15	-3.51	0.000486	Oral cavity cancer	
THCA	cis	1	rs6749509	chr2:69739714	AAK1	chr2:69685127-69870977:-	-0.24	-5.13	4.28E-7	Parkinson's disease (age of onset)	
THCA	cis	1	rs6749509	chr2:69739714	NFU1	chr2:69623255-69664753:-	-0.17	-3.78	0.000176	Parkinson's disease (age of onset)	
THCA	cis	1	rs6749855	chr2:26255263	GPR113	chr2:26531041-26569685:-	-0.44	-6.75	4.38E-11	Gut microbiome composition (summer)	
THCA	cis	1	rs67505314	chr10:17240134	TRDMT1	chr10:17184983-17243681:-	-0.42	-9.92	3.31E-21	Homocysteine levels	
THCA	cis	1	rs67505314	chr10:17240134	VIM	chr10:17270258-17279592:+	-0.19	-3.52	0.000467	Homocysteine levels	
THCA	cis	1	rs6750599	chr2:111893869	BCL2L11	chr2:111878491-111926022:+	0.14	3.58	0.000376	Chronic lymphocytic leukemia	
THCA	cis	1	rs6750681	chr2:26329677	GPR113	chr2:26531041-26569685:-	-0.42	-6.71	5.42E-11	Gut microbiome composition (summer)	
THCA	cis	1	rs6750765	chr2:86300308	LOC90784	chr2:86247339-86250991:-	-0.38	-3.99	7.7E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs6750765	chr2:86300308	POLR1A	chr2:86253453-86333278:-	-0.26	-3.64	0.000298	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs6750943	chr2:27777904	FNDC4	chr2:27714751-27718126:-	-0.15	-3.64	0.000304	Oral cavity cancer	
THCA	cis	1	rs6751693	chr2:241837332	C2orf54	chr2:241825466-241835573:-	0.29	6.16	1.56E-9	Urinary metabolites	
THCA	cis	1	rs675185	chr11:71775572	FAM86C	chr11:71498557-71512276:+	0.32	3.91	0.000107	Severe influenza A (H1N1) infection	
THCA	cis	1	rs6752050	chr2:242228780	ANO7	chr2:242127924-242164791:+	0.36	4.24	2.71E-5	Prostate cancer	
THCA	cis	1	rs6752050	chr2:242228780	SEPT2	chr2:242254723-242293439:+	-0.28	-4.23	2.84E-5	Prostate cancer	
THCA	cis	1	rs6752707	chr2:227766822	COL4A4	chr2:227867435-228029275:-	0.15	3.8	0.000166	Pulmonary function	
THCA	cis	1	rs6753304	chr2:160040094	WDSUB1	chr2:160092305-160143236:-	-0.21	-4.36	1.59E-5	Resting heart rate	
THCA	cis	1	rs6753344	chr2:73653138	ALMS1P	chr2:73872046-73912692:+	-0.77	-12	3.63E-29	Metabolite levels	
THCA	cis	1	rs6753344	chr2:73653138	NAT8	chr2:73867850-73869537:-	-0.41	-6.37	4.47E-10	Metabolite levels	
THCA	cis	1	rs67536397	chr7:65947917	CCT6P1	chr7:65216092-65228661:+	0.43	6.65	8.2E-11	Diabetic kidney disease	
THCA	cis	1	rs67536397	chr7:65947917	CRCP	chr7:65579805-65619551:+	-0.26	-3.9	0.000109	Diabetic kidney disease	
THCA	cis	1	rs67536397	chr7:65947917	RABGEF1	chr7:66093890-66276446:+	0.62	7.54	2.38E-13	Diabetic kidney disease	
THCA	cis	1	rs6753739	chr2:220028900	NHEJ1	chr2:219940051-220034817:-	-0.24	-4.46	1.04E-5	Height	
THCA	cis	1	rs675413	chr15:45936745	SPATA5L1	chr15:45694519-45713614:+	0.29	4.77	2.43E-6	Obesity-related traits	
THCA	cis	1	rs67544533	chr15:75361539	ARID3B	chr15:74833548-74890470:+	-0.15	-3.99	7.75E-5	Blood trace element (Zn levels)	
THCA	cis	1	rs67544533	chr15:75361539	PPCDC	chr15:75315927-75343066:+	0.15	4.28	2.28E-5	Blood trace element (Zn levels)	
THCA	cis	1	rs67544533	chr15:75361539	SCAMP5	chr15:75287901-75313836:+	0.43	7.7	8.03E-14	Blood trace element (Zn levels)	
THCA	cis	1	rs6755217	chr2:73641285	ALMS1P	chr2:73872046-73912692:+	0.75	11.46	5.02E-27	Metabolite levels	
THCA	cis	1	rs6755217	chr2:73641285	NAT8	chr2:73867850-73869537:-	0.41	6.28	7.43E-10	Metabolite levels	
THCA	cis	1	rs6755241	chr2:73641364	ALMS1P	chr2:73872046-73912692:+	0.75	11.62	1.14E-27	Metabolite levels	
THCA	cis	1	rs6755241	chr2:73641364	NAT8	chr2:73867850-73869537:-	0.4	6.21	1.16E-9	Metabolite levels	
THCA	cis	1	rs6755797	chr2:67598633	ETAA1	chr2:67624442-67637533:+	-0.17	-4.07	5.59E-5	Pancreatic cancer	
THCA	cis	1	rs6755934	chr2:216907198	MREG	chr2:216807315-216878346:-	0.38	8.03	7.74E-15	Alcohol dependence	
THCA	cis	1	rs6755934	chr2:216907198	PECR	chr2:216861029-216946532:-	0.25	5.08	5.41E-7	Alcohol dependence	
THCA	cis	1	rs6756238	chr2:27841305	FNDC4	chr2:27714751-27718126:-	-0.15	-3.48	0.000551	Oral cavity cancer	
THCA	cis	1	rs67569278	chr3:10149893	C3orf10	chr3:10157333-10168873:+	-0.2	-4.31	1.99E-5	Alzheimer's disease	
THCA	cis	1	rs67569278	chr3:10149893	VHL	chr3:10183319-10193744:+	-0.17	-3.94	9.48E-5	Alzheimer's disease	
THCA	cis	1	rs6756987	chr2:73687077	ALMS1P	chr2:73872046-73912692:+	0.69	11.05	2.0E-25	Metabolite levels	
THCA	cis	1	rs6756987	chr2:73687077	NAT8	chr2:73867850-73869537:-	0.37	5.86	8.81E-9	Metabolite levels	
THCA	cis	1	rs6756987	chr2:73687077	TPRKB	chr2:73956957-73964517:-	-0.17	-4.24	2.72E-5	Metabolite levels	
THCA	cis	1	rs67575175	chr3:127880226	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.46	1.03E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs6757825	chr2:69741801	AAK1	chr2:69685127-69870977:-	-0.24	-5.18	3.35E-7	Parkinson's disease (age of onset)	
THCA	cis	1	rs6757825	chr2:69741801	NFU1	chr2:69623255-69664753:-	-0.18	-3.89	0.000114	Parkinson's disease (age of onset)	
THCA	cis	1	rs675876	chr15:45936856	SPATA5L1	chr15:45694519-45713614:+	0.3	4.96	9.8E-7	Obesity-related traits	
THCA	cis	1	rs6758992	chr2:45604509	SRBD1	chr2:45615820-45838433:-	-0.3	-3.77	0.000182	Glaucoma	
THCA	cis	1	rs6759004	chr2:202004676	CFLAR	chr2:201980816-202029001:+	-0.31	-6.35	5.14E-10	Triptolide cytotoxicity	
THCA	cis	1	rs6759004	chr2:202004676	NIF3L1	chr2:201754050-201768655:+	-0.25	-3.48	0.000556	Triptolide cytotoxicity	
THCA	cis	1	rs6759004	chr2:202004676	PPIL3	chr2:201735680-201753999:-	-0.91	-16.45	1.62E-48	Triptolide cytotoxicity	
THCA	cis	1	rs6759836	chr2:160912802	LY75	chr2:160625141-160761262:-	0.21	4.81	2.0E-6	Idiopathic membranous nephropathy	
THCA	cis	1	rs6759924	chr2:160912747	LY75	chr2:160625141-160761262:-	0.23	5.34	1.48E-7	Idiopathic membranous nephropathy	
THCA	cis	1	rs67600807	chr17:38001559	C17orf37	chr17:37885411-37886788:-	-0.28	-4.58	5.85E-6	Systemic lupus erythematosus	
THCA	cis	1	rs676056	chr6:132642659	MOXD1	chr6:132617195-132722664:-	0.27	4.67	3.96E-6	Obesity-related traits	
THCA	cis	1	rs6761514	chr2:202227549	ALS2CR12	chr2:202153148-202222101:-	-0.38	-7.57	1.91E-13	Basal cell carcinoma	
THCA	cis	1	rs6761514	chr2:202227549	PPIL3	chr2:201735680-201753999:-	-0.24	-5.03	6.95E-7	Basal cell carcinoma	
THCA	cis	1	rs6763088	chr3:134254989	ANAPC13	chr3:134196547-134204865:-	-0.39	-12.14	9.6E-30	Height	
THCA	cis	1	rs6763088	chr3:134254989	CEP63	chr3:134204575-134293852:+	-0.31	-6.6	1.07E-10	Height	
THCA	cis	1	rs6763093	chr3:134254995	ANAPC13	chr3:134196547-134204865:-	-0.39	-12.14	9.6E-30	Height	
THCA	cis	1	rs6763093	chr3:134254995	CEP63	chr3:134204575-134293852:+	-0.31	-6.6	1.07E-10	Height	
THCA	cis	1	rs67634762	chr15:31748055	FAM7A2	chr15:30864758-30892900:+	-0.39	-3.6	0.000349	Survival in colorectal cancer (non-distant metastatic)	
THCA	cis	1	rs6763829	chr3:41897046	ULK4	chr3:41288091-42003660:-	1.09	20.95	1.23E-69	Diastolic blood pressure	
THCA	cis	1	rs67640320	chr14:52511596	NID2	chr14:52471521-52535946:-	-0.19	-4.04	6.25E-5	Pulmonary function	
THCA	cis	1	rs6764068	chr3:10153842	C3orf10	chr3:10157333-10168873:+	-0.21	-4.49	8.8E-6	Alzheimer's disease	
THCA	cis	1	rs6764068	chr3:10153842	VHL	chr3:10183319-10193744:+	-0.19	-4.42	1.21E-5	Alzheimer's disease	
THCA	cis	1	rs6764168	chr3:10123805	C3orf10	chr3:10157333-10168873:+	-0.21	-4.32	1.86E-5	Alzheimer's disease	
THCA	cis	1	rs6764168	chr3:10123805	VHL	chr3:10183319-10193744:+	-0.19	-4.37	1.53E-5	Alzheimer's disease	
THCA	cis	1	rs6764184	chr3:58006266	PDHB	chr3:58413355-58419565:-	-0.17	-3.8	0.000166	Optic cup area	
THCA	cis	1	rs67646369	chr6:163003233	PACRG	chr6:163148164-163736523:+	0.46	7.08	5.13E-12	Body mass index	
THCA	cis	1	rs6765233	chr3:128002850	EEFSEC	chr3:127872313-128127488:+	0.26	4.53	7.38E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs67652499	chr20:47926691	DDX27	chr20:47835832-47860612:+	0.27	4.95	1.02E-6	Height	
THCA	cis	1	rs6765269	chr3:160948542	NMD3	chr3:160939099-160971319:+	-0.11	-3.74	0.000209	Morning vs. evening chronotype	
THCA	cis	1	rs67654320	chr12:51356459	SLC11A2	chr12:51373319-51422058:-	-0.24	-4.74	2.88E-6	Type 2 diabetes	
THCA	cis	1	rs67654320	chr12:51356459	TFCP2	chr12:51488608-51566917:-	-0.2	-4.29	2.15E-5	Type 2 diabetes	
THCA	cis	1	rs6765505	chr3:134208132	ANAPC13	chr3:134196547-134204865:-	0.39	12.57	1.72E-31	Height	
THCA	cis	1	rs6765505	chr3:134208132	CEP63	chr3:134204575-134293852:+	0.29	6.4	3.83E-10	Height	
THCA	cis	1	rs6766554	chr3:184728846	C3orf70	chr3:184795840-184870802:-	-0.23	-4.62	4.96E-6	Heschl's gyrus morphology	
THCA	cis	1	rs6766818	chr3:134226159	ANAPC13	chr3:134196547-134204865:-	0.4	12.84	1.2E-32	Height	
THCA	cis	1	rs6766818	chr3:134226159	CEP63	chr3:134204575-134293852:+	0.29	6.27	8.12E-10	Height	
THCA	cis	1	rs6766897	chr3:134191303	ANAPC13	chr3:134196547-134204865:-	0.34	10.49	2.55E-23	Height	
THCA	cis	1	rs6766897	chr3:134191303	CEP63	chr3:134204575-134293852:+	0.28	6.15	1.59E-9	Height	
THCA	cis	1	rs6767049	chr3:20220712	KAT2B	chr3:20081524-20195894:+	-0.16	-3.72	0.000224	Temperament (bipolar disorder)	
THCA	cis	1	rs6767366	chr3:184753814	C3orf70	chr3:184795840-184870802:-	-0.23	-4.68	3.82E-6	Heschl's gyrus morphology	
THCA	cis	1	rs67674204	chr3:127824778	EEFSEC	chr3:127872313-128127488:+	-0.25	-4.42	1.23E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs6768102	chr3:10149380	C3orf10	chr3:10157333-10168873:+	-0.2	-4.38	1.48E-5	Alzheimer's disease	
THCA	cis	1	rs6768102	chr3:10149380	VHL	chr3:10183319-10193744:+	-0.17	-4.08	5.24E-5	Alzheimer's disease	
THCA	cis	1	rs6768128	chr3:41865080	ULK4	chr3:41288091-42003660:-	1.04	19.41	2.7E-62	Diastolic blood pressure	
THCA	cis	1	rs6768542	chr3:41865474	ULK4	chr3:41288091-42003660:-	1.04	19.1	7.17E-61	Diastolic blood pressure	
THCA	cis	1	rs6768563	chr3:41865541	ULK4	chr3:41288091-42003660:-	1.04	19.1	7.17E-61	Diastolic blood pressure	
THCA	cis	1	rs67689846	chr11:93660950	HEPHL1	chr11:93754378-93847374:+	0.5	4.26	2.42E-5	Obesity-related traits	
THCA	cis	1	rs67689846	chr11:93660950	PANX1	chr11:93862094-93915135:+	0.35	3.46	0.000579	Obesity-related traits	
THCA	cis	1	rs67696450	chr10:1090684	IDI2	chr10:1064847-1071799:-	-0.24	-3.46	0.000597	Response to angiotensin II receptor blocker therapy	
THCA	cis	1	rs6769885	chr3:134286913	ANAPC13	chr3:134196547-134204865:-	0.4	12.93	5.06E-33	Height	
THCA	cis	1	rs6769885	chr3:134286913	CEP63	chr3:134204575-134293852:+	0.31	6.72	5.18E-11	Height	
THCA	cis	1	rs6770152	chr3:53100214	NT5DC2	chr3:52558386-52569093:-	0.16	3.58	0.000379	Ulcerative colitis	
THCA	cis	1	rs67701624	chr12:50928938	DIP2B	chr12:50898768-51142448:+	0.12	3.82	0.000151	Fibrinogen	
THCA	cis	1	rs6770470	chr3:48435123	ATRIP	chr3:48488141-48507708:+	0.17	3.78	0.000176	Longevity	
THCA	cis	1	rs6770470	chr3:48435123	TREX1	chr3:48501186-48509043:+	-0.24	-5.66	2.59E-8	Longevity	
THCA	cis	1	rs6770670	chr3:49686682	MST1	chr3:49721381-49726196:-	0.13	3.88	0.000117	Crohn's disease;Ulcerative colitis	
THCA	cis	1	rs6771941	chr3:20157077	EFHB	chr3:19920968-19988501:-	0.21	3.4	0.000722	Bipolar disorder and schizophrenia	
THCA	cis	1	rs6772046	chr3:38479660	ACVR2B	chr3:38495790-38534631:+	0.13	3.39	0.000763	Electrocardiographic conduction measures	
THCA	cis	1	rs6772046	chr3:38479660	LOC100128640	chr3:38492524-38496311:-	0.24	5.12	4.34E-7	Electrocardiographic conduction measures	
THCA	cis	1	rs6772046	chr3:38479660	XYLB	chr3:38388251-38456467:+	0.2	4.89	1.38E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs6772315	chr3:10113644	C3orf10	chr3:10157333-10168873:+	-0.21	-4.34	1.71E-5	Alzheimer's disease	
THCA	cis	1	rs6772315	chr3:10113644	VHL	chr3:10183319-10193744:+	-0.2	-4.51	8.09E-6	Alzheimer's disease	
THCA	cis	1	rs6772407	chr3:128044372	EEFSEC	chr3:127872313-128127488:+	-0.19	-3.44	0.000634	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs6772548	chr3:37075934	EPM2AIP1	chr3:37027358-37034795:-	0.13	3.88	0.000118	Cerebrospinal P-tau181p levels	
THCA	cis	1	rs6772548	chr3:37075934	LRRFIP2	chr3:37094117-37217851:-	0.51	14.09	6.12E-38	Cerebrospinal P-tau181p levels	
THCA	cis	1	rs677279	chr11:71770469	FAM86C	chr11:71498557-71512276:+	0.32	3.91	0.000107	Severe influenza A (H1N1) infection	
THCA	cis	1	rs67728539	chr7:65378124	CCT6P1	chr7:65216092-65228661:+	0.38	5.99	4.15E-9	Diabetic kidney disease	
THCA	cis	1	rs67728539	chr7:65378124	CRCP	chr7:65579805-65619551:+	-0.26	-3.95	8.96E-5	Diabetic kidney disease	
THCA	cis	1	rs67728539	chr7:65378124	RABGEF1	chr7:66093890-66276446:+	0.55	6.82	2.68E-11	Diabetic kidney disease	
THCA	cis	1	rs6772896	chr3:134203347	ANAPC13	chr3:134196547-134204865:-	0.39	12.49	3.63E-31	Height	
THCA	cis	1	rs6772896	chr3:134203347	CEP63	chr3:134204575-134293852:+	0.3	6.35	4.92E-10	Height	
THCA	cis	1	rs67733885	chr20:47896557	DDX27	chr20:47835832-47860612:+	0.26	4.81	2.03E-6	Height	
THCA	cis	1	rs6773957	chr3:186573705	RTP4	chr3:187086168-187089367:+	0.15	3.54	0.000433	Adiponectin levels	
THCA	cis	1	rs67747005	chr6:163150845	PACRG	chr6:163148164-163736523:+	0.47	6.79	3.43E-11	Body mass index	
THCA	cis	1	rs6774724	chr3:49381911	GMPPB	chr3:49758932-49761384:-	-0.16	-3.59	0.000366	Menarche (age at onset)	
THCA	cis	1	rs6774724	chr3:49381911	P4HTM	chr3:49027341-49044579:+	0.18	4.54	7.0E-6	Menarche (age at onset)	
THCA	cis	1	rs6775591	chr3:184743844	C3orf70	chr3:184795840-184870802:-	-0.23	-4.68	3.82E-6	Heschl's gyrus morphology	
THCA	cis	1	rs6775627	chr3:160953609	NMD3	chr3:160939099-160971319:+	-0.11	-3.73	0.000218	Morning vs. evening chronotype	
THCA	cis	1	rs67766926	chr2:61163581	C2orf74	chr2:61372243-61391964:+	0.42	6.22	1.08E-9	Inflammatory skin disease	
THCA	cis	1	rs6776700	chr3:48496758	ATRIP	chr3:48488141-48507708:+	0.19	4.14	4.15E-5	Longevity	
THCA	cis	1	rs6776700	chr3:48496758	TREX1	chr3:48501186-48509043:+	-0.26	-6	3.88E-9	Longevity	
THCA	cis	1	rs677977	chr1:147083744	ACP6	chr1:147119168-147142634:-	-0.75	-15.8	1.58E-45	Schizophrenia (negative symptoms)	
THCA	cis	1	rs67805055	chr14:55587552	KIAA0831	chr14:55833110-55878576:-	-0.12	-3.46	0.000582	Protein biomarker	
THCA	cis	1	rs6781326	chr3:41777028	ULK4	chr3:41288091-42003660:-	1.05	19.46	1.48E-62	Diastolic blood pressure	
THCA	cis	1	rs6781811	chr3:10121922	C3orf10	chr3:10157333-10168873:+	0.19	4.12	4.39E-5	Alzheimer's disease	
THCA	cis	1	rs6781811	chr3:10121922	VHL	chr3:10183319-10193744:+	0.17	3.89	0.000115	Alzheimer's disease	
THCA	cis	1	rs6782563	chr3:134295959	ANAPC13	chr3:134196547-134204865:-	-0.36	-11.4	8.25E-27	Height	
THCA	cis	1	rs6782563	chr3:134295959	CEP63	chr3:134204575-134293852:+	-0.3	-6.62	9.81E-11	Height	
THCA	cis	1	rs6782602	chr3:10116541	C3orf10	chr3:10157333-10168873:+	-0.2	-4.19	3.28E-5	Alzheimer's disease	
THCA	cis	1	rs6782602	chr3:10116541	VHL	chr3:10183319-10193744:+	-0.19	-4.47	9.88E-6	Alzheimer's disease	
THCA	cis	1	rs6782799	chr3:119610793	GSK3B	chr3:119540804-119813264:-	0.14	4.81	2.01E-6	HDL cholesterol	
THCA	cis	1	rs678292	chr10:105957561	C10orf79	chr10:105889647-105992120:-	0.24	7.9	1.89E-14	Attention deficit hyperactivity disorder	
THCA	cis	1	rs6783001	chr3:41862232	ULK4	chr3:41288091-42003660:-	1.1	21.29	2.98E-71	Diastolic blood pressure	
THCA	cis	1	rs6783003	chr3:49524778	GMPPB	chr3:49758932-49761384:-	0.16	3.71	0.000228	Menarche (age at onset)	
THCA	cis	1	rs6783003	chr3:49524778	P4HTM	chr3:49027341-49044579:+	-0.18	-4.5	8.58E-6	Menarche (age at onset)	
THCA	cis	1	rs6783253	chr3:127851561	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.47	9.77E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs67840803	chr6:163049048	PACRG	chr6:163148164-163736523:+	0.53	7.55	2.2E-13	Body mass index	
THCA	cis	1	rs6784159	chr3:127843378	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.62	5.04E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs6784322	chr3:48422235	ATRIP	chr3:48488141-48507708:+	0.17	3.78	0.000175	Longevity	
THCA	cis	1	rs6784322	chr3:48422235	TREX1	chr3:48501186-48509043:+	-0.25	-5.79	1.28E-8	Longevity	
THCA	cis	1	rs6784421	chr3:156655494	LEKR1	chr3:156544076-156763918:+	0.31	8.62	9.96E-17	Multiple sclerosis (severity)	
THCA	cis	1	rs6784934	chr3:151039018	GPR87	chr3:151011876-151034636:-	0.21	4.64	4.43E-6	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs6784934	chr3:151039018	P2RY14	chr3:150929905-150996230:-	-0.2	-4.32	1.89E-5	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs6785027	chr3:134211649	ANAPC13	chr3:134196547-134204865:-	-0.39	-12.7	4.73E-32	Height	
THCA	cis	1	rs6785027	chr3:134211649	CEP63	chr3:134204575-134293852:+	-0.29	-6.44	2.89E-10	Height	
THCA	cis	1	rs6785045	chr3:49435243	GMPPB	chr3:49758932-49761384:-	0.17	3.83	0.000148	Menarche (age at onset)	
THCA	cis	1	rs6785045	chr3:49435243	P4HTM	chr3:49027341-49044579:+	-0.17	-4.29	2.19E-5	Menarche (age at onset)	
THCA	cis	1	rs6785045	chr3:49435243	WDR6	chr3:49044637-49053386:+	0.17	3.59	0.000359	Menarche (age at onset)	
THCA	cis	1	rs67852463	chr3:10157205	C3orf10	chr3:10157333-10168873:+	-0.21	-4.44	1.1E-5	Alzheimer's disease	
THCA	cis	1	rs67852463	chr3:10157205	VHL	chr3:10183319-10193744:+	-0.19	-4.37	1.53E-5	Alzheimer's disease	
THCA	cis	1	rs6785535	chr3:127834695	EEFSEC	chr3:127872313-128127488:+	-0.25	-4.42	1.23E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs6785930	chr3:151056616	GPR87	chr3:151011876-151034636:-	0.2	4.46	1.04E-5	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs6785930	chr3:151056616	P2RY14	chr3:150929905-150996230:-	-0.18	-3.83	0.000144	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs67865942	chr8:89596642	MMP16	chr8:89049462-89339717:-	0.16	3.62	0.000324	Body mass index and cholesterol (psychopharmacological treatment)	
THCA	cis	1	rs6786638	chr3:10118075	C3orf10	chr3:10157333-10168873:+	-0.21	-4.33	1.85E-5	Alzheimer's disease	
THCA	cis	1	rs6786638	chr3:10118075	VHL	chr3:10183319-10193744:+	-0.19	-4.41	1.28E-5	Alzheimer's disease	
THCA	cis	1	rs6787172	chr3:158187811	LXN	chr3:158384204-158390482:-	0.19	4.54	7.02E-6	Subjective well-being	
THCA	cis	1	rs6787172	chr3:158187811	RARRES1	chr3:158414899-158450275:-	0.1	3.45	0.000616	Subjective well-being	
THCA	cis	1	rs6787312	chr3:51650510	TEX264	chr3:51705222-51738338:+	-0.2	-5.49	6.64E-8	Melanoma	
THCA	cis	1	rs6787371	chr3:134254991	ANAPC13	chr3:134196547-134204865:-	0.39	12.53	2.41E-31	Height	
THCA	cis	1	rs6787371	chr3:134254991	CEP63	chr3:134204575-134293852:+	0.3	6.59	1.14E-10	Height	
THCA	cis	1	rs6787614	chr3:127817478	EEFSEC	chr3:127872313-128127488:+	-0.25	-4.42	1.23E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs6787952	chr3:156609375	LEKR1	chr3:156544076-156763918:+	-0.55	-10.87	9.92E-25	Bone mineral density	
THCA	cis	1	rs678815	chr11:102713777	MMP1	chr11:102660641-102668966:-	0.25	4.53	7.34E-6	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	
THCA	cis	1	rs6789043	chr3:37025867	EPM2AIP1	chr3:37027358-37034795:-	0.13	3.88	0.000121	Cerebrospinal P-tau181p levels	
THCA	cis	1	rs6789043	chr3:37025867	LRRFIP2	chr3:37094117-37217851:-	0.5	13.73	2.16E-36	Cerebrospinal P-tau181p levels	
THCA	cis	1	rs6789156	chr3:10124120	C3orf10	chr3:10157333-10168873:+	-0.2	-4.23	2.8E-5	Alzheimer's disease	
THCA	cis	1	rs6789156	chr3:10124120	VHL	chr3:10183319-10193744:+	-0.17	-3.91	0.000106	Alzheimer's disease	
THCA	cis	1	rs6789260	chr3:41776350	ULK4	chr3:41288091-42003660:-	1.02	17.78	1.21E-54	Diastolic blood pressure	
THCA	cis	1	rs6790466	chr3:134197740	ANAPC13	chr3:134196547-134204865:-	0.4	12.64	8.41E-32	Height	
THCA	cis	1	rs6790466	chr3:134197740	CEP63	chr3:134204575-134293852:+	0.3	6.35	4.99E-10	Height	
THCA	cis	1	rs6790732	chr3:41864872	ULK4	chr3:41288091-42003660:-	1.1	21.32	2.24E-71	Diastolic blood pressure	
THCA	cis	1	rs6791806	chr3:41889995	ULK4	chr3:41288091-42003660:-	1.09	20.95	1.23E-69	Diastolic blood pressure	
THCA	cis	1	rs6791810	chr3:10124444	C3orf10	chr3:10157333-10168873:+	0.19	4.13	4.31E-5	Alzheimer's disease	
THCA	cis	1	rs6791810	chr3:10124444	VHL	chr3:10183319-10193744:+	0.19	4.39	1.42E-5	Alzheimer's disease	
THCA	cis	1	rs6792572	chr3:119636096	GSK3B	chr3:119540804-119813264:-	0.14	4.81	2.06E-6	HDL cholesterol	
THCA	cis	1	rs67927699	chr2:61187415	AHSA2	chr2:61404553-61414058:+	-0.13	-4.86	1.56E-6	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs67927699	chr2:61187415	C2orf74	chr2:61372243-61391964:+	0.5	9.67	2.46E-20	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs6793295	chr3:169518455	LRRC34	chr3:169511266-169530720:-	-0.24	-4.51	8.02E-6	Multiple myeloma and monoclonal gammopathy;Interstitial lung disease	
THCA	cis	1	rs6793396	chr3:10110927	C3orf10	chr3:10157333-10168873:+	-0.21	-4.34	1.71E-5	Alzheimer's disease	
THCA	cis	1	rs6793396	chr3:10110927	VHL	chr3:10183319-10193744:+	-0.2	-4.51	8.09E-6	Alzheimer's disease	
THCA	cis	1	rs6793487	chr3:134299426	ANAPC13	chr3:134196547-134204865:-	-0.36	-11.4	8.25E-27	Height	
THCA	cis	1	rs6793487	chr3:134299426	CEP63	chr3:134204575-134293852:+	-0.3	-6.62	9.81E-11	Height	
THCA	cis	1	rs67940364	chr3:127833353	EEFSEC	chr3:127872313-128127488:+	-0.25	-4.42	1.23E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs6794591	chr3:128031219	EEFSEC	chr3:127872313-128127488:+	-0.19	-3.44	0.000634	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs6794601	chr3:160946769	NMD3	chr3:160939099-160971319:+	-0.1	-3.54	0.000445	Morning vs. evening chronotype	
THCA	cis	1	rs6794875	chr3:48455626	ATRIP	chr3:48488141-48507708:+	0.2	4.31	1.95E-5	Longevity	
THCA	cis	1	rs6794875	chr3:48455626	TREX1	chr3:48501186-48509043:+	-0.25	-5.75	1.58E-8	Longevity	
THCA	cis	1	rs679515	chr1:207750568	CR1	chr1:207669473-207815109:+	0.16	3.36	0.000828	Alzheimer's disease in APOE e4+ carriers	
THCA	cis	1	rs6795653	chr3:119610565	GSK3B	chr3:119540804-119813264:-	0.14	4.82	1.94E-6	HDL cholesterol	
THCA	cis	1	rs679620	chr11:102713620	MMP1	chr11:102660641-102668966:-	0.25	4.39	1.38E-5	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	
THCA	cis	1	rs6796210	chr3:41851718	ULK4	chr3:41288091-42003660:-	1.09	21.12	2.07E-70	Diastolic blood pressure	
THCA	cis	1	rs6796491	chr3:48430465	ATRIP	chr3:48488141-48507708:+	0.17	3.81	0.000155	Longevity	
THCA	cis	1	rs6796491	chr3:48430465	TREX1	chr3:48501186-48509043:+	-0.26	-5.97	4.57E-9	Longevity	
THCA	cis	1	rs6797165	chr3:41887777	ULK4	chr3:41288091-42003660:-	1.09	20.95	1.28E-69	Diastolic blood pressure	
THCA	cis	1	rs6797178	chr3:137253713	NCK1	chr3:136581073-136667967:+	0.13	3.49	0.000519	Glucocorticoid-induced osteonecrosis	
THCA	cis	1	rs6797834	chr3:127856400	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.47	9.77E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs67978911	chr4:17991423	DCAF16	chr4:17802280-17812381:-	-0.2	-4.39	1.41E-5	Height	
THCA	cis	1	rs67981189	chr14:71472226	PCNX	chr14:71374122-71582099:+	-0.2	-6.84	2.45E-11	Schizophrenia	
THCA	cis	1	rs6798749	chr3:128056897	EEFSEC	chr3:127872313-128127488:+	0.21	3.55	0.000422	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs67988338	chr11:93704731	HEPHL1	chr11:93754378-93847374:+	0.48	3.87	0.000126	Obesity-related traits	
THCA	cis	1	rs679926	chr11:71769936	FAM86C	chr11:71498557-71512276:+	-0.33	-4.1	4.89E-5	Severe influenza A (H1N1) infection	
THCA	cis	1	rs6800225	chr3:127862178	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.47	9.77E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs68005215	chr10:4977435	AKR1C2	chr10:4964715-5060207:-	0.32	4.2	3.25E-5	Height	
THCA	cis	1	rs6800554	chr3:37143879	EPM2AIP1	chr3:37027358-37034795:-	-0.13	-3.85	0.000132	Cerebrospinal P-tau181p levels	
THCA	cis	1	rs6800554	chr3:37143879	LRRFIP2	chr3:37094117-37217851:-	-0.5	-13.54	1.44E-35	Cerebrospinal P-tau181p levels	
THCA	cis	1	rs6800622	chr3:119580678	GSK3B	chr3:119540804-119813264:-	-0.14	-4.93	1.11E-6	HDL cholesterol	
THCA	cis	1	rs6800862	chr3:134228628	ANAPC13	chr3:134196547-134204865:-	0.37	11.71	4.87E-28	Height	
THCA	cis	1	rs6800862	chr3:134228628	CEP63	chr3:134204575-134293852:+	0.29	6.38	4.28E-10	Height	
THCA	cis	1	rs6800	chr1:156262653	BGLAP	chr1:156182784-156213112:+	0.23	5.32	1.63E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs6800	chr1:156262653	C1orf85	chr1:156259882-156265449:-	-0.17	-3.99	7.72E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs6800	chr1:156262653	CCT3	chr1:156278752-156308195:-	-0.32	-6.95	1.24E-11	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs6801142	chr3:184698444	C3orf70	chr3:184795840-184870802:-	-0.23	-4.61	5.21E-6	Heschl's gyrus morphology	
THCA	cis	1	rs68012338	chr17:46856405	CALCOCO2	chr17:46908372-46942228:+	-0.13	-3.57	0.000393	Schizophrenia or bipolar disorder	
THCA	cis	1	rs68012338	chr17:46856405	SNF8	chr17:47007461-47022154:-	-0.22	-6.74	4.47E-11	Schizophrenia or bipolar disorder	
THCA	cis	1	rs68012338	chr17:46856405	UBE2Z	chr17:46985767-47006422:+	-0.18	-4.04	6.21E-5	Schizophrenia or bipolar disorder	
THCA	cis	1	rs68012976	chr11:93625796	HEPHL1	chr11:93754378-93847374:+	0.46	3.69	0.000253	Obesity-related traits	
THCA	cis	1	rs6801343	chr3:41767234	ULK4	chr3:41288091-42003660:-	1.06	19.49	1.1E-62	Diastolic blood pressure	
THCA	cis	1	rs68014903	chr20:47912039	DDX27	chr20:47835832-47860612:+	0.27	4.9	1.31E-6	Height	
THCA	cis	1	rs6801596	chr3:134252114	ANAPC13	chr3:134196547-134204865:-	0.37	11.81	2.02E-28	Height	
THCA	cis	1	rs6801596	chr3:134252114	CEP63	chr3:134204575-134293852:+	0.3	6.54	1.6E-10	Height	
THCA	cis	1	rs68019383	chr11:93676398	HEPHL1	chr11:93754378-93847374:+	0.46	3.98	7.93E-5	Obesity-related traits	
THCA	cis	1	rs6802109	chr3:137250416	NCK1	chr3:136581073-136667967:+	0.13	3.51	0.000483	Glucocorticoid-induced osteonecrosis	
THCA	cis	1	rs6802315	chr3:158514360	MFSD1	chr3:158519912-158547504:+	-0.14	-3.74	0.000207	Periodontitis (CDC/AAP)	
THCA	cis	1	rs6802340	chr3:41894034	ULK4	chr3:41288091-42003660:-	1.09	20.95	1.23E-69	Diastolic blood pressure	
THCA	cis	1	rs6802654	chr3:134217072	ANAPC13	chr3:134196547-134204865:-	0.39	12.57	1.72E-31	Height	
THCA	cis	1	rs6802654	chr3:134217072	CEP63	chr3:134204575-134293852:+	0.29	6.4	3.83E-10	Height	
THCA	cis	1	rs6803443	chr3:184940052	CHRD	chr3:184097861-184107619:+	0.14	3.79	0.000168	Cognitive performance	
THCA	cis	1	rs6803560	chr3:41824480	ULK4	chr3:41288091-42003660:-	1.07	19.88	1.58E-64	Diastolic blood pressure	
THCA	cis	1	rs6803652	chr3:41824556	ULK4	chr3:41288091-42003660:-	1.07	19.88	1.58E-64	Diastolic blood pressure	
THCA	cis	1	rs6804449	chr3:184667576	C3orf70	chr3:184795840-184870802:-	-0.26	-4.96	9.92E-7	Heschl's gyrus morphology	
THCA	cis	1	rs6804473	chr3:10060425	C3orf10	chr3:10157333-10168873:+	-0.21	-4.43	1.18E-5	Alzheimer's disease	
THCA	cis	1	rs6804473	chr3:10060425	VHL	chr3:10183319-10193744:+	-0.18	-4.18	3.51E-5	Alzheimer's disease	
THCA	cis	1	rs68045038	chr3:10151828	C3orf10	chr3:10157333-10168873:+	-0.21	-4.51	8.24E-6	Alzheimer's disease	
THCA	cis	1	rs68045038	chr3:10151828	VHL	chr3:10183319-10193744:+	-0.19	-4.44	1.13E-5	Alzheimer's disease	
THCA	cis	1	rs68045643	chr6:163029709	PACRG	chr6:163148164-163736523:+	0.46	6.91	1.57E-11	Body mass index	
THCA	cis	1	rs6804655	chr3:49738945	CCDC36	chr3:49235861-49295537:+	0.18	3.78	0.000179	Resting heart rate	
THCA	cis	1	rs6804655	chr3:49738945	RBM6	chr3:49977592-50137484:+	-0.14	-4.19	3.28E-5	Resting heart rate	
THCA	cis	1	rs6804770	chr3:134230234	ANAPC13	chr3:134196547-134204865:-	0.39	12.57	1.72E-31	Height	
THCA	cis	1	rs6804770	chr3:134230234	CEP63	chr3:134204575-134293852:+	0.29	6.4	3.83E-10	Height	
THCA	cis	1	rs6804774	chr3:48430617	ATRIP	chr3:48488141-48507708:+	0.17	3.81	0.000155	Longevity	
THCA	cis	1	rs6804774	chr3:48430617	TREX1	chr3:48501186-48509043:+	-0.26	-5.97	4.57E-9	Longevity	
THCA	cis	1	rs6805251	chr3:119560606	GSK3B	chr3:119540804-119813264:-	0.14	4.81	2.02E-6	HDL cholesterol	
THCA	cis	1	rs6805582	chr3:128029008	EEFSEC	chr3:127872313-128127488:+	-0.2	-3.52	0.000478	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs6805609	chr3:49471522	GMPPB	chr3:49758932-49761384:-	0.17	3.96	8.54E-5	Menarche (age at onset)	
THCA	cis	1	rs6805609	chr3:49471522	P4HTM	chr3:49027341-49044579:+	-0.15	-3.84	0.000139	Menarche (age at onset)	
THCA	cis	1	rs6805621	chr3:128029204	EEFSEC	chr3:127872313-128127488:+	-0.2	-3.52	0.000478	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs6805880	chr3:41865397	ULK4	chr3:41288091-42003660:-	1.04	19.1	7.17E-61	Diastolic blood pressure	
THCA	cis	1	rs6806417	chr3:134211446	ANAPC13	chr3:134196547-134204865:-	-0.38	-12.22	4.36E-30	Height	
THCA	cis	1	rs6806417	chr3:134211446	CEP63	chr3:134204575-134293852:+	-0.29	-6.32	5.92E-10	Height	
THCA	cis	1	rs680668	chr6:84229366	SNAP91	chr6:84262607-84419127:-	-0.18	-3.71	0.000232	Bipolar disorder with mood-incongruent psychosis	
THCA	cis	1	rs68067759	chr3:10150535	C3orf10	chr3:10157333-10168873:+	-0.21	-4.45	1.05E-5	Alzheimer's disease	
THCA	cis	1	rs68067759	chr3:10150535	VHL	chr3:10183319-10193744:+	-0.19	-4.48	9.4E-6	Alzheimer's disease	
THCA	cis	1	rs6807015	chr3:41754514	ULK4	chr3:41288091-42003660:-	1.04	18.5	5.28E-58	Diastolic blood pressure	
THCA	cis	1	rs6807627	chr3:72939767	GXYLT2	chr3:72937385-73024520:+	0.26	5.6	3.68E-8	Motion sickness	
THCA	cis	1	rs6807846	chr3:10134491	C3orf10	chr3:10157333-10168873:+	-0.2	-4.37	1.56E-5	Alzheimer's disease	
THCA	cis	1	rs6807846	chr3:10134491	VHL	chr3:10183319-10193744:+	-0.19	-4.45	1.08E-5	Alzheimer's disease	
THCA	cis	1	rs6808091	chr3:151073997	GPR87	chr3:151011876-151034636:-	0.19	4.29	2.14E-5	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs6808091	chr3:151073997	P2RY14	chr3:150929905-150996230:-	-0.19	-4.1	4.86E-5	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs6809155	chr3:51623216	TEX264	chr3:51705222-51738338:+	-0.22	-5.72	1.9E-8	Melanoma	
THCA	cis	1	rs6810006	chr3:127856058	EEFSEC	chr3:127872313-128127488:+	-0.27	-4.69	3.52E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs6810060	chr3:48434748	ATRIP	chr3:48488141-48507708:+	0.17	3.78	0.000176	Longevity	
THCA	cis	1	rs6810060	chr3:48434748	TREX1	chr3:48501186-48509043:+	-0.24	-5.66	2.59E-8	Longevity	
THCA	cis	1	rs6810665	chr4:17984462	DCAF16	chr4:17802280-17812381:-	-0.2	-4.39	1.41E-5	Height	
THCA	cis	1	rs6810869	chr4:103558514	CISD2	chr4:103790135-103809913:+	-0.16	-3.62	0.000321	Primary biliary cirrhosis	
THCA	cis	1	rs6810869	chr4:103558514	NFKB1	chr4:103422486-103538458:+	0.15	4.2	3.16E-5	Primary biliary cirrhosis	
THCA	cis	1	rs6811520	chr4:56315178	TMEM165	chr4:56262090-56292342:+	-0.15	-3.6	0.000351	Personality dimensions	
THCA	cis	1	rs6811842	chr4:18009798	DCAF16	chr4:17802280-17812381:-	-0.2	-4.48	9.24E-6	Height	
THCA	cis	1	rs6812042	chr4:56396079	TMEM165	chr4:56262090-56292342:+	-0.15	-3.71	0.000234	Personality dimensions	
THCA	cis	1	rs68120925	chr14:51169258	SAV1	chr14:51100360-51135023:-	0.31	6.33	5.71E-10	Cognitive performance	
THCA	cis	1	rs6812540	chr4:39116423	KLHL5	chr4:39046659-39123828:+	-0.21	-5.73	1.77E-8	Uric acid levels	
THCA	cis	1	rs6813340	chr4:17922866	DCAF16	chr4:17802280-17812381:-	-0.2	-4.53	7.49E-6	Height	
THCA	cis	1	rs68141011	chr6:28217797	ZKSCAN3	chr6:28317691-28334523:+	-0.24	-4.56	6.37E-6	Depression	
THCA	cis	1	rs68141011	chr6:28217797	ZNF187	chr6:28234788-28245978:+	-0.36	-7.18	2.67E-12	Depression	
THCA	cis	1	rs68141011	chr6:28217797	ZNF193	chr6:28193067-28201260:+	0.21	3.83	0.000145	Depression	
THCA	cis	1	rs68141011	chr6:28217797	ZNF323	chr6:28292517-28324048:-	0.42	5.57	4.3E-8	Depression	
THCA	cis	1	rs68141011	chr6:28217797	ZNF389	chr6:28129551-28137375:+	-0.49	-6.83	2.67E-11	Depression	
THCA	cis	1	rs68141011	chr6:28217797	ZSCAN23	chr6:28393287-28411279:-	0.24	5	8.2E-7	Depression	
THCA	cis	1	rs68144677	chr6:163149024	PACRG	chr6:163148164-163736523:+	0.55	7.6	1.62E-13	Body mass index	
THCA	cis	1	rs6814995	chr4:122664963	EXOSC9	chr4:122722472-122738175:+	-0.14	-3.76	0.000193	Type 2 diabetes	
THCA	cis	1	rs6815464	chr4:1309901	KIAA1530	chr4:1341104-1381836:+	-0.23	-3.57	0.000394	Type 2 diabetes	
THCA	cis	1	rs68157165	chr14:51169220	SAV1	chr14:51100360-51135023:-	0.31	6.48	2.27E-10	Cognitive performance	
THCA	cis	1	rs6816071	chr4:122665185	EXOSC9	chr4:122722472-122738175:+	0.15	3.97	8.17E-5	Type 2 diabetes	
THCA	cis	1	rs6816352	chr4:48367968	OCIAD1	chr4:48833015-48863831:+	0.14	4.12	4.5E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs68168863	chr6:33758238	IP6K3	chr6:33689443-33714762:-	0.41	6.71	5.55E-11	Obesity (extreme)	
THCA	cis	1	rs68171315	chr6:86707400	SNHG5	chr6:86386726-86388451:-	-0.49	-10.83	1.35E-24	Response to antipsychotic treatment	
THCA	cis	1	rs68180496	chr3:119278915	ADPRH	chr3:119298523-119308791:+	-0.22	-3.6	0.000347	Vitiligo	
THCA	cis	1	rs68181489	chr6:70487027	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.4	0.000729	Sleep duration	
THCA	cis	1	rs6818319	chr4:90642868	MMRN1	chr4:90816003-90875778:+	0.32	4.04	6.27E-5	Parkinson's disease	
THCA	cis	1	rs68187092	chr15:56380718	MNS1	chr15:56720929-56757335:-	-0.26	-3.82	0.000151	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs68187092	chr15:56380718	TEX9	chr15:56657644-56738071:+	-0.36	-6.26	8.64E-10	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs68189316	chr7:65409169	CCT6P1	chr7:65216092-65228661:+	0.39	6.18	1.36E-9	Diabetic kidney disease	
THCA	cis	1	rs68189316	chr7:65409169	CRCP	chr7:65579805-65619551:+	-0.26	-3.99	7.58E-5	Diabetic kidney disease	
THCA	cis	1	rs68189316	chr7:65409169	RABGEF1	chr7:66093890-66276446:+	0.54	6.71	5.64E-11	Diabetic kidney disease	
THCA	cis	1	rs6819660	chr4:56374577	TMEM165	chr4:56262090-56292342:+	-0.16	-4.1	4.79E-5	Personality dimensions	
THCA	cis	1	rs6821119	chr4:103555233	NFKB1	chr4:103422486-103538458:+	0.15	4.31	2.03E-5	Primary biliary cirrhosis	
THCA	cis	1	rs6821168	chr4:18005019	DCAF16	chr4:17802280-17812381:-	-0.2	-4.49	8.81E-6	Height	
THCA	cis	1	rs6821283	chr4:165901645	C4orf39	chr4:165878100-165880273:+	0.2	5.53	5.14E-8	Ovarian cancer in BRCA1 mutation carriers	
THCA	cis	1	rs6823347	chr4:106962725	TBCK	chr4:106967233-107237861:-	0.33	6.81	2.9E-11	Airflow obstruction	
THCA	cis	1	rs6823488	chr4:122664819	EXOSC9	chr4:122722472-122738175:+	0.15	3.84	0.000137	Type 2 diabetes	
THCA	cis	1	rs6824057	chr4:56367278	TMEM165	chr4:56262090-56292342:+	-0.14	-3.55	0.000426	Personality dimensions	
THCA	cis	1	rs6824748	chr4:17997066	DCAF16	chr4:17802280-17812381:-	-0.2	-4.49	8.95E-6	Height	
THCA	cis	1	rs6825911	chr4:111381638	ENPEP	chr4:111397229-111484491:+	0.17	4.21	3.11E-5	Blood pressure	
THCA	cis	1	rs6827269	chr4:54320617	SCFD2	chr4:53739152-54232242:-	0.2	3.92	0.000101	DNA methylation (variation)	
THCA	cis	1	rs6827617	chr4:76916146	NAAA	chr4:76831809-76862166:-	-0.33	-6.64	8.71E-11	Longevity	
THCA	cis	1	rs6828122	chr4:18006052	DCAF16	chr4:17802280-17812381:-	-0.2	-4.49	8.81E-6	Height	
THCA	cis	1	rs6829234	chr4:39116206	KLHL5	chr4:39046659-39123828:+	-0.21	-5.73	1.77E-8	Uric acid levels	
THCA	cis	1	rs6829450	chr4:39116341	KLHL5	chr4:39046659-39123828:+	-0.19	-5.41	1.01E-7	Uric acid levels	
THCA	cis	1	rs6830062	chr4:18017730	DCAF16	chr4:17802280-17812381:-	-0.19	-4.2	3.2E-5	Height	
THCA	cis	1	rs6831102	chr4:18018236	DCAF16	chr4:17802280-17812381:-	-0.2	-4.52	7.89E-6	Height	
THCA	cis	1	rs6831256	chr4:3473139	LRPAP1	chr4:3514290-3534224:-	0.19	4.77	2.43E-6	Triglycerides;Cholesterol, total;LDL cholesterol	
THCA	cis	1	rs683125	chr11:83276245	CCDC90B	chr11:82972506-82997414:-	0.17	3.97	8.36E-5	Subcortical brain region volumes	
THCA	cis	1	rs6832503	chr4:48028442	CNGA1	chr4:47937996-48018610:-	-0.53	-9.47	1.27E-19	Renal underexcretion gout;Gout	
THCA	cis	1	rs6832503	chr4:48028442	FRYL	chr4:48499380-48782316:-	-0.12	-3.66	0.000277	Renal underexcretion gout;Gout	
THCA	cis	1	rs6832503	chr4:48028442	NIPAL1	chr4:48018791-48039078:+	-0.29	-9.76	1.21E-20	Renal underexcretion gout;Gout	
THCA	cis	1	rs683250	chr11:83276168	CCDC90B	chr11:82972506-82997414:-	0.16	3.86	0.00013	Subcortical brain region volumes	
THCA	cis	1	rs6832769	chr4:56298194	TMEM165	chr4:56262090-56292342:+	-0.15	-3.86	0.00013	Personality dimensions	
THCA	cis	1	rs6833988	chr4:10295586	SLC2A9	chr4:9827850-10041872:-	0.19	3.37	0.000803	Schizophrenia (age at onset)	
THCA	cis	1	rs6834676	chr4:56298414	TMEM165	chr4:56262090-56292342:+	-0.14	-3.61	0.000335	Personality dimensions	
THCA	cis	1	rs6834806	chr4:75715826	BTC	chr4:75671448-75719882:-	0.2	3.95	8.9E-5	Electroencephalogram traits	
THCA	cis	1	rs6834934	chr4:54242085	SCFD2	chr4:53739152-54232242:-	0.2	3.76	0.000189	DNA methylation (variation)	
THCA	cis	1	rs6835186	chr4:17984316	DCAF16	chr4:17802280-17812381:-	-0.2	-4.39	1.41E-5	Height	
THCA	cis	1	rs6837335	chr4:48363983	OCIAD1	chr4:48833015-48863831:+	0.14	4.18	3.45E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs6837429	chr4:8502374	C4orf23	chr4:8440604-8495258:+	-0.35	-7.42	5.46E-13	Response to antineoplastic agents	
THCA	cis	1	rs6837710	chr4:56374455	TMEM165	chr4:56262090-56292342:+	-0.14	-3.55	0.000426	Personality dimensions	
THCA	cis	1	rs6839064	chr4:103555676	CISD2	chr4:103790135-103809913:+	-0.16	-3.62	0.000321	Primary biliary cirrhosis	
THCA	cis	1	rs6839064	chr4:103555676	NFKB1	chr4:103422486-103538458:+	0.15	4.2	3.16E-5	Primary biliary cirrhosis	
THCA	cis	1	rs683978	chr11:68192421	LOC645332	chr11:67559240-67572807:-	0.16	3.5	0.000514	Bone mineral density (spine)	
THCA	cis	1	rs6839954	chr4:17984129	DCAF16	chr4:17802280-17812381:-	-0.19	-4.34	1.73E-5	Height	
THCA	cis	1	rs6840334	chr4:17984277	DCAF16	chr4:17802280-17812381:-	-0.2	-4.39	1.41E-5	Height	
THCA	cis	1	rs6840868	chr4:17939331	DCAF16	chr4:17802280-17812381:-	-0.2	-4.48	9.3E-6	Height	
THCA	cis	1	rs6841793	chr4:17933810	DCAF16	chr4:17802280-17812381:-	-0.22	-4.83	1.86E-6	Height	
THCA	cis	1	rs6841898	chr4:24578097	LGI2	chr4:25000471-25032414:-	0.3	3.34	0.000893	Myopia (pathological)	
THCA	cis	1	rs6842114	chr4:18008199	DCAF16	chr4:17802280-17812381:-	-0.2	-4.57	6.12E-6	Height	
THCA	cis	1	rs6843330	chr4:17952056	DCAF16	chr4:17802280-17812381:-	-0.2	-4.36	1.59E-5	Height	
THCA	cis	1	rs6845078	chr4:17952208	DCAF16	chr4:17802280-17812381:-	-0.18	-4.19	3.27E-5	Height	
THCA	cis	1	rs6846232	chr4:122664805	EXOSC9	chr4:122722472-122738175:+	0.15	3.96	8.71E-5	Type 2 diabetes	
THCA	cis	1	rs6846238	chr4:17629939	MED28	chr4:17616273-17629791:+	0.2	4.4	1.33E-5	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs6846579	chr4:107011756	TBCK	chr4:106967233-107237861:-	0.36	7.41	5.71E-13	Airflow obstruction	
THCA	cis	1	rs6847968	chr4:75715519	BTC	chr4:75671448-75719882:-	0.2	3.95	8.9E-5	Electroencephalogram traits	
THCA	cis	1	rs6848360	chr4:17634442	MED28	chr4:17616273-17629791:+	0.18	3.94	9.3E-5	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs6848395	chr4:48394593	OCIAD1	chr4:48833015-48863831:+	0.13	4.02	6.83E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs6848411	chr4:75715789	BTC	chr4:75671448-75719882:-	0.2	3.95	8.9E-5	Electroencephalogram traits	
THCA	cis	1	rs685001	chr1:48025063	FOXD2	chr1:47901689-47906362:+	0.25	4.35	1.67E-5	Obesity-related traits	
THCA	cis	1	rs685001	chr1:48025063	MGC12982	chr1:47897808-47900313:-	0.2	4.22	2.89E-5	Obesity-related traits	
THCA	cis	1	rs6850259	chr4:17949607	DCAF16	chr4:17802280-17812381:-	-0.2	-4.36	1.59E-5	Height	
THCA	cis	1	rs6850306	chr4:18006089	DCAF16	chr4:17802280-17812381:-	-0.22	-4.37	1.54E-5	Height	
THCA	cis	1	rs6850893	chr4:103254421	BANK1	chr4:102341118-102995967:+	-0.24	-3.4	0.000742	Erythrocyte cadmium concentration in never smokers	
THCA	cis	1	rs6851838	chr4:56420747	TMEM165	chr4:56262090-56292342:+	0.16	3.98	8.05E-5	Personality dimensions	
THCA	cis	1	rs6853192	chr4:56409254	TMEM165	chr4:56262090-56292342:+	0.16	3.89	0.000114	Personality dimensions	
THCA	cis	1	rs6853216	chr4:17970655	DCAF16	chr4:17802280-17812381:-	-0.2	-4.45	1.06E-5	Height	
THCA	cis	1	rs6853522	chr4:154706220	RNF175	chr4:154631313-154681387:-	0.2	4.21	3.0E-5	Electrocardiographic conduction measures	
THCA	cis	1	rs6854381	chr4:139130390	SLC7A11	chr4:139085248-139163503:-	0.22	4.49	9.06E-6	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	
THCA	cis	1	rs6855591	chr4:165906723	C4orf39	chr4:165878100-165880273:+	0.18	5.04	6.62E-7	Ovarian cancer in BRCA1 mutation carriers	
THCA	cis	1	rs6857024	chr4:54242283	SCFD2	chr4:53739152-54232242:-	0.2	3.76	0.000189	DNA methylation (variation)	
THCA	cis	1	rs6859811	chr5:101663195	SLCO4C1	chr5:101569694-101632253:-	0.25	5.65	2.77E-8	Schizophrenia	
THCA	cis	1	rs6860381	chr5:101663536	SLCO4C1	chr5:101569694-101632253:-	0.25	5.65	2.77E-8	Schizophrenia	
THCA	cis	1	rs6860540	chr5:156938327	NIPAL4	chr5:156887027-156901729:+	-0.33	-6.82	2.75E-11	Inflammatory skin disease	
THCA	cis	1	rs6861497	chr5:101403586	SLCO4C1	chr5:101569694-101632253:-	-0.18	-4	7.25E-5	QRS duration	
THCA	cis	1	rs6862270	chr5:101701227	SLCO4C1	chr5:101569694-101632253:-	0.25	5.67	2.5E-8	Schizophrenia	
THCA	cis	1	rs6862814	chr5:150245259	LOC134466	chr5:150310000-150326146:-	0.38	5.36	1.31E-7	Crohn's disease	
THCA	cis	1	rs6863068	chr5:101769728	SLCO4C1	chr5:101569694-101632253:-	0.24	5.49	6.41E-8	Schizophrenia	
THCA	cis	1	rs686441	chr10:105950233	C10orf79	chr10:105889647-105992120:-	0.24	7.65	1.15E-13	Attention deficit hyperactivity disorder	
THCA	cis	1	rs6867264	chr5:101693046	SLCO4C1	chr5:101569694-101632253:-	0.25	5.62	3.21E-8	Schizophrenia	
THCA	cis	1	rs6867496	chr5:101770045	SLCO4C1	chr5:101569694-101632253:-	0.24	5.54	5.1E-8	Schizophrenia	
THCA	cis	1	rs6869502	chr5:110166083	TMEM232	chr5:109624934-110062381:-	0.21	4.23	2.85E-5	Asthma and hay fever	
THCA	cis	1	rs6869774	chr5:110467086	TSLP	chr5:110405778-110413722:+	-0.33	-4.72	3.08E-6	Eosinophil counts	
THCA	cis	1	rs6869774	chr5:110467086	WDR36	chr5:110427870-110466201:+	0.19	3.75	0.000198	Eosinophil counts	
THCA	cis	1	rs6870097	chr5:151734471	NMUR2	chr5:151771102-151784840:-	-0.51	-9.43	1.73E-19	Optic nerve measurement (cup area)	
THCA	cis	1	rs6870356	chr5:110467237	TSLP	chr5:110405778-110413722:+	-0.37	-5.32	1.56E-7	Eosinophil counts	
THCA	cis	1	rs6870816	chr5:151734701	NMUR2	chr5:151771102-151784840:-	-0.51	-9.43	1.73E-19	Optic nerve measurement (cup area)	
THCA	cis	1	rs6872341	chr5:101776535	SLCO4C1	chr5:101569694-101632253:-	0.25	5.62	3.21E-8	Schizophrenia	
THCA	cis	1	rs6873305	chr5:101724307	SLCO4C1	chr5:101569694-101632253:-	0.26	5.86	8.84E-9	Schizophrenia	
THCA	cis	1	rs6874560	chr5:150182713	LOC134466	chr5:150310000-150326146:-	0.44	5.7	2.13E-8	Crohn's disease	
THCA	cis	1	rs6874560	chr5:150182713	ZNF300	chr5:150273964-150284391:-	0.18	3.72	0.000222	Crohn's disease	
THCA	cis	1	rs6874653	chr5:179730843	MAPK9	chr5:179660597-179719071:-	0.15	3.88	0.000119	Height	
THCA	cis	1	rs6875011	chr5:150182710	LOC134466	chr5:150310000-150326146:-	0.44	5.78	1.35E-8	Crohn's disease	
THCA	cis	1	rs6875011	chr5:150182710	ZNF300	chr5:150273964-150284391:-	0.19	3.87	0.000123	Crohn's disease	
THCA	cis	1	rs687557	chr10:105989509	C10orf79	chr10:105889647-105992120:-	0.24	7.79	4.15E-14	Attention deficit hyperactivity disorder	
THCA	cis	1	rs6875748	chr5:37041593	C5orf42	chr5:37106330-37249530:-	0.09	3.53	0.000452	Height	
THCA	cis	1	rs687672	chr11:65649984	CTSW	chr11:65647284-65651212:+	0.6	16.12	5.46E-47	Crohn's disease	
THCA	cis	1	rs687672	chr11:65649984	SNX32	chr11:65601410-65621170:+	-0.62	-9.33	3.97E-19	Crohn's disease	
THCA	cis	1	rs6876972	chr5:115642519	COMMD10	chr5:115420727-115628978:+	0.4	4.86	1.58E-6	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs6877722	chr5:101709936	SLCO4C1	chr5:101569694-101632253:-	0.25	5.81	1.13E-8	Schizophrenia	
THCA	cis	1	rs6878284	chr5:101769726	SLCO4C1	chr5:101569694-101632253:-	0.24	5.45	8.22E-8	Schizophrenia	
THCA	cis	1	rs6878326	chr5:101757265	SLCO4C1	chr5:101569694-101632253:-	0.24	5.52	5.5E-8	Schizophrenia	
THCA	cis	1	rs6879260	chr5:179731014	MAPK9	chr5:179660597-179719071:-	0.16	4.02	6.68E-5	Height	
THCA	cis	1	rs6880213	chr5:115447414	COMMD10	chr5:115420727-115628978:+	0.5	6.16	1.54E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs6880889	chr5:115167896	ATG12	chr5:115165818-115177520:-	-0.27	-5.77	1.41E-8	IgG glycosylation	
THCA	cis	1	rs6880889	chr5:115167896	CCDC112	chr5:114602885-114632458:-	-0.17	-3.54	0.000445	IgG glycosylation	
THCA	cis	1	rs6880889	chr5:115167896	CDO1	chr5:115140432-115152405:-	-0.37	-7.27	1.52E-12	IgG glycosylation	
THCA	cis	1	rs6885541	chr5:56110857	C5orf35	chr5:56205103-56213010:+	1	22.45	9.16E-77	Type 2 diabetes	
THCA	cis	1	rs6885792	chr5:110165413	TMEM232	chr5:109624934-110062381:-	0.21	4.17	3.66E-5	Asthma and hay fever	
THCA	cis	1	rs6886255	chr5:176718361	MXD3	chr5:176732501-176739292:-	-0.16	-4.99	8.64E-7	Migraine without aura	
THCA	cis	1	rs6886744	chr5:101693031	SLCO4C1	chr5:101569694-101632253:-	0.25	5.62	3.21E-8	Schizophrenia	
THCA	cis	1	rs6887276	chr5:127378294	SLC12A2	chr5:127419483-127525379:+	0.12	3.42	0.000669	Height	
THCA	cis	1	rs688967	chr15:45936127	SPATA5L1	chr15:45694519-45713614:+	0.3	4.94	1.08E-6	Obesity-related traits	
THCA	cis	1	rs6890099	chr5:151151962	SPARC	chr5:151041019-151066517:-	0.13	3.42	0.000692	Preschool internalizing problems	
THCA	cis	1	rs6890695	chr5:130888424	P4HA2	chr5:131528306-131563556:-	0.22	4.2	3.25E-5	Alzheimer's disease in APOE e4- carriers	
THCA	cis	1	rs6892350	chr5:101777664	SLCO4C1	chr5:101569694-101632253:-	0.24	5.54	5.1E-8	Schizophrenia	
THCA	cis	1	rs6895795	chr5:101780797	SLCO4C1	chr5:101569694-101632253:-	0.24	5.54	5.1E-8	Schizophrenia	
THCA	cis	1	rs6896780	chr5:151735124	NMUR2	chr5:151771102-151784840:-	-0.51	-9.43	1.73E-19	Optic nerve measurement (cup area)	
THCA	cis	1	rs690037	chr3:16395668	OXNAD1	chr3:16306714-16378866:+	0.21	4.29	2.13E-5	Optic nerve measurement (cup-to-disc ratio);Optic nerve measurement (cup area)	
THCA	cis	1	rs6900530	chr6:35280971	C6orf106	chr6:34555066-34664625:-	-0.35	-3.44	0.000623	Cataracts in type 2 diabetes	
THCA	cis	1	rs6900902	chr6:105235757	HACE1	chr6:105175968-105307794:-	-0.16	-4.02	6.67E-5	Thyroid stimulating hormone	
THCA	cis	1	rs6901178	chr6:46631886	CYP39A1	chr6:46517445-46620523:-	0.32	4.95	1.05E-6	Lipoprotein-associated phospholipase A2 activity and mass	
THCA	cis	1	rs690140	chr9:93333075	DIRAS2	chr9:93372114-93405108:-	-0.19	-4.58	5.88E-6	Age-related hearing impairment (interaction)	
THCA	cis	1	rs6901575	chr6:28250984	ZKSCAN3	chr6:28317691-28334523:+	-0.27	-5.25	2.35E-7	Depression	
THCA	cis	1	rs6901575	chr6:28250984	ZNF187	chr6:28234788-28245978:+	-0.34	-6.81	3.0E-11	Depression	
THCA	cis	1	rs6901575	chr6:28250984	ZNF193	chr6:28193067-28201260:+	0.2	3.76	0.000193	Depression	
THCA	cis	1	rs6901575	chr6:28250984	ZNF323	chr6:28292517-28324048:-	0.45	6.09	2.31E-9	Depression	
THCA	cis	1	rs6901575	chr6:28250984	ZNF389	chr6:28129551-28137375:+	-0.48	-6.8	3.1E-11	Depression	
THCA	cis	1	rs6901575	chr6:28250984	ZSCAN23	chr6:28393287-28411279:-	0.23	5.04	6.61E-7	Depression	
THCA	cis	1	rs6901703	chr6:24475300	GMNN	chr6:24775159-24786276:+	0.29	3.94	9.37E-5	Hematological and biochemical traits	
THCA	cis	1	rs6901703	chr6:24475300	GPLD1	chr6:24428405-24489850:-	-0.22	-4.2	3.2E-5	Hematological and biochemical traits	
THCA	cis	1	rs6901703	chr6:24475300	MRS2	chr6:24403153-24425809:+	-0.24	-5.36	1.27E-7	Hematological and biochemical traits	
THCA	cis	1	rs6902429	chr6:49393500	CENPQ	chr6:49431096-49460820:+	-0.32	-6.83	2.6E-11	Homocysteine levels	
THCA	cis	1	rs6903665	chr6:101148234	GRIK2	chr6:101846905-102517957:+	0.15	3.62	0.00032	Menarche (age at onset)	
THCA	cis	1	rs6903973	chr6:26499942	BTN2A3	chr6:26422317-26431927:+	0.19	4.54	7.18E-6	Educational attainment	
THCA	cis	1	rs6903973	chr6:26499942	HCG11	chr6:26521934-26527610:+	-0.23	-4.54	7.04E-6	Educational attainment	
THCA	cis	1	rs6903973	chr6:26499942	HMGN4	chr6:26538572-26547162:+	-0.16	-4	7.43E-5	Educational attainment	
THCA	cis	1	rs6903973	chr6:26499942	ZNF322A	chr6:26634612-26659963:-	-0.14	-3.79	0.000169	Educational attainment	
THCA	cis	1	rs6904133	chr6:151881805	C6orf97	chr6:151815175-151942327:+	0.36	5	8.02E-7	Bone mineral density (spine)	
THCA	cis	1	rs6904343	chr6:24317666	MRS2	chr6:24403153-24425809:+	0.15	3.43	0.000645	Uric acid levels	
THCA	cis	1	rs6904373	chr6:46628067	CYP39A1	chr6:46517445-46620523:-	-0.32	-4.93	1.14E-6	Lipoprotein-associated phospholipase A2 activity and mass	
THCA	cis	1	rs6904601	chr6:170131905	C6orf70	chr6:170151721-170181617:+	0.25	5.11	4.56E-7	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs6904601	chr6:170131905	WDR27	chr6:169857307-170102159:-	-0.18	-5.54	5.0E-8	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs6904680	chr6:70453849	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.38	0.000787	Sleep duration	
THCA	cis	1	rs6904991	chr6:33732262	LEMD2	chr6:33738991-33756906:-	-0.3	-6.8	3.22E-11	Crohn's disease	
THCA	cis	1	rs6905391	chr6:28262686	ZKSCAN3	chr6:28317691-28334523:+	-0.26	-5.15	3.75E-7	Depression	
THCA	cis	1	rs6905391	chr6:28262686	ZNF187	chr6:28234788-28245978:+	-0.3	-6.08	2.53E-9	Depression	
THCA	cis	1	rs6905391	chr6:28262686	ZNF193	chr6:28193067-28201260:+	0.19	3.52	0.000475	Depression	
THCA	cis	1	rs6905391	chr6:28262686	ZNF323	chr6:28292517-28324048:-	0.44	6.21	1.15E-9	Depression	
THCA	cis	1	rs6905391	chr6:28262686	ZNF389	chr6:28129551-28137375:+	-0.44	-6.37	4.46E-10	Depression	
THCA	cis	1	rs6905391	chr6:28262686	ZSCAN23	chr6:28393287-28411279:-	0.22	4.83	1.88E-6	Depression	
THCA	cis	1	rs6908390	chr6:25609756	SCGN	chr6:25652429-25702006:+	0.3	5.92	6.13E-9	Uric acid levels	
THCA	cis	1	rs6909229	chr6:158572379	SERAC1	chr6:158530536-158589312:-	0.25	5.1	4.98E-7	Lipoprotein (a) levels	
THCA	cis	1	rs6910233	chr6:33534726	HLA-DPB2	chr6:33080293-33096890:+	0.12	3.41	0.0007	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs6910233	chr6:33534726	ZBTB9	chr6:33422356-33425318:+	-0.16	-3.47	0.000577	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs6910460	chr6:24471712	GMNN	chr6:24775159-24786276:+	-0.28	-3.81	0.000159	Hematological and biochemical traits	
THCA	cis	1	rs6910460	chr6:24471712	GPLD1	chr6:24428405-24489850:-	0.25	4.7	3.49E-6	Hematological and biochemical traits	
THCA	cis	1	rs6910460	chr6:24471712	MRS2	chr6:24403153-24425809:+	0.24	5.47	7.34E-8	Hematological and biochemical traits	
THCA	cis	1	rs6910639	chr6:133120553	C6orf192	chr6:133090507-133119747:-	-0.25	-4.1	4.87E-5	Type 2 diabetes nephropathy	
THCA	cis	1	rs6910899	chr6:26524339	BTN2A3	chr6:26422317-26431927:+	0.19	4.52	7.82E-6	Educational attainment	
THCA	cis	1	rs6910899	chr6:26524339	HCG11	chr6:26521934-26527610:+	-0.23	-4.43	1.19E-5	Educational attainment	
THCA	cis	1	rs6910899	chr6:26524339	HMGN4	chr6:26538572-26547162:+	-0.16	-4.05	5.86E-5	Educational attainment	
THCA	cis	1	rs6910899	chr6:26524339	ZNF322A	chr6:26634612-26659963:-	-0.14	-3.77	0.00018	Educational attainment	
THCA	cis	1	rs6911965	chr6:24480295	MRS2	chr6:24403153-24425809:+	-0.27	-5.92	6.21E-9	Hematological and biochemical traits	
THCA	cis	1	rs6912959	chr6:170126224	C6orf70	chr6:170151721-170181617:+	0.25	5.08	5.39E-7	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs6912959	chr6:170126224	WDR27	chr6:169857307-170102159:-	-0.18	-5.53	5.37E-8	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs6914463	chr6:86653415	SNHG5	chr6:86386726-86388451:-	-0.53	-12.62	1.01E-31	Response to antipsychotic treatment	
THCA	cis	1	rs6915187	chr6:49423547	CENPQ	chr6:49431096-49460820:+	-0.33	-6.99	9.56E-12	Homocysteine levels	
THCA	cis	1	rs6916802	chr6:24465722	GMNN	chr6:24775159-24786276:+	-0.27	-3.61	0.000342	Hematological and biochemical traits	
THCA	cis	1	rs6916802	chr6:24465722	GPLD1	chr6:24428405-24489850:-	0.25	4.63	4.73E-6	Hematological and biochemical traits	
THCA	cis	1	rs6916802	chr6:24465722	MRS2	chr6:24403153-24425809:+	0.24	5.43	8.87E-8	Hematological and biochemical traits	
THCA	cis	1	rs6916888	chr6:49383804	CENPQ	chr6:49431096-49460820:+	-0.32	-6.83	2.6E-11	Homocysteine levels	
THCA	cis	1	rs6918347	chr6:49406348	CENPQ	chr6:49431096-49460820:+	-0.32	-6.85	2.3E-11	Homocysteine levels	
THCA	cis	1	rs6918586	chr6:26097384	BTN3A2	chr6:26365398-26378546:+	-0.2	-5.32	1.6E-7	Schizophrenia	
THCA	cis	1	rs6918838	chr6:3286134	PSMG4	chr6:3259162-3268300:+	0.3	6.62	9.66E-11	Obesity-related traits	
THCA	cis	1	rs6919210	chr6:70589630	COL19A1	chr6:70576448-70922157:+	-0.27	-4.1	4.9E-5	Subjective well-being	
THCA	cis	1	rs6920075	chr6:33731797	LEMD2	chr6:33738991-33756906:-	-0.3	-6.87	1.95E-11	Crohn's disease	
THCA	cis	1	rs6920280	chr6:70489142	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.37	0.000826	Sleep duration	
THCA	cis	1	rs6921487	chr6:33749293	LEMD2	chr6:33738991-33756906:-	0.24	5.15	3.74E-7	Body mass index	
THCA	cis	1	rs6922313	chr6:24438719	MRS2	chr6:24403153-24425809:+	-0.16	-4.53	7.31E-6	Liver enzyme levels	
THCA	cis	1	rs6922631	chr6:24438734	MRS2	chr6:24403153-24425809:+	-0.17	-4.65	4.39E-6	Liver enzyme levels	
THCA	cis	1	rs6922824	chr6:26553815	BTN2A3	chr6:26422317-26431927:+	-0.18	-4.36	1.6E-5	Educational attainment	
THCA	cis	1	rs6922824	chr6:26553815	BTN3A3	chr6:26440763-26453642:+	-0.12	-3.35	0.000885	Educational attainment	
THCA	cis	1	rs6922824	chr6:26553815	HCG11	chr6:26521934-26527610:+	0.22	4.42	1.22E-5	Educational attainment	
THCA	cis	1	rs6922824	chr6:26553815	HMGN4	chr6:26538572-26547162:+	0.15	3.88	0.000119	Educational attainment	
THCA	cis	1	rs6922824	chr6:26553815	LOC100270746	chr6:26987146-26988085:-	0.16	3.76	0.000191	Educational attainment	
THCA	cis	1	rs6922824	chr6:26553815	ZNF322A	chr6:26634612-26659963:-	0.16	4.53	7.58E-6	Educational attainment	
THCA	cis	1	rs6923124	chr6:49419864	CENPQ	chr6:49431096-49460820:+	-0.27	-5.64	2.89E-8	Folate pathway vitamin levels	
THCA	cis	1	rs6923124	chr6:49419864	MUT	chr6:49398994-49431031:-	0.28	9.64	3.23E-20	Folate pathway vitamin levels	
THCA	cis	1	rs6923148	chr6:86767786	SNHG5	chr6:86386726-86388451:-	0.55	12.77	2.43E-32	Response to antipsychotic treatment	
THCA	cis	1	rs6923339	chr6:170128033	C6orf70	chr6:170151721-170181617:+	0.25	5.11	4.56E-7	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs6923339	chr6:170128033	WDR27	chr6:169857307-170102159:-	-0.18	-5.54	5.0E-8	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs6924373	chr6:87804222	C6orf164	chr6:88032306-88109459:+	0.23	4.6	5.4E-6	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	
THCA	cis	1	rs6924838	chr6:26571756	BTN2A3	chr6:26422317-26431927:+	0.18	4.22	2.98E-5	Educational attainment	
THCA	cis	1	rs6924838	chr6:26571756	HCG11	chr6:26521934-26527610:+	-0.21	-4.11	4.7E-5	Educational attainment	
THCA	cis	1	rs6924838	chr6:26571756	HMGN4	chr6:26538572-26547162:+	-0.16	-4.16	3.71E-5	Educational attainment	
THCA	cis	1	rs6924838	chr6:26571756	LOC100270746	chr6:26987146-26988085:-	-0.14	-3.36	0.000857	Educational attainment	
THCA	cis	1	rs6924838	chr6:26571756	ZNF322A	chr6:26634612-26659963:-	-0.16	-4.59	5.75E-6	Educational attainment	
THCA	cis	1	rs6925273	chr6:33732448	LEMD2	chr6:33738991-33756906:-	-0.3	-6.72	5.1E-11	Crohn's disease	
THCA	cis	1	rs6925703	chr6:26521589	BTN2A3	chr6:26422317-26431927:+	0.19	4.52	7.82E-6	Educational attainment	
THCA	cis	1	rs6925703	chr6:26521589	HCG11	chr6:26521934-26527610:+	-0.23	-4.43	1.19E-5	Educational attainment	
THCA	cis	1	rs6925703	chr6:26521589	HMGN4	chr6:26538572-26547162:+	-0.16	-4.05	5.86E-5	Educational attainment	
THCA	cis	1	rs6925703	chr6:26521589	ZNF322A	chr6:26634612-26659963:-	-0.14	-3.77	0.00018	Educational attainment	
THCA	cis	1	rs6925895	chr6:26572165	BTN2A3	chr6:26422317-26431927:+	0.18	4.22	2.98E-5	Educational attainment	
THCA	cis	1	rs6925895	chr6:26572165	HCG11	chr6:26521934-26527610:+	-0.21	-4.11	4.7E-5	Educational attainment	
THCA	cis	1	rs6925895	chr6:26572165	HMGN4	chr6:26538572-26547162:+	-0.16	-4.16	3.71E-5	Educational attainment	
THCA	cis	1	rs6925895	chr6:26572165	LOC100270746	chr6:26987146-26988085:-	-0.14	-3.36	0.000857	Educational attainment	
THCA	cis	1	rs6925895	chr6:26572165	ZNF322A	chr6:26634612-26659963:-	-0.16	-4.59	5.75E-6	Educational attainment	
THCA	cis	1	rs6926629	chr6:26499903	BTN2A3	chr6:26422317-26431927:+	0.19	4.54	7.18E-6	Educational attainment	
THCA	cis	1	rs6926629	chr6:26499903	HCG11	chr6:26521934-26527610:+	-0.23	-4.54	7.04E-6	Educational attainment	
THCA	cis	1	rs6926629	chr6:26499903	HMGN4	chr6:26538572-26547162:+	-0.16	-4	7.43E-5	Educational attainment	
THCA	cis	1	rs6926629	chr6:26499903	ZNF322A	chr6:26634612-26659963:-	-0.14	-3.79	0.000169	Educational attainment	
THCA	cis	1	rs6927188	chr6:42912589	GNMT	chr6:42928500-42931617:+	0.41	8.65	7.93E-17	Diabetic kidney disease	
THCA	cis	1	rs6927188	chr6:42912589	PEX6	chr6:42931613-42946981:-	-0.51	-10.39	6.42E-23	Diabetic kidney disease	
THCA	cis	1	rs6928435	chr6:24467366	GMNN	chr6:24775159-24786276:+	-0.28	-3.8	0.000163	Hematological and biochemical traits	
THCA	cis	1	rs6928435	chr6:24467366	GPLD1	chr6:24428405-24489850:-	0.25	4.74	2.85E-6	Hematological and biochemical traits	
THCA	cis	1	rs6928435	chr6:24467366	MRS2	chr6:24403153-24425809:+	0.24	5.48	6.98E-8	Hematological and biochemical traits	
THCA	cis	1	rs6928546	chr6:46632006	CYP39A1	chr6:46517445-46620523:-	-0.31	-4.83	1.81E-6	Lipoprotein-associated phospholipase A2 activity and mass	
THCA	cis	1	rs6930076	chr6:88088654	C6orf162	chr6:88032306-88052043:+	-0.18	-3.91	0.000105	Depressive episodes in bipolar disorder	
THCA	cis	1	rs6930076	chr6:88088654	C6orf164	chr6:88032306-88109459:+	-0.32	-5.91	6.54E-9	Depressive episodes in bipolar disorder	
THCA	cis	1	rs6930120	chr6:26555484	BTN2A3	chr6:26422317-26431927:+	0.18	4.3	2.03E-5	Educational attainment	
THCA	cis	1	rs6930120	chr6:26555484	HCG11	chr6:26521934-26527610:+	-0.21	-4.14	4.06E-5	Educational attainment	
THCA	cis	1	rs6930120	chr6:26555484	HMGN4	chr6:26538572-26547162:+	-0.16	-4.02	6.69E-5	Educational attainment	
THCA	cis	1	rs6930120	chr6:26555484	LOC100270746	chr6:26987146-26988085:-	-0.14	-3.44	0.000623	Educational attainment	
THCA	cis	1	rs6930120	chr6:26555484	ZNF322A	chr6:26634612-26659963:-	-0.16	-4.55	6.93E-6	Educational attainment	
THCA	cis	1	rs6930201	chr6:33738749	LEMD2	chr6:33738991-33756906:-	0.24	5.05	6.4E-7	Body mass index	
THCA	cis	1	rs6931884	chr6:100158873	USP45	chr6:99880184-99963312:-	0.21	3.42	0.000687	Menarche (age at onset)	
THCA	cis	1	rs6932156	chr6:26571506	BTN2A3	chr6:26422317-26431927:+	0.18	4.22	2.98E-5	Educational attainment	
THCA	cis	1	rs6932156	chr6:26571506	HCG11	chr6:26521934-26527610:+	-0.21	-4.11	4.7E-5	Educational attainment	
THCA	cis	1	rs6932156	chr6:26571506	HMGN4	chr6:26538572-26547162:+	-0.16	-4.16	3.71E-5	Educational attainment	
THCA	cis	1	rs6932156	chr6:26571506	LOC100270746	chr6:26987146-26988085:-	-0.14	-3.36	0.000857	Educational attainment	
THCA	cis	1	rs6932156	chr6:26571506	ZNF322A	chr6:26634612-26659963:-	-0.16	-4.59	5.75E-6	Educational attainment	
THCA	cis	1	rs6932590	chr6:27248931	BTN3A2	chr6:26365398-26378546:+	-0.27	-6.26	8.7E-10	Schizophrenia	
THCA	cis	1	rs6933094	chr6:150297603	RAET1K	chr6:150319157-150326280:-	0.68	6.06	2.81E-9	Radiation response	
THCA	cis	1	rs6933094	chr6:150297603	ULBP1	chr6:150285143-150294844:+	-0.49	-7.46	4.2E-13	Radiation response	
THCA	cis	1	rs6933094	chr6:150297603	ULBP2	chr6:150263136-150270366:+	0.64	6.91	1.57E-11	Radiation response	
THCA	cis	1	rs6933174	chr6:33751003	LEMD2	chr6:33738991-33756906:-	0.25	4.99	8.49E-7	Body mass index	
THCA	cis	1	rs6933176	chr6:26540178	BTN2A3	chr6:26422317-26431927:+	0.18	4.32	1.9E-5	Educational attainment	
THCA	cis	1	rs6933176	chr6:26540178	HCG11	chr6:26521934-26527610:+	-0.22	-4.34	1.75E-5	Educational attainment	
THCA	cis	1	rs6933176	chr6:26540178	HMGN4	chr6:26538572-26547162:+	-0.16	-4.03	6.38E-5	Educational attainment	
THCA	cis	1	rs6933176	chr6:26540178	ZNF322A	chr6:26634612-26659963:-	-0.14	-3.91	0.000106	Educational attainment	
THCA	cis	1	rs6933377	chr6:86705255	SNHG5	chr6:86386726-86388451:-	0.38	8.76	3.46E-17	Response to antipsychotic treatment	
THCA	cis	1	rs6933568	chr6:33751261	LEMD2	chr6:33738991-33756906:-	0.25	4.99	8.42E-7	Body mass index	
THCA	cis	1	rs6933607	chr6:33743997	LEMD2	chr6:33738991-33756906:-	0.25	5.01	7.83E-7	Body mass index	
THCA	cis	1	rs6934161	chr6:133124077	C6orf192	chr6:133090507-133119747:-	0.23	3.86	0.000128	Type 2 diabetes nephropathy	
THCA	cis	1	rs6935599	chr6:20717095	SOX4	chr6:21593972-21598847:+	-0.13	-3.95	8.86E-5	Type 2 diabetes	
THCA	cis	1	rs6935976	chr6:35498098	TULP1	chr6:35465653-35480647:-	-0.27	-3.76	0.000195	Hepatitis C induced liver fibrosis	
THCA	cis	1	rs6936048	chr6:86702608	SNHG5	chr6:86386726-86388451:-	-0.48	-10.68	5.19E-24	Response to antipsychotic treatment	
THCA	cis	1	rs6936177	chr6:34783717	C6orf106	chr6:34555066-34664625:-	0.2	3.38	0.000796	Pubertal anthropometrics	
THCA	cis	1	rs6936177	chr6:34783717	SNRPC	chr6:34725312-34741571:+	-0.14	-3.47	0.000558	Pubertal anthropometrics	
THCA	cis	1	rs6938239	chr6:34683635	C6orf106	chr6:34555066-34664625:-	-0.22	-3.57	0.000393	Pubertal anthropometrics	
THCA	cis	1	rs693824	chr11:65654783	CTSW	chr11:65647284-65651212:+	-0.6	-15.88	6.69E-46	Crohn's disease	
THCA	cis	1	rs693824	chr11:65654783	SNX32	chr11:65601410-65621170:+	0.63	9.47	1.33E-19	Crohn's disease	
THCA	cis	1	rs6938385	chr6:158371962	SNX9	chr6:158244294-158366109:+	-0.29	-4.41	1.27E-5	Lipoprotein (a) - cholesterol levels	
THCA	cis	1	rs6938986	chr6:111436452	KIAA1919	chr6:111580482-111590259:+	-0.23	-5.06	6.08E-7	Blood metabolite levels;Amino acid levels	
THCA	cis	1	rs6940053	chr6:26562122	BTN2A3	chr6:26422317-26431927:+	0.18	4.29	2.18E-5	Educational attainment	
THCA	cis	1	rs6940053	chr6:26562122	HCG11	chr6:26521934-26527610:+	-0.22	-4.3	2.03E-5	Educational attainment	
THCA	cis	1	rs6940053	chr6:26562122	HMGN4	chr6:26538572-26547162:+	-0.16	-4.19	3.33E-5	Educational attainment	
THCA	cis	1	rs6940053	chr6:26562122	LOC100270746	chr6:26987146-26988085:-	-0.14	-3.47	0.000578	Educational attainment	
THCA	cis	1	rs6940053	chr6:26562122	ZNF322A	chr6:26634612-26659963:-	-0.16	-4.64	4.57E-6	Educational attainment	
THCA	cis	1	rs6940188	chr6:26562029	BTN2A3	chr6:26422317-26431927:+	0.18	4.29	2.16E-5	Educational attainment	
THCA	cis	1	rs6940188	chr6:26562029	HCG11	chr6:26521934-26527610:+	-0.22	-4.3	2.1E-5	Educational attainment	
THCA	cis	1	rs6940188	chr6:26562029	HMGN4	chr6:26538572-26547162:+	-0.16	-4.19	3.36E-5	Educational attainment	
THCA	cis	1	rs6940188	chr6:26562029	LOC100270746	chr6:26987146-26988085:-	-0.14	-3.47	0.000571	Educational attainment	
THCA	cis	1	rs6940188	chr6:26562029	ZNF322A	chr6:26634612-26659963:-	-0.16	-4.64	4.48E-6	Educational attainment	
THCA	cis	1	rs6940353	chr6:33752550	LEMD2	chr6:33738991-33756906:-	0.25	4.99	8.5E-7	Body mass index	
THCA	cis	1	rs6940458	chr6:86644992	SNHG5	chr6:86386726-86388451:-	-0.48	-10.71	3.96E-24	Response to antipsychotic treatment	
THCA	cis	1	rs6941766	chr6:170131653	C6orf70	chr6:170151721-170181617:+	0.25	5.11	4.56E-7	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs6941766	chr6:170131653	WDR27	chr6:169857307-170102159:-	-0.18	-5.54	5.0E-8	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs6942231	chr6:105191814	HACE1	chr6:105175968-105307794:-	-0.16	-4.09	5.17E-5	Thyroid stimulating hormone	
THCA	cis	1	rs6942332	chr6:170131934	C6orf70	chr6:170151721-170181617:+	0.25	5.05	6.2E-7	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs6942332	chr6:170131934	WDR27	chr6:169857307-170102159:-	-0.19	-5.83	1.04E-8	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs6945843	chr7:65734783	ASL	chr7:65540776-65558321:+	0.16	4.24	2.68E-5	Aortic root size	
THCA	cis	1	rs6945843	chr7:65734783	GUSB	chr7:65425675-65447246:-	-0.29	-5.57	4.23E-8	Aortic root size	
THCA	cis	1	rs6945843	chr7:65734783	RABGEF1	chr7:66093890-66276446:+	-0.66	-14.35	4.51E-39	Aortic root size	
THCA	cis	1	rs694609	chr13:28194806	POLR1D	chr13:28194895-28241547:+	-0.18	-4.2	3.16E-5	Large B-cell lymphoma	
THCA	cis	1	rs6946131	chr7:54783373	SEC61G	chr7:54819941-54826939:-	0.16	4.66	4.17E-6	Systemic lupus erythematosus	
THCA	cis	1	rs6946143	chr7:65579722	ASL	chr7:65540776-65558321:+	-0.16	-4.13	4.3E-5	Aortic root size	
THCA	cis	1	rs6946143	chr7:65579722	GUSB	chr7:65425675-65447246:-	0.25	4.71	3.22E-6	Aortic root size	
THCA	cis	1	rs6946143	chr7:65579722	RABGEF1	chr7:66093890-66276446:+	0.65	13.38	6.7E-35	Aortic root size	
THCA	cis	1	rs6947471	chr7:154381475	LOC100132707	chr7:154720227-154741194:+	0.23	3.51	0.00049	Pelvic organ prolapse	
THCA	cis	1	rs6947674	chr7:107193504	DLD	chr7:107531586-107561642:+	0.15	3.58	0.00038	Osteoarthritis	
THCA	cis	1	rs6948297	chr7:27149404	HOXA9	chr7:27202058-27205149:-	-0.41	-4.59	5.8E-6	Hypospadias	
THCA	cis	1	rs6948433	chr7:118030666	ANKRD7	chr7:117864712-117882782:+	-0.27	-4.33	1.78E-5	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs6949812	chr7:65387101	CCT6P1	chr7:65216092-65228661:+	0.39	6.18	1.36E-9	Diabetic kidney disease	
THCA	cis	1	rs6949812	chr7:65387101	CRCP	chr7:65579805-65619551:+	-0.26	-3.99	7.58E-5	Diabetic kidney disease	
THCA	cis	1	rs6949812	chr7:65387101	RABGEF1	chr7:66093890-66276446:+	0.54	6.71	5.64E-11	Diabetic kidney disease	
THCA	cis	1	rs6949897	chr7:50621920	FIGNL1	chr7:50511834-50518088:-	-0.16	-4.33	1.79E-5	Malaria	
THCA	cis	1	rs694994	chr11:65653309	CTSW	chr11:65647284-65651212:+	-0.6	-15.78	1.87E-45	Crohn's disease	
THCA	cis	1	rs694994	chr11:65653309	SNX32	chr11:65601410-65621170:+	0.61	9.22	9.4E-19	Crohn's disease	
THCA	cis	1	rs6951067	chr7:87288324	DBF4	chr7:87505544-87538856:+	-0.26	-3.93	9.57E-5	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs6951245	chr7:1058193	ZFAND2A	chr7:1192544-1199855:-	-0.25	-3.73	0.000215	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs6951801	chr7:54174070	SEC61G	chr7:54819941-54826939:-	-0.22	-3.38	0.000785	Periodontal disease-related phenotypes	
THCA	cis	1	rs6952407	chr7:66045512	GUSB	chr7:65425675-65447246:-	-0.35	-7.08	5.1E-12	Cotinine glucuronidation	
THCA	cis	1	rs6952407	chr7:66045512	LOC493754	chr7:65993446-66057363:-	0.19	3.38	0.000778	Cotinine glucuronidation	
THCA	cis	1	rs6952407	chr7:66045512	RABGEF1	chr7:66093890-66276446:+	-0.51	-10.33	1.04E-22	Cotinine glucuronidation	
THCA	cis	1	rs6952407	chr7:66045512	TYW1	chr7:66461817-66704496:+	-0.18	-3.96	8.68E-5	Cotinine glucuronidation	
THCA	cis	1	rs6952943	chr7:87505653	DBF4	chr7:87505544-87538856:+	-0.27	-3.74	0.000203	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs6955117	chr7:23234140	NUPL2	chr7:23221446-23240629:+	-0.39	-5.44	8.44E-8	Chronic obstructive pulmonary disease	
THCA	cis	1	rs6955934	chr7:23251499	NUPL2	chr7:23221446-23240629:+	-0.43	-5.76	1.49E-8	Chronic obstructive pulmonary disease	
THCA	cis	1	rs6956179	chr7:65806659	ASL	chr7:65540776-65558321:+	0.16	4.26	2.51E-5	Aortic root size	
THCA	cis	1	rs6956179	chr7:65806659	GUSB	chr7:65425675-65447246:-	-0.27	-5.27	2.02E-7	Aortic root size	
THCA	cis	1	rs6956179	chr7:65806659	RABGEF1	chr7:66093890-66276446:+	-0.63	-13.39	5.87E-35	Aortic root size	
THCA	cis	1	rs6957186	chr7:107200592	DLD	chr7:107531586-107561642:+	0.14	3.53	0.000461	Osteoarthritis	
THCA	cis	1	rs6957199	chr7:65978519	ASL	chr7:65540776-65558321:+	-0.16	-4.21	3.07E-5	Aortic root size	
THCA	cis	1	rs6957199	chr7:65978519	GUSB	chr7:65425675-65447246:-	0.27	5.34	1.44E-7	Aortic root size	
THCA	cis	1	rs6957199	chr7:65978519	RABGEF1	chr7:66093890-66276446:+	0.66	14.13	4.09E-38	Aortic root size	
THCA	cis	1	rs6958271	chr7:65979331	ASL	chr7:65540776-65558321:+	-0.16	-4.2	3.18E-5	Aortic root size	
THCA	cis	1	rs6958271	chr7:65979331	GUSB	chr7:65425675-65447246:-	0.27	5.2	3.0E-7	Aortic root size	
THCA	cis	1	rs6958271	chr7:65979331	RABGEF1	chr7:66093890-66276446:+	0.66	14.05	8.49E-38	Aortic root size	
THCA	cis	1	rs6958277	chr7:65979349	ASL	chr7:65540776-65558321:+	-0.16	-4.2	3.18E-5	Aortic root size	
THCA	cis	1	rs6958277	chr7:65979349	GUSB	chr7:65425675-65447246:-	0.27	5.2	3.0E-7	Aortic root size	
THCA	cis	1	rs6958277	chr7:65979349	RABGEF1	chr7:66093890-66276446:+	0.66	14.05	8.49E-38	Aortic root size	
THCA	cis	1	rs6958289	chr7:65657111	CCT6P1	chr7:65216092-65228661:+	-0.42	-6.79	3.36E-11	Diabetic kidney disease	
THCA	cis	1	rs6958289	chr7:65657111	CRCP	chr7:65579805-65619551:+	0.29	4.56	6.49E-6	Diabetic kidney disease	
THCA	cis	1	rs6958289	chr7:65657111	RABGEF1	chr7:66093890-66276446:+	-0.56	-6.99	9.07E-12	Diabetic kidney disease	
THCA	cis	1	rs6958420	chr7:65751171	CCT6P1	chr7:65216092-65228661:+	-0.44	-6.92	1.49E-11	Diabetic kidney disease	
THCA	cis	1	rs6958420	chr7:65751171	CRCP	chr7:65579805-65619551:+	0.29	4.43	1.19E-5	Diabetic kidney disease	
THCA	cis	1	rs6958420	chr7:65751171	LOC493754	chr7:65993446-66057363:-	-0.3	-3.38	0.000785	Diabetic kidney disease	
THCA	cis	1	rs6958420	chr7:65751171	RABGEF1	chr7:66093890-66276446:+	-0.6	-7.44	4.68E-13	Diabetic kidney disease	
THCA	cis	1	rs6958484	chr7:65599446	ASL	chr7:65540776-65558321:+	0.16	4.27	2.34E-5	Aortic root size	
THCA	cis	1	rs6958484	chr7:65599446	GUSB	chr7:65425675-65447246:-	-0.27	-5.31	1.66E-7	Aortic root size	
THCA	cis	1	rs6958484	chr7:65599446	LOC729156	chr7:66274980-66309813:-	-0.16	-3.49	0.000535	Aortic root size	
THCA	cis	1	rs6958484	chr7:65599446	RABGEF1	chr7:66093890-66276446:+	-0.66	-14.15	3.18E-38	Aortic root size	
THCA	cis	1	rs6958520	chr7:66151453	GUSB	chr7:65425675-65447246:-	0.33	6.8	3.22E-11	Aortic root size	
THCA	cis	1	rs6958520	chr7:66151453	RABGEF1	chr7:66093890-66276446:+	0.51	10.49	2.65E-23	Aortic root size	
THCA	cis	1	rs6958520	chr7:66151453	TYW1	chr7:66461817-66704496:+	0.18	3.93	9.79E-5	Aortic root size	
THCA	cis	1	rs6958969	chr7:107197755	DLD	chr7:107531586-107561642:+	0.14	3.49	0.000521	Osteoarthritis	
THCA	cis	1	rs6959002	chr7:65650496	CCT6P1	chr7:65216092-65228661:+	-0.42	-6.7	5.9E-11	Diabetic kidney disease	
THCA	cis	1	rs6959002	chr7:65650496	CRCP	chr7:65579805-65619551:+	0.3	4.63	4.66E-6	Diabetic kidney disease	
THCA	cis	1	rs6959002	chr7:65650496	LOC493754	chr7:65993446-66057363:-	-0.29	-3.36	0.000833	Diabetic kidney disease	
THCA	cis	1	rs6959002	chr7:65650496	RABGEF1	chr7:66093890-66276446:+	-0.57	-7.14	3.42E-12	Diabetic kidney disease	
THCA	cis	1	rs6959273	chr7:118041733	ANKRD7	chr7:117864712-117882782:+	0.27	4.28	2.22E-5	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs6959670	chr7:110909169	IMMP2L	chr7:110303110-111202538:-	0.17	3.71	0.000235	Schizophrenia	
THCA	cis	1	rs6961155	chr7:65933295	ASL	chr7:65540776-65558321:+	-0.16	-4.18	3.49E-5	Aortic root size	
THCA	cis	1	rs6961155	chr7:65933295	GUSB	chr7:65425675-65447246:-	0.27	5.27	2.11E-7	Aortic root size	
THCA	cis	1	rs6961155	chr7:65933295	RABGEF1	chr7:66093890-66276446:+	0.65	14.02	1.14E-37	Aortic root size	
THCA	cis	1	rs6961380	chr7:127148072	GRM8	chr7:126078652-126893147:-	-0.35	-3.57	0.000398	Medication adherence in chronic diseases	
THCA	cis	1	rs6961717	chr7:65587537	ASL	chr7:65540776-65558321:+	0.16	4.27	2.34E-5	Aortic root size	
THCA	cis	1	rs6961717	chr7:65587537	GUSB	chr7:65425675-65447246:-	-0.27	-5.31	1.66E-7	Aortic root size	
THCA	cis	1	rs6961717	chr7:65587537	LOC729156	chr7:66274980-66309813:-	-0.16	-3.49	0.000535	Aortic root size	
THCA	cis	1	rs6961717	chr7:65587537	RABGEF1	chr7:66093890-66276446:+	-0.66	-14.15	3.18E-38	Aortic root size	
THCA	cis	1	rs6961990	chr7:65888570	ASL	chr7:65540776-65558321:+	-0.16	-4.14	4.19E-5	Aortic root size	
THCA	cis	1	rs6961990	chr7:65888570	GUSB	chr7:65425675-65447246:-	0.26	4.98	8.85E-7	Aortic root size	
THCA	cis	1	rs6961990	chr7:65888570	LOC729156	chr7:66274980-66309813:-	0.16	3.44	0.00064	Aortic root size	
THCA	cis	1	rs6961990	chr7:65888570	RABGEF1	chr7:66093890-66276446:+	0.66	14.26	1.04E-38	Aortic root size	
THCA	cis	1	rs6962032	chr7:127151489	GRM8	chr7:126078652-126893147:-	-0.35	-3.6	0.000351	Medication adherence in chronic diseases	
THCA	cis	1	rs6963495	chr7:105166853	RINT1	chr7:105172532-105208124:+	-0.25	-3.68	0.000256	Bipolar disorder (body mass index interaction)	
THCA	cis	1	rs6963646	chr7:65685767	ASL	chr7:65540776-65558321:+	0.16	4.22	2.88E-5	Aortic root size	
THCA	cis	1	rs6963646	chr7:65685767	GUSB	chr7:65425675-65447246:-	-0.28	-5.43	8.96E-8	Aortic root size	
THCA	cis	1	rs6963646	chr7:65685767	LOC729156	chr7:66274980-66309813:-	-0.16	-3.37	0.0008	Aortic root size	
THCA	cis	1	rs6963646	chr7:65685767	RABGEF1	chr7:66093890-66276446:+	-0.65	-13.95	2.4E-37	Aortic root size	
THCA	cis	1	rs6964245	chr7:65718717	CCT6P1	chr7:65216092-65228661:+	-0.44	-6.89	1.74E-11	Diabetic kidney disease	
THCA	cis	1	rs6964245	chr7:65718717	CRCP	chr7:65579805-65619551:+	0.3	4.52	7.98E-6	Diabetic kidney disease	
THCA	cis	1	rs6964245	chr7:65718717	RABGEF1	chr7:66093890-66276446:+	-0.59	-7.26	1.54E-12	Diabetic kidney disease	
THCA	cis	1	rs6964530	chr7:65718851	CCT6P1	chr7:65216092-65228661:+	-0.44	-6.8	3.23E-11	Diabetic kidney disease	
THCA	cis	1	rs6964530	chr7:65718851	CRCP	chr7:65579805-65619551:+	0.3	4.57	6.18E-6	Diabetic kidney disease	
THCA	cis	1	rs6964530	chr7:65718851	RABGEF1	chr7:66093890-66276446:+	-0.59	-7.23	1.92E-12	Diabetic kidney disease	
THCA	cis	1	rs6965016	chr7:97807882	BRI3	chr7:97910979-97922275:+	-0.11	-4.02	6.89E-5	Prostate cancer (gene x gene interaction);Prostate cancer	
THCA	cis	1	rs6965016	chr7:97807882	TECPR1	chr7:97846060-97881468:-	-0.13	-3.72	0.000225	Prostate cancer (gene x gene interaction);Prostate cancer	
THCA	cis	1	rs6965685	chr7:158726462	ESYT2	chr7:158523689-158622319:-	0.12	3.43	0.000659	Height	
THCA	cis	1	rs6965685	chr7:158726462	WDR60	chr7:158649269-158738882:+	-0.15	-3.92	0.000104	Height	
THCA	cis	1	rs6966322	chr7:65646754	CCT6P1	chr7:65216092-65228661:+	-0.42	-6.7	5.9E-11	Diabetic kidney disease	
THCA	cis	1	rs6966322	chr7:65646754	CRCP	chr7:65579805-65619551:+	0.3	4.63	4.66E-6	Diabetic kidney disease	
THCA	cis	1	rs6966322	chr7:65646754	LOC493754	chr7:65993446-66057363:-	-0.29	-3.36	0.000833	Diabetic kidney disease	
THCA	cis	1	rs6966322	chr7:65646754	RABGEF1	chr7:66093890-66276446:+	-0.57	-7.14	3.42E-12	Diabetic kidney disease	
THCA	cis	1	rs6969722	chr7:12278437	VWDE	chr7:12370509-12443852:-	-0.24	-4.15	3.9E-5	Response to amphetamines	
THCA	cis	1	rs6969780	chr7:27159136	HOXA9	chr7:27202058-27205149:-	-0.38	-4.38	1.48E-5	Hypospadias	
THCA	cis	1	rs6970030	chr7:65968679	ASL	chr7:65540776-65558321:+	-0.16	-4.21	3.03E-5	Aortic root size	
THCA	cis	1	rs6970030	chr7:65968679	GUSB	chr7:65425675-65447246:-	0.27	5.32	1.57E-7	Aortic root size	
THCA	cis	1	rs6970030	chr7:65968679	RABGEF1	chr7:66093890-66276446:+	0.66	14.13	3.92E-38	Aortic root size	
THCA	cis	1	rs6970243	chr7:65388490	CCT6P1	chr7:65216092-65228661:+	0.39	6.18	1.36E-9	Diabetic kidney disease	
THCA	cis	1	rs6970243	chr7:65388490	CRCP	chr7:65579805-65619551:+	-0.26	-3.99	7.58E-5	Diabetic kidney disease	
THCA	cis	1	rs6970243	chr7:65388490	RABGEF1	chr7:66093890-66276446:+	0.54	6.71	5.64E-11	Diabetic kidney disease	
THCA	cis	1	rs6970597	chr7:21583519	DNAH11	chr7:21582833-21941455:+	-0.26	-5.6	3.72E-8	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
THCA	cis	1	rs6970985	chr7:21583597	DNAH11	chr7:21582833-21941455:+	-0.26	-5.65	2.75E-8	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
THCA	cis	1	rs6971688	chr7:54174397	SEC61G	chr7:54819941-54826939:-	-0.22	-3.38	0.000778	Periodontal disease-related phenotypes	
THCA	cis	1	rs6972098	chr7:87352349	DBF4	chr7:87505544-87538856:+	-0.26	-3.98	8.12E-5	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs6973182	chr7:27172321	HOXA9	chr7:27202058-27205149:-	-0.4	-4.66	4.14E-6	Hypospadias	
THCA	cis	1	rs6974373	chr7:99590893	TRIM4	chr7:99488037-99517154:-	-0.31	-5.97	4.51E-9	Interstitial lung disease	
THCA	cis	1	rs6974723	chr7:65637939	CCT6P1	chr7:65216092-65228661:+	-0.42	-6.7	5.9E-11	Diabetic kidney disease	
THCA	cis	1	rs6974723	chr7:65637939	CRCP	chr7:65579805-65619551:+	0.3	4.63	4.66E-6	Diabetic kidney disease	
THCA	cis	1	rs6974723	chr7:65637939	LOC493754	chr7:65993446-66057363:-	-0.29	-3.36	0.000833	Diabetic kidney disease	
THCA	cis	1	rs6974723	chr7:65637939	RABGEF1	chr7:66093890-66276446:+	-0.57	-7.14	3.42E-12	Diabetic kidney disease	
THCA	cis	1	rs6975195	chr7:66124774	GUSB	chr7:65425675-65447246:-	-0.33	-6.8	3.22E-11	Aortic root size	
THCA	cis	1	rs6975195	chr7:66124774	RABGEF1	chr7:66093890-66276446:+	-0.51	-10.49	2.65E-23	Aortic root size	
THCA	cis	1	rs6975195	chr7:66124774	TYW1	chr7:66461817-66704496:+	-0.18	-3.93	9.79E-5	Aortic root size	
THCA	cis	1	rs6975531	chr7:38219350	STARD3NL	chr7:38217933-38270269:+	-0.52	-12.31	1.94E-30	Treatment response for severe sepsis	
THCA	cis	1	rs6976053	chr7:100512119	UFSP1	chr7:100486346-100487339:-	-0.27	-5.58	3.93E-8	Plasminogen activator inhibitor type 1 levels (PAI-1)	
THCA	cis	1	rs6976129	chr7:27177746	HOXA9	chr7:27202058-27205149:-	-0.4	-4.63	4.79E-6	Hypospadias	
THCA	cis	1	rs6976759	chr7:107158506	DLD	chr7:107531586-107561642:+	0.14	3.5	0.00051	Osteoarthritis	
THCA	cis	1	rs697691	chr1:7885354	VAMP3	chr1:7831329-7841491:+	-0.19	-3.36	0.000828	Crohn's disease	
THCA	cis	1	rs6976930	chr7:72885810	MLXIPL	chr7:73007524-73038870:-	0.21	3.93	9.92E-5	Triglycerides	
THCA	cis	1	rs6977321	chr7:97774859	BHLHA15	chr7:97840778-97842271:+	-0.15	-3.42	0.000677	Prostate cancer (gene x gene interaction);Prostate cancer	
THCA	cis	1	rs6977321	chr7:97774859	BRI3	chr7:97910979-97922275:+	-0.11	-4	7.25E-5	Prostate cancer (gene x gene interaction);Prostate cancer	
THCA	cis	1	rs6977321	chr7:97774859	TECPR1	chr7:97846060-97881468:-	-0.13	-3.74	0.000204	Prostate cancer (gene x gene interaction);Prostate cancer	
THCA	cis	1	rs6979382	chr7:65886375	ASL	chr7:65540776-65558321:+	-0.16	-4.14	4.19E-5	Aortic root size	
THCA	cis	1	rs6979382	chr7:65886375	GUSB	chr7:65425675-65447246:-	0.26	4.98	8.85E-7	Aortic root size	
THCA	cis	1	rs6979382	chr7:65886375	LOC729156	chr7:66274980-66309813:-	0.16	3.44	0.00064	Aortic root size	
THCA	cis	1	rs6979382	chr7:65886375	RABGEF1	chr7:66093890-66276446:+	0.66	14.26	1.04E-38	Aortic root size	
THCA	cis	1	rs6979663	chr7:118050881	ANKRD7	chr7:117864712-117882782:+	-0.27	-4.47	9.57E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs697970	chr7:65560052	ASL	chr7:65540776-65558321:+	0.18	4.67	3.91E-6	Aortic root size	
THCA	cis	1	rs697970	chr7:65560052	GUSB	chr7:65425675-65447246:-	-0.26	-4.9	1.33E-6	Aortic root size	
THCA	cis	1	rs697970	chr7:65560052	RABGEF1	chr7:66093890-66276446:+	-0.65	-13.54	1.34E-35	Aortic root size	
THCA	cis	1	rs6980734	chr8:89446680	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs6981354	chr8:66865183	PDE7A	chr8:66629906-66753755:-	-0.17	-3.78	0.000178	Myopia (pathological)	
THCA	cis	1	rs6982238	chr8:94069299	C8orf83	chr8:93895865-94029901:-	0.3	4.75	2.65E-6	Attention deficit hyperactivity disorder	
THCA	cis	1	rs6982751	chr8:10813474	CTSB	chr8:11700036-11725646:-	0.22	3.5	0.000501	Asthma and hay fever	
THCA	cis	1	rs6982927	chr8:10813598	CTSB	chr8:11700036-11725646:-	0.22	3.5	0.000501	Asthma and hay fever	
THCA	cis	1	rs6983795	chr8:124185296	FAM83A	chr8:124191287-124222317:+	-0.34	-4.19	3.33E-5	Urinary uromodulin levels	
THCA	cis	1	rs6984009	chr8:96289091	C8orf37	chr8:96258235-96281437:-	0.31	4.11	4.67E-5	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	
THCA	cis	1	rs698500	chr15:83237769	CPEB1	chr15:83211952-83316728:-	-0.17	-3.69	0.00025	Schizophrenia	
THCA	cis	1	rs698500	chr15:83237769	GOLGA6L9	chr15:82711895-82731584:+;chr15	-0.15	-4.74	2.85E-6	Schizophrenia	
THCA	cis	1	rs6985880	chr8:96027599	C8orf38	chr8:95908040-96088396:+	-0.25	-4.26	2.48E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs6986006	chr8:100869479	VPS13B	chr8:100025494-100889807:+	-0.12	-3.56	0.000408	Glucose homeostasis traits	
THCA	cis	1	rs6987050	chr8:94082293	C8orf83	chr8:93895865-94029901:-	0.2	3.37	0.000806	Attention deficit hyperactivity disorder	
THCA	cis	1	rs6987711	chr8:89425711	MMP16	chr8:89049462-89339717:-	0.32	5.17	3.5E-7	Electrodermal activity	
THCA	cis	1	rs6988021	chr8:89450084	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs6988108	chr8:94072176	C8orf83	chr8:93895865-94029901:-	0.28	4.45	1.07E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs6988636	chr8:124185970	FAM83A	chr8:124191287-124222317:+	-0.32	-4.13	4.19E-5	Urinary uromodulin levels	
THCA	cis	1	rs6989203	chr8:41523745	ANK1	chr8:41510745-41754280:-	0.23	4.85	1.68E-6	Type 2 diabetes	
THCA	cis	1	rs6989862	chr8:96027568	C8orf38	chr8:95908040-96088396:+	-0.25	-4.26	2.48E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs6994725	chr8:66844743	PDE7A	chr8:66629906-66753755:-	0.17	3.81	0.000156	Myopia (pathological)	
THCA	cis	1	rs6997118	chr8:17371403	SLC7A2	chr8:17354600-17428073:+	-0.28	-5.3	1.75E-7	Plasma omega-6 polyunsaturated fatty acid levels (adrenic acid)	
THCA	cis	1	rs6997306	chr8:17371520	SLC7A2	chr8:17354600-17428073:+	-0.27	-5.17	3.46E-7	Plasma omega-6 polyunsaturated fatty acid levels (adrenic acid)	
THCA	cis	1	rs6997458	chr8:86274030	LRRCC1	chr8:86019377-86058312:+	0.18	4.56	6.59E-6	Blood trace element (Zn levels)	
THCA	cis	1	rs6999	chr20:55093901	C20orf43	chr20:55043647-55093942:+	0.28	7.51	2.95E-13	Refractive astigmatism	
THCA	cis	1	rs6999	chr20:55093901	CSTF1	chr20:54967427-54979582:+	0.17	3.52	0.000478	Refractive astigmatism	
THCA	cis	1	rs7000731	chr8:94069301	C8orf83	chr8:93895865-94029901:-	0.3	4.75	2.65E-6	Attention deficit hyperactivity disorder	
THCA	cis	1	rs7000891	chr8:89446259	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs7001241	chr8:89446459	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs7001591	chr8:141834000	EIF2C2	chr8:141541265-141645645:-	0.12	3.55	0.00042	Acute graft versus host disease in bone marrow transplantation (recipient effect)	
THCA	cis	1	rs7001875	chr8:89446812	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs7002021	chr8:124185250	FAM83A	chr8:124191287-124222317:+	-0.34	-4.19	3.33E-5	Urinary uromodulin levels	
THCA	cis	1	rs7002332	chr8:124185442	FAM83A	chr8:124191287-124222317:+	-0.34	-4.19	3.33E-5	Urinary uromodulin levels	
THCA	cis	1	rs7002940	chr8:96027392	C8orf38	chr8:95908040-96088396:+	-0.25	-4.22	2.95E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs7003387	chr8:95961979	INTS8	chr8:95835534-95892720:+	0.16	3.87	0.000123	Type 2 diabetes	
THCA	cis	1	rs7004438	chr8:8574379	SGK223	chr8:8175259-8239257:-	-0.3	-5.55	4.75E-8	Obesity-related traits	
THCA	cis	1	rs7004757	chr8:89446178	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs7005380	chr8:120953873	DSCC1	chr8:120846182-120868170:-	-0.28	-5.74	1.68E-8	Interstitial lung disease	
THCA	cis	1	rs7006316	chr8:94082090	C8orf83	chr8:93895865-94029901:-	0.2	3.37	0.000806	Attention deficit hyperactivity disorder	
THCA	cis	1	rs7006506	chr8:89426102	MMP16	chr8:89049462-89339717:-	0.32	5.16	3.61E-7	Electrodermal activity	
THCA	cis	1	rs7006612	chr8:10813636	CTSB	chr8:11700036-11725646:-	0.22	3.5	0.000501	Asthma and hay fever	
THCA	cis	1	rs7006842	chr8:94082345	C8orf83	chr8:93895865-94029901:-	0.21	3.47	0.000575	Attention deficit hyperactivity disorder	
THCA	cis	1	rs7007450	chr8:71640269	XKR9	chr8:71581600-71648176:+	1.06	27.41	4.36E-100	Bone mineral density	
THCA	cis	1	rs7008219	chr8:89451970	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs7008542	chr8:96027863	C8orf38	chr8:95908040-96088396:+	-0.25	-4.26	2.48E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs7009302	chr8:11685981	CTSB	chr8:11700036-11725646:-	-0.17	-3.97	8.43E-5	Non-alcoholic fatty liver disease histology (lobular);Non-alcoholic fatty liver disease histology (other)	
THCA	cis	1	rs7009516	chr8:24208847	ADAMDEC1	chr8:24241798-24263526:+	0.18	5.31	1.7E-7	Hair greying	
THCA	cis	1	rs7011959	chr8:94072252	C8orf83	chr8:93895865-94029901:-	0.28	4.45	1.07E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs7012814	chr8:9173358	SGK223	chr8:8175259-8239257:-	-0.23	-4.27	2.36E-5	Fibrinogen levels	
THCA	cis	1	rs7014273	chr8:67358694	ADHFE1	chr8:67344718-67381042:+	0.26	5.46	7.52E-8	Blood metabolite levels	
THCA	cis	1	rs7014273	chr8:67358694	C8orf46	chr8:67405491-67430757:+	-0.3	-5.02	7.27E-7	Blood metabolite levels	
THCA	cis	1	rs7014578	chr8:92077568	LRRC69	chr8:92114847-92231464:+	-0.22	-3.62	0.000323	Migraine - clinic-based	
THCA	cis	1	rs7017914	chr8:71591203	XKR9	chr8:71581600-71648176:+	1.06	27.98	1.01E-102	Bone mineral density	
THCA	cis	1	rs7018226	chr8:89446335	MMP16	chr8:89049462-89339717:-	0.33	5.32	1.58E-7	Electrodermal activity	
THCA	cis	1	rs7018	chr20:25278261	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.94	1.26E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7018	chr20:25278261	FAM182A	chr20:26035250-26067552:+	-0.18	-3.41	0.000699	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7018	chr20:25278261	FAM182B	chr20:25744102-25848786:-	0.26	5.52	5.64E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7018	chr20:25278261	NINL	chr20:25433338-25566153:-	-0.35	-7.26	1.6E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7018	chr20:25278261	PYGB	chr20:25228706-25278647:+	-0.15	-3.73	0.000212	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7019	chr20:25278278	ENTPD6	chr20:25176339-25207360:+	-0.31	-7.15	3.21E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7019	chr20:25278278	FAM182A	chr20:26035250-26067552:+	-0.18	-3.41	0.000708	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7019	chr20:25278278	FAM182B	chr20:25744102-25848786:-	0.26	5.44	8.73E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7019	chr20:25278278	NINL	chr20:25433338-25566153:-	-0.36	-7.5	3.18E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7019	chr20:25278278	PYGB	chr20:25228706-25278647:+	-0.14	-3.55	0.00042	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7020708	chr9:131885131	CRAT	chr9:131857075-131873070:-	0.29	6.95	1.19E-11	Blood metabolite ratios	
THCA	cis	1	rs7020976	chr9:100547972	C9orf156	chr9:100666772-100684852:-	0.13	3.6	0.000349	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	cis	1	rs7020	chr20:25278600	ENTPD6	chr20:25176339-25207360:+	-0.3	-6.73	4.98E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7020	chr20:25278600	FAM182B	chr20:25744102-25848786:-	0.28	5.8	1.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7020	chr20:25278600	NINL	chr20:25433338-25566153:-	-0.35	-7.16	2.97E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7020	chr20:25278600	PYGB	chr20:25228706-25278647:+	-0.14	-3.57	0.000386	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7021449	chr9:131899312	CRAT	chr9:131857075-131873070:-	0.29	6.93	1.38E-11	Blood metabolite ratios	
THCA	cis	1	rs7022397	chr9:116007677	CDC26	chr9:116029290-116037869:-	-0.47	-10.6	1.04E-23	Hematology traits	
THCA	cis	1	rs7022397	chr9:116007677	PRPF4	chr9:116037974-116055054:+	0.18	4.3	2.1E-5	Hematology traits	
THCA	cis	1	rs7022999	chr9:102694400	STX17	chr9:102668915-102736817:+	-0.17	-4.33	1.86E-5	Alopecia areata	
THCA	cis	1	rs7023900	chr9:131891152	CRAT	chr9:131857075-131873070:-	0.28	6.86	2.15E-11	Blood metabolite ratios	
THCA	cis	1	rs7024214	chr9:99239173	CDC14B	chr9:99262397-99382112:-	-0.17	-5.1	5.0E-7	Height	
THCA	cis	1	rs702485	chr7:6449272	DAGLB	chr7:6448748-6523849:-	-0.19	-3.96	8.63E-5	HDL cholesterol	
THCA	cis	1	rs702485	chr7:6449272	RAC1	chr7:6414126-6443597:+	0.16	3.66	0.000276	HDL cholesterol	
THCA	cis	1	rs7027030	chr9:100550455	C9orf156	chr9:100666772-100684852:-	0.13	3.64	0.000297	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	cis	1	rs7027110	chr9:109599046	ZNF462	chr9:109625378-109773789:+	-0.11	-3.84	0.000137	Height	
THCA	cis	1	rs7027619	chr9:102719728	STX17	chr9:102668915-102736817:+	-0.17	-4.35	1.63E-5	Alopecia areata	
THCA	cis	1	rs7027813	chr9:102675372	STX17	chr9:102668915-102736817:+	-0.17	-4.29	2.17E-5	Alopecia areata	
THCA	cis	1	rs7028661	chr9:100538470	C9orf156	chr9:100666772-100684852:-	0.13	3.39	0.000753	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	cis	1	rs7029536	chr9:130110411	SLC2A8	chr9:130159465-130170161:+	-0.13	-3.48	0.000549	Metabolite levels (HVA)	
THCA	cis	1	rs7030241	chr9:100550375	C9orf156	chr9:100666772-100684852:-	0.14	3.69	0.000248	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	cis	1	rs7030256	chr9:100535203	C9orf156	chr9:100666772-100684852:-	0.14	3.85	0.000135	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	cis	1	rs7030280	chr9:100535267	C9orf156	chr9:100666772-100684852:-	0.14	3.86	0.000131	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	cis	1	rs7030887	chr9:100688511	C9orf156	chr9:100666772-100684852:-	-0.14	-3.65	0.000296	Quantitative traits	
THCA	cis	1	rs7030907	chr9:100688577	C9orf156	chr9:100666772-100684852:-	-0.14	-3.65	0.000296	Quantitative traits	
THCA	cis	1	rs7032019	chr9:100548144	C9orf156	chr9:100666772-100684852:-	0.13	3.6	0.000349	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	cis	1	rs7032889	chr9:99621802	FAM22G	chr9:99690592-99704572:+	0.93	8.57	1.42E-16	Height	
THCA	cis	1	rs7032889	chr9:99621802	HIATL2	chr9:99695549-99775862:-	0.68	6.2	1.19E-9	Height	
THCA	cis	1	rs7032889	chr9:99621802	LOC441454	chr9:99671357-99672736:+	0.36	3.6	0.000358	Height	
THCA	cis	1	rs7036114	chr9:131893406	CRAT	chr9:131857075-131873070:-	0.28	6.86	2.15E-11	Blood metabolite ratios	
THCA	cis	1	rs7036236	chr9:131899299	CRAT	chr9:131857075-131873070:-	0.29	7.06	5.88E-12	Blood metabolite ratios	
THCA	cis	1	rs7037140	chr9:123656327	LOC253039	chr9:123605320-123616644:+	-0.5	-9.11	2.3E-18	Rheumatoid arthritis	
THCA	cis	1	rs7037140	chr9:123656327	PSMD5	chr9:123578334-123605206:-	-0.27	-5.21	2.76E-7	Rheumatoid arthritis	
THCA	cis	1	rs7037163	chr9:131894340	CRAT	chr9:131857075-131873070:-	0.28	6.64	8.68E-11	Blood metabolite ratios	
THCA	cis	1	rs703842	chr12:58162739	FAM119B	chr12:58166383-58176323:+	-0.39	-11.02	2.53E-25	Multiple sclerosis	
THCA	cis	1	rs703842	chr12:58162739	METTL1	chr12:58162352-58165914:-	0.17	4.12	4.51E-5	Multiple sclerosis	
THCA	cis	1	rs703842	chr12:58162739	TSFM	chr12:58176536-58191367:+	0.53	17.89	3.72E-55	Multiple sclerosis	
THCA	cis	1	rs703842	chr12:58162739	XRCC6BP1	chr12:58335445-58351051:+	0.22	4.55	6.78E-6	Multiple sclerosis	
THCA	cis	1	rs7038506	chr9:102710132	STX17	chr9:102668915-102736817:+	-0.16	-4.17	3.68E-5	Alopecia areata	
THCA	cis	1	rs7038769	chr9:116007583	CDC26	chr9:116029290-116037869:-	-0.47	-10.6	1.04E-23	Hematology traits	
THCA	cis	1	rs7038769	chr9:116007583	PRPF4	chr9:116037974-116055054:+	0.18	4.3	2.1E-5	Hematology traits	
THCA	cis	1	rs7039716	chr9:102670215	STX17	chr9:102668915-102736817:+	-0.16	-4.19	3.39E-5	Alopecia areata	
THCA	cis	1	rs7044116	chr9:109595771	ZNF462	chr9:109625378-109773789:+	-0.11	-3.86	0.000132	Height	
THCA	cis	1	rs7045138	chr9:100591463	C9orf156	chr9:100666772-100684852:-	0.17	4.69	3.54E-6	Thyroid hormone levels	
THCA	cis	1	rs7045881	chr9:26935996	IFT74	chr9:26947037-27062923:+	0.24	4.56	6.56E-6	Schizophrenia	
THCA	cis	1	rs7045881	chr9:26935996	LRRC19	chr9:26993143-27005691:-	-0.74	-9.99	1.77E-21	Schizophrenia	
THCA	cis	1	rs7046217	chr9:91780877	CKS2	chr9:91926113-91931617:+	-0.25	-4.44	1.13E-5	Pelvic organ prolapse (moderate/severe)	
THCA	cis	1	rs7047644	chr9:91826500	CKS2	chr9:91926113-91931617:+	-0.24	-4.57	6.12E-6	Pelvic organ prolapse (moderate/severe)	
THCA	cis	1	rs704	chr17:26694861	TMEM97	chr17:26646121-26655710:+	0.3	6.27	8.06E-10	Osteoprotegerin levels	
THCA	cis	1	rs705696	chr12:56480648	RAB5B	chr12:56367760-56388478:+	0.25	4.36	1.57E-5	Cognitive function	
THCA	cis	1	rs705696	chr12:56480648	RPS26	chr12:56435686-56438005:+	0.7	12.79	2.08E-32	Cognitive function	
THCA	cis	1	rs7061710	chr1:171080615	FMO3	chr1:171060018-171086957:+	-0.29	-4.81	2.05E-6	Blood metabolite levels	
THCA	cis	1	rs706201	chr7:134251041	AKR1B1	chr7:134127107-134143888:-	-0.23	-4.89	1.4E-6	Longevity	
THCA	cis	1	rs706202	chr7:134250704	AKR1B1	chr7:134127107-134143888:-	-0.21	-4.45	1.06E-5	Longevity	
THCA	cis	1	rs7068921	chr10:124733526	C10orf88	chr10:124690419-124713919:-	-0.22	-4.04	6.23E-5	Migraine without aura	
THCA	cis	1	rs7069183	chr10:52756339	PRKG1	chr10:52750945-54055274:+	-0.2	-4.65	4.3E-6	Migraine	
THCA	cis	1	rs7069346	chr10:124729876	C10orf88	chr10:124690419-124713919:-	-0.22	-4.08	5.3E-5	Migraine without aura	
THCA	cis	1	rs7070052	chr10:64903814	LOC84989	chr10:65224989-65226320:+	-0.27	-4.43	1.15E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs7070052	chr10:64903814	NRBF2	chr10:64893007-64914785:+	-0.28	-4.69	3.58E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs7070296	chr10:65070438	NRBF2	chr10:64893007-64914785:+	-0.29	-6.8	3.13E-11	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7070635	chr10:135190127	ECHS1	chr10:135175988-135186908:-	-0.42	-6.58	1.23E-10	Lifespan	
THCA	cis	1	rs7070776	chr10:102264672	SEC31B	chr10:102246403-102289636:-	-0.27	-8.69	5.7E-17	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs7071271	chr10:102264824	SEC31B	chr10:102246403-102289636:-	-0.27	-8.53	1.88E-16	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs7072204	chr10:124195485	PLEKHA1	chr10:124134220-124191866:+	-0.21	-5.89	7.48E-9	Height	
THCA	cis	1	rs7072216	chr10:100156853	PYROXD2	chr10:100143323-100174978:-	0.96	29.61	3.26E-110	Metabolite levels	
THCA	cis	1	rs7072634	chr10:17240918	TRDMT1	chr10:17184983-17243681:-	-0.44	-10.12	6.22E-22	Homocysteine levels	
THCA	cis	1	rs7072634	chr10:17240918	VIM	chr10:17270258-17279592:+	-0.18	-3.41	0.0007	Homocysteine levels	
THCA	cis	1	rs7073432	chr10:75953350	VCL	chr10:75754951-75879912:+	-0.21	-3.87	0.000125	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs7073497	chr10:100153688	PYROXD2	chr10:100143323-100174978:-	0.53	5.39	1.11E-7	Aspartate aminotransferase	
THCA	cis	1	rs7073586	chr10:102307671	SEC31B	chr10:102246403-102289636:-	-0.29	-9.33	3.82E-19	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs7073746	chr10:64904071	NRBF2	chr10:64893007-64914785:+	-0.28	-6.54	1.59E-10	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7074435	chr10:135190570	ECHS1	chr10:135175988-135186908:-	0.55	7.77	4.88E-14	Lifespan	
THCA	cis	1	rs707472	chr1:7906008	VAMP3	chr1:7831329-7841491:+	0.2	3.48	0.000538	Crohn's disease	
THCA	cis	1	rs7075426	chr10:88216402	WAPAL	chr10:88195014-88281541:-	-0.1	-3.68	0.000263	Migraine without aura	
THCA	cis	1	rs7076120	chr10:54340942	DKK1	chr10:54074041-54077416:+	-0.25	-4.69	3.59E-6	Metabolite levels  (X-11787)	
THCA	cis	1	rs7076631	chr10:52759323	PRKG1	chr10:52750945-54055274:+	-0.2	-4.65	4.3E-6	Migraine	
THCA	cis	1	rs7076721	chr10:75996682	VCL	chr10:75754951-75879912:+	-0.18	-3.38	0.000795	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs7078003	chr10:99359412	DHDPSL	chr10:99344102-99372553:+	0.31	4.4	1.34E-5	Metabolite levels (small molecules and protein measures)	
THCA	cis	1	rs7078219	chr10:101274365	NKX2-3	chr10:101292690-101296278:+	0.32	5.67	2.43E-8	Dental caries	
THCA	cis	1	rs7078799	chr10:102301447	SEC31B	chr10:102246403-102289636:-	-0.28	-9.04	3.94E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs7079041	chr10:32993268	C10orf68	chr10:32856598-33171791:+	0.21	4.86	1.58E-6	Suicide in bipolar disorder	
THCA	cis	1	rs7079136	chr10:102292709	SEC31B	chr10:102246403-102289636:-	-0.28	-9.14	1.74E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs7079237	chr10:23659587	C10orf67	chr10:23605521-23633772:-	-0.23	-4.6	5.31E-6	Crohn's disease and sarcoidosis (combined)	
THCA	cis	1	rs7079679	chr10:102055546	CWF19L1	chr10:101992055-102027437:-	-0.25	-4.68	3.68E-6	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	
THCA	cis	1	rs7079756	chr10:102302105	SEC31B	chr10:102246403-102289636:-	-0.28	-9.28	6.11E-19	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs7079976	chr10:124172108	PLEKHA1	chr10:124134220-124191866:+	-0.21	-5.75	1.61E-8	Height	
THCA	cis	1	rs7080356	chr10:102266735	SEC31B	chr10:102246403-102289636:-	-0.27	-8.69	5.7E-17	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs7080757	chr10:52759553	PRKG1	chr10:52750945-54055274:+	-0.2	-4.66	4.1E-6	Migraine	
THCA	cis	1	rs7080828	chr10:7733770	ITIH5	chr10:7601636-7708934:-	-0.18	-3.72	0.00022	Ovarian reserve	
THCA	cis	1	rs7081155	chr10:17263140	TRDMT1	chr10:17184983-17243681:-	0.25	5.59	3.77E-8	Cholesterol, total	
THCA	cis	1	rs7081275	chr10:65106551	LOC84989	chr10:65224989-65226320:+	-0.27	-4.39	1.39E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs7081275	chr10:65106551	NRBF2	chr10:64893007-64914785:+	-0.28	-4.77	2.5E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs7081330	chr10:101274465	NKX2-3	chr10:101292690-101296278:+	-0.32	-5.68	2.39E-8	Dental caries	
THCA	cis	1	rs7081792	chr10:132948840	TCERG1L	chr10:132890656-133109984:-	0.4	6.04	3.08E-9	Type 2 diabetes	
THCA	cis	1	rs708224	chr12:32436409	BICD1	chr12:32260185-32531140:+	0.12	3.94	9.39E-5	Pancreatic cancer	
THCA	cis	1	rs708224	chr12:32436409	FGD4	chr12:32638906-32798982:+	0.15	4.14	4.1E-5	Pancreatic cancer	
THCA	cis	1	rs7082376	chr10:17232223	TRDMT1	chr10:17184983-17243681:-	-0.45	-10.34	9.33E-23	Homocysteine levels	
THCA	cis	1	rs7082376	chr10:17232223	VIM	chr10:17270258-17279592:+	-0.19	-3.49	0.000532	Homocysteine levels	
THCA	cis	1	rs7083655	chr10:17142702	CUBN	chr10:16865966-17171816:-	0.21	4.89	1.37E-6	Whole-brain volume	
THCA	cis	1	rs7084476	chr10:17211383	TRDMT1	chr10:17184983-17243681:-	-0.43	-10.12	5.94E-22	Homocysteine levels	
THCA	cis	1	rs7084476	chr10:17211383	VIM	chr10:17270258-17279592:+	-0.18	-3.42	0.000688	Homocysteine levels	
THCA	cis	1	rs7084810	chr10:102297546	SEC31B	chr10:102246403-102289636:-	-0.28	-8.96	7.03E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs7084900	chr10:25201585	PRTFDC1	chr10:25137554-25241533:-	0.25	3.43	0.000644	Metabolite levels (Pyroglutamine)	
THCA	cis	1	rs7084921	chr10:101813802	CWF19L1	chr10:101992055-102027437:-	0.43	7.84	2.88E-14	Bone mineral density	
THCA	cis	1	rs7085439	chr10:102210100	SEC31B	chr10:102246403-102289636:-	-0.3	-10.17	3.96E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs708547	chr4:57821309	C4orf14	chr4:57829517-57843826:-	-0.22	-4.09	5.11E-5	Response to bleomycin (chromatid breaks)	
THCA	cis	1	rs7086833	chr10:38277025	LOC399744	chr10:38717074-38741080:+	-0.26	-3.57	0.000393	Obesity (extreme)	
THCA	cis	1	rs7087279	chr10:65291936	LOC84989	chr10:65224989-65226320:+	-0.27	-4.38	1.48E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs7087279	chr10:65291936	NRBF2	chr10:64893007-64914785:+	-0.27	-4.46	1.02E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs7088512	chr10:102303498	SEC31B	chr10:102246403-102289636:-	-0.28	-9.2	1.13E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs7088827	chr10:102303865	SEC31B	chr10:102246403-102289636:-	-0.28	-9.09	2.61E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs7090431	chr10:102261753	SEC31B	chr10:102246403-102289636:-	-0.27	-8.74	4.1E-17	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs7091404	chr10:124745458	C10orf88	chr10:124690419-124713919:-	-0.22	-4.12	4.51E-5	Migraine without aura	
THCA	cis	1	rs709400	chr14:104149475	KLC1	chr14:104029299-104167887:+	-0.22	-4.37	1.52E-5	Body mass index	
THCA	cis	1	rs7094311	chr10:132948685	TCERG1L	chr10:132890656-133109984:-	0.4	6.04	3.08E-9	Type 2 diabetes	
THCA	cis	1	rs7094406	chr10:101815573	CWF19L1	chr10:101992055-102027437:-	0.44	7.99	1.02E-14	Bone mineral density	
THCA	cis	1	rs7095889	chr10:124744265	C10orf88	chr10:124690419-124713919:-	-0.22	-4.03	6.38E-5	Migraine without aura	
THCA	cis	1	rs709592	chr17:38175553	GSDMA	chr17:38119226-38134019:+	-0.32	-7.25	1.67E-12	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THCA	cis	1	rs709592	chr17:38175553	ORMDL3	chr17:38077296-38083854:-	0.14	3.37	0.000809	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THCA	cis	1	rs7095944	chr10:126302936	METTL10	chr10:126447406-126480439:-	-0.36	-8.01	8.78E-15	Asthma	
THCA	cis	1	rs709595	chr7:65817333	ASL	chr7:65540776-65558321:+	-0.16	-4.31	1.96E-5	Aortic root size	
THCA	cis	1	rs709595	chr7:65817333	GUSB	chr7:65425675-65447246:-	0.28	5.45	8.07E-8	Aortic root size	
THCA	cis	1	rs709595	chr7:65817333	RABGEF1	chr7:66093890-66276446:+	0.66	14.35	4.44E-39	Aortic root size	
THCA	cis	1	rs709597	chr7:65825983	ASL	chr7:65540776-65558321:+	0.16	4.2	3.2E-5	Aortic root size	
THCA	cis	1	rs709597	chr7:65825983	GUSB	chr7:65425675-65447246:-	-0.25	-4.91	1.23E-6	Aortic root size	
THCA	cis	1	rs709597	chr7:65825983	LOC729156	chr7:66274980-66309813:-	-0.16	-3.38	0.00079	Aortic root size	
THCA	cis	1	rs709597	chr7:65825983	RABGEF1	chr7:66093890-66276446:+	-0.65	-13.81	1.01E-36	Aortic root size	
THCA	cis	1	rs709607	chr7:65449541	CCT6P1	chr7:65216092-65228661:+	-0.35	-5.42	9.29E-8	Diabetic kidney disease	
THCA	cis	1	rs709607	chr7:65449541	CRCP	chr7:65579805-65619551:+	0.29	4.46	1.01E-5	Diabetic kidney disease	
THCA	cis	1	rs709607	chr7:65449541	RABGEF1	chr7:66093890-66276446:+	-0.47	-5.69	2.26E-8	Diabetic kidney disease	
THCA	cis	1	rs7096678	chr10:96069208	TBC1D12	chr10:96162186-96296089:+	-0.19	-4.21	3.0E-5	Esophageal cancer and gastric cancer	
THCA	cis	1	rs7096692	chr10:17180828	TRDMT1	chr10:17184983-17243681:-	-0.45	-10.19	3.44E-22	Homocysteine levels	
THCA	cis	1	rs7097701	chr10:124171857	PLEKHA1	chr10:124134220-124191866:+	-0.21	-5.75	1.61E-8	Height	
THCA	cis	1	rs7097	chr13:28197436	POLR1D	chr13:28194895-28241547:+	0.17	4.06	5.67E-5	Large B-cell lymphoma	
THCA	cis	1	rs7098825	chr10:104628234	AS3MT	chr10:104613967-104661653:+	-0.28	-3.76	0.000189	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs7098825	chr10:104628234	C10orf26	chr10:104503727-104591851:+	-0.21	-3.64	0.000299	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs7098825	chr10:104628234	SFXN2	chr10:104474298-104498946:+	-0.34	-4.06	5.64E-5	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs709937	chr2:233744021	GIGYF2	chr2:233562015-233725285:+	0.11	3.81	0.000158	Schizophrenia	
THCA	cis	1	rs709937	chr2:233744021	KCNJ13	chr2:233630860-233641275:-	0.13	3.48	0.000551	Schizophrenia	
THCA	cis	1	rs7099425	chr10:64960717	LOC84989	chr10:65224989-65226320:+	-0.28	-4.51	8.21E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs7099425	chr10:64960717	NRBF2	chr10:64893007-64914785:+	-0.28	-4.78	2.31E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs7099913	chr10:102314777	SEC31B	chr10:102246403-102289636:-	-0.29	-9.35	3.47E-19	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs7099965	chr10:102301165	SEC31B	chr10:102246403-102289636:-	-0.29	-9.16	1.47E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs7099	chr20:43997646	ZNF335	chr20:44577293-44600833:-	0.14	3.4	0.000738	Psoriasis	
THCA	cis	1	rs7100163	chr10:17181177	TRDMT1	chr10:17184983-17243681:-	-0.44	-9.9	3.96E-21	Homocysteine levels	
THCA	cis	1	rs7100386	chr10:102301417	SEC31B	chr10:102246403-102289636:-	-0.28	-9.04	3.94E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs7100697	chr10:124745323	C10orf88	chr10:124690419-124713919:-	-0.22	-4.08	5.37E-5	Migraine without aura	
THCA	cis	1	rs7101429	chr11:77992967	NARS2	chr11:78147017-78285909:-	-0.36	-6.49	2.15E-10	Testicular germ cell tumor	
THCA	cis	1	rs7101701	chr11:71762155	FAM86C	chr11:71498557-71512276:+	0.32	3.91	0.000107	Severe influenza A (H1N1) infection	
THCA	cis	1	rs7102084	chr11:74358132	POLD3	chr11:74303629-74353765:+	-0.23	-3.8	0.000162	Response to metformin (IC50)	
THCA	cis	1	rs7103210	chr11:71648966	FAM86C	chr11:71498557-71512276:+	0.3	3.83	0.000142	Severe influenza A (H1N1) infection	
THCA	cis	1	rs7103222	chr11:108309239	ACAT1	chr11:107992258-108018889:+	-0.26	-6.12	1.91E-9	Melanoma	
THCA	cis	1	rs7103969	chr11:3260150	MRGPRE	chr11:3249042-3253616:-	-0.19	-3.69	0.000253	Multiple sclerosis	
THCA	cis	1	rs7104094	chr11:3260259	MRGPRE	chr11:3249042-3253616:-	-0.19	-3.81	0.000156	Multiple sclerosis	
THCA	cis	1	rs7104222	chr11:78007169	NARS2	chr11:78147017-78285909:-	-0.36	-6.72	5.15E-11	Testicular germ cell tumor	
THCA	cis	1	rs7104488	chr11:3259830	MRGPRE	chr11:3249042-3253616:-	-0.18	-3.58	0.000372	Multiple sclerosis	
THCA	cis	1	rs7104661	chr11:8902501	TMEM9B	chr11:8968840-8986481:-	-0.24	-4.43	1.18E-5	Schizophrenia	
THCA	cis	1	rs7104764	chr11:229977	PSMD13	chr11:236808-252984:+	-0.22	-6.78	3.46E-11	Menarche (age at onset)	
THCA	cis	1	rs7104764	chr11:229977	SIRT3	chr11:214625-236931:-	0.12	3.44	0.000626	Menarche (age at onset)	
THCA	cis	1	rs7105178	chr11:64145109	VEGFB	chr11:64002266-64006258:+	0.13	3.59	0.000372	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs7105185	chr11:22817586	SVIP	chr11:22843600-22851382:-	0.21	3.42	0.000672	Dialysis-related mortality	
THCA	cis	1	rs7105282	chr11:47805614	C1QTNF4	chr11:47611216-47615961:-	-0.3	-5.23	2.56E-7	Subjective well-being	
THCA	cis	1	rs7106748	chr11:71645803	FAM86C	chr11:71498557-71512276:+	0.32	3.89	0.000116	Severe influenza A (H1N1) infection	
THCA	cis	1	rs7107174	chr11:77997936	NARS2	chr11:78147017-78285909:-	-0.35	-6.33	5.53E-10	Testicular germ cell tumor	
THCA	cis	1	rs710865	chr1:19568972	CAPZB	chr1:19665274-19811992:-	0.12	3.48	0.000552	Brain structure	
THCA	cis	1	rs710865	chr1:19568972	KIAA0090	chr1:19544585-19578046:-	-0.29	-9.65	2.9E-20	Brain structure	
THCA	cis	1	rs710866	chr1:19568722	CAPZB	chr1:19665274-19811992:-	0.12	3.52	0.000475	Brain structure	
THCA	cis	1	rs710866	chr1:19568722	KIAA0090	chr1:19544585-19578046:-	-0.29	-9.67	2.58E-20	Brain structure	
THCA	cis	1	rs7109698	chr11:46673344	PACSIN3	chr11:47199085-47207958:-	-0.15	-3.57	0.000395	Schizophrenia	
THCA	cis	1	rs7111986	chr11:78102266	NARS2	chr11:78147017-78285909:-	-0.4	-7.05	6.34E-12	Testicular germ cell tumor	
THCA	cis	1	rs7111	chr15:90373873	AP3S2	chr15:90373832-90456222:-	-0.75	-18.8	1.86E-59	Type 2 diabetes	
THCA	cis	1	rs7111	chr15:90373873	C15orf38	chr15:90443832-90456222:-	0.36	7.6	1.54E-13	Type 2 diabetes	
THCA	cis	1	rs7112229	chr11:46513249	PACSIN3	chr11:47199085-47207958:-	0.17	3.88	0.000121	Schizophrenia	
THCA	cis	1	rs7112234	chr11:78102470	NARS2	chr11:78147017-78285909:-	-0.38	-7.1	4.55E-12	Testicular germ cell tumor	
THCA	cis	1	rs7112513	chr11:117037361	PCSK7	chr11:117075789-117102811:-	-0.38	-6.66	7.48E-11	Protein quantitative trait loci	
THCA	cis	1	rs7113042	chr11:78035832	NARS2	chr11:78147017-78285909:-	0.37	6.99	9.18E-12	Testicular germ cell tumor	
THCA	cis	1	rs7113549	chr11:71829967	FAM86C	chr11:71498557-71512276:+	-0.31	-3.95	8.86E-5	Severe influenza A (H1N1) infection	
THCA	cis	1	rs7114252	chr11:71237606	NADSYN1	chr11:71164217-71212579:+	0.18	4.11	4.67E-5	Vitamin D levels	
THCA	cis	1	rs7114963	chr11:116875983	PCSK7	chr11:117075789-117102811:-	-0.29	-5.09	5.09E-7	Protein quantitative trait loci	
THCA	cis	1	rs7115737	chr11:43681249	HSD17B12	chr11:43702143-43878160:+	-0.69	-14.36	4.1E-39	Forced vital capacity	
THCA	cis	1	rs7116495	chr11:71762085	FAM86C	chr11:71498557-71512276:+	0.32	3.91	0.000107	Severe influenza A (H1N1) infection	
THCA	cis	1	rs7116611	chr11:78030046	NARS2	chr11:78147017-78285909:-	-0.37	-6.59	1.15E-10	Testicular germ cell tumor	
THCA	cis	1	rs7116650	chr11:120041917	TRIM29	chr11:119981995-120008863:-	0.41	7.05	6.15E-12	Stroke (pediatric)	
THCA	cis	1	rs7116698	chr11:77995191	NARS2	chr11:78147017-78285909:-	-0.37	-6.75	4.22E-11	Testicular germ cell tumor	
THCA	cis	1	rs7117238	chr11:78040259	NARS2	chr11:78147017-78285909:-	-0.41	-7.95	1.37E-14	Testicular germ cell tumor	
THCA	cis	1	rs7118648	chr11:96108428	CCDC82	chr11:96085930-96123083:-	-0.26	-4.22	2.92E-5	Parkinson's disease	
THCA	cis	1	rs7119933	chr11:78049750	NARS2	chr11:78147017-78285909:-	-0.39	-7.38	6.84E-13	Testicular germ cell tumor	
THCA	cis	1	rs7119954	chr11:120046224	TRIM29	chr11:119981995-120008863:-	0.41	7.02	7.48E-12	Stroke (pediatric)	
THCA	cis	1	rs7119	chr15:77777632	HMG20A	chr15:77713243-77777943:+	0.16	3.48	0.00055	Type 2 diabetes	
THCA	cis	1	rs7119	chr15:77777632	SGK269	chr15:77400471-77577333:-	0.16	5.34	1.47E-7	Type 2 diabetes	
THCA	cis	1	rs7120029	chr11:71198957	NADSYN1	chr11:71164217-71212579:+	0.2	4.74	2.85E-6	Vitamin D levels	
THCA	cis	1	rs712022	chr11:22843155	SVIP	chr11:22843600-22851382:-	-0.29	-7.04	6.67E-12	Dialysis-related mortality	
THCA	cis	1	rs7120333	chr11:47817441	C1QTNF4	chr11:47611216-47615961:-	-0.31	-5.38	1.2E-7	Subjective well-being	
THCA	cis	1	rs712039	chr17:35850553	TADA2A	chr17:35766981-35837224:+	-0.2	-4.75	2.67E-6	Tuberculosis	
THCA	cis	1	rs7120668	chr11:5567854	UBQLNL	chr11:5535624-5537956:-	-0.28	-6.23	1.05E-9	QRS duration in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs7121260	chr11:71700566	FAM86C	chr11:71498557-71512276:+	0.28	3.55	0.000418	Severe influenza A (H1N1) infection	
THCA	cis	1	rs7121347	chr11:116867209	PCSK7	chr11:117075789-117102811:-	-0.28	-5.03	7.12E-7	Protein quantitative trait loci	
THCA	cis	1	rs7121554	chr11:112048051	BCO2	chr11:112046208-112095421:+	0.24	4.89	1.37E-6	Interleukin-18 levels	
THCA	cis	1	rs7121554	chr11:112048051	IL18	chr11:112013976-112034840:-	-0.23	-4.36	1.62E-5	Interleukin-18 levels	
THCA	cis	1	rs7122375	chr11:111171071	C11orf92	chr11:111164171-111175770:-	-0.18	-3.98	8.02E-5	Colorectal cancer	
THCA	cis	1	rs7122944	chr11:117034619	PCSK7	chr11:117075789-117102811:-	-0.39	-6.84	2.39E-11	Protein quantitative trait loci	
THCA	cis	1	rs7123517	chr11:117027755	PCSK7	chr11:117075789-117102811:-	-0.4	-6.89	1.74E-11	Protein quantitative trait loci	
THCA	cis	1	rs7123908	chr11:3260189	MRGPRE	chr11:3249042-3253616:-	-0.19	-3.69	0.000253	Multiple sclerosis	
THCA	cis	1	rs7124000	chr11:71754338	FAM86C	chr11:71498557-71512276:+	0.3	3.8	0.000166	Severe influenza A (H1N1) infection	
THCA	cis	1	rs7124741	chr11:116752219	PCSK7	chr11:117075789-117102811:-	-0.27	-4.68	3.79E-6	Protein quantitative trait loci	
THCA	cis	1	rs7124974	chr11:59906972	MS4A14	chr11:60145958-60185226:+	0.18	4.47	9.6E-6	Alzheimer's disease (late onset)	
THCA	cis	1	rs7125746	chr11:5556005	UBQLNL	chr11:5535624-5537956:-	-0.28	-6.5	2.07E-10	QRS duration in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs7126396	chr11:22130513	ANO5	chr11:22214722-22304913:+	0.29	5.69	2.17E-8	Parkinson's disease	
THCA	cis	1	rs7127187	chr11:77995188	NARS2	chr11:78147017-78285909:-	-0.37	-6.78	3.47E-11	Testicular germ cell tumor	
THCA	cis	1	rs7127529	chr11:46582072	PACSIN3	chr11:47199085-47207958:-	0.16	3.59	0.000359	Schizophrenia	
THCA	cis	1	rs7127865	chr11:71747781	FAM86C	chr11:71498557-71512276:+	0.32	3.91	0.000107	Severe influenza A (H1N1) infection	
THCA	cis	1	rs7128029	chr11:244141	PSMD13	chr11:236808-252984:+	-0.22	-6.73	4.91E-11	Menarche (age at onset)	
THCA	cis	1	rs7128029	chr11:244141	SIRT3	chr11:214625-236931:-	0.12	3.37	0.000812	Menarche (age at onset)	
THCA	cis	1	rs7128044	chr11:244115	PSMD13	chr11:236808-252984:+	-0.22	-6.73	4.91E-11	Menarche (age at onset)	
THCA	cis	1	rs7128044	chr11:244115	SIRT3	chr11:214625-236931:-	0.12	3.37	0.000812	Menarche (age at onset)	
THCA	cis	1	rs7128317	chr11:71701367	FAM86C	chr11:71498557-71512276:+	-0.3	-3.66	0.00028	Severe influenza A (H1N1) infection	
THCA	cis	1	rs7128666	chr11:78102363	NARS2	chr11:78147017-78285909:-	-0.4	-7.06	5.95E-12	Testicular germ cell tumor	
THCA	cis	1	rs7129491	chr11:57095082	TIMM10	chr11:57295936-57298232:-	-0.24	-4.38	1.49E-5	Low high density lipoprotein cholesterol levels	
THCA	cis	1	rs7129556	chr11:77300048	AQP11	chr11:77300436-77320691:+	-0.4	-6.19	1.26E-9	Weight loss (gastric bypass surgery)	
THCA	cis	1	rs71299622	chr3:52917038	RFT1	chr3:53122503-53164470:-	0.61	6.95	1.18E-11	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs71299622	chr3:52917038	TMEM110	chr3:52867139-52931547:-	0.41	4.71	3.28E-6	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs71301804	chr3:53073314	RFT1	chr3:53122503-53164470:-	0.58	6.72	5.1E-11	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs71301804	chr3:53073314	TMEM110	chr3:52867139-52931547:-	0.35	4.05	6.03E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs71301808	chr3:53085577	RFT1	chr3:53122503-53164470:-	0.64	7.57	2.0E-13	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs71301808	chr3:53085577	TMEM110	chr3:52867139-52931547:-	0.32	3.8	0.000167	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs71301809	chr3:53090312	RFT1	chr3:53122503-53164470:-	0.64	7.59	1.65E-13	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs71301809	chr3:53090312	TMEM110	chr3:52867139-52931547:-	0.32	3.77	0.000184	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs71301814	chr3:53117663	RFT1	chr3:53122503-53164470:-	0.63	7.39	6.57E-13	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs71301814	chr3:53117663	SFMBT1	chr3:52938628-53080070:-	-0.2	-3.41	0.000717	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs7130829	chr11:71237702	NADSYN1	chr11:71164217-71212579:+	0.17	3.89	0.000114	Vitamin D levels	
THCA	cis	1	rs7131094	chr11:112044917	BCO2	chr11:112046208-112095421:+	0.24	4.89	1.37E-6	Interleukin-18 levels	
THCA	cis	1	rs7131094	chr11:112044917	IL18	chr11:112013976-112034840:-	-0.23	-4.36	1.62E-5	Interleukin-18 levels	
THCA	cis	1	rs71311855	chr3:58320507	PXK	chr3:58318617-58410878:+	0.33	5.99	4.22E-9	Cholesterol, total	
THCA	cis	1	rs71311857	chr3:58323377	PXK	chr3:58318617-58410878:+	0.34	6.03	3.22E-9	Cholesterol, total	
THCA	cis	1	rs71311858	chr3:58323793	PXK	chr3:58318617-58410878:+	0.34	6.03	3.22E-9	Cholesterol, total	
THCA	cis	1	rs71311864	chr3:58372324	PXK	chr3:58318617-58410878:+	0.34	6.01	3.64E-9	Cholesterol, total	
THCA	cis	1	rs71311865	chr3:58372423	PXK	chr3:58318617-58410878:+	0.34	6.01	3.64E-9	Cholesterol, total	
THCA	cis	1	rs71311868	chr3:58392874	PXK	chr3:58318617-58410878:+	0.33	5.81	1.16E-8	Cholesterol, total	
THCA	cis	1	rs71311869	chr3:58398922	PXK	chr3:58318617-58410878:+	0.33	5.77	1.42E-8	Cholesterol, total	
THCA	cis	1	rs71311870	chr3:58399283	PXK	chr3:58318617-58410878:+	0.33	5.77	1.42E-8	Cholesterol, total	
THCA	cis	1	rs71311871	chr3:58420613	PXK	chr3:58318617-58410878:+	0.35	5.94	5.37E-9	Cholesterol, total	
THCA	cis	1	rs71311873	chr3:58447106	PXK	chr3:58318617-58410878:+	0.36	6.2	1.24E-9	Cholesterol, total	
THCA	cis	1	rs7131305	chr11:5567735	UBQLNL	chr11:5535624-5537956:-	-0.27	-6.16	1.55E-9	QRS duration in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs7131882	chr12:124426736	ZNF664	chr12:124457670-124499967:+	-0.18	-5.02	7.43E-7	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs713219	chr9:131900920	CRAT	chr9:131857075-131873070:-	0.29	6.92	1.47E-11	Blood metabolite ratios	
THCA	cis	1	rs71324766	chr22:29839659	NIPSNAP1	chr22:29950800-29977144:-	0.3	3.89	0.000115	Carotid atherosclerosis in HIV infection	
THCA	cis	1	rs71324766	chr22:29839659	THOC5	chr22:29904157-29949736:-	0.2	3.61	0.000334	Carotid atherosclerosis in HIV infection	
THCA	cis	1	rs7132655	chr12:124438973	ZNF664	chr12:124457670-124499967:+	-0.18	-5.13	4.32E-7	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs71327718	chr3:125592857	LOC100125556	chr3:125635444-125648865:+	0.68	9.92	3.33E-21	Metabolite levels (HVA/5-HIAA ratio)	
THCA	cis	1	rs71329486	chr22:29831208	NIPSNAP1	chr22:29950800-29977144:-	0.29	3.86	0.00013	Carotid atherosclerosis in HIV infection	
THCA	cis	1	rs71329486	chr22:29831208	THOC5	chr22:29904157-29949736:-	0.18	3.4	0.000739	Carotid atherosclerosis in HIV infection	
THCA	cis	1	rs71329487	chr22:29833469	NIPSNAP1	chr22:29950800-29977144:-	0.28	3.71	0.000228	Carotid atherosclerosis in HIV infection	
THCA	cis	1	rs71329487	chr22:29833469	THOC5	chr22:29904157-29949736:-	0.19	3.52	0.000473	Carotid atherosclerosis in HIV infection	
THCA	cis	1	rs7133079	chr12:81439523	ACSS3	chr12:81471809-81649582:+	0.22	4.67	4.01E-6	Neuroticism	
THCA	cis	1	rs7134594	chr12:110000193	KCTD10	chr12:109886460-109915155:-	-0.23	-5.91	6.66E-9	HDL cholesterol	
THCA	cis	1	rs7134718	chr12:22568271	KIAA0528	chr12:22601526-22697452:-	0.23	3.79	0.000171	Coronary artery calcification	
THCA	cis	1	rs7135854	chr12:129279988	GLT1D1	chr12:129338081-129469509:+	-0.22	-5.54	5.11E-8	Systemic lupus erythematosus	
THCA	cis	1	rs7135854	chr12:129279988	SLC15A4	chr12:129277739-129308541:-	-0.19	-4.57	6.09E-6	Systemic lupus erythematosus	
THCA	cis	1	rs7135987	chr12:129280117	GLT1D1	chr12:129338081-129469509:+	-0.22	-5.47	7.23E-8	Systemic lupus erythematosus	
THCA	cis	1	rs7135987	chr12:129280117	SLC15A4	chr12:129277739-129308541:-	-0.18	-4.51	8.29E-6	Systemic lupus erythematosus	
THCA	cis	1	rs7136092	chr12:129280164	GLT1D1	chr12:129338081-129469509:+	-0.22	-5.54	5.11E-8	Systemic lupus erythematosus	
THCA	cis	1	rs7136092	chr12:129280164	SLC15A4	chr12:129277739-129308541:-	-0.19	-4.57	6.09E-6	Systemic lupus erythematosus	
THCA	cis	1	rs71367913	chr17:40589869	NAGLU	chr17:40687951-40696464:+	-0.24	-5.08	5.33E-7	Crohn's disease	
THCA	cis	1	rs71367913	chr17:40589869	TUBG2	chr17:40811266-40819023:+	-0.23	-5.4	1.08E-7	Crohn's disease	
THCA	cis	1	rs713835	chr22:38064650	LGALS2	chr22:37966254-37976024:-	0.13	3.52	0.000477	Fat distribution (HIV)	
THCA	cis	1	rs713835	chr22:38064650	PDXP	chr22:38054737-38062939:+	-0.18	-3.38	0.000775	Fat distribution (HIV)	
THCA	cis	1	rs713835	chr22:38064650	SH3BP1	chr22:38030661-38062939:+	0.11	3.56	0.000403	Fat distribution (HIV)	
THCA	cis	1	rs713875	chr22:30592487	MTMR3	chr22:30279158-30426855:+	-0.21	-5.28	1.95E-7	Crohn's disease	
THCA	cis	1	rs71388556	chr16:4070872	NAT15	chr16:3493668-3536962:+	-0.3	-3.69	0.000248	Diisocyanate-induced asthma	
THCA	cis	1	rs71391092	chr16:74567075	MLKL	chr16:74705753-74734789:-	-0.16	-3.35	0.000884	Schizophrenia	
THCA	cis	1	rs71391092	chr16:74567075	RFWD3	chr16:74655298-74700779:-	0.27	5.25	2.31E-7	Schizophrenia	
THCA	cis	1	rs7139533	chr13:95865575	ABCC4	chr13:95672084-95953687:-	-0.19	-3.65	0.000292	Breast cancer	
THCA	cis	1	rs7140261	chr14:65973956	LOC645431	chr14:65877313-65879335:-	-0.59	-7.49	3.44E-13	Ischemic stroke	
THCA	cis	1	rs71403859	chr16:71640207	ZNF19	chr16:71507976-71523254:-	0.26	4.09	5.0E-5	Post bronchodilator FEV1	
THCA	cis	1	rs7141087	chr14:101036052	BEGAIN	chr14:101003486-101036131:-	-0.29	-7.25	1.67E-12	Menarche (age at onset)	
THCA	cis	1	rs7141319	chr14:55336360	GCH1	chr14:55308724-55369542:-	-0.22	-4.54	7.03E-6	Rheumatoid arthritis;Obesity-related traits	
THCA	cis	1	rs7142180	chr14:71759895	SIPA1L1	chr14:71933902-72206118:+	0.27	5.57	4.19E-8	Mitral valve prolapse	
THCA	cis	1	rs7142235	chr14:75559963	EIF2B2	chr14:75469612-75476292:+	0.19	5.14	4.06E-7	Height	
THCA	cis	1	rs7142235	chr14:75559963	MLH3	chr14:75480467-75518235:-	0.3	8.94	8.33E-18	Height	
THCA	cis	1	rs7142235	chr14:75559963	RPS6KL1	chr14:75372347-75389958:-	0.32	6.85	2.28E-11	Height	
THCA	cis	1	rs71423932	chr2:47202613	MCFD2	chr2:47129017-47168878:-	-0.26	-3.99	7.65E-5	Response to statin therapy	
THCA	cis	1	rs7142457	chr14:50097862	MGAT2	chr14:50087489-50090198:+	0.22	4.39	1.37E-5	Carotid intima media thickness	
THCA	cis	1	rs7142457	chr14:50097862	RPL36AL	chr14:50085407-50087349:-	0.54	15.61	1.07E-44	Carotid intima media thickness	
THCA	cis	1	rs71426508	chr2:239137767	LOC151174	chr2:239133754-239140318:-	0.63	6.43	3.01E-10	Irritable bowel syndrome	
THCA	cis	1	rs71426509	chr2:239175334	LOC151174	chr2:239133754-239140318:-	0.49	5.35	1.34E-7	Irritable bowel syndrome	
THCA	cis	1	rs71426510	chr2:239178909	LOC151174	chr2:239133754-239140318:-	0.49	5.35	1.34E-7	Irritable bowel syndrome	
THCA	cis	1	rs7142704	chr14:55630603	FBXO34	chr14:55738021-55893431:+	-0.14	-3.46	0.000584	Protein biomarker	
THCA	cis	1	rs7142704	chr14:55630603	KIAA0831	chr14:55833110-55878576:-	-0.13	-3.61	0.000334	Protein biomarker	
THCA	cis	1	rs71430278	chr2:218312448	IGFBP5	chr2:217536829-217560272:-	-0.23	-4.86	1.6E-6	Metabolite levels (MHPG)	
THCA	cis	1	rs7144423	chr14:35572547	FAM177A1	chr14:35514113-35552587:+	-0.2	-3.63	0.000318	Atopic dermatitis	
THCA	cis	1	rs7144423	chr14:35572547	KIAA0391	chr14:35591776-35786673:+	0.32	5.86	8.46E-9	Atopic dermatitis	
THCA	cis	1	rs7144423	chr14:35572547	PPP2R3C	chr14:35554679-35591679:-	0.54	9.81	7.91E-21	Atopic dermatitis	
THCA	cis	1	rs7145159	chr14:75583268	EIF2B2	chr14:75469612-75476292:+	0.17	4.65	4.38E-6	Height	
THCA	cis	1	rs7145159	chr14:75583268	MLH3	chr14:75480467-75518235:-	0.29	8.63	8.93E-17	Height	
THCA	cis	1	rs7145159	chr14:75583268	RPS6KL1	chr14:75372347-75389958:-	0.32	6.83	2.63E-11	Height	
THCA	cis	1	rs7145574	chr14:65884402	LOC645431	chr14:65877313-65879335:-	-0.6	-7.88	2.31E-14	Ischemic stroke	
THCA	cis	1	rs7145588	chr14:88826796	SPATA7	chr14:88852012-88904802:+	-0.17	-3.58	0.000384	Coronary artery calcification	
THCA	cis	1	rs7146488	chr14:81781795	STON2	chr14:81727000-81893748:-	0.2	4.08	5.37E-5	Obesity-related traits	
THCA	cis	1	rs7147118	chr14:75610170	EIF2B2	chr14:75469612-75476292:+	0.19	5.12	4.49E-7	Height	
THCA	cis	1	rs7147118	chr14:75610170	MLH3	chr14:75480467-75518235:-	0.3	8.98	6.21E-18	Height	
THCA	cis	1	rs7147118	chr14:75610170	RPS6KL1	chr14:75372347-75389958:-	0.32	6.87	1.95E-11	Height	
THCA	cis	1	rs7147624	chr14:65865625	LOC645431	chr14:65877313-65879335:-	-0.25	-3.47	0.000576	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs7147996	chr14:90396574	TDP1	chr14:90421283-90511106:+	-0.16	-4.45	1.05E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs7148538	chr14:74392342	LIN52	chr14:74551656-74667117:+	0.24	4.4	1.31E-5	Morning vs. evening chronotype	
THCA	cis	1	rs7148538	chr14:74392342	PTGR2	chr14:74318534-74352166:+	0.22	3.57	0.000399	Morning vs. evening chronotype	
THCA	cis	1	rs7148538	chr14:74392342	ZNF410	chr14:74318674-74398803:+	0.23	3.95	9.18E-5	Morning vs. evening chronotype	
THCA	cis	1	rs71487292	chr11:486076	IRF7	chr11:612556-615999:-	0.25	3.63	0.000309	Body mass index	
THCA	cis	1	rs714909	chr22:31741067	RNF185	chr22:31556138-31603004:+	0.26	4.77	2.44E-6	Paclitaxel-induced neuropathy	
THCA	cis	1	rs7150141	chr14:104129352	KLC1	chr14:104029299-104167887:+	-0.22	-4.65	4.38E-6	Body mass index	
THCA	cis	1	rs7150233	chr14:66200816	LOC645431	chr14:65877313-65879335:-	0.26	3.4	0.00073	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs71514277	chr1:27034428	PIGV	chr1:27114455-27124886:+	-0.3	-3.42	0.000676	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs71514277	chr1:27034428	ZDHHC18	chr1:27153201-27182207:+	0.79	8.34	7.99E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs71519448	chr8:57157795	LYN	chr8:56792386-56923936:+	-0.15	-3.87	0.000124	Height	
THCA	cis	1	rs7152001	chr14:67461348	ATP6V1D	chr14:67761090-67826591:-	0.2	4.63	4.83E-6	Depression (quantitative trait)	
THCA	cis	1	rs7152001	chr14:67461348	EIF2S1	chr14:67827034-67853232:+	-0.22	-4.9	1.34E-6	Depression (quantitative trait)	
THCA	cis	1	rs71526949	chr8:89582882	MMP16	chr8:89049462-89339717:-	0.16	3.69	0.000254	Body mass index and cholesterol (psychopharmacological treatment)	
THCA	cis	1	rs71526953	chr8:89595818	MMP16	chr8:89049462-89339717:-	0.16	3.61	0.000333	Body mass index and cholesterol (psychopharmacological treatment)	
THCA	cis	1	rs7153097	chr14:81772203	STON2	chr14:81727000-81893748:-	0.21	4.2	3.16E-5	Obesity-related traits	
THCA	cis	1	rs7153160	chr14:74509377	C14orf45	chr14:74486059-74549566:+	0.18	5.08	5.29E-7	Common traits (Other)	
THCA	cis	1	rs7153160	chr14:74509377	LIN52	chr14:74551656-74667117:+	0.45	11.7	5.56E-28	Common traits (Other)	
THCA	cis	1	rs7153497	chr14:65998415	LOC645431	chr14:65877313-65879335:-	0.27	3.48	0.000554	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs7153538	chr14:81779507	STON2	chr14:81727000-81893748:-	0.21	4.2	3.16E-5	Obesity-related traits	
THCA	cis	1	rs7153587	chr14:74509660	C14orf45	chr14:74486059-74549566:+	0.17	4.93	1.13E-6	Common traits (Other)	
THCA	cis	1	rs7153587	chr14:74509660	COQ6	chr14:74416643-74429811:+	0.13	3.61	0.00034	Common traits (Other)	
THCA	cis	1	rs7153587	chr14:74509660	LIN52	chr14:74551656-74667117:+	0.49	13.17	5.3E-34	Common traits (Other)	
THCA	cis	1	rs7153679	chr14:66012954	LOC645431	chr14:65877313-65879335:-	-0.54	-6.99	9.15E-12	Ischemic stroke	
THCA	cis	1	rs7154306	chr14:35540499	FAM177A1	chr14:35514113-35552587:+	-0.22	-4.11	4.65E-5	Atopic dermatitis	
THCA	cis	1	rs7154306	chr14:35540499	KIAA0391	chr14:35591776-35786673:+	0.29	5.48	6.94E-8	Atopic dermatitis	
THCA	cis	1	rs7154306	chr14:35540499	PPP2R3C	chr14:35554679-35591679:-	0.53	10.11	6.8E-22	Atopic dermatitis	
THCA	cis	1	rs7154309	chr14:81782933	STON2	chr14:81727000-81893748:-	0.2	4.01	7.15E-5	Obesity-related traits	
THCA	cis	1	rs71550519	chr6:56780272	BEND6	chr6:56819773-56892138:+	-0.31	-6.51	1.96E-10	Menarche (age at onset)	
THCA	cis	1	rs71550519	chr6:56780272	KIAA1586	chr6:56911384-56920021:+	-0.33	-5.14	3.93E-7	Menarche (age at onset)	
THCA	cis	1	rs715510	chr22:31690528	RNF185	chr22:31556138-31603004:+	-0.29	-5.29	1.84E-7	Paclitaxel-induced neuropathy	
THCA	cis	1	rs7155275	chr14:65502271	CHURC1	chr14:65381140-65411309:+	0.22	4.47	9.73E-6	Red blood cell traits	
THCA	cis	1	rs7155275	chr14:65502271	FNTB	chr14:65381140-65529369:+	-0.21	-4.36	1.58E-5	Red blood cell traits	
THCA	cis	1	rs7155454	chr14:65502239	CHURC1	chr14:65381140-65411309:+	0.23	4.59	5.66E-6	Red blood cell traits	
THCA	cis	1	rs7155454	chr14:65502239	FNTB	chr14:65381140-65529369:+	-0.22	-4.52	7.77E-6	Red blood cell traits	
THCA	cis	1	rs7155930	chr14:81776026	STON2	chr14:81727000-81893748:-	0.21	4.2	3.16E-5	Obesity-related traits	
THCA	cis	1	rs7156105	chr14:75541954	EIF2B2	chr14:75469612-75476292:+	0.19	5.1	4.83E-7	Height	
THCA	cis	1	rs7156105	chr14:75541954	MLH3	chr14:75480467-75518235:-	0.3	8.97	6.75E-18	Height	
THCA	cis	1	rs7156105	chr14:75541954	RPS6KL1	chr14:75372347-75389958:-	0.32	6.9	1.68E-11	Height	
THCA	cis	1	rs7156146	chr14:81776297	STON2	chr14:81727000-81893748:-	0.21	4.19	3.34E-5	Obesity-related traits	
THCA	cis	1	rs7156251	chr14:81776179	STON2	chr14:81727000-81893748:-	0.21	4.2	3.16E-5	Obesity-related traits	
THCA	cis	1	rs7156322	chr14:35544330	FAM177A1	chr14:35514113-35552587:+	-0.22	-4.07	5.41E-5	Atopic dermatitis	
THCA	cis	1	rs7156322	chr14:35544330	KIAA0391	chr14:35591776-35786673:+	0.29	5.41	9.94E-8	Atopic dermatitis	
THCA	cis	1	rs7156322	chr14:35544330	PPP2R3C	chr14:35554679-35591679:-	0.52	9.86	5.21E-21	Atopic dermatitis	
THCA	cis	1	rs7156328	chr14:75532941	EIF2B2	chr14:75469612-75476292:+	0.18	4.85	1.67E-6	Height	
THCA	cis	1	rs7156328	chr14:75532941	MLH3	chr14:75480467-75518235:-	0.29	8.58	1.38E-16	Height	
THCA	cis	1	rs7156328	chr14:75532941	RPS6KL1	chr14:75372347-75389958:-	0.31	6.77	3.84E-11	Height	
THCA	cis	1	rs71563547	chr7:97615831	MGC72080	chr7:97503667-97601638:-	0.25	3.38	0.000793	Sudden cardiac arrest	
THCA	cis	1	rs7156355	chr14:97293713	VRK1	chr14:97263684-97347950:+	0.17	4.01	6.98E-5	Neutrophil count	
THCA	cis	1	rs7156460	chr14:71855334	SIPA1L1	chr14:71933902-72206118:+	0.27	5.4	1.04E-7	Mitral valve prolapse	
THCA	cis	1	rs71564866	chr6:56771207	BEND6	chr6:56819773-56892138:+	-0.32	-6.5	1.97E-10	Menarche (age at onset)	
THCA	cis	1	rs71564866	chr6:56771207	KIAA1586	chr6:56911384-56920021:+	-0.34	-5.17	3.45E-7	Menarche (age at onset)	
THCA	cis	1	rs71564868	chr6:56798441	BEND6	chr6:56819773-56892138:+	-0.29	-6.04	3.16E-9	Menarche (age at onset)	
THCA	cis	1	rs71564868	chr6:56798441	KIAA1586	chr6:56911384-56920021:+	-0.32	-4.92	1.18E-6	Menarche (age at onset)	
THCA	cis	1	rs71567659	chr6:163001736	PACRG	chr6:163148164-163736523:+	0.46	7.08	5.13E-12	Body mass index	
THCA	cis	1	rs7157566	chr14:74649129	C14orf45	chr14:74486059-74549566:+	-0.16	-4.59	5.7E-6	Common traits (Other)	
THCA	cis	1	rs7157566	chr14:74649129	COQ6	chr14:74416643-74429811:+	-0.14	-3.96	8.65E-5	Common traits (Other)	
THCA	cis	1	rs7157566	chr14:74649129	LIN52	chr14:74551656-74667117:+	-0.5	-13.52	1.71E-35	Common traits (Other)	
THCA	cis	1	rs7157940	chr14:94563193	IFI27L1	chr14:94547639-94569059:+	0.17	4.74	2.87E-6	Anthropometric traits	
THCA	cis	1	rs71586101	chr5:125908586	ALDH7A1	chr5:125878918-125931082:-	0.44	6.2	1.25E-9	Osteoporosis	
THCA	cis	1	rs7160110	chr14:55594635	FBXO34	chr14:55738021-55893431:+	-0.14	-3.38	0.00078	Protein biomarker	
THCA	cis	1	rs7160110	chr14:55594635	KIAA0831	chr14:55833110-55878576:-	-0.14	-3.91	0.000108	Protein biomarker	
THCA	cis	1	rs7160390	chr14:66052460	LOC645431	chr14:65877313-65879335:-	0.26	3.51	0.000487	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs71617204	chr3:53042951	RFT1	chr3:53122503-53164470:-	0.62	6.93	1.34E-11	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs71617204	chr3:53042951	TMEM110	chr3:52867139-52931547:-	0.37	4.15	3.91E-5	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs7162129	chr15:84566444	LOC388152	chr15:84867600-84898920:-	-0.21	-3.89	0.000116	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs7162175	chr15:90897473	IQGAP1	chr15:90931473-91045475:+	0.14	4.3	2.07E-5	Rheumatoid arthritis	
THCA	cis	1	rs7162175	chr15:90897473	TTLL13	chr15:90792764-90815443:+	0.27	4.44	1.13E-5	Rheumatoid arthritis	
THCA	cis	1	rs7162243	chr15:90892631	IQGAP1	chr15:90931473-91045475:+	0.13	4.3	2.1E-5	Rheumatoid arthritis	
THCA	cis	1	rs7162243	chr15:90892631	TTLL13	chr15:90792764-90815443:+	0.25	4.32	1.86E-5	Rheumatoid arthritis	
THCA	cis	1	rs7162536	chr15:62373459	VPS13C	chr15:62144592-62352647:-	-0.1	-3.84	0.000142	Height	
THCA	cis	1	rs7162900	chr15:75368017	ARID3B	chr15:74833548-74890470:+	-0.16	-4.14	4.12E-5	Blood trace element (Zn levels)	
THCA	cis	1	rs7162900	chr15:75368017	PPCDC	chr15:75315927-75343066:+	0.13	3.68	0.000255	Blood trace element (Zn levels)	
THCA	cis	1	rs7162900	chr15:75368017	SCAMP2	chr15:75136073-75165670:-	-0.16	-3.49	0.000528	Blood trace element (Zn levels)	
THCA	cis	1	rs7162900	chr15:75368017	SCAMP5	chr15:75287901-75313836:+	0.4	7.2	2.39E-12	Blood trace element (Zn levels)	
THCA	cis	1	rs7163482	chr15:65739683	DPP8	chr15:65737999-65810035:-	-0.09	-3.95	8.88E-5	Mean corpuscular hemoglobin	
THCA	cis	1	rs7163482	chr15:65739683	SLC24A1	chr15:65903704-65953256:+	-0.16	-3.86	0.00013	Mean corpuscular hemoglobin	
THCA	cis	1	rs71636769	chr1:27020591	ZDHHC18	chr1:27153201-27182207:+	0.8	8.6	1.15E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs71636770	chr1:27021115	ZDHHC18	chr1:27153201-27182207:+	0.8	8.6	1.15E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs71636773	chr1:27051319	ZDHHC18	chr1:27153201-27182207:+	0.8	8.6	1.18E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs71636777	chr1:27088268	PIGV	chr1:27114455-27124886:+	-0.29	-3.4	0.000724	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs71636777	chr1:27088268	ZDHHC18	chr1:27153201-27182207:+	0.8	8.61	1.06E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs71636783	chr1:27139861	ZDHHC18	chr1:27153201-27182207:+	0.81	8.65	7.95E-17	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs71636795	chr1:27241025	PIGV	chr1:27114455-27124886:+	-0.25	-4.08	5.36E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs71636795	chr1:27241025	ZDHHC18	chr1:27153201-27182207:+	0.77	12.28	2.65E-30	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs71640337	chr1:27004388	ZDHHC18	chr1:27153201-27182207:+	0.78	8.53	2.0E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs71640338	chr1:27011449	ZDHHC18	chr1:27153201-27182207:+	0.78	8.36	6.94E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs7164132	chr15:40675155	C15orf23	chr15:40674922-40686488:+	0.67	9.31	4.72E-19	Heschl's gyrus morphology	
THCA	cis	1	rs7164132	chr15:40675155	IVD	chr15:40697686-40713512:+	-0.55	-10.25	2.01E-22	Heschl's gyrus morphology	
THCA	cis	1	rs7165102	chr15:65888359	DPP8	chr15:65737999-65810035:-	-0.09	-3.66	0.000285	Mean corpuscular hemoglobin	
THCA	cis	1	rs7165102	chr15:65888359	SLC24A1	chr15:65903704-65953256:+	-0.15	-3.73	0.000212	Mean corpuscular hemoglobin	
THCA	cis	1	rs7166453	chr15:66013143	DPP8	chr15:65737999-65810035:-	-0.09	-3.96	8.81E-5	Mean corpuscular hemoglobin	
THCA	cis	1	rs7166453	chr15:66013143	SLC24A1	chr15:65903704-65953256:+	-0.16	-3.78	0.000177	Mean corpuscular hemoglobin	
THCA	cis	1	rs7166991	chr15:40671957	C15orf23	chr15:40674922-40686488:+	0.66	9.17	1.38E-18	Heschl's gyrus morphology	
THCA	cis	1	rs7166991	chr15:40671957	IVD	chr15:40697686-40713512:+	-0.54	-9.98	1.93E-21	Heschl's gyrus morphology	
THCA	cis	1	rs7167138	chr15:50958998	SPPL2A	chr15:50999739-51057910:-	0.28	7.46	4.1E-13	QT interval	
THCA	cis	1	rs7167285	chr15:75368769	ARID3B	chr15:74833548-74890470:+	-0.15	-4.01	7.14E-5	Blood trace element (Zn levels)	
THCA	cis	1	rs7167285	chr15:75368769	PPCDC	chr15:75315927-75343066:+	0.13	3.78	0.000179	Blood trace element (Zn levels)	
THCA	cis	1	rs7167285	chr15:75368769	SCAMP2	chr15:75136073-75165670:-	-0.15	-3.4	0.000741	Blood trace element (Zn levels)	
THCA	cis	1	rs7167285	chr15:75368769	SCAMP5	chr15:75287901-75313836:+	0.41	7.36	7.97E-13	Blood trace element (Zn levels)	
THCA	cis	1	rs7168680	chr15:75369212	ARID3B	chr15:74833548-74890470:+	-0.15	-4.02	6.81E-5	Blood trace element (Zn levels)	
THCA	cis	1	rs7168680	chr15:75369212	PPCDC	chr15:75315927-75343066:+	0.13	3.78	0.000175	Blood trace element (Zn levels)	
THCA	cis	1	rs7168680	chr15:75369212	SCAMP2	chr15:75136073-75165670:-	-0.15	-3.34	0.000897	Blood trace element (Zn levels)	
THCA	cis	1	rs7168680	chr15:75369212	SCAMP5	chr15:75287901-75313836:+	0.41	7.35	8.43E-13	Blood trace element (Zn levels)	
THCA	cis	1	rs7169404	chr15:40675443	C15orf23	chr15:40674922-40686488:+	0.68	9.23	8.62E-19	Heschl's gyrus morphology	
THCA	cis	1	rs7169404	chr15:40675443	IVD	chr15:40697686-40713512:+	-0.55	-9.9	3.9E-21	Heschl's gyrus morphology	
THCA	cis	1	rs7169463	chr15:66745929	TIPIN	chr15:66629008-66649054:-	-0.42	-4.3	2.09E-5	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs7170930	chr15:66580853	DIS3L	chr15:66585633-66626235:+	0.54	8.83	2.01E-17	Response to cytadine analogues (cytosine arabinoside)	
THCA	cis	1	rs7170930	chr15:66580853	TIPIN	chr15:66629008-66649054:-	-1.11	-11.22	4.23E-26	Response to cytadine analogues (cytosine arabinoside)	
THCA	cis	1	rs7172118	chr15:78862453	CHRNA5	chr15:78857906-78886458:+	-0.43	-8.33	8.58E-16	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs7172335	chr15:65977204	DPP8	chr15:65737999-65810035:-	-0.09	-3.88	0.00012	Mean corpuscular hemoglobin	
THCA	cis	1	rs7172335	chr15:65977204	SLC24A1	chr15:65903704-65953256:+	-0.16	-3.85	0.000132	Mean corpuscular hemoglobin	
THCA	cis	1	rs7173833	chr15:75369618	ARID3B	chr15:74833548-74890470:+	-0.15	-4.05	5.86E-5	Blood trace element (Zn levels)	
THCA	cis	1	rs7173833	chr15:75369618	PPCDC	chr15:75315927-75343066:+	0.12	3.44	0.000641	Blood trace element (Zn levels)	
THCA	cis	1	rs7173833	chr15:75369618	SCAMP5	chr15:75287901-75313836:+	0.42	7.5	3.23E-13	Blood trace element (Zn levels)	
THCA	cis	1	rs7174	chr12:121017171	COQ5	chr12:120941083-120966964:-	0.14	3.56	0.000406	Type 1 diabetes nephropathy	
THCA	cis	1	rs7174	chr12:121017171	POP5	chr12:121016849-121019201:-	-0.16	-4.88	1.45E-6	Type 1 diabetes nephropathy	
THCA	cis	1	rs7175720	chr15:75348962	ARID3B	chr15:74833548-74890470:+	0.13	3.41	0.000697	Blood trace element (Zn levels)	
THCA	cis	1	rs7175720	chr15:75348962	PPCDC	chr15:75315927-75343066:+	-0.13	-3.75	0.000198	Blood trace element (Zn levels)	
THCA	cis	1	rs7175720	chr15:75348962	SCAMP5	chr15:75287901-75313836:+	-0.45	-7.8	3.86E-14	Blood trace element (Zn levels)	
THCA	cis	1	rs717593	chr20:33652964	PROCR	chr20:33758727-33765164:+	-0.34	-5.45	8.29E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs717593	chr20:33652964	TRPC4AP	chr20:33590215-33680618:-	0.33	3.93	9.8E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs717658	chr7:150503637	TMEM176A	chr7:150497854-150502208:+	0.18	4.97	9.2E-7	Forced expiratory volume in 1 second (environmental interaction)	
THCA	cis	1	rs717658	chr7:150503637	TMEM176B	chr7:150488378-150498448:-	0.13	3.81	0.000155	Forced expiratory volume in 1 second (environmental interaction)	
THCA	cis	1	rs7177276	chr15:62379668	VPS13C	chr15:62144592-62352647:-	-0.12	-4.34	1.75E-5	Height	
THCA	cis	1	rs7177486	chr15:90897109	IQGAP1	chr15:90931473-91045475:+	0.14	4.3	2.07E-5	Rheumatoid arthritis	
THCA	cis	1	rs7177486	chr15:90897109	TTLL13	chr15:90792764-90815443:+	0.27	4.44	1.13E-5	Rheumatoid arthritis	
THCA	cis	1	rs7177711	chr15:62379971	VPS13C	chr15:62144592-62352647:-	-0.12	-4.4	1.35E-5	Height	
THCA	cis	1	rs7178424	chr15:62380259	VPS13C	chr15:62144592-62352647:-	-0.12	-4.34	1.75E-5	Height	
THCA	cis	1	rs7178496	chr15:90896959	IQGAP1	chr15:90931473-91045475:+	0.12	4.12	4.39E-5	Rheumatoid arthritis	
THCA	cis	1	rs7178496	chr15:90896959	TTLL13	chr15:90792764-90815443:+	0.18	3.37	0.000805	Rheumatoid arthritis	
THCA	cis	1	rs7178540	chr15:62380132	VPS13C	chr15:62144592-62352647:-	0.11	4.15	3.9E-5	Height	
THCA	cis	1	rs7178584	chr15:65795200	DPP8	chr15:65737999-65810035:-	0.09	3.77	0.000185	Mean corpuscular hemoglobin	
THCA	cis	1	rs7178584	chr15:65795200	SLC24A1	chr15:65903704-65953256:+	0.15	3.6	0.000347	Mean corpuscular hemoglobin	
THCA	cis	1	rs7178663	chr15:90897058	IQGAP1	chr15:90931473-91045475:+	0.14	4.3	2.07E-5	Rheumatoid arthritis	
THCA	cis	1	rs7178663	chr15:90897058	TTLL13	chr15:90792764-90815443:+	0.27	4.44	1.13E-5	Rheumatoid arthritis	
THCA	cis	1	rs7178945	chr15:62379814	VPS13C	chr15:62144592-62352647:-	-0.11	-4.26	2.41E-5	Height	
THCA	cis	1	rs7178962	chr15:84573248	LOC388152	chr15:84867600-84898920:-	-0.21	-3.99	7.52E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs7180201	chr15:24832671	PWRN1	chr15:24778839-24832924:+	-0.39	-8.23	1.86E-15	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
THCA	cis	1	rs7181333	chr15:66039826	DPP8	chr15:65737999-65810035:-	0.1	4.07	5.47E-5	Mean corpuscular hemoglobin	
THCA	cis	1	rs7181333	chr15:66039826	SLC24A1	chr15:65903704-65953256:+	0.16	3.83	0.000147	Mean corpuscular hemoglobin	
THCA	cis	1	rs7182169	chr15:66748213	TIPIN	chr15:66629008-66649054:-	-0.39	-3.95	8.95E-5	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs7182544	chr15:90897480	IQGAP1	chr15:90931473-91045475:+	0.12	4.12	4.45E-5	Rheumatoid arthritis	
THCA	cis	1	rs7182544	chr15:90897480	TTLL13	chr15:90792764-90815443:+	0.19	3.4	0.000718	Rheumatoid arthritis	
THCA	cis	1	rs7183263	chr15:84573041	LOC388152	chr15:84867600-84898920:-	-0.21	-4	7.19E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs7183477	chr15:66748212	TIPIN	chr15:66629008-66649054:-	-0.39	-3.95	8.95E-5	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs7184131	chr16:69470711	CYB5B	chr16:69458498-69500167:+	-0.23	-3.99	7.7E-5	Blood pressure (smoking interaction)	
THCA	cis	1	rs718444	chr13:33147052	N4BP2L2	chr13:33006930-33112936:-	0.26	7.7	7.67E-14	Body mass index	
THCA	cis	1	rs7186908	chr16:72220373	DHODH	chr16:72042643-72058954:+	0.19	4.26	2.48E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7186908	chr16:72220373	HP	chr16:72088508-72094957:+	-0.26	-4.19	3.28E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7186908	chr16:72220373	KIAA0174	chr16:71924472-71962906:+	-0.21	-3.63	0.000317	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7186983	chr16:50098852	HEATR3	chr16:50099881-50139373:+	-0.4	-6.49	2.13E-10	Esophageal cancer (squamous cell)	
THCA	cis	1	rs7187350	chr16:50099036	HEATR3	chr16:50099881-50139373:+	-0.4	-6.49	2.13E-10	Esophageal cancer (squamous cell)	
THCA	cis	1	rs7188445	chr16:79734987	MAF	chr16:79627746-79634622:-	-0.24	-4.16	3.82E-5	Urate levels	
THCA	cis	1	rs718847	chr11:116734146	PCSK7	chr11:117075789-117102811:-	-0.3	-5.14	4.02E-7	Protein quantitative trait loci	
THCA	cis	1	rs7189424	chr16:69782746	COG4	chr16:70514473-70557457:-	-0.2	-3.96	8.59E-5	IgE levels	
THCA	cis	1	rs7190066	chr16:19032780	COQ7	chr16:19078927-19091350:+	-0.29	-3.92	0.000101	Response to angiotensin II receptor blocker therapy	
THCA	cis	1	rs7190187	chr16:79735178	MAF	chr16:79627746-79634622:-	-0.24	-3.97	8.21E-5	Urate levels	
THCA	cis	1	rs7191384	chr16:50104234	HEATR3	chr16:50099881-50139373:+	-0.39	-6.07	2.54E-9	Esophageal cancer (squamous cell)	
THCA	cis	1	rs719147	chr18:33698192	SLC39A6	chr18:33688495-33709357:-	0.14	3.93	9.89E-5	Esophageal squamous cell cancer (length of survival)	
THCA	cis	1	rs7191665	chr16:74688948	RFWD3	chr16:74655298-74700779:-	-0.31	-7.96	1.29E-14	Testicular germ cell tumor	
THCA	cis	1	rs7191700	chr16:11406803	C16orf75	chr16:11343506-11445617:+	0.44	8.65	7.94E-17	Multiple sclerosis	
THCA	cis	1	rs7193341	chr16:69475620	CYB5B	chr16:69458498-69500167:+	-0.23	-3.99	7.7E-5	Blood pressure (smoking interaction)	
THCA	cis	1	rs7193487	chr16:50093406	HEATR3	chr16:50099881-50139373:+	-0.4	-6.49	2.13E-10	Esophageal cancer (squamous cell)	
THCA	cis	1	rs719394	chr6:52290988	EFHC1	chr6:52284994-52387892:+	0.14	4.37	1.55E-5	Atopic march	
THCA	cis	1	rs7195415	chr16:67689057	C16orf86	chr16:67700717-67702659:+	-0.41	-4.97	9.18E-7	Crohn's disease	
THCA	cis	1	rs7195415	chr16:67689057	FAM65A	chr16:67562754-67580688:+	-0.38	-3.96	8.71E-5	Crohn's disease	
THCA	cis	1	rs7195415	chr16:67689057	LRRC36	chr16:67360747-67419108:+	0.39	3.57	0.000394	Crohn's disease	
THCA	cis	1	rs7195415	chr16:67689057	ZDHHC1	chr16:67428323-67450339:-	0.35	3.86	0.000127	Crohn's disease	
THCA	cis	1	rs719620	chr16:69475828	CYB5B	chr16:69458498-69500167:+	-0.23	-3.99	7.7E-5	Blood pressure (smoking interaction)	
THCA	cis	1	rs719909	chr10:91345696	FLJ37201	chr10:91451057-91457685:-	-0.19	-4.16	3.81E-5	Metabolic traits	
THCA	cis	1	rs7199957	chr16:69468435	CYB5B	chr16:69458498-69500167:+	-0.24	-4.19	3.35E-5	Blood pressure (smoking interaction)	
THCA	cis	1	rs7200543	chr16:15129970	PDXDC1	chr16:15068599-15233195:+	-0.3	-6.99	9.4E-12	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs7200950	chr16:67689752	C16orf86	chr16:67700717-67702659:+	-0.38	-4.83	1.82E-6	Crohn's disease	
THCA	cis	1	rs7200950	chr16:67689752	FAM65A	chr16:67562754-67580688:+	-0.36	-3.94	9.52E-5	Crohn's disease	
THCA	cis	1	rs7200950	chr16:67689752	LRRC36	chr16:67360747-67419108:+	0.38	3.57	0.000398	Crohn's disease	
THCA	cis	1	rs7200950	chr16:67689752	ZDHHC1	chr16:67428323-67450339:-	0.37	4.17	3.56E-5	Crohn's disease	
THCA	cis	1	rs7201161	chr16:69468362	CYB5B	chr16:69458498-69500167:+	-0.24	-4.19	3.35E-5	Blood pressure (smoking interaction)	
THCA	cis	1	rs7201320	chr16:74694058	RFWD3	chr16:74655298-74700779:-	-0.31	-7.91	1.77E-14	Testicular germ cell tumor	
THCA	cis	1	rs7203315	chr16:10188060	GRIN2A	chr16:9847267-10276611:-	0.63	9.23	8.89E-19	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs720475	chr7:144074929	OR2A7	chr7:143955790-143974852:-	-0.47	-7.29	1.26E-12	Breast cancer	
THCA	cis	1	rs7204827	chr16:4467533	C16orf5	chr16:4560679-4588816:-	0.2	5.04	6.54E-7	Schizophrenia	
THCA	cis	1	rs7204827	chr16:4467533	LOC342346	chr16:4606491-4650317:+	0.15	3.36	0.000849	Schizophrenia	
THCA	cis	1	rs7205409	chr16:642610	WDR90	chr16:699363-717829:+	-0.12	-3.62	0.000331	Height	
THCA	cis	1	rs7205409	chr16:642610	WFIKKN1	chr16:679239-684116:+	0.34	7.55	2.2E-13	Height	
THCA	cis	1	rs7207021	chr17:28400516	ANKRD13B	chr17:27916801-27941778:+	-0.36	-8.94	8.52E-18	Coffee consumption (cups per day)	
THCA	cis	1	rs7207021	chr17:28400516	CORO6	chr17:27941774-27948441:-	-0.49	-11.3	2.08E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs7207021	chr17:28400516	EFCAB5	chr17:28256874-28435469:+	-0.6	-11.41	7.54E-27	Coffee consumption (cups per day)	
THCA	cis	1	rs7207021	chr17:28400516	GIT1	chr17:27900487-27916610:-	-0.27	-6.36	4.59E-10	Coffee consumption (cups per day)	
THCA	cis	1	rs7207021	chr17:28400516	LRRC37B2	chr17:28903483-28992715:+	-0.18	-3.89	0.000116	Coffee consumption (cups per day)	
THCA	cis	1	rs7207021	chr17:28400516	SSH2	chr17:27952965-28257018:-	-0.34	-7.71	7.4E-14	Coffee consumption (cups per day)	
THCA	cis	1	rs7207021	chr17:28400516	TP53I13	chr17:27895739-27900174:+	-0.2	-5.38	1.16E-7	Coffee consumption (cups per day)	
THCA	cis	1	rs7207276	chr17:18065737	LLGL1	chr17:18128936-18148186:+	-0.15	-4.49	8.84E-6	Obesity-related traits	
THCA	cis	1	rs7207276	chr17:18065737	LOC220594	chr17:18414577-18445234:-	-0.26	-3.39	0.000748	Obesity-related traits	
THCA	cis	1	rs7207276	chr17:18065737	MYO15A	chr17:18012020-18083115:+	0.2	3.7	0.000243	Obesity-related traits	
THCA	cis	1	rs7207724	chr17:20924236	USP22	chr17:20902908-20947073:-	-0.18	-3.83	0.000146	Blood trace element (Se levels)	
THCA	cis	1	rs7208663	chr17:65885171	C17orf58	chr17:65987218-65989765:-	0.23	4.75	2.68E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs7209131	chr17:7376411	CHRNB1	chr17:7348406-7360931:+	-0.19	-3.9	0.000109	Height	
THCA	cis	1	rs7209180	chr17:79581519	ARL16	chr17:79648234-79650954:-	-0.12	-3.39	0.000748	Eye color traits	
THCA	cis	1	rs7209180	chr17:79581519	TSPAN10	chr17:79609349-79615778:+	0.8	17.82	7.47E-55	Eye color traits	
THCA	cis	1	rs7209435	chr17:61712964	FTSJ3	chr17:61896795-61905031:-	0.3	5.78	1.32E-8	Body mass index	
THCA	cis	1	rs7209435	chr17:61712964	MAP3K3	chr17:61699775-61773669:+	0.26	5.33	1.5E-7	Body mass index	
THCA	cis	1	rs7209460	chr17:2048713	SRR	chr17:2207248-2228553:+	-0.38	-6.58	1.23E-10	Bone mineral density	
THCA	cis	1	rs7209675	chr17:65831258	C17orf58	chr17:65987218-65989765:-	0.23	4.64	4.42E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs7209700	chr17:45351118	TBKBP1	chr17:45772630-45789427:+	0.17	3.72	0.000219	IgG glycosylation	
THCA	cis	1	rs7209758	chr17:61913621	FTSJ3	chr17:61896795-61905031:-	0.3	5.58	3.94E-8	Body mass index	
THCA	cis	1	rs7209758	chr17:61913621	MAP3K3	chr17:61699775-61773669:+	0.25	5.1	4.8E-7	Body mass index	
THCA	cis	1	rs7210027	chr17:65977053	C17orf58	chr17:65987218-65989765:-	-0.21	-4.42	1.2E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs7210738	chr17:45757598	TBKBP1	chr17:45772630-45789427:+	0.38	10.74	3.12E-24	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
THCA	cis	1	rs7211094	chr17:20923750	USP22	chr17:20902908-20947073:-	0.16	3.43	0.000655	Blood trace element (Se levels)	
THCA	cis	1	rs7211213	chr17:61769456	FTSJ3	chr17:61896795-61905031:-	0.3	5.71	2.03E-8	Body mass index	
THCA	cis	1	rs7211213	chr17:61769456	MAP3K3	chr17:61699775-61773669:+	0.23	4.69	3.49E-6	Body mass index	
THCA	cis	1	rs7212293	chr17:65847325	C17orf58	chr17:65987218-65989765:-	0.25	5.01	7.79E-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs7212497	chr17:28335949	ANKRD13B	chr17:27916801-27941778:+	-0.36	-8.77	3.25E-17	Coffee consumption (cups per day)	
THCA	cis	1	rs7212497	chr17:28335949	CORO6	chr17:27941774-27948441:-	-0.5	-11.59	1.52E-27	Coffee consumption (cups per day)	
THCA	cis	1	rs7212497	chr17:28335949	EFCAB5	chr17:28256874-28435469:+	-0.6	-11.32	1.68E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs7212497	chr17:28335949	GIT1	chr17:27900487-27916610:-	-0.29	-6.71	5.58E-11	Coffee consumption (cups per day)	
THCA	cis	1	rs7212497	chr17:28335949	LRRC37B2	chr17:28903483-28992715:+	-0.17	-3.76	0.000188	Coffee consumption (cups per day)	
THCA	cis	1	rs7212497	chr17:28335949	SSH2	chr17:27952965-28257018:-	-0.34	-7.62	1.39E-13	Coffee consumption (cups per day)	
THCA	cis	1	rs7212497	chr17:28335949	TP53I13	chr17:27895739-27900174:+	-0.2	-5.3	1.81E-7	Coffee consumption (cups per day)	
THCA	cis	1	rs7213129	chr17:79581573	ARL16	chr17:79648234-79650954:-	-0.12	-3.39	0.000748	Eye color traits	
THCA	cis	1	rs7213129	chr17:79581573	TSPAN10	chr17:79609349-79615778:+	0.8	17.82	7.47E-55	Eye color traits	
THCA	cis	1	rs7214085	chr17:38169095	GSDMA	chr17:38119226-38134019:+	-0.31	-7.24	1.75E-12	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THCA	cis	1	rs7214312	chr17:61870863	FTSJ3	chr17:61896795-61905031:-	0.3	5.77	1.4E-8	Body mass index	
THCA	cis	1	rs7214312	chr17:61870863	MAP3K3	chr17:61699775-61773669:+	0.26	5.4	1.03E-7	Body mass index	
THCA	cis	1	rs7214758	chr17:65880538	C17orf58	chr17:65987218-65989765:-	0.21	4.08	5.31E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs7214921	chr17:40294025	HSPB9	chr17:40274756-40275371:+	0.34	5.08	5.4E-7	Fibrinogen levels	
THCA	cis	1	rs7214988	chr17:17491836	ATPAF2	chr17:17918373-17942480:-	-0.21	-3.59	0.000359	Obsessive-compulsive symptoms	
THCA	cis	1	rs7215147	chr17:30266711	C17orf79	chr17:30178885-30186326:-	-0.16	-4.06	5.71E-5	Height	
THCA	cis	1	rs7215369	chr17:20916856	USP22	chr17:20902908-20947073:-	-0.18	-3.81	0.000159	Blood trace element (Se levels)	
THCA	cis	1	rs7215564	chr17:78737287	NPTX1	chr17:78440633-78450404:-	-0.27	-3.43	0.000658	Myopia (pathological)	
THCA	cis	1	rs7216064	chr17:65898809	C17orf58	chr17:65987218-65989765:-	0.19	3.86	0.000127	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs7216449	chr17:20930876	USP22	chr17:20902908-20947073:-	0.17	3.7	0.00024	Blood trace element (Se levels)	
THCA	cis	1	rs7216786	chr17:20931064	USP22	chr17:20902908-20947073:-	-0.18	-3.83	0.000146	Blood trace element (Se levels)	
THCA	cis	1	rs7216798	chr17:61740963	FTSJ3	chr17:61896795-61905031:-	0.31	5.82	1.06E-8	Body mass index	
THCA	cis	1	rs7216798	chr17:61740963	MAP3K3	chr17:61699775-61773669:+	0.25	5.16	3.68E-7	Body mass index	
THCA	cis	1	rs7216978	chr17:20926294	USP22	chr17:20902908-20947073:-	-0.17	-3.6	0.000349	Blood trace element (Se levels)	
THCA	cis	1	rs7217764	chr17:17495766	ATPAF2	chr17:17918373-17942480:-	-0.24	-3.86	0.000131	Obsessive-compulsive symptoms	
THCA	cis	1	rs7217982	chr17:61832150	FTSJ3	chr17:61896795-61905031:-	0.3	5.77	1.4E-8	Body mass index	
THCA	cis	1	rs7217982	chr17:61832150	MAP3K3	chr17:61699775-61773669:+	0.26	5.4	1.03E-7	Body mass index	
THCA	cis	1	rs7218362	chr17:56888299	SUPT4H1	chr17:56422539-56429563:-	-0.16	-4.04	6.15E-5	Cognitive test performance	
THCA	cis	1	rs7219014	chr17:37624790	PGAP3	chr17:37827376-37844310:-	-0.19	-4.92	1.22E-6	Urinary metabolites	
THCA	cis	1	rs7219014	chr17:37624790	PNMT	chr17:37824507-37826728:+	-0.15	-3.53	0.000461	Urinary metabolites	
THCA	cis	1	rs7219021	chr17:46840541	ATP5G1	chr17:46970148-46973230:+	-0.1	-3.51	0.000486	Schizophrenia or bipolar disorder	
THCA	cis	1	rs7219021	chr17:46840541	SNF8	chr17:47007461-47022154:-	-0.25	-7.44	4.8E-13	Schizophrenia or bipolar disorder	
THCA	cis	1	rs7219021	chr17:46840541	UBE2Z	chr17:46985767-47006422:+	-0.19	-3.99	7.59E-5	Schizophrenia or bipolar disorder	
THCA	cis	1	rs7219220	chr17:40294280	HSPB9	chr17:40274756-40275371:+	0.34	5.03	7.09E-7	Fibrinogen levels	
THCA	cis	1	rs7219244	chr17:20926595	USP22	chr17:20902908-20947073:-	-0.18	-3.85	0.000135	Blood trace element (Se levels)	
THCA	cis	1	rs7219874	chr17:53065807	STXBP4	chr17:53046126-53241449:+	-0.16	-4.31	1.96E-5	Breast cancer	
THCA	cis	1	rs7220821	chr17:61704147	FTSJ3	chr17:61896795-61905031:-	0.3	5.68	2.37E-8	Body mass index	
THCA	cis	1	rs7220821	chr17:61704147	MAP3K3	chr17:61699775-61773669:+	0.27	5.5	6.2E-8	Body mass index	
THCA	cis	1	rs7220892	chr17:61908316	FTSJ3	chr17:61896795-61905031:-	0.3	5.71	1.93E-8	Body mass index	
THCA	cis	1	rs7220892	chr17:61908316	MAP3K3	chr17:61699775-61773669:+	0.25	5.12	4.47E-7	Body mass index	
THCA	cis	1	rs7221109	chr17:38770286	IGFBP4	chr17:38599676-38613981:+	0.17	3.6	0.000356	Type 1 diabetes	
THCA	cis	1	rs7221109	chr17:38770286	SMARCE1	chr17:38783976-38804103:-	-0.19	-4.33	1.82E-5	Type 1 diabetes	
THCA	cis	1	rs7221223	chr17:53059007	STXBP4	chr17:53046126-53241449:+	-0.14	-3.75	0.000201	Breast cancer	
THCA	cis	1	rs7221223	chr17:53059007	TOM1L1	chr17:52978052-53039328:+	-0.17	-4.32	1.9E-5	Breast cancer	
THCA	cis	1	rs7221651	chr17:65832390	C17orf58	chr17:65987218-65989765:-	-0.24	-4.93	1.13E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs7221743	chr17:28407876	ANKRD13B	chr17:27916801-27941778:+	-0.36	-8.76	3.43E-17	Coffee consumption (cups per day)	
THCA	cis	1	rs7221743	chr17:28407876	CORO6	chr17:27941774-27948441:-	-0.5	-11.45	5.5E-27	Coffee consumption (cups per day)	
THCA	cis	1	rs7221743	chr17:28407876	EFCAB5	chr17:28256874-28435469:+	-0.59	-11.27	2.8E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs7221743	chr17:28407876	GIT1	chr17:27900487-27916610:-	-0.28	-6.6	1.08E-10	Coffee consumption (cups per day)	
THCA	cis	1	rs7221743	chr17:28407876	LRRC37B2	chr17:28903483-28992715:+	-0.18	-3.96	8.69E-5	Coffee consumption (cups per day)	
THCA	cis	1	rs7221743	chr17:28407876	SSH2	chr17:27952965-28257018:-	-0.34	-7.76	5.26E-14	Coffee consumption (cups per day)	
THCA	cis	1	rs7221743	chr17:28407876	TP53I13	chr17:27895739-27900174:+	-0.2	-5.43	9.17E-8	Coffee consumption (cups per day)	
THCA	cis	1	rs7222060	chr17:61868279	FTSJ3	chr17:61896795-61905031:-	0.3	5.77	1.4E-8	Body mass index	
THCA	cis	1	rs7222060	chr17:61868279	MAP3K3	chr17:61699775-61773669:+	0.26	5.4	1.03E-7	Body mass index	
THCA	cis	1	rs7222197	chr17:53047499	STXBP4	chr17:53046126-53241449:+	0.15	4.18	3.4E-5	Breast cancer	
THCA	cis	1	rs7222197	chr17:53047499	TOM1L1	chr17:52978052-53039328:+	0.13	3.37	0.000824	Breast cancer	
THCA	cis	1	rs7222241	chr17:79574714	TSPAN10	chr17:79609349-79615778:+	0.79	17.7	2.67E-54	Eye color traits	
THCA	cis	1	rs7222308	chr17:28277041	ANKRD13B	chr17:27916801-27941778:+	0.37	9.19	1.19E-18	Coffee consumption (cups per day)	
THCA	cis	1	rs7222308	chr17:28277041	CORO6	chr17:27941774-27948441:-	0.51	12.08	1.59E-29	Coffee consumption (cups per day)	
THCA	cis	1	rs7222308	chr17:28277041	EFCAB5	chr17:28256874-28435469:+	0.59	11.28	2.54E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs7222308	chr17:28277041	GIT1	chr17:27900487-27916610:-	0.3	6.98	9.68E-12	Coffee consumption (cups per day)	
THCA	cis	1	rs7222308	chr17:28277041	LRRC37B2	chr17:28903483-28992715:+	0.18	3.93	9.65E-5	Coffee consumption (cups per day)	
THCA	cis	1	rs7222308	chr17:28277041	SSH2	chr17:27952965-28257018:-	0.33	7.59	1.64E-13	Coffee consumption (cups per day)	
THCA	cis	1	rs7222308	chr17:28277041	TP53I13	chr17:27895739-27900174:+	0.2	5.46	7.66E-8	Coffee consumption (cups per day)	
THCA	cis	1	rs7223231	chr17:18811846	FAM18B	chr17:18684582-18710026:+	-0.42	-10.82	1.54E-24	Educational attainment (years of education)	
THCA	cis	1	rs7223231	chr17:18811846	FBXW10	chr17:18647326-18682661:+	-0.23	-5.1	5.03E-7	Educational attainment (years of education)	
THCA	cis	1	rs7223257	chr17:61787684	FTSJ3	chr17:61896795-61905031:-	0.24	5.09	5.06E-7	Height	
THCA	cis	1	rs7223257	chr17:61787684	TCAM1P	chr17:61934376-61941738:+	-0.36	-6.02	3.54E-9	Height	
THCA	cis	1	rs7223412	chr17:61808172	FTSJ3	chr17:61896795-61905031:-	0.3	5.78	1.32E-8	Body mass index	
THCA	cis	1	rs7223412	chr17:61808172	MAP3K3	chr17:61699775-61773669:+	0.26	5.37	1.26E-7	Body mass index	
THCA	cis	1	rs7223613	chr17:79574803	ARL16	chr17:79648234-79650954:-	0.12	3.39	0.000748	Eye color traits	
THCA	cis	1	rs7223613	chr17:79574803	TSPAN10	chr17:79609349-79615778:+	-0.8	-17.82	7.47E-55	Eye color traits	
THCA	cis	1	rs7223672	chr17:61720565	FTSJ3	chr17:61896795-61905031:-	0.31	6	3.9E-9	Body mass index	
THCA	cis	1	rs7223672	chr17:61720565	MAP3K3	chr17:61699775-61773669:+	0.27	5.51	5.76E-8	Body mass index	
THCA	cis	1	rs7223784	chr17:40577580	NAGLU	chr17:40687951-40696464:+	-0.23	-4.93	1.14E-6	Crohn's disease	
THCA	cis	1	rs7223784	chr17:40577580	TUBG2	chr17:40811266-40819023:+	-0.23	-5.38	1.18E-7	Crohn's disease	
THCA	cis	1	rs7223786	chr17:28332107	ANKRD13B	chr17:27916801-27941778:+	-0.36	-8.85	1.7E-17	Coffee consumption (cups per day)	
THCA	cis	1	rs7223786	chr17:28332107	CORO6	chr17:27941774-27948441:-	-0.51	-11.7	5.47E-28	Coffee consumption (cups per day)	
THCA	cis	1	rs7223786	chr17:28332107	EFCAB5	chr17:28256874-28435469:+	-0.6	-11.3	2.02E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs7223786	chr17:28332107	GIT1	chr17:27900487-27916610:-	-0.29	-6.8	3.15E-11	Coffee consumption (cups per day)	
THCA	cis	1	rs7223786	chr17:28332107	LRRC37B2	chr17:28903483-28992715:+	-0.18	-3.84	0.000141	Coffee consumption (cups per day)	
THCA	cis	1	rs7223786	chr17:28332107	SSH2	chr17:27952965-28257018:-	-0.34	-7.64	1.18E-13	Coffee consumption (cups per day)	
THCA	cis	1	rs7223786	chr17:28332107	TP53I13	chr17:27895739-27900174:+	-0.2	-5.3	1.81E-7	Coffee consumption (cups per day)	
THCA	cis	1	rs7223813	chr17:65945840	C17orf58	chr17:65987218-65989765:-	0.2	4	7.24E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs7223930	chr17:65842186	C17orf58	chr17:65987218-65989765:-	0.24	4.84	1.75E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs7223966	chr17:61893398	FTSJ3	chr17:61896795-61905031:-	0.3	5.66	2.56E-8	Body mass index	
THCA	cis	1	rs7223966	chr17:61893398	MAP3K3	chr17:61699775-61773669:+	0.25	5.16	3.58E-7	Body mass index	
THCA	cis	1	rs7224725	chr17:17484654	ATPAF2	chr17:17918373-17942480:-	-0.21	-3.63	0.000315	Obsessive-compulsive symptoms	
THCA	cis	1	rs7224737	chr17:40289364	HSPB9	chr17:40274756-40275371:+	-0.33	-4.96	9.58E-7	Fibrinogen levels	
THCA	cis	1	rs7224923	chr17:65842265	C17orf58	chr17:65987218-65989765:-	0.2	3.95	8.87E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs722509	chr3:10102377	C3orf10	chr3:10157333-10168873:+	-0.21	-4.34	1.71E-5	Alzheimer's disease	
THCA	cis	1	rs722509	chr3:10102377	VHL	chr3:10183319-10193744:+	-0.2	-4.51	8.09E-6	Alzheimer's disease	
THCA	cis	1	rs7225151	chr17:5137047	C17orf87	chr17:5113901-5138083:-	0.16	3.65	0.000289	Alzheimer's disease (late onset)	
THCA	cis	1	rs7225151	chr17:5137047	SPNS2	chr17:4402129-4443228:+	0.19	3.97	8.4E-5	Alzheimer's disease (late onset)	
THCA	cis	1	rs7225151	chr17:5137047	ZNF232	chr17:5008839-5026397:-	-0.29	-3.89	0.000116	Alzheimer's disease (late onset)	
THCA	cis	1	rs7225608	chr17:40298326	HSPB9	chr17:40274756-40275371:+	0.33	4.88	1.46E-6	Fibrinogen levels	
THCA	cis	1	rs7226229	chr17:20924077	USP22	chr17:20902908-20947073:-	-0.16	-3.45	0.000608	Blood trace element (Se levels)	
THCA	cis	1	rs7227742	chr18:23585752	SS18	chr18:23596219-23671164:-	0.26	3.4	0.000737	Rhegmatogenous retinal detachment	
THCA	cis	1	rs7228051	chr18:71788898	FBXO15	chr18:71740588-71815100:-	0.24	6.38	4.29E-10	Venous thromboembolism (SNP x SNP interaction)	
THCA	cis	1	rs7229639	chr18:46450976	SMAD2	chr18:45359467-45457515:-	0.17	3.74	0.000206	Colorectal cancer	
THCA	cis	1	rs722997	chr22:26849666	HPS4	chr22:26847447-26879820:-	0.29	3.55	0.000421	Ischemic stroke	
THCA	cis	1	rs7235001	chr18:23714109	SS18	chr18:23596219-23671164:-	0.28	3.59	0.000371	Rhegmatogenous retinal detachment	
THCA	cis	1	rs723810	chr14:97287970	VRK1	chr14:97263684-97347950:+	-0.17	-3.95	9.01E-5	Neutrophil count	
THCA	cis	1	rs723966	chr14:71765910	SIPA1L1	chr14:71933902-72206118:+	0.27	5.57	4.19E-8	Mitral valve prolapse	
THCA	cis	1	rs724356	chr7:124387374	POT1	chr7:124462441-124570037:-	0.15	3.47	0.000572	Reading and spelling	
THCA	cis	1	rs724553	chr10:65140384	LOC84989	chr10:65224989-65226320:+	0.28	4.46	1.03E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs724553	chr10:65140384	NRBF2	chr10:64893007-64914785:+	0.28	4.65	4.26E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs7246064	chr19:52442262	ZNF577	chr19:52359056-52394145:-	-0.19	-4.05	6.0E-5	Survival in endocrine treated breast cancer (estrogen-receptor positive)	
THCA	cis	1	rs7246419	chr19:12162712	ZNF763	chr19:12035900-12091196:+	-0.4	-4.79	2.26E-6	Multiple sclerosis	
THCA	cis	1	rs7246657	chr19:37747108	ZNF607	chr19:38187276-38210691:-	0.19	3.43	0.000665	Coronary artery calcification	
THCA	cis	1	rs7246967	chr19:23056346	ZNF492	chr19:22817126-22850472:+	-0.44	-6.55	1.45E-10	Bronchopulmonary dysplasia	
THCA	cis	1	rs7247513	chr19:12691185	RTBDN	chr19:12936293-12946230:-	0.21	3.66	0.000277	Bipolar disorder	
THCA	cis	1	rs7247672	chr19:37743928	ZNF793	chr19:37997841-38034237:+	0.15	3.42	0.000669	Coronary artery calcification	
THCA	cis	1	rs7248104	chr19:7224431	ZNF557	chr19:7069471-7087976:+	-0.16	-3.43	0.000665	Triglycerides	
THCA	cis	1	rs72483951	chr19:52573682	ZNF432	chr19:52536678-52552073:-	-0.18	-4.57	6.29E-6	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	
THCA	cis	1	rs7248470	chr19:53013539	ZNF578	chr19:52956829-53020130:+	0.27	3.55	0.000427	Longitudinal alcohol consumption	
THCA	cis	1	rs7248680	chr19:12165770	ZNF763	chr19:12035900-12091196:+	0.38	4.62	4.95E-6	Multiple sclerosis	
THCA	cis	1	rs7250427	chr19:12147201	ZNF763	chr19:12035900-12091196:+	-0.4	-5.26	2.15E-7	Multiple sclerosis	
THCA	cis	1	rs7251653	chr19:18608283	ELL	chr19:18553475-18632937:-	-0.25	-6.47	2.39E-10	Breast cancer	
THCA	cis	1	rs7251653	chr19:18608283	ISYNA1	chr19:18545625-18548943:-	0.13	4.81	1.98E-6	Breast cancer	
THCA	cis	1	rs7251653	chr19:18608283	LRRC25	chr19:18501955-18508421:-	-0.14	-4.76	2.61E-6	Breast cancer	
THCA	cis	1	rs7251903	chr19:39184811	LGALS7	chr19:39261608-39264157:-	-0.22	-4.44	1.11E-5	Heart rate	
THCA	cis	1	rs7252589	chr19:39170908	LGALS7	chr19:39261608-39264157:-	-0.22	-4.38	1.45E-5	Heart rate	
THCA	cis	1	rs7252707	chr19:18612257	ELL	chr19:18553475-18632937:-	-0.26	-6.69	6.29E-11	Breast cancer	
THCA	cis	1	rs7252707	chr19:18612257	ISYNA1	chr19:18545625-18548943:-	0.12	4.38	1.48E-5	Breast cancer	
THCA	cis	1	rs7252707	chr19:18612257	LRRC25	chr19:18501955-18508421:-	-0.13	-4.53	7.49E-6	Breast cancer	
THCA	cis	1	rs7252848	chr19:18612351	ELL	chr19:18553475-18632937:-	-0.27	-7.02	7.81E-12	Breast cancer	
THCA	cis	1	rs7252848	chr19:18612351	ISYNA1	chr19:18545625-18548943:-	0.11	4.23	2.77E-5	Breast cancer	
THCA	cis	1	rs7252848	chr19:18612351	LRRC25	chr19:18501955-18508421:-	-0.14	-4.79	2.22E-6	Breast cancer	
THCA	cis	1	rs7253039	chr19:32973077	DPY19L3	chr19:32896677-32975236:+	0.18	4.96	9.87E-7	Bipolar disorder	
THCA	cis	1	rs7253039	chr19:32973077	ZNF507	chr19:32836514-32878571:+	0.3	7.54	2.42E-13	Bipolar disorder	
THCA	cis	1	rs725309	chr3:48418708	ATRIP	chr3:48488141-48507708:+	-0.18	-3.95	9.09E-5	Longevity	
THCA	cis	1	rs725309	chr3:48418708	TREX1	chr3:48501186-48509043:+	0.24	5.6	3.68E-8	Longevity	
THCA	cis	1	rs725310	chr3:48418571	ATRIP	chr3:48488141-48507708:+	-0.19	-4.07	5.55E-5	Longevity	
THCA	cis	1	rs725310	chr3:48418571	TREX1	chr3:48501186-48509043:+	0.24	5.54	4.88E-8	Longevity	
THCA	cis	1	rs7253326	chr19:53009541	ZNF578	chr19:52956829-53020130:+	0.26	3.55	0.000417	Longitudinal alcohol consumption	
THCA	cis	1	rs7254349	chr19:24230343	LOC100101266	chr19:24344995-24346249:-	0.37	6.19	1.27E-9	Response to taxane treatment (placlitaxel)	
THCA	cis	1	rs7254758	chr19:33608047	GPATCH1	chr19:33571786-33621318:+	0.35	8.68	6.17E-17	Bone properties (heel)	
THCA	cis	1	rs7255066	chr19:45146103	PVR	chr19:45147098-45169426:+	0.25	5.02	7.39E-7	Multiple sclerosis	
THCA	cis	1	rs7255420	chr19:12157839	ZNF763	chr19:12035900-12091196:+	-0.37	-4.48	9.33E-6	Multiple sclerosis	
THCA	cis	1	rs7255436	chr19:8433196	KANK3	chr19:8387469-8408146:-	-0.2	-5.01	7.86E-7	HDL cholesterol	
THCA	cis	1	rs7255436	chr19:8433196	MARCH2	chr19:8478187-8503897:+	-0.17	-3.91	0.000108	HDL cholesterol	
THCA	cis	1	rs7255436	chr19:8433196	RPS28	chr19:8386384-8387278:+	-0.31	-5.35	1.37E-7	HDL cholesterol	
THCA	cis	1	rs7255679	chr19:42063981	CEACAM21	chr19:42055886-42093196:+	0.6	15.25	4.31E-43	Schizophrenia	
THCA	cis	1	rs7255968	chr19:33601902	GPATCH1	chr19:33571786-33621318:+	0.32	7.68	9.07E-14	Bone properties (heel)	
THCA	cis	1	rs725673	chr14:71878468	SIPA1L1	chr14:71933902-72206118:+	0.27	5.53	5.21E-8	Mitral valve prolapse	
THCA	cis	1	rs7256759	chr19:12065010	ZNF763	chr19:12035900-12091196:+	-0.41	-4.95	1.04E-6	Multiple sclerosis	
THCA	cis	1	rs7257127	chr19:23056699	ZNF492	chr19:22817126-22850472:+	-0.43	-6.57	1.34E-10	Bronchopulmonary dysplasia	
THCA	cis	1	rs7258196	chr19:32944565	DPY19L3	chr19:32896677-32975236:+	0.18	4.85	1.65E-6	Bipolar disorder	
THCA	cis	1	rs7258196	chr19:32944565	ZNF507	chr19:32836514-32878571:+	0.3	7.38	7.29E-13	Bipolar disorder	
THCA	cis	1	rs7258465	chr19:18533642	ELL	chr19:18553475-18632937:-	-0.26	-6.6	1.12E-10	Breast cancer	
THCA	cis	1	rs7258465	chr19:18533642	ISYNA1	chr19:18545625-18548943:-	0.13	4.99	8.48E-7	Breast cancer	
THCA	cis	1	rs7258465	chr19:18533642	LRRC25	chr19:18501955-18508421:-	-0.14	-4.7	3.36E-6	Breast cancer	
THCA	cis	1	rs725908	chr20:33968067	CPNE1	chr20:34213968-34262539:-	0.3	5.78	1.31E-8	Height	
THCA	cis	1	rs725908	chr20:33968067	GDF5	chr20:33897002-34042568:-	-0.18	-3.77	0.000187	Height	
THCA	cis	1	rs725908	chr20:33968067	UQCC	chr20:33890383-33999833:-	0.32	10.17	4.02E-22	Height	
THCA	cis	1	rs7259376	chr19:22507705	ZNF492	chr19:22817126-22850472:+	-0.21	-3.66	0.000281	Telomere length	
THCA	cis	1	rs7259376	chr19:22507705	ZNF98	chr19:22573899-22605148:-	-0.41	-9.43	1.73E-19	Telomere length	
THCA	cis	1	rs7260482	chr19:45143942	PVR	chr19:45147098-45169426:+	0.25	5	8.15E-7	Multiple sclerosis	
THCA	cis	1	rs7260598	chr19:24222786	LOC100101266	chr19:24344995-24346249:-	-0.37	-6.23	1.05E-9	Response to taxane treatment (placlitaxel)	
THCA	cis	1	rs7261167	chr20:33576205	PROCR	chr20:33758727-33765164:+	-0.31	-5.37	1.24E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs7261167	chr20:33576205	TRPC4AP	chr20:33590215-33680618:-	0.27	3.52	0.000466	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs72612130	chr8:39391406	ADAM32	chr8:38965050-39142435:+	0.24	3.39	0.000753	Visceral adipose tissue/subcutaneous adipose tissue ratio	
THCA	cis	1	rs72612131	chr8:39399304	ADAM32	chr8:38965050-39142435:+	0.24	3.37	0.00081	Visceral adipose tissue/subcutaneous adipose tissue ratio	
THCA	cis	1	rs72612132	chr8:39400371	ADAM32	chr8:38965050-39142435:+	0.24	3.37	0.00081	Visceral adipose tissue/subcutaneous adipose tissue ratio	
THCA	cis	1	rs7261312	chr20:33684909	PROCR	chr20:33758727-33765164:+	-0.33	-5.88	7.74E-9	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs7261312	chr20:33684909	TRPC4AP	chr20:33590215-33680618:-	0.3	4.09	5.14E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs72626249	chr19:52364875	ZNF577	chr19:52359056-52394145:-	-0.22	-5.13	4.15E-7	Breast cancer	
THCA	cis	1	rs72626249	chr19:52364875	ZNF649	chr19:52392489-52408247:-	-0.17	-3.55	0.000416	Breast cancer	
THCA	cis	1	rs72627113	chr14:74340141	PTGR2	chr14:74318534-74352166:+	0.33	4.44	1.14E-5	Morning vs. evening chronotype	
THCA	cis	1	rs72627117	chr14:74355233	LIN52	chr14:74551656-74667117:+	0.25	4.58	6.04E-6	Morning vs. evening chronotype	
THCA	cis	1	rs72627117	chr14:74355233	PTGR2	chr14:74318534-74352166:+	0.22	3.56	0.000404	Morning vs. evening chronotype	
THCA	cis	1	rs72627117	chr14:74355233	ZNF410	chr14:74318674-74398803:+	0.23	3.96	8.73E-5	Morning vs. evening chronotype	
THCA	cis	1	rs72627119	chr14:74356274	LIN52	chr14:74551656-74667117:+	0.24	4.52	7.81E-6	Morning vs. evening chronotype	
THCA	cis	1	rs72627119	chr14:74356274	PTGR2	chr14:74318534-74352166:+	0.22	3.59	0.000367	Morning vs. evening chronotype	
THCA	cis	1	rs72627119	chr14:74356274	ZNF410	chr14:74318674-74398803:+	0.24	4.07	5.48E-5	Morning vs. evening chronotype	
THCA	cis	1	rs72627120	chr14:74363480	LIN52	chr14:74551656-74667117:+	0.24	4.51	8.26E-6	Morning vs. evening chronotype	
THCA	cis	1	rs72627120	chr14:74363480	PTGR2	chr14:74318534-74352166:+	0.22	3.55	0.000429	Morning vs. evening chronotype	
THCA	cis	1	rs72627120	chr14:74363480	ZNF410	chr14:74318674-74398803:+	0.24	4.02	6.81E-5	Morning vs. evening chronotype	
THCA	cis	1	rs72627122	chr14:74368236	LIN52	chr14:74551656-74667117:+	0.24	4.51	8.26E-6	Morning vs. evening chronotype	
THCA	cis	1	rs72627122	chr14:74368236	PTGR2	chr14:74318534-74352166:+	0.22	3.55	0.000429	Morning vs. evening chronotype	
THCA	cis	1	rs72627122	chr14:74368236	ZNF410	chr14:74318674-74398803:+	0.24	4.02	6.81E-5	Morning vs. evening chronotype	
THCA	cis	1	rs72627123	chr14:74368331	LIN52	chr14:74551656-74667117:+	0.24	4.51	8.26E-6	Morning vs. evening chronotype	
THCA	cis	1	rs72627123	chr14:74368331	PTGR2	chr14:74318534-74352166:+	0.22	3.55	0.000429	Morning vs. evening chronotype	
THCA	cis	1	rs72627123	chr14:74368331	ZNF410	chr14:74318674-74398803:+	0.24	4.02	6.81E-5	Morning vs. evening chronotype	
THCA	cis	1	rs72627124	chr14:74369128	LIN52	chr14:74551656-74667117:+	0.24	4.51	8.26E-6	Morning vs. evening chronotype	
THCA	cis	1	rs72627124	chr14:74369128	PTGR2	chr14:74318534-74352166:+	0.22	3.55	0.000429	Morning vs. evening chronotype	
THCA	cis	1	rs72627124	chr14:74369128	ZNF410	chr14:74318674-74398803:+	0.24	4.02	6.81E-5	Morning vs. evening chronotype	
THCA	cis	1	rs72627125	chr14:74369623	LIN52	chr14:74551656-74667117:+	0.24	4.51	8.26E-6	Morning vs. evening chronotype	
THCA	cis	1	rs72627125	chr14:74369623	PTGR2	chr14:74318534-74352166:+	0.22	3.55	0.000429	Morning vs. evening chronotype	
THCA	cis	1	rs72627125	chr14:74369623	ZNF410	chr14:74318674-74398803:+	0.24	4.02	6.81E-5	Morning vs. evening chronotype	
THCA	cis	1	rs72627126	chr14:74370024	LIN52	chr14:74551656-74667117:+	0.24	4.5	8.38E-6	Morning vs. evening chronotype	
THCA	cis	1	rs72627126	chr14:74370024	PTGR2	chr14:74318534-74352166:+	0.22	3.55	0.000417	Morning vs. evening chronotype	
THCA	cis	1	rs72627126	chr14:74370024	ZNF410	chr14:74318674-74398803:+	0.24	4.01	6.94E-5	Morning vs. evening chronotype	
THCA	cis	1	rs72627127	chr14:74370098	LIN52	chr14:74551656-74667117:+	0.24	4.51	8.26E-6	Morning vs. evening chronotype	
THCA	cis	1	rs72627127	chr14:74370098	PTGR2	chr14:74318534-74352166:+	0.22	3.55	0.000429	Morning vs. evening chronotype	
THCA	cis	1	rs72627127	chr14:74370098	ZNF410	chr14:74318674-74398803:+	0.24	4.02	6.81E-5	Morning vs. evening chronotype	
THCA	cis	1	rs72627129	chr14:74374805	LIN52	chr14:74551656-74667117:+	0.24	4.51	8.26E-6	Morning vs. evening chronotype	
THCA	cis	1	rs72627129	chr14:74374805	PTGR2	chr14:74318534-74352166:+	0.22	3.55	0.000429	Morning vs. evening chronotype	
THCA	cis	1	rs72627129	chr14:74374805	ZNF410	chr14:74318674-74398803:+	0.24	4.02	6.81E-5	Morning vs. evening chronotype	
THCA	cis	1	rs72627130	chr14:74374897	LIN52	chr14:74551656-74667117:+	0.24	4.51	8.26E-6	Morning vs. evening chronotype	
THCA	cis	1	rs72627130	chr14:74374897	PTGR2	chr14:74318534-74352166:+	0.22	3.55	0.000429	Morning vs. evening chronotype	
THCA	cis	1	rs72627130	chr14:74374897	ZNF410	chr14:74318674-74398803:+	0.24	4.02	6.81E-5	Morning vs. evening chronotype	
THCA	cis	1	rs72627138	chr14:74401900	LIN52	chr14:74551656-74667117:+	0.24	4.51	8.26E-6	Morning vs. evening chronotype	
THCA	cis	1	rs72627138	chr14:74401900	PTGR2	chr14:74318534-74352166:+	0.22	3.55	0.000429	Morning vs. evening chronotype	
THCA	cis	1	rs72627138	chr14:74401900	ZNF410	chr14:74318674-74398803:+	0.24	4.02	6.81E-5	Morning vs. evening chronotype	
THCA	cis	1	rs7263203	chr20:33773375	PROCR	chr20:33758727-33765164:+	-0.31	-5.04	6.77E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs7263203	chr20:33773375	TRPC4AP	chr20:33590215-33680618:-	0.32	3.95	9.07E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs7263203	chr20:33773375	UQCC	chr20:33890383-33999833:-	-0.18	-3.36	0.000832	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs7263253	chr20:33649376	PROCR	chr20:33758727-33765164:+	-0.34	-5.4	1.03E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs7263253	chr20:33649376	TRPC4AP	chr20:33590215-33680618:-	0.32	3.84	0.000138	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs72632952	chr11:8917976	TMEM9B	chr11:8968840-8986481:-	-0.22	-4.44	1.12E-5	Schizophrenia	
THCA	cis	1	rs72639533	chr10:37997810	LOC399744	chr10:38717074-38741080:+	0.25	3.44	0.000625	Obesity (extreme)	
THCA	cis	1	rs72639538	chr10:38360516	LOC399744	chr10:38717074-38741080:+	0.25	3.36	0.000856	Obesity (extreme)	
THCA	cis	1	rs72644211	chr10:81781695	LOC219347	chr10:81805991-81838949:-	1.02	14.48	1.2E-39	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs72644212	chr10:81782514	LOC219347	chr10:81805991-81838949:-	1.03	14.68	1.53E-40	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs72644213	chr10:81783660	LOC219347	chr10:81805991-81838949:-	1.05	15.23	5.47E-43	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs72649163	chr1:20900592	CDA	chr1:20915444-20945398:+	-0.22	-4.58	5.98E-6	Age-related hearing impairment (interaction)	
THCA	cis	1	rs72649163	chr1:20900592	FAM43B	chr1:20878932-20881512:+	0.21	4.06	5.75E-5	Age-related hearing impairment (interaction)	
THCA	cis	1	rs7265317	chr20:33768523	PROCR	chr20:33758727-33765164:+	-0.31	-5.04	6.77E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs7265317	chr20:33768523	TRPC4AP	chr20:33590215-33680618:-	0.32	3.95	9.07E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs7265317	chr20:33768523	UQCC	chr20:33890383-33999833:-	-0.18	-3.36	0.000832	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs72655523	chr4:77054154	NUP54	chr4:77035818-77069655:-	-0.17	-3.7	0.00024	Body mass index	
THCA	cis	1	rs72655536	chr4:77127104	NUP54	chr4:77035818-77069655:-	-0.16	-3.6	0.000345	Body mass index	
THCA	cis	1	rs72655538	chr4:77128253	NUP54	chr4:77035818-77069655:-	-0.16	-3.49	0.000527	Body mass index	
THCA	cis	1	rs7265697	chr20:55070664	C20orf43	chr20:55043647-55093942:+	0.28	7.51	2.99E-13	Refractive astigmatism	
THCA	cis	1	rs7265697	chr20:55070664	CSTF1	chr20:54967427-54979582:+	0.17	3.44	0.000627	Refractive astigmatism	
THCA	cis	1	rs72660447	chr8:94066834	C8orf83	chr8:93895865-94029901:-	0.3	4.7	3.47E-6	Attention deficit hyperactivity disorder	
THCA	cis	1	rs72660453	chr8:94069803	C8orf83	chr8:93895865-94029901:-	0.27	4.34	1.74E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs72660462	chr8:94070912	C8orf83	chr8:93895865-94029901:-	0.26	4.07	5.41E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs72660464	chr8:94071811	C8orf83	chr8:93895865-94029901:-	0.27	4.43	1.19E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs72660467	chr8:94071860	C8orf83	chr8:93895865-94029901:-	0.26	4.1	4.91E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs72660471	chr8:94078042	C8orf83	chr8:93895865-94029901:-	0.28	4.45	1.07E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs72660473	chr8:94078243	C8orf83	chr8:93895865-94029901:-	0.26	4.07	5.41E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs72660478	chr8:94079813	C8orf83	chr8:93895865-94029901:-	0.28	4.45	1.07E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs72660479	chr8:94080105	C8orf83	chr8:93895865-94029901:-	0.28	4.45	1.07E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs72660481	chr8:94080220	C8orf83	chr8:93895865-94029901:-	0.28	4.45	1.07E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs72660485	chr8:94082786	C8orf83	chr8:93895865-94029901:-	0.27	4.25	2.54E-5	Attention deficit hyperactivity disorder	
THCA	cis	1	rs72669974	chr4:106519627	INTS12	chr4:106603787-106629881:-	-0.58	-4.6	5.37E-6	Post bronchodilator FEV1	
THCA	cis	1	rs72669978	chr4:106520852	INTS12	chr4:106603787-106629881:-	-0.58	-4.74	2.79E-6	Post bronchodilator FEV1	
THCA	cis	1	rs72669980	chr4:106523563	INTS12	chr4:106603787-106629881:-	-0.59	-4.78	2.3E-6	Post bronchodilator FEV1	
THCA	cis	1	rs72669982	chr4:106524954	INTS12	chr4:106603787-106629881:-	-0.55	-4.68	3.79E-6	Post bronchodilator FEV1	
THCA	cis	1	rs72669993	chr4:106583144	INTS12	chr4:106603787-106629881:-	-0.6	-4.89	1.38E-6	Post bronchodilator FEV1	
THCA	cis	1	rs72669995	chr4:106585256	INTS12	chr4:106603787-106629881:-	-0.6	-4.88	1.42E-6	Post bronchodilator FEV1	
THCA	cis	1	rs72669997	chr4:106589782	INTS12	chr4:106603787-106629881:-	-0.6	-4.88	1.42E-6	Post bronchodilator FEV1	
THCA	cis	1	rs72671805	chr4:106603014	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72671808	chr4:106605720	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72671809	chr4:106611537	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72671811	chr4:106615603	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72671815	chr4:106618219	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72671820	chr4:106620983	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72671824	chr4:106623223	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72671826	chr4:106624502	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72671828	chr4:106624800	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72671835	chr4:106631356	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72671836	chr4:106633045	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72671837	chr4:106635902	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72671840	chr4:106638697	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72671849	chr4:106643818	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72671852	chr4:106646349	INTS12	chr4:106603787-106629881:-	-0.62	-5.31	1.66E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72671853	chr4:106646886	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72671854	chr4:106647023	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72671856	chr4:106647366	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72671858	chr4:106647679	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72671866	chr4:106657658	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72671869	chr4:106658658	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72671870	chr4:106659345	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72671871	chr4:106660324	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72671873	chr4:106661194	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72671874	chr4:106661970	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72671878	chr4:106662692	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72671880	chr4:106664424	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72671885	chr4:106668546	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72671886	chr4:106670589	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72671892	chr4:106680363	INTS12	chr4:106603787-106629881:-	-0.62	-5.3	1.78E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72671895	chr4:106685633	INTS12	chr4:106603787-106629881:-	-0.62	-5.3	1.78E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72671896	chr4:106685825	INTS12	chr4:106603787-106629881:-	-0.62	-5.3	1.78E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72673803	chr4:106696756	INTS12	chr4:106603787-106629881:-	-0.62	-5.3	1.78E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72673811	chr4:106707297	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.85E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72673812	chr4:106710454	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.85E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72673813	chr4:106710653	INTS12	chr4:106603787-106629881:-	-0.62	-5.3	1.78E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72673817	chr4:106713490	INTS12	chr4:106603787-106629881:-	-0.62	-5.3	1.78E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72673821	chr4:106718253	INTS12	chr4:106603787-106629881:-	-0.59	-5.09	5.07E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72673823	chr4:106719973	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72673824	chr4:106724464	INTS12	chr4:106603787-106629881:-	-0.62	-5.3	1.78E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72673828	chr4:106730342	INTS12	chr4:106603787-106629881:-	-0.62	-5.19	3.05E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72673831	chr4:106733380	INTS12	chr4:106603787-106629881:-	-0.61	-5.18	3.31E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72673832	chr4:106738760	INTS12	chr4:106603787-106629881:-	-0.61	-5.18	3.25E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72673834	chr4:106739374	INTS12	chr4:106603787-106629881:-	-0.61	-5.18	3.25E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72673853	chr4:106756877	INTS12	chr4:106603787-106629881:-	-0.58	-5	8.08E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72673858	chr4:106758056	INTS12	chr4:106603787-106629881:-	-0.58	-5	8.08E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72673860	chr4:106762900	INTS12	chr4:106603787-106629881:-	-0.58	-5	8.08E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72673866	chr4:106771155	INTS12	chr4:106603787-106629881:-	-0.61	-5.18	3.23E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72673870	chr4:106779865	INTS12	chr4:106603787-106629881:-	-0.61	-5.18	3.23E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72673872	chr4:106779925	INTS12	chr4:106603787-106629881:-	-0.61	-5.18	3.23E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72673873	chr4:106780301	INTS12	chr4:106603787-106629881:-	-0.59	-5.13	4.15E-7	Post bronchodilator FEV1	
THCA	cis	1	rs72677306	chr4:106997678	TBCK	chr4:106967233-107237861:-	0.36	7.38	7.17E-13	Airflow obstruction	
THCA	cis	1	rs72678650	chr4:122666000	EXOSC9	chr4:122722472-122738175:+	0.15	3.97	8.17E-5	Type 2 diabetes	
THCA	cis	1	rs7267979	chr20:25298087	ENTPD6	chr20:25176339-25207360:+	-0.31	-7.06	5.91E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7267979	chr20:25298087	FAM182A	chr20:26035250-26067552:+	-0.18	-3.35	0.000874	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7267979	chr20:25298087	FAM182B	chr20:25744102-25848786:-	0.27	5.55	4.79E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7267979	chr20:25298087	NINL	chr20:25433338-25566153:-	-0.35	-7.15	3.23E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7267979	chr20:25298087	PYGB	chr20:25228706-25278647:+	-0.15	-3.75	0.000199	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7268053	chr20:25328286	ENTPD6	chr20:25176339-25207360:+	0.32	7.29	1.31E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7268053	chr20:25328286	FAM182A	chr20:26035250-26067552:+	0.18	3.39	0.000746	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7268053	chr20:25328286	FAM182B	chr20:25744102-25848786:-	-0.26	-5.44	8.59E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7268053	chr20:25328286	NINL	chr20:25433338-25566153:-	0.34	7.13	3.83E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7268053	chr20:25328286	PYGB	chr20:25228706-25278647:+	0.17	4.21	3.08E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs72681672	chr14:51169600	SAV1	chr14:51100360-51135023:-	0.3	6.23	1.02E-9	Cognitive performance	
THCA	cis	1	rs72681673	chr14:51171922	SAV1	chr14:51100360-51135023:-	0.33	6.72	5.19E-11	Cognitive performance	
THCA	cis	1	rs72681677	chr14:51173590	SAV1	chr14:51100360-51135023:-	0.32	6.53	1.66E-10	Cognitive performance	
THCA	cis	1	rs7268447	chr20:33649593	PROCR	chr20:33758727-33765164:+	-0.34	-5.4	1.03E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs7268447	chr20:33649593	TRPC4AP	chr20:33590215-33680618:-	0.32	3.84	0.000138	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs72686191	chr1:76218319	ACADM	chr1:76190043-76229353:+	0.13	3.58	0.000374	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs72686191	chr1:76218319	MSH4	chr1:76262630-76378923:+	0.25	4.23	2.82E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs7269138	chr20:33570007	PROCR	chr20:33758727-33765164:+	-0.29	-4.73	2.91E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs72694715	chr1:146840183	FMO5	chr1:146655885-146697230:-	0.26	4.13	4.25E-5	Protein quantitative trait loci	
THCA	cis	1	rs72694720	chr1:146843654	FMO5	chr1:146655885-146697230:-	0.27	4.15	3.86E-5	Protein quantitative trait loci	
THCA	cis	1	rs72694750	chr1:146868586	FMO5	chr1:146655885-146697230:-	0.24	3.87	0.000125	Protein quantitative trait loci	
THCA	cis	1	rs726967	chr4:56421713	TMEM165	chr4:56262090-56292342:+	0.14	3.41	0.000697	Personality dimensions	
THCA	cis	1	rs72696952	chr1:152172694	FLG	chr1:152274651-152297679:-	0.31	4.56	6.58E-6	Atopic dermatitis	
THCA	cis	1	rs72696952	chr1:152172694	HRNR	chr1:152184558-152196669:-	-0.43	-5.76	1.5E-8	Atopic dermatitis	
THCA	cis	1	rs72696963	chr1:152181189	FLG	chr1:152274651-152297679:-	0.3	4.52	7.76E-6	Atopic dermatitis	
THCA	cis	1	rs72696963	chr1:152181189	HRNR	chr1:152184558-152196669:-	-0.42	-5.63	3.08E-8	Atopic dermatitis	
THCA	cis	1	rs72696969	chr1:152196339	FLG	chr1:152274651-152297679:-	0.31	4.54	7.2E-6	Atopic dermatitis	
THCA	cis	1	rs72696969	chr1:152196339	HRNR	chr1:152184558-152196669:-	-0.43	-5.69	2.17E-8	Atopic dermatitis	
THCA	cis	1	rs72696989	chr1:152248674	FLG	chr1:152274651-152297679:-	0.29	4.18	3.53E-5	Atopic dermatitis	
THCA	cis	1	rs72696989	chr1:152248674	HRNR	chr1:152184558-152196669:-	-0.42	-5.46	7.49E-8	Atopic dermatitis	
THCA	cis	1	rs72697000	chr1:152276772	FLG	chr1:152274651-152297679:-	0.29	4.09	5.07E-5	Atopic dermatitis	
THCA	cis	1	rs72697000	chr1:152276772	HRNR	chr1:152184558-152196669:-	-0.43	-5.59	3.8E-8	Atopic dermatitis	
THCA	cis	1	rs72698906	chr1:152307184	FLG	chr1:152274651-152297679:-	0.3	4.36	1.62E-5	Atopic dermatitis	
THCA	cis	1	rs72698906	chr1:152307184	HRNR	chr1:152184558-152196669:-	-0.4	-5.26	2.18E-7	Atopic dermatitis	
THCA	cis	1	rs72699846	chr14:93098617	RIN3	chr14:92980125-93155332:+	0.16	3.37	0.000824	Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs7270326	chr20:33693582	PROCR	chr20:33758727-33765164:+	-0.33	-5.91	6.58E-9	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs7270326	chr20:33693582	TRPC4AP	chr20:33590215-33680618:-	0.29	3.96	8.48E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs7270354	chr20:44607661	KCNS1	chr20:43720951-43729753:-	-0.28	-4.19	3.38E-5	Abdominal aortic aneurysm	
THCA	cis	1	rs7270354	chr20:44607661	WFDC3	chr20:44402847-44420547:-	-0.42	-5.9	6.92E-9	Abdominal aortic aneurysm	
THCA	cis	1	rs7271729	chr20:33610992	PROCR	chr20:33758727-33765164:+	-0.36	-5.7	2.14E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs7271729	chr20:33610992	TRPC4AP	chr20:33590215-33680618:-	0.31	3.77	0.000182	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs72717410	chr5:428785	C5orf55	chr5:441645-443258:-	0.34	8.47	3.09E-16	Cystic fibrosis severity	
THCA	cis	1	rs72717410	chr5:428785	ZDHHC11	chr5:795720-851101:-	-0.18	-3.37	0.000804	Cystic fibrosis severity	
THCA	cis	1	rs72717411	chr5:429124	C5orf55	chr5:441645-443258:-	0.34	8.33	8.6E-16	Cystic fibrosis severity	
THCA	cis	1	rs72717412	chr5:429381	C5orf55	chr5:441645-443258:-	0.34	8.37	6.26E-16	Cystic fibrosis severity	
THCA	cis	1	rs72717414	chr5:429818	C5orf55	chr5:441645-443258:-	0.34	8.32	9.15E-16	Cystic fibrosis severity	
THCA	cis	1	rs7272164	chr20:47766197	ARFGEF2	chr20:47538275-47653229:+	-0.12	-3.94	9.39E-5	Anger	
THCA	cis	1	rs7272164	chr20:47766197	CSE1L	chr20:47662838-47713484:+	0.41	10.23	2.37E-22	Anger	
THCA	cis	1	rs72722829	chr15:31639114	FAM7A2	chr15:30864758-30892900:+	-0.45	-4.06	5.85E-5	Survival in colorectal cancer (non-distant metastatic)	
THCA	cis	1	rs72722847	chr15:31682346	FAM7A2	chr15:30864758-30892900:+	-0.52	-4.56	6.62E-6	Survival in colorectal cancer (non-distant metastatic)	
THCA	cis	1	rs72722861	chr15:31704288	FAM7A2	chr15:30864758-30892900:+	-0.49	-4.48	9.49E-6	Survival in colorectal cancer (non-distant metastatic)	
THCA	cis	1	rs72730186	chr14:74942313	LTBP2	chr14:74964889-75079034:-	-0.19	-3.69	0.000247	Advanced glycation end-product levels	
THCA	cis	1	rs72734373	chr15:56262183	ZNF280D	chr15:56922376-57210697:-	-0.13	-3.97	8.3E-5	Keloid	
THCA	cis	1	rs72736464	chr15:56372722	MNS1	chr15:56720929-56757335:-	-0.25	-3.7	0.00024	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72736464	chr15:56372722	TEX9	chr15:56657644-56738071:+	-0.35	-5.96	4.81E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72736479	chr15:56398952	MNS1	chr15:56720929-56757335:-	-0.25	-3.66	0.000279	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72736479	chr15:56398952	TEX9	chr15:56657644-56738071:+	-0.35	-6.11	2.11E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72736495	chr15:56410911	MNS1	chr15:56720929-56757335:-	-0.25	-3.62	0.000326	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72736495	chr15:56410911	TEX9	chr15:56657644-56738071:+	-0.35	-6.06	2.7E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72736498	chr15:56420710	MNS1	chr15:56720929-56757335:-	-0.26	-3.75	0.000195	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72736498	chr15:56420710	TEX9	chr15:56657644-56738071:+	-0.38	-6.49	2.15E-10	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs7273734	chr20:33599403	PROCR	chr20:33758727-33765164:+	-0.34	-5.65	2.75E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs7273734	chr20:33599403	TRPC4AP	chr20:33590215-33680618:-	0.28	3.48	0.000549	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs72738604	chr15:56425189	MNS1	chr15:56720929-56757335:-	-0.24	-3.57	0.000388	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738604	chr15:56425189	TEX9	chr15:56657644-56738071:+	-0.35	-6.05	3.0E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738605	chr15:56425335	MNS1	chr15:56720929-56757335:-	-0.24	-3.57	0.000388	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738605	chr15:56425335	TEX9	chr15:56657644-56738071:+	-0.35	-6.05	3.0E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738607	chr15:56425615	MNS1	chr15:56720929-56757335:-	-0.24	-3.57	0.000388	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738607	chr15:56425615	TEX9	chr15:56657644-56738071:+	-0.35	-6.05	3.0E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738608	chr15:56425746	MNS1	chr15:56720929-56757335:-	-0.24	-3.57	0.000388	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738608	chr15:56425746	TEX9	chr15:56657644-56738071:+	-0.35	-6.05	3.0E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738615	chr15:56449456	MNS1	chr15:56720929-56757335:-	-0.25	-3.61	0.000334	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738615	chr15:56449456	TEX9	chr15:56657644-56738071:+	-0.35	-6	3.94E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738616	chr15:56451242	MNS1	chr15:56720929-56757335:-	-0.25	-3.61	0.000334	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738616	chr15:56451242	TEX9	chr15:56657644-56738071:+	-0.35	-6	3.94E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738618	chr15:56451415	MNS1	chr15:56720929-56757335:-	-0.25	-3.61	0.000334	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738618	chr15:56451415	TEX9	chr15:56657644-56738071:+	-0.35	-6	3.94E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738631	chr15:56466615	MNS1	chr15:56720929-56757335:-	-0.25	-3.58	0.000385	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738631	chr15:56466615	TEX9	chr15:56657644-56738071:+	-0.35	-5.99	4.06E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738636	chr15:56473321	MNS1	chr15:56720929-56757335:-	-0.25	-3.58	0.000385	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738636	chr15:56473321	TEX9	chr15:56657644-56738071:+	-0.35	-5.99	4.06E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738638	chr15:56474085	MNS1	chr15:56720929-56757335:-	-0.25	-3.6	0.000346	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738638	chr15:56474085	TEX9	chr15:56657644-56738071:+	-0.35	-5.99	4.2E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738646	chr15:56490848	TEX9	chr15:56657644-56738071:+	-0.34	-5.88	7.84E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738648	chr15:56491847	TEX9	chr15:56657644-56738071:+	-0.34	-5.88	7.84E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738654	chr15:56496290	TEX9	chr15:56657644-56738071:+	-0.34	-5.88	7.84E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738656	chr15:56496952	TEX9	chr15:56657644-56738071:+	-0.34	-5.88	7.84E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738662	chr15:56500064	TEX9	chr15:56657644-56738071:+	-0.34	-5.88	7.84E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738664	chr15:56500907	MNS1	chr15:56720929-56757335:-	-0.23	-3.4	0.000723	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738664	chr15:56500907	TEX9	chr15:56657644-56738071:+	-0.34	-5.91	6.66E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738666	chr15:56501019	MNS1	chr15:56720929-56757335:-	-0.23	-3.4	0.000723	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738666	chr15:56501019	TEX9	chr15:56657644-56738071:+	-0.34	-5.91	6.66E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738667	chr15:56501027	MNS1	chr15:56720929-56757335:-	-0.23	-3.4	0.000723	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738667	chr15:56501027	TEX9	chr15:56657644-56738071:+	-0.34	-5.91	6.66E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738668	chr15:56501415	MNS1	chr15:56720929-56757335:-	-0.23	-3.4	0.000723	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738668	chr15:56501415	TEX9	chr15:56657644-56738071:+	-0.34	-5.91	6.66E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738674	chr15:56507438	MNS1	chr15:56720929-56757335:-	-0.23	-3.41	0.000699	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738674	chr15:56507438	TEX9	chr15:56657644-56738071:+	-0.34	-5.84	9.5E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738675	chr15:56507582	MNS1	chr15:56720929-56757335:-	-0.23	-3.41	0.000699	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738675	chr15:56507582	TEX9	chr15:56657644-56738071:+	-0.34	-5.84	9.5E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738676	chr15:56507635	MNS1	chr15:56720929-56757335:-	-0.23	-3.41	0.000699	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738676	chr15:56507635	TEX9	chr15:56657644-56738071:+	-0.34	-5.84	9.5E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738679	chr15:56509260	MNS1	chr15:56720929-56757335:-	-0.23	-3.41	0.000699	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738679	chr15:56509260	TEX9	chr15:56657644-56738071:+	-0.34	-5.84	9.5E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738680	chr15:56509389	MNS1	chr15:56720929-56757335:-	-0.23	-3.41	0.000699	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738680	chr15:56509389	TEX9	chr15:56657644-56738071:+	-0.34	-5.84	9.5E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738682	chr15:56510796	MNS1	chr15:56720929-56757335:-	-0.23	-3.41	0.000699	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738682	chr15:56510796	TEX9	chr15:56657644-56738071:+	-0.34	-5.84	9.5E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738683	chr15:56510989	MNS1	chr15:56720929-56757335:-	-0.23	-3.41	0.000699	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738683	chr15:56510989	TEX9	chr15:56657644-56738071:+	-0.34	-5.84	9.5E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738684	chr15:56511122	MNS1	chr15:56720929-56757335:-	-0.23	-3.41	0.000699	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738684	chr15:56511122	TEX9	chr15:56657644-56738071:+	-0.34	-5.84	9.5E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738694	chr15:56518254	MNS1	chr15:56720929-56757335:-	-0.24	-3.54	0.000447	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738694	chr15:56518254	TEX9	chr15:56657644-56738071:+	-0.34	-5.76	1.53E-8	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738696	chr15:56520352	MNS1	chr15:56720929-56757335:-	-0.24	-3.51	0.000485	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738696	chr15:56520352	TEX9	chr15:56657644-56738071:+	-0.34	-5.81	1.12E-8	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738701	chr15:56531056	MNS1	chr15:56720929-56757335:-	-0.24	-3.55	0.000417	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72738701	chr15:56531056	TEX9	chr15:56657644-56738071:+	-0.34	-5.86	8.84E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72740503	chr15:56532219	MNS1	chr15:56720929-56757335:-	-0.24	-3.55	0.000417	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72740503	chr15:56532219	TEX9	chr15:56657644-56738071:+	-0.34	-5.86	8.84E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72740506	chr15:56533177	MNS1	chr15:56720929-56757335:-	-0.24	-3.5	0.000518	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72740506	chr15:56533177	TEX9	chr15:56657644-56738071:+	-0.34	-5.76	1.55E-8	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72740509	chr15:56533519	MNS1	chr15:56720929-56757335:-	-0.24	-3.5	0.000518	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs72740509	chr15:56533519	TEX9	chr15:56657644-56738071:+	-0.34	-5.76	1.55E-8	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs7274581	chr20:55018260	CASS4	chr20:54987168-55034396:+	0.39	6.66	7.49E-11	Alzheimer's disease (late onset)	
THCA	cis	1	rs7274581	chr20:55018260	CSTF1	chr20:54967427-54979582:+	-0.35	-4.12	4.49E-5	Alzheimer's disease (late onset)	
THCA	cis	1	rs72746858	chr1:200783153	DDX59	chr1:200610119-200639126:-	-0.26	-3.94	9.36E-5	Epilepsy	
THCA	cis	1	rs72746859	chr1:200783811	DDX59	chr1:200610119-200639126:-	-0.28	-4.16	3.79E-5	Epilepsy	
THCA	cis	1	rs72746876	chr1:200829360	DDX59	chr1:200610119-200639126:-	-0.23	-3.52	0.000465	Epilepsy	
THCA	cis	1	rs7274866	chr20:33608616	PROCR	chr20:33758727-33765164:+	-0.34	-5.59	3.77E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs7274866	chr20:33608616	TRPC4AP	chr20:33590215-33680618:-	0.27	3.37	0.000808	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs7276302	chr21:45614159	ICOSLG	chr21:45646724-45660834:-	0.19	4.02	6.64E-5	Inflammatory bowel disease	
THCA	cis	1	rs7276302	chr21:45614159	PWP2	chr21:45527208-45551062:+	0.24	4.29	2.12E-5	Inflammatory bowel disease	
THCA	cis	1	rs72768397	chr1:247219411	OR2T8	chr1:248084320-248085256:+	-0.2	-3.77	0.000181	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs72768397	chr1:247219411	OR2W3	chr1:248031265-248060142:+	-0.17	-3.38	0.000772	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs72774845	chr16:15147954	NTAN1	chr16:15131717-15149833:-	0.12	3.58	0.000379	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs72774845	chr16:15147954	PDXDC1	chr16:15068599-15233195:+	0.31	7.08	5.28E-12	Metabolic traits;Glycerophospholipid levels	
THCA	cis	1	rs72782294	chr2:28953390	PPP1CB	chr2:28974612-29025805:+	-0.17	-4.28	2.23E-5	Body mass index	
THCA	cis	1	rs72782294	chr2:28953390	TRMT61B	chr2:29072690-29093175:-	0.5	10.04	1.2E-21	Body mass index	
THCA	cis	1	rs72788434	chr10:23662769	C10orf67	chr10:23605521-23633772:-	-0.25	-4.79	2.27E-6	Crohn's disease and sarcoidosis (combined)	
THCA	cis	1	rs72796115	chr16:50077722	HEATR3	chr16:50099881-50139373:+	-0.4	-6.19	1.29E-9	Esophageal cancer (squamous cell)	
THCA	cis	1	rs72796149	chr16:50114885	HEATR3	chr16:50099881-50139373:+	-0.4	-6.08	2.48E-9	Esophageal cancer (squamous cell)	
THCA	cis	1	rs72796151	chr16:50117077	HEATR3	chr16:50099881-50139373:+	-0.4	-6.08	2.48E-9	Esophageal cancer (squamous cell)	
THCA	cis	1	rs72796155	chr16:50121763	HEATR3	chr16:50099881-50139373:+	-0.4	-6.09	2.26E-9	Esophageal cancer (squamous cell)	
THCA	cis	1	rs72796159	chr16:50126320	HEATR3	chr16:50099881-50139373:+	-0.4	-6.08	2.48E-9	Esophageal cancer (squamous cell)	
THCA	cis	1	rs72796169	chr16:50132067	HEATR3	chr16:50099881-50139373:+	-0.4	-6.09	2.36E-9	Esophageal cancer (squamous cell)	
THCA	cis	1	rs72798038	chr16:50149163	HEATR3	chr16:50099881-50139373:+	-0.3	-4.93	1.15E-6	Esophageal cancer (squamous cell)	
THCA	cis	1	rs72798040	chr16:50149693	HEATR3	chr16:50099881-50139373:+	-0.3	-4.93	1.15E-6	Esophageal cancer (squamous cell)	
THCA	cis	1	rs72800847	chr16:31022639	C16orf93	chr16:30768753-30773542:-	-0.14	-3.87	0.000123	Response to metformin (IC50)	
THCA	cis	1	rs72800847	chr16:31022639	HSD3B7	chr16:30996519-31000473:+	0.45	10.9	7.7E-25	Response to metformin (IC50)	
THCA	cis	1	rs72800847	chr16:31022639	MYST1	chr16:31128985-31142713:+	0.14	4.39	1.37E-5	Response to metformin (IC50)	
THCA	cis	1	rs72800847	chr16:31022639	PRSS53	chr16:31094747-31106276:-	-0.16	-4.19	3.38E-5	Response to metformin (IC50)	
THCA	cis	1	rs72813408	chr2:63363242	C2orf86	chr2:63348537-63815851:-	-0.21	-4.47	9.98E-6	Subjective well-being	
THCA	cis	1	rs72813411	chr2:63364225	C2orf86	chr2:63348537-63815851:-	-0.22	-4.77	2.5E-6	Subjective well-being	
THCA	cis	1	rs72813412	chr2:63365500	C2orf86	chr2:63348537-63815851:-	-0.19	-3.96	8.8E-5	Subjective well-being	
THCA	cis	1	rs72813418	chr2:63385242	C2orf86	chr2:63348537-63815851:-	-0.2	-4.24	2.68E-5	Subjective well-being	
THCA	cis	1	rs72818709	chr10:91371446	FLJ37201	chr10:91451057-91457685:-	-0.19	-4.04	6.25E-5	Metabolic traits	
THCA	cis	1	rs72819593	chr17:2199489	SRR	chr17:2207248-2228553:+	-0.82	-16.73	8.56E-50	Esophageal cancer (squamous cell)	
THCA	cis	1	rs72823064	chr17:40569974	HSD17B1	chr17:40703984-40707224:+	-0.12	-3.37	0.000808	Crohn's disease	
THCA	cis	1	rs72823064	chr17:40569974	NAGLU	chr17:40687951-40696464:+	-0.23	-5.06	5.88E-7	Crohn's disease	
THCA	cis	1	rs72823064	chr17:40569974	TUBG2	chr17:40811266-40819023:+	-0.22	-5.27	2.04E-7	Crohn's disease	
THCA	cis	1	rs72823592	chr17:46123004	LRRC46	chr17:45909100-45914690:+	-0.22	-4.36	1.59E-5	Epilepsy (generalized)	
THCA	cis	1	rs72823592	chr17:46123004	PRR15L	chr17:46029335-46035110:-	0.19	3.96	8.53E-5	Epilepsy (generalized)	
THCA	cis	1	rs72823619	chr2:102924615	IL1RL1	chr2:102927962-102968497:+	0.24	4.65	4.24E-6	Asthma	
THCA	cis	1	rs72823621	chr2:102925435	IL1RL1	chr2:102927962-102968497:+	0.23	4.52	7.72E-6	Asthma	
THCA	cis	1	rs72823632	chr2:102931534	IL1RL1	chr2:102927962-102968497:+	0.22	4.31	2.02E-5	Asthma	
THCA	cis	1	rs72823635	chr2:102931612	IL1RL1	chr2:102927962-102968497:+	0.22	4.31	2.02E-5	Asthma	
THCA	cis	1	rs72823646	chr2:102954213	IL1RL1	chr2:102927962-102968497:+	0.22	4.43	1.15E-5	Asthma	
THCA	cis	1	rs72825704	chr2:99239164	UNC50	chr2:99225042-99234975:+	-0.23	-4.65	4.24E-6	Bipolar disorder	
THCA	cis	1	rs72825710	chr2:99239497	UNC50	chr2:99225042-99234975:+	-0.23	-4.65	4.24E-6	Bipolar disorder	
THCA	cis	1	rs72825718	chr2:99247152	UNC50	chr2:99225042-99234975:+	-0.22	-4.56	6.4E-6	Bipolar disorder	
THCA	cis	1	rs72825719	chr2:99247465	UNC50	chr2:99225042-99234975:+	-0.23	-4.5	8.53E-6	Bipolar disorder	
THCA	cis	1	rs72825720	chr2:99247508	UNC50	chr2:99225042-99234975:+	-0.22	-4.39	1.41E-5	Bipolar disorder	
THCA	cis	1	rs72825725	chr2:99251259	UNC50	chr2:99225042-99234975:+	-0.22	-4.4	1.36E-5	Bipolar disorder	
THCA	cis	1	rs72825727	chr2:99252750	UNC50	chr2:99225042-99234975:+	-0.23	-4.74	2.79E-6	Bipolar disorder	
THCA	cis	1	rs72825732	chr2:99259778	UNC50	chr2:99225042-99234975:+	-0.22	-4.37	1.54E-5	Bipolar disorder	
THCA	cis	1	rs72825746	chr17:30364610	C17orf79	chr17:30178885-30186326:-	-0.23	-5.21	2.88E-7	Height	
THCA	cis	1	rs72829170	chr10:64940289	LOC84989	chr10:65224989-65226320:+	0.27	4.38	1.44E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs72829170	chr10:64940289	NRBF2	chr10:64893007-64914785:+	0.28	4.68	3.68E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs72830699	chr6:20704424	SOX4	chr6:21593972-21598847:+	-0.12	-3.52	0.00047	Type 2 diabetes	
THCA	cis	1	rs72831853	chr17:46842575	CALCOCO2	chr17:46908372-46942228:+	-0.13	-3.48	0.00054	Schizophrenia or bipolar disorder	
THCA	cis	1	rs72831853	chr17:46842575	SNF8	chr17:47007461-47022154:-	-0.25	-7.36	8.1E-13	Schizophrenia or bipolar disorder	
THCA	cis	1	rs72831853	chr17:46842575	UBE2Z	chr17:46985767-47006422:+	-0.19	-4	7.44E-5	Schizophrenia or bipolar disorder	
THCA	cis	1	rs72837025	chr10:65194491	LOC84989	chr10:65224989-65226320:+	0.26	4.19	3.3E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs72837025	chr10:65194491	NRBF2	chr10:64893007-64914785:+	0.28	4.63	4.68E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs72837056	chr10:65260478	LOC84989	chr10:65224989-65226320:+	0.27	4.29	2.17E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs72837056	chr10:65260478	NRBF2	chr10:64893007-64914785:+	0.26	4.37	1.5E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs72837070	chr10:65274679	LOC84989	chr10:65224989-65226320:+	0.27	4.31	1.98E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs72837070	chr10:65274679	NRBF2	chr10:64893007-64914785:+	0.27	4.42	1.2E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs72837952	chr2:69742989	AAK1	chr2:69685127-69870977:-	-0.24	-5.17	3.39E-7	Parkinson's disease (age of onset)	
THCA	cis	1	rs72837952	chr2:69742989	NFU1	chr2:69623255-69664753:-	-0.18	-3.83	0.000144	Parkinson's disease (age of onset)	
THCA	cis	1	rs72839341	chr6:3293287	PSMG4	chr6:3259162-3268300:+	-0.34	-5.54	5.06E-8	Survival in rectal cancer	
THCA	cis	1	rs72840063	chr2:85550396	CAPG	chr2:85621871-85641170:-	-0.15	-4.39	1.4E-5	Ear protrusion	
THCA	cis	1	rs72840063	chr2:85550396	TGOLN2	chr2:85545147-85555374:-	-0.17	-5.8	1.17E-8	Ear protrusion	
THCA	cis	1	rs72843784	chr6:26498758	BTN3A2	chr6:26365398-26378546:+	-0.88	-10.89	8.31E-25	Schizophrenia	
THCA	cis	1	rs72845397	chr11:6950903	ZNF215	chr11:6947654-7005861:+	-0.28	-4.42	1.2E-5	Response to cytadine analogues (cytosine arabinoside)	
THCA	cis	1	rs72848797	chr17:61934664	FTSJ3	chr17:61896795-61905031:-	0.3	5.52	5.51E-8	Body mass index	
THCA	cis	1	rs72848797	chr17:61934664	MAP3K3	chr17:61699775-61773669:+	0.26	5.09	5.14E-7	Body mass index	
THCA	cis	1	rs72852940	chr6:39234605	KCNK16	chr6:39282475-39290330:-	0.14	3.45	0.000612	Cholesterol, total	
THCA	cis	1	rs7285566	chr22:18445288	MICAL3	chr22:18270418-18507325:-	-0.2	-3.98	8.1E-5	Presence of antiphospholipid antibodies	
THCA	cis	1	rs72855860	chr4:75714054	BTC	chr4:75671448-75719882:-	0.2	3.89	0.000113	Electroencephalogram traits	
THCA	cis	1	rs72859113	chr17:80417443	C17orf62	chr17:80400520-80408694:-	-0.27	-6.45	2.75E-10	Protein quantitative trait loci	
THCA	cis	1	rs72859120	chr17:80421110	C17orf62	chr17:80400520-80408694:-	-0.27	-6.37	4.52E-10	Protein quantitative trait loci	
THCA	cis	1	rs72859125	chr17:80427975	C17orf62	chr17:80400520-80408694:-	-0.26	-6.33	5.52E-10	Protein quantitative trait loci	
THCA	cis	1	rs728615	chr10:81848089	MBL1P	chr10:81664654-81710783:+	0.35	5.39	1.11E-7	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs728615	chr10:81848089	PLAC9	chr10:81892258-81904784:+	-0.24	-5.24	2.36E-7	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs728615	chr10:81848089	SFTPD	chr10:81697498-81708861:-	0.26	3.38	0.000794	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs728615	chr10:81848089	TSPAN14	chr10:82214038-82282390:+	0.22	3.42	0.000682	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs728616	chr10:81847914	MBL1P	chr10:81664654-81710783:+	0.33	5.15	3.79E-7	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs728616	chr10:81847914	PLAC9	chr10:81892258-81904784:+	-0.25	-5.45	8.0E-8	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs728616	chr10:81847914	TSPAN14	chr10:82214038-82282390:+	0.22	3.44	0.000633	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs7286219	chr22:18445709	MICAL3	chr22:18270418-18507325:-	-0.19	-3.96	8.62E-5	Presence of antiphospholipid antibodies	
THCA	cis	1	rs7286607	chr22:18444657	MICAL3	chr22:18270418-18507325:-	-0.21	-4.27	2.33E-5	Presence of antiphospholipid antibodies	
THCA	cis	1	rs72867573	chr4:75696002	BTC	chr4:75671448-75719882:-	0.19	3.62	0.000325	Electroencephalogram traits	
THCA	cis	1	rs72867579	chr4:75698204	BTC	chr4:75671448-75719882:-	0.2	3.76	0.000191	Electroencephalogram traits	
THCA	cis	1	rs72867588	chr4:75706640	BTC	chr4:75671448-75719882:-	0.21	4.01	7.08E-5	Electroencephalogram traits	
THCA	cis	1	rs72867590	chr4:75706651	BTC	chr4:75671448-75719882:-	0.21	4.01	7.08E-5	Electroencephalogram traits	
THCA	cis	1	rs72867592	chr4:75706767	BTC	chr4:75671448-75719882:-	0.21	4.1	4.88E-5	Electroencephalogram traits	
THCA	cis	1	rs72867594	chr4:75706808	BTC	chr4:75671448-75719882:-	0.21	4.1	4.88E-5	Electroencephalogram traits	
THCA	cis	1	rs72872548	chr11:5289139	HBG1	chr11:5269502-5271087:-	0.24	3.76	0.000188	Hemoglobin levels	
THCA	cis	1	rs72872548	chr11:5289139	HBG2	chr11:5269502-5667011:-	0.28	4.38	1.43E-5	Hemoglobin levels	
THCA	cis	1	rs7289577	chr22:39042214	JOSD1	chr22:39081549-39096459:-	-0.15	-3.87	0.000122	Resting heart rate	
THCA	cis	1	rs7289577	chr22:39042214	TOMM22	chr22:39077954-39080763:+	-0.17	-3.66	0.000278	Resting heart rate	
THCA	cis	1	rs72896354	chr2:53224841	CHAC2	chr2:53994929-54002287:+	0.23	3.59	0.000363	Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs7290684	chr22:29857664	NIPSNAP1	chr22:29950800-29977144:-	0.29	3.84	0.00014	Carotid atherosclerosis in HIV infection	
THCA	cis	1	rs7290684	chr22:29857664	THOC5	chr22:29904157-29949736:-	0.2	3.65	0.000288	Carotid atherosclerosis in HIV infection	
THCA	cis	1	rs7290855	chr22:29852474	NIPSNAP1	chr22:29950800-29977144:-	0.33	4.19	3.35E-5	Carotid atherosclerosis in HIV infection	
THCA	cis	1	rs7290855	chr22:29852474	THOC5	chr22:29904157-29949736:-	0.21	3.94	9.38E-5	Carotid atherosclerosis in HIV infection	
THCA	cis	1	rs7291169	chr22:18449038	MICAL3	chr22:18270418-18507325:-	-0.2	-4.09	5.01E-5	Presence of antiphospholipid antibodies	
THCA	cis	1	rs7291412	chr22:46459132	LOC100271722	chr22:46435789-46440748:-	0.26	6.07	2.56E-9	Subjective well-being	
THCA	cis	1	rs7291867	chr22:38062112	LGALS2	chr22:37966254-37976024:-	0.14	3.69	0.000248	Fat distribution (HIV)	
THCA	cis	1	rs7291867	chr22:38062112	SH3BP1	chr22:38030661-38062939:+	0.11	3.44	0.000639	Fat distribution (HIV)	
THCA	cis	1	rs72922733	chr11:65520746	CTSW	chr11:65647284-65651212:+	-0.27	-5.41	9.89E-8	Systemic lupus erythematosus	
THCA	cis	1	rs72922733	chr11:65520746	RNASEH2C	chr11:65485146-65488409:-	-0.19	-4.6	5.38E-6	Systemic lupus erythematosus	
THCA	cis	1	rs72922733	chr11:65520746	SNX32	chr11:65601410-65621170:+	0.41	5.25	2.25E-7	Systemic lupus erythematosus	
THCA	cis	1	rs72926038	chr11:64142391	GPR137	chr11:64037534-64056965:+	-0.16	-3.49	0.00052	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs72926046	chr11:64143387	GPR137	chr11:64037534-64056965:+	-0.15	-3.4	0.000722	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs72926050	chr11:64143574	GPR137	chr11:64037534-64056965:+	-0.15	-3.4	0.000722	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs72926767	chr2:203796814	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.95	5.24E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72926767	chr2:203796814	ICA1L	chr2:203637873-203736371:-	0.26	4.29	2.13E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72926769	chr2:203798318	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.95	5.24E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72926769	chr2:203798318	ICA1L	chr2:203637873-203736371:-	0.26	4.29	2.13E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72926771	chr2:203801226	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.95	5.24E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72926771	chr2:203801226	ICA1L	chr2:203637873-203736371:-	0.26	4.29	2.13E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72926772	chr2:203804289	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.95	5.24E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72926772	chr2:203804289	ICA1L	chr2:203637873-203736371:-	0.26	4.29	2.13E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72926779	chr2:203805929	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.95	5.24E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72926779	chr2:203805929	ICA1L	chr2:203637873-203736371:-	0.26	4.29	2.13E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72926781	chr2:203808835	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.95	5.24E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72926781	chr2:203808835	ICA1L	chr2:203637873-203736371:-	0.26	4.29	2.13E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72926782	chr2:203811628	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.95	5.24E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72926782	chr2:203811628	ICA1L	chr2:203637873-203736371:-	0.26	4.29	2.13E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72926783	chr2:203815740	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.95	5.24E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72926783	chr2:203815740	ICA1L	chr2:203637873-203736371:-	0.26	4.29	2.13E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72926786	chr2:203816494	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.95	5.24E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72926786	chr2:203816494	ICA1L	chr2:203637873-203736371:-	0.26	4.29	2.13E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72926787	chr2:203818299	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.69	2.21E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72926787	chr2:203818299	ICA1L	chr2:203637873-203736371:-	0.27	4.48	9.33E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72926791	chr2:203822891	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.69	2.21E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72926791	chr2:203822891	ICA1L	chr2:203637873-203736371:-	0.27	4.48	9.33E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72926793	chr2:203826396	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.69	2.21E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72926793	chr2:203826396	ICA1L	chr2:203637873-203736371:-	0.27	4.48	9.33E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72926794	chr2:203827432	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.69	2.21E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72926794	chr2:203827432	ICA1L	chr2:203637873-203736371:-	0.27	4.48	9.33E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72926796	chr2:203827480	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.69	2.21E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72926796	chr2:203827480	ICA1L	chr2:203637873-203736371:-	0.27	4.48	9.33E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72926802	chr2:203830228	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.69	2.21E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72926802	chr2:203830228	ICA1L	chr2:203637873-203736371:-	0.27	4.48	9.33E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72928605	chr2:203832120	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.65	2.71E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72928605	chr2:203832120	ICA1L	chr2:203637873-203736371:-	0.24	3.77	0.000182	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72928608	chr2:203836507	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.69	2.21E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72928608	chr2:203836507	ICA1L	chr2:203637873-203736371:-	0.27	4.48	9.33E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72928609	chr2:203837573	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.69	2.21E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72928609	chr2:203837573	ICA1L	chr2:203637873-203736371:-	0.27	4.48	9.33E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72928613	chr2:203839628	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.7	2.07E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72928613	chr2:203839628	ICA1L	chr2:203637873-203736371:-	0.27	4.46	1.02E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72928620	chr2:203840973	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.57	4.19E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72928620	chr2:203840973	ICA1L	chr2:203637873-203736371:-	0.25	4.19	3.38E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72931639	chr11:78036703	NARS2	chr11:78147017-78285909:-	-0.39	-6.92	1.48E-11	Testicular germ cell tumor	
THCA	cis	1	rs72931642	chr11:78037862	NARS2	chr11:78147017-78285909:-	-0.39	-6.92	1.48E-11	Testicular germ cell tumor	
THCA	cis	1	rs72931690	chr11:78073192	NARS2	chr11:78147017-78285909:-	-0.4	-7.04	6.55E-12	Testicular germ cell tumor	
THCA	cis	1	rs72932553	chr2:203842661	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.69	2.21E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932553	chr2:203842661	ICA1L	chr2:203637873-203736371:-	0.27	4.48	9.33E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932554	chr2:203845828	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.69	2.21E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932554	chr2:203845828	ICA1L	chr2:203637873-203736371:-	0.27	4.48	9.33E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932557	chr2:203846817	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.69	2.21E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932557	chr2:203846817	ICA1L	chr2:203637873-203736371:-	0.27	4.48	9.33E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932558	chr2:203847325	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.69	2.21E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932558	chr2:203847325	ICA1L	chr2:203637873-203736371:-	0.27	4.48	9.33E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932561	chr2:203848402	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.69	2.21E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932561	chr2:203848402	ICA1L	chr2:203637873-203736371:-	0.27	4.48	9.33E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932566	chr2:203855342	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.72	1.86E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932566	chr2:203855342	ICA1L	chr2:203637873-203736371:-	0.27	4.48	9.19E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932572	chr2:203859391	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.72	1.86E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932572	chr2:203859391	ICA1L	chr2:203637873-203736371:-	0.27	4.48	9.19E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932573	chr2:203861113	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.72	1.86E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932573	chr2:203861113	ICA1L	chr2:203637873-203736371:-	0.27	4.48	9.19E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932574	chr2:203866336	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.72	1.86E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932574	chr2:203866336	ICA1L	chr2:203637873-203736371:-	0.27	4.48	9.19E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932588	chr2:203883193	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.72	1.86E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932588	chr2:203883193	ICA1L	chr2:203637873-203736371:-	0.27	4.48	9.19E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932590	chr2:203884308	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.72	1.86E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932590	chr2:203884308	ICA1L	chr2:203637873-203736371:-	0.27	4.48	9.19E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932763	chr2:203678658	ALS2CR8	chr2:203776978-203851060:+	-0.26	-5.05	6.4E-7	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932763	chr2:203678658	ICA1L	chr2:203637873-203736371:-	0.29	4.72	3.11E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932765	chr2:203679183	ALS2CR8	chr2:203776978-203851060:+	-0.26	-5.05	6.4E-7	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932765	chr2:203679183	ICA1L	chr2:203637873-203736371:-	0.29	4.72	3.11E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932767	chr2:203679306	ALS2CR8	chr2:203776978-203851060:+	-0.26	-5.05	6.4E-7	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932767	chr2:203679306	ICA1L	chr2:203637873-203736371:-	0.29	4.72	3.11E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932772	chr2:203682304	ALS2CR8	chr2:203776978-203851060:+	-0.27	-5.27	2.11E-7	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932772	chr2:203682304	ICA1L	chr2:203637873-203736371:-	0.27	4.44	1.12E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932774	chr2:203685728	ALS2CR8	chr2:203776978-203851060:+	-0.27	-5.34	1.43E-7	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932774	chr2:203685728	ICA1L	chr2:203637873-203736371:-	0.27	4.53	7.59E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932776	chr2:203688300	ALS2CR8	chr2:203776978-203851060:+	-0.27	-5.34	1.43E-7	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932776	chr2:203688300	ICA1L	chr2:203637873-203736371:-	0.27	4.53	7.59E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932777	chr2:203689914	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.59	3.79E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932777	chr2:203689914	ICA1L	chr2:203637873-203736371:-	0.27	4.49	9.12E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932780	chr2:203695826	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.7	2.12E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932780	chr2:203695826	ICA1L	chr2:203637873-203736371:-	0.26	4.37	1.53E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932781	chr2:203697278	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.67	2.47E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932781	chr2:203697278	ICA1L	chr2:203637873-203736371:-	0.27	4.41	1.26E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932784	chr2:203698470	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.67	2.47E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932784	chr2:203698470	ICA1L	chr2:203637873-203736371:-	0.27	4.41	1.26E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932786	chr2:203698737	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.67	2.47E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932786	chr2:203698737	ICA1L	chr2:203637873-203736371:-	0.27	4.41	1.26E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932789	chr2:203699379	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.67	2.47E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932789	chr2:203699379	ICA1L	chr2:203637873-203736371:-	0.27	4.41	1.26E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932791	chr2:203700870	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.67	2.47E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932791	chr2:203700870	ICA1L	chr2:203637873-203736371:-	0.27	4.41	1.26E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932793	chr2:203701004	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.67	2.47E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72932793	chr2:203701004	ICA1L	chr2:203637873-203736371:-	0.27	4.41	1.26E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934505	chr2:203916487	ALS2CR8	chr2:203776978-203851060:+	-0.27	-5.37	1.24E-7	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934505	chr2:203916487	ICA1L	chr2:203637873-203736371:-	0.27	4.44	1.11E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934510	chr2:203925360	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.68	2.35E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934510	chr2:203925360	ICA1L	chr2:203637873-203736371:-	0.28	4.58	5.97E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934512	chr2:203926271	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.68	2.35E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934512	chr2:203926271	ICA1L	chr2:203637873-203736371:-	0.28	4.58	5.97E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934513	chr2:203927587	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.68	2.35E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934513	chr2:203927587	ICA1L	chr2:203637873-203736371:-	0.28	4.58	5.97E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934514	chr2:203933339	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.59	3.74E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934514	chr2:203933339	ICA1L	chr2:203637873-203736371:-	0.24	3.85	0.000132	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934518	chr2:203937908	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.68	2.35E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934518	chr2:203937908	ICA1L	chr2:203637873-203736371:-	0.28	4.61	5.22E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934519	chr2:203939640	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.88	7.86E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934519	chr2:203939640	ICA1L	chr2:203637873-203736371:-	0.29	4.75	2.67E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934537	chr2:203969504	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.73	1.79E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934537	chr2:203969504	ICA1L	chr2:203637873-203736371:-	0.27	4.53	7.53E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934545	chr2:203975958	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.73	1.79E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934545	chr2:203975958	ICA1L	chr2:203637873-203736371:-	0.27	4.53	7.53E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934554	chr2:203987806	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.7	2.08E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934554	chr2:203987806	ICA1L	chr2:203637873-203736371:-	0.28	4.62	4.85E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934556	chr2:203990789	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.54	5.09E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934556	chr2:203990789	ICA1L	chr2:203637873-203736371:-	0.24	3.81	0.000155	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934563	chr2:203995405	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.63	3.06E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934563	chr2:203995405	ICA1L	chr2:203637873-203736371:-	0.27	4.54	7.1E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934573	chr2:204005072	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.85	9.1E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934573	chr2:204005072	ICA1L	chr2:203637873-203736371:-	0.26	4.27	2.34E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934704	chr2:203706433	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.67	2.47E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934704	chr2:203706433	ICA1L	chr2:203637873-203736371:-	0.27	4.41	1.26E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934706	chr2:203707752	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.67	2.47E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934706	chr2:203707752	ICA1L	chr2:203637873-203736371:-	0.27	4.41	1.26E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934707	chr2:203707878	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.67	2.47E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934707	chr2:203707878	ICA1L	chr2:203637873-203736371:-	0.27	4.41	1.26E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934710	chr2:203709776	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.69	2.17E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934710	chr2:203709776	ICA1L	chr2:203637873-203736371:-	0.27	4.54	7.1E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934711	chr2:203709997	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.69	2.17E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934711	chr2:203709997	ICA1L	chr2:203637873-203736371:-	0.27	4.54	7.1E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934714	chr2:203711581	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.69	2.17E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934714	chr2:203711581	ICA1L	chr2:203637873-203736371:-	0.27	4.54	7.1E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934715	chr2:203713280	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.72	1.85E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934715	chr2:203713280	ICA1L	chr2:203637873-203736371:-	0.27	4.5	8.65E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934729	chr2:203737770	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.93	5.93E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934729	chr2:203737770	ICA1L	chr2:203637873-203736371:-	0.25	4.18	3.49E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934732	chr2:203739856	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.93	5.93E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934732	chr2:203739856	ICA1L	chr2:203637873-203736371:-	0.25	4.18	3.49E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934735	chr2:203740010	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.93	5.93E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934735	chr2:203740010	ICA1L	chr2:203637873-203736371:-	0.25	4.18	3.49E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934737	chr2:203740798	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.93	5.93E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934737	chr2:203740798	ICA1L	chr2:203637873-203736371:-	0.25	4.18	3.49E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934738	chr2:203740861	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.93	5.93E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934738	chr2:203740861	ICA1L	chr2:203637873-203736371:-	0.25	4.18	3.49E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934740	chr2:203741362	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.93	5.93E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934740	chr2:203741362	ICA1L	chr2:203637873-203736371:-	0.25	4.18	3.49E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934745	chr2:203744454	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.93	5.93E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934745	chr2:203744454	ICA1L	chr2:203637873-203736371:-	0.25	4.18	3.49E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934749	chr2:203746816	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.93	5.93E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934749	chr2:203746816	ICA1L	chr2:203637873-203736371:-	0.25	4.18	3.49E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934751	chr2:203747522	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.93	5.93E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934751	chr2:203747522	ICA1L	chr2:203637873-203736371:-	0.25	4.18	3.49E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934753	chr2:203750272	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.93	5.93E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934753	chr2:203750272	ICA1L	chr2:203637873-203736371:-	0.25	4.18	3.49E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934763	chr2:203758396	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.93	5.93E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934763	chr2:203758396	ICA1L	chr2:203637873-203736371:-	0.25	4.18	3.49E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934764	chr2:203758521	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.93	5.93E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934764	chr2:203758521	ICA1L	chr2:203637873-203736371:-	0.25	4.18	3.49E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934765	chr2:203758551	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.93	5.93E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934765	chr2:203758551	ICA1L	chr2:203637873-203736371:-	0.25	4.18	3.49E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934767	chr2:203766563	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.94	5.6E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934767	chr2:203766563	ICA1L	chr2:203637873-203736371:-	0.25	4.21	3.08E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72934944	chr2:202190610	CFLAR	chr2:201980816-202029001:+	-0.26	-4.07	5.47E-5	Rheumatoid arthritis	
THCA	cis	1	rs72934944	chr2:202190610	PPIL3	chr2:201735680-201753999:-	-0.69	-8.6	1.13E-16	Rheumatoid arthritis	
THCA	cis	1	rs72934960	chr2:202204749	CFLAR	chr2:201980816-202029001:+	-0.25	-3.67	0.000274	Rheumatoid arthritis	
THCA	cis	1	rs72934960	chr2:202204749	PPIL3	chr2:201735680-201753999:-	-0.7	-7.89	2.15E-14	Rheumatoid arthritis	
THCA	cis	1	rs72934973	chr2:202213934	CFLAR	chr2:201980816-202029001:+	-0.25	-3.7	0.000243	Rheumatoid arthritis	
THCA	cis	1	rs72934973	chr2:202213934	PPIL3	chr2:201735680-201753999:-	-0.7	-7.95	1.36E-14	Rheumatoid arthritis	
THCA	cis	1	rs72934999	chr2:202223524	CFLAR	chr2:201980816-202029001:+	-0.27	-3.93	9.82E-5	Rheumatoid arthritis	
THCA	cis	1	rs72934999	chr2:202223524	PPIL3	chr2:201735680-201753999:-	-0.69	-7.86	2.57E-14	Rheumatoid arthritis	
THCA	cis	1	rs729354	chr11:77962453	NARS2	chr11:78147017-78285909:-	-0.41	-7.57	1.88E-13	Testicular germ cell tumor	
THCA	cis	1	rs72936304	chr2:204036357	ALS2CR8	chr2:203776978-203851060:+	-0.3	-6.13	1.81E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936304	chr2:204036357	ICA1L	chr2:203637873-203736371:-	0.26	4.25	2.61E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936309	chr2:204040296	ALS2CR8	chr2:203776978-203851060:+	-0.3	-6.13	1.81E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936309	chr2:204040296	ICA1L	chr2:203637873-203736371:-	0.26	4.25	2.61E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936323	chr2:204050474	ALS2CR8	chr2:203776978-203851060:+	-0.29	-6.02	3.57E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936323	chr2:204050474	ICA1L	chr2:203637873-203736371:-	0.27	4.53	7.32E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936326	chr2:204054141	ALS2CR8	chr2:203776978-203851060:+	-0.29	-6.02	3.57E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936326	chr2:204054141	ICA1L	chr2:203637873-203736371:-	0.27	4.53	7.32E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936332	chr2:204056678	ALS2CR8	chr2:203776978-203851060:+	-0.29	-6.02	3.57E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936332	chr2:204056678	ICA1L	chr2:203637873-203736371:-	0.27	4.53	7.32E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936348	chr2:204064839	ALS2CR8	chr2:203776978-203851060:+	-0.29	-6.02	3.57E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936348	chr2:204064839	ICA1L	chr2:203637873-203736371:-	0.27	4.53	7.32E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936353	chr2:204070956	ALS2CR8	chr2:203776978-203851060:+	-0.29	-6.02	3.57E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936353	chr2:204070956	ICA1L	chr2:203637873-203736371:-	0.27	4.53	7.32E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936830	chr2:203769803	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.94	5.6E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936830	chr2:203769803	ICA1L	chr2:203637873-203736371:-	0.25	4.21	3.08E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936834	chr2:203771260	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.94	5.6E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936834	chr2:203771260	ICA1L	chr2:203637873-203736371:-	0.25	4.21	3.08E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936838	chr2:203772984	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.94	5.6E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936838	chr2:203772984	ICA1L	chr2:203637873-203736371:-	0.25	4.21	3.08E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936842	chr2:203773686	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.94	5.6E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936842	chr2:203773686	ICA1L	chr2:203637873-203736371:-	0.25	4.21	3.08E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936846	chr2:203774734	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.94	5.6E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936846	chr2:203774734	ICA1L	chr2:203637873-203736371:-	0.25	4.21	3.08E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936847	chr2:203774748	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.94	5.6E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936847	chr2:203774748	ICA1L	chr2:203637873-203736371:-	0.25	4.21	3.08E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936852	chr2:203775475	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.94	5.6E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936852	chr2:203775475	ICA1L	chr2:203637873-203736371:-	0.25	4.21	3.08E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936856	chr2:203775712	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.94	5.6E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936856	chr2:203775712	ICA1L	chr2:203637873-203736371:-	0.25	4.21	3.08E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936862	chr2:203786812	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.95	5.24E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936862	chr2:203786812	ICA1L	chr2:203637873-203736371:-	0.26	4.29	2.13E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936869	chr2:203788950	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.95	5.24E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936869	chr2:203788950	ICA1L	chr2:203637873-203736371:-	0.26	4.29	2.13E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936870	chr2:203789679	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.95	5.24E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936870	chr2:203789679	ICA1L	chr2:203637873-203736371:-	0.26	4.29	2.13E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936872	chr2:203790889	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.95	5.24E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936872	chr2:203790889	ICA1L	chr2:203637873-203736371:-	0.26	4.29	2.13E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936873	chr2:203791333	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.95	5.24E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936873	chr2:203791333	ICA1L	chr2:203637873-203736371:-	0.26	4.29	2.13E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936881	chr2:203794262	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.95	5.24E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936881	chr2:203794262	ICA1L	chr2:203637873-203736371:-	0.26	4.29	2.13E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936882	chr2:203794439	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.95	5.24E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72936882	chr2:203794439	ICA1L	chr2:203637873-203736371:-	0.26	4.29	2.13E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs72937106	chr2:202225520	CFLAR	chr2:201980816-202029001:+	-0.27	-3.93	9.82E-5	Rheumatoid arthritis	
THCA	cis	1	rs72937106	chr2:202225520	PPIL3	chr2:201735680-201753999:-	-0.69	-7.86	2.57E-14	Rheumatoid arthritis	
THCA	cis	1	rs72937118	chr2:202229527	CFLAR	chr2:201980816-202029001:+	-0.27	-3.93	9.82E-5	Rheumatoid arthritis	
THCA	cis	1	rs72937118	chr2:202229527	PPIL3	chr2:201735680-201753999:-	-0.69	-7.86	2.57E-14	Rheumatoid arthritis	
THCA	cis	1	rs72937120	chr2:202232611	CFLAR	chr2:201980816-202029001:+	-0.27	-3.95	8.99E-5	Rheumatoid arthritis	
THCA	cis	1	rs72937120	chr2:202232611	PPIL3	chr2:201735680-201753999:-	-0.69	-7.77	4.72E-14	Rheumatoid arthritis	
THCA	cis	1	rs729376	chr6:33704823	IP6K3	chr6:33689443-33714762:-	0.4	6.8	3.2E-11	Obesity (extreme)	
THCA	cis	1	rs729376	chr6:33704823	PSMB8	chr6:32808497-32812712:-	-0.14	-4.02	6.66E-5	Obesity (extreme)	
THCA	cis	1	rs72941051	chr11:65478893	RNASEH2C	chr11:65485146-65488409:-	0.19	3.6	0.000355	Inflammatory bowel disease	
THCA	cis	1	rs7294478	chr12:7266805	LOC283314	chr12:7260904-7274446:+	0.21	5.93	5.9E-9	Neuritic plaque	
THCA	cis	1	rs7294478	chr12:7266805	PEX5	chr12:7341759-7371167:+	0.19	4.22	2.96E-5	Neuritic plaque	
THCA	cis	1	rs72954221	chr2:99899445	LIPT1	chr2:99771418-99779611:+	0.21	4.05	5.91E-5	IgG glycosylation	
THCA	cis	1	rs729568	chr5:179732350	MAPK9	chr5:179660597-179719071:-	-0.14	-3.64	0.000298	Height	
THCA	cis	1	rs72961173	chr2:99886868	LIPT1	chr2:99771418-99779611:+	0.21	4.07	5.43E-5	IgG glycosylation	
THCA	cis	1	rs72964631	chr11:93710455	HEPHL1	chr11:93754378-93847374:+	0.48	3.87	0.000126	Obesity-related traits	
THCA	cis	1	rs72964645	chr11:93715704	HEPHL1	chr11:93754378-93847374:+	0.43	3.55	0.00042	Obesity-related traits	
THCA	cis	1	rs7297610	chr12:69824024	YEATS4	chr12:69753532-69784575:+	0.34	4.1	4.77E-5	Response to diuretic therapy	
THCA	cis	1	rs7298108	chr12:9376168	DDX12	chr12:9570288-9600768:-	-0.16	-3.62	0.00033	Non-alcoholic fatty liver disease histology (AST)	
THCA	cis	1	rs7298108	chr12:9376168	LOC144571	chr12:9217773-9220651:+	-0.16	-4.23	2.83E-5	Non-alcoholic fatty liver disease histology (AST)	
THCA	cis	1	rs7298108	chr12:9376168	LOC642846	chr12:9436253-9466684:+	-0.4	-7.92	1.65E-14	Non-alcoholic fatty liver disease histology (AST)	
THCA	cis	1	rs72992152	chr11:108301299	ACAT1	chr11:107992258-108018889:+	-0.34	-7.44	4.65E-13	Melanoma	
THCA	cis	1	rs72992152	chr11:108301299	ATM	chr11:108093559-108239826:+	-0.16	-3.39	0.000763	Melanoma	
THCA	cis	1	rs72992163	chr11:108311255	ACAT1	chr11:107992258-108018889:+	-0.34	-7.44	4.65E-13	Melanoma	
THCA	cis	1	rs72992163	chr11:108311255	ATM	chr11:108093559-108239826:+	-0.16	-3.39	0.000763	Melanoma	
THCA	cis	1	rs72992191	chr11:108344264	ACAT1	chr11:107992258-108018889:+	-0.34	-7.46	4.0E-13	Melanoma	
THCA	cis	1	rs72992191	chr11:108344264	ATM	chr11:108093559-108239826:+	-0.17	-3.62	0.000326	Melanoma	
THCA	cis	1	rs73002111	chr2:242277833	ANO7	chr2:242127924-242164791:+	0.36	4.13	4.26E-5	Prostate cancer	
THCA	cis	1	rs73002111	chr2:242277833	SEPT2	chr2:242254723-242293439:+	-0.29	-4.17	3.59E-5	Prostate cancer	
THCA	cis	1	rs73002147	chr2:242302934	ANO7	chr2:242127924-242164791:+	0.37	4.19	3.3E-5	Prostate cancer	
THCA	cis	1	rs73002147	chr2:242302934	SEPT2	chr2:242254723-242293439:+	-0.28	-4	7.35E-5	Prostate cancer	
THCA	cis	1	rs73004354	chr2:242356239	ANO7	chr2:242127924-242164791:+	0.32	3.8	0.000164	Prostate cancer	
THCA	cis	1	rs73004354	chr2:242356239	SEPT2	chr2:242254723-242293439:+	-0.31	-4.57	6.31E-6	Prostate cancer	
THCA	cis	1	rs73004382	chr2:242382192	ANO7	chr2:242127924-242164791:+	0.32	3.7	0.000239	Prostate cancer	
THCA	cis	1	rs73004382	chr2:242382192	SEPT2	chr2:242254723-242293439:+	-0.3	-4.49	9.03E-6	Prostate cancer	
THCA	cis	1	rs73004754	chr11:120053576	TRIM29	chr11:119981995-120008863:-	0.43	7.24	1.81E-12	Stroke (pediatric)	
THCA	cis	1	rs73004764	chr11:120055326	TRIM29	chr11:119981995-120008863:-	0.42	6.97	1.04E-11	Stroke (pediatric)	
THCA	cis	1	rs73006241	chr11:108089151	ACAT1	chr11:107992258-108018889:+	-0.33	-7.22	2.08E-12	Melanoma	
THCA	cis	1	rs73008229	chr11:108187689	ACAT1	chr11:107992258-108018889:+	-0.33	-7.37	7.82E-13	Melanoma	
THCA	cis	1	rs73008453	chr6:163013384	PACRG	chr6:163148164-163736523:+	0.45	7.03	7.07E-12	Body mass index	
THCA	cis	1	rs7300900	chr12:82166821	PPFIA2	chr12:81652880-82153109:-	0.21	3.88	0.00012	Resting heart rate	
THCA	cis	1	rs73010930	chr3:150469735	SIAH2	chr3:150458911-150481263:-	0.24	3.53	0.000448	Breast cancer	
THCA	cis	1	rs73016459	chr6:163066323	PACRG	chr6:163148164-163736523:+	0.52	7.34	9.39E-13	Body mass index	
THCA	cis	1	rs73018141	chr2:242221570	ANO7	chr2:242127924-242164791:+	0.36	4.22	2.97E-5	Prostate cancer	
THCA	cis	1	rs73018141	chr2:242221570	SEPT2	chr2:242254723-242293439:+	-0.29	-4.3	2.06E-5	Prostate cancer	
THCA	cis	1	rs73020143	chr2:242261240	ANO7	chr2:242127924-242164791:+	0.36	4.13	4.26E-5	Prostate cancer	
THCA	cis	1	rs73020143	chr2:242261240	SEPT2	chr2:242254723-242293439:+	-0.29	-4.17	3.59E-5	Prostate cancer	
THCA	cis	1	rs7302634	chr12:129279931	GLT1D1	chr12:129338081-129469509:+	-0.23	-5.65	2.7E-8	Systemic lupus erythematosus	
THCA	cis	1	rs7302634	chr12:129279931	SLC15A4	chr12:129277739-129308541:-	-0.18	-4.44	1.11E-5	Systemic lupus erythematosus	
THCA	cis	1	rs730287	chr10:91376346	FLJ37201	chr10:91451057-91457685:-	-0.18	-3.74	0.000209	Metabolic traits	
THCA	cis	1	rs73034207	chr19:32875769	DPY19L3	chr19:32896677-32975236:+	0.21	5.6	3.55E-8	Bipolar disorder	
THCA	cis	1	rs73034207	chr19:32875769	ZNF507	chr19:32836514-32878571:+	0.32	8	9.37E-15	Bipolar disorder	
THCA	cis	1	rs73034216	chr19:32883416	DPY19L3	chr19:32896677-32975236:+	0.2	5.38	1.17E-7	Bipolar disorder	
THCA	cis	1	rs73034216	chr19:32883416	ZNF507	chr19:32836514-32878571:+	0.32	7.92	1.73E-14	Bipolar disorder	
THCA	cis	1	rs73035012	chr6:162997279	PACRG	chr6:163148164-163736523:+	0.46	7.03	7.01E-12	Body mass index	
THCA	cis	1	rs73035021	chr6:163000716	PACRG	chr6:163148164-163736523:+	0.46	7.08	5.13E-12	Body mass index	
THCA	cis	1	rs73035023	chr6:163000927	PACRG	chr6:163148164-163736523:+	0.46	7.05	6.48E-12	Body mass index	
THCA	cis	1	rs73035025	chr6:163000988	PACRG	chr6:163148164-163736523:+	0.46	7.08	5.13E-12	Body mass index	
THCA	cis	1	rs73036023	chr19:32948320	DPY19L3	chr19:32896677-32975236:+	0.19	4.91	1.28E-6	Bipolar disorder	
THCA	cis	1	rs73036023	chr19:32948320	ZNF507	chr19:32836514-32878571:+	0.3	7.37	7.32E-13	Bipolar disorder	
THCA	cis	1	rs73036062	chr11:133828187	IGSF9B	chr11:133785186-133826880:-	0.25	5.08	5.36E-7	Schizophrenia	
THCA	cis	1	rs73036062	chr11:133828187	LOC283174	chr11:133766330-133771635:-	0.21	3.89	0.000112	Schizophrenia	
THCA	cis	1	rs73036063	chr11:133828758	IGSF9B	chr11:133785186-133826880:-	0.24	4.99	8.48E-7	Schizophrenia	
THCA	cis	1	rs73036063	chr11:133828758	LOC283174	chr11:133766330-133771635:-	0.21	3.99	7.71E-5	Schizophrenia	
THCA	cis	1	rs73036064	chr11:133829442	IGSF9B	chr11:133785186-133826880:-	0.24	4.97	9.38E-7	Schizophrenia	
THCA	cis	1	rs73036064	chr11:133829442	LOC283174	chr11:133766330-133771635:-	0.22	4.21	3.08E-5	Schizophrenia	
THCA	cis	1	rs73036065	chr11:133830067	IGSF9B	chr11:133785186-133826880:-	0.25	5.15	3.76E-7	Schizophrenia	
THCA	cis	1	rs73036065	chr11:133830067	LOC283174	chr11:133766330-133771635:-	0.23	4.25	2.58E-5	Schizophrenia	
THCA	cis	1	rs73036735	chr1:179426268	C1orf125	chr1:179335107-179523868:+	0.57	5.88	7.6E-9	Multiple sclerosis (age of onset)	
THCA	cis	1	rs73036765	chr1:179457254	C1orf125	chr1:179335107-179523868:+	0.58	6.21	1.13E-9	Multiple sclerosis (age of onset)	
THCA	cis	1	rs73036771	chr1:179463925	C1orf125	chr1:179335107-179523868:+	0.58	6.12	1.94E-9	Multiple sclerosis (age of onset)	
THCA	cis	1	rs73038232	chr19:32987653	DPY19L3	chr19:32896677-32975236:+	0.19	4.82	1.94E-6	Bipolar disorder	
THCA	cis	1	rs73038232	chr19:32987653	ZNF507	chr19:32836514-32878571:+	0.3	6.88	1.9E-11	Bipolar disorder	
THCA	cis	1	rs73038541	chr1:179479775	C1orf125	chr1:179335107-179523868:+	0.33	3.81	0.00016	Multiple sclerosis (age of onset)	
THCA	cis	1	rs7303	chr14:75520065	EIF2B2	chr14:75469612-75476292:+	0.18	4.81	2.06E-6	Height	
THCA	cis	1	rs7303	chr14:75520065	MLH3	chr14:75480467-75518235:-	0.29	8.57	1.45E-16	Height	
THCA	cis	1	rs7303	chr14:75520065	RPS6KL1	chr14:75372347-75389958:-	0.31	6.75	4.41E-11	Height	
THCA	cis	1	rs730532	chr14:52518811	NID2	chr14:52471521-52535946:-	0.18	3.84	0.000138	Pulmonary function	
THCA	cis	1	rs730543	chr20:47635715	ARFGEF2	chr20:47538275-47653229:+	0.13	4.05	5.99E-5	Anger	
THCA	cis	1	rs730543	chr20:47635715	CSE1L	chr20:47662838-47713484:+	-0.4	-9.99	1.77E-21	Anger	
THCA	cis	1	rs7305655	chr12:51005289	DIP2B	chr12:50898768-51142448:+	-0.12	-3.87	0.000123	Fibrinogen	
THCA	cis	1	rs73057882	chr19:53670106	ZNF665	chr19:53666552-53696619:-	-0.15	-4.1	4.83E-5	Yu-Zhi constitution type in type 2 diabetes	
THCA	cis	1	rs7306395	chr12:82175867	PPFIA2	chr12:81652880-82153109:-	0.21	3.89	0.000112	Resting heart rate	
THCA	cis	1	rs73069392	chr3:41787009	ULK4	chr3:41288091-42003660:-	1.03	18.15	2.22E-56	Diastolic blood pressure	
THCA	cis	1	rs73069394	chr3:41787233	ULK4	chr3:41288091-42003660:-	1.05	19.47	1.29E-62	Diastolic blood pressure	
THCA	cis	1	rs73069396	chr3:41787236	ULK4	chr3:41288091-42003660:-	1.05	19.47	1.29E-62	Diastolic blood pressure	
THCA	cis	1	rs73069940	chr4:1236502	KIAA1530	chr4:1341104-1381836:+	-0.21	-3.6	0.000354	Type 2 diabetes	
THCA	cis	1	rs73070048	chr2:207641394	MDH1B	chr2:207598943-207630050:-	0.42	6.76	4.08E-11	Episodic memory	
THCA	cis	1	rs73070422	chr4:1016645	DGKQ	chr4:952676-967344:-	-0.22	-3.46	0.000596	Bone mineral density	
THCA	cis	1	rs73070422	chr4:1016645	FGFRL1	chr4:1004940-1020685:+	-0.24	-3.76	0.000187	Bone mineral density	
THCA	cis	1	rs73071329	chr3:41810539	ULK4	chr3:41288091-42003660:-	1.1	20.25	2.83E-66	Diastolic blood pressure	
THCA	cis	1	rs73071548	chr7:27147430	HOXA9	chr7:27202058-27205149:-	-0.39	-4.33	1.86E-5	Hypospadias	
THCA	cis	1	rs73071550	chr7:27149099	HOXA9	chr7:27202058-27205149:-	-0.36	-4.11	4.74E-5	Hypospadias	
THCA	cis	1	rs73072707	chr12:22492270	KIAA0528	chr12:22601526-22697452:-	0.2	3.4	0.000736	Coronary artery calcification	
THCA	cis	1	rs73072723	chr12:22501958	KIAA0528	chr12:22601526-22697452:-	0.2	3.34	0.00089	Coronary artery calcification	
THCA	cis	1	rs73072735	chr12:22507942	KIAA0528	chr12:22601526-22697452:-	0.2	3.34	0.00089	Coronary artery calcification	
THCA	cis	1	rs73072739	chr12:22508234	KIAA0528	chr12:22601526-22697452:-	0.2	3.34	0.00089	Coronary artery calcification	
THCA	cis	1	rs73072795	chr12:22536554	KIAA0528	chr12:22601526-22697452:-	0.22	3.76	0.000189	Coronary artery calcification	
THCA	cis	1	rs73072798	chr12:22537631	KIAA0528	chr12:22601526-22697452:-	0.22	3.73	0.000218	Coronary artery calcification	
THCA	cis	1	rs73072801	chr12:22538073	KIAA0528	chr12:22601526-22697452:-	0.22	3.73	0.000218	Coronary artery calcification	
THCA	cis	1	rs73074358	chr3:48427247	ATRIP	chr3:48488141-48507708:+	0.17	3.81	0.000155	Longevity	
THCA	cis	1	rs73074358	chr3:48427247	TREX1	chr3:48501186-48509043:+	-0.26	-5.97	4.57E-9	Longevity	
THCA	cis	1	rs73074643	chr12:22545960	KIAA0528	chr12:22601526-22697452:-	0.22	3.78	0.000175	Coronary artery calcification	
THCA	cis	1	rs73074650	chr12:22547929	KIAA0528	chr12:22601526-22697452:-	0.21	3.56	0.000404	Coronary artery calcification	
THCA	cis	1	rs73074659	chr12:22548841	KIAA0528	chr12:22601526-22697452:-	0.21	3.56	0.000404	Coronary artery calcification	
THCA	cis	1	rs73074689	chr12:22561383	KIAA0528	chr12:22601526-22697452:-	0.22	3.84	0.000141	Coronary artery calcification	
THCA	cis	1	rs73074692	chr12:22562566	KIAA0528	chr12:22601526-22697452:-	0.22	3.79	0.000167	Coronary artery calcification	
THCA	cis	1	rs73077367	chr3:41851959	ULK4	chr3:41288091-42003660:-	1.08	20.66	3.03E-68	Diastolic blood pressure	
THCA	cis	1	rs7307815	chr12:50922710	DIP2B	chr12:50898768-51142448:+	0.12	3.84	0.000142	Fibrinogen	
THCA	cis	1	rs73079316	chr3:41863859	ULK4	chr3:41288091-42003660:-	1.04	19.1	7.18E-61	Diastolic blood pressure	
THCA	cis	1	rs73079321	chr3:41863910	ULK4	chr3:41288091-42003660:-	1.05	19.9	1.26E-64	Diastolic blood pressure	
THCA	cis	1	rs73081353	chr3:41906448	ULK4	chr3:41288091-42003660:-	1.04	18.86	9.68E-60	Diastolic blood pressure	
THCA	cis	1	rs73081364	chr3:41913616	ULK4	chr3:41288091-42003660:-	1.02	18.5	5.2E-58	Diastolic blood pressure	
THCA	cis	1	rs73084575	chr20:3906768	MAVS	chr20:3827449-3856761:+	-0.26	-3.89	0.000114	Response to antidepressants in depression	
THCA	cis	1	rs73084594	chr20:3916380	MAVS	chr20:3827449-3856761:+	-0.23	-3.56	0.000411	Response to antidepressants in depression	
THCA	cis	1	rs73086505	chr20:3921571	MAVS	chr20:3827449-3856761:+	-0.24	-3.58	0.000381	Response to antidepressants in depression	
THCA	cis	1	rs73086508	chr20:3921715	MAVS	chr20:3827449-3856761:+	-0.24	-3.58	0.000381	Response to antidepressants in depression	
THCA	cis	1	rs73086510	chr20:3922131	MAVS	chr20:3827449-3856761:+	-0.24	-3.58	0.000381	Response to antidepressants in depression	
THCA	cis	1	rs73086512	chr20:3922772	MAVS	chr20:3827449-3856761:+	-0.25	-3.9	0.000112	Response to antidepressants in depression	
THCA	cis	1	rs73086535	chr20:3944150	MAVS	chr20:3827449-3856761:+	-0.22	-3.46	0.000596	Response to antidepressants in depression	
THCA	cis	1	rs73086540	chr20:3950850	MAVS	chr20:3827449-3856761:+	-0.23	-3.51	0.000484	Response to antidepressants in depression	
THCA	cis	1	rs73086544	chr20:3950928	MAVS	chr20:3827449-3856761:+	-0.23	-3.51	0.000484	Response to antidepressants in depression	
THCA	cis	1	rs73086549	chr20:3954662	MAVS	chr20:3827449-3856761:+	-0.23	-3.51	0.000484	Response to antidepressants in depression	
THCA	cis	1	rs73086581	chr20:3977325	MAVS	chr20:3827449-3856761:+	-0.23	-3.51	0.000496	Response to antidepressants in depression	
THCA	cis	1	rs73086588	chr20:3982224	MAVS	chr20:3827449-3856761:+	-0.22	-3.42	0.000669	Response to antidepressants in depression	
THCA	cis	1	rs73086595	chr20:3983448	MAVS	chr20:3827449-3856761:+	-0.22	-3.42	0.000669	Response to antidepressants in depression	
THCA	cis	1	rs73086597	chr20:3983571	MAVS	chr20:3827449-3856761:+	-0.22	-3.45	0.000618	Response to antidepressants in depression	
THCA	cis	1	rs73088137	chr3:49448423	GMPPB	chr3:49758932-49761384:-	0.17	3.73	0.000218	Menarche (age at onset)	
THCA	cis	1	rs73088137	chr3:49448423	P4HTM	chr3:49027341-49044579:+	-0.19	-4.65	4.33E-6	Menarche (age at onset)	
THCA	cis	1	rs73088416	chr20:3995276	MAVS	chr20:3827449-3856761:+	-0.22	-3.38	0.00078	Response to antidepressants in depression	
THCA	cis	1	rs73088421	chr20:3997871	MAVS	chr20:3827449-3856761:+	-0.25	-3.57	0.000388	Response to antidepressants in depression	
THCA	cis	1	rs73089254	chr12:22490321	KIAA0528	chr12:22601526-22697452:-	0.2	3.4	0.000736	Coronary artery calcification	
THCA	cis	1	rs73089257	chr12:22491595	KIAA0528	chr12:22601526-22697452:-	0.2	3.4	0.000736	Coronary artery calcification	
THCA	cis	1	rs73089261	chr12:22491657	KIAA0528	chr12:22601526-22697452:-	0.2	3.4	0.000736	Coronary artery calcification	
THCA	cis	1	rs73090629	chr12:51335777	SLC11A2	chr12:51373319-51422058:-	-0.24	-4.64	4.48E-6	Type 2 diabetes	
THCA	cis	1	rs73090629	chr12:51335777	TFCP2	chr12:51488608-51566917:-	-0.19	-3.97	8.18E-5	Type 2 diabetes	
THCA	cis	1	rs73090647	chr12:51345465	SLC11A2	chr12:51373319-51422058:-	-0.23	-4.64	4.46E-6	Type 2 diabetes	
THCA	cis	1	rs73090647	chr12:51345465	TFCP2	chr12:51488608-51566917:-	-0.19	-4.07	5.58E-5	Type 2 diabetes	
THCA	cis	1	rs73090649	chr12:51349641	SLC11A2	chr12:51373319-51422058:-	-0.24	-4.74	2.86E-6	Type 2 diabetes	
THCA	cis	1	rs73090649	chr12:51349641	TFCP2	chr12:51488608-51566917:-	-0.19	-4.09	5.06E-5	Type 2 diabetes	
THCA	cis	1	rs73090666	chr12:51356502	SLC11A2	chr12:51373319-51422058:-	-0.24	-4.74	2.88E-6	Type 2 diabetes	
THCA	cis	1	rs73090666	chr12:51356502	TFCP2	chr12:51488608-51566917:-	-0.2	-4.29	2.15E-5	Type 2 diabetes	
THCA	cis	1	rs7309116	chr12:70735094	YEATS4	chr12:69753532-69784575:+	-0.24	-3.64	0.000308	Amyotrophic lateral sclerosis (age of onset)	
THCA	cis	1	rs73092531	chr12:51357987	SLC11A2	chr12:51373319-51422058:-	-0.25	-4.89	1.4E-6	Type 2 diabetes	
THCA	cis	1	rs73092531	chr12:51357987	TFCP2	chr12:51488608-51566917:-	-0.2	-4.34	1.77E-5	Type 2 diabetes	
THCA	cis	1	rs73092537	chr12:51358517	SLC11A2	chr12:51373319-51422058:-	-0.25	-4.89	1.4E-6	Type 2 diabetes	
THCA	cis	1	rs73092537	chr12:51358517	TFCP2	chr12:51488608-51566917:-	-0.2	-4.34	1.77E-5	Type 2 diabetes	
THCA	cis	1	rs73098845	chr4:17940718	DCAF16	chr4:17802280-17812381:-	-0.2	-4.37	1.51E-5	Height	
THCA	cis	1	rs73098848	chr4:17941027	DCAF16	chr4:17802280-17812381:-	-0.2	-4.37	1.51E-5	Height	
THCA	cis	1	rs7309927	chr12:1000185	RAD52	chr12:1021255-1099219:-	-0.3	-4.72	3.09E-6	Colorectal cancer	
THCA	cis	1	rs73100947	chr4:18021307	DCAF16	chr4:17802280-17812381:-	-0.2	-4.52	7.89E-6	Height	
THCA	cis	1	rs7311497	chr12:70737598	YEATS4	chr12:69753532-69784575:+	-0.24	-3.58	0.00038	Amyotrophic lateral sclerosis (age of onset)	
THCA	cis	1	rs731152	chr17:40279680	HSPB9	chr17:40274756-40275371:+	0.34	4.97	9.22E-7	Fibrinogen levels	
THCA	cis	1	rs73116394	chr2:242367915	SEPT2	chr2:242254723-242293439:+	1.04	21.91	3.43E-74	Chronic lymphocytic leukemia	
THCA	cis	1	rs73116396	chr2:242368693	SEPT2	chr2:242254723-242293439:+	1.04	21.91	3.43E-74	Chronic lymphocytic leukemia	
THCA	cis	1	rs7312145	chr12:123825339	C12orf65	chr12:123717841-123742481:+	0.24	3.99	7.74E-5	HDL cholesterol	
THCA	cis	1	rs7312329	chr12:3970007	PARP11	chr12:3918027-3982608:-	-0.17	-3.87	0.000122	Cognitive performance	
THCA	cis	1	rs7312404	chr12:124446728	ZNF664	chr12:124457670-124499967:+	-0.17	-5.03	7.03E-7	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs7312774	chr12:107305728	MTERFD3	chr12:107371069-107380929:-	-0.18	-4.08	5.2E-5	Severe influenza A (H1N1) infection	
THCA	cis	1	rs7312774	chr12:107305728	PRDM4	chr12:108126644-108155021:-	0.19	3.35	0.000861	Severe influenza A (H1N1) infection	
THCA	cis	1	rs73129298	chr20:48566065	SLC9A8	chr20:48429250-48508772:+	-0.5	-6.39	3.94E-10	Inflammatory skin disease	
THCA	cis	1	rs7312933	chr12:42503467	PPHLN1	chr12:42632249-42853517:+	0.13	3.34	0.000897	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	
THCA	cis	1	rs7313402	chr12:108602970	CORO1C	chr12:109038889-109125295:-	-0.12	-3.35	0.000866	Temperament (bipolar disorder)	
THCA	cis	1	rs73140069	chr7:75986790	STYXL1	chr7:75625656-75677321:-	-0.16	-3.98	8.12E-5	Multiple sclerosis	
THCA	cis	1	rs73140069	chr7:75986790	UPK3B	chr7:76139745-76157197:+	-0.27	-4.67	3.88E-6	Multiple sclerosis	
THCA	cis	1	rs7314056	chr12:122342964	WDR66	chr12:122356480-122441830:+	-0.22	-3.54	0.000434	Urinary metabolites	
THCA	cis	1	rs73142121	chr7:65311206	CCT6P1	chr7:65216092-65228661:+	0.4	6.32	6.1E-10	Diabetic kidney disease	
THCA	cis	1	rs73142121	chr7:65311206	CRCP	chr7:65579805-65619551:+	-0.27	-4.14	4.11E-5	Diabetic kidney disease	
THCA	cis	1	rs73142121	chr7:65311206	LOC493754	chr7:65993446-66057363:-	0.29	3.35	0.00088	Diabetic kidney disease	
THCA	cis	1	rs73142121	chr7:65311206	RABGEF1	chr7:66093890-66276446:+	0.52	6.54	1.58E-10	Diabetic kidney disease	
THCA	cis	1	rs73142122	chr7:65311298	CCT6P1	chr7:65216092-65228661:+	0.41	6.56	1.43E-10	Diabetic kidney disease	
THCA	cis	1	rs73142122	chr7:65311298	CRCP	chr7:65579805-65619551:+	-0.27	-4.1	4.83E-5	Diabetic kidney disease	
THCA	cis	1	rs73142122	chr7:65311298	LOC168474	chr7:64310071-64314178:-	0.27	3.46	0.000587	Diabetic kidney disease	
THCA	cis	1	rs73142122	chr7:65311298	RABGEF1	chr7:66093890-66276446:+	0.51	6.3	6.87E-10	Diabetic kidney disease	
THCA	cis	1	rs73142162	chr7:65374296	CCT6P1	chr7:65216092-65228661:+	0.42	6.54	1.62E-10	Diabetic kidney disease	
THCA	cis	1	rs73142162	chr7:65374296	CRCP	chr7:65579805-65619551:+	-0.29	-4.32	1.89E-5	Diabetic kidney disease	
THCA	cis	1	rs73142162	chr7:65374296	RABGEF1	chr7:66093890-66276446:+	0.52	6.26	8.38E-10	Diabetic kidney disease	
THCA	cis	1	rs73142166	chr7:65375832	CCT6P1	chr7:65216092-65228661:+	0.42	6.45	2.8E-10	Diabetic kidney disease	
THCA	cis	1	rs73142166	chr7:65375832	CRCP	chr7:65579805-65619551:+	-0.28	-4.19	3.32E-5	Diabetic kidney disease	
THCA	cis	1	rs73142166	chr7:65375832	RABGEF1	chr7:66093890-66276446:+	0.52	6.31	6.55E-10	Diabetic kidney disease	
THCA	cis	1	rs73150014	chr7:65450919	CCT6P1	chr7:65216092-65228661:+	0.4	6.51	1.95E-10	Diabetic kidney disease	
THCA	cis	1	rs73150014	chr7:65450919	CRCP	chr7:65579805-65619551:+	-0.28	-4.37	1.54E-5	Diabetic kidney disease	
THCA	cis	1	rs73150014	chr7:65450919	RABGEF1	chr7:66093890-66276446:+	0.49	6.06	2.74E-9	Diabetic kidney disease	
THCA	cis	1	rs7315453	chr12:123825389	C12orf65	chr12:123717841-123742481:+	0.24	3.99	7.74E-5	HDL cholesterol	
THCA	cis	1	rs731600	chr11:77963133	NARS2	chr11:78147017-78285909:-	-0.4	-7.81	3.54E-14	Testicular germ cell tumor	
THCA	cis	1	rs7316927	chr13:85678043	SLITRK6	chr13:86366922-86373483:-	0.22	4.14	4.04E-5	Bipolar disorder (mania)	
THCA	cis	1	rs7317019	chr13:38057812	RFXAP	chr13:37393339-37403740:+	-0.31	-3.79	0.000168	Age-related macular degeneration	
THCA	cis	1	rs731820	chr15:62378136	VPS13C	chr15:62144592-62352647:-	-0.12	-4.4	1.32E-5	Height	
THCA	cis	1	rs73183643	chr7:101418653	RABL5	chr7:100956649-100965093:-	0.16	3.6	0.000351	Basal cell carcinoma	
THCA	cis	1	rs73183650	chr7:101421000	RABL5	chr7:100956649-100965093:-	0.16	3.72	0.000225	Basal cell carcinoma	
THCA	cis	1	rs73192978	chr3:127868275	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.49	8.76E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs73192979	chr3:127868321	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.49	8.76E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs73193868	chr21:30600224	CCT8	chr21:30428650-30446010:-	0.6	8.78	2.93E-17	Response to mTOR inhibitor (everolimus)	
THCA	cis	1	rs73193868	chr21:30600224	RWDD2B	chr21:30378082-30391685:-	0.3	3.35	0.00087	Response to mTOR inhibitor (everolimus)	
THCA	cis	1	rs73197383	chr3:128030474	EEFSEC	chr3:127872313-128127488:+	-0.22	-3.84	0.000141	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs73197388	chr3:128043920	EEFSEC	chr3:127872313-128127488:+	-0.21	-3.7	0.000237	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs731974	chr11:68847156	TPCN2	chr11:68816350-68929907:+	-0.16	-4.04	6.1E-5	Hair color	
THCA	cis	1	rs73201462	chr3:128059293	EEFSEC	chr3:127872313-128127488:+	-0.22	-3.79	0.000173	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs73205806	chr3:196472865	PIGX	chr3:196439246-196462874:+	0.29	3.64	0.000301	Glucose homeostasis traits	
THCA	cis	1	rs73206853	chr12:110708746	VPS29	chr12:110929331-110939916:-	0.18	3.39	0.000747	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	
THCA	cis	1	rs73208601	chr8:17159489	VPS37A	chr8:17104401-17155532:+	-0.25	-4	7.42E-5	Calcium levels	
THCA	cis	1	rs7321552	chr13:85660546	SLITRK6	chr13:86366922-86373483:-	0.24	5.08	5.42E-7	Bipolar disorder (mania)	
THCA	cis	1	rs7321623	chr13:95871951	ABCC4	chr13:95672084-95953687:-	-0.18	-3.53	0.000449	Breast cancer	
THCA	cis	1	rs732172	chr16:31050033	C16orf93	chr16:30768753-30773542:-	-0.15	-4.1	4.86E-5	Response to metformin (IC50)	
THCA	cis	1	rs732172	chr16:31050033	HSD3B7	chr16:30996519-31000473:+	0.43	11.09	1.41E-25	Response to metformin (IC50)	
THCA	cis	1	rs732172	chr16:31050033	MYST1	chr16:31128985-31142713:+	0.15	4.8	2.15E-6	Response to metformin (IC50)	
THCA	cis	1	rs732172	chr16:31050033	PRSS53	chr16:31094747-31106276:-	-0.15	-4.02	6.7E-5	Response to metformin (IC50)	
THCA	cis	1	rs732173	chr16:31050023	C16orf93	chr16:30768753-30773542:-	-0.15	-4.13	4.32E-5	Response to metformin (IC50)	
THCA	cis	1	rs732173	chr16:31050023	HSD3B7	chr16:30996519-31000473:+	0.43	11.04	2.13E-25	Response to metformin (IC50)	
THCA	cis	1	rs732173	chr16:31050023	MYST1	chr16:31128985-31142713:+	0.14	4.76	2.59E-6	Response to metformin (IC50)	
THCA	cis	1	rs732173	chr16:31050023	PRSS53	chr16:31094747-31106276:-	-0.15	-4.05	5.87E-5	Response to metformin (IC50)	
THCA	cis	1	rs73217798	chr8:26264363	PPP2R2A	chr8:25230075-26228645:+	0.19	3.58	0.000382	Schizophrenia	
THCA	cis	1	rs73219805	chr8:26272768	PPP2R2A	chr8:25230075-26228645:+	0.19	3.56	0.000412	Schizophrenia	
THCA	cis	1	rs7322604	chr13:85773768	SLITRK6	chr13:86366922-86373483:-	-0.23	-4.32	1.94E-5	Bipolar disorder (mania)	
THCA	cis	1	rs7322825	chr13:95865372	ABCC4	chr13:95672084-95953687:-	-0.19	-3.65	0.000288	Breast cancer	
THCA	cis	1	rs73231952	chr12:123785538	C12orf65	chr12:123717841-123742481:+	-0.25	-4.25	2.6E-5	HDL cholesterol	
THCA	cis	1	rs73242910	chr6:170114670	C6orf70	chr6:170151721-170181617:+	0.26	5.19	3.05E-7	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs73242910	chr6:170114670	WDR27	chr6:169857307-170102159:-	-0.2	-5.99	4.09E-9	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs73242927	chr6:170129573	C6orf70	chr6:170151721-170181617:+	0.25	5.11	4.56E-7	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs73242927	chr6:170129573	WDR27	chr6:169857307-170102159:-	-0.18	-5.54	5.0E-8	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs7324410	chr13:24437465	C1QTNF9B	chr13:24465238-24471641:-	-0.35	-3.6	0.000357	3-hydroxypropylmercapturic acid levels in smokers	
THCA	cis	1	rs7324557	chr13:24296862	PCOTH	chr13:24463028-24466241:+	0.33	6.94	1.29E-11	Visceral adipose tissue adjusted for BMI	
THCA	cis	1	rs73248639	chr4:53350761	KIAA0114	chr4:53578621-53580305:+	0.18	3.47	0.000572	Biochemical measures	
THCA	cis	1	rs73248641	chr4:53358246	KIAA0114	chr4:53578621-53580305:+	0.18	3.47	0.000572	Biochemical measures	
THCA	cis	1	rs73248643	chr4:53378633	KIAA0114	chr4:53578621-53580305:+	0.17	3.42	0.000674	Biochemical measures	
THCA	cis	1	rs7325019	chr13:95875518	ABCC4	chr13:95672084-95953687:-	-0.18	-3.46	0.000596	Breast cancer	
THCA	cis	1	rs7325749	chr13:85667031	SLITRK6	chr13:86366922-86373483:-	-0.22	-4.15	3.98E-5	Bipolar disorder (mania)	
THCA	cis	1	rs7326015	chr13:85667289	SLITRK6	chr13:86366922-86373483:-	-0.22	-4.12	4.41E-5	Bipolar disorder (mania)	
THCA	cis	1	rs7326558	chr13:85666708	SLITRK6	chr13:86366922-86373483:-	-0.21	-3.79	0.000171	Bipolar disorder (mania)	
THCA	cis	1	rs732680	chr4:154725211	RNF175	chr4:154631313-154681387:-	-0.2	-4.29	2.18E-5	Electrocardiographic conduction measures	
THCA	cis	1	rs73268512	chr14:66088905	LOC645431	chr14:65877313-65879335:-	-0.53	-6.84	2.46E-11	Ischemic stroke	
THCA	cis	1	rs73268521	chr14:66093243	LOC645431	chr14:65877313-65879335:-	-0.6	-7.74	6.07E-14	Ischemic stroke	
THCA	cis	1	rs73275307	chr8:89458895	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs73275324	chr8:89461761	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs73275325	chr8:89461776	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs73275337	chr8:89463754	MMP16	chr8:89049462-89339717:-	0.33	5.34	1.47E-7	Electrodermal activity	
THCA	cis	1	rs73275354	chr8:89465442	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs73275371	chr8:89467552	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs73276406	chr8:96021760	C8orf38	chr8:95908040-96088396:+	-0.25	-4.32	1.87E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs73276417	chr8:96026312	C8orf38	chr8:95908040-96088396:+	-0.25	-4.26	2.48E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs73276437	chr8:96035511	C8orf38	chr8:95908040-96088396:+	-0.26	-4.4	1.32E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs73276444	chr8:96039247	C8orf38	chr8:95908040-96088396:+	-0.26	-4.55	6.71E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs73277124	chr8:89386882	MMP16	chr8:89049462-89339717:-	0.3	4.79	2.21E-6	Electrodermal activity	
THCA	cis	1	rs73279219	chr8:89403161	MMP16	chr8:89049462-89339717:-	0.32	5.08	5.34E-7	Electrodermal activity	
THCA	cis	1	rs73279224	chr8:89404266	MMP16	chr8:89049462-89339717:-	0.31	5.04	6.5E-7	Electrodermal activity	
THCA	cis	1	rs73279229	chr8:89404575	MMP16	chr8:89049462-89339717:-	0.31	5.04	6.5E-7	Electrodermal activity	
THCA	cis	1	rs73279231	chr8:89404664	MMP16	chr8:89049462-89339717:-	0.31	5.04	6.5E-7	Electrodermal activity	
THCA	cis	1	rs73280512	chr14:55337129	GCH1	chr14:55308724-55369542:-	-0.22	-4.28	2.25E-5	Rheumatoid arthritis;Obesity-related traits	
THCA	cis	1	rs73282209	chr5:150174959	LOC134466	chr5:150310000-150326146:-	0.44	5.78	1.38E-8	Crohn's disease	
THCA	cis	1	rs73282209	chr5:150174959	ZNF300	chr5:150273964-150284391:-	0.19	3.87	0.000122	Crohn's disease	
THCA	cis	1	rs73282213	chr14:65852139	LOC645431	chr14:65877313-65879335:-	-0.48	-6.16	1.51E-9	Ischemic stroke	
THCA	cis	1	rs73282223	chr14:65854555	LOC645431	chr14:65877313-65879335:-	-0.41	-5.29	1.85E-7	Ischemic stroke	
THCA	cis	1	rs73282230	chr14:65856015	LOC645431	chr14:65877313-65879335:-	-0.41	-5.29	1.85E-7	Ischemic stroke	
THCA	cis	1	rs73282232	chr14:65856077	LOC645431	chr14:65877313-65879335:-	-0.41	-5.29	1.85E-7	Ischemic stroke	
THCA	cis	1	rs73282234	chr5:150195924	LOC134466	chr5:150310000-150326146:-	0.47	6.08	2.42E-9	Crohn's disease	
THCA	cis	1	rs73282234	chr5:150195924	ZNF300	chr5:150273964-150284391:-	0.17	3.53	0.000448	Crohn's disease	
THCA	cis	1	rs73282255	chr5:150223647	LOC134466	chr5:150310000-150326146:-	0.39	5.41	1.02E-7	Crohn's disease	
THCA	cis	1	rs73282260	chr14:65858964	LOC645431	chr14:65877313-65879335:-	-0.54	-6.83	2.65E-11	Ischemic stroke	
THCA	cis	1	rs73284121	chr14:65936936	LOC645431	chr14:65877313-65879335:-	-0.59	-7.8	4.04E-14	Ischemic stroke	
THCA	cis	1	rs73284126	chr5:150261307	LOC134466	chr5:150310000-150326146:-	0.38	5.28	2.01E-7	Crohn's disease	
THCA	cis	1	rs73284133	chr14:65946612	LOC645431	chr14:65877313-65879335:-	-0.59	-7.83	3.27E-14	Ischemic stroke	
THCA	cis	1	rs73284141	chr5:150266086	LOC134466	chr5:150310000-150326146:-	0.38	5.28	2.01E-7	Crohn's disease	
THCA	cis	1	rs73284257	chr10:76000710	VCL	chr10:75754951-75879912:+	-0.19	-3.49	0.00053	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs732856	chr22:38060691	LGALS2	chr22:37966254-37976024:-	-0.14	-3.82	0.000148	Fat distribution (HIV)	
THCA	cis	1	rs732856	chr22:38060691	PDXP	chr22:38054737-38062939:+	0.19	3.6	0.000347	Fat distribution (HIV)	
THCA	cis	1	rs732856	chr22:38060691	SH3BP1	chr22:38030661-38062939:+	-0.11	-3.54	0.000437	Fat distribution (HIV)	
THCA	cis	1	rs73286118	chr14:66034821	LOC645431	chr14:65877313-65879335:-	-0.58	-7.14	3.43E-12	Ischemic stroke	
THCA	cis	1	rs73286169	chr14:66078448	LOC645431	chr14:65877313-65879335:-	-0.61	-7.8	3.94E-14	Ischemic stroke	
THCA	cis	1	rs73286173	chr14:66079540	LOC645431	chr14:65877313-65879335:-	-0.53	-6.84	2.46E-11	Ischemic stroke	
THCA	cis	1	rs73287339	chr8:89418809	MMP16	chr8:89049462-89339717:-	0.32	5.19	3.04E-7	Electrodermal activity	
THCA	cis	1	rs73287345	chr8:89421184	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.65E-7	Electrodermal activity	
THCA	cis	1	rs73287349	chr8:89421980	MMP16	chr8:89049462-89339717:-	0.32	5.19	3.04E-7	Electrodermal activity	
THCA	cis	1	rs73287352	chr8:89422227	MMP16	chr8:89049462-89339717:-	0.32	5.19	3.04E-7	Electrodermal activity	
THCA	cis	1	rs73287358	chr8:89423653	MMP16	chr8:89049462-89339717:-	0.32	5.19	3.04E-7	Electrodermal activity	
THCA	cis	1	rs73287359	chr8:89423785	MMP16	chr8:89049462-89339717:-	0.32	5.19	3.04E-7	Electrodermal activity	
THCA	cis	1	rs73289232	chr8:89428731	MMP16	chr8:89049462-89339717:-	0.32	5.19	3.04E-7	Electrodermal activity	
THCA	cis	1	rs73289254	chr8:89436902	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs73289257	chr8:89437106	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs73289264	chr8:89437684	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs73289267	chr8:89438027	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs73291151	chr8:89442174	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs73291154	chr8:89442943	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs73291157	chr8:89443271	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs73291159	chr8:89443807	MMP16	chr8:89049462-89339717:-	0.31	5.07	5.61E-7	Electrodermal activity	
THCA	cis	1	rs73291160	chr8:89443985	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs73291164	chr8:89445005	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs73291166	chr8:89445225	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs73291175	chr8:89446930	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs73291177	chr8:89447266	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs73291179	chr8:89447372	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs73291181	chr8:89448076	MMP16	chr8:89049462-89339717:-	0.32	5.28	2.0E-7	Electrodermal activity	
THCA	cis	1	rs73291191	chr8:89450629	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs73291192	chr8:89450832	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs73292857	chr8:89452516	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs73292867	chr8:89454305	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs7329432	chr13:95881372	ABCC4	chr13:95672084-95953687:-	-0.18	-3.38	0.000774	Breast cancer	
THCA	cis	1	rs73295896	chr12:51351846	SLC11A2	chr12:51373319-51422058:-	-0.23	-4.6	5.43E-6	Type 2 diabetes	
THCA	cis	1	rs73295896	chr12:51351846	TFCP2	chr12:51488608-51566917:-	-0.2	-4.22	2.98E-5	Type 2 diabetes	
THCA	cis	1	rs732975	chr15:53950390	WDR72	chr15:53805938-54051859:-	-0.15	-3.49	0.000524	Chronic kidney disease;Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs73301712	chr14:59898245	C14orf149	chr14:59939406-59951126:-	-0.35	-4.29	2.14E-5	Schizophrenia	
THCA	cis	1	rs73301712	chr14:59898245	JKAMP	chr14:59951161-59972080:+	0.41	5.1	4.92E-7	Schizophrenia	
THCA	cis	1	rs73301725	chr14:59902159	C14orf149	chr14:59939406-59951126:-	-0.35	-4.32	1.89E-5	Schizophrenia	
THCA	cis	1	rs73301725	chr14:59902159	JKAMP	chr14:59951161-59972080:+	0.44	5.41	1.02E-7	Schizophrenia	
THCA	cis	1	rs73301741	chr14:59908444	C14orf149	chr14:59939406-59951126:-	-0.37	-4.39	1.4E-5	Schizophrenia	
THCA	cis	1	rs73301741	chr14:59908444	JKAMP	chr14:59951161-59972080:+	0.45	5.27	2.11E-7	Schizophrenia	
THCA	cis	1	rs73301746	chr14:59908485	C14orf149	chr14:59939406-59951126:-	-0.37	-4.39	1.4E-5	Schizophrenia	
THCA	cis	1	rs73301746	chr14:59908485	JKAMP	chr14:59951161-59972080:+	0.45	5.27	2.11E-7	Schizophrenia	
THCA	cis	1	rs73307913	chr20:44548301	WFDC3	chr20:44402847-44420547:-	-0.27	-3.85	0.000132	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
THCA	cis	1	rs7332115	chr13:33147548	N4BP2L2	chr13:33006930-33112936:-	0.26	7.66	1.05E-13	Body mass index	
THCA	cis	1	rs7332189	chr13:36755610	SOHLH2	chr13:36742347-36871992:-	-0.38	-6.62	9.96E-11	Glucose homeostasis traits	
THCA	cis	1	rs7332200	chr13:85725579	SLITRK6	chr13:86366922-86373483:-	-0.24	-5.07	5.78E-7	Bipolar disorder (mania)	
THCA	cis	1	rs7332663	chr13:95864478	ABCC4	chr13:95672084-95953687:-	-0.19	-3.73	0.000212	Breast cancer	
THCA	cis	1	rs7332763	chr13:33147888	N4BP2L2	chr13:33006930-33112936:-	0.26	7.7	7.67E-14	Body mass index	
THCA	cis	1	rs7332932	chr13:36755636	SOHLH2	chr13:36742347-36871992:-	-0.38	-6.62	9.96E-11	Glucose homeostasis traits	
THCA	cis	1	rs733318	chr2:190724141	ASNSD1	chr2:190526125-190535556:+	-0.56	-5.79	1.27E-8	Subcutaneous adipose tissue	
THCA	cis	1	rs73336014	chr5:176966623	DOK3	chr5:176928915-176937427:-	0.27	6.01	3.65E-9	Alzheimer disease and age of onset	
THCA	cis	1	rs73337598	chr17:61732576	FTSJ3	chr17:61896795-61905031:-	0.31	6	3.89E-9	Body mass index	
THCA	cis	1	rs73337598	chr17:61732576	MAP3K3	chr17:61699775-61773669:+	0.27	5.61	3.43E-8	Body mass index	
THCA	cis	1	rs73342417	chr21:30586627	CCT8	chr21:30428650-30446010:-	0.49	8.18	2.66E-15	Response to mTOR inhibitor (everolimus)	
THCA	cis	1	rs73342417	chr21:30586627	RWDD2B	chr21:30378082-30391685:-	0.28	3.66	0.000286	Response to mTOR inhibitor (everolimus)	
THCA	cis	1	rs73343333	chr5:125913560	ALDH7A1	chr5:125878918-125931082:-	0.44	6.74	4.52E-11	Osteoporosis	
THCA	cis	1	rs73348070	chr5:127893533	FBN2	chr5:127593602-127873916:-	0.51	6.91	1.56E-11	Multiple system atrophy	
THCA	cis	1	rs7335233	chr13:95881331	ABCC4	chr13:95672084-95953687:-	-0.18	-3.38	0.000774	Breast cancer	
THCA	cis	1	rs73352808	chr17:65875157	C17orf58	chr17:65987218-65989765:-	0.23	4.68	3.71E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs73370819	chr21:46904736	SUMO3	chr21:46225532-46238044:-	-0.39	-4.06	5.77E-5	Alzheimer disease and age of onset	
THCA	cis	1	rs73370824	chr21:46907338	SUMO3	chr21:46225532-46238044:-	-0.41	-4.27	2.36E-5	Alzheimer disease and age of onset	
THCA	cis	1	rs7337198	chr13:85784964	SLITRK6	chr13:86366922-86373483:-	-0.22	-3.91	0.000105	Bipolar disorder (mania)	
THCA	cis	1	rs73405097	chr22:29855836	NIPSNAP1	chr22:29950800-29977144:-	0.29	3.84	0.00014	Carotid atherosclerosis in HIV infection	
THCA	cis	1	rs73405097	chr22:29855836	THOC5	chr22:29904157-29949736:-	0.2	3.65	0.000288	Carotid atherosclerosis in HIV infection	
THCA	cis	1	rs7340989	chr4:107148720	TBCK	chr4:106967233-107237861:-	0.34	7.07	5.54E-12	Airflow obstruction	
THCA	cis	1	rs73412140	chr6:33757014	LEMD2	chr6:33738991-33756906:-	0.25	4.99	8.53E-7	Body mass index	
THCA	cis	1	rs734165	chr10:111697789	DUSP5	chr10:112257625-112271300:+	-0.13	-3.49	0.000522	Biliary atresia	
THCA	cis	1	rs73429729	chr6:44086727	TMEM63B	chr6:44095376-44123255:+	0.16	3.49	0.00053	Major depressive disorder	
THCA	cis	1	rs73429745	chr6:44101422	TMEM63B	chr6:44095376-44123255:+	0.16	3.6	0.000349	Major depressive disorder	
THCA	cis	1	rs73434663	chr6:42497519	PRPH2	chr6:42664334-42690358:-	-0.27	-3.65	0.000296	Obesity-related traits	
THCA	cis	1	rs73434687	chr6:42504868	PRPH2	chr6:42664334-42690358:-	-0.3	-3.94	9.25E-5	Obesity-related traits	
THCA	cis	1	rs7343481	chr20:25300113	ENTPD6	chr20:25176339-25207360:+	0.31	6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7343481	chr20:25300113	FAM182A	chr20:26035250-26067552:+	0.18	3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7343481	chr20:25300113	FAM182B	chr20:25744102-25848786:-	-0.27	-5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7343481	chr20:25300113	NINL	chr20:25433338-25566153:-	0.35	7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7343481	chr20:25300113	PYGB	chr20:25228706-25278647:+	0.16	4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs73436638	chr11:18440305	LDHC	chr11:18433853-18472792:+	-0.31	-3.71	0.000236	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73436642	chr11:18440635	LDHC	chr11:18433853-18472792:+	-0.31	-3.71	0.000236	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73436645	chr11:18440783	LDHC	chr11:18433853-18472792:+	-0.31	-3.77	0.000186	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73436655	chr11:18441967	LDHC	chr11:18433853-18472792:+	-0.31	-3.77	0.000186	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73436662	chr11:18442623	LDHC	chr11:18433853-18472792:+	-0.31	-3.77	0.000186	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73436666	chr11:18442930	LDHC	chr11:18433853-18472792:+	-0.31	-3.71	0.000236	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73436668	chr11:18443093	LDHC	chr11:18433853-18472792:+	-0.34	-4.07	5.6E-5	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73436682	chr11:18443689	LDHC	chr11:18433853-18472792:+	-0.31	-3.77	0.000186	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73436685	chr11:18443776	LDHC	chr11:18433853-18472792:+	-0.31	-3.77	0.000186	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73436701	chr11:18446663	LDHC	chr11:18433853-18472792:+	-0.31	-3.77	0.000186	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73438604	chr11:18447103	LDHC	chr11:18433853-18472792:+	-0.33	-3.95	9.07E-5	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73438607	chr11:18447521	LDHC	chr11:18433853-18472792:+	-0.31	-3.77	0.000186	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73438611	chr11:18447676	LDHC	chr11:18433853-18472792:+	-0.31	-3.71	0.000236	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73438627	chr11:18451916	LDHC	chr11:18433853-18472792:+	-0.31	-3.77	0.000186	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73438631	chr11:18452118	LDHC	chr11:18433853-18472792:+	-0.31	-3.76	0.000194	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73438634	chr11:18452356	LDHC	chr11:18433853-18472792:+	-0.31	-3.77	0.000186	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73438666	chr11:18456511	LDHC	chr11:18433853-18472792:+	-0.3	-3.51	0.000484	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73438668	chr11:18456536	LDHC	chr11:18433853-18472792:+	-0.3	-3.57	0.000386	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73438674	chr11:18456889	LDHC	chr11:18433853-18472792:+	-0.3	-3.51	0.000484	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73438686	chr11:18459785	LDHC	chr11:18433853-18472792:+	-0.34	-4	7.31E-5	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73438687	chr11:18459859	LDHC	chr11:18433853-18472792:+	-0.3	-3.57	0.000386	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73438690	chr11:18461214	LDHC	chr11:18433853-18472792:+	-0.3	-3.51	0.000484	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73438695	chr11:18462101	LDHC	chr11:18433853-18472792:+	-0.3	-3.51	0.000484	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73438697	chr11:18462377	LDHC	chr11:18433853-18472792:+	-0.3	-3.57	0.000399	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73438699	chr11:18462684	LDHC	chr11:18433853-18472792:+	-0.3	-3.57	0.000386	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73440604	chr11:18463671	LDHC	chr11:18433853-18472792:+	-0.3	-3.57	0.000386	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73440606	chr11:18464120	LDHC	chr11:18433853-18472792:+	-0.3	-3.51	0.000484	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73440610	chr11:18464469	LDHC	chr11:18433853-18472792:+	-0.3	-3.57	0.000386	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73440614	chr11:18466700	LDHC	chr11:18433853-18472792:+	-0.33	-3.88	0.000119	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73440615	chr11:18467283	LDHC	chr11:18433853-18472792:+	-0.29	-3.49	0.000532	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73440625	chr11:18470800	LDHC	chr11:18433853-18472792:+	-0.34	-3.99	7.69E-5	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73440634	chr11:18473546	LDHC	chr11:18433853-18472792:+	-0.34	-4.04	6.13E-5	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73440636	chr11:18473556	LDHAL6A	chr11:18477374-18501147:+	0.27	3.39	0.000746	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73440636	chr11:18473556	LDHC	chr11:18433853-18472792:+	-0.33	-4	7.42E-5	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73440637	chr11:18474128	LDHC	chr11:18433853-18472792:+	-0.36	-4.19	3.27E-5	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs73444884	chr13:28090321	MTIF3	chr13:28009783-28024711:-	0.19	3.78	0.00018	Weight	
THCA	cis	1	rs73449983	chr11:46612332	PACSIN3	chr11:47199085-47207958:-	0.18	4.04	6.11E-5	Schizophrenia	
THCA	cis	1	rs734512	chr10:37973072	LOC399744	chr10:38717074-38741080:+	-0.23	-3.38	0.000779	Obesity (extreme)	
THCA	cis	1	rs734512	chr10:37973072	ZNF248	chr10:38090447-38147012:-	0.14	3.46	0.000585	Obesity (extreme)	
THCA	cis	1	rs73484234	chr11:22822211	SVIP	chr11:22843600-22851382:-	0.23	3.99	7.63E-5	Dialysis-related mortality	
THCA	cis	1	rs734999	chr1:2513216	MMEL1	chr1:2522081-2564481:-	-0.16	-4.28	2.27E-5	Ulcerative colitis	
THCA	cis	1	rs7350852	chr16:69472608	CYB5B	chr16:69458498-69500167:+	-0.23	-3.99	7.7E-5	Blood pressure (smoking interaction)	
THCA	cis	1	rs73509996	chr19:17393449	ABHD8	chr19:17402941-17414282:-	0.25	4.14	4.17E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs73509996	chr19:17393449	ANKLE1	chr19:17392454-17398454:+	0.3	5.05	6.39E-7	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs73509996	chr19:17393449	OCEL1	chr19:17337055-17340027:+	0.21	4.15	3.93E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs73539529	chr11:71815596	FAM86C	chr11:71498557-71512276:+	-0.32	-3.91	0.000107	Severe influenza A (H1N1) infection	
THCA	cis	1	rs73539532	chr11:71815684	FAM86C	chr11:71498557-71512276:+	-0.32	-3.91	0.000107	Severe influenza A (H1N1) infection	
THCA	cis	1	rs735403	chr4:103553543	NFKB1	chr4:103422486-103538458:+	-0.15	-4.08	5.18E-5	Primary biliary cirrhosis	
THCA	cis	1	rs735404	chr4:103553665	CISD2	chr4:103790135-103809913:+	-0.15	-3.54	0.000433	Primary biliary cirrhosis	
THCA	cis	1	rs735404	chr4:103553665	NFKB1	chr4:103422486-103538458:+	0.13	3.63	0.000313	Primary biliary cirrhosis	
THCA	cis	1	rs735405	chr4:103553916	CISD2	chr4:103790135-103809913:+	-0.15	-3.5	0.000517	Primary biliary cirrhosis	
THCA	cis	1	rs735405	chr4:103553916	NFKB1	chr4:103422486-103538458:+	0.14	4.04	6.22E-5	Primary biliary cirrhosis	
THCA	cis	1	rs73543609	chr11:71816619	FAM86C	chr11:71498557-71512276:+	-0.32	-3.91	0.000107	Severe influenza A (H1N1) infection	
THCA	cis	1	rs73543633	chr11:71828844	FAM86C	chr11:71498557-71512276:+	-0.32	-3.86	0.00013	Severe influenza A (H1N1) infection	
THCA	cis	1	rs735531	chr20:33947730	CPNE1	chr20:34213968-34262539:-	0.3	5.88	7.84E-9	Height	
THCA	cis	1	rs735531	chr20:33947730	GDF5	chr20:33897002-34042568:-	-0.17	-3.74	0.000207	Height	
THCA	cis	1	rs735531	chr20:33947730	UQCC	chr20:33890383-33999833:-	0.32	10.18	3.81E-22	Height	
THCA	cis	1	rs73554431	chr6:133129922	C6orf192	chr6:133090507-133119747:-	-0.25	-4.27	2.4E-5	Type 2 diabetes nephropathy	
THCA	cis	1	rs73559130	chr19:52022169	ZNF175	chr19:52074531-52092990:+	-0.36	-4.26	2.49E-5	Carotid intima media thickness	
THCA	cis	1	rs73559183	chr19:52032367	ZNF175	chr19:52074531-52092990:+	-0.32	-3.85	0.000132	Carotid intima media thickness	
THCA	cis	1	rs7356093	chr3:134238753	ANAPC13	chr3:134196547-134204865:-	0.39	12.42	6.55E-31	Height	
THCA	cis	1	rs7356093	chr3:134238753	CEP63	chr3:134204575-134293852:+	0.3	6.32	6.02E-10	Height	
THCA	cis	1	rs7356705	chr5:101807025	SLCO4C1	chr5:101569694-101632253:-	0.25	5.65	2.77E-8	Schizophrenia	
THCA	cis	1	rs73573834	chr6:158272300	SNX9	chr6:158244294-158366109:+	-0.25	-3.67	0.000274	Lipoprotein (a) - cholesterol levels	
THCA	cis	1	rs735765	chr6:28170297	ZKSCAN3	chr6:28317691-28334523:+	-0.29	-5.19	3.05E-7	Depression	
THCA	cis	1	rs735765	chr6:28170297	ZNF187	chr6:28234788-28245978:+	-0.34	-6.3	6.78E-10	Depression	
THCA	cis	1	rs735765	chr6:28170297	ZNF193	chr6:28193067-28201260:+	0.24	4.07	5.6E-5	Depression	
THCA	cis	1	rs735765	chr6:28170297	ZNF323	chr6:28292517-28324048:-	0.36	4.57	6.35E-6	Depression	
THCA	cis	1	rs735765	chr6:28170297	ZNF389	chr6:28129551-28137375:+	-0.44	-5.71	1.94E-8	Depression	
THCA	cis	1	rs735765	chr6:28170297	ZSCAN23	chr6:28393287-28411279:-	0.25	4.98	8.93E-7	Depression	
THCA	cis	1	rs73579458	chr16:69804764	COG4	chr16:70514473-70557457:-	-0.18	-3.68	0.000264	IgE levels	
THCA	cis	1	rs73579497	chr16:69824150	COG4	chr16:70514473-70557457:-	-0.19	-3.81	0.000156	IgE levels	
THCA	cis	1	rs735854	chr22:36679058	MYH9	chr22:36677324-36784063:-	-0.12	-3.72	0.000223	Optic nerve measurement (rim area)	
THCA	cis	1	rs73591936	chr16:67761825	C16orf86	chr16:67700717-67702659:+	-0.32	-4.04	6.34E-5	Crohn's disease	
THCA	cis	1	rs73591936	chr16:67761825	ZDHHC1	chr16:67428323-67450339:-	0.43	4.96	9.82E-7	Crohn's disease	
THCA	cis	1	rs736344	chr12:110001195	KCTD10	chr12:109886460-109915155:-	-0.23	-5.91	6.54E-9	HDL cholesterol	
THCA	cis	1	rs7364180	chr22:42218856	C22orf32	chr22:42475699-42480287:+	-0.19	-4.55	6.9E-6	Alzheimer's disease biomarkers	
THCA	cis	1	rs7364180	chr22:42218856	NDUFA6	chr22:42481531-42486888:-	0.18	3.95	9.06E-5	Alzheimer's disease biomarkers	
THCA	cis	1	rs7365904	chr1:20904528	CDA	chr1:20915444-20945398:+	-0.21	-4.33	1.81E-5	Age-related hearing impairment (interaction)	
THCA	cis	1	rs7365904	chr1:20904528	FAM43B	chr1:20878932-20881512:+	0.18	3.54	0.000445	Age-related hearing impairment (interaction)	
THCA	cis	1	rs736678	chr17:30347423	C17orf79	chr17:30178885-30186326:-	-0.21	-4.88	1.44E-6	Height	
THCA	cis	1	rs73692253	chr8:89413736	MMP16	chr8:89049462-89339717:-	0.31	5.01	7.65E-7	Electrodermal activity	
THCA	cis	1	rs73692561	chr8:89422086	MMP16	chr8:89049462-89339717:-	0.32	5.19	3.04E-7	Electrodermal activity	
THCA	cis	1	rs73692563	chr8:89422311	MMP16	chr8:89049462-89339717:-	0.32	5.19	3.04E-7	Electrodermal activity	
THCA	cis	1	rs73692564	chr8:89422312	MMP16	chr8:89049462-89339717:-	0.32	5.19	3.04E-7	Electrodermal activity	
THCA	cis	1	rs73692565	chr8:89422384	MMP16	chr8:89049462-89339717:-	0.32	5.19	3.04E-7	Electrodermal activity	
THCA	cis	1	rs73692571	chr8:89436877	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs73694050	chr8:89443368	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs73694056	chr8:89447140	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs73694066	chr8:89453493	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs73694076	chr8:89454910	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs73694079	chr8:89456953	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs737008	chr16:11374866	C16orf75	chr16:11343506-11445617:+	-0.26	-5.45	8.12E-8	Obesity-related traits	
THCA	cis	1	rs73701316	chr8:117654342	EIF3H	chr8:117657056-117778494:-	-0.21	-3.86	0.000128	Body mass index	
THCA	cis	1	rs73701461	chr8:117736068	EIF3H	chr8:117657056-117778494:-	-0.22	-4.16	3.77E-5	Body mass index	
THCA	cis	1	rs73701465	chr8:117752170	EIF3H	chr8:117657056-117778494:-	-0.23	-4.25	2.56E-5	Body mass index	
THCA	cis	1	rs73706914	chr7:87369685	DBF4	chr7:87505544-87538856:+	-0.31	-4.46	1.05E-5	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs73706922	chr7:87413272	DBF4	chr7:87505544-87538856:+	-0.3	-4.51	8.03E-6	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs73706950	chr7:87523791	DBF4	chr7:87505544-87538856:+	-0.25	-3.86	0.000131	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs737093	chr19:32977406	DPY19L3	chr19:32896677-32975236:+	0.19	5.07	5.81E-7	Bipolar disorder	
THCA	cis	1	rs737093	chr19:32977406	ZNF507	chr19:32836514-32878571:+	0.3	7.48	3.56E-13	Bipolar disorder	
THCA	cis	1	rs7371896	chr3:134249769	ANAPC13	chr3:134196547-134204865:-	0.39	12.61	1.18E-31	Height	
THCA	cis	1	rs7371896	chr3:134249769	CEP63	chr3:134204575-134293852:+	0.3	6.6	1.11E-10	Height	
THCA	cis	1	rs7372217	chr3:41990122	ULK4	chr3:41288091-42003660:-	-1.1	-21.38	1.21E-71	Diastolic blood pressure	
THCA	cis	1	rs7373805	chr3:38455439	EXOG	chr3:38537763-38567796:+	-0.16	-3.36	0.000854	Electrocardiographic conduction measures	
THCA	cis	1	rs7373805	chr3:38455439	LOC100128640	chr3:38492524-38496311:-	0.23	4.73	3.02E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs7373805	chr3:38455439	SCN5A	chr3:38589554-38691164:-	0.16	3.42	0.00068	Electrocardiographic conduction measures	
THCA	cis	1	rs7373805	chr3:38455439	XYLB	chr3:38388251-38456467:+	0.2	4.9	1.34E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs7373816	chr3:38490443	LOC100128640	chr3:38492524-38496311:-	0.23	4.89	1.35E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs7373816	chr3:38490443	SCN5A	chr3:38589554-38691164:-	0.17	3.49	0.000531	Electrocardiographic conduction measures	
THCA	cis	1	rs7373816	chr3:38490443	XYLB	chr3:38388251-38456467:+	0.21	5.02	7.16E-7	Electrocardiographic conduction measures	
THCA	cis	1	rs7373998	chr3:128008223	EEFSEC	chr3:127872313-128127488:+	0.27	4.82	1.91E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs7374158	chr3:134270156	ANAPC13	chr3:134196547-134204865:-	0.39	12.58	1.56E-31	Height	
THCA	cis	1	rs7374158	chr3:134270156	CEP63	chr3:134204575-134293852:+	0.3	6.54	1.63E-10	Height	
THCA	cis	1	rs7374227	chr3:128001515	EEFSEC	chr3:127872313-128127488:+	-0.26	-4.67	4.01E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs7374325	chr3:134275601	ANAPC13	chr3:134196547-134204865:-	0.4	12.55	1.92E-31	Height	
THCA	cis	1	rs7374325	chr3:134275601	CEP63	chr3:134204575-134293852:+	0.31	6.53	1.69E-10	Height	
THCA	cis	1	rs7374394	chr3:184945849	CHRD	chr3:184097861-184107619:+	0.13	3.44	0.000642	Cognitive performance	
THCA	cis	1	rs7374752	chr3:184732819	C3orf70	chr3:184795840-184870802:-	-0.23	-4.63	4.63E-6	Heschl's gyrus morphology	
THCA	cis	1	rs7374952	chr3:128001367	EEFSEC	chr3:127872313-128127488:+	-0.24	-4.23	2.8E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs737684	chr22:31659827	RNF185	chr22:31556138-31603004:+	-0.27	-5.04	6.59E-7	Paclitaxel-induced neuropathy	
THCA	cis	1	rs737887	chr22:31696615	RNF185	chr22:31556138-31603004:+	-0.29	-5.29	1.84E-7	Paclitaxel-induced neuropathy	
THCA	cis	1	rs738093	chr19:32930507	DPY19L3	chr19:32896677-32975236:+	0.19	5.18	3.27E-7	Bipolar disorder	
THCA	cis	1	rs738093	chr19:32930507	ZNF507	chr19:32836514-32878571:+	0.3	7.45	4.45E-13	Bipolar disorder	
THCA	cis	1	rs7383628	chr6:25607876	SCGN	chr6:25652429-25702006:+	-0.3	-5.78	1.36E-8	Uric acid levels	
THCA	cis	1	rs73844281	chr4:122664688	EXOSC9	chr4:122722472-122738175:+	0.15	3.81	0.000155	Type 2 diabetes	
THCA	cis	1	rs73844281	chr4:122664688	KIAA1109	chr4:123091758-123283905:+	-0.09	-3.45	0.000599	Type 2 diabetes	
THCA	cis	1	rs738722	chr22:29130012	CHEK2	chr22:29083731-29137822:-	0.17	4.12	4.5E-5	Esophageal cancer and gastric cancer	
THCA	cis	1	rs73903009	chr20:33678732	PROCR	chr20:33758727-33765164:+	-0.32	-5.27	2.05E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs73903009	chr20:33678732	TRPC4AP	chr20:33590215-33680618:-	0.28	3.53	0.000455	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs73903017	chr20:33724758	MMP24	chr20:33814539-33864804:+	-0.22	-3.4	0.000718	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs73903017	chr20:33724758	PROCR	chr20:33758727-33765164:+	-0.29	-4.75	2.68E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs73903019	chr20:33727779	MMP24	chr20:33814539-33864804:+	-0.22	-3.43	0.000648	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs73903019	chr20:33727779	PROCR	chr20:33758727-33765164:+	-0.3	-5.04	6.58E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs73903019	chr20:33727779	TRPC4AP	chr20:33590215-33680618:-	0.29	3.7	0.000244	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs73905019	chr20:33560314	PROCR	chr20:33758727-33765164:+	-0.34	-5.39	1.13E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs73905019	chr20:33560314	TRPC4AP	chr20:33590215-33680618:-	0.29	3.46	0.000591	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs73905041	chr20:33592148	PROCR	chr20:33758727-33765164:+	-0.34	-5.6	3.62E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs73905041	chr20:33592148	TRPC4AP	chr20:33590215-33680618:-	0.27	3.45	0.00061	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs739139	chr22:38067011	LGALS2	chr22:37966254-37976024:-	0.13	3.51	0.000499	Fat distribution (HIV)	
THCA	cis	1	rs739139	chr22:38067011	PDXP	chr22:38054737-38062939:+	-0.18	-3.38	0.000779	Fat distribution (HIV)	
THCA	cis	1	rs739139	chr22:38067011	SH3BP1	chr22:38030661-38062939:+	0.11	3.56	0.000407	Fat distribution (HIV)	
THCA	cis	1	rs73921003	chr2:17775205	GEN1	chr2:17935162-17966632:+	0.51	6.84	2.49E-11	Psychosis and Alzheimer's disease	
THCA	cis	1	rs739310	chr22:27051299	HPS4	chr22:26847447-26879820:-	-0.23	-4.11	4.67E-5	Obesity-related traits	
THCA	cis	1	rs7394190	chr10:75421648	BMS1P4	chr10:75458909-75490272:-	-0.28	-5.82	1.11E-8	Atrial fibrillation	
THCA	cis	1	rs7394190	chr10:75421648	NUDT13	chr10:74870210-74891580:+	-0.24	-4.37	1.51E-5	Atrial fibrillation	
THCA	cis	1	rs73943920	chr2:86186195	POLR1A	chr2:86253453-86333278:-	-0.29	-3.84	0.000141	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs7394449	chr11:962190	TSPAN4	chr11:842824-867116:+	0.15	3.68	0.00026	Alzheimer's disease (late onset)	
THCA	cis	1	rs73947314	chr2:86273116	POLR1A	chr2:86253453-86333278:-	-0.35	-4.91	1.25E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs7395328	chr11:242624	PSMD13	chr11:236808-252984:+	-0.22	-6.72	5.21E-11	Menarche (age at onset)	
THCA	cis	1	rs7395328	chr11:242624	SIRT3	chr11:214625-236931:-	0.12	3.41	0.000702	Menarche (age at onset)	
THCA	cis	1	rs73958618	chr2:136500475	DARS	chr2:136664254-136743222:-	0.36	6.55	1.47E-10	Corneal structure	
THCA	cis	1	rs7396366	chr11:986185	TSPAN4	chr11:842824-867116:+	0.16	3.87	0.000123	Alzheimer's disease (late onset)	
THCA	cis	1	rs739636	chr17:40281063	HSPB9	chr17:40274756-40275371:+	0.33	4.86	1.56E-6	Fibrinogen levels	
THCA	cis	1	rs739637	chr17:40280944	HSPB9	chr17:40274756-40275371:+	0.34	4.97	9.22E-7	Fibrinogen levels	
THCA	cis	1	rs7396798	chr11:970510	TSPAN4	chr11:842824-867116:+	0.16	3.75	0.000198	Alzheimer's disease (late onset)	
THCA	cis	1	rs7397068	chr12:51401904	SLC11A2	chr12:51373319-51422058:-	-0.25	-4.98	9.1E-7	Type 2 diabetes	
THCA	cis	1	rs7397068	chr12:51401904	TFCP2	chr12:51488608-51566917:-	-0.2	-4.34	1.76E-5	Type 2 diabetes	
THCA	cis	1	rs739734	chr7:27159405	HOXA9	chr7:27202058-27205149:-	-0.41	-4.59	5.73E-6	Hypospadias	
THCA	cis	1	rs73978990	chr17:17504559	ATPAF2	chr17:17918373-17942480:-	-0.27	-4.35	1.63E-5	Obsessive-compulsive symptoms	
THCA	cis	1	rs73979024	chr2:190536755	ASNSD1	chr2:190526125-190535556:+	-0.73	-7.32	1.06E-12	Subcutaneous adipose tissue	
THCA	cis	1	rs73985728	chr2:207668245	MDH1B	chr2:207598943-207630050:-	0.41	5.63	3.15E-8	Episodic memory	
THCA	cis	1	rs739954	chr5:139701920	HBEGF	chr5:139712429-139726188:-	0.14	3.48	0.000553	Alzheimer's disease in APOE e4- carriers	
THCA	cis	1	rs739954	chr5:139701920	PCDHA9	chr5:140227357-140391929:+	0.2	3.49	0.000521	Alzheimer's disease in APOE e4- carriers	
THCA	cis	1	rs739954	chr5:139701920	ZMAT2	chr5:140080032-140086239:+	0.14	3.36	0.000841	Alzheimer's disease in APOE e4- carriers	
THCA	cis	1	rs7402778	chr15:24774948	PWRN1	chr15:24778839-24832924:+	0.46	9.55	6.78E-20	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
THCA	cis	1	rs7402804	chr15:24836600	PWRN1	chr15:24778839-24832924:+	0.39	7.98	1.06E-14	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
THCA	cis	1	rs7402908	chr15:24836980	PWRN1	chr15:24778839-24832924:+	0.39	8.01	8.89E-15	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
THCA	cis	1	rs7403037	chr15:24818497	PWRN1	chr15:24778839-24832924:+	-0.43	-8.92	1.01E-17	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
THCA	cis	1	rs7406003	chr17:79597597	ARL16	chr17:79648234-79650954:-	-0.13	-3.39	0.000759	Eye color traits	
THCA	cis	1	rs7406003	chr17:79597597	TSPAN10	chr17:79609349-79615778:+	0.79	17.47	3.23E-53	Eye color traits	
THCA	cis	1	rs74071851	chr14:88882202	SPATA7	chr14:88852012-88904802:+	-0.17	-3.54	0.000432	Coronary artery calcification	
THCA	cis	1	rs7411035	chr1:160856076	CD244	chr1:160799951-160832645:-	-0.12	-3.38	0.000782	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs7411035	chr1:160856076	ITLN1	chr1:160846332-160854960:-	0.2	3.35	0.000868	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs7411387	chr1:111837135	OVGP1	chr1:111956938-111970399:-	0.15	4	7.26E-5	Interferon alpha levels in systemic lupus erythematosus	
THCA	cis	1	rs74117831	chr10:1145707	IDI2	chr10:1064847-1071799:-	0.34	3.51	0.00049	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs74117848	chr10:1160974	IDI2	chr10:1064847-1071799:-	0.43	4.18	3.54E-5	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs74117849	chr10:1165425	IDI2	chr10:1064847-1071799:-	0.39	3.92	0.000103	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs74117850	chr10:1165777	IDI2	chr10:1064847-1071799:-	0.39	3.95	8.86E-5	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs74120451	chr10:1126866	IDI2	chr10:1064847-1071799:-	0.33	3.38	0.000797	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs7412746	chr1:150860471	ARNT	chr1:150782186-150849186:-	-0.14	-3.53	0.000456	Melanoma	
THCA	cis	1	rs7412746	chr1:150860471	CTSS	chr1:150702554-150738305:-	-0.33	-11.08	1.53E-25	Melanoma	
THCA	cis	1	rs7412746	chr1:150860471	HORMAD1	chr1:150670542-150693352:-	-0.35	-6.76	4.09E-11	Melanoma	
THCA	cis	1	rs74174932	chr20:43756133	STK4	chr20:43595120-43708591:+	-0.17	-4.05	5.93E-5	Parental longevity (mother's age at death)	
THCA	cis	1	rs74174934	chr20:43761331	STK4	chr20:43595120-43708591:+	-0.17	-3.9	0.00011	Parental longevity (mother's age at death)	
THCA	cis	1	rs74210981	chr10:102287520	SEC31B	chr10:102246403-102289636:-	-0.29	-9.04	3.84E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs742132	chr6:25607571	SCGN	chr6:25652429-25702006:+	-0.29	-5.73	1.8E-8	Uric acid levels	
THCA	cis	1	rs742134	chr22:43518275	A4GALT	chr22:43088128-43117286:-	-0.18	-3.57	0.000395	Prostate cancer	
THCA	cis	1	rs742134	chr22:43518275	BIK	chr22:43506757-43525717:+	-0.38	-6.28	7.8E-10	Prostate cancer	
THCA	cis	1	rs74256103	chr17:76069773	TMC6	chr17:76108999-76128488:-	0.21	3.94	9.41E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs7425670	chr2:88522028	KRCC1	chr2:88326724-88355248:-	-0.23	-3.71	0.000233	Plasma clusterin levels	
THCA	cis	1	rs7425670	chr2:88522028	THNSL2	chr2:88469835-88486145:+	-0.67	-8.56	1.59E-16	Plasma clusterin levels	
THCA	cis	1	rs7426847	chr3:134267519	ANAPC13	chr3:134196547-134204865:-	-0.39	-12.14	9.6E-30	Height	
THCA	cis	1	rs7426847	chr3:134267519	CEP63	chr3:134204575-134293852:+	-0.31	-6.6	1.07E-10	Height	
THCA	cis	1	rs7427165	chr3:121364624	IQCB1	chr3:121488610-121553926:-	0.52	10.12	5.87E-22	Cognitive performance	
THCA	cis	1	rs7427492	chr3:134261654	ANAPC13	chr3:134196547-134204865:-	0.4	12.53	2.47E-31	Height	
THCA	cis	1	rs7427492	chr3:134261654	CEP63	chr3:134204575-134293852:+	0.3	6.36	4.83E-10	Height	
THCA	cis	1	rs7428326	chr3:134251184	ANAPC13	chr3:134196547-134204865:-	0.39	12.58	1.56E-31	Height	
THCA	cis	1	rs7428326	chr3:134251184	CEP63	chr3:134204575-134293852:+	0.3	6.54	1.63E-10	Height	
THCA	cis	1	rs74284373	chr3:57988088	PDHB	chr3:58413355-58419565:-	-0.15	-3.45	0.0006	Optic cup area	
THCA	cis	1	rs7428	chr2:85545490	CAPG	chr2:85621871-85641170:-	0.14	4.37	1.56E-5	Ear protrusion	
THCA	cis	1	rs7428	chr2:85545490	TGOLN2	chr2:85545147-85555374:-	0.16	5.81	1.12E-8	Ear protrusion	
THCA	cis	1	rs742930	chr6:116522615	TSPYL4	chr6:116571133-116575261:-	0.15	4.14	4.08E-5	Dental caries	
THCA	cis	1	rs74293240	chr6:24483896	GPLD1	chr6:24428405-24489850:-	0.2	3.75	0.0002	Hematological and biochemical traits	
THCA	cis	1	rs74293240	chr6:24483896	MRS2	chr6:24403153-24425809:+	0.24	5.35	1.35E-7	Hematological and biochemical traits	
THCA	cis	1	rs74298052	chr6:159405298	RSPH3	chr6:159398268-159421198:-	0.29	6.05	2.96E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs74298057	chr6:159417303	RSPH3	chr6:159398268-159421198:-	0.28	5.96	4.98E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs74298058	chr6:159419953	RSPH3	chr6:159398268-159421198:-	0.28	5.98	4.25E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs7429866	chr3:134236306	ANAPC13	chr3:134196547-134204865:-	-0.38	-12.04	2.37E-29	Height	
THCA	cis	1	rs7429866	chr3:134236306	CEP63	chr3:134204575-134293852:+	-0.31	-6.57	1.33E-10	Height	
THCA	cis	1	rs7429990	chr3:47901803	CDC25A	chr3:48198668-48229801:-	0.33	6.81	2.98E-11	Educational attainment (years of education)	
THCA	cis	1	rs7429990	chr3:47901803	NME6	chr3:48335591-48342886:-	-0.28	-5.63	3.09E-8	Educational attainment (years of education)	
THCA	cis	1	rs7429990	chr3:47901803	ZNF589	chr3:48282596-48329113:+	0.39	8.41	4.94E-16	Educational attainment (years of education)	
THCA	cis	1	rs7432268	chr3:134242051	ANAPC13	chr3:134196547-134204865:-	0.4	12.53	2.34E-31	Height	
THCA	cis	1	rs7432268	chr3:134242051	CEP63	chr3:134204575-134293852:+	0.31	6.57	1.33E-10	Height	
THCA	cis	1	rs7433663	chr3:134235790	ANAPC13	chr3:134196547-134204865:-	0.39	12.51	3.0E-31	Height	
THCA	cis	1	rs7433663	chr3:134235790	CEP63	chr3:134204575-134293852:+	0.31	6.67	7.14E-11	Height	
THCA	cis	1	rs7433707	chr3:38443180	LOC100128640	chr3:38492524-38496311:-	0.22	4.54	7.07E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs7433707	chr3:38443180	XYLB	chr3:38388251-38456467:+	0.2	4.91	1.25E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs7433991	chr3:134312292	ANAPC13	chr3:134196547-134204865:-	0.37	11.55	2.1E-27	Height	
THCA	cis	1	rs7433991	chr3:134312292	CEP63	chr3:134204575-134293852:+	0.29	6.27	8.23E-10	Height	
THCA	cis	1	rs74342219	chr7:101386701	RABL5	chr7:100956649-100965093:-	0.18	4.02	6.68E-5	Basal cell carcinoma	
THCA	cis	1	rs74347384	chr7:1072440	ZFAND2A	chr7:1192544-1199855:-	-0.3	-4.4	1.33E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs743479	chr21:45611950	ICOSLG	chr21:45646724-45660834:-	0.19	4.13	4.3E-5	Inflammatory bowel disease	
THCA	cis	1	rs743479	chr21:45611950	PWP2	chr21:45527208-45551062:+	0.25	4.48	9.33E-6	Inflammatory bowel disease	
THCA	cis	1	rs7436021	chr4:76905472	NAAA	chr4:76831809-76862166:-	-0.35	-7.07	5.39E-12	Longevity	
THCA	cis	1	rs74363821	chr6:26189524	HIST1H2AE	chr6:26217148-26217711:+	-0.23	-3.69	0.000249	Renal underexcretion gout;Gout	
THCA	cis	1	rs74363821	chr6:26189524	HIST1H3E	chr6:26224427-26226589:+	0.43	7.04	6.71E-12	Renal underexcretion gout;Gout	
THCA	cis	1	rs74366004	chr7:1088630	ZFAND2A	chr7:1192544-1199855:-	-0.37	-5.37	1.24E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs74369356	chr7:1071711	ZFAND2A	chr7:1192544-1199855:-	-0.3	-4.4	1.33E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs7436973	chr4:90643921	MMRN1	chr4:90816003-90875778:+	0.32	4.06	5.69E-5	Parkinson's disease	
THCA	cis	1	rs74372131	chr10:81787214	LOC219347	chr10:81805991-81838949:-	1.04	14.91	1.49E-41	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs74374590	chr7:107172470	DLD	chr7:107531586-107561642:+	0.14	3.5	0.00051	Osteoarthritis	
THCA	cis	1	rs7438704	chr4:48363245	OCIAD1	chr4:48833015-48863831:+	-0.14	-4.16	3.77E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs74398423	chr4:106720966	INTS12	chr4:106603787-106629881:-	-0.6	-5.04	6.61E-7	Post bronchodilator FEV1	
THCA	cis	1	rs74403477	chr1:179424380	C1orf125	chr1:179335107-179523868:+	0.59	5.94	5.62E-9	Multiple sclerosis (age of onset)	
THCA	cis	1	rs74408158	chr8:89368945	MMP16	chr8:89049462-89339717:-	0.32	4.95	1.04E-6	Electrodermal activity	
THCA	cis	1	rs74410979	chr6:159361089	RSPH3	chr6:159398268-159421198:-	0.27	5.79	1.27E-8	Bladder cancer (smoking interaction)	
THCA	cis	1	rs74421437	chr2:203831252	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.69	2.21E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs74421437	chr2:203831252	ICA1L	chr2:203637873-203736371:-	0.27	4.48	9.33E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs74427244	chr15:56519917	MNS1	chr15:56720929-56757335:-	-0.24	-3.51	0.000485	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs74427244	chr15:56519917	TEX9	chr15:56657644-56738071:+	-0.34	-5.81	1.12E-8	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs7443669	chr5:115527611	COMMD10	chr5:115420727-115628978:+	0.48	5.84	9.44E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs74460214	chr11:116865207	PCSK7	chr11:117075789-117102811:-	0.41	5.18	3.34E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs74471041	chr3:49542543	GMPPB	chr3:49758932-49761384:-	0.16	3.64	0.0003	Menarche (age at onset)	
THCA	cis	1	rs74471041	chr3:49542543	P4HTM	chr3:49027341-49044579:+	-0.17	-4.2	3.19E-5	Menarche (age at onset)	
THCA	cis	1	rs74471041	chr3:49542543	WDR6	chr3:49044637-49053386:+	0.18	3.71	0.000235	Menarche (age at onset)	
THCA	cis	1	rs744910	chr15:67446785	SMAD3	chr15:67358195-67487532:+	0.16	4.15	3.89E-5	Asthma	
THCA	cis	1	rs74497593	chr4:106616214	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs7450492	chr6:55935891	COL21A1	chr6:55921389-56258892:-	-0.64	-7.91	1.86E-14	Psychosis (atypical)	
THCA	cis	1	rs74521803	chr15:66832261	TIPIN	chr15:66629008-66649054:-	-0.39	-3.87	0.000122	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs7452753	chr6:101053726	ASCC3	chr6:100956609-101329224:-	0.11	4.41	1.28E-5	Menarche (age at onset)	
THCA	cis	1	rs7454056	chr6:56003136	COL21A1	chr6:55921389-56258892:-	-0.66	-8.09	4.8E-15	Psychosis (atypical)	
THCA	cis	1	rs74543591	chr20:33658658	PROCR	chr20:33758727-33765164:+	-0.34	-5.45	8.29E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs74543591	chr20:33658658	TRPC4AP	chr20:33590215-33680618:-	0.33	3.93	9.8E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs74544416	chr8:82657745	CHMP4C	chr8:82644688-82671746:+	-1.3	-16.69	1.28E-49	Epithelial ovarian cancer;Ovarian cancer	
THCA	cis	1	rs7456042	chr7:65299778	CCT6P1	chr7:65216092-65228661:+	0.4	6.32	6.1E-10	Diabetic kidney disease	
THCA	cis	1	rs7456042	chr7:65299778	CRCP	chr7:65579805-65619551:+	-0.27	-4.14	4.11E-5	Diabetic kidney disease	
THCA	cis	1	rs7456042	chr7:65299778	LOC493754	chr7:65993446-66057363:-	0.29	3.35	0.00088	Diabetic kidney disease	
THCA	cis	1	rs7456042	chr7:65299778	RABGEF1	chr7:66093890-66276446:+	0.52	6.54	1.58E-10	Diabetic kidney disease	
THCA	cis	1	rs74568699	chr4:106665995	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs74589786	chr20:61860939	BIRC7	chr20:61867276-61871853:+	0.34	3.95	8.96E-5	Response to cytadine analogues (cytosine arabinoside)	
THCA	cis	1	rs74589786	chr20:61860939	NKAIN4	chr20:61872137-61885892:-	0.34	3.54	0.000438	Response to cytadine analogues (cytosine arabinoside)	
THCA	cis	1	rs74599371	chr20:33561495	PROCR	chr20:33758727-33765164:+	-0.36	-5.71	1.97E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs74599371	chr20:33561495	TRPC4AP	chr20:33590215-33680618:-	0.33	4	7.46E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs74607112	chr2:86305534	LOC90784	chr2:86247339-86250991:-	-0.55	-6.06	2.84E-9	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs74609824	chr17:17481353	ATPAF2	chr17:17918373-17942480:-	-0.21	-3.54	0.000443	Obsessive-compulsive symptoms	
THCA	cis	1	rs74611500	chr14:66009789	LOC645431	chr14:65877313-65879335:-	-0.59	-7.57	1.88E-13	Ischemic stroke	
THCA	cis	1	rs74614887	chr1:108364795	VAV3	chr1:108113782-108507545:-	0.57	8.13	3.63E-15	Hypothyroidism	
THCA	cis	1	rs74615346	chr11:116802972	PCSK7	chr11:117075789-117102811:-	0.45	5.41	1.02E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs74617736	chr14:55620919	FBXO34	chr14:55738021-55893431:+	-0.14	-3.38	0.000776	Protein biomarker	
THCA	cis	1	rs7462228	chr8:89410365	MMP16	chr8:89049462-89339717:-	0.31	5.04	6.5E-7	Electrodermal activity	
THCA	cis	1	rs74626382	chr20:33746668	PROCR	chr20:33758727-33765164:+	-0.34	-5.58	3.98E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs74626382	chr20:33746668	TRPC4AP	chr20:33590215-33680618:-	0.32	4.02	6.89E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs7463933	chr8:89464868	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs74640397	chr8:117679912	EIF3H	chr8:117657056-117778494:-	-0.21	-3.72	0.000224	Body mass index	
THCA	cis	1	rs746489	chr9:131910093	CRAT	chr9:131857075-131873070:-	0.29	7.12	4.04E-12	Blood metabolite ratios	
THCA	cis	1	rs74650218	chr10:102293830	SEC31B	chr10:102246403-102289636:-	-0.28	-9.14	1.74E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs74652290	chr7:1090109	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.56	4.53E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs74663287	chr11:18460300	LDHC	chr11:18433853-18472792:+	-0.3	-3.57	0.000386	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs74678088	chr1:108357797	VAV3	chr1:108113782-108507545:-	0.56	8.05	6.61E-15	Hypothyroidism	
THCA	cis	1	rs74703743	chr2:190792622	ASNSD1	chr2:190526125-190535556:+	-0.55	-5.75	1.63E-8	Subcutaneous adipose tissue	
THCA	cis	1	rs74713356	chr1:183236667	RNASEL	chr1:182542772-182558391:-	0.34	3.57	0.0004	Systemic lupus erythematosus and Systemic sclerosis	
THCA	cis	1	rs747136	chr20:31768145	C20orf70	chr20:31755960-31769223:+	-0.41	-3.62	0.000323	Smooth-surface caries	
THCA	cis	1	rs74733602	chr2:86303442	POLR1A	chr2:86253453-86333278:-	-0.34	-4.45	1.06E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs74737585	chr11:96114921	CCDC82	chr11:96085930-96123083:-	-0.24	-3.71	0.000234	Parkinson's disease	
THCA	cis	1	rs74741949	chr11:18453048	LDHC	chr11:18433853-18472792:+	-0.3	-3.58	0.000379	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs74743307	chr8:89422498	MMP16	chr8:89049462-89339717:-	0.32	5.19	3.04E-7	Electrodermal activity	
THCA	cis	1	rs7474896	chr10:37982097	LOC399744	chr10:38717074-38741080:+	0.25	3.41	0.000697	Obesity (extreme)	
THCA	cis	1	rs7475154	chr10:131440584	MGMT	chr10:131265454-131565783:+	-0.37	-11.15	7.86E-26	Response to temozolomide	
THCA	cis	1	rs74752617	chr13:24435981	C1QTNF9B	chr13:24465238-24471641:-	0.36	3.59	0.000367	3-hydroxypropylmercapturic acid levels in smokers	
THCA	cis	1	rs74758321	chr8:82667320	CHMP4C	chr8:82644688-82671746:+	-1.3	-17.36	1.1E-52	Epithelial ovarian cancer;Ovarian cancer	
THCA	cis	1	rs747692	chr6:33737436	LEMD2	chr6:33738991-33756906:-	0.23	4.57	6.18E-6	Body mass index	
THCA	cis	1	rs747695	chr6:33736672	LEMD2	chr6:33738991-33756906:-	-0.29	-6.43	3.04E-10	Crohn's disease	
THCA	cis	1	rs7477246	chr10:102261538	SEC31B	chr10:102246403-102289636:-	-0.28	-8.77	3.23E-17	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs7477	chr17:16246016	ADORA2B	chr17:15848231-15879210:+	-0.36	-7.46	4.18E-13	Amyotrophic lateral sclerosis	
THCA	cis	1	rs7477	chr17:16246016	TTC19	chr17:15902782-15932096:+	0.25	6.21	1.16E-9	Amyotrophic lateral sclerosis	
THCA	cis	1	rs7477	chr17:16246016	ZSWIM7	chr17:15879877-15903006:-	-0.33	-8.62	1.0E-16	Amyotrophic lateral sclerosis	
THCA	cis	1	rs74783281	chr16:77781601	NUDT7	chr16:77756411-77776153:+	0.35	4.83	1.86E-6	Obesity-related traits	
THCA	cis	1	rs74785791	chr7:1088494	ZFAND2A	chr7:1192544-1199855:-	-0.37	-5.37	1.24E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs7480278	chr11:116809789	PCSK7	chr11:117075789-117102811:-	0.46	5.6	3.67E-8	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs74805725	chr16:77784484	NUDT7	chr16:77756411-77776153:+	0.36	5.02	7.33E-7	Obesity-related traits	
THCA	cis	1	rs7481312	chr11:46596674	PACSIN3	chr11:47199085-47207958:-	0.18	3.92	0.000101	Schizophrenia	
THCA	cis	1	rs7481993	chr11:237875	PSMD13	chr11:236808-252984:+	-0.22	-6.75	4.25E-11	Menarche (age at onset)	
THCA	cis	1	rs7481993	chr11:237875	SIRT3	chr11:214625-236931:-	0.12	3.38	0.000785	Menarche (age at onset)	
THCA	cis	1	rs74825034	chr1:27095132	PIGV	chr1:27114455-27124886:+	-0.29	-3.39	0.000755	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs74825034	chr1:27095132	ZDHHC18	chr1:27153201-27182207:+	0.8	8.61	1.03E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs7482591	chr11:245861	PSMD13	chr11:236808-252984:+	-0.22	-6.73	4.91E-11	Menarche (age at onset)	
THCA	cis	1	rs7482591	chr11:245861	SIRT3	chr11:214625-236931:-	0.12	3.37	0.000812	Menarche (age at onset)	
THCA	cis	1	rs74834816	chr3:58321828	PXK	chr3:58318617-58410878:+	0.38	6.49	2.13E-10	Cholesterol, total	
THCA	cis	1	rs7483951	chr11:231758	PSMD13	chr11:236808-252984:+	-0.22	-6.75	4.25E-11	Menarche (age at onset)	
THCA	cis	1	rs7483951	chr11:231758	SIRT3	chr11:214625-236931:-	0.12	3.38	0.000785	Menarche (age at onset)	
THCA	cis	1	rs7484002	chr11:46640503	PACSIN3	chr11:47199085-47207958:-	0.17	3.92	0.000103	Schizophrenia	
THCA	cis	1	rs748404	chr15:43559231	STRC	chr15:43891762-43924561:-	0.29	5.9	6.72E-9	Lung cancer	
THCA	cis	1	rs74858697	chr4:17963076	DCAF16	chr4:17802280-17812381:-	-0.22	-4.42	1.25E-5	Height	
THCA	cis	1	rs74881320	chr11:116765925	PCSK7	chr11:117075789-117102811:-	0.43	5.23	2.51E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs74887741	chr7:1110658	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.69	2.27E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs74894249	chr15:66818647	TIPIN	chr15:66629008-66649054:-	-0.35	-3.46	0.000588	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs74900588	chr6:170102180	C6orf70	chr6:170151721-170181617:+	0.25	5.07	5.64E-7	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs74900588	chr6:170102180	WDR27	chr6:169857307-170102159:-	-0.19	-5.96	4.77E-9	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs74916804	chr3:57989395	PDHB	chr3:58413355-58419565:-	-0.15	-3.5	0.000504	Optic cup area	
THCA	cis	1	rs74917833	chr4:106643161	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs7492600	chr14:55336875	GCH1	chr14:55308724-55369542:-	-0.21	-4.46	1.03E-5	Rheumatoid arthritis;Obesity-related traits	
THCA	cis	1	rs74927399	chr11:116846266	PCSK7	chr11:117075789-117102811:-	0.43	5.18	3.29E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs7494918	chr15:24833624	PWRN1	chr15:24778839-24832924:+	0.39	8.23	1.78E-15	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
THCA	cis	1	rs7495122	chr15:24833611	PWRN1	chr15:24778839-24832924:+	0.39	8.23	1.78E-15	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
THCA	cis	1	rs74955473	chr5:150174558	LOC134466	chr5:150310000-150326146:-	0.44	5.72	1.89E-8	Crohn's disease	
THCA	cis	1	rs74955473	chr5:150174558	ZNF300	chr5:150273964-150284391:-	0.19	3.75	0.000197	Crohn's disease	
THCA	cis	1	rs74957607	chr2:207583731	MDH1B	chr2:207598943-207630050:-	0.39	4.72	3.05E-6	Episodic memory	
THCA	cis	1	rs7496335	chr15:65758868	DPP8	chr15:65737999-65810035:-	-0.1	-4.24	2.7E-5	Mean corpuscular hemoglobin	
THCA	cis	1	rs7496335	chr15:65758868	SLC24A1	chr15:65903704-65953256:+	-0.17	-4.12	4.52E-5	Mean corpuscular hemoglobin	
THCA	cis	1	rs74963873	chr4:17970326	DCAF16	chr4:17802280-17812381:-	-0.22	-4.4	1.35E-5	Height	
THCA	cis	1	rs7496814	chr15:84584959	LOC388152	chr15:84867600-84898920:-	-0.21	-3.98	7.86E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs7496954	chr15:83345536	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.14	4.46	1.03E-5	Schizophrenia	
THCA	cis	1	rs74975304	chr6:110094039	AKD1	chr6:109814059-110012415:-	-0.44	-6.59	1.13E-10	Hematological parameters	
THCA	cis	1	rs74975304	chr6:110094039	FIG4	chr6:110012424-110146634:+	-0.29	-4.03	6.37E-5	Hematological parameters	
THCA	cis	1	rs74984113	chr4:250522	ZNF718	chr4:53272-156488:+	0.5	9.35	3.49E-19	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs74984740	chr2:17796007	GEN1	chr2:17935162-17966632:+	0.6	6.99	9.04E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs7499306	chr16:20555474	ACSM1	chr16:20634559-20709066:-	0.48	4.26	2.47E-5	Serum metabolite levels	
THCA	cis	1	rs75010364	chr11:18448966	LDHC	chr11:18433853-18472792:+	-0.31	-3.77	0.000186	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs75016635	chr7:1094121	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.5	6.04E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs75017201	chr10:96055152	TMEM20	chr10:95653730-95713998:+	-0.17	-3.36	0.00085	Sudden cardiac arrest	
THCA	cis	1	rs750192	chr13:78390743	EDNRB	chr13:78469616-78549664:-	0.14	4.12	4.44E-5	Hair color	
THCA	cis	1	rs7503679	chr17:79583843	ARL16	chr17:79648234-79650954:-	-0.12	-3.39	0.000745	Eye color traits	
THCA	cis	1	rs7503679	chr17:79583843	TSPAN10	chr17:79609349-79615778:+	0.8	17.82	7.25E-55	Eye color traits	
THCA	cis	1	rs750450	chr2:26324631	GPR113	chr2:26531041-26569685:-	-0.42	-6.74	4.47E-11	Gut microbiome composition (summer)	
THCA	cis	1	rs750451	chr2:26324241	GPR113	chr2:26531041-26569685:-	-0.42	-6.67	7.27E-11	Gut microbiome composition (summer)	
THCA	cis	1	rs750452	chr2:26324995	GPR113	chr2:26531041-26569685:-	-0.42	-6.71	5.42E-11	Gut microbiome composition (summer)	
THCA	cis	1	rs7504595	chr18:23735213	SS18	chr18:23596219-23671164:-	0.28	3.51	0.000493	Rhegmatogenous retinal detachment	
THCA	cis	1	rs750472	chr8:145701453	KIFC2	chr8:145691738-145699498:+	-0.15	-4.47	9.72E-6	Age at first birth	
THCA	cis	1	rs750472	chr8:145701453	LRRC14	chr8:145743391-145750557:+	0.16	4.38	1.43E-5	Age at first birth	
THCA	cis	1	rs750472	chr8:145701453	RECQL4	chr8:145736672-145743200:-	0.15	3.45	0.000608	Age at first birth	
THCA	cis	1	rs750472	chr8:145701453	ZNF34	chr8:145998503-146012725:-	0.14	3.7	0.000237	Age at first birth	
THCA	cis	1	rs750474	chr3:53085280	RFT1	chr3:53122503-53164470:-	0.58	7.76	5.27E-14	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs75059851	chr11:133822569	IGSF9B	chr11:133785186-133826880:-	0.25	5.03	7.0E-7	Schizophrenia	
THCA	cis	1	rs75059851	chr11:133822569	LOC283174	chr11:133766330-133771635:-	0.22	4.01	6.91E-5	Schizophrenia	
THCA	cis	1	rs750625	chr8:41525914	ANK1	chr8:41510745-41754280:-	-0.22	-4.55	6.86E-6	Type 2 diabetes	
THCA	cis	1	rs75063298	chr10:102213600	SEC31B	chr10:102246403-102289636:-	-0.3	-10.21	2.82E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs75071288	chr5:150224379	LOC134466	chr5:150310000-150326146:-	0.39	5.45	8.07E-8	Crohn's disease	
THCA	cis	1	rs75080838	chr5:115557467	COMMD10	chr5:115420727-115628978:+	0.48	5.7	2.09E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs75083896	chr4:154719082	RNF175	chr4:154631313-154681387:-	-0.19	-4	7.43E-5	Electrocardiographic conduction measures	
THCA	cis	1	rs75085043	chr5:109729109	TMEM232	chr5:109624934-110062381:-	0.42	4.6	5.5E-6	Cardiac structure and function	
THCA	cis	1	rs75085794	chr13:28095944	MTIF3	chr13:28009783-28024711:-	0.19	3.69	0.000253	Weight	
THCA	cis	1	rs7508679	chr19:7222832	ZNF557	chr19:7069471-7087976:+	-0.18	-3.77	0.000182	Triglycerides	
THCA	cis	1	rs75092650	chr4:106523436	INTS12	chr4:106603787-106629881:-	-0.59	-4.78	2.3E-6	Post bronchodilator FEV1	
THCA	cis	1	rs751075	chr3:51377300	HEMK1	chr3:50606583-50622419:+	0.2	4.21	3.08E-5	Melanoma	
THCA	cis	1	rs751075	chr3:51377300	TEX264	chr3:51705222-51738338:+	-0.23	-6.19	1.26E-9	Melanoma	
THCA	cis	1	rs75108039	chr11:93717552	HEPHL1	chr11:93754378-93847374:+	0.43	3.48	0.000553	Obesity-related traits	
THCA	cis	1	rs75109362	chr2:86289889	POLR1A	chr2:86253453-86333278:-	-0.34	-4.48	9.18E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs751095	chr6:33742718	IP6K3	chr6:33689443-33714762:-	0.41	6.74	4.57E-11	Obesity (extreme)	
THCA	cis	1	rs751096	chr6:33742838	LEMD2	chr6:33738991-33756906:-	-0.27	-5.15	3.76E-7	Body mass index	
THCA	cis	1	rs7511868	chr1:161463331	FCGR2C	chr1:161551129-161570031:+	-0.11	-4.17	3.59E-5	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	
THCA	cis	1	rs7511962	chr1:247212122	OR2T8	chr1:248084320-248085256:+	-0.18	-3.43	0.000647	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs7511962	chr1:247212122	OR2W3	chr1:248031265-248060142:+	-0.18	-3.57	0.00039	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs7511962	chr1:247212122	TRIM58	chr1:248020501-248043436:+	-0.15	-3.35	0.000879	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs7512150	chr1:247212326	OR2T8	chr1:248084320-248085256:+	-0.19	-3.64	0.000299	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs7512150	chr1:247212326	OR2W3	chr1:248031265-248060142:+	-0.17	-3.34	0.000889	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs7512422	chr1:207508950	CD55	chr1:207494817-207534309:+	0.15	6.55	1.47E-10	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs75125154	chr1:108363526	VAV3	chr1:108113782-108507545:-	0.56	8.05	6.61E-15	Hypothyroidism	
THCA	cis	1	rs7512552	chr1:150265704	C1orf54	chr1:150244773-150253325:+	0.1	3.62	0.000325	Atopic dermatitis	
THCA	cis	1	rs7512552	chr1:150265704	TARS2	chr1:150459920-150479747:+	0.13	3.37	0.00081	Atopic dermatitis	
THCA	cis	1	rs7513559	chr1:76173744	MSH4	chr1:76262630-76378923:+	0.25	4.2	3.16E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs75136686	chr7:107180949	DLD	chr7:107531586-107561642:+	0.14	3.5	0.00051	Osteoarthritis	
THCA	cis	1	rs75141346	chr2:203685119	ALS2CR8	chr2:203776978-203851060:+	-0.27	-5.22	2.61E-7	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs75141346	chr2:203685119	ICA1L	chr2:203637873-203736371:-	0.28	4.58	6.06E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs7514501	chr1:200833649	DDX59	chr1:200610119-200639126:-	-0.22	-3.42	0.000687	Epilepsy	
THCA	cis	1	rs75145948	chr8:89394233	MMP16	chr8:89049462-89339717:-	0.31	4.88	1.48E-6	Electrodermal activity	
THCA	cis	1	rs7515491	chr1:46355079	CCDC163P	chr1:45960581-45965646:-	-0.5	-9.64	3.37E-20	Body mass index	
THCA	cis	1	rs7515491	chr1:46355079	GPBP1L1	chr1:46092978-46152302:-	0.16	4.09	5.0E-5	Body mass index	
THCA	cis	1	rs7515491	chr1:46355079	MMACHC	chr1:45965856-45976737:+	-0.2	-4.34	1.73E-5	Body mass index	
THCA	cis	1	rs7515491	chr1:46355079	MUTYH	chr1:45794915-45806142:-	0.31	8.37	6.21E-16	Body mass index	
THCA	cis	1	rs75156726	chr4:106677999	INTS12	chr4:106603787-106629881:-	-0.62	-5.3	1.78E-7	Post bronchodilator FEV1	
THCA	cis	1	rs7516226	chr1:76234257	ACADM	chr1:76190043-76229353:+	0.13	3.45	0.000607	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs7516226	chr1:76234257	MSH4	chr1:76262630-76378923:+	0.26	4.34	1.77E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs75165171	chr20:33651453	PROCR	chr20:33758727-33765164:+	-0.34	-5.45	8.29E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs75165171	chr20:33651453	TRPC4AP	chr20:33590215-33680618:-	0.33	3.93	9.8E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs75166090	chr2:203692760	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.66	2.61E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs75166090	chr2:203692760	ICA1L	chr2:203637873-203736371:-	0.27	4.43	1.15E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs7516616	chr1:47186274	CYP4B1	chr1:47264670-47285020:+	-0.23	-3.5	0.000509	Response to hepatitis C treatment	
THCA	cis	1	rs7516616	chr1:47186274	CYP4Z1	chr1:47533160-47583992:+	-0.27	-3.94	9.46E-5	Response to hepatitis C treatment	
THCA	cis	1	rs7516616	chr1:47186274	DMBX1	chr1:46972668-46979884:+	-0.23	-3.8	0.000163	Response to hepatitis C treatment	
THCA	cis	1	rs7516739	chr1:180948506	MR1	chr1:181003139-181024633:+	-0.12	-3.39	0.000761	Progressive supranuclear palsy	
THCA	cis	1	rs7516739	chr1:180948506	STX6	chr1:180913175-180992046:-	-0.2	-4.08	5.22E-5	Progressive supranuclear palsy	
THCA	cis	1	rs751728	chr6:33764033	LEMD2	chr6:33738991-33756906:-	-0.29	-6.89	1.81E-11	Crohn's disease	
THCA	cis	1	rs7517314	chr1:31861187	ZCCHC17	chr1:31769842-31837780:+	-0.31	-6.02	3.47E-9	Schizophrenia	
THCA	cis	1	rs75178169	chr2:190568752	ASNSD1	chr2:190526125-190535556:+	-0.69	-6.66	7.72E-11	Subcutaneous adipose tissue	
THCA	cis	1	rs7518038	chr1:76154430	ACADM	chr1:76190043-76229353:+	0.12	3.39	0.000753	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs7518038	chr1:76154430	MSH4	chr1:76262630-76378923:+	0.23	3.86	0.000129	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs75181745	chr2:88520408	KRCC1	chr2:88326724-88355248:-	-0.23	-3.71	0.000233	Plasma clusterin levels	
THCA	cis	1	rs75181745	chr2:88520408	THNSL2	chr2:88469835-88486145:+	-0.67	-8.56	1.59E-16	Plasma clusterin levels	
THCA	cis	1	rs75183624	chr3:184777207	C3orf70	chr3:184795840-184870802:-	-0.25	-4.89	1.37E-6	Heschl's gyrus morphology	
THCA	cis	1	rs7518565	chr1:207420343	CD55	chr1:207494817-207534309:+	0.19	7.47	3.96E-13	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs75185853	chr11:46751401	ZNF408	chr11:46722368-46727461:+	-0.18	-3.56	0.000405	HDL cholesterol	
THCA	cis	1	rs7518849	chr1:65948791	LEPR	chr1:65886318-66102820:+	-0.27	-3.88	0.000118	Obesity (early onset extreme)	
THCA	cis	1	rs75192006	chr13:96303624	DZIP1	chr13:96229329-96296957:-	0.2	3.78	0.000176	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
THCA	cis	1	rs75192006	chr13:96303624	UGGT2	chr13:96453838-96705736:-	-0.25	-3.78	0.000178	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
THCA	cis	1	rs75192957	chr5:176978967	DOK3	chr5:176928915-176937427:-	0.28	6.02	3.55E-9	Alzheimer disease and age of onset	
THCA	cis	1	rs75197893	chr3:184640870	C3orf70	chr3:184795840-184870802:-	-0.23	-4.6	5.44E-6	Heschl's gyrus morphology	
THCA	cis	1	rs7519795	chr1:247212126	OR2T8	chr1:248084320-248085256:+	-0.18	-3.43	0.000647	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs7519795	chr1:247212126	OR2W3	chr1:248031265-248060142:+	-0.18	-3.57	0.00039	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs7519795	chr1:247212126	TRIM58	chr1:248020501-248043436:+	-0.15	-3.35	0.000879	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs7520651	chr1:10329872	KIF1B	chr1:10270764-10441659:+	0.21	6.41	3.45E-10	Hepatocellular carcinoma	
THCA	cis	1	rs7520780	chr1:200710186	DDX59	chr1:200610119-200639126:-	-0.27	-4.13	4.35E-5	Epilepsy	
THCA	cis	1	rs7520935	chr1:10354271	KIF1B	chr1:10270764-10441659:+	0.21	6.51	1.9E-10	Hepatocellular carcinoma	
THCA	cis	1	rs75212922	chr11:116856992	PCSK7	chr11:117075789-117102811:-	0.45	5.37	1.24E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs7521457	chr1:207457147	CD55	chr1:207494817-207534309:+	0.19	7.69	8.48E-14	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs75217232	chr3:53132373	RFT1	chr3:53122503-53164470:-	0.61	7.4	6.29E-13	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs7521902	chr1:22490724	WNT4	chr1:22443800-22470385:-	-0.15	-3.68	0.000256	Bone mineral density;Endometriosis;Ovarian cancer	
THCA	cis	1	rs7522601	chr1:46419021	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.14	5.21E-22	Body mass index	
THCA	cis	1	rs7522601	chr1:46419021	GPBP1L1	chr1:46092978-46152302:-	0.15	3.83	0.000146	Body mass index	
THCA	cis	1	rs7522601	chr1:46419021	MMACHC	chr1:45965856-45976737:+	-0.21	-4.57	6.3E-6	Body mass index	
THCA	cis	1	rs7522601	chr1:46419021	MUTYH	chr1:45794915-45806142:-	0.3	8.13	3.66E-15	Body mass index	
THCA	cis	1	rs7522618	chr1:207417426	CD55	chr1:207494817-207534309:+	0.19	7.43	5.15E-13	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs7522701	chr1:207410965	CD55	chr1:207494817-207534309:+	0.14	6.44	2.86E-10	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs7522705	chr1:45992300	AKR1A1	chr1:46016498-46035720:+	0.13	3.67	0.00027	Homocysteine levels	
THCA	cis	1	rs7522705	chr1:45992300	CCDC163P	chr1:45960581-45965646:-	1.01	27.44	3.18E-100	Homocysteine levels	
THCA	cis	1	rs7522705	chr1:45992300	MUTYH	chr1:45794915-45806142:-	-0.2	-4.78	2.33E-6	Homocysteine levels	
THCA	cis	1	rs7522705	chr1:45992300	PRDX1	chr1:45976708-45987609:-	0.38	9.95	2.59E-21	Homocysteine levels	
THCA	cis	1	rs7522948	chr1:156275308	BGLAP	chr1:156182784-156213112:+	0.23	5.4	1.05E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs7522948	chr1:156275308	C1orf85	chr1:156259882-156265449:-	-0.18	-4.17	3.63E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs7522948	chr1:156275308	CCT3	chr1:156278752-156308195:-	-0.32	-6.87	2.02E-11	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THCA	cis	1	rs7523455	chr1:19332076	TMCO4	chr1:20008707-20126758:-	0.15	3.54	0.000432	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
THCA	cis	1	rs7524467	chr1:76194054	ACADM	chr1:76190043-76229353:+	0.14	3.73	0.000216	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs7524467	chr1:76194054	MSH4	chr1:76262630-76378923:+	0.24	4.06	5.68E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs7524495	chr1:46266932	CCDC163P	chr1:45960581-45965646:-	-0.51	-10	1.64E-21	Body mass index	
THCA	cis	1	rs7524495	chr1:46266932	GPBP1L1	chr1:46092978-46152302:-	0.16	4.03	6.53E-5	Body mass index	
THCA	cis	1	rs7524495	chr1:46266932	MMACHC	chr1:45965856-45976737:+	-0.19	-4.25	2.57E-5	Body mass index	
THCA	cis	1	rs7524495	chr1:46266932	MUTYH	chr1:45794915-45806142:-	0.31	8.35	7.39E-16	Body mass index	
THCA	cis	1	rs75247012	chr8:89465349	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs752584	chr10:111682934	DUSP5	chr10:112257625-112271300:+	-0.14	-3.67	0.000266	Biliary atresia	
THCA	cis	1	rs7526103	chr1:200833217	DDX59	chr1:200610119-200639126:-	-0.22	-3.42	0.000687	Epilepsy	
THCA	cis	1	rs752621	chr17:61901880	FTSJ3	chr17:61896795-61905031:-	0.3	5.61	3.5E-8	Body mass index	
THCA	cis	1	rs752621	chr17:61901880	MAP3K3	chr17:61699775-61773669:+	0.26	5.18	3.23E-7	Body mass index	
THCA	cis	1	rs7526831	chr1:207438606	CD55	chr1:207494817-207534309:+	0.19	7.39	6.82E-13	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs7526831	chr1:207438606	CR1	chr1:207669473-207815109:+	-0.14	-3.45	0.000613	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs75278386	chr15:40678312	C15orf23	chr15:40674922-40686488:+	0.67	9.23	8.73E-19	Heschl's gyrus morphology	
THCA	cis	1	rs75278386	chr15:40678312	IVD	chr15:40697686-40713512:+	-0.55	-9.94	2.76E-21	Heschl's gyrus morphology	
THCA	cis	1	rs7528526	chr1:180948574	MR1	chr1:181003139-181024633:+	-0.12	-3.39	0.000761	Progressive supranuclear palsy	
THCA	cis	1	rs7528526	chr1:180948574	STX6	chr1:180913175-180992046:-	-0.2	-4.08	5.22E-5	Progressive supranuclear palsy	
THCA	cis	1	rs7528684	chr1:157670816	FCRL3	chr1:157646278-157670775:-	0.27	8.57	1.42E-16	Type 1 diabetes autoantibodies	
THCA	cis	1	rs75287019	chr20:33721261	PROCR	chr20:33758727-33765164:+	-0.32	-5.22	2.66E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs75287019	chr20:33721261	TRPC4AP	chr20:33590215-33680618:-	0.3	3.72	0.000222	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs75294699	chr11:116749072	PCSK7	chr11:117075789-117102811:-	0.44	5.3	1.74E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs75294883	chr5:150196503	LOC134466	chr5:150310000-150326146:-	0.43	5.36	1.31E-7	Crohn's disease	
THCA	cis	1	rs75294883	chr5:150196503	ZNF300	chr5:150273964-150284391:-	0.18	3.52	0.000464	Crohn's disease	
THCA	cis	1	rs7530167	chr1:10453374	KIF1B	chr1:10270764-10441659:+	0.21	6.52	1.77E-10	Hepatocellular carcinoma	
THCA	cis	1	rs753050	chr14:52505375	C14orf166	chr14:52456228-52471419:+	-0.14	-4.13	4.34E-5	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs753051	chr14:52505360	C14orf166	chr14:52456228-52471419:+	-0.14	-4.1	4.92E-5	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs75306531	chr7:127151869	GRM8	chr7:126078652-126893147:-	-0.34	-3.47	0.000569	Medication adherence in chronic diseases	
THCA	cis	1	rs75309929	chr2:88524377	KRCC1	chr2:88326724-88355248:-	-0.23	-3.7	0.000239	Plasma clusterin levels	
THCA	cis	1	rs75309929	chr2:88524377	THNSL2	chr2:88469835-88486145:+	-0.67	-8.61	1.05E-16	Plasma clusterin levels	
THCA	cis	1	rs7531202	chr1:110616474	ALX3	chr1:110602998-110613322:-	-0.32	-7.79	4.32E-14	Blood metabolite levels	
THCA	cis	1	rs753129	chr4:56668431	EXOC1	chr4:56719816-56771244:+	0.22	4.3	2.03E-5	Psychosis in Alzheimer's disease	
THCA	cis	1	rs75321546	chr12:124447465	ZNF664	chr12:124457670-124499967:+	-0.18	-5.07	5.57E-7	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs75324925	chr2:203698300	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.67	2.47E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs75324925	chr2:203698300	ICA1L	chr2:203637873-203736371:-	0.27	4.41	1.26E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs7532615	chr1:121172840	HIST2H2BA	chr1:120906034-120914842:+	-0.23	-5.09	5.14E-7	Hip geometry	
THCA	cis	1	rs7532664	chr1:207426943	CD55	chr1:207494817-207534309:+	0.19	7.47	3.96E-13	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs7532866	chr1:26741544	CNKSR1	chr1:26503981-26516373:+	0.13	3.53	0.000455	Height	
THCA	cis	1	rs7533623	chr1:110616475	ALX3	chr1:110602998-110613322:-	-0.32	-7.86	2.56E-14	Blood metabolite levels	
THCA	cis	1	rs7533888	chr1:76160449	ACADM	chr1:76190043-76229353:+	0.12	3.38	0.000783	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs7533888	chr1:76160449	MSH4	chr1:76262630-76378923:+	0.24	4.12	4.42E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs75339672	chr1:183191898	RNASEL	chr1:182542772-182558391:-	0.32	3.46	0.000579	Systemic lupus erythematosus and Systemic sclerosis	
THCA	cis	1	rs7534177	chr1:65965720	LEPR	chr1:65886318-66102820:+	-0.27	-3.85	0.000132	Obesity (early onset extreme)	
THCA	cis	1	rs7534392	chr1:31863595	ZCCHC17	chr1:31769842-31837780:+	-0.3	-5.66	2.61E-8	Schizophrenia	
THCA	cis	1	rs7534465	chr1:31863663	ZCCHC17	chr1:31769842-31837780:+	-0.3	-5.69	2.24E-8	Schizophrenia	
THCA	cis	1	rs7534467	chr1:45988691	AKR1A1	chr1:46016498-46035720:+	-0.14	-3.91	0.000108	Homocysteine levels	
THCA	cis	1	rs7534467	chr1:45988691	CCDC163P	chr1:45960581-45965646:-	-1.1	-31.76	7.21E-120	Homocysteine levels	
THCA	cis	1	rs7534467	chr1:45988691	MUTYH	chr1:45794915-45806142:-	0.21	5.1	4.79E-7	Homocysteine levels	
THCA	cis	1	rs7534467	chr1:45988691	PRDX1	chr1:45976708-45987609:-	-0.4	-10.2	3.08E-22	Homocysteine levels	
THCA	cis	1	rs7534624	chr1:22494627	HSPC157	chr1:22351707-22357713:+	0.22	4.1	4.92E-5	Obesity-related traits	
THCA	cis	1	rs7534754	chr1:76185308	ACADM	chr1:76190043-76229353:+	0.13	3.49	0.000531	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs7534754	chr1:76185308	MSH4	chr1:76262630-76378923:+	0.24	4.07	5.48E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs7535475	chr1:161463587	FCGR2C	chr1:161551129-161570031:+	0.11	4.03	6.42E-5	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	
THCA	cis	1	rs7535532	chr1:207438336	CD55	chr1:207494817-207534309:+	0.19	7.52	2.67E-13	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs75358288	chr6:55987364	COL21A1	chr6:55921389-56258892:-	-0.67	-8.28	1.22E-15	Psychosis (atypical)	
THCA	cis	1	rs7536557	chr1:45992114	AKR1A1	chr1:46016498-46035720:+	-0.13	-3.67	0.000272	Homocysteine levels	
THCA	cis	1	rs7536557	chr1:45992114	CCDC163P	chr1:45960581-45965646:-	-1.01	-27.64	3.57E-101	Homocysteine levels	
THCA	cis	1	rs7536557	chr1:45992114	MUTYH	chr1:45794915-45806142:-	0.2	4.95	1.05E-6	Homocysteine levels	
THCA	cis	1	rs7536557	chr1:45992114	PRDX1	chr1:45976708-45987609:-	-0.38	-9.85	5.85E-21	Homocysteine levels	
THCA	cis	1	rs753760	chr6:166046483	PDE10A	chr6:165740779-166075584:-	-0.24	-4.86	1.62E-6	Thyroid hormone levels	
THCA	cis	1	rs75381502	chr11:18451886	LDHC	chr11:18433853-18472792:+	-0.31	-3.71	0.000236	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs75382989	chr1:108356935	VAV3	chr1:108113782-108507545:-	0.56	8.05	6.61E-15	Hypothyroidism	
THCA	cis	1	rs7539932	chr1:46292354	CCDC163P	chr1:45960581-45965646:-	-0.51	-10.03	1.26E-21	Body mass index	
THCA	cis	1	rs7539932	chr1:46292354	GPBP1L1	chr1:46092978-46152302:-	0.16	4.07	5.44E-5	Body mass index	
THCA	cis	1	rs7539932	chr1:46292354	MMACHC	chr1:45965856-45976737:+	-0.19	-4.28	2.24E-5	Body mass index	
THCA	cis	1	rs7539932	chr1:46292354	MUTYH	chr1:45794915-45806142:-	0.31	8.34	7.9E-16	Body mass index	
THCA	cis	1	rs75399471	chr1:76339092	ACADM	chr1:76190043-76229353:+	-0.21	-3.58	0.000378	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs75399471	chr1:76339092	ST6GALNAC3	chr1:76540389-77096669:+	-0.3	-3.48	0.000552	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs7540325	chr1:46338217	CCDC163P	chr1:45960581-45965646:-	-0.51	-10.06	9.97E-22	Body mass index	
THCA	cis	1	rs7540325	chr1:46338217	GPBP1L1	chr1:46092978-46152302:-	0.16	4.06	5.77E-5	Body mass index	
THCA	cis	1	rs7540325	chr1:46338217	MMACHC	chr1:45965856-45976737:+	-0.2	-4.32	1.87E-5	Body mass index	
THCA	cis	1	rs7540325	chr1:46338217	MUTYH	chr1:45794915-45806142:-	0.31	8.43	4.17E-16	Body mass index	
THCA	cis	1	rs75408336	chr1:179459485	C1orf125	chr1:179335107-179523868:+	0.58	6.12	1.94E-9	Multiple sclerosis (age of onset)	
THCA	cis	1	rs75410648	chr11:116813438	PCSK7	chr11:117075789-117102811:-	0.46	5.6	3.67E-8	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs75418383	chr4:154719084	RNF175	chr4:154631313-154681387:-	-0.19	-4	7.43E-5	Electrocardiographic conduction measures	
THCA	cis	1	rs75422257	chr8:119842831	TNFRSF11B	chr8:119935797-119964383:-	-0.29	-3.58	0.000383	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs7543089	chr1:107591693	NTNG1	chr1:107682629-108024471:+	0.2	3.5	0.000506	AIDS	
THCA	cis	1	rs7543117	chr1:207438696	CD55	chr1:207494817-207534309:+	0.19	7.52	2.67E-13	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs7543250	chr1:207425043	CD55	chr1:207494817-207534309:+	-0.14	-6.27	8.08E-10	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs75439527	chr2:48388666	FOXN2	chr2:48541795-48606434:+	0.24	4.25	2.54E-5	Schizophrenia	
THCA	cis	1	rs75444304	chr15:90894246	IQGAP1	chr15:90931473-91045475:+	0.12	4.04	6.31E-5	Rheumatoid arthritis	
THCA	cis	1	rs75444304	chr15:90894246	TTLL13	chr15:90792764-90815443:+	0.18	3.39	0.000747	Rheumatoid arthritis	
THCA	cis	1	rs754466	chr10:79680434	DLG5	chr10:79550551-79686348:-	0.22	3.91	0.000106	Liver enzyme levels (gamma-glutamyl transferase)	
THCA	cis	1	rs7545125	chr1:207424727	CD55	chr1:207494817-207534309:+	0.16	6.86	2.2E-11	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs7546304	chr1:151114484	BNIPL	chr1:151009029-151020076:+	-0.18	-3.66	0.00028	Body mass index	
THCA	cis	1	rs7546342	chr1:247213292	OR2T8	chr1:248084320-248085256:+	-0.19	-3.64	0.000299	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs7546342	chr1:247213292	OR2W3	chr1:248031265-248060142:+	-0.17	-3.34	0.000889	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs7547522	chr1:47179918	CYP4B1	chr1:47264670-47285020:+	0.22	3.42	0.000687	Response to hepatitis C treatment	
THCA	cis	1	rs7547522	chr1:47179918	CYP4Z1	chr1:47533160-47583992:+	0.27	4.04	6.34E-5	Response to hepatitis C treatment	
THCA	cis	1	rs7547522	chr1:47179918	DMBX1	chr1:46972668-46979884:+	0.23	4	7.19E-5	Response to hepatitis C treatment	
THCA	cis	1	rs7548463	chr1:207502891	CD55	chr1:207494817-207534309:+	0.15	6.6	1.11E-10	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs75487138	chr11:18461878	LDHC	chr11:18433853-18472792:+	-0.33	-3.93	9.81E-5	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs75488469	chr7:1102122	ZFAND2A	chr7:1192544-1199855:-	-0.37	-5.52	5.72E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs7548962	chr1:76139266	MSH4	chr1:76262630-76378923:+	0.25	4.19	3.29E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs7549410	chr1:247214167	OR2T8	chr1:248084320-248085256:+	-0.18	-3.43	0.000647	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs7549410	chr1:247214167	OR2W3	chr1:248031265-248060142:+	-0.18	-3.57	0.00039	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs7549410	chr1:247214167	TRIM58	chr1:248020501-248043436:+	-0.15	-3.35	0.000879	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs7550746	chr1:46351719	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.29	1.45E-22	Body mass index	
THCA	cis	1	rs7550746	chr1:46351719	GPBP1L1	chr1:46092978-46152302:-	0.15	3.96	8.67E-5	Body mass index	
THCA	cis	1	rs7550746	chr1:46351719	MMACHC	chr1:45965856-45976737:+	-0.2	-4.44	1.1E-5	Body mass index	
THCA	cis	1	rs7550746	chr1:46351719	MUTYH	chr1:45794915-45806142:-	0.31	8.5	2.46E-16	Body mass index	
THCA	cis	1	rs755109	chr9:100696203	C9orf156	chr9:100666772-100684852:-	0.14	3.64	0.000301	Quantitative traits	
THCA	cis	1	rs7551124	chr1:23785760	ASAP3	chr1:23755056-23811057:-	0.31	5.08	5.56E-7	Cholesterol, total	
THCA	cis	1	rs7551124	chr1:23785760	TCEA3	chr1:23707555-23751261:-	0.24	4.42	1.25E-5	Cholesterol, total	
THCA	cis	1	rs7551345	chr1:31831870	SNRNP40	chr1:31732417-31769644:-	-0.17	-3.36	0.000833	Schizophrenia	
THCA	cis	1	rs7551345	chr1:31831870	ZCCHC17	chr1:31769842-31837780:+	-0.33	-6.35	5.0E-10	Schizophrenia	
THCA	cis	1	rs75514524	chr2:42277179	COX7A2L	chr2:42577647-42596150:-	0.19	3.35	0.000866	Atopy	
THCA	cis	1	rs7551732	chr1:89139041	CCBL2	chr1:89401456-89458643:-	0.63	13.75	1.73E-36	Height	
THCA	cis	1	rs75518097	chr19:52026510	SIGLEC6	chr19:52022784-52035064:-	-0.31	-3.92	0.0001	Carotid intima media thickness	
THCA	cis	1	rs75518097	chr19:52026510	ZNF175	chr19:52074531-52092990:+	-0.39	-4.83	1.82E-6	Carotid intima media thickness	
THCA	cis	1	rs7552404	chr1:76135946	MSH4	chr1:76262630-76378923:+	0.25	4.22	2.88E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs7553157	chr1:207457267	CD55	chr1:207494817-207534309:+	0.19	7.69	8.48E-14	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs75532475	chr15:66832466	TIPIN	chr15:66629008-66649054:-	-0.37	-3.6	0.000352	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs7553330	chr1:180956015	MR1	chr1:181003139-181024633:+	-0.13	-3.62	0.000324	Progressive supranuclear palsy	
THCA	cis	1	rs7553330	chr1:180956015	STX6	chr1:180913175-180992046:-	-0.2	-4.03	6.43E-5	Progressive supranuclear palsy	
THCA	cis	1	rs7553339	chr1:207457420	CD55	chr1:207494817-207534309:+	0.19	7.69	8.48E-14	Posterior cortical atrophy and Alzheimer's disease	
THCA	cis	1	rs75535620	chr20:33601498	PROCR	chr20:33758727-33765164:+	-0.36	-5.75	1.55E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs75535620	chr20:33601498	TRPC4AP	chr20:33590215-33680618:-	0.32	3.88	0.000118	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs75537616	chr20:33592588	PROCR	chr20:33758727-33765164:+	-0.36	-5.75	1.55E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs75537616	chr20:33592588	TRPC4AP	chr20:33590215-33680618:-	0.32	3.88	0.000118	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs755495	chr6:33734128	LEMD2	chr6:33738991-33756906:-	-0.24	-4.82	1.91E-6	Body mass index	
THCA	cis	1	rs755496	chr6:33734376	LEMD2	chr6:33738991-33756906:-	-0.3	-6.83	2.52E-11	Crohn's disease	
THCA	cis	1	rs7555030	chr1:207508730	CD55	chr1:207494817-207534309:+	0.15	6.55	1.47E-10	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs7555523	chr1:165718979	ALDH9A1	chr1:165631449-165667900:-	0.25	5.4	1.07E-7	Glaucoma (high intraocular pressure);Intraocular pressure	
THCA	cis	1	rs755587	chr20:47720957	ARFGEF2	chr20:47538275-47653229:+	-0.13	-4.09	5.13E-5	Anger	
THCA	cis	1	rs755587	chr20:47720957	CSE1L	chr20:47662838-47713484:+	0.41	10.23	2.32E-22	Anger	
THCA	cis	1	rs755589	chr20:47721385	ARFGEF2	chr20:47538275-47653229:+	-0.12	-3.71	0.000233	Anger	
THCA	cis	1	rs755589	chr20:47721385	CSE1L	chr20:47662838-47713484:+	0.41	9.98	1.91E-21	Anger	
THCA	cis	1	rs7556436	chr1:46363880	CCDC163P	chr1:45960581-45965646:-	0.52	10.19	3.48E-22	Body mass index	
THCA	cis	1	rs7556436	chr1:46363880	GPBP1L1	chr1:46092978-46152302:-	-0.16	-4.11	4.71E-5	Body mass index	
THCA	cis	1	rs7556436	chr1:46363880	MMACHC	chr1:45965856-45976737:+	0.21	4.51	8.34E-6	Body mass index	
THCA	cis	1	rs7556436	chr1:46363880	MUTYH	chr1:45794915-45806142:-	-0.32	-8.57	1.48E-16	Body mass index	
THCA	cis	1	rs7556615	chr1:46461369	CCDC163P	chr1:45960581-45965646:-	-0.51	-10.04	1.15E-21	Body mass index	
THCA	cis	1	rs7556615	chr1:46461369	GPBP1L1	chr1:46092978-46152302:-	0.15	3.78	0.000179	Body mass index	
THCA	cis	1	rs7556615	chr1:46461369	MMACHC	chr1:45965856-45976737:+	-0.21	-4.52	7.96E-6	Body mass index	
THCA	cis	1	rs7556615	chr1:46461369	MUTYH	chr1:45794915-45806142:-	0.3	8.1	4.77E-15	Body mass index	
THCA	cis	1	rs75575209	chr2:58138192	VRK2	chr2:58134786-58387055:+	-0.25	-3.34	0.000891	Schizophrenia	
THCA	cis	1	rs7557535	chr2:242206555	ANO7	chr2:242127924-242164791:+	0.37	4.34	1.76E-5	Prostate cancer	
THCA	cis	1	rs7557535	chr2:242206555	SEPT2	chr2:242254723-242293439:+	-0.28	-4.27	2.35E-5	Prostate cancer	
THCA	cis	1	rs75580831	chr2:48379382	FOXN2	chr2:48541795-48606434:+	0.24	4.25	2.62E-5	Schizophrenia	
THCA	cis	1	rs7558944	chr2:73810909	ALMS1P	chr2:73872046-73912692:+	0.75	11.55	2.21E-27	Metabolite levels	
THCA	cis	1	rs7558944	chr2:73810909	NAT8	chr2:73867850-73869537:-	0.42	6.41	3.41E-10	Metabolite levels	
THCA	cis	1	rs7559031	chr2:216902583	MREG	chr2:216807315-216878346:-	0.37	7.97	1.19E-14	Alcohol dependence	
THCA	cis	1	rs7559031	chr2:216902583	PECR	chr2:216861029-216946532:-	0.24	4.97	9.3E-7	Alcohol dependence	
THCA	cis	1	rs7560327	chr2:190772522	ASNSD1	chr2:190526125-190535556:+	-0.59	-5.97	4.61E-9	Subcutaneous adipose tissue	
THCA	cis	1	rs7560328	chr2:202164837	ALS2CR12	chr2:202153148-202222101:-	-0.44	-9.08	2.91E-18	Melanoma;Esophageal squamous cell carcinoma	
THCA	cis	1	rs7560357	chr2:99247820	UNC50	chr2:99225042-99234975:+	0.2	4.15	3.9E-5	Bipolar disorder	
THCA	cis	1	rs7560547	chr2:203757916	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.93	5.93E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs7560547	chr2:203757916	ICA1L	chr2:203637873-203736371:-	0.25	4.18	3.49E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs75607323	chr2:207635770	MDH1B	chr2:207598943-207630050:-	0.48	6.08	2.48E-9	Episodic memory	
THCA	cis	1	rs7561378	chr2:227772248	COL4A4	chr2:227867435-228029275:-	0.16	3.88	0.000117	Pulmonary function	
THCA	cis	1	rs75615599	chr11:96112059	CCDC82	chr11:96085930-96123083:-	-0.24	-3.81	0.000157	Parkinson's disease	
THCA	cis	1	rs7561906	chr2:218312731	IGFBP5	chr2:217536829-217560272:-	-0.23	-4.86	1.6E-6	Metabolite levels (MHPG)	
THCA	cis	1	rs7562072	chr2:218312691	IGFBP5	chr2:217536829-217560272:-	-0.23	-4.86	1.6E-6	Metabolite levels (MHPG)	
THCA	cis	1	rs7562091	chr2:218312748	IGFBP5	chr2:217536829-217560272:-	-0.23	-4.86	1.6E-6	Metabolite levels (MHPG)	
THCA	cis	1	rs7562170	chr2:28943516	PPP1CB	chr2:28974612-29025805:+	-0.17	-4.13	4.3E-5	Body mass index	
THCA	cis	1	rs7562170	chr2:28943516	TRMT61B	chr2:29072690-29093175:-	0.5	9.93	2.87E-21	Body mass index	
THCA	cis	1	rs75635914	chr20:33555815	PROCR	chr20:33758727-33765164:+	-0.36	-5.62	3.24E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs75635914	chr20:33555815	TRPC4AP	chr20:33590215-33680618:-	0.32	3.82	0.00015	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs75647856	chr11:18459806	LDHC	chr11:18433853-18472792:+	-0.3	-3.57	0.000386	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs75648520	chr20:33724221	PROCR	chr20:33758727-33765164:+	-0.32	-5.23	2.6E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs75648520	chr20:33724221	TRPC4AP	chr20:33590215-33680618:-	0.3	3.73	0.000216	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs7564890	chr2:73641853	ALMS1P	chr2:73872046-73912692:+	0.76	11.88	1.11E-28	Metabolite levels	
THCA	cis	1	rs7564890	chr2:73641853	NAT8	chr2:73867850-73869537:-	0.41	6.3	6.74E-10	Metabolite levels	
THCA	cis	1	rs7565792	chr2:48649705	FOXN2	chr2:48541795-48606434:+	-0.13	-3.61	0.00034	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	
THCA	cis	1	rs7565792	chr2:48649705	KLRAQ1	chr2:48667908-48742524:+	0.19	4.04	6.35E-5	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	
THCA	cis	1	rs7566277	chr2:99916242	LIPT1	chr2:99771418-99779611:+	0.24	4.48	9.39E-6	IgG glycosylation	
THCA	cis	1	rs7566279	chr2:281178	SH3YL1	chr2:218138-264810:-	-0.94	-25.95	2.55E-93	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs756631	chr22:23463183	GNAZ	chr22:23412669-23467221:+	-0.27	-5.59	3.9E-8	Bone mineral density	
THCA	cis	1	rs75664917	chr8:89393033	MMP16	chr8:89049462-89339717:-	0.32	4.95	1.04E-6	Electrodermal activity	
THCA	cis	1	rs7567025	chr2:70185108	ASPRV1	chr2:70187226-70314147:-	0.2	4.31	2.02E-5	Obesity-related traits	
THCA	cis	1	rs756769	chr9:135774059	C9orf98	chr9:135600965-135754198:-	0.23	5.58	4.1E-8	Psoriasis	
THCA	cis	1	rs7567847	chr2:218279573	DIRC3	chr2:218148748-218621316:-	0.21	5.07	5.84E-7	Height	
THCA	cis	1	rs7568069	chr2:71584485	ZNF638	chr2:71503723-71662187:+	-0.17	-5.75	1.57E-8	Height	
THCA	cis	1	rs7569033	chr2:42276405	COX7A2L	chr2:42577647-42596150:-	0.19	3.35	0.000866	Atopy	
THCA	cis	1	rs7569331	chr2:70182776	ASPRV1	chr2:70187226-70314147:-	-0.18	-3.95	9.12E-5	Obesity-related traits	
THCA	cis	1	rs75700031	chr1:108357003	VAV3	chr1:108113782-108507545:-	0.56	8.05	6.58E-15	Hypothyroidism	
THCA	cis	1	rs7570554	chr2:218279689	DIRC3	chr2:218148748-218621316:-	0.21	4.98	8.87E-7	Height	
THCA	cis	1	rs75713195	chr2:86290659	LOC90784	chr2:86247339-86250991:-	-0.36	-3.43	0.000645	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs75713195	chr2:86290659	POLR1A	chr2:86253453-86333278:-	-0.29	-3.78	0.000176	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs7571716	chr2:233441420	EIF4E2	chr2:233415357-233448349:+	0.23	4.31	2.01E-5	Height	
THCA	cis	1	rs7572722	chr2:73724675	ALMS1P	chr2:73872046-73912692:+	0.75	11.62	1.18E-27	Metabolite levels	
THCA	cis	1	rs7572722	chr2:73724675	NAT8	chr2:73867850-73869537:-	0.4	6.11	2.02E-9	Metabolite levels	
THCA	cis	1	rs7573118	chr2:26308086	GPR113	chr2:26531041-26569685:-	-0.45	-7.05	6.34E-12	Gut microbiome composition (summer)	
THCA	cis	1	rs7573400	chr2:53226542	CHAC2	chr2:53994929-54002287:+	0.24	3.68	0.000257	Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs7573615	chr2:53226695	CHAC2	chr2:53994929-54002287:+	0.24	3.69	0.000247	Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs75740864	chr11:18470689	LDHC	chr11:18433853-18472792:+	-0.31	-3.74	0.000207	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs7576245	chr2:73829678	ALMS1P	chr2:73872046-73912692:+	0.73	11.63	1.03E-27	Metabolite levels	
THCA	cis	1	rs7576245	chr2:73829678	NAT8	chr2:73867850-73869537:-	0.38	6.08	2.53E-9	Metabolite levels	
THCA	cis	1	rs7576245	chr2:73829678	TPRKB	chr2:73956957-73964517:-	-0.17	-4.29	2.13E-5	Metabolite levels	
THCA	cis	1	rs75774363	chr5:150223722	LOC134466	chr5:150310000-150326146:-	0.42	5.82	1.06E-8	Crohn's disease	
THCA	cis	1	rs75774363	chr5:150223722	ZNF300	chr5:150273964-150284391:-	0.16	3.43	0.000659	Crohn's disease	
THCA	cis	1	rs7577615	chr2:218287181	DIRC3	chr2:218148748-218621316:-	-0.2	-4.73	2.96E-6	Height	
THCA	cis	1	rs75776964	chr11:116801061	PCSK7	chr11:117075789-117102811:-	0.45	5.41	1.02E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs7577696	chr2:32278782	NLRC4	chr2:32449518-32490801:-	-0.11	-3.42	0.00067	Inflammatory biomarkers	
THCA	cis	1	rs7577696	chr2:32278782	SPAST	chr2:32288680-32382705:+	0.17	4.19	3.33E-5	Inflammatory biomarkers	
THCA	cis	1	rs7577762	chr2:70184590	ASPRV1	chr2:70187226-70314147:-	-0.19	-4.12	4.38E-5	Obesity-related traits	
THCA	cis	1	rs7577851	chr2:69723710	AAK1	chr2:69685127-69870977:-	-0.15	-3.54	0.000446	Parkinson's disease (age of onset)	
THCA	cis	1	rs75778624	chr1:108359790	VAV3	chr1:108113782-108507545:-	0.56	8.05	6.61E-15	Hypothyroidism	
THCA	cis	1	rs7578199	chr2:242192848	FARP2	chr2:242295711-242434255:+	-0.24	-5.12	4.54E-7	Chronic lymphocytic leukemia	
THCA	cis	1	rs7578199	chr2:242192848	SEPT2	chr2:242254723-242293439:+	0.25	4.88	1.43E-6	Chronic lymphocytic leukemia	
THCA	cis	1	rs75783371	chr13:28109961	MTIF3	chr13:28009783-28024711:-	0.18	3.62	0.000331	Weight	
THCA	cis	1	rs7578456	chr2:202235348	ALS2CR12	chr2:202153148-202222101:-	-0.37	-7.16	3.09E-12	Basal cell carcinoma	
THCA	cis	1	rs7578456	chr2:202235348	PPIL3	chr2:201735680-201753999:-	-0.23	-4.76	2.53E-6	Basal cell carcinoma	
THCA	cis	1	rs7579277	chr2:28996295	PPP1CB	chr2:28974612-29025805:+	0.17	4.34	1.71E-5	Body mass index	
THCA	cis	1	rs7579277	chr2:28996295	TRMT61B	chr2:29072690-29093175:-	-0.52	-10.67	5.59E-24	Body mass index	
THCA	cis	1	rs757978	chr2:242371101	SEPT2	chr2:242254723-242293439:+	1.02	21.75	1.92E-73	Chronic lymphocytic leukemia	
THCA	cis	1	rs7579961	chr2:227776976	COL4A4	chr2:227867435-228029275:-	0.15	3.79	0.00017	Pulmonary function	
THCA	cis	1	rs75800624	chr18:44633605	HDHD2	chr18:44633782-44676871:-	0.28	5.21	2.84E-7	Sitting height ratio	
THCA	cis	1	rs75800624	chr18:44633605	PIAS2	chr18:44392061-44500123:-	-0.16	-3.35	0.000869	Sitting height ratio	
THCA	cis	1	rs7580240	chr2:29114372	TRMT61B	chr2:29072690-29093175:-	0.4	6.92	1.45E-11	Breast cancer (estrogen-receptor negative);Breast cancer	
THCA	cis	1	rs75804032	chr15:56501130	TEX9	chr15:56657644-56738071:+	-0.32	-5.62	3.24E-8	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs7580825	chr2:73635148	ALMS1P	chr2:73872046-73912692:+	0.71	10.92	6.32E-25	Metabolite levels	
THCA	cis	1	rs7580825	chr2:73635148	NAT8	chr2:73867850-73869537:-	0.39	5.95	5.2E-9	Metabolite levels	
THCA	cis	1	rs75809958	chr3:168687800	MECOM	chr3:168801287-169381563:-	0.53	5.9	7.02E-9	Aging (time to event)	
THCA	cis	1	rs7581224	chr2:84709215	DNAH6	chr2:84743579-85046711:+	0.17	5.22	2.69E-7	Coronary artery calcification	
THCA	cis	1	rs75817507	chr4:106767623	INTS12	chr4:106603787-106629881:-	-0.61	-5.16	3.7E-7	Post bronchodilator FEV1	
THCA	cis	1	rs75824542	chr14:74523047	C14orf45	chr14:74486059-74549566:+	0.17	4.93	1.15E-6	Common traits (Other)	
THCA	cis	1	rs75824542	chr14:74523047	COQ6	chr14:74416643-74429811:+	0.13	3.63	0.000314	Common traits (Other)	
THCA	cis	1	rs75824542	chr14:74523047	LIN52	chr14:74551656-74667117:+	0.5	13.2	3.96E-34	Common traits (Other)	
THCA	cis	1	rs75824619	chr20:61856471	BIRC7	chr20:61867276-61871853:+	0.35	3.97	8.37E-5	Response to cytadine analogues (cytosine arabinoside)	
THCA	cis	1	rs75824619	chr20:61856471	NKAIN4	chr20:61872137-61885892:-	0.35	3.58	0.000384	Response to cytadine analogues (cytosine arabinoside)	
THCA	cis	1	rs7582606	chr2:73813945	ALMS1P	chr2:73872046-73912692:+	0.75	11.64	9.29E-28	Metabolite levels	
THCA	cis	1	rs7582606	chr2:73813945	NAT8	chr2:73867850-73869537:-	0.41	6.42	3.29E-10	Metabolite levels	
THCA	cis	1	rs75826529	chr11:116865100	PCSK7	chr11:117075789-117102811:-	0.41	5.18	3.34E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs7582720	chr2:203753072	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.93	5.93E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs7582720	chr2:203753072	ICA1L	chr2:203637873-203736371:-	0.25	4.18	3.49E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs75828026	chr3:58346736	KCTD6	chr3:58477823-58488085:+	0.23	3.42	0.000689	Cholesterol, total	
THCA	cis	1	rs75828026	chr3:58346736	PXK	chr3:58318617-58410878:+	0.36	6.36	4.82E-10	Cholesterol, total	
THCA	cis	1	rs7583236	chr2:70182805	ASPRV1	chr2:70187226-70314147:-	-0.18	-3.95	8.91E-5	Obesity-related traits	
THCA	cis	1	rs758324	chr5:131109545	P4HA2	chr5:131528306-131563556:-	0.25	4.89	1.4E-6	Alzheimer's disease in APOE e4- carriers	
THCA	cis	1	rs7583255	chr2:73797996	ALMS1P	chr2:73872046-73912692:+	0.75	11.65	9.0E-28	Metabolite levels	
THCA	cis	1	rs7583255	chr2:73797996	NAT8	chr2:73867850-73869537:-	0.42	6.47	2.38E-10	Metabolite levels	
THCA	cis	1	rs7584330	chr2:238387228	MLPH	chr2:238395053-238463960:+	-0.28	-7.17	2.87E-12	Prostate cancer	
THCA	cis	1	rs7584535	chr2:232106857	ARMC9	chr2:232063342-232238606:+	0.43	10.37	7.48E-23	Food antigen IgG levels	
THCA	cis	1	rs7584575	chr2:73666402	ALMS1P	chr2:73872046-73912692:+	0.71	11.17	6.62E-26	Metabolite levels	
THCA	cis	1	rs7584575	chr2:73666402	NAT8	chr2:73867850-73869537:-	0.37	5.82	1.1E-8	Metabolite levels	
THCA	cis	1	rs7584575	chr2:73666402	TPRKB	chr2:73956957-73964517:-	-0.17	-4.23	2.83E-5	Metabolite levels	
THCA	cis	1	rs7585004	chr2:73666645	ALMS1P	chr2:73872046-73912692:+	0.68	10.51	2.29E-23	Metabolite levels	
THCA	cis	1	rs7585004	chr2:73666645	NAT8	chr2:73867850-73869537:-	0.4	6.16	1.5E-9	Metabolite levels	
THCA	cis	1	rs7585004	chr2:73666645	TPRKB	chr2:73956957-73964517:-	-0.17	-4.24	2.7E-5	Metabolite levels	
THCA	cis	1	rs7586463	chr2:73798476	ALMS1P	chr2:73872046-73912692:+	0.75	11.65	9.0E-28	Metabolite levels	
THCA	cis	1	rs7586463	chr2:73798476	NAT8	chr2:73867850-73869537:-	0.42	6.47	2.38E-10	Metabolite levels	
THCA	cis	1	rs75866240	chr20:33558839	PROCR	chr20:33758727-33765164:+	-0.36	-5.62	3.24E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs75866240	chr20:33558839	TRPC4AP	chr20:33590215-33680618:-	0.32	3.82	0.00015	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs75869289	chr2:203806724	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.95	5.24E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs75869289	chr2:203806724	ICA1L	chr2:203637873-203736371:-	0.26	4.29	2.13E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs7587557	chr2:53226607	CHAC2	chr2:53994929-54002287:+	0.23	3.54	0.000432	Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs7588296	chr2:218312698	IGFBP5	chr2:217536829-217560272:-	-0.23	-4.86	1.6E-6	Metabolite levels (MHPG)	
THCA	cis	1	rs75884992	chr2:42277209	COX7A2L	chr2:42577647-42596150:-	0.19	3.35	0.000866	Atopy	
THCA	cis	1	rs7588654	chr2:219983030	NHEJ1	chr2:219940051-220034817:-	-0.26	-3.53	0.000449	Height	
THCA	cis	1	rs7588802	chr2:26277789	GPR113	chr2:26531041-26569685:-	-0.47	-7.26	1.58E-12	Gut microbiome composition (summer)	
THCA	cis	1	rs7588802	chr2:26277789	HADHA	chr2:26413505-26467594:-	-0.17	-3.46	0.000589	Gut microbiome composition (summer)	
THCA	cis	1	rs75888794	chr20:33702998	PROCR	chr20:33758727-33765164:+	-0.34	-5.97	4.71E-9	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs75888794	chr20:33702998	TRPC4AP	chr20:33590215-33680618:-	0.34	4.58	6.02E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs75889859	chr14:35539054	FAM177A1	chr14:35514113-35552587:+	-0.22	-4.11	4.65E-5	Atopic dermatitis	
THCA	cis	1	rs75889859	chr14:35539054	KIAA0391	chr14:35591776-35786673:+	0.29	5.48	6.94E-8	Atopic dermatitis	
THCA	cis	1	rs75889859	chr14:35539054	PPP2R3C	chr14:35554679-35591679:-	0.53	10.11	6.8E-22	Atopic dermatitis	
THCA	cis	1	rs758944	chr7:75953297	STYXL1	chr7:75625656-75677321:-	-0.16	-3.95	9.11E-5	Multiple sclerosis	
THCA	cis	1	rs758944	chr7:75953297	UPK3B	chr7:76139745-76157197:+	-0.26	-4.55	6.86E-6	Multiple sclerosis	
THCA	cis	1	rs7589728	chr2:88518440	KRCC1	chr2:88326724-88355248:-	-0.23	-3.62	0.000321	Plasma clusterin levels	
THCA	cis	1	rs7589728	chr2:88518440	THNSL2	chr2:88469835-88486145:+	-0.67	-8.56	1.53E-16	Plasma clusterin levels	
THCA	cis	1	rs7590071	chr2:240900947	NDUFA10	chr2:240900158-240964798:-	0.31	8.58	1.3E-16	Odorant perception (isobutyraldehyde)	
THCA	cis	1	rs75904349	chr4:106526694	INTS12	chr4:106603787-106629881:-	-0.6	-4.85	1.68E-6	Post bronchodilator FEV1	
THCA	cis	1	rs7590720	chr2:216898658	MREG	chr2:216807315-216878346:-	-0.38	-8.26	1.44E-15	Alcohol dependence	
THCA	cis	1	rs7590720	chr2:216898658	PECR	chr2:216861029-216946532:-	-0.24	-5.05	6.39E-7	Alcohol dependence	
THCA	cis	1	rs7590720	chr2:216898658	TMEM169	chr2:216946589-216967505:+	-0.17	-3.36	0.000848	Alcohol dependence	
THCA	cis	1	rs75913297	chr10:81789845	LOC219347	chr10:81805991-81838949:-	1.04	15.15	1.21E-42	Chronic obstructive pulmonary disease-related biomarkers	
THCA	cis	1	rs7591472	chr2:201889751	CFLAR	chr2:201980816-202029001:+	-0.25	-4.85	1.71E-6	Triptolide cytotoxicity	
THCA	cis	1	rs7591472	chr2:201889751	PPIL3	chr2:201735680-201753999:-	-1.03	-19.75	6.71E-64	Triptolide cytotoxicity	
THCA	cis	1	rs75921373	chr6:26191843	HIST1H2AE	chr6:26217148-26217711:+	-0.23	-3.64	0.000301	Renal underexcretion gout;Gout	
THCA	cis	1	rs75921373	chr6:26191843	HIST1H3E	chr6:26224427-26226589:+	0.43	7.08	5.04E-12	Renal underexcretion gout;Gout	
THCA	cis	1	rs7592387	chr2:227777095	COL4A4	chr2:227867435-228029275:-	0.15	3.79	0.00017	Pulmonary function	
THCA	cis	1	rs75924839	chr8:89465223	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs7592663	chr2:216894978	MREG	chr2:216807315-216878346:-	0.38	8.18	2.58E-15	Alcohol dependence	
THCA	cis	1	rs7592663	chr2:216894978	PECR	chr2:216861029-216946532:-	0.25	5.19	3.06E-7	Alcohol dependence	
THCA	cis	1	rs7592663	chr2:216894978	TMEM169	chr2:216946589-216967505:+	0.18	3.38	0.000792	Alcohol dependence	
THCA	cis	1	rs75927128	chr14:65895320	LOC645431	chr14:65877313-65879335:-	-0.6	-7.69	8.6E-14	Ischemic stroke	
THCA	cis	1	rs7593448	chr2:27449293	C2orf28	chr2:27434899-27440044:+	0.16	4.78	2.3E-6	Blood metabolite levels	
THCA	cis	1	rs7593448	chr2:27449293	SLC5A6	chr2:27422459-27435071:-	-0.34	-7.17	2.94E-12	Blood metabolite levels	
THCA	cis	1	rs75936301	chr16:77781742	NUDT7	chr16:77756411-77776153:+	0.35	4.83	1.86E-6	Obesity-related traits	
THCA	cis	1	rs75936657	chr1:41001689	DEM1	chr1:40974433-40982212:+	0.34	4.89	1.36E-6	Age-related hearing impairment (interaction)	
THCA	cis	1	rs7594511	chr2:73681639	ALMS1P	chr2:73872046-73912692:+	0.76	11.72	4.55E-28	Metabolite levels	
THCA	cis	1	rs7594511	chr2:73681639	NAT8	chr2:73867850-73869537:-	0.41	6.3	6.7E-10	Metabolite levels	
THCA	cis	1	rs7594645	chr2:207646674	MDH1B	chr2:207598943-207630050:-	0.41	5.57	4.37E-8	Episodic memory	
THCA	cis	1	rs7595075	chr2:264019	SH3YL1	chr2:218138-264810:-	-0.95	-26.05	9.49E-94	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs75961339	chr4:75704620	BTC	chr4:75671448-75719882:-	0.2	3.79	0.000173	Electroencephalogram traits	
THCA	cis	1	rs7596362	chr2:61204688	AHSA2	chr2:61404553-61414058:+	-0.13	-5.03	6.98E-7	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs7596362	chr2:61204688	C2orf74	chr2:61372243-61391964:+	0.48	9.36	3.15E-19	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs7598283	chr2:70128717	ASPRV1	chr2:70187226-70314147:-	-0.12	-3.35	0.000866	Carotid plaque burden (smoking interaction)	
THCA	cis	1	rs7598396	chr2:73652628	ALMS1P	chr2:73872046-73912692:+	0.76	11.82	1.84E-28	Metabolite levels	
THCA	cis	1	rs7598396	chr2:73652628	NAT8	chr2:73867850-73869537:-	0.41	6.28	7.78E-10	Metabolite levels	
THCA	cis	1	rs7598396	chr2:73652628	TPRKB	chr2:73956957-73964517:-	-0.14	-3.4	0.000726	Metabolite levels	
THCA	cis	1	rs7598419	chr2:73798223	ALMS1P	chr2:73872046-73912692:+	0.76	11.44	6.16E-27	Metabolite levels	
THCA	cis	1	rs7598419	chr2:73798223	NAT8	chr2:73867850-73869537:-	0.44	6.6	1.07E-10	Metabolite levels	
THCA	cis	1	rs7598759	chr2:232321956	C2orf52	chr2:232373137-232379050:-	-0.24	-4.68	3.77E-6	Noise-induced hearing loss	
THCA	cis	1	rs7598759	chr2:232321956	NMUR1	chr2:232387872-232395182:-	-0.22	-4.34	1.77E-5	Noise-induced hearing loss	
THCA	cis	1	rs7598876	chr2:28974466	PPP1CB	chr2:28974612-29025805:+	0.17	4.16	3.74E-5	Body mass index	
THCA	cis	1	rs7598876	chr2:28974466	TRMT61B	chr2:29072690-29093175:-	-0.51	-10.29	1.5E-22	Body mass index	
THCA	cis	1	rs7599132	chr2:26279810	GPR113	chr2:26531041-26569685:-	0.45	7.05	6.2E-12	Gut microbiome composition (summer)	
THCA	cis	1	rs7601738	chr2:242375813	SEPT2	chr2:242254723-242293439:+	-0.99	-20.78	7.93E-69	Chronic lymphocytic leukemia	
THCA	cis	1	rs76024966	chr7:75995021	STYXL1	chr7:75625656-75677321:-	-0.14	-3.42	0.000684	Multiple sclerosis	
THCA	cis	1	rs76024966	chr7:75995021	UPK3B	chr7:76139745-76157197:+	-0.3	-5.19	3.11E-7	Multiple sclerosis	
THCA	cis	1	rs7603771	chr2:218287114	DIRC3	chr2:218148748-218621316:-	-0.2	-4.73	2.96E-6	Height	
THCA	cis	1	rs76041173	chr3:10078695	C3orf10	chr3:10157333-10168873:+	-0.21	-4.31	1.99E-5	Alzheimer's disease	
THCA	cis	1	rs76041173	chr3:10078695	VHL	chr3:10183319-10193744:+	-0.19	-4.42	1.21E-5	Alzheimer's disease	
THCA	cis	1	rs7604393	chr2:241825034	C2orf54	chr2:241825466-241835573:-	0.29	6.35	4.88E-10	Urinary metabolites	
THCA	cis	1	rs7604682	chr2:73788026	ALMS1P	chr2:73872046-73912692:+	0.7	11.06	1.8E-25	Metabolite levels	
THCA	cis	1	rs7604682	chr2:73788026	NAT8	chr2:73867850-73869537:-	0.4	6.32	6.01E-10	Metabolite levels	
THCA	cis	1	rs7604682	chr2:73788026	TPRKB	chr2:73956957-73964517:-	-0.16	-4	7.28E-5	Metabolite levels	
THCA	cis	1	rs7604798	chr2:27824940	FNDC4	chr2:27714751-27718126:-	-0.15	-3.64	0.000306	Oral cavity cancer	
THCA	cis	1	rs76052260	chr2:86328727	POLR1A	chr2:86253453-86333278:-	-0.32	-4.29	2.19E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs7605484	chr2:203724495	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.98	4.33E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs7605484	chr2:203724495	ICA1L	chr2:203637873-203736371:-	0.26	4.31	1.98E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs7605824	chr2:280819	SH3YL1	chr2:218138-264810:-	0.94	25.92	3.87E-93	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs7605827	chr2:15598740	NBAS	chr2:15307032-15701454:-	-0.28	-5.84	9.41E-9	Educational attainment (years of education)	
THCA	cis	1	rs76062966	chr11:18462404	LDHC	chr11:18433853-18472792:+	-0.29	-3.5	0.0005	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs76067258	chr1:183204346	RNASEL	chr1:182542772-182558391:-	0.33	3.64	0.000303	Systemic lupus erythematosus and Systemic sclerosis	
THCA	cis	1	rs7606754	chr2:228135180	MFF	chr2:228189978-228222547:+	-0.23	-4.95	1.03E-6	Corneal structure	
THCA	cis	1	rs76068439	chr10:1121018	IDI2	chr10:1064847-1071799:-	0.45	3.83	0.000143	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs760699	chr22:43523188	BIK	chr22:43506757-43525717:+	0.38	6.07	2.65E-9	Prostate cancer	
THCA	cis	1	rs7607014	chr2:73730174	ALMS1P	chr2:73872046-73912692:+	-0.72	-11.26	3.02E-26	Metabolite levels	
THCA	cis	1	rs7607014	chr2:73730174	NAT8	chr2:73867850-73869537:-	-0.36	-5.59	3.73E-8	Metabolite levels	
THCA	cis	1	rs7607014	chr2:73730174	TPRKB	chr2:73956957-73964517:-	0.17	4.26	2.52E-5	Metabolite levels	
THCA	cis	1	rs76081054	chr2:86285037	LOC90784	chr2:86247339-86250991:-	-0.61	-6.49	2.17E-10	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs7608623	chr2:23948953	LOC375190	chr2:24299728-24397519:+	0.32	7.98	1.08E-14	Obesity-related traits	
THCA	cis	1	rs7608697	chr2:61204641	AHSA2	chr2:61404553-61414058:+	-0.12	-4.55	6.68E-6	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs7608697	chr2:61204641	C2orf74	chr2:61372243-61391964:+	0.47	9.13	1.99E-18	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs7608910	chr2:61204856	AHSA2	chr2:61404553-61414058:+	0.13	4.68	3.67E-6	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs7608910	chr2:61204856	C2orf74	chr2:61372243-61391964:+	-0.49	-9.63	3.44E-20	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs7609851	chr3:156638503	LEKR1	chr3:156544076-156763918:+	-0.55	-11.18	6.33E-26	Bone mineral density	
THCA	cis	1	rs761025	chr20:25426968	ENTPD6	chr20:25176339-25207360:+	-0.3	-6.79	3.31E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs761025	chr20:25426968	FAM182A	chr20:26035250-26067552:+	-0.18	-3.4	0.000729	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs761025	chr20:25426968	FAM182B	chr20:25744102-25848786:-	0.25	5.23	2.5E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs761025	chr20:25426968	NINL	chr20:25433338-25566153:-	-0.36	-7.3	1.18E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs7610821	chr3:10136150	C3orf10	chr3:10157333-10168873:+	-0.2	-4.32	1.93E-5	Alzheimer's disease	
THCA	cis	1	rs7610821	chr3:10136150	VHL	chr3:10183319-10193744:+	-0.18	-4.18	3.41E-5	Alzheimer's disease	
THCA	cis	1	rs7611218	chr3:10063960	C3orf10	chr3:10157333-10168873:+	-0.21	-4.37	1.53E-5	Alzheimer's disease	
THCA	cis	1	rs7611218	chr3:10063960	VHL	chr3:10183319-10193744:+	-0.18	-4.05	6.05E-5	Alzheimer's disease	
THCA	cis	1	rs76112204	chr5:115618889	COMMD10	chr5:115420727-115628978:+	0.48	5.66	2.56E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs7611238	chr3:195072918	C3orf21	chr3:194789015-194991895:-	0.25	5.65	2.74E-8	Body mass index	
THCA	cis	1	rs76112431	chr6:55988182	COL21A1	chr6:55921389-56258892:-	-0.67	-8.28	1.22E-15	Psychosis (atypical)	
THCA	cis	1	rs7611611	chr3:134307877	ANAPC13	chr3:134196547-134204865:-	0.37	11.55	2.1E-27	Height	
THCA	cis	1	rs7611611	chr3:134307877	CEP63	chr3:134204575-134293852:+	0.29	6.27	8.23E-10	Height	
THCA	cis	1	rs7611694	chr3:113275624	SIDT1	chr3:113251218-113348421:+	0.15	3.36	0.00083	Prostate cancer	
THCA	cis	1	rs7611828	chr3:134250325	ANAPC13	chr3:134196547-134204865:-	0.39	12.58	1.56E-31	Height	
THCA	cis	1	rs7611828	chr3:134250325	CEP63	chr3:134204575-134293852:+	0.3	6.54	1.63E-10	Height	
THCA	cis	1	rs76129108	chr7:1089159	ZFAND2A	chr7:1192544-1199855:-	-0.37	-5.37	1.24E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs7613282	chr3:47389409	C3orf75	chr3:47537131-47555199:-	0.1	4.38	1.48E-5	Colorectal cancer	
THCA	cis	1	rs7613282	chr3:47389409	NBEAL2	chr3:47021173-47051193:+	0.12	3.84	0.000141	Colorectal cancer	
THCA	cis	1	rs76134821	chr1:108357743	VAV3	chr1:108113782-108507545:-	0.56	7.98	1.07E-14	Hypothyroidism	
THCA	cis	1	rs7613491	chr3:49508976	GMPPB	chr3:49758932-49761384:-	0.16	3.71	0.000228	Menarche (age at onset)	
THCA	cis	1	rs7613491	chr3:49508976	P4HTM	chr3:49027341-49044579:+	-0.18	-4.5	8.58E-6	Menarche (age at onset)	
THCA	cis	1	rs76146269	chr11:116823617	PCSK7	chr11:117075789-117102811:-	0.45	5.41	1.01E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs7614727	chr3:52295895	NEK4	chr3:52744803-52804951:-	-0.12	-3.97	8.15E-5	Electroencephalogram traits	
THCA	cis	1	rs7614727	chr3:52295895	NT5DC2	chr3:52558386-52569093:-	-0.24	-5.84	9.6E-9	Electroencephalogram traits	
THCA	cis	1	rs7614727	chr3:52295895	PBRM1	chr3:52579368-52719866:-	0.13	5.04	6.52E-7	Electroencephalogram traits	
THCA	cis	1	rs761500	chr20:43772272	GDAP1L1	chr20:42875908-42909011:+	0.32	3.82	0.000154	Parental longevity (mother's age at death)	
THCA	cis	1	rs761500	chr20:43772272	STK4	chr20:43595120-43708591:+	0.16	3.74	0.000209	Parental longevity (mother's age at death)	
THCA	cis	1	rs7615646	chr3:10089773	C3orf10	chr3:10157333-10168873:+	-0.21	-4.34	1.71E-5	Alzheimer's disease	
THCA	cis	1	rs7615646	chr3:10089773	VHL	chr3:10183319-10193744:+	-0.2	-4.51	8.09E-6	Alzheimer's disease	
THCA	cis	1	rs7615764	chr3:10082592	C3orf10	chr3:10157333-10168873:+	-0.21	-4.32	1.87E-5	Alzheimer's disease	
THCA	cis	1	rs7615764	chr3:10082592	VHL	chr3:10183319-10193744:+	-0.2	-4.51	8.05E-6	Alzheimer's disease	
THCA	cis	1	rs7615952	chr3:125649403	ALG1L	chr3:125648118-125655882:-	0.27	3.79	0.000171	Blood pressure (smoking interaction)	
THCA	cis	1	rs7615952	chr3:125649403	LOC100125556	chr3:125635444-125648865:+	-0.63	-10.85	1.1E-24	Blood pressure (smoking interaction)	
THCA	cis	1	rs7616044	chr3:125649354	ALG1L	chr3:125648118-125655882:-	-0.27	-3.86	0.000129	Blood pressure (smoking interaction)	
THCA	cis	1	rs7616044	chr3:125649354	LOC100125556	chr3:125635444-125648865:+	0.63	10.81	1.61E-24	Blood pressure (smoking interaction)	
THCA	cis	1	rs7616215	chr3:46205686	CCR3	chr3:46205096-46308162:+	-0.19	-3.84	0.00014	Behcet's disease	
THCA	cis	1	rs7616215	chr3:46205686	FYCO1	chr3:45959396-46037307:-	0.13	3.77	0.000185	Behcet's disease	
THCA	cis	1	rs7616844	chr3:41874343	ULK4	chr3:41288091-42003660:-	1.09	21.14	1.55E-70	Diastolic blood pressure	
THCA	cis	1	rs76170957	chr11:96126851	CCDC82	chr11:96085930-96123083:-	-0.26	-3.86	0.000127	Parkinson's disease	
THCA	cis	1	rs7617397	chr3:41959037	ULK4	chr3:41288091-42003660:-	-1.1	-21.05	4.17E-70	Diastolic blood pressure	
THCA	cis	1	rs7617912	chr3:156576412	LEKR1	chr3:156544076-156763918:+	-0.54	-10.47	3.04E-23	Bone mineral density	
THCA	cis	1	rs76191812	chr20:33563911	PROCR	chr20:33758727-33765164:+	-0.36	-5.71	1.97E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs76191812	chr20:33563911	TRPC4AP	chr20:33590215-33680618:-	0.33	4	7.46E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs76192904	chr1:76359995	ACADM	chr1:76190043-76229353:+	-0.25	-5.05	6.18E-7	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs7619340	chr3:10108178	C3orf10	chr3:10157333-10168873:+	-0.2	-4.22	2.93E-5	Alzheimer's disease	
THCA	cis	1	rs7619340	chr3:10108178	VHL	chr3:10183319-10193744:+	-0.19	-4.44	1.1E-5	Alzheimer's disease	
THCA	cis	1	rs7619451	chr3:134233238	ANAPC13	chr3:134196547-134204865:-	0.37	11.03	2.44E-25	Height	
THCA	cis	1	rs7619451	chr3:134233238	CEP63	chr3:134204575-134293852:+	0.3	6.25	8.99E-10	Height	
THCA	cis	1	rs76194	chr19:18630580	ELL	chr19:18553475-18632937:-	-0.25	-6.26	8.61E-10	Breast cancer	
THCA	cis	1	rs76194	chr19:18630580	ISYNA1	chr19:18545625-18548943:-	0.12	4.63	4.69E-6	Breast cancer	
THCA	cis	1	rs76194	chr19:18630580	LRRC25	chr19:18501955-18508421:-	-0.15	-5.29	1.85E-7	Breast cancer	
THCA	cis	1	rs7619789	chr3:49476263	GMPPB	chr3:49758932-49761384:-	-0.18	-4.05	5.9E-5	Menarche (age at onset)	
THCA	cis	1	rs7619789	chr3:49476263	P4HTM	chr3:49027341-49044579:+	0.17	4.28	2.28E-5	Menarche (age at onset)	
THCA	cis	1	rs7619789	chr3:49476263	WDR6	chr3:49044637-49053386:+	-0.18	-3.84	0.000138	Menarche (age at onset)	
THCA	cis	1	rs76198862	chr6:55988150	COL21A1	chr6:55921389-56258892:-	-0.67	-8.28	1.22E-15	Psychosis (atypical)	
THCA	cis	1	rs7620458	chr3:156576850	LEKR1	chr3:156544076-156763918:+	-0.55	-10.77	2.27E-24	Bone mineral density	
THCA	cis	1	rs76214082	chr7:1102097	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.69	2.27E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs76214624	chr8:117720715	EIF3H	chr8:117657056-117778494:-	-0.21	-3.84	0.000137	Body mass index	
THCA	cis	1	rs7622259	chr3:41881351	ULK4	chr3:41288091-42003660:-	1.09	21.14	1.55E-70	Diastolic blood pressure	
THCA	cis	1	rs7622420	chr3:53111069	RFT1	chr3:53122503-53164470:-	0.57	7.1	4.61E-12	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs7622963	chr3:10139825	C3orf10	chr3:10157333-10168873:+	-0.2	-4.29	2.2E-5	Alzheimer's disease	
THCA	cis	1	rs7622963	chr3:10139825	VHL	chr3:10183319-10193744:+	-0.18	-4.19	3.32E-5	Alzheimer's disease	
THCA	cis	1	rs7622966	chr3:10139833	C3orf10	chr3:10157333-10168873:+	-0.2	-4.37	1.55E-5	Alzheimer's disease	
THCA	cis	1	rs7622966	chr3:10139833	VHL	chr3:10183319-10193744:+	-0.18	-4.17	3.55E-5	Alzheimer's disease	
THCA	cis	1	rs762317	chr3:38497659	EXOG	chr3:38537763-38567796:+	-0.16	-3.37	0.000813	Electrocardiographic conduction measures	
THCA	cis	1	rs762317	chr3:38497659	LOC100128640	chr3:38492524-38496311:-	0.23	4.85	1.66E-6	Electrocardiographic conduction measures	
THCA	cis	1	rs762317	chr3:38497659	SCN5A	chr3:38589554-38691164:-	0.16	3.42	0.00069	Electrocardiographic conduction measures	
THCA	cis	1	rs762317	chr3:38497659	XYLB	chr3:38388251-38456467:+	0.21	5.17	3.52E-7	Electrocardiographic conduction measures	
THCA	cis	1	rs762421	chr21:45615561	ICOSLG	chr21:45646724-45660834:-	-0.2	-4.29	2.14E-5	Inflammatory bowel disease	
THCA	cis	1	rs762421	chr21:45615561	PWP2	chr21:45527208-45551062:+	-0.26	-4.8	2.11E-6	Inflammatory bowel disease	
THCA	cis	1	rs7624320	chr3:137267600	NCK1	chr3:136581073-136667967:+	0.13	3.55	0.00042	Glucocorticoid-induced osteonecrosis	
THCA	cis	1	rs7624372	chr3:41881107	ULK4	chr3:41288091-42003660:-	1.09	21.14	1.55E-70	Diastolic blood pressure	
THCA	cis	1	rs76243942	chr16:77781637	NUDT7	chr16:77756411-77776153:+	0.35	4.83	1.86E-6	Obesity-related traits	
THCA	cis	1	rs7624642	chr3:184561541	C3orf70	chr3:184795840-184870802:-	-0.26	-4.97	9.49E-7	Heschl's gyrus morphology	
THCA	cis	1	rs7624766	chr3:160429869	B3GALNT1	chr3:160801673-160823160:-	-0.16	-3.61	0.000337	Response to methotrexate in rheumatoid arthritis	
THCA	cis	1	rs7625042	chr3:137261371	NCK1	chr3:136581073-136667967:+	-0.13	-3.51	0.000497	Glucocorticoid-induced osteonecrosis	
THCA	cis	1	rs7625448	chr3:53120766	RFT1	chr3:53122503-53164470:-	0.59	7.31	1.17E-12	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs7625734	chr3:169508915	LRRC34	chr3:169511266-169530720:-	-0.24	-4.47	9.81E-6	Multiple myeloma and monoclonal gammopathy;Interstitial lung disease	
THCA	cis	1	rs7625821	chr3:51513236	HEMK1	chr3:50606583-50622419:+	0.16	4.23	2.85E-5	Melanoma	
THCA	cis	1	rs7625821	chr3:51513236	TEX264	chr3:51705222-51738338:+	-0.12	-3.83	0.000144	Melanoma	
THCA	cis	1	rs7626117	chr3:10140671	C3orf10	chr3:10157333-10168873:+	-0.17	-3.82	0.00015	Alzheimer's disease	
THCA	cis	1	rs7626117	chr3:10140671	VHL	chr3:10183319-10193744:+	-0.15	-3.61	0.000338	Alzheimer's disease	
THCA	cis	1	rs762629	chr3:119280892	ADPRH	chr3:119298523-119308791:+	-0.22	-3.6	0.000347	Vitiligo	
THCA	cis	1	rs762676	chr22:51017794	CHKB	chr22:51017378-51021428:-	0.51	6.14	1.73E-9	Narcolepsy	
THCA	cis	1	rs762676	chr22:51017794	CPT1B	chr22:51007291-51017096:-	-0.42	-8.49	2.62E-16	Narcolepsy	
THCA	cis	1	rs762677	chr22:51017713	CHKB	chr22:51017378-51021428:-	0.51	6.14	1.73E-9	Narcolepsy	
THCA	cis	1	rs762677	chr22:51017713	CPT1B	chr22:51007291-51017096:-	-0.42	-8.49	2.62E-16	Narcolepsy	
THCA	cis	1	rs7627656	chr3:137269010	NCK1	chr3:136581073-136667967:+	0.13	3.57	0.000395	Glucocorticoid-induced osteonecrosis	
THCA	cis	1	rs76277863	chr15:40649863	C15orf23	chr15:40674922-40686488:+	0.62	8.41	4.85E-16	Heschl's gyrus morphology	
THCA	cis	1	rs76277863	chr15:40649863	IVD	chr15:40697686-40713512:+	-0.48	-8.54	1.75E-16	Heschl's gyrus morphology	
THCA	cis	1	rs7628448	chr3:10146828	C3orf10	chr3:10157333-10168873:+	-0.2	-4.26	2.5E-5	Alzheimer's disease	
THCA	cis	1	rs7628448	chr3:10146828	VHL	chr3:10183319-10193744:+	-0.2	-4.59	5.57E-6	Alzheimer's disease	
THCA	cis	1	rs7629072	chr3:52305633	NEK4	chr3:52744803-52804951:-	-0.12	-3.99	7.62E-5	Electroencephalogram traits	
THCA	cis	1	rs7629072	chr3:52305633	NT5DC2	chr3:52558386-52569093:-	-0.24	-5.83	1.0E-8	Electroencephalogram traits	
THCA	cis	1	rs7629072	chr3:52305633	PBRM1	chr3:52579368-52719866:-	0.13	4.94	1.09E-6	Electroencephalogram traits	
THCA	cis	1	rs76292674	chr5:115625260	COMMD10	chr5:115420727-115628978:+	0.48	5.83	1.01E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs7629490	chr3:87241497	CHMP2B	chr3:87276413-87304697:+	-0.19	-5.55	4.67E-8	Prostate cancer	
THCA	cis	1	rs76297018	chr2:86227007	POLR1A	chr2:86253453-86333278:-	-0.34	-4.76	2.62E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs76298043	chr2:203814694	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.95	5.24E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs76298043	chr2:203814694	ICA1L	chr2:203637873-203736371:-	0.26	4.29	2.13E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs763014	chr16:675680	WFIKKN1	chr16:679239-684116:+	0.36	8.08	5.24E-15	Height	
THCA	cis	1	rs7630741	chr3:48419723	ATRIP	chr3:48488141-48507708:+	0.17	3.78	0.000175	Longevity	
THCA	cis	1	rs7630741	chr3:48419723	TREX1	chr3:48501186-48509043:+	-0.25	-5.75	1.6E-8	Longevity	
THCA	cis	1	rs7630874	chr3:134293291	ANAPC13	chr3:134196547-134204865:-	-0.39	-12.33	1.64E-30	Height	
THCA	cis	1	rs7630874	chr3:134293291	CEP63	chr3:134204575-134293852:+	-0.31	-6.56	1.43E-10	Height	
THCA	cis	1	rs7631057	chr3:41817951	ULK4	chr3:41288091-42003660:-	1.08	19.87	1.76E-64	Diastolic blood pressure	
THCA	cis	1	rs76315659	chr16:77781650	NUDT7	chr16:77756411-77776153:+	0.36	4.99	8.33E-7	Obesity-related traits	
THCA	cis	1	rs7631605	chr3:37234589	EPM2AIP1	chr3:37027358-37034795:-	0.14	4.02	6.84E-5	Cerebrospinal P-tau181p levels	
THCA	cis	1	rs7631605	chr3:37234589	LRRFIP2	chr3:37094117-37217851:-	0.5	13.97	2.05E-37	Cerebrospinal P-tau181p levels	
THCA	cis	1	rs7631678	chr3:10078816	C3orf10	chr3:10157333-10168873:+	-0.2	-4.3	2.08E-5	Alzheimer's disease	
THCA	cis	1	rs7631678	chr3:10078816	VHL	chr3:10183319-10193744:+	-0.19	-4.42	1.24E-5	Alzheimer's disease	
THCA	cis	1	rs7632387	chr3:41853161	ULK4	chr3:41288091-42003660:-	1.08	20.22	3.77E-66	Diastolic blood pressure	
THCA	cis	1	rs76329209	chr6:26196430	HIST1H2AE	chr6:26217148-26217711:+	-0.23	-3.69	0.000249	Renal underexcretion gout;Gout	
THCA	cis	1	rs76329209	chr6:26196430	HIST1H3E	chr6:26224427-26226589:+	0.43	7.04	6.71E-12	Renal underexcretion gout;Gout	
THCA	cis	1	rs76329678	chr5:49830286	EMB	chr5:49692033-49737234:-	0.21	4.27	2.32E-5	Schizophrenia	
THCA	cis	1	rs7633265	chr3:195048814	C3orf21	chr3:194789015-194991895:-	0.28	6.46	2.63E-10	Body mass index	
THCA	cis	1	rs7633750	chr3:169509244	LRRC34	chr3:169511266-169530720:-	-0.25	-4.83	1.8E-6	Multiple myeloma and monoclonal gammopathy;Interstitial lung disease	
THCA	cis	1	rs7633752	chr3:191000252	UTS2D	chr3:190984945-191048325:-	0.18	3.56	0.000414	Total ventricular volume (Alzheimer's disease interaction)	
THCA	cis	1	rs763386	chr7:107196723	DLD	chr7:107531586-107561642:+	0.14	3.49	0.000521	Osteoarthritis	
THCA	cis	1	rs7634188	chr3:72941289	GXYLT2	chr3:72937385-73024520:+	-0.25	-5.56	4.47E-8	Motion sickness	
THCA	cis	1	rs7634345	chr3:195073403	C3orf21	chr3:194789015-194991895:-	0.28	6.51	1.9E-10	Body mass index	
THCA	cis	1	rs7634377	chr3:48421258	ATRIP	chr3:48488141-48507708:+	0.17	3.72	0.000223	Longevity	
THCA	cis	1	rs7634377	chr3:48421258	TREX1	chr3:48501186-48509043:+	-0.25	-5.83	9.99E-9	Longevity	
THCA	cis	1	rs76348195	chr1:182958801	RGS8	chr1:182615792-182642067:-	-0.18	-3.39	0.000762	Diabetic kidney disease	
THCA	cis	1	rs7635522	chr3:48423656	ATRIP	chr3:48488141-48507708:+	0.18	3.9	0.000108	Longevity	
THCA	cis	1	rs7635522	chr3:48423656	TREX1	chr3:48501186-48509043:+	-0.24	-5.59	3.72E-8	Longevity	
THCA	cis	1	rs7635522	chr3:48423656	ZNF589	chr3:48282596-48329113:+	0.16	3.47	0.000567	Longevity	
THCA	cis	1	rs7636044	chr3:48484560	ATRIP	chr3:48488141-48507708:+	0.19	4.22	2.93E-5	Longevity	
THCA	cis	1	rs7636044	chr3:48484560	TREX1	chr3:48501186-48509043:+	-0.25	-5.72	1.88E-8	Longevity	
THCA	cis	1	rs76363448	chr20:33655535	PROCR	chr20:33758727-33765164:+	-0.34	-5.45	8.29E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs76363448	chr20:33655535	TRPC4AP	chr20:33590215-33680618:-	0.33	3.93	9.8E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs7636782	chr3:48421387	ATRIP	chr3:48488141-48507708:+	0.17	3.77	0.000181	Longevity	
THCA	cis	1	rs7636782	chr3:48421387	TREX1	chr3:48501186-48509043:+	-0.24	-5.54	4.94E-8	Longevity	
THCA	cis	1	rs7636782	chr3:48421387	ZNF589	chr3:48282596-48329113:+	0.15	3.39	0.000765	Longevity	
THCA	cis	1	rs76368799	chr19:52561507	ZNF432	chr19:52536678-52552073:-	-0.18	-4.57	6.29E-6	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	
THCA	cis	1	rs7637227	chr3:134244155	ANAPC13	chr3:134196547-134204865:-	0.39	12.61	1.14E-31	Height	
THCA	cis	1	rs7637227	chr3:134244155	CEP63	chr3:134204575-134293852:+	0.31	6.71	5.59E-11	Height	
THCA	cis	1	rs7637888	chr3:10080722	C3orf10	chr3:10157333-10168873:+	-0.2	-4.3	2.08E-5	Alzheimer's disease	
THCA	cis	1	rs7637888	chr3:10080722	VHL	chr3:10183319-10193744:+	-0.19	-4.42	1.24E-5	Alzheimer's disease	
THCA	cis	1	rs7638668	chr3:161047283	NMD3	chr3:160939099-160971319:+	-0.11	-3.64	0.000304	Morning vs. evening chronotype	
THCA	cis	1	rs76388414	chr7:1100694	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.81	1.11E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs7638909	chr3:38594973	SCN5A	chr3:38589554-38691164:-	0.18	3.49	0.000536	Electrocardiographic conduction measures	
THCA	cis	1	rs7639477	chr3:51915752	RAD54L2	chr3:51575596-51697610:+	0.08	3.68	0.000257	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs7639514	chr3:156576067	LEKR1	chr3:156544076-156763918:+	-0.55	-11.1	1.28E-25	Bone mineral density	
THCA	cis	1	rs76403598	chr19:12166182	ZNF763	chr19:12035900-12091196:+	-0.4	-4.74	2.76E-6	Multiple sclerosis	
THCA	cis	1	rs76412521	chr16:77780916	NUDT7	chr16:77756411-77776153:+	0.35	4.83	1.86E-6	Obesity-related traits	
THCA	cis	1	rs76414143	chr5:115625396	COMMD10	chr5:115420727-115628978:+	0.48	5.83	1.01E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs76419734	chr4:106624285	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs76433514	chr5:150306532	LOC134466	chr5:150310000-150326146:-	0.45	5.97	4.64E-9	Crohn's disease	
THCA	cis	1	rs76435345	chr13:28107638	MTIF3	chr13:28009783-28024711:-	0.18	3.63	0.000312	Weight	
THCA	cis	1	rs7644148	chr3:49545241	GMPPB	chr3:49758932-49761384:-	0.16	3.64	0.0003	Menarche (age at onset)	
THCA	cis	1	rs7644148	chr3:49545241	P4HTM	chr3:49027341-49044579:+	-0.17	-4.2	3.19E-5	Menarche (age at onset)	
THCA	cis	1	rs7644148	chr3:49545241	WDR6	chr3:49044637-49053386:+	0.18	3.71	0.000235	Menarche (age at onset)	
THCA	cis	1	rs76449411	chr2:17799354	GEN1	chr2:17935162-17966632:+	0.6	7.03	7.16E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs7644967	chr3:190999675	UTS2D	chr3:190984945-191048325:-	0.18	3.56	0.000414	Total ventricular volume (Alzheimer's disease interaction)	
THCA	cis	1	rs7645295	chr3:134307734	ANAPC13	chr3:134196547-134204865:-	0.37	11.36	1.22E-26	Height	
THCA	cis	1	rs7645295	chr3:134307734	CEP63	chr3:134204575-134293852:+	0.3	6.32	6.02E-10	Height	
THCA	cis	1	rs7645540	chr3:191000322	UTS2D	chr3:190984945-191048325:-	0.18	3.54	0.000444	Total ventricular volume (Alzheimer's disease interaction)	
THCA	cis	1	rs7645611	chr3:53125297	RFT1	chr3:53122503-53164470:-	0.57	7.01	8.07E-12	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs7646144	chr3:41853125	ULK4	chr3:41288091-42003660:-	1.08	20.22	3.77E-66	Diastolic blood pressure	
THCA	cis	1	rs76461893	chr2:203865515	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.72	1.86E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs76461893	chr2:203865515	ICA1L	chr2:203637873-203736371:-	0.27	4.48	9.19E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs76471037	chr3:41799414	ULK4	chr3:41288091-42003660:-	1.08	19.9	1.28E-64	Diastolic blood pressure	
THCA	cis	1	rs7647307	chr3:69623188	FRMD4B	chr3:69219146-69591733:-	-0.14	-3.96	8.66E-5	Brain imaging	
THCA	cis	1	rs7647327	chr3:161016421	NMD3	chr3:160939099-160971319:+	-0.1	-3.43	0.00066	Morning vs. evening chronotype	
THCA	cis	1	rs76475039	chr1:179476763	C1orf125	chr1:179335107-179523868:+	0.53	5.46	7.79E-8	Multiple sclerosis (age of onset)	
THCA	cis	1	rs7647973	chr3:49510931	GMPPB	chr3:49758932-49761384:-	0.16	3.71	0.000228	Menarche (age at onset)	
THCA	cis	1	rs7647973	chr3:49510931	P4HTM	chr3:49027341-49044579:+	-0.18	-4.5	8.58E-6	Menarche (age at onset)	
THCA	cis	1	rs7648104	chr3:10073311	C3orf10	chr3:10157333-10168873:+	-0.2	-4.3	2.08E-5	Alzheimer's disease	
THCA	cis	1	rs7648104	chr3:10073311	VHL	chr3:10183319-10193744:+	-0.19	-4.42	1.24E-5	Alzheimer's disease	
THCA	cis	1	rs7648357	chr3:41849670	ULK4	chr3:41288091-42003660:-	1.09	20.56	8.89E-68	Diastolic blood pressure	
THCA	cis	1	rs7648578	chr3:41858731	ULK4	chr3:41288091-42003660:-	1.1	21.64	6.54E-73	Diastolic blood pressure	
THCA	cis	1	rs7648875	chr3:151073381	GPR87	chr3:151011876-151034636:-	0.2	4.39	1.4E-5	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs7648875	chr3:151073381	P2RY14	chr3:150929905-150996230:-	-0.18	-3.84	0.000138	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
THCA	cis	1	rs7648990	chr3:134244390	ANAPC13	chr3:134196547-134204865:-	0.39	12.58	1.56E-31	Height	
THCA	cis	1	rs7648990	chr3:134244390	CEP63	chr3:134204575-134293852:+	0.3	6.54	1.63E-10	Height	
THCA	cis	1	rs7648995	chr3:49438803	GMPPB	chr3:49758932-49761384:-	0.17	3.83	0.000148	Menarche (age at onset)	
THCA	cis	1	rs7648995	chr3:49438803	P4HTM	chr3:49027341-49044579:+	-0.17	-4.29	2.19E-5	Menarche (age at onset)	
THCA	cis	1	rs7648995	chr3:49438803	WDR6	chr3:49044637-49053386:+	0.17	3.59	0.000359	Menarche (age at onset)	
THCA	cis	1	rs76494403	chr10:81729731	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs7650227	chr3:41794937	ULK4	chr3:41288091-42003660:-	1.06	19.57	4.75E-63	Diastolic blood pressure	
THCA	cis	1	rs76506978	chr18:51790340	POLI	chr18:51795849-51824602:+	0.18	5.26	2.13E-7	Psoriasis	
THCA	cis	1	rs76507298	chr20:33623522	PROCR	chr20:33758727-33765164:+	-0.36	-5.7	2.14E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs76507298	chr20:33623522	TRPC4AP	chr20:33590215-33680618:-	0.31	3.77	0.000182	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs7651058	chr3:10066964	C3orf10	chr3:10157333-10168873:+	-0.2	-4.12	4.46E-5	Alzheimer's disease	
THCA	cis	1	rs7651058	chr3:10066964	VHL	chr3:10183319-10193744:+	-0.18	-4.17	3.59E-5	Alzheimer's disease	
THCA	cis	1	rs7651407	chr3:48443816	ATRIP	chr3:48488141-48507708:+	0.18	3.95	8.97E-5	Longevity	
THCA	cis	1	rs7651407	chr3:48443816	TREX1	chr3:48501186-48509043:+	-0.25	-5.85	9.11E-9	Longevity	
THCA	cis	1	rs7651757	chr3:195077305	C3orf21	chr3:194789015-194991895:-	0.28	6.45	2.82E-10	Body mass index	
THCA	cis	1	rs7652935	chr3:10151138	C3orf10	chr3:10157333-10168873:+	-0.21	-4.51	8.24E-6	Alzheimer's disease	
THCA	cis	1	rs7652935	chr3:10151138	VHL	chr3:10183319-10193744:+	-0.19	-4.44	1.13E-5	Alzheimer's disease	
THCA	cis	1	rs7653233	chr3:160992033	NMD3	chr3:160939099-160971319:+	-0.11	-3.59	0.000363	Morning vs. evening chronotype	
THCA	cis	1	rs7653361	chr3:160992291	NMD3	chr3:160939099-160971319:+	-0.11	-3.72	0.000221	Morning vs. evening chronotype	
THCA	cis	1	rs7653691	chr3:48419689	ATRIP	chr3:48488141-48507708:+	-0.18	-3.95	9.14E-5	Longevity	
THCA	cis	1	rs7653691	chr3:48419689	TREX1	chr3:48501186-48509043:+	0.25	5.8	1.23E-8	Longevity	
THCA	cis	1	rs765377	chr13:78377834	EDNRB	chr13:78469616-78549664:-	-0.14	-4.22	2.89E-5	Hair color	
THCA	cis	1	rs7654271	chr4:75708071	BTC	chr4:75671448-75719882:-	0.21	3.93	9.85E-5	Electroencephalogram traits	
THCA	cis	1	rs76542740	chr15:43891512	ADAL	chr15:43622872-43646094:+	-0.42	-9.11	2.27E-18	Tumor biomarkers	
THCA	cis	1	rs76542740	chr15:43891512	CATSPER2	chr15:43922774-43959900:-	-0.32	-5.71	2.03E-8	Tumor biomarkers	
THCA	cis	1	rs76542740	chr15:43891512	STRC	chr15:43891762-43924561:-	0.4	7.38	6.9E-13	Tumor biomarkers	
THCA	cis	1	rs76542740	chr15:43891512	TUBGCP4	chr15:43663313-43698238:+	0.14	3.94	9.3E-5	Tumor biomarkers	
THCA	cis	1	rs7654345	chr4:17691796	MED28	chr4:17616273-17629791:+	0.15	3.36	0.000847	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs76546854	chr10:81728658	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs76548544	chr5:150223515	LOC134466	chr5:150310000-150326146:-	0.39	5.36	1.31E-7	Crohn's disease	
THCA	cis	1	rs7655122	chr4:39122016	KLHL5	chr4:39046659-39123828:+	-0.21	-5.77	1.47E-8	Uric acid levels	
THCA	cis	1	rs765516	chr6:117728118	DCBLD1	chr6:117803820-117891018:+	0.45	9.79	9.74E-21	Lung cancer	
THCA	cis	1	rs765516	chr6:117728118	GOPC	chr6:117639351-117923681:-	0.22	6.36	4.72E-10	Lung cancer	
THCA	cis	1	rs76552490	chr11:212015	PSMD13	chr11:236808-252984:+	0.22	6.57	1.33E-10	Menarche (age at onset)	
THCA	cis	1	rs765527	chr19:22129555	ZNF257	chr19:22235266-22273901:+	-0.32	-6.49	2.11E-10	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs765529	chr18:23590854	SS18	chr18:23596219-23671164:-	0.29	3.64	0.000299	Rhegmatogenous retinal detachment	
THCA	cis	1	rs76553384	chr14:74383679	LIN52	chr14:74551656-74667117:+	0.22	4.12	4.46E-5	Morning vs. evening chronotype	
THCA	cis	1	rs76553384	chr14:74383679	ZNF410	chr14:74318674-74398803:+	0.24	4	7.24E-5	Morning vs. evening chronotype	
THCA	cis	1	rs7655399	chr4:75705096	BTC	chr4:75671448-75719882:-	0.21	3.93	9.95E-5	Electroencephalogram traits	
THCA	cis	1	rs7655792	chr4:90642025	MMRN1	chr4:90816003-90875778:+	0.32	4.07	5.41E-5	Parkinson's disease	
THCA	cis	1	rs7655841	chr4:129890790	C4orf33	chr4:130014829-130033842:+	0.61	9.58	5.34E-20	Chronic obstructive pulmonary disease (moderate to severe)	
THCA	cis	1	rs7656037	chr4:39717965	RPL9	chr4:39455747-39460568:-	-0.44	-8.06	6.27E-15	Plasma amyloid beta peptide concentrations (ABx-40)	
THCA	cis	1	rs7656037	chr4:39717965	UBE2K	chr4:39699664-39784408:+	-0.15	-3.68	0.000256	Plasma amyloid beta peptide concentrations (ABx-40)	
THCA	cis	1	rs7657678	chr4:17951035	DCAF16	chr4:17802280-17812381:-	-0.2	-4.36	1.59E-5	Height	
THCA	cis	1	rs765787	chr15:45500047	GATM	chr15:45653324-45670980:-	-0.17	-3.5	0.000501	Uric acid levels	
THCA	cis	1	rs7657926	chr4:39134063	KLHL5	chr4:39046659-39123828:+	-0.21	-5.77	1.46E-8	Uric acid levels	
THCA	cis	1	rs7657962	chr4:106966715	TBCK	chr4:106967233-107237861:-	0.35	7.23	1.94E-12	Airflow obstruction	
THCA	cis	1	rs76579763	chr14:59935971	C14orf149	chr14:59939406-59951126:-	-0.42	-4.83	1.84E-6	Schizophrenia	
THCA	cis	1	rs76579763	chr14:59935971	JKAMP	chr14:59951161-59972080:+	0.46	5.22	2.73E-7	Schizophrenia	
THCA	cis	1	rs7658118	chr4:99994608	ADH5	chr4:99992132-100009931:-	0.21	3.42	0.000678	Smoking initiation	
THCA	cis	1	rs7658200	chr4:75712363	BTC	chr4:75671448-75719882:-	0.2	3.92	0.000101	Electroencephalogram traits	
THCA	cis	1	rs76586692	chr11:18453726	LDHC	chr11:18433853-18472792:+	-0.29	-3.5	0.0005	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs76590353	chr1:108342624	VAV3	chr1:108113782-108507545:-	0.47	6.92	1.42E-11	Hypothyroidism	
THCA	cis	1	rs7659195	chr4:18022692	DCAF16	chr4:17802280-17812381:-	-0.2	-4.52	7.89E-6	Height	
THCA	cis	1	rs76594057	chr18:44637272	HDHD2	chr18:44633782-44676871:-	0.27	5.09	5.15E-7	Sitting height ratio	
THCA	cis	1	rs76594057	chr18:44637272	PIAS2	chr18:44392061-44500123:-	-0.16	-3.42	0.000686	Sitting height ratio	
THCA	cis	1	rs7659604	chr4:122665514	EXOSC9	chr4:122722472-122738175:+	-0.14	-3.78	0.000176	Type 2 diabetes	
THCA	cis	1	rs7659718	chr4:17638020	MED28	chr4:17616273-17629791:+	0.18	3.94	9.3E-5	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs76599129	chr11:18471627	LDHC	chr11:18433853-18472792:+	-0.33	-3.94	9.26E-5	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs7659943	chr4:122665560	EXOSC9	chr4:122722472-122738175:+	0.15	4.06	5.85E-5	Type 2 diabetes	
THCA	cis	1	rs7660078	chr4:122665577	EXOSC9	chr4:122722472-122738175:+	0.15	3.97	8.17E-5	Type 2 diabetes	
THCA	cis	1	rs76604840	chr12:51376494	SLC11A2	chr12:51373319-51422058:-	-0.27	-5.24	2.47E-7	Type 2 diabetes	
THCA	cis	1	rs76604840	chr12:51376494	TFCP2	chr12:51488608-51566917:-	-0.19	-4.06	5.75E-5	Type 2 diabetes	
THCA	cis	1	rs7660642	chr4:17956017	DCAF16	chr4:17802280-17812381:-	-0.2	-4.41	1.28E-5	Height	
THCA	cis	1	rs76609693	chr2:48381731	FOXN2	chr2:48541795-48606434:+	0.24	4.25	2.62E-5	Schizophrenia	
THCA	cis	1	rs7661070	chr4:39724365	RPL9	chr4:39455747-39460568:-	-0.44	-7.98	1.1E-14	Plasma amyloid beta peptide concentrations (ABx-40)	
THCA	cis	1	rs7661070	chr4:39724365	UBE2K	chr4:39699664-39784408:+	-0.15	-3.71	0.000229	Plasma amyloid beta peptide concentrations (ABx-40)	
THCA	cis	1	rs7661129	chr4:17973171	DCAF16	chr4:17802280-17812381:-	-0.2	-4.41	1.26E-5	Height	
THCA	cis	1	rs7661148	chr4:17973217	DCAF16	chr4:17802280-17812381:-	-0.22	-4.4	1.35E-5	Height	
THCA	cis	1	rs7661702	chr4:104140129	BDH2	chr4:103998783-104021024:-	0.26	5.97	4.72E-9	Testicular germ cell tumor	
THCA	cis	1	rs7661702	chr4:104140129	CISD2	chr4:103790135-103809913:+	-0.15	-3.6	0.000352	Testicular germ cell tumor	
THCA	cis	1	rs7661702	chr4:104140129	MANBA	chr4:103552644-103682151:-	0.16	4.08	5.32E-5	Testicular germ cell tumor	
THCA	cis	1	rs7662221	chr4:17966468	DCAF16	chr4:17802280-17812381:-	-0.2	-4.37	1.51E-5	Height	
THCA	cis	1	rs76623374	chr15:66767868	TIPIN	chr15:66629008-66649054:-	-0.38	-3.84	0.000138	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs7663737	chr4:139132905	SLC7A11	chr4:139085248-139163503:-	0.22	4.47	9.9E-6	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	
THCA	cis	1	rs7663818	chr4:17936443	DCAF16	chr4:17802280-17812381:-	-0.21	-4.63	4.68E-6	Height	
THCA	cis	1	rs7663887	chr4:17902920	DCAF16	chr4:17802280-17812381:-	-0.21	-4.57	6.21E-6	Height	
THCA	cis	1	rs7664078	chr4:39118203	KLHL5	chr4:39046659-39123828:+	-0.21	-5.77	1.47E-8	Uric acid levels	
THCA	cis	1	rs7664683	chr4:103255692	BANK1	chr4:102341118-102995967:+	-0.24	-3.41	0.0007	Erythrocyte cadmium concentration in never smokers	
THCA	cis	1	rs76648234	chr20:33689941	PROCR	chr20:33758727-33765164:+	-0.33	-5.4	1.03E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs76648234	chr20:33689941	TRPC4AP	chr20:33590215-33680618:-	0.34	4.24	2.67E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs7664828	chr4:103551376	CISD2	chr4:103790135-103809913:+	-0.15	-3.4	0.000729	Primary biliary cirrhosis	
THCA	cis	1	rs7664828	chr4:103551376	NFKB1	chr4:103422486-103538458:+	0.14	3.96	8.67E-5	Primary biliary cirrhosis	
THCA	cis	1	rs7665090	chr4:103551603	CISD2	chr4:103790135-103809913:+	0.15	3.51	0.000487	Primary biliary cirrhosis	
THCA	cis	1	rs7665090	chr4:103551603	NFKB1	chr4:103422486-103538458:+	-0.14	-3.9	0.00011	Primary biliary cirrhosis	
THCA	cis	1	rs76654964	chr11:116823521	PCSK7	chr11:117075789-117102811:-	0.45	5.41	1.01E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs76655667	chr8:89422327	MMP16	chr8:89049462-89339717:-	0.32	5.19	3.04E-7	Electrodermal activity	
THCA	cis	1	rs7665590	chr4:99796784	EIF4E	chr4:99799607-99851786:-	-0.2	-4.3	2.06E-5	Primary biliary cirrhosis	
THCA	cis	1	rs7665659	chr4:103551818	CISD2	chr4:103790135-103809913:+	-0.15	-3.4	0.000729	Primary biliary cirrhosis	
THCA	cis	1	rs7665659	chr4:103551818	NFKB1	chr4:103422486-103538458:+	0.14	3.96	8.67E-5	Primary biliary cirrhosis	
THCA	cis	1	rs7665727	chr4:277057	ZNF718	chr4:53272-156488:+	0.5	9.42	1.94E-19	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs7665727	chr4:277057	ZNF876P	chr4:206389-249771:+	-0.24	-3.35	0.000858	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs7665854	chr4:103551909	CISD2	chr4:103790135-103809913:+	-0.15	-3.4	0.000729	Primary biliary cirrhosis	
THCA	cis	1	rs7665854	chr4:103551909	NFKB1	chr4:103422486-103538458:+	0.14	3.96	8.67E-5	Primary biliary cirrhosis	
THCA	cis	1	rs7667496	chr4:103509455	NFKB1	chr4:103422486-103538458:+	0.16	4.56	6.41E-6	Ulcerative colitis	
THCA	cis	1	rs7667849	chr4:56388199	TMEM165	chr4:56262090-56292342:+	0.15	3.71	0.000234	Personality dimensions	
THCA	cis	1	rs7667	chr1:19718824	CAPZB	chr1:19665274-19811992:-	0.13	3.59	0.000365	Crohn's disease and psoriasis	
THCA	cis	1	rs7668147	chr4:56339384	TMEM165	chr4:56262090-56292342:+	-0.16	-4.06	5.7E-5	Personality dimensions	
THCA	cis	1	rs76683040	chr11:119152684	CBL	chr11:119076990-119178858:+	-0.21	-4.02	6.71E-5	Platelet count	
THCA	cis	1	rs76683169	chr10:102358397	SEC31B	chr10:102246403-102289636:-	-0.27	-7.79	4.29E-14	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs7668417	chr4:18025029	DCAF16	chr4:17802280-17812381:-	-0.2	-4.49	8.89E-6	Height	
THCA	cis	1	rs76688555	chr2:190747415	ASNSD1	chr2:190526125-190535556:+	-0.55	-5.72	1.9E-8	Subcutaneous adipose tissue	
THCA	cis	1	rs7668933	chr4:17988141	DCAF16	chr4:17802280-17812381:-	-0.2	-4.52	7.87E-6	Height	
THCA	cis	1	rs76689818	chr8:89486770	MMP16	chr8:89049462-89339717:-	0.33	5.09	5.11E-7	Electrodermal activity	
THCA	cis	1	rs76693798	chr3:184711113	C3orf70	chr3:184795840-184870802:-	-0.26	-4.96	9.92E-7	Heschl's gyrus morphology	
THCA	cis	1	rs76694233	chr4:106681036	INTS12	chr4:106603787-106629881:-	-0.62	-5.3	1.78E-7	Post bronchodilator FEV1	
THCA	cis	1	rs7669892	chr4:309253	ZNF718	chr4:53272-156488:+	-0.3	-6.58	1.21E-10	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs7669892	chr4:309253	ZNF732	chr4:259482-299263:-	0.4	5.73	1.75E-8	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs7670225	chr4:56368018	TMEM165	chr4:56262090-56292342:+	-0.15	-3.67	0.000266	Personality dimensions	
THCA	cis	1	rs7670435	chr4:17962260	DCAF16	chr4:17802280-17812381:-	-0.2	-4.37	1.51E-5	Height	
THCA	cis	1	rs76708296	chr11:18456133	LDHC	chr11:18433853-18472792:+	-0.3	-3.57	0.000386	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs7671110	chr4:17874089	DCAF16	chr4:17802280-17812381:-	-0.2	-4.34	1.78E-5	Height	
THCA	cis	1	rs76722536	chr6:26192946	HIST1H2AE	chr6:26217148-26217711:+	-0.22	-3.44	0.000627	Renal underexcretion gout;Gout	
THCA	cis	1	rs76722536	chr6:26192946	HIST1H3E	chr6:26224427-26226589:+	0.44	7.15	3.32E-12	Renal underexcretion gout;Gout	
THCA	cis	1	rs7672884	chr4:75707822	BTC	chr4:75671448-75719882:-	0.21	4.08	5.34E-5	Electroencephalogram traits	
THCA	cis	1	rs767322	chr13:85729583	SLITRK6	chr13:86366922-86373483:-	-0.21	-3.84	0.000142	Bipolar disorder (mania)	
THCA	cis	1	rs7673299	chr4:39110758	KLHL5	chr4:39046659-39123828:+	-0.21	-5.78	1.38E-8	Uric acid levels	
THCA	cis	1	rs7673321	chr4:17957688	DCAF16	chr4:17802280-17812381:-	-0.24	-5.17	3.45E-7	Height	
THCA	cis	1	rs7673500	chr4:17621383	MED28	chr4:17616273-17629791:+	0.2	4.48	9.15E-6	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs7673908	chr4:56394819	TMEM165	chr4:56262090-56292342:+	0.16	4.13	4.35E-5	Personality dimensions	
THCA	cis	1	rs76740259	chr15:56520860	MNS1	chr15:56720929-56757335:-	-0.24	-3.51	0.000485	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs76740259	chr15:56520860	TEX9	chr15:56657644-56738071:+	-0.34	-5.81	1.12E-8	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs76742243	chr7:107144202	DLD	chr7:107531586-107561642:+	0.14	3.5	0.00051	Osteoarthritis	
THCA	cis	1	rs7674560	chr4:263319	ZNF718	chr4:53272-156488:+	0.51	9.89	4.07E-21	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs767471	chr6:26557854	BTN2A3	chr6:26422317-26431927:+	0.18	4.34	1.74E-5	Educational attainment	
THCA	cis	1	rs767471	chr6:26557854	HCG11	chr6:26521934-26527610:+	-0.22	-4.36	1.63E-5	Educational attainment	
THCA	cis	1	rs767471	chr6:26557854	HMGN4	chr6:26538572-26547162:+	-0.16	-4.09	5.11E-5	Educational attainment	
THCA	cis	1	rs767471	chr6:26557854	LOC100270746	chr6:26987146-26988085:-	-0.14	-3.39	0.00077	Educational attainment	
THCA	cis	1	rs767471	chr6:26557854	ZNF322A	chr6:26634612-26659963:-	-0.16	-4.45	1.07E-5	Educational attainment	
THCA	cis	1	rs76751500	chr16:77785771	NUDT7	chr16:77756411-77776153:+	0.34	4.68	3.81E-6	Obesity-related traits	
THCA	cis	1	rs7675290	chr4:90645003	MMRN1	chr4:90816003-90875778:+	0.3	3.82	0.000148	Parkinson's disease	
THCA	cis	1	rs76753180	chr5:130763701	P4HA2	chr5:131528306-131563556:-	-0.27	-5.13	4.12E-7	Life satisfaction	
THCA	cis	1	rs7675782	chr4:39121668	KLHL5	chr4:39046659-39123828:+	-0.21	-5.97	4.76E-9	Uric acid levels	
THCA	cis	1	rs7675806	chr4:17952959	DCAF16	chr4:17802280-17812381:-	-0.19	-4.37	1.54E-5	Height	
THCA	cis	1	rs7676008	chr4:39121774	KLHL5	chr4:39046659-39123828:+	-0.21	-5.77	1.47E-8	Uric acid levels	
THCA	cis	1	rs76768215	chr19:52572623	ZNF432	chr19:52536678-52552073:-	-0.18	-4.56	6.48E-6	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	
THCA	cis	1	rs7676975	chr4:106763811	INTS12	chr4:106603787-106629881:-	-0.45	-4.22	2.97E-5	Post bronchodilator FEV1	
THCA	cis	1	rs7677194	chr4:17962684	DCAF16	chr4:17802280-17812381:-	-0.22	-4.42	1.25E-5	Height	
THCA	cis	1	rs7677248	chr4:106960497	TBCK	chr4:106967233-107237861:-	-0.33	-6.9	1.64E-11	Airflow obstruction	
THCA	cis	1	rs7677509	chr4:103550006	NFKB1	chr4:103422486-103538458:+	0.14	4	7.36E-5	Primary biliary cirrhosis	
THCA	cis	1	rs7677526	chr4:56349908	TMEM165	chr4:56262090-56292342:+	-0.17	-4.28	2.29E-5	Personality dimensions	
THCA	cis	1	rs76784350	chr2:27764278	FNDC4	chr2:27714751-27718126:-	-0.15	-3.48	0.000544	Oral cavity cancer	
THCA	cis	1	rs7678847	chr4:106987426	TBCK	chr4:106967233-107237861:-	0.34	7.12	4.08E-12	Airflow obstruction	
THCA	cis	1	rs76796947	chr5:115501040	COMMD10	chr5:115420727-115628978:+	0.46	5.74	1.65E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs7679	chr20:44576502	WFDC3	chr20:44402847-44420547:-	0.28	4.06	5.79E-5	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
THCA	cis	1	rs76804143	chr7:1082021	ZFAND2A	chr7:1192544-1199855:-	-0.32	-4.7	3.38E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs7681116	chr4:39134635	KLHL5	chr4:39046659-39123828:+	-0.21	-5.77	1.46E-8	Uric acid levels	
THCA	cis	1	rs76812330	chr19:50531860	SIGLEC16	chr19:50472912-50479075:+	0.57	5.63	3.04E-8	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
THCA	cis	1	rs7681312	chr4:90638527	MMRN1	chr4:90816003-90875778:+	0.32	4.07	5.41E-5	Parkinson's disease	
THCA	cis	1	rs7681815	chr4:90638614	MMRN1	chr4:90816003-90875778:+	0.32	4.07	5.5E-5	Parkinson's disease	
THCA	cis	1	rs76819459	chr16:79718917	MAF	chr16:79627746-79634622:-	-0.23	-3.86	0.000128	Urate levels	
THCA	cis	1	rs7682206	chr4:68428980	CENPC1	chr4:68337989-68411256:-	0.28	6.16	1.54E-9	Parkinson's disease	
THCA	cis	1	rs7682497	chr4:139135399	SLC7A11	chr4:139085248-139163503:-	0.22	4.46	1.0E-5	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	
THCA	cis	1	rs76833820	chr7:1070278	ZFAND2A	chr7:1192544-1199855:-	-0.3	-4.4	1.33E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs76841360	chr1:40060025	PABPC4	chr1:40026485-40042521:-	-0.27	-4.72	3.12E-6	C-reactive protein levels or triglyceride levels (pleiotropy)	
THCA	cis	1	rs76841451	chr1:101656441	SLC30A7	chr1:101361632-101447311:+	-0.24	-3.61	0.000337	Refractive astigmatism	
THCA	cis	1	rs76841836	chr11:120051217	TRIM29	chr11:119981995-120008863:-	0.42	7.06	6.02E-12	Stroke (pediatric)	
THCA	cis	1	rs7684221	chr4:17957354	DCAF16	chr4:17802280-17812381:-	-0.2	-4.37	1.51E-5	Height	
THCA	cis	1	rs7684318	chr4:90655003	MMRN1	chr4:90816003-90875778:+	0.32	3.86	0.000131	Parkinson's disease	
THCA	cis	1	rs76847935	chr15:66769613	TIPIN	chr15:66629008-66649054:-	-0.4	-4.1	4.79E-5	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs76850134	chr20:33671725	PROCR	chr20:33758727-33765164:+	-0.34	-5.45	8.29E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs76850134	chr20:33671725	TRPC4AP	chr20:33590215-33680618:-	0.33	3.93	9.8E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs7685082	chr4:39118092	KLHL5	chr4:39046659-39123828:+	-0.21	-5.77	1.47E-8	Uric acid levels	
THCA	cis	1	rs76852223	chr6:159370432	RSPH3	chr6:159398268-159421198:-	0.28	6	3.97E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs7685468	chr4:39118269	KLHL5	chr4:39046659-39123828:+	-0.21	-5.81	1.12E-8	Uric acid levels	
THCA	cis	1	rs7686082	chr4:17957576	DCAF16	chr4:17802280-17812381:-	-0.2	-4.51	8.21E-6	Height	
THCA	cis	1	rs7686546	chr4:240614	ZNF718	chr4:53272-156488:+	0.5	9.29	5.55E-19	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs7686546	chr4:240614	ZNF732	chr4:259482-299263:-	-0.24	-3.38	0.000776	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs7686578	chr4:75712726	BTC	chr4:75671448-75719882:-	0.2	3.9	0.00011	Electroencephalogram traits	
THCA	cis	1	rs76873509	chr8:38021982	LSM1	chr8:38020861-38034169:-	-0.15	-4.01	7.13E-5	Schizophrenia	
THCA	cis	1	rs7687557	chr4:39769260	RPL9	chr4:39455747-39460568:-	-0.43	-7.97	1.14E-14	Plasma amyloid beta peptide concentrations (ABx-40)	
THCA	cis	1	rs7687557	chr4:39769260	UBE2K	chr4:39699664-39784408:+	-0.15	-3.75	0.000198	Plasma amyloid beta peptide concentrations (ABx-40)	
THCA	cis	1	rs7688014	chr4:103975060	BDH2	chr4:103998783-104021024:-	0.31	6.72	5.15E-11	Schizophrenia	
THCA	cis	1	rs7688014	chr4:103975060	CISD2	chr4:103790135-103809913:+	-0.19	-4.12	4.4E-5	Schizophrenia	
THCA	cis	1	rs7688014	chr4:103975060	MANBA	chr4:103552644-103682151:-	0.17	3.93	9.8E-5	Schizophrenia	
THCA	cis	1	rs76890136	chr2:203850011	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.69	2.21E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs76890136	chr2:203850011	ICA1L	chr2:203637873-203736371:-	0.27	4.48	9.33E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs7689714	chr4:122665943	EXOSC9	chr4:122722472-122738175:+	0.15	3.97	8.17E-5	Type 2 diabetes	
THCA	cis	1	rs7689722	chr4:122665955	EXOSC9	chr4:122722472-122738175:+	0.15	3.97	8.17E-5	Type 2 diabetes	
THCA	cis	1	rs768994	chr6:159399348	RSPH3	chr6:159398268-159421198:-	0.29	6.05	2.96E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs76901676	chr1:179452520	C1orf125	chr1:179335107-179523868:+	0.58	6.12	1.94E-9	Multiple sclerosis (age of onset)	
THCA	cis	1	rs76904798	chr12:40614434	SLC2A13	chr12:40148825-40499661:-	-0.18	-3.56	0.000401	Parkinson's disease	
THCA	cis	1	rs7690823	chr4:17957698	DCAF16	chr4:17802280-17812381:-	-0.2	-4.37	1.51E-5	Height	
THCA	cis	1	rs7691115	chr4:139132812	SLC7A11	chr4:139085248-139163503:-	0.22	4.49	9.05E-6	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	
THCA	cis	1	rs7692069	chr4:106959289	TBCK	chr4:106967233-107237861:-	0.33	6.78	3.49E-11	Airflow obstruction	
THCA	cis	1	rs7692290	chr4:75712720	BTC	chr4:75671448-75719882:-	0.2	3.9	0.00011	Electroencephalogram traits	
THCA	cis	1	rs76924513	chr7:107205887	DLD	chr7:107531586-107561642:+	0.14	3.45	0.0006	Osteoarthritis	
THCA	cis	1	rs7692503	chr4:75712852	BTC	chr4:75671448-75719882:-	0.2	3.89	0.000113	Electroencephalogram traits	
THCA	cis	1	rs7692606	chr4:103509681	NFKB1	chr4:103422486-103538458:+	0.16	4.56	6.41E-6	Ulcerative colitis	
THCA	cis	1	rs7692669	chr4:75712905	BTC	chr4:75671448-75719882:-	0.2	3.89	0.000113	Electroencephalogram traits	
THCA	cis	1	rs7692919	chr4:165902781	C4orf39	chr4:165878100-165880273:+	0.17	4.89	1.37E-6	Ovarian cancer in BRCA1 mutation carriers	
THCA	cis	1	rs7692995	chr4:17936634	DCAF16	chr4:17802280-17812381:-	-0.21	-4.63	4.68E-6	Height	
THCA	cis	1	rs76935404	chr19:41419294	CYP2B7P1	chr19:41430170-41456563:+	-0.24	-4.21	3.06E-5	nicotine metabolite ratio in current smokers	
THCA	cis	1	rs7693977	chr4:165903050	C4orf39	chr4:165878100-165880273:+	0.17	4.69	3.61E-6	Ovarian cancer in BRCA1 mutation carriers	
THCA	cis	1	rs7694020	chr4:17682597	MED28	chr4:17616273-17629791:+	0.16	3.45	0.000609	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs7694190	chr4:104168017	BDH2	chr4:103998783-104021024:-	0.24	5.43	8.85E-8	Testicular germ cell tumor	
THCA	cis	1	rs7694190	chr4:104168017	CISD2	chr4:103790135-103809913:+	-0.15	-3.44	0.000641	Testicular germ cell tumor	
THCA	cis	1	rs7694190	chr4:104168017	MANBA	chr4:103552644-103682151:-	0.16	3.84	0.00014	Testicular germ cell tumor	
THCA	cis	1	rs7694379	chr4:88186509	HSD17B11	chr4:88257691-88312455:-	0.31	6.23	1.04E-9	Platelet count	
THCA	cis	1	rs7694606	chr4:18028987	DCAF16	chr4:17802280-17812381:-	-0.2	-4.54	7.09E-6	Height	
THCA	cis	1	rs7694760	chr4:39128101	KLHL5	chr4:39046659-39123828:+	-0.21	-5.77	1.46E-8	Uric acid levels	
THCA	cis	1	rs7694806	chr4:18029100	DCAF16	chr4:17802280-17812381:-	-0.2	-4.54	7.09E-6	Height	
THCA	cis	1	rs76949321	chr11:116846343	PCSK7	chr11:117075789-117102811:-	0.43	5.18	3.29E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs76949596	chr1:75862560	SLC44A5	chr1:75667816-76143610:-	-0.34	-3.49	0.000533	Whole-brain volume (Alzheimer's disease interaction)	
THCA	cis	1	rs7695840	chr4:17962379	DCAF16	chr4:17802280-17812381:-	-0.2	-4.37	1.51E-5	Height	
THCA	cis	1	rs76959488	chr11:30376314	C11orf46	chr11:30344649-30359978:+	0.23	4.28	2.24E-5	Sex hormone levels;Menopause (age at onset)	
THCA	cis	1	rs7695989	chr4:139135332	SLC7A11	chr4:139085248-139163503:-	0.23	4.55	6.94E-6	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	
THCA	cis	1	rs76964550	chr10:81729733	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs76964971	chr2:9763904	IAH1	chr2:9614670-9636671:+	0.15	3.37	0.000803	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	
THCA	cis	1	rs7696532	chr4:18029299	DCAF16	chr4:17802280-17812381:-	-0.21	-4.68	3.69E-6	Height	
THCA	cis	1	rs7697447	chr4:75226137	EREG	chr4:75230860-75254477:+	0.13	3.4	0.000722	Attention deficit hyperactivity disorder	
THCA	cis	1	rs7697634	chr4:17966746	DCAF16	chr4:17802280-17812381:-	-0.2	-4.49	9.02E-6	Height	
THCA	cis	1	rs7697889	chr4:17617961	MED28	chr4:17616273-17629791:+	0.21	4.57	6.14E-6	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs7698271	chr4:18019413	DCAF16	chr4:17802280-17812381:-	-0.2	-4.52	7.89E-6	Height	
THCA	cis	1	rs76986350	chr16:77784738	NUDT7	chr16:77756411-77776153:+	0.36	4.96	9.82E-7	Obesity-related traits	
THCA	cis	1	rs7698644	chr4:18019572	DCAF16	chr4:17802280-17812381:-	-0.2	-4.52	7.89E-6	Height	
THCA	cis	1	rs76994419	chr15:40714150	C15orf23	chr15:40674922-40686488:+	0.65	8.59	1.26E-16	Heschl's gyrus morphology	
THCA	cis	1	rs76994419	chr15:40714150	IVD	chr15:40697686-40713512:+	-0.56	-9.98	1.94E-21	Heschl's gyrus morphology	
THCA	cis	1	rs7699678	chr4:103550096	NFKB1	chr4:103422486-103538458:+	0.14	4	7.36E-5	Primary biliary cirrhosis	
THCA	cis	1	rs77005033	chr13:28109793	MTIF3	chr13:28009783-28024711:-	0.18	3.62	0.000331	Weight	
THCA	cis	1	rs77020228	chr12:124418472	ZNF664	chr12:124457670-124499967:+	-0.18	-4.87	1.53E-6	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs77022811	chr2:190793046	ASNSD1	chr2:190526125-190535556:+	-0.55	-5.63	3.03E-8	Subcutaneous adipose tissue	
THCA	cis	1	rs7702905	chr5:2788906	C5orf38	chr5:2752262-2755512:+	-0.23	-3.46	0.000594	Toenail selenium levels	
THCA	cis	1	rs7702905	chr5:2788906	IRX2	chr5:2746281-2751769:-	-0.28	-4.24	2.67E-5	Toenail selenium levels	
THCA	cis	1	rs7703937	chr5:151729454	NMUR2	chr5:151771102-151784840:-	-0.52	-9.44	1.7E-19	Optic nerve measurement (cup area)	
THCA	cis	1	rs7705093	chr5:96290647	ERAP2	chr5:96211644-96255398:+	1.16	38.96	1.83E-150	Birdshot chorioretinopathy	
THCA	cis	1	rs7705542	chr5:150228318	LOC134466	chr5:150310000-150326146:-	0.39	5.38	1.17E-7	Crohn's disease	
THCA	cis	1	rs77056542	chr7:107089751	DLD	chr7:107531586-107561642:+	0.15	3.67	0.000272	Osteoarthritis	
THCA	cis	1	rs77066891	chr3:184553376	C3orf70	chr3:184795840-184870802:-	-0.26	-5.02	7.19E-7	Heschl's gyrus morphology	
THCA	cis	1	rs7706951	chr5:179733407	MAPK9	chr5:179660597-179719071:-	0.14	3.61	0.000339	Height	
THCA	cis	1	rs77078697	chr4:252048	ZNF718	chr4:53272-156488:+	0.51	9.89	4.07E-21	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs77083167	chr7:1071823	ZFAND2A	chr7:1192544-1199855:-	-0.3	-4.4	1.33E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs77092773	chr11:96110320	CCDC82	chr11:96085930-96123083:-	-0.25	-3.71	0.000228	Parkinson's disease	
THCA	cis	1	rs7709388	chr5:150246539	LOC134466	chr5:150310000-150326146:-	0.38	5.36	1.31E-7	Crohn's disease	
THCA	cis	1	rs7709464	chr5:150269441	LOC134466	chr5:150310000-150326146:-	0.38	5.28	2.01E-7	Crohn's disease	
THCA	cis	1	rs7709650	chr5:150246685	LOC134466	chr5:150310000-150326146:-	0.42	5.86	8.57E-9	Crohn's disease	
THCA	cis	1	rs7709650	chr5:150246685	ZNF300	chr5:150273964-150284391:-	0.16	3.46	0.000586	Crohn's disease	
THCA	cis	1	rs77097088	chr6:159354815	RSPH3	chr6:159398268-159421198:-	0.26	5.49	6.43E-8	Bladder cancer (smoking interaction)	
THCA	cis	1	rs7710963	chr5:110164629	TMEM232	chr5:109624934-110062381:-	0.21	4.14	4.1E-5	Asthma and hay fever	
THCA	cis	1	rs7711186	chr5:178086924	CLK4	chr5:178029665-178057616:-	0.18	4.06	5.79E-5	Urate levels in obese individuals	
THCA	cis	1	rs7712015	chr5:110428781	TSLP	chr5:110405778-110413722:+	-0.32	-4.15	3.93E-5	Eosinophil counts	
THCA	cis	1	rs7712015	chr5:110428781	WDR36	chr5:110427870-110466201:+	0.21	3.89	0.000115	Eosinophil counts	
THCA	cis	1	rs7712152	chr5:101708772	SLCO4C1	chr5:101569694-101632253:-	0.25	5.81	1.13E-8	Schizophrenia	
THCA	cis	1	rs77125988	chr1:108364711	VAV3	chr1:108113782-108507545:-	0.57	8.13	3.63E-15	Hypothyroidism	
THCA	cis	1	rs7713025	chr5:110416223	TSLP	chr5:110405778-110413722:+	0.34	4.6	5.48E-6	Eosinophil counts	
THCA	cis	1	rs7713025	chr5:110416223	WDR36	chr5:110427870-110466201:+	-0.17	-3.37	0.00082	Eosinophil counts	
THCA	cis	1	rs77136879	chr11:116808453	PCSK7	chr11:117075789-117102811:-	0.46	5.6	3.67E-8	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs7714415	chr5:150270292	LOC134466	chr5:150310000-150326146:-	0.38	5.29	1.84E-7	Crohn's disease	
THCA	cis	1	rs7714584	chr5:150270420	LOC134466	chr5:150310000-150326146:-	0.38	5.28	2.01E-7	Crohn's disease	
THCA	cis	1	rs77148055	chr5:115509920	COMMD10	chr5:115420727-115628978:+	0.48	5.7	2.09E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs7715981	chr5:150258107	LOC134466	chr5:150310000-150326146:-	0.38	5.3	1.77E-7	Crohn's disease	
THCA	cis	1	rs7716903	chr5:150258574	LOC134466	chr5:150310000-150326146:-	0.38	5.28	2.01E-7	Crohn's disease	
THCA	cis	1	rs77187281	chr19:50507667	SIGLEC16	chr19:50472912-50479075:+	0.64	5.96	5.01E-9	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
THCA	cis	1	rs7718874	chr5:176358065	ZNF346	chr5:176449697-176508190:+	-0.16	-5.45	8.25E-8	Menopause (age at onset);Menarche and menopause (age at onset)	
THCA	cis	1	rs7719149	chr5:109761489	TMEM232	chr5:109624934-110062381:-	0.45	4.88	1.45E-6	Cardiac structure and function	
THCA	cis	1	rs77199844	chr1:152757094	THEM4	chr1:151846060-151882113:-	0.4	3.51	0.000493	Inflammatory skin disease	
THCA	cis	1	rs771998	chr12:52358195	KRT80	chr12:52562781-52585784:-	-0.15	-3.82	0.000148	Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs77204473	chr11:116805064	PCSK7	chr11:117075789-117102811:-	0.5	5.42	9.69E-8	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs7720894	chr5:60733933	ERCC8	chr5:60169659-60240905:-	0.14	3.76	0.000192	Schizophrenia	
THCA	cis	1	rs77225875	chr6:159418145	RSPH3	chr6:159398268-159421198:-	0.28	5.96	4.98E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs77230711	chr2:203805552	ALS2CR8	chr2:203776978-203851060:+	-0.3	-5.95	5.24E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs77230711	chr2:203805552	ICA1L	chr2:203637873-203736371:-	0.26	4.29	2.13E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs77234191	chr4:258294	ZNF718	chr4:53272-156488:+	0.49	9.09	2.61E-18	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs7724036	chr5:150284808	LOC134466	chr5:150310000-150326146:-	-0.37	-5.36	1.33E-7	Crohn's disease	
THCA	cis	1	rs7724036	chr5:150284808	ZNF300	chr5:150273964-150284391:-	-0.15	-3.35	0.000875	Crohn's disease	
THCA	cis	1	rs7724496	chr5:101661468	SLCO4C1	chr5:101569694-101632253:-	0.25	5.65	2.77E-8	Schizophrenia	
THCA	cis	1	rs77245075	chr2:17810302	GEN1	chr2:17935162-17966632:+	0.63	7.2	2.42E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs77245705	chr8:89384911	MMP16	chr8:89049462-89339717:-	0.32	4.95	1.04E-6	Electrodermal activity	
THCA	cis	1	rs7724920	chr5:101779612	SLCO4C1	chr5:101569694-101632253:-	0.25	5.62	3.21E-8	Schizophrenia	
THCA	cis	1	rs7725605	chr5:179732678	MAPK9	chr5:179660597-179719071:-	0.15	3.81	0.000158	Height	
THCA	cis	1	rs77257477	chr8:96045399	C8orf38	chr8:95908040-96088396:+	-0.27	-4.61	5.09E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs77263937	chr20:50144303	ATP9A	chr20:50213314-50384908:-	-0.21	-3.38	0.000783	Self-reported allergy	
THCA	cis	1	rs7726839	chr5:618586	CEP72	chr5:612405-653664:+	-0.34	-6.41	3.4E-10	Obesity-related traits	
THCA	cis	1	rs77268589	chr2:203751981	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.93	5.93E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs77268589	chr2:203751981	ICA1L	chr2:203637873-203736371:-	0.25	4.18	3.49E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs7727038	chr5:131590257	P4HA2	chr5:131528306-131563556:-	0.48	11.33	1.62E-26	Blood metabolite levels	
THCA	cis	1	rs7727544	chr5:131590534	P4HA2	chr5:131528306-131563556:-	0.48	11.33	1.62E-26	Blood metabolite levels	
THCA	cis	1	rs7727882	chr5:115614507	COMMD10	chr5:115420727-115628978:+	0.43	5.49	6.7E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs77279246	chr11:96109554	CCDC82	chr11:96085930-96123083:-	-0.24	-3.84	0.000141	Parkinson's disease	
THCA	cis	1	rs7728612	chr5:110164674	TMEM232	chr5:109624934-110062381:-	0.21	4.14	4.1E-5	Asthma and hay fever	
THCA	cis	1	rs7729432	chr5:2793841	IRX2	chr5:2746281-2751769:-	-0.26	-3.91	0.000105	Toenail selenium levels	
THCA	cis	1	rs7729832	chr5:110428744	TSLP	chr5:110405778-110413722:+	0.31	3.98	7.92E-5	Eosinophil counts	
THCA	cis	1	rs7729832	chr5:110428744	WDR36	chr5:110427870-110466201:+	-0.21	-3.93	9.91E-5	Eosinophil counts	
THCA	cis	1	rs77303550	chr16:72079657	HP	chr16:72088508-72094957:+	-0.32	-4.88	1.45E-6	Metabolite levels (small molecules and protein measures)	
THCA	cis	1	rs7730585	chr5:179733440	MAPK9	chr5:179660597-179719071:-	0.14	3.61	0.000339	Height	
THCA	cis	1	rs77305932	chr7:1100861	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.81	1.11E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs77309268	chr2:86293294	LOC90784	chr2:86247339-86250991:-	-0.36	-3.43	0.000645	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs77309268	chr2:86293294	POLR1A	chr2:86253453-86333278:-	-0.29	-3.78	0.000176	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs7731256	chr5:101737777	SLCO4C1	chr5:101569694-101632253:-	0.25	5.62	3.23E-8	Schizophrenia	
THCA	cis	1	rs7731310	chr5:101808937	SLCO4C1	chr5:101569694-101632253:-	0.24	5.56	4.4E-8	Schizophrenia	
THCA	cis	1	rs7731821	chr5:110467918	TSLP	chr5:110405778-110413722:+	-0.34	-4.35	1.69E-5	Eosinophil counts	
THCA	cis	1	rs7731821	chr5:110467918	WDR36	chr5:110427870-110466201:+	0.2	3.58	0.000386	Eosinophil counts	
THCA	cis	1	rs7732643	chr5:150261436	LOC134466	chr5:150310000-150326146:-	0.39	5.38	1.19E-7	Crohn's disease	
THCA	cis	1	rs7732942	chr5:101800228	SLCO4C1	chr5:101569694-101632253:-	0.26	5.91	6.36E-9	Schizophrenia	
THCA	cis	1	rs7732945	chr5:150261601	LOC134466	chr5:150310000-150326146:-	0.38	5.28	2.01E-7	Crohn's disease	
THCA	cis	1	rs77335224	chr10:104636276	AS3MT	chr10:104613967-104661653:+	-0.31	-3.83	0.000148	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs77335224	chr10:104636276	C10orf26	chr10:104503727-104591851:+	-0.28	-4.4	1.32E-5	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs77335224	chr10:104636276	SFXN2	chr10:104474298-104498946:+	-0.38	-4.17	3.56E-5	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THCA	cis	1	rs77339045	chr8:117686048	EIF3H	chr8:117657056-117778494:-	-0.21	-3.69	0.000246	Body mass index	
THCA	cis	1	rs77346188	chr7:1114023	ZFAND2A	chr7:1192544-1199855:-	-0.37	-5.59	3.91E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs77346255	chr1:108376004	VAV3	chr1:108113782-108507545:-	0.56	8.07	5.6E-15	Hypothyroidism	
THCA	cis	1	rs7734635	chr5:110158844	TMEM232	chr5:109624934-110062381:-	0.2	3.97	8.29E-5	Asthma and hay fever	
THCA	cis	1	rs7734778	chr5:150256556	LOC134466	chr5:150310000-150326146:-	0.37	5.29	1.83E-7	Crohn's disease	
THCA	cis	1	rs7734910	chr5:176986300	DOK3	chr5:176928915-176937427:-	0.27	6.12	1.99E-9	Alzheimer disease and age of onset	
THCA	cis	1	rs7734928	chr5:150256613	LOC134466	chr5:150310000-150326146:-	0.37	5.2	2.97E-7	Crohn's disease	
THCA	cis	1	rs7734928	chr5:150256613	ZNF300	chr5:150273964-150284391:-	0.15	3.4	0.000719	Crohn's disease	
THCA	cis	1	rs77349713	chr11:116765476	PCSK7	chr11:117075789-117102811:-	0.42	5.14	4.05E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs7735519	chr5:110153341	TMEM232	chr5:109624934-110062381:-	0.21	4.22	2.89E-5	Asthma and hay fever	
THCA	cis	1	rs7735635	chr5:137508336	KLHL3	chr5:136953190-137071779:-	0.12	3.41	0.000702	Resting heart rate	
THCA	cis	1	rs7735940	chr5:36423931	UGT3A2	chr5:36035124-36066984:-	0.19	3.64	0.000307	Hypertension	
THCA	cis	1	rs7736554	chr5:150258308	LOC134466	chr5:150310000-150326146:-	0.38	5.28	2.01E-7	Crohn's disease	
THCA	cis	1	rs7736579	chr5:101760969	SLCO4C1	chr5:101569694-101632253:-	0.25	5.62	3.21E-8	Schizophrenia	
THCA	cis	1	rs7736873	chr5:150258482	LOC134466	chr5:150310000-150326146:-	0.38	5.28	2.01E-7	Crohn's disease	
THCA	cis	1	rs77374467	chr6:24475278	GMNN	chr6:24775159-24786276:+	-0.29	-3.36	0.000835	Hematological and biochemical traits	
THCA	cis	1	rs77374467	chr6:24475278	GPLD1	chr6:24428405-24489850:-	0.32	5.28	1.99E-7	Hematological and biochemical traits	
THCA	cis	1	rs77374467	chr6:24475278	MRS2	chr6:24403153-24425809:+	0.29	5.8	1.2E-8	Hematological and biochemical traits	
THCA	cis	1	rs77379383	chr10:70759169	KIAA1279	chr10:70748493-70776734:+	-0.15	-3.57	0.0004	Schizophrenia	
THCA	cis	1	rs7737963	chr5:101668619	SLCO4C1	chr5:101569694-101632253:-	0.25	5.73	1.83E-8	Schizophrenia	
THCA	cis	1	rs7738044	chr6:47469273	CD2AP	chr6:47445525-47594994:+	0.15	3.78	0.000177	Alzheimer's disease (late onset)	
THCA	cis	1	rs7738109	chr6:105610727	BVES	chr6:105544700-105585049:-	0.22	3.63	0.000314	Multiple sclerosis	
THCA	cis	1	rs7738792	chr6:70463417	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.42	0.000691	Sleep duration	
THCA	cis	1	rs7739633	chr6:70463199	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.42	0.000691	Sleep duration	
THCA	cis	1	rs77399357	chr2:48218576	FOXN2	chr2:48541795-48606434:+	0.24	4.23	2.75E-5	Schizophrenia	
THCA	cis	1	rs7740487	chr6:28216486	ZKSCAN3	chr6:28317691-28334523:+	-0.24	-4.56	6.37E-6	Depression	
THCA	cis	1	rs7740487	chr6:28216486	ZNF187	chr6:28234788-28245978:+	-0.36	-7.18	2.67E-12	Depression	
THCA	cis	1	rs7740487	chr6:28216486	ZNF193	chr6:28193067-28201260:+	0.21	3.83	0.000145	Depression	
THCA	cis	1	rs7740487	chr6:28216486	ZNF323	chr6:28292517-28324048:-	0.42	5.57	4.3E-8	Depression	
THCA	cis	1	rs7740487	chr6:28216486	ZNF389	chr6:28129551-28137375:+	-0.49	-6.83	2.67E-11	Depression	
THCA	cis	1	rs7740487	chr6:28216486	ZSCAN23	chr6:28393287-28411279:-	0.24	5	8.2E-7	Depression	
THCA	cis	1	rs7741758	chr6:70412380	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.46	0.000595	Sleep duration	
THCA	cis	1	rs7742030	chr6:44065062	TMEM63B	chr6:44095376-44123255:+	0.15	3.41	0.000697	Major depressive disorder	
THCA	cis	1	rs7742425	chr6:41340338	GUCA1B	chr6:42151023-42162694:-	0.28	3.6	0.000351	Alzheimer's disease biomarkers	
THCA	cis	1	rs7742626	chr6:136132496	C6orf217	chr6:135818939-136037192:+	0.34	8.97	6.92E-18	Phosphorus levels	
THCA	cis	1	rs7742824	chr6:44065311	TMEM63B	chr6:44095376-44123255:+	0.15	3.41	0.000697	Major depressive disorder	
THCA	cis	1	rs774356	chr9:27559721	C9orf72	chr9:27546544-27573842:-	0.23	5.32	1.57E-7	Amyotrophic lateral sclerosis	
THCA	cis	1	rs774359	chr9:27561049	C9orf72	chr9:27546544-27573842:-	0.23	5.36	1.31E-7	Amyotrophic lateral sclerosis	
THCA	cis	1	rs77436627	chr1:108358108	VAV3	chr1:108113782-108507545:-	0.56	8.05	6.61E-15	Hypothyroidism	
THCA	cis	1	rs77437249	chr20:33564738	PROCR	chr20:33758727-33765164:+	-0.36	-5.71	1.97E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs77437249	chr20:33564738	TRPC4AP	chr20:33590215-33680618:-	0.33	4	7.46E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs77446828	chr6:159414034	RSPH3	chr6:159398268-159421198:-	0.28	5.96	4.98E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs77464790	chr16:77777609	NUDT7	chr16:77756411-77776153:+	0.38	5.19	3.15E-7	Obesity-related traits	
THCA	cis	1	rs7746598	chr6:170084933	C6orf70	chr6:170151721-170181617:+	0.26	5.17	3.44E-7	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs7746598	chr6:170084933	WDR27	chr6:169857307-170102159:-	-0.2	-5.93	5.87E-9	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs77467134	chr11:116823107	PCSK7	chr11:117075789-117102811:-	0.45	5.41	1.01E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs77475507	chr1:108362107	VAV3	chr1:108113782-108507545:-	0.58	8.28	1.22E-15	Hypothyroidism	
THCA	cis	1	rs7747645	chr6:170070291	C6orf70	chr6:170151721-170181617:+	0.27	5.21	2.84E-7	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs7747645	chr6:170070291	WDR27	chr6:169857307-170102159:-	-0.2	-5.94	5.36E-9	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs77477310	chr14:35615793	FAM177A1	chr14:35514113-35552587:+	-0.19	-3.52	0.00047	Atopic dermatitis	
THCA	cis	1	rs77477310	chr14:35615793	KIAA0391	chr14:35591776-35786673:+	0.31	5.78	1.36E-8	Atopic dermatitis	
THCA	cis	1	rs77477310	chr14:35615793	PPP2R3C	chr14:35554679-35591679:-	0.52	9.82	7.55E-21	Atopic dermatitis	
THCA	cis	1	rs7747824	chr6:86647106	SNHG5	chr6:86386726-86388451:-	-0.53	-12.62	1.01E-31	Response to antipsychotic treatment	
THCA	cis	1	rs7748555	chr6:105543214	BVES	chr6:105544700-105585049:-	0.24	4.03	6.47E-5	Multiple sclerosis	
THCA	cis	1	rs77491711	chr8:117662112	EIF3H	chr8:117657056-117778494:-	-0.2	-3.61	0.000342	Body mass index	
THCA	cis	1	rs77494594	chr10:65197309	LOC84989	chr10:65224989-65226320:+	0.26	4.18	3.51E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs77494594	chr10:65197309	NRBF2	chr10:64893007-64914785:+	0.27	4.44	1.12E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs7750434	chr6:3281726	PSMG4	chr6:3259162-3268300:+	-0.31	-7.26	1.55E-12	Obesity-related traits	
THCA	cis	1	rs7750803	chr6:111800113	KIAA1919	chr6:111580482-111590259:+	-0.49	-5.68	2.31E-8	Psoriasis	
THCA	cis	1	rs7750918	chr6:49430082	CENPQ	chr6:49431096-49460820:+	-0.27	-5.56	4.45E-8	Folate pathway vitamin levels	
THCA	cis	1	rs7750918	chr6:49430082	MUT	chr6:49398994-49431031:-	0.29	9.68	2.3E-20	Folate pathway vitamin levels	
THCA	cis	1	rs7751419	chr6:39115413	GLP1R	chr6:39016557-39055519:+	0.2	3.81	0.000157	Cardiovascular disease in hypertension (calcium channel blocker interaction)	
THCA	cis	1	rs775227	chr3:112995074	SIDT1	chr3:113251218-113348421:+	0.23	4.09	5.1E-5	Dental caries	
THCA	cis	1	rs7752394	chr6:3293649	PSMG4	chr6:3259162-3268300:+	-0.34	-5.61	3.38E-8	Survival in rectal cancer	
THCA	cis	1	rs7752533	chr6:70496001	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.37	0.000826	Sleep duration	
THCA	cis	1	rs7752653	chr6:44093808	TMEM63B	chr6:44095376-44123255:+	0.16	3.53	0.000463	Major depressive disorder	
THCA	cis	1	rs77528108	chr16:77782435	NUDT7	chr16:77756411-77776153:+	0.35	4.83	1.86E-6	Obesity-related traits	
THCA	cis	1	rs77531164	chr15:40673466	C15orf23	chr15:40674922-40686488:+	0.63	9.09	2.55E-18	Heschl's gyrus morphology	
THCA	cis	1	rs77531164	chr15:40673466	IVD	chr15:40697686-40713512:+	-0.53	-10.21	2.75E-22	Heschl's gyrus morphology	
THCA	cis	1	rs775322	chr12:57958313	FAM119B	chr12:58166383-58176323:+	0.17	4.49	8.82E-6	Rheumatoid arthritis	
THCA	cis	1	rs775322	chr12:57958313	TSFM	chr12:58176536-58191367:+	-0.26	-7.13	3.83E-12	Rheumatoid arthritis	
THCA	cis	1	rs77536160	chr1:183233889	RNASEL	chr1:182542772-182558391:-	0.36	3.76	0.000189	Systemic lupus erythematosus and Systemic sclerosis	
THCA	cis	1	rs77543683	chr5:109953122	TMEM232	chr5:109624934-110062381:-	0.49	5.55	4.83E-8	Cardiac structure and function	
THCA	cis	1	rs7755323	chr6:33761159	LEMD2	chr6:33738991-33756906:-	0.24	5.13	4.21E-7	Body mass index	
THCA	cis	1	rs7756203	chr6:86627707	SNHG5	chr6:86386726-86388451:-	-0.48	-10.64	6.96E-24	Response to antipsychotic treatment	
THCA	cis	1	rs77562891	chr18:51791235	POLI	chr18:51795849-51824602:+	0.18	5.26	2.13E-7	Psoriasis	
THCA	cis	1	rs77564939	chr5:115564294	COMMD10	chr5:115420727-115628978:+	0.48	5.89	7.35E-9	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs77565539	chr10:81732604	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs7756860	chr6:158276048	SNX9	chr6:158244294-158366109:+	-0.22	-3.54	0.000443	Lipoprotein (a) - cholesterol levels	
THCA	cis	1	rs7756935	chr6:46675025	CYP39A1	chr6:46517445-46620523:-	-0.26	-4.11	4.71E-5	Lipoprotein-associated phospholipase A2 activity and mass	
THCA	cis	1	rs7756935	chr6:46675025	TDRD6	chr6:46655866-46670149:+	0.16	3.36	0.00085	Lipoprotein-associated phospholipase A2 activity and mass	
THCA	cis	1	rs7759001	chr6:27341409	ZNF184	chr6:27418522-27440897:-	-0.2	-4.32	1.93E-5	Glomerular filtration rate (creatinine)	
THCA	cis	1	rs7759001	chr6:27341409	ZNF391	chr6:27356524-27369227:+	0.23	6.15	1.59E-9	Glomerular filtration rate (creatinine)	
THCA	cis	1	rs7759071	chr6:49433198	CENPQ	chr6:49431096-49460820:+	-0.33	-7.07	5.59E-12	Homocysteine levels	
THCA	cis	1	rs7760207	chr6:86721700	SNHG5	chr6:86386726-86388451:-	-0.48	-10.83	1.34E-24	Response to antipsychotic treatment	
THCA	cis	1	rs77605770	chr6:159370528	RSPH3	chr6:159398268-159421198:-	0.28	6	3.97E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs7761365	chr6:133101561	C6orf192	chr6:133090507-133119747:-	-0.26	-4.14	4.05E-5	Type 2 diabetes nephropathy	
THCA	cis	1	rs77613724	chr10:81730629	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs7762018	chr6:170113244	C6orf70	chr6:170151721-170181617:+	0.23	4.71	3.29E-6	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs7762018	chr6:170113244	WDR27	chr6:169857307-170102159:-	-0.18	-5.64	2.88E-8	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs77621359	chr2:86330353	POLR1A	chr2:86253453-86333278:-	-0.32	-4.29	2.19E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs7762400	chr6:70445634	LMBRD1	chr6:70385751-70506888:-	-0.09	-3.35	0.000866	Sleep duration	
THCA	cis	1	rs7762901	chr6:24449639	MRS2	chr6:24403153-24425809:+	-0.16	-4.41	1.28E-5	Liver enzyme levels	
THCA	cis	1	rs7763191	chr6:86118317	NT5E	chr6:86159302-86205496:+	0.24	3.83	0.000148	Blood metabolite levels;Metabolic traits	
THCA	cis	1	rs77640423	chr1:183209018	RNASEL	chr1:182542772-182558391:-	0.33	3.51	0.000488	Systemic lupus erythematosus and Systemic sclerosis	
THCA	cis	1	rs7764785	chr6:163009967	PACRG	chr6:163148164-163736523:+	0.45	7.03	7.07E-12	Body mass index	
THCA	cis	1	rs7765224	chr6:133101624	C6orf192	chr6:133090507-133119747:-	-0.26	-4.14	4.05E-5	Type 2 diabetes nephropathy	
THCA	cis	1	rs77654484	chr11:47206594	MADD	chr11:47290927-47351582:+	0.28	3.44	0.00063	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs7766645	chr6:86622238	SNHG5	chr6:86386726-86388451:-	-0.53	-12.62	1.01E-31	Response to antipsychotic treatment	
THCA	cis	1	rs776746	chr7:99270539	ATP5J2	chr7:99055785-99063808:-	0.2	4.18	3.43E-5	Blood metabolite levels	
THCA	cis	1	rs776746	chr7:99270539	ZNF655	chr7:99156045-99174074:+	0.18	3.71	0.000234	Blood metabolite levels	
THCA	cis	1	rs7769051	chr6:133146796	C6orf192	chr6:133090507-133119747:-	-0.23	-3.73	0.000214	Type 2 diabetes nephropathy	
THCA	cis	1	rs7769686	chr6:163199467	PACRG	chr6:163148164-163736523:+	0.51	7.2	2.43E-12	Body mass index	
THCA	cis	1	rs77698001	chr5:150250367	LOC134466	chr5:150310000-150326146:-	0.4	5.53	5.29E-8	Crohn's disease	
THCA	cis	1	rs7770203	chr6:116526409	TSPYL4	chr6:116571133-116575261:-	-0.15	-4.11	4.59E-5	Dental caries	
THCA	cis	1	rs77702926	chr7:1088838	ZFAND2A	chr7:1192544-1199855:-	-0.37	-5.37	1.24E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs7770848	chr6:44769237	SLC35B2	chr6:44221839-44225283:-	-0.29	-3.52	0.000464	Asthma (childhood onset)	
THCA	cis	1	rs7770923	chr6:117726980	DCBLD1	chr6:117803820-117891018:+	0.45	9.74	1.46E-20	Lung cancer	
THCA	cis	1	rs7770923	chr6:117726980	GOPC	chr6:117639351-117923681:-	0.22	6.29	7.06E-10	Lung cancer	
THCA	cis	1	rs7771211	chr6:117727025	DCBLD1	chr6:117803820-117891018:+	0.46	10.17	3.85E-22	Lung cancer	
THCA	cis	1	rs7771211	chr6:117727025	GOPC	chr6:117639351-117923681:-	0.23	6.66	7.78E-11	Lung cancer	
THCA	cis	1	rs7771271	chr6:117727236	DCBLD1	chr6:117803820-117891018:+	0.46	10.17	3.85E-22	Lung cancer	
THCA	cis	1	rs7771271	chr6:117727236	GOPC	chr6:117639351-117923681:-	0.23	6.66	7.78E-11	Lung cancer	
THCA	cis	1	rs7771342	chr6:86631936	SNHG5	chr6:86386726-86388451:-	-0.48	-10.64	6.96E-24	Response to antipsychotic treatment	
THCA	cis	1	rs7771394	chr6:24324421	MRS2	chr6:24403153-24425809:+	-0.15	-3.48	0.000547	Uric acid levels	
THCA	cis	1	rs7771437	chr6:117727313	DCBLD1	chr6:117803820-117891018:+	0.46	10.17	3.85E-22	Lung cancer	
THCA	cis	1	rs7771437	chr6:117727313	GOPC	chr6:117639351-117923681:-	0.23	6.66	7.78E-11	Lung cancer	
THCA	cis	1	rs7771637	chr6:117727491	DCBLD1	chr6:117803820-117891018:+	0.46	10.08	8.31E-22	Lung cancer	
THCA	cis	1	rs7771637	chr6:117727491	GOPC	chr6:117639351-117923681:-	0.22	6.55	1.46E-10	Lung cancer	
THCA	cis	1	rs7772046	chr6:117727485	DCBLD1	chr6:117803820-117891018:+	0.46	10.17	3.85E-22	Lung cancer	
THCA	cis	1	rs7772046	chr6:117727485	GOPC	chr6:117639351-117923681:-	0.23	6.66	7.78E-11	Lung cancer	
THCA	cis	1	rs7772983	chr6:158278973	SNX9	chr6:158244294-158366109:+	-0.23	-3.67	0.000266	Lipoprotein (a) - cholesterol levels	
THCA	cis	1	rs77734751	chr5:109731517	TMEM232	chr5:109624934-110062381:-	0.38	4.19	3.3E-5	Cardiac structure and function	
THCA	cis	1	rs7773700	chr6:44097472	TMEM63B	chr6:44095376-44123255:+	0.16	3.6	0.000348	Major depressive disorder	
THCA	cis	1	rs7773987	chr6:135707486	C6orf217	chr6:135818939-136037192:+	0.25	6.39	3.98E-10	Selective IgA deficiency	
THCA	cis	1	rs7774688	chr6:49387292	CENPQ	chr6:49431096-49460820:+	-0.32	-6.83	2.6E-11	Homocysteine levels	
THCA	cis	1	rs7775172	chr6:70465703	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.36	0.000852	Sleep duration	
THCA	cis	1	rs77755392	chr6:41340512	GUCA1B	chr6:42151023-42162694:-	0.28	3.62	0.000331	Alzheimer's disease biomarkers	
THCA	cis	1	rs77760339	chr7:1083927	ZFAND2A	chr7:1192544-1199855:-	-0.33	-4.78	2.35E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs7776244	chr6:117727949	DCBLD1	chr6:117803820-117891018:+	0.46	10.17	3.85E-22	Lung cancer	
THCA	cis	1	rs7776244	chr6:117727949	GOPC	chr6:117639351-117923681:-	0.23	6.66	7.78E-11	Lung cancer	
THCA	cis	1	rs77763497	chr20:3250007	ITPA	chr20:3190056-3204504:+	-0.24	-5.87	8.02E-9	IFN-related cytopenia	
THCA	cis	1	rs77767132	chr1:183222678	RNASEL	chr1:182542772-182558391:-	0.33	3.56	0.000401	Systemic lupus erythematosus and Systemic sclerosis	
THCA	cis	1	rs7777389	chr7:143744802	ARHGEF35	chr7:143883677-143892736:-	-0.52	-10.76	2.43E-24	Obesity-related traits	
THCA	cis	1	rs7777389	chr7:143744802	OR2A1	chr7:144015236-144016148:+;chr7	-0.19	-4.14	4.12E-5	Obesity-related traits	
THCA	cis	1	rs7777389	chr7:143744802	OR2A9P	chr7:143991573-143997832:+;chr7	-0.31	-6.76	4.08E-11	Obesity-related traits	
THCA	cis	1	rs7777754	chr7:50666033	FIGNL1	chr7:50511834-50518088:-	0.14	3.54	0.000435	Response to zileuton treatment in asthma (FEV1 change interaction)	
THCA	cis	1	rs7778258	chr7:50666378	FIGNL1	chr7:50511834-50518088:-	-0.2	-4.75	2.73E-6	Response to zileuton treatment in asthma (FEV1 change interaction)	
THCA	cis	1	rs7778911	chr7:65694506	CCT6P1	chr7:65216092-65228661:+	-0.44	-6.89	1.74E-11	Diabetic kidney disease	
THCA	cis	1	rs7778911	chr7:65694506	CRCP	chr7:65579805-65619551:+	0.3	4.52	7.98E-6	Diabetic kidney disease	
THCA	cis	1	rs7778911	chr7:65694506	RABGEF1	chr7:66093890-66276446:+	-0.59	-7.26	1.54E-12	Diabetic kidney disease	
THCA	cis	1	rs77789667	chr14:59940418	C14orf149	chr14:59939406-59951126:-	-0.43	-4.88	1.46E-6	Schizophrenia	
THCA	cis	1	rs77789667	chr14:59940418	JKAMP	chr14:59951161-59972080:+	0.46	5.24	2.37E-7	Schizophrenia	
THCA	cis	1	rs77790737	chr8:96037156	C8orf38	chr8:95908040-96088396:+	-0.26	-4.56	6.5E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs77794066	chr5:109708872	TMEM232	chr5:109624934-110062381:-	0.37	4.26	2.44E-5	Cardiac structure and function	
THCA	cis	1	rs7781698	chr7:65896312	ASL	chr7:65540776-65558321:+	-0.16	-4.27	2.37E-5	Aortic root size	
THCA	cis	1	rs7781698	chr7:65896312	GUSB	chr7:65425675-65447246:-	0.27	5.34	1.42E-7	Aortic root size	
THCA	cis	1	rs7781698	chr7:65896312	LOC729156	chr7:66274980-66309813:-	0.16	3.42	0.000687	Aortic root size	
THCA	cis	1	rs7781698	chr7:65896312	RABGEF1	chr7:66093890-66276446:+	0.65	14.01	1.28E-37	Aortic root size	
THCA	cis	1	rs7782320	chr7:66177098	GUSB	chr7:65425675-65447246:-	0.32	6.49	2.16E-10	Aortic root size	
THCA	cis	1	rs7782320	chr7:66177098	RABGEF1	chr7:66093890-66276446:+	0.5	10.23	2.48E-22	Aortic root size	
THCA	cis	1	rs7782320	chr7:66177098	TYW1	chr7:66461817-66704496:+	0.18	3.83	0.000147	Aortic root size	
THCA	cis	1	rs7782699	chr7:150915948	RHEB	chr7:151163098-151217010:-	-0.2	-3.5	0.000502	Bone mineral density	
THCA	cis	1	rs77828254	chr14:32225501	NUBPL	chr14:32030591-32330417:+	0.16	4.99	8.41E-7	Polychlorinated biphenyl levels	
THCA	cis	1	rs77832597	chr17:76083611	TMC6	chr17:76108999-76128488:-	0.21	3.93	9.92E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs7783613	chr7:65805261	ASL	chr7:65540776-65558321:+	0.16	4.29	2.21E-5	Aortic root size	
THCA	cis	1	rs7783613	chr7:65805261	GUSB	chr7:65425675-65447246:-	-0.26	-5.09	5.27E-7	Aortic root size	
THCA	cis	1	rs7783613	chr7:65805261	LOC729156	chr7:66274980-66309813:-	-0.16	-3.53	0.000456	Aortic root size	
THCA	cis	1	rs7783613	chr7:65805261	RABGEF1	chr7:66093890-66276446:+	-0.67	-14.52	7.7E-40	Aortic root size	
THCA	cis	1	rs778370	chr2:233743363	GIGYF2	chr2:233562015-233725285:+	-0.11	-4.03	6.37E-5	Schizophrenia	
THCA	cis	1	rs778370	chr2:233743363	KCNJ13	chr2:233630860-233641275:-	-0.13	-3.53	0.000454	Schizophrenia	
THCA	cis	1	rs778370	chr2:233743363	NGEF	chr2:233743396-233877951:-	-0.13	-3.37	0.000807	Schizophrenia	
THCA	cis	1	rs778371	chr2:233743109	GIGYF2	chr2:233562015-233725285:+	-0.1	-3.37	0.00081	Schizophrenia	
THCA	cis	1	rs778371	chr2:233743109	KCNJ13	chr2:233630860-233641275:-	-0.16	-4.21	3.08E-5	Schizophrenia	
THCA	cis	1	rs778371	chr2:233743109	NGEF	chr2:233743396-233877951:-	-0.15	-3.8	0.000161	Schizophrenia	
THCA	cis	1	rs7783924	chr7:66209057	GUSB	chr7:65425675-65447246:-	0.34	6.84	2.43E-11	Aortic root size	
THCA	cis	1	rs7783924	chr7:66209057	RABGEF1	chr7:66093890-66276446:+	0.52	10.69	4.74E-24	Aortic root size	
THCA	cis	1	rs7783924	chr7:66209057	TYW1	chr7:66461817-66704496:+	0.18	3.89	0.000116	Aortic root size	
THCA	cis	1	rs7784398	chr7:118082335	ANKRD7	chr7:117864712-117882782:+	-0.27	-4.29	2.16E-5	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs77846263	chr8:89486176	MMP16	chr8:89049462-89339717:-	0.33	5.09	5.11E-7	Electrodermal activity	
THCA	cis	1	rs7784906	chr7:107148386	DLD	chr7:107531586-107561642:+	0.14	3.5	0.00051	Osteoarthritis	
THCA	cis	1	rs77849630	chr5:115556900	COMMD10	chr5:115420727-115628978:+	0.48	5.7	2.09E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs7785213	chr7:66138978	GUSB	chr7:65425675-65447246:-	-0.33	-6.62	9.39E-11	Aortic root size	
THCA	cis	1	rs7785213	chr7:66138978	RABGEF1	chr7:66093890-66276446:+	-0.5	-10.29	1.51E-22	Aortic root size	
THCA	cis	1	rs7785213	chr7:66138978	TYW1	chr7:66461817-66704496:+	-0.18	-3.94	9.43E-5	Aortic root size	
THCA	cis	1	rs77856716	chr5:115565660	COMMD10	chr5:115420727-115628978:+	0.49	5.8	1.18E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs7786410	chr7:55922323	GBAS	chr7:56032296-56067871:+	0.22	4.54	7.1E-6	Age-related hearing impairment	
THCA	cis	1	rs7786410	chr7:55922323	PSPH	chr7:56078746-56184090:-	0.26	5.05	6.33E-7	Age-related hearing impairment	
THCA	cis	1	rs778679	chr7:65840911	CCT6P1	chr7:65216092-65228661:+	0.43	6.71	5.64E-11	Diabetic kidney disease	
THCA	cis	1	rs778679	chr7:65840911	CRCP	chr7:65579805-65619551:+	-0.27	-3.97	8.2E-5	Diabetic kidney disease	
THCA	cis	1	rs778679	chr7:65840911	RABGEF1	chr7:66093890-66276446:+	0.63	7.65	1.11E-13	Diabetic kidney disease	
THCA	cis	1	rs77868187	chr7:1093968	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.51	5.78E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs778685	chr7:65836176	ASL	chr7:65540776-65558321:+	-0.16	-4.16	3.75E-5	Aortic root size	
THCA	cis	1	rs778685	chr7:65836176	GUSB	chr7:65425675-65447246:-	0.27	5.34	1.43E-7	Aortic root size	
THCA	cis	1	rs778685	chr7:65836176	RABGEF1	chr7:66093890-66276446:+	0.65	14.09	5.98E-38	Aortic root size	
THCA	cis	1	rs778691	chr7:65873092	CCT6P1	chr7:65216092-65228661:+	0.43	6.71	5.64E-11	Diabetic kidney disease	
THCA	cis	1	rs778691	chr7:65873092	CRCP	chr7:65579805-65619551:+	-0.27	-3.97	8.2E-5	Diabetic kidney disease	
THCA	cis	1	rs778691	chr7:65873092	RABGEF1	chr7:66093890-66276446:+	0.63	7.65	1.11E-13	Diabetic kidney disease	
THCA	cis	1	rs778694	chr7:65871558	ASL	chr7:65540776-65558321:+	-0.16	-4.27	2.36E-5	Aortic root size	
THCA	cis	1	rs778694	chr7:65871558	GUSB	chr7:65425675-65447246:-	0.28	5.47	7.42E-8	Aortic root size	
THCA	cis	1	rs778694	chr7:65871558	RABGEF1	chr7:66093890-66276446:+	0.66	14.31	6.19E-39	Aortic root size	
THCA	cis	1	rs778696	chr7:65870813	ASL	chr7:65540776-65558321:+	-0.16	-4.27	2.36E-5	Aortic root size	
THCA	cis	1	rs778696	chr7:65870813	GUSB	chr7:65425675-65447246:-	0.28	5.47	7.42E-8	Aortic root size	
THCA	cis	1	rs778696	chr7:65870813	RABGEF1	chr7:66093890-66276446:+	0.66	14.31	6.19E-39	Aortic root size	
THCA	cis	1	rs778699	chr7:65868290	ASL	chr7:65540776-65558321:+	-0.16	-4.16	3.75E-5	Aortic root size	
THCA	cis	1	rs778699	chr7:65868290	GUSB	chr7:65425675-65447246:-	0.27	5.34	1.43E-7	Aortic root size	
THCA	cis	1	rs778699	chr7:65868290	RABGEF1	chr7:66093890-66276446:+	0.65	14.09	5.98E-38	Aortic root size	
THCA	cis	1	rs778704	chr7:65863467	CCT6P1	chr7:65216092-65228661:+	0.43	6.71	5.64E-11	Diabetic kidney disease	
THCA	cis	1	rs778704	chr7:65863467	CRCP	chr7:65579805-65619551:+	-0.27	-3.97	8.2E-5	Diabetic kidney disease	
THCA	cis	1	rs778704	chr7:65863467	RABGEF1	chr7:66093890-66276446:+	0.63	7.65	1.11E-13	Diabetic kidney disease	
THCA	cis	1	rs778706	chr7:65860424	ASL	chr7:65540776-65558321:+	-0.16	-4.16	3.75E-5	Aortic root size	
THCA	cis	1	rs778706	chr7:65860424	GUSB	chr7:65425675-65447246:-	0.27	5.34	1.43E-7	Aortic root size	
THCA	cis	1	rs778706	chr7:65860424	RABGEF1	chr7:66093890-66276446:+	0.65	14.09	5.98E-38	Aortic root size	
THCA	cis	1	rs778710	chr7:65854834	ASL	chr7:65540776-65558321:+	-0.16	-4.27	2.36E-5	Aortic root size	
THCA	cis	1	rs778710	chr7:65854834	GUSB	chr7:65425675-65447246:-	0.28	5.47	7.42E-8	Aortic root size	
THCA	cis	1	rs778710	chr7:65854834	RABGEF1	chr7:66093890-66276446:+	0.66	14.31	6.19E-39	Aortic root size	
THCA	cis	1	rs778722	chr7:65844828	ASL	chr7:65540776-65558321:+	-0.16	-4.16	3.75E-5	Aortic root size	
THCA	cis	1	rs778722	chr7:65844828	GUSB	chr7:65425675-65447246:-	0.27	5.34	1.43E-7	Aortic root size	
THCA	cis	1	rs778722	chr7:65844828	RABGEF1	chr7:66093890-66276446:+	0.65	14.09	5.98E-38	Aortic root size	
THCA	cis	1	rs7787230	chr7:65629099	CCT6P1	chr7:65216092-65228661:+	-0.42	-6.7	5.9E-11	Diabetic kidney disease	
THCA	cis	1	rs7787230	chr7:65629099	CRCP	chr7:65579805-65619551:+	0.3	4.63	4.66E-6	Diabetic kidney disease	
THCA	cis	1	rs7787230	chr7:65629099	LOC493754	chr7:65993446-66057363:-	-0.29	-3.36	0.000833	Diabetic kidney disease	
THCA	cis	1	rs7787230	chr7:65629099	RABGEF1	chr7:66093890-66276446:+	-0.57	-7.14	3.42E-12	Diabetic kidney disease	
THCA	cis	1	rs778726	chr7:65828731	ASL	chr7:65540776-65558321:+	-0.16	-4.16	3.75E-5	Aortic root size	
THCA	cis	1	rs778726	chr7:65828731	GUSB	chr7:65425675-65447246:-	0.27	5.34	1.43E-7	Aortic root size	
THCA	cis	1	rs778726	chr7:65828731	RABGEF1	chr7:66093890-66276446:+	0.65	14.09	5.98E-38	Aortic root size	
THCA	cis	1	rs7787274	chr7:2275993	FTSJ2	chr7:2273928-2281833:-	0.24	4.49	9.05E-6	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	
THCA	cis	1	rs778729	chr7:65824419	CCT6P1	chr7:65216092-65228661:+	0.43	6.71	5.64E-11	Diabetic kidney disease	
THCA	cis	1	rs778729	chr7:65824419	CRCP	chr7:65579805-65619551:+	-0.27	-3.97	8.2E-5	Diabetic kidney disease	
THCA	cis	1	rs778729	chr7:65824419	RABGEF1	chr7:66093890-66276446:+	0.63	7.65	1.11E-13	Diabetic kidney disease	
THCA	cis	1	rs778758	chr2:61782161	AHSA2	chr2:61404553-61414058:+	-0.23	-9.37	2.83E-19	Tuberculosis	
THCA	cis	1	rs778758	chr2:61782161	C2orf74	chr2:61372243-61391964:+	0.59	12.91	6.66E-33	Tuberculosis	
THCA	cis	1	rs778762	chr2:61782921	AHSA2	chr2:61404553-61414058:+	-0.23	-9.56	6.27E-20	Tuberculosis	
THCA	cis	1	rs778762	chr2:61782921	C2orf74	chr2:61372243-61391964:+	0.59	12.77	2.48E-32	Tuberculosis	
THCA	cis	1	rs778763	chr2:61785639	AHSA2	chr2:61404553-61414058:+	-0.23	-9.43	1.81E-19	Tuberculosis	
THCA	cis	1	rs778763	chr2:61785639	C2orf74	chr2:61372243-61391964:+	0.59	12.75	3.11E-32	Tuberculosis	
THCA	cis	1	rs77876414	chr6:159414811	RSPH3	chr6:159398268-159421198:-	0.28	5.96	4.98E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs7787818	chr7:134251597	AKR1B1	chr7:134127107-134143888:-	0.21	4.52	7.66E-6	Longevity	
THCA	cis	1	rs7788576	chr7:66148302	GUSB	chr7:65425675-65447246:-	-0.33	-6.8	3.22E-11	Aortic root size	
THCA	cis	1	rs7788576	chr7:66148302	RABGEF1	chr7:66093890-66276446:+	-0.51	-10.49	2.65E-23	Aortic root size	
THCA	cis	1	rs7788576	chr7:66148302	TYW1	chr7:66461817-66704496:+	-0.18	-3.93	9.79E-5	Aortic root size	
THCA	cis	1	rs7788819	chr7:38226658	STARD3NL	chr7:38217933-38270269:+	-0.52	-12.39	8.84E-31	Treatment response for severe sepsis	
THCA	cis	1	rs7789181	chr7:97621263	MGC72080	chr7:97503667-97601638:-	0.24	3.39	0.000753	Sudden cardiac arrest	
THCA	cis	1	rs7789184	chr7:66210195	GUSB	chr7:65425675-65447246:-	0.34	6.84	2.43E-11	Aortic root size	
THCA	cis	1	rs7789184	chr7:66210195	RABGEF1	chr7:66093890-66276446:+	0.52	10.69	4.74E-24	Aortic root size	
THCA	cis	1	rs7789184	chr7:66210195	TYW1	chr7:66461817-66704496:+	0.18	3.89	0.000116	Aortic root size	
THCA	cis	1	rs7789554	chr7:65946038	ASL	chr7:65540776-65558321:+	-0.16	-4.22	2.91E-5	Aortic root size	
THCA	cis	1	rs7789554	chr7:65946038	GUSB	chr7:65425675-65447246:-	0.27	5.25	2.29E-7	Aortic root size	
THCA	cis	1	rs7789554	chr7:65946038	RABGEF1	chr7:66093890-66276446:+	0.65	14.05	8.4E-38	Aortic root size	
THCA	cis	1	rs7789577	chr7:127150498	GRM8	chr7:126078652-126893147:-	-0.35	-3.59	0.00036	Medication adherence in chronic diseases	
THCA	cis	1	rs7789737	chr7:127150683	GRM8	chr7:126078652-126893147:-	-0.35	-3.59	0.00036	Medication adherence in chronic diseases	
THCA	cis	1	rs7789768	chr7:65938980	ASL	chr7:65540776-65558321:+	-0.16	-4.18	3.49E-5	Aortic root size	
THCA	cis	1	rs7789768	chr7:65938980	GUSB	chr7:65425675-65447246:-	0.27	5.27	2.11E-7	Aortic root size	
THCA	cis	1	rs7789768	chr7:65938980	RABGEF1	chr7:66093890-66276446:+	0.65	14.02	1.14E-37	Aortic root size	
THCA	cis	1	rs7789940	chr7:75951230	STYXL1	chr7:75625656-75677321:-	-0.15	-3.57	0.0004	Multiple sclerosis	
THCA	cis	1	rs7789940	chr7:75951230	UPK3B	chr7:76139745-76157197:+	-0.27	-4.73	3.02E-6	Multiple sclerosis	
THCA	cis	1	rs77902909	chr6:24478715	GPLD1	chr6:24428405-24489850:-	0.32	5.19	3.11E-7	Hematological and biochemical traits	
THCA	cis	1	rs77902909	chr6:24478715	MRS2	chr6:24403153-24425809:+	0.3	5.94	5.35E-9	Hematological and biochemical traits	
THCA	cis	1	rs77906836	chr2:190768109	ASNSD1	chr2:190526125-190535556:+	-0.58	-6.01	3.77E-9	Subcutaneous adipose tissue	
THCA	cis	1	rs7790722	chr7:87293223	DBF4	chr7:87505544-87538856:+	-0.3	-4.47	9.7E-6	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs7792262	chr7:23915743	C7orf46	chr7:23719749-23742268:+	-0.13	-3.94	9.2E-5	Schizophrenia	
THCA	cis	1	rs77923355	chr17:76084084	TMC6	chr17:76108999-76128488:-	0.22	4.15	3.91E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs7792391	chr7:65773429	CCT6P1	chr7:65216092-65228661:+	-0.42	-6.62	9.41E-11	Diabetic kidney disease	
THCA	cis	1	rs7792391	chr7:65773429	CRCP	chr7:65579805-65619551:+	0.28	4.19	3.25E-5	Diabetic kidney disease	
THCA	cis	1	rs7792391	chr7:65773429	LOC493754	chr7:65993446-66057363:-	-0.29	-3.34	0.000897	Diabetic kidney disease	
THCA	cis	1	rs7792391	chr7:65773429	RABGEF1	chr7:66093890-66276446:+	-0.6	-7.29	1.25E-12	Diabetic kidney disease	
THCA	cis	1	rs7792762	chr7:66004138	ASL	chr7:65540776-65558321:+	-0.14	-3.54	0.000433	Aortic root size	
THCA	cis	1	rs7792762	chr7:66004138	GUSB	chr7:65425675-65447246:-	0.27	5.22	2.62E-7	Aortic root size	
THCA	cis	1	rs7792762	chr7:66004138	LOC729156	chr7:66274980-66309813:-	0.17	3.56	0.000402	Aortic root size	
THCA	cis	1	rs7792762	chr7:66004138	RABGEF1	chr7:66093890-66276446:+	0.7	15.48	4.02E-44	Aortic root size	
THCA	cis	1	rs7792939	chr7:99207876	TRIM4	chr7:99488037-99517154:-	0.27	3.48	0.000552	Anthropometric traits	
THCA	cis	1	rs77930391	chr13:96297821	DZIP1	chr13:96229329-96296957:-	0.2	3.96	8.71E-5	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
THCA	cis	1	rs77930391	chr13:96297821	UGGT2	chr13:96453838-96705736:-	-0.25	-3.78	0.000175	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
THCA	cis	1	rs77931721	chr2:203763076	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.93	5.93E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs77931721	chr2:203763076	ICA1L	chr2:203637873-203736371:-	0.25	4.18	3.49E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs77934397	chr2:190792255	ASNSD1	chr2:190526125-190535556:+	-0.61	-5.94	5.48E-9	Subcutaneous adipose tissue	
THCA	cis	1	rs7794273	chr7:18848534	TWIST1	chr7:19155093-19157295:-	0.13	3.46	0.000581	Night sleep phenotypes	
THCA	cis	1	rs7794661	chr7:65389730	CCT6P1	chr7:65216092-65228661:+	0.39	6.21	1.17E-9	Diabetic kidney disease	
THCA	cis	1	rs7794661	chr7:65389730	CRCP	chr7:65579805-65619551:+	-0.28	-4.28	2.3E-5	Diabetic kidney disease	
THCA	cis	1	rs7794661	chr7:65389730	LOC493754	chr7:65993446-66057363:-	0.29	3.34	0.000904	Diabetic kidney disease	
THCA	cis	1	rs7794661	chr7:65389730	RABGEF1	chr7:66093890-66276446:+	0.54	6.61	1.01E-10	Diabetic kidney disease	
THCA	cis	1	rs7795242	chr7:65390094	CCT6P1	chr7:65216092-65228661:+	0.38	6	3.93E-9	Diabetic kidney disease	
THCA	cis	1	rs7795242	chr7:65390094	CRCP	chr7:65579805-65619551:+	-0.26	-4	7.24E-5	Diabetic kidney disease	
THCA	cis	1	rs7795242	chr7:65390094	RABGEF1	chr7:66093890-66276446:+	0.55	6.89	1.73E-11	Diabetic kidney disease	
THCA	cis	1	rs7795499	chr7:38268395	STARD3NL	chr7:38217933-38270269:+	-0.51	-11.82	1.91E-28	Treatment response for severe sepsis	
THCA	cis	1	rs77956314	chr12:117323367	FBXW8	chr12:117348761-117470180:+	-0.27	-4.54	7.15E-6	Subcortical brain region volumes	
THCA	cis	1	rs77957229	chr6:26185226	HIST1H2AE	chr6:26217148-26217711:+	-0.22	-3.35	0.000886	Renal underexcretion gout;Gout	
THCA	cis	1	rs77957229	chr6:26185226	HIST1H3E	chr6:26224427-26226589:+	0.44	6.87	2.07E-11	Renal underexcretion gout;Gout	
THCA	cis	1	rs77961951	chr6:26186075	HIST1H2AE	chr6:26217148-26217711:+	-0.23	-3.38	0.000778	Renal underexcretion gout;Gout	
THCA	cis	1	rs77961951	chr6:26186075	HIST1H3E	chr6:26224427-26226589:+	0.44	6.82	2.73E-11	Renal underexcretion gout;Gout	
THCA	cis	1	rs7796393	chr7:118038928	ANKRD7	chr7:117864712-117882782:+	-0.27	-4.33	1.78E-5	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs7797626	chr7:118042798	ANKRD7	chr7:117864712-117882782:+	-0.27	-4.47	9.57E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs7797900	chr7:151117495	CRYGN	chr7:151127057-151137899:-	0.15	3.67	0.000273	Coronary heart disease	
THCA	cis	1	rs7798074	chr7:87488221	DBF4	chr7:87505544-87538856:+	-0.26	-3.92	0.000103	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs7798194	chr7:151117695	CRYGN	chr7:151127057-151137899:-	0.14	3.53	0.000449	Coronary heart disease	
THCA	cis	1	rs77981979	chr2:48209839	FOXN2	chr2:48541795-48606434:+	0.25	4.55	6.84E-6	Schizophrenia	
THCA	cis	1	rs7798197	chr7:19037661	TWIST1	chr7:19155093-19157295:-	0.2	5.05	6.18E-7	Intracranial aneurysm	
THCA	cis	1	rs7799006	chr7:2278226	FTSJ2	chr7:2273928-2281833:-	0.24	4.47	9.89E-6	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	
THCA	cis	1	rs77994758	chr8:117689443	EIF3H	chr8:117657056-117778494:-	-0.2	-3.65	0.000289	Body mass index	
THCA	cis	1	rs780092	chr2:27743154	FNDC4	chr2:27714751-27718126:-	0.51	9.2	1.15E-18	Triglycerides;Metabolite levels;Lipid traits	
THCA	cis	1	rs780092	chr2:27743154	GCKR	chr2:27719706-27746548:+	0.47	7.23	1.98E-12	Triglycerides;Metabolite levels;Lipid traits	
THCA	cis	1	rs780092	chr2:27743154	NRBP1	chr2:27650657-27665122:+	0.21	3.93	9.69E-5	Triglycerides;Metabolite levels;Lipid traits	
THCA	cis	1	rs780094	chr2:27741237	FNDC4	chr2:27714751-27718126:-	-0.3	-7.34	9.03E-13	Crohn's disease;Metabolic syndrome;Urate levels;Fasting glucose-related traits (interaction with BMI);Fasting plasma glucose;Urate levels in obese individuals;Hypertriglyceridemia;Urate levels in overweight individuals;Fasting insulin-related traits;Uric acid levels;Height;Calcium levels;Metabolic t	
THCA	cis	1	rs780094	chr2:27741237	GCKR	chr2:27719706-27746548:+	-0.28	-6.05	2.93E-9	Crohn's disease;Metabolic syndrome;Urate levels;Fasting glucose-related traits (interaction with BMI);Fasting plasma glucose;Urate levels in obese individuals;Hypertriglyceridemia;Urate levels in overweight individuals;Fasting insulin-related traits;Uric acid levels;Height;Calcium levels;Metabolic t	
THCA	cis	1	rs780094	chr2:27741237	KRTCAP3	chr2:27665263-27667163:+	-0.16	-3.58	0.000372	Crohn's disease;Metabolic syndrome;Urate levels;Fasting glucose-related traits (interaction with BMI);Fasting plasma glucose;Urate levels in obese individuals;Hypertriglyceridemia;Urate levels in overweight individuals;Fasting insulin-related traits;Uric acid levels;Height;Calcium levels;Metabolic t	
THCA	cis	1	rs78012445	chr6:26195080	HIST1H2AE	chr6:26217148-26217711:+	-0.23	-3.65	0.000289	Renal underexcretion gout;Gout	
THCA	cis	1	rs78012445	chr6:26195080	HIST1H3E	chr6:26224427-26226589:+	0.43	7.09	4.97E-12	Renal underexcretion gout;Gout	
THCA	cis	1	rs7801282	chr7:65613687	ASL	chr7:65540776-65558321:+	0.16	4.28	2.23E-5	Aortic root size	
THCA	cis	1	rs7801282	chr7:65613687	GUSB	chr7:65425675-65447246:-	-0.27	-5.32	1.61E-7	Aortic root size	
THCA	cis	1	rs7801282	chr7:65613687	LOC729156	chr7:66274980-66309813:-	-0.16	-3.47	0.000572	Aortic root size	
THCA	cis	1	rs7801282	chr7:65613687	RABGEF1	chr7:66093890-66276446:+	-0.66	-14.15	3.08E-38	Aortic root size	
THCA	cis	1	rs780151	chr10:80931481	LOC219347	chr10:81805991-81838949:-	0.19	3.47	0.000559	Sitting height ratio;Height	
THCA	cis	1	rs7802043	chr7:54775318	SEC61G	chr7:54819941-54826939:-	0.17	4.9	1.34E-6	Systemic lupus erythematosus	
THCA	cis	1	rs7802263	chr7:124384327	POT1	chr7:124462441-124570037:-	-0.15	-3.45	0.00062	Reading and spelling	
THCA	cis	1	rs7802797	chr7:110911133	IMMP2L	chr7:110303110-111202538:-	0.17	3.71	0.000235	Schizophrenia	
THCA	cis	1	rs78032828	chr2:86309032	LOC90784	chr2:86247339-86250991:-	-0.44	-4.63	4.72E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs78036474	chr16:77785721	NUDT7	chr16:77756411-77776153:+	0.36	4.91	1.25E-6	Obesity-related traits	
THCA	cis	1	rs7804223	chr7:65664559	CCT6P1	chr7:65216092-65228661:+	-0.45	-7.06	6.07E-12	Diabetic kidney disease	
THCA	cis	1	rs7804223	chr7:65664559	CRCP	chr7:65579805-65619551:+	0.28	4.28	2.25E-5	Diabetic kidney disease	
THCA	cis	1	rs7804223	chr7:65664559	RABGEF1	chr7:66093890-66276446:+	-0.6	-7.33	1.01E-12	Diabetic kidney disease	
THCA	cis	1	rs7805314	chr7:118076277	ANKRD7	chr7:117864712-117882782:+	-0.26	-4.26	2.41E-5	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs78055011	chr20:33618606	PROCR	chr20:33758727-33765164:+	-0.36	-5.7	2.14E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs78055011	chr20:33618606	TRPC4AP	chr20:33590215-33680618:-	0.31	3.77	0.000182	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs78062696	chr2:48377720	FOXN2	chr2:48541795-48606434:+	0.24	4.25	2.62E-5	Schizophrenia	
THCA	cis	1	rs78066444	chr11:116812058	PCSK7	chr11:117075789-117102811:-	0.46	5.6	3.67E-8	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs7806994	chr7:56139505	PSPH	chr7:56078746-56184090:-	-0.18	-3.46	0.000597	PR interval in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs7806994	chr7:56139505	ZNF713	chr7:55955162-56008433:+	-0.23	-4.37	1.52E-5	PR interval in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs7807154	chr7:107161391	DLD	chr7:107531586-107561642:+	0.14	3.46	0.000581	Osteoarthritis	
THCA	cis	1	rs78075030	chr6:55987294	COL21A1	chr6:55921389-56258892:-	-0.67	-8.28	1.22E-15	Psychosis (atypical)	
THCA	cis	1	rs7808022	chr7:99220083	ATP5J2	chr7:99055785-99063808:-	-0.18	-3.77	0.000187	Blood metabolite levels	
THCA	cis	1	rs7808022	chr7:99220083	ZNF655	chr7:99156045-99174074:+	-0.16	-3.37	0.000823	Blood metabolite levels	
THCA	cis	1	rs7808314	chr7:118092365	ANKRD7	chr7:117864712-117882782:+	-0.28	-4.52	7.98E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs7808329	chr7:100512232	EPHB4	chr7:100400187-100425143:-	0.22	3.34	0.000892	Type 2 diabetes	
THCA	cis	1	rs7809615	chr7:99184778	ARPC1B	chr7:98972329-98992402:+	0.19	3.5	0.000515	Blood metabolite ratios	
THCA	cis	1	rs78100089	chr7:23223839	NUPL2	chr7:23221446-23240629:+	-0.44	-5.81	1.12E-8	Chronic obstructive pulmonary disease	
THCA	cis	1	rs78104330	chr2:58173577	FANCL	chr2:58386380-58468515:-	-0.19	-3.43	0.000662	Schizophrenia	
THCA	cis	1	rs7810543	chr7:110894778	IMMP2L	chr7:110303110-111202538:-	-0.17	-3.83	0.000146	Schizophrenia	
THCA	cis	1	rs7810970	chr7:2276385	FTSJ2	chr7:2273928-2281833:-	0.23	4.36	1.59E-5	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	
THCA	cis	1	rs781142	chr7:65438778	CCT6P1	chr7:65216092-65228661:+	0.38	6.13	1.85E-9	Diabetic kidney disease	
THCA	cis	1	rs781142	chr7:65438778	CRCP	chr7:65579805-65619551:+	-0.26	-4	7.45E-5	Diabetic kidney disease	
THCA	cis	1	rs781142	chr7:65438778	RABGEF1	chr7:66093890-66276446:+	0.55	6.88	1.92E-11	Diabetic kidney disease	
THCA	cis	1	rs781149	chr7:65481284	CCT6P1	chr7:65216092-65228661:+	0.39	6.3	6.96E-10	Diabetic kidney disease	
THCA	cis	1	rs781149	chr7:65481284	CRCP	chr7:65579805-65619551:+	-0.29	-4.43	1.16E-5	Diabetic kidney disease	
THCA	cis	1	rs781149	chr7:65481284	RABGEF1	chr7:66093890-66276446:+	0.55	6.85	2.32E-11	Diabetic kidney disease	
THCA	cis	1	rs781150	chr7:65480973	CCT6P1	chr7:65216092-65228661:+	0.42	6.65	8.13E-11	Diabetic kidney disease	
THCA	cis	1	rs781150	chr7:65480973	CRCP	chr7:65579805-65619551:+	-0.31	-4.71	3.26E-6	Diabetic kidney disease	
THCA	cis	1	rs781150	chr7:65480973	RABGEF1	chr7:66093890-66276446:+	0.54	6.57	1.3E-10	Diabetic kidney disease	
THCA	cis	1	rs781156	chr7:65479141	CCT6P1	chr7:65216092-65228661:+	0.41	6.48	2.28E-10	Diabetic kidney disease	
THCA	cis	1	rs781156	chr7:65479141	CRCP	chr7:65579805-65619551:+	-0.29	-4.42	1.22E-5	Diabetic kidney disease	
THCA	cis	1	rs781156	chr7:65479141	RABGEF1	chr7:66093890-66276446:+	0.53	6.66	7.52E-11	Diabetic kidney disease	
THCA	cis	1	rs781157	chr7:65478311	CCT6P1	chr7:65216092-65228661:+	0.39	6.28	7.6E-10	Diabetic kidney disease	
THCA	cis	1	rs781157	chr7:65478311	CRCP	chr7:65579805-65619551:+	-0.28	-4.41	1.28E-5	Diabetic kidney disease	
THCA	cis	1	rs781157	chr7:65478311	RABGEF1	chr7:66093890-66276446:+	0.55	6.83	2.56E-11	Diabetic kidney disease	
THCA	cis	1	rs7812088	chr7:150919829	RHEB	chr7:151163098-151217010:-	0.2	3.62	0.000323	Bone mineral density	
THCA	cis	1	rs78131177	chr8:89389442	MMP16	chr8:89049462-89339717:-	0.32	4.95	1.04E-6	Electrodermal activity	
THCA	cis	1	rs78133532	chr18:51794210	POLI	chr18:51795849-51824602:+	0.18	5.29	1.85E-7	Psoriasis	
THCA	cis	1	rs7814319	chr8:97263418	PTDSS1	chr8:97274167-97346774:+	0.19	4.12	4.48E-5	Lung function (FVC)	
THCA	cis	1	rs78143408	chr7:1096846	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.51	5.78E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs78153629	chr15:40673465	C15orf23	chr15:40674922-40686488:+	0.63	9.09	2.55E-18	Heschl's gyrus morphology	
THCA	cis	1	rs78153629	chr15:40673465	IVD	chr15:40697686-40713512:+	-0.53	-10.21	2.75E-22	Heschl's gyrus morphology	
THCA	cis	1	rs78158942	chr7:1090440	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.51	5.97E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs78162577	chr19:10839195	SLC44A2	chr19:10713121-10755234:+	0.3	3.4	0.000743	LDL cholesterol	
THCA	cis	1	rs78172786	chr17:61847114	FTSJ3	chr17:61896795-61905031:-	0.31	5.7	2.1E-8	Body mass index	
THCA	cis	1	rs78172786	chr17:61847114	MAP3K3	chr17:61699775-61773669:+	0.27	5.35	1.38E-7	Body mass index	
THCA	cis	1	rs7817474	chr8:66851918	PDE7A	chr8:66629906-66753755:-	0.17	3.81	0.000156	Myopia (pathological)	
THCA	cis	1	rs78185558	chr7:1090183	ZFAND2A	chr7:1192544-1199855:-	-0.37	-5.48	6.8E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs78185801	chr7:1096367	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.51	5.78E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs78186489	chr22:29845703	NIPSNAP1	chr22:29950800-29977144:-	0.29	3.83	0.000145	Carotid atherosclerosis in HIV infection	
THCA	cis	1	rs78186489	chr22:29845703	THOC5	chr22:29904157-29949736:-	0.19	3.57	0.000387	Carotid atherosclerosis in HIV infection	
THCA	cis	1	rs7818688	chr8:96024082	C8orf38	chr8:95908040-96088396:+	-0.26	-4.46	1.03E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs7819570	chr8:89588626	MMP16	chr8:89049462-89339717:-	0.16	3.59	0.00036	Schizophrenia	
THCA	cis	1	rs7819898	chr8:89452923	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs7820159	chr8:8576215	SGK223	chr8:8175259-8239257:-	-0.31	-5.53	5.23E-8	Obesity-related traits	
THCA	cis	1	rs7820191	chr8:89453170	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs78202808	chr20:33667424	PROCR	chr20:33758727-33765164:+	-0.32	-5.36	1.32E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs78202808	chr20:33667424	TRPC4AP	chr20:33590215-33680618:-	0.28	3.53	0.000461	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs78207779	chr14:35506387	FAM177A1	chr14:35514113-35552587:+	-0.21	-3.94	9.24E-5	Atopic dermatitis	
THCA	cis	1	rs78207779	chr14:35506387	KIAA0391	chr14:35591776-35786673:+	0.27	5.1	4.92E-7	Atopic dermatitis	
THCA	cis	1	rs78207779	chr14:35506387	PPP2R3C	chr14:35554679-35591679:-	0.52	9.82	7.54E-21	Atopic dermatitis	
THCA	cis	1	rs78210154	chr11:96109480	CCDC82	chr11:96085930-96123083:-	-0.24	-3.81	0.000157	Parkinson's disease	
THCA	cis	1	rs7822232	chr8:145145687	KIAA1875	chr8:145162629-145173218:+	-0.32	-6.64	8.51E-11	Blood metabolite levels	
THCA	cis	1	rs78223982	chr1:76465203	ACADM	chr1:76190043-76229353:+	-0.22	-4.65	4.26E-6	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs78223982	chr1:76465203	ST6GALNAC3	chr1:76540389-77096669:+	-0.27	-3.75	0.000199	Attention function in attention deficit hyperactive disorder	
THCA	cis	1	rs7823498	chr8:32403573	NRG1	chr8:31497268-32622558:+	0.41	6.04	3.16E-9	Emphysema imaging phenotypes;Post bronchodilator FEV1/FVC ratio in COPD	
THCA	cis	1	rs7824557	chr8:11104111	TDH	chr8:11197146-11225961:+	0.17	5.15	3.87E-7	Retinal vascular caliber	
THCA	cis	1	rs78246812	chr3:184761338	C3orf70	chr3:184795840-184870802:-	-0.24	-4.7	3.35E-6	Heschl's gyrus morphology	
THCA	cis	1	rs78249279	chr4:154718783	RNF175	chr4:154631313-154681387:-	-0.19	-4	7.43E-5	Electrocardiographic conduction measures	
THCA	cis	1	rs7825171	chr8:89424098	MMP16	chr8:89049462-89339717:-	0.32	5.19	3.04E-7	Electrodermal activity	
THCA	cis	1	rs7825175	chr8:32416274	NRG1	chr8:31497268-32622558:+	0.61	9.9	3.77E-21	Thyroid hormone levels	
THCA	cis	1	rs78267272	chr2:17790782	GEN1	chr2:17935162-17966632:+	0.61	7.14	3.5E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs78268237	chr8:89422511	MMP16	chr8:89049462-89339717:-	0.32	5.19	3.04E-7	Electrodermal activity	
THCA	cis	1	rs7828596	chr8:89449818	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs78287223	chr1:108322646	VAV3	chr1:108113782-108507545:-	0.49	6.72	5.34E-11	Hypothyroidism	
THCA	cis	1	rs782876	chr7:134240770	AKR1B1	chr7:134127107-134143888:-	0.24	4.95	1.01E-6	Longevity	
THCA	cis	1	rs78288367	chr15:66772721	TIPIN	chr15:66629008-66649054:-	-0.37	-3.62	0.000331	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs78288858	chr1:108362293	VAV3	chr1:108113782-108507545:-	0.55	7.49	3.36E-13	Hypothyroidism	
THCA	cis	1	rs78300366	chr11:71205514	NADSYN1	chr11:71164217-71212579:+	0.19	4.32	1.89E-5	Vitamin D levels	
THCA	cis	1	rs78308415	chr7:1072634	ZFAND2A	chr7:1192544-1199855:-	-0.3	-4.31	2.01E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs7832570	chr8:96023795	C8orf38	chr8:95908040-96088396:+	-0.26	-4.46	1.03E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs78326196	chr1:108377132	VAV3	chr1:108113782-108507545:-	0.55	7.32	1.06E-12	Hypothyroidism	
THCA	cis	1	rs7833294	chr8:58008281	IMPAD1	chr8:57870491-57906427:-	-0.31	-3.79	0.000169	Milk allergy	
THCA	cis	1	rs7833971	chr8:32420054	NRG1	chr8:31497268-32622558:+	0.63	10.08	8.49E-22	Thyroid hormone levels	
THCA	cis	1	rs78343340	chr4:267437	ZNF718	chr4:53272-156488:+	0.49	9.17	1.37E-18	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs783531	chr15:83249119	GOLGA6L9	chr15:82711895-82731584:+;chr15	-0.14	-4.45	1.07E-5	Schizophrenia	
THCA	cis	1	rs783540	chr15:83254708	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.15	4.86	1.59E-6	Schizophrenia	
THCA	cis	1	rs78360366	chr5:109769080	TMEM232	chr5:109624934-110062381:-	0.46	4.84	1.76E-6	Cardiac structure and function	
THCA	cis	1	rs78362565	chr5:115564293	COMMD10	chr5:115420727-115628978:+	0.48	5.83	1.01E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs78378661	chr6:41337948	GUCA1B	chr6:42151023-42162694:-	0.28	3.61	0.000337	Alzheimer's disease biomarkers	
THCA	cis	1	rs7838490	chr8:89585048	MMP16	chr8:89049462-89339717:-	0.16	3.76	0.000188	Body mass index and cholesterol (psychopharmacological treatment)	
THCA	cis	1	rs7839040	chr8:82894306	SNX16	chr8:82711820-82754521:-	0.17	3.96	8.58E-5	Response to methotrexate in juvenile idiopathic arthritis	
THCA	cis	1	rs78398345	chr19:12154448	ZNF763	chr19:12035900-12091196:+	-0.39	-4.61	5.28E-6	Multiple sclerosis	
THCA	cis	1	rs7840103	chr8:89462721	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs78420872	chr6:24464429	GMNN	chr6:24775159-24786276:+	-0.29	-3.44	0.000627	Hematological and biochemical traits	
THCA	cis	1	rs78420872	chr6:24464429	GPLD1	chr6:24428405-24489850:-	0.33	5.38	1.17E-7	Hematological and biochemical traits	
THCA	cis	1	rs78420872	chr6:24464429	MRS2	chr6:24403153-24425809:+	0.3	5.83	1.03E-8	Hematological and biochemical traits	
THCA	cis	1	rs78431982	chr11:96105659	CCDC82	chr11:96085930-96123083:-	-0.24	-3.84	0.000141	Parkinson's disease	
THCA	cis	1	rs7843488	chr8:8576217	SGK223	chr8:8175259-8239257:-	-0.31	-5.6	3.61E-8	Obesity-related traits	
THCA	cis	1	rs78449408	chr10:81730699	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs7845586	chr8:89449435	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs78465528	chr5:115474406	COMMD10	chr5:115420727-115628978:+	0.46	5.6	3.56E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs7847117	chr9:99544187	FAM22G	chr9:99690592-99704572:+	0.98	7.96	1.27E-14	Height	
THCA	cis	1	rs7847117	chr9:99544187	HIATL2	chr9:99695549-99775862:-	0.71	5.75	1.6E-8	Height	
THCA	cis	1	rs7847117	chr9:99544187	LOC441454	chr9:99671357-99672736:+	0.44	3.89	0.000113	Height	
THCA	cis	1	rs7847663	chr9:100544868	C9orf156	chr9:100666772-100684852:-	0.13	3.49	0.000531	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	cis	1	rs7847673	chr9:99544821	FAM22G	chr9:99690592-99704572:+	0.96	8.66	7.31E-17	Height	
THCA	cis	1	rs7847673	chr9:99544821	HIATL2	chr9:99695549-99775862:-	0.71	6.39	4.04E-10	Height	
THCA	cis	1	rs7847673	chr9:99544821	LOC441454	chr9:99671357-99672736:+	0.42	4.03	6.49E-5	Height	
THCA	cis	1	rs7848081	chr9:99545120	FAM22G	chr9:99690592-99704572:+	0.96	8.66	7.31E-17	Height	
THCA	cis	1	rs7848081	chr9:99545120	HIATL2	chr9:99695549-99775862:-	0.71	6.39	4.04E-10	Height	
THCA	cis	1	rs7848081	chr9:99545120	LOC441454	chr9:99671357-99672736:+	0.42	4.03	6.49E-5	Height	
THCA	cis	1	rs78487399	chr2:43809347	DYNC2LI1	chr2:44001182-44037147:+	-0.34	-4.79	2.28E-6	Inflammatory bowel disease	
THCA	cis	1	rs7849160	chr9:131874552	CRAT	chr9:131857075-131873070:-	0.28	6.7	5.79E-11	Blood metabolite ratios	
THCA	cis	1	rs7849270	chr9:131874641	CRAT	chr9:131857075-131873070:-	0.28	6.83	2.63E-11	Blood metabolite ratios	
THCA	cis	1	rs78495697	chr1:108355719	VAV3	chr1:108113782-108507545:-	0.56	8.05	6.61E-15	Hypothyroidism	
THCA	cis	1	rs78500566	chr11:46769788	ZNF408	chr11:46722368-46727461:+	-0.19	-3.64	0.000307	HDL cholesterol	
THCA	cis	1	rs7850258	chr9:100549013	C9orf156	chr9:100666772-100684852:-	-0.13	-3.36	0.00083	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	cis	1	rs7850707	chr9:99544745	FAM22G	chr9:99690592-99704572:+	0.96	8.66	7.31E-17	Height	
THCA	cis	1	rs7850707	chr9:99544745	HIATL2	chr9:99695549-99775862:-	0.71	6.39	4.04E-10	Height	
THCA	cis	1	rs7850707	chr9:99544745	LOC441454	chr9:99671357-99672736:+	0.42	4.03	6.49E-5	Height	
THCA	cis	1	rs7850776	chr9:91817364	CKS2	chr9:91926113-91931617:+	-0.24	-4.63	4.67E-6	Pelvic organ prolapse (moderate/severe)	
THCA	cis	1	rs78515849	chr16:77781998	NUDT7	chr16:77756411-77776153:+	0.35	4.83	1.86E-6	Obesity-related traits	
THCA	cis	1	rs78523927	chr7:1089458	ZFAND2A	chr7:1192544-1199855:-	-0.37	-5.37	1.24E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs78539389	chr1:183226726	RNASEL	chr1:182542772-182558391:-	0.33	3.56	0.000401	Systemic lupus erythematosus and Systemic sclerosis	
THCA	cis	1	rs78542065	chr17:76086345	TMC6	chr17:76108999-76128488:-	0.21	3.93	9.92E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs78543982	chr19:52550867	ZNF432	chr19:52536678-52552073:-	-0.18	-4.57	6.14E-6	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	
THCA	cis	1	rs785464	chr1:46523089	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.26	1.85E-22	Body mass index	
THCA	cis	1	rs785464	chr1:46523089	GPBP1L1	chr1:46092978-46152302:-	0.13	3.43	0.000647	Body mass index	
THCA	cis	1	rs785464	chr1:46523089	MMACHC	chr1:45965856-45976737:+	-0.21	-4.64	4.45E-6	Body mass index	
THCA	cis	1	rs785464	chr1:46523089	MUTYH	chr1:45794915-45806142:-	0.29	7.71	7.53E-14	Body mass index	
THCA	cis	1	rs785471	chr1:46518677	CCDC163P	chr1:45960581-45965646:-	-0.51	-9.92	3.29E-21	Body mass index	
THCA	cis	1	rs785471	chr1:46518677	GPBP1L1	chr1:46092978-46152302:-	0.15	3.78	0.000176	Body mass index	
THCA	cis	1	rs785471	chr1:46518677	MMACHC	chr1:45965856-45976737:+	-0.21	-4.62	4.85E-6	Body mass index	
THCA	cis	1	rs785471	chr1:46518677	MUTYH	chr1:45794915-45806142:-	0.3	7.85	2.83E-14	Body mass index	
THCA	cis	1	rs785479	chr1:46492144	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.16	4.31E-22	Body mass index	
THCA	cis	1	rs785479	chr1:46492144	GPBP1L1	chr1:46092978-46152302:-	0.15	3.77	0.000181	Body mass index	
THCA	cis	1	rs785479	chr1:46492144	MMACHC	chr1:45965856-45976737:+	-0.21	-4.61	5.23E-6	Body mass index	
THCA	cis	1	rs785479	chr1:46492144	MUTYH	chr1:45794915-45806142:-	0.3	7.98	1.08E-14	Body mass index	
THCA	cis	1	rs785481	chr1:46554518	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.17	4.03E-22	Body mass index	
THCA	cis	1	rs785481	chr1:46554518	GPBP1L1	chr1:46092978-46152302:-	0.13	3.41	0.000705	Body mass index	
THCA	cis	1	rs785481	chr1:46554518	MMACHC	chr1:45965856-45976737:+	-0.21	-4.48	9.32E-6	Body mass index	
THCA	cis	1	rs785481	chr1:46554518	MUTYH	chr1:45794915-45806142:-	0.28	7.49	3.29E-13	Body mass index	
THCA	cis	1	rs785485	chr1:46574424	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.12	6.33E-22	Body mass index	
THCA	cis	1	rs785485	chr1:46574424	GPBP1L1	chr1:46092978-46152302:-	0.13	3.37	0.000808	Body mass index	
THCA	cis	1	rs785485	chr1:46574424	MMACHC	chr1:45965856-45976737:+	-0.2	-4.39	1.4E-5	Body mass index	
THCA	cis	1	rs785485	chr1:46574424	MUTYH	chr1:45794915-45806142:-	0.28	7.41	5.75E-13	Body mass index	
THCA	cis	1	rs785488	chr1:46576095	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.18	3.8E-22	Body mass index	
THCA	cis	1	rs785488	chr1:46576095	GPBP1L1	chr1:46092978-46152302:-	0.13	3.39	0.000763	Body mass index	
THCA	cis	1	rs785488	chr1:46576095	MMACHC	chr1:45965856-45976737:+	-0.2	-4.45	1.06E-5	Body mass index	
THCA	cis	1	rs785488	chr1:46576095	MUTYH	chr1:45794915-45806142:-	0.28	7.44	4.82E-13	Body mass index	
THCA	cis	1	rs785489	chr1:46576390	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.18	3.8E-22	Body mass index	
THCA	cis	1	rs785489	chr1:46576390	GPBP1L1	chr1:46092978-46152302:-	0.13	3.39	0.000763	Body mass index	
THCA	cis	1	rs785489	chr1:46576390	MMACHC	chr1:45965856-45976737:+	-0.2	-4.45	1.06E-5	Body mass index	
THCA	cis	1	rs785489	chr1:46576390	MUTYH	chr1:45794915-45806142:-	0.28	7.44	4.82E-13	Body mass index	
THCA	cis	1	rs78549183	chr11:18459715	LDHC	chr11:18433853-18472792:+	-0.29	-3.46	0.000586	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs785491	chr1:46583418	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.19	3.37E-22	Body mass index	
THCA	cis	1	rs785491	chr1:46583418	GPBP1L1	chr1:46092978-46152302:-	0.13	3.38	0.000793	Body mass index	
THCA	cis	1	rs785491	chr1:46583418	MMACHC	chr1:45965856-45976737:+	-0.2	-4.45	1.05E-5	Body mass index	
THCA	cis	1	rs785491	chr1:46583418	MUTYH	chr1:45794915-45806142:-	0.28	7.45	4.38E-13	Body mass index	
THCA	cis	1	rs785492	chr1:46583607	CCDC163P	chr1:45960581-45965646:-	-0.51	-9.92	3.29E-21	Body mass index	
THCA	cis	1	rs785492	chr1:46583607	GPBP1L1	chr1:46092978-46152302:-	0.14	3.7	0.000244	Body mass index	
THCA	cis	1	rs785492	chr1:46583607	MMACHC	chr1:45965856-45976737:+	-0.21	-4.5	8.39E-6	Body mass index	
THCA	cis	1	rs785492	chr1:46583607	MUTYH	chr1:45794915-45806142:-	0.29	7.61	1.5E-13	Body mass index	
THCA	cis	1	rs785494	chr1:46586626	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.19	3.29E-22	Body mass index	
THCA	cis	1	rs785494	chr1:46586626	GPBP1L1	chr1:46092978-46152302:-	0.13	3.38	0.000785	Body mass index	
THCA	cis	1	rs785494	chr1:46586626	MMACHC	chr1:45965856-45976737:+	-0.2	-4.45	1.08E-5	Body mass index	
THCA	cis	1	rs785494	chr1:46586626	MUTYH	chr1:45794915-45806142:-	0.28	7.45	4.27E-13	Body mass index	
THCA	cis	1	rs785495	chr1:46587887	CCDC163P	chr1:45960581-45965646:-	-0.51	-9.92	3.18E-21	Body mass index	
THCA	cis	1	rs785495	chr1:46587887	GPBP1L1	chr1:46092978-46152302:-	0.14	3.69	0.000246	Body mass index	
THCA	cis	1	rs785495	chr1:46587887	MMACHC	chr1:45965856-45976737:+	-0.21	-4.51	8.02E-6	Body mass index	
THCA	cis	1	rs785495	chr1:46587887	MUTYH	chr1:45794915-45806142:-	0.29	7.62	1.35E-13	Body mass index	
THCA	cis	1	rs785503	chr1:46595868	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.19	3.37E-22	Body mass index	
THCA	cis	1	rs785503	chr1:46595868	GPBP1L1	chr1:46092978-46152302:-	0.13	3.38	0.000793	Body mass index	
THCA	cis	1	rs785503	chr1:46595868	MMACHC	chr1:45965856-45976737:+	-0.2	-4.45	1.05E-5	Body mass index	
THCA	cis	1	rs785503	chr1:46595868	MUTYH	chr1:45794915-45806142:-	0.28	7.45	4.38E-13	Body mass index	
THCA	cis	1	rs785520	chr1:46568836	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.17	4.03E-22	Body mass index	
THCA	cis	1	rs785520	chr1:46568836	GPBP1L1	chr1:46092978-46152302:-	0.13	3.41	0.000705	Body mass index	
THCA	cis	1	rs785520	chr1:46568836	MMACHC	chr1:45965856-45976737:+	-0.21	-4.48	9.32E-6	Body mass index	
THCA	cis	1	rs785520	chr1:46568836	MUTYH	chr1:45794915-45806142:-	0.28	7.49	3.29E-13	Body mass index	
THCA	cis	1	rs78552657	chr6:159417840	RSPH3	chr6:159398268-159421198:-	0.28	5.96	4.98E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs7855278	chr9:131921365	CRAT	chr9:131857075-131873070:-	-0.33	-8.18	2.57E-15	Blood metabolite ratios	
THCA	cis	1	rs7856392	chr9:101068967	TBC1D2	chr9:100961281-101018003:-	0.19	5	7.96E-7	Schizophrenia	
THCA	cis	1	rs7856667	chr9:99605179	FAM22G	chr9:99690592-99704572:+	0.96	7.5	3.08E-13	Height	
THCA	cis	1	rs7856667	chr9:99605179	HIATL2	chr9:99695549-99775862:-	0.7	5.46	7.65E-8	Height	
THCA	cis	1	rs7856667	chr9:99605179	LOC441454	chr9:99671357-99672736:+	0.42	3.56	0.000408	Height	
THCA	cis	1	rs7857261	chr9:99219779	CDC14B	chr9:99262397-99382112:-	-0.17	-5.33	1.51E-7	Height	
THCA	cis	1	rs7858045	chr9:102914361	LPPR1	chr9:103791031-104087416:+	-0.23	-3.39	0.000756	Preeclampsia	
THCA	cis	1	rs78581866	chr1:27247566	ZDHHC18	chr1:27153201-27182207:+	0.75	7.77	4.97E-14	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs7859307	chr9:99604771	FAM22G	chr9:99690592-99704572:+	0.94	8.69	5.82E-17	Height	
THCA	cis	1	rs7859307	chr9:99604771	HIATL2	chr9:99695549-99775862:-	0.69	6.28	7.52E-10	Height	
THCA	cis	1	rs7859307	chr9:99604771	LOC441454	chr9:99671357-99672736:+	0.37	3.64	0.0003	Height	
THCA	cis	1	rs78594996	chr17:40570109	HSD17B1	chr17:40703984-40707224:+	-0.12	-3.37	0.000808	Crohn's disease	
THCA	cis	1	rs78594996	chr17:40570109	NAGLU	chr17:40687951-40696464:+	-0.23	-5.06	5.88E-7	Crohn's disease	
THCA	cis	1	rs78594996	chr17:40570109	TUBG2	chr17:40811266-40819023:+	-0.22	-5.27	2.04E-7	Crohn's disease	
THCA	cis	1	rs78599153	chr16:77782054	NUDT7	chr16:77756411-77776153:+	0.35	4.83	1.86E-6	Obesity-related traits	
THCA	cis	1	rs78604110	chr15:40681854	C15orf23	chr15:40674922-40686488:+	0.67	9.23	8.73E-19	Heschl's gyrus morphology	
THCA	cis	1	rs78604110	chr15:40681854	IVD	chr15:40697686-40713512:+	-0.55	-9.94	2.76E-21	Heschl's gyrus morphology	
THCA	cis	1	rs7861089	chr9:79041902	RFK	chr9:79000433-79009444:-	-0.16	-3.38	0.000788	Dialysis-related mortality	
THCA	cis	1	rs7861658	chr9:100679954	C9orf156	chr9:100666772-100684852:-	-0.14	-3.51	0.000499	Quantitative traits	
THCA	cis	1	rs78620881	chr11:96100517	CCDC82	chr11:96085930-96123083:-	-0.25	-3.71	0.000228	Parkinson's disease	
THCA	cis	1	rs78623713	chr16:77782739	NUDT7	chr16:77756411-77776153:+	0.35	4.8	2.09E-6	Obesity-related traits	
THCA	cis	1	rs78628466	chr7:1068453	ZFAND2A	chr7:1192544-1199855:-	-0.3	-4.4	1.33E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs78639398	chr1:66006571	LEPR	chr1:65886318-66102820:+	-0.29	-4.12	4.53E-5	Obesity (early onset extreme)	
THCA	cis	1	rs786425	chr12:124085502	ATP6V0A2	chr12:124196865-124246299:+	-0.4	-8.22	1.87E-15	Pubertal anthropometrics	
THCA	cis	1	rs786425	chr12:124085502	DDX55	chr12:124086672-124105483:+	0.35	8.91	1.06E-17	Pubertal anthropometrics	
THCA	cis	1	rs786425	chr12:124085502	SNRNP35	chr12:123942651-123956909:+	0.11	3.61	0.000335	Pubertal anthropometrics	
THCA	cis	1	rs786425	chr12:124085502	TMED2	chr12:124069076-124082681:+	-0.14	-3.54	0.000439	Pubertal anthropometrics	
THCA	cis	1	rs7864322	chr9:100548934	C9orf156	chr9:100666772-100684852:-	0.13	3.6	0.000356	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	cis	1	rs78646493	chr2:86283195	LOC90784	chr2:86247339-86250991:-	-0.62	-6.54	1.54E-10	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs78650586	chr2:86190783	POLR1A	chr2:86253453-86333278:-	-0.32	-4.38	1.45E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs7866350	chr9:100983826	TBC1D2	chr9:100961281-101018003:-	0.25	6.77	3.72E-11	Post-traumatic stress disorder	
THCA	cis	1	rs7867456	chr9:21035307	PTPLAD2	chr9:21003625-21031635:-	0.22	4.81	1.99E-6	Axial length	
THCA	cis	1	rs7867465	chr9:101069078	TBC1D2	chr9:100961281-101018003:-	0.19	4.95	1.03E-6	Schizophrenia	
THCA	cis	1	rs7867834	chr9:101069333	TBC1D2	chr9:100961281-101018003:-	0.19	4.97	9.2E-7	Schizophrenia	
THCA	cis	1	rs78679088	chr21:33910827	TCP10L	chr21:33947152-33957845:-	-0.53	-9.47	1.31E-19	Gastritis	
THCA	cis	1	rs7868408	chr9:131917864	CRAT	chr9:131857075-131873070:-	0.31	7.55	2.17E-13	Blood metabolite ratios	
THCA	cis	1	rs78692246	chr11:116791307	PCSK7	chr11:117075789-117102811:-	0.45	5.41	1.02E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs78694306	chr11:116774244	PCSK7	chr11:117075789-117102811:-	0.44	5.3	1.74E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs7869804	chr9:131913144	CRAT	chr9:131857075-131873070:-	0.29	7.12	4.04E-12	Blood metabolite ratios	
THCA	cis	1	rs78704524	chr8:89436384	MMP16	chr8:89049462-89339717:-	0.33	5.31	1.72E-7	Electrodermal activity	
THCA	cis	1	rs78706991	chr5:109905439	TMEM232	chr5:109624934-110062381:-	0.52	6.21	1.15E-9	Cardiac structure and function	
THCA	cis	1	rs7870753	chr9:99201585	CDC14B	chr9:99262397-99382112:-	-0.17	-5.15	3.76E-7	Height	
THCA	cis	1	rs7870763	chr9:91825818	CKS2	chr9:91926113-91931617:+	-0.23	-4.49	8.99E-6	Pelvic organ prolapse (moderate/severe)	
THCA	cis	1	rs78720986	chr8:117686953	EIF3H	chr8:117657056-117778494:-	-0.2	-3.66	0.000284	Body mass index	
THCA	cis	1	rs78724141	chr8:82659661	CHMP4C	chr8:82644688-82671746:+	-1.33	-17.92	2.68E-55	Epithelial ovarian cancer;Ovarian cancer	
THCA	cis	1	rs78731097	chr17:76083879	TMC6	chr17:76108999-76128488:-	0.21	3.93	9.92E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
THCA	cis	1	rs78740005	chr8:82659306	CHMP4C	chr8:82644688-82671746:+	-1.26	-16.18	2.78E-47	Epithelial ovarian cancer;Ovarian cancer	
THCA	cis	1	rs7874781	chr9:99573065	FAM22G	chr9:99690592-99704572:+	0.98	7.96	1.27E-14	Height	
THCA	cis	1	rs7874781	chr9:99573065	HIATL2	chr9:99695549-99775862:-	0.71	5.75	1.6E-8	Height	
THCA	cis	1	rs7874781	chr9:99573065	LOC441454	chr9:99671357-99672736:+	0.44	3.89	0.000113	Height	
THCA	cis	1	rs78780050	chr16:77781788	NUDT7	chr16:77756411-77776153:+	0.35	4.83	1.86E-6	Obesity-related traits	
THCA	cis	1	rs78784055	chr16:69468869	CYB5B	chr16:69458498-69500167:+	-0.23	-3.99	7.7E-5	Blood pressure (smoking interaction)	
THCA	cis	1	rs78803505	chr7:65382572	CCT6P1	chr7:65216092-65228661:+	0.38	6	3.93E-9	Diabetic kidney disease	
THCA	cis	1	rs78803505	chr7:65382572	CRCP	chr7:65579805-65619551:+	-0.26	-4	7.24E-5	Diabetic kidney disease	
THCA	cis	1	rs78803505	chr7:65382572	RABGEF1	chr7:66093890-66276446:+	0.55	6.89	1.73E-11	Diabetic kidney disease	
THCA	cis	1	rs78808915	chr6:24481312	GPLD1	chr6:24428405-24489850:-	0.19	3.55	0.000417	Hematological and biochemical traits	
THCA	cis	1	rs78808915	chr6:24481312	MRS2	chr6:24403153-24425809:+	0.24	5.44	8.45E-8	Hematological and biochemical traits	
THCA	cis	1	rs78827343	chr8:89367130	MMP16	chr8:89049462-89339717:-	0.32	4.95	1.04E-6	Electrodermal activity	
THCA	cis	1	rs78836001	chr10:4981992	AKR1C2	chr10:4964715-5060207:-	0.37	4.78	2.39E-6	Height	
THCA	cis	1	rs78839411	chr16:77781514	NUDT7	chr16:77756411-77776153:+	0.35	4.83	1.86E-6	Obesity-related traits	
THCA	cis	1	rs78841515	chr16:77785455	NUDT7	chr16:77756411-77776153:+	0.36	4.91	1.25E-6	Obesity-related traits	
THCA	cis	1	rs78861357	chr7:1095418	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.51	5.78E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs78868331	chr5:110038493	TMEM232	chr5:109624934-110062381:-	0.48	5.53	5.18E-8	Cardiac structure and function	
THCA	cis	1	rs78896566	chr7:1080182	ZFAND2A	chr7:1192544-1199855:-	-0.32	-4.7	3.38E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs78900394	chr16:77784109	NUDT7	chr16:77756411-77776153:+	0.36	5.02	7.21E-7	Obesity-related traits	
THCA	cis	1	rs78907692	chr2:203932176	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.68	2.35E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs78907692	chr2:203932176	ICA1L	chr2:203637873-203736371:-	0.28	4.58	5.97E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs789208	chr10:105935096	C10orf79	chr10:105889647-105992120:-	0.25	8	9.25E-15	Attention deficit hyperactivity disorder	
THCA	cis	1	rs789227	chr3:128600585	ACAD9	chr3:128598333-128634910:+	-0.17	-3.39	0.000762	IgG glycosylation	
THCA	cis	1	rs789232	chr3:128603080	ACAD9	chr3:128598333-128634910:+	-0.17	-3.39	0.000762	IgG glycosylation	
THCA	cis	1	rs7893456	chr10:5007862	AKR1C2	chr10:4964715-5060207:-	0.36	4.83	1.87E-6	Height	
THCA	cis	1	rs7893480	chr10:124734829	C10orf88	chr10:124690419-124713919:-	-0.22	-4.04	6.23E-5	Migraine without aura	
THCA	cis	1	rs7894051	chr10:135184421	ECHS1	chr10:135175988-135186908:-	-0.44	-6.89	1.78E-11	Lifespan	
THCA	cis	1	rs7894268	chr10:17199830	TRDMT1	chr10:17184983-17243681:-	-0.44	-10.1	6.97E-22	Homocysteine levels	
THCA	cis	1	rs78945802	chr6:111728346	KIAA1919	chr6:111580482-111590259:+	0.48	5.69	2.21E-8	Psoriasis	
THCA	cis	1	rs7895030	chr10:132941656	TCERG1L	chr10:132890656-133109984:-	0.37	5.54	5.0E-8	Type 2 diabetes	
THCA	cis	1	rs7895348	chr10:65109541	LOC84989	chr10:65224989-65226320:+	-0.27	-4.39	1.39E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs7895348	chr10:65109541	NRBF2	chr10:64893007-64914785:+	-0.28	-4.77	2.5E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs78953577	chr8:32429839	NRG1	chr8:31497268-32622558:+	0.62	9.93	3.06E-21	Thyroid hormone levels	
THCA	cis	1	rs7895755	chr10:52774048	PRKG1	chr10:52750945-54055274:+	-0.22	-4.91	1.28E-6	Migraine	
THCA	cis	1	rs7896033	chr10:124731507	C10orf88	chr10:124690419-124713919:-	-0.22	-4.02	6.65E-5	Migraine without aura	
THCA	cis	1	rs7896691	chr10:3155173	PITRM1	chr10:3179116-3215003:-	0.53	5.98	4.33E-9	Disc degeneration (lumbar)	
THCA	cis	1	rs78967641	chr20:33783053	PROCR	chr20:33758727-33765164:+	-0.3	-4.9	1.32E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs78967641	chr20:33783053	TRPC4AP	chr20:33590215-33680618:-	0.33	4.11	4.61E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs78974622	chr22:38059925	LGALS2	chr22:37966254-37976024:-	0.14	3.71	0.000232	Fat distribution (HIV)	
THCA	cis	1	rs78974622	chr22:38059925	PDXP	chr22:38054737-38062939:+	-0.18	-3.34	0.000892	Fat distribution (HIV)	
THCA	cis	1	rs78974622	chr22:38059925	SH3BP1	chr22:38030661-38062939:+	0.12	3.74	0.00021	Fat distribution (HIV)	
THCA	cis	1	rs7897778	chr10:75916105	VCL	chr10:75754951-75879912:+	-0.22	-3.98	8.0E-5	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs7898235	chr10:74038181	ASCC1	chr10:73856278-73976892:-	0.18	3.34	0.000893	Heschl's gyrus morphology	
THCA	cis	1	rs7898235	chr10:74038181	DNAJB12	chr10:74092588-74114907:-	0.2	4.76	2.56E-6	Heschl's gyrus morphology	
THCA	cis	1	rs78994203	chr11:96123360	CCDC82	chr11:96085930-96123083:-	-0.24	-3.6	0.000351	Parkinson's disease	
THCA	cis	1	rs7899476	chr10:135197214	ECHS1	chr10:135175988-135186908:-	0.49	6.78	3.55E-11	Lifespan	
THCA	cis	1	rs78996483	chr6:55934556	COL21A1	chr6:55921389-56258892:-	-0.64	-7.91	1.86E-14	Psychosis (atypical)	
THCA	cis	1	rs789970	chr10:105977721	C10orf79	chr10:105889647-105992120:-	0.25	8.07	5.61E-15	Attention deficit hyperactivity disorder	
THCA	cis	1	rs7899715	chr10:65078455	LOC84989	chr10:65224989-65226320:+	-0.27	-4.33	1.8E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs7899715	chr10:65078455	NRBF2	chr10:64893007-64914785:+	-0.28	-4.66	4.04E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs7900134	chr10:124744123	C10orf88	chr10:124690419-124713919:-	-0.22	-4.08	5.37E-5	Migraine without aura	
THCA	cis	1	rs79007113	chr11:120039835	TRIM29	chr11:119981995-120008863:-	0.42	6.35	5.14E-10	Stroke (pediatric)	
THCA	cis	1	rs7901428	chr10:7732419	ITIH5	chr10:7601636-7708934:-	-0.17	-3.37	0.000818	Ovarian reserve	
THCA	cis	1	rs79021324	chr14:59941424	C14orf149	chr14:59939406-59951126:-	-0.43	-4.88	1.46E-6	Schizophrenia	
THCA	cis	1	rs79021324	chr14:59941424	JKAMP	chr14:59951161-59972080:+	0.46	5.24	2.37E-7	Schizophrenia	
THCA	cis	1	rs7902253	chr10:124739748	C10orf88	chr10:124690419-124713919:-	-0.22	-4.08	5.37E-5	Migraine without aura	
THCA	cis	1	rs7902273	chr10:124734824	C10orf88	chr10:124690419-124713919:-	-0.22	-4.04	6.23E-5	Migraine without aura	
THCA	cis	1	rs7903259	chr10:17259642	TRDMT1	chr10:17184983-17243681:-	-0.23	-5.33	1.54E-7	Cholesterol, total	
THCA	cis	1	rs7903402	chr10:17259772	TRDMT1	chr10:17184983-17243681:-	0.24	5.49	6.6E-8	Cholesterol, total	
THCA	cis	1	rs7904207	chr10:75884474	VCL	chr10:75754951-75879912:+	-0.19	-3.57	0.00039	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs79044335	chr11:47200402	MADD	chr11:47290927-47351582:+	0.28	3.44	0.00063	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs79044944	chr15:40676285	C15orf23	chr15:40674922-40686488:+	0.68	9.23	8.62E-19	Heschl's gyrus morphology	
THCA	cis	1	rs79044944	chr15:40676285	IVD	chr15:40697686-40713512:+	-0.55	-9.9	3.9E-21	Heschl's gyrus morphology	
THCA	cis	1	rs79045902	chr7:127147127	GRM8	chr7:126078652-126893147:-	-0.35	-3.57	0.000398	Medication adherence in chronic diseases	
THCA	cis	1	rs79048371	chr20:33731484	PROCR	chr20:33758727-33765164:+	-0.33	-5.57	4.15E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs79048371	chr20:33731484	TRPC4AP	chr20:33590215-33680618:-	0.33	4.2	3.21E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs7905163	chr10:91383930	FLJ37201	chr10:91451057-91457685:-	-0.2	-4.21	3.06E-5	Metabolic traits	
THCA	cis	1	rs7905961	chr10:102297391	SEC31B	chr10:102246403-102289636:-	-0.28	-9.12	2.08E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs7907801	chr10:75976638	VCL	chr10:75754951-75879912:+	-0.19	-3.47	0.000558	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs79089647	chr8:89386114	MMP16	chr8:89049462-89339717:-	0.32	4.95	1.04E-6	Electrodermal activity	
THCA	cis	1	rs7908994	chr10:5008383	AKR1C2	chr10:4964715-5060207:-	0.38	5.17	3.38E-7	Height	
THCA	cis	1	rs79091964	chr8:89398005	MMP16	chr8:89049462-89339717:-	0.33	5	8.01E-7	Electrodermal activity	
THCA	cis	1	rs79094565	chr4:154718997	RNF175	chr4:154631313-154681387:-	-0.19	-4	7.43E-5	Electrocardiographic conduction measures	
THCA	cis	1	rs79096665	chr15:56507616	MNS1	chr15:56720929-56757335:-	-0.23	-3.41	0.000699	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs79096665	chr15:56507616	TEX9	chr15:56657644-56738071:+	-0.34	-5.84	9.5E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs79097157	chr15:66764814	TIPIN	chr15:66629008-66649054:-	-0.38	-3.84	0.000138	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs7909915	chr10:75960942	VCL	chr10:75754951-75879912:+	-0.19	-3.47	0.000558	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs7910927	chr10:65138910	NRBF2	chr10:64893007-64914785:+	-0.29	-6.82	2.69E-11	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs79112827	chr16:77782558	NUDT7	chr16:77756411-77776153:+	0.35	4.82	1.97E-6	Obesity-related traits	
THCA	cis	1	rs79116314	chr16:77782432	NUDT7	chr16:77756411-77776153:+	0.35	4.83	1.86E-6	Obesity-related traits	
THCA	cis	1	rs7912093	chr10:17203934	TRDMT1	chr10:17184983-17243681:-	-0.44	-10.08	8.75E-22	Homocysteine levels	
THCA	cis	1	rs7913069	chr10:105714399	OBFC1	chr10:105637320-105678045:-	0.46	4.4	1.32E-5	Uterine fibroids	
THCA	cis	1	rs7914926	chr10:80930698	LOC219347	chr10:81805991-81838949:-	0.19	3.54	0.000438	Sitting height ratio;Height	
THCA	cis	1	rs79152960	chr2:86290661	LOC90784	chr2:86247339-86250991:-	-0.36	-3.43	0.000645	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs79152960	chr2:86290661	POLR1A	chr2:86253453-86333278:-	-0.29	-3.78	0.000176	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
THCA	cis	1	rs7915455	chr10:100123819	PYROXD2	chr10:100143323-100174978:-	0.52	4.84	1.76E-6	Aspartate aminotransferase	
THCA	cis	1	rs79157715	chr11:116800270	PCSK7	chr11:117075789-117102811:-	0.45	5.41	1.02E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs7916094	chr10:52757269	PRKG1	chr10:52750945-54055274:+	-0.2	-4.65	4.3E-6	Migraine	
THCA	cis	1	rs7916282	chr10:65031811	LOC84989	chr10:65224989-65226320:+	-0.26	-4.27	2.33E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs7916282	chr10:65031811	NRBF2	chr10:64893007-64914785:+	-0.28	-4.64	4.43E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs7916441	chr10:80925577	LOC219347	chr10:81805991-81838949:-	0.18	3.39	0.000753	Sitting height ratio;Height	
THCA	cis	1	rs7916441	chr10:80925577	MBL1P	chr10:81664654-81710783:+	0.14	3.39	0.000747	Sitting height ratio;Height	
THCA	cis	1	rs7916466	chr10:23662108	C10orf67	chr10:23605521-23633772:-	-0.24	-4.67	3.84E-6	Crohn's disease and sarcoidosis (combined)	
THCA	cis	1	rs7916697	chr10:69991853	PBLD	chr10:70042417-70092684:-	-0.31	-5.26	2.23E-7	Optic disc area	
THCA	cis	1	rs7917456	chr10:7732323	ITIH5	chr10:7601636-7708934:-	-0.19	-3.83	0.000147	Ovarian reserve	
THCA	cis	1	rs79175320	chr8:117735067	EIF3H	chr8:117657056-117778494:-	-0.21	-3.85	0.000136	Body mass index	
THCA	cis	1	rs7918015	chr10:25216991	PRTFDC1	chr10:25137554-25241533:-	0.25	3.49	0.000537	Metabolite levels (Pyroglutamine)	
THCA	cis	1	rs791856	chr6:86681841	SNHG5	chr6:86386726-86388451:-	0.54	12.72	4.07E-32	Response to antipsychotic treatment	
THCA	cis	1	rs7919300	chr10:52757241	PRKG1	chr10:52750945-54055274:+	-0.2	-4.65	4.3E-6	Migraine	
THCA	cis	1	rs79197732	chr20:33562476	PROCR	chr20:33758727-33765164:+	-0.36	-5.71	1.97E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs79197732	chr20:33562476	TRPC4AP	chr20:33590215-33680618:-	0.33	4	7.46E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs79199019	chr14:35581125	FAM177A1	chr14:35514113-35552587:+	-0.2	-3.76	0.000191	Atopic dermatitis	
THCA	cis	1	rs79199019	chr14:35581125	KIAA0391	chr14:35591776-35786673:+	0.31	5.74	1.65E-8	Atopic dermatitis	
THCA	cis	1	rs79199019	chr14:35581125	PPP2R3C	chr14:35554679-35591679:-	0.54	10.32	1.13E-22	Atopic dermatitis	
THCA	cis	1	rs79199586	chr11:18452146	LDHC	chr11:18433853-18472792:+	-0.34	-3.99	7.76E-5	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs7920002	chr10:17259766	TRDMT1	chr10:17184983-17243681:-	0.24	5.49	6.6E-8	Cholesterol, total	
THCA	cis	1	rs7920112	chr10:17259863	TRDMT1	chr10:17184983-17243681:-	0.24	5.49	6.6E-8	Cholesterol, total	
THCA	cis	1	rs79207844	chr11:116805441	PCSK7	chr11:117075789-117102811:-	0.46	5.26	2.17E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs7921096	chr10:124731468	C10orf88	chr10:124690419-124713919:-	-0.22	-4.02	6.65E-5	Migraine without aura	
THCA	cis	1	rs7921162	chr10:17229004	TRDMT1	chr10:17184983-17243681:-	-0.44	-10.27	1.79E-22	Homocysteine levels	
THCA	cis	1	rs7921162	chr10:17229004	VIM	chr10:17270258-17279592:+	-0.19	-3.55	0.000429	Homocysteine levels	
THCA	cis	1	rs7921185	chr10:4976430	AKR1C2	chr10:4964715-5060207:-	0.31	4.17	3.56E-5	Height	
THCA	cis	1	rs79214560	chr5:109710289	TMEM232	chr5:109624934-110062381:-	0.38	4.24	2.67E-5	Cardiac structure and function	
THCA	cis	1	rs7923609	chr10:65133822	NRBF2	chr10:64893007-64914785:+	-0.29	-6.82	2.69E-11	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs79264785	chr6:26194121	HIST1H2AE	chr6:26217148-26217711:+	-0.23	-3.69	0.000249	Renal underexcretion gout;Gout	
THCA	cis	1	rs79264785	chr6:26194121	HIST1H3E	chr6:26224427-26226589:+	0.43	7.04	6.71E-12	Renal underexcretion gout;Gout	
THCA	cis	1	rs79270274	chr16:77777624	NUDT7	chr16:77756411-77776153:+	0.38	5.19	3.15E-7	Obesity-related traits	
THCA	cis	1	rs7927156	chr11:970607	TSPAN4	chr11:842824-867116:+	0.15	3.49	0.000521	Alzheimer's disease (late onset)	
THCA	cis	1	rs79271996	chr1:108350770	VAV3	chr1:108113782-108507545:-	0.46	6.98	9.83E-12	Hypothyroidism	
THCA	cis	1	rs7927771	chr11:47781306	C1QTNF4	chr11:47611216-47615961:-	-0.3	-5.23	2.59E-7	Subjective well-being	
THCA	cis	1	rs79282796	chr16:77784282	NUDT7	chr16:77756411-77776153:+	0.36	5.02	7.33E-7	Obesity-related traits	
THCA	cis	1	rs79292725	chr10:81730770	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs79295036	chr7:107193669	DLD	chr7:107531586-107561642:+	0.14	3.51	0.000487	Osteoarthritis	
THCA	cis	1	rs7930103	chr11:46484254	PACSIN3	chr11:47199085-47207958:-	0.18	3.93	9.58E-5	Schizophrenia	
THCA	cis	1	rs7930721	chr11:71737481	FAM86C	chr11:71498557-71512276:+	0.31	3.77	0.000186	Severe influenza A (H1N1) infection	
THCA	cis	1	rs79317378	chr11:46641654	PACSIN3	chr11:47199085-47207958:-	0.18	4.08	5.26E-5	Schizophrenia	
THCA	cis	1	rs79318564	chr15:84786150	GOLGA6L5	chr15:85047738-85060078:-	-0.2	-5.21	2.76E-7	Schizophrenia	
THCA	cis	1	rs79318564	chr15:84786150	LOC388152	chr15:84867600-84898920:-	-0.72	-12.85	1.18E-32	Schizophrenia	
THCA	cis	1	rs79318564	chr15:84786150	NMB	chr15:85198362-85201802:-	0.23	4.54	7.12E-6	Schizophrenia	
THCA	cis	1	rs79318564	chr15:84786150	SH3GL3	chr15:84116091-84287491:+	0.23	3.59	0.000368	Schizophrenia	
THCA	cis	1	rs7931930	chr11:108268286	ATM	chr11:108093559-108239826:+	-0.1	-3.39	0.000758	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
THCA	cis	1	rs7931941	chr11:71667604	FAM86C	chr11:71498557-71512276:+	0.31	3.86	0.000126	Severe influenza A (H1N1) infection	
THCA	cis	1	rs7932631	chr11:93644429	HEPHL1	chr11:93754378-93847374:+	-0.41	-3.71	0.000229	Obesity-related traits	
THCA	cis	1	rs79327308	chr7:1108141	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.8	1.19E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs79341738	chr20:33702104	PROCR	chr20:33758727-33765164:+	-0.33	-5.75	1.57E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs79341738	chr20:33702104	TRPC4AP	chr20:33590215-33680618:-	0.33	4.32	1.93E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs79349393	chr11:116865367	PCSK7	chr11:117075789-117102811:-	0.41	5.18	3.34E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs7935426	chr11:74363890	POLD3	chr11:74303629-74353765:+	-0.22	-3.65	0.000289	Response to metformin (IC50)	
THCA	cis	1	rs79357647	chr6:159402432	RSPH3	chr6:159398268-159421198:-	0.28	6	3.81E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs7936413	chr11:46393958	PACSIN3	chr11:47199085-47207958:-	0.16	3.69	0.000249	Schizophrenia	
THCA	cis	1	rs79366248	chr4:266659	ZNF718	chr4:53272-156488:+	0.49	9.17	1.37E-18	Immune response to smallpox vaccine (IL-6)	
THCA	cis	1	rs7937006	chr11:68843932	TPCN2	chr11:68816350-68929907:+	-0.16	-4.07	5.48E-5	Hair color	
THCA	cis	1	rs7937582	chr11:71744613	FAM86C	chr11:71498557-71512276:+	0.32	3.91	0.000107	Severe influenza A (H1N1) infection	
THCA	cis	1	rs7937890	chr11:14396485	RRAS2	chr11:14299467-14380729:-	-0.16	-3.78	0.000178	Mitochondrial DNA levels	
THCA	cis	1	rs7937	chr19:41302706	C19orf54	chr19:41246761-41256408:-	-0.15	-3.72	0.000219	Post bronchodilator FEV1;Emphysema imaging phenotypes;Chronic obstructive pulmonary disease;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs7937	chr19:41302706	RAB4B	chr19:41281657-41302847:+	-0.16	-5.03	6.91E-7	Post bronchodilator FEV1;Emphysema imaging phenotypes;Chronic obstructive pulmonary disease;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs7938380	chr11:64034866	PRDX5	chr11:64085569-64089282:+	-0.18	-4.76	2.54E-6	Mean platelet volume	
THCA	cis	1	rs79385727	chr8:117748526	EIF3H	chr8:117657056-117778494:-	-0.21	-3.83	0.000147	Body mass index	
THCA	cis	1	rs7939107	chr11:64034773	PRDX5	chr11:64085569-64089282:+	-0.18	-4.76	2.54E-6	Mean platelet volume	
THCA	cis	1	rs7939352	chr11:78003151	NARS2	chr11:78147017-78285909:-	-0.36	-6.94	1.27E-11	Testicular germ cell tumor	
THCA	cis	1	rs79396265	chr8:96071272	C8orf38	chr8:95908040-96088396:+	-0.27	-4.51	8.03E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs7939646	chr11:78111613	NARS2	chr11:78147017-78285909:-	0.38	7.18	2.73E-12	Testicular germ cell tumor	
THCA	cis	1	rs7940310	chr11:117024481	PCSK7	chr11:117075789-117102811:-	-0.38	-6.71	5.47E-11	Protein quantitative trait loci	
THCA	cis	1	rs79404901	chr5:115449332	COMMD10	chr5:115420727-115628978:+	0.48	5.75	1.63E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs7940554	chr11:118142930	AMICA1	chr11:118064442-118095809:-	0.09	4.36	1.63E-5	Pain	
THCA	cis	1	rs7940554	chr11:118142930	MPZL2	chr11:118124135-118135009:-	0.22	7.61	1.45E-13	Pain	
THCA	cis	1	rs7940554	chr11:118142930	TREH	chr11:118528942-118550381:-	-0.17	-3.56	0.000411	Pain	
THCA	cis	1	rs7940866	chr11:130817579	SNX19	chr11:130745767-130786382:-	0.18	6.45	2.67E-10	Schizophrenia	
THCA	cis	1	rs79409507	chr16:77781480	NUDT7	chr16:77756411-77776153:+	0.35	4.83	1.86E-6	Obesity-related traits	
THCA	cis	1	rs79412014	chr4:106755444	INTS12	chr4:106603787-106629881:-	-0.58	-5	8.08E-7	Post bronchodilator FEV1	
THCA	cis	1	rs7941617	chr11:78021146	NARS2	chr11:78147017-78285909:-	-0.37	-7	8.86E-12	Testicular germ cell tumor	
THCA	cis	1	rs79419293	chr2:190625076	ASNSD1	chr2:190526125-190535556:+	-0.72	-6.81	2.86E-11	Subcutaneous adipose tissue	
THCA	cis	1	rs7941964	chr11:46805575	DDB2	chr11:47236493-47260769:+	-0.22	-3.68	0.000258	HDL cholesterol	
THCA	cis	1	rs7942031	chr11:47868474	FAM180B	chr11:47608245-47610746:+	0.2	3.39	0.000752	Intraocular pressure	
THCA	cis	1	rs79422648	chr7:1080241	ZFAND2A	chr7:1192544-1199855:-	-0.32	-4.7	3.38E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs7943121	chr11:18656062	SPTY2D1	chr11:18627949-18656020:-	-0.14	-4.61	5.13E-6	Cholesterol, total	
THCA	cis	1	rs79436302	chr14:35578797	FAM177A1	chr14:35514113-35552587:+	-0.2	-3.76	0.000191	Atopic dermatitis	
THCA	cis	1	rs79436302	chr14:35578797	KIAA0391	chr14:35591776-35786673:+	0.31	5.74	1.65E-8	Atopic dermatitis	
THCA	cis	1	rs79436302	chr14:35578797	PPP2R3C	chr14:35554679-35591679:-	0.54	10.32	1.13E-22	Atopic dermatitis	
THCA	cis	1	rs79438986	chr20:33702280	PROCR	chr20:33758727-33765164:+	-0.34	-5.66	2.6E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs79438986	chr20:33702280	TRPC4AP	chr20:33590215-33680618:-	0.34	4.25	2.58E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs79439610	chr20:33654689	PROCR	chr20:33758727-33765164:+	-0.34	-5.45	8.29E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs79439610	chr20:33654689	TRPC4AP	chr20:33590215-33680618:-	0.33	3.93	9.8E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs79440439	chr11:478147	IRF7	chr11:612556-615999:-	0.25	3.63	0.000309	Body mass index	
THCA	cis	1	rs7944109	chr11:5564919	UBQLNL	chr11:5535624-5537956:-	-0.27	-6.11	2.02E-9	QRS duration in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs79443843	chr7:1075245	ZFAND2A	chr7:1192544-1199855:-	-0.31	-4.55	6.75E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs79444544	chr2:190758532	ASNSD1	chr2:190526125-190535556:+	-0.53	-5.54	5.01E-8	Subcutaneous adipose tissue	
THCA	cis	1	rs7944584	chr11:47336320	C1QTNF4	chr11:47611216-47615961:-	0.25	3.79	0.000169	Fasting glucose-related traits (interaction with BMI);Fasting glucose-related traits	
THCA	cis	1	rs79451333	chr1:108363636	VAV3	chr1:108113782-108507545:-	0.56	8.05	6.61E-15	Hypothyroidism	
THCA	cis	1	rs7947378	chr11:18381327	GTF2H1	chr11:18343816-18388590:+	0.37	9.81	7.86E-21	Pancreatic cancer	
THCA	cis	1	rs79477087	chr11:22116168	ANO5	chr11:22214722-22304913:+	0.34	6.34	5.4E-10	Parkinson's disease	
THCA	cis	1	rs7947730	chr11:47786184	C1QTNF4	chr11:47611216-47615961:-	-0.3	-5.23	2.59E-7	Subjective well-being	
THCA	cis	1	rs7948821	chr11:71652485	FAM86C	chr11:71498557-71512276:+	0.34	4.06	5.73E-5	Severe influenza A (H1N1) infection	
THCA	cis	1	rs79490511	chr8:89363816	MMP16	chr8:89049462-89339717:-	0.31	4.88	1.48E-6	Electrodermal activity	
THCA	cis	1	rs7949480	chr11:71697588	FAM86C	chr11:71498557-71512276:+	0.32	3.89	0.000116	Severe influenza A (H1N1) infection	
THCA	cis	1	rs7949790	chr11:30374608	C11orf46	chr11:30344649-30359978:+	0.23	4.28	2.22E-5	Sex hormone levels;Menopause (age at onset)	
THCA	cis	1	rs7950364	chr11:116898886	PCSK7	chr11:117075789-117102811:-	-0.29	-5.09	5.09E-7	Protein quantitative trait loci	
THCA	cis	1	rs7950657	chr11:68834831	TPCN2	chr11:68816350-68929907:+	-0.16	-4.02	6.66E-5	Hair color	
THCA	cis	1	rs7953014	chr12:109998097	KCTD10	chr12:109886460-109915155:-	-0.23	-6.05	3.0E-9	HDL cholesterol	
THCA	cis	1	rs79538247	chr7:32467792	AVL9	chr7:32535176-33079034:+	-0.15	-4.43	1.17E-5	Metabolite levels (HVA/MHPG ratio)	
THCA	cis	1	rs79539678	chr2:203740938	ALS2CR8	chr2:203776978-203851060:+	-0.29	-5.93	5.93E-9	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs79539678	chr2:203740938	ICA1L	chr2:203637873-203736371:-	0.25	4.18	3.49E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs7954144	chr12:110015893	KCTD10	chr12:109886460-109915155:-	-0.23	-5.9	6.79E-9	HDL cholesterol	
THCA	cis	1	rs7954638	chr12:96314795	AMDHD1	chr12:96337071-96362369:+	0.53	9.32	4.43E-19	Metabolite levels (small molecules and protein measures)	
THCA	cis	1	rs795484	chr12:118589862	PEBP1	chr12:118573870-118583390:+	-0.11	-4.12	4.38E-5	Morphine dose requirement in tonsillectomy and adenoidectomy surgery	
THCA	cis	1	rs79548696	chr3:41803385	ULK4	chr3:41288091-42003660:-	1.08	19.56	5.1E-63	Diastolic blood pressure	
THCA	cis	1	rs79562877	chr8:89469271	MMP16	chr8:89049462-89339717:-	0.33	5.11	4.7E-7	Electrodermal activity	
THCA	cis	1	rs79568175	chr1:27038216	ZDHHC18	chr1:27153201-27182207:+	0.8	8.6	1.15E-16	HDL cholesterol;Triglycerides;LDL cholesterol	
THCA	cis	1	rs7956826	chr12:82173365	PPFIA2	chr12:81652880-82153109:-	0.2	3.81	0.00016	Resting heart rate	
THCA	cis	1	rs79571438	chr4:106616198	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs7957213	chr12:42475438	GXYLT1	chr12:42475650-42538673:-	-0.15	-3.89	0.000116	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	
THCA	cis	1	rs7957213	chr12:42475438	PPHLN1	chr12:42632249-42853517:+	-0.13	-3.54	0.000437	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	
THCA	cis	1	rs79573650	chr5:109732668	TMEM232	chr5:109624934-110062381:-	0.4	4.38	1.45E-5	Cardiac structure and function	
THCA	cis	1	rs79574287	chr3:168699620	MECOM	chr3:168801287-169381563:-	0.6	6.12	1.96E-9	Aging (time to event)	
THCA	cis	1	rs79577870	chr8:89388893	MMP16	chr8:89049462-89339717:-	0.32	4.95	1.04E-6	Electrodermal activity	
THCA	cis	1	rs79579293	chr14:88822068	SPATA7	chr14:88852012-88904802:+	-0.17	-3.4	0.000742	Coronary artery calcification	
THCA	cis	1	rs79583958	chr1:183229061	RNASEL	chr1:182542772-182558391:-	0.34	3.63	0.000316	Systemic lupus erythematosus and Systemic sclerosis	
THCA	cis	1	rs7958691	chr12:124440743	DNAH10	chr12:124247042-124420265:+	0.18	3.79	0.000168	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs7958691	chr12:124440743	ZNF664	chr12:124457670-124499967:+	-0.17	-5.04	6.47E-7	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs79592437	chr2:48383328	FOXN2	chr2:48541795-48606434:+	0.22	4.05	5.89E-5	Schizophrenia	
THCA	cis	1	rs79598582	chr8:117688394	EIF3H	chr8:117657056-117778494:-	-0.21	-3.69	0.000251	Body mass index	
THCA	cis	1	rs79602855	chr19:50525725	SIGLEC16	chr19:50472912-50479075:+	0.61	5.88	7.6E-9	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
THCA	cis	1	rs7960483	chr12:45925755	LOC400027	chr12:46119810-46121530:-	-0.12	-3.38	0.000781	Hypertension	
THCA	cis	1	rs7961449	chr12:124437215	DNAH10	chr12:124247042-124420265:+	-0.18	-3.68	0.000256	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs7961449	chr12:124437215	ZNF664	chr12:124457670-124499967:+	0.16	4.81	2.03E-6	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs7961569	chr12:120157345	TMEM233	chr12:120031264-120079363:+	0.22	5.44	8.68E-8	Urgency urinary incontinence	
THCA	cis	1	rs79617366	chr7:1111958	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.69	2.27E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs79633844	chr2:203683990	ALS2CR8	chr2:203776978-203851060:+	-0.27	-5.24	2.36E-7	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs79633844	chr2:203683990	ICA1L	chr2:203637873-203736371:-	0.27	4.37	1.5E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs79633979	chr19:50488612	SIGLEC16	chr19:50472912-50479075:+	0.64	6.05	3.01E-9	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
THCA	cis	1	rs79634040	chr11:71230169	NADSYN1	chr11:71164217-71212579:+	0.18	4.14	4.11E-5	Vitamin D levels	
THCA	cis	1	rs7963577	chr12:82174115	PPFIA2	chr12:81652880-82153109:-	0.21	3.89	0.000114	Resting heart rate	
THCA	cis	1	rs7964021	chr12:109997645	KCTD10	chr12:109886460-109915155:-	-0.23	-5.93	5.78E-9	HDL cholesterol	
THCA	cis	1	rs79642273	chr2:203830851	ALS2CR8	chr2:203776978-203851060:+	-0.28	-5.69	2.21E-8	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs79642273	chr2:203830851	ICA1L	chr2:203637873-203736371:-	0.27	4.48	9.33E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
THCA	cis	1	rs7966755	chr12:82221604	PPFIA2	chr12:81652880-82153109:-	0.22	4.06	5.72E-5	Resting heart rate	
THCA	cis	1	rs79683221	chr7:1096139	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.51	5.78E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs7968440	chr12:51134741	DIP2B	chr12:50898768-51142448:+	0.11	3.61	0.000335	Fibrinogen	
THCA	cis	1	rs7968682	chr12:66371880	IRAK3	chr12:66582978-66648392:+	0.12	3.59	0.000361	Height	
THCA	cis	1	rs7969761	chr12:355842	CCDC77	chr12:498516-551804:+	0.36	6.41	3.52E-10	Blood metabolite ratios	
THCA	cis	1	rs79702597	chr14:35558856	FAM177A1	chr14:35514113-35552587:+	-0.21	-4.01	7.04E-5	Atopic dermatitis	
THCA	cis	1	rs79702597	chr14:35558856	KIAA0391	chr14:35591776-35786673:+	0.29	5.55	4.8E-8	Atopic dermatitis	
THCA	cis	1	rs79702597	chr14:35558856	PPP2R3C	chr14:35554679-35591679:-	0.53	10.21	2.82E-22	Atopic dermatitis	
THCA	cis	1	rs79704582	chr16:77781159	NUDT7	chr16:77756411-77776153:+	0.35	4.83	1.86E-6	Obesity-related traits	
THCA	cis	1	rs7970815	chr12:129288366	GLT1D1	chr12:129338081-129469509:+	-0.22	-5.52	5.65E-8	Systemic lupus erythematosus	
THCA	cis	1	rs7970815	chr12:129288366	SLC15A4	chr12:129277739-129308541:-	-0.17	-4.22	2.86E-5	Systemic lupus erythematosus	
THCA	cis	1	rs79711490	chr11:116785341	PCSK7	chr11:117075789-117102811:-	0.43	5.33	1.53E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs79716074	chr2:277003	SH3YL1	chr2:218138-264810:-	-0.95	-26.37	2.92E-95	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs7973683	chr12:124449223	DNAH10	chr12:124247042-124420265:+	0.18	3.81	0.000157	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs7973683	chr12:124449223	ZNF664	chr12:124457670-124499967:+	-0.17	-5.03	6.79E-7	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs7973719	chr12:7334813	PEX5	chr12:7341759-7371167:+	0.42	10.06	1.03E-21	IgG glycosylation	
THCA	cis	1	rs79738251	chr2:17786558	GEN1	chr2:17935162-17966632:+	0.61	7.13	3.63E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs7973904	chr12:51333424	SLC11A2	chr12:51373319-51422058:-	-0.23	-4.67	4.01E-6	Type 2 diabetes	
THCA	cis	1	rs7973904	chr12:51333424	TFCP2	chr12:51488608-51566917:-	-0.18	-3.86	0.000129	Type 2 diabetes	
THCA	cis	1	rs79744793	chr8:89344949	MMP16	chr8:89049462-89339717:-	0.33	4.98	8.77E-7	Electrodermal activity	
THCA	cis	1	rs79744929	chr8:89370279	MMP16	chr8:89049462-89339717:-	0.32	4.95	1.04E-6	Electrodermal activity	
THCA	cis	1	rs7975863	chr12:82227288	PPFIA2	chr12:81652880-82153109:-	0.22	4.06	5.72E-5	Resting heart rate	
THCA	cis	1	rs79765398	chr7:1073764	ZFAND2A	chr7:1192544-1199855:-	-0.3	-4.4	1.33E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs79770253	chr2:17784158	GEN1	chr2:17935162-17966632:+	0.61	7.08	5.1E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs7977690	chr12:51130414	DIP2B	chr12:50898768-51142448:+	0.12	3.7	0.000242	Fibrinogen	
THCA	cis	1	rs79780973	chr5:150174810	LOC134466	chr5:150310000-150326146:-	0.44	5.72	1.89E-8	Crohn's disease	
THCA	cis	1	rs79780973	chr5:150174810	ZNF300	chr5:150273964-150284391:-	0.19	3.75	0.000197	Crohn's disease	
THCA	cis	1	rs7978454	chr12:124316876	ATP6V0A2	chr12:124196865-124246299:+	0.26	5.34	1.41E-7	IgG glycosylation	
THCA	cis	1	rs7978454	chr12:124316876	DDX55	chr12:124086672-124105483:+	-0.16	-3.88	0.000119	IgG glycosylation	
THCA	cis	1	rs7980501	chr12:3912972	PARP11	chr12:3918027-3982608:-	-0.24	-5.26	2.22E-7	Cognitive performance	
THCA	cis	1	rs7980687	chr12:123822711	CDK2AP1	chr12:123745542-123756687:-	-0.28	-7.8	4.0E-14	Educational attainment;Height;Head circumference (infant)	
THCA	cis	1	rs7980687	chr12:123822711	MPHOSPH9	chr12:123640948-123717658:-	0.19	5.35	1.34E-7	Educational attainment;Height;Head circumference (infant)	
THCA	cis	1	rs7980687	chr12:123822711	PITPNM2	chr12:123468027-123635285:-	0.26	5.12	4.46E-7	Educational attainment;Height;Head circumference (infant)	
THCA	cis	1	rs79817140	chr19:52571657	ZNF432	chr19:52536678-52552073:-	-0.18	-4.57	6.14E-6	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	
THCA	cis	1	rs79831012	chr10:102237059	SEC31B	chr10:102246403-102289636:-	-0.3	-10.21	2.73E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs798412	chr5:130698474	P4HA2	chr5:131528306-131563556:-	-0.26	-4.97	9.28E-7	Life satisfaction	
THCA	cis	1	rs798415	chr5:130693723	P4HA2	chr5:131528306-131563556:-	-0.26	-4.92	1.18E-6	Life satisfaction	
THCA	cis	1	rs798416	chr5:130693100	P4HA2	chr5:131528306-131563556:-	-0.26	-5.1	4.94E-7	Life satisfaction	
THCA	cis	1	rs79846980	chr19:22141343	ZNF492	chr19:22817126-22850472:+	0.24	3.37	0.000806	Body mass index (change over time)	
THCA	cis	1	rs798536	chr7:2766383	AMZ1	chr7:2719163-2755069:+	-0.37	-5.74	1.65E-8	Height	
THCA	cis	1	rs798540	chr7:2764130	AMZ1	chr7:2719163-2755069:+	-0.37	-5.79	1.25E-8	Height	
THCA	cis	1	rs79854439	chr10:81730092	LOC219347	chr10:81805991-81838949:-	0.51	5.21	2.88E-7	Rheumatoid arthritis	
THCA	cis	1	rs798544	chr7:2763102	AMZ1	chr7:2719163-2755069:+	0.39	6.18	1.38E-9	Height	
THCA	cis	1	rs798545	chr7:2762386	AMZ1	chr7:2719163-2755069:+	-0.4	-6.18	1.36E-9	Height	
THCA	cis	1	rs798548	chr7:2760935	AMZ1	chr7:2719163-2755069:+	-0.38	-5.99	4.2E-9	Height	
THCA	cis	1	rs798550	chr7:2760609	AMZ1	chr7:2719163-2755069:+	-0.39	-6.1	2.17E-9	Height	
THCA	cis	1	rs798554	chr7:2759795	AMZ1	chr7:2719163-2755069:+	-0.41	-6.3	6.96E-10	Height	
THCA	cis	1	rs798559	chr7:2758341	AMZ1	chr7:2719163-2755069:+	-0.41	-6.3	6.9E-10	Height	
THCA	cis	1	rs798560	chr7:2758309	AMZ1	chr7:2719163-2755069:+	-0.4	-6.18	1.4E-9	Height	
THCA	cis	1	rs79868973	chr6:26189312	HIST1H2AE	chr6:26217148-26217711:+	-0.27	-4.18	3.47E-5	Renal underexcretion gout;Gout	
THCA	cis	1	rs79868973	chr6:26189312	HIST1H3E	chr6:26224427-26226589:+	0.44	7.14	3.5E-12	Renal underexcretion gout;Gout	
THCA	cis	1	rs7987653	chr13:95866467	ABCC4	chr13:95672084-95953687:-	-0.19	-3.64	0.000303	Breast cancer	
THCA	cis	1	rs79885511	chr16:77781539	NUDT7	chr16:77756411-77776153:+	0.35	4.83	1.86E-6	Obesity-related traits	
THCA	cis	1	rs79888893	chr14:35510676	FAM177A1	chr14:35514113-35552587:+	-0.22	-4.17	3.6E-5	Atopic dermatitis	
THCA	cis	1	rs79888893	chr14:35510676	KIAA0391	chr14:35591776-35786673:+	0.28	5.31	1.68E-7	Atopic dermatitis	
THCA	cis	1	rs79888893	chr14:35510676	PPP2R3C	chr14:35554679-35591679:-	0.52	9.83	6.95E-21	Atopic dermatitis	
THCA	cis	1	rs79889615	chr5:115591292	COMMD10	chr5:115420727-115628978:+	0.48	5.7	2.09E-8	Asthma or chronic obstructive pulmonary disease	
THCA	cis	1	rs79917044	chr16:77784411	NUDT7	chr16:77756411-77776153:+	0.36	5.02	7.33E-7	Obesity-related traits	
THCA	cis	1	rs7992643	chr13:100555038	CLYBL	chr13:100258936-100544823:+	-0.19	-4.82	1.94E-6	Attention deficit hyperactivity disorder	
THCA	cis	1	rs7992980	chr13:33181142	N4BP2L2	chr13:33006930-33112936:-	0.26	7.79	4.18E-14	Body mass index	
THCA	cis	1	rs79945532	chr8:117697898	EIF3H	chr8:117657056-117778494:-	-0.21	-3.72	0.000224	Body mass index	
THCA	cis	1	rs7997137	chr13:85677311	SLITRK6	chr13:86366922-86373483:-	-0.22	-4.02	6.79E-5	Bipolar disorder (mania)	
THCA	cis	1	rs7997302	chr13:94035652	GPC6	chr13:93879078-95060267:+	-0.28	-3.66	0.000284	Neuroticism	
THCA	cis	1	rs7998585	chr13:24435195	C1QTNF9B	chr13:24465238-24471641:-	-0.35	-3.53	0.00045	3-hydroxypropylmercapturic acid levels in smokers	
THCA	cis	1	rs79987695	chr3:184535604	C3orf70	chr3:184795840-184870802:-	-0.25	-4.75	2.72E-6	Heschl's gyrus morphology	
THCA	cis	1	rs7999125	chr13:33145995	CG030	chr13:33078645-33083532:-	-0.12	-3.34	0.000888	Body mass index	
THCA	cis	1	rs7999125	chr13:33145995	N4BP2L2	chr13:33006930-33112936:-	0.27	8	9.63E-15	Body mass index	
THCA	cis	1	rs7999175	chr13:95867402	ABCC4	chr13:95672084-95953687:-	-0.19	-3.64	0.000303	Breast cancer	
THCA	cis	1	rs79999461	chr7:117976981	ANKRD7	chr7:117864712-117882782:+	0.28	4.51	8.34E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs8000149	chr13:50090025	CAB39L	chr13:49882787-50018221:-	-0.29	-5.56	4.6E-8	Cardiac hypertrophy	
THCA	cis	1	rs8000149	chr13:50090025	RCBTB1	chr13:50106082-50159719:-	-0.23	-5.93	5.91E-9	Cardiac hypertrophy	
THCA	cis	1	rs8000149	chr13:50090025	SETDB2	chr13:50018429-50069138:+	-0.26	-6.5	2.06E-10	Cardiac hypertrophy	
THCA	cis	1	rs800142	chr11:2385071	CD81	chr11:2398547-2418649:+	0.17	3.41	0.0007	Bacteremia	
THCA	cis	1	rs80015203	chr11:116810906	PCSK7	chr11:117075789-117102811:-	0.46	5.6	3.67E-8	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs800153	chr11:2373515	CD81	chr11:2398547-2418649:+	0.17	3.45	0.000618	Bacteremia	
THCA	cis	1	rs800156	chr11:2376436	CD81	chr11:2398547-2418649:+	0.17	3.45	0.000609	Bacteremia	
THCA	cis	1	rs800157	chr11:2376602	CD81	chr11:2398547-2418649:+	0.17	3.48	0.000551	Bacteremia	
THCA	cis	1	rs800158	chr11:2378447	CD81	chr11:2398547-2418649:+	-0.17	-3.46	0.000596	Bacteremia	
THCA	cis	1	rs800160	chr11:2380134	C11orf21	chr11:2317507-2323143:-	0.18	3.42	0.000674	Bacteremia	
THCA	cis	1	rs8001810	chr13:85726583	SLITRK6	chr13:86366922-86373483:-	-0.22	-4.17	3.59E-5	Bipolar disorder (mania)	
THCA	cis	1	rs8002861	chr13:44474517	CCDC122	chr13:44410491-44453826:-	-0.4	-7.89	2.04E-14	Leprosy	
THCA	cis	1	rs800292	chr1:196642233	CFHR3	chr1:196743930-196762872:+	0.24	4.58	5.91E-6	Circulating myeloperoxidase levels (serum)	
THCA	cis	1	rs80031817	chr7:1096793	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.51	5.78E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs8003506	chr14:75586288	EIF2B2	chr14:75469612-75476292:+	-0.18	-4.98	8.79E-7	Height	
THCA	cis	1	rs8003506	chr14:75586288	MLH3	chr14:75480467-75518235:-	-0.27	-8.12	4.11E-15	Height	
THCA	cis	1	rs8003506	chr14:75586288	RPS6KL1	chr14:75372347-75389958:-	-0.31	-6.79	3.35E-11	Height	
THCA	cis	1	rs8004018	chr14:55350696	GCH1	chr14:55308724-55369542:-	-0.22	-4.55	6.68E-6	Rheumatoid arthritis;Obesity-related traits	
THCA	cis	1	rs80048132	chr1:183191024	RNASEL	chr1:182542772-182558391:-	0.32	3.46	0.000579	Systemic lupus erythematosus and Systemic sclerosis	
THCA	cis	1	rs80050131	chr8:89383361	MMP16	chr8:89049462-89339717:-	0.32	4.95	1.04E-6	Electrodermal activity	
THCA	cis	1	rs8005309	chr14:66056508	LOC645431	chr14:65877313-65879335:-	-0.6	-7.74	6.07E-14	Ischemic stroke	
THCA	cis	1	rs8005686	chr14:76633967	ESRRB	chr14:76837690-76968178:+	0.28	4.54	6.98E-6	Blood pressure	
THCA	cis	1	rs800586	chr8:116813905	TRPS1	chr8:116420725-116681228:-	0.15	3.69	0.000248	Response to tocilizumab in rheumatoid arthritis	
THCA	cis	1	rs800587	chr8:116813278	TRPS1	chr8:116420725-116681228:-	0.17	3.79	0.000168	Response to tocilizumab in rheumatoid arthritis	
THCA	cis	1	rs800588	chr8:116813143	TRPS1	chr8:116420725-116681228:-	-0.17	-4.03	6.41E-5	Response to tocilizumab in rheumatoid arthritis	
THCA	cis	1	rs8006048	chr14:76683508	ESRRB	chr14:76837690-76968178:+	0.3	4.73	2.92E-6	Blood pressure	
THCA	cis	1	rs8006176	chr14:101033288	BEGAIN	chr14:101003486-101036131:-	-0.3	-7.31	1.14E-12	Menarche (age at onset)	
THCA	cis	1	rs8006419	chr14:65500735	CHURC1	chr14:65381140-65411309:+	-0.22	-4.44	1.11E-5	Red blood cell traits	
THCA	cis	1	rs8006419	chr14:65500735	FNTB	chr14:65381140-65529369:+	0.21	4.4	1.33E-5	Red blood cell traits	
THCA	cis	1	rs80068722	chr14:65856111	LOC645431	chr14:65877313-65879335:-	-0.41	-5.29	1.85E-7	Ischemic stroke	
THCA	cis	1	rs80075680	chr5:150223737	LOC134466	chr5:150310000-150326146:-	0.39	5.43	8.95E-8	Crohn's disease	
THCA	cis	1	rs80076579	chr4:106991115	TBCK	chr4:106967233-107237861:-	0.34	7.1	4.48E-12	Airflow obstruction	
THCA	cis	1	rs80085676	chr2:242347907	SEPT2	chr2:242254723-242293439:+	1.04	21.71	3.06E-73	Chronic lymphocytic leukemia	
THCA	cis	1	rs80094562	chr13:24437572	C1QTNF9B	chr13:24465238-24471641:-	0.35	3.65	0.000293	3-hydroxypropylmercapturic acid levels in smokers	
THCA	cis	1	rs80094748	chr7:1103958	ZFAND2A	chr7:1192544-1199855:-	-0.37	-5.43	8.86E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs80095925	chr6:26184942	HIST1H2AE	chr6:26217148-26217711:+	-0.23	-3.38	0.000778	Renal underexcretion gout;Gout	
THCA	cis	1	rs80095925	chr6:26184942	HIST1H3E	chr6:26224427-26226589:+	0.44	6.82	2.73E-11	Renal underexcretion gout;Gout	
THCA	cis	1	rs8010461	chr14:55351185	GCH1	chr14:55308724-55369542:-	-0.21	-4.32	1.87E-5	Rheumatoid arthritis;Obesity-related traits	
THCA	cis	1	rs8010545	chr14:81778787	STON2	chr14:81727000-81893748:-	0.21	4.2	3.16E-5	Obesity-related traits	
THCA	cis	1	rs8010715	chr14:24609147	DCAF11	chr14:24583906-24594450:+	0.13	3.4	0.000735	IgG glycosylation	
THCA	cis	1	rs8010715	chr14:24609147	FAM158A	chr14:24608175-24610797:-	-0.6	-24.34	1.04E-85	IgG glycosylation	
THCA	cis	1	rs80109502	chr20:33587596	PROCR	chr20:33758727-33765164:+	-0.36	-5.75	1.55E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs80109502	chr20:33587596	TRPC4AP	chr20:33590215-33680618:-	0.32	3.88	0.000118	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs8011834	chr14:55625977	FBXO34	chr14:55738021-55893431:+	-0.14	-3.47	0.000558	Protein biomarker	
THCA	cis	1	rs8011834	chr14:55625977	KIAA0831	chr14:55833110-55878576:-	-0.13	-3.63	0.000317	Protein biomarker	
THCA	cis	1	rs80123796	chr3:184739700	C3orf70	chr3:184795840-184870802:-	-0.26	-4.97	9.38E-7	Heschl's gyrus morphology	
THCA	cis	1	rs8013540	chr14:35513760	FAM177A1	chr14:35514113-35552587:+	-0.23	-4.32	1.91E-5	Atopic dermatitis	
THCA	cis	1	rs8013540	chr14:35513760	KIAA0391	chr14:35591776-35786673:+	0.28	5.34	1.42E-7	Atopic dermatitis	
THCA	cis	1	rs8013540	chr14:35513760	PPP2R3C	chr14:35554679-35591679:-	0.53	9.99	1.74E-21	Atopic dermatitis	
THCA	cis	1	rs8014170	chr14:50071694	MGAT2	chr14:50087489-50090198:+	0.22	4.34	1.77E-5	Carotid intima media thickness	
THCA	cis	1	rs8014170	chr14:50071694	RPL36AL	chr14:50085407-50087349:-	0.53	15.2	7.7E-43	Carotid intima media thickness	
THCA	cis	1	rs8014204	chr14:75322794	MLH3	chr14:75480467-75518235:-	0.12	3.34	0.000905	Caffeine consumption	
THCA	cis	1	rs8014204	chr14:75322794	RPS6KL1	chr14:75372347-75389958:-	0.33	6.73	5.0E-11	Caffeine consumption	
THCA	cis	1	rs8014374	chr14:75322914	MLH3	chr14:75480467-75518235:-	-0.13	-3.52	0.000481	Caffeine consumption	
THCA	cis	1	rs8014374	chr14:75322914	RPS6KL1	chr14:75372347-75389958:-	-0.33	-6.76	4.03E-11	Caffeine consumption	
THCA	cis	1	rs8015478	chr14:23586018	C14orf119	chr14:23564788-23569664:+	0.16	3.82	0.000148	Acute lymphoblastic leukemia (childhood)	
THCA	cis	1	rs8015478	chr14:23586018	CDH24	chr14:23516271-23526747:-	0.18	3.96	8.76E-5	Acute lymphoblastic leukemia (childhood)	
THCA	cis	1	rs80161161	chr2:17812016	GEN1	chr2:17935162-17966632:+	0.62	7.05	6.23E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs8016614	chr14:97356919	VRK1	chr14:97263684-97347950:+	0.18	4.18	3.54E-5	Neutrophil count	
THCA	cis	1	rs80170004	chr20:33551462	PROCR	chr20:33758727-33765164:+	-0.36	-5.62	3.24E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs80170004	chr20:33551462	TRPC4AP	chr20:33590215-33680618:-	0.32	3.82	0.00015	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs8017202	chr14:65854958	LOC645431	chr14:65877313-65879335:-	-0.41	-5.29	1.85E-7	Ischemic stroke	
THCA	cis	1	rs8017642	chr14:75590822	EIF2B2	chr14:75469612-75476292:+	0.18	4.97	9.37E-7	Height	
THCA	cis	1	rs8017642	chr14:75590822	MLH3	chr14:75480467-75518235:-	0.29	8.7	5.25E-17	Height	
THCA	cis	1	rs8017642	chr14:75590822	RPS6KL1	chr14:75372347-75389958:-	0.32	6.81	3.0E-11	Height	
THCA	cis	1	rs8018822	chr14:51170609	SAV1	chr14:51100360-51135023:-	0.3	6.26	8.75E-10	Cognitive performance	
THCA	cis	1	rs8018909	chr14:65960405	LOC645431	chr14:65877313-65879335:-	-0.59	-7.8	4.04E-14	Ischemic stroke	
THCA	cis	1	rs8018967	chr14:73976934	HEATR4	chr14:73945193-74025651:-	-0.29	-5.78	1.35E-8	Blood metabolite ratios	
THCA	cis	1	rs8018979	chr14:104109087	KLC1	chr14:104029299-104167887:+	-0.22	-4.46	1.01E-5	Body mass index	
THCA	cis	1	rs8019491	chr14:66168110	LOC645431	chr14:65877313-65879335:-	-0.54	-6.93	1.34E-11	Ischemic stroke	
THCA	cis	1	rs8020095	chr14:67453858	ATP6V1D	chr14:67761090-67826591:-	0.2	4.72	3.09E-6	Depression (quantitative trait)	
THCA	cis	1	rs8020095	chr14:67453858	EIF2S1	chr14:67827034-67853232:+	-0.23	-4.94	1.06E-6	Depression (quantitative trait)	
THCA	cis	1	rs80202648	chr19:50494386	SIGLEC16	chr19:50472912-50479075:+	0.66	6.17	1.49E-9	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
THCA	cis	1	rs8020441	chr14:51170879	SAV1	chr14:51100360-51135023:-	0.29	6.03	3.34E-9	Cognitive performance	
THCA	cis	1	rs80212261	chr7:1114012	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.62	3.2E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs80216128	chr11:22822870	SVIP	chr11:22843600-22851382:-	0.21	3.43	0.000659	Dialysis-related mortality	
THCA	cis	1	rs8023482	chr15:40307095	SRP14	chr15:40327891-40331389:-	-0.23	-4.43	1.18E-5	Response to haloperidol in psychosis	
THCA	cis	1	rs8023644	chr15:50937123	SPPL2A	chr15:50999739-51057910:-	0.27	7.32	1.04E-12	QT interval	
THCA	cis	1	rs8023644	chr15:50937123	TRPM7	chr15:50852491-50978994:-	0.11	3.49	0.000523	QT interval	
THCA	cis	1	rs8023716	chr15:65744861	DPP8	chr15:65737999-65810035:-	-0.09	-3.86	0.000131	Mean corpuscular hemoglobin	
THCA	cis	1	rs8023716	chr15:65744861	SLC24A1	chr15:65903704-65953256:+	-0.16	-3.99	7.51E-5	Mean corpuscular hemoglobin	
THCA	cis	1	rs8023776	chr15:90897952	IQGAP1	chr15:90931473-91045475:+	-0.13	-4.26	2.43E-5	Rheumatoid arthritis	
THCA	cis	1	rs8024039	chr15:24826345	PWRN1	chr15:24778839-24832924:+	0.4	8.38	6.11E-16	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
THCA	cis	1	rs8024058	chr15:89165031	ISG20	chr15:89178904-89198879:+	-0.15	-3.68	0.00026	Night sleep phenotypes	
THCA	cis	1	rs8024418	chr15:84586308	LOC388152	chr15:84867600-84898920:-	-0.21	-3.98	7.86E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs80245547	chr4:106628955	INTS12	chr4:106603787-106629881:-	-0.62	-5.29	1.83E-7	Post bronchodilator FEV1	
THCA	cis	1	rs8024628	chr15:84586463	LOC388152	chr15:84867600-84898920:-	-0.21	-3.87	0.000125	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs8025877	chr15:62377820	VPS13C	chr15:62144592-62352647:-	-0.12	-4.37	1.54E-5	Height	
THCA	cis	1	rs80259160	chr6:26190199	HIST1H2AE	chr6:26217148-26217711:+	-0.23	-3.65	0.000289	Renal underexcretion gout;Gout	
THCA	cis	1	rs80259160	chr6:26190199	HIST1H3E	chr6:26224427-26226589:+	0.43	7.09	4.97E-12	Renal underexcretion gout;Gout	
THCA	cis	1	rs8026008	chr15:62377805	VPS13C	chr15:62144592-62352647:-	-0.12	-4.37	1.54E-5	Height	
THCA	cis	1	rs80260495	chr2:17803101	GEN1	chr2:17935162-17966632:+	0.59	6.91	1.56E-11	Psychosis and Alzheimer's disease	
THCA	cis	1	rs8026533	chr15:90893228	IQGAP1	chr15:90931473-91045475:+	0.13	4.25	2.56E-5	Rheumatoid arthritis	
THCA	cis	1	rs8026533	chr15:90893228	TTLL13	chr15:90792764-90815443:+	0.19	3.46	0.000589	Rheumatoid arthritis	
THCA	cis	1	rs8027260	chr15:65955172	DPP8	chr15:65737999-65810035:-	0.08	3.52	0.000467	Mean corpuscular hemoglobin	
THCA	cis	1	rs8027260	chr15:65955172	SLC24A1	chr15:65903704-65953256:+	0.16	3.81	0.000154	Mean corpuscular hemoglobin	
THCA	cis	1	rs8027427	chr15:43025174	GANC	chr15:42565856-42645863:+	-0.18	-3.84	0.000142	MGMT methylation in smokers	
THCA	cis	1	rs80277764	chr20:33739456	PROCR	chr20:33758727-33765164:+	-0.34	-5.46	7.64E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs80277764	chr20:33739456	TRPC4AP	chr20:33590215-33680618:-	0.31	3.83	0.000143	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs80278704	chr19:52549183	ZNF432	chr19:52536678-52552073:-	-0.18	-4.57	6.14E-6	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	
THCA	cis	1	rs80279339	chr16:77782062	NUDT7	chr16:77756411-77776153:+	0.35	4.83	1.86E-6	Obesity-related traits	
THCA	cis	1	rs8028182	chr15:75718669	NEIL1	chr15:75639331-75647586:+	0.22	6.19	1.28E-9	Sudden cardiac arrest	
THCA	cis	1	rs8028182	chr15:75718669	SNUPN	chr15:75890426-75918719:-	0.24	4.63	4.78E-6	Sudden cardiac arrest	
THCA	cis	1	rs80285556	chr19:50540170	SIGLEC16	chr19:50472912-50479075:+	0.58	5.66	2.64E-8	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
THCA	cis	1	rs8029016	chr15:84586464	LOC388152	chr15:84867600-84898920:-	-0.21	-3.87	0.000125	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs8029247	chr15:56273446	ZNF280D	chr15:56922376-57210697:-	0.12	3.69	0.000251	Keloid	
THCA	cis	1	rs80298548	chr15:66690448	TIPIN	chr15:66629008-66649054:-	-0.42	-4.34	1.71E-5	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs8030379	chr15:84590910	LOC388152	chr15:84867600-84898920:-	-0.2	-3.81	0.000157	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs8030605	chr15:56504598	MNS1	chr15:56720929-56757335:-	-0.23	-3.41	0.000699	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs8030605	chr15:56504598	TEX9	chr15:56657644-56738071:+	-0.34	-5.84	9.5E-9	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs80308641	chr7:127147638	GRM8	chr7:126078652-126893147:-	-0.35	-3.57	0.000398	Medication adherence in chronic diseases	
THCA	cis	1	rs8031179	chr15:65952034	DPP8	chr15:65737999-65810035:-	-0.09	-3.66	0.000277	Mean corpuscular hemoglobin	
THCA	cis	1	rs8031179	chr15:65952034	SLC24A1	chr15:65903704-65953256:+	-0.16	-3.9	0.00011	Mean corpuscular hemoglobin	
THCA	cis	1	rs80313145	chr6:26194965	HIST1H2AE	chr6:26217148-26217711:+	-0.24	-3.6	0.000348	Renal underexcretion gout;Gout	
THCA	cis	1	rs80313145	chr6:26194965	HIST1H3E	chr6:26224427-26226589:+	0.41	6.44	2.97E-10	Renal underexcretion gout;Gout	
THCA	cis	1	rs80314222	chr19:50525514	SIGLEC16	chr19:50472912-50479075:+	0.63	5.9	6.71E-9	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
THCA	cis	1	rs8031576	chr15:90380214	AP3S2	chr15:90373832-90456222:-	-0.76	-19.34	5.46E-62	Type 2 diabetes	
THCA	cis	1	rs8031576	chr15:90380214	C15orf38	chr15:90443832-90456222:-	0.34	7.34	9.15E-13	Type 2 diabetes	
THCA	cis	1	rs80317109	chr5:109891669	TMEM232	chr5:109624934-110062381:-	0.52	6.21	1.15E-9	Cardiac structure and function	
THCA	cis	1	rs8031915	chr15:91519291	HDDC3	chr15:91474157-91475774:-	-0.15	-4.14	4.02E-5	Type 2 diabetes	
THCA	cis	1	rs8031948	chr15:78816057	CHRNA5	chr15:78857906-78886458:+	-0.42	-8.16	2.97E-15	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs8032675	chr15:67959464	IQCH	chr15:67547188-67794139:+	0.16	5.13	4.28E-7	Motion sickness	
THCA	cis	1	rs8033837	chr15:75353975	ARID3B	chr15:74833548-74890470:+	-0.14	-3.7	0.000245	Blood trace element (Zn levels)	
THCA	cis	1	rs8033837	chr15:75353975	MAN2C1	chr15:75648135-75660941:-	0.14	3.43	0.000653	Blood trace element (Zn levels)	
THCA	cis	1	rs8033837	chr15:75353975	PPCDC	chr15:75315927-75343066:+	0.14	3.93	9.57E-5	Blood trace element (Zn levels)	
THCA	cis	1	rs8033837	chr15:75353975	SCAMP5	chr15:75287901-75313836:+	0.44	7.79	4.16E-14	Blood trace element (Zn levels)	
THCA	cis	1	rs8033938	chr15:40703114	C15orf23	chr15:40674922-40686488:+	0.66	9	5.19E-18	Heschl's gyrus morphology	
THCA	cis	1	rs8033938	chr15:40703114	IVD	chr15:40697686-40713512:+	-0.56	-10.25	2.1E-22	Heschl's gyrus morphology	
THCA	cis	1	rs8034191	chr15:78806023	CHRNA5	chr15:78857906-78886458:+	-0.42	-8.21	2.03E-15	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs8034542	chr15:79228371	CHRNA5	chr15:78857906-78886458:+	0.3	3.68	0.000257	Bipolar disorder	
THCA	cis	1	rs8035639	chr15:65944548	DPP8	chr15:65737999-65810035:-	-0.09	-3.99	7.65E-5	Mean corpuscular hemoglobin	
THCA	cis	1	rs8035639	chr15:65944548	SLC24A1	chr15:65903704-65953256:+	-0.16	-3.78	0.000176	Mean corpuscular hemoglobin	
THCA	cis	1	rs8035675	chr15:67965581	C15orf61	chr15:67813522-67819638:+	0.12	3.35	0.000873	Motion sickness	
THCA	cis	1	rs8035675	chr15:67965581	IQCH	chr15:67547188-67794139:+	0.17	5.26	2.12E-7	Motion sickness	
THCA	cis	1	rs8035675	chr15:67965581	MAP2K5	chr15:67835021-68099451:+	0.15	3.57	0.000392	Motion sickness	
THCA	cis	1	rs8036075	chr15:45934921	SPATA5L1	chr15:45694519-45713614:+	0.31	5.09	5.14E-7	Obesity-related traits	
THCA	cis	1	rs8036197	chr15:75370232	ARID3B	chr15:74833548-74890470:+	-0.15	-4.02	6.81E-5	Blood trace element (Zn levels)	
THCA	cis	1	rs8036197	chr15:75370232	PPCDC	chr15:75315927-75343066:+	0.13	3.78	0.000175	Blood trace element (Zn levels)	
THCA	cis	1	rs8036197	chr15:75370232	SCAMP2	chr15:75136073-75165670:-	-0.15	-3.34	0.000897	Blood trace element (Zn levels)	
THCA	cis	1	rs8036197	chr15:75370232	SCAMP5	chr15:75287901-75313836:+	0.41	7.35	8.43E-13	Blood trace element (Zn levels)	
THCA	cis	1	rs8036588	chr15:50956834	SPPL2A	chr15:50999739-51057910:-	0.29	7.44	4.83E-13	QT interval	
THCA	cis	1	rs803688	chr15:83216793	CPEB1	chr15:83211952-83316728:-	-0.16	-3.46	0.000594	Schizophrenia	
THCA	cis	1	rs803688	chr15:83216793	GOLGA6L9	chr15:82711895-82731584:+;chr15	-0.16	-4.98	9.1E-7	Schizophrenia	
THCA	cis	1	rs8037254	chr15:91520099	HDDC3	chr15:91474157-91475774:-	-0.15	-4.17	3.68E-5	Type 2 diabetes	
THCA	cis	1	rs8038646	chr15:56263346	ZNF280D	chr15:56922376-57210697:-	-0.13	-3.97	8.2E-5	Keloid	
THCA	cis	1	rs8038932	chr15:62364257	VPS13C	chr15:62144592-62352647:-	-0.11	-4.15	4.01E-5	Height	
THCA	cis	1	rs8039651	chr15:62359350	VPS13C	chr15:62144592-62352647:-	-0.11	-4.13	4.34E-5	Height	
THCA	cis	1	rs8040855	chr15:85699207	LOC388152	chr15:84867600-84898920:-	0.23	4.12	4.53E-5	Bulimia nervosa	
THCA	cis	1	rs8041056	chr15:84564817	LOC388152	chr15:84867600-84898920:-	-0.21	-3.9	0.00011	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs8042366	chr15:66012443	DPP8	chr15:65737999-65810035:-	-0.1	-4.06	5.77E-5	Mean corpuscular hemoglobin	
THCA	cis	1	rs8042366	chr15:66012443	SLC24A1	chr15:65903704-65953256:+	-0.16	-3.8	0.000162	Mean corpuscular hemoglobin	
THCA	cis	1	rs8042680	chr15:91521337	HDDC3	chr15:91474157-91475774:-	0.13	3.59	0.000364	Type 2 diabetes	
THCA	cis	1	rs8042807	chr15:66012444	DPP8	chr15:65737999-65810035:-	-0.1	-4.06	5.75E-5	Mean corpuscular hemoglobin	
THCA	cis	1	rs8042807	chr15:66012444	SLC24A1	chr15:65903704-65953256:+	-0.16	-3.8	0.000162	Mean corpuscular hemoglobin	
THCA	cis	1	rs804280	chr8:11612698	NEIL2	chr8:11627172-11644854:+	0.16	4.02	6.75E-5	Myopia (pathological)	
THCA	cis	1	rs804280	chr8:11612698	TDH	chr8:11197146-11225961:+	-0.12	-3.35	0.000882	Myopia (pathological)	
THCA	cis	1	rs804281	chr8:11611865	FAM66D	chr8:11973291-12424354:+	-0.2	-3.47	0.000563	Myopia (pathological)	
THCA	cis	1	rs804281	chr8:11611865	NEIL2	chr8:11627172-11644854:+	0.17	3.95	8.96E-5	Myopia (pathological)	
THCA	cis	1	rs804281	chr8:11611865	TDH	chr8:11197146-11225961:+	-0.12	-3.36	0.000857	Myopia (pathological)	
THCA	cis	1	rs8042825	chr15:90897885	IQGAP1	chr15:90931473-91045475:+	-0.13	-4.25	2.6E-5	Rheumatoid arthritis	
THCA	cis	1	rs8042849	chr15:78817929	CHRNA5	chr15:78857906-78886458:+	0.37	7.64	1.21E-13	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs8042970	chr15:84586368	LOC388152	chr15:84867600-84898920:-	-0.21	-3.98	7.86E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs8045682	chr16:69786092	COG4	chr16:70514473-70557457:-	-0.19	-3.88	0.000118	IgE levels	
THCA	cis	1	rs8046998	chr16:58825013	GOT2	chr16:58741035-58768246:-	-0.24	-6.71	5.52E-11	Blood metabolite ratios	
THCA	cis	1	rs8046998	chr16:58825013	SLC38A7	chr16:58700298-58718674:-	-0.15	-5.23	2.5E-7	Blood metabolite ratios	
THCA	cis	1	rs8049439	chr16:28837515	EIF3C	chr16:28722782-28747052:+;chr16	0.26	4.88	1.43E-6	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
THCA	cis	1	rs8049439	chr16:28837515	EIF3CL	chr16:28699879-28747052:+;chr16	0.43	8.57	1.47E-16	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
THCA	cis	1	rs8049439	chr16:28837515	SULT1A1	chr16:28616918-28634866:-	-0.15	-3.54	0.000446	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
THCA	cis	1	rs8049439	chr16:28837515	TUFM	chr16:28853732-28857729:-	0.32	11.88	1.07E-28	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
THCA	cis	1	rs8049478	chr16:69457548	CYB5B	chr16:69458498-69500167:+	-0.23	-3.93	9.58E-5	Blood pressure (smoking interaction)	
THCA	cis	1	rs8049622	chr16:67800927	ZDHHC1	chr16:67428323-67450339:-	0.41	4.67	3.87E-6	Crohn's disease	
THCA	cis	1	rs8050352	chr16:69508496	CYB5B	chr16:69458498-69500167:+	-0.23	-4.07	5.49E-5	Blood pressure (smoking interaction)	
THCA	cis	1	rs8050675	chr16:51466372	SALL1	chr16:51169886-51185183:-	0.25	6.1	2.15E-9	Optic disc area;Optic disc parameters	
THCA	cis	1	rs8051547	chr16:19028869	COQ7	chr16:19078927-19091350:+	-0.29	-3.91	0.000105	Response to angiotensin II receptor blocker therapy	
THCA	cis	1	rs8051653	chr16:67848515	C16orf86	chr16:67700717-67702659:+	-0.28	-3.41	0.000704	Crohn's disease	
THCA	cis	1	rs8051653	chr16:67848515	ZDHHC1	chr16:67428323-67450339:-	0.42	4.73	3.03E-6	Crohn's disease	
THCA	cis	1	rs8051	chr4:1694809	FAM53A	chr4:1641609-1685854:-	-0.16	-3.63	0.000319	Height	
THCA	cis	1	rs8051	chr4:1694809	TMEM129	chr4:1717680-1723084:-	-0.16	-4.96	9.71E-7	Height	
THCA	cis	1	rs8053238	chr16:69504229	CYB5B	chr16:69458498-69500167:+	-0.23	-4.07	5.47E-5	Blood pressure (smoking interaction)	
THCA	cis	1	rs8054034	chr16:67773652	C16orf86	chr16:67700717-67702659:+	-0.32	-4.08	5.3E-5	Crohn's disease	
THCA	cis	1	rs8054034	chr16:67773652	ZDHHC1	chr16:67428323-67450339:-	0.42	4.84	1.72E-6	Crohn's disease	
THCA	cis	1	rs8054842	chr16:672799	WFIKKN1	chr16:679239-684116:+	0.36	7.77	4.78E-14	Height	
THCA	cis	1	rs8056208	chr16:50097104	HEATR3	chr16:50099881-50139373:+	-0.4	-6.49	2.13E-10	Esophageal cancer (squamous cell)	
THCA	cis	1	rs8056893	chr16:68304392	NFATC3	chr16:68118654-68260837:+	0.16	4.28	2.28E-5	Blood metabolite levels;Blood metabolite ratios;Glomerular filtration rate (creatinine)	
THCA	cis	1	rs8057892	chr16:58832759	GOT2	chr16:58741035-58768246:-	-0.27	-7.59	1.64E-13	Blood metabolite ratios	
THCA	cis	1	rs8057892	chr16:58832759	SLC38A7	chr16:58700298-58718674:-	-0.15	-5.15	3.83E-7	Blood metabolite ratios	
THCA	cis	1	rs8058835	chr16:67814865	C16orf86	chr16:67700717-67702659:+	-0.27	-3.44	0.000644	Crohn's disease	
THCA	cis	1	rs8058835	chr16:67814865	LRRC36	chr16:67360747-67419108:+	0.36	3.38	0.000787	Crohn's disease	
THCA	cis	1	rs8058835	chr16:67814865	ZDHHC1	chr16:67428323-67450339:-	0.42	4.89	1.38E-6	Crohn's disease	
THCA	cis	1	rs8060686	chr16:67911517	DPEP2	chr16:68021295-68034489:-	0.19	3.79	0.000167	HDL cholesterol;Metabolic syndrome	
THCA	cis	1	rs8060686	chr16:67911517	LCAT	chr16:67973787-67978015:-	0.15	4.5	8.54E-6	HDL cholesterol;Metabolic syndrome	
THCA	cis	1	rs8060686	chr16:67911517	PRMT7	chr16:68344945-68391162:+	0.21	4.66	4.19E-6	HDL cholesterol;Metabolic syndrome	
THCA	cis	1	rs8060686	chr16:67911517	ZDHHC1	chr16:67428323-67450339:-	0.22	3.73	0.000211	HDL cholesterol;Metabolic syndrome	
THCA	cis	1	rs8061384	chr16:67911874	C16orf86	chr16:67700717-67702659:+	-0.29	-3.6	0.000355	Crohn's disease	
THCA	cis	1	rs8061384	chr16:67911874	LRRC36	chr16:67360747-67419108:+	0.36	3.37	0.000825	Crohn's disease	
THCA	cis	1	rs8061384	chr16:67911874	ZDHHC1	chr16:67428323-67450339:-	0.41	4.67	4.01E-6	Crohn's disease	
THCA	cis	1	rs8062783	chr16:74691264	RFWD3	chr16:74655298-74700779:-	0.29	7.46	4.25E-13	Testicular germ cell tumor	
THCA	cis	1	rs8063761	chr16:90027626	CDK10	chr16:89753076-89762771:+	0.11	4.14	4.14E-5	Squamous cell carcinoma	
THCA	cis	1	rs8064089	chr16:50094482	HEATR3	chr16:50099881-50139373:+	-0.4	-6.49	2.13E-10	Esophageal cancer (squamous cell)	
THCA	cis	1	rs8064107	chr16:50094323	HEATR3	chr16:50099881-50139373:+	-0.4	-6.49	2.13E-10	Esophageal cancer (squamous cell)	
THCA	cis	1	rs8064261	chr17:61705212	FTSJ3	chr17:61896795-61905031:-	0.32	6.01	3.66E-9	Body mass index	
THCA	cis	1	rs8064261	chr17:61705212	MAP3K3	chr17:61699775-61773669:+	0.28	5.76	1.47E-8	Body mass index	
THCA	cis	1	rs8064435	chr17:20917782	USP22	chr17:20902908-20947073:-	-0.18	-3.81	0.000159	Blood trace element (Se levels)	
THCA	cis	1	rs8065059	chr17:28417376	ANKRD13B	chr17:27916801-27941778:+	-0.36	-8.79	2.79E-17	Coffee consumption (cups per day)	
THCA	cis	1	rs8065059	chr17:28417376	CORO6	chr17:27941774-27948441:-	-0.49	-11.49	3.62E-27	Coffee consumption (cups per day)	
THCA	cis	1	rs8065059	chr17:28417376	EFCAB5	chr17:28256874-28435469:+	-0.59	-11.15	8.04E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs8065059	chr17:28417376	GIT1	chr17:27900487-27916610:-	-0.28	-6.67	7.23E-11	Coffee consumption (cups per day)	
THCA	cis	1	rs8065059	chr17:28417376	LRRC37B2	chr17:28903483-28992715:+	-0.17	-3.84	0.000142	Coffee consumption (cups per day)	
THCA	cis	1	rs8065059	chr17:28417376	SSH2	chr17:27952965-28257018:-	-0.36	-8.13	3.66E-15	Coffee consumption (cups per day)	
THCA	cis	1	rs8065059	chr17:28417376	TP53I13	chr17:27895739-27900174:+	-0.21	-5.66	2.63E-8	Coffee consumption (cups per day)	
THCA	cis	1	rs8065261	chr17:28418041	ANKRD13B	chr17:27916801-27941778:+	-0.36	-8.78	3.0E-17	Coffee consumption (cups per day)	
THCA	cis	1	rs8065261	chr17:28418041	CORO6	chr17:27941774-27948441:-	-0.5	-11.53	2.52E-27	Coffee consumption (cups per day)	
THCA	cis	1	rs8065261	chr17:28418041	EFCAB5	chr17:28256874-28435469:+	-0.59	-11.15	8.35E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs8065261	chr17:28418041	GIT1	chr17:27900487-27916610:-	-0.29	-6.66	7.44E-11	Coffee consumption (cups per day)	
THCA	cis	1	rs8065261	chr17:28418041	LRRC37B2	chr17:28903483-28992715:+	-0.17	-3.81	0.000159	Coffee consumption (cups per day)	
THCA	cis	1	rs8065261	chr17:28418041	SSH2	chr17:27952965-28257018:-	-0.36	-8.14	3.4E-15	Coffee consumption (cups per day)	
THCA	cis	1	rs8065261	chr17:28418041	TP53I13	chr17:27895739-27900174:+	-0.21	-5.66	2.58E-8	Coffee consumption (cups per day)	
THCA	cis	1	rs8065388	chr17:56562132	TRIM37	chr17:57060002-57184266:-	0.13	3.47	0.000563	Vitamin D levels	
THCA	cis	1	rs8065437	chr17:45721653	TBKBP1	chr17:45772630-45789427:+	-0.38	-10.61	9.36E-24	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
THCA	cis	1	rs8065669	chr17:45724996	TBKBP1	chr17:45772630-45789427:+	-0.38	-10.81	1.67E-24	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
THCA	cis	1	rs8066156	chr17:30361629	C17orf79	chr17:30178885-30186326:-	-0.18	-4.33	1.81E-5	Height	
THCA	cis	1	rs8066385	chr17:18761133	FAM18B	chr17:18684582-18710026:+	-0.42	-10.63	7.77E-24	Educational attainment (years of education)	
THCA	cis	1	rs8066385	chr17:18761133	FBXW10	chr17:18647326-18682661:+	-0.22	-4.84	1.75E-6	Educational attainment (years of education)	
THCA	cis	1	rs8066558	chr17:30272879	C17orf79	chr17:30178885-30186326:-	-0.18	-4.4	1.31E-5	Height	
THCA	cis	1	rs8066719	chr17:61825764	FTSJ3	chr17:61896795-61905031:-	0.3	5.74	1.65E-8	Body mass index	
THCA	cis	1	rs8066719	chr17:61825764	MAP3K3	chr17:61699775-61773669:+	0.27	5.51	5.79E-8	Body mass index	
THCA	cis	1	rs8067064	chr17:61825984	FTSJ3	chr17:61896795-61905031:-	0.3	5.74	1.65E-8	Body mass index	
THCA	cis	1	rs8067064	chr17:61825984	MAP3K3	chr17:61699775-61773669:+	0.27	5.51	5.79E-8	Body mass index	
THCA	cis	1	rs8067431	chr17:61817048	FTSJ3	chr17:61896795-61905031:-	0.31	5.69	2.16E-8	Body mass index	
THCA	cis	1	rs8067431	chr17:61817048	MAP3K3	chr17:61699775-61773669:+	0.27	5.39	1.09E-7	Body mass index	
THCA	cis	1	rs8067523	chr17:37977814	C17orf37	chr17:37885411-37886788:-	-0.27	-4.38	1.43E-5	Systemic lupus erythematosus	
THCA	cis	1	rs8067892	chr17:65837983	C17orf58	chr17:65987218-65989765:-	0.24	4.79	2.28E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs8068453	chr17:45852354	TBKBP1	chr17:45772630-45789427:+	-0.18	-3.64	0.000301	IgG glycosylation	
THCA	cis	1	rs8068603	chr17:61755211	FTSJ3	chr17:61896795-61905031:-	0.31	5.82	1.06E-8	Body mass index	
THCA	cis	1	rs8068603	chr17:61755211	MAP3K3	chr17:61699775-61773669:+	0.25	5.16	3.68E-7	Body mass index	
THCA	cis	1	rs8069531	chr17:38009344	C17orf37	chr17:37885411-37886788:-	-0.27	-4.55	6.76E-6	Systemic lupus erythematosus	
THCA	cis	1	rs8069687	chr17:61883023	FTSJ3	chr17:61896795-61905031:-	-0.31	-5.93	5.91E-9	Body mass index	
THCA	cis	1	rs8069687	chr17:61883023	MAP3K3	chr17:61699775-61773669:+	-0.26	-5.35	1.38E-7	Body mass index	
THCA	cis	1	rs8070432	chr17:17480474	ATPAF2	chr17:17918373-17942480:-	-0.25	-4.22	2.9E-5	Obsessive-compulsive symptoms	
THCA	cis	1	rs8070446	chr17:40285879	HSPB9	chr17:40274756-40275371:+	0.34	4.97	9.22E-7	Fibrinogen levels	
THCA	cis	1	rs8070454	chr17:38160754	GSDMA	chr17:38119226-38134019:+	-0.32	-7.28	1.39E-12	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THCA	cis	1	rs8070650	chr17:61744040	FTSJ3	chr17:61896795-61905031:-	0.31	6.04	3.13E-9	Body mass index	
THCA	cis	1	rs8070650	chr17:61744040	MAP3K3	chr17:61699775-61773669:+	0.26	5.46	7.79E-8	Body mass index	
THCA	cis	1	rs8071007	chr17:17506892	ATPAF2	chr17:17918373-17942480:-	-0.26	-4.16	3.8E-5	Obsessive-compulsive symptoms	
THCA	cis	1	rs8071463	chr17:65938655	C17orf58	chr17:65987218-65989765:-	-0.24	-4.83	1.88E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs8071789	chr17:38006333	GSDMA	chr17:38119226-38134019:+	0.16	3.76	0.000193	Selective IgA deficiency	
THCA	cis	1	rs8071789	chr17:38006333	GSDMB	chr17:38060850-38074903:-	-0.16	-5.57	4.2E-8	Selective IgA deficiency	
THCA	cis	1	rs8071789	chr17:38006333	ORMDL3	chr17:38077296-38083854:-	-0.37	-9.96	2.36E-21	Selective IgA deficiency	
THCA	cis	1	rs8071789	chr17:38006333	PGAP3	chr17:37827376-37844310:-	-0.18	-5.03	6.89E-7	Selective IgA deficiency	
THCA	cis	1	rs8071789	chr17:38006333	STARD3	chr17:37793412-37819722:+	-0.14	-4.01	6.99E-5	Selective IgA deficiency	
THCA	cis	1	rs8072100	chr17:45674687	TBKBP1	chr17:45772630-45789427:+	0.38	10.65	6.4E-24	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
THCA	cis	1	rs8072225	chr17:65912960	C17orf58	chr17:65987218-65989765:-	0.24	4.86	1.59E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs8072471	chr17:65367062	PSMD12	chr17:65336620-65362721:-	-0.17	-3.36	0.000854	Diisocyanate-induced asthma	
THCA	cis	1	rs8073373	chr17:61703320	FTSJ3	chr17:61896795-61905031:-	0.3	5.68	2.37E-8	Body mass index	
THCA	cis	1	rs8073373	chr17:61703320	MAP3K3	chr17:61699775-61773669:+	0.27	5.5	6.2E-8	Body mass index	
THCA	cis	1	rs8074078	chr17:65838743	C17orf58	chr17:65987218-65989765:-	0.24	4.86	1.6E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs8074708	chr17:40286354	HSPB9	chr17:40274756-40275371:+	-0.34	-5.01	7.62E-7	Fibrinogen levels	
THCA	cis	1	rs8074742	chr17:17455196	ATPAF2	chr17:17918373-17942480:-	-0.24	-4.03	6.5E-5	Obsessive-compulsive symptoms	
THCA	cis	1	rs8074771	chr17:61735865	FTSJ3	chr17:61896795-61905031:-	0.31	6.04	3.13E-9	Body mass index	
THCA	cis	1	rs8074771	chr17:61735865	MAP3K3	chr17:61699775-61773669:+	0.26	5.46	7.79E-8	Body mass index	
THCA	cis	1	rs8075061	chr17:61804723	FTSJ3	chr17:61896795-61905031:-	0.3	5.78	1.32E-8	Body mass index	
THCA	cis	1	rs8075061	chr17:61804723	MAP3K3	chr17:61699775-61773669:+	0.26	5.37	1.26E-7	Body mass index	
THCA	cis	1	rs8075257	chr17:61728750	FTSJ3	chr17:61896795-61905031:-	0.31	5.92	6.17E-9	Body mass index	
THCA	cis	1	rs8075257	chr17:61728750	MAP3K3	chr17:61699775-61773669:+	0.28	5.75	1.61E-8	Body mass index	
THCA	cis	1	rs8075273	chr17:61728881	MAP3K3	chr17:61699775-61773669:+	0.31	5.3	1.75E-7	Body mass index	
THCA	cis	1	rs8075422	chr17:61804686	FTSJ3	chr17:61896795-61905031:-	0.31	5.88	7.87E-9	Body mass index	
THCA	cis	1	rs8075422	chr17:61804686	MAP3K3	chr17:61699775-61773669:+	0.26	5.4	1.06E-7	Body mass index	
THCA	cis	1	rs8075521	chr17:61804954	FTSJ3	chr17:61896795-61905031:-	0.3	5.78	1.32E-8	Body mass index	
THCA	cis	1	rs8075521	chr17:61804954	MAP3K3	chr17:61699775-61773669:+	0.26	5.37	1.26E-7	Body mass index	
THCA	cis	1	rs8076336	chr17:18212614	FLII	chr17:18148153-18162055:-	0.09	3.44	0.000636	Parental longevity (combined parental age at death)	
THCA	cis	1	rs8076336	chr17:18212614	LLGL1	chr17:18128936-18148186:+	-0.09	-3.35	0.000877	Parental longevity (combined parental age at death)	
THCA	cis	1	rs8076336	chr17:18212614	SMCR7	chr17:18163848-18169093:+	0.12	3.46	0.000586	Parental longevity (combined parental age at death)	
THCA	cis	1	rs8076336	chr17:18212614	TOP3A	chr17:18177235-18218321:-	0.21	5.38	1.17E-7	Parental longevity (combined parental age at death)	
THCA	cis	1	rs807669	chr22:19154522	SLC25A1	chr22:19163095-19166301:-	-0.44	-9.31	4.71E-19	Metabolite levels	
THCA	cis	1	rs807670	chr22:19154608	SLC25A1	chr22:19163095-19166301:-	-0.37	-8.96	7.2E-18	Metabolite levels	
THCA	cis	1	rs8076717	chr17:61850301	FTSJ3	chr17:61896795-61905031:-	-0.31	-5.75	1.57E-8	Body mass index	
THCA	cis	1	rs8076717	chr17:61850301	MAP3K3	chr17:61699775-61773669:+	-0.27	-5.46	7.83E-8	Body mass index	
THCA	cis	1	rs8077265	chr17:61732727	FTSJ3	chr17:61896795-61905031:-	0.3	5.81	1.17E-8	Body mass index	
THCA	cis	1	rs8077265	chr17:61732727	MAP3K3	chr17:61699775-61773669:+	0.26	5.29	1.87E-7	Body mass index	
THCA	cis	1	rs8077577	chr17:18064730	LLGL1	chr17:18128936-18148186:+	-0.14	-4.19	3.28E-5	Obesity-related traits	
THCA	cis	1	rs8077577	chr17:18064730	LOC220594	chr17:18414577-18445234:-	-0.27	-3.58	0.000375	Obesity-related traits	
THCA	cis	1	rs8077577	chr17:18064730	MYO15A	chr17:18012020-18083115:+	0.19	3.55	0.000427	Obesity-related traits	
THCA	cis	1	rs8077577	chr17:18064730	SMCR7	chr17:18163848-18169093:+	0.15	3.5	0.000515	Obesity-related traits	
THCA	cis	1	rs8077889	chr17:41878166	MPP3	chr17:41878169-41910538:-	-0.29	-4.91	1.26E-6	Triglycerides	
THCA	cis	1	rs807810	chr3:47403892	C3orf75	chr3:47537131-47555199:-	0.09	4.18	3.45E-5	Colorectal cancer	
THCA	cis	1	rs807810	chr3:47403892	NBEAL2	chr3:47021173-47051193:+	0.11	3.52	0.00047	Colorectal cancer	
THCA	cis	1	rs807810	chr3:47403892	PRSS45	chr3:46783582-46790130:-	0.16	3.59	0.000361	Colorectal cancer	
THCA	cis	1	rs8078462	chr17:61857937	FTSJ3	chr17:61896795-61905031:-	0.3	5.77	1.4E-8	Body mass index	
THCA	cis	1	rs8078462	chr17:61857937	MAP3K3	chr17:61699775-61773669:+	0.26	5.4	1.03E-7	Body mass index	
THCA	cis	1	rs8078550	chr17:53053379	STXBP4	chr17:53046126-53241449:+	-0.15	-4.2	3.2E-5	Breast cancer	
THCA	cis	1	rs8078550	chr17:53053379	TOM1L1	chr17:52978052-53039328:+	-0.13	-3.35	0.000871	Breast cancer	
THCA	cis	1	rs8078723	chr17:38166879	GSDMA	chr17:38119226-38134019:+	-0.32	-7.37	7.39E-13	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THCA	cis	1	rs8078862	chr17:61854068	FTSJ3	chr17:61896795-61905031:-	0.3	5.77	1.4E-8	Body mass index	
THCA	cis	1	rs8078862	chr17:61854068	MAP3K3	chr17:61699775-61773669:+	0.26	5.4	1.03E-7	Body mass index	
THCA	cis	1	rs807931	chr3:47389317	C3orf75	chr3:47537131-47555199:-	-0.09	-4.33	1.85E-5	Colorectal cancer	
THCA	cis	1	rs807931	chr3:47389317	NBEAL2	chr3:47021173-47051193:+	-0.12	-3.74	0.000209	Colorectal cancer	
THCA	cis	1	rs807931	chr3:47389317	PRSS45	chr3:46783582-46790130:-	-0.15	-3.42	0.000678	Colorectal cancer	
THCA	cis	1	rs807936	chr3:47322496	C3orf75	chr3:47537131-47555199:-	-0.09	-4.11	4.75E-5	Colorectal cancer	
THCA	cis	1	rs807936	chr3:47322496	NBEAL2	chr3:47021173-47051193:+	-0.11	-3.38	0.000778	Colorectal cancer	
THCA	cis	1	rs807936	chr3:47322496	PRSS45	chr3:46783582-46790130:-	-0.17	-3.88	0.00012	Colorectal cancer	
THCA	cis	1	rs8079754	chr17:65887896	C17orf58	chr17:65987218-65989765:-	0.19	3.78	0.000178	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs8080211	chr17:61729882	FTSJ3	chr17:61896795-61905031:-	0.31	5.78	1.38E-8	Body mass index	
THCA	cis	1	rs8080211	chr17:61729882	MAP3K3	chr17:61699775-61773669:+	0.27	5.39	1.1E-7	Body mass index	
THCA	cis	1	rs8080491	chr17:53049869	STXBP4	chr17:53046126-53241449:+	-0.15	-4.2	3.2E-5	Breast cancer	
THCA	cis	1	rs8080491	chr17:53049869	TOM1L1	chr17:52978052-53039328:+	-0.13	-3.35	0.000871	Breast cancer	
THCA	cis	1	rs8081517	chr17:65845697	C17orf58	chr17:65987218-65989765:-	0.24	4.84	1.75E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs8081541	chr17:61812483	FTSJ3	chr17:61896795-61905031:-	0.3	5.78	1.32E-8	Body mass index	
THCA	cis	1	rs8081541	chr17:61812483	MAP3K3	chr17:61699775-61773669:+	0.26	5.37	1.26E-7	Body mass index	
THCA	cis	1	rs8081612	chr17:61724695	FTSJ3	chr17:61896795-61905031:-	-0.29	-5.44	8.44E-8	Body mass index	
THCA	cis	1	rs8081612	chr17:61724695	MAP3K3	chr17:61699775-61773669:+	-0.24	-5.01	7.57E-7	Body mass index	
THCA	cis	1	rs808225	chr14:58397916	SLC35F4	chr14:58030640-58063615:-	0.24	4.76	2.52E-6	Pulmonary function	
THCA	cis	1	rs8082471	chr17:53067993	STXBP4	chr17:53046126-53241449:+	-0.16	-4.34	1.77E-5	Breast cancer	
THCA	cis	1	rs8082471	chr17:53067993	TOM1L1	chr17:52978052-53039328:+	-0.13	-3.37	0.000816	Breast cancer	
THCA	cis	1	rs8082512	chr17:65837059	C17orf58	chr17:65987218-65989765:-	0.2	3.9	0.000109	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs8082590	chr17:17958402	C17orf39	chr17:17942611-17971718:+	-0.19	-4.26	2.48E-5	Schizophrenia	
THCA	cis	1	rs8082647	chr17:2010597	RILP	chr17:1549447-1553392:-	-0.14	-3.38	0.00078	Body mass index	
THCA	cis	1	rs8093197	chr18:23660709	SS18	chr18:23596219-23671164:-	0.26	3.35	0.000877	Rhegmatogenous retinal detachment	
THCA	cis	1	rs809775	chr1:46538040	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.17	3.98E-22	Body mass index	
THCA	cis	1	rs809775	chr1:46538040	GPBP1L1	chr1:46092978-46152302:-	0.13	3.42	0.000686	Body mass index	
THCA	cis	1	rs809775	chr1:46538040	MMACHC	chr1:45965856-45976737:+	-0.21	-4.49	8.96E-6	Body mass index	
THCA	cis	1	rs809775	chr1:46538040	MUTYH	chr1:45794915-45806142:-	0.28	7.51	3.01E-13	Body mass index	
THCA	cis	1	rs8100168	chr19:33093084	LRP3	chr19:33685599-33699767:+	0.24	3.44	0.000626	Eosinophilic esophagitis	
THCA	cis	1	rs8100392	chr19:33605933	GPATCH1	chr19:33571786-33621318:+	0.35	8.68	6.17E-17	Bone properties (heel)	
THCA	cis	1	rs8101881	chr19:33364628	C19orf40	chr19:33463148-33467955:+	-0.2	-3.91	0.000105	Blood metabolite levels;Urinary metabolites (H-NMR features);Urinary metabolites	
THCA	cis	1	rs8101881	chr19:33364628	SLC7A9	chr19:33321421-33360683:-	-0.31	-7.55	2.18E-13	Blood metabolite levels;Urinary metabolites (H-NMR features);Urinary metabolites	
THCA	cis	1	rs8103622	chr19:18572834	ELL	chr19:18553475-18632937:-	-0.26	-6.5	2.0E-10	Breast cancer	
THCA	cis	1	rs8103622	chr19:18572834	ISYNA1	chr19:18545625-18548943:-	0.12	4.58	5.88E-6	Breast cancer	
THCA	cis	1	rs8103622	chr19:18572834	LRRC25	chr19:18501955-18508421:-	-0.14	-4.93	1.16E-6	Breast cancer	
THCA	cis	1	rs8104385	chr19:12700284	RTBDN	chr19:12936293-12946230:-	0.21	3.58	0.000375	Bipolar disorder	
THCA	cis	1	rs8104559	chr19:22205167	ZNF492	chr19:22817126-22850472:+	0.25	3.46	0.000585	Body mass index (change over time)	
THCA	cis	1	rs8104737	chr19:52441697	ZNF577	chr19:52359056-52394145:-	-0.17	-3.62	0.000326	Survival in endocrine treated breast cancer (estrogen-receptor positive)	
THCA	cis	1	rs8104845	chr19:46161326	SNRPD2	chr19:46190713-46195443:-	-0.09	-3.4	0.000725	Type 2 diabetes	
THCA	cis	1	rs8105440	chr19:52451900	ZNF577	chr19:52359056-52394145:-	-0.18	-3.98	7.83E-5	Survival in endocrine treated breast cancer (estrogen-receptor positive)	
THCA	cis	1	rs8105833	chr19:41896145	B3GNT8	chr19:41931265-41934635:-	-0.35	-8.05	6.73E-15	Height	
THCA	cis	1	rs8105994	chr19:18593553	ELL	chr19:18553475-18632937:-	-0.26	-6.4	3.69E-10	Breast cancer	
THCA	cis	1	rs8105994	chr19:18593553	ISYNA1	chr19:18545625-18548943:-	0.12	4.41	1.29E-5	Breast cancer	
THCA	cis	1	rs8105994	chr19:18593553	LRRC25	chr19:18501955-18508421:-	-0.13	-4.48	9.36E-6	Breast cancer	
THCA	cis	1	rs8106929	chr19:52368467	ZNF577	chr19:52359056-52394145:-	-0.21	-4.84	1.75E-6	Breast cancer	
THCA	cis	1	rs8106929	chr19:52368467	ZNF649	chr19:52392489-52408247:-	-0.18	-3.66	0.000282	Breast cancer	
THCA	cis	1	rs8107236	chr19:46158436	SNRPD2	chr19:46190713-46195443:-	-0.1	-3.45	0.00061	Type 2 diabetes	
THCA	cis	1	rs8107367	chr19:18564705	ELL	chr19:18553475-18632937:-	-0.25	-6.4	3.81E-10	Breast cancer	
THCA	cis	1	rs8107367	chr19:18564705	ISYNA1	chr19:18545625-18548943:-	0.12	4.64	4.41E-6	Breast cancer	
THCA	cis	1	rs8107367	chr19:18564705	LRRC25	chr19:18501955-18508421:-	-0.14	-4.78	2.28E-6	Breast cancer	
THCA	cis	1	rs8107416	chr19:39237950	LGALS7	chr19:39261608-39264157:-	-0.22	-4.36	1.61E-5	Heart rate	
THCA	cis	1	rs8108477	chr19:52364902	ZNF577	chr19:52359056-52394145:-	-0.23	-5.53	5.29E-8	Breast cancer	
THCA	cis	1	rs8108477	chr19:52364902	ZNF649	chr19:52392489-52408247:-	-0.18	-3.76	0.000195	Breast cancer	
THCA	cis	1	rs8108583	chr19:52364977	ZNF577	chr19:52359056-52394145:-	-0.24	-5.66	2.56E-8	Breast cancer	
THCA	cis	1	rs8108583	chr19:52364977	ZNF649	chr19:52392489-52408247:-	-0.18	-3.76	0.000194	Breast cancer	
THCA	cis	1	rs8109345	chr19:52364933	ZNF577	chr19:52359056-52394145:-	-0.24	-5.66	2.56E-8	Breast cancer	
THCA	cis	1	rs8109345	chr19:52364933	ZNF649	chr19:52392489-52408247:-	-0.18	-3.76	0.000194	Breast cancer	
THCA	cis	1	rs8109573	chr19:18617151	ELL	chr19:18553475-18632937:-	-0.25	-6.54	1.6E-10	Breast cancer	
THCA	cis	1	rs8109573	chr19:18617151	ISYNA1	chr19:18545625-18548943:-	0.12	4.63	4.71E-6	Breast cancer	
THCA	cis	1	rs8109573	chr19:18617151	LRRC25	chr19:18501955-18508421:-	-0.15	-5.17	3.39E-7	Breast cancer	
THCA	cis	1	rs8110011	chr19:37745813	ZNF793	chr19:37997841-38034237:+	0.15	3.42	0.000669	Coronary artery calcification	
THCA	cis	1	rs8110181	chr19:33605939	GPATCH1	chr19:33571786-33621318:+	0.35	8.68	6.17E-17	Bone properties (heel)	
THCA	cis	1	rs8110727	chr19:24230916	LOC100101266	chr19:24344995-24346249:-	0.37	6.18	1.37E-9	Response to taxane treatment (placlitaxel)	
THCA	cis	1	rs8111071	chr19:46307406	OPA3	chr19:46031027-46105466:-	-0.27	-3.37	0.000801	Sudden cardiac arrest	
THCA	cis	1	rs8111071	chr19:46307406	TRAPPC6A	chr19:45666187-45681495:-	-0.17	-3.75	0.000202	Sudden cardiac arrest	
THCA	cis	1	rs811115	chr3:47322133	C3orf75	chr3:47537131-47555199:-	-0.09	-4.11	4.75E-5	Colorectal cancer	
THCA	cis	1	rs811115	chr3:47322133	NBEAL2	chr3:47021173-47051193:+	-0.11	-3.38	0.000778	Colorectal cancer	
THCA	cis	1	rs811115	chr3:47322133	PRSS45	chr3:46783582-46790130:-	-0.17	-3.88	0.00012	Colorectal cancer	
THCA	cis	1	rs8111316	chr19:52369069	ZNF577	chr19:52359056-52394145:-	-0.25	-5.89	7.21E-9	Breast cancer	
THCA	cis	1	rs8111316	chr19:52369069	ZNF649	chr19:52392489-52408247:-	-0.19	-3.88	0.00012	Breast cancer	
THCA	cis	1	rs8111708	chr19:18558876	ELL	chr19:18553475-18632937:-	-0.25	-6.28	7.44E-10	Breast cancer	
THCA	cis	1	rs8111708	chr19:18558876	ISYNA1	chr19:18545625-18548943:-	0.13	4.67	3.88E-6	Breast cancer	
THCA	cis	1	rs8111708	chr19:18558876	LRRC25	chr19:18501955-18508421:-	-0.13	-4.25	2.61E-5	Breast cancer	
THCA	cis	1	rs8111746	chr19:39212859	LGALS7	chr19:39261608-39264157:-	-0.23	-4.75	2.64E-6	Heart rate	
THCA	cis	1	rs8111946	chr19:45152394	PVR	chr19:45147098-45169426:+	0.24	4.83	1.87E-6	Multiple sclerosis	
THCA	cis	1	rs8113308	chr19:52445386	ZNF577	chr19:52359056-52394145:-	-0.18	-3.91	0.000106	Survival in endocrine treated breast cancer (estrogen-receptor positive)	
THCA	cis	1	rs8113312	chr19:23061182	ZNF492	chr19:22817126-22850472:+	-0.43	-6.33	5.74E-10	Bronchopulmonary dysplasia	
THCA	cis	1	rs8114671	chr20:33789142	UQCC	chr20:33890383-33999833:-	0.11	3.51	0.000483	Height	
THCA	cis	1	rs8115327	chr20:48022828	KCNB1	chr20:47988505-48100490:-	0.15	3.41	0.000716	Obesity-related traits	
THCA	cis	1	rs8117100	chr20:33692261	PROCR	chr20:33758727-33765164:+	-0.33	-5.64	2.88E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs8117100	chr20:33692261	TRPC4AP	chr20:33590215-33680618:-	0.34	4.45	1.09E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs8117111	chr20:47884185	DDX27	chr20:47835832-47860612:+	0.27	4.94	1.06E-6	Height	
THCA	cis	1	rs8117847	chr20:33642480	PROCR	chr20:33758727-33765164:+	-0.32	-5.37	1.21E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs8117847	chr20:33642480	TRPC4AP	chr20:33590215-33680618:-	0.28	3.55	0.000429	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs8118005	chr20:33636219	PROCR	chr20:33758727-33765164:+	-0.34	-5.57	4.2E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs8118005	chr20:33636219	TRPC4AP	chr20:33590215-33680618:-	0.27	3.37	0.00081	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs8118008	chr20:3168166	DDRGK1	chr20:3171018-3185295:-	-0.15	-4.08	5.23E-5	Parkinson's disease	
THCA	cis	1	rs8118008	chr20:3168166	ITPA	chr20:3190056-3204504:+	0.16	4.85	1.71E-6	Parkinson's disease	
THCA	cis	1	rs811880	chr7:65818646	ASL	chr7:65540776-65558321:+	-0.16	-4.31	1.96E-5	Aortic root size	
THCA	cis	1	rs811880	chr7:65818646	GUSB	chr7:65425675-65447246:-	0.28	5.45	8.07E-8	Aortic root size	
THCA	cis	1	rs811880	chr7:65818646	RABGEF1	chr7:66093890-66276446:+	0.66	14.35	4.44E-39	Aortic root size	
THCA	cis	1	rs8118978	chr20:33574458	PROCR	chr20:33758727-33765164:+	-0.32	-5.33	1.55E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs8119827	chr20:33726873	PROCR	chr20:33758727-33765164:+	-0.33	-5.27	2.05E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs8119827	chr20:33726873	TRPC4AP	chr20:33590215-33680618:-	0.31	3.79	0.000169	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs8121957	chr20:33676109	PROCR	chr20:33758727-33765164:+	-0.32	-5.27	2.05E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs8121957	chr20:33676109	TRPC4AP	chr20:33590215-33680618:-	0.28	3.53	0.000455	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs8123062	chr20:55069310	C20orf43	chr20:55043647-55093942:+	0.28	7.58	1.83E-13	Refractive astigmatism	
THCA	cis	1	rs8123062	chr20:55069310	CSTF1	chr20:54967427-54979582:+	0.17	3.49	0.000536	Refractive astigmatism	
THCA	cis	1	rs8123289	chr20:3253831	ITPA	chr20:3190056-3204504:+	-0.24	-5.87	8.16E-9	IFN-related cytopenia	
THCA	cis	1	rs8123912	chr20:47863282	DDX27	chr20:47835832-47860612:+	0.27	4.92	1.18E-6	Height	
THCA	cis	1	rs8123978	chr20:33598789	PROCR	chr20:33758727-33765164:+	-0.36	-5.75	1.55E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs8123978	chr20:33598789	TRPC4AP	chr20:33590215-33680618:-	0.32	3.88	0.000118	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs8124662	chr20:33639256	PROCR	chr20:33758727-33765164:+	-0.33	-5.54	4.96E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs8124662	chr20:33639256	TRPC4AP	chr20:33590215-33680618:-	0.27	3.39	0.000762	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs8125425	chr20:55067135	C20orf43	chr20:55043647-55093942:+	-0.24	-6.49	2.2E-10	Refractive astigmatism	
THCA	cis	1	rs8125868	chr20:25324410	ENTPD6	chr20:25176339-25207360:+	0.3	6.74	4.56E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs8125868	chr20:25324410	FAM182A	chr20:26035250-26067552:+	0.18	3.38	0.000774	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs8125868	chr20:25324410	FAM182B	chr20:25744102-25848786:-	-0.26	-5.48	6.79E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs8125868	chr20:25324410	NINL	chr20:25433338-25566153:-	0.35	7.28	1.4E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs8125868	chr20:25324410	PYGB	chr20:25228706-25278647:+	0.15	3.76	0.00019	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs8127691	chr21:45614860	ICOSLG	chr21:45646724-45660834:-	0.2	4.28	2.23E-5	Inflammatory bowel disease	
THCA	cis	1	rs8127691	chr21:45614860	PWP2	chr21:45527208-45551062:+	0.25	4.6	5.38E-6	Inflammatory bowel disease	
THCA	cis	1	rs8129913	chr21:27064339	MRPL39	chr21:26957970-26979801:-	-0.17	-4.42	1.21E-5	Longitudinal change in brain amyloid plaque burden	
THCA	cis	1	rs8130986	chr21:44459743	PKNOX1	chr21:44394643-44453688:+	0.29	4.12	4.41E-5	Information processing speed	
THCA	cis	1	rs8131214	chr21:30483386	C21orf7	chr21:30449812-30548200:+	0.2	3.95	9.0E-5	Dental caries	
THCA	cis	1	rs8133932	chr21:47211085	PCBP3	chr21:47063683-47362367:+	-0.21	-3.44	0.00063	Schizophrenia	
THCA	cis	1	rs8134050	chr21:44462363	PKNOX1	chr21:44394643-44453688:+	0.33	4.56	6.46E-6	Information processing speed	
THCA	cis	1	rs8135828	chr22:29929239	NIPSNAP1	chr22:29950800-29977144:-	-0.31	-4.58	5.82E-6	Lipid traits	
THCA	cis	1	rs8137478	chr22:51017296	CHKB	chr22:51017378-51021428:-	0.51	6.13	1.87E-9	Narcolepsy	
THCA	cis	1	rs8137478	chr22:51017296	CPT1B	chr22:51007291-51017096:-	-0.43	-8.55	1.69E-16	Narcolepsy	
THCA	cis	1	rs8138799	chr22:24556902	SUSD2	chr22:24577444-24585074:+	0.27	3.4	0.000721	Amyotrophic lateral sclerosis	
THCA	cis	1	rs8138996	chr22:39047435	JOSD1	chr22:39081549-39096459:-	-0.15	-3.94	9.33E-5	Resting heart rate	
THCA	cis	1	rs8138996	chr22:39047435	TOMM22	chr22:39077954-39080763:+	-0.16	-3.58	0.000379	Resting heart rate	
THCA	cis	1	rs8140617	chr22:38970439	JOSD1	chr22:39081549-39096459:-	0.17	4.42	1.22E-5	Resting heart rate	
THCA	cis	1	rs8140617	chr22:38970439	TOMM22	chr22:39077954-39080763:+	0.23	5.14	4.11E-7	Resting heart rate	
THCA	cis	1	rs8142098	chr22:39058757	JOSD1	chr22:39081549-39096459:-	-0.15	-3.92	0.0001	Resting heart rate	
THCA	cis	1	rs8142098	chr22:39058757	TOMM22	chr22:39077954-39080763:+	-0.16	-3.57	0.000395	Resting heart rate	
THCA	cis	1	rs815306	chr1:76168624	ACADM	chr1:76190043-76229353:+	0.17	5.17	3.5E-7	Daytime sleep phenotypes	
THCA	cis	1	rs8170	chr19:17389704	ABHD8	chr19:17402941-17414282:-	0.25	4.13	4.35E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs8170	chr19:17389704	ANKLE1	chr19:17392454-17398454:+	0.29	4.94	1.08E-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs8170	chr19:17389704	OCEL1	chr19:17337055-17340027:+	0.21	4.22	2.91E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
THCA	cis	1	rs8177876	chr16:81124275	ATMIN	chr16:81069458-81080951:+	0.25	3.52	0.000469	Plasma omega-3 polyunsaturated fatty acid level (eicosapentaenoic acid)	
THCA	cis	1	rs8177876	chr16:81124275	C16orf46	chr16:81087103-81110872:-	0.23	4.22	2.87E-5	Plasma omega-3 polyunsaturated fatty acid level (eicosapentaenoic acid)	
THCA	cis	1	rs8180040	chr3:47388947	C3orf75	chr3:47537131-47555199:-	-0.1	-4.4	1.31E-5	Colorectal cancer	
THCA	cis	1	rs8180040	chr3:47388947	NBEAL2	chr3:47021173-47051193:+	-0.12	-3.74	0.000207	Colorectal cancer	
THCA	cis	1	rs8180209	chr4:90644454	MMRN1	chr4:90816003-90875778:+	0.3	3.82	0.000148	Parkinson's disease	
THCA	cis	1	rs8180214	chr4:90644508	MMRN1	chr4:90816003-90875778:+	-0.29	-3.74	0.000206	Parkinson's disease	
THCA	cis	1	rs8180599	chr6:70469372	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.44	0.000628	Sleep duration	
THCA	cis	1	rs8180747	chr7:107106308	DLD	chr7:107531586-107561642:+	0.15	3.55	0.000417	Osteoarthritis	
THCA	cis	1	rs8181644	chr12:58173466	FAM119B	chr12:58166383-58176323:+	0.41	11.26	3.03E-26	Multiple sclerosis	
THCA	cis	1	rs8181644	chr12:58173466	METTL1	chr12:58162352-58165914:-	-0.2	-4.84	1.72E-6	Multiple sclerosis	
THCA	cis	1	rs8181644	chr12:58173466	TSFM	chr12:58176536-58191367:+	-0.59	-20.26	2.31E-66	Multiple sclerosis	
THCA	cis	1	rs8181644	chr12:58173466	XRCC6BP1	chr12:58335445-58351051:+	-0.23	-4.54	7.02E-6	Multiple sclerosis	
THCA	cis	1	rs8181679	chr12:50611020	C12orf62	chr12:50505900-50514234:+	0.1	4.15	4.01E-5	Schizophrenia	
THCA	cis	1	rs8192482	chr15:78886198	CHRNA5	chr15:78857906-78886458:+	-0.42	-8.22	1.9E-15	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs822554	chr7:148651532	ZNF786	chr7:148766733-148787869:-	-0.22	-3.91	0.000104	Height	
THCA	cis	1	rs823144	chr1:205744546	PM20D1	chr1:205797154-205819245:-	-0.22	-3.71	0.000234	Parkinson's disease	
THCA	cis	1	rs823144	chr1:205744546	RAB7L1	chr1:205737115-205744610:-	0.24	6.42	3.27E-10	Parkinson's disease	
THCA	cis	1	rs823301	chr3:195123495	C3orf21	chr3:194789015-194991895:-	-0.26	-6	4.0E-9	Body mass index	
THCA	cis	1	rs823302	chr3:195104741	C3orf21	chr3:194789015-194991895:-	-0.28	-6.54	1.6E-10	Body mass index	
THCA	cis	1	rs823306	chr3:195108320	C3orf21	chr3:194789015-194991895:-	-0.27	-6.25	9.32E-10	Body mass index	
THCA	cis	1	rs823310	chr3:195127093	C3orf21	chr3:194789015-194991895:-	-0.27	-6.2	1.19E-9	Body mass index	
THCA	cis	1	rs823311	chr3:195141029	C3orf21	chr3:194789015-194991895:-	-0.26	-6	4.0E-9	Body mass index	
THCA	cis	1	rs823314	chr3:195132402	C3orf21	chr3:194789015-194991895:-	-0.27	-6.25	9.32E-10	Body mass index	
THCA	cis	1	rs830116	chr12:122412832	WDR66	chr12:122356480-122441830:+	-0.22	-3.56	0.000411	Urinary metabolites	
THCA	cis	1	rs830124	chr12:122395777	WDR66	chr12:122356480-122441830:+	0.2	3.37	0.000823	Urinary metabolites	
THCA	cis	1	rs832551	chr5:56180112	C5orf35	chr5:56205103-56213010:+	1	23.23	1.8E-80	Type 2 diabetes	
THCA	cis	1	rs832553	chr5:56114786	C5orf35	chr5:56205103-56213010:+	1.01	23.54	6.48E-82	Type 2 diabetes	
THCA	cis	1	rs832554	chr5:56115036	C5orf35	chr5:56205103-56213010:+	1.01	22.97	3.32E-79	Type 2 diabetes	
THCA	cis	1	rs832565	chr5:56150803	C5orf35	chr5:56205103-56213010:+	1	22.98	2.89E-79	Type 2 diabetes	
THCA	cis	1	rs832568	chr5:56153776	C5orf35	chr5:56205103-56213010:+	1	22.98	2.89E-79	Type 2 diabetes	
THCA	cis	1	rs832569	chr5:56154584	C5orf35	chr5:56205103-56213010:+	1	22.98	2.89E-79	Type 2 diabetes	
THCA	cis	1	rs832578	chr5:56164223	C5orf35	chr5:56205103-56213010:+	1.01	23.63	2.4E-82	Type 2 diabetes	
THCA	cis	1	rs832582	chr5:56177743	C5orf35	chr5:56205103-56213010:+	1	23.23	1.8E-80	Type 2 diabetes	
THCA	cis	1	rs832583	chr5:56178217	C5orf35	chr5:56205103-56213010:+	1	23.08	9.13E-80	Type 2 diabetes	
THCA	cis	1	rs832584	chr5:56179212	C5orf35	chr5:56205103-56213010:+	-1	-23.04	1.52E-79	Type 2 diabetes	
THCA	cis	1	rs833087	chr13:28177227	POLR1D	chr13:28194895-28241547:+	-0.16	-3.85	0.000133	Large B-cell lymphoma	
THCA	cis	1	rs835575	chr1:120456563	HMGCS2	chr1:120291005-120311518:-	0.24	3.34	0.000902	Crohn's disease	
THCA	cis	1	rs835576	chr1:120455586	HMGCS2	chr1:120291005-120311518:-	0.24	3.4	0.000724	Crohn's disease	
THCA	cis	1	rs835576	chr1:120455586	TBX15	chr1:119425666-119532179:-	0.23	3.41	0.000712	Crohn's disease	
THCA	cis	1	rs838705	chr2:234273242	USP40	chr2:234384166-234475428:-	-0.19	-5.14	3.99E-7	Calcium levels	
THCA	cis	1	rs8396	chr4:159630817	PPID	chr4:159630280-159644552:-	0.24	4.6	5.4E-6	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
THCA	cis	1	rs842361	chr2:135340840	TMEM163	chr2:135213331-135525334:-	-0.17	-4.51	8.17E-6	Neuroticism	
THCA	cis	1	rs843532	chr3:196482211	PIGX	chr3:196439246-196462874:+	0.3	3.75	0.000202	Glucose homeostasis traits	
THCA	cis	1	rs847845	chr6:34923864	TAF11	chr6:34845555-34855819:-	-0.26	-5.51	6.01E-8	Non-small cell lung cancer	
THCA	cis	1	rs847861	chr6:34938809	TAF11	chr6:34845555-34855819:-	0.27	5.62	3.31E-8	Non-small cell lung cancer	
THCA	cis	1	rs848222	chr2:150550496	RND3	chr2:151324712-151344180:-	-0.14	-3.62	0.000323	Liver enzyme levels (alanine transaminase)	
THCA	cis	1	rs848226	chr2:150556774	RND3	chr2:151324712-151344180:-	-0.15	-3.71	0.000231	Liver enzyme levels (alanine transaminase)	
THCA	cis	1	rs848490	chr7:77555005	PTPN12	chr7:77166773-77269388:+	0.17	3.73	0.000211	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs848490	chr7:77555005	RSBN1L	chr7:77325743-77409120:+	-0.15	-3.77	0.000187	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
THCA	cis	1	rs849142	chr7:28185891	JAZF1	chr7:27870196-28220437:-	-0.22	-5.55	4.64E-8	Crohn's disease;Type 2 diabetes	
THCA	cis	1	rs853676	chr6:28299687	ZKSCAN3	chr6:28317691-28334523:+	-0.28	-5.59	3.92E-8	Depression	
THCA	cis	1	rs853676	chr6:28299687	ZNF187	chr6:28234788-28245978:+	-0.31	-6.21	1.12E-9	Depression	
THCA	cis	1	rs853676	chr6:28299687	ZNF323	chr6:28292517-28324048:-	0.46	6.29	7.03E-10	Depression	
THCA	cis	1	rs853676	chr6:28299687	ZNF389	chr6:28129551-28137375:+	-0.46	-6.57	1.33E-10	Depression	
THCA	cis	1	rs853676	chr6:28299687	ZSCAN23	chr6:28393287-28411279:-	0.23	5.04	6.75E-7	Depression	
THCA	cis	1	rs853678	chr6:28297313	ZKSCAN3	chr6:28317691-28334523:+	-0.27	-5.45	8.25E-8	Depression	
THCA	cis	1	rs853678	chr6:28297313	ZNF187	chr6:28234788-28245978:+	-0.29	-5.99	4.23E-9	Depression	
THCA	cis	1	rs853678	chr6:28297313	ZNF193	chr6:28193067-28201260:+	0.18	3.35	0.000871	Depression	
THCA	cis	1	rs853678	chr6:28297313	ZNF323	chr6:28292517-28324048:-	0.46	6.46	2.52E-10	Depression	
THCA	cis	1	rs853678	chr6:28297313	ZNF389	chr6:28129551-28137375:+	-0.45	-6.46	2.66E-10	Depression	
THCA	cis	1	rs853678	chr6:28297313	ZSCAN23	chr6:28393287-28411279:-	0.22	4.88	1.48E-6	Depression	
THCA	cis	1	rs853679	chr6:28296863	ZKSCAN3	chr6:28317691-28334523:+	-0.27	-5.45	8.25E-8	Depression	
THCA	cis	1	rs853679	chr6:28296863	ZNF187	chr6:28234788-28245978:+	-0.29	-5.99	4.23E-9	Depression	
THCA	cis	1	rs853679	chr6:28296863	ZNF193	chr6:28193067-28201260:+	0.18	3.35	0.000871	Depression	
THCA	cis	1	rs853679	chr6:28296863	ZNF323	chr6:28292517-28324048:-	0.46	6.46	2.52E-10	Depression	
THCA	cis	1	rs853679	chr6:28296863	ZNF389	chr6:28129551-28137375:+	-0.45	-6.46	2.66E-10	Depression	
THCA	cis	1	rs853679	chr6:28296863	ZSCAN23	chr6:28393287-28411279:-	0.22	4.88	1.48E-6	Depression	
THCA	cis	1	rs853685	chr6:28288785	ZKSCAN3	chr6:28317691-28334523:+	-0.27	-5.46	7.68E-8	Depression	
THCA	cis	1	rs853685	chr6:28288785	ZNF187	chr6:28234788-28245978:+	-0.29	-5.88	7.82E-9	Depression	
THCA	cis	1	rs853685	chr6:28288785	ZNF193	chr6:28193067-28201260:+	0.19	3.63	0.000313	Depression	
THCA	cis	1	rs853685	chr6:28288785	ZNF323	chr6:28292517-28324048:-	0.46	6.5	2.05E-10	Depression	
THCA	cis	1	rs853685	chr6:28288785	ZNF389	chr6:28129551-28137375:+	-0.44	-6.33	5.71E-10	Depression	
THCA	cis	1	rs853685	chr6:28288785	ZSCAN23	chr6:28393287-28411279:-	0.22	4.87	1.55E-6	Depression	
THCA	cis	1	rs853694	chr6:28279100	ZKSCAN3	chr6:28317691-28334523:+	-0.26	-5.23	2.59E-7	Depression	
THCA	cis	1	rs853694	chr6:28279100	ZNF187	chr6:28234788-28245978:+	-0.29	-5.93	5.89E-9	Depression	
THCA	cis	1	rs853694	chr6:28279100	ZNF193	chr6:28193067-28201260:+	0.19	3.61	0.000334	Depression	
THCA	cis	1	rs853694	chr6:28279100	ZNF323	chr6:28292517-28324048:-	0.45	6.32	5.86E-10	Depression	
THCA	cis	1	rs853694	chr6:28279100	ZNF389	chr6:28129551-28137375:+	-0.43	-6.31	6.47E-10	Depression	
THCA	cis	1	rs853694	chr6:28279100	ZSCAN23	chr6:28393287-28411279:-	0.22	4.84	1.72E-6	Depression	
THCA	cis	1	rs853758	chr12:122408855	WDR66	chr12:122356480-122441830:+	-0.22	-3.59	0.000362	Urinary metabolites	
THCA	cis	1	rs858232	chr7:23241719	NUPL2	chr7:23221446-23240629:+	-0.44	-5.89	7.28E-9	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858233	chr7:23241533	NUPL2	chr7:23221446-23240629:+	-0.39	-5.44	8.44E-8	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858234	chr7:23240815	NUPL2	chr7:23221446-23240629:+	0.39	5.48	7.01E-8	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858237	chr7:23239223	NUPL2	chr7:23221446-23240629:+	-0.45	-6.22	1.06E-9	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858238	chr7:23239133	NUPL2	chr7:23221446-23240629:+	-0.39	-5.44	8.44E-8	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858239	chr7:23286315	KLHL7	chr7:23145353-23215036:+	0.24	5.31	1.67E-7	Parkinson's disease	
THCA	cis	1	rs858240	chr7:23284237	KLHL7	chr7:23145353-23215036:+	0.24	5.33	1.52E-7	Parkinson's disease	
THCA	cis	1	rs858242	chr7:23225342	NUPL2	chr7:23221446-23240629:+	-0.39	-5.44	8.44E-8	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858243	chr7:23224357	NUPL2	chr7:23221446-23240629:+	-0.39	-5.44	8.44E-8	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858245	chr7:23222727	NUPL2	chr7:23221446-23240629:+	-0.45	-6.13	1.83E-9	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858247	chr7:23221283	NUPL2	chr7:23221446-23240629:+	-0.47	-6.42	3.31E-10	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858249	chr7:23220639	NUPL2	chr7:23221446-23240629:+	0.37	5.49	6.55E-8	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858250	chr7:23218560	NUPL2	chr7:23221446-23240629:+	-0.42	-5.74	1.64E-8	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858251	chr7:23218351	NUPL2	chr7:23221446-23240629:+	-0.46	-6.06	2.77E-9	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858252	chr7:23217872	NUPL2	chr7:23221446-23240629:+	-0.42	-5.74	1.64E-8	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858253	chr7:23217720	NUPL2	chr7:23221446-23240629:+	-0.42	-5.74	1.64E-8	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858254	chr7:23217203	NUPL2	chr7:23221446-23240629:+	-0.41	-5.41	9.82E-8	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858256	chr7:23215636	NUPL2	chr7:23221446-23240629:+	-0.42	-5.46	7.79E-8	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858276	chr7:23252553	NUPL2	chr7:23221446-23240629:+	-0.41	-5.63	3.11E-8	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858277	chr7:23252261	NUPL2	chr7:23221446-23240629:+	0.35	4.87	1.49E-6	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858278	chr7:23252202	NUPL2	chr7:23221446-23240629:+	-0.42	-5.92	6.11E-9	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858280	chr7:23250874	NUPL2	chr7:23221446-23240629:+	-0.43	-5.76	1.49E-8	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858281	chr7:23250567	NUPL2	chr7:23221446-23240629:+	-0.43	-5.76	1.49E-8	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858282	chr7:23250035	NUPL2	chr7:23221446-23240629:+	-0.44	-6.1	2.19E-9	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858285	chr7:23249518	NUPL2	chr7:23221446-23240629:+	-0.44	-5.89	7.28E-9	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858286	chr7:23249463	NUPL2	chr7:23221446-23240629:+	-0.39	-5.44	8.44E-8	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858287	chr7:23249213	NUPL2	chr7:23221446-23240629:+	-0.39	-5.44	8.44E-8	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858291	chr7:23247361	NUPL2	chr7:23221446-23240629:+	-0.45	-6.22	1.06E-9	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858292	chr7:23246733	NUPL2	chr7:23221446-23240629:+	-0.44	-5.89	7.28E-9	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858293	chr7:23246324	NUPL2	chr7:23221446-23240629:+	-0.45	-5.98	4.27E-9	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858296	chr7:23245548	NUPL2	chr7:23221446-23240629:+	-0.45	-6.22	1.06E-9	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858297	chr7:23244961	NUPL2	chr7:23221446-23240629:+	-0.45	-6.22	1.06E-9	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858298	chr7:23244920	NUPL2	chr7:23221446-23240629:+	-0.44	-5.89	7.28E-9	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858301	chr7:23244323	NUPL2	chr7:23221446-23240629:+	-0.45	-6.22	1.06E-9	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858302	chr7:23244243	NUPL2	chr7:23221446-23240629:+	-0.45	-6.22	1.06E-9	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858303	chr7:23243498	NUPL2	chr7:23221446-23240629:+	-0.4	-5.57	4.27E-8	Chronic obstructive pulmonary disease	
THCA	cis	1	rs858304	chr7:23243153	NUPL2	chr7:23221446-23240629:+	0.46	6.18	1.34E-9	Chronic obstructive pulmonary disease	
THCA	cis	1	rs8589	chr6:49403282	CENPQ	chr6:49431096-49460820:+	-0.32	-6.85	2.3E-11	Homocysteine levels	
THCA	cis	1	rs859637	chr1:172711000	C1orf9	chr1:172502260-172580971:+	0.17	4.22	2.89E-5	Celiac disease	
THCA	cis	1	rs859767	chr2:135341200	TMEM163	chr2:135213331-135525334:-	-0.17	-4.52	7.88E-6	Neuroticism	
THCA	cis	1	rs860580	chr5:56149429	C5orf35	chr5:56205103-56213010:+	-1	-23.24	1.75E-80	Type 2 diabetes	
THCA	cis	1	rs860817	chr7:23251469	NUPL2	chr7:23221446-23240629:+	-0.38	-5.34	1.47E-7	Chronic obstructive pulmonary disease	
THCA	cis	1	rs860818	chr7:23250363	NUPL2	chr7:23221446-23240629:+	-0.38	-5.33	1.49E-7	Chronic obstructive pulmonary disease	
THCA	cis	1	rs861283	chr5:56184610	C5orf35	chr5:56205103-56213010:+	1.01	23.57	4.67E-82	Type 2 diabetes	
THCA	cis	1	rs861536	chr14:104167564	KLC1	chr14:104029299-104167887:+	-0.2	-4.03	6.48E-5	Body mass index	
THCA	cis	1	rs861538	chr14:104166733	KLC1	chr14:104029299-104167887:+	-0.21	-4.19	3.39E-5	Body mass index	
THCA	cis	1	rs861539	chr14:104165753	KLC1	chr14:104029299-104167887:+	-0.21	-4.16	3.85E-5	Body mass index	
THCA	cis	1	rs862031	chr14:74991855	MLH3	chr14:75480467-75518235:-	0.14	3.39	0.000764	Height	
THCA	cis	1	rs863840	chr5:56128999	C5orf35	chr5:56205103-56213010:+	0.94	20.21	3.98E-66	Type 2 diabetes	
THCA	cis	1	rs864745	chr7:28180556	JAZF1	chr7:27870196-28220437:-	0.16	4.13	4.26E-5	Crohn's disease;Type 2 diabetes	
THCA	cis	1	rs866222	chr5:56184444	C5orf35	chr5:56205103-56213010:+	1.01	23.57	4.67E-82	Type 2 diabetes	
THCA	cis	1	rs867186	chr20:33764554	PROCR	chr20:33758727-33765164:+	0.33	5.67	2.48E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs867186	chr20:33764554	TRPC4AP	chr20:33590215-33680618:-	-0.31	-4.08	5.36E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs867234	chr3:119281636	ADPRH	chr3:119298523-119308791:+	-0.22	-3.6	0.000347	Vitiligo	
THCA	cis	1	rs867400	chr12:64976850	RASSF3	chr12:65004293-65089190:+	-0.12	-3.65	0.000289	Resting heart rate	
THCA	cis	1	rs867529	chr2:88913273	RPIA	chr2:88991176-89050451:+	0.36	6.64	8.75E-11	Height	
THCA	cis	1	rs868105	chr4:8501030	C4orf23	chr4:8440604-8495258:+	0.34	7.31	1.16E-12	Response to antineoplastic agents	
THCA	cis	1	rs868798	chr10:64895010	LOC84989	chr10:65224989-65226320:+	0.28	4.51	8.24E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs868798	chr10:64895010	NRBF2	chr10:64893007-64914785:+	0.28	4.69	3.52E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs870355	chr17:76166196	SYNGR2	chr17:76164671-76169009:+	0.12	3.85	0.000135	Adenocarcinoma;Lung cancer	
THCA	cis	1	rs872842	chr22:43530631	BIK	chr22:43506757-43525717:+	0.36	6.06	2.75E-9	Prostate cancer	
THCA	cis	1	rs873063	chr8:8572447	SGK223	chr8:8175259-8239257:-	-0.3	-5.46	7.78E-8	Obesity-related traits	
THCA	cis	1	rs873064	chr8:8572380	SGK223	chr8:8175259-8239257:-	-0.3	-5.44	8.49E-8	Obesity-related traits	
THCA	cis	1	rs873686	chr4:185638876	CCDC111	chr4:185570767-185616112:+	-0.29	-6.73	5.02E-11	Kawasaki disease	
THCA	cis	1	rs873686	chr4:185638876	MLF1IP	chr4:185615220-185655286:-	0.41	9.16	1.47E-18	Kawasaki disease	
THCA	cis	1	rs874628	chr19:18304700	IL12RB1	chr19:18170371-18209626:-	-0.09	-3.44	0.000624	Multiple sclerosis	
THCA	cis	1	rs8756	chr12:66359752	IRAK3	chr12:66582978-66648392:+	0.12	3.58	0.000373	Height	
THCA	cis	1	rs875971	chr7:65617595	ASL	chr7:65540776-65558321:+	0.16	4.24	2.69E-5	Aortic root size	
THCA	cis	1	rs875971	chr7:65617595	GUSB	chr7:65425675-65447246:-	-0.27	-5.25	2.26E-7	Aortic root size	
THCA	cis	1	rs875971	chr7:65617595	LOC729156	chr7:66274980-66309813:-	-0.17	-3.65	0.000287	Aortic root size	
THCA	cis	1	rs875971	chr7:65617595	RABGEF1	chr7:66093890-66276446:+	-0.65	-13.98	1.85E-37	Aortic root size	
THCA	cis	1	rs876402	chr14:75601862	EIF2B2	chr14:75469612-75476292:+	-0.18	-5.06	5.96E-7	Height	
THCA	cis	1	rs876402	chr14:75601862	MLH3	chr14:75480467-75518235:-	-0.29	-8.86	1.55E-17	Height	
THCA	cis	1	rs876402	chr14:75601862	RPS6KL1	chr14:75372347-75389958:-	-0.31	-6.79	3.37E-11	Height	
THCA	cis	1	rs876403	chr14:75602834	EIF2B2	chr14:75469612-75476292:+	0.19	5.12	4.49E-7	Height	
THCA	cis	1	rs876403	chr14:75602834	MLH3	chr14:75480467-75518235:-	0.3	8.98	6.21E-18	Height	
THCA	cis	1	rs876403	chr14:75602834	RPS6KL1	chr14:75372347-75389958:-	0.32	6.87	1.95E-11	Height	
THCA	cis	1	rs876701	chr11:46370767	PACSIN3	chr11:47199085-47207958:-	-0.18	-3.96	8.54E-5	Schizophrenia	
THCA	cis	1	rs876808	chr13:94044062	GPC6	chr13:93879078-95060267:+	-0.27	-3.36	0.000831	Neuroticism	
THCA	cis	1	rs877049	chr1:207422996	CD55	chr1:207494817-207534309:+	0.15	6.77	3.75E-11	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs877187	chr6:33706211	IP6K3	chr6:33689443-33714762:-	-0.41	-6.89	1.74E-11	Obesity (extreme)	
THCA	cis	1	rs877187	chr6:33706211	PSMB8	chr6:32808497-32812712:-	0.14	4.08	5.28E-5	Obesity (extreme)	
THCA	cis	1	rs877636	chr12:56480583	RAB5B	chr12:56367760-56388478:+	-0.21	-3.84	0.000138	Cognitive function	
THCA	cis	1	rs877636	chr12:56480583	RPS26	chr12:56435686-56438005:+	-0.73	-14.23	1.45E-38	Cognitive function	
THCA	cis	1	rs877710	chr12:109993976	KCTD10	chr12:109886460-109915155:-	-0.23	-6.05	2.99E-9	HDL cholesterol	
THCA	cis	1	rs878082	chr19:41897674	B3GNT8	chr19:41931265-41934635:-	-0.34	-8.01	8.53E-15	Height	
THCA	cis	1	rs878082	chr19:41897674	EXOSC5	chr19:41892278-41903256:-	-0.1	-3.44	0.000639	Height	
THCA	cis	1	rs878083	chr19:41897688	B3GNT8	chr19:41931265-41934635:-	-0.34	-7.85	2.85E-14	Height	
THCA	cis	1	rs878083	chr19:41897688	EXOSC5	chr19:41892278-41903256:-	-0.1	-3.44	0.000641	Height	
THCA	cis	1	rs878692	chr11:116828939	PCSK7	chr11:117075789-117102811:-	0.42	5.02	7.46E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs879568	chr18:34311659	C18orf10	chr18:34366472-34409158:-	-0.44	-7.64	1.23E-13	QRS duration	
THCA	cis	1	rs879620	chr16:4015729	ADCY9	chr16:4012653-4166186:-	-0.13	-3.76	0.00019	Body mass index;Obesity	
THCA	cis	1	rs880800	chr20:16528537	KIF16B	chr20:16252749-16554078:-	0.28	5.2	3.03E-7	Response to taxane treatment (docetaxel)	
THCA	cis	1	rs881299	chr8:38332249	TM2D2	chr8:38846328-38854041:-	-0.11	-3.44	0.000629	Response to cognitive-behavioural therapy in anxiety disorder	
THCA	cis	1	rs881301	chr8:38332318	TM2D2	chr8:38846328-38854041:-	-0.12	-3.6	0.000346	Response to cognitive-behavioural therapy in anxiety disorder	
THCA	cis	1	rs881375	chr9:123652898	LOC253039	chr9:123605320-123616644:+	-0.5	-9.21	1.0E-18	Rheumatoid arthritis	
THCA	cis	1	rs881375	chr9:123652898	PSMD5	chr9:123578334-123605206:-	-0.27	-5.21	2.77E-7	Rheumatoid arthritis	
THCA	cis	1	rs881802	chr7:118099945	ANKRD7	chr7:117864712-117882782:+	-0.28	-4.53	7.31E-6	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs881827	chr21:48019868	C21orf56	chr21:47581063-47604373:-	-0.26	-4.65	4.38E-6	Lymphocyte counts	
THCA	cis	1	rs882803	chr1:45976147	AKR1A1	chr1:46016498-46035720:+	-0.14	-3.8	0.000161	Homocysteine levels	
THCA	cis	1	rs882803	chr1:45976147	CCDC163P	chr1:45960581-45965646:-	-1.02	-28.2	9.64E-104	Homocysteine levels	
THCA	cis	1	rs882803	chr1:45976147	MUTYH	chr1:45794915-45806142:-	0.21	5.2	2.89E-7	Homocysteine levels	
THCA	cis	1	rs882803	chr1:45976147	PRDX1	chr1:45976708-45987609:-	-0.38	-10.05	1.12E-21	Homocysteine levels	
THCA	cis	1	rs883394	chr19:39205613	LGALS7	chr19:39261608-39264157:-	-0.22	-4.47	9.99E-6	Heart rate	
THCA	cis	1	rs883433	chr19:39206288	LGALS7	chr19:39261608-39264157:-	0.23	4.75	2.64E-6	Heart rate	
THCA	cis	1	rs883565	chr3:39055317	SCN11A	chr3:38887260-38992052:-	0.19	3.73	0.000215	Handedness	
THCA	cis	1	rs883565	chr3:39055317	TTC21A	chr3:39149152-39180394:+	0.3	8.21	2.06E-15	Handedness	
THCA	cis	1	rs883648	chr8:8569521	SGK223	chr8:8175259-8239257:-	-0.31	-5.6	3.68E-8	Obesity-related traits	
THCA	cis	1	rs883838	chr9:135815474	C9orf98	chr9:135600965-135754198:-	0.22	5.52	5.53E-8	Psoriasis	
THCA	cis	1	rs884247	chr14:65895706	LOC645431	chr14:65877313-65879335:-	-0.6	-7.85	2.85E-14	Ischemic stroke	
THCA	cis	1	rs884613	chr20:25288505	ENTPD6	chr20:25176339-25207360:+	0.31	6.96	1.09E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs884613	chr20:25288505	FAM182A	chr20:26035250-26067552:+	0.18	3.41	0.000693	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs884613	chr20:25288505	FAM182B	chr20:25744102-25848786:-	-0.26	-5.37	1.21E-7	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs884613	chr20:25288505	NINL	chr20:25433338-25566153:-	0.37	7.55	2.24E-13	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs884613	chr20:25288505	PYGB	chr20:25228706-25278647:+	0.15	3.71	0.000228	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs884841	chr6:86680300	SNHG5	chr6:86386726-86388451:-	-0.48	-10.72	3.68E-24	Response to antipsychotic treatment	
THCA	cis	1	rs884977	chr7:1066410	ZFAND2A	chr7:1192544-1199855:-	-0.27	-4.31	2.03E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
THCA	cis	1	rs885000	chr8:8568875	SGK223	chr8:8175259-8239257:-	-0.31	-5.58	3.98E-8	Obesity-related traits	
THCA	cis	1	rs885304	chr13:102204834	FGF14	chr13:102372163-103054124:-	-0.15	-3.37	0.000819	Waist-to-hip circumference ratio (interaction)	
THCA	cis	1	rs885654	chr3:119281590	ADPRH	chr3:119298523-119308791:+	-0.23	-3.68	0.000256	Vitiligo	
THCA	cis	1	rs885964	chr22:23461003	GNAZ	chr22:23412669-23467221:+	-0.26	-5.49	6.46E-8	Bone mineral density	
THCA	cis	1	rs885965	chr22:23461425	GNAZ	chr22:23412669-23467221:+	-0.28	-5.97	4.68E-9	Bone mineral density	
THCA	cis	1	rs888192	chr12:109995097	KCTD10	chr12:109886460-109915155:-	0.23	6.05	2.99E-9	HDL cholesterol	
THCA	cis	1	rs888405	chr3:64201702	PRICKLE2	chr3:64079527-64211131:-	-0.14	-3.35	0.000884	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	
THCA	cis	1	rs888407	chr3:64212532	PRICKLE2	chr3:64079527-64211131:-	-0.15	-3.71	0.000227	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	
THCA	cis	1	rs888922	chr5:179731635	MAPK9	chr5:179660597-179719071:-	0.15	3.83	0.000144	Height	
THCA	cis	1	rs889312	chr5:56031884	C5orf35	chr5:56205103-56213010:+	0.32	5.67	2.5E-8	Breast cancer (early onset);Breast cancer	
THCA	cis	1	rs889398	chr16:69556715	CLEC18A	chr16:69984626-69997887:+	0.22	4.07	5.46E-5	Body mass index	
THCA	cis	1	rs889399	chr16:69556583	CLEC18A	chr16:69984626-69997887:+	0.21	3.88	0.000118	Body mass index	
THCA	cis	1	rs889399	chr16:69556583	NFAT5	chr16:69598997-69738553:+	-0.13	-3.69	0.000254	Body mass index	
THCA	cis	1	rs889704	chr16:71392062	CALB2	chr16:71392626-71424339:+	0.39	4.88	1.43E-6	Schizophrenia	
THCA	cis	1	rs889704	chr16:71392062	HPR	chr16:72097125-72111144:+	-0.29	-3.54	0.000439	Schizophrenia	
THCA	cis	1	rs8897	chr3:49460407	CCDC51	chr3:48473582-48481529:-	0.14	3.42	0.000679	Menarche (age at onset)	
THCA	cis	1	rs8897	chr3:49460407	GMPPB	chr3:49758932-49761384:-	-0.17	-3.82	0.000153	Menarche (age at onset)	
THCA	cis	1	rs8897	chr3:49460407	P4HTM	chr3:49027341-49044579:+	0.16	4.23	2.83E-5	Menarche (age at onset)	
THCA	cis	1	rs8897	chr3:49460407	WDR6	chr3:49044637-49053386:+	-0.16	-3.4	0.000718	Menarche (age at onset)	
THCA	cis	1	rs889877	chr7:134232615	AKR1B1	chr7:134127107-134143888:-	0.2	4.19	3.28E-5	Longevity	
THCA	cis	1	rs891368	chr3:53123273	ITIH4	chr3:52847007-52866554:-	0.16	4.58	6.06E-6	Height	
THCA	cis	1	rs891368	chr3:53123273	RFT1	chr3:53122503-53164470:-	-0.75	-18.21	1.15E-56	Height	
THCA	cis	1	rs891376	chr1:207491489	CD55	chr1:207494817-207534309:+	0.15	6.49	2.12E-10	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs891378	chr1:207490319	CD55	chr1:207494817-207534309:+	0.16	6.82	2.7E-11	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs891386	chr18:21103971	NPC1	chr18:21108363-21166581:-	0.16	5.15	3.77E-7	Body mass index	
THCA	cis	1	rs892055	chr19:38912764	C19orf33	chr19:38794804-38795646:+	0.11	3.98	7.98E-5	Asperger disorder	
THCA	cis	1	rs892864	chr5:127835859	FBN2	chr5:127593602-127873916:-	0.48	6.16	1.52E-9	Multiple system atrophy	
THCA	cis	1	rs892974	chr3:49398514	GMPPB	chr3:49758932-49761384:-	-0.17	-3.75	0.000197	Menarche (age at onset)	
THCA	cis	1	rs892974	chr3:49398514	P4HTM	chr3:49027341-49044579:+	0.18	4.37	1.51E-5	Menarche (age at onset)	
THCA	cis	1	rs893158	chr15:62378608	VPS13C	chr15:62144592-62352647:-	-0.12	-4.36	1.62E-5	Height	
THCA	cis	1	rs893363	chr3:53847062	CHDH	chr3:53850388-53880419:-	0.34	5.97	4.52E-9	Axial length	
THCA	cis	1	rs894737	chr12:54418143	SMUG1	chr12:54573783-54582757:-	-0.1	-3.38	0.000795	Bone mineral density	
THCA	cis	1	rs894738	chr12:54417525	SMUG1	chr12:54573783-54582757:-	-0.11	-3.59	0.000358	Bone mineral density	
THCA	cis	1	rs895958	chr12:122378206	WDR66	chr12:122356480-122441830:+	-0.23	-3.68	0.000256	Urinary metabolites	
THCA	cis	1	rs895959	chr12:122320352	WDR66	chr12:122356480-122441830:+	-0.23	-3.81	0.000157	Urinary metabolites	
THCA	cis	1	rs896854	chr8:95960511	INTS8	chr8:95835534-95892720:+	0.16	3.87	0.000123	Type 2 diabetes	
THCA	cis	1	rs897120	chr2:70160982	ASPRV1	chr2:70187226-70314147:-	0.12	3.45	0.000613	Carotid plaque burden (smoking interaction)	
THCA	cis	1	rs897456	chr17:17422608	ATPAF2	chr17:17918373-17942480:-	-0.23	-4.3	2.07E-5	Obsessive-compulsive symptoms	
THCA	cis	1	rs898225	chr3:48413179	ATRIP	chr3:48488141-48507708:+	-0.18	-3.87	0.000125	Longevity	
THCA	cis	1	rs898225	chr3:48413179	TREX1	chr3:48501186-48509043:+	0.24	5.59	3.82E-8	Longevity	
THCA	cis	1	rs899335	chr17:20898362	USP22	chr17:20902908-20947073:-	-0.18	-3.76	0.000193	Blood trace element (Se levels)	
THCA	cis	1	rs899336	chr17:20898393	USP22	chr17:20902908-20947073:-	-0.18	-3.72	0.000224	Blood trace element (Se levels)	
THCA	cis	1	rs899495	chr13:95862196	ABCC4	chr13:95672084-95953687:-	-0.19	-3.5	0.000517	Breast cancer	
THCA	cis	1	rs900012	chr11:116966435	PCSK7	chr11:117075789-117102811:-	-0.28	-4.88	1.48E-6	Protein quantitative trait loci	
THCA	cis	1	rs901103	chr11:77931346	NARS2	chr11:78147017-78285909:-	-0.39	-6.97	1.02E-11	Testicular germ cell tumor	
THCA	cis	1	rs901104	chr11:77930499	NARS2	chr11:78147017-78285909:-	-0.38	-6.86	2.18E-11	Testicular germ cell tumor	
THCA	cis	1	rs904061	chr14:52504624	C14orf166	chr14:52456228-52471419:+	-0.14	-4.1	4.92E-5	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs904093	chr4:100263247	ADH1C	chr4:100257651-100273917:-	-0.18	-3.36	0.00083	Oral cavity and pharyngeal cancer	
THCA	cis	1	rs904094	chr4:100263252	ADH1C	chr4:100257651-100273917:-	-0.18	-3.36	0.00083	Oral cavity and pharyngeal cancer	
THCA	cis	1	rs904095	chr4:100263383	ADH1C	chr4:100257651-100273917:-	-0.18	-3.39	0.000747	Oral cavity and pharyngeal cancer	
THCA	cis	1	rs904096	chr4:100263584	ADH1C	chr4:100257651-100273917:-	-0.18	-3.39	0.000747	Oral cavity and pharyngeal cancer	
THCA	cis	1	rs904251	chr6:37451696	C6orf129	chr6:37450699-37467700:-	0.19	6.02	3.41E-9	Cognitive performance	
THCA	cis	1	rs905928	chr1:31863017	ZCCHC17	chr1:31769842-31837780:+	-0.3	-5.6	3.59E-8	Schizophrenia	
THCA	cis	1	rs906134	chr7:65444288	CCT6P1	chr7:65216092-65228661:+	0.41	6.46	2.56E-10	Diabetic kidney disease	
THCA	cis	1	rs906134	chr7:65444288	CRCP	chr7:65579805-65619551:+	-0.28	-4.26	2.51E-5	Diabetic kidney disease	
THCA	cis	1	rs906134	chr7:65444288	RABGEF1	chr7:66093890-66276446:+	0.54	6.57	1.31E-10	Diabetic kidney disease	
THCA	cis	1	rs906867	chr2:30478628	LBH	chr2:30454397-30482899:+	-0.17	-3.35	0.00088	Systemic lupus erythematosus	
THCA	cis	1	rs909341	chr20:62328742	LIME1	chr20:62367053-62370459:+	0.13	3.53	0.000459	Atopic dermatitis	
THCA	cis	1	rs909341	chr20:62328742	SLC2A4RG	chr20:62371211-62375401:+	-0.14	-3.68	0.000256	Atopic dermatitis	
THCA	cis	1	rs909341	chr20:62328742	ZGPAT	chr20:62338794-62370459:+	-0.18	-5.74	1.68E-8	Atopic dermatitis	
THCA	cis	1	rs909349	chr4:103556316	CISD2	chr4:103790135-103809913:+	0.15	3.47	0.000572	Primary biliary cirrhosis	
THCA	cis	1	rs909349	chr4:103556316	NFKB1	chr4:103422486-103538458:+	-0.15	-4.2	3.2E-5	Primary biliary cirrhosis	
THCA	cis	1	rs910316	chr14:75626042	EIF2B2	chr14:75469612-75476292:+	0.19	5.08	5.3E-7	Height	
THCA	cis	1	rs910316	chr14:75626042	MLH3	chr14:75480467-75518235:-	0.29	8.63	8.98E-17	Height	
THCA	cis	1	rs910316	chr14:75626042	RPS6KL1	chr14:75372347-75389958:-	0.31	6.63	8.96E-11	Height	
THCA	cis	1	rs910997	chr20:25267301	ENTPD6	chr20:25176339-25207360:+	-0.31	-6.94	1.24E-11	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs910997	chr20:25267301	FAM182A	chr20:26035250-26067552:+	-0.18	-3.4	0.000741	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs910997	chr20:25267301	FAM182B	chr20:25744102-25848786:-	0.27	5.62	3.21E-8	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs910997	chr20:25267301	NINL	chr20:25433338-25566153:-	-0.35	-7.18	2.68E-12	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs910997	chr20:25267301	PYGB	chr20:25228706-25278647:+	-0.16	-4.05	5.93E-5	Liver enzyme levels (alkaline phosphatase)	
THCA	cis	1	rs911411	chr20:47718431	ARFGEF2	chr20:47538275-47653229:+	-0.13	-4.12	4.47E-5	Anger	
THCA	cis	1	rs911411	chr20:47718431	CSE1L	chr20:47662838-47713484:+	0.41	10.23	2.31E-22	Anger	
THCA	cis	1	rs913074	chr6:41538545	MDFI	chr6:41604930-41621981:+	0.18	5.39	1.12E-7	Prostate cancer	
THCA	cis	1	rs914912	chr13:78381602	EDNRB	chr13:78469616-78549664:-	0.14	4.12	4.49E-5	Hair color	
THCA	cis	1	rs916134	chr12:54069803	SOAT2	chr12:53497274-53518322:+	-0.2	-4.42	1.2E-5	Height	
THCA	cis	1	rs916583	chr22:23469267	GNAZ	chr22:23412669-23467221:+	-0.26	-5.61	3.43E-8	Bone mineral density	
THCA	cis	1	rs916584	chr22:23469433	GNAZ	chr22:23412669-23467221:+	-0.26	-5.49	6.38E-8	Bone mineral density	
THCA	cis	1	rs916585	chr22:23469438	GNAZ	chr22:23412669-23467221:+	-0.26	-5.52	5.55E-8	Bone mineral density	
THCA	cis	1	rs916926	chr17:39030283	TMEM99	chr17:38975374-38992526:+	0.22	5.41	1.01E-7	Height	
THCA	cis	1	rs917098	chr7:44750079	OGDH	chr7:44646171-44748668:+	0.19	3.56	0.000403	Systolic blood pressure change trajectories	
THCA	cis	1	rs9174	chr4:25419283	ZCCHC4	chr4:25314396-25372003:+	-0.17	-3.89	0.000115	Rheumatoid arthritis	
THCA	cis	1	rs917665	chr4:17668504	MED28	chr4:17616273-17629791:+	-0.17	-3.71	0.00023	Parasitemia in Tripanosoma cruzi seropositivity	
THCA	cis	1	rs917761	chr7:117859053	ANKRD7	chr7:117864712-117882782:+	-0.26	-4.46	1.04E-5	Response to platinum-based chemotherapy in non-small-cell lung cancer	
THCA	cis	1	rs917911	chr12:9905851	CLECL1	chr12:9868457-9885860:-	0.27	8.77	3.27E-17	Type 1 diabetes	
THCA	cis	1	rs917911	chr12:9905851	LOC642846	chr12:9436253-9466684:+	-0.16	-3.54	0.000444	Type 1 diabetes	
THCA	cis	1	rs918814	chr2:23948466	C2orf84	chr2:24397531-24414566:+	-0.2	-3.34	0.000888	Obesity-related traits	
THCA	cis	1	rs918814	chr2:23948466	LOC375190	chr2:24299728-24397519:+	0.31	7.89	2.09E-14	Obesity-related traits	
THCA	cis	1	rs920573	chr11:59924959	MS4A14	chr11:60145958-60185226:+	0.17	4.34	1.73E-5	Alzheimer's disease (late onset)	
THCA	cis	1	rs9213	chr2:218386	SH3YL1	chr2:218138-264810:-	-0.92	-25.26	4.75E-90	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs921450	chr7:50623260	FIGNL1	chr7:50511834-50518088:-	0.16	4.36	1.61E-5	Malaria	
THCA	cis	1	rs921451	chr7:50623285	FIGNL1	chr7:50511834-50518088:-	-0.16	-4.26	2.47E-5	Malaria	
THCA	cis	1	rs9217	chr17:7363088	CHRNB1	chr17:7348406-7360931:+	0.19	3.91	0.000104	Height	
THCA	cis	1	rs921972	chr6:70409877	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.39	0.000763	Sleep duration	
THCA	cis	1	rs922075	chr3:48489398	ATRIP	chr3:48488141-48507708:+	-0.2	-4.43	1.16E-5	Longevity	
THCA	cis	1	rs922075	chr3:48489398	TREX1	chr3:48501186-48509043:+	0.24	5.58	3.96E-8	Longevity	
THCA	cis	1	rs922075	chr3:48489398	ZNF589	chr3:48282596-48329113:+	-0.16	-3.58	0.000378	Longevity	
THCA	cis	1	rs922664	chr15:84569555	LOC388152	chr15:84867600-84898920:-	-0.21	-3.95	8.82E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs923372	chr4:48410454	OCIAD1	chr4:48833015-48863831:+	-0.14	-4.21	3.0E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs924607	chr5:610093	CEP72	chr5:612405-653664:+	0.39	7.49	3.26E-13	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs925098	chr4:17919811	DCAF16	chr4:17802280-17812381:-	0.22	5.42	9.69E-8	Height	
THCA	cis	1	rs925130	chr1:207503432	CD55	chr1:207494817-207534309:+	0.15	6.6	1.11E-10	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs925131	chr1:207503721	CD55	chr1:207494817-207534309:+	0.14	5.9	6.7E-9	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs925410	chr2:160912652	LY75	chr2:160625141-160761262:-	-0.21	-4.99	8.29E-7	Idiopathic membranous nephropathy	
THCA	cis	1	rs925488	chr9:100546391	C9orf156	chr9:100666772-100684852:-	0.14	3.9	0.000108	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	cis	1	rs925489	chr9:100546600	C9orf156	chr9:100666772-100684852:-	0.13	3.57	0.000396	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	cis	1	rs926299	chr22:39095698	LOC646851	chr22:38974125-39052634:-	0.14	3.64	0.000308	Resting heart rate	
THCA	cis	1	rs926299	chr22:39095698	TOMM22	chr22:39077954-39080763:+	-0.16	-3.45	0.000615	Resting heart rate	
THCA	cis	1	rs926829	chr6:116555878	DSE	chr6:116575336-116759440:+	0.14	3.5	0.000509	Dental caries	
THCA	cis	1	rs926829	chr6:116555878	TSPYL4	chr6:116571133-116575261:-	-0.14	-3.97	8.26E-5	Dental caries	
THCA	cis	1	rs9283717	chr5:56078659	C5orf35	chr5:56205103-56213010:+	0.98	22.43	1.23E-76	Type 2 diabetes	
THCA	cis	1	rs9285425	chr6:117871836	DCBLD1	chr6:117803820-117891018:+	0.23	4.51	8.03E-6	Height	
THCA	cis	1	rs9285425	chr6:117871836	GOPC	chr6:117639351-117923681:-	0.18	4.92	1.19E-6	Height	
THCA	cis	1	rs9285600	chr14:97279220	VRK1	chr14:97263684-97347950:+	0.18	4.2	3.19E-5	Neutrophil count	
THCA	cis	1	rs9285943	chr5:101708465	SLCO4C1	chr5:101569694-101632253:-	0.25	5.81	1.13E-8	Schizophrenia	
THCA	cis	1	rs9285946	chr5:101735721	SLCO4C1	chr5:101569694-101632253:-	0.24	5.54	5.12E-8	Schizophrenia	
THCA	cis	1	rs9288316	chr2:202163483	ALS2CR12	chr2:202153148-202222101:-	0.36	7.41	5.77E-13	Melanoma;Esophageal squamous cell carcinoma	
THCA	cis	1	rs9288617	chr2:227762815	COL4A4	chr2:227867435-228029275:-	0.16	3.94	9.38E-5	Pulmonary function	
THCA	cis	1	rs9289275	chr3:125648659	ALG1L	chr3:125648118-125655882:-	-0.26	-3.62	0.000321	Blood pressure (smoking interaction)	
THCA	cis	1	rs9289275	chr3:125648659	LOC100125556	chr3:125635444-125648865:+	0.63	10.81	1.6E-24	Blood pressure (smoking interaction)	
THCA	cis	1	rs9289471	chr3:134230811	ANAPC13	chr3:134196547-134204865:-	0.39	12.57	1.72E-31	Height	
THCA	cis	1	rs9289471	chr3:134230811	CEP63	chr3:134204575-134293852:+	0.29	6.4	3.83E-10	Height	
THCA	cis	1	rs9289475	chr3:134236459	ANAPC13	chr3:134196547-134204865:-	0.39	12.51	3.0E-31	Height	
THCA	cis	1	rs9289475	chr3:134236459	CEP63	chr3:134204575-134293852:+	0.31	6.67	7.14E-11	Height	
THCA	cis	1	rs9289476	chr3:134237103	ANAPC13	chr3:134196547-134204865:-	0.37	11.72	4.84E-28	Height	
THCA	cis	1	rs9289476	chr3:134237103	CEP63	chr3:134204575-134293852:+	0.3	6.49	2.09E-10	Height	
THCA	cis	1	rs9289478	chr3:134268619	ANAPC13	chr3:134196547-134204865:-	0.37	11.85	1.35E-28	Height	
THCA	cis	1	rs9289478	chr3:134268619	CEP63	chr3:134204575-134293852:+	0.3	6.46	2.65E-10	Height	
THCA	cis	1	rs929039	chr22:38071511	LGALS2	chr22:37966254-37976024:-	0.14	3.73	0.000216	Fat distribution (HIV)	
THCA	cis	1	rs929039	chr22:38071511	SH3BP1	chr22:38030661-38062939:+	0.12	3.69	0.000246	Fat distribution (HIV)	
THCA	cis	1	rs9291683	chr4:10324160	SLC2A9	chr4:9827850-10041872:-	-0.15	-3.54	0.000446	Bone mineral density	
THCA	cis	1	rs9291683	chr4:10324160	WDR1	chr4:10075964-10118573:-	0.21	5.05	6.43E-7	Bone mineral density	
THCA	cis	1	rs929249	chr7:27167537	HOXA9	chr7:27202058-27205149:-	-0.41	-4.57	6.23E-6	Hypospadias	
THCA	cis	1	rs929354	chr7:157045557	UBE3C	chr7:156931655-157062065:+	-0.11	-3.8	0.000166	Body mass index	
THCA	cis	1	rs9294377	chr6:88084839	C6orf162	chr6:88032306-88052043:+	-0.18	-3.85	0.000137	Depressive episodes in bipolar disorder	
THCA	cis	1	rs9294377	chr6:88084839	C6orf164	chr6:88032306-88109459:+	-0.31	-5.82	1.08E-8	Depressive episodes in bipolar disorder	
THCA	cis	1	rs9294377	chr6:88084839	SLC35A1	chr6:88146444-88222051:+	0.17	3.34	0.000896	Depressive episodes in bipolar disorder	
THCA	cis	1	rs9294851	chr6:70457629	LMBRD1	chr6:70385751-70506888:-	0.1	3.52	0.000479	Sleep duration	
THCA	cis	1	rs9295624	chr6:24439600	MRS2	chr6:24403153-24425809:+	0.16	4.52	7.88E-6	Liver enzyme levels	
THCA	cis	1	rs9295695	chr6:26528250	BTN2A3	chr6:26422317-26431927:+	-0.19	-4.52	7.82E-6	Educational attainment	
THCA	cis	1	rs9295695	chr6:26528250	HCG11	chr6:26521934-26527610:+	0.23	4.43	1.19E-5	Educational attainment	
THCA	cis	1	rs9295695	chr6:26528250	HMGN4	chr6:26538572-26547162:+	0.16	4.05	5.86E-5	Educational attainment	
THCA	cis	1	rs9295695	chr6:26528250	ZNF322A	chr6:26634612-26659963:-	0.14	3.77	0.00018	Educational attainment	
THCA	cis	1	rs9296095	chr6:33542523	C6orf227	chr6:33553883-33561115:-	-0.2	-3.64	0.000299	Platelet count	
THCA	cis	1	rs9296365	chr6:41535379	MDFI	chr6:41604930-41621981:+	0.18	5.31	1.71E-7	Prostate cancer	
THCA	cis	1	rs9296404	chr6:42925803	GNMT	chr6:42928500-42931617:+	-0.5	-13.64	5.08E-36	Plasma homocysteine levels (post-methionine load test)	
THCA	cis	1	rs9296404	chr6:42925803	PEX6	chr6:42931613-42946981:-	0.64	18.29	5.01E-57	Plasma homocysteine levels (post-methionine load test)	
THCA	cis	1	rs9296450	chr6:44953786	SUPT3H	chr6:44777054-45345670:-	-0.17	-3.43	0.000656	Height	
THCA	cis	1	rs9296504	chr6:46629505	CYP39A1	chr6:46517445-46620523:-	0.43	9.98	1.89E-21	QRS complex (Sokolow-Lyon)	
THCA	cis	1	rs9296504	chr6:46629505	SLC25A27	chr6:46620679-46645925:+	0.18	6.56	1.39E-10	QRS complex (Sokolow-Lyon)	
THCA	cis	1	rs9296504	chr6:46629505	TDRD6	chr6:46655866-46670149:+	-0.18	-5.14	3.97E-7	QRS complex (Sokolow-Lyon)	
THCA	cis	1	rs9296505	chr6:46629841	CYP39A1	chr6:46517445-46620523:-	0.42	9.91	3.65E-21	QRS complex (Sokolow-Lyon)	
THCA	cis	1	rs9296505	chr6:46629841	SLC25A27	chr6:46620679-46645925:+	0.18	6.71	5.59E-11	QRS complex (Sokolow-Lyon)	
THCA	cis	1	rs9296505	chr6:46629841	TDRD6	chr6:46655866-46670149:+	-0.18	-5.22	2.65E-7	QRS complex (Sokolow-Lyon)	
THCA	cis	1	rs9296616	chr6:49414235	CENPQ	chr6:49431096-49460820:+	-0.27	-5.65	2.7E-8	Folate pathway vitamin levels	
THCA	cis	1	rs9296616	chr6:49414235	MUT	chr6:49398994-49431031:-	0.28	9.58	5.24E-20	Folate pathway vitamin levels	
THCA	cis	1	rs9296617	chr6:49428360	CENPQ	chr6:49431096-49460820:+	-0.27	-5.59	3.84E-8	Folate pathway vitamin levels	
THCA	cis	1	rs9296617	chr6:49428360	MUT	chr6:49398994-49431031:-	0.29	9.76	1.26E-20	Folate pathway vitamin levels	
THCA	cis	1	rs9296832	chr6:56100909	COL21A1	chr6:55921389-56258892:-	0.77	16.55	5.6E-49	Pulse pressure	
THCA	cis	1	rs9297464	chr8:89415996	MMP16	chr8:89049462-89339717:-	0.31	5.04	6.5E-7	Electrodermal activity	
THCA	cis	1	rs9297465	chr8:89416826	MMP16	chr8:89049462-89339717:-	0.32	5.17	3.49E-7	Electrodermal activity	
THCA	cis	1	rs9297469	chr8:89431787	MMP16	chr8:89049462-89339717:-	0.3	4.95	1.03E-6	Electrodermal activity	
THCA	cis	1	rs9297470	chr8:89432036	MMP16	chr8:89049462-89339717:-	0.32	5.19	3.04E-7	Electrodermal activity	
THCA	cis	1	rs9297950	chr8:96025659	C8orf38	chr8:95908040-96088396:+	-0.25	-4.32	1.87E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs9297951	chr8:96041437	C8orf38	chr8:95908040-96088396:+	-0.26	-4.56	6.5E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
THCA	cis	1	rs9297994	chr8:59392324	UBXN2B	chr8:59323823-59364059:+	-0.13	-3.48	0.00055	LDL cholesterol	
THCA	cis	1	rs929843	chr16:70045748	CLEC18A	chr16:69984626-69997887:+	-0.74	-12.2	5.66E-30	Menarche (age at onset)	
THCA	cis	1	rs929843	chr16:70045748	EXOSC6	chr16:70284134-70285833:-	-0.34	-4.74	2.79E-6	Menarche (age at onset)	
THCA	cis	1	rs929843	chr16:70045748	PDXDC2	chr16:70010210-70099851:-	-0.33	-8.46	3.35E-16	Menarche (age at onset)	
THCA	cis	1	rs9299335	chr9:102691446	STX17	chr9:102668915-102736817:+	-0.17	-4.33	1.86E-5	Alopecia areata	
THCA	cis	1	rs9303029	chr17:80408815	C17orf62	chr17:80400520-80408694:-	-0.26	-6.18	1.34E-9	Protein quantitative trait loci	
THCA	cis	1	rs9303280	chr17:38074031	GSDMB	chr17:38060850-38074903:-	0.15	4.96	9.87E-7	Self-reported allergy	
THCA	cis	1	rs9303280	chr17:38074031	ORMDL3	chr17:38077296-38083854:-	0.31	7.74	6.16E-14	Self-reported allergy	
THCA	cis	1	rs9303280	chr17:38074031	PGAP3	chr17:37827376-37844310:-	0.16	4.2	3.25E-5	Self-reported allergy	
THCA	cis	1	rs9303401	chr17:56847945	SUPT4H1	chr17:56422539-56429563:-	-0.16	-4.11	4.67E-5	Cognitive test performance	
THCA	cis	1	rs9304491	chr18:23718609	SS18	chr18:23596219-23671164:-	-0.28	-3.55	0.000425	Rhegmatogenous retinal detachment	
THCA	cis	1	rs9304578	chr19:39250337	LGALS7	chr19:39261608-39264157:-	0.22	4.3	2.12E-5	Heart rate	
THCA	cis	1	rs9304593	chr19:41942875	B3GNT8	chr19:41931265-41934635:-	0.34	7.83	3.19E-14	Height	
THCA	cis	1	rs9304593	chr19:41942875	EXOSC5	chr19:41892278-41903256:-	0.11	3.56	0.00041	Height	
THCA	cis	1	rs9304742	chr19:53451291	ZNF321	chr19:53430388-53466114:-	0.21	4.06	5.68E-5	Psoriasis	
THCA	cis	1	rs9304861	chr19:35271888	ZNF302	chr19:35168567-35177302:+	-0.29	-5.39	1.1E-7	Alzheimer disease and age of onset	
THCA	cis	1	rs9306329	chr22:39072454	JOSD1	chr22:39081549-39096459:-	-0.15	-3.89	0.000115	Resting heart rate	
THCA	cis	1	rs9306329	chr22:39072454	LOC646851	chr22:38974125-39052634:-	0.13	3.4	0.000739	Resting heart rate	
THCA	cis	1	rs9306329	chr22:39072454	TOMM22	chr22:39077954-39080763:+	-0.16	-3.55	0.000423	Resting heart rate	
THCA	cis	1	rs9307050	chr4:76905649	NAAA	chr4:76831809-76862166:-	-0.35	-7.07	5.39E-12	Longevity	
THCA	cis	1	rs9308433	chr1:214457009	SMYD2	chr1:214454565-214510477:+	0.19	3.67	0.000274	IgG glycosylation	
THCA	cis	1	rs9309331	chr2:61141615	C2orf74	chr2:61372243-61391964:+	0.42	6.61	1.03E-10	Inflammatory skin disease	
THCA	cis	1	rs9309473	chr2:73743982	ALMS1P	chr2:73872046-73912692:+	0.76	11.64	9.74E-28	Metabolite levels	
THCA	cis	1	rs9309473	chr2:73743982	NAT8	chr2:73867850-73869537:-	0.42	6.34	5.33E-10	Metabolite levels	
THCA	cis	1	rs931058	chr5:150333698	LOC134466	chr5:150310000-150326146:-	0.43	5.28	1.93E-7	Crohn's disease	
THCA	cis	1	rs9311288	chr3:41804581	ULK4	chr3:41288091-42003660:-	1.1	20.48	2.29E-67	Diastolic blood pressure	
THCA	cis	1	rs9311423	chr3:48420308	ATRIP	chr3:48488141-48507708:+	0.17	3.72	0.000223	Longevity	
THCA	cis	1	rs9311423	chr3:48420308	TREX1	chr3:48501186-48509043:+	-0.25	-5.83	9.99E-9	Longevity	
THCA	cis	1	rs9311474	chr3:52338852	NEK4	chr3:52744803-52804951:-	-0.12	-3.99	7.77E-5	Electroencephalogram traits	
THCA	cis	1	rs9311474	chr3:52338852	NT5DC2	chr3:52558386-52569093:-	-0.25	-5.92	6.06E-9	Electroencephalogram traits	
THCA	cis	1	rs9311474	chr3:52338852	PBRM1	chr3:52579368-52719866:-	0.13	4.95	1.01E-6	Electroencephalogram traits	
THCA	cis	1	rs9311676	chr3:58470351	ABHD6	chr3:58223259-58280459:+	0.28	5.64	2.86E-8	Systemic lupus erythematosus	
THCA	cis	1	rs9311676	chr3:58470351	PDHB	chr3:58413355-58419565:-	-0.24	-5.96	4.96E-9	Systemic lupus erythematosus	
THCA	cis	1	rs9311676	chr3:58470351	RPP14	chr3:58291972-58305919:+	-0.14	-3.64	0.000307	Systemic lupus erythematosus	
THCA	cis	1	rs931182	chr4:54243230	SCFD2	chr4:53739152-54232242:-	0.2	3.76	0.000189	DNA methylation (variation)	
THCA	cis	1	rs9312662	chr4:56386371	TMEM165	chr4:56262090-56292342:+	0.15	3.72	0.000223	Personality dimensions	
THCA	cis	1	rs9312711	chr4:53402146	KIAA0114	chr4:53578621-53580305:+	0.18	3.66	0.000277	Biochemical measures	
THCA	cis	1	rs931608	chr19:22614122	ZNF98	chr19:22573899-22605148:-	-0.28	-4.12	4.39E-5	Dental caries;Response to statins (LDL cholesterol change)	
THCA	cis	1	rs931794	chr15:78826180	CHRNA5	chr15:78857906-78886458:+	0.42	8.62	9.65E-17	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs9318086	chr13:24432467	PCOTH	chr13:24463028-24466241:+	0.42	9.54	7.48E-20	Myopia (pathological)	
THCA	cis	1	rs931812	chr8:101919321	YWHAZ	chr8:101930804-101965623:-	0.18	4.75	2.74E-6	Attention deficit hyperactivity disorder and conduct disorder	
THCA	cis	1	rs9319118	chr13:85737693	SLITRK6	chr13:86366922-86373483:-	-0.2	-3.75	0.000196	Bipolar disorder (mania)	
THCA	cis	1	rs9319374	chr13:28047587	MTIF3	chr13:28009783-28024711:-	0.19	3.79	0.000168	Weight	
THCA	cis	1	rs9320287	chr6:109744690	AKD1	chr6:109814059-110012415:-	-0.34	-7.49	3.3E-13	Height	
THCA	cis	1	rs9320287	chr6:109744690	FIG4	chr6:110012424-110146634:+	-0.19	-3.87	0.000123	Height	
THCA	cis	1	rs9320287	chr6:109744690	SMPD2	chr6:109761931-109765121:+	0.34	8.53	1.89E-16	Height	
THCA	cis	1	rs9321659	chr6:100116092	USP45	chr6:99880184-99963312:-	-0.22	-3.42	0.000692	Menarche (age at onset)	
THCA	cis	1	rs9321674	chr6:139122341	CCDC28A	chr6:139094657-139114454:+	0.18	3.53	0.000464	Colorectal or endometrial cancer	
THCA	cis	1	rs9322193	chr6:149919143	C6orf72	chr6:149887528-149912067:+	-0.18	-5.01	7.61E-7	Lung cancer	
THCA	cis	1	rs9322193	chr6:149919143	NUP43	chr6:150045453-150067688:-	-0.23	-4.1	4.82E-5	Lung cancer	
THCA	cis	1	rs9322193	chr6:149919143	RAET1E	chr6:150204512-150217195:-	0.25	5.63	3.04E-8	Lung cancer	
THCA	cis	1	rs9322817	chr6:105232233	HACE1	chr6:105175968-105307794:-	-0.16	-4.02	6.67E-5	Thyroid stimulating hormone	
THCA	cis	1	rs9323624	chr14:76500303	C14orf179	chr14:76452096-76550930:+	0.08	3.37	0.000806	Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced)	
THCA	cis	1	rs9324660	chr5:150257054	LOC134466	chr5:150310000-150326146:-	0.38	5.31	1.7E-7	Crohn's disease	
THCA	cis	1	rs932541	chr20:16455774	KIF16B	chr20:16252749-16554078:-	-0.16	-3.77	0.000186	Intelligence	
THCA	cis	1	rs9327608	chr5:130650134	P4HA2	chr5:131528306-131563556:-	0.26	5.01	7.64E-7	Life satisfaction	
THCA	cis	1	rs9327841	chr5:101697752	SLCO4C1	chr5:101569694-101632253:-	0.25	5.62	3.21E-8	Schizophrenia	
THCA	cis	1	rs9327844	chr5:101698122	SLCO4C1	chr5:101569694-101632253:-	0.25	5.62	3.21E-8	Schizophrenia	
THCA	cis	1	rs932833	chr9:131884041	CRAT	chr9:131857075-131873070:-	0.28	6.75	4.3E-11	Blood metabolite ratios	
THCA	cis	1	rs932835	chr9:131887071	CRAT	chr9:131857075-131873070:-	0.28	6.83	2.59E-11	Blood metabolite ratios	
THCA	cis	1	rs9329165	chr8:8576642	SGK223	chr8:8175259-8239257:-	0.31	5.64	2.89E-8	Obesity-related traits	
THCA	cis	1	rs9329166	chr8:8576655	SGK223	chr8:8175259-8239257:-	-0.35	-6.19	1.29E-9	Obesity-related traits	
THCA	cis	1	rs933683	chr5:78324003	BHMT2	chr5:78365583-78385273:+	0.22	3.43	0.000656	Blood trace element (Se levels);Blood and toenail selenium levels	
THCA	cis	1	rs934093	chr3:134195885	ANAPC13	chr3:134196547-134204865:-	0.4	12.81	1.69E-32	Height	
THCA	cis	1	rs934093	chr3:134195885	CEP63	chr3:134204575-134293852:+	0.29	6.2	1.22E-9	Height	
THCA	cis	1	rs934154	chr2:216901933	MREG	chr2:216807315-216878346:-	0.37	7.97	1.19E-14	Alcohol dependence	
THCA	cis	1	rs934154	chr2:216901933	PECR	chr2:216861029-216946532:-	0.24	4.97	9.3E-7	Alcohol dependence	
THCA	cis	1	rs934156	chr2:216901482	MREG	chr2:216807315-216878346:-	-0.38	-8.18	2.65E-15	Alcohol dependence	
THCA	cis	1	rs934156	chr2:216901482	PECR	chr2:216861029-216946532:-	-0.25	-5.15	3.77E-7	Alcohol dependence	
THCA	cis	1	rs934156	chr2:216901482	TMEM169	chr2:216946589-216967505:+	-0.19	-3.63	0.000312	Alcohol dependence	
THCA	cis	1	rs9342774	chr6:70489409	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.46	0.000579	Sleep duration	
THCA	cis	1	rs9342828	chr6:71993657	OGFRL1	chr6:71998477-72011973:+	-0.19	-3.39	0.000744	Antipsychotic drug-induced weight gain (time interaction);Antipsychotic drug-induced weight gain	
THCA	cis	1	rs934298	chr2:137338721	THSD7B	chr2:137523115-138435287:+	0.23	4.24	2.64E-5	Cognitive test performance	
THCA	cis	1	rs934299	chr2:137338940	THSD7B	chr2:137523115-138435287:+	0.23	4.23	2.81E-5	Cognitive test performance	
THCA	cis	1	rs934624	chr15:50968906	SPPL2A	chr15:50999739-51057910:-	0.28	7.42	5.25E-13	QT interval	
THCA	cis	1	rs934625	chr15:50968756	ATP8B4	chr15:50150436-50411419:-	-0.11	-3.42	0.000682	QT interval	
THCA	cis	1	rs934625	chr15:50968756	SPPL2A	chr15:50999739-51057910:-	0.29	7.45	4.3E-13	QT interval	
THCA	cis	1	rs9346333	chr6:70426479	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.58	0.000375	Sleep duration	
THCA	cis	1	rs9346335	chr6:70427425	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.4	0.000718	Sleep duration	
THCA	cis	1	rs9346336	chr6:70430687	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.44	0.000634	Sleep duration	
THCA	cis	1	rs9346343	chr6:70455024	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.47	0.000576	Sleep duration	
THCA	cis	1	rs9346344	chr6:70458530	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.4	0.000737	Sleep duration	
THCA	cis	1	rs9346346	chr6:70463956	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.42	0.000691	Sleep duration	
THCA	cis	1	rs9346348	chr6:70482951	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.45	0.0006	Sleep duration	
THCA	cis	1	rs9346352	chr6:70489920	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.41	0.000693	Sleep duration	
THCA	cis	1	rs9346353	chr6:70490511	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.41	0.000704	Sleep duration	
THCA	cis	1	rs9346354	chr6:70490528	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.37	0.000817	Sleep duration	
THCA	cis	1	rs9347719	chr6:158288320	SNX9	chr6:158244294-158366109:+	-0.23	-3.63	0.000311	Lipoprotein (a) - cholesterol levels	
THCA	cis	1	rs9348968	chr6:35117251	UHRF1BP1	chr6:34759794-34853117:+	-0.11	-3.77	0.000183	Airway responsiveness in chronic obstructive pulmonary disease	
THCA	cis	1	rs9349804	chr6:56098876	COL21A1	chr6:55921389-56258892:-	0.77	16.4	2.95E-48	Pulse pressure	
THCA	cis	1	rs9350272	chr6:20720818	SOX4	chr6:21593972-21598847:+	-0.11	-3.45	0.000615	Type 2 diabetes	
THCA	cis	1	rs935334	chr14:76613678	ESRRB	chr14:76837690-76968178:+	0.3	4.79	2.28E-6	Blood pressure	
THCA	cis	1	rs9354888	chr6:70478068	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.56	0.000404	Sleep duration	
THCA	cis	1	rs9354889	chr6:70487301	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.4	0.000729	Sleep duration	
THCA	cis	1	rs9354891	chr6:70505017	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.34	0.000889	Sleep duration	
THCA	cis	1	rs9354986	chr6:71996205	OGFRL1	chr6:71998477-72011973:+	-0.19	-3.39	0.000753	Antipsychotic drug-induced weight gain (time interaction);Antipsychotic drug-induced weight gain	
THCA	cis	1	rs9355256	chr6:159375477	RSPH3	chr6:159398268-159421198:-	0.28	6	3.97E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs9355413	chr6:158280471	SNX9	chr6:158244294-158366109:+	-0.23	-3.65	0.000293	Lipoprotein (a) - cholesterol levels	
THCA	cis	1	rs9356096	chr6:158288962	SNX9	chr6:158244294-158366109:+	-0.23	-3.63	0.000311	Lipoprotein (a) - cholesterol levels	
THCA	cis	1	rs9356933	chr6:24321213	MRS2	chr6:24403153-24425809:+	0.15	3.43	0.000662	Uric acid levels	
THCA	cis	1	rs9357010	chr6:26527945	BTN2A3	chr6:26422317-26431927:+	0.18	4.34	1.71E-5	Educational attainment	
THCA	cis	1	rs9357010	chr6:26527945	HCG11	chr6:26521934-26527610:+	-0.23	-4.49	9.02E-6	Educational attainment	
THCA	cis	1	rs9357010	chr6:26527945	HMGN4	chr6:26538572-26547162:+	-0.16	-4.12	4.43E-5	Educational attainment	
THCA	cis	1	rs9357010	chr6:26527945	ZNF322A	chr6:26634612-26659963:-	-0.13	-3.58	0.000378	Educational attainment	
THCA	cis	1	rs9357037	chr6:27327349	ZNF184	chr6:27418522-27440897:-	-0.21	-4.47	9.97E-6	Glomerular filtration rate (creatinine)	
THCA	cis	1	rs9357037	chr6:27327349	ZNF391	chr6:27356524-27369227:+	0.21	5.69	2.2E-8	Glomerular filtration rate (creatinine)	
THCA	cis	1	rs9357512	chr6:46642875	CYP39A1	chr6:46517445-46620523:-	0.32	5.05	6.32E-7	Lipoprotein-associated phospholipase A2 activity and mass	
THCA	cis	1	rs9357733	chr6:52292136	EFHC1	chr6:52284994-52387892:+	0.15	4.45	1.05E-5	Atopic march	
THCA	cis	1	rs9358357	chr6:20719145	SOX4	chr6:21593972-21598847:+	-0.11	-3.37	0.000804	Type 2 diabetes	
THCA	cis	1	rs9360401	chr6:70463955	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.43	0.000654	Sleep duration	
THCA	cis	1	rs936228	chr15:75132164	MPI	chr15:75182410-75190565:+	0.33	7.13	3.62E-12	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
THCA	cis	1	rs936228	chr15:75132164	ULK3	chr15:75128459-75135552:-	-0.17	-5.02	7.21E-7	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
THCA	cis	1	rs936229	chr15:75132319	MPI	chr15:75182410-75190565:+	0.33	7.22	2.05E-12	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
THCA	cis	1	rs936229	chr15:75132319	ULK3	chr15:75128459-75135552:-	-0.17	-5.07	5.67E-7	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
THCA	cis	1	rs9362395	chr6:87854341	C6orf162	chr6:88032306-88052043:+	0.48	5.81	1.11E-8	Schizophrenia	
THCA	cis	1	rs9362426	chr6:88089874	C6orf162	chr6:88032306-88052043:+	-0.18	-3.91	0.000107	Depressive episodes in bipolar disorder	
THCA	cis	1	rs9362426	chr6:88089874	C6orf164	chr6:88032306-88109459:+	-0.29	-5.27	2.03E-7	Depressive episodes in bipolar disorder	
THCA	cis	1	rs9364054	chr6:70446749	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.47	0.000566	Sleep duration	
THCA	cis	1	rs9364058	chr6:70474755	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.38	0.000778	Sleep duration	
THCA	cis	1	rs9364061	chr6:70495377	LMBRD1	chr6:70385751-70506888:-	-0.1	-3.37	0.000826	Sleep duration	
THCA	cis	1	rs9364505	chr6:159375426	RSPH3	chr6:159398268-159421198:-	0.28	6	3.97E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs9365012	chr6:159373408	RSPH3	chr6:159398268-159421198:-	0.28	6	3.97E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs9365013	chr6:159373446	RSPH3	chr6:159398268-159421198:-	0.28	6	3.97E-9	Bladder cancer (smoking interaction)	
THCA	cis	1	rs936525	chr19:23056189	ZNF492	chr19:22817126-22850472:+	-0.43	-6.56	1.44E-10	Bronchopulmonary dysplasia	
THCA	cis	1	rs936526	chr19:23055987	ZNF492	chr19:22817126-22850472:+	-0.44	-6.55	1.45E-10	Bronchopulmonary dysplasia	
THCA	cis	1	rs9366567	chr6:24323858	MRS2	chr6:24403153-24425809:+	-0.16	-3.51	0.000484	Uric acid levels	
THCA	cis	1	rs9368224	chr6:20719232	SOX4	chr6:21593972-21598847:+	-0.11	-3.37	0.000804	Type 2 diabetes	
THCA	cis	1	rs9368849	chr6:35118236	UHRF1BP1	chr6:34759794-34853117:+	-0.11	-3.76	0.00019	Airway responsiveness in chronic obstructive pulmonary disease	
THCA	cis	1	rs9369716	chr6:47552180	CD2AP	chr6:47445525-47594994:+	0.13	3.39	0.000744	Alzheimer's disease (late onset)	
THCA	cis	1	rs9369898	chr6:49382193	CENPQ	chr6:49431096-49460820:+	-0.32	-6.83	2.6E-11	Homocysteine levels	
THCA	cis	1	rs937108	chr7:65428452	CCT6P1	chr7:65216092-65228661:+	0.38	6.09	2.35E-9	Diabetic kidney disease	
THCA	cis	1	rs937108	chr7:65428452	CRCP	chr7:65579805-65619551:+	-0.25	-3.91	0.000104	Diabetic kidney disease	
THCA	cis	1	rs937108	chr7:65428452	RABGEF1	chr7:66093890-66276446:+	0.54	6.78	3.58E-11	Diabetic kidney disease	
THCA	cis	1	rs9371221	chr6:151885986	C6orf97	chr6:151815175-151942327:+	0.34	4.74	2.77E-6	Bone mineral density (spine)	
THCA	cis	1	rs9371537	chr6:151872500	C6orf97	chr6:151815175-151942327:+	-0.3	-4.29	2.14E-5	Bone mineral density (spine)	
THCA	cis	1	rs9371884	chr6:155645607	TFB1M	chr6:155578791-155635626:-	-0.31	-4.95	1.02E-6	Life satisfaction	
THCA	cis	1	rs9372149	chr6:107473218	AIM1	chr6:106959730-107018332:+	-0.18	-3.49	0.000533	Childhood and early adolescence aggressive behavior	
THCA	cis	1	rs9372149	chr6:107473218	PDSS2	chr6:107473761-107780779:-	-0.24	-4.21	3.0E-5	Childhood and early adolescence aggressive behavior	
THCA	cis	1	rs9372480	chr6:117760579	DCBLD1	chr6:117803820-117891018:+	0.51	11.11	1.1E-25	Lung cancer	
THCA	cis	1	rs9372480	chr6:117760579	GOPC	chr6:117639351-117923681:-	0.24	7.08	5.33E-12	Lung cancer	
THCA	cis	1	rs9373571	chr6:101133834	ASCC3	chr6:100956609-101329224:-	0.12	4.58	5.99E-6	Menarche (age at onset)	
THCA	cis	1	rs9374662	chr6:117777804	DCBLD1	chr6:117803820-117891018:+	0.51	11.27	2.83E-26	Lung cancer	
THCA	cis	1	rs9374662	chr6:117777804	GOPC	chr6:117639351-117923681:-	0.23	6.81	2.94E-11	Lung cancer	
THCA	cis	1	rs9374663	chr6:117782634	DCBLD1	chr6:117803820-117891018:+	0.51	11.46	4.85E-27	Lung cancer	
THCA	cis	1	rs9374663	chr6:117782634	GOPC	chr6:117639351-117923681:-	0.25	7.37	7.49E-13	Lung cancer	
THCA	cis	1	rs937495	chr7:65779798	ASL	chr7:65540776-65558321:+	0.16	4.29	2.21E-5	Aortic root size	
THCA	cis	1	rs937495	chr7:65779798	GUSB	chr7:65425675-65447246:-	-0.26	-5.09	5.27E-7	Aortic root size	
THCA	cis	1	rs937495	chr7:65779798	LOC729156	chr7:66274980-66309813:-	-0.16	-3.53	0.000456	Aortic root size	
THCA	cis	1	rs937495	chr7:65779798	RABGEF1	chr7:66093890-66276446:+	-0.67	-14.52	7.7E-40	Aortic root size	
THCA	cis	1	rs9377228	chr6:149921998	C6orf72	chr6:149887528-149912067:+	-0.19	-5.12	4.41E-7	Lung cancer	
THCA	cis	1	rs9377228	chr6:149921998	NUP43	chr6:150045453-150067688:-	-0.27	-4.8	2.17E-6	Lung cancer	
THCA	cis	1	rs9377228	chr6:149921998	RAET1E	chr6:150204512-150217195:-	0.26	5.93	5.95E-9	Lung cancer	
THCA	cis	1	rs9377229	chr6:149928791	C6orf72	chr6:149887528-149912067:+	-0.18	-4.81	2.03E-6	Lung cancer	
THCA	cis	1	rs9377229	chr6:149928791	NUP43	chr6:150045453-150067688:-	-0.22	-3.89	0.000115	Lung cancer	
THCA	cis	1	rs9377229	chr6:149928791	RAET1E	chr6:150204512-150217195:-	0.26	5.76	1.49E-8	Lung cancer	
THCA	cis	1	rs9378930	chr6:5070042	LYRM4	chr6:5108654-5261168:-	-0.15	-3.58	0.000381	Venous thromboembolism (SNP x SNP interaction)	
THCA	cis	1	rs9378931	chr6:5070238	LYRM4	chr6:5108654-5261168:-	-0.15	-3.39	0.000755	Venous thromboembolism (SNP x SNP interaction)	
THCA	cis	1	rs9378932	chr6:5071198	LYRM4	chr6:5108654-5261168:-	-0.15	-3.37	0.000799	Venous thromboembolism (SNP x SNP interaction)	
THCA	cis	1	rs9380378	chr6:33765479	LEMD2	chr6:33738991-33756906:-	-0.29	-6.81	3.03E-11	Crohn's disease	
THCA	cis	1	rs9380516	chr6:35502202	TULP1	chr6:35465653-35480647:-	-0.27	-3.76	0.000195	Hepatitis C induced liver fibrosis	
THCA	cis	1	rs9381040	chr6:41154650	LOC221442	chr6:41068773-41108567:+	0.23	7.55	2.21E-13	Alzheimer's disease (late onset)	
THCA	cis	1	rs9381080	chr6:41527698	MDFI	chr6:41604930-41621981:+	0.18	5.27	2.11E-7	Prostate cancer	
THCA	cis	1	rs9381082	chr6:41542214	MDFI	chr6:41604930-41621981:+	0.19	5.58	4.11E-8	Prostate cancer	
THCA	cis	1	rs9381469	chr6:46630068	CYP39A1	chr6:46517445-46620523:-	-0.42	-9.83	7.07E-21	QRS complex (Sokolow-Lyon)	
THCA	cis	1	rs9381469	chr6:46630068	SLC25A27	chr6:46620679-46645925:+	-0.18	-6.67	7.26E-11	QRS complex (Sokolow-Lyon)	
THCA	cis	1	rs9381469	chr6:46630068	TDRD6	chr6:46655866-46670149:+	0.18	5.21	2.78E-7	QRS complex (Sokolow-Lyon)	
THCA	cis	1	rs9381784	chr6:49398115	CENPQ	chr6:49431096-49460820:+	0.31	6.46	2.54E-10	Homocysteine levels	
THCA	cis	1	rs9383993	chr6:150299299	RAET1K	chr6:150319157-150326280:-	0.29	3.98	8.11E-5	Radiation response	
THCA	cis	1	rs9383993	chr6:150299299	ULBP1	chr6:150285143-150294844:+	0.46	7.34	9.5E-13	Radiation response	
THCA	cis	1	rs9383993	chr6:150299299	ULBP2	chr6:150263136-150270366:+	0.33	5.48	6.74E-8	Radiation response	
THCA	cis	1	rs9384299	chr6:150578067	RAET1K	chr6:150319157-150326280:-	0.48	3.64	0.000297	Pulmonary function;Pulmonary function (interaction)	
THCA	cis	1	rs9385012	chr6:117733191	DCBLD1	chr6:117803820-117891018:+	0.47	10.23	2.47E-22	Lung cancer	
THCA	cis	1	rs9385012	chr6:117733191	GOPC	chr6:117639351-117923681:-	0.22	6.61	1.01E-10	Lung cancer	
THCA	cis	1	rs9387010	chr6:111705944	KIAA1919	chr6:111580482-111590259:+	-0.45	-5.3	1.8E-7	Psoriasis	
THCA	cis	1	rs9387478	chr6:117786180	DCBLD1	chr6:117803820-117891018:+	0.49	10.72	3.42E-24	Lung cancer	
THCA	cis	1	rs9387478	chr6:117786180	GOPC	chr6:117639351-117923681:-	0.23	6.67	6.89E-11	Lung cancer	
THCA	cis	1	rs9388451	chr6:126090377	HEY2	chr6:126068780-126082414:+	-0.15	-3.72	0.000219	Brugada syndrome	
THCA	cis	1	rs938875	chr15:67952922	IQCH	chr15:67547188-67794139:+	0.17	5.24	2.46E-7	Motion sickness	
THCA	cis	1	rs938875	chr15:67952922	MAP2K5	chr15:67835021-68099451:+	0.14	3.4	0.000731	Motion sickness	
THCA	cis	1	rs938878	chr15:67993366	C15orf61	chr15:67813522-67819638:+	0.12	3.36	0.00084	Motion sickness	
THCA	cis	1	rs938878	chr15:67993366	IQCH	chr15:67547188-67794139:+	0.17	5.27	2.09E-7	Motion sickness	
THCA	cis	1	rs938878	chr15:67993366	MAP2K5	chr15:67835021-68099451:+	0.15	3.64	0.000308	Motion sickness	
THCA	cis	1	rs9390502	chr6:101057478	ASCC3	chr6:100956609-101329224:-	0.11	4.41	1.28E-5	Menarche (age at onset)	
THCA	cis	1	rs9390626	chr6:101163109	ASCC3	chr6:100956609-101329224:-	0.12	4.81	2.04E-6	Menarche (age at onset)	
THCA	cis	1	rs9392650	chr6:5070660	LYRM4	chr6:5108654-5261168:-	-0.16	-3.71	0.000236	Venous thromboembolism (SNP x SNP interaction)	
THCA	cis	1	rs9392651	chr6:5071059	LYRM4	chr6:5108654-5261168:-	-0.15	-3.45	0.000617	Venous thromboembolism (SNP x SNP interaction)	
THCA	cis	1	rs9392652	chr6:5071102	LYRM4	chr6:5108654-5261168:-	-0.16	-3.83	0.000145	Venous thromboembolism (SNP x SNP interaction)	
THCA	cis	1	rs9392653	chr6:5071492	LYRM4	chr6:5108654-5261168:-	-0.17	-3.96	8.76E-5	Venous thromboembolism (SNP x SNP interaction)	
THCA	cis	1	rs9393728	chr6:26509330	BTN2A3	chr6:26422317-26431927:+	0.2	4.64	4.57E-6	Educational attainment	
THCA	cis	1	rs9393728	chr6:26509330	HCG11	chr6:26521934-26527610:+	-0.23	-4.47	9.87E-6	Educational attainment	
THCA	cis	1	rs9393728	chr6:26509330	HMGN4	chr6:26538572-26547162:+	-0.16	-4.08	5.38E-5	Educational attainment	
THCA	cis	1	rs9393728	chr6:26509330	ZNF322A	chr6:26634612-26659963:-	-0.14	-3.78	0.000176	Educational attainment	
THCA	cis	1	rs9393729	chr6:26514166	BTN2A3	chr6:26422317-26431927:+	0.19	4.52	7.82E-6	Educational attainment	
THCA	cis	1	rs9393729	chr6:26514166	HCG11	chr6:26521934-26527610:+	-0.23	-4.43	1.19E-5	Educational attainment	
THCA	cis	1	rs9393729	chr6:26514166	HMGN4	chr6:26538572-26547162:+	-0.16	-4.05	5.86E-5	Educational attainment	
THCA	cis	1	rs9393729	chr6:26514166	ZNF322A	chr6:26634612-26659963:-	-0.14	-3.77	0.00018	Educational attainment	
THCA	cis	1	rs9393731	chr6:26529374	BTN2A3	chr6:26422317-26431927:+	0.19	4.52	7.72E-6	Educational attainment	
THCA	cis	1	rs9393731	chr6:26529374	HCG11	chr6:26521934-26527610:+	-0.23	-4.43	1.18E-5	Educational attainment	
THCA	cis	1	rs9393731	chr6:26529374	HMGN4	chr6:26538572-26547162:+	-0.16	-4.05	5.86E-5	Educational attainment	
THCA	cis	1	rs9393731	chr6:26529374	ZNF322A	chr6:26634612-26659963:-	-0.14	-3.77	0.000183	Educational attainment	
THCA	cis	1	rs9393732	chr6:26530898	BTN2A3	chr6:26422317-26431927:+	0.19	4.52	7.72E-6	Educational attainment	
THCA	cis	1	rs9393732	chr6:26530898	HCG11	chr6:26521934-26527610:+	-0.23	-4.43	1.18E-5	Educational attainment	
THCA	cis	1	rs9393732	chr6:26530898	HMGN4	chr6:26538572-26547162:+	-0.16	-4.05	5.86E-5	Educational attainment	
THCA	cis	1	rs9393732	chr6:26530898	ZNF322A	chr6:26634612-26659963:-	-0.14	-3.77	0.000183	Educational attainment	
THCA	cis	1	rs9394159	chr6:33618162	C6orf227	chr6:33553883-33561115:-	0.19	4	7.24E-5	Graves' disease	
THCA	cis	1	rs9394166	chr6:33751122	LEMD2	chr6:33738991-33756906:-	-0.31	-7.16	3.12E-12	Crohn's disease	
THCA	cis	1	rs9394169	chr6:33778964	MLN	chr6:33762449-33771793:-	-0.19	-4.85	1.69E-6	Essential tremor	
THCA	cis	1	rs9394931	chr6:42873245	GNMT	chr6:42928500-42931617:+	0.26	6.43	3.15E-10	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	
THCA	cis	1	rs9394931	chr6:42873245	PEX6	chr6:42931613-42946981:-	-0.29	-6.89	1.75E-11	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	
THCA	cis	1	rs9395493	chr6:49427409	CENPQ	chr6:49431096-49460820:+	-0.33	-7.08	5.09E-12	Homocysteine levels	
THCA	cis	1	rs939558	chr3:41976040	ULK4	chr3:41288091-42003660:-	-1.1	-21.05	4.17E-70	Diastolic blood pressure	
THCA	cis	1	rs9397240	chr6:155648579	TFB1M	chr6:155578791-155635626:-	0.32	5.29	1.88E-7	Life satisfaction	
THCA	cis	1	rs9397424	chr6:151872791	C6orf97	chr6:151815175-151942327:+	0.3	4.33	1.84E-5	Bone mineral density (spine)	
THCA	cis	1	rs9397425	chr6:151873024	C6orf97	chr6:151815175-151942327:+	0.3	4.21	3.07E-5	Bone mineral density (spine)	
THCA	cis	1	rs9397427	chr6:151875034	C6orf97	chr6:151815175-151942327:+	0.29	4.18	3.46E-5	Bone mineral density (spine)	
THCA	cis	1	rs9397428	chr6:151875080	C6orf97	chr6:151815175-151942327:+	0.29	4.01	7.12E-5	Bone mineral density (spine)	
THCA	cis	1	rs9397429	chr6:151877569	C6orf97	chr6:151815175-151942327:+	0.32	4.45	1.07E-5	Bone mineral density (spine)	
THCA	cis	1	rs9397431	chr6:151883930	C6orf97	chr6:151815175-151942327:+	0.37	5.25	2.32E-7	Bone mineral density (spine)	
THCA	cis	1	rs9398235	chr6:110732116	DDO	chr6:110713384-110736753:-	-0.29	-4.18	3.49E-5	Systemic lupus erythematosus	
THCA	cis	1	rs9399041	chr6:133096233	C6orf192	chr6:133090507-133119747:-	-0.27	-4.23	2.8E-5	Type 2 diabetes nephropathy	
THCA	cis	1	rs9399652	chr6:101120006	GRIK2	chr6:101846905-102517957:+	-0.14	-3.4	0.000732	Menarche (age at onset)	
THCA	cis	1	rs9399656	chr6:101127124	ASCC3	chr6:100956609-101329224:-	0.11	4.3	2.1E-5	Menarche (age at onset)	
THCA	cis	1	rs9399693	chr6:149933854	C6orf72	chr6:149887528-149912067:+	-0.19	-5.18	3.23E-7	Lung cancer	
THCA	cis	1	rs9399693	chr6:149933854	NUP43	chr6:150045453-150067688:-	-0.25	-4.53	7.37E-6	Lung cancer	
THCA	cis	1	rs9399693	chr6:149933854	RAET1E	chr6:150204512-150217195:-	0.27	5.99	4.13E-9	Lung cancer	
THCA	cis	1	rs940045	chr3:49449638	GMPPB	chr3:49758932-49761384:-	-0.18	-4.12	4.51E-5	Menarche (age at onset)	
THCA	cis	1	rs940045	chr3:49449638	P4HTM	chr3:49027341-49044579:+	0.17	4.32	1.9E-5	Menarche (age at onset)	
THCA	cis	1	rs940045	chr3:49449638	WDR6	chr3:49044637-49053386:+	-0.18	-3.77	0.000181	Menarche (age at onset)	
THCA	cis	1	rs9400467	chr6:111424015	KIAA1919	chr6:111580482-111590259:+	0.23	4.97	9.41E-7	Blood metabolite levels;Amino acid levels	
THCA	cis	1	rs9400478	chr6:111799644	KIAA1919	chr6:111580482-111590259:+	-0.49	-5.64	2.88E-8	Psoriasis	
THCA	cis	1	rs9401006	chr6:117732924	DCBLD1	chr6:117803820-117891018:+	0.46	9.76	1.2E-20	Lung cancer	
THCA	cis	1	rs9401006	chr6:117732924	GOPC	chr6:117639351-117923681:-	0.22	6.27	8.23E-10	Lung cancer	
THCA	cis	1	rs940174	chr3:136309710	PCCB	chr3:135969167-136056737:+	0.21	5.93	5.95E-9	Schizophrenia	
THCA	cis	1	rs9403962	chr6:101129997	ASCC3	chr6:100956609-101329224:-	0.11	4.31	1.98E-5	Menarche (age at onset)	
THCA	cis	1	rs940934	chr15:84575528	LOC388152	chr15:84867600-84898920:-	-0.21	-4	7.19E-5	Waist circumference adjusted for body mass index;Waist circumference	
THCA	cis	1	rs9410	chr4:159631991	ETFDH	chr4:159593277-159629839:+	0.15	3.69	0.000248	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
THCA	cis	1	rs9410	chr4:159631991	PPID	chr4:159630280-159644552:-	-0.27	-5.15	3.73E-7	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
THCA	cis	1	rs9414780	chr10:65001433	LOC84989	chr10:65224989-65226320:+	0.27	4.38	1.45E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs9414780	chr10:65001433	NRBF2	chr10:64893007-64914785:+	0.27	4.57	6.16E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs9414786	chr10:65044322	LOC84989	chr10:65224989-65226320:+	-0.26	-4.27	2.33E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs9414786	chr10:65044322	NRBF2	chr10:64893007-64914785:+	-0.28	-4.64	4.43E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs9414788	chr10:65056712	LOC84989	chr10:65224989-65226320:+	-0.23	-3.8	0.000163	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs9414788	chr10:65056712	NRBF2	chr10:64893007-64914785:+	-0.28	-4.72	3.11E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs9414793	chr10:65075109	LOC84989	chr10:65224989-65226320:+	-0.27	-4.35	1.66E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs9414793	chr10:65075109	NRBF2	chr10:64893007-64914785:+	-0.28	-4.71	3.21E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs9414799	chr10:65129602	LOC84989	chr10:65224989-65226320:+	0.27	4.44	1.14E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs9414799	chr10:65129602	NRBF2	chr10:64893007-64914785:+	0.28	4.67	3.88E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs9414800	chr10:65131282	LOC84989	chr10:65224989-65226320:+	0.28	4.51	8.24E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs9414800	chr10:65131282	NRBF2	chr10:64893007-64914785:+	0.27	4.58	5.99E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs9414803	chr10:65188069	LOC84989	chr10:65224989-65226320:+	0.26	4.13	4.27E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs9414803	chr10:65188069	NRBF2	chr10:64893007-64914785:+	0.27	4.45	1.09E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs9415680	chr10:65020890	LOC84989	chr10:65224989-65226320:+	-0.26	-4.25	2.58E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs9415680	chr10:65020890	NRBF2	chr10:64893007-64914785:+	-0.27	-4.59	5.57E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs9415692	chr10:65115152	LOC84989	chr10:65224989-65226320:+	0.27	4.39	1.39E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs9415692	chr10:65115152	NRBF2	chr10:64893007-64914785:+	0.28	4.77	2.5E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs9415696	chr10:65134348	LOC84989	chr10:65224989-65226320:+	0.28	4.46	1.03E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs9415696	chr10:65134348	NRBF2	chr10:64893007-64914785:+	0.28	4.65	4.26E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs9415697	chr10:65135137	LOC84989	chr10:65224989-65226320:+	0.28	4.46	1.03E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs9415697	chr10:65135137	NRBF2	chr10:64893007-64914785:+	0.28	4.65	4.26E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs9415701	chr10:65151509	LOC84989	chr10:65224989-65226320:+	0.27	4.27	2.41E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs9415701	chr10:65151509	NRBF2	chr10:64893007-64914785:+	0.26	4.37	1.49E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs9415705	chr10:65161550	LOC84989	chr10:65224989-65226320:+	0.26	4.24	2.65E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs9415705	chr10:65161550	NRBF2	chr10:64893007-64914785:+	0.28	4.82	1.96E-6	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs9415707	chr10:65188290	LOC84989	chr10:65224989-65226320:+	0.26	4.13	4.27E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs9415707	chr10:65188290	NRBF2	chr10:64893007-64914785:+	0.27	4.45	1.09E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs9415708	chr10:65190042	LOC84989	chr10:65224989-65226320:+	0.26	4.18	3.51E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs9415708	chr10:65190042	NRBF2	chr10:64893007-64914785:+	0.27	4.44	1.12E-5	Arthritis (juvenile idiopathic)	
THCA	cis	1	rs941653	chr14:35592538	FAM177A1	chr14:35514113-35552587:+	-0.2	-3.83	0.000143	Atopic dermatitis	
THCA	cis	1	rs941653	chr14:35592538	KIAA0391	chr14:35591776-35786673:+	0.31	5.78	1.34E-8	Atopic dermatitis	
THCA	cis	1	rs941653	chr14:35592538	PPP2R3C	chr14:35554679-35591679:-	0.55	10.49	2.64E-23	Atopic dermatitis	
THCA	cis	1	rs9417261	chr10:38111769	LOC399744	chr10:38717074-38741080:+	0.3	4.17	3.57E-5	Obesity (extreme)	
THCA	cis	1	rs9417261	chr10:38111769	ZNF25	chr10:38238795-38265453:-	0.17	3.54	0.000432	Obesity (extreme)	
THCA	cis	1	rs9417263	chr10:38114690	LOC399744	chr10:38717074-38741080:+	0.29	4.03	6.53E-5	Obesity (extreme)	
THCA	cis	1	rs9417263	chr10:38114690	ZNF25	chr10:38238795-38265453:-	0.16	3.49	0.000527	Obesity (extreme)	
THCA	cis	1	rs9417264	chr10:38117570	LOC399744	chr10:38717074-38741080:+	0.29	4.03	6.53E-5	Obesity (extreme)	
THCA	cis	1	rs9417264	chr10:38117570	ZNF25	chr10:38238795-38265453:-	0.16	3.49	0.000527	Obesity (extreme)	
THCA	cis	1	rs9417268	chr10:38133194	LOC399744	chr10:38717074-38741080:+	0.3	4.2	3.24E-5	Obesity (extreme)	
THCA	cis	1	rs9417268	chr10:38133194	ZNF25	chr10:38238795-38265453:-	0.16	3.41	0.000695	Obesity (extreme)	
THCA	cis	1	rs9418288	chr10:38107136	LOC399744	chr10:38717074-38741080:+	0.31	4.27	2.34E-5	Obesity (extreme)	
THCA	cis	1	rs9418288	chr10:38107136	ZNF25	chr10:38238795-38265453:-	0.16	3.47	0.000575	Obesity (extreme)	
THCA	cis	1	rs9418289	chr10:38109805	LOC399744	chr10:38717074-38741080:+	0.31	4.3	2.09E-5	Obesity (extreme)	
THCA	cis	1	rs9418289	chr10:38109805	ZNF25	chr10:38238795-38265453:-	0.16	3.48	0.000541	Obesity (extreme)	
THCA	cis	1	rs9418294	chr10:38115586	LOC399744	chr10:38717074-38741080:+	0.31	4.27	2.34E-5	Obesity (extreme)	
THCA	cis	1	rs9418294	chr10:38115586	ZNF25	chr10:38238795-38265453:-	0.16	3.47	0.000575	Obesity (extreme)	
THCA	cis	1	rs9418298	chr10:38137236	LOC399744	chr10:38717074-38741080:+	0.29	4.05	5.92E-5	Obesity (extreme)	
THCA	cis	1	rs9418298	chr10:38137236	ZNF25	chr10:38238795-38265453:-	0.16	3.36	0.000843	Obesity (extreme)	
THCA	cis	1	rs9418299	chr10:38140227	LOC399744	chr10:38717074-38741080:+	0.3	4.18	3.42E-5	Obesity (extreme)	
THCA	cis	1	rs9418299	chr10:38140227	ZNF25	chr10:38238795-38265453:-	0.16	3.48	0.00054	Obesity (extreme)	
THCA	cis	1	rs941898	chr14:100599437	DEGS2	chr14:100612753-100626012:-	0.25	4.18	3.42E-5	White matter hyperintensity burden	
THCA	cis	1	rs9419897	chr10:102246125	SEC31B	chr10:102246403-102289636:-	-0.3	-10.05	1.12E-21	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs9420782	chr10:102235015	SEC31B	chr10:102246403-102289636:-	-0.3	-10.07	9.04E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs9420785	chr10:102240451	SEC31B	chr10:102246403-102289636:-	-0.3	-10.08	8.78E-22	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs9420797	chr10:102331147	SEC31B	chr10:102246403-102289636:-	-0.28	-9.17	1.44E-18	Palmitoleic acid (16:1n-7) plasma levels	
THCA	cis	1	rs9420	chr11:57510294	MED19	chr11:57471182-57479673:-	0.2	4.26	2.42E-5	Schizophrenia	
THCA	cis	1	rs9420	chr11:57510294	TIMM10	chr11:57295936-57298232:-	0.25	6.12	1.95E-9	Schizophrenia	
THCA	cis	1	rs942270	chr1:76177332	MSH4	chr1:76262630-76378923:+	0.25	4.19	3.35E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs9423239	chr10:124740727	C10orf88	chr10:124690419-124713919:-	0.2	3.63	0.000309	Migraine without aura	
THCA	cis	1	rs9423295	chr10:124733664	C10orf88	chr10:124690419-124713919:-	-0.2	-3.6	0.000353	Migraine without aura	
THCA	cis	1	rs9425766	chr1:173853127	SERPINC1	chr1:173872943-173886516:-	0.31	5.11	4.69E-7	Life satisfaction	
THCA	cis	1	rs9426935	chr1:153769400	CREB3L4	chr1:153940379-153946832:+	-0.28	-6.22	1.11E-9	Lentiform nucleus volume	
THCA	cis	1	rs942812	chr10:100153664	PYROXD2	chr10:100143323-100174978:-	0.53	5.39	1.11E-7	Aspartate aminotransferase	
THCA	cis	1	rs9429183	chr1:46524582	CCDC163P	chr1:45960581-45965646:-	-0.52	-10.27	1.71E-22	Body mass index	
THCA	cis	1	rs9429183	chr1:46524582	MMACHC	chr1:45965856-45976737:+	-0.21	-4.54	7.21E-6	Body mass index	
THCA	cis	1	rs9429183	chr1:46524582	MUTYH	chr1:45794915-45806142:-	0.29	7.56	2.09E-13	Body mass index	
THCA	cis	1	rs943060	chr13:24432088	C1QTNF9B	chr13:24465238-24471641:-	-0.35	-3.53	0.000449	3-hydroxypropylmercapturic acid levels in smokers	
THCA	cis	1	rs943125	chr10:91379546	FLJ37201	chr10:91451057-91457685:-	-0.18	-3.72	0.000225	Metabolic traits	
THCA	cis	1	rs9433030	chr1:86901465	CLCA2	chr1:86889769-86922238:+	-0.26	-4.13	4.28E-5	Crohn's disease-related phenotypes	
THCA	cis	1	rs9433030	chr1:86901465	ODF2L	chr1:86814412-86862003:-	-0.17	-3.86	0.000131	Crohn's disease-related phenotypes	
THCA	cis	1	rs943461	chr6:33769409	LEMD2	chr6:33738991-33756906:-	0.25	4.94	1.06E-6	Body mass index	
THCA	cis	1	rs943462	chr6:33769578	LEMD2	chr6:33738991-33756906:-	0.25	4.94	1.06E-6	Body mass index	
THCA	cis	1	rs943466	chr6:33731787	LEMD2	chr6:33738991-33756906:-	-0.2	-4.3	2.09E-5	Body mass index	
THCA	cis	1	rs943477	chr6:33750931	LEMD2	chr6:33738991-33756906:-	-0.31	-7.09	4.92E-12	Crohn's disease	
THCA	cis	1	rs9436116	chr1:150454724	CA14	chr1:150230218-150237476:+	0.15	3.7	0.000242	Morning vs. evening chronotype	
THCA	cis	1	rs9436116	chr1:150454724	MRPS21	chr1:150266269-150280818:+	0.12	3.9	0.000112	Morning vs. evening chronotype	
THCA	cis	1	rs944289	chr14:36649246	MBIP	chr14:36767764-36789882:-	0.15	3.79	0.000169	Thyroid cancer	
THCA	cis	1	rs944289	chr14:36649246	SFTA3	chr14:36942496-36988817:-	0.16	5.27	2.07E-7	Thyroid cancer	
THCA	cis	1	rs9450662	chr6:88088593	C6orf162	chr6:88032306-88052043:+	-0.18	-3.85	0.000137	Depressive episodes in bipolar disorder	
THCA	cis	1	rs9450662	chr6:88088593	C6orf164	chr6:88032306-88109459:+	-0.31	-5.82	1.08E-8	Depressive episodes in bipolar disorder	
THCA	cis	1	rs9450662	chr6:88088593	SLC35A1	chr6:88146444-88222051:+	0.17	3.34	0.000896	Depressive episodes in bipolar disorder	
THCA	cis	1	rs945635	chr1:157670290	FCRL3	chr1:157646278-157670775:-	0.28	8.97	6.69E-18	Type 1 diabetes autoantibodies	
THCA	cis	1	rs945961	chr20:33769926	PROCR	chr20:33758727-33765164:+	-0.31	-5.04	6.77E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs945961	chr20:33769926	TRPC4AP	chr20:33590215-33680618:-	0.32	3.95	9.07E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs945961	chr20:33769926	UQCC	chr20:33890383-33999833:-	-0.18	-3.36	0.000832	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs9460550	chr6:20719561	SOX4	chr6:21593972-21598847:+	-0.11	-3.37	0.000804	Type 2 diabetes	
THCA	cis	1	rs9461010	chr6:24440206	MRS2	chr6:24403153-24425809:+	-0.16	-4.52	7.83E-6	Liver enzyme levels	
THCA	cis	1	rs9461011	chr6:24440351	MRS2	chr6:24403153-24425809:+	0.15	4.14	4.13E-5	Liver enzyme levels	
THCA	cis	1	rs9461012	chr6:24441844	MRS2	chr6:24403153-24425809:+	0.16	4.43	1.16E-5	Liver enzyme levels	
THCA	cis	1	rs9461259	chr6:26504835	BTN2A3	chr6:26422317-26431927:+	0.2	4.64	4.57E-6	Educational attainment	
THCA	cis	1	rs9461259	chr6:26504835	HCG11	chr6:26521934-26527610:+	-0.23	-4.47	9.87E-6	Educational attainment	
THCA	cis	1	rs9461259	chr6:26504835	HMGN4	chr6:26538572-26547162:+	-0.16	-4.08	5.38E-5	Educational attainment	
THCA	cis	1	rs9461259	chr6:26504835	ZNF322A	chr6:26634612-26659963:-	-0.14	-3.78	0.000176	Educational attainment	
THCA	cis	1	rs9461271	chr6:26554968	BTN2A3	chr6:26422317-26431927:+	0.18	4.35	1.64E-5	Educational attainment	
THCA	cis	1	rs9461271	chr6:26554968	HCG11	chr6:26521934-26527610:+	-0.22	-4.27	2.41E-5	Educational attainment	
THCA	cis	1	rs9461271	chr6:26554968	HMGN4	chr6:26538572-26547162:+	-0.16	-4.03	6.61E-5	Educational attainment	
THCA	cis	1	rs9461271	chr6:26554968	LOC100270746	chr6:26987146-26988085:-	-0.15	-3.53	0.00046	Educational attainment	
THCA	cis	1	rs9461271	chr6:26554968	ZNF322A	chr6:26634612-26659963:-	-0.16	-4.53	7.46E-6	Educational attainment	
THCA	cis	1	rs9462007	chr6:34715341	C6orf106	chr6:34555066-34664625:-	0.21	3.49	0.000533	Pubertal anthropometrics	
THCA	cis	1	rs9462007	chr6:34715341	SNRPC	chr6:34725312-34741571:+	-0.14	-3.51	0.00049	Pubertal anthropometrics	
THCA	cis	1	rs9462016	chr6:34739790	C6orf106	chr6:34555066-34664625:-	0.21	3.54	0.000446	Pubertal anthropometrics	
THCA	cis	1	rs9462016	chr6:34739790	SNRPC	chr6:34725312-34741571:+	-0.15	-3.57	0.000386	Pubertal anthropometrics	
THCA	cis	1	rs9462083	chr6:35400907	TCP11	chr6:35085849-35109187:-	-0.24	-3.4	0.000725	Height	
THCA	cis	1	rs9463078	chr6:45181340	SUPT3H	chr6:44777054-45345670:-	-0.19	-4.09	5.08E-5	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	
THCA	cis	1	rs9463473	chr6:49380121	CENPQ	chr6:49431096-49460820:+	-0.27	-5.52	5.44E-8	Folate pathway vitamin levels	
THCA	cis	1	rs9463473	chr6:49380121	MUT	chr6:49398994-49431031:-	0.28	9.59	4.89E-20	Folate pathway vitamin levels	
THCA	cis	1	rs9463474	chr6:49380199	CENPQ	chr6:49431096-49460820:+	-0.27	-5.52	5.44E-8	Folate pathway vitamin levels	
THCA	cis	1	rs9463474	chr6:49380199	MUT	chr6:49398994-49431031:-	0.28	9.59	4.89E-20	Folate pathway vitamin levels	
THCA	cis	1	rs9463475	chr6:49380899	CENPQ	chr6:49431096-49460820:+	0.26	5.42	9.49E-8	Folate pathway vitamin levels	
THCA	cis	1	rs9463475	chr6:49380899	MUT	chr6:49398994-49431031:-	-0.28	-9.48	1.17E-19	Folate pathway vitamin levels	
THCA	cis	1	rs9463477	chr6:49386446	CENPQ	chr6:49431096-49460820:+	-0.26	-5.43	8.84E-8	Folate pathway vitamin levels	
THCA	cis	1	rs9463477	chr6:49386446	MUT	chr6:49398994-49431031:-	0.28	9.54	7.4E-20	Folate pathway vitamin levels	
THCA	cis	1	rs9463478	chr6:49386564	CENPQ	chr6:49431096-49460820:+	-0.32	-6.83	2.6E-11	Homocysteine levels	
THCA	cis	1	rs9463479	chr6:49393275	CENPQ	chr6:49431096-49460820:+	-0.26	-5.43	8.84E-8	Folate pathway vitamin levels	
THCA	cis	1	rs9463479	chr6:49393275	MUT	chr6:49398994-49431031:-	0.28	9.54	7.4E-20	Folate pathway vitamin levels	
THCA	cis	1	rs9463480	chr6:49400795	CENPQ	chr6:49431096-49460820:+	-0.26	-5.41	9.74E-8	Folate pathway vitamin levels	
THCA	cis	1	rs9463480	chr6:49400795	MUT	chr6:49398994-49431031:-	0.28	9.58	5.18E-20	Folate pathway vitamin levels	
THCA	cis	1	rs946529	chr1:46485548	CCDC163P	chr1:45960581-45965646:-	-0.53	-10.31	1.25E-22	Body mass index	
THCA	cis	1	rs946529	chr1:46485548	GPBP1L1	chr1:46092978-46152302:-	0.14	3.6	0.000358	Body mass index	
THCA	cis	1	rs946529	chr1:46485548	MMACHC	chr1:45965856-45976737:+	-0.21	-4.63	4.68E-6	Body mass index	
THCA	cis	1	rs946529	chr1:46485548	MUTYH	chr1:45794915-45806142:-	0.3	8.07	5.92E-15	Body mass index	
THCA	cis	1	rs9465871	chr6:20717255	SOX4	chr6:21593972-21598847:+	0.12	3.83	0.000147	Type 2 diabetes	
THCA	cis	1	rs9467157	chr6:24440644	MRS2	chr6:24403153-24425809:+	-0.16	-4.49	9.09E-6	Liver enzyme levels	
THCA	cis	1	rs9467158	chr6:24441215	MRS2	chr6:24403153-24425809:+	-0.16	-4.55	6.71E-6	Liver enzyme levels	
THCA	cis	1	rs9467160	chr6:24441746	MRS2	chr6:24403153-24425809:+	-0.16	-4.55	6.75E-6	Liver enzyme levels	
THCA	cis	1	rs9467161	chr6:24441963	MRS2	chr6:24403153-24425809:+	-0.16	-4.43	1.16E-5	Liver enzyme levels	
THCA	cis	1	rs9467162	chr6:24442047	MRS2	chr6:24403153-24425809:+	-0.16	-4.37	1.53E-5	Liver enzyme levels	
THCA	cis	1	rs9467166	chr6:24444435	MRS2	chr6:24403153-24425809:+	-0.16	-4.36	1.59E-5	Liver enzyme levels	
THCA	cis	1	rs9467176	chr6:24464907	GMNN	chr6:24775159-24786276:+	0.27	3.68	0.000263	Hematological and biochemical traits	
THCA	cis	1	rs9467176	chr6:24464907	GPLD1	chr6:24428405-24489850:-	-0.25	-4.78	2.32E-6	Hematological and biochemical traits	
THCA	cis	1	rs9467176	chr6:24464907	MRS2	chr6:24403153-24425809:+	-0.24	-5.5	6.15E-8	Hematological and biochemical traits	
THCA	cis	1	rs9467182	chr6:24468654	GMNN	chr6:24775159-24786276:+	-0.28	-3.74	0.000203	Hematological and biochemical traits	
THCA	cis	1	rs9467182	chr6:24468654	GPLD1	chr6:24428405-24489850:-	0.25	4.7	3.46E-6	Hematological and biochemical traits	
THCA	cis	1	rs9467182	chr6:24468654	MRS2	chr6:24403153-24425809:+	0.24	5.44	8.49E-8	Hematological and biochemical traits	
THCA	cis	1	rs9467190	chr6:24474771	GPLD1	chr6:24428405-24489850:-	0.2	3.76	0.000189	Hematological and biochemical traits	
THCA	cis	1	rs9467190	chr6:24474771	MRS2	chr6:24403153-24425809:+	0.24	5.5	6.33E-8	Hematological and biochemical traits	
THCA	cis	1	rs9467773	chr6:26498426	BTN2A3	chr6:26422317-26431927:+	0.19	4.54	7.18E-6	Educational attainment	
THCA	cis	1	rs9467773	chr6:26498426	HCG11	chr6:26521934-26527610:+	-0.23	-4.54	7.04E-6	Educational attainment	
THCA	cis	1	rs9467773	chr6:26498426	HMGN4	chr6:26538572-26547162:+	-0.16	-4	7.43E-5	Educational attainment	
THCA	cis	1	rs9467773	chr6:26498426	ZNF322A	chr6:26634612-26659963:-	-0.14	-3.79	0.000169	Educational attainment	
THCA	cis	1	rs9467774	chr6:26505036	BTN2A3	chr6:26422317-26431927:+	0.2	4.64	4.57E-6	Educational attainment	
THCA	cis	1	rs9467774	chr6:26505036	HCG11	chr6:26521934-26527610:+	-0.23	-4.47	9.87E-6	Educational attainment	
THCA	cis	1	rs9467774	chr6:26505036	HMGN4	chr6:26538572-26547162:+	-0.16	-4.08	5.38E-5	Educational attainment	
THCA	cis	1	rs9467774	chr6:26505036	ZNF322A	chr6:26634612-26659963:-	-0.14	-3.78	0.000176	Educational attainment	
THCA	cis	1	rs9467778	chr6:26534743	BTN2A3	chr6:26422317-26431927:+	0.19	4.52	7.72E-6	Educational attainment	
THCA	cis	1	rs9467778	chr6:26534743	HCG11	chr6:26521934-26527610:+	-0.23	-4.43	1.18E-5	Educational attainment	
THCA	cis	1	rs9467778	chr6:26534743	HMGN4	chr6:26538572-26547162:+	-0.16	-4.05	5.86E-5	Educational attainment	
THCA	cis	1	rs9467778	chr6:26534743	ZNF322A	chr6:26634612-26659963:-	-0.14	-3.77	0.000183	Educational attainment	
THCA	cis	1	rs9467779	chr6:26536687	BTN2A3	chr6:26422317-26431927:+	-0.18	-4.3	2.06E-5	Educational attainment	
THCA	cis	1	rs9467779	chr6:26536687	HCG11	chr6:26521934-26527610:+	0.22	4.36	1.57E-5	Educational attainment	
THCA	cis	1	rs9467779	chr6:26536687	HMGN4	chr6:26538572-26547162:+	0.16	4.06	5.83E-5	Educational attainment	
THCA	cis	1	rs9467779	chr6:26536687	ZNF322A	chr6:26634612-26659963:-	0.13	3.62	0.000321	Educational attainment	
THCA	cis	1	rs9467782	chr6:26542773	BTN2A3	chr6:26422317-26431927:+	0.18	4.31	1.98E-5	Educational attainment	
THCA	cis	1	rs9467782	chr6:26542773	HCG11	chr6:26521934-26527610:+	-0.22	-4.33	1.78E-5	Educational attainment	
THCA	cis	1	rs9467782	chr6:26542773	HMGN4	chr6:26538572-26547162:+	-0.16	-4.03	6.41E-5	Educational attainment	
THCA	cis	1	rs9467782	chr6:26542773	ZNF322A	chr6:26634612-26659963:-	-0.14	-3.91	0.000104	Educational attainment	
THCA	cis	1	rs9467783	chr6:26542894	BTN2A3	chr6:26422317-26431927:+	0.18	4.36	1.6E-5	Educational attainment	
THCA	cis	1	rs9467783	chr6:26542894	HCG11	chr6:26521934-26527610:+	-0.22	-4.3	2.03E-5	Educational attainment	
THCA	cis	1	rs9467783	chr6:26542894	HMGN4	chr6:26538572-26547162:+	-0.16	-3.96	8.63E-5	Educational attainment	
THCA	cis	1	rs9467783	chr6:26542894	ZNF322A	chr6:26634612-26659963:-	-0.14	-3.79	0.000171	Educational attainment	
THCA	cis	1	rs9467787	chr6:26556769	BTN2A3	chr6:26422317-26431927:+	0.18	4.36	1.63E-5	Educational attainment	
THCA	cis	1	rs9467787	chr6:26556769	HCG11	chr6:26521934-26527610:+	-0.22	-4.27	2.4E-5	Educational attainment	
THCA	cis	1	rs9467787	chr6:26556769	HMGN4	chr6:26538572-26547162:+	-0.16	-4.03	6.57E-5	Educational attainment	
THCA	cis	1	rs9467787	chr6:26556769	LOC100270746	chr6:26987146-26988085:-	-0.15	-3.53	0.000461	Educational attainment	
THCA	cis	1	rs9467787	chr6:26556769	ZNF322A	chr6:26634612-26659963:-	-0.16	-4.53	7.42E-6	Educational attainment	
THCA	cis	1	rs9467791	chr6:26562486	BTN2A3	chr6:26422317-26431927:+	-0.18	-4.24	2.68E-5	Educational attainment	
THCA	cis	1	rs9467791	chr6:26562486	HCG11	chr6:26521934-26527610:+	0.23	4.45	1.08E-5	Educational attainment	
THCA	cis	1	rs9467791	chr6:26562486	HMGN4	chr6:26538572-26547162:+	0.17	4.35	1.65E-5	Educational attainment	
THCA	cis	1	rs9467791	chr6:26562486	LOC100270746	chr6:26987146-26988085:-	0.15	3.59	0.000363	Educational attainment	
THCA	cis	1	rs9467791	chr6:26562486	ZNF322A	chr6:26634612-26659963:-	0.16	4.62	4.9E-6	Educational attainment	
THCA	cis	1	rs9467796	chr6:26568411	BTN2A3	chr6:26422317-26431927:+	0.17	4.13	4.22E-5	Educational attainment	
THCA	cis	1	rs9467796	chr6:26568411	HCG11	chr6:26521934-26527610:+	-0.21	-4.1	4.77E-5	Educational attainment	
THCA	cis	1	rs9467796	chr6:26568411	HMGN4	chr6:26538572-26547162:+	-0.16	-4.2	3.22E-5	Educational attainment	
THCA	cis	1	rs9467796	chr6:26568411	LOC100270746	chr6:26987146-26988085:-	-0.14	-3.44	0.000627	Educational attainment	
THCA	cis	1	rs9467796	chr6:26568411	ZNF322A	chr6:26634612-26659963:-	-0.16	-4.62	5.05E-6	Educational attainment	
THCA	cis	1	rs9467797	chr6:26568473	BTN2A3	chr6:26422317-26431927:+	0.17	4.13	4.22E-5	Educational attainment	
THCA	cis	1	rs9467797	chr6:26568473	HCG11	chr6:26521934-26527610:+	-0.21	-4.1	4.77E-5	Educational attainment	
THCA	cis	1	rs9467797	chr6:26568473	HMGN4	chr6:26538572-26547162:+	-0.16	-4.2	3.22E-5	Educational attainment	
THCA	cis	1	rs9467797	chr6:26568473	LOC100270746	chr6:26987146-26988085:-	-0.14	-3.44	0.000627	Educational attainment	
THCA	cis	1	rs9467797	chr6:26568473	ZNF322A	chr6:26634612-26659963:-	-0.16	-4.62	5.05E-6	Educational attainment	
THCA	cis	1	rs9468186	chr6:27626631	ZNF184	chr6:27418522-27440897:-	0.22	5.11	4.59E-7	Neuroticism	
THCA	cis	1	rs9468186	chr6:27626631	ZNF323	chr6:28292517-28324048:-	0.29	5.07	5.63E-7	Neuroticism	
THCA	cis	1	rs9468186	chr6:27626631	ZSCAN23	chr6:28393287-28411279:-	0.2	5.54	4.98E-8	Neuroticism	
THCA	cis	1	rs9469860	chr6:34724815	C6orf106	chr6:34555066-34664625:-	0.21	3.54	0.000446	Pubertal anthropometrics	
THCA	cis	1	rs9469860	chr6:34724815	SNRPC	chr6:34725312-34741571:+	-0.15	-3.57	0.000386	Pubertal anthropometrics	
THCA	cis	1	rs9469890	chr6:34763982	C6orf106	chr6:34555066-34664625:-	0.2	3.38	0.000796	Pubertal anthropometrics	
THCA	cis	1	rs9469890	chr6:34763982	SNRPC	chr6:34725312-34741571:+	-0.14	-3.47	0.000558	Pubertal anthropometrics	
THCA	cis	1	rs947211	chr1:205752665	PM20D1	chr1:205797154-205819245:-	-0.22	-3.66	0.000278	Parkinson's disease	
THCA	cis	1	rs947211	chr1:205752665	RAB7L1	chr1:205737115-205744610:-	0.24	6.43	3.17E-10	Parkinson's disease	
THCA	cis	1	rs9472414	chr6:44946506	SUPT3H	chr6:44777054-45345670:-	0.17	3.41	0.000708	Height	
THCA	cis	1	rs9472819	chr6:46653789	CYP39A1	chr6:46517445-46620523:-	0.32	5.08	5.39E-7	Lipoprotein-associated phospholipase A2 activity and mass	
THCA	cis	1	rs9473126	chr6:47481833	CD2AP	chr6:47445525-47594994:+	0.13	3.42	0.000676	Alzheimer's disease (late onset)	
THCA	cis	1	rs9473549	chr6:49380020	CENPQ	chr6:49431096-49460820:+	-0.27	-5.6	3.69E-8	Folate pathway vitamin levels	
THCA	cis	1	rs9473549	chr6:49380020	MUT	chr6:49398994-49431031:-	0.29	9.58	5.39E-20	Folate pathway vitamin levels	
THCA	cis	1	rs9473550	chr6:49385182	CENPQ	chr6:49431096-49460820:+	-0.29	-6.2	1.25E-9	Homocysteine levels	
THCA	cis	1	rs9473552	chr6:49387154	CENPQ	chr6:49431096-49460820:+	-0.26	-5.43	8.84E-8	Folate pathway vitamin levels	
THCA	cis	1	rs9473552	chr6:49387154	MUT	chr6:49398994-49431031:-	0.28	9.54	7.4E-20	Folate pathway vitamin levels	
THCA	cis	1	rs9473553	chr6:49395977	CENPQ	chr6:49431096-49460820:+	-0.26	-5.43	8.84E-8	Folate pathway vitamin levels	
THCA	cis	1	rs9473553	chr6:49395977	MUT	chr6:49398994-49431031:-	0.28	9.54	7.4E-20	Folate pathway vitamin levels	
THCA	cis	1	rs9473555	chr6:49409487	CENPQ	chr6:49431096-49460820:+	-0.26	-5.5	6.14E-8	Folate pathway vitamin levels	
THCA	cis	1	rs9473555	chr6:49409487	MUT	chr6:49398994-49431031:-	0.28	9.69	2.22E-20	Folate pathway vitamin levels	
THCA	cis	1	rs9473560	chr6:49427918	CENPQ	chr6:49431096-49460820:+	-0.27	-5.59	3.84E-8	Folate pathway vitamin levels	
THCA	cis	1	rs9473560	chr6:49427918	MUT	chr6:49398994-49431031:-	0.29	9.76	1.26E-20	Folate pathway vitamin levels	
THCA	cis	1	rs9473561	chr6:49428755	CENPQ	chr6:49431096-49460820:+	-0.26	-5.52	5.72E-8	Folate pathway vitamin levels	
THCA	cis	1	rs9473561	chr6:49428755	MUT	chr6:49398994-49431031:-	0.29	9.91	3.38E-21	Folate pathway vitamin levels	
THCA	cis	1	rs9473563	chr6:49453651	CENPQ	chr6:49431096-49460820:+	-0.27	-5.49	6.38E-8	Folate pathway vitamin levels	
THCA	cis	1	rs9473563	chr6:49453651	MUT	chr6:49398994-49431031:-	0.29	9.65	3.1E-20	Folate pathway vitamin levels	
THCA	cis	1	rs9474616	chr6:53517854	KLHL31	chr6:53512700-53530506:-	-0.27	-3.34	0.000889	Obesity-related traits	
THCA	cis	1	rs9475752	chr6:56780741	BEND6	chr6:56819773-56892138:+	-0.28	-6.32	5.95E-10	Menarche (age at onset)	
THCA	cis	1	rs9475752	chr6:56780741	KIAA1586	chr6:56911384-56920021:+	-0.3	-4.99	8.37E-7	Menarche (age at onset)	
THCA	cis	1	rs947583	chr6:136133659	C6orf217	chr6:135818939-136037192:+	-0.34	-8.95	7.77E-18	Phosphorus levels	
THCA	cis	1	rs947932	chr11:71656705	FAM86C	chr11:71498557-71512276:+	0.34	4.06	5.73E-5	Severe influenza A (H1N1) infection	
THCA	cis	1	rs9480933	chr6:109671391	AKD1	chr6:109814059-110012415:-	-0.34	-7.61	1.48E-13	Height	
THCA	cis	1	rs9480933	chr6:109671391	FIG4	chr6:110012424-110146634:+	-0.19	-3.86	0.000128	Height	
THCA	cis	1	rs9480933	chr6:109671391	SMPD2	chr6:109761931-109765121:+	0.32	8.04	7.2E-15	Height	
THCA	cis	1	rs9480953	chr6:109739144	AKD1	chr6:109814059-110012415:-	-0.34	-7.62	1.34E-13	Height	
THCA	cis	1	rs9480953	chr6:109739144	FIG4	chr6:110012424-110146634:+	-0.18	-3.72	0.000225	Height	
THCA	cis	1	rs9480953	chr6:109739144	SMPD2	chr6:109761931-109765121:+	0.34	8.55	1.72E-16	Height	
THCA	cis	1	rs9480955	chr6:109744533	AKD1	chr6:109814059-110012415:-	-0.34	-7.49	3.3E-13	Height	
THCA	cis	1	rs9480955	chr6:109744533	FIG4	chr6:110012424-110146634:+	-0.19	-3.87	0.000123	Height	
THCA	cis	1	rs9480955	chr6:109744533	SMPD2	chr6:109761931-109765121:+	0.34	8.53	1.89E-16	Height	
THCA	cis	1	rs9486044	chr6:105608645	BVES	chr6:105544700-105585049:-	0.22	3.83	0.000144	Multiple sclerosis	
THCA	cis	1	rs9486047	chr6:105621724	BVES	chr6:105544700-105585049:-	0.23	3.78	0.000179	Multiple sclerosis	
THCA	cis	1	rs948662	chr11:77979829	NARS2	chr11:78147017-78285909:-	-0.38	-6.87	2.01E-11	Testicular germ cell tumor	
THCA	cis	1	rs9487034	chr6:109605899	CD164	chr6:109687718-109703762:-	0.13	3.41	0.000702	Red blood cell traits	
THCA	cis	1	rs9487043	chr6:109610474	CD164	chr6:109687718-109703762:-	0.13	3.43	0.000644	Red blood cell traits	
THCA	cis	1	rs9487094	chr6:109742015	AKD1	chr6:109814059-110012415:-	-0.34	-7.55	2.2E-13	Height	
THCA	cis	1	rs9487094	chr6:109742015	FIG4	chr6:110012424-110146634:+	-0.19	-3.87	0.000125	Height	
THCA	cis	1	rs9487094	chr6:109742015	SMPD2	chr6:109761931-109765121:+	0.34	8.53	2.01E-16	Height	
THCA	cis	1	rs9487605	chr6:111582885	KIAA1919	chr6:111580482-111590259:+	-0.51	-11.32	1.71E-26	Inflammatory skin disease	
THCA	cis	1	rs949325	chr11:71729656	FAM86C	chr11:71498557-71512276:+	0.32	3.84	0.000137	Severe influenza A (H1N1) infection	
THCA	cis	1	rs9493438	chr6:133098349	C6orf192	chr6:133090507-133119747:-	-0.27	-4.23	2.8E-5	Type 2 diabetes nephropathy	
THCA	cis	1	rs9493443	chr6:133121349	C6orf192	chr6:133090507-133119747:-	-0.25	-4.14	4.1E-5	Type 2 diabetes nephropathy	
THCA	cis	1	rs9493444	chr6:133125320	C6orf192	chr6:133090507-133119747:-	-0.24	-4.01	6.96E-5	Type 2 diabetes nephropathy	
THCA	cis	1	rs9493445	chr6:133125409	C6orf192	chr6:133090507-133119747:-	-0.24	-4	7.46E-5	Type 2 diabetes nephropathy	
THCA	cis	1	rs9493446	chr6:133125643	C6orf192	chr6:133090507-133119747:-	-0.24	-4	7.46E-5	Type 2 diabetes nephropathy	
THCA	cis	1	rs9493454	chr6:133144629	C6orf192	chr6:133090507-133119747:-	0.24	3.99	7.73E-5	Type 2 diabetes nephropathy	
THCA	cis	1	rs9494145	chr6:135432552	ALDH8A1	chr6:135238529-135271244:-	-0.27	-3.96	8.78E-5	Fetal hemoglobin levels in sickle cell anemia;Platelet count;Mean platelet volume;Red blood cell traits	
THCA	cis	1	rs9500028	chr6:105543946	BVES	chr6:105544700-105585049:-	0.26	4.45	1.05E-5	Multiple sclerosis	
THCA	cis	1	rs9500044	chr6:105608979	BVES	chr6:105544700-105585049:-	-0.23	-3.84	0.000139	Multiple sclerosis	
THCA	cis	1	rs9500256	chr6:58308955	GUSBL2	chr6:58246159-58287724:-	-0.38	-7.73	6.47E-14	Eosinophilic esophagitis (pediatric)	
THCA	cis	1	rs950027	chr15:45801035	DUOX1	chr15:45422192-45457774:+	-0.11	-3.65	0.000294	Response to fenofibrate (adiponectin levels)	
THCA	cis	1	rs950027	chr15:45801035	DUOXA1	chr15:45409688-45422075:-	-0.13	-4.34	1.71E-5	Response to fenofibrate (adiponectin levels)	
THCA	cis	1	rs950027	chr15:45801035	GATM	chr15:45653324-45670980:-	0.14	3.49	0.000535	Response to fenofibrate (adiponectin levels)	
THCA	cis	1	rs950027	chr15:45801035	SPATA5L1	chr15:45694519-45713614:+	-0.43	-8.67	6.83E-17	Response to fenofibrate (adiponectin levels)	
THCA	cis	1	rs950169	chr15:84706461	GOLGA6L5	chr15:85047738-85060078:-	-0.21	-5.26	2.17E-7	Schizophrenia	
THCA	cis	1	rs950169	chr15:84706461	LOC388152	chr15:84867600-84898920:-	-0.74	-13.29	1.61E-34	Schizophrenia	
THCA	cis	1	rs950169	chr15:84706461	NMB	chr15:85198362-85201802:-	0.24	4.68	3.68E-6	Schizophrenia	
THCA	cis	1	rs950169	chr15:84706461	SH3GL3	chr15:84116091-84287491:+	0.25	3.84	0.00014	Schizophrenia	
THCA	cis	1	rs9510907	chr13:24435564	C1QTNF9B	chr13:24465238-24471641:-	-0.35	-3.53	0.00045	3-hydroxypropylmercapturic acid levels in smokers	
THCA	cis	1	rs9510908	chr13:24435768	C1QTNF9B	chr13:24465238-24471641:-	-0.35	-3.53	0.00045	3-hydroxypropylmercapturic acid levels in smokers	
THCA	cis	1	rs9510910	chr13:24437265	C1QTNF9B	chr13:24465238-24471641:-	-0.33	-3.58	0.000378	3-hydroxypropylmercapturic acid levels in smokers	
THCA	cis	1	rs9510913	chr13:24440550	C1QTNF9B	chr13:24465238-24471641:-	0.35	3.65	0.000293	3-hydroxypropylmercapturic acid levels in smokers	
THCA	cis	1	rs9510920	chr13:24447172	C1QTNF9B	chr13:24465238-24471641:-	0.35	3.65	0.000293	3-hydroxypropylmercapturic acid levels in smokers	
THCA	cis	1	rs9512760	chr13:28173662	POLR1D	chr13:28194895-28241547:+	0.16	3.71	0.000231	Large B-cell lymphoma	
THCA	cis	1	rs951366	chr1:205685352	FAM72A	chr1:206138911-206155066:+	-0.16	-3.41	0.000697	Menarche (age at onset)	
THCA	cis	1	rs951366	chr1:205685352	PM20D1	chr1:205797154-205819245:-	-0.34	-5.95	5.22E-9	Menarche (age at onset)	
THCA	cis	1	rs951366	chr1:205685352	RAB7L1	chr1:205737115-205744610:-	0.32	9.22	9.21E-19	Menarche (age at onset)	
THCA	cis	1	rs9515201	chr13:111040798	CARKD	chr13:111267881-111292340:+	0.14	3.75	0.000202	White matter hyperintensity burden	
THCA	cis	1	rs9516228	chr13:94038194	GPC6	chr13:93879078-95060267:+	-0.26	-3.42	0.000679	Neuroticism	
THCA	cis	1	rs9516537	chr13:95864160	ABCC4	chr13:95672084-95953687:-	-0.2	-3.79	0.000172	Breast cancer	
THCA	cis	1	rs9524029	chr13:94029148	GPC6	chr13:93879078-95060267:+	-0.27	-3.49	0.000526	Neuroticism	
THCA	cis	1	rs9524038	chr13:94038182	GPC6	chr13:93879078-95060267:+	-0.28	-3.7	0.000239	Neuroticism	
THCA	cis	1	rs9524039	chr13:94038262	GPC6	chr13:93879078-95060267:+	-0.26	-3.42	0.000679	Neuroticism	
THCA	cis	1	rs9524833	chr13:95866614	ABCC4	chr13:95672084-95953687:-	-0.19	-3.64	0.000303	Breast cancer	
THCA	cis	1	rs9524835	chr13:95867629	ABCC4	chr13:95672084-95953687:-	-0.19	-3.64	0.000302	Breast cancer	
THCA	cis	1	rs9524836	chr13:95867632	ABCC4	chr13:95672084-95953687:-	-0.19	-3.64	0.000302	Breast cancer	
THCA	cis	1	rs9524840	chr13:95870922	ABCC4	chr13:95672084-95953687:-	-0.18	-3.53	0.000449	Breast cancer	
THCA	cis	1	rs9524845	chr13:95878641	ABCC4	chr13:95672084-95953687:-	-0.18	-3.35	0.000867	Breast cancer	
THCA	cis	1	rs9524850	chr13:95882812	ABCC4	chr13:95672084-95953687:-	-0.19	-3.52	0.000465	Breast cancer	
THCA	cis	1	rs9527	chr10:104623578	AS3MT	chr10:104613967-104661653:+	-0.26	-4.63	4.69E-6	Arsenic metabolism	
THCA	cis	1	rs9527	chr10:104623578	C10orf32	chr10:104613967-104624718:+	-0.51	-13.48	2.61E-35	Arsenic metabolism	
THCA	cis	1	rs9531455	chr13:36685304	SOHLH2	chr13:36742347-36871992:-	0.32	4.34	1.72E-5	Optic cup area	
THCA	cis	1	rs9533900	chr13:45116132	CCDC122	chr13:44410491-44453826:-	0.32	3.52	0.00047	Antineutrophil cytoplasmic antibody-associated vasculitis	
THCA	cis	1	rs9533901	chr13:45116611	CCDC122	chr13:44410491-44453826:-	0.32	3.52	0.00047	Antineutrophil cytoplasmic antibody-associated vasculitis	
THCA	cis	1	rs9533907	chr13:45131721	CCDC122	chr13:44410491-44453826:-	0.32	3.52	0.00047	Antineutrophil cytoplasmic antibody-associated vasculitis	
THCA	cis	1	rs9544611	chr13:78400617	EDNRB	chr13:78469616-78549664:-	0.14	4.03	6.5E-5	Hair color	
THCA	cis	1	rs9546421	chr13:36690750	SOHLH2	chr13:36742347-36871992:-	0.34	4.51	8.24E-6	Optic cup area	
THCA	cis	1	rs9546430	chr13:36692673	SOHLH2	chr13:36742347-36871992:-	0.34	4.56	6.52E-6	Optic cup area	
THCA	cis	1	rs9546434	chr13:36694391	SOHLH2	chr13:36742347-36871992:-	0.34	4.58	6.02E-6	Optic cup area	
THCA	cis	1	rs955196	chr6:86729951	SNHG5	chr6:86386726-86388451:-	0.49	10.77	2.23E-24	Response to antipsychotic treatment	
THCA	cis	1	rs955197	chr6:86729675	SNHG5	chr6:86386726-86388451:-	-0.49	-10.84	1.25E-24	Response to antipsychotic treatment	
THCA	cis	1	rs955227	chr6:86651032	SNHG5	chr6:86386726-86388451:-	-0.51	-11.15	8.37E-26	Response to antipsychotic treatment	
THCA	cis	1	rs9553082	chr13:24433244	C1QTNF9B	chr13:24465238-24471641:-	-0.35	-3.52	0.000479	3-hydroxypropylmercapturic acid levels in smokers	
THCA	cis	1	rs9561336	chr13:94034140	GPC6	chr13:93879078-95060267:+	0.27	3.64	0.000299	Neuroticism	
THCA	cis	1	rs9561347	chr13:94077228	GPC6	chr13:93879078-95060267:+	-0.27	-3.6	0.000346	Neuroticism	
THCA	cis	1	rs9565369	chr13:78399695	EDNRB	chr13:78469616-78549664:-	0.13	3.85	0.000135	Hair color	
THCA	cis	1	rs9566017	chr13:85664694	SLITRK6	chr13:86366922-86373483:-	-0.21	-3.79	0.000172	Bipolar disorder (mania)	
THCA	cis	1	rs9566020	chr13:85671944	SLITRK6	chr13:86366922-86373483:-	-0.24	-5.11	4.62E-7	Bipolar disorder (mania)	
THCA	cis	1	rs9566021	chr13:85675548	SLITRK6	chr13:86366922-86373483:-	-0.2	-3.66	0.000279	Bipolar disorder (mania)	
THCA	cis	1	rs9566029	chr13:85706065	SLITRK6	chr13:86366922-86373483:-	-0.21	-3.74	0.000203	Bipolar disorder (mania)	
THCA	cis	1	rs9566031	chr13:85715015	SLITRK6	chr13:86366922-86373483:-	-0.21	-3.75	0.000196	Bipolar disorder (mania)	
THCA	cis	1	rs9566035	chr13:85721640	SLITRK6	chr13:86366922-86373483:-	-0.21	-3.85	0.000135	Bipolar disorder (mania)	
THCA	cis	1	rs9566042	chr13:85752762	SLITRK6	chr13:86366922-86373483:-	-0.2	-3.91	0.000107	Bipolar disorder (mania)	
THCA	cis	1	rs9566043	chr13:85758591	SLITRK6	chr13:86366922-86373483:-	-0.2	-3.91	0.000107	Bipolar disorder (mania)	
THCA	cis	1	rs9566044	chr13:85758871	SLITRK6	chr13:86366922-86373483:-	0.19	3.76	0.000188	Bipolar disorder (mania)	
THCA	cis	1	rs9566046	chr13:85761116	SLITRK6	chr13:86366922-86373483:-	-0.21	-4.02	6.84E-5	Bipolar disorder (mania)	
THCA	cis	1	rs9568274	chr13:50179334	KPNA3	chr13:50273443-50367057:-	0.21	3.38	0.000783	Multiple sclerosis	
THCA	cis	1	rs9568281	chr13:50185204	KPNA3	chr13:50273443-50367057:-	0.21	3.46	0.000583	Multiple sclerosis	
THCA	cis	1	rs9573967	chr13:77565139	CLN5	chr13:77566059-77576651:+	-0.28	-3.52	0.000474	Morning vs. evening chronotype	
THCA	cis	1	rs9573968	chr13:77565259	CLN5	chr13:77566059-77576651:+	-0.28	-3.52	0.000474	Morning vs. evening chronotype	
THCA	cis	1	rs9573969	chr13:77565308	CLN5	chr13:77566059-77576651:+	-0.28	-3.52	0.000474	Morning vs. evening chronotype	
THCA	cis	1	rs9573973	chr13:77573660	CLN5	chr13:77566059-77576651:+	-0.28	-3.38	0.000779	Morning vs. evening chronotype	
THCA	cis	1	rs9573974	chr13:77575137	CLN5	chr13:77566059-77576651:+	-0.27	-3.39	0.000765	Morning vs. evening chronotype	
THCA	cis	1	rs9574111	chr13:78395696	EDNRB	chr13:78469616-78549664:-	0.14	4.03	6.44E-5	Hair color	
THCA	cis	1	rs9575763	chr13:85659922	SLITRK6	chr13:86366922-86373483:-	-0.21	-3.88	0.000119	Bipolar disorder (mania)	
THCA	cis	1	rs9575764	chr13:85664467	SLITRK6	chr13:86366922-86373483:-	0.22	4.03	6.56E-5	Bipolar disorder (mania)	
THCA	cis	1	rs9575766	chr13:85687070	SLITRK6	chr13:86366922-86373483:-	-0.21	-3.79	0.000171	Bipolar disorder (mania)	
THCA	cis	1	rs9575769	chr13:85693761	SLITRK6	chr13:86366922-86373483:-	-0.21	-3.79	0.000171	Bipolar disorder (mania)	
THCA	cis	1	rs9575771	chr13:85694119	SLITRK6	chr13:86366922-86373483:-	-0.19	-3.36	0.000848	Bipolar disorder (mania)	
THCA	cis	1	rs9575794	chr13:85730038	SLITRK6	chr13:86366922-86373483:-	-0.22	-4.56	6.4E-6	Bipolar disorder (mania)	
THCA	cis	1	rs9575795	chr13:85731131	SLITRK6	chr13:86366922-86373483:-	-0.2	-3.9	0.000109	Bipolar disorder (mania)	
THCA	cis	1	rs9575800	chr13:85743401	SLITRK6	chr13:86366922-86373483:-	-0.21	-3.97	8.27E-5	Bipolar disorder (mania)	
THCA	cis	1	rs9575802	chr13:85745299	SLITRK6	chr13:86366922-86373483:-	-0.2	-3.91	0.000107	Bipolar disorder (mania)	
THCA	cis	1	rs9575805	chr13:85752303	SLITRK6	chr13:86366922-86373483:-	-0.2	-3.75	0.000196	Bipolar disorder (mania)	
THCA	cis	1	rs9575807	chr13:85756678	SLITRK6	chr13:86366922-86373483:-	-0.2	-3.91	0.000107	Bipolar disorder (mania)	
THCA	cis	1	rs9575808	chr13:85756946	SLITRK6	chr13:86366922-86373483:-	-0.2	-3.91	0.000107	Bipolar disorder (mania)	
THCA	cis	1	rs9575813	chr13:85760513	SLITRK6	chr13:86366922-86373483:-	-0.2	-3.88	0.000119	Bipolar disorder (mania)	
THCA	cis	1	rs9575814	chr13:85761093	SLITRK6	chr13:86366922-86373483:-	-0.22	-3.98	7.91E-5	Bipolar disorder (mania)	
THCA	cis	1	rs9575815	chr13:85761183	SLITRK6	chr13:86366922-86373483:-	-0.22	-3.98	7.91E-5	Bipolar disorder (mania)	
THCA	cis	1	rs9575820	chr13:85764196	SLITRK6	chr13:86366922-86373483:-	0.22	3.93	9.81E-5	Bipolar disorder (mania)	
THCA	cis	1	rs9575822	chr13:85767570	SLITRK6	chr13:86366922-86373483:-	-0.22	-4.11	4.67E-5	Bipolar disorder (mania)	
THCA	cis	1	rs9575827	chr13:85772949	SLITRK6	chr13:86366922-86373483:-	-0.21	-3.85	0.000136	Bipolar disorder (mania)	
THCA	cis	1	rs9575830	chr13:85774959	SLITRK6	chr13:86366922-86373483:-	-0.23	-4.32	1.9E-5	Bipolar disorder (mania)	
THCA	cis	1	rs9575831	chr13:85778369	SLITRK6	chr13:86366922-86373483:-	-0.23	-4.4	1.33E-5	Bipolar disorder (mania)	
THCA	cis	1	rs9575832	chr13:85782931	SLITRK6	chr13:86366922-86373483:-	-0.22	-3.91	0.000105	Bipolar disorder (mania)	
THCA	cis	1	rs957644	chr1:165616157	ALDH9A1	chr1:165631449-165667900:-	0.12	3.37	0.000805	Total ventricular volume	
THCA	cis	1	rs957644	chr1:165616157	MGST3	chr1:165600450-165624853:+	0.15	3.8	0.000167	Total ventricular volume	
THCA	cis	1	rs957788	chr13:108257220	FAM155A	chr13:107820880-108519460:-	-0.2	-3.34	0.000899	Anorexia nervosa	
THCA	cis	1	rs9578	chr1:29445598	MECR	chr1:29519385-29557454:-	0.16	3.77	0.000185	Amyotrophic lateral sclerosis (sporadic)	
THCA	cis	1	rs9579094	chr13:28081495	MTIF3	chr13:28009783-28024711:-	0.19	3.6	0.000352	Weight	
THCA	cis	1	rs9579095	chr13:28082555	MTIF3	chr13:28009783-28024711:-	0.19	3.6	0.000352	Weight	
THCA	cis	1	rs9579096	chr13:28084069	MTIF3	chr13:28009783-28024711:-	0.19	3.6	0.000352	Weight	
THCA	cis	1	rs9581869	chr13:28082498	MTIF3	chr13:28009783-28024711:-	0.19	3.59	0.000369	Weight	
THCA	cis	1	rs9581870	chr13:28083957	MTIF3	chr13:28009783-28024711:-	0.16	3.44	0.000633	Weight	
THCA	cis	1	rs9581871	chr13:28085767	MTIF3	chr13:28009783-28024711:-	0.17	3.48	0.000545	Weight	
THCA	cis	1	rs9581872	chr13:28086058	MTIF3	chr13:28009783-28024711:-	0.18	3.58	0.000375	Weight	
THCA	cis	1	rs9581876	chr13:28101113	MTIF3	chr13:28009783-28024711:-	0.19	3.69	0.000251	Weight	
THCA	cis	1	rs9581877	chr13:28104321	MTIF3	chr13:28009783-28024711:-	0.18	3.63	0.000312	Weight	
THCA	cis	1	rs9581878	chr13:28104552	MTIF3	chr13:28009783-28024711:-	0.18	3.63	0.000312	Weight	
THCA	cis	1	rs9581881	chr13:28106637	MTIF3	chr13:28009783-28024711:-	0.18	3.63	0.000312	Weight	
THCA	cis	1	rs9581882	chr13:28110682	MTIF3	chr13:28009783-28024711:-	0.18	3.63	0.000309	Weight	
THCA	cis	1	rs958283	chr6:151887150	C6orf97	chr6:151815175-151942327:+	0.34	4.74	2.77E-6	Bone mineral density (spine)	
THCA	cis	1	rs958550	chr7:65635679	CCT6P1	chr7:65216092-65228661:+	-0.4	-6.31	6.31E-10	Diabetic kidney disease	
THCA	cis	1	rs958550	chr7:65635679	CRCP	chr7:65579805-65619551:+	0.28	4.34	1.76E-5	Diabetic kidney disease	
THCA	cis	1	rs958550	chr7:65635679	RABGEF1	chr7:66093890-66276446:+	-0.47	-5.76	1.54E-8	Diabetic kidney disease	
THCA	cis	1	rs9591134	chr13:33148216	N4BP2L2	chr13:33006930-33112936:-	0.26	7.7	7.67E-14	Body mass index	
THCA	cis	1	rs9591143	chr13:33159438	CG030	chr13:33078645-33083532:-	-0.12	-3.42	0.000689	Body mass index	
THCA	cis	1	rs9591143	chr13:33159438	N4BP2L2	chr13:33006930-33112936:-	0.26	7.75	5.54E-14	Body mass index	
THCA	cis	1	rs9591145	chr13:33161459	CG030	chr13:33078645-33083532:-	-0.12	-3.36	0.000847	Body mass index	
THCA	cis	1	rs9591145	chr13:33161459	N4BP2L2	chr13:33006930-33112936:-	0.26	7.59	1.72E-13	Body mass index	
THCA	cis	1	rs9591165	chr13:33185153	N4BP2L2	chr13:33006930-33112936:-	0.28	8.4	5.24E-16	Body mass index	
THCA	cis	1	rs9593992	chr13:85727941	SLITRK6	chr13:86366922-86373483:-	-0.2	-3.89	0.000115	Bipolar disorder (mania)	
THCA	cis	1	rs9593	chr12:109994870	KCTD10	chr12:109886460-109915155:-	-0.23	-6.05	2.99E-9	HDL cholesterol	
THCA	cis	1	rs9595905	chr13:33183403	N4BP2L2	chr13:33006930-33112936:-	0.28	8.4	4.99E-16	Body mass index	
THCA	cis	1	rs9595908	chr13:33184288	N4BP2L2	chr13:33006930-33112936:-	0.27	7.82	3.5E-14	Body mass index	
THCA	cis	1	rs959617	chr1:165616881	ALDH9A1	chr1:165631449-165667900:-	0.13	3.59	0.000369	Total ventricular volume	
THCA	cis	1	rs959617	chr1:165616881	MGST3	chr1:165600450-165624853:+	0.15	3.59	0.000369	Total ventricular volume	
THCA	cis	1	rs9606830	chr22:31717799	RNF185	chr22:31556138-31603004:+	0.24	4.45	1.06E-5	Paclitaxel-induced neuropathy	
THCA	cis	1	rs9606831	chr22:31732512	RNF185	chr22:31556138-31603004:+	0.26	4.88	1.43E-6	Paclitaxel-induced neuropathy	
THCA	cis	1	rs9607566	chr22:39075434	JOSD1	chr22:39081549-39096459:-	-0.14	-3.76	0.000189	Resting heart rate	
THCA	cis	1	rs9607566	chr22:39075434	LOC646851	chr22:38974125-39052634:-	0.13	3.42	0.000677	Resting heart rate	
THCA	cis	1	rs9607566	chr22:39075434	TOMM22	chr22:39077954-39080763:+	-0.16	-3.37	0.000816	Resting heart rate	
THCA	cis	1	rs9609254	chr22:31705942	RNF185	chr22:31556138-31603004:+	0.25	4.67	3.86E-6	Paclitaxel-induced neuropathy	
THCA	cis	1	rs9609264	chr22:31746719	RNF185	chr22:31556138-31603004:+	0.24	4.48	9.47E-6	Paclitaxel-induced neuropathy	
THCA	cis	1	rs9609527	chr22:32795751	C22orf28	chr22:32783562-32808274:-	0.18	3.34	0.000894	IgG glycosylation	
THCA	cis	1	rs9610986	chr22:39025277	JOSD1	chr22:39081549-39096459:-	-0.16	-4.26	2.45E-5	Resting heart rate	
THCA	cis	1	rs9610986	chr22:39025277	LOC646851	chr22:38974125-39052634:-	0.13	3.4	0.000739	Resting heart rate	
THCA	cis	1	rs9610986	chr22:39025277	TOMM22	chr22:39077954-39080763:+	-0.17	-3.84	0.000142	Resting heart rate	
THCA	cis	1	rs9610993	chr22:39042818	JOSD1	chr22:39081549-39096459:-	-0.15	-3.94	9.33E-5	Resting heart rate	
THCA	cis	1	rs9610993	chr22:39042818	TOMM22	chr22:39077954-39080763:+	-0.16	-3.58	0.000379	Resting heart rate	
THCA	cis	1	rs9620326	chr22:24146629	C22orf43	chr22:23950640-23974487:-	0.23	3.72	0.000221	IgG glycosylation	
THCA	cis	1	rs9621346	chr22:32230185	SFI1	chr22:31892261-32014533:+	0.22	4.13	4.25E-5	Intelligence	
THCA	cis	1	rs9622833	chr22:39000397	JOSD1	chr22:39081549-39096459:-	-0.14	-3.76	0.000191	Resting heart rate	
THCA	cis	1	rs9622833	chr22:39000397	LOC646851	chr22:38974125-39052634:-	0.13	3.52	0.00047	Resting heart rate	
THCA	cis	1	rs9622833	chr22:39000397	TOMM22	chr22:39077954-39080763:+	-0.16	-3.57	0.000398	Resting heart rate	
THCA	cis	1	rs962366	chr8:11684403	CTSB	chr8:11700036-11725646:-	-0.18	-4.21	3.05E-5	Non-alcoholic fatty liver disease histology (lobular);Non-alcoholic fatty liver disease histology (other)	
THCA	cis	1	rs9624326	chr22:24135043	C22orf43	chr22:23950640-23974487:-	-0.23	-3.63	0.000318	IgG glycosylation	
THCA	cis	1	rs9624447	chr22:24681555	CYTSA	chr22:24666786-24813707:+	-0.15	-3.74	0.000206	Gut microbiome composition (summer)	
THCA	cis	1	rs9624447	chr22:24681555	GGT5	chr22:24615623-24641110:-	-0.2	-4.24	2.71E-5	Gut microbiome composition (summer)	
THCA	cis	1	rs9624447	chr22:24681555	POM121L9P	chr22:24647589-24661490:+	-0.41	-9.35	3.48E-19	Gut microbiome composition (summer)	
THCA	cis	1	rs962856	chr2:67593803	ETAA1	chr2:67624442-67637533:+	-0.17	-4.03	6.58E-5	Pancreatic cancer	
THCA	cis	1	rs962888	chr17:43059071	C17orf104	chr17:42733982-42755658:+	0.19	3.36	0.000832	White matter hyperintensity burden	
THCA	cis	1	rs962888	chr17:43059071	DBF4B	chr17:42785976-42829631:+	0.19	4.7	3.39E-6	White matter hyperintensity burden	
THCA	cis	1	rs9629901	chr10:54349425	DKK1	chr10:54074041-54077416:+	-0.29	-5.2	3.01E-7	Metabolite levels  (X-11787)	
THCA	cis	1	rs9635063	chr13:85680734	SLITRK6	chr13:86366922-86373483:-	-0.21	-3.79	0.000171	Bipolar disorder (mania)	
THCA	cis	1	rs9635251	chr14:65928468	LOC645431	chr14:65877313-65879335:-	-0.59	-7.8	4.04E-14	Ischemic stroke	
THCA	cis	1	rs9635324	chr15:40703211	C15orf23	chr15:40674922-40686488:+	-0.25	-4.98	8.8E-7	Blood metabolite levels;Blood metabolite ratios	
THCA	cis	1	rs9635324	chr15:40703211	DISP2	chr15:40650434-40663256:+	0.3	5.58	4.08E-8	Blood metabolite levels;Blood metabolite ratios	
THCA	cis	1	rs9636202	chr19:18449238	PGPEP1	chr19:18451408-18480763:+	0.21	4.13	4.35E-5	Life satisfaction	
THCA	cis	1	rs9638180	chr7:72998952	MLXIPL	chr7:73007524-73038870:-	0.24	4.39	1.38E-5	Triglycerides	
THCA	cis	1	rs9638182	chr7:72999105	MLXIPL	chr7:73007524-73038870:-	0.23	4.29	2.13E-5	Triglycerides	
THCA	cis	1	rs9642699	chr8:32414614	NRG1	chr8:31497268-32622558:+	0.62	10.14	4.97E-22	Thyroid hormone levels	
THCA	cis	1	rs9642728	chr8:32430690	NRG1	chr8:31497268-32622558:+	0.58	9.08	2.9E-18	Thyroid hormone levels	
THCA	cis	1	rs9645990	chr13:45130934	CCDC122	chr13:44410491-44453826:-	0.32	3.52	0.00047	Antineutrophil cytoplasmic antibody-associated vasculitis	
THCA	cis	1	rs9647448	chr4:18005250	DCAF16	chr4:17802280-17812381:-	-0.22	-4.39	1.37E-5	Height	
THCA	cis	1	rs9647603	chr6:86639341	SNHG5	chr6:86386726-86388451:-	-0.53	-12.62	1.01E-31	Response to antipsychotic treatment	
THCA	cis	1	rs9650183	chr8:57156676	LYN	chr8:56792386-56923936:+	-0.15	-3.7	0.000236	Height	
THCA	cis	1	rs9650184	chr8:57156686	LYN	chr8:56792386-56923936:+	-0.15	-3.71	0.000231	Height	
THCA	cis	1	rs9650199	chr8:61346197	CA8	chr8:61101423-61193954:-	0.28	3.72	0.000223	Response to amphetamines	
THCA	cis	1	rs9651681	chr11:116778065	PCSK7	chr11:117075789-117102811:-	0.43	5.27	2.03E-7	Infantile hypertrophic pyloric stenosis	
THCA	cis	1	rs9651768	chr11:77996020	NARS2	chr11:78147017-78285909:-	-0.36	-6.9	1.69E-11	Testicular germ cell tumor	
THCA	cis	1	rs9651769	chr11:77996166	NARS2	chr11:78147017-78285909:-	-0.38	-6.94	1.28E-11	Testicular germ cell tumor	
THCA	cis	1	rs9653557	chr2:73795962	ALMS1P	chr2:73872046-73912692:+	0.75	11.51	3.12E-27	Metabolite levels	
THCA	cis	1	rs9653557	chr2:73795962	NAT8	chr2:73867850-73869537:-	0.42	6.5	1.99E-10	Metabolite levels	
THCA	cis	1	rs965469	chr20:3381549	ITPA	chr20:3190056-3204504:+	-0.24	-5.92	6.2E-9	IFN-related cytopenia	
THCA	cis	1	rs965513	chr9:100556109	C9orf156	chr9:100666772-100684852:-	0.13	3.65	0.000295	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	cis	1	rs9655607	chr7:151114229	CRYGN	chr7:151127057-151137899:-	0.15	3.65	0.000289	Coronary heart disease	
THCA	cis	1	rs9655613	chr7:151713518	LOC100128822	chr7:152161209-152162628:+	0.15	3.36	0.000835	Kidney function decline traits	
THCA	cis	1	rs9655954	chr7:87438081	DBF4	chr7:87505544-87538856:+	-0.28	-3.82	0.000149	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs9655955	chr7:87505430	DBF4	chr7:87505544-87538856:+	-0.28	-4.13	4.22E-5	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs966121	chr1:234982074	TBCE	chr1:235530728-235612280:+	-0.19	-3.62	0.000324	HIV-1 control	
THCA	cis	1	rs9661504	chr1:205915667	PM20D1	chr1:205797154-205819245:-	0.25	4.44	1.13E-5	Cystic fibrosis-related diabetes	
THCA	cis	1	rs9662166	chr1:76235906	ACADM	chr1:76190043-76229353:+	0.13	3.61	0.000343	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs9662166	chr1:76235906	MSH4	chr1:76262630-76378923:+	0.26	4.36	1.57E-5	Blood metabolite levels;Acylcarnitine levels	
THCA	cis	1	rs9662221	chr1:205915745	PM20D1	chr1:205797154-205819245:-	0.24	4.29	2.17E-5	Cystic fibrosis-related diabetes	
THCA	cis	1	rs9665468	chr10:75938838	VCL	chr10:75754951-75879912:+	-0.22	-3.96	8.5E-5	Soluble interleukin-2 receptor subunit alpha	
THCA	cis	1	rs9665626	chr10:104300638	ARL3	chr10:104433490-104474190:-	0.31	4.96	9.94E-7	Schizophrenia	
THCA	cis	1	rs9665626	chr10:104300638	C10orf26	chr10:104503727-104591851:+	0.25	4.47	9.82E-6	Schizophrenia	
THCA	cis	1	rs9665626	chr10:104300638	SFXN2	chr10:104474298-104498946:+	0.32	3.95	8.86E-5	Schizophrenia	
THCA	cis	1	rs9665626	chr10:104300638	TMEM180	chr10:104221170-104238858:+	-0.44	-5.96	5.03E-9	Schizophrenia	
THCA	cis	1	rs9665626	chr10:104300638	TRIM8	chr10:104404252-104418076:+	0.23	3.77	0.000183	Schizophrenia	
THCA	cis	1	rs9668015	chr12:62506495	FAM19A2	chr12:62102043-62653925:-	-0.15	-3.34	0.000892	Post bronchodilator FEV1/FVC ratio in COPD	
THCA	cis	1	rs9668191	chr12:122305295	WDR66	chr12:122356480-122441830:+	-0.23	-3.74	0.000205	Urinary metabolites	
THCA	cis	1	rs9668369	chr12:62506842	FAM19A2	chr12:62102043-62653925:-	-0.15	-3.34	0.000892	Post bronchodilator FEV1/FVC ratio in COPD	
THCA	cis	1	rs9668676	chr12:62504199	FAM19A2	chr12:62102043-62653925:-	-0.15	-3.34	0.000892	Post bronchodilator FEV1/FVC ratio in COPD	
THCA	cis	1	rs9668865	chr12:62507589	FAM19A2	chr12:62102043-62653925:-	-0.15	-3.37	0.00082	Post bronchodilator FEV1/FVC ratio in COPD	
THCA	cis	1	rs9669295	chr12:123842670	C12orf65	chr12:123717841-123742481:+	0.24	3.99	7.67E-5	HDL cholesterol	
THCA	cis	1	rs9671989	chr14:95013581	OTUB2	chr14:94492724-94515274:+	-0.15	-3.34	0.000894	Vaspin levels	
THCA	cis	1	rs9672214	chr15:31677775	CHRFAM7A	chr15:30653443-30685864:-	-0.34	-3.39	0.00075	Survival in colorectal cancer (non-distant metastatic)	
THCA	cis	1	rs9672214	chr15:31677775	FAM7A2	chr15:30864758-30892900:+	-0.51	-4.54	6.98E-6	Survival in colorectal cancer (non-distant metastatic)	
THCA	cis	1	rs9672789	chr15:66713633	TIPIN	chr15:66629008-66649054:-	-0.42	-4.28	2.29E-5	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs9673404	chr16:31347592	HSD3B7	chr16:30996519-31000473:+	-0.16	-3.94	9.39E-5	IgA nephropathy	
THCA	cis	1	rs9673405	chr16:31347599	HSD3B7	chr16:30996519-31000473:+	-0.16	-3.94	9.39E-5	IgA nephropathy	
THCA	cis	1	rs9674009	chr16:31347541	HSD3B7	chr16:30996519-31000473:+	-0.16	-3.94	9.39E-5	IgA nephropathy	
THCA	cis	1	rs9674872	chr17:79581931	ARL16	chr17:79648234-79650954:-	-0.12	-3.39	0.000748	Eye color traits	
THCA	cis	1	rs9674872	chr17:79581931	TSPAN10	chr17:79609349-79615778:+	0.8	17.82	7.47E-55	Eye color traits	
THCA	cis	1	rs9677476	chr2:232126290	ARMC9	chr2:232063342-232238606:+	-0.43	-10.61	9.38E-24	Food antigen IgG levels	
THCA	cis	1	rs9678841	chr2:191561760	ORMDL1	chr2:190634994-190649097:-	0.14	3.38	0.000784	Primary biliary cirrhosis	
THCA	cis	1	rs9684708	chr4:56430381	TMEM165	chr4:56262090-56292342:+	0.15	3.64	0.000298	Personality dimensions	
THCA	cis	1	rs968567	chr11:61595564	C11orf10	chr11:61556603-61560085:-	0.17	3.74	0.000208	Blood metabolite levels;Rheumatoid arthritis;Glycerophospholipid levels	
THCA	cis	1	rs968567	chr11:61595564	FADS2	chr11:61583728-61634825:+	0.93	17.75	1.61E-54	Blood metabolite levels;Rheumatoid arthritis;Glycerophospholipid levels	
THCA	cis	1	rs9687282	chr5:139065988	SLC4A9	chr5:139739787-139754722:+	-0.21	-3.35	0.000873	Schizophrenia	
THCA	cis	1	rs9689	chr1:25688276	RHCE	chr1:25688741-25756683:-	0.71	15.96	2.85E-46	Erythrocyte sedimentation rate	
THCA	cis	1	rs9689	chr1:25688276	RHD	chr1:25598981-25656935:+	-0.63	-12.38	9.9E-31	Erythrocyte sedimentation rate	
THCA	cis	1	rs9689	chr1:25688276	TMEM57	chr1:25757388-25826696:+	0.19	5.08	5.52E-7	Erythrocyte sedimentation rate	
THCA	cis	1	rs9697030	chr9:131920181	CRAT	chr9:131857075-131873070:-	0.32	7.52	2.68E-13	Blood metabolite ratios	
THCA	cis	1	rs971317	chr1:207476040	CD55	chr1:207494817-207534309:+	0.16	6.79	3.39E-11	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs971318	chr1:207475596	CD55	chr1:207494817-207534309:+	-0.16	-6.91	1.53E-11	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs971779	chr12:66182455	RPSAP52	chr12:66151803-66220754:-	0.17	3.51	0.000483	Type 2 diabetes	
THCA	cis	1	rs9738216	chr12:129281788	GLT1D1	chr12:129338081-129469509:+	-0.22	-5.72	1.93E-8	Systemic lupus erythematosus	
THCA	cis	1	rs9738216	chr12:129281788	SLC15A4	chr12:129277739-129308541:-	-0.18	-4.49	9.02E-6	Systemic lupus erythematosus	
THCA	cis	1	rs9738294	chr12:62508489	FAM19A2	chr12:62102043-62653925:-	-0.15	-3.34	0.000892	Post bronchodilator FEV1/FVC ratio in COPD	
THCA	cis	1	rs9739546	chr12:62508437	FAM19A2	chr12:62102043-62653925:-	-0.15	-3.34	0.000892	Post bronchodilator FEV1/FVC ratio in COPD	
THCA	cis	1	rs974014	chr4:48409363	OCIAD1	chr4:48833015-48863831:+	0.15	4.43	1.19E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs974015	chr4:48409347	OCIAD1	chr4:48833015-48863831:+	-0.14	-4.18	3.52E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs974016	chr4:48409315	OCIAD1	chr4:48833015-48863831:+	-0.14	-4.17	3.63E-5	Crohn's disease;Inflammatory bowel disease	
THCA	cis	1	rs974495	chr3:49400482	GMPPB	chr3:49758932-49761384:-	-0.18	-4.12	4.51E-5	Menarche (age at onset)	
THCA	cis	1	rs974495	chr3:49400482	P4HTM	chr3:49027341-49044579:+	0.17	4.32	1.9E-5	Menarche (age at onset)	
THCA	cis	1	rs974495	chr3:49400482	WDR6	chr3:49044637-49053386:+	-0.18	-3.77	0.000181	Menarche (age at onset)	
THCA	cis	1	rs9747164	chr17:61864787	FTSJ3	chr17:61896795-61905031:-	0.32	5.91	6.34E-9	Body mass index	
THCA	cis	1	rs9747164	chr17:61864787	MAP3K3	chr17:61699775-61773669:+	0.27	5.26	2.15E-7	Body mass index	
THCA	cis	1	rs9747349	chr17:79584297	ARL16	chr17:79648234-79650954:-	-0.12	-3.39	0.000748	Eye color traits	
THCA	cis	1	rs9747349	chr17:79584297	TSPAN10	chr17:79609349-79615778:+	0.8	17.82	7.47E-55	Eye color traits	
THCA	cis	1	rs9748176	chr17:79584043	ARL16	chr17:79648234-79650954:-	-0.12	-3.38	0.000786	Eye color traits	
THCA	cis	1	rs9748176	chr17:79584043	TSPAN10	chr17:79609349-79615778:+	0.78	17.49	2.66E-53	Eye color traits	
THCA	cis	1	rs975323	chr3:161021322	NMD3	chr3:160939099-160971319:+	-0.11	-3.62	0.000321	Morning vs. evening chronotype	
THCA	cis	1	rs9753608	chr20:47837206	CSE1L	chr20:47662838-47713484:+	-0.19	-3.34	0.000892	Height	
THCA	cis	1	rs9753608	chr20:47837206	DDX27	chr20:47835832-47860612:+	0.27	4.93	1.11E-6	Height	
THCA	cis	1	rs975459	chr6:151876909	C6orf97	chr6:151815175-151942327:+	0.33	4.64	4.43E-6	Bone mineral density (spine)	
THCA	cis	1	rs975739	chr13:78381146	EDNRB	chr13:78469616-78549664:-	-0.13	-3.92	0.000103	Hair color	
THCA	cis	1	rs9767077	chr6:150109615	C6orf72	chr6:149887528-149912067:+	-0.18	-4.87	1.51E-6	Lung cancer	
THCA	cis	1	rs9767077	chr6:150109615	NUP43	chr6:150045453-150067688:-	-0.26	-4.74	2.88E-6	Lung cancer	
THCA	cis	1	rs9767077	chr6:150109615	RAET1E	chr6:150204512-150217195:-	0.25	5.64	2.95E-8	Lung cancer	
THCA	cis	1	rs9769098	chr7:23916732	C7orf46	chr7:23719749-23742268:+	0.13	3.95	9.03E-5	Schizophrenia	
THCA	cis	1	rs9769882	chr7:65642925	CCT6P1	chr7:65216092-65228661:+	-0.42	-6.7	5.9E-11	Diabetic kidney disease	
THCA	cis	1	rs9769882	chr7:65642925	CRCP	chr7:65579805-65619551:+	0.3	4.63	4.66E-6	Diabetic kidney disease	
THCA	cis	1	rs9769882	chr7:65642925	LOC493754	chr7:65993446-66057363:-	-0.29	-3.36	0.000833	Diabetic kidney disease	
THCA	cis	1	rs9769882	chr7:65642925	RABGEF1	chr7:66093890-66276446:+	-0.57	-7.14	3.42E-12	Diabetic kidney disease	
THCA	cis	1	rs9782955	chr1:236039877	LYST	chr1:235824345-236046940:-	-0.32	-9.68	2.29E-20	Systemic lupus erythematosus	
THCA	cis	1	rs9783304	chr11:43660255	HSD17B12	chr11:43702143-43878160:+	0.68	14.09	5.68E-38	Forced vital capacity	
THCA	cis	1	rs9783347	chr11:18384938	GTF2H1	chr11:18343816-18388590:+	0.33	8.8	2.57E-17	Pancreatic cancer	
THCA	cis	1	rs9783747	chr16:69458193	CYB5B	chr16:69458498-69500167:+	-0.22	-3.82	0.000152	Blood pressure (smoking interaction)	
THCA	cis	1	rs9783749	chr16:69458248	CYB5B	chr16:69458498-69500167:+	-0.23	-3.94	9.22E-5	Blood pressure (smoking interaction)	
THCA	cis	1	rs9783992	chr2:231035589	SP110	chr2:231033645-231084827:-	0.24	5.02	7.49E-7	Obesity-related traits	
THCA	cis	1	rs9784019	chr2:231035575	SP110	chr2:231033645-231084827:-	0.24	5.02	7.49E-7	Obesity-related traits	
THCA	cis	1	rs9787296	chr1:108382827	VAV3	chr1:108113782-108507545:-	0.55	7.31	1.1E-12	Hypothyroidism	
THCA	cis	1	rs978777	chr11:93743870	HEPHL1	chr11:93754378-93847374:+	-0.41	-3.35	0.000882	Obesity-related traits	
THCA	cis	1	rs9787791	chr11:93696885	HEPHL1	chr11:93754378-93847374:+	0.56	4.59	5.71E-6	Obesity-related traits	
THCA	cis	1	rs9788721	chr15:78802869	CHRNA5	chr15:78857906-78886458:+	0.39	8.03	7.69E-15	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs9788767	chr15:24761453	PWRN1	chr15:24778839-24832924:+	0.45	9.31	4.55E-19	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
THCA	cis	1	rs978909	chr2:227771389	COL4A4	chr2:227867435-228029275:-	0.15	3.82	0.00015	Pulmonary function	
THCA	cis	1	rs9789167	chr18:23676404	SS18	chr18:23596219-23671164:-	0.26	3.35	0.000865	Rhegmatogenous retinal detachment	
THCA	cis	1	rs978950	chr11:93643906	HEPHL1	chr11:93754378-93847374:+	-0.41	-3.71	0.000229	Obesity-related traits	
THCA	cis	1	rs9789748	chr2:17801397	GEN1	chr2:17935162-17966632:+	0.6	7.03	7.16E-12	Psychosis and Alzheimer's disease	
THCA	cis	1	rs9790314	chr3:161019558	NMD3	chr3:160939099-160971319:+	-0.1	-3.39	0.000765	Morning vs. evening chronotype	
THCA	cis	1	rs979043	chr2:67566281	ETAA1	chr2:67624442-67637533:+	-0.18	-4.28	2.3E-5	Pancreatic cancer	
THCA	cis	1	rs979355	chr7:32463933	AVL9	chr7:32535176-33079034:+	0.16	4.7	3.41E-6	Metabolite levels (HVA/MHPG ratio)	
THCA	cis	1	rs979532	chr4:17901679	DCAF16	chr4:17802280-17812381:-	-0.24	-5.62	3.29E-8	Height	
THCA	cis	1	rs9795476	chr11:235894	PSMD13	chr11:236808-252984:+	-0.22	-6.75	4.25E-11	Menarche (age at onset)	
THCA	cis	1	rs9795476	chr11:235894	SIRT3	chr11:214625-236931:-	0.12	3.38	0.000785	Menarche (age at onset)	
THCA	cis	1	rs9797279	chr17:20908325	USP22	chr17:20902908-20947073:-	-0.18	-3.77	0.000184	Blood trace element (Se levels)	
THCA	cis	1	rs9797861	chr19:10743126	SLC44A2	chr19:10713121-10755234:+	-0.39	-6.71	5.42E-11	Thrombosis	
THCA	cis	1	rs979971	chr19:39144244	LGALS7	chr19:39261608-39264157:-	-0.21	-4.17	3.57E-5	Heart rate	
THCA	cis	1	rs9804870	chr12:70740735	YEATS4	chr12:69753532-69784575:+	-0.24	-3.64	0.000308	Amyotrophic lateral sclerosis (age of onset)	
THCA	cis	1	rs9804992	chr12:988894	RAD52	chr12:1021255-1099219:-	0.32	5.15	3.83E-7	Colorectal cancer	
THCA	cis	1	rs9805979	chr14:75566209	EIF2B2	chr14:75469612-75476292:+	0.19	5.13	4.3E-7	Height	
THCA	cis	1	rs9805979	chr14:75566209	MLH3	chr14:75480467-75518235:-	0.3	9.04	3.85E-18	Height	
THCA	cis	1	rs9805979	chr14:75566209	RPS6KL1	chr14:75372347-75389958:-	0.32	6.92	1.5E-11	Height	
THCA	cis	1	rs9806474	chr15:66646513	TIPIN	chr15:66629008-66649054:-	-0.38	-3.79	0.000168	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs9806600	chr15:66594447	TIPIN	chr15:66629008-66649054:-	-0.41	-4.01	6.97E-5	Spherical equivalent (joint main effects and education interaction)	
THCA	cis	1	rs9807825	chr19:52019947	ZNF175	chr19:52074531-52092990:+	-0.36	-4.26	2.49E-5	Carotid intima media thickness	
THCA	cis	1	rs9808651	chr21:40466468	SH3BGR	chr21:40817797-40887426:+	-0.22	-4.18	3.41E-5	Fibrinogen levels	
THCA	cis	1	rs9809061	chr3:10085130	C3orf10	chr3:10157333-10168873:+	-0.2	-4.17	3.56E-5	Alzheimer's disease	
THCA	cis	1	rs9809061	chr3:10085130	VHL	chr3:10183319-10193744:+	-0.19	-4.47	9.82E-6	Alzheimer's disease	
THCA	cis	1	rs9809619	chr3:134280948	ANAPC13	chr3:134196547-134204865:-	0.4	12.83	1.42E-32	Height	
THCA	cis	1	rs9809619	chr3:134280948	CEP63	chr3:134204575-134293852:+	0.3	6.49	2.19E-10	Height	
THCA	cis	1	rs9809843	chr3:48434398	ATRIP	chr3:48488141-48507708:+	0.17	3.81	0.000155	Longevity	
THCA	cis	1	rs9809843	chr3:48434398	TREX1	chr3:48501186-48509043:+	-0.26	-5.97	4.57E-9	Longevity	
THCA	cis	1	rs9810077	chr3:195005422	C3orf21	chr3:194789015-194991895:-	0.29	6.71	5.36E-11	Body mass index	
THCA	cis	1	rs9810089	chr3:135807609	PCCB	chr3:135969167-136056737:+	-0.21	-6.31	6.28E-10	Gestational age at birth (child effect)	
THCA	cis	1	rs9811216	chr3:169487501	LRRC34	chr3:169511266-169530720:-	-0.2	-3.76	0.000195	Multiple myeloma and monoclonal gammopathy;Interstitial lung disease	
THCA	cis	1	rs9811771	chr3:10133949	C3orf10	chr3:10157333-10168873:+	-0.2	-4.29	2.21E-5	Alzheimer's disease	
THCA	cis	1	rs9811771	chr3:10133949	VHL	chr3:10183319-10193744:+	-0.16	-3.66	0.000283	Alzheimer's disease	
THCA	cis	1	rs9812647	chr3:48448914	ATRIP	chr3:48488141-48507708:+	-0.18	-3.91	0.000108	Longevity	
THCA	cis	1	rs9812647	chr3:48448914	TREX1	chr3:48501186-48509043:+	0.25	5.66	2.68E-8	Longevity	
THCA	cis	1	rs9812791	chr3:49682311	MST1	chr3:49721381-49726196:-	0.13	3.77	0.000183	Crohn's disease;Ulcerative colitis	
THCA	cis	1	rs9813712	chr3:129971101	COL6A4P2	chr3:129931663-129992648:+	0.23	4.4	1.31E-5	Response to amphetamines	
THCA	cis	1	rs9813712	chr3:129971101	LOC729375	chr3:129816625-129830276:-	0.23	4.27	2.34E-5	Response to amphetamines	
THCA	cis	1	rs9813762	chr3:184756624	C3orf70	chr3:184795840-184870802:-	-0.23	-4.68	3.82E-6	Heschl's gyrus morphology	
THCA	cis	1	rs9813774	chr3:134227100	ANAPC13	chr3:134196547-134204865:-	0.39	12.57	1.72E-31	Height	
THCA	cis	1	rs9813774	chr3:134227100	CEP63	chr3:134204575-134293852:+	0.29	6.4	3.83E-10	Height	
THCA	cis	1	rs9813864	chr3:119590974	GSK3B	chr3:119540804-119813264:-	-0.14	-4.93	1.11E-6	HDL cholesterol	
THCA	cis	1	rs9814567	chr3:134218557	ANAPC13	chr3:134196547-134204865:-	-0.39	-12.29	2.29E-30	Height	
THCA	cis	1	rs9814567	chr3:134218557	CEP63	chr3:134204575-134293852:+	-0.29	-6.26	8.71E-10	Height	
THCA	cis	1	rs9815103	chr3:48414215	ATRIP	chr3:48488141-48507708:+	0.17	3.76	0.000194	Longevity	
THCA	cis	1	rs9815103	chr3:48414215	TREX1	chr3:48501186-48509043:+	-0.25	-5.86	8.45E-9	Longevity	
THCA	cis	1	rs9815354	chr3:41912651	ULK4	chr3:41288091-42003660:-	1.02	18.5	5.2E-58	Diastolic blood pressure	
THCA	cis	1	rs9815925	chr3:184717901	C3orf70	chr3:184795840-184870802:-	-0.2	-4.09	4.99E-5	Heschl's gyrus morphology	
THCA	cis	1	rs9817615	chr3:48470756	ATRIP	chr3:48488141-48507708:+	0.19	4.17	3.61E-5	Longevity	
THCA	cis	1	rs9817615	chr3:48470756	TREX1	chr3:48501186-48509043:+	-0.25	-5.71	2.02E-8	Longevity	
THCA	cis	1	rs9817946	chr3:69795157	MITF	chr3:69788633-70017486:+	0.31	5.41	9.79E-8	QRS complex (12-leadsum)	
THCA	cis	1	rs9818169	chr3:41860599	ULK4	chr3:41288091-42003660:-	1.04	19.87	1.7E-64	Diastolic blood pressure	
THCA	cis	1	rs9819072	chr3:58353647	KCTD6	chr3:58477823-58488085:+	0.23	3.4	0.000728	Cholesterol, total	
THCA	cis	1	rs9819072	chr3:58353647	PXK	chr3:58318617-58410878:+	0.36	6.32	5.96E-10	Cholesterol, total	
THCA	cis	1	rs981938	chr2:218275818	DIRC3	chr2:218148748-218621316:-	-0.2	-4.7	3.49E-6	Height	
THCA	cis	1	rs9819511	chr3:49884261	CCDC36	chr3:49235861-49295537:+	0.2	4.04	6.14E-5	Resting heart rate	
THCA	cis	1	rs9819511	chr3:49884261	RBM6	chr3:49977592-50137484:+	-0.15	-4.37	1.56E-5	Resting heart rate	
THCA	cis	1	rs9819532	chr3:134288644	ANAPC13	chr3:134196547-134204865:-	0.4	12.9	7.22E-33	Height	
THCA	cis	1	rs9819532	chr3:134288644	CEP63	chr3:134204575-134293852:+	0.3	6.55	1.51E-10	Height	
THCA	cis	1	rs9820192	chr3:41889281	ULK4	chr3:41288091-42003660:-	1.09	20.95	1.23E-69	Diastolic blood pressure	
THCA	cis	1	rs9820598	chr3:10117912	C3orf10	chr3:10157333-10168873:+	-0.2	-4.18	3.51E-5	Alzheimer's disease	
THCA	cis	1	rs9820598	chr3:10117912	VHL	chr3:10183319-10193744:+	-0.19	-4.37	1.54E-5	Alzheimer's disease	
THCA	cis	1	rs9821570	chr3:58335919	KCTD6	chr3:58477823-58488085:+	0.23	3.36	0.000839	Cholesterol, total	
THCA	cis	1	rs9821570	chr3:58335919	PXK	chr3:58318617-58410878:+	0.37	6.46	2.55E-10	Cholesterol, total	
THCA	cis	1	rs9822268	chr3:49719729	MST1	chr3:49721381-49726196:-	0.13	3.8	0.000161	Crohn's disease;Ulcerative colitis	
THCA	cis	1	rs9822370	chr3:184661756	C3orf70	chr3:184795840-184870802:-	-0.22	-4.43	1.18E-5	Heschl's gyrus morphology	
THCA	cis	1	rs982256	chr7:110904226	IMMP2L	chr7:110303110-111202538:-	0.18	4.06	5.7E-5	Schizophrenia	
THCA	cis	1	rs9822885	chr3:169486144	LRRC34	chr3:169511266-169530720:-	-0.25	-4.69	3.64E-6	Multiple myeloma and monoclonal gammopathy;Interstitial lung disease	
THCA	cis	1	rs9823254	chr3:41894768	ULK4	chr3:41288091-42003660:-	1.04	18.86	9.68E-60	Diastolic blood pressure	
THCA	cis	1	rs9823546	chr3:49705512	MST1	chr3:49721381-49726196:-	0.14	4.1	4.77E-5	Crohn's disease;Ulcerative colitis	
THCA	cis	1	rs9823546	chr3:49705512	UBA7	chr3:49842639-49851391:-	0.16	3.67	0.000265	Crohn's disease;Ulcerative colitis	
THCA	cis	1	rs9823696	chr3:183783353	CAMK2N2	chr3:183977003-183979251:-	-0.19	-3.67	0.000274	Esophageal adenocarcinoma	
THCA	cis	1	rs9824585	chr3:10114802	C3orf10	chr3:10157333-10168873:+	-0.19	-4.13	4.31E-5	Alzheimer's disease	
THCA	cis	1	rs9824585	chr3:10114802	VHL	chr3:10183319-10193744:+	-0.17	-3.99	7.78E-5	Alzheimer's disease	
THCA	cis	1	rs9824731	chr3:41889698	ULK4	chr3:41288091-42003660:-	1.04	18.86	9.68E-60	Diastolic blood pressure	
THCA	cis	1	rs9824965	chr3:58433505	PXK	chr3:58318617-58410878:+	0.32	5.75	1.64E-8	Cholesterol, total	
THCA	cis	1	rs9825741	chr3:41761828	ULK4	chr3:41288091-42003660:-	-1.07	-19.85	2.21E-64	Diastolic blood pressure	
THCA	cis	1	rs9826058	chr3:41762062	ULK4	chr3:41288091-42003660:-	1.06	19.78	4.62E-64	Diastolic blood pressure	
THCA	cis	1	rs9826195	chr3:48433635	ATRIP	chr3:48488141-48507708:+	0.17	3.81	0.000155	Longevity	
THCA	cis	1	rs9826195	chr3:48433635	TREX1	chr3:48501186-48509043:+	-0.26	-5.97	4.57E-9	Longevity	
THCA	cis	1	rs9826284	chr3:100651088	NIT2	chr3:100053562-100074477:+	-0.16	-3.44	0.000626	Optic disc area	
THCA	cis	1	rs9826496	chr3:134224437	ANAPC13	chr3:134196547-134204865:-	0.39	12.7	4.73E-32	Height	
THCA	cis	1	rs9826496	chr3:134224437	CEP63	chr3:134204575-134293852:+	0.29	6.44	2.89E-10	Height	
THCA	cis	1	rs9827694	chr3:100648298	NIT2	chr3:100053562-100074477:+	-0.16	-3.44	0.000626	Optic disc area	
THCA	cis	1	rs9827740	chr3:10120531	C3orf10	chr3:10157333-10168873:+	-0.2	-4.18	3.51E-5	Alzheimer's disease	
THCA	cis	1	rs9827740	chr3:10120531	VHL	chr3:10183319-10193744:+	-0.19	-4.37	1.54E-5	Alzheimer's disease	
THCA	cis	1	rs9827987	chr3:134272621	ANAPC13	chr3:134196547-134204865:-	0.4	12.53	2.47E-31	Height	
THCA	cis	1	rs9827987	chr3:134272621	CEP63	chr3:134204575-134293852:+	0.3	6.36	4.83E-10	Height	
THCA	cis	1	rs9828398	chr3:41895893	ULK4	chr3:41288091-42003660:-	1.09	20.95	1.23E-69	Diastolic blood pressure	
THCA	cis	1	rs9828717	chr3:57998986	PDHB	chr3:58413355-58419565:-	0.15	3.45	0.000618	Optic cup area	
THCA	cis	1	rs9828815	chr3:134265749	ANAPC13	chr3:134196547-134204865:-	0.39	12.58	1.56E-31	Height	
THCA	cis	1	rs9828815	chr3:134265749	CEP63	chr3:134204575-134293852:+	0.3	6.54	1.63E-10	Height	
THCA	cis	1	rs9829092	chr3:134229866	ANAPC13	chr3:134196547-134204865:-	0.39	12.35	1.27E-30	Height	
THCA	cis	1	rs9829092	chr3:134229866	CEP63	chr3:134204575-134293852:+	0.29	6.33	5.5E-10	Height	
THCA	cis	1	rs9830064	chr3:41881801	ULK4	chr3:41288091-42003660:-	1.09	21	7.68E-70	Diastolic blood pressure	
THCA	cis	1	rs9830469	chr3:41762535	ULK4	chr3:41288091-42003660:-	1.06	19.75	6.57E-64	Diastolic blood pressure	
THCA	cis	1	rs9831461	chr3:168662497	MECOM	chr3:168801287-169381563:-	0.51	5.25	2.34E-7	Aging (time to event)	
THCA	cis	1	rs9831620	chr3:100636843	NIT2	chr3:100053562-100074477:+	-0.16	-3.49	0.000533	Optic disc area	
THCA	cis	1	rs9831661	chr3:169528523	LRRC34	chr3:169511266-169530720:-	0.25	4.81	2.0E-6	Multiple myeloma and monoclonal gammopathy;Interstitial lung disease	
THCA	cis	1	rs9832785	chr3:134213070	ANAPC13	chr3:134196547-134204865:-	0.4	12.84	1.2E-32	Height	
THCA	cis	1	rs9832785	chr3:134213070	CEP63	chr3:134204575-134293852:+	0.29	6.27	8.12E-10	Height	
THCA	cis	1	rs983392	chr11:59923508	MS4A14	chr11:60145958-60185226:+	0.17	4.2	3.18E-5	Alzheimer's disease (late onset)	
THCA	cis	1	rs9834098	chr3:41833493	ULK4	chr3:41288091-42003660:-	1.09	20.58	7.62E-68	Diastolic blood pressure	
THCA	cis	1	rs9834459	chr3:2484710	CNTN4	chr3:2140550-3099644:+	0.35	8.24	1.65E-15	Blood pressure (smoking interaction)	
THCA	cis	1	rs9834755	chr3:134206845	ANAPC13	chr3:134196547-134204865:-	0.4	12.84	1.23E-32	Height	
THCA	cis	1	rs9834755	chr3:134206845	CEP63	chr3:134204575-134293852:+	0.29	6.26	8.6E-10	Height	
THCA	cis	1	rs9834980	chr3:10065528	C3orf10	chr3:10157333-10168873:+	-0.21	-4.37	1.53E-5	Alzheimer's disease	
THCA	cis	1	rs9834980	chr3:10065528	VHL	chr3:10183319-10193744:+	-0.18	-4.05	6.05E-5	Alzheimer's disease	
THCA	cis	1	rs9835204	chr3:134261342	ANAPC13	chr3:134196547-134204865:-	0.39	12.58	1.56E-31	Height	
THCA	cis	1	rs9835204	chr3:134261342	CEP63	chr3:134204575-134293852:+	0.3	6.54	1.63E-10	Height	
THCA	cis	1	rs9836291	chr3:49697459	MST1	chr3:49721381-49726196:-	0.12	3.51	0.000487	Crohn's disease;Ulcerative colitis	
THCA	cis	1	rs9836291	chr3:49697459	UBA7	chr3:49842639-49851391:-	0.16	3.54	0.000445	Crohn's disease;Ulcerative colitis	
THCA	cis	1	rs9837038	chr3:156568469	LEKR1	chr3:156544076-156763918:+	-0.3	-8.35	7.33E-16	Multiple sclerosis (severity)	
THCA	cis	1	rs9838618	chr3:48487353	ATRIP	chr3:48488141-48507708:+	0.19	4.21	3.08E-5	Longevity	
THCA	cis	1	rs9838618	chr3:48487353	TREX1	chr3:48501186-48509043:+	-0.25	-5.83	1.03E-8	Longevity	
THCA	cis	1	rs9838965	chr3:41927938	ULK4	chr3:41288091-42003660:-	-1.09	-20.92	1.8E-69	Diastolic blood pressure	
THCA	cis	1	rs9839399	chr3:41928044	ULK4	chr3:41288091-42003660:-	-1.09	-20.92	1.8E-69	Diastolic blood pressure	
THCA	cis	1	rs9840037	chr3:41827522	ULK4	chr3:41288091-42003660:-	1.07	19.94	7.89E-65	Diastolic blood pressure	
THCA	cis	1	rs9840532	chr3:41885697	ULK4	chr3:41288091-42003660:-	1.09	20.61	5.22E-68	Diastolic blood pressure	
THCA	cis	1	rs9841212	chr3:134191938	ANAPC13	chr3:134196547-134204865:-	0.35	10.86	1.06E-24	Height	
THCA	cis	1	rs9841212	chr3:134191938	CEP63	chr3:134204575-134293852:+	0.28	6.03	3.26E-9	Height	
THCA	cis	1	rs9842132	chr3:49427933	GMPPB	chr3:49758932-49761384:-	0.17	3.83	0.000148	Menarche (age at onset)	
THCA	cis	1	rs9842132	chr3:49427933	P4HTM	chr3:49027341-49044579:+	-0.17	-4.29	2.19E-5	Menarche (age at onset)	
THCA	cis	1	rs9842132	chr3:49427933	WDR6	chr3:49044637-49053386:+	0.17	3.59	0.000359	Menarche (age at onset)	
THCA	cis	1	rs984222	chr1:119503843	WARS2	chr1:119573841-119683295:-	-0.54	-11.56	2.06E-27	Waist-to-hip ratio adjusted for body mass index;Waist-hip ratio	
THCA	cis	1	rs9842261	chr3:41822708	ULK4	chr3:41288091-42003660:-	-0.94	-15.89	5.93E-46	Diastolic blood pressure	
THCA	cis	1	rs9842305	chr3:41998412	ULK4	chr3:41288091-42003660:-	-1.1	-21.36	1.5E-71	Diastolic blood pressure	
THCA	cis	1	rs9843304	chr3:149211387	COMMD2	chr3:149456260-149470278:-	-0.17	-3.74	0.000207	Gallstone disease	
THCA	cis	1	rs9843304	chr3:149211387	TM4SF1	chr3:149086805-149095568:-	-0.16	-4.25	2.55E-5	Gallstone disease	
THCA	cis	1	rs9843304	chr3:149211387	TM4SF4	chr3:149192434-149221068:+	-0.25	-6.07	2.53E-9	Gallstone disease	
THCA	cis	1	rs9844128	chr3:58391127	PXK	chr3:58318617-58410878:+	0.33	5.78	1.33E-8	Cholesterol, total	
THCA	cis	1	rs9845756	chr3:10067548	C3orf10	chr3:10157333-10168873:+	-0.2	-4.26	2.51E-5	Alzheimer's disease	
THCA	cis	1	rs9845756	chr3:10067548	VHL	chr3:10183319-10193744:+	-0.19	-4.32	1.89E-5	Alzheimer's disease	
THCA	cis	1	rs9846634	chr3:41894049	ULK4	chr3:41288091-42003660:-	1.04	18.86	9.68E-60	Diastolic blood pressure	
THCA	cis	1	rs9846756	chr3:160983809	NMD3	chr3:160939099-160971319:+	-0.11	-3.73	0.000212	Morning vs. evening chronotype	
THCA	cis	1	rs9847006	chr3:41755359	ULK4	chr3:41288091-42003660:-	1.07	19.39	3.29E-62	Diastolic blood pressure	
THCA	cis	1	rs9847485	chr3:100639697	NIT2	chr3:100053562-100074477:+	-0.16	-3.49	0.000535	Optic disc area	
THCA	cis	1	rs9847710	chr3:53062661	GLYCTK	chr3:52321836-52329271:+	0.16	3.59	0.000369	Ulcerative colitis	
THCA	cis	1	rs9847975	chr3:41786904	ULK4	chr3:41288091-42003660:-	1.02	17.94	2.21E-55	Diastolic blood pressure	
THCA	cis	1	rs9848754	chr3:41753647	ULK4	chr3:41288091-42003660:-	1.07	18.45	8.76E-58	Diastolic blood pressure	
THCA	cis	1	rs9849248	chr3:88241274	C3orf38	chr3:88198893-88207113:+	0.29	5.4	1.06E-7	Menarche (age at onset)	
THCA	cis	1	rs9849248	chr3:88241274	ZNF654	chr3:88188262-88193812:+	-0.21	-3.99	7.66E-5	Menarche (age at onset)	
THCA	cis	1	rs9849434	chr3:10133710	C3orf10	chr3:10157333-10168873:+	0.19	4.08	5.22E-5	Alzheimer's disease	
THCA	cis	1	rs9849434	chr3:10133710	VHL	chr3:10183319-10193744:+	0.18	4.1	4.96E-5	Alzheimer's disease	
THCA	cis	1	rs9849482	chr3:58422087	PXK	chr3:58318617-58410878:+	0.33	5.77	1.42E-8	Cholesterol, total	
THCA	cis	1	rs9849509	chr3:48483432	ATRIP	chr3:48488141-48507708:+	0.19	4.22	2.93E-5	Longevity	
THCA	cis	1	rs9849509	chr3:48483432	TREX1	chr3:48501186-48509043:+	-0.25	-5.72	1.88E-8	Longevity	
THCA	cis	1	rs9850015	chr3:134269541	ANAPC13	chr3:134196547-134204865:-	0.4	12.53	2.47E-31	Height	
THCA	cis	1	rs9850015	chr3:134269541	CEP63	chr3:134204575-134293852:+	0.3	6.36	4.83E-10	Height	
THCA	cis	1	rs9850455	chr3:161017192	NMD3	chr3:160939099-160971319:+	-0.1	-3.39	0.000765	Morning vs. evening chronotype	
THCA	cis	1	rs9850717	chr3:58351875	PXK	chr3:58318617-58410878:+	0.34	6.04	3.09E-9	Cholesterol, total	
THCA	cis	1	rs9851441	chr3:134315091	ANAPC13	chr3:134196547-134204865:-	0.36	11.48	3.96E-27	Height	
THCA	cis	1	rs9851441	chr3:134315091	CEP63	chr3:134204575-134293852:+	0.3	6.49	2.15E-10	Height	
THCA	cis	1	rs9852303	chr3:41759525	ULK4	chr3:41288091-42003660:-	1.06	19.75	6.57E-64	Diastolic blood pressure	
THCA	cis	1	rs9854299	chr3:134206728	ANAPC13	chr3:134196547-134204865:-	0.39	12.58	1.51E-31	Height	
THCA	cis	1	rs9854299	chr3:134206728	CEP63	chr3:134204575-134293852:+	0.29	6.4	3.64E-10	Height	
THCA	cis	1	rs9854833	chr3:41775577	ULK4	chr3:41288091-42003660:-	1.02	17.79	1.05E-54	Diastolic blood pressure	
THCA	cis	1	rs9854838	chr3:41805670	ULK4	chr3:41288091-42003660:-	1.1	20.48	2.29E-67	Diastolic blood pressure	
THCA	cis	1	rs9854956	chr3:37218588	EPM2AIP1	chr3:37027358-37034795:-	0.13	3.84	0.000139	Cerebrospinal P-tau181p levels	
THCA	cis	1	rs9854956	chr3:37218588	LRRFIP2	chr3:37094117-37217851:-	0.51	14.11	4.86E-38	Cerebrospinal P-tau181p levels	
THCA	cis	1	rs9855965	chr3:41860508	ULK4	chr3:41288091-42003660:-	1.04	19.87	1.7E-64	Diastolic blood pressure	
THCA	cis	1	rs9856088	chr3:41860482	ULK4	chr3:41288091-42003660:-	1.04	19.87	1.7E-64	Diastolic blood pressure	
THCA	cis	1	rs9856633	chr3:42013850	ULK4	chr3:41288091-42003660:-	1.11	21.88	4.83E-74	Diastolic blood pressure	
THCA	cis	1	rs9856693	chr3:134306913	ANAPC13	chr3:134196547-134204865:-	0.37	11.48	4.06E-27	Height	
THCA	cis	1	rs9856693	chr3:134306913	CEP63	chr3:134204575-134293852:+	0.3	6.4	3.75E-10	Height	
THCA	cis	1	rs9857175	chr3:41822054	ULK4	chr3:41288091-42003660:-	1.07	19.97	5.84E-65	Diastolic blood pressure	
THCA	cis	1	rs9858213	chr3:49731861	MST1	chr3:49721381-49726196:-	0.13	3.78	0.000176	Educational attainment	
THCA	cis	1	rs9858542	chr3:49701983	APEH	chr3:49711435-49720933:+	-0.14	-3.5	0.000502	Crohn's disease;Ulcerative colitis	
THCA	cis	1	rs9858542	chr3:49701983	MST1	chr3:49721381-49726196:-	-0.14	-4.38	1.49E-5	Crohn's disease;Ulcerative colitis	
THCA	cis	1	rs9858542	chr3:49701983	UBA7	chr3:49842639-49851391:-	-0.17	-3.75	0.000201	Crohn's disease;Ulcerative colitis	
THCA	cis	1	rs9860055	chr3:49506900	GMPPB	chr3:49758932-49761384:-	0.16	3.64	0.0003	Menarche (age at onset)	
THCA	cis	1	rs9860055	chr3:49506900	P4HTM	chr3:49027341-49044579:+	-0.17	-4.2	3.19E-5	Menarche (age at onset)	
THCA	cis	1	rs9860055	chr3:49506900	WDR6	chr3:49044637-49053386:+	0.18	3.71	0.000235	Menarche (age at onset)	
THCA	cis	1	rs9860874	chr3:169486271	LRRC34	chr3:169511266-169530720:-	-0.25	-4.69	3.64E-6	Multiple myeloma and monoclonal gammopathy;Interstitial lung disease	
THCA	cis	1	rs9860970	chr3:58353781	PXK	chr3:58318617-58410878:+	0.36	6.2	1.24E-9	Cholesterol, total	
THCA	cis	1	rs9862534	chr3:49598064	AMIGO3	chr3:49754268-49757238:-	-0.15	-3.49	0.000529	Menarche (age at onset)	
THCA	cis	1	rs9862534	chr3:49598064	GMPPB	chr3:49758932-49761384:-	-0.18	-4.06	5.82E-5	Menarche (age at onset)	
THCA	cis	1	rs9862534	chr3:49598064	P4HTM	chr3:49027341-49044579:+	0.17	4.31	1.97E-5	Menarche (age at onset)	
THCA	cis	1	rs9862534	chr3:49598064	WDR6	chr3:49044637-49053386:+	-0.17	-3.49	0.000523	Menarche (age at onset)	
THCA	cis	1	rs9862969	chr3:58341917	KCTD6	chr3:58477823-58488085:+	0.23	3.36	0.000839	Cholesterol, total	
THCA	cis	1	rs9862969	chr3:58341917	PXK	chr3:58318617-58410878:+	0.37	6.46	2.55E-10	Cholesterol, total	
THCA	cis	1	rs9863786	chr3:134247203	ANAPC13	chr3:134196547-134204865:-	0.39	12.58	1.56E-31	Height	
THCA	cis	1	rs9863786	chr3:134247203	CEP63	chr3:134204575-134293852:+	0.3	6.54	1.63E-10	Height	
THCA	cis	1	rs9863915	chr3:41762002	ULK4	chr3:41288091-42003660:-	1.06	19.75	6.57E-64	Diastolic blood pressure	
THCA	cis	1	rs9864217	chr3:41762206	ULK4	chr3:41288091-42003660:-	1.04	18.08	4.79E-56	Diastolic blood pressure	
THCA	cis	1	rs9864325	chr3:58336846	KCTD6	chr3:58477823-58488085:+	0.24	3.72	0.000222	Cholesterol, total	
THCA	cis	1	rs9864325	chr3:58336846	PXK	chr3:58318617-58410878:+	0.36	6.6	1.07E-10	Cholesterol, total	
THCA	cis	1	rs9864346	chr3:134312352	ANAPC13	chr3:134196547-134204865:-	0.38	12.06	2.05E-29	Height	
THCA	cis	1	rs9864346	chr3:134312352	CEP63	chr3:134204575-134293852:+	0.29	6.21	1.14E-9	Height	
THCA	cis	1	rs9864371	chr3:48426766	ATRIP	chr3:48488141-48507708:+	0.18	3.88	0.000121	Longevity	
THCA	cis	1	rs9864371	chr3:48426766	TREX1	chr3:48501186-48509043:+	-0.25	-5.89	7.48E-9	Longevity	
THCA	cis	1	rs9864439	chr3:134298671	ANAPC13	chr3:134196547-134204865:-	0.36	11.4	8.25E-27	Height	
THCA	cis	1	rs9864439	chr3:134298671	CEP63	chr3:134204575-134293852:+	0.3	6.62	9.81E-11	Height	
THCA	cis	1	rs9864582	chr3:129970462	COL6A4P2	chr3:129931663-129992648:+	0.23	4.45	1.08E-5	Response to amphetamines	
THCA	cis	1	rs9864582	chr3:129970462	LOC729375	chr3:129816625-129830276:-	0.23	4.3	2.09E-5	Response to amphetamines	
THCA	cis	1	rs9864824	chr3:58394835	PXK	chr3:58318617-58410878:+	-0.34	-5.94	5.61E-9	Cholesterol, total	
THCA	cis	1	rs9865127	chr3:41807448	ULK4	chr3:41288091-42003660:-	1.09	20.46	2.85E-67	Diastolic blood pressure	
THCA	cis	1	rs9865780	chr3:41895802	ULK4	chr3:41288091-42003660:-	1.09	20.95	1.23E-69	Diastolic blood pressure	
THCA	cis	1	rs9865905	chr3:156649594	LEKR1	chr3:156544076-156763918:+	0.31	8.62	9.96E-17	Multiple sclerosis (severity)	
THCA	cis	1	rs9866092	chr3:41895967	ULK4	chr3:41288091-42003660:-	1.09	20.95	1.23E-69	Diastolic blood pressure	
THCA	cis	1	rs9866430	chr3:51591265	HEMK1	chr3:50606583-50622419:+	0.16	4.23	2.74E-5	Melanoma	
THCA	cis	1	rs9866430	chr3:51591265	TEX264	chr3:51705222-51738338:+	-0.11	-3.74	0.000209	Melanoma	
THCA	cis	1	rs9866759	chr3:41758418	ULK4	chr3:41288091-42003660:-	1.06	19.69	1.27E-63	Diastolic blood pressure	
THCA	cis	1	rs9866776	chr3:169487651	LRRC34	chr3:169511266-169530720:-	-0.24	-4.66	4.05E-6	Multiple myeloma and monoclonal gammopathy;Interstitial lung disease	
THCA	cis	1	rs9867627	chr3:41795841	ULK4	chr3:41288091-42003660:-	-1.03	-18.3	4.52E-57	Diastolic blood pressure	
THCA	cis	1	rs9868000	chr3:169510789	LRRC34	chr3:169511266-169530720:-	-0.24	-4.51	8.02E-6	Multiple myeloma and monoclonal gammopathy;Interstitial lung disease	
THCA	cis	1	rs9868809	chr3:48681053	NCKIPSD	chr3:48711280-48723334:-	-0.38	-5.43	8.95E-8	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs9868809	chr3:48681053	SLC26A6	chr3:48663158-48672926:-	0.32	5.54	4.94E-8	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THCA	cis	1	rs9869207	chr3:41878661	ULK4	chr3:41288091-42003660:-	1.09	21.14	1.55E-70	Diastolic blood pressure	
THCA	cis	1	rs9869276	chr3:58401076	PXK	chr3:58318617-58410878:+	0.33	5.75	1.61E-8	Cholesterol, total	
THCA	cis	1	rs9869282	chr3:41756064	ULK4	chr3:41288091-42003660:-	1.07	19.39	3.29E-62	Diastolic blood pressure	
THCA	cis	1	rs9869440	chr3:41763155	ULK4	chr3:41288091-42003660:-	1.06	19.66	1.66E-63	Diastolic blood pressure	
THCA	cis	1	rs9869576	chr3:58401262	PXK	chr3:58318617-58410878:+	0.33	5.77	1.42E-8	Cholesterol, total	
THCA	cis	1	rs9869826	chr3:50998816	MAPKAPK3	chr3:50649339-50686719:+	0.21	3.9	0.000112	Bacteremia	
THCA	cis	1	rs9869940	chr3:58401523	PXK	chr3:58318617-58410878:+	0.33	5.77	1.42E-8	Cholesterol, total	
THCA	cis	1	rs9869981	chr3:134248801	ANAPC13	chr3:134196547-134204865:-	0.39	12.61	1.14E-31	Height	
THCA	cis	1	rs9869981	chr3:134248801	CEP63	chr3:134204575-134293852:+	0.31	6.71	5.59E-11	Height	
THCA	cis	1	rs9870059	chr3:161017240	NMD3	chr3:160939099-160971319:+	-0.11	-3.55	0.000425	Morning vs. evening chronotype	
THCA	cis	1	rs9871024	chr3:49554241	GMPPB	chr3:49758932-49761384:-	0.16	3.68	0.00026	Menarche (age at onset)	
THCA	cis	1	rs9871024	chr3:49554241	P4HTM	chr3:49027341-49044579:+	-0.17	-4.29	2.16E-5	Menarche (age at onset)	
THCA	cis	1	rs9871024	chr3:49554241	WDR6	chr3:49044637-49053386:+	0.17	3.62	0.000324	Menarche (age at onset)	
THCA	cis	1	rs9871305	chr3:134213538	ANAPC13	chr3:134196547-134204865:-	0.39	12.35	1.27E-30	Height	
THCA	cis	1	rs9871305	chr3:134213538	CEP63	chr3:134204575-134293852:+	0.29	6.33	5.5E-10	Height	
THCA	cis	1	rs9872514	chr3:161042833	NMD3	chr3:160939099-160971319:+	-0.1	-3.34	0.000905	Morning vs. evening chronotype	
THCA	cis	1	rs9873207	chr3:41884750	ULK4	chr3:41288091-42003660:-	1.04	19.01	1.99E-60	Diastolic blood pressure	
THCA	cis	1	rs9873477	chr3:119645976	GSK3B	chr3:119540804-119813264:-	0.13	4.67	3.98E-6	HDL cholesterol	
THCA	cis	1	rs9874513	chr3:41909508	ULK4	chr3:41288091-42003660:-	1.02	18.5	5.2E-58	Diastolic blood pressure	
THCA	cis	1	rs9874517	chr3:53128371	RFT1	chr3:53122503-53164470:-	0.61	7.51	3.0E-13	Immune reponse to smallpox (secreted IL-2)	
THCA	cis	1	rs9874975	chr3:41764300	ULK4	chr3:41288091-42003660:-	1.05	19.54	6.55E-63	Diastolic blood pressure	
THCA	cis	1	rs9875081	chr3:10083935	C3orf10	chr3:10157333-10168873:+	-0.2	-4.17	3.56E-5	Alzheimer's disease	
THCA	cis	1	rs9875081	chr3:10083935	VHL	chr3:10183319-10193744:+	-0.19	-4.47	9.82E-6	Alzheimer's disease	
THCA	cis	1	rs9875083	chr3:41775786	ULK4	chr3:41288091-42003660:-	1.02	17.79	1.05E-54	Diastolic blood pressure	
THCA	cis	1	rs9875107	chr3:41822313	ULK4	chr3:41288091-42003660:-	1.07	19.91	1.1E-64	Diastolic blood pressure	
THCA	cis	1	rs9876658	chr3:134179453	ANAPC13	chr3:134196547-134204865:-	-0.35	-10.99	3.29E-25	Height	
THCA	cis	1	rs9876658	chr3:134179453	CEP63	chr3:134204575-134293852:+	-0.28	-6.17	1.49E-9	Height	
THCA	cis	1	rs9876781	chr3:48487338	ATRIP	chr3:48488141-48507708:+	0.18	4.03	6.4E-5	Longevity	
THCA	cis	1	rs9876781	chr3:48487338	TREX1	chr3:48501186-48509043:+	-0.25	-5.91	6.6E-9	Longevity	
THCA	cis	1	rs9876960	chr3:41985812	ULK4	chr3:41288091-42003660:-	-1.1	-21.38	1.21E-71	Diastolic blood pressure	
THCA	cis	1	rs9878473	chr3:119650788	GSK3B	chr3:119540804-119813264:-	0.14	4.92	1.22E-6	HDL cholesterol	
THCA	cis	1	rs9878978	chr3:2485969	CNTN4	chr3:2140550-3099644:+	0.33	7.79	4.32E-14	Blood pressure (smoking interaction)	
THCA	cis	1	rs9879080	chr3:10084224	C3orf10	chr3:10157333-10168873:+	-0.19	-4.06	5.78E-5	Alzheimer's disease	
THCA	cis	1	rs9879080	chr3:10084224	VHL	chr3:10183319-10193744:+	-0.19	-4.47	9.92E-6	Alzheimer's disease	
THCA	cis	1	rs9879311	chr3:10415343	GHRLOS	chr3:10322637-10335132:+	0.19	4.62	4.96E-6	Schizophrenia	
THCA	cis	1	rs9879474	chr3:168677984	MECOM	chr3:168801287-169381563:-	0.55	6.04	3.1E-9	Aging (time to event)	
THCA	cis	1	rs9879725	chr3:51009435	MAPKAPK3	chr3:50649339-50686719:+	-0.2	-3.62	0.000323	Bacteremia	
THCA	cis	1	rs9881491	chr3:48487911	ATRIP	chr3:48488141-48507708:+	0.19	4.27	2.39E-5	Longevity	
THCA	cis	1	rs9881491	chr3:48487911	TREX1	chr3:48501186-48509043:+	-0.26	-5.93	5.92E-9	Longevity	
THCA	cis	1	rs9881859	chr3:10072814	C3orf10	chr3:10157333-10168873:+	-0.2	-4.29	2.2E-5	Alzheimer's disease	
THCA	cis	1	rs9881859	chr3:10072814	VHL	chr3:10183319-10193744:+	-0.19	-4.3	2.06E-5	Alzheimer's disease	
THCA	cis	1	rs9882329	chr3:41767154	ULK4	chr3:41288091-42003660:-	1.06	19.46	1.58E-62	Diastolic blood pressure	
THCA	cis	1	rs9882740	chr3:49702484	MST1	chr3:49721381-49726196:-	0.14	4.11	4.72E-5	Crohn's disease;Ulcerative colitis	
THCA	cis	1	rs9882740	chr3:49702484	UBA7	chr3:49842639-49851391:-	0.17	3.73	0.000215	Crohn's disease;Ulcerative colitis	
THCA	cis	1	rs9883753	chr3:134247231	ANAPC13	chr3:134196547-134204865:-	0.37	11.81	2.02E-28	Height	
THCA	cis	1	rs9883753	chr3:134247231	CEP63	chr3:134204575-134293852:+	0.3	6.54	1.6E-10	Height	
THCA	cis	1	rs9883759	chr3:48463618	ATRIP	chr3:48488141-48507708:+	0.2	4.37	1.51E-5	Longevity	
THCA	cis	1	rs9883759	chr3:48463618	TREX1	chr3:48501186-48509043:+	-0.25	-5.82	1.09E-8	Longevity	
THCA	cis	1	rs9883927	chr3:48463711	ATRIP	chr3:48488141-48507708:+	0.19	4.23	2.8E-5	Longevity	
THCA	cis	1	rs9883927	chr3:48463711	TREX1	chr3:48501186-48509043:+	-0.25	-5.76	1.47E-8	Longevity	
THCA	cis	1	rs9884031	chr3:134256500	ANAPC13	chr3:134196547-134204865:-	0.39	12.58	1.56E-31	Height	
THCA	cis	1	rs9884031	chr3:134256500	CEP63	chr3:134204575-134293852:+	0.3	6.54	1.63E-10	Height	
THCA	cis	1	rs9885413	chr5:110176128	TMEM232	chr5:109624934-110062381:-	0.25	3.87	0.000125	Mortality in heart failure	
THCA	cis	1	rs9885796	chr6:44961999	SUPT3H	chr6:44777054-45345670:-	0.17	3.4	0.000732	Height	
THCA	cis	1	rs988712	chr11:27563382	BDNFOS	chr11:27528399-27719773:+	0.24	5.47	7.21E-8	Obesity	
THCA	cis	1	rs9889618	chr17:40293467	HSPB9	chr17:40274756-40275371:+	0.34	5.08	5.4E-7	Fibrinogen levels	
THCA	cis	1	rs9889640	chr17:40293497	HSPB9	chr17:40274756-40275371:+	0.34	5.08	5.4E-7	Fibrinogen levels	
THCA	cis	1	rs9890032	chr17:29165934	SUZ12P	chr17:29035714-29097067:+	0.16	4.58	5.95E-6	Height	
THCA	cis	1	rs9890205	chr17:28382704	ANKRD13B	chr17:27916801-27941778:+	-0.36	-8.96	7.37E-18	Coffee consumption (cups per day)	
THCA	cis	1	rs9890205	chr17:28382704	CORO6	chr17:27941774-27948441:-	-0.5	-11.6	1.33E-27	Coffee consumption (cups per day)	
THCA	cis	1	rs9890205	chr17:28382704	EFCAB5	chr17:28256874-28435469:+	-0.59	-11.24	3.52E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs9890205	chr17:28382704	GIT1	chr17:27900487-27916610:-	-0.28	-6.57	1.35E-10	Coffee consumption (cups per day)	
THCA	cis	1	rs9890205	chr17:28382704	LRRC37B2	chr17:28903483-28992715:+	-0.18	-3.85	0.000134	Coffee consumption (cups per day)	
THCA	cis	1	rs9890205	chr17:28382704	SSH2	chr17:27952965-28257018:-	-0.33	-7.54	2.31E-13	Coffee consumption (cups per day)	
THCA	cis	1	rs9890205	chr17:28382704	TP53I13	chr17:27895739-27900174:+	-0.2	-5.29	1.87E-7	Coffee consumption (cups per day)	
THCA	cis	1	rs9890886	chr17:28391076	ANKRD13B	chr17:27916801-27941778:+	-0.36	-8.96	7.37E-18	Coffee consumption (cups per day)	
THCA	cis	1	rs9890886	chr17:28391076	CORO6	chr17:27941774-27948441:-	-0.5	-11.6	1.33E-27	Coffee consumption (cups per day)	
THCA	cis	1	rs9890886	chr17:28391076	EFCAB5	chr17:28256874-28435469:+	-0.59	-11.24	3.52E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs9890886	chr17:28391076	GIT1	chr17:27900487-27916610:-	-0.28	-6.57	1.35E-10	Coffee consumption (cups per day)	
THCA	cis	1	rs9890886	chr17:28391076	LRRC37B2	chr17:28903483-28992715:+	-0.18	-3.85	0.000134	Coffee consumption (cups per day)	
THCA	cis	1	rs9890886	chr17:28391076	SSH2	chr17:27952965-28257018:-	-0.33	-7.54	2.31E-13	Coffee consumption (cups per day)	
THCA	cis	1	rs9890886	chr17:28391076	TP53I13	chr17:27895739-27900174:+	-0.2	-5.29	1.87E-7	Coffee consumption (cups per day)	
THCA	cis	1	rs9890971	chr17:53059776	STXBP4	chr17:53046126-53241449:+	-0.17	-4.18	3.4E-5	Breast cancer	
THCA	cis	1	rs9891018	chr17:61827856	FTSJ3	chr17:61896795-61905031:-	0.29	5.56	4.49E-8	Body mass index	
THCA	cis	1	rs9891018	chr17:61827856	MAP3K3	chr17:61699775-61773669:+	0.27	5.47	7.16E-8	Body mass index	
THCA	cis	1	rs9891865	chr17:53060033	STXBP4	chr17:53046126-53241449:+	-0.15	-4.2	3.2E-5	Breast cancer	
THCA	cis	1	rs9891865	chr17:53060033	TOM1L1	chr17:52978052-53039328:+	-0.13	-3.35	0.000871	Breast cancer	
THCA	cis	1	rs9891871	chr17:28370191	ANKRD13B	chr17:27916801-27941778:+	-0.36	-8.97	6.79E-18	Coffee consumption (cups per day)	
THCA	cis	1	rs9891871	chr17:28370191	CORO6	chr17:27941774-27948441:-	-0.5	-11.57	1.82E-27	Coffee consumption (cups per day)	
THCA	cis	1	rs9891871	chr17:28370191	EFCAB5	chr17:28256874-28435469:+	-0.59	-11.22	4.4E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs9891871	chr17:28370191	GIT1	chr17:27900487-27916610:-	-0.28	-6.57	1.32E-10	Coffee consumption (cups per day)	
THCA	cis	1	rs9891871	chr17:28370191	LRRC37B2	chr17:28903483-28992715:+	-0.17	-3.75	0.000202	Coffee consumption (cups per day)	
THCA	cis	1	rs9891871	chr17:28370191	SSH2	chr17:27952965-28257018:-	-0.33	-7.52	2.82E-13	Coffee consumption (cups per day)	
THCA	cis	1	rs9891871	chr17:28370191	TP53I13	chr17:27895739-27900174:+	-0.2	-5.3	1.81E-7	Coffee consumption (cups per day)	
THCA	cis	1	rs9891900	chr17:80424386	C17orf62	chr17:80400520-80408694:-	-0.27	-6.24	9.64E-10	Protein quantitative trait loci	
THCA	cis	1	rs9892173	chr17:53060214	STXBP4	chr17:53046126-53241449:+	-0.15	-4.2	3.2E-5	Breast cancer	
THCA	cis	1	rs9892173	chr17:53060214	TOM1L1	chr17:52978052-53039328:+	-0.13	-3.35	0.000871	Breast cancer	
THCA	cis	1	rs9892848	chr17:53059775	STXBP4	chr17:53046126-53241449:+	-0.17	-4.29	2.12E-5	Breast cancer	
THCA	cis	1	rs9892976	chr17:53060329	STXBP4	chr17:53046126-53241449:+	-0.16	-4.23	2.77E-5	Breast cancer	
THCA	cis	1	rs9892976	chr17:53060329	TOM1L1	chr17:52978052-53039328:+	-0.13	-3.4	0.000723	Breast cancer	
THCA	cis	1	rs9893306	chr17:53054749	STXBP4	chr17:53046126-53241449:+	-0.15	-4.2	3.2E-5	Breast cancer	
THCA	cis	1	rs9893306	chr17:53054749	TOM1L1	chr17:52978052-53039328:+	-0.13	-3.35	0.000871	Breast cancer	
THCA	cis	1	rs9893348	chr17:61676534	FTSJ3	chr17:61896795-61905031:-	0.31	5.7	2.09E-8	Body mass index	
THCA	cis	1	rs9893348	chr17:61676534	MAP3K3	chr17:61699775-61773669:+	0.22	4.18	3.51E-5	Body mass index	
THCA	cis	1	rs9894370	chr17:37926004	C17orf37	chr17:37885411-37886788:-	-0.26	-4.4	1.35E-5	Systemic lupus erythematosus	
THCA	cis	1	rs9894429	chr17:79596811	ARL16	chr17:79648234-79650954:-	-0.13	-3.39	0.000759	Eye color traits	
THCA	cis	1	rs9894429	chr17:79596811	TSPAN10	chr17:79609349-79615778:+	0.79	17.47	3.23E-53	Eye color traits	
THCA	cis	1	rs9894529	chr17:53055246	STXBP4	chr17:53046126-53241449:+	-0.15	-4.1	4.86E-5	Breast cancer	
THCA	cis	1	rs9895808	chr17:53048442	STXBP4	chr17:53046126-53241449:+	-0.15	-4.21	3.08E-5	Breast cancer	
THCA	cis	1	rs9895920	chr17:61852719	FTSJ3	chr17:61896795-61905031:-	0.31	5.86	8.41E-9	Body mass index	
THCA	cis	1	rs9895920	chr17:61852719	MAP3K3	chr17:61699775-61773669:+	0.26	5.44	8.47E-8	Body mass index	
THCA	cis	1	rs9896044	chr17:53048542	STXBP4	chr17:53046126-53241449:+	-0.15	-4.11	4.67E-5	Breast cancer	
THCA	cis	1	rs9896062	chr17:28357047	ANKRD13B	chr17:27916801-27941778:+	-0.36	-8.85	1.7E-17	Coffee consumption (cups per day)	
THCA	cis	1	rs9896062	chr17:28357047	CORO6	chr17:27941774-27948441:-	-0.51	-11.7	5.47E-28	Coffee consumption (cups per day)	
THCA	cis	1	rs9896062	chr17:28357047	EFCAB5	chr17:28256874-28435469:+	-0.6	-11.3	2.02E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs9896062	chr17:28357047	GIT1	chr17:27900487-27916610:-	-0.29	-6.8	3.15E-11	Coffee consumption (cups per day)	
THCA	cis	1	rs9896062	chr17:28357047	LRRC37B2	chr17:28903483-28992715:+	-0.18	-3.84	0.000141	Coffee consumption (cups per day)	
THCA	cis	1	rs9896062	chr17:28357047	SSH2	chr17:27952965-28257018:-	-0.34	-7.64	1.18E-13	Coffee consumption (cups per day)	
THCA	cis	1	rs9896062	chr17:28357047	TP53I13	chr17:27895739-27900174:+	-0.2	-5.3	1.81E-7	Coffee consumption (cups per day)	
THCA	cis	1	rs9896259	chr17:20927835	USP22	chr17:20902908-20947073:-	-0.18	-3.83	0.000146	Blood trace element (Se levels)	
THCA	cis	1	rs9896301	chr17:20927886	USP22	chr17:20902908-20947073:-	-0.18	-3.82	0.000153	Blood trace element (Se levels)	
THCA	cis	1	rs9896933	chr17:80898088	FN3KRP	chr17:80674582-80685889:+	-0.46	-5.91	6.56E-9	Bone mineral accretion in asthma (oral corticosteroid dose interaction)	
THCA	cis	1	rs9897206	chr17:28406108	ANKRD13B	chr17:27916801-27941778:+	-0.36	-8.94	8.52E-18	Coffee consumption (cups per day)	
THCA	cis	1	rs9897206	chr17:28406108	CORO6	chr17:27941774-27948441:-	-0.49	-11.3	2.08E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs9897206	chr17:28406108	EFCAB5	chr17:28256874-28435469:+	-0.6	-11.41	7.54E-27	Coffee consumption (cups per day)	
THCA	cis	1	rs9897206	chr17:28406108	GIT1	chr17:27900487-27916610:-	-0.27	-6.36	4.59E-10	Coffee consumption (cups per day)	
THCA	cis	1	rs9897206	chr17:28406108	LRRC37B2	chr17:28903483-28992715:+	-0.18	-3.89	0.000116	Coffee consumption (cups per day)	
THCA	cis	1	rs9897206	chr17:28406108	SSH2	chr17:27952965-28257018:-	-0.34	-7.71	7.4E-14	Coffee consumption (cups per day)	
THCA	cis	1	rs9897206	chr17:28406108	TP53I13	chr17:27895739-27900174:+	-0.2	-5.38	1.16E-7	Coffee consumption (cups per day)	
THCA	cis	1	rs9897362	chr17:17456746	ATPAF2	chr17:17918373-17942480:-	-0.24	-4.03	6.5E-5	Obsessive-compulsive symptoms	
THCA	cis	1	rs9897447	chr17:53048469	STXBP4	chr17:53046126-53241449:+	-0.15	-4.21	3.08E-5	Breast cancer	
THCA	cis	1	rs9897982	chr17:65879592	C17orf58	chr17:65987218-65989765:-	0.25	5.05	6.14E-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs9898265	chr17:20940688	USP22	chr17:20902908-20947073:-	-0.18	-3.86	0.000128	Blood trace element (Se levels)	
THCA	cis	1	rs9898723	chr17:80439907	C17orf62	chr17:80400520-80408694:-	-0.27	-6.55	1.46E-10	Protein quantitative trait loci	
THCA	cis	1	rs9899006	chr17:38017065	C17orf37	chr17:37885411-37886788:-	-0.27	-4.55	6.76E-6	Systemic lupus erythematosus	
THCA	cis	1	rs9899336	chr17:38017780	C17orf37	chr17:37885411-37886788:-	-0.27	-4.55	6.76E-6	Systemic lupus erythematosus	
THCA	cis	1	rs9899491	chr17:61934384	FTSJ3	chr17:61896795-61905031:-	0.29	5.54	5.03E-8	Body mass index	
THCA	cis	1	rs9899491	chr17:61934384	MAP3K3	chr17:61699775-61773669:+	0.26	5.21	2.87E-7	Body mass index	
THCA	cis	1	rs9899788	chr17:61756384	FTSJ3	chr17:61896795-61905031:-	0.31	5.82	1.06E-8	Body mass index	
THCA	cis	1	rs9899788	chr17:61756384	MAP3K3	chr17:61699775-61773669:+	0.25	5.16	3.68E-7	Body mass index	
THCA	cis	1	rs9900541	chr17:37996071	C17orf37	chr17:37885411-37886788:-	-0.28	-4.58	5.85E-6	Systemic lupus erythematosus	
THCA	cis	1	rs9901112	chr17:61730617	FTSJ3	chr17:61896795-61905031:-	0.33	6.34	5.42E-10	Body mass index	
THCA	cis	1	rs9901112	chr17:61730617	MAP3K3	chr17:61699775-61773669:+	0.27	5.54	4.91E-8	Body mass index	
THCA	cis	1	rs9901225	chr17:40755811	CNTNAP1	chr17:40834632-40852010:+	0.15	4.85	1.65E-6	Colorectal or endometrial cancer	
THCA	cis	1	rs9901225	chr17:40755811	HSD17B1	chr17:40703984-40707224:+	-0.17	-5.42	9.35E-8	Colorectal or endometrial cancer	
THCA	cis	1	rs9901225	chr17:40755811	TUBG2	chr17:40811266-40819023:+	-0.27	-7.64	1.2E-13	Colorectal or endometrial cancer	
THCA	cis	1	rs9901483	chr17:37932774	C17orf37	chr17:37885411-37886788:-	-0.25	-4.33	1.82E-5	Systemic lupus erythematosus	
THCA	cis	1	rs9901507	chr17:61765524	FTSJ3	chr17:61896795-61905031:-	0.31	5.82	1.06E-8	Body mass index	
THCA	cis	1	rs9901507	chr17:61765524	MAP3K3	chr17:61699775-61773669:+	0.25	5.16	3.68E-7	Body mass index	
THCA	cis	1	rs9902303	chr17:20927931	USP22	chr17:20902908-20947073:-	-0.18	-3.83	0.000146	Blood trace element (Se levels)	
THCA	cis	1	rs9902453	chr17:28349095	ANKRD13B	chr17:27916801-27941778:+	-0.36	-8.56	1.57E-16	Coffee consumption (cups per day)	
THCA	cis	1	rs9902453	chr17:28349095	CORO6	chr17:27941774-27948441:-	-0.5	-11.56	1.94E-27	Coffee consumption (cups per day)	
THCA	cis	1	rs9902453	chr17:28349095	EFCAB5	chr17:28256874-28435469:+	-0.6	-11.27	2.85E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs9902453	chr17:28349095	GIT1	chr17:27900487-27916610:-	-0.3	-6.83	2.59E-11	Coffee consumption (cups per day)	
THCA	cis	1	rs9902453	chr17:28349095	LRRC37B2	chr17:28903483-28992715:+	-0.18	-3.82	0.000152	Coffee consumption (cups per day)	
THCA	cis	1	rs9902453	chr17:28349095	SSH2	chr17:27952965-28257018:-	-0.35	-7.72	7.04E-14	Coffee consumption (cups per day)	
THCA	cis	1	rs9902453	chr17:28349095	TP53I13	chr17:27895739-27900174:+	-0.19	-5.11	4.55E-7	Coffee consumption (cups per day)	
THCA	cis	1	rs9902687	chr17:53048924	STXBP4	chr17:53046126-53241449:+	-0.15	-4.2	3.2E-5	Breast cancer	
THCA	cis	1	rs9902687	chr17:53048924	TOM1L1	chr17:52978052-53039328:+	-0.13	-3.35	0.000871	Breast cancer	
THCA	cis	1	rs9902718	chr17:53061622	STXBP4	chr17:53046126-53241449:+	-0.15	-4.08	5.33E-5	Breast cancer	
THCA	cis	1	rs9902718	chr17:53061622	TOM1L1	chr17:52978052-53039328:+	-0.13	-3.37	0.000824	Breast cancer	
THCA	cis	1	rs9903146	chr17:53057747	STXBP4	chr17:53046126-53241449:+	-0.15	-4.2	3.2E-5	Breast cancer	
THCA	cis	1	rs9903146	chr17:53057747	TOM1L1	chr17:52978052-53039328:+	-0.13	-3.35	0.000871	Breast cancer	
THCA	cis	1	rs9903204	chr17:40288062	HSPB9	chr17:40274756-40275371:+	0.34	4.95	1.03E-6	Fibrinogen levels	
THCA	cis	1	rs9903220	chr17:53057865	STXBP4	chr17:53046126-53241449:+	-0.15	-4.2	3.2E-5	Breast cancer	
THCA	cis	1	rs9903220	chr17:53057865	TOM1L1	chr17:52978052-53039328:+	-0.13	-3.35	0.000871	Breast cancer	
THCA	cis	1	rs9903444	chr17:53057893	STXBP4	chr17:53046126-53241449:+	-0.15	-4.2	3.19E-5	Breast cancer	
THCA	cis	1	rs9903444	chr17:53057893	TOM1L1	chr17:52978052-53039328:+	-0.13	-3.36	0.000847	Breast cancer	
THCA	cis	1	rs9903503	chr17:17457227	ATPAF2	chr17:17918373-17942480:-	-0.24	-4.01	7.11E-5	Obsessive-compulsive symptoms	
THCA	cis	1	rs9903825	chr17:53057914	STXBP4	chr17:53046126-53241449:+	-0.15	-4.2	3.2E-5	Breast cancer	
THCA	cis	1	rs9903825	chr17:53057914	TOM1L1	chr17:52978052-53039328:+	-0.13	-3.35	0.000871	Breast cancer	
THCA	cis	1	rs9903897	chr17:61716705	FTSJ3	chr17:61896795-61905031:-	0.3	5.78	1.32E-8	Body mass index	
THCA	cis	1	rs9903897	chr17:61716705	MAP3K3	chr17:61699775-61773669:+	0.26	5.33	1.5E-7	Body mass index	
THCA	cis	1	rs9903903	chr17:61762044	FTSJ3	chr17:61896795-61905031:-	0.31	5.82	1.06E-8	Body mass index	
THCA	cis	1	rs9903903	chr17:61762044	MAP3K3	chr17:61699775-61773669:+	0.25	5.16	3.68E-7	Body mass index	
THCA	cis	1	rs9904004	chr17:17476791	ATPAF2	chr17:17918373-17942480:-	-0.25	-4.1	4.9E-5	Obsessive-compulsive symptoms	
THCA	cis	1	rs9904677	chr17:56873025	SUPT4H1	chr17:56422539-56429563:-	-0.16	-4.11	4.67E-5	Cognitive test performance	
THCA	cis	1	rs9905032	chr17:17457768	ATPAF2	chr17:17918373-17942480:-	-0.24	-4	7.33E-5	Obsessive-compulsive symptoms	
THCA	cis	1	rs9905191	chr17:17469918	ATPAF2	chr17:17918373-17942480:-	-0.23	-3.65	0.000288	Obsessive-compulsive symptoms	
THCA	cis	1	rs9905565	chr17:18758641	FAM18B	chr17:18684582-18710026:+	-0.3	-6.87	2.01E-11	Pancreatic cancer	
THCA	cis	1	rs9905704	chr17:56632543	SKA2	chr17:57187308-57232800:-	0.2	4.13	4.32E-5	Testicular germ cell tumor	
THCA	cis	1	rs9905881	chr17:38018955	C17orf37	chr17:37885411-37886788:-	-0.27	-4.55	6.76E-6	Systemic lupus erythematosus	
THCA	cis	1	rs9906340	chr17:28398977	ANKRD13B	chr17:27916801-27941778:+	-0.35	-8.66	7.45E-17	Coffee consumption (cups per day)	
THCA	cis	1	rs9906340	chr17:28398977	CORO6	chr17:27941774-27948441:-	-0.48	-11.1	1.26E-25	Coffee consumption (cups per day)	
THCA	cis	1	rs9906340	chr17:28398977	EFCAB5	chr17:28256874-28435469:+	-0.59	-11.37	1.1E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs9906340	chr17:28398977	GIT1	chr17:27900487-27916610:-	-0.25	-5.78	1.33E-8	Coffee consumption (cups per day)	
THCA	cis	1	rs9906340	chr17:28398977	SSH2	chr17:27952965-28257018:-	-0.34	-7.63	1.26E-13	Coffee consumption (cups per day)	
THCA	cis	1	rs9906340	chr17:28398977	TP53I13	chr17:27895739-27900174:+	-0.21	-5.64	2.95E-8	Coffee consumption (cups per day)	
THCA	cis	1	rs9907291	chr17:38010037	C17orf37	chr17:37885411-37886788:-	-0.27	-4.55	6.76E-6	Systemic lupus erythematosus	
THCA	cis	1	rs9908044	chr17:61747032	FTSJ3	chr17:61896795-61905031:-	0.31	5.82	1.06E-8	Body mass index	
THCA	cis	1	rs9908044	chr17:61747032	MAP3K3	chr17:61699775-61773669:+	0.25	5.16	3.68E-7	Body mass index	
THCA	cis	1	rs9908102	chr17:12896553	ELAC2	chr17:12895703-12921359:-	0.5	12.4	8.32E-31	Schizophrenia	
THCA	cis	1	rs9908349	chr17:76165368	SYNGR2	chr17:76164671-76169009:+	-0.12	-4.01	7.03E-5	Adenocarcinoma;Lung cancer	
THCA	cis	1	rs9908446	chr17:20935471	USP22	chr17:20902908-20947073:-	-0.18	-3.82	0.000153	Blood trace element (Se levels)	
THCA	cis	1	rs9909940	chr17:80689036	FN3KRP	chr17:80674582-80685889:+	-0.55	-10.74	2.92E-24	Glycated hemoglobin levels	
THCA	cis	1	rs9909992	chr17:61731931	FTSJ3	chr17:61896795-61905031:-	0.31	6	3.82E-9	Body mass index	
THCA	cis	1	rs9909992	chr17:61731931	MAP3K3	chr17:61699775-61773669:+	0.27	5.52	5.51E-8	Body mass index	
THCA	cis	1	rs9909	chr11:47799775	C1QTNF4	chr11:47611216-47615961:-	-0.3	-5.23	2.56E-7	Subjective well-being	
THCA	cis	1	rs9911634	chr17:37943731	C17orf37	chr17:37885411-37886788:-	-0.25	-4.26	2.41E-5	Systemic lupus erythematosus	
THCA	cis	1	rs9911854	chr17:80408348	C17orf62	chr17:80400520-80408694:-	-0.26	-6.35	5.12E-10	Protein quantitative trait loci	
THCA	cis	1	rs9911854	chr17:80408348	NARF	chr17:80416060-80446141:+	-0.16	-3.38	0.000772	Protein quantitative trait loci	
THCA	cis	1	rs9912084	chr17:65868035	C17orf58	chr17:65987218-65989765:-	0.24	4.91	1.24E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs9912088	chr17:40288278	HSPB9	chr17:40274756-40275371:+	0.34	4.95	1.03E-6	Fibrinogen levels	
THCA	cis	1	rs9912201	chr17:61763208	FTSJ3	chr17:61896795-61905031:-	0.32	5.85	9.36E-9	Body mass index	
THCA	cis	1	rs9912201	chr17:61763208	MAP3K3	chr17:61699775-61773669:+	0.27	5.32	1.64E-7	Body mass index	
THCA	cis	1	rs9912741	chr17:28359511	ANKRD13B	chr17:27916801-27941778:+	-0.36	-8.97	6.79E-18	Coffee consumption (cups per day)	
THCA	cis	1	rs9912741	chr17:28359511	CORO6	chr17:27941774-27948441:-	-0.5	-11.57	1.82E-27	Coffee consumption (cups per day)	
THCA	cis	1	rs9912741	chr17:28359511	EFCAB5	chr17:28256874-28435469:+	-0.59	-11.22	4.4E-26	Coffee consumption (cups per day)	
THCA	cis	1	rs9912741	chr17:28359511	GIT1	chr17:27900487-27916610:-	-0.28	-6.57	1.32E-10	Coffee consumption (cups per day)	
THCA	cis	1	rs9912741	chr17:28359511	LRRC37B2	chr17:28903483-28992715:+	-0.17	-3.75	0.000202	Coffee consumption (cups per day)	
THCA	cis	1	rs9912741	chr17:28359511	SSH2	chr17:27952965-28257018:-	-0.33	-7.52	2.82E-13	Coffee consumption (cups per day)	
THCA	cis	1	rs9912741	chr17:28359511	TP53I13	chr17:27895739-27900174:+	-0.2	-5.3	1.81E-7	Coffee consumption (cups per day)	
THCA	cis	1	rs9912770	chr17:65868233	C17orf58	chr17:65987218-65989765:-	0.24	4.91	1.24E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs9912904	chr17:61763534	FTSJ3	chr17:61896795-61905031:-	0.31	6.04	3.13E-9	Body mass index	
THCA	cis	1	rs9912904	chr17:61763534	MAP3K3	chr17:61699775-61773669:+	0.26	5.46	7.79E-8	Body mass index	
THCA	cis	1	rs9913471	chr17:65874495	C17orf58	chr17:65987218-65989765:-	0.24	4.78	2.28E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs9914266	chr17:2133250	SRR	chr17:2207248-2228553:+	0.33	5.78	1.38E-8	Myocardial infarction	
THCA	cis	1	rs9914518	chr17:9709946	GAS7	chr17:9813926-10101868:-	0.15	3.53	0.000455	Venous thromboembolism (SNP x SNP interaction)	
THCA	cis	1	rs9914544	chr17:18787828	FAM18B	chr17:18684582-18710026:+	-0.42	-10.74	3.11E-24	Educational attainment (years of education)	
THCA	cis	1	rs9914544	chr17:18787828	FBXW10	chr17:18647326-18682661:+	-0.23	-5.05	6.34E-7	Educational attainment (years of education)	
THCA	cis	1	rs9914732	chr17:53054367	STXBP4	chr17:53046126-53241449:+	-0.15	-4.2	3.2E-5	Breast cancer	
THCA	cis	1	rs9914732	chr17:53054367	TOM1L1	chr17:52978052-53039328:+	-0.13	-3.35	0.000871	Breast cancer	
THCA	cis	1	rs9914757	chr17:37967562	C17orf37	chr17:37885411-37886788:-	-0.27	-4.36	1.56E-5	Systemic lupus erythematosus	
THCA	cis	1	rs9915108	chr17:65874463	C17orf58	chr17:65987218-65989765:-	0.24	4.78	2.28E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs9915183	chr17:53047137	STXBP4	chr17:53046126-53241449:+	-0.15	-4.21	3.08E-5	Breast cancer	
THCA	cis	1	rs9915255	chr17:40284191	HSPB9	chr17:40274756-40275371:+	0.34	5.01	7.8E-7	Fibrinogen levels	
THCA	cis	1	rs9915591	chr17:65826090	C17orf58	chr17:65987218-65989765:-	0.22	4.45	1.05E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
THCA	cis	1	rs9915832	chr17:53054697	STXBP4	chr17:53046126-53241449:+	-0.15	-4.2	3.2E-5	Breast cancer	
THCA	cis	1	rs9915832	chr17:53054697	TOM1L1	chr17:52978052-53039328:+	-0.13	-3.35	0.000871	Breast cancer	
THCA	cis	1	rs9916245	chr17:18766825	FAM18B	chr17:18684582-18710026:+	-0.42	-10.63	7.77E-24	Educational attainment (years of education)	
THCA	cis	1	rs9916245	chr17:18766825	FBXW10	chr17:18647326-18682661:+	-0.22	-4.84	1.75E-6	Educational attainment (years of education)	
THCA	cis	1	rs9916642	chr17:53054497	STXBP4	chr17:53046126-53241449:+	-0.15	-4.2	3.2E-5	Breast cancer	
THCA	cis	1	rs9916642	chr17:53054497	TOM1L1	chr17:52978052-53039328:+	-0.13	-3.35	0.000871	Breast cancer	
THCA	cis	1	rs9917978	chr4:165885143	C4orf39	chr4:165878100-165880273:+	0.19	5.28	1.98E-7	Ovarian cancer in BRCA1 mutation carriers	
THCA	cis	1	rs9918016	chr4:159621997	ETFDH	chr4:159593277-159629839:+	0.17	4.17	3.58E-5	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
THCA	cis	1	rs9918016	chr4:159621997	PPID	chr4:159630280-159644552:-	-0.25	-4.78	2.37E-6	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
THCA	cis	1	rs9919599	chr11:116745484	PCSK7	chr11:117075789-117102811:-	-0.28	-4.72	3.08E-6	Protein quantitative trait loci	
THCA	cis	1	rs9920079	chr15:24795919	PWRN1	chr15:24778839-24832924:+	0.44	9.15	1.62E-18	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
THCA	cis	1	rs9920830	chr15:24795916	PWRN1	chr15:24778839-24832924:+	0.44	9.15	1.62E-18	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
THCA	cis	1	rs9921222	chr16:375782	DECR2	chr16:451858-462486:+	-0.22	-4.81	1.99E-6	Bone mineral density (spine);Bone mineral density	
THCA	cis	1	rs9923145	chr16:74686166	RFWD3	chr16:74655298-74700779:-	-0.32	-8.21	2.12E-15	Testicular germ cell tumor	
THCA	cis	1	rs9923856	chr16:11210415	CLEC16A	chr16:11038345-11276044:+	-0.12	-3.39	0.00075	Adult asthma;Atopic dermatitis	
THCA	cis	1	rs992416	chr17:61745905	FTSJ3	chr17:61896795-61905031:-	0.31	6.04	3.13E-9	Body mass index	
THCA	cis	1	rs992416	chr17:61745905	MAP3K3	chr17:61699775-61773669:+	0.26	5.46	7.79E-8	Body mass index	
THCA	cis	1	rs992422	chr7:87397345	DBF4	chr7:87505544-87538856:+	-0.27	-4.08	5.34E-5	Bone mineral density (spine) and age at menarche	
THCA	cis	1	rs9924629	chr16:50095506	HEATR3	chr16:50099881-50139373:+	-0.4	-6.49	2.13E-10	Esophageal cancer (squamous cell)	
THCA	cis	1	rs9925215	chr16:50096130	HEATR3	chr16:50099881-50139373:+	0.39	6.21	1.14E-9	Esophageal cancer (squamous cell)	
THCA	cis	1	rs9925964	chr16:31129895	C16orf93	chr16:30768753-30773542:-	0.2	5.87	8.28E-9	Body mass index	
THCA	cis	1	rs9925964	chr16:31129895	HSD3B7	chr16:30996519-31000473:+	-0.27	-6.6	1.08E-10	Body mass index	
THCA	cis	1	rs9925964	chr16:31129895	MYST1	chr16:31128985-31142713:+	-0.22	-7.74	5.84E-14	Body mass index	
THCA	cis	1	rs9929423	chr16:67733113	C16orf86	chr16:67700717-67702659:+	-0.32	-4.04	6.34E-5	Crohn's disease	
THCA	cis	1	rs9929423	chr16:67733113	ZDHHC1	chr16:67428323-67450339:-	0.43	4.96	9.82E-7	Crohn's disease	
THCA	cis	1	rs9929461	chr16:69478168	CYB5B	chr16:69458498-69500167:+	-0.23	-3.99	7.7E-5	Blood pressure (smoking interaction)	
THCA	cis	1	rs9929496	chr16:74668473	RFWD3	chr16:74655298-74700779:-	-0.3	-7.76	5.16E-14	Testicular germ cell tumor	
THCA	cis	1	rs9929857	chr16:69471417	CYB5B	chr16:69458498-69500167:+	-0.23	-3.99	7.7E-5	Blood pressure (smoking interaction)	
THCA	cis	1	rs9930094	chr16:69465673	CYB5B	chr16:69458498-69500167:+	-0.24	-4.19	3.35E-5	Blood pressure (smoking interaction)	
THCA	cis	1	rs9930728	chr16:69466275	CYB5B	chr16:69458498-69500167:+	0.27	4.79	2.22E-6	Blood pressure (smoking interaction)	
THCA	cis	1	rs9931225	chr16:74699293	RFWD3	chr16:74655298-74700779:-	-0.31	-7.91	1.77E-14	Testicular germ cell tumor	
THCA	cis	1	rs9932240	chr16:50094227	HEATR3	chr16:50099881-50139373:+	-0.4	-6.48	2.25E-10	Esophageal cancer (squamous cell)	
THCA	cis	1	rs9933309	chr16:88844932	TRAPPC2L	chr16:88922628-88927591:+	-0.13	-4.12	4.41E-5	Glycated hemoglobin levels	
THCA	cis	1	rs9936966	chr16:50090366	HEATR3	chr16:50099881-50139373:+	0.39	6.14	1.71E-9	Esophageal cancer (squamous cell)	
THCA	cis	1	rs9937829	chr16:69473614	CYB5B	chr16:69458498-69500167:+	-0.23	-3.96	8.78E-5	Blood pressure (smoking interaction)	
THCA	cis	1	rs9938630	chr16:29837108	MAPK3	chr16:30125427-30134630:-	-0.24	-3.47	0.000562	Multiple sclerosis	
THCA	cis	1	rs9938862	chr16:67723801	ZDHHC1	chr16:67428323-67450339:-	0.47	5.37	1.26E-7	Crohn's disease	
THCA	cis	1	rs9939085	chr16:67733237	LRRC36	chr16:67360747-67419108:+	0.38	3.46	0.000583	Crohn's disease	
THCA	cis	1	rs9939085	chr16:67733237	ZDHHC1	chr16:67428323-67450339:-	0.49	5.48	6.91E-8	Crohn's disease	
THCA	cis	1	rs9939434	chr16:20396958	ACSM1	chr16:20634559-20709066:-	-0.26	-3.4	0.000742	Urinary uromodulin levels	
THCA	cis	1	rs9939710	chr16:50093951	HEATR3	chr16:50099881-50139373:+	-0.4	-6.49	2.13E-10	Esophageal cancer (squamous cell)	
THCA	cis	1	rs9941002	chr16:69502639	CYB5B	chr16:69458498-69500167:+	-0.23	-4.13	4.26E-5	Blood pressure (smoking interaction)	
THCA	cis	1	rs9941751	chr20:33645709	PROCR	chr20:33758727-33765164:+	-0.32	-5.31	1.64E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs9941751	chr20:33645709	TRPC4AP	chr20:33590215-33680618:-	0.27	3.44	0.000635	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
THCA	cis	1	rs9942937	chr9:109616137	ZNF462	chr9:109625378-109773789:+	-0.11	-3.74	0.000203	Height	
THCA	cis	1	rs9943661	chr11:32893777	CCDC73	chr11:32623627-32816187:-	0.32	6.72	5.21E-11	Parkinson's disease (age of onset)	
THCA	cis	1	rs9943661	chr11:32893777	QSER1	chr11:32914792-33014862:+	0.1	3.51	0.000499	Parkinson's disease (age of onset)	
THCA	cis	1	rs9943849	chr12:69370756	CPM	chr12:69244958-69357020:-	-0.17	-3.36	0.000855	Major depressive disorder	
THCA	cis	1	rs9944423	chr17:17484934	ATPAF2	chr17:17918373-17942480:-	-0.25	-4.22	2.97E-5	Obsessive-compulsive symptoms	
THCA	cis	1	rs994532	chr2:218284210	DIRC3	chr2:218148748-218621316:-	-0.21	-4.94	1.06E-6	Height	
THCA	cis	1	rs994533	chr2:218284278	DIRC3	chr2:218148748-218621316:-	-0.21	-4.94	1.07E-6	Height	
THCA	cis	1	rs9945428	chr18:71788676	FBXO15	chr18:71740588-71815100:-	0.24	6.35	5.15E-10	Venous thromboembolism (SNP x SNP interaction)	
THCA	cis	1	rs9948342	chr18:23699545	SS18	chr18:23596219-23671164:-	0.27	3.42	0.00067	Rhegmatogenous retinal detachment	
THCA	cis	1	rs9950515	chr18:23736634	SS18	chr18:23596219-23671164:-	0.28	3.51	0.000493	Rhegmatogenous retinal detachment	
THCA	cis	1	rs9952498	chr18:23728300	SS18	chr18:23596219-23671164:-	0.28	3.51	0.000493	Rhegmatogenous retinal detachment	
THCA	cis	1	rs9955622	chr18:47203955	CXXC1	chr18:47808715-47814692:-	0.09	3.34	0.000897	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	
THCA	cis	1	rs9956068	chr18:23584823	SS18	chr18:23596219-23671164:-	0.26	3.4	0.000737	Rhegmatogenous retinal detachment	
THCA	cis	1	rs996065	chr17:20936403	USP22	chr17:20902908-20947073:-	-0.18	-3.83	0.000146	Blood trace element (Se levels)	
THCA	cis	1	rs9962034	chr18:23601153	SS18	chr18:23596219-23671164:-	0.27	3.42	0.000688	Rhegmatogenous retinal detachment	
THCA	cis	1	rs9963862	chr18:20587911	NPC1	chr18:21108363-21166581:-	-0.11	-3.44	0.000637	Late-onset myasthenia gravis	
THCA	cis	1	rs9967283	chr18:23720885	SS18	chr18:23596219-23671164:-	0.28	3.54	0.000435	Rhegmatogenous retinal detachment	
THCA	cis	1	rs9968172	chr3:134231251	ANAPC13	chr3:134196547-134204865:-	-0.4	-12.79	2.04E-32	Height	
THCA	cis	1	rs9968172	chr3:134231251	CEP63	chr3:134204575-134293852:+	-0.29	-6.33	5.73E-10	Height	
THCA	cis	1	rs9971695	chr12:124413491	DNAH10	chr12:124247042-124420265:+	0.19	3.77	0.000184	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs9971695	chr12:124413491	ZNF664	chr12:124457670-124499967:+	-0.16	-4.41	1.29E-5	Waist-to-hip ratio adjusted for body mass index	
THCA	cis	1	rs997295	chr15:68016343	C15orf61	chr15:67813522-67819638:+	0.12	3.38	0.000791	Motion sickness	
THCA	cis	1	rs997295	chr15:68016343	IQCH	chr15:67547188-67794139:+	0.17	5.24	2.46E-7	Motion sickness	
THCA	cis	1	rs997295	chr15:68016343	MAP2K5	chr15:67835021-68099451:+	0.14	3.48	0.000539	Motion sickness	
THCA	cis	1	rs9973718	chr2:53224326	CHAC2	chr2:53994929-54002287:+	0.22	3.45	0.000618	Post bronchodilator FEV1/FVC ratio	
THCA	cis	1	rs9975986	chr21:44458961	PKNOX1	chr21:44394643-44453688:+	0.33	4.56	6.46E-6	Information processing speed	
THCA	cis	1	rs9981595	chr21:40560678	HMGN1	chr21:40714247-40721270:-	-0.24	-3.87	0.000125	Venous thromboembolism (SNP x SNP interaction)	
THCA	cis	1	rs9982088	chr21:34686841	IFNAR1	chr21:34696734-34732126:+	0.22	5.34	1.46E-7	Narcolepsy	
THCA	cis	1	rs9984563	chr21:44423653	PKNOX1	chr21:44394643-44453688:+	0.34	4.61	5.25E-6	Information processing speed	
THCA	cis	1	rs9984793	chr21:30486471	C21orf7	chr21:30449812-30548200:+	0.2	3.9	0.00011	Dental caries	
THCA	cis	1	rs9985356	chr3:134232920	ANAPC13	chr3:134196547-134204865:-	-0.38	-12	3.66E-29	Height	
THCA	cis	1	rs9985356	chr3:134232920	CEP63	chr3:134204575-134293852:+	-0.3	-6.45	2.76E-10	Height	
THCA	cis	1	rs9986382	chr6:26550619	BTN2A3	chr6:26422317-26431927:+	0.17	4.1	4.87E-5	Educational attainment	
THCA	cis	1	rs9986382	chr6:26550619	HCG11	chr6:26521934-26527610:+	-0.21	-4.11	4.68E-5	Educational attainment	
THCA	cis	1	rs9986382	chr6:26550619	HMGN4	chr6:26538572-26547162:+	-0.16	-4	7.44E-5	Educational attainment	
THCA	cis	1	rs9986382	chr6:26550619	ZNF322A	chr6:26634612-26659963:-	-0.16	-4.4	1.34E-5	Educational attainment	
THCA	cis	1	rs9986596	chr6:28219661	ZKSCAN3	chr6:28317691-28334523:+	-0.25	-4.64	4.46E-6	Depression	
THCA	cis	1	rs9986596	chr6:28219661	ZNF187	chr6:28234788-28245978:+	-0.36	-7.08	5.03E-12	Depression	
THCA	cis	1	rs9986596	chr6:28219661	ZNF193	chr6:28193067-28201260:+	0.2	3.62	0.000323	Depression	
THCA	cis	1	rs9986596	chr6:28219661	ZNF323	chr6:28292517-28324048:-	0.43	5.79	1.25E-8	Depression	
THCA	cis	1	rs9986596	chr6:28219661	ZNF389	chr6:28129551-28137375:+	-0.49	-6.86	2.12E-11	Depression	
THCA	cis	1	rs9986596	chr6:28219661	ZSCAN23	chr6:28393287-28411279:-	0.23	4.95	1.05E-6	Depression	
THCA	cis	1	rs9986696	chr7:65704576	ASL	chr7:65540776-65558321:+	0.16	4.19	3.29E-5	Aortic root size	
THCA	cis	1	rs9986696	chr7:65704576	GUSB	chr7:65425675-65447246:-	-0.27	-5.35	1.35E-7	Aortic root size	
THCA	cis	1	rs9986696	chr7:65704576	RABGEF1	chr7:66093890-66276446:+	-0.65	-13.96	2.22E-37	Aortic root size	
THCA	cis	1	rs9987289	chr8:9183358	SGK223	chr8:8175259-8239257:-	0.32	3.35	0.00086	C-reactive protein levels or triglyceride levels (pleiotropy);HDL cholesterol;HDL Cholesterol - Triglycerides (HDLC-TG);C-reactive protein levels or LDL-cholesterol levels (pleiotropy);Cholesterol, total;C-reactive protein levels;C-reactive protein levels or HDL-cholesterol levels (pleiotropy);Metab	
THCA	cis	1	rs9987353	chr8:9116349	SGK223	chr8:8175259-8239257:-	0.39	6.76	4.02E-11	Recombination measurement	
THCA	cis	1	rs9987357	chr8:124187620	FAM83A	chr8:124191287-124222317:+	-0.34	-4.39	1.41E-5	Urinary uromodulin levels	
THCA	cis	1	rs9988450	chr1:62924448	DOCK7	chr1:62920398-63153969:-	-0.1	-4.02	6.64E-5	Triglycerides	
THCA	cis	1	rs9988866	chr11:18392983	GTF2H1	chr11:18343816-18388590:+	0.35	9.46	1.42E-19	Pancreatic cancer	
THCA	cis	1	rs9989967	chr3:134238964	ANAPC13	chr3:134196547-134204865:-	0.37	11.72	4.84E-28	Height	
THCA	cis	1	rs9989967	chr3:134238964	CEP63	chr3:134204575-134293852:+	0.3	6.49	2.09E-10	Height	
THCA	cis	1	rs9990333	chr3:195827205	SDHAP2	chr3:195384910-195415733:+	-0.21	-4.14	4.16E-5	Iron status biomarkers (transferrin saturation);Iron status biomarkers (transferrin levels)	
THCA	cis	1	rs9990351	chr3:134239191	ANAPC13	chr3:134196547-134204865:-	-0.36	-11.47	4.48E-27	Height	
THCA	cis	1	rs9990351	chr3:134239191	CEP63	chr3:134204575-134293852:+	-0.29	-6.36	4.81E-10	Height	
THCA	cis	1	rs9990742	chr4:39121414	KLHL5	chr4:39046659-39123828:+	-0.2	-5.4	1.06E-7	Uric acid levels	
THCA	cis	1	rs9990755	chr4:39121439	KLHL5	chr4:39046659-39123828:+	-0.21	-5.77	1.47E-8	Uric acid levels	
THCA	cis	1	rs9991678	chr4:165885039	C4orf39	chr4:165878100-165880273:+	0.2	5.56	4.48E-8	Ovarian cancer in BRCA1 mutation carriers	
THCA	cis	1	rs9992101	chr4:77360431	CCDC158	chr4:77234193-77328458:-	0.18	3.83	0.000147	Creatinine levels	
THCA	cis	1	rs9992101	chr4:77360431	FAM47E	chr4:77135193-77204923:+	0.14	3.58	0.000374	Creatinine levels	
THCA	cis	1	rs9995007	chr4:76897791	NAAA	chr4:76831809-76862166:-	-0.35	-7.07	5.45E-12	Longevity	
THCA	cis	1	rs9996285	chr4:39132176	KLHL5	chr4:39046659-39123828:+	-0.2	-5.72	1.9E-8	Uric acid levels	
THCA	cis	1	rs9996834	chr4:103557529	CISD2	chr4:103790135-103809913:+	-0.16	-3.62	0.000321	Primary biliary cirrhosis	
THCA	cis	1	rs9996834	chr4:103557529	NFKB1	chr4:103422486-103538458:+	0.15	4.2	3.16E-5	Primary biliary cirrhosis	
THCA	cis	1	rs9997089	chr4:39120883	KLHL5	chr4:39046659-39123828:+	-0.21	-5.77	1.47E-8	Uric acid levels	
THCA	cis	1	rs9997288	chr4:56347227	TMEM165	chr4:56262090-56292342:+	-0.15	-3.69	0.000252	Personality dimensions	
THCA	cis	1	rs9997663	chr4:75705378	BTC	chr4:75671448-75719882:-	0.21	3.95	9.15E-5	Electroencephalogram traits	
THCA	cis	1	rs9998146	chr4:56397977	TMEM165	chr4:56262090-56292342:+	0.15	3.71	0.000234	Personality dimensions	
THCA	cis	1	rs9998442	chr4:75706141	BTC	chr4:75671448-75719882:-	0.2	3.88	0.00012	Electroencephalogram traits	
THCA	cis	1	rs9998481	chr4:39118835	KLHL5	chr4:39046659-39123828:+	-0.21	-5.77	1.47E-8	Uric acid levels	
THCA	cis	1	rs9998867	chr4:39119162	KLHL5	chr4:39046659-39123828:+	-0.21	-5.77	1.47E-8	Uric acid levels	
THCA	cis	1	rs9999327	chr4:39111731	KLHL5	chr4:39046659-39123828:+	-0.21	-5.73	1.77E-8	Uric acid levels	
THCA	trans	1	rs10037055	chr5:176691279	LOC388955	chr2:63849182-63850159:-	-0.73	-19.34	5.71E-62	Migraine without aura	
THCA	trans	1	rs10214634	chr6:26564582	ZNF322B	chr9:99957633-99961910:-	0.58	11.37	1.09E-26	Educational attainment	
THCA	trans	1	rs10456362	chr6:28221816	BTN3A2	chr6:26365398-26378546:+	0.43	8.7	5.47E-17	Depression	
THCA	trans	1	rs10484442	chr6:26555879	ZNF322B	chr9:99957633-99961910:-	0.57	10.95	4.62E-25	Educational attainment	
THCA	trans	1	rs1056667	chr6:26510564	ZNF322B	chr9:99957633-99961910:-	0.55	10.32	1.08E-22	Educational attainment	
THCA	trans	1	rs10739496	chr9:100552559	ABCC11	chr16:48200822-48281479:-	0.29	5.89	7.21E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10739496	chr9:100552559	BMPR1A	chr10:88516396-88684944:+	-0.25	-6.4	3.76E-10	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10739496	chr9:100552559	CLDN2	chrX:106143394-106174091:+	0.26	6.09	2.26E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10739496	chr9:100552559	EFNB2	chr13:107142098-107187337:-	-0.25	-6	3.85E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10739496	chr9:100552559	EML5	chr14:89081205-89259157:-	0.3	6.84	2.44E-11	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10739496	chr9:100552559	EPDR1	chr7:37960163-37991539:+	0.33	7.43	5.06E-13	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10739496	chr9:100552559	MALL	chr2:110841452-110874143:-	0.29	5.97	4.71E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10739496	chr9:100552559	NKX6-1	chr4:85414436-85419387:-	0.49	8.44	3.89E-16	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10739496	chr9:100552559	TTC8	chr14:89290497-89344334:+	0.25	6.11	2.11E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10759927	chr9:100542176	CLDN2	chrX:106143394-106174091:+	0.27	6.08	2.45E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10759927	chr9:100542176	EML5	chr14:89081205-89259157:-	0.29	6.69	6.16E-11	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10759927	chr9:100542176	EPDR1	chr7:37960163-37991539:+	0.32	7	8.99E-12	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10759927	chr9:100542176	LRRC42	chr1:54412037-54433839:+	-0.24	-6.2	1.23E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10759927	chr9:100542176	NKX6-1	chr4:85414436-85419387:-	0.5	8.7	5.52E-17	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10759927	chr9:100542176	PLCE1	chr10:95753746-96088146:+	0.27	6.2	1.22E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs1078679	chr6:26568741	ZNF322B	chr9:99957633-99961910:-	0.59	11.32	1.79E-26	Educational attainment	
THCA	trans	1	rs10794671	chr1:121168242	NBPF14	chr1:148003643-148346791:-	0.44	10.33	1.04E-22	Hip geometry	
THCA	trans	1	rs10903159	chr1:121181997	NBPF14	chr1:148003643-148346791:-	0.43	10.32	1.08E-22	Hip geometry	
THCA	trans	1	rs10903161	chr1:121178741	NBPF14	chr1:148003643-148346791:-	0.41	9.7	1.99E-20	Hip geometry	
THCA	trans	1	rs10946834	chr6:26533664	ZNF322B	chr9:99957633-99961910:-	0.54	10.29	1.42E-22	Educational attainment	
THCA	trans	1	rs10946835	chr6:26533757	ZNF322B	chr9:99957633-99961910:-	0.54	10.29	1.42E-22	Educational attainment	
THCA	trans	1	rs10983700	chr9:100537455	CLDN2	chrX:106143394-106174091:+	0.27	6.08	2.45E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10983700	chr9:100537455	EML5	chr14:89081205-89259157:-	0.29	6.69	6.16E-11	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10983700	chr9:100537455	EPDR1	chr7:37960163-37991539:+	0.32	7	8.99E-12	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10983700	chr9:100537455	LRRC42	chr1:54412037-54433839:+	-0.24	-6.2	1.23E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10983700	chr9:100537455	NKX6-1	chr4:85414436-85419387:-	0.5	8.7	5.52E-17	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10983700	chr9:100537455	PLCE1	chr10:95753746-96088146:+	0.27	6.2	1.22E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10983701	chr9:100537577	BMPR1A	chr10:88516396-88684944:+	-0.23	-5.93	5.73E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10983701	chr9:100537577	C10orf47	chr10:11865397-11914274:+	-0.22	-5.89	7.32E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10983701	chr9:100537577	CLDN2	chrX:106143394-106174091:+	0.27	6.14	1.69E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10983701	chr9:100537577	EML5	chr14:89081205-89259157:-	0.3	6.76	4.15E-11	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10983701	chr9:100537577	EPDR1	chr7:37960163-37991539:+	0.3	6.72	5.24E-11	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10983701	chr9:100537577	LRRC42	chr1:54412037-54433839:+	-0.24	-6.22	1.1E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10983701	chr9:100537577	NKX6-1	chr4:85414436-85419387:-	0.5	8.68	6.4E-17	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10983701	chr9:100537577	PLCE1	chr10:95753746-96088146:+	0.28	6.27	8.31E-10	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10983761	chr9:100553957	BMPR1A	chr10:88516396-88684944:+	-0.24	-6.3	6.58E-10	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10983761	chr9:100553957	CLDN2	chrX:106143394-106174091:+	0.26	6.02	3.46E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10983761	chr9:100553957	EML5	chr14:89081205-89259157:-	0.3	6.88	1.9E-11	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10983761	chr9:100553957	EPDR1	chr7:37960163-37991539:+	0.32	7.17	2.86E-12	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10983761	chr9:100553957	GGT5	chr22:24615623-24641110:-	0.26	5.98	4.48E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10983761	chr9:100553957	LRRC42	chr1:54412037-54433839:+	-0.23	-5.96	4.79E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10983761	chr9:100553957	NKX6-1	chr4:85414436-85419387:-	0.48	8.35	7.4E-16	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs10983761	chr9:100553957	PLCE1	chr10:95753746-96088146:+	0.27	6.07	2.66E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs11249350	chr1:121178446	NBPF14	chr1:148003643-148346791:-	0.44	10.43	4.37E-23	Hip geometry	
THCA	trans	1	rs11249351	chr1:121171942	NBPF14	chr1:148003643-148346791:-	0.42	9.85	6.01E-21	Hip geometry	
THCA	trans	1	rs1167827	chr7:75163169	TRIM74	chr7:75021265-75040277:+	-0.34	-6.76	4.14E-11	Body mass index	
THCA	trans	1	rs11756120	chr6:26529808	ZNF322B	chr9:99957633-99961910:-	0.54	10.29	1.42E-22	Educational attainment	
THCA	trans	1	rs11965538	chr6:28239915	BTN3A2	chr6:26365398-26378546:+	-0.5	-9.8	9.06E-21	Depression	
THCA	trans	1	rs12047116	chr1:121185770	NBPF14	chr1:148003643-148346791:-	0.43	10.36	7.92E-23	Hip geometry	
THCA	trans	1	rs12145080	chr1:121185531	NBPF14	chr1:148003643-148346791:-	-0.41	-9.58	5.27E-20	Hip geometry	
THCA	trans	1	rs12158264	chr22:38001504	AP1B1	chr22:29723671-29784569:-	-0.53	-5.96	4.82E-9	Response to anti-depressant treatment in major depressive disorder	
THCA	trans	1	rs12158264	chr22:38001504	C22orf32	chr22:42475699-42480287:+	-0.45	-6.2	1.2E-9	Response to anti-depressant treatment in major depressive disorder	
THCA	trans	1	rs12158264	chr22:38001504	HPS4	chr22:26847447-26879820:-	-0.54	-6.34	5.46E-10	Response to anti-depressant treatment in major depressive disorder	
THCA	trans	1	rs12158264	chr22:38001504	LOC284900	chr22:28315364-28404267:+	-0.42	-6.27	8.2E-10	Response to anti-depressant treatment in major depressive disorder	
THCA	trans	1	rs12158264	chr22:38001504	POLDIP3	chr22:42979728-43010962:-	-0.5	-6.37	4.35E-10	Response to anti-depressant treatment in major depressive disorder	
THCA	trans	1	rs12158264	chr22:38001504	PPIL2	chr22:22020273-22052201:+	-0.5	-5.91	6.68E-9	Response to anti-depressant treatment in major depressive disorder	
THCA	trans	1	rs12158264	chr22:38001504	SAMM50	chr22:44351261-44392411:+	-0.52	-6.55	1.54E-10	Response to anti-depressant treatment in major depressive disorder	
THCA	trans	1	rs12158264	chr22:38001504	SLC2A11	chr22:24199059-24227723:+	-0.62	-6.32	6.15E-10	Response to anti-depressant treatment in major depressive disorder	
THCA	trans	1	rs12158264	chr22:38001504	TUBGCP6	chr22:50656118-50683400:-	-0.39	-5.98	4.32E-9	Response to anti-depressant treatment in major depressive disorder	
THCA	trans	1	rs12158264	chr22:38001504	TXN2	chr22:36863093-36877687:-	-0.48	-6.5	2.05E-10	Response to anti-depressant treatment in major depressive disorder	
THCA	trans	1	rs12158264	chr22:38001504	UBE2L3	chr22:21921957-21978323:+	-0.49	-6.15	1.68E-9	Response to anti-depressant treatment in major depressive disorder	
THCA	trans	1	rs12158264	chr22:38001504	XRCC6	chr22:42017295-42060052:+	-0.52	-6.41	3.4E-10	Response to anti-depressant treatment in major depressive disorder	
THCA	trans	1	rs12158264	chr22:38001504	ZMAT5	chr22:30126946-30163000:-	-0.42	-6.58	1.22E-10	Response to anti-depressant treatment in major depressive disorder	
THCA	trans	1	rs12209877	chr6:21027761	CAMSAP1	chr9:138700334-138799005:-	-0.2	-6.04	3.02E-9	Cognitive function	
THCA	trans	1	rs12293522	chr11:49558425	FOLH1B	chr11:89392465-89431885:+	-0.35	-6.23	1.01E-9	Height	
THCA	trans	1	rs12526680	chr6:26550954	ZNF322B	chr9:99957633-99961910:-	0.55	10.75	2.86E-24	Educational attainment	
THCA	trans	1	rs13195401	chr6:26463574	RNF5P1	chr8:38457695-38458775:-	0.74	6.45	2.75E-10	Schizophrenia	
THCA	trans	1	rs13195401	chr6:26463574	ZFP57	chr6:29640171-29648887:-	0.84	7.79	4.28E-14	Schizophrenia	
THCA	trans	1	rs13195401	chr6:26463574	ZNF389	chr6:28129551-28137375:+	-0.64	-6.25	8.95E-10	Schizophrenia	
THCA	trans	1	rs13195402	chr6:26463575	RNF5P1	chr8:38457695-38458775:-	0.74	6.45	2.75E-10	Schizophrenia	
THCA	trans	1	rs13195402	chr6:26463575	ZFP57	chr6:29640171-29648887:-	0.84	7.79	4.28E-14	Schizophrenia	
THCA	trans	1	rs13195402	chr6:26463575	ZNF389	chr6:28129551-28137375:+	-0.64	-6.25	8.95E-10	Schizophrenia	
THCA	trans	1	rs13200462	chr6:28218199	BTN3A2	chr6:26365398-26378546:+	-0.54	-10.42	4.69E-23	Depression	
THCA	trans	1	rs1321479	chr6:26501897	ZNF322B	chr9:99957633-99961910:-	-0.53	-9.99	1.77E-21	Educational attainment	
THCA	trans	1	rs1321480	chr6:26532742	ZNF322B	chr9:99957633-99961910:-	0.54	10.29	1.46E-22	Educational attainment	
THCA	trans	1	rs1321481	chr6:26538210	ZNF322B	chr9:99957633-99961910:-	0.54	10.32	1.12E-22	Educational attainment	
THCA	trans	1	rs13220495	chr6:26441640	RNF5P1	chr8:38457695-38458775:-	0.75	6.37	4.35E-10	Schizophrenia	
THCA	trans	1	rs13220495	chr6:26441640	ZFP57	chr6:29640171-29648887:-	0.83	7.49	3.39E-13	Schizophrenia	
THCA	trans	1	rs1355062	chr12:88906789	ATP6V1B1	chr2:71162998-71192560:+	-0.41	-5.94	5.43E-9	Testicular germ cell tumor	
THCA	trans	1	rs1419183	chr6:28242794	BTN3A2	chr6:26365398-26378546:+	-0.5	-9.8	9.06E-21	Depression	
THCA	trans	1	rs1443438	chr9:100550028	BMPR1A	chr10:88516396-88684944:+	-0.24	-6.19	1.26E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs1443438	chr9:100550028	CLDN2	chrX:106143394-106174091:+	0.26	6.08	2.48E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs1443438	chr9:100550028	EFNB2	chr13:107142098-107187337:-	-0.25	-5.87	7.95E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs1443438	chr9:100550028	EML5	chr14:89081205-89259157:-	0.3	6.83	2.65E-11	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs1443438	chr9:100550028	EPDR1	chr7:37960163-37991539:+	0.32	7.23	1.88E-12	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs1443438	chr9:100550028	NKX6-1	chr4:85414436-85419387:-	0.5	8.61	1.08E-16	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs1443438	chr9:100550028	PLCE1	chr10:95753746-96088146:+	0.26	5.99	4.14E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs1443438	chr9:100550028	TTC8	chr14:89290497-89344334:+	0.24	6	3.88E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs1535277	chr6:26567802	ZNF322B	chr9:99957633-99961910:-	0.59	11.41	7.49E-27	Educational attainment	
THCA	trans	1	rs1561962	chr9:100546219	BMPR1A	chr10:88516396-88684944:+	-0.24	-6.26	8.41E-10	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs1561962	chr9:100546219	CLDN2	chrX:106143394-106174091:+	0.27	6.17	1.48E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs1561962	chr9:100546219	EML5	chr14:89081205-89259157:-	0.3	6.97	1.07E-11	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs1561962	chr9:100546219	EPDR1	chr7:37960163-37991539:+	0.32	7.15	3.25E-12	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs1561962	chr9:100546219	GGT5	chr22:24615623-24641110:-	0.27	6.18	1.35E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs1561962	chr9:100546219	LRRC42	chr1:54412037-54433839:+	-0.24	-6.2	1.24E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs1561962	chr9:100546219	NKX6-1	chr4:85414436-85419387:-	0.49	8.65	8.04E-17	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs1561962	chr9:100546219	PLCE1	chr10:95753746-96088146:+	0.28	6.42	3.32E-10	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs1588635	chr9:100537802	EML5	chr14:89081205-89259157:-	0.31	6.79	3.31E-11	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs1588635	chr9:100537802	EPDR1	chr7:37960163-37991539:+	0.31	6.57	1.32E-10	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs1588635	chr9:100537802	LRRC42	chr1:54412037-54433839:+	-0.24	-6.02	3.56E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs1588635	chr9:100537802	NKX6-1	chr4:85414436-85419387:-	0.51	8.51	2.31E-16	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs1588635	chr9:100537802	PLCE1	chr10:95753746-96088146:+	0.29	6.38	4.1E-10	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs1591882	chr1:121183313	NBPF14	chr1:148003643-148346791:-	0.41	9.86	5.29E-21	Hip geometry	
THCA	trans	1	rs1679709	chr6:28228342	BTN3A2	chr6:26365398-26378546:+	0.5	9.8	9.06E-21	Depression	
THCA	trans	1	rs1679732	chr6:28221264	BTN3A2	chr6:26365398-26378546:+	0.51	9.93	3.09E-21	Depression	
THCA	trans	1	rs16958445	chr15:74176557	AGPAT1	chr6:32135990-32145842:-	0.66	6.3	6.94E-10	Exfoliation glaucoma or exfoliation syndrome	
THCA	trans	1	rs1778508	chr6:28229881	BTN3A2	chr6:26365398-26378546:+	0.49	9.66	2.76E-20	Depression	
THCA	trans	1	rs1778511	chr6:28229411	BTN3A2	chr6:26365398-26378546:+	0.5	9.8	9.06E-21	Depression	
THCA	trans	1	rs1814175	chr11:49559172	FOLH1B	chr11:89392465-89431885:+	-0.35	-6.41	3.48E-10	Height	
THCA	trans	1	rs1832558	chr1:121177380	NBPF14	chr1:148003643-148346791:-	0.4	9.31	4.82E-19	Hip geometry	
THCA	trans	1	rs1856572	chr1:121169579	NBPF14	chr1:148003643-148346791:-	0.44	10.31	1.2E-22	Hip geometry	
THCA	trans	1	rs1884946	chr6:26545308	ZNF322B	chr9:99957633-99961910:-	0.54	10.32	1.14E-22	Educational attainment	
THCA	trans	1	rs1884948	chr6:26567988	ZNF322B	chr9:99957633-99961910:-	0.59	11.41	7.49E-27	Educational attainment	
THCA	trans	1	rs1884949	chr6:26568067	ZNF322B	chr9:99957633-99961910:-	0.59	11.37	1.09E-26	Educational attainment	
THCA	trans	1	rs1896295	chr2:60724086	HBG1	chr11:5269502-5271087:-	-0.45	-6.35	4.9E-10	Beta thalassemia/hemoglobin E disease;F-cell distribution;Fetal hemoglobin levels;Hemoglobin A2 levels in sickle cell anemia;Sickle cell anemia (haemolysis)	
THCA	trans	1	rs1896296	chr2:60724087	HBG1	chr11:5269502-5271087:-	-0.45	-6.54	1.57E-10	Beta thalassemia/hemoglobin E disease;F-cell distribution;Fetal hemoglobin levels;Hemoglobin A2 levels in sickle cell anemia;Sickle cell anemia (haemolysis)	
THCA	trans	1	rs1936365	chr6:28268452	BTN3A2	chr6:26365398-26378546:+	0.46	9.05	3.49E-18	Depression	
THCA	trans	1	rs1945360	chr11:21846314	AKR7L	chr1:19592476-19600568:-	0.33	5.93	5.77E-9	Attention function in attention deficit hyperactive disorder	
THCA	trans	1	rs1979	chr6:26377591	RNF5P1	chr8:38457695-38458775:-	0.57	6.18	1.39E-9	Schizophrenia	
THCA	trans	1	rs1979	chr6:26377591	ZFP57	chr6:29640171-29648887:-	0.53	6	3.99E-9	Schizophrenia	
THCA	trans	1	rs1986111	chr1:121204788	NBPF14	chr1:148003643-148346791:-	0.44	10.38	6.72E-23	Hip geometry	
THCA	trans	1	rs199307	chr20:15177580	MACROD2	chr20:13976146-16033839:+	0.4	7.13	3.61E-12	Obesity-related traits	
THCA	trans	1	rs2084385	chr3:196553867	LOC646214	chr15:21932514-21940739:-	-0.47	-6.21	1.19E-9	Total ventricular volume (Alzheimer's disease interaction)	
THCA	trans	1	rs2084386	chr3:196554020	LOC646214	chr15:21932514-21940739:-	-0.55	-6.47	2.44E-10	Total ventricular volume (Alzheimer's disease interaction)	
THCA	trans	1	rs2185281	chr1:121179991	NBPF14	chr1:148003643-148346791:-	0.42	10.02	1.45E-21	Hip geometry	
THCA	trans	1	rs2208331	chr6:26507319	ZNF322B	chr9:99957633-99961910:-	0.55	10.32	1.08E-22	Educational attainment	
THCA	trans	1	rs2224380	chr6:26553943	ZNF322B	chr9:99957633-99961910:-	0.57	11.17	6.6E-26	Educational attainment	
THCA	trans	1	rs2255070	chr6:26501777	ZNF322B	chr9:99957633-99961910:-	0.54	10.2	3.09E-22	Educational attainment	
THCA	trans	1	rs2292239	chr12:56482180	RPS26P11	chrX:71264259-71264809:+	0.47	8.44	3.93E-16	Cognitive function	
THCA	trans	1	rs2319969	chr1:121207335	NBPF14	chr1:148003643-148346791:-	0.4	8.82	2.11E-17	Hip geometry	
THCA	trans	1	rs2393670	chr6:26535541	ZNF322B	chr9:99957633-99961910:-	0.54	10.29	1.42E-22	Educational attainment	
THCA	trans	1	rs2736371	chr8:11105529	SGK223	chr8:8175259-8239257:-	0.33	6.26	8.67E-10	Retinal vascular caliber	
THCA	trans	1	rs2799077	chr6:28234597	BTN3A2	chr6:26365398-26378546:+	-0.51	-9.96	2.38E-21	Depression	
THCA	trans	1	rs2799079	chr6:28235176	BTN3A2	chr6:26365398-26378546:+	-0.49	-9.62	3.95E-20	Depression	
THCA	trans	1	rs28558133	chr6:26531433	ZNF322B	chr9:99957633-99961910:-	0.54	10.29	1.42E-22	Educational attainment	
THCA	trans	1	rs3736781	chr6:26505362	ZNF322B	chr9:99957633-99961910:-	0.55	10.32	1.08E-22	Educational attainment	
THCA	trans	1	rs3736782	chr6:26505403	ZNF322B	chr9:99957633-99961910:-	0.55	10.32	1.08E-22	Educational attainment	
THCA	trans	1	rs41266839	chr6:26409890	ZFP57	chr6:29640171-29648887:-	0.91	7.48	3.61E-13	Schizophrenia	
THCA	trans	1	rs4284478	chr12:88907563	ATP6V1B1	chr2:71162998-71192560:+	-0.42	-5.97	4.56E-9	Testicular germ cell tumor	
THCA	trans	1	rs4533720	chr4:164959804	FOXJ2	chr12:8185359-8208117:+	-0.24	-5.88	7.82E-9	Urinary uromodulin levels	
THCA	trans	1	rs4671393	chr2:60720951	HBG1	chr11:5269502-5271087:-	-0.45	-6.42	3.33E-10	Beta thalassemia/hemoglobin E disease;F-cell distribution;Fetal hemoglobin levels;Hemoglobin A2 levels in sickle cell anemia;Sickle cell anemia (haemolysis)	
THCA	trans	1	rs4713006	chr6:26519872	ZNF322B	chr9:99957633-99961910:-	0.54	10.3	1.35E-22	Educational attainment	
THCA	trans	1	rs4713008	chr6:26538268	ZNF322B	chr9:99957633-99961910:-	0.54	10.31	1.21E-22	Educational attainment	
THCA	trans	1	rs4743130	chr9:100546040	ABCC11	chr16:48200822-48281479:-	0.29	5.9	6.75E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs4743130	chr9:100546040	BMPR1A	chr10:88516396-88684944:+	-0.24	-6.21	1.13E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs4743130	chr9:100546040	CENPJ	chr13:25456414-25497085:-	0.22	5.98	4.36E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs4743130	chr9:100546040	CLDN2	chrX:106143394-106174091:+	0.27	6.29	7.37E-10	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs4743130	chr9:100546040	EML5	chr14:89081205-89259157:-	0.29	6.79	3.32E-11	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs4743130	chr9:100546040	EPDR1	chr7:37960163-37991539:+	0.32	7.17	2.94E-12	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs4743130	chr9:100546040	GGT5	chr22:24615623-24641110:-	0.26	5.99	4.03E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs4743130	chr9:100546040	LRRC42	chr1:54412037-54433839:+	-0.24	-6.22	1.08E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs4743130	chr9:100546040	NKX6-1	chr4:85414436-85419387:-	0.5	8.8	2.53E-17	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs4743130	chr9:100546040	PLCE1	chr10:95753746-96088146:+	0.27	6.26	8.51E-10	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs4743131	chr9:100554907	BMPR1A	chr10:88516396-88684944:+	-0.24	-6.3	6.58E-10	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs4743131	chr9:100554907	CLDN2	chrX:106143394-106174091:+	0.26	6.02	3.46E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs4743131	chr9:100554907	EML5	chr14:89081205-89259157:-	0.3	6.88	1.9E-11	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs4743131	chr9:100554907	EPDR1	chr7:37960163-37991539:+	0.32	7.17	2.86E-12	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs4743131	chr9:100554907	GGT5	chr22:24615623-24641110:-	0.26	5.98	4.48E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs4743131	chr9:100554907	LRRC42	chr1:54412037-54433839:+	-0.23	-5.96	4.79E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs4743131	chr9:100554907	NKX6-1	chr4:85414436-85419387:-	0.48	8.35	7.4E-16	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs4743131	chr9:100554907	PLCE1	chr10:95753746-96088146:+	0.27	6.07	2.66E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs4759229	chr12:56474480	RPS26P11	chrX:71264259-71264809:+	-0.51	-9.13	1.91E-18	Cognitive function	
THCA	trans	1	rs479596	chr10:44760473	TWISTNB	chr7:19735085-19748660:-	-0.33	-5.99	4.25E-9	Coronary artery disease;Coronary heart disease	
THCA	trans	1	rs4844380	chr1:121193620	NBPF14	chr1:148003643-148346791:-	0.42	10	1.71E-21	Hip geometry	
THCA	trans	1	rs4844381	chr1:121184898	NBPF14	chr1:148003643-148346791:-	0.43	10.4	5.75E-23	Hip geometry	
THCA	trans	1	rs4844607	chr1:121184059	NBPF14	chr1:148003643-148346791:-	-0.42	-10.02	1.44E-21	Hip geometry	
THCA	trans	1	rs4844616	chr1:121171208	NBPF14	chr1:148003643-148346791:-	0.44	10.48	2.83E-23	Hip geometry	
THCA	trans	1	rs4871	chr6:26545632	ZNF322B	chr9:99957633-99961910:-	0.54	10.3	1.3E-22	Educational attainment	
THCA	trans	1	rs5751901	chr22:24992266	GGTLC2	chr22:22988782-22990368:+	-0.26	-6.12	1.92E-9	Protein quantitative trait loci	
THCA	trans	1	rs6456733	chr6:26566804	ZNF322B	chr9:99957633-99961910:-	0.59	11.41	7.49E-27	Educational attainment	
THCA	trans	1	rs6456734	chr6:26566965	ZNF322B	chr9:99957633-99961910:-	0.59	11.41	7.49E-27	Educational attainment	
THCA	trans	1	rs6483800	chr11:21846130	AKR7L	chr1:19592476-19600568:-	-0.32	-5.94	5.64E-9	Attention function in attention deficit hyperactive disorder	
THCA	trans	1	rs6600669	chr1:121213639	NBPF14	chr1:148003643-148346791:-	0.44	10.35	8.97E-23	Hip geometry	
THCA	trans	1	rs6600671	chr1:121200490	NBPF14	chr1:148003643-148346791:-	-0.38	-8.42	4.58E-16	Hip geometry	
THCA	trans	1	rs68141011	chr6:28217797	BTN3A2	chr6:26365398-26378546:+	-0.54	-10.42	4.69E-23	Depression	
THCA	trans	1	rs6886255	chr5:176718361	LOC388955	chr2:63849182-63850159:-	0.73	19.01	1.94E-60	Migraine without aura	
THCA	trans	1	rs6901575	chr6:28250984	BTN3A2	chr6:26365398-26378546:+	-0.5	-9.8	9.06E-21	Depression	
THCA	trans	1	rs6903973	chr6:26499942	ZNF322B	chr9:99957633-99961910:-	0.54	10.2	3.09E-22	Educational attainment	
THCA	trans	1	rs6905391	chr6:28262686	BTN3A2	chr6:26365398-26378546:+	-0.47	-9.24	7.9E-19	Depression	
THCA	trans	1	rs6910899	chr6:26524339	ZNF322B	chr9:99957633-99961910:-	0.54	10.3	1.35E-22	Educational attainment	
THCA	trans	1	rs6922824	chr6:26553815	ZNF322B	chr9:99957633-99961910:-	-0.57	-11.06	1.79E-25	Educational attainment	
THCA	trans	1	rs6924838	chr6:26571756	ZNF322B	chr9:99957633-99961910:-	0.59	11.32	1.79E-26	Educational attainment	
THCA	trans	1	rs6925703	chr6:26521589	ZNF322B	chr9:99957633-99961910:-	0.54	10.3	1.35E-22	Educational attainment	
THCA	trans	1	rs6925895	chr6:26572165	ZNF322B	chr9:99957633-99961910:-	0.59	11.32	1.79E-26	Educational attainment	
THCA	trans	1	rs6926629	chr6:26499903	ZNF322B	chr9:99957633-99961910:-	0.54	10.2	3.09E-22	Educational attainment	
THCA	trans	1	rs6930120	chr6:26555484	ZNF322B	chr9:99957633-99961910:-	0.57	11.04	2.09E-25	Educational attainment	
THCA	trans	1	rs6932156	chr6:26571506	ZNF322B	chr9:99957633-99961910:-	0.59	11.32	1.79E-26	Educational attainment	
THCA	trans	1	rs6933176	chr6:26540178	ZNF322B	chr9:99957633-99961910:-	0.54	10.32	1.12E-22	Educational attainment	
THCA	trans	1	rs6940053	chr6:26562122	ZNF322B	chr9:99957633-99961910:-	0.58	11.36	1.17E-26	Educational attainment	
THCA	trans	1	rs6940188	chr6:26562029	ZNF322B	chr9:99957633-99961910:-	0.58	11.36	1.27E-26	Educational attainment	
THCA	trans	1	rs7020976	chr9:100547972	BMPR1A	chr10:88516396-88684944:+	-0.24	-6.18	1.35E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7020976	chr9:100547972	CLDN2	chrX:106143394-106174091:+	0.26	6.06	2.81E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7020976	chr9:100547972	EML5	chr14:89081205-89259157:-	0.3	6.86	2.11E-11	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7020976	chr9:100547972	EPDR1	chr7:37960163-37991539:+	0.32	7.11	4.19E-12	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7020976	chr9:100547972	GGT5	chr22:24615623-24641110:-	0.26	5.94	5.54E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7020976	chr9:100547972	LRRC42	chr1:54412037-54433839:+	-0.23	-6.05	2.94E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7020976	chr9:100547972	NKX6-1	chr4:85414436-85419387:-	0.5	8.83	2.07E-17	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7020976	chr9:100547972	PLCE1	chr10:95753746-96088146:+	0.27	6.13	1.81E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7021576	chr9:100540541	CD302	chr2:160625141-160654766:-	0.24	5.98	4.43E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7021576	chr9:100540541	CLDN2	chrX:106143394-106174091:+	0.27	6.11	2.11E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7021576	chr9:100540541	EML5	chr14:89081205-89259157:-	0.3	6.77	3.71E-11	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7021576	chr9:100540541	EPDR1	chr7:37960163-37991539:+	0.32	7.06	5.96E-12	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7021576	chr9:100540541	GGT5	chr22:24615623-24641110:-	0.26	6.04	3.1E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7021576	chr9:100540541	LRRC42	chr1:54412037-54433839:+	-0.24	-6.3	6.58E-10	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7021576	chr9:100540541	NKX6-1	chr4:85414436-85419387:-	0.5	8.65	7.61E-17	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7021576	chr9:100540541	PLCE1	chr10:95753746-96088146:+	0.28	6.39	3.94E-10	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7027030	chr9:100550455	BMPR1A	chr10:88516396-88684944:+	-0.24	-6.27	8.15E-10	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7027030	chr9:100550455	CLDN2	chrX:106143394-106174091:+	0.26	6.07	2.61E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7027030	chr9:100550455	EML5	chr14:89081205-89259157:-	0.3	6.96	1.12E-11	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7027030	chr9:100550455	EPDR1	chr7:37960163-37991539:+	0.33	7.31	1.1E-12	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7027030	chr9:100550455	GGT5	chr22:24615623-24641110:-	0.26	6.06	2.78E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7027030	chr9:100550455	LRRC42	chr1:54412037-54433839:+	-0.23	-5.95	5.14E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7027030	chr9:100550455	MALL	chr2:110841452-110874143:-	0.29	5.91	6.44E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7027030	chr9:100550455	NKX6-1	chr4:85414436-85419387:-	0.49	8.55	1.71E-16	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7027030	chr9:100550455	PLCE1	chr10:95753746-96088146:+	0.27	6.15	1.6E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7027030	chr9:100550455	TTC8	chr14:89290497-89344334:+	0.24	5.97	4.67E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7028661	chr9:100538470	BMPR1A	chr10:88516396-88684944:+	-0.23	-6.01	3.77E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7028661	chr9:100538470	CLDN2	chrX:106143394-106174091:+	0.27	6.14	1.77E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7028661	chr9:100538470	EML5	chr14:89081205-89259157:-	0.3	6.89	1.76E-11	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7028661	chr9:100538470	EPDR1	chr7:37960163-37991539:+	0.31	6.8	3.13E-11	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7028661	chr9:100538470	GGT5	chr22:24615623-24641110:-	0.26	5.98	4.36E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7028661	chr9:100538470	LRRC42	chr1:54412037-54433839:+	-0.24	-6.3	6.82E-10	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7028661	chr9:100538470	NKX6-1	chr4:85414436-85419387:-	0.5	8.61	1.03E-16	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7028661	chr9:100538470	PLCE1	chr10:95753746-96088146:+	0.28	6.43	3.1E-10	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7030241	chr9:100550375	BMPR1A	chr10:88516396-88684944:+	-0.24	-6.19	1.26E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7030241	chr9:100550375	CLDN2	chrX:106143394-106174091:+	0.26	6.08	2.48E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7030241	chr9:100550375	EFNB2	chr13:107142098-107187337:-	-0.25	-5.87	7.95E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7030241	chr9:100550375	EML5	chr14:89081205-89259157:-	0.3	6.83	2.65E-11	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7030241	chr9:100550375	EPDR1	chr7:37960163-37991539:+	0.32	7.23	1.88E-12	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7030241	chr9:100550375	NKX6-1	chr4:85414436-85419387:-	0.5	8.61	1.08E-16	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7030241	chr9:100550375	PLCE1	chr10:95753746-96088146:+	0.26	5.99	4.14E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7030241	chr9:100550375	TTC8	chr14:89290497-89344334:+	0.24	6	3.88E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7030256	chr9:100535203	ABCC11	chr16:48200822-48281479:-	0.3	5.93	5.87E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7030256	chr9:100535203	BMPR1A	chr10:88516396-88684944:+	-0.24	-6.19	1.27E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7030256	chr9:100535203	CLDN2	chrX:106143394-106174091:+	0.27	6.17	1.48E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7030256	chr9:100535203	EFNB2	chr13:107142098-107187337:-	-0.26	-6	3.84E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7030256	chr9:100535203	EML5	chr14:89081205-89259157:-	0.3	6.76	4.15E-11	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7030256	chr9:100535203	EPDR1	chr7:37960163-37991539:+	0.34	7.51	2.96E-13	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7030256	chr9:100535203	GGT5	chr22:24615623-24641110:-	0.26	5.89	7.32E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7030256	chr9:100535203	LRRC42	chr1:54412037-54433839:+	-0.23	-6.05	2.96E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7030256	chr9:100535203	NKX6-1	chr4:85414436-85419387:-	0.51	8.85	1.75E-17	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7030280	chr9:100535267	ABCC11	chr16:48200822-48281479:-	0.3	6.04	3.02E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7030280	chr9:100535267	BMPR1A	chr10:88516396-88684944:+	-0.25	-6.4	3.81E-10	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7030280	chr9:100535267	CLDN2	chrX:106143394-106174091:+	0.26	6.14	1.72E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7030280	chr9:100535267	EFNB2	chr13:107142098-107187337:-	-0.25	-5.95	5.21E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7030280	chr9:100535267	EML5	chr14:89081205-89259157:-	0.3	6.84	2.41E-11	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7030280	chr9:100535267	EPDR1	chr7:37960163-37991539:+	0.34	7.6	1.58E-13	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7030280	chr9:100535267	GGT5	chr22:24615623-24641110:-	0.27	6.21	1.17E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7030280	chr9:100535267	LRRC42	chr1:54412037-54433839:+	-0.23	-6.03	3.21E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7030280	chr9:100535267	MALL	chr2:110841452-110874143:-	0.29	5.91	6.59E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7030280	chr9:100535267	NKX6-1	chr4:85414436-85419387:-	0.5	8.77	3.05E-17	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7030280	chr9:100535267	PLCE1	chr10:95753746-96088146:+	0.26	6.08	2.53E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7030280	chr9:100535267	SEMA5B	chr3:122628043-122747452:-	-0.31	-5.9	6.83E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7032019	chr9:100548144	BMPR1A	chr10:88516396-88684944:+	-0.24	-6.18	1.35E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7032019	chr9:100548144	CLDN2	chrX:106143394-106174091:+	0.26	6.06	2.81E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7032019	chr9:100548144	EML5	chr14:89081205-89259157:-	0.3	6.86	2.11E-11	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7032019	chr9:100548144	EPDR1	chr7:37960163-37991539:+	0.32	7.11	4.19E-12	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7032019	chr9:100548144	GGT5	chr22:24615623-24641110:-	0.26	5.94	5.54E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7032019	chr9:100548144	LRRC42	chr1:54412037-54433839:+	-0.23	-6.05	2.94E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7032019	chr9:100548144	NKX6-1	chr4:85414436-85419387:-	0.5	8.83	2.07E-17	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7032019	chr9:100548144	PLCE1	chr10:95753746-96088146:+	0.27	6.13	1.81E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7045138	chr9:100591463	NKX6-1	chr4:85414436-85419387:-	0.36	6.18	1.39E-9	Thyroid hormone levels	
THCA	trans	1	rs705696	chr12:56480648	RPS26P11	chrX:71264259-71264809:+	0.52	8.99	5.79E-18	Cognitive function	
THCA	trans	1	rs7129556	chr11:77300048	INTS4L1	chr7:64601603-64694599:+	-0.53	-8.02	8.41E-15	Weight loss (gastric bypass surgery)	
THCA	trans	1	rs7201498	chr16:20449449	ZMYND12	chr1:42896003-42921938:-	0.26	5.97	4.74E-9	Blood metabolite levels	
THCA	trans	1	rs72798038	chr16:50149163	NELF	chr9:140342025-140353786:-	0.45	5.91	6.53E-9	Esophageal cancer (squamous cell)	
THCA	trans	1	rs72798040	chr16:50149693	NELF	chr9:140342025-140353786:-	0.45	5.91	6.53E-9	Esophageal cancer (squamous cell)	
THCA	trans	1	rs72843784	chr6:26498758	ZFP57	chr6:29640171-29648887:-	0.93	7.82	3.48E-14	Schizophrenia	
THCA	trans	1	rs735765	chr6:28170297	BTN3A2	chr6:26365398-26378546:+	-0.56	-10.21	2.78E-22	Depression	
THCA	trans	1	rs735765	chr6:28170297	ZFP57	chr6:29640171-29648887:-	0.52	6.42	3.35E-10	Depression	
THCA	trans	1	rs7532615	chr1:121172840	NBPF14	chr1:148003643-148346791:-	-0.45	-10.44	3.88E-23	Hip geometry	
THCA	trans	1	rs76329678	chr5:49830286	LOC647121	chr1:121260910-121313686:+	-0.38	-7.89	2.09E-14	Schizophrenia	
THCA	trans	1	rs766432	chr2:60719970	HBG1	chr11:5269502-5271087:-	-0.46	-6.75	4.24E-11	Beta thalassemia/hemoglobin E disease;F-cell distribution;Fetal hemoglobin levels;Hemoglobin A2 levels in sickle cell anemia;Sickle cell anemia (haemolysis)	
THCA	trans	1	rs767471	chr6:26557854	ZNF322B	chr9:99957633-99961910:-	0.58	11.4	8.92E-27	Educational attainment	
THCA	trans	1	rs7740487	chr6:28216486	BTN3A2	chr6:26365398-26378546:+	-0.54	-10.42	4.69E-23	Depression	
THCA	trans	1	rs7824557	chr8:11104111	SGK223	chr8:8175259-8239257:-	0.34	6.58	1.25E-10	Retinal vascular caliber	
THCA	trans	1	rs7847663	chr9:100544868	BMPR1A	chr10:88516396-88684944:+	-0.24	-6.06	2.78E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7847663	chr9:100544868	CLDN2	chrX:106143394-106174091:+	0.27	6.15	1.61E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7847663	chr9:100544868	EML5	chr14:89081205-89259157:-	0.29	6.67	7.13E-11	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7847663	chr9:100544868	EPDR1	chr7:37960163-37991539:+	0.32	7.08	5.03E-12	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7847663	chr9:100544868	GGT5	chr22:24615623-24641110:-	0.26	5.99	4.23E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7847663	chr9:100544868	LRRC42	chr1:54412037-54433839:+	-0.24	-6.16	1.56E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7847663	chr9:100544868	NKX6-1	chr4:85414436-85419387:-	0.51	8.83	1.94E-17	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7847663	chr9:100544868	PLCE1	chr10:95753746-96088146:+	0.27	6.19	1.32E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7850258	chr9:100549013	BMPR1A	chr10:88516396-88684944:+	0.25	6.28	7.76E-10	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7850258	chr9:100549013	EML5	chr14:89081205-89259157:-	-0.31	-7.09	4.74E-12	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7850258	chr9:100549013	EPDR1	chr7:37960163-37991539:+	-0.32	-7.08	5.18E-12	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7850258	chr9:100549013	GGT5	chr22:24615623-24641110:-	-0.26	-6	3.98E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7850258	chr9:100549013	NKX6-1	chr4:85414436-85419387:-	-0.5	-8.49	2.62E-16	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7864322	chr9:100548934	BMPR1A	chr10:88516396-88684944:+	-0.24	-6.19	1.33E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7864322	chr9:100548934	CLDN2	chrX:106143394-106174091:+	0.26	6.07	2.56E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7864322	chr9:100548934	EML5	chr14:89081205-89259157:-	0.3	6.86	2.13E-11	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7864322	chr9:100548934	EPDR1	chr7:37960163-37991539:+	0.32	7.11	4.27E-12	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7864322	chr9:100548934	GGT5	chr22:24615623-24641110:-	0.26	5.95	5.33E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7864322	chr9:100548934	LRRC42	chr1:54412037-54433839:+	-0.23	-6.06	2.78E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7864322	chr9:100548934	NKX6-1	chr4:85414436-85419387:-	0.5	8.81	2.25E-17	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7864322	chr9:100548934	PLCE1	chr10:95753746-96088146:+	0.27	6.15	1.64E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs7903456	chr10:88919319	FAM35B	chr10:46897641-46939143:+	0.37	7.23	1.87E-12	Renal underexcretion gout;Gout	
THCA	trans	1	rs804280	chr8:11612698	SGK223	chr8:8175259-8239257:-	-0.36	-6.59	1.18E-10	Myopia (pathological)	
THCA	trans	1	rs853676	chr6:28299687	BTN3A2	chr6:26365398-26378546:+	-0.46	-8.87	1.52E-17	Depression	
THCA	trans	1	rs853678	chr6:28297313	BTN3A2	chr6:26365398-26378546:+	-0.44	-8.66	7.5E-17	Depression	
THCA	trans	1	rs853679	chr6:28296863	BTN3A2	chr6:26365398-26378546:+	-0.44	-8.66	7.5E-17	Depression	
THCA	trans	1	rs853685	chr6:28288785	BTN3A2	chr6:26365398-26378546:+	-0.45	-8.82	2.07E-17	Depression	
THCA	trans	1	rs853694	chr6:28279100	BTN3A2	chr6:26365398-26378546:+	-0.46	-9.11	2.31E-18	Depression	
THCA	trans	1	rs877636	chr12:56480583	RPS26P11	chrX:71264259-71264809:+	-0.49	-8.83	1.98E-17	Cognitive function	
THCA	trans	1	rs925488	chr9:100546391	ABCC11	chr16:48200822-48281479:-	0.3	6.11	2.02E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs925488	chr9:100546391	BMPR1A	chr10:88516396-88684944:+	-0.25	-6.49	2.21E-10	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs925488	chr9:100546391	C10orf47	chr10:11865397-11914274:+	-0.22	-5.9	6.99E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs925488	chr9:100546391	CLDN2	chrX:106143394-106174091:+	0.27	6.29	7.02E-10	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs925488	chr9:100546391	EFNB2	chr13:107142098-107187337:-	-0.26	-6.15	1.64E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs925488	chr9:100546391	EML5	chr14:89081205-89259157:-	0.3	6.97	1.05E-11	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs925488	chr9:100546391	EPDR1	chr7:37960163-37991539:+	0.33	7.3	1.18E-12	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs925488	chr9:100546391	GGT5	chr22:24615623-24641110:-	0.26	5.94	5.35E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs925488	chr9:100546391	LRRC42	chr1:54412037-54433839:+	-0.23	-5.93	5.85E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs925488	chr9:100546391	NKX6-1	chr4:85414436-85419387:-	0.5	8.7	5.46E-17	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs925488	chr9:100546391	PLCE1	chr10:95753746-96088146:+	0.27	6.17	1.49E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs925489	chr9:100546600	BMPR1A	chr10:88516396-88684944:+	-0.24	-6.28	7.82E-10	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs925489	chr9:100546600	CENPJ	chr13:25456414-25497085:-	0.22	5.9	6.96E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs925489	chr9:100546600	CLDN2	chrX:106143394-106174091:+	0.27	6.15	1.69E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs925489	chr9:100546600	EML5	chr14:89081205-89259157:-	0.3	6.89	1.77E-11	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs925489	chr9:100546600	EPDR1	chr7:37960163-37991539:+	0.32	7.09	4.78E-12	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs925489	chr9:100546600	GGT5	chr22:24615623-24641110:-	0.26	6.01	3.65E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs925489	chr9:100546600	LRRC42	chr1:54412037-54433839:+	-0.23	-6.1	2.25E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs925489	chr9:100546600	NKX6-1	chr4:85414436-85419387:-	0.5	8.69	5.66E-17	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs925489	chr9:100546600	PLCE1	chr10:95753746-96088146:+	0.27	6.23	1.01E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs9295695	chr6:26528250	ZNF322B	chr9:99957633-99961910:-	-0.54	-10.3	1.35E-22	Educational attainment	
THCA	trans	1	rs9357010	chr6:26527945	ZNF322B	chr9:99957633-99961910:-	0.55	10.43	4.54E-23	Educational attainment	
THCA	trans	1	rs9393728	chr6:26509330	ZNF322B	chr9:99957633-99961910:-	0.55	10.32	1.08E-22	Educational attainment	
THCA	trans	1	rs9393729	chr6:26514166	ZNF322B	chr9:99957633-99961910:-	0.54	10.3	1.35E-22	Educational attainment	
THCA	trans	1	rs9393731	chr6:26529374	ZNF322B	chr9:99957633-99961910:-	0.54	10.29	1.42E-22	Educational attainment	
THCA	trans	1	rs9393732	chr6:26530898	ZNF322B	chr9:99957633-99961910:-	0.54	10.29	1.42E-22	Educational attainment	
THCA	trans	1	rs9461259	chr6:26504835	ZNF322B	chr9:99957633-99961910:-	0.55	10.32	1.08E-22	Educational attainment	
THCA	trans	1	rs9461271	chr6:26554968	ZNF322B	chr9:99957633-99961910:-	0.57	11.17	6.6E-26	Educational attainment	
THCA	trans	1	rs9467773	chr6:26498426	ZNF322B	chr9:99957633-99961910:-	0.54	10.2	3.09E-22	Educational attainment	
THCA	trans	1	rs9467774	chr6:26505036	ZNF322B	chr9:99957633-99961910:-	0.55	10.32	1.08E-22	Educational attainment	
THCA	trans	1	rs9467778	chr6:26534743	ZNF322B	chr9:99957633-99961910:-	0.54	10.29	1.42E-22	Educational attainment	
THCA	trans	1	rs9467779	chr6:26536687	ZNF322B	chr9:99957633-99961910:-	-0.54	-10.29	1.48E-22	Educational attainment	
THCA	trans	1	rs9467782	chr6:26542773	ZNF322B	chr9:99957633-99961910:-	0.54	10.32	1.16E-22	Educational attainment	
THCA	trans	1	rs9467783	chr6:26542894	ZNF322B	chr9:99957633-99961910:-	0.53	9.98	2.0E-21	Educational attainment	
THCA	trans	1	rs9467787	chr6:26556769	ZNF322B	chr9:99957633-99961910:-	0.57	11.17	6.52E-26	Educational attainment	
THCA	trans	1	rs9467791	chr6:26562486	ZNF322B	chr9:99957633-99961910:-	-0.58	-11.07	1.71E-25	Educational attainment	
THCA	trans	1	rs9467796	chr6:26568411	ZNF322B	chr9:99957633-99961910:-	0.59	11.31	1.98E-26	Educational attainment	
THCA	trans	1	rs9467797	chr6:26568473	ZNF322B	chr9:99957633-99961910:-	0.59	11.31	1.98E-26	Educational attainment	
THCA	trans	1	rs965513	chr9:100556109	BMPR1A	chr10:88516396-88684944:+	-0.24	-6.3	6.58E-10	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs965513	chr9:100556109	CLDN2	chrX:106143394-106174091:+	0.26	6.02	3.46E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs965513	chr9:100556109	EML5	chr14:89081205-89259157:-	0.3	6.88	1.9E-11	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs965513	chr9:100556109	EPDR1	chr7:37960163-37991539:+	0.32	7.17	2.86E-12	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs965513	chr9:100556109	GGT5	chr22:24615623-24641110:-	0.26	5.98	4.48E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs965513	chr9:100556109	LRRC42	chr1:54412037-54433839:+	-0.23	-5.96	4.79E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs965513	chr9:100556109	NKX6-1	chr4:85414436-85419387:-	0.48	8.35	7.4E-16	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs965513	chr9:100556109	PLCE1	chr10:95753746-96088146:+	0.27	6.07	2.66E-9	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
THCA	trans	1	rs9986382	chr6:26550619	ZNF322B	chr9:99957633-99961910:-	0.57	11.02	2.67E-25	Educational attainment	
THCA	trans	1	rs9986596	chr6:28219661	BTN3A2	chr6:26365398-26378546:+	-0.54	-10.31	1.17E-22	Depression	
